id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
125087812|NCT04144140|449939250|FG000|Overall Study|Other|0|||
125087813|NCT04144140|449939251|FG001|Overall Study|Other|0|||
125087814|NCT04144140|449939252|FG002|Overall Study|Other|0|||
125087815|NCT04144140|449939253|FG003|Overall Study|Other|0|||
125087816|NCT04144140|449939254|FG004|Overall Study|Other|0|||
125087817|NCT04144140|449939255|FG005|Overall Study|Other|1|||
125087818|NCT04144140|449939256|FG006|Overall Study|Other|0|||
125087819|NCT00959192|449939261|FG000|Overall Study|Adverse Event|1|||
125087820|NCT00959192|449939262|FG001|Overall Study|Adverse Event|1|||
125087821|NCT00959192|449939263|FG002|Overall Study|Adverse Event|1|||
125087822|NCT00959192|449939264|FG003|Overall Study|Adverse Event|0|||
125087823|NCT00959192|449939261|FG000|Overall Study|Investigator Request|1|||
125087824|NCT00959192|449939262|FG001|Overall Study|Investigator Request|0|||
125087825|NCT00959192|449939263|FG002|Overall Study|Investigator Request|0|||
125087826|NCT00959192|449939264|FG003|Overall Study|Investigator Request|0|||
125087827|NCT00959192|449939261|FG000|Overall Study|Caregiver Request|0|||
125087828|NCT00959192|449939262|FG001|Overall Study|Caregiver Request|0|||
125087829|NCT00959192|449939263|FG002|Overall Study|Caregiver Request|2|||
125087830|NCT00959192|449939264|FG003|Overall Study|Caregiver Request|1|||
125087831|NCT01967134|449939265|FG000|Overall Study|Lost to Follow-up|0|||
125087832|NCT01967134|449939266|FG001|Overall Study|Lost to Follow-up|1|||
125087833|NCT01967134|449939267|FG002|Overall Study|Lost to Follow-up|0|||
125087834|NCT00443534|449939268|FG000|Overall Study|Lack of Efficacy|67|||
125087835|NCT00443534|449939268|FG000|Overall Study|Adverse Event|16|||
125087836|NCT00443534|449939268|FG000|Overall Study|Death|9|||
125087837|NCT00443534|449939268|FG000|Overall Study|Withdrawal by Subject|8|||
125087838|NCT00443534|449939268|FG000|Overall Study|Study Terminated by Sponsor|12|||
125087839|NCT00443534|449939268|FG000|Overall Study|Other|10|||
125087840|NCT00443534|449939268|FG000|Overall Study|Enrolled, Not Treated|1|||
125087841|NCT00364611|449939269|FG000|Overall Study|Did not receive study medication|0|||
125087842|NCT00364611|449939270|FG001|Overall Study|Did not receive study medication|1|||
125087843|NCT00364611|449939269|FG000|Overall Study|Adverse Event|7|||
125087844|NCT00364611|449939270|FG001|Overall Study|Adverse Event|4|||
125087845|NCT00364611|449939269|FG000|Overall Study|Participant's Request|3|||
125087846|NCT00364611|449939270|FG001|Overall Study|Participant's Request|4|||
125087847|NCT00364611|449939269|FG000|Overall Study|Disease Progression|38|||
125087848|NCT00364611|449939270|FG001|Overall Study|Disease Progression|8|||
125087849|NCT00364611|449939269|FG000|Overall Study|Investigator decision|2|||
125087850|NCT00364611|449939270|FG001|Overall Study|Investigator decision|2|||
125087851|NCT00364611|449939269|FG000|Overall Study|Found Ineligible|1|||
125087852|NCT00364611|449939270|FG001|Overall Study|Found Ineligible|0|||
125087853|NCT00364611|449939269|FG000|Overall Study|Presumed CR on Study|0|||
125087854|NCT00364611|449939270|FG001|Overall Study|Presumed CR on Study|1|||
125087855|NCT00364611|449939269|FG000|Overall Study|Receiving Liver Ablation|0|||
125087856|NCT00364611|449939270|FG001|Overall Study|Receiving Liver Ablation|1|||
125087857|NCT05466240|449939271|FG000|Overall Study|Adverse Event|1|||
125087858|NCT05466240|449939272|FG001|Overall Study|Adverse Event|0|||
125087859|NCT05466240|449939271|FG000|Overall Study|Withdrawal by Subject|1|||
125087860|NCT05466240|449939272|FG001|Overall Study|Withdrawal by Subject|0|||
125087861|NCT00305773|449939273|FG000|Overall Study|Death|3|||
125087862|NCT00305773|449939274|FG001|Overall Study|Death|2|||
125087863|NCT00305773|449939273|FG000|Overall Study|Adverse Event|1|||
125087864|NCT00305773|449939274|FG001|Overall Study|Adverse Event|2|||
125087865|NCT00305773|449939273|FG000|Overall Study|Alternative Treatment|4|||
125087866|NCT00305773|449939274|FG001|Overall Study|Alternative Treatment|4|||
125087867|NCT00305773|449939273|FG000|Overall Study|Physician Decision|1|||
125087868|NCT00305773|449939274|FG001|Overall Study|Physician Decision|1|||
125087869|NCT00305773|449939273|FG000|Overall Study|Withdrawal by Subject|1|||
125087870|NCT00305773|449939274|FG001|Overall Study|Withdrawal by Subject|4|||
125087871|NCT00305773|449939273|FG000|Overall Study|Disease Progression|1|||
125087872|NCT00305773|449939274|FG001|Overall Study|Disease Progression|3|||
125087873|NCT00305773|449939273|FG000|Overall Study|All other reasons|3|||
125087874|NCT00305773|449939274|FG001|Overall Study|All other reasons|2|||
125087875|NCT04097925|449939275|FG000|Overall Study|Withdrawal by Subject|1|||
125087876|NCT02679222|449939276|FG000|Overall Study|No time for project|1|||
125087877|NCT04735432|449939280|FG000|Overall Study|Other - due to personal reason|1|||
125087878|NCT04735432|449939281|FG001|Overall Study|Other - due to personal reason|0|||
124976632|NCT03838731|449541849|FG000|Overall Study|Pregnancy|0|||
124865365|NCT02119260|449128732|FG000|Overall Study|Adverse Event|1|||
125087879|NCT04735432|449939280|FG000|Overall Study|Adverse Event|2|||
124865366|NCT02119260|449128733|FG001|Overall Study|Adverse Event|0|||
124865367|NCT02119260|449128734|FG002|Overall Study|Adverse Event|0|||
125087880|NCT04735432|449939281|FG001|Overall Study|Adverse Event|0|||
125087881|NCT04397757|449939282|FG000|Overall Study|Death|3|||
125087882|NCT04397757|449939283|FG001|Overall Study|Death|11|||
125087883|NCT04397757|449939282|FG000|Overall Study|Withdrawal by Subject|2|||
124976633|NCT03838731|449541850|FG001|Overall Study|Pregnancy|1|||
125087884|NCT04397757|449939283|FG001|Overall Study|Withdrawal by Subject|0|||
125087885|NCT04397757|449939282|FG000|Overall Study|Lost to Follow-up|4|||
125087886|NCT04397757|449939283|FG001|Overall Study|Lost to Follow-up|3|||
125087887|NCT00413231|449939284|FG000|0 to 30-day Post Treatment|Death|5|||
125087888|NCT00413231|449939284|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
125087889|NCT00413231|449939284|FG000|30-day to 365-day Post Treatment|Death|13|||
125087890|NCT00413231|449939284|FG000|365-day to 60-month Post Treatment|Death|36|||
125087891|NCT00413231|449939284|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
125087892|NCT00413231|449939284|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
125087893|NCT00413231|449939284|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
125087894|NCT00945945|449939285|FG000|Overall Study|Adverse Event|15|||
125087895|NCT00945945|449939286|FG001|Overall Study|Adverse Event|35|||
125087896|NCT00945945|449939285|FG000|Overall Study|Withdrawal by Subject|7|||
125087897|NCT00945945|449939286|FG001|Overall Study|Withdrawal by Subject|10|||
125087898|NCT00945945|449939285|FG000|Overall Study|Lost to Follow-up|4|||
124865368|NCT02119260|449128735|FG003|Overall Study|Adverse Event|0|||
124865369|NCT02119260|449128736|FG004|Overall Study|Adverse Event|0|||
124865370|NCT02119260|449128737|FG005|Overall Study|Adverse Event|0|||
124865371|NCT02119260|449128738|FG006|Overall Study|Adverse Event|0|||
124865372|NCT02119260|449128732|FG000|Overall Study|Withdrew consent|0|||
124865373|NCT02119260|449128733|FG001|Overall Study|Withdrew consent|1|||
124865374|NCT02119260|449128734|FG002|Overall Study|Withdrew consent|1|||
124865375|NCT02119260|449128735|FG003|Overall Study|Withdrew consent|0|||
124865376|NCT02119260|449128736|FG004|Overall Study|Withdrew consent|0|||
124865377|NCT02119260|449128737|FG005|Overall Study|Withdrew consent|0|||
124865378|NCT02119260|449128738|FG006|Overall Study|Withdrew consent|0|||
124865379|NCT01738984|449128739|FG000|Overall Study|Pregnancy|4|||
124865380|NCT01738984|449128740|FG001|Overall Study|Pregnancy|0|||
124865381|NCT01738984|449128739|FG000|Overall Study|Withdrawal by Subject|1|||
124865382|NCT01738984|449128740|FG001|Overall Study|Withdrawal by Subject|0|||
124865383|NCT01738984|449128739|FG000|Overall Study|Lost to Follow-up|59|||
124865384|NCT01738984|449128740|FG001|Overall Study|Lost to Follow-up|39|||
124865385|NCT00857207|449128741|FG000|Overall Study|Withdrawal by Subject|13|||
124865386|NCT00857207|449128742|FG001|Overall Study|Withdrawal by Subject|0|||
124865387|NCT00857207|449128741|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
124865388|NCT00857207|449128742|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
124865389|NCT00857207|449128741|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
124865390|NCT00857207|449128742|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
124865391|NCT00447057|449128747|FG000|Overall Study|Adverse Event|4|||
124865392|NCT00447057|449128748|FG001|Overall Study|Adverse Event|10|||
124865393|NCT00447057|449128749|FG002|Overall Study|Adverse Event|0|||
124865394|NCT00447057|449128750|FG003|Overall Study|Adverse Event|3|||
124865395|NCT00447057|449128747|FG000|Overall Study|Death due to study disease|6|||
124865396|NCT00447057|449128748|FG001|Overall Study|Death due to study disease|4|||
124865397|NCT00447057|449128749|FG002|Overall Study|Death due to study disease|1|||
124865398|NCT00447057|449128750|FG003|Overall Study|Death due to study disease|1|||
124865399|NCT00447057|449128747|FG000|Overall Study|Lost to Follow-up|0|||
124865400|NCT00447057|449128748|FG001|Overall Study|Lost to Follow-up|1|||
124865401|NCT00447057|449128749|FG002|Overall Study|Lost to Follow-up|0|||
124865402|NCT00447057|449128750|FG003|Overall Study|Lost to Follow-up|0|||
124865403|NCT00447057|449128747|FG000|Overall Study|Entry criteria not met|1|||
124865404|NCT00447057|449128748|FG001|Overall Study|Entry criteria not met|1|||
124865405|NCT00447057|449128749|FG002|Overall Study|Entry criteria not met|0|||
124865406|NCT00447057|449128750|FG003|Overall Study|Entry criteria not met|0|||
124865407|NCT00447057|449128747|FG000|Overall Study|Protocol Violation|0|||
124865408|NCT00447057|449128748|FG001|Overall Study|Protocol Violation|1|||
124865409|NCT00447057|449128749|FG002|Overall Study|Protocol Violation|0|||
124865410|NCT00447057|449128750|FG003|Overall Study|Protocol Violation|0|||
124865411|NCT00447057|449128747|FG000|Overall Study|Withdrawal by Subject|4|||
124865412|NCT00447057|449128748|FG001|Overall Study|Withdrawal by Subject|5|||
124865413|NCT00447057|449128749|FG002|Overall Study|Withdrawal by Subject|1|||
124865414|NCT00447057|449128750|FG003|Overall Study|Withdrawal by Subject|1|||
124865415|NCT00447057|449128747|FG000|Overall Study|Physician Decision|9|||
124865416|NCT00447057|449128748|FG001|Overall Study|Physician Decision|6|||
124865417|NCT00447057|449128749|FG002|Overall Study|Physician Decision|3|||
124865418|NCT00447057|449128750|FG003|Overall Study|Physician Decision|1|||
124865419|NCT00447057|449128747|FG000|Overall Study|Sponsor decision|1|||
124865420|NCT00447057|449128748|FG001|Overall Study|Sponsor decision|1|||
124865421|NCT00447057|449128749|FG002|Overall Study|Sponsor decision|0|||
124865422|NCT00447057|449128750|FG003|Overall Study|Sponsor decision|0|||
124865423|NCT00447057|449128747|FG000|Overall Study|Progressive disease|58|||
125087899|NCT00945945|449939286|FG001|Overall Study|Lost to Follow-up|5|||
124865424|NCT00447057|449128748|FG001|Overall Study|Progressive disease|43|||
124865425|NCT00447057|449128749|FG002|Overall Study|Progressive disease|13|||
124865426|NCT00447057|449128750|FG003|Overall Study|Progressive disease|18|||
124865427|NCT00447057|449128747|FG000|Overall Study|Death due to adverse event|0|||
124865428|NCT00447057|449128748|FG001|Overall Study|Death due to adverse event|0|||
124865429|NCT00447057|449128749|FG002|Overall Study|Death due to adverse event|1|||
124969460|NCT01377389|449517397|FG000|Overall Study|Screen failure|2|||
124865430|NCT00447057|449128750|FG003|Overall Study|Death due to adverse event|2|||
124865431|NCT00447057|449128747|FG000|Overall Study|Death, study drug related|0|||
124865432|NCT00447057|449128748|FG001|Overall Study|Death, study drug related|1|||
124865433|NCT00447057|449128749|FG002|Overall Study|Death, study drug related|0|||
124865434|NCT00447057|449128750|FG003|Overall Study|Death, study drug related|0|||
124865435|NCT00440531|449128751|FG000|Overall Study|Adverse Event|1|||
124976634|NCT03838731|449541849|FG000|Overall Study|Withdrawal of consent|1|||
125087900|NCT00945945|449939285|FG000|Overall Study|Lack of Efficacy|6|||
125087901|NCT00945945|449939286|FG001|Overall Study|Lack of Efficacy|2|||
125087902|NCT00945945|449939285|FG000|Overall Study|Protocol Violation|4|||
125087903|NCT00945945|449939286|FG001|Overall Study|Protocol Violation|2|||
125087904|NCT00945945|449939285|FG000|Overall Study|Entry Criteria Not Met|0|||
125087905|NCT00945945|449939286|FG001|Overall Study|Entry Criteria Not Met|1|||
125087906|NCT01823991|449939287|FG000|Overall Study|Withdrawal by Subject|8|||
125087907|NCT01823991|449939288|FG001|Overall Study|Withdrawal by Subject|5|||
125087908|NCT05158244|449939289|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
125087909|NCT05158244|449939290|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
125087910|NCT05158244|449939291|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
125087911|NCT05158244|449939292|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
125087912|NCT05158244|449939293|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
125198603|NCT00199797|450350976|FG000|Overall Study|Progressive Disease|1|||
125309893|NCT02871635|450761923|FG000|Overall Study|Primary lack of efficacy|4|||
125309894|NCT02871635|450761924|FG001|Overall Study|Primary lack of efficacy|4|||
125309895|NCT02871635|450761923|FG000|Overall Study|Protocol Violation|3|||
125309896|NCT02871635|450761924|FG001|Overall Study|Protocol Violation|1|||
125309897|NCT02871635|450761923|FG000|Overall Study|Lost to Follow-up|1|||
125309898|NCT02871635|450761924|FG001|Overall Study|Lost to Follow-up|2|||
125309899|NCT02871635|450761923|FG000|Overall Study|Pregnancy|0|||
125309900|NCT02871635|450761924|FG001|Overall Study|Pregnancy|2|||
125309901|NCT02871635|450761923|FG000|Overall Study|Physician Decision|1|||
125309902|NCT02871635|450761924|FG001|Overall Study|Physician Decision|1|||
125309903|NCT02871635|450761923|FG000|Overall Study|Withdrawal by Subject|3|||
125309904|NCT02871635|450761924|FG001|Overall Study|Withdrawal by Subject|4|||
125309905|NCT02871635|450761923|FG000|Overall Study|Adverse Event|4|||
125309906|NCT02871635|450761924|FG001|Overall Study|Adverse Event|4|||
125309907|NCT02871635|450761923|FG000|Overall Study|Secondary lack of efficacy|2|||
125309908|NCT02871635|450761924|FG001|Overall Study|Secondary lack of efficacy|1|||
125309909|NCT02420379|450761925|FG000|Overall Study|Withdrawal by Subject|0|||
125309910|NCT02420379|450761926|FG001|Overall Study|Withdrawal by Subject|3|||
125309911|NCT02420379|450761925|FG000|Overall Study|Unable to complete due to schooling|0|||
125309912|NCT02420379|450761926|FG001|Overall Study|Unable to complete due to schooling|1|||
125309913|NCT02420379|450761925|FG000|Overall Study|Transitioned to commercial drug|1|||
125309914|NCT02420379|450761926|FG001|Overall Study|Transitioned to commercial drug|0|||
125309915|NCT00502671|450761927|FG000|Overall Study|Disease Progression|13|||
125309916|NCT00502671|450761927|FG000|Overall Study|Personal Reasons|22|||
125309917|NCT00502671|450761927|FG000|Overall Study|Lost to Follow-up|7|||
125309918|NCT00502671|450761927|FG000|Overall Study|Protocol Violation|16|||
125309919|NCT00502671|450761927|FG000|Overall Study|Adverse Event|19|||
125309920|NCT00412893|450761936|FG000|Overall Study|Adverse Event|31|||
125309921|NCT00412893|450761937|FG001|Overall Study|Adverse Event|53|||
125309922|NCT00412893|450761936|FG000|Overall Study|Death|17|||
125309923|NCT00412893|450761937|FG001|Overall Study|Death|21|||
125309924|NCT00412893|450761936|FG000|Overall Study|Insufficient Therapeutic Response|39|||
125309925|NCT00412893|450761937|FG001|Overall Study|Insufficient Therapeutic Response|23|||
125309926|NCT00412893|450761936|FG000|Overall Study|Lost to Follow-up|2|||
125309927|NCT00412893|450761937|FG001|Overall Study|Lost to Follow-up|1|||
125309928|NCT00412893|450761936|FG000|Overall Study|Violation of Selection at Entry|17|||
125309929|NCT00412893|450761937|FG001|Overall Study|Violation of Selection at Entry|10|||
125309930|NCT00412893|450761936|FG000|Overall Study|Other Protocol Violation|10|||
125309931|NCT00412893|450761937|FG001|Overall Study|Other Protocol Violation|6|||
125309932|NCT00412893|450761936|FG000|Overall Study|Did Not Cooperate|12|||
125309933|NCT00412893|450761937|FG001|Overall Study|Did Not Cooperate|9|||
125309934|NCT00412893|450761936|FG000|Overall Study|Administrative Reason|12|||
125309935|NCT00412893|450761937|FG001|Overall Study|Administrative Reason|15|||
125309936|NCT00412893|450761936|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
125309937|NCT00412893|450761937|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
125309938|NCT00853151|450761938|FG000|Overall Study|Adverse Event|1|||
125309939|NCT00853151|450761939|FG001|Overall Study|Adverse Event|4|||
125309940|NCT00853151|450761940|FG002|Overall Study|Adverse Event|2|||
125309941|NCT00853151|450761941|FG003|Overall Study|Adverse Event|0|||
125309942|NCT00853151|450761938|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
125309943|NCT00853151|450761939|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124865436|NCT00440531|449128752|FG001|Overall Study|Adverse Event|0|||
124865437|NCT00440531|449128753|FG002|Overall Study|Adverse Event|2|||
125309944|NCT00853151|450761940|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124865438|NCT00440531|449128751|FG000|Overall Study|Withdrawal by Subject|2|||
124865439|NCT00440531|449128752|FG001|Overall Study|Withdrawal by Subject|0|||
124865440|NCT00440531|449128753|FG002|Overall Study|Withdrawal by Subject|0|||
125087913|NCT05158244|449939289|FG000|Overall Study|Withdrawal by Subject|0|||
125087914|NCT05158244|449939290|FG001|Overall Study|Withdrawal by Subject|0|||
124865441|NCT00440531|449128751|FG000|Overall Study|Protocol Violation|1|||
124976635|NCT03838731|449541850|FG001|Overall Study|Withdrawal of consent|0|||
124976636|NCT00603525|449541856|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
124976637|NCT00603525|449541857|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
124865442|NCT00440531|449128752|FG001|Overall Study|Protocol Violation|2|||
124865443|NCT00440531|449128753|FG002|Overall Study|Protocol Violation|0|||
124865444|NCT00440531|449128751|FG000|Overall Study|Lost to Follow-up|4|||
124865445|NCT00440531|449128752|FG001|Overall Study|Lost to Follow-up|3|||
124865446|NCT00440531|449128753|FG002|Overall Study|Lost to Follow-up|5|||
124865447|NCT00440531|449128751|FG000|Overall Study|see pre-assignment details|2|||
124865448|NCT00440531|449128752|FG001|Overall Study|see pre-assignment details|0|||
124865449|NCT00440531|449128753|FG002|Overall Study|see pre-assignment details|0|||
124865450|NCT02181803|449128756|FG000|Overall Study|Withdrawal by Subject|0|||
124865451|NCT02181803|449128757|FG001|Overall Study|Withdrawal by Subject|2|||
125087915|NCT05158244|449939291|FG002|Overall Study|Withdrawal by Subject|1|||
125087916|NCT05158244|449939292|FG003|Overall Study|Withdrawal by Subject|0|||
125087917|NCT05158244|449939293|FG004|Overall Study|Withdrawal by Subject|0|||
125087918|NCT01066819|449939295|FG000|Overall Study|Adverse Event|18|||
125087919|NCT01066819|449939296|FG001|Overall Study|Adverse Event|1|||
125087920|NCT01066819|449939297|FG002|Overall Study|Adverse Event|6|||
125087921|NCT01066819|449939298|FG003|Overall Study|Adverse Event|0|||
125087922|NCT01066819|449939299|FG004|Overall Study|Adverse Event|0|||
125087923|NCT01066819|449939300|FG005|Overall Study|Adverse Event|0|||
125087924|NCT01066819|449939295|FG000|Overall Study|Death|5|||
125087925|NCT01066819|449939296|FG001|Overall Study|Death|0|||
125087926|NCT01066819|449939297|FG002|Overall Study|Death|1|||
124865452|NCT02181803|449128758|FG002|Overall Study|Withdrawal by Subject|0|||
124865453|NCT02181803|449128759|FG003|Overall Study|Withdrawal by Subject|0|||
124976638|NCT00603525|449541858|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
124976639|NCT00603525|449541856|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
124976640|NCT00603525|449541857|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
124976641|NCT00603525|449541858|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
124976642|NCT00603525|449541856|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
124976643|NCT00603525|449541857|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
124976644|NCT00603525|449541858|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
124976645|NCT00603525|449541856|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
124976646|NCT00603525|449541857|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
124976647|NCT00603525|449541858|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124976648|NCT00603525|449541856|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
124976649|NCT00603525|449541857|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
124976650|NCT00603525|449541858|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124976651|NCT00603525|449541856|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
124976652|NCT00603525|449541857|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
124976653|NCT00603525|449541858|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
124976654|NCT00603525|449541856|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
124976655|NCT00603525|449541857|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
124865454|NCT02181803|449128760|FG004|Overall Study|Withdrawal by Subject|0|||
124865455|NCT02181803|449128761|FG005|Overall Study|Withdrawal by Subject|0|||
124865456|NCT02181803|449128762|FG006|Overall Study|Withdrawal by Subject|0|||
124976656|NCT00603525|449541858|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
124976657|NCT00603525|449541856|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
124976658|NCT00603525|449541857|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
124976659|NCT00603525|449541858|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
124976660|NCT00603525|449541856|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
124976661|NCT00603525|449541857|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
124976662|NCT00603525|449541858|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
124976663|NCT00603525|449541856|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
124976664|NCT00603525|449541857|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
124976665|NCT00603525|449541858|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
125087927|NCT01066819|449939298|FG003|Overall Study|Death|0|||
125087928|NCT01066819|449939299|FG004|Overall Study|Death|0|||
125198604|NCT00199797|450350976|FG000|Overall Study|Adverse Event|1|||
124865457|NCT02181803|449128763|FG007|Overall Study|Withdrawal by Subject|0|||
124865458|NCT02181803|449128764|FG008|Overall Study|Withdrawal by Subject|0|||
124865459|NCT02181803|449128756|FG000|Overall Study|Physician Decision|0|||
124865460|NCT02181803|449128757|FG001|Overall Study|Physician Decision|0|||
124865461|NCT02181803|449128758|FG002|Overall Study|Physician Decision|0|||
125087929|NCT01066819|449939300|FG005|Overall Study|Death|0|||
125087930|NCT01066819|449939295|FG000|Overall Study|Lack of Efficacy|22|||
125087931|NCT01066819|449939296|FG001|Overall Study|Lack of Efficacy|1|||
124865462|NCT02181803|449128759|FG003|Overall Study|Physician Decision|1|||
125087932|NCT01066819|449939297|FG002|Overall Study|Lack of Efficacy|2|||
125087933|NCT01066819|449939298|FG003|Overall Study|Lack of Efficacy|1|||
125087934|NCT01066819|449939299|FG004|Overall Study|Lack of Efficacy|0|||
125087935|NCT01066819|449939300|FG005|Overall Study|Lack of Efficacy|0|||
125087936|NCT01066819|449939295|FG000|Overall Study|Physician Decision|6|||
125087937|NCT01066819|449939296|FG001|Overall Study|Physician Decision|2|||
125087938|NCT01066819|449939297|FG002|Overall Study|Physician Decision|3|||
125087939|NCT01066819|449939298|FG003|Overall Study|Physician Decision|0|||
125087940|NCT01066819|449939299|FG004|Overall Study|Physician Decision|0|||
125087941|NCT01066819|449939300|FG005|Overall Study|Physician Decision|0|||
125087942|NCT01066819|449939295|FG000|Overall Study|Protocol Violation|12|||
125087943|NCT01066819|449939296|FG001|Overall Study|Protocol Violation|6|||
125087944|NCT01066819|449939297|FG002|Overall Study|Protocol Violation|0|||
125087945|NCT01066819|449939298|FG003|Overall Study|Protocol Violation|0|||
125087946|NCT01066819|449939299|FG004|Overall Study|Protocol Violation|0|||
125087947|NCT01066819|449939300|FG005|Overall Study|Protocol Violation|0|||
125087948|NCT01066819|449939295|FG000|Overall Study|Withdrawal by Subject|29|||
125087949|NCT01066819|449939296|FG001|Overall Study|Withdrawal by Subject|11|||
125087950|NCT01066819|449939297|FG002|Overall Study|Withdrawal by Subject|6|||
125087951|NCT01066819|449939298|FG003|Overall Study|Withdrawal by Subject|0|||
125087952|NCT01066819|449939299|FG004|Overall Study|Withdrawal by Subject|0|||
125087953|NCT01066819|449939300|FG005|Overall Study|Withdrawal by Subject|0|||
125087954|NCT01066819|449939295|FG000|Overall Study|Administrative|6|||
125087955|NCT01066819|449939296|FG001|Overall Study|Administrative|4|||
125087956|NCT01066819|449939297|FG002|Overall Study|Administrative|2|||
125087957|NCT01066819|449939298|FG003|Overall Study|Administrative|0|||
125087958|NCT01066819|449939299|FG004|Overall Study|Administrative|0|||
125087959|NCT01066819|449939300|FG005|Overall Study|Administrative|0|||
125087960|NCT01066819|449939295|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
125087961|NCT01066819|449939296|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
125087962|NCT01066819|449939297|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
125087963|NCT01066819|449939298|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
125087964|NCT01066819|449939299|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
125087965|NCT01066819|449939300|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
125087966|NCT01066819|449939295|FG000|Overall Study|Early termination|2|||
125087967|NCT01066819|449939296|FG001|Overall Study|Early termination|0|||
125087968|NCT01066819|449939297|FG002|Overall Study|Early termination|0|||
125087969|NCT01066819|449939298|FG003|Overall Study|Early termination|0|||
125087970|NCT01066819|449939299|FG004|Overall Study|Early termination|0|||
125087971|NCT01066819|449939300|FG005|Overall Study|Early termination|0|||
125087972|NCT01066819|449939295|FG000|Overall Study|Failed to return|298|||
125087973|NCT01066819|449939296|FG001|Overall Study|Failed to return|107|||
125087974|NCT01066819|449939297|FG002|Overall Study|Failed to return|68|||
125087975|NCT01066819|449939298|FG003|Overall Study|Failed to return|7|||
125087976|NCT01066819|449939299|FG004|Overall Study|Failed to return|2|||
125087977|NCT01066819|449939300|FG005|Overall Study|Failed to return|3|||
125087978|NCT01066819|449939295|FG000|Overall Study|Lab test not done|9|||
125087979|NCT01066819|449939296|FG001|Overall Study|Lab test not done|0|||
125087980|NCT01066819|449939297|FG002|Overall Study|Lab test not done|2|||
125087981|NCT01066819|449939298|FG003|Overall Study|Lab test not done|1|||
125087982|NCT01066819|449939299|FG004|Overall Study|Lab test not done|0|||
125087983|NCT01066819|449939300|FG005|Overall Study|Lab test not done|0|||
125087984|NCT01066819|449939295|FG000|Overall Study|Miscellaneous|28|||
125087985|NCT01066819|449939296|FG001|Overall Study|Miscellaneous|10|||
125087986|NCT01066819|449939297|FG002|Overall Study|Miscellaneous|18|||
124865463|NCT02181803|449128760|FG004|Overall Study|Physician Decision|0|||
124865464|NCT02181803|449128761|FG005|Overall Study|Physician Decision|0|||
124865465|NCT02181803|449128762|FG006|Overall Study|Physician Decision|0|||
124865466|NCT02181803|449128763|FG007|Overall Study|Physician Decision|1|||
124865467|NCT02181803|449128764|FG008|Overall Study|Physician Decision|0|||
124865468|NCT02181803|449128756|FG000|Overall Study|Adverse Event|0|||
124865469|NCT02181803|449128757|FG001|Overall Study|Adverse Event|2|||
124865470|NCT02181803|449128758|FG002|Overall Study|Adverse Event|0|||
124865471|NCT02181803|449128759|FG003|Overall Study|Adverse Event|1|||
124865472|NCT02181803|449128760|FG004|Overall Study|Adverse Event|0|||
124865473|NCT02181803|449128761|FG005|Overall Study|Adverse Event|0|||
124865474|NCT02181803|449128762|FG006|Overall Study|Adverse Event|1|||
125087987|NCT01066819|449939298|FG003|Overall Study|Miscellaneous|1|||
125087988|NCT01066819|449939299|FG004|Overall Study|Miscellaneous|0|||
125198605|NCT00199797|450350976|FG000|Overall Study|Physician Decision|1|||
125087989|NCT01066819|449939300|FG005|Overall Study|Miscellaneous|0|||
125087990|NCT01066819|449939295|FG000|Overall Study|Non responders|123|||
125087991|NCT01066819|449939296|FG001|Overall Study|Non responders|2|||
125087992|NCT01066819|449939297|FG002|Overall Study|Non responders|7|||
125087993|NCT01066819|449939298|FG003|Overall Study|Non responders|2|||
125087994|NCT01066819|449939299|FG004|Overall Study|Non responders|0|||
125087995|NCT01066819|449939300|FG005|Overall Study|Non responders|1|||
125087996|NCT01066819|449939295|FG000|Overall Study|Not categorised|9|||
125087997|NCT01066819|449939296|FG001|Overall Study|Not categorised|2|||
125087998|NCT01066819|449939297|FG002|Overall Study|Not categorised|6|||
125087999|NCT01066819|449939298|FG003|Overall Study|Not categorised|1|||
125088000|NCT01066819|449939299|FG004|Overall Study|Not categorised|0|||
125088001|NCT01066819|449939300|FG005|Overall Study|Not categorised|0|||
125088002|NCT01066819|449939295|FG000|Overall Study|Relapse|16|||
125088003|NCT01066819|449939296|FG001|Overall Study|Relapse|4|||
125088004|NCT01066819|449939297|FG002|Overall Study|Relapse|3|||
125088005|NCT01066819|449939298|FG003|Overall Study|Relapse|0|||
124865475|NCT02181803|449128763|FG007|Overall Study|Adverse Event|0|||
124865476|NCT02181803|449128764|FG008|Overall Study|Adverse Event|0|||
124865477|NCT03151005|449128765|FG000|Overall Study|Lost to Follow-up|5|||
124865478|NCT03151005|449128766|FG001|Overall Study|Lost to Follow-up|5|||
124865479|NCT04786444|449128769|FG000|Overall Study|Withdrawal by Subject|4|||
124865480|NCT04786444|449128770|FG001|Overall Study|Withdrawal by Subject|7|||
124865481|NCT04786444|449128771|FG002|Overall Study|Withdrawal by Subject|2|||
124865482|NCT04786444|449128769|FG000|Overall Study|Lost to Follow-up|11|||
124976666|NCT00603525|449541856|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
124976667|NCT00603525|449541857|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
124865483|NCT04786444|449128770|FG001|Overall Study|Lost to Follow-up|9|||
124865484|NCT04786444|449128771|FG002|Overall Study|Lost to Follow-up|10|||
124865485|NCT04786444|449128769|FG000|Overall Study|Subject would like to become pregnant|0|||
124865486|NCT04786444|449128770|FG001|Overall Study|Subject would like to become pregnant|1|||
124865487|NCT04786444|449128771|FG002|Overall Study|Subject would like to become pregnant|0|||
124976668|NCT00603525|449541858|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
125088006|NCT01066819|449939299|FG004|Overall Study|Relapse|0|||
125088007|NCT01066819|449939300|FG005|Overall Study|Relapse|0|||
125088008|NCT01066819|449939295|FG000|Overall Study|Results not available|1|||
125088009|NCT01066819|449939296|FG001|Overall Study|Results not available|0|||
125088010|NCT01066819|449939297|FG002|Overall Study|Results not available|0|||
124976669|NCT00603525|449541856|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
124976670|NCT00603525|449541857|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
125088011|NCT01066819|449939298|FG003|Overall Study|Results not available|0|||
125088012|NCT01066819|449939299|FG004|Overall Study|Results not available|0|||
125088013|NCT01066819|449939300|FG005|Overall Study|Results not available|0|||
125088014|NCT01066819|449939295|FG000|Overall Study|Screen failure|1|||
125088015|NCT01066819|449939296|FG001|Overall Study|Screen failure|0|||
125088016|NCT01066819|449939297|FG002|Overall Study|Screen failure|0|||
125088017|NCT01066819|449939298|FG003|Overall Study|Screen failure|0|||
125088018|NCT01066819|449939299|FG004|Overall Study|Screen failure|0|||
125088019|NCT01066819|449939300|FG005|Overall Study|Screen failure|0|||
125088020|NCT01066819|449939295|FG000|Overall Study|Spontaneous cure|1|||
125088021|NCT01066819|449939296|FG001|Overall Study|Spontaneous cure|0|||
125088022|NCT01066819|449939297|FG002|Overall Study|Spontaneous cure|0|||
124976671|NCT00603525|449541858|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
124976672|NCT00603525|449541856|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
124976673|NCT00603525|449541857|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
124976674|NCT00603525|449541858|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
125088023|NCT01066819|449939298|FG003|Overall Study|Spontaneous cure|0|||
125088024|NCT01066819|449939299|FG004|Overall Study|Spontaneous cure|0|||
125088025|NCT01066819|449939300|FG005|Overall Study|Spontaneous cure|0|||
125088026|NCT01066819|449939295|FG000|Overall Study|Treatment never started|85|||
125088027|NCT01066819|449939296|FG001|Overall Study|Treatment never started|19|||
125088028|NCT01066819|449939297|FG002|Overall Study|Treatment never started|19|||
125088029|NCT01066819|449939298|FG003|Overall Study|Treatment never started|3|||
125088030|NCT01066819|449939299|FG004|Overall Study|Treatment never started|2|||
125088031|NCT01066819|449939300|FG005|Overall Study|Treatment never started|2|||
125088032|NCT01066819|449939295|FG000|Overall Study|Treatment stopped|12|||
125088033|NCT01066819|449939296|FG001|Overall Study|Treatment stopped|1|||
125088034|NCT01066819|449939297|FG002|Overall Study|Treatment stopped|2|||
125309945|NCT00853151|450761941|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
125309946|NCT00853151|450761938|FG000|Overall Study|Lost to Follow-up|2|||
125309947|NCT00853151|450761939|FG001|Overall Study|Lost to Follow-up|0|||
124865488|NCT02131272|449128772|FG000|Overall Study|Withdrawal by parent|0|||
124865489|NCT02131272|449128773|FG001|Overall Study|Withdrawal by parent|1|||
124865490|NCT02131272|449128772|FG000|Overall Study|Withdrawal by Subject|0|||
124865491|NCT02131272|449128773|FG001|Overall Study|Withdrawal by Subject|1|||
124865492|NCT02131272|449128772|FG000|Overall Study|Withdrawal Criteria|1|||
125088035|NCT01066819|449939298|FG003|Overall Study|Treatment stopped|1|||
125088036|NCT01066819|449939299|FG004|Overall Study|Treatment stopped|0|||
125088037|NCT01066819|449939300|FG005|Overall Study|Treatment stopped|0|||
125088038|NCT01066819|449939295|FG000|Overall Study|Other|5|||
125088039|NCT01066819|449939296|FG001|Overall Study|Other|1|||
125088040|NCT01066819|449939297|FG002|Overall Study|Other|1|||
125088041|NCT01066819|449939298|FG003|Overall Study|Other|0|||
125088042|NCT01066819|449939299|FG004|Overall Study|Other|0|||
125088043|NCT01066819|449939300|FG005|Overall Study|Other|0|||
125088044|NCT00805194|449939301|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
125088045|NCT00805194|449939302|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
125088046|NCT00805194|449939301|FG000|Overall Study|Worsening or AE of underlying disease|64|||
125088047|NCT00805194|449939302|FG001|Overall Study|Worsening or AE of underlying disease|70|||
125088048|NCT00805194|449939301|FG000|Overall Study|Other AE|84|||
125088049|NCT00805194|449939302|FG001|Overall Study|Other AE|73|||
125088050|NCT00805194|449939301|FG000|Overall Study|Protocol Violation|9|||
125088051|NCT00805194|449939302|FG001|Overall Study|Protocol Violation|9|||
125088052|NCT00805194|449939301|FG000|Overall Study|Lost to Follow-up|5|||
125088053|NCT00805194|449939302|FG001|Overall Study|Lost to Follow-up|5|||
125088054|NCT00805194|449939301|FG000|Overall Study|Withdrawal by Subject|60|||
125088055|NCT00805194|449939302|FG001|Overall Study|Withdrawal by Subject|42|||
125088056|NCT00805194|449939301|FG000|Overall Study|Not treated|3|||
125088057|NCT00805194|449939302|FG001|Overall Study|Not treated|4|||
125088058|NCT00805194|449939301|FG000|Overall Study|Reasons other than stated above|20|||
125088059|NCT00805194|449939302|FG001|Overall Study|Reasons other than stated above|16|||
125088060|NCT02275052|449939308|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125088061|NCT02275052|449939309|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
125088062|NCT02275052|449939310|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125088063|NCT02275052|449939311|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125088064|NCT02275052|449939308|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
125088065|NCT02275052|449939309|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
125088066|NCT02275052|449939310|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
125088067|NCT02275052|449939311|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
125088068|NCT02275052|449939308|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
125088069|NCT02275052|449939309|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
125088070|NCT02275052|449939310|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
125088071|NCT02275052|449939311|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
125088072|NCT02275052|449939308|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
125088073|NCT02275052|449939309|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
125088074|NCT02275052|449939310|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
125088075|NCT02275052|449939311|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
125088076|NCT02275052|449939308|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
125088077|NCT02275052|449939309|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
125088078|NCT02275052|449939310|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
125088079|NCT02275052|449939311|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
125088080|NCT02275052|449939308|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
125088081|NCT02275052|449939309|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
125088082|NCT02275052|449939310|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
125088083|NCT02275052|449939311|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
125088084|NCT02275052|449939308|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
125088085|NCT02275052|449939309|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
125088086|NCT02275052|449939310|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
125088087|NCT02275052|449939311|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
125088088|NCT02275052|449939308|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
125088089|NCT02275052|449939309|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
125088090|NCT02275052|449939310|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
125088091|NCT02275052|449939311|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
125088092|NCT02275052|449939308|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125088093|NCT02275052|449939309|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125088094|NCT02275052|449939310|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
125088095|NCT02275052|449939311|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
125088096|NCT02275052|449939308|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
125088097|NCT02275052|449939309|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
125088098|NCT02275052|449939310|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
125088099|NCT02275052|449939311|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
125088100|NCT02275052|449939308|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
125088101|NCT02275052|449939309|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
125088102|NCT02275052|449939310|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
125088103|NCT02275052|449939311|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
125088104|NCT00808028|449939314|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
125088105|NCT00808028|449939315|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
125088106|NCT00808028|449939316|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
125088107|NCT00808028|449939317|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
125088108|NCT00808028|449939314|FG000|Stage 1 (6 Months)|Other|1|||
125088109|NCT00808028|449939315|FG001|Stage 1 (6 Months)|Other|0|||
125088110|NCT00808028|449939316|FG002|Stage 1 (6 Months)|Other|2|||
125088111|NCT00808028|449939317|FG003|Stage 1 (6 Months)|Other|4|||
125088112|NCT00808028|449939314|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
125088113|NCT00808028|449939315|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
125088114|NCT00808028|449939316|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
125088115|NCT00808028|449939317|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
124976675|NCT00603525|449541856|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
125088116|NCT00808028|449939314|FG000|Stage 1 (6 Months)|Adverse Event|0|||
125088117|NCT00808028|449939315|FG001|Stage 1 (6 Months)|Adverse Event|0|||
125088118|NCT00808028|449939316|FG002|Stage 1 (6 Months)|Adverse Event|1|||
125088119|NCT00808028|449939317|FG003|Stage 1 (6 Months)|Adverse Event|2|||
125088120|NCT00808028|449939314|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
125088121|NCT00808028|449939315|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
125088122|NCT00808028|449939316|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
125088123|NCT00808028|449939317|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
125088124|NCT00808028|449939314|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
125088125|NCT00808028|449939315|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
125088126|NCT00808028|449939316|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
125088127|NCT00808028|449939317|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
125088128|NCT00808028|449939314|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
125088129|NCT00808028|449939315|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
125088130|NCT00808028|449939316|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
125088131|NCT00808028|449939317|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
125088132|NCT00808028|449939314|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
125088133|NCT00808028|449939315|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
125088134|NCT00808028|449939316|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
125088135|NCT00808028|449939317|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
125088136|NCT00808028|449939314|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
125088137|NCT00808028|449939315|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
125088138|NCT00808028|449939316|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
125088139|NCT00808028|449939317|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
125088140|NCT00808028|449939314|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
125088141|NCT00808028|449939315|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
125088142|NCT00808028|449939316|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
125088143|NCT00808028|449939317|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
125088144|NCT00808028|449939314|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
125088145|NCT00808028|449939315|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
125088146|NCT00808028|449939316|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
125088147|NCT00808028|449939317|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
125088148|NCT00808028|449939314|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
125088149|NCT00808028|449939315|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
125088150|NCT00808028|449939316|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
125088151|NCT00808028|449939317|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
125088152|NCT00808028|449939314|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
125088153|NCT00808028|449939315|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
125088154|NCT00808028|449939316|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
125088155|NCT00808028|449939317|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
124976676|NCT00603525|449541857|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
125088156|NCT00808028|449939314|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
125088157|NCT00808028|449939315|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
125088158|NCT00808028|449939316|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
124976677|NCT00603525|449541858|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
124976678|NCT00603525|449541856|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
124976679|NCT00603525|449541857|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
125088159|NCT00808028|449939317|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
125088160|NCT00808028|449939314|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
125088161|NCT00808028|449939315|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
125088162|NCT00808028|449939316|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
125088163|NCT00808028|449939317|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
125088164|NCT02773849|449939318|FG000|Overall Study|Lost to Follow-up|11|||
125088165|NCT02773849|449939318|FG000|Overall Study|Death|26|||
125088166|NCT02773849|449939318|FG000|Overall Study|Withdrawal by Subject|5|||
125088167|NCT02773849|449939318|FG000|Overall Study|Withdrawal of Consent|9|||
124976680|NCT00603525|449541858|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
125088168|NCT02773849|449939318|FG000|Overall Study|Other: not due to lack of tolerability|11|||
125088169|NCT00948389|449939319|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
125088170|NCT00948389|449939320|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
125088171|NCT00948389|449939321|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
125088172|NCT00948389|449939322|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
125088173|NCT00948389|449939323|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
125088174|NCT00948389|449939319|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
125088175|NCT00948389|449939320|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
125088176|NCT00948389|449939321|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
125088177|NCT00948389|449939322|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
125088178|NCT00948389|449939323|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
125088179|NCT00948389|449939319|FG000|Overall Study|Both Progression and Toxicity|1|||
125088180|NCT00948389|449939320|FG001|Overall Study|Both Progression and Toxicity|0|||
125088181|NCT00948389|449939321|FG002|Overall Study|Both Progression and Toxicity|0|||
125088182|NCT00948389|449939322|FG003|Overall Study|Both Progression and Toxicity|0|||
125088183|NCT00948389|449939323|FG004|Overall Study|Both Progression and Toxicity|0|||
125088184|NCT02418000|449939328|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
125088185|NCT02418000|449939329|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
125088186|NCT02418000|449939330|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
125088187|NCT02418000|449939331|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
125088188|NCT02418000|449939332|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
125088189|NCT02418000|449939328|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
125088190|NCT02418000|449939329|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
125088191|NCT02418000|449939330|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
125088192|NCT02418000|449939331|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
125088193|NCT02418000|449939332|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
125088194|NCT02418000|449939328|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
125088195|NCT02418000|449939329|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
125088196|NCT02418000|449939330|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
125088197|NCT02418000|449939331|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
125088198|NCT02418000|449939332|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
124865493|NCT02131272|449128773|FG001|Overall Study|Withdrawal Criteria|0|||
124865494|NCT02462876|449128774|FG000|Overall Study|Death|3|||
124865495|NCT02462876|449128774|FG000|Overall Study|Lost to Follow-up|7|||
124865496|NCT02462876|449128774|FG000|Overall Study|Surgical Bypass|9|||
124865497|NCT02462876|449128774|FG000|Overall Study|Amputation Above the Metatarsals|1|||
124865498|NCT02462876|449128774|FG000|Overall Study|36 months follow-up visit missed|1|||
124865499|NCT02462876|449128774|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
124865500|NCT02462876|449128774|FG000|Overall Study|Patient did not come back to the vascular department|1|||
124865501|NCT02462876|449128774|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
124865502|NCT02462876|449128774|FG000|Overall Study|Patient refused to come back|1|||
124865503|NCT02462876|449128774|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
124865504|NCT02462876|449128774|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
124865505|NCT01786512|449128777|FG000|Overall Study|Lost to Follow-up|0|||
124865506|NCT01786512|449128778|FG001|Overall Study|Lost to Follow-up|0|||
124865507|NCT01786512|449128779|FG002|Overall Study|Lost to Follow-up|0|||
124865508|NCT01786512|449128780|FG003|Overall Study|Lost to Follow-up|0|||
124865509|NCT01786512|449128781|FG004|Overall Study|Lost to Follow-up|0|||
124865510|NCT01786512|449128782|FG005|Overall Study|Lost to Follow-up|0|||
124865511|NCT01786512|449128783|FG006|Overall Study|Lost to Follow-up|0|||
124865512|NCT01786512|449128784|FG007|Overall Study|Lost to Follow-up|0|||
124865513|NCT01786512|449128785|FG008|Overall Study|Lost to Follow-up|0|||
124865514|NCT01786512|449128786|FG009|Overall Study|Lost to Follow-up|1|||
124865515|NCT01786512|449128787|FG010|Overall Study|Lost to Follow-up|0|||
124865516|NCT01786512|449128777|FG000|Overall Study|Decision by sponsor|0|||
124865517|NCT01786512|449128778|FG001|Overall Study|Decision by sponsor|0|||
124865518|NCT01786512|449128779|FG002|Overall Study|Decision by sponsor|0|||
124865519|NCT01786512|449128780|FG003|Overall Study|Decision by sponsor|0|||
124865520|NCT01786512|449128781|FG004|Overall Study|Decision by sponsor|0|||
124865521|NCT01786512|449128782|FG005|Overall Study|Decision by sponsor|0|||
124865522|NCT01786512|449128783|FG006|Overall Study|Decision by sponsor|0|||
124865523|NCT01786512|449128784|FG007|Overall Study|Decision by sponsor|0|||
124865524|NCT01786512|449128785|FG008|Overall Study|Decision by sponsor|0|||
124865525|NCT01786512|449128786|FG009|Overall Study|Decision by sponsor|0|||
124865526|NCT01786512|449128787|FG010|Overall Study|Decision by sponsor|2|||
124865527|NCT01786512|449128777|FG000|Overall Study|Withdrawal by Subject|0|||
124865528|NCT01786512|449128778|FG001|Overall Study|Withdrawal by Subject|1|||
124865529|NCT01786512|449128779|FG002|Overall Study|Withdrawal by Subject|0|||
124865530|NCT01786512|449128780|FG003|Overall Study|Withdrawal by Subject|0|||
124865531|NCT01786512|449128781|FG004|Overall Study|Withdrawal by Subject|0|||
124865532|NCT01786512|449128782|FG005|Overall Study|Withdrawal by Subject|0|||
124865533|NCT01786512|449128783|FG006|Overall Study|Withdrawal by Subject|1|||
124865534|NCT01786512|449128784|FG007|Overall Study|Withdrawal by Subject|0|||
124865535|NCT01786512|449128785|FG008|Overall Study|Withdrawal by Subject|0|||
124865536|NCT01786512|449128786|FG009|Overall Study|Withdrawal by Subject|3|||
124865537|NCT01786512|449128787|FG010|Overall Study|Withdrawal by Subject|7|||
124865538|NCT01786512|449128777|FG000|Overall Study|Death|0|||
124865539|NCT01786512|449128778|FG001|Overall Study|Death|0|||
124865540|NCT01786512|449128779|FG002|Overall Study|Death|0|||
125088199|NCT02418000|449939328|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
125088200|NCT02418000|449939329|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
125088201|NCT02418000|449939330|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
125088202|NCT02418000|449939331|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
125088203|NCT02418000|449939332|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
125088204|NCT02418000|449939328|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
125088205|NCT02418000|449939329|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
125088206|NCT02418000|449939330|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
125088207|NCT02418000|449939331|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
124865541|NCT01786512|449128780|FG003|Overall Study|Death|0|||
124865542|NCT01786512|449128781|FG004|Overall Study|Death|0|||
124865543|NCT01786512|449128782|FG005|Overall Study|Death|0|||
124865544|NCT01786512|449128783|FG006|Overall Study|Death|0|||
125088208|NCT02418000|449939332|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
125088209|NCT02418000|449939328|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125088210|NCT02418000|449939329|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125088211|NCT02418000|449939330|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
125088212|NCT02418000|449939331|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125088213|NCT02418000|449939332|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125088214|NCT02418000|449939328|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125088215|NCT02418000|449939329|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125088216|NCT02418000|449939330|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125088217|NCT02418000|449939331|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
125088218|NCT02418000|449939332|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125088219|NCT02418000|449939328|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
125088220|NCT02418000|449939329|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
125088221|NCT02418000|449939330|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
125088222|NCT02418000|449939331|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
125088223|NCT02418000|449939332|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
125088224|NCT02418000|449939328|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125088225|NCT02418000|449939329|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
124865545|NCT01786512|449128784|FG007|Overall Study|Death|0|||
124865546|NCT01786512|449128785|FG008|Overall Study|Death|4|||
124865547|NCT01786512|449128786|FG009|Overall Study|Death|1|||
124865548|NCT01786512|449128787|FG010|Overall Study|Death|3|||
124865549|NCT03166618|449128788|FG000|Overall Study|Study was Terminated|0|||
124865550|NCT03166618|449128789|FG001|Overall Study|Study was Terminated|1|||
125088226|NCT02418000|449939330|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125088227|NCT02418000|449939331|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125088228|NCT02418000|449939332|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
125088229|NCT00508001|449939333|FG000|Overall Study|Adverse Event|2|||
125088230|NCT00508001|449939334|FG001|Overall Study|Adverse Event|0|||
125088231|NCT00508001|449939335|FG002|Overall Study|Adverse Event|4|||
125088232|NCT00508001|449939333|FG000|Overall Study|condition under investigation worsened|13|||
125088233|NCT00508001|449939334|FG001|Overall Study|condition under investigation worsened|7|||
125088234|NCT00508001|449939335|FG002|Overall Study|condition under investigation worsened|1|||
125088235|NCT00508001|449939333|FG000|Overall Study|Death|0|||
124865551|NCT01925950|449128790|FG000|Part 2|Withdrawal by Subject|1|||
124865552|NCT01925950|449128791|FG001|Part 2|Withdrawal by Subject|0|||
124865553|NCT00605293|449128794|FG000|Overall Study|Death|2|||
124865554|NCT00605293|449128795|FG001|Overall Study|Death|1|||
124865555|NCT00605293|449128794|FG000|Overall Study|Insufficient Therapeutic Response|2|||
124865556|NCT00605293|449128795|FG001|Overall Study|Insufficient Therapeutic Response|0|||
124865557|NCT00605293|449128794|FG000|Overall Study|Adverse Event|1|||
124865558|NCT00605293|449128795|FG001|Overall Study|Adverse Event|0|||
124865559|NCT00605293|449128794|FG000|Overall Study|Holidays Dialysis Out|1|||
125088236|NCT00508001|449939334|FG001|Overall Study|Death|1|||
125088237|NCT00508001|449939335|FG002|Overall Study|Death|1|||
125088238|NCT00508001|449939333|FG000|Overall Study|Withdrawal by Subject|4|||
125088239|NCT00508001|449939334|FG001|Overall Study|Withdrawal by Subject|4|||
125088240|NCT00508001|449939335|FG002|Overall Study|Withdrawal by Subject|1|||
125088241|NCT00732199|449939341|FG000|Overall Study|Withdrawal by Subject|25|||
124865560|NCT00605293|449128795|FG001|Overall Study|Holidays Dialysis Out|0|||
124865561|NCT00605293|449128794|FG000|Overall Study|Blood Transfusion|7|||
125088242|NCT00732199|449939342|FG001|Overall Study|Withdrawal by Subject|18|||
125088243|NCT00732199|449939341|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
125088244|NCT00732199|449939342|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
125088245|NCT01051856|449939357|FG000|Overall Study|Withdrawal by Subject|1|||
125198606|NCT04250350|450350980|FG000|Overall Study|Withdrawal by Subject|13|||
124865562|NCT00605293|449128795|FG001|Overall Study|Blood Transfusion|1|||
124865563|NCT00605293|449128794|FG000|Overall Study|Renal Transplantation|3|||
124865564|NCT00605293|449128795|FG001|Overall Study|Renal Transplantation|1|||
125088246|NCT01051856|449939358|FG001|Overall Study|Withdrawal by Subject|0|||
125088247|NCT02381795|449939362|FG000|Overall Study|Withdrawal by Subject|1|||
124976681|NCT02304705|449541859|FG000|Overall Study|Withdrawal by Subject|2|||
124976682|NCT02304705|449541860|FG001|Overall Study|Withdrawal by Subject|0|||
124976683|NCT02304705|449541859|FG000|Overall Study|Physician Decision|2|||
125088248|NCT02381795|449939362|FG000|Overall Study|Study Terminated|2|||
125088249|NCT01412333|449939370|FG000|Overall Study|Adverse Event|40|||
125088250|NCT01412333|449939371|FG001|Overall Study|Adverse Event|42|||
125088251|NCT01412333|449939370|FG000|Overall Study|Death|5|||
125088252|NCT01412333|449939371|FG001|Overall Study|Death|6|||
125088253|NCT01412333|449939370|FG000|Overall Study|Lack of Efficacy|22|||
125088254|NCT01412333|449939371|FG001|Overall Study|Lack of Efficacy|10|||
125088255|NCT01412333|449939370|FG000|Overall Study|Lost to Follow-up|15|||
125088256|NCT01412333|449939371|FG001|Overall Study|Lost to Follow-up|12|||
125088257|NCT01412333|449939370|FG000|Overall Study|Non-Compliance|3|||
125088258|NCT01412333|449939371|FG001|Overall Study|Non-Compliance|7|||
124976684|NCT02304705|449541860|FG001|Overall Study|Physician Decision|4|||
125088259|NCT01412333|449939370|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125088260|NCT01412333|449939371|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125088261|NCT01412333|449939370|FG000|Overall Study|Other|30|||
125088262|NCT01412333|449939371|FG001|Overall Study|Other|33|||
125088263|NCT01412333|449939370|FG000|Overall Study|Physician Decision|11|||
125088264|NCT01412333|449939371|FG001|Overall Study|Physician Decision|16|||
125088265|NCT01412333|449939370|FG000|Overall Study|Pregnancy|6|||
125088266|NCT01412333|449939371|FG001|Overall Study|Pregnancy|4|||
125088267|NCT01412333|449939370|FG000|Overall Study|Protocol Violation|1|||
125088268|NCT01412333|449939371|FG001|Overall Study|Protocol Violation|2|||
125088269|NCT01412333|449939370|FG000|Overall Study|Study Terminated By Sponsor|3|||
125088270|NCT01412333|449939371|FG001|Overall Study|Study Terminated By Sponsor|2|||
125088271|NCT01412333|449939370|FG000|Overall Study|Withdrawal by Subject|51|||
125088272|NCT01412333|449939371|FG001|Overall Study|Withdrawal by Subject|54|||
125088273|NCT01412333|449939370|FG000|Overall Study|Missing|1|||
125088274|NCT01412333|449939371|FG001|Overall Study|Missing|3|||
125088275|NCT00750867|449939372|FG000|Overall Study|Adverse Event|2|||
125088276|NCT01060150|449939373|FG000|Overall Study|Adverse Event|6|||
125088277|NCT01060150|449939373|FG000|Overall Study|Lost to Follow-up|1|||
125088278|NCT01060150|449939373|FG000|Overall Study|Protocol Violation|6|||
125088279|NCT01060150|449939373|FG000|Overall Study|Withdrawal by Subject|8|||
125088280|NCT01060150|449939373|FG000|Overall Study|Enrolled, but not treated|2|||
125088281|NCT01969565|449939374|FG000|Overall Study|Withdrawal by Subject|1|||
125088282|NCT01683058|449939375|FG000|Overall Study|Lost to Follow-up|9|||
125088283|NCT01683058|449939375|FG000|Overall Study|Adverse Event|6|||
125088284|NCT01683058|449939375|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
125088285|NCT01683058|449939375|FG000|Overall Study|Withdrawal by Subject|7|||
124976685|NCT02304705|449541859|FG000|Overall Study|Death|0|||
124976686|NCT02304705|449541860|FG001|Overall Study|Death|1|||
124976687|NCT02304705|449541859|FG000|Overall Study|Lost to Follow-up|0|||
125088286|NCT01683058|449939375|FG000|Overall Study|Lack of Efficacy|2|||
125088287|NCT04062240|449939376|FG000|Overall Study|equipment malfunction|1|||
125088288|NCT01957111|449939377|FG000|Overall Study|Withdrawal by Subject|1|||
125088289|NCT01957111|449939378|FG001|Overall Study|Withdrawal by Subject|1|||
125088290|NCT01057394|449939379|FG000|Overall Study|Not eligible|0|||
125088291|NCT01057394|449939380|FG001|Overall Study|Not eligible|2|||
125088292|NCT03500419|449939381|FG000|Overall Study|Withdrawal by Subject|2|||
125088293|NCT03500419|449939382|FG001|Overall Study|Withdrawal by Subject|25|||
125088294|NCT01948791|449939387|FG000|Overall Study|Adverse Event|12|||
125088295|NCT01948791|449939387|FG000|Overall Study|Lack of Efficacy|3|||
125088296|NCT01948791|449939387|FG000|Overall Study|Protocol Violation|2|||
125088297|NCT01948791|449939387|FG000|Overall Study|Withdrawal by Subject|5|||
125088298|NCT01948791|449939387|FG000|Overall Study|Lost to Follow-up|6|||
125088299|NCT01948791|449939387|FG000|Overall Study|Management issues|1|||
125088300|NCT01948791|449939387|FG000|Overall Study|Others|7|||
125088301|NCT01948791|449939387|FG000|Overall Study|Screening failure|35|||
124976688|NCT02304705|449541860|FG001|Overall Study|Lost to Follow-up|2|||
125088302|NCT03481634|449939388|FG000|Overall Study|Withdrawal by Subject|16|||
125088303|NCT03481634|449939389|FG001|Overall Study|Withdrawal by Subject|19|||
125088304|NCT03481634|449939390|FG002|Overall Study|Withdrawal by Subject|14|||
124976689|NCT01195948|449541861|FG000|Overall Study|Lost to Follow-up|0|||
124976690|NCT01195948|449541862|FG001|Overall Study|Lost to Follow-up|1|||
124976691|NCT01195948|449541863|FG002|Overall Study|Lost to Follow-up|2|||
125088305|NCT03481634|449939388|FG000|Overall Study|Protocol Violation|1|||
125088306|NCT03481634|449939389|FG001|Overall Study|Protocol Violation|0|||
125088307|NCT03481634|449939390|FG002|Overall Study|Protocol Violation|1|||
125088308|NCT03481634|449939388|FG000|Overall Study|Progressive disease|0|||
125088309|NCT03481634|449939389|FG001|Overall Study|Progressive disease|1|||
125088310|NCT03481634|449939390|FG002|Overall Study|Progressive disease|0|||
125088311|NCT03481634|449939388|FG000|Overall Study|Physician Decision|3|||
125088312|NCT03481634|449939389|FG001|Overall Study|Physician Decision|0|||
125088313|NCT03481634|449939390|FG002|Overall Study|Physician Decision|1|||
125088314|NCT03481634|449939388|FG000|Overall Study|Lost to Follow-up|3|||
125088315|NCT03481634|449939389|FG001|Overall Study|Lost to Follow-up|4|||
125088316|NCT03481634|449939390|FG002|Overall Study|Lost to Follow-up|4|||
125088317|NCT03481634|449939388|FG000|Overall Study|Death|4|||
125088318|NCT03481634|449939389|FG001|Overall Study|Death|8|||
125088319|NCT03481634|449939390|FG002|Overall Study|Death|7|||
125088320|NCT03481634|449939388|FG000|Overall Study|Adverse Event|6|||
125088321|NCT03481634|449939389|FG001|Overall Study|Adverse Event|3|||
125088322|NCT03481634|449939390|FG002|Overall Study|Adverse Event|7|||
125088323|NCT00994890|449939391|FG000|Overall Study|Adverse Event|13|||
125088324|NCT00994890|449939392|FG001|Overall Study|Adverse Event|9|||
125088325|NCT00994890|449939393|FG002|Overall Study|Adverse Event|11|||
125088326|NCT00994890|449939391|FG000|Overall Study|Lack of Efficacy|0|||
125088327|NCT00994890|449939392|FG001|Overall Study|Lack of Efficacy|0|||
125088328|NCT00994890|449939393|FG002|Overall Study|Lack of Efficacy|1|||
125088329|NCT00994890|449939391|FG000|Overall Study|Lost to Follow-up|6|||
125088330|NCT00994890|449939392|FG001|Overall Study|Lost to Follow-up|1|||
125088331|NCT00994890|449939393|FG002|Overall Study|Lost to Follow-up|3|||
125088332|NCT00994890|449939391|FG000|Overall Study|No longer willing to participate|8|||
125088333|NCT00994890|449939392|FG001|Overall Study|No longer willing to participate|5|||
125088334|NCT00994890|449939393|FG002|Overall Study|No longer willing to participate|13|||
125088335|NCT00994890|449939391|FG000|Overall Study|Protocol Violation|2|||
125088336|NCT00994890|449939392|FG001|Overall Study|Protocol Violation|4|||
125088337|NCT00994890|449939393|FG002|Overall Study|Protocol Violation|0|||
125088338|NCT00994890|449939391|FG000|Overall Study|Study terminated by sponsor|199|||
125088339|NCT00994890|449939392|FG001|Overall Study|Study terminated by sponsor|201|||
125088340|NCT00994890|449939393|FG002|Overall Study|Study terminated by sponsor|197|||
125088341|NCT00994890|449939391|FG000|Overall Study|Randomized, but not treated|1|||
125088342|NCT00994890|449939392|FG001|Overall Study|Randomized, but not treated|0|||
125088343|NCT00994890|449939393|FG002|Overall Study|Randomized, but not treated|0|||
125088344|NCT00994890|449939391|FG000|Overall Study|Other|2|||
125088345|NCT00994890|449939392|FG001|Overall Study|Other|2|||
125088346|NCT00994890|449939393|FG002|Overall Study|Other|1|||
125088347|NCT01469637|449939394|FG000|First Intervention|Unacceptable behavior|0|||
125088348|NCT01469637|449939395|FG001|First Intervention|Unacceptable behavior|1|||
125088349|NCT01469637|449939394|FG000|Second Intervention|Incarcerated|1|||
125088350|NCT01469637|449939395|FG001|Second Intervention|Incarcerated|0|||
125088351|NCT04491591|449939396|FG000|Overall Study|Accidently randomized|3|||
125088352|NCT04491591|449939397|FG001|Overall Study|Accidently randomized|1|||
125088353|NCT04491591|449939398|FG002|Overall Study|Accidently randomized|0|||
125088354|NCT04491591|449939396|FG000|Overall Study|Did not complete survey|28|||
125088355|NCT04491591|449939397|FG001|Overall Study|Did not complete survey|20|||
125088356|NCT04491591|449939398|FG002|Overall Study|Did not complete survey|3|||
125088357|NCT00472043|449939399|FG000|Overall Study|Withdrawal by Subject|1|||
125088358|NCT00472043|449939400|FG001|Overall Study|Withdrawal by Subject|0|||
125088359|NCT00472043|449939399|FG000|Overall Study|Death|1|||
125088360|NCT00472043|449939400|FG001|Overall Study|Death|0|||
125088361|NCT02802735|449939401|FG000|Overall Study|Withdrawal by Subject|0|||
125088362|NCT02802735|449939402|FG001|Overall Study|Withdrawal by Subject|1|||
125088363|NCT02802735|449939403|FG002|Overall Study|Withdrawal by Subject|0|||
125088364|NCT02802735|449939404|FG003|Overall Study|Withdrawal by Subject|0|||
125088365|NCT02802735|449939405|FG004|Overall Study|Withdrawal by Subject|0|||
125088366|NCT02975206|449939407|FG000|Overall Study|Withdrawal by Subject|14|||
125088367|NCT02975206|449939408|FG001|Overall Study|Withdrawal by Subject|11|||
125088368|NCT02975206|449939409|FG002|Overall Study|Withdrawal by Subject|11|||
125088369|NCT02975206|449939407|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
125088370|NCT02975206|449939408|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
125088371|NCT02975206|449939409|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
125088372|NCT00866606|449939410|FG000|Overall Study|Lost to Follow-up|3|||
125088373|NCT00866606|449939410|FG000|Overall Study|Adverse Event|1|||
125088374|NCT01058356|449939414|FG000|Overall Study|Adverse Event|5|||
125088375|NCT01058356|449939414|FG000|Overall Study|Administration of contraindicated drugs|12|||
125088376|NCT01058356|449939414|FG000|Overall Study|Withdrawal by Subject|21|||
125088377|NCT01058356|449939414|FG000|Overall Study|Lost to Follow-up|4|||
124976692|NCT00770029|449541864|FG000|Overall Study|Lost to Follow-up|2|||
125088378|NCT00606021|449939417|FG000|Induction Phase|Death|73|||
125088379|NCT00606021|449939418|FG001|Induction Phase|Death|0|||
125088380|NCT00606021|449939419|FG002|Induction Phase|Death|0|||
125088381|NCT00606021|449939417|FG000|Induction Phase|Physician Decision|2|||
125088382|NCT00606021|449939418|FG001|Induction Phase|Physician Decision|0|||
125088383|NCT00606021|449939419|FG002|Induction Phase|Physician Decision|0|||
125088384|NCT00606021|449939417|FG000|Induction Phase|Withdrawal by Subject|2|||
125088385|NCT00606021|449939418|FG001|Induction Phase|Withdrawal by Subject|0|||
125198607|NCT04250350|450350980|FG000|Overall Study|Lost to Follow-up|8|||
125198608|NCT04250350|450350980|FG000|Overall Study|Adverse Event|5|||
125198609|NCT04250350|450350980|FG000|Overall Study|Lack of Efficacy|4|||
125198610|NCT04250350|450350980|FG000|Overall Study|Physician Decision|1|||
125088386|NCT00606021|449939419|FG002|Induction Phase|Withdrawal by Subject|0|||
125088387|NCT00606021|449939417|FG000|Induction Phase|Lost to Follow-up|10|||
125088388|NCT00606021|449939418|FG001|Induction Phase|Lost to Follow-up|0|||
125088389|NCT00606021|449939419|FG002|Induction Phase|Lost to Follow-up|0|||
125088390|NCT00606021|449939417|FG000|Maintenance Phase|Death|0|||
125088391|NCT00606021|449939418|FG001|Maintenance Phase|Death|17|||
125088392|NCT00606021|449939419|FG002|Maintenance Phase|Death|15|||
125088393|NCT00606021|449939417|FG000|Maintenance Phase|Physician Decision|0|||
125088394|NCT00606021|449939418|FG001|Maintenance Phase|Physician Decision|1|||
125088395|NCT00606021|449939419|FG002|Maintenance Phase|Physician Decision|0|||
125088396|NCT00606021|449939417|FG000|Maintenance Phase|Lost to Follow-up|0|||
125088397|NCT00606021|449939418|FG001|Maintenance Phase|Lost to Follow-up|5|||
125088398|NCT00606021|449939419|FG002|Maintenance Phase|Lost to Follow-up|2|||
125131279|NCT01864174|450108086|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
125131280|NCT01864174|450108085|FG000|Double Blind - Compliant Randomized|Death|1|||
125131281|NCT01864174|450108086|FG001|Double Blind - Compliant Randomized|Death|0|||
125131282|NCT01864174|450108085|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
125131283|NCT01864174|450108086|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
125131284|NCT01864174|450108085|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
125131285|NCT01864174|450108086|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
125131286|NCT01864174|450108085|FG000|Double Blind - Compliant Randomized|Other|6|||
125131287|NCT01864174|450108086|FG001|Double Blind - Compliant Randomized|Other|10|||
125131288|NCT01864174|450108085|FG000|Off Treatment Follow-Up|Other|2|||
125131289|NCT01864174|450108086|FG001|Off Treatment Follow-Up|Other|0|||
125131290|NCT01864174|450108085|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
125131291|NCT01864174|450108086|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
125131292|NCT02739997|450108087|FG000|Overall Study|Death|1|||
125131293|NCT02739997|450108087|FG000|Overall Study|Withdrawal by Subject|1|||
125131294|NCT00468286|450108088|FG000|Overall Study|Adverse Event|1|||
125131295|NCT00468286|450108089|FG001|Overall Study|Adverse Event|6|||
125131296|NCT00468286|450108088|FG000|Overall Study|Protocol Violation|2|||
125131297|NCT00468286|450108089|FG001|Overall Study|Protocol Violation|2|||
125131298|NCT00468286|450108088|FG000|Overall Study|Withdrawal by Subject|4|||
125131299|NCT00468286|450108089|FG001|Overall Study|Withdrawal by Subject|3|||
125131300|NCT00468286|450108088|FG000|Overall Study|Physician Decision|0|||
125131301|NCT00468286|450108089|FG001|Overall Study|Physician Decision|1|||
125131302|NCT02158663|450108090|FG000|Overall Study|Withdrawal by Subject|5|||
125131303|NCT02158663|450108091|FG001|Overall Study|Withdrawal by Subject|4|||
125131304|NCT03552393|450108096|FG000|Core Period|Kidney Transplant|1|||
125131305|NCT03552393|450108096|FG000|Core Period|Prohibited Medication|1|||
125131306|NCT03552393|450108096|FG000|Safety Extension Period|Kidney Transplant|4|||
125131307|NCT02414152|450108098|FG000|Overall Study|Withdrawal by Subject|1|||
125131308|NCT02414152|450108098|FG000|Overall Study|Lack of Efficacy|1|||
125131309|NCT02601625|450108099|FG000|Overall Study|Lost to Follow-up|0|||
125131310|NCT02601625|450108100|FG001|Overall Study|Lost to Follow-up|0|||
125131311|NCT02601625|450108101|FG002|Overall Study|Lost to Follow-up|1|||
125131312|NCT02601625|450108102|FG003|Overall Study|Lost to Follow-up|1|||
125131313|NCT00359281|450108103|FG000|Overall Study|Adverse Event|1|||
125131314|NCT00359281|450108104|FG001|Overall Study|Adverse Event|0|||
125131315|NCT00359281|450108105|FG002|Overall Study|Adverse Event|0|||
125131316|NCT00359281|450108106|FG003|Overall Study|Adverse Event|0|||
125131317|NCT00359281|450108107|FG004|Overall Study|Adverse Event|0|||
125131318|NCT00359281|450108108|FG005|Overall Study|Adverse Event|0|||
125131319|NCT00359281|450108109|FG006|Overall Study|Adverse Event|1|||
125131320|NCT00359281|450108110|FG007|Overall Study|Adverse Event|0|||
125131321|NCT00359281|450108111|FG008|Overall Study|Adverse Event|0|||
125131322|NCT00359281|450108103|FG000|Overall Study|Withdrawal by Subject|0|||
125131323|NCT00359281|450108104|FG001|Overall Study|Withdrawal by Subject|0|||
125131324|NCT00359281|450108105|FG002|Overall Study|Withdrawal by Subject|0|||
125131325|NCT00359281|450108106|FG003|Overall Study|Withdrawal by Subject|0|||
125131326|NCT00359281|450108107|FG004|Overall Study|Withdrawal by Subject|0|||
125131327|NCT00359281|450108108|FG005|Overall Study|Withdrawal by Subject|0|||
125131328|NCT00359281|450108109|FG006|Overall Study|Withdrawal by Subject|1|||
124976693|NCT00770029|449541865|FG001|Overall Study|Lost to Follow-up|0|||
124976694|NCT00770029|449541864|FG000|Overall Study|Withdrawal by Subject|3|||
124976695|NCT00770029|449541865|FG001|Overall Study|Withdrawal by Subject|3|||
125131329|NCT00359281|450108110|FG007|Overall Study|Withdrawal by Subject|0|||
125131330|NCT00359281|450108111|FG008|Overall Study|Withdrawal by Subject|0|||
125131331|NCT04887415|450108112|FG000|Overall Study|Lost to Follow-up|2|||
125131332|NCT01415986|450108113|FG000|Overall Study|Lost to Follow-up|1|||
124865565|NCT00605293|449128794|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
125131333|NCT03792477|450108114|FG000|Overall Study|Adverse Event|0|||
125131334|NCT03792477|450108115|FG001|Overall Study|Adverse Event|0|||
125131335|NCT03792477|450108116|FG002|Overall Study|Adverse Event|0|||
125131336|NCT03792477|450108117|FG003|Overall Study|Adverse Event|1|||
125131337|NCT03792477|450108118|FG004|Overall Study|Adverse Event|0|||
125131338|NCT03792477|450108114|FG000|Overall Study|Lost to Follow-up|0|||
125198611|NCT04250350|450350980|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
124976696|NCT00770029|449541864|FG000|Overall Study|Adverse Event|1|||
125088399|NCT02390167|449941372|FG000|Overall Study|Lost to Follow-up|1|||
125088400|NCT01265719|449941378|FG000|Overall Study|Does not meet entrance criteria|0|||
125088401|NCT01265719|449941379|FG001|Overall Study|Does not meet entrance criteria|3|||
125088402|NCT01265719|449941378|FG000|Overall Study|Other reasons|2|||
125088403|NCT01265719|449941379|FG001|Overall Study|Other reasons|0|||
125088404|NCT01265719|449941378|FG000|Overall Study|Withdrawal by Subject|8|||
125088405|NCT01265719|449941379|FG001|Overall Study|Withdrawal by Subject|3|||
125088406|NCT01265719|449941378|FG000|Overall Study|Lost to Follow-up|2|||
125088407|NCT01265719|449941379|FG001|Overall Study|Lost to Follow-up|7|||
125088408|NCT01265719|449941378|FG000|Overall Study|Adverse Event|2|||
125088409|NCT01265719|449941379|FG001|Overall Study|Adverse Event|0|||
125088410|NCT04335929|449941380|FG000|Overall Study|Lost to Follow-up|10|||
125088411|NCT05604781|449941385|FG000|Overall Study|Lost to Follow-up|3|||
125088412|NCT05604781|449941385|FG000|Overall Study|Adverse Event|1|||
125088413|NCT02408016|449941386|FG000|Overall Study|Death|6|||
125088414|NCT02408016|449941387|FG001|Overall Study|Death|1|||
125088415|NCT02408016|449941388|FG002|Overall Study|Death|0|||
125088416|NCT02408016|449941386|FG000|Overall Study|Physician Decision|0|||
125088417|NCT02408016|449941387|FG001|Overall Study|Physician Decision|2|||
125088418|NCT02408016|449941388|FG002|Overall Study|Physician Decision|0|||
125088419|NCT02967562|449941390|FG000|Overall Study|Consent not obtained|1|||
125088420|NCT02967562|449941391|FG001|Overall Study|Consent not obtained|0|||
125088421|NCT02967562|449941390|FG000|Overall Study|High leak precluding analysis|1|||
125088422|NCT02967562|449941391|FG001|Overall Study|High leak precluding analysis|1|||
125088423|NCT00106626|449941392|FG000|Overall Study|Adverse Event|5|||
125088424|NCT00106626|449941393|FG001|Overall Study|Adverse Event|4|||
125088425|NCT00106626|449941394|FG002|Overall Study|Adverse Event|3|||
125088426|NCT00106626|449941395|FG003|Overall Study|Adverse Event|3|||
125088427|NCT00106626|449941392|FG000|Overall Study|Progressive Disease|4|||
125088428|NCT00106626|449941393|FG001|Overall Study|Progressive Disease|1|||
125088429|NCT00106626|449941394|FG002|Overall Study|Progressive Disease|9|||
125088430|NCT00106626|449941395|FG003|Overall Study|Progressive Disease|10|||
125088431|NCT00106626|449941392|FG000|Overall Study|Received radiation on new therapy|1|||
125088432|NCT00106626|449941393|FG001|Overall Study|Received radiation on new therapy|0|||
125088433|NCT00106626|449941394|FG002|Overall Study|Received radiation on new therapy|0|||
125088434|NCT00106626|449941395|FG003|Overall Study|Received radiation on new therapy|0|||
125088435|NCT00106626|449941392|FG000|Overall Study|> 14 day delay in therapy start|0|||
125088436|NCT00106626|449941393|FG001|Overall Study|> 14 day delay in therapy start|1|||
125088437|NCT00106626|449941394|FG002|Overall Study|> 14 day delay in therapy start|0|||
125088438|NCT00106626|449941395|FG003|Overall Study|> 14 day delay in therapy start|0|||
125088439|NCT02870348|449941400|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
125309948|NCT00853151|450761940|FG002|Overall Study|Lost to Follow-up|3|||
125309949|NCT00853151|450761941|FG003|Overall Study|Lost to Follow-up|0|||
125309950|NCT00853151|450761938|FG000|Overall Study|Death|1|||
125309951|NCT00853151|450761939|FG001|Overall Study|Death|0|||
125309952|NCT00853151|450761940|FG002|Overall Study|Death|0|||
125309953|NCT00853151|450761941|FG003|Overall Study|Death|1|||
125309954|NCT00853151|450761938|FG000|Overall Study|Protocol Violation|0|||
125309955|NCT00853151|450761939|FG001|Overall Study|Protocol Violation|0|||
125309956|NCT00853151|450761940|FG002|Overall Study|Protocol Violation|0|||
125309957|NCT00853151|450761941|FG003|Overall Study|Protocol Violation|1|||
125309958|NCT00853151|450761938|FG000|Overall Study|Withdrawal by Subject|5|||
125309959|NCT00853151|450761939|FG001|Overall Study|Withdrawal by Subject|4|||
125309960|NCT00853151|450761940|FG002|Overall Study|Withdrawal by Subject|2|||
125309961|NCT00853151|450761941|FG003|Overall Study|Withdrawal by Subject|1|||
125309962|NCT00853151|450761938|FG000|Overall Study|Physician Decision|0|||
125309963|NCT00853151|450761939|FG001|Overall Study|Physician Decision|2|||
125309964|NCT00853151|450761940|FG002|Overall Study|Physician Decision|1|||
125309965|NCT00853151|450761941|FG003|Overall Study|Physician Decision|0|||
125309966|NCT00853151|450761938|FG000|Overall Study|Sponsor Decision|0|||
125309967|NCT00853151|450761939|FG001|Overall Study|Sponsor Decision|3|||
125309968|NCT00853151|450761940|FG002|Overall Study|Sponsor Decision|0|||
125309969|NCT00853151|450761941|FG003|Overall Study|Sponsor Decision|0|||
125309970|NCT00269919|450761942|FG000|Overall Study|Other|26|||
125309971|NCT00269919|450761942|FG000|Overall Study|Started but not treated|1|||
125309972|NCT04473963|450761943|FG000|Overall Study|Withdrawal by Subject|1|||
125309973|NCT04473963|450761944|FG001|Overall Study|Withdrawal by Subject|1|||
125309974|NCT04473963|450761945|FG002|Overall Study|Withdrawal by Subject|0|||
125309975|NCT04473963|450761943|FG000|Overall Study|Not inducible in AF|0|||
125309976|NCT04473963|450761944|FG001|Overall Study|Not inducible in AF|0|||
125309977|NCT04473963|450761945|FG002|Overall Study|Not inducible in AF|2|||
125309978|NCT01799226|450761948|FG000|Overall Study|Withdrawal by Subject|1|||
125309979|NCT01799226|450761949|FG001|Overall Study|Withdrawal by Subject|0|||
125088440|NCT00672139|449941401|FG000|Overall Study|Death|14|||
125309980|NCT01799226|450761948|FG000|Overall Study|Disqualified at Day 14|1|||
125309981|NCT01799226|450761949|FG001|Overall Study|Disqualified at Day 14|0|||
125309982|NCT02274792|450761950|FG000|Overall Study|Withdrawal by Subject|13|||
125309983|NCT02274792|450761950|FG000|Overall Study|Lost to Follow-up|8|||
125309984|NCT02274792|450761950|FG000|Overall Study|Protocol Specified Criteria|2|||
125309985|NCT02274792|450761950|FG000|Overall Study|Sponsor Decision|2|||
125309986|NCT03361293|450761959|FG000|Overall Study|Lost to Follow-up|0|||
125309987|NCT03361293|450761960|FG001|Overall Study|Lost to Follow-up|2|||
125309988|NCT03361293|450761959|FG000|Overall Study|Withdrawal by Subject|1|||
125309989|NCT03361293|450761960|FG001|Overall Study|Withdrawal by Subject|3|||
125309990|NCT01550757|450761964|FG000|Overall Study|Lost to Follow-up|21|||
125309991|NCT01550757|450761965|FG001|Overall Study|Lost to Follow-up|14|||
125309992|NCT01550757|450761966|FG002|Overall Study|Lost to Follow-up|42|||
125309993|NCT01550757|450761967|FG003|Overall Study|Lost to Follow-up|53|||
125309994|NCT01550757|450761964|FG000|Overall Study|Withdrawal by Subject|2|||
125309995|NCT01550757|450761965|FG001|Overall Study|Withdrawal by Subject|0|||
125309996|NCT01550757|450761966|FG002|Overall Study|Withdrawal by Subject|3|||
125309997|NCT01550757|450761967|FG003|Overall Study|Withdrawal by Subject|1|||
125309998|NCT04098809|450761969|FG000|Overall Study|Withdrawal by Subject|1|||
125309999|NCT04098809|450761970|FG001|Overall Study|Withdrawal by Subject|3|||
125310000|NCT04098809|450761969|FG000|Overall Study|Physician Decision|2|||
125310001|NCT04098809|450761970|FG001|Overall Study|Physician Decision|1|||
125310002|NCT02741596|450761971|FG000|Overall Study|Adverse Event|1|||
125088441|NCT00672139|449941402|FG001|Overall Study|Death|23|||
125310003|NCT02741596|450761972|FG001|Overall Study|Adverse Event|5|||
125310004|NCT02741596|450761971|FG000|Overall Study|Lost to Follow-up|1|||
125310005|NCT02741596|450761972|FG001|Overall Study|Lost to Follow-up|1|||
125310006|NCT02741596|450761971|FG000|Overall Study|Physician Decision|2|||
125310007|NCT02741596|450761972|FG001|Overall Study|Physician Decision|1|||
125310008|NCT02741596|450761971|FG000|Overall Study|Pregnancy|3|||
125310009|NCT02741596|450761972|FG001|Overall Study|Pregnancy|1|||
125310010|NCT02741596|450761971|FG000|Overall Study|Other (Unspecified)|0|||
125310011|NCT02741596|450761972|FG001|Overall Study|Other (Unspecified)|3|||
125310012|NCT02741596|450761971|FG000|Overall Study|Subject withdrawn-Other|17|||
125310013|NCT02741596|450761972|FG001|Overall Study|Subject withdrawn-Other|4|||
125310014|NCT02741596|450761971|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
125310015|NCT02741596|450761972|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
125310016|NCT01426958|450761973|FG000|Overall Study|Adverse Event|2|||
125310017|NCT02859246|450761976|FG000|Overall Study|Screen fails|3|||
125310018|NCT02859246|450761976|FG000|Overall Study|Adverse Event|1|||
125310019|NCT02859246|450761976|FG000|Overall Study|Withdrawal by Subject|1|||
125310020|NCT00100789|450761977|FG000|Overall Study|Adverse Event|10|||
125310021|NCT00100789|450761977|FG000|Overall Study|Withdrawal by Subject|1|||
125310022|NCT00100789|450761977|FG000|Overall Study|Progression/relapse|42|||
125310023|NCT00100789|450761977|FG000|Overall Study|Death|2|||
125310024|NCT00100789|450761977|FG000|Overall Study|Not protocol specified|5|||
125310025|NCT00100789|450761977|FG000|Overall Study|Ineligible|3|||
125310026|NCT00100789|450761977|FG000|Overall Study|Never received treatment|1|||
125310027|NCT01746368|450761978|FG000|Overall Study|Lost to Follow-up|2|||
125310028|NCT01746368|450761979|FG001|Overall Study|Lost to Follow-up|0|||
125310029|NCT01746368|450761978|FG000|Overall Study|Withdrawal by Subject|0|||
125310030|NCT01746368|450761979|FG001|Overall Study|Withdrawal by Subject|1|||
125310031|NCT05280717|450761980|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
125310032|NCT05280717|450761981|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
125310033|NCT05280717|450761982|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
125310034|NCT05280717|450761983|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
125310035|NCT05280717|450761984|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
125310036|NCT05280717|450761985|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
125310037|NCT05280717|450761986|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
125310038|NCT05280717|450761980|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
125310039|NCT05280717|450761981|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
125310040|NCT05280717|450761982|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
125310041|NCT05280717|450761983|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
125310042|NCT05280717|450761984|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
125310043|NCT05280717|450761985|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
125310044|NCT05280717|450761986|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
125310045|NCT05280717|450761980|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
125310046|NCT05280717|450761981|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
125310047|NCT05280717|450761982|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
125310048|NCT05280717|450761983|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
125310049|NCT05280717|450761984|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
125310050|NCT05280717|450761985|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
125310051|NCT05280717|450761986|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
125310052|NCT05280717|450761980|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
124976697|NCT00770029|449541865|FG001|Overall Study|Adverse Event|0|||
125088442|NCT00672139|449941401|FG000|Overall Study|Withdrawal by Subject|2|||
125088443|NCT00672139|449941402|FG001|Overall Study|Withdrawal by Subject|11|||
125088444|NCT00672139|449941401|FG000|Overall Study|Adverse Event|4|||
125088445|NCT00672139|449941402|FG001|Overall Study|Adverse Event|7|||
125088446|NCT00672139|449941401|FG000|Overall Study|Physician Decision|2|||
125088447|NCT00672139|449941402|FG001|Overall Study|Physician Decision|0|||
125088448|NCT00672139|449941401|FG000|Overall Study|Lack of Efficacy|4|||
125088449|NCT00672139|449941402|FG001|Overall Study|Lack of Efficacy|1|||
125088450|NCT00672139|449941401|FG000|Overall Study|Protocol Violation|1|||
125088451|NCT00672139|449941402|FG001|Overall Study|Protocol Violation|1|||
125088452|NCT00672139|449941401|FG000|Overall Study|hospice discharge, caregiver requests|3|||
125088453|NCT00672139|449941402|FG001|Overall Study|hospice discharge, caregiver requests|2|||
125088454|NCT01038635|449941406|FG000|Overall Study|Disease Progression|2|||
125088455|NCT01038635|449941407|FG001|Overall Study|Disease Progression|0|||
125088456|NCT01038635|449941408|FG002|Overall Study|Disease Progression|0|||
125088457|NCT01038635|449941409|FG003|Overall Study|Disease Progression|0|||
125088458|NCT01038635|449941410|FG004|Overall Study|Disease Progression|0|||
125088459|NCT01038635|449941411|FG005|Overall Study|Disease Progression|0|||
125088460|NCT01038635|449941412|FG006|Overall Study|Disease Progression|1|||
125088461|NCT01038635|449941413|FG007|Overall Study|Disease Progression|4|||
125088462|NCT01038635|449941414|FG008|Overall Study|Disease Progression|0|||
125088463|NCT01038635|449941406|FG000|Overall Study|Death|0|||
125088464|NCT01038635|449941407|FG001|Overall Study|Death|0|||
125088465|NCT01038635|449941408|FG002|Overall Study|Death|0|||
125088466|NCT01038635|449941409|FG003|Overall Study|Death|0|||
125088467|NCT01038635|449941410|FG004|Overall Study|Death|1|||
125088468|NCT01038635|449941411|FG005|Overall Study|Death|0|||
125088469|NCT01038635|449941412|FG006|Overall Study|Death|1|||
125088470|NCT01038635|449941413|FG007|Overall Study|Death|1|||
125088471|NCT01038635|449941414|FG008|Overall Study|Death|2|||
125088472|NCT01034709|449941415|FG000|Overall Study|Protocol Violation|9|||
125088473|NCT01034709|449941416|FG001|Overall Study|Protocol Violation|16|||
125088474|NCT01562327|449941419|FG000|Overall Study|Adverse Event|2|||
125088475|NCT01562327|449941419|FG000|Overall Study|Lack of Efficacy|1|||
125088476|NCT01562327|449941419|FG000|Overall Study|Participant drop-out|1|||
125088477|NCT01562327|449941419|FG000|Overall Study|Infusion not received at 6 month window|4|||
125088478|NCT03018340|449941420|FG000|Overall Study|Adverse Event|1|||
125088479|NCT03018340|449941421|FG001|Overall Study|Adverse Event|2|||
125088480|NCT03018340|449941420|FG000|Overall Study|Withdrawal by Subject|0|||
125088481|NCT03018340|449941421|FG001|Overall Study|Withdrawal by Subject|8|||
125088482|NCT03018340|449941420|FG000|Overall Study|Lack of Efficacy|0|||
125088483|NCT03018340|449941421|FG001|Overall Study|Lack of Efficacy|1|||
125088484|NCT03018340|449941420|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
125088485|NCT03018340|449941421|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
125088486|NCT03018340|449941420|FG000|Overall Study|Lost to Follow-up|1|||
125088487|NCT03018340|449941421|FG001|Overall Study|Lost to Follow-up|7|||
125088488|NCT03018340|449941420|FG000|Overall Study|Protocol Violation|3|||
125088489|NCT03018340|449941421|FG001|Overall Study|Protocol Violation|7|||
125088490|NCT03018340|449941420|FG000|Overall Study|Not further specified|0|||
125088491|NCT03018340|449941421|FG001|Overall Study|Not further specified|1|||
125088492|NCT01195636|449941426|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
125088493|NCT01195636|449941427|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
125088494|NCT01195636|449941426|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
125088495|NCT01195636|449941427|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
125088496|NCT01195636|449941426|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
125088497|NCT01195636|449941427|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
125088498|NCT01195636|449941426|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
125088499|NCT01195636|449941427|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
125088500|NCT01195636|449941426|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
125088501|NCT01195636|449941427|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
125088502|NCT01195636|449941426|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
125088503|NCT01195636|449941427|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
125088504|NCT01195636|449941426|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
125088505|NCT01195636|449941427|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
125088506|NCT01195636|449941426|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
125088507|NCT01195636|449941427|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
125088508|NCT00203294|449941428|FG000|Overall Study|Withdrawal by Subject|8|||
125088509|NCT00203294|449941429|FG001|Overall Study|Withdrawal by Subject|13|||
125088510|NCT00256204|449941430|FG000|Overall Study|Adverse Event|10|||
125088511|NCT00256204|449941431|FG001|Overall Study|Adverse Event|14|||
125088512|NCT00256204|449941432|FG002|Overall Study|Adverse Event|16|||
125088513|NCT00256204|449941433|FG003|Overall Study|Adverse Event|14|||
125088514|NCT00256204|449941430|FG000|Overall Study|Death|0|||
125088515|NCT00256204|449941431|FG001|Overall Study|Death|1|||
125088516|NCT00256204|449941432|FG002|Overall Study|Death|0|||
125088517|NCT00256204|449941433|FG003|Overall Study|Death|0|||
125088518|NCT00256204|449941430|FG000|Overall Study|Lost to Follow-up|1|||
125088519|NCT00256204|449941431|FG001|Overall Study|Lost to Follow-up|1|||
125088520|NCT00256204|449941432|FG002|Overall Study|Lost to Follow-up|1|||
125088521|NCT00256204|449941433|FG003|Overall Study|Lost to Follow-up|2|||
125088522|NCT00256204|449941430|FG000|Overall Study|Protocol Violation|1|||
125088523|NCT00256204|449941431|FG001|Overall Study|Protocol Violation|0|||
125088524|NCT00256204|449941432|FG002|Overall Study|Protocol Violation|2|||
125088525|NCT00256204|449941433|FG003|Overall Study|Protocol Violation|1|||
125088526|NCT00256204|449941430|FG000|Overall Study|Physician Decision|0|||
125088527|NCT00256204|449941431|FG001|Overall Study|Physician Decision|0|||
125088528|NCT00256204|449941432|FG002|Overall Study|Physician Decision|1|||
125088529|NCT00256204|449941433|FG003|Overall Study|Physician Decision|2|||
125088530|NCT00256204|449941430|FG000|Overall Study|Withdrawal by Subject|17|||
125088531|NCT00256204|449941431|FG001|Overall Study|Withdrawal by Subject|6|||
125088532|NCT00256204|449941432|FG002|Overall Study|Withdrawal by Subject|7|||
125088533|NCT00256204|449941433|FG003|Overall Study|Withdrawal by Subject|5|||
125088534|NCT00256204|449941430|FG000|Overall Study|Need for additional prohibited treatment|38|||
125088535|NCT00256204|449941431|FG001|Overall Study|Need for additional prohibited treatment|28|||
125088536|NCT00256204|449941432|FG002|Overall Study|Need for additional prohibited treatment|27|||
125088537|NCT00256204|449941433|FG003|Overall Study|Need for additional prohibited treatment|25|||
125088538|NCT00808132|449941436|FG000|Overall Study|Adverse Event|34|||
125088539|NCT00808132|449941437|FG001|Overall Study|Adverse Event|33|||
125088540|NCT00808132|449941438|FG002|Overall Study|Adverse Event|16|||
125088541|NCT00808132|449941439|FG003|Overall Study|Adverse Event|31|||
125088542|NCT00808132|449941440|FG004|Overall Study|Adverse Event|33|||
125088543|NCT00808132|449941436|FG000|Overall Study|Death|0|||
125088544|NCT00808132|449941437|FG001|Overall Study|Death|0|||
125088545|NCT00808132|449941438|FG002|Overall Study|Death|0|||
125088546|NCT00808132|449941439|FG003|Overall Study|Death|0|||
125088547|NCT00808132|449941440|FG004|Overall Study|Death|1|||
125088548|NCT00808132|449941436|FG000|Overall Study|Physician Decision|0|||
125088549|NCT00808132|449941437|FG001|Overall Study|Physician Decision|1|||
125088550|NCT00808132|449941438|FG002|Overall Study|Physician Decision|0|||
125088551|NCT00808132|449941439|FG003|Overall Study|Physician Decision|0|||
125088552|NCT00808132|449941440|FG004|Overall Study|Physician Decision|0|||
125088553|NCT00808132|449941436|FG000|Overall Study|Lost to Follow-up|8|||
125088554|NCT00808132|449941437|FG001|Overall Study|Lost to Follow-up|10|||
125088555|NCT00808132|449941438|FG002|Overall Study|Lost to Follow-up|11|||
125088556|NCT00808132|449941439|FG003|Overall Study|Lost to Follow-up|8|||
125088557|NCT00808132|449941440|FG004|Overall Study|Lost to Follow-up|9|||
125088558|NCT00808132|449941436|FG000|Overall Study|Protocol Violation|8|||
125088559|NCT00808132|449941437|FG001|Overall Study|Protocol Violation|9|||
125088560|NCT00808132|449941438|FG002|Overall Study|Protocol Violation|4|||
125088561|NCT00808132|449941439|FG003|Overall Study|Protocol Violation|9|||
125088562|NCT00808132|449941440|FG004|Overall Study|Protocol Violation|5|||
125088563|NCT00808132|449941436|FG000|Overall Study|Withdrawal by Subject|27|||
125088564|NCT00808132|449941437|FG001|Overall Study|Withdrawal by Subject|18|||
125088565|NCT00808132|449941438|FG002|Overall Study|Withdrawal by Subject|2|||
125088566|NCT00808132|449941439|FG003|Overall Study|Withdrawal by Subject|7|||
125088567|NCT00808132|449941440|FG004|Overall Study|Withdrawal by Subject|16|||
125088568|NCT00808132|449941436|FG000|Overall Study|Other|6|||
125088569|NCT00808132|449941437|FG001|Overall Study|Other|4|||
125088570|NCT00808132|449941438|FG002|Overall Study|Other|6|||
125088571|NCT00808132|449941439|FG003|Overall Study|Other|2|||
125088572|NCT00808132|449941440|FG004|Overall Study|Other|15|||
125088573|NCT00808132|449941436|FG000|Overall Study|Randomized, but not treated|10|||
125088574|NCT00808132|449941437|FG001|Overall Study|Randomized, but not treated|7|||
125088575|NCT00808132|449941438|FG002|Overall Study|Randomized, but not treated|9|||
125088576|NCT00808132|449941439|FG003|Overall Study|Randomized, but not treated|8|||
125088577|NCT00808132|449941440|FG004|Overall Study|Randomized, but not treated|9|||
125088578|NCT00808132|449941436|FG000|Overall Study|Unsatisfactory response|5|||
125088579|NCT00808132|449941437|FG001|Overall Study|Unsatisfactory response|6|||
125088580|NCT00808132|449941438|FG002|Overall Study|Unsatisfactory response|6|||
125088581|NCT00808132|449941439|FG003|Overall Study|Unsatisfactory response|4|||
125088582|NCT00808132|449941440|FG004|Overall Study|Unsatisfactory response|12|||
125088583|NCT00550615|449941441|FG000|Overall Study|Withdrawal by Subject|0|||
125088584|NCT00550615|449941442|FG001|Overall Study|Withdrawal by Subject|0|||
125088585|NCT00550615|449941443|FG002|Overall Study|Withdrawal by Subject|2|||
125088586|NCT00550615|449941444|FG003|Overall Study|Withdrawal by Subject|3|||
125088587|NCT00550615|449941441|FG000|Overall Study|Not evaluable|0|||
125088588|NCT00550615|449941442|FG001|Overall Study|Not evaluable|0|||
125088589|NCT00550615|449941443|FG002|Overall Study|Not evaluable|2|||
124865566|NCT00605293|449128795|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
125088590|NCT00550615|449941444|FG003|Overall Study|Not evaluable|7|||
125088591|NCT02405091|449941445|FG000|Overall Study|Adverse Event|16|||
125088592|NCT02405091|449941446|FG001|Overall Study|Adverse Event|10|||
125088593|NCT02405091|449941447|FG002|Overall Study|Adverse Event|0|||
125088594|NCT02405091|449941445|FG000|Overall Study|Protocol Violation|1|||
125088595|NCT02405091|449941446|FG001|Overall Study|Protocol Violation|0|||
125088596|NCT02405091|449941447|FG002|Overall Study|Protocol Violation|0|||
125310053|NCT05280717|450761981|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
125310054|NCT05280717|450761982|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
125310055|NCT05280717|450761983|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
125310056|NCT05280717|450761984|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
125310057|NCT05280717|450761985|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
125310058|NCT05280717|450761986|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
125088597|NCT02405091|449941445|FG000|Overall Study|Noncompliance|1|||
125088598|NCT02405091|449941446|FG001|Overall Study|Noncompliance|6|||
125088599|NCT02405091|449941447|FG002|Overall Study|Noncompliance|2|||
125310059|NCT05280717|450761980|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
125310060|NCT05280717|450761981|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
125310061|NCT05280717|450761982|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
125310062|NCT05280717|450761983|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
125310063|NCT05280717|450761984|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
125310064|NCT05280717|450761985|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
125310065|NCT05280717|450761986|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
125310066|NCT05280717|450761980|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
125310067|NCT05280717|450761981|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
125310068|NCT05280717|450761982|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
125310069|NCT05280717|450761983|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
125310070|NCT05280717|450761984|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
125310071|NCT05280717|450761985|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
125310072|NCT05280717|450761986|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
125310073|NCT00080301|450761987|FG000|Overall Study|Randomized but Never Treated|5|||
125310074|NCT00080301|450761988|FG001|Overall Study|Randomized but Never Treated|10|||
125310075|NCT00080301|450761987|FG000|Overall Study|Still on Treatment as of CSR date|0|||
125310076|NCT00080301|450761988|FG001|Overall Study|Still on Treatment as of CSR date|1|||
125310077|NCT00740584|450761989|FG000|Overall Study|Withdrawal by Subject|1|||
125310078|NCT02073682|450761997|FG000|Overall Study|Low Creatinine Clearance|1|||
125310079|NCT02073682|450761998|FG001|Overall Study|Low Creatinine Clearance|2|||
125310080|NCT02073682|450761997|FG000|Overall Study|Death|86|||
125310081|NCT02073682|450761998|FG001|Overall Study|Death|100|||
125310082|NCT02073682|450761997|FG000|Overall Study|Cancer Cured|10|||
125310083|NCT02073682|450761998|FG001|Overall Study|Cancer Cured|15|||
125310084|NCT02073682|450761997|FG000|Overall Study|ID: Patient Noncompliance|1|||
125310085|NCT02073682|450761998|FG001|Overall Study|ID: Patient Noncompliance|2|||
125310086|NCT02073682|450761997|FG000|Overall Study|ID: Palliative Treatment Only|10|||
124976698|NCT01174446|449541870|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
125088600|NCT02405091|449941445|FG000|Overall Study|Withdrawal by Subject|4|||
125088601|NCT02405091|449941446|FG001|Overall Study|Withdrawal by Subject|8|||
125088602|NCT02405091|449941447|FG002|Overall Study|Withdrawal by Subject|0|||
125088603|NCT02405091|449941445|FG000|Overall Study|Death|0|||
125088604|NCT02405091|449941446|FG001|Overall Study|Death|1|||
125088605|NCT02405091|449941447|FG002|Overall Study|Death|0|||
125088606|NCT02405091|449941445|FG000|Overall Study|Lost to Follow-up|5|||
125088607|NCT02405091|449941446|FG001|Overall Study|Lost to Follow-up|6|||
125088608|NCT02405091|449941447|FG002|Overall Study|Lost to Follow-up|0|||
125088609|NCT02405091|449941445|FG000|Overall Study|Physician Decision|2|||
125088610|NCT02405091|449941446|FG001|Overall Study|Physician Decision|2|||
125088611|NCT02405091|449941447|FG002|Overall Study|Physician Decision|0|||
125088612|NCT00247962|449941465|FG000|Overall Study|Adverse Event|15|||
125088613|NCT00247962|449941466|FG001|Overall Study|Adverse Event|12|||
125088614|NCT00247962|449941465|FG000|Overall Study|Lost to Follow-up|3|||
125088615|NCT00247962|449941466|FG001|Overall Study|Lost to Follow-up|1|||
125088616|NCT00247962|449941465|FG000|Overall Study|Physician Decision|0|||
125088617|NCT00247962|449941466|FG001|Overall Study|Physician Decision|1|||
125088618|NCT00247962|449941465|FG000|Overall Study|Protocol Violation|1|||
125088619|NCT00247962|449941466|FG001|Overall Study|Protocol Violation|1|||
125088620|NCT00247962|449941465|FG000|Overall Study|Withdrawal by Subject|3|||
125088621|NCT00247962|449941466|FG001|Overall Study|Withdrawal by Subject|2|||
125088622|NCT00247962|449941465|FG000|Overall Study|Lack of Efficacy|4|||
125088623|NCT00247962|449941466|FG001|Overall Study|Lack of Efficacy|2|||
125088624|NCT01955005|449941467|FG000|Overall Study|Withdrawal by Subject|3|||
125088625|NCT01955005|449941468|FG001|Overall Study|Withdrawal by Subject|5|||
125088626|NCT02555722|449941473|FG000|Week 2|Adverse Event|0|||
125088627|NCT02555722|449941474|FG001|Week 2|Adverse Event|1|||
125088628|NCT02555722|449941473|FG000|Week 2|Withdrawal by Subject|1|||
125088629|NCT02555722|449941474|FG001|Week 2|Withdrawal by Subject|0|||
125088630|NCT02555722|449941473|FG000|Month 1|Lens Discomfort|1|||
125088631|NCT02555722|449941474|FG001|Month 1|Lens Discomfort|0|||
125088632|NCT02555722|449941473|FG000|Month 2|Withdrawal by Subject|3|||
125088633|NCT02555722|449941474|FG001|Month 2|Withdrawal by Subject|0|||
125088634|NCT02555722|449941473|FG000|Month 2|Lost to Follow-up|1|||
125088635|NCT02555722|449941474|FG001|Month 2|Lost to Follow-up|0|||
125088636|NCT00352027|449941475|FG000|Overall Study|Progressive disease|3|||
125088637|NCT00702949|449941476|FG000|Overall Study|Refusal|3|||
125088638|NCT00702949|449941477|FG001|Overall Study|Refusal|2|||
125088639|NCT00702949|449941478|FG002|Overall Study|Refusal|2|||
125088640|NCT00702949|449941476|FG000|Overall Study|Adverse Event|1|||
125088641|NCT00702949|449941477|FG001|Overall Study|Adverse Event|6|||
125088642|NCT00702949|449941478|FG002|Overall Study|Adverse Event|3|||
125088643|NCT00702949|449941476|FG000|Overall Study|Other Medical Reason/unknown|1|||
125088644|NCT00702949|449941477|FG001|Overall Study|Other Medical Reason/unknown|1|||
125088645|NCT00702949|449941478|FG002|Overall Study|Other Medical Reason/unknown|3|||
125088646|NCT00598585|449941479|FG000|Overall Study|Lost to Follow-up|1|||
125088647|NCT00598585|449941480|FG001|Overall Study|Lost to Follow-up|0|||
125088648|NCT00135694|449941482|FG000|Overall Study|Adverse Event|17|||
125088649|NCT00135694|449941483|FG001|Overall Study|Adverse Event|4|||
125088650|NCT00135694|449941484|FG002|Overall Study|Adverse Event|0|||
125088651|NCT00135694|449941482|FG000|Overall Study|Death|14|||
125088652|NCT00135694|449941483|FG001|Overall Study|Death|1|||
125088653|NCT00135694|449941484|FG002|Overall Study|Death|2|||
125088654|NCT00135694|449941482|FG000|Overall Study|Lost to Follow-up|8|||
125088655|NCT00135694|449941483|FG001|Overall Study|Lost to Follow-up|7|||
125088656|NCT00135694|449941484|FG002|Overall Study|Lost to Follow-up|1|||
125088657|NCT00135694|449941482|FG000|Overall Study|Withdrawal by Subject|41|||
125088658|NCT00135694|449941483|FG001|Overall Study|Withdrawal by Subject|7|||
125088659|NCT00135694|449941484|FG002|Overall Study|Withdrawal by Subject|4|||
125088660|NCT00135694|449941482|FG000|Overall Study|Protocol Violation|19|||
125088661|NCT00135694|449941483|FG001|Overall Study|Protocol Violation|1|||
125088662|NCT00135694|449941484|FG002|Overall Study|Protocol Violation|0|||
125088663|NCT00135694|449941482|FG000|Overall Study|Hepatitis C related reasons|39|||
125088664|NCT00135694|449941483|FG001|Overall Study|Hepatitis C related reasons|1|||
125088665|NCT00135694|449941484|FG002|Overall Study|Hepatitis C related reasons|0|||
125088666|NCT00135694|449941482|FG000|Overall Study|Ineligible for Random assignment|42|||
125088667|NCT00135694|449941483|FG001|Overall Study|Ineligible for Random assignment|0|||
125088668|NCT00135694|449941484|FG002|Overall Study|Ineligible for Random assignment|0|||
125088669|NCT03922711|449941486|FG000|Overall Study|Adverse Event|3|||
125088670|NCT03922711|449941487|FG001|Overall Study|Adverse Event|2|||
125088671|NCT03922711|449941488|FG002|Overall Study|Adverse Event|2|||
125088672|NCT03922711|449941486|FG000|Overall Study|Protocol Violation|1|||
125088673|NCT03922711|449941487|FG001|Overall Study|Protocol Violation|0|||
125088674|NCT03922711|449941488|FG002|Overall Study|Protocol Violation|0|||
125088675|NCT03922711|449941486|FG000|Overall Study|Withdrawal by Subject|0|||
125088676|NCT03922711|449941487|FG001|Overall Study|Withdrawal by Subject|3|||
125088677|NCT03922711|449941488|FG002|Overall Study|Withdrawal by Subject|1|||
125088678|NCT03922711|449941486|FG000|Overall Study|Not further specified|0|||
125088679|NCT03922711|449941487|FG001|Overall Study|Not further specified|0|||
125088680|NCT03922711|449941488|FG002|Overall Study|Not further specified|1|||
125088681|NCT03147495|449941491|FG000|Overall Study|Physician Decision|0|||
125088682|NCT03147495|449941492|FG001|Overall Study|Physician Decision|6|||
125088683|NCT02607735|449941493|FG000|Primary Study|Randomized but Never Treated|1|||
125088684|NCT02607735|449941494|FG001|Primary Study|Randomized but Never Treated|0|||
125088685|NCT02607735|449941495|FG002|Primary Study|Randomized but Never Treated|0|||
125088686|NCT02607735|449941493|FG000|Primary Study|Lost to Follow-up|4|||
125088687|NCT02607735|449941494|FG001|Primary Study|Lost to Follow-up|0|||
125088688|NCT02607735|449941495|FG002|Primary Study|Lost to Follow-up|0|||
125088689|NCT02607735|449941493|FG000|Primary Study|Withdrew Consent|2|||
125088690|NCT02607735|449941494|FG001|Primary Study|Withdrew Consent|0|||
125088691|NCT02607735|449941495|FG002|Primary Study|Withdrew Consent|0|||
125088692|NCT02607735|449941493|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
125088693|NCT02607735|449941494|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
125088694|NCT02607735|449941495|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
125088695|NCT02607735|449941493|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
125088696|NCT02607735|449941494|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
125088697|NCT02607735|449941495|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
125088698|NCT00877890|449941500|FG000|Overall Study|Adverse Event|6|||
125088699|NCT00877890|449941501|FG001|Overall Study|Adverse Event|6|||
124865567|NCT00605293|449128794|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
124865568|NCT00605293|449128795|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
125088700|NCT00877890|449941500|FG000|Overall Study|Lost to Follow-up|5|||
125088701|NCT00877890|449941501|FG001|Overall Study|Lost to Follow-up|5|||
124969461|NCT01439867|449517398|FG000|Overall Study|Non-compliance|0|||
125088702|NCT00877890|449941500|FG000|Overall Study|Protocol Violation|0|||
125088703|NCT00877890|449941501|FG001|Overall Study|Protocol Violation|1|||
125088704|NCT00877890|449941500|FG000|Overall Study|Withdrawal of Consent|6|||
125088705|NCT00877890|449941501|FG001|Overall Study|Withdrawal of Consent|12|||
125088706|NCT00877890|449941500|FG000|Overall Study|Investigator Decision|0|||
125088707|NCT00877890|449941501|FG001|Overall Study|Investigator Decision|2|||
125088708|NCT00877890|449941500|FG000|Overall Study|Loss of Glucose Control|3|||
125088709|NCT00877890|449941501|FG001|Overall Study|Loss of Glucose Control|4|||
125088710|NCT00742391|449941502|FG000|Overall Study|Adverse Event|2|||
125088711|NCT00742391|449941503|FG001|Overall Study|Adverse Event|1|||
125088712|NCT00742391|449941502|FG000|Overall Study|Lost to Follow-up|1|||
125088713|NCT00742391|449941503|FG001|Overall Study|Lost to Follow-up|0|||
125088714|NCT00742391|449941502|FG000|Overall Study|Protocol Violation|1|||
125088715|NCT00742391|449941503|FG001|Overall Study|Protocol Violation|0|||
125088716|NCT02363322|449941520|FG000|Overall Study|Lost to Follow-up|1|||
125088717|NCT02363322|449941521|FG001|Overall Study|Lost to Follow-up|0|||
125088718|NCT01230827|449941522|FG000|Overall Study|Lost to Follow-up|0|||
125088719|NCT01230827|449941523|FG001|Overall Study|Lost to Follow-up|0|||
125088720|NCT01230827|449941524|FG002|Overall Study|Lost to Follow-up|1|||
125088721|NCT01230827|449941525|FG003|Overall Study|Lost to Follow-up|3|||
125088722|NCT01230827|449941522|FG000|Overall Study|Withdrawal by Subject|1|||
125088723|NCT01230827|449941523|FG001|Overall Study|Withdrawal by Subject|0|||
125088724|NCT01230827|449941524|FG002|Overall Study|Withdrawal by Subject|3|||
124865569|NCT00605293|449128794|FG000|Overall Study|Principal Investigator Decision|0|||
124865570|NCT00605293|449128795|FG001|Overall Study|Principal Investigator Decision|1|||
124865571|NCT00381940|449128796|FG000|Overall Study|Lack of Efficacy|3|||
124865572|NCT00381940|449128796|FG000|Overall Study|Protocol Violation|1|||
124865573|NCT00381940|449128796|FG000|Overall Study|Ineligible|1|||
124865574|NCT03137303|449128798|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
124865575|NCT03137303|449128799|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
124865576|NCT03137303|449128798|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
124865577|NCT03137303|449128799|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
124865578|NCT03137303|449128798|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
124865579|NCT03137303|449128799|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
124865580|NCT03137303|449128798|FG000|T3: 9-month Follow-up|Death|1|||
124865581|NCT03137303|449128799|FG001|T3: 9-month Follow-up|Death|0|||
124865582|NCT03137303|449128798|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
124865583|NCT03137303|449128799|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
124865584|NCT03137303|449128798|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
124865585|NCT03137303|449128799|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
124865586|NCT03137303|449128798|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
124865587|NCT03137303|449128799|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
124865588|NCT03561090|449128802|FG000|Overall Study|Adverse Event|11|||
124865589|NCT03561090|449128803|FG001|Overall Study|Adverse Event|7|||
124865590|NCT03561090|449128802|FG000|Overall Study|Non-Compliance With Study Drug|2|||
124865591|NCT03561090|449128803|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124865592|NCT03561090|449128802|FG000|Overall Study|Protocol Violation|2|||
124865593|NCT03561090|449128803|FG001|Overall Study|Protocol Violation|2|||
124865594|NCT03561090|449128802|FG000|Overall Study|Withdrawal by Subject|7|||
124865595|NCT03561090|449128803|FG001|Overall Study|Withdrawal by Subject|7|||
124865596|NCT03561090|449128802|FG000|Overall Study|Lost to Follow-up|7|||
124865597|NCT03561090|449128803|FG001|Overall Study|Lost to Follow-up|2|||
124865598|NCT03561090|449128802|FG000|Overall Study|Study Terminated by Sponsor|10|||
124865599|NCT03561090|449128803|FG001|Overall Study|Study Terminated by Sponsor|15|||
124865600|NCT03561090|449128802|FG000|Overall Study|Randomized by Mistake|1|||
124865601|NCT03561090|449128803|FG001|Overall Study|Randomized by Mistake|1|||
124865602|NCT03561090|449128802|FG000|Overall Study|Other Not Specified|0|||
124865603|NCT03561090|449128803|FG001|Overall Study|Other Not Specified|2|||
124865604|NCT04162769|449128810|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
124865605|NCT04162769|449128811|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
124865606|NCT04162769|449128812|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
124865607|NCT04162769|449128813|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
124865608|NCT04162769|449128810|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
124865609|NCT04162769|449128811|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
124865610|NCT04162769|449128812|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
125310087|NCT02073682|450761998|FG001|Overall Study|ID: Palliative Treatment Only|7|||
125310088|NCT02073682|450761997|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
125310089|NCT02073682|450761998|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
125310090|NCT02073682|450761997|FG000|Overall Study|Platelet Count <50,000/mL|1|||
125310091|NCT02073682|450761998|FG001|Overall Study|Platelet Count <50,000/mL|2|||
125310092|NCT02073682|450761997|FG000|Overall Study|Surgery/Medical Procedure|3|||
124865611|NCT04162769|449128813|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
124865612|NCT04162769|449128810|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
124865613|NCT04162769|449128811|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
124865614|NCT04162769|449128812|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
124865615|NCT04162769|449128813|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
124865616|NCT04162769|449128810|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
125088725|NCT01230827|449941525|FG003|Overall Study|Withdrawal by Subject|2|||
125088726|NCT01230827|449941522|FG000|Overall Study|Lack of Efficacy|14|||
125088727|NCT01230827|449941523|FG001|Overall Study|Lack of Efficacy|1|||
125088728|NCT01230827|449941524|FG002|Overall Study|Lack of Efficacy|2|||
125198612|NCT02836236|450350983|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
124865617|NCT04162769|449128811|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
124865618|NCT04162769|449128812|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
124865619|NCT04162769|449128813|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
124865620|NCT04162769|449128810|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
124865621|NCT04162769|449128811|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
124865622|NCT04162769|449128812|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
124976699|NCT01174446|449541871|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
124976700|NCT01174446|449541872|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
124976701|NCT01174446|449541873|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
124976702|NCT01174446|449541870|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
124976703|NCT01174446|449541871|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
124976704|NCT01174446|449541872|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
124976705|NCT01174446|449541873|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
125088729|NCT01230827|449941525|FG003|Overall Study|Lack of Efficacy|3|||
125088730|NCT01230827|449941522|FG000|Overall Study|Adverse Event|4|||
125088731|NCT01230827|449941523|FG001|Overall Study|Adverse Event|2|||
125088732|NCT01230827|449941524|FG002|Overall Study|Adverse Event|3|||
125310093|NCT02073682|450761998|FG001|Overall Study|Surgery/Medical Procedure|1|||
125310094|NCT02073682|450761997|FG000|Overall Study|Withdrawal by Subject|6|||
125310095|NCT02073682|450761998|FG001|Overall Study|Withdrawal by Subject|8|||
125310096|NCT02073682|450761997|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
125310097|NCT02073682|450761998|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
125310098|NCT02073682|450761997|FG000|Overall Study|Cancer Progression|53|||
125310099|NCT02073682|450761998|FG001|Overall Study|Cancer Progression|33|||
125310100|NCT02073682|450761997|FG000|Overall Study|Protocol Violation|1|||
125310101|NCT02073682|450761998|FG001|Overall Study|Protocol Violation|0|||
125310102|NCT02073682|450761997|FG000|Overall Study|Adverse Event|79|||
125310103|NCT02073682|450761998|FG001|Overall Study|Adverse Event|62|||
125310104|NCT02073682|450761997|FG000|Overall Study|No reason provided|11|||
125310105|NCT02073682|450761998|FG001|Overall Study|No reason provided|9|||
125310106|NCT02073682|450761997|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
125310107|NCT02073682|450761998|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
125310108|NCT02073682|450761997|FG000|Overall Study|Lost to Follow-up|1|||
125310109|NCT02073682|450761998|FG001|Overall Study|Lost to Follow-up|1|||
125310110|NCT02073682|450761997|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
125310111|NCT02073682|450761998|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
125310112|NCT03461146|450761999|FG000|Overall Study|Adverse Event|2|||
125310113|NCT03461146|450761999|FG000|Overall Study|Physician Decision|1|||
125310114|NCT00181766|450762000|FG000|Overall Study|Lost to Follow-up|6|||
125310115|NCT00181766|450762000|FG000|Overall Study|Adverse Event|4|||
125310116|NCT00181766|450762000|FG000|Overall Study|non-compliance|2|||
125310117|NCT00855816|450762001|FG000|Overall Study|Withdrawal by Subject|22|||
125310118|NCT00855816|450762002|FG001|Overall Study|Withdrawal by Subject|15|||
125310119|NCT00855816|450762001|FG000|Overall Study|Lost to Follow-up|3|||
125310120|NCT00855816|450762002|FG001|Overall Study|Lost to Follow-up|5|||
125310121|NCT00855816|450762001|FG000|Overall Study|Death|1|||
125310122|NCT00855816|450762002|FG001|Overall Study|Death|0|||
125310123|NCT00855816|450762001|FG000|Overall Study|Became ineligible|0|||
125310124|NCT00855816|450762002|FG001|Overall Study|Became ineligible|1|||
125088733|NCT01230827|449941525|FG003|Overall Study|Adverse Event|7|||
125088734|NCT01230827|449941522|FG000|Overall Study|Recovery|0|||
125088735|NCT01230827|449941523|FG001|Overall Study|Recovery|6|||
125088736|NCT01230827|449941524|FG002|Overall Study|Recovery|0|||
125088737|NCT01230827|449941525|FG003|Overall Study|Recovery|0|||
125088738|NCT01230827|449941522|FG000|Overall Study|Study terminated by Sponsor|0|||
125088739|NCT01230827|449941523|FG001|Overall Study|Study terminated by Sponsor|2|||
125088740|NCT01230827|449941524|FG002|Overall Study|Study terminated by Sponsor|56|||
125088741|NCT01230827|449941525|FG003|Overall Study|Study terminated by Sponsor|63|||
125088742|NCT00805142|449941526|FG000|Titration Period|Adverse Event|3|||
125088743|NCT00805142|449941527|FG001|Titration Period|Adverse Event|3|||
125088744|NCT00805142|449941526|FG000|Titration Period|Lack of Efficacy|1|||
125088745|NCT00805142|449941527|FG001|Titration Period|Lack of Efficacy|1|||
125088746|NCT00805142|449941526|FG000|Titration Period|Lost to Follow-up|0|||
125217402|NCT05415462|450423518|FG000|Overall Study|Lost to Follow-up|72|||
125310125|NCT01965704|450762006|FG000|Overall Study|Withdrawal by Subject|2|||
125310126|NCT01965704|450762007|FG001|Overall Study|Withdrawal by Subject|2|||
124865623|NCT04162769|449128813|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
124865624|NCT04162769|449128810|FG000|Double-blind Treatment (12-Week)|Other|0|||
125088747|NCT00805142|449941527|FG001|Titration Period|Lost to Follow-up|1|||
125088748|NCT00805142|449941526|FG000|Titration Period|Disease Progression|2|||
125310127|NCT01965704|450762008|FG002|Overall Study|Withdrawal by Subject|1|||
125310128|NCT01965704|450762009|FG003|Overall Study|Withdrawal by Subject|1|||
125310129|NCT01965704|450762006|FG000|Overall Study|Delivered at home|1|||
125310130|NCT01965704|450762007|FG001|Overall Study|Delivered at home|1|||
125310131|NCT01965704|450762008|FG002|Overall Study|Delivered at home|0|||
125310132|NCT01965704|450762009|FG003|Overall Study|Delivered at home|0|||
125310133|NCT01965704|450762006|FG000|Overall Study|Experienced complications|0|||
125310134|NCT01965704|450762007|FG001|Overall Study|Experienced complications|0|||
125310135|NCT01965704|450762008|FG002|Overall Study|Experienced complications|2|||
125310136|NCT01965704|450762009|FG003|Overall Study|Experienced complications|2|||
125310137|NCT01965704|450762006|FG000|Overall Study|Adverse Event|0|||
125310138|NCT01965704|450762007|FG001|Overall Study|Adverse Event|0|||
125310139|NCT01965704|450762008|FG002|Overall Study|Adverse Event|1|||
125310140|NCT01965704|450762009|FG003|Overall Study|Adverse Event|1|||
125310141|NCT01965704|450762006|FG000|Overall Study|Did not meet inclusion criteria|0|||
124865625|NCT04162769|449128811|FG001|Double-blind Treatment (12-Week)|Other|1|||
124865626|NCT04162769|449128812|FG002|Double-blind Treatment (12-Week)|Other|1|||
124865627|NCT04162769|449128813|FG003|Double-blind Treatment (12-Week)|Other|0|||
124865628|NCT04162769|449128810|FG000|OLE Period (52-Week)|Adverse Event|0|||
124865629|NCT04162769|449128811|FG001|OLE Period (52-Week)|Adverse Event|0|||
124865630|NCT04162769|449128812|FG002|OLE Period (52-Week)|Adverse Event|0|||
124865631|NCT04162769|449128813|FG003|OLE Period (52-Week)|Adverse Event|5|||
124865632|NCT04162769|449128810|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
124865633|NCT04162769|449128811|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
124865634|NCT04162769|449128812|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
124865635|NCT04162769|449128813|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
124865636|NCT04162769|449128810|FG000|OLE Period (52-Week)|Physician Decision|0|||
124865637|NCT04162769|449128811|FG001|OLE Period (52-Week)|Physician Decision|0|||
124865638|NCT04162769|449128812|FG002|OLE Period (52-Week)|Physician Decision|0|||
124865639|NCT04162769|449128813|FG003|OLE Period (52-Week)|Physician Decision|1|||
124865640|NCT04162769|449128810|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
124865641|NCT04162769|449128811|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
124865642|NCT04162769|449128812|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
124865643|NCT04162769|449128813|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
124865644|NCT04162769|449128810|FG000|OLE Period (52-Week)|Protocol deviation|0|||
124865645|NCT04162769|449128811|FG001|OLE Period (52-Week)|Protocol deviation|0|||
124865646|NCT04162769|449128812|FG002|OLE Period (52-Week)|Protocol deviation|0|||
124865647|NCT04162769|449128813|FG003|OLE Period (52-Week)|Protocol deviation|2|||
124865648|NCT02163733|449128814|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
124865649|NCT02163733|449128815|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
124865650|NCT02163733|449128816|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
124865651|NCT02163733|449128814|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
124865652|NCT02163733|449128815|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
124865653|NCT02163733|449128816|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
124865654|NCT02633800|449128817|FG000|Overall Study|Death|3|||
124865655|NCT02633800|449128818|FG001|Overall Study|Death|3|||
124865656|NCT02633800|449128817|FG000|Overall Study|Reason not provided|1|||
124865657|NCT02633800|449128818|FG001|Overall Study|Reason not provided|0|||
124865658|NCT02633800|449128817|FG000|Overall Study|Radiologic(al) progression|23|||
124865659|NCT02633800|449128818|FG001|Overall Study|Radiologic(al) progression|23|||
124865660|NCT02633800|449128817|FG000|Overall Study|Clinical progression|3|||
124865661|NCT02633800|449128818|FG001|Overall Study|Clinical progression|6|||
124865662|NCT02633800|449128817|FG000|Overall Study|Study terminated by sponsor|6|||
124865663|NCT02633800|449128818|FG001|Overall Study|Study terminated by sponsor|5|||
124865664|NCT02633800|449128817|FG000|Overall Study|Adverse event, non-fatal|7|||
124865665|NCT02633800|449128818|FG001|Overall Study|Adverse event, non-fatal|2|||
124865666|NCT02633800|449128817|FG000|Overall Study|Withdrawal by Subject|0|||
124865667|NCT02633800|449128818|FG001|Overall Study|Withdrawal by Subject|3|||
124865668|NCT02633800|449128817|FG000|Overall Study|Patient Request|1|||
124865669|NCT02633800|449128818|FG001|Overall Study|Patient Request|1|||
124865670|NCT01358968|449128826|FG000|Period 2|Adverse Event|0|||
124865671|NCT01358968|449128827|FG001|Period 2|Adverse Event|1|||
124865672|NCT01358968|449128828|FG002|Period 2|Adverse Event|0|||
124865673|NCT01358968|449128829|FG003|Period 2|Adverse Event|0|||
124865674|NCT01358968|449128826|FG000|Continued Access Phase|Progression of Disease|0|||
124865675|NCT01358968|449128827|FG001|Continued Access Phase|Progression of Disease|0|||
125310142|NCT01965704|450762007|FG001|Overall Study|Did not meet inclusion criteria|0|||
124865676|NCT01358968|449128828|FG002|Continued Access Phase|Progression of Disease|8|||
124865677|NCT01358968|449128829|FG003|Continued Access Phase|Progression of Disease|4|||
124865678|NCT01358968|449128826|FG000|Continued Access Phase|Protocol Violation|0|||
124865679|NCT01358968|449128827|FG001|Continued Access Phase|Protocol Violation|0|||
124865680|NCT01358968|449128828|FG002|Continued Access Phase|Protocol Violation|0|||
124865681|NCT01358968|449128829|FG003|Continued Access Phase|Protocol Violation|2|||
124865682|NCT01358968|449128826|FG000|Continued Access Phase|Withdrawal by Subject|0|||
124865683|NCT01358968|449128827|FG001|Continued Access Phase|Withdrawal by Subject|0|||
124865684|NCT01358968|449128828|FG002|Continued Access Phase|Withdrawal by Subject|3|||
124865685|NCT01358968|449128829|FG003|Continued Access Phase|Withdrawal by Subject|0|||
125310143|NCT01965704|450762008|FG002|Overall Study|Did not meet inclusion criteria|1|||
125310144|NCT01965704|450762009|FG003|Overall Study|Did not meet inclusion criteria|1|||
125088749|NCT00805142|449941527|FG001|Titration Period|Disease Progression|1|||
125310145|NCT00687804|450762017|FG000|Core Study|Adverse Event|5|||
125310146|NCT00687804|450762018|FG001|Core Study|Adverse Event|3|||
125310147|NCT00687804|450762019|FG002|Core Study|Adverse Event|3|||
125310148|NCT00687804|450762017|FG000|Core Study|Abnormal laboratory value(s)|1|||
125310149|NCT00687804|450762018|FG001|Core Study|Abnormal laboratory value(s)|0|||
125310150|NCT00687804|450762019|FG002|Core Study|Abnormal laboratory value(s)|0|||
125310151|NCT00687804|450762017|FG000|Core Study|Lack of Efficacy|1|||
125310152|NCT00687804|450762018|FG001|Core Study|Lack of Efficacy|1|||
125310153|NCT00687804|450762019|FG002|Core Study|Lack of Efficacy|1|||
125310154|NCT00687804|450762017|FG000|Core Study|Withdrawal by Subject|4|||
125310155|NCT00687804|450762018|FG001|Core Study|Withdrawal by Subject|7|||
125310156|NCT00687804|450762019|FG002|Core Study|Withdrawal by Subject|7|||
125310157|NCT00687804|450762017|FG000|Core Study|Lost to Follow-up|0|||
125310158|NCT00687804|450762018|FG001|Core Study|Lost to Follow-up|1|||
125310159|NCT00687804|450762019|FG002|Core Study|Lost to Follow-up|0|||
125310160|NCT00687804|450762017|FG000|Core Study|Death|2|||
125310161|NCT00687804|450762018|FG001|Core Study|Death|2|||
125310162|NCT00687804|450762019|FG002|Core Study|Death|2|||
125310163|NCT00687804|450762017|FG000|Core Study|Protocol Violation|1|||
125310164|NCT00687804|450762018|FG001|Core Study|Protocol Violation|1|||
125310165|NCT00687804|450762019|FG002|Core Study|Protocol Violation|0|||
125310166|NCT00687804|450762017|FG000|Open-Label Extension Study|Adverse Event|2|||
125310167|NCT00687804|450762018|FG001|Open-Label Extension Study|Adverse Event|2|||
125310168|NCT00687804|450762019|FG002|Open-Label Extension Study|Adverse Event|2|||
125310169|NCT00687804|450762017|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
125310170|NCT00687804|450762018|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
125310171|NCT00687804|450762019|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
125088750|NCT00805142|449941526|FG000|Titration Period|Withdrawal of consent|0|||
125088751|NCT00805142|449941527|FG001|Titration Period|Withdrawal of consent|1|||
125088752|NCT00805142|449941526|FG000|Titration Period|Other|0|||
125310172|NCT00687804|450762017|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
125310173|NCT00687804|450762018|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
125310174|NCT00687804|450762019|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
125310175|NCT00687804|450762017|FG000|Open-Label Extension Study|Administrative problems|1|||
125310176|NCT00687804|450762018|FG001|Open-Label Extension Study|Administrative problems|1|||
125310177|NCT00687804|450762019|FG002|Open-Label Extension Study|Administrative problems|0|||
125310178|NCT00687804|450762017|FG000|Open-Label Extension Study|Death|2|||
125310179|NCT00687804|450762018|FG001|Open-Label Extension Study|Death|3|||
125310180|NCT00687804|450762019|FG002|Open-Label Extension Study|Death|3|||
125310181|NCT04390243|450762020|FG000|Overall Study|Death|1|||
125310182|NCT04390243|450762020|FG000|Overall Study|Disease Progression|4|||
125310183|NCT04390243|450762020|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
124865686|NCT01358968|449128826|FG000|Continued Access Phase|Death|0|||
124865687|NCT01358968|449128827|FG001|Continued Access Phase|Death|0|||
124865688|NCT01358968|449128828|FG002|Continued Access Phase|Death|1|||
124865689|NCT01358968|449128829|FG003|Continued Access Phase|Death|1|||
124865690|NCT00476476|449128836|FG000|Overall Study|Adverse Event|2|||
124865691|NCT00476476|449128837|FG001|Overall Study|Adverse Event|7|||
124865692|NCT00476476|449128836|FG000|Overall Study|Progressive Disease|0|||
124865693|NCT00476476|449128837|FG001|Overall Study|Progressive Disease|17|||
124865694|NCT00423176|449128842|FG000|Overall Study|Adverse Event|4|||
124865695|NCT00423176|449128843|FG001|Overall Study|Adverse Event|6|||
124865696|NCT00423176|449128842|FG000|Overall Study|Treatment Failure|1|||
124865697|NCT00423176|449128843|FG001|Overall Study|Treatment Failure|6|||
124865698|NCT00423176|449128842|FG000|Overall Study|Lost to Follow-up|4|||
124865699|NCT00423176|449128843|FG001|Overall Study|Lost to Follow-up|7|||
124865700|NCT00423176|449128842|FG000|Overall Study|Withdrawal by Subject|4|||
124865701|NCT00423176|449128843|FG001|Overall Study|Withdrawal by Subject|3|||
124865702|NCT00423176|449128842|FG000|Overall Study|Protocol Violation|1|||
124865703|NCT00423176|449128843|FG001|Overall Study|Protocol Violation|3|||
124865704|NCT00423176|449128842|FG000|Overall Study|Did not meet protocol eligibility|2|||
124865705|NCT00423176|449128843|FG001|Overall Study|Did not meet protocol eligibility|4|||
124865706|NCT01654549|449128844|FG000|Overall Study|H.pylori eradication not successful|0|||
124865707|NCT01654549|449128845|FG001|Overall Study|H.pylori eradication not successful|1|||
124865708|NCT05072080|449128846|FG000|Overall Study|Death|0|||
124865709|NCT05072080|449128847|FG001|Overall Study|Death|0|||
124865710|NCT05072080|449128848|FG002|Overall Study|Death|1|||
124865711|NCT05072080|449128849|FG003|Overall Study|Death|0|||
124865712|NCT05072080|449128846|FG000|Overall Study|Lost to Follow-up|65|||
124865713|NCT05072080|449128847|FG001|Overall Study|Lost to Follow-up|70|||
125088753|NCT00805142|449941527|FG001|Titration Period|Other|3|||
125088754|NCT00805142|449941526|FG000|Maintenance Period|Adverse Event|0|||
125088755|NCT00805142|449941527|FG001|Maintenance Period|Adverse Event|1|||
125088756|NCT00805142|449941526|FG000|Maintenance Period|Other|0|||
125310184|NCT00413218|450762023|FG000|Overall Study|Randomized but didn't receive study drug|2|||
125310185|NCT00413218|450762024|FG001|Overall Study|Randomized but didn't receive study drug|8|||
125310186|NCT00413218|450762023|FG000|Overall Study|Death|57|||
124865714|NCT05072080|449128848|FG002|Overall Study|Lost to Follow-up|58|||
125088757|NCT00805142|449941527|FG001|Maintenance Period|Other|1|||
125310187|NCT00413218|450762024|FG001|Overall Study|Death|56|||
124865715|NCT05072080|449128849|FG003|Overall Study|Lost to Follow-up|23|||
124865716|NCT05072080|449128846|FG000|Overall Study|Physician Decision|2|||
124865717|NCT05072080|449128847|FG001|Overall Study|Physician Decision|1|||
124865718|NCT05072080|449128848|FG002|Overall Study|Physician Decision|1|||
124865719|NCT05072080|449128849|FG003|Overall Study|Physician Decision|0|||
124865720|NCT05072080|449128846|FG000|Overall Study|Withdrawal by Subject|45|||
124865721|NCT05072080|449128847|FG001|Overall Study|Withdrawal by Subject|30|||
124865722|NCT05072080|449128848|FG002|Overall Study|Withdrawal by Subject|27|||
124865723|NCT05072080|449128849|FG003|Overall Study|Withdrawal by Subject|7|||
124865724|NCT05072080|449128846|FG000|Overall Study|Sponsor Decision|0|||
124865725|NCT05072080|449128847|FG001|Overall Study|Sponsor Decision|1|||
124865726|NCT05072080|449128848|FG002|Overall Study|Sponsor Decision|0|||
124865727|NCT05072080|449128849|FG003|Overall Study|Sponsor Decision|0|||
124865728|NCT05072080|449128846|FG000|Overall Study|Subject moved|1|||
124865729|NCT05072080|449128847|FG001|Overall Study|Subject moved|3|||
124865730|NCT05072080|449128848|FG002|Overall Study|Subject moved|5|||
124865731|NCT05072080|449128849|FG003|Overall Study|Subject moved|2|||
124865732|NCT05072080|449128846|FG000|Overall Study|Withdrawal by parent|0|||
124865733|NCT05072080|449128847|FG001|Overall Study|Withdrawal by parent|0|||
124865734|NCT05072080|449128848|FG002|Overall Study|Withdrawal by parent|1|||
124865735|NCT05072080|449128849|FG003|Overall Study|Withdrawal by parent|0|||
124865736|NCT05072080|449128846|FG000|Overall Study|Subject was deployed|0|||
124976706|NCT01174446|449541870|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
124976707|NCT01174446|449541871|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
124976708|NCT01174446|449541872|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
124976709|NCT01174446|449541873|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
124976710|NCT01174446|449541870|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
124976711|NCT01174446|449541871|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
124976712|NCT01174446|449541872|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
124976713|NCT01174446|449541873|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
124976714|NCT00847626|449541876|FG000|Overall Study|Adverse Event|10|||
124976715|NCT00847626|449541877|FG001|Overall Study|Adverse Event|10|||
124976716|NCT00847626|449541878|FG002|Overall Study|Adverse Event|6|||
124976717|NCT00847626|449541879|FG003|Overall Study|Adverse Event|19|||
124976718|NCT00847626|449541880|FG004|Overall Study|Adverse Event|11|||
125088758|NCT01021423|449941529|FG000|Overall Study|Study terminated|4|||
125088759|NCT01021423|449941530|FG001|Overall Study|Study terminated|5|||
124976719|NCT00847626|449541881|FG005|Overall Study|Adverse Event|22|||
124976720|NCT00847626|449541882|FG006|Overall Study|Adverse Event|4|||
124976721|NCT00847626|449541883|FG007|Overall Study|Adverse Event|6|||
124976722|NCT00847626|449541884|FG008|Overall Study|Adverse Event|3|||
124976723|NCT00847626|449541885|FG009|Overall Study|Adverse Event|6|||
124976724|NCT00847626|449541886|FG010|Overall Study|Adverse Event|6|||
124976725|NCT00847626|449541876|FG000|Overall Study|Protocol Violation|2|||
124976726|NCT00847626|449541877|FG001|Overall Study|Protocol Violation|1|||
124976727|NCT00847626|449541878|FG002|Overall Study|Protocol Violation|2|||
125088760|NCT02886338|449941531|FG000|Overall Study|Withdrawal by Subject|1|||
125088761|NCT00394654|449941532|FG000|Overall Study|Lost to Follow-up|1|||
125088762|NCT00394654|449941533|FG001|Overall Study|Lost to Follow-up|0|||
125088763|NCT00394654|449941532|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
125088764|NCT00394654|449941533|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
125088765|NCT00122317|449941534|FG000|Overall Study|Death|3|||
125088766|NCT00122317|449941534|FG000|Overall Study|Adverse Event|4|||
125088767|NCT00122317|449941534|FG000|Overall Study|Physician Decision|2|||
125088768|NCT00122317|449941534|FG000|Overall Study|patient non-compliance|1|||
125198613|NCT02836236|450350984|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
125198614|NCT02836236|450350985|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
125198615|NCT02836236|450350986|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
125198616|NCT02836236|450350983|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
125198617|NCT02836236|450350984|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
125198618|NCT02836236|450350985|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
125198619|NCT02836236|450350986|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
125198620|NCT02836236|450350983|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
125198621|NCT02836236|450350984|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
125198622|NCT02836236|450350985|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
125198623|NCT02836236|450350986|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
125198624|NCT02836236|450350983|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
125198625|NCT02836236|450350984|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
125198626|NCT02836236|450350985|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
125198627|NCT02836236|450350986|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
125198628|NCT02836236|450350983|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
125198629|NCT02836236|450350984|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
125198630|NCT02836236|450350985|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
124865737|NCT05072080|449128847|FG001|Overall Study|Subject was deployed|1|||
124865738|NCT05072080|449128848|FG002|Overall Study|Subject was deployed|0|||
124865739|NCT05072080|449128849|FG003|Overall Study|Subject was deployed|0|||
124865740|NCT05072080|449128846|FG000|Overall Study|Subject left site without receiving dose|0|||
124865741|NCT05072080|449128847|FG001|Overall Study|Subject left site without receiving dose|1|||
124865742|NCT05072080|449128848|FG002|Overall Study|Subject left site without receiving dose|0|||
124865743|NCT05072080|449128849|FG003|Overall Study|Subject left site without receiving dose|0|||
124865744|NCT05072080|449128846|FG000|Overall Study|Subject incarcerated|0|||
124865745|NCT05072080|449128847|FG001|Overall Study|Subject incarcerated|1|||
124865746|NCT05072080|449128848|FG002|Overall Study|Subject incarcerated|0|||
124865747|NCT05072080|449128849|FG003|Overall Study|Subject incarcerated|1|||
124865748|NCT05072080|449128846|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
124865749|NCT05072080|449128847|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
124865750|NCT05072080|449128848|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
124865751|NCT05072080|449128849|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
124865752|NCT05072080|449128846|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
124865753|NCT05072080|449128847|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
124865754|NCT05072080|449128848|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
124865755|NCT05072080|449128849|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
124865756|NCT02633137|449128850|FG000|Overall Study|Adverse Event|1|||
124865757|NCT02633137|449128850|FG000|Overall Study|Lack of Efficacy|2|||
124865758|NCT02633137|449128850|FG000|Overall Study|Withdrawal by Subject|1|||
124865759|NCT05554237|449128851|FG000|Part 2 (7 Days)|Adverse Event|0|||
124865760|NCT05554237|449128852|FG001|Part 2 (7 Days)|Adverse Event|0|||
124865761|NCT05554237|449128853|FG002|Part 2 (7 Days)|Adverse Event|0|||
124865762|NCT05554237|449128854|FG003|Part 2 (7 Days)|Adverse Event|0|||
124865763|NCT05554237|449128855|FG004|Part 2 (7 Days)|Adverse Event|2|||
124865764|NCT05554237|449128856|FG005|Part 2 (7 Days)|Adverse Event|0|||
124865765|NCT05554237|449128857|FG006|Part 2 (7 Days)|Adverse Event|0|||
124865766|NCT05554237|449128858|FG007|Part 2 (7 Days)|Adverse Event|0|||
124865767|NCT05554237|449128859|FG008|Part 2 (7 Days)|Adverse Event|0|||
124865768|NCT05554237|449128860|FG009|Part 2 (7 Days)|Adverse Event|1|||
124865769|NCT05554237|449128861|FG010|Part 2 (7 Days)|Adverse Event|0|||
124865770|NCT05554237|449128862|FG011|Part 2 (7 Days)|Adverse Event|0|||
124865771|NCT05554237|449128863|FG012|Part 2 (7 Days)|Adverse Event|1|||
124865772|NCT05554237|449128864|FG013|Part 2 (7 Days)|Adverse Event|0|||
124865773|NCT02395042|449128867|FG000|Treatment 1 Period|Adverse Event|1|||
124865774|NCT02395042|449128868|FG001|Treatment 1 Period|Adverse Event|3|||
124865775|NCT02395042|449128869|FG002|Treatment 1 Period|Adverse Event|1|||
124865776|NCT02395042|449128867|FG000|Treatment 1 Period|Lack of Efficacy|1|||
124865777|NCT02395042|449128868|FG001|Treatment 1 Period|Lack of Efficacy|1|||
124865778|NCT02395042|449128869|FG002|Treatment 1 Period|Lack of Efficacy|0|||
124865779|NCT02395042|449128867|FG000|Treatment 1 Period|Lost to Follow-up|1|||
124865780|NCT02395042|449128868|FG001|Treatment 1 Period|Lost to Follow-up|0|||
124865781|NCT02395042|449128869|FG002|Treatment 1 Period|Lost to Follow-up|0|||
124865782|NCT02395042|449128867|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
124865783|NCT02395042|449128868|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
124865784|NCT02395042|449128869|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
124865785|NCT02395042|449128867|FG000|Treatment 2 Period|Lack of Efficacy|1|||
124976728|NCT00847626|449541879|FG003|Overall Study|Protocol Violation|1|||
124976729|NCT00847626|449541880|FG004|Overall Study|Protocol Violation|1|||
124976730|NCT00847626|449541881|FG005|Overall Study|Protocol Violation|1|||
124976731|NCT00847626|449541882|FG006|Overall Study|Protocol Violation|1|||
124976732|NCT00847626|449541883|FG007|Overall Study|Protocol Violation|1|||
124976733|NCT00847626|449541884|FG008|Overall Study|Protocol Violation|0|||
124976734|NCT00847626|449541885|FG009|Overall Study|Protocol Violation|1|||
124976735|NCT00847626|449541886|FG010|Overall Study|Protocol Violation|1|||
124976736|NCT00847626|449541876|FG000|Overall Study|Lost to Follow-up|0|||
124976737|NCT00847626|449541877|FG001|Overall Study|Lost to Follow-up|1|||
124976738|NCT00847626|449541878|FG002|Overall Study|Lost to Follow-up|1|||
124976739|NCT00847626|449541879|FG003|Overall Study|Lost to Follow-up|1|||
124976740|NCT00847626|449541880|FG004|Overall Study|Lost to Follow-up|0|||
124976741|NCT00847626|449541881|FG005|Overall Study|Lost to Follow-up|3|||
124976742|NCT00847626|449541882|FG006|Overall Study|Lost to Follow-up|1|||
124976743|NCT00847626|449541883|FG007|Overall Study|Lost to Follow-up|3|||
124976744|NCT00847626|449541884|FG008|Overall Study|Lost to Follow-up|1|||
124976745|NCT00847626|449541885|FG009|Overall Study|Lost to Follow-up|0|||
124976746|NCT00847626|449541886|FG010|Overall Study|Lost to Follow-up|1|||
124976747|NCT00847626|449541876|FG000|Overall Study|Withdrawal by Subject|5|||
124976748|NCT00847626|449541877|FG001|Overall Study|Withdrawal by Subject|5|||
124976749|NCT00847626|449541878|FG002|Overall Study|Withdrawal by Subject|3|||
124976750|NCT00847626|449541879|FG003|Overall Study|Withdrawal by Subject|8|||
124976751|NCT00847626|449541880|FG004|Overall Study|Withdrawal by Subject|12|||
124976752|NCT00847626|449541881|FG005|Overall Study|Withdrawal by Subject|9|||
124976753|NCT00847626|449541882|FG006|Overall Study|Withdrawal by Subject|8|||
124976754|NCT00847626|449541883|FG007|Overall Study|Withdrawal by Subject|4|||
124865786|NCT02395042|449128868|FG001|Treatment 2 Period|Lack of Efficacy|1|||
124976755|NCT00847626|449541884|FG008|Overall Study|Withdrawal by Subject|4|||
124976756|NCT00847626|449541885|FG009|Overall Study|Withdrawal by Subject|5|||
124976757|NCT00847626|449541886|FG010|Overall Study|Withdrawal by Subject|2|||
124976758|NCT00847626|449541876|FG000|Overall Study|Lack of Efficacy|3|||
124976759|NCT00847626|449541877|FG001|Overall Study|Lack of Efficacy|1|||
124976760|NCT00847626|449541878|FG002|Overall Study|Lack of Efficacy|0|||
124976761|NCT00847626|449541879|FG003|Overall Study|Lack of Efficacy|1|||
124976762|NCT00847626|449541880|FG004|Overall Study|Lack of Efficacy|2|||
124976763|NCT00847626|449541881|FG005|Overall Study|Lack of Efficacy|0|||
124976764|NCT00847626|449541882|FG006|Overall Study|Lack of Efficacy|6|||
124976765|NCT00847626|449541883|FG007|Overall Study|Lack of Efficacy|2|||
124976766|NCT00847626|449541884|FG008|Overall Study|Lack of Efficacy|5|||
125198631|NCT02836236|450350986|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
124865787|NCT02395042|449128869|FG002|Treatment 2 Period|Lack of Efficacy|0|||
124865788|NCT01324271|449128870|FG000|Overall Study|Lost to Follow-up|3|||
124865789|NCT01324271|449128871|FG001|Overall Study|Lost to Follow-up|0|||
124865790|NCT01324271|449128870|FG000|Overall Study|Physician Decision|1|||
124865791|NCT01324271|449128871|FG001|Overall Study|Physician Decision|0|||
124865792|NCT05130970|449128872|FG000|Overall Study|Adverse Event|1|||
124865793|NCT05130970|449128873|FG001|Overall Study|Adverse Event|1|||
124865794|NCT05130970|449128872|FG000|Overall Study|Death|0|||
124865795|NCT05130970|449128873|FG001|Overall Study|Death|1|||
124865796|NCT05130970|449128872|FG000|Overall Study|Lost to Follow-up|0|||
124865797|NCT05130970|449128873|FG001|Overall Study|Lost to Follow-up|1|||
124865798|NCT05130970|449128872|FG000|Overall Study|Physician Decision|0|||
124865799|NCT05130970|449128873|FG001|Overall Study|Physician Decision|1|||
124865800|NCT05130970|449128872|FG000|Overall Study|Withdrawal by Subject|1|||
124865801|NCT05130970|449128873|FG001|Overall Study|Withdrawal by Subject|1|||
124865802|NCT02308748|449128874|FG000|Period 1|Withdrawal by Subject|0|||
124865803|NCT02308748|449128875|FG001|Period 1|Withdrawal by Subject|0|||
124865804|NCT02308748|449128876|FG002|Period 1|Withdrawal by Subject|1|||
124865805|NCT02308748|449128877|FG003|Period 1|Withdrawal by Subject|0|||
124865806|NCT02308748|449128878|FG004|Period 1|Withdrawal by Subject|0|||
124865807|NCT02308748|449128879|FG005|Period 1|Withdrawal by Subject|0|||
124865808|NCT02308748|449128880|FG006|Period 1|Withdrawal by Subject|0|||
124865809|NCT02308748|449128881|FG007|Period 1|Withdrawal by Subject|0|||
124865810|NCT02308748|449128882|FG008|Period 1|Withdrawal by Subject|0|||
124865811|NCT02308748|449128883|FG009|Period 1|Withdrawal by Subject|0|||
124865812|NCT02308748|449128874|FG000|Period 2|Adverse Event|0|||
124865813|NCT02308748|449128875|FG001|Period 2|Adverse Event|0|||
124865814|NCT02308748|449128876|FG002|Period 2|Adverse Event|0|||
124976767|NCT00847626|449541885|FG009|Overall Study|Lack of Efficacy|1|||
124976768|NCT00847626|449541886|FG010|Overall Study|Lack of Efficacy|7|||
124976769|NCT00847626|449541876|FG000|Overall Study|Other|1|||
124976770|NCT00847626|449541877|FG001|Overall Study|Other|5|||
124976771|NCT00847626|449541878|FG002|Overall Study|Other|4|||
124976772|NCT00847626|449541879|FG003|Overall Study|Other|1|||
124976773|NCT00847626|449541880|FG004|Overall Study|Other|2|||
124976774|NCT00847626|449541881|FG005|Overall Study|Other|2|||
124976775|NCT00847626|449541882|FG006|Overall Study|Other|2|||
124976776|NCT00847626|449541883|FG007|Overall Study|Other|3|||
124976777|NCT00847626|449541884|FG008|Overall Study|Other|1|||
124976778|NCT00847626|449541885|FG009|Overall Study|Other|1|||
124976779|NCT00847626|449541886|FG010|Overall Study|Other|3|||
124976780|NCT03057847|449541887|FG000|Overall Study|Lost to Follow-up|16|||
124976781|NCT05627258|449541890|FG000|Overall Study|Lost to Follow-up|1|||
124976782|NCT05627258|449541891|FG001|Overall Study|Lost to Follow-up|0|||
124976783|NCT05627258|449541892|FG002|Overall Study|Lost to Follow-up|0|||
124976784|NCT05627258|449541893|FG003|Overall Study|Lost to Follow-up|0|||
124976785|NCT05627258|449541894|FG004|Overall Study|Lost to Follow-up|0|||
124976786|NCT05627258|449541895|FG005|Overall Study|Lost to Follow-up|0|||
124976787|NCT05627258|449541890|FG000|Overall Study|Withdrawal by Subject|0|||
124976788|NCT05627258|449541891|FG001|Overall Study|Withdrawal by Subject|0|||
124976789|NCT05627258|449541892|FG002|Overall Study|Withdrawal by Subject|0|||
124976790|NCT05627258|449541893|FG003|Overall Study|Withdrawal by Subject|0|||
124976791|NCT05627258|449541894|FG004|Overall Study|Withdrawal by Subject|2|||
124976792|NCT05627258|449541895|FG005|Overall Study|Withdrawal by Subject|0|||
124976793|NCT05627258|449541890|FG000|Overall Study|Enrolled, but product not administered|1|||
124976794|NCT05627258|449541891|FG001|Overall Study|Enrolled, but product not administered|0|||
124976795|NCT05627258|449541892|FG002|Overall Study|Enrolled, but product not administered|0|||
124976796|NCT05627258|449541893|FG003|Overall Study|Enrolled, but product not administered|0|||
124976797|NCT05627258|449541894|FG004|Overall Study|Enrolled, but product not administered|0|||
124976798|NCT05627258|449541895|FG005|Overall Study|Enrolled, but product not administered|0|||
124976799|NCT05627258|449541890|FG000|Overall Study|Other subject illness/injury|1|||
124976800|NCT05627258|449541891|FG001|Overall Study|Other subject illness/injury|0|||
124976801|NCT05627258|449541892|FG002|Overall Study|Other subject illness/injury|0|||
125198632|NCT02836236|450350983|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
124976802|NCT05627258|449541893|FG003|Overall Study|Other subject illness/injury|0|||
124976803|NCT05627258|449541894|FG004|Overall Study|Other subject illness/injury|0|||
124865815|NCT02308748|449128877|FG003|Period 2|Adverse Event|0|||
124865816|NCT02308748|449128878|FG004|Period 2|Adverse Event|0|||
124865817|NCT02308748|449128879|FG005|Period 2|Adverse Event|0|||
124865818|NCT02308748|449128880|FG006|Period 2|Adverse Event|0|||
124865819|NCT02308748|449128881|FG007|Period 2|Adverse Event|1|||
124865820|NCT02308748|449128882|FG008|Period 2|Adverse Event|0|||
124865821|NCT02308748|449128883|FG009|Period 2|Adverse Event|0|||
124865822|NCT02308748|449128874|FG000|Period 3|Protocol Violation|0|||
124865823|NCT02308748|449128875|FG001|Period 3|Protocol Violation|0|||
124865824|NCT02308748|449128876|FG002|Period 3|Protocol Violation|0|||
124865825|NCT02308748|449128877|FG003|Period 3|Protocol Violation|0|||
124865826|NCT02308748|449128878|FG004|Period 3|Protocol Violation|0|||
124865827|NCT02308748|449128879|FG005|Period 3|Protocol Violation|0|||
124865828|NCT02308748|449128880|FG006|Period 3|Protocol Violation|0|||
124865829|NCT02308748|449128881|FG007|Period 3|Protocol Violation|0|||
124865830|NCT02308748|449128882|FG008|Period 3|Protocol Violation|0|||
124865831|NCT02308748|449128883|FG009|Period 3|Protocol Violation|1|||
124865832|NCT02308748|449128874|FG000|Period 5|Adverse Event|1|||
124865833|NCT02308748|449128875|FG001|Period 5|Adverse Event|0|||
124865834|NCT02308748|449128876|FG002|Period 5|Adverse Event|0|||
124865835|NCT02308748|449128877|FG003|Period 5|Adverse Event|0|||
124865836|NCT02308748|449128878|FG004|Period 5|Adverse Event|0|||
124865837|NCT02308748|449128879|FG005|Period 5|Adverse Event|0|||
124865838|NCT02308748|449128880|FG006|Period 5|Adverse Event|0|||
124865839|NCT02308748|449128881|FG007|Period 5|Adverse Event|0|||
124865840|NCT02308748|449128882|FG008|Period 5|Adverse Event|1|||
124865841|NCT02308748|449128883|FG009|Period 5|Adverse Event|0|||
124865842|NCT05207813|449128886|FG000|Overall Study|Lost to Follow-up|2|||
124865843|NCT04988308|449128890|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
124865844|NCT04988308|449128891|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
124865845|NCT04988308|449128892|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
124865846|NCT04988308|449128893|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
124865847|NCT04988308|449128894|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
124865848|NCT04988308|449128895|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
124865849|NCT04988308|449128890|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
124865850|NCT04988308|449128891|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
124865851|NCT04988308|449128892|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
124865852|NCT04988308|449128893|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
124865853|NCT04988308|449128894|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
124865854|NCT04988308|449128895|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
124865855|NCT04988308|449128890|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
124976804|NCT05627258|449541895|FG005|Overall Study|Other subject illness/injury|0|||
124976805|NCT05627258|449541890|FG000|Overall Study|Subject moved from area|0|||
124976806|NCT05627258|449541891|FG001|Overall Study|Subject moved from area|0|||
124976807|NCT05627258|449541892|FG002|Overall Study|Subject moved from area|1|||
124976808|NCT05627258|449541893|FG003|Overall Study|Subject moved from area|0|||
124976809|NCT05627258|449541894|FG004|Overall Study|Subject moved from area|0|||
124976810|NCT05627258|449541895|FG005|Overall Study|Subject moved from area|0|||
124976811|NCT01294397|449541898|FG000|Overall Study|Withdrawal by Subject|1|||
124976812|NCT01294397|449541898|FG000|Overall Study|Administrative Decision|1|||
124976813|NCT01199068|449541899|FG000|Overall Study|Unacceptable toxicity|0|||
124976814|NCT01199068|449541900|FG001|Overall Study|Unacceptable toxicity|0|||
124976815|NCT01199068|449541901|FG002|Overall Study|Unacceptable toxicity|2|||
124976816|NCT01199068|449541899|FG000|Overall Study|Progressive disease|3|||
124976817|NCT01199068|449541900|FG001|Overall Study|Progressive disease|3|||
124976818|NCT01199068|449541901|FG002|Overall Study|Progressive disease|6|||
124976819|NCT01199068|449541899|FG000|Overall Study|Withdrawal by Subject|0|||
124976820|NCT01199068|449541900|FG001|Overall Study|Withdrawal by Subject|0|||
124976821|NCT01199068|449541901|FG002|Overall Study|Withdrawal by Subject|1|||
124976822|NCT01250925|449541902|FG000|Overall Study|Lost to Follow-up|1|||
124976823|NCT01250925|449541903|FG001|Overall Study|Lost to Follow-up|1|||
124976824|NCT01250925|449541904|FG002|Overall Study|Lost to Follow-up|0|||
124976825|NCT01250925|449541902|FG000|Overall Study|Withdrawal by Subject|2|||
124976826|NCT01250925|449541903|FG001|Overall Study|Withdrawal by Subject|0|||
124976827|NCT01250925|449541904|FG002|Overall Study|Withdrawal by Subject|0|||
124976828|NCT01250925|449541902|FG000|Overall Study|Protocol Violation|2|||
124976829|NCT01250925|449541903|FG001|Overall Study|Protocol Violation|0|||
124976830|NCT01250925|449541904|FG002|Overall Study|Protocol Violation|0|||
124976831|NCT01250925|449541902|FG000|Overall Study|Physician Decision|0|||
124976832|NCT01250925|449541903|FG001|Overall Study|Physician Decision|2|||
124976833|NCT01250925|449541904|FG002|Overall Study|Physician Decision|1|||
124865856|NCT04988308|449128891|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
124865857|NCT04988308|449128892|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
124976834|NCT01250925|449541902|FG000|Overall Study|Adverse Event|0|||
124976835|NCT01250925|449541903|FG001|Overall Study|Adverse Event|0|||
124976836|NCT01250925|449541904|FG002|Overall Study|Adverse Event|1|||
124865858|NCT04988308|449128893|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
124976837|NCT00678301|449541905|FG000|Overall Study|Non-compliance with study procedures|0|||
124976838|NCT00678301|449541906|FG001|Overall Study|Non-compliance with study procedures|1|||
124976839|NCT00678301|449541905|FG000|Overall Study|Adverse Event|1|||
124976840|NCT00678301|449541906|FG001|Overall Study|Adverse Event|0|||
124976841|NCT00678301|449541905|FG000|Overall Study|Withdrawal by Subject|4|||
124976842|NCT00678301|449541906|FG001|Overall Study|Withdrawal by Subject|0|||
124976843|NCT00678301|449541905|FG000|Overall Study|Lost to Follow-up|3|||
124976844|NCT00678301|449541906|FG001|Overall Study|Lost to Follow-up|1|||
124976845|NCT03338296|449541907|FG000|Overall Study|Adverse Event|0|||
124976846|NCT03338296|449541908|FG001|Overall Study|Adverse Event|1|||
124976847|NCT03338296|449541907|FG000|Overall Study|Withdrawal by Subject|14|||
124976848|NCT03338296|449541908|FG001|Overall Study|Withdrawal by Subject|13|||
124976849|NCT03338296|449541907|FG000|Overall Study|Lost to Follow-up|10|||
124976850|NCT03338296|449541908|FG001|Overall Study|Lost to Follow-up|10|||
124976851|NCT03338296|449541907|FG000|Overall Study|Study Terminated by Sponsor|77|||
124976852|NCT03338296|449541908|FG001|Overall Study|Study Terminated by Sponsor|76|||
124865859|NCT04988308|449128894|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
124865860|NCT04988308|449128895|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
124865861|NCT04988308|449128890|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
124865862|NCT04988308|449128891|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
124976853|NCT03338296|449541907|FG000|Overall Study|Other|2|||
124976854|NCT03338296|449541908|FG001|Overall Study|Other|7|||
124976855|NCT03338296|449541907|FG000|Overall Study|Missing|0|||
124976856|NCT03338296|449541908|FG001|Overall Study|Missing|1|||
124976857|NCT04421950|449541909|FG000|Overall Study|Dropped or lost to follow up|4|||
124976858|NCT04421950|449541910|FG001|Overall Study|Dropped or lost to follow up|2|||
124976859|NCT01725126|449541912|FG000|Overall Study|Protocol Violation|0|||
124976860|NCT01725126|449541913|FG001|Overall Study|Protocol Violation|1|||
124976861|NCT01725126|449541914|FG002|Overall Study|Protocol Violation|0|||
124976862|NCT01725126|449541915|FG003|Overall Study|Protocol Violation|0|||
124976863|NCT01725126|449541916|FG004|Overall Study|Protocol Violation|0|||
124976864|NCT01725126|449541917|FG005|Overall Study|Protocol Violation|0|||
124976865|NCT01725126|449541912|FG000|Overall Study|Withdrawal by Subject|0|||
124976866|NCT01725126|449541913|FG001|Overall Study|Withdrawal by Subject|0|||
124976867|NCT01725126|449541914|FG002|Overall Study|Withdrawal by Subject|0|||
124976868|NCT01725126|449541915|FG003|Overall Study|Withdrawal by Subject|1|||
124976869|NCT01725126|449541916|FG004|Overall Study|Withdrawal by Subject|0|||
124976870|NCT01725126|449541917|FG005|Overall Study|Withdrawal by Subject|0|||
124976871|NCT00677534|449541922|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
124976872|NCT00677534|449541922|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
124976873|NCT00677534|449541922|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
124976874|NCT02687035|449541923|FG000|Overall Study|Withdrawal by Subject|1|||
124976875|NCT02687035|449541923|FG000|Overall Study|Death|87|||
124976876|NCT02687035|449541923|FG000|Overall Study|Lost to Follow-up|1|||
124976877|NCT02687035|449541923|FG000|Overall Study|Missed Visit|87|||
124976878|NCT02687035|449541923|FG000|Overall Study|Did not receive Study Device|8|||
124976879|NCT04076943|449541932|FG000|Overall Study|Withdrawal by Subject|12|||
124976880|NCT04076943|449541932|FG000|Overall Study|Adverse Event|1|||
124976881|NCT04076943|449541932|FG000|Overall Study|Progressive Disease|2|||
124976882|NCT04076943|449541932|FG000|Overall Study|Death|13|||
124976883|NCT04076943|449541932|FG000|Overall Study|Other than specified|6|||
124976884|NCT01031628|449541933|FG000|Overall Study|Study terminated early|0|||
124976885|NCT01031628|449541934|FG001|Overall Study|Study terminated early|1|||
124976886|NCT01031628|449541935|FG002|Overall Study|Study terminated early|3|||
124976887|NCT01031628|449541936|FG003|Overall Study|Study terminated early|0|||
124976888|NCT00967005|449541939|FG000|Overall Study|Lost to Follow-up|7|||
124976889|NCT00967005|449541940|FG001|Overall Study|Lost to Follow-up|10|||
124976890|NCT01371825|449541943|FG000|Overall Study|Death|4|||
124976891|NCT00895895|449541944|FG000|Period 1|Adverse Event|7|||
124976892|NCT00895895|449541945|FG001|Period 1|Adverse Event|6|||
124976893|NCT00895895|449541946|FG002|Period 1|Adverse Event|4|||
124976894|NCT00895895|449541947|FG003|Period 1|Adverse Event|6|||
124976895|NCT00895895|449541948|FG004|Period 1|Adverse Event|7|||
124976896|NCT00895895|449541944|FG000|Period 1|Death|0|||
124976897|NCT00895895|449541945|FG001|Period 1|Death|0|||
124976898|NCT00895895|449541946|FG002|Period 1|Death|0|||
124976899|NCT00895895|449541947|FG003|Period 1|Death|0|||
124976900|NCT00895895|449541948|FG004|Period 1|Death|1|||
124976901|NCT00895895|449541944|FG000|Period 1|discontinued by sponsor|2|||
124976902|NCT00895895|449541945|FG001|Period 1|discontinued by sponsor|1|||
124976903|NCT00895895|449541946|FG002|Period 1|discontinued by sponsor|2|||
124976904|NCT00895895|449541947|FG003|Period 1|discontinued by sponsor|1|||
124976905|NCT00895895|449541948|FG004|Period 1|discontinued by sponsor|1|||
124976906|NCT00895895|449541944|FG000|Period 1|failed to return|0|||
124976907|NCT00895895|449541945|FG001|Period 1|failed to return|0|||
124976908|NCT00895895|449541946|FG002|Period 1|failed to return|1|||
124976909|NCT00895895|449541947|FG003|Period 1|failed to return|0|||
124976910|NCT00895895|449541948|FG004|Period 1|failed to return|1|||
124976911|NCT00895895|449541944|FG000|Period 1|investigator request|0|||
124976912|NCT00895895|449541945|FG001|Period 1|investigator request|1|||
124976913|NCT00895895|449541946|FG002|Period 1|investigator request|0|||
124976914|NCT00895895|449541947|FG003|Period 1|investigator request|0|||
124976915|NCT00895895|449541948|FG004|Period 1|investigator request|0|||
124976916|NCT00895895|449541944|FG000|Period 1|Lost to Follow-up|2|||
124976917|NCT00895895|449541945|FG001|Period 1|Lost to Follow-up|1|||
124976918|NCT00895895|449541946|FG002|Period 1|Lost to Follow-up|3|||
124976919|NCT00895895|449541947|FG003|Period 1|Lost to Follow-up|2|||
124976920|NCT00895895|449541948|FG004|Period 1|Lost to Follow-up|3|||
124976921|NCT00895895|449541944|FG000|Period 1|Other|1|||
124976922|NCT00895895|449541945|FG001|Period 1|Other|2|||
124976923|NCT00895895|449541946|FG002|Period 1|Other|1|||
124976924|NCT00895895|449541947|FG003|Period 1|Other|1|||
124976925|NCT00895895|449541948|FG004|Period 1|Other|1|||
124976926|NCT00895895|449541944|FG000|Period 1|Protocol Violation|0|||
124976927|NCT00895895|449541945|FG001|Period 1|Protocol Violation|1|||
124976928|NCT00895895|449541946|FG002|Period 1|Protocol Violation|0|||
124976929|NCT00895895|449541947|FG003|Period 1|Protocol Violation|0|||
124976930|NCT00895895|449541948|FG004|Period 1|Protocol Violation|0|||
124976931|NCT00895895|449541944|FG000|Period 1|Withdrawal by Subject|6|||
124976932|NCT00895895|449541945|FG001|Period 1|Withdrawal by Subject|6|||
124976933|NCT00895895|449541946|FG002|Period 1|Withdrawal by Subject|8|||
124976934|NCT00895895|449541947|FG003|Period 1|Withdrawal by Subject|2|||
124976935|NCT00895895|449541948|FG004|Period 1|Withdrawal by Subject|4|||
124976936|NCT00895895|449541944|FG000|Period 1|unsatisfactory response-efficacy|2|||
124976937|NCT00895895|449541945|FG001|Period 1|unsatisfactory response-efficacy|0|||
124976938|NCT00895895|449541946|FG002|Period 1|unsatisfactory response-efficacy|0|||
124976939|NCT00895895|449541947|FG003|Period 1|unsatisfactory response-efficacy|0|||
124976940|NCT00895895|449541948|FG004|Period 1|unsatisfactory response-efficacy|0|||
124976941|NCT00895895|449541944|FG000|Period 1|randomized and not treated|1|||
124976942|NCT00895895|449541945|FG001|Period 1|randomized and not treated|3|||
124976943|NCT00895895|449541946|FG002|Period 1|randomized and not treated|1|||
124976944|NCT00895895|449541947|FG003|Period 1|randomized and not treated|1|||
124976945|NCT00895895|449541948|FG004|Period 1|randomized and not treated|2|||
124976946|NCT00895895|449541944|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
124976947|NCT00895895|449541945|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
124976948|NCT00895895|449541946|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
124976949|NCT00895895|449541947|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
124976950|NCT00895895|449541948|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
124976951|NCT00895895|449541944|FG000|After Period 1, Prior to Period 2|Other|0|||
124976952|NCT00895895|449541945|FG001|After Period 1, Prior to Period 2|Other|0|||
124976953|NCT00895895|449541946|FG002|After Period 1, Prior to Period 2|Other|1|||
124976954|NCT00895895|449541947|FG003|After Period 1, Prior to Period 2|Other|0|||
124976955|NCT00895895|449541948|FG004|After Period 1, Prior to Period 2|Other|0|||
124976956|NCT00895895|449541944|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
124976957|NCT00895895|449541945|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
124976958|NCT00895895|449541946|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
125310188|NCT00413218|450762023|FG000|Overall Study|Lost to Follow-up|14|||
124865863|NCT04988308|449128892|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
124865864|NCT04988308|449128893|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
124865865|NCT04988308|449128894|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
124865866|NCT04988308|449128895|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
124865867|NCT04988308|449128890|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
124865868|NCT04988308|449128891|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
124865869|NCT04988308|449128892|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
124865870|NCT04988308|449128893|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
124865871|NCT04988308|449128894|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
124865872|NCT04988308|449128895|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
124865873|NCT04988308|449128890|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
124865874|NCT04988308|449128891|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
124865875|NCT04988308|449128892|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
124865876|NCT04988308|449128893|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
124865877|NCT04988308|449128894|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
124865878|NCT04988308|449128895|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
124865879|NCT04988308|449128890|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
124976959|NCT00895895|449541947|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
124976960|NCT00895895|449541948|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
124976961|NCT00895895|449541944|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
124976962|NCT00895895|449541945|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
124976963|NCT00895895|449541946|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
124976964|NCT00895895|449541947|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
124976965|NCT00895895|449541948|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
124976966|NCT00895895|449541944|FG000|Period 2|Adverse Event|3|||
124865880|NCT04988308|449128891|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
124865881|NCT04988308|449128892|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
124865882|NCT04988308|449128893|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
124865883|NCT04988308|449128894|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
124865884|NCT04988308|449128895|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
124865885|NCT04988308|449128890|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
124865886|NCT04988308|449128891|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
124865887|NCT04988308|449128892|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
124865888|NCT04988308|449128893|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
124865889|NCT04988308|449128894|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
124865890|NCT04988308|449128895|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
124865891|NCT04988308|449128890|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
124865892|NCT04988308|449128891|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
124865893|NCT04988308|449128892|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
124865894|NCT04988308|449128893|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
124865895|NCT04988308|449128894|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
124865896|NCT04988308|449128895|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
124865897|NCT02625623|449128897|FG000|Overall Study|Participants randomized but not treated|9|||
124865898|NCT02625623|449128898|FG001|Overall Study|Participants randomized but not treated|1|||
124865899|NCT00808808|449128899|FG000|Overall Study|Vaccinated; survey not completed|131|||
124865900|NCT00808808|449128900|FG001|Overall Study|Vaccinated; survey not completed|169|||
124865901|NCT00808808|449128901|FG002|Overall Study|Vaccinated; survey not completed|302|||
124865902|NCT00808808|449128899|FG000|Overall Study|Employee was not vaccinated.|2686|||
124865903|NCT00808808|449128900|FG001|Overall Study|Employee was not vaccinated.|2268|||
124865904|NCT00808808|449128901|FG002|Overall Study|Employee was not vaccinated.|2255|||
124865905|NCT02352948|449128903|FG000|Overall Study|Death|47|||
124865906|NCT02352948|449128904|FG001|Overall Study|Death|48|||
124865907|NCT02352948|449128905|FG002|Overall Study|Death|114|||
124865908|NCT02352948|449128906|FG003|Overall Study|Death|74|||
124865909|NCT02352948|449128907|FG004|Overall Study|Death|77|||
124865910|NCT02352948|449128908|FG005|Overall Study|Death|44|||
124865911|NCT02352948|449128903|FG000|Overall Study|Lost to Follow-up|1|||
124865912|NCT02352948|449128904|FG001|Overall Study|Lost to Follow-up|0|||
124865913|NCT02352948|449128905|FG002|Overall Study|Lost to Follow-up|2|||
124865914|NCT02352948|449128906|FG003|Overall Study|Lost to Follow-up|1|||
124865915|NCT02352948|449128907|FG004|Overall Study|Lost to Follow-up|2|||
124865916|NCT02352948|449128908|FG005|Overall Study|Lost to Follow-up|1|||
124865917|NCT02352948|449128903|FG000|Overall Study|Withdrawal by Subject|1|||
124865918|NCT02352948|449128904|FG001|Overall Study|Withdrawal by Subject|10|||
124865919|NCT02352948|449128905|FG002|Overall Study|Withdrawal by Subject|11|||
124865920|NCT02352948|449128906|FG003|Overall Study|Withdrawal by Subject|23|||
124865921|NCT02352948|449128907|FG004|Overall Study|Withdrawal by Subject|9|||
124865922|NCT02352948|449128908|FG005|Overall Study|Withdrawal by Subject|4|||
124865923|NCT02352948|449128903|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124865924|NCT02352948|449128904|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
124865925|NCT02352948|449128905|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
124865926|NCT02352948|449128906|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
124865927|NCT02352948|449128907|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
124865928|NCT02352948|449128908|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
124865929|NCT02352948|449128903|FG000|Overall Study|Other|0|||
124865930|NCT02352948|449128904|FG001|Overall Study|Other|0|||
124865931|NCT02352948|449128905|FG002|Overall Study|Other|2|||
124865932|NCT02352948|449128906|FG003|Overall Study|Other|0|||
124865933|NCT02352948|449128907|FG004|Overall Study|Other|0|||
124865934|NCT02352948|449128908|FG005|Overall Study|Other|0|||
124865935|NCT00490646|449128909|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
124865936|NCT00490646|449128910|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
124865937|NCT00490646|449128909|FG000|Overall Study|Never Treated (had an adverse event)|1|||
124865938|NCT00490646|449128910|FG001|Overall Study|Never Treated (had an adverse event)|0|||
124865939|NCT00490646|449128909|FG000|Overall Study|Never Treated (withdrew consent)|0|||
124865940|NCT00490646|449128910|FG001|Overall Study|Never Treated (withdrew consent)|1|||
124865941|NCT01178086|449128911|FG000|Overall Study|Participant refusal|7|||
124865942|NCT01178086|449128911|FG000|Overall Study|Physician Decision|44|||
124865943|NCT01178086|449128911|FG000|Overall Study|Switch to other CLL therapy|113|||
125310189|NCT00413218|450762024|FG001|Overall Study|Lost to Follow-up|17|||
125310190|NCT00413218|450762023|FG000|Overall Study|Admin|20|||
124865944|NCT01178086|449128911|FG000|Overall Study|Death|59|||
124865945|NCT01178086|449128911|FG000|Overall Study|Other unspecified|89|||
124865946|NCT01178086|449128911|FG000|Overall Study|Excluded from EAS|20|||
124865947|NCT02313428|449128912|FG000|Overall Study|Lost to Follow-up|1|||
124865948|NCT02313428|449128913|FG001|Overall Study|Lost to Follow-up|1|||
124865949|NCT02057874|449131353|FG000|Overall Study|participant did not return for scan|1|||
124865950|NCT01258608|449131358|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
124865951|NCT01258608|449131359|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
124865952|NCT01258608|449131358|FG000|Overall Study|Clinical progression|1|||
124865953|NCT01258608|449131359|FG001|Overall Study|Clinical progression|0|||
124865954|NCT01258608|449131358|FG000|Overall Study|Sponsor decision|0|||
124865955|NCT01258608|449131359|FG001|Overall Study|Sponsor decision|1|||
124865956|NCT01258608|449131358|FG000|Overall Study|Physician Decision|6|||
124865957|NCT01258608|449131359|FG001|Overall Study|Physician Decision|1|||
124865958|NCT01258608|449131358|FG000|Overall Study|Lost to Follow-up|0|||
124865959|NCT01258608|449131359|FG001|Overall Study|Lost to Follow-up|1|||
124865960|NCT01258608|449131358|FG000|Overall Study|Lack of compliance|1|||
124865961|NCT01258608|449131359|FG001|Overall Study|Lack of compliance|0|||
124865962|NCT01258608|449131358|FG000|Overall Study|Lack of Efficacy|0|||
124865963|NCT01258608|449131359|FG001|Overall Study|Lack of Efficacy|1|||
124865964|NCT01258608|449131358|FG000|Overall Study|Adverse Event|6|||
124865965|NCT01258608|449131359|FG001|Overall Study|Adverse Event|10|||
124865966|NCT01258608|449131358|FG000|Overall Study|Withdrawal by Subject|6|||
124976967|NCT00895895|449541945|FG001|Period 2|Adverse Event|3|||
124976968|NCT00895895|449541946|FG002|Period 2|Adverse Event|5|||
124865967|NCT01258608|449131359|FG001|Overall Study|Withdrawal by Subject|5|||
124865968|NCT02943408|449131361|FG000|Overall Study|Lost to Follow-up|7|||
124865969|NCT02943408|449131362|FG001|Overall Study|Lost to Follow-up|1|||
124865970|NCT02943408|449131361|FG000|Overall Study|Withdrawal by Subject|0|||
124865971|NCT02943408|449131362|FG001|Overall Study|Withdrawal by Subject|1|||
124865972|NCT01621126|449131365|FG000|Overall Study|Physician Decision|6|||
124976969|NCT00895895|449541947|FG003|Period 2|Adverse Event|2|||
124976970|NCT00895895|449541948|FG004|Period 2|Adverse Event|5|||
124865973|NCT00886340|449131366|FG000|Overall Study|Withdrawal by Subject|0|||
124865974|NCT00886340|449131367|FG001|Overall Study|Withdrawal by Subject|7|||
124865975|NCT01949311|449131369|FG000|Overall Study|Lost to Follow-up|73|||
124865976|NCT01949311|449131369|FG000|Overall Study|Terminated by Sponsor|708|||
124865977|NCT01949311|449131369|FG000|Overall Study|Withdrawal by Subject|375|||
124865978|NCT01949311|449131369|FG000|Overall Study|Lack of Efficacy|50|||
124865979|NCT01949311|449131369|FG000|Overall Study|Protocol Deviation|34|||
124865980|NCT01949311|449131369|FG000|Overall Study|Pregnancy|20|||
124865981|NCT01949311|449131369|FG000|Overall Study|Physician Decision|9|||
124865982|NCT01949311|449131369|FG000|Overall Study|Other|4|||
124865983|NCT01949311|449131369|FG000|Overall Study|Adverse Event|107|||
124865984|NCT02338154|449131370|FG000|Overall Study|Death|46|||
124865985|NCT02338154|449131370|FG000|Overall Study|Valve Implant Failure|17|||
124865986|NCT02338154|449131370|FG000|Overall Study|Valve Explant|11|||
124865987|NCT02338154|449131370|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
124865988|NCT02338154|449131370|FG000|Overall Study|Lost to Follow-up|8|||
124865989|NCT02338154|449131370|FG000|Overall Study|Other Reason|3|||
124865990|NCT02338154|449131370|FG000|Overall Study|Patients Without Exit Form|47|||
124865991|NCT02338154|449131370|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
124865992|NCT02120027|449131371|FG000|Overall Study|Adverse Event|4|||
124865993|NCT02120027|449131372|FG001|Overall Study|Adverse Event|5|||
124865994|NCT02120027|449131371|FG000|Overall Study|Lack of Efficacy|3|||
124865995|NCT02120027|449131372|FG001|Overall Study|Lack of Efficacy|5|||
124865996|NCT02120027|449131371|FG000|Overall Study|Lost to Follow-up|5|||
124865997|NCT02120027|449131372|FG001|Overall Study|Lost to Follow-up|13|||
124865998|NCT02120027|449131371|FG000|Overall Study|Other|4|||
124865999|NCT02120027|449131372|FG001|Overall Study|Other|0|||
124866000|NCT02120027|449131371|FG000|Overall Study|Physician Decision|4|||
124866001|NCT02120027|449131372|FG001|Overall Study|Physician Decision|3|||
124866002|NCT02120027|449131371|FG000|Overall Study|Protocol Violation|18|||
124866003|NCT02120027|449131372|FG001|Overall Study|Protocol Violation|21|||
124866004|NCT02120027|449131371|FG000|Overall Study|Study terminated by Sponsor|45|||
124866005|NCT02120027|449131372|FG001|Overall Study|Study terminated by Sponsor|47|||
124866006|NCT02120027|449131371|FG000|Overall Study|Withdrawal by Subject|33|||
124866007|NCT02120027|449131372|FG001|Overall Study|Withdrawal by Subject|25|||
124866008|NCT03393000|449131383|FG000|Overall Study|Death|11|||
124866009|NCT03393000|449131383|FG000|Overall Study|Withdrawal by Subject|2|||
124866010|NCT03393000|449131383|FG000|Overall Study|Physician Decision|1|||
124866011|NCT01773070|449131384|FG000|Overall Study|Withdrawal by Subject|24|||
124866012|NCT01773070|449131384|FG000|Overall Study|Lost to Follow-up|39|||
124866013|NCT01773070|449131384|FG000|Overall Study|Other|15|||
124866014|NCT01773070|449131384|FG000|Overall Study|Death (unrelated to study procedures)|3|||
124866015|NCT01471054|449131385|FG000|Overall Study|Study terminated prematurely|4|||
124866016|NCT01471054|449131386|FG001|Overall Study|Study terminated prematurely|0|||
124866017|NCT01843192|449131387|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
124866018|NCT01843192|449131388|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
124866019|NCT01843192|449131389|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
124866020|NCT01559844|449131390|FG000|Overall Study|Consent Withdrawn|7|||
124866021|NCT01559844|449131390|FG000|Overall Study|Death|5|||
124866022|NCT01559844|449131390|FG000|Overall Study|Efficacy Failure|10|||
124866023|NCT01559844|449131390|FG000|Overall Study|No Longer A Transplant Candidate|3|||
124866024|NCT00951041|449131391|FG000|Overall Study|Withdrawal by Subject|1|||
124976971|NCT00895895|449541944|FG000|Period 2|Death|0|||
124866025|NCT00951041|449131392|FG001|Overall Study|Withdrawal by Subject|1|||
124866026|NCT00951041|449131391|FG000|Overall Study|Lost to Follow-up|1|||
124866027|NCT00951041|449131392|FG001|Overall Study|Lost to Follow-up|0|||
124866028|NCT00951041|449131391|FG000|Overall Study|Other|3|||
124866029|NCT00951041|449131392|FG001|Overall Study|Other|0|||
124866030|NCT01514448|449131393|FG000|Overall Study|Death|7|||
124866031|NCT01514448|449131394|FG001|Overall Study|Death|8|||
124866032|NCT01514448|449131393|FG000|Overall Study|Withdrawal by Subject|2|||
124866033|NCT01514448|449131394|FG001|Overall Study|Withdrawal by Subject|0|||
124866034|NCT01514448|449131393|FG000|Overall Study|Lost to Follow-up|2|||
124866035|NCT01514448|449131394|FG001|Overall Study|Lost to Follow-up|0|||
124866036|NCT01514448|449131393|FG000|Overall Study|New Cancer Therapy|1|||
124866037|NCT01514448|449131394|FG001|Overall Study|New Cancer Therapy|0|||
124866038|NCT02314624|449131395|FG000|Overall Study|No participating patient|16|||
124866039|NCT02314624|449131396|FG001|Overall Study|No participating patient|13|||
124866040|NCT02314624|449131395|FG000|Overall Study|Participant withdrew|7|||
124866041|NCT02314624|449131396|FG001|Overall Study|Participant withdrew|2|||
124866042|NCT02314624|449131395|FG000|Overall Study|Lost to Follow-up|2|||
124866043|NCT02314624|449131396|FG001|Overall Study|Lost to Follow-up|5|||
124866044|NCT02314624|449131395|FG000|Overall Study|Dropped/Excluded by PI|6|||
124866045|NCT02314624|449131396|FG001|Overall Study|Dropped/Excluded by PI|6|||
124866046|NCT00725452|449131398|FG000|Overall Study|Adverse Event|3|||
124866047|NCT00725452|449131398|FG000|Overall Study|Lack of Efficacy|2|||
124866048|NCT00725452|449131398|FG000|Overall Study|Reason not specified|1|||
124866049|NCT00725452|449131398|FG000|Overall Study|Physician Decision|1|||
124866050|NCT00725452|449131398|FG000|Overall Study|Withdrawal by Subject|3|||
124866051|NCT00725452|449131398|FG000|Overall Study|Lost to Follow-up|1|||
124866052|NCT00620750|449131399|FG000|Overall Study|Lost to Follow-up|25|||
124866053|NCT04477187|449131400|FG000|Overall Study|Lost to Follow-up|2|||
124866054|NCT00713648|449131405|FG000|Overall Study|Adverse Event|1|||
124866055|NCT00713648|449131405|FG000|Overall Study|Unclassified|2|||
124866056|NCT00713648|449131405|FG000|Overall Study|According to Protocol|2|||
124866057|NCT00713648|449131405|FG000|Overall Study|Development of antibodies|3|||
124866058|NCT00082173|449131406|FG000|Overall Study|Withdrawal by Subject|3|||
124866059|NCT00082173|449131407|FG001|Overall Study|Withdrawal by Subject|5|||
124866060|NCT00082173|449131406|FG000|Overall Study|Lost to Follow-up|1|||
124866061|NCT00082173|449131407|FG001|Overall Study|Lost to Follow-up|0|||
124866062|NCT00082173|449131406|FG000|Overall Study|Adverse Event|1|||
124866063|NCT00082173|449131407|FG001|Overall Study|Adverse Event|0|||
124866064|NCT00082173|449131406|FG000|Overall Study|Culture negative or resistant at baselin|5|||
124866065|NCT00082173|449131407|FG001|Overall Study|Culture negative or resistant at baselin|6|||
124866066|NCT01733732|449131408|FG000|Overall Study|Adverse Event|1|||
124866067|NCT01733732|449131409|FG001|Overall Study|Adverse Event|0|||
124866068|NCT01733732|449131408|FG000|Overall Study|Did not attend all study visits|1|||
124866069|NCT01733732|449131409|FG001|Overall Study|Did not attend all study visits|0|||
124866070|NCT00746590|449131410|FG000|Overall Study|Death|1|||
124866071|NCT00464815|449131414|FG000|Overall Study|Withdrawal by Subject|6|||
124866072|NCT00464815|449131415|FG001|Overall Study|Withdrawal by Subject|3|||
124866073|NCT01260350|449131422|FG000|Overall Study|Lack of Efficacy|0|||
124866074|NCT01260350|449131423|FG001|Overall Study|Lack of Efficacy|0|||
124866075|NCT01260350|449131424|FG002|Overall Study|Lack of Efficacy|0|||
124866076|NCT01260350|449131425|FG003|Overall Study|Lack of Efficacy|0|||
124866077|NCT01260350|449131426|FG004|Overall Study|Lack of Efficacy|0|||
124866078|NCT01260350|449131427|FG005|Overall Study|Lack of Efficacy|0|||
124866079|NCT01260350|449131428|FG006|Overall Study|Lack of Efficacy|0|||
124866080|NCT01260350|449131429|FG007|Overall Study|Lack of Efficacy|0|||
124866081|NCT01260350|449131430|FG008|Overall Study|Lack of Efficacy|0|||
124866082|NCT01260350|449131431|FG009|Overall Study|Lack of Efficacy|0|||
124866083|NCT01260350|449131432|FG010|Overall Study|Lack of Efficacy|0|||
124866084|NCT01260350|449131433|FG011|Overall Study|Lack of Efficacy|0|||
124866085|NCT01260350|449131434|FG012|Overall Study|Lack of Efficacy|0|||
124866086|NCT01260350|449131435|FG013|Overall Study|Lack of Efficacy|0|||
124866087|NCT01260350|449131436|FG014|Overall Study|Lack of Efficacy|0|||
124866088|NCT01260350|449131437|FG015|Overall Study|Lack of Efficacy|0|||
124866089|NCT01260350|449131438|FG016|Overall Study|Lack of Efficacy|0|||
124866090|NCT01260350|449131439|FG017|Overall Study|Lack of Efficacy|1|||
124866091|NCT01260350|449131440|FG018|Overall Study|Lack of Efficacy|0|||
124866092|NCT01260350|449131441|FG019|Overall Study|Lack of Efficacy|0|||
124866093|NCT01260350|449131442|FG020|Overall Study|Lack of Efficacy|3|||
124866094|NCT01260350|449131443|FG021|Overall Study|Lack of Efficacy|0|||
124866095|NCT01260350|449131422|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866096|NCT01260350|449131423|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866097|NCT01260350|449131424|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866098|NCT01260350|449131425|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866099|NCT01260350|449131426|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866100|NCT01260350|449131427|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866101|NCT01260350|449131428|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866102|NCT01260350|449131429|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866103|NCT01260350|449131430|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
124866104|NCT01260350|449131431|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866105|NCT01260350|449131432|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866106|NCT01260350|449131433|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866107|NCT01260350|449131434|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866108|NCT01260350|449131435|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866109|NCT01260350|449131436|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866110|NCT01260350|449131437|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866111|NCT01260350|449131438|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866112|NCT01260350|449131439|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866113|NCT01260350|449131440|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866114|NCT01260350|449131441|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866115|NCT01260350|449131442|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866116|NCT01260350|449131443|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866117|NCT04402866|449131444|FG000|Overall Study|Discontinued Prior to Treatment|0|||
124866118|NCT04402866|449131445|FG001|Overall Study|Discontinued Prior to Treatment|0|||
124866119|NCT04402866|449131446|FG002|Overall Study|Discontinued Prior to Treatment|0|||
124866120|NCT04402866|449131447|FG003|Overall Study|Discontinued Prior to Treatment|0|||
124866121|NCT04402866|449131448|FG004|Overall Study|Discontinued Prior to Treatment|2|||
124866122|NCT04402866|449131449|FG005|Overall Study|Discontinued Prior to Treatment|3|||
124866123|NCT04402866|449131444|FG000|Overall Study|Adverse Event|2|||
124866124|NCT04402866|449131445|FG001|Overall Study|Adverse Event|1|||
124866125|NCT04402866|449131446|FG002|Overall Study|Adverse Event|0|||
124866126|NCT04402866|449131447|FG003|Overall Study|Adverse Event|0|||
124866127|NCT04402866|449131448|FG004|Overall Study|Adverse Event|13|||
124866128|NCT04402866|449131449|FG005|Overall Study|Adverse Event|8|||
124866129|NCT04402866|449131444|FG000|Overall Study|Miscellaneous|0|||
124866130|NCT04402866|449131445|FG001|Overall Study|Miscellaneous|0|||
124866131|NCT04402866|449131446|FG002|Overall Study|Miscellaneous|1|||
124866132|NCT04402866|449131447|FG003|Overall Study|Miscellaneous|0|||
124866133|NCT04402866|449131448|FG004|Overall Study|Miscellaneous|0|||
124866134|NCT04402866|449131449|FG005|Overall Study|Miscellaneous|0|||
124866135|NCT04402866|449131444|FG000|Overall Study|Lost to Follow-up|0|||
124866136|NCT04402866|449131445|FG001|Overall Study|Lost to Follow-up|0|||
124866137|NCT04402866|449131446|FG002|Overall Study|Lost to Follow-up|0|||
124866138|NCT04402866|449131447|FG003|Overall Study|Lost to Follow-up|0|||
124866139|NCT04402866|449131448|FG004|Overall Study|Lost to Follow-up|0|||
124866140|NCT04402866|449131449|FG005|Overall Study|Lost to Follow-up|1|||
124866141|NCT04402866|449131444|FG000|Overall Study|Withdrawal by Subject|0|||
124866142|NCT04402866|449131445|FG001|Overall Study|Withdrawal by Subject|0|||
124866143|NCT04402866|449131446|FG002|Overall Study|Withdrawal by Subject|0|||
124866144|NCT04402866|449131447|FG003|Overall Study|Withdrawal by Subject|0|||
124866145|NCT04402866|449131448|FG004|Overall Study|Withdrawal by Subject|0|||
124866146|NCT04402866|449131449|FG005|Overall Study|Withdrawal by Subject|2|||
124866147|NCT01814371|449131450|FG000|Overall Study|Lost to Follow-up|30|||
124866148|NCT01814371|449131451|FG001|Overall Study|Lost to Follow-up|27|||
124866149|NCT02794285|449131452|FG000|Overall Study|Adverse Event|11|||
124866150|NCT02794285|449131453|FG001|Overall Study|Adverse Event|4|||
124866151|NCT02794285|449131454|FG002|Overall Study|Adverse Event|5|||
124866152|NCT02794285|449131455|FG003|Overall Study|Adverse Event|8|||
124866153|NCT02794285|449131452|FG000|Overall Study|Condition Under Investigation Improved|1|||
124866154|NCT02794285|449131453|FG001|Overall Study|Condition Under Investigation Improved|0|||
124866155|NCT02794285|449131454|FG002|Overall Study|Condition Under Investigation Improved|0|||
124866156|NCT02794285|449131455|FG003|Overall Study|Condition Under Investigation Improved|0|||
124866157|NCT02794285|449131452|FG000|Overall Study|Condition Under Investigation Worsened|0|||
124866158|NCT02794285|449131453|FG001|Overall Study|Condition Under Investigation Worsened|2|||
124866159|NCT02794285|449131454|FG002|Overall Study|Condition Under Investigation Worsened|1|||
124866160|NCT02794285|449131455|FG003|Overall Study|Condition Under Investigation Worsened|0|||
124866161|NCT02794285|449131452|FG000|Overall Study|Death|2|||
124866162|NCT02794285|449131453|FG001|Overall Study|Death|1|||
125310191|NCT00413218|450762024|FG001|Overall Study|Admin|14|||
125310192|NCT00413218|450762023|FG000|Overall Study|Missing|1|||
125310193|NCT00413218|450762024|FG001|Overall Study|Missing|0|||
124866163|NCT02794285|449131454|FG002|Overall Study|Death|2|||
124866164|NCT02794285|449131455|FG003|Overall Study|Death|0|||
124866165|NCT02794285|449131452|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
124866166|NCT02794285|449131453|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
124866167|NCT02794285|449131454|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
124866168|NCT02794285|449131455|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
124866169|NCT02794285|449131452|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
124866170|NCT02794285|449131453|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
124866171|NCT02794285|449131454|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
125310194|NCT00413218|450762023|FG000|Overall Study|Withdrawal by Subject|9|||
124976972|NCT00895895|449541945|FG001|Period 2|Death|0|||
125310195|NCT00413218|450762024|FG001|Overall Study|Withdrawal by Subject|1|||
125310196|NCT01196026|450762026|FG000|Overall Study|Withdrawal by Subject|1|||
125310197|NCT01196026|450762027|FG001|Overall Study|Withdrawal by Subject|4|||
125310198|NCT01196026|450762028|FG002|Overall Study|Withdrawal by Subject|0|||
125310199|NCT01196026|450762029|FG003|Overall Study|Withdrawal by Subject|0|||
125310200|NCT01196026|450762030|FG004|Overall Study|Withdrawal by Subject|0|||
125310201|NCT01196026|450762031|FG005|Overall Study|Withdrawal by Subject|0|||
125310202|NCT01196026|450762026|FG000|Overall Study|Lost to Follow-up|0|||
125310203|NCT01196026|450762027|FG001|Overall Study|Lost to Follow-up|3|||
124866172|NCT02794285|449131455|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
124866173|NCT02794285|449131452|FG000|Overall Study|Lack of Efficacy|10|||
124866174|NCT02794285|449131453|FG001|Overall Study|Lack of Efficacy|6|||
124866175|NCT02794285|449131454|FG002|Overall Study|Lack of Efficacy|3|||
124866176|NCT02794285|449131455|FG003|Overall Study|Lack of Efficacy|3|||
124866177|NCT02794285|449131452|FG000|Overall Study|Lost to Follow-up|5|||
124866178|NCT02794285|449131453|FG001|Overall Study|Lost to Follow-up|6|||
124866179|NCT02794285|449131454|FG002|Overall Study|Lost to Follow-up|3|||
124866180|NCT02794285|449131455|FG003|Overall Study|Lost to Follow-up|1|||
124866181|NCT02794285|449131452|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
124866182|NCT02794285|449131453|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
124866183|NCT02794285|449131454|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
124866184|NCT02794285|449131455|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
124866185|NCT02794285|449131452|FG000|Overall Study|Withdrawal by Subject|38|||
124866186|NCT02794285|449131453|FG001|Overall Study|Withdrawal by Subject|29|||
124866187|NCT02794285|449131454|FG002|Overall Study|Withdrawal by Subject|20|||
124866188|NCT02794285|449131455|FG003|Overall Study|Withdrawal by Subject|12|||
124866189|NCT02794285|449131452|FG000|Overall Study|Missing|1|||
124866190|NCT02794285|449131453|FG001|Overall Study|Missing|0|||
124866191|NCT02794285|449131454|FG002|Overall Study|Missing|0|||
124866192|NCT02794285|449131455|FG003|Overall Study|Missing|0|||
124866193|NCT02794285|449131452|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
124866194|NCT02794285|449131453|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
124866195|NCT02794285|449131454|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
124866196|NCT02794285|449131455|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
124866197|NCT02794285|449131452|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
124866198|NCT02794285|449131453|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
124866199|NCT02794285|449131454|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
124866200|NCT02794285|449131455|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
124866201|NCT03996473|449131458|FG000|Treatment Assignment|Withdrawal by Subject|1|||
124866202|NCT03996473|449131458|FG000|Treatment Assignment|Progressive disease|6|||
124866203|NCT03996473|449131458|FG000|Treatment Assignment|Study drug never administered|1|||
124866204|NCT03996473|449131458|FG000|Active Follow-up|Death|1|||
124866205|NCT03996473|449131458|FG000|Long-term Follow-up|Death|5|||
124866206|NCT06116591|449131459|FG000|Overall Study|No longer met eligibility criteria|0|||
124866207|NCT06116591|449131460|FG001|Overall Study|No longer met eligibility criteria|1|||
124866208|NCT06116591|449131459|FG000|Overall Study|Other: Change in life situation|0|||
124866209|NCT06116591|449131460|FG001|Overall Study|Other: Change in life situation|1|||
124866210|NCT01972841|449131461|FG000|Overall Study|Randomized but Never Received Treatment|2|||
124866211|NCT01972841|449131462|FG001|Overall Study|Randomized but Never Received Treatment|5|||
124866212|NCT01972841|449131463|FG002|Overall Study|Randomized but Never Received Treatment|4|||
124866213|NCT01972841|449131464|FG003|Overall Study|Randomized but Never Received Treatment|2|||
124866214|NCT01972841|449131465|FG004|Overall Study|Randomized but Never Received Treatment|6|||
124866215|NCT01972841|449131466|FG005|Overall Study|Randomized but Never Received Treatment|13|||
124866216|NCT01972841|449131461|FG000|Overall Study|Adverse Event|13|||
124976973|NCT00895895|449541946|FG002|Period 2|Death|1|||
124976974|NCT00895895|449541947|FG003|Period 2|Death|0|||
124866217|NCT01972841|449131462|FG001|Overall Study|Adverse Event|8|||
124866218|NCT01972841|449131463|FG002|Overall Study|Adverse Event|12|||
124866219|NCT01972841|449131464|FG003|Overall Study|Adverse Event|9|||
124866220|NCT01972841|449131465|FG004|Overall Study|Adverse Event|21|||
124866221|NCT01972841|449131466|FG005|Overall Study|Adverse Event|26|||
124866222|NCT01972841|449131461|FG000|Overall Study|Lack of Efficacy|1|||
125310204|NCT01196026|450762028|FG002|Overall Study|Lost to Follow-up|0|||
125310205|NCT01196026|450762029|FG003|Overall Study|Lost to Follow-up|0|||
124866223|NCT01972841|449131462|FG001|Overall Study|Lack of Efficacy|0|||
124866224|NCT01972841|449131463|FG002|Overall Study|Lack of Efficacy|0|||
124866225|NCT01972841|449131464|FG003|Overall Study|Lack of Efficacy|2|||
124866226|NCT01972841|449131465|FG004|Overall Study|Lack of Efficacy|4|||
124866227|NCT01972841|449131466|FG005|Overall Study|Lack of Efficacy|1|||
125310206|NCT01196026|450762030|FG004|Overall Study|Lost to Follow-up|1|||
124866228|NCT01972841|449131461|FG000|Overall Study|Lost to Follow-up|4|||
124866229|NCT01972841|449131462|FG001|Overall Study|Lost to Follow-up|2|||
124866230|NCT01972841|449131463|FG002|Overall Study|Lost to Follow-up|4|||
124866231|NCT01972841|449131464|FG003|Overall Study|Lost to Follow-up|2|||
124976975|NCT00895895|449541948|FG004|Period 2|Death|0|||
125310207|NCT01196026|450762031|FG005|Overall Study|Lost to Follow-up|0|||
125310208|NCT01196026|450762026|FG000|Overall Study|Other|0|||
124866232|NCT01972841|449131465|FG004|Overall Study|Lost to Follow-up|9|||
124866233|NCT01972841|449131466|FG005|Overall Study|Lost to Follow-up|3|||
124866234|NCT01972841|449131461|FG000|Overall Study|Protocol Violation|2|||
124866235|NCT01972841|449131462|FG001|Overall Study|Protocol Violation|2|||
124866236|NCT01972841|449131463|FG002|Overall Study|Protocol Violation|3|||
124866237|NCT01972841|449131464|FG003|Overall Study|Protocol Violation|5|||
124866238|NCT01972841|449131465|FG004|Overall Study|Protocol Violation|9|||
124866239|NCT01972841|449131466|FG005|Overall Study|Protocol Violation|4|||
124866240|NCT01972841|449131461|FG000|Overall Study|Withdrawal by participants|21|||
124866241|NCT01972841|449131462|FG001|Overall Study|Withdrawal by participants|27|||
124866242|NCT01972841|449131463|FG002|Overall Study|Withdrawal by participants|23|||
124866243|NCT01972841|449131464|FG003|Overall Study|Withdrawal by participants|16|||
124866244|NCT01972841|449131465|FG004|Overall Study|Withdrawal by participants|33|||
124866245|NCT01972841|449131466|FG005|Overall Study|Withdrawal by participants|34|||
124866246|NCT01972841|449131461|FG000|Overall Study|Miscellaneous|0|||
124866247|NCT01972841|449131462|FG001|Overall Study|Miscellaneous|0|||
124866248|NCT01972841|449131463|FG002|Overall Study|Miscellaneous|4|||
124866249|NCT01972841|449131464|FG003|Overall Study|Miscellaneous|1|||
124866250|NCT01972841|449131465|FG004|Overall Study|Miscellaneous|0|||
124866251|NCT01972841|449131466|FG005|Overall Study|Miscellaneous|4|||
124866252|NCT01972841|449131461|FG000|Overall Study|Did not have end of treatment page|0|||
124866253|NCT01972841|449131462|FG001|Overall Study|Did not have end of treatment page|0|||
124866254|NCT01972841|449131463|FG002|Overall Study|Did not have end of treatment page|0|||
124866255|NCT01972841|449131464|FG003|Overall Study|Did not have end of treatment page|0|||
124866256|NCT01972841|449131465|FG004|Overall Study|Did not have end of treatment page|1|||
124866257|NCT01972841|449131466|FG005|Overall Study|Did not have end of treatment page|0|||
124866258|NCT04969198|449131469|FG000|Overall Study|Withdrawal by Subject|20|||
124866259|NCT04969198|449131469|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
124866260|NCT04969198|449131469|FG000|Overall Study|Lost to Follow-up|20|||
124866261|NCT05553808|449131473|FG000|Overall Study|Death|25|||
124866262|NCT05553808|449131474|FG001|Overall Study|Death|62|||
124866263|NCT05553808|449131473|FG000|Overall Study|Site Closed|6|||
124866264|NCT05553808|449131474|FG001|Overall Study|Site Closed|6|||
124866265|NCT05553808|449131473|FG000|Overall Study|Lost to Follow-up|1|||
124866266|NCT05553808|449131474|FG001|Overall Study|Lost to Follow-up|0|||
124866267|NCT05553808|449131473|FG000|Overall Study|Withdrawal by Subject|3|||
124866268|NCT05553808|449131474|FG001|Overall Study|Withdrawal by Subject|2|||
124866269|NCT01328574|449131485|FG000|Overall Study|Refused further treatment|1|||
124866270|NCT01483924|449131486|FG000|Overall Study|Withdrawal by Subject|2|||
124866271|NCT01483924|449131487|FG001|Overall Study|Withdrawal by Subject|0|||
124866272|NCT01483924|449131488|FG002|Overall Study|Withdrawal by Subject|0|||
124866273|NCT01483924|449131489|FG003|Overall Study|Withdrawal by Subject|1|||
124866274|NCT01483924|449131490|FG004|Overall Study|Withdrawal by Subject|1|||
125310209|NCT01196026|450762027|FG001|Overall Study|Other|1|||
125310210|NCT01196026|450762028|FG002|Overall Study|Other|0|||
125310211|NCT01196026|450762029|FG003|Overall Study|Other|0|||
125310212|NCT01196026|450762030|FG004|Overall Study|Other|0|||
125310213|NCT01196026|450762031|FG005|Overall Study|Other|0|||
125310214|NCT01687296|450762032|FG000|Overall Study|Lack of Efficacy|1|||
125310215|NCT01687296|450762033|FG001|Overall Study|Lack of Efficacy|1|||
125310216|NCT01687296|450762032|FG000|Overall Study|Protocol Violation|0|||
125310217|NCT01687296|450762033|FG001|Overall Study|Protocol Violation|1|||
125310218|NCT01687296|450762032|FG000|Overall Study|Withdrawal by Subject|6|||
125310219|NCT01687296|450762033|FG001|Overall Study|Withdrawal by Subject|3|||
125310220|NCT03672292|450762037|FG000|Overall Study|Adverse Event|3|||
125310221|NCT03672292|450762038|FG001|Overall Study|Adverse Event|1|||
125310222|NCT03672292|450762037|FG000|Overall Study|Physician Decision|0|||
125310223|NCT03672292|450762038|FG001|Overall Study|Physician Decision|1|||
125310224|NCT03672292|450762037|FG000|Overall Study|Withdrawal by Subject|1|||
125310225|NCT03672292|450762038|FG001|Overall Study|Withdrawal by Subject|2|||
125310226|NCT00799903|450762039|FG000|Overall Study|Investigator Site Closed|25|||
125310227|NCT00799903|450762040|FG001|Overall Study|Investigator Site Closed|23|||
125310228|NCT00799903|450762039|FG000|Overall Study|Withdrawal by Subject|179|||
124866275|NCT01483924|449131486|FG000|Overall Study|Adverse Event|0|||
124866276|NCT01483924|449131487|FG001|Overall Study|Adverse Event|0|||
124866277|NCT01483924|449131488|FG002|Overall Study|Adverse Event|1|||
124866278|NCT01483924|449131489|FG003|Overall Study|Adverse Event|1|||
124866279|NCT01483924|449131490|FG004|Overall Study|Adverse Event|0|||
124866280|NCT01483924|449131486|FG000|Overall Study|Non-compliance|0|||
124866281|NCT01483924|449131487|FG001|Overall Study|Non-compliance|0|||
124866282|NCT01483924|449131488|FG002|Overall Study|Non-compliance|0|||
125310229|NCT00799903|450762040|FG001|Overall Study|Withdrawal by Subject|175|||
125310230|NCT00799903|450762039|FG000|Overall Study|Lost to Follow-up|69|||
125310231|NCT00799903|450762040|FG001|Overall Study|Lost to Follow-up|80|||
125310232|NCT02518971|450762041|FG000|Overall Study|Lost to Follow-up|0|||
125310233|NCT02518971|450762042|FG001|Overall Study|Lost to Follow-up|1|||
124866283|NCT01483924|449131489|FG003|Overall Study|Non-compliance|1|||
124866284|NCT01483924|449131490|FG004|Overall Study|Non-compliance|1|||
125310234|NCT02518971|450762041|FG000|Overall Study|Physician Decision|6|||
124866285|NCT01483924|449131486|FG000|Overall Study|Sponsor concern over ECG result|0|||
124866286|NCT01483924|449131487|FG001|Overall Study|Sponsor concern over ECG result|0|||
124866287|NCT01483924|449131488|FG002|Overall Study|Sponsor concern over ECG result|0|||
124866288|NCT01483924|449131489|FG003|Overall Study|Sponsor concern over ECG result|1|||
124866289|NCT01483924|449131490|FG004|Overall Study|Sponsor concern over ECG result|0|||
124866290|NCT01994954|449131496|FG000|Overall Study|Death|1|||
124866291|NCT01994954|449131497|FG001|Overall Study|Death|0|||
124866292|NCT01994954|449131496|FG000|Overall Study|Withdrawal by Subject|9|||
124866293|NCT01994954|449131497|FG001|Overall Study|Withdrawal by Subject|14|||
124866294|NCT01994954|449131496|FG000|Overall Study|Physician Decision|2|||
124866295|NCT01994954|449131497|FG001|Overall Study|Physician Decision|2|||
124866296|NCT01994954|449131496|FG000|Overall Study|Lost to Follow-up|8|||
124866297|NCT01994954|449131497|FG001|Overall Study|Lost to Follow-up|10|||
124866298|NCT01994954|449131496|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
124866299|NCT01994954|449131497|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
124866300|NCT00449176|449131499|FG000|Overall Study|Withdrawal by Subject|39|||
124866301|NCT00449176|449131500|FG001|Overall Study|Withdrawal by Subject|43|||
124866302|NCT00449176|449131501|FG002|Overall Study|Withdrawal by Subject|59|||
124866303|NCT00449176|449131499|FG000|Overall Study|Lost to Follow-up|13|||
124866304|NCT00449176|449131500|FG001|Overall Study|Lost to Follow-up|8|||
124866305|NCT00449176|449131501|FG002|Overall Study|Lost to Follow-up|12|||
124866306|NCT00449176|449131499|FG000|Overall Study|Adverse Event|51|||
124866307|NCT00449176|449131500|FG001|Overall Study|Adverse Event|107|||
124866308|NCT00449176|449131501|FG002|Overall Study|Adverse Event|15|||
124866309|NCT00449176|449131499|FG000|Overall Study|Lack of Efficacy|13|||
124866310|NCT00449176|449131500|FG001|Overall Study|Lack of Efficacy|7|||
124866311|NCT00449176|449131501|FG002|Overall Study|Lack of Efficacy|50|||
124866312|NCT00449176|449131499|FG000|Overall Study|Study drug non-compliant|14|||
124866313|NCT00449176|449131500|FG001|Overall Study|Study drug non-compliant|11|||
124976976|NCT00895895|449541944|FG000|Period 2|discontinued by sponsor|44|||
124976977|NCT00895895|449541945|FG001|Period 2|discontinued by sponsor|44|||
124976978|NCT00895895|449541946|FG002|Period 2|discontinued by sponsor|38|||
124976979|NCT00895895|449541947|FG003|Period 2|discontinued by sponsor|46|||
124976980|NCT00895895|449541948|FG004|Period 2|discontinued by sponsor|37|||
124976981|NCT00895895|449541944|FG000|Period 2|failed to return|2|||
124866314|NCT00449176|449131501|FG002|Overall Study|Study drug non-compliant|11|||
124866315|NCT00449176|449131499|FG000|Overall Study|all other|22|||
124866316|NCT00449176|449131500|FG001|Overall Study|all other|19|||
124866317|NCT00449176|449131501|FG002|Overall Study|all other|20|||
124866318|NCT02363946|449131509|FG000|Overall Study|Lost to Follow-up|0|||
124866319|NCT02363946|449131510|FG001|Overall Study|Lost to Follow-up|0|||
124866320|NCT02363946|449131511|FG002|Overall Study|Lost to Follow-up|0|||
124866321|NCT02363946|449131512|FG003|Overall Study|Lost to Follow-up|0|||
124866322|NCT02363946|449131513|FG004|Overall Study|Lost to Follow-up|0|||
124866323|NCT02363946|449131514|FG005|Overall Study|Lost to Follow-up|0|||
124866324|NCT02363946|449131515|FG006|Overall Study|Lost to Follow-up|0|||
124866325|NCT02363946|449131516|FG007|Overall Study|Lost to Follow-up|1|||
124866326|NCT02363946|449131517|FG008|Overall Study|Lost to Follow-up|0|||
124866327|NCT02363946|449131518|FG009|Overall Study|Lost to Follow-up|0|||
124866328|NCT02363946|449131519|FG010|Overall Study|Lost to Follow-up|0|||
124866329|NCT02363946|449131520|FG011|Overall Study|Lost to Follow-up|0|||
124866330|NCT02363946|449131521|FG012|Overall Study|Lost to Follow-up|0|||
124866331|NCT00262821|449131522|FG000|Overall Study|Ineligible - wrong stage|0|||
124866332|NCT00262821|449131523|FG001|Overall Study|Ineligible - wrong stage|3|||
124866333|NCT00262821|449131522|FG000|Overall Study|Ineligible - wrong cell type|2|||
124866334|NCT00262821|449131523|FG001|Overall Study|Ineligible - wrong cell type|2|||
124866335|NCT00262821|449131522|FG000|Overall Study|Ineligible - wrong primary|0|||
124866336|NCT00262821|449131523|FG001|Overall Study|Ineligible - wrong primary|1|||
124866337|NCT00262821|449131522|FG000|Overall Study|Ineligible - inadequate pathology|1|||
124866338|NCT00262821|449131523|FG001|Overall Study|Ineligible - inadequate pathology|3|||
124866339|NCT00262821|449131522|FG000|Overall Study|Ineligible - elevated creatinine|0|||
124866340|NCT00262821|449131523|FG001|Overall Study|Ineligible - elevated creatinine|2|||
124866341|NCT00262821|449131522|FG000|Overall Study|Ineligible - required test not done|1|||
124866342|NCT00262821|449131523|FG001|Overall Study|Ineligible - required test not done|4|||
124866343|NCT00262821|449131522|FG000|Overall Study|Inevaluable - inadequate data|0|||
124866344|NCT00262821|449131523|FG001|Overall Study|Inevaluable - inadequate data|4|||
124866345|NCT01988779|449131524|FG000|Overall Study|Withdrawal by Subject|2|||
124866346|NCT01988779|449131525|FG001|Overall Study|Withdrawal by Subject|2|||
124866347|NCT01988779|449131524|FG000|Overall Study|Protocol Violation|1|||
124866348|NCT01988779|449131525|FG001|Overall Study|Protocol Violation|0|||
124866349|NCT01041638|449131526|FG000|Overall Study|Adverse Event|4|||
124866350|NCT01041638|449131526|FG000|Overall Study|Death|1|||
124866351|NCT01041638|449131526|FG000|Overall Study|Lack of Efficacy|7|||
124866352|NCT01041638|449131526|FG000|Overall Study|Physician Decision|4|||
124866353|NCT01041638|449131526|FG000|Overall Study|Withdrawal by Subject|11|||
124866354|NCT01922076|449131530|FG000|Overall Study|Adverse Event|0|||
124866355|NCT01922076|449131531|FG001|Overall Study|Adverse Event|0|||
124976982|NCT00895895|449541945|FG001|Period 2|failed to return|0|||
124866356|NCT01922076|449131532|FG002|Overall Study|Adverse Event|0|||
124866357|NCT01922076|449131533|FG003|Overall Study|Adverse Event|0|||
124866358|NCT01922076|449131534|FG004|Overall Study|Adverse Event|1|||
124866359|NCT01922076|449131535|FG005|Overall Study|Adverse Event|0|||
124866360|NCT01922076|449131536|FG006|Overall Study|Adverse Event|0|||
124866361|NCT01922076|449131530|FG000|Overall Study|Physician Decision|0|||
124866362|NCT01922076|449131531|FG001|Overall Study|Physician Decision|0|||
124866363|NCT01922076|449131532|FG002|Overall Study|Physician Decision|1|||
124866364|NCT01922076|449131533|FG003|Overall Study|Physician Decision|0|||
124866365|NCT01922076|449131534|FG004|Overall Study|Physician Decision|0|||
124866366|NCT01922076|449131535|FG005|Overall Study|Physician Decision|0|||
124866367|NCT01922076|449131536|FG006|Overall Study|Physician Decision|0|||
124866368|NCT01922076|449131530|FG000|Overall Study|Withdrawal by Subject|0|||
124866369|NCT01922076|449131531|FG001|Overall Study|Withdrawal by Subject|0|||
124866370|NCT01922076|449131532|FG002|Overall Study|Withdrawal by Subject|0|||
124866371|NCT01922076|449131533|FG003|Overall Study|Withdrawal by Subject|1|||
124866372|NCT01922076|449131534|FG004|Overall Study|Withdrawal by Subject|0|||
124866373|NCT01922076|449131535|FG005|Overall Study|Withdrawal by Subject|1|||
124866374|NCT01922076|449131536|FG006|Overall Study|Withdrawal by Subject|1|||
124866375|NCT04493216|449133474|FG000|Overall Study|Study terminated by sponsor|30|||
124866376|NCT04493216|449133475|FG001|Overall Study|Study terminated by sponsor|33|||
124866377|NCT04493216|449133476|FG002|Overall Study|Study terminated by sponsor|28|||
124866378|NCT04493216|449133477|FG003|Overall Study|Study terminated by sponsor|27|||
124976983|NCT00895895|449541946|FG002|Period 2|failed to return|0|||
124976984|NCT00895895|449541947|FG003|Period 2|failed to return|0|||
124976985|NCT00895895|449541948|FG004|Period 2|failed to return|0|||
124976986|NCT00895895|449541944|FG000|Period 2|investigator request|2|||
124976987|NCT00895895|449541945|FG001|Period 2|investigator request|0|||
124976988|NCT00895895|449541946|FG002|Period 2|investigator request|0|||
124976989|NCT00895895|449541947|FG003|Period 2|investigator request|0|||
124976990|NCT00895895|449541948|FG004|Period 2|investigator request|0|||
124976991|NCT00895895|449541944|FG000|Period 2|Lost to Follow-up|1|||
124976992|NCT00895895|449541945|FG001|Period 2|Lost to Follow-up|2|||
124976993|NCT00895895|449541946|FG002|Period 2|Lost to Follow-up|1|||
124976994|NCT00895895|449541947|FG003|Period 2|Lost to Follow-up|1|||
124976995|NCT00895895|449541948|FG004|Period 2|Lost to Follow-up|0|||
124976996|NCT00895895|449541944|FG000|Period 2|Other|1|||
124976997|NCT00895895|449541945|FG001|Period 2|Other|1|||
124976998|NCT00895895|449541946|FG002|Period 2|Other|3|||
124976999|NCT00895895|449541947|FG003|Period 2|Other|1|||
124977000|NCT00895895|449541948|FG004|Period 2|Other|1|||
124977001|NCT00895895|449541944|FG000|Period 2|Protocol Violation|1|||
124977002|NCT00895895|449541945|FG001|Period 2|Protocol Violation|0|||
124977003|NCT00895895|449541946|FG002|Period 2|Protocol Violation|1|||
124977004|NCT00895895|449541947|FG003|Period 2|Protocol Violation|1|||
124977005|NCT00895895|449541948|FG004|Period 2|Protocol Violation|1|||
124977006|NCT00895895|449541944|FG000|Period 2|Withdrawal by Subject|0|||
124977007|NCT00895895|449541945|FG001|Period 2|Withdrawal by Subject|2|||
124977008|NCT00895895|449541946|FG002|Period 2|Withdrawal by Subject|0|||
124977009|NCT00895895|449541947|FG003|Period 2|Withdrawal by Subject|3|||
124977010|NCT00895895|449541948|FG004|Period 2|Withdrawal by Subject|5|||
124977011|NCT00895895|449541944|FG000|Period 2|unsatisfactory response-efficacy|2|||
124977012|NCT00895895|449541945|FG001|Period 2|unsatisfactory response-efficacy|1|||
125198633|NCT02836236|450350984|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
124866379|NCT04493216|449133474|FG000|Overall Study|Withdrawal by Subject|2|||
124866380|NCT04493216|449133475|FG001|Overall Study|Withdrawal by Subject|1|||
124866381|NCT04493216|449133476|FG002|Overall Study|Withdrawal by Subject|1|||
124866382|NCT04493216|449133477|FG003|Overall Study|Withdrawal by Subject|2|||
124866383|NCT04493216|449133474|FG000|Overall Study|Protocol Violation|1|||
124866384|NCT04493216|449133475|FG001|Overall Study|Protocol Violation|2|||
124866385|NCT04493216|449133476|FG002|Overall Study|Protocol Violation|0|||
124866386|NCT04493216|449133477|FG003|Overall Study|Protocol Violation|2|||
124866387|NCT04493216|449133474|FG000|Overall Study|Physician Decision|0|||
124866388|NCT04493216|449133475|FG001|Overall Study|Physician Decision|0|||
124866389|NCT04493216|449133476|FG002|Overall Study|Physician Decision|1|||
124866390|NCT04493216|449133477|FG003|Overall Study|Physician Decision|0|||
124866391|NCT04493216|449133474|FG000|Overall Study|Lost to Follow-up|2|||
124866392|NCT04493216|449133475|FG001|Overall Study|Lost to Follow-up|1|||
124866393|NCT04493216|449133476|FG002|Overall Study|Lost to Follow-up|0|||
124866394|NCT04493216|449133477|FG003|Overall Study|Lost to Follow-up|1|||
124866395|NCT04493216|449133474|FG000|Overall Study|Adverse Event|1|||
124977013|NCT00895895|449541946|FG002|Period 2|unsatisfactory response-efficacy|0|||
124866396|NCT04493216|449133475|FG001|Overall Study|Adverse Event|4|||
124866397|NCT04493216|449133476|FG002|Overall Study|Adverse Event|5|||
124866398|NCT04493216|449133477|FG003|Overall Study|Adverse Event|2|||
124866399|NCT04493216|449133474|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
124977014|NCT00895895|449541947|FG003|Period 2|unsatisfactory response-efficacy|0|||
124977015|NCT00895895|449541948|FG004|Period 2|unsatisfactory response-efficacy|0|||
124977016|NCT01261000|449541949|FG000|Overall Study|Screen failure|1|||
124977017|NCT00504777|449541950|FG000|Overall Study|Adverse Event|1|||
124977018|NCT03552523|449541957|FG000|Overall Study|Withdrawal by Subject|1|||
124977019|NCT03552523|449541958|FG001|Overall Study|Withdrawal by Subject|1|||
124977020|NCT00755105|449541961|FG000|Overall Study|Withdrawal by Subject|9|||
124977021|NCT00755105|449541962|FG001|Overall Study|Withdrawal by Subject|11|||
124977022|NCT00755105|449541963|FG002|Overall Study|Withdrawal by Subject|4|||
124977023|NCT03995316|449541964|FG000|Overall Study|Lost to Follow-up|10|||
124977024|NCT03995316|449541965|FG001|Overall Study|Lost to Follow-up|3|||
124977025|NCT01250509|449541969|FG000|Overall Study|Lost to Follow-up|5|||
124977026|NCT01250509|449541970|FG001|Overall Study|Lost to Follow-up|2|||
124977027|NCT00203268|449541976|FG000|Early Treatment|only treated one headache|2|||
124977028|NCT00203268|449541976|FG000|Early Treatment|Lost to Follow-up|1|||
124977029|NCT00203268|449541976|FG000|Early Treatment|Withdrawal by Subject|1|||
124977030|NCT00600613|449541977|FG000|Overall Study|Protocol Deviation|1|||
124977031|NCT02807883|449541979|FG000|Overall Study|Withdrawal by Subject|2|||
124977032|NCT01399918|449541985|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
124977033|NCT05415748|449541988|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
124977034|NCT05415748|449541989|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
124977035|NCT05415748|449541990|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
124977036|NCT05415748|449541991|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
124977037|NCT05415748|449541988|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
124977038|NCT05415748|449541989|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
124977039|NCT05415748|449541990|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
124977040|NCT05415748|449541991|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
124977041|NCT04520659|449541992|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
124977042|NCT04520659|449541993|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
124977043|NCT04520659|449541994|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
124977044|NCT04520659|449541995|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
124977045|NCT03852719|449541996|FG000|Overall Study|Withdrawal of consent|8|||
124977046|NCT03852719|449541997|FG001|Overall Study|Withdrawal of consent|8|||
124977047|NCT03852719|449541998|FG002|Overall Study|Withdrawal of consent|9|||
124977048|NCT03852719|449541996|FG000|Overall Study|Physician Decision|5|||
124977049|NCT03852719|449541997|FG001|Overall Study|Physician Decision|4|||
124977050|NCT03852719|449541998|FG002|Overall Study|Physician Decision|1|||
124977051|NCT03852719|449541996|FG000|Overall Study|Pregnancy|2|||
124977052|NCT03852719|449541997|FG001|Overall Study|Pregnancy|1|||
124977053|NCT03852719|449541998|FG002|Overall Study|Pregnancy|0|||
124977054|NCT03852719|449541996|FG000|Overall Study|Death|1|||
124977055|NCT03852719|449541997|FG001|Overall Study|Death|0|||
124977056|NCT03852719|449541998|FG002|Overall Study|Death|0|||
125198634|NCT02836236|450350985|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
125198635|NCT02836236|450350986|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
125198636|NCT02836236|450350983|FG000|Open-Label TAF Treatment Phase|Death|0|||
125198637|NCT02836236|450350984|FG001|Open-Label TAF Treatment Phase|Death|0|||
125198638|NCT02836236|450350985|FG002|Open-Label TAF Treatment Phase|Death|1|||
125198639|NCT02836236|450350986|FG003|Open-Label TAF Treatment Phase|Death|1|||
125198640|NCT02836236|450350983|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
125198641|NCT02836236|450350984|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
125198642|NCT02836236|450350985|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
125198643|NCT02836236|450350986|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
125198644|NCT01806961|450350987|FG000|Overall Study|sponsor decision|16|||
125198645|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
125198646|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
125198647|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
125198648|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
125198649|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Death|0|||
125198650|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Death|0|||
125198651|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Death|1|||
125198652|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Death|0|||
125198653|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
125198654|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
125198655|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
125198656|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
125198657|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
125198658|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
125198659|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
125198660|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
125198661|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
125198662|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
125198663|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
125198664|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
125198665|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
125217403|NCT05415462|450423519|FG001|Overall Study|Lost to Follow-up|64|||
124977057|NCT03852719|449541996|FG000|Overall Study|Reason not Specified|3|||
124977058|NCT03852719|449541997|FG001|Overall Study|Reason not Specified|3|||
124977059|NCT03852719|449541998|FG002|Overall Study|Reason not Specified|5|||
124977060|NCT03852719|449541996|FG000|Overall Study|Adverse Event|2|||
124977061|NCT03852719|449541997|FG001|Overall Study|Adverse Event|1|||
124977062|NCT03852719|449541998|FG002|Overall Study|Adverse Event|4|||
124977063|NCT03852719|449541996|FG000|Overall Study|Progressive disease|1|||
124977064|NCT03852719|449541997|FG001|Overall Study|Progressive disease|4|||
124977065|NCT03852719|449541998|FG002|Overall Study|Progressive disease|1|||
124977066|NCT03852719|449541996|FG000|Overall Study|Lost to Follow-up|1|||
124977067|NCT03852719|449541997|FG001|Overall Study|Lost to Follow-up|0|||
124977068|NCT03852719|449541998|FG002|Overall Study|Lost to Follow-up|0|||
124977069|NCT02819024|449541999|FG000|Overall Study|Withdrawal by Subject|1|||
124977070|NCT00792948|449542000|FG000|Overall Study|Adverse Event|6|||
124977071|NCT00792948|449542000|FG000|Overall Study|Death|4|||
124977072|NCT00792948|449542000|FG000|Overall Study|Withdrawal by Subject|3|||
124977073|NCT00792948|449542000|FG000|Overall Study|Ineligible|2|||
124977074|NCT00792948|449542000|FG000|Overall Study|Insurance denial - not treated|1|||
124977075|NCT00792948|449542000|FG000|Overall Study|Physician Decision|11|||
124977076|NCT00792948|449542000|FG000|Overall Study|Protocol Violation|1|||
125033566|NCT00408005|449743812|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
125033567|NCT00408005|449743813|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
125033568|NCT00408005|449743814|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
125033569|NCT00408005|449743815|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
125033570|NCT00408005|449743816|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
125033571|NCT00408005|449743817|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
125033572|NCT00408005|449743818|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
125033573|NCT00408005|449743811|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
125033574|NCT00408005|449743812|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
125033575|NCT00408005|449743813|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
125033576|NCT00408005|449743814|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
125033577|NCT00408005|449743815|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
125131339|NCT03792477|450108115|FG001|Overall Study|Lost to Follow-up|0|||
125131340|NCT03792477|450108116|FG002|Overall Study|Lost to Follow-up|2|||
125198666|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
125198667|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
125131341|NCT03792477|450108117|FG003|Overall Study|Lost to Follow-up|0|||
125198668|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
125198669|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
125198670|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
125198671|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
125198672|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
125198673|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
125198674|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
125198675|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
125198676|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
125198677|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
125198678|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
125198679|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
125198680|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
125217404|NCT05415462|450423518|FG000|Overall Study|Physician Decision|5|||
125131342|NCT03792477|450108118|FG004|Overall Study|Lost to Follow-up|0|||
125131343|NCT03792477|450108114|FG000|Overall Study|Other|0|||
125131344|NCT03792477|450108115|FG001|Overall Study|Other|0|||
125131345|NCT03792477|450108116|FG002|Overall Study|Other|0|||
125131346|NCT03792477|450108117|FG003|Overall Study|Other|0|||
125131347|NCT03792477|450108118|FG004|Overall Study|Other|1|||
125131348|NCT00840411|450108120|FG000|First Intervention|Adverse Event|1|||
125131349|NCT00840411|450108121|FG001|First Intervention|Adverse Event|0|||
125131350|NCT00840411|450108120|FG000|Washout|Withdrawal by Subject|1|||
125131351|NCT00840411|450108121|FG001|Washout|Withdrawal by Subject|0|||
125131352|NCT00576056|450108126|FG000|Overall Study|Adverse Event|1|||
125131353|NCT00576056|450108126|FG000|Overall Study|Death|1|||
125131354|NCT00576056|450108126|FG000|Overall Study|Lack of Efficacy|1|||
125131355|NCT00576056|450108126|FG000|Overall Study|Withdrawal by Subject|2|||
125131356|NCT00576056|450108126|FG000|Overall Study|did not meet eligibility criteria|8|||
125131357|NCT00576056|450108126|FG000|Overall Study|Physician Decision|1|||
125131358|NCT01854047|450108127|FG000|Overall Study|Lack of Efficacy|1|||
125131359|NCT01854047|450108128|FG001|Overall Study|Lack of Efficacy|0|||
125131360|NCT01854047|450108129|FG002|Overall Study|Lack of Efficacy|0|||
125131361|NCT01854047|450108130|FG003|Overall Study|Lack of Efficacy|0|||
125131362|NCT01854047|450108131|FG004|Overall Study|Lack of Efficacy|0|||
125310235|NCT02518971|450762042|FG001|Overall Study|Physician Decision|6|||
125310236|NCT02518971|450762041|FG000|Overall Study|Protocol Violation|6|||
125310237|NCT02518971|450762042|FG001|Overall Study|Protocol Violation|4|||
125310238|NCT02518971|450762041|FG000|Overall Study|Withdrawal by Subject|4|||
125310239|NCT02518971|450762042|FG001|Overall Study|Withdrawal by Subject|5|||
125310240|NCT02518971|450762041|FG000|Overall Study|Side effects|1|||
125310241|NCT02518971|450762042|FG001|Overall Study|Side effects|0|||
124866400|NCT04493216|449133475|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
124866401|NCT04493216|449133476|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
124866402|NCT04493216|449133477|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
124866403|NCT03643952|449133484|FG000|Overall Study|Lack of Efficacy|1|||
124866404|NCT01597050|449133485|FG000|Overall Study|Withdrawal by Subject|1|||
125310242|NCT02518971|450762041|FG000|Overall Study|medication lost in mail|0|||
125310243|NCT02518971|450762042|FG001|Overall Study|medication lost in mail|1|||
125310244|NCT02518971|450762041|FG000|Overall Study|eligibility criteria no longer met|6|||
125310245|NCT02518971|450762042|FG001|Overall Study|eligibility criteria no longer met|3|||
125310246|NCT02336230|450762043|FG000|Overall Study|Adverse Event|1|||
125198681|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
125198682|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
125198683|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
125198684|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
125198685|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
125198686|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
125198687|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
125198688|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
125310247|NCT02336230|450762043|FG000|Overall Study|Withdrawal of consent|1|||
125198689|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Other|8|||
125198690|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Other|14|||
125310248|NCT02336230|450762043|FG000|Overall Study|Death|9|||
125310249|NCT02336230|450762043|FG000|Overall Study|Dose not received due to shipping delay|1|||
125310250|NCT02336230|450762043|FG000|Overall Study|Discontinuation of MSC infusion|1|||
125310251|NCT02524171|450762044|FG000|6-month Follow-up|Lost to Follow-up|53|||
125310252|NCT02524171|450762045|FG001|6-month Follow-up|Lost to Follow-up|45|||
124866405|NCT01597050|449133486|FG001|Overall Study|Withdrawal by Subject|0|||
124866406|NCT00483184|449133487|FG000|Overall Study|Withdrawal by Subject|2|||
124866407|NCT00483184|449133488|FG001|Overall Study|Withdrawal by Subject|2|||
124866408|NCT00483184|449133489|FG002|Overall Study|Withdrawal by Subject|0|||
124866409|NCT00483184|449133487|FG000|Overall Study|Lost to Follow-up|1|||
124866410|NCT00483184|449133488|FG001|Overall Study|Lost to Follow-up|0|||
124866411|NCT00483184|449133489|FG002|Overall Study|Lost to Follow-up|0|||
124866412|NCT00483184|449133487|FG000|Overall Study|Adverse Event|1|||
124866413|NCT00483184|449133488|FG001|Overall Study|Adverse Event|2|||
124866414|NCT00483184|449133489|FG002|Overall Study|Adverse Event|2|||
124977077|NCT03809039|449543723|FG000|Part 1|Withdrawal by Subject|1|||
124977078|NCT03809039|449543724|FG001|Part 1|Withdrawal by Subject|0|||
124977079|NCT03809039|449543725|FG002|Part 1|Withdrawal by Subject|0|||
124977080|NCT03809039|449543726|FG003|Part 1|Withdrawal by Subject|1|||
125198691|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Other|8|||
125198692|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Other|23|||
125198693|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
125198694|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
125198695|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
125198696|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
125198697|NCT01106677|450350991|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
125198698|NCT01106677|450350992|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
125198699|NCT01106677|450350993|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
125198700|NCT01106677|450350994|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
125198701|NCT01106677|450350991|FG000|Extension Period: Week 26 to Week 52|Death|0|||
125198702|NCT01106677|450350992|FG001|Extension Period: Week 26 to Week 52|Death|0|||
125198703|NCT01106677|450350993|FG002|Extension Period: Week 26 to Week 52|Death|0|||
125198704|NCT01106677|450350994|FG003|Extension Period: Week 26 to Week 52|Death|1|||
125198705|NCT01106677|450350991|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
125310253|NCT02524171|450762044|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
125310254|NCT02524171|450762045|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
125310255|NCT00757237|450762048|FG000|Overall Study|Lost to Follow-up|0|||
125310256|NCT00757237|450762049|FG001|Overall Study|Lost to Follow-up|1|||
125310257|NCT00757237|450762048|FG000|Overall Study|Protocol Violation|0|||
124977081|NCT03809039|449543727|FG004|Part 1|Withdrawal by Subject|0|||
124977082|NCT03809039|449543728|FG005|Part 1|Withdrawal by Subject|0|||
124977083|NCT03809039|449543729|FG006|Part 1|Withdrawal by Subject|0|||
124977084|NCT03809039|449543730|FG007|Part 1|Withdrawal by Subject|0|||
124977085|NCT03809039|449543731|FG008|Part 1|Withdrawal by Subject|0|||
124977086|NCT03809039|449543723|FG000|Part 3|Withdrawn by study termination|0|||
124977087|NCT03809039|449543724|FG001|Part 3|Withdrawn by study termination|0|||
124977088|NCT03809039|449543725|FG002|Part 3|Withdrawn by study termination|0|||
124977089|NCT03809039|449543726|FG003|Part 3|Withdrawn by study termination|0|||
124977090|NCT03809039|449543727|FG004|Part 3|Withdrawn by study termination|0|||
125198706|NCT01106677|450350992|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
125198707|NCT01106677|450350993|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
125198708|NCT01106677|450350994|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
125198709|NCT01106677|450350991|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
125198710|NCT01106677|450350992|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
125198711|NCT01106677|450350993|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
125198712|NCT01106677|450350994|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
125198713|NCT01106677|450350991|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
125198714|NCT01106677|450350992|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
125198715|NCT01106677|450350993|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
125198716|NCT01106677|450350994|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
125198717|NCT01106677|450350991|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
125198718|NCT01106677|450350992|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
125198719|NCT01106677|450350993|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
125198720|NCT01106677|450350994|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
125198721|NCT01106677|450350991|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
125198722|NCT01106677|450350992|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
125198723|NCT01106677|450350993|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
125198724|NCT01106677|450350994|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
125198725|NCT01106677|450350991|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
125198726|NCT01106677|450350992|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
125198727|NCT01106677|450350993|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
124866415|NCT00483184|449133487|FG000|Overall Study|Protocol Violation|1|||
124866416|NCT00483184|449133488|FG001|Overall Study|Protocol Violation|0|||
124866417|NCT00483184|449133489|FG002|Overall Study|Protocol Violation|1|||
124866418|NCT00558428|449133490|FG000|Overall Study|Adverse Event|6|||
124866419|NCT00558428|449133491|FG001|Overall Study|Adverse Event|22|||
124866420|NCT00558428|449133492|FG002|Overall Study|Adverse Event|3|||
124866421|NCT00558428|449133493|FG003|Overall Study|Adverse Event|4|||
124866422|NCT00558428|449133490|FG000|Overall Study|Lost to Follow-up|0|||
124866423|NCT00558428|449133491|FG001|Overall Study|Lost to Follow-up|1|||
124866424|NCT00558428|449133492|FG002|Overall Study|Lost to Follow-up|0|||
124866425|NCT00558428|449133493|FG003|Overall Study|Lost to Follow-up|0|||
124866426|NCT00558428|449133490|FG000|Overall Study|Lack of Efficacy|0|||
124866427|NCT00558428|449133491|FG001|Overall Study|Lack of Efficacy|0|||
124866428|NCT00558428|449133492|FG002|Overall Study|Lack of Efficacy|1|||
124866429|NCT00558428|449133493|FG003|Overall Study|Lack of Efficacy|2|||
125198728|NCT01106677|450350994|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
125198729|NCT01106677|450350991|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
125198730|NCT01106677|450350992|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
125198731|NCT01106677|450350993|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
125198732|NCT01106677|450350994|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
125198733|NCT01106677|450350991|FG000|Extension Period: Week 26 to Week 52|Other|6|||
124866430|NCT00558428|449133490|FG000|Overall Study|Non compliant with protocol|1|||
124866431|NCT00558428|449133491|FG001|Overall Study|Non compliant with protocol|0|||
124866432|NCT00558428|449133492|FG002|Overall Study|Non compliant with protocol|0|||
124866433|NCT00558428|449133493|FG003|Overall Study|Non compliant with protocol|3|||
124866434|NCT00558428|449133490|FG000|Overall Study|Consent withdrawn|2|||
124866435|NCT00558428|449133491|FG001|Overall Study|Consent withdrawn|1|||
125198734|NCT01106677|450350992|FG001|Extension Period: Week 26 to Week 52|Other|5|||
124866436|NCT00558428|449133492|FG002|Overall Study|Consent withdrawn|0|||
124866437|NCT00558428|449133493|FG003|Overall Study|Consent withdrawn|1|||
124866438|NCT00558428|449133490|FG000|Overall Study|Other|3|||
124866439|NCT00558428|449133491|FG001|Overall Study|Other|0|||
124866440|NCT00558428|449133492|FG002|Overall Study|Other|0|||
124866441|NCT00558428|449133493|FG003|Overall Study|Other|1|||
124866442|NCT05224050|449133494|FG000|Overall Study|Withdrawal by Subject|9|||
124866443|NCT05224050|449133494|FG000|Overall Study|Lost to Follow-up|3|||
124866444|NCT01292876|449133495|FG000|Overall Study|Physician Decision|4|||
124866445|NCT01627327|449133496|FG000|Overall Study|Adverse Event|6|||
124866446|NCT01627327|449133497|FG001|Overall Study|Adverse Event|12|||
124866447|NCT01627327|449133496|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
124866448|NCT01627327|449133497|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
124866449|NCT01627327|449133496|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
124866450|NCT01627327|449133497|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
124866451|NCT01627327|449133496|FG000|Overall Study|Protocol Violation|4|||
124866452|NCT01627327|449133497|FG001|Overall Study|Protocol Violation|10|||
124866453|NCT01627327|449133496|FG000|Overall Study|Lost to Follow-up|1|||
124866454|NCT01627327|449133497|FG001|Overall Study|Lost to Follow-up|3|||
124866455|NCT01627327|449133496|FG000|Overall Study|Physician Decision|1|||
124866456|NCT01627327|449133497|FG001|Overall Study|Physician Decision|0|||
124866457|NCT01627327|449133496|FG000|Overall Study|Withdrawal by Subject|3|||
124866458|NCT01627327|449133497|FG001|Overall Study|Withdrawal by Subject|3|||
124866459|NCT04528069|449133503|FG000|Overall Study|Adverse Event|1|||
124866460|NCT04528069|449133503|FG000|Overall Study|Lost to Follow-up|1|||
124866461|NCT04528069|449133503|FG000|Overall Study|Patient Unable to Come|1|||
124866462|NCT04528069|449133503|FG000|Overall Study|Patient Unable to Attend|1|||
124866463|NCT02525874|449133508|FG000|Overall Study|Other|1|||
124866464|NCT02525874|449133508|FG000|Overall Study|Investigator Decision|1|||
124866465|NCT02525874|449133508|FG000|Overall Study|Consent withdrawn|22|||
124866466|NCT02525874|449133508|FG000|Overall Study|Non-compliance with study drug|3|||
124866467|NCT02525874|449133508|FG000|Overall Study|Adverse Event|17|||
124866468|NCT02525874|449133508|FG000|Overall Study|Lost to Follow-up|7|||
124866469|NCT02525874|449133508|FG000|Overall Study|Disease progression, defined by protocol|2|||
124866470|NCT02525874|449133508|FG000|Overall Study|Disease relapse|4|||
124866471|NCT02525874|449133508|FG000|Overall Study|Alternative Treatment for MS|2|||
124866472|NCT02525874|449133508|FG000|Overall Study|New lesions in Brain|1|||
124866473|NCT01692782|449133509|FG000|Overall Study|Adverse Event|12|||
124866474|NCT01692782|449133510|FG001|Overall Study|Adverse Event|32|||
124866475|NCT01692782|449133511|FG002|Overall Study|Adverse Event|2|||
124866476|NCT01692782|449133509|FG000|Overall Study|Lack of Efficacy|1|||
124866477|NCT01692782|449133510|FG001|Overall Study|Lack of Efficacy|2|||
124866478|NCT01692782|449133511|FG002|Overall Study|Lack of Efficacy|0|||
124866479|NCT01692782|449133509|FG000|Overall Study|Lost to Follow-up|2|||
124866480|NCT01692782|449133510|FG001|Overall Study|Lost to Follow-up|7|||
124866481|NCT01692782|449133511|FG002|Overall Study|Lost to Follow-up|1|||
124866482|NCT01692782|449133509|FG000|Overall Study|Pregnancy|1|||
124866483|NCT01692782|449133510|FG001|Overall Study|Pregnancy|0|||
124866484|NCT01692782|449133511|FG002|Overall Study|Pregnancy|0|||
124866485|NCT01692782|449133509|FG000|Overall Study|Protocol Violation|1|||
124866486|NCT01692782|449133510|FG001|Overall Study|Protocol Violation|0|||
124866487|NCT01692782|449133511|FG002|Overall Study|Protocol Violation|2|||
124866488|NCT01692782|449133509|FG000|Overall Study|Non-complance with study drug|0|||
124866489|NCT01692782|449133510|FG001|Overall Study|Non-complance with study drug|4|||
124866490|NCT01692782|449133511|FG002|Overall Study|Non-complance with study drug|1|||
125198735|NCT01106677|450350993|FG002|Extension Period: Week 26 to Week 52|Other|8|||
125198736|NCT01106677|450350994|FG003|Extension Period: Week 26 to Week 52|Other|5|||
125198737|NCT03937908|450350996|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
125198738|NCT03937908|450350997|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
125198739|NCT03205761|450350998|FG000|Overall Study|Withdrawal by Subject|1|||
125198740|NCT03205761|450350998|FG000|Overall Study|Progressive Disease|10|||
125198741|NCT04420585|450350999|FG000|Overall Study|Adverse Event|1|||
125198742|NCT04420585|450350999|FG000|Overall Study|Never initiated medication|2|||
125198743|NCT00972816|450351000|FG000|Overall Study|Adverse Event|0|||
125198744|NCT00972816|450351001|FG001|Overall Study|Adverse Event|0|||
125198745|NCT00972816|450351002|FG002|Overall Study|Adverse Event|1|||
125198746|NCT00972816|450351003|FG003|Overall Study|Adverse Event|0|||
125198747|NCT00972816|450351004|FG004|Overall Study|Adverse Event|0|||
125198748|NCT00972816|450351005|FG005|Overall Study|Adverse Event|0|||
125198749|NCT00972816|450351006|FG006|Overall Study|Adverse Event|0|||
125198750|NCT00972816|450351007|FG007|Overall Study|Adverse Event|0|||
125198751|NCT00972816|450351000|FG000|Overall Study|Withdrawal by Subject|4|||
125198752|NCT00972816|450351001|FG001|Overall Study|Withdrawal by Subject|2|||
125198753|NCT00972816|450351002|FG002|Overall Study|Withdrawal by Subject|1|||
125198754|NCT00972816|450351003|FG003|Overall Study|Withdrawal by Subject|3|||
125198755|NCT00972816|450351004|FG004|Overall Study|Withdrawal by Subject|0|||
125198756|NCT00972816|450351005|FG005|Overall Study|Withdrawal by Subject|1|||
125198757|NCT00972816|450351006|FG006|Overall Study|Withdrawal by Subject|1|||
125198758|NCT00972816|450351007|FG007|Overall Study|Withdrawal by Subject|2|||
124866491|NCT01692782|449133509|FG000|Overall Study|Non-compliant with study visits|0|||
124866492|NCT01692782|449133510|FG001|Overall Study|Non-compliant with study visits|0|||
124866493|NCT01692782|449133511|FG002|Overall Study|Non-compliant with study visits|1|||
124866494|NCT01692782|449133509|FG000|Overall Study|SAE not related to study drug|0|||
125198759|NCT00972816|450351000|FG000|Overall Study|Lost to Follow-up|11|||
125198760|NCT00972816|450351001|FG001|Overall Study|Lost to Follow-up|9|||
125198761|NCT00972816|450351002|FG002|Overall Study|Lost to Follow-up|7|||
124866495|NCT01692782|449133510|FG001|Overall Study|SAE not related to study drug|1|||
125198762|NCT00972816|450351003|FG003|Overall Study|Lost to Follow-up|5|||
125198763|NCT00972816|450351004|FG004|Overall Study|Lost to Follow-up|11|||
125198764|NCT00972816|450351005|FG005|Overall Study|Lost to Follow-up|10|||
125198765|NCT00972816|450351006|FG006|Overall Study|Lost to Follow-up|7|||
124866496|NCT01692782|449133511|FG002|Overall Study|SAE not related to study drug|0|||
124866497|NCT01692782|449133509|FG000|Overall Study|Withdrawal by Subject|3|||
124866498|NCT01692782|449133510|FG001|Overall Study|Withdrawal by Subject|10|||
125310258|NCT00757237|450762049|FG001|Overall Study|Protocol Violation|2|||
125310259|NCT00757237|450762048|FG000|Overall Study|Physician Decision|2|||
125310260|NCT00757237|450762049|FG001|Overall Study|Physician Decision|3|||
125310261|NCT00757237|450762048|FG000|Overall Study|Withdrawal by Subject|8|||
125310262|NCT00757237|450762049|FG001|Overall Study|Withdrawal by Subject|12|||
125310263|NCT00757237|450762048|FG000|Overall Study|Safety or Tolerability|3|||
125310264|NCT00757237|450762049|FG001|Overall Study|Safety or Tolerability|5|||
125310265|NCT00757237|450762048|FG000|Overall Study|Other|0|||
125310266|NCT00757237|450762049|FG001|Overall Study|Other|2|||
125310267|NCT05150990|450762050|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
125310268|NCT05150990|450762051|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
125310269|NCT05150990|450762050|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
125310270|NCT05150990|450762051|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
124866499|NCT01692782|449133511|FG002|Overall Study|Withdrawal by Subject|3|||
124866500|NCT03252587|449133512|FG000|Overall Study|Adverse Event|3|||
124866501|NCT03252587|449133513|FG001|Overall Study|Adverse Event|8|||
124866502|NCT03252587|449133514|FG002|Overall Study|Adverse Event|6|||
124866503|NCT03252587|449133515|FG003|Overall Study|Adverse Event|12|||
124866504|NCT03252587|449133512|FG000|Overall Study|Lack of Efficacy|7|||
124866505|NCT03252587|449133513|FG001|Overall Study|Lack of Efficacy|2|||
124866506|NCT03252587|449133514|FG002|Overall Study|Lack of Efficacy|2|||
125310271|NCT05150990|450762050|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
125310272|NCT05150990|450762051|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
125310273|NCT05150990|450762050|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
125310274|NCT05150990|450762051|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
125310275|NCT05150990|450762050|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
125310276|NCT05150990|450762051|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
125310277|NCT05150990|450762050|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
125310278|NCT05150990|450762051|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
125310279|NCT05150990|450762050|FG000|Overall Study|Death (unrelated to the intervention)|1|||
125310280|NCT05150990|450762051|FG001|Overall Study|Death (unrelated to the intervention)|2|||
124866507|NCT03252587|449133515|FG003|Overall Study|Lack of Efficacy|4|||
124866508|NCT03252587|449133512|FG000|Overall Study|Lost to Follow-up|2|||
124866509|NCT03252587|449133513|FG001|Overall Study|Lost to Follow-up|0|||
124866510|NCT03252587|449133514|FG002|Overall Study|Lost to Follow-up|0|||
124866511|NCT03252587|449133515|FG003|Overall Study|Lost to Follow-up|2|||
124866512|NCT03252587|449133512|FG000|Overall Study|Pregnancy|2|||
124866513|NCT03252587|449133513|FG001|Overall Study|Pregnancy|1|||
124866514|NCT03252587|449133514|FG002|Overall Study|Pregnancy|0|||
124866515|NCT03252587|449133515|FG003|Overall Study|Pregnancy|1|||
124866516|NCT03252587|449133512|FG000|Overall Study|Withdrawal by Subject|8|||
124866517|NCT03252587|449133513|FG001|Overall Study|Withdrawal by Subject|4|||
124866518|NCT03252587|449133514|FG002|Overall Study|Withdrawal by Subject|4|||
124866519|NCT03252587|449133515|FG003|Overall Study|Withdrawal by Subject|4|||
124866520|NCT03252587|449133512|FG000|Overall Study|Other Reasons|2|||
124866521|NCT03252587|449133513|FG001|Overall Study|Other Reasons|5|||
124866522|NCT03252587|449133514|FG002|Overall Study|Other Reasons|5|||
124866523|NCT03252587|449133515|FG003|Overall Study|Other Reasons|4|||
124866524|NCT04052204|449133516|FG000|Overall Study|Death|1|||
124866525|NCT04052204|449133517|FG001|Overall Study|Death|0|||
124866526|NCT04052204|449133518|FG002|Overall Study|Death|0|||
124866527|NCT04052204|449133516|FG000|Overall Study|Progressive disease|1|||
124866528|NCT04052204|449133517|FG001|Overall Study|Progressive disease|0|||
124866529|NCT04052204|449133518|FG002|Overall Study|Progressive disease|0|||
124866530|NCT04052204|449133516|FG000|Overall Study|Other|1|||
124866531|NCT04052204|449133517|FG001|Overall Study|Other|0|||
124866532|NCT04052204|449133518|FG002|Overall Study|Other|0|||
124866533|NCT03945188|449133524|FG000|Overall Study|Protocol Violation|1|||
124866534|NCT03945188|449133525|FG001|Overall Study|Protocol Violation|0|||
124866535|NCT03945188|449133524|FG000|Overall Study|Disease worsening|79|||
124866536|NCT03945188|449133525|FG001|Overall Study|Disease worsening|73|||
124866537|NCT03945188|449133524|FG000|Overall Study|Physician Decision|2|||
124866538|NCT03945188|449133525|FG001|Overall Study|Physician Decision|2|||
124866539|NCT03945188|449133524|FG000|Overall Study|Lack of Efficacy|7|||
124866540|NCT03945188|449133525|FG001|Overall Study|Lack of Efficacy|4|||
124866541|NCT03945188|449133524|FG000|Overall Study|Pregnancy|2|||
124866542|NCT03945188|449133525|FG001|Overall Study|Pregnancy|0|||
124866543|NCT03945188|449133524|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
124866544|NCT03945188|449133525|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
125310281|NCT00466921|450762052|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
124866545|NCT03945188|449133524|FG000|Overall Study|Adverse Event|10|||
124866546|NCT03945188|449133525|FG001|Overall Study|Adverse Event|5|||
124866547|NCT03945188|449133524|FG000|Overall Study|Other|2|||
124866548|NCT03945188|449133525|FG001|Overall Study|Other|2|||
125310282|NCT00466921|450762052|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
124866549|NCT03945188|449133524|FG000|Overall Study|Lost to Follow-up|1|||
124866550|NCT03945188|449133525|FG001|Overall Study|Lost to Follow-up|2|||
124866551|NCT02807558|449133551|FG000|Overall Study|Consent withdrawn by participant|4|||
124866552|NCT02807558|449133552|FG001|Overall Study|Consent withdrawn by participant|0|||
124866553|NCT02807558|449133553|FG002|Overall Study|Consent withdrawn by participant|4|||
124866554|NCT02807558|449133554|FG003|Overall Study|Consent withdrawn by participant|2|||
124866555|NCT02807558|449133555|FG004|Overall Study|Consent withdrawn by participant|1|||
124866556|NCT02807558|449133556|FG005|Overall Study|Consent withdrawn by participant|0|||
124866557|NCT02807558|449133551|FG000|Overall Study|Non-compliance with Study Drug|0|||
124866558|NCT02807558|449133552|FG001|Overall Study|Non-compliance with Study Drug|0|||
124866559|NCT02807558|449133553|FG002|Overall Study|Non-compliance with Study Drug|1|||
124866560|NCT02807558|449133554|FG003|Overall Study|Non-compliance with Study Drug|0|||
124866561|NCT02807558|449133555|FG004|Overall Study|Non-compliance with Study Drug|0|||
124866562|NCT02807558|449133556|FG005|Overall Study|Non-compliance with Study Drug|0|||
124866563|NCT02807558|449133551|FG000|Overall Study|Adverse Event|0|||
124866564|NCT02807558|449133552|FG001|Overall Study|Adverse Event|0|||
124866565|NCT02807558|449133553|FG002|Overall Study|Adverse Event|9|||
124866566|NCT02807558|449133554|FG003|Overall Study|Adverse Event|0|||
124866567|NCT02807558|449133555|FG004|Overall Study|Adverse Event|0|||
124866568|NCT02807558|449133556|FG005|Overall Study|Adverse Event|0|||
124866569|NCT02807558|449133551|FG000|Overall Study|Death|23|||
124866570|NCT02807558|449133552|FG001|Overall Study|Death|2|||
124866571|NCT02807558|449133553|FG002|Overall Study|Death|3|||
124866572|NCT02807558|449133554|FG003|Overall Study|Death|43|||
124866573|NCT02807558|449133555|FG004|Overall Study|Death|24|||
124866574|NCT02807558|449133556|FG005|Overall Study|Death|15|||
124866575|NCT02807558|449133551|FG000|Overall Study|Progressive Disease|0|||
124866576|NCT02807558|449133552|FG001|Overall Study|Progressive Disease|0|||
124866577|NCT02807558|449133553|FG002|Overall Study|Progressive Disease|1|||
124866578|NCT02807558|449133554|FG003|Overall Study|Progressive Disease|0|||
124866579|NCT02807558|449133555|FG004|Overall Study|Progressive Disease|0|||
124866580|NCT02807558|449133556|FG005|Overall Study|Progressive Disease|0|||
124866581|NCT02807558|449133551|FG000|Overall Study|Other than specified|1|||
124866582|NCT02807558|449133552|FG001|Overall Study|Other than specified|0|||
124866583|NCT02807558|449133553|FG002|Overall Study|Other than specified|2|||
124866584|NCT02807558|449133554|FG003|Overall Study|Other than specified|0|||
124866585|NCT02807558|449133555|FG004|Overall Study|Other than specified|1|||
124866586|NCT02807558|449133556|FG005|Overall Study|Other than specified|1|||
124866587|NCT02807558|449133551|FG000|Overall Study|Lack of Efficacy|0|||
124866588|NCT02807558|449133552|FG001|Overall Study|Lack of Efficacy|0|||
124866589|NCT02807558|449133553|FG002|Overall Study|Lack of Efficacy|9|||
124866590|NCT02807558|449133554|FG003|Overall Study|Lack of Efficacy|0|||
124866591|NCT02807558|449133555|FG004|Overall Study|Lack of Efficacy|0|||
124866592|NCT02807558|449133556|FG005|Overall Study|Lack of Efficacy|0|||
124866593|NCT04575467|449133557|FG000|Overall Study|Adverse Event|0|||
124866594|NCT04575467|449133558|FG001|Overall Study|Adverse Event|1|||
124866595|NCT04575467|449133559|FG002|Overall Study|Adverse Event|0|||
124866596|NCT04575467|449133560|FG003|Overall Study|Adverse Event|0|||
124866597|NCT00003298|449133561|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
124866598|NCT00003298|449133561|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
124866599|NCT00003298|449133561|FG000|Surgery|Unresectable at surgery|3|||
124866600|NCT00003298|449133561|FG000|Surgery|Progression before surgery|2|||
124866601|NCT00003298|449133561|FG000|Surgery|Unevaluable and off study|2|||
124866602|NCT00003298|449133561|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
124866603|NCT00003298|449133561|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
124866604|NCT00003298|449133561|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
124866605|NCT00003298|449133561|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
124866606|NCT00003298|449133561|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
124866607|NCT00003298|449133561|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
124866608|NCT00003298|449133561|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
124866609|NCT00003298|449133561|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
124866610|NCT00003298|449133561|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
124866611|NCT00003298|449133561|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
124866612|NCT03565887|449133566|FG000|Overall Study|Adverse Event|1|||
124866613|NCT03565887|449133567|FG001|Overall Study|Adverse Event|0|||
124866614|NCT03565887|449133566|FG000|Overall Study|Withdrawal by Subject|0|||
124866615|NCT03565887|449133567|FG001|Overall Study|Withdrawal by Subject|2|||
124866616|NCT01454583|449133568|FG000|1st Year|Lost to Follow-up|1057|||
124866617|NCT01454583|449133569|FG001|1st Year|Lost to Follow-up|318|||
124866618|NCT01454583|449133570|FG002|1st Year|Lost to Follow-up|180|||
124866619|NCT01454583|449133568|FG000|2nd Year|Lost to Follow-up|3965|||
124866620|NCT01454583|449133569|FG001|2nd Year|Lost to Follow-up|1049|||
124866621|NCT01454583|449133570|FG002|2nd Year|Lost to Follow-up|737|||
124866622|NCT01454583|449133568|FG000|3rd Year|Lost to Follow-up|1959|||
124866623|NCT01454583|449133569|FG001|3rd Year|Lost to Follow-up|512|||
124866624|NCT01454583|449133570|FG002|3rd Year|Lost to Follow-up|297|||
124866625|NCT02677116|449133573|FG000|Overall Study|Adverse Event|0|||
124866626|NCT02677116|449133574|FG001|Overall Study|Adverse Event|1|||
124866627|NCT02677116|449133575|FG002|Overall Study|Adverse Event|0|||
124866628|NCT02677116|449133576|FG003|Overall Study|Adverse Event|0|||
124866629|NCT02677116|449133577|FG004|Overall Study|Adverse Event|0|||
124866630|NCT02677116|449133578|FG005|Overall Study|Adverse Event|1|||
124866631|NCT02677116|449133579|FG006|Overall Study|Adverse Event|1|||
124866632|NCT02677116|449133580|FG007|Overall Study|Adverse Event|0|||
124866633|NCT02677116|449133581|FG008|Overall Study|Adverse Event|0|||
124866634|NCT02677116|449133573|FG000|Overall Study|Physician Decision|0|||
124866635|NCT02677116|449133574|FG001|Overall Study|Physician Decision|2|||
124866636|NCT02677116|449133575|FG002|Overall Study|Physician Decision|3|||
124866637|NCT02677116|449133576|FG003|Overall Study|Physician Decision|2|||
124866638|NCT02677116|449133577|FG004|Overall Study|Physician Decision|1|||
124866639|NCT02677116|449133578|FG005|Overall Study|Physician Decision|3|||
124866640|NCT02677116|449133579|FG006|Overall Study|Physician Decision|1|||
124866641|NCT02677116|449133580|FG007|Overall Study|Physician Decision|1|||
124866642|NCT02677116|449133581|FG008|Overall Study|Physician Decision|2|||
124866643|NCT02677116|449133573|FG000|Overall Study|Withdrawal by parent or guardian|2|||
124866644|NCT02677116|449133574|FG001|Overall Study|Withdrawal by parent or guardian|1|||
124866645|NCT02677116|449133575|FG002|Overall Study|Withdrawal by parent or guardian|0|||
124866646|NCT02677116|449133576|FG003|Overall Study|Withdrawal by parent or guardian|1|||
124866647|NCT02677116|449133577|FG004|Overall Study|Withdrawal by parent or guardian|0|||
124866648|NCT02677116|449133578|FG005|Overall Study|Withdrawal by parent or guardian|0|||
124866649|NCT02677116|449133579|FG006|Overall Study|Withdrawal by parent or guardian|2|||
124866650|NCT02677116|449133580|FG007|Overall Study|Withdrawal by parent or guardian|1|||
124866651|NCT02677116|449133581|FG008|Overall Study|Withdrawal by parent or guardian|0|||
124866652|NCT02677116|449133573|FG000|Overall Study|Withdrawal by Subject|1|||
124866653|NCT02677116|449133574|FG001|Overall Study|Withdrawal by Subject|0|||
124866654|NCT02677116|449133575|FG002|Overall Study|Withdrawal by Subject|0|||
124866655|NCT02677116|449133576|FG003|Overall Study|Withdrawal by Subject|0|||
124866656|NCT02677116|449133577|FG004|Overall Study|Withdrawal by Subject|0|||
124866657|NCT02677116|449133578|FG005|Overall Study|Withdrawal by Subject|0|||
124866658|NCT02677116|449133579|FG006|Overall Study|Withdrawal by Subject|0|||
124866659|NCT02677116|449133580|FG007|Overall Study|Withdrawal by Subject|0|||
124866660|NCT02677116|449133581|FG008|Overall Study|Withdrawal by Subject|0|||
124866661|NCT03182868|449133582|FG000|Overall Study|Protocol Violation|3|||
124866662|NCT03182868|449133583|FG001|Overall Study|Protocol Violation|0|||
124866663|NCT03182868|449133584|FG002|Overall Study|Protocol Violation|4|||
124866664|NCT03182868|449133585|FG003|Overall Study|Protocol Violation|1|||
124866665|NCT03182868|449133586|FG004|Overall Study|Protocol Violation|8|||
124866666|NCT01967732|449133587|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
124866667|NCT01967732|449133588|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
124866668|NCT01967732|449133589|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
124866669|NCT01967732|449133590|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
124866670|NCT01967732|449133587|FG000|First Intervention (Day 1)|Poor venous access|0|||
124866671|NCT01967732|449133588|FG001|First Intervention (Day 1)|Poor venous access|1|||
124866672|NCT01967732|449133589|FG002|First Intervention (Day 1)|Poor venous access|0|||
124866673|NCT01967732|449133590|FG003|First Intervention (Day 1)|Poor venous access|0|||
124866674|NCT03342638|449133591|FG000|Overall Study|Withdrawal by Subject|1|||
124866675|NCT03342638|449133592|FG001|Overall Study|Withdrawal by Subject|0|||
124866676|NCT03342638|449133591|FG000|Overall Study|Physician Decision|0|||
124866677|NCT03342638|449133592|FG001|Overall Study|Physician Decision|1|||
124866678|NCT01292239|449133608|FG000|Overall Study|Other|1|||
124866679|NCT01292239|449133609|FG001|Overall Study|Other|1|||
124866680|NCT01292239|449133608|FG000|Overall Study|Withdrawal by Subject|3|||
124866681|NCT01292239|449133609|FG001|Overall Study|Withdrawal by Subject|6|||
124866682|NCT00113568|449133610|FG000|Overall Study|Adverse Event|97|||
124866683|NCT00113568|449133610|FG000|Overall Study|Death|1|||
124866684|NCT00113568|449133610|FG000|Overall Study|Lack of Efficacy|30|||
124866685|NCT00113568|449133610|FG000|Overall Study|Lost to Follow-up|156|||
124866686|NCT00113568|449133610|FG000|Overall Study|Protocol Violation|32|||
124866687|NCT00113568|449133610|FG000|Overall Study|Withdrawal by Subject|117|||
124866688|NCT00113568|449133610|FG000|Overall Study|Other|112|||
124866689|NCT00584727|449133612|FG000|First Intervention|Discontinuation|0|||
124866690|NCT00584727|449133613|FG001|First Intervention|Discontinuation|0|||
124866691|NCT00584727|449133614|FG002|First Intervention|Discontinuation|1|||
124866692|NCT00584727|449133615|FG003|First Intervention|Discontinuation|0|||
124866693|NCT00584727|449133616|FG004|First Intervention|Discontinuation|0|||
124866694|NCT00584727|449133617|FG005|First Intervention|Discontinuation|0|||
124866695|NCT00584727|449133612|FG000|Third Intervention|Protocol Violation|0|||
124866696|NCT00584727|449133613|FG001|Third Intervention|Protocol Violation|0|||
124866697|NCT00584727|449133614|FG002|Third Intervention|Protocol Violation|1|||
124866698|NCT00584727|449133615|FG003|Third Intervention|Protocol Violation|0|||
124866699|NCT00584727|449133616|FG004|Third Intervention|Protocol Violation|4|||
124866700|NCT00584727|449133617|FG005|Third Intervention|Protocol Violation|2|||
124866701|NCT00377403|449133619|FG000|Overall Study|Unable to contact for telephone intervie|4|||
124866702|NCT00377403|449133620|FG001|Overall Study|Unable to contact for telephone intervie|7|||
124866703|NCT01687257|449133621|FG000|Overall Study|Efficacy Failure|6|||
124866704|NCT01687257|449133622|FG001|Overall Study|Efficacy Failure|0|||
124866705|NCT01687257|449133623|FG002|Overall Study|Efficacy Failure|5|||
124866706|NCT01687257|449133621|FG000|Overall Study|Subject Withdrew Consent|1|||
124866707|NCT01687257|449133622|FG001|Overall Study|Subject Withdrew Consent|1|||
124866708|NCT01687257|449133623|FG002|Overall Study|Subject Withdrew Consent|1|||
124866709|NCT01687257|449133621|FG000|Overall Study|Adverse Event|1|||
124866710|NCT01687257|449133622|FG001|Overall Study|Adverse Event|0|||
124866711|NCT01687257|449133623|FG002|Overall Study|Adverse Event|0|||
124866712|NCT01687257|449133621|FG000|Overall Study|Investigator's Discretion|0|||
124866713|NCT01687257|449133622|FG001|Overall Study|Investigator's Discretion|3|||
124866714|NCT01687257|449133623|FG002|Overall Study|Investigator's Discretion|0|||
124866715|NCT00736645|449133625|FG000|Overall Study|Adverse Event|0|||
124866716|NCT00736645|449133626|FG001|Overall Study|Adverse Event|2|||
124866717|NCT00736645|449133627|FG002|Overall Study|Adverse Event|0|||
124866718|NCT00736645|449133628|FG003|Overall Study|Adverse Event|0|||
124866719|NCT00295022|449133629|FG000|Overall Study|Adverse Event|1|||
124866720|NCT00295022|449133630|FG001|Overall Study|Adverse Event|1|||
124866721|NCT00295022|449133631|FG002|Overall Study|Adverse Event|2|||
124866722|NCT00295022|449133629|FG000|Overall Study|Lost to Follow-up|0|||
124866723|NCT00295022|449133630|FG001|Overall Study|Lost to Follow-up|0|||
124866724|NCT00295022|449133631|FG002|Overall Study|Lost to Follow-up|1|||
124866725|NCT00295022|449133629|FG000|Overall Study|Withdrawal by Subject|0|||
124866726|NCT00295022|449133630|FG001|Overall Study|Withdrawal by Subject|0|||
124866727|NCT00295022|449133631|FG002|Overall Study|Withdrawal by Subject|2|||
124866728|NCT00734630|449133632|FG000|Overall Study|Lack of Efficacy|4|||
124866729|NCT00734630|449133633|FG001|Overall Study|Lack of Efficacy|4|||
124866730|NCT00734630|449133632|FG000|Overall Study|Withdrawal by Subject|7|||
124866731|NCT00734630|449133633|FG001|Overall Study|Withdrawal by Subject|9|||
124866732|NCT00734630|449133632|FG000|Overall Study|Lost to Follow-up|13|||
124866733|NCT00734630|449133633|FG001|Overall Study|Lost to Follow-up|7|||
124866734|NCT00734630|449133632|FG000|Overall Study|Protocol Violation|0|||
124866735|NCT00734630|449133633|FG001|Overall Study|Protocol Violation|3|||
125198766|NCT00972816|450351007|FG007|Overall Study|Lost to Follow-up|7|||
125198767|NCT00972816|450351000|FG000|Overall Study|Inappropriate enrolment|0|||
125198768|NCT00972816|450351001|FG001|Overall Study|Inappropriate enrolment|0|||
125198769|NCT00972816|450351002|FG002|Overall Study|Inappropriate enrolment|0|||
125198770|NCT00972816|450351003|FG003|Overall Study|Inappropriate enrolment|0|||
125198771|NCT00972816|450351004|FG004|Overall Study|Inappropriate enrolment|0|||
125198772|NCT00972816|450351005|FG005|Overall Study|Inappropriate enrolment|0|||
125198773|NCT00972816|450351006|FG006|Overall Study|Inappropriate enrolment|2|||
125198774|NCT00972816|450351007|FG007|Overall Study|Inappropriate enrolment|0|||
125198775|NCT00972816|450351000|FG000|Overall Study|Unable to classify|2|||
125198776|NCT00972816|450351001|FG001|Overall Study|Unable to classify|0|||
125198777|NCT00972816|450351002|FG002|Overall Study|Unable to classify|0|||
125198778|NCT00972816|450351003|FG003|Overall Study|Unable to classify|0|||
125198779|NCT00972816|450351004|FG004|Overall Study|Unable to classify|1|||
125198780|NCT00972816|450351005|FG005|Overall Study|Unable to classify|0|||
125198781|NCT00972816|450351006|FG006|Overall Study|Unable to classify|0|||
125198782|NCT00972816|450351007|FG007|Overall Study|Unable to classify|0|||
125198783|NCT04114357|450351008|FG000|Baseline-Randomization|Adverse Event|2|||
125198784|NCT04114357|450351009|FG001|Baseline-Randomization|Adverse Event|1|||
125198785|NCT04114357|450351008|FG000|Baseline-Randomization|Lost to Follow-up|1|||
125198786|NCT04114357|450351009|FG001|Baseline-Randomization|Lost to Follow-up|1|||
125198787|NCT04114357|450351008|FG000|Cross-over|Adverse Event|0|||
125198788|NCT04114357|450351009|FG001|Cross-over|Adverse Event|1|||
125198789|NCT02163226|450351010|FG000|Overall Study|Death|2|||
125198790|NCT02163226|450351011|FG001|Overall Study|Death|1|||
125198791|NCT02163226|450351010|FG000|Overall Study|Withdrawal by Subject|5|||
125198792|NCT02163226|450351011|FG001|Overall Study|Withdrawal by Subject|2|||
125198793|NCT02163226|450351010|FG000|Overall Study|Returned home, local radiotherapy|3|||
124866736|NCT00734630|449133632|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
124866737|NCT00734630|449133633|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
124866738|NCT00734630|449133632|FG000|Overall Study|Adverse Event|3|||
124866739|NCT00734630|449133633|FG001|Overall Study|Adverse Event|6|||
124866740|NCT00734630|449133632|FG000|Overall Study|Randomized in Error|0|||
124866741|NCT00734630|449133633|FG001|Overall Study|Randomized in Error|1|||
124866742|NCT00734630|449133632|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
124866743|NCT00734630|449133633|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
124866744|NCT00734630|449133632|FG000|Overall Study|Poor Compliance|1|||
124866745|NCT00734630|449133633|FG001|Overall Study|Poor Compliance|1|||
125198794|NCT02163226|450351011|FG001|Overall Study|Returned home, local radiotherapy|0|||
125198795|NCT02163226|450351010|FG000|Overall Study|Repeat imaging showed no disease|2|||
125198796|NCT02163226|450351011|FG001|Overall Study|Repeat imaging showed no disease|0|||
124866746|NCT01018394|449133636|FG000|Overall Study|Withdrawal by Subject|5|||
124866747|NCT01018394|449133637|FG001|Overall Study|Withdrawal by Subject|5|||
124866748|NCT01018394|449133636|FG000|Overall Study|Lost to Follow-up|4|||
125198797|NCT02163226|450351010|FG000|Overall Study|Incomplete radiotherapy|3|||
125198798|NCT02163226|450351011|FG001|Overall Study|Incomplete radiotherapy|0|||
125198799|NCT02163226|450351010|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
125198800|NCT02163226|450351011|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
125198801|NCT02163226|450351010|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
125198802|NCT02163226|450351011|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
125198803|NCT02163226|450351010|FG000|Overall Study|ineligible|0|||
125198804|NCT02163226|450351011|FG001|Overall Study|ineligible|3|||
125198805|NCT00477750|450351012|FG000|Overall Study|Currently Receiving Treatment|11|||
125198806|NCT03558152|450351014|FG000|Overall Study|Adverse Event|0|||
125198807|NCT03558152|450351015|FG001|Overall Study|Adverse Event|0|||
125198808|NCT03558152|450351016|FG002|Overall Study|Adverse Event|1|||
125198809|NCT03558152|450351017|FG003|Overall Study|Adverse Event|1|||
125198810|NCT03558152|450351018|FG004|Overall Study|Adverse Event|2|||
125198811|NCT03558152|450351019|FG005|Overall Study|Adverse Event|1|||
125198812|NCT03558152|450351020|FG006|Overall Study|Adverse Event|1|||
125198813|NCT03558152|450351021|FG007|Overall Study|Adverse Event|0|||
125198814|NCT03558152|450351014|FG000|Overall Study|Death|0|||
125198815|NCT03558152|450351015|FG001|Overall Study|Death|0|||
125198816|NCT03558152|450351016|FG002|Overall Study|Death|0|||
125198817|NCT03558152|450351017|FG003|Overall Study|Death|0|||
125198818|NCT03558152|450351018|FG004|Overall Study|Death|1|||
125198819|NCT03558152|450351019|FG005|Overall Study|Death|0|||
125198820|NCT03558152|450351020|FG006|Overall Study|Death|0|||
125198821|NCT03558152|450351021|FG007|Overall Study|Death|0|||
125198822|NCT03558152|450351014|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
125198823|NCT03558152|450351015|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
125198824|NCT03558152|450351016|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
125198825|NCT03558152|450351017|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
125198826|NCT03558152|450351018|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
125198827|NCT03558152|450351019|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
125198828|NCT03558152|450351020|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
125198829|NCT03558152|450351021|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
125198830|NCT03558152|450351014|FG000|Overall Study|Miscalculation in mmcs|0|||
125198831|NCT03558152|450351015|FG001|Overall Study|Miscalculation in mmcs|0|||
125198832|NCT03558152|450351016|FG002|Overall Study|Miscalculation in mmcs|0|||
125198833|NCT03558152|450351017|FG003|Overall Study|Miscalculation in mmcs|0|||
125198834|NCT03558152|450351018|FG004|Overall Study|Miscalculation in mmcs|0|||
125198835|NCT03558152|450351019|FG005|Overall Study|Miscalculation in mmcs|0|||
125198836|NCT03558152|450351020|FG006|Overall Study|Miscalculation in mmcs|1|||
125198837|NCT03558152|450351021|FG007|Overall Study|Miscalculation in mmcs|0|||
125198838|NCT03558152|450351014|FG000|Overall Study|Mistake in calculation|0|||
125198839|NCT03558152|450351015|FG001|Overall Study|Mistake in calculation|0|||
124866749|NCT01018394|449133637|FG001|Overall Study|Lost to Follow-up|3|||
124866750|NCT03240692|449133638|FG000|Overall Study|Physician Decision|1|||
124866751|NCT03240692|449133638|FG000|Overall Study|Withdrawal by Subject|1|||
124866752|NCT00683644|449133639|FG000|Overall Study|Withdrawal by Subject|4|||
124866753|NCT00683644|449133640|FG001|Overall Study|Withdrawal by Subject|2|||
124866754|NCT00683644|449133639|FG000|Overall Study|Lost to Follow-up|1|||
124866755|NCT00683644|449133640|FG001|Overall Study|Lost to Follow-up|4|||
124866756|NCT00683644|449133639|FG000|Overall Study|Adverse Event|1|||
124866757|NCT00683644|449133640|FG001|Overall Study|Adverse Event|2|||
124866758|NCT00683644|449133639|FG000|Overall Study|Low copper, other health problems,|7|||
124866759|NCT00683644|449133640|FG001|Overall Study|Low copper, other health problems,|6|||
124866760|NCT04123067|449133642|FG000|Overall Study|Lost to Follow-up|0|||
124866761|NCT04123067|449133643|FG001|Overall Study|Lost to Follow-up|1|||
124866762|NCT00127101|449133644|FG000|Base Protocol|Adverse Event|0|||
124866763|NCT00127101|449133645|FG001|Base Protocol|Adverse Event|2|||
124866764|NCT00127101|449133646|FG002|Base Protocol|Adverse Event|1|||
124866765|NCT00127101|449133647|FG003|Base Protocol|Adverse Event|0|||
124977091|NCT03809039|449543728|FG005|Part 3|Withdrawn by study termination|0|||
124977092|NCT03809039|449543729|FG006|Part 3|Withdrawn by study termination|0|||
124977093|NCT03809039|449543730|FG007|Part 3|Withdrawn by study termination|2|||
124977094|NCT03809039|449543731|FG008|Part 3|Withdrawn by study termination|6|||
124977095|NCT01252355|449543732|FG000|Overall Study|Adverse Event|9|||
124977096|NCT01252355|449543733|FG001|Overall Study|Adverse Event|17|||
124977097|NCT01252355|449543734|FG002|Overall Study|Adverse Event|22|||
124977098|NCT01252355|449543732|FG000|Overall Study|Lack of Efficacy|6|||
124977099|NCT01252355|449543733|FG001|Overall Study|Lack of Efficacy|4|||
124977100|NCT01252355|449543734|FG002|Overall Study|Lack of Efficacy|2|||
124977101|NCT01252355|449543732|FG000|Overall Study|Lost to Follow-up|0|||
124977102|NCT01252355|449543733|FG001|Overall Study|Lost to Follow-up|0|||
124977103|NCT01252355|449543734|FG002|Overall Study|Lost to Follow-up|1|||
125198840|NCT03558152|450351016|FG002|Overall Study|Mistake in calculation|0|||
125198841|NCT03558152|450351017|FG003|Overall Study|Mistake in calculation|1|||
125198842|NCT03558152|450351018|FG004|Overall Study|Mistake in calculation|0|||
125198843|NCT03558152|450351019|FG005|Overall Study|Mistake in calculation|0|||
125198844|NCT03558152|450351020|FG006|Overall Study|Mistake in calculation|0|||
125198845|NCT03558152|450351021|FG007|Overall Study|Mistake in calculation|0|||
125198846|NCT03558152|450351014|FG000|Overall Study|Mistake in evaluation of disease status|0|||
125198847|NCT03558152|450351015|FG001|Overall Study|Mistake in evaluation of disease status|0|||
125198848|NCT03558152|450351016|FG002|Overall Study|Mistake in evaluation of disease status|0|||
125198849|NCT03558152|450351017|FG003|Overall Study|Mistake in evaluation of disease status|0|||
125198850|NCT03558152|450351018|FG004|Overall Study|Mistake in evaluation of disease status|0|||
125198851|NCT03558152|450351019|FG005|Overall Study|Mistake in evaluation of disease status|0|||
125198852|NCT03558152|450351020|FG006|Overall Study|Mistake in evaluation of disease status|0|||
125198853|NCT03558152|450351021|FG007|Overall Study|Mistake in evaluation of disease status|1|||
125198854|NCT03558152|450351014|FG000|Overall Study|Physician Decision|0|||
125198855|NCT03558152|450351015|FG001|Overall Study|Physician Decision|0|||
125198856|NCT03558152|450351016|FG002|Overall Study|Physician Decision|0|||
125198857|NCT03558152|450351017|FG003|Overall Study|Physician Decision|0|||
125198858|NCT03558152|450351018|FG004|Overall Study|Physician Decision|0|||
125198859|NCT03558152|450351019|FG005|Overall Study|Physician Decision|0|||
125198860|NCT03558152|450351020|FG006|Overall Study|Physician Decision|1|||
125198861|NCT03558152|450351021|FG007|Overall Study|Physician Decision|0|||
125198862|NCT03558152|450351014|FG000|Overall Study|Withdrawal by Subject|2|||
125198863|NCT03558152|450351015|FG001|Overall Study|Withdrawal by Subject|3|||
125198864|NCT03558152|450351016|FG002|Overall Study|Withdrawal by Subject|2|||
125198865|NCT03558152|450351017|FG003|Overall Study|Withdrawal by Subject|1|||
125198866|NCT03558152|450351018|FG004|Overall Study|Withdrawal by Subject|1|||
125198867|NCT03558152|450351019|FG005|Overall Study|Withdrawal by Subject|1|||
125198868|NCT03558152|450351020|FG006|Overall Study|Withdrawal by Subject|3|||
125198869|NCT03558152|450351021|FG007|Overall Study|Withdrawal by Subject|2|||
125198870|NCT03558152|450351014|FG000|Overall Study|Lack of Efficacy|11|||
125198871|NCT03558152|450351015|FG001|Overall Study|Lack of Efficacy|11|||
125198872|NCT03558152|450351016|FG002|Overall Study|Lack of Efficacy|10|||
125198873|NCT03558152|450351017|FG003|Overall Study|Lack of Efficacy|11|||
125198874|NCT03558152|450351018|FG004|Overall Study|Lack of Efficacy|14|||
125198875|NCT03558152|450351019|FG005|Overall Study|Lack of Efficacy|12|||
125198876|NCT03558152|450351020|FG006|Overall Study|Lack of Efficacy|14|||
125198877|NCT03558152|450351021|FG007|Overall Study|Lack of Efficacy|13|||
125198878|NCT03558152|450351014|FG000|Overall Study|Protocol Violation|1|||
125198879|NCT03558152|450351015|FG001|Overall Study|Protocol Violation|1|||
125198880|NCT03558152|450351016|FG002|Overall Study|Protocol Violation|0|||
125198881|NCT03558152|450351017|FG003|Overall Study|Protocol Violation|1|||
125198882|NCT03558152|450351018|FG004|Overall Study|Protocol Violation|1|||
125198883|NCT03558152|450351019|FG005|Overall Study|Protocol Violation|0|||
125198884|NCT03558152|450351020|FG006|Overall Study|Protocol Violation|2|||
125198885|NCT03558152|450351021|FG007|Overall Study|Protocol Violation|0|||
125198886|NCT03693612|450351022|FG000|Overall Study|Lost to Follow-up|0|||
125198887|NCT03693612|450351023|FG001|Overall Study|Lost to Follow-up|0|||
125198888|NCT03693612|450351024|FG002|Overall Study|Lost to Follow-up|0|||
125198889|NCT03693612|450351025|FG003|Overall Study|Lost to Follow-up|0|||
125198890|NCT03693612|450351026|FG004|Overall Study|Lost to Follow-up|1|||
125198891|NCT03693612|450351027|FG005|Overall Study|Lost to Follow-up|0|||
125198892|NCT03693612|450351028|FG006|Overall Study|Lost to Follow-up|0|||
125198893|NCT03693612|450351022|FG000|Overall Study|Withdrawal by Subject|0|||
125198894|NCT03693612|450351023|FG001|Overall Study|Withdrawal by Subject|0|||
125198895|NCT03693612|450351024|FG002|Overall Study|Withdrawal by Subject|1|||
125198896|NCT03693612|450351025|FG003|Overall Study|Withdrawal by Subject|0|||
125198897|NCT03693612|450351026|FG004|Overall Study|Withdrawal by Subject|2|||
125198898|NCT03693612|450351027|FG005|Overall Study|Withdrawal by Subject|0|||
125198899|NCT03693612|450351028|FG006|Overall Study|Withdrawal by Subject|0|||
125198900|NCT03693612|450351022|FG000|Overall Study|Study Terminated by Sponsor|0|||
125198901|NCT03693612|450351023|FG001|Overall Study|Study Terminated by Sponsor|1|||
125198902|NCT03693612|450351024|FG002|Overall Study|Study Terminated by Sponsor|0|||
125198903|NCT03693612|450351025|FG003|Overall Study|Study Terminated by Sponsor|0|||
125198904|NCT03693612|450351026|FG004|Overall Study|Study Terminated by Sponsor|3|||
125198905|NCT03693612|450351027|FG005|Overall Study|Study Terminated by Sponsor|0|||
125198906|NCT03693612|450351028|FG006|Overall Study|Study Terminated by Sponsor|0|||
125198907|NCT05318092|450351031|FG000|Overall Study|Lost to Follow-up|3|||
125198908|NCT05318092|450351031|FG000|Overall Study|Withdrawal by Subject|1|||
125198909|NCT00601172|450351032|FG000|Overall Study|Adverse Event|43|||
125198910|NCT00601172|450351033|FG001|Overall Study|Adverse Event|32|||
125198911|NCT00601172|450351032|FG000|Overall Study|Lack of Efficacy|11|||
125198912|NCT00601172|450351033|FG001|Overall Study|Lack of Efficacy|12|||
125198913|NCT00601172|450351032|FG000|Overall Study|Protocol Violation|2|||
125198914|NCT00601172|450351033|FG001|Overall Study|Protocol Violation|5|||
125198915|NCT00601172|450351032|FG000|Overall Study|Lost to Follow-up|4|||
125198916|NCT00601172|450351033|FG001|Overall Study|Lost to Follow-up|3|||
125198917|NCT00601172|450351032|FG000|Overall Study|Physician Decision|27|||
125198918|NCT00601172|450351033|FG001|Overall Study|Physician Decision|28|||
125198919|NCT00601172|450351032|FG000|Overall Study|Withdrawal by Subject|35|||
125198920|NCT00601172|450351033|FG001|Overall Study|Withdrawal by Subject|27|||
125198921|NCT00601172|450351032|FG000|Overall Study|Did not meet continuation criteria|19|||
125198922|NCT00601172|450351033|FG001|Overall Study|Did not meet continuation criteria|20|||
125198923|NCT03030989|450351037|FG000|Overall Study|Fever|2|||
125198924|NCT03030989|450351038|FG001|Overall Study|Fever|2|||
125198925|NCT03030989|450351037|FG000|Overall Study|Rash|2|||
125198926|NCT03030989|450351038|FG001|Overall Study|Rash|1|||
124977104|NCT01252355|449543732|FG000|Overall Study|Poor Compliance to Protocol|1|||
124977105|NCT01252355|449543733|FG001|Overall Study|Poor Compliance to Protocol|1|||
124977106|NCT01252355|449543734|FG002|Overall Study|Poor Compliance to Protocol|1|||
124977107|NCT01252355|449543732|FG000|Overall Study|Progressive Disease|2|||
124977108|NCT01252355|449543733|FG001|Overall Study|Progressive Disease|0|||
124977109|NCT01252355|449543734|FG002|Overall Study|Progressive Disease|0|||
124977110|NCT01252355|449543732|FG000|Overall Study|Sponsor Early Termination of Study|149|||
124977111|NCT01252355|449543733|FG001|Overall Study|Sponsor Early Termination of Study|149|||
124977112|NCT01252355|449543734|FG002|Overall Study|Sponsor Early Termination of Study|146|||
124977113|NCT01252355|449543732|FG000|Overall Study|Randomized but not Treated|2|||
124977114|NCT01252355|449543733|FG001|Overall Study|Randomized but not Treated|0|||
124977115|NCT01252355|449543734|FG002|Overall Study|Randomized but not Treated|0|||
124977116|NCT01252355|449543732|FG000|Overall Study|Other Than Above|8|||
124977117|NCT01252355|449543733|FG001|Overall Study|Other Than Above|7|||
124977118|NCT01252355|449543734|FG002|Overall Study|Other Than Above|7|||
124977119|NCT02224703|449543742|FG000|Overall Study|Adverse Event|0|||
124977120|NCT02224703|449543743|FG001|Overall Study|Adverse Event|5|||
124977121|NCT02224703|449543744|FG002|Overall Study|Adverse Event|0|||
124977122|NCT02224703|449543742|FG000|Overall Study|Withdrawn by investigator|1|||
124977123|NCT02224703|449543743|FG001|Overall Study|Withdrawn by investigator|0|||
124977124|NCT02224703|449543744|FG002|Overall Study|Withdrawn by investigator|0|||
124977125|NCT02224703|449543742|FG000|Overall Study|Advised by medical monitor|1|||
124977126|NCT02224703|449543743|FG001|Overall Study|Advised by medical monitor|0|||
124977127|NCT02224703|449543744|FG002|Overall Study|Advised by medical monitor|0|||
124977128|NCT02224703|449543742|FG000|Overall Study|Withdrawn by parent/guardian|0|||
124977129|NCT02224703|449543743|FG001|Overall Study|Withdrawn by parent/guardian|1|||
124977130|NCT02224703|449543744|FG002|Overall Study|Withdrawn by parent/guardian|0|||
124977131|NCT02224703|449543742|FG000|Overall Study|Lack of Efficacy|1|||
124977132|NCT02224703|449543743|FG001|Overall Study|Lack of Efficacy|0|||
124977133|NCT02224703|449543744|FG002|Overall Study|Lack of Efficacy|0|||
124977134|NCT02922023|449543745|FG000|Overall Study|Lost to Follow-up|2|||
124977135|NCT02922023|449543746|FG001|Overall Study|Lost to Follow-up|0|||
124977136|NCT00863681|449543747|FG000|Overall Study|Other|2|||
124977137|NCT00863681|449543748|FG001|Overall Study|Other|0|||
124977138|NCT00863681|449543749|FG002|Overall Study|Other|0|||
124977139|NCT00863681|449543747|FG000|Overall Study|Missing|1|||
124977140|NCT00863681|449543748|FG001|Overall Study|Missing|0|||
124977141|NCT00863681|449543749|FG002|Overall Study|Missing|0|||
124977142|NCT00863681|449543747|FG000|Overall Study|Death|40|||
124977143|NCT00863681|449543748|FG001|Overall Study|Death|23|||
124977144|NCT00863681|449543749|FG002|Overall Study|Death|6|||
124977145|NCT00863681|449543747|FG000|Overall Study|Withdrawal by Subject|12|||
124977146|NCT00863681|449543748|FG001|Overall Study|Withdrawal by Subject|5|||
124977147|NCT00863681|449543749|FG002|Overall Study|Withdrawal by Subject|2|||
125198927|NCT03030989|450351037|FG000|Overall Study|Fatigue/Overwhelmed|1|||
125198928|NCT03030989|450351038|FG001|Overall Study|Fatigue/Overwhelmed|5|||
125198929|NCT03030989|450351037|FG000|Overall Study|Positive Blood Cultures|2|||
125198930|NCT03030989|450351038|FG001|Overall Study|Positive Blood Cultures|1|||
125198931|NCT03030989|450351037|FG000|Overall Study|Line Removed|0|||
125198932|NCT03030989|450351038|FG001|Overall Study|Line Removed|2|||
125198933|NCT03030989|450351037|FG000|Overall Study|No longer interested|5|||
125198934|NCT03030989|450351038|FG001|Overall Study|No longer interested|3|||
124977148|NCT00863681|449543747|FG000|Overall Study|Protocol Violation|2|||
124977149|NCT00863681|449543748|FG001|Overall Study|Protocol Violation|0|||
124977150|NCT00863681|449543749|FG002|Overall Study|Protocol Violation|0|||
124977151|NCT00863681|449543747|FG000|Overall Study|Lost to Follow-up|3|||
124977152|NCT00863681|449543748|FG001|Overall Study|Lost to Follow-up|0|||
124977153|NCT00863681|449543749|FG002|Overall Study|Lost to Follow-up|3|||
124977154|NCT00863681|449543747|FG000|Overall Study|Adverse Event|28|||
124977155|NCT00863681|449543748|FG001|Overall Study|Adverse Event|10|||
124977156|NCT00863681|449543749|FG002|Overall Study|Adverse Event|6|||
124977157|NCT00863681|449543747|FG000|Overall Study|Lack of Efficacy|2|||
124977158|NCT00863681|449543748|FG001|Overall Study|Lack of Efficacy|2|||
124977159|NCT00863681|449543749|FG002|Overall Study|Lack of Efficacy|1|||
124977160|NCT00863681|449543747|FG000|Overall Study|Non-compliance with study drug|1|||
124977161|NCT00863681|449543748|FG001|Overall Study|Non-compliance with study drug|3|||
124977162|NCT00863681|449543749|FG002|Overall Study|Non-compliance with study drug|0|||
124977163|NCT03031496|449543750|FG000|Period 1|Adverse Event|2|||
124977164|NCT03031496|449543751|FG001|Period 1|Adverse Event|0|||
125198935|NCT03917472|450351039|FG000|Overall Study|Physician Decision|4|||
125198936|NCT03917472|450351040|FG001|Overall Study|Physician Decision|0|||
125198937|NCT03917472|450351039|FG000|Overall Study|Adverse Event|3|||
125198938|NCT03917472|450351040|FG001|Overall Study|Adverse Event|1|||
125198939|NCT03917472|450351039|FG000|Overall Study|Death|7|||
125198940|NCT03917472|450351040|FG001|Overall Study|Death|5|||
125198941|NCT03917472|450351039|FG000|Overall Study|Withdrawal by Subject|11|||
125198942|NCT03917472|450351040|FG001|Overall Study|Withdrawal by Subject|4|||
125198943|NCT03917472|450351039|FG000|Overall Study|Lost to Follow-up|10|||
125198944|NCT03917472|450351040|FG001|Overall Study|Lost to Follow-up|5|||
125198945|NCT02706886|450351041|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
125198946|NCT02706886|450351042|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
125198947|NCT02706886|450351043|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
125198948|NCT02706886|450351044|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
125198949|NCT02706886|450351045|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
125198950|NCT02706886|450351046|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
125198951|NCT02706886|450351047|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
125198952|NCT02706886|450351048|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
124977165|NCT03031496|449543750|FG000|Period 1|Withdrawal by Subject|0|||
124977166|NCT03031496|449543751|FG001|Period 1|Withdrawal by Subject|2|||
124977167|NCT02766777|449543757|FG000|Overall Study|Adverse Event|12|||
124977168|NCT02766777|449543757|FG000|Overall Study|Lost to Follow-up|16|||
124977169|NCT02766777|449543757|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124977170|NCT02766777|449543757|FG000|Overall Study|Protocol Violation|1|||
124977171|NCT02766777|449543757|FG000|Overall Study|Withdrawal by Subject|4|||
124977172|NCT01886287|449543758|FG000|Overall Study|Radiographic disease progression|1|||
124977173|NCT01886287|449543758|FG000|Overall Study|Clinical progression due to disease|1|||
124977174|NCT03596762|449543759|FG000|Overall Study|Protocol Violation|0|||
124977175|NCT03596762|449543760|FG001|Overall Study|Protocol Violation|0|||
124977176|NCT03596762|449543761|FG002|Overall Study|Protocol Violation|0|||
124977177|NCT03596762|449543762|FG003|Overall Study|Protocol Violation|0|||
124977178|NCT03596762|449543763|FG004|Overall Study|Protocol Violation|1|||
124977179|NCT03596762|449543759|FG000|Overall Study|Adverse Event|2|||
124977180|NCT03596762|449543760|FG001|Overall Study|Adverse Event|0|||
124977181|NCT03596762|449543761|FG002|Overall Study|Adverse Event|1|||
124977182|NCT03596762|449543762|FG003|Overall Study|Adverse Event|0|||
124977183|NCT03596762|449543763|FG004|Overall Study|Adverse Event|5|||
124977184|NCT03596762|449543759|FG000|Overall Study|Withdrawal by Subject|2|||
124977185|NCT03596762|449543760|FG001|Overall Study|Withdrawal by Subject|1|||
124977186|NCT03596762|449543761|FG002|Overall Study|Withdrawal by Subject|0|||
124977187|NCT03596762|449543762|FG003|Overall Study|Withdrawal by Subject|1|||
124977188|NCT03596762|449543763|FG004|Overall Study|Withdrawal by Subject|1|||
124977189|NCT01263509|449543764|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
124977190|NCT01263509|449543765|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
124977191|NCT01263509|449543766|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
124977192|NCT01263509|449543767|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
124977193|NCT01263509|449543764|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
124977194|NCT01263509|449543765|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
124977195|NCT01263509|449543766|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
124977196|NCT01263509|449543767|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
124977197|NCT01263509|449543764|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
124977198|NCT01263509|449543765|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
124977199|NCT01263509|449543766|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
124977200|NCT01263509|449543767|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
124977201|NCT01263509|449543764|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
124977202|NCT01263509|449543765|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
124977203|NCT01263509|449543766|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
124977204|NCT01263509|449543767|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
124977205|NCT01263509|449543764|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
124977206|NCT01263509|449543765|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
124977207|NCT01263509|449543766|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
124977208|NCT01263509|449543767|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
124977209|NCT02593123|449543768|FG000|Overall Study|Physician Decision|2|||
124977210|NCT02593123|449543769|FG001|Overall Study|Physician Decision|1|||
124977211|NCT02593123|449543768|FG000|Overall Study|Relapse|1|||
124977212|NCT02593123|449543769|FG001|Overall Study|Relapse|1|||
124977213|NCT02440425|449543770|FG000|Overall Study|Death likely due to disease progression|1|||
124977214|NCT02440425|449543770|FG000|Overall Study|Withdrawal by Subject|2|||
124977215|NCT02440425|449543770|FG000|Overall Study|Adverse Event|1|||
125198953|NCT02706886|450351049|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
125198954|NCT04434469|450351056|FG000|Overall Study|Death|2|||
125198955|NCT04434469|450351057|FG001|Overall Study|Death|3|||
125198956|NCT04434469|450351058|FG002|Overall Study|Death|2|||
125198957|NCT04434469|450351059|FG003|Overall Study|Death|2|||
124977216|NCT02440425|449543770|FG000|Overall Study|Adverse Event/Ineligible|1|||
124977217|NCT02807272|449543771|FG000|Overall Study|Death|9|||
124977218|NCT02807272|449543772|FG001|Overall Study|Death|5|||
124977219|NCT02807272|449543773|FG002|Overall Study|Death|2|||
124977220|NCT02807272|449543774|FG003|Overall Study|Death|0|||
124977221|NCT02807272|449543775|FG004|Overall Study|Death|1|||
124977222|NCT02807272|449543771|FG000|Overall Study|Lost to Follow-up|1|||
124977223|NCT02807272|449543772|FG001|Overall Study|Lost to Follow-up|0|||
124977224|NCT02807272|449543773|FG002|Overall Study|Lost to Follow-up|0|||
124977225|NCT02807272|449543774|FG003|Overall Study|Lost to Follow-up|0|||
124977226|NCT02807272|449543775|FG004|Overall Study|Lost to Follow-up|0|||
124977227|NCT02807272|449543771|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
124977228|NCT02807272|449543772|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
124977229|NCT02807272|449543773|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
124977230|NCT02807272|449543774|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
124977231|NCT02807272|449543775|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
124977232|NCT02807272|449543771|FG000|Overall Study|Protocol-defined Disease Progression|0|||
124977233|NCT02807272|449543772|FG001|Overall Study|Protocol-defined Disease Progression|1|||
124977234|NCT02807272|449543773|FG002|Overall Study|Protocol-defined Disease Progression|0|||
124977235|NCT02807272|449543774|FG003|Overall Study|Protocol-defined Disease Progression|0|||
124977236|NCT02807272|449543775|FG004|Overall Study|Protocol-defined Disease Progression|1|||
124977237|NCT02807272|449543771|FG000|Overall Study|Study Terminated by Sponsor|1|||
124977238|NCT02807272|449543772|FG001|Overall Study|Study Terminated by Sponsor|0|||
124977239|NCT02807272|449543773|FG002|Overall Study|Study Terminated by Sponsor|0|||
124977240|NCT02807272|449543774|FG003|Overall Study|Study Terminated by Sponsor|1|||
124977241|NCT02807272|449543775|FG004|Overall Study|Study Terminated by Sponsor|0|||
124977242|NCT02807272|449543771|FG000|Overall Study|Other|1|||
124977243|NCT02807272|449543772|FG001|Overall Study|Other|0|||
124977244|NCT02807272|449543773|FG002|Overall Study|Other|0|||
124977245|NCT02807272|449543774|FG003|Overall Study|Other|0|||
124977246|NCT02807272|449543775|FG004|Overall Study|Other|1|||
124977247|NCT01038427|449543776|FG000|Overall Study|Lost to follow up|1|||
124977248|NCT01038427|449543777|FG001|Overall Study|Lost to follow up|1|||
124977249|NCT01038427|449543778|FG002|Overall Study|Lost to follow up|0|||
124977250|NCT01038427|449543776|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
124977251|NCT01038427|449543777|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
124977252|NCT01038427|449543778|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
124977253|NCT01038427|449543776|FG000|Overall Study|Withdrew consent|0|||
124977254|NCT01038427|449543777|FG001|Overall Study|Withdrew consent|0|||
124977255|NCT01038427|449543778|FG002|Overall Study|Withdrew consent|1|||
124977256|NCT01038427|449543776|FG000|Overall Study|Adverse Event|2|||
124977257|NCT01038427|449543777|FG001|Overall Study|Adverse Event|2|||
124977258|NCT01038427|449543778|FG002|Overall Study|Adverse Event|1|||
124977259|NCT01038427|449543776|FG000|Overall Study|Enrolled in error|0|||
124977260|NCT01038427|449543777|FG001|Overall Study|Enrolled in error|1|||
124977261|NCT01038427|449543778|FG002|Overall Study|Enrolled in error|1|||
124977262|NCT01038427|449543776|FG000|Overall Study|Other|0|||
124977263|NCT01038427|449543777|FG001|Overall Study|Other|2|||
124977264|NCT01038427|449543778|FG002|Overall Study|Other|0|||
124977265|NCT01162863|449543779|FG000|Overall Study|Lack of Efficacy|1|||
124977266|NCT01162863|449543780|FG001|Overall Study|Lack of Efficacy|0|||
124977267|NCT01162863|449543781|FG002|Overall Study|Lack of Efficacy|0|||
124977268|NCT01162863|449543779|FG000|Overall Study|Adverse Event|0|||
124977269|NCT01162863|449543780|FG001|Overall Study|Adverse Event|1|||
124977270|NCT01162863|449543781|FG002|Overall Study|Adverse Event|0|||
124977271|NCT00588692|449543782|FG000|Overall Study|Withdrawal by Subject|4|||
124977272|NCT00588692|449543783|FG001|Overall Study|Withdrawal by Subject|2|||
124977273|NCT00588692|449543782|FG000|Overall Study|Hip Surgery|0|||
124977274|NCT00588692|449543783|FG001|Overall Study|Hip Surgery|1|||
124977275|NCT00588692|449543782|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
124977276|NCT00588692|449543783|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
124977277|NCT00588692|449543782|FG000|Overall Study|Cancer|1|||
124977278|NCT00588692|449543783|FG001|Overall Study|Cancer|0|||
124977279|NCT00588692|449543782|FG000|Overall Study|Death|1|||
124977280|NCT00588692|449543783|FG001|Overall Study|Death|0|||
124977281|NCT01374568|449543784|FG000|Overall Study|Lab unable to analyze BTM|0|||
124977282|NCT01374568|449543785|FG001|Overall Study|Lab unable to analyze BTM|2|||
124977283|NCT01912404|449543786|FG000|Overall Study|Due to personal reasons|1|||
124977284|NCT01912404|449543787|FG001|Overall Study|Due to personal reasons|0|||
125198958|NCT04434469|450351060|FG004|Overall Study|Death|2|||
124977285|NCT00820170|449543789|FG000|Overall Study|Adverse Event|0|||
124977286|NCT00820170|449543790|FG001|Overall Study|Adverse Event|0|||
124977287|NCT00820170|449543791|FG002|Overall Study|Adverse Event|0|||
124977288|NCT00820170|449543792|FG003|Overall Study|Adverse Event|0|||
124977289|NCT00820170|449543793|FG004|Overall Study|Adverse Event|2|||
124977290|NCT00820170|449543789|FG000|Overall Study|Progressive Disease|0|||
124977291|NCT00820170|449543790|FG001|Overall Study|Progressive Disease|0|||
124977292|NCT00820170|449543791|FG002|Overall Study|Progressive Disease|0|||
125198959|NCT04434469|450351061|FG005|Overall Study|Death|0|||
124977293|NCT00820170|449543792|FG003|Overall Study|Progressive Disease|0|||
124977294|NCT00820170|449543793|FG004|Overall Study|Progressive Disease|2|||
124977295|NCT03538938|449543794|FG000|Overall Study|Death|0|||
124977296|NCT03538938|449543795|FG001|Overall Study|Death|0|||
124977297|NCT03538938|449543796|FG002|Overall Study|Death|2|||
124977298|NCT03538938|449543797|FG003|Overall Study|Death|0|||
124977299|NCT03538938|449543798|FG004|Overall Study|Death|0|||
124977300|NCT03538938|449543799|FG005|Overall Study|Death|1|||
124977301|NCT03538938|449543800|FG006|Overall Study|Death|0|||
124977302|NCT03538938|449543801|FG007|Overall Study|Death|1|||
124977303|NCT03538938|449543802|FG008|Overall Study|Death|1|||
124977304|NCT03538938|449543803|FG009|Overall Study|Death|1|||
124977305|NCT03538938|449543804|FG010|Overall Study|Death|0|||
124977306|NCT03538938|449543805|FG011|Overall Study|Death|0|||
124977307|NCT03538938|449543806|FG012|Overall Study|Death|1|||
124977308|NCT03538938|449543807|FG013|Overall Study|Death|1|||
124977309|NCT03538938|449543808|FG014|Overall Study|Death|0|||
124977310|NCT03538938|449543809|FG015|Overall Study|Death|1|||
124977311|NCT03538938|449543794|FG000|Overall Study|Withdrawal by Subject|4|||
124977312|NCT03538938|449543795|FG001|Overall Study|Withdrawal by Subject|6|||
124977313|NCT03538938|449543796|FG002|Overall Study|Withdrawal by Subject|5|||
124977314|NCT03538938|449543797|FG003|Overall Study|Withdrawal by Subject|3|||
124977315|NCT03538938|449543798|FG004|Overall Study|Withdrawal by Subject|0|||
124977316|NCT03538938|449543799|FG005|Overall Study|Withdrawal by Subject|0|||
124977317|NCT03538938|449543800|FG006|Overall Study|Withdrawal by Subject|3|||
124977318|NCT03538938|449543801|FG007|Overall Study|Withdrawal by Subject|1|||
124977319|NCT03538938|449543802|FG008|Overall Study|Withdrawal by Subject|5|||
124977320|NCT03538938|449543803|FG009|Overall Study|Withdrawal by Subject|1|||
124977321|NCT03538938|449543804|FG010|Overall Study|Withdrawal by Subject|2|||
124977322|NCT03538938|449543805|FG011|Overall Study|Withdrawal by Subject|1|||
124977323|NCT03538938|449543806|FG012|Overall Study|Withdrawal by Subject|3|||
124977324|NCT03538938|449543807|FG013|Overall Study|Withdrawal by Subject|0|||
124977325|NCT03538938|449543808|FG014|Overall Study|Withdrawal by Subject|2|||
124977326|NCT03538938|449543809|FG015|Overall Study|Withdrawal by Subject|4|||
124977327|NCT03538938|449543794|FG000|Overall Study|Incarcerated|0|||
124977328|NCT03538938|449543795|FG001|Overall Study|Incarcerated|0|||
124977329|NCT03538938|449543796|FG002|Overall Study|Incarcerated|0|||
124977330|NCT03538938|449543797|FG003|Overall Study|Incarcerated|0|||
124977331|NCT03538938|449543798|FG004|Overall Study|Incarcerated|0|||
124977332|NCT03538938|449543799|FG005|Overall Study|Incarcerated|0|||
124977333|NCT03538938|449543800|FG006|Overall Study|Incarcerated|0|||
124977334|NCT03538938|449543801|FG007|Overall Study|Incarcerated|0|||
124977335|NCT03538938|449543802|FG008|Overall Study|Incarcerated|0|||
124977336|NCT03538938|449543803|FG009|Overall Study|Incarcerated|0|||
124977337|NCT03538938|449543804|FG010|Overall Study|Incarcerated|0|||
124977338|NCT03538938|449543805|FG011|Overall Study|Incarcerated|1|||
124977339|NCT03538938|449543806|FG012|Overall Study|Incarcerated|0|||
124977340|NCT03538938|449543807|FG013|Overall Study|Incarcerated|0|||
124977341|NCT03538938|449543808|FG014|Overall Study|Incarcerated|0|||
124977342|NCT03538938|449543809|FG015|Overall Study|Incarcerated|0|||
124977343|NCT00604708|449543810|FG000|Overall Study|Withdrawal by Subject|9|||
124977344|NCT00604708|449543811|FG001|Overall Study|Withdrawal by Subject|10|||
124977345|NCT00604708|449543810|FG000|Overall Study|Protocol Violation|2|||
124977346|NCT00604708|449543811|FG001|Overall Study|Protocol Violation|8|||
124977347|NCT00604708|449543810|FG000|Overall Study|Lost to Follow-up|5|||
124977348|NCT00604708|449543811|FG001|Overall Study|Lost to Follow-up|5|||
124977349|NCT00604708|449543810|FG000|Overall Study|administrative reasons|9|||
124977350|NCT00604708|449543811|FG001|Overall Study|administrative reasons|11|||
124977351|NCT00604708|449543810|FG000|Overall Study|Adverse Event|6|||
124977352|NCT00604708|449543811|FG001|Overall Study|Adverse Event|6|||
124977353|NCT01361594|449543812|FG000|Overall Study|Withdrawal by Subject|1|||
124977354|NCT01361594|449543813|FG001|Overall Study|Withdrawal by Subject|2|||
124977355|NCT01754753|449543814|FG000|Overall Study|Study close|43|||
124977356|NCT01754753|449543815|FG001|Overall Study|Study close|44|||
124977357|NCT01754753|449543814|FG000|Overall Study|Lost to Follow-up|9|||
124977358|NCT01754753|449543815|FG001|Overall Study|Lost to Follow-up|5|||
124977359|NCT03197766|449543820|FG000|Overall Study|Withdrawal by Subject|2|||
124977360|NCT03197766|449543821|FG001|Overall Study|Withdrawal by Subject|0|||
124977361|NCT04485611|449543824|FG000|Prehabilitation|Physician Decision|1|||
124977362|NCT03361865|449543825|FG000|Overall Study|Death|17|||
124977363|NCT03361865|449543826|FG001|Overall Study|Death|18|||
124977364|NCT03361865|449543825|FG000|Overall Study|Physician Decision|1|||
124977365|NCT03361865|449543826|FG001|Overall Study|Physician Decision|9|||
124977366|NCT03361865|449543825|FG000|Overall Study|Withdrawal by Subject|1|||
124977367|NCT03361865|449543826|FG001|Overall Study|Withdrawal by Subject|0|||
124977368|NCT05543187|449543827|FG000|Overall Study|Ongoing|3|||
125198960|NCT04434469|450351056|FG000|Overall Study|Lost to Follow-up|0|||
124977369|NCT05543187|449543828|FG001|Overall Study|Ongoing|2|||
124977370|NCT01647542|449543830|FG000|Overall Study|Major Protocol Deviation|1|||
124977371|NCT01647542|449543831|FG001|Overall Study|Major Protocol Deviation|0|||
124977372|NCT01647542|449543832|FG002|Overall Study|Major Protocol Deviation|0|||
124977373|NCT01647542|449543830|FG000|Overall Study|Adverse Event|4|||
124977374|NCT01647542|449543831|FG001|Overall Study|Adverse Event|5|||
124977375|NCT01647542|449543832|FG002|Overall Study|Adverse Event|4|||
124977376|NCT01647542|449543830|FG000|Overall Study|Lost to Follow-up|0|||
124977377|NCT01647542|449543831|FG001|Overall Study|Lost to Follow-up|2|||
124977378|NCT01647542|449543832|FG002|Overall Study|Lost to Follow-up|2|||
124977379|NCT01647542|449543830|FG000|Overall Study|Withdrawal by Subject|6|||
124977380|NCT01647542|449543831|FG001|Overall Study|Withdrawal by Subject|4|||
124977381|NCT01647542|449543832|FG002|Overall Study|Withdrawal by Subject|0|||
124977382|NCT01647542|449543830|FG000|Overall Study|Study Termination|64|||
124977383|NCT01647542|449543831|FG001|Overall Study|Study Termination|61|||
124977384|NCT01647542|449543832|FG002|Overall Study|Study Termination|65|||
124977385|NCT01647542|449543830|FG000|Overall Study|Lack of Efficacy|1|||
124977386|NCT01647542|449543831|FG001|Overall Study|Lack of Efficacy|1|||
124977387|NCT01647542|449543832|FG002|Overall Study|Lack of Efficacy|0|||
124977388|NCT01647542|449543830|FG000|Overall Study|Death|0|||
124977389|NCT01647542|449543831|FG001|Overall Study|Death|0|||
124977390|NCT01647542|449543832|FG002|Overall Study|Death|1|||
124977391|NCT03086655|449543833|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
124977392|NCT03086655|449543834|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
124977393|NCT03086655|449543833|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
124977394|NCT03086655|449543834|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
124977395|NCT03086655|449543833|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
124977396|NCT03086655|449543834|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
124977397|NCT03086655|449543833|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
124977398|NCT03086655|449543834|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
124977399|NCT03086655|449543833|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
124977400|NCT03086655|449543834|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
124977401|NCT03086655|449543833|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
124977402|NCT03086655|449543834|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
124977403|NCT03086655|449543833|FG000|12 Month Follow-up = Final Assessment|Death|0|||
124977404|NCT03086655|449543834|FG001|12 Month Follow-up = Final Assessment|Death|1|||
124977405|NCT03008005|449543835|FG000|Overall Study|Physician Decision|1|||
124977406|NCT03008005|449543836|FG001|Overall Study|Physician Decision|0|||
124977407|NCT03008005|449543837|FG002|Overall Study|Physician Decision|0|||
124977408|NCT03008005|449543835|FG000|Overall Study|Withdrawal by Subject|1|||
124977409|NCT03008005|449543836|FG001|Overall Study|Withdrawal by Subject|0|||
124977410|NCT03008005|449543837|FG002|Overall Study|Withdrawal by Subject|0|||
124977411|NCT03008005|449543835|FG000|Overall Study|Ineligible|0|||
124977412|NCT03008005|449543836|FG001|Overall Study|Ineligible|1|||
124977413|NCT03008005|449543837|FG002|Overall Study|Ineligible|0|||
124977414|NCT01040169|449543853|FG000|Overall Study|Lost to Follow-up|3|||
124977415|NCT01040169|449543854|FG001|Overall Study|Lost to Follow-up|8|||
124977416|NCT03633799|449543859|FG000|Overall Study|Adverse Event|349|||
124977417|NCT03633799|449543859|FG000|Overall Study|Withdrawal by Subject|288|||
124977418|NCT03633799|449543859|FG000|Overall Study|Lost to Follow-up|97|||
124977419|NCT03633799|449543859|FG000|Overall Study|Physician Decision|9|||
124977420|NCT03633799|449543859|FG000|Overall Study|Protocol Violation|4|||
124977421|NCT03633799|449543859|FG000|Overall Study|Pregnancy|20|||
124977422|NCT03633799|449543859|FG000|Overall Study|other|39|||
124977423|NCT03633799|449543859|FG000|Overall Study|ongoing within third year of study|106|||
124977424|NCT03633799|449543859|FG000|Overall Study|unsuccessful study drug placement|19|||
124977425|NCT03551691|449543860|FG000|Overall Study|Withdrawal by Subject|3|||
124977426|NCT03551691|449543861|FG001|Overall Study|Withdrawal by Subject|3|||
124977427|NCT05855967|449543862|FG000|Overall Study|Withdrawal by Subject|7|||
124977428|NCT05855967|449543863|FG001|Overall Study|Withdrawal by Subject|5|||
124977429|NCT05855967|449543862|FG000|Overall Study|Lost to Follow-up|2|||
124977430|NCT05855967|449543863|FG001|Overall Study|Lost to Follow-up|1|||
124977431|NCT02446821|449543864|FG000|Overall Study|Adverse Event|28|||
124977432|NCT02446821|449543864|FG000|Overall Study|Withdrawal by Subject|6|||
124977433|NCT02446821|449543864|FG000|Overall Study|Lost to Follow-up|22|||
124977434|NCT02446821|449543864|FG000|Overall Study|other|9|||
124977435|NCT02446821|449543864|FG000|Overall Study|insertion failure|3|||
124977436|NCT02284009|449543866|FG000|Overall Study|Adverse Event|3|||
124977437|NCT02284009|449543867|FG001|Overall Study|Adverse Event|0|||
124977438|NCT02284009|449543866|FG000|Overall Study|Lost to Follow-up|1|||
124977439|NCT02284009|449543867|FG001|Overall Study|Lost to Follow-up|3|||
124977440|NCT02284009|449543866|FG000|Overall Study|Physician Decision|0|||
124977441|NCT02284009|449543867|FG001|Overall Study|Physician Decision|2|||
124977442|NCT02284009|449543866|FG000|Overall Study|Withdrawal by Subject|2|||
124977443|NCT02284009|449543867|FG001|Overall Study|Withdrawal by Subject|5|||
124977444|NCT04942366|449545373|FG000|Overall Study|Withdrawal by Subject|5|||
124866766|NCT00127101|449133648|FG004|Base Protocol|Adverse Event|0|||
124977445|NCT04942366|449545374|FG001|Overall Study|Withdrawal by Subject|5|||
124977446|NCT03301155|449545375|FG000|Overall Study|Сompliance with exclusion criteria|8|||
124866767|NCT00127101|449133649|FG005|Base Protocol|Adverse Event|0|||
124977447|NCT03301155|449545376|FG001|Overall Study|Сompliance with exclusion criteria|7|||
124977448|NCT00384189|449545378|FG000|Overall Study|Reason Not Specified|50|||
124977449|NCT00384189|449545379|FG001|Overall Study|Reason Not Specified|57|||
124977450|NCT00384189|449545380|FG002|Overall Study|Reason Not Specified|58|||
124977451|NCT00384189|449545381|FG003|Overall Study|Reason Not Specified|40|||
124977452|NCT00608868|449545382|FG000|Overall Study|Withdrawal by Subject|7|||
124977453|NCT00608868|449545382|FG000|Overall Study|Protocol Violation|3|||
124977454|NCT00608868|449545382|FG000|Overall Study|Lost to Follow-up|2|||
124977455|NCT00608868|449545382|FG000|Overall Study|Adverse Event|1|||
125088769|NCT00122317|449941534|FG000|Overall Study|Withdrawal by Subject|1|||
125088770|NCT03756285|449941535|FG000|Overall Study|Lost to Follow-up|0|||
125088771|NCT03756285|449941536|FG001|Overall Study|Lost to Follow-up|1|||
125088772|NCT03756285|449941535|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
125088773|NCT03756285|449941536|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
125088774|NCT03756285|449941535|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
125088775|NCT03756285|449941536|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
125088776|NCT02705755|449941538|FG000|Part A (6 Days)|Adverse Event|1|||
125088777|NCT02705755|449941539|FG001|Part A (6 Days)|Adverse Event|0|||
125088778|NCT02705755|449941540|FG002|Part A (6 Days)|Adverse Event|0|||
125088779|NCT02705755|449941541|FG003|Part A (6 Days)|Adverse Event|0|||
125088780|NCT02705755|449941538|FG000|Part A (6 Days)|Physician Decision|3|||
125088781|NCT02705755|449941539|FG001|Part A (6 Days)|Physician Decision|0|||
125088782|NCT02705755|449941540|FG002|Part A (6 Days)|Physician Decision|0|||
125088783|NCT02705755|449941541|FG003|Part A (6 Days)|Physician Decision|0|||
125088784|NCT02705755|449941538|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
125088785|NCT02705755|449941539|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
125088786|NCT02705755|449941540|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
125088787|NCT02705755|449941541|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
125088788|NCT02705755|449941538|FG000|Part C (20 Weeks)|Physician Decision|0|||
125088789|NCT02705755|449941539|FG001|Part C (20 Weeks)|Physician Decision|0|||
125088790|NCT02705755|449941540|FG002|Part C (20 Weeks)|Physician Decision|0|||
125088791|NCT02705755|449941541|FG003|Part C (20 Weeks)|Physician Decision|2|||
125088792|NCT02705755|449941538|FG000|Part C (20 Weeks)|Adverse Event|0|||
125088793|NCT02705755|449941539|FG001|Part C (20 Weeks)|Adverse Event|0|||
125088794|NCT02705755|449941540|FG002|Part C (20 Weeks)|Adverse Event|0|||
125088795|NCT02705755|449941541|FG003|Part C (20 Weeks)|Adverse Event|6|||
125088796|NCT02705755|449941538|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
125088797|NCT02705755|449941539|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
125088798|NCT02705755|449941540|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
125088799|NCT02705755|449941541|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
125088800|NCT01021293|449941544|FG000|Overall Study|Serious Adverse Event|2|||
125088801|NCT01021293|449941545|FG001|Overall Study|Serious Adverse Event|1|||
125088802|NCT01021293|449941544|FG000|Overall Study|Adverse Event|2|||
125088803|NCT01021293|449941545|FG001|Overall Study|Adverse Event|1|||
125088804|NCT01021293|449941544|FG000|Overall Study|Withdrawal by Subject|1|||
125088805|NCT01021293|449941545|FG001|Overall Study|Withdrawal by Subject|3|||
125088806|NCT01021293|449941544|FG000|Overall Study|Migrated/moved from study area|6|||
125088807|NCT01021293|449941545|FG001|Overall Study|Migrated/moved from study area|18|||
125088808|NCT01021293|449941544|FG000|Overall Study|Lost to Follow-up|1|||
125088809|NCT01021293|449941545|FG001|Overall Study|Lost to Follow-up|1|||
125088810|NCT01084096|449944477|FG000|Overall Study|Lost to Follow-up|1501|||
125088811|NCT01084096|449944478|FG001|Overall Study|Lost to Follow-up|1833|||
125088812|NCT01084096|449944477|FG000|Overall Study|Withdrawal by Subject|3|||
125088813|NCT01084096|449944478|FG001|Overall Study|Withdrawal by Subject|0|||
125088814|NCT01084096|449944477|FG000|Overall Study|Woman had a miscarriage|21|||
125088815|NCT01084096|449944478|FG001|Overall Study|Woman had a miscarriage|17|||
125088816|NCT00027846|449944479|FG000|Overall Study|Lost to Follow-up|0|||
125088817|NCT00027846|449944480|FG001|Overall Study|Lost to Follow-up|41|||
125088818|NCT00027846|449944481|FG002|Overall Study|Lost to Follow-up|9|||
125088819|NCT00027846|449944479|FG000|Overall Study|Withdrawal by Subject|0|||
125088820|NCT00027846|449944480|FG001|Overall Study|Withdrawal by Subject|14|||
124977456|NCT00608868|449545382|FG000|Overall Study|Physician Decision|2|||
124977457|NCT00335140|449545385|FG000|Overall Study|Ineligible|1|||
124977458|NCT04546425|449545386|FG000|Overall Study|Protocol Violation|1|||
124977459|NCT04546425|449545387|FG001|Overall Study|Protocol Violation|1|||
124977460|NCT04546425|449545388|FG002|Overall Study|Protocol Violation|0|||
125088821|NCT00027846|449944481|FG002|Overall Study|Withdrawal by Subject|7|||
125088822|NCT00027846|449944479|FG000|Overall Study|Ineligible for study|2|||
125088823|NCT00027846|449944480|FG001|Overall Study|Ineligible for study|6|||
125088824|NCT00027846|449944481|FG002|Overall Study|Ineligible for study|14|||
125088825|NCT00027846|449944479|FG000|Overall Study|Entry into another COG therapeutic study|0|||
125088826|NCT00027846|449944480|FG001|Overall Study|Entry into another COG therapeutic study|5|||
125088827|NCT00027846|449944481|FG002|Overall Study|Entry into another COG therapeutic study|2|||
125088828|NCT00027846|449944479|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
125088829|NCT00027846|449944480|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
124977461|NCT04546425|449545389|FG003|Overall Study|Protocol Violation|0|||
124977462|NCT04546425|449545386|FG000|Overall Study|Adverse Event|3|||
124977463|NCT04546425|449545387|FG001|Overall Study|Adverse Event|0|||
124977464|NCT04546425|449545388|FG002|Overall Study|Adverse Event|0|||
124977465|NCT04546425|449545389|FG003|Overall Study|Adverse Event|0|||
124977466|NCT04546425|449545386|FG000|Overall Study|Lost to Follow-up|5|||
124977467|NCT04546425|449545387|FG001|Overall Study|Lost to Follow-up|4|||
124977468|NCT04546425|449545388|FG002|Overall Study|Lost to Follow-up|0|||
124977469|NCT04546425|449545389|FG003|Overall Study|Lost to Follow-up|0|||
124977470|NCT04546425|449545386|FG000|Overall Study|No Longer met eligibility criteria|3|||
125198961|NCT04434469|450351057|FG001|Overall Study|Lost to Follow-up|0|||
125198962|NCT04434469|450351058|FG002|Overall Study|Lost to Follow-up|0|||
125198963|NCT04434469|450351059|FG003|Overall Study|Lost to Follow-up|1|||
125198964|NCT04434469|450351060|FG004|Overall Study|Lost to Follow-up|1|||
125198965|NCT04434469|450351061|FG005|Overall Study|Lost to Follow-up|0|||
125198966|NCT04434469|450351056|FG000|Overall Study|Study terminated by sponsor|1|||
125198967|NCT04434469|450351057|FG001|Overall Study|Study terminated by sponsor|1|||
125198968|NCT04434469|450351058|FG002|Overall Study|Study terminated by sponsor|1|||
125198969|NCT04434469|450351059|FG003|Overall Study|Study terminated by sponsor|2|||
125198970|NCT04434469|450351060|FG004|Overall Study|Study terminated by sponsor|3|||
125198971|NCT04434469|450351061|FG005|Overall Study|Study terminated by sponsor|3|||
125198972|NCT04434469|450351056|FG000|Overall Study|Withdrawal by Subject|0|||
125198973|NCT04434469|450351057|FG001|Overall Study|Withdrawal by Subject|0|||
125198974|NCT04434469|450351058|FG002|Overall Study|Withdrawal by Subject|1|||
125198975|NCT04434469|450351059|FG003|Overall Study|Withdrawal by Subject|0|||
125198976|NCT04434469|450351060|FG004|Overall Study|Withdrawal by Subject|0|||
125198977|NCT04434469|450351061|FG005|Overall Study|Withdrawal by Subject|0|||
125198978|NCT01669174|450351062|FG000|Overall Study|Subject withdrew consent|2|||
125198979|NCT01669174|450351063|FG001|Overall Study|Subject withdrew consent|2|||
125198980|NCT01669174|450351062|FG000|Overall Study|Lost to Follow-up|1|||
125198981|NCT01669174|450351063|FG001|Overall Study|Lost to Follow-up|0|||
125198982|NCT01669174|450351062|FG000|Overall Study|Adverse Event|2|||
125198983|NCT01669174|450351063|FG001|Overall Study|Adverse Event|2|||
125198984|NCT01669174|450351062|FG000|Overall Study|Administrative problems|1|||
125198985|NCT01669174|450351063|FG001|Overall Study|Administrative problems|2|||
125198986|NCT01953601|450351067|FG000|Part 1 (Base Study)|Adverse Event|24|||
125198987|NCT01953601|450351068|FG001|Part 1 (Base Study)|Adverse Event|37|||
125198988|NCT01953601|450351069|FG002|Part 1 (Base Study)|Adverse Event|15|||
125198989|NCT01953601|450351067|FG000|Part 1 (Base Study)|Death|2|||
125198990|NCT01953601|450351068|FG001|Part 1 (Base Study)|Death|0|||
125198991|NCT01953601|450351069|FG002|Part 1 (Base Study)|Death|3|||
125198992|NCT01953601|450351067|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
125198993|NCT01953601|450351068|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
125198994|NCT01953601|450351069|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
125198995|NCT01953601|450351067|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
125198996|NCT01953601|450351068|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
125198997|NCT01953601|450351069|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
125198998|NCT01953601|450351067|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
125198999|NCT01953601|450351068|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
125199000|NCT01953601|450351069|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
125199001|NCT01953601|450351067|FG000|Part 1 (Base Study)|Physician Decision|3|||
125199002|NCT01953601|450351068|FG001|Part 1 (Base Study)|Physician Decision|7|||
125199003|NCT01953601|450351069|FG002|Part 1 (Base Study)|Physician Decision|4|||
125199004|NCT01953601|450351067|FG000|Part 1 (Base Study)|Screen failure|1|||
125199005|NCT01953601|450351068|FG001|Part 1 (Base Study)|Screen failure|0|||
125199006|NCT01953601|450351069|FG002|Part 1 (Base Study)|Screen failure|1|||
125199007|NCT01953601|450351067|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
125199008|NCT01953601|450351068|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
125199009|NCT01953601|450351069|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
125199010|NCT01953601|450351067|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
125199011|NCT01953601|450351068|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
125199012|NCT01953601|450351069|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
125199013|NCT01953601|450351067|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
125199014|NCT01953601|450351068|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
125199015|NCT01953601|450351069|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
125199016|NCT01953601|450351067|FG000|Part 1 (Base Study)|Subject moved|2|||
125199017|NCT01953601|450351068|FG001|Part 1 (Base Study)|Subject moved|2|||
125199018|NCT01953601|450351069|FG002|Part 1 (Base Study)|Subject moved|1|||
124977471|NCT04546425|449545387|FG001|Overall Study|No Longer met eligibility criteria|3|||
125199019|NCT01953601|450351067|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
125199020|NCT01953601|450351068|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
125199021|NCT01953601|450351069|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
125199022|NCT01953601|450351067|FG000|Part 2 (Extension Study)|Adverse Event|1|||
125199023|NCT01953601|450351068|FG001|Part 2 (Extension Study)|Adverse Event|1|||
125199024|NCT01953601|450351069|FG002|Part 2 (Extension Study)|Adverse Event|10|||
125199025|NCT01953601|450351067|FG000|Part 2 (Extension Study)|Death|0|||
125199026|NCT01953601|450351068|FG001|Part 2 (Extension Study)|Death|3|||
125199027|NCT01953601|450351069|FG002|Part 2 (Extension Study)|Death|0|||
125199028|NCT01953601|450351067|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
125199029|NCT01953601|450351068|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
125199030|NCT01953601|450351069|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
125199031|NCT01953601|450351067|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
125199032|NCT01953601|450351068|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
125199033|NCT01953601|450351069|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
125199034|NCT01953601|450351067|FG000|Part 2 (Extension Study)|Physician Decision|2|||
125199035|NCT01953601|450351068|FG001|Part 2 (Extension Study)|Physician Decision|0|||
125199036|NCT01953601|450351069|FG002|Part 2 (Extension Study)|Physician Decision|2|||
125199037|NCT01953601|450351067|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
125199038|NCT01953601|450351068|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
124977472|NCT04546425|449545388|FG002|Overall Study|No Longer met eligibility criteria|1|||
124977473|NCT04546425|449545389|FG003|Overall Study|No Longer met eligibility criteria|1|||
124977474|NCT04546425|449545386|FG000|Overall Study|Withdrawal by parent/guardian|6|||
124977475|NCT04546425|449545387|FG001|Overall Study|Withdrawal by parent/guardian|5|||
124977476|NCT04546425|449545388|FG002|Overall Study|Withdrawal by parent/guardian|1|||
124977477|NCT04546425|449545389|FG003|Overall Study|Withdrawal by parent/guardian|1|||
124977478|NCT02979249|449545392|FG000|Overall Study|Lost to Follow-up|2|||
124977479|NCT02979249|449545392|FG000|Overall Study|Withdrawal by Subject|4|||
124977480|NCT01125046|449545393|FG000|First 6 Months of Treatment|Death|1|||
124977481|NCT01125046|449545393|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
124977482|NCT01125046|449545393|FG000|First 6 Months of Treatment|Non-compliance|1|||
124977483|NCT01125046|449545393|FG000|First 6 Months of Treatment|Surgery|1|||
124977484|NCT01125046|449545393|FG000|First 6 Months of Treatment|Progressive Disease|7|||
124977485|NCT01125046|449545393|FG000|First 6 Months of Treatment|Adverse Event|2|||
124977486|NCT01125046|449545393|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
124977487|NCT01125046|449545393|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
125199039|NCT01953601|450351069|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
125199040|NCT01953601|450351067|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
125199041|NCT01953601|450351068|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
125199042|NCT01953601|450351069|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
125199043|NCT01953601|450351067|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
125199044|NCT01953601|450351068|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
125199045|NCT01953601|450351069|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
125199046|NCT01953601|450351067|FG000|Part 2 (Extension Study)|Subject moved|0|||
125199047|NCT01953601|450351068|FG001|Part 2 (Extension Study)|Subject moved|0|||
125199048|NCT01953601|450351069|FG002|Part 2 (Extension Study)|Subject moved|1|||
125199049|NCT01953601|450351067|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
125199050|NCT01953601|450351068|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
125199051|NCT01953601|450351069|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
125199052|NCT01154296|450351075|FG000|Randomization and Intervention|Decided to decline|1|||
125199053|NCT01154296|450351076|FG001|Randomization and Intervention|Decided to decline|1|||
125199054|NCT01154296|450351075|FG000|Randomization and Intervention|Declined by staff|1|||
125199055|NCT01154296|450351076|FG001|Randomization and Intervention|Declined by staff|0|||
125199056|NCT01154296|450351075|FG000|Randomization and Intervention|Did not return|1|||
125199057|NCT01154296|450351076|FG001|Randomization and Intervention|Did not return|0|||
125199058|NCT01154296|450351075|FG000|Randomization and Intervention|Left before test|0|||
125199059|NCT01154296|450351076|FG001|Randomization and Intervention|Left before test|1|||
125199060|NCT01154296|450351075|FG000|Randomization and Intervention|Left clinic early|2|||
125199061|NCT01154296|450351076|FG001|Randomization and Intervention|Left clinic early|0|||
125199062|NCT01154296|450351075|FG000|6-month Follow-up|Lost contact|269|||
125199063|NCT01154296|450351076|FG001|6-month Follow-up|Lost contact|275|||
125199064|NCT01154296|450351075|FG000|6-month Follow-up|Incarcerated|37|||
125199065|NCT01154296|450351076|FG001|6-month Follow-up|Incarcerated|32|||
125199066|NCT01154296|450351075|FG000|6-month Follow-up|Withdrew consent|14|||
125199067|NCT01154296|450351076|FG001|6-month Follow-up|Withdrew consent|15|||
125199068|NCT01154296|450351075|FG000|6-month Follow-up|Death|3|||
125199069|NCT01154296|450351076|FG001|6-month Follow-up|Death|2|||
125199070|NCT01154296|450351075|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
125199071|NCT01154296|450351076|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
125199072|NCT04310397|450351079|FG000|Overall Study|Lack of Efficacy|3|||
125199073|NCT04310397|450351079|FG000|Overall Study|Withdrawal by Subject|1|||
125199074|NCT00664859|450351106|FG000|Overall Study|Adverse Event|2|||
125199075|NCT00664859|450351107|FG001|Overall Study|Adverse Event|1|||
125199076|NCT00664859|450351108|FG002|Overall Study|Adverse Event|3|||
125199077|NCT00664859|450351106|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
125199078|NCT00664859|450351107|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
125199079|NCT00664859|450351108|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
125199080|NCT00664859|450351106|FG000|Overall Study|Noncompliance with protocol|1|||
125199081|NCT00664859|450351107|FG001|Overall Study|Noncompliance with protocol|0|||
125199082|NCT00664859|450351108|FG002|Overall Study|Noncompliance with protocol|4|||
125217405|NCT05415462|450423519|FG001|Overall Study|Physician Decision|5|||
124977488|NCT01125046|449545393|FG000|Follow-up/Data Cut Off Point|Death|29|||
124977489|NCT01125046|449545393|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
124977490|NCT03868787|449545395|FG000|Overall Study|Withdrawal by Subject|2|||
124977491|NCT03868787|449545396|FG001|Overall Study|Withdrawal by Subject|1|||
124977492|NCT01685229|449545397|FG000|Overall Study|Subjects missing Study Exit form|3|||
124977493|NCT01685229|449545398|FG001|Overall Study|Subjects missing Study Exit form|1|||
124977494|NCT01685229|449545397|FG000|Overall Study|Lost to Follow-up|16|||
124977495|NCT01685229|449545398|FG001|Overall Study|Lost to Follow-up|10|||
124977496|NCT01685229|449545397|FG000|Overall Study|Withdrawal by Subject|6|||
124977497|NCT01685229|449545398|FG001|Overall Study|Withdrawal by Subject|5|||
124977498|NCT01685229|449545397|FG000|Overall Study|Death|1|||
124977499|NCT01685229|449545398|FG001|Overall Study|Death|0|||
124977500|NCT01399697|449545411|FG000|Overall Study|Adverse Event|13|||
124977501|NCT01399697|449545412|FG001|Overall Study|Adverse Event|3|||
124977502|NCT01399697|449545413|FG002|Overall Study|Adverse Event|1|||
124977503|NCT01399697|449545411|FG000|Overall Study|Lost to Follow-up|2|||
124977504|NCT01399697|449545412|FG001|Overall Study|Lost to Follow-up|0|||
124977505|NCT01399697|449545413|FG002|Overall Study|Lost to Follow-up|0|||
124977506|NCT01399697|449545411|FG000|Overall Study|Withdrawal by Subject|8|||
124977507|NCT01399697|449545412|FG001|Overall Study|Withdrawal by Subject|0|||
124977508|NCT01399697|449545413|FG002|Overall Study|Withdrawal by Subject|0|||
124977509|NCT01399697|449545411|FG000|Overall Study|Investigator Decisión|1|||
124977510|NCT01399697|449545412|FG001|Overall Study|Investigator Decisión|0|||
124977511|NCT01399697|449545413|FG002|Overall Study|Investigator Decisión|2|||
124977512|NCT01399697|449545411|FG000|Overall Study|Lack of Efficacy|9|||
124977513|NCT01399697|449545412|FG001|Overall Study|Lack of Efficacy|0|||
124977514|NCT01399697|449545413|FG002|Overall Study|Lack of Efficacy|1|||
124977515|NCT01399697|449545411|FG000|Overall Study|Protocol Violation|2|||
124977516|NCT01399697|449545412|FG001|Overall Study|Protocol Violation|0|||
124977517|NCT01399697|449545413|FG002|Overall Study|Protocol Violation|0|||
124977518|NCT01399697|449545411|FG000|Overall Study|Non-Compliant|1|||
124977519|NCT01399697|449545412|FG001|Overall Study|Non-Compliant|0|||
124977520|NCT01399697|449545413|FG002|Overall Study|Non-Compliant|0|||
124977521|NCT01399697|449545411|FG000|Overall Study|Inclusion Error|2|||
124977522|NCT01399697|449545412|FG001|Overall Study|Inclusion Error|0|||
124977523|NCT01399697|449545413|FG002|Overall Study|Inclusion Error|0|||
124977524|NCT01399697|449545411|FG000|Overall Study|Positive result for hepatitis B|1|||
124977525|NCT01399697|449545412|FG001|Overall Study|Positive result for hepatitis B|0|||
124977526|NCT01399697|449545413|FG002|Overall Study|Positive result for hepatitis B|0|||
124977527|NCT01399697|449545411|FG000|Overall Study|Clinical RA remission|1|||
124977528|NCT01399697|449545412|FG001|Overall Study|Clinical RA remission|0|||
124977529|NCT01399697|449545413|FG002|Overall Study|Clinical RA remission|0|||
124977530|NCT01399697|449545411|FG000|Overall Study|Sponsor Decision|1|||
124977531|NCT01399697|449545412|FG001|Overall Study|Sponsor Decision|0|||
124977532|NCT01399697|449545413|FG002|Overall Study|Sponsor Decision|0|||
124977533|NCT04313608|449545414|FG000|Overall Study|Death|12|||
124977534|NCT04313608|449545415|FG001|Overall Study|Death|3|||
124977535|NCT03019640|449545417|FG000|Overall Study|Screen Failures|4|||
124977536|NCT03019640|449545417|FG000|Overall Study|Adverse Event|3|||
124977537|NCT03019640|449545417|FG000|Overall Study|Participant Relapsed|1|||
124977538|NCT02817906|449545426|FG000|Overall Study|Adverse Event|3|||
124977539|NCT02817906|449545427|FG001|Overall Study|Adverse Event|0|||
124977540|NCT02817906|449545426|FG000|Overall Study|Lack of Efficacy|1|||
124977541|NCT02817906|449545427|FG001|Overall Study|Lack of Efficacy|0|||
124977542|NCT02817906|449545426|FG000|Overall Study|Protocol Violation|1|||
124977543|NCT02817906|449545427|FG001|Overall Study|Protocol Violation|1|||
124977544|NCT02817906|449545426|FG000|Overall Study|Study Terminated by Sponsor|2|||
124977545|NCT02817906|449545427|FG001|Overall Study|Study Terminated by Sponsor|2|||
124977546|NCT02817906|449545426|FG000|Overall Study|Withdrawal by Subject|7|||
124977547|NCT02817906|449545427|FG001|Overall Study|Withdrawal by Subject|0|||
124977548|NCT02817906|449545426|FG000|Overall Study|Other|2|||
124977549|NCT02817906|449545427|FG001|Overall Study|Other|2|||
124977550|NCT03686423|449545428|FG000|Overall Study|Withdrawal by Subject|9|||
124977551|NCT03686423|449545428|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
124977552|NCT02833077|449545429|FG000|Overall Study|Adverse Event|1|||
124977553|NCT02833077|449545430|FG001|Overall Study|Adverse Event|2|||
124977554|NCT02833077|449545429|FG000|Overall Study|Lost to Follow-up|10|||
124977555|NCT02833077|449545430|FG001|Overall Study|Lost to Follow-up|1|||
124977556|NCT02833077|449545429|FG000|Overall Study|Personal Reasons|6|||
124977557|NCT02833077|449545430|FG001|Overall Study|Personal Reasons|4|||
124977558|NCT02833077|449545429|FG000|Overall Study|Protocol Deviation|0|||
124977559|NCT02833077|449545430|FG001|Overall Study|Protocol Deviation|1|||
124977560|NCT00972322|449545431|FG000|Overall Study|Adverse Event|2|||
124977561|NCT00972322|449545432|FG001|Overall Study|Adverse Event|1|||
124977562|NCT00972322|449545431|FG000|Overall Study|Positive drug screen|0|||
124977563|NCT00972322|449545432|FG001|Overall Study|Positive drug screen|1|||
124977564|NCT00972322|449545431|FG000|Overall Study|Lost to Follow-up|0|||
124977565|NCT00972322|449545432|FG001|Overall Study|Lost to Follow-up|1|||
124977566|NCT00972322|449545431|FG000|Overall Study|Consistently high glucose values|1|||
124977567|NCT00972322|449545432|FG001|Overall Study|Consistently high glucose values|0|||
124977568|NCT01077518|449545433|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
125199083|NCT00664859|450351106|FG000|Overall Study|Laboratory abnormality|2|||
125199084|NCT00664859|450351107|FG001|Overall Study|Laboratory abnormality|1|||
125199085|NCT00664859|450351108|FG002|Overall Study|Laboratory abnormality|4|||
125199086|NCT00664859|450351106|FG000|Overall Study|Withdrawal by Subject|4|||
125199087|NCT00664859|450351107|FG001|Overall Study|Withdrawal by Subject|1|||
125199088|NCT00664859|450351108|FG002|Overall Study|Withdrawal by Subject|3|||
125199089|NCT00664859|450351106|FG000|Overall Study|Lost to Follow-up|2|||
125199090|NCT00664859|450351107|FG001|Overall Study|Lost to Follow-up|2|||
124977569|NCT01077518|449545434|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
124977570|NCT01077518|449545435|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
124977571|NCT01077518|449545433|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
124977572|NCT01077518|449545434|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
124977573|NCT01077518|449545435|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
124977574|NCT01077518|449545433|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
124977575|NCT01077518|449545434|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
124977576|NCT01077518|449545435|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
125199091|NCT00664859|450351108|FG002|Overall Study|Lost to Follow-up|1|||
125199092|NCT00664859|450351106|FG000|Overall Study|Other|0|||
125199093|NCT00664859|450351107|FG001|Overall Study|Other|1|||
125199094|NCT00664859|450351108|FG002|Overall Study|Other|2|||
125199095|NCT01943851|450351109|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199096|NCT01943851|450351110|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199097|NCT01943851|450351111|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199098|NCT01943851|450351112|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
125199099|NCT01943851|450351113|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199100|NCT01943851|450351114|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199101|NCT01943851|450351115|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
125199102|NCT01943851|450351116|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
125199103|NCT01943851|450351117|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
125199104|NCT01943851|450351118|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199105|NCT01943851|450351119|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199106|NCT01943851|450351120|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199107|NCT01943851|450351121|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199108|NCT01943851|450351122|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199109|NCT01943851|450351123|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199110|NCT01943851|450351124|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199111|NCT01943851|450351125|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199112|NCT01943851|450351126|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199113|NCT01943851|450351109|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199114|NCT01943851|450351110|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199115|NCT01943851|450351111|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199116|NCT01943851|450351112|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199117|NCT01943851|450351113|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
125199118|NCT01943851|450351114|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199119|NCT01943851|450351115|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199120|NCT01943851|450351116|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
125199121|NCT01943851|450351117|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199122|NCT01943851|450351118|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199123|NCT01943851|450351119|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199124|NCT01943851|450351120|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199125|NCT01943851|450351121|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199126|NCT01943851|450351122|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199127|NCT01943851|450351123|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
124977577|NCT01077518|449545433|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
124977578|NCT01077518|449545434|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
124977579|NCT01077518|449545435|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
124977580|NCT01077518|449545433|FG000|Optional Ofa Phase|Physician Decision|0|||
124977581|NCT01077518|449545434|FG001|Optional Ofa Phase|Physician Decision|0|||
124977582|NCT01077518|449545435|FG002|Optional Ofa Phase|Physician Decision|1|||
124977583|NCT01077518|449545433|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
124977584|NCT01077518|449545434|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
125199128|NCT01943851|450351124|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199129|NCT01943851|450351125|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199130|NCT01943851|450351126|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199131|NCT01943851|450351109|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199132|NCT01943851|450351110|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199133|NCT01943851|450351111|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199134|NCT01943851|450351112|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199135|NCT01943851|450351113|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199136|NCT01943851|450351114|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199137|NCT01943851|450351115|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199138|NCT01943851|450351116|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199139|NCT01943851|450351117|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199140|NCT01943851|450351118|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199141|NCT01943851|450351119|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199142|NCT01943851|450351120|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199143|NCT01943851|450351121|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199144|NCT01943851|450351122|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
125199145|NCT01943851|450351123|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199146|NCT01943851|450351124|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199147|NCT01943851|450351125|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199148|NCT01943851|450351126|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199149|NCT01943851|450351109|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199150|NCT01943851|450351110|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199151|NCT01943851|450351111|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199152|NCT01943851|450351112|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199153|NCT01943851|450351113|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199154|NCT01943851|450351114|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199155|NCT01943851|450351115|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199156|NCT01943851|450351116|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199157|NCT01943851|450351117|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199158|NCT01943851|450351118|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199159|NCT01943851|450351119|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199160|NCT01943851|450351120|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199161|NCT01943851|450351121|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199162|NCT01943851|450351122|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199163|NCT01943851|450351123|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199164|NCT01943851|450351124|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
125199165|NCT01943851|450351125|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199166|NCT01943851|450351126|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199167|NCT01943851|450351109|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199168|NCT01943851|450351110|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199169|NCT01943851|450351111|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199170|NCT01943851|450351112|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199171|NCT01943851|450351113|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199172|NCT01943851|450351114|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199173|NCT01943851|450351115|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199174|NCT01943851|450351116|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199175|NCT01943851|450351117|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199176|NCT01943851|450351118|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199177|NCT01943851|450351119|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199178|NCT01943851|450351120|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199179|NCT01943851|450351121|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199180|NCT01943851|450351122|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199181|NCT01943851|450351123|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199182|NCT01943851|450351124|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
125199183|NCT01943851|450351125|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
125199184|NCT01943851|450351126|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
125199185|NCT00900757|450351127|FG000|Overall Study|screen failure|19|||
125199186|NCT03320850|450351128|FG000|Overall Study|Lost to Follow-up|0|||
125199187|NCT03320850|450351129|FG001|Overall Study|Lost to Follow-up|0|||
125199188|NCT03320850|450351130|FG002|Overall Study|Lost to Follow-up|0|||
125199189|NCT03320850|450351131|FG003|Overall Study|Lost to Follow-up|0|||
125199190|NCT03320850|450351132|FG004|Overall Study|Lost to Follow-up|1|||
125199191|NCT03320850|450351133|FG005|Overall Study|Lost to Follow-up|2|||
125199192|NCT03320850|450351134|FG006|Overall Study|Lost to Follow-up|2|||
125199193|NCT03320850|450351135|FG007|Overall Study|Lost to Follow-up|0|||
125199194|NCT03320850|450351136|FG008|Overall Study|Lost to Follow-up|6|||
125199195|NCT03320850|450351137|FG009|Overall Study|Lost to Follow-up|4|||
125199196|NCT03320850|450351128|FG000|Overall Study|Withdrawal by Subject|0|||
125199197|NCT03320850|450351129|FG001|Overall Study|Withdrawal by Subject|0|||
125199198|NCT03320850|450351130|FG002|Overall Study|Withdrawal by Subject|0|||
125199199|NCT03320850|450351131|FG003|Overall Study|Withdrawal by Subject|0|||
125199200|NCT03320850|450351132|FG004|Overall Study|Withdrawal by Subject|1|||
125199201|NCT03320850|450351133|FG005|Overall Study|Withdrawal by Subject|2|||
125199202|NCT03320850|450351134|FG006|Overall Study|Withdrawal by Subject|4|||
125199203|NCT03320850|450351135|FG007|Overall Study|Withdrawal by Subject|5|||
125310283|NCT00466921|450762052|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
125199204|NCT03320850|450351136|FG008|Overall Study|Withdrawal by Subject|2|||
125199205|NCT03320850|450351137|FG009|Overall Study|Withdrawal by Subject|1|||
125199206|NCT03320850|450351128|FG000|Overall Study|Lack of Efficacy|0|||
125199207|NCT03320850|450351129|FG001|Overall Study|Lack of Efficacy|0|||
125199208|NCT03320850|450351130|FG002|Overall Study|Lack of Efficacy|0|||
125199209|NCT03320850|450351131|FG003|Overall Study|Lack of Efficacy|1|||
125199210|NCT03320850|450351132|FG004|Overall Study|Lack of Efficacy|0|||
125199211|NCT03320850|450351133|FG005|Overall Study|Lack of Efficacy|1|||
125199212|NCT03320850|450351134|FG006|Overall Study|Lack of Efficacy|0|||
125199213|NCT03320850|450351135|FG007|Overall Study|Lack of Efficacy|2|||
125199214|NCT03320850|450351136|FG008|Overall Study|Lack of Efficacy|0|||
125199215|NCT03320850|450351137|FG009|Overall Study|Lack of Efficacy|3|||
125199216|NCT03320850|450351128|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
125199217|NCT03320850|450351129|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
125199218|NCT03320850|450351130|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
125199219|NCT03320850|450351131|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
125199220|NCT03320850|450351132|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
125199221|NCT03320850|450351133|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
125199222|NCT03320850|450351134|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
125199223|NCT03320850|450351135|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
125199224|NCT03320850|450351136|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
125199225|NCT03320850|450351137|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
125199226|NCT03320850|450351128|FG000|Overall Study|Adverse Event|0|||
125199227|NCT03320850|450351129|FG001|Overall Study|Adverse Event|0|||
125199228|NCT03320850|450351130|FG002|Overall Study|Adverse Event|0|||
125199229|NCT03320850|450351131|FG003|Overall Study|Adverse Event|0|||
125199230|NCT03320850|450351132|FG004|Overall Study|Adverse Event|0|||
125199231|NCT03320850|450351133|FG005|Overall Study|Adverse Event|2|||
125199232|NCT03320850|450351134|FG006|Overall Study|Adverse Event|1|||
125199233|NCT03320850|450351135|FG007|Overall Study|Adverse Event|0|||
125199234|NCT03320850|450351136|FG008|Overall Study|Adverse Event|2|||
125199235|NCT03320850|450351137|FG009|Overall Study|Adverse Event|0|||
125199236|NCT03320850|450351128|FG000|Overall Study|Reason Not Specified|0|||
125199237|NCT03320850|450351129|FG001|Overall Study|Reason Not Specified|0|||
125199238|NCT03320850|450351130|FG002|Overall Study|Reason Not Specified|0|||
125199239|NCT03320850|450351131|FG003|Overall Study|Reason Not Specified|0|||
125199240|NCT03320850|450351132|FG004|Overall Study|Reason Not Specified|0|||
125199241|NCT03320850|450351133|FG005|Overall Study|Reason Not Specified|1|||
125199242|NCT03320850|450351134|FG006|Overall Study|Reason Not Specified|0|||
125199243|NCT03320850|450351135|FG007|Overall Study|Reason Not Specified|0|||
125199244|NCT03320850|450351136|FG008|Overall Study|Reason Not Specified|0|||
125199245|NCT03320850|450351137|FG009|Overall Study|Reason Not Specified|1|||
125199246|NCT00546117|450351138|FG000|Overall Study|Withdrawal by Subject|3|||
125199247|NCT00546117|450351139|FG001|Overall Study|Withdrawal by Subject|0|||
125199248|NCT00546117|450351138|FG000|Overall Study|Inability to schedule follow-up visit|1|||
125199249|NCT00546117|450351139|FG001|Overall Study|Inability to schedule follow-up visit|0|||
125199250|NCT01609543|450351155|FG000|Overall Study|Disease Progression|28|||
125199251|NCT01609543|450351155|FG000|Overall Study|Adverse Event|5|||
125199252|NCT01609543|450351155|FG000|Overall Study|Withdrawal by Subject|1|||
125199253|NCT01609543|450351155|FG000|Overall Study|Protocol Violation|1|||
125199254|NCT01609543|450351155|FG000|Overall Study|Death|7|||
125199255|NCT00507819|450351156|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
125199256|NCT00507819|450351157|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
125199257|NCT03452488|450351158|FG000|Overall Study|Adverse Event|4|||
125199258|NCT03452488|450351159|FG001|Overall Study|Adverse Event|6|||
125199259|NCT03452488|450351160|FG002|Overall Study|Adverse Event|1|||
125199260|NCT03452488|450351158|FG000|Overall Study|Death|0|||
125199261|NCT03452488|450351159|FG001|Overall Study|Death|0|||
125199262|NCT03452488|450351160|FG002|Overall Study|Death|1|||
125199263|NCT03452488|450351158|FG000|Overall Study|Lost to Follow-up|1|||
125199264|NCT03452488|450351159|FG001|Overall Study|Lost to Follow-up|2|||
125199265|NCT03452488|450351160|FG002|Overall Study|Lost to Follow-up|0|||
125199266|NCT03452488|450351158|FG000|Overall Study|PI Decision|1|||
125199267|NCT03452488|450351159|FG001|Overall Study|PI Decision|0|||
125199268|NCT03452488|450351160|FG002|Overall Study|PI Decision|0|||
125199269|NCT03452488|450351158|FG000|Overall Study|Withdrew consent|4|||
125199270|NCT03452488|450351159|FG001|Overall Study|Withdrew consent|2|||
125199271|NCT03452488|450351160|FG002|Overall Study|Withdrew consent|2|||
125199272|NCT03452488|450351158|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
125199273|NCT03452488|450351159|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
125199274|NCT03452488|450351160|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
125199275|NCT03452488|450351158|FG000|Overall Study|Other|0|||
125199276|NCT03452488|450351159|FG001|Overall Study|Other|2|||
125199277|NCT03452488|450351160|FG002|Overall Study|Other|2|||
125199278|NCT01254318|450351161|FG000|Overall Study|Lost to Follow-up|5|||
125199279|NCT01254318|450351161|FG000|Overall Study|Death|47|||
125199280|NCT00782184|450351168|FG000|Overall Study|Adverse Event|1|||
125199281|NCT00782184|450351169|FG001|Overall Study|Adverse Event|2|||
125199282|NCT00782184|450351168|FG000|Overall Study|Protocol Violation|0|||
125199283|NCT00782184|450351169|FG001|Overall Study|Protocol Violation|1|||
125199284|NCT00782184|450351168|FG000|Overall Study|Withdrawal by Subject|3|||
125199285|NCT00782184|450351169|FG001|Overall Study|Withdrawal by Subject|2|||
125199286|NCT01992653|450351172|FG000|Overall Study|Death|0|||
125199287|NCT01992653|450351173|FG001|Overall Study|Death|0|||
125199288|NCT01992653|450351174|FG002|Overall Study|Death|1|||
125199289|NCT01992653|450351175|FG003|Overall Study|Death|0|||
125199290|NCT01992653|450351176|FG004|Overall Study|Death|1|||
125199291|NCT01992653|450351177|FG005|Overall Study|Death|0|||
125199292|NCT01992653|450351178|FG006|Overall Study|Death|4|||
125199293|NCT01992653|450351179|FG007|Overall Study|Death|2|||
125199294|NCT01992653|450351172|FG000|Overall Study|Lost to Follow-up|0|||
125199295|NCT01992653|450351173|FG001|Overall Study|Lost to Follow-up|0|||
125199296|NCT01992653|450351174|FG002|Overall Study|Lost to Follow-up|0|||
125199297|NCT01992653|450351175|FG003|Overall Study|Lost to Follow-up|0|||
125199298|NCT01992653|450351176|FG004|Overall Study|Lost to Follow-up|0|||
125199299|NCT01992653|450351177|FG005|Overall Study|Lost to Follow-up|0|||
125199300|NCT01992653|450351178|FG006|Overall Study|Lost to Follow-up|0|||
125199301|NCT01992653|450351179|FG007|Overall Study|Lost to Follow-up|1|||
125199302|NCT01992653|450351172|FG000|Overall Study|Study Completed|0|||
125199303|NCT01992653|450351173|FG001|Overall Study|Study Completed|0|||
125199304|NCT01992653|450351174|FG002|Overall Study|Study Completed|0|||
125199305|NCT01992653|450351175|FG003|Overall Study|Study Completed|0|||
125199306|NCT01992653|450351176|FG004|Overall Study|Study Completed|0|||
125199307|NCT01992653|450351177|FG005|Overall Study|Study Completed|0|||
125199308|NCT01992653|450351178|FG006|Overall Study|Study Completed|0|||
125199309|NCT01992653|450351179|FG007|Overall Study|Study Completed|1|||
125199310|NCT01992653|450351172|FG000|Overall Study|Disease Progression|0|||
125199311|NCT01992653|450351173|FG001|Overall Study|Disease Progression|0|||
125199312|NCT01992653|450351174|FG002|Overall Study|Disease Progression|0|||
125199313|NCT01992653|450351175|FG003|Overall Study|Disease Progression|0|||
125199314|NCT01992653|450351176|FG004|Overall Study|Disease Progression|0|||
125199315|NCT01992653|450351177|FG005|Overall Study|Disease Progression|0|||
125199316|NCT01992653|450351178|FG006|Overall Study|Disease Progression|4|||
125199317|NCT01992653|450351179|FG007|Overall Study|Disease Progression|0|||
125199318|NCT02572076|450351180|FG000|Overall Study|Protocol Violation|1|||
125199319|NCT03395184|450351185|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
125199320|NCT03395184|450351186|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
125199321|NCT03395184|450351187|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
125199322|NCT03395184|450351188|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
125199323|NCT03395184|450351189|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
125199324|NCT03395184|450351190|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
125199325|NCT03395184|450351191|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
125199326|NCT03395184|450351185|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
125199327|NCT03395184|450351186|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
125199328|NCT03395184|450351187|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
125199329|NCT03395184|450351188|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
125199330|NCT03395184|450351189|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
125199331|NCT03395184|450351190|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
125199332|NCT03395184|450351191|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
125199333|NCT03395184|450351185|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
125199334|NCT03395184|450351186|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
125199335|NCT03395184|450351187|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
125199336|NCT03395184|450351188|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
125199337|NCT03395184|450351189|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
125199338|NCT03395184|450351190|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
125199339|NCT03395184|450351191|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
125199340|NCT03395184|450351185|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
125199341|NCT03395184|450351186|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
125199342|NCT03395184|450351187|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
125199343|NCT03395184|450351188|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
125199344|NCT03395184|450351189|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
125199345|NCT03395184|450351190|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
125199346|NCT03395184|450351191|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
125199347|NCT03395184|450351185|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
125199348|NCT03395184|450351186|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125199349|NCT03395184|450351187|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
125199350|NCT03395184|450351188|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125199351|NCT03395184|450351189|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125199352|NCT03395184|450351190|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125199353|NCT03395184|450351191|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125199354|NCT03395184|450351185|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
125199355|NCT03395184|450351186|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
125199356|NCT03395184|450351187|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
124866768|NCT00127101|449133644|FG000|Base Protocol|Lack of Efficacy|1|||
124866769|NCT00127101|449133645|FG001|Base Protocol|Lack of Efficacy|0|||
124866770|NCT00127101|449133646|FG002|Base Protocol|Lack of Efficacy|0|||
125199357|NCT03395184|450351188|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
125199358|NCT03395184|450351189|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
125199359|NCT03395184|450351190|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
125199360|NCT03395184|450351191|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
125199361|NCT03395184|450351185|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
125199362|NCT03395184|450351186|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
125199363|NCT03395184|450351187|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
125199364|NCT03395184|450351188|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
125199365|NCT03395184|450351189|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
125199366|NCT03395184|450351190|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
125199367|NCT03395184|450351191|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
125199368|NCT03395184|450351185|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
125199369|NCT03395184|450351186|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
125199370|NCT03395184|450351187|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
125199371|NCT03395184|450351188|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
125199372|NCT03395184|450351189|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
125199373|NCT03395184|450351190|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
125199374|NCT03395184|450351191|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
125199375|NCT03395184|450351185|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
125199376|NCT03395184|450351186|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
125199377|NCT03395184|450351187|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
125199378|NCT03395184|450351188|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
125199379|NCT03395184|450351189|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
125199380|NCT03395184|450351190|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
125199381|NCT03395184|450351191|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
125199382|NCT03395184|450351185|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
125199383|NCT03395184|450351186|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
125199384|NCT03395184|450351187|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
125199385|NCT03395184|450351188|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
125199386|NCT03395184|450351189|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
125199387|NCT03395184|450351190|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
125199388|NCT03395184|450351191|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
125199389|NCT03395184|450351185|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
125199390|NCT03395184|450351186|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
125199391|NCT03395184|450351187|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
125199392|NCT03395184|450351188|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
125199393|NCT03395184|450351189|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
125199394|NCT03395184|450351190|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
125199395|NCT03395184|450351191|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
125199396|NCT03395184|450351185|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
125199397|NCT03395184|450351186|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
125199398|NCT03395184|450351187|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
125199399|NCT03395184|450351188|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
125199400|NCT03395184|450351189|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
125199401|NCT03395184|450351190|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
125199402|NCT03395184|450351191|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
125217406|NCT05415462|450423518|FG000|Overall Study|Protocol Deviation|1|||
125217407|NCT05415462|450423519|FG001|Overall Study|Protocol Deviation|0|||
125217408|NCT05415462|450423518|FG000|Overall Study|Withdrawal by Subject|129|||
125217409|NCT05415462|450423519|FG001|Overall Study|Withdrawal by Subject|101|||
125217410|NCT05415462|450423518|FG000|Overall Study|Other Than Specified|8|||
125217411|NCT05415462|450423519|FG001|Overall Study|Other Than Specified|8|||
125217412|NCT01348100|450423520|FG000|Overall Study|Subject Withdrew Consent|0|||
125217413|NCT01348100|450423521|FG001|Overall Study|Subject Withdrew Consent|0|||
125217414|NCT01348100|450423522|FG002|Overall Study|Subject Withdrew Consent|2|||
125217415|NCT01348100|450423523|FG003|Overall Study|Subject Withdrew Consent|0|||
125217416|NCT01348100|450423524|FG004|Overall Study|Subject Withdrew Consent|1|||
125217417|NCT01348100|450423525|FG005|Overall Study|Subject Withdrew Consent|0|||
125217418|NCT01348100|450423526|FG006|Overall Study|Subject Withdrew Consent|1|||
125217419|NCT01348100|450423520|FG000|Overall Study|Protocol Deviation|0|||
125217420|NCT01348100|450423521|FG001|Overall Study|Protocol Deviation|0|||
125217421|NCT01348100|450423522|FG002|Overall Study|Protocol Deviation|0|||
125217422|NCT01348100|450423523|FG003|Overall Study|Protocol Deviation|1|||
125217423|NCT01348100|450423524|FG004|Overall Study|Protocol Deviation|0|||
125217424|NCT01348100|450423525|FG005|Overall Study|Protocol Deviation|0|||
125217425|NCT01348100|450423526|FG006|Overall Study|Protocol Deviation|0|||
125217433|NCT01348100|450423520|FG000|Overall Study|Lost to Follow-up|0|||
124866771|NCT00127101|449133647|FG003|Base Protocol|Lack of Efficacy|0|||
125199403|NCT01397786|450352961|FG000|Phase A|Lost to Follow-up|0|||
125199404|NCT01397786|450352962|FG001|Phase A|Lost to Follow-up|0|||
125199405|NCT01397786|450352963|FG002|Phase A|Lost to Follow-up|6|||
125199406|NCT01397786|450352961|FG000|Phase A|Adverse Event|0|||
125199407|NCT01397786|450352962|FG001|Phase A|Adverse Event|0|||
125199408|NCT01397786|450352963|FG002|Phase A|Adverse Event|8|||
125199409|NCT01397786|450352961|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
125199410|NCT01397786|450352962|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
125199411|NCT01397786|450352963|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
125199412|NCT01397786|450352961|FG000|Phase A|Physician Decision|0|||
125199413|NCT01397786|450352962|FG001|Phase A|Physician Decision|0|||
125199414|NCT01397786|450352963|FG002|Phase A|Physician Decision|1|||
125199415|NCT01397786|450352961|FG000|Phase A|Withdrawal by Subject|0|||
125199416|NCT01397786|450352962|FG001|Phase A|Withdrawal by Subject|0|||
125199417|NCT01397786|450352963|FG002|Phase A|Withdrawal by Subject|5|||
125199418|NCT01397786|450352961|FG000|Phase A|Lack of Efficacy|0|||
125199419|NCT01397786|450352962|FG001|Phase A|Lack of Efficacy|0|||
125199420|NCT01397786|450352963|FG002|Phase A|Lack of Efficacy|1|||
125199421|NCT01397786|450352961|FG000|Phase B|Lost to Follow-up|22|||
125199422|NCT01397786|450352962|FG001|Phase B|Lost to Follow-up|12|||
125199423|NCT01397786|450352963|FG002|Phase B|Lost to Follow-up|22|||
125199424|NCT01397786|450352961|FG000|Phase B|Adverse Event|109|||
125199425|NCT01397786|450352962|FG001|Phase B|Adverse Event|23|||
125199426|NCT01397786|450352963|FG002|Phase B|Adverse Event|27|||
125199427|NCT01397786|450352961|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
125199428|NCT01397786|450352962|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
125199429|NCT01397786|450352963|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
125199430|NCT01397786|450352961|FG000|Phase B|Physician Decision|9|||
125199431|NCT01397786|450352962|FG001|Phase B|Physician Decision|1|||
125199432|NCT01397786|450352963|FG002|Phase B|Physician Decision|3|||
125199433|NCT01397786|450352961|FG000|Phase B|Withdrawal by Subject|102|||
125199434|NCT01397786|450352962|FG001|Phase B|Withdrawal by Subject|45|||
125199435|NCT01397786|450352963|FG002|Phase B|Withdrawal by Subject|30|||
125199436|NCT01397786|450352961|FG000|Phase B|Protocol Deviation|1|||
125199437|NCT01397786|450352962|FG001|Phase B|Protocol Deviation|2|||
125199438|NCT01397786|450352963|FG002|Phase B|Protocol Deviation|4|||
125199439|NCT01397786|450352961|FG000|Phase B|Lack of Efficacy|22|||
125199440|NCT01397786|450352962|FG001|Phase B|Lack of Efficacy|7|||
125199441|NCT01397786|450352963|FG002|Phase B|Lack of Efficacy|14|||
125199442|NCT00784550|450352964|FG000|Overall Study|Adverse Event|12|||
125199443|NCT00784550|450352965|FG001|Overall Study|Adverse Event|10|||
125199444|NCT00784550|450352964|FG000|Overall Study|Lack of Efficacy|0|||
125199445|NCT00784550|450352965|FG001|Overall Study|Lack of Efficacy|1|||
125199446|NCT00784550|450352964|FG000|Overall Study|Protocol Violation|10|||
125199447|NCT00784550|450352965|FG001|Overall Study|Protocol Violation|10|||
125199448|NCT00784550|450352964|FG000|Overall Study|Lost to Follow-up|8|||
125199449|NCT00784550|450352965|FG001|Overall Study|Lost to Follow-up|5|||
125199450|NCT00784550|450352964|FG000|Overall Study|Physician Decision|2|||
125199451|NCT00784550|450352965|FG001|Overall Study|Physician Decision|3|||
125199452|NCT00784550|450352964|FG000|Overall Study|Withdrawal by Subject|4|||
125199453|NCT00784550|450352965|FG001|Overall Study|Withdrawal by Subject|13|||
125199454|NCT00688701|450352966|FG000|Overall Study|Adverse Event|1|||
125199455|NCT00688701|450352967|FG001|Overall Study|Adverse Event|0|||
125199456|NCT00688701|450352968|FG002|Overall Study|Adverse Event|5|||
125199457|NCT00688701|450352969|FG003|Overall Study|Adverse Event|3|||
125199458|NCT00688701|450352966|FG000|Overall Study|Lack of Efficacy|0|||
125199459|NCT00688701|450352967|FG001|Overall Study|Lack of Efficacy|1|||
125199460|NCT00688701|450352968|FG002|Overall Study|Lack of Efficacy|0|||
125199461|NCT00688701|450352969|FG003|Overall Study|Lack of Efficacy|0|||
125199462|NCT00688701|450352966|FG000|Overall Study|Withdrawal by Subject|3|||
125199463|NCT00688701|450352967|FG001|Overall Study|Withdrawal by Subject|3|||
125199464|NCT00688701|450352968|FG002|Overall Study|Withdrawal by Subject|4|||
125199465|NCT00688701|450352969|FG003|Overall Study|Withdrawal by Subject|8|||
125199466|NCT00688701|450352966|FG000|Overall Study|Poor compliance to protocol|0|||
125199467|NCT00688701|450352967|FG001|Overall Study|Poor compliance to protocol|1|||
125199468|NCT00688701|450352968|FG002|Overall Study|Poor compliance to protocol|1|||
125199469|NCT00688701|450352969|FG003|Overall Study|Poor compliance to protocol|0|||
125199470|NCT03875092|450352975|FG000|Overall Study|Adverse Event|2|||
125199471|NCT03875092|450352976|FG001|Overall Study|Adverse Event|5|||
125199472|NCT03875092|450352975|FG000|Overall Study|Death|44|||
125199473|NCT03875092|450352976|FG001|Overall Study|Death|51|||
125199474|NCT03875092|450352975|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
125199475|NCT03875092|450352976|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
125199476|NCT00784238|450352977|FG000|Overall Study|Adverse Event|14|||
125199477|NCT00784238|450352977|FG000|Overall Study|Death|2|||
125199478|NCT00784238|450352977|FG000|Overall Study|Lack of Efficacy|33|||
125199479|NCT00784238|450352977|FG000|Overall Study|Lost to Follow-up|29|||
125199480|NCT00784238|450352977|FG000|Overall Study|Pregnancy|1|||
124866772|NCT00127101|449133648|FG004|Base Protocol|Lack of Efficacy|2|||
125199481|NCT00784238|450352977|FG000|Overall Study|Withdrawal by Subject|26|||
125199482|NCT00784238|450352977|FG000|Overall Study|Other|14|||
125199483|NCT02759055|450352978|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
125199484|NCT02759055|450352979|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
125199485|NCT00723255|450352980|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
125199486|NCT00723255|450352980|FG000|Overall Study|Ineligible: Second primary|1|||
125199487|NCT00723255|450352980|FG000|Overall Study|Ineligible: Wrong Primary|2|||
125199488|NCT00614523|450352981|FG000|Overall Study|Adverse Event|4|||
125199489|NCT00614523|450352982|FG001|Overall Study|Adverse Event|20|||
125199490|NCT00614523|450352981|FG000|Overall Study|Death|5|||
125199491|NCT00614523|450352982|FG001|Overall Study|Death|8|||
125199492|NCT00614523|450352981|FG000|Overall Study|Lack of Efficacy|9|||
125199493|NCT00614523|450352982|FG001|Overall Study|Lack of Efficacy|11|||
125199494|NCT00614523|450352981|FG000|Overall Study|Lost to Follow-up|0|||
125199495|NCT00614523|450352982|FG001|Overall Study|Lost to Follow-up|1|||
125199496|NCT00614523|450352981|FG000|Overall Study|Protocol Violation|3|||
125199497|NCT00614523|450352982|FG001|Overall Study|Protocol Violation|2|||
125199498|NCT00614523|450352981|FG000|Overall Study|Withdrawal by Subject|12|||
125199499|NCT00614523|450352982|FG001|Overall Study|Withdrawal by Subject|22|||
125199500|NCT00614523|450352981|FG000|Overall Study|Other|6|||
125199501|NCT00614523|450352982|FG001|Overall Study|Other|11|||
125199502|NCT00614523|450352981|FG000|Overall Study|Ineligibility Determined|1|||
125199503|NCT00614523|450352982|FG001|Overall Study|Ineligibility Determined|2|||
125199504|NCT00614523|450352981|FG000|Overall Study|Disease Progression|0|||
125199505|NCT00614523|450352982|FG001|Overall Study|Disease Progression|8|||
125199506|NCT00614523|450352981|FG000|Overall Study|Administrative Decision|23|||
125199507|NCT00614523|450352982|FG001|Overall Study|Administrative Decision|46|||
125199508|NCT03692325|450352983|FG000|Overall Study|Adverse Event|2|||
125199509|NCT03692325|450352983|FG000|Overall Study|Progression/Recurrence|2|||
125199510|NCT02461524|450352984|FG000|Overall Study|Death|16|||
125199511|NCT02461524|450352984|FG000|Overall Study|Withdrawal by Subject|4|||
125199512|NCT02461524|450352984|FG000|Overall Study|Device Explanted|5|||
125199513|NCT02461524|450352984|FG000|Overall Study|Missed Visit|6|||
125199514|NCT04481191|450352995|FG000|Overall Study|Withdrawn by parent/guardian|15|||
125199515|NCT04481191|450352996|FG001|Overall Study|Withdrawn by parent/guardian|10|||
125199516|NCT02487771|450352997|FG000|Overall Study|Lost to Follow-up|2|||
125199517|NCT02487771|450352998|FG001|Overall Study|Lost to Follow-up|3|||
125199518|NCT02487771|450352997|FG000|Overall Study|Moved out of area|5|||
125199519|NCT02487771|450352998|FG001|Overall Study|Moved out of area|6|||
125199520|NCT02487771|450352997|FG000|Overall Study|Withdrawal by Subject|3|||
125199521|NCT02487771|450352998|FG001|Overall Study|Withdrawal by Subject|5|||
125199522|NCT02002533|450352999|FG000|Overall Study|Withdrawal by Subject|6|||
125199523|NCT02002533|450353000|FG001|Overall Study|Withdrawal by Subject|13|||
125199524|NCT02002533|450352999|FG000|Overall Study|Protocol Violation|0|||
125199525|NCT02002533|450353000|FG001|Overall Study|Protocol Violation|1|||
125199526|NCT02002533|450352999|FG000|Overall Study|Adverse Event|0|||
125199527|NCT02002533|450353000|FG001|Overall Study|Adverse Event|3|||
125199528|NCT02002533|450352999|FG000|Overall Study|Lost to Follow-up|0|||
125199529|NCT02002533|450353000|FG001|Overall Study|Lost to Follow-up|1|||
125199530|NCT04984278|450353005|FG000|Period 1|Withdrawal by Subject|1|||
125199531|NCT04984278|450353006|FG001|Period 1|Withdrawal by Subject|0|||
125199532|NCT04984278|450353005|FG000|Period 1|Other|0|||
125199533|NCT04984278|450353006|FG001|Period 1|Other|1|||
125199534|NCT04984278|450353005|FG000|Period 2|Adverse Event|1|||
125199535|NCT04984278|450353006|FG001|Period 2|Adverse Event|0|||
125199536|NCT04984278|450353005|FG000|Period 2|Other|0|||
125199537|NCT04984278|450353006|FG001|Period 2|Other|1|||
125199538|NCT01482065|450353007|FG000|Overall Study|Withdrawal by Subject|0|||
125199539|NCT01482065|450353008|FG001|Overall Study|Withdrawal by Subject|1|||
125199540|NCT00425061|450353009|FG000|Overall Study|Adverse Event|1|||
125199541|NCT00425061|450353010|FG001|Overall Study|Adverse Event|0|||
125199542|NCT00425061|450353011|FG002|Overall Study|Adverse Event|0|||
125199543|NCT00425061|450353012|FG003|Overall Study|Adverse Event|2|||
125199544|NCT00425061|450353013|FG004|Overall Study|Adverse Event|2|||
125199545|NCT00425061|450353014|FG005|Overall Study|Adverse Event|0|||
125199546|NCT00425061|450353015|FG006|Overall Study|Adverse Event|0|||
125199547|NCT00425061|450353009|FG000|Overall Study|Lost to Follow-up|0|||
125199548|NCT00425061|450353010|FG001|Overall Study|Lost to Follow-up|1|||
125199549|NCT00425061|450353011|FG002|Overall Study|Lost to Follow-up|0|||
125199550|NCT00425061|450353012|FG003|Overall Study|Lost to Follow-up|0|||
125199551|NCT00425061|450353013|FG004|Overall Study|Lost to Follow-up|0|||
125199552|NCT00425061|450353014|FG005|Overall Study|Lost to Follow-up|0|||
125199553|NCT00425061|450353015|FG006|Overall Study|Lost to Follow-up|0|||
125199554|NCT00425061|450353009|FG000|Overall Study|Protocol Violation|1|||
125199555|NCT00425061|450353010|FG001|Overall Study|Protocol Violation|0|||
125199556|NCT00425061|450353011|FG002|Overall Study|Protocol Violation|0|||
125199557|NCT00425061|450353012|FG003|Overall Study|Protocol Violation|0|||
125199558|NCT00425061|450353013|FG004|Overall Study|Protocol Violation|0|||
125199559|NCT00425061|450353014|FG005|Overall Study|Protocol Violation|0|||
125199560|NCT00425061|450353015|FG006|Overall Study|Protocol Violation|0|||
125199561|NCT00425061|450353009|FG000|Overall Study|Withdrawal by Subject|0|||
125199562|NCT00425061|450353010|FG001|Overall Study|Withdrawal by Subject|1|||
125199563|NCT00425061|450353011|FG002|Overall Study|Withdrawal by Subject|0|||
125199564|NCT00425061|450353012|FG003|Overall Study|Withdrawal by Subject|0|||
125199565|NCT00425061|450353013|FG004|Overall Study|Withdrawal by Subject|1|||
125199566|NCT00425061|450353014|FG005|Overall Study|Withdrawal by Subject|0|||
125199567|NCT00425061|450353015|FG006|Overall Study|Withdrawal by Subject|3|||
125199568|NCT00425061|450353009|FG000|Overall Study|Sponsor's request|0|||
125199569|NCT00425061|450353010|FG001|Overall Study|Sponsor's request|0|||
125199570|NCT00425061|450353011|FG002|Overall Study|Sponsor's request|0|||
125199571|NCT00425061|450353012|FG003|Overall Study|Sponsor's request|0|||
125199572|NCT00425061|450353013|FG004|Overall Study|Sponsor's request|19|||
125199573|NCT00425061|450353014|FG005|Overall Study|Sponsor's request|4|||
125199574|NCT00425061|450353015|FG006|Overall Study|Sponsor's request|15|||
125199575|NCT00425061|450353009|FG000|Overall Study|Physician Decision|0|||
125199576|NCT00425061|450353010|FG001|Overall Study|Physician Decision|0|||
125199577|NCT00425061|450353011|FG002|Overall Study|Physician Decision|0|||
125199578|NCT00425061|450353012|FG003|Overall Study|Physician Decision|0|||
125199579|NCT00425061|450353013|FG004|Overall Study|Physician Decision|1|||
125199580|NCT00425061|450353014|FG005|Overall Study|Physician Decision|0|||
125199581|NCT00425061|450353015|FG006|Overall Study|Physician Decision|0|||
125199582|NCT00425061|450353009|FG000|Overall Study|Other|0|||
125199583|NCT00425061|450353010|FG001|Overall Study|Other|0|||
125199584|NCT00425061|450353011|FG002|Overall Study|Other|0|||
125199585|NCT00425061|450353012|FG003|Overall Study|Other|0|||
125199586|NCT00425061|450353013|FG004|Overall Study|Other|3|||
125199587|NCT00425061|450353014|FG005|Overall Study|Other|0|||
125199588|NCT00425061|450353015|FG006|Overall Study|Other|1|||
125199589|NCT02137850|450353018|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
125199590|NCT02137850|450353019|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
125199591|NCT02137850|450353020|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
125199592|NCT02137850|450353018|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
125199593|NCT02137850|450353019|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
125199594|NCT02137850|450353020|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
125199595|NCT02137850|450353018|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
125199596|NCT02137850|450353019|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
125199597|NCT02137850|450353020|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
125199598|NCT02137850|450353018|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
125199599|NCT02137850|450353019|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
125199600|NCT02137850|450353020|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
125199601|NCT02137850|450353018|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
125199602|NCT02137850|450353019|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
125199603|NCT02137850|450353020|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
125199604|NCT02137850|450353018|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
125199605|NCT02137850|450353019|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
125199606|NCT02137850|450353020|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
125199607|NCT02137850|450353018|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
125199608|NCT02137850|450353019|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
125199609|NCT02137850|450353020|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
125199610|NCT02137850|450353018|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
125199611|NCT02137850|450353019|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
125199612|NCT02137850|450353020|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
125199613|NCT02137850|450353018|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
125199614|NCT02137850|450353019|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
125199615|NCT02137850|450353020|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
125199616|NCT02137850|450353018|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
125199617|NCT02137850|450353019|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
125199618|NCT02137850|450353020|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
125199619|NCT02137850|450353018|FG000|Main Phase: Prophylaxis|Other|0|||
125199620|NCT02137850|450353019|FG001|Main Phase: Prophylaxis|Other|1|||
125199621|NCT02137850|450353020|FG002|Main Phase: Prophylaxis|Other|0|||
125199622|NCT02137850|450353018|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
125199623|NCT02137850|450353019|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
125199624|NCT02137850|450353020|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
125199625|NCT02137850|450353018|FG000|Main Phase: Prophylaxis|Early site closure|0|||
125199626|NCT02137850|450353019|FG001|Main Phase: Prophylaxis|Early site closure|2|||
125199627|NCT02137850|450353020|FG002|Main Phase: Prophylaxis|Early site closure|0|||
125199628|NCT02137850|450353018|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
125199629|NCT02137850|450353019|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
125199630|NCT02137850|450353020|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
125199631|NCT02137850|450353018|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
125199632|NCT02137850|450353019|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
125199633|NCT02137850|450353020|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
125199634|NCT02137850|450353018|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
125199635|NCT02137850|450353019|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
125199636|NCT02137850|450353020|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
125199637|NCT02137850|450353018|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
125199638|NCT02137850|450353019|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
125199639|NCT02137850|450353020|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
125199640|NCT02137850|450353018|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
125199641|NCT02137850|450353019|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
125199642|NCT02137850|450353020|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
125199643|NCT02137850|450353018|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
125199644|NCT02137850|450353019|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
125199645|NCT02137850|450353020|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
125199646|NCT02137850|450353018|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
125199647|NCT02137850|450353019|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
125199648|NCT02137850|450353020|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
125199649|NCT02137850|450353018|FG000|Extension Phase: Prophylaxis|Other|0|||
125199650|NCT02137850|450353019|FG001|Extension Phase: Prophylaxis|Other|1|||
125199651|NCT02137850|450353020|FG002|Extension Phase: Prophylaxis|Other|0|||
125199652|NCT02137850|450353018|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
125199653|NCT02137850|450353019|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
125199654|NCT02137850|450353020|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
125199655|NCT02651155|450353021|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
125199656|NCT02651155|450353022|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
125199657|NCT02651155|450353021|FG000|Overall Study|Voluntary Withdrawal|5|||
125199658|NCT02651155|450353022|FG001|Overall Study|Voluntary Withdrawal|0|||
125199659|NCT04533412|450353023|FG000|Overall Study|Withdrawal by Subject|1|||
125199660|NCT04533412|450353024|FG001|Overall Study|Withdrawal by Subject|1|||
125199661|NCT04533412|450353023|FG000|Overall Study|Lost to Follow-up|1|||
125199662|NCT04533412|450353024|FG001|Overall Study|Lost to Follow-up|4|||
125199663|NCT00968981|450353030|FG000|Overall Study|Adverse Event|2|||
125199664|NCT00968981|450353031|FG001|Overall Study|Adverse Event|0|||
125199665|NCT00968981|450353032|FG002|Overall Study|Adverse Event|0|||
125199666|NCT00968981|450353030|FG000|Overall Study|Disease Progression|14|||
125199667|NCT00968981|450353031|FG001|Overall Study|Disease Progression|16|||
125199668|NCT00968981|450353032|FG002|Overall Study|Disease Progression|13|||
125199669|NCT00968981|450353030|FG000|Overall Study|Lost to Follow-up|0|||
125199670|NCT00968981|450353031|FG001|Overall Study|Lost to Follow-up|0|||
125199671|NCT00968981|450353032|FG002|Overall Study|Lost to Follow-up|1|||
125199672|NCT00968981|450353030|FG000|Overall Study|Physician Decision|5|||
125199673|NCT00968981|450353031|FG001|Overall Study|Physician Decision|3|||
125199674|NCT00968981|450353032|FG002|Overall Study|Physician Decision|5|||
125199675|NCT00968981|450353030|FG000|Overall Study|Withdrawal by Subject|1|||
125199676|NCT00968981|450353031|FG001|Overall Study|Withdrawal by Subject|3|||
125199677|NCT00968981|450353032|FG002|Overall Study|Withdrawal by Subject|3|||
125199678|NCT01489254|450353035|FG000|Double-blind Part|Adverse Event|7|||
125199679|NCT01489254|450353036|FG001|Double-blind Part|Adverse Event|2|||
125199680|NCT01489254|450353037|FG002|Double-blind Part|Adverse Event|2|||
125199681|NCT01489254|450353038|FG003|Double-blind Part|Adverse Event|0|||
125199682|NCT01489254|450353035|FG000|Double-blind Part|Pregnancy|1|||
125199683|NCT01489254|450353036|FG001|Double-blind Part|Pregnancy|3|||
125199684|NCT01489254|450353037|FG002|Double-blind Part|Pregnancy|0|||
125199685|NCT01489254|450353038|FG003|Double-blind Part|Pregnancy|0|||
125199686|NCT01489254|450353035|FG000|Double-blind Part|Withdrawal by Subject|12|||
125199687|NCT01489254|450353036|FG001|Double-blind Part|Withdrawal by Subject|20|||
125199688|NCT01489254|450353037|FG002|Double-blind Part|Withdrawal by Subject|1|||
125199689|NCT01489254|450353038|FG003|Double-blind Part|Withdrawal by Subject|0|||
125199690|NCT01489254|450353035|FG000|Double-blind Part|Lost to Follow-up|1|||
125199691|NCT01489254|450353036|FG001|Double-blind Part|Lost to Follow-up|2|||
125199692|NCT01489254|450353037|FG002|Double-blind Part|Lost to Follow-up|0|||
125199693|NCT01489254|450353038|FG003|Double-blind Part|Lost to Follow-up|0|||
125199694|NCT01489254|450353035|FG000|Double-blind Part|Other reasons for not completing study|4|||
125199695|NCT01489254|450353036|FG001|Double-blind Part|Other reasons for not completing study|6|||
125199696|NCT01489254|450353037|FG002|Double-blind Part|Other reasons for not completing study|0|||
125199697|NCT01489254|450353038|FG003|Double-blind Part|Other reasons for not completing study|0|||
125199698|NCT01489254|450353035|FG000|Open-label Extension Part|Adverse Event|0|||
125199699|NCT01489254|450353036|FG001|Open-label Extension Part|Adverse Event|0|||
125199700|NCT01489254|450353037|FG002|Open-label Extension Part|Adverse Event|0|||
125199701|NCT01489254|450353038|FG003|Open-label Extension Part|Adverse Event|10|||
125199702|NCT01489254|450353035|FG000|Open-label Extension Part|Pregnancy|0|||
125199703|NCT01489254|450353036|FG001|Open-label Extension Part|Pregnancy|0|||
125199704|NCT01489254|450353037|FG002|Open-label Extension Part|Pregnancy|0|||
125199705|NCT01489254|450353038|FG003|Open-label Extension Part|Pregnancy|3|||
125199706|NCT01489254|450353035|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
125088830|NCT00027846|449944481|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
125199707|NCT01489254|450353036|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
125199708|NCT01489254|450353037|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
125199709|NCT01489254|450353038|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
125199710|NCT01489254|450353035|FG000|Open-label Extension Part|Protocol Violation|0|||
125199711|NCT01489254|450353036|FG001|Open-label Extension Part|Protocol Violation|0|||
125199712|NCT01489254|450353037|FG002|Open-label Extension Part|Protocol Violation|0|||
125199713|NCT01489254|450353038|FG003|Open-label Extension Part|Protocol Violation|1|||
125199714|NCT01489254|450353035|FG000|Open-label Extension Part|Lost to Follow-up|0|||
125199715|NCT01489254|450353036|FG001|Open-label Extension Part|Lost to Follow-up|0|||
125199716|NCT01489254|450353037|FG002|Open-label Extension Part|Lost to Follow-up|0|||
125199717|NCT01489254|450353038|FG003|Open-label Extension Part|Lost to Follow-up|9|||
125199718|NCT01489254|450353035|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
125199719|NCT01489254|450353036|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
125199720|NCT01489254|450353037|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
125199721|NCT01489254|450353038|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
125199722|NCT01878084|450353040|FG000|Overall Study|Physician Decision|2|||
125199723|NCT00749684|450353041|FG000|Overall Study|Death|1|||
125199724|NCT00749684|450353041|FG000|Overall Study|Adverse Event|27|||
125199725|NCT00749684|450353041|FG000|Overall Study|Participant's Wish|10|||
125310284|NCT00466921|450762052|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
125310285|NCT00466921|450762052|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
125310286|NCT00466921|450762052|FG000|Follow up for a Minimum of 1 Year|Death|6|||
125310287|NCT02864901|450762053|FG000|Overall Study|Withdrawal by Subject|1|||
125310288|NCT02864901|450762054|FG001|Overall Study|Withdrawal by Subject|0|||
125310289|NCT01219985|450762055|FG000|Overall Study|Physician Decision|20|||
125310290|NCT04797780|450762056|FG000|Overall Study|Lost to Follow-up|1|||
125310291|NCT04797780|450762057|FG001|Overall Study|Lost to Follow-up|1|||
125310292|NCT04797780|450762056|FG000|Overall Study|Withdrawal by Subject|14|||
125310293|NCT04797780|450762057|FG001|Overall Study|Withdrawal by Subject|9|||
125310294|NCT04797780|450762056|FG000|Overall Study|Death|49|||
125310295|NCT04797780|450762057|FG001|Overall Study|Death|20|||
125310296|NCT04669301|450762058|FG000|Overall Study|Lost to Follow-up|0|||
125310297|NCT04669301|450762059|FG001|Overall Study|Lost to Follow-up|1|||
125310298|NCT04669301|450762060|FG002|Overall Study|Lost to Follow-up|0|||
125310299|NCT04669301|450762058|FG000|Overall Study|Withdrawal by Subject|3|||
125310300|NCT04669301|450762059|FG001|Overall Study|Withdrawal by Subject|2|||
125310301|NCT04669301|450762060|FG002|Overall Study|Withdrawal by Subject|0|||
125310302|NCT02863328|450762061|FG000|Overall Study|Lost to Follow-up|4|||
125310303|NCT02863328|450762062|FG001|Overall Study|Lost to Follow-up|10|||
125310304|NCT02863328|450762061|FG000|Overall Study|Withdrawal by Subject|7|||
125310305|NCT02863328|450762062|FG001|Overall Study|Withdrawal by Subject|12|||
125310306|NCT02863328|450762061|FG000|Overall Study|Died|0|||
125310307|NCT02863328|450762062|FG001|Overall Study|Died|1|||
125310308|NCT00398320|450762063|FG000|Overall Study|Death|1|||
125310309|NCT00398320|450762063|FG000|Overall Study|Adverse Event|4|||
125310310|NCT00398320|450762063|FG000|Overall Study|Physician Decision|1|||
125310311|NCT00163020|450762067|FG000|Overall Study|Lost to Follow-up|0|||
125310312|NCT00163020|450762068|FG001|Overall Study|Lost to Follow-up|2|||
125310313|NCT03553758|450763250|FG000|Overall Study|Lost to Follow-up|1|||
125310314|NCT00447226|450763252|FG000|12-Week Open-label Phase|Adverse Event|0|||
125310315|NCT00447226|450763253|FG001|12-Week Open-label Phase|Adverse Event|3|||
125310316|NCT00447226|450763252|FG000|12-Week Open-label Phase|Protocol Violation|0|||
125310317|NCT00447226|450763253|FG001|12-Week Open-label Phase|Protocol Violation|1|||
125310318|NCT00447226|450763252|FG000|12-Week Open-label Phase|Disease Progression|0|||
125310319|NCT00447226|450763253|FG001|12-Week Open-label Phase|Disease Progression|20|||
125310320|NCT00447226|450763252|FG000|12-Week Open-label Phase|Physician Decision|0|||
125310321|NCT00447226|450763253|FG001|12-Week Open-label Phase|Physician Decision|1|||
125310322|NCT00447226|450763252|FG000|Double-blind Phase|Disease Progression|4|||
125310323|NCT00447226|450763253|FG001|Double-blind Phase|Disease Progression|3|||
125310324|NCT01388907|450763267|FG000|Overall Study|Adverse Event|2|||
125310325|NCT01388907|450763268|FG001|Overall Study|Adverse Event|0|||
125310326|NCT03187132|450763269|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
125310327|NCT03187132|450763270|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
125310328|NCT03187132|450763269|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
124977585|NCT01077518|449545435|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
124977586|NCT01077518|449545433|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
124977587|NCT01077518|449545434|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
124977588|NCT01077518|449545435|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
124977589|NCT01495598|449545436|FG000|Overall Study|Death during follow up period|2|||
124977590|NCT01495598|449545436|FG000|Overall Study|Death on study|1|||
124977591|NCT01495598|449545436|FG000|Overall Study|Lost to Follow-up|3|||
125310329|NCT03187132|450763270|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
125310330|NCT03187132|450763269|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
125310331|NCT03187132|450763270|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
125310332|NCT03187132|450763269|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
124977592|NCT01495598|449545436|FG000|Overall Study|Physician Decision|8|||
125199726|NCT00749684|450353041|FG000|Overall Study|Not Documented|1|||
125199727|NCT00749684|450353041|FG000|Overall Study|Progressive Desease|31|||
125199728|NCT00749684|450353041|FG000|Overall Study|Therapy according to protocol + AE|2|||
125199729|NCT00749684|450353041|FG000|Overall Study|AE+discontinuation on participants wish|1|||
125199730|NCT00749684|450353041|FG000|Overall Study|Missing|9|||
125199731|NCT02892422|450353043|FG000|Overall Study|Enrolled not treated|4|||
125199732|NCT02892422|450353043|FG000|Overall Study|Adverse Event|38|||
125199733|NCT02892422|450353043|FG000|Overall Study|Lack of Efficacy|32|||
125199734|NCT02892422|450353043|FG000|Overall Study|Non-compliance with study drug|11|||
125199735|NCT02892422|450353043|FG000|Overall Study|Protocol Violation|4|||
125199736|NCT02892422|450353043|FG000|Overall Study|Withdrawal by Subject|56|||
125199737|NCT02892422|450353043|FG000|Overall Study|Lost to Follow-up|5|||
125199738|NCT02892422|450353043|FG000|Overall Study|sponsor information 16159A results|21|||
125199739|NCT02892422|450353043|FG000|Overall Study|withdrawal of consent|13|||
125199740|NCT02892422|450353043|FG000|Overall Study|exclusion criteria met|3|||
125199741|NCT02892422|450353043|FG000|Overall Study|moving elsewhere|4|||
125199742|NCT02892422|450353043|FG000|Overall Study|non-compliance|10|||
125199743|NCT02892422|450353043|FG000|Overall Study|patient legally incapable|1|||
125199744|NCT02892422|450353043|FG000|Overall Study|patient decision|7|||
125199745|NCT02892422|450353043|FG000|Overall Study|Investigator decision|1|||
125199746|NCT01023256|450353044|FG000|Overall Study|Protocol Violation|2|||
125199747|NCT01023256|450353045|FG001|Overall Study|Protocol Violation|3|||
125199748|NCT01023256|450353046|FG002|Overall Study|Protocol Violation|0|||
125199749|NCT01023256|450353047|FG003|Overall Study|Protocol Violation|0|||
125199750|NCT01023256|450353044|FG000|Overall Study|Randomized but not treated|1|||
125199751|NCT01023256|450353045|FG001|Overall Study|Randomized but not treated|0|||
125199752|NCT01023256|450353046|FG002|Overall Study|Randomized but not treated|1|||
125199753|NCT01023256|450353047|FG003|Overall Study|Randomized but not treated|0|||
125199754|NCT01023256|450353044|FG000|Overall Study|Other|1|||
125199755|NCT01023256|450353045|FG001|Overall Study|Other|0|||
125199756|NCT01023256|450353046|FG002|Overall Study|Other|0|||
125199757|NCT01023256|450353047|FG003|Overall Study|Other|2|||
125199758|NCT01023256|450353044|FG000|Overall Study|Adverse Event|0|||
125199759|NCT01023256|450353045|FG001|Overall Study|Adverse Event|0|||
125199760|NCT01023256|450353046|FG002|Overall Study|Adverse Event|0|||
125199761|NCT01023256|450353047|FG003|Overall Study|Adverse Event|1|||
125199762|NCT01023256|450353044|FG000|Overall Study|Withdrawal by Subject|0|||
125199763|NCT01023256|450353045|FG001|Overall Study|Withdrawal by Subject|0|||
125199764|NCT01023256|450353046|FG002|Overall Study|Withdrawal by Subject|0|||
125199765|NCT01023256|450353047|FG003|Overall Study|Withdrawal by Subject|2|||
125199766|NCT03155178|450353048|FG000|Overall Study|Did not meet treatment day baseline|7|||
125199767|NCT03155178|450353049|FG001|Overall Study|Did not meet treatment day baseline|7|||
125199768|NCT03155178|450353050|FG002|Overall Study|Did not meet treatment day baseline|7|||
125199769|NCT03155178|450353051|FG003|Overall Study|Did not meet treatment day baseline|7|||
125199770|NCT03089697|450353052|FG000|Overall Study|Adverse Event|1|||
125199771|NCT03089697|450353053|FG001|Overall Study|Adverse Event|2|||
125199772|NCT03089697|450353052|FG000|Overall Study|Withdrawal by Subject|1|||
125199773|NCT03089697|450353053|FG001|Overall Study|Withdrawal by Subject|0|||
125199774|NCT03613649|450353054|FG000|Second Treatment|Lost to Follow-up|0|||
125199775|NCT03613649|450353055|FG001|Second Treatment|Lost to Follow-up|0|||
125199776|NCT03613649|450353056|FG002|Second Treatment|Lost to Follow-up|1|||
125199777|NCT03613649|450353057|FG003|Second Treatment|Lost to Follow-up|0|||
125199778|NCT03613649|450353058|FG004|Second Treatment|Lost to Follow-up|0|||
125199779|NCT03613649|450353059|FG005|Second Treatment|Lost to Follow-up|0|||
125199780|NCT03613649|450353060|FG006|Second Treatment|Lost to Follow-up|0|||
125199781|NCT03613649|450353061|FG007|Second Treatment|Lost to Follow-up|0|||
125199782|NCT03613649|450353062|FG008|Second Treatment|Lost to Follow-up|0|||
125199783|NCT03613649|450353063|FG009|Second Treatment|Lost to Follow-up|0|||
125199784|NCT03613649|450353064|FG010|Second Treatment|Lost to Follow-up|0|||
125199785|NCT03613649|450353065|FG011|Second Treatment|Lost to Follow-up|0|||
124866773|NCT00127101|449133649|FG005|Base Protocol|Lack of Efficacy|0|||
124866774|NCT00127101|449133644|FG000|Base Protocol|Withdrawal by Subject|1|||
124866775|NCT00127101|449133645|FG001|Base Protocol|Withdrawal by Subject|2|||
124866776|NCT00127101|449133646|FG002|Base Protocol|Withdrawal by Subject|1|||
124866777|NCT00127101|449133647|FG003|Base Protocol|Withdrawal by Subject|0|||
124866778|NCT00127101|449133648|FG004|Base Protocol|Withdrawal by Subject|0|||
124866779|NCT00127101|449133649|FG005|Base Protocol|Withdrawal by Subject|1|||
124866780|NCT00127101|449133644|FG000|Continuation Phase|Adverse Event|0|||
124866781|NCT00127101|449133645|FG001|Continuation Phase|Adverse Event|0|||
124866782|NCT00127101|449133646|FG002|Continuation Phase|Adverse Event|0|||
124866783|NCT00127101|449133647|FG003|Continuation Phase|Adverse Event|0|||
124866784|NCT00127101|449133648|FG004|Continuation Phase|Adverse Event|1|||
124866785|NCT00127101|449133649|FG005|Continuation Phase|Adverse Event|1|||
124866786|NCT00127101|449133644|FG000|Continuation Phase|Lack of Efficacy|0|||
124866787|NCT00127101|449133645|FG001|Continuation Phase|Lack of Efficacy|0|||
124866788|NCT00127101|449133646|FG002|Continuation Phase|Lack of Efficacy|0|||
124866789|NCT00127101|449133647|FG003|Continuation Phase|Lack of Efficacy|0|||
124977593|NCT05511038|449545440|FG000|Overall|Withdrawal by Subject|5|||
124977594|NCT05511038|449545441|FG001|Overall|Withdrawal by Subject|3|||
124977595|NCT05511038|449545440|FG000|Overall|Screen Failure|20|||
124977596|NCT05511038|449545441|FG001|Overall|Screen Failure|1|||
124977597|NCT05511038|449545440|FG000|Overall|Physician Decision|3|||
124977598|NCT05511038|449545441|FG001|Overall|Physician Decision|0|||
124977599|NCT05511038|449545440|FG000|Overall|Lost to Follow-up|3|||
124977600|NCT05511038|449545441|FG001|Overall|Lost to Follow-up|0|||
124977601|NCT05511038|449545440|FG000|Overall|Death|1|||
125199786|NCT03613649|450353054|FG000|Second Treatment|Withdrawal by Subject|0|||
125199787|NCT03613649|450353055|FG001|Second Treatment|Withdrawal by Subject|0|||
125199788|NCT03613649|450353056|FG002|Second Treatment|Withdrawal by Subject|0|||
125199789|NCT03613649|450353057|FG003|Second Treatment|Withdrawal by Subject|0|||
125199790|NCT03613649|450353058|FG004|Second Treatment|Withdrawal by Subject|1|||
125199791|NCT03613649|450353059|FG005|Second Treatment|Withdrawal by Subject|0|||
125199792|NCT03613649|450353060|FG006|Second Treatment|Withdrawal by Subject|0|||
125199793|NCT03613649|450353061|FG007|Second Treatment|Withdrawal by Subject|0|||
125199794|NCT03613649|450353062|FG008|Second Treatment|Withdrawal by Subject|0|||
125199795|NCT03613649|450353063|FG009|Second Treatment|Withdrawal by Subject|0|||
125199796|NCT03613649|450353064|FG010|Second Treatment|Withdrawal by Subject|0|||
125199797|NCT03613649|450353065|FG011|Second Treatment|Withdrawal by Subject|0|||
125199798|NCT03613649|450353054|FG000|Third Treatment|Lost to Follow-up|0|||
125199799|NCT03613649|450353055|FG001|Third Treatment|Lost to Follow-up|0|||
125199800|NCT03613649|450353056|FG002|Third Treatment|Lost to Follow-up|0|||
125199801|NCT03613649|450353057|FG003|Third Treatment|Lost to Follow-up|0|||
125199802|NCT03613649|450353058|FG004|Third Treatment|Lost to Follow-up|1|||
125199803|NCT03613649|450353059|FG005|Third Treatment|Lost to Follow-up|0|||
125199804|NCT03613649|450353060|FG006|Third Treatment|Lost to Follow-up|0|||
125199805|NCT03613649|450353061|FG007|Third Treatment|Lost to Follow-up|0|||
125199806|NCT03613649|450353062|FG008|Third Treatment|Lost to Follow-up|0|||
125199807|NCT03613649|450353063|FG009|Third Treatment|Lost to Follow-up|0|||
125199808|NCT03613649|450353064|FG010|Third Treatment|Lost to Follow-up|0|||
125199809|NCT03613649|450353065|FG011|Third Treatment|Lost to Follow-up|1|||
125199810|NCT03613649|450353054|FG000|Third Treatment|Protocol Violation|0|||
125199811|NCT03613649|450353055|FG001|Third Treatment|Protocol Violation|0|||
125199812|NCT03613649|450353056|FG002|Third Treatment|Protocol Violation|0|||
125199813|NCT03613649|450353057|FG003|Third Treatment|Protocol Violation|0|||
125199814|NCT03613649|450353058|FG004|Third Treatment|Protocol Violation|0|||
125199815|NCT03613649|450353059|FG005|Third Treatment|Protocol Violation|0|||
125199816|NCT03613649|450353060|FG006|Third Treatment|Protocol Violation|1|||
125199817|NCT03613649|450353061|FG007|Third Treatment|Protocol Violation|0|||
125199818|NCT03613649|450353062|FG008|Third Treatment|Protocol Violation|0|||
125199819|NCT03613649|450353063|FG009|Third Treatment|Protocol Violation|0|||
125199820|NCT03613649|450353064|FG010|Third Treatment|Protocol Violation|0|||
125199821|NCT03613649|450353065|FG011|Third Treatment|Protocol Violation|1|||
125199822|NCT03613649|450353054|FG000|Fourth Treatment|Protocol Violation|1|||
125199823|NCT03613649|450353055|FG001|Fourth Treatment|Protocol Violation|0|||
125199824|NCT03613649|450353056|FG002|Fourth Treatment|Protocol Violation|0|||
125199825|NCT03613649|450353057|FG003|Fourth Treatment|Protocol Violation|0|||
125199826|NCT03613649|450353058|FG004|Fourth Treatment|Protocol Violation|1|||
125199827|NCT03613649|450353059|FG005|Fourth Treatment|Protocol Violation|0|||
125199828|NCT03613649|450353060|FG006|Fourth Treatment|Protocol Violation|0|||
125199829|NCT03613649|450353061|FG007|Fourth Treatment|Protocol Violation|0|||
125199830|NCT03613649|450353062|FG008|Fourth Treatment|Protocol Violation|0|||
125199831|NCT03613649|450353063|FG009|Fourth Treatment|Protocol Violation|0|||
125199832|NCT03613649|450353064|FG010|Fourth Treatment|Protocol Violation|0|||
125199833|NCT03613649|450353065|FG011|Fourth Treatment|Protocol Violation|0|||
125199834|NCT03613649|450353054|FG000|Fourth Treatment|Physician Decision|0|||
125199835|NCT03613649|450353055|FG001|Fourth Treatment|Physician Decision|0|||
125199836|NCT03613649|450353056|FG002|Fourth Treatment|Physician Decision|0|||
125199837|NCT03613649|450353057|FG003|Fourth Treatment|Physician Decision|0|||
125199838|NCT03613649|450353058|FG004|Fourth Treatment|Physician Decision|0|||
124977602|NCT05511038|449545441|FG001|Overall|Death|0|||
124977603|NCT05511038|449545440|FG000|Screening|Withdrawal by Subject|1|||
124977604|NCT05511038|449545441|FG001|Screening|Withdrawal by Subject|0|||
125199839|NCT03613649|450353059|FG005|Fourth Treatment|Physician Decision|0|||
125199840|NCT03613649|450353060|FG006|Fourth Treatment|Physician Decision|1|||
125199841|NCT03613649|450353061|FG007|Fourth Treatment|Physician Decision|0|||
125199842|NCT03613649|450353062|FG008|Fourth Treatment|Physician Decision|0|||
125199843|NCT03613649|450353063|FG009|Fourth Treatment|Physician Decision|0|||
125199844|NCT03613649|450353064|FG010|Fourth Treatment|Physician Decision|0|||
125199845|NCT03613649|450353065|FG011|Fourth Treatment|Physician Decision|0|||
125199846|NCT00675428|450353066|FG000|Overall Study|Disease Progression|2|||
125199847|NCT00675428|450353067|FG001|Overall Study|Disease Progression|2|||
124977605|NCT05511038|449545440|FG000|Screening|Lost to Follow Up (1 participant)|1|||
125199848|NCT00675428|450353066|FG000|Overall Study|No Disease Response After Cycle 6|0|||
125199849|NCT00675428|450353067|FG001|Overall Study|No Disease Response After Cycle 6|1|||
125199850|NCT00675428|450353066|FG000|Overall Study|Physician Decision|1|||
125199851|NCT00675428|450353067|FG001|Overall Study|Physician Decision|0|||
125199852|NCT00319592|450353068|FG000|Overall Study|Protocol Violation|1|||
125199853|NCT00319592|450353069|FG001|Overall Study|Protocol Violation|0|||
125199854|NCT00319592|450353068|FG000|Overall Study|Physician Decision|0|||
125199855|NCT00319592|450353069|FG001|Overall Study|Physician Decision|1|||
125199856|NCT01500187|450353072|FG000|Overall Study|Lost to Follow-up|6|||
125199857|NCT01500187|450353073|FG001|Overall Study|Lost to Follow-up|0|||
125199858|NCT02537431|450353074|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
125199859|NCT02727777|450353075|FG000|Overall Study|Screen Failure|2|||
125199860|NCT02727777|450353076|FG001|Overall Study|Screen Failure|0|||
125199861|NCT02727777|450353077|FG002|Overall Study|Screen Failure|0|||
125199862|NCT02727777|450353075|FG000|Overall Study|Progressive disease|2|||
125199863|NCT02727777|450353076|FG001|Overall Study|Progressive disease|0|||
125199864|NCT02727777|450353077|FG002|Overall Study|Progressive disease|0|||
125199865|NCT01340027|450353079|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
125199866|NCT01340027|450353080|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
125199867|NCT01340027|450353081|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
125199868|NCT01340027|450353082|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
125199869|NCT01340027|450353083|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
125199870|NCT01340027|450353084|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
125199871|NCT01340027|450353085|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
125199872|NCT01340027|450353086|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
125199873|NCT01340027|450353087|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
125199874|NCT01340027|450353088|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
125199875|NCT01340027|450353089|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
125199876|NCT01340027|450353090|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
125199877|NCT01340027|450353079|FG000|Overall Study|Adverse Event|0|||
125199878|NCT01340027|450353080|FG001|Overall Study|Adverse Event|1|||
125199879|NCT01340027|450353081|FG002|Overall Study|Adverse Event|2|||
125199880|NCT01340027|450353082|FG003|Overall Study|Adverse Event|0|||
125199881|NCT01340027|450353083|FG004|Overall Study|Adverse Event|1|||
125199882|NCT01340027|450353084|FG005|Overall Study|Adverse Event|2|||
125199883|NCT01340027|450353085|FG006|Overall Study|Adverse Event|2|||
125199884|NCT01340027|450353086|FG007|Overall Study|Adverse Event|1|||
125199885|NCT01340027|450353087|FG008|Overall Study|Adverse Event|4|||
125199886|NCT01340027|450353088|FG009|Overall Study|Adverse Event|1|||
125199887|NCT01340027|450353089|FG010|Overall Study|Adverse Event|1|||
125199888|NCT01340027|450353090|FG011|Overall Study|Adverse Event|3|||
125199889|NCT01340027|450353079|FG000|Overall Study|Lack of Efficacy|0|||
125199890|NCT01340027|450353080|FG001|Overall Study|Lack of Efficacy|0|||
125199891|NCT01340027|450353081|FG002|Overall Study|Lack of Efficacy|0|||
125199892|NCT01340027|450353082|FG003|Overall Study|Lack of Efficacy|0|||
125199893|NCT01340027|450353083|FG004|Overall Study|Lack of Efficacy|0|||
125199894|NCT01340027|450353084|FG005|Overall Study|Lack of Efficacy|0|||
125199895|NCT01340027|450353085|FG006|Overall Study|Lack of Efficacy|1|||
125199896|NCT01340027|450353086|FG007|Overall Study|Lack of Efficacy|1|||
125199897|NCT01340027|450353087|FG008|Overall Study|Lack of Efficacy|1|||
125199898|NCT01340027|450353088|FG009|Overall Study|Lack of Efficacy|0|||
125199899|NCT01340027|450353089|FG010|Overall Study|Lack of Efficacy|0|||
125199900|NCT01340027|450353090|FG011|Overall Study|Lack of Efficacy|0|||
125199901|NCT01340027|450353079|FG000|Overall Study|Lost to Follow-up|0|||
125199902|NCT01340027|450353080|FG001|Overall Study|Lost to Follow-up|1|||
125199903|NCT01340027|450353081|FG002|Overall Study|Lost to Follow-up|0|||
125199904|NCT01340027|450353082|FG003|Overall Study|Lost to Follow-up|0|||
125199905|NCT01340027|450353083|FG004|Overall Study|Lost to Follow-up|0|||
125199906|NCT01340027|450353084|FG005|Overall Study|Lost to Follow-up|0|||
125199907|NCT01340027|450353085|FG006|Overall Study|Lost to Follow-up|1|||
125199908|NCT01340027|450353086|FG007|Overall Study|Lost to Follow-up|0|||
125199909|NCT01340027|450353087|FG008|Overall Study|Lost to Follow-up|0|||
125199910|NCT01340027|450353088|FG009|Overall Study|Lost to Follow-up|1|||
125199911|NCT01340027|450353089|FG010|Overall Study|Lost to Follow-up|0|||
125199912|NCT01340027|450353090|FG011|Overall Study|Lost to Follow-up|0|||
125199913|NCT01340027|450353079|FG000|Overall Study|Protocol Violation|1|||
125199914|NCT01340027|450353080|FG001|Overall Study|Protocol Violation|2|||
125199915|NCT01340027|450353081|FG002|Overall Study|Protocol Violation|0|||
125199916|NCT01340027|450353082|FG003|Overall Study|Protocol Violation|0|||
125199917|NCT01340027|450353083|FG004|Overall Study|Protocol Violation|6|||
125199918|NCT01340027|450353084|FG005|Overall Study|Protocol Violation|0|||
125199919|NCT01340027|450353085|FG006|Overall Study|Protocol Violation|0|||
125199920|NCT01340027|450353086|FG007|Overall Study|Protocol Violation|1|||
125199921|NCT01340027|450353087|FG008|Overall Study|Protocol Violation|2|||
125199922|NCT01340027|450353088|FG009|Overall Study|Protocol Violation|2|||
125199923|NCT01340027|450353089|FG010|Overall Study|Protocol Violation|0|||
125199924|NCT01340027|450353090|FG011|Overall Study|Protocol Violation|0|||
125199925|NCT01340027|450353079|FG000|Overall Study|Withdrawal by Subject|4|||
125199926|NCT01340027|450353080|FG001|Overall Study|Withdrawal by Subject|3|||
125199927|NCT01340027|450353081|FG002|Overall Study|Withdrawal by Subject|1|||
125199928|NCT01340027|450353082|FG003|Overall Study|Withdrawal by Subject|3|||
125199929|NCT01340027|450353083|FG004|Overall Study|Withdrawal by Subject|3|||
125199930|NCT01340027|450353084|FG005|Overall Study|Withdrawal by Subject|2|||
125199931|NCT01340027|450353085|FG006|Overall Study|Withdrawal by Subject|3|||
125199932|NCT01340027|450353086|FG007|Overall Study|Withdrawal by Subject|4|||
125199933|NCT01340027|450353087|FG008|Overall Study|Withdrawal by Subject|1|||
125199934|NCT01340027|450353088|FG009|Overall Study|Withdrawal by Subject|2|||
125199935|NCT01340027|450353089|FG010|Overall Study|Withdrawal by Subject|0|||
125199936|NCT01340027|450353090|FG011|Overall Study|Withdrawal by Subject|1|||
125199937|NCT01340027|450353079|FG000|Overall Study|Miscellaneous|0|||
125199938|NCT01340027|450353080|FG001|Overall Study|Miscellaneous|0|||
125199939|NCT01340027|450353081|FG002|Overall Study|Miscellaneous|0|||
125199940|NCT01340027|450353082|FG003|Overall Study|Miscellaneous|1|||
125199941|NCT01340027|450353083|FG004|Overall Study|Miscellaneous|0|||
125199942|NCT01340027|450353084|FG005|Overall Study|Miscellaneous|0|||
125199943|NCT01340027|450353085|FG006|Overall Study|Miscellaneous|0|||
125199944|NCT01340027|450353086|FG007|Overall Study|Miscellaneous|0|||
125199945|NCT01340027|450353087|FG008|Overall Study|Miscellaneous|0|||
125199946|NCT01340027|450353088|FG009|Overall Study|Miscellaneous|0|||
125199947|NCT01340027|450353089|FG010|Overall Study|Miscellaneous|1|||
125199948|NCT01340027|450353090|FG011|Overall Study|Miscellaneous|0|||
125199949|NCT01758731|450353091|FG000|Overall Study|Physician Decision|1|||
125199950|NCT04687072|450353092|FG000|Overall Study|Adverse Event|2|||
125199951|NCT04687072|450353093|FG001|Overall Study|Adverse Event|0|||
125199952|NCT04687072|450353092|FG000|Overall Study|Death|1|||
125199953|NCT04687072|450353093|FG001|Overall Study|Death|0|||
125199954|NCT04687072|450353092|FG000|Overall Study|Lack of Efficacy|2|||
125199955|NCT04687072|450353093|FG001|Overall Study|Lack of Efficacy|1|||
125199956|NCT04687072|450353092|FG000|Overall Study|Physician Decision|1|||
125199957|NCT04687072|450353093|FG001|Overall Study|Physician Decision|0|||
125199958|NCT04687072|450353092|FG000|Overall Study|Pregnancy|1|||
125199959|NCT04687072|450353093|FG001|Overall Study|Pregnancy|0|||
125199960|NCT04687072|450353092|FG000|Overall Study|Requires Prohibited Medication|2|||
125199961|NCT04687072|450353093|FG001|Overall Study|Requires Prohibited Medication|0|||
125199962|NCT04687072|450353092|FG000|Overall Study|Withdrawal of Consent|11|||
125199963|NCT04687072|450353093|FG001|Overall Study|Withdrawal of Consent|6|||
125199964|NCT04687072|450353092|FG000|Overall Study|Miscellaneous|4|||
125199965|NCT04687072|450353093|FG001|Overall Study|Miscellaneous|1|||
125199966|NCT00915876|450353094|FG000|Overall Study|Adverse Event|0|||
125199967|NCT00915876|450353095|FG001|Overall Study|Adverse Event|1|||
125199968|NCT01300338|450354918|FG000|Overall Study|Lost to Follow-up|5|||
125199969|NCT01300338|450354919|FG001|Overall Study|Lost to Follow-up|0|||
125199970|NCT01895270|450354920|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
125199971|NCT01895270|450354921|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
125199972|NCT01895270|450354920|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
125199973|NCT01895270|450354921|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
125199974|NCT01895270|450354920|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
125199975|NCT01895270|450354921|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
125199976|NCT01895270|450354920|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
125199977|NCT01895270|450354921|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
125199978|NCT01895270|450354920|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
125199979|NCT01895270|450354921|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
125199980|NCT01895270|450354920|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
125199981|NCT01895270|450354921|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
125199982|NCT01895270|450354920|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
125199983|NCT01895270|450354921|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
125199984|NCT00976820|450354922|FG000|Overall Study|Lost to Follow-up|5|||
125199985|NCT00976820|450354923|FG001|Overall Study|Lost to Follow-up|16|||
125199986|NCT00976820|450354924|FG002|Overall Study|Lost to Follow-up|2|||
125199987|NCT00976820|450354925|FG003|Overall Study|Lost to Follow-up|3|||
125199988|NCT00976820|450354922|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
125199989|NCT00976820|450354923|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
125199990|NCT00976820|450354924|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
125199991|NCT00976820|450354925|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
125199992|NCT00976820|450354922|FG000|Overall Study|Withdrawal by Subject|2|||
124977606|NCT05511038|449545441|FG001|Screening|Lost to Follow Up (1 participant)|0|||
124977607|NCT05511038|449545440|FG000|Screening|Screen Failure|3|||
125199993|NCT00976820|450354923|FG001|Overall Study|Withdrawal by Subject|4|||
125199994|NCT00976820|450354924|FG002|Overall Study|Withdrawal by Subject|1|||
125199995|NCT00976820|450354925|FG003|Overall Study|Withdrawal by Subject|4|||
124977608|NCT05511038|449545441|FG001|Screening|Screen Failure|0|||
124977609|NCT05511038|449545440|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
125199996|NCT03261674|450354931|FG000|Overall Study|Lost to Follow-up|6|||
125199997|NCT03261674|450354932|FG001|Overall Study|Lost to Follow-up|7|||
125033578|NCT00408005|449743816|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
125199998|NCT03261674|450354931|FG000|Overall Study|Protocol Violation|1|||
125199999|NCT03261674|450354932|FG001|Overall Study|Protocol Violation|4|||
125200000|NCT03261674|450354931|FG000|Overall Study|Withdrawal by Subject|1|||
125200001|NCT03261674|450354932|FG001|Overall Study|Withdrawal by Subject|4|||
125200002|NCT03261674|450354931|FG000|Overall Study|Physician Decision|1|||
125200003|NCT03261674|450354932|FG001|Overall Study|Physician Decision|0|||
125200004|NCT00623935|450354935|FG000|Overall Study|Death|1|||
125200005|NCT00623935|450354935|FG000|Overall Study|Patient Declined Transplant|1|||
125200006|NCT00747474|450354940|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200007|NCT00747474|450354941|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200008|NCT00747474|450354942|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200009|NCT00747474|450354943|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200010|NCT00747474|450354944|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200011|NCT00747474|450354945|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200012|NCT00747474|450354946|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200013|NCT00747474|450354947|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
125200014|NCT00747474|450354948|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200015|NCT00747474|450354949|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200016|NCT00747474|450354950|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200017|NCT00747474|450354951|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200018|NCT04507256|450354952|FG000|Overall Study|Withdrawal by Subject|1|||
125200019|NCT04507256|450354953|FG001|Overall Study|Withdrawal by Subject|0|||
125200020|NCT04507256|450354954|FG002|Overall Study|Withdrawal by Subject|0|||
125200021|NCT04507256|450354955|FG003|Overall Study|Withdrawal by Subject|1|||
125200022|NCT04507256|450354956|FG004|Overall Study|Withdrawal by Subject|0|||
125200023|NCT04507256|450354957|FG005|Overall Study|Withdrawal by Subject|0|||
125200024|NCT00631410|450354958|FG000|Overall Study|Adverse Event|1|||
125200025|NCT00631410|450354959|FG001|Overall Study|Adverse Event|3|||
125200026|NCT00631410|450354958|FG000|Overall Study|Objective Progression or Relapse|4|||
125200027|NCT00631410|450354959|FG001|Overall Study|Objective Progression or Relapse|3|||
125200028|NCT00631410|450354958|FG000|Overall Study|Surgery|1|||
125200029|NCT00631410|450354959|FG001|Overall Study|Surgery|0|||
125200030|NCT00890084|450354960|FG000|Overall Study|Adverse Event|16|||
125200031|NCT00890084|450354960|FG000|Overall Study|Lost to Follow-up|126|||
125200032|NCT02980341|450354965|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
125200033|NCT02980341|450354966|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
125200034|NCT02980341|450354967|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
125200035|NCT02980341|450354968|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
125200036|NCT02980341|450354969|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
125200037|NCT02980341|450354970|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
125200038|NCT02980341|450354971|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
125200039|NCT02980341|450354972|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
125200040|NCT02980341|450354973|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
125200041|NCT02980341|450354974|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
125200042|NCT02980341|450354975|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
125200043|NCT02980341|450354965|FG000|Dose Escalation|Clinical progression|0|||
125200044|NCT02980341|450354966|FG001|Dose Escalation|Clinical progression|0|||
125200045|NCT02980341|450354967|FG002|Dose Escalation|Clinical progression|2|||
125200046|NCT02980341|450354968|FG003|Dose Escalation|Clinical progression|1|||
125310333|NCT03187132|450763270|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
125310334|NCT03187132|450763269|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
125310335|NCT03187132|450763270|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
125310336|NCT03187132|450763269|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
125310337|NCT03187132|450763270|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
125310338|NCT03187132|450763269|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
125310339|NCT03187132|450763270|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
125310340|NCT03187132|450763269|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
125310341|NCT03187132|450763270|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
125310342|NCT03187132|450763269|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
125310343|NCT03187132|450763270|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
125310344|NCT03187132|450763269|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
125310345|NCT03187132|450763270|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
125310346|NCT03187132|450763269|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
125310347|NCT03187132|450763270|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
125310348|NCT03594773|450763271|FG000|Overall Study|Withdrawal by Subject|3|||
125310349|NCT03594773|450763272|FG001|Overall Study|Withdrawal by Subject|2|||
125310350|NCT03594773|450763271|FG000|Overall Study|Lost to Follow-up|3|||
125310351|NCT03594773|450763272|FG001|Overall Study|Lost to Follow-up|4|||
125310352|NCT00991939|450763276|FG000|Overall Study|Lost to Follow-up|0|||
125310353|NCT00991939|450763277|FG001|Overall Study|Lost to Follow-up|1|||
125310354|NCT00991939|450763276|FG000|Overall Study|Withdrawal by Subject|1|||
125310355|NCT00991939|450763277|FG001|Overall Study|Withdrawal by Subject|0|||
125310356|NCT00991939|450763276|FG000|Overall Study|Entire study terminated|4|||
125310357|NCT00991939|450763277|FG001|Overall Study|Entire study terminated|1|||
125310358|NCT00714415|450763280|FG000|Overall Study|Lack of Efficacy|1|||
125310359|NCT00714415|450763281|FG001|Overall Study|Lack of Efficacy|0|||
125310360|NCT00714415|450763280|FG000|Overall Study|Death|1|||
125310361|NCT00714415|450763281|FG001|Overall Study|Death|0|||
125310362|NCT01461707|450763284|FG000|Overall Study|Withdrawal by Subject|1|||
125310363|NCT01461707|450763285|FG001|Overall Study|Withdrawal by Subject|0|||
125310364|NCT01100320|450763302|FG000|Period 1|Withdrawal by Subject|2|||
125310365|NCT01100320|450763303|FG001|Period 1|Withdrawal by Subject|4|||
125310366|NCT01100320|450763302|FG000|Period 1|Positive Drug Screen|1|||
125310367|NCT01100320|450763303|FG001|Period 1|Positive Drug Screen|1|||
125310368|NCT01100320|450763302|FG000|Period 1|Adverse Event|2|||
125310369|NCT01100320|450763303|FG001|Period 1|Adverse Event|2|||
125310370|NCT01100320|450763302|FG000|Period 2|Withdrawal by Subject|1|||
125310371|NCT01100320|450763303|FG001|Period 2|Withdrawal by Subject|1|||
125310372|NCT03797586|450763304|FG000|Overall Study|Lost to Follow-up|3|||
125310373|NCT03797586|450763305|FG001|Overall Study|Lost to Follow-up|6|||
125310374|NCT03797586|450763304|FG000|Overall Study|Death|1|||
125310375|NCT03797586|450763305|FG001|Overall Study|Death|1|||
125310376|NCT03797586|450763304|FG000|Overall Study|Adverse Event|0|||
125310377|NCT03797586|450763305|FG001|Overall Study|Adverse Event|2|||
125310378|NCT04980612|450763306|FG000|Overall Study|Withdrawal by Subject|7|||
125310379|NCT04980612|450763307|FG001|Overall Study|Withdrawal by Subject|5|||
125310380|NCT05730387|450763308|FG000|Overall Study|Stillbirth|0|||
125310381|NCT05730387|450763309|FG001|Overall Study|Stillbirth|262|||
125310382|NCT05730387|450763308|FG000|Overall Study|Died during or after delivery|2|||
125310383|NCT05730387|450763309|FG001|Overall Study|Died during or after delivery|85|||
125310384|NCT05730387|450763308|FG000|Overall Study|Died after being admitted|0|||
125310385|NCT05730387|450763309|FG001|Overall Study|Died after being admitted|44|||
125310386|NCT05730387|450763308|FG000|Overall Study|Lost to Follow-up|69|||
125310387|NCT05730387|450763309|FG001|Overall Study|Lost to Follow-up|77|||
125310388|NCT01369784|450763312|FG000|Overall Study|Protocol Violation|12|||
125310389|NCT02680665|450763313|FG000|Overall Study|No visit after the first prescription|5|||
125310390|NCT00596752|450763314|FG000|Overall Study|Other Reason|44|||
125310391|NCT00596752|450763315|FG001|Overall Study|Other Reason|49|||
125310392|NCT00596752|450763314|FG000|Overall Study|Adverse Event|34|||
125310393|NCT00596752|450763315|FG001|Overall Study|Adverse Event|34|||
124977610|NCT05511038|449545441|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
125310394|NCT00596752|450763314|FG000|Overall Study|Lost to Follow-up|22|||
125310395|NCT00596752|450763315|FG001|Overall Study|Lost to Follow-up|38|||
125310396|NCT00596752|450763314|FG000|Overall Study|Withdrawal by Subject|12|||
125310397|NCT00596752|450763315|FG001|Overall Study|Withdrawal by Subject|9|||
125310398|NCT00596752|450763314|FG000|Overall Study|Unsatisfactory Compliance|9|||
125310399|NCT00596752|450763315|FG001|Overall Study|Unsatisfactory Compliance|6|||
125310400|NCT00596752|450763314|FG000|Overall Study|Lack of Efficacy|4|||
125310401|NCT00596752|450763315|FG001|Overall Study|Lack of Efficacy|7|||
125310402|NCT00596752|450763314|FG000|Overall Study|Protocol Violation|1|||
125310403|NCT00596752|450763315|FG001|Overall Study|Protocol Violation|0|||
125310404|NCT05973006|450763316|FG000|Overall Study|Early termination|3|||
125310405|NCT05973006|450763317|FG001|Overall Study|Early termination|9|||
125310406|NCT04378270|450763319|FG000|Overall Study|Lack of Efficacy|1|||
125310407|NCT04378270|450763319|FG000|Overall Study|Withdrawal by Subject|1|||
125310408|NCT04378270|450763319|FG000|Overall Study|Screen Failure|1|||
125310409|NCT04378270|450763319|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
125310410|NCT01327599|450763320|FG000|Overall Study|Adverse Event|1|||
125310411|NCT01327599|450763320|FG000|Overall Study|Could Not Attend Visit|1|||
125310412|NCT01327599|450763320|FG000|Overall Study|Withdrawal of Consent|1|||
125310413|NCT04544956|450763323|FG000|Overall Study|Withdrawal by Subject|1|||
125310414|NCT00548145|450763326|FG000|Overall Study|Death|0|||
125310415|NCT00548145|450763327|FG001|Overall Study|Death|1|||
125310416|NCT00548145|450763326|FG000|Overall Study|Withdrawal by Subject|0|||
125310417|NCT00548145|450763327|FG001|Overall Study|Withdrawal by Subject|2|||
125310418|NCT00548145|450763326|FG000|Overall Study|Physician Decision|1|||
125310419|NCT00548145|450763327|FG001|Overall Study|Physician Decision|1|||
125310420|NCT02119663|450763328|FG000|Overall Study|Disease progression|26|||
125310421|NCT02119663|450763329|FG001|Overall Study|Disease progression|27|||
125310422|NCT02119663|450763328|FG000|Overall Study|Adverse Event|5|||
125310423|NCT02119663|450763329|FG001|Overall Study|Adverse Event|5|||
125310424|NCT02119663|450763328|FG000|Overall Study|Death|3|||
125310425|NCT02119663|450763329|FG001|Overall Study|Death|2|||
125310426|NCT02119663|450763328|FG000|Overall Study|Physician Decision|1|||
125310427|NCT02119663|450763329|FG001|Overall Study|Physician Decision|2|||
125310428|NCT02119663|450763328|FG000|Overall Study|Other unspecified|2|||
125310429|NCT02119663|450763329|FG001|Overall Study|Other unspecified|0|||
125310430|NCT02119663|450763328|FG000|Overall Study|Subject decision|0|||
125310431|NCT02119663|450763329|FG001|Overall Study|Subject decision|1|||
125310432|NCT02119663|450763328|FG000|Overall Study|Study Terminated by the Sponsor|3|||
125310433|NCT02119663|450763329|FG001|Overall Study|Study Terminated by the Sponsor|4|||
125310434|NCT00892775|450763330|FG000|Overall Study|Protocol Violation|1|||
125310435|NCT00892775|450763331|FG001|Overall Study|Protocol Violation|0|||
125310436|NCT00892775|450763330|FG000|Overall Study|Subject difficulties with blood drawing|1|||
125310437|NCT00892775|450763331|FG001|Overall Study|Subject difficulties with blood drawing|0|||
125310438|NCT00892775|450763330|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
125310439|NCT00892775|450763331|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
125310440|NCT00892775|450763330|FG000|Overall Study|Migrated/ moved from study area|1|||
125310441|NCT00892775|450763331|FG001|Overall Study|Migrated/ moved from study area|0|||
125310442|NCT00892775|450763330|FG000|Overall Study|Withdrawal by Subject|0|||
125310443|NCT00892775|450763331|FG001|Overall Study|Withdrawal by Subject|1|||
125310444|NCT00892775|450763330|FG000|Overall Study|Lost to Follow-up|1|||
125310445|NCT00892775|450763331|FG001|Overall Study|Lost to Follow-up|0|||
125310446|NCT00699660|450763332|FG000|Overall Study|Lost to Follow-up|4|||
125310447|NCT00699660|450763333|FG001|Overall Study|Lost to Follow-up|2|||
125310448|NCT00699660|450763332|FG000|Overall Study|missing reports and recording failures|10|||
125310449|NCT00699660|450763333|FG001|Overall Study|missing reports and recording failures|6|||
125310450|NCT00064792|450763334|FG000|Overall Study|Withdrawal by Subject|2|||
125310451|NCT00064792|450763335|FG001|Overall Study|Withdrawal by Subject|0|||
125310452|NCT00064792|450763334|FG000|Overall Study|Adverse Event|3|||
125310453|NCT00064792|450763335|FG001|Overall Study|Adverse Event|0|||
125310454|NCT03301350|450763336|FG000|Overall Study|Withdrawal by Subject|4|||
125310455|NCT03301350|450763336|FG000|Overall Study|Adverse Event|1|||
125310456|NCT03301350|450763336|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
125310457|NCT03301350|450763336|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
125310458|NCT03301350|450763336|FG000|Overall Study|no detail provided|1|||
125310459|NCT01248949|450763339|FG000|Overall Study|Lost to Follow-up|2|||
125310460|NCT01248949|450763340|FG001|Overall Study|Lost to Follow-up|2|||
125310461|NCT01248949|450763341|FG002|Overall Study|Lost to Follow-up|2|||
125310462|NCT01248949|450763342|FG003|Overall Study|Lost to Follow-up|1|||
125310463|NCT01248949|450763343|FG004|Overall Study|Lost to Follow-up|0|||
125310464|NCT01248949|450763339|FG000|Overall Study|Withdrawal by Subject|5|||
125310465|NCT01248949|450763340|FG001|Overall Study|Withdrawal by Subject|3|||
125310466|NCT01248949|450763341|FG002|Overall Study|Withdrawal by Subject|11|||
125310467|NCT01248949|450763342|FG003|Overall Study|Withdrawal by Subject|3|||
125310468|NCT01248949|450763343|FG004|Overall Study|Withdrawal by Subject|1|||
125310469|NCT01248949|450763339|FG000|Overall Study|Death|22|||
125310470|NCT01248949|450763340|FG001|Overall Study|Death|7|||
125310471|NCT01248949|450763341|FG002|Overall Study|Death|21|||
125310472|NCT01248949|450763342|FG003|Overall Study|Death|6|||
125310473|NCT01248949|450763343|FG004|Overall Study|Death|2|||
125310474|NCT01248949|450763339|FG000|Overall Study|Alternative Therapy|1|||
125310475|NCT01248949|450763340|FG001|Overall Study|Alternative Therapy|0|||
125310476|NCT01248949|450763341|FG002|Overall Study|Alternative Therapy|0|||
125310477|NCT01248949|450763342|FG003|Overall Study|Alternative Therapy|0|||
125310478|NCT01248949|450763343|FG004|Overall Study|Alternative Therapy|0|||
125310479|NCT01248949|450763339|FG000|Overall Study|Alternative Therapy.|1|||
125310480|NCT01248949|450763340|FG001|Overall Study|Alternative Therapy.|0|||
125310481|NCT01248949|450763341|FG002|Overall Study|Alternative Therapy.|0|||
125310482|NCT01248949|450763342|FG003|Overall Study|Alternative Therapy.|0|||
125310483|NCT01248949|450763343|FG004|Overall Study|Alternative Therapy.|0|||
125310484|NCT01248949|450763339|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
125310485|NCT01248949|450763340|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
125310486|NCT01248949|450763341|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
125310487|NCT01248949|450763342|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
125310488|NCT01248949|450763343|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
125310489|NCT01248949|450763339|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
125310490|NCT01248949|450763340|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
125310491|NCT01248949|450763341|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
125310492|NCT01248949|450763342|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
125310493|NCT01248949|450763343|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
125310494|NCT01248949|450763339|FG000|Overall Study|Participant Went To Hospice|0|||
125310495|NCT01248949|450763340|FG001|Overall Study|Participant Went To Hospice|0|||
125310496|NCT01248949|450763341|FG002|Overall Study|Participant Went To Hospice|1|||
125310497|NCT01248949|450763342|FG003|Overall Study|Participant Went To Hospice|0|||
125310498|NCT01248949|450763343|FG004|Overall Study|Participant Went To Hospice|0|||
125310499|NCT01248949|450763339|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
125310500|NCT01248949|450763340|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
124866790|NCT00127101|449133648|FG004|Continuation Phase|Lack of Efficacy|0|||
125310501|NCT01248949|450763341|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
125310502|NCT01248949|450763342|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
125310503|NCT01248949|450763343|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
125310504|NCT01248949|450763339|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
125310505|NCT01248949|450763340|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
125310506|NCT01248949|450763341|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
125310507|NCT01248949|450763342|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
125310508|NCT01248949|450763343|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
125310509|NCT01248949|450763339|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
125310510|NCT01248949|450763340|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
125310511|NCT01248949|450763341|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
125310512|NCT01248949|450763342|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
125310513|NCT01248949|450763343|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
125310514|NCT01248949|450763339|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
125310515|NCT01248949|450763340|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
125310516|NCT01248949|450763341|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
125310517|NCT01248949|450763342|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
125310518|NCT01248949|450763343|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
125310519|NCT03915470|450763346|FG000|Overall Study|Death|3|||
125310520|NCT03915470|450763347|FG001|Overall Study|Death|1|||
125310521|NCT03915470|450763346|FG000|Overall Study|Adverse Event|1|||
125310522|NCT03915470|450763347|FG001|Overall Study|Adverse Event|0|||
125310523|NCT03915470|450763346|FG000|Overall Study|Physician Decision|1|||
125310524|NCT03915470|450763347|FG001|Overall Study|Physician Decision|0|||
125310525|NCT03915470|450763346|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
125310526|NCT03915470|450763347|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
125310527|NCT03245775|450763350|FG000|Overall Study|Lost to Follow-up|25|||
125310528|NCT03245775|450763351|FG001|Overall Study|Lost to Follow-up|26|||
125310529|NCT03245775|450763352|FG002|Overall Study|Lost to Follow-up|16|||
125310530|NCT03245775|450763353|FG003|Overall Study|Lost to Follow-up|16|||
125310531|NCT02713828|450763354|FG000|Overall Study|Death|2|||
125310532|NCT02713828|450763355|FG001|Overall Study|Death|0|||
125310533|NCT02713828|450763354|FG000|Overall Study|Withdrawal by Subject|1|||
125310534|NCT02713828|450763355|FG001|Overall Study|Withdrawal by Subject|0|||
125310535|NCT02713828|450763354|FG000|Overall Study|study terminated but patient allowed to|2|||
125310536|NCT02713828|450763355|FG001|Overall Study|study terminated but patient allowed to|0|||
125310537|NCT00434109|450763356|FG000|Overall Study|Physician Decision|9|||
125310538|NCT00434109|450763356|FG000|Overall Study|Adverse Event|5|||
125310539|NCT00434109|450763356|FG000|Overall Study|Protocol Violation|1|||
125310540|NCT00434109|450763356|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
125310541|NCT02978833|450763359|FG000|Overall Study|Study terminated|1|||
125310542|NCT02978833|450763360|FG001|Overall Study|Study terminated|1|||
125310543|NCT00103740|450763361|FG000|Period 1 - Core|Adverse Event|1|||
125310544|NCT00103740|450763362|FG001|Period 1 - Core|Adverse Event|0|||
125310545|NCT00103740|450763361|FG000|Period 1 - Core|Protocol Violation|3|||
125310546|NCT00103740|450763362|FG001|Period 1 - Core|Protocol Violation|2|||
125310547|NCT00103740|450763361|FG000|Period 1 - Core|Patient withdrew consent|3|||
125310548|NCT00103740|450763362|FG001|Period 1 - Core|Patient withdrew consent|2|||
125310549|NCT00103740|450763361|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
125310550|NCT00103740|450763362|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
125310551|NCT00103740|450763361|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
125310552|NCT00103740|450763362|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
125310553|NCT00103740|450763361|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
125310554|NCT00103740|450763362|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
125310555|NCT00103740|450763361|FG000|Period 2 - Extended Observation Period|Death|6|||
125310556|NCT00103740|450763362|FG001|Period 2 - Extended Observation Period|Death|2|||
125310557|NCT00103740|450763361|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
125310558|NCT00103740|450763362|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
125310559|NCT00291486|450763367|FG000|Overall Study|Adverse Event|0|||
125310560|NCT00291486|450763368|FG001|Overall Study|Adverse Event|3|||
125310561|NCT00291486|450763369|FG002|Overall Study|Adverse Event|0|||
125310562|NCT00291486|450763370|FG003|Overall Study|Adverse Event|1|||
125310563|NCT00291486|450763371|FG004|Overall Study|Adverse Event|0|||
125310564|NCT00291486|450763367|FG000|Overall Study|Withdrawal by Subject|0|||
125310565|NCT00291486|450763368|FG001|Overall Study|Withdrawal by Subject|0|||
125310566|NCT00291486|450763369|FG002|Overall Study|Withdrawal by Subject|0|||
125310567|NCT00291486|450763370|FG003|Overall Study|Withdrawal by Subject|0|||
125310568|NCT00291486|450763371|FG004|Overall Study|Withdrawal by Subject|1|||
125310569|NCT00291486|450763367|FG000|Overall Study|Disease progression|1|||
125310570|NCT00291486|450763368|FG001|Overall Study|Disease progression|0|||
125310571|NCT00291486|450763369|FG002|Overall Study|Disease progression|1|||
125310572|NCT00291486|450763370|FG003|Overall Study|Disease progression|0|||
125310573|NCT00291486|450763371|FG004|Overall Study|Disease progression|0|||
125310574|NCT01099397|450763372|FG000|Overall Study|Lost to Follow-up|4|||
125310575|NCT01099397|450763372|FG000|Overall Study|Protocol Violation|4|||
125310576|NCT01099397|450763372|FG000|Overall Study|Withdrawal by Subject|5|||
125310577|NCT01900652|450763375|FG000|Overall Study|Progressive Disease|1|||
125310578|NCT01900652|450763376|FG001|Overall Study|Progressive Disease|0|||
125310579|NCT01900652|450763375|FG000|Overall Study|Consent withdrawn by subject|1|||
125310580|NCT01900652|450763376|FG001|Overall Study|Consent withdrawn by subject|1|||
125310581|NCT01900652|450763375|FG000|Overall Study|Death|3|||
125310582|NCT01900652|450763376|FG001|Overall Study|Death|0|||
125310583|NCT01900652|450763375|FG000|Overall Study|Adverse Event|2|||
125310584|NCT01900652|450763376|FG001|Overall Study|Adverse Event|1|||
125310585|NCT01900652|450763375|FG000|Overall Study|Physician Decision|1|||
125310586|NCT01900652|450763376|FG001|Overall Study|Physician Decision|1|||
125310587|NCT02663622|450763379|FG000|Overall Study|Death|3|||
125310588|NCT02663622|450763380|FG001|Overall Study|Death|1|||
125310589|NCT02663622|450763381|FG002|Overall Study|Death|1|||
125310590|NCT02663622|450763382|FG003|Overall Study|Death|8|||
125310591|NCT02663622|450763379|FG000|Overall Study|Protocol Violation|0|||
125310592|NCT02663622|450763380|FG001|Overall Study|Protocol Violation|0|||
125310593|NCT02663622|450763381|FG002|Overall Study|Protocol Violation|0|||
125310594|NCT02663622|450763382|FG003|Overall Study|Protocol Violation|1|||
125310595|NCT01792115|450763383|FG000|Overall Study|Lost to Follow-up|0|||
125310596|NCT01792115|450763384|FG001|Overall Study|Lost to Follow-up|1|||
125310597|NCT01792115|450763385|FG002|Overall Study|Lost to Follow-up|0|||
125310598|NCT00900029|450763386|FG000|Overall Study|Lost to Follow-up|0|||
125310599|NCT00900029|450763387|FG001|Overall Study|Lost to Follow-up|2|||
125310600|NCT00900029|450763388|FG002|Overall Study|Lost to Follow-up|1|||
125310601|NCT00900029|450763389|FG003|Overall Study|Lost to Follow-up|4|||
125310602|NCT00900029|450763390|FG004|Overall Study|Lost to Follow-up|4|||
125310603|NCT00900029|450763386|FG000|Overall Study|Withdrawal by Subject|2|||
125310604|NCT00900029|450763387|FG001|Overall Study|Withdrawal by Subject|2|||
125310605|NCT00900029|450763388|FG002|Overall Study|Withdrawal by Subject|1|||
125310606|NCT00900029|450763389|FG003|Overall Study|Withdrawal by Subject|1|||
125310607|NCT00900029|450763390|FG004|Overall Study|Withdrawal by Subject|1|||
125310608|NCT00900029|450763386|FG000|Overall Study|Adverse Event|0|||
125310609|NCT00900029|450763387|FG001|Overall Study|Adverse Event|0|||
125310610|NCT00900029|450763388|FG002|Overall Study|Adverse Event|1|||
125310611|NCT00900029|450763389|FG003|Overall Study|Adverse Event|1|||
125310612|NCT00900029|450763390|FG004|Overall Study|Adverse Event|1|||
125310613|NCT00900029|450763386|FG000|Overall Study|Death|1|||
125310614|NCT00900029|450763387|FG001|Overall Study|Death|0|||
125310615|NCT00900029|450763388|FG002|Overall Study|Death|0|||
125310616|NCT00900029|450763389|FG003|Overall Study|Death|1|||
125310617|NCT00900029|450763390|FG004|Overall Study|Death|0|||
124969462|NCT01439867|449517399|FG001|Overall Study|Non-compliance|1|||
125310618|NCT01594931|450766468|FG000|Overall Study|Adverse Event|3|||
125310619|NCT01594931|450766469|FG001|Overall Study|Adverse Event|1|||
125310620|NCT01594931|450766470|FG002|Overall Study|Adverse Event|1|||
125310621|NCT01594931|450766468|FG000|Overall Study|Withdrawal by Subject|2|||
125310622|NCT01594931|450766469|FG001|Overall Study|Withdrawal by Subject|1|||
125310623|NCT01594931|450766470|FG002|Overall Study|Withdrawal by Subject|1|||
125310624|NCT01594931|450766468|FG000|Overall Study|Lack of Efficacy|7|||
125310625|NCT01594931|450766469|FG001|Overall Study|Lack of Efficacy|2|||
125310626|NCT01594931|450766470|FG002|Overall Study|Lack of Efficacy|2|||
125310627|NCT01594931|450766468|FG000|Overall Study|Lost to Follow-up|4|||
125310628|NCT01594931|450766469|FG001|Overall Study|Lost to Follow-up|3|||
125310629|NCT01594931|450766470|FG002|Overall Study|Lost to Follow-up|3|||
125310630|NCT01594931|450766468|FG000|Overall Study|Protocol Violation|2|||
125310631|NCT01594931|450766469|FG001|Overall Study|Protocol Violation|1|||
125310632|NCT01594931|450766470|FG002|Overall Study|Protocol Violation|0|||
125310633|NCT01594931|450766468|FG000|Overall Study|No defiined|11|||
125310634|NCT01594931|450766469|FG001|Overall Study|No defiined|4|||
125310635|NCT01594931|450766470|FG002|Overall Study|No defiined|7|||
125310636|NCT02936635|450766479|FG000|Overall Study|Adverse Event|43|||
125310637|NCT02936635|450766480|FG001|Overall Study|Adverse Event|25|||
125310638|NCT02936635|450766479|FG000|Overall Study|Progressive Disease|10|||
125310639|NCT02936635|450766480|FG001|Overall Study|Progressive Disease|18|||
125310640|NCT02936635|450766479|FG000|Overall Study|Sponsor Discretion|10|||
125310641|NCT02936635|450766480|FG001|Overall Study|Sponsor Discretion|16|||
125310642|NCT02936635|450766479|FG000|Overall Study|Death|9|||
125310643|NCT02936635|450766480|FG001|Overall Study|Death|15|||
125310644|NCT02936635|450766479|FG000|Overall Study|Withdrawal by Subject|8|||
125310645|NCT02936635|450766480|FG001|Overall Study|Withdrawal by Subject|15|||
125310646|NCT02936635|450766479|FG000|Overall Study|Physician Decision|2|||
125310647|NCT02936635|450766480|FG001|Overall Study|Physician Decision|9|||
125310648|NCT02936635|450766479|FG000|Overall Study|Lost to Follow-up|1|||
125310649|NCT02936635|450766480|FG001|Overall Study|Lost to Follow-up|2|||
125310650|NCT02936635|450766479|FG000|Overall Study|Protocol Violation|1|||
125310651|NCT02936635|450766480|FG001|Overall Study|Protocol Violation|0|||
125310652|NCT02936635|450766479|FG000|Overall Study|Lack of effect/Entry into other study|31|||
125310653|NCT02936635|450766480|FG001|Overall Study|Lack of effect/Entry into other study|65|||
125310654|NCT01633788|450766481|FG000|Overall Study|Adverse Event|1|||
125310655|NCT01633788|450766482|FG001|Overall Study|Adverse Event|3|||
125310656|NCT01633788|450766483|FG002|Overall Study|Adverse Event|3|||
125310657|NCT01633788|450766484|FG003|Overall Study|Adverse Event|3|||
125310658|NCT01633788|450766481|FG000|Overall Study|Lost to Follow-up|2|||
125310659|NCT01633788|450766482|FG001|Overall Study|Lost to Follow-up|2|||
125310660|NCT01633788|450766483|FG002|Overall Study|Lost to Follow-up|2|||
125310661|NCT01633788|450766484|FG003|Overall Study|Lost to Follow-up|0|||
125310662|NCT01633788|450766481|FG000|Overall Study|Personal Reasons|3|||
125310663|NCT01633788|450766482|FG001|Overall Study|Personal Reasons|1|||
125310664|NCT01633788|450766483|FG002|Overall Study|Personal Reasons|1|||
125310665|NCT01633788|450766484|FG003|Overall Study|Personal Reasons|3|||
125310666|NCT01633788|450766481|FG000|Overall Study|Protocol Violation|1|||
125310667|NCT01633788|450766482|FG001|Overall Study|Protocol Violation|0|||
125310668|NCT01633788|450766483|FG002|Overall Study|Protocol Violation|1|||
125310669|NCT01633788|450766484|FG003|Overall Study|Protocol Violation|0|||
125310670|NCT01633788|450766481|FG000|Overall Study|Other Reasons|0|||
125310671|NCT01633788|450766482|FG001|Overall Study|Other Reasons|2|||
125310672|NCT01633788|450766483|FG002|Overall Study|Other Reasons|3|||
125310673|NCT01633788|450766484|FG003|Overall Study|Other Reasons|7|||
125310674|NCT01929226|450766485|FG000|Overall Study|Lost to Follow-up|4|||
125310675|NCT01929226|450766486|FG001|Overall Study|Lost to Follow-up|0|||
125310676|NCT01929226|450766485|FG000|Overall Study|Withdrawal by Subject|1|||
125310677|NCT01929226|450766486|FG001|Overall Study|Withdrawal by Subject|1|||
125310678|NCT01473732|450766488|FG000|Overall Study|Adverse Event|1|||
125310679|NCT01473732|450766489|FG001|Overall Study|Adverse Event|0|||
125310680|NCT01473732|450766488|FG000|Overall Study|Death|1|||
125310681|NCT01473732|450766489|FG001|Overall Study|Death|0|||
125310682|NCT01217944|450766496|FG000|Overall Study|Protocol Violation|1|||
125310683|NCT01217944|450766497|FG001|Overall Study|Protocol Violation|1|||
125310684|NCT01217944|450766498|FG002|Overall Study|Protocol Violation|0|||
125310685|NCT01217944|450766496|FG000|Overall Study|Lost to Follow-up|3|||
125310686|NCT01217944|450766497|FG001|Overall Study|Lost to Follow-up|1|||
125310687|NCT01217944|450766498|FG002|Overall Study|Lost to Follow-up|0|||
125310688|NCT01217944|450766496|FG000|Overall Study|Withdrawal by Subject|1|||
125310689|NCT01217944|450766497|FG001|Overall Study|Withdrawal by Subject|2|||
125310690|NCT01217944|450766498|FG002|Overall Study|Withdrawal by Subject|0|||
125310691|NCT01217944|450766496|FG000|Overall Study|Lack of Efficacy|1|||
125310692|NCT01217944|450766497|FG001|Overall Study|Lack of Efficacy|0|||
125310693|NCT01217944|450766498|FG002|Overall Study|Lack of Efficacy|0|||
125310694|NCT03579940|450766499|FG000|Period 2|Withdrawal by Subject|0|||
125310695|NCT03579940|450766500|FG001|Period 2|Withdrawal by Subject|0|||
125310696|NCT03579940|450766501|FG002|Period 2|Withdrawal by Subject|1|||
125310697|NCT03579940|450766502|FG003|Period 2|Withdrawal by Subject|0|||
125310698|NCT03579940|450766503|FG004|Period 2|Withdrawal by Subject|0|||
125310699|NCT03579940|450766504|FG005|Period 2|Withdrawal by Subject|0|||
125310700|NCT03579940|450766505|FG006|Period 2|Withdrawal by Subject|0|||
125310701|NCT03579940|450766506|FG007|Period 2|Withdrawal by Subject|0|||
125310702|NCT03579940|450766507|FG008|Period 2|Withdrawal by Subject|0|||
125310703|NCT03579940|450766508|FG009|Period 2|Withdrawal by Subject|0|||
125310704|NCT03579940|450766509|FG010|Period 2|Withdrawal by Subject|0|||
125310705|NCT00671034|450766510|FG000|Overall Study|Adverse Event|5|||
125310706|NCT00671034|450766511|FG001|Overall Study|Adverse Event|7|||
125310707|NCT00671034|450766512|FG002|Overall Study|Adverse Event|1|||
125310708|NCT00671034|450766510|FG000|Overall Study|Death|3|||
125310709|NCT00671034|450766511|FG001|Overall Study|Death|2|||
125310710|NCT00671034|450766512|FG002|Overall Study|Death|1|||
125310711|NCT00671034|450766510|FG000|Overall Study|Physician Decision|12|||
125310712|NCT00671034|450766511|FG001|Overall Study|Physician Decision|4|||
125310713|NCT00671034|450766512|FG002|Overall Study|Physician Decision|5|||
125310714|NCT00671034|450766510|FG000|Overall Study|VHR ALL feature|8|||
125310715|NCT00671034|450766511|FG001|Overall Study|VHR ALL feature|3|||
125310716|NCT00671034|450766512|FG002|Overall Study|VHR ALL feature|5|||
125310717|NCT00671034|450766510|FG000|Overall Study|Refusal|5|||
125310718|NCT00671034|450766511|FG001|Overall Study|Refusal|3|||
125310719|NCT00671034|450766512|FG002|Overall Study|Refusal|5|||
125310720|NCT00671034|450766510|FG000|Overall Study|includes Alternative therapy, etc.|6|||
125310721|NCT00671034|450766511|FG001|Overall Study|includes Alternative therapy, etc.|1|||
125310722|NCT00671034|450766512|FG002|Overall Study|includes Alternative therapy, etc.|7|||
125310723|NCT01751984|450766513|FG000|Overall Study|Adverse Event|5|||
125310724|NCT01751984|450766514|FG001|Overall Study|Adverse Event|3|||
125310725|NCT01751984|450766513|FG000|Overall Study|Withdrawal by Subject|0|||
125310726|NCT01751984|450766514|FG001|Overall Study|Withdrawal by Subject|1|||
125310727|NCT01751984|450766513|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
125310728|NCT01751984|450766514|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
125310729|NCT01797263|450766515|FG000|Overall Study|Withdrawal by Subject|21|||
125310730|NCT01797263|450766516|FG001|Overall Study|Withdrawal by Subject|25|||
125310731|NCT01797263|450766515|FG000|Overall Study|Death|1|||
125310732|NCT01797263|450766516|FG001|Overall Study|Death|0|||
125310733|NCT01797263|450766515|FG000|Overall Study|Lost to Follow-up|15|||
125310734|NCT01797263|450766516|FG001|Overall Study|Lost to Follow-up|15|||
125310735|NCT02045095|450766517|FG000|Overall Study|Other|0|||
125310736|NCT02045095|450766518|FG001|Overall Study|Other|0|||
125310737|NCT02045095|450766519|FG002|Overall Study|Other|1|||
125310738|NCT02045095|450766520|FG003|Overall Study|Other|0|||
125310739|NCT02045095|450766521|FG004|Overall Study|Other|0|||
125310740|NCT02045095|450766522|FG005|Overall Study|Other|2|||
125310741|NCT02045095|450766523|FG006|Overall Study|Other|0|||
125310742|NCT02045095|450766517|FG000|Overall Study|Progressive Disease|3|||
125310743|NCT02045095|450766518|FG001|Overall Study|Progressive Disease|3|||
125310744|NCT02045095|450766519|FG002|Overall Study|Progressive Disease|2|||
125310745|NCT02045095|450766520|FG003|Overall Study|Progressive Disease|4|||
125310746|NCT02045095|450766521|FG004|Overall Study|Progressive Disease|2|||
125310747|NCT02045095|450766522|FG005|Overall Study|Progressive Disease|4|||
125310748|NCT02045095|450766523|FG006|Overall Study|Progressive Disease|1|||
125310749|NCT02045095|450766517|FG000|Overall Study|Withdrawal by Subject|0|||
125310750|NCT02045095|450766518|FG001|Overall Study|Withdrawal by Subject|0|||
125310751|NCT02045095|450766519|FG002|Overall Study|Withdrawal by Subject|0|||
125310752|NCT02045095|450766520|FG003|Overall Study|Withdrawal by Subject|0|||
125310753|NCT02045095|450766521|FG004|Overall Study|Withdrawal by Subject|3|||
125310754|NCT02045095|450766522|FG005|Overall Study|Withdrawal by Subject|0|||
125310755|NCT02045095|450766523|FG006|Overall Study|Withdrawal by Subject|0|||
125310756|NCT02045095|450766517|FG000|Overall Study|Adverse Event|0|||
125310757|NCT02045095|450766518|FG001|Overall Study|Adverse Event|1|||
125310758|NCT02045095|450766519|FG002|Overall Study|Adverse Event|1|||
125310759|NCT02045095|450766520|FG003|Overall Study|Adverse Event|0|||
125310760|NCT02045095|450766521|FG004|Overall Study|Adverse Event|0|||
125310761|NCT02045095|450766522|FG005|Overall Study|Adverse Event|2|||
125310762|NCT02045095|450766523|FG006|Overall Study|Adverse Event|0|||
125310763|NCT01450761|450766524|FG000|Randomization|Subject no longer meets study criteria|1|||
125310764|NCT01450761|450766525|FG001|Randomization|Subject no longer meets study criteria|2|||
125310765|NCT01450761|450766524|FG000|Randomization|Withdrawal by Subject|2|||
125310766|NCT01450761|450766525|FG001|Randomization|Withdrawal by Subject|0|||
125310767|NCT01450761|450766524|FG000|Randomization|Disease progression|0|||
125310768|NCT01450761|450766525|FG001|Randomization|Disease progression|2|||
125310769|NCT01450761|450766524|FG000|Randomization|Adverse Event unrelated to study drug|1|||
125310770|NCT01450761|450766525|FG001|Randomization|Adverse Event unrelated to study drug|0|||
125310771|NCT01450761|450766524|FG000|Randomization|Other|0|||
125310772|NCT01450761|450766525|FG001|Randomization|Other|1|||
125310773|NCT01450761|450766524|FG000|Lead-in Chemotherapy|Disease progression|33|||
125310774|NCT01450761|450766525|FG001|Lead-in Chemotherapy|Disease progression|32|||
125310775|NCT01450761|450766524|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
125310776|NCT01450761|450766525|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
125310777|NCT01450761|450766524|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
125310778|NCT01450761|450766525|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
125310779|NCT01450761|450766524|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
125310780|NCT01450761|450766525|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
125310781|NCT01450761|450766524|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
125310782|NCT01450761|450766525|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
125310783|NCT01450761|450766524|FG000|Lead-in Chemotherapy|Death|3|||
125310784|NCT01450761|450766525|FG001|Lead-in Chemotherapy|Death|3|||
125310785|NCT01450761|450766524|FG000|Lead-in Chemotherapy|Other|2|||
125310786|NCT01450761|450766525|FG001|Lead-in Chemotherapy|Other|2|||
125310787|NCT01450761|450766524|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
125310788|NCT01450761|450766525|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
125310789|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
125310790|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
125310791|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
125310792|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
125310793|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
125310794|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
125310795|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
125310796|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
125310797|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
125310798|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
125310799|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Death|5|||
125310800|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Death|6|||
125310801|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
125310802|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
125310803|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
125310804|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
125310805|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
125310806|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
125310807|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
125310808|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
125310809|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
125310810|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
125310811|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
125310812|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
125310813|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
125310814|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
125310815|NCT00337207|450766526|FG000|Overall Study|Withdrawal by Subject|3|||
125310816|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
125310817|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
125310818|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
125310819|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
125310820|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
125310821|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
125310822|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
125310823|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
125310824|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
125310825|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
125310826|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
125310827|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
125310828|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
125310829|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
125310830|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
125310831|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
125310832|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
125310833|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
125310834|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
125310835|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
125310836|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
125310837|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
125310838|NCT03573323|450766527|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
125310839|NCT03573323|450766528|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
125310840|NCT03573323|450766527|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
125310841|NCT03573323|450766528|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
125310842|NCT03573323|450766527|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
124977611|NCT05511038|449545440|FG000|Treatment|Withdrawal by Subject|5|||
124977612|NCT05511038|449545441|FG001|Treatment|Withdrawal by Subject|3|||
124977613|NCT05511038|449545440|FG000|Treatment|Physician Decision|4|||
124977614|NCT05511038|449545441|FG001|Treatment|Physician Decision|0|||
124977615|NCT05511038|449545440|FG000|Treatment|Lost to Follow-up|2|||
124977616|NCT05511038|449545441|FG001|Treatment|Lost to Follow-up|0|||
125310843|NCT03573323|450766528|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
125310844|NCT03573323|450766527|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
125310845|NCT03573323|450766528|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
125310846|NCT03573323|450766527|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
125310847|NCT03573323|450766528|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
125310848|NCT03573323|450766527|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
125310849|NCT03573323|450766528|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
125310850|NCT03573323|450766527|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
125310851|NCT03573323|450766528|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
125310852|NCT03573323|450766527|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
125310853|NCT03573323|450766528|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
125310854|NCT00837213|450766532|FG000|Overall Study|Lost to Follow-up|3|||
125310855|NCT00837213|450766533|FG001|Overall Study|Lost to Follow-up|2|||
125310856|NCT00837213|450766532|FG000|Overall Study|Withdrawal by Subject|2|||
125310857|NCT00837213|450766533|FG001|Overall Study|Withdrawal by Subject|2|||
125310858|NCT00837213|450766532|FG000|Overall Study|not stated|1|||
125310859|NCT00837213|450766533|FG001|Overall Study|not stated|1|||
125310860|NCT02698826|450766535|FG000|Overall Study|Death|13|||
125310861|NCT02698826|450766535|FG000|Overall Study|Adverse Event|1|||
125310862|NCT00216671|450766541|FG000|Overall Study|Adverse Event|4|||
125310863|NCT00216671|450766542|FG001|Overall Study|Adverse Event|9|||
125310864|NCT00216671|450766541|FG000|Overall Study|Pregnancy|0|||
125310865|NCT00216671|450766542|FG001|Overall Study|Pregnancy|1|||
125310866|NCT00216671|450766541|FG000|Overall Study|Withdrawal by Subject|4|||
125310867|NCT00216671|450766542|FG001|Overall Study|Withdrawal by Subject|2|||
125310868|NCT00216671|450766541|FG000|Overall Study|Refused Injections|3|||
125310869|NCT00216671|450766542|FG001|Overall Study|Refused Injections|13|||
125310870|NCT00216671|450766541|FG000|Overall Study|No Need to Continue Medication|1|||
125310871|NCT00216671|450766542|FG001|Overall Study|No Need to Continue Medication|1|||
125310872|NCT00216671|450766541|FG000|Overall Study|Insufficient Response|9|||
125310873|NCT00216671|450766542|FG001|Overall Study|Insufficient Response|4|||
124977617|NCT05511038|449545440|FG000|Treatment|Death|1|||
125310874|NCT00216671|450766541|FG000|Overall Study|Lost to Follow-up|3|||
125310875|NCT00216671|450766542|FG001|Overall Study|Lost to Follow-up|5|||
125310876|NCT00216671|450766541|FG000|Overall Study|Non compliant|2|||
125310877|NCT00216671|450766542|FG001|Overall Study|Non compliant|2|||
125310878|NCT00216671|450766541|FG000|Overall Study|Ineligible|0|||
125310879|NCT00216671|450766542|FG001|Overall Study|Ineligible|2|||
125310880|NCT00216671|450766541|FG000|Overall Study|Physician Decision|1|||
125310881|NCT00216671|450766542|FG001|Overall Study|Physician Decision|1|||
125310882|NCT00216671|450766541|FG000|Overall Study|Protocol Violation|3|||
125310883|NCT00216671|450766542|FG001|Overall Study|Protocol Violation|5|||
125310884|NCT00216671|450766541|FG000|Overall Study|Relapse|1|||
125310885|NCT00216671|450766542|FG001|Overall Study|Relapse|0|||
125310886|NCT00216671|450766541|FG000|Overall Study|Investigator Illness|0|||
125310887|NCT00216671|450766542|FG001|Overall Study|Investigator Illness|1|||
125310888|NCT00216671|450766541|FG000|Overall Study|Patient Moved|0|||
125310889|NCT00216671|450766542|FG001|Overall Study|Patient Moved|1|||
125310890|NCT00216671|450766541|FG000|Overall Study|Ineligible, no efficacy data|2|||
125310891|NCT00216671|450766542|FG001|Overall Study|Ineligible, no efficacy data|2|||
125310892|NCT00216671|450766541|FG000|Overall Study|Insufficient Response Adverse Event|2|||
125310893|NCT00216671|450766542|FG001|Overall Study|Insufficient Response Adverse Event|1|||
125310894|NCT04961541|450766543|FG000|Overall Study|Adverse Event|0|||
125310895|NCT04961541|450766544|FG001|Overall Study|Adverse Event|0|||
125200047|NCT02980341|450354969|FG004|Dose Escalation|Clinical progression|0|||
125200048|NCT02980341|450354970|FG005|Dose Escalation|Clinical progression|0|||
125200049|NCT02980341|450354971|FG006|Dose Escalation|Clinical progression|0|||
125200050|NCT02980341|450354972|FG007|Dose Escalation|Clinical progression|0|||
125200051|NCT02980341|450354973|FG008|Dose Escalation|Clinical progression|0|||
125200052|NCT02980341|450354974|FG009|Dose Escalation|Clinical progression|0|||
125200053|NCT02980341|450354975|FG010|Dose Escalation|Clinical progression|0|||
125200054|NCT02980341|450354965|FG000|Dose Escalation|Adverse Event|0|||
125200055|NCT02980341|450354966|FG001|Dose Escalation|Adverse Event|0|||
124977618|NCT05511038|449545441|FG001|Treatment|Death|0|||
125200056|NCT02980341|450354967|FG002|Dose Escalation|Adverse Event|1|||
125310896|NCT04961541|450766545|FG002|Overall Study|Adverse Event|0|||
125310897|NCT04961541|450766546|FG003|Overall Study|Adverse Event|0|||
125310898|NCT04961541|450766547|FG004|Overall Study|Adverse Event|0|||
125310899|NCT04961541|450766548|FG005|Overall Study|Adverse Event|1|||
125200057|NCT02980341|450354968|FG003|Dose Escalation|Adverse Event|2|||
125200058|NCT02980341|450354969|FG004|Dose Escalation|Adverse Event|2|||
125200059|NCT02980341|450354970|FG005|Dose Escalation|Adverse Event|0|||
125200060|NCT02980341|450354971|FG006|Dose Escalation|Adverse Event|0|||
125200061|NCT02980341|450354972|FG007|Dose Escalation|Adverse Event|0|||
125200062|NCT02980341|450354973|FG008|Dose Escalation|Adverse Event|0|||
125200063|NCT02980341|450354974|FG009|Dose Escalation|Adverse Event|0|||
125200064|NCT02980341|450354975|FG010|Dose Escalation|Adverse Event|0|||
125200065|NCT02980341|450354965|FG000|Dose Escalation|Withdrawal by Subject|0|||
125200066|NCT02980341|450354966|FG001|Dose Escalation|Withdrawal by Subject|0|||
125200067|NCT02980341|450354967|FG002|Dose Escalation|Withdrawal by Subject|1|||
125200068|NCT02980341|450354968|FG003|Dose Escalation|Withdrawal by Subject|0|||
125200069|NCT02980341|450354969|FG004|Dose Escalation|Withdrawal by Subject|0|||
125310900|NCT04961541|450766549|FG006|Overall Study|Adverse Event|0|||
125310901|NCT04961541|450766550|FG007|Overall Study|Adverse Event|0|||
125310902|NCT04961541|450766551|FG008|Overall Study|Adverse Event|0|||
125310903|NCT04961541|450766552|FG009|Overall Study|Adverse Event|0|||
125310904|NCT04961541|450766553|FG010|Overall Study|Adverse Event|0|||
125310905|NCT04961541|450766554|FG011|Overall Study|Adverse Event|0|||
125310906|NCT04961541|450766555|FG012|Overall Study|Adverse Event|0|||
125310907|NCT04961541|450766556|FG013|Overall Study|Adverse Event|0|||
125310908|NCT04961541|450766543|FG000|Overall Study|Lost to Follow-up|0|||
125310909|NCT04961541|450766544|FG001|Overall Study|Lost to Follow-up|0|||
125310910|NCT04961541|450766545|FG002|Overall Study|Lost to Follow-up|3|||
125310911|NCT04961541|450766546|FG003|Overall Study|Lost to Follow-up|0|||
125310912|NCT04961541|450766547|FG004|Overall Study|Lost to Follow-up|0|||
125310913|NCT04961541|450766548|FG005|Overall Study|Lost to Follow-up|0|||
125310914|NCT04961541|450766549|FG006|Overall Study|Lost to Follow-up|1|||
125310915|NCT04961541|450766550|FG007|Overall Study|Lost to Follow-up|1|||
125310916|NCT04961541|450766551|FG008|Overall Study|Lost to Follow-up|0|||
125310917|NCT04961541|450766552|FG009|Overall Study|Lost to Follow-up|1|||
125310918|NCT04961541|450766553|FG010|Overall Study|Lost to Follow-up|0|||
125310919|NCT04961541|450766554|FG011|Overall Study|Lost to Follow-up|0|||
125310920|NCT04961541|450766555|FG012|Overall Study|Lost to Follow-up|1|||
125310921|NCT04961541|450766556|FG013|Overall Study|Lost to Follow-up|0|||
125310922|NCT04961541|450766543|FG000|Overall Study|Withdrawal by Subject|0|||
125310923|NCT04961541|450766544|FG001|Overall Study|Withdrawal by Subject|0|||
125310924|NCT04961541|450766545|FG002|Overall Study|Withdrawal by Subject|1|||
125310925|NCT04961541|450766546|FG003|Overall Study|Withdrawal by Subject|1|||
125310926|NCT04961541|450766547|FG004|Overall Study|Withdrawal by Subject|0|||
125310927|NCT04961541|450766548|FG005|Overall Study|Withdrawal by Subject|0|||
125310928|NCT04961541|450766549|FG006|Overall Study|Withdrawal by Subject|0|||
125310929|NCT04961541|450766550|FG007|Overall Study|Withdrawal by Subject|0|||
125310930|NCT04961541|450766551|FG008|Overall Study|Withdrawal by Subject|0|||
125310931|NCT04961541|450766552|FG009|Overall Study|Withdrawal by Subject|1|||
125310932|NCT04961541|450766553|FG010|Overall Study|Withdrawal by Subject|0|||
125310933|NCT04961541|450766554|FG011|Overall Study|Withdrawal by Subject|0|||
125310934|NCT04961541|450766555|FG012|Overall Study|Withdrawal by Subject|0|||
125310935|NCT04961541|450766556|FG013|Overall Study|Withdrawal by Subject|0|||
125310936|NCT01843023|450766558|FG000|Overall Study|Death|1|||
125310937|NCT01843023|450766559|FG001|Overall Study|Death|0|||
125310938|NCT01843023|450766558|FG000|Overall Study|Lost to Follow-up|24|||
125310939|NCT01843023|450766559|FG001|Overall Study|Lost to Follow-up|29|||
125310940|NCT01843023|450766558|FG000|Overall Study|Withdrawal by Subject|8|||
125310941|NCT01843023|450766559|FG001|Overall Study|Withdrawal by Subject|6|||
125310942|NCT03305770|450766560|FG000|Overall Study|Physician Decision - prior to dispense|0|||
125310943|NCT03305770|450766561|FG001|Overall Study|Physician Decision - prior to dispense|1|||
125310944|NCT03305770|450766560|FG000|Overall Study|Subject moved|1|||
125310945|NCT03305770|450766561|FG001|Overall Study|Subject moved|0|||
125310946|NCT03539601|450766562|FG000|Overall Study|Withdraw by parent/guardian|1|||
125310947|NCT03539601|450766563|FG001|Overall Study|Withdraw by parent/guardian|0|||
125310948|NCT03539601|450766564|FG002|Overall Study|Withdraw by parent/guardian|1|||
125310949|NCT03539601|450766565|FG003|Overall Study|Withdraw by parent/guardian|0|||
125310950|NCT03539601|450766562|FG000|Overall Study|Adverse Event|0|||
125310951|NCT03539601|450766563|FG001|Overall Study|Adverse Event|2|||
125310952|NCT03539601|450766564|FG002|Overall Study|Adverse Event|0|||
125310953|NCT03539601|450766565|FG003|Overall Study|Adverse Event|0|||
125310954|NCT03539601|450766562|FG000|Overall Study|Lost to Follow-up|2|||
125310955|NCT03539601|450766563|FG001|Overall Study|Lost to Follow-up|4|||
125310956|NCT03539601|450766564|FG002|Overall Study|Lost to Follow-up|5|||
125310957|NCT03539601|450766565|FG003|Overall Study|Lost to Follow-up|0|||
125310958|NCT03539601|450766562|FG000|Overall Study|Withdrawal by Subject|2|||
125310959|NCT03539601|450766563|FG001|Overall Study|Withdrawal by Subject|0|||
125310960|NCT03539601|450766564|FG002|Overall Study|Withdrawal by Subject|0|||
125310961|NCT03539601|450766565|FG003|Overall Study|Withdrawal by Subject|1|||
125310962|NCT03539601|450766562|FG000|Overall Study|Randomized but not treated|1|||
125310963|NCT03539601|450766563|FG001|Overall Study|Randomized but not treated|1|||
125200070|NCT02980341|450354970|FG005|Dose Escalation|Withdrawal by Subject|0|||
125310964|NCT03539601|450766564|FG002|Overall Study|Randomized but not treated|0|||
125310965|NCT03539601|450766565|FG003|Overall Study|Randomized but not treated|0|||
125310966|NCT01970306|450766566|FG000|Overall Study|Not eligible|3|||
125310967|NCT01970306|450766566|FG000|Overall Study|Not able to be treated|9|||
125310968|NCT00226811|450766567|FG000|Overall Study|Death|8|||
125310969|NCT00226811|450766567|FG000|Overall Study|Adverse Event|11|||
125310970|NCT00226811|450766567|FG000|Overall Study|Lack of Efficacy|55|||
125310971|NCT00226811|450766567|FG000|Overall Study|Withdrawal by Subject|2|||
125310972|NCT02741635|450766568|FG000|Overall Study|Withdrawal by Subject|1|||
125310973|NCT01427933|450766569|FG000|Overall Study|Withdrawal by Subject|5|||
125310974|NCT01427933|450766570|FG001|Overall Study|Withdrawal by Subject|8|||
125310975|NCT01427933|450766569|FG000|Overall Study|Lost to Follow-up|1|||
125310976|NCT01427933|450766570|FG001|Overall Study|Lost to Follow-up|5|||
125310977|NCT01427933|450766569|FG000|Overall Study|Other|1|||
125310978|NCT01427933|450766570|FG001|Overall Study|Other|0|||
125310979|NCT01427933|450766569|FG000|Overall Study|Investigator's Decision|1|||
125310980|NCT01427933|450766570|FG001|Overall Study|Investigator's Decision|0|||
125310981|NCT01633541|450766571|FG000|Overall Study|Death|1|||
125310982|NCT01633541|450766572|FG001|Overall Study|Death|0|||
125310983|NCT03472326|450766575|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
125310984|NCT03472326|450766576|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
125310985|NCT03472326|450766577|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
125310986|NCT03472326|450766578|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
125310987|NCT03472326|450766575|FG000|Part 2: Combination Therapy|Pregnancy|0|||
125310988|NCT03472326|450766576|FG001|Part 2: Combination Therapy|Pregnancy|0|||
125310989|NCT03472326|450766577|FG002|Part 2: Combination Therapy|Pregnancy|0|||
125310990|NCT03472326|450766578|FG003|Part 2: Combination Therapy|Pregnancy|1|||
125310991|NCT01010971|450766579|FG000|Overall Study|Adverse Event|2|||
125310992|NCT01010971|450766580|FG001|Overall Study|Adverse Event|4|||
125310993|NCT01010971|450766581|FG002|Overall Study|Adverse Event|3|||
125310994|NCT01010971|450766579|FG000|Overall Study|Withdrawal by Subject|0|||
125310995|NCT01010971|450766580|FG001|Overall Study|Withdrawal by Subject|2|||
125310996|NCT01010971|450766581|FG002|Overall Study|Withdrawal by Subject|5|||
125310997|NCT01010971|450766579|FG000|Overall Study|Lost to Follow-up|0|||
125310998|NCT01010971|450766580|FG001|Overall Study|Lost to Follow-up|2|||
125310999|NCT01010971|450766581|FG002|Overall Study|Lost to Follow-up|3|||
125311000|NCT01010971|450766579|FG000|Overall Study|Other|1|||
125311001|NCT01010971|450766580|FG001|Overall Study|Other|0|||
125311002|NCT01010971|450766581|FG002|Overall Study|Other|2|||
125311003|NCT03386721|450766582|FG000|Overall Study|Death|12|||
125311004|NCT03386721|450766583|FG001|Overall Study|Death|21|||
125311005|NCT03386721|450766584|FG002|Overall Study|Death|2|||
125311006|NCT03386721|450766585|FG003|Overall Study|Death|5|||
125311007|NCT03386721|450766586|FG004|Overall Study|Death|1|||
125311008|NCT03386721|450766587|FG005|Overall Study|Death|12|||
125311009|NCT03386721|450766588|FG006|Overall Study|Death|1|||
125311010|NCT03386721|450766589|FG007|Overall Study|Death|1|||
125311011|NCT03386721|450766590|FG008|Overall Study|Death|12|||
125311012|NCT03386721|450766591|FG009|Overall Study|Death|20|||
125311013|NCT03386721|450766592|FG010|Overall Study|Death|21|||
125311014|NCT03386721|450766593|FG011|Overall Study|Death|21|||
125311015|NCT03386721|450766594|FG012|Overall Study|Death|14|||
125311016|NCT03386721|450766595|FG013|Overall Study|Death|2|||
125311017|NCT03386721|450766596|FG014|Overall Study|Death|1|||
125311018|NCT03386721|450766582|FG000|Overall Study|Lost to Follow-up|1|||
125311019|NCT03386721|450766583|FG001|Overall Study|Lost to Follow-up|3|||
125311020|NCT03386721|450766584|FG002|Overall Study|Lost to Follow-up|0|||
125311021|NCT03386721|450766585|FG003|Overall Study|Lost to Follow-up|0|||
125311022|NCT03386721|450766586|FG004|Overall Study|Lost to Follow-up|0|||
125311023|NCT03386721|450766587|FG005|Overall Study|Lost to Follow-up|2|||
125311024|NCT03386721|450766588|FG006|Overall Study|Lost to Follow-up|1|||
125311025|NCT03386721|450766589|FG007|Overall Study|Lost to Follow-up|0|||
125311026|NCT03386721|450766590|FG008|Overall Study|Lost to Follow-up|1|||
125311027|NCT03386721|450766591|FG009|Overall Study|Lost to Follow-up|2|||
125311028|NCT03386721|450766592|FG010|Overall Study|Lost to Follow-up|1|||
125311029|NCT03386721|450766593|FG011|Overall Study|Lost to Follow-up|0|||
125311030|NCT03386721|450766594|FG012|Overall Study|Lost to Follow-up|0|||
125311031|NCT03386721|450766595|FG013|Overall Study|Lost to Follow-up|0|||
125311032|NCT03386721|450766596|FG014|Overall Study|Lost to Follow-up|0|||
125311033|NCT03386721|450766582|FG000|Overall Study|Reason not specified|3|||
125311034|NCT03386721|450766583|FG001|Overall Study|Reason not specified|0|||
125311035|NCT03386721|450766584|FG002|Overall Study|Reason not specified|0|||
125311036|NCT03386721|450766585|FG003|Overall Study|Reason not specified|0|||
125311037|NCT03386721|450766586|FG004|Overall Study|Reason not specified|0|||
125311038|NCT03386721|450766587|FG005|Overall Study|Reason not specified|3|||
125311039|NCT03386721|450766588|FG006|Overall Study|Reason not specified|1|||
125311040|NCT03386721|450766589|FG007|Overall Study|Reason not specified|0|||
125311041|NCT03386721|450766590|FG008|Overall Study|Reason not specified|0|||
125311042|NCT03386721|450766591|FG009|Overall Study|Reason not specified|1|||
125311043|NCT03386721|450766592|FG010|Overall Study|Reason not specified|2|||
125311044|NCT03386721|450766593|FG011|Overall Study|Reason not specified|6|||
125311045|NCT03386721|450766594|FG012|Overall Study|Reason not specified|1|||
125311046|NCT03386721|450766595|FG013|Overall Study|Reason not specified|0|||
125311047|NCT03386721|450766596|FG014|Overall Study|Reason not specified|0|||
125311048|NCT03386721|450766582|FG000|Overall Study|Progressive Disease|0|||
125311049|NCT03386721|450766583|FG001|Overall Study|Progressive Disease|0|||
125311050|NCT03386721|450766584|FG002|Overall Study|Progressive Disease|1|||
125311051|NCT03386721|450766585|FG003|Overall Study|Progressive Disease|0|||
125311052|NCT03386721|450766586|FG004|Overall Study|Progressive Disease|0|||
125311053|NCT03386721|450766587|FG005|Overall Study|Progressive Disease|1|||
125311054|NCT03386721|450766588|FG006|Overall Study|Progressive Disease|0|||
125311055|NCT03386721|450766589|FG007|Overall Study|Progressive Disease|0|||
125311056|NCT03386721|450766590|FG008|Overall Study|Progressive Disease|2|||
125311057|NCT03386721|450766591|FG009|Overall Study|Progressive Disease|1|||
125311058|NCT03386721|450766592|FG010|Overall Study|Progressive Disease|1|||
125311059|NCT03386721|450766593|FG011|Overall Study|Progressive Disease|0|||
125311060|NCT03386721|450766594|FG012|Overall Study|Progressive Disease|1|||
125311061|NCT03386721|450766595|FG013|Overall Study|Progressive Disease|0|||
125311062|NCT03386721|450766596|FG014|Overall Study|Progressive Disease|0|||
125311063|NCT03386721|450766582|FG000|Overall Study|Site Terminated by Sponsor|5|||
125311064|NCT03386721|450766583|FG001|Overall Study|Site Terminated by Sponsor|5|||
125311065|NCT03386721|450766584|FG002|Overall Study|Site Terminated by Sponsor|0|||
125311066|NCT03386721|450766585|FG003|Overall Study|Site Terminated by Sponsor|0|||
125311067|NCT03386721|450766586|FG004|Overall Study|Site Terminated by Sponsor|1|||
125311068|NCT03386721|450766587|FG005|Overall Study|Site Terminated by Sponsor|3|||
125311069|NCT03386721|450766588|FG006|Overall Study|Site Terminated by Sponsor|0|||
125311070|NCT03386721|450766589|FG007|Overall Study|Site Terminated by Sponsor|1|||
125311071|NCT03386721|450766590|FG008|Overall Study|Site Terminated by Sponsor|4|||
125311072|NCT03386721|450766591|FG009|Overall Study|Site Terminated by Sponsor|5|||
125311073|NCT03386721|450766592|FG010|Overall Study|Site Terminated by Sponsor|3|||
125311074|NCT03386721|450766593|FG011|Overall Study|Site Terminated by Sponsor|11|||
125311075|NCT03386721|450766594|FG012|Overall Study|Site Terminated by Sponsor|6|||
125311076|NCT03386721|450766595|FG013|Overall Study|Site Terminated by Sponsor|0|||
125311077|NCT03386721|450766596|FG014|Overall Study|Site Terminated by Sponsor|0|||
125311078|NCT03386721|450766582|FG000|Overall Study|Symptomatic Deterioration|0|||
125311079|NCT03386721|450766583|FG001|Overall Study|Symptomatic Deterioration|0|||
125311080|NCT03386721|450766584|FG002|Overall Study|Symptomatic Deterioration|0|||
125311081|NCT03386721|450766585|FG003|Overall Study|Symptomatic Deterioration|0|||
125311082|NCT03386721|450766586|FG004|Overall Study|Symptomatic Deterioration|0|||
125311083|NCT03386721|450766587|FG005|Overall Study|Symptomatic Deterioration|0|||
125311084|NCT03386721|450766588|FG006|Overall Study|Symptomatic Deterioration|0|||
125311085|NCT03386721|450766589|FG007|Overall Study|Symptomatic Deterioration|0|||
125311086|NCT03386721|450766590|FG008|Overall Study|Symptomatic Deterioration|1|||
125311087|NCT03386721|450766591|FG009|Overall Study|Symptomatic Deterioration|0|||
125311088|NCT03386721|450766592|FG010|Overall Study|Symptomatic Deterioration|0|||
125311089|NCT03386721|450766593|FG011|Overall Study|Symptomatic Deterioration|1|||
125311090|NCT03386721|450766594|FG012|Overall Study|Symptomatic Deterioration|0|||
125311091|NCT03386721|450766595|FG013|Overall Study|Symptomatic Deterioration|0|||
125311092|NCT03386721|450766596|FG014|Overall Study|Symptomatic Deterioration|0|||
125311093|NCT03386721|450766582|FG000|Overall Study|Withdrawal by Subject|1|||
125311094|NCT03386721|450766583|FG001|Overall Study|Withdrawal by Subject|2|||
125311095|NCT03386721|450766584|FG002|Overall Study|Withdrawal by Subject|0|||
125311096|NCT03386721|450766585|FG003|Overall Study|Withdrawal by Subject|0|||
125311097|NCT03386721|450766586|FG004|Overall Study|Withdrawal by Subject|0|||
125311098|NCT03386721|450766587|FG005|Overall Study|Withdrawal by Subject|0|||
125311099|NCT03386721|450766588|FG006|Overall Study|Withdrawal by Subject|0|||
125311100|NCT03386721|450766589|FG007|Overall Study|Withdrawal by Subject|0|||
125311101|NCT03386721|450766590|FG008|Overall Study|Withdrawal by Subject|2|||
125311102|NCT03386721|450766591|FG009|Overall Study|Withdrawal by Subject|1|||
125311103|NCT03386721|450766592|FG010|Overall Study|Withdrawal by Subject|3|||
125311104|NCT03386721|450766593|FG011|Overall Study|Withdrawal by Subject|2|||
125311105|NCT03386721|450766594|FG012|Overall Study|Withdrawal by Subject|3|||
125311106|NCT03386721|450766595|FG013|Overall Study|Withdrawal by Subject|0|||
125311107|NCT03386721|450766596|FG014|Overall Study|Withdrawal by Subject|0|||
125311108|NCT03081884|450766597|FG000|Overall Study|deferred prostate cancer treatment|1|||
125311109|NCT03081884|450766597|FG000|Overall Study|metastasis managed with systemic therapy|3|||
125311110|NCT03948334|450766599|FG000|Overall Study|Adverse Event|1|||
125311111|NCT03948334|450766600|FG001|Overall Study|Adverse Event|4|||
125311112|NCT03948334|450766599|FG000|Overall Study|Lack of Efficacy|2|||
125311113|NCT03948334|450766600|FG001|Overall Study|Lack of Efficacy|0|||
125311114|NCT03948334|450766599|FG000|Overall Study|Lost to Follow-up|1|||
125311115|NCT03948334|450766600|FG001|Overall Study|Lost to Follow-up|0|||
125311116|NCT03948334|450766599|FG000|Overall Study|Physician Decision|1|||
125311117|NCT03948334|450766600|FG001|Overall Study|Physician Decision|0|||
125311118|NCT03948334|450766599|FG000|Overall Study|Pregnancy|0|||
125311119|NCT03948334|450766600|FG001|Overall Study|Pregnancy|1|||
125311120|NCT03948334|450766599|FG000|Overall Study|Protocol Deviation|1|||
125311121|NCT03948334|450766600|FG001|Overall Study|Protocol Deviation|0|||
125311122|NCT03948334|450766599|FG000|Overall Study|Study terminated by Sponsor|50|||
125311123|NCT03948334|450766600|FG001|Overall Study|Study terminated by Sponsor|51|||
125311124|NCT03948334|450766599|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
125311125|NCT03948334|450766600|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
125311126|NCT05114473|450766601|FG000|Overall Study|Lost to Follow-up|2|||
125311127|NCT05114473|450766602|FG001|Overall Study|Lost to Follow-up|2|||
125311128|NCT05114473|450766603|FG002|Overall Study|Lost to Follow-up|0|||
125311129|NCT00700713|450766604|FG000|Overall Study|Protocol Violation|1|||
125311130|NCT00700713|450766605|FG001|Overall Study|Protocol Violation|0|||
125311131|NCT00700713|450766606|FG002|Overall Study|Protocol Violation|1|||
125311132|NCT00700713|450766604|FG000|Overall Study|Withdrawal by Subject|0|||
125311133|NCT00700713|450766605|FG001|Overall Study|Withdrawal by Subject|0|||
125311134|NCT00700713|450766606|FG002|Overall Study|Withdrawal by Subject|1|||
125311135|NCT00550953|450766608|FG000|Overall Study|Adverse Event|4|||
125311136|NCT00550953|450766609|FG001|Overall Study|Adverse Event|3|||
125311137|NCT00550953|450766608|FG000|Overall Study|Not able to visit the site|2|||
125311138|NCT00550953|450766609|FG001|Overall Study|Not able to visit the site|3|||
125311139|NCT02446717|450766610|FG000|Overall Study|Adverse Event|0|||
125311140|NCT02446717|450766611|FG001|Overall Study|Adverse Event|0|||
125311141|NCT02446717|450766612|FG002|Overall Study|Adverse Event|1|||
125311142|NCT02446717|450766613|FG003|Overall Study|Adverse Event|0|||
125311143|NCT02446717|450766614|FG004|Overall Study|Adverse Event|0|||
125311144|NCT02446717|450766610|FG000|Overall Study|Lost to Follow-up|0|||
125311145|NCT02446717|450766611|FG001|Overall Study|Lost to Follow-up|1|||
125311146|NCT02446717|450766612|FG002|Overall Study|Lost to Follow-up|1|||
125311147|NCT02446717|450766613|FG003|Overall Study|Lost to Follow-up|0|||
125311148|NCT02446717|450766614|FG004|Overall Study|Lost to Follow-up|1|||
125311149|NCT02446717|450766610|FG000|Overall Study|Withdrew consent|0|||
125311150|NCT02446717|450766611|FG001|Overall Study|Withdrew consent|0|||
125311151|NCT02446717|450766612|FG002|Overall Study|Withdrew consent|0|||
125311152|NCT02446717|450766613|FG003|Overall Study|Withdrew consent|1|||
125311153|NCT02446717|450766614|FG004|Overall Study|Withdrew consent|0|||
125311154|NCT02905266|450766615|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
125311155|NCT02905266|450766616|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
125311156|NCT02905266|450766615|FG000|Treatment Phase Part 1|Disease Progression|6|||
125311157|NCT02905266|450766616|FG001|Treatment Phase Part 1|Disease Progression|7|||
125311158|NCT02905266|450766615|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
125311159|NCT02905266|450766616|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
125311160|NCT02905266|450766615|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
125311161|NCT02905266|450766616|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
125311162|NCT02905266|450766615|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
125311163|NCT02905266|450766616|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
125311164|NCT02905266|450766615|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
125311165|NCT02905266|450766616|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
125311166|NCT02905266|450766615|FG000|Transition From Part 1 to Part 2|Death|0|||
125311167|NCT02905266|450766616|FG001|Transition From Part 1 to Part 2|Death|1|||
125311168|NCT02905266|450766615|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
125311169|NCT02905266|450766616|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
125311170|NCT02905266|450766615|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
125311171|NCT02905266|450766616|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
125311172|NCT02905266|450766615|FG000|Maintenance Phase Part 2|Disease Progression|9|||
125311173|NCT02905266|450766616|FG001|Maintenance Phase Part 2|Disease Progression|2|||
125311174|NCT02905266|450766615|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
125311175|NCT02905266|450766616|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
125311176|NCT02905266|450766615|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
125311177|NCT02905266|450766616|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
125311178|NCT02777827|450766622|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
125311179|NCT02777827|450766623|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
125311180|NCT02777827|450766624|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
125311181|NCT02777827|450766625|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
125311182|NCT02777827|450766626|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
125311183|NCT02777827|450766627|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
125311184|NCT03160898|450766628|FG000|Overall Study|Adverse Event|4|||
125311185|NCT03160898|450766629|FG001|Overall Study|Adverse Event|8|||
125311186|NCT03160898|450766630|FG002|Overall Study|Adverse Event|7|||
125311187|NCT03160898|450766631|FG003|Overall Study|Adverse Event|10|||
125311188|NCT03160898|450766628|FG000|Overall Study|Death|1|||
125088831|NCT02033369|449944482|FG000|Overall Study|Physician Decision|1|||
125311189|NCT03160898|450766629|FG001|Overall Study|Death|0|||
125311190|NCT03160898|450766630|FG002|Overall Study|Death|0|||
125311191|NCT03160898|450766631|FG003|Overall Study|Death|1|||
125311192|NCT03160898|450766628|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
125311193|NCT03160898|450766629|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
125311194|NCT03160898|450766630|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
125311195|NCT03160898|450766631|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
125311196|NCT03160898|450766628|FG000|Overall Study|Lost to Follow-up|1|||
125311197|NCT03160898|450766629|FG001|Overall Study|Lost to Follow-up|1|||
125311198|NCT03160898|450766630|FG002|Overall Study|Lost to Follow-up|1|||
125311199|NCT03160898|450766631|FG003|Overall Study|Lost to Follow-up|2|||
125311200|NCT03160898|450766628|FG000|Overall Study|Physician Decision|1|||
125311201|NCT03160898|450766629|FG001|Overall Study|Physician Decision|0|||
125311202|NCT03160898|450766630|FG002|Overall Study|Physician Decision|0|||
125311203|NCT03160898|450766631|FG003|Overall Study|Physician Decision|1|||
125311204|NCT03160898|450766628|FG000|Overall Study|Progressive Disease|4|||
125311205|NCT03160898|450766629|FG001|Overall Study|Progressive Disease|1|||
125311206|NCT03160898|450766630|FG002|Overall Study|Progressive Disease|2|||
125311207|NCT03160898|450766631|FG003|Overall Study|Progressive Disease|1|||
125311208|NCT03160898|450766628|FG000|Overall Study|Protocol Violation|1|||
125311209|NCT03160898|450766629|FG001|Overall Study|Protocol Violation|0|||
125311210|NCT03160898|450766630|FG002|Overall Study|Protocol Violation|2|||
125311211|NCT03160898|450766631|FG003|Overall Study|Protocol Violation|0|||
125311212|NCT03160898|450766628|FG000|Overall Study|Sponsor Discretion|2|||
125311213|NCT03160898|450766629|FG001|Overall Study|Sponsor Discretion|0|||
125311214|NCT03160898|450766630|FG002|Overall Study|Sponsor Discretion|0|||
125311215|NCT03160898|450766631|FG003|Overall Study|Sponsor Discretion|0|||
125311216|NCT03160898|450766628|FG000|Overall Study|Withdrawal by Subject|1|||
125311217|NCT03160898|450766629|FG001|Overall Study|Withdrawal by Subject|3|||
125311218|NCT03160898|450766630|FG002|Overall Study|Withdrawal by Subject|2|||
125311219|NCT03160898|450766631|FG003|Overall Study|Withdrawal by Subject|1|||
125311220|NCT03160898|450766628|FG000|Overall Study|Other|2|||
125311221|NCT03160898|450766629|FG001|Overall Study|Other|0|||
125311222|NCT03160898|450766630|FG002|Overall Study|Other|2|||
125311223|NCT03160898|450766631|FG003|Overall Study|Other|2|||
125311224|NCT04178720|450766638|FG000|Overall Study|Withdrawal by Subject|2|||
125311225|NCT04178720|450766639|FG001|Overall Study|Withdrawal by Subject|0|||
125311226|NCT04178720|450766638|FG000|Overall Study|Relocation|0|||
125311227|NCT04178720|450766639|FG001|Overall Study|Relocation|1|||
125311228|NCT04177212|450766641|FG000|Overall Study|Withdrawal by Subject|9|||
125311229|NCT04177212|450766642|FG001|Overall Study|Withdrawal by Subject|7|||
125311230|NCT04177212|450766641|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
125311231|NCT04177212|450766642|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
125311232|NCT04177212|450766641|FG000|Overall Study|Physician Decision|1|||
125311233|NCT04177212|450766642|FG001|Overall Study|Physician Decision|0|||
125311234|NCT04177212|450766641|FG000|Overall Study|Lost to Follow-up|0|||
125311235|NCT04177212|450766642|FG001|Overall Study|Lost to Follow-up|3|||
125311236|NCT04177212|450766641|FG000|Overall Study|Adverse Event|0|||
125311237|NCT04177212|450766642|FG001|Overall Study|Adverse Event|1|||
125311238|NCT04177212|450766641|FG000|Overall Study|Other|1|||
125311239|NCT04177212|450766642|FG001|Overall Study|Other|2|||
125311240|NCT04725500|450766643|FG000|Screening|Screen Failure|26|||
125311241|NCT04725500|450766643|FG000|Screening|Withdrawal by Subject|1|||
125311242|NCT04725500|450766643|FG000|2 Week Take Home|Screen Fail|5|||
125311243|NCT04618744|450766645|FG000|Overall Study|Adverse Event|0|||
125311244|NCT04618744|450766646|FG001|Overall Study|Adverse Event|1|||
125311245|NCT04618744|450766645|FG000|Overall Study|Withdrawal by Subject|0|||
125311246|NCT04618744|450766646|FG001|Overall Study|Withdrawal by Subject|1|||
125311247|NCT00930930|450766647|FG000|Overall Study|Death|1|||
125311248|NCT00930930|450766648|FG001|Overall Study|Death|0|||
125311249|NCT00930930|450766647|FG000|Overall Study|Physician Decision|1|||
125311250|NCT00930930|450766648|FG001|Overall Study|Physician Decision|0|||
125311251|NCT00930930|450766647|FG000|Overall Study|Adverse Event|13|||
125311252|NCT00930930|450766648|FG001|Overall Study|Adverse Event|3|||
125311253|NCT00930930|450766647|FG000|Overall Study|Withdrawal by Subject|3|||
125311254|NCT00930930|450766648|FG001|Overall Study|Withdrawal by Subject|1|||
125311255|NCT00930930|450766647|FG000|Overall Study|Disease progression|2|||
125311256|NCT00930930|450766648|FG001|Overall Study|Disease progression|3|||
125311257|NCT00930930|450766647|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
125311258|NCT00930930|450766648|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
125311259|NCT00930930|450766647|FG000|Overall Study|patients not compliant|1|||
125311260|NCT00930930|450766648|FG001|Overall Study|patients not compliant|1|||
125311261|NCT02709330|450766649|FG000|Overall Study|Death|5|||
125311262|NCT02709330|450766650|FG001|Overall Study|Death|0|||
125311263|NCT02709330|450766649|FG000|Overall Study|Lost to Follow-up|2|||
125311264|NCT02709330|450766650|FG001|Overall Study|Lost to Follow-up|0|||
125311265|NCT02709330|450766649|FG000|Overall Study|Physician Decision|2|||
124977619|NCT05511038|449545440|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
125311266|NCT02709330|450766650|FG001|Overall Study|Physician Decision|0|||
125311267|NCT02709330|450766649|FG000|Overall Study|Withdrawal by Subject|4|||
125311268|NCT02709330|450766650|FG001|Overall Study|Withdrawal by Subject|0|||
125311269|NCT01172535|450768631|FG000|Overall Study|Death|3|||
125311270|NCT01172535|450768631|FG000|Overall Study|Withdrawal by Subject|2|||
125311271|NCT01172535|450768631|FG000|Overall Study|Lost to Follow-up|1|||
125311272|NCT01172535|450768631|FG000|Overall Study|Ineligible at study entry|1|||
125311273|NCT01172535|450768631|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
125311274|NCT00988598|450768632|FG000|Overall Study|Withdrawal by Subject|2|||
125311275|NCT00988598|450768633|FG001|Overall Study|Withdrawal by Subject|0|||
125311276|NCT04317040|450768634|FG000|Overall Study|Lost to Follow-up|2|||
125311277|NCT04317040|450768635|FG001|Overall Study|Lost to Follow-up|0|||
125311278|NCT04317040|450768634|FG000|Overall Study|Death|16|||
125311279|NCT04317040|450768635|FG001|Overall Study|Death|18|||
125311280|NCT04317040|450768634|FG000|Overall Study|Withdrawal by Subject|0|||
125311281|NCT04317040|450768635|FG001|Overall Study|Withdrawal by Subject|1|||
125311282|NCT04317040|450768634|FG000|Overall Study|Incomplete assessments|0|||
125311283|NCT04317040|450768635|FG001|Overall Study|Incomplete assessments|1|||
125311284|NCT01177007|450768636|FG000|Overall Study|Lost to Follow-up|2|||
125311285|NCT01177007|450768636|FG000|Overall Study|Death|4|||
125311286|NCT01177007|450768636|FG000|Overall Study|Entered hospice care|5|||
125311287|NCT01177007|450768636|FG000|Overall Study|Required additional Y90 treatment|6|||
125311288|NCT01177007|450768636|FG000|Overall Study|Change in treatment modality|21|||
125311289|NCT02366195|450768648|FG000|Overall Study|Protocol-specified criteria|3|||
125311290|NCT02366195|450768648|FG000|Overall Study|Withdrawal by Subject|9|||
125311291|NCT02366195|450768648|FG000|Overall Study|Lost to Follow-up|1|||
125311292|NCT02366195|450768648|FG000|Overall Study|Death|41|||
125311293|NCT01338818|450768649|FG000|Overall Study|Adverse Event|8|||
125311294|NCT01338818|450768649|FG000|Overall Study|Lack of Efficacy|5|||
125311295|NCT01338818|450768649|FG000|Overall Study|no longer require study drug|1|||
125311296|NCT01338818|450768649|FG000|Overall Study|Withdrawal by Subject|11|||
125311297|NCT01338818|450768649|FG000|Overall Study|Lost to Follow-up|4|||
125311298|NCT01338818|450768649|FG000|Overall Study|Administrative problems|3|||
125311299|NCT01338818|450768649|FG000|Overall Study|Protocol Deviation|4|||
125311300|NCT00556998|450768654|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
125311301|NCT00556998|450768654|FG000|Voriconazole Intravenous (IV)|Other|4|||
125311302|NCT00556998|450768654|FG000|Voriconazole Oral|Adverse Event|1|||
125311303|NCT00556998|450768654|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
125311304|NCT03030417|450768663|FG000|Dose Expansion|Disease progression before treatment|0|||
125311305|NCT03030417|450768664|FG001|Dose Expansion|Disease progression before treatment|0|||
125311306|NCT03030417|450768665|FG002|Dose Expansion|Disease progression before treatment|0|||
125311307|NCT03030417|450768666|FG003|Dose Expansion|Disease progression before treatment|0|||
125311308|NCT03030417|450768667|FG004|Dose Expansion|Disease progression before treatment|0|||
125311309|NCT03030417|450768668|FG005|Dose Expansion|Disease progression before treatment|0|||
125311310|NCT03030417|450768669|FG006|Dose Expansion|Disease progression before treatment|0|||
125311311|NCT03030417|450768670|FG007|Dose Expansion|Disease progression before treatment|0|||
125311312|NCT03030417|450768671|FG008|Dose Expansion|Disease progression before treatment|0|||
125311313|NCT03030417|450768672|FG009|Dose Expansion|Disease progression before treatment|0|||
125311314|NCT03030417|450768673|FG010|Dose Expansion|Disease progression before treatment|0|||
125311315|NCT03030417|450768674|FG011|Dose Expansion|Disease progression before treatment|0|||
125311316|NCT03030417|450768675|FG012|Dose Expansion|Disease progression before treatment|1|||
125311317|NCT01684202|450768676|FG000|Dose-escalation Period|Adverse Event|0|||
125311318|NCT01684202|450768677|FG001|Dose-escalation Period|Adverse Event|1|||
125311319|NCT01684202|450768678|FG002|Dose-escalation Period|Adverse Event|0|||
125311320|NCT01684202|450768679|FG003|Dose-escalation Period|Adverse Event|0|||
125311321|NCT01684202|450768676|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
125311322|NCT01684202|450768677|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
125311323|NCT01684202|450768678|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
125311324|NCT01684202|450768679|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
125311325|NCT01684202|450768676|FG000|Maintenance Period|Adverse Event|1|||
125311326|NCT01684202|450768677|FG001|Maintenance Period|Adverse Event|1|||
125311327|NCT01684202|450768678|FG002|Maintenance Period|Adverse Event|1|||
125311328|NCT01684202|450768679|FG003|Maintenance Period|Adverse Event|1|||
125311329|NCT01684202|450768676|FG000|Maintenance Period|Physician Decision|0|||
125311330|NCT01684202|450768677|FG001|Maintenance Period|Physician Decision|1|||
125311331|NCT01684202|450768678|FG002|Maintenance Period|Physician Decision|0|||
125311332|NCT01684202|450768679|FG003|Maintenance Period|Physician Decision|0|||
125311333|NCT01684202|450768676|FG000|Maintenance Period|Withdrawal by Subject|0|||
125311334|NCT01684202|450768677|FG001|Maintenance Period|Withdrawal by Subject|1|||
125311335|NCT01684202|450768678|FG002|Maintenance Period|Withdrawal by Subject|0|||
125311336|NCT01684202|450768679|FG003|Maintenance Period|Withdrawal by Subject|0|||
125311337|NCT00191308|450768680|FG000|Overall Study|Adverse Event|1|||
125311338|NCT00779025|450768681|FG000|Overall Study|Withdrawal by Subject|1|||
125311339|NCT03710642|450768682|FG000|Overall Study|Adverse Event|5|||
125311340|NCT03710642|450768683|FG001|Overall Study|Adverse Event|1|||
125311341|NCT03710642|450768682|FG000|Overall Study|non-site physician recommendation|1|||
125311342|NCT03710642|450768683|FG001|Overall Study|non-site physician recommendation|0|||
125311343|NCT03710642|450768682|FG000|Overall Study|Participant unwilling or unable to participate|1|||
125311344|NCT03710642|450768683|FG001|Overall Study|Participant unwilling or unable to participate|1|||
125311345|NCT03710642|450768682|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
125311346|NCT03710642|450768683|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
125311347|NCT03710642|450768682|FG000|Overall Study|NA-no code provided|1|||
125311348|NCT03710642|450768683|FG001|Overall Study|NA-no code provided|0|||
125311349|NCT03710642|450768682|FG000|Overall Study|Withdrawal by Subject|1|||
125311350|NCT03710642|450768683|FG001|Overall Study|Withdrawal by Subject|0|||
125311351|NCT00782717|450768684|FG000|Overall Study|Adverse Event|2|||
125311352|NCT00782717|450768685|FG001|Overall Study|Adverse Event|5|||
125311353|NCT00782717|450768684|FG000|Overall Study|Patient decision unrelated to AE|6|||
125311354|NCT00782717|450768685|FG001|Overall Study|Patient decision unrelated to AE|3|||
125311355|NCT00782717|450768684|FG000|Overall Study|Noncompliance|2|||
125311356|NCT00782717|450768685|FG001|Overall Study|Noncompliance|1|||
125311357|NCT00782717|450768684|FG000|Overall Study|Treatment failure|3|||
125311358|NCT00782717|450768685|FG001|Overall Study|Treatment failure|14|||
125311359|NCT00782717|450768684|FG000|Overall Study|Enrollment close prior to surgery|1|||
125311360|NCT00782717|450768685|FG001|Overall Study|Enrollment close prior to surgery|0|||
125311361|NCT00782717|450768684|FG000|Overall Study|Did not meet entrance criteria|1|||
125311362|NCT00782717|450768685|FG001|Overall Study|Did not meet entrance criteria|3|||
125311363|NCT00782717|450768684|FG000|Overall Study|Exited in error|0|||
125311364|NCT00782717|450768685|FG001|Overall Study|Exited in error|2|||
125311365|NCT02292719|450768686|FG000|Overall Study|Withdrawal by Subject|0|||
125311366|NCT02292719|450768687|FG001|Overall Study|Withdrawal by Subject|0|||
125311367|NCT02292719|450768688|FG002|Overall Study|Withdrawal by Subject|0|||
125311368|NCT02292719|450768689|FG003|Overall Study|Withdrawal by Subject|1|||
125311369|NCT02292719|450768690|FG004|Overall Study|Withdrawal by Subject|1|||
125311370|NCT02292719|450768691|FG005|Overall Study|Withdrawal by Subject|0|||
125311371|NCT02292719|450768686|FG000|Overall Study|Subject enrolled in new study.|0|||
125311372|NCT02292719|450768687|FG001|Overall Study|Subject enrolled in new study.|0|||
125311373|NCT02292719|450768688|FG002|Overall Study|Subject enrolled in new study.|1|||
125311374|NCT02292719|450768689|FG003|Overall Study|Subject enrolled in new study.|0|||
125311375|NCT02292719|450768690|FG004|Overall Study|Subject enrolled in new study.|0|||
125311376|NCT02292719|450768691|FG005|Overall Study|Subject enrolled in new study.|0|||
125311377|NCT02586727|450768697|FG000|Overall Study|Lost to Follow-up|1|||
125311378|NCT02586727|450768698|FG001|Overall Study|Lost to Follow-up|0|||
125311379|NCT04628780|450768703|FG000|Overall Study|Death|0|||
125311380|NCT04628780|450768704|FG001|Overall Study|Death|1|||
125311381|NCT04628780|450768705|FG002|Overall Study|Death|0|||
125311382|NCT04628780|450768706|FG003|Overall Study|Death|0|||
125311383|NCT04628780|450768707|FG004|Overall Study|Death|1|||
125311384|NCT04628780|450768708|FG005|Overall Study|Death|0|||
125311385|NCT04628780|450768703|FG000|Overall Study|Physician Decision|2|||
125311386|NCT04628780|450768704|FG001|Overall Study|Physician Decision|0|||
125311387|NCT04628780|450768705|FG002|Overall Study|Physician Decision|0|||
125311388|NCT04628780|450768706|FG003|Overall Study|Physician Decision|0|||
125311389|NCT04628780|450768707|FG004|Overall Study|Physician Decision|2|||
125311390|NCT04628780|450768708|FG005|Overall Study|Physician Decision|0|||
125311391|NCT04628780|450768703|FG000|Overall Study|Progressive disease|2|||
125311392|NCT04628780|450768704|FG001|Overall Study|Progressive disease|2|||
125311393|NCT04628780|450768705|FG002|Overall Study|Progressive disease|2|||
125311394|NCT04628780|450768706|FG003|Overall Study|Progressive disease|3|||
125311395|NCT04628780|450768707|FG004|Overall Study|Progressive disease|9|||
125311396|NCT04628780|450768708|FG005|Overall Study|Progressive disease|4|||
125311397|NCT04628780|450768703|FG000|Overall Study|Withdrawal by Subject|0|||
125311398|NCT04628780|450768704|FG001|Overall Study|Withdrawal by Subject|1|||
125311399|NCT04628780|450768705|FG002|Overall Study|Withdrawal by Subject|2|||
125311400|NCT04628780|450768706|FG003|Overall Study|Withdrawal by Subject|0|||
125311401|NCT04628780|450768707|FG004|Overall Study|Withdrawal by Subject|3|||
125311402|NCT04628780|450768708|FG005|Overall Study|Withdrawal by Subject|1|||
125311403|NCT04628780|450768703|FG000|Overall Study|Global deterioration of health status|0|||
125311404|NCT04628780|450768704|FG001|Overall Study|Global deterioration of health status|0|||
125311405|NCT04628780|450768705|FG002|Overall Study|Global deterioration of health status|0|||
124977620|NCT05511038|449545441|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
124977621|NCT05511038|449545440|FG000|Treatment|Refuse by subject|1|||
124977622|NCT05511038|449545441|FG001|Treatment|Refuse by subject|0|||
124977623|NCT05511038|449545440|FG000|Treatment|Subject did not go to the site for visit|1|||
124977624|NCT05511038|449545441|FG001|Treatment|Subject did not go to the site for visit|0|||
124977625|NCT05140915|449545442|FG000|Overall Study|Lost to Follow-up|2|||
124977626|NCT05140915|449545443|FG001|Overall Study|Lost to Follow-up|1|||
124977627|NCT04879849|449545444|FG000|Overall Study|Lost to Follow-up|0|||
124977628|NCT04879849|449545445|FG001|Overall Study|Lost to Follow-up|0|||
124977629|NCT04879849|449545446|FG002|Overall Study|Lost to Follow-up|0|||
124977630|NCT04879849|449545447|FG003|Overall Study|Lost to Follow-up|1|||
124977631|NCT04879849|449545448|FG004|Overall Study|Lost to Follow-up|0|||
124977632|NCT04879849|449545449|FG005|Overall Study|Lost to Follow-up|0|||
124977633|NCT04879849|449545450|FG006|Overall Study|Lost to Follow-up|0|||
124977634|NCT04879849|449545451|FG007|Overall Study|Lost to Follow-up|0|||
124977635|NCT04879849|449545444|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
124977636|NCT04879849|449545445|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
124977637|NCT04879849|449545446|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
124977638|NCT04879849|449545447|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
124977639|NCT04879849|449545448|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
124977640|NCT04879849|449545449|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
124977641|NCT04879849|449545450|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
124977642|NCT04879849|449545451|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
124977643|NCT04879849|449545444|FG000|Overall Study|Withdrawal by Subject|0|||
125311406|NCT04628780|450768706|FG003|Overall Study|Global deterioration of health status|0|||
125311407|NCT04628780|450768707|FG004|Overall Study|Global deterioration of health status|1|||
125311408|NCT04628780|450768708|FG005|Overall Study|Global deterioration of health status|1|||
125311409|NCT03622814|450768710|FG000|Overall Study|Lost to Follow-up|8|||
125311410|NCT03622814|450768711|FG001|Overall Study|Lost to Follow-up|14|||
125311411|NCT01288989|450768714|FG000|Overall Study|Death|0|||
125311412|NCT01288989|450768715|FG001|Overall Study|Death|0|||
125311413|NCT01288989|450768716|FG002|Overall Study|Death|0|||
125311414|NCT01288989|450768717|FG003|Overall Study|Death|1|||
125311415|NCT01288989|450768718|FG004|Overall Study|Death|0|||
125311416|NCT01288989|450768714|FG000|Overall Study|Dose limiting toxicity|1|||
125311417|NCT01288989|450768715|FG001|Overall Study|Dose limiting toxicity|0|||
125311418|NCT01288989|450768716|FG002|Overall Study|Dose limiting toxicity|0|||
125311419|NCT01288989|450768717|FG003|Overall Study|Dose limiting toxicity|0|||
125311420|NCT01288989|450768718|FG004|Overall Study|Dose limiting toxicity|0|||
125311421|NCT01288989|450768714|FG000|Overall Study|Adverse Event|0|||
125311422|NCT01288989|450768715|FG001|Overall Study|Adverse Event|0|||
125311423|NCT01288989|450768716|FG002|Overall Study|Adverse Event|0|||
125311424|NCT01288989|450768717|FG003|Overall Study|Adverse Event|0|||
125311425|NCT01288989|450768718|FG004|Overall Study|Adverse Event|2|||
125311426|NCT01288989|450768714|FG000|Overall Study|Physician Decision|0|||
125311427|NCT01288989|450768715|FG001|Overall Study|Physician Decision|0|||
125311428|NCT01288989|450768716|FG002|Overall Study|Physician Decision|0|||
125311429|NCT01288989|450768717|FG003|Overall Study|Physician Decision|0|||
125311430|NCT01288989|450768718|FG004|Overall Study|Physician Decision|1|||
125311431|NCT01288989|450768714|FG000|Overall Study|Withdrawal by Subject|0|||
125311432|NCT01288989|450768715|FG001|Overall Study|Withdrawal by Subject|0|||
125311433|NCT01288989|450768716|FG002|Overall Study|Withdrawal by Subject|0|||
125311434|NCT01288989|450768717|FG003|Overall Study|Withdrawal by Subject|0|||
124977644|NCT04879849|449545445|FG001|Overall Study|Withdrawal by Subject|0|||
124977645|NCT04879849|449545446|FG002|Overall Study|Withdrawal by Subject|0|||
124977646|NCT04879849|449545447|FG003|Overall Study|Withdrawal by Subject|0|||
125311435|NCT01288989|450768718|FG004|Overall Study|Withdrawal by Subject|3|||
125311436|NCT01156714|450768719|FG000|Overall Study|Withdrawal by Subject|9|||
125311437|NCT01156714|450768720|FG001|Overall Study|Withdrawal by Subject|4|||
124977647|NCT04879849|449545448|FG004|Overall Study|Withdrawal by Subject|2|||
125311438|NCT01156714|450768721|FG002|Overall Study|Withdrawal by Subject|3|||
125311439|NCT01132313|450768722|FG000|Overall Study|Lack of Efficacy|1|||
125311440|NCT01132313|450768723|FG001|Overall Study|Lack of Efficacy|0|||
125311441|NCT01132313|450768724|FG002|Overall Study|Lack of Efficacy|0|||
125311442|NCT01132313|450768725|FG003|Overall Study|Lack of Efficacy|0|||
125311443|NCT01132313|450768726|FG004|Overall Study|Lack of Efficacy|0|||
125311444|NCT01132313|450768727|FG005|Overall Study|Lack of Efficacy|0|||
125311445|NCT01132313|450768728|FG006|Overall Study|Lack of Efficacy|0|||
125311446|NCT01132313|450768729|FG007|Overall Study|Lack of Efficacy|3|||
125311447|NCT01132313|450768730|FG008|Overall Study|Lack of Efficacy|14|||
124866791|NCT00127101|449133649|FG005|Continuation Phase|Lack of Efficacy|1|||
124866792|NCT00127101|449133644|FG000|Continuation Phase|Withdrawal by Subject|0|||
124866793|NCT00127101|449133645|FG001|Continuation Phase|Withdrawal by Subject|0|||
124866794|NCT00127101|449133646|FG002|Continuation Phase|Withdrawal by Subject|1|||
125311448|NCT01132313|450768731|FG009|Overall Study|Lack of Efficacy|16|||
125311449|NCT01132313|450768732|FG010|Overall Study|Lack of Efficacy|0|||
125311450|NCT01132313|450768733|FG011|Overall Study|Lack of Efficacy|0|||
125311451|NCT01132313|450768722|FG000|Overall Study|Not treated|2|||
125311452|NCT01132313|450768723|FG001|Overall Study|Not treated|0|||
125311453|NCT01132313|450768724|FG002|Overall Study|Not treated|0|||
125311454|NCT01132313|450768725|FG003|Overall Study|Not treated|0|||
125311455|NCT01132313|450768726|FG004|Overall Study|Not treated|2|||
125311456|NCT01132313|450768727|FG005|Overall Study|Not treated|1|||
125311457|NCT01132313|450768728|FG006|Overall Study|Not treated|3|||
125311458|NCT01132313|450768729|FG007|Overall Study|Not treated|0|||
125311459|NCT01132313|450768730|FG008|Overall Study|Not treated|0|||
125311460|NCT01132313|450768731|FG009|Overall Study|Not treated|0|||
125311461|NCT01132313|450768732|FG010|Overall Study|Not treated|0|||
125311462|NCT01132313|450768733|FG011|Overall Study|Not treated|0|||
125311463|NCT01132313|450768722|FG000|Overall Study|Adverse Event|0|||
125311464|NCT01132313|450768723|FG001|Overall Study|Adverse Event|0|||
125311465|NCT01132313|450768724|FG002|Overall Study|Adverse Event|4|||
125311466|NCT01132313|450768725|FG003|Overall Study|Adverse Event|10|||
125311467|NCT01132313|450768726|FG004|Overall Study|Adverse Event|19|||
125311468|NCT01132313|450768727|FG005|Overall Study|Adverse Event|6|||
125311469|NCT01132313|450768728|FG006|Overall Study|Adverse Event|5|||
125311470|NCT01132313|450768729|FG007|Overall Study|Adverse Event|3|||
125311471|NCT01132313|450768730|FG008|Overall Study|Adverse Event|7|||
125311472|NCT01132313|450768731|FG009|Overall Study|Adverse Event|2|||
125311473|NCT01132313|450768732|FG010|Overall Study|Adverse Event|0|||
125311474|NCT01132313|450768733|FG011|Overall Study|Adverse Event|0|||
125311475|NCT01132313|450768722|FG000|Overall Study|Protocol Violation|0|||
125311476|NCT01132313|450768723|FG001|Overall Study|Protocol Violation|0|||
125311477|NCT01132313|450768724|FG002|Overall Study|Protocol Violation|0|||
125311478|NCT01132313|450768725|FG003|Overall Study|Protocol Violation|1|||
125311479|NCT01132313|450768726|FG004|Overall Study|Protocol Violation|0|||
125311480|NCT01132313|450768727|FG005|Overall Study|Protocol Violation|0|||
125311481|NCT01132313|450768728|FG006|Overall Study|Protocol Violation|0|||
125311482|NCT01132313|450768729|FG007|Overall Study|Protocol Violation|0|||
125311483|NCT01132313|450768730|FG008|Overall Study|Protocol Violation|0|||
124866795|NCT00127101|449133647|FG003|Continuation Phase|Withdrawal by Subject|0|||
124866796|NCT00127101|449133648|FG004|Continuation Phase|Withdrawal by Subject|2|||
124866797|NCT00127101|449133649|FG005|Continuation Phase|Withdrawal by Subject|1|||
124866798|NCT00843167|449133650|FG000|Treatment Period|Adverse Event|1|||
124866799|NCT00843167|449133651|FG001|Treatment Period|Adverse Event|5|||
124866800|NCT00843167|449133650|FG000|Treatment Period|Withdrawal by Subject|2|||
124866801|NCT00843167|449133651|FG001|Treatment Period|Withdrawal by Subject|3|||
124866802|NCT01565707|449133652|FG000|Overall Study|Adverse Event|1|||
124866803|NCT01565707|449133653|FG001|Overall Study|Adverse Event|6|||
124866804|NCT01565707|449133654|FG002|Overall Study|Adverse Event|2|||
124866805|NCT01565707|449133655|FG003|Overall Study|Adverse Event|1|||
124866806|NCT01565707|449133652|FG000|Overall Study|Lost to Follow-up|1|||
124866807|NCT01565707|449133653|FG001|Overall Study|Lost to Follow-up|0|||
124866808|NCT01565707|449133654|FG002|Overall Study|Lost to Follow-up|0|||
124866809|NCT01565707|449133655|FG003|Overall Study|Lost to Follow-up|0|||
125311484|NCT01132313|450768731|FG009|Overall Study|Protocol Violation|0|||
125311485|NCT01132313|450768732|FG010|Overall Study|Protocol Violation|0|||
125311486|NCT01132313|450768733|FG011|Overall Study|Protocol Violation|0|||
125311487|NCT01132313|450768722|FG000|Overall Study|Lost to Follow-up|0|||
125311488|NCT01132313|450768723|FG001|Overall Study|Lost to Follow-up|0|||
125311489|NCT01132313|450768724|FG002|Overall Study|Lost to Follow-up|1|||
125311490|NCT01132313|450768725|FG003|Overall Study|Lost to Follow-up|0|||
125311491|NCT01132313|450768726|FG004|Overall Study|Lost to Follow-up|0|||
125311492|NCT01132313|450768727|FG005|Overall Study|Lost to Follow-up|0|||
125311493|NCT01132313|450768728|FG006|Overall Study|Lost to Follow-up|0|||
125311494|NCT01132313|450768729|FG007|Overall Study|Lost to Follow-up|1|||
125311495|NCT01132313|450768730|FG008|Overall Study|Lost to Follow-up|0|||
125311496|NCT01132313|450768731|FG009|Overall Study|Lost to Follow-up|0|||
125311497|NCT01132313|450768732|FG010|Overall Study|Lost to Follow-up|0|||
125311498|NCT01132313|450768733|FG011|Overall Study|Lost to Follow-up|0|||
125311499|NCT01132313|450768722|FG000|Overall Study|Withdrawal by Subject|0|||
124866810|NCT01565707|449133652|FG000|Overall Study|Protocol Violation|1|||
124866811|NCT01565707|449133653|FG001|Overall Study|Protocol Violation|0|||
124866812|NCT01565707|449133654|FG002|Overall Study|Protocol Violation|0|||
124866813|NCT01565707|449133655|FG003|Overall Study|Protocol Violation|1|||
124866814|NCT01565707|449133652|FG000|Overall Study|Withdrawal by Subject|3|||
124866815|NCT01565707|449133653|FG001|Overall Study|Withdrawal by Subject|1|||
124866816|NCT01565707|449133654|FG002|Overall Study|Withdrawal by Subject|1|||
124866817|NCT01565707|449133655|FG003|Overall Study|Withdrawal by Subject|1|||
124866818|NCT01565707|449133652|FG000|Overall Study|Randomized but not evaluable|2|||
124866819|NCT01565707|449133653|FG001|Overall Study|Randomized but not evaluable|0|||
124866820|NCT01565707|449133654|FG002|Overall Study|Randomized but not evaluable|0|||
124866821|NCT01565707|449133655|FG003|Overall Study|Randomized but not evaluable|0|||
124866822|NCT01565707|449133652|FG000|Overall Study|Miscellaneous|1|||
125311500|NCT01132313|450768723|FG001|Overall Study|Withdrawal by Subject|0|||
125311501|NCT01132313|450768724|FG002|Overall Study|Withdrawal by Subject|3|||
125311502|NCT01132313|450768725|FG003|Overall Study|Withdrawal by Subject|3|||
125311503|NCT01132313|450768726|FG004|Overall Study|Withdrawal by Subject|6|||
125311504|NCT01132313|450768727|FG005|Overall Study|Withdrawal by Subject|0|||
125311505|NCT01132313|450768728|FG006|Overall Study|Withdrawal by Subject|1|||
125311506|NCT01132313|450768729|FG007|Overall Study|Withdrawal by Subject|0|||
125311507|NCT01132313|450768730|FG008|Overall Study|Withdrawal by Subject|0|||
125311508|NCT01132313|450768731|FG009|Overall Study|Withdrawal by Subject|2|||
125311509|NCT01132313|450768732|FG010|Overall Study|Withdrawal by Subject|0|||
125311510|NCT01132313|450768733|FG011|Overall Study|Withdrawal by Subject|0|||
125311511|NCT01132313|450768722|FG000|Overall Study|Lack of antiviral response|0|||
125311512|NCT01132313|450768723|FG001|Overall Study|Lack of antiviral response|0|||
125311513|NCT01132313|450768724|FG002|Overall Study|Lack of antiviral response|12|||
125311514|NCT01132313|450768725|FG003|Overall Study|Lack of antiviral response|18|||
125311515|NCT01132313|450768726|FG004|Overall Study|Lack of antiviral response|18|||
125311516|NCT01132313|450768727|FG005|Overall Study|Lack of antiviral response|18|||
125311517|NCT01132313|450768728|FG006|Overall Study|Lack of antiviral response|21|||
125311518|NCT01132313|450768729|FG007|Overall Study|Lack of antiviral response|0|||
125311519|NCT01132313|450768730|FG008|Overall Study|Lack of antiviral response|0|||
125311520|NCT01132313|450768731|FG009|Overall Study|Lack of antiviral response|0|||
125311521|NCT01132313|450768732|FG010|Overall Study|Lack of antiviral response|1|||
125311522|NCT01132313|450768733|FG011|Overall Study|Lack of antiviral response|0|||
125311523|NCT01132313|450768722|FG000|Overall Study|Other reason not defined above|0|||
125311524|NCT01132313|450768723|FG001|Overall Study|Other reason not defined above|0|||
125311525|NCT01132313|450768724|FG002|Overall Study|Other reason not defined above|0|||
125311526|NCT01132313|450768725|FG003|Overall Study|Other reason not defined above|0|||
125311527|NCT01132313|450768726|FG004|Overall Study|Other reason not defined above|0|||
125311528|NCT01132313|450768727|FG005|Overall Study|Other reason not defined above|0|||
125311529|NCT01132313|450768728|FG006|Overall Study|Other reason not defined above|0|||
125311530|NCT01132313|450768729|FG007|Overall Study|Other reason not defined above|1|||
125311531|NCT01132313|450768730|FG008|Overall Study|Other reason not defined above|0|||
125311532|NCT01132313|450768731|FG009|Overall Study|Other reason not defined above|0|||
125311533|NCT01132313|450768732|FG010|Overall Study|Other reason not defined above|0|||
125311534|NCT01132313|450768733|FG011|Overall Study|Other reason not defined above|0|||
125311535|NCT00165672|450768734|FG000|Overall Study|Adverse Event|0|||
125311536|NCT00165672|450768735|FG001|Overall Study|Adverse Event|1|||
125311537|NCT02715609|450768741|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
125311538|NCT02715609|450768742|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
125311539|NCT02715609|450768743|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
125311540|NCT02715609|450768741|FG000|Overall Study|Withdrawal by Subject|0|||
125311541|NCT02715609|450768742|FG001|Overall Study|Withdrawal by Subject|0|||
125311542|NCT02715609|450768743|FG002|Overall Study|Withdrawal by Subject|1|||
125311543|NCT03201419|450768744|FG000|Overall Study|Adverse Event|3|||
125311544|NCT03201419|450768745|FG001|Overall Study|Adverse Event|1|||
125311545|NCT03201419|450768746|FG002|Overall Study|Adverse Event|0|||
125311546|NCT03201419|450768747|FG003|Overall Study|Adverse Event|0|||
125311547|NCT03201419|450768748|FG004|Overall Study|Adverse Event|1|||
125311548|NCT03201419|450768749|FG005|Overall Study|Adverse Event|1|||
125311549|NCT03201419|450768750|FG006|Overall Study|Adverse Event|5|||
125311550|NCT03201419|450768751|FG007|Overall Study|Adverse Event|0|||
125311551|NCT03201419|450768752|FG008|Overall Study|Adverse Event|0|||
125311552|NCT03201419|450768744|FG000|Overall Study|Lost to Follow-up|1|||
125311553|NCT03201419|450768745|FG001|Overall Study|Lost to Follow-up|0|||
125311554|NCT03201419|450768746|FG002|Overall Study|Lost to Follow-up|0|||
125311555|NCT03201419|450768747|FG003|Overall Study|Lost to Follow-up|0|||
125311556|NCT03201419|450768748|FG004|Overall Study|Lost to Follow-up|0|||
125311557|NCT03201419|450768749|FG005|Overall Study|Lost to Follow-up|0|||
125311558|NCT03201419|450768750|FG006|Overall Study|Lost to Follow-up|0|||
125311559|NCT03201419|450768751|FG007|Overall Study|Lost to Follow-up|0|||
124866823|NCT01565707|449133653|FG001|Overall Study|Miscellaneous|1|||
125311560|NCT03201419|450768752|FG008|Overall Study|Lost to Follow-up|0|||
124866824|NCT01565707|449133654|FG002|Overall Study|Miscellaneous|0|||
124866825|NCT01565707|449133655|FG003|Overall Study|Miscellaneous|2|||
124866826|NCT04302350|449133656|FG000|Overall Study|Physician Decision|1|||
124866827|NCT04302350|449133657|FG001|Overall Study|Physician Decision|1|||
124866828|NCT04302350|449133658|FG002|Overall Study|Physician Decision|2|||
124866829|NCT04302350|449133656|FG000|Overall Study|Lack of Efficacy|1|||
124866830|NCT04302350|449133657|FG001|Overall Study|Lack of Efficacy|1|||
124866831|NCT04302350|449133658|FG002|Overall Study|Lack of Efficacy|4|||
124977648|NCT04879849|449545449|FG005|Overall Study|Withdrawal by Subject|0|||
124977649|NCT04879849|449545450|FG006|Overall Study|Withdrawal by Subject|1|||
124977650|NCT04879849|449545451|FG007|Overall Study|Withdrawal by Subject|0|||
124977651|NCT04879849|449545444|FG000|Overall Study|Progressive Disease|0|||
124977652|NCT04879849|449545445|FG001|Overall Study|Progressive Disease|0|||
124977653|NCT04879849|449545446|FG002|Overall Study|Progressive Disease|1|||
124977654|NCT04879849|449545447|FG003|Overall Study|Progressive Disease|0|||
124977655|NCT04879849|449545448|FG004|Overall Study|Progressive Disease|0|||
124977656|NCT04879849|449545449|FG005|Overall Study|Progressive Disease|0|||
124977657|NCT04879849|449545450|FG006|Overall Study|Progressive Disease|0|||
124977658|NCT04879849|449545451|FG007|Overall Study|Progressive Disease|0|||
124977659|NCT04879849|449545444|FG000|Overall Study|Death|0|||
124866832|NCT04302350|449133656|FG000|Overall Study|Adverse Event|0|||
124977660|NCT04879849|449545445|FG001|Overall Study|Death|0|||
124977661|NCT04879849|449545446|FG002|Overall Study|Death|1|||
124866833|NCT04302350|449133657|FG001|Overall Study|Adverse Event|1|||
124866834|NCT04302350|449133658|FG002|Overall Study|Adverse Event|2|||
124866835|NCT02012491|449133659|FG000|Overall Study|Lost to Follow-up|1|||
124866836|NCT02012491|449133660|FG001|Overall Study|Lost to Follow-up|0|||
124866837|NCT02012491|449133659|FG000|Overall Study|Protocol Violation|0|||
124866838|NCT02012491|449133660|FG001|Overall Study|Protocol Violation|1|||
124866839|NCT02012491|449133659|FG000|Overall Study|Withdrawal by Subject|1|||
124866840|NCT02012491|449133660|FG001|Overall Study|Withdrawal by Subject|0|||
124866841|NCT03762473|449133661|FG000|Overall Study|Death|1|||
124866842|NCT03762473|449133662|FG001|Overall Study|Death|0|||
124866843|NCT00126438|449133663|FG000|Overall Study|Withdrawal due to adverse event|1|||
124866844|NCT00126438|449133664|FG001|Overall Study|Withdrawal due to adverse event|0|||
124866845|NCT00126438|449133663|FG000|Overall Study|Lost to Follow-up|22|||
124866846|NCT00126438|449133664|FG001|Overall Study|Lost to Follow-up|0|||
124866847|NCT00126438|449133663|FG000|Overall Study|Protocol Violation|8|||
124866848|NCT00126438|449133664|FG001|Overall Study|Protocol Violation|8|||
124977662|NCT04879849|449545447|FG003|Overall Study|Death|1|||
124977663|NCT04879849|449545448|FG004|Overall Study|Death|1|||
124977664|NCT04879849|449545449|FG005|Overall Study|Death|2|||
124977665|NCT04879849|449545450|FG006|Overall Study|Death|1|||
124977666|NCT04879849|449545451|FG007|Overall Study|Death|2|||
124977667|NCT04879849|449545444|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
124977668|NCT04879849|449545445|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
124977669|NCT04879849|449545446|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
124977670|NCT04879849|449545447|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
124977671|NCT04879849|449545448|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
124977672|NCT04879849|449545449|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
124977673|NCT04879849|449545450|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
124977674|NCT04879849|449545451|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
124977675|NCT04879849|449545444|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
124977676|NCT04879849|449545445|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
124977677|NCT04879849|449545446|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
124977678|NCT04879849|449545447|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
124977679|NCT04879849|449545448|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
124977680|NCT04879849|449545449|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
124977681|NCT04879849|449545450|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
124977682|NCT04879849|449545451|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
124977683|NCT04879849|449545444|FG000|Overall Study|Reason Not Specified|1|||
124977684|NCT04879849|449545445|FG001|Overall Study|Reason Not Specified|0|||
124977685|NCT04879849|449545446|FG002|Overall Study|Reason Not Specified|0|||
124977686|NCT04879849|449545447|FG003|Overall Study|Reason Not Specified|0|||
124977687|NCT04879849|449545448|FG004|Overall Study|Reason Not Specified|0|||
124866849|NCT00126438|449133663|FG000|Overall Study|Withdrawal by Subject|3|||
124866850|NCT00126438|449133664|FG001|Overall Study|Withdrawal by Subject|2|||
124866851|NCT01389973|449133668|FG000|Overall Study|Lost to Follow-up|1|||
124866852|NCT01389973|449133668|FG000|Overall Study|Trial Stopped by Sponsor|9|||
124866853|NCT01389973|449133668|FG000|Overall Study|Other|10|||
124866854|NCT02626780|449133669|FG000|Overall Study|Withdrawal by Subject|3|||
124866855|NCT03456700|449133670|FG000|Overall Study|Withdrawal by Subject|1|||
124977688|NCT04879849|449545449|FG005|Overall Study|Reason Not Specified|0|||
124977689|NCT04879849|449545450|FG006|Overall Study|Reason Not Specified|0|||
124977690|NCT04879849|449545451|FG007|Overall Study|Reason Not Specified|0|||
124977691|NCT03810235|449545454|FG000|Overall Study|Withdrawal by Subject|2|||
124977692|NCT03810235|449545455|FG001|Overall Study|Withdrawal by Subject|0|||
124977693|NCT04777864|449545456|FG000|Overall Study|Lost to Follow-up|8|||
124977694|NCT04777864|449545457|FG001|Overall Study|Lost to Follow-up|19|||
124977695|NCT05576662|449545458|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
124977696|NCT05576662|449545459|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
124977697|NCT05576662|449545458|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
124977698|NCT05576662|449545459|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
124977699|NCT05576662|449545458|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
124977700|NCT05576662|449545459|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
124977701|NCT05576662|449545458|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
124977702|NCT05576662|449545459|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
125311561|NCT03201419|450768744|FG000|Overall Study|Protocol Deviation|0|||
125311562|NCT03201419|450768745|FG001|Overall Study|Protocol Deviation|0|||
125311563|NCT03201419|450768746|FG002|Overall Study|Protocol Deviation|0|||
125311564|NCT03201419|450768747|FG003|Overall Study|Protocol Deviation|0|||
125311565|NCT03201419|450768748|FG004|Overall Study|Protocol Deviation|0|||
124866856|NCT04154787|449133671|FG000|Overall Study|Adverse Event|0|||
124866857|NCT04154787|449133672|FG001|Overall Study|Adverse Event|1|||
124866858|NCT04154787|449133673|FG002|Overall Study|Adverse Event|0|||
124866859|NCT04154787|449133671|FG000|Overall Study|Patient Requires Other Treatment|0|||
124866860|NCT04154787|449133672|FG001|Overall Study|Patient Requires Other Treatment|1|||
124866861|NCT04154787|449133673|FG002|Overall Study|Patient Requires Other Treatment|0|||
124866862|NCT04154787|449133671|FG000|Overall Study|Study Terminated By Sponsor|0|||
124866863|NCT04154787|449133672|FG001|Overall Study|Study Terminated By Sponsor|6|||
124866864|NCT04154787|449133673|FG002|Overall Study|Study Terminated By Sponsor|1|||
124866865|NCT04154787|449133671|FG000|Overall Study|Subject Decision|0|||
124866866|NCT04154787|449133672|FG001|Overall Study|Subject Decision|1|||
124866867|NCT04154787|449133673|FG002|Overall Study|Subject Decision|0|||
124866868|NCT04154787|449133671|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
124866869|NCT04154787|449133672|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
124866870|NCT04154787|449133673|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
124866871|NCT02858895|449133678|FG000|Overall Study|Disease progression|31|||
124866872|NCT02858895|449133678|FG000|Overall Study|Death|2|||
124866873|NCT02858895|449133678|FG000|Overall Study|Adverse Event|1|||
124866874|NCT02858895|449133678|FG000|Overall Study|Withdrawal by Subject|3|||
124866875|NCT02858895|449133678|FG000|Overall Study|hospice,|1|||
124866876|NCT02858895|449133678|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
124866877|NCT02277444|449133690|FG000|Overall Study|Adverse Event|10|||
124866878|NCT02277444|449133690|FG000|Overall Study|Withdrawal by Subject|3|||
124866879|NCT02277444|449133690|FG000|Overall Study|Other|1|||
124866880|NCT02277444|449133690|FG000|Overall Study|Enrolled and not Treated|3|||
125311566|NCT03201419|450768749|FG005|Overall Study|Protocol Deviation|0|||
125311567|NCT03201419|450768750|FG006|Overall Study|Protocol Deviation|1|||
125311568|NCT03201419|450768751|FG007|Overall Study|Protocol Deviation|0|||
125311569|NCT03201419|450768752|FG008|Overall Study|Protocol Deviation|0|||
125311570|NCT03201419|450768744|FG000|Overall Study|Withdrawal by Subject|4|||
125311571|NCT03201419|450768745|FG001|Overall Study|Withdrawal by Subject|2|||
125311572|NCT03201419|450768746|FG002|Overall Study|Withdrawal by Subject|1|||
125311573|NCT03201419|450768747|FG003|Overall Study|Withdrawal by Subject|0|||
125311574|NCT03201419|450768748|FG004|Overall Study|Withdrawal by Subject|0|||
125311575|NCT03201419|450768749|FG005|Overall Study|Withdrawal by Subject|0|||
125311576|NCT03201419|450768750|FG006|Overall Study|Withdrawal by Subject|0|||
125311577|NCT03201419|450768751|FG007|Overall Study|Withdrawal by Subject|1|||
125311578|NCT03201419|450768752|FG008|Overall Study|Withdrawal by Subject|2|||
125311579|NCT03201419|450768744|FG000|Overall Study|Other|0|||
125311580|NCT03201419|450768745|FG001|Overall Study|Other|0|||
125311581|NCT03201419|450768746|FG002|Overall Study|Other|1|||
125311582|NCT03201419|450768747|FG003|Overall Study|Other|0|||
125311583|NCT03201419|450768748|FG004|Overall Study|Other|0|||
125311584|NCT03201419|450768749|FG005|Overall Study|Other|0|||
124866881|NCT02277444|449133690|FG000|Overall Study|Ongoing|113|||
124969463|NCT01439867|449517398|FG000|Overall Study|Withdrawal by Subject|1|||
124969464|NCT01439867|449517399|FG001|Overall Study|Withdrawal by Subject|2|||
124969465|NCT01439867|449517398|FG000|Overall Study|Administrative Decision|4|||
124969466|NCT01439867|449517399|FG001|Overall Study|Administrative Decision|5|||
125311585|NCT03201419|450768750|FG006|Overall Study|Other|0|||
124969467|NCT01439867|449517398|FG000|Overall Study|Protocol-specified Criteria|1|||
124969468|NCT01439867|449517399|FG001|Overall Study|Protocol-specified Criteria|0|||
124969469|NCT00334542|449517400|FG000|Overall Study|Adverse Event|3|||
124969470|NCT00334542|449517400|FG000|Overall Study|Withdrawal by Subject|1|||
125311586|NCT03201419|450768751|FG007|Overall Study|Other|0|||
125311587|NCT03201419|450768752|FG008|Overall Study|Other|0|||
124977703|NCT01217437|449545460|FG000|Overall Study|Adverse Event|0|||
125311588|NCT05907395|450768755|FG000|Period 1|No longer met eligibility criteria|0|||
125311589|NCT05907395|450768756|FG001|Period 1|No longer met eligibility criteria|1|||
125311590|NCT05907395|450768757|FG002|Period 1|No longer met eligibility criteria|0|||
124866882|NCT04918784|449135367|FG000|Overall Study|Amputation - no longer eligible|1|||
124866883|NCT04918784|449135368|FG001|Overall Study|Amputation - no longer eligible|2|||
124866884|NCT04918784|449135367|FG000|Overall Study|Death|1|||
124866885|NCT04918784|449135368|FG001|Overall Study|Death|0|||
124866886|NCT04918784|449135367|FG000|Overall Study|patient non-compliance|3|||
124866887|NCT04918784|449135368|FG001|Overall Study|patient non-compliance|1|||
124866888|NCT04918784|449135367|FG000|Overall Study|Adverse Event|1|||
124866889|NCT04918784|449135368|FG001|Overall Study|Adverse Event|0|||
124866890|NCT02160314|449135369|FG000|Overall Study|Adverse Event|0|||
124866891|NCT02160314|449135370|FG001|Overall Study|Adverse Event|6|||
124866892|NCT02160314|449135369|FG000|Overall Study|Protocol Violation|0|||
124866893|NCT02160314|449135370|FG001|Overall Study|Protocol Violation|4|||
124866894|NCT02160314|449135369|FG000|Overall Study|Withdrawal by Subject|1|||
124866895|NCT02160314|449135370|FG001|Overall Study|Withdrawal by Subject|2|||
124866896|NCT02160314|449135369|FG000|Overall Study|Lost to Follow-up|0|||
124866897|NCT02160314|449135370|FG001|Overall Study|Lost to Follow-up|1|||
124866898|NCT02586025|449135379|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
124866899|NCT02586025|449135380|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
124866900|NCT02586025|449135379|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
124866901|NCT02586025|449135380|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
124866902|NCT02586025|449135379|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
124866903|NCT02586025|449135380|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
124866904|NCT02586025|449135379|FG000|Neoadjuvant Treatment|Death|1|||
124866905|NCT02586025|449135380|FG001|Neoadjuvant Treatment|Death|0|||
124866906|NCT02586025|449135379|FG000|Neoadjuvant Treatment|Adverse Event|1|||
124866907|NCT02586025|449135380|FG001|Neoadjuvant Treatment|Adverse Event|0|||
124866908|NCT02586025|449135379|FG000|Neoadjuvant Treatment|Physician Decision|2|||
124866909|NCT02586025|449135380|FG001|Neoadjuvant Treatment|Physician Decision|1|||
124866910|NCT02586025|449135379|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
124866911|NCT02586025|449135380|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
124866912|NCT02586025|449135379|FG000|Adjuvant Treatment|Recurrent Disease|4|||
124866913|NCT02586025|449135380|FG001|Adjuvant Treatment|Recurrent Disease|5|||
124866914|NCT02586025|449135379|FG000|Adjuvant Treatment|Physician Decision|0|||
124866915|NCT02586025|449135380|FG001|Adjuvant Treatment|Physician Decision|1|||
124866916|NCT02586025|449135379|FG000|Adjuvant Treatment|Pregnancy|1|||
125311591|NCT05907395|450768758|FG003|Period 1|No longer met eligibility criteria|0|||
125311592|NCT05907395|450768759|FG004|Period 1|No longer met eligibility criteria|0|||
125311593|NCT05907395|450768760|FG005|Period 1|No longer met eligibility criteria|1|||
125311594|NCT05907395|450768761|FG006|Period 1|No longer met eligibility criteria|1|||
125311595|NCT05907395|450768762|FG007|Period 1|No longer met eligibility criteria|0|||
125311596|NCT05907395|450768763|FG008|Period 1|No longer met eligibility criteria|0|||
125311597|NCT05907395|450768764|FG009|Period 1|No longer met eligibility criteria|0|||
125311598|NCT05907395|450768765|FG010|Period 1|No longer met eligibility criteria|0|||
125311599|NCT05907395|450768766|FG011|Period 1|No longer met eligibility criteria|0|||
125311600|NCT05907395|450768755|FG000|Period 2|Adverse Event|0|||
125311601|NCT05907395|450768756|FG001|Period 2|Adverse Event|0|||
125311602|NCT05907395|450768757|FG002|Period 2|Adverse Event|0|||
125311603|NCT05907395|450768758|FG003|Period 2|Adverse Event|1|||
125311604|NCT05907395|450768759|FG004|Period 2|Adverse Event|0|||
125311605|NCT05907395|450768760|FG005|Period 2|Adverse Event|0|||
125311606|NCT05907395|450768761|FG006|Period 2|Adverse Event|0|||
125311607|NCT05907395|450768762|FG007|Period 2|Adverse Event|1|||
125311608|NCT05907395|450768763|FG008|Period 2|Adverse Event|0|||
125311609|NCT05907395|450768764|FG009|Period 2|Adverse Event|0|||
125311610|NCT05907395|450768765|FG010|Period 2|Adverse Event|0|||
125311611|NCT05907395|450768766|FG011|Period 2|Adverse Event|0|||
125311612|NCT05907395|450768755|FG000|Period 2|Personal reason|0|||
125311613|NCT05907395|450768756|FG001|Period 2|Personal reason|0|||
125311614|NCT05907395|450768757|FG002|Period 2|Personal reason|0|||
125311615|NCT05907395|450768758|FG003|Period 2|Personal reason|0|||
125311616|NCT05907395|450768759|FG004|Period 2|Personal reason|0|||
125311617|NCT05907395|450768760|FG005|Period 2|Personal reason|0|||
125311618|NCT05907395|450768761|FG006|Period 2|Personal reason|0|||
125311619|NCT05907395|450768762|FG007|Period 2|Personal reason|0|||
125311620|NCT05907395|450768763|FG008|Period 2|Personal reason|0|||
125311621|NCT05907395|450768764|FG009|Period 2|Personal reason|1|||
125311622|NCT05907395|450768765|FG010|Period 2|Personal reason|0|||
125311623|NCT05907395|450768766|FG011|Period 2|Personal reason|0|||
124866917|NCT02586025|449135380|FG001|Adjuvant Treatment|Pregnancy|0|||
124866918|NCT02586025|449135379|FG000|Treatment-Free Follow-Up|Death|11|||
125311624|NCT05907395|450768755|FG000|Period 3|Adverse Event|0|||
125311625|NCT05907395|450768756|FG001|Period 3|Adverse Event|0|||
125311626|NCT05907395|450768757|FG002|Period 3|Adverse Event|0|||
125311627|NCT05907395|450768758|FG003|Period 3|Adverse Event|0|||
125311628|NCT05907395|450768759|FG004|Period 3|Adverse Event|1|||
124977704|NCT01217437|449545461|FG001|Overall Study|Adverse Event|8|||
124977705|NCT01217437|449545460|FG000|Overall Study|Death|5|||
124977706|NCT01217437|449545461|FG001|Overall Study|Death|0|||
124977707|NCT01217437|449545460|FG000|Overall Study|Lack of Efficacy|29|||
124977708|NCT01217437|449545461|FG001|Overall Study|Lack of Efficacy|25|||
124977709|NCT01217437|449545460|FG000|Overall Study|Physician Decision|8|||
124977710|NCT01217437|449545461|FG001|Overall Study|Physician Decision|5|||
124977711|NCT01217437|449545460|FG000|Overall Study|Withdrawal by Subject|0|||
124977712|NCT01217437|449545461|FG001|Overall Study|Withdrawal by Subject|2|||
124977713|NCT01217437|449545460|FG000|Overall Study|Ineligible|1|||
124977714|NCT01217437|449545461|FG001|Overall Study|Ineligible|1|||
124977715|NCT03682185|449545464|FG000|Overall Study|Lost to Follow-up|4|||
124977716|NCT03682185|449545465|FG001|Overall Study|Lost to Follow-up|7|||
124977717|NCT03682185|449545466|FG002|Overall Study|Lost to Follow-up|4|||
124977718|NCT03682185|449545467|FG003|Overall Study|Lost to Follow-up|7|||
124977719|NCT03682185|449545468|FG004|Overall Study|Lost to Follow-up|1|||
124977720|NCT03682185|449545464|FG000|Overall Study|Withdrawal by Subject|7|||
124977721|NCT03682185|449545465|FG001|Overall Study|Withdrawal by Subject|3|||
124977722|NCT03682185|449545466|FG002|Overall Study|Withdrawal by Subject|7|||
124977723|NCT03682185|449545467|FG003|Overall Study|Withdrawal by Subject|3|||
124977724|NCT03682185|449545468|FG004|Overall Study|Withdrawal by Subject|0|||
124977725|NCT00350727|449545469|FG000|Phase I: Dose Escalation|Adverse Event|4|||
124977726|NCT00350727|449545470|FG001|Phase I: Dose Escalation|Adverse Event|0|||
124977727|NCT00350727|449545471|FG002|Phase I: Dose Escalation|Adverse Event|0|||
124977728|NCT00350727|449545469|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
124977729|NCT00350727|449545470|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
124977730|NCT00350727|449545471|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
124977731|NCT00350727|449545469|FG000|Phase I: Dose Escalation|Death|1|||
124977732|NCT00350727|449545470|FG001|Phase I: Dose Escalation|Death|0|||
124977733|NCT00350727|449545471|FG002|Phase I: Dose Escalation|Death|0|||
124977734|NCT00350727|449545469|FG000|Phase I: Dose Escalation|Physician Decision|1|||
124977735|NCT00350727|449545470|FG001|Phase I: Dose Escalation|Physician Decision|0|||
125311629|NCT05907395|450768760|FG005|Period 3|Adverse Event|0|||
125311630|NCT05907395|450768761|FG006|Period 3|Adverse Event|0|||
125311631|NCT05907395|450768762|FG007|Period 3|Adverse Event|0|||
125311632|NCT05907395|450768763|FG008|Period 3|Adverse Event|0|||
125311633|NCT05907395|450768764|FG009|Period 3|Adverse Event|0|||
125311634|NCT05907395|450768765|FG010|Period 3|Adverse Event|0|||
125311635|NCT05907395|450768766|FG011|Period 3|Adverse Event|0|||
125311636|NCT04896593|450768767|FG000|Overall Study|Withdrawal by Subject|2|||
125311637|NCT04896593|450768767|FG000|Overall Study|Lost to Follow-up|1|||
125311638|NCT04896593|450768767|FG000|Overall Study|Did not complete onboarding|2|||
125311639|NCT00369577|450768769|FG000|Overall Study|Withdrawal by Subject|0|||
125311640|NCT00369577|450768770|FG001|Overall Study|Withdrawal by Subject|0|||
125311641|NCT00369577|450768771|FG002|Overall Study|Withdrawal by Subject|1|||
125311642|NCT02360228|450768780|FG000|Overall Study|Withdrawal by Subject|1|||
125311643|NCT02360228|450768781|FG001|Overall Study|Withdrawal by Subject|0|||
125311644|NCT02360228|450768782|FG002|Overall Study|Withdrawal by Subject|0|||
125311645|NCT02360228|450768780|FG000|Overall Study|Self-discontinued medication|0|||
125311646|NCT02360228|450768781|FG001|Overall Study|Self-discontinued medication|1|||
125311647|NCT02360228|450768782|FG002|Overall Study|Self-discontinued medication|0|||
125311648|NCT02360228|450768780|FG000|Overall Study|Unstable symptoms during screening|0|||
125311649|NCT02360228|450768781|FG001|Overall Study|Unstable symptoms during screening|0|||
125311650|NCT02360228|450768782|FG002|Overall Study|Unstable symptoms during screening|1|||
125311651|NCT01059318|450768783|FG000|Core Study (26 Week)|Adverse Event|3|||
125311652|NCT01059318|450768783|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
125311653|NCT01059318|450768783|FG000|Extension (36 Week)|Adverse Event|3|||
125311654|NCT03790917|450768786|FG000|Overall Study|Death|1|||
125311655|NCT04186871|450768787|FG000|Overall Study|Lack of Efficacy|0|||
125311656|NCT04186871|450768788|FG001|Overall Study|Lack of Efficacy|1|||
125311657|NCT04186871|450768789|FG002|Overall Study|Lack of Efficacy|0|||
125311658|NCT04186871|450768790|FG003|Overall Study|Lack of Efficacy|0|||
125311659|NCT04186871|450768791|FG004|Overall Study|Lack of Efficacy|1|||
125311660|NCT04186871|450768792|FG005|Overall Study|Lack of Efficacy|1|||
125311661|NCT04186871|450768787|FG000|Overall Study|Adverse Event|1|||
125311662|NCT04186871|450768788|FG001|Overall Study|Adverse Event|1|||
125311663|NCT04186871|450768789|FG002|Overall Study|Adverse Event|0|||
125311664|NCT04186871|450768790|FG003|Overall Study|Adverse Event|0|||
125311665|NCT04186871|450768791|FG004|Overall Study|Adverse Event|0|||
125311666|NCT04186871|450768792|FG005|Overall Study|Adverse Event|2|||
125311667|NCT04186871|450768787|FG000|Overall Study|Study terminated by sponsor|1|||
125311668|NCT04186871|450768788|FG001|Overall Study|Study terminated by sponsor|2|||
124866919|NCT02586025|449135380|FG001|Treatment-Free Follow-Up|Death|11|||
125311669|NCT04186871|450768789|FG002|Overall Study|Study terminated by sponsor|0|||
125311670|NCT04186871|450768790|FG003|Overall Study|Study terminated by sponsor|1|||
124977736|NCT00350727|449545471|FG002|Phase I: Dose Escalation|Physician Decision|0|||
125311671|NCT04186871|450768791|FG004|Overall Study|Study terminated by sponsor|0|||
124977737|NCT00350727|449545469|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
124977738|NCT00350727|449545470|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
124977739|NCT00350727|449545471|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
124977740|NCT00350727|449545469|FG000|Phase II|Disease Progression|0|||
124977741|NCT00350727|449545470|FG001|Phase II|Disease Progression|15|||
124977742|NCT00350727|449545471|FG002|Phase II|Disease Progression|16|||
124977743|NCT00350727|449545469|FG000|Phase II|Clinical Deterioration|0|||
124977744|NCT00350727|449545470|FG001|Phase II|Clinical Deterioration|1|||
124977745|NCT00350727|449545471|FG002|Phase II|Clinical Deterioration|0|||
124977746|NCT00350727|449545469|FG000|Phase II|Withdrawal by Subject|0|||
124977747|NCT00350727|449545470|FG001|Phase II|Withdrawal by Subject|2|||
124977748|NCT00350727|449545471|FG002|Phase II|Withdrawal by Subject|1|||
124977749|NCT00350727|449545469|FG000|Phase II|Adverse Event|0|||
124977750|NCT00350727|449545470|FG001|Phase II|Adverse Event|1|||
124977751|NCT00350727|449545471|FG002|Phase II|Adverse Event|1|||
124977752|NCT00350727|449545469|FG000|Phase II|Death|0|||
124977753|NCT00350727|449545470|FG001|Phase II|Death|0|||
124977754|NCT00350727|449545471|FG002|Phase II|Death|2|||
124977755|NCT00350727|449545469|FG000|Phase II|Sponsor Terminated Study|0|||
124977756|NCT00350727|449545470|FG001|Phase II|Sponsor Terminated Study|0|||
124977757|NCT00350727|449545471|FG002|Phase II|Sponsor Terminated Study|1|||
124977758|NCT00350727|449545469|FG000|Phase II|Enrolled in Rollover Study|0|||
124977759|NCT00350727|449545470|FG001|Phase II|Enrolled in Rollover Study|0|||
124977760|NCT00350727|449545471|FG002|Phase II|Enrolled in Rollover Study|1|||
124977761|NCT04908631|449545472|FG000|Overall Study|Lost to Follow-up|1|||
124977762|NCT04908631|449545472|FG000|Overall Study|Physician Decision|1|||
124977763|NCT04908631|449545472|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
124977764|NCT03520712|449545473|FG000|Overall Study|Early termination of the study by Sponsor|2|||
124977765|NCT03841526|449545474|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
124977766|NCT03841526|449545475|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
124977767|NCT03841526|449545476|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
124977768|NCT03841526|449545477|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
124977769|NCT03841526|449545478|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
124977770|NCT03841526|449545479|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
124977771|NCT03841526|449545474|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
124977772|NCT03841526|449545475|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
124977773|NCT03841526|449545476|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
124977774|NCT03841526|449545477|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
124977775|NCT03841526|449545478|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
124977776|NCT03841526|449545479|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
124977777|NCT03841526|449545474|FG000|Outpatient Phase Treatment|Physician Decision|0|||
124977778|NCT03841526|449545475|FG001|Outpatient Phase Treatment|Physician Decision|1|||
124977779|NCT03841526|449545476|FG002|Outpatient Phase Treatment|Physician Decision|0|||
124977780|NCT03841526|449545477|FG003|Outpatient Phase Treatment|Physician Decision|0|||
124977781|NCT03841526|449545478|FG004|Outpatient Phase Treatment|Physician Decision|0|||
124977782|NCT03841526|449545479|FG005|Outpatient Phase Treatment|Physician Decision|0|||
124977783|NCT03841526|449545474|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
124977784|NCT03841526|449545475|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
124977785|NCT03841526|449545476|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
124977786|NCT03841526|449545477|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
124977787|NCT03841526|449545478|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
124977788|NCT03841526|449545479|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
124977789|NCT04047862|449545480|FG000|Overall Study|Death|0|||
124977790|NCT04047862|449545481|FG001|Overall Study|Death|0|||
124977791|NCT04047862|449545482|FG002|Overall Study|Death|4|||
124977792|NCT04047862|449545483|FG003|Overall Study|Death|7|||
124977793|NCT04047862|449545484|FG004|Overall Study|Death|2|||
124977794|NCT04047862|449545485|FG005|Overall Study|Death|4|||
124977795|NCT04047862|449545486|FG006|Overall Study|Death|3|||
124977796|NCT04047862|449545487|FG007|Overall Study|Death|24|||
124977797|NCT04047862|449545488|FG008|Overall Study|Death|24|||
124977798|NCT04047862|449545489|FG009|Overall Study|Death|22|||
124977799|NCT04047862|449545490|FG010|Overall Study|Death|35|||
124977800|NCT04047862|449545491|FG011|Overall Study|Death|18|||
124977801|NCT04047862|449545492|FG012|Overall Study|Death|14|||
124977802|NCT04047862|449545493|FG013|Overall Study|Death|6|||
124977803|NCT04047862|449545494|FG014|Overall Study|Death|19|||
124977804|NCT04047862|449545495|FG015|Overall Study|Death|42|||
124977805|NCT04047862|449545496|FG016|Overall Study|Death|9|||
124977806|NCT04047862|449545497|FG017|Overall Study|Death|8|||
124977807|NCT04047862|449545498|FG018|Overall Study|Death|10|||
124977808|NCT04047862|449545480|FG000|Overall Study|Withdrawal by Subject|0|||
124977809|NCT04047862|449545481|FG001|Overall Study|Withdrawal by Subject|0|||
124977810|NCT04047862|449545482|FG002|Overall Study|Withdrawal by Subject|0|||
124977811|NCT04047862|449545483|FG003|Overall Study|Withdrawal by Subject|5|||
124977812|NCT04047862|449545484|FG004|Overall Study|Withdrawal by Subject|2|||
124977813|NCT04047862|449545485|FG005|Overall Study|Withdrawal by Subject|0|||
124977814|NCT04047862|449545486|FG006|Overall Study|Withdrawal by Subject|1|||
124977815|NCT04047862|449545487|FG007|Overall Study|Withdrawal by Subject|0|||
124977816|NCT04047862|449545488|FG008|Overall Study|Withdrawal by Subject|4|||
124977817|NCT04047862|449545489|FG009|Overall Study|Withdrawal by Subject|4|||
124977818|NCT04047862|449545490|FG010|Overall Study|Withdrawal by Subject|4|||
124977819|NCT04047862|449545491|FG011|Overall Study|Withdrawal by Subject|2|||
124977820|NCT04047862|449545492|FG012|Overall Study|Withdrawal by Subject|3|||
124977821|NCT04047862|449545493|FG013|Overall Study|Withdrawal by Subject|0|||
124977822|NCT04047862|449545494|FG014|Overall Study|Withdrawal by Subject|9|||
124977823|NCT04047862|449545495|FG015|Overall Study|Withdrawal by Subject|5|||
124977824|NCT04047862|449545496|FG016|Overall Study|Withdrawal by Subject|1|||
124977825|NCT04047862|449545497|FG017|Overall Study|Withdrawal by Subject|3|||
124977826|NCT04047862|449545498|FG018|Overall Study|Withdrawal by Subject|1|||
124977827|NCT04047862|449545480|FG000|Overall Study|Lost to Follow-up|0|||
124977828|NCT04047862|449545481|FG001|Overall Study|Lost to Follow-up|0|||
124977829|NCT04047862|449545482|FG002|Overall Study|Lost to Follow-up|1|||
124977830|NCT04047862|449545483|FG003|Overall Study|Lost to Follow-up|0|||
124977831|NCT04047862|449545484|FG004|Overall Study|Lost to Follow-up|0|||
124977832|NCT04047862|449545485|FG005|Overall Study|Lost to Follow-up|0|||
124977833|NCT04047862|449545486|FG006|Overall Study|Lost to Follow-up|0|||
124977834|NCT04047862|449545487|FG007|Overall Study|Lost to Follow-up|1|||
124977835|NCT04047862|449545488|FG008|Overall Study|Lost to Follow-up|0|||
124977836|NCT04047862|449545489|FG009|Overall Study|Lost to Follow-up|1|||
124977837|NCT04047862|449545490|FG010|Overall Study|Lost to Follow-up|0|||
124977838|NCT04047862|449545491|FG011|Overall Study|Lost to Follow-up|3|||
124977839|NCT04047862|449545492|FG012|Overall Study|Lost to Follow-up|0|||
124977840|NCT04047862|449545493|FG013|Overall Study|Lost to Follow-up|0|||
124977841|NCT04047862|449545494|FG014|Overall Study|Lost to Follow-up|2|||
124977842|NCT04047862|449545495|FG015|Overall Study|Lost to Follow-up|2|||
124977843|NCT04047862|449545496|FG016|Overall Study|Lost to Follow-up|1|||
124977844|NCT04047862|449545497|FG017|Overall Study|Lost to Follow-up|0|||
124977845|NCT04047862|449545498|FG018|Overall Study|Lost to Follow-up|0|||
124977846|NCT04047862|449545480|FG000|Overall Study|Physician Decision|0|||
124977847|NCT04047862|449545481|FG001|Overall Study|Physician Decision|0|||
124977848|NCT04047862|449545482|FG002|Overall Study|Physician Decision|0|||
124977849|NCT04047862|449545483|FG003|Overall Study|Physician Decision|1|||
124977850|NCT04047862|449545484|FG004|Overall Study|Physician Decision|0|||
124977851|NCT04047862|449545485|FG005|Overall Study|Physician Decision|0|||
124977852|NCT04047862|449545486|FG006|Overall Study|Physician Decision|0|||
124977853|NCT04047862|449545487|FG007|Overall Study|Physician Decision|0|||
124977854|NCT04047862|449545488|FG008|Overall Study|Physician Decision|0|||
124977855|NCT04047862|449545489|FG009|Overall Study|Physician Decision|0|||
124977856|NCT04047862|449545490|FG010|Overall Study|Physician Decision|0|||
124977857|NCT04047862|449545491|FG011|Overall Study|Physician Decision|0|||
124977858|NCT04047862|449545492|FG012|Overall Study|Physician Decision|0|||
124977859|NCT04047862|449545493|FG013|Overall Study|Physician Decision|0|||
124977860|NCT04047862|449545494|FG014|Overall Study|Physician Decision|1|||
124977861|NCT04047862|449545495|FG015|Overall Study|Physician Decision|0|||
124977862|NCT04047862|449545496|FG016|Overall Study|Physician Decision|1|||
124977863|NCT04047862|449545497|FG017|Overall Study|Physician Decision|0|||
124977864|NCT04047862|449545498|FG018|Overall Study|Physician Decision|0|||
124977865|NCT04047862|449545480|FG000|Overall Study|Completed all Assessments|1|||
124977866|NCT04047862|449545481|FG001|Overall Study|Completed all Assessments|3|||
124977867|NCT04047862|449545482|FG002|Overall Study|Completed all Assessments|1|||
124977868|NCT04047862|449545483|FG003|Overall Study|Completed all Assessments|3|||
124977869|NCT04047862|449545484|FG004|Overall Study|Completed all Assessments|2|||
124977870|NCT04047862|449545485|FG005|Overall Study|Completed all Assessments|5|||
124977871|NCT04047862|449545486|FG006|Overall Study|Completed all Assessments|7|||
124977872|NCT04047862|449545487|FG007|Overall Study|Completed all Assessments|0|||
124977873|NCT04047862|449545488|FG008|Overall Study|Completed all Assessments|0|||
124977874|NCT04047862|449545489|FG009|Overall Study|Completed all Assessments|0|||
124977875|NCT04047862|449545490|FG010|Overall Study|Completed all Assessments|0|||
124977876|NCT04047862|449545491|FG011|Overall Study|Completed all Assessments|0|||
124977877|NCT04047862|449545492|FG012|Overall Study|Completed all Assessments|0|||
124977878|NCT04047862|449545493|FG013|Overall Study|Completed all Assessments|0|||
124977879|NCT04047862|449545494|FG014|Overall Study|Completed all Assessments|0|||
124977880|NCT04047862|449545495|FG015|Overall Study|Completed all Assessments|0|||
124977881|NCT04047862|449545496|FG016|Overall Study|Completed all Assessments|0|||
124977882|NCT04047862|449545497|FG017|Overall Study|Completed all Assessments|0|||
124977883|NCT04047862|449545498|FG018|Overall Study|Completed all Assessments|0|||
124977884|NCT04047862|449545480|FG000|Overall Study|Sponsor Decision|0|||
124977885|NCT04047862|449545481|FG001|Overall Study|Sponsor Decision|0|||
124977886|NCT04047862|449545482|FG002|Overall Study|Sponsor Decision|0|||
124977887|NCT04047862|449545483|FG003|Overall Study|Sponsor Decision|0|||
124977888|NCT04047862|449545484|FG004|Overall Study|Sponsor Decision|0|||
124977889|NCT04047862|449545485|FG005|Overall Study|Sponsor Decision|0|||
124977890|NCT04047862|449545486|FG006|Overall Study|Sponsor Decision|0|||
124977891|NCT04047862|449545487|FG007|Overall Study|Sponsor Decision|13|||
124977892|NCT04047862|449545488|FG008|Overall Study|Sponsor Decision|10|||
124977893|NCT04047862|449545489|FG009|Overall Study|Sponsor Decision|18|||
124977894|NCT04047862|449545490|FG010|Overall Study|Sponsor Decision|3|||
124977895|NCT04047862|449545491|FG011|Overall Study|Sponsor Decision|3|||
124977896|NCT04047862|449545492|FG012|Overall Study|Sponsor Decision|4|||
124977897|NCT04047862|449545493|FG013|Overall Study|Sponsor Decision|0|||
124977898|NCT04047862|449545494|FG014|Overall Study|Sponsor Decision|7|||
124977899|NCT04047862|449545495|FG015|Overall Study|Sponsor Decision|8|||
124977900|NCT04047862|449545496|FG016|Overall Study|Sponsor Decision|9|||
124977901|NCT04047862|449545497|FG017|Overall Study|Sponsor Decision|7|||
124977902|NCT04047862|449545498|FG018|Overall Study|Sponsor Decision|8|||
124977903|NCT04047862|449545480|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977904|NCT04047862|449545481|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977905|NCT04047862|449545482|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977906|NCT04047862|449545483|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977907|NCT04047862|449545484|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977908|NCT04047862|449545485|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977909|NCT04047862|449545486|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977910|NCT04047862|449545487|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
124977911|NCT04047862|449545488|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
124977912|NCT04047862|449545489|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977913|NCT04047862|449545490|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
124977914|NCT04047862|449545491|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977915|NCT04047862|449545492|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977916|NCT04047862|449545493|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977917|NCT04047862|449545494|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
124977918|NCT04047862|449545495|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
124977919|NCT04047862|449545496|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
124977920|NCT04047862|449545497|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
124977921|NCT04047862|449545498|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
124977922|NCT04047862|449545480|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977923|NCT04047862|449545481|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977924|NCT04047862|449545482|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977925|NCT04047862|449545483|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977926|NCT04047862|449545484|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977927|NCT04047862|449545485|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977928|NCT04047862|449545486|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977929|NCT04047862|449545487|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977930|NCT04047862|449545488|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977931|NCT04047862|449545489|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977932|NCT04047862|449545490|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977933|NCT04047862|449545491|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977934|NCT04047862|449545492|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977935|NCT04047862|449545493|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977936|NCT04047862|449545494|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977937|NCT04047862|449545495|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
124977938|NCT04047862|449545496|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977939|NCT04047862|449545497|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977940|NCT04047862|449545498|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
124977941|NCT04047862|449545480|FG000|Overall Study|Other|0|||
124977942|NCT04047862|449545481|FG001|Overall Study|Other|0|||
124977943|NCT04047862|449545482|FG002|Overall Study|Other|0|||
124977944|NCT04047862|449545483|FG003|Overall Study|Other|0|||
124977945|NCT04047862|449545484|FG004|Overall Study|Other|0|||
124977946|NCT04047862|449545485|FG005|Overall Study|Other|0|||
124977947|NCT04047862|449545486|FG006|Overall Study|Other|0|||
124977948|NCT04047862|449545487|FG007|Overall Study|Other|0|||
124977949|NCT04047862|449545488|FG008|Overall Study|Other|0|||
124977950|NCT04047862|449545489|FG009|Overall Study|Other|0|||
124977951|NCT04047862|449545490|FG010|Overall Study|Other|0|||
124977952|NCT04047862|449545491|FG011|Overall Study|Other|0|||
124977953|NCT04047862|449545492|FG012|Overall Study|Other|0|||
124977954|NCT04047862|449545493|FG013|Overall Study|Other|0|||
124977955|NCT04047862|449545494|FG014|Overall Study|Other|2|||
124977956|NCT04047862|449545495|FG015|Overall Study|Other|1|||
124977957|NCT04047862|449545496|FG016|Overall Study|Other|1|||
124977958|NCT04047862|449545497|FG017|Overall Study|Other|1|||
124977959|NCT04047862|449545498|FG018|Overall Study|Other|0|||
124977960|NCT04996004|449546778|FG000|Phase I|Death|1|||
124977961|NCT04996004|449546779|FG001|Phase I|Death|2|||
124977962|NCT04996004|449546780|FG002|Phase I|Death|1|||
124977963|NCT04996004|449546781|FG003|Phase I|Death|0|||
124977964|NCT04996004|449546782|FG004|Phase I|Death|0|||
124977965|NCT04996004|449546783|FG005|Phase I|Death|0|||
125088832|NCT02033369|449944483|FG001|Overall Study|Physician Decision|2|||
124977966|NCT04996004|449546778|FG000|Phase I|Study terminated by sponsor|2|||
124977967|NCT04996004|449546779|FG001|Phase I|Study terminated by sponsor|1|||
124977968|NCT04996004|449546780|FG002|Phase I|Study terminated by sponsor|2|||
124977969|NCT04996004|449546781|FG003|Phase I|Study terminated by sponsor|0|||
124977970|NCT04996004|449546782|FG004|Phase I|Study terminated by sponsor|0|||
124977971|NCT04996004|449546783|FG005|Phase I|Study terminated by sponsor|0|||
124977972|NCT04996004|449546778|FG000|Phase II|Study terminated by sponsor|0|||
124977973|NCT04996004|449546779|FG001|Phase II|Study terminated by sponsor|0|||
124977974|NCT04996004|449546780|FG002|Phase II|Study terminated by sponsor|0|||
124977975|NCT04996004|449546781|FG003|Phase II|Study terminated by sponsor|20|||
124977976|NCT04996004|449546782|FG004|Phase II|Study terminated by sponsor|10|||
124977977|NCT04996004|449546783|FG005|Phase II|Study terminated by sponsor|10|||
124977978|NCT04996004|449546778|FG000|Phase II|Withdrawal by Subject|0|||
124977979|NCT04996004|449546779|FG001|Phase II|Withdrawal by Subject|0|||
124977980|NCT04996004|449546780|FG002|Phase II|Withdrawal by Subject|0|||
124977981|NCT04996004|449546781|FG003|Phase II|Withdrawal by Subject|0|||
124977982|NCT04996004|449546782|FG004|Phase II|Withdrawal by Subject|1|||
124977983|NCT04996004|449546783|FG005|Phase II|Withdrawal by Subject|2|||
124977984|NCT04996004|449546778|FG000|Phase II|Death|0|||
124977985|NCT04996004|449546779|FG001|Phase II|Death|0|||
124977986|NCT04996004|449546780|FG002|Phase II|Death|0|||
124977987|NCT04996004|449546781|FG003|Phase II|Death|12|||
124977988|NCT04996004|449546782|FG004|Phase II|Death|2|||
124977989|NCT04996004|449546783|FG005|Phase II|Death|9|||
124977990|NCT04996004|449546778|FG000|Phase II|Other|0|||
124977991|NCT04996004|449546779|FG001|Phase II|Other|0|||
124977992|NCT04996004|449546780|FG002|Phase II|Other|0|||
124977993|NCT04996004|449546781|FG003|Phase II|Other|0|||
124977994|NCT04996004|449546782|FG004|Phase II|Other|0|||
124977995|NCT04996004|449546783|FG005|Phase II|Other|1|||
124977996|NCT02942277|449546784|FG000|Year 1|Withdrawal by Subject|0|||
124977997|NCT02942277|449546785|FG001|Year 1|Withdrawal by Subject|0|||
124977998|NCT02942277|449546786|FG002|Year 1|Withdrawal by Subject|0|||
124977999|NCT02942277|449546787|FG003|Year 1|Withdrawal by Subject|0|||
124978000|NCT02942277|449546788|FG004|Year 1|Withdrawal by Subject|1|||
124978001|NCT02942277|449546789|FG005|Year 1|Withdrawal by Subject|3|||
124978002|NCT02942277|449546790|FG006|Year 1|Withdrawal by Subject|0|||
124978003|NCT02942277|449546791|FG007|Year 1|Withdrawal by Subject|1|||
124978004|NCT02942277|449546792|FG008|Year 1|Withdrawal by Subject|0|||
124978005|NCT02942277|449546793|FG009|Year 1|Withdrawal by Subject|0|||
124978006|NCT02942277|449546794|FG010|Year 1|Withdrawal by Subject|3|||
124978007|NCT02942277|449546784|FG000|Year 1|Travel|0|||
124978008|NCT02942277|449546785|FG001|Year 1|Travel|1|||
124978009|NCT02942277|449546786|FG002|Year 1|Travel|0|||
124978010|NCT02942277|449546787|FG003|Year 1|Travel|0|||
124978011|NCT02942277|449546788|FG004|Year 1|Travel|4|||
124978012|NCT02942277|449546789|FG005|Year 1|Travel|5|||
124978013|NCT02942277|449546790|FG006|Year 1|Travel|0|||
124978014|NCT02942277|449546791|FG007|Year 1|Travel|0|||
124978015|NCT02942277|449546792|FG008|Year 1|Travel|0|||
124978016|NCT02942277|449546793|FG009|Year 1|Travel|0|||
124978017|NCT02942277|449546794|FG010|Year 1|Travel|8|||
124978018|NCT02942277|449546784|FG000|Year 1|Joined Army|0|||
124978019|NCT02942277|449546785|FG001|Year 1|Joined Army|1|||
124978020|NCT02942277|449546786|FG002|Year 1|Joined Army|0|||
124978021|NCT02942277|449546787|FG003|Year 1|Joined Army|0|||
124978022|NCT02942277|449546788|FG004|Year 1|Joined Army|0|||
124978023|NCT02942277|449546789|FG005|Year 1|Joined Army|0|||
124978024|NCT02942277|449546790|FG006|Year 1|Joined Army|0|||
124978025|NCT02942277|449546791|FG007|Year 1|Joined Army|0|||
124978026|NCT02942277|449546792|FG008|Year 1|Joined Army|0|||
124978027|NCT02942277|449546793|FG009|Year 1|Joined Army|0|||
124978028|NCT02942277|449546794|FG010|Year 1|Joined Army|0|||
124978029|NCT02942277|449546784|FG000|Year 1|Subject met withdrawal criteria|0|||
124978030|NCT02942277|449546785|FG001|Year 1|Subject met withdrawal criteria|0|||
124978031|NCT02942277|449546786|FG002|Year 1|Subject met withdrawal criteria|0|||
124978032|NCT02942277|449546787|FG003|Year 1|Subject met withdrawal criteria|1|||
124978033|NCT02942277|449546788|FG004|Year 1|Subject met withdrawal criteria|0|||
124978034|NCT02942277|449546789|FG005|Year 1|Subject met withdrawal criteria|0|||
124978035|NCT02942277|449546790|FG006|Year 1|Subject met withdrawal criteria|0|||
124978036|NCT02942277|449546791|FG007|Year 1|Subject met withdrawal criteria|0|||
124978037|NCT02942277|449546792|FG008|Year 1|Subject met withdrawal criteria|0|||
124978038|NCT02942277|449546793|FG009|Year 1|Subject met withdrawal criteria|0|||
124978039|NCT02942277|449546794|FG010|Year 1|Subject met withdrawal criteria|0|||
124978040|NCT02942277|449546784|FG000|Year 1|Lost to Follow-up|0|||
124978041|NCT02942277|449546785|FG001|Year 1|Lost to Follow-up|0|||
124978042|NCT02942277|449546786|FG002|Year 1|Lost to Follow-up|0|||
124978043|NCT02942277|449546787|FG003|Year 1|Lost to Follow-up|0|||
124978044|NCT02942277|449546788|FG004|Year 1|Lost to Follow-up|1|||
124978045|NCT02942277|449546789|FG005|Year 1|Lost to Follow-up|0|||
124978046|NCT02942277|449546790|FG006|Year 1|Lost to Follow-up|0|||
124978047|NCT02942277|449546791|FG007|Year 1|Lost to Follow-up|0|||
124978048|NCT02942277|449546792|FG008|Year 1|Lost to Follow-up|0|||
124978049|NCT02942277|449546793|FG009|Year 1|Lost to Follow-up|0|||
124978050|NCT02942277|449546794|FG010|Year 1|Lost to Follow-up|2|||
124978051|NCT02942277|449546784|FG000|Year 1|Protocol Violation|0|||
124978052|NCT02942277|449546785|FG001|Year 1|Protocol Violation|0|||
124978053|NCT02942277|449546786|FG002|Year 1|Protocol Violation|0|||
124978054|NCT02942277|449546787|FG003|Year 1|Protocol Violation|0|||
124978055|NCT02942277|449546788|FG004|Year 1|Protocol Violation|1|||
124978056|NCT02942277|449546789|FG005|Year 1|Protocol Violation|1|||
124978057|NCT02942277|449546790|FG006|Year 1|Protocol Violation|0|||
124978058|NCT02942277|449546791|FG007|Year 1|Protocol Violation|0|||
124978059|NCT02942277|449546792|FG008|Year 1|Protocol Violation|0|||
124978060|NCT02942277|449546793|FG009|Year 1|Protocol Violation|0|||
124978061|NCT02942277|449546794|FG010|Year 1|Protocol Violation|2|||
124978062|NCT02942277|449546784|FG000|Year 1|Pregnancy|0|||
124978063|NCT02942277|449546785|FG001|Year 1|Pregnancy|0|||
124978064|NCT02942277|449546786|FG002|Year 1|Pregnancy|0|||
124978065|NCT02942277|449546787|FG003|Year 1|Pregnancy|0|||
124978066|NCT02942277|449546788|FG004|Year 1|Pregnancy|0|||
124978067|NCT02942277|449546789|FG005|Year 1|Pregnancy|1|||
124978068|NCT02942277|449546790|FG006|Year 1|Pregnancy|0|||
124978069|NCT02942277|449546791|FG007|Year 1|Pregnancy|0|||
124978070|NCT02942277|449546792|FG008|Year 1|Pregnancy|0|||
124978071|NCT02942277|449546793|FG009|Year 1|Pregnancy|0|||
124978072|NCT02942277|449546794|FG010|Year 1|Pregnancy|0|||
124978073|NCT02942277|449546784|FG000|Year 2|Lost to Follow-up|0|||
124978074|NCT02942277|449546785|FG001|Year 2|Lost to Follow-up|0|||
124978075|NCT02942277|449546786|FG002|Year 2|Lost to Follow-up|0|||
124978076|NCT02942277|449546787|FG003|Year 2|Lost to Follow-up|0|||
124978077|NCT02942277|449546788|FG004|Year 2|Lost to Follow-up|2|||
124978078|NCT02942277|449546789|FG005|Year 2|Lost to Follow-up|1|||
124978079|NCT02942277|449546790|FG006|Year 2|Lost to Follow-up|0|||
124978080|NCT02942277|449546791|FG007|Year 2|Lost to Follow-up|0|||
124978081|NCT02942277|449546792|FG008|Year 2|Lost to Follow-up|0|||
124978082|NCT02942277|449546793|FG009|Year 2|Lost to Follow-up|0|||
124978083|NCT02942277|449546794|FG010|Year 2|Lost to Follow-up|0|||
124978084|NCT02942277|449546784|FG000|Year 2|Did not rescreen|0|||
124978085|NCT02942277|449546785|FG001|Year 2|Did not rescreen|0|||
124978086|NCT02942277|449546786|FG002|Year 2|Did not rescreen|1|||
124978087|NCT02942277|449546787|FG003|Year 2|Did not rescreen|1|||
124978088|NCT02942277|449546788|FG004|Year 2|Did not rescreen|9|||
124978089|NCT02942277|449546789|FG005|Year 2|Did not rescreen|6|||
124978090|NCT02942277|449546790|FG006|Year 2|Did not rescreen|0|||
124978091|NCT02942277|449546791|FG007|Year 2|Did not rescreen|1|||
124978092|NCT02942277|449546792|FG008|Year 2|Did not rescreen|0|||
124978093|NCT02942277|449546793|FG009|Year 2|Did not rescreen|0|||
124978094|NCT02942277|449546794|FG010|Year 2|Did not rescreen|21|||
124978095|NCT02942277|449546784|FG000|Year 2|Met withdrawal criteria|0|||
124978096|NCT02942277|449546785|FG001|Year 2|Met withdrawal criteria|0|||
124978097|NCT02942277|449546786|FG002|Year 2|Met withdrawal criteria|0|||
124978098|NCT02942277|449546787|FG003|Year 2|Met withdrawal criteria|0|||
124978099|NCT02942277|449546788|FG004|Year 2|Met withdrawal criteria|1|||
124978100|NCT02942277|449546789|FG005|Year 2|Met withdrawal criteria|2|||
124978101|NCT02942277|449546790|FG006|Year 2|Met withdrawal criteria|0|||
124978102|NCT02942277|449546791|FG007|Year 2|Met withdrawal criteria|0|||
124978103|NCT02942277|449546792|FG008|Year 2|Met withdrawal criteria|0|||
124978104|NCT02942277|449546793|FG009|Year 2|Met withdrawal criteria|0|||
124978105|NCT02942277|449546794|FG010|Year 2|Met withdrawal criteria|1|||
124978106|NCT02942277|449546784|FG000|Year 2|Travel|0|||
124978107|NCT02942277|449546785|FG001|Year 2|Travel|1|||
124978108|NCT02942277|449546786|FG002|Year 2|Travel|0|||
124978109|NCT02942277|449546787|FG003|Year 2|Travel|0|||
124978110|NCT02942277|449546788|FG004|Year 2|Travel|0|||
124978111|NCT02942277|449546789|FG005|Year 2|Travel|1|||
124978112|NCT02942277|449546790|FG006|Year 2|Travel|0|||
124978113|NCT02942277|449546791|FG007|Year 2|Travel|0|||
124978114|NCT02942277|449546792|FG008|Year 2|Travel|0|||
124978115|NCT02942277|449546793|FG009|Year 2|Travel|1|||
124978116|NCT02942277|449546794|FG010|Year 2|Travel|3|||
124978117|NCT02942277|449546784|FG000|Year 2|Non-compliant|0|||
124978118|NCT02942277|449546785|FG001|Year 2|Non-compliant|0|||
124978119|NCT02942277|449546786|FG002|Year 2|Non-compliant|0|||
124978120|NCT02942277|449546787|FG003|Year 2|Non-compliant|0|||
124978121|NCT02942277|449546788|FG004|Year 2|Non-compliant|1|||
124978122|NCT02942277|449546789|FG005|Year 2|Non-compliant|1|||
124978123|NCT02942277|449546790|FG006|Year 2|Non-compliant|0|||
124978124|NCT02942277|449546791|FG007|Year 2|Non-compliant|0|||
124978125|NCT02942277|449546792|FG008|Year 2|Non-compliant|0|||
124978126|NCT02942277|449546793|FG009|Year 2|Non-compliant|0|||
124978127|NCT02942277|449546794|FG010|Year 2|Non-compliant|0|||
124978128|NCT02942277|449546784|FG000|Year 2|Withdrawal by Subject|0|||
124978129|NCT02942277|449546785|FG001|Year 2|Withdrawal by Subject|0|||
124978130|NCT02942277|449546786|FG002|Year 2|Withdrawal by Subject|0|||
124978131|NCT02942277|449546787|FG003|Year 2|Withdrawal by Subject|0|||
124978132|NCT02942277|449546788|FG004|Year 2|Withdrawal by Subject|0|||
124978133|NCT02942277|449546789|FG005|Year 2|Withdrawal by Subject|0|||
124978134|NCT02942277|449546790|FG006|Year 2|Withdrawal by Subject|1|||
124978135|NCT02942277|449546791|FG007|Year 2|Withdrawal by Subject|0|||
124978136|NCT02942277|449546792|FG008|Year 2|Withdrawal by Subject|0|||
124978137|NCT02942277|449546793|FG009|Year 2|Withdrawal by Subject|0|||
124978138|NCT02942277|449546794|FG010|Year 2|Withdrawal by Subject|0|||
124978139|NCT05577715|449546795|FG000|Overall Study|Withdrawal by Subject|1|||
124978140|NCT05577715|449546795|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
124978141|NCT05577715|449546795|FG000|Overall Study|Lost to Follow-up|1|||
124978142|NCT05577715|449546795|FG000|Overall Study|Death|6|||
124978143|NCT04833127|449546800|FG000|Overall Study|Lost to Follow-up|1|||
124978144|NCT04833127|449546801|FG001|Overall Study|Lost to Follow-up|1|||
124978145|NCT04552899|449546804|FG000|Overall Study|Adverse Event|4|||
124978146|NCT04552899|449546805|FG001|Overall Study|Adverse Event|3|||
124978147|NCT04552899|449546804|FG000|Overall Study|Death|4|||
124978148|NCT04552899|449546805|FG001|Overall Study|Death|4|||
124978149|NCT04552899|449546804|FG000|Overall Study|Lost to Follow-up|8|||
124978150|NCT04552899|449546805|FG001|Overall Study|Lost to Follow-up|13|||
124978151|NCT04552899|449546804|FG000|Overall Study|Lung Transplant|4|||
124978152|NCT04552899|449546805|FG001|Overall Study|Lung Transplant|3|||
124978153|NCT04552899|449546804|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
124978154|NCT04552899|449546805|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
124978155|NCT04552899|449546804|FG000|Overall Study|Physician Decision|3|||
124978156|NCT04552899|449546805|FG001|Overall Study|Physician Decision|4|||
124978157|NCT04552899|449546804|FG000|Overall Study|Study Terminated By Sponsor|237|||
124978158|NCT04552899|449546805|FG001|Overall Study|Study Terminated By Sponsor|239|||
124978159|NCT04552899|449546804|FG000|Overall Study|Withdrawal by Subject|15|||
124978160|NCT04552899|449546805|FG001|Overall Study|Withdrawal by Subject|17|||
124978161|NCT05282121|449546806|FG000|Overall Study|Adverse Event|1|||
124978162|NCT05282121|449546807|FG001|Overall Study|Adverse Event|1|||
124978163|NCT05282121|449546808|FG002|Overall Study|Adverse Event|4|||
124978164|NCT05282121|449546809|FG003|Overall Study|Adverse Event|1|||
124978165|NCT05282121|449546806|FG000|Overall Study|Study Terminated by Sponsor|1|||
124978166|NCT05282121|449546807|FG001|Overall Study|Study Terminated by Sponsor|2|||
124978167|NCT05282121|449546808|FG002|Overall Study|Study Terminated by Sponsor|2|||
124978168|NCT05282121|449546809|FG003|Overall Study|Study Terminated by Sponsor|2|||
124978169|NCT05282121|449546806|FG000|Overall Study|Other than listed|0|||
124978170|NCT05282121|449546807|FG001|Overall Study|Other than listed|0|||
124978171|NCT05282121|449546808|FG002|Overall Study|Other than listed|1|||
124978172|NCT05282121|449546809|FG003|Overall Study|Other than listed|0|||
124978173|NCT05282121|449546806|FG000|Overall Study|No reason available|0|||
124978174|NCT05282121|449546807|FG001|Overall Study|No reason available|0|||
124978175|NCT05282121|449546808|FG002|Overall Study|No reason available|1|||
124978176|NCT05282121|449546809|FG003|Overall Study|No reason available|0|||
124978177|NCT01736189|449546810|FG000|Overall Study|Violation of registration criteria|41|||
124978178|NCT01736189|449546810|FG000|Overall Study|Protocol Violation|4|||
124978179|NCT01736189|449546810|FG000|Overall Study|Criteria and protocol violations|1|||
124978180|NCT00731133|449546817|FG000|Overall Study|Withdrawal by Subject|10|||
124978181|NCT03510455|449546818|FG000|Overall Study|Physician Decision|1|||
124978182|NCT02964325|449546827|FG000|Overall Study|Lost to Follow-up|3|||
124978183|NCT02964325|449546828|FG001|Overall Study|Lost to Follow-up|3|||
124978184|NCT02964325|449546827|FG000|Overall Study|Physician Decision|5|||
124978185|NCT02964325|449546828|FG001|Overall Study|Physician Decision|4|||
124978186|NCT02964325|449546827|FG000|Overall Study|Death|1|||
124978187|NCT02964325|449546828|FG001|Overall Study|Death|3|||
124978188|NCT02964325|449546827|FG000|Overall Study|Withdrawal by Subject|2|||
124978189|NCT02964325|449546828|FG001|Overall Study|Withdrawal by Subject|1|||
124978190|NCT02964325|449546827|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
124978191|NCT02964325|449546828|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
124978192|NCT02510040|449546829|FG000|Overall Study|Deemed no longer eligible|18|||
124978193|NCT02510040|449546830|FG001|Overall Study|Deemed no longer eligible|3|||
124978194|NCT02510040|449546831|FG002|Overall Study|Deemed no longer eligible|1|||
124978195|NCT00643617|449546832|FG000|Overall Study|Death|6|||
124978196|NCT00643617|449546833|FG001|Overall Study|Death|9|||
124978197|NCT00643617|449546832|FG000|Overall Study|Lost to Follow-up|42|||
124978198|NCT00643617|449546833|FG001|Overall Study|Lost to Follow-up|51|||
124978199|NCT02202785|449546843|FG000|Overall Study|Study Terminated by Sponsor|1|||
124978200|NCT02202785|449546844|FG001|Overall Study|Study Terminated by Sponsor|6|||
125311672|NCT04186871|450768792|FG005|Overall Study|Study terminated by sponsor|0|||
124978201|NCT02202785|449546845|FG002|Overall Study|Study Terminated by Sponsor|4|||
124978202|NCT02202785|449546843|FG000|Overall Study|Withdrawal by Subject|0|||
124978203|NCT02202785|449546844|FG001|Overall Study|Withdrawal by Subject|1|||
124978204|NCT02202785|449546845|FG002|Overall Study|Withdrawal by Subject|0|||
124978205|NCT02202785|449546843|FG000|Overall Study|Lost to Follow-up|0|||
124978206|NCT02202785|449546844|FG001|Overall Study|Lost to Follow-up|1|||
124978207|NCT02202785|449546845|FG002|Overall Study|Lost to Follow-up|0|||
124978208|NCT02202785|449546843|FG000|Overall Study|Reason not Specified|10|||
124978209|NCT02202785|449546844|FG001|Overall Study|Reason not Specified|7|||
124978210|NCT02202785|449546845|FG002|Overall Study|Reason not Specified|13|||
124978211|NCT02180243|449546846|FG000|Overall Study|Withdrawal by Subject|12|||
124978212|NCT02180243|449546847|FG001|Overall Study|Withdrawal by Subject|12|||
125311673|NCT04186871|450768787|FG000|Overall Study|Other reasons|0|||
125311674|NCT04186871|450768788|FG001|Overall Study|Other reasons|0|||
125311675|NCT04186871|450768789|FG002|Overall Study|Other reasons|0|||
124978213|NCT02180243|449546846|FG000|Overall Study|Lost to Follow-up|12|||
124978214|NCT02180243|449546847|FG001|Overall Study|Lost to Follow-up|2|||
124978215|NCT01137578|449546848|FG000|Overall Study|Participant requested to Discontinue|3|||
124978216|NCT01137578|449546849|FG001|Overall Study|Participant requested to Discontinue|0|||
124978217|NCT01137578|449546850|FG002|Overall Study|Participant requested to Discontinue|0|||
124978218|NCT01137578|449546848|FG000|Overall Study|Withdrawal by Subject|1|||
124978219|NCT01137578|449546849|FG001|Overall Study|Withdrawal by Subject|0|||
124978220|NCT01137578|449546850|FG002|Overall Study|Withdrawal by Subject|0|||
124978221|NCT01137578|449546848|FG000|Overall Study|Other|12|||
124978222|NCT01137578|449546849|FG001|Overall Study|Other|2|||
124978223|NCT01137578|449546850|FG002|Overall Study|Other|6|||
124978224|NCT04145700|449546852|FG000|Overall Study|Withdrawal by Subject|8|||
124978225|NCT04145700|449546853|FG001|Overall Study|Withdrawal by Subject|3|||
124978226|NCT00818779|449546854|FG000|Overall Study|Protocol Violation|1|||
124978227|NCT00818779|449546855|FG001|Overall Study|Protocol Violation|0|||
124978228|NCT00818779|449546854|FG000|Overall Study|Lost to Follow-up|1|||
124978229|NCT00818779|449546855|FG001|Overall Study|Lost to Follow-up|0|||
124978230|NCT00818779|449546854|FG000|Overall Study|Adverse Event|4|||
124978231|NCT00818779|449546855|FG001|Overall Study|Adverse Event|1|||
124978232|NCT04978493|449546856|FG000|Overall Study|No reason available|0|||
124978233|NCT04978493|449546857|FG001|Overall Study|No reason available|1|||
124978234|NCT04978493|449546856|FG000|Overall Study|Adverse Event|1|||
124978235|NCT04978493|449546857|FG001|Overall Study|Adverse Event|0|||
124978236|NCT01327846|449546858|FG000|Core Phase|Subject decision (vital status: missing)|1|||
124978237|NCT01327846|449546859|FG001|Core Phase|Subject decision (vital status: missing)|2|||
124978238|NCT01327846|449546860|FG002|Core Phase|Subject decision (vital status: missing)|2|||
124978239|NCT01327846|449546861|FG003|Core Phase|Subject decision (vital status: missing)|1|||
124978240|NCT01327846|449546858|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
124978241|NCT01327846|449546859|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
124978242|NCT01327846|449546860|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
124978243|NCT01327846|449546861|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
124978244|NCT01327846|449546858|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
124978245|NCT01327846|449546859|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
124978246|NCT01327846|449546860|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
124978247|NCT01327846|449546861|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
124978248|NCT01327846|449546858|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
124978249|NCT01327846|449546859|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
124978250|NCT01327846|449546860|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
124978251|NCT01327846|449546861|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
124978252|NCT01327846|449546858|FG000|Core Phase|Lost to Follow-up|3|||
124978253|NCT01327846|449546859|FG001|Core Phase|Lost to Follow-up|3|||
124978254|NCT01327846|449546860|FG002|Core Phase|Lost to Follow-up|4|||
124978255|NCT01327846|449546861|FG003|Core Phase|Lost to Follow-up|5|||
124978256|NCT01327846|449546858|FG000|Extension Phase|Study terminated by sponsor|1073|||
124978257|NCT01327846|449546859|FG001|Extension Phase|Study terminated by sponsor|1124|||
124978258|NCT01327846|449546860|FG002|Extension Phase|Study terminated by sponsor|1067|||
124978259|NCT01327846|449546861|FG003|Extension Phase|Study terminated by sponsor|1660|||
124978260|NCT01327846|449546858|FG000|Extension Phase|Withdrawal by Subject|20|||
124978261|NCT01327846|449546859|FG001|Extension Phase|Withdrawal by Subject|13|||
124978262|NCT01327846|449546860|FG002|Extension Phase|Withdrawal by Subject|19|||
124978263|NCT01327846|449546861|FG003|Extension Phase|Withdrawal by Subject|37|||
124978264|NCT01327846|449546858|FG000|Extension Phase|Lost to Follow-up|4|||
124978265|NCT01327846|449546859|FG001|Extension Phase|Lost to Follow-up|3|||
124978266|NCT01327846|449546860|FG002|Extension Phase|Lost to Follow-up|4|||
124978267|NCT01327846|449546861|FG003|Extension Phase|Lost to Follow-up|7|||
124978268|NCT01327846|449546858|FG000|Extension Phase|Technical Problems|2|||
124978269|NCT01327846|449546859|FG001|Extension Phase|Technical Problems|4|||
124978270|NCT01327846|449546860|FG002|Extension Phase|Technical Problems|2|||
124978271|NCT01327846|449546861|FG003|Extension Phase|Technical Problems|2|||
124978272|NCT04343976|449546862|FG000|Overall Study|Withdrawal by Subject|0|||
124978273|NCT04343976|449546863|FG001|Overall Study|Withdrawal by Subject|1|||
124978274|NCT00594880|449546864|FG000|Overall Study|Withdrawal by Subject|1|||
124978275|NCT00594880|449546865|FG001|Overall Study|Withdrawal by Subject|1|||
124978276|NCT00594880|449546864|FG000|Overall Study|Lost to Follow-up|1|||
124978277|NCT00594880|449546865|FG001|Overall Study|Lost to Follow-up|0|||
124978278|NCT01371708|449546866|FG000|Overall Study|Insufficient clinical response|3|||
124978279|NCT01371708|449546867|FG001|Overall Study|Insufficient clinical response|2|||
124978280|NCT01371708|449546868|FG002|Overall Study|Insufficient clinical response|0|||
124978281|NCT01371708|449546866|FG000|Overall Study|Lost to Follow-up|5|||
124978282|NCT01371708|449546867|FG001|Overall Study|Lost to Follow-up|9|||
124978283|NCT01371708|449546868|FG002|Overall Study|Lost to Follow-up|7|||
124978284|NCT01371708|449546866|FG000|Overall Study|Protocol Violation|2|||
124978285|NCT01371708|449546867|FG001|Overall Study|Protocol Violation|1|||
124978286|NCT01371708|449546868|FG002|Overall Study|Protocol Violation|2|||
124978287|NCT01371708|449546866|FG000|Overall Study|No longer willing to participate|7|||
124978288|NCT01371708|449546867|FG001|Overall Study|No longer willing to participate|7|||
124978289|NCT01371708|449546868|FG002|Overall Study|No longer willing to participate|13|||
124978290|NCT01371708|449546866|FG000|Overall Study|Medication error/not related to AE|0|||
124978291|NCT01371708|449546867|FG001|Overall Study|Medication error/not related to AE|1|||
124978292|NCT01371708|449546868|FG002|Overall Study|Medication error/not related to AE|0|||
124978293|NCT01371708|449546866|FG000|Overall Study|Other|3|||
124978294|NCT01371708|449546867|FG001|Overall Study|Other|2|||
124978295|NCT01371708|449546868|FG002|Overall Study|Other|4|||
124978296|NCT01371708|449546866|FG000|Overall Study|Adverse Event|5|||
124978297|NCT01371708|449546867|FG001|Overall Study|Adverse Event|8|||
124978298|NCT01371708|449546868|FG002|Overall Study|Adverse Event|12|||
124978299|NCT01371708|449546866|FG000|Overall Study|Started but did not receive treatment|1|||
124978300|NCT01371708|449546867|FG001|Overall Study|Started but did not receive treatment|0|||
124978301|NCT01371708|449546868|FG002|Overall Study|Started but did not receive treatment|1|||
124978302|NCT00694109|449546869|FG000|Overall Study|Physician Decision|3|||
124978303|NCT00694109|449546869|FG000|Overall Study|Adverse Event|74|||
124978304|NCT00694109|449546869|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
124978305|NCT00694109|449546869|FG000|Overall Study|Lack of Efficacy|2|||
124978306|NCT00694109|449546869|FG000|Overall Study|Withdrawal by Subject|13|||
124978307|NCT00694109|449546869|FG000|Overall Study|Pregnancy|1|||
124978308|NCT00694109|449546869|FG000|Overall Study|Enrolled but not treated|1|||
124978309|NCT00694109|449546869|FG000|Overall Study|Other|2|||
124978310|NCT00694109|449546869|FG000|Overall Study|Consented but no additional treatment|3|||
124978311|NCT01254747|449546870|FG000|Overall Study|Unacceptable subjective vision|0|||
124978312|NCT01254747|449546871|FG001|Overall Study|Unacceptable subjective vision|0|||
124978313|NCT01254747|449546872|FG002|Overall Study|Unacceptable subjective vision|0|||
124978314|NCT01254747|449546873|FG003|Overall Study|Unacceptable subjective vision|2|||
124978315|NCT01254747|449546870|FG000|Overall Study|Difficult removal handling|0|||
124978316|NCT01254747|449546871|FG001|Overall Study|Difficult removal handling|0|||
124978317|NCT01254747|449546872|FG002|Overall Study|Difficult removal handling|1|||
124978318|NCT01254747|449546873|FG003|Overall Study|Difficult removal handling|0|||
124978319|NCT01254747|449546870|FG000|Overall Study|Symptoms and problems|0|||
124978320|NCT01254747|449546871|FG001|Overall Study|Symptoms and problems|2|||
124978321|NCT01254747|449546872|FG002|Overall Study|Symptoms and problems|1|||
124978322|NCT01254747|449546873|FG003|Overall Study|Symptoms and problems|0|||
124978323|NCT01254747|449546870|FG000|Overall Study|Lost to Follow-up|0|||
124978324|NCT01254747|449546871|FG001|Overall Study|Lost to Follow-up|0|||
124978325|NCT01254747|449546872|FG002|Overall Study|Lost to Follow-up|1|||
124978326|NCT01254747|449546873|FG003|Overall Study|Lost to Follow-up|0|||
124978327|NCT01254747|449546870|FG000|Overall Study|Biomicroscopy|0|||
124978328|NCT01254747|449546871|FG001|Overall Study|Biomicroscopy|0|||
124978329|NCT01254747|449546872|FG002|Overall Study|Biomicroscopy|1|||
124978330|NCT01254747|449546873|FG003|Overall Study|Biomicroscopy|0|||
124978331|NCT01254747|449546870|FG000|Overall Study|Discomfort|0|||
124978332|NCT01254747|449546871|FG001|Overall Study|Discomfort|4|||
124978333|NCT01254747|449546872|FG002|Overall Study|Discomfort|0|||
124978334|NCT01254747|449546873|FG003|Overall Study|Discomfort|0|||
124978335|NCT00846807|449546874|FG000|Overall Study|Adverse Event|270|||
124978336|NCT00846807|449546874|FG000|Overall Study|Lost to Follow-up|94|||
124978337|NCT00846807|449546874|FG000|Overall Study|Withdrawal by Subject|56|||
124978338|NCT00846807|449546874|FG000|Overall Study|Non compliant with European label|7|||
124978339|NCT00846807|449546874|FG000|Overall Study|Switch to other anticoagulants|89|||
124978340|NCT00846807|449546874|FG000|Overall Study|No prescription after hospital discharge|56|||
124978341|NCT00846807|449546874|FG000|Overall Study|Other|60|||
124978342|NCT00245960|449546875|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
124978343|NCT00245960|449546876|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
124978344|NCT00245960|449546875|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
124978345|NCT00245960|449546876|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
124978346|NCT00245960|449546875|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
124978347|NCT00245960|449546876|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
124978348|NCT00245960|449546875|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
124978349|NCT00245960|449546876|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
124978350|NCT00245960|449546875|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
124978351|NCT00245960|449546876|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
124978352|NCT00245960|449546875|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
124978353|NCT00245960|449546876|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
124978354|NCT00245960|449546875|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
124978355|NCT00245960|449546876|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
124978356|NCT00245960|449546875|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
124978357|NCT00245960|449546876|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
124978358|NCT00245960|449546875|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
124978359|NCT00245960|449546876|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
124978360|NCT00245960|449546875|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
124978361|NCT00245960|449546876|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
124978362|NCT00245960|449546875|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
124978363|NCT00245960|449546876|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
124978364|NCT00245960|449546875|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
125311676|NCT04186871|450768790|FG003|Overall Study|Other reasons|0|||
125311677|NCT04186871|450768791|FG004|Overall Study|Other reasons|0|||
125311678|NCT04186871|450768792|FG005|Overall Study|Other reasons|1|||
125311679|NCT04186871|450768787|FG000|Overall Study|Withdrawal by Subject|0|||
125311680|NCT04186871|450768788|FG001|Overall Study|Withdrawal by Subject|0|||
125311681|NCT04186871|450768789|FG002|Overall Study|Withdrawal by Subject|0|||
125311682|NCT04186871|450768790|FG003|Overall Study|Withdrawal by Subject|0|||
125311683|NCT04186871|450768791|FG004|Overall Study|Withdrawal by Subject|0|||
125311684|NCT04186871|450768792|FG005|Overall Study|Withdrawal by Subject|1|||
125311685|NCT04186871|450768787|FG000|Overall Study|Lost to Follow-up|0|||
125311686|NCT04186871|450768788|FG001|Overall Study|Lost to Follow-up|0|||
125311687|NCT04186871|450768789|FG002|Overall Study|Lost to Follow-up|0|||
125311688|NCT04186871|450768790|FG003|Overall Study|Lost to Follow-up|0|||
125311689|NCT04186871|450768791|FG004|Overall Study|Lost to Follow-up|0|||
125311690|NCT04186871|450768792|FG005|Overall Study|Lost to Follow-up|1|||
125311691|NCT02464410|450768793|FG000|Overall Study|Death|3|||
125311692|NCT02464410|450768794|FG001|Overall Study|Death|4|||
125311693|NCT02464410|450768793|FG000|Overall Study|Lost to Follow-up|7|||
125311694|NCT02464410|450768794|FG001|Overall Study|Lost to Follow-up|9|||
125311695|NCT02464410|450768793|FG000|Overall Study|Withdrawal by Subject|12|||
125311696|NCT02464410|450768794|FG001|Overall Study|Withdrawal by Subject|3|||
125311697|NCT00176462|450768798|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
125311698|NCT00176462|450768799|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
125311699|NCT00176462|450768798|FG000|Induction (4 Weeks)|Death|1|||
125311700|NCT00176462|450768799|FG001|Induction (4 Weeks)|Death|2|||
125311701|NCT00176462|450768798|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
125311702|NCT00176462|450768799|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
125311703|NCT00176462|450768798|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
125311704|NCT00176462|450768799|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
125311705|NCT00176462|450768798|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
124978365|NCT00245960|449546876|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
124978366|NCT00737698|449546877|FG000|Overall Study|Withdrawal by Subject|6|||
124978367|NCT00737698|449546878|FG001|Overall Study|Withdrawal by Subject|5|||
124978368|NCT00737698|449546879|FG002|Overall Study|Withdrawal by Subject|3|||
124978369|NCT00737698|449546877|FG000|Overall Study|Death|0|||
124978370|NCT00737698|449546878|FG001|Overall Study|Death|0|||
124978371|NCT00737698|449546879|FG002|Overall Study|Death|1|||
124978372|NCT01067846|449546880|FG000|Overall Study|Lost to Follow-up|17|||
124978373|NCT01067846|449546881|FG001|Overall Study|Lost to Follow-up|19|||
124978374|NCT01067846|449546880|FG000|Overall Study|Withdrawal by Subject|1|||
124978375|NCT01067846|449546881|FG001|Overall Study|Withdrawal by Subject|0|||
124978376|NCT01067846|449546880|FG000|Overall Study|participation in other tx study|1|||
124978377|NCT01067846|449546881|FG001|Overall Study|participation in other tx study|0|||
124978378|NCT04608773|449546885|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
124978379|NCT04608773|449546886|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
124978380|NCT04608773|449546885|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
124978381|NCT04608773|449546886|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
124978382|NCT04608773|449546885|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
124978383|NCT04608773|449546886|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
124978384|NCT04608773|449546885|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
124978385|NCT04608773|449546886|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
124978386|NCT04608773|449546885|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
124978387|NCT04608773|449546886|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
124978388|NCT02387970|449546887|FG000|Overall Study|Did not complete 1-year follow up|1|||
124978389|NCT02387970|449546888|FG001|Overall Study|Did not complete 1-year follow up|2|||
124978390|NCT01436253|449546893|FG000|Overall Study|Lost to Follow-up|182|||
124978391|NCT01436253|449546893|FG000|Overall Study|Not meeting all eligibility criteria|117|||
124978392|NCT00316017|449546895|FG000|Overall Study|Protocol Violation|11|||
124978393|NCT00316017|449546896|FG001|Overall Study|Protocol Violation|13|||
124978394|NCT00316017|449546897|FG002|Overall Study|Protocol Violation|19|||
124978395|NCT04531982|449546900|FG000|Overall Study|Withdrawal by Subject|10|||
124978396|NCT04531982|449546901|FG001|Overall Study|Withdrawal by Subject|11|||
124978397|NCT04531982|449546900|FG000|Overall Study|Adverse Event|6|||
124978398|NCT04531982|449546901|FG001|Overall Study|Adverse Event|14|||
124978399|NCT04531982|449546900|FG000|Overall Study|Protocol Violation|6|||
124978400|NCT04531982|449546901|FG001|Overall Study|Protocol Violation|9|||
124978401|NCT04531982|449546900|FG000|Overall Study|Non-compliance with study drug|3|||
124978402|NCT04531982|449546901|FG001|Overall Study|Non-compliance with study drug|2|||
124978403|NCT04531982|449546900|FG000|Overall Study|Use of prohibited medication|2|||
124978404|NCT04531982|449546901|FG001|Overall Study|Use of prohibited medication|0|||
124978405|NCT04531982|449546900|FG000|Overall Study|Lost to Follow-up|0|||
124978406|NCT04531982|449546901|FG001|Overall Study|Lost to Follow-up|1|||
124978407|NCT04531982|449546900|FG000|Overall Study|Geopolitical conflict|2|||
124978408|NCT04531982|449546901|FG001|Overall Study|Geopolitical conflict|0|||
124978409|NCT04531982|449546900|FG000|Overall Study|Lack of Efficacy|3|||
124978410|NCT04531982|449546901|FG001|Overall Study|Lack of Efficacy|1|||
124978411|NCT04266795|449546906|FG000|Overall Study|Adverse Event|10|||
124978412|NCT04266795|449546907|FG001|Overall Study|Adverse Event|19|||
124978413|NCT04266795|449546906|FG000|Overall Study|Death|7|||
124978414|NCT04266795|449546907|FG001|Overall Study|Death|8|||
124978415|NCT04266795|449546906|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
124978416|NCT04266795|449546907|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
124978417|NCT04266795|449546906|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
124978418|NCT04266795|449546907|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
124978419|NCT04266795|449546906|FG000|Overall Study|Progressive Disease|12|||
124978420|NCT04266795|449546907|FG001|Overall Study|Progressive Disease|9|||
124978421|NCT04266795|449546906|FG000|Overall Study|Withdrawal by Patient|5|||
124978422|NCT04266795|449546907|FG001|Overall Study|Withdrawal by Patient|6|||
124978423|NCT04266795|449546906|FG000|Overall Study|Disease Relapse|3|||
124978424|NCT04266795|449546907|FG001|Overall Study|Disease Relapse|6|||
124978425|NCT04266795|449546906|FG000|Overall Study|Reason not Specified|12|||
124978426|NCT04266795|449546907|FG001|Overall Study|Reason not Specified|10|||
124978427|NCT04266795|449546906|FG000|Overall Study|Participants Ongoing on Treatment|25|||
124978428|NCT04266795|449546907|FG001|Overall Study|Participants Ongoing on Treatment|23|||
124978429|NCT03570892|449546908|FG000|Overall Study|Death|51|||
124978430|NCT03570892|449546909|FG001|Overall Study|Death|45|||
124978431|NCT03570892|449546908|FG000|Overall Study|Subject decision|5|||
124978432|NCT03570892|449546909|FG001|Overall Study|Subject decision|3|||
124978433|NCT03570892|449546908|FG000|Overall Study|Protocol Violation|1|||
124978434|NCT03570892|449546909|FG001|Overall Study|Protocol Violation|4|||
124978435|NCT03570892|449546908|FG000|Overall Study|Physician Decision|0|||
124978436|NCT03570892|449546909|FG001|Overall Study|Physician Decision|2|||
124978437|NCT01876082|449548481|FG000|Overall Study|Withdrawal by Subject|0|||
124978438|NCT01876082|449548482|FG001|Overall Study|Withdrawal by Subject|2|||
124978439|NCT01876082|449548481|FG000|Overall Study|Protocol Violation|1|||
124978440|NCT01876082|449548482|FG001|Overall Study|Protocol Violation|0|||
124978441|NCT01876082|449548481|FG000|Overall Study|Adverse Event|1|||
124978442|NCT01876082|449548482|FG001|Overall Study|Adverse Event|1|||
124978443|NCT01876082|449548481|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
124978444|NCT01876082|449548482|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
124978445|NCT04427280|449548484|FG000|Overall Study|Withdrawal by Subject|0|||
124978446|NCT04427280|449548485|FG001|Overall Study|Withdrawal by Subject|2|||
124978447|NCT03829501|449548488|FG000|Overall Study|Withdrawal of Consent|2|||
124978448|NCT03829501|449548489|FG001|Overall Study|Withdrawal of Consent|0|||
124978449|NCT03829501|449548490|FG002|Overall Study|Withdrawal of Consent|3|||
124978450|NCT03829501|449548491|FG003|Overall Study|Withdrawal of Consent|0|||
124978451|NCT03829501|449548492|FG004|Overall Study|Withdrawal of Consent|1|||
124978452|NCT03829501|449548493|FG005|Overall Study|Withdrawal of Consent|1|||
124978453|NCT03829501|449548494|FG006|Overall Study|Withdrawal of Consent|0|||
124978454|NCT03829501|449548495|FG007|Overall Study|Withdrawal of Consent|10|||
124978455|NCT03829501|449548496|FG008|Overall Study|Withdrawal of Consent|10|||
124978456|NCT03829501|449548497|FG009|Overall Study|Withdrawal of Consent|3|||
124978457|NCT03829501|449548498|FG010|Overall Study|Withdrawal of Consent|4|||
124978458|NCT03829501|449548499|FG011|Overall Study|Withdrawal of Consent|4|||
124978459|NCT03829501|449548500|FG012|Overall Study|Withdrawal of Consent|4|||
124978460|NCT03829501|449548501|FG013|Overall Study|Withdrawal of Consent|0|||
124978461|NCT03829501|449548502|FG014|Overall Study|Withdrawal of Consent|3|||
124978462|NCT03829501|449548503|FG015|Overall Study|Withdrawal of Consent|0|||
124978463|NCT03829501|449548504|FG016|Overall Study|Withdrawal of Consent|1|||
124978464|NCT03829501|449548505|FG017|Overall Study|Withdrawal of Consent|1|||
124978465|NCT03829501|449548506|FG018|Overall Study|Withdrawal of Consent|0|||
124978466|NCT03829501|449548507|FG019|Overall Study|Withdrawal of Consent|0|||
124978467|NCT03829501|449548508|FG020|Overall Study|Withdrawal of Consent|3|||
124978468|NCT03829501|449548509|FG021|Overall Study|Withdrawal of Consent|0|||
124978469|NCT03829501|449548510|FG022|Overall Study|Withdrawal of Consent|1|||
124978470|NCT03829501|449548488|FG000|Overall Study|PD|0|||
124978471|NCT03829501|449548489|FG001|Overall Study|PD|0|||
124978472|NCT03829501|449548490|FG002|Overall Study|PD|0|||
124978473|NCT03829501|449548491|FG003|Overall Study|PD|2|||
124978474|NCT03829501|449548492|FG004|Overall Study|PD|0|||
124978475|NCT03829501|449548493|FG005|Overall Study|PD|0|||
124978476|NCT03829501|449548494|FG006|Overall Study|PD|0|||
124978477|NCT03829501|449548495|FG007|Overall Study|PD|0|||
124978478|NCT03829501|449548496|FG008|Overall Study|PD|0|||
125088833|NCT02033369|449944482|FG000|Overall Study|Not a good demographic match|0|||
125088834|NCT02033369|449944483|FG001|Overall Study|Not a good demographic match|2|||
125088835|NCT02033369|449944482|FG000|Overall Study|Withdrawal by Subject|1|||
125088836|NCT02033369|449944483|FG001|Overall Study|Withdrawal by Subject|1|||
125088837|NCT02033369|449944482|FG000|Overall Study|Lost to Follow-up|1|||
125088838|NCT02033369|449944483|FG001|Overall Study|Lost to Follow-up|0|||
125088839|NCT02033369|449944482|FG000|Overall Study|Protocol Violation|2|||
125088840|NCT02033369|449944483|FG001|Overall Study|Protocol Violation|0|||
125088841|NCT01354964|449944484|FG000|Overall Study|Lost to Follow-up|2|||
125088842|NCT01354964|449944485|FG001|Overall Study|Lost to Follow-up|0|||
125088843|NCT01354964|449944484|FG000|Overall Study|IV access issues|1|||
125088844|NCT01354964|449944485|FG001|Overall Study|IV access issues|1|||
125088845|NCT01354964|449944484|FG000|Overall Study|Physician Decision|1|||
125088846|NCT01354964|449944485|FG001|Overall Study|Physician Decision|0|||
125088847|NCT02889861|449944496|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
125088848|NCT01864746|449944497|FG000|Overall Study|Disease recurrence|25|||
125088849|NCT01864746|449944498|FG001|Overall Study|Disease recurrence|40|||
125088850|NCT01864746|449944497|FG000|Overall Study|Second primary invasive nonbreast|2|||
125088851|NCT01864746|449944498|FG001|Overall Study|Second primary invasive nonbreast|3|||
125088852|NCT01864746|449944497|FG000|Overall Study|Death|2|||
125088853|NCT01864746|449944498|FG001|Overall Study|Death|1|||
125088854|NCT01864746|449944497|FG000|Overall Study|Adverse Event|33|||
125088855|NCT01864746|449944498|FG001|Overall Study|Adverse Event|5|||
125088856|NCT01864746|449944497|FG000|Overall Study|Withdrawal by Subject|56|||
125088857|NCT01864746|449944498|FG001|Overall Study|Withdrawal by Subject|41|||
125088858|NCT01864746|449944497|FG000|Overall Study|Physician Decision|5|||
125088859|NCT01864746|449944498|FG001|Overall Study|Physician Decision|6|||
125088860|NCT01005966|449944499|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
125088861|NCT01005966|449944500|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
125088862|NCT01005966|449944501|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
125088863|NCT01005966|449944502|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
125088864|NCT01005966|449944503|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
125088865|NCT01005966|449944499|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
125088866|NCT01005966|449944500|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
125088867|NCT01005966|449944501|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
125088868|NCT01005966|449944502|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
125088869|NCT01005966|449944503|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
125088870|NCT01005966|449944499|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
125088871|NCT01005966|449944500|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
125088872|NCT01005966|449944501|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
125088873|NCT01005966|449944502|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
125088874|NCT01005966|449944503|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
125088875|NCT01005966|449944499|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
125088876|NCT01005966|449944500|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
125088877|NCT01005966|449944501|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
125088878|NCT01005966|449944502|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
125088879|NCT01005966|449944503|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
125088880|NCT01005966|449944499|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125088881|NCT01005966|449944500|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125088882|NCT01005966|449944501|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125088883|NCT01005966|449944502|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
125088884|NCT01005966|449944503|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125088885|NCT01005966|449944499|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
125088886|NCT01005966|449944500|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
125088887|NCT01005966|449944501|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
125088888|NCT01005966|449944502|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
125088889|NCT01005966|449944503|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
125088890|NCT01005966|449944499|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
125088891|NCT01005966|449944500|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
125088892|NCT01005966|449944501|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
125088893|NCT01005966|449944502|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
125088894|NCT01005966|449944503|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
125088895|NCT01005966|449944499|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
125088896|NCT01005966|449944500|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
125088897|NCT01005966|449944501|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
125088898|NCT01005966|449944502|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
125088899|NCT01005966|449944503|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
125088900|NCT01005966|449944499|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
125088901|NCT01005966|449944500|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
125088902|NCT01005966|449944501|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
125088903|NCT01005966|449944502|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
125088904|NCT01005966|449944503|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
125088905|NCT01451203|449944504|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
125088906|NCT01451203|449944505|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
125088907|NCT01451203|449944504|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
125088908|NCT01451203|449944505|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
125088909|NCT01451203|449944504|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
125088910|NCT01451203|449944505|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
125088911|NCT01451203|449944504|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
125088912|NCT01451203|449944505|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
125088913|NCT01451203|449944504|FG000|Double-blind Treatment Period|Adverse Event|6|||
125088914|NCT01451203|449944505|FG001|Double-blind Treatment Period|Adverse Event|9|||
125088915|NCT01451203|449944504|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
125088916|NCT01451203|449944505|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
125088917|NCT01451203|449944504|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
125088918|NCT01451203|449944505|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
125088919|NCT01451203|449944504|FG000|Double-blind Treatment Period|Investigator decision|2|||
125088920|NCT01451203|449944505|FG001|Double-blind Treatment Period|Investigator decision|0|||
125088921|NCT01451203|449944504|FG000|Post-treatment Period|Consent withdrawn|2|||
125088922|NCT01451203|449944505|FG001|Post-treatment Period|Consent withdrawn|4|||
125088923|NCT01451203|449944504|FG000|Post-treatment Period|Lack of Efficacy|12|||
125088924|NCT01451203|449944505|FG001|Post-treatment Period|Lack of Efficacy|28|||
125088925|NCT01451203|449944504|FG000|Post-treatment Period|Adverse Event|0|||
125088926|NCT01451203|449944505|FG001|Post-treatment Period|Adverse Event|1|||
125088927|NCT01451203|449944504|FG000|Post-treatment Period|Investigator decision|0|||
125088928|NCT01451203|449944505|FG001|Post-treatment Period|Investigator decision|1|||
125088929|NCT03890731|449944506|FG000|Overall Study|Progressive disease|1|||
125088930|NCT03890731|449944506|FG000|Overall Study|Patient's decision|1|||
125088931|NCT03890731|449944506|FG000|Overall Study|Adverse Event|4|||
125088932|NCT00027027|449944510|FG000|Overall Study|Adverse Event|0|||
125088933|NCT00027027|449944511|FG001|Overall Study|Adverse Event|0|||
125088934|NCT00027027|449944512|FG002|Overall Study|Adverse Event|1|||
125088935|NCT00027027|449944513|FG003|Overall Study|Adverse Event|0|||
125088936|NCT00027027|449944514|FG004|Overall Study|Adverse Event|1|||
125088937|NCT00027027|449944510|FG000|Overall Study|Admitted for Signs of PD|0|||
125088938|NCT00027027|449944511|FG001|Overall Study|Admitted for Signs of PD|0|||
125088939|NCT00027027|449944512|FG002|Overall Study|Admitted for Signs of PD|0|||
125088940|NCT00027027|449944513|FG003|Overall Study|Admitted for Signs of PD|0|||
125088941|NCT00027027|449944514|FG004|Overall Study|Admitted for Signs of PD|1|||
125088942|NCT00027027|449944510|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
125088943|NCT00027027|449944511|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
125088944|NCT00027027|449944512|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
125088945|NCT00027027|449944513|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
125088946|NCT00027027|449944514|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
125088947|NCT00027027|449944510|FG000|Overall Study|PD Requiring Surgery|0|||
125088948|NCT00027027|449944511|FG001|Overall Study|PD Requiring Surgery|0|||
125088949|NCT00027027|449944512|FG002|Overall Study|PD Requiring Surgery|1|||
125088950|NCT00027027|449944513|FG003|Overall Study|PD Requiring Surgery|0|||
125088951|NCT00027027|449944514|FG004|Overall Study|PD Requiring Surgery|0|||
125088952|NCT00027027|449944510|FG000|Overall Study|Physician Decision Due To PD|2|||
125088953|NCT00027027|449944511|FG001|Overall Study|Physician Decision Due To PD|3|||
125088954|NCT00027027|449944512|FG002|Overall Study|Physician Decision Due To PD|2|||
125088955|NCT00027027|449944513|FG003|Overall Study|Physician Decision Due To PD|3|||
125088956|NCT00027027|449944514|FG004|Overall Study|Physician Decision Due To PD|5|||
125088957|NCT00027027|449944510|FG000|Overall Study|Withdrawal by Subject|0|||
125088958|NCT00027027|449944511|FG001|Overall Study|Withdrawal by Subject|0|||
125088959|NCT00027027|449944512|FG002|Overall Study|Withdrawal by Subject|0|||
125088960|NCT00027027|449944513|FG003|Overall Study|Withdrawal by Subject|0|||
125088961|NCT00027027|449944514|FG004|Overall Study|Withdrawal by Subject|1|||
125088962|NCT02039687|449944520|FG000|Overall Study|Adverse Event|0|||
125088963|NCT02039687|449944521|FG001|Overall Study|Adverse Event|0|||
125088964|NCT02039687|449944522|FG002|Overall Study|Adverse Event|1|||
125088965|NCT02039687|449944523|FG003|Overall Study|Adverse Event|0|||
125088966|NCT02039687|449944520|FG000|Overall Study|Withdrawal by Subject|0|||
125088967|NCT02039687|449944521|FG001|Overall Study|Withdrawal by Subject|1|||
125088968|NCT02039687|449944522|FG002|Overall Study|Withdrawal by Subject|0|||
125088969|NCT02039687|449944523|FG003|Overall Study|Withdrawal by Subject|0|||
125088970|NCT02039687|449944520|FG000|Overall Study|treatment assignment could not be confir|0|||
125088971|NCT02039687|449944521|FG001|Overall Study|treatment assignment could not be confir|0|||
125088972|NCT02039687|449944522|FG002|Overall Study|treatment assignment could not be confir|2|||
125088973|NCT02039687|449944523|FG003|Overall Study|treatment assignment could not be confir|0|||
125088974|NCT00303329|449944535|FG000|Overall Study|Adverse Event|7|||
125088975|NCT00303329|449944536|FG001|Overall Study|Adverse Event|14|||
125088976|NCT00303329|449944535|FG000|Overall Study|Abnormal Laboratory Values|0|||
125088977|NCT00303329|449944536|FG001|Overall Study|Abnormal Laboratory Values|1|||
125088978|NCT00303329|449944535|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
125088979|NCT00303329|449944536|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125088980|NCT00303329|449944535|FG000|Overall Study|Condition no longer requires study drug|0|||
125088981|NCT00303329|449944536|FG001|Overall Study|Condition no longer requires study drug|8|||
125088982|NCT00303329|449944535|FG000|Overall Study|Protocol Violation|3|||
125088983|NCT00303329|449944536|FG001|Overall Study|Protocol Violation|0|||
125088984|NCT00303329|449944535|FG000|Overall Study|Withdrawal by Subject|9|||
125088985|NCT00303329|449944536|FG001|Overall Study|Withdrawal by Subject|15|||
125088986|NCT00303329|449944535|FG000|Overall Study|Lost to Follow-up|0|||
125088987|NCT00303329|449944536|FG001|Overall Study|Lost to Follow-up|1|||
125088988|NCT00303329|449944535|FG000|Overall Study|Administrative problems|1|||
125088989|NCT00303329|449944536|FG001|Overall Study|Administrative problems|0|||
125088990|NCT00303329|449944535|FG000|Overall Study|Death|2|||
125088991|NCT00303329|449944536|FG001|Overall Study|Death|12|||
125088992|NCT00303329|449944535|FG000|Overall Study|Stopped at end of core|3|||
125088993|NCT00303329|449944536|FG001|Overall Study|Stopped at end of core|9|||
125088994|NCT00303329|449944535|FG000|Overall Study|Stopped at end of extension 1|1|||
125088995|NCT00303329|449944536|FG001|Overall Study|Stopped at end of extension 1|0|||
125088996|NCT03812224|449944537|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
125088997|NCT03812224|449944538|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
125088998|NCT03812224|449944537|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
125088999|NCT03812224|449944538|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
125089000|NCT03812224|449944537|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
125089001|NCT03812224|449944538|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
125089002|NCT03812224|449944537|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
125089003|NCT03812224|449944538|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
125089004|NCT01641952|449944539|FG000|Overall Study|Lost to Follow-up|28|||
125089005|NCT01641952|449944539|FG000|Overall Study|Adverse Event|6|||
125089006|NCT02500901|449944540|FG000|Overall Study|Disease ProgressionDD|2|||
125089007|NCT00561912|449944541|FG000|Overall Study|ineligible|1|||
125089008|NCT01398176|449944542|FG000|Overall Study|Lost to Follow-up|1|||
125089009|NCT01398176|449944543|FG001|Overall Study|Lost to Follow-up|3|||
125200071|NCT02980341|450354971|FG006|Dose Escalation|Withdrawal by Subject|0|||
125200072|NCT02980341|450354972|FG007|Dose Escalation|Withdrawal by Subject|0|||
125089010|NCT01398176|449944542|FG000|Overall Study|Physician Decision|2|||
125089011|NCT01398176|449944543|FG001|Overall Study|Physician Decision|3|||
125089012|NCT01258738|449944544|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
125089013|NCT01258738|449944545|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
125089014|NCT01258738|449944544|FG000|Double-blind Period|Withdrawal by Subject|2|||
125089015|NCT01258738|449944545|FG001|Double-blind Period|Withdrawal by Subject|2|||
125311706|NCT00176462|450768799|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
125311707|NCT00176462|450768798|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
125311708|NCT00176462|450768799|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
125311709|NCT00176462|450768798|FG000|Consolidation (12 Weeks)|Not documented|0|||
125311710|NCT00176462|450768799|FG001|Consolidation (12 Weeks)|Not documented|1|||
125311711|NCT00176462|450768798|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
125311712|NCT00176462|450768799|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
125311713|NCT00176462|450768798|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
125311714|NCT00176462|450768799|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
125311715|NCT01408459|450768800|FG000|Overall Study|Withdrawal by Subject|1|||
125311716|NCT01408459|450768801|FG001|Overall Study|Withdrawal by Subject|1|||
125311717|NCT01657292|450768806|FG000|Overall Study|Adverse Event|6|||
125311718|NCT01657292|450768806|FG000|Overall Study|Withdrawal by Subject|2|||
125311719|NCT01657292|450768806|FG000|Overall Study|Violation of eligibility criteria|1|||
125311720|NCT01657292|450768806|FG000|Overall Study|Change of therapy|1|||
125311721|NCT00650845|450768807|FG000|Overall Study|Withdrawal by Subject|5|||
125311722|NCT00650845|450768808|FG001|Overall Study|Withdrawal by Subject|0|||
125311723|NCT00650845|450768807|FG000|Overall Study|Protocol Violation|0|||
125311724|NCT00650845|450768808|FG001|Overall Study|Protocol Violation|13|||
125089016|NCT01258738|449944544|FG000|Double-blind Period|Protocol Violation|1|||
125089017|NCT01258738|449944545|FG001|Double-blind Period|Protocol Violation|1|||
125089018|NCT01258738|449944544|FG000|Double-blind Period|Adverse Event|3|||
125089019|NCT01258738|449944545|FG001|Double-blind Period|Adverse Event|1|||
125311725|NCT03932760|450768809|FG000|Overall Study|Became Ineligible|2|||
125089020|NCT01258738|449944544|FG000|Open-label Period|Did not meet inclusion criteria|0|||
125089021|NCT01258738|449944545|FG001|Open-label Period|Did not meet inclusion criteria|1|||
125089022|NCT01258738|449944544|FG000|Open-label Period|Insufficient clinical response|5|||
125089023|NCT01258738|449944545|FG001|Open-label Period|Insufficient clinical response|3|||
125311726|NCT03932760|450768810|FG001|Overall Study|Became Ineligible|5|||
125089024|NCT01258738|449944544|FG000|Open-label Period|Lost to Follow-up|0|||
125311727|NCT03932760|450768809|FG000|Overall Study|Withdrawal by Subject|6|||
125311728|NCT03932760|450768810|FG001|Overall Study|Withdrawal by Subject|6|||
125311729|NCT01301833|450768811|FG000|Overall Study|Adverse Event|7|||
125311730|NCT01301833|450768812|FG001|Overall Study|Adverse Event|5|||
125311731|NCT01301833|450768813|FG002|Overall Study|Adverse Event|5|||
125089025|NCT01258738|449944545|FG001|Open-label Period|Lost to Follow-up|2|||
125089026|NCT01258738|449944544|FG000|Open-label Period|Withdrawal by Subject|5|||
125089027|NCT01258738|449944545|FG001|Open-label Period|Withdrawal by Subject|6|||
125089028|NCT01258738|449944544|FG000|Open-label Period|Protocol Violation|2|||
125089029|NCT01258738|449944545|FG001|Open-label Period|Protocol Violation|2|||
125089030|NCT01258738|449944544|FG000|Open-label Period|Adverse Event|4|||
125089031|NCT01258738|449944545|FG001|Open-label Period|Adverse Event|5|||
125089032|NCT01258738|449944544|FG000|Open-label Period|Other Reasons|0|||
125089033|NCT01258738|449944545|FG001|Open-label Period|Other Reasons|1|||
125089034|NCT01258738|449944544|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
125089035|NCT01258738|449944545|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
125089036|NCT00689611|449944546|FG000|Overall Study|Death|6|||
125089037|NCT00689611|449944547|FG001|Overall Study|Death|9|||
125089038|NCT00689611|449944546|FG000|Overall Study|Withdrawal by Subject|8|||
125089039|NCT00689611|449944547|FG001|Overall Study|Withdrawal by Subject|9|||
125089040|NCT00689611|449944546|FG000|Overall Study|Lost to Follow-up|27|||
125089041|NCT00689611|449944547|FG001|Overall Study|Lost to Follow-up|28|||
125089042|NCT00568399|449944548|FG000|Overall Study|Death|2|||
125089043|NCT00568399|449944548|FG000|Overall Study|Adverse Event|5|||
125089044|NCT00568399|449944548|FG000|Overall Study|Withdrawal by Subject|8|||
125089045|NCT03018028|449944549|FG000|Overall Study|Withdrawal by Subject|3|||
125089046|NCT03018028|449944550|FG001|Overall Study|Withdrawal by Subject|0|||
125089047|NCT03018028|449944551|FG002|Overall Study|Withdrawal by Subject|1|||
125089048|NCT03018028|449944552|FG003|Overall Study|Withdrawal by Subject|2|||
125089049|NCT03018028|449944553|FG004|Overall Study|Withdrawal by Subject|0|||
125089050|NCT02543801|449944554|FG000|Overall Study|Protocol Violation|1|||
125089051|NCT02543801|449944555|FG001|Overall Study|Protocol Violation|2|||
125089052|NCT02543801|449944556|FG002|Overall Study|Protocol Violation|0|||
125089053|NCT02543801|449944557|FG003|Overall Study|Protocol Violation|0|||
125089054|NCT02364999|449944567|FG000|Overall Study|Death|136|||
125089055|NCT02364999|449944568|FG001|Overall Study|Death|138|||
125089056|NCT02364999|449944567|FG000|Overall Study|Lost to Follow-up|10|||
125089057|NCT02364999|449944568|FG001|Overall Study|Lost to Follow-up|15|||
125089058|NCT02364999|449944567|FG000|Overall Study|Protocol Violation|3|||
125089059|NCT02364999|449944568|FG001|Overall Study|Protocol Violation|2|||
125089060|NCT02364999|449944567|FG000|Overall Study|Withdrawal by Subject|14|||
125089061|NCT02364999|449944568|FG001|Overall Study|Withdrawal by Subject|14|||
125089062|NCT02364999|449944567|FG000|Overall Study|Other|0|||
125089063|NCT02364999|449944568|FG001|Overall Study|Other|1|||
125089064|NCT02364999|449944567|FG000|Overall Study|Randomized but did not receive treatment|2|||
125089065|NCT02364999|449944568|FG001|Overall Study|Randomized but did not receive treatment|3|||
125089066|NCT01566981|449944569|FG000|Overall Study|Lost to Follow-up|5|||
125089067|NCT01566981|449944570|FG001|Overall Study|Lost to Follow-up|8|||
125089068|NCT03323385|449944577|FG000|Overall Study|Withdrawal by Subject|1|||
125089069|NCT03323385|449944578|FG001|Overall Study|Withdrawal by Subject|2|||
125089070|NCT03323385|449944577|FG000|Overall Study|Noncompliance|0|||
125089071|NCT03323385|449944578|FG001|Overall Study|Noncompliance|1|||
125089072|NCT01849289|449944579|FG000|Overall Study|Adverse Event|3|||
125089073|NCT01849289|449944580|FG001|Overall Study|Adverse Event|3|||
125089074|NCT01849289|449944579|FG000|Overall Study|Protocol Violation|3|||
125089075|NCT01849289|449944580|FG001|Overall Study|Protocol Violation|3|||
125089076|NCT01849289|449944579|FG000|Overall Study|Withdrawal criteria|1|||
125089077|NCT01849289|449944580|FG001|Overall Study|Withdrawal criteria|0|||
125089078|NCT01849289|449944579|FG000|Overall Study|Unclassified|25|||
125089079|NCT01849289|449944580|FG001|Overall Study|Unclassified|18|||
125089080|NCT00660816|449944584|FG000|Overall Study|Adverse Event|1|||
125089081|NCT00660816|449944585|FG001|Overall Study|Adverse Event|2|||
125089082|NCT00660816|449944584|FG000|Overall Study|Withdrawal by Subject|1|||
125089083|NCT00660816|449944585|FG001|Overall Study|Withdrawal by Subject|0|||
125089084|NCT00660816|449944584|FG000|Overall Study|Death|0|||
125089085|NCT00660816|449944585|FG001|Overall Study|Death|2|||
125089086|NCT00660816|449944584|FG000|Overall Study|Lack of Efficacy|1|||
125089087|NCT00660816|449944585|FG001|Overall Study|Lack of Efficacy|0|||
125089088|NCT00660816|449944584|FG000|Overall Study|Physician Decision|0|||
125089089|NCT00660816|449944585|FG001|Overall Study|Physician Decision|2|||
125089090|NCT00660816|449944584|FG000|Overall Study|Protocol Violation|1|||
125089091|NCT00660816|449944585|FG001|Overall Study|Protocol Violation|0|||
125089092|NCT00660816|449944584|FG000|Overall Study|Disease Progression|16|||
125089093|NCT00660816|449944585|FG001|Overall Study|Disease Progression|12|||
125089094|NCT00660816|449944584|FG000|Overall Study|Complicating Disease|0|||
125089095|NCT00660816|449944585|FG001|Overall Study|Complicating Disease|1|||
125089096|NCT02692560|449944586|FG000|Overall Study|Withdrawal by Subject|0|||
125089097|NCT02692560|449944587|FG001|Overall Study|Withdrawal by Subject|6|||
125089098|NCT00420212|449944590|FG000|Overall Study|Adverse Event|22|||
125089099|NCT00420212|449944591|FG001|Overall Study|Adverse Event|40|||
125089100|NCT00420212|449944592|FG002|Overall Study|Adverse Event|36|||
125089101|NCT00420212|449944590|FG000|Overall Study|Lost to Follow-up|9|||
125089102|NCT00420212|449944591|FG001|Overall Study|Lost to Follow-up|11|||
125089103|NCT00420212|449944592|FG002|Overall Study|Lost to Follow-up|11|||
125089104|NCT00420212|449944590|FG000|Overall Study|Withdrawal by Subject|31|||
125089105|NCT00420212|449944591|FG001|Overall Study|Withdrawal by Subject|22|||
125089106|NCT00420212|449944592|FG002|Overall Study|Withdrawal by Subject|19|||
125089107|NCT00420212|449944590|FG000|Overall Study|Physician Decision|4|||
125089108|NCT00420212|449944591|FG001|Overall Study|Physician Decision|4|||
125089109|NCT00420212|449944592|FG002|Overall Study|Physician Decision|3|||
125089110|NCT00420212|449944590|FG000|Overall Study|Protocol Violation|4|||
125089111|NCT00420212|449944591|FG001|Overall Study|Protocol Violation|4|||
125089112|NCT00420212|449944592|FG002|Overall Study|Protocol Violation|8|||
125089113|NCT00420212|449944590|FG000|Overall Study|Death|0|||
125311732|NCT01301833|450768814|FG003|Overall Study|Adverse Event|5|||
125311733|NCT01301833|450768811|FG000|Overall Study|Lack of Efficacy|1|||
125089114|NCT00420212|449944591|FG001|Overall Study|Death|0|||
125089115|NCT00420212|449944592|FG002|Overall Study|Death|1|||
125089116|NCT00420212|449944590|FG000|Overall Study|Other-Unspecified|21|||
125089117|NCT00420212|449944591|FG001|Overall Study|Other-Unspecified|14|||
125089118|NCT00420212|449944592|FG002|Overall Study|Other-Unspecified|18|||
125089119|NCT01326910|449944593|FG000|Overall Study|Withdrawal by Subject|3|||
125089120|NCT01326910|449944594|FG001|Overall Study|Withdrawal by Subject|2|||
125200073|NCT02980341|450354973|FG008|Dose Escalation|Withdrawal by Subject|0|||
125200074|NCT02980341|450354974|FG009|Dose Escalation|Withdrawal by Subject|0|||
125200075|NCT02980341|450354975|FG010|Dose Escalation|Withdrawal by Subject|0|||
125200076|NCT02980341|450354965|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
125200077|NCT02980341|450354966|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
125200078|NCT02980341|450354967|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
125200079|NCT02980341|450354968|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
125200080|NCT02980341|450354969|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
125217434|NCT01348100|450423521|FG001|Overall Study|Lost to Follow-up|0|||
125311734|NCT01301833|450768812|FG001|Overall Study|Lack of Efficacy|1|||
125089121|NCT01326910|449944593|FG000|Overall Study|Protocol Violation|1|||
125089122|NCT01326910|449944594|FG001|Overall Study|Protocol Violation|1|||
125089123|NCT01681836|449944595|FG000|Second Intervention|Withdrawal by Subject|0|||
125089124|NCT01681836|449944596|FG001|Second Intervention|Withdrawal by Subject|1|||
125089125|NCT02394028|449944597|FG000|Induction Phase|Adverse Event|2|||
125089126|NCT02394028|449944598|FG001|Induction Phase|Adverse Event|4|||
125089127|NCT02394028|449944599|FG002|Induction Phase|Adverse Event|1|||
125089128|NCT02394028|449944600|FG003|Induction Phase|Adverse Event|2|||
125089129|NCT02394028|449944601|FG004|Induction Phase|Adverse Event|5|||
125089130|NCT02394028|449944602|FG005|Induction Phase|Adverse Event|2|||
125089131|NCT02394028|449944603|FG006|Induction Phase|Adverse Event|0|||
125089132|NCT02394028|449944604|FG007|Induction Phase|Adverse Event|0|||
125089133|NCT02394028|449944605|FG008|Induction Phase|Adverse Event|0|||
125089134|NCT02394028|449944606|FG009|Induction Phase|Adverse Event|0|||
125089135|NCT02394028|449944607|FG010|Induction Phase|Adverse Event|0|||
125089136|NCT02394028|449944597|FG000|Induction Phase|Lack of Efficacy|3|||
125089137|NCT02394028|449944598|FG001|Induction Phase|Lack of Efficacy|6|||
125089138|NCT02394028|449944599|FG002|Induction Phase|Lack of Efficacy|2|||
125089139|NCT02394028|449944600|FG003|Induction Phase|Lack of Efficacy|17|||
125089140|NCT02394028|449944601|FG004|Induction Phase|Lack of Efficacy|14|||
125089141|NCT02394028|449944602|FG005|Induction Phase|Lack of Efficacy|8|||
125089142|NCT02394028|449944603|FG006|Induction Phase|Lack of Efficacy|17|||
125089143|NCT02394028|449944604|FG007|Induction Phase|Lack of Efficacy|23|||
125089144|NCT02394028|449944605|FG008|Induction Phase|Lack of Efficacy|0|||
125089145|NCT02394028|449944606|FG009|Induction Phase|Lack of Efficacy|0|||
125089146|NCT02394028|449944607|FG010|Induction Phase|Lack of Efficacy|0|||
125089147|NCT02394028|449944597|FG000|Induction Phase|Lost to Follow-up|1|||
125089148|NCT02394028|449944598|FG001|Induction Phase|Lost to Follow-up|0|||
125089149|NCT02394028|449944599|FG002|Induction Phase|Lost to Follow-up|0|||
125089150|NCT02394028|449944600|FG003|Induction Phase|Lost to Follow-up|1|||
125089151|NCT02394028|449944601|FG004|Induction Phase|Lost to Follow-up|0|||
125089152|NCT02394028|449944602|FG005|Induction Phase|Lost to Follow-up|0|||
125089153|NCT02394028|449944603|FG006|Induction Phase|Lost to Follow-up|1|||
125089154|NCT02394028|449944604|FG007|Induction Phase|Lost to Follow-up|0|||
125089155|NCT02394028|449944605|FG008|Induction Phase|Lost to Follow-up|0|||
125089156|NCT02394028|449944606|FG009|Induction Phase|Lost to Follow-up|0|||
125089157|NCT02394028|449944607|FG010|Induction Phase|Lost to Follow-up|0|||
125089158|NCT02394028|449944597|FG000|Induction Phase|Non-compliance|0|||
125089159|NCT02394028|449944598|FG001|Induction Phase|Non-compliance|1|||
125089160|NCT02394028|449944599|FG002|Induction Phase|Non-compliance|3|||
125089161|NCT02394028|449944600|FG003|Induction Phase|Non-compliance|1|||
125089162|NCT02394028|449944601|FG004|Induction Phase|Non-compliance|3|||
125089163|NCT02394028|449944602|FG005|Induction Phase|Non-compliance|0|||
125089164|NCT02394028|449944603|FG006|Induction Phase|Non-compliance|1|||
125089165|NCT02394028|449944604|FG007|Induction Phase|Non-compliance|1|||
125089166|NCT02394028|449944605|FG008|Induction Phase|Non-compliance|0|||
125089167|NCT02394028|449944606|FG009|Induction Phase|Non-compliance|0|||
125089168|NCT02394028|449944607|FG010|Induction Phase|Non-compliance|0|||
125089169|NCT02394028|449944597|FG000|Induction Phase|Physician Decision|0|||
125089170|NCT02394028|449944598|FG001|Induction Phase|Physician Decision|0|||
125311735|NCT01301833|450768813|FG002|Overall Study|Lack of Efficacy|0|||
125311736|NCT01301833|450768814|FG003|Overall Study|Lack of Efficacy|0|||
125311737|NCT01301833|450768811|FG000|Overall Study|Physician Decision|3|||
125311738|NCT01301833|450768812|FG001|Overall Study|Physician Decision|1|||
125311739|NCT01301833|450768813|FG002|Overall Study|Physician Decision|1|||
125311740|NCT01301833|450768814|FG003|Overall Study|Physician Decision|0|||
125311741|NCT01301833|450768811|FG000|Overall Study|Withdrawal by Subject|3|||
125311742|NCT01301833|450768812|FG001|Overall Study|Withdrawal by Subject|1|||
125311743|NCT01301833|450768813|FG002|Overall Study|Withdrawal by Subject|1|||
125311744|NCT01301833|450768814|FG003|Overall Study|Withdrawal by Subject|2|||
125311745|NCT01301833|450768811|FG000|Overall Study|Personal matter|1|||
125311746|NCT01301833|450768812|FG001|Overall Study|Personal matter|0|||
125311747|NCT01301833|450768813|FG002|Overall Study|Personal matter|0|||
125311748|NCT01301833|450768814|FG003|Overall Study|Personal matter|0|||
125311749|NCT03922620|450768815|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
125311750|NCT03922620|450768816|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
125311751|NCT03566082|450768817|FG000|Overall Study|Death|7|||
125089171|NCT02394028|449944599|FG002|Induction Phase|Physician Decision|1|||
125089172|NCT02394028|449944600|FG003|Induction Phase|Physician Decision|4|||
125089173|NCT02394028|449944601|FG004|Induction Phase|Physician Decision|0|||
125089174|NCT02394028|449944602|FG005|Induction Phase|Physician Decision|2|||
125089175|NCT02394028|449944603|FG006|Induction Phase|Physician Decision|1|||
125089176|NCT02394028|449944604|FG007|Induction Phase|Physician Decision|0|||
125089177|NCT02394028|449944605|FG008|Induction Phase|Physician Decision|0|||
125089178|NCT02394028|449944606|FG009|Induction Phase|Physician Decision|0|||
125089179|NCT02394028|449944607|FG010|Induction Phase|Physician Decision|0|||
125089180|NCT02394028|449944597|FG000|Induction Phase|Protocol Violation|0|||
125089181|NCT02394028|449944598|FG001|Induction Phase|Protocol Violation|2|||
125089182|NCT02394028|449944599|FG002|Induction Phase|Protocol Violation|0|||
125089183|NCT02394028|449944600|FG003|Induction Phase|Protocol Violation|3|||
125089184|NCT02394028|449944601|FG004|Induction Phase|Protocol Violation|0|||
125089185|NCT02394028|449944602|FG005|Induction Phase|Protocol Violation|1|||
125089186|NCT02394028|449944603|FG006|Induction Phase|Protocol Violation|1|||
125089187|NCT02394028|449944604|FG007|Induction Phase|Protocol Violation|0|||
125089188|NCT02394028|449944605|FG008|Induction Phase|Protocol Violation|0|||
125089189|NCT02394028|449944606|FG009|Induction Phase|Protocol Violation|0|||
125089190|NCT02394028|449944607|FG010|Induction Phase|Protocol Violation|0|||
125089191|NCT02394028|449944597|FG000|Induction Phase|Withdrawal by Subject|1|||
125089192|NCT02394028|449944598|FG001|Induction Phase|Withdrawal by Subject|2|||
125089193|NCT02394028|449944599|FG002|Induction Phase|Withdrawal by Subject|4|||
125089194|NCT02394028|449944600|FG003|Induction Phase|Withdrawal by Subject|6|||
125089195|NCT02394028|449944601|FG004|Induction Phase|Withdrawal by Subject|7|||
125089196|NCT02394028|449944602|FG005|Induction Phase|Withdrawal by Subject|4|||
125089197|NCT02394028|449944603|FG006|Induction Phase|Withdrawal by Subject|3|||
125089198|NCT02394028|449944604|FG007|Induction Phase|Withdrawal by Subject|6|||
125089199|NCT02394028|449944605|FG008|Induction Phase|Withdrawal by Subject|0|||
125089200|NCT02394028|449944606|FG009|Induction Phase|Withdrawal by Subject|0|||
125089201|NCT02394028|449944607|FG010|Induction Phase|Withdrawal by Subject|0|||
125089202|NCT02394028|449944597|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
125089203|NCT02394028|449944598|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
125089204|NCT02394028|449944599|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
125089205|NCT02394028|449944600|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
125089206|NCT02394028|449944601|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
125089207|NCT02394028|449944602|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
125089208|NCT02394028|449944603|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
125089209|NCT02394028|449944604|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
125089210|NCT02394028|449944605|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
125089211|NCT02394028|449944606|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
125089212|NCT02394028|449944607|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
125089213|NCT02394028|449944597|FG000|Induction Phase|Sponsor decision|0|||
125089214|NCT02394028|449944598|FG001|Induction Phase|Sponsor decision|1|||
124866920|NCT02586025|449135379|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
124978479|NCT03829501|449548497|FG009|Overall Study|PD|0|||
125089215|NCT02394028|449944599|FG002|Induction Phase|Sponsor decision|2|||
125089216|NCT02394028|449944600|FG003|Induction Phase|Sponsor decision|0|||
125089217|NCT02394028|449944601|FG004|Induction Phase|Sponsor decision|0|||
125089218|NCT02394028|449944602|FG005|Induction Phase|Sponsor decision|0|||
125089219|NCT02394028|449944603|FG006|Induction Phase|Sponsor decision|0|||
125089220|NCT02394028|449944604|FG007|Induction Phase|Sponsor decision|0|||
125089221|NCT02394028|449944605|FG008|Induction Phase|Sponsor decision|0|||
125089222|NCT02394028|449944606|FG009|Induction Phase|Sponsor decision|0|||
125089223|NCT02394028|449944607|FG010|Induction Phase|Sponsor decision|0|||
125089224|NCT02394028|449944597|FG000|Induction Phase|Technical reason|0|||
125089225|NCT02394028|449944598|FG001|Induction Phase|Technical reason|0|||
125089226|NCT02394028|449944599|FG002|Induction Phase|Technical reason|0|||
125089227|NCT02394028|449944600|FG003|Induction Phase|Technical reason|1|||
125089228|NCT02394028|449944601|FG004|Induction Phase|Technical reason|0|||
125089229|NCT02394028|449944602|FG005|Induction Phase|Technical reason|0|||
125089230|NCT02394028|449944603|FG006|Induction Phase|Technical reason|0|||
125089231|NCT02394028|449944604|FG007|Induction Phase|Technical reason|0|||
125089232|NCT02394028|449944605|FG008|Induction Phase|Technical reason|0|||
125089233|NCT02394028|449944606|FG009|Induction Phase|Technical reason|0|||
125089234|NCT02394028|449944607|FG010|Induction Phase|Technical reason|0|||
125089235|NCT02394028|449944597|FG000|Induction Phase|:ack of calculation|0|||
125089236|NCT02394028|449944598|FG001|Induction Phase|:ack of calculation|0|||
125089237|NCT02394028|449944599|FG002|Induction Phase|:ack of calculation|0|||
125089238|NCT02394028|449944600|FG003|Induction Phase|:ack of calculation|0|||
125089239|NCT02394028|449944601|FG004|Induction Phase|:ack of calculation|0|||
125089240|NCT02394028|449944602|FG005|Induction Phase|:ack of calculation|0|||
125089241|NCT02394028|449944603|FG006|Induction Phase|:ack of calculation|0|||
125089242|NCT02394028|449944604|FG007|Induction Phase|:ack of calculation|1|||
125089243|NCT02394028|449944605|FG008|Induction Phase|:ack of calculation|0|||
125089244|NCT02394028|449944606|FG009|Induction Phase|:ack of calculation|0|||
125089245|NCT02394028|449944607|FG010|Induction Phase|:ack of calculation|0|||
125089246|NCT02394028|449944597|FG000|Maintenance Phase|Protocol Violation|0|||
125089247|NCT02394028|449944598|FG001|Maintenance Phase|Protocol Violation|0|||
125089248|NCT02394028|449944599|FG002|Maintenance Phase|Protocol Violation|0|||
125089249|NCT02394028|449944600|FG003|Maintenance Phase|Protocol Violation|0|||
125089250|NCT02394028|449944601|FG004|Maintenance Phase|Protocol Violation|0|||
125089251|NCT02394028|449944602|FG005|Maintenance Phase|Protocol Violation|0|||
125089252|NCT02394028|449944603|FG006|Maintenance Phase|Protocol Violation|0|||
125089253|NCT02394028|449944604|FG007|Maintenance Phase|Protocol Violation|0|||
125089254|NCT02394028|449944605|FG008|Maintenance Phase|Protocol Violation|0|||
125089255|NCT02394028|449944606|FG009|Maintenance Phase|Protocol Violation|0|||
125089256|NCT02394028|449944607|FG010|Maintenance Phase|Protocol Violation|1|||
125089257|NCT02394028|449944597|FG000|Maintenance Phase|Physician Decision|0|||
125089258|NCT02394028|449944598|FG001|Maintenance Phase|Physician Decision|0|||
125089259|NCT02394028|449944599|FG002|Maintenance Phase|Physician Decision|0|||
125089260|NCT02394028|449944600|FG003|Maintenance Phase|Physician Decision|0|||
125089261|NCT02394028|449944601|FG004|Maintenance Phase|Physician Decision|0|||
125089262|NCT02394028|449944602|FG005|Maintenance Phase|Physician Decision|0|||
125089263|NCT02394028|449944603|FG006|Maintenance Phase|Physician Decision|0|||
125089264|NCT02394028|449944604|FG007|Maintenance Phase|Physician Decision|0|||
125089265|NCT02394028|449944605|FG008|Maintenance Phase|Physician Decision|1|||
125089266|NCT02394028|449944606|FG009|Maintenance Phase|Physician Decision|3|||
125089267|NCT02394028|449944607|FG010|Maintenance Phase|Physician Decision|2|||
125089268|NCT02394028|449944597|FG000|Maintenance Phase|Lack of Efficacy|0|||
125089269|NCT02394028|449944598|FG001|Maintenance Phase|Lack of Efficacy|0|||
125089270|NCT02394028|449944599|FG002|Maintenance Phase|Lack of Efficacy|0|||
125089271|NCT02394028|449944600|FG003|Maintenance Phase|Lack of Efficacy|0|||
125089272|NCT02394028|449944601|FG004|Maintenance Phase|Lack of Efficacy|0|||
125089273|NCT02394028|449944602|FG005|Maintenance Phase|Lack of Efficacy|0|||
125089274|NCT02394028|449944603|FG006|Maintenance Phase|Lack of Efficacy|0|||
125089275|NCT02394028|449944604|FG007|Maintenance Phase|Lack of Efficacy|0|||
125089276|NCT02394028|449944605|FG008|Maintenance Phase|Lack of Efficacy|7|||
125089277|NCT02394028|449944606|FG009|Maintenance Phase|Lack of Efficacy|25|||
125089278|NCT02394028|449944607|FG010|Maintenance Phase|Lack of Efficacy|33|||
125089279|NCT02394028|449944597|FG000|Maintenance Phase|Death|0|||
125089280|NCT02394028|449944598|FG001|Maintenance Phase|Death|0|||
125089281|NCT02394028|449944599|FG002|Maintenance Phase|Death|0|||
125089282|NCT02394028|449944600|FG003|Maintenance Phase|Death|0|||
125089283|NCT02394028|449944601|FG004|Maintenance Phase|Death|0|||
125089284|NCT02394028|449944602|FG005|Maintenance Phase|Death|0|||
125089285|NCT02394028|449944603|FG006|Maintenance Phase|Death|0|||
125089286|NCT02394028|449944604|FG007|Maintenance Phase|Death|0|||
125089287|NCT02394028|449944605|FG008|Maintenance Phase|Death|0|||
125089288|NCT02394028|449944606|FG009|Maintenance Phase|Death|0|||
125089289|NCT02394028|449944607|FG010|Maintenance Phase|Death|1|||
125089290|NCT02394028|449944597|FG000|Maintenance Phase|Adverse Event|0|||
125089291|NCT02394028|449944598|FG001|Maintenance Phase|Adverse Event|0|||
125089292|NCT02394028|449944599|FG002|Maintenance Phase|Adverse Event|0|||
125089293|NCT02394028|449944600|FG003|Maintenance Phase|Adverse Event|0|||
125089294|NCT02394028|449944601|FG004|Maintenance Phase|Adverse Event|0|||
125089295|NCT02394028|449944602|FG005|Maintenance Phase|Adverse Event|0|||
125089296|NCT02394028|449944603|FG006|Maintenance Phase|Adverse Event|0|||
125089297|NCT02394028|449944604|FG007|Maintenance Phase|Adverse Event|0|||
125089298|NCT02394028|449944605|FG008|Maintenance Phase|Adverse Event|1|||
125089299|NCT02394028|449944606|FG009|Maintenance Phase|Adverse Event|1|||
125089300|NCT02394028|449944607|FG010|Maintenance Phase|Adverse Event|3|||
125089301|NCT02394028|449944597|FG000|Maintenance Phase|Site closure|0|||
125089302|NCT02394028|449944598|FG001|Maintenance Phase|Site closure|0|||
125089303|NCT02394028|449944599|FG002|Maintenance Phase|Site closure|0|||
125089304|NCT02394028|449944600|FG003|Maintenance Phase|Site closure|0|||
125089305|NCT02394028|449944601|FG004|Maintenance Phase|Site closure|0|||
125089306|NCT02394028|449944602|FG005|Maintenance Phase|Site closure|0|||
125089307|NCT02394028|449944603|FG006|Maintenance Phase|Site closure|0|||
125089308|NCT02394028|449944604|FG007|Maintenance Phase|Site closure|0|||
125089309|NCT02394028|449944605|FG008|Maintenance Phase|Site closure|0|||
125089310|NCT02394028|449944606|FG009|Maintenance Phase|Site closure|1|||
125089311|NCT02394028|449944607|FG010|Maintenance Phase|Site closure|0|||
125089312|NCT02394028|449944597|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125089313|NCT02394028|449944598|FG001|Maintenance Phase|Withdrawal by Subject|0|||
125089314|NCT02394028|449944599|FG002|Maintenance Phase|Withdrawal by Subject|0|||
125089315|NCT02394028|449944600|FG003|Maintenance Phase|Withdrawal by Subject|0|||
125089316|NCT02394028|449944601|FG004|Maintenance Phase|Withdrawal by Subject|0|||
125089317|NCT02394028|449944602|FG005|Maintenance Phase|Withdrawal by Subject|0|||
125089318|NCT02394028|449944603|FG006|Maintenance Phase|Withdrawal by Subject|0|||
125089319|NCT02394028|449944604|FG007|Maintenance Phase|Withdrawal by Subject|0|||
125089320|NCT02394028|449944605|FG008|Maintenance Phase|Withdrawal by Subject|3|||
125089321|NCT02394028|449944606|FG009|Maintenance Phase|Withdrawal by Subject|12|||
125089322|NCT02394028|449944607|FG010|Maintenance Phase|Withdrawal by Subject|12|||
125089323|NCT02142712|449944610|FG000|Overall Study|Lost to Follow-up|1|||
125089324|NCT02142712|449944611|FG001|Overall Study|Lost to Follow-up|1|||
125089325|NCT02142712|449944612|FG002|Overall Study|Lost to Follow-up|1|||
125089326|NCT02142712|449944613|FG003|Overall Study|Lost to Follow-up|0|||
125089327|NCT01981096|449944620|FG000|Overall Study|Parent illness|1|||
125089328|NCT01981096|449944621|FG001|Overall Study|Parent illness|0|||
125089329|NCT01981096|449944620|FG000|Overall Study|Withdrawal by Subject|0|||
125089330|NCT01981096|449944621|FG001|Overall Study|Withdrawal by Subject|1|||
125089331|NCT01981096|449944620|FG000|Overall Study|Lost to Follow-up|2|||
125089332|NCT01981096|449944621|FG001|Overall Study|Lost to Follow-up|0|||
125089333|NCT01225211|449944622|FG000|Overall Study|Adverse Event|0|||
125089334|NCT01225211|449944623|FG001|Overall Study|Adverse Event|0|||
125089335|NCT01225211|449944624|FG002|Overall Study|Adverse Event|1|||
125089336|NCT01225211|449944625|FG003|Overall Study|Adverse Event|0|||
125089337|NCT01225211|449944626|FG004|Overall Study|Adverse Event|0|||
125089338|NCT01225211|449944627|FG005|Overall Study|Adverse Event|0|||
125089339|NCT01225211|449944628|FG006|Overall Study|Adverse Event|0|||
125089340|NCT01225211|449944629|FG007|Overall Study|Adverse Event|0|||
125089341|NCT01225211|449944630|FG008|Overall Study|Adverse Event|0|||
125089342|NCT01225211|449944631|FG009|Overall Study|Adverse Event|1|||
125089343|NCT01225211|449944622|FG000|Overall Study|Withdrawal by Subject|0|||
125089344|NCT01225211|449944623|FG001|Overall Study|Withdrawal by Subject|0|||
125089345|NCT01225211|449944624|FG002|Overall Study|Withdrawal by Subject|0|||
125089346|NCT01225211|449944625|FG003|Overall Study|Withdrawal by Subject|0|||
125089347|NCT01225211|449944626|FG004|Overall Study|Withdrawal by Subject|0|||
125089348|NCT01225211|449944627|FG005|Overall Study|Withdrawal by Subject|0|||
125089349|NCT01225211|449944628|FG006|Overall Study|Withdrawal by Subject|1|||
125089350|NCT01225211|449944629|FG007|Overall Study|Withdrawal by Subject|0|||
124978480|NCT03829501|449548498|FG010|Overall Study|PD|0|||
124866921|NCT02586025|449135380|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
124978481|NCT03829501|449548499|FG011|Overall Study|PD|0|||
124866922|NCT02586025|449135379|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
124866923|NCT02586025|449135380|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
124866924|NCT02586025|449135379|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
125089351|NCT01225211|449944630|FG008|Overall Study|Withdrawal by Subject|1|||
125089352|NCT01225211|449944631|FG009|Overall Study|Withdrawal by Subject|3|||
125089353|NCT01225211|449944622|FG000|Overall Study|Other|0|||
125089354|NCT01225211|449944623|FG001|Overall Study|Other|0|||
124866925|NCT02586025|449135380|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
124866926|NCT02586025|449135379|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
124866927|NCT02586025|449135380|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
124866928|NCT04205630|449135381|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
124866929|NCT04205630|449135381|FG000|Overall Study|Disease clinical progression|7|||
124866930|NCT04205630|449135381|FG000|Overall Study|Withdrawal by Subject|2|||
124866931|NCT04205630|449135381|FG000|Overall Study|Adverse Event|17|||
124866932|NCT04205630|449135381|FG000|Overall Study|Other|1|||
124866933|NCT01618162|449135382|FG000|Overall Study|Protocol Violation|13|||
124866934|NCT01618162|449135383|FG001|Overall Study|Protocol Violation|10|||
124866935|NCT01618162|449135382|FG000|Overall Study|Adverse Event|9|||
124866936|NCT01618162|449135383|FG001|Overall Study|Adverse Event|2|||
124866937|NCT01618162|449135382|FG000|Overall Study|Withdrawal Criteria|2|||
124866938|NCT01618162|449135383|FG001|Overall Study|Withdrawal Criteria|10|||
124866939|NCT01618162|449135382|FG000|Overall Study|Unclassified|14|||
124866940|NCT01618162|449135383|FG001|Overall Study|Unclassified|13|||
124866941|NCT04124926|449135384|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
124866942|NCT04124926|449135385|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
124866943|NCT04124926|449135386|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
124866944|NCT04124926|449135387|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
124866945|NCT04124926|449135388|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
124866946|NCT04124926|449135384|FG000|Healing Phase|Protocol Violation|0|||
124866947|NCT04124926|449135385|FG001|Healing Phase|Protocol Violation|1|||
124866948|NCT04124926|449135386|FG002|Healing Phase|Protocol Violation|0|||
124866949|NCT04124926|449135387|FG003|Healing Phase|Protocol Violation|0|||
124866950|NCT04124926|449135388|FG004|Healing Phase|Protocol Violation|0|||
124866951|NCT04124926|449135384|FG000|Healing Phase|Lost to Follow-up|5|||
124866952|NCT04124926|449135385|FG001|Healing Phase|Lost to Follow-up|4|||
124866953|NCT04124926|449135386|FG002|Healing Phase|Lost to Follow-up|0|||
124866954|NCT04124926|449135387|FG003|Healing Phase|Lost to Follow-up|0|||
124866955|NCT04124926|449135388|FG004|Healing Phase|Lost to Follow-up|0|||
124866956|NCT04124926|449135384|FG000|Healing Phase|Voluntary Withdrawal|10|||
124866957|NCT04124926|449135385|FG001|Healing Phase|Voluntary Withdrawal|7|||
124866958|NCT04124926|449135386|FG002|Healing Phase|Voluntary Withdrawal|0|||
124866959|NCT04124926|449135387|FG003|Healing Phase|Voluntary Withdrawal|0|||
124866960|NCT04124926|449135388|FG004|Healing Phase|Voluntary Withdrawal|0|||
124866961|NCT04124926|449135384|FG000|Healing Phase|Withdrawal of Consent|5|||
124866962|NCT04124926|449135385|FG001|Healing Phase|Withdrawal of Consent|3|||
124866963|NCT04124926|449135386|FG002|Healing Phase|Withdrawal of Consent|0|||
124866964|NCT04124926|449135387|FG003|Healing Phase|Withdrawal of Consent|0|||
124866965|NCT04124926|449135388|FG004|Healing Phase|Withdrawal of Consent|0|||
124866966|NCT04124926|449135384|FG000|Healing Phase|Miscellaneous|8|||
124866967|NCT04124926|449135385|FG001|Healing Phase|Miscellaneous|7|||
124866968|NCT04124926|449135386|FG002|Healing Phase|Miscellaneous|0|||
124866969|NCT04124926|449135387|FG003|Healing Phase|Miscellaneous|0|||
124866970|NCT04124926|449135388|FG004|Healing Phase|Miscellaneous|0|||
124866971|NCT04124926|449135384|FG000|Healing Phase|Randomized but not Treated|0|||
124866972|NCT04124926|449135385|FG001|Healing Phase|Randomized but not Treated|3|||
124866973|NCT04124926|449135386|FG002|Healing Phase|Randomized but not Treated|0|||
124866974|NCT04124926|449135387|FG003|Healing Phase|Randomized but not Treated|0|||
124866975|NCT04124926|449135388|FG004|Healing Phase|Randomized but not Treated|0|||
124866976|NCT04124926|449135384|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
124866977|NCT04124926|449135385|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
124866978|NCT04124926|449135386|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
124866979|NCT04124926|449135387|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
124866980|NCT04124926|449135388|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
124866981|NCT04124926|449135384|FG000|Maintenance Phase|Protocol Violation|0|||
124866982|NCT04124926|449135385|FG001|Maintenance Phase|Protocol Violation|0|||
124866983|NCT04124926|449135386|FG002|Maintenance Phase|Protocol Violation|3|||
124866984|NCT04124926|449135387|FG003|Maintenance Phase|Protocol Violation|0|||
124866985|NCT04124926|449135388|FG004|Maintenance Phase|Protocol Violation|0|||
124866986|NCT04124926|449135384|FG000|Maintenance Phase|Lost to Follow-up|0|||
124866987|NCT04124926|449135385|FG001|Maintenance Phase|Lost to Follow-up|0|||
124866988|NCT04124926|449135386|FG002|Maintenance Phase|Lost to Follow-up|7|||
124866989|NCT04124926|449135387|FG003|Maintenance Phase|Lost to Follow-up|8|||
124866990|NCT04124926|449135388|FG004|Maintenance Phase|Lost to Follow-up|9|||
124866991|NCT04124926|449135384|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
124866992|NCT04124926|449135385|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
124866993|NCT04124926|449135386|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
124866994|NCT04124926|449135387|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
124866995|NCT04124926|449135388|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
124866996|NCT04124926|449135384|FG000|Maintenance Phase|Pregnancy|0|||
124866997|NCT04124926|449135385|FG001|Maintenance Phase|Pregnancy|0|||
124866998|NCT04124926|449135386|FG002|Maintenance Phase|Pregnancy|0|||
124866999|NCT04124926|449135387|FG003|Maintenance Phase|Pregnancy|1|||
124867000|NCT04124926|449135388|FG004|Maintenance Phase|Pregnancy|0|||
124867001|NCT04124926|449135384|FG000|Maintenance Phase|Lack of Efficacy|0|||
124867002|NCT04124926|449135385|FG001|Maintenance Phase|Lack of Efficacy|0|||
124867003|NCT04124926|449135386|FG002|Maintenance Phase|Lack of Efficacy|0|||
124867004|NCT04124926|449135387|FG003|Maintenance Phase|Lack of Efficacy|0|||
124867005|NCT04124926|449135388|FG004|Maintenance Phase|Lack of Efficacy|1|||
124867006|NCT04124926|449135384|FG000|Maintenance Phase|Withdrawal of Consent|0|||
124867007|NCT04124926|449135385|FG001|Maintenance Phase|Withdrawal of Consent|0|||
124867008|NCT04124926|449135386|FG002|Maintenance Phase|Withdrawal of Consent|5|||
124867009|NCT04124926|449135387|FG003|Maintenance Phase|Withdrawal of Consent|5|||
124867010|NCT04124926|449135388|FG004|Maintenance Phase|Withdrawal of Consent|5|||
124867011|NCT04124926|449135384|FG000|Maintenance Phase|Miscellaneous|0|||
124867012|NCT04124926|449135385|FG001|Maintenance Phase|Miscellaneous|0|||
124867013|NCT04124926|449135386|FG002|Maintenance Phase|Miscellaneous|1|||
124867014|NCT04124926|449135387|FG003|Maintenance Phase|Miscellaneous|2|||
124867015|NCT04124926|449135388|FG004|Maintenance Phase|Miscellaneous|4|||
124867016|NCT04124926|449135384|FG000|Maintenance Phase|Randomized but not Treated|0|||
124867017|NCT04124926|449135385|FG001|Maintenance Phase|Randomized but not Treated|0|||
124867018|NCT04124926|449135386|FG002|Maintenance Phase|Randomized but not Treated|2|||
124867019|NCT04124926|449135387|FG003|Maintenance Phase|Randomized but not Treated|2|||
124867020|NCT04124926|449135388|FG004|Maintenance Phase|Randomized but not Treated|0|||
124867021|NCT00911534|449135393|FG000|Overall Study|Adverse Event|4|||
124867022|NCT00911534|449135394|FG001|Overall Study|Adverse Event|4|||
124867023|NCT00911534|449135393|FG000|Overall Study|Lost to Follow-up|2|||
124867024|NCT00911534|449135394|FG001|Overall Study|Lost to Follow-up|4|||
124867025|NCT00911534|449135393|FG000|Overall Study|Withdrawal by Subject|2|||
124867026|NCT00911534|449135394|FG001|Overall Study|Withdrawal by Subject|1|||
124867027|NCT00911534|449135393|FG000|Overall Study|Lack of Efficacy|4|||
124867028|NCT00911534|449135394|FG001|Overall Study|Lack of Efficacy|1|||
124867029|NCT00911534|449135393|FG000|Overall Study|Withdrawal of consent|1|||
124867030|NCT00911534|449135394|FG001|Overall Study|Withdrawal of consent|4|||
124867031|NCT00911534|449135393|FG000|Overall Study|Other|2|||
124867032|NCT00911534|449135394|FG001|Overall Study|Other|2|||
124867033|NCT03152526|449135395|FG000|Overall Study|Withdrawal by Subject|0|||
124867034|NCT03152526|449135396|FG001|Overall Study|Withdrawal by Subject|1|||
124867035|NCT04867369|449135397|FG000|Overall Study|Withdrawal by Subject|1|||
124867036|NCT04867369|449135398|FG001|Overall Study|Withdrawal by Subject|0|||
124867037|NCT04435366|449135399|FG000|Year 1 (12 Months)|Adverse Event|3|||
124867038|NCT04435366|449135400|FG001|Year 1 (12 Months)|Adverse Event|0|||
124867039|NCT04435366|449135401|FG002|Year 1 (12 Months)|Adverse Event|2|||
124867040|NCT04435366|449135399|FG000|Year 1 (12 Months)|Death|2|||
124867041|NCT04435366|449135400|FG001|Year 1 (12 Months)|Death|0|||
124867042|NCT04435366|449135401|FG002|Year 1 (12 Months)|Death|1|||
124867043|NCT04435366|449135399|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
124867044|NCT04435366|449135400|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
124867045|NCT04435366|449135401|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
124867046|NCT04435366|449135399|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
124867047|NCT04435366|449135400|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
124867048|NCT04435366|449135401|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
124867049|NCT04435366|449135399|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
124867050|NCT04435366|449135400|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
124867051|NCT04435366|449135401|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
124867052|NCT04435366|449135399|FG000|Year 1 (12 Months)|Not treated|0|||
124867053|NCT04435366|449135400|FG001|Year 1 (12 Months)|Not treated|0|||
124867054|NCT04435366|449135401|FG002|Year 1 (12 Months)|Not treated|1|||
124867055|NCT04435366|449135399|FG000|Year 2 (12 Months)|Death|1|||
124867056|NCT04435366|449135400|FG001|Year 2 (12 Months)|Death|4|||
124867057|NCT04435366|449135401|FG002|Year 2 (12 Months)|Death|6|||
124867058|NCT04435366|449135399|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
124867059|NCT04435366|449135400|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
124867060|NCT04435366|449135401|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
124867061|NCT04435366|449135399|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
124867062|NCT04435366|449135400|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
124867063|NCT04435366|449135401|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
124867064|NCT04435366|449135399|FG000|Year 2 (12 Months)|Adverse Event|2|||
124867065|NCT04435366|449135400|FG001|Year 2 (12 Months)|Adverse Event|1|||
124867066|NCT04435366|449135401|FG002|Year 2 (12 Months)|Adverse Event|6|||
124867067|NCT05711641|449135402|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
124867068|NCT05711641|449135403|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
124867069|NCT05711641|449135402|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
124978482|NCT03829501|449548500|FG012|Overall Study|PD|0|||
124978483|NCT03829501|449548501|FG013|Overall Study|PD|0|||
125089355|NCT01225211|449944624|FG002|Overall Study|Other|0|||
125089356|NCT01225211|449944625|FG003|Overall Study|Other|0|||
125089357|NCT01225211|449944626|FG004|Overall Study|Other|0|||
125089358|NCT01225211|449944627|FG005|Overall Study|Other|0|||
125089359|NCT01225211|449944628|FG006|Overall Study|Other|0|||
125089360|NCT01225211|449944629|FG007|Overall Study|Other|0|||
125089361|NCT01225211|449944630|FG008|Overall Study|Other|0|||
125089362|NCT01225211|449944631|FG009|Overall Study|Other|1|||
125089363|NCT01241318|449944634|FG000|Overall Study|Woman: false pregnancies|27|||
125089364|NCT01241318|449944635|FG001|Overall Study|Woman: false pregnancies|15|||
125089365|NCT01241318|449944634|FG000|Overall Study|Woman: miscarriage/abortion|46|||
125089366|NCT01241318|449944635|FG001|Overall Study|Woman: miscarriage/abortion|38|||
125089367|NCT01241318|449944634|FG000|Overall Study|Withdrawal by Subject|175|||
125089368|NCT01241318|449944635|FG001|Overall Study|Withdrawal by Subject|46|||
125089369|NCT01241318|449944634|FG000|Overall Study|Lost to Follow-up|740|||
125089370|NCT01241318|449944635|FG001|Overall Study|Lost to Follow-up|455|||
125089371|NCT01241318|449944634|FG000|Overall Study|Death|2|||
125089372|NCT01241318|449944635|FG001|Overall Study|Death|4|||
125089373|NCT01241318|449944634|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
125089374|NCT01241318|449944635|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
125089375|NCT01241318|449944634|FG000|Overall Study|Woman: Stillborn infant|129|||
125089376|NCT01241318|449944635|FG001|Overall Study|Woman: Stillborn infant|146|||
125089377|NCT02355665|449944638|FG000|Overall Study|Adverse Event|16|||
125089378|NCT02355665|449944639|FG001|Overall Study|Adverse Event|24|||
125089379|NCT02355665|449944638|FG000|Overall Study|Protocol Violation|2|||
125089380|NCT02355665|449944639|FG001|Overall Study|Protocol Violation|0|||
125089381|NCT02355665|449944638|FG000|Overall Study|Withdrawal by Subject|90|||
125089382|NCT02355665|449944639|FG001|Overall Study|Withdrawal by Subject|100|||
125089383|NCT02355665|449944638|FG000|Overall Study|Lost to Follow-up|131|||
125089384|NCT02355665|449944639|FG001|Overall Study|Lost to Follow-up|103|||
125089385|NCT02355665|449944638|FG000|Overall Study|Death|4|||
125089386|NCT02355665|449944639|FG001|Overall Study|Death|2|||
125089387|NCT02355665|449944638|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
125089388|NCT02355665|449944639|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
125089389|NCT04129242|449944645|FG000|Overall Study|Physician Decision|1|||
125089390|NCT04129242|449944646|FG001|Overall Study|Physician Decision|1|||
125089391|NCT04129242|449944645|FG000|Overall Study|Protocol Violation|0|||
125089392|NCT04129242|449944646|FG001|Overall Study|Protocol Violation|1|||
125089393|NCT00392210|449944650|FG000|First Voiding Trial|Physician Decision|2|||
125089394|NCT00392210|449944651|FG001|First Voiding Trial|Physician Decision|2|||
125089395|NCT04815291|449944652|FG000|Overall Study|Lost to Follow-up|1|||
125089396|NCT04815291|449944652|FG000|Overall Study|Physician Decision|4|||
125089397|NCT04815291|449944652|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
125089398|NCT02140762|449944653|FG000|Overall Study|Adverse Event|1|||
125089399|NCT02140762|449944654|FG001|Overall Study|Adverse Event|1|||
125089400|NCT02140762|449944653|FG000|Overall Study|Lost to Follow-up|9|||
125089401|NCT02140762|449944654|FG001|Overall Study|Lost to Follow-up|5|||
125089402|NCT02140762|449944653|FG000|Overall Study|Protocol Violation|1|||
125089403|NCT02140762|449944654|FG001|Overall Study|Protocol Violation|1|||
125089404|NCT02140762|449944653|FG000|Overall Study|Withdrawal by Subject|6|||
125089405|NCT02140762|449944654|FG001|Overall Study|Withdrawal by Subject|4|||
125089406|NCT02140762|449944653|FG000|Overall Study|Other|0|||
125089407|NCT02140762|449944654|FG001|Overall Study|Other|1|||
125089408|NCT00989664|449944655|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
125089409|NCT00989664|449944655|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
125089410|NCT00989664|449944655|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
125089411|NCT00989664|449944655|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
125089412|NCT00989664|449944655|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
125089413|NCT00989664|449944655|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
125089414|NCT00989664|449944655|FG000|Long-Term Follow-Up|Death|3|||
125089415|NCT00095836|449944656|FG000|Overall Study|Lost to Follow-up|1|||
125089416|NCT00095836|449944656|FG000|Overall Study|Adverse Event|1|||
125089417|NCT00095836|449944656|FG000|Overall Study|Death|2|||
125089418|NCT00962780|449944660|FG000|Overall Study|Death|0|||
125089419|NCT00962780|449944661|FG001|Overall Study|Death|1|||
125089420|NCT00962780|449944660|FG000|Overall Study|Protocol Violation|9|||
125089421|NCT00962780|449944661|FG001|Overall Study|Protocol Violation|4|||
125089422|NCT00962780|449944660|FG000|Overall Study|Withdrawal by Subject|1|||
125089423|NCT00962780|449944661|FG001|Overall Study|Withdrawal by Subject|8|||
125089424|NCT00962780|449944660|FG000|Overall Study|Other|0|||
125089425|NCT00962780|449944661|FG001|Overall Study|Other|1|||
125089426|NCT01775995|449944662|FG000|Overall Study|Lost to Follow-up|1|||
125089427|NCT01775995|449944663|FG001|Overall Study|Lost to Follow-up|1|||
125089428|NCT02055976|449944664|FG000|Overall Study|Other|0|||
125089429|NCT02055976|449944665|FG001|Overall Study|Other|0|||
125089430|NCT02055976|449944666|FG002|Overall Study|Other|1|||
125089431|NCT02055976|449944667|FG003|Overall Study|Other|0|||
125089432|NCT02055976|449944668|FG004|Overall Study|Other|0|||
125089433|NCT02055976|449944669|FG005|Overall Study|Other|0|||
124867070|NCT05711641|449135403|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
124867071|NCT02477111|449135404|FG000|Overall Study|Death|28|||
124867072|NCT02477111|449135404|FG000|Overall Study|Withdrawal by Subject|19|||
124867073|NCT02477111|449135404|FG000|Overall Study|Lost to Follow-up|4|||
124867074|NCT00162370|449135406|FG000|Efficacy Population|Lost to Follow-up|51|||
124867075|NCT03896035|449135410|FG000|Overall Study|Lost to Follow-up|2|||
124867076|NCT03896035|449135411|FG001|Overall Study|Lost to Follow-up|6|||
124867077|NCT03896035|449135410|FG000|Overall Study|Withdrawal by Subject|0|||
124867078|NCT03896035|449135411|FG001|Overall Study|Withdrawal by Subject|1|||
124867079|NCT03896035|449135410|FG000|Overall Study|Health/family health issues during COVID|0|||
124867080|NCT03896035|449135411|FG001|Overall Study|Health/family health issues during COVID|4|||
124867081|NCT03492281|449135412|FG000|Overall Study|Withdrawal by Subject|21|||
124867082|NCT03492281|449135413|FG001|Overall Study|Withdrawal by Subject|14|||
124867083|NCT03492281|449135414|FG002|Overall Study|Withdrawal by Subject|13|||
124867084|NCT03492281|449135412|FG000|Overall Study|Lost to Follow-up|14|||
125089434|NCT02055976|449944670|FG006|Overall Study|Other|0|||
125089435|NCT02055976|449944671|FG007|Overall Study|Other|0|||
124867085|NCT03492281|449135413|FG001|Overall Study|Lost to Follow-up|15|||
125089436|NCT02055976|449944672|FG008|Overall Study|Other|0|||
125089437|NCT02055976|449944664|FG000|Overall Study|Adverse Event|0|||
124867086|NCT03492281|449135414|FG002|Overall Study|Lost to Follow-up|10|||
124867087|NCT03492281|449135412|FG000|Overall Study|Adverse Event|6|||
125089438|NCT02055976|449944665|FG001|Overall Study|Adverse Event|0|||
124867088|NCT03492281|449135413|FG001|Overall Study|Adverse Event|8|||
124867089|NCT03492281|449135414|FG002|Overall Study|Adverse Event|13|||
124867090|NCT03492281|449135412|FG000|Overall Study|Lack of Efficacy|3|||
124867091|NCT03492281|449135413|FG001|Overall Study|Lack of Efficacy|0|||
124867092|NCT03492281|449135414|FG002|Overall Study|Lack of Efficacy|1|||
124867093|NCT03492281|449135412|FG000|Overall Study|Physician Decision|1|||
124867094|NCT03492281|449135413|FG001|Overall Study|Physician Decision|0|||
124867095|NCT03492281|449135414|FG002|Overall Study|Physician Decision|3|||
124867096|NCT03492281|449135412|FG000|Overall Study|Protocol Violation|0|||
124867097|NCT03492281|449135413|FG001|Overall Study|Protocol Violation|2|||
124867098|NCT03492281|449135414|FG002|Overall Study|Protocol Violation|1|||
124867099|NCT03492281|449135412|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
124867100|NCT03492281|449135413|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
125089439|NCT02055976|449944666|FG002|Overall Study|Adverse Event|0|||
124867101|NCT03492281|449135414|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
124867102|NCT03492281|449135412|FG000|Overall Study|Death|0|||
124867103|NCT03492281|449135413|FG001|Overall Study|Death|0|||
124867104|NCT03492281|449135414|FG002|Overall Study|Death|1|||
124867105|NCT03492281|449135412|FG000|Overall Study|Captured as Other in Database|8|||
124867106|NCT03492281|449135413|FG001|Overall Study|Captured as Other in Database|6|||
124867107|NCT03492281|449135414|FG002|Overall Study|Captured as Other in Database|3|||
124867108|NCT01506193|449135415|FG000|Overall Study|Protocol Violation|1|||
124867109|NCT01506193|449135416|FG001|Overall Study|Protocol Violation|0|||
124867110|NCT01506193|449135417|FG002|Overall Study|Protocol Violation|1|||
124867111|NCT01506193|449135415|FG000|Overall Study|Migrated/moved from study area|0|||
124867112|NCT01506193|449135416|FG001|Overall Study|Migrated/moved from study area|0|||
124867113|NCT01506193|449135417|FG002|Overall Study|Migrated/moved from study area|1|||
124867114|NCT01506193|449135415|FG000|Overall Study|Adverse event, non-fatal|0|||
124867115|NCT01506193|449135416|FG001|Overall Study|Adverse event, non-fatal|0|||
124867116|NCT01506193|449135417|FG002|Overall Study|Adverse event, non-fatal|1|||
124867117|NCT01506193|449135415|FG000|Overall Study|Withdrawal by Subject|5|||
124867118|NCT01506193|449135416|FG001|Overall Study|Withdrawal by Subject|1|||
124867119|NCT01506193|449135417|FG002|Overall Study|Withdrawal by Subject|8|||
124867120|NCT01506193|449135415|FG000|Overall Study|Lost to Follow-up|8|||
124867121|NCT01506193|449135416|FG001|Overall Study|Lost to Follow-up|3|||
124867122|NCT01506193|449135417|FG002|Overall Study|Lost to Follow-up|3|||
124867123|NCT00743366|449135418|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
124867124|NCT00743366|449135419|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
124867125|NCT03206203|449135420|FG000|Treatment|Death|38|||
124867126|NCT03206203|449135421|FG001|Treatment|Death|26|||
124867127|NCT03206203|449135422|FG002|Treatment|Death|0|||
124867128|NCT03206203|449135420|FG000|Treatment|Withdrawal by Subject|1|||
124867129|NCT03206203|449135421|FG001|Treatment|Withdrawal by Subject|0|||
124867130|NCT03206203|449135422|FG002|Treatment|Withdrawal by Subject|0|||
124867131|NCT03206203|449135420|FG000|Treatment|Lost to Follow-up|4|||
124867132|NCT03206203|449135421|FG001|Treatment|Lost to Follow-up|0|||
124867133|NCT03206203|449135422|FG002|Treatment|Lost to Follow-up|0|||
124867134|NCT03206203|449135420|FG000|Treatment|N/A in Follow-Up|8|||
124867135|NCT03206203|449135421|FG001|Treatment|N/A in Follow-Up|1|||
124867136|NCT03206203|449135422|FG002|Treatment|N/A in Follow-Up|0|||
124867137|NCT03206203|449135420|FG000|Treatment|Disease progression|0|||
124867138|NCT03206203|449135421|FG001|Treatment|Disease progression|1|||
124867139|NCT03206203|449135422|FG002|Treatment|Disease progression|0|||
124867140|NCT03206203|449135420|FG000|Treatment|Refused follow-up|0|||
124867141|NCT03206203|449135421|FG001|Treatment|Refused follow-up|1|||
124867142|NCT03206203|449135422|FG002|Treatment|Refused follow-up|0|||
124867143|NCT03206203|449135420|FG000|Treatment|Cross over to Arm 1|0|||
124867144|NCT03206203|449135421|FG001|Treatment|Cross over to Arm 1|19|||
124867145|NCT03206203|449135422|FG002|Treatment|Cross over to Arm 1|0|||
124867146|NCT03206203|449135420|FG000|Optional Cross-Over|Death|0|||
124867147|NCT03206203|449135421|FG001|Optional Cross-Over|Death|0|||
124867148|NCT03206203|449135422|FG002|Optional Cross-Over|Death|14|||
124867149|NCT03206203|449135420|FG000|Optional Cross-Over|Refused follow-up|0|||
124867150|NCT03206203|449135421|FG001|Optional Cross-Over|Refused follow-up|0|||
124867151|NCT03206203|449135422|FG002|Optional Cross-Over|Refused follow-up|2|||
124867152|NCT00335322|449135423|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
124867153|NCT00335322|449135424|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
124867154|NCT00335322|449135425|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
124867155|NCT01152580|449135426|FG000|Overall Study|Withdrawal by Subject|0|||
124867156|NCT01152580|449135427|FG001|Overall Study|Withdrawal by Subject|1|||
124867157|NCT03364751|449135430|FG000|Overall Study|Withdrawal by Subject|1|||
124867158|NCT03364751|449135431|FG001|Overall Study|Withdrawal by Subject|0|||
124867159|NCT03364751|449135432|FG002|Overall Study|Withdrawal by Subject|0|||
124867160|NCT03364751|449135433|FG003|Overall Study|Withdrawal by Subject|0|||
124867161|NCT03364751|449135430|FG000|Overall Study|Lost to Follow-up|0|||
124867162|NCT03364751|449135431|FG001|Overall Study|Lost to Follow-up|1|||
124867163|NCT03364751|449135432|FG002|Overall Study|Lost to Follow-up|0|||
124867164|NCT03364751|449135433|FG003|Overall Study|Lost to Follow-up|0|||
124867165|NCT00675766|449135434|FG000|Overall Study|Lost to Follow-up|6|||
124867166|NCT00675766|449135435|FG001|Overall Study|Lost to Follow-up|5|||
124867167|NCT00675766|449135436|FG002|Overall Study|Lost to Follow-up|21|||
124867168|NCT00675766|449135437|FG003|Overall Study|Lost to Follow-up|26|||
124867169|NCT02275065|449135439|FG000|Overall Study|Randomized but not treated|1|||
124867170|NCT02275065|449135440|FG001|Overall Study|Randomized but not treated|0|||
124867171|NCT02275065|449135441|FG002|Overall Study|Randomized but not treated|1|||
124867172|NCT02275065|449135442|FG003|Overall Study|Randomized but not treated|1|||
124867173|NCT02275065|449135443|FG004|Overall Study|Randomized but not treated|0|||
124867174|NCT03213158|449135444|FG000|Overall Study|Withdrawal by Subject|1|||
124867175|NCT03213158|449135444|FG000|Overall Study|Physician Decision|2|||
124867176|NCT01777854|449135445|FG000|Overall Study|Physician Decision|3|||
124867177|NCT01777854|449135446|FG001|Overall Study|Physician Decision|3|||
124867178|NCT01239030|449135451|FG000|Double Blind|Adverse Event|0|||
124867179|NCT01239030|449135452|FG001|Double Blind|Adverse Event|1|||
124867180|NCT01239030|449135453|FG002|Double Blind|Adverse Event|0|||
124867181|NCT01239030|449135454|FG003|Double Blind|Adverse Event|2|||
124867182|NCT01239030|449135455|FG004|Double Blind|Adverse Event|0|||
124867183|NCT01239030|449135451|FG000|Double Blind|Withdrawal by Subject|0|||
124867184|NCT01239030|449135452|FG001|Double Blind|Withdrawal by Subject|1|||
124867185|NCT01239030|449135453|FG002|Double Blind|Withdrawal by Subject|1|||
124867186|NCT01239030|449135454|FG003|Double Blind|Withdrawal by Subject|0|||
124867187|NCT01239030|449135455|FG004|Double Blind|Withdrawal by Subject|1|||
124867188|NCT01239030|449135451|FG000|Double Blind|Lost to Follow-up|1|||
124867189|NCT01239030|449135452|FG001|Double Blind|Lost to Follow-up|1|||
124867190|NCT01239030|449135453|FG002|Double Blind|Lost to Follow-up|0|||
124867191|NCT01239030|449135454|FG003|Double Blind|Lost to Follow-up|0|||
124867192|NCT01239030|449135455|FG004|Double Blind|Lost to Follow-up|0|||
124867193|NCT01239030|449135451|FG000|Double Blind|Physician Decision|0|||
124867194|NCT01239030|449135452|FG001|Double Blind|Physician Decision|1|||
124867195|NCT01239030|449135453|FG002|Double Blind|Physician Decision|0|||
124867196|NCT01239030|449135454|FG003|Double Blind|Physician Decision|0|||
124867197|NCT01239030|449135455|FG004|Double Blind|Physician Decision|0|||
124867198|NCT01239030|449135451|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
124867199|NCT01239030|449135452|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
124867200|NCT01239030|449135453|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
124867201|NCT01239030|449135454|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
124867202|NCT01239030|449135455|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
124867203|NCT01239030|449135451|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
124867204|NCT01239030|449135452|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
124867205|NCT01239030|449135453|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
124867206|NCT01239030|449135454|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
124867207|NCT01239030|449135455|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
124867208|NCT01239030|449135451|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
124867209|NCT01239030|449135452|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
124867210|NCT01239030|449135453|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
124867211|NCT01239030|449135454|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
124867212|NCT01239030|449135455|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
124867213|NCT01239030|449135451|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
124867214|NCT01239030|449135452|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
124867215|NCT01239030|449135453|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
124867216|NCT01239030|449135454|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
124867217|NCT01239030|449135455|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
124867218|NCT03085485|449135463|FG000|Overall Study|Death|1|||
124867219|NCT03085485|449135464|FG001|Overall Study|Death|0|||
124867220|NCT03085485|449135463|FG000|Overall Study|Lost to Follow-up|1|||
124867221|NCT03085485|449135464|FG001|Overall Study|Lost to Follow-up|0|||
124867222|NCT01775904|449135468|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
124867223|NCT01775904|449135468|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
124867224|NCT00518115|449135469|FG000|Overall Study|Adverse Event|6|||
124867225|NCT00518115|449135470|FG001|Overall Study|Adverse Event|1|||
124867226|NCT00518115|449135471|FG002|Overall Study|Adverse Event|5|||
124867227|NCT00518115|449135472|FG003|Overall Study|Adverse Event|6|||
124867228|NCT00518115|449135473|FG004|Overall Study|Adverse Event|5|||
124867229|NCT00518115|449135474|FG005|Overall Study|Adverse Event|5|||
124867230|NCT00518115|449135475|FG006|Overall Study|Adverse Event|5|||
124867231|NCT00518115|449135476|FG007|Overall Study|Adverse Event|10|||
124867232|NCT00518115|449135477|FG008|Overall Study|Adverse Event|2|||
124867233|NCT00518115|449135478|FG009|Overall Study|Adverse Event|9|||
124867234|NCT00518115|449135469|FG000|Overall Study|Lost to Follow-up|0|||
124867235|NCT00518115|449135470|FG001|Overall Study|Lost to Follow-up|0|||
124867236|NCT00518115|449135471|FG002|Overall Study|Lost to Follow-up|2|||
124867237|NCT00518115|449135472|FG003|Overall Study|Lost to Follow-up|3|||
124867238|NCT00518115|449135473|FG004|Overall Study|Lost to Follow-up|1|||
124867239|NCT00518115|449135474|FG005|Overall Study|Lost to Follow-up|3|||
124867240|NCT00518115|449135475|FG006|Overall Study|Lost to Follow-up|0|||
124867241|NCT00518115|449135476|FG007|Overall Study|Lost to Follow-up|1|||
124867242|NCT00518115|449135477|FG008|Overall Study|Lost to Follow-up|1|||
124867243|NCT00518115|449135478|FG009|Overall Study|Lost to Follow-up|1|||
124867244|NCT00518115|449135469|FG000|Overall Study|Protocol Violation|1|||
124867245|NCT00518115|449135470|FG001|Overall Study|Protocol Violation|3|||
124867246|NCT00518115|449135471|FG002|Overall Study|Protocol Violation|1|||
124867247|NCT00518115|449135472|FG003|Overall Study|Protocol Violation|0|||
124867248|NCT00518115|449135473|FG004|Overall Study|Protocol Violation|0|||
124867249|NCT00518115|449135474|FG005|Overall Study|Protocol Violation|0|||
124867250|NCT00518115|449135475|FG006|Overall Study|Protocol Violation|0|||
124867251|NCT00518115|449135476|FG007|Overall Study|Protocol Violation|0|||
124867252|NCT00518115|449135477|FG008|Overall Study|Protocol Violation|0|||
124867253|NCT00518115|449135478|FG009|Overall Study|Protocol Violation|0|||
124867254|NCT00518115|449135469|FG000|Overall Study|Withdrawal by Subject|1|||
124867255|NCT00518115|449135470|FG001|Overall Study|Withdrawal by Subject|1|||
124867256|NCT00518115|449135471|FG002|Overall Study|Withdrawal by Subject|5|||
124867257|NCT00518115|449135472|FG003|Overall Study|Withdrawal by Subject|0|||
124867258|NCT00518115|449135473|FG004|Overall Study|Withdrawal by Subject|2|||
124867259|NCT00518115|449135474|FG005|Overall Study|Withdrawal by Subject|1|||
124867260|NCT00518115|449135475|FG006|Overall Study|Withdrawal by Subject|0|||
124867261|NCT00518115|449135476|FG007|Overall Study|Withdrawal by Subject|2|||
124867262|NCT00518115|449135477|FG008|Overall Study|Withdrawal by Subject|1|||
124867263|NCT00518115|449135478|FG009|Overall Study|Withdrawal by Subject|3|||
124867264|NCT00518115|449135469|FG000|Overall Study|Lack of Efficacy|1|||
124867265|NCT00518115|449135470|FG001|Overall Study|Lack of Efficacy|0|||
124867266|NCT00518115|449135471|FG002|Overall Study|Lack of Efficacy|1|||
124867267|NCT00518115|449135472|FG003|Overall Study|Lack of Efficacy|1|||
124867268|NCT00518115|449135473|FG004|Overall Study|Lack of Efficacy|0|||
124867269|NCT00518115|449135474|FG005|Overall Study|Lack of Efficacy|0|||
124867270|NCT00518115|449135475|FG006|Overall Study|Lack of Efficacy|0|||
124867271|NCT00518115|449135476|FG007|Overall Study|Lack of Efficacy|1|||
124867272|NCT00518115|449135477|FG008|Overall Study|Lack of Efficacy|0|||
124867273|NCT00518115|449135478|FG009|Overall Study|Lack of Efficacy|0|||
124867274|NCT00518115|449135469|FG000|Overall Study|Non-Compliance|1|||
124867275|NCT00518115|449135470|FG001|Overall Study|Non-Compliance|0|||
124867276|NCT00518115|449135471|FG002|Overall Study|Non-Compliance|1|||
124867277|NCT00518115|449135472|FG003|Overall Study|Non-Compliance|0|||
124867278|NCT00518115|449135473|FG004|Overall Study|Non-Compliance|1|||
124867279|NCT00518115|449135474|FG005|Overall Study|Non-Compliance|1|||
124867280|NCT00518115|449135475|FG006|Overall Study|Non-Compliance|1|||
124867281|NCT00518115|449135476|FG007|Overall Study|Non-Compliance|1|||
124867282|NCT00518115|449135477|FG008|Overall Study|Non-Compliance|0|||
124867283|NCT00518115|449135478|FG009|Overall Study|Non-Compliance|1|||
124867284|NCT00518115|449135469|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
124867285|NCT00518115|449135470|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
124867286|NCT00518115|449135471|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
124867287|NCT00518115|449135472|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
124867288|NCT00518115|449135473|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
124867289|NCT00518115|449135474|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
124867290|NCT00518115|449135475|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
124867291|NCT00518115|449135476|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
124867292|NCT00518115|449135477|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
124867293|NCT00518115|449135478|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
124978484|NCT03829501|449548502|FG014|Overall Study|PD|0|||
124867294|NCT00518115|449135469|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
124867295|NCT00518115|449135470|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
124867296|NCT00518115|449135471|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
124867297|NCT00518115|449135472|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
124867298|NCT00518115|449135473|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
124867299|NCT00518115|449135474|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
124867300|NCT00518115|449135475|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
124867301|NCT00518115|449135476|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
124867302|NCT00518115|449135477|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
124867303|NCT00518115|449135478|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
124867304|NCT00518115|449135469|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
124867305|NCT00518115|449135470|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
124867306|NCT00518115|449135471|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
124867307|NCT00518115|449135472|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
124867308|NCT00518115|449135473|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
124867309|NCT00518115|449135474|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
124867310|NCT00518115|449135475|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
124867311|NCT00518115|449135476|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
124867312|NCT00518115|449135477|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
124867313|NCT00518115|449135478|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
124867314|NCT00518115|449135469|FG000|Overall Study|Wrong Monotherapy Administered|0|||
124867315|NCT00518115|449135470|FG001|Overall Study|Wrong Monotherapy Administered|0|||
124867316|NCT00518115|449135471|FG002|Overall Study|Wrong Monotherapy Administered|1|||
124867317|NCT00518115|449135472|FG003|Overall Study|Wrong Monotherapy Administered|0|||
124867318|NCT00518115|449135473|FG004|Overall Study|Wrong Monotherapy Administered|0|||
124867319|NCT00518115|449135474|FG005|Overall Study|Wrong Monotherapy Administered|0|||
124867320|NCT00518115|449135475|FG006|Overall Study|Wrong Monotherapy Administered|1|||
124867321|NCT00518115|449135476|FG007|Overall Study|Wrong Monotherapy Administered|0|||
124867322|NCT00518115|449135477|FG008|Overall Study|Wrong Monotherapy Administered|0|||
125089440|NCT02055976|449944667|FG003|Overall Study|Adverse Event|0|||
125089441|NCT02055976|449944668|FG004|Overall Study|Adverse Event|0|||
125089442|NCT02055976|449944669|FG005|Overall Study|Adverse Event|1|||
125089443|NCT02055976|449944670|FG006|Overall Study|Adverse Event|1|||
125089444|NCT02055976|449944671|FG007|Overall Study|Adverse Event|0|||
125089445|NCT02055976|449944672|FG008|Overall Study|Adverse Event|0|||
125089446|NCT02055976|449944664|FG000|Overall Study|Does not meet entrance criteria|0|||
125089447|NCT02055976|449944665|FG001|Overall Study|Does not meet entrance criteria|0|||
125089448|NCT02055976|449944666|FG002|Overall Study|Does not meet entrance criteria|0|||
125089449|NCT02055976|449944667|FG003|Overall Study|Does not meet entrance criteria|0|||
125089450|NCT02055976|449944668|FG004|Overall Study|Does not meet entrance criteria|0|||
125089451|NCT02055976|449944669|FG005|Overall Study|Does not meet entrance criteria|0|||
125089452|NCT02055976|449944670|FG006|Overall Study|Does not meet entrance criteria|1|||
125089453|NCT02055976|449944671|FG007|Overall Study|Does not meet entrance criteria|0|||
125089454|NCT02055976|449944672|FG008|Overall Study|Does not meet entrance criteria|0|||
125089455|NCT02055976|449944664|FG000|Overall Study|Lost to Follow-up|0|||
125089456|NCT02055976|449944665|FG001|Overall Study|Lost to Follow-up|0|||
125089457|NCT02055976|449944666|FG002|Overall Study|Lost to Follow-up|0|||
125089458|NCT02055976|449944667|FG003|Overall Study|Lost to Follow-up|1|||
125089459|NCT02055976|449944668|FG004|Overall Study|Lost to Follow-up|0|||
125089460|NCT02055976|449944669|FG005|Overall Study|Lost to Follow-up|0|||
125089461|NCT02055976|449944670|FG006|Overall Study|Lost to Follow-up|0|||
125089462|NCT02055976|449944671|FG007|Overall Study|Lost to Follow-up|0|||
125089463|NCT02055976|449944672|FG008|Overall Study|Lost to Follow-up|0|||
125089464|NCT03458234|449944680|FG000|Overall Study|Withdrawal by Subject|1|||
125089465|NCT01640353|449946880|FG000|Overall Study|Withdrew prior to treatment|10|||
125089466|NCT01640353|449946880|FG000|Overall Study|Withdrawn from analysis at term site|12|||
125089467|NCT01640353|449946880|FG000|Overall Study|Withdrawal by Subject|5|||
125089468|NCT01640353|449946880|FG000|Overall Study|Death|2|||
125089469|NCT01640353|449946880|FG000|Overall Study|Early site termination|3|||
125089470|NCT01640353|449946880|FG000|Overall Study|Lost to Follow-up|12|||
125089471|NCT01640353|449946880|FG000|Overall Study|Physician Decision|1|||
125089472|NCT03758612|449946881|FG000|Washout Period|Withdrawal by Subject|0|||
125089473|NCT03758612|449946882|FG001|Washout Period|Withdrawal by Subject|0|||
125089474|NCT03758612|449946883|FG002|Washout Period|Withdrawal by Subject|2|||
125089475|NCT03758612|449946884|FG003|Washout Period|Withdrawal by Subject|0|||
125089476|NCT03758612|449946885|FG004|Washout Period|Withdrawal by Subject|0|||
125089477|NCT03758612|449946886|FG005|Washout Period|Withdrawal by Subject|0|||
125089478|NCT03758612|449946887|FG006|Washout Period|Withdrawal by Subject|0|||
125089479|NCT03758612|449946888|FG007|Washout Period|Withdrawal by Subject|0|||
125089480|NCT03758612|449946889|FG008|Washout Period|Withdrawal by Subject|0|||
125089481|NCT03758612|449946890|FG009|Washout Period|Withdrawal by Subject|0|||
125089482|NCT03758612|449946891|FG010|Washout Period|Withdrawal by Subject|0|||
125200081|NCT02980341|450354970|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
124867323|NCT00518115|449135478|FG009|Overall Study|Wrong Monotherapy Administered|0|||
124867324|NCT00518115|449135469|FG000|Overall Study|Violation of Exclusion Criteria|0|||
124867325|NCT00518115|449135470|FG001|Overall Study|Violation of Exclusion Criteria|0|||
124867326|NCT00518115|449135471|FG002|Overall Study|Violation of Exclusion Criteria|0|||
124867327|NCT00518115|449135472|FG003|Overall Study|Violation of Exclusion Criteria|1|||
124867328|NCT00518115|449135473|FG004|Overall Study|Violation of Exclusion Criteria|0|||
124867329|NCT00518115|449135474|FG005|Overall Study|Violation of Exclusion Criteria|0|||
124867330|NCT00518115|449135475|FG006|Overall Study|Violation of Exclusion Criteria|1|||
124867331|NCT00518115|449135476|FG007|Overall Study|Violation of Exclusion Criteria|0|||
124867332|NCT00518115|449135477|FG008|Overall Study|Violation of Exclusion Criteria|0|||
124867333|NCT00518115|449135478|FG009|Overall Study|Violation of Exclusion Criteria|0|||
124867334|NCT00518115|449135469|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
124867335|NCT00518115|449135470|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
124867336|NCT00518115|449135471|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
124867337|NCT00518115|449135472|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
124867338|NCT00518115|449135473|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
124867339|NCT00518115|449135474|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
124867340|NCT00518115|449135475|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
124867341|NCT00518115|449135476|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
124867342|NCT00518115|449135477|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
124867343|NCT00518115|449135478|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
124867344|NCT00518115|449135469|FG000|Overall Study|Withdrew Consent|0|||
124867345|NCT00518115|449135470|FG001|Overall Study|Withdrew Consent|0|||
124867346|NCT00518115|449135471|FG002|Overall Study|Withdrew Consent|0|||
124867347|NCT00518115|449135472|FG003|Overall Study|Withdrew Consent|0|||
124867348|NCT00518115|449135473|FG004|Overall Study|Withdrew Consent|0|||
124867349|NCT00518115|449135474|FG005|Overall Study|Withdrew Consent|1|||
124867350|NCT00518115|449135475|FG006|Overall Study|Withdrew Consent|0|||
124867351|NCT00518115|449135476|FG007|Overall Study|Withdrew Consent|0|||
124867352|NCT00518115|449135477|FG008|Overall Study|Withdrew Consent|0|||
124867353|NCT00518115|449135478|FG009|Overall Study|Withdrew Consent|0|||
124867354|NCT00518115|449135469|FG000|Overall Study|Moved Out of State|0|||
124867355|NCT00518115|449135470|FG001|Overall Study|Moved Out of State|0|||
124867356|NCT00518115|449135471|FG002|Overall Study|Moved Out of State|0|||
124867357|NCT00518115|449135472|FG003|Overall Study|Moved Out of State|0|||
124867358|NCT00518115|449135473|FG004|Overall Study|Moved Out of State|0|||
124867359|NCT00518115|449135474|FG005|Overall Study|Moved Out of State|0|||
124867360|NCT00518115|449135475|FG006|Overall Study|Moved Out of State|0|||
124867361|NCT00518115|449135476|FG007|Overall Study|Moved Out of State|0|||
124867362|NCT00518115|449135477|FG008|Overall Study|Moved Out of State|0|||
124867363|NCT00518115|449135478|FG009|Overall Study|Moved Out of State|1|||
124867364|NCT04891419|449135479|FG000|Overall Study|Withdrawal by Subject|4|||
124867365|NCT04891419|449135480|FG001|Overall Study|Withdrawal by Subject|0|||
124867366|NCT04891419|449135479|FG000|Overall Study|Lost to Follow-up|1|||
124867367|NCT04891419|449135480|FG001|Overall Study|Lost to Follow-up|3|||
124867368|NCT00827918|449135481|FG000|Overall Study|Adverse Event|4|||
124867369|NCT00827918|449135482|FG001|Overall Study|Adverse Event|0|||
124867370|NCT00827918|449135483|FG002|Overall Study|Adverse Event|0|||
124867371|NCT00827918|449135481|FG000|Overall Study|Lack of Efficacy|16|||
124867372|NCT00827918|449135482|FG001|Overall Study|Lack of Efficacy|4|||
124867373|NCT00827918|449135483|FG002|Overall Study|Lack of Efficacy|15|||
124867374|NCT00827918|449135481|FG000|Overall Study|Physician Decision|1|||
124867375|NCT00827918|449135482|FG001|Overall Study|Physician Decision|0|||
124867376|NCT00827918|449135483|FG002|Overall Study|Physician Decision|0|||
124867377|NCT00827918|449135481|FG000|Overall Study|Pregnancy|0|||
124867378|NCT00827918|449135482|FG001|Overall Study|Pregnancy|1|||
124867379|NCT00827918|449135483|FG002|Overall Study|Pregnancy|0|||
124867380|NCT00827918|449135481|FG000|Overall Study|Progressive Disease|1|||
124867381|NCT00827918|449135482|FG001|Overall Study|Progressive Disease|1|||
124867382|NCT00827918|449135483|FG002|Overall Study|Progressive Disease|0|||
124867383|NCT00827918|449135481|FG000|Overall Study|Protocol Violation|0|||
124867384|NCT00827918|449135482|FG001|Overall Study|Protocol Violation|1|||
124867385|NCT00827918|449135483|FG002|Overall Study|Protocol Violation|0|||
124867386|NCT00827918|449135481|FG000|Overall Study|Withdrawal by Subject|6|||
124867387|NCT00827918|449135482|FG001|Overall Study|Withdrawal by Subject|2|||
124867388|NCT00827918|449135483|FG002|Overall Study|Withdrawal by Subject|6|||
124867389|NCT00450411|449135491|FG000|Overall Study|Protocol Violation|6|||
124867390|NCT00450411|449135491|FG000|Overall Study|No protocol treatment|2|||
124867391|NCT02137369|449135502|FG000|Overall Study|Withdrawal by Subject|3|||
124867392|NCT02137369|449135503|FG001|Overall Study|Withdrawal by Subject|2|||
124867393|NCT02137369|449135502|FG000|Overall Study|Adverse Event|2|||
124867394|NCT02137369|449135503|FG001|Overall Study|Adverse Event|0|||
124867395|NCT02137369|449135502|FG000|Overall Study|Lost to Follow-up|1|||
124867396|NCT02137369|449135503|FG001|Overall Study|Lost to Follow-up|0|||
124867397|NCT02137369|449135502|FG000|Overall Study|Moved away|2|||
124867398|NCT02137369|449135503|FG001|Overall Study|Moved away|0|||
124867399|NCT01297959|449135505|FG000|Overall Study|Adverse Event|0|||
125089483|NCT03758612|449946892|FG011|Washout Period|Withdrawal by Subject|0|||
125089484|NCT03758612|449946881|FG000|Period 2|Protocol Violation|0|||
125089485|NCT03758612|449946882|FG001|Period 2|Protocol Violation|0|||
125089486|NCT03758612|449946883|FG002|Period 2|Protocol Violation|0|||
124867400|NCT01297959|449135506|FG001|Overall Study|Adverse Event|1|||
124867401|NCT01297959|449135505|FG000|Overall Study|Protocol Violation|2|||
124867402|NCT01297959|449135506|FG001|Overall Study|Protocol Violation|1|||
124867403|NCT01297959|449135505|FG000|Overall Study|Withdrawal by Subject|5|||
124867404|NCT01297959|449135506|FG001|Overall Study|Withdrawal by Subject|4|||
124867405|NCT01297959|449135505|FG000|Overall Study|Physician Decision|0|||
124867406|NCT01297959|449135506|FG001|Overall Study|Physician Decision|1|||
124867407|NCT01297959|449135505|FG000|Overall Study|Unrelated medical illness / complication|0|||
124867408|NCT01297959|449135506|FG001|Overall Study|Unrelated medical illness / complication|2|||
124867409|NCT01297959|449135505|FG000|Overall Study|Other|13|||
124867410|NCT01297959|449135506|FG001|Overall Study|Other|7|||
124867411|NCT01667432|449135509|FG000|Overall Study|Premature Study Termination|26|||
124867412|NCT01667432|449135509|FG000|Overall Study|Failure to Return|10|||
124867413|NCT01667432|449135509|FG000|Overall Study|Moved to Another Center|3|||
124867414|NCT01667432|449135509|FG000|Overall Study|Lost to Follow-up|3|||
124867415|NCT01667432|449135509|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
124867416|NCT01667432|449135509|FG000|Overall Study|Insufficient Therapeutic Response|4|||
124867417|NCT01667432|449135509|FG000|Overall Study|Adverse Event|1|||
125089487|NCT03758612|449946884|FG003|Period 2|Protocol Violation|0|||
125089488|NCT03758612|449946885|FG004|Period 2|Protocol Violation|1|||
125089489|NCT03758612|449946886|FG005|Period 2|Protocol Violation|0|||
125089490|NCT03758612|449946887|FG006|Period 2|Protocol Violation|0|||
125089491|NCT03758612|449946888|FG007|Period 2|Protocol Violation|0|||
125089492|NCT03758612|449946889|FG008|Period 2|Protocol Violation|0|||
125089493|NCT03758612|449946890|FG009|Period 2|Protocol Violation|0|||
125089494|NCT03758612|449946891|FG010|Period 2|Protocol Violation|0|||
125089495|NCT03758612|449946892|FG011|Period 2|Protocol Violation|0|||
125089496|NCT01603615|449946894|FG000|Overall Study|Did not Receive Treatment|7|||
125089497|NCT01603615|449946894|FG000|Overall Study|Lost to Follow-up|9|||
125089498|NCT01603615|449946894|FG000|Overall Study|Personal Reasons|17|||
125089499|NCT01603615|449946894|FG000|Overall Study|Other Miscellaneous|1|||
125089500|NCT03419741|449946895|FG000|Overall Study|Adverse Event|1|||
125089501|NCT03419741|449946896|FG001|Overall Study|Adverse Event|0|||
125089502|NCT03419741|449946895|FG000|Overall Study|Withdrawal by Subject|1|||
125089503|NCT03419741|449946896|FG001|Overall Study|Withdrawal by Subject|2|||
125089504|NCT04354870|449946897|FG000|Overall Study|Lost to Follow-up|32|||
125089505|NCT04354870|449946898|FG001|Overall Study|Lost to Follow-up|12|||
125089506|NCT04354870|449946897|FG000|Overall Study|Withdrawal by Subject|10|||
125089507|NCT04354870|449946898|FG001|Overall Study|Withdrawal by Subject|16|||
125089508|NCT04354870|449946897|FG000|Overall Study|Did not complete all study visits|6|||
125089509|NCT04354870|449946898|FG001|Overall Study|Did not complete all study visits|5|||
125089510|NCT03384316|449946899|FG000|Overall Study|Screen failure|0|||
125089511|NCT03384316|449946900|FG001|Overall Study|Screen failure|1|||
125089512|NCT04450394|449946911|FG000|Overall Study|Adverse Event|2|||
125089513|NCT04450394|449946912|FG001|Overall Study|Adverse Event|0|||
125089514|NCT04450394|449946913|FG002|Overall Study|Adverse Event|0|||
125089515|NCT04450394|449946911|FG000|Overall Study|Death|0|||
125089516|NCT04450394|449946912|FG001|Overall Study|Death|1|||
125089517|NCT04450394|449946913|FG002|Overall Study|Death|0|||
125089518|NCT04450394|449946911|FG000|Overall Study|Lost to Follow-up|0|||
125089519|NCT04450394|449946912|FG001|Overall Study|Lost to Follow-up|3|||
125089520|NCT04450394|449946913|FG002|Overall Study|Lost to Follow-up|0|||
125089521|NCT04450394|449946911|FG000|Overall Study|Physician Decision|0|||
125089522|NCT04450394|449946912|FG001|Overall Study|Physician Decision|1|||
125089523|NCT04450394|449946913|FG002|Overall Study|Physician Decision|0|||
125089524|NCT04450394|449946911|FG000|Overall Study|Protocol Violation|2|||
125089525|NCT04450394|449946912|FG001|Overall Study|Protocol Violation|0|||
125089526|NCT04450394|449946913|FG002|Overall Study|Protocol Violation|0|||
125089527|NCT04450394|449946911|FG000|Overall Study|Withdrawal by Subject|6|||
125089528|NCT04450394|449946912|FG001|Overall Study|Withdrawal by Subject|9|||
125089529|NCT04450394|449946913|FG002|Overall Study|Withdrawal by Subject|0|||
125089530|NCT02194699|449946917|FG000|Randomised|Did not receive treatment|1|||
124867418|NCT01667432|449135509|FG000|Overall Study|Protocol Deviation|2|||
124867419|NCT01667432|449135509|FG000|Overall Study|Principal Investigator Decision|1|||
124867420|NCT01667432|449135509|FG000|Overall Study|Reason Not Specified|2|||
125089531|NCT02194699|449946918|FG001|Randomised|Did not receive treatment|5|||
125089532|NCT02194699|449946917|FG000|Randomised|Without potential for 52 weeks of IP|5|||
125089533|NCT02194699|449946918|FG001|Randomised|Without potential for 52 weeks of IP|5|||
125089534|NCT02194699|449946917|FG000|Randomised|Duplicate patient|2|||
125089535|NCT02194699|449946918|FG001|Randomised|Duplicate patient|1|||
125089536|NCT02194699|449946917|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
125089537|NCT02194699|449946918|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
125089538|NCT02194699|449946917|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
125089539|NCT02194699|449946918|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
124867421|NCT01667432|449135509|FG000|Overall Study|Missing Information|4|||
124867422|NCT02077166|449135512|FG000|Overall Study|Death|6|||
124867423|NCT02077166|449135513|FG001|Overall Study|Death|7|||
124867424|NCT02077166|449135514|FG002|Overall Study|Death|5|||
124867425|NCT02077166|449135515|FG003|Overall Study|Death|6|||
124867426|NCT02077166|449135516|FG004|Overall Study|Death|4|||
124867427|NCT02077166|449135517|FG005|Overall Study|Death|32|||
124867428|NCT02077166|449135518|FG006|Overall Study|Death|22|||
124867429|NCT02077166|449135512|FG000|Overall Study|Study Closure by Sponsor|3|||
124867430|NCT02077166|449135513|FG001|Overall Study|Study Closure by Sponsor|0|||
124867431|NCT02077166|449135514|FG002|Overall Study|Study Closure by Sponsor|2|||
124867432|NCT02077166|449135515|FG003|Overall Study|Study Closure by Sponsor|2|||
124867433|NCT02077166|449135516|FG004|Overall Study|Study Closure by Sponsor|2|||
124867434|NCT02077166|449135517|FG005|Overall Study|Study Closure by Sponsor|12|||
124867435|NCT02077166|449135518|FG006|Overall Study|Study Closure by Sponsor|4|||
124867436|NCT02077166|449135512|FG000|Overall Study|Lost to Follow-up|0|||
124867437|NCT02077166|449135513|FG001|Overall Study|Lost to Follow-up|0|||
124867438|NCT02077166|449135514|FG002|Overall Study|Lost to Follow-up|0|||
124867439|NCT02077166|449135515|FG003|Overall Study|Lost to Follow-up|0|||
124867440|NCT02077166|449135516|FG004|Overall Study|Lost to Follow-up|0|||
124867441|NCT02077166|449135517|FG005|Overall Study|Lost to Follow-up|1|||
124867442|NCT02077166|449135518|FG006|Overall Study|Lost to Follow-up|0|||
124867443|NCT02077166|449135512|FG000|Overall Study|Withdrawal by Subject|3|||
124867444|NCT02077166|449135513|FG001|Overall Study|Withdrawal by Subject|0|||
124867445|NCT02077166|449135514|FG002|Overall Study|Withdrawal by Subject|1|||
124867446|NCT02077166|449135515|FG003|Overall Study|Withdrawal by Subject|1|||
124867447|NCT02077166|449135516|FG004|Overall Study|Withdrawal by Subject|1|||
124867448|NCT02077166|449135517|FG005|Overall Study|Withdrawal by Subject|3|||
124867449|NCT02077166|449135518|FG006|Overall Study|Withdrawal by Subject|0|||
124867450|NCT02077166|449135512|FG000|Overall Study|Other, Not Specified|0|||
124867451|NCT02077166|449135513|FG001|Overall Study|Other, Not Specified|0|||
124867452|NCT02077166|449135514|FG002|Overall Study|Other, Not Specified|1|||
124867453|NCT02077166|449135515|FG003|Overall Study|Other, Not Specified|0|||
124867454|NCT02077166|449135516|FG004|Overall Study|Other, Not Specified|1|||
124867455|NCT02077166|449135517|FG005|Overall Study|Other, Not Specified|7|||
124867456|NCT02077166|449135518|FG006|Overall Study|Other, Not Specified|8|||
124867457|NCT03519854|449135519|FG000|Overall Study|Technical Error|0|||
124867458|NCT03519854|449135520|FG001|Overall Study|Technical Error|0|||
124867459|NCT03519854|449135521|FG002|Overall Study|Technical Error|1|||
124867460|NCT03519854|449135522|FG003|Overall Study|Technical Error|0|||
124867461|NCT03519854|449135523|FG004|Overall Study|Technical Error|0|||
124867462|NCT03519854|449135524|FG005|Overall Study|Technical Error|0|||
124867463|NCT03519854|449135525|FG006|Overall Study|Technical Error|0|||
124867464|NCT03519854|449135526|FG007|Overall Study|Technical Error|0|||
124867465|NCT03519854|449135527|FG008|Overall Study|Technical Error|0|||
124867466|NCT03519854|449135528|FG009|Overall Study|Technical Error|0|||
124867467|NCT03519854|449135529|FG010|Overall Study|Technical Error|0|||
124867468|NCT03519854|449135530|FG011|Overall Study|Technical Error|0|||
124867469|NCT03519854|449135531|FG012|Overall Study|Technical Error|0|||
124867470|NCT03519854|449135532|FG013|Overall Study|Technical Error|0|||
124867471|NCT03519854|449135533|FG014|Overall Study|Technical Error|0|||
124867472|NCT03519854|449135534|FG015|Overall Study|Technical Error|0|||
124867473|NCT03519854|449135535|FG016|Overall Study|Technical Error|0|||
124867474|NCT03519854|449135536|FG017|Overall Study|Technical Error|0|||
124867475|NCT00818753|449135540|FG000|Overall Study|Protocol Violation|1|||
124867476|NCT00818753|449135541|FG001|Overall Study|Protocol Violation|0|||
124867477|NCT00818753|449135542|FG002|Overall Study|Protocol Violation|0|||
124867478|NCT00818753|449135540|FG000|Overall Study|Other reason (not specified)|0|||
124867479|NCT00818753|449135541|FG001|Overall Study|Other reason (not specified)|0|||
124867480|NCT00818753|449135542|FG002|Overall Study|Other reason (not specified)|1|||
124867481|NCT00818753|449135540|FG000|Overall Study|Randomised and not treated|2|||
125089540|NCT02194699|449946917|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
125089541|NCT02194699|449946918|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
125089542|NCT02194699|449946917|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
125089543|NCT02194699|449946918|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
125089544|NCT02194699|449946917|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
124867482|NCT00818753|449135541|FG001|Overall Study|Randomised and not treated|0|||
124867483|NCT00818753|449135542|FG002|Overall Study|Randomised and not treated|0|||
124867484|NCT01712009|449137961|FG000|Overall Study|Withdrawal by Subject|24|||
124867485|NCT01712009|449137962|FG001|Overall Study|Withdrawal by Subject|15|||
124867486|NCT01712009|449137963|FG002|Overall Study|Withdrawal by Subject|8|||
124867487|NCT01712009|449137961|FG000|Overall Study|Lost to Follow-up|2|||
124867488|NCT01712009|449137962|FG001|Overall Study|Lost to Follow-up|0|||
124867489|NCT01712009|449137963|FG002|Overall Study|Lost to Follow-up|1|||
124867490|NCT01712009|449137961|FG000|Overall Study|Decision by Sponsor|12|||
124867491|NCT01712009|449137962|FG001|Overall Study|Decision by Sponsor|14|||
124867492|NCT01712009|449137963|FG002|Overall Study|Decision by Sponsor|12|||
125089545|NCT02194699|449946918|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
125089546|NCT02194699|449946917|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
125089547|NCT02194699|449946918|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
125089548|NCT02155660|449946920|FG000|Overall Study|Other Reason|8|||
125089549|NCT02155660|449946921|FG001|Overall Study|Other Reason|6|||
125089550|NCT02155660|449946922|FG002|Overall Study|Other Reason|10|||
125089551|NCT02155660|449946923|FG003|Overall Study|Other Reason|10|||
125089552|NCT02155660|449946920|FG000|Overall Study|Study-specific withdrawal criteria|0|||
125089553|NCT02155660|449946921|FG001|Overall Study|Study-specific withdrawal criteria|1|||
125089554|NCT02155660|449946922|FG002|Overall Study|Study-specific withdrawal criteria|1|||
125089555|NCT02155660|449946923|FG003|Overall Study|Study-specific withdrawal criteria|1|||
125089556|NCT02155660|449946920|FG000|Overall Study|Severe non-compliance|0|||
125089557|NCT02155660|449946921|FG001|Overall Study|Severe non-compliance|4|||
125089558|NCT02155660|449946922|FG002|Overall Study|Severe non-compliance|0|||
125089559|NCT02155660|449946923|FG003|Overall Study|Severe non-compliance|1|||
125089560|NCT02155660|449946920|FG000|Overall Study|Adverse Event|2|||
125089561|NCT02155660|449946921|FG001|Overall Study|Adverse Event|6|||
125089562|NCT02155660|449946922|FG002|Overall Study|Adverse Event|3|||
125089563|NCT02155660|449946923|FG003|Overall Study|Adverse Event|1|||
125089564|NCT02155660|449946920|FG000|Overall Study|Lost to Follow-up|3|||
125089565|NCT02155660|449946921|FG001|Overall Study|Lost to Follow-up|6|||
125089566|NCT02155660|449946922|FG002|Overall Study|Lost to Follow-up|5|||
125089567|NCT02155660|449946923|FG003|Overall Study|Lost to Follow-up|8|||
125089568|NCT02155660|449946920|FG000|Overall Study|Death|17|||
125089569|NCT02155660|449946921|FG001|Overall Study|Death|19|||
125089570|NCT02155660|449946922|FG002|Overall Study|Death|17|||
125089571|NCT02155660|449946923|FG003|Overall Study|Death|19|||
125089572|NCT02155660|449946920|FG000|Overall Study|Withdrawal by Subject|28|||
125089573|NCT02155660|449946921|FG001|Overall Study|Withdrawal by Subject|31|||
125089574|NCT02155660|449946922|FG002|Overall Study|Withdrawal by Subject|24|||
125089575|NCT02155660|449946923|FG003|Overall Study|Withdrawal by Subject|21|||
125089576|NCT00303719|449946930|FG000|Overall Study|Not evaluable, prior therapies|0|||
125089577|NCT00303719|449946931|FG001|Overall Study|Not evaluable, prior therapies|30|||
125089578|NCT00303719|449946930|FG000|Overall Study|Lost to Follow-up|0|||
125089579|NCT00303719|449946931|FG001|Overall Study|Lost to Follow-up|7|||
125089580|NCT02643420|449946952|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
125089581|NCT02643420|449946953|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
125089582|NCT02643420|449946952|FG000|Overall Study|Withdrawal by Subject|25|||
125089583|NCT02643420|449946953|FG001|Overall Study|Withdrawal by Subject|19|||
125089584|NCT02643420|449946952|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
125089585|NCT02643420|449946953|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
125089586|NCT02643420|449946952|FG000|Overall Study|Lost to Follow-up|6|||
125089587|NCT02643420|449946953|FG001|Overall Study|Lost to Follow-up|10|||
125089588|NCT02643420|449946952|FG000|Overall Study|Investigator Decision|2|||
125089589|NCT02643420|449946953|FG001|Overall Study|Investigator Decision|4|||
125089590|NCT02643420|449946952|FG000|Overall Study|Sponsor decision|1|||
125089591|NCT02643420|449946953|FG001|Overall Study|Sponsor decision|1|||
125089592|NCT02643420|449946952|FG000|Overall Study|Death|0|||
125089593|NCT02643420|449946953|FG001|Overall Study|Death|2|||
125089594|NCT02643420|449946952|FG000|Overall Study|Reason not Specified|8|||
125089595|NCT02643420|449946953|FG001|Overall Study|Reason not Specified|7|||
125089596|NCT02127970|449946954|FG000|Overall Study|Adverse Event|2|||
125089597|NCT02127970|449946955|FG001|Overall Study|Adverse Event|1|||
125089598|NCT02127970|449946954|FG000|Overall Study|Death|1|||
125089599|NCT02127970|449946955|FG001|Overall Study|Death|1|||
125089600|NCT02127970|449946954|FG000|Overall Study|Lost to Follow-up|14|||
125089601|NCT02127970|449946955|FG001|Overall Study|Lost to Follow-up|14|||
125089602|NCT02127970|449946954|FG000|Overall Study|Reason not Specified|4|||
125089603|NCT02127970|449946955|FG001|Overall Study|Reason not Specified|7|||
125089604|NCT02127970|449946954|FG000|Overall Study|Pregnancy|0|||
125089605|NCT02127970|449946955|FG001|Overall Study|Pregnancy|1|||
124867493|NCT00593567|449137964|FG000|Overall Study|Adverse Event|2|||
124867494|NCT00593567|449137965|FG001|Overall Study|Adverse Event|0|||
124867495|NCT00593567|449137964|FG000|Overall Study|Physician Decision|2|||
124867496|NCT00593567|449137965|FG001|Overall Study|Physician Decision|0|||
124867497|NCT00593567|449137964|FG000|Overall Study|Protocol Violation|13|||
124867498|NCT00593567|449137965|FG001|Overall Study|Protocol Violation|7|||
125089606|NCT02127970|449946954|FG000|Overall Study|Subject Withdrew Consent|5|||
125089607|NCT02127970|449946955|FG001|Overall Study|Subject Withdrew Consent|3|||
125089608|NCT01710709|449946956|FG000|Overall Study|Lost to Follow-up|29|||
125089609|NCT01710709|449946956|FG000|Overall Study|Adverse Event|48|||
125089610|NCT01710709|449946956|FG000|Overall Study|Participant met withdrawal criteria|33|||
125089611|NCT01710709|449946956|FG000|Overall Study|Participant withdrawn by investigator|2|||
125089612|NCT01710709|449946956|FG000|Overall Study|Withdrawal by Subject|53|||
125089613|NCT01710709|449946956|FG000|Overall Study|Protocol Violation|5|||
125089614|NCT01710709|449946956|FG000|Overall Study|Lack of Efficacy|3|||
125089615|NCT00542321|449946958|FG000|Overall Study|Death|0|||
125089616|NCT00542321|449946959|FG001|Overall Study|Death|1|||
125089617|NCT00718887|449946972|FG000|Overall Study|Withdrawal by Subject|3|||
125089618|NCT00718887|449946973|FG001|Overall Study|Withdrawal by Subject|2|||
125089619|NCT00718887|449946972|FG000|Overall Study|Not identified|2|||
125089620|NCT00718887|449946973|FG001|Overall Study|Not identified|7|||
125089621|NCT05102734|449946974|FG000|Overall Study|Did not require vasopressors|1|||
125089622|NCT05102734|449946975|FG001|Overall Study|Did not require vasopressors|0|||
125089623|NCT05102734|449946974|FG000|Overall Study|Did not have functioning PA catheter|1|||
125089624|NCT05102734|449946975|FG001|Overall Study|Did not have functioning PA catheter|0|||
124867499|NCT00593567|449137964|FG000|Overall Study|Lack of Efficacy|2|||
125089625|NCT05102734|449946974|FG000|Overall Study|Inadequate video quality|2|||
125089626|NCT05102734|449946975|FG001|Overall Study|Inadequate video quality|0|||
125089627|NCT03055806|449946976|FG000|Overall Study|Adverse Event|0|||
125089628|NCT03055806|449946977|FG001|Overall Study|Adverse Event|0|||
125089629|NCT03055806|449946978|FG002|Overall Study|Adverse Event|1|||
125089630|NCT03055806|449946979|FG003|Overall Study|Adverse Event|1|||
125089631|NCT03055806|449946976|FG000|Overall Study|Lost to Follow-up|0|||
125089632|NCT03055806|449946977|FG001|Overall Study|Lost to Follow-up|3|||
125089633|NCT03055806|449946978|FG002|Overall Study|Lost to Follow-up|6|||
125089634|NCT03055806|449946979|FG003|Overall Study|Lost to Follow-up|7|||
125089635|NCT03055806|449946976|FG000|Overall Study|Physician Decision|1|||
125089636|NCT03055806|449946977|FG001|Overall Study|Physician Decision|0|||
125089637|NCT03055806|449946978|FG002|Overall Study|Physician Decision|0|||
125089638|NCT03055806|449946979|FG003|Overall Study|Physician Decision|1|||
125089639|NCT03055806|449946976|FG000|Overall Study|Protocol Violation|1|||
125089640|NCT03055806|449946977|FG001|Overall Study|Protocol Violation|0|||
124867500|NCT00593567|449137965|FG001|Overall Study|Lack of Efficacy|1|||
124867501|NCT00593567|449137964|FG000|Overall Study|Withdrawal by Subject|1|||
124867502|NCT00593567|449137965|FG001|Overall Study|Withdrawal by Subject|2|||
124867503|NCT00590902|449137968|FG000|Overall Study|Death|1|||
124867504|NCT00785291|449137970|FG000|Overall Study|Never began treatment|8|||
124867505|NCT00785291|449137971|FG001|Overall Study|Never began treatment|4|||
124867506|NCT00785291|449137972|FG002|Overall Study|Never began treatment|4|||
124867507|NCT00785291|449137970|FG000|Overall Study|Adverse Event|39|||
124867508|NCT00785291|449137971|FG001|Overall Study|Adverse Event|70|||
124867509|NCT00785291|449137972|FG002|Overall Study|Adverse Event|56|||
124867510|NCT00785291|449137970|FG000|Overall Study|Death|7|||
124867511|NCT00785291|449137971|FG001|Overall Study|Death|4|||
124867512|NCT00785291|449137972|FG002|Overall Study|Death|3|||
124867513|NCT00785291|449137970|FG000|Overall Study|Withdrawal by Subject|35|||
124867514|NCT00785291|449137971|FG001|Overall Study|Withdrawal by Subject|36|||
124867515|NCT00785291|449137972|FG002|Overall Study|Withdrawal by Subject|17|||
124867516|NCT00785291|449137970|FG000|Overall Study|Alternative Therapy|12|||
124867517|NCT00785291|449137971|FG001|Overall Study|Alternative Therapy|6|||
124867518|NCT00785291|449137972|FG002|Overall Study|Alternative Therapy|7|||
124867519|NCT00785291|449137970|FG000|Overall Study|Complicating illness|6|||
124867520|NCT00785291|449137971|FG001|Overall Study|Complicating illness|4|||
124867521|NCT00785291|449137972|FG002|Overall Study|Complicating illness|4|||
124867522|NCT00785291|449137970|FG000|Overall Study|Other Medical Reasons|29|||
124867523|NCT00785291|449137971|FG001|Overall Study|Other Medical Reasons|25|||
124867524|NCT00785291|449137972|FG002|Overall Study|Other Medical Reasons|15|||
124867525|NCT00844857|449137973|FG000|Overall Study|Adverse Event|24|||
124867526|NCT00844857|449137974|FG001|Overall Study|Adverse Event|5|||
124867527|NCT00844857|449137973|FG000|Overall Study|Sponsor Decision|1|||
124867528|NCT00844857|449137974|FG001|Overall Study|Sponsor Decision|1|||
124867529|NCT00844857|449137973|FG000|Overall Study|Physician Decision|2|||
124867530|NCT00844857|449137974|FG001|Overall Study|Physician Decision|0|||
124867531|NCT00844857|449137973|FG000|Overall Study|Parent/Caregiver Decision|6|||
124867532|NCT00844857|449137974|FG001|Overall Study|Parent/Caregiver Decision|2|||
124867533|NCT00844857|449137973|FG000|Overall Study|Withdrawal by Subject|8|||
124867534|NCT00844857|449137974|FG001|Overall Study|Withdrawal by Subject|7|||
124867535|NCT00844857|449137973|FG000|Overall Study|Protocol Violation|6|||
124867536|NCT00844857|449137974|FG001|Overall Study|Protocol Violation|0|||
124867537|NCT00844857|449137973|FG000|Overall Study|Lack of Efficacy|5|||
124867538|NCT00844857|449137974|FG001|Overall Study|Lack of Efficacy|5|||
124867539|NCT00844857|449137973|FG000|Overall Study|Clinical Relapse|0|||
125089641|NCT03055806|449946978|FG002|Overall Study|Protocol Violation|0|||
125089642|NCT03055806|449946979|FG003|Overall Study|Protocol Violation|0|||
124867540|NCT00844857|449137974|FG001|Overall Study|Clinical Relapse|1|||
124867541|NCT00844857|449137973|FG000|Overall Study|Entry Criteria Not Met|0|||
124867542|NCT00844857|449137974|FG001|Overall Study|Entry Criteria Not Met|1|||
124867543|NCT00844857|449137973|FG000|Overall Study|Lost to Follow-up|2|||
124867544|NCT00844857|449137974|FG001|Overall Study|Lost to Follow-up|3|||
124867545|NCT00844857|449137973|FG000|Overall Study|Did Not Take Study Drug|3|||
124867546|NCT00844857|449137974|FG001|Overall Study|Did Not Take Study Drug|1|||
124867547|NCT00844857|449137973|FG000|Overall Study|Good Clinical Practice Violations|21|||
124867548|NCT00844857|449137974|FG001|Overall Study|Good Clinical Practice Violations|11|||
125089643|NCT03055806|449946976|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
124867549|NCT00570674|449137975|FG000|Overall Study|Withdrawal by Subject|0|||
124867550|NCT00570674|449137976|FG001|Overall Study|Withdrawal by Subject|0|||
124867551|NCT00570674|449137977|FG002|Overall Study|Withdrawal by Subject|1|||
124867552|NCT00570674|449137978|FG003|Overall Study|Withdrawal by Subject|0|||
124867553|NCT00570674|449137979|FG004|Overall Study|Withdrawal by Subject|0|||
124867554|NCT00570674|449137980|FG005|Overall Study|Withdrawal by Subject|0|||
124867555|NCT00570674|449137981|FG006|Overall Study|Withdrawal by Subject|0|||
124867556|NCT02979639|449137983|FG000|Overall Study|Withdrawal based on medical judgement|1|||
124867557|NCT02979639|449137983|FG000|Overall Study|Lost to Follow-up|8|||
124867558|NCT02979639|449137983|FG000|Overall Study|Withdrawal by Subject|3|||
124867559|NCT02979639|449137983|FG000|Overall Study|Adverse Event|2|||
124867560|NCT04050865|449137987|FG000|Overall Study|Adverse Event|1|||
124867561|NCT04050865|449137988|FG001|Overall Study|Adverse Event|0|||
124867562|NCT04050865|449137987|FG000|Overall Study|no insert|1|||
124867563|NCT04050865|449137988|FG001|Overall Study|no insert|0|||
124867564|NCT04050865|449137987|FG000|Overall Study|Only 1 insert|2|||
124867565|NCT04050865|449137988|FG001|Overall Study|Only 1 insert|3|||
124867566|NCT04050865|449137987|FG000|Overall Study|Physician Decision|0|||
124867567|NCT04050865|449137988|FG001|Overall Study|Physician Decision|1|||
124867568|NCT04050865|449137987|FG000|Overall Study|Withdrawal by Subject|0|||
124867569|NCT04050865|449137988|FG001|Overall Study|Withdrawal by Subject|1|||
124867570|NCT00175825|449137995|FG000|Overall Study|Adverse Event|3|||
124867571|NCT00175825|449137996|FG001|Overall Study|Adverse Event|2|||
124867572|NCT00175825|449137997|FG002|Overall Study|Adverse Event|1|||
124867573|NCT00175825|449137998|FG003|Overall Study|Adverse Event|1|||
124867574|NCT00175825|449137995|FG000|Overall Study|Lost to Follow-up|1|||
124867575|NCT00175825|449137996|FG001|Overall Study|Lost to Follow-up|2|||
124867576|NCT00175825|449137997|FG002|Overall Study|Lost to Follow-up|0|||
124867577|NCT00175825|449137998|FG003|Overall Study|Lost to Follow-up|0|||
124867578|NCT00175825|449137995|FG000|Overall Study|Withdrawal by Subject|1|||
124867579|NCT00175825|449137996|FG001|Overall Study|Withdrawal by Subject|0|||
124867580|NCT00175825|449137997|FG002|Overall Study|Withdrawal by Subject|0|||
124867581|NCT00175825|449137998|FG003|Overall Study|Withdrawal by Subject|0|||
124867582|NCT00608582|449137999|FG000|Overall Study|Lost to Follow-up|2|||
124867583|NCT00608582|449138000|FG001|Overall Study|Lost to Follow-up|0|||
124867584|NCT00608582|449137999|FG000|Overall Study|No Best Response in Phase 1 located|1|||
124867585|NCT00608582|449138000|FG001|Overall Study|No Best Response in Phase 1 located|1|||
124867586|NCT00608582|449137999|FG000|Overall Study|Illicit Drug Use|1|||
124867587|NCT00608582|449138000|FG001|Overall Study|Illicit Drug Use|0|||
124867588|NCT00608582|449137999|FG000|Overall Study|Early stage Design Change|0|||
124867589|NCT00608582|449138000|FG001|Overall Study|Early stage Design Change|3|||
124867590|NCT00160680|449138003|FG000|Overall Study|Adverse Event|0|||
124867591|NCT00160680|449138004|FG001|Overall Study|Adverse Event|1|||
124867592|NCT00160680|449138003|FG000|Overall Study|Lack of Efficacy|2|||
124867593|NCT00160680|449138004|FG001|Overall Study|Lack of Efficacy|1|||
124867594|NCT00160680|449138003|FG000|Overall Study|Lost to Follow-up|3|||
124867595|NCT00160680|449138004|FG001|Overall Study|Lost to Follow-up|2|||
124867596|NCT00160680|449138003|FG000|Overall Study|Withdrawal by Subject|4|||
124867597|NCT00160680|449138004|FG001|Overall Study|Withdrawal by Subject|9|||
124867598|NCT00985725|449138008|FG000|Overall Study|Adverse Event|4|||
124867599|NCT00985725|449138009|FG001|Overall Study|Adverse Event|1|||
124867600|NCT00985725|449138008|FG000|Overall Study|Protocol Violation|1|||
124867601|NCT00985725|449138009|FG001|Overall Study|Protocol Violation|3|||
124867602|NCT00985725|449138008|FG000|Overall Study|Withdrawal by Subject|4|||
124867603|NCT00985725|449138009|FG001|Overall Study|Withdrawal by Subject|4|||
124867604|NCT00985725|449138008|FG000|Overall Study|Lost to Follow-up|1|||
124867605|NCT00985725|449138009|FG001|Overall Study|Lost to Follow-up|1|||
124867606|NCT00985725|449138008|FG000|Overall Study|Lack of Efficacy|0|||
124867607|NCT00985725|449138009|FG001|Overall Study|Lack of Efficacy|1|||
124867608|NCT00985725|449138008|FG000|Overall Study|Non-compliance|1|||
124867609|NCT00985725|449138009|FG001|Overall Study|Non-compliance|2|||
124867610|NCT00985725|449138008|FG000|Overall Study|Out-of-window visits|0|||
124867611|NCT00985725|449138009|FG001|Overall Study|Out-of-window visits|1|||
124867612|NCT02450331|449138013|FG000|Overall Study|Death|162|||
124867613|NCT02450331|449138014|FG001|Overall Study|Death|171|||
124867614|NCT02450331|449138013|FG000|Overall Study|Lost to Follow-up|14|||
124867615|NCT02450331|449138014|FG001|Overall Study|Lost to Follow-up|12|||
124867616|NCT02450331|449138013|FG000|Overall Study|Withdrawal by Subject|55|||
124867617|NCT02450331|449138014|FG001|Overall Study|Withdrawal by Subject|44|||
124867618|NCT02450331|449138013|FG000|Overall Study|Non-specified other|1|||
124867619|NCT02450331|449138014|FG001|Overall Study|Non-specified other|1|||
124867620|NCT01410474|449138015|FG000|Overall Study|Withdrawal by Subject|0|||
124867621|NCT01410474|449138016|FG001|Overall Study|Withdrawal by Subject|1|||
124867622|NCT03232983|449138017|FG000|Period 1|Physician Decision|0|||
124867623|NCT03232983|449138018|FG001|Period 1|Physician Decision|0|||
124867624|NCT03232983|449138019|FG002|Period 1|Physician Decision|1|||
124867625|NCT03232983|449138020|FG003|Period 1|Physician Decision|0|||
124867626|NCT03232983|449138017|FG000|Washout Period 2|Physician Decision|0|||
124867627|NCT03232983|449138018|FG001|Washout Period 2|Physician Decision|0|||
125089644|NCT03055806|449946977|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
125089645|NCT03055806|449946978|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
125089646|NCT03055806|449946979|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
125089647|NCT03055806|449946976|FG000|Overall Study|Withdrawal of consent to continue study|2|||
125089648|NCT03055806|449946977|FG001|Overall Study|Withdrawal of consent to continue study|3|||
125089649|NCT03055806|449946978|FG002|Overall Study|Withdrawal of consent to continue study|4|||
125089650|NCT03055806|449946979|FG003|Overall Study|Withdrawal of consent to continue study|6|||
125089651|NCT03055806|449946976|FG000|Overall Study|Partner not willing to try intercourse|1|||
125089652|NCT03055806|449946977|FG001|Overall Study|Partner not willing to try intercourse|0|||
125089653|NCT03055806|449946978|FG002|Overall Study|Partner not willing to try intercourse|0|||
125089654|NCT03055806|449946979|FG003|Overall Study|Partner not willing to try intercourse|0|||
125089655|NCT04601194|449946980|FG000|Overall Study|Lost to Follow-up|7|||
125089656|NCT00125138|449946981|FG000|Overall Study|Adverse Event|1|||
125089657|NCT00125138|449946982|FG001|Overall Study|Adverse Event|0|||
125089658|NCT00125138|449946983|FG002|Overall Study|Adverse Event|3|||
125089659|NCT00125138|449946984|FG003|Overall Study|Adverse Event|2|||
125089660|NCT00125138|449946981|FG000|Overall Study|Withdrawal by Subject|2|||
125089661|NCT00125138|449946982|FG001|Overall Study|Withdrawal by Subject|3|||
125089662|NCT00125138|449946983|FG002|Overall Study|Withdrawal by Subject|1|||
125089663|NCT00125138|449946984|FG003|Overall Study|Withdrawal by Subject|1|||
125089664|NCT00125138|449946981|FG000|Overall Study|Lack of Efficacy|0|||
125089665|NCT00125138|449946982|FG001|Overall Study|Lack of Efficacy|0|||
125089666|NCT00125138|449946983|FG002|Overall Study|Lack of Efficacy|0|||
125089667|NCT00125138|449946984|FG003|Overall Study|Lack of Efficacy|1|||
125089668|NCT00125138|449946981|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
125089669|NCT00125138|449946982|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
125089670|NCT00125138|449946983|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
125089671|NCT00125138|449946984|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
125200082|NCT02980341|450354971|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
125200083|NCT02980341|450354972|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
125200084|NCT02980341|450354973|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
125200085|NCT02980341|450354974|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
125200086|NCT02980341|450354975|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
125200087|NCT02980341|450354965|FG000|Dose Escalation|Due to investigator's decision|0|||
125200088|NCT02980341|450354966|FG001|Dose Escalation|Due to investigator's decision|0|||
125200089|NCT02980341|450354967|FG002|Dose Escalation|Due to investigator's decision|0|||
125200090|NCT02980341|450354968|FG003|Dose Escalation|Due to investigator's decision|0|||
125200091|NCT02980341|450354969|FG004|Dose Escalation|Due to investigator's decision|1|||
125200092|NCT02980341|450354970|FG005|Dose Escalation|Due to investigator's decision|0|||
125200093|NCT02980341|450354971|FG006|Dose Escalation|Due to investigator's decision|0|||
125200094|NCT02980341|450354972|FG007|Dose Escalation|Due to investigator's decision|0|||
125200095|NCT02980341|450354973|FG008|Dose Escalation|Due to investigator's decision|0|||
125200096|NCT02980341|450354974|FG009|Dose Escalation|Due to investigator's decision|0|||
125200097|NCT02980341|450354975|FG010|Dose Escalation|Due to investigator's decision|0|||
125200098|NCT02980341|450354965|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
125200099|NCT02980341|450354966|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
125200100|NCT02980341|450354967|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
125200101|NCT02980341|450354968|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
124867628|NCT03232983|449138019|FG002|Washout Period 2|Physician Decision|1|||
124867629|NCT03232983|449138020|FG003|Washout Period 2|Physician Decision|0|||
124867630|NCT03232983|449138017|FG000|Washout Period 2|Withdrawal by Subject|0|||
124867631|NCT03232983|449138018|FG001|Washout Period 2|Withdrawal by Subject|0|||
124867632|NCT03232983|449138019|FG002|Washout Period 2|Withdrawal by Subject|0|||
124867633|NCT03232983|449138020|FG003|Washout Period 2|Withdrawal by Subject|1|||
124867634|NCT03232983|449138017|FG000|Period 4|Withdrawal by Subject|1|||
124867635|NCT03232983|449138018|FG001|Period 4|Withdrawal by Subject|0|||
125200102|NCT02980341|450354969|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
125200103|NCT02980341|450354970|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
125200104|NCT02980341|450354971|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
125200105|NCT02980341|450354972|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
125200106|NCT02980341|450354973|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
125200107|NCT02980341|450354974|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
125200108|NCT02980341|450354975|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
125200109|NCT02980341|450354965|FG000|Dose Finding|Adverse Event|0|||
125200110|NCT02980341|450354966|FG001|Dose Finding|Adverse Event|0|||
125200111|NCT02980341|450354967|FG002|Dose Finding|Adverse Event|0|||
125200112|NCT02980341|450354968|FG003|Dose Finding|Adverse Event|0|||
125200113|NCT02980341|450354969|FG004|Dose Finding|Adverse Event|0|||
125200114|NCT02980341|450354970|FG005|Dose Finding|Adverse Event|3|||
125200115|NCT02980341|450354971|FG006|Dose Finding|Adverse Event|0|||
124867636|NCT03232983|449138019|FG002|Period 4|Withdrawal by Subject|0|||
124867637|NCT03232983|449138020|FG003|Period 4|Withdrawal by Subject|0|||
124867638|NCT02261493|449138023|FG000|Overall Study|Noncompliance|0|||
124867639|NCT02261493|449138024|FG001|Overall Study|Noncompliance|0|||
124867640|NCT02261493|449138025|FG002|Overall Study|Noncompliance|2|||
124867641|NCT02261493|449138023|FG000|Overall Study|Physician Decision|0|||
124867642|NCT02261493|449138024|FG001|Overall Study|Physician Decision|1|||
124867643|NCT02261493|449138025|FG002|Overall Study|Physician Decision|0|||
124867644|NCT02261493|449138023|FG000|Overall Study|Undisclosed alcohol abuse|0|||
124867645|NCT02261493|449138024|FG001|Overall Study|Undisclosed alcohol abuse|1|||
124867646|NCT02261493|449138025|FG002|Overall Study|Undisclosed alcohol abuse|0|||
124867647|NCT02261493|449138023|FG000|Overall Study|Protocol Violation|1|||
124867648|NCT02261493|449138024|FG001|Overall Study|Protocol Violation|0|||
124867649|NCT02261493|449138025|FG002|Overall Study|Protocol Violation|0|||
124867650|NCT02261493|449138023|FG000|Overall Study|Personal Reasons|14|||
124867651|NCT02261493|449138024|FG001|Overall Study|Personal Reasons|14|||
124867652|NCT02261493|449138025|FG002|Overall Study|Personal Reasons|16|||
124867653|NCT02261493|449138023|FG000|Overall Study|Lost to Follow-up|14|||
124867654|NCT02261493|449138024|FG001|Overall Study|Lost to Follow-up|27|||
124867655|NCT02261493|449138025|FG002|Overall Study|Lost to Follow-up|8|||
124867656|NCT02261493|449138023|FG000|Overall Study|Pregnancy|1|||
124867657|NCT02261493|449138024|FG001|Overall Study|Pregnancy|2|||
124867658|NCT02261493|449138025|FG002|Overall Study|Pregnancy|0|||
124867659|NCT02261493|449138023|FG000|Overall Study|Lack of Efficacy|0|||
124867660|NCT02261493|449138024|FG001|Overall Study|Lack of Efficacy|1|||
124867661|NCT02261493|449138025|FG002|Overall Study|Lack of Efficacy|0|||
124867662|NCT02261493|449138023|FG000|Overall Study|Adverse Event|0|||
124867663|NCT02261493|449138024|FG001|Overall Study|Adverse Event|1|||
124867664|NCT02261493|449138025|FG002|Overall Study|Adverse Event|0|||
124867665|NCT00530855|449138026|FG000|Overall Study|Lack of Efficacy|20|||
124867666|NCT00530855|449138026|FG000|Overall Study|Withdrawal by Subject|30|||
124867667|NCT00530855|449138026|FG000|Overall Study|Fatal Serious AE|3|||
124867668|NCT00530855|449138026|FG000|Overall Study|Non Fatal Serious AE|7|||
124867669|NCT00530855|449138026|FG000|Overall Study|Non Fatal Non Serious AE|12|||
124867670|NCT00530855|449138026|FG000|Overall Study|Protocol Violation|3|||
124867671|NCT00530855|449138026|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
124867672|NCT00530855|449138026|FG000|Overall Study|Lost to Follow-up|9|||
124867673|NCT00530855|449138026|FG000|Overall Study|Other reason for premature termination|17|||
124867674|NCT00815295|449138027|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
124867675|NCT00815295|449138028|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
124867676|NCT00815295|449138029|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
124867677|NCT01137474|449138030|FG000|Overall Study|Adverse Event|3|||
124867678|NCT01137474|449138031|FG001|Overall Study|Adverse Event|5|||
124867679|NCT01137474|449138032|FG002|Overall Study|Adverse Event|1|||
124867680|NCT01137474|449138033|FG003|Overall Study|Adverse Event|3|||
124867681|NCT01137474|449138030|FG000|Overall Study|Withdrawal by Subject|7|||
124867682|NCT01137474|449138031|FG001|Overall Study|Withdrawal by Subject|2|||
124867683|NCT01137474|449138032|FG002|Overall Study|Withdrawal by Subject|6|||
124867684|NCT01137474|449138033|FG003|Overall Study|Withdrawal by Subject|9|||
124867685|NCT01137474|449138030|FG000|Overall Study|No longer met study criteria|6|||
124867686|NCT01137474|449138031|FG001|Overall Study|No longer met study criteria|1|||
124867687|NCT01137474|449138032|FG002|Overall Study|No longer met study criteria|0|||
124867688|NCT01137474|449138033|FG003|Overall Study|No longer met study criteria|5|||
124867689|NCT01137474|449138030|FG000|Overall Study|Lost to Follow-up|5|||
124867690|NCT01137474|449138031|FG001|Overall Study|Lost to Follow-up|1|||
124867691|NCT01137474|449138032|FG002|Overall Study|Lost to Follow-up|0|||
124867692|NCT01137474|449138033|FG003|Overall Study|Lost to Follow-up|2|||
124867693|NCT01137474|449138030|FG000|Overall Study|Lack of Efficacy|0|||
124867694|NCT01137474|449138031|FG001|Overall Study|Lack of Efficacy|0|||
124867695|NCT01137474|449138032|FG002|Overall Study|Lack of Efficacy|0|||
124867696|NCT01137474|449138033|FG003|Overall Study|Lack of Efficacy|2|||
124867697|NCT01137474|449138030|FG000|Overall Study|Other|3|||
124867698|NCT01137474|449138031|FG001|Overall Study|Other|1|||
124867699|NCT01137474|449138032|FG002|Overall Study|Other|0|||
124867700|NCT01137474|449138033|FG003|Overall Study|Other|0|||
124867701|NCT01137474|449138030|FG000|Overall Study|Pregnancy|0|||
124867702|NCT01137474|449138031|FG001|Overall Study|Pregnancy|1|||
124867703|NCT01137474|449138032|FG002|Overall Study|Pregnancy|0|||
124867704|NCT01137474|449138033|FG003|Overall Study|Pregnancy|0|||
124867705|NCT01137474|449138030|FG000|Overall Study|Administrative reason by sponsor|0|||
124867706|NCT01137474|449138031|FG001|Overall Study|Administrative reason by sponsor|1|||
124867707|NCT01137474|449138032|FG002|Overall Study|Administrative reason by sponsor|0|||
124867708|NCT01137474|449138033|FG003|Overall Study|Administrative reason by sponsor|0|||
124867709|NCT02219048|449138034|FG000|Overall Study|Adverse Event|2|||
124867710|NCT02219048|449138035|FG001|Overall Study|Adverse Event|5|||
124867711|NCT02219048|449138034|FG000|Overall Study|No longer meets eligibility criteria|1|||
124867712|NCT02219048|449138035|FG001|Overall Study|No longer meets eligibility criteria|0|||
124867713|NCT02219048|449138034|FG000|Overall Study|Study terminated by sponsor|16|||
124867714|NCT02219048|449138035|FG001|Overall Study|Study terminated by sponsor|15|||
124867715|NCT02219048|449138034|FG000|Overall Study|Withdrawal by Subject|2|||
125200116|NCT02980341|450354972|FG007|Dose Finding|Adverse Event|0|||
125200117|NCT02980341|450354973|FG008|Dose Finding|Adverse Event|0|||
124867716|NCT02219048|449138035|FG001|Overall Study|Withdrawal by Subject|0|||
124867717|NCT02219048|449138034|FG000|Overall Study|Other|0|||
124867718|NCT02219048|449138035|FG001|Overall Study|Other|1|||
124867719|NCT04794803|449138036|FG000|Overall Study|Death|1|||
124867720|NCT04794803|449138037|FG001|Overall Study|Death|3|||
124867721|NCT04794803|449138036|FG000|Overall Study|Lost to Follow-up|2|||
124867722|NCT04794803|449138037|FG001|Overall Study|Lost to Follow-up|2|||
124867723|NCT04794803|449138036|FG000|Overall Study|Withdrawal by Subject|1|||
124867724|NCT04794803|449138037|FG001|Overall Study|Withdrawal by Subject|0|||
124867725|NCT04794803|449138036|FG000|Overall Study|Physician Decision|1|||
124867726|NCT04794803|449138037|FG001|Overall Study|Physician Decision|1|||
124867727|NCT04794803|449138036|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
124867728|NCT04794803|449138037|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
124867729|NCT04794803|449138036|FG000|Overall Study|Refused to continue the treatment|1|||
125200118|NCT02980341|450354974|FG009|Dose Finding|Adverse Event|0|||
125200119|NCT02980341|450354975|FG010|Dose Finding|Adverse Event|0|||
125200120|NCT02980341|450354965|FG000|Dose Finding|Withdrawal by Subject|0|||
125200121|NCT02980341|450354966|FG001|Dose Finding|Withdrawal by Subject|0|||
125200122|NCT02980341|450354967|FG002|Dose Finding|Withdrawal by Subject|0|||
125200123|NCT02980341|450354968|FG003|Dose Finding|Withdrawal by Subject|0|||
125200124|NCT02980341|450354969|FG004|Dose Finding|Withdrawal by Subject|0|||
125200125|NCT02980341|450354970|FG005|Dose Finding|Withdrawal by Subject|1|||
125200126|NCT02980341|450354971|FG006|Dose Finding|Withdrawal by Subject|1|||
125200127|NCT02980341|450354972|FG007|Dose Finding|Withdrawal by Subject|0|||
125200128|NCT02980341|450354973|FG008|Dose Finding|Withdrawal by Subject|0|||
125200129|NCT02980341|450354974|FG009|Dose Finding|Withdrawal by Subject|0|||
125200130|NCT02980341|450354975|FG010|Dose Finding|Withdrawal by Subject|0|||
125200131|NCT02980341|450354965|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
125200132|NCT02980341|450354966|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
125200133|NCT02980341|450354967|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
125200134|NCT02980341|450354968|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
125200135|NCT02980341|450354969|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
124867730|NCT04794803|449138037|FG001|Overall Study|Refused to continue the treatment|0|||
124867731|NCT04794803|449138036|FG000|Overall Study|Patient admitted to ICU|0|||
124867732|NCT04794803|449138037|FG001|Overall Study|Patient admitted to ICU|1|||
124867733|NCT04040751|449138039|FG000|Overall Study|Withdrawal by Subject|2|||
124867734|NCT04040751|449138040|FG001|Overall Study|Withdrawal by Subject|0|||
124867735|NCT04040751|449138041|FG002|Overall Study|Withdrawal by Subject|2|||
124867736|NCT04040751|449138042|FG003|Overall Study|Withdrawal by Subject|0|||
124867737|NCT03624504|449138043|FG000|Overall Study|Unsuccessful Implant|1|||
124867738|NCT02862457|449138044|FG000|Overall Study|Death|1|||
124867739|NCT02862457|449138045|FG001|Overall Study|Death|3|||
124867740|NCT02862457|449138046|FG002|Overall Study|Death|2|||
124867741|NCT02862457|449138047|FG003|Overall Study|Death|3|||
125200136|NCT02980341|450354970|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
125200137|NCT02980341|450354971|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
125200138|NCT02980341|450354972|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
125200139|NCT02980341|450354973|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
125200140|NCT02980341|450354974|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
125200141|NCT02980341|450354975|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
125200142|NCT02980341|450354965|FG000|Dose Expansion|Clinical progression|0|||
125200143|NCT02980341|450354966|FG001|Dose Expansion|Clinical progression|0|||
125200144|NCT02980341|450354967|FG002|Dose Expansion|Clinical progression|0|||
125200145|NCT02980341|450354968|FG003|Dose Expansion|Clinical progression|0|||
125200146|NCT02980341|450354969|FG004|Dose Expansion|Clinical progression|0|||
125200147|NCT02980341|450354970|FG005|Dose Expansion|Clinical progression|0|||
125200148|NCT02980341|450354971|FG006|Dose Expansion|Clinical progression|0|||
125200149|NCT02980341|450354972|FG007|Dose Expansion|Clinical progression|4|||
125200150|NCT02980341|450354973|FG008|Dose Expansion|Clinical progression|3|||
125200151|NCT02980341|450354974|FG009|Dose Expansion|Clinical progression|1|||
125200152|NCT02980341|450354975|FG010|Dose Expansion|Clinical progression|4|||
125200153|NCT02980341|450354965|FG000|Dose Expansion|Adverse Event|0|||
125200154|NCT02980341|450354966|FG001|Dose Expansion|Adverse Event|0|||
125200155|NCT02980341|450354967|FG002|Dose Expansion|Adverse Event|0|||
125200156|NCT02980341|450354968|FG003|Dose Expansion|Adverse Event|0|||
125200157|NCT02980341|450354969|FG004|Dose Expansion|Adverse Event|0|||
124867742|NCT02862457|449138048|FG004|Overall Study|Death|0|||
124867743|NCT02862457|449138049|FG005|Overall Study|Death|2|||
124867744|NCT02862457|449138050|FG006|Overall Study|Death|1|||
124867745|NCT02862457|449138044|FG000|Overall Study|Lost to Follow-up|1|||
125200158|NCT02980341|450354970|FG005|Dose Expansion|Adverse Event|0|||
125200159|NCT02980341|450354971|FG006|Dose Expansion|Adverse Event|0|||
124867746|NCT02862457|449138045|FG001|Overall Study|Lost to Follow-up|0|||
125200160|NCT02980341|450354972|FG007|Dose Expansion|Adverse Event|3|||
124867747|NCT02862457|449138046|FG002|Overall Study|Lost to Follow-up|0|||
124867748|NCT02862457|449138047|FG003|Overall Study|Lost to Follow-up|1|||
124867749|NCT02862457|449138048|FG004|Overall Study|Lost to Follow-up|0|||
124867750|NCT02862457|449138049|FG005|Overall Study|Lost to Follow-up|0|||
124867751|NCT02862457|449138050|FG006|Overall Study|Lost to Follow-up|0|||
124867752|NCT02862457|449138044|FG000|Overall Study|Withdrawal by Subject|0|||
124867753|NCT02862457|449138045|FG001|Overall Study|Withdrawal by Subject|0|||
124867754|NCT02862457|449138046|FG002|Overall Study|Withdrawal by Subject|1|||
124867755|NCT02862457|449138047|FG003|Overall Study|Withdrawal by Subject|0|||
124867756|NCT02862457|449138048|FG004|Overall Study|Withdrawal by Subject|0|||
124867757|NCT02862457|449138049|FG005|Overall Study|Withdrawal by Subject|1|||
124867758|NCT02862457|449138050|FG006|Overall Study|Withdrawal by Subject|0|||
124867759|NCT01388816|449138051|FG000|Overall Study|Adverse Event|0|||
124867760|NCT01388816|449138052|FG001|Overall Study|Adverse Event|2|||
124867761|NCT01388816|449138053|FG002|Overall Study|Adverse Event|0|||
124867762|NCT01388816|449138054|FG003|Overall Study|Adverse Event|0|||
124867763|NCT01388816|449138051|FG000|Overall Study|Lost to Follow-up|0|||
124867764|NCT01388816|449138052|FG001|Overall Study|Lost to Follow-up|1|||
124867765|NCT01388816|449138053|FG002|Overall Study|Lost to Follow-up|0|||
124867766|NCT01388816|449138054|FG003|Overall Study|Lost to Follow-up|0|||
124867767|NCT01388816|449138051|FG000|Overall Study|Withdrawal by Subject|2|||
124867768|NCT01388816|449138052|FG001|Overall Study|Withdrawal by Subject|1|||
124867769|NCT01388816|449138053|FG002|Overall Study|Withdrawal by Subject|1|||
124867770|NCT01388816|449138054|FG003|Overall Study|Withdrawal by Subject|0|||
124867771|NCT01388816|449138051|FG000|Overall Study|Protocol Violation|0|||
124867772|NCT01388816|449138052|FG001|Overall Study|Protocol Violation|0|||
124867773|NCT01388816|449138053|FG002|Overall Study|Protocol Violation|2|||
124867774|NCT01388816|449138054|FG003|Overall Study|Protocol Violation|0|||
124867775|NCT00951483|449138055|FG000|Overall Study|Physician Decision|4|||
124867776|NCT00951483|449138056|FG001|Overall Study|Physician Decision|0|||
124867777|NCT00951483|449138055|FG000|Overall Study|Withdrawal by Subject|15|||
124867778|NCT00951483|449138056|FG001|Overall Study|Withdrawal by Subject|0|||
124867779|NCT03015402|449138057|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
124867780|NCT03015402|449138058|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
124867781|NCT03015402|449138057|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
124867782|NCT03015402|449138058|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
124867783|NCT01813474|449138059|FG000|Overall Study|Withdrawal by Subject|0|||
124867784|NCT01813474|449138060|FG001|Overall Study|Withdrawal by Subject|0|||
124867785|NCT01813474|449138061|FG002|Overall Study|Withdrawal by Subject|1|||
124867786|NCT01813474|449138059|FG000|Overall Study|Adverse Event|1|||
124867787|NCT01813474|449138060|FG001|Overall Study|Adverse Event|1|||
124867788|NCT01813474|449138061|FG002|Overall Study|Adverse Event|0|||
124867789|NCT01813474|449138059|FG000|Overall Study|Lack of Efficacy|2|||
124867790|NCT01813474|449138060|FG001|Overall Study|Lack of Efficacy|6|||
124867791|NCT01813474|449138061|FG002|Overall Study|Lack of Efficacy|9|||
124867792|NCT01813474|449138059|FG000|Overall Study|Death|0|||
124867793|NCT01813474|449138060|FG001|Overall Study|Death|0|||
124867794|NCT01813474|449138061|FG002|Overall Study|Death|1|||
124867795|NCT01995461|449138064|FG000|Overall Study|Death|1|||
124867796|NCT01995461|449138064|FG000|Overall Study|Lost to Follow-up|2|||
124867797|NCT01995461|449138064|FG000|Overall Study|Withdrawal by Subject|2|||
124867798|NCT00540124|449138071|FG000|Overall Study|Adverse Event|0|||
124867799|NCT00540124|449138072|FG001|Overall Study|Adverse Event|2|||
124867800|NCT00540124|449138073|FG002|Overall Study|Adverse Event|1|||
124867801|NCT00540124|449138071|FG000|Overall Study|Entry Criteria Not Met|2|||
124867802|NCT00540124|449138072|FG001|Overall Study|Entry Criteria Not Met|0|||
124867803|NCT00540124|449138073|FG002|Overall Study|Entry Criteria Not Met|0|||
124867804|NCT00540124|449138071|FG000|Overall Study|Lack of Efficacy|1|||
124867805|NCT00540124|449138072|FG001|Overall Study|Lack of Efficacy|0|||
124867806|NCT00540124|449138073|FG002|Overall Study|Lack of Efficacy|0|||
124867807|NCT00540124|449138071|FG000|Overall Study|Withdrawal by Subject|1|||
124867808|NCT00540124|449138072|FG001|Overall Study|Withdrawal by Subject|1|||
124867809|NCT00540124|449138073|FG002|Overall Study|Withdrawal by Subject|0|||
124867810|NCT01207102|449138077|FG000|Overall Study|Withdrawal by Subject|5|||
124867811|NCT01207102|449138077|FG000|Overall Study|Adverse Event|2|||
124867812|NCT01207102|449138077|FG000|Overall Study|progression|2|||
124867813|NCT01207102|449138077|FG000|Overall Study|Withdrawal by Treating Physician|1|||
125200161|NCT02980341|450354973|FG008|Dose Expansion|Adverse Event|0|||
124867814|NCT03792126|449138078|FG000|Overall Study|Adverse Event|1|||
124867815|NCT03792126|449138079|FG001|Overall Study|Adverse Event|2|||
124867816|NCT03792126|449138078|FG000|Overall Study|Death|0|||
124867817|NCT03792126|449138079|FG001|Overall Study|Death|1|||
124867818|NCT03792126|449138078|FG000|Overall Study|Lost to Follow-up|1|||
124867819|NCT03792126|449138079|FG001|Overall Study|Lost to Follow-up|0|||
124867820|NCT03792126|449138078|FG000|Overall Study|Withdrawal by Subject|0|||
124867821|NCT03792126|449138079|FG001|Overall Study|Withdrawal by Subject|1|||
124867822|NCT03792126|449138078|FG000|Overall Study|COVID-19 Restrictions|1|||
124867823|NCT03792126|449138079|FG001|Overall Study|COVID-19 Restrictions|3|||
125200162|NCT02980341|450354974|FG009|Dose Expansion|Adverse Event|1|||
125200163|NCT02980341|450354975|FG010|Dose Expansion|Adverse Event|3|||
125200164|NCT02980341|450354965|FG000|Dose Expansion|Death|0|||
125200165|NCT02980341|450354966|FG001|Dose Expansion|Death|0|||
125200166|NCT02980341|450354967|FG002|Dose Expansion|Death|0|||
125200167|NCT02980341|450354968|FG003|Dose Expansion|Death|0|||
125200168|NCT02980341|450354969|FG004|Dose Expansion|Death|0|||
125200169|NCT02980341|450354970|FG005|Dose Expansion|Death|0|||
125200170|NCT02980341|450354971|FG006|Dose Expansion|Death|0|||
125200171|NCT02980341|450354972|FG007|Dose Expansion|Death|0|||
125200172|NCT02980341|450354973|FG008|Dose Expansion|Death|2|||
125200173|NCT02980341|450354974|FG009|Dose Expansion|Death|1|||
125200174|NCT02980341|450354975|FG010|Dose Expansion|Death|0|||
125200175|NCT02980341|450354965|FG000|Dose Expansion|Withdrawal by Subject|0|||
125200176|NCT02980341|450354966|FG001|Dose Expansion|Withdrawal by Subject|0|||
125200177|NCT02980341|450354967|FG002|Dose Expansion|Withdrawal by Subject|0|||
125200178|NCT02980341|450354968|FG003|Dose Expansion|Withdrawal by Subject|0|||
125200179|NCT02980341|450354969|FG004|Dose Expansion|Withdrawal by Subject|0|||
125200180|NCT02980341|450354970|FG005|Dose Expansion|Withdrawal by Subject|0|||
125200181|NCT02980341|450354971|FG006|Dose Expansion|Withdrawal by Subject|0|||
125200182|NCT02980341|450354972|FG007|Dose Expansion|Withdrawal by Subject|2|||
125200183|NCT02980341|450354973|FG008|Dose Expansion|Withdrawal by Subject|0|||
125200184|NCT02980341|450354974|FG009|Dose Expansion|Withdrawal by Subject|1|||
125200185|NCT02980341|450354975|FG010|Dose Expansion|Withdrawal by Subject|0|||
125200186|NCT02980341|450354965|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
125200187|NCT02980341|450354966|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
125200188|NCT02980341|450354967|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
125200189|NCT02980341|450354968|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
125200190|NCT02980341|450354969|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
125200191|NCT02980341|450354970|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
125200192|NCT02980341|450354971|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
125200193|NCT02980341|450354972|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
125200194|NCT02980341|450354973|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
125200195|NCT02980341|450354974|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
125200196|NCT02980341|450354975|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
125200197|NCT02980341|450354965|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
125200198|NCT02980341|450354966|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
125200199|NCT02980341|450354967|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
125200200|NCT02980341|450354968|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
125200201|NCT02980341|450354969|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
125200202|NCT02980341|450354970|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
125200203|NCT02980341|450354971|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
125200204|NCT02980341|450354972|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
125200205|NCT02980341|450354973|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
125200206|NCT02980341|450354974|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
125200207|NCT02980341|450354975|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
124867824|NCT03792126|449138078|FG000|Overall Study|Symptoms resolved|0|||
124867825|NCT03792126|449138079|FG001|Overall Study|Symptoms resolved|3|||
124867826|NCT02300220|449138080|FG000|Overall Study|Lost to Follow-up|1|||
124867827|NCT02300220|449138081|FG001|Overall Study|Lost to Follow-up|2|||
124867828|NCT02300220|449138080|FG000|Overall Study|Death|1|||
124867829|NCT02300220|449138081|FG001|Overall Study|Death|1|||
124867830|NCT02300220|449138080|FG000|Overall Study|Adverse Event|1|||
124867831|NCT02300220|449138081|FG001|Overall Study|Adverse Event|1|||
124867832|NCT02300220|449138080|FG000|Overall Study|Protocol Violation|1|||
124867833|NCT02300220|449138081|FG001|Overall Study|Protocol Violation|0|||
124867834|NCT02300220|449138080|FG000|Overall Study|Withdrawal by Subject|0|||
124867835|NCT02300220|449138081|FG001|Overall Study|Withdrawal by Subject|2|||
124867836|NCT02300220|449138080|FG000|Overall Study|Did not tolerate IMP|0|||
124867837|NCT02300220|449138081|FG001|Overall Study|Did not tolerate IMP|1|||
124867838|NCT04322682|449138082|FG000|Overall Study|Withdrawal by Subject|33|||
124867839|NCT04322682|449138083|FG001|Overall Study|Withdrawal by Subject|47|||
124867840|NCT04322682|449138082|FG000|Overall Study|Death|5|||
124867841|NCT04322682|449138083|FG001|Overall Study|Death|9|||
124867842|NCT04322682|449138082|FG000|Overall Study|Lost to Follow-up|4|||
124867843|NCT04322682|449138083|FG001|Overall Study|Lost to Follow-up|8|||
124867844|NCT04322682|449138082|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
124867845|NCT04322682|449138083|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
124867846|NCT02238379|449138084|FG000|Overall Study|Lost to Follow-up|1|||
124867847|NCT02238379|449138085|FG001|Overall Study|Lost to Follow-up|0|||
124867848|NCT00441090|449138086|FG000|Overall Study|Adverse Event|0|||
124867849|NCT00441090|449138087|FG001|Overall Study|Adverse Event|1|||
124867850|NCT00441090|449138088|FG002|Overall Study|Adverse Event|1|||
124867851|NCT00441090|449138089|FG003|Overall Study|Adverse Event|0|||
124867852|NCT00441090|449138090|FG004|Overall Study|Adverse Event|0|||
124867853|NCT00441090|449138086|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
124867854|NCT00441090|449138087|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
124867855|NCT00441090|449138088|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
124867856|NCT00441090|449138089|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
124867857|NCT00441090|449138090|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
124867858|NCT00441090|449138086|FG000|Overall Study|Withdrawal by Subject|1|||
124867859|NCT00441090|449138087|FG001|Overall Study|Withdrawal by Subject|0|||
124867860|NCT00441090|449138088|FG002|Overall Study|Withdrawal by Subject|1|||
124867861|NCT00441090|449138089|FG003|Overall Study|Withdrawal by Subject|0|||
124867862|NCT00441090|449138090|FG004|Overall Study|Withdrawal by Subject|0|||
124867863|NCT00441090|449138086|FG000|Overall Study|Lack of Efficacy|1|||
124867864|NCT00441090|449138087|FG001|Overall Study|Lack of Efficacy|0|||
124867865|NCT00441090|449138088|FG002|Overall Study|Lack of Efficacy|0|||
124867866|NCT00441090|449138089|FG003|Overall Study|Lack of Efficacy|0|||
124867867|NCT00441090|449138090|FG004|Overall Study|Lack of Efficacy|0|||
124867868|NCT01441102|449138091|FG000|Overall Study|Adverse Event|1|||
124867869|NCT01441102|449138091|FG000|Overall Study|Withdrawal by Subject|2|||
124867870|NCT00605280|449138092|FG000|Year 1|Protocol Violation|0|||
124867871|NCT00605280|449138093|FG001|Year 1|Protocol Violation|0|||
124867872|NCT00605280|449138094|FG002|Year 1|Protocol Violation|0|||
124867873|NCT00605280|449138095|FG003|Year 1|Protocol Violation|1|||
124867874|NCT00605280|449138092|FG000|Year 1|Adverse Event|3|||
124867875|NCT00605280|449138093|FG001|Year 1|Adverse Event|1|||
124867876|NCT00605280|449138094|FG002|Year 1|Adverse Event|1|||
124867877|NCT00605280|449138095|FG003|Year 1|Adverse Event|5|||
124867878|NCT00605280|449138092|FG000|Year 1|Physician Decision|7|||
124867879|NCT00605280|449138093|FG001|Year 1|Physician Decision|4|||
124867880|NCT00605280|449138094|FG002|Year 1|Physician Decision|0|||
124867881|NCT00605280|449138095|FG003|Year 1|Physician Decision|6|||
124867882|NCT00605280|449138092|FG000|Year 1|Withdrawal by Subject|2|||
124867883|NCT00605280|449138093|FG001|Year 1|Withdrawal by Subject|4|||
124867884|NCT00605280|449138094|FG002|Year 1|Withdrawal by Subject|0|||
124867885|NCT00605280|449138095|FG003|Year 1|Withdrawal by Subject|4|||
124867886|NCT00605280|449138092|FG000|Year 1|Other|2|||
124867887|NCT00605280|449138093|FG001|Year 1|Other|1|||
124867888|NCT00605280|449138094|FG002|Year 1|Other|0|||
124867889|NCT00605280|449138095|FG003|Year 1|Other|1|||
124867890|NCT00605280|449138092|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
124867891|NCT00605280|449138093|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
124867892|NCT00605280|449138094|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
124867893|NCT00605280|449138095|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
124867894|NCT00605280|449138092|FG000|Year 2|Adverse Event|4|||
124867895|NCT00605280|449138093|FG001|Year 2|Adverse Event|0|||
124867896|NCT00605280|449138094|FG002|Year 2|Adverse Event|2|||
124867897|NCT00605280|449138095|FG003|Year 2|Adverse Event|4|||
124867898|NCT00605280|449138092|FG000|Year 2|Physician Decision|11|||
124867899|NCT00605280|449138093|FG001|Year 2|Physician Decision|6|||
124867900|NCT00605280|449138094|FG002|Year 2|Physician Decision|4|||
124867901|NCT00605280|449138095|FG003|Year 2|Physician Decision|11|||
124867902|NCT00605280|449138092|FG000|Year 2|Withdrawal by Subject|4|||
124867903|NCT00605280|449138093|FG001|Year 2|Withdrawal by Subject|0|||
124867904|NCT00605280|449138094|FG002|Year 2|Withdrawal by Subject|0|||
124867905|NCT00605280|449138095|FG003|Year 2|Withdrawal by Subject|4|||
124867906|NCT00605280|449138092|FG000|Year 2|Other|1|||
124867907|NCT00605280|449138093|FG001|Year 2|Other|0|||
124867908|NCT00605280|449138094|FG002|Year 2|Other|0|||
124867909|NCT00605280|449138095|FG003|Year 2|Other|1|||
124867910|NCT00605280|449138092|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
124867911|NCT00605280|449138093|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
124867912|NCT00605280|449138094|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
124867913|NCT00605280|449138095|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
124867914|NCT00605280|449138092|FG000|Year 3 Extension|Adverse Event|2|||
124867915|NCT00605280|449138093|FG001|Year 3 Extension|Adverse Event|0|||
124867916|NCT00605280|449138094|FG002|Year 3 Extension|Adverse Event|0|||
124867917|NCT00605280|449138095|FG003|Year 3 Extension|Adverse Event|2|||
124867918|NCT00605280|449138092|FG000|Year 3 Extension|Physician Decision|0|||
124867919|NCT00605280|449138093|FG001|Year 3 Extension|Physician Decision|0|||
124867920|NCT00605280|449138094|FG002|Year 3 Extension|Physician Decision|0|||
124867921|NCT00605280|449138095|FG003|Year 3 Extension|Physician Decision|2|||
124867922|NCT00605280|449138092|FG000|Year 3 Extension|Withdrawal by Subject|2|||
124867923|NCT00605280|449138093|FG001|Year 3 Extension|Withdrawal by Subject|0|||
124867924|NCT00605280|449138094|FG002|Year 3 Extension|Withdrawal by Subject|0|||
124867925|NCT00605280|449138095|FG003|Year 3 Extension|Withdrawal by Subject|5|||
124867926|NCT00605280|449138092|FG000|Year 3 Extension|Other|2|||
124867927|NCT00605280|449138093|FG001|Year 3 Extension|Other|0|||
124867928|NCT00605280|449138094|FG002|Year 3 Extension|Other|0|||
124867929|NCT00605280|449138095|FG003|Year 3 Extension|Other|0|||
124867930|NCT00605280|449138092|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
124867931|NCT00605280|449138093|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
124867932|NCT00605280|449138094|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
124867933|NCT00605280|449138095|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
124867934|NCT02291614|449138096|FG000|Overall Study|Lost to Follow-up|0|||
124867935|NCT02291614|449138097|FG001|Overall Study|Lost to Follow-up|0|||
124867936|NCT02291614|449138098|FG002|Overall Study|Lost to Follow-up|0|||
124867937|NCT02291614|449138099|FG003|Overall Study|Lost to Follow-up|0|||
124867938|NCT02291614|449138100|FG004|Overall Study|Lost to Follow-up|0|||
124867939|NCT02291614|449138101|FG005|Overall Study|Lost to Follow-up|0|||
124867940|NCT02291614|449138102|FG006|Overall Study|Lost to Follow-up|0|||
124867941|NCT02291614|449138103|FG007|Overall Study|Lost to Follow-up|1|||
124867942|NCT02291614|449138104|FG008|Overall Study|Lost to Follow-up|0|||
124867943|NCT02291614|449138105|FG009|Overall Study|Lost to Follow-up|0|||
124867944|NCT02291614|449138106|FG010|Overall Study|Lost to Follow-up|0|||
124867945|NCT02291614|449138096|FG000|Overall Study|Withdrawal by Subject|0|||
124867946|NCT02291614|449138097|FG001|Overall Study|Withdrawal by Subject|1|||
124867947|NCT02291614|449138098|FG002|Overall Study|Withdrawal by Subject|0|||
124867948|NCT02291614|449138099|FG003|Overall Study|Withdrawal by Subject|0|||
124867949|NCT02291614|449138100|FG004|Overall Study|Withdrawal by Subject|0|||
125200208|NCT02980341|450354965|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
125200209|NCT02980341|450354966|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
125200210|NCT02980341|450354967|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
125200211|NCT02980341|450354968|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
125200212|NCT02980341|450354969|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
125200213|NCT02980341|450354970|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
125200214|NCT02980341|450354971|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
125200215|NCT02980341|450354972|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
125200216|NCT02980341|450354973|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
125200217|NCT02980341|450354974|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
125200218|NCT02980341|450354975|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
125200219|NCT02980341|450354965|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
125200220|NCT02980341|450354966|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
125200221|NCT02980341|450354967|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
125200222|NCT02980341|450354968|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
125200223|NCT02980341|450354969|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
124867950|NCT02291614|449138101|FG005|Overall Study|Withdrawal by Subject|0|||
124867951|NCT02291614|449138102|FG006|Overall Study|Withdrawal by Subject|0|||
124867952|NCT02291614|449138103|FG007|Overall Study|Withdrawal by Subject|0|||
124867953|NCT02291614|449138104|FG008|Overall Study|Withdrawal by Subject|0|||
124867954|NCT02291614|449138105|FG009|Overall Study|Withdrawal by Subject|2|||
124867955|NCT02291614|449138106|FG010|Overall Study|Withdrawal by Subject|2|||
124867956|NCT02291614|449138096|FG000|Overall Study|Decision by sponsor|0|||
124867957|NCT02291614|449138097|FG001|Overall Study|Decision by sponsor|0|||
124867958|NCT02291614|449138098|FG002|Overall Study|Decision by sponsor|0|||
124867959|NCT02291614|449138099|FG003|Overall Study|Decision by sponsor|1|||
124867960|NCT02291614|449138100|FG004|Overall Study|Decision by sponsor|0|||
124867961|NCT02291614|449138101|FG005|Overall Study|Decision by sponsor|0|||
124867962|NCT02291614|449138102|FG006|Overall Study|Decision by sponsor|0|||
124867963|NCT02291614|449138103|FG007|Overall Study|Decision by sponsor|0|||
124867964|NCT02291614|449138104|FG008|Overall Study|Decision by sponsor|0|||
124867965|NCT02291614|449138105|FG009|Overall Study|Decision by sponsor|0|||
124867966|NCT02291614|449138106|FG010|Overall Study|Decision by sponsor|0|||
124867967|NCT02291614|449138096|FG000|Overall Study|Death|0|||
125200224|NCT02980341|450354970|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
125200225|NCT02980341|450354971|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
125200226|NCT02980341|450354972|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
125200227|NCT02980341|450354973|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
124867968|NCT02291614|449138097|FG001|Overall Study|Death|0|||
124867969|NCT02291614|449138098|FG002|Overall Study|Death|1|||
124867970|NCT02291614|449138099|FG003|Overall Study|Death|0|||
124867971|NCT02291614|449138100|FG004|Overall Study|Death|1|||
124867972|NCT02291614|449138101|FG005|Overall Study|Death|1|||
124867973|NCT02291614|449138102|FG006|Overall Study|Death|1|||
124867974|NCT02291614|449138103|FG007|Overall Study|Death|0|||
124867975|NCT02291614|449138104|FG008|Overall Study|Death|0|||
124867976|NCT02291614|449138105|FG009|Overall Study|Death|0|||
124867977|NCT02291614|449138106|FG010|Overall Study|Death|0|||
124867978|NCT01662310|449138107|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
124867979|NCT01662310|449138108|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
124867980|NCT01662310|449138109|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
124867981|NCT01662310|449138110|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
124867982|NCT01662310|449138111|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
124867983|NCT01662310|449138107|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
124867984|NCT01662310|449138108|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
124867985|NCT01662310|449138109|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
124867986|NCT01662310|449138110|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
124867987|NCT01662310|449138111|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
124867988|NCT01662310|449138107|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
124867989|NCT01662310|449138108|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
124867990|NCT01662310|449138109|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
124867991|NCT01662310|449138110|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
125200228|NCT02980341|450354974|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
125200229|NCT02980341|450354975|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
125200230|NCT01647516|450354976|FG000|Induction Period (IP)|Physician Decision|2|||
125200231|NCT01647516|450354977|FG001|Induction Period (IP)|Physician Decision|0|||
125200232|NCT01647516|450354978|FG002|Induction Period (IP)|Physician Decision|0|||
125200233|NCT01647516|450354979|FG003|Induction Period (IP)|Physician Decision|0|||
125200234|NCT01647516|450354980|FG004|Induction Period (IP)|Physician Decision|0|||
125200235|NCT01647516|450354981|FG005|Induction Period (IP)|Physician Decision|0|||
125200236|NCT01647516|450354976|FG000|Induction Period (IP)|Adverse Event|1|||
125200237|NCT01647516|450354977|FG001|Induction Period (IP)|Adverse Event|2|||
125200238|NCT01647516|450354978|FG002|Induction Period (IP)|Adverse Event|0|||
125200239|NCT01647516|450354979|FG003|Induction Period (IP)|Adverse Event|0|||
125200240|NCT01647516|450354980|FG004|Induction Period (IP)|Adverse Event|0|||
125200241|NCT01647516|450354981|FG005|Induction Period (IP)|Adverse Event|0|||
125200242|NCT01647516|450354976|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
125200243|NCT01647516|450354977|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
125200244|NCT01647516|450354978|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
125200245|NCT01647516|450354979|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
125200246|NCT01647516|450354980|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
125200247|NCT01647516|450354981|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
125200248|NCT01647516|450354976|FG000|Induction Period (IP)|Participant Choice|0|||
125200249|NCT01647516|450354977|FG001|Induction Period (IP)|Participant Choice|0|||
125200250|NCT01647516|450354978|FG002|Induction Period (IP)|Participant Choice|1|||
125200251|NCT01647516|450354979|FG003|Induction Period (IP)|Participant Choice|0|||
125200252|NCT01647516|450354980|FG004|Induction Period (IP)|Participant Choice|0|||
125200253|NCT01647516|450354981|FG005|Induction Period (IP)|Participant Choice|0|||
125200254|NCT01647516|450354976|FG000|Induction Period (IP)|Lack of Efficacy|1|||
125200255|NCT01647516|450354977|FG001|Induction Period (IP)|Lack of Efficacy|0|||
125200256|NCT01647516|450354978|FG002|Induction Period (IP)|Lack of Efficacy|0|||
125200257|NCT01647516|450354979|FG003|Induction Period (IP)|Lack of Efficacy|0|||
125200258|NCT01647516|450354980|FG004|Induction Period (IP)|Lack of Efficacy|0|||
125200259|NCT01647516|450354981|FG005|Induction Period (IP)|Lack of Efficacy|0|||
125200260|NCT01647516|450354976|FG000|Induction Period (IP)|No study drug received|1|||
125200261|NCT01647516|450354977|FG001|Induction Period (IP)|No study drug received|1|||
125200262|NCT01647516|450354978|FG002|Induction Period (IP)|No study drug received|0|||
125200263|NCT01647516|450354979|FG003|Induction Period (IP)|No study drug received|0|||
125200264|NCT01647516|450354980|FG004|Induction Period (IP)|No study drug received|0|||
125200265|NCT01647516|450354981|FG005|Induction Period (IP)|No study drug received|0|||
125200266|NCT01647516|450354976|FG000|Maintenance Period (MP)|Adverse Event|2|||
125200267|NCT01647516|450354977|FG001|Maintenance Period (MP)|Adverse Event|1|||
125200268|NCT01647516|450354978|FG002|Maintenance Period (MP)|Adverse Event|0|||
125200269|NCT01647516|450354979|FG003|Maintenance Period (MP)|Adverse Event|0|||
125200270|NCT01647516|450354980|FG004|Maintenance Period (MP)|Adverse Event|0|||
125200271|NCT01647516|450354981|FG005|Maintenance Period (MP)|Adverse Event|0|||
125200272|NCT01647516|450354976|FG000|Maintenance Period (MP)|Non-compliance|1|||
125200273|NCT01647516|450354977|FG001|Maintenance Period (MP)|Non-compliance|0|||
125200274|NCT01647516|450354978|FG002|Maintenance Period (MP)|Non-compliance|0|||
125200275|NCT01647516|450354979|FG003|Maintenance Period (MP)|Non-compliance|0|||
125200276|NCT01647516|450354980|FG004|Maintenance Period (MP)|Non-compliance|0|||
125200277|NCT01647516|450354981|FG005|Maintenance Period (MP)|Non-compliance|0|||
125200278|NCT01647516|450354976|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
124867992|NCT01662310|449138111|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
124867993|NCT01662310|449138107|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
125200279|NCT01647516|450354977|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
125200280|NCT01647516|450354978|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
125200281|NCT01647516|450354979|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
125200282|NCT01647516|450354980|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
125200283|NCT01647516|450354981|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
124867994|NCT01662310|449138108|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
124867995|NCT01662310|449138109|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
124867996|NCT01662310|449138110|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
124867997|NCT01662310|449138111|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
124867998|NCT01662310|449138107|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
124867999|NCT01662310|449138108|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
124868000|NCT01662310|449138109|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
125200284|NCT01647516|450354976|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
125200285|NCT01647516|450354977|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
125200286|NCT01647516|450354978|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
125200287|NCT01647516|450354979|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
125200288|NCT01647516|450354980|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
125200289|NCT01647516|450354981|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
125200290|NCT01647516|450354976|FG000|Open-Label Period|Adverse Event|0|||
125200291|NCT01647516|450354977|FG001|Open-Label Period|Adverse Event|0|||
125200292|NCT01647516|450354978|FG002|Open-Label Period|Adverse Event|0|||
125200293|NCT01647516|450354979|FG003|Open-Label Period|Adverse Event|5|||
125200294|NCT01647516|450354980|FG004|Open-Label Period|Adverse Event|6|||
125200295|NCT01647516|450354981|FG005|Open-Label Period|Adverse Event|3|||
125200296|NCT01647516|450354976|FG000|Open-Label Period|Pregnancy|0|||
125200297|NCT01647516|450354977|FG001|Open-Label Period|Pregnancy|0|||
125200298|NCT01647516|450354978|FG002|Open-Label Period|Pregnancy|0|||
125200299|NCT01647516|450354979|FG003|Open-Label Period|Pregnancy|0|||
125200300|NCT01647516|450354980|FG004|Open-Label Period|Pregnancy|0|||
125200301|NCT01647516|450354981|FG005|Open-Label Period|Pregnancy|1|||
125200302|NCT01647516|450354976|FG000|Open-Label Period|Non-compliance|0|||
125200303|NCT01647516|450354977|FG001|Open-Label Period|Non-compliance|0|||
125200304|NCT01647516|450354978|FG002|Open-Label Period|Non-compliance|0|||
125200305|NCT01647516|450354979|FG003|Open-Label Period|Non-compliance|1|||
125200306|NCT01647516|450354980|FG004|Open-Label Period|Non-compliance|0|||
125200307|NCT01647516|450354981|FG005|Open-Label Period|Non-compliance|1|||
125200308|NCT01647516|450354976|FG000|Open-Label Period|Physician Decision|0|||
125200309|NCT01647516|450354977|FG001|Open-Label Period|Physician Decision|0|||
125200310|NCT01647516|450354978|FG002|Open-Label Period|Physician Decision|0|||
125200311|NCT01647516|450354979|FG003|Open-Label Period|Physician Decision|1|||
125200312|NCT01647516|450354980|FG004|Open-Label Period|Physician Decision|1|||
125200313|NCT01647516|450354981|FG005|Open-Label Period|Physician Decision|0|||
125200314|NCT01647516|450354976|FG000|Open-Label Period|Withdrawal by Subject|0|||
125200315|NCT01647516|450354977|FG001|Open-Label Period|Withdrawal by Subject|0|||
125200316|NCT01647516|450354978|FG002|Open-Label Period|Withdrawal by Subject|0|||
125200317|NCT01647516|450354979|FG003|Open-Label Period|Withdrawal by Subject|9|||
125200318|NCT01647516|450354980|FG004|Open-Label Period|Withdrawal by Subject|11|||
125200319|NCT01647516|450354981|FG005|Open-Label Period|Withdrawal by Subject|6|||
125200320|NCT01647516|450354976|FG000|Open-Label Period|Lost to Follow-up|0|||
125200321|NCT01647516|450354977|FG001|Open-Label Period|Lost to Follow-up|0|||
125200322|NCT01647516|450354978|FG002|Open-Label Period|Lost to Follow-up|0|||
125200323|NCT01647516|450354979|FG003|Open-Label Period|Lost to Follow-up|1|||
125200324|NCT01647516|450354980|FG004|Open-Label Period|Lost to Follow-up|0|||
125200325|NCT01647516|450354981|FG005|Open-Label Period|Lost to Follow-up|1|||
125200326|NCT01647516|450354976|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
125200327|NCT01647516|450354977|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
125200328|NCT01647516|450354978|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
125200329|NCT01647516|450354979|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
124868001|NCT01662310|449138110|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
124868002|NCT01662310|449138111|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
124868003|NCT01662310|449138107|FG000|Run-In or Stabilization Phase|Other|1|||
124868004|NCT01662310|449138108|FG001|Run-In or Stabilization Phase|Other|0|||
124868005|NCT01662310|449138109|FG002|Run-In or Stabilization Phase|Other|0|||
124868006|NCT01662310|449138110|FG003|Run-In or Stabilization Phase|Other|0|||
124868007|NCT01662310|449138111|FG004|Run-In or Stabilization Phase|Other|0|||
124868008|NCT01662310|449138107|FG000|Double-Blind Phase|Adverse Event|0|||
125200330|NCT01647516|450354980|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
125200331|NCT01647516|450354981|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
125200332|NCT01647516|450354976|FG000|Open-Label Period|Lack of Efficacy|0|||
125200333|NCT01647516|450354977|FG001|Open-Label Period|Lack of Efficacy|0|||
125200334|NCT01647516|450354978|FG002|Open-Label Period|Lack of Efficacy|0|||
125200335|NCT01647516|450354979|FG003|Open-Label Period|Lack of Efficacy|7|||
125200336|NCT01647516|450354980|FG004|Open-Label Period|Lack of Efficacy|9|||
125200337|NCT01647516|450354981|FG005|Open-Label Period|Lack of Efficacy|10|||
125200338|NCT01647516|450354976|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
125200339|NCT01647516|450354977|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
125200340|NCT01647516|450354978|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
124868009|NCT01662310|449138108|FG001|Double-Blind Phase|Adverse Event|0|||
124868010|NCT01662310|449138109|FG002|Double-Blind Phase|Adverse Event|1|||
124868011|NCT01662310|449138110|FG003|Double-Blind Phase|Adverse Event|0|||
124868012|NCT01662310|449138111|FG004|Double-Blind Phase|Adverse Event|0|||
124868013|NCT01662310|449138107|FG000|Double-Blind Phase|Lost to Follow-up|0|||
124868014|NCT01662310|449138108|FG001|Double-Blind Phase|Lost to Follow-up|3|||
124868015|NCT01662310|449138109|FG002|Double-Blind Phase|Lost to Follow-up|0|||
124868016|NCT01662310|449138110|FG003|Double-Blind Phase|Lost to Follow-up|0|||
124868017|NCT01662310|449138111|FG004|Double-Blind Phase|Lost to Follow-up|0|||
124868018|NCT01662310|449138107|FG000|Double-Blind Phase|Pregnancy|0|||
124868019|NCT01662310|449138108|FG001|Double-Blind Phase|Pregnancy|2|||
124868020|NCT01662310|449138109|FG002|Double-Blind Phase|Pregnancy|0|||
124868021|NCT01662310|449138110|FG003|Double-Blind Phase|Pregnancy|0|||
124868022|NCT01662310|449138111|FG004|Double-Blind Phase|Pregnancy|0|||
124868023|NCT01662310|449138107|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
124868024|NCT01662310|449138108|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
124868025|NCT01662310|449138109|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
124868026|NCT01662310|449138110|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
124868027|NCT01662310|449138111|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
124868028|NCT01662310|449138107|FG000|Double-Blind Phase|Other|0|||
124868029|NCT01662310|449138108|FG001|Double-Blind Phase|Other|0|||
124868030|NCT01662310|449138109|FG002|Double-Blind Phase|Other|1|||
124868031|NCT01662310|449138110|FG003|Double-Blind Phase|Other|0|||
124868032|NCT01662310|449138111|FG004|Double-Blind Phase|Other|0|||
124868033|NCT01662310|449138107|FG000|Double-Blind Phase|Randomized but not treated|0|||
124868034|NCT01662310|449138108|FG001|Double-Blind Phase|Randomized but not treated|1|||
124868035|NCT01662310|449138109|FG002|Double-Blind Phase|Randomized but not treated|0|||
124868036|NCT01662310|449138110|FG003|Double-Blind Phase|Randomized but not treated|0|||
124868037|NCT01662310|449138111|FG004|Double-Blind Phase|Randomized but not treated|0|||
124868038|NCT01662310|449138107|FG000|Open-Label Extension Phase|Adverse Event|0|||
124868039|NCT01662310|449138108|FG001|Open-Label Extension Phase|Adverse Event|0|||
124868040|NCT01662310|449138109|FG002|Open-Label Extension Phase|Adverse Event|0|||
124868041|NCT01662310|449138110|FG003|Open-Label Extension Phase|Adverse Event|3|||
124868042|NCT01662310|449138111|FG004|Open-Label Extension Phase|Adverse Event|0|||
124868043|NCT01662310|449138107|FG000|Open-Label Extension Phase|Death|0|||
124868044|NCT01662310|449138108|FG001|Open-Label Extension Phase|Death|0|||
124868045|NCT01662310|449138109|FG002|Open-Label Extension Phase|Death|0|||
124868046|NCT01662310|449138110|FG003|Open-Label Extension Phase|Death|1|||
124868047|NCT01662310|449138111|FG004|Open-Label Extension Phase|Death|0|||
124868048|NCT01662310|449138107|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
124868049|NCT01662310|449138108|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
124868050|NCT01662310|449138109|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
124868051|NCT01662310|449138110|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
124868052|NCT01662310|449138111|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
124868053|NCT01662310|449138107|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
124868054|NCT01662310|449138108|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
124868055|NCT01662310|449138109|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
124868056|NCT01662310|449138110|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
124868057|NCT01662310|449138111|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
124868058|NCT01662310|449138107|FG000|Open-Label Extension Phase|Pregnancy|0|||
124868059|NCT01662310|449138108|FG001|Open-Label Extension Phase|Pregnancy|0|||
124868060|NCT01662310|449138109|FG002|Open-Label Extension Phase|Pregnancy|0|||
124868061|NCT01662310|449138110|FG003|Open-Label Extension Phase|Pregnancy|1|||
124868062|NCT01662310|449138111|FG004|Open-Label Extension Phase|Pregnancy|0|||
124868063|NCT01662310|449138107|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
124868064|NCT01662310|449138108|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
124868065|NCT01662310|449138109|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
124868066|NCT01662310|449138110|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
124868067|NCT01662310|449138111|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
124868068|NCT01302847|449138113|FG000|Overall Study|Death|0|||
124868069|NCT01302847|449138114|FG001|Overall Study|Death|1|||
124868070|NCT01302847|449138115|FG002|Overall Study|Death|0|||
124868071|NCT01302847|449138116|FG003|Overall Study|Death|0|||
124868072|NCT01302847|449138117|FG004|Overall Study|Death|0|||
124868073|NCT01302847|449138118|FG005|Overall Study|Death|1|||
124868074|NCT01302847|449138119|FG006|Overall Study|Death|1|||
124868075|NCT01302847|449138120|FG007|Overall Study|Death|0|||
124868076|NCT01302847|449138113|FG000|Overall Study|Pregnancy|2|||
124868077|NCT01302847|449138114|FG001|Overall Study|Pregnancy|0|||
124868078|NCT01302847|449138115|FG002|Overall Study|Pregnancy|0|||
124868079|NCT01302847|449138116|FG003|Overall Study|Pregnancy|0|||
124868080|NCT01302847|449138117|FG004|Overall Study|Pregnancy|0|||
124868081|NCT01302847|449138118|FG005|Overall Study|Pregnancy|0|||
124868082|NCT01302847|449138119|FG006|Overall Study|Pregnancy|0|||
124868083|NCT01302847|449138120|FG007|Overall Study|Pregnancy|0|||
124868084|NCT01302847|449138113|FG000|Overall Study|Virologic failure|0|||
124868085|NCT01302847|449138114|FG001|Overall Study|Virologic failure|2|||
124868086|NCT01302847|449138115|FG002|Overall Study|Virologic failure|0|||
125200341|NCT01647516|450354979|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
124868087|NCT01302847|449138116|FG003|Overall Study|Virologic failure|2|||
124868088|NCT01302847|449138117|FG004|Overall Study|Virologic failure|1|||
125200342|NCT01647516|450354980|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
125200343|NCT01647516|450354981|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
125200344|NCT01647516|450354976|FG000|Open-Label Period|No completion / discontinuation visit|0|||
125200345|NCT01647516|450354977|FG001|Open-Label Period|No completion / discontinuation visit|0|||
125200346|NCT01647516|450354978|FG002|Open-Label Period|No completion / discontinuation visit|0|||
125200347|NCT01647516|450354979|FG003|Open-Label Period|No completion / discontinuation visit|0|||
125200348|NCT01647516|450354980|FG004|Open-Label Period|No completion / discontinuation visit|2|||
125200349|NCT01647516|450354981|FG005|Open-Label Period|No completion / discontinuation visit|1|||
125200350|NCT03193801|450354986|FG000|Overall Study|Physician Decision|2|||
125200351|NCT03193801|450354986|FG000|Overall Study|Withdrawal by Subject|1|||
125200352|NCT04964544|450354987|FG000|Overall Study|Screen failure or other uncategorised|10|||
125200353|NCT04964544|450354987|FG000|Overall Study|Physician Decision|4|||
125200354|NCT04964544|450354987|FG000|Overall Study|Lost to Follow-up|9|||
125200355|NCT04964544|450354987|FG000|Overall Study|Withdrawal by Subject|18|||
125200356|NCT04964544|450354987|FG000|Overall Study|Death|1|||
125200357|NCT01613222|450354990|FG000|Overall Study|Physician Decision|1|||
125200358|NCT01613222|450354990|FG000|Overall Study|Unable to place arterial line|1|||
125200359|NCT01613222|450354990|FG000|Overall Study|Reused disposable sensors|10|||
125200360|NCT03696108|450354991|FG000|Overall Study|Physician Decision|1|||
125200361|NCT03696108|450354992|FG001|Overall Study|Physician Decision|0|||
125200362|NCT03696108|450354991|FG000|Overall Study|Withdrawal by Subject|3|||
125200363|NCT03696108|450354992|FG001|Overall Study|Withdrawal by Subject|6|||
125200364|NCT02833844|450354996|FG000|Double-Blind Period|Withdrawal by Subject|2|||
125200365|NCT02833844|450354997|FG001|Double-Blind Period|Withdrawal by Subject|3|||
125200366|NCT02833844|450354996|FG000|Double-Blind Period|Protocol Violation|0|||
125200367|NCT02833844|450354997|FG001|Double-Blind Period|Protocol Violation|4|||
125200368|NCT02833844|450354996|FG000|Open-Label Period|Death|0|||
125200369|NCT02833844|450354997|FG001|Open-Label Period|Death|2|||
125200370|NCT02833844|450354996|FG000|Open-Label Period|Lost to Follow-up|1|||
125200371|NCT02833844|450354997|FG001|Open-Label Period|Lost to Follow-up|0|||
125200372|NCT02833844|450354996|FG000|Open-Label Period|Withdrawal by Subject|1|||
125200373|NCT02833844|450354997|FG001|Open-Label Period|Withdrawal by Subject|0|||
125200374|NCT01899742|450354998|FG000|Overall Study|Adverse Event|5|||
125200375|NCT01899742|450354999|FG001|Overall Study|Adverse Event|4|||
125200376|NCT01899742|450354998|FG000|Overall Study|Lack of Efficacy|1|||
125200377|NCT01899742|450354999|FG001|Overall Study|Lack of Efficacy|5|||
125200378|NCT01899742|450354998|FG000|Overall Study|Protocol Violation|2|||
125200379|NCT01899742|450354999|FG001|Overall Study|Protocol Violation|2|||
125200380|NCT01899742|450354998|FG000|Overall Study|Withdrawal by Subject|9|||
125200381|NCT01899742|450354999|FG001|Overall Study|Withdrawal by Subject|5|||
125200382|NCT02662764|450355000|FG000|Overall Study|Adverse Event|6|||
125200383|NCT02662764|450355000|FG000|Overall Study|Lack of Efficacy|8|||
125200384|NCT02662764|450355000|FG000|Overall Study|Protocol Violation|1|||
125200385|NCT02662764|450355000|FG000|Overall Study|Withdrawal by Subject|5|||
125200386|NCT02662764|450355000|FG000|Overall Study|Device failure|4|||
125200387|NCT02662764|450355000|FG000|Overall Study|Patient changed treatment|1|||
125200388|NCT02662764|450355000|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
125200389|NCT04323306|450355001|FG000|Overall Study|Physician Decision|1|||
125200390|NCT04323306|450355002|FG001|Overall Study|Physician Decision|0|||
125200391|NCT04323306|450355003|FG002|Overall Study|Physician Decision|0|||
125200392|NCT04323306|450355004|FG003|Overall Study|Physician Decision|0|||
125200393|NCT04323306|450355005|FG004|Overall Study|Physician Decision|0|||
125200394|NCT04323306|450355006|FG005|Overall Study|Physician Decision|0|||
125200395|NCT04323306|450355007|FG006|Overall Study|Physician Decision|0|||
125200396|NCT04323306|450355008|FG007|Overall Study|Physician Decision|0|||
125200397|NCT04323306|450355009|FG008|Overall Study|Physician Decision|0|||
125200398|NCT04323306|450355001|FG000|Overall Study|Withdrawal by Subject|0|||
125200399|NCT04323306|450355002|FG001|Overall Study|Withdrawal by Subject|0|||
125200400|NCT04323306|450355003|FG002|Overall Study|Withdrawal by Subject|0|||
125200401|NCT04323306|450355004|FG003|Overall Study|Withdrawal by Subject|0|||
125200402|NCT04323306|450355005|FG004|Overall Study|Withdrawal by Subject|0|||
125200403|NCT04323306|450355006|FG005|Overall Study|Withdrawal by Subject|1|||
125200404|NCT04323306|450355007|FG006|Overall Study|Withdrawal by Subject|3|||
125200405|NCT04323306|450355008|FG007|Overall Study|Withdrawal by Subject|0|||
125200406|NCT04323306|450355009|FG008|Overall Study|Withdrawal by Subject|1|||
125200407|NCT00089778|450355010|FG000|Overall Study|Protocol Violation|0|||
124868089|NCT01302847|449138118|FG005|Overall Study|Virologic failure|3|||
125200408|NCT00089778|450355011|FG001|Overall Study|Protocol Violation|0|||
125200409|NCT00089778|450355012|FG002|Overall Study|Protocol Violation|1|||
125200410|NCT01154088|450355015|FG000|Overall Study|Lost to Follow-up|4|||
125200411|NCT01154088|450355016|FG001|Overall Study|Lost to Follow-up|6|||
125200412|NCT01154088|450355017|FG002|Overall Study|Lost to Follow-up|7|||
125200413|NCT05129137|450355018|FG000|Second Period|Adverse Event|1|||
125200414|NCT05129137|450355019|FG001|Second Period|Adverse Event|0|||
125200415|NCT05129137|450355020|FG002|Second Period|Adverse Event|0|||
125200416|NCT05129137|450355021|FG003|Second Period|Adverse Event|0|||
124868090|NCT01302847|449138119|FG006|Overall Study|Virologic failure|1|||
124868091|NCT01302847|449138120|FG007|Overall Study|Virologic failure|2|||
124868092|NCT01302847|449138113|FG000|Overall Study|Severe debilitation, unable to continue|0|||
124868093|NCT01302847|449138114|FG001|Overall Study|Severe debilitation, unable to continue|0|||
124868094|NCT01302847|449138115|FG002|Overall Study|Severe debilitation, unable to continue|0|||
124868095|NCT01302847|449138116|FG003|Overall Study|Severe debilitation, unable to continue|0|||
124868096|NCT01302847|449138117|FG004|Overall Study|Severe debilitation, unable to continue|0|||
124868097|NCT01302847|449138118|FG005|Overall Study|Severe debilitation, unable to continue|1|||
124868098|NCT01302847|449138119|FG006|Overall Study|Severe debilitation, unable to continue|1|||
124868099|NCT01302847|449138120|FG007|Overall Study|Severe debilitation, unable to continue|0|||
124868100|NCT01302847|449138113|FG000|Overall Study|Not able to get to clinic|1|||
124868101|NCT01302847|449138114|FG001|Overall Study|Not able to get to clinic|1|||
124868102|NCT01302847|449138115|FG002|Overall Study|Not able to get to clinic|0|||
124868103|NCT01302847|449138116|FG003|Overall Study|Not able to get to clinic|0|||
124868104|NCT01302847|449138117|FG004|Overall Study|Not able to get to clinic|0|||
124868105|NCT01302847|449138118|FG005|Overall Study|Not able to get to clinic|0|||
124868106|NCT01302847|449138119|FG006|Overall Study|Not able to get to clinic|0|||
124868107|NCT01302847|449138120|FG007|Overall Study|Not able to get to clinic|0|||
124868108|NCT01302847|449138113|FG000|Overall Study|Site closing|2|||
124868109|NCT01302847|449138114|FG001|Overall Study|Site closing|2|||
125200417|NCT05129137|450355018|FG000|Second Period|Protocol Violation|0|||
125200418|NCT05129137|450355019|FG001|Second Period|Protocol Violation|0|||
125200419|NCT05129137|450355020|FG002|Second Period|Protocol Violation|0|||
125200420|NCT05129137|450355021|FG003|Second Period|Protocol Violation|1|||
125200421|NCT05129137|450355018|FG000|Third Period|Protocol Violation|0|||
125200422|NCT05129137|450355019|FG001|Third Period|Protocol Violation|0|||
125200423|NCT05129137|450355020|FG002|Third Period|Protocol Violation|0|||
125200424|NCT05129137|450355021|FG003|Third Period|Protocol Violation|1|||
125200425|NCT05129137|450355018|FG000|Forth Period|Protocol Violation|0|||
125200426|NCT05129137|450355019|FG001|Forth Period|Protocol Violation|1|||
125200427|NCT05129137|450355020|FG002|Forth Period|Protocol Violation|0|||
125200428|NCT05129137|450355021|FG003|Forth Period|Protocol Violation|0|||
125200429|NCT05129137|450355018|FG000|Forth Period|Withdrawal by Subject|0|||
125200430|NCT05129137|450355019|FG001|Forth Period|Withdrawal by Subject|0|||
125200431|NCT05129137|450355020|FG002|Forth Period|Withdrawal by Subject|1|||
125200432|NCT05129137|450355021|FG003|Forth Period|Withdrawal by Subject|0|||
125200433|NCT01104246|450355022|FG000|Overall Study|Withdrawal by Subject|1|||
125200434|NCT01104246|450355022|FG000|Overall Study|did not meet inclusion criteria|4|||
125200435|NCT05178641|450355033|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
125200436|NCT05178641|450355034|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
125200437|NCT05178641|450355033|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
125200438|NCT05178641|450355034|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
125200439|NCT01869699|450355035|FG000|Overall Study|Withdrawal by Subject|1|||
125200440|NCT01869699|450355036|FG001|Overall Study|Withdrawal by Subject|0|||
125200441|NCT01475851|450355037|FG000|Overall Study|Protocol defined stopping criteria|1|||
125200442|NCT01475851|450355038|FG001|Overall Study|Protocol defined stopping criteria|0|||
125200443|NCT01867294|450355039|FG000|Overall Study|Withdrawal by Subject|1|||
125200444|NCT01867294|450355040|FG001|Overall Study|Withdrawal by Subject|1|||
125200445|NCT01867294|450355041|FG002|Overall Study|Withdrawal by Subject|0|||
125200446|NCT01867294|450355042|FG003|Overall Study|Withdrawal by Subject|0|||
125200447|NCT02017912|450355045|FG000|Overall Study|Withdrawal by Subject|2|||
125200448|NCT02017912|450355046|FG001|Overall Study|Withdrawal by Subject|1|||
125200449|NCT02017912|450355045|FG000|Overall Study|miscellaneous|1|||
125200450|NCT02017912|450355046|FG001|Overall Study|miscellaneous|1|||
125200451|NCT01508130|450355050|FG000|Overall Study|Adverse Event|81|||
125200452|NCT01508130|450355051|FG001|Overall Study|Adverse Event|28|||
125200453|NCT01508130|450355050|FG000|Overall Study|Death|3|||
125200454|NCT01508130|450355051|FG001|Overall Study|Death|1|||
125200455|NCT01508130|450355050|FG000|Overall Study|Protocol Violation|2|||
125200456|NCT01508130|450355051|FG001|Overall Study|Protocol Violation|0|||
125200457|NCT01508130|450355050|FG000|Overall Study|Lost to Follow-up|25|||
125200458|NCT01508130|450355051|FG001|Overall Study|Lost to Follow-up|2|||
125200459|NCT01508130|450355050|FG000|Overall Study|Withdrawal by Subject|3|||
125200460|NCT01508130|450355051|FG001|Overall Study|Withdrawal by Subject|3|||
125200461|NCT01508130|450355050|FG000|Overall Study|Subject's substantial non-compliance|25|||
125200462|NCT01508130|450355051|FG001|Overall Study|Subject's substantial non-compliance|9|||
125200463|NCT01508130|450355050|FG000|Overall Study|Insufficient therapeutic response|74|||
125200464|NCT01508130|450355051|FG001|Overall Study|Insufficient therapeutic response|23|||
125200465|NCT01508130|450355050|FG000|Overall Study|Administrative|14|||
125200466|NCT01508130|450355051|FG001|Overall Study|Administrative|3|||
124868110|NCT01302847|449138115|FG002|Overall Study|Site closing|0|||
124868111|NCT01302847|449138116|FG003|Overall Study|Site closing|0|||
124868112|NCT01302847|449138117|FG004|Overall Study|Site closing|0|||
124868113|NCT01302847|449138118|FG005|Overall Study|Site closing|0|||
124868114|NCT01302847|449138119|FG006|Overall Study|Site closing|0|||
125200467|NCT01680159|450355052|FG000|Screening Period|Not meet criteria for dose-up period|7|||
125200468|NCT01680159|450355052|FG000|Increased Dose Period|Adverse Event|6|||
125200469|NCT01680159|450355052|FG000|Increased Dose Period|Withdrawal by Subject|2|||
125200470|NCT03429244|450355057|FG000|Overall Study|Withdrawal by Subject|2|||
125200471|NCT03429244|450355058|FG001|Overall Study|Withdrawal by Subject|1|||
125200472|NCT03429244|450355059|FG002|Overall Study|Withdrawal by Subject|1|||
125200473|NCT03403751|450355060|FG000|Overall Study|Death|5|||
125200474|NCT03403751|450355061|FG001|Overall Study|Death|6|||
125200475|NCT03403751|450355060|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
125200476|NCT03403751|450355061|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
125200477|NCT00750139|450355062|FG000|Overall Study|Adverse Event|1|||
124868115|NCT01302847|449138120|FG007|Overall Study|Site closing|0|||
124868116|NCT01302847|449138113|FG000|Overall Study|Withdrawal by Subject|1|||
125200478|NCT00750139|450355063|FG001|Overall Study|Adverse Event|2|||
125200479|NCT00750139|450355064|FG002|Overall Study|Adverse Event|0|||
125200480|NCT00750139|450355065|FG003|Overall Study|Adverse Event|1|||
124868117|NCT01302847|449138114|FG001|Overall Study|Withdrawal by Subject|0|||
125200481|NCT00750139|450355062|FG000|Overall Study|Lost to Follow-up|17|||
125200482|NCT00750139|450355063|FG001|Overall Study|Lost to Follow-up|12|||
125200483|NCT00750139|450355064|FG002|Overall Study|Lost to Follow-up|15|||
125200484|NCT00750139|450355065|FG003|Overall Study|Lost to Follow-up|6|||
125200485|NCT00750139|450355062|FG000|Overall Study|Withdrawal by Subject|3|||
125200486|NCT00750139|450355063|FG001|Overall Study|Withdrawal by Subject|2|||
125200487|NCT00750139|450355064|FG002|Overall Study|Withdrawal by Subject|6|||
125200488|NCT00750139|450355065|FG003|Overall Study|Withdrawal by Subject|2|||
125200489|NCT00750139|450355062|FG000|Overall Study|Physician Decision|1|||
125200490|NCT00750139|450355063|FG001|Overall Study|Physician Decision|1|||
125200491|NCT00750139|450355064|FG002|Overall Study|Physician Decision|0|||
125200492|NCT00750139|450355065|FG003|Overall Study|Physician Decision|0|||
125200493|NCT00750139|450355062|FG000|Overall Study|Non-compliance|1|||
125200494|NCT00750139|450355063|FG001|Overall Study|Non-compliance|0|||
125200495|NCT00750139|450355064|FG002|Overall Study|Non-compliance|1|||
125200496|NCT00750139|450355065|FG003|Overall Study|Non-compliance|3|||
125200497|NCT00750139|450355062|FG000|Overall Study|Termination by sponsor|4|||
125200498|NCT00750139|450355063|FG001|Overall Study|Termination by sponsor|0|||
125200499|NCT00750139|450355064|FG002|Overall Study|Termination by sponsor|0|||
125200500|NCT00750139|450355065|FG003|Overall Study|Termination by sponsor|1|||
124868118|NCT01302847|449138115|FG002|Overall Study|Withdrawal by Subject|0|||
124868119|NCT01302847|449138116|FG003|Overall Study|Withdrawal by Subject|0|||
124868120|NCT01302847|449138117|FG004|Overall Study|Withdrawal by Subject|1|||
124868121|NCT01302847|449138118|FG005|Overall Study|Withdrawal by Subject|0|||
124868122|NCT01302847|449138119|FG006|Overall Study|Withdrawal by Subject|0|||
124868123|NCT01302847|449138120|FG007|Overall Study|Withdrawal by Subject|1|||
124868124|NCT01302847|449138113|FG000|Overall Study|Not willing to adhere to requirements|5|||
124868125|NCT01302847|449138114|FG001|Overall Study|Not willing to adhere to requirements|0|||
124868126|NCT01302847|449138115|FG002|Overall Study|Not willing to adhere to requirements|1|||
124868127|NCT01302847|449138116|FG003|Overall Study|Not willing to adhere to requirements|0|||
124868128|NCT01302847|449138117|FG004|Overall Study|Not willing to adhere to requirements|0|||
124868129|NCT01302847|449138118|FG005|Overall Study|Not willing to adhere to requirements|0|||
124868130|NCT01302847|449138119|FG006|Overall Study|Not willing to adhere to requirements|0|||
124868131|NCT01302847|449138120|FG007|Overall Study|Not willing to adhere to requirements|2|||
124868132|NCT01302847|449138113|FG000|Overall Study|Site unable to contact participant|2|||
124868133|NCT01302847|449138114|FG001|Overall Study|Site unable to contact participant|1|||
124868134|NCT01302847|449138115|FG002|Overall Study|Site unable to contact participant|0|||
124868135|NCT01302847|449138116|FG003|Overall Study|Site unable to contact participant|0|||
124868136|NCT01302847|449138117|FG004|Overall Study|Site unable to contact participant|0|||
124868137|NCT01302847|449138118|FG005|Overall Study|Site unable to contact participant|0|||
124868138|NCT01302847|449138119|FG006|Overall Study|Site unable to contact participant|2|||
124868139|NCT01302847|449138120|FG007|Overall Study|Site unable to contact participant|0|||
124868140|NCT00374322|449138122|FG000|Overall Study|Lost to Follow-up|92|||
124868141|NCT00374322|449138123|FG001|Overall Study|Lost to Follow-up|90|||
124868142|NCT00374322|449138122|FG000|Overall Study|Protocol Violation|8|||
124868143|NCT00374322|449138123|FG001|Overall Study|Protocol Violation|3|||
124868144|NCT00374322|449138122|FG000|Overall Study|Withdrawal by Subject|235|||
124868145|NCT00374322|449138123|FG001|Overall Study|Withdrawal by Subject|167|||
124868146|NCT00374322|449138122|FG000|Overall Study|Sponsor Terminated Study|866|||
124868147|NCT00374322|449138123|FG001|Overall Study|Sponsor Terminated Study|990|||
125200501|NCT00750139|450355062|FG000|Overall Study|Non-specific|62|||
125200502|NCT00750139|450355063|FG001|Overall Study|Non-specific|42|||
125200503|NCT00750139|450355064|FG002|Overall Study|Non-specific|79|||
125200504|NCT00750139|450355065|FG003|Overall Study|Non-specific|33|||
125200505|NCT00658775|450355068|FG000|Overall Study|Adverse Event|4|||
125200506|NCT00658775|450355069|FG001|Overall Study|Adverse Event|6|||
125200507|NCT00658775|450355068|FG000|Overall Study|Lost to Follow-up|17|||
125200508|NCT00658775|450355069|FG001|Overall Study|Lost to Follow-up|18|||
124868148|NCT00374322|449138122|FG000|Overall Study|Physician Decision|36|||
124868149|NCT00374322|449138123|FG001|Overall Study|Physician Decision|32|||
124868150|NCT00374322|449138122|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
124868151|NCT00374322|449138123|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
124868152|NCT00374322|449138122|FG000|Overall Study|Sponsor Decision|2|||
124868153|NCT00374322|449138123|FG001|Overall Study|Sponsor Decision|3|||
124868154|NCT00374322|449138122|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
124868155|NCT00374322|449138123|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
125200509|NCT00658775|450355068|FG000|Overall Study|Withdrawal by Subject|6|||
125200510|NCT00658775|450355069|FG001|Overall Study|Withdrawal by Subject|4|||
125200511|NCT00658775|450355068|FG000|Overall Study|Withdrawal of consent|8|||
125200512|NCT00658775|450355069|FG001|Overall Study|Withdrawal of consent|7|||
125200513|NCT00658775|450355068|FG000|Overall Study|Other|7|||
125200514|NCT00658775|450355069|FG001|Overall Study|Other|8|||
125200515|NCT05033262|450355070|FG000|Overall Study|Lost to Follow-up|1|||
125200516|NCT05033262|450355071|FG001|Overall Study|Lost to Follow-up|0|||
125200517|NCT05033262|450355072|FG002|Overall Study|Lost to Follow-up|0|||
125200518|NCT05033262|450355073|FG003|Overall Study|Lost to Follow-up|1|||
125200519|NCT04413552|450355075|FG000|Overall Study|Adverse Event|0|||
125200520|NCT04413552|450355076|FG001|Overall Study|Adverse Event|0|||
125200521|NCT04413552|450355077|FG002|Overall Study|Adverse Event|0|||
125200522|NCT04413552|450355078|FG003|Overall Study|Adverse Event|0|||
125200523|NCT04413552|450355079|FG004|Overall Study|Adverse Event|0|||
125200524|NCT04413552|450355080|FG005|Overall Study|Adverse Event|0|||
125200525|NCT04413552|450355081|FG006|Overall Study|Adverse Event|1|||
125200526|NCT04413552|450355082|FG007|Overall Study|Adverse Event|0|||
125200527|NCT04413552|450355083|FG008|Overall Study|Adverse Event|0|||
125200528|NCT04413552|450355084|FG009|Overall Study|Adverse Event|0|||
125200529|NCT01741792|450357534|FG000|Overall Study|Death|6|||
125200530|NCT01741792|450357535|FG001|Overall Study|Death|1|||
125200531|NCT01741792|450357536|FG002|Overall Study|Death|12|||
125200532|NCT02222545|450357537|FG000|Overall Study|Adverse Event|1|||
125200533|NCT02222545|450357538|FG001|Overall Study|Adverse Event|0|||
125200534|NCT02222545|450357539|FG002|Overall Study|Adverse Event|2|||
125200535|NCT02222545|450357537|FG000|Overall Study|Death|0|||
125200536|NCT02222545|450357538|FG001|Overall Study|Death|0|||
125200537|NCT02222545|450357539|FG002|Overall Study|Death|9|||
125200538|NCT02222545|450357537|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
125200539|NCT02222545|450357538|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
125200540|NCT02222545|450357539|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
125200541|NCT02222545|450357537|FG000|Overall Study|Withdrawal by Subject|0|||
125200542|NCT02222545|450357538|FG001|Overall Study|Withdrawal by Subject|0|||
125200543|NCT02222545|450357539|FG002|Overall Study|Withdrawal by Subject|3|||
125200544|NCT02222545|450357537|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
125200545|NCT02222545|450357538|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
125200546|NCT02222545|450357539|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
125200547|NCT00761280|450357540|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
125200548|NCT00761280|450357541|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
125200549|NCT00761280|450357540|FG000|Randomization to First Dose|Sponsor decision|1|||
125200550|NCT00761280|450357541|FG001|Randomization to First Dose|Sponsor decision|0|||
125200551|NCT00761280|450357540|FG000|Randomization to First Dose|Other|1|||
125200552|NCT00761280|450357541|FG001|Randomization to First Dose|Other|0|||
125200553|NCT00761280|450357540|FG000|First Dose to End of Study|End of trial|5|||
125200554|NCT00761280|450357541|FG001|First Dose to End of Study|End of trial|5|||
125200555|NCT00761280|450357540|FG000|First Dose to End of Study|Progressive disease|5|||
125200556|NCT00761280|450357541|FG001|First Dose to End of Study|Progressive disease|3|||
125200557|NCT00761280|450357540|FG000|First Dose to End of Study|Sponsor decision|1|||
125200558|NCT00761280|450357541|FG001|First Dose to End of Study|Sponsor decision|2|||
125200559|NCT00761280|450357540|FG000|First Dose to End of Study|Death|1|||
125200560|NCT00761280|450357541|FG001|First Dose to End of Study|Death|0|||
125200561|NCT00761280|450357540|FG000|First Dose to End of Study|Lost to Follow-up|0|||
125200562|NCT00761280|450357541|FG001|First Dose to End of Study|Lost to Follow-up|1|||
125200563|NCT01938430|450357542|FG000|Overall Study|Randomized but Not Treated|0|||
125200564|NCT01938430|450357543|FG001|Overall Study|Randomized but Not Treated|0|||
125200565|NCT01938430|450357544|FG002|Overall Study|Randomized but Not Treated|0|||
125200566|NCT01938430|450357545|FG003|Overall Study|Randomized but Not Treated|0|||
125200567|NCT01938430|450357546|FG004|Overall Study|Randomized but Not Treated|0|||
125200568|NCT01938430|450357547|FG005|Overall Study|Randomized but Not Treated|0|||
125200569|NCT01938430|450357548|FG006|Overall Study|Randomized but Not Treated|0|||
125200570|NCT01938430|450357549|FG007|Overall Study|Randomized but Not Treated|0|||
125200571|NCT01938430|450357550|FG008|Overall Study|Randomized but Not Treated|0|||
125200572|NCT01938430|450357551|FG009|Overall Study|Randomized but Not Treated|0|||
124868156|NCT00374322|449138122|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
124868157|NCT00374322|449138123|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
124868158|NCT00374322|449138122|FG000|Overall Study|Severe Toxicity|1|||
124868159|NCT00374322|449138123|FG001|Overall Study|Severe Toxicity|0|||
124868160|NCT00374322|449138122|FG000|Overall Study|Site Closed|2|||
124868161|NCT00374322|449138123|FG001|Overall Study|Site Closed|2|||
124868162|NCT00374322|449138122|FG000|Overall Study|Participant Changed Physician|1|||
124868163|NCT00374322|449138123|FG001|Overall Study|Participant Changed Physician|0|||
124868164|NCT00374322|449138122|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
124868165|NCT00374322|449138123|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
124868166|NCT00374322|449138122|FG000|Overall Study|Noncompliance with Study Requirements|0|||
124868167|NCT00374322|449138123|FG001|Overall Study|Noncompliance with Study Requirements|1|||
124868168|NCT00374322|449138122|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
124868169|NCT00374322|449138123|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
124868170|NCT00374322|449138122|FG000|Overall Study|Did Not Receive Study Medication|8|||
124868171|NCT00374322|449138123|FG001|Overall Study|Did Not Receive Study Medication|6|||
124868172|NCT03969719|449138124|FG000|Overall Study|Other reasons not specified|1|||
124868173|NCT03969719|449138125|FG001|Overall Study|Other reasons not specified|1|||
124868174|NCT03969719|449138126|FG002|Overall Study|Other reasons not specified|3|||
124868175|NCT03969719|449138124|FG000|Overall Study|Withdrawal by Subject|2|||
124868176|NCT03969719|449138125|FG001|Overall Study|Withdrawal by Subject|3|||
124868177|NCT03969719|449138126|FG002|Overall Study|Withdrawal by Subject|2|||
124868178|NCT03969719|449138124|FG000|Overall Study|Protocol Violation|1|||
124868179|NCT03969719|449138125|FG001|Overall Study|Protocol Violation|2|||
124868180|NCT03969719|449138126|FG002|Overall Study|Protocol Violation|0|||
124868181|NCT03969719|449138124|FG000|Overall Study|Adverse Event|0|||
124868182|NCT03969719|449138125|FG001|Overall Study|Adverse Event|2|||
124868183|NCT03969719|449138126|FG002|Overall Study|Adverse Event|0|||
124868184|NCT03969719|449138124|FG000|Overall Study|Lost to Follow-up|0|||
124868185|NCT03969719|449138125|FG001|Overall Study|Lost to Follow-up|1|||
124868186|NCT03969719|449138126|FG002|Overall Study|Lost to Follow-up|0|||
124868187|NCT02130193|449138129|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
124868188|NCT02130193|449138130|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
124868189|NCT02130193|449138131|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
124868190|NCT02130193|449138129|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
124868191|NCT02130193|449138130|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
124868192|NCT02130193|449138131|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
124868193|NCT02130193|449138129|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
124868194|NCT02130193|449138130|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
124868195|NCT02130193|449138131|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
124868196|NCT02130193|449138129|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
124868197|NCT02130193|449138130|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
124868198|NCT02130193|449138131|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
124868199|NCT01212770|449138132|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
124868200|NCT01212770|449138133|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
124868201|NCT01212770|449138134|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
124868202|NCT01212770|449138135|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124868203|NCT01212770|449138136|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124868204|NCT01212770|449138137|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124868205|NCT01212770|449138138|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124868206|NCT01212770|449138139|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124868207|NCT01212770|449138140|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124868208|NCT01212770|449138132|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
124868209|NCT01212770|449138133|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
124868210|NCT01212770|449138134|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
124868211|NCT01212770|449138135|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124868212|NCT01212770|449138136|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124868213|NCT01212770|449138137|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124868214|NCT01212770|449138138|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124868215|NCT01212770|449138139|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124868216|NCT01212770|449138140|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124868217|NCT01212770|449138132|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
124868218|NCT01212770|449138133|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
124868219|NCT01212770|449138134|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
124868220|NCT01212770|449138135|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124868221|NCT01212770|449138136|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124868222|NCT01212770|449138137|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125200573|NCT01938430|450357552|FG010|Overall Study|Randomized but Not Treated|1|||
125200574|NCT01938430|450357553|FG011|Overall Study|Randomized but Not Treated|0|||
125200575|NCT01938430|450357554|FG012|Overall Study|Randomized but Not Treated|0|||
124868223|NCT01212770|449138138|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124868224|NCT01212770|449138139|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124868225|NCT01212770|449138140|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124868226|NCT01212770|449138132|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
124868227|NCT01212770|449138133|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124868228|NCT01212770|449138134|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
124868229|NCT01212770|449138135|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124868230|NCT01212770|449138136|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124868231|NCT01212770|449138137|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124868232|NCT01212770|449138138|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124868233|NCT01212770|449138139|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124868234|NCT01212770|449138140|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124868235|NCT01212770|449138132|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124868236|NCT01212770|449138133|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124868237|NCT01212770|449138134|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
124868238|NCT01212770|449138135|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124868239|NCT01212770|449138136|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124868240|NCT01212770|449138137|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124868241|NCT01212770|449138138|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124868242|NCT01212770|449138139|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124868243|NCT01212770|449138140|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124868244|NCT01212770|449138132|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
124868245|NCT01212770|449138133|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
124868246|NCT01212770|449138134|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
124868247|NCT01212770|449138135|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
124868248|NCT01212770|449138136|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
124868249|NCT01212770|449138137|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
124868250|NCT01212770|449138138|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
124868251|NCT01212770|449138139|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
124868252|NCT01212770|449138140|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
124868253|NCT01212770|449138132|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
124868254|NCT01212770|449138133|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
124868255|NCT01212770|449138134|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
124868256|NCT01212770|449138135|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
124868257|NCT01212770|449138136|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
124868258|NCT01212770|449138137|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
124868259|NCT01212770|449138138|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
124868260|NCT01212770|449138139|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
124868261|NCT01212770|449138140|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
124868262|NCT01212770|449138132|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
124868263|NCT01212770|449138133|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
124868264|NCT01212770|449138134|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
124868265|NCT01212770|449138135|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
124868266|NCT01212770|449138136|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
124868267|NCT01212770|449138137|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
124868268|NCT01212770|449138138|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
124868269|NCT01212770|449138139|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
124868270|NCT01212770|449138140|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
124868271|NCT01212770|449138132|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
124868272|NCT01212770|449138133|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
124868273|NCT01212770|449138134|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
124868274|NCT01212770|449138135|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
124868275|NCT01212770|449138136|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
124868276|NCT01212770|449138137|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
124868277|NCT01212770|449138138|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
124868278|NCT01212770|449138139|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
124868279|NCT01212770|449138140|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
124868280|NCT01212770|449138132|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
124868281|NCT01212770|449138133|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
124868282|NCT01212770|449138134|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
124868283|NCT01212770|449138135|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
124868284|NCT01212770|449138136|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
124868285|NCT01212770|449138137|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
124868286|NCT01212770|449138138|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
124868287|NCT01212770|449138139|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
124868288|NCT01212770|449138140|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
124868289|NCT01212770|449138132|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
124868290|NCT01212770|449138133|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
124868291|NCT01212770|449138134|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
124868292|NCT01212770|449138135|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
124868293|NCT01212770|449138136|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
124868294|NCT01212770|449138137|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
124868295|NCT01212770|449138138|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
124868296|NCT01212770|449138139|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
124868297|NCT01212770|449138140|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
124868298|NCT01212770|449138132|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
124868299|NCT01212770|449138133|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
124868300|NCT01212770|449138134|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
124868301|NCT01212770|449138135|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
124868302|NCT01212770|449138136|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
124868303|NCT01212770|449138137|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
124868304|NCT01212770|449138138|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
124868305|NCT01212770|449138139|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
124868306|NCT01212770|449138140|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
124868307|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
124868308|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
124868309|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
124868310|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
124868311|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
124868312|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
124868313|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
124868314|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
124868315|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
124868316|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
124868317|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
124868318|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
124868319|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
124868320|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
124868321|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
124868322|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
124868323|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
124868324|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
124868325|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
124868326|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
124868327|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
124868328|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
124868329|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
124868330|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
124868331|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
124868332|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
124868333|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
124868334|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124868335|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
124868336|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
124868337|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124868338|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124868339|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124868340|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124868341|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
124868342|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
124868343|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
124868344|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
124868345|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
124868346|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
124868347|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
124868348|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
124868349|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
124868350|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
124868351|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
124868352|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
124868353|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
124868354|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
124868355|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
124868356|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
124868357|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
124868358|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
124868359|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
124868360|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
124868361|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
124868362|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
124868363|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
124868364|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
124868365|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
124868366|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
124868367|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
124868368|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
124868369|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
124868370|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
124868371|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
124868372|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
124868373|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
124868374|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
124868375|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
124868376|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
124868377|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
124868378|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
124868379|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124868380|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
124868381|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
124868382|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124868383|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124868384|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124868385|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124868386|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
124868387|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
124868388|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
124868389|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
124868390|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
124868391|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
124868392|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
124868393|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
124868394|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
124868395|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
124868396|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
124868397|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
124868398|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
124868399|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
124868400|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
124868401|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
124868402|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
124868403|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
124868404|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
124868405|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
124868406|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
124868407|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
124868408|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
124868409|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
124868410|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
124868411|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
124868412|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
124868413|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
124868414|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
125200576|NCT01938430|450357555|FG013|Overall Study|Randomized but Not Treated|1|||
125200577|NCT01938430|450357542|FG000|Overall Study|Adverse Event|0|||
125200578|NCT01938430|450357543|FG001|Overall Study|Adverse Event|0|||
124868415|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
124868416|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
124868417|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
124868418|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
124868419|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
124868420|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
124868421|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
124868422|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
124868423|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
124868424|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
124868425|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
124868426|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
124868427|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
124868428|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
124868429|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
124868430|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
124868431|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
124868432|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
124868433|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
124868434|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
124868435|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
124868436|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
124868437|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
125089672|NCT00348686|449946989|FG000|Overall Study|Withdrawal by Subject|45|||
124868438|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
125089673|NCT00348686|449946989|FG000|Overall Study|Adverse Event|5|||
125089674|NCT00348686|449946989|FG000|Overall Study|Protocol Violation|6|||
125089675|NCT00348686|449946989|FG000|Overall Study|Lost to Follow-up|2|||
125089676|NCT00348686|449946989|FG000|Overall Study|Multiple Reasons|8|||
125089677|NCT01904760|449946996|FG000|Overall Study|Protocol Violation|1|||
125089678|NCT01904760|449946997|FG001|Overall Study|Protocol Violation|0|||
125089679|NCT04249076|449947009|FG000|Overall Study|Adverse Event|1|||
125089680|NCT04249076|449947010|FG001|Overall Study|Adverse Event|1|||
125089681|NCT04249076|449947009|FG000|Overall Study|Protocol Violation|1|||
125089682|NCT04249076|449947010|FG001|Overall Study|Protocol Violation|2|||
125089683|NCT04249076|449947009|FG000|Overall Study|Lack of Efficacy|0|||
125089684|NCT04249076|449947010|FG001|Overall Study|Lack of Efficacy|1|||
125089685|NCT04249076|449947009|FG000|Overall Study|Withdrawal by Subject|0|||
125089686|NCT04249076|449947010|FG001|Overall Study|Withdrawal by Subject|1|||
125089687|NCT00783263|449947011|FG000|Overall Study|Adverse Event|3|||
125089688|NCT00783263|449947012|FG001|Overall Study|Adverse Event|0|||
125089689|NCT00783263|449947013|FG002|Overall Study|Adverse Event|2|||
125089690|NCT00783263|449947014|FG003|Overall Study|Adverse Event|1|||
125089691|NCT00783263|449947011|FG000|Overall Study|Lost to Follow-up|1|||
125089692|NCT00783263|449947012|FG001|Overall Study|Lost to Follow-up|1|||
125089693|NCT00783263|449947013|FG002|Overall Study|Lost to Follow-up|0|||
125089694|NCT00783263|449947014|FG003|Overall Study|Lost to Follow-up|0|||
125089695|NCT00783263|449947011|FG000|Overall Study|Withdrawal by Subject|0|||
125089696|NCT00783263|449947012|FG001|Overall Study|Withdrawal by Subject|1|||
125089697|NCT00783263|449947013|FG002|Overall Study|Withdrawal by Subject|1|||
125089698|NCT00783263|449947014|FG003|Overall Study|Withdrawal by Subject|2|||
125089699|NCT00405756|449947015|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
125089700|NCT00405756|449947016|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
125089701|NCT00405756|449947017|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
125089702|NCT00405756|449947015|FG000|Double-blind Treatment|Adverse Event|31|||
125089703|NCT00405756|449947016|FG001|Double-blind Treatment|Adverse Event|27|||
125089704|NCT00405756|449947017|FG002|Double-blind Treatment|Adverse Event|12|||
125089705|NCT00405756|449947015|FG000|Double-blind Treatment|Disease Progression|47|||
125089706|NCT00405756|449947016|FG001|Double-blind Treatment|Disease Progression|81|||
125089707|NCT00405756|449947017|FG002|Double-blind Treatment|Disease Progression|102|||
125089708|NCT00405756|449947015|FG000|Double-blind Treatment|Lack of Efficacy|1|||
125089709|NCT00405756|449947016|FG001|Double-blind Treatment|Lack of Efficacy|4|||
125089710|NCT00405756|449947017|FG002|Double-blind Treatment|Lack of Efficacy|2|||
125089711|NCT00405756|449947015|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
125089712|NCT00405756|449947016|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
125089713|NCT00405756|449947017|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
125089714|NCT00405756|449947015|FG000|Double-blind Treatment|Lost to Follow-up|1|||
125089715|NCT00405756|449947016|FG001|Double-blind Treatment|Lost to Follow-up|0|||
125089716|NCT00405756|449947017|FG002|Double-blind Treatment|Lost to Follow-up|0|||
125089717|NCT00405756|449947015|FG000|Double-blind Treatment|Death|4|||
125089718|NCT00405756|449947016|FG001|Double-blind Treatment|Death|4|||
125089719|NCT00405756|449947017|FG002|Double-blind Treatment|Death|4|||
125089720|NCT00405756|449947015|FG000|Double-blind Treatment|Protocol Violation|1|||
125089721|NCT00405756|449947016|FG001|Double-blind Treatment|Protocol Violation|0|||
125089722|NCT00405756|449947017|FG002|Double-blind Treatment|Protocol Violation|2|||
125089723|NCT00405756|449947015|FG000|Double-blind Treatment|Other|7|||
125089724|NCT00405756|449947016|FG001|Double-blind Treatment|Other|4|||
125089725|NCT00405756|449947017|FG002|Double-blind Treatment|Other|4|||
125089726|NCT00405756|449947015|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
125089727|NCT00405756|449947016|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
125089728|NCT00405756|449947017|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
125089729|NCT00405756|449947015|FG000|Open-label Extension|Adverse Event|1|||
124868439|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
124868440|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
124868441|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
124868442|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124868443|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
124868444|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
124868445|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124868446|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124868447|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124868448|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124868449|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124868450|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124868451|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124868452|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124868453|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
124868454|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124868455|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124868456|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124868457|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124868458|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124868459|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124868460|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124868461|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
124868462|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124868463|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124868464|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124868465|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124868466|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124868467|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124868468|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
124868469|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
124868470|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
124868471|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
124868472|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
124868473|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
124868474|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
124868475|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
124868476|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
124868477|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
124868478|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124868479|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124868480|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
124868481|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124868482|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124868483|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124868484|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124868485|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124868486|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124868487|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
124868488|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
124868489|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
124868490|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
124868491|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
124868492|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
124868493|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
124868494|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
124868495|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
124868496|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124868497|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124868498|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
124868499|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124868500|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124868501|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124868502|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124868503|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124868504|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124868505|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124868506|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
124868507|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
124868508|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124868509|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124868510|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124868511|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124868512|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
124868513|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124868514|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 5)|Death|0|||
124868515|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 5)|Death|0|||
124868516|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 5)|Death|0|||
124868517|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 5)|Death|0|||
124868518|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 5)|Death|0|||
124868519|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 5)|Death|0|||
124868520|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 5)|Death|0|||
124868521|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 5)|Death|1|||
124868522|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 5)|Death|0|||
124868523|NCT00829387|449138141|FG000|Overall Study|Withdrawal by Subject|2|||
124868524|NCT00829387|449138142|FG001|Overall Study|Withdrawal by Subject|3|||
124868525|NCT00829387|449138141|FG000|Overall Study|Disqualified by PI|1|||
124868526|NCT00829387|449138142|FG001|Overall Study|Disqualified by PI|0|||
124868527|NCT00707031|449138150|FG000|Overall Study|Adverse Event|45|||
124868528|NCT00707031|449138151|FG001|Overall Study|Adverse Event|45|||
124868529|NCT00707031|449138150|FG000|Overall Study|Lack of Efficacy|19|||
124868530|NCT00707031|449138151|FG001|Overall Study|Lack of Efficacy|6|||
124868531|NCT00707031|449138150|FG000|Overall Study|Lost to Follow-up|2|||
124868532|NCT00707031|449138151|FG001|Overall Study|Lost to Follow-up|1|||
124868533|NCT00707031|449138150|FG000|Overall Study|Protocol Violation|1|||
124868534|NCT00707031|449138151|FG001|Overall Study|Protocol Violation|0|||
124868535|NCT00707031|449138150|FG000|Overall Study|Withdrawal by Subject|7|||
124868536|NCT00707031|449138151|FG001|Overall Study|Withdrawal by Subject|8|||
124868537|NCT00707031|449138150|FG000|Overall Study|Poor Compliance to Protocol|7|||
124868538|NCT00707031|449138151|FG001|Overall Study|Poor Compliance to Protocol|13|||
124868539|NCT00707031|449138150|FG000|Overall Study|Familial or Personal Reasons|12|||
124868540|NCT00707031|449138151|FG001|Overall Study|Familial or Personal Reasons|15|||
124868541|NCT00707031|449138150|FG000|Overall Study|Serious Noncompliance|2|||
124868542|NCT00707031|449138151|FG001|Overall Study|Serious Noncompliance|3|||
124868543|NCT00707031|449138150|FG000|Overall Study|Sponsor Decision|9|||
124868544|NCT00707031|449138151|FG001|Overall Study|Sponsor Decision|8|||
124868545|NCT02747238|449138158|FG000|Overall Study|Lack of Efficacy|0|||
124868546|NCT02747238|449138159|FG001|Overall Study|Lack of Efficacy|1|||
124868547|NCT02747238|449138158|FG000|Overall Study|Data lost|3|||
124868548|NCT02747238|449138159|FG001|Overall Study|Data lost|5|||
124868549|NCT02085252|449138160|FG000|Overall Study|Withdrawal of Consent|1|||
124868550|NCT02085252|449138161|FG001|Overall Study|Withdrawal of Consent|0|||
124868551|NCT02085252|449138160|FG000|Overall Study|Adverse Event|0|||
124868552|NCT02085252|449138161|FG001|Overall Study|Adverse Event|1|||
124868553|NCT02085252|449138160|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
124868554|NCT02085252|449138161|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
124868555|NCT02085252|449138160|FG000|Overall Study|Reason Not Specified|0|||
124868556|NCT02085252|449138161|FG001|Overall Study|Reason Not Specified|1|||
124868557|NCT02085252|449138160|FG000|Overall Study|Reason Unknown|0|||
124868558|NCT02085252|449138161|FG001|Overall Study|Reason Unknown|1|||
124868559|NCT00951275|449138162|FG000|Overall Study|Administrative Reason|1|||
124868560|NCT00951275|449138162|FG000|Overall Study|Adverse Event|7|||
124868561|NCT00951275|449138162|FG000|Overall Study|Withdrawal by Subject|4|||
124868562|NCT00951275|449138162|FG000|Overall Study|Protocol Violation|1|||
124868563|NCT01112579|449138164|FG000|Overall Study|Missed Visit|1|||
124868564|NCT01112579|449138165|FG001|Overall Study|Missed Visit|1|||
124868565|NCT01112579|449138164|FG000|Overall Study|Death|0|||
124868566|NCT01112579|449138165|FG001|Overall Study|Death|2|||
124868567|NCT04304833|449138166|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
124868568|NCT04304833|449138167|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
124868569|NCT01951625|449138168|FG000|Treatment Period|Protocol Violation|2|||
124868570|NCT01951625|449138169|FG001|Treatment Period|Protocol Violation|0|||
124868571|NCT01951625|449138170|FG002|Treatment Period|Protocol Violation|1|||
124868572|NCT01951625|449138171|FG003|Treatment Period|Protocol Violation|3|||
124868573|NCT01951625|449138172|FG004|Treatment Period|Protocol Violation|2|||
124868574|NCT01951625|449138168|FG000|Treatment Period|Physician Decision|0|||
124868575|NCT01951625|449138169|FG001|Treatment Period|Physician Decision|0|||
125200579|NCT01938430|450357544|FG002|Overall Study|Adverse Event|0|||
125200580|NCT01938430|450357545|FG003|Overall Study|Adverse Event|0|||
124868576|NCT01951625|449138170|FG002|Treatment Period|Physician Decision|0|||
124868577|NCT01951625|449138171|FG003|Treatment Period|Physician Decision|0|||
124868578|NCT01951625|449138172|FG004|Treatment Period|Physician Decision|1|||
124868579|NCT01951625|449138168|FG000|Treatment Period|Protocol driven decision point|0|||
125200581|NCT01938430|450357546|FG004|Overall Study|Adverse Event|0|||
125200582|NCT01938430|450357547|FG005|Overall Study|Adverse Event|0|||
124868580|NCT01951625|449138169|FG001|Treatment Period|Protocol driven decision point|5|||
124868581|NCT01951625|449138170|FG002|Treatment Period|Protocol driven decision point|0|||
124868582|NCT01951625|449138171|FG003|Treatment Period|Protocol driven decision point|2|||
124868583|NCT01951625|449138172|FG004|Treatment Period|Protocol driven decision point|1|||
124868584|NCT01951625|449138168|FG000|Treatment Period|Non compliance with study drug|1|||
124868585|NCT01951625|449138169|FG001|Treatment Period|Non compliance with study drug|2|||
124868586|NCT01951625|449138170|FG002|Treatment Period|Non compliance with study drug|2|||
124868587|NCT01951625|449138171|FG003|Treatment Period|Non compliance with study drug|0|||
124868588|NCT01951625|449138172|FG004|Treatment Period|Non compliance with study drug|0|||
124868589|NCT01951625|449138168|FG000|Treatment Period|Death|3|||
124868590|NCT01951625|449138169|FG001|Treatment Period|Death|2|||
124868591|NCT01951625|449138170|FG002|Treatment Period|Death|2|||
124868592|NCT01951625|449138171|FG003|Treatment Period|Death|1|||
124868593|NCT01951625|449138172|FG004|Treatment Period|Death|2|||
124868594|NCT01951625|449138168|FG000|Treatment Period|Adverse Event|7|||
124868595|NCT01951625|449138169|FG001|Treatment Period|Adverse Event|10|||
124868596|NCT01951625|449138170|FG002|Treatment Period|Adverse Event|9|||
124868597|NCT01951625|449138171|FG003|Treatment Period|Adverse Event|8|||
124868598|NCT01951625|449138172|FG004|Treatment Period|Adverse Event|8|||
124868599|NCT01951625|449138168|FG000|Treatment Period|Withdrawal by Subject|5|||
124868600|NCT01951625|449138169|FG001|Treatment Period|Withdrawal by Subject|2|||
124868601|NCT01951625|449138170|FG002|Treatment Period|Withdrawal by Subject|1|||
124868602|NCT01951625|449138171|FG003|Treatment Period|Withdrawal by Subject|7|||
124868603|NCT01951625|449138172|FG004|Treatment Period|Withdrawal by Subject|3|||
124868604|NCT01951625|449138168|FG000|Treatment Period|Lost to Follow-up|1|||
124868605|NCT01951625|449138169|FG001|Treatment Period|Lost to Follow-up|0|||
124868606|NCT01951625|449138170|FG002|Treatment Period|Lost to Follow-up|0|||
124868607|NCT01951625|449138171|FG003|Treatment Period|Lost to Follow-up|1|||
124868608|NCT01951625|449138172|FG004|Treatment Period|Lost to Follow-up|0|||
124868609|NCT01951625|449138168|FG000|Follow Up Period|Non-compliance with study drug|1|||
124868610|NCT01951625|449138169|FG001|Follow Up Period|Non-compliance with study drug|0|||
124868611|NCT01951625|449138170|FG002|Follow Up Period|Non-compliance with study drug|0|||
124868612|NCT01951625|449138171|FG003|Follow Up Period|Non-compliance with study drug|0|||
124868613|NCT01951625|449138172|FG004|Follow Up Period|Non-compliance with study drug|0|||
124868614|NCT01951625|449138168|FG000|Follow Up Period|Death|1|||
124868615|NCT01951625|449138169|FG001|Follow Up Period|Death|3|||
124868616|NCT01951625|449138170|FG002|Follow Up Period|Death|2|||
124868617|NCT01951625|449138171|FG003|Follow Up Period|Death|2|||
124868618|NCT01951625|449138172|FG004|Follow Up Period|Death|1|||
124868619|NCT01951625|449138168|FG000|Follow Up Period|Logistical difficulties|1|||
124868620|NCT01951625|449138169|FG001|Follow Up Period|Logistical difficulties|2|||
124868621|NCT01951625|449138170|FG002|Follow Up Period|Logistical difficulties|0|||
124868622|NCT01951625|449138171|FG003|Follow Up Period|Logistical difficulties|0|||
124868623|NCT01951625|449138172|FG004|Follow Up Period|Logistical difficulties|0|||
124868624|NCT01951625|449138168|FG000|Follow Up Period|Adverse Event|0|||
124868625|NCT01951625|449138169|FG001|Follow Up Period|Adverse Event|3|||
124868626|NCT01951625|449138170|FG002|Follow Up Period|Adverse Event|2|||
124868627|NCT01951625|449138171|FG003|Follow Up Period|Adverse Event|3|||
124868628|NCT01951625|449138172|FG004|Follow Up Period|Adverse Event|5|||
124868629|NCT01951625|449138168|FG000|Follow Up Period|Withdrawal by Subject|4|||
124868630|NCT01951625|449138169|FG001|Follow Up Period|Withdrawal by Subject|1|||
124868631|NCT01951625|449138170|FG002|Follow Up Period|Withdrawal by Subject|0|||
124868632|NCT01951625|449138171|FG003|Follow Up Period|Withdrawal by Subject|5|||
124868633|NCT01951625|449138172|FG004|Follow Up Period|Withdrawal by Subject|3|||
124868634|NCT01951625|449138168|FG000|Follow Up Period|Lost to Follow-up|1|||
124868635|NCT01951625|449138169|FG001|Follow Up Period|Lost to Follow-up|0|||
124868636|NCT01951625|449138170|FG002|Follow Up Period|Lost to Follow-up|0|||
124868637|NCT01951625|449138171|FG003|Follow Up Period|Lost to Follow-up|1|||
124868638|NCT01951625|449138172|FG004|Follow Up Period|Lost to Follow-up|1|||
124868639|NCT04866017|449138173|FG000|Overall Study|Study Terminated by Sponsor|13|||
124868640|NCT04866017|449138174|FG001|Overall Study|Study Terminated by Sponsor|14|||
124868641|NCT04866017|449138175|FG002|Overall Study|Study Terminated by Sponsor|13|||
124868642|NCT04866017|449138173|FG000|Overall Study|Death|8|||
124868643|NCT04866017|449138174|FG001|Overall Study|Death|4|||
124868644|NCT04866017|449138175|FG002|Overall Study|Death|8|||
124868645|NCT04866017|449138173|FG000|Overall Study|Withdrawal by Subject|1|||
125200583|NCT01938430|450357548|FG006|Overall Study|Adverse Event|1|||
125200584|NCT01938430|450357549|FG007|Overall Study|Adverse Event|0|||
124868646|NCT04866017|449138174|FG001|Overall Study|Withdrawal by Subject|0|||
124868647|NCT04866017|449138175|FG002|Overall Study|Withdrawal by Subject|1|||
124868648|NCT04866017|449138173|FG000|Overall Study|Physician Decision|0|||
124868649|NCT04866017|449138174|FG001|Overall Study|Physician Decision|1|||
124868650|NCT04866017|449138175|FG002|Overall Study|Physician Decision|0|||
124868651|NCT01475136|449138176|FG000|Overall Study|Sponsor Decision|0|||
124868652|NCT01475136|449138177|FG001|Overall Study|Sponsor Decision|1|||
124868653|NCT01475136|449138178|FG002|Overall Study|Sponsor Decision|0|||
124868654|NCT01475136|449138179|FG003|Overall Study|Sponsor Decision|0|||
125200585|NCT01938430|450357550|FG008|Overall Study|Adverse Event|0|||
125200586|NCT01938430|450357551|FG009|Overall Study|Adverse Event|0|||
125200587|NCT01938430|450357552|FG010|Overall Study|Adverse Event|0|||
125200588|NCT01938430|450357553|FG011|Overall Study|Adverse Event|0|||
125200589|NCT01938430|450357554|FG012|Overall Study|Adverse Event|0|||
124868655|NCT01475136|449138176|FG000|Overall Study|Entry Criteria Not Met|0|||
124868656|NCT01475136|449138177|FG001|Overall Study|Entry Criteria Not Met|2|||
124868657|NCT01475136|449138178|FG002|Overall Study|Entry Criteria Not Met|3|||
124868658|NCT01475136|449138179|FG003|Overall Study|Entry Criteria Not Met|1|||
124868659|NCT01475136|449138176|FG000|Overall Study|Withdrawal by Subject|0|||
124868660|NCT01475136|449138177|FG001|Overall Study|Withdrawal by Subject|0|||
124868661|NCT01475136|449138178|FG002|Overall Study|Withdrawal by Subject|0|||
124868662|NCT01475136|449138179|FG003|Overall Study|Withdrawal by Subject|2|||
124868663|NCT01475136|449138176|FG000|Overall Study|Adverse Event|1|||
124868664|NCT01475136|449138177|FG001|Overall Study|Adverse Event|0|||
124868665|NCT01475136|449138178|FG002|Overall Study|Adverse Event|0|||
124868666|NCT01475136|449138179|FG003|Overall Study|Adverse Event|1|||
124868667|NCT01475136|449138176|FG000|Overall Study|Death|0|||
124868668|NCT01475136|449138177|FG001|Overall Study|Death|0|||
124868669|NCT01475136|449138178|FG002|Overall Study|Death|0|||
124868670|NCT01475136|449138179|FG003|Overall Study|Death|1|||
124868671|NCT03355326|449138182|FG000|Overall Study|Protocol Violation|3|||
124868672|NCT03355326|449138183|FG001|Overall Study|Protocol Violation|3|||
124868673|NCT00003508|449140169|FG000|Overall Study|Not evaluable|5|||
124868674|NCT01377480|449140170|FG000|Overall Study|Protocol Violation|0|||
124868675|NCT01377480|449140171|FG001|Overall Study|Protocol Violation|0|||
124868676|NCT01377480|449140172|FG002|Overall Study|Protocol Violation|0|||
124868677|NCT01377480|449140173|FG003|Overall Study|Protocol Violation|4|||
124868678|NCT01377480|449140170|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
124868679|NCT01377480|449140171|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
124868680|NCT01377480|449140172|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
124868681|NCT01377480|449140173|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
124868682|NCT01377480|449140170|FG000|Overall Study|Withdrawal by Subject|0|||
124868683|NCT01377480|449140171|FG001|Overall Study|Withdrawal by Subject|0|||
124868684|NCT01377480|449140172|FG002|Overall Study|Withdrawal by Subject|1|||
124868685|NCT01377480|449140173|FG003|Overall Study|Withdrawal by Subject|0|||
124868686|NCT01377480|449140170|FG000|Overall Study|Serious adverse event|0|||
124868687|NCT01377480|449140171|FG001|Overall Study|Serious adverse event|0|||
124868688|NCT01377480|449140172|FG002|Overall Study|Serious adverse event|1|||
124868689|NCT01377480|449140173|FG003|Overall Study|Serious adverse event|1|||
124868690|NCT01377480|449140170|FG000|Overall Study|Other|0|||
124868691|NCT01377480|449140171|FG001|Overall Study|Other|0|||
124868692|NCT01377480|449140172|FG002|Overall Study|Other|7|||
124868693|NCT01377480|449140173|FG003|Overall Study|Other|6|||
124868694|NCT03576768|449140175|FG000|Overall Study|Lost to Follow-up|3|||
124868695|NCT03576768|449140176|FG001|Overall Study|Lost to Follow-up|3|||
124868696|NCT03576768|449140177|FG002|Overall Study|Lost to Follow-up|0|||
124868697|NCT03576768|449140178|FG003|Overall Study|Lost to Follow-up|0|||
124868698|NCT01986881|449140181|FG000|Overall Study|Death|228|||
124868699|NCT01986881|449140182|FG001|Overall Study|Death|233|||
124868700|NCT01986881|449140183|FG002|Overall Study|Death|247|||
124868701|NCT01986881|449140181|FG000|Overall Study|Lost to Follow-up|51|||
124868702|NCT01986881|449140182|FG001|Overall Study|Lost to Follow-up|44|||
124868703|NCT01986881|449140183|FG002|Overall Study|Lost to Follow-up|55|||
124868704|NCT01986881|449140181|FG000|Overall Study|Physician Decision|7|||
124868705|NCT01986881|449140182|FG001|Overall Study|Physician Decision|4|||
124868706|NCT01986881|449140183|FG002|Overall Study|Physician Decision|6|||
124868707|NCT01986881|449140181|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
124868708|NCT01986881|449140182|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
124868709|NCT01986881|449140183|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
124868710|NCT01986881|449140181|FG000|Overall Study|Withdrawal by Subject|41|||
124868711|NCT01986881|449140182|FG001|Overall Study|Withdrawal by Subject|60|||
124868712|NCT01986881|449140183|FG002|Overall Study|Withdrawal by Subject|45|||
124868713|NCT01986881|449140181|FG000|Overall Study|Subject Moved|0|||
124868714|NCT01986881|449140182|FG001|Overall Study|Subject Moved|1|||
124868715|NCT01986881|449140183|FG002|Overall Study|Subject Moved|0|||
124868716|NCT01986881|449140181|FG000|Overall Study|Other|1|||
124868717|NCT01986881|449140182|FG001|Overall Study|Other|2|||
124868718|NCT01986881|449140183|FG002|Overall Study|Other|2|||
124868719|NCT04179175|449140188|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
124868720|NCT04179175|449140189|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
124868721|NCT04179175|449140190|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
124868722|NCT04179175|449140191|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
124868723|NCT04179175|449140192|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
124868724|NCT04179175|449140193|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
124868725|NCT04179175|449140188|FG000|Overall Study|Adverse Event|5|||
124868726|NCT04179175|449140189|FG001|Overall Study|Adverse Event|3|||
124868727|NCT04179175|449140190|FG002|Overall Study|Adverse Event|3|||
124868728|NCT04179175|449140191|FG003|Overall Study|Adverse Event|4|||
124868729|NCT04179175|449140192|FG004|Overall Study|Adverse Event|6|||
124868730|NCT04179175|449140193|FG005|Overall Study|Adverse Event|6|||
124868731|NCT04179175|449140188|FG000|Overall Study|Lack of Efficacy|5|||
124868732|NCT04179175|449140189|FG001|Overall Study|Lack of Efficacy|1|||
124868733|NCT04179175|449140190|FG002|Overall Study|Lack of Efficacy|3|||
124868734|NCT04179175|449140191|FG003|Overall Study|Lack of Efficacy|2|||
124868735|NCT04179175|449140192|FG004|Overall Study|Lack of Efficacy|18|||
124868736|NCT04179175|449140193|FG005|Overall Study|Lack of Efficacy|7|||
124868737|NCT04179175|449140188|FG000|Overall Study|Lost to Follow-up|5|||
124868738|NCT04179175|449140189|FG001|Overall Study|Lost to Follow-up|3|||
124868739|NCT04179175|449140190|FG002|Overall Study|Lost to Follow-up|2|||
124868740|NCT04179175|449140191|FG003|Overall Study|Lost to Follow-up|2|||
124868741|NCT04179175|449140192|FG004|Overall Study|Lost to Follow-up|4|||
124868742|NCT04179175|449140193|FG005|Overall Study|Lost to Follow-up|5|||
124868743|NCT04179175|449140188|FG000|Overall Study|Physician Decision|2|||
124868744|NCT04179175|449140189|FG001|Overall Study|Physician Decision|0|||
124868745|NCT04179175|449140190|FG002|Overall Study|Physician Decision|2|||
124868746|NCT04179175|449140191|FG003|Overall Study|Physician Decision|3|||
124868747|NCT04179175|449140192|FG004|Overall Study|Physician Decision|1|||
124868748|NCT04179175|449140193|FG005|Overall Study|Physician Decision|1|||
124868749|NCT04179175|449140188|FG000|Overall Study|Pregnancy|3|||
124868750|NCT04179175|449140189|FG001|Overall Study|Pregnancy|0|||
124868751|NCT04179175|449140190|FG002|Overall Study|Pregnancy|3|||
124868752|NCT04179175|449140191|FG003|Overall Study|Pregnancy|0|||
124868753|NCT04179175|449140192|FG004|Overall Study|Pregnancy|1|||
124868754|NCT04179175|449140193|FG005|Overall Study|Pregnancy|2|||
124868755|NCT04179175|449140188|FG000|Overall Study|Withdrawal by Subject|22|||
124868756|NCT04179175|449140189|FG001|Overall Study|Withdrawal by Subject|10|||
124868757|NCT04179175|449140190|FG002|Overall Study|Withdrawal by Subject|12|||
124868758|NCT04179175|449140191|FG003|Overall Study|Withdrawal by Subject|8|||
124868759|NCT04179175|449140192|FG004|Overall Study|Withdrawal by Subject|23|||
124868760|NCT04179175|449140193|FG005|Overall Study|Withdrawal by Subject|31|||
124868761|NCT04179175|449140188|FG000|Overall Study|Technical problems|0|||
124868762|NCT04179175|449140189|FG001|Overall Study|Technical problems|0|||
124868763|NCT04179175|449140190|FG002|Overall Study|Technical problems|1|||
124868764|NCT04179175|449140191|FG003|Overall Study|Technical problems|1|||
124868765|NCT04179175|449140192|FG004|Overall Study|Technical problems|0|||
124868766|NCT04179175|449140193|FG005|Overall Study|Technical problems|0|||
124868767|NCT02030015|449140199|FG000|Overall Study|Withdrawal by Subject|3|||
124868768|NCT02030015|449140199|FG000|Overall Study|Death|13|||
124868769|NCT03014674|449140201|FG000|Overall Study|Withdrawal by Subject|1|||
124868770|NCT03014674|449140202|FG001|Overall Study|Withdrawal by Subject|0|||
124868771|NCT03014674|449140203|FG002|Overall Study|Withdrawal by Subject|0|||
124868772|NCT03224182|449140216|FG000|Overall Study|Study Drug Not Instilled|6|||
124868773|NCT03224182|449140217|FG001|Overall Study|Study Drug Not Instilled|1|||
124868774|NCT03224182|449140216|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
124868775|NCT03224182|449140217|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
124868776|NCT03224182|449140216|FG000|Overall Study|Withdrew of Consent|4|||
124868777|NCT03224182|449140217|FG001|Overall Study|Withdrew of Consent|2|||
124868778|NCT03224182|449140216|FG000|Overall Study|Investigator Decision|3|||
124868779|NCT03224182|449140217|FG001|Overall Study|Investigator Decision|1|||
124868780|NCT03224182|449140216|FG000|Overall Study|Sponsor Decision|26|||
124868781|NCT03224182|449140217|FG001|Overall Study|Sponsor Decision|12|||
124868782|NCT03224182|449140216|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
124868783|NCT03224182|449140217|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
124868784|NCT03224182|449140216|FG000|Overall Study|Lost to Follow-up|1|||
124868785|NCT03224182|449140217|FG001|Overall Study|Lost to Follow-up|0|||
124868786|NCT03224182|449140216|FG000|Overall Study|Participant Had Recurrence|11|||
124868787|NCT03224182|449140217|FG001|Overall Study|Participant Had Recurrence|5|||
124868788|NCT03224182|449140216|FG000|Overall Study|Death|0|||
124868789|NCT03224182|449140217|FG001|Overall Study|Death|1|||
124868790|NCT03224182|449140216|FG000|Overall Study|Reason not Specified|3|||
124868791|NCT03224182|449140217|FG001|Overall Study|Reason not Specified|3|||
124868792|NCT03224182|449140216|FG000|Overall Study|Other|1|||
124868793|NCT03224182|449140217|FG001|Overall Study|Other|0|||
124868794|NCT02822222|449140218|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
124868795|NCT02822222|449140219|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
124868796|NCT04279314|449140220|FG000|Overall Study|Adverse Event|55|||
124868797|NCT04279314|449140220|FG000|Overall Study|Withdrawal by Subject|5|||
124868798|NCT04279314|449140220|FG000|Overall Study|Lack of Efficacy|5|||
124868799|NCT04279314|449140220|FG000|Overall Study|Protocol Violation|3|||
124868800|NCT04279314|449140220|FG000|Overall Study|Other (not COVID-19 related)|2|||
124868801|NCT02481310|449140221|FG000|Follow up|Still in follow up|0|||
124868802|NCT02481310|449140222|FG001|Follow up|Still in follow up|3|||
124868803|NCT02481310|449140223|FG002|Follow up|Still in follow up|0|||
124868804|NCT00833560|449140224|FG000|Overall Study|Toxicity|13|||
124868805|NCT00833560|449140224|FG000|Overall Study|Adverse Event|11|||
124868806|NCT00833560|449140224|FG000|Overall Study|Protocol Violation|6|||
124868807|NCT00833560|449140224|FG000|Overall Study|Lack of Efficacy|4|||
124868808|NCT00833560|449140224|FG000|Overall Study|Death|2|||
124868809|NCT00833560|449140224|FG000|Overall Study|Pregression of other disease|1|||
124868810|NCT00833560|449140224|FG000|Overall Study|Other|5|||
124868811|NCT00643916|449140225|FG000|Overall Study|Protocol Violation|0|||
124868812|NCT00643916|449140226|FG001|Overall Study|Protocol Violation|1|||
124868813|NCT00643916|449140227|FG002|Overall Study|Protocol Violation|1|||
124868814|NCT00643916|449140228|FG003|Overall Study|Protocol Violation|1|||
124868815|NCT00643916|449140229|FG004|Overall Study|Protocol Violation|0|||
124868816|NCT00643916|449140230|FG005|Overall Study|Protocol Violation|0|||
124868817|NCT00643916|449140225|FG000|Overall Study|Lost to Follow-up|0|||
124868818|NCT00643916|449140226|FG001|Overall Study|Lost to Follow-up|1|||
124868819|NCT00643916|449140227|FG002|Overall Study|Lost to Follow-up|0|||
124868820|NCT00643916|449140228|FG003|Overall Study|Lost to Follow-up|0|||
124868821|NCT00643916|449140229|FG004|Overall Study|Lost to Follow-up|0|||
124868822|NCT00643916|449140230|FG005|Overall Study|Lost to Follow-up|0|||
124868823|NCT00643916|449140225|FG000|Overall Study|Withdrawal by Subject|2|||
124868824|NCT00643916|449140226|FG001|Overall Study|Withdrawal by Subject|2|||
124868825|NCT00643916|449140227|FG002|Overall Study|Withdrawal by Subject|2|||
124868826|NCT00643916|449140228|FG003|Overall Study|Withdrawal by Subject|1|||
124868827|NCT00643916|449140229|FG004|Overall Study|Withdrawal by Subject|0|||
124868828|NCT00643916|449140230|FG005|Overall Study|Withdrawal by Subject|1|||
124868829|NCT00643916|449140225|FG000|Overall Study|Not Vaccinated|2|||
124868830|NCT00643916|449140226|FG001|Overall Study|Not Vaccinated|2|||
124868831|NCT00643916|449140227|FG002|Overall Study|Not Vaccinated|3|||
124868832|NCT00643916|449140228|FG003|Overall Study|Not Vaccinated|0|||
124868833|NCT00643916|449140229|FG004|Overall Study|Not Vaccinated|2|||
124868834|NCT00643916|449140230|FG005|Overall Study|Not Vaccinated|0|||
124868835|NCT01791725|449140231|FG000|Overall Study|Withdrawal by Subject|0|||
124868836|NCT01791725|449140232|FG001|Overall Study|Withdrawal by Subject|1|||
124868837|NCT01791725|449140233|FG002|Overall Study|Withdrawal by Subject|0|||
124868838|NCT00512148|449140234|FG000|Primay Study Period|Withdrawal by Subject|1|||
124868839|NCT00677833|449140235|FG000|Overall Study|Withdrawal by Subject|4|||
124868840|NCT00677833|449140236|FG001|Overall Study|Withdrawal by Subject|0|||
124868841|NCT00677833|449140237|FG002|Overall Study|Withdrawal by Subject|1|||
124868842|NCT00677833|449140238|FG003|Overall Study|Withdrawal by Subject|3|||
124868843|NCT00677833|449140235|FG000|Overall Study|Lost to Follow-up|0|||
124868844|NCT00677833|449140236|FG001|Overall Study|Lost to Follow-up|0|||
124868845|NCT00677833|449140237|FG002|Overall Study|Lost to Follow-up|1|||
124868846|NCT00677833|449140238|FG003|Overall Study|Lost to Follow-up|0|||
124868847|NCT02001194|449140240|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
124868848|NCT02001194|449140241|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
124868849|NCT02001194|449140242|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
124868850|NCT02001194|449140243|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
124868851|NCT02001194|449140240|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
124868852|NCT02001194|449140241|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
124868853|NCT02001194|449140242|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
124868854|NCT02001194|449140243|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
124868855|NCT02606279|449140248|FG000|Overall Study|Lost to Follow-up|0|||
124868856|NCT02606279|449140249|FG001|Overall Study|Lost to Follow-up|1|||
124868857|NCT02690974|449140250|FG000|Overall Study|Adverse Event|16|||
124868858|NCT02690974|449140250|FG000|Overall Study|Death|9|||
124868859|NCT02690974|449140250|FG000|Overall Study|Subject/guardian decision|4|||
124868860|NCT02690974|449140250|FG000|Overall Study|Lost to Follow-up|3|||
124868861|NCT02690974|449140250|FG000|Overall Study|Withdrawal of Informed Consent|3|||
124868862|NCT02690974|449140250|FG000|Overall Study|Physician Decision|2|||
124868863|NCT02690974|449140250|FG000|Overall Study|Non-compliance with study treatment|1|||
124868864|NCT02690974|449140250|FG000|Overall Study|Protocol-defined stopping criteria|1|||
124868865|NCT02690974|449140250|FG000|Overall Study|Protocol Deviation|1|||
124868866|NCT02184611|449140256|FG000|Overall Study|Lack of Efficacy|11|||
124868867|NCT02184611|449140257|FG001|Overall Study|Lack of Efficacy|15|||
124868868|NCT02184611|449140256|FG000|Overall Study|Withdrawal by Subject|5|||
124868869|NCT02184611|449140257|FG001|Overall Study|Withdrawal by Subject|6|||
124868870|NCT02184611|449140256|FG000|Overall Study|Adverse Event|4|||
124868871|NCT02184611|449140257|FG001|Overall Study|Adverse Event|5|||
124868872|NCT02184611|449140256|FG000|Overall Study|Protocol Violation|1|||
124868873|NCT02184611|449140257|FG001|Overall Study|Protocol Violation|1|||
125200590|NCT01938430|450357555|FG013|Overall Study|Adverse Event|0|||
124868874|NCT02184611|449140256|FG000|Overall Study|Protocol defined stopping criteria|0|||
125200591|NCT01938430|450357542|FG000|Overall Study|Death|1|||
124868875|NCT02184611|449140257|FG001|Overall Study|Protocol defined stopping criteria|1|||
124868876|NCT00522301|449140258|FG000|Overall Study|Withdrawal by Subject|1|||
124868877|NCT00522301|449140258|FG000|Overall Study|Adverse Event|5|||
124868878|NCT01666951|449140259|FG000|Overall Study|Not dosed|1|||
124868879|NCT01666951|449140260|FG001|Overall Study|Not dosed|1|||
124868880|NCT02366910|449140261|FG000|Overall Study|Withdrawal by Subject|2|||
124868881|NCT02366910|449140261|FG000|Overall Study|Screen Failure|3|||
124868882|NCT02623322|449140264|FG000|Overall Study|Lost to Follow-up|2|||
124868883|NCT02623322|449140265|FG001|Overall Study|Lost to Follow-up|1|||
124868884|NCT02623322|449140266|FG002|Overall Study|Lost to Follow-up|0|||
125200592|NCT01938430|450357543|FG001|Overall Study|Death|2|||
124868885|NCT03563716|449140267|FG000|Overall Study|Death|20|||
124868886|NCT03563716|449140268|FG001|Overall Study|Death|14|||
124868887|NCT03563716|449140267|FG000|Overall Study|Withdrawal by Subject|3|||
124868888|NCT03563716|449140268|FG001|Overall Study|Withdrawal by Subject|3|||
124868889|NCT03563716|449140267|FG000|Overall Study|Still on Study|45|||
124868890|NCT03563716|449140268|FG001|Overall Study|Still on Study|50|||
124868891|NCT04605978|449140272|FG000|Overall Study|Adverse Event|2|||
124868892|NCT04605978|449140273|FG001|Overall Study|Adverse Event|1|||
124868893|NCT04605978|449140272|FG000|Overall Study|Withdrawal nonmedical reason|1|||
124868894|NCT04605978|449140273|FG001|Overall Study|Withdrawal nonmedical reason|1|||
124868895|NCT03813238|449140274|FG000|Overall Study|Adverse Event|0|||
124868896|NCT03813238|449140275|FG001|Overall Study|Adverse Event|6|||
124868897|NCT03813238|449140274|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124868898|NCT03813238|449140275|FG001|Overall Study|Withdrawal by parent/guardian|2|||
124868899|NCT03813238|449140274|FG000|Overall Study|Lost to Follow-up|0|||
124868900|NCT03813238|449140275|FG001|Overall Study|Lost to Follow-up|1|||
124868901|NCT03813238|449140274|FG000|Overall Study|Other than specified|1|||
124868902|NCT03813238|449140275|FG001|Overall Study|Other than specified|2|||
124868903|NCT02583425|449140276|FG000|Screening|Did not meet entry criteria|12|||
124868904|NCT02583425|449140276|FG000|Baseline|Did not meet continued criteria|5|||
124868905|NCT02583425|449140276|FG000|Treatment Period|Adverse Event|1|||
124868906|NCT03318523|449140277|FG000|PC Period: Up to Year 1|Adverse Event|1|||
124868907|NCT03318523|449140278|FG001|PC Period: Up to Year 1|Adverse Event|0|||
124868908|NCT03318523|449140279|FG002|PC Period: Up to Year 1|Adverse Event|2|||
124868909|NCT03318523|449140280|FG003|PC Period: Up to Year 1|Adverse Event|0|||
124868910|NCT03318523|449140281|FG004|PC Period: Up to Year 1|Adverse Event|0|||
124868911|NCT03318523|449140282|FG005|PC Period: Up to Year 1|Adverse Event|0|||
124868912|NCT03318523|449140283|FG006|PC Period: Up to Year 1|Adverse Event|0|||
124868913|NCT03318523|449140284|FG007|PC Period: Up to Year 1|Adverse Event|0|||
124868914|NCT03318523|449140285|FG008|PC Period: Up to Year 1|Adverse Event|0|||
124868915|NCT03318523|449140286|FG009|PC Period: Up to Year 1|Adverse Event|0|||
124868916|NCT03318523|449140277|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
124868917|NCT03318523|449140278|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
124868918|NCT03318523|449140279|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
124868919|NCT03318523|449140280|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
124868920|NCT03318523|449140281|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
124868921|NCT03318523|449140282|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
124868922|NCT03318523|449140283|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
124868923|NCT03318523|449140284|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
124868924|NCT03318523|449140285|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
124868925|NCT03318523|449140286|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
124868926|NCT03318523|449140277|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
124868927|NCT03318523|449140278|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
124868928|NCT03318523|449140279|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
124868929|NCT03318523|449140280|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
124868930|NCT03318523|449140281|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
124868931|NCT03318523|449140282|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
124868932|NCT03318523|449140283|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
124868933|NCT03318523|449140284|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
124868934|NCT03318523|449140285|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
124868935|NCT03318523|449140286|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
124868936|NCT03318523|449140277|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
124868937|NCT03318523|449140278|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
124868938|NCT03318523|449140279|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
124868939|NCT03318523|449140280|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
124868940|NCT03318523|449140281|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
124868941|NCT03318523|449140282|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
124868942|NCT03318523|449140283|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
124868943|NCT03318523|449140284|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
124868944|NCT03318523|449140285|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
124868945|NCT03318523|449140286|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
124868946|NCT03318523|449140277|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
124868947|NCT03318523|449140278|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
124868948|NCT03318523|449140279|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
124868949|NCT03318523|449140280|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
124868950|NCT03318523|449140281|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
124868951|NCT03318523|449140282|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
124868952|NCT03318523|449140283|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
124868953|NCT03318523|449140284|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
124868954|NCT03318523|449140285|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
124868955|NCT03318523|449140286|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
124868956|NCT03318523|449140277|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
124868957|NCT03318523|449140278|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
124868958|NCT03318523|449140279|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
124868959|NCT03318523|449140280|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
124868960|NCT03318523|449140281|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
124868961|NCT03318523|449140282|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
124868962|NCT03318523|449140283|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
124868963|NCT03318523|449140284|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
124868964|NCT03318523|449140285|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
124868965|NCT03318523|449140286|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
124868966|NCT03318523|449140277|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
124868967|NCT03318523|449140278|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
124868968|NCT03318523|449140279|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
124868969|NCT03318523|449140280|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
124868970|NCT03318523|449140281|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
124868971|NCT03318523|449140282|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
124868972|NCT03318523|449140283|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
124868973|NCT03318523|449140284|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
124868974|NCT03318523|449140285|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
124868975|NCT03318523|449140286|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
124868976|NCT03318523|449140277|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
124868977|NCT03318523|449140278|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
124868978|NCT03318523|449140279|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
124868979|NCT03318523|449140280|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
124868980|NCT03318523|449140281|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
124868981|NCT03318523|449140282|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
124868982|NCT03318523|449140283|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
124868983|NCT03318523|449140284|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
124868984|NCT03318523|449140285|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
124868985|NCT03318523|449140286|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
124868986|NCT03581981|449140287|FG000|Overall Study|Withdrawal by Subject|12|||
124868987|NCT03581981|449140288|FG001|Overall Study|Withdrawal by Subject|13|||
124868988|NCT03581981|449140287|FG000|Overall Study|Physician Decision|1|||
124868989|NCT03581981|449140288|FG001|Overall Study|Physician Decision|2|||
124868990|NCT03581981|449140287|FG000|Overall Study|Lost to Follow-up|0|||
124868991|NCT03581981|449140288|FG001|Overall Study|Lost to Follow-up|4|||
124868992|NCT02080871|449140289|FG000|Overall Study|Death|1|||
124868993|NCT02080871|449140289|FG000|Overall Study|Lost to Follow-up|1|||
124868994|NCT00234052|449140290|FG000|Treatment|Withdrawal by Subject|3|||
124868995|NCT00234052|449140290|FG000|Treatment|Adverse Event|5|||
124868996|NCT00234052|449140290|FG000|Treatment|Death|2|||
124868997|NCT00234052|449140290|FG000|Treatment|Progressive Disease|11|||
124868998|NCT00234052|449140290|FG000|Follow-up for 5 Years|Death|41|||
124868999|NCT00234052|449140290|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
124869000|NCT00234052|449140290|FG000|Follow-up for 5 Years|Other|7|||
124869001|NCT02428296|449140291|FG000|Overall Study|Adverse Event|7|||
124869002|NCT02428296|449140291|FG000|Overall Study|Withdrawal by Subject|2|||
124869003|NCT02723864|449140292|FG000|Overall Study|Refused further treatment|1|||
124869004|NCT02723864|449140293|FG001|Overall Study|Refused further treatment|0|||
124869005|NCT02723864|449140294|FG002|Overall Study|Refused further treatment|0|||
124869006|NCT02723864|449140295|FG003|Overall Study|Refused further treatment|0|||
124869007|NCT02723864|449140296|FG004|Overall Study|Refused further treatment|1|||
124869008|NCT02723864|449140297|FG005|Overall Study|Refused further treatment|2|||
124869009|NCT02723864|449140298|FG006|Overall Study|Refused further treatment|0|||
124869010|NCT02723864|449140292|FG000|Overall Study|Exceed treatment hold time|0|||
124869011|NCT02723864|449140293|FG001|Overall Study|Exceed treatment hold time|1|||
124869012|NCT02723864|449140294|FG002|Overall Study|Exceed treatment hold time|0|||
124869013|NCT02723864|449140295|FG003|Overall Study|Exceed treatment hold time|0|||
124869014|NCT02723864|449140296|FG004|Overall Study|Exceed treatment hold time|0|||
124869015|NCT02723864|449140297|FG005|Overall Study|Exceed treatment hold time|0|||
124869016|NCT02723864|449140298|FG006|Overall Study|Exceed treatment hold time|0|||
124869017|NCT02723864|449140292|FG000|Overall Study|Clinical progression|0|||
124869018|NCT02723864|449140293|FG001|Overall Study|Clinical progression|0|||
124869019|NCT02723864|449140294|FG002|Overall Study|Clinical progression|1|||
124869020|NCT02723864|449140295|FG003|Overall Study|Clinical progression|0|||
124869021|NCT02723864|449140296|FG004|Overall Study|Clinical progression|0|||
124869022|NCT02723864|449140297|FG005|Overall Study|Clinical progression|3|||
124869023|NCT02723864|449140298|FG006|Overall Study|Clinical progression|1|||
124869024|NCT02723864|449140292|FG000|Overall Study|Physician Decision|0|||
124869025|NCT02723864|449140293|FG001|Overall Study|Physician Decision|0|||
124869026|NCT02723864|449140294|FG002|Overall Study|Physician Decision|0|||
124869027|NCT02723864|449140295|FG003|Overall Study|Physician Decision|0|||
124869028|NCT02723864|449140296|FG004|Overall Study|Physician Decision|0|||
124869029|NCT02723864|449140297|FG005|Overall Study|Physician Decision|0|||
124869030|NCT02723864|449140298|FG006|Overall Study|Physician Decision|1|||
124869031|NCT02723864|449140292|FG000|Overall Study|Changes in patient condition|0|||
124869032|NCT02723864|449140293|FG001|Overall Study|Changes in patient condition|0|||
124869033|NCT02723864|449140294|FG002|Overall Study|Changes in patient condition|0|||
124869034|NCT02723864|449140295|FG003|Overall Study|Changes in patient condition|0|||
124869035|NCT02723864|449140296|FG004|Overall Study|Changes in patient condition|0|||
124869036|NCT02723864|449140297|FG005|Overall Study|Changes in patient condition|1|||
124869037|NCT02723864|449140298|FG006|Overall Study|Changes in patient condition|0|||
124869038|NCT02723864|449140292|FG000|Overall Study|Patient choice|0|||
124869039|NCT02723864|449140293|FG001|Overall Study|Patient choice|0|||
124869040|NCT02723864|449140294|FG002|Overall Study|Patient choice|0|||
124869041|NCT02723864|449140295|FG003|Overall Study|Patient choice|0|||
124869042|NCT02723864|449140296|FG004|Overall Study|Patient choice|0|||
124869043|NCT02723864|449140297|FG005|Overall Study|Patient choice|1|||
124869044|NCT02723864|449140298|FG006|Overall Study|Patient choice|0|||
124869045|NCT02723864|449140292|FG000|Overall Study|Adverse Event|0|||
124869046|NCT02723864|449140293|FG001|Overall Study|Adverse Event|0|||
124869047|NCT02723864|449140294|FG002|Overall Study|Adverse Event|0|||
124869048|NCT02723864|449140295|FG003|Overall Study|Adverse Event|0|||
124869049|NCT02723864|449140296|FG004|Overall Study|Adverse Event|0|||
124869050|NCT02723864|449140297|FG005|Overall Study|Adverse Event|1|||
124869051|NCT02723864|449140298|FG006|Overall Study|Adverse Event|0|||
124869052|NCT02723864|449140292|FG000|Overall Study|Started new treatment|0|||
124869053|NCT02723864|449140293|FG001|Overall Study|Started new treatment|0|||
124869054|NCT02723864|449140294|FG002|Overall Study|Started new treatment|0|||
124869055|NCT02723864|449140295|FG003|Overall Study|Started new treatment|0|||
124869056|NCT02723864|449140296|FG004|Overall Study|Started new treatment|0|||
124869057|NCT02723864|449140297|FG005|Overall Study|Started new treatment|1|||
124869058|NCT02723864|449140298|FG006|Overall Study|Started new treatment|0|||
124869059|NCT02723864|449140292|FG000|Overall Study|Switched to alternative treatment|0|||
124869060|NCT02723864|449140293|FG001|Overall Study|Switched to alternative treatment|0|||
124869061|NCT02723864|449140294|FG002|Overall Study|Switched to alternative treatment|0|||
124869062|NCT02723864|449140295|FG003|Overall Study|Switched to alternative treatment|0|||
124869063|NCT02723864|449140296|FG004|Overall Study|Switched to alternative treatment|0|||
124869064|NCT02723864|449140297|FG005|Overall Study|Switched to alternative treatment|1|||
124869065|NCT02723864|449140298|FG006|Overall Study|Switched to alternative treatment|0|||
124869066|NCT02723864|449140292|FG000|Overall Study|Late determination of ineligibility|0|||
124869067|NCT02723864|449140293|FG001|Overall Study|Late determination of ineligibility|0|||
124869068|NCT02723864|449140294|FG002|Overall Study|Late determination of ineligibility|0|||
124869069|NCT02723864|449140295|FG003|Overall Study|Late determination of ineligibility|0|||
124869070|NCT02723864|449140296|FG004|Overall Study|Late determination of ineligibility|0|||
124869071|NCT02723864|449140297|FG005|Overall Study|Late determination of ineligibility|1|||
124869072|NCT02723864|449140298|FG006|Overall Study|Late determination of ineligibility|0|||
124869073|NCT00828984|449140299|FG000|Overall Study|Adverse Event|2|||
124869074|NCT00828984|449140300|FG001|Overall Study|Adverse Event|3|||
124869075|NCT00828984|449140301|FG002|Overall Study|Adverse Event|0|||
124869076|NCT00828984|449140299|FG000|Overall Study|Lost to Follow-up|5|||
124869077|NCT00828984|449140300|FG001|Overall Study|Lost to Follow-up|3|||
124869078|NCT00828984|449140301|FG002|Overall Study|Lost to Follow-up|1|||
124869079|NCT00828984|449140299|FG000|Overall Study|Withdrawal by Subject|4|||
124869080|NCT00828984|449140300|FG001|Overall Study|Withdrawal by Subject|4|||
124869081|NCT00828984|449140301|FG002|Overall Study|Withdrawal by Subject|4|||
124869082|NCT00828984|449140299|FG000|Overall Study|Ineligable|1|||
124869083|NCT00828984|449140300|FG001|Overall Study|Ineligable|2|||
124869084|NCT00828984|449140301|FG002|Overall Study|Ineligable|0|||
124869085|NCT00828984|449140299|FG000|Overall Study|Medical Contraindication|0|||
124869086|NCT00828984|449140300|FG001|Overall Study|Medical Contraindication|1|||
124869087|NCT00828984|449140301|FG002|Overall Study|Medical Contraindication|0|||
124869088|NCT00828984|449140299|FG000|Overall Study|Noncompliant|1|||
124869089|NCT00828984|449140300|FG001|Overall Study|Noncompliant|2|||
124869090|NCT00828984|449140301|FG002|Overall Study|Noncompliant|3|||
124869091|NCT00828984|449140299|FG000|Overall Study|ConMed|1|||
124869092|NCT00828984|449140300|FG001|Overall Study|ConMed|1|||
124869093|NCT00828984|449140301|FG002|Overall Study|ConMed|1|||
124869094|NCT04465357|449140302|FG000|Overall Study|Adverse Event|2|||
124869095|NCT04465357|449140302|FG000|Overall Study|Lack of Efficacy|1|||
124869096|NCT04465357|449140302|FG000|Overall Study|Lost to Follow-up|2|||
124869097|NCT04465357|449140302|FG000|Overall Study|Withdrawal by Subject|6|||
124869098|NCT04465357|449140302|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
124869099|NCT02548455|449140305|FG000|Overall Study|Withdrawal by Subject|27|||
124869100|NCT02548455|449140305|FG000|Overall Study|Death|26|||
124869101|NCT02548455|449140305|FG000|Overall Study|Lost to Follow-up|14|||
124869102|NCT02548455|449140305|FG000|Overall Study|Visit not completed|173|||
124869103|NCT00831779|449140307|FG000|Overall Study|Lost to Follow-up|1|||
124869104|NCT00831779|449140308|FG001|Overall Study|Lost to Follow-up|0|||
124869105|NCT00831779|449140307|FG000|Overall Study|No longer met criteria|0|||
124869106|NCT00831779|449140308|FG001|Overall Study|No longer met criteria|1|||
124869107|NCT02436330|449140309|FG000|Cohort 1|Lost to Follow-up|5|||
124869108|NCT02436330|449140310|FG001|Cohort 1|Lost to Follow-up|2|||
124869109|NCT02436330|449140309|FG000|Cohort 1|Withdrawal by Subject|0|||
124869110|NCT02436330|449140310|FG001|Cohort 1|Withdrawal by Subject|1|||
124869111|NCT02436330|449140309|FG000|Cohort 2|Lost to Follow-up|2|||
124869112|NCT02436330|449140310|FG001|Cohort 2|Lost to Follow-up|0|||
124869113|NCT02436330|449140309|FG000|Cohort 2|Withdrawal by Subject|2|||
124869114|NCT02436330|449140310|FG001|Cohort 2|Withdrawal by Subject|3|||
124869115|NCT02436330|449140309|FG000|Cohort 3|Lost to Follow-up|1|||
124869116|NCT02436330|449140310|FG001|Cohort 3|Lost to Follow-up|0|||
124869117|NCT02436330|449140309|FG000|Cohort 3|Withdrawal by Subject|4|||
124869118|NCT02436330|449140310|FG001|Cohort 3|Withdrawal by Subject|0|||
124869119|NCT02436330|449140309|FG000|Cohort 4|Lost to Follow-up|1|||
124869120|NCT02436330|449140310|FG001|Cohort 4|Lost to Follow-up|0|||
124869121|NCT02436330|449140309|FG000|Cohort 4|Withdrawal by Subject|1|||
124869122|NCT02436330|449140310|FG001|Cohort 4|Withdrawal by Subject|0|||
124869123|NCT02436330|449140309|FG000|Cohort 5|Lost to Follow-up|3|||
124869124|NCT02436330|449140310|FG001|Cohort 5|Lost to Follow-up|2|||
124869125|NCT02436330|449140309|FG000|Cohort 5|Withdrawal by Subject|3|||
124869126|NCT02436330|449140310|FG001|Cohort 5|Withdrawal by Subject|2|||
124869127|NCT02436330|449140309|FG000|Cohort 6|Lost to Follow-up|2|||
124869128|NCT02436330|449140310|FG001|Cohort 6|Lost to Follow-up|0|||
124869129|NCT02436330|449140309|FG000|Cohort 6|Withdrawal by Subject|1|||
124869130|NCT02436330|449140310|FG001|Cohort 6|Withdrawal by Subject|1|||
124869131|NCT02230956|449140311|FG000|Overall Study|Adverse Event|1|||
124869132|NCT02230956|449140312|FG001|Overall Study|Adverse Event|1|||
124869133|NCT02230956|449140313|FG002|Overall Study|Adverse Event|0|||
124869134|NCT02230956|449140311|FG000|Overall Study|Lack of Efficacy|1|||
124869135|NCT02230956|449140312|FG001|Overall Study|Lack of Efficacy|1|||
124869136|NCT02230956|449140313|FG002|Overall Study|Lack of Efficacy|1|||
124869137|NCT02230956|449140311|FG000|Overall Study|Lost to Follow-up|1|||
124869138|NCT02230956|449140312|FG001|Overall Study|Lost to Follow-up|1|||
124869139|NCT02230956|449140313|FG002|Overall Study|Lost to Follow-up|2|||
124869140|NCT02230956|449140311|FG000|Overall Study|Personal Reasons|2|||
124869141|NCT02230956|449140312|FG001|Overall Study|Personal Reasons|1|||
124869142|NCT02230956|449140313|FG002|Overall Study|Personal Reasons|1|||
124869143|NCT02230956|449140311|FG000|Overall Study|Protocol Violation|0|||
124869144|NCT02230956|449140312|FG001|Overall Study|Protocol Violation|1|||
124869145|NCT02230956|449140313|FG002|Overall Study|Protocol Violation|1|||
124869146|NCT02230956|449140311|FG000|Overall Study|Other Miscellaneous Reason|0|||
124869147|NCT02230956|449140312|FG001|Overall Study|Other Miscellaneous Reason|1|||
124869148|NCT02230956|449140313|FG002|Overall Study|Other Miscellaneous Reason|2|||
124869149|NCT00338884|449140314|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
124869150|NCT00338884|449140314|FG000|Overall Study|Adverse Event|14|||
124869151|NCT00338884|449140314|FG000|Overall Study|Death|8|||
124869152|NCT00338884|449140314|FG000|Overall Study|Other|4|||
124869153|NCT00338884|449140314|FG000|Overall Study|Global Deterioration of Health Status|3|||
124869154|NCT00338884|449140314|FG000|Overall Study|Withdrawal by Subject|3|||
124869155|NCT00338884|449140314|FG000|Overall Study|Lost to Follow-up|1|||
124869156|NCT00338884|449140314|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
124869157|NCT01970982|449140316|FG000|Overall Study|Withdrawal by Subject|0|||
124869158|NCT01970982|449140317|FG001|Overall Study|Withdrawal by Subject|0|||
124869159|NCT01970982|449140318|FG002|Overall Study|Withdrawal by Subject|2|||
124869160|NCT00765674|449140323|FG000|Overall Study|Adverse Event|7|||
124869161|NCT00765674|449140324|FG001|Overall Study|Adverse Event|2|||
124869162|NCT00765674|449140325|FG002|Overall Study|Adverse Event|8|||
124869163|NCT00765674|449140326|FG003|Overall Study|Adverse Event|11|||
124869164|NCT00765674|449140323|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
124869165|NCT00765674|449140324|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
124869166|NCT00765674|449140325|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
124869167|NCT00765674|449140326|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
124869168|NCT00765674|449140323|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
124869169|NCT00765674|449140324|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
124869170|NCT00765674|449140325|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
124869171|NCT00765674|449140326|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
124869172|NCT00765674|449140323|FG000|Overall Study|Lack of Efficacy|2|||
124869173|NCT00765674|449140324|FG001|Overall Study|Lack of Efficacy|3|||
124869174|NCT00765674|449140325|FG002|Overall Study|Lack of Efficacy|1|||
124869175|NCT00765674|449140326|FG003|Overall Study|Lack of Efficacy|2|||
124869176|NCT00765674|449140323|FG000|Overall Study|Protocol Violation|2|||
124869177|NCT00765674|449140324|FG001|Overall Study|Protocol Violation|0|||
124869178|NCT00765674|449140325|FG002|Overall Study|Protocol Violation|1|||
124869179|NCT00765674|449140326|FG003|Overall Study|Protocol Violation|0|||
124869180|NCT00765674|449140323|FG000|Overall Study|Withdrawal by Subject|5|||
124869181|NCT00765674|449140324|FG001|Overall Study|Withdrawal by Subject|7|||
124869182|NCT00765674|449140325|FG002|Overall Study|Withdrawal by Subject|3|||
124869183|NCT00765674|449140326|FG003|Overall Study|Withdrawal by Subject|8|||
124869184|NCT00765674|449140323|FG000|Overall Study|Lost to Follow-up|4|||
124869185|NCT00765674|449140324|FG001|Overall Study|Lost to Follow-up|6|||
124869186|NCT00765674|449140325|FG002|Overall Study|Lost to Follow-up|2|||
124869187|NCT00765674|449140326|FG003|Overall Study|Lost to Follow-up|1|||
124869188|NCT00765674|449140323|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
124869189|NCT00765674|449140324|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
124869190|NCT00765674|449140325|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
124869191|NCT00765674|449140326|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
124869192|NCT02432105|449140327|FG000|Overall Study|Lost to Follow-up|1|||
124869193|NCT02432105|449140328|FG001|Overall Study|Lost to Follow-up|1|||
124869194|NCT02432105|449140329|FG002|Overall Study|Lost to Follow-up|0|||
124869195|NCT02432105|449140327|FG000|Overall Study|Withdrawal by Subject|1|||
124869196|NCT02432105|449140328|FG001|Overall Study|Withdrawal by Subject|0|||
124869197|NCT02432105|449140329|FG002|Overall Study|Withdrawal by Subject|1|||
124869198|NCT02432105|449140327|FG000|Overall Study|Culture positive for yeast|0|||
124869199|NCT02432105|449140328|FG001|Overall Study|Culture positive for yeast|1|||
124869200|NCT02432105|449140329|FG002|Overall Study|Culture positive for yeast|0|||
124869201|NCT02432105|449140327|FG000|Overall Study|Randomized in error|0|||
124869202|NCT02432105|449140328|FG001|Overall Study|Randomized in error|0|||
124869203|NCT02432105|449140329|FG002|Overall Study|Randomized in error|2|||
124869204|NCT03053050|449140330|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
124869205|NCT03053050|449140331|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
124869206|NCT03053050|449140332|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
124869207|NCT03053050|449140333|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
124869208|NCT03053050|449140330|FG000|Randomized Phase|Withdrew Consent|16|||
124869209|NCT03053050|449140331|FG001|Randomized Phase|Withdrew Consent|8|||
124869210|NCT03053050|449140332|FG002|Randomized Phase|Withdrew Consent|9|||
124869211|NCT03053050|449140333|FG003|Randomized Phase|Withdrew Consent|0|||
124869212|NCT03053050|449140330|FG000|Randomized Phase|Investigator's Discretion|6|||
124869213|NCT03053050|449140331|FG001|Randomized Phase|Investigator's Discretion|6|||
124869214|NCT03053050|449140332|FG002|Randomized Phase|Investigator's Discretion|3|||
124869215|NCT03053050|449140333|FG003|Randomized Phase|Investigator's Discretion|0|||
124869216|NCT03053050|449140330|FG000|Randomized Phase|Lost to Follow-up|5|||
124869217|NCT03053050|449140331|FG001|Randomized Phase|Lost to Follow-up|1|||
124869218|NCT03053050|449140332|FG002|Randomized Phase|Lost to Follow-up|1|||
124869219|NCT03053050|449140333|FG003|Randomized Phase|Lost to Follow-up|0|||
124869220|NCT03053050|449140330|FG000|Randomized Phase|Adverse Event|0|||
124869221|NCT03053050|449140331|FG001|Randomized Phase|Adverse Event|1|||
124869222|NCT03053050|449140332|FG002|Randomized Phase|Adverse Event|0|||
124869223|NCT03053050|449140333|FG003|Randomized Phase|Adverse Event|0|||
124869224|NCT03053050|449140330|FG000|Randomized Phase|Randomized but Never Treated|2|||
124869225|NCT03053050|449140331|FG001|Randomized Phase|Randomized but Never Treated|2|||
124869226|NCT03053050|449140332|FG002|Randomized Phase|Randomized but Never Treated|2|||
124869227|NCT03053050|449140333|FG003|Randomized Phase|Randomized but Never Treated|0|||
124869228|NCT03053050|449140330|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
124869229|NCT03053050|449140331|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
124869230|NCT03053050|449140332|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
124869231|NCT03053050|449140333|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
124869232|NCT03053050|449140330|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
124869233|NCT03053050|449140331|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
124869234|NCT03053050|449140332|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
124869235|NCT03053050|449140333|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
124869236|NCT03053050|449140330|FG000|Open-label Phase|Withdrew Consent|0|||
124869237|NCT03053050|449140331|FG001|Open-label Phase|Withdrew Consent|0|||
124869238|NCT03053050|449140332|FG002|Open-label Phase|Withdrew Consent|0|||
124869239|NCT03053050|449140333|FG003|Open-label Phase|Withdrew Consent|6|||
124869240|NCT03053050|449140330|FG000|Open-label Phase|Investigator's Discretion|0|||
124869241|NCT03053050|449140331|FG001|Open-label Phase|Investigator's Discretion|0|||
124869242|NCT03053050|449140332|FG002|Open-label Phase|Investigator's Discretion|0|||
124869243|NCT03053050|449140333|FG003|Open-label Phase|Investigator's Discretion|4|||
124869244|NCT02459574|449140334|FG000|Overall Study|Withdrawal by Subject|6|||
124869245|NCT02459574|449140335|FG001|Overall Study|Withdrawal by Subject|6|||
124869246|NCT02459574|449140336|FG002|Overall Study|Withdrawal by Subject|2|||
124869247|NCT02459574|449140334|FG000|Overall Study|Lost to Follow-up|1|||
124869248|NCT02459574|449140335|FG001|Overall Study|Lost to Follow-up|1|||
124869249|NCT02459574|449140336|FG002|Overall Study|Lost to Follow-up|0|||
124869250|NCT02459574|449140334|FG000|Overall Study|Death|0|||
124869251|NCT02459574|449140335|FG001|Overall Study|Death|1|||
124869252|NCT02459574|449140336|FG002|Overall Study|Death|0|||
124869253|NCT00251745|449140337|FG000|Overall Study|Adverse Event|7|||
124869254|NCT00251745|449140338|FG001|Overall Study|Adverse Event|9|||
124869255|NCT00251745|449140339|FG002|Overall Study|Adverse Event|11|||
124869256|NCT00251745|449140337|FG000|Overall Study|Lost to Follow-up|4|||
124869257|NCT00251745|449140338|FG001|Overall Study|Lost to Follow-up|2|||
124869258|NCT00251745|449140339|FG002|Overall Study|Lost to Follow-up|5|||
124869259|NCT00251745|449140337|FG000|Overall Study|Withdrawal by Subject|13|||
124869260|NCT00251745|449140338|FG001|Overall Study|Withdrawal by Subject|7|||
124869261|NCT00251745|449140339|FG002|Overall Study|Withdrawal by Subject|3|||
124869262|NCT00251745|449140337|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
124869263|NCT00251745|449140338|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
124869264|NCT00251745|449140339|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
124869265|NCT00251745|449140337|FG000|Overall Study|Lack of Efficacy|3|||
124869266|NCT00251745|449140338|FG001|Overall Study|Lack of Efficacy|0|||
124869267|NCT00251745|449140339|FG002|Overall Study|Lack of Efficacy|0|||
124869268|NCT00251745|449140337|FG000|Overall Study|Noncompliant|0|||
124869269|NCT00251745|449140338|FG001|Overall Study|Noncompliant|2|||
124869270|NCT00251745|449140339|FG002|Overall Study|Noncompliant|2|||
124869271|NCT00251745|449140337|FG000|Overall Study|Pregnancy|0|||
124869272|NCT00251745|449140338|FG001|Overall Study|Pregnancy|1|||
124869273|NCT00251745|449140339|FG002|Overall Study|Pregnancy|0|||
124869274|NCT00251745|449140337|FG000|Overall Study|Per Subject Request|0|||
124869275|NCT00251745|449140338|FG001|Overall Study|Per Subject Request|0|||
124869276|NCT00251745|449140339|FG002|Overall Study|Per Subject Request|1|||
124869277|NCT00251745|449140337|FG000|Overall Study|Per Investigator Request|1|||
124869278|NCT00251745|449140338|FG001|Overall Study|Per Investigator Request|0|||
124869279|NCT00251745|449140339|FG002|Overall Study|Per Investigator Request|0|||
124869280|NCT04508699|449140342|FG000|Overall Study|Lack of Efficacy|2|||
124869281|NCT04508699|449140343|FG001|Overall Study|Lack of Efficacy|15|||
124869282|NCT04508699|449140342|FG000|Overall Study|Withdrawal by Subject|0|||
124869283|NCT04508699|449140343|FG001|Overall Study|Withdrawal by Subject|2|||
124869284|NCT00499031|449141642|FG000|Overall Study|Improper pre-protocol treatment|1|||
124869285|NCT00499031|449141642|FG000|Overall Study|Required test not done|1|||
124869286|NCT00499031|449141642|FG000|Overall Study|Never treated|1|||
124869287|NCT03409666|449141648|FG000|Overall Study|Physician Decision|0|||
124869288|NCT03409666|449141649|FG001|Overall Study|Physician Decision|1|||
124869289|NCT03409666|449141648|FG000|Overall Study|Protocol Violation|0|||
124869290|NCT03409666|449141649|FG001|Overall Study|Protocol Violation|3|||
124869291|NCT03432364|449141653|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
124869292|NCT03320018|449141657|FG000|Treatment Period|Withdrawal by Subject|1|||
124869293|NCT03320018|449141658|FG001|Treatment Period|Withdrawal by Subject|0|||
124869294|NCT03320018|449141657|FG000|Day 90 Follow up|Death|0|||
124869295|NCT03320018|449141658|FG001|Day 90 Follow up|Death|1|||
124869296|NCT03284788|449141662|FG000|Overall Study|Withdrawal by Subject|2|||
124869297|NCT03104699|449141667|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
124869298|NCT03104699|449141668|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
124869299|NCT03104699|449141669|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
124869300|NCT03104699|449141670|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
124869301|NCT03104699|449141671|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
124869302|NCT03104699|449141672|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124869303|NCT03104699|449141667|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
124869304|NCT03104699|449141668|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
124869305|NCT03104699|449141669|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
124869306|NCT03104699|449141670|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
124869307|NCT03104699|449141671|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
124869308|NCT03104699|449141672|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
124869309|NCT03104699|449141667|FG000|Phase 1: Dose Escalation|Death|6|||
124869310|NCT03104699|449141668|FG001|Phase 1: Dose Escalation|Death|3|||
124869311|NCT03104699|449141669|FG002|Phase 1: Dose Escalation|Death|0|||
124869312|NCT03104699|449141670|FG003|Phase 1: Dose Escalation|Death|1|||
124869313|NCT03104699|449141671|FG004|Phase 1: Dose Escalation|Death|1|||
124869314|NCT03104699|449141672|FG005|Phase 1: Dose Escalation|Death|0|||
124869315|NCT03104699|449141667|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
124869316|NCT03104699|449141668|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
124869317|NCT03104699|449141669|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
124869318|NCT03104699|449141670|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
124869319|NCT03104699|449141671|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
124869320|NCT03104699|449141672|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
124869321|NCT03104699|449141667|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
124869322|NCT03104699|449141668|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
124869323|NCT03104699|449141669|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
124869324|NCT03104699|449141670|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
124869325|NCT03104699|449141671|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
124869326|NCT03104699|449141672|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
124869327|NCT03104699|449141667|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
124869328|NCT03104699|449141668|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
124869329|NCT03104699|449141669|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
124869330|NCT03104699|449141670|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
124869331|NCT03104699|449141671|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
124869332|NCT03104699|449141672|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
124869333|NCT03104699|449141667|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
124869334|NCT03104699|449141668|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
124869335|NCT03104699|449141669|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
124869336|NCT03104699|449141670|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
124869337|NCT03104699|449141671|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
124869338|NCT03104699|449141672|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
124869339|NCT03104699|449141667|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
124869340|NCT03104699|449141668|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
124869341|NCT03104699|449141669|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
124869342|NCT03104699|449141670|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
124869343|NCT03104699|449141671|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
124869344|NCT03104699|449141672|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
124869345|NCT03104699|449141667|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
124869346|NCT03104699|449141668|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
124869347|NCT03104699|449141669|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
124869348|NCT03104699|449141670|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
124869349|NCT03104699|449141671|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
124869350|NCT03104699|449141672|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
124869351|NCT03104699|449141667|FG000|Phase 2: Dose Expansion|Death|0|||
124869352|NCT03104699|449141668|FG001|Phase 2: Dose Expansion|Death|0|||
124869353|NCT03104699|449141669|FG002|Phase 2: Dose Expansion|Death|0|||
124869354|NCT03104699|449141670|FG003|Phase 2: Dose Expansion|Death|0|||
124869355|NCT03104699|449141671|FG004|Phase 2: Dose Expansion|Death|0|||
124869356|NCT03104699|449141672|FG005|Phase 2: Dose Expansion|Death|107|||
124869357|NCT03104699|449141667|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
124869358|NCT03104699|449141668|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
124869359|NCT03104699|449141669|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
124869360|NCT03104699|449141670|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
124869361|NCT03104699|449141671|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
124869362|NCT03104699|449141672|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
124869363|NCT03104699|449141667|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
124869364|NCT03104699|449141668|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
124869365|NCT03104699|449141669|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
124869366|NCT03104699|449141670|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
124869367|NCT03104699|449141671|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
124869368|NCT03104699|449141672|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
124869369|NCT03104699|449141667|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124869370|NCT03104699|449141668|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124869371|NCT03104699|449141669|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124869372|NCT03104699|449141670|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124869373|NCT03104699|449141671|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124869374|NCT03104699|449141672|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
124869375|NCT03104699|449141667|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
124869376|NCT03104699|449141668|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
124869377|NCT03104699|449141669|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
124869378|NCT03104699|449141670|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
124869379|NCT03104699|449141671|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
124869380|NCT03104699|449141672|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
124869381|NCT01690130|449141673|FG000|Overall Study|Subject have cancelled visit.|1|||
124869382|NCT01690130|449141674|FG001|Overall Study|Subject have cancelled visit.|0|||
124869383|NCT00152464|449141675|FG000|Overall Study|Adverse Event|3|||
124869384|NCT00152464|449141676|FG001|Overall Study|Adverse Event|6|||
124869385|NCT00152464|449141675|FG000|Overall Study|Lost to Follow-up|8|||
124869386|NCT00152464|449141676|FG001|Overall Study|Lost to Follow-up|4|||
124869387|NCT00152464|449141675|FG000|Overall Study|Protocol Violation|3|||
124869388|NCT00152464|449141676|FG001|Overall Study|Protocol Violation|1|||
124869389|NCT00152464|449141675|FG000|Overall Study|Withdrawal by Subject|21|||
124869390|NCT00152464|449141676|FG001|Overall Study|Withdrawal by Subject|22|||
124869391|NCT00152464|449141675|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
124869392|NCT00152464|449141676|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
124869393|NCT00152464|449141675|FG000|Overall Study|Eczema deterioration|0|||
125200593|NCT01938430|450357544|FG002|Overall Study|Death|2|||
124869394|NCT00152464|449141676|FG001|Overall Study|Eczema deterioration|1|||
125200594|NCT01938430|450357545|FG003|Overall Study|Death|1|||
124869395|NCT00152464|449141675|FG000|Overall Study|Parent decision|1|||
124869396|NCT00152464|449141676|FG001|Overall Study|Parent decision|1|||
124869397|NCT00152464|449141675|FG000|Overall Study|Investigator decision|1|||
124869398|NCT00152464|449141676|FG001|Overall Study|Investigator decision|0|||
124869399|NCT00152464|449141675|FG000|Overall Study|Lack of Efficacy|1|||
124869400|NCT00152464|449141676|FG001|Overall Study|Lack of Efficacy|0|||
124869401|NCT00152464|449141675|FG000|Overall Study|Eczema poorly controlled|1|||
124869402|NCT00152464|449141676|FG001|Overall Study|Eczema poorly controlled|0|||
124869403|NCT00152464|449141675|FG000|Overall Study|Patient relocated|1|||
125200595|NCT01938430|450357546|FG004|Overall Study|Death|0|||
124869404|NCT00152464|449141676|FG001|Overall Study|Patient relocated|0|||
124869405|NCT01644734|449141677|FG000|Overall Study|Adverse Event|4|||
124869406|NCT01644734|449141677|FG000|Overall Study|Lost to Follow-up|17|||
124869407|NCT01644734|449141677|FG000|Overall Study|Reasons other than stated above|7|||
124869408|NCT01644734|449141677|FG000|Overall Study|Missing documentation|238|||
124869409|NCT05159622|449141678|FG000|Overall Study|Lost to Follow-up|4|||
124869410|NCT05159622|449141679|FG001|Overall Study|Lost to Follow-up|5|||
124869411|NCT01615328|449141687|FG000|Overall Study|Lost to Follow-up|3|||
124869412|NCT01615328|449141688|FG001|Overall Study|Lost to Follow-up|5|||
124869413|NCT03338894|449141689|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
124869414|NCT00626028|449141690|FG000|Overall Study|Adverse Event|1|||
124869415|NCT00626028|449141691|FG001|Overall Study|Adverse Event|1|||
124869416|NCT00626028|449141690|FG000|Overall Study|Device Failure|0|||
124869417|NCT00626028|449141691|FG001|Overall Study|Device Failure|1|||
124869418|NCT00626028|449141690|FG000|Overall Study|Physician Decision|2|||
124869419|NCT00626028|449141691|FG001|Overall Study|Physician Decision|1|||
124869420|NCT00626028|449141690|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
124869421|NCT00626028|449141691|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
124869422|NCT01984684|449141694|FG000|Overall Study|Lost to Follow-up|25|||
124869423|NCT01984684|449141695|FG001|Overall Study|Lost to Follow-up|24|||
124869424|NCT01984684|449141694|FG000|Overall Study|Adverse Event|8|||
124869425|NCT01984684|449141695|FG001|Overall Study|Adverse Event|12|||
124869426|NCT01984684|449141694|FG000|Overall Study|Withdrawal by Subject|9|||
124869427|NCT01984684|449141695|FG001|Overall Study|Withdrawal by Subject|9|||
124869428|NCT01984684|449141694|FG000|Overall Study|Lack of Efficacy|3|||
124869429|NCT01984684|449141695|FG001|Overall Study|Lack of Efficacy|6|||
124869430|NCT01984684|449141694|FG000|Overall Study|Physician Decision|4|||
124869431|NCT01984684|449141695|FG001|Overall Study|Physician Decision|2|||
124869432|NCT01984684|449141694|FG000|Overall Study|Protocol Violation|4|||
124869433|NCT01984684|449141695|FG001|Overall Study|Protocol Violation|2|||
124869434|NCT01984684|449141694|FG000|Overall Study|Death|0|||
124869435|NCT01984684|449141695|FG001|Overall Study|Death|1|||
124869436|NCT01984684|449141694|FG000|Overall Study|Noncompliance with study drug|2|||
124869437|NCT01984684|449141695|FG001|Overall Study|Noncompliance with study drug|1|||
124869438|NCT01984684|449141694|FG000|Overall Study|Subject incarcerated|1|||
124869439|NCT01984684|449141695|FG001|Overall Study|Subject incarcerated|0|||
124869440|NCT01984684|449141694|FG000|Overall Study|Study drug not available at site|1|||
124869441|NCT01984684|449141695|FG001|Overall Study|Study drug not available at site|1|||
124869442|NCT01984684|449141694|FG000|Overall Study|Subject had inadequate IV access|0|||
124869443|NCT01984684|449141695|FG001|Overall Study|Subject had inadequate IV access|1|||
124869444|NCT04575051|449141696|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
124869445|NCT04575051|449141697|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
124869446|NCT04575051|449141698|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
124869447|NCT04575051|449141699|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
124869448|NCT04575051|449141700|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
124869449|NCT04575051|449141696|FG000|Time Period 1|Missing follow up|1|||
124869450|NCT04575051|449141697|FG001|Time Period 1|Missing follow up|3|||
124869451|NCT04575051|449141698|FG002|Time Period 1|Missing follow up|1|||
124869452|NCT04575051|449141699|FG003|Time Period 1|Missing follow up|3|||
124869453|NCT04575051|449141700|FG004|Time Period 1|Missing follow up|2|||
124869454|NCT04575051|449141696|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
124869455|NCT04575051|449141697|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
124869456|NCT04575051|449141698|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
124869457|NCT04575051|449141699|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
124869458|NCT04575051|449141700|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
124869459|NCT04575051|449141696|FG000|Time Period 2|Missing follow up|1|||
124869460|NCT04575051|449141697|FG001|Time Period 2|Missing follow up|8|||
124869461|NCT04575051|449141698|FG002|Time Period 2|Missing follow up|7|||
124869462|NCT04575051|449141699|FG003|Time Period 2|Missing follow up|0|||
124869463|NCT04575051|449141700|FG004|Time Period 2|Missing follow up|1|||
124869464|NCT04575051|449141696|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
124869465|NCT04575051|449141697|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
124869466|NCT04575051|449141698|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
124869467|NCT04575051|449141699|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
124869468|NCT04575051|449141700|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
124869469|NCT04575051|449141696|FG000|Time Period 3|Missing follow up|8|||
124869470|NCT04575051|449141697|FG001|Time Period 3|Missing follow up|6|||
124869471|NCT04575051|449141698|FG002|Time Period 3|Missing follow up|4|||
124869472|NCT04575051|449141699|FG003|Time Period 3|Missing follow up|3|||
124869473|NCT04575051|449141700|FG004|Time Period 3|Missing follow up|0|||
124869474|NCT04575051|449141696|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
125089730|NCT00405756|449947016|FG001|Open-label Extension|Adverse Event|3|||
124869475|NCT04575051|449141697|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
124869476|NCT04575051|449141698|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
124869477|NCT04575051|449141699|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
124869478|NCT04575051|449141700|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
124869479|NCT04575051|449141696|FG000|Time Period 4|Missing follow up|17|||
124869480|NCT04575051|449141697|FG001|Time Period 4|Missing follow up|3|||
124869481|NCT04575051|449141698|FG002|Time Period 4|Missing follow up|4|||
124869482|NCT04575051|449141699|FG003|Time Period 4|Missing follow up|2|||
124869483|NCT04575051|449141700|FG004|Time Period 4|Missing follow up|1|||
124869484|NCT04575051|449141696|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
124869485|NCT04575051|449141697|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
124869486|NCT04575051|449141698|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
124869487|NCT04575051|449141699|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
124869488|NCT04575051|449141700|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
124869489|NCT04575051|449141696|FG000|Time Period 5|Missing follow up|11|||
124869490|NCT04575051|449141697|FG001|Time Period 5|Missing follow up|8|||
124869491|NCT04575051|449141698|FG002|Time Period 5|Missing follow up|12|||
124869492|NCT04575051|449141699|FG003|Time Period 5|Missing follow up|3|||
124869493|NCT04575051|449141700|FG004|Time Period 5|Missing follow up|11|||
124869494|NCT03583554|449141703|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
124869495|NCT03583554|449141704|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
124869496|NCT03583554|449141705|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
124869497|NCT03178266|449141706|FG000|Overall Study|Death|0|||
124869498|NCT03178266|449141707|FG001|Overall Study|Death|1|||
124869499|NCT03178266|449141706|FG000|Overall Study|Disont. Early|0|||
124869500|NCT03178266|449141707|FG001|Overall Study|Disont. Early|1|||
124869501|NCT03178266|449141706|FG000|Overall Study|Withdrawal by Subject|0|||
124869502|NCT03178266|449141707|FG001|Overall Study|Withdrawal by Subject|2|||
124869503|NCT02472964|449141708|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
124869504|NCT02472964|449141709|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
124869505|NCT02472964|449141708|FG000|Part 1 (up to Week 24)|disease progression|58|||
124869506|NCT02472964|449141709|FG001|Part 1 (up to Week 24)|disease progression|47|||
124869507|NCT02472964|449141708|FG000|Part 1 (up to Week 24)|Death|3|||
124869508|NCT02472964|449141709|FG001|Part 1 (up to Week 24)|Death|6|||
124869509|NCT02472964|449141708|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
124869510|NCT02472964|449141709|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
124869511|NCT02472964|449141708|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
124869512|NCT02472964|449141709|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
124869513|NCT02472964|449141708|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
124869514|NCT02472964|449141709|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
124869515|NCT02472964|449141708|FG000|Part 1 (up to Week 24)|Other|2|||
124869516|NCT02472964|449141709|FG001|Part 1 (up to Week 24)|Other|1|||
124869517|NCT02472964|449141708|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
124869518|NCT02472964|449141709|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
124869519|NCT02472964|449141708|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
124869520|NCT02472964|449141709|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
124869521|NCT02472964|449141708|FG000|Part 2 (Week 24-week 48)|Death|0|||
124869522|NCT02472964|449141709|FG001|Part 2 (Week 24-week 48)|Death|1|||
124869523|NCT02472964|449141708|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
124869524|NCT02472964|449141709|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
125200596|NCT01938430|450357547|FG005|Overall Study|Death|0|||
125200597|NCT01938430|450357548|FG006|Overall Study|Death|1|||
125200598|NCT01938430|450357549|FG007|Overall Study|Death|1|||
124869525|NCT02472964|449141708|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
124869526|NCT02472964|449141709|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
124869527|NCT02472964|449141708|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
124869528|NCT02472964|449141709|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
124869529|NCT02472964|449141708|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
124869530|NCT02472964|449141709|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
124869531|NCT04672941|449141715|FG000|Overall Study|Investigator decision|1|||
124869532|NCT04672941|449141715|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
124869533|NCT04672941|449141715|FG000|Overall Study|COVID-19 related but no adverse event|1|||
124869534|NCT04672941|449141715|FG000|Overall Study|Adverse Event|2|||
124869535|NCT04672941|449141715|FG000|Overall Study|Lost to Follow-up|2|||
124869536|NCT00765388|449141717|FG000|Period 1|Lack of Efficacy|1|||
124869537|NCT00765388|449141718|FG001|Period 1|Lack of Efficacy|2|||
124869538|NCT00765388|449141717|FG000|Period 1|Lost to Follow-up|0|||
124869539|NCT00765388|449141718|FG001|Period 1|Lost to Follow-up|1|||
124869540|NCT00765388|449141717|FG000|Period 1|Herpes Zoster|0|||
124869541|NCT00765388|449141718|FG001|Period 1|Herpes Zoster|1|||
124869542|NCT00765388|449141717|FG000|Period 1|Hip operation|0|||
124869543|NCT00765388|449141718|FG001|Period 1|Hip operation|1|||
124869544|NCT02342886|449141722|FG000|Overall Study|Treatment non-compliance|1|||
125200599|NCT01938430|450357550|FG008|Overall Study|Death|2|||
124869545|NCT02342886|449141723|FG001|Overall Study|Treatment non-compliance|0|||
124869546|NCT02342886|449141724|FG002|Overall Study|Treatment non-compliance|0|||
124869547|NCT02342886|449141725|FG003|Overall Study|Treatment non-compliance|1|||
124869548|NCT02342886|449141726|FG004|Overall Study|Treatment non-compliance|0|||
124869549|NCT02342886|449141722|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
124869550|NCT02342886|449141723|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
124869551|NCT02342886|449141724|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
124869552|NCT02342886|449141725|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
124869553|NCT02342886|449141726|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
124869554|NCT02342886|449141722|FG000|Overall Study|Adverse event/specific toxicity|4|||
124869555|NCT02342886|449141723|FG001|Overall Study|Adverse event/specific toxicity|3|||
124978485|NCT03829501|449548503|FG015|Overall Study|PD|1|||
124978486|NCT03829501|449548504|FG016|Overall Study|PD|0|||
124978487|NCT03829501|449548505|FG017|Overall Study|PD|0|||
124978488|NCT03829501|449548506|FG018|Overall Study|PD|0|||
124978489|NCT03829501|449548507|FG019|Overall Study|PD|0|||
124978490|NCT03829501|449548508|FG020|Overall Study|PD|1|||
124978491|NCT03829501|449548509|FG021|Overall Study|PD|0|||
124978492|NCT03829501|449548510|FG022|Overall Study|PD|0|||
124978493|NCT03829501|449548488|FG000|Overall Study|Study Terminated by Sponsor|0|||
124978494|NCT03829501|449548489|FG001|Overall Study|Study Terminated by Sponsor|0|||
124978495|NCT03829501|449548490|FG002|Overall Study|Study Terminated by Sponsor|0|||
124978496|NCT03829501|449548491|FG003|Overall Study|Study Terminated by Sponsor|0|||
124978497|NCT03829501|449548492|FG004|Overall Study|Study Terminated by Sponsor|0|||
124978498|NCT03829501|449548493|FG005|Overall Study|Study Terminated by Sponsor|0|||
124978499|NCT03829501|449548494|FG006|Overall Study|Study Terminated by Sponsor|0|||
124978500|NCT03829501|449548495|FG007|Overall Study|Study Terminated by Sponsor|3|||
124978501|NCT03829501|449548496|FG008|Overall Study|Study Terminated by Sponsor|1|||
124978502|NCT03829501|449548497|FG009|Overall Study|Study Terminated by Sponsor|0|||
124978503|NCT03829501|449548498|FG010|Overall Study|Study Terminated by Sponsor|0|||
124978504|NCT03829501|449548499|FG011|Overall Study|Study Terminated by Sponsor|0|||
124978505|NCT03829501|449548500|FG012|Overall Study|Study Terminated by Sponsor|0|||
124978506|NCT03829501|449548501|FG013|Overall Study|Study Terminated by Sponsor|0|||
124978507|NCT03829501|449548502|FG014|Overall Study|Study Terminated by Sponsor|3|||
124978508|NCT03829501|449548503|FG015|Overall Study|Study Terminated by Sponsor|2|||
124978509|NCT03829501|449548504|FG016|Overall Study|Study Terminated by Sponsor|2|||
124978510|NCT03829501|449548505|FG017|Overall Study|Study Terminated by Sponsor|0|||
124978511|NCT03829501|449548506|FG018|Overall Study|Study Terminated by Sponsor|0|||
124978512|NCT03829501|449548507|FG019|Overall Study|Study Terminated by Sponsor|0|||
124978513|NCT03829501|449548508|FG020|Overall Study|Study Terminated by Sponsor|1|||
124978514|NCT03829501|449548509|FG021|Overall Study|Study Terminated by Sponsor|0|||
124978515|NCT03829501|449548510|FG022|Overall Study|Study Terminated by Sponsor|3|||
124978516|NCT03829501|449548488|FG000|Overall Study|Lost to Follow Up|0|||
124978517|NCT03829501|449548489|FG001|Overall Study|Lost to Follow Up|0|||
124978518|NCT03829501|449548490|FG002|Overall Study|Lost to Follow Up|0|||
124978519|NCT03829501|449548491|FG003|Overall Study|Lost to Follow Up|0|||
124978520|NCT03829501|449548492|FG004|Overall Study|Lost to Follow Up|1|||
124978521|NCT03829501|449548493|FG005|Overall Study|Lost to Follow Up|0|||
124978522|NCT03829501|449548494|FG006|Overall Study|Lost to Follow Up|0|||
124978523|NCT03829501|449548495|FG007|Overall Study|Lost to Follow Up|2|||
124978524|NCT03829501|449548496|FG008|Overall Study|Lost to Follow Up|2|||
124978525|NCT03829501|449548497|FG009|Overall Study|Lost to Follow Up|0|||
124978526|NCT03829501|449548498|FG010|Overall Study|Lost to Follow Up|2|||
124978527|NCT03829501|449548499|FG011|Overall Study|Lost to Follow Up|1|||
124978528|NCT03829501|449548500|FG012|Overall Study|Lost to Follow Up|0|||
124978529|NCT03829501|449548501|FG013|Overall Study|Lost to Follow Up|1|||
124978530|NCT03829501|449548502|FG014|Overall Study|Lost to Follow Up|1|||
124978531|NCT03829501|449548503|FG015|Overall Study|Lost to Follow Up|0|||
124978532|NCT03829501|449548504|FG016|Overall Study|Lost to Follow Up|0|||
124978533|NCT03829501|449548505|FG017|Overall Study|Lost to Follow Up|0|||
124978534|NCT03829501|449548506|FG018|Overall Study|Lost to Follow Up|0|||
124978535|NCT03829501|449548507|FG019|Overall Study|Lost to Follow Up|0|||
124978536|NCT03829501|449548508|FG020|Overall Study|Lost to Follow Up|0|||
124978537|NCT03829501|449548509|FG021|Overall Study|Lost to Follow Up|0|||
124978538|NCT03829501|449548510|FG022|Overall Study|Lost to Follow Up|1|||
124978539|NCT03829501|449548488|FG000|Overall Study|Death|2|||
124978540|NCT03829501|449548489|FG001|Overall Study|Death|4|||
124978541|NCT03829501|449548490|FG002|Overall Study|Death|5|||
125200600|NCT01938430|450357551|FG009|Overall Study|Death|3|||
124978542|NCT03829501|449548491|FG003|Overall Study|Death|6|||
124978543|NCT03829501|449548492|FG004|Overall Study|Death|5|||
124978544|NCT03829501|449548493|FG005|Overall Study|Death|4|||
124978545|NCT03829501|449548494|FG006|Overall Study|Death|5|||
124978546|NCT03829501|449548495|FG007|Overall Study|Death|24|||
124978547|NCT03829501|449548496|FG008|Overall Study|Death|22|||
124978548|NCT03829501|449548497|FG009|Overall Study|Death|6|||
124978549|NCT03829501|449548498|FG010|Overall Study|Death|3|||
124978550|NCT03829501|449548499|FG011|Overall Study|Death|10|||
124978551|NCT03829501|449548500|FG012|Overall Study|Death|10|||
124978552|NCT03829501|449548501|FG013|Overall Study|Death|5|||
124869556|NCT02342886|449141724|FG002|Overall Study|Adverse event/specific toxicity|11|||
124869557|NCT02342886|449141725|FG003|Overall Study|Adverse event/specific toxicity|2|||
124869558|NCT02342886|449141726|FG004|Overall Study|Adverse event/specific toxicity|1|||
124869559|NCT02342886|449141722|FG000|Overall Study|Lost to Follow-up|1|||
124869560|NCT02342886|449141723|FG001|Overall Study|Lost to Follow-up|0|||
124869561|NCT02342886|449141724|FG002|Overall Study|Lost to Follow-up|0|||
124869562|NCT02342886|449141725|FG003|Overall Study|Lost to Follow-up|0|||
124869563|NCT02342886|449141726|FG004|Overall Study|Lost to Follow-up|0|||
124869564|NCT02342886|449141722|FG000|Overall Study|Death|1|||
124869565|NCT02342886|449141723|FG001|Overall Study|Death|2|||
124869566|NCT02342886|449141724|FG002|Overall Study|Death|1|||
124869567|NCT02342886|449141725|FG003|Overall Study|Death|0|||
124869568|NCT02342886|449141726|FG004|Overall Study|Death|1|||
124869569|NCT02342886|449141722|FG000|Overall Study|Withdrawal by Subject|0|||
124869570|NCT02342886|449141723|FG001|Overall Study|Withdrawal by Subject|1|||
124869571|NCT02342886|449141724|FG002|Overall Study|Withdrawal by Subject|0|||
124869572|NCT02342886|449141725|FG003|Overall Study|Withdrawal by Subject|1|||
124869573|NCT02342886|449141726|FG004|Overall Study|Withdrawal by Subject|0|||
124869574|NCT02342886|449141722|FG000|Overall Study|Investigator/sponsor decision|0|||
124869575|NCT02342886|449141723|FG001|Overall Study|Investigator/sponsor decision|2|||
124869576|NCT02342886|449141724|FG002|Overall Study|Investigator/sponsor decision|0|||
124869577|NCT02342886|449141725|FG003|Overall Study|Investigator/sponsor decision|3|||
124869578|NCT02342886|449141726|FG004|Overall Study|Investigator/sponsor decision|1|||
124869579|NCT02342886|449141722|FG000|Overall Study|Pregnancy|0|||
124869580|NCT02342886|449141723|FG001|Overall Study|Pregnancy|0|||
124869581|NCT02342886|449141724|FG002|Overall Study|Pregnancy|2|||
124869582|NCT02342886|449141725|FG003|Overall Study|Pregnancy|0|||
124869583|NCT02342886|449141726|FG004|Overall Study|Pregnancy|0|||
124869584|NCT02342886|449141722|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
124869585|NCT02342886|449141723|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
124869586|NCT02342886|449141724|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
124869587|NCT02342886|449141725|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
124869588|NCT02342886|449141726|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
124869589|NCT02342886|449141722|FG000|Overall Study|Protocol Violation|0|||
124869590|NCT02342886|449141723|FG001|Overall Study|Protocol Violation|0|||
124869591|NCT02342886|449141724|FG002|Overall Study|Protocol Violation|0|||
124869592|NCT02342886|449141725|FG003|Overall Study|Protocol Violation|2|||
124869593|NCT02342886|449141726|FG004|Overall Study|Protocol Violation|0|||
124869594|NCT01328080|449141727|FG000|Overall Study|Lost to Follow-up|5|||
124869595|NCT00862134|449141728|FG000|Overall Study|Death|1|||
124869596|NCT00862134|449141729|FG001|Overall Study|Death|0|||
124869597|NCT00862134|449141728|FG000|Overall Study|Physician Decision|0|||
124869598|NCT00862134|449141729|FG001|Overall Study|Physician Decision|1|||
124869599|NCT00862134|449141728|FG000|Overall Study|Withdrawal by Subject|1|||
124869600|NCT00862134|449141729|FG001|Overall Study|Withdrawal by Subject|2|||
124869601|NCT00862134|449141728|FG000|Overall Study|Sponsor terminated study|5|||
124869602|NCT00862134|449141729|FG001|Overall Study|Sponsor terminated study|7|||
124869603|NCT00862134|449141728|FG000|Overall Study|Adverse Event|2|||
124869604|NCT00862134|449141729|FG001|Overall Study|Adverse Event|2|||
124869605|NCT00862134|449141728|FG000|Overall Study|Withdrew prior to dosing|2|||
124869606|NCT00862134|449141729|FG001|Overall Study|Withdrew prior to dosing|0|||
124869607|NCT02191267|449141730|FG000|Overall Study|Withdrawal by Subject|1|||
124869608|NCT02191267|449141731|FG001|Overall Study|Withdrawal by Subject|0|||
124869609|NCT02191267|449141732|FG002|Overall Study|Withdrawal by Subject|0|||
124869610|NCT00316082|449141733|FG000|Overall Study|Lack of Efficacy|2|||
124869611|NCT00316082|449141734|FG001|Overall Study|Lack of Efficacy|3|||
124869612|NCT00316082|449141735|FG002|Overall Study|Lack of Efficacy|3|||
124869613|NCT00316082|449141736|FG003|Overall Study|Lack of Efficacy|4|||
124869614|NCT00316082|449141737|FG004|Overall Study|Lack of Efficacy|6|||
124869615|NCT00316082|449141733|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
124869616|NCT00316082|449141734|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
124869617|NCT00316082|449141735|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
124869618|NCT00316082|449141736|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
124869619|NCT00316082|449141737|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
124869620|NCT00316082|449141733|FG000|Overall Study|Lost to Follow-up|7|||
124869621|NCT00316082|449141734|FG001|Overall Study|Lost to Follow-up|6|||
124869622|NCT00316082|449141735|FG002|Overall Study|Lost to Follow-up|7|||
124869623|NCT00316082|449141736|FG003|Overall Study|Lost to Follow-up|8|||
124869624|NCT00316082|449141737|FG004|Overall Study|Lost to Follow-up|6|||
124869625|NCT00316082|449141733|FG000|Overall Study|Poor/noncompliance|6|||
124869626|NCT00316082|449141734|FG001|Overall Study|Poor/noncompliance|1|||
124869627|NCT00316082|449141735|FG002|Overall Study|Poor/noncompliance|4|||
124869628|NCT00316082|449141736|FG003|Overall Study|Poor/noncompliance|1|||
124869629|NCT00316082|449141737|FG004|Overall Study|Poor/noncompliance|4|||
124869630|NCT00316082|449141733|FG000|Overall Study|Adverse Event|4|||
124869631|NCT00316082|449141734|FG001|Overall Study|Adverse Event|2|||
124869632|NCT00316082|449141735|FG002|Overall Study|Adverse Event|5|||
124869633|NCT00316082|449141736|FG003|Overall Study|Adverse Event|1|||
124869634|NCT00316082|449141737|FG004|Overall Study|Adverse Event|3|||
124869635|NCT00316082|449141733|FG000|Overall Study|Subject no longer meets study criteria|3|||
124869636|NCT00316082|449141734|FG001|Overall Study|Subject no longer meets study criteria|1|||
124869637|NCT00316082|449141735|FG002|Overall Study|Subject no longer meets study criteria|2|||
124869638|NCT00316082|449141736|FG003|Overall Study|Subject no longer meets study criteria|2|||
124869639|NCT00316082|449141737|FG004|Overall Study|Subject no longer meets study criteria|1|||
124869640|NCT00316082|449141733|FG000|Overall Study|Physician Decision|1|||
124869641|NCT00316082|449141734|FG001|Overall Study|Physician Decision|1|||
124869642|NCT00316082|449141735|FG002|Overall Study|Physician Decision|2|||
124869643|NCT00316082|449141736|FG003|Overall Study|Physician Decision|1|||
124869644|NCT00316082|449141737|FG004|Overall Study|Physician Decision|1|||
124869645|NCT00316082|449141733|FG000|Overall Study|Death|0|||
124869646|NCT00316082|449141734|FG001|Overall Study|Death|0|||
124869647|NCT00316082|449141735|FG002|Overall Study|Death|1|||
124869648|NCT00316082|449141736|FG003|Overall Study|Death|0|||
124869649|NCT00316082|449141737|FG004|Overall Study|Death|0|||
124869650|NCT00316082|449141733|FG000|Overall Study|Administrative reason by sponsor|0|||
124869651|NCT00316082|449141734|FG001|Overall Study|Administrative reason by sponsor|0|||
124869652|NCT00316082|449141735|FG002|Overall Study|Administrative reason by sponsor|1|||
124869653|NCT00316082|449141736|FG003|Overall Study|Administrative reason by sponsor|0|||
124869654|NCT00316082|449141737|FG004|Overall Study|Administrative reason by sponsor|0|||
124869655|NCT00528775|449141738|FG000|Overall Study|Other not specified|1|||
124869656|NCT00587964|449141741|FG000|Overall Study|Withdrawal by Subject|1|||
124869657|NCT00587964|449141741|FG000|Overall Study|Lost to Follow-up|1|||
124869658|NCT00587964|449141741|FG000|Overall Study|Patient found to be ineligible|1|||
124869659|NCT00587964|449141741|FG000|Overall Study|Patient did not receive intervention|5|||
124869660|NCT00587964|449141741|FG000|Overall Study|Progression of Disease|4|||
124869661|NCT01569438|449141745|FG000|Overall Study|Lack of Efficacy|1|||
124869662|NCT01569438|449141746|FG001|Overall Study|Lack of Efficacy|2|||
124869663|NCT01569438|449141745|FG000|Overall Study|Withdrawal by Subject|0|||
124869664|NCT01569438|449141746|FG001|Overall Study|Withdrawal by Subject|3|||
124869665|NCT01569438|449141745|FG000|Overall Study|Adverse Event|2|||
124869666|NCT01569438|449141746|FG001|Overall Study|Adverse Event|15|||
124869667|NCT01569438|449141745|FG000|Overall Study|Protocol Violation|2|||
124869668|NCT01569438|449141746|FG001|Overall Study|Protocol Violation|0|||
124869669|NCT01569438|449141745|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
124869670|NCT01569438|449141746|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
124869671|NCT01569438|449141745|FG000|Overall Study|Sponsor/Physician decision|1|||
124869672|NCT01569438|449141746|FG001|Overall Study|Sponsor/Physician decision|1|||
124869673|NCT01569438|449141745|FG000|Overall Study|Unable to adhere to study schedule|0|||
124869674|NCT01569438|449141746|FG001|Overall Study|Unable to adhere to study schedule|1|||
124869675|NCT03649230|449141748|FG000|Overall Study|Adverse Event|12|||
124869676|NCT03649230|449141748|FG000|Overall Study|Death|8|||
124869677|NCT03649230|449141748|FG000|Overall Study|Withdrawal by Subject|6|||
124869678|NCT03649230|449141748|FG000|Overall Study|Physician Decision|5|||
124869679|NCT03649230|449141748|FG000|Overall Study|Disease progression|5|||
124869680|NCT03649230|449141748|FG000|Overall Study|Switched to non-HEC|5|||
124869681|NCT03649230|449141748|FG000|Overall Study|Chemotherapy discontinued|4|||
124869682|NCT03649230|449141748|FG000|Overall Study|Received only 3 HEC cycles|4|||
124869683|NCT03649230|449141748|FG000|Overall Study|Screen Failure|3|||
124869684|NCT03649230|449141748|FG000|Overall Study|Patient stopped treatment|2|||
124869685|NCT03649230|449141748|FG000|Overall Study|Protocol Violation|1|||
124869686|NCT03649230|449141748|FG000|Overall Study|Non-compliance|1|||
124869687|NCT03649230|449141748|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
124869688|NCT01693068|449141749|FG000|Randomization Period|On-study|2|||
124869689|NCT01693068|449141750|FG001|Randomization Period|On-study|5|||
124869690|NCT01693068|449141751|FG002|Randomization Period|On-study|0|||
124869691|NCT01693068|449141749|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
124869692|NCT01693068|449141750|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
124869693|NCT01693068|449141751|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
124869694|NCT00977665|449141757|FG000|Overall Study|Withdrawal by Subject|1|||
124869695|NCT00977665|449141758|FG001|Overall Study|Withdrawal by Subject|3|||
124978553|NCT03829501|449548502|FG014|Overall Study|Death|7|||
124978554|NCT03829501|449548503|FG015|Overall Study|Death|2|||
124869696|NCT00977665|449141757|FG000|Overall Study|Physician Decision|2|||
124869697|NCT00977665|449141758|FG001|Overall Study|Physician Decision|1|||
124869698|NCT00977665|449141757|FG000|Overall Study|Sponsor requested withdrawal|0|||
124869699|NCT00977665|449141758|FG001|Overall Study|Sponsor requested withdrawal|1|||
124869700|NCT00977665|449141757|FG000|Overall Study|Lost to Follow-up|1|||
124869701|NCT00977665|449141758|FG001|Overall Study|Lost to Follow-up|0|||
124869702|NCT00977665|449141757|FG000|Overall Study|Death|3|||
124869703|NCT00977665|449141758|FG001|Overall Study|Death|2|||
124869704|NCT00977665|449141757|FG000|Overall Study|Adverse Event|14|||
124869705|NCT00977665|449141758|FG001|Overall Study|Adverse Event|7|||
124869706|NCT00977665|449141757|FG000|Overall Study|Treatment failure|0|||
124869707|NCT00977665|449141758|FG001|Overall Study|Treatment failure|1|||
124978555|NCT03829501|449548504|FG016|Overall Study|Death|2|||
125200601|NCT01938430|450357552|FG010|Overall Study|Death|0|||
125200602|NCT01938430|450357553|FG011|Overall Study|Death|0|||
125200603|NCT01938430|450357554|FG012|Overall Study|Death|0|||
125200604|NCT01938430|450357555|FG013|Overall Study|Death|0|||
125200605|NCT01938430|450357542|FG000|Overall Study|Investigator's Discretion|0|||
125200606|NCT01938430|450357543|FG001|Overall Study|Investigator's Discretion|0|||
124869708|NCT01400503|449141765|FG000|Overall Study|Withdrawal by Subject|1|||
124869709|NCT01400503|449141765|FG000|Overall Study|Study Terminated by Sponsor|58|||
124869710|NCT01400503|449141765|FG000|Overall Study|Other|1|||
124869711|NCT00058123|449141766|FG000|Overall Study|Wrong histology|9|||
124869712|NCT00058123|449141766|FG000|Overall Study|Received >3 prior treatments|1|||
124869713|NCT02925676|449141767|FG000|Overall Study|Withdrawal by Subject|1|||
124869714|NCT02151266|449141768|FG000|Overall Study|Lost to Follow-up|1|||
124869715|NCT02151266|449141769|FG001|Overall Study|Lost to Follow-up|4|||
124869716|NCT02151266|449141770|FG002|Overall Study|Lost to Follow-up|1|||
124869717|NCT02151266|449141768|FG000|Overall Study|Did NOT receive intervention|3|||
124869718|NCT02151266|449141769|FG001|Overall Study|Did NOT receive intervention|6|||
124869719|NCT02151266|449141770|FG002|Overall Study|Did NOT receive intervention|2|||
124869720|NCT02151266|449141768|FG000|Overall Study|Not able to exercise|4|||
124869721|NCT02151266|449141769|FG001|Overall Study|Not able to exercise|5|||
124869722|NCT02151266|449141770|FG002|Overall Study|Not able to exercise|4|||
124869723|NCT01169675|449141771|FG000|Overall Study|Progressive disease|13|||
124869724|NCT01169675|449141772|FG001|Overall Study|Progressive disease|2|||
124869725|NCT01169675|449141773|FG002|Overall Study|Progressive disease|5|||
124869726|NCT01169675|449141774|FG003|Overall Study|Progressive disease|15|||
124869727|NCT01169675|449141775|FG004|Overall Study|Progressive disease|1|||
124869728|NCT01169675|449141771|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
124869729|NCT01169675|449141772|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124869730|NCT01169675|449141773|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124869731|NCT01169675|449141774|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124869732|NCT01169675|449141775|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
124869733|NCT01169675|449141771|FG000|Overall Study|Adverse Event|5|||
124869734|NCT01169675|449141772|FG001|Overall Study|Adverse Event|1|||
124869735|NCT01169675|449141773|FG002|Overall Study|Adverse Event|2|||
124869736|NCT01169675|449141774|FG003|Overall Study|Adverse Event|0|||
124869737|NCT01169675|449141775|FG004|Overall Study|Adverse Event|0|||
124869738|NCT01169675|449141771|FG000|Overall Study|Withdrawal by Subject|1|||
124869739|NCT01169675|449141772|FG001|Overall Study|Withdrawal by Subject|0|||
124869740|NCT01169675|449141773|FG002|Overall Study|Withdrawal by Subject|0|||
124869741|NCT01169675|449141774|FG003|Overall Study|Withdrawal by Subject|1|||
124869742|NCT01169675|449141775|FG004|Overall Study|Withdrawal by Subject|2|||
124869743|NCT01169675|449141771|FG000|Overall Study|Other Reason Not Defined Above|0|||
124869744|NCT01169675|449141772|FG001|Overall Study|Other Reason Not Defined Above|0|||
124869745|NCT01169675|449141773|FG002|Overall Study|Other Reason Not Defined Above|0|||
124869746|NCT01169675|449141774|FG003|Overall Study|Other Reason Not Defined Above|1|||
124869747|NCT01169675|449141775|FG004|Overall Study|Other Reason Not Defined Above|1|||
124869748|NCT02365519|449141779|FG000|Randomized and Treated|Adverse Event|0|||
124869749|NCT02365519|449141780|FG001|Randomized and Treated|Adverse Event|1|||
124869750|NCT02365519|449141781|FG002|Randomized and Treated|Adverse Event|0|||
124869751|NCT02365519|449141779|FG000|Randomized and Treated|Withdrawal by Subject|0|||
124869752|NCT02365519|449141780|FG001|Randomized and Treated|Withdrawal by Subject|1|||
124869753|NCT02365519|449141781|FG002|Randomized and Treated|Withdrawal by Subject|1|||
124869754|NCT02291679|449141782|FG000|Overall Study|Adverse Event|2|||
124869755|NCT02291679|449141783|FG001|Overall Study|Adverse Event|12|||
124869756|NCT02291679|449141784|FG002|Overall Study|Adverse Event|19|||
124869757|NCT02291679|449141782|FG000|Overall Study|Protocol Violation|5|||
124869758|NCT02291679|449141783|FG001|Overall Study|Protocol Violation|1|||
124869759|NCT02291679|449141784|FG002|Overall Study|Protocol Violation|7|||
124869760|NCT02291679|449141782|FG000|Overall Study|Withdrew Consent|18|||
124869761|NCT02291679|449141783|FG001|Overall Study|Withdrew Consent|10|||
124869762|NCT02291679|449141784|FG002|Overall Study|Withdrew Consent|15|||
124869763|NCT02291679|449141782|FG000|Overall Study|Lost to Follow-up|12|||
124869764|NCT02291679|449141783|FG001|Overall Study|Lost to Follow-up|10|||
124869765|NCT02291679|449141784|FG002|Overall Study|Lost to Follow-up|9|||
124869766|NCT02291679|449141782|FG000|Overall Study|Insufficient Therapeutic Response|5|||
124869767|NCT02291679|449141783|FG001|Overall Study|Insufficient Therapeutic Response|5|||
124869768|NCT02291679|449141784|FG002|Overall Study|Insufficient Therapeutic Response|7|||
124869769|NCT02291679|449141782|FG000|Overall Study|Other|2|||
124869770|NCT02291679|449141783|FG001|Overall Study|Other|4|||
124869771|NCT02291679|449141784|FG002|Overall Study|Other|2|||
124869772|NCT02048072|449141785|FG000|Overall Study|Adverse Event|3|||
124869773|NCT02048072|449141785|FG000|Overall Study|Lost to Follow-up|1|||
125200607|NCT01938430|450357544|FG002|Overall Study|Investigator's Discretion|1|||
124869774|NCT00725296|449141787|FG000|Overall Study|Adverse Event|11|||
124869775|NCT00725296|449141787|FG000|Overall Study|Lack of Efficacy|7|||
124869776|NCT00725296|449141787|FG000|Overall Study|Withdrawal by Subject|3|||
124869777|NCT00725296|449141787|FG000|Overall Study|Non-Compliance|2|||
124869778|NCT00725296|449141787|FG000|Overall Study|Lost to Follow-up|1|||
124869779|NCT00725296|449141787|FG000|Overall Study|Other|38|||
124869780|NCT03657277|449141788|FG000|Overall Study|Physician Decision|2|||
124869781|NCT03657277|449141788|FG000|Overall Study|Lost to Follow-up|1|||
124869782|NCT03657277|449141788|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
124869783|NCT03360942|449141790|FG000|Overall Study|Device explanted|2|||
124869784|NCT03360942|449141790|FG000|Overall Study|Study closure|1|||
124869785|NCT03360942|449141790|FG000|Overall Study|Withdrawal by Subject|2|||
124869786|NCT00657618|449141795|FG000|Overall Study|Adverse Event|32|||
124869787|NCT00657618|449141795|FG000|Overall Study|Withdrawal by Subject|8|||
124869788|NCT00657618|449141795|FG000|Overall Study|negative for leishmaniasis|2|||
124869789|NCT00657618|449141795|FG000|Overall Study|didn't start due to schedule conflicts|1|||
124869790|NCT03703466|449141798|FG000|Overall Study|Death|2|||
124869791|NCT03703466|449141799|FG001|Overall Study|Death|1|||
124869792|NCT03703466|449141800|FG002|Overall Study|Death|0|||
124869793|NCT03703466|449141798|FG000|Overall Study|Withdrawal by Subject|0|||
124869794|NCT03703466|449141799|FG001|Overall Study|Withdrawal by Subject|3|||
124869795|NCT03703466|449141800|FG002|Overall Study|Withdrawal by Subject|0|||
124869796|NCT03703466|449141798|FG000|Overall Study|Completed < 3 Cycles|2|||
124869797|NCT03703466|449141799|FG001|Overall Study|Completed < 3 Cycles|2|||
124869798|NCT03703466|449141800|FG002|Overall Study|Completed < 3 Cycles|2|||
124869799|NCT05338333|449141801|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
124869800|NCT05338333|449141802|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
124869801|NCT05073133|449141806|FG000|Overall Study|Death|2|||
124869802|NCT03751631|449143558|FG000|Overall Study|Withdrawal by Subject|0|||
124869803|NCT03751631|449143559|FG001|Overall Study|Withdrawal by Subject|0|||
124869804|NCT03751631|449143560|FG002|Overall Study|Withdrawal by Subject|1|||
124869805|NCT03751631|449143561|FG003|Overall Study|Withdrawal by Subject|1|||
124869806|NCT03751631|449143562|FG004|Overall Study|Withdrawal by Subject|0|||
124869807|NCT03751631|449143563|FG005|Overall Study|Withdrawal by Subject|0|||
124869808|NCT00428090|449143564|FG000|Overall Study|Adverse Event|10|||
124869809|NCT00428090|449143565|FG001|Overall Study|Adverse Event|8|||
124869810|NCT00428090|449143566|FG002|Overall Study|Adverse Event|10|||
124869811|NCT00428090|449143567|FG003|Overall Study|Adverse Event|11|||
124869812|NCT00428090|449143564|FG000|Overall Study|Lost to Follow-up|3|||
124869813|NCT00428090|449143565|FG001|Overall Study|Lost to Follow-up|6|||
124869814|NCT00428090|449143566|FG002|Overall Study|Lost to Follow-up|1|||
124869815|NCT00428090|449143567|FG003|Overall Study|Lost to Follow-up|4|||
124869816|NCT00428090|449143564|FG000|Overall Study|Protocol Violation|3|||
124869817|NCT00428090|449143565|FG001|Overall Study|Protocol Violation|1|||
124869818|NCT00428090|449143566|FG002|Overall Study|Protocol Violation|3|||
124869819|NCT00428090|449143567|FG003|Overall Study|Protocol Violation|3|||
124869820|NCT00428090|449143564|FG000|Overall Study|Withdrawal by Subject|10|||
124869821|NCT00428090|449143565|FG001|Overall Study|Withdrawal by Subject|12|||
124869822|NCT00428090|449143566|FG002|Overall Study|Withdrawal by Subject|15|||
124869823|NCT00428090|449143567|FG003|Overall Study|Withdrawal by Subject|5|||
124869824|NCT00428090|449143564|FG000|Overall Study|Sponsor terminated study|0|||
124869825|NCT00428090|449143565|FG001|Overall Study|Sponsor terminated study|1|||
124869826|NCT00428090|449143566|FG002|Overall Study|Sponsor terminated study|0|||
124869827|NCT00428090|449143567|FG003|Overall Study|Sponsor terminated study|0|||
124869828|NCT00428090|449143564|FG000|Overall Study|Non-compliance|4|||
124869829|NCT00428090|449143565|FG001|Overall Study|Non-compliance|0|||
124869830|NCT00428090|449143566|FG002|Overall Study|Non-compliance|1|||
124869831|NCT00428090|449143567|FG003|Overall Study|Non-compliance|3|||
124869832|NCT00428090|449143564|FG000|Overall Study|Par. did not returned to visit|1|||
124869833|NCT00428090|449143565|FG001|Overall Study|Par. did not returned to visit|0|||
124869834|NCT00428090|449143566|FG002|Overall Study|Par. did not returned to visit|0|||
124869835|NCT00428090|449143567|FG003|Overall Study|Par. did not returned to visit|1|||
124869836|NCT00428090|449143564|FG000|Overall Study|Follow-Up visit not possible|1|||
124869837|NCT00428090|449143565|FG001|Overall Study|Follow-Up visit not possible|0|||
124869838|NCT00428090|449143566|FG002|Overall Study|Follow-Up visit not possible|0|||
124869839|NCT00428090|449143567|FG003|Overall Study|Follow-Up visit not possible|0|||
124869840|NCT00428090|449143564|FG000|Overall Study|Prohibited medication used for SAE|1|||
125200608|NCT01938430|450357545|FG003|Overall Study|Investigator's Discretion|0|||
125200609|NCT01938430|450357546|FG004|Overall Study|Investigator's Discretion|0|||
124869841|NCT00428090|449143565|FG001|Overall Study|Prohibited medication used for SAE|0|||
124869842|NCT00428090|449143566|FG002|Overall Study|Prohibited medication used for SAE|0|||
124869843|NCT00428090|449143567|FG003|Overall Study|Prohibited medication used for SAE|0|||
124869844|NCT00428090|449143564|FG000|Overall Study|Death of par.|1|||
124869845|NCT00428090|449143565|FG001|Overall Study|Death of par.|0|||
124869846|NCT00428090|449143566|FG002|Overall Study|Death of par.|1|||
124869847|NCT00428090|449143567|FG003|Overall Study|Death of par.|0|||
124869848|NCT00428090|449143564|FG000|Overall Study|Visit 7 exceed the visit window|0|||
124869849|NCT00428090|449143565|FG001|Overall Study|Visit 7 exceed the visit window|1|||
124869850|NCT00428090|449143566|FG002|Overall Study|Visit 7 exceed the visit window|0|||
125200610|NCT01938430|450357547|FG005|Overall Study|Investigator's Discretion|0|||
124869851|NCT00428090|449143567|FG003|Overall Study|Visit 7 exceed the visit window|0|||
124869852|NCT00428090|449143564|FG000|Overall Study|Medical monitor terminated par.|0|||
124869853|NCT00428090|449143565|FG001|Overall Study|Medical monitor terminated par.|1|||
124869854|NCT00428090|449143566|FG002|Overall Study|Medical monitor terminated par.|0|||
124869855|NCT00428090|449143567|FG003|Overall Study|Medical monitor terminated par.|0|||
124869856|NCT00428090|449143564|FG000|Overall Study|Mental status of par. was|0|||
124869857|NCT00428090|449143565|FG001|Overall Study|Mental status of par. was|1|||
124869858|NCT00428090|449143566|FG002|Overall Study|Mental status of par. was|0|||
124869859|NCT00428090|449143567|FG003|Overall Study|Mental status of par. was|0|||
124869860|NCT00428090|449143564|FG000|Overall Study|Worsening of AD|0|||
124869861|NCT00428090|449143565|FG001|Overall Study|Worsening of AD|0|||
124869862|NCT00428090|449143566|FG002|Overall Study|Worsening of AD|1|||
124869863|NCT00428090|449143567|FG003|Overall Study|Worsening of AD|0|||
124869864|NCT00428090|449143564|FG000|Overall Study|Excluded for concerning QTc value|0|||
124869865|NCT00428090|449143565|FG001|Overall Study|Excluded for concerning QTc value|0|||
124869866|NCT00428090|449143566|FG002|Overall Study|Excluded for concerning QTc value|1|||
124869867|NCT00428090|449143567|FG003|Overall Study|Excluded for concerning QTc value|0|||
124869868|NCT00428090|449143564|FG000|Overall Study|Insufficient AD documentation|0|||
124869869|NCT00428090|449143565|FG001|Overall Study|Insufficient AD documentation|0|||
124869870|NCT00428090|449143566|FG002|Overall Study|Insufficient AD documentation|1|||
124869871|NCT00428090|449143567|FG003|Overall Study|Insufficient AD documentation|0|||
124869872|NCT00428090|449143564|FG000|Overall Study|High MMSE scores|0|||
124869873|NCT00428090|449143565|FG001|Overall Study|High MMSE scores|0|||
124869874|NCT00428090|449143566|FG002|Overall Study|High MMSE scores|1|||
124869875|NCT00428090|449143567|FG003|Overall Study|High MMSE scores|0|||
124869876|NCT00428090|449143564|FG000|Overall Study|Deterioration of cognitive status|0|||
124869877|NCT00428090|449143565|FG001|Overall Study|Deterioration of cognitive status|0|||
124869878|NCT00428090|449143566|FG002|Overall Study|Deterioration of cognitive status|1|||
124869879|NCT00428090|449143567|FG003|Overall Study|Deterioration of cognitive status|0|||
124869880|NCT00428090|449143564|FG000|Overall Study|Serious adverse event|0|||
124869881|NCT00428090|449143565|FG001|Overall Study|Serious adverse event|0|||
124869882|NCT00428090|449143566|FG002|Overall Study|Serious adverse event|1|||
124869883|NCT00428090|449143567|FG003|Overall Study|Serious adverse event|0|||
124869884|NCT00428090|449143564|FG000|Overall Study|Excluded for heart insufficiency|0|||
124869885|NCT00428090|449143565|FG001|Overall Study|Excluded for heart insufficiency|0|||
124869886|NCT00428090|449143566|FG002|Overall Study|Excluded for heart insufficiency|1|||
124869887|NCT00428090|449143567|FG003|Overall Study|Excluded for heart insufficiency|0|||
124869888|NCT00428090|449143564|FG000|Overall Study|Raised Creatinine Value|0|||
124869889|NCT00428090|449143565|FG001|Overall Study|Raised Creatinine Value|0|||
124869890|NCT00428090|449143566|FG002|Overall Study|Raised Creatinine Value|0|||
124869891|NCT00428090|449143567|FG003|Overall Study|Raised Creatinine Value|1|||
124869892|NCT03255824|449143568|FG000|Overall Study|Under-sedation|2|||
124869893|NCT03255824|449143569|FG001|Overall Study|Under-sedation|1|||
124869894|NCT00863655|449143572|FG000|Overall Study|Protocol Violation|4|||
124869895|NCT00863655|449143573|FG001|Overall Study|Protocol Violation|0|||
124869896|NCT00863655|449143572|FG000|Overall Study|Adverse Event|52|||
124869897|NCT00863655|449143573|FG001|Overall Study|Adverse Event|8|||
124869898|NCT00863655|449143572|FG000|Overall Study|Withdrawal by Subject|47|||
124869899|NCT00863655|449143573|FG001|Overall Study|Withdrawal by Subject|7|||
124869900|NCT00863655|449143572|FG000|Overall Study|Administrative problems|1|||
124869901|NCT00863655|449143573|FG001|Overall Study|Administrative problems|0|||
124869902|NCT00863655|449143572|FG000|Overall Study|Death|7|||
124869903|NCT00863655|449143573|FG001|Overall Study|Death|1|||
125200611|NCT01938430|450357548|FG006|Overall Study|Investigator's Discretion|0|||
125200612|NCT01938430|450357549|FG007|Overall Study|Investigator's Discretion|0|||
125200613|NCT01938430|450357550|FG008|Overall Study|Investigator's Discretion|0|||
125200614|NCT01938430|450357551|FG009|Overall Study|Investigator's Discretion|0|||
125200615|NCT01938430|450357552|FG010|Overall Study|Investigator's Discretion|0|||
125200616|NCT01938430|450357553|FG011|Overall Study|Investigator's Discretion|0|||
125200617|NCT01938430|450357554|FG012|Overall Study|Investigator's Discretion|0|||
125200618|NCT01938430|450357555|FG013|Overall Study|Investigator's Discretion|0|||
125200619|NCT01938430|450357542|FG000|Overall Study|Lack of Efficacy|3|||
125200620|NCT01938430|450357543|FG001|Overall Study|Lack of Efficacy|1|||
125200621|NCT01938430|450357544|FG002|Overall Study|Lack of Efficacy|1|||
125200622|NCT01938430|450357545|FG003|Overall Study|Lack of Efficacy|1|||
125200623|NCT01938430|450357546|FG004|Overall Study|Lack of Efficacy|0|||
125200624|NCT01938430|450357547|FG005|Overall Study|Lack of Efficacy|0|||
125200625|NCT01938430|450357548|FG006|Overall Study|Lack of Efficacy|0|||
125200626|NCT01938430|450357549|FG007|Overall Study|Lack of Efficacy|0|||
125200627|NCT01938430|450357550|FG008|Overall Study|Lack of Efficacy|1|||
125200628|NCT01938430|450357551|FG009|Overall Study|Lack of Efficacy|0|||
125200629|NCT01938430|450357552|FG010|Overall Study|Lack of Efficacy|2|||
124869904|NCT00863655|449143572|FG000|Overall Study|New cancer therapy|5|||
124869905|NCT00863655|449143573|FG001|Overall Study|New cancer therapy|1|||
124869906|NCT00863655|449143572|FG000|Overall Study|Disease progression|364|||
124869907|NCT00863655|449143573|FG001|Overall Study|Disease progression|221|||
125200630|NCT01938430|450357553|FG011|Overall Study|Lack of Efficacy|1|||
125200631|NCT01938430|450357554|FG012|Overall Study|Lack of Efficacy|0|||
125200632|NCT01938430|450357555|FG013|Overall Study|Lack of Efficacy|0|||
125200633|NCT01938430|450357542|FG000|Overall Study|Lost to Follow-up|0|||
125200634|NCT01938430|450357543|FG001|Overall Study|Lost to Follow-up|0|||
125200635|NCT01938430|450357544|FG002|Overall Study|Lost to Follow-up|1|||
125200636|NCT01938430|450357545|FG003|Overall Study|Lost to Follow-up|0|||
125200637|NCT01938430|450357546|FG004|Overall Study|Lost to Follow-up|0|||
125200638|NCT01938430|450357547|FG005|Overall Study|Lost to Follow-up|1|||
125200639|NCT01938430|450357548|FG006|Overall Study|Lost to Follow-up|0|||
125200640|NCT01938430|450357549|FG007|Overall Study|Lost to Follow-up|0|||
125200641|NCT01938430|450357550|FG008|Overall Study|Lost to Follow-up|0|||
125200642|NCT01938430|450357551|FG009|Overall Study|Lost to Follow-up|0|||
125200643|NCT01938430|450357552|FG010|Overall Study|Lost to Follow-up|0|||
125200644|NCT01938430|450357553|FG011|Overall Study|Lost to Follow-up|0|||
125200645|NCT01938430|450357554|FG012|Overall Study|Lost to Follow-up|0|||
125200646|NCT01938430|450357555|FG013|Overall Study|Lost to Follow-up|0|||
125200647|NCT01938430|450357542|FG000|Overall Study|Withdrew Consent|0|||
125200648|NCT01938430|450357543|FG001|Overall Study|Withdrew Consent|0|||
125200649|NCT01938430|450357544|FG002|Overall Study|Withdrew Consent|0|||
125200650|NCT01938430|450357545|FG003|Overall Study|Withdrew Consent|0|||
125200651|NCT01938430|450357546|FG004|Overall Study|Withdrew Consent|0|||
125200652|NCT01938430|450357547|FG005|Overall Study|Withdrew Consent|0|||
125200653|NCT01938430|450357548|FG006|Overall Study|Withdrew Consent|0|||
125200654|NCT01938430|450357549|FG007|Overall Study|Withdrew Consent|0|||
125200655|NCT01938430|450357550|FG008|Overall Study|Withdrew Consent|1|||
125200656|NCT01938430|450357551|FG009|Overall Study|Withdrew Consent|0|||
125200657|NCT01938430|450357552|FG010|Overall Study|Withdrew Consent|0|||
125200658|NCT01938430|450357553|FG011|Overall Study|Withdrew Consent|0|||
125200659|NCT01938430|450357554|FG012|Overall Study|Withdrew Consent|0|||
125200660|NCT01938430|450357555|FG013|Overall Study|Withdrew Consent|0|||
125200661|NCT03875482|450357556|FG000|Overall Study|Adverse Event|0|||
125200662|NCT03875482|450357557|FG001|Overall Study|Adverse Event|1|||
125200663|NCT03875482|450357556|FG000|Overall Study|Withdrew consent|5|||
125200664|NCT03875482|450357557|FG001|Overall Study|Withdrew consent|6|||
125200665|NCT03875482|450357556|FG000|Overall Study|Lost to Follow-up|8|||
125200666|NCT03875482|450357557|FG001|Overall Study|Lost to Follow-up|2|||
125200667|NCT03875482|450357556|FG000|Overall Study|Lack of Efficacy|0|||
125200668|NCT03875482|450357557|FG001|Overall Study|Lack of Efficacy|11|||
125200669|NCT02111785|450357559|FG000|Overall Study|Death|0|||
125200670|NCT02111785|450357560|FG001|Overall Study|Death|1|||
125200671|NCT02111785|450357561|FG002|Overall Study|Death|0|||
125200672|NCT02111785|450357562|FG003|Overall Study|Death|0|||
125200673|NCT02738879|450357569|FG000|Overall Study|Adverse Event|1|||
125200674|NCT02738879|450357570|FG001|Overall Study|Adverse Event|1|||
125200675|NCT02738879|450357569|FG000|Overall Study|Death|0|||
125200676|NCT02738879|450357570|FG001|Overall Study|Death|2|||
125200677|NCT02738879|450357569|FG000|Overall Study|Lost to Follow-up|1|||
125200678|NCT02738879|450357570|FG001|Overall Study|Lost to Follow-up|5|||
125200679|NCT02738879|450357569|FG000|Overall Study|Protocol Violation|1|||
125200680|NCT02738879|450357570|FG001|Overall Study|Protocol Violation|3|||
125200681|NCT02738879|450357569|FG000|Overall Study|Physician Decision|3|||
125200682|NCT02738879|450357570|FG001|Overall Study|Physician Decision|4|||
125200683|NCT02738879|450357569|FG000|Overall Study|Pregnancy|0|||
125200684|NCT02738879|450357570|FG001|Overall Study|Pregnancy|1|||
125200685|NCT02738879|450357569|FG000|Overall Study|Screen Failure|1|||
125200686|NCT02738879|450357570|FG001|Overall Study|Screen Failure|2|||
125200687|NCT02738879|450357569|FG000|Overall Study|Site Discontinued Study Participation|1|||
125200688|NCT02738879|450357570|FG001|Overall Study|Site Discontinued Study Participation|0|||
125200689|NCT02738879|450357569|FG000|Overall Study|Withdrawal by Subject|5|||
125200690|NCT02738879|450357570|FG001|Overall Study|Withdrawal by Subject|7|||
125200691|NCT01438294|450357571|FG000|Overall Study|Lost to Follow-up|3|||
125200692|NCT01438294|450357572|FG001|Overall Study|Lost to Follow-up|7|||
125200693|NCT01346189|450357575|FG000|Overall Study|Withdrawal by Subject|7|||
125200694|NCT01346189|450357576|FG001|Overall Study|Withdrawal by Subject|5|||
125200695|NCT01346189|450357577|FG002|Overall Study|Withdrawal by Subject|3|||
125200696|NCT01346189|450357578|FG003|Overall Study|Withdrawal by Subject|5|||
125200697|NCT01346189|450357575|FG000|Overall Study|Physician Decision|4|||
125200698|NCT01346189|450357576|FG001|Overall Study|Physician Decision|0|||
125200699|NCT01346189|450357577|FG002|Overall Study|Physician Decision|0|||
125200700|NCT01346189|450357578|FG003|Overall Study|Physician Decision|0|||
125200701|NCT01346189|450357575|FG000|Overall Study|Moved|3|||
125200702|NCT01346189|450357576|FG001|Overall Study|Moved|0|||
125200703|NCT01346189|450357577|FG002|Overall Study|Moved|4|||
125200704|NCT01346189|450357578|FG003|Overall Study|Moved|0|||
125200705|NCT01346189|450357575|FG000|Overall Study|Other|2|||
125200706|NCT01346189|450357576|FG001|Overall Study|Other|4|||
125200707|NCT01346189|450357577|FG002|Overall Study|Other|7|||
125200708|NCT01346189|450357578|FG003|Overall Study|Other|3|||
125200709|NCT01346189|450357575|FG000|Overall Study|Death|0|||
125200710|NCT01346189|450357576|FG001|Overall Study|Death|3|||
125200711|NCT01346189|450357577|FG002|Overall Study|Death|0|||
125200712|NCT01346189|450357578|FG003|Overall Study|Death|0|||
125200713|NCT01346189|450357575|FG000|Overall Study|Non-health system primary care physician|0|||
125200714|NCT01346189|450357576|FG001|Overall Study|Non-health system primary care physician|5|||
125200715|NCT01346189|450357577|FG002|Overall Study|Non-health system primary care physician|0|||
125200716|NCT01346189|450357578|FG003|Overall Study|Non-health system primary care physician|0|||
125200717|NCT01346189|450357575|FG000|Overall Study|Travel|0|||
125200718|NCT01346189|450357576|FG001|Overall Study|Travel|0|||
125200719|NCT01346189|450357577|FG002|Overall Study|Travel|0|||
125200720|NCT01346189|450357578|FG003|Overall Study|Travel|3|||
125200721|NCT01730534|450357585|FG000|Overall Study|Withdrawal by Subject|97|||
125200722|NCT01730534|450357586|FG001|Overall Study|Withdrawal by Subject|127|||
125200723|NCT01730534|450357585|FG000|Overall Study|Lost to Follow-up|12|||
125200724|NCT01730534|450357586|FG001|Overall Study|Lost to Follow-up|18|||
125200725|NCT01676896|450357587|FG000|Overall Study|Withdrawal by Subject|12|||
125200726|NCT01676896|450357588|FG001|Overall Study|Withdrawal by Subject|7|||
125200727|NCT01676896|450357589|FG002|Overall Study|Withdrawal by Subject|19|||
125200728|NCT02256982|450357590|FG000|Overall Study|Disease Progression|0|||
125200729|NCT02256982|450357591|FG001|Overall Study|Disease Progression|1|||
125200730|NCT00655733|450357595|FG000|Overall Study|Lost to Follow-up|2|||
125200731|NCT00655733|450357596|FG001|Overall Study|Lost to Follow-up|2|||
125200732|NCT00655733|450357595|FG000|Overall Study|Adverse Event|2|||
125200733|NCT00655733|450357596|FG001|Overall Study|Adverse Event|2|||
125200734|NCT00655733|450357595|FG000|Overall Study|Withdrawal by Subject|3|||
125200735|NCT00655733|450357596|FG001|Overall Study|Withdrawal by Subject|3|||
125200736|NCT00655733|450357595|FG000|Overall Study|Physician Decision|0|||
125200737|NCT00655733|450357596|FG001|Overall Study|Physician Decision|1|||
125200738|NCT02658734|450357597|FG000|Overall Study|Adverse Event|2|||
125200739|NCT02658734|450357597|FG000|Overall Study|Death|4|||
125200740|NCT02658734|450357597|FG000|Overall Study|Lost to Follow-up|7|||
125200741|NCT02658734|450357597|FG000|Overall Study|Withdrawal of Consent|16|||
125200742|NCT02658734|450357597|FG000|Overall Study|Disease Progression|28|||
125200743|NCT00459706|450357598|FG000|Overall Study|Adverse Event|19|||
125200744|NCT00459706|450357599|FG001|Overall Study|Adverse Event|13|||
125200745|NCT00459706|450357598|FG000|Overall Study|Withdrawal by Subject|1|||
125200746|NCT00459706|450357599|FG001|Overall Study|Withdrawal by Subject|6|||
125200747|NCT00459706|450357598|FG000|Overall Study|Physician Decision|2|||
125200748|NCT00459706|450357599|FG001|Overall Study|Physician Decision|0|||
125200749|NCT00459706|450357598|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
125200750|NCT00459706|450357599|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
125200751|NCT00459706|450357598|FG000|Overall Study|Protocol Violation|2|||
125200752|NCT00459706|450357599|FG001|Overall Study|Protocol Violation|1|||
125200753|NCT00459706|450357598|FG000|Overall Study|Failed to Return|1|||
125200754|NCT00459706|450357599|FG001|Overall Study|Failed to Return|0|||
125200755|NCT00459706|450357598|FG000|Overall Study|Other|0|||
125200756|NCT00459706|450357599|FG001|Overall Study|Other|1|||
125200757|NCT02447497|450357600|FG000|Overall Study|Did not meet treatment day baseline.|6|||
125200758|NCT02447497|450357601|FG001|Overall Study|Did not meet treatment day baseline.|5|||
125200759|NCT02447497|450357602|FG002|Overall Study|Did not meet treatment day baseline.|2|||
125200760|NCT02447497|450357603|FG003|Overall Study|Did not meet treatment day baseline.|2|||
125200761|NCT02447497|450357600|FG000|Overall Study|Dressing was compromised|0|||
125200762|NCT02447497|450357601|FG001|Overall Study|Dressing was compromised|1|||
125200763|NCT02447497|450357602|FG002|Overall Study|Dressing was compromised|0|||
125200764|NCT02447497|450357603|FG003|Overall Study|Dressing was compromised|0|||
125200765|NCT01322035|450357604|FG000|Overall Study|Lost to Follow-up|8|||
125200766|NCT01322035|450357605|FG001|Overall Study|Lost to Follow-up|3|||
125200767|NCT00732758|450357606|FG000|Overall Study|Lost to Follow-up|8|||
125200768|NCT00732758|450357607|FG001|Overall Study|Lost to Follow-up|16|||
125200769|NCT04240457|450357610|FG000|Overall Study|Lost to Follow-up|5|||
125200770|NCT04240457|450357611|FG001|Overall Study|Lost to Follow-up|1|||
125200771|NCT01252563|450357613|FG000|Overall Study|Contract Deviation|41|||
125200772|NCT01252563|450357613|FG000|Overall Study|Centralized Registration Deviation|30|||
125200773|NCT01252563|450357613|FG000|Overall Study|Lost to Follow-up|161|||
125200774|NCT01252563|450357613|FG000|Overall Study|No visit after first day of treatment|194|||
125200775|NCT01252563|450357613|FG000|Overall Study|No drug administration|6|||
125200776|NCT01880086|450357614|FG000|Overall Study|Lost to Follow-up|1|||
125200777|NCT01880086|450357615|FG001|Overall Study|Lost to Follow-up|1|||
125200778|NCT03843632|450357621|FG000|Overall Study|Withdrawal by Subject|1|||
125200779|NCT03843632|450357622|FG001|Overall Study|Withdrawal by Subject|0|||
125200780|NCT03843632|450357623|FG002|Overall Study|Withdrawal by Subject|0|||
125200781|NCT03843632|450357624|FG003|Overall Study|Withdrawal by Subject|0|||
125200782|NCT01820572|450357626|FG000|Randomization|Not Treated|2|||
125200783|NCT01820572|450357627|FG001|Randomization|Not Treated|1|||
125200784|NCT01820572|450357626|FG000|Treatment Period|Adverse Event|12|||
125200785|NCT01820572|450357627|FG001|Treatment Period|Adverse Event|7|||
125200786|NCT01820572|450357626|FG000|Treatment Period|Death|3|||
125200787|NCT01820572|450357627|FG001|Treatment Period|Death|3|||
125200788|NCT01820572|450357626|FG000|Treatment Period|Lack of Efficacy|1|||
125200789|NCT01820572|450357627|FG001|Treatment Period|Lack of Efficacy|0|||
125200790|NCT01820572|450357626|FG000|Treatment Period|poor/non compliance|0|||
125200791|NCT01820572|450357627|FG001|Treatment Period|poor/non compliance|3|||
125200792|NCT01820572|450357626|FG000|Treatment Period|request to discontinue|6|||
125200793|NCT01820572|450357627|FG001|Treatment Period|request to discontinue|11|||
125200794|NCT01820572|450357626|FG000|Treatment Period|No longer meets study criteria|3|||
125200795|NCT01820572|450357627|FG001|Treatment Period|No longer meets study criteria|10|||
125200796|NCT01820572|450357626|FG000|Treatment Period|withdrew consent|1|||
125200797|NCT01820572|450357627|FG001|Treatment Period|withdrew consent|2|||
125200798|NCT05036668|450357631|FG000|Overall Study|lost to follow Up|0|||
125200799|NCT05036668|450357632|FG001|Overall Study|lost to follow Up|0|||
125200800|NCT05036668|450357633|FG002|Overall Study|lost to follow Up|1|||
125200801|NCT00387010|450357634|FG000|Dose Titration Period|Adverse Event|12|||
125200802|NCT00387010|450357634|FG000|Dose Titration Period|Lack of Efficacy|5|||
125200803|NCT00387010|450357634|FG000|Dose Titration Period|Withdrawal by Subject|3|||
125200804|NCT00387010|450357634|FG000|Dose Titration Period|Protocol Violation|1|||
125200805|NCT00387010|450357634|FG000|Dose Titration Period|Lost to Follow-up|2|||
125200806|NCT00387010|450357634|FG000|Dose Titration Period|Noncompliance with study medication|8|||
125200807|NCT00387010|450357634|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
125200808|NCT00387010|450357634|FG000|Treatment Period|Adverse Event|4|||
125200809|NCT00387010|450357634|FG000|Treatment Period|Withdrawal by Subject|1|||
125200810|NCT00387010|450357634|FG000|Treatment Period|Noncompliance with study medication|2|||
125200811|NCT00387010|450357634|FG000|Treatment Period|Noncompliance with study procedures|3|||
125200812|NCT00387010|450357634|FG000|Treatment Period|Participant reported study drug stolen|1|||
125200813|NCT00520481|450357635|FG000|Overall Study|Adverse Event|4|||
125200814|NCT00520481|450357636|FG001|Overall Study|Adverse Event|1|||
125200815|NCT00520481|450357635|FG000|Overall Study|Withdrawal by Subject|3|||
125200816|NCT00520481|450357636|FG001|Overall Study|Withdrawal by Subject|0|||
125200817|NCT01190267|450357641|FG000|Overall Study|Adverse Event|10|||
125200818|NCT01190267|450357642|FG001|Overall Study|Adverse Event|0|||
125200819|NCT01190267|450357641|FG000|Overall Study|Treatment Failure|8|||
125200820|NCT01190267|450357642|FG001|Overall Study|Treatment Failure|2|||
125200821|NCT01190267|450357641|FG000|Overall Study|Lost to Follow-up|2|||
125200822|NCT01190267|450357642|FG001|Overall Study|Lost to Follow-up|0|||
125200823|NCT01190267|450357641|FG000|Overall Study|Withdrawal by Subject|13|||
125200824|NCT01190267|450357642|FG001|Overall Study|Withdrawal by Subject|1|||
125200825|NCT01190267|450357641|FG000|Overall Study|Protocol Violation|8|||
125200826|NCT01190267|450357642|FG001|Overall Study|Protocol Violation|1|||
125200827|NCT01931956|450357643|FG000|Overall Study|Death|42|||
125200828|NCT01931956|450357644|FG001|Overall Study|Death|7|||
125200829|NCT01931956|450357645|FG002|Overall Study|Death|379|||
125200830|NCT01931956|450357646|FG003|Overall Study|Death|96|||
125200831|NCT01931956|450357643|FG000|Overall Study|Withdrawal by Subject|5|||
125200832|NCT01931956|450357644|FG001|Overall Study|Withdrawal by Subject|0|||
125200833|NCT01931956|450357645|FG002|Overall Study|Withdrawal by Subject|70|||
125200834|NCT01931956|450357646|FG003|Overall Study|Withdrawal by Subject|30|||
125200835|NCT01931956|450357643|FG000|Overall Study|Lost to Follow-up|2|||
125200836|NCT01931956|450357644|FG001|Overall Study|Lost to Follow-up|0|||
125200837|NCT01931956|450357645|FG002|Overall Study|Lost to Follow-up|11|||
125200838|NCT01931956|450357646|FG003|Overall Study|Lost to Follow-up|7|||
125200839|NCT01931956|450357643|FG000|Overall Study|Expected|2|||
125200840|NCT01931956|450357644|FG001|Overall Study|Expected|0|||
125200841|NCT01931956|450357645|FG002|Overall Study|Expected|6|||
125200842|NCT01931956|450357646|FG003|Overall Study|Expected|0|||
125200843|NCT01931956|450357643|FG000|Overall Study|Not due|0|||
125200844|NCT01931956|450357644|FG001|Overall Study|Not due|0|||
125200845|NCT01931956|450357645|FG002|Overall Study|Not due|21|||
125200846|NCT01931956|450357646|FG003|Overall Study|Not due|0|||
125200847|NCT02847494|450357647|FG000|Overall Study|Lost to Follow-up|8|||
125200848|NCT02847494|450357648|FG001|Overall Study|Lost to Follow-up|5|||
125200849|NCT02841280|450357651|FG000|Overall Study|Adverse Event|2|||
125200850|NCT02841280|450357652|FG001|Overall Study|Adverse Event|1|||
125200851|NCT02841280|450357651|FG000|Overall Study|Death|1|||
125200852|NCT02841280|450357652|FG001|Overall Study|Death|0|||
125200853|NCT02841280|450357651|FG000|Overall Study|Lost to Follow-up|2|||
125200854|NCT02841280|450357652|FG001|Overall Study|Lost to Follow-up|2|||
125200855|NCT02841280|450357651|FG000|Overall Study|Withdrawal by Subject|7|||
125200856|NCT02841280|450357652|FG001|Overall Study|Withdrawal by Subject|3|||
125200857|NCT02841280|450357651|FG000|Overall Study|Stop Point: BP above threshold|2|||
125200858|NCT02841280|450357652|FG001|Overall Study|Stop Point: BP above threshold|0|||
125200859|NCT01738503|450357653|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
125200860|NCT01738503|450357654|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
125200861|NCT01738503|450357655|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
125200862|NCT01738503|450357656|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
125200863|NCT01738503|450357657|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
125200864|NCT01738503|450357658|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
125200865|NCT01738503|450357659|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
125200866|NCT01738503|450357653|FG000|Treatment Period|Adverse Event|0|||
125200867|NCT01738503|450357654|FG001|Treatment Period|Adverse Event|1|||
125200868|NCT01738503|450357655|FG002|Treatment Period|Adverse Event|0|||
125200869|NCT01738503|450357656|FG003|Treatment Period|Adverse Event|1|||
125200870|NCT01738503|450357657|FG004|Treatment Period|Adverse Event|2|||
125200871|NCT01738503|450357658|FG005|Treatment Period|Adverse Event|2|||
125200872|NCT01738503|450357659|FG006|Treatment Period|Adverse Event|2|||
125200873|NCT01738503|450357653|FG000|Treatment Period|Lost to Follow-up|0|||
125200874|NCT01738503|450357654|FG001|Treatment Period|Lost to Follow-up|0|||
125200875|NCT01738503|450357655|FG002|Treatment Period|Lost to Follow-up|3|||
125200876|NCT01738503|450357656|FG003|Treatment Period|Lost to Follow-up|4|||
125200877|NCT01738503|450357657|FG004|Treatment Period|Lost to Follow-up|1|||
125200878|NCT01738503|450357658|FG005|Treatment Period|Lost to Follow-up|1|||
125200879|NCT01738503|450357659|FG006|Treatment Period|Lost to Follow-up|5|||
125200880|NCT01738503|450357653|FG000|Treatment Period|Withdrawal by Subject|0|||
125200881|NCT01738503|450357654|FG001|Treatment Period|Withdrawal by Subject|1|||
125200882|NCT01738503|450357655|FG002|Treatment Period|Withdrawal by Subject|0|||
125200883|NCT01738503|450357656|FG003|Treatment Period|Withdrawal by Subject|1|||
125200884|NCT01738503|450357657|FG004|Treatment Period|Withdrawal by Subject|1|||
125200885|NCT01738503|450357658|FG005|Treatment Period|Withdrawal by Subject|1|||
125200886|NCT01738503|450357659|FG006|Treatment Period|Withdrawal by Subject|1|||
125200887|NCT01738503|450357653|FG000|Treatment Period|Protocol Violation|0|||
125200888|NCT01738503|450357654|FG001|Treatment Period|Protocol Violation|3|||
125200889|NCT01738503|450357655|FG002|Treatment Period|Protocol Violation|1|||
125200890|NCT01738503|450357656|FG003|Treatment Period|Protocol Violation|0|||
125200891|NCT01738503|450357657|FG004|Treatment Period|Protocol Violation|4|||
125200892|NCT01738503|450357658|FG005|Treatment Period|Protocol Violation|2|||
125200893|NCT01738503|450357659|FG006|Treatment Period|Protocol Violation|0|||
125200894|NCT01738503|450357653|FG000|Treatment Period|Other|0|||
125200895|NCT01738503|450357654|FG001|Treatment Period|Other|0|||
125200896|NCT01738503|450357655|FG002|Treatment Period|Other|1|||
125200897|NCT01738503|450357656|FG003|Treatment Period|Other|0|||
125200898|NCT01738503|450357657|FG004|Treatment Period|Other|0|||
125200899|NCT01738503|450357658|FG005|Treatment Period|Other|0|||
125200900|NCT01738503|450357659|FG006|Treatment Period|Other|0|||
125200901|NCT01738503|450357653|FG000|PET Imaging Sub-study|Adverse Event|0|||
125200902|NCT01738503|450357654|FG001|PET Imaging Sub-study|Adverse Event|0|||
125200903|NCT01738503|450357655|FG002|PET Imaging Sub-study|Adverse Event|0|||
125200904|NCT01738503|450357656|FG003|PET Imaging Sub-study|Adverse Event|0|||
125200905|NCT01738503|450357657|FG004|PET Imaging Sub-study|Adverse Event|0|||
125200906|NCT01738503|450357658|FG005|PET Imaging Sub-study|Adverse Event|1|||
125200907|NCT01738503|450357659|FG006|PET Imaging Sub-study|Adverse Event|0|||
125200908|NCT01738503|450357653|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
125200909|NCT01738503|450357654|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
125200910|NCT01738503|450357655|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
125200911|NCT01738503|450357656|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
125200912|NCT01738503|450357657|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
125200913|NCT01738503|450357658|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
125200914|NCT01738503|450357659|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
125200915|NCT03005327|450357660|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
125200916|NCT03005327|450357661|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
125200917|NCT03005327|450357662|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
125200918|NCT03005327|450357663|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
125200919|NCT03005327|450357660|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125200920|NCT03005327|450357661|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
125200921|NCT03005327|450357662|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125200922|NCT03005327|450357663|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125200923|NCT02496091|450357667|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
125200924|NCT02272842|450357668|FG000|Overall Study|Lost to Follow-up|8|||
125200925|NCT02272842|450357669|FG001|Overall Study|Lost to Follow-up|8|||
125200926|NCT02272842|450357668|FG000|Overall Study|Withdrawal by Subject|8|||
125200927|NCT02272842|450357669|FG001|Overall Study|Withdrawal by Subject|2|||
125200928|NCT01493284|450357671|FG000|Overall Study|Death|29|||
125200929|NCT01493284|450357671|FG000|Overall Study|Withdrawal by Subject|32|||
125200930|NCT00519428|450357672|FG000|Overall Study|Adverse Event|5|||
125200931|NCT00519428|450357673|FG001|Overall Study|Adverse Event|2|||
125200932|NCT00519428|450357674|FG002|Overall Study|Adverse Event|10|||
125200933|NCT00519428|450357672|FG000|Overall Study|Lost to Follow-up|7|||
125200934|NCT00519428|450357673|FG001|Overall Study|Lost to Follow-up|7|||
125200935|NCT00519428|450357674|FG002|Overall Study|Lost to Follow-up|6|||
125200936|NCT00519428|450357672|FG000|Overall Study|Withdrawal by Subject|8|||
125200937|NCT00519428|450357673|FG001|Overall Study|Withdrawal by Subject|3|||
125200938|NCT00519428|450357674|FG002|Overall Study|Withdrawal by Subject|7|||
125200939|NCT00519428|450357672|FG000|Overall Study|unstated|1|||
125200940|NCT00519428|450357673|FG001|Overall Study|unstated|3|||
125200941|NCT00519428|450357674|FG002|Overall Study|unstated|2|||
125200942|NCT00325156|450357675|FG000|Overall Study|Protocol Violation|8|||
125200943|NCT00325156|450357675|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
125200944|NCT00325156|450357675|FG000|Overall Study|Migrated/moved from study area|12|||
125200945|NCT00325156|450357675|FG000|Overall Study|Adverse event, non-fatal|3|||
125200946|NCT00325156|450357675|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
125200947|NCT00325156|450357675|FG000|Overall Study|Other|1|||
125200948|NCT00325156|450357675|FG000|Overall Study|Withdrawal by Subject|31|||
125200949|NCT03626363|450357676|FG000|Overall Study|Protocol Violation|4|||
125200950|NCT03626363|450357677|FG001|Overall Study|Protocol Violation|0|||
125200951|NCT03626363|450357676|FG000|Overall Study|Lost to Follow-up|5|||
125200952|NCT03626363|450357677|FG001|Overall Study|Lost to Follow-up|7|||
125200953|NCT00533702|450357680|FG000|Overall Study|Withdrawal by Subject|3|||
125200954|NCT00533702|450357681|FG001|Overall Study|Withdrawal by Subject|1|||
125200955|NCT00533702|450357680|FG000|Overall Study|Found ineligible after randomization|2|||
125200956|NCT00533702|450357681|FG001|Overall Study|Found ineligible after randomization|1|||
125200957|NCT03053063|450357684|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
125200958|NCT03053063|450357685|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
125200959|NCT03053063|450357686|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
125200960|NCT03053063|450357687|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
125200961|NCT03053063|450357684|FG000|Randomized Phase|Withdrew consent|8|||
125200962|NCT03053063|450357685|FG001|Randomized Phase|Withdrew consent|11|||
125200963|NCT03053063|450357686|FG002|Randomized Phase|Withdrew consent|5|||
125200964|NCT03053063|450357687|FG003|Randomized Phase|Withdrew consent|0|||
125200965|NCT03053063|450357684|FG000|Randomized Phase|Investigator's Discretion|8|||
125200966|NCT03053063|450357685|FG001|Randomized Phase|Investigator's Discretion|6|||
125200967|NCT03053063|450357686|FG002|Randomized Phase|Investigator's Discretion|2|||
125200968|NCT03053063|450357687|FG003|Randomized Phase|Investigator's Discretion|0|||
125200969|NCT03053063|450357684|FG000|Randomized Phase|Lost to Follow-up|3|||
125200970|NCT03053063|450357685|FG001|Randomized Phase|Lost to Follow-up|5|||
125200971|NCT03053063|450357686|FG002|Randomized Phase|Lost to Follow-up|1|||
125200972|NCT03053063|450357687|FG003|Randomized Phase|Lost to Follow-up|0|||
125200973|NCT03053063|450357684|FG000|Randomized Phase|Adverse Event|0|||
125200974|NCT03053063|450357685|FG001|Randomized Phase|Adverse Event|1|||
125200975|NCT03053063|450357686|FG002|Randomized Phase|Adverse Event|0|||
125200976|NCT03053063|450357687|FG003|Randomized Phase|Adverse Event|0|||
125200977|NCT03053063|450357684|FG000|Randomized Phase|Randomized but Never Treated|1|||
125200978|NCT03053063|450357685|FG001|Randomized Phase|Randomized but Never Treated|3|||
125200979|NCT03053063|450357686|FG002|Randomized Phase|Randomized but Never Treated|2|||
125200980|NCT03053063|450357687|FG003|Randomized Phase|Randomized but Never Treated|0|||
125200981|NCT03053063|450357684|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
125200982|NCT03053063|450357685|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
125200983|NCT03053063|450357686|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
125200984|NCT03053063|450357687|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
125200985|NCT03053063|450357684|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
125200986|NCT03053063|450357685|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
125200987|NCT03053063|450357686|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
125200988|NCT03053063|450357687|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
125200989|NCT03053063|450357684|FG000|Open-Label Phase|Death|0|||
125200990|NCT03053063|450357685|FG001|Open-Label Phase|Death|0|||
125200991|NCT03053063|450357686|FG002|Open-Label Phase|Death|0|||
125200992|NCT03053063|450357687|FG003|Open-Label Phase|Death|2|||
125200993|NCT03053063|450357684|FG000|Open-Label Phase|Investigator's discretion|0|||
125200994|NCT03053063|450357685|FG001|Open-Label Phase|Investigator's discretion|0|||
125200995|NCT03053063|450357686|FG002|Open-Label Phase|Investigator's discretion|0|||
125200996|NCT03053063|450357687|FG003|Open-Label Phase|Investigator's discretion|2|||
125200997|NCT02600845|450357688|FG000|Overall Study|Reason Not Specified|3|||
125200998|NCT02600845|450357688|FG000|Overall Study|Non-compliance with Study Procedures|10|||
125200999|NCT02600845|450357688|FG000|Overall Study|Consent Withdrawal|5|||
125201000|NCT02100670|450357691|FG000|Overall Study|Adverse Event|10|||
125201001|NCT02100670|450357692|FG001|Overall Study|Adverse Event|3|||
125201002|NCT02100670|450357693|FG002|Overall Study|Adverse Event|3|||
125201003|NCT02100670|450357694|FG003|Overall Study|Adverse Event|0|||
125201004|NCT02100670|450357691|FG000|Overall Study|Lost to Follow-up|1|||
125201005|NCT02100670|450357692|FG001|Overall Study|Lost to Follow-up|0|||
125201006|NCT02100670|450357693|FG002|Overall Study|Lost to Follow-up|0|||
125201007|NCT02100670|450357694|FG003|Overall Study|Lost to Follow-up|0|||
125201008|NCT02100670|450357691|FG000|Overall Study|Protocol Violation|0|||
125201009|NCT02100670|450357692|FG001|Overall Study|Protocol Violation|1|||
125201010|NCT02100670|450357693|FG002|Overall Study|Protocol Violation|0|||
125201011|NCT02100670|450357694|FG003|Overall Study|Protocol Violation|1|||
125201012|NCT02100670|450357691|FG000|Overall Study|Withdrawal of Consent|0|||
125201013|NCT02100670|450357692|FG001|Overall Study|Withdrawal of Consent|1|||
125201014|NCT02100670|450357693|FG002|Overall Study|Withdrawal of Consent|1|||
125201015|NCT02100670|450357694|FG003|Overall Study|Withdrawal of Consent|0|||
125201016|NCT02100670|450357691|FG000|Overall Study|No swelling no pain|1|||
125201017|NCT02100670|450357692|FG001|Overall Study|No swelling no pain|0|||
125201018|NCT02100670|450357693|FG002|Overall Study|No swelling no pain|0|||
125201019|NCT02100670|450357694|FG003|Overall Study|No swelling no pain|0|||
125201020|NCT02100670|450357691|FG000|Overall Study|Poor Efficacy|0|||
125201021|NCT02100670|450357692|FG001|Overall Study|Poor Efficacy|1|||
125201022|NCT02100670|450357693|FG002|Overall Study|Poor Efficacy|0|||
125201023|NCT02100670|450357694|FG003|Overall Study|Poor Efficacy|0|||
125201024|NCT02100670|450357691|FG000|Overall Study|Physician Decision|0|||
125201025|NCT02100670|450357692|FG001|Overall Study|Physician Decision|1|||
125201026|NCT02100670|450357693|FG002|Overall Study|Physician Decision|0|||
125201027|NCT02100670|450357694|FG003|Overall Study|Physician Decision|0|||
125201028|NCT02100670|450357691|FG000|Overall Study|Withdrawal by Subject|1|||
125201029|NCT02100670|450357692|FG001|Overall Study|Withdrawal by Subject|0|||
125201030|NCT02100670|450357693|FG002|Overall Study|Withdrawal by Subject|0|||
125201031|NCT02100670|450357694|FG003|Overall Study|Withdrawal by Subject|0|||
125201032|NCT04852679|450357695|FG000|Main Intervention Period|Withdrawal by Subject|3|||
125201033|NCT04852679|450357695|FG000|Main Intervention Period|Adverse Event|1|||
125201034|NCT04852679|450357695|FG000|Main Intervention Period|Progressive Disease|16|||
125201035|NCT04852679|450357695|FG000|Main Intervention Period|Refused study visit|1|||
125201036|NCT04852679|450357695|FG000|Independent Injection Period|Missed study visit|1|||
125201037|NCT01294696|450357696|FG000|Overall Study|Screening failures|7|||
125201038|NCT01294696|450357696|FG000|Overall Study|Protocol Violation|8|||
125201039|NCT01294696|450357696|FG000|Overall Study|Missing BPI Response|7|||
125201040|NCT01294696|450357696|FG000|Overall Study|Site closure|52|||
125201041|NCT03339726|450359577|FG000|Overall Study|Withdrawal by Subject|1|||
125201042|NCT03339726|450359578|FG001|Overall Study|Withdrawal by Subject|0|||
125201043|NCT03339726|450359579|FG002|Overall Study|Withdrawal by Subject|0|||
125201044|NCT03339726|450359577|FG000|Overall Study|Lost to Follow-up|0|||
125201045|NCT03339726|450359578|FG001|Overall Study|Lost to Follow-up|1|||
125201046|NCT03339726|450359579|FG002|Overall Study|Lost to Follow-up|0|||
125201047|NCT01275755|450359580|FG000|Double-blind Treatment Period|Adverse Event|0|||
125201048|NCT01275755|450359581|FG001|Double-blind Treatment Period|Adverse Event|2|||
125201049|NCT01275755|450359580|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
125201050|NCT01275755|450359581|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
125201051|NCT01275755|450359580|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
125201052|NCT01275755|450359581|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
125201053|NCT01275755|450359580|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
125201054|NCT01275755|450359581|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
125201055|NCT00636194|450359587|FG000|Overall Study|Study related symptoms and complaints|1|||
125201056|NCT00636194|450359588|FG001|Overall Study|Study related symptoms and complaints|0|||
125201057|NCT00636194|450359587|FG000|Overall Study|Protocol Violation|2|||
125201058|NCT00636194|450359588|FG001|Overall Study|Protocol Violation|0|||
125201059|NCT04934189|450359593|FG000|Overall Study|Lost to Follow-up|4|||
125201060|NCT04934189|450359593|FG000|Overall Study|Withdrawal by Subject|17|||
125201061|NCT03962790|450359594|FG000|Period 1|Adverse Event|0|||
125201062|NCT03962790|450359595|FG001|Period 1|Adverse Event|1|||
125201063|NCT03962790|450359594|FG000|Period 1|Failed to meet all eligibility criteria|1|||
125201064|NCT03962790|450359595|FG001|Period 1|Failed to meet all eligibility criteria|1|||
125201065|NCT03962790|450359594|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
125201066|NCT03962790|450359595|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
125201067|NCT03962790|450359594|FG000|Period 1|Withdrawal by Subject|1|||
125201068|NCT03962790|450359595|FG001|Period 1|Withdrawal by Subject|0|||
125201069|NCT01286168|450359597|FG000|Overall Study|Withdrawal by Subject|1|||
125201070|NCT01286168|450359597|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
125201071|NCT04598451|450359598|FG000|Overall Study|Adverse Event|3|||
125201072|NCT04598451|450359599|FG001|Overall Study|Adverse Event|2|||
125201073|NCT04598451|450359598|FG000|Overall Study|Withdrawal by Subject|3|||
125201074|NCT04598451|450359599|FG001|Overall Study|Withdrawal by Subject|7|||
125201075|NCT04598451|450359598|FG000|Overall Study|Lost to Follow-up|2|||
125201076|NCT04598451|450359599|FG001|Overall Study|Lost to Follow-up|0|||
125201077|NCT04598451|450359598|FG000|Overall Study|Physician Decision|4|||
125201078|NCT04598451|450359599|FG001|Overall Study|Physician Decision|1|||
125201079|NCT04598451|450359598|FG000|Overall Study|Requires Prohibited Medication|1|||
125201080|NCT04598451|450359599|FG001|Overall Study|Requires Prohibited Medication|0|||
125201081|NCT04598451|450359598|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
125201082|NCT04598451|450359599|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
125201083|NCT04594941|450359605|FG000|Overall Study|Other|0|||
125201084|NCT04594941|450359606|FG001|Overall Study|Other|3|||
125201085|NCT04594941|450359607|FG002|Overall Study|Other|1|||
125201086|NCT04594941|450359608|FG003|Overall Study|Other|0|||
125201087|NCT03535194|450359609|FG000|Induction Period|Adverse Event|2|||
125201088|NCT03535194|450359610|FG001|Induction Period|Adverse Event|2|||
125201089|NCT03535194|450359611|FG002|Induction Period|Adverse Event|1|||
125201090|NCT03535194|450359612|FG003|Induction Period|Adverse Event|3|||
125201091|NCT03535194|450359613|FG004|Induction Period|Adverse Event|0|||
125201092|NCT03535194|450359609|FG000|Induction Period|Death|0|||
125201093|NCT03535194|450359610|FG001|Induction Period|Death|1|||
125201094|NCT03535194|450359611|FG002|Induction Period|Death|0|||
125201095|NCT03535194|450359612|FG003|Induction Period|Death|0|||
125201096|NCT03535194|450359613|FG004|Induction Period|Death|0|||
125201097|NCT03535194|450359609|FG000|Induction Period|Lack of Efficacy|1|||
125201098|NCT03535194|450359610|FG001|Induction Period|Lack of Efficacy|3|||
125201099|NCT03535194|450359611|FG002|Induction Period|Lack of Efficacy|2|||
125201100|NCT03535194|450359612|FG003|Induction Period|Lack of Efficacy|2|||
125201101|NCT03535194|450359613|FG004|Induction Period|Lack of Efficacy|0|||
125201102|NCT03535194|450359609|FG000|Induction Period|Lost to Follow-up|3|||
125201103|NCT03535194|450359610|FG001|Induction Period|Lost to Follow-up|5|||
125201104|NCT03535194|450359611|FG002|Induction Period|Lost to Follow-up|2|||
125201105|NCT03535194|450359612|FG003|Induction Period|Lost to Follow-up|3|||
125201106|NCT03535194|450359613|FG004|Induction Period|Lost to Follow-up|0|||
125201107|NCT03535194|450359609|FG000|Induction Period|Physician Decision|1|||
125201108|NCT03535194|450359610|FG001|Induction Period|Physician Decision|1|||
125201109|NCT03535194|450359611|FG002|Induction Period|Physician Decision|0|||
125201110|NCT03535194|450359612|FG003|Induction Period|Physician Decision|0|||
125201111|NCT03535194|450359613|FG004|Induction Period|Physician Decision|0|||
125201112|NCT03535194|450359609|FG000|Induction Period|Protocol Violation|1|||
125201113|NCT03535194|450359610|FG001|Induction Period|Protocol Violation|0|||
125201114|NCT03535194|450359611|FG002|Induction Period|Protocol Violation|0|||
125201115|NCT03535194|450359612|FG003|Induction Period|Protocol Violation|1|||
125201116|NCT03535194|450359613|FG004|Induction Period|Protocol Violation|0|||
125201117|NCT03535194|450359609|FG000|Induction Period|Screen Failure|0|||
125201118|NCT03535194|450359610|FG001|Induction Period|Screen Failure|1|||
125201119|NCT03535194|450359611|FG002|Induction Period|Screen Failure|0|||
125201120|NCT03535194|450359612|FG003|Induction Period|Screen Failure|0|||
125201121|NCT03535194|450359613|FG004|Induction Period|Screen Failure|0|||
125201122|NCT03535194|450359609|FG000|Induction Period|Withdrawal by Subject|3|||
125201123|NCT03535194|450359610|FG001|Induction Period|Withdrawal by Subject|4|||
125201124|NCT03535194|450359611|FG002|Induction Period|Withdrawal by Subject|3|||
125201125|NCT03535194|450359612|FG003|Induction Period|Withdrawal by Subject|2|||
125201126|NCT03535194|450359613|FG004|Induction Period|Withdrawal by Subject|0|||
125201127|NCT03535194|450359609|FG000|Maintenance Period|Adverse Event|6|||
125201128|NCT03535194|450359610|FG001|Maintenance Period|Adverse Event|5|||
125201129|NCT03535194|450359611|FG002|Maintenance Period|Adverse Event|1|||
125201130|NCT03535194|450359612|FG003|Maintenance Period|Adverse Event|11|||
125201131|NCT03535194|450359613|FG004|Maintenance Period|Adverse Event|4|||
125201132|NCT03535194|450359609|FG000|Maintenance Period|Lack of Efficacy|3|||
125201133|NCT03535194|450359610|FG001|Maintenance Period|Lack of Efficacy|2|||
125201134|NCT03535194|450359611|FG002|Maintenance Period|Lack of Efficacy|5|||
125201135|NCT03535194|450359612|FG003|Maintenance Period|Lack of Efficacy|9|||
125201136|NCT03535194|450359613|FG004|Maintenance Period|Lack of Efficacy|0|||
125201137|NCT03535194|450359609|FG000|Maintenance Period|Lost to Follow-up|4|||
125201138|NCT03535194|450359610|FG001|Maintenance Period|Lost to Follow-up|2|||
125201139|NCT03535194|450359611|FG002|Maintenance Period|Lost to Follow-up|1|||
125201140|NCT03535194|450359612|FG003|Maintenance Period|Lost to Follow-up|5|||
125201141|NCT03535194|450359613|FG004|Maintenance Period|Lost to Follow-up|2|||
125201142|NCT03535194|450359609|FG000|Maintenance Period|Other|1|||
125201143|NCT03535194|450359610|FG001|Maintenance Period|Other|2|||
125201144|NCT03535194|450359611|FG002|Maintenance Period|Other|0|||
125201145|NCT03535194|450359612|FG003|Maintenance Period|Other|0|||
125201146|NCT03535194|450359613|FG004|Maintenance Period|Other|0|||
125201147|NCT03535194|450359609|FG000|Maintenance Period|Physician Decision|1|||
125201148|NCT03535194|450359610|FG001|Maintenance Period|Physician Decision|2|||
125201149|NCT03535194|450359611|FG002|Maintenance Period|Physician Decision|0|||
125201150|NCT03535194|450359612|FG003|Maintenance Period|Physician Decision|2|||
125201151|NCT03535194|450359613|FG004|Maintenance Period|Physician Decision|0|||
125201152|NCT03535194|450359609|FG000|Maintenance Period|Pregnancy|0|||
125201153|NCT03535194|450359610|FG001|Maintenance Period|Pregnancy|0|||
125201154|NCT03535194|450359611|FG002|Maintenance Period|Pregnancy|0|||
125201155|NCT03535194|450359612|FG003|Maintenance Period|Pregnancy|2|||
125201156|NCT03535194|450359613|FG004|Maintenance Period|Pregnancy|0|||
125201157|NCT03535194|450359609|FG000|Maintenance Period|Protocol Violation|0|||
125201158|NCT03535194|450359610|FG001|Maintenance Period|Protocol Violation|1|||
125201159|NCT03535194|450359611|FG002|Maintenance Period|Protocol Violation|0|||
125201160|NCT03535194|450359612|FG003|Maintenance Period|Protocol Violation|0|||
125201161|NCT03535194|450359613|FG004|Maintenance Period|Protocol Violation|0|||
125201162|NCT03535194|450359609|FG000|Maintenance Period|Withdrawal by Subject|7|||
125201163|NCT03535194|450359610|FG001|Maintenance Period|Withdrawal by Subject|2|||
125201164|NCT03535194|450359611|FG002|Maintenance Period|Withdrawal by Subject|1|||
125201165|NCT03535194|450359612|FG003|Maintenance Period|Withdrawal by Subject|8|||
125201166|NCT03535194|450359613|FG004|Maintenance Period|Withdrawal by Subject|0|||
125201167|NCT03535194|450359609|FG000|Post-Treatment Followup Period|Adverse Event|4|||
125201168|NCT03535194|450359610|FG001|Post-Treatment Followup Period|Adverse Event|5|||
125201169|NCT03535194|450359611|FG002|Post-Treatment Followup Period|Adverse Event|1|||
125201170|NCT03535194|450359612|FG003|Post-Treatment Followup Period|Adverse Event|8|||
125217435|NCT01348100|450423522|FG002|Overall Study|Lost to Follow-up|0|||
125201171|NCT03535194|450359613|FG004|Post-Treatment Followup Period|Adverse Event|0|||
125201172|NCT03535194|450359609|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
125201173|NCT03535194|450359610|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
125201174|NCT03535194|450359611|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
125201175|NCT03535194|450359612|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
125201176|NCT03535194|450359613|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
125201177|NCT03535194|450359609|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
125201178|NCT03535194|450359610|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
125201179|NCT03535194|450359611|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
125201180|NCT03535194|450359612|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
125201181|NCT03535194|450359613|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
125201182|NCT03535194|450359609|FG000|Post-Treatment Followup Period|Other|1|||
125201183|NCT03535194|450359610|FG001|Post-Treatment Followup Period|Other|0|||
125201184|NCT03535194|450359611|FG002|Post-Treatment Followup Period|Other|0|||
125201185|NCT03535194|450359612|FG003|Post-Treatment Followup Period|Other|5|||
125201186|NCT03535194|450359613|FG004|Post-Treatment Followup Period|Other|0|||
125201187|NCT03535194|450359609|FG000|Post-Treatment Followup Period|Physician Decision|0|||
125201188|NCT03535194|450359610|FG001|Post-Treatment Followup Period|Physician Decision|2|||
125201189|NCT03535194|450359611|FG002|Post-Treatment Followup Period|Physician Decision|1|||
125201190|NCT03535194|450359612|FG003|Post-Treatment Followup Period|Physician Decision|1|||
125201191|NCT03535194|450359613|FG004|Post-Treatment Followup Period|Physician Decision|0|||
125201192|NCT03535194|450359609|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
125201193|NCT03535194|450359610|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
125201194|NCT03535194|450359611|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
125201195|NCT03535194|450359612|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
125201196|NCT03535194|450359613|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125201197|NCT02091960|450359614|FG000|Overall Study|Death|7|||
125201198|NCT02091960|450359614|FG000|Overall Study|Withdrawal by Subject|1|||
125201199|NCT02091960|450359614|FG000|Overall Study|Miscellaneous Reasons|37|||
125201200|NCT02424630|450359627|FG000|Overall Study|No rotator cuff tear|1|||
125201201|NCT02424630|450359628|FG001|Overall Study|No rotator cuff tear|2|||
125201202|NCT02424630|450359627|FG000|Overall Study|Open procedure|0|||
125201203|NCT02424630|450359628|FG001|Overall Study|Open procedure|1|||
125201204|NCT02703272|450359629|FG000|Overall Study|Death|4|||
125201205|NCT02703272|450359630|FG001|Overall Study|Death|9|||
125201206|NCT02703272|450359631|FG002|Overall Study|Death|19|||
125201207|NCT02703272|450359632|FG003|Overall Study|Death|10|||
125201208|NCT02703272|450359629|FG000|Overall Study|Withdrawal by Subject|0|||
125201209|NCT02703272|450359630|FG001|Overall Study|Withdrawal by Subject|0|||
125201210|NCT02703272|450359631|FG002|Overall Study|Withdrawal by Subject|4|||
125201211|NCT02703272|450359632|FG003|Overall Study|Withdrawal by Subject|2|||
125201212|NCT02703272|450359629|FG000|Overall Study|Study Terminated by Sponsor|6|||
125201213|NCT02703272|450359630|FG001|Overall Study|Study Terminated by Sponsor|1|||
125201214|NCT02703272|450359631|FG002|Overall Study|Study Terminated by Sponsor|12|||
125201215|NCT02703272|450359632|FG003|Overall Study|Study Terminated by Sponsor|4|||
125201216|NCT02703272|450359629|FG000|Overall Study|Other|1|||
125201217|NCT02703272|450359630|FG001|Overall Study|Other|0|||
125201218|NCT02703272|450359631|FG002|Overall Study|Other|0|||
125201219|NCT02703272|450359632|FG003|Overall Study|Other|0|||
125201220|NCT02637895|450359635|FG000|Overall Study|Lost to Follow-up|4|||
125201221|NCT02637895|450359636|FG001|Overall Study|Lost to Follow-up|0|||
125201222|NCT02637895|450359635|FG000|Overall Study|Protocol Violation|0|||
125201223|NCT02637895|450359636|FG001|Overall Study|Protocol Violation|1|||
125201224|NCT02637895|450359635|FG000|Overall Study|Lack of Efficacy|1|||
125201225|NCT02637895|450359636|FG001|Overall Study|Lack of Efficacy|0|||
125201226|NCT02637895|450359635|FG000|Overall Study|Withdrawal by Subject|1|||
125201227|NCT02637895|450359636|FG001|Overall Study|Withdrawal by Subject|1|||
125201228|NCT02637895|450359635|FG000|Overall Study|Abnormal baseline lab|0|||
125201229|NCT02637895|450359636|FG001|Overall Study|Abnormal baseline lab|1|||
125201230|NCT02005692|450359637|FG000|Overall Study|Protocol Violation|1|||
125201231|NCT02005692|450359637|FG000|Overall Study|Withdrawal by Subject|1|||
125201232|NCT02005692|450359637|FG000|Overall Study|Discharged earlier than anticipated|5|||
125201233|NCT02091375|450359639|FG000|Overall Study|Adverse Event|8|||
125201234|NCT02091375|450359640|FG001|Overall Study|Adverse Event|1|||
125201235|NCT02091375|450359639|FG000|Overall Study|Lost to Follow-up|0|||
125201236|NCT02091375|450359640|FG001|Overall Study|Lost to Follow-up|1|||
125201237|NCT02091375|450359639|FG000|Overall Study|Withdrawal by Subject|0|||
125201238|NCT02091375|450359640|FG001|Overall Study|Withdrawal by Subject|1|||
125201239|NCT02091375|450359639|FG000|Overall Study|Withdrawn by the investigator|1|||
125201240|NCT02091375|450359640|FG001|Overall Study|Withdrawn by the investigator|0|||
125201241|NCT02682823|450359641|FG000|Overall Study|Withdrawal by Subject|0|||
125201242|NCT02682823|450359642|FG001|Overall Study|Withdrawal by Subject|0|||
125201243|NCT02682823|450359643|FG002|Overall Study|Withdrawal by Subject|1|||
125201244|NCT02682823|450359644|FG003|Overall Study|Withdrawal by Subject|0|||
125201245|NCT02682823|450359645|FG004|Overall Study|Withdrawal by Subject|1|||
125201246|NCT02682823|450359641|FG000|Overall Study|Protocol Deviation|0|||
125201247|NCT02682823|450359642|FG001|Overall Study|Protocol Deviation|1|||
125201248|NCT02682823|450359643|FG002|Overall Study|Protocol Deviation|0|||
125201249|NCT02682823|450359644|FG003|Overall Study|Protocol Deviation|0|||
125201250|NCT02682823|450359645|FG004|Overall Study|Protocol Deviation|0|||
125201251|NCT02682823|450359641|FG000|Overall Study|Adverse Event|0|||
125201252|NCT02682823|450359642|FG001|Overall Study|Adverse Event|0|||
125201253|NCT02682823|450359643|FG002|Overall Study|Adverse Event|0|||
125201254|NCT02682823|450359644|FG003|Overall Study|Adverse Event|1|||
125201255|NCT02682823|450359645|FG004|Overall Study|Adverse Event|0|||
125201256|NCT02122770|450359649|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
125201257|NCT02122770|450359650|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
125201258|NCT02122770|450359651|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
125201259|NCT02122770|450359652|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
125201260|NCT02122770|450359653|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
125201261|NCT02122770|450359654|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
125201262|NCT02122770|450359649|FG000|Part A: Drug-drug Interaction 2|Other|0|||
125201263|NCT02122770|450359650|FG001|Part A: Drug-drug Interaction 2|Other|0|||
125201264|NCT02122770|450359651|FG002|Part A: Drug-drug Interaction 2|Other|1|||
125201265|NCT02122770|450359652|FG003|Part A: Drug-drug Interaction 2|Other|0|||
125201266|NCT02122770|450359653|FG004|Part A: Drug-drug Interaction 2|Other|0|||
125201267|NCT02122770|450359654|FG005|Part A: Drug-drug Interaction 2|Other|0|||
125201268|NCT02122770|450359649|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
125201269|NCT02122770|450359650|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
125201270|NCT02122770|450359651|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
125201271|NCT02122770|450359652|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
125201272|NCT02122770|450359653|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
125201273|NCT02122770|450359654|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
125201274|NCT02122770|450359649|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
125201275|NCT02122770|450359650|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
125201276|NCT02122770|450359651|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
125201277|NCT02122770|450359652|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
125201278|NCT02122770|450359653|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
125201279|NCT02122770|450359654|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
125201280|NCT02122770|450359649|FG000|Part B: Standard of Care|Adverse Event|0|||
125201281|NCT02122770|450359650|FG001|Part B: Standard of Care|Adverse Event|0|||
125201282|NCT02122770|450359651|FG002|Part B: Standard of Care|Adverse Event|0|||
125201283|NCT02122770|450359652|FG003|Part B: Standard of Care|Adverse Event|0|||
125201284|NCT02122770|450359653|FG004|Part B: Standard of Care|Adverse Event|4|||
125201285|NCT02122770|450359654|FG005|Part B: Standard of Care|Adverse Event|1|||
125201286|NCT02122770|450359649|FG000|Part B: Standard of Care|Other|0|||
125201287|NCT02122770|450359650|FG001|Part B: Standard of Care|Other|0|||
125201288|NCT02122770|450359651|FG002|Part B: Standard of Care|Other|0|||
125201289|NCT02122770|450359652|FG003|Part B: Standard of Care|Other|0|||
125201290|NCT02122770|450359653|FG004|Part B: Standard of Care|Other|0|||
125201291|NCT02122770|450359654|FG005|Part B: Standard of Care|Other|2|||
125201292|NCT02122770|450359649|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
125201293|NCT02122770|450359650|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
125201294|NCT02122770|450359651|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
125201295|NCT02122770|450359652|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
125201296|NCT02122770|450359653|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
125201297|NCT02122770|450359654|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
125201298|NCT02122770|450359649|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
125201299|NCT02122770|450359650|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
125201300|NCT02122770|450359651|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
125201301|NCT02122770|450359652|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
125201302|NCT02122770|450359653|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
125201303|NCT02122770|450359654|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
125201304|NCT02122770|450359649|FG000|Part B: Standard of Care|Progressive Disease|0|||
125201305|NCT02122770|450359650|FG001|Part B: Standard of Care|Progressive Disease|0|||
125201306|NCT02122770|450359651|FG002|Part B: Standard of Care|Progressive Disease|0|||
125201307|NCT02122770|450359652|FG003|Part B: Standard of Care|Progressive Disease|0|||
125201308|NCT02122770|450359653|FG004|Part B: Standard of Care|Progressive Disease|10|||
125201309|NCT02122770|450359654|FG005|Part B: Standard of Care|Progressive Disease|8|||
125201310|NCT00189306|450359656|FG000|Treatment Period|Withdrawal by Subject|2|||
125201311|NCT00189306|450359656|FG000|Treatment Period|Adverse Event|2|||
125201312|NCT00189306|450359656|FG000|Treatment Period|Protocol Violation|1|||
125201313|NCT00189306|450359656|FG000|Posttreatment Period|Death|1|||
125201314|NCT00189306|450359656|FG000|Posttreatment Period|Withdrawal by Subject|2|||
125201315|NCT00189306|450359656|FG000|Posttreatment Period|Noncompliance|1|||
125201316|NCT00189306|450359656|FG000|Posttreatment Period|Target lesion excised|1|||
125201317|NCT00189306|450359656|FG000|Posttreatment Period|Protocol Violation|1|||
125201318|NCT00189306|450359656|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
125201319|NCT00189306|450359656|FG000|Posttreatment Period|Local skin reaction/sign|1|||
125201320|NCT00189306|450359656|FG000|Long-Term Follow-up|Adverse Event|2|||
125201321|NCT00189306|450359656|FG000|Long-Term Follow-up|Death|4|||
125201322|NCT00189306|450359656|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
125201323|NCT00189306|450359656|FG000|Long-Term Follow-up|Intercurrent disease|2|||
125201324|NCT00189306|450359656|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
125201325|NCT00189306|450359656|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
125201326|NCT03640481|450359657|FG000|Overall Study|Death|14|||
125201327|NCT03640481|450359658|FG001|Overall Study|Death|14|||
125201328|NCT03640481|450359659|FG002|Overall Study|Death|0|||
125201329|NCT03640481|450359660|FG003|Overall Study|Death|0|||
125201330|NCT03640481|450359657|FG000|Overall Study|Lost to Follow-up|2|||
125201331|NCT03640481|450359658|FG001|Overall Study|Lost to Follow-up|0|||
125201332|NCT03640481|450359659|FG002|Overall Study|Lost to Follow-up|0|||
125201333|NCT03640481|450359660|FG003|Overall Study|Lost to Follow-up|0|||
125201334|NCT03640481|450359657|FG000|Overall Study|Site terminated by sponsor|1|||
125201335|NCT03640481|450359658|FG001|Overall Study|Site terminated by sponsor|3|||
125201336|NCT03640481|450359659|FG002|Overall Study|Site terminated by sponsor|0|||
125201337|NCT03640481|450359660|FG003|Overall Study|Site terminated by sponsor|0|||
125201338|NCT03640481|450359657|FG000|Overall Study|Study terminated by sponsor|29|||
125201339|NCT03640481|450359658|FG001|Overall Study|Study terminated by sponsor|42|||
125201340|NCT03640481|450359659|FG002|Overall Study|Study terminated by sponsor|1|||
125201341|NCT03640481|450359660|FG003|Overall Study|Study terminated by sponsor|0|||
125201342|NCT03640481|450359657|FG000|Overall Study|Withdrawal by Subject|5|||
125201343|NCT03640481|450359658|FG001|Overall Study|Withdrawal by Subject|4|||
125201344|NCT03640481|450359659|FG002|Overall Study|Withdrawal by Subject|0|||
125201345|NCT03640481|450359660|FG003|Overall Study|Withdrawal by Subject|1|||
125201346|NCT03640481|450359657|FG000|Overall Study|Other|26|||
125201347|NCT03640481|450359658|FG001|Overall Study|Other|12|||
125201348|NCT03640481|450359659|FG002|Overall Study|Other|1|||
125201349|NCT03640481|450359660|FG003|Overall Study|Other|0|||
125201350|NCT03640481|450359657|FG000|Overall Study|Randomized, but not treated|1|||
125201351|NCT03640481|450359658|FG001|Overall Study|Randomized, but not treated|3|||
125201352|NCT03640481|450359659|FG002|Overall Study|Randomized, but not treated|0|||
125201353|NCT03640481|450359660|FG003|Overall Study|Randomized, but not treated|0|||
125201354|NCT00535847|450359661|FG000|Overall Study|Adverse Event|5|||
125201355|NCT00535847|450359662|FG001|Overall Study|Adverse Event|3|||
125201356|NCT00535847|450359663|FG002|Overall Study|Adverse Event|2|||
125201357|NCT00535847|450359661|FG000|Overall Study|Non compliance|1|||
125201358|NCT00535847|450359662|FG001|Overall Study|Non compliance|1|||
125201359|NCT00535847|450359663|FG002|Overall Study|Non compliance|0|||
125201360|NCT00535847|450359661|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
125201361|NCT00535847|450359662|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
125201362|NCT00535847|450359663|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
125201363|NCT00727844|450359664|FG000|Initial Randomization|Physician Decision|2|||
125201364|NCT00727844|450359665|FG001|Initial Randomization|Physician Decision|0|||
125201365|NCT00727844|450359666|FG002|Initial Randomization|Physician Decision|0|||
125201366|NCT00727844|450359667|FG003|Initial Randomization|Physician Decision|0|||
125201367|NCT04569968|450359668|FG000|Overall Study|Lost to Follow-up|2|||
125201368|NCT04569968|450359669|FG001|Overall Study|Lost to Follow-up|5|||
125201369|NCT04569968|450359668|FG000|Overall Study|Story of head and/or neck surgery|2|||
125201370|NCT04569968|450359669|FG001|Overall Study|Story of head and/or neck surgery|2|||
125201371|NCT04569968|450359668|FG000|Overall Study|Time of stroke onset|8|||
125201372|NCT04569968|450359669|FG001|Overall Study|Time of stroke onset|7|||
125201373|NCT04569968|450359668|FG000|Overall Study|Type of strokr|12|||
125201374|NCT04569968|450359669|FG001|Overall Study|Type of strokr|8|||
125201375|NCT04569968|450359668|FG000|Overall Study|Cooperation|8|||
125201376|NCT04569968|450359669|FG001|Overall Study|Cooperation|8|||
125201377|NCT04569968|450359668|FG000|Overall Study|Age interval|17|||
125201378|NCT04569968|450359669|FG001|Overall Study|Age interval|6|||
125201379|NCT04569968|450359668|FG000|Overall Study|Denial of participation to the study|0|||
125201380|NCT04569968|450359669|FG001|Overall Study|Denial of participation to the study|3|||
125201381|NCT04569968|450359668|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
125201382|NCT04569968|450359669|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
125201383|NCT04569968|450359668|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
125201384|NCT04569968|450359669|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
125201385|NCT04569968|450359668|FG000|Overall Study|Quarantine|1|||
125201386|NCT04569968|450359669|FG001|Overall Study|Quarantine|0|||
125201387|NCT04569968|450359668|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
125201388|NCT04569968|450359669|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
125201389|NCT04569968|450359668|FG000|Overall Study|Repetitive stroke|8|||
125201390|NCT04569968|450359669|FG001|Overall Study|Repetitive stroke|0|||
125201391|NCT04569968|450359668|FG000|Overall Study|Insufficient mastication|1|||
125201392|NCT04569968|450359669|FG001|Overall Study|Insufficient mastication|0|||
125201393|NCT04569968|450359668|FG000|Overall Study|Infection|1|||
125201394|NCT04569968|450359669|FG001|Overall Study|Infection|0|||
125201395|NCT00373958|450359670|FG000|Infant Series|Withdrawal by Subject|13|||
125201396|NCT00373958|450359671|FG001|Infant Series|Withdrawal by Subject|15|||
125201397|NCT00373958|450359670|FG000|Infant Series|Failed to return|8|||
125201398|NCT00373958|450359671|FG001|Infant Series|Failed to return|13|||
125201399|NCT00373958|450359670|FG000|Infant Series|Lost to Follow-up|6|||
125201400|NCT00373958|450359671|FG001|Infant Series|Lost to Follow-up|5|||
125201401|NCT00373958|450359670|FG000|Infant Series|Protocol Violation|3|||
125201402|NCT00373958|450359671|FG001|Infant Series|Protocol Violation|7|||
125201403|NCT00373958|450359670|FG000|Infant Series|Lost Kaiser coverage|4|||
125201404|NCT00373958|450359671|FG001|Infant Series|Lost Kaiser coverage|0|||
125201405|NCT00373958|450359670|FG000|Infant Series|Child relocated|1|||
125201406|NCT00373958|450359671|FG001|Infant Series|Child relocated|0|||
125201407|NCT00373958|450359670|FG000|Infant Series|Consent was not received|1|||
125201408|NCT00373958|450359671|FG001|Infant Series|Consent was not received|0|||
125201409|NCT00373958|450359670|FG000|Infant Series|Adverse Event|3|||
125201410|NCT00373958|450359671|FG001|Infant Series|Adverse Event|1|||
125201411|NCT00373958|450359670|FG000|Infant Series|Physician Decision|1|||
125201412|NCT00373958|450359671|FG001|Infant Series|Physician Decision|1|||
125201413|NCT00373958|450359670|FG000|Toddler Dose|Lost to Follow-up|5|||
125201414|NCT00373958|450359671|FG001|Toddler Dose|Lost to Follow-up|8|||
125201415|NCT00373958|450359670|FG000|Toddler Dose|Withdrawal by Subject|2|||
125201416|NCT00373958|450359671|FG001|Toddler Dose|Withdrawal by Subject|2|||
125201417|NCT00373958|450359670|FG000|Toddler Dose|Failed to return|1|||
125201418|NCT00373958|450359671|FG001|Toddler Dose|Failed to return|2|||
125201419|NCT00373958|450359670|FG000|Toddler Dose|Protocol Violation|0|||
125201420|NCT00373958|450359671|FG001|Toddler Dose|Protocol Violation|1|||
125201421|NCT00373958|450359670|FG000|Toddler Dose|Withdrawn after infant series|22|||
125201422|NCT00373958|450359671|FG001|Toddler Dose|Withdrawn after infant series|25|||
125201423|NCT05007041|450359672|FG000|Overall Study|Missing Diary Entries|0|||
125201424|NCT05007041|450359673|FG001|Overall Study|Missing Diary Entries|1|||
125201425|NCT01552915|450359674|FG000|Overall Study|Adverse Event|3|||
125201426|NCT01552915|450359675|FG001|Overall Study|Adverse Event|14|||
125201427|NCT01552915|450359676|FG002|Overall Study|Adverse Event|3|||
125201428|NCT01552915|450359674|FG000|Overall Study|Lost to Follow-up|4|||
125201429|NCT01552915|450359675|FG001|Overall Study|Lost to Follow-up|6|||
125201430|NCT01552915|450359676|FG002|Overall Study|Lost to Follow-up|5|||
125201431|NCT01552915|450359674|FG000|Overall Study|Withdrawal by Subject|6|||
125201432|NCT01552915|450359675|FG001|Overall Study|Withdrawal by Subject|4|||
125201433|NCT01552915|450359676|FG002|Overall Study|Withdrawal by Subject|5|||
125201434|NCT01552915|450359674|FG000|Overall Study|Protocol Violation|0|||
125201435|NCT01552915|450359675|FG001|Overall Study|Protocol Violation|4|||
125201436|NCT01552915|450359676|FG002|Overall Study|Protocol Violation|4|||
125201437|NCT01552915|450359674|FG000|Overall Study|Lack of Efficacy|8|||
125201438|NCT01552915|450359675|FG001|Overall Study|Lack of Efficacy|1|||
125201439|NCT01552915|450359676|FG002|Overall Study|Lack of Efficacy|4|||
125201440|NCT01552915|450359674|FG000|Overall Study|Other|2|||
125201441|NCT01552915|450359675|FG001|Overall Study|Other|0|||
125201442|NCT01552915|450359676|FG002|Overall Study|Other|6|||
125201443|NCT02850016|450359679|FG000|Overall Study|Withdrawal by Subject|1|||
125201444|NCT02850016|450359680|FG001|Overall Study|Withdrawal by Subject|2|||
125201445|NCT02457832|450359681|FG000|Training|Lost to Follow-up|10|||
125201446|NCT02457832|450359682|FG001|Training|Lost to Follow-up|6|||
125201447|NCT02457832|450359683|FG002|Training|Lost to Follow-up|3|||
125201448|NCT02457832|450359681|FG000|One Month Washout|Lost to Follow-up|0|||
125201449|NCT02457832|450359682|FG001|One Month Washout|Lost to Follow-up|1|||
125201450|NCT02457832|450359683|FG002|One Month Washout|Lost to Follow-up|1|||
125201451|NCT00423189|450359684|FG000|Overall Study|Death|0|||
125201452|NCT00423189|450359685|FG001|Overall Study|Death|1|||
125201453|NCT00423189|450359686|FG002|Overall Study|Death|0|||
125201454|NCT03973918|450359691|FG000|Overall Study|Adverse Event|0|||
125201455|NCT03973918|450359692|FG001|Overall Study|Adverse Event|0|||
125201456|NCT03973918|450359693|FG002|Overall Study|Adverse Event|0|||
125201457|NCT03973918|450359694|FG003|Overall Study|Adverse Event|1|||
125201458|NCT03973918|450359691|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
125201459|NCT03973918|450359692|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
125201460|NCT03973918|450359693|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
125201461|NCT03973918|450359694|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
125201462|NCT02951533|450359698|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
125201463|NCT02951533|450359699|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
125201464|NCT02951533|450359700|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
125201465|NCT02951533|450359698|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
125201466|NCT02951533|450359699|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
125201467|NCT02951533|450359700|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
125201468|NCT02951533|450359698|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
125201469|NCT02951533|450359699|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
125201470|NCT02951533|450359700|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
125201471|NCT02951533|450359698|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
125201472|NCT02951533|450359699|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
125201473|NCT02951533|450359700|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
125201474|NCT02951533|450359698|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
125201475|NCT02951533|450359699|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
125201476|NCT02951533|450359700|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
125201477|NCT02951533|450359698|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
125201478|NCT02951533|450359699|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
125201479|NCT02951533|450359700|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
125201480|NCT02951533|450359698|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
125201481|NCT02951533|450359699|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
125201482|NCT02951533|450359700|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
125201483|NCT02951533|450359698|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
125201484|NCT02951533|450359699|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
125201485|NCT02951533|450359700|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
125201486|NCT02951533|450359698|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
125201487|NCT02951533|450359699|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
125201488|NCT02951533|450359700|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
125201489|NCT02951533|450359698|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
125201490|NCT02951533|450359699|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
125201491|NCT02951533|450359700|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
125201492|NCT02951533|450359698|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
125201493|NCT02951533|450359699|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
125201494|NCT02951533|450359700|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
125201495|NCT01446237|450359709|FG000|Overall Study|Adverse Event|1|||
125201496|NCT01446237|450359709|FG000|Overall Study|Lost to Follow-up|2|||
125201497|NCT01446237|450359709|FG000|Overall Study|Withdrawal by Subject|7|||
125201498|NCT00742508|450359712|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
125201499|NCT00742508|450359713|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
125201500|NCT00742508|450359712|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
125201501|NCT00742508|450359713|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
125201502|NCT00742508|450359712|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
125201503|NCT00742508|450359713|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
125201504|NCT00742508|450359712|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
125201505|NCT00742508|450359713|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
125201506|NCT00742508|450359712|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
125201507|NCT00742508|450359713|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
125201508|NCT04017832|450359714|FG000|Overall Study|Withdrawal by Subject|13|||
125201509|NCT04017832|450359715|FG001|Overall Study|Withdrawal by Subject|12|||
125201510|NCT04017832|450359716|FG002|Overall Study|Withdrawal by Subject|21|||
125201511|NCT04017832|450359717|FG003|Overall Study|Withdrawal by Subject|7|||
125201512|NCT04017832|450359714|FG000|Overall Study|Lost to Follow-up|0|||
125201513|NCT04017832|450359715|FG001|Overall Study|Lost to Follow-up|3|||
125201514|NCT04017832|450359716|FG002|Overall Study|Lost to Follow-up|3|||
125201515|NCT04017832|450359717|FG003|Overall Study|Lost to Follow-up|1|||
125201516|NCT04017832|450359714|FG000|Overall Study|Physician Decision|1|||
125201517|NCT04017832|450359715|FG001|Overall Study|Physician Decision|1|||
125201518|NCT04017832|450359716|FG002|Overall Study|Physician Decision|1|||
125201519|NCT04017832|450359717|FG003|Overall Study|Physician Decision|1|||
125201520|NCT04017832|450359714|FG000|Overall Study|Death|2|||
125201521|NCT04017832|450359715|FG001|Overall Study|Death|2|||
125201522|NCT04017832|450359716|FG002|Overall Study|Death|1|||
125201523|NCT04017832|450359717|FG003|Overall Study|Death|0|||
125201524|NCT01901653|450359723|FG000|Overall Study|Death|2|||
125201525|NCT01901653|450359724|FG001|Overall Study|Death|1|||
125201526|NCT01901653|450359725|FG002|Overall Study|Death|8|||
125201527|NCT01901653|450359726|FG003|Overall Study|Death|3|||
125201528|NCT01901653|450359727|FG004|Overall Study|Death|2|||
125201529|NCT01901653|450359728|FG005|Overall Study|Death|2|||
125201530|NCT01901653|450359729|FG006|Overall Study|Death|6|||
125201531|NCT01901653|450359730|FG007|Overall Study|Death|9|||
125201532|NCT01901653|450359731|FG008|Overall Study|Death|1|||
125201533|NCT01901653|450359732|FG009|Overall Study|Death|16|||
125201534|NCT01901653|450359733|FG010|Overall Study|Death|2|||
125201535|NCT01901653|450359734|FG011|Overall Study|Death|15|||
125201536|NCT01901653|450359735|FG012|Overall Study|Death|4|||
125201537|NCT01901653|450359723|FG000|Overall Study|Lost to Follow-up|1|||
125201538|NCT01901653|450359724|FG001|Overall Study|Lost to Follow-up|0|||
125201539|NCT01901653|450359725|FG002|Overall Study|Lost to Follow-up|2|||
125201540|NCT01901653|450359726|FG003|Overall Study|Lost to Follow-up|0|||
125201541|NCT01901653|450359727|FG004|Overall Study|Lost to Follow-up|0|||
125201542|NCT01901653|450359728|FG005|Overall Study|Lost to Follow-up|1|||
125201543|NCT01901653|450359729|FG006|Overall Study|Lost to Follow-up|0|||
125201544|NCT01901653|450359730|FG007|Overall Study|Lost to Follow-up|1|||
125201545|NCT01901653|450359731|FG008|Overall Study|Lost to Follow-up|0|||
125201546|NCT01901653|450359732|FG009|Overall Study|Lost to Follow-up|0|||
125201547|NCT01901653|450359733|FG010|Overall Study|Lost to Follow-up|0|||
125201548|NCT01901653|450359734|FG011|Overall Study|Lost to Follow-up|0|||
125201549|NCT01901653|450359735|FG012|Overall Study|Lost to Follow-up|0|||
125201550|NCT01901653|450359723|FG000|Overall Study|Withdrawal by Subject|0|||
125201551|NCT01901653|450359724|FG001|Overall Study|Withdrawal by Subject|0|||
125201552|NCT01901653|450359725|FG002|Overall Study|Withdrawal by Subject|0|||
125201553|NCT01901653|450359726|FG003|Overall Study|Withdrawal by Subject|0|||
125201554|NCT01901653|450359727|FG004|Overall Study|Withdrawal by Subject|0|||
125201555|NCT01901653|450359728|FG005|Overall Study|Withdrawal by Subject|0|||
125201556|NCT01901653|450359729|FG006|Overall Study|Withdrawal by Subject|1|||
125201557|NCT01901653|450359730|FG007|Overall Study|Withdrawal by Subject|0|||
125201558|NCT01901653|450359731|FG008|Overall Study|Withdrawal by Subject|0|||
125201559|NCT01901653|450359732|FG009|Overall Study|Withdrawal by Subject|0|||
125201560|NCT01901653|450359733|FG010|Overall Study|Withdrawal by Subject|0|||
125201561|NCT01901653|450359734|FG011|Overall Study|Withdrawal by Subject|0|||
125201562|NCT01901653|450359735|FG012|Overall Study|Withdrawal by Subject|0|||
125201563|NCT01901653|450359723|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
125201564|NCT01901653|450359724|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
125201565|NCT01901653|450359725|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
125201566|NCT01901653|450359726|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
125201567|NCT01901653|450359727|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
125201568|NCT01901653|450359728|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
125201569|NCT01901653|450359729|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
125201570|NCT01901653|450359730|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
125201571|NCT01901653|450359731|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
125201572|NCT01901653|450359732|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
125201573|NCT01901653|450359733|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
125201574|NCT01901653|450359734|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
125201575|NCT01901653|450359735|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
125201576|NCT02091986|450359736|FG000|Overall Study|7 rand in error 1 patient decision|2|||
125201577|NCT02091986|450359737|FG001|Overall Study|7 rand in error 1 patient decision|3|||
125201578|NCT02091986|450359738|FG002|Overall Study|7 rand in error 1 patient decision|3|||
125201579|NCT02091986|450359736|FG000|Overall Study|Lost to Follow-up|1|||
125201580|NCT02091986|450359737|FG001|Overall Study|Lost to Follow-up|0|||
125201581|NCT02091986|450359738|FG002|Overall Study|Lost to Follow-up|0|||
125201582|NCT02091986|450359736|FG000|Overall Study|Withdrawal by Subject|4|||
125201583|NCT02091986|450359737|FG001|Overall Study|Withdrawal by Subject|8|||
125201584|NCT02091986|450359738|FG002|Overall Study|Withdrawal by Subject|3|||
125201585|NCT02091986|450359736|FG000|Overall Study|Adverse Event|0|||
125201586|NCT02091986|450359737|FG001|Overall Study|Adverse Event|0|||
125201587|NCT02091986|450359738|FG002|Overall Study|Adverse Event|2|||
125201588|NCT00957268|450359742|FG000|Overall Study|Voluntary Withdrawal|0|||
125201589|NCT00957268|450359743|FG001|Overall Study|Voluntary Withdrawal|0|||
125201590|NCT00957268|450359744|FG002|Overall Study|Voluntary Withdrawal|1|||
125201591|NCT00957268|450359745|FG003|Overall Study|Voluntary Withdrawal|0|||
125201592|NCT00957268|450359746|FG004|Overall Study|Voluntary Withdrawal|0|||
125201593|NCT00794040|450359747|FG000|Overall Study|Withdrawal by Subject|3|||
125201594|NCT00794040|450359748|FG001|Overall Study|Withdrawal by Subject|4|||
125201595|NCT00794040|450359747|FG000|Overall Study|Physician Decision|0|||
125201596|NCT00794040|450359748|FG001|Overall Study|Physician Decision|1|||
125201597|NCT02396420|450359749|FG000|Overall Study|Death|1|||
125201598|NCT01273623|450359750|FG000|Overall Study|did not meet IVUS criteria|29|||
125201599|NCT04064411|450359751|FG000|Overall Study|Adverse Event|29|||
125201600|NCT04064411|450359752|FG001|Overall Study|Adverse Event|19|||
125201601|NCT04064411|450359751|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
125201602|NCT04064411|450359752|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
125201603|NCT04064411|450359751|FG000|Overall Study|Protocol Deviation|0|||
125201604|NCT04064411|450359752|FG001|Overall Study|Protocol Deviation|2|||
125201605|NCT04064411|450359751|FG000|Overall Study|Withdrawal by Subject|25|||
125201606|NCT04064411|450359752|FG001|Overall Study|Withdrawal by Subject|29|||
125201607|NCT04064411|450359751|FG000|Overall Study|Lost to Follow-up|5|||
125201608|NCT04064411|450359752|FG001|Overall Study|Lost to Follow-up|2|||
125201609|NCT04064411|450359751|FG000|Overall Study|Other than Specified|4|||
125201610|NCT04064411|450359752|FG001|Overall Study|Other than Specified|1|||
125201611|NCT04064411|450359751|FG000|Overall Study|Death|1|||
125201612|NCT04064411|450359752|FG001|Overall Study|Death|0|||
125201613|NCT01970475|450359761|FG000|Overall Study|Withdrawal by Subject|11|||
125201614|NCT01970475|450359762|FG001|Overall Study|Withdrawal by Subject|6|||
125201615|NCT01970475|450359761|FG000|Overall Study|Adverse Event|7|||
125201616|NCT01970475|450359762|FG001|Overall Study|Adverse Event|3|||
125201617|NCT01970475|450359761|FG000|Overall Study|Lost to Follow-up|2|||
125201618|NCT01970475|450359762|FG001|Overall Study|Lost to Follow-up|2|||
125201619|NCT01970475|450359761|FG000|Overall Study|Protocol Violation|1|||
125201620|NCT01970475|450359762|FG001|Overall Study|Protocol Violation|0|||
125201621|NCT00381238|450361465|FG000|Overall Study|Adverse Event|3|||
125201622|NCT00381238|450361465|FG000|Overall Study|Protocol Violation|1|||
125201623|NCT00381238|450361465|FG000|Overall Study|Withdrawal by Subject|4|||
125201624|NCT00381238|450361465|FG000|Overall Study|Lack of Efficacy|2|||
125201625|NCT00381238|450361465|FG000|Overall Study|Withdrew by physician|1|||
125201626|NCT00381238|450361465|FG000|Overall Study|Disease progression|1|||
125201627|NCT02086448|450361469|FG000|Overall Study|Withdrawal by Subject|1|||
125201628|NCT02086448|450361470|FG001|Overall Study|Withdrawal by Subject|0|||
125201629|NCT02086448|450361471|FG002|Overall Study|Withdrawal by Subject|0|||
125201630|NCT02086448|450361472|FG003|Overall Study|Withdrawal by Subject|2|||
125201631|NCT00843037|450361473|FG000|Overall Study|Lost to Follow-up|1|||
125201632|NCT01871402|450361476|FG000|Overall Study|Lost to Follow-up|1|||
125201633|NCT01871402|450361477|FG001|Overall Study|Lost to Follow-up|0|||
125201634|NCT01871402|450361476|FG000|Overall Study|Withdrawal by Subject|0|||
125201635|NCT01871402|450361477|FG001|Overall Study|Withdrawal by Subject|2|||
125201636|NCT01871402|450361476|FG000|Overall Study|Non-compliance|0|||
125201637|NCT01871402|450361477|FG001|Overall Study|Non-compliance|1|||
125201638|NCT05896527|450361480|FG000|Overall Study|Withdrawal by Subject|11|||
125201639|NCT05896527|450361481|FG001|Overall Study|Withdrawal by Subject|10|||
125201640|NCT05896527|450361482|FG002|Overall Study|Withdrawal by Subject|4|||
125201641|NCT05896527|450361483|FG003|Overall Study|Withdrawal by Subject|3|||
125201642|NCT05896527|450361484|FG004|Overall Study|Withdrawal by Subject|2|||
125201643|NCT05896527|450361480|FG000|Overall Study|Lost to Follow-up|0|||
125201644|NCT05896527|450361481|FG001|Overall Study|Lost to Follow-up|2|||
125201645|NCT05896527|450361482|FG002|Overall Study|Lost to Follow-up|2|||
125201646|NCT05896527|450361483|FG003|Overall Study|Lost to Follow-up|2|||
125201647|NCT05896527|450361484|FG004|Overall Study|Lost to Follow-up|1|||
125201648|NCT05896527|450361480|FG000|Overall Study|Significant protocol noncompliance|0|||
125201649|NCT05896527|450361481|FG001|Overall Study|Significant protocol noncompliance|1|||
125201650|NCT05896527|450361482|FG002|Overall Study|Significant protocol noncompliance|0|||
125201651|NCT05896527|450361483|FG003|Overall Study|Significant protocol noncompliance|0|||
125201652|NCT05896527|450361484|FG004|Overall Study|Significant protocol noncompliance|0|||
125201653|NCT05896527|450361480|FG000|Overall Study|Eligibility criteria not met|1|||
125201654|NCT05896527|450361481|FG001|Overall Study|Eligibility criteria not met|0|||
125201655|NCT05896527|450361482|FG002|Overall Study|Eligibility criteria not met|0|||
125201656|NCT05896527|450361483|FG003|Overall Study|Eligibility criteria not met|0|||
125201657|NCT05896527|450361484|FG004|Overall Study|Eligibility criteria not met|0|||
125201658|NCT05896527|450361480|FG000|Overall Study|Sponsor's decision|0|||
125201659|NCT05896527|450361481|FG001|Overall Study|Sponsor's decision|0|||
125201660|NCT05896527|450361482|FG002|Overall Study|Sponsor's decision|0|||
125201661|NCT05896527|450361483|FG003|Overall Study|Sponsor's decision|1|||
125201662|NCT05896527|450361484|FG004|Overall Study|Sponsor's decision|0|||
125201663|NCT05896527|450361480|FG000|Overall Study|Investigator's decision|0|||
125201664|NCT05896527|450361481|FG001|Overall Study|Investigator's decision|1|||
125201665|NCT05896527|450361482|FG002|Overall Study|Investigator's decision|0|||
125201666|NCT05896527|450361483|FG003|Overall Study|Investigator's decision|0|||
125201667|NCT05896527|450361484|FG004|Overall Study|Investigator's decision|0|||
125201668|NCT05896527|450361480|FG000|Overall Study|Pregnancy of his partner|0|||
125201669|NCT05896527|450361481|FG001|Overall Study|Pregnancy of his partner|0|||
125201670|NCT05896527|450361482|FG002|Overall Study|Pregnancy of his partner|0|||
125201671|NCT05896527|450361483|FG003|Overall Study|Pregnancy of his partner|1|||
125201672|NCT05896527|450361484|FG004|Overall Study|Pregnancy of his partner|0|||
125201673|NCT01279070|450361485|FG000|Overall Study|Withdrawal by Subject|2|||
125201674|NCT01279070|450361486|FG001|Overall Study|Withdrawal by Subject|3|||
125201675|NCT01279070|450361485|FG000|Overall Study|Acute exacerbation|3|||
125201676|NCT01279070|450361486|FG001|Overall Study|Acute exacerbation|1|||
125201677|NCT03781583|450361487|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
125201678|NCT03781583|450361488|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
125201679|NCT03781583|450361489|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
125201680|NCT03781583|450361490|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
125201681|NCT03781583|450361487|FG000|Overall Study|Technology did not work for that person in that environment|1|||
125201682|NCT03781583|450361488|FG001|Overall Study|Technology did not work for that person in that environment|0|||
125201683|NCT03781583|450361489|FG002|Overall Study|Technology did not work for that person in that environment|0|||
125201684|NCT03781583|450361490|FG003|Overall Study|Technology did not work for that person in that environment|0|||
125201685|NCT03781583|450361487|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
125201686|NCT03781583|450361488|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
125201687|NCT03781583|450361489|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
125201688|NCT03781583|450361490|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
125201689|NCT03781583|450361487|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
125201690|NCT03781583|450361488|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
125201691|NCT03781583|450361489|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
125201692|NCT03781583|450361490|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
125201693|NCT05139303|450361491|FG000|Overall Study|Lost to Follow-up|3|||
125201694|NCT05139303|450361492|FG001|Overall Study|Lost to Follow-up|0|||
125201695|NCT05139303|450361491|FG000|Overall Study|Adverse Event|1|||
125201696|NCT05139303|450361492|FG001|Overall Study|Adverse Event|0|||
125201697|NCT02045862|450361493|FG000|Overall Study|Death|0|||
125201698|NCT02045862|450361494|FG001|Overall Study|Death|0|||
125201699|NCT02045862|450361495|FG002|Overall Study|Death|1|||
125201700|NCT02045862|450361493|FG000|Overall Study|Miscellaneous|5|||
125201701|NCT02045862|450361494|FG001|Overall Study|Miscellaneous|0|||
125201702|NCT02045862|450361495|FG002|Overall Study|Miscellaneous|8|||
125201703|NCT02045862|450361493|FG000|Overall Study|Withdrawal by Patient|18|||
125201704|NCT02045862|450361494|FG001|Overall Study|Withdrawal by Patient|27|||
125201705|NCT02045862|450361495|FG002|Overall Study|Withdrawal by Patient|57|||
125201706|NCT02045862|450361493|FG000|Overall Study|Protocol Violation|0|||
125201707|NCT02045862|450361494|FG001|Overall Study|Protocol Violation|0|||
125201708|NCT02045862|450361495|FG002|Overall Study|Protocol Violation|6|||
125201709|NCT02045862|450361493|FG000|Overall Study|Lack of Efficacy|8|||
125201710|NCT02045862|450361494|FG001|Overall Study|Lack of Efficacy|4|||
125089731|NCT00405756|449947017|FG002|Open-label Extension|Adverse Event|7|||
125089732|NCT00405756|449947015|FG000|Open-label Extension|Disease Progression|8|||
125089733|NCT00405756|449947016|FG001|Open-label Extension|Disease Progression|23|||
125089734|NCT00405756|449947017|FG002|Open-label Extension|Disease Progression|26|||
125089735|NCT00405756|449947015|FG000|Open-label Extension|Withdrawal by Subject|2|||
125089736|NCT00405756|449947016|FG001|Open-label Extension|Withdrawal by Subject|3|||
125089737|NCT00405756|449947017|FG002|Open-label Extension|Withdrawal by Subject|3|||
125089738|NCT00405756|449947015|FG000|Open-label Extension|Death|1|||
125089739|NCT00405756|449947016|FG001|Open-label Extension|Death|2|||
125089740|NCT00405756|449947017|FG002|Open-label Extension|Death|4|||
125089741|NCT00405756|449947015|FG000|Open-label Extension|Other|0|||
125089742|NCT00405756|449947016|FG001|Open-label Extension|Other|1|||
125089743|NCT00405756|449947017|FG002|Open-label Extension|Other|7|||
125089744|NCT00405756|449947015|FG000|Follow-up|Ongoing in Follow-up Period|52|||
125089745|NCT00405756|449947016|FG001|Follow-up|Ongoing in Follow-up Period|51|||
125089746|NCT00405756|449947017|FG002|Follow-up|Ongoing in Follow-up Period|60|||
125089747|NCT00405756|449947015|FG000|Follow-up|Death|21|||
125089748|NCT00405756|449947016|FG001|Follow-up|Death|31|||
125089749|NCT00405756|449947017|FG002|Follow-up|Death|24|||
125089750|NCT00405756|449947015|FG000|Follow-up|Lost to Follow-up|2|||
125089751|NCT00405756|449947016|FG001|Follow-up|Lost to Follow-up|8|||
125089752|NCT00405756|449947017|FG002|Follow-up|Lost to Follow-up|4|||
125089753|NCT00089505|449947018|FG000|Overall Study|Death|4|||
125089754|NCT00089505|449947019|FG001|Overall Study|Death|1|||
125089755|NCT00089505|449947020|FG002|Overall Study|Death|5|||
125089756|NCT00089505|449947021|FG003|Overall Study|Death|8|||
125089757|NCT00089505|449947018|FG000|Overall Study|Withdrawal by Subject|3|||
125089758|NCT00089505|449947019|FG001|Overall Study|Withdrawal by Subject|0|||
125089759|NCT00089505|449947020|FG002|Overall Study|Withdrawal by Subject|6|||
125089760|NCT00089505|449947021|FG003|Overall Study|Withdrawal by Subject|6|||
125089761|NCT00089505|449947018|FG000|Overall Study|Lost to Follow-up|1|||
125089762|NCT00089505|449947019|FG001|Overall Study|Lost to Follow-up|1|||
125089763|NCT00089505|449947020|FG002|Overall Study|Lost to Follow-up|9|||
125089764|NCT00089505|449947021|FG003|Overall Study|Lost to Follow-up|7|||
125089765|NCT00089505|449947018|FG000|Overall Study|Physician Decision|1|||
125089766|NCT00089505|449947019|FG001|Overall Study|Physician Decision|0|||
125089767|NCT00089505|449947020|FG002|Overall Study|Physician Decision|0|||
125089768|NCT00089505|449947021|FG003|Overall Study|Physician Decision|0|||
125089769|NCT00089505|449947018|FG000|Overall Study|Protocol Violation|0|||
125089770|NCT00089505|449947019|FG001|Overall Study|Protocol Violation|0|||
125089771|NCT00089505|449947020|FG002|Overall Study|Protocol Violation|1|||
125089772|NCT00089505|449947021|FG003|Overall Study|Protocol Violation|0|||
125089773|NCT01117428|449947023|FG000|Overall Study|Lack of Efficacy|1|||
125089774|NCT01117428|449947024|FG001|Overall Study|Lack of Efficacy|0|||
125089775|NCT01117428|449947025|FG002|Overall Study|Lack of Efficacy|0|||
125089776|NCT01117428|449947026|FG003|Overall Study|Lack of Efficacy|0|||
125089777|NCT01117428|449947027|FG004|Overall Study|Lack of Efficacy|0|||
125089778|NCT01117428|449947028|FG005|Overall Study|Lack of Efficacy|0|||
125089779|NCT01117428|449947023|FG000|Overall Study|Adverse Event|4|||
125089780|NCT01117428|449947024|FG001|Overall Study|Adverse Event|0|||
125089781|NCT01117428|449947025|FG002|Overall Study|Adverse Event|0|||
125089782|NCT01117428|449947026|FG003|Overall Study|Adverse Event|0|||
125089783|NCT01117428|449947027|FG004|Overall Study|Adverse Event|1|||
125201711|NCT02045862|450361495|FG002|Overall Study|Lack of Efficacy|13|||
125201712|NCT02045862|450361493|FG000|Overall Study|Randomized but not Received Study Drug|0|||
125201713|NCT02045862|450361494|FG001|Overall Study|Randomized but not Received Study Drug|2|||
125201714|NCT02045862|450361495|FG002|Overall Study|Randomized but not Received Study Drug|8|||
125201715|NCT02045862|450361493|FG000|Overall Study|Adverse Event|7|||
125201716|NCT02045862|450361494|FG001|Overall Study|Adverse Event|5|||
125201717|NCT02045862|450361495|FG002|Overall Study|Adverse Event|27|||
125201718|NCT02045862|450361493|FG000|Overall Study|Lost to Follow-up|1|||
125201719|NCT02045862|450361494|FG001|Overall Study|Lost to Follow-up|2|||
125201720|NCT02045862|450361495|FG002|Overall Study|Lost to Follow-up|6|||
125201721|NCT03164564|450361496|FG000|Overall Study|Death|3|||
125201722|NCT03164564|450361497|FG001|Overall Study|Death|0|||
125201723|NCT03164564|450361496|FG000|Overall Study|Withdrawal by Subject|20|||
125201724|NCT03164564|450361497|FG001|Overall Study|Withdrawal by Subject|15|||
125201725|NCT03164564|450361496|FG000|Overall Study|Lost to Follow-up|2|||
125201726|NCT03164564|450361497|FG001|Overall Study|Lost to Follow-up|0|||
125201727|NCT03164564|450361496|FG000|Overall Study|Physician Decision|0|||
125201728|NCT03164564|450361497|FG001|Overall Study|Physician Decision|1|||
125201729|NCT03164564|450361496|FG000|Overall Study|Adverse Event|0|||
125201730|NCT03164564|450361497|FG001|Overall Study|Adverse Event|1|||
125201731|NCT03164564|450361496|FG000|Overall Study|Ongoing|1586|||
125201732|NCT03164564|450361497|FG001|Overall Study|Ongoing|1586|||
125201733|NCT02691013|450361498|FG000|Overall Study|Withdrawal by Subject|3|||
125201734|NCT02691013|450361499|FG001|Overall Study|Withdrawal by Subject|0|||
125201735|NCT01075646|450361503|FG000|Overall Study|Lost to Follow-up|4|||
125201736|NCT01075646|450361504|FG001|Overall Study|Lost to Follow-up|3|||
125201737|NCT01075646|450361505|FG002|Overall Study|Lost to Follow-up|1|||
125201738|NCT01075646|450361506|FG003|Overall Study|Lost to Follow-up|2|||
125201739|NCT01895608|450361507|FG000|Overall Study|change in health status|0|||
125201740|NCT01895608|450361508|FG001|Overall Study|change in health status|1|||
125201741|NCT01895608|450361509|FG002|Overall Study|change in health status|1|||
125201742|NCT01895608|450361510|FG003|Overall Study|change in health status|0|||
125201743|NCT01895608|450361507|FG000|Overall Study|Withdrawal by Subject|0|||
125201744|NCT01895608|450361508|FG001|Overall Study|Withdrawal by Subject|0|||
125201745|NCT01895608|450361509|FG002|Overall Study|Withdrawal by Subject|2|||
125201746|NCT01895608|450361510|FG003|Overall Study|Withdrawal by Subject|0|||
125201747|NCT03505593|450361514|FG000|Overall Study|Withdrawal by Subject|1|||
125201748|NCT03505593|450361514|FG000|Overall Study|Died before procedure|1|||
125201749|NCT03505593|450361514|FG000|Overall Study|Anatomical abnormality|1|||
125201750|NCT03505593|450361514|FG000|Overall Study|Unable to pass through esophagus|1|||
125201751|NCT03505593|450361514|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
125201752|NCT02275780|450361515|FG000|Base Study: 96 Weeks|Adverse Event|6|||
125201753|NCT02275780|450361516|FG001|Base Study: 96 Weeks|Adverse Event|14|||
125201754|NCT02275780|450361515|FG000|Base Study: 96 Weeks|Death|3|||
125201755|NCT02275780|450361516|FG001|Base Study: 96 Weeks|Death|1|||
125201756|NCT02275780|450361515|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
125201757|NCT02275780|450361516|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
125201758|NCT02275780|450361515|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
125201759|NCT02275780|450361516|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
125201760|NCT02275780|450361515|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
125201761|NCT02275780|450361516|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
125201762|NCT02275780|450361515|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
125201763|NCT02275780|450361516|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
125201764|NCT02275780|450361515|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
125201765|NCT02275780|450361516|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
125201766|NCT02275780|450361515|FG000|Base Study: 96 Weeks|Physician Decision|2|||
125201767|NCT02275780|450361516|FG001|Base Study: 96 Weeks|Physician Decision|4|||
125201768|NCT02275780|450361515|FG000|Base Study: 96 Weeks|Pregnancy|2|||
125201769|NCT02275780|450361516|FG001|Base Study: 96 Weeks|Pregnancy|1|||
125201770|NCT02275780|450361515|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
125201771|NCT02275780|450361516|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
125201772|NCT02275780|450361515|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
125201773|NCT02275780|450361516|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
125201774|NCT02275780|450361515|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
125201775|NCT02275780|450361516|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
125201776|NCT02275780|450361515|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
125201777|NCT02275780|450361516|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
125201778|NCT02275780|450361515|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
125201779|NCT02275780|450361516|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
125201780|NCT02275780|450361515|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
125201781|NCT02275780|450361516|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
125201782|NCT02275780|450361515|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
125201783|NCT02275780|450361516|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
125201784|NCT02275780|450361515|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
125201785|NCT02275780|450361516|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
125217436|NCT01348100|450423523|FG003|Overall Study|Lost to Follow-up|0|||
125201786|NCT02275780|450361515|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
125201787|NCT02275780|450361516|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
125201788|NCT02275780|450361515|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
125201789|NCT02275780|450361516|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
125201790|NCT02275780|450361515|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
125201791|NCT02275780|450361516|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
125201792|NCT02275780|450361515|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
125201793|NCT02275780|450361516|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
125201794|NCT02275780|450361515|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
125201795|NCT02275780|450361516|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
125201796|NCT02275780|450361515|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
125201797|NCT02275780|450361516|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
125201798|NCT02275780|450361515|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
125201799|NCT02275780|450361516|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
125201800|NCT02275780|450361515|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
125201801|NCT02275780|450361516|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
125201802|NCT02275780|450361515|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
125201803|NCT02275780|450361516|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
125201804|NCT02275780|450361515|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
125201805|NCT02275780|450361516|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
125201806|NCT02275780|450361515|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
125201807|NCT02275780|450361516|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
125201808|NCT02275780|450361515|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
125201809|NCT02275780|450361516|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
125201810|NCT02275780|450361515|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
125201811|NCT02275780|450361516|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
125201812|NCT02275780|450361515|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
125201813|NCT02275780|450361516|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
125201814|NCT02855359|450361521|FG000|Overall Study|Death|2|||
125201815|NCT02855359|450361522|FG001|Overall Study|Death|2|||
125201816|NCT02855359|450361523|FG002|Overall Study|Death|0|||
125201817|NCT02855359|450361524|FG003|Overall Study|Death|0|||
125201818|NCT02855359|450361521|FG000|Overall Study|Study Termination by Sponsor|9|||
125201819|NCT02855359|450361522|FG001|Overall Study|Study Termination by Sponsor|11|||
125201820|NCT02855359|450361523|FG002|Overall Study|Study Termination by Sponsor|0|||
125201821|NCT02855359|450361524|FG003|Overall Study|Study Termination by Sponsor|0|||
125201822|NCT00738881|450361529|FG000|Overall Study|Withdrawal by Subject|0|||
125201823|NCT00738881|450361530|FG001|Overall Study|Withdrawal by Subject|2|||
125201824|NCT00348790|450361531|FG000|Completed Treatment|Withdrawal by Subject|4|||
125201825|NCT00348790|450361531|FG000|Completed Treatment|Disease progression|14|||
125201826|NCT00348790|450361531|FG000|Completed Treatment|Adverse Event|4|||
125201827|NCT00348790|450361531|FG000|Completed Treatment|Required surgery|2|||
125201828|NCT00348790|450361531|FG000|Completed Treatment|Unable to travel to study site|1|||
125201829|NCT01044290|450361532|FG000|Follow-up 1|Death|3|||
125201830|NCT01044290|450361533|FG001|Follow-up 1|Death|3|||
125201831|NCT01044290|450361534|FG002|Follow-up 1|Death|1|||
125201832|NCT01044290|450361532|FG000|Follow-up 1|Withdrawal by Subject|2|||
125201833|NCT01044290|450361533|FG001|Follow-up 1|Withdrawal by Subject|2|||
125201834|NCT01044290|450361534|FG002|Follow-up 1|Withdrawal by Subject|0|||
125201835|NCT01044290|450361532|FG000|Follow-Up 2|Death|0|||
125201836|NCT01044290|450361533|FG001|Follow-Up 2|Death|1|||
125201837|NCT01044290|450361534|FG002|Follow-Up 2|Death|1|||
125201838|NCT01044290|450361532|FG000|Follow-Up 2|Withdrawal by Subject|0|||
125201839|NCT01044290|450361533|FG001|Follow-Up 2|Withdrawal by Subject|1|||
125201840|NCT01044290|450361534|FG002|Follow-Up 2|Withdrawal by Subject|1|||
125201841|NCT00759785|450361540|FG000|Overall Study|Participant sample not evaluable|11|||
125201842|NCT00759785|450361541|FG001|Overall Study|Participant sample not evaluable|2|||
125201843|NCT00759785|450361540|FG000|Overall Study|Participant sample lost|0|||
125201844|NCT00759785|450361541|FG001|Overall Study|Participant sample lost|1|||
125201845|NCT00759785|450361540|FG000|Overall Study|Protocol Violation|1|||
125201846|NCT00759785|450361541|FG001|Overall Study|Protocol Violation|0|||
125201847|NCT00759785|450361540|FG000|Overall Study|Physician Decision|0|||
125201848|NCT00759785|450361541|FG001|Overall Study|Physician Decision|1|||
125201849|NCT00759785|450361540|FG000|Overall Study|Withdrawal by Subject|0|||
125201850|NCT00759785|450361541|FG001|Overall Study|Withdrawal by Subject|1|||
125201851|NCT01646021|450361542|FG000|Overall Study|Death|77|||
125201852|NCT01646021|450361543|FG001|Overall Study|Death|83|||
125201853|NCT01646021|450361542|FG000|Overall Study|Study Terminated by Sponsor|50|||
125201854|NCT01646021|450361543|FG001|Overall Study|Study Terminated by Sponsor|41|||
125201855|NCT01646021|450361542|FG000|Overall Study|Lost to Follow-up|2|||
125201856|NCT01646021|450361543|FG001|Overall Study|Lost to Follow-up|2|||
125201857|NCT01646021|450361542|FG000|Overall Study|Withdrawal by Subject|10|||
125201858|NCT01646021|450361543|FG001|Overall Study|Withdrawal by Subject|15|||
125201859|NCT04712019|450361544|FG000|Overall Study|Withdrawal by Subject|2|||
125201860|NCT04712019|450361545|FG001|Overall Study|Withdrawal by Subject|2|||
125201861|NCT04712019|450361544|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
125201862|NCT04712019|450361545|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
125201863|NCT04521621|450361546|FG000|Overall Study|Death|17|||
125201864|NCT04521621|450361547|FG001|Overall Study|Death|8|||
125201865|NCT04521621|450361548|FG002|Overall Study|Death|8|||
125201866|NCT04521621|450361549|FG003|Overall Study|Death|5|||
125201867|NCT04521621|450361550|FG004|Overall Study|Death|2|||
125201868|NCT04521621|450361551|FG005|Overall Study|Death|7|||
125201869|NCT04521621|450361552|FG006|Overall Study|Death|0|||
125201870|NCT04521621|450361553|FG007|Overall Study|Death|0|||
125201871|NCT04521621|450361546|FG000|Overall Study|Study Terminated by Sponsor|4|||
125201872|NCT04521621|450361547|FG001|Overall Study|Study Terminated by Sponsor|6|||
125201873|NCT04521621|450361548|FG002|Overall Study|Study Terminated by Sponsor|8|||
125201874|NCT04521621|450361549|FG003|Overall Study|Study Terminated by Sponsor|0|||
125201875|NCT04521621|450361550|FG004|Overall Study|Study Terminated by Sponsor|1|||
125201876|NCT04521621|450361551|FG005|Overall Study|Study Terminated by Sponsor|7|||
125201877|NCT04521621|450361552|FG006|Overall Study|Study Terminated by Sponsor|0|||
125201878|NCT04521621|450361553|FG007|Overall Study|Study Terminated by Sponsor|0|||
125201879|NCT04521621|450361546|FG000|Overall Study|Withdrawal by Subject|0|||
125201880|NCT04521621|450361547|FG001|Overall Study|Withdrawal by Subject|0|||
125201881|NCT04521621|450361548|FG002|Overall Study|Withdrawal by Subject|1|||
125201882|NCT04521621|450361549|FG003|Overall Study|Withdrawal by Subject|1|||
125201883|NCT04521621|450361550|FG004|Overall Study|Withdrawal by Subject|0|||
125201884|NCT04521621|450361551|FG005|Overall Study|Withdrawal by Subject|0|||
125201885|NCT04521621|450361552|FG006|Overall Study|Withdrawal by Subject|0|||
125201886|NCT04521621|450361553|FG007|Overall Study|Withdrawal by Subject|0|||
125201887|NCT04521621|450361546|FG000|Overall Study|Allocated in error without study intervention|1|||
125201888|NCT04521621|450361547|FG001|Overall Study|Allocated in error without study intervention|0|||
125201889|NCT04521621|450361548|FG002|Overall Study|Allocated in error without study intervention|0|||
125201890|NCT04521621|450361549|FG003|Overall Study|Allocated in error without study intervention|0|||
125201891|NCT04521621|450361550|FG004|Overall Study|Allocated in error without study intervention|0|||
125201892|NCT04521621|450361551|FG005|Overall Study|Allocated in error without study intervention|0|||
125201893|NCT04521621|450361552|FG006|Overall Study|Allocated in error without study intervention|0|||
125201894|NCT04521621|450361553|FG007|Overall Study|Allocated in error without study intervention|0|||
125201895|NCT01282164|450361554|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
125201896|NCT01282164|450361555|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
125201897|NCT01967706|450361570|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
125201898|NCT01967706|450361571|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
125201899|NCT01967706|450361572|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
125201900|NCT01967706|450361573|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
125201901|NCT02777970|450361574|FG000|Overall Study|Lost to Follow-up|0|||
125201902|NCT02777970|450361575|FG001|Overall Study|Lost to Follow-up|1|||
125201903|NCT02777970|450361576|FG002|Overall Study|Lost to Follow-up|0|||
125201904|NCT02777970|450361574|FG000|Overall Study|Protocol Violation|1|||
125201905|NCT02777970|450361575|FG001|Overall Study|Protocol Violation|0|||
125201906|NCT02777970|450361576|FG002|Overall Study|Protocol Violation|0|||
125201907|NCT02347891|450361580|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
125201908|NCT02347891|450361581|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
125201909|NCT02347891|450361580|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
125201910|NCT02347891|450361581|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
125201911|NCT05845567|450361582|FG000|Overall Study|Withdrawal by Subject|1|||
125201912|NCT02541669|450361583|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
125201913|NCT02541669|450361584|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
125201914|NCT02541669|450361585|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
125201915|NCT02541669|450361586|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
125201916|NCT02541669|450361587|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
125201917|NCT00725608|450361588|FG000|Overall Study|Lost to Follow-up|60|||
125201918|NCT00725608|450361588|FG000|Overall Study|Adverse Event|14|||
125201919|NCT00725608|450361588|FG000|Overall Study|Individual reasons|86|||
125201920|NCT00725608|450361588|FG000|Overall Study|Other|7|||
125201921|NCT03409107|450361589|FG000|Overall Study|Withdrawal by Subject|4|||
125201922|NCT03409107|450361590|FG001|Overall Study|Withdrawal by Subject|2|||
125201923|NCT03409107|450361589|FG000|Overall Study|Physician Decision|1|||
125201924|NCT03409107|450361590|FG001|Overall Study|Physician Decision|0|||
125201925|NCT03409107|450361589|FG000|Overall Study|Lost to Follow-up|7|||
125201926|NCT03409107|450361590|FG001|Overall Study|Lost to Follow-up|2|||
125201927|NCT03409107|450361589|FG000|Overall Study|Adverse Event|5|||
125201928|NCT03409107|450361590|FG001|Overall Study|Adverse Event|3|||
125201929|NCT01084668|450361592|FG000|Overall Study|Lack of Efficacy|5|||
125201930|NCT01084668|450361592|FG000|Overall Study|Withdrawal by Subject|2|||
125201931|NCT01084668|450361592|FG000|Overall Study|Pregnancy|1|||
125201932|NCT01084668|450361592|FG000|Overall Study|Non-compliance|1|||
125201933|NCT01083186|450361594|FG000|Overall Study|Lost to Follow-up|48|||
125201934|NCT01083186|450361594|FG000|Overall Study|Consent Withdrawal|7|||
125201935|NCT01083186|450361594|FG000|Overall Study|Death|3|||
125201936|NCT01083186|450361594|FG000|Overall Study|Adverse Event|3|||
125201937|NCT01083186|450361594|FG000|Overall Study|Lack of Efficacy|2|||
125201938|NCT01083186|450361594|FG000|Overall Study|Hemodialysis Initiation|28|||
125201939|NCT01083186|450361594|FG000|Overall Study|Administrative Reasons|2|||
125201940|NCT01083186|450361594|FG000|Overall Study|Non-compliance to Study Treatment|1|||
125201941|NCT01258075|450361615|FG000|Overall Study|Adverse Event|8|||
125201942|NCT01258075|450361616|FG001|Overall Study|Adverse Event|3|||
125201943|NCT01258075|450361615|FG000|Overall Study|Lost to Follow-up|11|||
125201944|NCT01258075|450361616|FG001|Overall Study|Lost to Follow-up|6|||
125201945|NCT01258075|450361615|FG000|Overall Study|Withdrawal by Subject|10|||
125201946|NCT01258075|450361616|FG001|Overall Study|Withdrawal by Subject|7|||
125201947|NCT01258075|450361615|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
125201948|NCT01258075|450361616|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
125201949|NCT01258075|450361615|FG000|Overall Study|Other|12|||
125201950|NCT01258075|450361616|FG001|Overall Study|Other|5|||
125201951|NCT01500213|450361617|FG000|Overall Study|Adverse Event|35|||
125201952|NCT01500213|450361618|FG001|Overall Study|Adverse Event|35|||
125201953|NCT01500213|450361617|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
125201954|NCT01500213|450361618|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
125201955|NCT01500213|450361617|FG000|Overall Study|Withdrawal by Subject|28|||
125201956|NCT01500213|450361618|FG001|Overall Study|Withdrawal by Subject|37|||
125201957|NCT01500213|450361617|FG000|Overall Study|Death|7|||
125201958|NCT01500213|450361618|FG001|Overall Study|Death|3|||
125201959|NCT01500213|450361617|FG000|Overall Study|Disease Progression|13|||
125201960|NCT01500213|450361618|FG001|Overall Study|Disease Progression|21|||
125201961|NCT01500213|450361617|FG000|Overall Study|Protocol Violation|19|||
125201962|NCT01500213|450361618|FG001|Overall Study|Protocol Violation|19|||
125201963|NCT01500213|450361617|FG000|Overall Study|Physician Decision|12|||
125201964|NCT01500213|450361618|FG001|Overall Study|Physician Decision|10|||
125201965|NCT01500213|450361617|FG000|Overall Study|Lack of Efficacy|9|||
125201966|NCT01500213|450361618|FG001|Overall Study|Lack of Efficacy|7|||
125201967|NCT01500213|450361617|FG000|Overall Study|Lost to Follow-up|3|||
125201968|NCT01500213|450361618|FG001|Overall Study|Lost to Follow-up|6|||
125201969|NCT01500213|450361617|FG000|Overall Study|Other Reasons|7|||
125201970|NCT01500213|450361618|FG001|Overall Study|Other Reasons|5|||
125201971|NCT03197870|450361623|FG000|Overall Study|Adverse Event|9|||
125201972|NCT03197870|450361624|FG001|Overall Study|Adverse Event|4|||
125201973|NCT03197870|450361625|FG002|Overall Study|Adverse Event|6|||
125201974|NCT03197870|450361623|FG000|Overall Study|Withdrawal by Subject|2|||
125201975|NCT03197870|450361624|FG001|Overall Study|Withdrawal by Subject|3|||
125201976|NCT03197870|450361625|FG002|Overall Study|Withdrawal by Subject|0|||
125201977|NCT03197870|450361623|FG000|Overall Study|Lost to Follow-up|2|||
125201978|NCT03197870|450361624|FG001|Overall Study|Lost to Follow-up|2|||
125201979|NCT03197870|450361625|FG002|Overall Study|Lost to Follow-up|0|||
125201980|NCT03197870|450361623|FG000|Overall Study|data not available|1|||
125201981|NCT03197870|450361624|FG001|Overall Study|data not available|1|||
125201982|NCT03197870|450361625|FG002|Overall Study|data not available|0|||
125201983|NCT01618019|450361627|FG000|Overall Study|Withdrawal by Subject|14|||
125201984|NCT01618019|450361628|FG001|Overall Study|Withdrawal by Subject|14|||
125201985|NCT05174949|450361629|FG000|Overall Study|Physician Decision|1|||
125201986|NCT05174949|450361630|FG001|Overall Study|Physician Decision|2|||
125201987|NCT05174949|450361631|FG002|Overall Study|Physician Decision|0|||
125201988|NCT05174949|450361632|FG003|Overall Study|Physician Decision|1|||
125201989|NCT05174949|450361633|FG004|Overall Study|Physician Decision|0|||
125201990|NCT05174949|450361634|FG005|Overall Study|Physician Decision|0|||
125201991|NCT05174949|450361629|FG000|Overall Study|Withdrawal by Subject|0|||
125201992|NCT05174949|450361630|FG001|Overall Study|Withdrawal by Subject|1|||
125201993|NCT05174949|450361631|FG002|Overall Study|Withdrawal by Subject|0|||
125201994|NCT05174949|450361632|FG003|Overall Study|Withdrawal by Subject|0|||
125201995|NCT05174949|450361633|FG004|Overall Study|Withdrawal by Subject|0|||
125201996|NCT05174949|450361634|FG005|Overall Study|Withdrawal by Subject|0|||
125201997|NCT05174949|450361629|FG000|Overall Study|Lost to Follow-up|0|||
125201998|NCT05174949|450361630|FG001|Overall Study|Lost to Follow-up|0|||
125201999|NCT05174949|450361631|FG002|Overall Study|Lost to Follow-up|0|||
125202000|NCT05174949|450361632|FG003|Overall Study|Lost to Follow-up|1|||
125202001|NCT05174949|450361633|FG004|Overall Study|Lost to Follow-up|0|||
125202002|NCT05174949|450361634|FG005|Overall Study|Lost to Follow-up|0|||
125202003|NCT02880865|450361635|FG000|Overall Study|Adverse Event|1|||
125202004|NCT02880865|450361636|FG001|Overall Study|Adverse Event|0|||
125202005|NCT02880865|450361635|FG000|Overall Study|Withdrawal by Subject|0|||
125202006|NCT02880865|450361636|FG001|Overall Study|Withdrawal by Subject|2|||
125202007|NCT02880865|450361635|FG000|Overall Study|Physician Decision|0|||
125202008|NCT02880865|450361636|FG001|Overall Study|Physician Decision|1|||
125217437|NCT01348100|450423524|FG004|Overall Study|Lost to Follow-up|0|||
125202009|NCT00860249|450363556|FG000|Overall Study|trial was terminated prior to completion|21|||
125202010|NCT00860249|450363557|FG001|Overall Study|trial was terminated prior to completion|18|||
125202011|NCT00860249|450363558|FG002|Overall Study|trial was terminated prior to completion|21|||
125202012|NCT00174967|450363559|FG000|Overall Study|Adverse Event|1|||
125202013|NCT00174967|450363560|FG001|Overall Study|Adverse Event|2|||
125202014|NCT00174967|450363561|FG002|Overall Study|Adverse Event|2|||
125202015|NCT00174967|450363562|FG003|Overall Study|Adverse Event|1|||
125202016|NCT00174967|450363559|FG000|Overall Study|Gout Flare|0|||
125202017|NCT00174967|450363560|FG001|Overall Study|Gout Flare|0|||
125202018|NCT00174967|450363561|FG002|Overall Study|Gout Flare|0|||
125202019|NCT00174967|450363562|FG003|Overall Study|Gout Flare|1|||
125202020|NCT00174967|450363559|FG000|Overall Study|Other|0|||
125202021|NCT00174967|450363560|FG001|Overall Study|Other|1|||
125202022|NCT00174967|450363561|FG002|Overall Study|Other|0|||
125202023|NCT00174967|450363562|FG003|Overall Study|Other|0|||
125202024|NCT02031640|450363563|FG000|Screening Period|Adverse Event|1|||
125202025|NCT02031640|450363564|FG001|Screening Period|Adverse Event|0|||
125202026|NCT02031640|450363565|FG002|Screening Period|Adverse Event|0|||
125202027|NCT02031640|450363566|FG003|Screening Period|Adverse Event|0|||
125202028|NCT02031640|450363567|FG004|Screening Period|Adverse Event|0|||
125202029|NCT02031640|450363568|FG005|Screening Period|Adverse Event|0|||
125202030|NCT02031640|450363563|FG000|Screening Period|Withdrawal by Subject|29|||
125202031|NCT02031640|450363564|FG001|Screening Period|Withdrawal by Subject|0|||
125202032|NCT02031640|450363565|FG002|Screening Period|Withdrawal by Subject|0|||
125202033|NCT02031640|450363566|FG003|Screening Period|Withdrawal by Subject|0|||
125202034|NCT02031640|450363567|FG004|Screening Period|Withdrawal by Subject|0|||
125202035|NCT02031640|450363568|FG005|Screening Period|Withdrawal by Subject|0|||
125202036|NCT02031640|450363563|FG000|Screening Period|Inclusion criteria not met|312|||
125202037|NCT02031640|450363564|FG001|Screening Period|Inclusion criteria not met|0|||
125202038|NCT02031640|450363565|FG002|Screening Period|Inclusion criteria not met|0|||
125202039|NCT02031640|450363566|FG003|Screening Period|Inclusion criteria not met|0|||
125202040|NCT02031640|450363567|FG004|Screening Period|Inclusion criteria not met|0|||
125202041|NCT02031640|450363568|FG005|Screening Period|Inclusion criteria not met|0|||
125202042|NCT02031640|450363563|FG000|Screening Period|Exclusion criteria met|30|||
125202043|NCT02031640|450363564|FG001|Screening Period|Exclusion criteria met|0|||
125202044|NCT02031640|450363565|FG002|Screening Period|Exclusion criteria met|0|||
125202045|NCT02031640|450363566|FG003|Screening Period|Exclusion criteria met|0|||
125202046|NCT02031640|450363567|FG004|Screening Period|Exclusion criteria met|0|||
125202047|NCT02031640|450363568|FG005|Screening Period|Exclusion criteria met|0|||
125202048|NCT02031640|450363563|FG000|Screening Period|Lost to Follow-up|14|||
125202049|NCT02031640|450363564|FG001|Screening Period|Lost to Follow-up|0|||
125202050|NCT02031640|450363565|FG002|Screening Period|Lost to Follow-up|0|||
125202051|NCT02031640|450363566|FG003|Screening Period|Lost to Follow-up|0|||
125202052|NCT02031640|450363567|FG004|Screening Period|Lost to Follow-up|0|||
125202053|NCT02031640|450363568|FG005|Screening Period|Lost to Follow-up|0|||
125202054|NCT02031640|450363563|FG000|Screening Period|Enrollment closed|26|||
125202055|NCT02031640|450363564|FG001|Screening Period|Enrollment closed|0|||
125202056|NCT02031640|450363565|FG002|Screening Period|Enrollment closed|0|||
125202057|NCT02031640|450363566|FG003|Screening Period|Enrollment closed|0|||
125202058|NCT02031640|450363567|FG004|Screening Period|Enrollment closed|0|||
125202059|NCT02031640|450363568|FG005|Screening Period|Enrollment closed|0|||
125202060|NCT02031640|450363563|FG000|Run-In Period|Adverse Event|4|||
125202061|NCT02031640|450363564|FG001|Run-In Period|Adverse Event|0|||
125202062|NCT02031640|450363565|FG002|Run-In Period|Adverse Event|0|||
125202063|NCT02031640|450363566|FG003|Run-In Period|Adverse Event|0|||
125202064|NCT02031640|450363567|FG004|Run-In Period|Adverse Event|0|||
125202065|NCT02031640|450363568|FG005|Run-In Period|Adverse Event|0|||
125202066|NCT02031640|450363563|FG000|Run-In Period|Withdrawal by Subject|17|||
125202067|NCT02031640|450363564|FG001|Run-In Period|Withdrawal by Subject|0|||
125202068|NCT02031640|450363565|FG002|Run-In Period|Withdrawal by Subject|0|||
125202069|NCT02031640|450363566|FG003|Run-In Period|Withdrawal by Subject|0|||
125202070|NCT02031640|450363567|FG004|Run-In Period|Withdrawal by Subject|0|||
125202071|NCT02031640|450363568|FG005|Run-In Period|Withdrawal by Subject|0|||
125202072|NCT02031640|450363563|FG000|Run-In Period|Inclusion criteria not met|38|||
125202073|NCT02031640|450363564|FG001|Run-In Period|Inclusion criteria not met|0|||
125202074|NCT02031640|450363565|FG002|Run-In Period|Inclusion criteria not met|0|||
125202075|NCT02031640|450363566|FG003|Run-In Period|Inclusion criteria not met|0|||
125202076|NCT02031640|450363567|FG004|Run-In Period|Inclusion criteria not met|0|||
125202077|NCT02031640|450363568|FG005|Run-In Period|Inclusion criteria not met|0|||
125202078|NCT02031640|450363563|FG000|Run-In Period|Exclusion criteria met|8|||
125202079|NCT02031640|450363564|FG001|Run-In Period|Exclusion criteria met|0|||
125202080|NCT02031640|450363565|FG002|Run-In Period|Exclusion criteria met|0|||
125202081|NCT02031640|450363566|FG003|Run-In Period|Exclusion criteria met|0|||
125202082|NCT02031640|450363567|FG004|Run-In Period|Exclusion criteria met|0|||
125202083|NCT02031640|450363568|FG005|Run-In Period|Exclusion criteria met|0|||
125202084|NCT02031640|450363563|FG000|Run-In Period|Randomization criteria not met|85|||
125217438|NCT01348100|450423525|FG005|Overall Study|Lost to Follow-up|0|||
125202085|NCT02031640|450363564|FG001|Run-In Period|Randomization criteria not met|0|||
125202086|NCT02031640|450363565|FG002|Run-In Period|Randomization criteria not met|0|||
125202087|NCT02031640|450363566|FG003|Run-In Period|Randomization criteria not met|0|||
125202088|NCT02031640|450363567|FG004|Run-In Period|Randomization criteria not met|0|||
125202089|NCT02031640|450363568|FG005|Run-In Period|Randomization criteria not met|0|||
125202090|NCT02031640|450363563|FG000|Run-In Period|Various administrative reasons|17|||
125202091|NCT02031640|450363564|FG001|Run-In Period|Various administrative reasons|0|||
125202092|NCT02031640|450363565|FG002|Run-In Period|Various administrative reasons|0|||
125202093|NCT02031640|450363566|FG003|Run-In Period|Various administrative reasons|0|||
125202094|NCT02031640|450363567|FG004|Run-In Period|Various administrative reasons|0|||
125202095|NCT02031640|450363568|FG005|Run-In Period|Various administrative reasons|0|||
125202096|NCT02031640|450363563|FG000|Double-blind Treatment Period|Protocol deviation|0|||
125202097|NCT02031640|450363564|FG001|Double-blind Treatment Period|Protocol deviation|2|||
125202098|NCT02031640|450363565|FG002|Double-blind Treatment Period|Protocol deviation|0|||
125202099|NCT02031640|450363566|FG003|Double-blind Treatment Period|Protocol deviation|1|||
125202100|NCT02031640|450363567|FG004|Double-blind Treatment Period|Protocol deviation|3|||
125202101|NCT02031640|450363568|FG005|Double-blind Treatment Period|Protocol deviation|1|||
125202102|NCT02031640|450363563|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
125202103|NCT02031640|450363564|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
125202104|NCT02031640|450363565|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
125202105|NCT02031640|450363566|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
125202106|NCT02031640|450363567|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
125202107|NCT02031640|450363568|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
125202108|NCT02031640|450363563|FG000|Double-blind Treatment Period|Non-compliance|0|||
125202109|NCT02031640|450363564|FG001|Double-blind Treatment Period|Non-compliance|1|||
125202110|NCT02031640|450363565|FG002|Double-blind Treatment Period|Non-compliance|0|||
125202111|NCT02031640|450363566|FG003|Double-blind Treatment Period|Non-compliance|1|||
125202112|NCT02031640|450363567|FG004|Double-blind Treatment Period|Non-compliance|1|||
125202113|NCT02031640|450363568|FG005|Double-blind Treatment Period|Non-compliance|0|||
125202114|NCT02031640|450363563|FG000|Double-blind Treatment Period|Adverse Event|0|||
125202115|NCT02031640|450363564|FG001|Double-blind Treatment Period|Adverse Event|0|||
125202116|NCT02031640|450363565|FG002|Double-blind Treatment Period|Adverse Event|0|||
125202117|NCT02031640|450363566|FG003|Double-blind Treatment Period|Adverse Event|2|||
125202118|NCT02031640|450363567|FG004|Double-blind Treatment Period|Adverse Event|0|||
125202119|NCT02031640|450363568|FG005|Double-blind Treatment Period|Adverse Event|0|||
125202120|NCT02031640|450363563|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
125202121|NCT02031640|450363564|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
125202122|NCT02031640|450363565|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
125202123|NCT02031640|450363566|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
125202124|NCT02031640|450363567|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
125202125|NCT02031640|450363568|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
125202126|NCT02031640|450363563|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
125202127|NCT02031640|450363564|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
125202128|NCT02031640|450363565|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
125202129|NCT02031640|450363566|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
125202130|NCT02031640|450363567|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
125202131|NCT02031640|450363568|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
125202132|NCT03085238|450363571|FG000|Overall Study|Adverse Event|2|||
125202133|NCT03085238|450363571|FG000|Overall Study|Death|2|||
125202134|NCT02822573|450363580|FG000|Overall Study|Lost to Follow-up|5|||
125202135|NCT02822573|450363581|FG001|Overall Study|Lost to Follow-up|3|||
125202136|NCT02822573|450363580|FG000|Overall Study|Physician Decision|1|||
125202137|NCT02822573|450363581|FG001|Overall Study|Physician Decision|1|||
125202138|NCT02822573|450363580|FG000|Overall Study|Withdrawal by Subject|9|||
125202139|NCT02822573|450363581|FG001|Overall Study|Withdrawal by Subject|5|||
125202140|NCT02822573|450363580|FG000|Overall Study|Protocol Violation|6|||
125202141|NCT02822573|450363581|FG001|Overall Study|Protocol Violation|4|||
125202142|NCT02822573|450363580|FG000|Overall Study|Too sick or ill|2|||
125202143|NCT02822573|450363581|FG001|Overall Study|Too sick or ill|1|||
125202144|NCT02822573|450363580|FG000|Overall Study|Disease Progression|1|||
125202145|NCT02822573|450363581|FG001|Overall Study|Disease Progression|1|||
125202146|NCT02822573|450363580|FG000|Overall Study|No reason given|6|||
125202147|NCT02822573|450363581|FG001|Overall Study|No reason given|4|||
125202148|NCT01054300|450363582|FG000|Period 1|Adverse Event|1|||
125202149|NCT01054300|450363583|FG001|Period 1|Adverse Event|0|||
125202150|NCT01054300|450363584|FG002|Period 1|Adverse Event|0|||
125202151|NCT01054300|450363585|FG003|Period 1|Adverse Event|0|||
125202152|NCT01054300|450363582|FG000|Period 2|Withdrawal by Subject|0|||
125202153|NCT01054300|450363583|FG001|Period 2|Withdrawal by Subject|0|||
125202154|NCT01054300|450363584|FG002|Period 2|Withdrawal by Subject|1|||
125202155|NCT01054300|450363585|FG003|Period 2|Withdrawal by Subject|0|||
125202156|NCT00308087|450363586|FG000|Overall Study|Progressive Disease|19|||
125202157|NCT00308087|450363587|FG001|Overall Study|Progressive Disease|21|||
125202158|NCT00308087|450363586|FG000|Overall Study|Study Closure|11|||
125202159|NCT00308087|450363587|FG001|Overall Study|Study Closure|12|||
125202160|NCT00308087|450363586|FG000|Overall Study|Withdrawal by Subject|2|||
125202161|NCT00308087|450363587|FG001|Overall Study|Withdrawal by Subject|1|||
125202162|NCT00308087|450363586|FG000|Overall Study|Other|4|||
125202163|NCT00308087|450363587|FG001|Overall Study|Other|3|||
125202164|NCT04186806|450363592|FG000|Period 1: 7 Days|Adverse Event|1|||
125202165|NCT04186806|450363593|FG001|Period 1: 7 Days|Adverse Event|0|||
125202166|NCT00177307|450363596|FG000|Overall Study|Withdrawal by Subject|1|||
125202167|NCT01459718|450363597|FG000|Overall Study|Physician Decision|1|||
125202168|NCT01459718|450363597|FG000|Overall Study|Lost to Follow-up|1|||
125202169|NCT01459718|450363597|FG000|Overall Study|Adverse Event|1|||
125202170|NCT01542034|450363600|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
125202171|NCT01542034|450363601|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
125202172|NCT01542034|450363600|FG000|Overall Study|Administrative decision|0|||
125202173|NCT01542034|450363601|FG001|Overall Study|Administrative decision|3|||
125202174|NCT01542034|450363600|FG000|Overall Study|Subject Noncompliance|1|||
125202175|NCT01542034|450363601|FG001|Overall Study|Subject Noncompliance|0|||
125202176|NCT01542034|450363600|FG000|Overall Study|Adverse Event|2|||
125202177|NCT01542034|450363601|FG001|Overall Study|Adverse Event|2|||
125202178|NCT01542034|450363600|FG000|Overall Study|Lost to Follow-up|7|||
125202179|NCT01542034|450363601|FG001|Overall Study|Lost to Follow-up|6|||
125202180|NCT02612610|450363602|FG000|Overall Study|Withdrawal by Subject|1|||
125202181|NCT02612610|450363603|FG001|Overall Study|Withdrawal by Subject|1|||
125202182|NCT02612610|450363604|FG002|Overall Study|Withdrawal by Subject|0|||
125202183|NCT02612610|450363605|FG003|Overall Study|Withdrawal by Subject|2|||
125202184|NCT02612610|450363602|FG000|Overall Study|Adverse Event|2|||
125202185|NCT02612610|450363603|FG001|Overall Study|Adverse Event|2|||
125202186|NCT02612610|450363604|FG002|Overall Study|Adverse Event|3|||
125202187|NCT02612610|450363605|FG003|Overall Study|Adverse Event|10|||
125202188|NCT02612610|450363602|FG000|Overall Study|Lost to Follow-up|0|||
125202189|NCT02612610|450363603|FG001|Overall Study|Lost to Follow-up|1|||
125202190|NCT02612610|450363604|FG002|Overall Study|Lost to Follow-up|0|||
125202191|NCT02612610|450363605|FG003|Overall Study|Lost to Follow-up|0|||
125202192|NCT02612610|450363602|FG000|Overall Study|Protocol Violation|0|||
125202193|NCT02612610|450363603|FG001|Overall Study|Protocol Violation|1|||
125202194|NCT02612610|450363604|FG002|Overall Study|Protocol Violation|1|||
125202195|NCT02612610|450363605|FG003|Overall Study|Protocol Violation|0|||
125202196|NCT02612610|450363602|FG000|Overall Study|Lack of Efficacy|1|||
125202197|NCT02612610|450363603|FG001|Overall Study|Lack of Efficacy|2|||
125202198|NCT02612610|450363604|FG002|Overall Study|Lack of Efficacy|0|||
125202199|NCT02612610|450363605|FG003|Overall Study|Lack of Efficacy|1|||
125202200|NCT02612610|450363602|FG000|Overall Study|Physician Decision|0|||
125202201|NCT02612610|450363603|FG001|Overall Study|Physician Decision|1|||
125202202|NCT02612610|450363604|FG002|Overall Study|Physician Decision|0|||
125202203|NCT02612610|450363605|FG003|Overall Study|Physician Decision|0|||
125202204|NCT02612610|450363602|FG000|Overall Study|Noncompliance|1|||
125202205|NCT02612610|450363603|FG001|Overall Study|Noncompliance|0|||
125202206|NCT02612610|450363604|FG002|Overall Study|Noncompliance|0|||
125202207|NCT02612610|450363605|FG003|Overall Study|Noncompliance|0|||
125202208|NCT02612610|450363602|FG000|Overall Study|Cough Improvement|0|||
125202209|NCT02612610|450363603|FG001|Overall Study|Cough Improvement|0|||
125202210|NCT02612610|450363604|FG002|Overall Study|Cough Improvement|1|||
125202211|NCT02612610|450363605|FG003|Overall Study|Cough Improvement|0|||
125202212|NCT00176644|450363606|FG000|Overall Study|Withdrawal by Subject|1|||
125202213|NCT01801280|450363607|FG000|Period 1|Withdrawal by Subject|0|||
125202214|NCT01801280|450363608|FG001|Period 1|Withdrawal by Subject|1|||
125202215|NCT01801280|450363609|FG002|Period 1|Withdrawal by Subject|0|||
125202216|NCT01801280|450363610|FG003|Period 1|Withdrawal by Subject|0|||
125202217|NCT01801280|450363607|FG000|Period 2|Withdrawal by Subject|1|||
125202218|NCT01801280|450363608|FG001|Period 2|Withdrawal by Subject|0|||
125202219|NCT01801280|450363609|FG002|Period 2|Withdrawal by Subject|0|||
125202220|NCT01801280|450363610|FG003|Period 2|Withdrawal by Subject|0|||
125202221|NCT01801280|450363607|FG000|Period 4|Protocol Violation|0|||
125202222|NCT01801280|450363608|FG001|Period 4|Protocol Violation|0|||
125202223|NCT01801280|450363609|FG002|Period 4|Protocol Violation|1|||
125202224|NCT01801280|450363610|FG003|Period 4|Protocol Violation|0|||
125202225|NCT02783729|450363611|FG000|Overall Study|Lack of Efficacy|1|||
125202226|NCT02783729|450363612|FG001|Overall Study|Lack of Efficacy|0|||
125202227|NCT02783729|450363613|FG002|Overall Study|Lack of Efficacy|0|||
125202228|NCT02783729|450363614|FG003|Overall Study|Lack of Efficacy|0|||
125202229|NCT02783729|450363611|FG000|Overall Study|Adverse Event|2|||
125202230|NCT02783729|450363612|FG001|Overall Study|Adverse Event|6|||
125202231|NCT02783729|450363613|FG002|Overall Study|Adverse Event|2|||
125202232|NCT02783729|450363614|FG003|Overall Study|Adverse Event|3|||
125202233|NCT02783729|450363611|FG000|Overall Study|Other|1|||
125202234|NCT02783729|450363612|FG001|Overall Study|Other|6|||
125202235|NCT02783729|450363613|FG002|Overall Study|Other|2|||
125202236|NCT02783729|450363614|FG003|Overall Study|Other|3|||
125202237|NCT02783729|450363611|FG000|Overall Study|Withdrawal by Subject|2|||
125202238|NCT02783729|450363612|FG001|Overall Study|Withdrawal by Subject|3|||
125202239|NCT02783729|450363613|FG002|Overall Study|Withdrawal by Subject|1|||
125202240|NCT02783729|450363614|FG003|Overall Study|Withdrawal by Subject|2|||
125202241|NCT02783729|450363611|FG000|Overall Study|Participant's choice|2|||
125202242|NCT02783729|450363612|FG001|Overall Study|Participant's choice|1|||
125202243|NCT02783729|450363613|FG002|Overall Study|Participant's choice|2|||
125202244|NCT02783729|450363614|FG003|Overall Study|Participant's choice|1|||
125202245|NCT02783729|450363611|FG000|Overall Study|Lost to Follow-up|2|||
125202246|NCT02783729|450363612|FG001|Overall Study|Lost to Follow-up|1|||
125202247|NCT02783729|450363613|FG002|Overall Study|Lost to Follow-up|1|||
125202248|NCT02783729|450363614|FG003|Overall Study|Lost to Follow-up|0|||
125202249|NCT02693171|450363615|FG000|Overall Study|Adverse Event|1|||
125202250|NCT02693171|450363615|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
125202251|NCT01866657|450363623|FG000|Overall Study|Surgery canceled|2|||
125202252|NCT01866657|450363624|FG001|Overall Study|Surgery canceled|0|||
125202253|NCT02288091|450363631|FG000|Overall Study|Lost to Follow-up|1|||
125202254|NCT02288091|450363631|FG000|Overall Study|Screen fail|7|||
125202255|NCT04021121|450363633|FG000|Overall Study|Death|3|||
125202256|NCT04021121|450363634|FG001|Overall Study|Death|3|||
125202257|NCT04021121|450363635|FG002|Overall Study|Death|5|||
125202258|NCT04021121|450363636|FG003|Overall Study|Death|4|||
125202259|NCT00978250|450363640|FG000|Overall Study|Late determination of ineligibility|0|||
125202260|NCT00978250|450363641|FG001|Overall Study|Late determination of ineligibility|1|||
125202261|NCT00978250|450363642|FG002|Overall Study|Late determination of ineligibility|0|||
125202262|NCT00978250|450363643|FG003|Overall Study|Late determination of ineligibility|1|||
125202263|NCT02029989|450363646|FG000|Overall Study|Withdrawal by Subject|1|||
125202264|NCT02029989|450363647|FG001|Overall Study|Withdrawal by Subject|0|||
124869908|NCT00863655|449143572|FG000|Overall Study|Treatment completed as per protocol|5|||
124869909|NCT00863655|449143573|FG001|Overall Study|Treatment completed as per protocol|1|||
124869910|NCT02157779|449143574|FG000|Overall Study|Logistical|9|||
124869911|NCT02157779|449143575|FG001|Overall Study|Logistical|3|||
124869912|NCT02157779|449143574|FG000|Overall Study|Stopped attending, reason unknown|11|||
124869913|NCT02157779|449143575|FG001|Overall Study|Stopped attending, reason unknown|7|||
124869914|NCT02157779|449143574|FG000|Overall Study|No response to outreach after Baseline|1|||
124869915|NCT02157779|449143575|FG001|Overall Study|No response to outreach after Baseline|1|||
124869916|NCT02157779|449143574|FG000|Overall Study|Moved|1|||
124869917|NCT02157779|449143575|FG001|Overall Study|Moved|0|||
124869918|NCT02157779|449143574|FG000|Overall Study|Medical|1|||
124869919|NCT02157779|449143575|FG001|Overall Study|Medical|0|||
124869920|NCT02157779|449143574|FG000|Overall Study|Legal issue|1|||
124869921|NCT02157779|449143575|FG001|Overall Study|Legal issue|0|||
124869922|NCT00430248|449143578|FG000|Overall Study|Adverse Event|49|||
124869923|NCT00430248|449143579|FG001|Overall Study|Adverse Event|61|||
124869924|NCT00430248|449143580|FG002|Overall Study|Adverse Event|64|||
124869925|NCT00430248|449143578|FG000|Overall Study|Protocol Violation|10|||
124869926|NCT00430248|449143579|FG001|Overall Study|Protocol Violation|2|||
124869927|NCT00430248|449143580|FG002|Overall Study|Protocol Violation|4|||
125202265|NCT02029989|450363646|FG000|Overall Study|Withdrawal: Fear of needles|1|||
125202266|NCT02029989|450363647|FG001|Overall Study|Withdrawal: Fear of needles|0|||
125202267|NCT02029989|450363646|FG000|Overall Study|Change of location|2|||
125202268|NCT02029989|450363647|FG001|Overall Study|Change of location|3|||
125202269|NCT02029989|450363646|FG000|Overall Study|Physician Decision|2|||
125202270|NCT02029989|450363647|FG001|Overall Study|Physician Decision|0|||
125202271|NCT02029989|450363646|FG000|Overall Study|Lost to Follow-up|9|||
125202272|NCT02029989|450363647|FG001|Overall Study|Lost to Follow-up|7|||
125202273|NCT02029989|450363646|FG000|Overall Study|Death|0|||
125202274|NCT02029989|450363647|FG001|Overall Study|Death|1|||
125202275|NCT02029989|450363646|FG000|Overall Study|Protocol Violation|1|||
125202276|NCT02029989|450363647|FG001|Overall Study|Protocol Violation|0|||
125202277|NCT04351373|450363648|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
124869928|NCT00430248|449143578|FG000|Overall Study|Personal Reasons|12|||
124869929|NCT00430248|449143579|FG001|Overall Study|Personal Reasons|24|||
124869930|NCT00430248|449143580|FG002|Overall Study|Personal Reasons|9|||
124869931|NCT00430248|449143578|FG000|Overall Study|Lost to Follow-up|28|||
124869932|NCT00430248|449143579|FG001|Overall Study|Lost to Follow-up|33|||
124869933|NCT00430248|449143580|FG002|Overall Study|Lost to Follow-up|28|||
124869934|NCT00430248|449143578|FG000|Overall Study|Therapeutic Failure|1|||
124869935|NCT00430248|449143579|FG001|Overall Study|Therapeutic Failure|1|||
124869936|NCT00430248|449143580|FG002|Overall Study|Therapeutic Failure|1|||
124869937|NCT00430248|449143578|FG000|Overall Study|Withdrawal by Subject|14|||
124869938|NCT00430248|449143579|FG001|Overall Study|Withdrawal by Subject|20|||
124869939|NCT00430248|449143580|FG002|Overall Study|Withdrawal by Subject|16|||
124869940|NCT00430248|449143578|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124869941|NCT00430248|449143579|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
124869942|NCT00430248|449143580|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124869943|NCT00430248|449143578|FG000|Overall Study|Gout Flare|3|||
124869944|NCT00430248|449143579|FG001|Overall Study|Gout Flare|7|||
124869945|NCT00430248|449143580|FG002|Overall Study|Gout Flare|2|||
124869946|NCT00430248|449143578|FG000|Overall Study|Reason Not Specified|8|||
124869947|NCT00430248|449143579|FG001|Overall Study|Reason Not Specified|8|||
124869948|NCT00430248|449143580|FG002|Overall Study|Reason Not Specified|11|||
124869949|NCT00002558|449143583|FG000|Overall Study|Withdrawal by Subject|0|||
124869950|NCT00002558|449143584|FG001|Overall Study|Withdrawal by Subject|1|||
124869951|NCT01754467|449143585|FG000|Overall Study|Lost to Follow-up|1|||
124869952|NCT02065336|449143586|FG000|Extension Phase|Study Terminated by Sponsor|0|||
124869953|NCT02065336|449143587|FG001|Extension Phase|Study Terminated by Sponsor|0|||
124869954|NCT02065336|449143588|FG002|Extension Phase|Study Terminated by Sponsor|0|||
124869955|NCT02065336|449143589|FG003|Extension Phase|Study Terminated by Sponsor|0|||
124869956|NCT02065336|449143590|FG004|Extension Phase|Study Terminated by Sponsor|0|||
124869957|NCT02065336|449143591|FG005|Extension Phase|Study Terminated by Sponsor|0|||
124869958|NCT02065336|449143592|FG006|Extension Phase|Study Terminated by Sponsor|0|||
124869959|NCT02065336|449143593|FG007|Extension Phase|Study Terminated by Sponsor|0|||
124869960|NCT02065336|449143594|FG008|Extension Phase|Study Terminated by Sponsor|2|||
124869961|NCT02065336|449143595|FG009|Extension Phase|Study Terminated by Sponsor|8|||
124869962|NCT01970462|449143596|FG000|Overall Study|Lost to Follow-up|0|||
124869963|NCT01970462|449143597|FG001|Overall Study|Lost to Follow-up|2|||
124869964|NCT02316769|449143600|FG000|Overall Study|Physician Decision|1|||
124869965|NCT02316769|449143601|FG001|Overall Study|Physician Decision|0|||
124869966|NCT02316769|449143600|FG000|Overall Study|Withdrawal by Subject|1|||
124869967|NCT02316769|449143601|FG001|Overall Study|Withdrawal by Subject|0|||
124869968|NCT00677235|449143602|FG000|Overall Study|Withdrawal by Subject|1|||
124869969|NCT00677235|449143603|FG001|Overall Study|Withdrawal by Subject|1|||
124869970|NCT00677235|449143602|FG000|Overall Study|Lost to Follow-up|2|||
124869971|NCT00677235|449143603|FG001|Overall Study|Lost to Follow-up|1|||
124869972|NCT00677235|449143602|FG000|Overall Study|Death|37|||
124869973|NCT00677235|449143603|FG001|Overall Study|Death|36|||
124869974|NCT00677235|449143602|FG000|Overall Study|Adverse Experience|1|||
124869975|NCT00677235|449143603|FG001|Overall Study|Adverse Experience|0|||
124869976|NCT01040260|449143604|FG000|Overall Study|Withdrawal by Subject|12|||
124869977|NCT01040260|449143605|FG001|Overall Study|Withdrawal by Subject|6|||
124869978|NCT01040260|449143604|FG000|Overall Study|Lost to Follow-up|3|||
124869979|NCT01040260|449143605|FG001|Overall Study|Lost to Follow-up|5|||
124869980|NCT04570436|449143606|FG000|Overall Study|Adverse Event|0|||
124869981|NCT04570436|449143607|FG001|Overall Study|Adverse Event|0|||
124869982|NCT04570436|449143608|FG002|Overall Study|Adverse Event|1|||
124869983|NCT04570436|449143609|FG003|Overall Study|Adverse Event|0|||
124869984|NCT04570436|449143610|FG004|Overall Study|Adverse Event|0|||
124869985|NCT04570436|449143611|FG005|Overall Study|Adverse Event|0|||
124869986|NCT04570436|449143612|FG006|Overall Study|Adverse Event|0|||
124869987|NCT04570436|449143613|FG007|Overall Study|Adverse Event|0|||
124869988|NCT04570436|449143614|FG008|Overall Study|Adverse Event|0|||
125202278|NCT00471718|450363660|FG000|Overall Study|Adverse Event|3|||
125202279|NCT00471718|450363660|FG000|Overall Study|other complicating disease|1|||
125202280|NCT00471718|450363660|FG000|Overall Study|disease progression|22|||
124869989|NCT04570436|449143615|FG009|Overall Study|Adverse Event|0|||
124869990|NCT04570436|449143606|FG000|Overall Study|Physician Decision|1|||
124869991|NCT04570436|449143607|FG001|Overall Study|Physician Decision|0|||
124869992|NCT04570436|449143608|FG002|Overall Study|Physician Decision|0|||
124869993|NCT04570436|449143609|FG003|Overall Study|Physician Decision|0|||
124869994|NCT04570436|449143610|FG004|Overall Study|Physician Decision|0|||
124869995|NCT04570436|449143611|FG005|Overall Study|Physician Decision|0|||
124869996|NCT04570436|449143612|FG006|Overall Study|Physician Decision|0|||
124869997|NCT04570436|449143613|FG007|Overall Study|Physician Decision|0|||
124869998|NCT04570436|449143614|FG008|Overall Study|Physician Decision|0|||
125202281|NCT00471718|450363660|FG000|Overall Study|Withdrawal by Subject|1|||
124869999|NCT04570436|449143615|FG009|Overall Study|Physician Decision|0|||
124870000|NCT00929162|449143617|FG000|Overall Study|Adverse Event|8|||
125202282|NCT01597375|450363663|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
124870001|NCT00929162|449143618|FG001|Overall Study|Adverse Event|5|||
124870002|NCT00929162|449143617|FG000|Overall Study|Withdrawal by Subject|3|||
124870003|NCT00929162|449143618|FG001|Overall Study|Withdrawal by Subject|1|||
124870004|NCT00929162|449143617|FG000|Overall Study|Protocol Violation|32|||
124870005|NCT00929162|449143618|FG001|Overall Study|Protocol Violation|30|||
124870006|NCT00929162|449143617|FG000|Overall Study|Other termination reason|5|||
124870007|NCT00929162|449143618|FG001|Overall Study|Other termination reason|6|||
124870008|NCT01274182|449143620|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
124870009|NCT01274182|449143621|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
124870010|NCT01274182|449143622|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
124870011|NCT01274182|449143620|FG000|Overall Study|Adverse Event|4|||
124870012|NCT01274182|449143621|FG001|Overall Study|Adverse Event|5|||
124870013|NCT01274182|449143622|FG002|Overall Study|Adverse Event|3|||
124870014|NCT01274182|449143620|FG000|Overall Study|Withdrawal by Subject|5|||
124870015|NCT01274182|449143621|FG001|Overall Study|Withdrawal by Subject|5|||
124870016|NCT01274182|449143622|FG002|Overall Study|Withdrawal by Subject|3|||
124870017|NCT01274182|449143620|FG000|Overall Study|Lost to Follow-up|2|||
124870018|NCT01274182|449143621|FG001|Overall Study|Lost to Follow-up|3|||
124870019|NCT01274182|449143622|FG002|Overall Study|Lost to Follow-up|1|||
124870020|NCT01274182|449143620|FG000|Overall Study|Protocol Violation|3|||
124870021|NCT01274182|449143621|FG001|Overall Study|Protocol Violation|2|||
124870022|NCT01274182|449143622|FG002|Overall Study|Protocol Violation|0|||
124870023|NCT01274182|449143620|FG000|Overall Study|Death|1|||
124870024|NCT01274182|449143621|FG001|Overall Study|Death|0|||
124870025|NCT01274182|449143622|FG002|Overall Study|Death|1|||
124870026|NCT02355002|449143623|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
124870027|NCT02355002|449143624|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
124870028|NCT02355002|449143623|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
124870029|NCT02355002|449143624|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
124870030|NCT02355002|449143623|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
124870031|NCT02355002|449143624|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
124870032|NCT02355002|449143623|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
124870033|NCT02355002|449143624|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
124870034|NCT02355002|449143623|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
124870035|NCT02355002|449143624|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
124870036|NCT02355002|449143623|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
124870037|NCT02355002|449143624|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
124870038|NCT02355002|449143623|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
124870039|NCT02355002|449143624|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
124870040|NCT03205371|449143627|FG000|Overall Study|Withdrawal by Subject|4|||
124870041|NCT03205371|449143628|FG001|Overall Study|Withdrawal by Subject|1|||
124870042|NCT03205371|449143629|FG002|Overall Study|Withdrawal by Subject|0|||
124870043|NCT03205371|449143630|FG003|Overall Study|Withdrawal by Subject|0|||
124870044|NCT03205371|449143631|FG004|Overall Study|Withdrawal by Subject|0|||
124870045|NCT03205371|449143632|FG005|Overall Study|Withdrawal by Subject|0|||
124870046|NCT03205371|449143633|FG006|Overall Study|Withdrawal by Subject|4|||
124870047|NCT03205371|449143634|FG007|Overall Study|Withdrawal by Subject|0|||
124870048|NCT03205371|449143635|FG008|Overall Study|Withdrawal by Subject|2|||
124870049|NCT03205371|449143636|FG009|Overall Study|Withdrawal by Subject|0|||
124870050|NCT03205371|449143637|FG010|Overall Study|Withdrawal by Subject|0|||
124870051|NCT03205371|449143638|FG011|Overall Study|Withdrawal by Subject|1|||
124870052|NCT03205371|449143627|FG000|Overall Study|Lost to Follow-up|0|||
124870053|NCT03205371|449143628|FG001|Overall Study|Lost to Follow-up|0|||
124870054|NCT03205371|449143629|FG002|Overall Study|Lost to Follow-up|0|||
124870055|NCT03205371|449143630|FG003|Overall Study|Lost to Follow-up|0|||
124870056|NCT03205371|449143631|FG004|Overall Study|Lost to Follow-up|0|||
124870057|NCT03205371|449143632|FG005|Overall Study|Lost to Follow-up|0|||
124870058|NCT03205371|449143633|FG006|Overall Study|Lost to Follow-up|5|||
124870059|NCT03205371|449143634|FG007|Overall Study|Lost to Follow-up|2|||
124870060|NCT03205371|449143635|FG008|Overall Study|Lost to Follow-up|3|||
124870061|NCT03205371|449143636|FG009|Overall Study|Lost to Follow-up|0|||
124870062|NCT03205371|449143637|FG010|Overall Study|Lost to Follow-up|0|||
124870063|NCT03205371|449143638|FG011|Overall Study|Lost to Follow-up|0|||
124870064|NCT03205371|449143627|FG000|Overall Study|Protocol Violation|0|||
124870065|NCT03205371|449143628|FG001|Overall Study|Protocol Violation|0|||
124870066|NCT03205371|449143629|FG002|Overall Study|Protocol Violation|0|||
124870067|NCT03205371|449143630|FG003|Overall Study|Protocol Violation|0|||
124870068|NCT03205371|449143631|FG004|Overall Study|Protocol Violation|0|||
124870069|NCT03205371|449143632|FG005|Overall Study|Protocol Violation|0|||
124870070|NCT03205371|449143633|FG006|Overall Study|Protocol Violation|1|||
124870071|NCT03205371|449143634|FG007|Overall Study|Protocol Violation|0|||
124870072|NCT03205371|449143635|FG008|Overall Study|Protocol Violation|0|||
124870073|NCT03205371|449143636|FG009|Overall Study|Protocol Violation|0|||
124870074|NCT03205371|449143637|FG010|Overall Study|Protocol Violation|0|||
124870075|NCT03205371|449143638|FG011|Overall Study|Protocol Violation|0|||
124870076|NCT03205371|449143627|FG000|Overall Study|Adverse Event|0|||
124870077|NCT03205371|449143628|FG001|Overall Study|Adverse Event|0|||
124870078|NCT03205371|449143629|FG002|Overall Study|Adverse Event|0|||
124870079|NCT03205371|449143630|FG003|Overall Study|Adverse Event|0|||
124870080|NCT03205371|449143631|FG004|Overall Study|Adverse Event|0|||
124870081|NCT03205371|449143632|FG005|Overall Study|Adverse Event|0|||
124870082|NCT03205371|449143633|FG006|Overall Study|Adverse Event|0|||
124870083|NCT03205371|449143634|FG007|Overall Study|Adverse Event|1|||
124870084|NCT03205371|449143635|FG008|Overall Study|Adverse Event|0|||
124870085|NCT03205371|449143636|FG009|Overall Study|Adverse Event|0|||
124870086|NCT03205371|449143637|FG010|Overall Study|Adverse Event|0|||
124870087|NCT03205371|449143638|FG011|Overall Study|Adverse Event|0|||
124870088|NCT02835339|449143640|FG000|Overall Study|Did not receive allocated intervention|13|||
124870089|NCT02835339|449143641|FG001|Overall Study|Did not receive allocated intervention|16|||
124870090|NCT01077544|449143642|FG000|Overall Study|New Cancer Therapy|3|||
124870091|NCT01077544|449143643|FG001|Overall Study|New Cancer Therapy|3|||
124870092|NCT01077544|449143642|FG000|Overall Study|Adverse Event|0|||
124870093|NCT01077544|449143643|FG001|Overall Study|Adverse Event|1|||
124870094|NCT01077544|449143642|FG000|Overall Study|Disease Progression|0|||
124870095|NCT01077544|449143643|FG001|Overall Study|Disease Progression|1|||
124870096|NCT03923959|449143644|FG000|Overall Study|Death|16|||
124870097|NCT03923959|449143645|FG001|Overall Study|Death|12|||
124870098|NCT03923959|449143644|FG000|Overall Study|Lost to Follow-up|56|||
124870099|NCT03923959|449143645|FG001|Overall Study|Lost to Follow-up|56|||
124870100|NCT03923959|449143644|FG000|Overall Study|Withdrawal by Subject|1|||
124870101|NCT03923959|449143645|FG001|Overall Study|Withdrawal by Subject|1|||
124870102|NCT03923959|449143644|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
124870103|NCT03923959|449143645|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
124870104|NCT04918147|449143646|FG000|Overall Study|Disease flare as defined in protocol|0|||
124870105|NCT04918147|449143647|FG001|Overall Study|Disease flare as defined in protocol|2|||
124870106|NCT01375114|449143649|FG000|Overall Study|Lost to Follow-up|1|||
124870107|NCT01375114|449143650|FG001|Overall Study|Lost to Follow-up|0|||
124870108|NCT01375114|449143651|FG002|Overall Study|Lost to Follow-up|1|||
124870109|NCT01375114|449143649|FG000|Overall Study|Disease Progression|3|||
124870110|NCT01375114|449143650|FG001|Overall Study|Disease Progression|2|||
124870111|NCT01375114|449143651|FG002|Overall Study|Disease Progression|2|||
124870112|NCT01375114|449143649|FG000|Overall Study|Patient Changed Mind|0|||
124870113|NCT01375114|449143650|FG001|Overall Study|Patient Changed Mind|0|||
124870114|NCT01375114|449143651|FG002|Overall Study|Patient Changed Mind|2|||
124870115|NCT01375114|449143649|FG000|Overall Study|Pruritus|0|||
124870116|NCT01375114|449143650|FG001|Overall Study|Pruritus|0|||
124870117|NCT01375114|449143651|FG002|Overall Study|Pruritus|1|||
124870118|NCT01375114|449143649|FG000|Overall Study|Restlessness|0|||
124870119|NCT01375114|449143650|FG001|Overall Study|Restlessness|0|||
124870120|NCT01375114|449143651|FG002|Overall Study|Restlessness|1|||
124870121|NCT01375114|449143649|FG000|Overall Study|Diarrhea|0|||
124870122|NCT01375114|449143650|FG001|Overall Study|Diarrhea|0|||
124870123|NCT01375114|449143651|FG002|Overall Study|Diarrhea|1|||
124870124|NCT01375114|449143649|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
124870125|NCT01375114|449143650|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
124870126|NCT01375114|449143651|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
124870127|NCT01375114|449143649|FG000|Overall Study|Nausea|0|||
124870128|NCT01375114|449143650|FG001|Overall Study|Nausea|1|||
124870129|NCT01375114|449143651|FG002|Overall Study|Nausea|0|||
124870130|NCT01375114|449143649|FG000|Overall Study|Increased AST/ALT|0|||
124870131|NCT01375114|449143650|FG001|Overall Study|Increased AST/ALT|1|||
124870132|NCT01375114|449143651|FG002|Overall Study|Increased AST/ALT|0|||
124870133|NCT01375114|449143649|FG000|Overall Study|Vaginal Hemorrhage|0|||
124870134|NCT01375114|449143650|FG001|Overall Study|Vaginal Hemorrhage|1|||
124870135|NCT01375114|449143651|FG002|Overall Study|Vaginal Hemorrhage|0|||
124870136|NCT01375114|449143649|FG000|Overall Study|Family problem|0|||
124870137|NCT01375114|449143650|FG001|Overall Study|Family problem|1|||
124870138|NCT01375114|449143651|FG002|Overall Study|Family problem|0|||
124870139|NCT01375114|449143649|FG000|Overall Study|Protocol Violation|2|||
124870140|NCT01375114|449143650|FG001|Overall Study|Protocol Violation|0|||
125202283|NCT01597375|450363664|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
125202284|NCT01597375|450363663|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
125202285|NCT01597375|450363664|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
124870141|NCT01375114|449143651|FG002|Overall Study|Protocol Violation|0|||
124870142|NCT03338829|449143652|FG000|Overall Study|Lost to Follow-up|4|||
124870143|NCT03338829|449143653|FG001|Overall Study|Lost to Follow-up|2|||
124870144|NCT03338829|449143654|FG002|Overall Study|Lost to Follow-up|4|||
124870145|NCT03338829|449143652|FG000|Overall Study|Pregnancy loss|1|||
124870146|NCT03338829|449143653|FG001|Overall Study|Pregnancy loss|1|||
124870147|NCT03338829|449143654|FG002|Overall Study|Pregnancy loss|0|||
124870148|NCT03338829|449143652|FG000|Overall Study|Protocol Violation|0|||
124870149|NCT03338829|449143653|FG001|Overall Study|Protocol Violation|1|||
124870150|NCT03338829|449143654|FG002|Overall Study|Protocol Violation|0|||
124870151|NCT03575325|449143658|FG000|Overall Study|Death|1|||
124870152|NCT02612311|449143659|FG000|Overall Study|Adverse Event|16|||
124870153|NCT02612311|449143660|FG001|Overall Study|Adverse Event|12|||
124870154|NCT02612311|449143661|FG002|Overall Study|Adverse Event|7|||
124870155|NCT02612311|449143662|FG003|Overall Study|Adverse Event|13|||
124870156|NCT02612311|449143659|FG000|Overall Study|Death|29|||
124870157|NCT02612311|449143660|FG001|Overall Study|Death|10|||
124870158|NCT02612311|449143661|FG002|Overall Study|Death|11|||
124870159|NCT02612311|449143662|FG003|Overall Study|Death|11|||
124870160|NCT02612311|449143659|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
124870161|NCT02612311|449143660|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
124870162|NCT02612311|449143661|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
124870163|NCT02612311|449143662|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
124870164|NCT02612311|449143659|FG000|Overall Study|Investigator's Decision|11|||
124870165|NCT02612311|449143660|FG001|Overall Study|Investigator's Decision|15|||
124870166|NCT02612311|449143661|FG002|Overall Study|Investigator's Decision|6|||
124870167|NCT02612311|449143662|FG003|Overall Study|Investigator's Decision|6|||
124870168|NCT02612311|449143659|FG000|Overall Study|Lack of Efficacy|0|||
124870169|NCT02612311|449143660|FG001|Overall Study|Lack of Efficacy|0|||
124870170|NCT02612311|449143661|FG002|Overall Study|Lack of Efficacy|1|||
124870171|NCT02612311|449143662|FG003|Overall Study|Lack of Efficacy|1|||
124870172|NCT02612311|449143659|FG000|Overall Study|Lost to Follow-up|2|||
124870173|NCT02612311|449143660|FG001|Overall Study|Lost to Follow-up|2|||
124870174|NCT02612311|449143661|FG002|Overall Study|Lost to Follow-up|1|||
124870175|NCT02612311|449143662|FG003|Overall Study|Lost to Follow-up|2|||
124870176|NCT02612311|449143659|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
124870177|NCT02612311|449143660|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
124870178|NCT02612311|449143661|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
124870179|NCT02612311|449143662|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
124870180|NCT02612311|449143659|FG000|Overall Study|Site Terminated by Sponsor|29|||
124870181|NCT02612311|449143660|FG001|Overall Study|Site Terminated by Sponsor|12|||
124870182|NCT02612311|449143661|FG002|Overall Study|Site Terminated by Sponsor|13|||
124870183|NCT02612311|449143662|FG003|Overall Study|Site Terminated by Sponsor|5|||
124870184|NCT02612311|449143659|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
124870185|NCT02612311|449143660|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
124870186|NCT02612311|449143661|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
124870187|NCT02612311|449143662|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
124870188|NCT02612311|449143659|FG000|Overall Study|Reason Not Specified|3|||
124870189|NCT02612311|449143660|FG001|Overall Study|Reason Not Specified|7|||
124870190|NCT02612311|449143661|FG002|Overall Study|Reason Not Specified|4|||
124870191|NCT02612311|449143662|FG003|Overall Study|Reason Not Specified|5|||
124870192|NCT02612311|449143659|FG000|Overall Study|Unknown/Missing|10|||
124870193|NCT02612311|449143660|FG001|Overall Study|Unknown/Missing|13|||
124870194|NCT02612311|449143661|FG002|Overall Study|Unknown/Missing|4|||
124870195|NCT02612311|449143662|FG003|Overall Study|Unknown/Missing|0|||
124870196|NCT02612311|449143659|FG000|Overall Study|Non-Compliance with Study|1|||
124870197|NCT02612311|449143660|FG001|Overall Study|Non-Compliance with Study|0|||
124870198|NCT02612311|449143661|FG002|Overall Study|Non-Compliance with Study|0|||
124870199|NCT02612311|449143662|FG003|Overall Study|Non-Compliance with Study|0|||
124870200|NCT00715429|449143663|FG000|Overall Study|Did not complete the study diary|0|||
124870201|NCT00715429|449143664|FG001|Overall Study|Did not complete the study diary|1|||
124870202|NCT04085328|449143665|FG000|Overall Study|Witihdrew Consent|16|||
124870203|NCT04085328|449143666|FG001|Overall Study|Witihdrew Consent|16|||
124870204|NCT04085328|449143665|FG000|Overall Study|Adverse Event|8|||
124870205|NCT04085328|449143666|FG001|Overall Study|Adverse Event|7|||
124870206|NCT04085328|449143665|FG000|Overall Study|Lost to Follow-up|7|||
124870207|NCT04085328|449143666|FG001|Overall Study|Lost to Follow-up|2|||
124870208|NCT04085328|449143665|FG000|Overall Study|Physician Decision|0|||
124870209|NCT04085328|449143666|FG001|Overall Study|Physician Decision|1|||
124870210|NCT04085328|449143665|FG000|Overall Study|Pregnancy|0|||
124870211|NCT04085328|449143666|FG001|Overall Study|Pregnancy|1|||
124870212|NCT04085328|449143665|FG000|Overall Study|Reasons Related to COVID-19|5|||
124870213|NCT04085328|449143666|FG001|Overall Study|Reasons Related to COVID-19|8|||
124870214|NCT04085328|449143665|FG000|Overall Study|Did not meet inclusion criteria|1|||
124870215|NCT04085328|449143666|FG001|Overall Study|Did not meet inclusion criteria|1|||
124870216|NCT04085328|449143665|FG000|Overall Study|Early termination|1|||
124870217|NCT04085328|449143666|FG001|Overall Study|Early termination|0|||
124870218|NCT00514735|449143667|FG000|Overall Study|Withdrawal by Subject|13|||
124870219|NCT00514735|449143668|FG001|Overall Study|Withdrawal by Subject|5|||
124870220|NCT00514735|449143667|FG000|Overall Study|Death|1|||
124870221|NCT00514735|449143668|FG001|Overall Study|Death|0|||
124870222|NCT00514735|449143667|FG000|Overall Study|Lost to Follow-up|0|||
124870223|NCT00514735|449143668|FG001|Overall Study|Lost to Follow-up|1|||
124870224|NCT04393441|449143669|FG000|Overall Study|Adverse Event|0|||
124870225|NCT04393441|449143670|FG001|Overall Study|Adverse Event|3|||
124870226|NCT04393441|449143669|FG000|Overall Study|Withdrawal by Subject|5|||
124870227|NCT04393441|449143670|FG001|Overall Study|Withdrawal by Subject|7|||
124870228|NCT04393441|449143669|FG000|Overall Study|Lost to Follow-up|0|||
124870229|NCT04393441|449143670|FG001|Overall Study|Lost to Follow-up|2|||
124870230|NCT04393441|449143669|FG000|Overall Study|Protocol Deviation|2|||
124870231|NCT04393441|449143670|FG001|Overall Study|Protocol Deviation|1|||
124870232|NCT04393441|449143669|FG000|Overall Study|Reason not Specified|1|||
124870233|NCT04393441|449143670|FG001|Overall Study|Reason not Specified|1|||
124870234|NCT00689221|449143671|FG000|Overall Study|Ongoing at cut-off date|39|||
124870235|NCT00689221|449143672|FG001|Overall Study|Ongoing at cut-off date|36|||
124870236|NCT01749982|449143673|FG000|Overall Study|Physician Decision|0|||
124870237|NCT01749982|449143674|FG001|Overall Study|Physician Decision|0|||
124870238|NCT01749982|449143675|FG002|Overall Study|Physician Decision|0|||
124870239|NCT01749982|449143676|FG003|Overall Study|Physician Decision|1|||
124870240|NCT01749982|449143673|FG000|Overall Study|Lost to Follow-up|0|||
124870241|NCT01749982|449143674|FG001|Overall Study|Lost to Follow-up|0|||
124870242|NCT01749982|449143675|FG002|Overall Study|Lost to Follow-up|0|||
124870243|NCT01749982|449143676|FG003|Overall Study|Lost to Follow-up|1|||
124870244|NCT01749982|449143673|FG000|Overall Study|Withdrawal by Subject|0|||
124870245|NCT01749982|449143674|FG001|Overall Study|Withdrawal by Subject|0|||
124870246|NCT01749982|449143675|FG002|Overall Study|Withdrawal by Subject|0|||
124870247|NCT01749982|449143676|FG003|Overall Study|Withdrawal by Subject|1|||
124870248|NCT01596582|449143678|FG000|Overall Study|Deemed ineligible after study visit|3|||
124870249|NCT01596582|449143679|FG001|Overall Study|Deemed ineligible after study visit|6|||
124870250|NCT01596582|449143678|FG000|Overall Study|Missing all outcome data|1|||
124870251|NCT01596582|449143679|FG001|Overall Study|Missing all outcome data|1|||
124870252|NCT04435665|449143680|FG000|Overall Study|Lost to Follow-up|0|||
124870253|NCT04435665|449143681|FG001|Overall Study|Lost to Follow-up|0|||
124870254|NCT04435665|449143682|FG002|Overall Study|Lost to Follow-up|0|||
124870255|NCT04435665|449143683|FG003|Overall Study|Lost to Follow-up|1|||
124870256|NCT03923933|449143684|FG000|Overall Study|Lost to Follow-up|1|||
124870257|NCT03923933|449143685|FG001|Overall Study|Lost to Follow-up|0|||
124870258|NCT03923933|449143684|FG000|Overall Study|Withdrawal by Subject|0|||
124870259|NCT03923933|449143685|FG001|Overall Study|Withdrawal by Subject|1|||
124870260|NCT02454101|449143686|FG000|Overall Study|Adverse Event|2|||
124870261|NCT02454101|449143687|FG001|Overall Study|Adverse Event|3|||
124870262|NCT02454101|449143686|FG000|Overall Study|Lost to Follow-up|3|||
124870263|NCT02454101|449143687|FG001|Overall Study|Lost to Follow-up|4|||
124870264|NCT00419263|449143688|FG000|Overall Study|Lost to Follow-up|2|||
124870265|NCT00419263|449143689|FG001|Overall Study|Lost to Follow-up|1|||
124870266|NCT00419263|449143690|FG002|Overall Study|Lost to Follow-up|1|||
124870267|NCT00419263|449143688|FG000|Overall Study|Randomized in Error, Not Treated|1|||
124870268|NCT00419263|449143689|FG001|Overall Study|Randomized in Error, Not Treated|1|||
124870269|NCT00419263|449143690|FG002|Overall Study|Randomized in Error, Not Treated|0|||
124870270|NCT00419263|449143688|FG000|Overall Study|Adverse Event|0|||
124870271|NCT00419263|449143689|FG001|Overall Study|Adverse Event|0|||
124870272|NCT00419263|449143690|FG002|Overall Study|Adverse Event|1|||
124870273|NCT00419263|449143688|FG000|Overall Study|Withdrawal by Subject|0|||
124870274|NCT00419263|449143689|FG001|Overall Study|Withdrawal by Subject|0|||
124870275|NCT00419263|449143690|FG002|Overall Study|Withdrawal by Subject|1|||
124870276|NCT03311373|449143691|FG000|Overall Study|Adverse Event|1|||
124870277|NCT03311373|449143691|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
124870278|NCT03311373|449143691|FG000|Overall Study|Lost to Follow-up|1|||
124870279|NCT03311373|449143691|FG000|Overall Study|Physician Decision|1|||
124870280|NCT03311373|449143691|FG000|Overall Study|Withdrawal by Subject|3|||
124870281|NCT01563536|449143698|FG000|Overall Study|Withdrawal by Subject|0|||
124870282|NCT01563536|449143699|FG001|Overall Study|Withdrawal by Subject|2|||
124870283|NCT01563536|449143698|FG000|Overall Study|Lost to Follow-up|1|||
124870284|NCT01563536|449143699|FG001|Overall Study|Lost to Follow-up|0|||
124870285|NCT00538590|449143705|FG000|Overall Study|Death|1|||
124870286|NCT00538590|449143706|FG001|Overall Study|Death|0|||
124870287|NCT01256567|449143707|FG000|Overall Study|Withdrawal by Subject|1|||
124870288|NCT00686881|449143722|FG000|Overall Study|Withdrawal by Subject|11|||
124870289|NCT00686881|449143723|FG001|Overall Study|Withdrawal by Subject|18|||
124870290|NCT00686881|449143722|FG000|Overall Study|Lost to Follow-up|0|||
124870291|NCT00686881|449143723|FG001|Overall Study|Lost to Follow-up|1|||
124870292|NCT00686881|449143722|FG000|Overall Study|Treatment-related adverse event|10|||
124870293|NCT00686881|449143723|FG001|Overall Study|Treatment-related adverse event|9|||
124870294|NCT00686881|449143722|FG000|Overall Study|Met discontinuation criteria|5|||
124870295|NCT00686881|449143723|FG001|Overall Study|Met discontinuation criteria|0|||
124870296|NCT00686881|449143722|FG000|Overall Study|Onset of malignant tumor|11|||
124870297|NCT00686881|449143723|FG001|Overall Study|Onset of malignant tumor|11|||
124870298|NCT00686881|449143722|FG000|Overall Study|Lack of Efficacy|4|||
124870299|NCT00686881|449143723|FG001|Overall Study|Lack of Efficacy|3|||
124870300|NCT00686881|449143722|FG000|Overall Study|Physician Decision|1|||
124870301|NCT00686881|449143723|FG001|Overall Study|Physician Decision|0|||
124870302|NCT00686881|449143722|FG000|Overall Study|Circumstances of site|1|||
124870303|NCT00686881|449143723|FG001|Overall Study|Circumstances of site|1|||
124870304|NCT00686881|449143722|FG000|Overall Study|Did not meet protocol eligibility|1|||
124870305|NCT00686881|449143723|FG001|Overall Study|Did not meet protocol eligibility|0|||
124870306|NCT00686881|449143722|FG000|Overall Study|Irregular visits|1|||
124870307|NCT00686881|449143723|FG001|Overall Study|Irregular visits|0|||
124870308|NCT00686881|449143722|FG000|Overall Study|Study discontinuation|35|||
124870309|NCT00686881|449143723|FG001|Overall Study|Study discontinuation|32|||
124870310|NCT00686881|449143722|FG000|Overall Study|Never received study drug|2|||
124870311|NCT00686881|449143723|FG001|Overall Study|Never received study drug|6|||
124870312|NCT00671931|449143724|FG000|Overall Study|Physician Decision|1|||
124870313|NCT00671931|449143725|FG001|Overall Study|Physician Decision|0|||
124870314|NCT00671931|449143726|FG002|Overall Study|Physician Decision|0|||
124870315|NCT00671931|449143727|FG003|Overall Study|Physician Decision|2|||
124870316|NCT00671931|449143728|FG004|Overall Study|Physician Decision|1|||
124870317|NCT03260868|449143732|FG000|Overall Study|Poor Compliance to Protocol|0|||
124870318|NCT03260868|449143733|FG001|Overall Study|Poor Compliance to Protocol|2|||
124870319|NCT03260868|449143732|FG000|Overall Study|Study Terminated By Sponsor|2|||
124870320|NCT03260868|449143733|FG001|Overall Study|Study Terminated By Sponsor|1|||
124870321|NCT03260868|449143732|FG000|Overall Study|Other than specified above|1|||
124870322|NCT03260868|449143733|FG001|Overall Study|Other than specified above|0|||
124870323|NCT01298999|449143734|FG000|Overall Study|Physician Decision|0|||
124870324|NCT01298999|449143735|FG001|Overall Study|Physician Decision|1|||
124870325|NCT01298999|449143734|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
124870326|NCT01298999|449143735|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
124870327|NCT00541450|449143736|FG000|Phase A|Adverse Event|3|||
124870328|NCT00541450|449143737|FG001|Phase A|Adverse Event|0|||
124870329|NCT00541450|449143736|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
124870330|NCT00541450|449143737|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
124870331|NCT00541450|449143736|FG000|Phase A|Hyperglycemia|0|||
124870332|NCT00541450|449143737|FG001|Phase A|Hyperglycemia|1|||
124870333|NCT00541450|449143736|FG000|Phase A|Lost to Follow-up|6|||
124870334|NCT00541450|449143737|FG001|Phase A|Lost to Follow-up|4|||
124870335|NCT00541450|449143736|FG000|Phase A|Physician Decision|2|||
124870336|NCT00541450|449143737|FG001|Phase A|Physician Decision|0|||
124870337|NCT00541450|449143736|FG000|Phase A|Protocol Violation|2|||
124870338|NCT00541450|449143737|FG001|Phase A|Protocol Violation|3|||
124870339|NCT00541450|449143736|FG000|Phase A|Withdrawal by Subject|7|||
124870340|NCT00541450|449143737|FG001|Phase A|Withdrawal by Subject|7|||
124870341|NCT00541450|449143736|FG000|Phase B|Adverse Event|6|||
124870342|NCT00541450|449143737|FG001|Phase B|Adverse Event|6|||
124870343|NCT00541450|449143736|FG000|Phase B|Hyperglycemia|10|||
124870344|NCT00541450|449143737|FG001|Phase B|Hyperglycemia|9|||
124870345|NCT00541450|449143736|FG000|Phase B|Lost to Follow-up|6|||
124870346|NCT00541450|449143737|FG001|Phase B|Lost to Follow-up|4|||
124870347|NCT00541450|449143736|FG000|Phase B|Physician Decision|4|||
124870348|NCT00541450|449143737|FG001|Phase B|Physician Decision|2|||
124870349|NCT00541450|449143736|FG000|Phase B|Pregnancy|0|||
124870350|NCT00541450|449143737|FG001|Phase B|Pregnancy|1|||
124870351|NCT00541450|449143736|FG000|Phase B|Protocol Violation|3|||
124870352|NCT00541450|449143737|FG001|Phase B|Protocol Violation|3|||
124870353|NCT00541450|449143736|FG000|Phase B|Withdrawal by Subject|8|||
124870354|NCT00541450|449143737|FG001|Phase B|Withdrawal by Subject|6|||
124870355|NCT00803452|449143738|FG000|Overall Study|Adverse Event|0|||
124870356|NCT00803452|449143739|FG001|Overall Study|Adverse Event|2|||
124870357|NCT00803452|449143738|FG000|Overall Study|Lost to Follow-up|0|||
124870358|NCT00803452|449143739|FG001|Overall Study|Lost to Follow-up|3|||
124870359|NCT04839965|449143740|FG000|Overall Study|Death|6|||
124870360|NCT04839965|449143741|FG001|Overall Study|Death|6|||
124870361|NCT04839965|449143740|FG000|Overall Study|Lost to Follow-up|1|||
124870362|NCT04839965|449143741|FG001|Overall Study|Lost to Follow-up|0|||
124870363|NCT02816138|449143742|FG000|Overall Study|Adverse Event|1|||
124870364|NCT00981084|449143743|FG000|Post Intervention (Data Analysis)|poor effort|1|||
124870365|NCT00981084|449143744|FG001|Post Intervention (Data Analysis)|poor effort|1|||
124870366|NCT00981084|449143743|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
124870367|NCT00981084|449143744|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
124870368|NCT00289887|449145459|FG000|Overall Study|Adverse Event|3|||
124870369|NCT00289887|449145460|FG001|Overall Study|Adverse Event|3|||
124870370|NCT00289887|449145459|FG000|Overall Study|Lack of Efficacy|3|||
124870371|NCT00289887|449145460|FG001|Overall Study|Lack of Efficacy|11|||
124870372|NCT00289887|449145459|FG000|Overall Study|Lost to Follow-up|3|||
124870373|NCT00289887|449145460|FG001|Overall Study|Lost to Follow-up|3|||
124870374|NCT00289887|449145459|FG000|Overall Study|Protocol Violation|3|||
124870375|NCT00289887|449145460|FG001|Overall Study|Protocol Violation|1|||
124870376|NCT00289887|449145459|FG000|Overall Study|Withdrawal by Subject|3|||
124870377|NCT00289887|449145460|FG001|Overall Study|Withdrawal by Subject|8|||
124870378|NCT00289887|449145459|FG000|Overall Study|Other|7|||
124870379|NCT00289887|449145460|FG001|Overall Study|Other|3|||
124870380|NCT01266850|449145461|FG000|Overall Study|Lost to Follow-up|19|||
124870381|NCT01266850|449145462|FG001|Overall Study|Lost to Follow-up|19|||
124870382|NCT01266850|449145463|FG002|Overall Study|Lost to Follow-up|13|||
124870383|NCT01266850|449145464|FG003|Overall Study|Lost to Follow-up|13|||
124870384|NCT01266850|449145465|FG004|Overall Study|Lost to Follow-up|12|||
124870385|NCT01266850|449145461|FG000|Overall Study|Withdrawal by Subject|8|||
124870386|NCT01266850|449145462|FG001|Overall Study|Withdrawal by Subject|9|||
124870387|NCT01266850|449145463|FG002|Overall Study|Withdrawal by Subject|6|||
124870388|NCT01266850|449145464|FG003|Overall Study|Withdrawal by Subject|9|||
124870389|NCT01266850|449145465|FG004|Overall Study|Withdrawal by Subject|12|||
124870390|NCT01266850|449145461|FG000|Overall Study|Physician Decision|3|||
124870391|NCT01266850|449145462|FG001|Overall Study|Physician Decision|6|||
124870392|NCT01266850|449145463|FG002|Overall Study|Physician Decision|4|||
124870393|NCT01266850|449145464|FG003|Overall Study|Physician Decision|4|||
124870394|NCT01266850|449145465|FG004|Overall Study|Physician Decision|3|||
124870395|NCT01266850|449145461|FG000|Overall Study|Protocol Violation|0|||
124870396|NCT01266850|449145462|FG001|Overall Study|Protocol Violation|1|||
124870397|NCT01266850|449145463|FG002|Overall Study|Protocol Violation|0|||
124870398|NCT01266850|449145464|FG003|Overall Study|Protocol Violation|1|||
124870399|NCT01266850|449145465|FG004|Overall Study|Protocol Violation|2|||
124870400|NCT01266850|449145461|FG000|Overall Study|Adverse Event|0|||
124870401|NCT01266850|449145462|FG001|Overall Study|Adverse Event|0|||
124870402|NCT01266850|449145463|FG002|Overall Study|Adverse Event|0|||
124870403|NCT01266850|449145464|FG003|Overall Study|Adverse Event|0|||
124870404|NCT01266850|449145465|FG004|Overall Study|Adverse Event|1|||
124870405|NCT01266850|449145461|FG000|Overall Study|Site Closure|0|||
124870406|NCT01266850|449145462|FG001|Overall Study|Site Closure|1|||
124870407|NCT01266850|449145463|FG002|Overall Study|Site Closure|1|||
124870408|NCT01266850|449145464|FG003|Overall Study|Site Closure|1|||
124870409|NCT01266850|449145465|FG004|Overall Study|Site Closure|0|||
124870410|NCT04128293|449145469|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
124870411|NCT04128293|449145470|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
124870412|NCT04128293|449145471|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
124870413|NCT04128293|449145472|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
124870414|NCT00437645|449145473|FG000|Overall Study|Adverse Event|15|||
124870415|NCT00437645|449145474|FG001|Overall Study|Adverse Event|84|||
124870416|NCT00437645|449145473|FG000|Overall Study|Withdrawal by Subject|10|||
124870417|NCT00437645|449145474|FG001|Overall Study|Withdrawal by Subject|22|||
124870418|NCT00437645|449145473|FG000|Overall Study|Protocol Violation|3|||
124870419|NCT00437645|449145474|FG001|Overall Study|Protocol Violation|3|||
124870420|NCT00437645|449145473|FG000|Overall Study|Lost to Follow-up|2|||
124870421|NCT00437645|449145474|FG001|Overall Study|Lost to Follow-up|3|||
124870422|NCT00437645|449145473|FG000|Overall Study|Administrative problems|2|||
124870423|NCT00437645|449145474|FG001|Overall Study|Administrative problems|1|||
124870424|NCT00437645|449145473|FG000|Overall Study|Lack of Efficacy|2|||
124870425|NCT00437645|449145474|FG001|Overall Study|Lack of Efficacy|1|||
124870426|NCT00437645|449145473|FG000|Overall Study|Condition no longer requires study drug|1|||
124870427|NCT00437645|449145474|FG001|Overall Study|Condition no longer requires study drug|1|||
124870428|NCT03597568|449145475|FG000|Overall Study|Withdrawal by Subject|1|||
124870429|NCT03597568|449145476|FG001|Overall Study|Withdrawal by Subject|1|||
124870430|NCT03597568|449145475|FG000|Overall Study|Unable to analyze vascular data|1|||
124870431|NCT03597568|449145476|FG001|Overall Study|Unable to analyze vascular data|1|||
124870432|NCT03382782|449145477|FG000|Cohort 1|Withdrawal by Subject|11|||
124870433|NCT03382782|449145478|FG001|Cohort 1|Withdrawal by Subject|5|||
124870434|NCT03382782|449145479|FG002|Cohort 1|Withdrawal by Subject|0|||
124870435|NCT03382782|449145477|FG000|Cohort 2|Withdrawal by Subject|1|||
124870436|NCT03382782|449145478|FG001|Cohort 2|Withdrawal by Subject|1|||
124870437|NCT03382782|449145479|FG002|Cohort 2|Withdrawal by Subject|0|||
124870438|NCT03382782|449145477|FG000|Cohort 3|Withdrawal by Subject|1|||
124870439|NCT03382782|449145478|FG001|Cohort 3|Withdrawal by Subject|2|||
124870440|NCT03382782|449145479|FG002|Cohort 3|Withdrawal by Subject|0|||
124870441|NCT00337272|449145484|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
124870442|NCT00337272|449145485|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
124870443|NCT00337272|449145484|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
124870444|NCT00337272|449145485|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
124870445|NCT00337272|449145484|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
124870446|NCT00337272|449145485|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
124870447|NCT00337272|449145484|FG000|Treatment Period|Non-compliance|1|||
124870448|NCT00337272|449145485|FG001|Treatment Period|Non-compliance|1|||
124870449|NCT00337272|449145484|FG000|Treatment Period|Withdrawal by Subject|0|||
125202286|NCT01597375|450363663|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
124870450|NCT00337272|449145485|FG001|Treatment Period|Withdrawal by Subject|1|||
125202287|NCT01597375|450363664|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
124870451|NCT00337272|449145484|FG000|Withdrawal Period|Non-compliance|0|||
124870452|NCT00337272|449145485|FG001|Withdrawal Period|Non-compliance|1|||
124870453|NCT01699022|449145488|FG000|Overall Study|Early discontinuation from the study|3|||
124870454|NCT02565914|449145493|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
124870455|NCT02565914|449145493|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
124978556|NCT03829501|449548505|FG017|Overall Study|Death|1|||
125202288|NCT01597375|450363663|FG000|Washout (2 Weeks)|Adverse Event|1|||
124870456|NCT02565914|449145493|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
124870457|NCT02565914|449145493|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
124870458|NCT02565914|449145493|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
124870459|NCT02565914|449145493|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
124870460|NCT02565914|449145493|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
124870461|NCT02565914|449145493|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
124870462|NCT02565914|449145493|FG000|Part A (Up to 96 Weeks)|Other|18|||
124870463|NCT02565914|449145493|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
124870464|NCT02565914|449145493|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
124870465|NCT02565914|449145493|FG000|Part B (Up to 96 Weeks)|Other|1|||
124870466|NCT02565914|449145493|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
124870467|NCT02565914|449145493|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
124870468|NCT02565914|449145493|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
124870469|NCT02565914|449145493|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
124870470|NCT02565914|449145493|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
124870471|NCT02565914|449145493|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
124870472|NCT02565914|449145493|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
124870473|NCT02565914|449145493|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
124870474|NCT02565914|449145493|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
124870475|NCT02565914|449145493|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
124870476|NCT02565914|449145493|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
124870477|NCT02565914|449145493|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
124870478|NCT01197508|449145502|FG000|Overall Study|Withdrawal by Subject|8|||
124870479|NCT01197508|449145503|FG001|Overall Study|Withdrawal by Subject|7|||
124870480|NCT01197508|449145504|FG002|Overall Study|Withdrawal by Subject|15|||
124870481|NCT01197508|449145505|FG003|Overall Study|Withdrawal by Subject|4|||
124870482|NCT01197508|449145502|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
124870483|NCT01197508|449145503|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
124870484|NCT01197508|449145504|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
124870485|NCT01197508|449145505|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
124870486|NCT01197508|449145502|FG000|Overall Study|Adverse Event|10|||
124870487|NCT01197508|449145503|FG001|Overall Study|Adverse Event|13|||
124870488|NCT01197508|449145504|FG002|Overall Study|Adverse Event|23|||
124870489|NCT01197508|449145505|FG003|Overall Study|Adverse Event|3|||
124870490|NCT01197508|449145502|FG000|Overall Study|Severe non-compliance to protocol|0|||
124870491|NCT01197508|449145503|FG001|Overall Study|Severe non-compliance to protocol|3|||
124870492|NCT01197508|449145504|FG002|Overall Study|Severe non-compliance to protocol|1|||
124870493|NCT01197508|449145505|FG003|Overall Study|Severe non-compliance to protocol|3|||
124870494|NCT01197508|449145502|FG000|Overall Study|Condition under investigation worsened|1|||
124870495|NCT01197508|449145503|FG001|Overall Study|Condition under investigation worsened|1|||
124870496|NCT01197508|449145504|FG002|Overall Study|Condition under investigation worsened|1|||
124870497|NCT01197508|449145505|FG003|Overall Study|Condition under investigation worsened|1|||
124870498|NCT01197508|449145502|FG000|Overall Study|Lack of Efficacy|1|||
124870499|NCT01197508|449145503|FG001|Overall Study|Lack of Efficacy|2|||
124870500|NCT01197508|449145504|FG002|Overall Study|Lack of Efficacy|2|||
124870501|NCT01197508|449145505|FG003|Overall Study|Lack of Efficacy|1|||
124870502|NCT01197508|449145502|FG000|Overall Study|Study-specific withdrawal criteria|0|||
124870503|NCT01197508|449145503|FG001|Overall Study|Study-specific withdrawal criteria|0|||
124870504|NCT01197508|449145504|FG002|Overall Study|Study-specific withdrawal criteria|1|||
124870505|NCT01197508|449145505|FG003|Overall Study|Study-specific withdrawal criteria|2|||
124870506|NCT01197508|449145502|FG000|Overall Study|Lost to Follow-up|1|||
124870507|NCT01197508|449145503|FG001|Overall Study|Lost to Follow-up|1|||
124870508|NCT01197508|449145504|FG002|Overall Study|Lost to Follow-up|2|||
124870509|NCT01197508|449145505|FG003|Overall Study|Lost to Follow-up|0|||
124870510|NCT01197508|449145502|FG000|Overall Study|Other|2|||
124870511|NCT01197508|449145503|FG001|Overall Study|Other|3|||
124870512|NCT01197508|449145504|FG002|Overall Study|Other|2|||
124870513|NCT01197508|449145505|FG003|Overall Study|Other|2|||
124870514|NCT01301391|449145506|FG000|Overall Study|Death|13|||
124870515|NCT01301391|449145506|FG000|Overall Study|Lost to Follow-up|3|||
124870516|NCT01301391|449145506|FG000|Overall Study|Physician Decision|2|||
124870517|NCT01301391|449145506|FG000|Overall Study|Sponsor's decision|8|||
124870518|NCT02799784|449145509|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
124870519|NCT02799784|449145510|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
124870520|NCT02799784|449145509|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
124870521|NCT02799784|449145510|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
124870522|NCT02799784|449145509|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
124870523|NCT02799784|449145510|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
124870524|NCT02799784|449145509|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
124870525|NCT02799784|449145510|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
125202289|NCT01597375|450363664|FG001|Washout (2 Weeks)|Adverse Event|0|||
125202290|NCT01597375|450363663|FG000|Second Intervention|Failed to react at both Aspirin|1|||
125202291|NCT01597375|450363664|FG001|Second Intervention|Failed to react at both Aspirin|1|||
125202292|NCT02294175|450363669|FG000|Overall Study|Withdrawal by Subject|1|||
125202293|NCT02294175|450363670|FG001|Overall Study|Withdrawal by Subject|2|||
125202294|NCT02294175|450363669|FG000|Overall Study|pt taking excluded medication|3|||
125202295|NCT02294175|450363670|FG001|Overall Study|pt taking excluded medication|1|||
125202296|NCT02294175|450363669|FG000|Overall Study|Protocol Violation|1|||
125202297|NCT02294175|450363670|FG001|Overall Study|Protocol Violation|0|||
125202298|NCT02294175|450363669|FG000|Overall Study|Lost to Follow-up|0|||
125202299|NCT02294175|450363670|FG001|Overall Study|Lost to Follow-up|1|||
125202300|NCT02294175|450363669|FG000|Overall Study|wound healed|0|||
125202301|NCT02294175|450363670|FG001|Overall Study|wound healed|2|||
125202302|NCT04696354|450363674|FG000|Overall Study|Study termination|6|||
125202303|NCT04696354|450363675|FG001|Overall Study|Study termination|6|||
125202304|NCT05238025|450363676|FG000|Overall Study|Adverse Event|2|||
125202305|NCT05238025|450363677|FG001|Overall Study|Adverse Event|2|||
125202306|NCT05238025|450363676|FG000|Overall Study|Lost to Follow-up|334|||
125202307|NCT05238025|450363677|FG001|Overall Study|Lost to Follow-up|339|||
125202308|NCT05238025|450363676|FG000|Overall Study|Withdrawal by Subject|203|||
125202309|NCT05238025|450363677|FG001|Overall Study|Withdrawal by Subject|222|||
125202310|NCT05238025|450363676|FG000|Overall Study|Physician Decision|20|||
125202311|NCT05238025|450363677|FG001|Overall Study|Physician Decision|8|||
125202312|NCT05238025|450363676|FG000|Overall Study|Protocol Violation|6|||
125202313|NCT05238025|450363677|FG001|Overall Study|Protocol Violation|2|||
125202314|NCT05238025|450363676|FG000|Overall Study|Death|38|||
125202315|NCT05238025|450363677|FG001|Overall Study|Death|32|||
125202316|NCT05238025|450363676|FG000|Overall Study|Study terminated by Sponsor|6358|||
125202317|NCT05238025|450363677|FG001|Overall Study|Study terminated by Sponsor|6358|||
125202318|NCT05238025|450363676|FG000|Overall Study|Other Reason|669|||
125202319|NCT05238025|450363677|FG001|Overall Study|Other Reason|690|||
125202320|NCT03814720|450363679|FG000|Overall Study|Lost to Follow-up|0|||
125202321|NCT03814720|450363680|FG001|Overall Study|Lost to Follow-up|1|||
125202322|NCT03814720|450363681|FG002|Overall Study|Lost to Follow-up|0|||
125202323|NCT03814720|450363682|FG003|Overall Study|Lost to Follow-up|0|||
125202324|NCT03814720|450363683|FG004|Overall Study|Lost to Follow-up|0|||
125202325|NCT03197324|450363684|FG000|Overall Study|Adverse Event|0|||
125202326|NCT03197324|450363685|FG001|Overall Study|Adverse Event|1|||
125202327|NCT00965341|450363686|FG000|Overall Study|Withdrew consent|1|||
125202328|NCT00965341|450363687|FG001|Overall Study|Withdrew consent|5|||
125202329|NCT00965341|450363686|FG000|Overall Study|Lost to Follow-up|1|||
125202330|NCT00965341|450363687|FG001|Overall Study|Lost to Follow-up|0|||
125202331|NCT00965341|450363686|FG000|Overall Study|Transportation issues|4|||
125202332|NCT00965341|450363687|FG001|Overall Study|Transportation issues|3|||
125202333|NCT03057054|450363693|FG000|Overall Study|Death|4|||
125202334|NCT03057054|450363694|FG001|Overall Study|Death|4|||
125202335|NCT03057054|450363693|FG000|Overall Study|Withdrawal by Subject|6|||
125202336|NCT03057054|450363694|FG001|Overall Study|Withdrawal by Subject|3|||
125202337|NCT03057054|450363693|FG000|Overall Study|Ineligible|1|||
125202338|NCT03057054|450363694|FG001|Overall Study|Ineligible|1|||
125202339|NCT01077739|450363695|FG000|Overall Study|Premature withdrawal|1|||
125202340|NCT01077739|450363696|FG001|Overall Study|Premature withdrawal|3|||
125202341|NCT01077739|450363695|FG000|Overall Study|Withdrawal by Subject|1|||
125202342|NCT01077739|450363696|FG001|Overall Study|Withdrawal by Subject|0|||
125202343|NCT01077739|450363695|FG000|Overall Study|Death|0|||
125202344|NCT01077739|450363696|FG001|Overall Study|Death|3|||
125202345|NCT01077739|450363695|FG000|Overall Study|Unacceptable toxicity|1|||
125202346|NCT01077739|450363696|FG001|Overall Study|Unacceptable toxicity|2|||
125202347|NCT01077739|450363695|FG000|Overall Study|Other|2|||
125202348|NCT01077739|450363696|FG001|Overall Study|Other|2|||
125202349|NCT00960986|450363697|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
125202350|NCT00960986|450363698|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
125202351|NCT00960986|450363699|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
125202352|NCT00960986|450363700|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
125202353|NCT00960986|450363697|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
125202354|NCT00960986|450363698|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
125202355|NCT00960986|450363699|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
125202356|NCT00960986|450363700|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
125202357|NCT00960986|450363697|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
125202358|NCT00960986|450363698|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
125202359|NCT00960986|450363699|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
125202360|NCT00960986|450363700|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
125202361|NCT00960986|450363697|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
125202362|NCT00960986|450363698|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
125202363|NCT00960986|450363699|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
125202364|NCT00960986|450363700|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
125202365|NCT00960986|450363697|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
124870526|NCT02799784|449145509|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
124870527|NCT02799784|449145510|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
124870528|NCT02799784|449145509|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
124870529|NCT02799784|449145510|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
124870530|NCT01949870|449145513|FG000|Overall Study|Lack of Efficacy|2|||
124870531|NCT01949870|449145513|FG000|Overall Study|Adverse Event|1|||
124870532|NCT01949870|449145513|FG000|Overall Study|Study termination|1|||
124870533|NCT01949870|449145513|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
124870534|NCT02570126|449145514|FG000|Overall Study|Lost to Follow-up|2|||
124870535|NCT02570126|449145515|FG001|Overall Study|Lost to Follow-up|0|||
124870536|NCT02570126|449145514|FG000|Overall Study|Unable To Arrange Visit 3|1|||
124870537|NCT02570126|449145515|FG001|Overall Study|Unable To Arrange Visit 3|0|||
124870538|NCT02570126|449145514|FG000|Overall Study|Violation Of Procedures GSK|0|||
124870539|NCT02570126|449145515|FG001|Overall Study|Violation Of Procedures GSK|1|||
124870540|NCT02570126|449145514|FG000|Overall Study|Protocol Violation|0|||
124870541|NCT02570126|449145515|FG001|Overall Study|Protocol Violation|1|||
124870542|NCT02570126|449145514|FG000|Overall Study|Withdrawal by Subject|3|||
124870543|NCT02570126|449145515|FG001|Overall Study|Withdrawal by Subject|7|||
124870544|NCT00917579|449145516|FG000|Washout >= 2 Weeks|Adverse Event|1|||
124870545|NCT00917579|449145517|FG001|Washout >= 2 Weeks|Adverse Event|0|||
124870546|NCT00917579|449145516|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
124870547|NCT00917579|449145517|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
124870548|NCT00754338|449145518|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
124870549|NCT00754338|449145519|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
124870550|NCT00754338|449145520|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
124870551|NCT00754338|449145521|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
124870552|NCT00754338|449145518|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
124870553|NCT00754338|449145519|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
124870554|NCT00754338|449145520|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
124870555|NCT00754338|449145521|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
124870556|NCT04683926|449145522|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
124870557|NCT04683926|449145523|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
124870558|NCT04683926|449145524|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
124870559|NCT04683926|449145525|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
124870560|NCT04385368|449145527|FG000|Overall Study|Death|5|||
124870561|NCT04385368|449145528|FG001|Overall Study|Death|5|||
124870562|NCT04385368|449145527|FG000|Overall Study|Physician Decision|3|||
124870563|NCT04385368|449145528|FG001|Overall Study|Physician Decision|0|||
124870564|NCT04385368|449145527|FG000|Overall Study|Withdrawal by Subject|4|||
124870565|NCT04385368|449145528|FG001|Overall Study|Withdrawal by Subject|3|||
124870566|NCT02740049|449145529|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
124870567|NCT01256411|449145530|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
124870568|NCT01256411|449145531|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
124870569|NCT01256411|449145532|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
124870570|NCT01256411|449145533|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
124870571|NCT01256411|449145534|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
124870572|NCT01256411|449145535|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
124870573|NCT01256411|449145530|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
124870574|NCT01256411|449145531|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
124870575|NCT01256411|449145532|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
124870576|NCT01256411|449145533|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
124870577|NCT01256411|449145534|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
124870578|NCT01256411|449145535|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
124870579|NCT01256411|449145530|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
124870580|NCT01256411|449145531|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
124870581|NCT01256411|449145532|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
124870582|NCT01256411|449145533|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
124870583|NCT01256411|449145534|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
124870584|NCT01256411|449145535|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
124870585|NCT01256411|449145530|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
124870586|NCT01256411|449145531|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
124870587|NCT01256411|449145532|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
124870588|NCT01256411|449145533|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
124870589|NCT01256411|449145534|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
124870590|NCT01256411|449145535|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
124870591|NCT01256411|449145530|FG000|Extension by Maximum Treatment|Adverse Event|4|||
124870592|NCT01256411|449145531|FG001|Extension by Maximum Treatment|Adverse Event|2|||
124870593|NCT01256411|449145532|FG002|Extension by Maximum Treatment|Adverse Event|1|||
124870594|NCT01256411|449145533|FG003|Extension by Maximum Treatment|Adverse Event|0|||
125202366|NCT00960986|450363698|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
125202367|NCT00960986|450363699|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
124870595|NCT01256411|449145534|FG004|Extension by Maximum Treatment|Adverse Event|0|||
124870596|NCT01256411|449145535|FG005|Extension by Maximum Treatment|Adverse Event|0|||
124870597|NCT01256411|449145530|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
124870598|NCT01256411|449145531|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
124870599|NCT01256411|449145532|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
124870600|NCT01256411|449145533|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
124870601|NCT01256411|449145534|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
124870602|NCT01256411|449145535|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
124870603|NCT01256411|449145530|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
124870604|NCT01256411|449145531|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
124870605|NCT01256411|449145532|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
124870606|NCT01256411|449145533|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
124870607|NCT01256411|449145534|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
124870608|NCT01256411|449145535|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
124870609|NCT01256411|449145530|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
124870610|NCT01256411|449145531|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
124870611|NCT01256411|449145532|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
124870612|NCT01256411|449145533|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
124870613|NCT01256411|449145534|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
124870614|NCT01256411|449145535|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
124870615|NCT01256411|449145530|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
124870616|NCT01256411|449145531|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
124870617|NCT01256411|449145532|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
124870618|NCT01256411|449145533|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
124870619|NCT01256411|449145534|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
124870620|NCT01256411|449145535|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
124870621|NCT01256411|449145530|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
124870622|NCT01256411|449145531|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
124870623|NCT01256411|449145532|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
124870624|NCT01256411|449145533|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
124870625|NCT01256411|449145534|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
124870626|NCT01256411|449145535|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
124870627|NCT02123108|449145536|FG000|Overall Study|Death|2|||
124870628|NCT02123108|449145537|FG001|Overall Study|Death|3|||
124870629|NCT04721925|449145538|FG000|2-Month Assessment|Lost to Follow-up|5|||
124870630|NCT04721925|449145539|FG001|2-Month Assessment|Lost to Follow-up|3|||
124870631|NCT04721925|449145538|FG000|4-Month Assessment|Lost to Follow-up|3|||
124870632|NCT04721925|449145539|FG001|4-Month Assessment|Lost to Follow-up|6|||
124870633|NCT01132326|449145540|FG000|Overall Study|Lack of Efficacy|25|||
124870634|NCT01132326|449145540|FG000|Overall Study|Adverse Event|37|||
124870635|NCT01132326|449145540|FG000|Overall Study|Protocol Violation|1|||
124870636|NCT01132326|449145540|FG000|Overall Study|Lost to Follow-up|16|||
124870637|NCT01132326|449145540|FG000|Overall Study|Withdrawal by Subject|40|||
124870638|NCT01132326|449145540|FG000|Overall Study|Physician Decision|10|||
125202368|NCT00960986|450363700|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
125202369|NCT00960986|450363697|FG000|Period 3 (7-week Therapy Period)|Death|0|||
125202370|NCT00960986|450363698|FG001|Period 3 (7-week Therapy Period)|Death|0|||
125202371|NCT00960986|450363699|FG002|Period 3 (7-week Therapy Period)|Death|1|||
125202372|NCT00960986|450363700|FG003|Period 3 (7-week Therapy Period)|Death|0|||
125202373|NCT00960986|450363697|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
124870639|NCT01132326|449145540|FG000|Overall Study|Study Termination|80|||
124870640|NCT01132326|449145540|FG000|Overall Study|Declining Health|1|||
124870641|NCT01132326|449145540|FG000|Overall Study|Pregnancy|1|||
124870642|NCT01132326|449145540|FG000|Overall Study|Caregiver Withdrew Consent|1|||
124870643|NCT01132326|449145540|FG000|Overall Study|Death|5|||
124870644|NCT01132326|449145540|FG000|Overall Study|Subject Unable to Come To Visits|1|||
124870645|NCT00952367|449145541|FG000|Overall Study|Withdrawal by Subject|2|||
124870646|NCT00952367|449145541|FG000|Overall Study|Noncoordination|1|||
124870647|NCT00952367|449145541|FG000|Overall Study|Protocol Violation|3|||
125202374|NCT00960986|450363698|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
125202375|NCT00960986|450363699|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
125202376|NCT00960986|450363700|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
125202377|NCT00960986|450363697|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
125202378|NCT00960986|450363698|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
125217439|NCT01348100|450423526|FG006|Overall Study|Lost to Follow-up|1|||
124870648|NCT00708916|449145546|FG000|Overall Study|Subject Noncompliance|2|||
124870649|NCT00708916|449145546|FG000|Overall Study|Adverse Event|2|||
124870650|NCT02954354|449145550|FG000|Overall Study|Adverse Event|2|||
124870651|NCT02954354|449145551|FG001|Overall Study|Adverse Event|2|||
124870652|NCT02954354|449145552|FG002|Overall Study|Adverse Event|4|||
124870653|NCT02954354|449145550|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
124870654|NCT02954354|449145551|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
124870655|NCT02954354|449145552|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
124870656|NCT02954354|449145550|FG000|Overall Study|Lack of Efficacy|0|||
124870657|NCT02954354|449145551|FG001|Overall Study|Lack of Efficacy|2|||
124870658|NCT02954354|449145552|FG002|Overall Study|Lack of Efficacy|0|||
124870659|NCT02954354|449145550|FG000|Overall Study|Withdrawal by Subject|17|||
124870660|NCT02954354|449145551|FG001|Overall Study|Withdrawal by Subject|9|||
124870661|NCT02954354|449145552|FG002|Overall Study|Withdrawal by Subject|11|||
124870662|NCT02954354|449145550|FG000|Overall Study|Lost to Follow-up|12|||
124870663|NCT02954354|449145551|FG001|Overall Study|Lost to Follow-up|5|||
124870664|NCT02954354|449145552|FG002|Overall Study|Lost to Follow-up|0|||
124870665|NCT02954354|449145550|FG000|Overall Study|Miscellaneous|2|||
124870666|NCT02954354|449145551|FG001|Overall Study|Miscellaneous|2|||
124870667|NCT02954354|449145552|FG002|Overall Study|Miscellaneous|1|||
124870668|NCT04495179|449145553|FG000|Overall Study|Lost to Follow-up|0|||
124870669|NCT04495179|449145554|FG001|Overall Study|Lost to Follow-up|1|||
124870670|NCT04495179|449145553|FG000|Overall Study|Withdrawal by Subject|2|||
124870671|NCT04495179|449145554|FG001|Overall Study|Withdrawal by Subject|4|||
124870672|NCT04495179|449145553|FG000|Overall Study|Study terminated by sponsor|0|||
124870673|NCT04495179|449145554|FG001|Overall Study|Study terminated by sponsor|18|||
124870674|NCT04495179|449145553|FG000|Overall Study|Death|0|||
124870675|NCT04495179|449145554|FG001|Overall Study|Death|4|||
124870676|NCT04495179|449145553|FG000|Overall Study|Adverse Event|0|||
124870677|NCT04495179|449145554|FG001|Overall Study|Adverse Event|1|||
124870678|NCT02355743|449145568|FG000|Overall Study|Withdrawal by Subject|1|||
124870679|NCT02355743|449145568|FG000|Overall Study|Lost to Follow-up|1|||
124870680|NCT04212091|449145569|FG000|Overall Study|Lost to Follow-up|0|||
124870681|NCT04212091|449145570|FG001|Overall Study|Lost to Follow-up|0|||
124870682|NCT04212091|449145571|FG002|Overall Study|Lost to Follow-up|0|||
124870683|NCT04212091|449145572|FG003|Overall Study|Lost to Follow-up|0|||
124870684|NCT04212091|449145573|FG004|Overall Study|Lost to Follow-up|1|||
124870685|NCT04212091|449145574|FG005|Overall Study|Lost to Follow-up|1|||
124870686|NCT04212091|449145569|FG000|Overall Study|Participant unable to adhere to visit|0|||
124870687|NCT04212091|449145570|FG001|Overall Study|Participant unable to adhere to visit|0|||
124870688|NCT04212091|449145571|FG002|Overall Study|Participant unable to adhere to visit|0|||
124870689|NCT04212091|449145572|FG003|Overall Study|Participant unable to adhere to visit|0|||
124870690|NCT04212091|449145573|FG004|Overall Study|Participant unable to adhere to visit|1|||
124870691|NCT04212091|449145574|FG005|Overall Study|Participant unable to adhere to visit|0|||
124870692|NCT01812655|449145575|FG000|Overall Study|Protocol Violation|1|||
124870693|NCT01812655|449145576|FG001|Overall Study|Protocol Violation|1|||
124870694|NCT01812655|449145577|FG002|Overall Study|Protocol Violation|0|||
124870695|NCT00344461|449145595|FG000|Overall Study|Adverse Event|6|||
124870696|NCT00344461|449145595|FG000|Overall Study|Death|1|||
124870697|NCT00344461|449145595|FG000|Overall Study|Lack of Efficacy|2|||
124870698|NCT00344461|449145595|FG000|Overall Study|Lost to Follow-up|2|||
124870699|NCT00344461|449145595|FG000|Overall Study|Physician Decision|2|||
124870700|NCT00344461|449145595|FG000|Overall Study|Protocol Violation|6|||
124870701|NCT00344461|449145595|FG000|Overall Study|Withdrawal by Subject|2|||
124870702|NCT00636610|449145598|FG000|Overall Study|Adverse Event|4|||
124870703|NCT00636610|449145599|FG001|Overall Study|Adverse Event|4|||
124870704|NCT00636610|449145598|FG000|Overall Study|Death|6|||
124870705|NCT00636610|449145599|FG001|Overall Study|Death|3|||
124870706|NCT00636610|449145598|FG000|Overall Study|Physician decision to withdraw patient|15|||
124870707|NCT00636610|449145599|FG001|Overall Study|Physician decision to withdraw patient|9|||
124870708|NCT00636610|449145598|FG000|Overall Study|Subject decision to withdraw|15|||
124870709|NCT00636610|449145599|FG001|Overall Study|Subject decision to withdraw|11|||
124870710|NCT00636610|449145598|FG000|Overall Study|Disease progression - radiographic|41|||
124870711|NCT00636610|449145599|FG001|Overall Study|Disease progression - radiographic|51|||
124870712|NCT00636610|449145598|FG000|Overall Study|Disease progression - clinical|8|||
124870713|NCT00636610|449145599|FG001|Overall Study|Disease progression - clinical|3|||
124870714|NCT00636610|449145598|FG000|Overall Study|Reason for discontinuation not available|3|||
124870715|NCT00636610|449145599|FG001|Overall Study|Reason for discontinuation not available|2|||
125202379|NCT00960986|450363699|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
125202380|NCT00960986|450363700|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
124870716|NCT02355028|449145600|FG000|Overall Study|Adverse Event|2|||
124870717|NCT02355028|449145601|FG001|Overall Study|Adverse Event|0|||
124870718|NCT02355028|449145600|FG000|Overall Study|Withdrawal by Subject|1|||
124870719|NCT02355028|449145601|FG001|Overall Study|Withdrawal by Subject|1|||
124870720|NCT02355028|449145600|FG000|Overall Study|Deemed ineligible after randomization|8|||
124870721|NCT02355028|449145601|FG001|Overall Study|Deemed ineligible after randomization|4|||
124870722|NCT01971723|449145602|FG000|Overall Study|Withdrawal by Subject|1|||
124870723|NCT01971723|449145603|FG001|Overall Study|Withdrawal by Subject|1|||
124870724|NCT01971723|449145602|FG000|Overall Study|Protocol Violation|1|||
124870725|NCT01971723|449145603|FG001|Overall Study|Protocol Violation|2|||
124870726|NCT05899686|449145604|FG000|Overall Study|Protocol Violation|1|||
124870727|NCT01592370|449145614|FG000|Overall Study|Disease Progression|62|||
124870728|NCT01592370|449145615|FG001|Overall Study|Disease Progression|16|||
124870729|NCT01592370|449145616|FG002|Overall Study|Disease Progression|52|||
124870730|NCT01592370|449145617|FG003|Overall Study|Disease Progression|3|||
124870731|NCT01592370|449145618|FG004|Overall Study|Disease Progression|3|||
124870732|NCT01592370|449145619|FG005|Overall Study|Disease Progression|31|||
124870733|NCT01592370|449145620|FG006|Overall Study|Disease Progression|14|||
124870734|NCT01592370|449145614|FG000|Overall Study|Study Drug Toxicity|14|||
124870735|NCT01592370|449145615|FG001|Overall Study|Study Drug Toxicity|3|||
124870736|NCT01592370|449145616|FG002|Overall Study|Study Drug Toxicity|0|||
124870737|NCT01592370|449145617|FG003|Overall Study|Study Drug Toxicity|0|||
124870738|NCT01592370|449145618|FG004|Overall Study|Study Drug Toxicity|0|||
124870739|NCT01592370|449145619|FG005|Overall Study|Study Drug Toxicity|0|||
124870740|NCT01592370|449145620|FG006|Overall Study|Study Drug Toxicity|1|||
124870741|NCT01592370|449145614|FG000|Overall Study|AE unrelated to study drug|4|||
124870742|NCT01592370|449145615|FG001|Overall Study|AE unrelated to study drug|3|||
124870743|NCT01592370|449145616|FG002|Overall Study|AE unrelated to study drug|0|||
124870744|NCT01592370|449145617|FG003|Overall Study|AE unrelated to study drug|0|||
124870745|NCT01592370|449145618|FG004|Overall Study|AE unrelated to study drug|0|||
124870746|NCT01592370|449145619|FG005|Overall Study|AE unrelated to study drug|0|||
124870747|NCT01592370|449145620|FG006|Overall Study|AE unrelated to study drug|1|||
124870748|NCT01592370|449145614|FG000|Overall Study|Request to discontinue study treatment|5|||
124870749|NCT01592370|449145615|FG001|Overall Study|Request to discontinue study treatment|0|||
124870750|NCT01592370|449145616|FG002|Overall Study|Request to discontinue study treatment|2|||
124870751|NCT01592370|449145617|FG003|Overall Study|Request to discontinue study treatment|0|||
124870752|NCT01592370|449145618|FG004|Overall Study|Request to discontinue study treatment|1|||
124870753|NCT01592370|449145619|FG005|Overall Study|Request to discontinue study treatment|2|||
124870754|NCT01592370|449145620|FG006|Overall Study|Request to discontinue study treatment|0|||
124870755|NCT01592370|449145614|FG000|Overall Study|Withdrew consent|1|||
124870756|NCT01592370|449145615|FG001|Overall Study|Withdrew consent|2|||
124870757|NCT01592370|449145616|FG002|Overall Study|Withdrew consent|1|||
124870758|NCT01592370|449145617|FG003|Overall Study|Withdrew consent|1|||
124870759|NCT01592370|449145618|FG004|Overall Study|Withdrew consent|0|||
124870760|NCT01592370|449145619|FG005|Overall Study|Withdrew consent|0|||
124870761|NCT01592370|449145620|FG006|Overall Study|Withdrew consent|0|||
124870762|NCT01592370|449145614|FG000|Overall Study|Maximum clinical benefit|11|||
124870763|NCT01592370|449145615|FG001|Overall Study|Maximum clinical benefit|1|||
124870764|NCT01592370|449145616|FG002|Overall Study|Maximum clinical benefit|7|||
124870765|NCT01592370|449145617|FG003|Overall Study|Maximum clinical benefit|1|||
124870766|NCT01592370|449145618|FG004|Overall Study|Maximum clinical benefit|0|||
124870767|NCT01592370|449145619|FG005|Overall Study|Maximum clinical benefit|0|||
124870768|NCT01592370|449145620|FG006|Overall Study|Maximum clinical benefit|0|||
124870769|NCT01592370|449145614|FG000|Overall Study|No longer meets study criteria|1|||
124870770|NCT01592370|449145615|FG001|Overall Study|No longer meets study criteria|0|||
124870771|NCT01592370|449145616|FG002|Overall Study|No longer meets study criteria|0|||
124870772|NCT01592370|449145617|FG003|Overall Study|No longer meets study criteria|0|||
124870773|NCT01592370|449145618|FG004|Overall Study|No longer meets study criteria|0|||
124870774|NCT01592370|449145619|FG005|Overall Study|No longer meets study criteria|0|||
124870775|NCT01592370|449145620|FG006|Overall Study|No longer meets study criteria|0|||
124870776|NCT01592370|449145614|FG000|Overall Study|Other Reasons|6|||
124870777|NCT01592370|449145615|FG001|Overall Study|Other Reasons|0|||
124870778|NCT01592370|449145616|FG002|Overall Study|Other Reasons|10|||
124870779|NCT01592370|449145617|FG003|Overall Study|Other Reasons|0|||
124870780|NCT01592370|449145618|FG004|Overall Study|Other Reasons|0|||
124870781|NCT01592370|449145619|FG005|Overall Study|Other Reasons|1|||
124870782|NCT01592370|449145620|FG006|Overall Study|Other Reasons|0|||
124870783|NCT01323530|449147152|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
124870784|NCT01323530|449147153|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
124870785|NCT01323530|449147154|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
124870786|NCT01323530|449147155|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
124870787|NCT01323530|449147156|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
124870788|NCT01323530|449147157|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
124870789|NCT01323530|449147158|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
124870790|NCT01323530|449147152|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
124870791|NCT01323530|449147153|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
124870792|NCT01323530|449147154|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
124870793|NCT01323530|449147155|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
124870794|NCT01323530|449147156|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
124870795|NCT01323530|449147157|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
124870796|NCT01323530|449147158|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
124870797|NCT01323530|449147152|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
124870798|NCT01323530|449147153|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
124870799|NCT01323530|449147154|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
124870800|NCT01323530|449147155|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
124870801|NCT01323530|449147156|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
124870802|NCT01323530|449147157|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
124870803|NCT01323530|449147158|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
124870804|NCT01323530|449147152|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
124870805|NCT01323530|449147153|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
124870806|NCT01323530|449147154|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
124870807|NCT01323530|449147155|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
124870808|NCT01323530|449147156|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
124870809|NCT01323530|449147157|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
124870810|NCT01323530|449147158|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
124870811|NCT01323530|449147152|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
124870812|NCT01323530|449147153|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
124870813|NCT01323530|449147154|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
124870814|NCT01323530|449147155|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
124870815|NCT01323530|449147156|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
124870816|NCT01323530|449147157|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
124870817|NCT01323530|449147158|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
124870818|NCT01323530|449147152|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
124870819|NCT01323530|449147153|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
124870820|NCT01323530|449147154|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
124870821|NCT01323530|449147155|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
124870822|NCT01323530|449147156|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
124870823|NCT01323530|449147157|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
124870824|NCT01323530|449147158|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
124870825|NCT01323530|449147152|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
124870826|NCT01323530|449147153|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
124870827|NCT01323530|449147154|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
124870828|NCT01323530|449147155|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
124870829|NCT01323530|449147156|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
124870830|NCT01323530|449147157|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
124870831|NCT01323530|449147158|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
124870832|NCT01323530|449147152|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
124870833|NCT01323530|449147153|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
124870834|NCT01323530|449147154|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
124870835|NCT01323530|449147155|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
124870836|NCT01323530|449147156|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
124870837|NCT01323530|449147157|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
124870838|NCT01323530|449147158|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
124870839|NCT01111123|449147159|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
124870840|NCT01111123|449147160|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
124870841|NCT01111123|449147159|FG000|Maintenance Phase|Lost to Follow-up|0|||
124870842|NCT01111123|449147160|FG001|Maintenance Phase|Lost to Follow-up|2|||
124870843|NCT00119405|449147161|FG000|Overall Study|Withdrawal by Subject|1|||
124870844|NCT01735201|449147163|FG000|Overall Study|Adverse Event|1|||
124870845|NCT01735201|449147164|FG001|Overall Study|Adverse Event|1|||
124870846|NCT01735201|449147165|FG002|Overall Study|Adverse Event|0|||
124870847|NCT01735201|449147166|FG003|Overall Study|Adverse Event|1|||
124870848|NCT01735201|449147167|FG004|Overall Study|Adverse Event|1|||
124870849|NCT01735201|449147168|FG005|Overall Study|Adverse Event|3|||
124870850|NCT01735201|449147169|FG006|Overall Study|Adverse Event|2|||
124870851|NCT01735201|449147170|FG007|Overall Study|Adverse Event|1|||
124870852|NCT01735201|449147163|FG000|Overall Study|Personal Reasons|1|||
124870853|NCT01735201|449147164|FG001|Overall Study|Personal Reasons|0|||
124870854|NCT01735201|449147165|FG002|Overall Study|Personal Reasons|0|||
124870855|NCT01735201|449147166|FG003|Overall Study|Personal Reasons|0|||
124870856|NCT01735201|449147167|FG004|Overall Study|Personal Reasons|0|||
124870857|NCT01735201|449147168|FG005|Overall Study|Personal Reasons|0|||
124870858|NCT01735201|449147169|FG006|Overall Study|Personal Reasons|0|||
124870859|NCT01735201|449147170|FG007|Overall Study|Personal Reasons|0|||
124870860|NCT01735201|449147163|FG000|Overall Study|Protocol Violation|1|||
124870861|NCT01735201|449147164|FG001|Overall Study|Protocol Violation|0|||
124870862|NCT01735201|449147165|FG002|Overall Study|Protocol Violation|0|||
124870863|NCT01735201|449147166|FG003|Overall Study|Protocol Violation|0|||
124870864|NCT01735201|449147167|FG004|Overall Study|Protocol Violation|0|||
124870865|NCT01735201|449147168|FG005|Overall Study|Protocol Violation|0|||
124870866|NCT01735201|449147169|FG006|Overall Study|Protocol Violation|0|||
124870867|NCT01735201|449147170|FG007|Overall Study|Protocol Violation|0|||
124870868|NCT01735201|449147163|FG000|Overall Study|Other Miscellaneous Reasons|0|||
124870869|NCT01735201|449147164|FG001|Overall Study|Other Miscellaneous Reasons|0|||
124870870|NCT01735201|449147165|FG002|Overall Study|Other Miscellaneous Reasons|0|||
124870871|NCT01735201|449147166|FG003|Overall Study|Other Miscellaneous Reasons|1|||
124870872|NCT01735201|449147167|FG004|Overall Study|Other Miscellaneous Reasons|0|||
124870873|NCT01735201|449147168|FG005|Overall Study|Other Miscellaneous Reasons|2|||
124870874|NCT01735201|449147169|FG006|Overall Study|Other Miscellaneous Reasons|1|||
124870875|NCT01735201|449147170|FG007|Overall Study|Other Miscellaneous Reasons|1|||
124870876|NCT01553318|449147171|FG000|Overall Study|Protocol Violation|3|||
124870877|NCT01553318|449147172|FG001|Overall Study|Protocol Violation|2|||
124870878|NCT02127372|449147178|FG000|Overall Study|Withdrawal by Subject|1|||
124870879|NCT02127372|449147179|FG001|Overall Study|Withdrawal by Subject|0|||
124870880|NCT01357616|449147183|FG000|Overall Study|Adverse Event|1|||
124870881|NCT01357616|449147184|FG001|Overall Study|Adverse Event|1|||
124870882|NCT01357616|449147183|FG000|Overall Study|Lost to Follow-up|4|||
124870883|NCT01357616|449147184|FG001|Overall Study|Lost to Follow-up|3|||
124870884|NCT01357616|449147183|FG000|Overall Study|Protocol Violation|0|||
124870885|NCT01357616|449147184|FG001|Overall Study|Protocol Violation|2|||
124870886|NCT01357616|449147183|FG000|Overall Study|Inadequate Control of IOP|1|||
124870887|NCT01357616|449147184|FG001|Overall Study|Inadequate Control of IOP|2|||
124870888|NCT01357616|449147183|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
124870889|NCT01357616|449147184|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
124870890|NCT01357616|449147183|FG000|Overall Study|Withdrawal by Subject|1|||
124870891|NCT01357616|449147184|FG001|Overall Study|Withdrawal by Subject|0|||
124870892|NCT02052310|449147188|FG000|Overall Study|Death|64|||
124870893|NCT02052310|449147189|FG001|Overall Study|Death|54|||
124870894|NCT02052310|449147188|FG000|Overall Study|Withdrawal by Subject|37|||
124870895|NCT02052310|449147189|FG001|Overall Study|Withdrawal by Subject|49|||
124870896|NCT02052310|449147188|FG000|Overall Study|Other than specified|32|||
124870897|NCT02052310|449147189|FG001|Overall Study|Other than specified|29|||
124870898|NCT02052310|449147188|FG000|Overall Study|Adverse Event|29|||
124870899|NCT02052310|449147189|FG001|Overall Study|Adverse Event|22|||
124870900|NCT02052310|449147188|FG000|Overall Study|Kidney Transplant|23|||
124870901|NCT02052310|449147189|FG001|Overall Study|Kidney Transplant|29|||
124870902|NCT02052310|449147188|FG000|Overall Study|Physician Decision|14|||
124870903|NCT02052310|449147189|FG001|Overall Study|Physician Decision|7|||
124870904|NCT02052310|449147188|FG000|Overall Study|Lack of Efficacy|6|||
124870905|NCT02052310|449147189|FG001|Overall Study|Lack of Efficacy|1|||
124870906|NCT02052310|449147188|FG000|Overall Study|Site Terminated by Sponsor|5|||
124870907|NCT02052310|449147189|FG001|Overall Study|Site Terminated by Sponsor|13|||
124870908|NCT02052310|449147188|FG000|Overall Study|Lost to Follow-up|4|||
124870909|NCT02052310|449147189|FG001|Overall Study|Lost to Follow-up|2|||
124870910|NCT02052310|449147188|FG000|Overall Study|Protocol Violation|1|||
124870911|NCT02052310|449147189|FG001|Overall Study|Protocol Violation|6|||
124870912|NCT01505387|449147192|FG000|Overall Study|Protocol Violation|1|||
124870913|NCT01505387|449147193|FG001|Overall Study|Protocol Violation|0|||
124870914|NCT01505387|449147192|FG000|Overall Study|Withdrawal by Subject|1|||
124870915|NCT01505387|449147193|FG001|Overall Study|Withdrawal by Subject|1|||
124870916|NCT00420199|449147195|FG000|Overall Study|Participant no longer met study criteria|1|||
124870917|NCT00420199|449147196|FG001|Overall Study|Participant no longer met study criteria|0|||
124870918|NCT03466086|449147200|FG000|Period 1|Sponsor decision due to study timeline|1|||
124870919|NCT03466086|449147201|FG001|Period 1|Sponsor decision due to study timeline|0|||
124870920|NCT03466086|449147200|FG000|Period 1|Withdrawal by Subject|1|||
124870921|NCT03466086|449147201|FG001|Period 1|Withdrawal by Subject|0|||
124870922|NCT04020341|449147204|FG000|Overall Study|Adverse Event|8|||
124870923|NCT04020341|449147205|FG001|Overall Study|Adverse Event|6|||
124870924|NCT04020341|449147204|FG000|Overall Study|Lost to Follow-up|8|||
124870925|NCT04020341|449147205|FG001|Overall Study|Lost to Follow-up|2|||
124870926|NCT04020341|449147204|FG000|Overall Study|Withdrawal by Subject|16|||
124870927|NCT04020341|449147205|FG001|Overall Study|Withdrawal by Subject|16|||
124870928|NCT04020341|449147204|FG000|Overall Study|Participant not able to swallow the tablet|1|||
124870929|NCT04020341|449147205|FG001|Overall Study|Participant not able to swallow the tablet|0|||
124870930|NCT04020341|449147204|FG000|Overall Study|Physician Decision|0|||
124870931|NCT04020341|449147205|FG001|Overall Study|Physician Decision|2|||
124870932|NCT04020341|449147204|FG000|Overall Study|Protocol Deviation|0|||
124870933|NCT04020341|449147205|FG001|Overall Study|Protocol Deviation|2|||
124870934|NCT00677352|449147206|FG000|Treatment Phase|Adverse Event|14|||
124870935|NCT00677352|449147207|FG001|Treatment Phase|Adverse Event|22|||
124870936|NCT00677352|449147206|FG000|Treatment Phase|Lack of Efficacy|2|||
124870937|NCT00677352|449147207|FG001|Treatment Phase|Lack of Efficacy|3|||
124870938|NCT00677352|449147206|FG000|Treatment Phase|Lost to Follow-up|0|||
124870939|NCT00677352|449147207|FG001|Treatment Phase|Lost to Follow-up|1|||
124870940|NCT00677352|449147206|FG000|Treatment Phase|Withdrawal by Subject|7|||
124870941|NCT00677352|449147207|FG001|Treatment Phase|Withdrawal by Subject|7|||
124870942|NCT00677352|449147206|FG000|Treatment Phase|Physician Decision|1|||
124870943|NCT00677352|449147207|FG001|Treatment Phase|Physician Decision|0|||
124870944|NCT00677352|449147206|FG000|Treatment Phase|Pregnancy|0|||
124870945|NCT00677352|449147207|FG001|Treatment Phase|Pregnancy|1|||
124870946|NCT00677352|449147206|FG000|Treatment Phase|Protocol Violation|1|||
124870947|NCT00677352|449147207|FG001|Treatment Phase|Protocol Violation|1|||
124870948|NCT00677352|449147206|FG000|Treatment Phase|Transference or work related matter|0|||
124870949|NCT00677352|449147207|FG001|Treatment Phase|Transference or work related matter|5|||
124870950|NCT00677352|449147206|FG000|Treatment Phase|Not treated|0|||
124870951|NCT00677352|449147207|FG001|Treatment Phase|Not treated|2|||
124870952|NCT00677352|449147206|FG000|Tapering Phase|Adverse Event|1|||
124870953|NCT00677352|449147207|FG001|Tapering Phase|Adverse Event|5|||
124870954|NCT00677352|449147206|FG000|Tapering Phase|Withdrawal by Subject|5|||
124870955|NCT00677352|449147207|FG001|Tapering Phase|Withdrawal by Subject|3|||
124870956|NCT00677352|449147206|FG000|Tapering Phase|Pregnancy|0|||
124870957|NCT00677352|449147207|FG001|Tapering Phase|Pregnancy|1|||
124870958|NCT00677352|449147206|FG000|Tapering Phase|Job transfer|0|||
124870959|NCT00677352|449147207|FG001|Tapering Phase|Job transfer|1|||
124870960|NCT05763628|449147208|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
124870961|NCT05763628|449147209|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
124870962|NCT05763628|449147208|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
124870963|NCT05763628|449147209|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
124870964|NCT05763628|449147208|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
124870965|NCT05763628|449147209|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
124870966|NCT00716092|449147210|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
124870967|NCT00716092|449147211|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
124870968|NCT00716092|449147212|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
124870969|NCT00781391|449147215|FG000|Overall Study|never received study drug|24|||
124870970|NCT00781391|449147216|FG001|Overall Study|never received study drug|23|||
124870971|NCT00781391|449147217|FG002|Overall Study|never received study drug|32|||
124870972|NCT00781391|449147215|FG000|Overall Study|Protocol Violation|19|||
124870973|NCT00781391|449147216|FG001|Overall Study|Protocol Violation|17|||
124870974|NCT00781391|449147217|FG002|Overall Study|Protocol Violation|20|||
124870975|NCT00781391|449147215|FG000|Overall Study|Death|789|||
124870976|NCT00781391|449147216|FG001|Overall Study|Death|730|||
124870977|NCT00781391|449147217|FG002|Overall Study|Death|706|||
124870978|NCT00781391|449147215|FG000|Overall Study|Withdrawal by Subject|47|||
124870979|NCT00781391|449147216|FG001|Overall Study|Withdrawal by Subject|37|||
124870980|NCT00781391|449147217|FG002|Overall Study|Withdrawal by Subject|25|||
124870981|NCT00781391|449147215|FG000|Overall Study|Lost to Follow-up|0|||
124870982|NCT00781391|449147216|FG001|Overall Study|Lost to Follow-up|0|||
124870983|NCT00781391|449147217|FG002|Overall Study|Lost to Follow-up|1|||
124870984|NCT04535947|449147218|FG000|Overall Study|Adverse Event|1|||
124870985|NCT04535947|449147219|FG001|Overall Study|Adverse Event|4|||
124870986|NCT04535947|449147218|FG000|Overall Study|Other reasons not specified|2|||
124870987|NCT04535947|449147219|FG001|Overall Study|Other reasons not specified|0|||
124870988|NCT04535947|449147218|FG000|Overall Study|Withdrawal by Subject|1|||
124870989|NCT04535947|449147219|FG001|Overall Study|Withdrawal by Subject|1|||
124870990|NCT03802123|449147221|FG000|Overall Study|Withdrawal by Subject|3|||
124870991|NCT03802123|449147221|FG000|Overall Study|Physician Decision|1|||
124870992|NCT03802123|449147221|FG000|Overall Study|Subject moved to hospice care|1|||
124870993|NCT03802123|449147221|FG000|Overall Study|technician error|1|||
124870994|NCT03802123|449147221|FG000|Overall Study|Death|3|||
124870995|NCT01822587|449147222|FG000|Overall Study|Lost to Follow-up|7|||
124870996|NCT01822587|449147223|FG001|Overall Study|Lost to Follow-up|9|||
124870997|NCT01822587|449147224|FG002|Overall Study|Lost to Follow-up|12|||
124870998|NCT01822587|449147222|FG000|Overall Study|Physician Decision|9|||
124870999|NCT01822587|449147223|FG001|Overall Study|Physician Decision|6|||
124871000|NCT01822587|449147224|FG002|Overall Study|Physician Decision|6|||
124871001|NCT00658567|449147227|FG000|Overall Study|Adverse Event|5|||
124871002|NCT00658567|449147228|FG001|Overall Study|Adverse Event|2|||
124871003|NCT00658567|449147229|FG002|Overall Study|Adverse Event|3|||
124871004|NCT00658567|449147227|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
124871005|NCT00658567|449147228|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
124871006|NCT00658567|449147229|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
124871007|NCT00658567|449147227|FG000|Overall Study|Physician Decision|0|||
124871008|NCT00658567|449147228|FG001|Overall Study|Physician Decision|1|||
124871009|NCT00658567|449147229|FG002|Overall Study|Physician Decision|0|||
124871010|NCT00658567|449147227|FG000|Overall Study|At Discretion of Sponsor|1|||
124871011|NCT00658567|449147228|FG001|Overall Study|At Discretion of Sponsor|1|||
124871012|NCT00658567|449147229|FG002|Overall Study|At Discretion of Sponsor|1|||
124871013|NCT01058304|449147240|FG000|Overall Study|Withdrawal by Subject|8|||
124871014|NCT01058304|449147241|FG001|Overall Study|Withdrawal by Subject|5|||
124871015|NCT01058304|449147240|FG000|Overall Study|Lost to Follow-up|13|||
124871016|NCT01058304|449147241|FG001|Overall Study|Lost to Follow-up|16|||
124871017|NCT01058304|449147240|FG000|Overall Study|Developed exclusion criterion|6|||
124871018|NCT01058304|449147241|FG001|Overall Study|Developed exclusion criterion|12|||
124871019|NCT01820559|449147242|FG000|Overall Study|Adverse Event|4|||
124871020|NCT01820559|449147243|FG001|Overall Study|Adverse Event|6|||
124871021|NCT01820559|449147244|FG002|Overall Study|Adverse Event|13|||
124871022|NCT01820559|449147242|FG000|Overall Study|Withdrawal by Subject|1|||
124871023|NCT01820559|449147243|FG001|Overall Study|Withdrawal by Subject|2|||
124871024|NCT01820559|449147244|FG002|Overall Study|Withdrawal by Subject|5|||
124871025|NCT01820559|449147242|FG000|Overall Study|Protocol Violation|2|||
124871026|NCT01820559|449147243|FG001|Overall Study|Protocol Violation|1|||
124871027|NCT01820559|449147244|FG002|Overall Study|Protocol Violation|3|||
124871028|NCT01820559|449147242|FG000|Overall Study|Subject's non-compliance|1|||
124871029|NCT01820559|449147243|FG001|Overall Study|Subject's non-compliance|0|||
124871030|NCT01820559|449147244|FG002|Overall Study|Subject's non-compliance|2|||
124871031|NCT01820559|449147242|FG000|Overall Study|Lost to Follow-up|3|||
124871032|NCT01820559|449147243|FG001|Overall Study|Lost to Follow-up|2|||
124871033|NCT01820559|449147244|FG002|Overall Study|Lost to Follow-up|2|||
124871034|NCT01820559|449147242|FG000|Overall Study|At sponsor request|0|||
124871035|NCT01820559|449147243|FG001|Overall Study|At sponsor request|0|||
124871036|NCT01820559|449147244|FG002|Overall Study|At sponsor request|1|||
124871037|NCT01820559|449147242|FG000|Overall Study|Lack of Efficacy|3|||
124871038|NCT01820559|449147243|FG001|Overall Study|Lack of Efficacy|2|||
124871039|NCT01820559|449147244|FG002|Overall Study|Lack of Efficacy|3|||
124871040|NCT02618967|449147245|FG000|Overall Study|Lost to Follow-up|0|||
124871041|NCT02618967|449147246|FG001|Overall Study|Lost to Follow-up|0|||
124871042|NCT02618967|449147247|FG002|Overall Study|Lost to Follow-up|1|||
124871043|NCT02618967|449147248|FG003|Overall Study|Lost to Follow-up|0|||
124871044|NCT02618967|449147249|FG004|Overall Study|Lost to Follow-up|2|||
124871045|NCT02618967|449147250|FG005|Overall Study|Lost to Follow-up|0|||
124871046|NCT02618967|449147251|FG006|Overall Study|Lost to Follow-up|0|||
124871047|NCT02618967|449147252|FG007|Overall Study|Lost to Follow-up|0|||
124871048|NCT02618967|449147245|FG000|Overall Study|Withdrawal by Subject|1|||
124871049|NCT02618967|449147246|FG001|Overall Study|Withdrawal by Subject|0|||
124871050|NCT02618967|449147247|FG002|Overall Study|Withdrawal by Subject|0|||
124871051|NCT02618967|449147248|FG003|Overall Study|Withdrawal by Subject|0|||
124871052|NCT02618967|449147249|FG004|Overall Study|Withdrawal by Subject|0|||
124871053|NCT02618967|449147250|FG005|Overall Study|Withdrawal by Subject|0|||
124871054|NCT02618967|449147251|FG006|Overall Study|Withdrawal by Subject|0|||
124871055|NCT02618967|449147252|FG007|Overall Study|Withdrawal by Subject|0|||
124871056|NCT01368965|449147253|FG000|Overall Study|Lost to Follow-up|12|||
124871057|NCT01936857|449147262|FG000|Overall Study|Sent to prison or 06 center|11|||
124871058|NCT01936857|449147263|FG001|Overall Study|Sent to prison or 06 center|12|||
124871059|NCT01936857|449147262|FG000|Overall Study|Lost to Follow-up|10|||
124871060|NCT01936857|449147263|FG001|Overall Study|Lost to Follow-up|7|||
124871061|NCT01936857|449147262|FG000|Overall Study|Death|7|||
124871062|NCT01936857|449147263|FG001|Overall Study|Death|3|||
124871063|NCT01936857|449147262|FG000|Overall Study|Moved|2|||
124871064|NCT01936857|449147263|FG001|Overall Study|Moved|1|||
124871065|NCT01936857|449147262|FG000|Overall Study|Withdrawal by Subject|1|||
124871066|NCT01936857|449147263|FG001|Overall Study|Withdrawal by Subject|0|||
124871067|NCT01936857|449147262|FG000|Overall Study|Side effect of medication|1|||
124871068|NCT01936857|449147263|FG001|Overall Study|Side effect of medication|0|||
124871069|NCT01936857|449147262|FG000|Overall Study|Other|2|||
124871070|NCT01936857|449147263|FG001|Overall Study|Other|2|||
124871071|NCT01939548|449147264|FG000|Overall Study|Non compliance|0|||
124871072|NCT01939548|449147265|FG001|Overall Study|Non compliance|2|||
124871073|NCT01939548|449147266|FG002|Overall Study|Non compliance|0|||
124871074|NCT01939548|449147264|FG000|Overall Study|Study Terminated by Sponsor|17|||
124871075|NCT01939548|449147265|FG001|Overall Study|Study Terminated by Sponsor|19|||
124871076|NCT01939548|449147266|FG002|Overall Study|Study Terminated by Sponsor|12|||
124871077|NCT01939548|449147264|FG000|Overall Study|Insufficient Clinical Response|1|||
124871078|NCT01939548|449147265|FG001|Overall Study|Insufficient Clinical Response|0|||
124871079|NCT01939548|449147266|FG002|Overall Study|Insufficient Clinical Response|0|||
124871080|NCT01939548|449147264|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
124871081|NCT01939548|449147265|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
124871082|NCT01939548|449147266|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
124871083|NCT01939548|449147264|FG000|Overall Study|Withdrawal by Subject|4|||
124871084|NCT01939548|449147265|FG001|Overall Study|Withdrawal by Subject|4|||
124871085|NCT01939548|449147266|FG002|Overall Study|Withdrawal by Subject|1|||
124871086|NCT01939548|449147264|FG000|Overall Study|Protocol Violation|7|||
124871087|NCT01939548|449147265|FG001|Overall Study|Protocol Violation|6|||
124871088|NCT01939548|449147266|FG002|Overall Study|Protocol Violation|5|||
124871089|NCT01939548|449147264|FG000|Overall Study|Lost to Follow-up|5|||
124871090|NCT01939548|449147265|FG001|Overall Study|Lost to Follow-up|5|||
124871091|NCT01939548|449147266|FG002|Overall Study|Lost to Follow-up|3|||
124871092|NCT01939548|449147264|FG000|Overall Study|Adverse Event|2|||
124871093|NCT01939548|449147265|FG001|Overall Study|Adverse Event|9|||
124871094|NCT01939548|449147266|FG002|Overall Study|Adverse Event|7|||
125202381|NCT00960986|450363697|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
125202382|NCT00960986|450363698|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
124871095|NCT01939548|449147264|FG000|Overall Study|Death|0|||
124871096|NCT01939548|449147265|FG001|Overall Study|Death|0|||
124871097|NCT01939548|449147266|FG002|Overall Study|Death|1|||
124871098|NCT01939548|449147264|FG000|Overall Study|Participant dropped|0|||
124871099|NCT01939548|449147265|FG001|Overall Study|Participant dropped|0|||
125202383|NCT00960986|450363699|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
124871100|NCT01939548|449147266|FG002|Overall Study|Participant dropped|1|||
124871101|NCT01939548|449147264|FG000|Overall Study|Participant unwilling to continue|0|||
124871102|NCT01939548|449147265|FG001|Overall Study|Participant unwilling to continue|1|||
124871103|NCT01939548|449147266|FG002|Overall Study|Participant unwilling to continue|0|||
124871104|NCT01939548|449147264|FG000|Overall Study|Participant withdrew consent|0|||
124871105|NCT01939548|449147265|FG001|Overall Study|Participant withdrew consent|2|||
124871106|NCT01939548|449147266|FG002|Overall Study|Participant withdrew consent|0|||
124871107|NCT01939548|449147264|FG000|Overall Study|Did not complete follow-up|0|||
124871108|NCT01939548|449147265|FG001|Overall Study|Did not complete follow-up|1|||
124871109|NCT01939548|449147266|FG002|Overall Study|Did not complete follow-up|0|||
124871110|NCT00490282|449147267|FG000|Overall Study|Withdrawal by Subject|3|||
124871111|NCT04198805|449147268|FG000|Overall Study|Death|0|||
124871112|NCT04198805|449147269|FG001|Overall Study|Death|0|||
124871113|NCT04198805|449147270|FG002|Overall Study|Death|0|||
124871114|NCT04198805|449147271|FG003|Overall Study|Death|1|||
124871115|NCT04198805|449147268|FG000|Overall Study|Early Termination|8|||
124871116|NCT04198805|449147269|FG001|Overall Study|Early Termination|4|||
124871117|NCT04198805|449147270|FG002|Overall Study|Early Termination|6|||
124871118|NCT04198805|449147271|FG003|Overall Study|Early Termination|9|||
124871119|NCT03599349|449147272|FG000|Overall Study|Lost to Follow-up|1|||
124871120|NCT03221387|449147276|FG000|Overall Study|Lost to Follow-up|1|||
124871121|NCT03221387|449147276|FG000|Overall Study|Lung transplant|1|||
124871122|NCT00553696|449147277|FG000|Overall Study|Adverse Event|2|||
124871123|NCT00553696|449147278|FG001|Overall Study|Adverse Event|4|||
124871124|NCT00553696|449147279|FG002|Overall Study|Adverse Event|0|||
124871125|NCT00553696|449147280|FG003|Overall Study|Adverse Event|1|||
124871126|NCT00553696|449147277|FG000|Overall Study|Global deterioration of health status|0|||
124871127|NCT00553696|449147278|FG001|Overall Study|Global deterioration of health status|2|||
124871128|NCT00553696|449147279|FG002|Overall Study|Global deterioration of health status|0|||
124871129|NCT00553696|449147280|FG003|Overall Study|Global deterioration of health status|0|||
124871130|NCT00553696|449147277|FG000|Overall Study|Objective progression or relapse|2|||
124871131|NCT00553696|449147278|FG001|Overall Study|Objective progression or relapse|9|||
124871132|NCT00553696|449147279|FG002|Overall Study|Objective progression or relapse|6|||
124871133|NCT00553696|449147280|FG003|Overall Study|Objective progression or relapse|0|||
124871134|NCT00553696|449147277|FG000|Overall Study|Withdrawal by Subject|0|||
124871135|NCT00553696|449147278|FG001|Overall Study|Withdrawal by Subject|1|||
124871136|NCT00553696|449147279|FG002|Overall Study|Withdrawal by Subject|0|||
124871137|NCT00553696|449147280|FG003|Overall Study|Withdrawal by Subject|0|||
124871138|NCT02276222|449147283|FG000|Overall Study|Adverse Event|62|||
124871139|NCT02276222|449147284|FG001|Overall Study|Adverse Event|11|||
124871140|NCT02276222|449147283|FG000|Overall Study|Death|3|||
124871141|NCT02276222|449147284|FG001|Overall Study|Death|4|||
124871142|NCT02276222|449147283|FG000|Overall Study|Lack of Efficacy|13|||
124871143|NCT02276222|449147284|FG001|Overall Study|Lack of Efficacy|3|||
124871144|NCT02276222|449147283|FG000|Overall Study|Protocol Violation|3|||
124871145|NCT02276222|449147284|FG001|Overall Study|Protocol Violation|2|||
124871146|NCT02276222|449147283|FG000|Overall Study|Withdrawal by Subject|79|||
124871147|NCT02276222|449147284|FG001|Overall Study|Withdrawal by Subject|33|||
124871148|NCT02276222|449147283|FG000|Overall Study|non compliance with study medication|6|||
124871149|NCT02276222|449147284|FG001|Overall Study|non compliance with study medication|2|||
124871150|NCT02276222|449147283|FG000|Overall Study|sponsor decision|0|||
124871151|NCT02276222|449147284|FG001|Overall Study|sponsor decision|3|||
124871152|NCT02276222|449147283|FG000|Overall Study|Lost to Follow-up|15|||
124871153|NCT02276222|449147284|FG001|Overall Study|Lost to Follow-up|5|||
124871154|NCT02276222|449147283|FG000|Overall Study|Physician Decision|2|||
124871155|NCT02276222|449147284|FG001|Overall Study|Physician Decision|1|||
124871156|NCT02276222|449147283|FG000|Overall Study|sheduling conflict|1|||
124871157|NCT02276222|449147284|FG001|Overall Study|sheduling conflict|0|||
124871158|NCT02276222|449147283|FG000|Overall Study|subject withdrew after randomization|1|||
124871159|NCT02276222|449147284|FG001|Overall Study|subject withdrew after randomization|0|||
124871160|NCT03645759|449147285|FG000|Overall Study|Lost to Follow-up|3|||
124871161|NCT03645759|449147286|FG001|Overall Study|Lost to Follow-up|2|||
124871162|NCT01648270|449147287|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
124871163|NCT02170025|449147288|FG000|Overall Study|Adverse Event|2|||
124871164|NCT02170025|449147289|FG001|Overall Study|Adverse Event|0|||
124871165|NCT00572195|449147290|FG000|Overall Study|Withdrawal by Subject|50|||
124871166|NCT00572195|449147290|FG000|Overall Study|Death|9|||
124871167|NCT00572195|449147290|FG000|Overall Study|Adverse Event|4|||
124871168|NCT00572195|449147290|FG000|Overall Study|Lost to Follow-up|5|||
124871169|NCT00902694|449147291|FG000|Overall Study|Death|1|||
124871170|NCT00902694|449147292|FG001|Overall Study|Death|3|||
124871171|NCT00902694|449147291|FG000|Overall Study|Lost to Follow-up|1|||
124871172|NCT00902694|449147292|FG001|Overall Study|Lost to Follow-up|0|||
124871173|NCT00902694|449147291|FG000|Overall Study|Censored per protocol|3|||
124871174|NCT00902694|449147292|FG001|Overall Study|Censored per protocol|1|||
124871175|NCT00902694|449147291|FG000|Overall Study|Pregnancy|1|||
124871176|NCT00902694|449147292|FG001|Overall Study|Pregnancy|1|||
124871177|NCT00902694|449147291|FG000|Overall Study|Incarceration|1|||
124871178|NCT00902694|449147292|FG001|Overall Study|Incarceration|0|||
124871179|NCT04969263|449147293|FG000|Overall Study|Death|1|||
124871180|NCT04969263|449147293|FG000|Overall Study|Lost to Follow-up|2|||
124871181|NCT04969263|449147293|FG000|Overall Study|Withdrawal by Subject|5|||
124871182|NCT04969263|449147293|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
124871183|NCT02693743|449147294|FG000|Overall Study|Physician Decision|1|||
124871184|NCT02693743|449147295|FG001|Overall Study|Physician Decision|0|||
124871185|NCT01024608|449147296|FG000|Overall Study|Adverse Event|1|||
124871186|NCT01024608|449147297|FG001|Overall Study|Adverse Event|0|||
124871187|NCT01024608|449147296|FG000|Overall Study|Withdrawal by Subject|1|||
124871188|NCT01024608|449147297|FG001|Overall Study|Withdrawal by Subject|0|||
124871189|NCT01024608|449147296|FG000|Overall Study|Lost to Follow-up|0|||
124871190|NCT01024608|449147297|FG001|Overall Study|Lost to Follow-up|1|||
124871191|NCT01024608|449147296|FG000|Overall Study|Protocol Violation|0|||
124871192|NCT01024608|449147297|FG001|Overall Study|Protocol Violation|3|||
124871193|NCT01024608|449147296|FG000|Overall Study|Never received study treatment|2|||
124871194|NCT01024608|449147297|FG001|Overall Study|Never received study treatment|0|||
124871195|NCT02412137|449147298|FG000|Overall Study|Withdrawal by Subject|2|||
124871196|NCT02412137|449147299|FG001|Overall Study|Withdrawal by Subject|0|||
124871197|NCT02412137|449147298|FG000|Overall Study|Lost to Follow-up|21|||
124871198|NCT02412137|449147299|FG001|Overall Study|Lost to Follow-up|14|||
124871199|NCT02412137|449147298|FG000|Overall Study|Physician Decision|28|||
124871200|NCT02412137|449147299|FG001|Overall Study|Physician Decision|9|||
124871201|NCT04981678|449147306|FG000|Overall Study|Lost to Follow-up|0|||
124871202|NCT04981678|449147307|FG001|Overall Study|Lost to Follow-up|1|||
124871203|NCT04922554|449147308|FG000|Overall Study|Adverse Event|4|||
124871204|NCT04922554|449147309|FG001|Overall Study|Adverse Event|0|||
124871205|NCT04922554|449147308|FG000|Overall Study|Withdrawal by Subject|1|||
124871206|NCT04922554|449147309|FG001|Overall Study|Withdrawal by Subject|0|||
124871207|NCT01332227|449149220|FG000|Overall Study|Adverse Event|4|||
124871208|NCT01332227|449149221|FG001|Overall Study|Adverse Event|1|||
124871209|NCT01332227|449149220|FG000|Overall Study|Withdrawal by Subject|5|||
124871210|NCT01332227|449149221|FG001|Overall Study|Withdrawal by Subject|1|||
124871211|NCT01332227|449149220|FG000|Overall Study|Lost to Follow-up|2|||
124871212|NCT01332227|449149221|FG001|Overall Study|Lost to Follow-up|0|||
124871213|NCT01332227|449149220|FG000|Overall Study|Lack of Efficacy|3|||
124871214|NCT01332227|449149221|FG001|Overall Study|Lack of Efficacy|1|||
124871215|NCT01332227|449149220|FG000|Overall Study|Poor compliance/noncompliance|1|||
124871216|NCT01332227|449149221|FG001|Overall Study|Poor compliance/noncompliance|1|||
124871217|NCT01332227|449149220|FG000|Overall Study|Patient moved from area|1|||
124871218|NCT01332227|449149221|FG001|Overall Study|Patient moved from area|0|||
124871219|NCT01332227|449149220|FG000|Overall Study|Patient began prohibited medication|0|||
124871220|NCT01332227|449149221|FG001|Overall Study|Patient began prohibited medication|1|||
124871221|NCT00514943|449149222|FG000|Stage 1|Progressive disease|4|||
124871222|NCT00514943|449149223|FG001|Stage 1|Progressive disease|8|||
124871223|NCT00514943|449149222|FG000|Stage 1|Other Adverse Event|16|||
124871224|NCT00514943|449149223|FG001|Stage 1|Other Adverse Event|6|||
124871225|NCT00514943|449149222|FG000|Stage 1|Not treated|1|||
124871226|NCT00514943|449149223|FG001|Stage 1|Not treated|2|||
124871227|NCT00514943|449149222|FG000|Stage 1|Patient refused to continue study meds|8|||
124871228|NCT00514943|449149223|FG001|Stage 1|Patient refused to continue study meds|3|||
124871229|NCT00514943|449149222|FG000|Stage 1|Other than stated above|1|||
124871230|NCT00514943|449149223|FG001|Stage 1|Other than stated above|7|||
124871231|NCT00514943|449149222|FG000|Stage 2|Progressive disease|27|||
124871232|NCT00514943|449149223|FG001|Stage 2|Progressive disease|24|||
124871233|NCT00514943|449149222|FG000|Stage 2|Other Adverse Event|3|||
124871234|NCT00514943|449149223|FG001|Stage 2|Other Adverse Event|10|||
124871235|NCT00514943|449149222|FG000|Stage 2|Patient refused to continue study meds|2|||
124871236|NCT00514943|449149223|FG001|Stage 2|Patient refused to continue study meds|0|||
124871237|NCT00514943|449149222|FG000|Stage 2|Other than stated above|0|||
124871238|NCT00514943|449149223|FG001|Stage 2|Other than stated above|2|||
124871239|NCT02173548|449149228|FG000|Overall Study|Lost to Follow-up|0|||
124871240|NCT02173548|449149229|FG001|Overall Study|Lost to Follow-up|2|||
124871241|NCT02173548|449149228|FG000|Overall Study|Withdrawal by Subject|1|||
124871242|NCT02173548|449149229|FG001|Overall Study|Withdrawal by Subject|0|||
124871243|NCT02066402|449149232|FG000|Overall Study|Adverse Event|1|||
124871244|NCT02066402|449149233|FG001|Overall Study|Adverse Event|2|||
124871245|NCT02066402|449149232|FG000|Overall Study|Lost to Follow-up|11|||
124871246|NCT02066402|449149233|FG001|Overall Study|Lost to Follow-up|8|||
124871247|NCT02066402|449149232|FG000|Overall Study|Withdrawal by Subject|14|||
124871248|NCT02066402|449149233|FG001|Overall Study|Withdrawal by Subject|11|||
124871249|NCT02066402|449149232|FG000|Overall Study|Progressive disease-clinical progression|0|||
124871250|NCT02066402|449149233|FG001|Overall Study|Progressive disease-clinical progression|1|||
124871251|NCT02066402|449149232|FG000|Overall Study|Protocol driven decision point|0|||
124871252|NCT02066402|449149233|FG001|Overall Study|Protocol driven decision point|1|||
124871253|NCT04493931|449149234|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
124871254|NCT04493931|449149235|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
124871255|NCT04493931|449149236|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
124871256|NCT04493931|449149237|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
124871257|NCT04493931|449149238|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
124871258|NCT04493931|449149239|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
124871259|NCT04493931|449149240|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
124871260|NCT04493931|449149234|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
124871261|NCT04493931|449149235|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
124871262|NCT04493931|449149236|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
124871263|NCT04493931|449149237|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
124871264|NCT04493931|449149238|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
124871265|NCT04493931|449149239|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
124871266|NCT04493931|449149240|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
124871267|NCT04493931|449149234|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
124871268|NCT04493931|449149235|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
124871269|NCT04493931|449149236|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
124871270|NCT04493931|449149237|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
124871271|NCT04493931|449149238|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
124871272|NCT04493931|449149239|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
124871273|NCT04493931|449149240|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
124871274|NCT04493931|449149234|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
124871275|NCT04493931|449149235|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
124871276|NCT04493931|449149236|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
124871277|NCT04493931|449149237|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
124871278|NCT04493931|449149238|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
124871279|NCT04493931|449149239|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
124871280|NCT04493931|449149240|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
124871281|NCT00266825|449149241|FG000|Completed Follow-Up|Lost to Follow-up|14|||
124871282|NCT00266825|449149242|FG001|Completed Follow-Up|Lost to Follow-up|19|||
124871283|NCT00266825|449149241|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
124871284|NCT00266825|449149242|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
124871285|NCT00595504|449149246|FG000|Overall Study|Withdrawal by Subject|1|||
124871286|NCT00595504|449149247|FG001|Overall Study|Withdrawal by Subject|3|||
124871287|NCT00595504|449149246|FG000|Overall Study|Physician Decision|1|||
124871288|NCT00595504|449149247|FG001|Overall Study|Physician Decision|0|||
124871289|NCT02182973|449149259|FG000|Overall Study|Withdrawal by Subject|3|||
124871290|NCT02182973|449149260|FG001|Overall Study|Withdrawal by Subject|0|||
124871291|NCT01235546|449149261|FG000|Overall Study|Staff error, medication not administered|1|||
124871292|NCT01235546|449149262|FG001|Overall Study|Staff error, medication not administered|0|||
124871293|NCT01235546|449149261|FG000|Overall Study|Protocol Violation|1|||
124871294|NCT01235546|449149262|FG001|Overall Study|Protocol Violation|1|||
124871295|NCT01123382|449149263|FG000|Overall Study|Withdrawal by Subject|1|||
124871296|NCT01123382|449149264|FG001|Overall Study|Withdrawal by Subject|4|||
124871297|NCT01123382|449149263|FG000|Overall Study|Lost to Follow-up|1|||
124871298|NCT01123382|449149264|FG001|Overall Study|Lost to Follow-up|2|||
124871299|NCT02054806|449149265|FG000|Overall Study|Sponsor Decision|31|||
124871300|NCT02054806|449149265|FG000|Overall Study|Withdrawal by Subject|43|||
124871301|NCT02054806|449149265|FG000|Overall Study|Protocol Violation|2|||
124871302|NCT02054806|449149265|FG000|Overall Study|Lost to Follow-up|10|||
124871303|NCT02054806|449149265|FG000|Overall Study|Death|391|||
124871304|NCT00645164|449149270|FG000|Overall Study|Lost to Follow-up|2|||
124871305|NCT00645164|449149270|FG000|Overall Study|Withdrawal by Subject|4|||
124871306|NCT00645164|449149270|FG000|Overall Study|Protocol Violation|1|||
124871307|NCT01362439|449149271|FG000|Overall Study|Adverse Event|1|||
124871308|NCT01362439|449149271|FG000|Overall Study|Lack of Efficacy|3|||
124871309|NCT01362439|449149271|FG000|Overall Study|Lost to Follow-up|2|||
124871310|NCT01362439|449149271|FG000|Overall Study|Study medication non-compliant|1|||
124871311|NCT01362439|449149271|FG000|Overall Study|Participant who withdrew consent|8|||
124871312|NCT01281644|449149273|FG000|Overall Study|Lost to Follow-up|3|||
124871313|NCT01281644|449149273|FG000|Overall Study|Withdrawal by Subject|2|||
124871314|NCT01755702|449149274|FG000|Wash Out Period I|Other Reason|3|||
124871315|NCT01755702|449149274|FG000|Washout Period II|Other Reason|5|||
124871316|NCT00691938|449149275|FG000|Overall Study|QTc prolongation|1|||
124871317|NCT00691938|449149276|FG001|Overall Study|QTc prolongation|0|||
125202384|NCT00960986|450363700|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
124871318|NCT00691938|449149277|FG002|Overall Study|QTc prolongation|0|||
124871319|NCT00691938|449149278|FG003|Overall Study|QTc prolongation|0|||
124871320|NCT00691938|449149279|FG004|Overall Study|QTc prolongation|0|||
124871321|NCT00691938|449149280|FG005|Overall Study|QTc prolongation|0|||
124871322|NCT00691938|449149281|FG006|Overall Study|QTc prolongation|0|||
124871323|NCT04860518|449149282|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
125202385|NCT00960986|450363697|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
124871324|NCT04860518|449149283|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
124871325|NCT02755597|449149285|FG000|Overall Study|Withdrew consent|27|||
124871326|NCT02755597|449149286|FG001|Overall Study|Withdrew consent|11|||
124871327|NCT02755597|449149285|FG000|Overall Study|Lost to Follow-up|1|||
124871328|NCT02755597|449149286|FG001|Overall Study|Lost to Follow-up|0|||
124871329|NCT02755597|449149285|FG000|Overall Study|Death|78|||
124871330|NCT02755597|449149286|FG001|Overall Study|Death|36|||
124871331|NCT02755597|449149285|FG000|Overall Study|Study terminated by Sponsor|67|||
124871332|NCT02755597|449149286|FG001|Overall Study|Study terminated by Sponsor|47|||
124871333|NCT02755597|449149285|FG000|Overall Study|Other, not specified|20|||
124871334|NCT02755597|449149286|FG001|Overall Study|Other, not specified|3|||
124871335|NCT02755597|449149285|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
124871336|NCT02755597|449149286|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
124871337|NCT00594854|449149288|FG000|Overall Study|Study terminated|7|||
124871338|NCT00594854|449149289|FG001|Overall Study|Study terminated|10|||
124871339|NCT02684006|449149290|FG000|Overall Study|Other|18|||
124871340|NCT02684006|449149291|FG001|Overall Study|Other|6|||
124871341|NCT02684006|449149290|FG000|Overall Study|Protocol Violation|2|||
124871342|NCT02684006|449149291|FG001|Overall Study|Protocol Violation|1|||
124871343|NCT02684006|449149290|FG000|Overall Study|Non-compliance with study drug|1|||
124871344|NCT02684006|449149291|FG001|Overall Study|Non-compliance with study drug|1|||
124871345|NCT02684006|449149290|FG000|Overall Study|No longer met eligibility criteria|6|||
124871346|NCT02684006|449149291|FG001|Overall Study|No longer met eligibility criteria|2|||
124871347|NCT02684006|449149290|FG000|Overall Study|Lost to Follow-up|0|||
124871348|NCT02684006|449149291|FG001|Overall Study|Lost to Follow-up|1|||
124871349|NCT02684006|449149290|FG000|Overall Study|Death|25|||
124871350|NCT02684006|449149291|FG001|Overall Study|Death|22|||
124871351|NCT02684006|449149290|FG000|Overall Study|Global deterioration of health status|18|||
124871352|NCT02684006|449149291|FG001|Overall Study|Global deterioration of health status|20|||
124871353|NCT02684006|449149290|FG000|Overall Study|Physician Decision|15|||
124871354|NCT02684006|449149291|FG001|Overall Study|Physician Decision|8|||
124871355|NCT02684006|449149290|FG000|Overall Study|Adverse Event|86|||
124871356|NCT02684006|449149291|FG001|Overall Study|Adverse Event|65|||
124871357|NCT02684006|449149290|FG000|Overall Study|Withdrawal by Subject|29|||
124871358|NCT02684006|449149291|FG001|Overall Study|Withdrawal by Subject|43|||
124871359|NCT02684006|449149290|FG000|Overall Study|Progressive disease|236|||
124871360|NCT02684006|449149291|FG001|Overall Study|Progressive disease|266|||
124871361|NCT02684006|449149290|FG000|Overall Study|Participation terminated by sponsor|6|||
124871362|NCT02684006|449149291|FG001|Overall Study|Participation terminated by sponsor|9|||
124871363|NCT03804710|449149293|FG000|Overall Study|Adverse Event|0|||
124871364|NCT03804710|449149294|FG001|Overall Study|Adverse Event|3|||
124871365|NCT03804710|449149293|FG000|Overall Study|Withdrawal by Subject|2|||
124871366|NCT03804710|449149294|FG001|Overall Study|Withdrawal by Subject|1|||
124871367|NCT03804710|449149293|FG000|Overall Study|Other|0|||
124871368|NCT03804710|449149294|FG001|Overall Study|Other|1|||
124871369|NCT02660827|449149295|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
124871370|NCT02660827|449149295|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
124871371|NCT02660827|449149295|FG000|From Study to End of Continued Access|Adverse Event|3|||
124871372|NCT02660827|449149295|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
124871373|NCT02660827|449149295|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
124871374|NCT02660827|449149295|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
124871375|NCT02660827|449149295|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
124871376|NCT02660827|449149295|FG000|Period 2: Continued Access Period|Adverse Event|3|||
124871377|NCT01428076|449149296|FG000|Overall Study|Adverse Event|0|||
124871378|NCT01428076|449149297|FG001|Overall Study|Adverse Event|1|||
124871379|NCT00045305|449149301|FG000|Overall Study|Lack of Efficacy|6|||
124871380|NCT00045305|449149301|FG000|Overall Study|Adverse Event|3|||
124871381|NCT00045305|449149301|FG000|Overall Study|Death|3|||
124871382|NCT00045305|449149301|FG000|Overall Study|site error|2|||
124871383|NCT02216773|449149307|FG000|Overall Study|Disease progression|4|||
124871384|NCT02216773|449149308|FG001|Overall Study|Disease progression|2|||
124871385|NCT02216773|449149307|FG000|Overall Study|Insufficient FLRV|4|||
124871386|NCT02216773|449149308|FG001|Overall Study|Insufficient FLRV|0|||
124871387|NCT02216773|449149307|FG000|Overall Study|Abandoned|4|||
124871388|NCT02216773|449149308|FG001|Overall Study|Abandoned|3|||
124871389|NCT04274894|449149309|FG000|Overall Study|Adverse Event|7|||
125202386|NCT00960986|450363698|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
124871390|NCT04274894|449149309|FG000|Overall Study|Withdrew consent|5|||
124871391|NCT04274894|449149309|FG000|Overall Study|Lost to Follow-up|9|||
124871392|NCT04274894|449149309|FG000|Overall Study|COVID-19 infection|1|||
124871393|NCT04274894|449149309|FG000|Overall Study|Other, not specified|20|||
124871394|NCT02279043|449149310|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
124871395|NCT02279043|449149311|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
124871396|NCT02279043|449149312|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
124871397|NCT02279043|449149310|FG000|Overall Study|Lost to Follow-up|46|||
124871398|NCT02279043|449149311|FG001|Overall Study|Lost to Follow-up|88|||
124871399|NCT02279043|449149312|FG002|Overall Study|Lost to Follow-up|0|||
124871400|NCT03848403|449149313|FG000|Period 2 (Day 8)|Adverse Event|1|||
124871401|NCT03848403|449149314|FG001|Period 2 (Day 8)|Adverse Event|2|||
124871402|NCT03848403|449149315|FG002|Period 2 (Day 8)|Adverse Event|2|||
124871403|NCT03848403|449149313|FG000|Period 2 (Day 8)|Physician Decision|0|||
124871404|NCT03848403|449149314|FG001|Period 2 (Day 8)|Physician Decision|1|||
124871405|NCT03848403|449149315|FG002|Period 2 (Day 8)|Physician Decision|0|||
124871406|NCT03848403|449149313|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
124871407|NCT03848403|449149314|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
124871408|NCT03848403|449149315|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
124871409|NCT02124265|449149316|FG000|Overall Study|Adverse Event|1|||
124871410|NCT04510675|449149318|FG000|Overall Study|Withdrawal by Subject|5|||
124871411|NCT01330433|449149323|FG000|Overall Study|Death|1|||
124871412|NCT01330433|449149324|FG001|Overall Study|Death|3|||
125202387|NCT00960986|450363699|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
125202388|NCT00960986|450363700|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
125202389|NCT00877071|450363701|FG000|Overall Study|disease progression|2|||
125202390|NCT01984892|450363702|FG000|Overall Study|Progressive disease|7|||
125202391|NCT04464720|450363703|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
125202392|NCT05723328|450363709|FG000|Overall Study|Investigator's Decision|5|||
125202393|NCT05723328|450363710|FG001|Overall Study|Investigator's Decision|2|||
125202394|NCT00954512|450363714|FG000|Overall Study|Withdrawal by Subject|0|||
125202395|NCT00954512|450363715|FG001|Overall Study|Withdrawal by Subject|0|||
125202396|NCT00954512|450363716|FG002|Overall Study|Withdrawal by Subject|0|||
125202397|NCT00954512|450363717|FG003|Overall Study|Withdrawal by Subject|0|||
124871413|NCT01330433|449149323|FG000|Overall Study|Lost to Follow-up|1|||
124871414|NCT01330433|449149324|FG001|Overall Study|Lost to Follow-up|0|||
124871415|NCT02114151|449149325|FG000|Overall Study|Death|1|||
124871416|NCT02114151|449149325|FG000|Overall Study|Lost to Follow-up|1|||
124871417|NCT02114151|449149325|FG000|Overall Study|Withdrawal by Subject|5|||
124871418|NCT01494584|449149326|FG000|Overall Study|Study Closed/Terminated|1|||
124871419|NCT01666808|449149327|FG000|Overall Study|Lost to Follow-up|9|||
124871420|NCT01666808|449149328|FG001|Overall Study|Lost to Follow-up|15|||
124871421|NCT01666808|449149327|FG000|Overall Study|Withdrawal by Subject|3|||
124871422|NCT01666808|449149328|FG001|Overall Study|Withdrawal by Subject|1|||
124871423|NCT01666808|449149327|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
124871424|NCT01666808|449149328|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
124871425|NCT01499082|449149329|FG000|Overall Study|Randomized but not Treated|0|||
124871426|NCT01499082|449149330|FG001|Overall Study|Randomized but not Treated|1|||
124871427|NCT01499082|449149329|FG000|Overall Study|Adverse Event|12|||
124871428|NCT01499082|449149330|FG001|Overall Study|Adverse Event|16|||
124871429|NCT01499082|449149329|FG000|Overall Study|Lack of Efficacy|1|||
124871430|NCT01499082|449149330|FG001|Overall Study|Lack of Efficacy|1|||
124871431|NCT01499082|449149329|FG000|Overall Study|Protocol Violation|6|||
124871432|NCT01499082|449149330|FG001|Overall Study|Protocol Violation|8|||
124871433|NCT01499082|449149329|FG000|Overall Study|Diverse Reasons|18|||
124871434|NCT01499082|449149330|FG001|Overall Study|Diverse Reasons|14|||
124871435|NCT01499082|449149329|FG000|Overall Study|Site Closure for Noncompliance|5|||
124871436|NCT01499082|449149330|FG001|Overall Study|Site Closure for Noncompliance|2|||
124871437|NCT01499082|449149329|FG000|Overall Study|Hypoglycemia|2|||
124871438|NCT01499082|449149330|FG001|Overall Study|Hypoglycemia|3|||
124871439|NCT01499082|449149329|FG000|Overall Study|Lost to Follow-up|1|||
124871440|NCT01499082|449149330|FG001|Overall Study|Lost to Follow-up|3|||
124871441|NCT02638948|449149331|FG000|Overall Study|Withdrawal by Subject|4|||
124871442|NCT02638948|449149332|FG001|Overall Study|Withdrawal by Subject|5|||
124871443|NCT02638948|449149333|FG002|Overall Study|Withdrawal by Subject|3|||
124871444|NCT02638948|449149334|FG003|Overall Study|Withdrawal by Subject|1|||
124871445|NCT02638948|449149331|FG000|Overall Study|Administrative Reason by Sponsor|0|||
124871446|NCT02638948|449149332|FG001|Overall Study|Administrative Reason by Sponsor|1|||
124871447|NCT02638948|449149333|FG002|Overall Study|Administrative Reason by Sponsor|0|||
124871448|NCT02638948|449149334|FG003|Overall Study|Administrative Reason by Sponsor|4|||
124871449|NCT02638948|449149331|FG000|Overall Study|Adverse Event|0|||
124871450|NCT02638948|449149332|FG001|Overall Study|Adverse Event|0|||
124871451|NCT02638948|449149333|FG002|Overall Study|Adverse Event|1|||
125202398|NCT00954512|450363718|FG004|Overall Study|Withdrawal by Subject|0|||
125202399|NCT00954512|450363719|FG005|Overall Study|Withdrawal by Subject|1|||
125202400|NCT00954512|450363714|FG000|Overall Study|Adverse Event|0|||
124871452|NCT02638948|449149334|FG003|Overall Study|Adverse Event|1|||
124871453|NCT02638948|449149331|FG000|Overall Study|Lack of Efficacy|1|||
124871454|NCT02638948|449149332|FG001|Overall Study|Lack of Efficacy|1|||
124871455|NCT02638948|449149333|FG002|Overall Study|Lack of Efficacy|0|||
124871456|NCT02638948|449149334|FG003|Overall Study|Lack of Efficacy|0|||
124871457|NCT02638948|449149331|FG000|Overall Study|Lost to Follow-up|0|||
124871458|NCT02638948|449149332|FG001|Overall Study|Lost to Follow-up|0|||
124871459|NCT02638948|449149333|FG002|Overall Study|Lost to Follow-up|1|||
124871460|NCT02638948|449149334|FG003|Overall Study|Lost to Follow-up|1|||
124871461|NCT02638948|449149331|FG000|Overall Study|Poor/Non-Compliance|0|||
124871462|NCT02638948|449149332|FG001|Overall Study|Poor/Non-Compliance|2|||
124871463|NCT02638948|449149333|FG002|Overall Study|Poor/Non-Compliance|1|||
124871464|NCT02638948|449149334|FG003|Overall Study|Poor/Non-Compliance|0|||
124871465|NCT02638948|449149331|FG000|Overall Study|Participant no longer met study criteria|0|||
124871466|NCT02638948|449149332|FG001|Overall Study|Participant no longer met study criteria|1|||
124871467|NCT02638948|449149333|FG002|Overall Study|Participant no longer met study criteria|0|||
124871468|NCT02638948|449149334|FG003|Overall Study|Participant no longer met study criteria|0|||
124871469|NCT02638948|449149331|FG000|Overall Study|Other than specified above|4|||
124871470|NCT02638948|449149332|FG001|Overall Study|Other than specified above|1|||
124871471|NCT02638948|449149333|FG002|Overall Study|Other than specified above|1|||
124871472|NCT02638948|449149334|FG003|Overall Study|Other than specified above|1|||
124871473|NCT00810264|449149338|FG000|Overall Study|Lost to Follow-up|191|||
124871474|NCT00810264|449149338|FG000|Overall Study|Withdrawal by subject or physician|721|||
124871475|NCT00810264|449149338|FG000|Overall Study|Death|641|||
124871476|NCT01830127|449149339|FG000|Overall Study|Adverse Event|1|||
124871477|NCT01830127|449149340|FG001|Overall Study|Adverse Event|6|||
124871478|NCT01830127|449149339|FG000|Overall Study|Lack of Efficacy|3|||
124871479|NCT01830127|449149340|FG001|Overall Study|Lack of Efficacy|0|||
124871480|NCT01830127|449149339|FG000|Overall Study|Withdrawal by Subject|1|||
124871481|NCT01830127|449149340|FG001|Overall Study|Withdrawal by Subject|1|||
124871482|NCT01830127|449149339|FG000|Overall Study|Other reason not defined above|0|||
124871483|NCT01830127|449149340|FG001|Overall Study|Other reason not defined above|2|||
124871484|NCT06213701|449149341|FG000|Overall Study|Withdrawal by Subject|2|||
124871485|NCT06213701|449149342|FG001|Overall Study|Withdrawal by Subject|1|||
124871486|NCT06213701|449149343|FG002|Overall Study|Withdrawal by Subject|0|||
124871487|NCT00567190|449149344|FG000|Overall Study|Death|235|||
124871488|NCT00567190|449149345|FG001|Overall Study|Death|280|||
124871489|NCT00567190|449149344|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
124871490|NCT00567190|449149345|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
124871491|NCT02495025|449149346|FG000|Overall Study|Lost to Follow-up|21|||
124871492|NCT02495025|449149347|FG001|Overall Study|Lost to Follow-up|14|||
124871493|NCT02495025|449149346|FG000|Overall Study|Withdrawal by Subject|5|||
124871494|NCT02495025|449149347|FG001|Overall Study|Withdrawal by Subject|0|||
124871495|NCT00313820|449149348|FG000|Assigned to Treatment|Other|1|||
124871496|NCT00313820|449149349|FG001|Assigned to Treatment|Other|0|||
124871497|NCT00313820|449149348|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
124871498|NCT00313820|449149349|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
124871499|NCT00313820|449149348|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
124871500|NCT00313820|449149349|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
124871501|NCT00313820|449149348|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
124871502|NCT00313820|449149349|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
124871503|NCT00313820|449149348|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
124871504|NCT00313820|449149349|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
124871505|NCT00313820|449149348|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
124871506|NCT00313820|449149349|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
124871507|NCT01515748|449149353|FG000|Overall Study|Withdrawal by Subject|32|||
124871508|NCT01515748|449149354|FG001|Overall Study|Withdrawal by Subject|41|||
124871509|NCT01515748|449149353|FG000|Overall Study|Lost to Follow-up|2|||
124871510|NCT01515748|449149354|FG001|Overall Study|Lost to Follow-up|4|||
124871511|NCT01515748|449149353|FG000|Overall Study|Other than specified above|5|||
124871512|NCT01515748|449149354|FG001|Overall Study|Other than specified above|10|||
124871513|NCT04102579|449149358|FG000|Overall Study|Withdrawal by Subject|3|||
124871514|NCT04102579|449149359|FG001|Overall Study|Withdrawal by Subject|4|||
124871515|NCT04102579|449149358|FG000|Overall Study|Lost to Follow-up|0|||
124871516|NCT04102579|449149359|FG001|Overall Study|Lost to Follow-up|1|||
124871517|NCT04102579|449149358|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
124871518|NCT04102579|449149359|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
124871519|NCT04102579|449149358|FG000|Overall Study|Other than Specified|1|||
124871520|NCT04102579|449149359|FG001|Overall Study|Other than Specified|0|||
124871521|NCT04102579|449149358|FG000|Overall Study|Not Dosed with Study Drug|0|||
124871522|NCT04102579|449149359|FG001|Overall Study|Not Dosed with Study Drug|1|||
124871523|NCT03419364|449149360|FG000|Overall Study|Delivery due to maternal condition|2|||
124871524|NCT03419364|449149361|FG001|Overall Study|Delivery due to maternal condition|0|||
124871525|NCT03419364|449149362|FG002|Overall Study|Delivery due to maternal condition|0|||
124871526|NCT02543658|449150770|FG000|Overall Study|Lack of Efficacy|0|||
124871527|NCT02543658|449150771|FG001|Overall Study|Lack of Efficacy|4|||
124871528|NCT00662857|449150772|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
124871529|NCT00662857|449150773|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
124871530|NCT00662857|449150772|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
124871531|NCT00662857|449150773|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
124871532|NCT00662857|449150772|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
124871533|NCT00662857|449150773|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
124871534|NCT00989092|449150774|FG000|Overall Study|Physician Decision|9|||
124871535|NCT00989092|449150775|FG001|Overall Study|Physician Decision|6|||
124871536|NCT00989092|449150774|FG000|Overall Study|Adverse Event|20|||
124871537|NCT00989092|449150775|FG001|Overall Study|Adverse Event|1|||
124871538|NCT00989092|449150774|FG000|Overall Study|Chemotherapy initiated|12|||
124871539|NCT00989092|449150775|FG001|Overall Study|Chemotherapy initiated|4|||
124871540|NCT00989092|449150774|FG000|Overall Study|Withdrawal by Subject|17|||
124871541|NCT00989092|449150775|FG001|Overall Study|Withdrawal by Subject|9|||
124871542|NCT00989092|449150774|FG000|Overall Study|Death|14|||
124871543|NCT00989092|449150775|FG001|Overall Study|Death|2|||
124871544|NCT00989092|449150774|FG000|Overall Study|Ineligibility determined|3|||
124871545|NCT00989092|449150775|FG001|Overall Study|Ineligibility determined|3|||
124871546|NCT00989092|449150774|FG000|Overall Study|Lost to Follow-up|6|||
124871547|NCT00989092|449150775|FG001|Overall Study|Lost to Follow-up|2|||
124871548|NCT00989092|449150774|FG000|Overall Study|Other|3|||
124871549|NCT00989092|449150775|FG001|Overall Study|Other|1|||
124871550|NCT00989092|449150774|FG000|Overall Study|Protocol deviation|2|||
124871551|NCT00989092|449150775|FG001|Overall Study|Protocol deviation|0|||
124871552|NCT00989092|449150774|FG000|Overall Study|Erythropoietin therapy initiated|2|||
124871553|NCT00989092|449150775|FG001|Overall Study|Erythropoietin therapy initiated|0|||
124871554|NCT00989092|449150774|FG000|Overall Study|Did not receive study drug|2|||
124871555|NCT00989092|449150775|FG001|Overall Study|Did not receive study drug|0|||
124871556|NCT03040713|449150776|FG000|Overall Study|Positive amyloid scan|3|||
124871557|NCT04539821|449150777|FG000|Overall Study|Withdrawal by Subject|2|||
124871558|NCT04539821|449150777|FG000|Overall Study|continued care with their physician|20|||
124871559|NCT04539821|449150777|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
124871560|NCT02691182|449150778|FG000|Overall Study|Withdrawal by Subject|4|||
124871561|NCT02691182|449150779|FG001|Overall Study|Withdrawal by Subject|7|||
124871562|NCT02691182|449150780|FG002|Overall Study|Withdrawal by Subject|6|||
124871563|NCT02691182|449150781|FG003|Overall Study|Withdrawal by Subject|8|||
124871564|NCT02691182|449150778|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
124871565|NCT02691182|449150779|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
124871566|NCT02691182|449150780|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
124871567|NCT02691182|449150781|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
124871568|NCT02691182|449150778|FG000|Overall Study|Lost to Follow-up|8|||
124871569|NCT02691182|449150779|FG001|Overall Study|Lost to Follow-up|33|||
124871570|NCT02691182|449150780|FG002|Overall Study|Lost to Follow-up|19|||
124871571|NCT02691182|449150781|FG003|Overall Study|Lost to Follow-up|22|||
124871572|NCT02691182|449150778|FG000|Overall Study|Adverse Event|3|||
124871573|NCT02691182|449150779|FG001|Overall Study|Adverse Event|10|||
124871574|NCT02691182|449150780|FG002|Overall Study|Adverse Event|10|||
124871575|NCT02691182|449150781|FG003|Overall Study|Adverse Event|11|||
124871576|NCT02691182|449150778|FG000|Overall Study|Physician Decision|3|||
124871577|NCT02691182|449150779|FG001|Overall Study|Physician Decision|7|||
124871578|NCT02691182|449150780|FG002|Overall Study|Physician Decision|14|||
124871579|NCT02691182|449150781|FG003|Overall Study|Physician Decision|8|||
124871580|NCT02691182|449150778|FG000|Overall Study|Lack of Efficacy|0|||
124871581|NCT02691182|449150779|FG001|Overall Study|Lack of Efficacy|0|||
124871582|NCT02691182|449150780|FG002|Overall Study|Lack of Efficacy|0|||
124871583|NCT02691182|449150781|FG003|Overall Study|Lack of Efficacy|4|||
124871584|NCT02691182|449150778|FG000|Overall Study|Protocol Violation|2|||
124871585|NCT02691182|449150779|FG001|Overall Study|Protocol Violation|6|||
124871586|NCT02691182|449150780|FG002|Overall Study|Protocol Violation|6|||
124871587|NCT02691182|449150781|FG003|Overall Study|Protocol Violation|8|||
124871588|NCT02691182|449150778|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
124871589|NCT02691182|449150779|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
124871590|NCT02691182|449150780|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
124871591|NCT02691182|449150781|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
124871592|NCT02691182|449150778|FG000|Overall Study|Missing|0|||
124871593|NCT02691182|449150779|FG001|Overall Study|Missing|5|||
124871594|NCT02691182|449150780|FG002|Overall Study|Missing|1|||
124871595|NCT02691182|449150781|FG003|Overall Study|Missing|5|||
125202401|NCT00954512|450363715|FG001|Overall Study|Adverse Event|0|||
125202402|NCT00954512|450363716|FG002|Overall Study|Adverse Event|0|||
125202403|NCT00954512|450363717|FG003|Overall Study|Adverse Event|0|||
125202404|NCT00954512|450363718|FG004|Overall Study|Adverse Event|1|||
124871596|NCT02563002|449150782|FG000|Overall Study|Death|72|||
124871597|NCT02563002|449150783|FG001|Overall Study|Death|87|||
124871598|NCT02563002|449150782|FG000|Overall Study|Lost to Follow-up|5|||
124871599|NCT02563002|449150783|FG001|Overall Study|Lost to Follow-up|0|||
124871600|NCT02563002|449150782|FG000|Overall Study|Physician Decision|0|||
124871601|NCT02563002|449150783|FG001|Overall Study|Physician Decision|2|||
124871602|NCT02563002|449150782|FG000|Overall Study|Withdrawal by Subject|2|||
124871603|NCT02563002|449150783|FG001|Overall Study|Withdrawal by Subject|10|||
124871604|NCT02563002|449150782|FG000|Overall Study|Sponsor decision|74|||
124871605|NCT02563002|449150783|FG001|Overall Study|Sponsor decision|55|||
124871606|NCT01844284|449150784|FG000|Overall Study|Lost to Follow-up|12|||
124871607|NCT01844284|449150785|FG001|Overall Study|Lost to Follow-up|7|||
124871608|NCT00611858|449150786|FG000|Overall Study|Adverse Event|2|||
124871609|NCT00611858|449150786|FG000|Overall Study|Withdrawal by Subject|2|||
124871610|NCT03172702|449150787|FG000|Overall Study|Adverse Event|9|||
124871611|NCT03172702|449150787|FG000|Overall Study|Death|2|||
124871612|NCT03172702|449150787|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
124871613|NCT03172702|449150787|FG000|Overall Study|Withdrawal by Subject|5|||
124871614|NCT03172702|449150787|FG000|Overall Study|Other|2|||
124871615|NCT06134180|449150788|FG000|Overall Study|Lost to Follow-up|4|||
124871616|NCT02152982|449150789|FG000|Overall Study|Ineligible|4|||
124871617|NCT02152982|449150790|FG001|Overall Study|Ineligible|4|||
124871618|NCT02152982|449150789|FG000|Overall Study|Did not start treatment|12|||
124871619|NCT02152982|449150790|FG001|Overall Study|Did not start treatment|6|||
124871620|NCT03641313|449150791|FG000|Overall Study|Death|1|||
124871621|NCT03641313|449150791|FG000|Overall Study|Withdrawal by Subject|2|||
124978557|NCT03829501|449548506|FG018|Overall Study|Death|1|||
124978558|NCT03829501|449548507|FG019|Overall Study|Death|1|||
124978559|NCT03829501|449548508|FG020|Overall Study|Death|1|||
124978560|NCT03829501|449548509|FG021|Overall Study|Death|2|||
124978561|NCT03829501|449548510|FG022|Overall Study|Death|3|||
124978562|NCT03829501|449548488|FG000|Overall Study|Miscellaneous|0|||
124978563|NCT03829501|449548489|FG001|Overall Study|Miscellaneous|0|||
124978564|NCT03829501|449548490|FG002|Overall Study|Miscellaneous|1|||
124978565|NCT03829501|449548491|FG003|Overall Study|Miscellaneous|0|||
124978566|NCT03829501|449548492|FG004|Overall Study|Miscellaneous|0|||
124978567|NCT03829501|449548493|FG005|Overall Study|Miscellaneous|0|||
124978568|NCT03829501|449548494|FG006|Overall Study|Miscellaneous|0|||
124978569|NCT03829501|449548495|FG007|Overall Study|Miscellaneous|1|||
124978570|NCT03829501|449548496|FG008|Overall Study|Miscellaneous|0|||
124978571|NCT03829501|449548497|FG009|Overall Study|Miscellaneous|0|||
124978572|NCT03829501|449548498|FG010|Overall Study|Miscellaneous|0|||
124978573|NCT03829501|449548499|FG011|Overall Study|Miscellaneous|0|||
124978574|NCT03829501|449548500|FG012|Overall Study|Miscellaneous|0|||
124978575|NCT03829501|449548501|FG013|Overall Study|Miscellaneous|0|||
124978576|NCT03829501|449548502|FG014|Overall Study|Miscellaneous|0|||
124978577|NCT03829501|449548503|FG015|Overall Study|Miscellaneous|0|||
124978578|NCT03829501|449548504|FG016|Overall Study|Miscellaneous|0|||
124978579|NCT03829501|449548505|FG017|Overall Study|Miscellaneous|0|||
124978580|NCT03829501|449548506|FG018|Overall Study|Miscellaneous|0|||
124978581|NCT03829501|449548507|FG019|Overall Study|Miscellaneous|0|||
124978582|NCT03829501|449548508|FG020|Overall Study|Miscellaneous|0|||
124978583|NCT03829501|449548509|FG021|Overall Study|Miscellaneous|0|||
124978584|NCT03829501|449548510|FG022|Overall Study|Miscellaneous|1|||
124978585|NCT01123070|449548511|FG000|Part B Double Blind Period|Protocol Violation|0|||
124978586|NCT01123070|449548512|FG001|Part B Double Blind Period|Protocol Violation|0|||
124978587|NCT01123070|449548513|FG002|Part B Double Blind Period|Protocol Violation|0|||
124978588|NCT01123070|449548514|FG003|Part B Double Blind Period|Protocol Violation|1|||
124978589|NCT01123070|449548511|FG000|Part B Double Blind Period|Adverse Event|0|||
124978590|NCT01123070|449548512|FG001|Part B Double Blind Period|Adverse Event|0|||
124978591|NCT01123070|449548513|FG002|Part B Double Blind Period|Adverse Event|2|||
124978592|NCT01123070|449548514|FG003|Part B Double Blind Period|Adverse Event|0|||
124871622|NCT03641313|449150791|FG000|Overall Study|Declining health|1|||
124871623|NCT03641313|449150791|FG000|Overall Study|Adverse Event|1|||
124871624|NCT04642898|449150792|FG000|Overall Study|Withdrawal by Subject|2|||
124871625|NCT04642898|449150793|FG001|Overall Study|Withdrawal by Subject|4|||
124871626|NCT04642898|449150794|FG002|Overall Study|Withdrawal by Subject|4|||
124871627|NCT04642898|449150795|FG003|Overall Study|Withdrawal by Subject|6|||
124871628|NCT04642898|449150796|FG004|Overall Study|Withdrawal by Subject|2|||
124871629|NCT04642898|449150797|FG005|Overall Study|Withdrawal by Subject|6|||
124871630|NCT04642898|449150792|FG000|Overall Study|Lost to Follow-up|0|||
124871631|NCT04642898|449150793|FG001|Overall Study|Lost to Follow-up|0|||
124871632|NCT04642898|449150794|FG002|Overall Study|Lost to Follow-up|0|||
125202405|NCT00954512|450363719|FG005|Overall Study|Adverse Event|2|||
124871633|NCT04642898|449150795|FG003|Overall Study|Lost to Follow-up|2|||
124871634|NCT04642898|449150796|FG004|Overall Study|Lost to Follow-up|0|||
124871635|NCT04642898|449150797|FG005|Overall Study|Lost to Follow-up|1|||
124871636|NCT04642898|449150792|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
124871637|NCT04642898|449150793|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
124871638|NCT04642898|449150794|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
124871639|NCT04642898|449150795|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
124871640|NCT04642898|449150796|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
124871641|NCT04642898|449150797|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
124871642|NCT04642898|449150792|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
124871643|NCT04642898|449150793|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
124978593|NCT01123070|449548511|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
124978594|NCT01123070|449548512|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
124871644|NCT04642898|449150794|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
124871645|NCT04642898|449150795|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
124871646|NCT04642898|449150796|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
124871647|NCT04642898|449150797|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
124871648|NCT03574597|449150798|FG000|Overall Study|Withdrawal by Subject|67|||
124871649|NCT03574597|449150799|FG001|Overall Study|Withdrawal by Subject|96|||
124871650|NCT03574597|449150798|FG000|Overall Study|Lost to Follow-up|192|||
124871651|NCT03574597|449150799|FG001|Overall Study|Lost to Follow-up|188|||
124871652|NCT03434678|449150800|FG000|Overall Study|Withdrawal by Subject|13|||
124871653|NCT03434678|449150801|FG001|Overall Study|Withdrawal by Subject|13|||
124871654|NCT03434678|449150800|FG000|Overall Study|Found to be ineligible post randomization|2|||
124871655|NCT03434678|449150801|FG001|Overall Study|Found to be ineligible post randomization|1|||
124871656|NCT06060457|449150804|FG000|Overall Study|Adverse Event|1|||
124871657|NCT06060457|449150805|FG001|Overall Study|Adverse Event|1|||
124871658|NCT06060457|449150804|FG000|Overall Study|Death|2|||
124871659|NCT06060457|449150805|FG001|Overall Study|Death|2|||
124871660|NCT06060457|449150804|FG000|Overall Study|Lost to Follow-up|17|||
124871661|NCT06060457|449150805|FG001|Overall Study|Lost to Follow-up|19|||
124871662|NCT06060457|449150804|FG000|Overall Study|Physician Decision|0|||
124871663|NCT06060457|449150805|FG001|Overall Study|Physician Decision|1|||
124871664|NCT06060457|449150804|FG000|Overall Study|Protocol Violation|1|||
124871665|NCT06060457|449150805|FG001|Overall Study|Protocol Violation|1|||
124871666|NCT06060457|449150804|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
124871667|NCT06060457|449150805|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
124871668|NCT06060457|449150804|FG000|Overall Study|Withdrawal by Subject|12|||
124871669|NCT06060457|449150805|FG001|Overall Study|Withdrawal by Subject|15|||
124871670|NCT06060457|449150804|FG000|Overall Study|Other Than Specified|2|||
124871671|NCT06060457|449150805|FG001|Overall Study|Other Than Specified|1|||
124871672|NCT02061202|449150806|FG000|Overall Study|Lost to Follow-up|1|||
124871673|NCT02061202|449150807|FG001|Overall Study|Lost to Follow-up|1|||
124871674|NCT00569582|449150811|FG000|Overall Study|Withdrawal by Subject|5|||
124871675|NCT00569582|449150811|FG000|Overall Study|Death|2|||
124871676|NCT00569582|449150811|FG000|Overall Study|Adverse Event|7|||
124871677|NCT00569582|449150811|FG000|Overall Study|Subject was too ill to travel.|1|||
124871678|NCT00569582|449150811|FG000|Overall Study|Subject was non-compliant.|1|||
124871679|NCT01533493|449150812|FG000|Overall Study|Adverse Event|2|||
124871680|NCT01533493|449150813|FG001|Overall Study|Adverse Event|1|||
124871681|NCT01533493|449150812|FG000|Overall Study|Withdrawal by Subject|1|||
124871682|NCT01533493|449150813|FG001|Overall Study|Withdrawal by Subject|2|||
124871683|NCT01533493|449150812|FG000|Overall Study|Lost to Follow-up|2|||
124871684|NCT01533493|449150813|FG001|Overall Study|Lost to Follow-up|0|||
124871685|NCT05163522|449150816|FG000|Overall Study|Withdrawal by Subject|0|||
124871686|NCT05163522|449150817|FG001|Overall Study|Withdrawal by Subject|0|||
124871687|NCT05163522|449150818|FG002|Overall Study|Withdrawal by Subject|1|||
124871688|NCT05163522|449150819|FG003|Overall Study|Withdrawal by Subject|0|||
124871689|NCT05163522|449150820|FG004|Overall Study|Withdrawal by Subject|0|||
124871690|NCT05163522|449150821|FG005|Overall Study|Withdrawal by Subject|0|||
124871691|NCT05163522|449150822|FG006|Overall Study|Withdrawal by Subject|0|||
124871692|NCT05163522|449150823|FG007|Overall Study|Withdrawal by Subject|0|||
124871693|NCT05163522|449150824|FG008|Overall Study|Withdrawal by Subject|0|||
124871694|NCT05163522|449150825|FG009|Overall Study|Withdrawal by Subject|0|||
124871695|NCT05163522|449150826|FG010|Overall Study|Withdrawal by Subject|0|||
124871696|NCT03412396|449150827|FG000|Overall Study|Withdrawal by Subject|2|||
124871697|NCT03412396|449150827|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
124871698|NCT03412396|449150827|FG000|Overall Study|Did not undergo RP|2|||
124871699|NCT02753595|449150835|FG000|Overall Study|Sponsor termination|2|||
124871700|NCT02753595|449150836|FG001|Overall Study|Sponsor termination|2|||
124871701|NCT01570868|449150837|FG000|Overall Study|Adverse Event|8|||
124871702|NCT01570868|449150838|FG001|Overall Study|Adverse Event|1|||
124871703|NCT01570868|449150837|FG000|Overall Study|FDA Recommendation|23|||
124871704|NCT01570868|449150838|FG001|Overall Study|FDA Recommendation|3|||
124871705|NCT01570868|449150837|FG000|Overall Study|Physician Decision|10|||
124871706|NCT01570868|449150838|FG001|Overall Study|Physician Decision|4|||
124871707|NCT01570868|449150837|FG000|Overall Study|Lost to Follow-up|1|||
124871708|NCT01570868|449150838|FG001|Overall Study|Lost to Follow-up|0|||
124871709|NCT01570868|449150837|FG000|Overall Study|Withdrawal by Subject|1|||
124871710|NCT01570868|449150838|FG001|Overall Study|Withdrawal by Subject|0|||
124871711|NCT02782169|449150847|FG000|Overall Study|Lost to Follow-up|1|||
124871712|NCT02782169|449150848|FG001|Overall Study|Lost to Follow-up|2|||
124871713|NCT02975973|449150849|FG000|Overall Study|Adverse Event|1|||
124871714|NCT02975973|449150850|FG001|Overall Study|Adverse Event|1|||
124871715|NCT02975973|449150851|FG002|Overall Study|Adverse Event|1|||
124871716|NCT02975973|449150852|FG003|Overall Study|Adverse Event|0|||
124871717|NCT00771810|449150853|FG000|Overall Study|Adverse Event|3|||
124871718|NCT00771810|449150854|FG001|Overall Study|Adverse Event|0|||
124871719|NCT00771810|449150855|FG002|Overall Study|Adverse Event|2|||
124871720|NCT00771810|449150853|FG000|Overall Study|Lost to Follow-up|0|||
124871721|NCT00771810|449150854|FG001|Overall Study|Lost to Follow-up|0|||
124871722|NCT00771810|449150855|FG002|Overall Study|Lost to Follow-up|1|||
124871723|NCT00771810|449150853|FG000|Overall Study|Physician Decision|1|||
124871724|NCT00771810|449150854|FG001|Overall Study|Physician Decision|2|||
124871725|NCT00771810|449150855|FG002|Overall Study|Physician Decision|2|||
124871726|NCT00771810|449150853|FG000|Overall Study|Protocol Violation|0|||
124871727|NCT00771810|449150854|FG001|Overall Study|Protocol Violation|1|||
124871728|NCT00771810|449150855|FG002|Overall Study|Protocol Violation|1|||
124978595|NCT01123070|449548513|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
124978596|NCT01123070|449548514|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
124978597|NCT03284229|449548515|FG000|Overall Study|Lost to Follow-up|3|||
124978598|NCT01977677|449548520|FG000|Overall Study|Unrelated Adverse Event|0|||
124978599|NCT01977677|449548521|FG001|Overall Study|Unrelated Adverse Event|0|||
124978600|NCT01977677|449548522|FG002|Overall Study|Unrelated Adverse Event|1|||
124978601|NCT00626197|449548525|FG000|Overall Study|Did not cooperate|2|||
124978602|NCT00626197|449548526|FG001|Overall Study|Did not cooperate|6|||
124978603|NCT00626197|449548527|FG002|Overall Study|Did not cooperate|1|||
124978604|NCT00626197|449548525|FG000|Overall Study|Failure to return|6|||
124978605|NCT00626197|449548526|FG001|Overall Study|Failure to return|5|||
124978606|NCT00626197|449548527|FG002|Overall Study|Failure to return|6|||
124978607|NCT00626197|449548525|FG000|Overall Study|Adverse event, serious fatal|3|||
124978608|NCT00626197|449548526|FG001|Overall Study|Adverse event, serious fatal|6|||
124871729|NCT00771810|449150853|FG000|Overall Study|Withdrawal by Subject|1|||
124871730|NCT00771810|449150854|FG001|Overall Study|Withdrawal by Subject|2|||
124871731|NCT00771810|449150855|FG002|Overall Study|Withdrawal by Subject|0|||
124871732|NCT00771810|449150853|FG000|Overall Study|Other|0|||
124871733|NCT00771810|449150854|FG001|Overall Study|Other|0|||
124871734|NCT00771810|449150855|FG002|Overall Study|Other|1|||
124871735|NCT04542018|449150858|FG000|Overall Study|Withdrawal by Subject|0|||
124871736|NCT04542018|449150859|FG001|Overall Study|Withdrawal by Subject|0|||
124871737|NCT04542018|449150860|FG002|Overall Study|Withdrawal by Subject|4|||
124871738|NCT04542018|449150858|FG000|Overall Study|Protocol Violation|0|||
124871739|NCT04542018|449150859|FG001|Overall Study|Protocol Violation|0|||
124871740|NCT04542018|449150860|FG002|Overall Study|Protocol Violation|2|||
124978609|NCT00626197|449548527|FG002|Overall Study|Adverse event, serious fatal|6|||
124978610|NCT00626197|449548525|FG000|Overall Study|Adverse Event|1|||
124978611|NCT00626197|449548526|FG001|Overall Study|Adverse Event|1|||
124978612|NCT00626197|449548527|FG002|Overall Study|Adverse Event|2|||
124978613|NCT00626197|449548525|FG000|Overall Study|Withdrawal by Subject|17|||
124978614|NCT00626197|449548526|FG001|Overall Study|Withdrawal by Subject|17|||
124978615|NCT00626197|449548527|FG002|Overall Study|Withdrawal by Subject|7|||
124978616|NCT00626197|449548525|FG000|Overall Study|Administrative reasons|15|||
124978617|NCT00626197|449548526|FG001|Overall Study|Administrative reasons|19|||
124871741|NCT02953938|449150861|FG000|Overall Study|Adverse Event|0|||
124871742|NCT02953938|449150862|FG001|Overall Study|Adverse Event|1|||
124871743|NCT02953938|449150861|FG000|Overall Study|Withdrawal by Subject|1|||
124871744|NCT02953938|449150862|FG001|Overall Study|Withdrawal by Subject|1|||
124871745|NCT02657031|449150868|FG000|Overall Study|Adverse Event|1|||
124871746|NCT02657031|449150869|FG001|Overall Study|Adverse Event|2|||
124871747|NCT03078816|449150870|FG000|Overall Study|Withdrawal by Subject|1|||
124871748|NCT01218126|449150873|FG000|Overall Study|Adverse Event|8|||
124871749|NCT01218126|449150874|FG001|Overall Study|Adverse Event|10|||
124871750|NCT01218126|449150875|FG002|Overall Study|Adverse Event|12|||
124871751|NCT01218126|449150876|FG003|Overall Study|Adverse Event|16|||
124871752|NCT01218126|449150873|FG000|Overall Study|Lack of Efficacy|7|||
124871753|NCT01218126|449150874|FG001|Overall Study|Lack of Efficacy|2|||
124871754|NCT01218126|449150875|FG002|Overall Study|Lack of Efficacy|2|||
124871755|NCT01218126|449150876|FG003|Overall Study|Lack of Efficacy|6|||
124871756|NCT01218126|449150873|FG000|Overall Study|Protocol Violation|5|||
124871757|NCT01218126|449150874|FG001|Overall Study|Protocol Violation|2|||
125202406|NCT00954512|450363714|FG000|Overall Study|Physician Decision|0|||
125202407|NCT00954512|450363715|FG001|Overall Study|Physician Decision|1|||
125202408|NCT00954512|450363716|FG002|Overall Study|Physician Decision|0|||
124871758|NCT01218126|449150875|FG002|Overall Study|Protocol Violation|2|||
124871759|NCT01218126|449150876|FG003|Overall Study|Protocol Violation|3|||
124871760|NCT01218126|449150873|FG000|Overall Study|Protocol-defined stopping criteria|1|||
124871761|NCT01218126|449150874|FG001|Overall Study|Protocol-defined stopping criteria|1|||
124871762|NCT01218126|449150875|FG002|Overall Study|Protocol-defined stopping criteria|0|||
124871763|NCT01218126|449150876|FG003|Overall Study|Protocol-defined stopping criteria|0|||
124871764|NCT01218126|449150873|FG000|Overall Study|Lost to Follow-up|0|||
124871765|NCT01218126|449150874|FG001|Overall Study|Lost to Follow-up|0|||
124871766|NCT01218126|449150875|FG002|Overall Study|Lost to Follow-up|0|||
124871767|NCT01218126|449150876|FG003|Overall Study|Lost to Follow-up|2|||
124871768|NCT01218126|449150873|FG000|Overall Study|Physician Decision|1|||
124871769|NCT01218126|449150874|FG001|Overall Study|Physician Decision|2|||
124871770|NCT01218126|449150875|FG002|Overall Study|Physician Decision|4|||
124978618|NCT00626197|449548527|FG002|Overall Study|Administrative reasons|55|||
125202409|NCT00954512|450363717|FG003|Overall Study|Physician Decision|1|||
124871771|NCT01218126|449150876|FG003|Overall Study|Physician Decision|2|||
124871772|NCT01218126|449150873|FG000|Overall Study|Withdrawal by Subject|2|||
124871773|NCT01218126|449150874|FG001|Overall Study|Withdrawal by Subject|5|||
124871774|NCT01218126|449150875|FG002|Overall Study|Withdrawal by Subject|4|||
124871775|NCT01218126|449150876|FG003|Overall Study|Withdrawal by Subject|6|||
124871776|NCT01860703|449150878|FG000|Overall Study|Adverse Event|1|||
124871777|NCT01860703|449150879|FG001|Overall Study|Adverse Event|4|||
124871778|NCT01860703|449150880|FG002|Overall Study|Adverse Event|0|||
124871779|NCT01860703|449150881|FG003|Overall Study|Adverse Event|2|||
124871780|NCT01860703|449150878|FG000|Overall Study|Withdrawal by Subject|0|||
124871781|NCT01860703|449150879|FG001|Overall Study|Withdrawal by Subject|1|||
124871782|NCT01860703|449150880|FG002|Overall Study|Withdrawal by Subject|0|||
124871783|NCT01860703|449150881|FG003|Overall Study|Withdrawal by Subject|0|||
124871784|NCT01860703|449150878|FG000|Overall Study|Personal reason|1|||
124871785|NCT01860703|449150879|FG001|Overall Study|Personal reason|0|||
124871786|NCT01860703|449150880|FG002|Overall Study|Personal reason|1|||
124871787|NCT01860703|449150881|FG003|Overall Study|Personal reason|0|||
124871788|NCT02134587|449150892|FG000|Overall Study|Did not completed all meetings|30|||
124871789|NCT00265889|449150893|FG000|Overall Study|Physician Decision|1|||
124871790|NCT00265889|449150893|FG000|Overall Study|Protocol Violation|1|||
124871791|NCT00265889|449150893|FG000|Overall Study|Insurance denied the request|3|||
124871792|NCT01525602|449150896|FG000|Overall Study|Adverse Event|1|||
124871793|NCT01525602|449150897|FG001|Overall Study|Adverse Event|0|||
124871794|NCT01525602|449150898|FG002|Overall Study|Adverse Event|1|||
124871795|NCT01525602|449150899|FG003|Overall Study|Adverse Event|1|||
124871796|NCT01525602|449150900|FG004|Overall Study|Adverse Event|3|||
124871797|NCT01525602|449150901|FG005|Overall Study|Adverse Event|3|||
124871798|NCT01525602|449150902|FG006|Overall Study|Adverse Event|0|||
124871799|NCT01525602|449150903|FG007|Overall Study|Adverse Event|1|||
124871800|NCT01525602|449150896|FG000|Overall Study|Disease progression|6|||
124871801|NCT01525602|449150897|FG001|Overall Study|Disease progression|3|||
124871802|NCT01525602|449150898|FG002|Overall Study|Disease progression|2|||
124871803|NCT01525602|449150899|FG003|Overall Study|Disease progression|5|||
124871804|NCT01525602|449150900|FG004|Overall Study|Disease progression|22|||
124871805|NCT01525602|449150901|FG005|Overall Study|Disease progression|2|||
124871806|NCT01525602|449150902|FG006|Overall Study|Disease progression|3|||
124871807|NCT01525602|449150903|FG007|Overall Study|Disease progression|3|||
124871808|NCT01525602|449150896|FG000|Overall Study|Clinical progression|2|||
124871809|NCT01525602|449150897|FG001|Overall Study|Clinical progression|0|||
124871810|NCT01525602|449150898|FG002|Overall Study|Clinical progression|0|||
124871811|NCT01525602|449150899|FG003|Overall Study|Clinical progression|0|||
124871812|NCT01525602|449150900|FG004|Overall Study|Clinical progression|0|||
124871813|NCT01525602|449150901|FG005|Overall Study|Clinical progression|0|||
124871814|NCT01525602|449150902|FG006|Overall Study|Clinical progression|1|||
124871815|NCT01525602|449150903|FG007|Overall Study|Clinical progression|1|||
124871816|NCT01525602|449150896|FG000|Overall Study|Non-compliance|0|||
124871817|NCT01525602|449150897|FG001|Overall Study|Non-compliance|0|||
124871818|NCT01525602|449150898|FG002|Overall Study|Non-compliance|0|||
124871819|NCT01525602|449150899|FG003|Overall Study|Non-compliance|0|||
124871820|NCT01525602|449150900|FG004|Overall Study|Non-compliance|1|||
124978619|NCT00461981|449548528|FG000|Overall Study|Lost to Follow-up|9|||
124978620|NCT00461981|449548529|FG001|Overall Study|Lost to Follow-up|6|||
124978621|NCT00461981|449548528|FG000|Overall Study|Withdrawal by Subject|2|||
124978622|NCT00461981|449548529|FG001|Overall Study|Withdrawal by Subject|3|||
124978623|NCT02383940|449548530|FG000|Overall Study|Adverse Event|1|||
124978624|NCT02383940|449548531|FG001|Overall Study|Adverse Event|0|||
124978625|NCT02383940|449548530|FG000|Overall Study|Lost to Follow-up|2|||
124978626|NCT02383940|449548531|FG001|Overall Study|Lost to Follow-up|2|||
124978627|NCT02383940|449548530|FG000|Overall Study|Physician Decision|2|||
124978628|NCT02383940|449548531|FG001|Overall Study|Physician Decision|0|||
124978629|NCT02383940|449548530|FG000|Overall Study|Withdrawal by Subject|1|||
124978630|NCT02383940|449548531|FG001|Overall Study|Withdrawal by Subject|1|||
124978631|NCT02383940|449548530|FG000|Overall Study|Randomized but not treated|2|||
124978632|NCT02383940|449548531|FG001|Overall Study|Randomized but not treated|0|||
124978633|NCT02383940|449548530|FG000|Overall Study|Other than specified above|1|||
124978634|NCT02383940|449548531|FG001|Overall Study|Other than specified above|0|||
124978635|NCT02672852|449548533|FG000|Part A1|Disease Worsening|1|||
124978636|NCT02672852|449548534|FG001|Part A1|Disease Worsening|0|||
124978637|NCT02672852|449548535|FG002|Part A1|Disease Worsening|0|||
124978638|NCT02672852|449548536|FG003|Part A1|Disease Worsening|0|||
124978639|NCT02672852|449548537|FG004|Part A1|Disease Worsening|0|||
124871821|NCT01525602|449150901|FG005|Overall Study|Non-compliance|0|||
124871822|NCT01525602|449150902|FG006|Overall Study|Non-compliance|0|||
124871823|NCT01525602|449150903|FG007|Overall Study|Non-compliance|0|||
124871824|NCT01525602|449150896|FG000|Overall Study|Withdrawal by Subject|0|||
124871825|NCT01525602|449150897|FG001|Overall Study|Withdrawal by Subject|0|||
124871826|NCT01525602|449150898|FG002|Overall Study|Withdrawal by Subject|0|||
124978640|NCT02672852|449548538|FG005|Part A1|Disease Worsening|0|||
125202410|NCT00954512|450363718|FG004|Overall Study|Physician Decision|0|||
124871827|NCT01525602|449150899|FG003|Overall Study|Withdrawal by Subject|0|||
124871828|NCT01525602|449150900|FG004|Overall Study|Withdrawal by Subject|3|||
124871829|NCT01525602|449150901|FG005|Overall Study|Withdrawal by Subject|1|||
124871830|NCT01525602|449150902|FG006|Overall Study|Withdrawal by Subject|0|||
124871831|NCT01525602|449150903|FG007|Overall Study|Withdrawal by Subject|1|||
124871832|NCT01525602|449150896|FG000|Overall Study|Physician Decision|0|||
124871833|NCT01525602|449150897|FG001|Overall Study|Physician Decision|0|||
124871834|NCT01525602|449150898|FG002|Overall Study|Physician Decision|0|||
124871835|NCT01525602|449150899|FG003|Overall Study|Physician Decision|0|||
124871836|NCT01525602|449150900|FG004|Overall Study|Physician Decision|3|||
124871837|NCT01525602|449150901|FG005|Overall Study|Physician Decision|0|||
124871838|NCT01525602|449150902|FG006|Overall Study|Physician Decision|1|||
124871839|NCT01525602|449150903|FG007|Overall Study|Physician Decision|0|||
124871840|NCT01525602|449150896|FG000|Overall Study|Death|0|||
124871841|NCT01525602|449150897|FG001|Overall Study|Death|0|||
124871842|NCT01525602|449150898|FG002|Overall Study|Death|0|||
124871843|NCT01525602|449150899|FG003|Overall Study|Death|0|||
124871844|NCT01525602|449150900|FG004|Overall Study|Death|1|||
124871845|NCT01525602|449150901|FG005|Overall Study|Death|1|||
124871846|NCT01525602|449150902|FG006|Overall Study|Death|0|||
124871847|NCT01525602|449150903|FG007|Overall Study|Death|0|||
124871848|NCT01525602|449150896|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
124871849|NCT01525602|449150897|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
124871850|NCT01525602|449150898|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
124871851|NCT01525602|449150899|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
124871852|NCT01525602|449150900|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
124871853|NCT01525602|449150901|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
124871854|NCT01525602|449150902|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
124871855|NCT01525602|449150903|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
124978641|NCT02672852|449548539|FG006|Part A1|Disease Worsening|0|||
124978642|NCT02672852|449548533|FG000|Part A1|Adverse Event|0|||
124978643|NCT02672852|449548534|FG001|Part A1|Adverse Event|1|||
124978644|NCT02672852|449548535|FG002|Part A1|Adverse Event|0|||
124978645|NCT02672852|449548536|FG003|Part A1|Adverse Event|0|||
124978646|NCT02672852|449548537|FG004|Part A1|Adverse Event|0|||
124978647|NCT02672852|449548538|FG005|Part A1|Adverse Event|0|||
124978648|NCT02672852|449548539|FG006|Part A1|Adverse Event|0|||
124978649|NCT02672852|449548533|FG000|Part A1|Lost to Follow-up|1|||
124978650|NCT02672852|449548534|FG001|Part A1|Lost to Follow-up|2|||
124978651|NCT02672852|449548535|FG002|Part A1|Lost to Follow-up|0|||
124978652|NCT02672852|449548536|FG003|Part A1|Lost to Follow-up|0|||
124978653|NCT02672852|449548537|FG004|Part A1|Lost to Follow-up|0|||
124978654|NCT02672852|449548538|FG005|Part A1|Lost to Follow-up|0|||
124978655|NCT02672852|449548539|FG006|Part A1|Lost to Follow-up|0|||
124978656|NCT02672852|449548533|FG000|Part A1|Withdrawal by Subject|1|||
124978657|NCT02672852|449548534|FG001|Part A1|Withdrawal by Subject|1|||
124978658|NCT02672852|449548535|FG002|Part A1|Withdrawal by Subject|0|||
124978659|NCT02672852|449548536|FG003|Part A1|Withdrawal by Subject|0|||
124978660|NCT02672852|449548537|FG004|Part A1|Withdrawal by Subject|0|||
124978661|NCT02672852|449548538|FG005|Part A1|Withdrawal by Subject|0|||
124978662|NCT02672852|449548539|FG006|Part A1|Withdrawal by Subject|0|||
124978663|NCT02672852|449548533|FG000|Part A2|Disease worsening|0|||
124978664|NCT02672852|449548534|FG001|Part A2|Disease worsening|0|||
124978665|NCT02672852|449548535|FG002|Part A2|Disease worsening|1|||
124978666|NCT02672852|449548536|FG003|Part A2|Disease worsening|0|||
124978667|NCT02672852|449548537|FG004|Part A2|Disease worsening|0|||
124978668|NCT02672852|449548538|FG005|Part A2|Disease worsening|0|||
124978669|NCT02672852|449548539|FG006|Part A2|Disease worsening|0|||
124978670|NCT02672852|449548533|FG000|Part A2|Adverse Event|0|||
124978671|NCT02672852|449548534|FG001|Part A2|Adverse Event|0|||
124978672|NCT02672852|449548535|FG002|Part A2|Adverse Event|3|||
124978673|NCT02672852|449548536|FG003|Part A2|Adverse Event|0|||
124978674|NCT02672852|449548537|FG004|Part A2|Adverse Event|0|||
124978675|NCT02672852|449548538|FG005|Part A2|Adverse Event|0|||
124978676|NCT02672852|449548539|FG006|Part A2|Adverse Event|0|||
124978677|NCT02672852|449548533|FG000|Part A2|Lost to Follow-up|0|||
124978678|NCT02672852|449548534|FG001|Part A2|Lost to Follow-up|0|||
124978679|NCT02672852|449548535|FG002|Part A2|Lost to Follow-up|2|||
124978680|NCT02672852|449548536|FG003|Part A2|Lost to Follow-up|0|||
124978681|NCT02672852|449548537|FG004|Part A2|Lost to Follow-up|0|||
124978682|NCT02672852|449548538|FG005|Part A2|Lost to Follow-up|0|||
124978683|NCT02672852|449548539|FG006|Part A2|Lost to Follow-up|0|||
124978684|NCT02672852|449548533|FG000|Part A2|Withdrawal by Subject|0|||
124978685|NCT02672852|449548534|FG001|Part A2|Withdrawal by Subject|0|||
125089784|NCT01117428|449947028|FG005|Overall Study|Adverse Event|2|||
124871856|NCT04349280|449150907|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
124871857|NCT04349280|449150908|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
124978686|NCT02672852|449548535|FG002|Part A2|Withdrawal by Subject|1|||
124978687|NCT02672852|449548536|FG003|Part A2|Withdrawal by Subject|0|||
124978688|NCT02672852|449548537|FG004|Part A2|Withdrawal by Subject|0|||
124978689|NCT02672852|449548538|FG005|Part A2|Withdrawal by Subject|0|||
124978690|NCT02672852|449548539|FG006|Part A2|Withdrawal by Subject|0|||
124978691|NCT02672852|449548533|FG000|Part A2|Other|0|||
124978692|NCT02672852|449548534|FG001|Part A2|Other|0|||
124978693|NCT02672852|449548535|FG002|Part A2|Other|3|||
124978694|NCT02672852|449548536|FG003|Part A2|Other|0|||
124978695|NCT02672852|449548537|FG004|Part A2|Other|0|||
124978696|NCT02672852|449548538|FG005|Part A2|Other|0|||
124978697|NCT02672852|449548539|FG006|Part A2|Other|0|||
124978698|NCT02672852|449548533|FG000|Part A2|Not entered in Part B|0|||
124978699|NCT02672852|449548534|FG001|Part A2|Not entered in Part B|0|||
124978700|NCT02672852|449548535|FG002|Part A2|Not entered in Part B|0|||
124978701|NCT02672852|449548536|FG003|Part A2|Not entered in Part B|4|||
124978702|NCT02672852|449548537|FG004|Part A2|Not entered in Part B|0|||
124978703|NCT02672852|449548538|FG005|Part A2|Not entered in Part B|0|||
124978704|NCT02672852|449548539|FG006|Part A2|Not entered in Part B|0|||
124978705|NCT02672852|449548533|FG000|Part B|Disease worsening|0|||
124871858|NCT04349280|449150907|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
124871859|NCT04349280|449150908|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
124871860|NCT04349280|449150907|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
124871861|NCT04349280|449150908|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
124871862|NCT02532179|449152688|FG000|Overall Study|Lost to Follow-up|1|||
124871863|NCT02532179|449152688|FG000|Overall Study|Pregnancy|1|||
124871864|NCT02532179|449152688|FG000|Overall Study|Subject received depot steroid injection|1|||
124871865|NCT03076970|449152692|FG000|Washout Period 2|Adverse Event|0|||
124871866|NCT03076970|449152693|FG001|Washout Period 2|Adverse Event|0|||
124871867|NCT03076970|449152694|FG002|Washout Period 2|Adverse Event|0|||
124871868|NCT03076970|449152695|FG003|Washout Period 2|Adverse Event|0|||
124978706|NCT02672852|449548534|FG001|Part B|Disease worsening|0|||
124978707|NCT02672852|449548535|FG002|Part B|Disease worsening|0|||
124978708|NCT02672852|449548536|FG003|Part B|Disease worsening|0|||
124978709|NCT02672852|449548537|FG004|Part B|Disease worsening|1|||
124978710|NCT02672852|449548538|FG005|Part B|Disease worsening|0|||
124978711|NCT02672852|449548539|FG006|Part B|Disease worsening|1|||
124978712|NCT02672852|449548533|FG000|Part B|Worsening pre-existing condition|0|||
124978713|NCT02672852|449548534|FG001|Part B|Worsening pre-existing condition|0|||
124978714|NCT02672852|449548535|FG002|Part B|Worsening pre-existing condition|0|||
124978715|NCT02672852|449548536|FG003|Part B|Worsening pre-existing condition|0|||
124978716|NCT02672852|449548537|FG004|Part B|Worsening pre-existing condition|0|||
124978717|NCT02672852|449548538|FG005|Part B|Worsening pre-existing condition|1|||
124978718|NCT02672852|449548539|FG006|Part B|Worsening pre-existing condition|0|||
124978719|NCT02672852|449548533|FG000|Part B|Other adverse event|0|||
124978720|NCT02672852|449548534|FG001|Part B|Other adverse event|0|||
124978721|NCT02672852|449548535|FG002|Part B|Other adverse event|0|||
124978722|NCT02672852|449548536|FG003|Part B|Other adverse event|0|||
124978723|NCT02672852|449548537|FG004|Part B|Other adverse event|3|||
124978724|NCT02672852|449548538|FG005|Part B|Other adverse event|5|||
124978725|NCT02672852|449548539|FG006|Part B|Other adverse event|1|||
124978726|NCT02672852|449548533|FG000|Part B|Lost to Follow-up|0|||
124978727|NCT02672852|449548534|FG001|Part B|Lost to Follow-up|0|||
124978728|NCT02672852|449548535|FG002|Part B|Lost to Follow-up|0|||
124978729|NCT02672852|449548536|FG003|Part B|Lost to Follow-up|0|||
124978730|NCT02672852|449548537|FG004|Part B|Lost to Follow-up|3|||
124978731|NCT02672852|449548538|FG005|Part B|Lost to Follow-up|4|||
124978732|NCT02672852|449548539|FG006|Part B|Lost to Follow-up|1|||
124978733|NCT02672852|449548533|FG000|Part B|Withdrawal by Subject|0|||
124978734|NCT02672852|449548534|FG001|Part B|Withdrawal by Subject|0|||
124978735|NCT02672852|449548535|FG002|Part B|Withdrawal by Subject|0|||
124978736|NCT02672852|449548536|FG003|Part B|Withdrawal by Subject|0|||
124978737|NCT02672852|449548537|FG004|Part B|Withdrawal by Subject|5|||
124978738|NCT02672852|449548538|FG005|Part B|Withdrawal by Subject|0|||
124978739|NCT02672852|449548539|FG006|Part B|Withdrawal by Subject|7|||
124978740|NCT02672852|449548533|FG000|Part B|Other|0|||
124978741|NCT02672852|449548534|FG001|Part B|Other|0|||
124978742|NCT02672852|449548535|FG002|Part B|Other|0|||
124978743|NCT02672852|449548536|FG003|Part B|Other|0|||
124978744|NCT02672852|449548537|FG004|Part B|Other|4|||
124978745|NCT02672852|449548538|FG005|Part B|Other|1|||
124978746|NCT02672852|449548539|FG006|Part B|Other|2|||
124978747|NCT04958642|449548540|FG000|Overall Study|Transferred to OLEX program|3|||
124978748|NCT04958642|449548541|FG001|Overall Study|Transferred to OLEX program|0|||
124978749|NCT04958642|449548542|FG002|Overall Study|Transferred to OLEX program|5|||
124978750|NCT04958642|449548540|FG000|Overall Study|Death|0|||
124978751|NCT04958642|449548541|FG001|Overall Study|Death|0|||
124978752|NCT04958642|449548542|FG002|Overall Study|Death|1|||
124978753|NCT04958642|449548540|FG000|Overall Study|Withdrawal by Subject|4|||
124978754|NCT04958642|449548541|FG001|Overall Study|Withdrawal by Subject|9|||
124978755|NCT04958642|449548542|FG002|Overall Study|Withdrawal by Subject|13|||
124871869|NCT03076970|449152696|FG004|Washout Period 2|Adverse Event|1|||
124978756|NCT04958642|449548540|FG000|Overall Study|Investigator's Decision|0|||
124978757|NCT04958642|449548541|FG001|Overall Study|Investigator's Decision|0|||
124978758|NCT04958642|449548542|FG002|Overall Study|Investigator's Decision|1|||
124978759|NCT04958642|449548540|FG000|Overall Study|Adverse Event|1|||
124978760|NCT04958642|449548541|FG001|Overall Study|Adverse Event|0|||
124978761|NCT04958642|449548542|FG002|Overall Study|Adverse Event|1|||
125202411|NCT00954512|450363719|FG005|Overall Study|Physician Decision|0|||
125202412|NCT00954512|450363714|FG000|Overall Study|Symptomatic Deterioration|0|||
125202413|NCT00954512|450363715|FG001|Overall Study|Symptomatic Deterioration|1|||
125202414|NCT00954512|450363716|FG002|Overall Study|Symptomatic Deterioration|0|||
125202415|NCT00954512|450363717|FG003|Overall Study|Symptomatic Deterioration|0|||
125202416|NCT00954512|450363718|FG004|Overall Study|Symptomatic Deterioration|2|||
125202417|NCT00954512|450363719|FG005|Overall Study|Symptomatic Deterioration|0|||
125202418|NCT00954512|450363714|FG000|Overall Study|Progression of Disease|2|||
125202419|NCT00954512|450363715|FG001|Overall Study|Progression of Disease|1|||
125202420|NCT00954512|450363716|FG002|Overall Study|Progression of Disease|0|||
125202421|NCT00954512|450363717|FG003|Overall Study|Progression of Disease|1|||
125202422|NCT00954512|450363718|FG004|Overall Study|Progression of Disease|1|||
125202423|NCT00954512|450363719|FG005|Overall Study|Progression of Disease|1|||
125202424|NCT01794793|450363720|FG000|Treatment Period|Withdrawal by Subject|24|||
125202425|NCT01794793|450363720|FG000|Treatment Period|Lack of Efficacy|22|||
125202426|NCT01794793|450363720|FG000|Treatment Period|Adverse Event|17|||
125202427|NCT01794793|450363720|FG000|Treatment Period|Physician Decision|14|||
125202428|NCT01794793|450363720|FG000|Treatment Period|Lost to Follow-up|7|||
125202429|NCT01794793|450363720|FG000|Treatment Period|Death|6|||
125202430|NCT01794793|450363720|FG000|Treatment Period|Protocol Violation|5|||
125202431|NCT01794793|450363720|FG000|Treatment Period|administrative problem|3|||
125202432|NCT01794793|450363720|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
125202433|NCT01794793|450363720|FG000|Post-treatment Follow-up|Adverse Event|8|||
125202434|NCT01794793|450363720|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
125202435|NCT01794793|450363720|FG000|Post-treatment Follow-up|administrative problem|5|||
125202436|NCT01794793|450363720|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
125202437|NCT01794793|450363720|FG000|Post-treatment Follow-up|Protocol Violation|3|||
125202438|NCT03495154|450363721|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
125202439|NCT03495154|450363721|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
125202440|NCT03495154|450363721|FG000|Overall Study|Screen Failures During Surgery|6|||
125202441|NCT03495154|450363721|FG000|Overall Study|Death|2|||
125202442|NCT03495154|450363721|FG000|Overall Study|Lost to Follow-up|16|||
125202443|NCT03495154|450363721|FG000|Overall Study|Withdrawal by Subject|2|||
125202444|NCT03495154|450363721|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
125202445|NCT05685732|450363722|FG000|Overall Study|Withdrawal by Subject|2|||
125202446|NCT05685732|450363723|FG001|Overall Study|Withdrawal by Subject|0|||
125202447|NCT05685732|450363724|FG002|Overall Study|Withdrawal by Subject|2|||
125202448|NCT05685732|450363725|FG003|Overall Study|Withdrawal by Subject|3|||
125202449|NCT05685732|450363722|FG000|Overall Study|Protocol Violation|1|||
125202450|NCT05685732|450363723|FG001|Overall Study|Protocol Violation|2|||
125202451|NCT05685732|450363724|FG002|Overall Study|Protocol Violation|4|||
125202452|NCT05685732|450363725|FG003|Overall Study|Protocol Violation|1|||
125202453|NCT05685732|450363722|FG000|Overall Study|Lost to Follow-up|5|||
125202454|NCT05685732|450363723|FG001|Overall Study|Lost to Follow-up|1|||
125202455|NCT05685732|450363724|FG002|Overall Study|Lost to Follow-up|3|||
125202456|NCT05685732|450363725|FG003|Overall Study|Lost to Follow-up|1|||
125202457|NCT05685732|450363722|FG000|Overall Study|Adverse Event|2|||
125202458|NCT05685732|450363723|FG001|Overall Study|Adverse Event|1|||
125202459|NCT05685732|450363724|FG002|Overall Study|Adverse Event|0|||
125202460|NCT05685732|450363725|FG003|Overall Study|Adverse Event|0|||
125202461|NCT05685732|450363722|FG000|Overall Study|Physician Decision|1|||
125202462|NCT05685732|450363723|FG001|Overall Study|Physician Decision|0|||
125202463|NCT05685732|450363724|FG002|Overall Study|Physician Decision|0|||
125202464|NCT05685732|450363725|FG003|Overall Study|Physician Decision|0|||
125202465|NCT02640404|450363726|FG000|Overall Study|Protocol Violation|1|||
124871870|NCT03076970|449152697|FG005|Washout Period 2|Adverse Event|0|||
124871871|NCT03076970|449152692|FG000|Period 3|Withdrawal by Subject|0|||
124871872|NCT03076970|449152693|FG001|Period 3|Withdrawal by Subject|0|||
124871873|NCT03076970|449152694|FG002|Period 3|Withdrawal by Subject|0|||
124871874|NCT03076970|449152695|FG003|Period 3|Withdrawal by Subject|0|||
124871875|NCT03076970|449152696|FG004|Period 3|Withdrawal by Subject|0|||
124871876|NCT03076970|449152697|FG005|Period 3|Withdrawal by Subject|1|||
124871877|NCT03076970|449152692|FG000|Period 3|Failure to meet I/E criteria|0|||
124871878|NCT03076970|449152693|FG001|Period 3|Failure to meet I/E criteria|0|||
124871879|NCT03076970|449152694|FG002|Period 3|Failure to meet I/E criteria|0|||
124871880|NCT03076970|449152695|FG003|Period 3|Failure to meet I/E criteria|0|||
124871881|NCT03076970|449152696|FG004|Period 3|Failure to meet I/E criteria|1|||
124871882|NCT03076970|449152697|FG005|Period 3|Failure to meet I/E criteria|0|||
124871883|NCT00789815|449152698|FG000|Overall Study|Protocol Violation|6|||
124871884|NCT00789815|449152699|FG001|Overall Study|Protocol Violation|1|||
124871885|NCT00789815|449152698|FG000|Overall Study|Intubation due to massive bleeding|1|||
124871886|NCT00789815|449152699|FG001|Overall Study|Intubation due to massive bleeding|0|||
124871887|NCT01203930|449152711|FG000|Overall Study|Disease Progression|0|||
124871888|NCT01203930|449152712|FG001|Overall Study|Disease Progression|4|||
124871889|NCT01203930|449152711|FG000|Overall Study|Death|3|||
124871890|NCT01203930|449152712|FG001|Overall Study|Death|1|||
124871891|NCT01203930|449152711|FG000|Overall Study|Withdrew Consent|1|||
125202466|NCT02640404|450363727|FG001|Overall Study|Protocol Violation|0|||
125202467|NCT02640404|450363726|FG000|Overall Study|Withdrawal by Subject|1|||
125202468|NCT02640404|450363727|FG001|Overall Study|Withdrawal by Subject|0|||
125202469|NCT05397171|450363728|FG000|Overall Study|Death|2|||
125202470|NCT05397171|450363729|FG001|Overall Study|Death|3|||
125202471|NCT05397171|450363730|FG002|Overall Study|Death|3|||
125202472|NCT05397171|450363728|FG000|Overall Study|Study Terminated By Sponsor|1|||
125202473|NCT05397171|450363729|FG001|Overall Study|Study Terminated By Sponsor|2|||
125202474|NCT05397171|450363730|FG002|Overall Study|Study Terminated By Sponsor|3|||
125202475|NCT05397171|450363728|FG000|Overall Study|Withdrawal by Subject|0|||
125202476|NCT05397171|450363729|FG001|Overall Study|Withdrawal by Subject|1|||
125202477|NCT05397171|450363730|FG002|Overall Study|Withdrawal by Subject|1|||
125202478|NCT02234596|450363731|FG000|Overall Study|Participant not treated|2|||
125202479|NCT03634033|450365398|FG000|Overall Study|Did not have a post-assessment|384|||
125202480|NCT03634033|450365399|FG001|Overall Study|Did not have a post-assessment|291|||
125202481|NCT03634033|450365400|FG002|Overall Study|Did not have a post-assessment|114|||
125202482|NCT03634033|450365401|FG003|Overall Study|Did not have a post-assessment|161|||
125202483|NCT03634033|450365402|FG004|Overall Study|Did not have a post-assessment|5|||
125202484|NCT03634033|450365403|FG005|Overall Study|Did not have a post-assessment|0|||
125202485|NCT03634033|450365404|FG006|Overall Study|Did not have a post-assessment|0|||
125202486|NCT03634033|450365398|FG000|Overall Study|Death|0|||
125202487|NCT03634033|450365399|FG001|Overall Study|Death|0|||
125202488|NCT03634033|450365400|FG002|Overall Study|Death|0|||
125202489|NCT03634033|450365401|FG003|Overall Study|Death|0|||
125202490|NCT03634033|450365402|FG004|Overall Study|Death|0|||
125202491|NCT03634033|450365403|FG005|Overall Study|Death|7|||
125202492|NCT03634033|450365404|FG006|Overall Study|Death|7|||
125202493|NCT03634033|450365398|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
125202494|NCT03634033|450365399|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
125202495|NCT03634033|450365400|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
125202496|NCT03634033|450365401|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
125202497|NCT03634033|450365402|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
125202498|NCT03634033|450365403|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
125202499|NCT03634033|450365404|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
125202500|NCT03634033|450365398|FG000|Overall Study|Lost to Follow-up|0|||
125202501|NCT03634033|450365399|FG001|Overall Study|Lost to Follow-up|0|||
125202502|NCT03634033|450365400|FG002|Overall Study|Lost to Follow-up|0|||
125202503|NCT03634033|450365401|FG003|Overall Study|Lost to Follow-up|0|||
125202504|NCT03634033|450365402|FG004|Overall Study|Lost to Follow-up|0|||
125202505|NCT03634033|450365403|FG005|Overall Study|Lost to Follow-up|1|||
125202506|NCT03634033|450365404|FG006|Overall Study|Lost to Follow-up|2|||
125202507|NCT03634033|450365398|FG000|Overall Study|Withdrawal by Subject|0|||
125202508|NCT03634033|450365399|FG001|Overall Study|Withdrawal by Subject|0|||
125202509|NCT03634033|450365400|FG002|Overall Study|Withdrawal by Subject|0|||
125202510|NCT03634033|450365401|FG003|Overall Study|Withdrawal by Subject|0|||
125202511|NCT03634033|450365402|FG004|Overall Study|Withdrawal by Subject|0|||
125202512|NCT03634033|450365403|FG005|Overall Study|Withdrawal by Subject|0|||
125202513|NCT03634033|450365404|FG006|Overall Study|Withdrawal by Subject|1|||
125202514|NCT06366087|450365405|FG000|Overall Study|Withdrawal by Subject|0|||
125202515|NCT06366087|450365406|FG001|Overall Study|Withdrawal by Subject|1|||
125202516|NCT01944670|450365410|FG000|Overall Study|Lost to Follow-up|2|||
125202517|NCT00743288|450365411|FG000|Overall Study|Adverse Event|1|||
125202518|NCT00743288|450365412|FG001|Overall Study|Adverse Event|1|||
125202519|NCT00743288|450365413|FG002|Overall Study|Adverse Event|2|||
125202520|NCT00743288|450365414|FG003|Overall Study|Adverse Event|2|||
125202521|NCT00743288|450365415|FG004|Overall Study|Adverse Event|1|||
125202522|NCT00743288|450365416|FG005|Overall Study|Adverse Event|1|||
125202523|NCT00743288|450365417|FG006|Overall Study|Adverse Event|2|||
125202524|NCT00743288|450365411|FG000|Overall Study|Withdrawal by Subject|0|||
125202525|NCT00743288|450365412|FG001|Overall Study|Withdrawal by Subject|0|||
125202526|NCT00743288|450365413|FG002|Overall Study|Withdrawal by Subject|1|||
125202527|NCT00743288|450365414|FG003|Overall Study|Withdrawal by Subject|0|||
125202528|NCT00743288|450365415|FG004|Overall Study|Withdrawal by Subject|0|||
125202529|NCT00743288|450365416|FG005|Overall Study|Withdrawal by Subject|1|||
125202530|NCT00743288|450365417|FG006|Overall Study|Withdrawal by Subject|1|||
125202531|NCT00743288|450365411|FG000|Overall Study|Progressive disease (PD)|2|||
125202532|NCT00743288|450365412|FG001|Overall Study|Progressive disease (PD)|0|||
125202533|NCT00743288|450365413|FG002|Overall Study|Progressive disease (PD)|1|||
125202534|NCT00743288|450365414|FG003|Overall Study|Progressive disease (PD)|4|||
125089785|NCT01117428|449947023|FG000|Overall Study|Death|0|||
125202535|NCT00743288|450365415|FG004|Overall Study|Progressive disease (PD)|5|||
125202536|NCT00743288|450365416|FG005|Overall Study|Progressive disease (PD)|3|||
125202537|NCT00743288|450365417|FG006|Overall Study|Progressive disease (PD)|6|||
125202538|NCT00743288|450365411|FG000|Overall Study|Worsening of condition (Not PD)|0|||
125202539|NCT00743288|450365412|FG001|Overall Study|Worsening of condition (Not PD)|2|||
125202540|NCT00743288|450365413|FG002|Overall Study|Worsening of condition (Not PD)|1|||
125202541|NCT00743288|450365414|FG003|Overall Study|Worsening of condition (Not PD)|1|||
125202542|NCT00743288|450365415|FG004|Overall Study|Worsening of condition (Not PD)|0|||
125202543|NCT00743288|450365416|FG005|Overall Study|Worsening of condition (Not PD)|0|||
125202544|NCT00743288|450365417|FG006|Overall Study|Worsening of condition (Not PD)|0|||
125202545|NCT05903924|450365418|FG000|Overall Study|Lost to Follow-up|1|||
125202546|NCT05903924|450365419|FG001|Overall Study|Lost to Follow-up|0|||
125202547|NCT05903924|450365420|FG002|Overall Study|Lost to Follow-up|0|||
125202548|NCT04338269|450365421|FG000|Overall Study|Death|86|||
125202549|NCT04338269|450365422|FG001|Overall Study|Death|89|||
125202550|NCT04338269|450365421|FG000|Overall Study|Lost to Follow-up|1|||
125202551|NCT04338269|450365422|FG001|Overall Study|Lost to Follow-up|2|||
125202552|NCT04338269|450365421|FG000|Overall Study|Physician Decision|1|||
125202553|NCT04338269|450365422|FG001|Overall Study|Physician Decision|0|||
125202554|NCT04338269|450365421|FG000|Overall Study|Withdrawal by Subject|14|||
125202555|NCT04338269|450365422|FG001|Overall Study|Withdrawal by Subject|11|||
125202556|NCT04166591|450365427|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
125202557|NCT04166591|450365428|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
125202558|NCT04166591|450365429|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
125202559|NCT04166591|450365430|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
125202560|NCT04166591|450365427|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
125202561|NCT04166591|450365428|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
125202562|NCT04166591|450365429|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
125202563|NCT04166591|450365430|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
125202564|NCT02730377|450365431|FG000|Overall Study|Other|5|||
125202565|NCT02730377|450365432|FG001|Overall Study|Other|4|||
125202566|NCT02730377|450365431|FG000|Overall Study|Death|1|||
125202567|NCT02730377|450365432|FG001|Overall Study|Death|8|||
125202568|NCT02730377|450365431|FG000|Overall Study|Inadequate glycaemic control|368|||
125202569|NCT02730377|450365432|FG001|Overall Study|Inadequate glycaemic control|473|||
125202570|NCT02730377|450365431|FG000|Overall Study|Adverse Event|79|||
125202571|NCT02730377|450365432|FG001|Overall Study|Adverse Event|41|||
125202572|NCT02730377|450365431|FG000|Overall Study|Protocol Violation|23|||
125202573|NCT02730377|450365432|FG001|Overall Study|Protocol Violation|30|||
125202574|NCT02730377|450365431|FG000|Overall Study|Lack of Efficacy|4|||
125202575|NCT02730377|450365432|FG001|Overall Study|Lack of Efficacy|13|||
125202576|NCT02730377|450365431|FG000|Overall Study|Pregnancy|0|||
125202577|NCT02730377|450365432|FG001|Overall Study|Pregnancy|1|||
125202578|NCT02730377|450365431|FG000|Overall Study|Withdrawal by Subject|45|||
125202579|NCT02730377|450365432|FG001|Overall Study|Withdrawal by Subject|42|||
125202580|NCT02730377|450365431|FG000|Overall Study|Lost to Follow-up|25|||
125202581|NCT02730377|450365432|FG001|Overall Study|Lost to Follow-up|21|||
125202582|NCT02203851|450365435|FG000|Overall Study|Lost to Follow-up|4|||
125202583|NCT02203851|450365435|FG000|Overall Study|Withdrawal by Subject|6|||
125202584|NCT02203851|450365435|FG000|Overall Study|Other|1|||
125202585|NCT04045132|450365438|FG000|Overall Study|Lost to Follow-up|3|||
125202586|NCT04045132|450365439|FG001|Overall Study|Lost to Follow-up|6|||
125202587|NCT02677038|450365445|FG000|Overall Study|Physician Decision|1|||
125202588|NCT02677038|450365445|FG000|Overall Study|Withdrawal by Subject|1|||
125202589|NCT03671564|450365447|FG000|Overall Study|Progressive Disease|3|||
125202590|NCT03671564|450365448|FG001|Overall Study|Progressive Disease|5|||
125202591|NCT03671564|450365449|FG002|Overall Study|Progressive Disease|3|||
125202592|NCT03671564|450365447|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
124978762|NCT04958642|449548540|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
124978763|NCT04958642|449548541|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
124978764|NCT04958642|449548542|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
124978765|NCT04958642|449548540|FG000|Overall Study|Lost to Follow-up|1|||
124978766|NCT04958642|449548541|FG001|Overall Study|Lost to Follow-up|0|||
124978767|NCT04958642|449548542|FG002|Overall Study|Lost to Follow-up|0|||
124978768|NCT04958642|449548540|FG000|Overall Study|Transferred to EAP following study termination|0|||
124978769|NCT04958642|449548541|FG001|Overall Study|Transferred to EAP following study termination|0|||
124978770|NCT04958642|449548542|FG002|Overall Study|Transferred to EAP following study termination|1|||
124978771|NCT04958642|449548540|FG000|Overall Study|Transferred to Expanded Access Program|1|||
124978772|NCT04958642|449548541|FG001|Overall Study|Transferred to Expanded Access Program|0|||
124978773|NCT04958642|449548542|FG002|Overall Study|Transferred to Expanded Access Program|0|||
124978774|NCT04308590|449548543|FG000|Overall Study|Adverse Event|12|||
125202593|NCT03671564|450365448|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
125202594|NCT03671564|450365449|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
125202595|NCT03671564|450365447|FG000|Overall Study|Withdrawal by Subject|1|||
125202596|NCT03671564|450365448|FG001|Overall Study|Withdrawal by Subject|1|||
125202597|NCT03671564|450365449|FG002|Overall Study|Withdrawal by Subject|0|||
125202598|NCT04739722|450365452|FG000|Overall Study|Lost to Follow-up|5301|||
125202599|NCT04739722|450365452|FG000|Overall Study|Withdrawal by Subject|42|||
125202600|NCT04739722|450365452|FG000|Overall Study|Non Average-risk|1157|||
125202601|NCT01185509|450365456|FG000|Overall Study|Progression/Relapse|9|||
125202602|NCT01185509|450365457|FG001|Overall Study|Progression/Relapse|15|||
124978775|NCT04308590|449548544|FG001|Overall Study|Adverse Event|2|||
124978776|NCT04308590|449548543|FG000|Overall Study|Withdrawal by Subject|10|||
124978777|NCT04308590|449548544|FG001|Overall Study|Withdrawal by Subject|4|||
125202603|NCT01185509|450365456|FG000|Overall Study|Physician Decision|2|||
125202604|NCT01185509|450365457|FG001|Overall Study|Physician Decision|2|||
125202605|NCT01185509|450365456|FG000|Overall Study|Withdrawal by Subject|0|||
125202606|NCT01185509|450365457|FG001|Overall Study|Withdrawal by Subject|1|||
125202607|NCT01185509|450365456|FG000|Overall Study|Death|0|||
125202608|NCT01185509|450365457|FG001|Overall Study|Death|1|||
125202609|NCT01185509|450365456|FG000|Overall Study|Intercurrent Illness|0|||
125202610|NCT01185509|450365457|FG001|Overall Study|Intercurrent Illness|1|||
125202611|NCT03687372|450365458|FG000|Overall Study|Lost to Follow-up|12|||
125202612|NCT03687372|450365459|FG001|Overall Study|Lost to Follow-up|21|||
125202613|NCT03687372|450365458|FG000|Overall Study|Withdrawal by Subject|4|||
125202614|NCT03687372|450365459|FG001|Overall Study|Withdrawal by Subject|17|||
125202615|NCT03687372|450365458|FG000|Overall Study|Investigator Decision|1|||
125202616|NCT03687372|450365459|FG001|Overall Study|Investigator Decision|1|||
125202617|NCT00878969|450365465|FG000|Overall Study|Physician Decision|5|||
125202618|NCT00878969|450365466|FG001|Overall Study|Physician Decision|3|||
125202619|NCT00878969|450365467|FG002|Overall Study|Physician Decision|2|||
125202620|NCT00878969|450365465|FG000|Overall Study|Withdrawal by Subject|1|||
125202621|NCT00878969|450365466|FG001|Overall Study|Withdrawal by Subject|6|||
125202622|NCT00878969|450365467|FG002|Overall Study|Withdrawal by Subject|3|||
125202623|NCT00878969|450365465|FG000|Overall Study|kidney transplant|2|||
125202624|NCT00878969|450365466|FG001|Overall Study|kidney transplant|3|||
125202625|NCT00878969|450365467|FG002|Overall Study|kidney transplant|2|||
125202626|NCT00878969|450365465|FG000|Overall Study|Adverse Event|3|||
125202627|NCT00878969|450365466|FG001|Overall Study|Adverse Event|1|||
125202628|NCT00878969|450365467|FG002|Overall Study|Adverse Event|2|||
125202629|NCT00878969|450365465|FG000|Overall Study|Lost to Follow-up|2|||
125202630|NCT00878969|450365466|FG001|Overall Study|Lost to Follow-up|1|||
125202631|NCT00878969|450365467|FG002|Overall Study|Lost to Follow-up|0|||
125202632|NCT00878969|450365465|FG000|Overall Study|Protocol Violation|2|||
125202633|NCT00878969|450365466|FG001|Overall Study|Protocol Violation|0|||
125202634|NCT00878969|450365467|FG002|Overall Study|Protocol Violation|0|||
125202635|NCT00878969|450365465|FG000|Overall Study|Death|0|||
125202636|NCT00878969|450365466|FG001|Overall Study|Death|0|||
125202637|NCT00878969|450365467|FG002|Overall Study|Death|2|||
125202638|NCT00878969|450365465|FG000|Overall Study|Pregnancy|0|||
125202639|NCT00878969|450365466|FG001|Overall Study|Pregnancy|1|||
125202640|NCT00878969|450365467|FG002|Overall Study|Pregnancy|0|||
125202641|NCT02083185|450365470|FG000|Overall Study|Lost to Follow-up|0|||
125202642|NCT02083185|450365471|FG001|Overall Study|Lost to Follow-up|3|||
125202643|NCT02083185|450365472|FG002|Overall Study|Lost to Follow-up|0|||
125202644|NCT02083185|450365470|FG000|Overall Study|Withdrawal by Subject|9|||
124978778|NCT04308590|449548543|FG000|Overall Study|Death|1|||
124978779|NCT04308590|449548544|FG001|Overall Study|Death|0|||
124978780|NCT04308590|449548543|FG000|Overall Study|Lost to Follow-up|1|||
124978781|NCT04308590|449548544|FG001|Overall Study|Lost to Follow-up|1|||
124978782|NCT04308590|449548543|FG000|Overall Study|Physician Decision|1|||
124978783|NCT04308590|449548544|FG001|Overall Study|Physician Decision|0|||
124978784|NCT04308590|449548543|FG000|Overall Study|Subject does not want to continue with Pi|0|||
124978785|NCT04308590|449548544|FG001|Overall Study|Subject does not want to continue with Pi|1|||
124978786|NCT05487586|449548548|FG000|Overall Study|Death|22|||
124978787|NCT05487586|449548548|FG000|Overall Study|Physician Decision|1|||
124978788|NCT05487586|449548548|FG000|Overall Study|Transfer to another hospital|4|||
124978789|NCT05487586|449548548|FG000|Overall Study|Other|1|||
124978790|NCT04798781|449548549|FG000|Overall Study|Withdrawal by Subject|1|||
124978791|NCT03853551|449548550|FG000|Overall Study|Death|2|||
124978792|NCT03853551|449548550|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
124978793|NCT02476175|449548551|FG000|Overall Study|Adverse Event|2|||
124978794|NCT02175641|449548553|FG000|Overall Study|Death|3|||
124978795|NCT02175641|449548554|FG001|Overall Study|Death|4|||
125202645|NCT02083185|450365471|FG001|Overall Study|Withdrawal by Subject|15|||
125202646|NCT02083185|450365472|FG002|Overall Study|Withdrawal by Subject|1|||
125202647|NCT02083185|450365470|FG000|Overall Study|Death|2|||
124978796|NCT02175641|449548553|FG000|Overall Study|Lost to Follow-up|4|||
124978797|NCT02175641|449548554|FG001|Overall Study|Lost to Follow-up|4|||
124978798|NCT02175641|449548553|FG000|Overall Study|Withdrawal by Subject|7|||
125202648|NCT02083185|450365471|FG001|Overall Study|Death|2|||
125202649|NCT02083185|450365472|FG002|Overall Study|Death|1|||
125202650|NCT02083185|450365470|FG000|Overall Study|Reason not Specified|9|||
125202651|NCT02083185|450365471|FG001|Overall Study|Reason not Specified|6|||
125202652|NCT02083185|450365472|FG002|Overall Study|Reason not Specified|5|||
125202653|NCT02083185|450365470|FG000|Overall Study|Study Terminated by Sponsor|0|||
125202654|NCT02083185|450365471|FG001|Overall Study|Study Terminated by Sponsor|1|||
125202655|NCT02083185|450365472|FG002|Overall Study|Study Terminated by Sponsor|0|||
124978799|NCT02175641|449548554|FG001|Overall Study|Withdrawal by Subject|4|||
125202656|NCT02083185|450365470|FG000|Overall Study|Did not Receive Study Drug|0|||
125202657|NCT02083185|450365471|FG001|Overall Study|Did not Receive Study Drug|2|||
125202658|NCT02083185|450365472|FG002|Overall Study|Did not Receive Study Drug|0|||
125202659|NCT03419598|450365473|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
125202660|NCT01740128|450365474|FG000|Overall Study|Pregnancy|0|||
125202661|NCT01740128|450365475|FG001|Overall Study|Pregnancy|1|||
125202662|NCT01740128|450365474|FG000|Overall Study|Protocol Violation|1|||
125202663|NCT01740128|450365475|FG001|Overall Study|Protocol Violation|2|||
125202664|NCT01740128|450365474|FG000|Overall Study|Lost to Follow-up|2|||
125202665|NCT01740128|450365475|FG001|Overall Study|Lost to Follow-up|2|||
125202666|NCT01740128|450365474|FG000|Overall Study|Withdrawal by Subject|1|||
125202667|NCT01740128|450365475|FG001|Overall Study|Withdrawal by Subject|0|||
124978800|NCT02175641|449548553|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
124978801|NCT02175641|449548554|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
124978802|NCT02175641|449548553|FG000|Overall Study|Developed Contraindicated Condition|8|||
124978803|NCT02175641|449548554|FG001|Overall Study|Developed Contraindicated Condition|0|||
124978804|NCT03921723|449548556|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
124978805|NCT03921723|449548556|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
124978806|NCT01876901|449548557|FG000|Overall Study|Protocol Violation|10|||
124978807|NCT01876901|449548558|FG001|Overall Study|Protocol Violation|2|||
124978808|NCT01876901|449548557|FG000|Overall Study|No or other surgical intervention|7|||
124978809|NCT01876901|449548558|FG001|Overall Study|No or other surgical intervention|5|||
124978810|NCT02683785|449548559|FG000|Overall Study|Withdrawal by Subject|1|||
124978811|NCT02683785|449548560|FG001|Overall Study|Withdrawal by Subject|1|||
124978812|NCT02683785|449548559|FG000|Overall Study|Lost to Follow-up|0|||
124978813|NCT02683785|449548560|FG001|Overall Study|Lost to Follow-up|1|||
124978814|NCT02683785|449548559|FG000|Overall Study|Adverse Event|0|||
124978815|NCT02683785|449548560|FG001|Overall Study|Adverse Event|2|||
124978816|NCT00534495|449548561|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
124978817|NCT00534495|449548562|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
124978818|NCT00534495|449548563|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
124978819|NCT00534495|449548561|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
124978820|NCT00534495|449548562|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
124978821|NCT00534495|449548563|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
124978822|NCT00534495|449548561|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
124978823|NCT00534495|449548562|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
124978824|NCT00534495|449548563|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
124978825|NCT00534495|449548561|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
124978826|NCT00534495|449548562|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
124978827|NCT00534495|449548563|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
124978828|NCT00534495|449548561|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
124978829|NCT00534495|449548562|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
124978830|NCT00534495|449548563|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
124978831|NCT00534495|449548561|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
124978832|NCT00534495|449548562|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
124978833|NCT00534495|449548563|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
124978834|NCT00534495|449548561|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
124978835|NCT00534495|449548562|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
124978836|NCT00534495|449548563|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
124978837|NCT00534495|449548561|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
124978838|NCT00534495|449548562|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
124978839|NCT00534495|449548563|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
124978840|NCT00534495|449548561|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
124978841|NCT00534495|449548562|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
124978842|NCT00534495|449548563|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
124978843|NCT02233803|449548568|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
124978844|NCT02233803|449548569|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
124978845|NCT02233803|449548568|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
124978846|NCT02233803|449548569|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
124978847|NCT02233803|449548568|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
124978848|NCT02233803|449548569|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
124978849|NCT02233803|449548568|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
124978850|NCT02233803|449548569|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
124978851|NCT02233803|449548568|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
124978852|NCT02233803|449548569|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
124978853|NCT02233803|449548568|FG000|Washout Period (4-Wks)|Physician Decision|1|||
124978854|NCT02233803|449548569|FG001|Washout Period (4-Wks)|Physician Decision|0|||
124978855|NCT02233803|449548568|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
124978856|NCT02233803|449548569|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
124978857|NCT02233803|449548568|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
125202668|NCT01740128|450365474|FG000|Overall Study|Insufficient protocol compliance|2|||
125202669|NCT01740128|450365475|FG001|Overall Study|Insufficient protocol compliance|2|||
125202670|NCT02474589|450365476|FG000|Overall Study|Adverse Event|6|||
125202671|NCT02474589|450365477|FG001|Overall Study|Adverse Event|2|||
125202672|NCT02474589|450365476|FG000|Overall Study|Lost to Follow-up|6|||
125202673|NCT02474589|450365477|FG001|Overall Study|Lost to Follow-up|1|||
125202674|NCT02474589|450365476|FG000|Overall Study|Protocol Violation|4|||
125202675|NCT02474589|450365477|FG001|Overall Study|Protocol Violation|1|||
125202676|NCT02474589|450365476|FG000|Overall Study|Withdrawal by Subject|4|||
125202677|NCT02474589|450365477|FG001|Overall Study|Withdrawal by Subject|0|||
125202678|NCT02474589|450365476|FG000|Overall Study|Inability to complete study procedures|5|||
125202679|NCT02474589|450365477|FG001|Overall Study|Inability to complete study procedures|1|||
125202680|NCT01041976|450365478|FG000|Overall Study|Withdrawal by Subject|3|||
125202681|NCT01041976|450365479|FG001|Overall Study|Withdrawal by Subject|0|||
125202682|NCT01041976|450365478|FG000|Overall Study|Incarceration|2|||
125202683|NCT01041976|450365479|FG001|Overall Study|Incarceration|0|||
125202684|NCT01041976|450365478|FG000|Overall Study|Death|0|||
125202685|NCT01041976|450365479|FG001|Overall Study|Death|4|||
125202686|NCT00380081|450365480|FG000|Overall Study|Withdrawal by Subject|0|||
125202687|NCT00380081|450365481|FG001|Overall Study|Withdrawal by Subject|0|||
125202688|NCT00380081|450365482|FG002|Overall Study|Withdrawal by Subject|0|||
125202689|NCT00380081|450365483|FG003|Overall Study|Withdrawal by Subject|0|||
125202690|NCT00380081|450365484|FG004|Overall Study|Withdrawal by Subject|1|||
125202691|NCT00380081|450365485|FG005|Overall Study|Withdrawal by Subject|0|||
125202692|NCT00380081|450365480|FG000|Overall Study|Family Emergency|0|||
125202693|NCT00380081|450365481|FG001|Overall Study|Family Emergency|0|||
125202694|NCT00380081|450365482|FG002|Overall Study|Family Emergency|0|||
125202695|NCT00380081|450365483|FG003|Overall Study|Family Emergency|0|||
125202696|NCT00380081|450365484|FG004|Overall Study|Family Emergency|0|||
125202697|NCT00380081|450365485|FG005|Overall Study|Family Emergency|1|||
125202698|NCT02231879|450365486|FG000|Overall Study|Adverse Event|2|||
125202699|NCT02231879|450365487|FG001|Overall Study|Adverse Event|1|||
125202700|NCT02231879|450365486|FG000|Overall Study|Lack of Efficacy|0|||
125202701|NCT02231879|450365487|FG001|Overall Study|Lack of Efficacy|1|||
125202702|NCT01546168|450365490|FG000|Overall Study|Lost to Follow-up|1|||
125202703|NCT01546168|450365491|FG001|Overall Study|Lost to Follow-up|0|||
125202704|NCT01546168|450365490|FG000|Overall Study|Withdrawal by Subject|1|||
125202705|NCT01546168|450365491|FG001|Overall Study|Withdrawal by Subject|0|||
125202706|NCT01546168|450365490|FG000|Overall Study|ineligible after signing consent|2|||
125202707|NCT01546168|450365491|FG001|Overall Study|ineligible after signing consent|0|||
125202708|NCT02370667|450365492|FG000|Overall Study|Lost to Follow-up|0|||
125202709|NCT02370667|450365493|FG001|Overall Study|Lost to Follow-up|1|||
125202710|NCT02370667|450365494|FG002|Overall Study|Lost to Follow-up|0|||
124978858|NCT02233803|449548569|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
124978859|NCT02233803|449548568|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
124978860|NCT02233803|449548569|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
124978861|NCT03635099|449548570|FG000|Period 1|Adverse Event|1|||
124978862|NCT03635099|449548571|FG001|Period 1|Adverse Event|0|||
124978863|NCT03635099|449548572|FG002|Period 1|Adverse Event|0|||
124978864|NCT03635099|449548573|FG003|Period 1|Adverse Event|1|||
124978865|NCT03635099|449548574|FG004|Period 1|Adverse Event|0|||
124978866|NCT03635099|449548575|FG005|Period 1|Adverse Event|0|||
124978867|NCT03635099|449548576|FG006|Period 1|Adverse Event|0|||
124978868|NCT03635099|449548577|FG007|Period 1|Adverse Event|0|||
124978869|NCT03635099|449548570|FG000|Period 1|Protocol Violation|0|||
124978870|NCT03635099|449548571|FG001|Period 1|Protocol Violation|0|||
124978871|NCT03635099|449548572|FG002|Period 1|Protocol Violation|1|||
124978872|NCT03635099|449548573|FG003|Period 1|Protocol Violation|0|||
124978873|NCT03635099|449548574|FG004|Period 1|Protocol Violation|0|||
124978874|NCT03635099|449548575|FG005|Period 1|Protocol Violation|0|||
124978875|NCT03635099|449548576|FG006|Period 1|Protocol Violation|0|||
124978876|NCT03635099|449548577|FG007|Period 1|Protocol Violation|0|||
124978877|NCT03635099|449548570|FG000|Period 1|Lost to Follow-up|0|||
124978878|NCT03635099|449548571|FG001|Period 1|Lost to Follow-up|0|||
124978879|NCT03635099|449548572|FG002|Period 1|Lost to Follow-up|1|||
125202711|NCT02954653|450365495|FG000|Overall Study|Death|3|||
125202712|NCT02954653|450365496|FG001|Overall Study|Death|1|||
125202713|NCT02954653|450365497|FG002|Overall Study|Death|0|||
125202714|NCT02954653|450365498|FG003|Overall Study|Death|0|||
124978880|NCT03635099|449548573|FG003|Period 1|Lost to Follow-up|2|||
124978881|NCT03635099|449548574|FG004|Period 1|Lost to Follow-up|1|||
124978882|NCT03635099|449548575|FG005|Period 1|Lost to Follow-up|0|||
124978883|NCT03635099|449548576|FG006|Period 1|Lost to Follow-up|1|||
124978884|NCT03635099|449548577|FG007|Period 1|Lost to Follow-up|2|||
124978885|NCT03635099|449548570|FG000|Period 1|Withdrawal by Subject|3|||
125202715|NCT02954653|450365499|FG004|Overall Study|Death|0|||
125202716|NCT02954653|450365500|FG005|Overall Study|Death|0|||
125202717|NCT02954653|450365501|FG006|Overall Study|Death|0|||
125202718|NCT02954653|450365502|FG007|Overall Study|Death|0|||
125202719|NCT02954653|450365503|FG008|Overall Study|Death|0|||
125202720|NCT02954653|450365495|FG000|Overall Study|Randomized but did not receive treatment|1|||
125202721|NCT02954653|450365496|FG001|Overall Study|Randomized but did not receive treatment|0|||
125202722|NCT02954653|450365497|FG002|Overall Study|Randomized but did not receive treatment|0|||
125202723|NCT02954653|450365498|FG003|Overall Study|Randomized but did not receive treatment|0|||
125202724|NCT02954653|450365499|FG004|Overall Study|Randomized but did not receive treatment|0|||
125202725|NCT02954653|450365500|FG005|Overall Study|Randomized but did not receive treatment|0|||
125202726|NCT02954653|450365501|FG006|Overall Study|Randomized but did not receive treatment|0|||
125202727|NCT02954653|450365502|FG007|Overall Study|Randomized but did not receive treatment|0|||
125202728|NCT02954653|450365503|FG008|Overall Study|Randomized but did not receive treatment|0|||
125202729|NCT02954653|450365495|FG000|Overall Study|Started another anti-cancer therapy|0|||
125202730|NCT02954653|450365496|FG001|Overall Study|Started another anti-cancer therapy|1|||
125202731|NCT02954653|450365497|FG002|Overall Study|Started another anti-cancer therapy|0|||
125202732|NCT02954653|450365498|FG003|Overall Study|Started another anti-cancer therapy|0|||
125202733|NCT02954653|450365499|FG004|Overall Study|Started another anti-cancer therapy|0|||
125202734|NCT02954653|450365500|FG005|Overall Study|Started another anti-cancer therapy|0|||
125202735|NCT02954653|450365501|FG006|Overall Study|Started another anti-cancer therapy|0|||
125202736|NCT02954653|450365502|FG007|Overall Study|Started another anti-cancer therapy|0|||
125202737|NCT02954653|450365503|FG008|Overall Study|Started another anti-cancer therapy|0|||
125202738|NCT02954653|450365495|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
125202739|NCT02954653|450365496|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
125202740|NCT02954653|450365497|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
125202741|NCT02954653|450365498|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
125202742|NCT02954653|450365499|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
125202743|NCT02954653|450365500|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
125202744|NCT02954653|450365501|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
125202745|NCT02954653|450365502|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
125202746|NCT02954653|450365503|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
125202747|NCT03054064|450365504|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
125202748|NCT03054064|450365504|FG000|Overall Study|Investigator Decision|2|||
125202749|NCT03054064|450365504|FG000|Overall Study|Bladder Issue|1|||
125202750|NCT03054064|450365504|FG000|Overall Study|High Blood Pressure|1|||
125202751|NCT03054064|450365504|FG000|Overall Study|Change in Status|1|||
125202752|NCT03787303|450365506|FG000|Overall Study|Death|1|||
125202753|NCT03787303|450365506|FG000|Overall Study|Premature Termination of Study|1|||
125202754|NCT01210495|450365507|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
125202755|NCT01210495|450365508|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
125202756|NCT01210495|450365509|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
125202757|NCT01210495|450365510|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
125202758|NCT01210495|450365507|FG000|Overall Study|Death|14|||
125202759|NCT01210495|450365508|FG001|Overall Study|Death|7|||
125202760|NCT01210495|450365509|FG002|Overall Study|Death|112|||
125202761|NCT01210495|450365510|FG003|Overall Study|Death|54|||
125202762|NCT01210495|450365507|FG000|Overall Study|Study Terminated by Sponsor|0|||
125202763|NCT01210495|450365508|FG001|Overall Study|Study Terminated by Sponsor|0|||
125202764|NCT01210495|450365509|FG002|Overall Study|Study Terminated by Sponsor|4|||
125202765|NCT01210495|450365510|FG003|Overall Study|Study Terminated by Sponsor|11|||
125202766|NCT01210495|450365507|FG000|Overall Study|Lost to Follow-up|0|||
125202767|NCT01210495|450365508|FG001|Overall Study|Lost to Follow-up|0|||
125202768|NCT01210495|450365509|FG002|Overall Study|Lost to Follow-up|1|||
125202769|NCT01210495|450365510|FG003|Overall Study|Lost to Follow-up|1|||
125202770|NCT01210495|450365507|FG000|Overall Study|Other unspecified|0|||
125202771|NCT01210495|450365508|FG001|Overall Study|Other unspecified|0|||
125202772|NCT01210495|450365509|FG002|Overall Study|Other unspecified|6|||
125202773|NCT01210495|450365510|FG003|Overall Study|Other unspecified|0|||
125202774|NCT00985959|450365520|FG000|Overall Study|Adverse Event|0|||
125202775|NCT00985959|450365521|FG001|Overall Study|Adverse Event|0|||
125202776|NCT00985959|450365522|FG002|Overall Study|Adverse Event|19|||
125202777|NCT00985959|450365520|FG000|Overall Study|Withdrawal by Subject|0|||
125202778|NCT00985959|450365521|FG001|Overall Study|Withdrawal by Subject|0|||
125202779|NCT00985959|450365522|FG002|Overall Study|Withdrawal by Subject|8|||
125202780|NCT00985959|450365520|FG000|Overall Study|Progressive disease|1|||
125202781|NCT00985959|450365521|FG001|Overall Study|Progressive disease|2|||
125202782|NCT00985959|450365522|FG002|Overall Study|Progressive disease|8|||
125202783|NCT00985959|450365520|FG000|Overall Study|Unrecovered toxicity|0|||
125202784|NCT00985959|450365521|FG001|Overall Study|Unrecovered toxicity|0|||
125202785|NCT00985959|450365522|FG002|Overall Study|Unrecovered toxicity|7|||
125202786|NCT00985959|450365520|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
125202787|NCT00985959|450365521|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
125202788|NCT00985959|450365522|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
125202789|NCT00985959|450365520|FG000|Overall Study|Complete response observed over 2 cycles|0|||
125202790|NCT00985959|450365521|FG001|Overall Study|Complete response observed over 2 cycles|1|||
125202791|NCT00985959|450365522|FG002|Overall Study|Complete response observed over 2 cycles|4|||
125202792|NCT00985959|450365520|FG000|Overall Study|Other|0|||
125202793|NCT00985959|450365521|FG001|Overall Study|Other|0|||
125202794|NCT00985959|450365522|FG002|Overall Study|Other|11|||
125202795|NCT00976209|450365523|FG000|Treatment Period 1|Protocol Violation|1|||
125202796|NCT00976209|450365524|FG001|Treatment Period 1|Protocol Violation|0|||
125202797|NCT00976209|450365523|FG000|Treatment Period 1|Lost to Follow-up|2|||
125202798|NCT00976209|450365524|FG001|Treatment Period 1|Lost to Follow-up|0|||
125202799|NCT00976209|450365523|FG000|Treatment Period 1|Other|0|||
125202800|NCT00976209|450365524|FG001|Treatment Period 1|Other|1|||
125202801|NCT00976209|450365523|FG000|Wash-out Period|Adverse Event|1|||
125202802|NCT00976209|450365524|FG001|Wash-out Period|Adverse Event|2|||
125202803|NCT00976209|450365523|FG000|Wash-out Period|Lost to Follow-up|1|||
125202804|NCT00976209|450365524|FG001|Wash-out Period|Lost to Follow-up|0|||
125202805|NCT00976209|450365523|FG000|Wash-out Period|Protocol Violation|1|||
125202806|NCT00976209|450365524|FG001|Wash-out Period|Protocol Violation|0|||
125202807|NCT00976209|450365523|FG000|Wash-out Period|Other|1|||
125202808|NCT00976209|450365524|FG001|Wash-out Period|Other|0|||
125202809|NCT00976209|450365523|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125202810|NCT00976209|450365524|FG001|Treatment Period 2|Withdrawal by Subject|1|||
125202811|NCT00976209|450365523|FG000|Treatment Period 2|Lost to Follow-up|0|||
125202812|NCT00976209|450365524|FG001|Treatment Period 2|Lost to Follow-up|1|||
125202813|NCT00979420|450365525|FG000|Overall Study|Adverse Event|1|||
125202814|NCT00979420|450365526|FG001|Overall Study|Adverse Event|0|||
125202815|NCT00979420|450365527|FG002|Overall Study|Adverse Event|0|||
125202816|NCT00979420|450365528|FG003|Overall Study|Adverse Event|0|||
125202817|NCT00979420|450365525|FG000|Overall Study|Lack of Efficacy|3|||
125202818|NCT00979420|450365526|FG001|Overall Study|Lack of Efficacy|0|||
125202819|NCT00979420|450365527|FG002|Overall Study|Lack of Efficacy|1|||
125202820|NCT00979420|450365528|FG003|Overall Study|Lack of Efficacy|1|||
125202821|NCT00979420|450365525|FG000|Overall Study|Other reasons not related to Viramune|3|||
125202822|NCT00979420|450365526|FG001|Overall Study|Other reasons not related to Viramune|0|||
125202823|NCT00979420|450365527|FG002|Overall Study|Other reasons not related to Viramune|0|||
125202824|NCT00979420|450365528|FG003|Overall Study|Other reasons not related to Viramune|1|||
125202825|NCT00574249|450365529|FG000|Overall Study|Adverse Event|6|||
125202826|NCT00574249|450365530|FG001|Overall Study|Adverse Event|18|||
125202827|NCT00574249|450365529|FG000|Overall Study|Lack of Efficacy|5|||
125202828|NCT00574249|450365530|FG001|Overall Study|Lack of Efficacy|3|||
125202829|NCT00574249|450365529|FG000|Overall Study|Lost to Follow-up|4|||
125202830|NCT00574249|450365530|FG001|Overall Study|Lost to Follow-up|3|||
125202831|NCT00574249|450365529|FG000|Overall Study|Protocol Violation|5|||
125202832|NCT00574249|450365530|FG001|Overall Study|Protocol Violation|2|||
125202833|NCT00574249|450365529|FG000|Overall Study|History of carcinoma|1|||
125202834|NCT00574249|450365530|FG001|Overall Study|History of carcinoma|0|||
125202835|NCT00574249|450365529|FG000|Overall Study|Withdrawal by Subject|3|||
125202836|NCT00574249|450365530|FG001|Overall Study|Withdrawal by Subject|0|||
125202837|NCT00574249|450365529|FG000|Overall Study|Physician Decision|1|||
125202838|NCT00574249|450365530|FG001|Overall Study|Physician Decision|0|||
125202839|NCT00574249|450365529|FG000|Overall Study|Pregnancy|1|||
125202840|NCT00574249|450365530|FG001|Overall Study|Pregnancy|0|||
125202841|NCT00574249|450365529|FG000|Overall Study|Excluded by company|0|||
125202842|NCT00574249|450365530|FG001|Overall Study|Excluded by company|1|||
125202843|NCT00574249|450365529|FG000|Overall Study|PPD test taken twice|0|||
125202844|NCT00574249|450365530|FG001|Overall Study|PPD test taken twice|1|||
125202845|NCT01259375|450365531|FG000|Overall Study|Adverse Event|1|||
125202846|NCT00478699|450365536|FG000|Overall Study|Inclusion Error|1|||
125202847|NCT00478699|450365537|FG001|Overall Study|Inclusion Error|7|||
125202848|NCT00478699|450365536|FG000|Overall Study|Not receive study treatment|6|||
125202849|NCT00478699|450365537|FG001|Overall Study|Not receive study treatment|30|||
125202850|NCT00656851|450365539|FG000|Overall Study|Withdrawal by Subject|0|||
124978886|NCT03635099|449548571|FG001|Period 1|Withdrawal by Subject|3|||
124978887|NCT03635099|449548572|FG002|Period 1|Withdrawal by Subject|5|||
124978888|NCT03635099|449548573|FG003|Period 1|Withdrawal by Subject|2|||
125202851|NCT00656851|450365540|FG001|Overall Study|Withdrawal by Subject|4|||
125202852|NCT01123941|450365541|FG000|Overall Study|Lost to Follow-up|2|||
125202853|NCT01123941|450365542|FG001|Overall Study|Lost to Follow-up|1|||
125202854|NCT04601103|450365543|FG000|Overall Study|Needed crown & cleaning|0|||
125202855|NCT04601103|450365544|FG001|Overall Study|Needed crown & cleaning|0|||
125202856|NCT04601103|450365545|FG002|Overall Study|Needed crown & cleaning|1|||
125202857|NCT04601103|450365543|FG000|Overall Study|study was terminated|18|||
125202858|NCT04601103|450365544|FG001|Overall Study|study was terminated|18|||
125202859|NCT04601103|450365545|FG002|Overall Study|study was terminated|16|||
125202860|NCT06011161|450365548|FG000|Overall Study|Withdrawal by Subject|2|||
125202861|NCT06011161|450365548|FG000|Overall Study|Lost to Follow-up|5|||
125202862|NCT04713592|450365551|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
125202863|NCT04713592|450365552|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
125202864|NCT04713592|450365553|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
125202865|NCT04713592|450365554|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
125202866|NCT04713592|450365551|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
124978889|NCT03635099|449548574|FG004|Period 1|Withdrawal by Subject|2|||
124978890|NCT03635099|449548575|FG005|Period 1|Withdrawal by Subject|0|||
124978891|NCT03635099|449548576|FG006|Period 1|Withdrawal by Subject|3|||
124978892|NCT03635099|449548577|FG007|Period 1|Withdrawal by Subject|0|||
124978893|NCT03635099|449548570|FG000|Period 1|History of suicidal ideation|0|||
124978894|NCT03635099|449548571|FG001|Period 1|History of suicidal ideation|0|||
124978895|NCT03635099|449548572|FG002|Period 1|History of suicidal ideation|1|||
124978896|NCT03635099|449548573|FG003|Period 1|History of suicidal ideation|0|||
124978897|NCT03635099|449548574|FG004|Period 1|History of suicidal ideation|0|||
124978898|NCT03635099|449548575|FG005|Period 1|History of suicidal ideation|0|||
124978899|NCT03635099|449548576|FG006|Period 1|History of suicidal ideation|0|||
124978900|NCT03635099|449548577|FG007|Period 1|History of suicidal ideation|0|||
124978901|NCT03635099|449548570|FG000|Period 1|pursue other treatment options|0|||
124978902|NCT03635099|449548571|FG001|Period 1|pursue other treatment options|0|||
124978903|NCT03635099|449548572|FG002|Period 1|pursue other treatment options|0|||
124978904|NCT03635099|449548573|FG003|Period 1|pursue other treatment options|0|||
124978905|NCT03635099|449548574|FG004|Period 1|pursue other treatment options|0|||
124978906|NCT03635099|449548575|FG005|Period 1|pursue other treatment options|1|||
124978907|NCT03635099|449548576|FG006|Period 1|pursue other treatment options|0|||
124978908|NCT03635099|449548577|FG007|Period 1|pursue other treatment options|0|||
124978909|NCT03635099|449548570|FG000|Not Eligible for Period 2|Pregnancy|0|||
124978910|NCT03635099|449548571|FG001|Not Eligible for Period 2|Pregnancy|0|||
124978911|NCT03635099|449548572|FG002|Not Eligible for Period 2|Pregnancy|0|||
124978912|NCT03635099|449548573|FG003|Not Eligible for Period 2|Pregnancy|1|||
124978913|NCT03635099|449548574|FG004|Not Eligible for Period 2|Pregnancy|0|||
124978914|NCT03635099|449548575|FG005|Not Eligible for Period 2|Pregnancy|0|||
124978915|NCT03635099|449548576|FG006|Not Eligible for Period 2|Pregnancy|0|||
124978916|NCT03635099|449548577|FG007|Not Eligible for Period 2|Pregnancy|0|||
124978917|NCT03635099|449548570|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
124978918|NCT03635099|449548571|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
124978919|NCT03635099|449548572|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
124978920|NCT03635099|449548573|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
124978921|NCT03635099|449548574|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
124978922|NCT03635099|449548575|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
124978923|NCT03635099|449548576|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
124978924|NCT03635099|449548577|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
124978925|NCT03635099|449548570|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
124978926|NCT03635099|449548571|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
124978927|NCT03635099|449548572|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
124978928|NCT03635099|449548573|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
124978929|NCT03635099|449548574|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
124978930|NCT03635099|449548575|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
124978931|NCT03635099|449548576|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
124978932|NCT03635099|449548577|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
124978933|NCT03635099|449548570|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
124978934|NCT03635099|449548571|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
124978935|NCT03635099|449548572|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
124978936|NCT03635099|449548573|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
124978937|NCT03635099|449548574|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
124978938|NCT03635099|449548575|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
124978939|NCT03635099|449548576|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
124978940|NCT03635099|449548577|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
124978941|NCT03635099|449548570|FG000|Period 2|Adverse Event|0|||
124978942|NCT03635099|449548571|FG001|Period 2|Adverse Event|0|||
124978943|NCT03635099|449548572|FG002|Period 2|Adverse Event|1|||
124978944|NCT03635099|449548573|FG003|Period 2|Adverse Event|0|||
124978945|NCT03635099|449548574|FG004|Period 2|Adverse Event|1|||
124978946|NCT03635099|449548575|FG005|Period 2|Adverse Event|0|||
124978947|NCT03635099|449548576|FG006|Period 2|Adverse Event|0|||
124978948|NCT03635099|449548577|FG007|Period 2|Adverse Event|0|||
124978949|NCT03635099|449548570|FG000|Period 2|Lost to Follow-up|0|||
124978950|NCT03635099|449548571|FG001|Period 2|Lost to Follow-up|0|||
124978951|NCT03635099|449548572|FG002|Period 2|Lost to Follow-up|1|||
124978952|NCT03635099|449548573|FG003|Period 2|Lost to Follow-up|0|||
124978953|NCT03635099|449548574|FG004|Period 2|Lost to Follow-up|4|||
124978954|NCT03635099|449548575|FG005|Period 2|Lost to Follow-up|0|||
124978955|NCT03635099|449548576|FG006|Period 2|Lost to Follow-up|0|||
124978956|NCT03635099|449548577|FG007|Period 2|Lost to Follow-up|0|||
124978957|NCT03635099|449548570|FG000|Period 2|Withdrawal by Subject|0|||
124978958|NCT03635099|449548571|FG001|Period 2|Withdrawal by Subject|0|||
124978959|NCT03635099|449548572|FG002|Period 2|Withdrawal by Subject|7|||
124978960|NCT03635099|449548573|FG003|Period 2|Withdrawal by Subject|4|||
124978961|NCT03635099|449548574|FG004|Period 2|Withdrawal by Subject|7|||
125202867|NCT04713592|450365552|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
125202868|NCT04713592|450365553|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
125202869|NCT04713592|450365554|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
125202870|NCT04713592|450365551|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
125202871|NCT04713592|450365552|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
125202872|NCT04713592|450365553|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
125202873|NCT04713592|450365554|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
125202874|NCT04713592|450365551|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125202875|NCT04713592|450365552|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125202876|NCT04713592|450365553|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
125202877|NCT04713592|450365554|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
125202878|NCT04713592|450365551|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
125202879|NCT04713592|450365552|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
125202880|NCT04713592|450365553|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
125202881|NCT04713592|450365554|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
125202882|NCT04713592|450365551|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125202883|NCT04713592|450365552|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125202884|NCT04713592|450365553|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
125202885|NCT04713592|450365554|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
125202886|NCT04713592|450365551|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
125202887|NCT04713592|450365552|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
125202888|NCT04713592|450365553|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
125202889|NCT04713592|450365554|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
125202890|NCT02548351|450365560|FG000|Overall Study|Withdrawal by Subject|149|||
125202891|NCT02548351|450365561|FG001|Overall Study|Withdrawal by Subject|154|||
125202892|NCT02548351|450365562|FG002|Overall Study|Withdrawal by Subject|152|||
125202893|NCT02548351|450365560|FG000|Overall Study|Death|11|||
125202894|NCT02548351|450365561|FG001|Overall Study|Death|15|||
125202895|NCT02548351|450365562|FG002|Overall Study|Death|12|||
125202896|NCT02548351|450365560|FG000|Overall Study|Adverse Event|22|||
125202897|NCT02548351|450365561|FG001|Overall Study|Adverse Event|56|||
125202898|NCT02548351|450365562|FG002|Overall Study|Adverse Event|36|||
125202899|NCT02548351|450365560|FG000|Overall Study|Study Terminated by Sponsor|549|||
125202900|NCT02548351|450365561|FG001|Overall Study|Study Terminated by Sponsor|509|||
125202901|NCT02548351|450365562|FG002|Overall Study|Study Terminated by Sponsor|528|||
125202902|NCT02548351|450365560|FG000|Overall Study|Site Closure|14|||
125202903|NCT02548351|450365561|FG001|Overall Study|Site Closure|5|||
125202904|NCT02548351|450365562|FG002|Overall Study|Site Closure|7|||
125202905|NCT02548351|450365560|FG000|Overall Study|Non-compliance with Study Drug|4|||
125202906|NCT02548351|450365561|FG001|Overall Study|Non-compliance with Study Drug|2|||
125202907|NCT02548351|450365562|FG002|Overall Study|Non-compliance with Study Drug|0|||
125202908|NCT02548351|450365560|FG000|Overall Study|Protocol Violation|2|||
125202909|NCT02548351|450365561|FG001|Overall Study|Protocol Violation|1|||
125202910|NCT02548351|450365562|FG002|Overall Study|Protocol Violation|2|||
125202911|NCT02548351|450365560|FG000|Overall Study|Physician Decision|11|||
125202912|NCT02548351|450365561|FG001|Overall Study|Physician Decision|18|||
125202913|NCT02548351|450365562|FG002|Overall Study|Physician Decision|11|||
125202914|NCT02548351|450365560|FG000|Overall Study|Lost to Follow-up|43|||
125202915|NCT02548351|450365561|FG001|Overall Study|Lost to Follow-up|50|||
125202916|NCT02548351|450365562|FG002|Overall Study|Lost to Follow-up|57|||
125202917|NCT02548351|450365560|FG000|Overall Study|Other|19|||
125202918|NCT02548351|450365561|FG001|Overall Study|Other|16|||
125202919|NCT02548351|450365562|FG002|Overall Study|Other|20|||
125202920|NCT02548351|450365560|FG000|Overall Study|Missing|1|||
125202921|NCT02548351|450365561|FG001|Overall Study|Missing|1|||
125202922|NCT02548351|450365562|FG002|Overall Study|Missing|0|||
125202923|NCT00125242|450365563|FG000|Overall Study|did not qualify|7|||
125202924|NCT00125242|450365564|FG001|Overall Study|did not qualify|2|||
125202925|NCT01664949|450365565|FG000|Overall Study|Adverse Event|11|||
125202926|NCT01664949|450365566|FG001|Overall Study|Adverse Event|12|||
125202927|NCT01664949|450365565|FG000|Overall Study|Lack of Efficacy|1|||
125202928|NCT01664949|450365566|FG001|Overall Study|Lack of Efficacy|1|||
125202929|NCT01664949|450365565|FG000|Overall Study|Lost to Follow-up|1|||
125202930|NCT01664949|450365566|FG001|Overall Study|Lost to Follow-up|2|||
125202931|NCT01664949|450365565|FG000|Overall Study|Personal Reasons|3|||
125202932|NCT01664949|450365566|FG001|Overall Study|Personal Reasons|4|||
125202933|NCT01664949|450365565|FG000|Overall Study|Protocol Violation|5|||
125202934|NCT01664949|450365566|FG001|Overall Study|Protocol Violation|5|||
125202935|NCT01664949|450365565|FG000|Overall Study|Other Miscellaneous Reasons|3|||
125202936|NCT01664949|450365566|FG001|Overall Study|Other Miscellaneous Reasons|1|||
125202937|NCT03003494|450365567|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
125202938|NCT01632150|450366867|FG000|Overall Study|Disease progression|27|||
125202939|NCT01632150|450366867|FG000|Overall Study|Study drug toxicity|1|||
125202940|NCT01632150|450366867|FG000|Overall Study|Unrelated adverse event|7|||
125202941|NCT01632150|450366867|FG000|Overall Study|Withdrawal by Subject|2|||
125202942|NCT01632150|450366867|FG000|Overall Study|Patient underwent autologous transplant|1|||
125202943|NCT01632150|450366867|FG000|Overall Study|Moved to compassionate program|2|||
125202944|NCT02143791|450366868|FG000|Enrolled|Withdrawal by Subject|4|||
125202945|NCT02143791|450366868|FG000|Trial Stimulation|Lack of Efficacy|21|||
125202946|NCT02143791|450366868|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
125202947|NCT02143791|450366868|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
125202948|NCT02143791|450366868|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
125202949|NCT02143791|450366868|FG000|Any Programming (3-6 Months)|Missing Data|1|||
125202950|NCT02143791|450366868|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
125202951|NCT00401544|450366871|FG000|Overall Study|Adverse Event|5|||
125202952|NCT00401544|450366872|FG001|Overall Study|Adverse Event|1|||
125202953|NCT00401544|450366873|FG002|Overall Study|Adverse Event|1|||
125202954|NCT00401544|450366874|FG003|Overall Study|Adverse Event|1|||
125202955|NCT00401544|450366871|FG000|Overall Study|Death|3|||
125202956|NCT00401544|450366872|FG001|Overall Study|Death|6|||
125202957|NCT00401544|450366873|FG002|Overall Study|Death|2|||
125202958|NCT00401544|450366874|FG003|Overall Study|Death|5|||
125202959|NCT00401544|450366871|FG000|Overall Study|Lost to Follow-up|2|||
125202960|NCT00401544|450366872|FG001|Overall Study|Lost to Follow-up|0|||
125202961|NCT00401544|450366873|FG002|Overall Study|Lost to Follow-up|1|||
125202962|NCT00401544|450366874|FG003|Overall Study|Lost to Follow-up|1|||
125202963|NCT00401544|450366871|FG000|Overall Study|Withdrawal by Subject|7|||
125202964|NCT00401544|450366872|FG001|Overall Study|Withdrawal by Subject|6|||
125202965|NCT00401544|450366873|FG002|Overall Study|Withdrawal by Subject|6|||
125202966|NCT00401544|450366874|FG003|Overall Study|Withdrawal by Subject|5|||
125202967|NCT00401544|450366871|FG000|Overall Study|Physician Decision|1|||
125202968|NCT00401544|450366872|FG001|Overall Study|Physician Decision|3|||
125202969|NCT00401544|450366873|FG002|Overall Study|Physician Decision|0|||
125202970|NCT00401544|450366874|FG003|Overall Study|Physician Decision|0|||
125202971|NCT00401544|450366871|FG000|Overall Study|Ineligibility determined|0|||
125202972|NCT00401544|450366872|FG001|Overall Study|Ineligibility determined|1|||
125202973|NCT00401544|450366873|FG002|Overall Study|Ineligibility determined|0|||
125202974|NCT00401544|450366874|FG003|Overall Study|Ineligibility determined|2|||
125202975|NCT00401544|450366871|FG000|Overall Study|Disease progression|0|||
125202976|NCT00401544|450366872|FG001|Overall Study|Disease progression|1|||
125202977|NCT00401544|450366873|FG002|Overall Study|Disease progression|0|||
125202978|NCT00401544|450366874|FG003|Overall Study|Disease progression|0|||
125202979|NCT00401544|450366871|FG000|Overall Study|Other|0|||
125202980|NCT00401544|450366872|FG001|Overall Study|Other|0|||
125202981|NCT00401544|450366873|FG002|Overall Study|Other|2|||
125202982|NCT00401544|450366874|FG003|Overall Study|Other|2|||
125202983|NCT02339155|450366882|FG000|Overall Study|Adverse Event|0|||
125202984|NCT02339155|450366883|FG001|Overall Study|Adverse Event|6|||
125202985|NCT02339155|450366882|FG000|Overall Study|Death|1|||
125202986|NCT02339155|450366883|FG001|Overall Study|Death|1|||
125202987|NCT02339155|450366882|FG000|Overall Study|Lost to Follow-up|8|||
125202988|NCT02339155|450366883|FG001|Overall Study|Lost to Follow-up|9|||
125202989|NCT02339155|450366882|FG000|Overall Study|Physician Decision|2|||
125202990|NCT02339155|450366883|FG001|Overall Study|Physician Decision|1|||
125202991|NCT02339155|450366882|FG000|Overall Study|Withdrawal by Subject|4|||
125202992|NCT02339155|450366883|FG001|Overall Study|Withdrawal by Subject|4|||
125202993|NCT01214252|450366884|FG000|Overall Study|Not eligible per protocol|82|||
125202994|NCT04327661|450366887|FG000|Overall Study|Withdrawal by Subject|1|||
125202995|NCT04327661|450366888|FG001|Overall Study|Withdrawal by Subject|0|||
125202996|NCT04327661|450366889|FG002|Overall Study|Withdrawal by Subject|0|||
125202997|NCT01877551|450366892|FG000|Overall Study|Physician Decision|0|||
125202998|NCT01877551|450366893|FG001|Overall Study|Physician Decision|1|||
125202999|NCT02659514|450366896|FG000|Overall Study|Adverse Event|3|||
125203000|NCT02659514|450366897|FG001|Overall Study|Adverse Event|12|||
125203001|NCT02659514|450366896|FG000|Overall Study|Disease Progression|23|||
125203002|NCT02659514|450366897|FG001|Overall Study|Disease Progression|13|||
125203003|NCT02659514|450366896|FG000|Overall Study|Withdrawal by Subject|0|||
125203004|NCT02659514|450366897|FG001|Overall Study|Withdrawal by Subject|4|||
125203005|NCT02659514|450366896|FG000|Overall Study|Lost to Follow-up|0|||
125203006|NCT02659514|450366897|FG001|Overall Study|Lost to Follow-up|1|||
125203007|NCT02659514|450366896|FG000|Overall Study|Death|6|||
125203008|NCT02659514|450366897|FG001|Overall Study|Death|1|||
125203009|NCT02659514|450366896|FG000|Overall Study|Reason Unspecified|0|||
125203010|NCT02659514|450366897|FG001|Overall Study|Reason Unspecified|3|||
125203011|NCT01968707|450366903|FG000|Overall Study|Did not meet treatment day baseline|49|||
125203012|NCT01968707|450366904|FG001|Overall Study|Did not meet treatment day baseline|12|||
125203013|NCT01968707|450366905|FG002|Overall Study|Did not meet treatment day baseline|41|||
125203014|NCT01968707|450366906|FG003|Overall Study|Did not meet treatment day baseline|44|||
125203015|NCT01968707|450366907|FG004|Overall Study|Did not meet treatment day baseline|36|||
125203016|NCT01968707|450366908|FG005|Overall Study|Did not meet treatment day baseline|11|||
125203017|NCT01968707|450366909|FG006|Overall Study|Did not meet treatment day baseline|34|||
125203018|NCT01968707|450366910|FG007|Overall Study|Did not meet treatment day baseline|35|||
124978962|NCT03635099|449548575|FG005|Period 2|Withdrawal by Subject|0|||
124978963|NCT03635099|449548576|FG006|Period 2|Withdrawal by Subject|0|||
124978964|NCT03635099|449548577|FG007|Period 2|Withdrawal by Subject|0|||
124978965|NCT01068665|449548578|FG000|Overall Study|Adverse Event|5|||
124978966|NCT01068665|449548579|FG001|Overall Study|Adverse Event|4|||
124978967|NCT01068665|449548578|FG000|Overall Study|Lack of Efficacy|0|||
124978968|NCT01068665|449548579|FG001|Overall Study|Lack of Efficacy|2|||
124978969|NCT01068665|449548578|FG000|Overall Study|Protocol Violation|5|||
124978970|NCT01068665|449548579|FG001|Overall Study|Protocol Violation|2|||
124978971|NCT01068665|449548578|FG000|Overall Study|Withdrawal Criteria|3|||
124978972|NCT01068665|449548579|FG001|Overall Study|Withdrawal Criteria|9|||
124978973|NCT01068665|449548578|FG000|Overall Study|Other|17|||
124978974|NCT01068665|449548579|FG001|Overall Study|Other|12|||
124978975|NCT04191616|449548581|FG000|Pre-assignment Period|Did not receive study treatment|2|||
124978976|NCT04191616|449548581|FG000|Treatment Period|Death|37|||
124978977|NCT04191616|449548581|FG000|Treatment Period|Sponsor decision|11|||
124978978|NCT04191616|449548581|FG000|Treatment Period|Withdrawal by Subject|4|||
124978979|NCT04230122|449548582|FG000|Overall Study|Lost to Follow-up|1|||
124978980|NCT04230122|449548583|FG001|Overall Study|Lost to Follow-up|0|||
124978981|NCT01840410|449548586|FG000|Overall Study|Physician Decision|1|||
124978982|NCT01840410|449548587|FG001|Overall Study|Physician Decision|2|||
124978983|NCT01840410|449548586|FG000|Overall Study|Pregnancy|1|||
124978984|NCT01840410|449548587|FG001|Overall Study|Pregnancy|0|||
124978985|NCT01840410|449548586|FG000|Overall Study|Protocol deviation|1|||
124978986|NCT01840410|449548587|FG001|Overall Study|Protocol deviation|0|||
124978987|NCT01840410|449548586|FG000|Overall Study|Lost to Follow-up|1|||
124978988|NCT01840410|449548587|FG001|Overall Study|Lost to Follow-up|0|||
124978989|NCT01840410|449548586|FG000|Overall Study|Withdrawal by Subject|2|||
124978990|NCT01840410|449548587|FG001|Overall Study|Withdrawal by Subject|1|||
124978991|NCT01840410|449548586|FG000|Overall Study|Adverse Event|1|||
124978992|NCT01840410|449548587|FG001|Overall Study|Adverse Event|1|||
124978993|NCT02671500|449548601|FG000|Overall Study|Lack of Efficacy|12|||
124978994|NCT02671500|449548601|FG000|Overall Study|Lost to Follow-up|2|||
124978995|NCT05235269|449548608|FG000|Overall Study|Adverse Event|1|||
124978996|NCT05235269|449548608|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
124978997|NCT05235269|449548608|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
124978998|NCT00798434|449548609|FG000|Double-Blind|Adverse Event|22|||
124978999|NCT00798434|449548610|FG001|Double-Blind|Adverse Event|46|||
124979000|NCT00798434|449548609|FG000|Double-Blind|Death|0|||
124979001|NCT00798434|449548610|FG001|Double-Blind|Death|1|||
124979002|NCT00798434|449548609|FG000|Double-Blind|Lost to Follow-up|1|||
124979003|NCT00798434|449548610|FG001|Double-Blind|Lost to Follow-up|0|||
124979004|NCT00798434|449548609|FG000|Double-Blind|Lack of Efficacy|8|||
124979005|NCT00798434|449548610|FG001|Double-Blind|Lack of Efficacy|12|||
124979006|NCT00798434|449548609|FG000|Double-Blind|Withdrawal by Subject|17|||
124979007|NCT00798434|449548610|FG001|Double-Blind|Withdrawal by Subject|14|||
124979008|NCT00798434|449548609|FG000|Double-Blind|Protocol Violation|1|||
124979009|NCT00798434|449548610|FG001|Double-Blind|Protocol Violation|4|||
124979010|NCT00798434|449548609|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
124979011|NCT00798434|449548610|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
124979012|NCT00798434|449548609|FG000|Double-Blind|Other|1|||
124979013|NCT00798434|449548610|FG001|Double-Blind|Other|0|||
124979014|NCT00798434|449548609|FG000|Double-Blind|Not Treated|3|||
124979015|NCT00798434|449548610|FG001|Double-Blind|Not Treated|6|||
124979016|NCT00798434|449548609|FG000|Open-Label|Adverse Event|33|||
124979017|NCT00798434|449548610|FG001|Open-Label|Adverse Event|11|||
124979018|NCT00798434|449548609|FG000|Open-Label|Lack of Efficacy|5|||
124979019|NCT00798434|449548610|FG001|Open-Label|Lack of Efficacy|11|||
124979020|NCT00798434|449548609|FG000|Open-Label|Withdrawal by Subject|2|||
124979021|NCT00798434|449548610|FG001|Open-Label|Withdrawal by Subject|7|||
124979022|NCT00798434|449548609|FG000|Open-Label|Protocol Violation|1|||
124979023|NCT00798434|449548610|FG001|Open-Label|Protocol Violation|0|||
124979024|NCT00798434|449548609|FG000|Open-Label|Other|1|||
124979025|NCT00798434|449548610|FG001|Open-Label|Other|2|||
124979026|NCT00798434|449548609|FG000|Open-Label|Not Treated|0|||
124979027|NCT00798434|449548610|FG001|Open-Label|Not Treated|1|||
124979028|NCT05292586|449548611|FG000|Overall Study|Withdrawal by Subject|3|||
124979029|NCT05292586|449548612|FG001|Overall Study|Withdrawal by Subject|10|||
124979030|NCT05292586|449548611|FG000|Overall Study|Randomization error|3|||
124979031|NCT05292586|449548612|FG001|Overall Study|Randomization error|7|||
124979032|NCT05292586|449548611|FG000|Overall Study|Adverse Event|3|||
124979033|NCT05292586|449548612|FG001|Overall Study|Adverse Event|0|||
124979034|NCT05292586|449548611|FG000|Overall Study|Lost to Follow-up|0|||
124979035|NCT05292586|449548612|FG001|Overall Study|Lost to Follow-up|1|||
124979036|NCT05292586|449548611|FG000|Overall Study|Patient refused treatment|1|||
124979037|NCT05292586|449548612|FG001|Overall Study|Patient refused treatment|0|||
124979038|NCT05292586|449548611|FG000|Overall Study|Patient could not travel to the study site|1|||
124979039|NCT05292586|449548612|FG001|Overall Study|Patient could not travel to the study site|0|||
124979040|NCT05292586|449548611|FG000|Overall Study|Technical issues with the masterscope|0|||
125089786|NCT01117428|449947024|FG001|Overall Study|Death|1|||
125203019|NCT00916344|450366911|FG000|Overall Study|Death|2|||
125203020|NCT00916344|450366911|FG000|Overall Study|ICD upgrade|1|||
125203021|NCT00916344|450366911|FG000|Overall Study|Drop-out|5|||
125203022|NCT00108485|450366915|FG000|Overall Study|Withdrawal by Subject|3|||
125203023|NCT00108485|450366916|FG001|Overall Study|Withdrawal by Subject|0|||
125203024|NCT00108485|450366915|FG000|Overall Study|Lost to Follow-up|0|||
125203025|NCT00108485|450366916|FG001|Overall Study|Lost to Follow-up|2|||
125203026|NCT01097421|450366917|FG000|Overall Study|Adverse Event|8|||
125203027|NCT01097421|450366917|FG000|Overall Study|Protocol Violation|2|||
125203028|NCT01097421|450366917|FG000|Overall Study|Lost to Follow-up|1|||
125203029|NCT01097421|450366917|FG000|Overall Study|Withdrawal by Subject|3|||
125203030|NCT01701193|450366922|FG000|Overall Study|Withdrawal by Subject|2|||
125203031|NCT01701193|450366923|FG001|Overall Study|Withdrawal by Subject|2|||
125203032|NCT01701193|450366924|FG002|Overall Study|Withdrawal by Subject|1|||
125203033|NCT01701193|450366925|FG003|Overall Study|Withdrawal by Subject|2|||
125203034|NCT01701193|450366922|FG000|Overall Study|Adverse Event|1|||
125203035|NCT01701193|450366923|FG001|Overall Study|Adverse Event|0|||
125203036|NCT01701193|450366924|FG002|Overall Study|Adverse Event|0|||
125203037|NCT01701193|450366925|FG003|Overall Study|Adverse Event|0|||
125203038|NCT02062944|450366926|FG000|Overall Study|Lost to Follow-up|1|||
125203039|NCT02062944|450366926|FG000|Overall Study|New hemotological disorder identified|1|||
125203040|NCT02062944|450366926|FG000|Overall Study|Uncontrolled Hypertension|1|||
125203041|NCT02062944|450366926|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
125203042|NCT00278148|450366927|FG000|Phase II - Expansion Phase|Disease progression|0|||
125203043|NCT00278148|450366928|FG001|Phase II - Expansion Phase|Disease progression|0|||
125203044|NCT00278148|450366929|FG002|Phase II - Expansion Phase|Disease progression|4|||
125203045|NCT00278148|450366927|FG000|Phase II - Expansion Phase|Adverse Event|0|||
125203046|NCT00278148|450366928|FG001|Phase II - Expansion Phase|Adverse Event|0|||
125203047|NCT00278148|450366929|FG002|Phase II - Expansion Phase|Adverse Event|2|||
125203048|NCT02035748|450366930|FG000|Overall Study|Adverse Event|5|||
125203049|NCT02035748|450366930|FG000|Overall Study|Death|3|||
125203050|NCT02035748|450366930|FG000|Overall Study|Lost to Follow-up|2|||
125203051|NCT02035748|450366930|FG000|Overall Study|Physician Decision|3|||
125203052|NCT02035748|450366930|FG000|Overall Study|Withdrawal by Subject|6|||
125203053|NCT02035748|450366930|FG000|Overall Study|Progressive Disease|1|||
125203054|NCT01088243|450366932|FG000|Overall Study|Adverse Event|1|||
125203055|NCT01088243|450366933|FG001|Overall Study|Adverse Event|0|||
125203056|NCT00454818|450366936|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
125203057|NCT00454818|450366937|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
125203058|NCT00454818|450366938|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
125203059|NCT00454818|450366939|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
125203060|NCT00454818|450366940|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
125203061|NCT00454818|450366936|FG000|Phase I: Open-label Dose-escalation|Death|0|||
125203062|NCT00454818|450366937|FG001|Phase I: Open-label Dose-escalation|Death|1|||
125203063|NCT00454818|450366938|FG002|Phase I: Open-label Dose-escalation|Death|0|||
125203064|NCT00454818|450366939|FG003|Phase I: Open-label Dose-escalation|Death|0|||
125203065|NCT00454818|450366940|FG004|Phase I: Open-label Dose-escalation|Death|0|||
125203066|NCT00454818|450366936|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
125203067|NCT00454818|450366937|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
125203068|NCT00454818|450366938|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
125203069|NCT00454818|450366939|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
125203070|NCT00454818|450366940|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
125203071|NCT00454818|450366936|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
125203072|NCT00454818|450366937|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
125203073|NCT00454818|450366938|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
125203074|NCT00454818|450366939|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
125203075|NCT00454818|450366940|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
125203076|NCT00454818|450366936|FG000|Phase 2: Randomized Double-blind|Death|0|||
125203077|NCT00454818|450366937|FG001|Phase 2: Randomized Double-blind|Death|1|||
125203078|NCT00454818|450366938|FG002|Phase 2: Randomized Double-blind|Death|0|||
125203079|NCT00454818|450366939|FG003|Phase 2: Randomized Double-blind|Death|0|||
125203080|NCT00454818|450366940|FG004|Phase 2: Randomized Double-blind|Death|1|||
125203081|NCT00454818|450366936|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
125203082|NCT00454818|450366937|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
125203083|NCT00454818|450366938|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
125203084|NCT00454818|450366939|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
125203085|NCT00454818|450366940|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
125203086|NCT00454818|450366936|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
125203087|NCT00454818|450366937|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
125203088|NCT00454818|450366938|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
125203089|NCT00454818|450366939|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
125203090|NCT00454818|450366940|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
125203091|NCT01384019|450366941|FG000|Overall Study|Withdrawal by Subject|3|||
125203092|NCT01384019|450366942|FG001|Overall Study|Withdrawal by Subject|0|||
125203093|NCT01384019|450366941|FG000|Overall Study|Death|1|||
125203094|NCT01384019|450366942|FG001|Overall Study|Death|0|||
125203095|NCT01384019|450366941|FG000|Overall Study|MRI refusal|6|||
125203096|NCT01384019|450366942|FG001|Overall Study|MRI refusal|6|||
125203097|NCT00767039|450366943|FG000|Overall Study|Death|5|||
125203098|NCT00767039|450366944|FG001|Overall Study|Death|2|||
125203099|NCT01826370|450366945|FG000|Overall Study|Protocol Violation|6|||
125203100|NCT01826370|450366945|FG000|Overall Study|Lost to Follow-up|12|||
125203101|NCT01826370|450366945|FG000|Overall Study|Other reason not defined above|2|||
125203102|NCT04416737|450366947|FG000|Week 1 (First Injection)|Physician Decision|0|||
125203103|NCT04416737|450366948|FG001|Week 1 (First Injection)|Physician Decision|1|||
125203104|NCT03332628|450366949|FG000|Overall Study|Physician Decision|2|||
125203105|NCT01472757|450366950|FG000|Overall Study|Withdrawal by Subject|1|||
125203106|NCT01472757|450366951|FG001|Overall Study|Withdrawal by Subject|2|||
125203107|NCT01472757|450366952|FG002|Overall Study|Withdrawal by Subject|2|||
125203108|NCT01472757|450366953|FG003|Overall Study|Withdrawal by Subject|0|||
125203109|NCT01472757|450366950|FG000|Overall Study|Asthma exacerbation|4|||
125203110|NCT01472757|450366951|FG001|Overall Study|Asthma exacerbation|1|||
125203111|NCT01472757|450366952|FG002|Overall Study|Asthma exacerbation|2|||
125203112|NCT01472757|450366953|FG003|Overall Study|Asthma exacerbation|1|||
125203113|NCT01472757|450366950|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
125203114|NCT01472757|450366951|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
125203115|NCT01472757|450366952|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
125203116|NCT01472757|450366953|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
125203117|NCT01472757|450366950|FG000|Overall Study|Protocol Violation|3|||
125203118|NCT01472757|450366951|FG001|Overall Study|Protocol Violation|2|||
125203119|NCT01472757|450366952|FG002|Overall Study|Protocol Violation|4|||
125203120|NCT01472757|450366953|FG003|Overall Study|Protocol Violation|4|||
125203121|NCT01472757|450366950|FG000|Overall Study|Other reasons|1|||
125203122|NCT01472757|450366951|FG001|Overall Study|Other reasons|0|||
125203123|NCT01472757|450366952|FG002|Overall Study|Other reasons|2|||
125203124|NCT01472757|450366953|FG003|Overall Study|Other reasons|2|||
125203125|NCT04489381|450366954|FG000|Overall Study|Lost to Follow-up|2|||
125203126|NCT04489381|450366955|FG001|Overall Study|Lost to Follow-up|3|||
125203127|NCT04489381|450366954|FG000|Overall Study|Withdrawal by Subject|1|||
125203128|NCT04489381|450366955|FG001|Overall Study|Withdrawal by Subject|0|||
125203129|NCT00070018|450366958|FG000|Overall Study|Adverse Event|2|||
125203130|NCT00070018|450366958|FG000|Overall Study|Lack of Efficacy|1|||
125203131|NCT00070018|450366958|FG000|Overall Study|Withdrawal by Subject|1|||
125203132|NCT02939716|450366962|FG000|Overall Study|scanner failure|0|||
125203133|NCT02939716|450366963|FG001|Overall Study|scanner failure|0|||
125203134|NCT02939716|450366964|FG002|Overall Study|scanner failure|0|||
125203135|NCT02939716|450366965|FG003|Overall Study|scanner failure|1|||
125203136|NCT02939716|450366966|FG004|Overall Study|scanner failure|1|||
125203137|NCT02939716|450366967|FG005|Overall Study|scanner failure|1|||
125203138|NCT02543892|450366970|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
125203139|NCT02543892|450366971|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
125203140|NCT02543892|450366972|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
125203141|NCT02543892|450366973|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
125203142|NCT02543892|450366974|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
125203143|NCT02543892|450366975|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
125203144|NCT02543892|450366976|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
125203145|NCT02543892|450366977|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
125203146|NCT02543892|450366970|FG000|Received Vaccination 2|Physician Decision|0|||
125203147|NCT02543892|450366971|FG001|Received Vaccination 2|Physician Decision|0|||
125203148|NCT02543892|450366972|FG002|Received Vaccination 2|Physician Decision|0|||
125203149|NCT02543892|450366973|FG003|Received Vaccination 2|Physician Decision|0|||
125203150|NCT02543892|450366974|FG004|Received Vaccination 2|Physician Decision|0|||
125203151|NCT02543892|450366975|FG005|Received Vaccination 2|Physician Decision|1|||
125203152|NCT02543892|450366976|FG006|Received Vaccination 2|Physician Decision|0|||
125203153|NCT02543892|450366977|FG007|Received Vaccination 2|Physician Decision|0|||
125203154|NCT02543892|450366970|FG000|Received Vaccination 2|Adverse Event|0|||
125203155|NCT02543892|450366971|FG001|Received Vaccination 2|Adverse Event|1|||
125203156|NCT02543892|450366972|FG002|Received Vaccination 2|Adverse Event|0|||
125203157|NCT02543892|450366973|FG003|Received Vaccination 2|Adverse Event|0|||
125203158|NCT02543892|450366974|FG004|Received Vaccination 2|Adverse Event|0|||
125203159|NCT02543892|450366975|FG005|Received Vaccination 2|Adverse Event|0|||
125203160|NCT02543892|450366976|FG006|Received Vaccination 2|Adverse Event|0|||
125203161|NCT02543892|450366977|FG007|Received Vaccination 2|Adverse Event|0|||
125203162|NCT02543892|450366970|FG000|Had Immunology Data|Withdrawal by Subject|0|||
125203163|NCT02543892|450366971|FG001|Had Immunology Data|Withdrawal by Subject|0|||
125203164|NCT02543892|450366972|FG002|Had Immunology Data|Withdrawal by Subject|0|||
125203165|NCT02543892|450366973|FG003|Had Immunology Data|Withdrawal by Subject|0|||
125203166|NCT02543892|450366974|FG004|Had Immunology Data|Withdrawal by Subject|0|||
125203167|NCT02543892|450366975|FG005|Had Immunology Data|Withdrawal by Subject|0|||
125203168|NCT02543892|450366976|FG006|Had Immunology Data|Withdrawal by Subject|1|||
125203169|NCT02543892|450366977|FG007|Had Immunology Data|Withdrawal by Subject|0|||
125203170|NCT00785213|450366978|FG000|Quinine Sulfate Alone|Adverse Event|4|||
125203171|NCT00785213|450366978|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
125203172|NCT00525902|450366979|FG000|Overall Study|Lack of Efficacy|1|||
125203173|NCT00844480|450366986|FG000|Overall Study|Withdrawal by Subject|2|||
125203174|NCT00844480|450366987|FG001|Overall Study|Withdrawal by Subject|3|||
125203175|NCT02858180|450366988|FG000|Overall Study|Lost to Follow-up|0|||
125203176|NCT02858180|450366989|FG001|Overall Study|Lost to Follow-up|2|||
125203177|NCT00526331|450366990|FG000|Overall Study|Sponsor Termination|55|||
125203178|NCT01043705|450366993|FG000|Overall Study|Death|28|||
125203179|NCT01043705|450366994|FG001|Overall Study|Death|60|||
125203180|NCT01043705|450366995|FG002|Overall Study|Death|26|||
125203181|NCT01043705|450366993|FG000|Overall Study|Lost to Follow-up|27|||
125203182|NCT01043705|450366994|FG001|Overall Study|Lost to Follow-up|12|||
125203183|NCT01043705|450366995|FG002|Overall Study|Lost to Follow-up|0|||
125203184|NCT01043705|450366993|FG000|Overall Study|Multiple Reasons|4|||
125203185|NCT01043705|450366994|FG001|Overall Study|Multiple Reasons|7|||
125203186|NCT01043705|450366995|FG002|Overall Study|Multiple Reasons|0|||
125203187|NCT01043705|450366993|FG000|Overall Study|Protocol Violation|2|||
125203188|NCT01043705|450366994|FG001|Overall Study|Protocol Violation|1|||
125203189|NCT01043705|450366995|FG002|Overall Study|Protocol Violation|0|||
125203190|NCT01043705|450366993|FG000|Overall Study|Withdrawal by Subject|8|||
125203191|NCT01043705|450366994|FG001|Overall Study|Withdrawal by Subject|6|||
125203192|NCT01043705|450366995|FG002|Overall Study|Withdrawal by Subject|0|||
125203193|NCT01043705|450366993|FG000|Overall Study|Site Closure|8|||
125203194|NCT01043705|450366994|FG001|Overall Study|Site Closure|0|||
125203195|NCT01043705|450366995|FG002|Overall Study|Site Closure|0|||
125203196|NCT01043705|450366993|FG000|Overall Study|Subsequent Procedure|9|||
125203197|NCT01043705|450366994|FG001|Overall Study|Subsequent Procedure|24|||
125203198|NCT01043705|450366995|FG002|Overall Study|Subsequent Procedure|29|||
125203199|NCT01043705|450366993|FG000|Overall Study|Adverse Event|0|||
125203200|NCT01043705|450366994|FG001|Overall Study|Adverse Event|2|||
125203201|NCT01043705|450366995|FG002|Overall Study|Adverse Event|0|||
125203202|NCT01043705|450366993|FG000|Overall Study|Screen Fail|21|||
125203203|NCT01043705|450366994|FG001|Overall Study|Screen Fail|0|||
125203204|NCT01043705|450366995|FG002|Overall Study|Screen Fail|0|||
125203205|NCT01043705|450366993|FG000|Overall Study|Other|0|||
125203206|NCT01043705|450366994|FG001|Overall Study|Other|19|||
125203207|NCT01043705|450366995|FG002|Overall Study|Other|25|||
125203208|NCT00581542|450366997|FG000|Overall Study|they met an exclusion criteria|2|||
125203209|NCT00581542|450366998|FG001|Overall Study|they met an exclusion criteria|2|||
125203210|NCT00581542|450366997|FG000|Overall Study|Lost to Follow-up|9|||
125203211|NCT00581542|450366998|FG001|Overall Study|Lost to Follow-up|21|||
125203212|NCT03099694|450367000|FG000|Overall Study|Withdrawal by Subject|11|||
125203213|NCT03099694|450367001|FG001|Overall Study|Withdrawal by Subject|13|||
125203214|NCT03099694|450367000|FG000|Overall Study|Lost to Follow-up|9|||
124979041|NCT05292586|449548612|FG001|Overall Study|Technical issues with the masterscope|3|||
125203215|NCT03099694|450367001|FG001|Overall Study|Lost to Follow-up|5|||
125203216|NCT02291601|450367002|FG000|Abdomen|Did not qualify|333|||
125203217|NCT02291601|450367003|FG001|Abdomen|Did not qualify|54|||
125203218|NCT02291601|450367004|FG002|Abdomen|Did not qualify|339|||
125203219|NCT02291601|450367002|FG000|Groin|Did not qualify|183|||
125203220|NCT02291601|450367003|FG001|Groin|Did not qualify|30|||
125203221|NCT02291601|450367004|FG002|Groin|Did not qualify|177|||
125203222|NCT00381043|450367005|FG000|Overall Study|Lost to Follow-up|8|||
125203223|NCT00381043|450367006|FG001|Overall Study|Lost to Follow-up|6|||
125203224|NCT00381043|450367005|FG000|Overall Study|Withdrawal by Subject|3|||
125203225|NCT00381043|450367006|FG001|Overall Study|Withdrawal by Subject|1|||
125203226|NCT00381043|450367005|FG000|Overall Study|wanted more care|0|||
125203227|NCT00381043|450367006|FG001|Overall Study|wanted more care|1|||
125203228|NCT00381043|450367005|FG000|Overall Study|incarcerated|1|||
125203229|NCT00381043|450367006|FG001|Overall Study|incarcerated|0|||
124979042|NCT05292586|449548611|FG000|Overall Study|Patient moved to a different state|0|||
125203230|NCT03045276|450367007|FG000|Intervention Phase|Withdrawal by Subject|7|||
125203231|NCT03045276|450367008|FG001|Intervention Phase|Withdrawal by Subject|2|||
125203232|NCT03045276|450367009|FG002|Intervention Phase|Withdrawal by Subject|3|||
125203233|NCT03045276|450367010|FG003|Intervention Phase|Withdrawal by Subject|7|||
125203234|NCT03045276|450367007|FG000|Intervention Phase|Developed exclusionary criteria|3|||
124979043|NCT05292586|449548612|FG001|Overall Study|Patient moved to a different state|1|||
125203235|NCT03045276|450367008|FG001|Intervention Phase|Developed exclusionary criteria|3|||
125203236|NCT03045276|450367009|FG002|Intervention Phase|Developed exclusionary criteria|0|||
125203237|NCT03045276|450367010|FG003|Intervention Phase|Developed exclusionary criteria|0|||
125203238|NCT03045276|450367007|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
125203239|NCT03045276|450367008|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
125203240|NCT03045276|450367009|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
125203241|NCT03045276|450367010|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
125203242|NCT03045276|450367007|FG000|Follow-Up Phase|Lost to Follow-up|0|||
125203243|NCT03045276|450367008|FG001|Follow-Up Phase|Lost to Follow-up|1|||
125203244|NCT03045276|450367009|FG002|Follow-Up Phase|Lost to Follow-up|0|||
125203245|NCT03045276|450367010|FG003|Follow-Up Phase|Lost to Follow-up|1|||
125203246|NCT03045276|450367007|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
125203247|NCT03045276|450367008|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
125203248|NCT03045276|450367009|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
125203249|NCT03045276|450367010|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
125203250|NCT00347919|450367011|FG000|Overall Study|Lost to Follow-up|11|||
125203251|NCT00347919|450367012|FG001|Overall Study|Lost to Follow-up|13|||
125203252|NCT00347919|450367013|FG002|Overall Study|Lost to Follow-up|0|||
125203253|NCT00347919|450367011|FG000|Overall Study|Withdrawal by Subject|6|||
125203254|NCT00347919|450367012|FG001|Overall Study|Withdrawal by Subject|8|||
125203255|NCT00347919|450367013|FG002|Overall Study|Withdrawal by Subject|0|||
125203256|NCT00347919|450367011|FG000|Overall Study|Physician Decision|1|||
125203257|NCT00347919|450367012|FG001|Overall Study|Physician Decision|1|||
125203258|NCT00347919|450367013|FG002|Overall Study|Physician Decision|0|||
125203259|NCT00347919|450367011|FG000|Overall Study|Sponsor terminated study|15|||
125203260|NCT00347919|450367012|FG001|Overall Study|Sponsor terminated study|10|||
125203261|NCT00347919|450367013|FG002|Overall Study|Sponsor terminated study|16|||
125203262|NCT00347919|450367011|FG000|Overall Study|Death|35|||
125203263|NCT00347919|450367012|FG001|Overall Study|Death|42|||
125203264|NCT00347919|450367013|FG002|Overall Study|Death|19|||
125203265|NCT00347919|450367011|FG000|Overall Study|Par. Started Other Treatment|1|||
125203266|NCT00347919|450367012|FG001|Overall Study|Par. Started Other Treatment|1|||
125203267|NCT00347919|450367013|FG002|Overall Study|Par. Started Other Treatment|1|||
125203268|NCT00347919|450367011|FG000|Overall Study|Missing|2|||
125203269|NCT00347919|450367012|FG001|Overall Study|Missing|1|||
125203270|NCT00347919|450367013|FG002|Overall Study|Missing|2|||
125203271|NCT03379753|450367014|FG000|Overall Study|Withdrawal by Subject|2|||
125203272|NCT03379753|450367015|FG001|Overall Study|Withdrawal by Subject|1|||
125203273|NCT03379753|450367014|FG000|Overall Study|not having correct procedure|1|||
125203274|NCT03379753|450367015|FG001|Overall Study|not having correct procedure|2|||
125203275|NCT03379753|450367014|FG000|Overall Study|No primary outcome|12|||
125203276|NCT03379753|450367015|FG001|Overall Study|No primary outcome|22|||
125203277|NCT01032239|450367016|FG000|Overall Study|Lost to Follow-up|3|||
125203278|NCT01032239|450367017|FG001|Overall Study|Lost to Follow-up|2|||
125203279|NCT01032239|450367016|FG000|Overall Study|Withdrawal by Subject|2|||
125203280|NCT01032239|450367017|FG001|Overall Study|Withdrawal by Subject|3|||
125203281|NCT01032239|450367016|FG000|Overall Study|Death|1|||
125203282|NCT01032239|450367017|FG001|Overall Study|Death|0|||
125203283|NCT01032239|450367016|FG000|Overall Study|Protocol Violation|1|||
125203284|NCT01032239|450367017|FG001|Overall Study|Protocol Violation|0|||
125203285|NCT01940900|450367024|FG000|Overall Study|Physician Decision|4|||
125203286|NCT01940900|450367025|FG001|Overall Study|Physician Decision|0|||
125203287|NCT01940900|450367024|FG000|Overall Study|Adverse Event|10|||
125203288|NCT01940900|450367025|FG001|Overall Study|Adverse Event|15|||
125203289|NCT01940900|450367024|FG000|Overall Study|Withdrawal by Subject|11|||
125203290|NCT01940900|450367025|FG001|Overall Study|Withdrawal by Subject|15|||
125203291|NCT01940900|450367024|FG000|Overall Study|Lost to Follow-up|1|||
125203292|NCT01940900|450367025|FG001|Overall Study|Lost to Follow-up|0|||
125203293|NCT01940900|450367024|FG000|Overall Study|Sponsor Decision|1|||
125203294|NCT01940900|450367025|FG001|Overall Study|Sponsor Decision|0|||
125203295|NCT01940900|450367024|FG000|Overall Study|subject non-compliance|1|||
125203296|NCT01940900|450367025|FG001|Overall Study|subject non-compliance|1|||
125203297|NCT01940900|450367024|FG000|Overall Study|other|1|||
125203298|NCT01940900|450367025|FG001|Overall Study|other|0|||
125203299|NCT02225366|450367026|FG000|Overall Study|Lack of Efficacy|1|||
125203300|NCT02225366|450367027|FG001|Overall Study|Lack of Efficacy|0|||
125203301|NCT03782298|450367039|FG000|Overall Study|Protocol Deviation|4|||
125203302|NCT01382225|450367040|FG000|Overall Study|Adverse Event|3|||
125203303|NCT01382225|450367041|FG001|Overall Study|Adverse Event|2|||
125203304|NCT01382225|450367040|FG000|Overall Study|Protocol Violation|2|||
125203305|NCT01382225|450367041|FG001|Overall Study|Protocol Violation|1|||
125203306|NCT01382225|450367040|FG000|Overall Study|Subject Withdrew Consent|5|||
125203307|NCT01382225|450367041|FG001|Overall Study|Subject Withdrew Consent|2|||
125203308|NCT01382225|450367040|FG000|Overall Study|Other|4|||
125203309|NCT01382225|450367041|FG001|Overall Study|Other|2|||
125203310|NCT01797081|450367044|FG000|Overall Study|Adverse Event|1|||
125203311|NCT01797081|450367045|FG001|Overall Study|Adverse Event|0|||
125203312|NCT01797081|450367046|FG002|Overall Study|Adverse Event|1|||
125203313|NCT01797081|450367047|FG003|Overall Study|Adverse Event|0|||
125203314|NCT01797081|450367044|FG000|Overall Study|Pregnancy|1|||
125203315|NCT01797081|450367045|FG001|Overall Study|Pregnancy|0|||
125203316|NCT01797081|450367046|FG002|Overall Study|Pregnancy|0|||
125203317|NCT01797081|450367047|FG003|Overall Study|Pregnancy|0|||
125203318|NCT01797081|450367044|FG000|Overall Study|Personal Reasons|12|||
125203319|NCT01797081|450367045|FG001|Overall Study|Personal Reasons|4|||
125203320|NCT01797081|450367046|FG002|Overall Study|Personal Reasons|4|||
125203321|NCT01797081|450367047|FG003|Overall Study|Personal Reasons|8|||
125203322|NCT01797081|450367044|FG000|Overall Study|Protocol Violation|0|||
125203323|NCT01797081|450367045|FG001|Overall Study|Protocol Violation|0|||
125203324|NCT01797081|450367046|FG002|Overall Study|Protocol Violation|0|||
125203325|NCT01797081|450367047|FG003|Overall Study|Protocol Violation|1|||
125203326|NCT03617861|450368707|FG000|Second Intervention (1 Day)|Adverse Event|0|||
125203327|NCT03617861|450368708|FG001|Second Intervention (1 Day)|Adverse Event|0|||
125203328|NCT03617861|450368709|FG002|Second Intervention (1 Day)|Adverse Event|1|||
125203329|NCT03617861|450368710|FG003|Second Intervention (1 Day)|Adverse Event|0|||
125203330|NCT00623597|450368711|FG000|Overall Study|Failed to return|1|||
125203331|NCT00623597|450368712|FG001|Overall Study|Failed to return|0|||
125203332|NCT02515994|450368713|FG000|Overall Study|Protocol Violation|3|||
125203333|NCT02515994|450368714|FG001|Overall Study|Protocol Violation|5|||
125203334|NCT02515994|450368713|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
125203335|NCT02515994|450368714|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
125203336|NCT02515994|450368713|FG000|Overall Study|Adverse Event|3|||
125203337|NCT02515994|450368714|FG001|Overall Study|Adverse Event|1|||
125203338|NCT02515994|450368713|FG000|Overall Study|Withdrawal by Subject|2|||
125203339|NCT02515994|450368714|FG001|Overall Study|Withdrawal by Subject|0|||
125203340|NCT01668966|450368724|FG000|Overall Study|Withdrawal by Subject|1|||
125203341|NCT01668966|450368724|FG000|Overall Study|Death|1|||
125203342|NCT01668966|450368724|FG000|Overall Study|Not treated|2|||
125203343|NCT00552032|450368726|FG000|Overall Study|Withdrawal by Subject|2|||
125203344|NCT00552032|450368727|FG001|Overall Study|Withdrawal by Subject|2|||
125203345|NCT00552032|450368726|FG000|Overall Study|Protocol Violation|7|||
125203346|NCT00552032|450368727|FG001|Overall Study|Protocol Violation|12|||
125203347|NCT00552032|450368726|FG000|Overall Study|Lost to Follow-up|8|||
125203348|NCT00552032|450368727|FG001|Overall Study|Lost to Follow-up|5|||
125203349|NCT00345878|450368728|FG000|Overall Study|Adverse Event|1|||
125203350|NCT00345878|450368729|FG001|Overall Study|Adverse Event|0|||
125203351|NCT00345878|450368728|FG000|Overall Study|Lost to Follow-up|2|||
125203352|NCT00345878|450368729|FG001|Overall Study|Lost to Follow-up|1|||
125203353|NCT00345878|450368728|FG000|Overall Study|Other|1|||
125203354|NCT00345878|450368729|FG001|Overall Study|Other|0|||
125203355|NCT01643798|450368730|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
125203356|NCT01643798|450368731|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
125203357|NCT00984061|450368737|FG000|Clarithromycin Alone|Protocol Violation|1|||
125203358|NCT00614120|450368739|FG000|Overall Study|Adverse Event|9|||
125203359|NCT00614120|450368740|FG001|Overall Study|Adverse Event|22|||
125203360|NCT00614120|450368741|FG002|Overall Study|Adverse Event|30|||
125203361|NCT00614120|450368742|FG003|Overall Study|Adverse Event|3|||
125203362|NCT00614120|450368739|FG000|Overall Study|Lack of Efficacy|3|||
125203363|NCT00614120|450368740|FG001|Overall Study|Lack of Efficacy|3|||
125203364|NCT00614120|450368741|FG002|Overall Study|Lack of Efficacy|2|||
125203365|NCT00614120|450368742|FG003|Overall Study|Lack of Efficacy|2|||
125203366|NCT00614120|450368739|FG000|Overall Study|Protocol Violation|2|||
125203367|NCT00614120|450368740|FG001|Overall Study|Protocol Violation|5|||
125203368|NCT00614120|450368741|FG002|Overall Study|Protocol Violation|3|||
125203369|NCT00614120|450368742|FG003|Overall Study|Protocol Violation|1|||
125203370|NCT00614120|450368739|FG000|Overall Study|Withdrawal criteria|1|||
125203371|NCT00614120|450368740|FG001|Overall Study|Withdrawal criteria|0|||
125203372|NCT00614120|450368741|FG002|Overall Study|Withdrawal criteria|0|||
125203373|NCT00614120|450368742|FG003|Overall Study|Withdrawal criteria|0|||
125203374|NCT00614120|450368739|FG000|Overall Study|Withdrawal by Subject|9|||
125203375|NCT00614120|450368740|FG001|Overall Study|Withdrawal by Subject|10|||
125203376|NCT00614120|450368741|FG002|Overall Study|Withdrawal by Subject|16|||
125203377|NCT00614120|450368742|FG003|Overall Study|Withdrawal by Subject|3|||
125203378|NCT00614120|450368739|FG000|Overall Study|Did not meet trial criteria|0|||
125203379|NCT00614120|450368740|FG001|Overall Study|Did not meet trial criteria|1|||
125203380|NCT00614120|450368741|FG002|Overall Study|Did not meet trial criteria|1|||
125203381|NCT00614120|450368742|FG003|Overall Study|Did not meet trial criteria|1|||
125203382|NCT00614120|450368739|FG000|Overall Study|hCG positive (not pregnant)|0|||
125203383|NCT00614120|450368740|FG001|Overall Study|hCG positive (not pregnant)|0|||
125203384|NCT00614120|450368741|FG002|Overall Study|hCG positive (not pregnant)|1|||
125203385|NCT00614120|450368742|FG003|Overall Study|hCG positive (not pregnant)|0|||
125203386|NCT00614120|450368739|FG000|Overall Study|Hypoglycaemia|0|||
125203387|NCT00614120|450368740|FG001|Overall Study|Hypoglycaemia|0|||
125203388|NCT00614120|450368741|FG002|Overall Study|Hypoglycaemia|0|||
125203389|NCT00614120|450368742|FG003|Overall Study|Hypoglycaemia|1|||
125203390|NCT00614120|450368739|FG000|Overall Study|Lack of trial product|3|||
125203391|NCT00614120|450368740|FG001|Overall Study|Lack of trial product|3|||
125203392|NCT00614120|450368741|FG002|Overall Study|Lack of trial product|2|||
125203393|NCT00614120|450368742|FG003|Overall Study|Lack of trial product|0|||
125203394|NCT00614120|450368739|FG000|Overall Study|Late syphilis, latent|1|||
125203395|NCT00614120|450368740|FG001|Overall Study|Late syphilis, latent|0|||
125203396|NCT00614120|450368741|FG002|Overall Study|Late syphilis, latent|0|||
125203397|NCT00614120|450368742|FG003|Overall Study|Late syphilis, latent|0|||
125203398|NCT00614120|450368739|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
125203399|NCT00614120|450368740|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
125203400|NCT00614120|450368741|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
125203401|NCT00614120|450368742|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
125203402|NCT00614120|450368739|FG000|Overall Study|Lost to Follow-up|1|||
125203403|NCT00614120|450368740|FG001|Overall Study|Lost to Follow-up|2|||
125203404|NCT00614120|450368741|FG002|Overall Study|Lost to Follow-up|3|||
125203405|NCT00614120|450368742|FG003|Overall Study|Lost to Follow-up|4|||
125203406|NCT03602391|450368749|FG000|Overall Study|COVID-19|7|||
125203407|NCT03602391|450368750|FG001|Overall Study|COVID-19|6|||
125203408|NCT00819780|450368755|FG000|Overall Study|Did not receive study drug|3|||
125203409|NCT00819780|450368756|FG001|Overall Study|Did not receive study drug|4|||
125203410|NCT00819780|450368755|FG000|Overall Study|Still in treatment|25|||
125203411|NCT00819780|450368756|FG001|Overall Study|Still in treatment|17|||
125203412|NCT01793688|450368757|FG000|Overall Study|Protocol Violation|2|||
125203413|NCT02484651|450368760|FG000|Overall Study|Patients' data files were corrupted.|1|||
125203414|NCT02484651|450368761|FG001|Overall Study|Patients' data files were corrupted.|1|||
125203415|NCT02484651|450368760|FG000|Overall Study|BIS monitoring failed.|1|||
125203416|NCT02484651|450368761|FG001|Overall Study|BIS monitoring failed.|1|||
125203417|NCT02484651|450368760|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
125203418|NCT02484651|450368761|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
125203419|NCT00150800|450368762|FG000|Overall Study|Adverse Event|89|||
125203420|NCT00150800|450368762|FG000|Overall Study|Death|18|||
125203421|NCT00150800|450368762|FG000|Overall Study|Lack of Efficacy|166|||
125203422|NCT00150800|450368762|FG000|Overall Study|Lost to Follow-up|58|||
125203423|NCT00150800|450368762|FG000|Overall Study|Subject's choice|90|||
125203424|NCT00150800|450368762|FG000|Overall Study|No compliance|18|||
125203425|NCT00150800|450368762|FG000|Overall Study|IP misshandling|1|||
125203426|NCT00150800|450368762|FG000|Overall Study|Site closure|24|||
125203427|NCT00150800|450368762|FG000|Overall Study|Protocol non-adherence|2|||
125203428|NCT00150800|450368762|FG000|Overall Study|Nobody to accompany patient|1|||
125203429|NCT00150800|450368762|FG000|Overall Study|Distance too long for patient|1|||
125203430|NCT00150800|450368762|FG000|Overall Study|Neurosurgery|2|||
125203431|NCT00150800|450368762|FG000|Overall Study|BRV monotherapy|1|||
125203432|NCT00150800|450368762|FG000|Overall Study|Visit refusal|3|||
125203433|NCT00150800|450368762|FG000|Overall Study|Sponsor's request|2|||
125203434|NCT00150800|450368762|FG000|Overall Study|Generalized Epilepsy|1|||
125203435|NCT00150800|450368762|FG000|Overall Study|Moved from area/country|8|||
125203436|NCT00150800|450368762|FG000|Overall Study|PI retiring|2|||
125203437|NCT00150800|450368762|FG000|Overall Study|PI leaving site|2|||
125203438|NCT00150800|450368762|FG000|Overall Study|Patient insurance|1|||
125203439|NCT00150800|450368762|FG000|Overall Study|Surgical intervention|4|||
125203440|NCT00150800|450368762|FG000|Overall Study|Pregnancy planned|1|||
125203441|NCT00150800|450368762|FG000|Overall Study|PI discontinuation request|1|||
125203442|NCT01698879|450368763|FG000|Overall Study|Withdrawal by Subject|1|||
125203443|NCT01698879|450368764|FG001|Overall Study|Withdrawal by Subject|0|||
125203444|NCT01698879|450368765|FG002|Overall Study|Withdrawal by Subject|0|||
125203445|NCT04972968|450368766|FG000|Overall Study|Adverse Event|3|||
125203446|NCT04972968|450368767|FG001|Overall Study|Adverse Event|1|||
125203447|NCT04972968|450368768|FG002|Overall Study|Adverse Event|1|||
125203448|NCT04972968|450368769|FG003|Overall Study|Adverse Event|7|||
125203449|NCT04972968|450368766|FG000|Overall Study|Lack of Efficacy|2|||
125203450|NCT04972968|450368767|FG001|Overall Study|Lack of Efficacy|1|||
125203451|NCT04972968|450368768|FG002|Overall Study|Lack of Efficacy|0|||
125203452|NCT04972968|450368769|FG003|Overall Study|Lack of Efficacy|0|||
125203453|NCT04972968|450368766|FG000|Overall Study|Withdrawal by Subject|7|||
125203454|NCT04972968|450368767|FG001|Overall Study|Withdrawal by Subject|4|||
125203455|NCT04972968|450368768|FG002|Overall Study|Withdrawal by Subject|3|||
125203456|NCT04972968|450368769|FG003|Overall Study|Withdrawal by Subject|2|||
125203457|NCT04972968|450368766|FG000|Overall Study|Study Terminated by Sponsor|25|||
125203458|NCT04972968|450368767|FG001|Overall Study|Study Terminated by Sponsor|28|||
125203459|NCT04972968|450368768|FG002|Overall Study|Study Terminated by Sponsor|32|||
125203460|NCT04972968|450368769|FG003|Overall Study|Study Terminated by Sponsor|27|||
125203461|NCT04972968|450368766|FG000|Overall Study|Other|1|||
125203462|NCT04972968|450368767|FG001|Overall Study|Other|0|||
125203463|NCT04972968|450368768|FG002|Overall Study|Other|1|||
125203464|NCT04972968|450368769|FG003|Overall Study|Other|1|||
125203465|NCT02375555|450368777|FG000|Induction Period|Adverse Event|7|||
125203466|NCT02375555|450368777|FG000|Induction Period|Withdrawal by Subject|2|||
125203467|NCT02375555|450368777|FG000|Induction Period|Other|1|||
125203468|NCT02375555|450368777|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
125203469|NCT02375555|450368777|FG000|Maintenance Period|Adverse Event|2|||
125203470|NCT02375555|450368777|FG000|Maintenance Period|Withdrawal by Subject|4|||
125203471|NCT02375555|450368777|FG000|Maintenance Period|Death|1|||
125203472|NCT02375555|450368777|FG000|Maintenance Period|Disease Progression|5|||
125203473|NCT02375555|450368777|FG000|Maintenance Period|Patient Non-compliance|1|||
125203474|NCT02375555|450368777|FG000|Maintenance Period|Still on maintenance|16|||
125203475|NCT01744184|450368789|FG000|Overall Study|Adverse Event|1|||
125203476|NCT01744184|450368790|FG001|Overall Study|Adverse Event|0|||
125203477|NCT01744184|450368789|FG000|Overall Study|Withdrawal by Subject|0|||
125203478|NCT01744184|450368790|FG001|Overall Study|Withdrawal by Subject|1|||
125203479|NCT01263782|450368798|FG000|Overall Study|Death|0|||
125203480|NCT01263782|450368799|FG001|Overall Study|Death|0|||
125203481|NCT01263782|450368800|FG002|Overall Study|Death|1|||
125203482|NCT01263782|450368801|FG003|Overall Study|Death|0|||
125203483|NCT01263782|450368798|FG000|Overall Study|Progressive disease|0|||
125203484|NCT01263782|450368799|FG001|Overall Study|Progressive disease|0|||
125203485|NCT01263782|450368800|FG002|Overall Study|Progressive disease|0|||
125203486|NCT01263782|450368801|FG003|Overall Study|Progressive disease|1|||
125203487|NCT01263782|450368798|FG000|Overall Study|Too early|0|||
125203488|NCT01263782|450368799|FG001|Overall Study|Too early|0|||
125203489|NCT01263782|450368800|FG002|Overall Study|Too early|1|||
125203490|NCT01263782|450368801|FG003|Overall Study|Too early|0|||
125203491|NCT01263782|450368798|FG000|Overall Study|Inevaluable|0|||
125203492|NCT01263782|450368799|FG001|Overall Study|Inevaluable|0|||
125203493|NCT01263782|450368800|FG002|Overall Study|Inevaluable|1|||
125203494|NCT01263782|450368801|FG003|Overall Study|Inevaluable|0|||
125203495|NCT04545567|450368803|FG000|Overall Study|tested positive for SARS-co-V2|1|||
125203496|NCT04545567|450368804|FG001|Overall Study|tested positive for SARS-co-V2|1|||
125203497|NCT04545567|450368803|FG000|Overall Study|Withdrawal by Subject|0|||
125203498|NCT04545567|450368804|FG001|Overall Study|Withdrawal by Subject|1|||
125203499|NCT02419612|450368811|FG000|Short-term Treatment Period|Adverse Event|1|||
125203500|NCT02419612|450368812|FG001|Short-term Treatment Period|Adverse Event|1|||
125203501|NCT02419612|450368811|FG000|Short-term Treatment Period|Death|0|||
125203502|NCT02419612|450368812|FG001|Short-term Treatment Period|Death|2|||
125203503|NCT02419612|450368811|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
125203504|NCT02419612|450368812|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
125203505|NCT02419612|450368811|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
125203506|NCT02419612|450368812|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
125203507|NCT02419612|450368811|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
125203508|NCT02419612|450368812|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
125203509|NCT02419612|450368811|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
125203510|NCT02419612|450368812|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
125203511|NCT02419612|450368811|FG000|Short-term Treatment Period|Worsening of liver function|0|||
125203512|NCT02419612|450368812|FG001|Short-term Treatment Period|Worsening of liver function|1|||
125203513|NCT02419612|450368811|FG000|Short-term Treatment Period|Subject moved out of state|0|||
125203514|NCT02419612|450368812|FG001|Short-term Treatment Period|Subject moved out of state|1|||
125203515|NCT02419612|450368811|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
125203516|NCT02419612|450368812|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
125203517|NCT02419612|450368811|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
125203518|NCT02419612|450368812|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
125203519|NCT02419612|450368811|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
125203520|NCT02419612|450368812|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
125203521|NCT02419612|450368811|FG000|Long-term Treatment Period|Death|0|||
125203522|NCT02419612|450368812|FG001|Long-term Treatment Period|Death|1|||
125203523|NCT02419612|450368811|FG000|Long-term Treatment Period|Adverse Event|0|||
125203524|NCT02419612|450368812|FG001|Long-term Treatment Period|Adverse Event|5|||
125203525|NCT02419612|450368811|FG000|Long-term Treatment Period|Other|4|||
125203526|NCT02419612|450368812|FG001|Long-term Treatment Period|Other|4|||
125203527|NCT02419612|450368811|FG000|Long-term Treatment Period|Subject Decision|2|||
125203528|NCT02419612|450368812|FG001|Long-term Treatment Period|Subject Decision|4|||
125203529|NCT02419612|450368811|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
125203530|NCT02419612|450368812|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
125203531|NCT01095978|450368813|FG000|Overall Study|Did not take Klacid SR|2|||
125203532|NCT01095978|450368813|FG000|Overall Study|Adverse Event|1|||
125203533|NCT02135107|450368814|FG000|Treatment Period|Withdrawal by Subject|11|||
125203534|NCT02135107|450368815|FG001|Treatment Period|Withdrawal by Subject|0|||
125203535|NCT02135107|450368816|FG002|Treatment Period|Withdrawal by Subject|0|||
125203536|NCT02135107|450368817|FG003|Treatment Period|Withdrawal by Subject|0|||
125203537|NCT02135107|450368814|FG000|Treatment Period|Adverse Event|5|||
125203538|NCT02135107|450368815|FG001|Treatment Period|Adverse Event|2|||
125203539|NCT02135107|450368816|FG002|Treatment Period|Adverse Event|0|||
125203540|NCT02135107|450368817|FG003|Treatment Period|Adverse Event|0|||
125203541|NCT02135107|450368814|FG000|Treatment Period|Pregnancy|1|||
125203542|NCT02135107|450368815|FG001|Treatment Period|Pregnancy|0|||
125203543|NCT02135107|450368816|FG002|Treatment Period|Pregnancy|0|||
125203544|NCT02135107|450368817|FG003|Treatment Period|Pregnancy|0|||
125203545|NCT02135107|450368814|FG000|Treatment Period|Other|115|||
125203546|NCT02135107|450368815|FG001|Treatment Period|Other|24|||
125203547|NCT02135107|450368816|FG002|Treatment Period|Other|0|||
125203548|NCT02135107|450368817|FG003|Treatment Period|Other|0|||
125203549|NCT02135107|450368814|FG000|Maintenance Therapy Period|Adverse Event|0|||
125203550|NCT02135107|450368815|FG001|Maintenance Therapy Period|Adverse Event|0|||
124979044|NCT01099215|449549872|FG000|Overall Study|Withdrawal by Subject|1|||
124979045|NCT01099215|449549873|FG001|Overall Study|Withdrawal by Subject|0|||
124979046|NCT01099215|449549872|FG000|Overall Study|Adverse Event|0|||
124979047|NCT01099215|449549873|FG001|Overall Study|Adverse Event|1|||
124979048|NCT00747227|449549875|FG000|Overall Study|Death|3|||
124979049|NCT00747227|449549876|FG001|Overall Study|Death|1|||
124979050|NCT00747227|449549875|FG000|Overall Study|Withdrawal by Subject|1|||
124979051|NCT00747227|449549876|FG001|Overall Study|Withdrawal by Subject|0|||
124979052|NCT00747227|449549875|FG000|Overall Study|Lost to Follow-up|1|||
124979053|NCT00747227|449549876|FG001|Overall Study|Lost to Follow-up|2|||
124979054|NCT00747227|449549875|FG000|Overall Study|Illness|1|||
124979055|NCT00747227|449549876|FG001|Overall Study|Illness|1|||
124979056|NCT03554629|449549877|FG000|Overall Study|Inadequate data|6|||
124979057|NCT00515671|449549886|FG000|Overall Study|Lost to Follow-up|13|||
124979058|NCT00515671|449549887|FG001|Overall Study|Lost to Follow-up|10|||
124979059|NCT00515671|449549886|FG000|Overall Study|Withdrawal by Subject|3|||
124979060|NCT00515671|449549887|FG001|Overall Study|Withdrawal by Subject|5|||
124979061|NCT00515671|449549886|FG000|Overall Study|incarcerated|1|||
124979062|NCT00515671|449549887|FG001|Overall Study|incarcerated|2|||
124979063|NCT00288639|449549890|FG000|Overall Study|Adverse Event|5|||
124979064|NCT00288639|449549890|FG000|Overall Study|Lack of Efficacy|4|||
124979065|NCT00288639|449549890|FG000|Overall Study|Withdrawal by Subject|2|||
124979066|NCT00288639|449549890|FG000|Overall Study|Other|1|||
124979067|NCT01014208|449549899|FG000|Overall Study|Lost to Follow-up|2|||
124979068|NCT01014208|449549900|FG001|Overall Study|Lost to Follow-up|5|||
124979069|NCT01014208|449549899|FG000|Overall Study|Participant Withdrew Consent|12|||
124979070|NCT01014208|449549900|FG001|Overall Study|Participant Withdrew Consent|12|||
124979071|NCT01014208|449549899|FG000|Overall Study|Did Not Receive Study Drug|2|||
124979072|NCT01014208|449549900|FG001|Overall Study|Did Not Receive Study Drug|0|||
124979073|NCT01014208|449549899|FG000|Overall Study|Study Closed/terminated|78|||
124979074|NCT01014208|449549900|FG001|Overall Study|Study Closed/terminated|83|||
124979075|NCT04165031|449549901|FG000|Overall Study|Adverse Event|1|||
124979076|NCT04165031|449549902|FG001|Overall Study|Adverse Event|1|||
124979077|NCT04165031|449549903|FG002|Overall Study|Adverse Event|0|||
124979078|NCT04165031|449549904|FG003|Overall Study|Adverse Event|0|||
124979079|NCT04165031|449549905|FG004|Overall Study|Adverse Event|0|||
124979080|NCT04165031|449549906|FG005|Overall Study|Adverse Event|0|||
124979081|NCT04165031|449549901|FG000|Overall Study|Withdrawal by Subject|0|||
124979082|NCT04165031|449549902|FG001|Overall Study|Withdrawal by Subject|0|||
124979083|NCT04165031|449549903|FG002|Overall Study|Withdrawal by Subject|1|||
124979084|NCT04165031|449549904|FG003|Overall Study|Withdrawal by Subject|0|||
125203551|NCT02135107|450368816|FG002|Maintenance Therapy Period|Adverse Event|3|||
125203552|NCT02135107|450368817|FG003|Maintenance Therapy Period|Adverse Event|7|||
125203553|NCT02135107|450368814|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
125203554|NCT02135107|450368815|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
124979085|NCT04165031|449549905|FG004|Overall Study|Withdrawal by Subject|0|||
124979086|NCT04165031|449549906|FG005|Overall Study|Withdrawal by Subject|0|||
124979087|NCT01332630|449549909|FG000|Overall Study|Withdrawal by Subject|3|||
124979088|NCT03140280|449549910|FG000|Overall Study|Physician Decision|5|||
124979089|NCT00663702|449549919|FG000|Overall Study|Adverse Event|8|||
124979090|NCT00663702|449549920|FG001|Overall Study|Adverse Event|4|||
124979091|NCT00663702|449549919|FG000|Overall Study|Withdrawal by Subject|3|||
124979092|NCT00663702|449549920|FG001|Overall Study|Withdrawal by Subject|1|||
124979093|NCT00663702|449549919|FG000|Overall Study|Pregnancy|0|||
124979094|NCT00663702|449549920|FG001|Overall Study|Pregnancy|1|||
124979095|NCT00663702|449549919|FG000|Overall Study|Lost to Follow-up|3|||
124979096|NCT00663702|449549920|FG001|Overall Study|Lost to Follow-up|0|||
124979097|NCT00663702|449549919|FG000|Overall Study|Death|1|||
124979098|NCT00663702|449549920|FG001|Overall Study|Death|1|||
124979099|NCT00663702|449549919|FG000|Overall Study|Lack of Efficacy|3|||
124979100|NCT00663702|449549920|FG001|Overall Study|Lack of Efficacy|3|||
124979101|NCT01498887|449549921|FG000|Overall Study|Administrative problems|1|||
124979102|NCT01498887|449549922|FG001|Overall Study|Administrative problems|0|||
124979103|NCT01498887|449549921|FG000|Overall Study|Lost to Follow-up|1|||
124979104|NCT01498887|449549922|FG001|Overall Study|Lost to Follow-up|1|||
125203555|NCT02135107|450368816|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
125203556|NCT02135107|450368817|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
125203557|NCT02135107|450368814|FG000|Maintenance Therapy Period|Pregnancy|0|||
125203558|NCT02135107|450368815|FG001|Maintenance Therapy Period|Pregnancy|0|||
124979105|NCT01498887|449549921|FG000|Overall Study|Withdrawal by Subject|1|||
124979106|NCT01498887|449549922|FG001|Overall Study|Withdrawal by Subject|0|||
124979107|NCT01498887|449549921|FG000|Overall Study|Protocol Violation|1|||
124979108|NCT01498887|449549922|FG001|Overall Study|Protocol Violation|3|||
124979109|NCT01498887|449549921|FG000|Overall Study|Lack of Efficacy|5|||
124979110|NCT01498887|449549922|FG001|Overall Study|Lack of Efficacy|3|||
124979111|NCT01498887|449549921|FG000|Overall Study|Abnormal result from test procedure|1|||
124979112|NCT01498887|449549922|FG001|Overall Study|Abnormal result from test procedure|1|||
124979113|NCT01498887|449549921|FG000|Overall Study|Abnormal laboratory value|2|||
125203559|NCT02135107|450368816|FG002|Maintenance Therapy Period|Pregnancy|0|||
125203560|NCT02135107|450368817|FG003|Maintenance Therapy Period|Pregnancy|1|||
125203561|NCT02135107|450368814|FG000|Maintenance Therapy Period|Other|0|||
125203562|NCT02135107|450368815|FG001|Maintenance Therapy Period|Other|0|||
125203563|NCT02135107|450368816|FG002|Maintenance Therapy Period|Other|7|||
125203564|NCT02135107|450368817|FG003|Maintenance Therapy Period|Other|8|||
125203565|NCT00474045|450368818|FG000|Overall Study|Adverse Event|18|||
125203566|NCT00474045|450368819|FG001|Overall Study|Adverse Event|8|||
125203567|NCT00474045|450368818|FG000|Overall Study|Unclassified|1|||
125203568|NCT00474045|450368819|FG001|Overall Study|Unclassified|3|||
125203569|NCT00474045|450368818|FG000|Overall Study|Lack of Efficacy|0|||
125203570|NCT00474045|450368819|FG001|Overall Study|Lack of Efficacy|9|||
125203571|NCT00474045|450368818|FG000|Overall Study|Lost to Follow-up|1|||
125203572|NCT00474045|450368819|FG001|Overall Study|Lost to Follow-up|1|||
125203573|NCT00474045|450368818|FG000|Overall Study|Protocol Violation|10|||
125203574|NCT00474045|450368819|FG001|Overall Study|Protocol Violation|12|||
125203575|NCT00474045|450368818|FG000|Overall Study|Withdrawal by Subject|16|||
125203576|NCT00474045|450368819|FG001|Overall Study|Withdrawal by Subject|18|||
125203577|NCT00474045|450368818|FG000|Overall Study|Withdrawal criteria|60|||
125203578|NCT00474045|450368819|FG001|Overall Study|Withdrawal criteria|50|||
125203579|NCT02009397|450368827|FG000|Overall Study|Protocol Violation|6|||
125203580|NCT02009397|450368827|FG000|Overall Study|Death|8|||
125203581|NCT02009397|450368827|FG000|Overall Study|Lost to Follow-up|6|||
125203582|NCT02278120|450368829|FG000|Treatment Period|Progressive disease|234|||
125203583|NCT02278120|450368830|FG001|Treatment Period|Progressive disease|260|||
125203584|NCT02278120|450368829|FG000|Treatment Period|Subject/guardian decision|23|||
125203585|NCT02278120|450368830|FG001|Treatment Period|Subject/guardian decision|20|||
125203586|NCT02278120|450368829|FG000|Treatment Period|Adverse Event|16|||
125203587|NCT02278120|450368830|FG001|Treatment Period|Adverse Event|14|||
125203588|NCT02278120|450368829|FG000|Treatment Period|Physician Decision|14|||
125203589|NCT02278120|450368830|FG001|Treatment Period|Physician Decision|27|||
125203590|NCT02278120|450368829|FG000|Treatment Period|Death|3|||
125203591|NCT02278120|450368830|FG001|Treatment Period|Death|3|||
125203592|NCT02278120|450368829|FG000|Treatment Period|Lost to Follow-up|2|||
125203593|NCT02278120|450368830|FG001|Treatment Period|Lost to Follow-up|0|||
125203594|NCT02278120|450368829|FG000|Treatment Period|Protocol deviation|0|||
125203595|NCT02278120|450368830|FG001|Treatment Period|Protocol deviation|2|||
125203596|NCT02278120|450368829|FG000|Treatment Period|Study terminated as per protocol|43|||
125203597|NCT02278120|450368830|FG001|Treatment Period|Study terminated as per protocol|11|||
125203598|NCT02278120|450368829|FG000|Post-treatment Efficacy Follow-up|Death|0|||
125203599|NCT02278120|450368830|FG001|Post-treatment Efficacy Follow-up|Death|1|||
125203600|NCT02278120|450368829|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
125203601|NCT02278120|450368830|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
125203602|NCT02278120|450368829|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
125203603|NCT02278120|450368830|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
125203604|NCT02278120|450368829|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
125203605|NCT02278120|450368830|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
125203606|NCT02278120|450368829|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
125203607|NCT02278120|450368830|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
125203608|NCT01966068|450368834|FG000|Overall Study|Withdrawal by Subject|57|||
125203609|NCT01966068|450368834|FG000|Overall Study|Lost to Follow-up|81|||
125203610|NCT00808639|450368837|FG000|Overall Study|Disease progression before surgery.|1|||
125203611|NCT00191282|450368842|FG000|Overall Study|Adverse Event|5|||
125203612|NCT00191282|450368843|FG001|Overall Study|Adverse Event|6|||
125203613|NCT00191282|450368842|FG000|Overall Study|Death|51|||
125203614|NCT00191282|450368843|FG001|Overall Study|Death|51|||
125203615|NCT00191282|450368842|FG000|Overall Study|Lack of Efficacy|11|||
125203616|NCT00191282|450368843|FG001|Overall Study|Lack of Efficacy|6|||
125203617|NCT00191282|450368842|FG000|Overall Study|Noncompliance|14|||
125203618|NCT00191282|450368843|FG001|Overall Study|Noncompliance|17|||
125203619|NCT00191282|450368842|FG000|Overall Study|Patient moved|11|||
125203620|NCT00191282|450368843|FG001|Overall Study|Patient moved|14|||
125203621|NCT00191282|450368842|FG000|Overall Study|Withdrawal by Subject|59|||
125203622|NCT00191282|450368843|FG001|Overall Study|Withdrawal by Subject|44|||
125203623|NCT00191282|450368842|FG000|Overall Study|Physician Decision|18|||
125203624|NCT00191282|450368843|FG001|Overall Study|Physician Decision|15|||
125203625|NCT00191282|450368842|FG000|Overall Study|Protocol entry criteria not met|14|||
125203626|NCT00191282|450368843|FG001|Overall Study|Protocol entry criteria not met|9|||
125203627|NCT00191282|450368842|FG000|Overall Study|Protocol Violation|9|||
125203628|NCT00191282|450368843|FG001|Overall Study|Protocol Violation|12|||
125203629|NCT00191282|450368842|FG000|Overall Study|Severity of outcome|2|||
125203630|NCT00191282|450368843|FG001|Overall Study|Severity of outcome|5|||
125203631|NCT00191282|450368842|FG000|Overall Study|Sponsor's decision|2|||
125203632|NCT00191282|450368843|FG001|Overall Study|Sponsor's decision|2|||
125203633|NCT00191282|450368842|FG000|Overall Study|Lost to Follow-up|24|||
125203634|NCT00191282|450368843|FG001|Overall Study|Lost to Follow-up|31|||
125203635|NCT00102531|450368844|FG000|Overall Study|Adverse Event|0|||
125203636|NCT00102531|450368845|FG001|Overall Study|Adverse Event|1|||
125203637|NCT00102531|450368844|FG000|Overall Study|Disease Progression|5|||
125203638|NCT00102531|450368845|FG001|Overall Study|Disease Progression|9|||
125203639|NCT00102531|450368844|FG000|Overall Study|Physician Decision|0|||
125203640|NCT00102531|450368845|FG001|Overall Study|Physician Decision|1|||
125203641|NCT04756154|450368847|FG000|Overall Study|Did not meet treatment day baseline|30|||
125203642|NCT04756154|450368848|FG001|Overall Study|Did not meet treatment day baseline|28|||
125203643|NCT04756154|450368849|FG002|Overall Study|Did not meet treatment day baseline|7|||
125203644|NCT04756154|450368847|FG000|Overall Study|Did not return for final sample collection|1|||
125203645|NCT04756154|450368848|FG001|Overall Study|Did not return for final sample collection|1|||
125203646|NCT04756154|450368849|FG002|Overall Study|Did not return for final sample collection|0|||
125203647|NCT01790828|450368851|FG000|Overall Study|Other|34|||
125203648|NCT03026530|450368856|FG000|Overall Study|Lost to Follow-up|19|||
125203649|NCT03026530|450368857|FG001|Overall Study|Lost to Follow-up|24|||
125203650|NCT03026530|450368856|FG000|Overall Study|Protocol Violation|2|||
125203651|NCT03026530|450368857|FG001|Overall Study|Protocol Violation|5|||
125203652|NCT03721835|450368858|FG000|Overall Study|Participant not able to return|1|||
125203653|NCT03721835|450368858|FG000|Overall Study|Lost to Follow-up|1|||
125203654|NCT03721835|450368858|FG000|Overall Study|Revision of the components of the study device|2|||
125203655|NCT03721835|450368858|FG000|Overall Study|Sponsor terminated study|6|||
125203656|NCT03721835|450368858|FG000|Overall Study|Death|1|||
125203657|NCT03721835|450368858|FG000|Overall Study|Sponsor decision|1|||
125203658|NCT05072964|450368863|FG000|Overall Study|Withdrawal by Subject|4|||
125203659|NCT05072964|450368863|FG000|Overall Study|Death|1|||
125203660|NCT03055494|450370218|FG000|Overall Study|Lost to Follow-up|6|||
125203661|NCT03055494|450370219|FG001|Overall Study|Lost to Follow-up|0|||
125203662|NCT03055494|450370218|FG000|Overall Study|Physician Decision|2|||
125203663|NCT03055494|450370219|FG001|Overall Study|Physician Decision|0|||
125203664|NCT03055494|450370218|FG000|Overall Study|Withdrawal by Subject|1|||
125203665|NCT03055494|450370219|FG001|Overall Study|Withdrawal by Subject|0|||
125203666|NCT03055494|450370218|FG000|Overall Study|Adverse Event|0|||
125203667|NCT03055494|450370219|FG001|Overall Study|Adverse Event|1|||
125203668|NCT03055494|450370218|FG000|Overall Study|Non-compliance with study treatment|1|||
125203669|NCT03055494|450370219|FG001|Overall Study|Non-compliance with study treatment|0|||
125203670|NCT05079750|450370220|FG000|Overall Study|Lost to Follow-up|0|||
125203671|NCT05079750|450370221|FG001|Overall Study|Lost to Follow-up|0|||
125203672|NCT05079750|450370222|FG002|Overall Study|Lost to Follow-up|1|||
125203673|NCT05897827|450370223|FG000|Overall Study|Lost to Follow-up|33|||
125203674|NCT05897827|450370224|FG001|Overall Study|Lost to Follow-up|14|||
125203675|NCT05897827|450370223|FG000|Overall Study|Withdrawal by Subject|1|||
125203676|NCT05897827|450370224|FG001|Overall Study|Withdrawal by Subject|1|||
125203677|NCT00197002|450370225|FG000|Overall Study|Adverse Event|0|||
125203678|NCT00197002|450370226|FG001|Overall Study|Adverse Event|1|||
125203679|NCT00197002|450370227|FG002|Overall Study|Adverse Event|0|||
125203680|NCT00197002|450370225|FG000|Overall Study|Protocol Violation|1|||
125203681|NCT00197002|450370226|FG001|Overall Study|Protocol Violation|0|||
125203682|NCT00197002|450370227|FG002|Overall Study|Protocol Violation|2|||
125203683|NCT00197002|450370225|FG000|Overall Study|Withdrawal by Subject|9|||
125203684|NCT00197002|450370226|FG001|Overall Study|Withdrawal by Subject|5|||
125203685|NCT00197002|450370227|FG002|Overall Study|Withdrawal by Subject|7|||
125203686|NCT00197002|450370225|FG000|Overall Study|Migrated/moved from study area|3|||
125203687|NCT00197002|450370226|FG001|Overall Study|Migrated/moved from study area|5|||
125203688|NCT00197002|450370227|FG002|Overall Study|Migrated/moved from study area|1|||
125203689|NCT00197002|450370225|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
125203690|NCT00197002|450370226|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
125203691|NCT00197002|450370227|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
125203692|NCT00197002|450370225|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
125203693|NCT00197002|450370226|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
125203694|NCT00197002|450370227|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
125203695|NCT00197002|450370225|FG000|Overall Study|Others|3|||
125203696|NCT00197002|450370226|FG001|Overall Study|Others|1|||
125203697|NCT00197002|450370227|FG002|Overall Study|Others|1|||
125203698|NCT02017717|450370228|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
125203699|NCT02017717|450370229|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
125203700|NCT02017717|450370230|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
125203701|NCT02017717|450370231|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
125203702|NCT02017717|450370232|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
125203703|NCT02017717|450370233|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
125203704|NCT02017717|450370234|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
125203705|NCT02017717|450370235|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
125203706|NCT02017717|450370236|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
125203707|NCT02017717|450370228|FG000|Before Treatment Period|Participant request to stop therapy|0|||
125203708|NCT02017717|450370229|FG001|Before Treatment Period|Participant request to stop therapy|0|||
125203709|NCT02017717|450370230|FG002|Before Treatment Period|Participant request to stop therapy|0|||
125203710|NCT02017717|450370231|FG003|Before Treatment Period|Participant request to stop therapy|0|||
125203711|NCT02017717|450370232|FG004|Before Treatment Period|Participant request to stop therapy|0|||
125203712|NCT02017717|450370233|FG005|Before Treatment Period|Participant request to stop therapy|0|||
125203713|NCT02017717|450370234|FG006|Before Treatment Period|Participant request to stop therapy|0|||
125203714|NCT02017717|450370235|FG007|Before Treatment Period|Participant request to stop therapy|0|||
125203715|NCT02017717|450370236|FG008|Before Treatment Period|Participant request to stop therapy|5|||
125203716|NCT02017717|450370228|FG000|Before Treatment Period|Participant withdrew consent|0|||
125203717|NCT02017717|450370229|FG001|Before Treatment Period|Participant withdrew consent|0|||
125203718|NCT02017717|450370230|FG002|Before Treatment Period|Participant withdrew consent|0|||
125203719|NCT02017717|450370231|FG003|Before Treatment Period|Participant withdrew consent|0|||
125203720|NCT02017717|450370232|FG004|Before Treatment Period|Participant withdrew consent|0|||
125203721|NCT02017717|450370233|FG005|Before Treatment Period|Participant withdrew consent|0|||
125203722|NCT02017717|450370234|FG006|Before Treatment Period|Participant withdrew consent|2|||
125203723|NCT02017717|450370235|FG007|Before Treatment Period|Participant withdrew consent|0|||
125203724|NCT02017717|450370236|FG008|Before Treatment Period|Participant withdrew consent|11|||
125203725|NCT02017717|450370228|FG000|Before Treatment Period|Lost to Follow-up|0|||
125203726|NCT02017717|450370229|FG001|Before Treatment Period|Lost to Follow-up|0|||
125203727|NCT02017717|450370230|FG002|Before Treatment Period|Lost to Follow-up|0|||
125203728|NCT02017717|450370231|FG003|Before Treatment Period|Lost to Follow-up|0|||
125203729|NCT02017717|450370232|FG004|Before Treatment Period|Lost to Follow-up|0|||
125203730|NCT02017717|450370233|FG005|Before Treatment Period|Lost to Follow-up|0|||
125203731|NCT02017717|450370234|FG006|Before Treatment Period|Lost to Follow-up|0|||
125203732|NCT02017717|450370235|FG007|Before Treatment Period|Lost to Follow-up|0|||
125203733|NCT02017717|450370236|FG008|Before Treatment Period|Lost to Follow-up|1|||
125203734|NCT02017717|450370228|FG000|Before Treatment Period|Participant no longer met criteria|0|||
125203735|NCT02017717|450370229|FG001|Before Treatment Period|Participant no longer met criteria|0|||
125203736|NCT02017717|450370230|FG002|Before Treatment Period|Participant no longer met criteria|0|||
125203737|NCT02017717|450370231|FG003|Before Treatment Period|Participant no longer met criteria|0|||
125203738|NCT02017717|450370232|FG004|Before Treatment Period|Participant no longer met criteria|0|||
125203739|NCT02017717|450370233|FG005|Before Treatment Period|Participant no longer met criteria|1|||
125203740|NCT02017717|450370234|FG006|Before Treatment Period|Participant no longer met criteria|0|||
125203741|NCT02017717|450370235|FG007|Before Treatment Period|Participant no longer met criteria|1|||
125203742|NCT02017717|450370236|FG008|Before Treatment Period|Participant no longer met criteria|2|||
125203743|NCT02017717|450370228|FG000|Before Treatment Period|other reason|0|||
125203744|NCT02017717|450370229|FG001|Before Treatment Period|other reason|0|||
125203745|NCT02017717|450370230|FG002|Before Treatment Period|other reason|0|||
125203746|NCT02017717|450370231|FG003|Before Treatment Period|other reason|0|||
125203747|NCT02017717|450370232|FG004|Before Treatment Period|other reason|0|||
125203748|NCT02017717|450370233|FG005|Before Treatment Period|other reason|0|||
125203749|NCT02017717|450370234|FG006|Before Treatment Period|other reason|0|||
125203750|NCT02017717|450370235|FG007|Before Treatment Period|other reason|0|||
125203751|NCT02017717|450370236|FG008|Before Treatment Period|other reason|1|||
125203752|NCT02017717|450370228|FG000|Treatment Period|Disease progression|7|||
125203753|NCT02017717|450370229|FG001|Treatment Period|Disease progression|9|||
125203754|NCT02017717|450370230|FG002|Treatment Period|Disease progression|12|||
125203755|NCT02017717|450370231|FG003|Treatment Period|Disease progression|20|||
125203756|NCT02017717|450370232|FG004|Treatment Period|Disease progression|26|||
125203757|NCT02017717|450370233|FG005|Treatment Period|Disease progression|16|||
125203758|NCT02017717|450370234|FG006|Treatment Period|Disease progression|22|||
125203759|NCT02017717|450370235|FG007|Treatment Period|Disease progression|165|||
125203760|NCT02017717|450370236|FG008|Treatment Period|Disease progression|135|||
125203761|NCT02017717|450370228|FG000|Treatment Period|Study drug toxicity|3|||
125203762|NCT02017717|450370229|FG001|Treatment Period|Study drug toxicity|0|||
125203763|NCT02017717|450370230|FG002|Treatment Period|Study drug toxicity|1|||
125203764|NCT02017717|450370231|FG003|Treatment Period|Study drug toxicity|4|||
125203765|NCT02017717|450370232|FG004|Treatment Period|Study drug toxicity|4|||
125203766|NCT02017717|450370233|FG005|Treatment Period|Study drug toxicity|5|||
125203767|NCT02017717|450370234|FG006|Treatment Period|Study drug toxicity|3|||
125203768|NCT02017717|450370235|FG007|Treatment Period|Study drug toxicity|7|||
125203769|NCT02017717|450370236|FG008|Treatment Period|Study drug toxicity|11|||
125203770|NCT02017717|450370228|FG000|Treatment Period|Death|0|||
125203771|NCT02017717|450370229|FG001|Treatment Period|Death|0|||
125203772|NCT02017717|450370230|FG002|Treatment Period|Death|1|||
125203773|NCT02017717|450370231|FG003|Treatment Period|Death|0|||
125203774|NCT02017717|450370232|FG004|Treatment Period|Death|0|||
125203775|NCT02017717|450370233|FG005|Treatment Period|Death|2|||
125203776|NCT02017717|450370234|FG006|Treatment Period|Death|0|||
125203777|NCT02017717|450370235|FG007|Treatment Period|Death|0|||
125203778|NCT02017717|450370236|FG008|Treatment Period|Death|0|||
125203779|NCT02017717|450370228|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
125203780|NCT02017717|450370229|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
125203781|NCT02017717|450370230|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
125203782|NCT02017717|450370231|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
125203783|NCT02017717|450370232|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
125203784|NCT02017717|450370233|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
125203785|NCT02017717|450370234|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
125203786|NCT02017717|450370235|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
125203787|NCT02017717|450370236|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
125203788|NCT02017717|450370228|FG000|Treatment Period|Participant request to stop therapy|0|||
125203789|NCT02017717|450370229|FG001|Treatment Period|Participant request to stop therapy|0|||
125203790|NCT02017717|450370230|FG002|Treatment Period|Participant request to stop therapy|3|||
125203791|NCT02017717|450370231|FG003|Treatment Period|Participant request to stop therapy|6|||
125203792|NCT02017717|450370232|FG004|Treatment Period|Participant request to stop therapy|0|||
125203793|NCT02017717|450370233|FG005|Treatment Period|Participant request to stop therapy|2|||
125203794|NCT02017717|450370234|FG006|Treatment Period|Participant request to stop therapy|1|||
125203795|NCT02017717|450370235|FG007|Treatment Period|Participant request to stop therapy|4|||
125203796|NCT02017717|450370236|FG008|Treatment Period|Participant request to stop therapy|7|||
125203797|NCT02017717|450370228|FG000|Treatment Period|Participant withdrew consent|0|||
125203798|NCT02017717|450370229|FG001|Treatment Period|Participant withdrew consent|0|||
125203799|NCT02017717|450370230|FG002|Treatment Period|Participant withdrew consent|1|||
125203800|NCT02017717|450370231|FG003|Treatment Period|Participant withdrew consent|0|||
125203801|NCT02017717|450370232|FG004|Treatment Period|Participant withdrew consent|0|||
125203802|NCT02017717|450370233|FG005|Treatment Period|Participant withdrew consent|2|||
125203803|NCT02017717|450370234|FG006|Treatment Period|Participant withdrew consent|0|||
125203804|NCT02017717|450370235|FG007|Treatment Period|Participant withdrew consent|1|||
125203805|NCT02017717|450370236|FG008|Treatment Period|Participant withdrew consent|4|||
125203806|NCT02017717|450370228|FG000|Treatment Period|Participant no longer met criteria|0|||
125203807|NCT02017717|450370229|FG001|Treatment Period|Participant no longer met criteria|0|||
125203808|NCT02017717|450370230|FG002|Treatment Period|Participant no longer met criteria|0|||
125203809|NCT02017717|450370231|FG003|Treatment Period|Participant no longer met criteria|0|||
125203810|NCT02017717|450370232|FG004|Treatment Period|Participant no longer met criteria|0|||
125203811|NCT02017717|450370233|FG005|Treatment Period|Participant no longer met criteria|0|||
125203812|NCT02017717|450370234|FG006|Treatment Period|Participant no longer met criteria|0|||
125203813|NCT02017717|450370235|FG007|Treatment Period|Participant no longer met criteria|0|||
125203814|NCT02017717|450370236|FG008|Treatment Period|Participant no longer met criteria|1|||
125203815|NCT02017717|450370228|FG000|Treatment Period|Other reasons|0|||
125203816|NCT02017717|450370229|FG001|Treatment Period|Other reasons|0|||
125203817|NCT02017717|450370230|FG002|Treatment Period|Other reasons|0|||
125203818|NCT02017717|450370231|FG003|Treatment Period|Other reasons|1|||
125203819|NCT02017717|450370232|FG004|Treatment Period|Other reasons|0|||
125203820|NCT02017717|450370233|FG005|Treatment Period|Other reasons|1|||
125203821|NCT02017717|450370234|FG006|Treatment Period|Other reasons|1|||
125203822|NCT02017717|450370235|FG007|Treatment Period|Other reasons|1|||
125203823|NCT02017717|450370236|FG008|Treatment Period|Other reasons|1|||
125203824|NCT02017717|450370228|FG000|Treatment Period|Maximum clinical benefit|0|||
125203825|NCT02017717|450370229|FG001|Treatment Period|Maximum clinical benefit|0|||
124979114|NCT01498887|449549922|FG001|Overall Study|Abnormal laboratory value|2|||
125203826|NCT02017717|450370230|FG002|Treatment Period|Maximum clinical benefit|0|||
125203827|NCT02017717|450370231|FG003|Treatment Period|Maximum clinical benefit|0|||
125203828|NCT02017717|450370232|FG004|Treatment Period|Maximum clinical benefit|0|||
125203829|NCT02017717|450370233|FG005|Treatment Period|Maximum clinical benefit|0|||
125203830|NCT02017717|450370234|FG006|Treatment Period|Maximum clinical benefit|0|||
125203831|NCT02017717|450370235|FG007|Treatment Period|Maximum clinical benefit|0|||
125203832|NCT02017717|450370236|FG008|Treatment Period|Maximum clinical benefit|1|||
125203833|NCT02017717|450370228|FG000|Treatment Period|Not reported|0|||
125203834|NCT02017717|450370229|FG001|Treatment Period|Not reported|1|||
125203835|NCT02017717|450370230|FG002|Treatment Period|Not reported|0|||
125203836|NCT02017717|450370231|FG003|Treatment Period|Not reported|0|||
125203837|NCT02017717|450370232|FG004|Treatment Period|Not reported|0|||
125203838|NCT02017717|450370233|FG005|Treatment Period|Not reported|0|||
125203839|NCT02017717|450370234|FG006|Treatment Period|Not reported|0|||
125203840|NCT02017717|450370235|FG007|Treatment Period|Not reported|0|||
124979115|NCT01498887|449549921|FG000|Overall Study|Adverse Event|4|||
124979116|NCT01498887|449549922|FG001|Overall Study|Adverse Event|1|||
125203841|NCT02017717|450370236|FG008|Treatment Period|Not reported|0|||
124979117|NCT00667225|449549925|FG000|Overall Study|Subject had no more lesions to treat.|1|||
125203842|NCT04488419|450370241|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
125203843|NCT04488419|450370242|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
125203844|NCT04488419|450370243|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
125203845|NCT04488419|450370241|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
125203846|NCT04488419|450370242|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
125203847|NCT04488419|450370243|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
125203848|NCT04488419|450370241|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
125203849|NCT04488419|450370242|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
125203850|NCT04488419|450370243|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
125203851|NCT04488419|450370241|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
125203852|NCT04488419|450370242|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
125203853|NCT04488419|450370243|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
125203854|NCT04488419|450370241|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
125203855|NCT04488419|450370242|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
125203856|NCT04488419|450370243|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
125203857|NCT04488419|450370241|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
125203858|NCT04488419|450370242|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
125203859|NCT04488419|450370243|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
125203860|NCT04488419|450370241|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
125203861|NCT04488419|450370242|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
125203862|NCT04488419|450370243|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
125203863|NCT04488419|450370241|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
125203864|NCT04488419|450370242|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
125203865|NCT04488419|450370243|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
125203866|NCT04488419|450370241|FG000|Primary Analysis Population|Adverse Event|6|||
125203867|NCT04488419|450370242|FG001|Primary Analysis Population|Adverse Event|9|||
125203868|NCT04488419|450370243|FG002|Primary Analysis Population|Adverse Event|0|||
125203869|NCT04488419|450370241|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
125203870|NCT04488419|450370242|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
125203871|NCT04488419|450370243|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
125203872|NCT04488419|450370241|FG000|Primary Analysis Population|Protocol Violation|1|||
125203873|NCT04488419|450370242|FG001|Primary Analysis Population|Protocol Violation|1|||
125203874|NCT04488419|450370243|FG002|Primary Analysis Population|Protocol Violation|0|||
125203875|NCT04488419|450370241|FG000|Primary Analysis Population|Undetermined|7|||
125203876|NCT04488419|450370242|FG001|Primary Analysis Population|Undetermined|3|||
125203877|NCT04488419|450370243|FG002|Primary Analysis Population|Undetermined|0|||
125203878|NCT04488419|450370241|FG000|Primary Analysis Population|>1 Reason|2|||
125203879|NCT04488419|450370242|FG001|Primary Analysis Population|>1 Reason|4|||
125203880|NCT04488419|450370243|FG002|Primary Analysis Population|>1 Reason|0|||
125203881|NCT02276053|450370246|FG000|Overall Study|Death|2|||
125203882|NCT02276053|450370246|FG000|Overall Study|Adverse Event|5|||
125203883|NCT02276053|450370246|FG000|Overall Study|Lack of Efficacy|2|||
125203884|NCT02276053|450370246|FG000|Overall Study|Withdrawal by Subject|1|||
125203885|NCT02276053|450370246|FG000|Overall Study|Patient does not meet selection criteria|3|||
125203886|NCT02276053|450370246|FG000|Overall Study|Patient needs to increase baseline AED|1|||
125203887|NCT04542499|450370249|FG000|Overall Study|Adverse Event|23|||
125203888|NCT04542499|450370250|FG001|Overall Study|Adverse Event|43|||
125203889|NCT04542499|450370249|FG000|Overall Study|Lack of Efficacy|5|||
125203890|NCT04542499|450370250|FG001|Overall Study|Lack of Efficacy|2|||
125203891|NCT04542499|450370249|FG000|Overall Study|Lost to Follow-up|3|||
125203892|NCT04542499|450370250|FG001|Overall Study|Lost to Follow-up|4|||
125203893|NCT04542499|450370249|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
125203894|NCT04542499|450370250|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
125203895|NCT04542499|450370249|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
125203896|NCT04542499|450370250|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
125203897|NCT04542499|450370249|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125203898|NCT04542499|450370250|FG001|Overall Study|Non-Compliance with Study Drug|2|||
125203899|NCT04542499|450370249|FG000|Overall Study|Physician Decision|0|||
125203900|NCT04542499|450370250|FG001|Overall Study|Physician Decision|1|||
125203901|NCT04542499|450370249|FG000|Overall Study|Site Terminated by Sponsor|3|||
125203902|NCT04542499|450370250|FG001|Overall Study|Site Terminated by Sponsor|5|||
125203903|NCT04542499|450370249|FG000|Overall Study|Withdrawal by Subject|12|||
125203904|NCT04542499|450370250|FG001|Overall Study|Withdrawal by Subject|33|||
125203905|NCT04542499|450370249|FG000|Overall Study|Other|2|||
125203906|NCT04542499|450370250|FG001|Overall Study|Other|2|||
125203907|NCT04161079|450370255|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
125203908|NCT03427268|450370259|FG000|Overall Study|Progressive disease|25|||
125203909|NCT03427268|450370259|FG000|Overall Study|Never treated|2|||
125203910|NCT03427268|450370259|FG000|Overall Study|Compassionate use|1|||
125203911|NCT03427268|450370259|FG000|Overall Study|Withdrawal by Subject|1|||
125203912|NCT03427268|450370259|FG000|Overall Study|Adverse Event|3|||
125203913|NCT03391232|450370260|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
125089787|NCT01117428|449947025|FG002|Overall Study|Death|2|||
125203914|NCT03391232|450370261|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
125203915|NCT03391232|450370260|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
125203916|NCT03391232|450370261|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
125203917|NCT01995175|450370262|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
125203918|NCT01995175|450370262|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
125203919|NCT01995175|450370262|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
125203920|NCT01995175|450370262|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
125203921|NCT01995175|450370262|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
125203922|NCT01995175|450370262|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
125203923|NCT01995175|450370262|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
125203924|NCT01995175|450370262|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
125203925|NCT01995175|450370262|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
125203926|NCT03047720|450370266|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
125203927|NCT03047720|450370267|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
125203928|NCT03729570|450370272|FG000|Overall Study|Lost to Follow-up|16|||
125203929|NCT03729570|450370273|FG001|Overall Study|Lost to Follow-up|20|||
125203930|NCT03729570|450370272|FG000|Overall Study|Seroconversion|5|||
125203931|NCT03729570|450370273|FG001|Overall Study|Seroconversion|0|||
125203932|NCT03729570|450370272|FG000|Overall Study|Moved out of the city|1|||
125203933|NCT03729570|450370273|FG001|Overall Study|Moved out of the city|0|||
125203934|NCT03729570|450370272|FG000|Overall Study|Time Conflict|1|||
125203935|NCT03729570|450370273|FG001|Overall Study|Time Conflict|0|||
125203936|NCT03729570|450370272|FG000|Overall Study|Time Commitment|2|||
125203937|NCT03729570|450370273|FG001|Overall Study|Time Commitment|0|||
125203938|NCT03729570|450370272|FG000|Overall Study|Bad Experience|0|||
125203939|NCT03729570|450370273|FG001|Overall Study|Bad Experience|1|||
125203940|NCT03729570|450370272|FG000|Overall Study|No reason provided|2|||
125203941|NCT03729570|450370273|FG001|Overall Study|No reason provided|1|||
125203942|NCT03729570|450370272|FG000|Overall Study|Family Conflict|0|||
125203943|NCT03729570|450370273|FG001|Overall Study|Family Conflict|1|||
125203944|NCT03729570|450370272|FG000|Overall Study|Did not want to continue taking medications|0|||
125203945|NCT03729570|450370273|FG001|Overall Study|Did not want to continue taking medications|1|||
125203946|NCT03729570|450370272|FG000|Overall Study|Found another PrEP provider|1|||
125203947|NCT03729570|450370273|FG001|Overall Study|Found another PrEP provider|0|||
125203948|NCT03729570|450370272|FG000|Overall Study|Did not enjoy being in the control group|0|||
125203949|NCT03729570|450370273|FG001|Overall Study|Did not enjoy being in the control group|1|||
125203950|NCT01482962|450370277|FG000|Overall Study|Progressive Disease|65|||
125203951|NCT01482962|450370278|FG001|Overall Study|Progressive Disease|53|||
125203952|NCT01482962|450370277|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
125203953|NCT01482962|450370278|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
125203954|NCT01482962|450370277|FG000|Overall Study|Adverse Event|18|||
125203955|NCT01482962|450370278|FG001|Overall Study|Adverse Event|22|||
125203956|NCT01482962|450370277|FG000|Overall Study|Withdrawal by Participant|8|||
125203957|NCT01482962|450370278|FG001|Overall Study|Withdrawal by Participant|13|||
125203958|NCT01482962|450370277|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
125203959|NCT01482962|450370278|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
125203960|NCT01482962|450370277|FG000|Overall Study|Other Reason|1|||
125203961|NCT01482962|450370278|FG001|Overall Study|Other Reason|5|||
125203962|NCT01482962|450370277|FG000|Overall Study|Study Terminated by Sponsor|5|||
125203963|NCT01482962|450370278|FG001|Overall Study|Study Terminated by Sponsor|2|||
125203964|NCT01482962|450370277|FG000|Overall Study|Did not Receive Study Drug|1|||
125203965|NCT01482962|450370278|FG001|Overall Study|Did not Receive Study Drug|6|||
125203966|NCT02407457|450370279|FG000|1 Month|Death|3|||
125203967|NCT02407457|450370280|FG001|1 Month|Death|0|||
125203968|NCT02407457|450370279|FG000|1 Month|Lost to Follow-up|1|||
125203969|NCT02407457|450370280|FG001|1 Month|Lost to Follow-up|1|||
125203970|NCT02407457|450370279|FG000|1 Month|missed visit|2|||
125203971|NCT02407457|450370280|FG001|1 Month|missed visit|5|||
125203972|NCT02407457|450370279|FG000|6-Month|Death|2|||
125203973|NCT02407457|450370280|FG001|6-Month|Death|8|||
125203974|NCT02407457|450370279|FG000|6-Month|Lost to Follow-up|2|||
125203975|NCT02407457|450370280|FG001|6-Month|Lost to Follow-up|2|||
125203976|NCT02407457|450370279|FG000|6-Month|missed visit|16|||
125203977|NCT02407457|450370280|FG001|6-Month|missed visit|14|||
125203978|NCT02407457|450370279|FG000|6-Month|Open Repair|0|||
125203979|NCT02407457|450370280|FG001|6-Month|Open Repair|1|||
125203980|NCT02407457|450370279|FG000|1 Year|Death|6|||
125203981|NCT02407457|450370280|FG001|1 Year|Death|11|||
125203982|NCT02407457|450370279|FG000|1 Year|Lost to Follow-up|3|||
125203983|NCT02407457|450370280|FG001|1 Year|Lost to Follow-up|2|||
125203984|NCT02407457|450370279|FG000|1 Year|Missed Visit|24|||
125203985|NCT02407457|450370280|FG001|1 Year|Missed Visit|14|||
125203986|NCT02407457|450370279|FG000|1 Year|Open Repair|0|||
125203987|NCT02407457|450370280|FG001|1 Year|Open Repair|1|||
125203988|NCT02407457|450370279|FG000|2-year|Death|14|||
125203989|NCT02407457|450370280|FG001|2-year|Death|8|||
125203990|NCT02407457|450370279|FG000|2-year|Lost to Follow-up|7|||
125203991|NCT02407457|450370280|FG001|2-year|Lost to Follow-up|10|||
125203992|NCT02407457|450370279|FG000|2-year|Missed Visit|13|||
125203993|NCT02407457|450370280|FG001|2-year|Missed Visit|15|||
125203994|NCT02407457|450370279|FG000|2-year|Open Repair|0|||
125203995|NCT02407457|450370280|FG001|2-year|Open Repair|2|||
125203996|NCT02407457|450370279|FG000|3-year|Death|11|||
125203997|NCT02407457|450370280|FG001|3-year|Death|10|||
125203998|NCT02407457|450370279|FG000|3-year|Lost to Follow-up|9|||
125203999|NCT02407457|450370280|FG001|3-year|Lost to Follow-up|10|||
125204000|NCT02407457|450370279|FG000|3-year|Missed Visit|19|||
125204001|NCT02407457|450370280|FG001|3-year|Missed Visit|16|||
125204002|NCT02407457|450370279|FG000|4-year|Death|18|||
125204003|NCT02407457|450370280|FG001|4-year|Death|10|||
125204004|NCT02407457|450370279|FG000|4-year|Lost to Follow-up|10|||
125204005|NCT02407457|450370280|FG001|4-year|Lost to Follow-up|12|||
125204006|NCT02407457|450370279|FG000|4-year|Missed Visit|18|||
125204007|NCT02407457|450370280|FG001|4-year|Missed Visit|16|||
125204008|NCT02407457|450370279|FG000|5-year|Death|10|||
125204009|NCT02407457|450370280|FG001|5-year|Death|3|||
125204010|NCT02407457|450370279|FG000|5-year|Lost to Follow-up|22|||
125204011|NCT02407457|450370280|FG001|5-year|Lost to Follow-up|13|||
125204012|NCT02407457|450370279|FG000|5-year|Missed Visit|9|||
125204013|NCT02407457|450370280|FG001|5-year|Missed Visit|1|||
125204014|NCT04495816|450370281|FG000|Overall Study|Lost to Follow-up|10|||
125204015|NCT04495816|450370282|FG001|Overall Study|Lost to Follow-up|4|||
125204016|NCT04495816|450370281|FG000|Overall Study|Withdrawal by Subject|3|||
125204017|NCT04495816|450370282|FG001|Overall Study|Withdrawal by Subject|5|||
125204018|NCT00558896|450370283|FG000|Overall Study|Adverse Event|1|||
125204019|NCT00558896|450370284|FG001|Overall Study|Adverse Event|1|||
125204020|NCT00558896|450370285|FG002|Overall Study|Adverse Event|1|||
125204021|NCT00558896|450370286|FG003|Overall Study|Adverse Event|3|||
125204022|NCT00558896|450370287|FG004|Overall Study|Adverse Event|4|||
125204023|NCT00558896|450370288|FG005|Overall Study|Adverse Event|10|||
125204024|NCT00558896|450370289|FG006|Overall Study|Adverse Event|3|||
125204025|NCT00558896|450370283|FG000|Overall Study|Death|3|||
125204026|NCT00558896|450370284|FG001|Overall Study|Death|0|||
125204027|NCT00558896|450370285|FG002|Overall Study|Death|2|||
125204028|NCT00558896|450370286|FG003|Overall Study|Death|3|||
125204029|NCT00558896|450370287|FG004|Overall Study|Death|2|||
125204030|NCT00558896|450370288|FG005|Overall Study|Death|2|||
125204031|NCT00558896|450370289|FG006|Overall Study|Death|6|||
125204032|NCT00558896|450370283|FG000|Overall Study|Withdrawal by Subject|2|||
125204033|NCT00558896|450370284|FG001|Overall Study|Withdrawal by Subject|1|||
125204034|NCT00558896|450370285|FG002|Overall Study|Withdrawal by Subject|1|||
125204035|NCT00558896|450370286|FG003|Overall Study|Withdrawal by Subject|1|||
125204036|NCT00558896|450370287|FG004|Overall Study|Withdrawal by Subject|1|||
125204037|NCT00558896|450370288|FG005|Overall Study|Withdrawal by Subject|5|||
125204038|NCT00558896|450370289|FG006|Overall Study|Withdrawal by Subject|5|||
125204039|NCT00558896|450370283|FG000|Overall Study|Alternative Treatment|2|||
125204040|NCT00558896|450370284|FG001|Overall Study|Alternative Treatment|2|||
125204041|NCT00558896|450370285|FG002|Overall Study|Alternative Treatment|0|||
125204042|NCT00558896|450370286|FG003|Overall Study|Alternative Treatment|2|||
125204043|NCT00558896|450370287|FG004|Overall Study|Alternative Treatment|6|||
125204044|NCT00558896|450370288|FG005|Overall Study|Alternative Treatment|7|||
125204045|NCT00558896|450370289|FG006|Overall Study|Alternative Treatment|1|||
125204046|NCT00558896|450370283|FG000|Overall Study|Physician discretion|3|||
125204047|NCT00558896|450370284|FG001|Overall Study|Physician discretion|2|||
125204048|NCT00558896|450370285|FG002|Overall Study|Physician discretion|1|||
125204049|NCT00558896|450370286|FG003|Overall Study|Physician discretion|2|||
125204050|NCT00558896|450370287|FG004|Overall Study|Physician discretion|1|||
125204051|NCT00558896|450370288|FG005|Overall Study|Physician discretion|3|||
125204052|NCT00558896|450370289|FG006|Overall Study|Physician discretion|3|||
125204053|NCT00558896|450370283|FG000|Overall Study|Continues on treatment|10|||
125204054|NCT00558896|450370284|FG001|Overall Study|Continues on treatment|1|||
125204055|NCT00558896|450370285|FG002|Overall Study|Continues on treatment|0|||
125204056|NCT00558896|450370286|FG003|Overall Study|Continues on treatment|1|||
125204057|NCT00558896|450370287|FG004|Overall Study|Continues on treatment|9|||
125204058|NCT00558896|450370288|FG005|Overall Study|Continues on treatment|25|||
125204059|NCT00558896|450370289|FG006|Overall Study|Continues on treatment|6|||
125204060|NCT04329091|450370292|FG000|Overall Study|Physician Decision|5|||
125204061|NCT01527487|450370293|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
125204062|NCT01527487|450370294|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
125204063|NCT01527487|450370293|FG000|Overall Study|Disease Progression|4|||
125204064|NCT01527487|450370294|FG001|Overall Study|Disease Progression|1|||
125204065|NCT01527487|450370293|FG000|Overall Study|Adverse Event|1|||
125204066|NCT01527487|450370294|FG001|Overall Study|Adverse Event|1|||
125204067|NCT01527487|450370293|FG000|Overall Study|Death|0|||
125204068|NCT01527487|450370294|FG001|Overall Study|Death|1|||
125204069|NCT02258542|450370301|FG000|Overall Study|eg. not made to the visit|7|||
125204070|NCT02258542|450370302|FG001|Overall Study|eg. not made to the visit|4|||
125204071|NCT02258542|450370303|FG002|Overall Study|eg. not made to the visit|0|||
125204072|NCT02258542|450370304|FG003|Overall Study|eg. not made to the visit|1|||
125204073|NCT02258542|450370301|FG000|Overall Study|study specific discount. criteria|1|||
125204074|NCT02258542|450370302|FG001|Overall Study|study specific discount. criteria|1|||
125204075|NCT02258542|450370303|FG002|Overall Study|study specific discount. criteria|0|||
125204076|NCT02258542|450370304|FG003|Overall Study|study specific discount. criteria|0|||
125204077|NCT02258542|450370301|FG000|Overall Study|Withdrawal by Subject|20|||
125204078|NCT02258542|450370302|FG001|Overall Study|Withdrawal by Subject|20|||
125204079|NCT02258542|450370303|FG002|Overall Study|Withdrawal by Subject|7|||
125204080|NCT02258542|450370304|FG003|Overall Study|Withdrawal by Subject|1|||
125204081|NCT02258542|450370301|FG000|Overall Study|Lost to Follow-up|5|||
125204082|NCT02258542|450370302|FG001|Overall Study|Lost to Follow-up|12|||
125204083|NCT02258542|450370303|FG002|Overall Study|Lost to Follow-up|1|||
125204084|NCT02258542|450370304|FG003|Overall Study|Lost to Follow-up|2|||
125204085|NCT02258542|450370301|FG000|Overall Study|Death|5|||
125204086|NCT02258542|450370302|FG001|Overall Study|Death|4|||
125204087|NCT02258542|450370303|FG002|Overall Study|Death|0|||
125204088|NCT02258542|450370304|FG003|Overall Study|Death|1|||
125204089|NCT02258542|450370301|FG000|Overall Study|Adverse Event|3|||
125204090|NCT02258542|450370302|FG001|Overall Study|Adverse Event|4|||
125204091|NCT02258542|450370303|FG002|Overall Study|Adverse Event|0|||
125204092|NCT02258542|450370304|FG003|Overall Study|Adverse Event|0|||
125204093|NCT02258542|450370301|FG000|Overall Study|Protocol Violation|1|||
125204094|NCT02258542|450370302|FG001|Overall Study|Protocol Violation|2|||
125204095|NCT02258542|450370303|FG002|Overall Study|Protocol Violation|0|||
125204096|NCT02258542|450370304|FG003|Overall Study|Protocol Violation|0|||
125204097|NCT02258542|450370301|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125204098|NCT02258542|450370302|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
125204099|NCT02258542|450370303|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
125204100|NCT02258542|450370304|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
125204101|NCT00986986|450370305|FG000|Overall Study|Lost to Follow-up|0|||
125204102|NCT00986986|450370306|FG001|Overall Study|Lost to Follow-up|1|||
125204103|NCT03589976|450370313|FG000|Overall Study|Death|5|||
125204104|NCT03589976|450370314|FG001|Overall Study|Death|1|||
125204105|NCT03589976|450370313|FG000|Overall Study|Adverse Event|5|||
125204106|NCT03589976|450370314|FG001|Overall Study|Adverse Event|1|||
125204107|NCT03589976|450370313|FG000|Overall Study|Withdrawal by Subject|4|||
125204108|NCT03589976|450370314|FG001|Overall Study|Withdrawal by Subject|1|||
125204109|NCT03589976|450370313|FG000|Overall Study|Lost to Follow-up|1|||
125204110|NCT03589976|450370314|FG001|Overall Study|Lost to Follow-up|0|||
125204111|NCT03589976|450370313|FG000|Overall Study|Other|4|||
125204112|NCT03589976|450370314|FG001|Overall Study|Other|3|||
125204113|NCT00514904|450370315|FG000|Overall Study|Withdrawal by Subject|3|||
125204114|NCT00514904|450370316|FG001|Overall Study|Withdrawal by Subject|2|||
125204115|NCT00514904|450370315|FG000|Overall Study|Lost to Follow-up|21|||
125204116|NCT00514904|450370316|FG001|Overall Study|Lost to Follow-up|3|||
125204117|NCT03430895|450370317|FG000|Overall Study|Not Treated|2|||
125204118|NCT00084318|450370318|FG000|Overall Study|Withdrawal by Subject|5|||
125204119|NCT00084318|450370319|FG001|Overall Study|Withdrawal by Subject|2|||
125204120|NCT00084318|450370318|FG000|Overall Study|Protocol Violation|15|||
125204121|NCT00084318|450370319|FG001|Overall Study|Protocol Violation|11|||
125204122|NCT00084318|450370318|FG000|Overall Study|No protocol treatment|2|||
125204123|NCT00084318|450370319|FG001|Overall Study|No protocol treatment|0|||
125204124|NCT01317797|450370322|FG000|Overall Study|Other|0|||
125204125|NCT01317797|450370323|FG001|Overall Study|Other|1|||
125204126|NCT01317797|450370324|FG002|Overall Study|Other|0|||
125204127|NCT01317797|450370322|FG000|Overall Study|Withdrawal of Patient|0|||
125204128|NCT01317797|450370323|FG001|Overall Study|Withdrawal of Patient|0|||
124979118|NCT00667225|449549926|FG001|Overall Study|Subject had no more lesions to treat.|0|||
125204129|NCT01317797|450370324|FG002|Overall Study|Withdrawal of Patient|1|||
124979119|NCT00667225|449549925|FG000|Overall Study|Lost to Follow-up|0|||
124979120|NCT00667225|449549926|FG001|Overall Study|Lost to Follow-up|1|||
124979121|NCT02993406|449549927|FG000|Overall Study|Withdrawal by Subject|170|||
124979122|NCT02993406|449549928|FG001|Overall Study|Withdrawal by Subject|196|||
125204130|NCT01645891|450370329|FG000|Overall Study|Adverse Event|6|||
124979123|NCT02993406|449549927|FG000|Overall Study|Physician Decision|3|||
124979124|NCT02993406|449549928|FG001|Overall Study|Physician Decision|5|||
125204131|NCT01645891|450370330|FG001|Overall Study|Adverse Event|10|||
125204132|NCT01645891|450370329|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
125204133|NCT01645891|450370330|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
125204134|NCT01645891|450370329|FG000|Overall Study|Withdrawal by Subject|3|||
124979125|NCT02993406|449549927|FG000|Overall Study|Lost to Follow-up|12|||
125204135|NCT01645891|450370330|FG001|Overall Study|Withdrawal by Subject|3|||
125204136|NCT01645891|450370329|FG000|Overall Study|Protocol Violation|4|||
125204137|NCT01645891|450370330|FG001|Overall Study|Protocol Violation|0|||
125204138|NCT01645891|450370329|FG000|Overall Study|Lost to Follow-up|4|||
125204139|NCT01645891|450370330|FG001|Overall Study|Lost to Follow-up|1|||
125204140|NCT01645891|450370329|FG000|Overall Study|Death|0|||
125204141|NCT01645891|450370330|FG001|Overall Study|Death|2|||
125204142|NCT00138073|450370333|FG000|Overall Study|lack of resources|55|||
125204143|NCT03301740|450370334|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
125204144|NCT03301740|450370335|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
125204145|NCT03301740|450370334|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
125204146|NCT03301740|450370335|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
125204147|NCT02342548|450370341|FG000|Overall Study|Adverse Event|12|||
124979126|NCT02993406|449549928|FG001|Overall Study|Lost to Follow-up|13|||
124979127|NCT02993406|449549927|FG000|Overall Study|Unclassifiable Response|105|||
124979128|NCT02993406|449549928|FG001|Overall Study|Unclassifiable Response|139|||
124979129|NCT02993406|449549927|FG000|Overall Study|Administrative decision|1|||
124979130|NCT02993406|449549928|FG001|Overall Study|Administrative decision|0|||
124979131|NCT02993406|449549927|FG000|Overall Study|Sponsor decision|4|||
124979132|NCT02993406|449549928|FG001|Overall Study|Sponsor decision|5|||
124979133|NCT02248818|449549929|FG000|Screening|Protocol Violation|0|||
124979134|NCT02248818|449549930|FG001|Screening|Protocol Violation|0|||
124979135|NCT02248818|449549931|FG002|Screening|Protocol Violation|0|||
124979136|NCT02248818|449549932|FG003|Screening|Protocol Violation|0|||
124979137|NCT02248818|449549933|FG004|Screening|Protocol Violation|0|||
124979138|NCT02248818|449549934|FG005|Screening|Protocol Violation|0|||
124979139|NCT02248818|449549935|FG006|Screening|Protocol Violation|0|||
124979140|NCT02248818|449549936|FG007|Screening|Protocol Violation|0|||
124979141|NCT02248818|449549937|FG008|Screening|Protocol Violation|7|||
124979142|NCT02248818|449549929|FG000|Screening|Study fully enrolled|0|||
124979143|NCT02248818|449549930|FG001|Screening|Study fully enrolled|0|||
124979144|NCT02248818|449549931|FG002|Screening|Study fully enrolled|0|||
124979145|NCT02248818|449549932|FG003|Screening|Study fully enrolled|0|||
124979146|NCT02248818|449549933|FG004|Screening|Study fully enrolled|0|||
124979147|NCT02248818|449549934|FG005|Screening|Study fully enrolled|0|||
124979148|NCT02248818|449549935|FG006|Screening|Study fully enrolled|0|||
124979149|NCT02248818|449549936|FG007|Screening|Study fully enrolled|0|||
124979150|NCT02248818|449549937|FG008|Screening|Study fully enrolled|14|||
124979151|NCT02248818|449549929|FG000|Screening|Physician Decision|0|||
124979152|NCT02248818|449549930|FG001|Screening|Physician Decision|0|||
124979153|NCT02248818|449549931|FG002|Screening|Physician Decision|0|||
124979154|NCT02248818|449549932|FG003|Screening|Physician Decision|0|||
124979155|NCT02248818|449549933|FG004|Screening|Physician Decision|0|||
124979156|NCT02248818|449549934|FG005|Screening|Physician Decision|0|||
125204148|NCT02342548|450370342|FG001|Overall Study|Adverse Event|17|||
125204149|NCT02342548|450370343|FG002|Overall Study|Adverse Event|13|||
125204150|NCT02342548|450370341|FG000|Overall Study|Lost to Follow-up|0|||
125204151|NCT02342548|450370342|FG001|Overall Study|Lost to Follow-up|1|||
125204152|NCT02342548|450370343|FG002|Overall Study|Lost to Follow-up|0|||
125204153|NCT02342548|450370341|FG000|Overall Study|Study terminated by sponsor|20|||
125204154|NCT02342548|450370342|FG001|Overall Study|Study terminated by sponsor|39|||
125204155|NCT02342548|450370343|FG002|Overall Study|Study terminated by sponsor|25|||
125204156|NCT02342548|450370341|FG000|Overall Study|Protocol Violation|0|||
124979157|NCT02248818|449549935|FG006|Screening|Physician Decision|0|||
124979158|NCT02248818|449549936|FG007|Screening|Physician Decision|0|||
124979159|NCT02248818|449549937|FG008|Screening|Physician Decision|73|||
124979160|NCT02248818|449549929|FG000|Screening|Withdrawal by Subject|0|||
124979161|NCT02248818|449549930|FG001|Screening|Withdrawal by Subject|0|||
124979162|NCT02248818|449549931|FG002|Screening|Withdrawal by Subject|0|||
124979163|NCT02248818|449549932|FG003|Screening|Withdrawal by Subject|0|||
124979164|NCT02248818|449549933|FG004|Screening|Withdrawal by Subject|0|||
124979165|NCT02248818|449549934|FG005|Screening|Withdrawal by Subject|0|||
124979166|NCT02248818|449549935|FG006|Screening|Withdrawal by Subject|0|||
124979167|NCT02248818|449549936|FG007|Screening|Withdrawal by Subject|0|||
124979168|NCT02248818|449549937|FG008|Screening|Withdrawal by Subject|6|||
124979169|NCT02248818|449549929|FG000|Screening|Lost to Follow-up|0|||
124979170|NCT02248818|449549930|FG001|Screening|Lost to Follow-up|0|||
124979171|NCT02248818|449549931|FG002|Screening|Lost to Follow-up|0|||
124979172|NCT02248818|449549932|FG003|Screening|Lost to Follow-up|0|||
124979173|NCT02248818|449549933|FG004|Screening|Lost to Follow-up|0|||
124979174|NCT02248818|449549934|FG005|Screening|Lost to Follow-up|0|||
124979175|NCT02248818|449549935|FG006|Screening|Lost to Follow-up|0|||
124979176|NCT02248818|449549936|FG007|Screening|Lost to Follow-up|0|||
124979177|NCT02248818|449549937|FG008|Screening|Lost to Follow-up|7|||
124979178|NCT02248818|449549929|FG000|Randomised Study|Administrative - randomization error|0|||
124979179|NCT02248818|449549930|FG001|Randomised Study|Administrative - randomization error|0|||
124979180|NCT02248818|449549931|FG002|Randomised Study|Administrative - randomization error|0|||
124979181|NCT02248818|449549932|FG003|Randomised Study|Administrative - randomization error|0|||
124979182|NCT02248818|449549933|FG004|Randomised Study|Administrative - randomization error|0|||
124979183|NCT02248818|449549934|FG005|Randomised Study|Administrative - randomization error|8|||
124979184|NCT02248818|449549935|FG006|Randomised Study|Administrative - randomization error|0|||
124979185|NCT02248818|449549936|FG007|Randomised Study|Administrative - randomization error|0|||
124979186|NCT02248818|449549937|FG008|Randomised Study|Administrative - randomization error|0|||
124979187|NCT05262517|449549938|FG000|Overall Study|Randomized but not treated|5|||
125204157|NCT02342548|450370342|FG001|Overall Study|Protocol Violation|1|||
125204158|NCT02342548|450370343|FG002|Overall Study|Protocol Violation|0|||
125204159|NCT02342548|450370341|FG000|Overall Study|Withdrawal by Subject|1|||
125204160|NCT02342548|450370342|FG001|Overall Study|Withdrawal by Subject|3|||
124979188|NCT05262517|449549939|FG001|Overall Study|Randomized but not treated|11|||
124979189|NCT04325282|449549940|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
124979190|NCT04325282|449549941|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
124979191|NCT04325282|449549940|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
124979192|NCT04325282|449549941|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
124979193|NCT00527787|449549943|FG000|Overall Study|Adverse Event|14|||
124979194|NCT00527787|449549944|FG001|Overall Study|Adverse Event|24|||
124979195|NCT00527787|449549943|FG000|Overall Study|Withdrawal by Subject|13|||
124979196|NCT00527787|449549944|FG001|Overall Study|Withdrawal by Subject|25|||
124979197|NCT00527787|449549943|FG000|Overall Study|Lost to Follow-up|5|||
124979198|NCT00527787|449549944|FG001|Overall Study|Lost to Follow-up|2|||
124979199|NCT00527787|449549943|FG000|Overall Study|Duodenal Ulcer|1|||
124979200|NCT00527787|449549944|FG001|Overall Study|Duodenal Ulcer|10|||
124979201|NCT00527787|449549943|FG000|Overall Study|misc|5|||
124979202|NCT00527787|449549944|FG001|Overall Study|misc|2|||
124979203|NCT03330405|449549945|FG000|Overall Study|Other|1|||
124979204|NCT03330405|449549946|FG001|Overall Study|Other|3|||
124979205|NCT03330405|449549947|FG002|Overall Study|Other|1|||
124979206|NCT03330405|449549948|FG003|Overall Study|Other|0|||
124979207|NCT03330405|449549949|FG004|Overall Study|Other|2|||
124979208|NCT03330405|449549950|FG005|Overall Study|Other|0|||
124979209|NCT03330405|449549951|FG006|Overall Study|Other|1|||
124979210|NCT03330405|449549952|FG007|Overall Study|Other|0|||
124979211|NCT03330405|449549953|FG008|Overall Study|Other|0|||
124979212|NCT03330405|449549954|FG009|Overall Study|Other|0|||
124979213|NCT03330405|449549955|FG010|Overall Study|Other|0|||
124979214|NCT03330405|449549945|FG000|Overall Study|Progressive disease|8|||
124979215|NCT03330405|449549946|FG001|Overall Study|Progressive disease|27|||
124979216|NCT03330405|449549947|FG002|Overall Study|Progressive disease|4|||
124979217|NCT03330405|449549948|FG003|Overall Study|Progressive disease|18|||
124979218|NCT03330405|449549949|FG004|Overall Study|Progressive disease|16|||
124979219|NCT03330405|449549950|FG005|Overall Study|Progressive disease|14|||
124979220|NCT03330405|449549951|FG006|Overall Study|Progressive disease|7|||
124979221|NCT03330405|449549952|FG007|Overall Study|Progressive disease|29|||
124979222|NCT03330405|449549953|FG008|Overall Study|Progressive disease|9|||
124979223|NCT03330405|449549954|FG009|Overall Study|Progressive disease|11|||
124979224|NCT03330405|449549955|FG010|Overall Study|Progressive disease|5|||
124979225|NCT03330405|449549945|FG000|Overall Study|Withdrawal by Subject|1|||
124979226|NCT03330405|449549946|FG001|Overall Study|Withdrawal by Subject|4|||
124979227|NCT03330405|449549947|FG002|Overall Study|Withdrawal by Subject|0|||
124979228|NCT03330405|449549948|FG003|Overall Study|Withdrawal by Subject|1|||
124979229|NCT03330405|449549949|FG004|Overall Study|Withdrawal by Subject|1|||
124979230|NCT03330405|449549950|FG005|Overall Study|Withdrawal by Subject|1|||
124979231|NCT03330405|449549951|FG006|Overall Study|Withdrawal by Subject|0|||
124979232|NCT03330405|449549952|FG007|Overall Study|Withdrawal by Subject|2|||
124979233|NCT03330405|449549953|FG008|Overall Study|Withdrawal by Subject|2|||
124979234|NCT03330405|449549954|FG009|Overall Study|Withdrawal by Subject|1|||
124979235|NCT03330405|449549955|FG010|Overall Study|Withdrawal by Subject|1|||
124979236|NCT03330405|449549945|FG000|Overall Study|Global deterioration of health status|2|||
124979237|NCT03330405|449549946|FG001|Overall Study|Global deterioration of health status|3|||
124979238|NCT03330405|449549947|FG002|Overall Study|Global deterioration of health status|0|||
124979239|NCT03330405|449549948|FG003|Overall Study|Global deterioration of health status|2|||
124979240|NCT03330405|449549949|FG004|Overall Study|Global deterioration of health status|3|||
124979241|NCT03330405|449549950|FG005|Overall Study|Global deterioration of health status|3|||
124979242|NCT03330405|449549951|FG006|Overall Study|Global deterioration of health status|0|||
124979243|NCT03330405|449549952|FG007|Overall Study|Global deterioration of health status|2|||
124979244|NCT03330405|449549953|FG008|Overall Study|Global deterioration of health status|8|||
124979245|NCT03330405|449549954|FG009|Overall Study|Global deterioration of health status|4|||
124979246|NCT03330405|449549955|FG010|Overall Study|Global deterioration of health status|1|||
124979247|NCT03330405|449549945|FG000|Overall Study|Adverse Event|0|||
124979248|NCT03330405|449549946|FG001|Overall Study|Adverse Event|1|||
124979249|NCT03330405|449549947|FG002|Overall Study|Adverse Event|0|||
125204161|NCT02342548|450370343|FG002|Overall Study|Withdrawal by Subject|4|||
124979250|NCT03330405|449549948|FG003|Overall Study|Adverse Event|1|||
125204162|NCT02342548|450370341|FG000|Overall Study|Other|1|||
124979251|NCT03330405|449549949|FG004|Overall Study|Adverse Event|1|||
124979252|NCT03330405|449549950|FG005|Overall Study|Adverse Event|1|||
124979253|NCT03330405|449549951|FG006|Overall Study|Adverse Event|3|||
124979254|NCT03330405|449549952|FG007|Overall Study|Adverse Event|4|||
124979255|NCT03330405|449549953|FG008|Overall Study|Adverse Event|2|||
124979256|NCT03330405|449549954|FG009|Overall Study|Adverse Event|2|||
124979257|NCT03330405|449549955|FG010|Overall Study|Adverse Event|2|||
124979258|NCT03330405|449549945|FG000|Overall Study|Death|0|||
124979259|NCT03330405|449549946|FG001|Overall Study|Death|4|||
124979260|NCT03330405|449549947|FG002|Overall Study|Death|0|||
124979261|NCT03330405|449549948|FG003|Overall Study|Death|0|||
125204163|NCT02342548|450370342|FG001|Overall Study|Other|1|||
124979262|NCT03330405|449549949|FG004|Overall Study|Death|0|||
124979263|NCT03330405|449549950|FG005|Overall Study|Death|1|||
124979264|NCT03330405|449549951|FG006|Overall Study|Death|0|||
124979265|NCT03330405|449549952|FG007|Overall Study|Death|2|||
124979266|NCT03330405|449549953|FG008|Overall Study|Death|0|||
124979267|NCT03330405|449549954|FG009|Overall Study|Death|0|||
124979268|NCT03330405|449549955|FG010|Overall Study|Death|0|||
124979269|NCT03330405|449549945|FG000|Overall Study|Physician Decision|0|||
124979270|NCT03330405|449549946|FG001|Overall Study|Physician Decision|0|||
124979271|NCT03330405|449549947|FG002|Overall Study|Physician Decision|0|||
124979272|NCT03330405|449549948|FG003|Overall Study|Physician Decision|0|||
124979273|NCT03330405|449549949|FG004|Overall Study|Physician Decision|0|||
124979274|NCT03330405|449549950|FG005|Overall Study|Physician Decision|0|||
124979275|NCT03330405|449549951|FG006|Overall Study|Physician Decision|0|||
124979276|NCT03330405|449549952|FG007|Overall Study|Physician Decision|1|||
124979277|NCT03330405|449549953|FG008|Overall Study|Physician Decision|0|||
124979278|NCT03330405|449549954|FG009|Overall Study|Physician Decision|0|||
124979279|NCT03330405|449549955|FG010|Overall Study|Physician Decision|0|||
124979280|NCT02643303|449549956|FG000|Overall Study|Progressive Disease|4|||
124979281|NCT02643303|449549957|FG001|Overall Study|Progressive Disease|4|||
124979282|NCT02643303|449549958|FG002|Overall Study|Progressive Disease|1|||
124979283|NCT02643303|449549959|FG003|Overall Study|Progressive Disease|12|||
124979284|NCT02643303|449549960|FG004|Overall Study|Progressive Disease|6|||
124979285|NCT02643303|449549961|FG005|Overall Study|Progressive Disease|4|||
124979286|NCT02643303|449549962|FG006|Overall Study|Progressive Disease|8|||
124979287|NCT02643303|449549963|FG007|Overall Study|Progressive Disease|2|||
124979288|NCT02643303|449549964|FG008|Overall Study|Progressive Disease|6|||
124979289|NCT02643303|449549956|FG000|Overall Study|Adverse Event|0|||
124979290|NCT02643303|449549957|FG001|Overall Study|Adverse Event|1|||
124979291|NCT02643303|449549958|FG002|Overall Study|Adverse Event|0|||
124979292|NCT02643303|449549959|FG003|Overall Study|Adverse Event|0|||
124979293|NCT02643303|449549960|FG004|Overall Study|Adverse Event|1|||
124979294|NCT02643303|449549961|FG005|Overall Study|Adverse Event|0|||
124979295|NCT02643303|449549962|FG006|Overall Study|Adverse Event|0|||
124979296|NCT02643303|449549963|FG007|Overall Study|Adverse Event|0|||
124979297|NCT02643303|449549964|FG008|Overall Study|Adverse Event|0|||
124979298|NCT02643303|449549956|FG000|Overall Study|Withdrawal by Subject|0|||
124979299|NCT02643303|449549957|FG001|Overall Study|Withdrawal by Subject|0|||
124979300|NCT02643303|449549958|FG002|Overall Study|Withdrawal by Subject|0|||
124979301|NCT02643303|449549959|FG003|Overall Study|Withdrawal by Subject|1|||
124979302|NCT02643303|449549960|FG004|Overall Study|Withdrawal by Subject|0|||
124979303|NCT02643303|449549961|FG005|Overall Study|Withdrawal by Subject|0|||
124979304|NCT02643303|449549962|FG006|Overall Study|Withdrawal by Subject|1|||
124979305|NCT02643303|449549963|FG007|Overall Study|Withdrawal by Subject|1|||
124979306|NCT02643303|449549964|FG008|Overall Study|Withdrawal by Subject|1|||
124979307|NCT01598662|449549967|FG000|Overall Study|Lost to Follow-up|10|||
124979308|NCT01598662|449549968|FG001|Overall Study|Lost to Follow-up|17|||
124979309|NCT01598662|449549967|FG000|Overall Study|Physician Decision|1|||
124979310|NCT01598662|449549968|FG001|Overall Study|Physician Decision|2|||
124979311|NCT01598662|449549967|FG000|Overall Study|IUD expelled before month 6|0|||
124979312|NCT01598662|449549968|FG001|Overall Study|IUD expelled before month 6|2|||
124979313|NCT03898167|449549969|FG000|Overall Study|Terminated phone call early|7|||
124979314|NCT03898167|449549970|FG001|Overall Study|Terminated phone call early|0|||
124979315|NCT03898167|449549971|FG002|Overall Study|Terminated phone call early|0|||
124979316|NCT03898167|449549969|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
124979317|NCT03898167|449549970|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
124979318|NCT03898167|449549971|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
124979319|NCT05177354|449549972|FG000|Implant to 30-day Visit|Physician Decision|1|||
124979320|NCT05177354|449549972|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
124979321|NCT05177354|449549972|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
124979322|NCT05177354|449549972|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
124979323|NCT03548220|449549974|FG000|Overall Study|Lost to Follow-up|1|||
124979324|NCT03548220|449549975|FG001|Overall Study|Lost to Follow-up|0|||
124979325|NCT03548220|449549976|FG002|Overall Study|Lost to Follow-up|0|||
124979326|NCT03548220|449549977|FG003|Overall Study|Lost to Follow-up|0|||
124979327|NCT02906007|449549978|FG000|Overall Study|Physician Decision|0|||
124979328|NCT02906007|449549979|FG001|Overall Study|Physician Decision|0|||
124979329|NCT02906007|449549980|FG002|Overall Study|Physician Decision|1|||
124979330|NCT02906007|449549978|FG000|Overall Study|Died|1|||
124979331|NCT02906007|449549979|FG001|Overall Study|Died|0|||
124979332|NCT02906007|449549980|FG002|Overall Study|Died|0|||
124979333|NCT01946529|449549983|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
124979334|NCT01946529|449549984|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
124979335|NCT01946529|449549985|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
124979336|NCT01946529|449549983|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
125204164|NCT02342548|450370343|FG002|Overall Study|Other|1|||
124979337|NCT01946529|449549984|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
125089788|NCT01117428|449947026|FG003|Overall Study|Death|0|||
124979338|NCT01946529|449549985|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
124979339|NCT06655558|449549989|FG000|Overall Study|Protocol Violation|1|||
124979340|NCT06748729|449549998|FG000|Overall Study|Withdrawal by Subject|1|||
124979341|NCT01253135|449551514|FG000|Original Protocol|Protocol Amendment|15|||
124979342|NCT01253135|449551514|FG000|Amended Protocol|Non-compliance|1|||
124979343|NCT01901432|449551519|FG000|Overall Study|Adverse Event|0|||
124979344|NCT01901432|449551520|FG001|Overall Study|Adverse Event|1|||
124979345|NCT01901432|449551521|FG002|Overall Study|Adverse Event|1|||
124979346|NCT01901432|449551522|FG003|Overall Study|Adverse Event|0|||
124979347|NCT01901432|449551523|FG004|Overall Study|Adverse Event|1|||
124979348|NCT01901432|449551519|FG000|Overall Study|Withdrawal by Subject|0|||
124979349|NCT01901432|449551520|FG001|Overall Study|Withdrawal by Subject|0|||
124979350|NCT01901432|449551521|FG002|Overall Study|Withdrawal by Subject|1|||
124979351|NCT01901432|449551522|FG003|Overall Study|Withdrawal by Subject|0|||
124979352|NCT01901432|449551523|FG004|Overall Study|Withdrawal by Subject|5|||
124979353|NCT01901432|449551519|FG000|Overall Study|Physician Decision|0|||
124979354|NCT01901432|449551520|FG001|Overall Study|Physician Decision|0|||
124979355|NCT01901432|449551521|FG002|Overall Study|Physician Decision|0|||
124979356|NCT01901432|449551522|FG003|Overall Study|Physician Decision|0|||
124979357|NCT01901432|449551523|FG004|Overall Study|Physician Decision|2|||
124979358|NCT01901432|449551519|FG000|Overall Study|Patient decision to stop study drug|0|||
124979359|NCT01901432|449551520|FG001|Overall Study|Patient decision to stop study drug|0|||
124979360|NCT01901432|449551521|FG002|Overall Study|Patient decision to stop study drug|0|||
124979361|NCT01901432|449551522|FG003|Overall Study|Patient decision to stop study drug|0|||
124979362|NCT01901432|449551523|FG004|Overall Study|Patient decision to stop study drug|1|||
124979363|NCT00379288|449551526|FG000|Overall Study|Adverse Event|5|||
124979364|NCT00379288|449551527|FG001|Overall Study|Adverse Event|6|||
124979365|NCT00379288|449551528|FG002|Overall Study|Adverse Event|2|||
124979366|NCT00379288|449551529|FG003|Overall Study|Adverse Event|0|||
124979367|NCT00379288|449551526|FG000|Overall Study|Treatment Failure|0|||
124979368|NCT00379288|449551527|FG001|Overall Study|Treatment Failure|1|||
124979369|NCT00379288|449551528|FG002|Overall Study|Treatment Failure|0|||
124979370|NCT00379288|449551529|FG003|Overall Study|Treatment Failure|1|||
124979371|NCT00379288|449551526|FG000|Overall Study|Lost to Follow-up|3|||
124979372|NCT00379288|449551527|FG001|Overall Study|Lost to Follow-up|3|||
124979373|NCT00379288|449551528|FG002|Overall Study|Lost to Follow-up|2|||
124979374|NCT00379288|449551529|FG003|Overall Study|Lost to Follow-up|0|||
124979375|NCT00379288|449551526|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
124979376|NCT00379288|449551527|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
124979377|NCT00379288|449551528|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
124979378|NCT00379288|449551529|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
124979379|NCT00379288|449551526|FG000|Overall Study|Subject withdrew-related to study drug|1|||
124979380|NCT00379288|449551527|FG001|Overall Study|Subject withdrew-related to study drug|0|||
124979381|NCT00379288|449551528|FG002|Overall Study|Subject withdrew-related to study drug|0|||
124979382|NCT00379288|449551529|FG003|Overall Study|Subject withdrew-related to study drug|1|||
124979383|NCT00379288|449551526|FG000|Overall Study|Noncompliance with protocol|8|||
124979384|NCT00379288|449551527|FG001|Overall Study|Noncompliance with protocol|6|||
124979385|NCT00379288|449551528|FG002|Overall Study|Noncompliance with protocol|2|||
124979386|NCT00379288|449551529|FG003|Overall Study|Noncompliance with protocol|1|||
124979387|NCT00379288|449551526|FG000|Overall Study|Did not meet protocol eligibility|0|||
124979388|NCT00379288|449551527|FG001|Overall Study|Did not meet protocol eligibility|1|||
124979389|NCT00379288|449551528|FG002|Overall Study|Did not meet protocol eligibility|0|||
124979390|NCT00379288|449551529|FG003|Overall Study|Did not meet protocol eligibility|2|||
124979391|NCT00379288|449551526|FG000|Overall Study|Administrative|2|||
124979392|NCT00379288|449551527|FG001|Overall Study|Administrative|2|||
124979393|NCT00379288|449551528|FG002|Overall Study|Administrative|0|||
124979394|NCT00379288|449551529|FG003|Overall Study|Administrative|1|||
124979395|NCT00918879|449551530|FG000|Overall Study|Withdrawal by Subject|4|||
124979396|NCT00918879|449551531|FG001|Overall Study|Withdrawal by Subject|4|||
124979397|NCT00918879|449551530|FG000|Overall Study|Lost to Follow-up|1|||
124979398|NCT00918879|449551531|FG001|Overall Study|Lost to Follow-up|1|||
124979399|NCT00918879|449551530|FG000|Overall Study|Severe non-compliance to protocol|1|||
125204165|NCT01047332|450370344|FG000|Overall Study|SEMS Obstruction|11|||
125204166|NCT01047332|450370345|FG001|Overall Study|SEMS Obstruction|20|||
124979400|NCT00918879|449551531|FG001|Overall Study|Severe non-compliance to protocol|1|||
124979401|NCT00833261|449551534|FG000|Overall Study|Withdrawal by Subject|4|||
124979402|NCT00357110|449551535|FG000|Overall Study|Early study termination|5|||
124979403|NCT00357110|449551536|FG001|Overall Study|Early study termination|5|||
124979404|NCT05602727|449551539|FG000|Overall Study|Physician Decision|0|||
124979405|NCT05602727|449551540|FG001|Overall Study|Physician Decision|1|||
124979406|NCT05602727|449551541|FG002|Overall Study|Physician Decision|0|||
124979407|NCT05602727|449551539|FG000|Overall Study|Randomized by mistake without study medication|1|||
124979408|NCT05602727|449551540|FG001|Overall Study|Randomized by mistake without study medication|0|||
124979409|NCT05602727|449551541|FG002|Overall Study|Randomized by mistake without study medication|0|||
125204167|NCT01047332|450370344|FG000|Overall Study|Died Unobstructed|38|||
124979410|NCT05602727|449551539|FG000|Overall Study|Study termination by Sponsor|18|||
124979411|NCT05602727|449551540|FG001|Overall Study|Study termination by Sponsor|15|||
124979412|NCT05602727|449551541|FG002|Overall Study|Study termination by Sponsor|19|||
124979413|NCT05602727|449551539|FG000|Overall Study|Withdrawal by Subject|2|||
124979414|NCT05602727|449551540|FG001|Overall Study|Withdrawal by Subject|1|||
124979415|NCT05602727|449551541|FG002|Overall Study|Withdrawal by Subject|1|||
124979416|NCT05602727|449551539|FG000|Overall Study|Various reasons|1|||
124979417|NCT05602727|449551540|FG001|Overall Study|Various reasons|6|||
124979418|NCT05602727|449551541|FG002|Overall Study|Various reasons|1|||
124979419|NCT01283152|449551544|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
124979420|NCT01283152|449551545|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
124979421|NCT01283152|449551544|FG000|Overall Study|Refused HESA|1|||
124979422|NCT01283152|449551545|FG001|Overall Study|Refused HESA|0|||
124979423|NCT04020185|449551550|FG000|Overall Study|Death|0|||
124979424|NCT04020185|449551551|FG001|Overall Study|Death|0|||
124979425|NCT04020185|449551552|FG002|Overall Study|Death|1|||
124979426|NCT04020185|449551553|FG003|Overall Study|Death|2|||
124979427|NCT04020185|449551554|FG004|Overall Study|Death|1|||
124979428|NCT04020185|449551555|FG005|Overall Study|Death|0|||
124979429|NCT04020185|449551556|FG006|Overall Study|Death|1|||
124979430|NCT04020185|449551557|FG007|Overall Study|Death|0|||
124979431|NCT04020185|449551550|FG000|Overall Study|Consent withdrawn|1|||
124979432|NCT04020185|449551551|FG001|Overall Study|Consent withdrawn|0|||
124979433|NCT04020185|449551552|FG002|Overall Study|Consent withdrawn|0|||
124979434|NCT04020185|449551553|FG003|Overall Study|Consent withdrawn|0|||
124979435|NCT04020185|449551554|FG004|Overall Study|Consent withdrawn|2|||
124979436|NCT04020185|449551555|FG005|Overall Study|Consent withdrawn|0|||
124979437|NCT04020185|449551556|FG006|Overall Study|Consent withdrawn|1|||
124979438|NCT04020185|449551557|FG007|Overall Study|Consent withdrawn|1|||
124979439|NCT04020185|449551550|FG000|Overall Study|Patient in hospice|0|||
124979440|NCT04020185|449551551|FG001|Overall Study|Patient in hospice|1|||
124979441|NCT04020185|449551552|FG002|Overall Study|Patient in hospice|0|||
124979442|NCT04020185|449551553|FG003|Overall Study|Patient in hospice|0|||
124979443|NCT04020185|449551554|FG004|Overall Study|Patient in hospice|0|||
124979444|NCT04020185|449551555|FG005|Overall Study|Patient in hospice|0|||
124979445|NCT04020185|449551556|FG006|Overall Study|Patient in hospice|0|||
124979446|NCT04020185|449551557|FG007|Overall Study|Patient in hospice|0|||
124979447|NCT04020185|449551550|FG000|Overall Study|Continuing on expanded access|0|||
124979448|NCT04020185|449551551|FG001|Overall Study|Continuing on expanded access|0|||
124979449|NCT04020185|449551552|FG002|Overall Study|Continuing on expanded access|0|||
124979450|NCT04020185|449551553|FG003|Overall Study|Continuing on expanded access|0|||
124979451|NCT04020185|449551554|FG004|Overall Study|Continuing on expanded access|0|||
124979452|NCT04020185|449551555|FG005|Overall Study|Continuing on expanded access|0|||
124979453|NCT04020185|449551556|FG006|Overall Study|Continuing on expanded access|1|||
124979454|NCT04020185|449551557|FG007|Overall Study|Continuing on expanded access|1|||
124979455|NCT03433677|449551559|FG000|Period 1|Protocol Violation|1|||
124979456|NCT03433677|449551560|FG001|Period 1|Protocol Violation|0|||
124979457|NCT03433677|449551559|FG000|Period 2|Withdrawal by Subject|1|||
124979458|NCT03433677|449551560|FG001|Period 2|Withdrawal by Subject|1|||
124979459|NCT01499303|449551565|FG000|Overall Study|Ongoing|2|||
124979460|NCT01499303|449551566|FG001|Overall Study|Ongoing|1|||
124979461|NCT01499303|449551565|FG000|Overall Study|Withdrawal by Subject|0|||
124979462|NCT01499303|449551566|FG001|Overall Study|Withdrawal by Subject|1|||
124979463|NCT01499303|449551565|FG000|Overall Study|Adverse Event|1|||
124979464|NCT01499303|449551566|FG001|Overall Study|Adverse Event|4|||
124979465|NCT01499303|449551565|FG000|Overall Study|Other|0|||
124979466|NCT01499303|449551566|FG001|Overall Study|Other|1|||
124979467|NCT04939701|449551569|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
124979468|NCT04939701|449551570|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
124979469|NCT04939701|449551571|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
124979470|NCT04939701|449551569|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
124979471|NCT04939701|449551570|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
124979472|NCT04939701|449551571|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
124979473|NCT04939701|449551569|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
124979474|NCT04939701|449551570|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
124979475|NCT04939701|449551571|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
124979476|NCT04939701|449551569|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
124979477|NCT04939701|449551570|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
124979478|NCT04939701|449551571|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
124979479|NCT04939701|449551569|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
124979480|NCT04939701|449551570|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
124979481|NCT04939701|449551571|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
124979482|NCT04939701|449551569|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
124979483|NCT04939701|449551570|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
124979484|NCT04939701|449551571|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
124979485|NCT04939701|449551569|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
124979486|NCT04939701|449551570|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
124979487|NCT04939701|449551571|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
124979488|NCT00565773|449551572|FG000|Overall Study|Withdrawal by Subject|1|||
124979489|NCT00565773|449551572|FG000|Overall Study|Physician Decision|1|||
124979490|NCT00702962|449551573|FG000|Overall Study|Progressive disease|0|||
124979491|NCT00702962|449551574|FG001|Overall Study|Progressive disease|1|||
124979492|NCT00702962|449551573|FG000|Overall Study|Hospitalized for other health disorder|1|||
124979493|NCT00702962|449551574|FG001|Overall Study|Hospitalized for other health disorder|0|||
124979494|NCT01923467|449551576|FG000|Overall Study|Lost to Follow-up|62|||
124979495|NCT01923467|449551576|FG000|Overall Study|Subject non-interest|479|||
124979496|NCT03015129|449551577|FG000|Overall Study|Death|2|||
124979497|NCT03015129|449551578|FG001|Overall Study|Death|2|||
124979498|NCT03015129|449551577|FG000|Overall Study|Lost to Follow-up|0|||
124979499|NCT03015129|449551578|FG001|Overall Study|Lost to Follow-up|1|||
124979500|NCT03015129|449551577|FG000|Overall Study|Progression of disease|38|||
124979501|NCT03015129|449551578|FG001|Overall Study|Progression of disease|33|||
124979502|NCT03015129|449551577|FG000|Overall Study|Adverse Event|0|||
124979503|NCT03015129|449551578|FG001|Overall Study|Adverse Event|4|||
124979504|NCT02242097|449551579|FG000|Ibrutinib Treatment|Adverse Event|16|||
124979505|NCT02242097|449551579|FG000|Ibrutinib Treatment|Physician Decision|1|||
124979506|NCT02242097|449551579|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
124979507|NCT02242097|449551579|FG000|Ibrutinib Treatment|Death|1|||
124979508|NCT02242097|449551579|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
124979509|NCT02242097|449551579|FG000|Post Therapy Follow Up|Death|3|||
124979510|NCT02242097|449551579|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
124979511|NCT01075958|449551580|FG000|Overall Study|Blood sample could not be obtained|44|||
124979512|NCT03733314|449551582|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
124979513|NCT03733314|449551583|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
124979514|NCT03733314|449551582|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
124979515|NCT03733314|449551583|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
124979516|NCT03733314|449551582|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
124979517|NCT03733314|449551583|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
124979518|NCT03733314|449551582|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
124979519|NCT03733314|449551583|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
124979520|NCT03733314|449551582|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
124979521|NCT03733314|449551583|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
124979522|NCT03733314|449551582|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
124979523|NCT03733314|449551583|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
124979524|NCT01240915|449551584|FG000|Overall Study|Adverse Event|0|||
124979525|NCT01240915|449551585|FG001|Overall Study|Adverse Event|0|||
124979526|NCT01240915|449551586|FG002|Overall Study|Adverse Event|0|||
124979527|NCT01240915|449551587|FG003|Overall Study|Adverse Event|1|||
124979528|NCT01240915|449551588|FG004|Overall Study|Adverse Event|0|||
124979529|NCT01240915|449551589|FG005|Overall Study|Adverse Event|2|||
124979530|NCT01240915|449551590|FG006|Overall Study|Adverse Event|0|||
124979531|NCT01240915|449551591|FG007|Overall Study|Adverse Event|0|||
124979532|NCT01240915|449551592|FG008|Overall Study|Adverse Event|1|||
124979533|NCT01240915|449551584|FG000|Overall Study|Lost to Follow-up|0|||
124979534|NCT01240915|449551585|FG001|Overall Study|Lost to Follow-up|0|||
124979535|NCT01240915|449551586|FG002|Overall Study|Lost to Follow-up|0|||
124979536|NCT01240915|449551587|FG003|Overall Study|Lost to Follow-up|0|||
124979537|NCT01240915|449551588|FG004|Overall Study|Lost to Follow-up|1|||
124979538|NCT01240915|449551589|FG005|Overall Study|Lost to Follow-up|1|||
124979539|NCT01240915|449551590|FG006|Overall Study|Lost to Follow-up|0|||
124979540|NCT01240915|449551591|FG007|Overall Study|Lost to Follow-up|1|||
124979541|NCT01240915|449551592|FG008|Overall Study|Lost to Follow-up|1|||
124979542|NCT01240915|449551584|FG000|Overall Study|Withdrawal by Subject|2|||
124979543|NCT01240915|449551585|FG001|Overall Study|Withdrawal by Subject|1|||
124979544|NCT01240915|449551586|FG002|Overall Study|Withdrawal by Subject|0|||
124979545|NCT01240915|449551587|FG003|Overall Study|Withdrawal by Subject|2|||
124979546|NCT01240915|449551588|FG004|Overall Study|Withdrawal by Subject|0|||
124979547|NCT01240915|449551589|FG005|Overall Study|Withdrawal by Subject|4|||
124979548|NCT01240915|449551590|FG006|Overall Study|Withdrawal by Subject|2|||
124979549|NCT01240915|449551591|FG007|Overall Study|Withdrawal by Subject|3|||
124979550|NCT01240915|449551592|FG008|Overall Study|Withdrawal by Subject|3|||
124979551|NCT01240915|449551584|FG000|Overall Study|Other|0|||
124979552|NCT01240915|449551585|FG001|Overall Study|Other|0|||
124979553|NCT01240915|449551586|FG002|Overall Study|Other|0|||
124979554|NCT01240915|449551587|FG003|Overall Study|Other|0|||
125204168|NCT01047332|450370345|FG001|Overall Study|Died Unobstructed|41|||
124979555|NCT01240915|449551588|FG004|Overall Study|Other|2|||
124979556|NCT01240915|449551589|FG005|Overall Study|Other|0|||
124979557|NCT01240915|449551590|FG006|Overall Study|Other|0|||
124979558|NCT01240915|449551591|FG007|Overall Study|Other|0|||
124979559|NCT01240915|449551592|FG008|Overall Study|Other|0|||
124979560|NCT01240915|449551584|FG000|Overall Study|Insufficient Clinical Response|0|||
125089789|NCT01117428|449947027|FG004|Overall Study|Death|0|||
124979561|NCT01240915|449551585|FG001|Overall Study|Insufficient Clinical Response|0|||
124979562|NCT01240915|449551586|FG002|Overall Study|Insufficient Clinical Response|0|||
124979563|NCT01240915|449551587|FG003|Overall Study|Insufficient Clinical Response|0|||
124979564|NCT01240915|449551588|FG004|Overall Study|Insufficient Clinical Response|1|||
124979565|NCT01240915|449551589|FG005|Overall Study|Insufficient Clinical Response|3|||
124979566|NCT01240915|449551590|FG006|Overall Study|Insufficient Clinical Response|6|||
124979567|NCT01240915|449551591|FG007|Overall Study|Insufficient Clinical Response|0|||
124979568|NCT01240915|449551592|FG008|Overall Study|Insufficient Clinical Response|3|||
124979569|NCT02574845|449551594|FG000|Overall Study|Consent withdrawn further participation|0|||
124979570|NCT02574845|449551595|FG001|Overall Study|Consent withdrawn further participation|0|||
124979571|NCT02574845|449551596|FG002|Overall Study|Consent withdrawn further participation|0|||
124979572|NCT02574845|449551597|FG003|Overall Study|Consent withdrawn further participation|0|||
124979573|NCT02574845|449551598|FG004|Overall Study|Consent withdrawn further participation|1|||
124979574|NCT02574845|449551599|FG005|Overall Study|Consent withdrawn further participation|0|||
124979575|NCT02574845|449551594|FG000|Overall Study|Adverse Event|0|||
124979576|NCT02574845|449551595|FG001|Overall Study|Adverse Event|1|||
124979577|NCT02574845|449551596|FG002|Overall Study|Adverse Event|0|||
124979578|NCT02574845|449551597|FG003|Overall Study|Adverse Event|0|||
124979579|NCT02574845|449551598|FG004|Overall Study|Adverse Event|0|||
124979580|NCT02574845|449551599|FG005|Overall Study|Adverse Event|1|||
124979581|NCT03435692|449551601|FG000|Overall Study|Lack of Efficacy|2|||
124979582|NCT03435692|449551602|FG001|Overall Study|Lack of Efficacy|2|||
124979583|NCT03435692|449551603|FG002|Overall Study|Lack of Efficacy|0|||
124979584|NCT00821587|449551608|FG000|Overall Study|Physician Decision|0|||
124979585|NCT00821587|449551609|FG001|Overall Study|Physician Decision|1|||
124979586|NCT01712061|449551612|FG000|Overall Study|Adverse Event|4|||
124979587|NCT01712061|449551613|FG001|Overall Study|Adverse Event|9|||
124979588|NCT01712061|449551614|FG002|Overall Study|Adverse Event|5|||
124979589|NCT01712061|449551612|FG000|Overall Study|Death|0|||
124979590|NCT01712061|449551613|FG001|Overall Study|Death|0|||
124979591|NCT01712061|449551614|FG002|Overall Study|Death|1|||
124979592|NCT01712061|449551612|FG000|Overall Study|Lost to Follow-up|1|||
124979593|NCT01712061|449551613|FG001|Overall Study|Lost to Follow-up|0|||
124979594|NCT01712061|449551614|FG002|Overall Study|Lost to Follow-up|1|||
124979595|NCT01712061|449551612|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
124979596|NCT01712061|449551613|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
124979597|NCT01712061|449551614|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
124979598|NCT01712061|449551612|FG000|Overall Study|Medication Error Without Associated AE|0|||
124979599|NCT01712061|449551613|FG001|Overall Study|Medication Error Without Associated AE|1|||
124979600|NCT01712061|449551614|FG002|Overall Study|Medication Error Without Associated AE|0|||
124979601|NCT01712061|449551612|FG000|Overall Study|Withdrawal by Subject|1|||
124979602|NCT01712061|449551613|FG001|Overall Study|Withdrawal by Subject|7|||
124979603|NCT01712061|449551614|FG002|Overall Study|Withdrawal by Subject|1|||
124979604|NCT01712061|449551612|FG000|Overall Study|Other|0|||
124979605|NCT01712061|449551613|FG001|Overall Study|Other|3|||
124979606|NCT01712061|449551614|FG002|Overall Study|Other|0|||
124979607|NCT00879775|449551617|FG000|Overall Study|Lost to Follow-up|2|||
124979608|NCT00879775|449551618|FG001|Overall Study|Lost to Follow-up|1|||
124979609|NCT01195623|449551619|FG000|Overall Study|Lost to Follow-up|35|||
124979610|NCT01195623|449551620|FG001|Overall Study|Lost to Follow-up|37|||
124979611|NCT01677767|449551621|FG000|Overall Study|Adverse Event|1|||
124979612|NCT01677767|449551621|FG000|Overall Study|Death|4|||
124979613|NCT01677767|449551621|FG000|Overall Study|Protocol Violation|4|||
124979614|NCT01677767|449551621|FG000|Overall Study|Withdrawal by Subject|10|||
124979615|NCT01677767|449551621|FG000|Overall Study|Non-compliance by the participants|3|||
124979616|NCT03846453|449551622|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
125204169|NCT01047332|450370344|FG000|Overall Study|Lost to Follow-up|8|||
125204170|NCT01047332|450370345|FG001|Overall Study|Lost to Follow-up|3|||
125204171|NCT03521817|450370350|FG000|Overall Study|Protocol Violation|0|||
125204172|NCT03521817|450370351|FG001|Overall Study|Protocol Violation|1|||
125204173|NCT01390428|450371935|FG000|Overall Study|Elective Surgery|0|||
125204174|NCT01390428|450371936|FG001|Overall Study|Elective Surgery|0|||
125204175|NCT01390428|450371937|FG002|Overall Study|Elective Surgery|0|||
125204176|NCT01390428|450371938|FG003|Overall Study|Elective Surgery|0|||
125204177|NCT01390428|450371939|FG004|Overall Study|Elective Surgery|1|||
125204178|NCT01390428|450371940|FG005|Overall Study|Elective Surgery|0|||
125204179|NCT01390428|450371935|FG000|Overall Study|Withdrawal by Subject|0|||
124979617|NCT03846453|449551623|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
124979618|NCT03846453|449551624|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
124979619|NCT03846453|449551622|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
124979620|NCT03846453|449551623|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
124979621|NCT03846453|449551624|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
124979622|NCT03846453|449551622|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
124979623|NCT03846453|449551623|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
124979624|NCT03846453|449551624|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
125204180|NCT01390428|450371936|FG001|Overall Study|Withdrawal by Subject|0|||
125204181|NCT01390428|450371937|FG002|Overall Study|Withdrawal by Subject|1|||
125204182|NCT01390428|450371938|FG003|Overall Study|Withdrawal by Subject|0|||
125204183|NCT01390428|450371939|FG004|Overall Study|Withdrawal by Subject|0|||
125204184|NCT01390428|450371940|FG005|Overall Study|Withdrawal by Subject|0|||
125204185|NCT04322539|450371949|FG000|Overall Study|Adverse Event|2|||
125204186|NCT04322539|450371950|FG001|Overall Study|Adverse Event|0|||
125204187|NCT04322539|450371949|FG000|Overall Study|Death|411|||
124979625|NCT03846453|449551622|FG000|Placebo Run-in (14 Days)|Other|2|||
124979626|NCT03846453|449551623|FG001|Placebo Run-in (14 Days)|Other|0|||
124979627|NCT03846453|449551624|FG002|Placebo Run-in (14 Days)|Other|0|||
124979628|NCT03846453|449551622|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
124979629|NCT03846453|449551623|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
124979630|NCT03846453|449551624|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
124979631|NCT03846453|449551622|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
124979632|NCT03846453|449551623|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
124979633|NCT03846453|449551624|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
125204188|NCT04322539|450371950|FG001|Overall Study|Death|203|||
125204189|NCT04322539|450371949|FG000|Overall Study|Lost to Follow-up|3|||
125204190|NCT04322539|450371950|FG001|Overall Study|Lost to Follow-up|1|||
125204191|NCT04322539|450371949|FG000|Overall Study|Withdrawal of consent|14|||
124979634|NCT03846453|449551622|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
124979635|NCT03846453|449551623|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
124979636|NCT03846453|449551624|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
124979637|NCT03846453|449551622|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
124979638|NCT03846453|449551623|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
124979639|NCT03846453|449551624|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
124979640|NCT03846453|449551622|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
124979641|NCT03846453|449551623|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
124979642|NCT03846453|449551624|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
124979643|NCT00468143|449551625|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
124979644|NCT00468143|449551626|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
124979645|NCT00468143|449551625|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
124979646|NCT00468143|449551626|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
124979647|NCT01606670|449551629|FG000|Overall Study|Adverse Event|6|||
124979648|NCT01606670|449551629|FG000|Overall Study|Lack of Efficacy|2|||
124979649|NCT01606670|449551629|FG000|Overall Study|Lost to Follow-up|3|||
124979650|NCT01606670|449551629|FG000|Overall Study|Withdrawal by Subject|3|||
124979651|NCT01606670|449551629|FG000|Overall Study|Other Reason|2|||
124979652|NCT02636725|449551631|FG000|Overall Study|Adverse Event|1|||
124979653|NCT02145468|449551632|FG000|Overall Study|Withdrawal by Subject|5|||
124979654|NCT02145468|449551633|FG001|Overall Study|Withdrawal by Subject|8|||
124979655|NCT00623805|449551634|FG000|Overall Study|Adverse Event|9|||
124979656|NCT00623805|449551635|FG001|Overall Study|Adverse Event|6|||
124979657|NCT00623805|449551634|FG000|Overall Study|Death|2|||
124979658|NCT00623805|449551635|FG001|Overall Study|Death|0|||
124979659|NCT00623805|449551634|FG000|Overall Study|Lack of Efficacy|3|||
124979660|NCT00623805|449551635|FG001|Overall Study|Lack of Efficacy|7|||
124979661|NCT00623805|449551634|FG000|Overall Study|Lost to Follow-up|2|||
124979662|NCT00623805|449551635|FG001|Overall Study|Lost to Follow-up|2|||
124979663|NCT00623805|449551634|FG000|Overall Study|Protocol Violation|1|||
124979664|NCT00623805|449551635|FG001|Overall Study|Protocol Violation|1|||
124979665|NCT00623805|449551634|FG000|Overall Study|Reason not Specified|3|||
124979666|NCT00623805|449551635|FG001|Overall Study|Reason not Specified|6|||
124979667|NCT04655027|449551639|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
124979668|NCT04655027|449551640|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
124979669|NCT03519997|449551643|FG000|Overall Study|Adverse Event|4|||
124979670|NCT03519997|449551643|FG000|Overall Study|Withdrawal by Subject|2|||
124979671|NCT03519997|449551643|FG000|Overall Study|Protocol Violation|1|||
124979672|NCT03820947|449551644|FG000|Overall Study|Physician Decision|0|||
124979673|NCT03820947|449551645|FG001|Overall Study|Physician Decision|1|||
124979674|NCT03820947|449551646|FG002|Overall Study|Physician Decision|1|||
125204192|NCT04322539|450371950|FG001|Overall Study|Withdrawal of consent|8|||
125204193|NCT04322539|450371949|FG000|Overall Study|Radiological Disease Progression|6|||
125204194|NCT04322539|450371950|FG001|Overall Study|Radiological Disease Progression|0|||
124979675|NCT03820947|449551647|FG003|Overall Study|Physician Decision|0|||
124979676|NCT03820947|449551648|FG004|Overall Study|Physician Decision|3|||
124979677|NCT03820947|449551644|FG000|Overall Study|Withdrawal by Subject|6|||
124979678|NCT03820947|449551645|FG001|Overall Study|Withdrawal by Subject|10|||
125204195|NCT04322539|450371949|FG000|Overall Study|Sponsor Decision|19|||
124979679|NCT03820947|449551646|FG002|Overall Study|Withdrawal by Subject|3|||
124979680|NCT03820947|449551647|FG003|Overall Study|Withdrawal by Subject|8|||
124979681|NCT03820947|449551648|FG004|Overall Study|Withdrawal by Subject|5|||
124979682|NCT03820947|449551644|FG000|Overall Study|Procedure Not Attempted|0|||
124979683|NCT03820947|449551645|FG001|Overall Study|Procedure Not Attempted|2|||
124979684|NCT03820947|449551646|FG002|Overall Study|Procedure Not Attempted|1|||
124979685|NCT03820947|449551647|FG003|Overall Study|Procedure Not Attempted|0|||
124979686|NCT03820947|449551648|FG004|Overall Study|Procedure Not Attempted|0|||
124979687|NCT03820947|449551644|FG000|Overall Study|Other Exit|1|||
124979688|NCT03820947|449551645|FG001|Overall Study|Other Exit|3|||
124979689|NCT03820947|449551646|FG002|Overall Study|Other Exit|3|||
124979690|NCT03820947|449551647|FG003|Overall Study|Other Exit|3|||
124979691|NCT03820947|449551648|FG004|Overall Study|Other Exit|0|||
124979692|NCT03820947|449551644|FG000|Overall Study|Follow-up Not Done|10|||
124979693|NCT03820947|449551645|FG001|Overall Study|Follow-up Not Done|13|||
124979694|NCT03820947|449551646|FG002|Overall Study|Follow-up Not Done|2|||
124979695|NCT03820947|449551647|FG003|Overall Study|Follow-up Not Done|3|||
124979696|NCT03820947|449551648|FG004|Overall Study|Follow-up Not Done|12|||
124979697|NCT03820947|449551644|FG000|Overall Study|Death|0|||
124979698|NCT03820947|449551645|FG001|Overall Study|Death|0|||
124979699|NCT03820947|449551646|FG002|Overall Study|Death|0|||
124979700|NCT03820947|449551647|FG003|Overall Study|Death|0|||
124979701|NCT03820947|449551648|FG004|Overall Study|Death|9|||
124979702|NCT03820947|449551644|FG000|Overall Study|Lost to Follow-up|4|||
124979703|NCT03820947|449551645|FG001|Overall Study|Lost to Follow-up|6|||
124979704|NCT03820947|449551646|FG002|Overall Study|Lost to Follow-up|0|||
124979705|NCT03820947|449551647|FG003|Overall Study|Lost to Follow-up|0|||
124979706|NCT03820947|449551648|FG004|Overall Study|Lost to Follow-up|9|||
124979707|NCT03578887|449551649|FG000|Overall Study|Withdrawal by Subject|7|||
124979708|NCT03578887|449551650|FG001|Overall Study|Withdrawal by Subject|2|||
124979709|NCT03578887|449551651|FG002|Overall Study|Withdrawal by Subject|1|||
124979710|NCT03578887|449551649|FG000|Overall Study|Lost to Follow-up|13|||
124979711|NCT03578887|449551650|FG001|Overall Study|Lost to Follow-up|1|||
124979712|NCT03578887|449551651|FG002|Overall Study|Lost to Follow-up|4|||
124979713|NCT03578887|449551649|FG000|Overall Study|Physician Decision|0|||
124979714|NCT03578887|449551650|FG001|Overall Study|Physician Decision|1|||
124979715|NCT03578887|449551651|FG002|Overall Study|Physician Decision|1|||
124979716|NCT00387426|449553429|FG000|Overall Study|Lack of Response|7|||
124979717|NCT00387426|449553429|FG000|Overall Study|Toxicities|4|||
124979718|NCT00387426|449553429|FG000|Overall Study|Disease Progression|3|||
124979719|NCT02218606|449553430|FG000|Overall Study|Adverse Event|1|||
124979720|NCT02218606|449553431|FG001|Overall Study|Adverse Event|1|||
124979721|NCT02218606|449553430|FG000|Overall Study|Death|15|||
124979722|NCT02218606|449553431|FG001|Overall Study|Death|28|||
124979723|NCT02218606|449553430|FG000|Overall Study|Physician Decision|0|||
124979724|NCT02218606|449553431|FG001|Overall Study|Physician Decision|1|||
124979725|NCT02218606|449553430|FG000|Overall Study|Withdrawal by Subject|4|||
124979726|NCT02218606|449553431|FG001|Overall Study|Withdrawal by Subject|0|||
124979727|NCT02218606|449553430|FG000|Overall Study|Noncompliance|1|||
124979728|NCT02218606|449553431|FG001|Overall Study|Noncompliance|0|||
124979729|NCT02218606|449553430|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
124979730|NCT02218606|449553431|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
124979731|NCT02218606|449553430|FG000|Overall Study|Other|2|||
124979732|NCT02218606|449553431|FG001|Overall Study|Other|1|||
124979733|NCT02218606|449553430|FG000|Overall Study|Never started treatment|0|||
124979734|NCT02218606|449553431|FG001|Overall Study|Never started treatment|1|||
124979735|NCT00890695|449553432|FG000|Overall Study|Protocol Violation|1|||
124979736|NCT00890695|449553433|FG001|Overall Study|Protocol Violation|0|||
124979737|NCT01531673|449553434|FG000|Overall Study|Non-Compliance|0|||
124979738|NCT01531673|449553435|FG001|Overall Study|Non-Compliance|0|||
124979739|NCT01531673|449553436|FG002|Overall Study|Non-Compliance|0|||
124979740|NCT01531673|449553437|FG003|Overall Study|Non-Compliance|0|||
124979741|NCT01531673|449553438|FG004|Overall Study|Non-Compliance|0|||
124979742|NCT01531673|449553439|FG005|Overall Study|Non-Compliance|1|||
124979743|NCT01531673|449553440|FG006|Overall Study|Non-Compliance|0|||
124979744|NCT01531673|449553441|FG007|Overall Study|Non-Compliance|0|||
124979745|NCT01531673|449553442|FG008|Overall Study|Non-Compliance|0|||
124979746|NCT01531673|449553443|FG009|Overall Study|Non-Compliance|0|||
124979747|NCT01531673|449553444|FG010|Overall Study|Non-Compliance|0|||
124979748|NCT01531673|449553445|FG011|Overall Study|Non-Compliance|0|||
124979749|NCT01531673|449553446|FG012|Overall Study|Non-Compliance|0|||
124979750|NCT01531673|449553434|FG000|Overall Study|Adverse Event|0|||
124979751|NCT01531673|449553435|FG001|Overall Study|Adverse Event|1|||
124979752|NCT01531673|449553436|FG002|Overall Study|Adverse Event|0|||
124979753|NCT01531673|449553437|FG003|Overall Study|Adverse Event|0|||
124979754|NCT01531673|449553438|FG004|Overall Study|Adverse Event|0|||
124979755|NCT01531673|449553439|FG005|Overall Study|Adverse Event|0|||
124979756|NCT01531673|449553440|FG006|Overall Study|Adverse Event|0|||
124979757|NCT01531673|449553441|FG007|Overall Study|Adverse Event|0|||
124979758|NCT01531673|449553442|FG008|Overall Study|Adverse Event|0|||
124979759|NCT01531673|449553443|FG009|Overall Study|Adverse Event|0|||
124979760|NCT01531673|449553444|FG010|Overall Study|Adverse Event|0|||
124979761|NCT01531673|449553445|FG011|Overall Study|Adverse Event|0|||
124979762|NCT01531673|449553446|FG012|Overall Study|Adverse Event|0|||
124979763|NCT01531673|449553434|FG000|Overall Study|Lost to Follow-up|0|||
124979764|NCT01531673|449553435|FG001|Overall Study|Lost to Follow-up|0|||
124979765|NCT01531673|449553436|FG002|Overall Study|Lost to Follow-up|0|||
124979766|NCT01531673|449553437|FG003|Overall Study|Lost to Follow-up|0|||
124979767|NCT01531673|449553438|FG004|Overall Study|Lost to Follow-up|1|||
124979768|NCT01531673|449553439|FG005|Overall Study|Lost to Follow-up|0|||
124979769|NCT01531673|449553440|FG006|Overall Study|Lost to Follow-up|0|||
124979770|NCT01531673|449553441|FG007|Overall Study|Lost to Follow-up|0|||
124979771|NCT01531673|449553442|FG008|Overall Study|Lost to Follow-up|0|||
124979772|NCT01531673|449553443|FG009|Overall Study|Lost to Follow-up|0|||
124979773|NCT01531673|449553444|FG010|Overall Study|Lost to Follow-up|0|||
124979774|NCT01531673|449553445|FG011|Overall Study|Lost to Follow-up|0|||
124979775|NCT01531673|449553446|FG012|Overall Study|Lost to Follow-up|0|||
124979776|NCT01531673|449553434|FG000|Overall Study|Other|0|||
124979777|NCT01531673|449553435|FG001|Overall Study|Other|0|||
124979778|NCT01531673|449553436|FG002|Overall Study|Other|0|||
124979779|NCT01531673|449553437|FG003|Overall Study|Other|1|||
124979780|NCT01531673|449553438|FG004|Overall Study|Other|0|||
124979781|NCT01531673|449553439|FG005|Overall Study|Other|0|||
124979782|NCT01531673|449553440|FG006|Overall Study|Other|0|||
124979783|NCT01531673|449553441|FG007|Overall Study|Other|0|||
124979784|NCT01531673|449553442|FG008|Overall Study|Other|0|||
124979785|NCT01531673|449553443|FG009|Overall Study|Other|1|||
124979786|NCT01531673|449553444|FG010|Overall Study|Other|0|||
124979787|NCT01531673|449553445|FG011|Overall Study|Other|0|||
124979788|NCT01531673|449553446|FG012|Overall Study|Other|0|||
124979789|NCT02187159|449553447|FG000|Overall Study|Protocol Violation|4|||
124979790|NCT02187159|449553448|FG001|Overall Study|Protocol Violation|6|||
124979791|NCT02187159|449553449|FG002|Overall Study|Protocol Violation|3|||
124979792|NCT02187159|449553450|FG003|Overall Study|Protocol Violation|4|||
124979793|NCT02187159|449553447|FG000|Overall Study|Lack of Efficacy|10|||
124979794|NCT02187159|449553448|FG001|Overall Study|Lack of Efficacy|5|||
124979795|NCT02187159|449553449|FG002|Overall Study|Lack of Efficacy|4|||
124979796|NCT02187159|449553450|FG003|Overall Study|Lack of Efficacy|7|||
124979797|NCT02187159|449553447|FG000|Overall Study|Adverse Event|28|||
124979798|NCT02187159|449553448|FG001|Overall Study|Adverse Event|33|||
124979799|NCT02187159|449553449|FG002|Overall Study|Adverse Event|42|||
124979800|NCT02187159|449553450|FG003|Overall Study|Adverse Event|50|||
124979801|NCT02187159|449553447|FG000|Overall Study|Withdrawal by Subject|24|||
124979802|NCT02187159|449553448|FG001|Overall Study|Withdrawal by Subject|28|||
124979803|NCT02187159|449553449|FG002|Overall Study|Withdrawal by Subject|25|||
124979804|NCT02187159|449553450|FG003|Overall Study|Withdrawal by Subject|26|||
124979805|NCT02187159|449553447|FG000|Overall Study|Other|3|||
124979806|NCT02187159|449553448|FG001|Overall Study|Other|7|||
124979807|NCT02187159|449553449|FG002|Overall Study|Other|3|||
124979808|NCT02187159|449553450|FG003|Overall Study|Other|9|||
124979809|NCT00567567|449553451|FG000|Overall Study|Adverse Event|0|||
124979810|NCT00567567|449553452|FG001|Overall Study|Adverse Event|2|||
124979811|NCT00567567|449553453|FG002|Overall Study|Adverse Event|5|||
124979812|NCT00567567|449553451|FG000|Overall Study|Death|8|||
124979813|NCT00567567|449553452|FG001|Overall Study|Death|1|||
124979814|NCT00567567|449553453|FG002|Overall Study|Death|5|||
124979815|NCT00567567|449553451|FG000|Overall Study|Lack of Efficacy|16|||
124979816|NCT00567567|449553452|FG001|Overall Study|Lack of Efficacy|17|||
124979817|NCT00567567|449553453|FG002|Overall Study|Lack of Efficacy|48|||
124979818|NCT00567567|449553451|FG000|Overall Study|Lost to Follow-up|0|||
124979819|NCT00567567|449553452|FG001|Overall Study|Lost to Follow-up|0|||
124979820|NCT00567567|449553453|FG002|Overall Study|Lost to Follow-up|1|||
124979821|NCT00567567|449553451|FG000|Overall Study|Physician Decision|16|||
124979822|NCT00567567|449553452|FG001|Overall Study|Physician Decision|18|||
124979823|NCT00567567|449553453|FG002|Overall Study|Physician Decision|84|||
124979824|NCT00567567|449553451|FG000|Overall Study|Withdrawal by Subject|0|||
124979825|NCT00567567|449553452|FG001|Overall Study|Withdrawal by Subject|0|||
124979826|NCT00567567|449553453|FG002|Overall Study|Withdrawal by Subject|2|||
124979827|NCT00567567|449553451|FG000|Overall Study|Ineligible|4|||
124979828|NCT00567567|449553452|FG001|Overall Study|Ineligible|0|||
124979829|NCT00567567|449553453|FG002|Overall Study|Ineligible|9|||
124979830|NCT00567567|449553451|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
124979831|NCT00567567|449553452|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
124979832|NCT00567567|449553453|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
124979833|NCT00567567|449553451|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
124979834|NCT00567567|449553452|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
124979835|NCT00567567|449553453|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
124979836|NCT00567567|449553451|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
124979837|NCT00567567|449553452|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
124979838|NCT00567567|449553453|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
124979839|NCT03889704|449553454|FG000|Overall Study|Study terminated due to pandemic|1|||
124979840|NCT03482466|449553455|FG000|Overall Study|Protocol Violation|2|||
124979841|NCT02060370|449553456|FG000|Overall Study|Physician Decision|1|||
124979842|NCT01493427|449553457|FG000|Overall Study|Adverse Event|10|||
124979843|NCT01493427|449553457|FG000|Overall Study|Personal Reasons|4|||
124979844|NCT01493427|449553457|FG000|Overall Study|Lost to Follow-up|2|||
124979845|NCT01493427|449553457|FG000|Overall Study|Inability to Follow Instructions|2|||
124979846|NCT01493427|449553457|FG000|Overall Study|Other|2|||
124979847|NCT01461811|449553458|FG000|Overall Study|Adverse Event|2|||
124979848|NCT01461811|449553459|FG001|Overall Study|Adverse Event|1|||
124979849|NCT01461811|449553458|FG000|Overall Study|Subject decision unrelated to an AE|1|||
124979850|NCT01461811|449553459|FG001|Overall Study|Subject decision unrelated to an AE|1|||
124979851|NCT01461811|449553458|FG000|Overall Study|Noncompliance|1|||
124979852|NCT01461811|449553459|FG001|Overall Study|Noncompliance|1|||
124979853|NCT02781090|449553460|FG000|3-Month Follow-Up|Missed Visit|20|||
124979854|NCT02781090|449553461|FG001|3-Month Follow-Up|Missed Visit|20|||
124979855|NCT02781090|449553460|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
124979856|NCT02781090|449553461|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
124979857|NCT02781090|449553460|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
124979858|NCT02781090|449553461|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
124979859|NCT02781090|449553460|FG000|3-Month Follow-Up|Death|1|||
124979860|NCT02781090|449553461|FG001|3-Month Follow-Up|Death|0|||
124979861|NCT02781090|449553460|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
124979862|NCT02781090|449553461|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
124979863|NCT02781090|449553460|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
124979864|NCT02781090|449553461|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
124979865|NCT02781090|449553460|FG000|6-Month Follow-Up|Death|0|||
124979866|NCT02781090|449553461|FG001|6-Month Follow-Up|Death|1|||
124979867|NCT01401153|449553463|FG000|First Test Day|Learning disabilities; illness|1|||
124979868|NCT01401153|449553464|FG001|First Test Day|Learning disabilities; illness|10|||
124979869|NCT01401153|449553463|FG000|Second Test Day|illness|0|||
124979870|NCT01401153|449553464|FG001|Second Test Day|illness|5|||
124979871|NCT00757627|449553465|FG000|Overall Study|Adverse Event|15|||
124979872|NCT00757627|449553465|FG000|Overall Study|Lack of Efficacy|10|||
124979873|NCT00757627|449553465|FG000|Overall Study|Lost to Follow-up|28|||
124979874|NCT00757627|449553465|FG000|Overall Study|Withdrawal by Subject|27|||
124979875|NCT00757627|449553465|FG000|Overall Study|Other|1|||
124979876|NCT00403767|449553466|FG000|Overall Study|Adverse Event|993|||
124979877|NCT00403767|449553467|FG001|Overall Study|Adverse Event|919|||
124979878|NCT00403767|449553466|FG000|Overall Study|Non-compliant with study medication|134|||
124979879|NCT00403767|449553467|FG001|Overall Study|Non-compliant with study medication|164|||
124979880|NCT00403767|449553466|FG000|Overall Study|Consent withdrawn|671|||
124979881|NCT00403767|449553467|FG001|Overall Study|Consent withdrawn|673|||
124979882|NCT00403767|449553466|FG000|Overall Study|Investigator dec./not protocol-related|191|||
124979883|NCT00403767|449553467|FG001|Overall Study|Investigator dec./not protocol-related|178|||
124979884|NCT00403767|449553466|FG000|Overall Study|Lost to Follow-up|6|||
124979885|NCT00403767|449553467|FG001|Overall Study|Lost to Follow-up|8|||
124979886|NCT00403767|449553466|FG000|Overall Study|Protocol Violation|142|||
124979887|NCT00403767|449553467|FG001|Overall Study|Protocol Violation|124|||
124979888|NCT00403767|449553466|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
124979889|NCT00403767|449553467|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
124979890|NCT00403767|449553466|FG000|Overall Study|Study terminated by sponsor|82|||
124979891|NCT00403767|449553467|FG001|Overall Study|Study terminated by sponsor|69|||
124979892|NCT00403767|449553466|FG000|Overall Study|Missing/incomplete data|1|||
124979893|NCT00403767|449553467|FG001|Overall Study|Missing/incomplete data|1|||
124979894|NCT05330676|449553468|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
124979895|NCT05330676|449553469|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
124979896|NCT00436605|449553470|FG000|Overall Study|Protocol Violation|3|||
124979897|NCT01559129|449553474|FG000|Treatment Phase|Adverse Event|0|||
124979898|NCT01559129|449553475|FG001|Treatment Phase|Adverse Event|2|||
124979899|NCT01559129|449553474|FG000|Treatment Phase|Progressive Disease|1|||
124979900|NCT01559129|449553475|FG001|Treatment Phase|Progressive Disease|1|||
124979901|NCT01559129|449553474|FG000|Treatment Phase|Lack of Efficacy|0|||
124979902|NCT01559129|449553475|FG001|Treatment Phase|Lack of Efficacy|1|||
124979903|NCT01559129|449553474|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
124979904|NCT01559129|449553475|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
124979905|NCT01559129|449553474|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
124979906|NCT01559129|449553475|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
124979907|NCT01559129|449553474|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
124979908|NCT01559129|449553475|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
124979909|NCT01559129|449553474|FG000|Open-label Extension Period|Adverse Event|1|||
124979910|NCT01559129|449553475|FG001|Open-label Extension Period|Adverse Event|0|||
124979911|NCT01559129|449553474|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
124979912|NCT01559129|449553475|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
124979913|NCT00368927|449553476|FG000|Overall Study|Lost to Follow-up|2|||
124979914|NCT00368927|449553477|FG001|Overall Study|Lost to Follow-up|0|||
124979915|NCT00368927|449553476|FG000|Overall Study|Adverse Event|1|||
124979916|NCT00368927|449553477|FG001|Overall Study|Adverse Event|1|||
124979917|NCT00368927|449553476|FG000|Overall Study|Withdrawal by Subject|1|||
124979918|NCT00368927|449553477|FG001|Overall Study|Withdrawal by Subject|2|||
124979919|NCT00368927|449553476|FG000|Overall Study|Physician Decision|1|||
124979920|NCT00368927|449553477|FG001|Overall Study|Physician Decision|0|||
124979921|NCT03525392|449553478|FG000|Overall Study|Adverse Event|1|||
124979922|NCT03525392|449553479|FG001|Overall Study|Adverse Event|0|||
124979923|NCT03525392|449553480|FG002|Overall Study|Adverse Event|2|||
124979924|NCT03525392|449553481|FG003|Overall Study|Adverse Event|0|||
124979925|NCT03525392|449553482|FG004|Overall Study|Adverse Event|0|||
124979926|NCT03525392|449553478|FG000|Overall Study|Progressive disease|0|||
124979927|NCT03525392|449553479|FG001|Overall Study|Progressive disease|1|||
124979928|NCT03525392|449553480|FG002|Overall Study|Progressive disease|1|||
124979929|NCT03525392|449553481|FG003|Overall Study|Progressive disease|3|||
124979930|NCT03525392|449553482|FG004|Overall Study|Progressive disease|1|||
124979931|NCT03284203|449553485|FG000|Overall Study|Lost to Follow-up|3|||
124979932|NCT02229851|449553486|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
124979933|NCT02229851|449553487|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
124979934|NCT02229851|449553488|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
124979935|NCT02229851|449553489|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
124979936|NCT02229851|449553490|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
124979937|NCT02229851|449553491|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
124979938|NCT02229851|449553492|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
124979939|NCT02229851|449553486|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
124979940|NCT02229851|449553487|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
124979941|NCT02229851|449553488|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
124979942|NCT02229851|449553489|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
124979943|NCT02229851|449553490|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
124979944|NCT02229851|449553491|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
124979945|NCT02229851|449553492|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
124979946|NCT02229851|449553486|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
124979947|NCT02229851|449553487|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
124979948|NCT02229851|449553488|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
124979949|NCT02229851|449553489|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
124979950|NCT02229851|449553490|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
124979951|NCT02229851|449553491|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
124979952|NCT02229851|449553492|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
124979953|NCT02229851|449553486|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
124979954|NCT02229851|449553487|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
124979955|NCT02229851|449553488|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
124979956|NCT02229851|449553489|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
124979957|NCT02229851|449553490|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
124979958|NCT02229851|449553491|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
124979959|NCT02229851|449553492|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
124979960|NCT02229851|449553486|FG000|Main Phase (Double-blind Phase)|Death|1|||
124979961|NCT02229851|449553487|FG001|Main Phase (Double-blind Phase)|Death|1|||
124979962|NCT02229851|449553488|FG002|Main Phase (Double-blind Phase)|Death|0|||
124979963|NCT02229851|449553489|FG003|Main Phase (Double-blind Phase)|Death|0|||
124979964|NCT02229851|449553490|FG004|Main Phase (Double-blind Phase)|Death|0|||
124979965|NCT02229851|449553491|FG005|Main Phase (Double-blind Phase)|Death|0|||
124979966|NCT02229851|449553492|FG006|Main Phase (Double-blind Phase)|Death|0|||
124979967|NCT02229851|449553486|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
124979968|NCT02229851|449553487|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
124979969|NCT02229851|449553488|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
124979970|NCT02229851|449553489|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
124979971|NCT02229851|449553490|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
124979972|NCT02229851|449553491|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
124979973|NCT02229851|449553492|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
124979974|NCT02229851|449553486|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
124979975|NCT02229851|449553487|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
124979976|NCT02229851|449553488|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
124979977|NCT02229851|449553489|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
124979978|NCT02229851|449553490|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
124979979|NCT02229851|449553491|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
124979980|NCT02229851|449553492|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
124979981|NCT02229851|449553486|FG000|Extension Phase (Open-label Phase)|Death|0|||
124979982|NCT02229851|449553487|FG001|Extension Phase (Open-label Phase)|Death|0|||
124979983|NCT02229851|449553488|FG002|Extension Phase (Open-label Phase)|Death|0|||
124979984|NCT02229851|449553489|FG003|Extension Phase (Open-label Phase)|Death|1|||
124979985|NCT02229851|449553490|FG004|Extension Phase (Open-label Phase)|Death|0|||
125204196|NCT04322539|450371950|FG001|Overall Study|Sponsor Decision|14|||
125204197|NCT04322539|450371949|FG000|Overall Study|Other|6|||
124979986|NCT02229851|449553491|FG005|Extension Phase (Open-label Phase)|Death|1|||
124979987|NCT02229851|449553492|FG006|Extension Phase (Open-label Phase)|Death|1|||
124979988|NCT01111240|449553493|FG000|Overall Study|Adverse Event|190|||
124979989|NCT01111240|449553493|FG000|Overall Study|Lack of Efficacy|545|||
124979990|NCT01111240|449553493|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
124979991|NCT01111240|449553493|FG000|Overall Study|Other|312|||
124979992|NCT02206061|449553494|FG000|Overall Study|Withdrawal by Subject|4|||
124979993|NCT02206061|449553495|FG001|Overall Study|Withdrawal by Subject|7|||
124979994|NCT02206061|449553496|FG002|Overall Study|Withdrawal by Subject|1|||
124979995|NCT02206061|449553494|FG000|Overall Study|Lost to Follow-up|14|||
124979996|NCT02206061|449553495|FG001|Overall Study|Lost to Follow-up|7|||
124979997|NCT02206061|449553496|FG002|Overall Study|Lost to Follow-up|20|||
124979998|NCT04187326|449553497|FG000|Overall Study|Lost to Follow-up|2|||
124979999|NCT04187326|449553498|FG001|Overall Study|Lost to Follow-up|1|||
124980000|NCT04187326|449553497|FG000|Overall Study|Computer error- task was only partially completed.|0|||
124980001|NCT04187326|449553498|FG001|Overall Study|Computer error- task was only partially completed.|1|||
124980002|NCT01607476|449553499|FG000|Overall Study|Withdrawal by Subject|1|||
124980003|NCT01607476|449553500|FG001|Overall Study|Withdrawal by Subject|0|||
124980004|NCT01607476|449553501|FG002|Overall Study|Withdrawal by Subject|1|||
124980005|NCT01607476|449553499|FG000|Overall Study|Lost to Follow-up|0|||
124980006|NCT01607476|449553500|FG001|Overall Study|Lost to Follow-up|0|||
124980007|NCT01607476|449553501|FG002|Overall Study|Lost to Follow-up|2|||
124980008|NCT04958200|449553508|FG000|Overall Study|Withdrawal by Subject|0|||
124980009|NCT04958200|449553509|FG001|Overall Study|Withdrawal by Subject|2|||
124980010|NCT04958200|449553508|FG000|Overall Study|Lost to Follow-up|3|||
124980011|NCT04958200|449553509|FG001|Overall Study|Lost to Follow-up|2|||
124980012|NCT04531098|449553515|FG000|Stage I|Adverse Event|0|||
124980013|NCT04531098|449553516|FG001|Stage I|Adverse Event|0|||
124980014|NCT04531098|449553517|FG002|Stage I|Adverse Event|3|||
124980015|NCT04531098|449553515|FG000|Stage I|Protocol Violation|0|||
124980016|NCT04531098|449553516|FG001|Stage I|Protocol Violation|0|||
124980017|NCT04531098|449553517|FG002|Stage I|Protocol Violation|5|||
124980018|NCT04531098|449553515|FG000|Stage I|Withdrawal by Subject|0|||
124980019|NCT04531098|449553516|FG001|Stage I|Withdrawal by Subject|5|||
124980020|NCT04531098|449553517|FG002|Stage I|Withdrawal by Subject|10|||
124980021|NCT04531098|449553515|FG000|Stage II|Adverse Event|1|||
124980022|NCT04531098|449553516|FG001|Stage II|Adverse Event|2|||
124980023|NCT04531098|449553517|FG002|Stage II|Adverse Event|0|||
124980024|NCT04531098|449553515|FG000|Stage II|Protocol Violation|1|||
124980025|NCT04531098|449553516|FG001|Stage II|Protocol Violation|2|||
124980026|NCT04531098|449553517|FG002|Stage II|Protocol Violation|0|||
124980027|NCT04531098|449553515|FG000|Stage II|Withdrawal by Subject|3|||
124980028|NCT04531098|449553516|FG001|Stage II|Withdrawal by Subject|1|||
124980029|NCT04531098|449553517|FG002|Stage II|Withdrawal by Subject|0|||
124980030|NCT04531098|449553515|FG000|Stage II|Moved from study area|8|||
124980031|NCT04531098|449553516|FG001|Stage II|Moved from study area|5|||
124980032|NCT04531098|449553517|FG002|Stage II|Moved from study area|0|||
124980033|NCT02628028|449553518|FG000|Dosing Period|Withdrawal by Subject|0|||
124980034|NCT02628028|449553519|FG001|Dosing Period|Withdrawal by Subject|0|||
124980035|NCT02628028|449553520|FG002|Dosing Period|Withdrawal by Subject|1|||
124980036|NCT02628028|449553521|FG003|Dosing Period|Withdrawal by Subject|0|||
124980037|NCT02628028|449553522|FG004|Dosing Period|Withdrawal by Subject|2|||
124980038|NCT02628028|449553523|FG005|Dosing Period|Withdrawal by Subject|4|||
124980039|NCT02628028|449553524|FG006|Dosing Period|Withdrawal by Subject|1|||
124980040|NCT02628028|449553525|FG007|Dosing Period|Withdrawal by Subject|1|||
124980041|NCT02628028|449553518|FG000|Dosing Period|Adverse Event|0|||
124980042|NCT02628028|449553519|FG001|Dosing Period|Adverse Event|0|||
124980043|NCT02628028|449553520|FG002|Dosing Period|Adverse Event|0|||
124980044|NCT02628028|449553521|FG003|Dosing Period|Adverse Event|0|||
124980045|NCT02628028|449553522|FG004|Dosing Period|Adverse Event|2|||
124980046|NCT02628028|449553523|FG005|Dosing Period|Adverse Event|1|||
124980047|NCT02628028|449553524|FG006|Dosing Period|Adverse Event|3|||
124980048|NCT02628028|449553525|FG007|Dosing Period|Adverse Event|2|||
124980049|NCT02628028|449553518|FG000|Dosing Period|Death|0|||
124980050|NCT02628028|449553519|FG001|Dosing Period|Death|0|||
124980051|NCT02628028|449553520|FG002|Dosing Period|Death|0|||
125204198|NCT04322539|450371950|FG001|Overall Study|Other|4|||
125204199|NCT01702532|450371951|FG000|Overall Study|Adverse Event|0|||
124980052|NCT02628028|449553521|FG003|Dosing Period|Death|0|||
124980053|NCT02628028|449553522|FG004|Dosing Period|Death|0|||
124980054|NCT02628028|449553523|FG005|Dosing Period|Death|0|||
124980055|NCT02628028|449553524|FG006|Dosing Period|Death|0|||
124980056|NCT02628028|449553525|FG007|Dosing Period|Death|1|||
124980057|NCT02628028|449553518|FG000|Dosing Period|Lack of Efficacy|0|||
124980058|NCT02628028|449553519|FG001|Dosing Period|Lack of Efficacy|0|||
124980059|NCT02628028|449553520|FG002|Dosing Period|Lack of Efficacy|0|||
124980060|NCT02628028|449553521|FG003|Dosing Period|Lack of Efficacy|0|||
124980061|NCT02628028|449553522|FG004|Dosing Period|Lack of Efficacy|3|||
124980062|NCT02628028|449553523|FG005|Dosing Period|Lack of Efficacy|0|||
124980063|NCT02628028|449553524|FG006|Dosing Period|Lack of Efficacy|1|||
124980064|NCT02628028|449553525|FG007|Dosing Period|Lack of Efficacy|0|||
124980065|NCT02628028|449553518|FG000|Dosing Period|Study Terminated by Sponsor|0|||
124980066|NCT02628028|449553519|FG001|Dosing Period|Study Terminated by Sponsor|0|||
124980067|NCT02628028|449553520|FG002|Dosing Period|Study Terminated by Sponsor|0|||
124980068|NCT02628028|449553521|FG003|Dosing Period|Study Terminated by Sponsor|0|||
124980069|NCT02628028|449553522|FG004|Dosing Period|Study Terminated by Sponsor|7|||
124980070|NCT02628028|449553523|FG005|Dosing Period|Study Terminated by Sponsor|6|||
124980071|NCT02628028|449553524|FG006|Dosing Period|Study Terminated by Sponsor|7|||
124980072|NCT02628028|449553525|FG007|Dosing Period|Study Terminated by Sponsor|7|||
124980073|NCT02628028|449553518|FG000|Dosing Period|Physician Decision|0|||
124980074|NCT02628028|449553519|FG001|Dosing Period|Physician Decision|0|||
124980075|NCT02628028|449553520|FG002|Dosing Period|Physician Decision|0|||
124980076|NCT02628028|449553521|FG003|Dosing Period|Physician Decision|0|||
124980077|NCT02628028|449553522|FG004|Dosing Period|Physician Decision|0|||
124980078|NCT02628028|449553523|FG005|Dosing Period|Physician Decision|1|||
124980079|NCT02628028|449553524|FG006|Dosing Period|Physician Decision|0|||
124980080|NCT02628028|449553525|FG007|Dosing Period|Physician Decision|0|||
124980081|NCT02628028|449553518|FG000|Dosing Period|Site Terminated by Sponsor|0|||
124980082|NCT02628028|449553519|FG001|Dosing Period|Site Terminated by Sponsor|0|||
124980083|NCT02628028|449553520|FG002|Dosing Period|Site Terminated by Sponsor|0|||
124980084|NCT02628028|449553521|FG003|Dosing Period|Site Terminated by Sponsor|0|||
124980085|NCT02628028|449553522|FG004|Dosing Period|Site Terminated by Sponsor|0|||
124980086|NCT02628028|449553523|FG005|Dosing Period|Site Terminated by Sponsor|1|||
124980087|NCT02628028|449553524|FG006|Dosing Period|Site Terminated by Sponsor|1|||
124980088|NCT02628028|449553525|FG007|Dosing Period|Site Terminated by Sponsor|0|||
124980089|NCT02628028|449553518|FG000|Dosing Period|Lost to Follow-up|0|||
124980090|NCT02628028|449553519|FG001|Dosing Period|Lost to Follow-up|0|||
124980091|NCT02628028|449553520|FG002|Dosing Period|Lost to Follow-up|0|||
124980092|NCT02628028|449553521|FG003|Dosing Period|Lost to Follow-up|0|||
124980093|NCT02628028|449553522|FG004|Dosing Period|Lost to Follow-up|0|||
124980094|NCT02628028|449553523|FG005|Dosing Period|Lost to Follow-up|0|||
124980095|NCT02628028|449553524|FG006|Dosing Period|Lost to Follow-up|1|||
124980096|NCT02628028|449553525|FG007|Dosing Period|Lost to Follow-up|0|||
124980097|NCT02628028|449553518|FG000|Dosing Period|Other|0|||
124980098|NCT02628028|449553519|FG001|Dosing Period|Other|0|||
124980099|NCT02628028|449553520|FG002|Dosing Period|Other|0|||
124980100|NCT02628028|449553521|FG003|Dosing Period|Other|0|||
124980101|NCT02628028|449553522|FG004|Dosing Period|Other|2|||
124980102|NCT02628028|449553523|FG005|Dosing Period|Other|1|||
124980103|NCT02628028|449553524|FG006|Dosing Period|Other|2|||
124980104|NCT02628028|449553525|FG007|Dosing Period|Other|4|||
124980105|NCT02628028|449553518|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
124980106|NCT02628028|449553519|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
124980107|NCT02628028|449553520|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
124980108|NCT02628028|449553521|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
124980109|NCT02628028|449553522|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
124980110|NCT02628028|449553523|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
124980111|NCT02628028|449553524|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
124980112|NCT02628028|449553525|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
124980113|NCT02628028|449553518|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
124980114|NCT02628028|449553519|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
124980115|NCT02628028|449553520|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
124980116|NCT02628028|449553521|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
124980117|NCT02628028|449553522|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
124980118|NCT02628028|449553523|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
124980119|NCT02628028|449553524|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
124980120|NCT02628028|449553525|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
124980121|NCT02628028|449553518|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
124980122|NCT02628028|449553519|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
124980123|NCT02628028|449553520|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
124980124|NCT02628028|449553521|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
124980125|NCT02628028|449553522|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
124980126|NCT02628028|449553523|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
124980127|NCT02628028|449553524|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
124980128|NCT02628028|449553525|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
124980129|NCT02628028|449553518|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
124980130|NCT02628028|449553519|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
124980131|NCT02628028|449553520|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
124980132|NCT02628028|449553521|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
124980133|NCT02628028|449553522|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
124980134|NCT02628028|449553523|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
124980135|NCT02628028|449553524|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
124980136|NCT02628028|449553525|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
125204200|NCT01702532|450371952|FG001|Overall Study|Adverse Event|1|||
125204201|NCT01451164|450371953|FG000|Overall Study|Adverse Event|19|||
124980137|NCT02628028|449553518|FG000|Long-term Extension (LTE) Period|Other|0|||
124980138|NCT02628028|449553519|FG001|Long-term Extension (LTE) Period|Other|0|||
124980139|NCT02628028|449553520|FG002|Long-term Extension (LTE) Period|Other|0|||
124980140|NCT02628028|449553521|FG003|Long-term Extension (LTE) Period|Other|0|||
124980141|NCT02628028|449553522|FG004|Long-term Extension (LTE) Period|Other|0|||
124980142|NCT02628028|449553523|FG005|Long-term Extension (LTE) Period|Other|3|||
124980143|NCT02628028|449553524|FG006|Long-term Extension (LTE) Period|Other|4|||
124980144|NCT02628028|449553525|FG007|Long-term Extension (LTE) Period|Other|3|||
124980145|NCT04157400|449553526|FG000|Overall Study|Withdrawal by Subject|1|||
124980146|NCT04157400|449553526|FG000|Overall Study|Lost to Follow-up|3|||
124980147|NCT00186888|449553528|FG000|Overall Study|Toxicity|0|||
124980148|NCT00186888|449553529|FG001|Overall Study|Toxicity|1|||
124980149|NCT00186888|449553530|FG002|Overall Study|Toxicity|0|||
124980150|NCT00186888|449553528|FG000|Overall Study|Relapse or progression of disease|4|||
124980151|NCT00186888|449553529|FG001|Overall Study|Relapse or progression of disease|2|||
124980152|NCT00186888|449553530|FG002|Overall Study|Relapse or progression of disease|0|||
124980153|NCT02108964|449553531|FG000|Overall Study|Progressive disease|15|||
124980154|NCT02108964|449553532|FG001|Overall Study|Progressive disease|31|||
124980155|NCT02108964|449553533|FG002|Overall Study|Progressive disease|54|||
124980156|NCT02108964|449553534|FG003|Overall Study|Progressive disease|7|||
124980157|NCT02108964|449553535|FG004|Overall Study|Progressive disease|20|||
124980158|NCT02108964|449553536|FG005|Overall Study|Progressive disease|4|||
124980159|NCT02108964|449553537|FG006|Overall Study|Progressive disease|6|||
124980160|NCT02108964|449553538|FG007|Overall Study|Progressive disease|33|||
124980161|NCT02108964|449553531|FG000|Overall Study|Physician Decision|1|||
124980162|NCT02108964|449553532|FG001|Overall Study|Physician Decision|5|||
124980163|NCT02108964|449553533|FG002|Overall Study|Physician Decision|7|||
124980164|NCT02108964|449553534|FG003|Overall Study|Physician Decision|1|||
124980165|NCT02108964|449553535|FG004|Overall Study|Physician Decision|2|||
124980166|NCT02108964|449553536|FG005|Overall Study|Physician Decision|1|||
124980167|NCT02108964|449553537|FG006|Overall Study|Physician Decision|1|||
124980168|NCT02108964|449553538|FG007|Overall Study|Physician Decision|3|||
124980169|NCT02108964|449553531|FG000|Overall Study|Adverse Event|0|||
124980170|NCT02108964|449553532|FG001|Overall Study|Adverse Event|0|||
124980171|NCT02108964|449553533|FG002|Overall Study|Adverse Event|4|||
124980172|NCT02108964|449553534|FG003|Overall Study|Adverse Event|0|||
124980173|NCT02108964|449553535|FG004|Overall Study|Adverse Event|1|||
124980174|NCT02108964|449553536|FG005|Overall Study|Adverse Event|0|||
124980175|NCT02108964|449553537|FG006|Overall Study|Adverse Event|3|||
124980176|NCT02108964|449553538|FG007|Overall Study|Adverse Event|2|||
124980177|NCT02108964|449553531|FG000|Overall Study|Death|1|||
124980178|NCT02108964|449553532|FG001|Overall Study|Death|1|||
124980179|NCT02108964|449553533|FG002|Overall Study|Death|4|||
124980180|NCT02108964|449553534|FG003|Overall Study|Death|0|||
124980181|NCT02108964|449553535|FG004|Overall Study|Death|3|||
124980182|NCT02108964|449553536|FG005|Overall Study|Death|0|||
124980183|NCT02108964|449553537|FG006|Overall Study|Death|0|||
124980184|NCT02108964|449553538|FG007|Overall Study|Death|2|||
124980185|NCT02108964|449553531|FG000|Overall Study|Subject/Guardian decision|0|||
124980186|NCT02108964|449553532|FG001|Overall Study|Subject/Guardian decision|1|||
124980187|NCT02108964|449553533|FG002|Overall Study|Subject/Guardian decision|4|||
124980188|NCT02108964|449553534|FG003|Overall Study|Subject/Guardian decision|0|||
124980189|NCT02108964|449553535|FG004|Overall Study|Subject/Guardian decision|2|||
124980190|NCT02108964|449553536|FG005|Overall Study|Subject/Guardian decision|0|||
124980191|NCT02108964|449553537|FG006|Overall Study|Subject/Guardian decision|1|||
124980192|NCT02108964|449553538|FG007|Overall Study|Subject/Guardian decision|2|||
124980193|NCT02108964|449553531|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
124980194|NCT02108964|449553532|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
124980195|NCT02108964|449553533|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
124980196|NCT02108964|449553534|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
124980197|NCT02108964|449553535|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
124980198|NCT02108964|449553536|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
124980199|NCT02108964|449553537|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
124980200|NCT02108964|449553538|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
124980201|NCT02344290|449553545|FG000|Overall Study|Withdrawal by Subject|315|||
124980202|NCT02344290|449553546|FG001|Overall Study|Withdrawal by Subject|324|||
124980203|NCT02344290|449553545|FG000|Overall Study|Lost to Follow-up|258|||
124980204|NCT02344290|449553546|FG001|Overall Study|Lost to Follow-up|249|||
124980205|NCT02344290|449553545|FG000|Overall Study|Unable to get to clinic|69|||
124980206|NCT02344290|449553546|FG001|Overall Study|Unable to get to clinic|60|||
124980207|NCT02344290|449553545|FG000|Overall Study|Physician Decision|25|||
124980208|NCT02344290|449553546|FG001|Overall Study|Physician Decision|25|||
124980209|NCT02344290|449553545|FG000|Overall Study|Site Closure|15|||
124980210|NCT02344290|449553546|FG001|Overall Study|Site Closure|19|||
124980211|NCT02344290|449553545|FG000|Overall Study|Other|5|||
124980212|NCT02344290|449553546|FG001|Overall Study|Other|3|||
124980213|NCT04998812|449553547|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
124980214|NCT04998812|449553548|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
124980215|NCT04998812|449553547|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
124980216|NCT04998812|449553548|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
124980217|NCT04998812|449553547|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
124980218|NCT04998812|449553548|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
124980219|NCT04998812|449553547|FG000|Vaccination Period|Ongoing in study|23|||
124980220|NCT04998812|449553548|FG001|Vaccination Period|Ongoing in study|23|||
124980221|NCT03826030|449553549|FG000|Overall Study|Withdrawal by Subject|2|||
124980222|NCT03826030|449553550|FG001|Overall Study|Withdrawal by Subject|0|||
124980223|NCT03826030|449553551|FG002|Overall Study|Withdrawal by Subject|1|||
124980224|NCT03826030|449553549|FG000|Overall Study|Lost to Follow-up|1|||
124980225|NCT03826030|449553550|FG001|Overall Study|Lost to Follow-up|1|||
124980226|NCT03826030|449553551|FG002|Overall Study|Lost to Follow-up|1|||
124980227|NCT03826030|449553549|FG000|Overall Study|Too busy to return for visits|1|||
124980228|NCT03826030|449553550|FG001|Overall Study|Too busy to return for visits|0|||
124980229|NCT03826030|449553551|FG002|Overall Study|Too busy to return for visits|0|||
124980230|NCT04893460|449553556|FG000|Overall Study|Lost to Follow-up|18|||
124980231|NCT05718466|449555064|FG000|Overall Study|Withdrawal by Subject|1|||
124980232|NCT05718466|449555065|FG001|Overall Study|Withdrawal by Subject|2|||
124980233|NCT05718466|449555064|FG000|Overall Study|Death|0|||
124980234|NCT05718466|449555065|FG001|Overall Study|Death|1|||
124980235|NCT03203473|449555066|FG000|Induction Phase|Never started primary treatment|2|||
124980236|NCT03203473|449555067|FG001|Induction Phase|Never started primary treatment|0|||
124980237|NCT03203473|449555068|FG002|Induction Phase|Never started primary treatment|0|||
124980238|NCT03203473|449555066|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
124980239|NCT03203473|449555067|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
125204202|NCT01451164|450371954|FG001|Overall Study|Adverse Event|12|||
125204203|NCT01451164|450371955|FG002|Overall Study|Adverse Event|18|||
125204204|NCT01451164|450371956|FG003|Overall Study|Adverse Event|21|||
125204205|NCT01451164|450371953|FG000|Overall Study|Withdrawal Criteria|1|||
125204206|NCT01451164|450371954|FG001|Overall Study|Withdrawal Criteria|1|||
125204207|NCT01451164|450371955|FG002|Overall Study|Withdrawal Criteria|1|||
125204208|NCT01451164|450371956|FG003|Overall Study|Withdrawal Criteria|1|||
125204209|NCT01451164|450371953|FG000|Overall Study|Physician Decision|2|||
125204210|NCT01451164|450371954|FG001|Overall Study|Physician Decision|0|||
125204211|NCT01451164|450371955|FG002|Overall Study|Physician Decision|1|||
125204212|NCT01451164|450371956|FG003|Overall Study|Physician Decision|0|||
125204213|NCT01451164|450371953|FG000|Overall Study|Withdrawal by Subject|14|||
125204214|NCT01451164|450371954|FG001|Overall Study|Withdrawal by Subject|11|||
125204215|NCT01451164|450371955|FG002|Overall Study|Withdrawal by Subject|16|||
125204216|NCT01451164|450371956|FG003|Overall Study|Withdrawal by Subject|17|||
125204217|NCT01451164|450371953|FG000|Overall Study|Protocol Violation|0|||
124871892|NCT01203930|449152712|FG001|Overall Study|Withdrew Consent|10|||
124871893|NCT01203930|449152711|FG000|Overall Study|Investigator Request|0|||
124871894|NCT01203930|449152712|FG001|Overall Study|Investigator Request|8|||
124871895|NCT01203930|449152711|FG000|Overall Study|Study Terminated by Sponsor|0|||
124871896|NCT01203930|449152712|FG001|Overall Study|Study Terminated by Sponsor|12|||
124871897|NCT01203930|449152711|FG000|Overall Study|Poor tolerance of study drug|0|||
124871898|NCT01203930|449152712|FG001|Overall Study|Poor tolerance of study drug|1|||
124871899|NCT01203930|449152711|FG000|Overall Study|Adverse Event|17|||
124871900|NCT01203930|449152712|FG001|Overall Study|Adverse Event|5|||
124871901|NCT03966053|449152713|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
124871902|NCT04098406|449152716|FG000|Overall Study|Adverse Event|2|||
124871903|NCT04098406|449152717|FG001|Overall Study|Adverse Event|1|||
124871904|NCT04098406|449152716|FG000|Overall Study|Withdrawal by Subject|1|||
124871905|NCT04098406|449152717|FG001|Overall Study|Withdrawal by Subject|0|||
124871906|NCT01783418|449152721|FG000|Overall Study|Withdrawal by Subject|1|||
124871907|NCT01783418|449152722|FG001|Overall Study|Withdrawal by Subject|0|||
124871908|NCT04791761|449152723|FG000|Overall Study|Lost to Follow-up|8|||
124871909|NCT04791761|449152724|FG001|Overall Study|Lost to Follow-up|6|||
124871910|NCT04791761|449152725|FG002|Overall Study|Lost to Follow-up|10|||
124871911|NCT04791761|449152723|FG000|Overall Study|Withdrawal by Subject|0|||
124871912|NCT04791761|449152724|FG001|Overall Study|Withdrawal by Subject|1|||
124871913|NCT04791761|449152725|FG002|Overall Study|Withdrawal by Subject|1|||
124871914|NCT04791761|449152723|FG000|Overall Study|Protocol Violation|0|||
124871915|NCT04791761|449152724|FG001|Overall Study|Protocol Violation|1|||
124871916|NCT04791761|449152725|FG002|Overall Study|Protocol Violation|1|||
124871917|NCT03548207|449152726|FG000|Overall Study|Death|10|||
124871918|NCT03548207|449152727|FG001|Overall Study|Death|23|||
124871919|NCT03548207|449152728|FG002|Overall Study|Death|3|||
124871920|NCT03548207|449152726|FG000|Overall Study|Lost to Follow-up|0|||
124871921|NCT03548207|449152727|FG001|Overall Study|Lost to Follow-up|2|||
124871922|NCT03548207|449152728|FG002|Overall Study|Lost to Follow-up|0|||
124980240|NCT03203473|449555068|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
124980241|NCT03203473|449555066|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
124980242|NCT03203473|449555067|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
124980243|NCT03203473|449555068|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
124980244|NCT03203473|449555066|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
124980245|NCT03203473|449555067|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
124980246|NCT03203473|449555068|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
124980247|NCT03203473|449555066|FG000|Arm Allocation Phase|started salvage therapy|0|||
124980248|NCT03203473|449555067|FG001|Arm Allocation Phase|started salvage therapy|5|||
124980249|NCT03203473|449555068|FG002|Arm Allocation Phase|started salvage therapy|0|||
124980250|NCT03203473|449555066|FG000|Arm Allocation Phase|Disease progression|0|||
124980251|NCT03203473|449555067|FG001|Arm Allocation Phase|Disease progression|0|||
124980252|NCT03203473|449555068|FG002|Arm Allocation Phase|Disease progression|37|||
124980253|NCT03203473|449555066|FG000|Arm Allocation Phase|Adverse Event|0|||
124980254|NCT03203473|449555067|FG001|Arm Allocation Phase|Adverse Event|0|||
124980255|NCT03203473|449555068|FG002|Arm Allocation Phase|Adverse Event|11|||
124980256|NCT03203473|449555066|FG000|Arm Allocation Phase|Physician Decision|0|||
124980257|NCT03203473|449555067|FG001|Arm Allocation Phase|Physician Decision|0|||
124980258|NCT03203473|449555068|FG002|Arm Allocation Phase|Physician Decision|3|||
124980259|NCT03203473|449555066|FG000|Arm Allocation Phase|Death|0|||
124980260|NCT03203473|449555067|FG001|Arm Allocation Phase|Death|0|||
124980261|NCT03203473|449555068|FG002|Arm Allocation Phase|Death|1|||
124980262|NCT03203473|449555066|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
124980263|NCT03203473|449555067|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
124980264|NCT03203473|449555068|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
124980265|NCT03203473|449555066|FG000|Arm Allocation Phase|Intercurrent illness|0|||
124980266|NCT03203473|449555067|FG001|Arm Allocation Phase|Intercurrent illness|0|||
124980267|NCT03203473|449555068|FG002|Arm Allocation Phase|Intercurrent illness|1|||
124980268|NCT03203473|449555066|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
124980269|NCT03203473|449555067|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
124980270|NCT03203473|449555068|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
124980271|NCT00568178|449555073|FG000|Double Blind Base Study|Adverse Event|0|||
124980272|NCT00568178|449555074|FG001|Double Blind Base Study|Adverse Event|2|||
124980273|NCT00568178|449555075|FG002|Double Blind Base Study|Adverse Event|1|||
124980274|NCT00568178|449555076|FG003|Double Blind Base Study|Adverse Event|2|||
124980275|NCT00568178|449555077|FG004|Double Blind Base Study|Adverse Event|0|||
124980276|NCT00568178|449555078|FG005|Double Blind Base Study|Adverse Event|0|||
124980277|NCT00568178|449555073|FG000|Double Blind Base Study|Lost to Follow-up|1|||
124980278|NCT00568178|449555074|FG001|Double Blind Base Study|Lost to Follow-up|0|||
124980279|NCT00568178|449555075|FG002|Double Blind Base Study|Lost to Follow-up|0|||
124980280|NCT00568178|449555076|FG003|Double Blind Base Study|Lost to Follow-up|1|||
124980281|NCT00568178|449555077|FG004|Double Blind Base Study|Lost to Follow-up|0|||
124980282|NCT00568178|449555078|FG005|Double Blind Base Study|Lost to Follow-up|0|||
124980283|NCT00568178|449555073|FG000|Double Blind Base Study|Physician Decision|1|||
124980284|NCT00568178|449555074|FG001|Double Blind Base Study|Physician Decision|1|||
124980285|NCT00568178|449555075|FG002|Double Blind Base Study|Physician Decision|0|||
124980286|NCT00568178|449555076|FG003|Double Blind Base Study|Physician Decision|1|||
124980287|NCT00568178|449555077|FG004|Double Blind Base Study|Physician Decision|0|||
124980288|NCT00568178|449555078|FG005|Double Blind Base Study|Physician Decision|0|||
124980289|NCT00568178|449555073|FG000|Double Blind Base Study|Protocol Violation|3|||
124980290|NCT00568178|449555074|FG001|Double Blind Base Study|Protocol Violation|2|||
124980291|NCT00568178|449555075|FG002|Double Blind Base Study|Protocol Violation|0|||
124980292|NCT00568178|449555076|FG003|Double Blind Base Study|Protocol Violation|0|||
124980293|NCT00568178|449555077|FG004|Double Blind Base Study|Protocol Violation|0|||
124980294|NCT00568178|449555078|FG005|Double Blind Base Study|Protocol Violation|0|||
124980295|NCT00568178|449555073|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
124980296|NCT00568178|449555074|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
124980297|NCT00568178|449555075|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
124980298|NCT00568178|449555076|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
124980299|NCT00568178|449555077|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
125204218|NCT01451164|450371954|FG001|Overall Study|Protocol Violation|1|||
125204219|NCT01451164|450371955|FG002|Overall Study|Protocol Violation|0|||
124980300|NCT00568178|449555078|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
124980301|NCT00568178|449555073|FG000|Double Blind Base Study|Progressive Disease|0|||
124980302|NCT00568178|449555074|FG001|Double Blind Base Study|Progressive Disease|0|||
124980303|NCT00568178|449555075|FG002|Double Blind Base Study|Progressive Disease|0|||
124980304|NCT00568178|449555076|FG003|Double Blind Base Study|Progressive Disease|1|||
124980305|NCT00568178|449555077|FG004|Double Blind Base Study|Progressive Disease|0|||
124980306|NCT00568178|449555078|FG005|Double Blind Base Study|Progressive Disease|0|||
125204220|NCT01451164|450371956|FG003|Overall Study|Protocol Violation|0|||
124980307|NCT00568178|449555073|FG000|Open Label Extension|Adverse Event|0|||
125204221|NCT01451164|450371953|FG000|Overall Study|Lack of Efficacy|7|||
125204222|NCT01451164|450371954|FG001|Overall Study|Lack of Efficacy|9|||
124980308|NCT00568178|449555074|FG001|Open Label Extension|Adverse Event|0|||
124980309|NCT00568178|449555075|FG002|Open Label Extension|Adverse Event|0|||
124980310|NCT00568178|449555076|FG003|Open Label Extension|Adverse Event|0|||
124980311|NCT00568178|449555077|FG004|Open Label Extension|Adverse Event|11|||
124980312|NCT00568178|449555078|FG005|Open Label Extension|Adverse Event|8|||
124980313|NCT00568178|449555073|FG000|Open Label Extension|Protocol Violation|0|||
124980314|NCT00568178|449555074|FG001|Open Label Extension|Protocol Violation|0|||
124980315|NCT00568178|449555075|FG002|Open Label Extension|Protocol Violation|0|||
124980316|NCT00568178|449555076|FG003|Open Label Extension|Protocol Violation|0|||
124980317|NCT00568178|449555077|FG004|Open Label Extension|Protocol Violation|1|||
124980318|NCT00568178|449555078|FG005|Open Label Extension|Protocol Violation|0|||
124980319|NCT00568178|449555073|FG000|Open Label Extension|Lost to Follow-up|0|||
124980320|NCT00568178|449555074|FG001|Open Label Extension|Lost to Follow-up|0|||
124980321|NCT00568178|449555075|FG002|Open Label Extension|Lost to Follow-up|0|||
124980322|NCT00568178|449555076|FG003|Open Label Extension|Lost to Follow-up|0|||
124980323|NCT00568178|449555077|FG004|Open Label Extension|Lost to Follow-up|6|||
124980324|NCT00568178|449555078|FG005|Open Label Extension|Lost to Follow-up|11|||
124980325|NCT00568178|449555073|FG000|Open Label Extension|Physician Decision|0|||
124980326|NCT00568178|449555074|FG001|Open Label Extension|Physician Decision|0|||
124980327|NCT00568178|449555075|FG002|Open Label Extension|Physician Decision|0|||
124980328|NCT00568178|449555076|FG003|Open Label Extension|Physician Decision|0|||
124980329|NCT00568178|449555077|FG004|Open Label Extension|Physician Decision|9|||
124980330|NCT00568178|449555078|FG005|Open Label Extension|Physician Decision|8|||
124980331|NCT00568178|449555073|FG000|Open Label Extension|Pregnancy|0|||
124980332|NCT00568178|449555074|FG001|Open Label Extension|Pregnancy|0|||
125204223|NCT01451164|450371955|FG002|Overall Study|Lack of Efficacy|9|||
125204224|NCT01451164|450371956|FG003|Overall Study|Lack of Efficacy|7|||
125204225|NCT01846221|450371957|FG000|Overall Study|Catheter Failure|2|||
125204226|NCT01846221|450371958|FG001|Overall Study|Catheter Failure|0|||
125204227|NCT01846221|450371957|FG000|Overall Study|Age Exclusion|1|||
125204228|NCT01846221|450371958|FG001|Overall Study|Age Exclusion|0|||
125204229|NCT02879994|450371959|FG000|Overall Study|off treatment early|7|||
125204230|NCT02879994|450371959|FG000|Overall Study|Adverse Event|2|||
125204231|NCT02879994|450371959|FG000|Overall Study|Death|2|||
125204232|NCT02052596|450371960|FG000|Active Phase|Adverse Event|3|||
125204233|NCT02052596|450371961|FG001|Active Phase|Adverse Event|2|||
125204234|NCT02052596|450371960|FG000|Active Phase|Lost to Follow-up|8|||
125204235|NCT02052596|450371961|FG001|Active Phase|Lost to Follow-up|11|||
125204236|NCT02052596|450371960|FG000|Active Phase|Protocol Violation|1|||
125204237|NCT02052596|450371961|FG001|Active Phase|Protocol Violation|2|||
125204238|NCT02052596|450371960|FG000|Active Phase|Withdrawal by Subject|3|||
125204239|NCT02052596|450371961|FG001|Active Phase|Withdrawal by Subject|4|||
125204240|NCT02052596|450371960|FG000|Active Phase|Enrolled in error|1|||
124871923|NCT03548207|449152726|FG000|Overall Study|Withdrawal by Subject|0|||
124871924|NCT03548207|449152727|FG001|Overall Study|Withdrawal by Subject|3|||
124871925|NCT03548207|449152728|FG002|Overall Study|Withdrawal by Subject|0|||
124871926|NCT03548207|449152726|FG000|Overall Study|Sponsor decision|19|||
124871927|NCT03548207|449152727|FG001|Overall Study|Sponsor decision|40|||
124871928|NCT03548207|449152728|FG002|Overall Study|Sponsor decision|6|||
124871929|NCT03548207|449152726|FG000|Overall Study|Randomized but not treated|6|||
124871930|NCT03548207|449152727|FG001|Overall Study|Randomized but not treated|10|||
124871931|NCT03548207|449152728|FG002|Overall Study|Randomized but not treated|4|||
124871932|NCT01756352|449152729|FG000|Overall Study|moved away and lost to followup|1|||
124871933|NCT00415610|449152730|FG000|Overall Study|Death|3|||
124871934|NCT00415610|449152731|FG001|Overall Study|Death|2|||
124871935|NCT00415610|449152732|FG002|Overall Study|Death|5|||
124871936|NCT00999466|449152735|FG000|Main Part|Withdrawal by Subject|0|||
124871937|NCT00999466|449152736|FG001|Main Part|Withdrawal by Subject|0|||
124871938|NCT00999466|449152737|FG002|Main Part|Withdrawal by Subject|2|||
124871939|NCT00999466|449152735|FG000|Main Part|Adverse Event|0|||
124871940|NCT00999466|449152736|FG001|Main Part|Adverse Event|4|||
124871941|NCT00999466|449152737|FG002|Main Part|Adverse Event|2|||
124871942|NCT01113502|449152739|FG000|Overall Study|Withdrawal by Subject|1|||
124871943|NCT01113502|449152740|FG001|Overall Study|Withdrawal by Subject|0|||
124871944|NCT01113502|449152741|FG002|Overall Study|Withdrawal by Subject|1|||
124871945|NCT01113502|449152742|FG003|Overall Study|Withdrawal by Subject|1|||
124871946|NCT01113502|449152743|FG004|Overall Study|Withdrawal by Subject|0|||
124871947|NCT01113502|449152739|FG000|Overall Study|Adverse Event|0|||
124871948|NCT01113502|449152740|FG001|Overall Study|Adverse Event|0|||
124871949|NCT01113502|449152741|FG002|Overall Study|Adverse Event|3|||
124871950|NCT01113502|449152742|FG003|Overall Study|Adverse Event|2|||
124871951|NCT01113502|449152743|FG004|Overall Study|Adverse Event|0|||
124871952|NCT03002610|449152752|FG000|Overall Study|Withdrawal by Subject|6|||
125204241|NCT02052596|450371961|FG001|Active Phase|Enrolled in error|0|||
124980333|NCT00568178|449555075|FG002|Open Label Extension|Pregnancy|0|||
125204242|NCT02052596|450371960|FG000|Active Phase|Lost due to Crohn's disease|0|||
125204243|NCT02052596|450371961|FG001|Active Phase|Lost due to Crohn's disease|1|||
124871953|NCT03002610|449152753|FG001|Overall Study|Withdrawal by Subject|25|||
124980334|NCT00568178|449555076|FG003|Open Label Extension|Pregnancy|0|||
124980335|NCT00568178|449555077|FG004|Open Label Extension|Pregnancy|0|||
124980336|NCT00568178|449555078|FG005|Open Label Extension|Pregnancy|1|||
124980337|NCT00568178|449555073|FG000|Open Label Extension|Progressive Disease|0|||
124980338|NCT00568178|449555074|FG001|Open Label Extension|Progressive Disease|0|||
124980339|NCT00568178|449555075|FG002|Open Label Extension|Progressive Disease|0|||
124980340|NCT00568178|449555076|FG003|Open Label Extension|Progressive Disease|0|||
124980341|NCT00568178|449555077|FG004|Open Label Extension|Progressive Disease|3|||
124980342|NCT00568178|449555078|FG005|Open Label Extension|Progressive Disease|1|||
124980343|NCT00568178|449555073|FG000|Open Label Extension|Termination of Trial|0|||
124980344|NCT00568178|449555074|FG001|Open Label Extension|Termination of Trial|0|||
125204244|NCT02052596|450371960|FG000|Safety Phase|Adverse Event|6|||
125204245|NCT02052596|450371961|FG001|Safety Phase|Adverse Event|3|||
125204246|NCT02052596|450371960|FG000|Safety Phase|Lost to Follow-up|11|||
125204247|NCT02052596|450371961|FG001|Safety Phase|Lost to Follow-up|18|||
125204248|NCT02052596|450371960|FG000|Safety Phase|Protocol Violation|1|||
125204249|NCT02052596|450371961|FG001|Safety Phase|Protocol Violation|2|||
125204250|NCT02052596|450371960|FG000|Safety Phase|Withdrawal by Subject|8|||
125204251|NCT02052596|450371961|FG001|Safety Phase|Withdrawal by Subject|11|||
125204252|NCT02052596|450371960|FG000|Safety Phase|Enrolled in error|1|||
125204253|NCT02052596|450371961|FG001|Safety Phase|Enrolled in error|0|||
125204254|NCT02052596|450371960|FG000|Safety Phase|Lost due to Crohn's disease|0|||
125204255|NCT02052596|450371961|FG001|Safety Phase|Lost due to Crohn's disease|1|||
125204256|NCT00705718|450371962|FG000|Overall Study|Death|6|||
125204257|NCT00705718|450371963|FG001|Overall Study|Death|6|||
125204258|NCT00705718|450371962|FG000|Overall Study|Not due for Visit|0|||
125204259|NCT00705718|450371963|FG001|Overall Study|Not due for Visit|12|||
125204260|NCT00705718|450371962|FG000|Overall Study|Follow up not done|1|||
125204261|NCT00705718|450371963|FG001|Overall Study|Follow up not done|4|||
125204262|NCT06137703|450371965|FG000|Overall Study|Other|0|||
125204263|NCT06137703|450371966|FG001|Overall Study|Other|1|||
125204264|NCT06137703|450371967|FG002|Overall Study|Other|0|||
125204265|NCT06137703|450371968|FG003|Overall Study|Other|0|||
125204266|NCT06137703|450371965|FG000|Overall Study|Adverse Event|0|||
125204267|NCT06137703|450371966|FG001|Overall Study|Adverse Event|0|||
125204268|NCT06137703|450371967|FG002|Overall Study|Adverse Event|1|||
125204269|NCT06137703|450371968|FG003|Overall Study|Adverse Event|0|||
125204270|NCT00741091|450371971|FG000|Overall Study|Death|13|||
125204271|NCT00741091|450371971|FG000|Overall Study|Lost to Follow-up|16|||
125204272|NCT00741091|450371971|FG000|Overall Study|Withdrawal by Subject|6|||
125204273|NCT00741091|450371971|FG000|Overall Study|Missed Visit|22|||
125204274|NCT01801358|450371972|FG000|Overall Study|Adverse Event|0|||
125204275|NCT01801358|450371973|FG001|Overall Study|Adverse Event|2|||
125204276|NCT01801358|450371974|FG002|Overall Study|Adverse Event|1|||
125204277|NCT01801358|450371975|FG003|Overall Study|Adverse Event|0|||
125204278|NCT01801358|450371976|FG004|Overall Study|Adverse Event|0|||
125204279|NCT01801358|450371977|FG005|Overall Study|Adverse Event|1|||
125204280|NCT01801358|450371972|FG000|Overall Study|Physician Decision|0|||
125204281|NCT01801358|450371973|FG001|Overall Study|Physician Decision|0|||
125204282|NCT01801358|450371974|FG002|Overall Study|Physician Decision|1|||
125204283|NCT01801358|450371975|FG003|Overall Study|Physician Decision|0|||
125204284|NCT01801358|450371976|FG004|Overall Study|Physician Decision|0|||
125204285|NCT01801358|450371977|FG005|Overall Study|Physician Decision|0|||
125204286|NCT01801358|450371972|FG000|Overall Study|Progressive Disease|6|||
125204287|NCT01801358|450371973|FG001|Overall Study|Progressive Disease|4|||
125204288|NCT01801358|450371974|FG002|Overall Study|Progressive Disease|4|||
125204289|NCT01801358|450371975|FG003|Overall Study|Progressive Disease|5|||
125204290|NCT01801358|450371976|FG004|Overall Study|Progressive Disease|6|||
125204291|NCT01801358|450371977|FG005|Overall Study|Progressive Disease|5|||
125204292|NCT01801358|450371972|FG000|Overall Study|Withdrawal by Subject|0|||
125204293|NCT01801358|450371973|FG001|Overall Study|Withdrawal by Subject|0|||
125204294|NCT01801358|450371974|FG002|Overall Study|Withdrawal by Subject|0|||
125204295|NCT01801358|450371975|FG003|Overall Study|Withdrawal by Subject|1|||
125204296|NCT01801358|450371976|FG004|Overall Study|Withdrawal by Subject|0|||
125204297|NCT01801358|450371977|FG005|Overall Study|Withdrawal by Subject|2|||
125204298|NCT00723190|450371979|FG000|Overall Study|Withdrawal by Subject|45|||
125204299|NCT00723190|450371979|FG000|Overall Study|Lost to Follow-up|37|||
124980345|NCT00568178|449555075|FG002|Open Label Extension|Termination of Trial|0|||
125204300|NCT00723190|450371979|FG000|Overall Study|Adverse Event|18|||
125204301|NCT00723190|450371979|FG000|Overall Study|Lack of Efficacy|16|||
124980346|NCT00568178|449555076|FG003|Open Label Extension|Termination of Trial|0|||
124980347|NCT00568178|449555077|FG004|Open Label Extension|Termination of Trial|45|||
125204302|NCT00723190|450371979|FG000|Overall Study|Protocol Violation|15|||
124980348|NCT00568178|449555078|FG005|Open Label Extension|Termination of Trial|47|||
125204303|NCT00723190|450371979|FG000|Overall Study|Other-Premature Discontinuation|9|||
125204304|NCT00723190|450371979|FG000|Overall Study|Other-Not included in safety population|2|||
125204305|NCT03181503|450371980|FG000|Overall Study|Adverse Event|2|||
125204306|NCT03181503|450371981|FG001|Overall Study|Adverse Event|2|||
125204307|NCT03181503|450371980|FG000|Overall Study|Protocol Violation|1|||
125204308|NCT03181503|450371981|FG001|Overall Study|Protocol Violation|0|||
125204309|NCT03181503|450371980|FG000|Overall Study|Withdrawal by Subject|3|||
125204310|NCT03181503|450371981|FG001|Overall Study|Withdrawal by Subject|0|||
125204311|NCT03181503|450371980|FG000|Overall Study|Lost to Follow-up|1|||
125204312|NCT03181503|450371981|FG001|Overall Study|Lost to Follow-up|1|||
125204313|NCT02505334|450371992|FG000|Main Treatment Period|Adverse Event|3|||
125204314|NCT02505334|450371993|FG001|Main Treatment Period|Adverse Event|3|||
125204315|NCT02505334|450371992|FG000|Main Treatment Period|Lack of Efficacy|7|||
124980349|NCT00568178|449555073|FG000|Open Label Extension|Withdrawal by Subject|0|||
124980350|NCT00568178|449555074|FG001|Open Label Extension|Withdrawal by Subject|0|||
124980351|NCT00568178|449555075|FG002|Open Label Extension|Withdrawal by Subject|0|||
124980352|NCT00568178|449555076|FG003|Open Label Extension|Withdrawal by Subject|0|||
124980353|NCT00568178|449555077|FG004|Open Label Extension|Withdrawal by Subject|4|||
124980354|NCT00568178|449555078|FG005|Open Label Extension|Withdrawal by Subject|4|||
124980355|NCT01008553|449555079|FG000|Period 1 (Titration Period)|Physician Decision|2|||
124980356|NCT01008553|449555080|FG001|Period 1 (Titration Period)|Physician Decision|0|||
124980357|NCT01008553|449555081|FG002|Period 1 (Titration Period)|Physician Decision|0|||
124980358|NCT01008553|449555079|FG000|Period 1 (Titration Period)|Adverse Event|33|||
124980359|NCT01008553|449555080|FG001|Period 1 (Titration Period)|Adverse Event|0|||
124980360|NCT01008553|449555081|FG002|Period 1 (Titration Period)|Adverse Event|0|||
124980361|NCT01008553|449555079|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
124980362|NCT01008553|449555080|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
124980363|NCT01008553|449555081|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
124980364|NCT01008553|449555079|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
124980365|NCT01008553|449555080|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
124980366|NCT01008553|449555081|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
124980367|NCT01008553|449555079|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
124980368|NCT01008553|449555080|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
124980369|NCT01008553|449555081|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
124980370|NCT01008553|449555079|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
124980371|NCT01008553|449555080|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
124980372|NCT01008553|449555081|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
124980373|NCT01008553|449555079|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
124980374|NCT01008553|449555080|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
124980375|NCT01008553|449555081|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
124980376|NCT01008553|449555079|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
124980377|NCT01008553|449555080|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
124980378|NCT01008553|449555081|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
124980379|NCT01008553|449555079|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
124980380|NCT01008553|449555080|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
124980381|NCT01008553|449555081|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
124980382|NCT01008553|449555079|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
124980383|NCT01008553|449555080|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
124980384|NCT01008553|449555081|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
124980385|NCT01008553|449555079|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
124980386|NCT01008553|449555080|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
124980387|NCT01008553|449555081|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
124980388|NCT01008553|449555079|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
124980389|NCT01008553|449555080|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
124980390|NCT01008553|449555081|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
124980391|NCT01008553|449555079|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
124980392|NCT01008553|449555080|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
124980393|NCT01008553|449555081|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
124980394|NCT01008553|449555079|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
124980395|NCT01008553|449555080|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
124980396|NCT01008553|449555081|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
124980397|NCT04138576|449555082|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
124980398|NCT03563157|449555089|FG000|Overall Study|Progressive Disease|2|||
124980399|NCT04335591|449555090|FG000|Overall Study|Adverse Event|5|||
124980400|NCT04335591|449555091|FG001|Overall Study|Adverse Event|2|||
124980401|NCT04335591|449555092|FG002|Overall Study|Adverse Event|3|||
124980402|NCT04335591|449555093|FG003|Overall Study|Adverse Event|2|||
124980403|NCT04335591|449555090|FG000|Overall Study|Protocol Violation|1|||
124980404|NCT04335591|449555091|FG001|Overall Study|Protocol Violation|0|||
124980405|NCT04335591|449555092|FG002|Overall Study|Protocol Violation|0|||
125204316|NCT02505334|450371993|FG001|Main Treatment Period|Lack of Efficacy|17|||
125204317|NCT02505334|450371992|FG000|Main Treatment Period|Protocol Violation|0|||
124980406|NCT04335591|449555093|FG003|Overall Study|Protocol Violation|0|||
124980407|NCT04335591|449555090|FG000|Overall Study|Withdrawal by Subject|8|||
124980408|NCT04335591|449555091|FG001|Overall Study|Withdrawal by Subject|4|||
124980409|NCT04335591|449555092|FG002|Overall Study|Withdrawal by Subject|4|||
124980410|NCT04335591|449555093|FG003|Overall Study|Withdrawal by Subject|5|||
124980411|NCT04335591|449555090|FG000|Overall Study|Subject planning pregnancy|0|||
124980412|NCT04335591|449555091|FG001|Overall Study|Subject planning pregnancy|1|||
124980413|NCT04335591|449555092|FG002|Overall Study|Subject planning pregnancy|0|||
124980414|NCT04335591|449555093|FG003|Overall Study|Subject planning pregnancy|0|||
124980415|NCT04335591|449555090|FG000|Overall Study|Ukrainian Russian war conflict|4|||
124980416|NCT04335591|449555091|FG001|Overall Study|Ukrainian Russian war conflict|5|||
124980417|NCT04335591|449555092|FG002|Overall Study|Ukrainian Russian war conflict|2|||
124980418|NCT04335591|449555093|FG003|Overall Study|Ukrainian Russian war conflict|0|||
124980419|NCT03268603|449555094|FG000|Overall Study|Withdrawal by Subject|6|||
124980420|NCT03268603|449555094|FG000|Overall Study|Physician Decision|1|||
124980421|NCT03268603|449555094|FG000|Overall Study|Withdrawn due to disease progression|2|||
124980422|NCT00356408|449555095|FG000|Overall Study|Adverse Event|9|||
124980423|NCT00356408|449555095|FG000|Overall Study|Lack of Efficacy|36|||
124980424|NCT00356408|449555095|FG000|Overall Study|Lost to Follow-up|2|||
124980425|NCT00356408|449555095|FG000|Overall Study|Withdrawal by Subject|6|||
124980426|NCT00356408|449555095|FG000|Overall Study|Other: Principal investigator discretion|3|||
124980427|NCT00356408|449555095|FG000|Overall Study|Other: Sponsor request|1|||
124980428|NCT00356408|449555095|FG000|Overall Study|Other: Azathioprine stopped|1|||
124980429|NCT00356408|449555095|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
124980430|NCT00356408|449555095|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
124980431|NCT05775991|449555097|FG000|Overall Study|Withdrawal by Subject|0|||
124980432|NCT05775991|449555098|FG001|Overall Study|Withdrawal by Subject|0|||
124980433|NCT05775991|449555099|FG002|Overall Study|Withdrawal by Subject|2|||
124980434|NCT04514510|449555100|FG000|Overall Study|Lost to Follow-up|0|||
124980435|NCT04514510|449555101|FG001|Overall Study|Lost to Follow-up|1|||
124980436|NCT04514510|449555100|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
124980437|NCT04514510|449555101|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
124980438|NCT00406692|449555102|FG000|Overall Study|Withdrawal by Subject|4|||
124980439|NCT00406692|449555102|FG000|Overall Study|Physician Decision|1|||
124980440|NCT00406692|449555102|FG000|Overall Study|Adverse Event|1|||
124980441|NCT00406692|449555102|FG000|Overall Study|Lack of Efficacy|1|||
124980442|NCT03174431|449555103|FG000|Overall Study|Withdrawal by Subject|14|||
124980443|NCT03174431|449555104|FG001|Overall Study|Withdrawal by Subject|11|||
124980444|NCT03174431|449555103|FG000|Overall Study|alternative treatment|2|||
124980445|NCT03174431|449555104|FG001|Overall Study|alternative treatment|0|||
124980446|NCT03174431|449555103|FG000|Overall Study|Lost to Follow-up|1|||
124980447|NCT03174431|449555104|FG001|Overall Study|Lost to Follow-up|5|||
124980448|NCT01867333|449555105|FG000|Overall Study|Withdrawal by Subject|1|||
124980449|NCT01867333|449555106|FG001|Overall Study|Withdrawal by Subject|0|||
125204318|NCT02505334|450371993|FG001|Main Treatment Period|Protocol Violation|1|||
125204319|NCT02505334|450371992|FG000|Main Treatment Period|Withdrawal by Subject|1|||
125204320|NCT02505334|450371993|FG001|Main Treatment Period|Withdrawal by Subject|8|||
125204321|NCT02505334|450371992|FG000|Main Treatment Period|Unclassified|4|||
125204322|NCT02505334|450371993|FG001|Main Treatment Period|Unclassified|10|||
125204323|NCT02505334|450371992|FG000|Extension Treatment Period|Adverse Event|5|||
125204324|NCT02505334|450371993|FG001|Extension Treatment Period|Adverse Event|0|||
125204325|NCT02505334|450371992|FG000|Extension Treatment Period|Lack of Efficacy|4|||
125204326|NCT02505334|450371993|FG001|Extension Treatment Period|Lack of Efficacy|0|||
125204327|NCT02505334|450371992|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
125204328|NCT02505334|450371993|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
125204329|NCT02505334|450371992|FG000|Extension Treatment Period|Unclassified|3|||
125204330|NCT02505334|450371993|FG001|Extension Treatment Period|Unclassified|0|||
125204331|NCT03199612|450371994|FG000|Overall Study|Adverse Event|1|||
124980450|NCT01867333|449555105|FG000|Overall Study|Adverse Event|1|||
124980451|NCT01867333|449555106|FG001|Overall Study|Adverse Event|0|||
124980452|NCT01867333|449555105|FG000|Overall Study|Participant choice|1|||
124980453|NCT01867333|449555106|FG001|Overall Study|Participant choice|2|||
125204332|NCT03199612|450371995|FG001|Overall Study|Adverse Event|0|||
125204333|NCT00081731|450372001|FG000|Overall Study|scientific integrity issue|8|||
124980454|NCT01867333|449555105|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
124980455|NCT01867333|449555106|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
124980456|NCT01867333|449555105|FG000|Overall Study|Death|0|||
124980457|NCT01867333|449555106|FG001|Overall Study|Death|1|||
125204334|NCT00081731|450372002|FG001|Overall Study|scientific integrity issue|8|||
125204335|NCT02386345|450372006|FG000|Overall Study|Not treated|14|||
125204336|NCT02386345|450372006|FG000|Overall Study|Lost to Follow-up|1|||
125204337|NCT02386345|450372006|FG000|Overall Study|Adverse Event|5|||
124980458|NCT01867333|449555105|FG000|Overall Study|Physician Decision|3|||
124980459|NCT01867333|449555106|FG001|Overall Study|Physician Decision|2|||
125089790|NCT01117428|449947028|FG005|Overall Study|Death|1|||
124980460|NCT01867333|449555105|FG000|Overall Study|Switched to alternative treatment|1|||
124980461|NCT01867333|449555106|FG001|Overall Study|Switched to alternative treatment|0|||
124980462|NCT01145898|449555107|FG000|3-year Treatment|medication change by treating physician|3|||
124980463|NCT01145898|449555108|FG001|3-year Treatment|medication change by treating physician|16|||
125204338|NCT02386345|450372006|FG000|Overall Study|Repeat Procedure|10|||
125204339|NCT02386345|450372006|FG000|Overall Study|Did not complete 12-month follow-up|72|||
125204340|NCT04050124|450372007|FG000|Overall Study|Death|1|||
125204341|NCT04050124|450372008|FG001|Overall Study|Death|0|||
124980464|NCT00951015|449555111|FG000|Randomization Phase 96 Week|Adverse Event|1|||
124980465|NCT00951015|449555112|FG001|Randomization Phase 96 Week|Adverse Event|1|||
124980466|NCT00951015|449555113|FG002|Randomization Phase 96 Week|Adverse Event|2|||
124980467|NCT00951015|449555114|FG003|Randomization Phase 96 Week|Adverse Event|5|||
124980468|NCT00951015|449555115|FG004|Randomization Phase 96 Week|Adverse Event|0|||
124980469|NCT00951015|449555111|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
124980470|NCT00951015|449555112|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
124980471|NCT00951015|449555113|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
124980472|NCT00951015|449555114|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
124980473|NCT00951015|449555115|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
124980474|NCT00951015|449555111|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
124980475|NCT00951015|449555112|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
124980476|NCT00951015|449555113|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
124980477|NCT00951015|449555114|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
124980478|NCT00951015|449555115|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
124980479|NCT00951015|449555111|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
124980480|NCT00951015|449555112|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
124980481|NCT00951015|449555113|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
125204342|NCT01537068|450372019|FG000|Overall Study|Lost to Follow-up|2|||
125204343|NCT01537068|450372020|FG001|Overall Study|Lost to Follow-up|1|||
125204344|NCT01537068|450372019|FG000|Overall Study|Adverse Event|0|||
125204345|NCT01537068|450372020|FG001|Overall Study|Adverse Event|1|||
125204346|NCT01537068|450372019|FG000|Overall Study|Withdrawal by Subject|1|||
125204347|NCT01537068|450372020|FG001|Overall Study|Withdrawal by Subject|1|||
125204348|NCT01537068|450372019|FG000|Overall Study|Lack of Efficacy|1|||
125204349|NCT01537068|450372020|FG001|Overall Study|Lack of Efficacy|0|||
125204350|NCT00483704|450372021|FG000|Randomization|Withdrawal by Subject|19|||
125204351|NCT00483704|450372022|FG001|Randomization|Withdrawal by Subject|28|||
125204352|NCT00483704|450372023|FG002|Randomization|Withdrawal by Subject|18|||
125204353|NCT00483704|450372021|FG000|Randomization|Protocol Violation|14|||
125204354|NCT00483704|450372022|FG001|Randomization|Protocol Violation|25|||
125204355|NCT00483704|450372023|FG002|Randomization|Protocol Violation|22|||
125204356|NCT00483704|450372021|FG000|Randomization|Lost to Follow-up|14|||
125204357|NCT00483704|450372022|FG001|Randomization|Lost to Follow-up|14|||
125204358|NCT00483704|450372023|FG002|Randomization|Lost to Follow-up|19|||
125204359|NCT00483704|450372021|FG000|Randomization|Pregnancy|1|||
125204360|NCT00483704|450372022|FG001|Randomization|Pregnancy|0|||
125204361|NCT00483704|450372023|FG002|Randomization|Pregnancy|0|||
125204362|NCT00483704|450372021|FG000|Randomization|Physician Decision|2|||
125204363|NCT00483704|450372022|FG001|Randomization|Physician Decision|4|||
125204364|NCT00483704|450372023|FG002|Randomization|Physician Decision|0|||
125204365|NCT00483704|450372021|FG000|Randomization|Progressive disease|0|||
125204366|NCT00483704|450372022|FG001|Randomization|Progressive disease|0|||
125204367|NCT00483704|450372023|FG002|Randomization|Progressive disease|1|||
125204368|NCT00483704|450372021|FG000|Randomization|Lack of qualifying migraines|21|||
125204369|NCT00483704|450372022|FG001|Randomization|Lack of qualifying migraines|25|||
125204370|NCT00483704|450372023|FG002|Randomization|Lack of qualifying migraines|31|||
125204371|NCT00483704|450372021|FG000|Treatment|Lack of qualifying migraines|101|||
125204372|NCT00483704|450372022|FG001|Treatment|Lack of qualifying migraines|99|||
125204373|NCT00483704|450372023|FG002|Treatment|Lack of qualifying migraines|116|||
125204374|NCT00483704|450372021|FG000|Treatment|Adverse Event|3|||
125204375|NCT00483704|450372022|FG001|Treatment|Adverse Event|5|||
125204376|NCT00483704|450372023|FG002|Treatment|Adverse Event|4|||
125204377|NCT00483704|450372021|FG000|Treatment|Withdrawal by Subject|16|||
125204378|NCT00483704|450372022|FG001|Treatment|Withdrawal by Subject|12|||
125204379|NCT00483704|450372023|FG002|Treatment|Withdrawal by Subject|21|||
124980482|NCT00951015|449555114|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
125204380|NCT00483704|450372021|FG000|Treatment|Protocol Violation|6|||
125204381|NCT00483704|450372022|FG001|Treatment|Protocol Violation|3|||
125204382|NCT00483704|450372023|FG002|Treatment|Protocol Violation|5|||
125089791|NCT01117428|449947023|FG000|Overall Study|Physician Decision|0|||
125204383|NCT00483704|450372021|FG000|Treatment|Lost to Follow-up|2|||
125204384|NCT00483704|450372022|FG001|Treatment|Lost to Follow-up|7|||
125204385|NCT00483704|450372023|FG002|Treatment|Lost to Follow-up|5|||
125204386|NCT00483704|450372021|FG000|Treatment|Lack of Efficacy|1|||
125204387|NCT00483704|450372022|FG001|Treatment|Lack of Efficacy|1|||
125204388|NCT00483704|450372023|FG002|Treatment|Lack of Efficacy|1|||
125204389|NCT00483704|450372021|FG000|Treatment|Pregnancy|0|||
125204390|NCT00483704|450372022|FG001|Treatment|Pregnancy|1|||
125204391|NCT00483704|450372023|FG002|Treatment|Pregnancy|0|||
125204392|NCT00483704|450372021|FG000|Treatment|Physician Decision|0|||
125204393|NCT00483704|450372022|FG001|Treatment|Physician Decision|1|||
125204394|NCT00483704|450372023|FG002|Treatment|Physician Decision|4|||
125204395|NCT04442269|450372024|FG000|Overall Study|Adverse Event|1|||
125204396|NCT04442269|450372025|FG001|Overall Study|Adverse Event|0|||
125204397|NCT04442269|450372024|FG000|Overall Study|Death|0|||
125204398|NCT04442269|450372025|FG001|Overall Study|Death|1|||
125204399|NCT04442269|450372024|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
125204400|NCT04442269|450372025|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
125204401|NCT04442269|450372024|FG000|Overall Study|Lost to Follow-up|1|||
125204402|NCT04442269|450372025|FG001|Overall Study|Lost to Follow-up|0|||
124980483|NCT00951015|449555115|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
124980484|NCT00951015|449555111|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
124980485|NCT00951015|449555112|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
124980486|NCT00951015|449555113|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
124980487|NCT00951015|449555114|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
124980488|NCT00951015|449555115|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
124980489|NCT00951015|449555111|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
124980490|NCT00951015|449555112|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
124980491|NCT00951015|449555113|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
125204403|NCT04442269|450372024|FG000|Overall Study|Withdrawal by Subject|3|||
125204404|NCT04442269|450372025|FG001|Overall Study|Withdrawal by Subject|2|||
124980492|NCT00951015|449555114|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
125204405|NCT04442269|450372024|FG000|Overall Study|Protocol Deviation|0|||
125204406|NCT04442269|450372025|FG001|Overall Study|Protocol Deviation|1|||
124980493|NCT00951015|449555115|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
124980494|NCT00951015|449555111|FG000|Open-label Phase|Adverse Event|0|||
124980495|NCT00951015|449555112|FG001|Open-label Phase|Adverse Event|0|||
124980496|NCT00951015|449555113|FG002|Open-label Phase|Adverse Event|0|||
124980497|NCT00951015|449555114|FG003|Open-label Phase|Adverse Event|0|||
124980498|NCT00951015|449555115|FG004|Open-label Phase|Adverse Event|3|||
124980499|NCT00951015|449555111|FG000|Open-label Phase|Lack of Efficacy|0|||
124980500|NCT00951015|449555112|FG001|Open-label Phase|Lack of Efficacy|0|||
124980501|NCT00951015|449555113|FG002|Open-label Phase|Lack of Efficacy|0|||
124980502|NCT00951015|449555114|FG003|Open-label Phase|Lack of Efficacy|0|||
124980503|NCT00951015|449555115|FG004|Open-label Phase|Lack of Efficacy|1|||
124980504|NCT00951015|449555111|FG000|Open-label Phase|Protocol Violation|0|||
124980505|NCT00951015|449555112|FG001|Open-label Phase|Protocol Violation|0|||
124980506|NCT00951015|449555113|FG002|Open-label Phase|Protocol Violation|0|||
124980507|NCT00951015|449555114|FG003|Open-label Phase|Protocol Violation|0|||
124980508|NCT00951015|449555115|FG004|Open-label Phase|Protocol Violation|12|||
125204407|NCT04442269|450372024|FG000|Overall Study|Travel Limitations|1|||
125204408|NCT04442269|450372025|FG001|Overall Study|Travel Limitations|1|||
125204409|NCT04450407|450372026|FG000|Overall Study|Withdrawal by Subject|10|||
125204410|NCT04450407|450372027|FG001|Overall Study|Withdrawal by Subject|1|||
124980509|NCT00951015|449555111|FG000|Open-label Phase|Lost to Follow-up|0|||
124980510|NCT00951015|449555112|FG001|Open-label Phase|Lost to Follow-up|0|||
124980511|NCT00951015|449555113|FG002|Open-label Phase|Lost to Follow-up|0|||
124980512|NCT00951015|449555114|FG003|Open-label Phase|Lost to Follow-up|0|||
124980513|NCT00951015|449555115|FG004|Open-label Phase|Lost to Follow-up|12|||
124980514|NCT00951015|449555111|FG000|Open-label Phase|Withdrawal by Subject|0|||
125204411|NCT04450407|450372028|FG002|Overall Study|Withdrawal by Subject|4|||
125204412|NCT04450407|450372026|FG000|Overall Study|Adverse Event|0|||
125204413|NCT04450407|450372027|FG001|Overall Study|Adverse Event|0|||
125204414|NCT04450407|450372028|FG002|Overall Study|Adverse Event|1|||
125204415|NCT04450407|450372026|FG000|Overall Study|Lost to Follow-up|1|||
125204416|NCT04450407|450372027|FG001|Overall Study|Lost to Follow-up|0|||
125204417|NCT04450407|450372028|FG002|Overall Study|Lost to Follow-up|0|||
125204418|NCT04450407|450372026|FG000|Overall Study|Physician Decision|0|||
125204419|NCT04450407|450372027|FG001|Overall Study|Physician Decision|0|||
125204420|NCT04450407|450372028|FG002|Overall Study|Physician Decision|1|||
125204421|NCT04450407|450372026|FG000|Overall Study|Pregnancy|1|||
125204422|NCT04450407|450372027|FG001|Overall Study|Pregnancy|0|||
125204423|NCT04450407|450372028|FG002|Overall Study|Pregnancy|0|||
125204424|NCT04450407|450372026|FG000|Overall Study|Protocol Violation|2|||
124980515|NCT00951015|449555112|FG001|Open-label Phase|Withdrawal by Subject|0|||
124980516|NCT00951015|449555113|FG002|Open-label Phase|Withdrawal by Subject|0|||
124980517|NCT00951015|449555114|FG003|Open-label Phase|Withdrawal by Subject|0|||
124980518|NCT00951015|449555115|FG004|Open-label Phase|Withdrawal by Subject|14|||
124980519|NCT00951015|449555111|FG000|Open-label Phase|Physician Decision|0|||
125204425|NCT04450407|450372027|FG001|Overall Study|Protocol Violation|0|||
125204426|NCT04450407|450372028|FG002|Overall Study|Protocol Violation|0|||
125204427|NCT04450407|450372026|FG000|Overall Study|Investigational site terminated by sponsor|3|||
125204428|NCT04450407|450372027|FG001|Overall Study|Investigational site terminated by sponsor|0|||
125204429|NCT04450407|450372028|FG002|Overall Study|Investigational site terminated by sponsor|2|||
125204430|NCT02089334|450372029|FG000|Overall Study|Withdrawal by Subject|0|||
125204431|NCT02089334|450372030|FG001|Overall Study|Withdrawal by Subject|0|||
125204432|NCT02089334|450372031|FG002|Overall Study|Withdrawal by Subject|0|||
125204433|NCT02089334|450372032|FG003|Overall Study|Withdrawal by Subject|2|||
125204434|NCT02089334|450372029|FG000|Overall Study|Adverse Event|0|||
125204435|NCT02089334|450372030|FG001|Overall Study|Adverse Event|0|||
125204436|NCT02089334|450372031|FG002|Overall Study|Adverse Event|0|||
124980520|NCT00951015|449555112|FG001|Open-label Phase|Physician Decision|0|||
124980521|NCT00951015|449555113|FG002|Open-label Phase|Physician Decision|0|||
125204437|NCT02089334|450372032|FG003|Overall Study|Adverse Event|2|||
125204438|NCT02089334|450372029|FG000|Overall Study|Progressive disease|0|||
125204439|NCT02089334|450372030|FG001|Overall Study|Progressive disease|0|||
125204440|NCT02089334|450372031|FG002|Overall Study|Progressive disease|0|||
124980522|NCT00951015|449555114|FG003|Open-label Phase|Physician Decision|0|||
124980523|NCT00951015|449555115|FG004|Open-label Phase|Physician Decision|8|||
124980524|NCT03819634|449555117|FG000|Overall Study|Physician Decision|2|||
124980525|NCT01208103|449555118|FG000|Overall Study|Adverse Event|1|||
124980526|NCT01208103|449555118|FG000|Overall Study|Withdrawal by Subject|1|||
124980527|NCT00299494|449555119|FG000|Overall Study|Withdrawal by Subject|0|||
124980528|NCT00299494|449555120|FG001|Overall Study|Withdrawal by Subject|0|||
124980529|NCT00299494|449555121|FG002|Overall Study|Withdrawal by Subject|0|||
124980530|NCT00299494|449555122|FG003|Overall Study|Withdrawal by Subject|3|||
124980531|NCT00299494|449555123|FG004|Overall Study|Withdrawal by Subject|1|||
124980532|NCT00299494|449555124|FG005|Overall Study|Withdrawal by Subject|4|||
124980533|NCT00299494|449555119|FG000|Overall Study|Physician Decision|0|||
124980534|NCT00299494|449555120|FG001|Overall Study|Physician Decision|0|||
124980535|NCT00299494|449555121|FG002|Overall Study|Physician Decision|0|||
124980536|NCT00299494|449555122|FG003|Overall Study|Physician Decision|0|||
124980537|NCT00299494|449555123|FG004|Overall Study|Physician Decision|1|||
124980538|NCT00299494|449555124|FG005|Overall Study|Physician Decision|0|||
124980539|NCT00299494|449555119|FG000|Overall Study|Death|3|||
124980540|NCT00299494|449555120|FG001|Overall Study|Death|1|||
124980541|NCT00299494|449555121|FG002|Overall Study|Death|4|||
124980542|NCT00299494|449555122|FG003|Overall Study|Death|6|||
124980543|NCT00299494|449555123|FG004|Overall Study|Death|18|||
124980544|NCT00299494|449555124|FG005|Overall Study|Death|19|||
125204441|NCT02089334|450372032|FG003|Overall Study|Progressive disease|2|||
125204442|NCT02089334|450372029|FG000|Overall Study|Physician Decision|0|||
125204443|NCT02089334|450372030|FG001|Overall Study|Physician Decision|0|||
125204444|NCT02089334|450372031|FG002|Overall Study|Physician Decision|1|||
125204445|NCT02089334|450372032|FG003|Overall Study|Physician Decision|1|||
125204446|NCT02832375|450372033|FG000|Overall Study|Lost to Follow-up|1|||
125204447|NCT02832375|450372034|FG001|Overall Study|Lost to Follow-up|0|||
125204448|NCT02832375|450372033|FG000|Overall Study|Withdrawal of Consent|1|||
125204449|NCT02832375|450372034|FG001|Overall Study|Withdrawal of Consent|0|||
125204450|NCT01173055|450372037|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
125204451|NCT01173055|450372038|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
125204452|NCT01173055|450372037|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
125204453|NCT01173055|450372038|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
125204454|NCT04325698|450372040|FG000|Overall Study|Study Terminated By Sponsor|1|||
125204455|NCT04325698|450372041|FG001|Overall Study|Study Terminated By Sponsor|1|||
125204456|NCT04325698|450372040|FG000|Overall Study|Withdrawal by Subject|0|||
125204457|NCT04325698|450372041|FG001|Overall Study|Withdrawal by Subject|2|||
125204458|NCT04253782|450372042|FG000|Overall Study|Death|2|||
125204459|NCT04253782|450372043|FG001|Overall Study|Death|0|||
125204460|NCT00962091|450372044|FG000|Overall Study|Withdrawal by Subject|1|||
124980545|NCT00299494|449555119|FG000|Overall Study|Lost to Follow-up|0|||
124980546|NCT00299494|449555120|FG001|Overall Study|Lost to Follow-up|0|||
124980547|NCT00299494|449555121|FG002|Overall Study|Lost to Follow-up|0|||
124980548|NCT00299494|449555122|FG003|Overall Study|Lost to Follow-up|0|||
124980549|NCT00299494|449555123|FG004|Overall Study|Lost to Follow-up|3|||
124980550|NCT00299494|449555124|FG005|Overall Study|Lost to Follow-up|1|||
125204461|NCT00962091|450372045|FG001|Overall Study|Withdrawal by Subject|2|||
125204462|NCT00962091|450372046|FG002|Overall Study|Withdrawal by Subject|1|||
125204463|NCT00962091|450372047|FG003|Overall Study|Withdrawal by Subject|1|||
124980551|NCT00299494|449555119|FG000|Overall Study|Other - Unspecified|0|||
124980552|NCT00299494|449555120|FG001|Overall Study|Other - Unspecified|0|||
124980553|NCT00299494|449555121|FG002|Overall Study|Other - Unspecified|0|||
124980554|NCT00299494|449555122|FG003|Overall Study|Other - Unspecified|0|||
124980555|NCT00299494|449555123|FG004|Overall Study|Other - Unspecified|3|||
124980556|NCT00299494|449555124|FG005|Overall Study|Other - Unspecified|1|||
124980557|NCT00299494|449555119|FG000|Overall Study|Other - site closure|0|||
124980558|NCT00299494|449555120|FG001|Overall Study|Other - site closure|0|||
125204464|NCT00962091|450372048|FG004|Overall Study|Withdrawal by Subject|0|||
125204465|NCT00962091|450372049|FG005|Overall Study|Withdrawal by Subject|1|||
125204466|NCT00962091|450372050|FG006|Overall Study|Withdrawal by Subject|0|||
125204467|NCT00962091|450372044|FG000|Overall Study|Adverse Event|0|||
125204468|NCT00962091|450372045|FG001|Overall Study|Adverse Event|0|||
125204469|NCT00962091|450372046|FG002|Overall Study|Adverse Event|0|||
125204470|NCT00962091|450372047|FG003|Overall Study|Adverse Event|0|||
124980559|NCT00299494|449555121|FG002|Overall Study|Other - site closure|0|||
124980560|NCT00299494|449555122|FG003|Overall Study|Other - site closure|1|||
124980561|NCT00299494|449555123|FG004|Overall Study|Other - site closure|1|||
124980562|NCT00299494|449555124|FG005|Overall Study|Other - site closure|1|||
124980563|NCT00416195|449555125|FG000|Overall Study|Adverse Event|1|||
124980564|NCT00416195|449555126|FG001|Overall Study|Adverse Event|2|||
124980565|NCT00416195|449555125|FG000|Overall Study|Protocol Violation|1|||
124980566|NCT00416195|449555126|FG001|Overall Study|Protocol Violation|1|||
124980567|NCT00416195|449555125|FG000|Overall Study|Other|0|||
124980568|NCT00416195|449555126|FG001|Overall Study|Other|1|||
124980569|NCT01417104|449555131|FG000|Overall Study|Withdrawal by Subject|5|||
124980570|NCT01417104|449555132|FG001|Overall Study|Withdrawal by Subject|1|||
124980571|NCT01417104|449555131|FG000|Overall Study|Failure to make contact|0|||
124980572|NCT01417104|449555132|FG001|Overall Study|Failure to make contact|1|||
124980573|NCT01417104|449555131|FG000|Overall Study|Adverse Event|1|||
124980574|NCT01417104|449555132|FG001|Overall Study|Adverse Event|0|||
124980575|NCT03101462|449555133|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
124980576|NCT03101462|449555134|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
124980577|NCT00214019|449555137|FG000|Overall Study|Lost to Follow-up|11|||
124980578|NCT00214019|449555137|FG000|Overall Study|Withdrawal by Subject|2|||
124980579|NCT00214019|449555137|FG000|Overall Study|Screen Failed prior to randomization|17|||
124980580|NCT00842244|449555138|FG000|Overall Study|Death|3|||
124980581|NCT00842244|449555138|FG000|Overall Study|Withdrawal by Subject|1|||
124980582|NCT00842244|449555138|FG000|Overall Study|Other|17|||
124980583|NCT00635661|449555144|FG000|Overall Study|Withdrawal by Subject|4|||
124980584|NCT01696955|449555147|FG000|Main Study|Protocol Violation|1|||
124980585|NCT01696955|449555148|FG001|Main Study|Protocol Violation|0|||
124980586|NCT01696955|449555147|FG000|Main Study|Withdrawal by Subject|1|||
124980587|NCT01696955|449555148|FG001|Main Study|Withdrawal by Subject|1|||
124980588|NCT03192475|449555149|FG000|Overall Study|Death|0|||
124980589|NCT03192475|449555150|FG001|Overall Study|Death|1|||
124980590|NCT03192475|449555149|FG000|Overall Study|Lost to Follow-up|13|||
124980591|NCT03192475|449555150|FG001|Overall Study|Lost to Follow-up|8|||
124980592|NCT01696045|449555153|FG000|Overall Study|Study drug toxicity|1|||
124980593|NCT01696045|449555154|FG001|Overall Study|Study drug toxicity|5|||
124980594|NCT01696045|449555153|FG000|Overall Study|Disease progression|2|||
124980595|NCT01696045|449555154|FG001|Overall Study|Disease progression|2|||
124980596|NCT00573859|449555155|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
124980597|NCT00573859|449555155|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
124980598|NCT03541200|449555162|FG000|Overall Study|Adverse Event|19|||
124980599|NCT03541200|449555162|FG000|Overall Study|Death|1|||
124980600|NCT03541200|449555162|FG000|Overall Study|Lost to Follow-up|10|||
124980601|NCT03541200|449555162|FG000|Overall Study|Physician Decision|1|||
124980602|NCT03541200|449555162|FG000|Overall Study|Protocol Violation|51|||
124980603|NCT03541200|449555162|FG000|Overall Study|Withdrawal by Subject|23|||
124980604|NCT03541200|449555162|FG000|Overall Study|other|8|||
124980605|NCT01276379|449555166|FG000|Overall Study|Screening failure|40|||
124980606|NCT00864253|449555167|FG000|Overall Study|Adverse Event|56|||
124980607|NCT00864253|449555168|FG001|Overall Study|Adverse Event|11|||
124980608|NCT00864253|449555167|FG000|Overall Study|Unrelated Adverse Event|3|||
124980609|NCT00864253|449555168|FG001|Overall Study|Unrelated Adverse Event|1|||
124980610|NCT00864253|449555167|FG000|Overall Study|Physician Decision|11|||
124980611|NCT00864253|449555168|FG001|Overall Study|Physician Decision|15|||
124980612|NCT00864253|449555167|FG000|Overall Study|Protocol Violation|0|||
124980613|NCT00864253|449555168|FG001|Overall Study|Protocol Violation|2|||
124980614|NCT00864253|449555167|FG000|Overall Study|Lost to Follow-up|1|||
124980615|NCT00864253|449555168|FG001|Overall Study|Lost to Follow-up|1|||
124980616|NCT00864253|449555167|FG000|Overall Study|Withdrawal by Subject|18|||
124980617|NCT00864253|449555168|FG001|Overall Study|Withdrawal by Subject|18|||
124980618|NCT00864253|449555167|FG000|Overall Study|Death|1|||
124980619|NCT00864253|449555168|FG001|Overall Study|Death|0|||
124980620|NCT00864253|449555167|FG000|Overall Study|Ongoing|2|||
124980621|NCT00864253|449555168|FG001|Overall Study|Ongoing|3|||
124980622|NCT00864253|449555167|FG000|Overall Study|Untreated|7|||
124980623|NCT00864253|449555168|FG001|Overall Study|Untreated|7|||
124980624|NCT01896726|449555169|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
124980625|NCT01896726|449555169|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
124980626|NCT01128114|449555170|FG000|Overall Study|Treatment Withdrawn|6|||
124980627|NCT01128114|449555170|FG000|Overall Study|Screening Failed|2|||
124980628|NCT00208325|449555171|FG000|Overall Study|Death|18|||
124980629|NCT00208325|449555172|FG001|Overall Study|Death|19|||
124980630|NCT00208325|449555173|FG002|Overall Study|Death|7|||
124980631|NCT00208325|449555174|FG003|Overall Study|Death|5|||
124980632|NCT00208325|449555171|FG000|Overall Study|Withdrawal by Subject|0|||
124980633|NCT00208325|449555172|FG001|Overall Study|Withdrawal by Subject|1|||
124980634|NCT00208325|449555173|FG002|Overall Study|Withdrawal by Subject|0|||
124980635|NCT00208325|449555174|FG003|Overall Study|Withdrawal by Subject|0|||
124980636|NCT00208325|449555171|FG000|Overall Study|Revision|4|||
124980637|NCT00208325|449555172|FG001|Overall Study|Revision|1|||
124980638|NCT00208325|449555173|FG002|Overall Study|Revision|0|||
124980639|NCT00208325|449555174|FG003|Overall Study|Revision|4|||
124980640|NCT00208325|449555171|FG000|Overall Study|Lost to Follow-up|1|||
124980641|NCT00208325|449555172|FG001|Overall Study|Lost to Follow-up|0|||
124980642|NCT00208325|449555173|FG002|Overall Study|Lost to Follow-up|2|||
124980643|NCT00208325|449555174|FG003|Overall Study|Lost to Follow-up|0|||
124980644|NCT00208325|449555171|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
124980645|NCT00208325|449555172|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
124980646|NCT00208325|449555173|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
124980647|NCT00208325|449555174|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
124980648|NCT00208325|449555171|FG000|Overall Study|Does not wish to Continue in Study|5|||
124980649|NCT00208325|449555172|FG001|Overall Study|Does not wish to Continue in Study|8|||
124980650|NCT00208325|449555173|FG002|Overall Study|Does not wish to Continue in Study|3|||
124980651|NCT00208325|449555174|FG003|Overall Study|Does not wish to Continue in Study|2|||
124980652|NCT00208325|449555171|FG000|Overall Study|Other|2|||
124980653|NCT00208325|449555172|FG001|Overall Study|Other|1|||
124980654|NCT00208325|449555173|FG002|Overall Study|Other|1|||
124980655|NCT00208325|449555174|FG003|Overall Study|Other|0|||
124980656|NCT00208325|449555171|FG000|Overall Study|Mis-Randomized|17|||
124980657|NCT00208325|449555172|FG001|Overall Study|Mis-Randomized|20|||
124980658|NCT00208325|449555173|FG002|Overall Study|Mis-Randomized|0|||
124980659|NCT00208325|449555174|FG003|Overall Study|Mis-Randomized|0|||
124980660|NCT04445987|449555175|FG000|Overall Study|Adverse Event|0|||
124980661|NCT04445987|449555176|FG001|Overall Study|Adverse Event|0|||
124980662|NCT04445987|449555177|FG002|Overall Study|Adverse Event|1|||
124980663|NCT04445987|449555178|FG003|Overall Study|Adverse Event|0|||
124980664|NCT04445987|449555179|FG004|Overall Study|Adverse Event|4|||
124980665|NCT04445987|449555180|FG005|Overall Study|Adverse Event|0|||
124980666|NCT04445987|449555175|FG000|Overall Study|Lost to Follow-up|4|||
124980667|NCT04445987|449555176|FG001|Overall Study|Lost to Follow-up|3|||
124980668|NCT04445987|449555177|FG002|Overall Study|Lost to Follow-up|1|||
124980669|NCT04445987|449555178|FG003|Overall Study|Lost to Follow-up|1|||
124980670|NCT04445987|449555179|FG004|Overall Study|Lost to Follow-up|29|||
124980671|NCT04445987|449555180|FG005|Overall Study|Lost to Follow-up|0|||
124980672|NCT04445987|449555175|FG000|Overall Study|Physician Decision|0|||
124980673|NCT04445987|449555176|FG001|Overall Study|Physician Decision|0|||
124980674|NCT04445987|449555177|FG002|Overall Study|Physician Decision|0|||
124980675|NCT04445987|449555178|FG003|Overall Study|Physician Decision|0|||
124980676|NCT04445987|449555179|FG004|Overall Study|Physician Decision|1|||
124980677|NCT04445987|449555180|FG005|Overall Study|Physician Decision|0|||
124980678|NCT04445987|449555175|FG000|Overall Study|Protocol Violation|1|||
124980679|NCT04445987|449555176|FG001|Overall Study|Protocol Violation|0|||
124980680|NCT04445987|449555177|FG002|Overall Study|Protocol Violation|0|||
124980681|NCT04445987|449555178|FG003|Overall Study|Protocol Violation|0|||
124980682|NCT04445987|449555179|FG004|Overall Study|Protocol Violation|2|||
124980683|NCT04445987|449555180|FG005|Overall Study|Protocol Violation|0|||
124980684|NCT04445987|449555175|FG000|Overall Study|Withdrawal by Subject|4|||
124980685|NCT04445987|449555176|FG001|Overall Study|Withdrawal by Subject|0|||
124980686|NCT04445987|449555177|FG002|Overall Study|Withdrawal by Subject|1|||
124980687|NCT04445987|449555178|FG003|Overall Study|Withdrawal by Subject|0|||
124980688|NCT04445987|449555179|FG004|Overall Study|Withdrawal by Subject|18|||
124980689|NCT04445987|449555180|FG005|Overall Study|Withdrawal by Subject|1|||
124980690|NCT04445987|449555175|FG000|Overall Study|Other reason|0|||
124980691|NCT04445987|449555176|FG001|Overall Study|Other reason|0|||
124980692|NCT04445987|449555177|FG002|Overall Study|Other reason|1|||
124980693|NCT04445987|449555178|FG003|Overall Study|Other reason|0|||
124980694|NCT04445987|449555179|FG004|Overall Study|Other reason|2|||
124980695|NCT04445987|449555180|FG005|Overall Study|Other reason|0|||
124980696|NCT01803282|449555181|FG000|Overall Study|Progressive Disease|4|||
124980697|NCT01803282|449555182|FG001|Overall Study|Progressive Disease|3|||
124980698|NCT01803282|449555183|FG002|Overall Study|Progressive Disease|6|||
124980699|NCT01803282|449555184|FG003|Overall Study|Progressive Disease|22|||
124980700|NCT01803282|449555185|FG004|Overall Study|Progressive Disease|5|||
124980701|NCT01803282|449555186|FG005|Overall Study|Progressive Disease|8|||
124980702|NCT01803282|449555187|FG006|Overall Study|Progressive Disease|23|||
124980703|NCT01803282|449555188|FG007|Overall Study|Progressive Disease|24|||
124980704|NCT01803282|449555189|FG008|Overall Study|Progressive Disease|3|||
124980705|NCT01803282|449555190|FG009|Overall Study|Progressive Disease|29|||
125204471|NCT00962091|450372048|FG004|Overall Study|Adverse Event|0|||
124980706|NCT01803282|449555191|FG010|Overall Study|Progressive Disease|6|||
124980707|NCT01803282|449555192|FG011|Overall Study|Progressive Disease|11|||
124980708|NCT01803282|449555181|FG000|Overall Study|Death|0|||
124980709|NCT01803282|449555182|FG001|Overall Study|Death|0|||
124980710|NCT01803282|449555183|FG002|Overall Study|Death|0|||
124980711|NCT01803282|449555184|FG003|Overall Study|Death|0|||
124980712|NCT01803282|449555185|FG004|Overall Study|Death|2|||
124980713|NCT01803282|449555186|FG005|Overall Study|Death|1|||
124980714|NCT01803282|449555187|FG006|Overall Study|Death|1|||
124980715|NCT01803282|449555188|FG007|Overall Study|Death|5|||
124980716|NCT01803282|449555189|FG008|Overall Study|Death|1|||
124980717|NCT01803282|449555190|FG009|Overall Study|Death|1|||
125204472|NCT00962091|450372049|FG005|Overall Study|Adverse Event|0|||
124980718|NCT01803282|449555191|FG010|Overall Study|Death|0|||
124980719|NCT01803282|449555192|FG011|Overall Study|Death|0|||
124980720|NCT01803282|449555181|FG000|Overall Study|Withdrew Consent|0|||
124980721|NCT01803282|449555182|FG001|Overall Study|Withdrew Consent|0|||
124980722|NCT01803282|449555183|FG002|Overall Study|Withdrew Consent|0|||
124980723|NCT01803282|449555184|FG003|Overall Study|Withdrew Consent|6|||
124980724|NCT01803282|449555185|FG004|Overall Study|Withdrew Consent|1|||
124980725|NCT01803282|449555186|FG005|Overall Study|Withdrew Consent|0|||
124980726|NCT01803282|449555187|FG006|Overall Study|Withdrew Consent|8|||
124980727|NCT01803282|449555188|FG007|Overall Study|Withdrew Consent|3|||
124980728|NCT01803282|449555189|FG008|Overall Study|Withdrew Consent|1|||
124980729|NCT01803282|449555190|FG009|Overall Study|Withdrew Consent|5|||
124980730|NCT01803282|449555191|FG010|Overall Study|Withdrew Consent|0|||
124980731|NCT01803282|449555192|FG011|Overall Study|Withdrew Consent|1|||
124980732|NCT01803282|449555181|FG000|Overall Study|Investigator's Discretion|0|||
124980733|NCT01803282|449555182|FG001|Overall Study|Investigator's Discretion|0|||
124980734|NCT01803282|449555183|FG002|Overall Study|Investigator's Discretion|0|||
124980735|NCT01803282|449555184|FG003|Overall Study|Investigator's Discretion|7|||
124980736|NCT01803282|449555185|FG004|Overall Study|Investigator's Discretion|2|||
124980737|NCT01803282|449555186|FG005|Overall Study|Investigator's Discretion|1|||
124980738|NCT01803282|449555187|FG006|Overall Study|Investigator's Discretion|7|||
124980739|NCT01803282|449555188|FG007|Overall Study|Investigator's Discretion|10|||
124980740|NCT01803282|449555189|FG008|Overall Study|Investigator's Discretion|6|||
124980741|NCT01803282|449555190|FG009|Overall Study|Investigator's Discretion|7|||
124980742|NCT01803282|449555191|FG010|Overall Study|Investigator's Discretion|1|||
124980743|NCT01803282|449555192|FG011|Overall Study|Investigator's Discretion|0|||
124980744|NCT01803282|449555181|FG000|Overall Study|Adverse Event|0|||
124980745|NCT01803282|449555182|FG001|Overall Study|Adverse Event|0|||
124980746|NCT01803282|449555183|FG002|Overall Study|Adverse Event|0|||
124980747|NCT01803282|449555184|FG003|Overall Study|Adverse Event|0|||
124980748|NCT01803282|449555185|FG004|Overall Study|Adverse Event|0|||
124980749|NCT01803282|449555186|FG005|Overall Study|Adverse Event|0|||
124980750|NCT01803282|449555187|FG006|Overall Study|Adverse Event|1|||
124980751|NCT01803282|449555188|FG007|Overall Study|Adverse Event|2|||
124980752|NCT01803282|449555189|FG008|Overall Study|Adverse Event|0|||
124980753|NCT01803282|449555190|FG009|Overall Study|Adverse Event|1|||
124980754|NCT01803282|449555191|FG010|Overall Study|Adverse Event|0|||
124980755|NCT01803282|449555192|FG011|Overall Study|Adverse Event|3|||
124980756|NCT01803282|449555181|FG000|Overall Study|Non-Compliance with Study Drug|0|||
124980757|NCT01803282|449555182|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124980758|NCT01803282|449555183|FG002|Overall Study|Non-Compliance with Study Drug|0|||
124980759|NCT01803282|449555184|FG003|Overall Study|Non-Compliance with Study Drug|1|||
124980760|NCT01803282|449555185|FG004|Overall Study|Non-Compliance with Study Drug|0|||
124980761|NCT01803282|449555186|FG005|Overall Study|Non-Compliance with Study Drug|0|||
124980762|NCT01803282|449555187|FG006|Overall Study|Non-Compliance with Study Drug|0|||
124980763|NCT01803282|449555188|FG007|Overall Study|Non-Compliance with Study Drug|0|||
124980764|NCT01803282|449555189|FG008|Overall Study|Non-Compliance with Study Drug|0|||
124980765|NCT01803282|449555190|FG009|Overall Study|Non-Compliance with Study Drug|0|||
124980766|NCT01803282|449555191|FG010|Overall Study|Non-Compliance with Study Drug|0|||
124980767|NCT01803282|449555192|FG011|Overall Study|Non-Compliance with Study Drug|0|||
124980768|NCT01803282|449555181|FG000|Overall Study|Unknown Reason|0|||
124980769|NCT01803282|449555182|FG001|Overall Study|Unknown Reason|0|||
124980770|NCT01803282|449555183|FG002|Overall Study|Unknown Reason|0|||
124980771|NCT01803282|449555184|FG003|Overall Study|Unknown Reason|0|||
124980772|NCT01803282|449555185|FG004|Overall Study|Unknown Reason|0|||
124980773|NCT01803282|449555186|FG005|Overall Study|Unknown Reason|0|||
124980774|NCT01803282|449555187|FG006|Overall Study|Unknown Reason|0|||
124980775|NCT01803282|449555188|FG007|Overall Study|Unknown Reason|1|||
124980776|NCT01803282|449555189|FG008|Overall Study|Unknown Reason|0|||
124980777|NCT01803282|449555190|FG009|Overall Study|Unknown Reason|0|||
124980778|NCT01803282|449555191|FG010|Overall Study|Unknown Reason|0|||
124980779|NCT01803282|449555192|FG011|Overall Study|Unknown Reason|0|||
124980780|NCT01803282|449555181|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
124980781|NCT01803282|449555182|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
125204473|NCT00962091|450372050|FG006|Overall Study|Adverse Event|1|||
124980782|NCT01803282|449555183|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
124980783|NCT01803282|449555184|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
124980784|NCT01803282|449555185|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
124980785|NCT01803282|449555186|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
124980786|NCT01803282|449555187|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
124980787|NCT01803282|449555188|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
124980788|NCT01803282|449555189|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
124980789|NCT01803282|449555190|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
124980790|NCT01803282|449555191|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
124980791|NCT01803282|449555192|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
124980792|NCT01803282|449555181|FG000|Overall Study|Enrolled but Never Treated|0|||
124980793|NCT01803282|449555182|FG001|Overall Study|Enrolled but Never Treated|0|||
125204474|NCT04216589|450372051|FG000|Overall Study|Withdrawal by Subject|2|||
125204475|NCT04216589|450372051|FG000|Overall Study|Protocol Violation|1|||
125204476|NCT04216589|450372051|FG000|Overall Study|Incarceration|1|||
125204477|NCT02326298|450372057|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204478|NCT02326298|450372058|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204479|NCT02326298|450372059|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
125204480|NCT02326298|450372060|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204481|NCT02326298|450372061|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204482|NCT02326298|450372062|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204483|NCT02326298|450372063|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204484|NCT02326298|450372064|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204485|NCT02326298|450372065|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204486|NCT02326298|450372066|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204487|NCT02326298|450372067|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124980794|NCT01803282|449555183|FG002|Overall Study|Enrolled but Never Treated|0|||
124980795|NCT01803282|449555184|FG003|Overall Study|Enrolled but Never Treated|0|||
124980796|NCT01803282|449555185|FG004|Overall Study|Enrolled but Never Treated|1|||
124980797|NCT01803282|449555186|FG005|Overall Study|Enrolled but Never Treated|0|||
124980798|NCT01803282|449555187|FG006|Overall Study|Enrolled but Never Treated|1|||
124980799|NCT01803282|449555188|FG007|Overall Study|Enrolled but Never Treated|1|||
124980800|NCT01803282|449555189|FG008|Overall Study|Enrolled but Never Treated|0|||
124980801|NCT01803282|449555190|FG009|Overall Study|Enrolled but Never Treated|1|||
124980802|NCT01803282|449555191|FG010|Overall Study|Enrolled but Never Treated|0|||
124980803|NCT01803282|449555192|FG011|Overall Study|Enrolled but Never Treated|0|||
124980804|NCT01743989|449555193|FG000|Treatment Phase|Unstable MR4.0|0|||
124980805|NCT01743989|449555194|FG001|Treatment Phase|Unstable MR4.0|6|||
124980806|NCT01743989|449555195|FG002|Treatment Phase|Unstable MR4.0|263|||
124980807|NCT01743989|449555193|FG000|Treatment Phase|Adverse Event|0|||
124980808|NCT01743989|449555194|FG001|Treatment Phase|Adverse Event|4|||
124980809|NCT01743989|449555195|FG002|Treatment Phase|Adverse Event|67|||
124980810|NCT01743989|449555193|FG000|Treatment Phase|Withdrawal by Subject|1|||
124980811|NCT01743989|449555194|FG001|Treatment Phase|Withdrawal by Subject|3|||
124980812|NCT01743989|449555195|FG002|Treatment Phase|Withdrawal by Subject|28|||
124980813|NCT01743989|449555193|FG000|Treatment Phase|Death|0|||
124980814|NCT01743989|449555194|FG001|Treatment Phase|Death|1|||
124980815|NCT01743989|449555195|FG002|Treatment Phase|Death|3|||
124980816|NCT01743989|449555193|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
124980817|NCT01743989|449555194|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
124980818|NCT01743989|449555195|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
124980819|NCT01743989|449555193|FG000|Treatment Phase|Protocol deviation|0|||
124980820|NCT01743989|449555194|FG001|Treatment Phase|Protocol deviation|0|||
124980821|NCT01743989|449555195|FG002|Treatment Phase|Protocol deviation|3|||
124980822|NCT01743989|449555193|FG000|Treatment Phase|Pregnancy|0|||
124980823|NCT01743989|449555194|FG001|Treatment Phase|Pregnancy|0|||
124980824|NCT01743989|449555195|FG002|Treatment Phase|Pregnancy|2|||
124980825|NCT01743989|449555193|FG000|Treatment Phase|Lost to Follow-up|0|||
124980826|NCT01743989|449555194|FG001|Treatment Phase|Lost to Follow-up|0|||
124980827|NCT01743989|449555195|FG002|Treatment Phase|Lost to Follow-up|2|||
124980828|NCT01743989|449555193|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
124980829|NCT01743989|449555194|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
124980830|NCT01743989|449555195|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
125204488|NCT02326298|450372068|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204489|NCT02326298|450372069|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204490|NCT02326298|450372070|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204491|NCT02326298|450372057|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
125204492|NCT02326298|450372058|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125204493|NCT02326298|450372059|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125204494|NCT02326298|450372060|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125204495|NCT02326298|450372061|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125204496|NCT02326298|450372062|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125204497|NCT02326298|450372063|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125204498|NCT02326298|450372064|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125204499|NCT02326298|450372065|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125204500|NCT02326298|450372066|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125204501|NCT02326298|450372067|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
124980831|NCT01743989|449555193|FG000|Treatment Phase|Administrative problems|0|||
124980832|NCT01743989|449555194|FG001|Treatment Phase|Administrative problems|0|||
124980833|NCT01743989|449555195|FG002|Treatment Phase|Administrative problems|1|||
124980834|NCT01743989|449555193|FG000|Treatment Phase|New cancer (CML) therapy|0|||
124980835|NCT01743989|449555194|FG001|Treatment Phase|New cancer (CML) therapy|1|||
124980836|NCT01743989|449555195|FG002|Treatment Phase|New cancer (CML) therapy|0|||
125204502|NCT02326298|450372068|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
124980837|NCT01743989|449555193|FG000|Treatment Phase|Physician Decision|0|||
124980838|NCT01743989|449555194|FG001|Treatment Phase|Physician Decision|0|||
124980839|NCT01743989|449555195|FG002|Treatment Phase|Physician Decision|3|||
124980840|NCT01743989|449555193|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
124980841|NCT01743989|449555194|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
124980842|NCT01743989|449555195|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
124980843|NCT01743989|449555193|FG000|Treatment Phase|Not randomized by mistake|0|||
124980844|NCT01743989|449555194|FG001|Treatment Phase|Not randomized by mistake|0|||
124980845|NCT01743989|449555195|FG002|Treatment Phase|Not randomized by mistake|1|||
124980846|NCT01743989|449555193|FG000|Treatment Phase|Included by mistake|0|||
124980847|NCT01743989|449555194|FG001|Treatment Phase|Included by mistake|0|||
124980848|NCT01743989|449555195|FG002|Treatment Phase|Included by mistake|1|||
124980849|NCT01743989|449555193|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
124980850|NCT01743989|449555194|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
124980851|NCT01743989|449555195|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
124980852|NCT01743989|449555193|FG000|TFR Phase|Adverse Event|0|||
124980853|NCT01743989|449555194|FG001|TFR Phase|Adverse Event|1|||
124980854|NCT01743989|449555195|FG002|TFR Phase|Adverse Event|0|||
124980855|NCT01743989|449555193|FG000|TFR Phase|Lost to Follow-up|0|||
124980856|NCT01743989|449555194|FG001|TFR Phase|Lost to Follow-up|2|||
124980857|NCT01743989|449555195|FG002|TFR Phase|Lost to Follow-up|0|||
124980858|NCT01743989|449555193|FG000|TFR Phase|Physician Decision|0|||
124980859|NCT01743989|449555194|FG001|TFR Phase|Physician Decision|1|||
124980860|NCT01743989|449555195|FG002|TFR Phase|Physician Decision|0|||
124980861|NCT01743989|449555193|FG000|TFR Phase|Logistical problems|0|||
124980862|NCT01743989|449555194|FG001|TFR Phase|Logistical problems|2|||
124980863|NCT01743989|449555195|FG002|TFR Phase|Logistical problems|0|||
124980864|NCT01743989|449555193|FG000|TFR Phase|Protocol deviation|0|||
124980865|NCT01743989|449555194|FG001|TFR Phase|Protocol deviation|1|||
124980866|NCT01743989|449555195|FG002|TFR Phase|Protocol deviation|0|||
124980867|NCT01743989|449555193|FG000|TFR Phase|Withdrawal by Subject|0|||
124980868|NCT01743989|449555194|FG001|TFR Phase|Withdrawal by Subject|2|||
124980869|NCT01743989|449555195|FG002|TFR Phase|Withdrawal by Subject|0|||
124980870|NCT01743989|449555193|FG000|Re-treatment Phase|Adverse Event|8|||
124980871|NCT01743989|449555194|FG001|Re-treatment Phase|Adverse Event|4|||
124980872|NCT01743989|449555195|FG002|Re-treatment Phase|Adverse Event|0|||
124980873|NCT01743989|449555193|FG000|Re-treatment Phase|Death|1|||
124980874|NCT01743989|449555194|FG001|Re-treatment Phase|Death|1|||
124980875|NCT01743989|449555195|FG002|Re-treatment Phase|Death|0|||
124980876|NCT01743989|449555193|FG000|Re-treatment Phase|Administrative problems|1|||
124980877|NCT01743989|449555194|FG001|Re-treatment Phase|Administrative problems|1|||
124980878|NCT01743989|449555195|FG002|Re-treatment Phase|Administrative problems|0|||
124980879|NCT01743989|449555193|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
124980880|NCT01743989|449555194|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
124980881|NCT01743989|449555195|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
124980882|NCT01743989|449555193|FG000|Re-treatment Phase|Unstable MR|1|||
124980883|NCT01743989|449555194|FG001|Re-treatment Phase|Unstable MR|0|||
124980884|NCT01743989|449555195|FG002|Re-treatment Phase|Unstable MR|0|||
124980885|NCT01743989|449555193|FG000|Re-treatment Phase|Physician Decision|0|||
124980886|NCT01743989|449555194|FG001|Re-treatment Phase|Physician Decision|1|||
124980887|NCT01743989|449555195|FG002|Re-treatment Phase|Physician Decision|0|||
124980888|NCT01743989|449555193|FG000|Re-treatment Phase|Lost to Follow-up|0|||
124980889|NCT01743989|449555194|FG001|Re-treatment Phase|Lost to Follow-up|1|||
124980890|NCT01743989|449555195|FG002|Re-treatment Phase|Lost to Follow-up|0|||
124980891|NCT02235311|449555198|FG000|Overall Study|Lost to Follow-up|0|||
124980892|NCT02235311|449555199|FG001|Overall Study|Lost to Follow-up|1|||
124980893|NCT02235311|449555198|FG000|Overall Study|Protocol Violation|0|||
124980894|NCT02235311|449555199|FG001|Overall Study|Protocol Violation|1|||
124980895|NCT05543707|449555200|FG000|Overall Study|Study drug non-compliance/|5|||
124980896|NCT05543707|449555201|FG001|Overall Study|Study drug non-compliance/|0|||
124980897|NCT05543707|449555200|FG000|Overall Study|Withdrawal by Subject|1|||
124980898|NCT05543707|449555201|FG001|Overall Study|Withdrawal by Subject|1|||
124980899|NCT05543707|449555200|FG000|Overall Study|Adverse Event|1|||
124980900|NCT05543707|449555201|FG001|Overall Study|Adverse Event|0|||
125204503|NCT02326298|450372069|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
124980901|NCT05543707|449555200|FG000|Overall Study|concurrent illness|0|||
124980902|NCT05543707|449555201|FG001|Overall Study|concurrent illness|1|||
124980903|NCT05543707|449555200|FG000|Overall Study|Pregnancy|1|||
124980904|NCT05543707|449555201|FG001|Overall Study|Pregnancy|1|||
124980905|NCT03006848|449555202|FG000|Overall Study|Adverse Event|1|||
124980906|NCT03006848|449555202|FG000|Overall Study|Physician Decision|1|||
124980907|NCT03006848|449555202|FG000|Overall Study|Lack of Efficacy|16|||
124980908|NCT00384397|449555204|FG000|Overall Study|Adverse Event|0|||
124980909|NCT00384397|449555205|FG001|Overall Study|Adverse Event|1|||
124980910|NCT00384397|449555206|FG002|Overall Study|Adverse Event|2|||
124980911|NCT00384397|449555204|FG000|Overall Study|Protocol Violation|7|||
124980912|NCT00384397|449555205|FG001|Overall Study|Protocol Violation|15|||
124980913|NCT00384397|449555206|FG002|Overall Study|Protocol Violation|13|||
124980914|NCT00384397|449555204|FG000|Overall Study|Lost to Follow-up|11|||
124980915|NCT00384397|449555205|FG001|Overall Study|Lost to Follow-up|13|||
124980916|NCT00384397|449555206|FG002|Overall Study|Lost to Follow-up|3|||
124980917|NCT00384397|449555204|FG000|Overall Study|Withdrawal by Subject|14|||
124980918|NCT00384397|449555205|FG001|Overall Study|Withdrawal by Subject|17|||
124980919|NCT00384397|449555206|FG002|Overall Study|Withdrawal by Subject|15|||
124980920|NCT02336451|449555207|FG000|Overall Study|Adverse Event|1|||
124980921|NCT02336451|449555208|FG001|Overall Study|Adverse Event|2|||
124980922|NCT02336451|449555209|FG002|Overall Study|Adverse Event|0|||
124980923|NCT02336451|449555210|FG003|Overall Study|Adverse Event|6|||
124980924|NCT02336451|449555211|FG004|Overall Study|Adverse Event|4|||
124980925|NCT02336451|449555207|FG000|Overall Study|Death|6|||
124980926|NCT02336451|449555208|FG001|Overall Study|Death|2|||
124980927|NCT02336451|449555209|FG002|Overall Study|Death|3|||
124980928|NCT02336451|449555210|FG003|Overall Study|Death|6|||
124980929|NCT02336451|449555211|FG004|Overall Study|Death|6|||
124980930|NCT02336451|449555207|FG000|Overall Study|Physician Decision|9|||
124980931|NCT02336451|449555208|FG001|Overall Study|Physician Decision|6|||
124980932|NCT02336451|449555209|FG002|Overall Study|Physician Decision|7|||
124980933|NCT02336451|449555210|FG003|Overall Study|Physician Decision|16|||
124980934|NCT02336451|449555211|FG004|Overall Study|Physician Decision|3|||
124980935|NCT02336451|449555207|FG000|Overall Study|Progressive disease|23|||
124980936|NCT02336451|449555208|FG001|Overall Study|Progressive disease|26|||
124980937|NCT02336451|449555209|FG002|Overall Study|Progressive disease|2|||
124980938|NCT02336451|449555210|FG003|Overall Study|Progressive disease|14|||
124980939|NCT02336451|449555211|FG004|Overall Study|Progressive disease|4|||
124980940|NCT02336451|449555207|FG000|Overall Study|Protocol Violation|1|||
124980941|NCT02336451|449555208|FG001|Overall Study|Protocol Violation|0|||
124980942|NCT02336451|449555209|FG002|Overall Study|Protocol Violation|0|||
124980943|NCT02336451|449555210|FG003|Overall Study|Protocol Violation|0|||
124980944|NCT02336451|449555211|FG004|Overall Study|Protocol Violation|0|||
124980945|NCT02336451|449555207|FG000|Overall Study|Patient/guardian decision|2|||
124980946|NCT02336451|449555208|FG001|Overall Study|Patient/guardian decision|4|||
124980947|NCT02336451|449555209|FG002|Overall Study|Patient/guardian decision|0|||
124980948|NCT02336451|449555210|FG003|Overall Study|Patient/guardian decision|2|||
124980949|NCT02336451|449555211|FG004|Overall Study|Patient/guardian decision|1|||
124980950|NCT01214642|449555212|FG000|Overall Study|Progressive Disease|3|||
124980951|NCT01214642|449555213|FG001|Overall Study|Progressive Disease|2|||
124980952|NCT01214642|449555214|FG002|Overall Study|Progressive Disease|3|||
124980953|NCT01214642|449555215|FG003|Overall Study|Progressive Disease|5|||
124980954|NCT01214642|449555216|FG004|Overall Study|Progressive Disease|5|||
124980955|NCT01214642|449555217|FG005|Overall Study|Progressive Disease|3|||
124980956|NCT01214642|449555218|FG006|Overall Study|Progressive Disease|5|||
124980957|NCT01214642|449555219|FG007|Overall Study|Progressive Disease|3|||
124980958|NCT01214642|449555220|FG008|Overall Study|Progressive Disease|10|||
124980959|NCT01214642|449555221|FG009|Overall Study|Progressive Disease|2|||
124980960|NCT01214642|449555222|FG010|Overall Study|Progressive Disease|1|||
124980961|NCT01214642|449555223|FG011|Overall Study|Progressive Disease|4|||
124980962|NCT01214642|449555212|FG000|Overall Study|Adverse Event|0|||
124980963|NCT01214642|449555213|FG001|Overall Study|Adverse Event|1|||
124980964|NCT01214642|449555214|FG002|Overall Study|Adverse Event|0|||
124980965|NCT01214642|449555215|FG003|Overall Study|Adverse Event|0|||
124980966|NCT01214642|449555216|FG004|Overall Study|Adverse Event|0|||
124980967|NCT01214642|449555217|FG005|Overall Study|Adverse Event|0|||
124980968|NCT01214642|449555218|FG006|Overall Study|Adverse Event|1|||
124980969|NCT01214642|449555219|FG007|Overall Study|Adverse Event|0|||
124980970|NCT01214642|449555220|FG008|Overall Study|Adverse Event|0|||
124980971|NCT01214642|449555221|FG009|Overall Study|Adverse Event|1|||
124980972|NCT01214642|449555222|FG010|Overall Study|Adverse Event|1|||
124980973|NCT01214642|449555223|FG011|Overall Study|Adverse Event|0|||
124980974|NCT01214642|449555212|FG000|Overall Study|Death|0|||
124980975|NCT01214642|449555213|FG001|Overall Study|Death|0|||
124980976|NCT01214642|449555214|FG002|Overall Study|Death|1|||
124980977|NCT01214642|449555215|FG003|Overall Study|Death|0|||
124980978|NCT01214642|449555216|FG004|Overall Study|Death|0|||
124980979|NCT01214642|449555217|FG005|Overall Study|Death|0|||
124980980|NCT01214642|449555218|FG006|Overall Study|Death|0|||
124980981|NCT01214642|449555219|FG007|Overall Study|Death|0|||
124980982|NCT01214642|449555220|FG008|Overall Study|Death|0|||
124980983|NCT01214642|449555221|FG009|Overall Study|Death|0|||
124980984|NCT01214642|449555222|FG010|Overall Study|Death|1|||
124980985|NCT01214642|449555223|FG011|Overall Study|Death|0|||
124980986|NCT01214642|449555212|FG000|Overall Study|Withdrawal by Subject|0|||
124980987|NCT01214642|449555213|FG001|Overall Study|Withdrawal by Subject|0|||
124980988|NCT01214642|449555214|FG002|Overall Study|Withdrawal by Subject|1|||
124980989|NCT01214642|449555215|FG003|Overall Study|Withdrawal by Subject|0|||
124980990|NCT01214642|449555216|FG004|Overall Study|Withdrawal by Subject|0|||
124980991|NCT01214642|449555217|FG005|Overall Study|Withdrawal by Subject|0|||
124980992|NCT01214642|449555218|FG006|Overall Study|Withdrawal by Subject|0|||
124980993|NCT01214642|449555219|FG007|Overall Study|Withdrawal by Subject|0|||
124980994|NCT01214642|449555220|FG008|Overall Study|Withdrawal by Subject|3|||
124980995|NCT01214642|449555221|FG009|Overall Study|Withdrawal by Subject|1|||
124980996|NCT01214642|449555222|FG010|Overall Study|Withdrawal by Subject|1|||
124980997|NCT01214642|449555223|FG011|Overall Study|Withdrawal by Subject|0|||
124980998|NCT01214642|449555212|FG000|Overall Study|Physician Decision|0|||
125204504|NCT02326298|450372070|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125204505|NCT02326298|450372057|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
125204506|NCT02326298|450372058|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
125204507|NCT02326298|450372059|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125204508|NCT02326298|450372060|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125204509|NCT02326298|450372061|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125204510|NCT02326298|450372062|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125204511|NCT02326298|450372063|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125204512|NCT02326298|450372064|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125204513|NCT02326298|450372065|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125204514|NCT02326298|450372066|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125204515|NCT02326298|450372067|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124980999|NCT01214642|449555213|FG001|Overall Study|Physician Decision|0|||
124981000|NCT01214642|449555214|FG002|Overall Study|Physician Decision|1|||
124981001|NCT01214642|449555215|FG003|Overall Study|Physician Decision|1|||
124981002|NCT01214642|449555216|FG004|Overall Study|Physician Decision|1|||
124981003|NCT01214642|449555217|FG005|Overall Study|Physician Decision|0|||
124981004|NCT01214642|449555218|FG006|Overall Study|Physician Decision|0|||
124981005|NCT01214642|449555219|FG007|Overall Study|Physician Decision|0|||
124981006|NCT01214642|449555220|FG008|Overall Study|Physician Decision|0|||
124981007|NCT01214642|449555221|FG009|Overall Study|Physician Decision|0|||
124981008|NCT01214642|449555222|FG010|Overall Study|Physician Decision|0|||
124981009|NCT01214642|449555223|FG011|Overall Study|Physician Decision|2|||
124981010|NCT04372121|449555228|FG000|Overall Study|Lost to Follow-up|0|||
124981011|NCT04372121|449555229|FG001|Overall Study|Lost to Follow-up|0|||
124981012|NCT04372121|449555230|FG002|Overall Study|Lost to Follow-up|0|||
124981013|NCT04372121|449555231|FG003|Overall Study|Lost to Follow-up|1|||
124981014|NCT04372121|449555228|FG000|Overall Study|Protocol Violation|0|||
124981015|NCT04372121|449555229|FG001|Overall Study|Protocol Violation|0|||
124981016|NCT04372121|449555230|FG002|Overall Study|Protocol Violation|1|||
124981017|NCT04372121|449555231|FG003|Overall Study|Protocol Violation|0|||
124981018|NCT04372121|449555228|FG000|Overall Study|Withdrawal by Subject|3|||
124981019|NCT04372121|449555229|FG001|Overall Study|Withdrawal by Subject|1|||
124981020|NCT04372121|449555230|FG002|Overall Study|Withdrawal by Subject|0|||
124981021|NCT04372121|449555231|FG003|Overall Study|Withdrawal by Subject|0|||
124981022|NCT04372121|449555228|FG000|Overall Study|Study termination|6|||
124981023|NCT04372121|449555229|FG001|Overall Study|Study termination|5|||
124981024|NCT04372121|449555230|FG002|Overall Study|Study termination|1|||
124981025|NCT04372121|449555231|FG003|Overall Study|Study termination|1|||
124981026|NCT04372121|449555228|FG000|Overall Study|Hysterectomy planned|1|||
124981027|NCT04372121|449555229|FG001|Overall Study|Hysterectomy planned|0|||
124981028|NCT04372121|449555230|FG002|Overall Study|Hysterectomy planned|0|||
124981029|NCT04372121|449555231|FG003|Overall Study|Hysterectomy planned|0|||
124981030|NCT03345576|449555232|FG000|Overall Study|Withdrawal by Subject|2|||
124981031|NCT03345576|449555233|FG001|Overall Study|Withdrawal by Subject|2|||
124981032|NCT03345576|449555232|FG000|Overall Study|Adverse Event|1|||
124981033|NCT03345576|449555233|FG001|Overall Study|Adverse Event|0|||
124981034|NCT01732822|449557317|FG000|Overall Study|Withdrawal by Subject|123|||
124981035|NCT01732822|449557318|FG001|Overall Study|Withdrawal by Subject|113|||
124981036|NCT02314780|449557319|FG000|Overall Study|organizational reasons|0|||
124981037|NCT02314780|449557320|FG001|Overall Study|organizational reasons|2|||
124981038|NCT02314780|449557321|FG002|Overall Study|organizational reasons|0|||
124981039|NCT02314780|449557319|FG000|Overall Study|Adverse Event|0|||
124981040|NCT02314780|449557320|FG001|Overall Study|Adverse Event|1|||
124981041|NCT02314780|449557321|FG002|Overall Study|Adverse Event|0|||
125204516|NCT02326298|450372068|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124981042|NCT00215137|449557325|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
124981043|NCT00215137|449557326|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
124981044|NCT00215137|449557327|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
124981045|NCT00215137|449557325|FG000|Randomization Period|Lost to Follow-up|0|||
124981046|NCT00215137|449557326|FG001|Randomization Period|Lost to Follow-up|1|||
124981047|NCT00215137|449557327|FG002|Randomization Period|Lost to Follow-up|0|||
124981048|NCT00215137|449557325|FG000|Randomization Period|Withdrawal by Subject|0|||
124981049|NCT00215137|449557326|FG001|Randomization Period|Withdrawal by Subject|1|||
124981050|NCT00215137|449557327|FG002|Randomization Period|Withdrawal by Subject|0|||
124981051|NCT01183260|449557329|FG000|Overall Study|Intraop screen failure|2|||
124981052|NCT01183260|449557330|FG001|Overall Study|Intraop screen failure|0|||
124981053|NCT01183260|449557329|FG000|Overall Study|Withdrawal by Subject|1|||
124981054|NCT01183260|449557330|FG001|Overall Study|Withdrawal by Subject|1|||
124981055|NCT01183260|449557329|FG000|Overall Study|Revised within 30 days|0|||
124981056|NCT01183260|449557330|FG001|Overall Study|Revised within 30 days|1|||
124981057|NCT01183260|449557329|FG000|Overall Study|Death|1|||
124981058|NCT01183260|449557330|FG001|Overall Study|Death|0|||
124981059|NCT01255631|449557331|FG000|Overall Study|poor enrollment, no data analyzed|9|||
124981060|NCT01255631|449557332|FG001|Overall Study|poor enrollment, no data analyzed|6|||
124981061|NCT00264303|449557342|FG000|Overall Study|Adverse Event|4|||
124981062|NCT00264303|449557343|FG001|Overall Study|Adverse Event|3|||
124981063|NCT00264303|449557342|FG000|Overall Study|Lack of Efficacy|10|||
124981064|NCT00264303|449557343|FG001|Overall Study|Lack of Efficacy|13|||
124981065|NCT00264303|449557342|FG000|Overall Study|Lost to Follow-up|3|||
124981066|NCT00264303|449557343|FG001|Overall Study|Lost to Follow-up|3|||
124981067|NCT00264303|449557342|FG000|Overall Study|Withdrawal by Subject|2|||
124981068|NCT00264303|449557343|FG001|Overall Study|Withdrawal by Subject|3|||
124981069|NCT00264303|449557342|FG000|Overall Study|Various reasons listed in study report|6|||
124981070|NCT00264303|449557343|FG001|Overall Study|Various reasons listed in study report|7|||
124981071|NCT02815579|449557344|FG000|Overall Study|Non-payment of loan down-payment|16|||
124981072|NCT02815579|449557345|FG001|Overall Study|Non-payment of loan down-payment|0|||
124981073|NCT02815579|449557344|FG000|Overall Study|Withdrawal by Subject|7|||
124981074|NCT02815579|449557345|FG001|Overall Study|Withdrawal by Subject|1|||
124981075|NCT02815579|449557344|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
124981076|NCT02815579|449557345|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
124981077|NCT02815579|449557344|FG000|Overall Study|Lost to Follow-up|7|||
124981078|NCT02815579|449557345|FG001|Overall Study|Lost to Follow-up|4|||
124981079|NCT02815579|449557344|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
124981080|NCT02815579|449557345|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
124981081|NCT02815579|449557344|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
124981082|NCT02815579|449557345|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
124981083|NCT02815579|449557344|FG000|Overall Study|Death|5|||
124981084|NCT02815579|449557345|FG001|Overall Study|Death|4|||
124981085|NCT02815579|449557344|FG000|Overall Study|Imprisoned|0|||
124981086|NCT02815579|449557345|FG001|Overall Study|Imprisoned|2|||
124981087|NCT02815579|449557344|FG000|Overall Study|Did not meet enrollment criteria|0|||
124981088|NCT02815579|449557345|FG001|Overall Study|Did not meet enrollment criteria|1|||
124981089|NCT02389452|449557346|FG000|Overall Study|Lost to Follow-up|13|||
124981090|NCT02389452|449557346|FG000|Overall Study|Adverse Event|1|||
124981091|NCT02389452|449557346|FG000|Overall Study|Withdrawal by Subject|5|||
124981092|NCT02389452|449557346|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
124981093|NCT02311673|449557347|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
124981094|NCT02311673|449557348|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
124981095|NCT02311673|449557349|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
124981096|NCT02311673|449557350|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
124981097|NCT00414908|449557356|FG000|Overall Study|Protocol Violation|1|||
124981098|NCT00414908|449557357|FG001|Overall Study|Protocol Violation|1|||
124981099|NCT00818168|449557358|FG000|Overall Study|Lack of Efficacy|18|||
124981100|NCT00818168|449557358|FG000|Overall Study|Pregnancy|2|||
124981101|NCT00818168|449557358|FG000|Overall Study|Withdrawal by Subject|16|||
124981102|NCT00818168|449557358|FG000|Overall Study|Lost to Follow-up|7|||
124981103|NCT00818168|449557358|FG000|Overall Study|Adverse Event|19|||
124981104|NCT00818168|449557358|FG000|Overall Study|Reason for Non-completion Not reported|6|||
124981105|NCT00818168|449557358|FG000|Overall Study|Participant Moved|2|||
124981106|NCT02040259|449557359|FG000|Overall Study|Death|280|||
124981107|NCT02040259|449557359|FG000|Overall Study|Lost to Follow-up|76|||
124981108|NCT02040259|449557359|FG000|Overall Study|Assessment not completed|3|||
124981109|NCT02040259|449557359|FG000|Overall Study|Withdrawal by Subject|4|||
124981110|NCT04476251|449557360|FG000|Overall Study|Not treated|1|||
124981111|NCT00316602|449557370|FG000|Overall Study|Withdrawal by Subject|3|||
125204517|NCT02326298|450372069|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125204518|NCT02326298|450372070|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124981112|NCT00316602|449557371|FG001|Overall Study|Withdrawal by Subject|2|||
124981113|NCT00316602|449557370|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
124981114|NCT00316602|449557371|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
124981115|NCT00316602|449557370|FG000|Overall Study|Adverse Event|1|||
124981116|NCT00316602|449557371|FG001|Overall Study|Adverse Event|0|||
124981117|NCT00316602|449557370|FG000|Overall Study|Other|3|||
124981118|NCT00316602|449557371|FG001|Overall Study|Other|6|||
124981119|NCT00626990|449557372|FG000|Overall Study|Lack of Efficacy|6|||
124981120|NCT00626990|449557373|FG001|Overall Study|Lack of Efficacy|7|||
124981121|NCT00626990|449557374|FG002|Overall Study|Lack of Efficacy|49|||
124981122|NCT00626990|449557375|FG003|Overall Study|Lack of Efficacy|40|||
124981123|NCT00626990|449557372|FG000|Overall Study|Adverse Event|1|||
124981124|NCT00626990|449557373|FG001|Overall Study|Adverse Event|7|||
124981125|NCT00626990|449557374|FG002|Overall Study|Adverse Event|14|||
124981126|NCT00626990|449557375|FG003|Overall Study|Adverse Event|28|||
124981127|NCT00626990|449557372|FG000|Overall Study|Death|0|||
124981128|NCT00626990|449557373|FG001|Overall Study|Death|1|||
124981129|NCT00626990|449557374|FG002|Overall Study|Death|0|||
124981130|NCT00626990|449557375|FG003|Overall Study|Death|0|||
124981131|NCT00626990|449557372|FG000|Overall Study|Withdrawal by Subject|3|||
124981132|NCT00626990|449557373|FG001|Overall Study|Withdrawal by Subject|1|||
124981133|NCT00626990|449557374|FG002|Overall Study|Withdrawal by Subject|5|||
124981134|NCT00626990|449557375|FG003|Overall Study|Withdrawal by Subject|11|||
124981135|NCT00626990|449557372|FG000|Overall Study|Protocol Violation|0|||
124981136|NCT00626990|449557373|FG001|Overall Study|Protocol Violation|1|||
124981137|NCT00626990|449557374|FG002|Overall Study|Protocol Violation|1|||
124981138|NCT00626990|449557375|FG003|Overall Study|Protocol Violation|0|||
124981139|NCT00626990|449557372|FG000|Overall Study|Various different reasons/missing|4|||
124981140|NCT00626990|449557373|FG001|Overall Study|Various different reasons/missing|8|||
124981141|NCT00626990|449557374|FG002|Overall Study|Various different reasons/missing|8|||
124981142|NCT00626990|449557375|FG003|Overall Study|Various different reasons/missing|16|||
124981143|NCT01008410|449557381|FG000|Overall Study|Adverse Event|13|||
124981144|NCT01008410|449557382|FG001|Overall Study|Adverse Event|7|||
124981145|NCT01008410|449557381|FG000|Overall Study|Withdrawal by Subject|6|||
124981146|NCT01008410|449557382|FG001|Overall Study|Withdrawal by Subject|2|||
124981147|NCT01008410|449557381|FG000|Overall Study|Lost to Follow-up|1|||
124981148|NCT01008410|449557382|FG001|Overall Study|Lost to Follow-up|0|||
124981149|NCT01008410|449557381|FG000|Overall Study|Noncompliance|1|||
124981150|NCT01008410|449557382|FG001|Overall Study|Noncompliance|0|||
124981151|NCT01008410|449557381|FG000|Overall Study|Low Cortisol|2|||
124981152|NCT01008410|449557382|FG001|Overall Study|Low Cortisol|0|||
124981153|NCT01008410|449557381|FG000|Overall Study|Lack of Efficacy|2|||
124981154|NCT01008410|449557382|FG001|Overall Study|Lack of Efficacy|6|||
124981155|NCT01008410|449557381|FG000|Overall Study|Met Exclusion Criterion|0|||
124981156|NCT01008410|449557382|FG001|Overall Study|Met Exclusion Criterion|1|||
124981157|NCT00297427|449557385|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
124981158|NCT00297427|449557386|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
124981159|NCT00297427|449557385|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
124981160|NCT00297427|449557386|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
124981161|NCT00297427|449557385|FG000|Phase 1: Initial Intervention|Death|0|||
124981162|NCT00297427|449557386|FG001|Phase 1: Initial Intervention|Death|1|||
124981163|NCT00297427|449557385|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
124981164|NCT00297427|449557386|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
124981165|NCT00297427|449557385|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
124981166|NCT00297427|449557386|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
124981167|NCT00297427|449557385|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
124981168|NCT00297427|449557386|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
125204519|NCT02326298|450372057|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
125204520|NCT02326298|450372058|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
125204521|NCT02326298|450372059|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204522|NCT02326298|450372060|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204523|NCT02326298|450372061|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204524|NCT02326298|450372062|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204525|NCT02326298|450372063|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204526|NCT02326298|450372064|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204527|NCT02326298|450372065|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204528|NCT02326298|450372066|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204529|NCT02326298|450372067|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204530|NCT02326298|450372068|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204531|NCT02326298|450372069|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204532|NCT02326298|450372070|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204533|NCT02326298|450372057|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204534|NCT02326298|450372058|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204535|NCT02326298|450372059|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
125204536|NCT02326298|450372060|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204537|NCT02326298|450372061|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204538|NCT02326298|450372062|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204539|NCT02326298|450372063|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204540|NCT02326298|450372064|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204541|NCT02326298|450372065|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204542|NCT02326298|450372066|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204543|NCT02326298|450372067|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
124981169|NCT00297427|449557385|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
124981170|NCT00297427|449557386|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
124981171|NCT00297427|449557385|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
125204544|NCT02326298|450372068|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204545|NCT02326298|450372069|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204546|NCT02326298|450372070|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204547|NCT02326298|450372057|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125204548|NCT02326298|450372058|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125204549|NCT02326298|450372059|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125204550|NCT02326298|450372060|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125204551|NCT02326298|450372061|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125204552|NCT02326298|450372062|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125204553|NCT02326298|450372063|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
125204554|NCT02326298|450372064|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125204555|NCT02326298|450372065|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125204556|NCT02326298|450372066|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125204557|NCT02326298|450372067|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125204558|NCT02326298|450372068|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125204559|NCT02326298|450372069|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125204560|NCT02326298|450372070|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125204561|NCT02326298|450372057|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204562|NCT02326298|450372058|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204563|NCT02326298|450372059|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204564|NCT02326298|450372060|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204565|NCT02326298|450372061|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204566|NCT02326298|450372062|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
125204567|NCT02326298|450372063|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
125204568|NCT02326298|450372064|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204569|NCT02326298|450372065|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
125204570|NCT02326298|450372066|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204571|NCT02326298|450372067|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204572|NCT02326298|450372068|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204573|NCT02326298|450372069|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204574|NCT02326298|450372070|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204575|NCT02326298|450372057|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204576|NCT02326298|450372058|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
124981172|NCT00297427|449557386|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
124981173|NCT03056300|449557388|FG000|Overall Study|Surgical reason per study protocol|3|||
124981174|NCT03248882|449557389|FG000|Overall Study|Adverse Event|3|||
124981175|NCT03248882|449557390|FG001|Overall Study|Adverse Event|3|||
124981176|NCT03248882|449557391|FG002|Overall Study|Adverse Event|2|||
124981177|NCT03248882|449557392|FG003|Overall Study|Adverse Event|6|||
124981178|NCT03248882|449557393|FG004|Overall Study|Adverse Event|9|||
124981179|NCT03248882|449557389|FG000|Overall Study|Lost to Follow-up|0|||
124981180|NCT03248882|449557390|FG001|Overall Study|Lost to Follow-up|0|||
124981181|NCT03248882|449557391|FG002|Overall Study|Lost to Follow-up|0|||
124981182|NCT03248882|449557392|FG003|Overall Study|Lost to Follow-up|0|||
124981183|NCT03248882|449557393|FG004|Overall Study|Lost to Follow-up|1|||
124981184|NCT03248882|449557389|FG000|Overall Study|Protocol Violation|2|||
124981185|NCT03248882|449557390|FG001|Overall Study|Protocol Violation|0|||
124981186|NCT03248882|449557391|FG002|Overall Study|Protocol Violation|2|||
124981187|NCT03248882|449557392|FG003|Overall Study|Protocol Violation|0|||
124981188|NCT03248882|449557393|FG004|Overall Study|Protocol Violation|1|||
124981189|NCT03248882|449557389|FG000|Overall Study|Withdrawal by Subject|2|||
124981190|NCT03248882|449557390|FG001|Overall Study|Withdrawal by Subject|2|||
124981191|NCT03248882|449557391|FG002|Overall Study|Withdrawal by Subject|3|||
124981192|NCT03248882|449557392|FG003|Overall Study|Withdrawal by Subject|4|||
124981193|NCT03248882|449557393|FG004|Overall Study|Withdrawal by Subject|2|||
124981194|NCT01656200|449557394|FG000|Overall Study|Withdrawal by Subject|1|||
124981195|NCT01156376|449557396|FG000|Overall Study|Adverse Event|1|||
124981196|NCT01156376|449557397|FG001|Overall Study|Adverse Event|0|||
124981197|NCT01156376|449557398|FG002|Overall Study|Adverse Event|1|||
124981198|NCT01156376|449557396|FG000|Overall Study|Withdrawal by Subject|0|||
124981199|NCT01156376|449557397|FG001|Overall Study|Withdrawal by Subject|0|||
124981200|NCT01156376|449557398|FG002|Overall Study|Withdrawal by Subject|3|||
124981201|NCT02797080|449557400|FG000|Overall Study|Lost to Follow-up|1|||
124981202|NCT02797080|449557400|FG000|Overall Study|Withdrawal by Subject|1|||
124981203|NCT01305408|449557401|FG000|Overall Study|Adverse Event|10|||
124981204|NCT01305408|449557402|FG001|Overall Study|Adverse Event|7|||
124981205|NCT01305408|449557401|FG000|Overall Study|Lack of Efficacy|3|||
124981206|NCT01305408|449557402|FG001|Overall Study|Lack of Efficacy|4|||
124981207|NCT01305408|449557401|FG000|Overall Study|Withdrawal by Subject|9|||
124981208|NCT01305408|449557402|FG001|Overall Study|Withdrawal by Subject|9|||
124981209|NCT01305408|449557401|FG000|Overall Study|Protocol Violation|4|||
124981210|NCT01305408|449557402|FG001|Overall Study|Protocol Violation|6|||
124981211|NCT01305408|449557401|FG000|Overall Study|Lost to Follow-up|5|||
124981212|NCT01305408|449557402|FG001|Overall Study|Lost to Follow-up|3|||
124981213|NCT01305408|449557401|FG000|Overall Study|Noncompliance with study medication|0|||
124981214|NCT01305408|449557402|FG001|Overall Study|Noncompliance with study medication|1|||
124981215|NCT01305408|449557401|FG000|Overall Study|Noncompliance with study procedures|0|||
124981216|NCT01305408|449557402|FG001|Overall Study|Noncompliance with study procedures|1|||
124981217|NCT01305408|449557401|FG000|Overall Study|Other|1|||
124981218|NCT01305408|449557402|FG001|Overall Study|Other|0|||
124981219|NCT02530970|449557403|FG000|Overall Study|Adverse Event|8|||
124981220|NCT02530970|449557403|FG000|Overall Study|Lost to Follow-up|88|||
124981221|NCT02530970|449557403|FG000|Overall Study|Physician Decision|5|||
124981222|NCT02530970|449557403|FG000|Overall Study|Withdrawal by Subject|14|||
124981223|NCT02530970|449557403|FG000|Overall Study|Death|6|||
124981224|NCT02530970|449557403|FG000|Overall Study|Hospitalization|1|||
124981225|NCT02530970|449557403|FG000|Overall Study|Insurance|2|||
124981226|NCT02530970|449557403|FG000|Overall Study|Explant|2|||
124981227|NCT02530970|449557403|FG000|Overall Study|Change in Provider|5|||
124981228|NCT02530970|449557403|FG000|Overall Study|Relocation|3|||
124981229|NCT01365481|449557410|FG000|Overall Study|Adverse Event|6|||
124981230|NCT01365481|449557411|FG001|Overall Study|Adverse Event|9|||
124981231|NCT01365481|449557412|FG002|Overall Study|Adverse Event|0|||
124981232|NCT01365481|449557413|FG003|Overall Study|Adverse Event|2|||
124981233|NCT01365481|449557410|FG000|Overall Study|Withdrawal by Subject|0|||
124981234|NCT01365481|449557411|FG001|Overall Study|Withdrawal by Subject|2|||
124981235|NCT01365481|449557412|FG002|Overall Study|Withdrawal by Subject|1|||
124981236|NCT01365481|449557413|FG003|Overall Study|Withdrawal by Subject|1|||
124981237|NCT01365481|449557410|FG000|Overall Study|Lost to Follow-up|1|||
124981238|NCT01365481|449557411|FG001|Overall Study|Lost to Follow-up|1|||
124981239|NCT01365481|449557412|FG002|Overall Study|Lost to Follow-up|2|||
124981240|NCT01365481|449557413|FG003|Overall Study|Lost to Follow-up|3|||
124981241|NCT01365481|449557410|FG000|Overall Study|Abnormal laboratory value(s)|0|||
124981242|NCT01365481|449557411|FG001|Overall Study|Abnormal laboratory value(s)|1|||
124981243|NCT01365481|449557412|FG002|Overall Study|Abnormal laboratory value(s)|0|||
124981244|NCT01365481|449557413|FG003|Overall Study|Abnormal laboratory value(s)|0|||
124981245|NCT01365481|449557410|FG000|Overall Study|Administrative problems|0|||
124981246|NCT01365481|449557411|FG001|Overall Study|Administrative problems|1|||
124981247|NCT01365481|449557412|FG002|Overall Study|Administrative problems|0|||
124981248|NCT01365481|449557413|FG003|Overall Study|Administrative problems|0|||
124981249|NCT01365481|449557410|FG000|Overall Study|Protocol deviation|0|||
124981250|NCT01365481|449557411|FG001|Overall Study|Protocol deviation|1|||
124981251|NCT01365481|449557412|FG002|Overall Study|Protocol deviation|0|||
124981252|NCT01365481|449557413|FG003|Overall Study|Protocol deviation|1|||
124981253|NCT01365481|449557410|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124981254|NCT01365481|449557411|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124981255|NCT01365481|449557412|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
124981256|NCT01365481|449557413|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
124981257|NCT01641159|449557424|FG000|Overall Study|Lost to Follow-up|2|||
124981258|NCT01641159|449557425|FG001|Overall Study|Lost to Follow-up|1|||
124981259|NCT01641159|449557424|FG000|Overall Study|Withdrawal by Subject|0|||
124981260|NCT01641159|449557425|FG001|Overall Study|Withdrawal by Subject|1|||
124981261|NCT03653208|449557429|FG000|Overall Study|Withdrawal by Subject|0|||
124981262|NCT03653208|449557430|FG001|Overall Study|Withdrawal by Subject|0|||
124981263|NCT03653208|449557431|FG002|Overall Study|Withdrawal by Subject|0|||
124981264|NCT03653208|449557432|FG003|Overall Study|Withdrawal by Subject|0|||
124981265|NCT03653208|449557433|FG004|Overall Study|Withdrawal by Subject|1|||
124981266|NCT03653208|449557434|FG005|Overall Study|Withdrawal by Subject|0|||
124981267|NCT03653208|449557435|FG006|Overall Study|Withdrawal by Subject|0|||
124981268|NCT03653208|449557436|FG007|Overall Study|Withdrawal by Subject|1|||
124981269|NCT03653208|449557437|FG008|Overall Study|Withdrawal by Subject|1|||
124981270|NCT03752970|449557439|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
124981271|NCT03752970|449557440|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
124981272|NCT03752970|449557441|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
124981273|NCT03752970|449557439|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
124981274|NCT03752970|449557440|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
124981275|NCT03752970|449557441|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
124981276|NCT03752970|449557439|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
124981277|NCT03752970|449557440|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
124981278|NCT03752970|449557441|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
124981279|NCT03752970|449557439|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
124981280|NCT03752970|449557440|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
124981281|NCT03752970|449557441|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
124981282|NCT03752970|449557439|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
124981283|NCT03752970|449557440|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
124871954|NCT03002610|449152754|FG002|Overall Study|Withdrawal by Subject|13|||
124871955|NCT02227875|449152757|FG000|Overall Study|Protocol Violation|10|||
124871956|NCT02227875|449152758|FG001|Overall Study|Protocol Violation|7|||
124871957|NCT02227875|449152757|FG000|Overall Study|Other|1|||
124871958|NCT02227875|449152758|FG001|Overall Study|Other|3|||
124871959|NCT02227875|449152757|FG000|Overall Study|Physician Decision|1|||
124871960|NCT02227875|449152758|FG001|Overall Study|Physician Decision|0|||
124871961|NCT02227875|449152757|FG000|Overall Study|Adverse Event|3|||
124871962|NCT02227875|449152758|FG001|Overall Study|Adverse Event|0|||
124871963|NCT02227875|449152757|FG000|Overall Study|Withdrawal by Subject|12|||
124871964|NCT02227875|449152758|FG001|Overall Study|Withdrawal by Subject|13|||
124871965|NCT02227875|449152757|FG000|Overall Study|Lost to Follow-up|10|||
124871966|NCT02227875|449152758|FG001|Overall Study|Lost to Follow-up|10|||
124871967|NCT04209725|449152759|FG000|Overall Study|Adverse Event|1|||
124871968|NCT02657317|449152760|FG000|Overall Study|Withdrawal by Subject|2|||
124871969|NCT02657317|449152761|FG001|Overall Study|Withdrawal by Subject|0|||
124871970|NCT02657317|449152760|FG000|Overall Study|Lost to Follow-up|3|||
124871971|NCT02657317|449152761|FG001|Overall Study|Lost to Follow-up|3|||
124871972|NCT03033225|449152772|FG000|Overall Study|Withdrawal by Subject|5|||
124871973|NCT02515279|449152773|FG000|Overall Study|Adverse Event|7|||
124871974|NCT02515279|449152773|FG000|Overall Study|Lack of Efficacy|31|||
124871975|NCT02515279|449152773|FG000|Overall Study|Lost to Follow-up|9|||
124871976|NCT02515279|449152773|FG000|Overall Study|Withdrawal by Subject|18|||
124871977|NCT02515279|449152773|FG000|Overall Study|End-of-treatment visit not attended|17|||
124871978|NCT02515279|449152773|FG000|Overall Study|Other|22|||
124871979|NCT01800968|449152775|FG000|Overall Study|Death|23|||
124871980|NCT01800968|449152776|FG001|Overall Study|Death|16|||
124871981|NCT01800968|449152775|FG000|Overall Study|Lost to Follow-up|5|||
124871982|NCT01800968|449152776|FG001|Overall Study|Lost to Follow-up|7|||
124871983|NCT01800968|449152775|FG000|Overall Study|Withdrawal by Subject|7|||
124871984|NCT01800968|449152776|FG001|Overall Study|Withdrawal by Subject|9|||
124871985|NCT01800968|449152775|FG000|Overall Study|Physician Decision|1|||
124871986|NCT01800968|449152776|FG001|Overall Study|Physician Decision|0|||
124871987|NCT03266770|449152779|FG000|Overall Study|Physician Decision|3|||
124871988|NCT03266770|449152779|FG000|Overall Study|Insufficient study supplies|1|||
124871989|NCT03266770|449152779|FG000|Overall Study|Adverse Event|1|||
124871990|NCT02220894|449152780|FG000|Overall Study|Adverse Event|127|||
124871991|NCT02220894|449152781|FG001|Overall Study|Adverse Event|74|||
124871992|NCT02220894|449152780|FG000|Overall Study|Death|418|||
124871993|NCT02220894|449152781|FG001|Overall Study|Death|508|||
124871994|NCT02220894|449152780|FG000|Overall Study|Lost to Follow-up|0|||
124871995|NCT02220894|449152781|FG001|Overall Study|Lost to Follow-up|4|||
124871996|NCT02220894|449152780|FG000|Overall Study|Site Terminated by Sponsor|2|||
124871997|NCT02220894|449152781|FG001|Overall Study|Site Terminated by Sponsor|0|||
124871998|NCT02220894|449152780|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
124871999|NCT02220894|449152781|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
124872000|NCT02220894|449152780|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124872001|NCT02220894|449152781|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
124872002|NCT02220894|449152780|FG000|Overall Study|Withdrawal by Subject|10|||
124872003|NCT02220894|449152781|FG001|Overall Study|Withdrawal by Subject|9|||
124872004|NCT05007392|449152782|FG000|Overall Study|Randomized but not treated|1|||
124872005|NCT05007392|449152783|FG001|Overall Study|Randomized but not treated|2|||
124872006|NCT05007392|449152782|FG000|Overall Study|Other|5|||
124872007|NCT05007392|449152783|FG001|Overall Study|Other|4|||
124872008|NCT05007392|449152782|FG000|Overall Study|Lost to Follow-up|1|||
124872009|NCT05007392|449152783|FG001|Overall Study|Lost to Follow-up|2|||
124872010|NCT05007392|449152782|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
124872011|NCT05007392|449152783|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
124872012|NCT05007392|449152782|FG000|Overall Study|Use of prohibited concomitant drug|1|||
124872013|NCT05007392|449152783|FG001|Overall Study|Use of prohibited concomitant drug|1|||
124872014|NCT05007392|449152782|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
124872015|NCT05007392|449152783|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
124872016|NCT05007392|449152782|FG000|Overall Study|Adverse Event|10|||
124872017|NCT05007392|449152783|FG001|Overall Study|Adverse Event|6|||
124872018|NCT05007392|449152782|FG000|Overall Study|Participant choice|5|||
124872019|NCT05007392|449152783|FG001|Overall Study|Participant choice|10|||
124872020|NCT05007392|449152782|FG000|Overall Study|Withdrawal of consent|5|||
124872021|NCT05007392|449152783|FG001|Overall Study|Withdrawal of consent|4|||
124872022|NCT02453685|449152784|FG000|Overall Study|Adverse Event|0|||
124872023|NCT02453685|449152785|FG001|Overall Study|Adverse Event|1|||
124981284|NCT03752970|449557441|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
124981285|NCT01152814|449557443|FG000|Overall Study|Lost to Follow-up|2|||
124981286|NCT01669577|449557447|FG000|Overall Study|Death|22|||
124981287|NCT01669577|449557447|FG000|Overall Study|Lost to Follow-up|78|||
124981288|NCT01669577|449557447|FG000|Overall Study|Physician Decision|34|||
124981289|NCT01283516|449557448|FG000|Overall Study|Adverse Event|0|||
124981290|NCT01283516|449557449|FG001|Overall Study|Adverse Event|0|||
125204577|NCT02326298|450372059|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204578|NCT02326298|450372060|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204579|NCT02326298|450372061|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204580|NCT02326298|450372062|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
125204581|NCT02326298|450372063|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204582|NCT02326298|450372064|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204583|NCT02326298|450372065|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204584|NCT02326298|450372066|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204585|NCT02326298|450372067|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204586|NCT02326298|450372068|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204587|NCT02326298|450372069|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204588|NCT02326298|450372070|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204589|NCT02326298|450372057|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204590|NCT02326298|450372058|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204591|NCT02326298|450372059|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204592|NCT02326298|450372060|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204593|NCT02326298|450372061|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204594|NCT02326298|450372062|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204595|NCT02326298|450372063|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
125204596|NCT02326298|450372064|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204597|NCT02326298|450372065|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204598|NCT02326298|450372066|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204599|NCT02326298|450372067|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204600|NCT02326298|450372068|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204601|NCT02326298|450372069|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204602|NCT02326298|450372070|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204603|NCT02326298|450372057|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204604|NCT02326298|450372058|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204605|NCT02326298|450372059|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204606|NCT02326298|450372060|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204607|NCT02326298|450372061|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204608|NCT02326298|450372062|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204609|NCT02326298|450372063|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204610|NCT02326298|450372064|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
125204611|NCT02326298|450372065|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204612|NCT02326298|450372066|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204613|NCT02326298|450372067|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204614|NCT02326298|450372068|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204615|NCT02326298|450372069|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204616|NCT02326298|450372070|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204617|NCT02326298|450372057|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204618|NCT02326298|450372058|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204619|NCT02326298|450372059|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204620|NCT02326298|450372060|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204621|NCT02326298|450372061|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124981291|NCT01283516|449557450|FG002|Overall Study|Adverse Event|0|||
124981292|NCT01283516|449557451|FG003|Overall Study|Adverse Event|0|||
124981293|NCT01283516|449557452|FG004|Overall Study|Adverse Event|0|||
124981294|NCT01283516|449557453|FG005|Overall Study|Adverse Event|0|||
124981295|NCT01283516|449557454|FG006|Overall Study|Adverse Event|2|||
124981296|NCT01283516|449557455|FG007|Overall Study|Adverse Event|0|||
124981297|NCT01283516|449557456|FG008|Overall Study|Adverse Event|28|||
124981298|NCT01283516|449557448|FG000|Overall Study|Death|0|||
124981299|NCT01283516|449557449|FG001|Overall Study|Death|0|||
124981300|NCT01283516|449557450|FG002|Overall Study|Death|0|||
124981301|NCT01283516|449557451|FG003|Overall Study|Death|0|||
124981302|NCT01283516|449557452|FG004|Overall Study|Death|0|||
124981303|NCT01283516|449557453|FG005|Overall Study|Death|1|||
124981304|NCT01283516|449557454|FG006|Overall Study|Death|0|||
124981305|NCT01283516|449557455|FG007|Overall Study|Death|1|||
125204622|NCT02326298|450372062|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204623|NCT02326298|450372063|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
125204624|NCT02326298|450372064|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
125204625|NCT02326298|450372065|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204626|NCT02326298|450372066|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204627|NCT02326298|450372067|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204628|NCT02326298|450372068|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204629|NCT02326298|450372069|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204630|NCT02326298|450372070|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204631|NCT02326298|450372057|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204632|NCT02326298|450372058|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204633|NCT02326298|450372059|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204634|NCT02326298|450372060|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204635|NCT02326298|450372061|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204636|NCT02326298|450372062|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204637|NCT02326298|450372063|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204638|NCT02326298|450372064|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
125204639|NCT02326298|450372065|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204640|NCT02326298|450372066|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204641|NCT02326298|450372067|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204642|NCT02326298|450372068|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204643|NCT02326298|450372069|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204644|NCT02326298|450372070|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204645|NCT02326298|450372057|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204646|NCT02326298|450372058|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204647|NCT02326298|450372059|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204648|NCT02326298|450372060|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204649|NCT02326298|450372061|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204650|NCT02326298|450372062|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
125204651|NCT02326298|450372063|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204652|NCT02326298|450372064|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204653|NCT02326298|450372065|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204654|NCT02326298|450372066|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204655|NCT02326298|450372067|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204656|NCT02326298|450372068|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204657|NCT02326298|450372069|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204658|NCT02326298|450372070|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204659|NCT02326298|450372057|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
125204660|NCT02326298|450372058|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
125204661|NCT02326298|450372059|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
125204662|NCT02326298|450372060|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
125204663|NCT02326298|450372061|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
125204664|NCT02326298|450372062|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
125204665|NCT02326298|450372063|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
125204666|NCT02326298|450372064|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
125204667|NCT02326298|450372065|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
125204668|NCT02326298|450372066|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
125204669|NCT02326298|450372067|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
125204670|NCT02326298|450372068|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
125204671|NCT02326298|450372069|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
125204672|NCT02326298|450372070|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
125204673|NCT02326298|450372057|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204674|NCT02326298|450372058|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204675|NCT02326298|450372059|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204676|NCT02326298|450372060|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204677|NCT02326298|450372061|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204678|NCT02326298|450372062|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204679|NCT02326298|450372063|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204680|NCT02326298|450372064|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204681|NCT02326298|450372065|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204682|NCT02326298|450372066|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204683|NCT02326298|450372067|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124872024|NCT02453685|449152784|FG000|Overall Study|Protocol Violation|7|||
125204684|NCT02326298|450372068|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
125204685|NCT02326298|450372069|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
125204686|NCT02326298|450372070|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204687|NCT02326298|450372057|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204688|NCT02326298|450372058|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204689|NCT02326298|450372059|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204690|NCT02326298|450372060|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204691|NCT02326298|450372061|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204692|NCT02326298|450372062|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204693|NCT02326298|450372063|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204694|NCT02326298|450372064|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204695|NCT02326298|450372065|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204696|NCT02326298|450372066|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204697|NCT02326298|450372067|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204698|NCT02326298|450372068|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
125204699|NCT02326298|450372069|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
125204700|NCT02326298|450372070|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204701|NCT02326298|450372057|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204702|NCT02326298|450372058|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204703|NCT02326298|450372059|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204704|NCT02326298|450372060|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204705|NCT02326298|450372061|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204706|NCT02326298|450372062|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204707|NCT02326298|450372063|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204708|NCT02326298|450372064|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204709|NCT02326298|450372065|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204710|NCT02326298|450372066|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204711|NCT02326298|450372067|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204712|NCT02326298|450372068|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204713|NCT02326298|450372069|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204714|NCT02326298|450372070|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
125204715|NCT02326298|450372057|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204716|NCT02326298|450372058|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204717|NCT02326298|450372059|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204718|NCT02326298|450372060|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204719|NCT02326298|450372061|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204720|NCT02326298|450372062|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204721|NCT02326298|450372063|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204722|NCT02326298|450372064|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204723|NCT02326298|450372065|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204724|NCT02326298|450372066|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204725|NCT02326298|450372067|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204726|NCT02326298|450372068|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
125204727|NCT02326298|450372069|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
125204728|NCT02326298|450372070|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
125204729|NCT02326298|450372057|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204730|NCT02326298|450372058|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204731|NCT02326298|450372059|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204732|NCT02326298|450372060|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204733|NCT02326298|450372061|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204734|NCT02326298|450372062|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204735|NCT02326298|450372063|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204736|NCT02326298|450372064|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204737|NCT02326298|450372065|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204738|NCT02326298|450372066|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204739|NCT02326298|450372067|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204740|NCT02326298|450372068|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
125204741|NCT02326298|450372069|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
125204742|NCT02326298|450372070|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
125204743|NCT02326298|450372057|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204744|NCT02326298|450372058|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204745|NCT02326298|450372059|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204746|NCT02326298|450372060|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204747|NCT02326298|450372061|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204748|NCT02326298|450372062|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204749|NCT02326298|450372063|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204750|NCT02326298|450372064|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204751|NCT02326298|450372065|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204752|NCT02326298|450372066|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204753|NCT02326298|450372067|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204754|NCT02326298|450372068|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
125204755|NCT02326298|450372069|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
125204756|NCT02326298|450372070|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
125204757|NCT03191864|450372071|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
125204758|NCT03191864|450372072|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
125204759|NCT03191864|450372073|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
125204760|NCT03191864|450372074|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
125204761|NCT03191864|450372075|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
125204762|NCT03191864|450372076|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
125204763|NCT03191864|450372071|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
125204764|NCT03191864|450372072|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
125204765|NCT03191864|450372073|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
125204766|NCT03191864|450372074|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
125204767|NCT03191864|450372075|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
125204768|NCT03191864|450372076|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
125204769|NCT03191864|450372071|FG000|Baseline Symptom Assessment|Adverse Event|0|||
125204770|NCT03191864|450372072|FG001|Baseline Symptom Assessment|Adverse Event|0|||
125204771|NCT03191864|450372073|FG002|Baseline Symptom Assessment|Adverse Event|0|||
125204772|NCT03191864|450372074|FG003|Baseline Symptom Assessment|Adverse Event|0|||
125204773|NCT03191864|450372075|FG004|Baseline Symptom Assessment|Adverse Event|0|||
125204774|NCT03191864|450372076|FG005|Baseline Symptom Assessment|Adverse Event|2|||
125204775|NCT03191864|450372071|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
125204776|NCT03191864|450372072|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
125204777|NCT03191864|450372073|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
125204778|NCT03191864|450372074|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
125204779|NCT03191864|450372075|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
125204780|NCT03191864|450372076|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
125204781|NCT03191864|450372071|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
125204782|NCT03191864|450372072|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
125204783|NCT03191864|450372073|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
125204784|NCT03191864|450372074|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
125204785|NCT03191864|450372075|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
125204786|NCT03191864|450372076|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
125204787|NCT03191864|450372071|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
125204788|NCT03191864|450372072|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
125204789|NCT03191864|450372073|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
125204790|NCT03191864|450372074|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
125204791|NCT03191864|450372075|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
125204792|NCT03191864|450372076|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
125204793|NCT03191864|450372071|FG000|Part 1 - Induction|Adverse Event|0|||
125204794|NCT03191864|450372072|FG001|Part 1 - Induction|Adverse Event|2|||
125204795|NCT03191864|450372073|FG002|Part 1 - Induction|Adverse Event|0|||
125204796|NCT03191864|450372074|FG003|Part 1 - Induction|Adverse Event|1|||
125204797|NCT03191864|450372075|FG004|Part 1 - Induction|Adverse Event|0|||
125204798|NCT03191864|450372076|FG005|Part 1 - Induction|Adverse Event|2|||
125204799|NCT03191864|450372071|FG000|Part 1 - Induction|Randomized but never dosed|0|||
125204800|NCT03191864|450372072|FG001|Part 1 - Induction|Randomized but never dosed|0|||
125204801|NCT03191864|450372073|FG002|Part 1 - Induction|Randomized but never dosed|1|||
125204802|NCT03191864|450372074|FG003|Part 1 - Induction|Randomized but never dosed|0|||
125204803|NCT03191864|450372075|FG004|Part 1 - Induction|Randomized but never dosed|0|||
125204804|NCT03191864|450372076|FG005|Part 1 - Induction|Randomized but never dosed|0|||
125204805|NCT03191864|450372071|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
125204806|NCT03191864|450372072|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
125204807|NCT03191864|450372073|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
125204808|NCT03191864|450372074|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
125204809|NCT03191864|450372075|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
125204810|NCT03191864|450372076|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
125204811|NCT03191864|450372071|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
125204812|NCT03191864|450372072|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
125204813|NCT03191864|450372073|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
125204814|NCT03191864|450372074|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
125204815|NCT03191864|450372075|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
125204816|NCT03191864|450372076|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
125204817|NCT03191864|450372071|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
125204818|NCT03191864|450372072|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
125204819|NCT03191864|450372073|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
125204820|NCT03191864|450372074|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
125204821|NCT03191864|450372075|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
125204822|NCT03191864|450372076|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
125204823|NCT03191864|450372071|FG000|Part 2 - Maintenance|Physician Decision|1|||
125204824|NCT03191864|450372072|FG001|Part 2 - Maintenance|Physician Decision|0|||
125204825|NCT03191864|450372073|FG002|Part 2 - Maintenance|Physician Decision|0|||
125204826|NCT03191864|450372074|FG003|Part 2 - Maintenance|Physician Decision|0|||
125204827|NCT03191864|450372075|FG004|Part 2 - Maintenance|Physician Decision|0|||
125204828|NCT03191864|450372076|FG005|Part 2 - Maintenance|Physician Decision|0|||
125204829|NCT03191864|450372071|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
125204830|NCT03191864|450372072|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
125204831|NCT03191864|450372073|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
125204832|NCT03191864|450372074|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
125204833|NCT03191864|450372075|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
125204834|NCT03191864|450372076|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
125204835|NCT03191864|450372071|FG000|Part 2 - Maintenance|Adverse Event|0|||
125204836|NCT03191864|450372072|FG001|Part 2 - Maintenance|Adverse Event|0|||
125204837|NCT03191864|450372073|FG002|Part 2 - Maintenance|Adverse Event|0|||
125204838|NCT03191864|450372074|FG003|Part 2 - Maintenance|Adverse Event|0|||
125204839|NCT03191864|450372075|FG004|Part 2 - Maintenance|Adverse Event|1|||
125204840|NCT03191864|450372076|FG005|Part 2 - Maintenance|Adverse Event|0|||
125204841|NCT03191864|450372071|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
125204842|NCT03191864|450372072|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
125204843|NCT03191864|450372073|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
125204844|NCT03191864|450372074|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
125204845|NCT03191864|450372075|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
125204846|NCT03191864|450372076|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
125204847|NCT03191864|450372071|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
125204848|NCT03191864|450372072|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
125204849|NCT03191864|450372073|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
125204850|NCT03191864|450372074|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
125204851|NCT03191864|450372075|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
125204852|NCT03191864|450372076|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
125204853|NCT00787917|450372080|FG000|Blinded Treatment|Adverse Event|1|||
125204854|NCT00787917|450372081|FG001|Blinded Treatment|Adverse Event|0|||
125204855|NCT00787917|450372080|FG000|Blinded Treatment|Lack of Efficacy|1|||
125204856|NCT00787917|450372081|FG001|Blinded Treatment|Lack of Efficacy|0|||
125204857|NCT00787917|450372080|FG000|Blinded Treatment|Administrative problems|3|||
125204858|NCT00787917|450372081|FG001|Blinded Treatment|Administrative problems|2|||
125204859|NCT00787917|450372080|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
125204860|NCT00787917|450372081|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
125204861|NCT00787917|450372080|FG000|Open Label|Administrative problems|3|||
125204862|NCT00787917|450372081|FG001|Open Label|Administrative problems|0|||
125204863|NCT01328548|450372082|FG000|Overall Study|Death|3|||
125204864|NCT01328548|450372083|FG001|Overall Study|Death|0|||
125204865|NCT01328548|450372082|FG000|Overall Study|Protocol Violation|1|||
125204866|NCT01328548|450372083|FG001|Overall Study|Protocol Violation|0|||
125204867|NCT00073983|450372084|FG000|Overall Study|not evaluable|1|||
125204868|NCT03800836|450372085|FG000|Overall Study|Other|2|||
125204869|NCT03800836|450372086|FG001|Overall Study|Other|1|||
125204870|NCT03800836|450372087|FG002|Overall Study|Other|0|||
125204871|NCT03800836|450372088|FG003|Overall Study|Other|2|||
125204872|NCT03800836|450372089|FG004|Overall Study|Other|0|||
124872025|NCT02453685|449152785|FG001|Overall Study|Protocol Violation|4|||
124872026|NCT02453685|449152784|FG000|Overall Study|Lost to Follow-up|0|||
124872027|NCT02453685|449152785|FG001|Overall Study|Lost to Follow-up|1|||
124872028|NCT02453685|449152784|FG000|Overall Study|Withdrawal by Subject|8|||
124872029|NCT02453685|449152785|FG001|Overall Study|Withdrawal by Subject|4|||
124872030|NCT02453685|449152784|FG000|Overall Study|Unclassified|4|||
124872031|NCT02453685|449152785|FG001|Overall Study|Unclassified|2|||
124872032|NCT00453986|449152788|FG000|Overall Study|Lost to Follow-up|6|||
124872033|NCT00453986|449152789|FG001|Overall Study|Lost to Follow-up|5|||
125204873|NCT03800836|450372090|FG005|Overall Study|Other|1|||
125204874|NCT03800836|450372085|FG000|Overall Study|Lost to Follow-up|2|||
125204875|NCT03800836|450372086|FG001|Overall Study|Lost to Follow-up|0|||
125204876|NCT03800836|450372087|FG002|Overall Study|Lost to Follow-up|1|||
125204877|NCT03800836|450372088|FG003|Overall Study|Lost to Follow-up|1|||
125204878|NCT03800836|450372089|FG004|Overall Study|Lost to Follow-up|3|||
125204879|NCT03800836|450372090|FG005|Overall Study|Lost to Follow-up|0|||
125204880|NCT03800836|450372085|FG000|Overall Study|Withdrawal by Subject|1|||
125204881|NCT03800836|450372086|FG001|Overall Study|Withdrawal by Subject|0|||
125204882|NCT03800836|450372087|FG002|Overall Study|Withdrawal by Subject|0|||
125204883|NCT03800836|450372088|FG003|Overall Study|Withdrawal by Subject|0|||
125204884|NCT03800836|450372089|FG004|Overall Study|Withdrawal by Subject|0|||
125204885|NCT03800836|450372090|FG005|Overall Study|Withdrawal by Subject|0|||
125204886|NCT03800836|450372085|FG000|Overall Study|Physician Decision|31|||
125204887|NCT03800836|450372086|FG001|Overall Study|Physician Decision|3|||
125204888|NCT03800836|450372087|FG002|Overall Study|Physician Decision|6|||
125204889|NCT03800836|450372088|FG003|Overall Study|Physician Decision|4|||
125204890|NCT03800836|450372089|FG004|Overall Study|Physician Decision|4|||
125204891|NCT03800836|450372090|FG005|Overall Study|Physician Decision|5|||
125204892|NCT03800836|450372085|FG000|Overall Study|Death|34|||
125204893|NCT03800836|450372086|FG001|Overall Study|Death|16|||
125204894|NCT03800836|450372087|FG002|Overall Study|Death|5|||
125204895|NCT03800836|450372088|FG003|Overall Study|Death|5|||
125204896|NCT03800836|450372089|FG004|Overall Study|Death|10|||
125204897|NCT03800836|450372090|FG005|Overall Study|Death|0|||
125204898|NCT03800836|450372085|FG000|Overall Study|Symptomatic Deterioration|1|||
125204899|NCT03800836|450372086|FG001|Overall Study|Symptomatic Deterioration|0|||
125204900|NCT03800836|450372087|FG002|Overall Study|Symptomatic Deterioration|1|||
125204901|NCT03800836|450372088|FG003|Overall Study|Symptomatic Deterioration|0|||
125204902|NCT03800836|450372089|FG004|Overall Study|Symptomatic Deterioration|0|||
125204903|NCT03800836|450372090|FG005|Overall Study|Symptomatic Deterioration|0|||
125204904|NCT03197467|450373234|FG000|Overall Study|Withdrawal by Subject|1|||
125204905|NCT04599933|450373242|FG000|Overall Study|Adverse Event|4|||
125204906|NCT04599933|450373243|FG001|Overall Study|Adverse Event|1|||
125204907|NCT04599933|450373242|FG000|Overall Study|Withdrawal by Subject|4|||
125204908|NCT04599933|450373243|FG001|Overall Study|Withdrawal by Subject|2|||
125204909|NCT04599933|450373242|FG000|Overall Study|Lost to Follow-up|0|||
125204910|NCT04599933|450373243|FG001|Overall Study|Lost to Follow-up|1|||
125204911|NCT04599933|450373242|FG000|Overall Study|Physician Decision|0|||
125204912|NCT04599933|450373243|FG001|Overall Study|Physician Decision|1|||
125204913|NCT04599933|450373242|FG000|Overall Study|Screen Failure|1|||
125204914|NCT04599933|450373243|FG001|Overall Study|Screen Failure|2|||
125204915|NCT04392167|450373251|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
125204916|NCT04063657|450373252|FG000|Overall Study|Lost to Follow-up|1|||
125204917|NCT04063657|450373253|FG001|Overall Study|Lost to Follow-up|0|||
125204918|NCT03408444|450373254|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
125204919|NCT03408444|450373255|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
125204920|NCT03408444|450373256|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
125204921|NCT03408444|450373257|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
125204922|NCT03408444|450373254|FG000|Overall Study|Lens Discomfort|0|||
125204923|NCT03408444|450373255|FG001|Overall Study|Lens Discomfort|1|||
125204924|NCT03408444|450373256|FG002|Overall Study|Lens Discomfort|0|||
125204925|NCT03408444|450373257|FG003|Overall Study|Lens Discomfort|0|||
125204926|NCT03408444|450373254|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
125204927|NCT03408444|450373255|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
125204928|NCT03408444|450373256|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
125204929|NCT03408444|450373257|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
125204930|NCT03408444|450373254|FG000|Overall Study|Withdrawal by Subject|0|||
125204931|NCT03408444|450373255|FG001|Overall Study|Withdrawal by Subject|2|||
125204932|NCT03408444|450373256|FG002|Overall Study|Withdrawal by Subject|3|||
125204933|NCT03408444|450373257|FG003|Overall Study|Withdrawal by Subject|0|||
125204934|NCT03408444|450373254|FG000|Overall Study|Lost to Follow-up|0|||
125204935|NCT03408444|450373255|FG001|Overall Study|Lost to Follow-up|0|||
125204936|NCT03408444|450373256|FG002|Overall Study|Lost to Follow-up|1|||
125204937|NCT03408444|450373257|FG003|Overall Study|Lost to Follow-up|0|||
125204938|NCT03408444|450373254|FG000|Overall Study|Adverse Event|0|||
125204939|NCT03408444|450373255|FG001|Overall Study|Adverse Event|0|||
125204940|NCT03408444|450373256|FG002|Overall Study|Adverse Event|0|||
125204941|NCT03408444|450373257|FG003|Overall Study|Adverse Event|1|||
125204942|NCT03408444|450373254|FG000|Overall Study|Lens Handling Difficulties|0|||
125204943|NCT03408444|450373255|FG001|Overall Study|Lens Handling Difficulties|0|||
125204944|NCT03408444|450373256|FG002|Overall Study|Lens Handling Difficulties|1|||
125204945|NCT03408444|450373257|FG003|Overall Study|Lens Handling Difficulties|0|||
125204946|NCT03408444|450373254|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
125204947|NCT03408444|450373255|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
125204948|NCT03408444|450373256|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
125204949|NCT03408444|450373257|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
125204950|NCT04984681|450373258|FG000|Overall Study|Lost to Follow-up|3|||
125204951|NCT04984681|450373259|FG001|Overall Study|Lost to Follow-up|1|||
125204952|NCT01473394|450373260|FG000|Overall Study|Adverse Event|13|||
125204953|NCT01473394|450373261|FG001|Overall Study|Adverse Event|16|||
125204954|NCT01473394|450373260|FG000|Overall Study|Insufficient Therapeutic Response|4|||
125204955|NCT01473394|450373261|FG001|Overall Study|Insufficient Therapeutic Response|1|||
125204956|NCT01473394|450373260|FG000|Overall Study|Protocol Violation|7|||
125204957|NCT01473394|450373261|FG001|Overall Study|Protocol Violation|5|||
125204958|NCT01473394|450373260|FG000|Overall Study|Withdrew Consent|12|||
125204959|NCT01473394|450373261|FG001|Overall Study|Withdrew Consent|10|||
125204960|NCT01473394|450373260|FG000|Overall Study|Lost to Follow-up|9|||
125204961|NCT01473394|450373261|FG001|Overall Study|Lost to Follow-up|11|||
125204962|NCT03117881|450373264|FG000|Baseline|Withdrawal by Subject|21|||
125204963|NCT03117881|450373265|FG001|Baseline|Withdrawal by Subject|10|||
125204964|NCT03117881|450373266|FG002|Baseline|Withdrawal by Subject|0|||
125204965|NCT03117881|450373264|FG000|Baseline|Lost to Follow-up|22|||
125204966|NCT03117881|450373265|FG001|Baseline|Lost to Follow-up|25|||
125204967|NCT03117881|450373266|FG002|Baseline|Lost to Follow-up|0|||
125204968|NCT03117881|450373264|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
125204969|NCT03117881|450373265|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
125204970|NCT03117881|450373266|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
125204971|NCT03117881|450373264|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
125204972|NCT03117881|450373265|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
125204973|NCT03117881|450373266|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
125204974|NCT03117881|450373264|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
125204975|NCT03117881|450373265|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
125204976|NCT03117881|450373266|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
125204977|NCT03117881|450373264|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
125204978|NCT03117881|450373265|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
125204979|NCT03117881|450373266|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
125204980|NCT03117881|450373264|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
125204981|NCT03117881|450373265|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
125204982|NCT03117881|450373266|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
125204983|NCT03117881|450373264|FG000|6-Month Follow-Up|Did not complete test|53|||
125204984|NCT03117881|450373265|FG001|6-Month Follow-Up|Did not complete test|25|||
125204985|NCT03117881|450373266|FG002|6-Month Follow-Up|Did not complete test|7|||
125204986|NCT03117881|450373264|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
125204987|NCT03117881|450373265|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
125204988|NCT03117881|450373266|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
125204989|NCT03117881|450373264|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
125204990|NCT03117881|450373265|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
125204991|NCT03117881|450373266|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
125204992|NCT03117881|450373264|FG000|12-Month Follow-Up|Did not complete test|40|||
125204993|NCT03117881|450373265|FG001|12-Month Follow-Up|Did not complete test|0|||
125204994|NCT03117881|450373266|FG002|12-Month Follow-Up|Did not complete test|0|||
125204995|NCT01027897|450373267|FG000|Overall Study|Protocol Violation|1|||
125204996|NCT01027897|450373267|FG000|Overall Study|Withdrawal by Subject|1|||
125204997|NCT00473824|450373270|FG000|Overall Study|Virologic Breakthrough|1|||
125204998|NCT00473824|450373271|FG001|Overall Study|Virologic Breakthrough|0|||
125204999|NCT00473824|450373270|FG000|Overall Study|Adverse Event|1|||
125205000|NCT00473824|450373271|FG001|Overall Study|Adverse Event|0|||
125205001|NCT00473824|450373270|FG000|Overall Study|Death|1|||
125205002|NCT00473824|450373271|FG001|Overall Study|Death|0|||
125205003|NCT00473824|450373270|FG000|Overall Study|Lost to Follow-up|1|||
125205004|NCT00473824|450373271|FG001|Overall Study|Lost to Follow-up|0|||
125205005|NCT00473824|450373270|FG000|Overall Study|Withdrawal by physician|1|||
125205006|NCT00473824|450373271|FG001|Overall Study|Withdrawal by physician|0|||
125205007|NCT02560623|450373272|FG000|Overall Study|Unable to swallow sponge|0|||
125205008|NCT02560623|450373273|FG001|Overall Study|Unable to swallow sponge|1|||
125205009|NCT02560623|450373274|FG002|Overall Study|Unable to swallow sponge|0|||
125205010|NCT02560623|450373275|FG003|Overall Study|Unable to swallow sponge|0|||
125205011|NCT02560623|450373272|FG000|Overall Study|Intervention prior to sponge administration|0|||
125205012|NCT02560623|450373273|FG001|Overall Study|Intervention prior to sponge administration|1|||
125205013|NCT02560623|450373274|FG002|Overall Study|Intervention prior to sponge administration|0|||
125205014|NCT02560623|450373275|FG003|Overall Study|Intervention prior to sponge administration|0|||
125205015|NCT01661933|450373279|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
125205016|NCT01661933|450373279|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
125205017|NCT02720744|450373280|FG000|Overall Study|Protocol Violation|0|||
125205018|NCT02720744|450373281|FG001|Overall Study|Protocol Violation|2|||
125205019|NCT02720744|450373280|FG000|Overall Study|Pregnancy|2|||
125205020|NCT02720744|450373281|FG001|Overall Study|Pregnancy|0|||
124981306|NCT01283516|449557456|FG008|Overall Study|Death|12|||
125205021|NCT02720744|450373280|FG000|Overall Study|Lack of Efficacy|2|||
125205022|NCT02720744|450373281|FG001|Overall Study|Lack of Efficacy|8|||
124981307|NCT01283516|449557448|FG000|Overall Study|Disease Progression|2|||
125205023|NCT02720744|450373280|FG000|Overall Study|Adverse Event|21|||
125205024|NCT02720744|450373281|FG001|Overall Study|Adverse Event|3|||
125205025|NCT02720744|450373280|FG000|Overall Study|Withdrawal by Subject|11|||
125205026|NCT02720744|450373281|FG001|Overall Study|Withdrawal by Subject|11|||
125205027|NCT02720744|450373280|FG000|Overall Study|Lost to follow up|2|||
125205028|NCT02720744|450373281|FG001|Overall Study|Lost to follow up|0|||
125205029|NCT02720744|450373280|FG000|Overall Study|Non Compliance with Investigational Product|0|||
125205030|NCT02720744|450373281|FG001|Overall Study|Non Compliance with Investigational Product|1|||
125205031|NCT02720744|450373280|FG000|Overall Study|Excluded Concomitant Medication|0|||
125205032|NCT02720744|450373281|FG001|Overall Study|Excluded Concomitant Medication|1|||
125205033|NCT01447446|450373282|FG000|Overall Study|Death|6|||
125205034|NCT01447446|450373283|FG001|Overall Study|Death|3|||
125205035|NCT01447446|450373284|FG002|Overall Study|Death|2|||
125205036|NCT01447446|450373285|FG003|Overall Study|Death|1|||
125205037|NCT01447446|450373286|FG004|Overall Study|Death|7|||
125205038|NCT01447446|450373287|FG005|Overall Study|Death|0|||
125205039|NCT01447446|450373282|FG000|Overall Study|Adverse Event|3|||
125205040|NCT01447446|450373283|FG001|Overall Study|Adverse Event|0|||
125205041|NCT01447446|450373284|FG002|Overall Study|Adverse Event|1|||
125205042|NCT01447446|450373285|FG003|Overall Study|Adverse Event|0|||
125205043|NCT01447446|450373286|FG004|Overall Study|Adverse Event|2|||
125205044|NCT01447446|450373287|FG005|Overall Study|Adverse Event|0|||
125205045|NCT01447446|450373282|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
125205046|NCT01447446|450373283|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
125205047|NCT01447446|450373284|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
125205048|NCT01447446|450373285|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
125205049|NCT01447446|450373286|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
125205050|NCT01447446|450373287|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
125205051|NCT01447446|450373282|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
125205052|NCT01447446|450373283|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
125205053|NCT01447446|450373284|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
125205054|NCT01447446|450373285|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
125205055|NCT01447446|450373286|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
125205056|NCT01447446|450373287|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
125205057|NCT01447446|450373282|FG000|Overall Study|Administrative/Other|34|||
125205058|NCT01447446|450373283|FG001|Overall Study|Administrative/Other|9|||
125205059|NCT01447446|450373284|FG002|Overall Study|Administrative/Other|10|||
125205060|NCT01447446|450373285|FG003|Overall Study|Administrative/Other|2|||
125205061|NCT01447446|450373286|FG004|Overall Study|Administrative/Other|33|||
125205062|NCT01447446|450373287|FG005|Overall Study|Administrative/Other|4|||
125205063|NCT01447446|450373282|FG000|Overall Study|SVR12 Assessment|13|||
125205064|NCT01447446|450373283|FG001|Overall Study|SVR12 Assessment|1|||
125205065|NCT01447446|450373284|FG002|Overall Study|SVR12 Assessment|2|||
125205066|NCT01447446|450373285|FG003|Overall Study|SVR12 Assessment|1|||
125205067|NCT01447446|450373286|FG004|Overall Study|SVR12 Assessment|5|||
125205068|NCT01447446|450373287|FG005|Overall Study|SVR12 Assessment|5|||
125205069|NCT01447446|450373282|FG000|Overall Study|New Treatment Started|8|||
125205070|NCT01447446|450373283|FG001|Overall Study|New Treatment Started|2|||
125205071|NCT01447446|450373284|FG002|Overall Study|New Treatment Started|1|||
125205072|NCT01447446|450373285|FG003|Overall Study|New Treatment Started|0|||
125205073|NCT01447446|450373286|FG004|Overall Study|New Treatment Started|2|||
125205074|NCT01447446|450373287|FG005|Overall Study|New Treatment Started|0|||
125205075|NCT01447446|450373282|FG000|Overall Study|Reason not Specified|1|||
125205076|NCT01447446|450373283|FG001|Overall Study|Reason not Specified|1|||
125205077|NCT01447446|450373284|FG002|Overall Study|Reason not Specified|1|||
125205078|NCT01447446|450373285|FG003|Overall Study|Reason not Specified|1|||
125205079|NCT01447446|450373286|FG004|Overall Study|Reason not Specified|1|||
125205080|NCT01447446|450373287|FG005|Overall Study|Reason not Specified|0|||
125205081|NCT03536949|450373300|FG000|Overall Study|Adverse Event|4|||
125205082|NCT03536949|450373301|FG001|Overall Study|Adverse Event|0|||
125205083|NCT03536949|450373300|FG000|Overall Study|Lost to Follow-up|2|||
125205084|NCT03536949|450373301|FG001|Overall Study|Lost to Follow-up|1|||
125205085|NCT03536949|450373300|FG000|Overall Study|Withdrawal by Subject|6|||
125205086|NCT03536949|450373301|FG001|Overall Study|Withdrawal by Subject|0|||
125205087|NCT03536949|450373300|FG000|Overall Study|Non-compliance|2|||
125205088|NCT03536949|450373301|FG001|Overall Study|Non-compliance|1|||
125205089|NCT00250458|450373307|FG000|Overall Study|Lost to Follow-up|4|||
125205090|NCT00250458|450373308|FG001|Overall Study|Lost to Follow-up|2|||
125205091|NCT00250458|450373307|FG000|Overall Study|Protocol Violation|0|||
125205092|NCT00250458|450373308|FG001|Overall Study|Protocol Violation|1|||
125205093|NCT00250458|450373307|FG000|Overall Study|Withdrawal by Subject|4|||
125205094|NCT00250458|450373308|FG001|Overall Study|Withdrawal by Subject|2|||
125205095|NCT00250458|450373307|FG000|Overall Study|Lack of Migraine Attack|20|||
125205096|NCT00250458|450373308|FG001|Overall Study|Lack of Migraine Attack|9|||
125205097|NCT00250458|450373307|FG000|Overall Study|Qualifying migraine but did not treat|3|||
125205098|NCT00250458|450373308|FG001|Overall Study|Qualifying migraine but did not treat|3|||
125205099|NCT00250458|450373307|FG000|Overall Study|Other|1|||
125205100|NCT00250458|450373308|FG001|Overall Study|Other|0|||
125205101|NCT01892085|450373311|FG000|Overall Study|Death|4|||
125205102|NCT01892085|450373312|FG001|Overall Study|Death|1|||
125205103|NCT01892085|450373313|FG002|Overall Study|Death|3|||
125205104|NCT01892085|450373311|FG000|Overall Study|Withdrawal by Subject|2|||
125205105|NCT01892085|450373312|FG001|Overall Study|Withdrawal by Subject|0|||
125205106|NCT01892085|450373313|FG002|Overall Study|Withdrawal by Subject|2|||
125205107|NCT01549041|450373314|FG000|Overall Study|Lack of Efficacy|2|||
125205108|NCT01549041|450373315|FG001|Overall Study|Lack of Efficacy|4|||
125205109|NCT01549041|450373314|FG000|Overall Study|Adverse Event|0|||
125205110|NCT01549041|450373315|FG001|Overall Study|Adverse Event|4|||
125205111|NCT00597506|450373316|FG000|Overall Study|Subject is being followed for survival|1|||
125205112|NCT02609724|450373317|FG000|Overall Study|Death|2|||
125205113|NCT02609724|450373318|FG001|Overall Study|Death|0|||
125205114|NCT02609724|450373319|FG002|Overall Study|Death|1|||
125205115|NCT02609724|450373317|FG000|Overall Study|Withdrawal by Subject|1|||
125205116|NCT02609724|450373318|FG001|Overall Study|Withdrawal by Subject|2|||
125205117|NCT02609724|450373319|FG002|Overall Study|Withdrawal by Subject|3|||
125205118|NCT02609724|450373317|FG000|Overall Study|Illness|2|||
125205119|NCT02609724|450373318|FG001|Overall Study|Illness|1|||
125205120|NCT02609724|450373319|FG002|Overall Study|Illness|0|||
125205121|NCT03077659|450373320|FG000|Overall Study|Withdrawal by Subject|0|||
125205122|NCT03077659|450373321|FG001|Overall Study|Withdrawal by Subject|0|||
125205123|NCT03077659|450373322|FG002|Overall Study|Withdrawal by Subject|1|||
125205124|NCT02844907|450373323|FG000|With Dexamethasone|No IV access|1|||
125205125|NCT00426660|450373324|FG000|Overall Study|Death|14|||
125205126|NCT00426660|450373324|FG000|Overall Study|Adverse Event|23|||
125205127|NCT00426660|450373324|FG000|Overall Study|Insufficient Clinical Response|22|||
125205128|NCT00426660|450373324|FG000|Overall Study|Lost to Follow-up|15|||
125205129|NCT00426660|450373324|FG000|Overall Study|Other|23|||
125205130|NCT00426660|450373324|FG000|Overall Study|Withdrawal by Subject|18|||
125205131|NCT00426660|450373324|FG000|Overall Study|Protocol Violation|1|||
125205132|NCT00426660|450373324|FG000|Overall Study|Enrolled Not Treated|15|||
125205133|NCT04326439|450373327|FG000|Overall Study|Withdrawal by Subject|1|||
125205134|NCT04326439|450373328|FG001|Overall Study|Withdrawal by Subject|0|||
125205135|NCT04326439|450373327|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
125205136|NCT04326439|450373328|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
125205137|NCT04326439|450373327|FG000|Overall Study|Relapse after Induction 2|0|||
125205138|NCT04326439|450373328|FG001|Overall Study|Relapse after Induction 2|1|||
125205139|NCT04326439|450373327|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
125205140|NCT04326439|450373328|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
125205141|NCT00204477|450373331|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
125205142|NCT00204477|450373332|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
125205143|NCT00204477|450373331|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
125205144|NCT00204477|450373332|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
125205145|NCT04272606|450373335|FG000|Overall Study|Protocol Violation|1|||
125205146|NCT04272606|450373336|FG001|Overall Study|Protocol Violation|1|||
125205147|NCT04272606|450373335|FG000|Overall Study|Physician Decision|0|||
125205148|NCT04272606|450373336|FG001|Overall Study|Physician Decision|1|||
125205149|NCT01037127|450373337|FG000|Overall Study|Lost to Follow-up|2|||
125205150|NCT01037127|450373338|FG001|Overall Study|Lost to Follow-up|4|||
125205151|NCT01037127|450373337|FG000|Overall Study|Physician Decision|1|||
125205152|NCT01037127|450373338|FG001|Overall Study|Physician Decision|0|||
125205153|NCT01037127|450373337|FG000|Overall Study|Study Closed Terminated|2|||
125205154|NCT01037127|450373338|FG001|Overall Study|Study Closed Terminated|17|||
125205155|NCT02637713|450373342|FG000|Overall Study|Screen Failure|2|||
125205156|NCT02847182|450373343|FG000|Overall Study|Withdrawal by Subject|0|||
125205157|NCT02847182|450373344|FG001|Overall Study|Withdrawal by Subject|1|||
125205158|NCT02345889|450373345|FG000|Overall Study|Inadequate Bowel Prep|17|||
125205159|NCT02345889|450373346|FG001|Overall Study|Inadequate Bowel Prep|16|||
125205160|NCT02345889|450373347|FG002|Overall Study|Inadequate Bowel Prep|18|||
125205161|NCT02345889|450373348|FG003|Overall Study|Inadequate Bowel Prep|14|||
125205162|NCT02345889|450373345|FG000|Overall Study|Polyposis identified during procedure|1|||
125205163|NCT02345889|450373346|FG001|Overall Study|Polyposis identified during procedure|1|||
125205164|NCT02345889|450373347|FG002|Overall Study|Polyposis identified during procedure|0|||
125205165|NCT02345889|450373348|FG003|Overall Study|Polyposis identified during procedure|1|||
125205166|NCT02345889|450373345|FG000|Overall Study|Recognized ineligible post-randomization|1|||
125205167|NCT02345889|450373346|FG001|Overall Study|Recognized ineligible post-randomization|0|||
125205168|NCT02345889|450373347|FG002|Overall Study|Recognized ineligible post-randomization|2|||
125205169|NCT02345889|450373348|FG003|Overall Study|Recognized ineligible post-randomization|1|||
125205170|NCT02345889|450373345|FG000|Overall Study|Ulcerative Colitis identified|1|||
125205171|NCT02345889|450373346|FG001|Overall Study|Ulcerative Colitis identified|0|||
125205172|NCT02345889|450373347|FG002|Overall Study|Ulcerative Colitis identified|0|||
125205173|NCT02345889|450373348|FG003|Overall Study|Ulcerative Colitis identified|0|||
125205174|NCT02345889|450373345|FG000|Overall Study|Cecum not intubated|1|||
125205175|NCT02345889|450373346|FG001|Overall Study|Cecum not intubated|0|||
125205176|NCT02345889|450373347|FG002|Overall Study|Cecum not intubated|0|||
125205177|NCT02345889|450373348|FG003|Overall Study|Cecum not intubated|0|||
125205178|NCT00778102|450373349|FG000|Overall Study|Adverse Event|8|||
125205179|NCT00778102|450373350|FG001|Overall Study|Adverse Event|5|||
125205180|NCT00778102|450373349|FG000|Overall Study|Death|1|||
125205181|NCT00778102|450373350|FG001|Overall Study|Death|1|||
125205182|NCT00778102|450373349|FG000|Overall Study|Lost to Follow-up|1|||
125205183|NCT00778102|450373350|FG001|Overall Study|Lost to Follow-up|0|||
125205184|NCT00778102|450373349|FG000|Overall Study|Violation of Selection Criteria|1|||
125205185|NCT00778102|450373350|FG001|Overall Study|Violation of Selection Criteria|1|||
125205186|NCT00778102|450373349|FG000|Overall Study|Protocol Violation|0|||
125205187|NCT00778102|450373350|FG001|Overall Study|Protocol Violation|1|||
125205188|NCT00778102|450373349|FG000|Overall Study|Refused Treatment|2|||
125205189|NCT00778102|450373350|FG001|Overall Study|Refused Treatment|3|||
125205190|NCT00778102|450373349|FG000|Overall Study|Withdrawal by Subject|1|||
125205191|NCT00778102|450373350|FG001|Overall Study|Withdrawal by Subject|1|||
125205192|NCT00778102|450373349|FG000|Overall Study|Administrative Reason|7|||
125205193|NCT00778102|450373350|FG001|Overall Study|Administrative Reason|10|||
125205194|NCT02417961|450374675|FG000|Overall Study|Adverse Event|1|||
125205195|NCT02417961|450374675|FG000|Overall Study|Lost to Follow-up|1|||
125205196|NCT02417961|450374675|FG000|Overall Study|Withdrawal by Subject|2|||
125205197|NCT03666533|450374679|FG000|Overall Study|Lost to Follow-up|2|||
125205198|NCT03666533|450374680|FG001|Overall Study|Lost to Follow-up|2|||
125205199|NCT04240886|450374681|FG000|Treatment Phase|Death|4|||
125205200|NCT04240886|450374681|FG000|Treatment Phase|Discontinuation by Subject|1|||
125205201|NCT04240886|450374681|FG000|Treatment Phase|Adverse Event|5|||
125205202|NCT04240886|450374681|FG000|Follow-up Phase|Withdrawal by Subject|1|||
125205203|NCT04240886|450374681|FG000|Follow-up Phase|Discontinuation by Subject|1|||
125205204|NCT04240886|450374681|FG000|Follow-up Phase|Death|2|||
125205205|NCT04743804|450374682|FG000|Overall Study|Other|1|||
125205206|NCT04743804|450374683|FG001|Overall Study|Other|0|||
125205207|NCT04743804|450374682|FG000|Overall Study|Withdrawal by Subject|0|||
125205208|NCT04743804|450374683|FG001|Overall Study|Withdrawal by Subject|1|||
125205209|NCT04743804|450374682|FG000|Overall Study|Study Terminated by Sponsor|1|||
125205210|NCT04743804|450374683|FG001|Overall Study|Study Terminated by Sponsor|4|||
125205211|NCT04743804|450374682|FG000|Overall Study|Physician Decision|0|||
125205212|NCT04743804|450374683|FG001|Overall Study|Physician Decision|1|||
125205213|NCT04743804|450374682|FG000|Overall Study|Death|3|||
125205214|NCT04743804|450374683|FG001|Overall Study|Death|0|||
125205215|NCT01632904|450374684|FG000|Overall Study|Adverse Event|4|||
125205216|NCT01632904|450374685|FG001|Overall Study|Adverse Event|1|||
125205217|NCT01632904|450374684|FG000|Overall Study|Physician Decision|0|||
125205218|NCT01632904|450374685|FG001|Overall Study|Physician Decision|1|||
125205219|NCT01632904|450374684|FG000|Overall Study|Subject decision|3|||
125205220|NCT01632904|450374685|FG001|Overall Study|Subject decision|2|||
125205221|NCT01632904|450374684|FG000|Overall Study|Disease Progression|0|||
125205222|NCT01632904|450374685|FG001|Overall Study|Disease Progression|1|||
125205223|NCT01632904|450374684|FG000|Overall Study|Reason for discontinuation not available|0|||
125205224|NCT01632904|450374685|FG001|Overall Study|Reason for discontinuation not available|1|||
125205225|NCT02059434|450374686|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
125205226|NCT02059434|450374687|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
125205227|NCT02059434|450374688|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
125205228|NCT02059434|450374689|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
125205229|NCT02059434|450374690|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
125205230|NCT02059434|450374691|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
125205231|NCT02059434|450374692|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
125205232|NCT02059434|450374693|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
125205233|NCT02059434|450374694|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
125205234|NCT02059434|450374686|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
125205235|NCT02059434|450374687|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
125205236|NCT02059434|450374688|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
125205237|NCT02059434|450374689|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
125205238|NCT02059434|450374690|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
125205239|NCT02059434|450374691|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
125205240|NCT02059434|450374692|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
125205241|NCT02059434|450374693|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
125205242|NCT02059434|450374694|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
125205243|NCT02059434|450374686|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
125205244|NCT02059434|450374687|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
125205245|NCT02059434|450374688|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
125205246|NCT02059434|450374689|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
125205247|NCT02059434|450374690|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
125205248|NCT02059434|450374691|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
125205249|NCT02059434|450374692|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
125205250|NCT02059434|450374693|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
125205251|NCT02059434|450374694|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
125205252|NCT02059434|450374686|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
125205253|NCT02059434|450374687|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
125205254|NCT02059434|450374688|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
125205255|NCT02059434|450374689|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
125205256|NCT02059434|450374690|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
125205257|NCT02059434|450374691|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
125205258|NCT02059434|450374692|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
125205259|NCT02059434|450374693|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
125205260|NCT02059434|450374694|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
125205261|NCT02059434|450374686|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
125205262|NCT02059434|450374687|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
125205263|NCT02059434|450374688|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
125205264|NCT02059434|450374689|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
125205265|NCT02059434|450374690|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
125205266|NCT02059434|450374691|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
125205267|NCT02059434|450374692|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
125205268|NCT02059434|450374693|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
125205269|NCT02059434|450374694|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
125205270|NCT01004406|450374699|FG000|Overall Study|Withdrawal by Subject|2|||
125205271|NCT01004406|450374700|FG001|Overall Study|Withdrawal by Subject|0|||
125205272|NCT01004406|450374699|FG000|Overall Study|Lost to Follow-up|1|||
125205273|NCT01004406|450374700|FG001|Overall Study|Lost to Follow-up|0|||
125205274|NCT02928770|450374701|FG000|Overall Study|Withdrawal by Subject|2|||
125205275|NCT03201874|450374702|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
125205276|NCT03201874|450374703|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
125205277|NCT03201874|450374702|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
125205278|NCT03201874|450374703|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
125205279|NCT02907593|450374706|FG000|Overall Study|Withdrawal by Subject|0|||
125205280|NCT02907593|450374707|FG001|Overall Study|Withdrawal by Subject|0|||
125205281|NCT02907593|450374708|FG002|Overall Study|Withdrawal by Subject|1|||
125205282|NCT02907593|450374709|FG003|Overall Study|Withdrawal by Subject|0|||
125205283|NCT04618471|450374710|FG000|Overall Study|Screen Failure|62|||
125205284|NCT04618471|450374710|FG000|Overall Study|Withdrawal by Subject|6|||
125205285|NCT04618471|450374710|FG000|Overall Study|Physician Decision|2|||
125205286|NCT04618471|450374710|FG000|Overall Study|Lost to Follow-up|1|||
125205287|NCT04618471|450374710|FG000|Overall Study|Various other reasons|2|||
125205288|NCT04618471|450374710|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
125205289|NCT01752634|450374711|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
125205290|NCT01752634|450374712|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
125205291|NCT01752634|450374713|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
125205292|NCT01752634|450374714|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
125205293|NCT01752634|450374715|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
125205294|NCT01752634|450374716|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
125205295|NCT01752634|450374711|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
125205296|NCT01752634|450374712|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
125205297|NCT01752634|450374713|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
125205298|NCT01752634|450374714|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
125205299|NCT01752634|450374715|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
125205300|NCT01752634|450374716|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
125205301|NCT01752634|450374711|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
125205302|NCT01752634|450374712|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
124872034|NCT00453986|449152790|FG002|Overall Study|Lost to Follow-up|6|||
124872035|NCT00453986|449152791|FG003|Overall Study|Lost to Follow-up|2|||
124872036|NCT00453986|449152792|FG004|Overall Study|Lost to Follow-up|0|||
124872037|NCT02778100|449152794|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
124872038|NCT02778100|449152795|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
124872039|NCT00522626|449152800|FG000|Overall Study|Lost to Follow-up|7|||
124872040|NCT00552084|449152803|FG000|Overall Study|Adverse Event|2|||
124872041|NCT00552084|449152804|FG001|Overall Study|Adverse Event|3|||
124872042|NCT00552084|449152803|FG000|Overall Study|Withdrawal by Subject|4|||
124872043|NCT00552084|449152804|FG001|Overall Study|Withdrawal by Subject|5|||
124872044|NCT00552084|449152803|FG000|Overall Study|Protocol Violation|1|||
124872045|NCT00552084|449152804|FG001|Overall Study|Protocol Violation|0|||
124872046|NCT00552084|449152803|FG000|Overall Study|change in anti-arrythmic drug|1|||
124872047|NCT00552084|449152804|FG001|Overall Study|change in anti-arrythmic drug|1|||
124872048|NCT01338025|449152805|FG000|Overall Study|Unexpected closure of study|10|||
124872049|NCT01338025|449152806|FG001|Overall Study|Unexpected closure of study|9|||
124872050|NCT01338025|449152805|FG000|Overall Study|Withdrawal by Subject|0|||
124872051|NCT01338025|449152806|FG001|Overall Study|Withdrawal by Subject|2|||
125205303|NCT01752634|450374713|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
125205304|NCT01752634|450374714|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
125205305|NCT01752634|450374715|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
125205306|NCT01752634|450374716|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
125205307|NCT01752634|450374711|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
125205308|NCT01752634|450374712|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
125205309|NCT01752634|450374713|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
125205310|NCT01752634|450374714|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
125205311|NCT01752634|450374715|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
125205312|NCT01752634|450374716|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
125205313|NCT01752634|450374711|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
125205314|NCT01752634|450374712|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
125205315|NCT01752634|450374713|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
125205316|NCT01752634|450374714|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
125205317|NCT01752634|450374715|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
125205318|NCT01752634|450374716|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
125205319|NCT01752634|450374711|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
125205320|NCT01752634|450374712|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
125205321|NCT01752634|450374713|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
125205322|NCT01752634|450374714|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
124981308|NCT01283516|449557449|FG001|Overall Study|Disease Progression|2|||
124981309|NCT01283516|449557450|FG002|Overall Study|Disease Progression|3|||
125205323|NCT01752634|450374715|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
125205324|NCT01752634|450374716|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
125205325|NCT01752634|450374711|FG000|Week 24 to Week 260|Physician Decision|1|||
125205326|NCT01752634|450374712|FG001|Week 24 to Week 260|Physician Decision|2|||
125205327|NCT01752634|450374713|FG002|Week 24 to Week 260|Physician Decision|4|||
125205328|NCT01752634|450374714|FG003|Week 24 to Week 260|Physician Decision|2|||
125205329|NCT01752634|450374715|FG004|Week 24 to Week 260|Physician Decision|1|||
125205330|NCT01752634|450374716|FG005|Week 24 to Week 260|Physician Decision|0|||
125205331|NCT01752634|450374711|FG000|Week 24 to Week 260|Death|0|||
125205332|NCT01752634|450374712|FG001|Week 24 to Week 260|Death|1|||
125205333|NCT01752634|450374713|FG002|Week 24 to Week 260|Death|0|||
125205334|NCT01752634|450374714|FG003|Week 24 to Week 260|Death|0|||
125205335|NCT01752634|450374715|FG004|Week 24 to Week 260|Death|0|||
125205336|NCT01752634|450374716|FG005|Week 24 to Week 260|Death|0|||
125205337|NCT01752634|450374711|FG000|Week 24 to Week 260|Pregnancy|0|||
125205338|NCT01752634|450374712|FG001|Week 24 to Week 260|Pregnancy|0|||
125205339|NCT01752634|450374713|FG002|Week 24 to Week 260|Pregnancy|1|||
125205340|NCT01752634|450374714|FG003|Week 24 to Week 260|Pregnancy|0|||
125205341|NCT01752634|450374715|FG004|Week 24 to Week 260|Pregnancy|0|||
125205342|NCT01752634|450374716|FG005|Week 24 to Week 260|Pregnancy|0|||
125205343|NCT01752634|450374711|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
125205344|NCT01752634|450374712|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
125205345|NCT01752634|450374713|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
125205346|NCT01752634|450374714|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
125205347|NCT01752634|450374715|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
125205348|NCT01752634|450374716|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
125205349|NCT01752634|450374711|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
125205350|NCT01752634|450374712|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
125205351|NCT01752634|450374713|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
125205352|NCT01752634|450374714|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
125205353|NCT01752634|450374715|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
125205354|NCT01752634|450374716|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
125205355|NCT01752634|450374711|FG000|Week 24 to Week 260|Adverse Event|4|||
125205356|NCT01752634|450374712|FG001|Week 24 to Week 260|Adverse Event|8|||
125205357|NCT01752634|450374713|FG002|Week 24 to Week 260|Adverse Event|8|||
125205358|NCT01752634|450374714|FG003|Week 24 to Week 260|Adverse Event|4|||
125205359|NCT01752634|450374715|FG004|Week 24 to Week 260|Adverse Event|2|||
125205360|NCT01752634|450374716|FG005|Week 24 to Week 260|Adverse Event|0|||
125205361|NCT01250171|450374717|FG000|Overall Study|Administrative reasons|1|||
125205362|NCT01250171|450374718|FG001|Overall Study|Administrative reasons|0|||
125205363|NCT01250171|450374719|FG002|Overall Study|Administrative reasons|0|||
125205364|NCT04557124|450374727|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
125205365|NCT04557124|450374728|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
125205366|NCT04557124|450374727|FG000|Mid-point (1 Month)|Missed testing|5|||
125205367|NCT04557124|450374728|FG001|Mid-point (1 Month)|Missed testing|4|||
125205368|NCT04557124|450374727|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
125205369|NCT04557124|450374728|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
125205370|NCT04557124|450374727|FG000|Post-testing (2 Months)|Missed testing|1|||
125205371|NCT04557124|450374728|FG001|Post-testing (2 Months)|Missed testing|5|||
125205372|NCT04557124|450374727|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
125205373|NCT04557124|450374728|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
125205374|NCT04557124|450374727|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
124981310|NCT01283516|449557451|FG003|Overall Study|Disease Progression|3|||
125205375|NCT04557124|450374728|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
125205376|NCT03226678|450374735|FG000|Part A (Core Study Phase)|Adverse Event|0|||
125205377|NCT03226678|450374736|FG001|Part A (Core Study Phase)|Adverse Event|1|||
125205378|NCT03226678|450374737|FG002|Part A (Core Study Phase)|Adverse Event|0|||
125205379|NCT03226678|450374738|FG003|Part A (Core Study Phase)|Adverse Event|0|||
125205380|NCT03226678|450374739|FG004|Part A (Core Study Phase)|Adverse Event|0|||
125205381|NCT03226678|450374740|FG005|Part A (Core Study Phase)|Adverse Event|0|||
125205382|NCT03226678|450374735|FG000|Part A (Core Study Phase)|Death|0|||
125205383|NCT03226678|450374736|FG001|Part A (Core Study Phase)|Death|0|||
125205384|NCT03226678|450374737|FG002|Part A (Core Study Phase)|Death|1|||
125205385|NCT03226678|450374738|FG003|Part A (Core Study Phase)|Death|0|||
125205386|NCT03226678|450374739|FG004|Part A (Core Study Phase)|Death|0|||
125205387|NCT03226678|450374740|FG005|Part A (Core Study Phase)|Death|0|||
125205388|NCT03226678|450374735|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
125205389|NCT03226678|450374736|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
125205390|NCT03226678|450374737|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
125205391|NCT03226678|450374738|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
125205392|NCT03226678|450374739|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
125205393|NCT03226678|450374740|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
125205394|NCT03226678|450374735|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
125205395|NCT03226678|450374736|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
125205396|NCT03226678|450374737|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
125205397|NCT03226678|450374738|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
125205398|NCT03226678|450374739|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
125205399|NCT03226678|450374740|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
125205400|NCT03226678|450374735|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
125205401|NCT03226678|450374736|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
125205402|NCT03226678|450374737|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
125205403|NCT03226678|450374738|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
125205404|NCT03226678|450374739|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
125205405|NCT03226678|450374740|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
125205406|NCT03226678|450374735|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
125205407|NCT03226678|450374736|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
125205408|NCT03226678|450374737|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
125205409|NCT03226678|450374738|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
125205410|NCT03226678|450374739|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
125205411|NCT03226678|450374740|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
125205412|NCT03226678|450374735|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
125205413|NCT03226678|450374736|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
125205414|NCT03226678|450374737|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
125205415|NCT03226678|450374738|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
125205416|NCT03226678|450374739|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
125205417|NCT03226678|450374740|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
125205418|NCT03226678|450374735|FG000|Part B (Long-Term Extension Phase)|Death|0|||
125205419|NCT03226678|450374736|FG001|Part B (Long-Term Extension Phase)|Death|0|||
125205420|NCT03226678|450374737|FG002|Part B (Long-Term Extension Phase)|Death|0|||
125205421|NCT03226678|450374738|FG003|Part B (Long-Term Extension Phase)|Death|0|||
125205422|NCT03226678|450374739|FG004|Part B (Long-Term Extension Phase)|Death|0|||
125205423|NCT03226678|450374740|FG005|Part B (Long-Term Extension Phase)|Death|1|||
125205424|NCT03226678|450374735|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
125205425|NCT03226678|450374736|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
125205426|NCT03226678|450374737|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
125205427|NCT03226678|450374738|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
125205428|NCT03226678|450374739|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
125205429|NCT03226678|450374740|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
125205430|NCT03226678|450374735|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
125205431|NCT03226678|450374736|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
125205432|NCT03226678|450374737|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
125205433|NCT03226678|450374738|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
125205434|NCT03226678|450374739|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
125205435|NCT03226678|450374740|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
125205436|NCT03226678|450374735|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
125205437|NCT03226678|450374736|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
125205438|NCT03226678|450374737|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
125205439|NCT03226678|450374738|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
125205440|NCT03226678|450374739|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
125205441|NCT03226678|450374740|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
125205442|NCT01911780|450374743|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
125205443|NCT01911780|450374744|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
125205444|NCT01911780|450374743|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
125205445|NCT01911780|450374744|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
125205446|NCT01911780|450374743|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
125205447|NCT01911780|450374744|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
125205448|NCT01911780|450374743|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
125205449|NCT01911780|450374744|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
125205450|NCT01911780|450374743|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
125205451|NCT01911780|450374744|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
125205452|NCT01911780|450374743|FG000|Extension Period (52 Weeks)|Personal reason|1|||
125205453|NCT01911780|450374744|FG001|Extension Period (52 Weeks)|Personal reason|1|||
125205454|NCT02045732|450374745|FG000|Overall Study|At the discretion of the investigator|1|||
124981311|NCT01283516|449557452|FG004|Overall Study|Disease Progression|13|||
125205455|NCT02045732|450374746|FG001|Overall Study|At the discretion of the investigator|1|||
125205456|NCT05014815|450374747|FG000|Overall Study|Death|63|||
125205457|NCT05014815|450374748|FG001|Overall Study|Death|70|||
125205458|NCT05014815|450374747|FG000|Overall Study|Withdrawal by Subject|10|||
125205459|NCT05014815|450374748|FG001|Overall Study|Withdrawal by Subject|10|||
125205460|NCT05014815|450374747|FG000|Overall Study|Lost to Follow-up|4|||
125205461|NCT05014815|450374748|FG001|Overall Study|Lost to Follow-up|2|||
125205462|NCT05014815|450374747|FG000|Overall Study|Physician Decision|2|||
125205463|NCT05014815|450374748|FG001|Overall Study|Physician Decision|4|||
125205464|NCT04247880|450374749|FG000|Overall Study|Lost to Follow-up|24|||
125205465|NCT04247880|450374750|FG001|Overall Study|Lost to Follow-up|17|||
125205466|NCT04247880|450374749|FG000|Overall Study|Withdrawal by Subject|3|||
125205467|NCT04247880|450374750|FG001|Overall Study|Withdrawal by Subject|0|||
125205468|NCT06303167|450374751|FG000|Overall Study|Ineligible|1|||
125205469|NCT06303167|450374751|FG000|Overall Study|Never start protocol therapy|2|||
125205470|NCT06303167|450374751|FG000|Overall Study|Disease progression|16|||
125205471|NCT02453282|450374752|FG000|Overall Study|Death|275|||
125205472|NCT02453282|450374753|FG001|Overall Study|Death|277|||
125205473|NCT02453282|450374754|FG002|Overall Study|Death|296|||
125205474|NCT02453282|450374752|FG000|Overall Study|Lost to Follow-up|1|||
125205475|NCT02453282|450374753|FG001|Overall Study|Lost to Follow-up|0|||
125205476|NCT02453282|450374754|FG002|Overall Study|Lost to Follow-up|2|||
125205477|NCT02453282|450374752|FG000|Overall Study|Withdrawal by Subject|12|||
125205478|NCT02453282|450374753|FG001|Overall Study|Withdrawal by Subject|10|||
125205479|NCT02453282|450374754|FG002|Overall Study|Withdrawal by Subject|11|||
125205480|NCT02453282|450374752|FG000|Overall Study|Participants ongoing at data cut-off|85|||
125205481|NCT02453282|450374753|FG001|Overall Study|Participants ongoing at data cut-off|84|||
125205482|NCT02453282|450374754|FG002|Overall Study|Participants ongoing at data cut-off|62|||
125205483|NCT02453282|450374752|FG000|Overall Study|Other|1|||
125205484|NCT02453282|450374753|FG001|Overall Study|Other|1|||
125205485|NCT02453282|450374754|FG002|Overall Study|Other|1|||
125205486|NCT03385304|450374756|FG000|Overall Study|Death|19|||
125205487|NCT03385304|450374757|FG001|Overall Study|Death|7|||
125205488|NCT03385304|450374756|FG000|Overall Study|Lost to Follow-up|17|||
125205489|NCT03385304|450374757|FG001|Overall Study|Lost to Follow-up|14|||
125205490|NCT03385304|450374756|FG000|Overall Study|Withdrawal by Subject|3|||
125205491|NCT03385304|450374757|FG001|Overall Study|Withdrawal by Subject|2|||
125205492|NCT03385304|450374756|FG000|Overall Study|Incarceration|2|||
125205493|NCT03385304|450374757|FG001|Overall Study|Incarceration|3|||
125205494|NCT01120249|450374758|FG000|Overall Study|No protocol treatment received|21|||
125205495|NCT01120249|450374759|FG001|Overall Study|No protocol treatment received|15|||
125205496|NCT01120249|450374758|FG000|Overall Study|Disease recurrence|107|||
125205497|NCT01120249|450374759|FG001|Overall Study|Disease recurrence|57|||
125205498|NCT01120249|450374758|FG000|Overall Study|Death|1|||
125205499|NCT01120249|450374759|FG001|Overall Study|Death|0|||
125205500|NCT01120249|450374758|FG000|Overall Study|Adverse Event|40|||
125205501|NCT01120249|450374759|FG001|Overall Study|Adverse Event|276|||
125205502|NCT01120249|450374758|FG000|Overall Study|Participant refusal|34|||
125205503|NCT01120249|450374759|FG001|Overall Study|Participant refusal|42|||
125205504|NCT01120249|450374758|FG000|Overall Study|Other reasons, not protocol specified|29|||
125205505|NCT01120249|450374759|FG001|Overall Study|Other reasons, not protocol specified|22|||
125205506|NCT01629823|450374765|FG000|Trial Period|Missed visit|11|||
125205507|NCT01629823|450374766|FG001|Trial Period|Missed visit|9|||
125205508|NCT01629823|450374767|FG002|Trial Period|Missed visit|8|||
125205509|NCT01629823|450374765|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
125205510|NCT01629823|450374766|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
125205511|NCT01629823|450374767|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
125205512|NCT01629823|450374765|FG000|Trial Period|Pregnancy|1|||
125205513|NCT01629823|450374766|FG001|Trial Period|Pregnancy|0|||
125205514|NCT01629823|450374767|FG002|Trial Period|Pregnancy|0|||
125205515|NCT01629823|450374765|FG000|Trial Period|Adverse Event|0|||
125205516|NCT01629823|450374766|FG001|Trial Period|Adverse Event|1|||
125205517|NCT01629823|450374767|FG002|Trial Period|Adverse Event|0|||
125205518|NCT01629823|450374765|FG000|Trial Period|Out-of-window visit|0|||
125205519|NCT01629823|450374766|FG001|Trial Period|Out-of-window visit|2|||
125205520|NCT01629823|450374767|FG002|Trial Period|Out-of-window visit|0|||
125205521|NCT01629823|450374765|FG000|Trial Period|Failed to hold medication|0|||
125205522|NCT01629823|450374766|FG001|Trial Period|Failed to hold medication|0|||
125205523|NCT01629823|450374767|FG002|Trial Period|Failed to hold medication|1|||
125205524|NCT01629823|450374765|FG000|Washout Period|Safety|2|||
125205525|NCT01629823|450374766|FG001|Washout Period|Safety|5|||
125205526|NCT01629823|450374767|FG002|Washout Period|Safety|0|||
125205527|NCT01629823|450374765|FG000|Washout Period|Pregnancy|1|||
125205528|NCT01629823|450374766|FG001|Washout Period|Pregnancy|0|||
125205529|NCT01629823|450374767|FG002|Washout Period|Pregnancy|0|||
125205530|NCT01629823|450374765|FG000|Washout Period|Protocol Violation|0|||
125205531|NCT01629823|450374766|FG001|Washout Period|Protocol Violation|1|||
125205532|NCT01629823|450374767|FG002|Washout Period|Protocol Violation|0|||
125205533|NCT00480493|450374768|FG000|Overall Study|moved|2|||
125205534|NCT00480493|450374769|FG001|Overall Study|moved|7|||
125205535|NCT00738062|450374770|FG000|Open Label Treatment|Lack of Efficacy|5|||
125205536|NCT00738062|450374771|FG001|Open Label Treatment|Lack of Efficacy|0|||
125205537|NCT00738062|450374772|FG002|Open Label Treatment|Lack of Efficacy|0|||
125205538|NCT00738062|450374770|FG000|Open Label Treatment|Adverse Event|11|||
125205539|NCT00738062|450374771|FG001|Open Label Treatment|Adverse Event|0|||
125205540|NCT00738062|450374772|FG002|Open Label Treatment|Adverse Event|0|||
125205541|NCT00738062|450374770|FG000|Open Label Treatment|Protocol Violation|2|||
125205542|NCT00738062|450374771|FG001|Open Label Treatment|Protocol Violation|0|||
125205543|NCT00738062|450374772|FG002|Open Label Treatment|Protocol Violation|0|||
125205544|NCT00738062|450374770|FG000|Open Label Treatment|Withdrawal by Subject|9|||
125205545|NCT00738062|450374771|FG001|Open Label Treatment|Withdrawal by Subject|0|||
125205546|NCT00738062|450374772|FG002|Open Label Treatment|Withdrawal by Subject|0|||
125205547|NCT00738062|450374770|FG000|Open Label Treatment|Investigator Decision|1|||
125205548|NCT00738062|450374771|FG001|Open Label Treatment|Investigator Decision|0|||
125205549|NCT00738062|450374772|FG002|Open Label Treatment|Investigator Decision|0|||
125205550|NCT00738062|450374770|FG000|Open-Label Extension|Adverse Event|5|||
125205551|NCT00738062|450374771|FG001|Open-Label Extension|Adverse Event|0|||
125205552|NCT00738062|450374772|FG002|Open-Label Extension|Adverse Event|0|||
125205553|NCT00738062|450374770|FG000|Open-Label Extension|Physician Decision|1|||
125205554|NCT00738062|450374771|FG001|Open-Label Extension|Physician Decision|0|||
125205555|NCT00738062|450374772|FG002|Open-Label Extension|Physician Decision|0|||
125205556|NCT00738062|450374770|FG000|Open-Label Extension|Lack of Efficacy|2|||
125205557|NCT00738062|450374771|FG001|Open-Label Extension|Lack of Efficacy|0|||
125205558|NCT00738062|450374772|FG002|Open-Label Extension|Lack of Efficacy|0|||
125205559|NCT00738062|450374770|FG000|Open-Label Extension|Withdrawal by Subject|6|||
125205560|NCT00738062|450374771|FG001|Open-Label Extension|Withdrawal by Subject|0|||
125205561|NCT00738062|450374772|FG002|Open-Label Extension|Withdrawal by Subject|0|||
125205562|NCT00738062|450374770|FG000|Open-Label Extension|Protocol Violation|1|||
125205563|NCT00738062|450374771|FG001|Open-Label Extension|Protocol Violation|0|||
125205564|NCT00738062|450374772|FG002|Open-Label Extension|Protocol Violation|0|||
125205565|NCT00738062|450374770|FG000|Open-Label Extension|Study Terminated|2|||
125205566|NCT00738062|450374771|FG001|Open-Label Extension|Study Terminated|0|||
125205567|NCT00738062|450374772|FG002|Open-Label Extension|Study Terminated|0|||
125205568|NCT00550862|450374773|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
125205569|NCT00550862|450374774|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
125205570|NCT00550862|450374775|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
125205571|NCT00550862|450374776|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
125205572|NCT00550862|450374777|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
125205573|NCT00550862|450374773|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
125205574|NCT00550862|450374774|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
125205575|NCT00550862|450374775|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
125205576|NCT00550862|450374776|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
125205577|NCT00550862|450374777|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
125205578|NCT00550862|450374773|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
125205579|NCT00550862|450374774|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
125205580|NCT00550862|450374775|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
125205581|NCT00550862|450374776|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
125205582|NCT00550862|450374777|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
125205583|NCT00550862|450374773|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
125205584|NCT00550862|450374774|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
125205585|NCT00550862|450374775|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
125205586|NCT00550862|450374776|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
124981312|NCT01283516|449557453|FG005|Overall Study|Disease Progression|8|||
124981313|NCT01283516|449557454|FG006|Overall Study|Disease Progression|6|||
124981314|NCT01283516|449557455|FG007|Overall Study|Disease Progression|3|||
124981315|NCT01283516|449557456|FG008|Overall Study|Disease Progression|139|||
124981316|NCT01283516|449557448|FG000|Overall Study|Withdrawal by Subject|0|||
124981317|NCT01283516|449557449|FG001|Overall Study|Withdrawal by Subject|0|||
124981318|NCT01283516|449557450|FG002|Overall Study|Withdrawal by Subject|0|||
124981319|NCT01283516|449557451|FG003|Overall Study|Withdrawal by Subject|0|||
124981320|NCT01283516|449557452|FG004|Overall Study|Withdrawal by Subject|1|||
124981321|NCT01283516|449557453|FG005|Overall Study|Withdrawal by Subject|0|||
124981322|NCT01283516|449557454|FG006|Overall Study|Withdrawal by Subject|1|||
124981323|NCT01283516|449557455|FG007|Overall Study|Withdrawal by Subject|0|||
124981324|NCT01283516|449557456|FG008|Overall Study|Withdrawal by Subject|36|||
124981325|NCT01283516|449557448|FG000|Overall Study|Administrative problems|0|||
124981326|NCT01283516|449557449|FG001|Overall Study|Administrative problems|0|||
124981327|NCT01283516|449557450|FG002|Overall Study|Administrative problems|0|||
124981328|NCT01283516|449557451|FG003|Overall Study|Administrative problems|0|||
124981329|NCT01283516|449557452|FG004|Overall Study|Administrative problems|0|||
124981330|NCT01283516|449557453|FG005|Overall Study|Administrative problems|1|||
124981331|NCT01283516|449557454|FG006|Overall Study|Administrative problems|1|||
124981332|NCT01283516|449557455|FG007|Overall Study|Administrative problems|1|||
124981333|NCT01283516|449557456|FG008|Overall Study|Administrative problems|39|||
124981334|NCT01283516|449557448|FG000|Overall Study|Lost to Follow-up|0|||
124981335|NCT01283516|449557449|FG001|Overall Study|Lost to Follow-up|0|||
124981336|NCT01283516|449557450|FG002|Overall Study|Lost to Follow-up|0|||
124981337|NCT01283516|449557451|FG003|Overall Study|Lost to Follow-up|0|||
124981338|NCT01283516|449557452|FG004|Overall Study|Lost to Follow-up|0|||
124981339|NCT01283516|449557453|FG005|Overall Study|Lost to Follow-up|0|||
124981340|NCT01283516|449557454|FG006|Overall Study|Lost to Follow-up|0|||
124981341|NCT01283516|449557455|FG007|Overall Study|Lost to Follow-up|0|||
124981342|NCT01283516|449557456|FG008|Overall Study|Lost to Follow-up|1|||
124981343|NCT00132873|449557460|FG000|Overall Study|Adverse Event|3|||
124981344|NCT00132873|449557460|FG000|Overall Study|Lost to Follow-up|1|||
124981345|NCT00132873|449557460|FG000|Overall Study|Lack of Efficacy|1|||
124981346|NCT00132873|449557460|FG000|Overall Study|Withdrawal by Subject|3|||
124981347|NCT00132873|449557460|FG000|Overall Study|Planned Pregnancy|1|||
124981348|NCT02045875|449557461|FG000|Overall Study|Lost to Follow-up|3|||
124981349|NCT02045875|449557462|FG001|Overall Study|Lost to Follow-up|0|||
124981350|NCT02045875|449557461|FG000|Overall Study|Withdrawal by Subject|4|||
124981351|NCT02045875|449557462|FG001|Overall Study|Withdrawal by Subject|3|||
124981352|NCT00444275|449557463|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
124981353|NCT00444275|449557464|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
124981354|NCT00444275|449557465|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
124981355|NCT00444275|449557466|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
124981356|NCT00444275|449557467|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
124981357|NCT00444275|449557463|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
124981358|NCT00444275|449557464|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
124981359|NCT00444275|449557465|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
124981360|NCT00444275|449557466|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
124981361|NCT00444275|449557467|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
124981362|NCT00444275|449557463|FG000|Maintenance Treatment Phase|Adverse Event|0|||
124981363|NCT00444275|449557464|FG001|Maintenance Treatment Phase|Adverse Event|0|||
124981364|NCT00444275|449557465|FG002|Maintenance Treatment Phase|Adverse Event|3|||
124981365|NCT00444275|449557466|FG003|Maintenance Treatment Phase|Adverse Event|2|||
124981366|NCT00444275|449557467|FG004|Maintenance Treatment Phase|Adverse Event|13|||
124981367|NCT00444275|449557463|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
124981368|NCT00444275|449557464|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
124981369|NCT00444275|449557465|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
124981370|NCT00444275|449557466|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
124981371|NCT00444275|449557467|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
124981372|NCT00444275|449557463|FG000|Maintenance Treatment Phase|Patient's wish|0|||
124981373|NCT00444275|449557464|FG001|Maintenance Treatment Phase|Patient's wish|0|||
124981374|NCT00444275|449557465|FG002|Maintenance Treatment Phase|Patient's wish|19|||
124981375|NCT00444275|449557466|FG003|Maintenance Treatment Phase|Patient's wish|9|||
124981376|NCT00444275|449557467|FG004|Maintenance Treatment Phase|Patient's wish|20|||
124981377|NCT00444275|449557463|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
124981378|NCT00444275|449557464|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
124981379|NCT00444275|449557465|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
124981380|NCT00444275|449557466|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
124981381|NCT00444275|449557467|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
124981382|NCT00444275|449557463|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
124981383|NCT00444275|449557464|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
124981384|NCT00444275|449557465|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
124981385|NCT00444275|449557466|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
125205587|NCT00550862|450374777|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
125205588|NCT00550862|450374773|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
125205589|NCT00550862|450374774|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
125205590|NCT00550862|450374775|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
125205591|NCT00550862|450374776|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
125205592|NCT00550862|450374777|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
125205593|NCT00550862|450374773|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
125205594|NCT00550862|450374774|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
125205595|NCT00550862|450374775|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
125205596|NCT00550862|450374776|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
125205597|NCT00550862|450374777|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
125205598|NCT00550862|450374773|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
125205599|NCT00550862|450374774|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
125205600|NCT00550862|450374775|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
125205601|NCT00550862|450374776|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
125205602|NCT00550862|450374777|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
125205603|NCT00550862|450374773|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
125205604|NCT00550862|450374774|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
125205605|NCT00550862|450374775|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
125205606|NCT00550862|450374776|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
125205607|NCT00550862|450374777|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
125205608|NCT00550862|450374773|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
125205609|NCT00550862|450374774|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
125205610|NCT00550862|450374775|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
125205611|NCT00550862|450374776|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
125205612|NCT00550862|450374777|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
125205613|NCT00550862|450374773|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
125205614|NCT00550862|450374774|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
125205615|NCT00550862|450374775|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
125205616|NCT00550862|450374776|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
125205617|NCT00550862|450374777|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
125205618|NCT00980174|450374778|FG000|Overall Study|Withdrawal by Subject|1|||
125205619|NCT00980174|450374779|FG001|Overall Study|Withdrawal by Subject|4|||
125205620|NCT00980174|450374778|FG000|Overall Study|Adverse Event|0|||
125205621|NCT00980174|450374779|FG001|Overall Study|Adverse Event|3|||
125205622|NCT00980174|450374778|FG000|Overall Study|Ineligibility determined|2|||
125205623|NCT00980174|450374779|FG001|Overall Study|Ineligibility determined|1|||
125205624|NCT00980174|450374778|FG000|Overall Study|Death|1|||
125205625|NCT00980174|450374779|FG001|Overall Study|Death|1|||
125205626|NCT00980174|450374778|FG000|Overall Study|Other|0|||
125205627|NCT00980174|450374779|FG001|Overall Study|Other|1|||
125205628|NCT04631107|450374783|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
125205629|NCT04631107|450374783|FG000|Second Intervention (1 Night)|Adverse Event|1|||
125205630|NCT04631107|450374783|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
125205631|NCT04631107|450374783|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
125205632|NCT02003963|450374784|FG000|Overall Study|Lost to Follow-up|2|||
125205633|NCT02003963|450374785|FG001|Overall Study|Lost to Follow-up|1|||
125205634|NCT01935128|450374787|FG000|Overall Study|Death|1|||
125205635|NCT01935128|450374787|FG000|Overall Study|Adverse Event|6|||
125205636|NCT01440569|450374788|FG000|Main Study|Enrolled but not treated|1|||
125205637|NCT01440569|450374789|FG001|Main Study|Enrolled but not treated|0|||
125205638|NCT01440569|450374788|FG000|Main Study|Adverse Event|9|||
125205639|NCT01440569|450374789|FG001|Main Study|Adverse Event|0|||
125205640|NCT01440569|450374788|FG000|Main Study|Pregnancy|1|||
125205641|NCT01440569|450374789|FG001|Main Study|Pregnancy|0|||
125205642|NCT01440569|450374788|FG000|Main Study|Investigator's Discretion|1|||
125205643|NCT01440569|450374789|FG001|Main Study|Investigator's Discretion|1|||
125205644|NCT01440569|450374788|FG000|Main Study|Withdrew Consent|7|||
125205645|NCT01440569|450374789|FG001|Main Study|Withdrew Consent|1|||
125205646|NCT01440569|450374788|FG000|Main Study|Lost to Follow-up|13|||
125205647|NCT01440569|450374789|FG001|Main Study|Lost to Follow-up|2|||
125205648|NCT01440569|450374788|FG000|Main Study|Subject Non-Compliance|3|||
125205649|NCT01440569|450374789|FG001|Main Study|Subject Non-Compliance|0|||
125205650|NCT01440569|450374788|FG000|Main Study|Protocol Violation|1|||
125205651|NCT01440569|450374789|FG001|Main Study|Protocol Violation|0|||
125205652|NCT01440569|450374788|FG000|Open-Label Rollover Phase|Adverse Event|3|||
125205653|NCT01440569|450374789|FG001|Open-Label Rollover Phase|Adverse Event|0|||
125205654|NCT01440569|450374788|FG000|Open-Label Rollover Phase|Pregnancy|1|||
125205655|NCT01440569|450374789|FG001|Open-Label Rollover Phase|Pregnancy|0|||
125205656|NCT01440569|450374788|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
125205657|NCT01440569|450374789|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
125205658|NCT01440569|450374788|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
125205659|NCT01440569|450374789|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
125205660|NCT01440569|450374788|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
125205661|NCT01440569|450374789|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
125205662|NCT01440569|450374788|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
125205663|NCT01440569|450374789|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
125205664|NCT01440569|450374788|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
125205665|NCT01440569|450374789|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
125205666|NCT05020366|450374790|FG000|Overall Study|Lost to Follow-up|2|||
125205667|NCT05020366|450374791|FG001|Overall Study|Lost to Follow-up|0|||
125205668|NCT05020366|450374790|FG000|Overall Study|Withdrawal by Subject|2|||
125205669|NCT05020366|450374791|FG001|Overall Study|Withdrawal by Subject|0|||
125205670|NCT03589326|450374807|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
125205671|NCT03589326|450374808|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
125205672|NCT03589326|450374807|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
125205673|NCT03589326|450374808|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
125205674|NCT03589326|450374807|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
125205675|NCT03589326|450374808|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
125205676|NCT03589326|450374807|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
125205677|NCT03589326|450374808|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
125205678|NCT03589326|450374807|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
125205679|NCT03589326|450374808|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
125205680|NCT00435487|450374809|FG000|Overall Study|Death|3|||
125205681|NCT00435487|450374810|FG001|Overall Study|Death|4|||
125205682|NCT00435487|450374809|FG000|Overall Study|Adverse Event|0|||
125205683|NCT00435487|450374810|FG001|Overall Study|Adverse Event|3|||
125205684|NCT00435487|450374809|FG000|Overall Study|Lost to Follow-up|2|||
125205685|NCT00435487|450374810|FG001|Overall Study|Lost to Follow-up|2|||
125205686|NCT00435487|450374809|FG000|Overall Study|Other|5|||
125205687|NCT00435487|450374810|FG001|Overall Study|Other|2|||
125205688|NCT00435487|450374809|FG000|Overall Study|Withdrawal by Subject|2|||
125205689|NCT00435487|450374810|FG001|Overall Study|Withdrawal by Subject|1|||
125205690|NCT00435487|450374809|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
125205691|NCT00435487|450374810|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
125205692|NCT00435487|450374809|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
125205693|NCT00435487|450374810|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
125205694|NCT03301844|450374811|FG000|Overall Study|suspected colon cancer|1|||
125205695|NCT03301844|450374812|FG001|Overall Study|suspected colon cancer|1|||
125205696|NCT05087966|450374813|FG000|Overall Study|Lost to Follow-up|1|||
125205697|NCT05087966|450374813|FG000|Overall Study|Withdrawal by Subject|5|||
125205698|NCT00501059|450374814|FG000|Overall Study|Protocol Violation|80|||
125205699|NCT00501059|450374815|FG001|Overall Study|Protocol Violation|69|||
125205700|NCT00501059|450374814|FG000|Overall Study|Death|140|||
125205701|NCT00501059|450374815|FG001|Overall Study|Death|137|||
125205702|NCT00501059|450374814|FG000|Overall Study|Other|236|||
125205703|NCT00501059|450374815|FG001|Overall Study|Other|239|||
125205704|NCT00501059|450374814|FG000|Overall Study|Missing end-of-study page|91|||
125205705|NCT00501059|450374815|FG001|Overall Study|Missing end-of-study page|92|||
125205706|NCT00501059|450374814|FG000|Overall Study|Clinical endpoint reached|110|||
125205707|NCT00501059|450374815|FG001|Overall Study|Clinical endpoint reached|123|||
125205708|NCT00501059|450374814|FG000|Overall Study|Insufficient therapeutic effect|4|||
125205709|NCT00501059|450374815|FG001|Overall Study|Insufficient therapeutic effect|5|||
125205710|NCT00501059|450374814|FG000|Overall Study|Consent withdrawn by subject|817|||
125205711|NCT00501059|450374815|FG001|Overall Study|Consent withdrawn by subject|873|||
125205712|NCT00501059|450374814|FG000|Overall Study|Non-compliant with study treatment|23|||
125205713|NCT00501059|450374815|FG001|Overall Study|Non-compliant with study treatment|16|||
125205714|NCT00501059|450374814|FG000|Overall Study|Reason not given|3|||
125205715|NCT00501059|450374815|FG001|Overall Study|Reason not given|1|||
125205716|NCT00501059|450374814|FG000|Overall Study|Adverse Event|129|||
125205717|NCT00501059|450374815|FG001|Overall Study|Adverse Event|122|||
125205718|NCT00501059|450374814|FG000|Overall Study|Lost to Follow-up|210|||
125205719|NCT00501059|450374815|FG001|Overall Study|Lost to Follow-up|198|||
125205720|NCT00501059|450374814|FG000|Overall Study|Not treated|25|||
125205721|NCT00501059|450374815|FG001|Overall Study|Not treated|17|||
125205722|NCT00430352|450374819|FG000|Overall Study|Disease progression|58|||
125205723|NCT00430352|450374819|FG000|Overall Study|Withdrawal by Subject|11|||
125205724|NCT00430352|450374819|FG000|Overall Study|Adverse Event|16|||
125205725|NCT00430352|450374819|FG000|Overall Study|Death|5|||
125205726|NCT00430352|450374819|FG000|Overall Study|Other|48|||
125205727|NCT01785849|450374824|FG000|Overall Study|Death|7|||
125205728|NCT01785849|450374825|FG001|Overall Study|Death|9|||
125205729|NCT01785849|450374824|FG000|Overall Study|Protocol Specified Criteria|29|||
125205730|NCT01785849|450374825|FG001|Overall Study|Protocol Specified Criteria|1|||
125205731|NCT01785849|450374824|FG000|Overall Study|Withdrawal by Subject|15|||
125205732|NCT01785849|450374825|FG001|Overall Study|Withdrawal by Subject|12|||
125205733|NCT01785849|450374824|FG000|Overall Study|Sponsor Decision|0|||
125205734|NCT01785849|450374825|FG001|Overall Study|Sponsor Decision|1|||
125205735|NCT01785849|450374824|FG000|Overall Study|Lost to Follow-up|10|||
125205736|NCT01785849|450374825|FG001|Overall Study|Lost to Follow-up|11|||
125205737|NCT04550832|450377117|FG000|Overall Study|Adverse Event|0|||
125205738|NCT04550832|450377118|FG001|Overall Study|Adverse Event|0|||
125205739|NCT04550832|450377119|FG002|Overall Study|Adverse Event|2|||
125205740|NCT04550832|450377120|FG003|Overall Study|Adverse Event|0|||
125205741|NCT04550832|450377121|FG004|Overall Study|Adverse Event|1|||
124981386|NCT00444275|449557467|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
124981387|NCT01204710|449557471|FG000|Randomization Treatment|Lost to Follow-up|1|||
124981388|NCT01204710|449557472|FG001|Randomization Treatment|Lost to Follow-up|0|||
124981389|NCT01204710|449557471|FG000|Randomization Treatment|Withdrawal by Subject|6|||
124981390|NCT01204710|449557472|FG001|Randomization Treatment|Withdrawal by Subject|5|||
124981391|NCT01204710|449557471|FG000|Randomization Treatment|Physician Decision|3|||
124981392|NCT01204710|449557472|FG001|Randomization Treatment|Physician Decision|2|||
124981393|NCT01204710|449557471|FG000|Randomization Treatment|Entry criteria not met|0|||
124981394|NCT01204710|449557472|FG001|Randomization Treatment|Entry criteria not met|1|||
125205742|NCT04823130|450377122|FG000|Overall Study|Withdrawal by Subject|2|||
125205743|NCT04823130|450377123|FG001|Overall Study|Withdrawal by Subject|3|||
125205744|NCT04823130|450377122|FG000|Overall Study|Failure to meet inclusion criteria|6|||
125205745|NCT04823130|450377123|FG001|Overall Study|Failure to meet inclusion criteria|4|||
125205746|NCT04823130|450377122|FG000|Overall Study|Other-unspecified|1|||
125205747|NCT04823130|450377123|FG001|Overall Study|Other-unspecified|0|||
125205748|NCT03315455|450377124|FG000|Overall Study|Ongoing in the Study|13|||
125205749|NCT03315455|450377125|FG001|Overall Study|Ongoing in the Study|24|||
125205750|NCT03315455|450377126|FG002|Overall Study|Ongoing in the Study|17|||
125205751|NCT03315455|450377127|FG003|Overall Study|Ongoing in the Study|15|||
125205752|NCT03315455|450377124|FG000|Overall Study|Withdrawal by Subject|0|||
125205753|NCT03315455|450377125|FG001|Overall Study|Withdrawal by Subject|1|||
125205754|NCT03315455|450377126|FG002|Overall Study|Withdrawal by Subject|0|||
125205755|NCT03315455|450377127|FG003|Overall Study|Withdrawal by Subject|0|||
125205756|NCT03030118|450377131|FG000|Overall Study|Achieved SLE Diagnosis|11|||
125205757|NCT03030118|450377132|FG001|Overall Study|Achieved SLE Diagnosis|10|||
125205758|NCT03030118|450377131|FG000|Overall Study|Adverse Event|1|||
125205759|NCT03030118|450377132|FG001|Overall Study|Adverse Event|1|||
125205760|NCT03030118|450377131|FG000|Overall Study|Pregnancy|2|||
125205761|NCT03030118|450377132|FG001|Overall Study|Pregnancy|2|||
125205762|NCT03030118|450377131|FG000|Overall Study|Lost to Follow-up|5|||
125205763|NCT03030118|450377132|FG001|Overall Study|Lost to Follow-up|6|||
125205764|NCT03030118|450377131|FG000|Overall Study|Concomitant Medications|1|||
125205765|NCT03030118|450377132|FG001|Overall Study|Concomitant Medications|1|||
125205766|NCT03030118|450377131|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
125205767|NCT03030118|450377132|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
125205768|NCT03030118|450377131|FG000|Overall Study|Other|2|||
125205769|NCT03030118|450377132|FG001|Overall Study|Other|0|||
125205770|NCT03030118|450377131|FG000|Overall Study|Withdrawal by Subject|26|||
125205771|NCT03030118|450377132|FG001|Overall Study|Withdrawal by Subject|21|||
125205772|NCT03030118|450377131|FG000|Overall Study|Protocol Violation|1|||
125205773|NCT03030118|450377132|FG001|Overall Study|Protocol Violation|6|||
125205774|NCT01032070|450377133|FG000|Overall Study|Disease progression|13|||
125205775|NCT01032070|450377134|FG001|Overall Study|Disease progression|8|||
125205776|NCT01032070|450377133|FG000|Overall Study|Medical or ethical reasons|0|||
125205777|NCT01032070|450377134|FG001|Overall Study|Medical or ethical reasons|2|||
125205778|NCT01032070|450377133|FG000|Overall Study|Withdrawal by Subject|0|||
125205779|NCT01032070|450377134|FG001|Overall Study|Withdrawal by Subject|2|||
125205780|NCT03488225|450377137|FG000|Overall Study|Off Protocol Therapy|2|||
125205781|NCT03488225|450377137|FG000|Overall Study|Stem Cell Transplant|2|||
125205782|NCT00894790|450377138|FG000|Overall Study|Protocol Violation|0|||
125205783|NCT00894790|450377139|FG001|Overall Study|Protocol Violation|1|||
125205784|NCT00894790|450377138|FG000|Overall Study|Lost to Follow-up|0|||
125205785|NCT00894790|450377139|FG001|Overall Study|Lost to Follow-up|1|||
125205786|NCT00894790|450377138|FG000|Overall Study|Did not meet entrance criteria|1|||
125205787|NCT00894790|450377139|FG001|Overall Study|Did not meet entrance criteria|0|||
125205788|NCT04093492|450377140|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
125205789|NCT04093492|450377141|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
125205790|NCT04093492|450377142|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
125205791|NCT04093492|450377143|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
125205792|NCT04093492|450377140|FG000|25 Weeks Gestational Age (GA)|No response|5|||
125205793|NCT04093492|450377141|FG001|25 Weeks Gestational Age (GA)|No response|5|||
125205794|NCT04093492|450377142|FG002|25 Weeks Gestational Age (GA)|No response|5|||
125205795|NCT04093492|450377143|FG003|25 Weeks Gestational Age (GA)|No response|2|||
125205796|NCT04093492|450377140|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
125205797|NCT04093492|450377141|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
125205798|NCT04093492|450377142|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
125205799|NCT04093492|450377143|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
125205800|NCT04093492|450377140|FG000|30 Weeks GA|Delivered before assessment|1|||
125205801|NCT04093492|450377141|FG001|30 Weeks GA|Delivered before assessment|2|||
125205802|NCT04093492|450377142|FG002|30 Weeks GA|Delivered before assessment|0|||
125205803|NCT04093492|450377143|FG003|30 Weeks GA|Delivered before assessment|0|||
125205804|NCT04093492|450377140|FG000|30 Weeks GA|No response|7|||
125205805|NCT04093492|450377141|FG001|30 Weeks GA|No response|5|||
125205806|NCT04093492|450377142|FG002|30 Weeks GA|No response|5|||
125205807|NCT04093492|450377143|FG003|30 Weeks GA|No response|2|||
125205808|NCT04093492|450377140|FG000|30 Weeks GA|Lost to Follow-up|0|||
125205809|NCT04093492|450377141|FG001|30 Weeks GA|Lost to Follow-up|1|||
125205810|NCT04093492|450377142|FG002|30 Weeks GA|Lost to Follow-up|0|||
125205811|NCT04093492|450377143|FG003|30 Weeks GA|Lost to Follow-up|0|||
125205812|NCT04093492|450377140|FG000|34 Weeks GA|Delivered before assessment|6|||
125205813|NCT04093492|450377141|FG001|34 Weeks GA|Delivered before assessment|3|||
125205814|NCT04093492|450377142|FG002|34 Weeks GA|Delivered before assessment|0|||
125205815|NCT04093492|450377143|FG003|34 Weeks GA|Delivered before assessment|0|||
125205816|NCT04093492|450377140|FG000|34 Weeks GA|No response|0|||
125205817|NCT04093492|450377141|FG001|34 Weeks GA|No response|7|||
125205818|NCT04093492|450377142|FG002|34 Weeks GA|No response|5|||
125205819|NCT04093492|450377143|FG003|34 Weeks GA|No response|3|||
125205820|NCT04093492|450377140|FG000|34 Weeks GA|Lost to Follow-up|0|||
125205821|NCT04093492|450377141|FG001|34 Weeks GA|Lost to Follow-up|1|||
125205822|NCT04093492|450377142|FG002|34 Weeks GA|Lost to Follow-up|0|||
125205823|NCT04093492|450377143|FG003|34 Weeks GA|Lost to Follow-up|0|||
125205824|NCT00503997|450377148|FG000|Overall Study|disease progression|1|||
125205825|NCT00503997|450377148|FG000|Overall Study|Adverse Event|5|||
125205826|NCT00503997|450377148|FG000|Overall Study|Death|1|||
125205827|NCT00503997|450377148|FG000|Overall Study|Withdrawal by Subject|1|||
125205828|NCT01195844|450377149|FG000|Overall Study|Fecal sample not collected|40|||
125205829|NCT05385224|450377150|FG000|Overall Study|Unable to swallow capsule|2|||
125205830|NCT05385224|450377150|FG000|Overall Study|Withdrawal by Subject|2|||
125205831|NCT05385224|450377150|FG000|Overall Study|Did not meet study criteria|1|||
125205832|NCT00551161|450377151|FG000|Overall Study|Withdrawal by Subject|1|||
125205833|NCT00096993|450377152|FG000|Overall Study|Death|1|||
125205834|NCT00096993|450377153|FG001|Overall Study|Death|0|||
125205835|NCT00096993|450377152|FG000|Overall Study|Disease progression|56|||
125205836|NCT00096993|450377153|FG001|Overall Study|Disease progression|53|||
125205837|NCT00096993|450377152|FG000|Overall Study|Adverse Event|2|||
125205838|NCT00096993|450377153|FG001|Overall Study|Adverse Event|8|||
125205839|NCT00096993|450377152|FG000|Overall Study|Subject's decision|3|||
125205840|NCT00096993|450377153|FG001|Overall Study|Subject's decision|1|||
125205841|NCT00096993|450377152|FG000|Overall Study|Physician Decision|2|||
125205842|NCT00096993|450377153|FG001|Overall Study|Physician Decision|1|||
125205843|NCT00096993|450377152|FG000|Overall Study|Non-compliance|0|||
125205844|NCT00096993|450377153|FG001|Overall Study|Non-compliance|1|||
125205845|NCT00096993|450377152|FG000|Overall Study|Other unspecified|1|||
125205846|NCT00096993|450377153|FG001|Overall Study|Other unspecified|1|||
125205847|NCT00772005|450377155|FG000|Overall Study|Adverse Event|9|||
125205848|NCT00772005|450377156|FG001|Overall Study|Adverse Event|14|||
125205849|NCT00772005|450377157|FG002|Overall Study|Adverse Event|10|||
125205850|NCT00772005|450377158|FG003|Overall Study|Adverse Event|13|||
125205851|NCT00772005|450377155|FG000|Overall Study|Lack of Efficacy|0|||
125205852|NCT00772005|450377156|FG001|Overall Study|Lack of Efficacy|1|||
125205853|NCT00772005|450377157|FG002|Overall Study|Lack of Efficacy|0|||
125205854|NCT00772005|450377158|FG003|Overall Study|Lack of Efficacy|0|||
125205855|NCT00772005|450377155|FG000|Overall Study|Withdrawal by Subject|3|||
125205856|NCT00772005|450377156|FG001|Overall Study|Withdrawal by Subject|7|||
125205857|NCT00772005|450377157|FG002|Overall Study|Withdrawal by Subject|10|||
125205858|NCT00772005|450377158|FG003|Overall Study|Withdrawal by Subject|2|||
125205859|NCT00772005|450377155|FG000|Overall Study|Protocol Violation|2|||
125205860|NCT00772005|450377156|FG001|Overall Study|Protocol Violation|4|||
125205861|NCT00772005|450377157|FG002|Overall Study|Protocol Violation|1|||
125205862|NCT00772005|450377158|FG003|Overall Study|Protocol Violation|6|||
125205863|NCT00772005|450377155|FG000|Overall Study|Lost to Follow-up|7|||
125205864|NCT00772005|450377156|FG001|Overall Study|Lost to Follow-up|3|||
125205865|NCT00772005|450377157|FG002|Overall Study|Lost to Follow-up|6|||
125205866|NCT00772005|450377158|FG003|Overall Study|Lost to Follow-up|3|||
125205867|NCT00772005|450377155|FG000|Overall Study|Non-compliance with study procedures|1|||
125205868|NCT00772005|450377156|FG001|Overall Study|Non-compliance with study procedures|1|||
125205869|NCT00772005|450377157|FG002|Overall Study|Non-compliance with study procedures|0|||
125205870|NCT00772005|450377158|FG003|Overall Study|Non-compliance with study procedures|1|||
125205871|NCT00772005|450377155|FG000|Overall Study|Non-compliance with drug administration|3|||
125205872|NCT00772005|450377156|FG001|Overall Study|Non-compliance with drug administration|0|||
125205873|NCT00772005|450377157|FG002|Overall Study|Non-compliance with drug administration|1|||
125205874|NCT00772005|450377158|FG003|Overall Study|Non-compliance with drug administration|1|||
125205875|NCT01606202|450377162|FG000|Overall Study|Adverse Event|5|||
125205876|NCT01606202|450377163|FG001|Overall Study|Adverse Event|0|||
125205877|NCT01606202|450377162|FG000|Overall Study|Withdrawal by Subject|2|||
125205878|NCT01606202|450377163|FG001|Overall Study|Withdrawal by Subject|1|||
125205879|NCT01606202|450377162|FG000|Overall Study|Personal problems|0|||
125205880|NCT01606202|450377163|FG001|Overall Study|Personal problems|1|||
125205881|NCT01606202|450377162|FG000|Overall Study|Problems with administration|0|||
125205882|NCT01606202|450377163|FG001|Overall Study|Problems with administration|1|||
125205883|NCT01267201|450377164|FG000|First Intervention Period|Withdrawal by Subject|1|||
125205884|NCT01267201|450377165|FG001|First Intervention Period|Withdrawal by Subject|0|||
125205885|NCT01267201|450377166|FG002|First Intervention Period|Withdrawal by Subject|0|||
125205886|NCT01267201|450377167|FG003|First Intervention Period|Withdrawal by Subject|0|||
125205887|NCT01267201|450377168|FG004|First Intervention Period|Withdrawal by Subject|0|||
125205888|NCT01267201|450377169|FG005|First Intervention Period|Withdrawal by Subject|0|||
125205889|NCT01267201|450377164|FG000|Second Intervention Period|Withdrawal by Subject|0|||
125205890|NCT01267201|450377165|FG001|Second Intervention Period|Withdrawal by Subject|1|||
125205891|NCT01267201|450377166|FG002|Second Intervention Period|Withdrawal by Subject|0|||
125205892|NCT01267201|450377167|FG003|Second Intervention Period|Withdrawal by Subject|0|||
125205893|NCT01267201|450377168|FG004|Second Intervention Period|Withdrawal by Subject|0|||
125205894|NCT01267201|450377169|FG005|Second Intervention Period|Withdrawal by Subject|0|||
125205895|NCT00955968|450377173|FG000|Overall Study|Death|2|||
125205896|NCT00955968|450377174|FG001|Overall Study|Death|4|||
125205897|NCT00955968|450377173|FG000|Overall Study|Withdrawal by Subject|35|||
125205898|NCT00955968|450377174|FG001|Overall Study|Withdrawal by Subject|31|||
125205899|NCT00955968|450377173|FG000|Overall Study|Lost to Follow-up|45|||
125205900|NCT00955968|450377174|FG001|Overall Study|Lost to Follow-up|39|||
125205901|NCT00955968|450377173|FG000|Overall Study|Site closed|55|||
125205902|NCT00955968|450377174|FG001|Overall Study|Site closed|52|||
125205903|NCT05020899|450377176|FG000|8 Week Follow-up|Lost to Follow-up|3|||
125205904|NCT05020899|450377177|FG001|8 Week Follow-up|Lost to Follow-up|6|||
125205905|NCT05020899|450377176|FG000|12 Week Follow-up|Lost to Follow-up|1|||
125205906|NCT05020899|450377177|FG001|12 Week Follow-up|Lost to Follow-up|0|||
125205907|NCT05020899|450377176|FG000|12 Week Follow-up|Death|0|||
125205908|NCT05020899|450377177|FG001|12 Week Follow-up|Death|1|||
125205909|NCT01294371|450377178|FG000|Overall Study|Adverse Event|1|||
125205910|NCT01294371|450377178|FG000|Overall Study|Withdrawal by Subject|12|||
125205911|NCT01294371|450377178|FG000|Overall Study|Lost to Follow-up|6|||
125205912|NCT01294371|450377178|FG000|Overall Study|Administrative Reason|1|||
125205913|NCT01294371|450377178|FG000|Overall Study|Other|14|||
125205914|NCT05619536|450377179|FG000|Overall Study|Withdrawal by Subject|0|||
125205915|NCT05619536|450377180|FG001|Overall Study|Withdrawal by Subject|1|||
125205916|NCT05619536|450377181|FG002|Overall Study|Withdrawal by Subject|0|||
125205917|NCT05619536|450377182|FG003|Overall Study|Withdrawal by Subject|1|||
125205918|NCT05619536|450377179|FG000|Overall Study|Lost to Follow-up|0|||
125205919|NCT05619536|450377180|FG001|Overall Study|Lost to Follow-up|1|||
125205920|NCT05619536|450377181|FG002|Overall Study|Lost to Follow-up|1|||
125205921|NCT05619536|450377182|FG003|Overall Study|Lost to Follow-up|0|||
125205922|NCT02923245|450377183|FG000|Overall Study|ultrasound order was cancelled|2|||
125205923|NCT02923245|450377184|FG001|Overall Study|ultrasound order was cancelled|1|||
125205924|NCT02520427|450377185|FG000|Overall Study|Decision by sponsor|0|||
125205925|NCT02520427|450377186|FG001|Overall Study|Decision by sponsor|0|||
125205926|NCT02520427|450377187|FG002|Overall Study|Decision by sponsor|0|||
125205927|NCT02520427|450377188|FG003|Overall Study|Decision by sponsor|0|||
125205928|NCT02520427|450377189|FG004|Overall Study|Decision by sponsor|0|||
125205929|NCT02520427|450377190|FG005|Overall Study|Decision by sponsor|0|||
125205930|NCT02520427|450377191|FG006|Overall Study|Decision by sponsor|0|||
125205931|NCT02520427|450377192|FG007|Overall Study|Decision by sponsor|0|||
125205932|NCT02520427|450377193|FG008|Overall Study|Decision by sponsor|1|||
125205933|NCT02520427|450377194|FG009|Overall Study|Decision by sponsor|1|||
125205934|NCT02520427|450377195|FG010|Overall Study|Decision by sponsor|0|||
125205935|NCT02520427|450377196|FG011|Overall Study|Decision by sponsor|0|||
125205936|NCT02520427|450377197|FG012|Overall Study|Decision by sponsor|0|||
125205937|NCT02520427|450377198|FG013|Overall Study|Decision by sponsor|0|||
125205938|NCT02520427|450377199|FG014|Overall Study|Decision by sponsor|0|||
125205939|NCT02520427|450377200|FG015|Overall Study|Decision by sponsor|0|||
125205940|NCT02520427|450377201|FG016|Overall Study|Decision by sponsor|0|||
125205941|NCT02520427|450377202|FG017|Overall Study|Decision by sponsor|0|||
125205942|NCT02520427|450377203|FG018|Overall Study|Decision by sponsor|0|||
125205943|NCT02520427|450377204|FG019|Overall Study|Decision by sponsor|0|||
125205944|NCT02520427|450377205|FG020|Overall Study|Decision by sponsor|0|||
125205945|NCT02520427|450377206|FG021|Overall Study|Decision by sponsor|0|||
125205946|NCT02520427|450377207|FG022|Overall Study|Decision by sponsor|0|||
125205947|NCT02520427|450377208|FG023|Overall Study|Decision by sponsor|0|||
125205948|NCT02520427|450377209|FG024|Overall Study|Decision by sponsor|0|||
124981395|NCT01204710|449557471|FG000|Randomization Treatment|Adverse Event|4|||
125205949|NCT02520427|450377210|FG025|Overall Study|Decision by sponsor|0|||
125205950|NCT02520427|450377185|FG000|Overall Study|Withdrawal by Subject|0|||
125205951|NCT02520427|450377186|FG001|Overall Study|Withdrawal by Subject|0|||
125205952|NCT02520427|450377187|FG002|Overall Study|Withdrawal by Subject|1|||
125205953|NCT02520427|450377188|FG003|Overall Study|Withdrawal by Subject|0|||
125205954|NCT02520427|450377189|FG004|Overall Study|Withdrawal by Subject|0|||
125205955|NCT02520427|450377190|FG005|Overall Study|Withdrawal by Subject|0|||
125205956|NCT02520427|450377191|FG006|Overall Study|Withdrawal by Subject|0|||
125205957|NCT02520427|450377192|FG007|Overall Study|Withdrawal by Subject|0|||
125205958|NCT02520427|450377193|FG008|Overall Study|Withdrawal by Subject|0|||
125205959|NCT02520427|450377194|FG009|Overall Study|Withdrawal by Subject|0|||
125205960|NCT02520427|450377195|FG010|Overall Study|Withdrawal by Subject|0|||
125205961|NCT02520427|450377196|FG011|Overall Study|Withdrawal by Subject|0|||
125205962|NCT02520427|450377197|FG012|Overall Study|Withdrawal by Subject|1|||
125205963|NCT02520427|450377198|FG013|Overall Study|Withdrawal by Subject|1|||
125205964|NCT02520427|450377199|FG014|Overall Study|Withdrawal by Subject|1|||
125205965|NCT02520427|450377200|FG015|Overall Study|Withdrawal by Subject|0|||
125205966|NCT02520427|450377201|FG016|Overall Study|Withdrawal by Subject|1|||
125205967|NCT02520427|450377202|FG017|Overall Study|Withdrawal by Subject|0|||
125205968|NCT02520427|450377203|FG018|Overall Study|Withdrawal by Subject|0|||
125205969|NCT02520427|450377204|FG019|Overall Study|Withdrawal by Subject|3|||
125205970|NCT02520427|450377205|FG020|Overall Study|Withdrawal by Subject|2|||
125205971|NCT02520427|450377206|FG021|Overall Study|Withdrawal by Subject|0|||
125205972|NCT02520427|450377207|FG022|Overall Study|Withdrawal by Subject|0|||
125205973|NCT02520427|450377208|FG023|Overall Study|Withdrawal by Subject|0|||
125205974|NCT02520427|450377209|FG024|Overall Study|Withdrawal by Subject|0|||
125205975|NCT02520427|450377210|FG025|Overall Study|Withdrawal by Subject|0|||
125205976|NCT02520427|450377185|FG000|Overall Study|Death|1|||
125205977|NCT02520427|450377186|FG001|Overall Study|Death|0|||
125205978|NCT02520427|450377187|FG002|Overall Study|Death|0|||
125205979|NCT02520427|450377188|FG003|Overall Study|Death|0|||
125205980|NCT02520427|450377189|FG004|Overall Study|Death|0|||
125205981|NCT02520427|450377190|FG005|Overall Study|Death|0|||
125205982|NCT02520427|450377191|FG006|Overall Study|Death|0|||
125205983|NCT02520427|450377192|FG007|Overall Study|Death|0|||
125205984|NCT02520427|450377193|FG008|Overall Study|Death|0|||
125205985|NCT02520427|450377194|FG009|Overall Study|Death|0|||
125205986|NCT02520427|450377195|FG010|Overall Study|Death|0|||
125205987|NCT02520427|450377196|FG011|Overall Study|Death|0|||
125205988|NCT02520427|450377197|FG012|Overall Study|Death|0|||
125205989|NCT02520427|450377198|FG013|Overall Study|Death|0|||
125205990|NCT02520427|450377199|FG014|Overall Study|Death|0|||
125205991|NCT02520427|450377200|FG015|Overall Study|Death|0|||
125205992|NCT02520427|450377201|FG016|Overall Study|Death|2|||
125205993|NCT02520427|450377202|FG017|Overall Study|Death|1|||
125205994|NCT02520427|450377203|FG018|Overall Study|Death|3|||
125205995|NCT02520427|450377204|FG019|Overall Study|Death|2|||
125205996|NCT02520427|450377205|FG020|Overall Study|Death|0|||
125205997|NCT02520427|450377206|FG021|Overall Study|Death|0|||
125205998|NCT02520427|450377207|FG022|Overall Study|Death|1|||
125205999|NCT02520427|450377208|FG023|Overall Study|Death|0|||
125206000|NCT02520427|450377209|FG024|Overall Study|Death|1|||
125206001|NCT02520427|450377210|FG025|Overall Study|Death|0|||
125206002|NCT00793624|450377213|FG000|Overall Study|Adverse Event|18|||
125206003|NCT00793624|450377214|FG001|Overall Study|Adverse Event|16|||
125206004|NCT00793624|450377215|FG002|Overall Study|Adverse Event|15|||
125206005|NCT00793624|450377216|FG003|Overall Study|Adverse Event|20|||
125206006|NCT00793624|450377213|FG000|Overall Study|Lost to Follow-up|2|||
125206007|NCT00793624|450377214|FG001|Overall Study|Lost to Follow-up|2|||
125206008|NCT00793624|450377215|FG002|Overall Study|Lost to Follow-up|4|||
125206009|NCT00793624|450377216|FG003|Overall Study|Lost to Follow-up|0|||
125206010|NCT00793624|450377213|FG000|Overall Study|Withdrawal by Subject|20|||
125206011|NCT00793624|450377214|FG001|Overall Study|Withdrawal by Subject|9|||
125206012|NCT00793624|450377215|FG002|Overall Study|Withdrawal by Subject|11|||
125206013|NCT00793624|450377216|FG003|Overall Study|Withdrawal by Subject|14|||
125206014|NCT00793624|450377213|FG000|Overall Study|Lack of Efficacy|9|||
125206015|NCT00793624|450377214|FG001|Overall Study|Lack of Efficacy|2|||
125206016|NCT00793624|450377215|FG002|Overall Study|Lack of Efficacy|1|||
125206017|NCT00793624|450377216|FG003|Overall Study|Lack of Efficacy|3|||
125206018|NCT00793624|450377213|FG000|Overall Study|Non compliance with protocol|2|||
125206019|NCT00793624|450377214|FG001|Overall Study|Non compliance with protocol|3|||
125206020|NCT00793624|450377215|FG002|Overall Study|Non compliance with protocol|2|||
125206021|NCT00793624|450377216|FG003|Overall Study|Non compliance with protocol|3|||
125206022|NCT00793624|450377213|FG000|Overall Study|Other reason not described above|6|||
125206023|NCT00793624|450377214|FG001|Overall Study|Other reason not described above|4|||
125206024|NCT00793624|450377215|FG002|Overall Study|Other reason not described above|6|||
125206025|NCT00793624|450377216|FG003|Overall Study|Other reason not described above|3|||
125206026|NCT00710684|450377217|FG000|Overall Study|Adverse Event|11|||
125206027|NCT00710684|450377218|FG001|Overall Study|Adverse Event|19|||
125206028|NCT00710684|450377219|FG002|Overall Study|Adverse Event|16|||
125206029|NCT00710684|450377217|FG000|Overall Study|Lack of Efficacy|4|||
125206030|NCT00710684|450377218|FG001|Overall Study|Lack of Efficacy|3|||
125206031|NCT00710684|450377219|FG002|Overall Study|Lack of Efficacy|5|||
125206032|NCT00710684|450377217|FG000|Overall Study|Protocol Violation|5|||
125206033|NCT00710684|450377218|FG001|Overall Study|Protocol Violation|5|||
125206034|NCT00710684|450377219|FG002|Overall Study|Protocol Violation|5|||
125206035|NCT00710684|450377217|FG000|Overall Study|Lost to Follow-up|4|||
125206036|NCT00710684|450377218|FG001|Overall Study|Lost to Follow-up|6|||
125206037|NCT00710684|450377219|FG002|Overall Study|Lost to Follow-up|7|||
125206038|NCT00710684|450377217|FG000|Overall Study|Physician Decision|0|||
125206039|NCT00710684|450377218|FG001|Overall Study|Physician Decision|2|||
125206040|NCT00710684|450377219|FG002|Overall Study|Physician Decision|4|||
125206041|NCT00710684|450377217|FG000|Overall Study|Withdrawal by Subject|24|||
125206042|NCT00710684|450377218|FG001|Overall Study|Withdrawal by Subject|18|||
125206043|NCT00710684|450377219|FG002|Overall Study|Withdrawal by Subject|11|||
125206044|NCT00710684|450377217|FG000|Overall Study|Missing|1|||
125206045|NCT00710684|450377218|FG001|Overall Study|Missing|0|||
125206046|NCT00710684|450377219|FG002|Overall Study|Missing|0|||
124981396|NCT01204710|449557472|FG001|Randomization Treatment|Adverse Event|2|||
124981397|NCT01204710|449557471|FG000|Randomization Treatment|Sponsor Decision|0|||
124981398|NCT01204710|449557472|FG001|Randomization Treatment|Sponsor Decision|1|||
124981399|NCT01204710|449557471|FG000|Randomization Treatment|Worsening of General condition|0|||
124981400|NCT01204710|449557472|FG001|Randomization Treatment|Worsening of General condition|1|||
124981401|NCT01204710|449557471|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
124981402|NCT01204710|449557472|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
125206047|NCT00710684|450377217|FG000|Overall Study|Did not continue after week 24|25|||
125206048|NCT00710684|450377218|FG001|Overall Study|Did not continue after week 24|21|||
125206049|NCT00710684|450377219|FG002|Overall Study|Did not continue after week 24|16|||
125206050|NCT04778059|450377220|FG000|Overall Study|Death|2|||
125206051|NCT04778059|450377221|FG001|Overall Study|Death|2|||
125206052|NCT04778059|450377222|FG002|Overall Study|Death|1|||
125206053|NCT04778059|450377223|FG003|Overall Study|Death|1|||
125206054|NCT04778059|450377224|FG004|Overall Study|Death|1|||
125206055|NCT04778059|450377220|FG000|Overall Study|Lost to Follow-up|0|||
125206056|NCT04778059|450377221|FG001|Overall Study|Lost to Follow-up|0|||
125206057|NCT04778059|450377222|FG002|Overall Study|Lost to Follow-up|0|||
125206058|NCT04778059|450377223|FG003|Overall Study|Lost to Follow-up|0|||
125206059|NCT04778059|450377224|FG004|Overall Study|Lost to Follow-up|1|||
125206060|NCT04778059|450377220|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
125206061|NCT04778059|450377221|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
125206062|NCT04778059|450377222|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
125206063|NCT04778059|450377223|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
125206064|NCT04778059|450377224|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
125206065|NCT00157248|450377229|FG000|Overall Study|Adverse Event|36|||
125206066|NCT00157248|450377230|FG001|Overall Study|Adverse Event|25|||
125206067|NCT00157248|450377231|FG002|Overall Study|Adverse Event|13|||
125206068|NCT00157248|450377232|FG003|Overall Study|Adverse Event|33|||
125206069|NCT00157248|450377229|FG000|Overall Study|Protocol Violation|4|||
125206070|NCT00157248|450377230|FG001|Overall Study|Protocol Violation|0|||
125206071|NCT00157248|450377231|FG002|Overall Study|Protocol Violation|2|||
125206072|NCT00157248|450377232|FG003|Overall Study|Protocol Violation|2|||
125206073|NCT00157248|450377229|FG000|Overall Study|Lost to Follow-up|0|||
125206074|NCT00157248|450377230|FG001|Overall Study|Lost to Follow-up|1|||
125206075|NCT00157248|450377231|FG002|Overall Study|Lost to Follow-up|0|||
125206076|NCT00157248|450377232|FG003|Overall Study|Lost to Follow-up|0|||
125206077|NCT00157248|450377229|FG000|Overall Study|Withdrawal by Subject|1|||
125206078|NCT00157248|450377230|FG001|Overall Study|Withdrawal by Subject|4|||
125206079|NCT00157248|450377231|FG002|Overall Study|Withdrawal by Subject|3|||
125206080|NCT00157248|450377232|FG003|Overall Study|Withdrawal by Subject|3|||
125206081|NCT00157248|450377229|FG000|Overall Study|site closures, subject moving|7|||
125206082|NCT00157248|450377230|FG001|Overall Study|site closures, subject moving|7|||
125206083|NCT00157248|450377231|FG002|Overall Study|site closures, subject moving|3|||
125206084|NCT00157248|450377232|FG003|Overall Study|site closures, subject moving|9|||
125206085|NCT01306045|450377237|FG000|Met General Eligibility Criteria|Screen failures|193|||
125206086|NCT01306045|450377238|FG001|Met General Eligibility Criteria|Screen failures|11|||
125206087|NCT01306045|450377239|FG002|Met General Eligibility Criteria|Screen failures|8|||
125206088|NCT02987972|450377240|FG000|Overall Study|Adverse Event|1|||
125206089|NCT02987972|450377241|FG001|Overall Study|Adverse Event|1|||
125206090|NCT02987972|450377242|FG002|Overall Study|Adverse Event|0|||
125206091|NCT02987972|450377240|FG000|Overall Study|Death|1|||
124981403|NCT01204710|449557471|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
124981404|NCT01204710|449557472|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
125206092|NCT02987972|450377241|FG001|Overall Study|Death|0|||
125089792|NCT01117428|449947024|FG001|Overall Study|Physician Decision|1|||
125206093|NCT02987972|450377242|FG002|Overall Study|Death|0|||
125206094|NCT02987972|450377240|FG000|Overall Study|Lack of Efficacy|9|||
125206095|NCT02987972|450377241|FG001|Overall Study|Lack of Efficacy|12|||
125206096|NCT02987972|450377242|FG002|Overall Study|Lack of Efficacy|12|||
125206097|NCT02987972|450377240|FG000|Overall Study|Lost to Follow-up|7|||
125206098|NCT02987972|450377241|FG001|Overall Study|Lost to Follow-up|8|||
125206099|NCT02987972|450377242|FG002|Overall Study|Lost to Follow-up|4|||
125206100|NCT02987972|450377240|FG000|Overall Study|Physician Decision|1|||
125206101|NCT02987972|450377241|FG001|Overall Study|Physician Decision|6|||
125206102|NCT02987972|450377242|FG002|Overall Study|Physician Decision|0|||
125206103|NCT02987972|450377240|FG000|Overall Study|Protocol Violation|2|||
125206104|NCT02987972|450377241|FG001|Overall Study|Protocol Violation|1|||
125206105|NCT02987972|450377242|FG002|Overall Study|Protocol Violation|5|||
125206106|NCT02987972|450377240|FG000|Overall Study|Withdrawal by Subject|22|||
125206107|NCT02987972|450377241|FG001|Overall Study|Withdrawal by Subject|17|||
125206108|NCT02987972|450377242|FG002|Overall Study|Withdrawal by Subject|21|||
125206109|NCT05128773|450378343|FG000|Overall Study|Sponsor decision to terminate study|3|||
125206110|NCT04250714|450378345|FG000|Overall Study|Treatment - withdrawal by subject|14|||
125206111|NCT04250714|450378345|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
125206112|NCT04250714|450378345|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
125206113|NCT04250714|450378345|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
125206114|NCT04250714|450378345|FG000|Overall Study|Treatment - Death|1|||
125206115|NCT04250714|450378345|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
125206116|NCT04250714|450378345|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
125206117|NCT04250714|450378345|FG000|Overall Study|Attempt|2|||
125206118|NCT04250714|450378345|FG000|Overall Study|Intent|7|||
125206119|NCT04676412|450378346|FG000|Overall Study|Death|28|||
125206120|NCT04676412|450378347|FG001|Overall Study|Death|31|||
125206121|NCT04676412|450378346|FG000|Overall Study|Lost to Follow-up|1|||
125206122|NCT04676412|450378347|FG001|Overall Study|Lost to Follow-up|2|||
125206123|NCT04676412|450378346|FG000|Overall Study|Sponsor Decision|20|||
125206124|NCT04676412|450378347|FG001|Overall Study|Sponsor Decision|23|||
125206125|NCT04676412|450378346|FG000|Overall Study|Withdrawal by Subject|0|||
125206126|NCT04676412|450378347|FG001|Overall Study|Withdrawal by Subject|2|||
125206127|NCT04697056|450378348|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
125206128|NCT04697056|450378349|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
125206129|NCT04439357|450378351|FG000|Overall Study|Disease Progression|4|||
125206130|NCT05906836|450378357|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
125206131|NCT05906836|450378357|FG000|Overall Study|Lost to Follow-up|1|||
125206132|NCT02542293|450378358|FG000|Overall Study|Death|367|||
125206133|NCT02542293|450378359|FG001|Overall Study|Death|377|||
125206134|NCT02542293|450378358|FG000|Overall Study|Withdrawal by Subject|8|||
125206135|NCT02542293|450378359|FG001|Overall Study|Withdrawal by Subject|19|||
125206136|NCT04529850|450378360|FG000|Overall Study|Death|2|||
125206137|NCT04529850|450378360|FG000|Overall Study|Physician Decision|1|||
125206138|NCT04529850|450378360|FG000|Overall Study|Withdrawal by Subject|2|||
125206139|NCT01458951|450378363|FG000|Overall Study|Other|1|||
125206140|NCT01458951|450378364|FG001|Overall Study|Other|0|||
125206141|NCT01458951|450378365|FG002|Overall Study|Other|0|||
125206142|NCT01458951|450378363|FG000|Overall Study|Protocol Violation|5|||
125206143|NCT01458951|450378364|FG001|Overall Study|Protocol Violation|1|||
125206144|NCT01458951|450378365|FG002|Overall Study|Protocol Violation|0|||
125206145|NCT01458951|450378363|FG000|Overall Study|Withdrawal by Subject|2|||
125206146|NCT01458951|450378364|FG001|Overall Study|Withdrawal by Subject|0|||
125206147|NCT01458951|450378365|FG002|Overall Study|Withdrawal by Subject|2|||
125206148|NCT01458951|450378363|FG000|Overall Study|Adverse Event|7|||
125206149|NCT01458951|450378364|FG001|Overall Study|Adverse Event|0|||
125206150|NCT01458951|450378365|FG002|Overall Study|Adverse Event|2|||
125206151|NCT01458951|450378363|FG000|Overall Study|Insufficient Clinical Response|17|||
125206152|NCT01458951|450378364|FG001|Overall Study|Insufficient Clinical Response|0|||
125206153|NCT01458951|450378365|FG002|Overall Study|Insufficient Clinical Response|11|||
125206154|NCT02963558|450378368|FG000|Overall Study|Withdrawn by investigator|1|||
125206155|NCT02963558|450378369|FG001|Overall Study|Withdrawn by investigator|0|||
125206156|NCT02963558|450378368|FG000|Overall Study|Withdrawal by Subject|0|||
125206157|NCT02963558|450378369|FG001|Overall Study|Withdrawal by Subject|1|||
125206158|NCT03309696|450378370|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
125206159|NCT03309696|450378371|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
124981405|NCT01204710|449557471|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
124981406|NCT01204710|449557472|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
124981407|NCT01204710|449557471|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
124981408|NCT01204710|449557472|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
125206160|NCT03309696|450378372|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
125206161|NCT03309696|450378373|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
125206162|NCT01573767|450378374|FG000|Overall Study|Adverse Event|0|||
125206163|NCT01573767|450378375|FG001|Overall Study|Adverse Event|1|||
125206164|NCT01573767|450378376|FG002|Overall Study|Adverse Event|0|||
125206165|NCT01573767|450378377|FG003|Overall Study|Adverse Event|1|||
125206166|NCT01573767|450378374|FG000|Overall Study|Lack of Efficacy|18|||
125206167|NCT01573767|450378375|FG001|Overall Study|Lack of Efficacy|15|||
125206168|NCT01573767|450378376|FG002|Overall Study|Lack of Efficacy|12|||
125206169|NCT01573767|450378377|FG003|Overall Study|Lack of Efficacy|17|||
125206170|NCT01573767|450378374|FG000|Overall Study|Protocol Violation|3|||
125206171|NCT01573767|450378375|FG001|Overall Study|Protocol Violation|1|||
125206172|NCT01573767|450378376|FG002|Overall Study|Protocol Violation|1|||
125206173|NCT01573767|450378377|FG003|Overall Study|Protocol Violation|3|||
125206174|NCT01573767|450378374|FG000|Overall Study|Lost to Follow-up|0|||
125206175|NCT01573767|450378375|FG001|Overall Study|Lost to Follow-up|1|||
125206176|NCT01573767|450378376|FG002|Overall Study|Lost to Follow-up|1|||
125206177|NCT01573767|450378377|FG003|Overall Study|Lost to Follow-up|1|||
125206178|NCT01573767|450378374|FG000|Overall Study|Physician Decision|1|||
125206179|NCT01573767|450378375|FG001|Overall Study|Physician Decision|2|||
125206180|NCT01573767|450378376|FG002|Overall Study|Physician Decision|0|||
125206181|NCT01573767|450378377|FG003|Overall Study|Physician Decision|2|||
125206182|NCT01573767|450378374|FG000|Overall Study|Withdrawal by Subject|0|||
125206183|NCT01573767|450378375|FG001|Overall Study|Withdrawal by Subject|1|||
125206184|NCT01573767|450378376|FG002|Overall Study|Withdrawal by Subject|0|||
125206185|NCT01573767|450378377|FG003|Overall Study|Withdrawal by Subject|0|||
125206186|NCT02368210|450378378|FG000|Overall Study|Withdrawal by Subject|1|||
125206187|NCT02368210|450378379|FG001|Overall Study|Withdrawal by Subject|0|||
125206188|NCT02368210|450378378|FG000|Overall Study|Adverse Event|0|||
125206189|NCT02368210|450378379|FG001|Overall Study|Adverse Event|1|||
125206190|NCT00078949|450378380|FG000|Overall Study|No treated|4|||
125206191|NCT00078949|450378381|FG001|Overall Study|No treated|5|||
125206192|NCT00078949|450378382|FG002|Overall Study|No treated|3|||
125206193|NCT00078949|450378383|FG003|Overall Study|No treated|3|||
125206194|NCT01143064|450378384|FG000|Overall Study|Death|109|||
125206195|NCT01143064|450378385|FG001|Overall Study|Death|91|||
125206196|NCT01143064|450378384|FG000|Overall Study|Adverse Event|0|||
125206197|NCT01143064|450378385|FG001|Overall Study|Adverse Event|1|||
125206198|NCT01143064|450378384|FG000|Overall Study|Withdrawal by Subject|7|||
125206199|NCT01143064|450378385|FG001|Overall Study|Withdrawal by Subject|5|||
125206200|NCT01143064|450378384|FG000|Overall Study|Lost to Follow-up|17|||
125206201|NCT01143064|450378385|FG001|Overall Study|Lost to Follow-up|14|||
125206202|NCT01143064|450378384|FG000|Overall Study|Physician Decision|0|||
125206203|NCT01143064|450378385|FG001|Overall Study|Physician Decision|4|||
125206204|NCT01199822|450378391|FG000|Overall Study|Investigator discontinued therapy|0|||
125206205|NCT01199822|450378392|FG001|Overall Study|Investigator discontinued therapy|1|||
125206206|NCT01199822|450378393|FG002|Overall Study|Investigator discontinued therapy|0|||
125206207|NCT03747302|450378394|FG000|Overall Study|Withdrawal by Subject|1|||
125206208|NCT03747302|450378395|FG001|Overall Study|Withdrawal by Subject|2|||
125206209|NCT03769675|450378396|FG000|Overall Study|Lost to Follow-up|1|||
125206210|NCT01432275|450378399|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
125206211|NCT01432275|450378400|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
125206212|NCT01432275|450378399|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
125206213|NCT01432275|450378400|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
125206214|NCT01432275|450378399|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
125206215|NCT01432275|450378400|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
125206216|NCT01432275|450378399|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
125206217|NCT01432275|450378400|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
125206218|NCT01432275|450378399|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
125206219|NCT01432275|450378400|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
125206220|NCT01432275|450378399|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
125206221|NCT01432275|450378400|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
125206222|NCT01432275|450378399|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
125206223|NCT01432275|450378400|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
125206224|NCT01432275|450378399|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
125206225|NCT01432275|450378400|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
125206226|NCT01432275|450378399|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
125206227|NCT01432275|450378400|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
125206228|NCT02565706|450378401|FG000|Overall Study|Withdrawal by Subject|5|||
125206229|NCT02565706|450378402|FG001|Overall Study|Withdrawal by Subject|7|||
125206230|NCT02565706|450378403|FG002|Overall Study|Withdrawal by Subject|7|||
125206231|NCT02565706|450378404|FG003|Overall Study|Withdrawal by Subject|11|||
125206232|NCT02565706|450378401|FG000|Overall Study|Lost to Follow-up|72|||
125206233|NCT02565706|450378402|FG001|Overall Study|Lost to Follow-up|75|||
125206234|NCT02565706|450378403|FG002|Overall Study|Lost to Follow-up|82|||
125206235|NCT02565706|450378404|FG003|Overall Study|Lost to Follow-up|74|||
125206236|NCT01935700|450378405|FG000|Overall Study|Withdrawal by Subject|1|||
125206237|NCT01935700|450378406|FG001|Overall Study|Withdrawal by Subject|0|||
125206238|NCT01935700|450378405|FG000|Overall Study|Physician Decision|4|||
125206239|NCT01935700|450378406|FG001|Overall Study|Physician Decision|0|||
125206240|NCT03802565|450378412|FG000|Overall Study|Adverse Event|0|||
125206241|NCT03802565|450378413|FG001|Overall Study|Adverse Event|1|||
125206242|NCT03802565|450378414|FG002|Overall Study|Adverse Event|2|||
125206243|NCT03802565|450378415|FG003|Overall Study|Adverse Event|1|||
125206244|NCT03802565|450378416|FG004|Overall Study|Adverse Event|1|||
125206245|NCT03802565|450378412|FG000|Overall Study|Withdrawal by Subject|2|||
125206246|NCT03802565|450378413|FG001|Overall Study|Withdrawal by Subject|2|||
125206247|NCT03802565|450378414|FG002|Overall Study|Withdrawal by Subject|2|||
125206248|NCT03802565|450378415|FG003|Overall Study|Withdrawal by Subject|0|||
125206249|NCT03802565|450378416|FG004|Overall Study|Withdrawal by Subject|1|||
125206250|NCT03802565|450378412|FG000|Overall Study|Protocol Violation|2|||
125206251|NCT03802565|450378413|FG001|Overall Study|Protocol Violation|1|||
125206252|NCT03802565|450378414|FG002|Overall Study|Protocol Violation|4|||
125206253|NCT03802565|450378415|FG003|Overall Study|Protocol Violation|5|||
125206254|NCT03802565|450378416|FG004|Overall Study|Protocol Violation|1|||
125206255|NCT03802565|450378412|FG000|Overall Study|Lost to Follow-up|0|||
125206256|NCT03802565|450378413|FG001|Overall Study|Lost to Follow-up|0|||
125206257|NCT03802565|450378414|FG002|Overall Study|Lost to Follow-up|1|||
125206258|NCT03802565|450378415|FG003|Overall Study|Lost to Follow-up|0|||
125206259|NCT03802565|450378416|FG004|Overall Study|Lost to Follow-up|0|||
125206260|NCT03802565|450378412|FG000|Overall Study|Subjects Related to Each Other|1|||
125206261|NCT03802565|450378413|FG001|Overall Study|Subjects Related to Each Other|0|||
125206262|NCT03802565|450378414|FG002|Overall Study|Subjects Related to Each Other|0|||
125206263|NCT03802565|450378415|FG003|Overall Study|Subjects Related to Each Other|2|||
125206264|NCT03802565|450378416|FG004|Overall Study|Subjects Related to Each Other|1|||
125206265|NCT03802565|450378412|FG000|Overall Study|Elevated Enzymes|0|||
125206266|NCT03802565|450378413|FG001|Overall Study|Elevated Enzymes|0|||
125206267|NCT03802565|450378414|FG002|Overall Study|Elevated Enzymes|0|||
125206268|NCT03802565|450378415|FG003|Overall Study|Elevated Enzymes|0|||
125206269|NCT03802565|450378416|FG004|Overall Study|Elevated Enzymes|2|||
125206270|NCT02124759|450378417|FG000|Overall Study|Withdrawal by Subject|3|||
125206271|NCT02124759|450378418|FG001|Overall Study|Withdrawal by Subject|1|||
125206272|NCT02124759|450378419|FG002|Overall Study|Withdrawal by Subject|1|||
125206273|NCT02124759|450378417|FG000|Overall Study|Screen Fail|2|||
125206274|NCT02124759|450378418|FG001|Overall Study|Screen Fail|2|||
125206275|NCT02124759|450378419|FG002|Overall Study|Screen Fail|3|||
125206276|NCT01068626|450378420|FG000|Overall Study|Adverse Event|3|||
125206277|NCT01068626|450378421|FG001|Overall Study|Adverse Event|0|||
125206278|NCT01068626|450378420|FG000|Overall Study|Withdrawal by Subject|0|||
125206279|NCT01068626|450378421|FG001|Overall Study|Withdrawal by Subject|2|||
125206280|NCT04340843|450378422|FG000|Overall Study|Adverse Event|0|||
125206281|NCT04340843|450378423|FG001|Overall Study|Adverse Event|2|||
125206282|NCT04340843|450378422|FG000|Overall Study|Withdrawal by Subject|0|||
125206283|NCT04340843|450378423|FG001|Overall Study|Withdrawal by Subject|2|||
125206284|NCT04249622|450378424|FG000|Overall Study|Withdrawal by Subject|1|||
125206285|NCT04249622|450378425|FG001|Overall Study|Withdrawal by Subject|1|||
125206286|NCT04249622|450378424|FG000|Overall Study|Alternative therapy|1|||
125206287|NCT04249622|450378425|FG001|Overall Study|Alternative therapy|0|||
125206288|NCT04249622|450378424|FG000|Overall Study|Discontinuation of pertuzumab|1|||
125206289|NCT04249622|450378425|FG001|Overall Study|Discontinuation of pertuzumab|0|||
125206290|NCT03619902|450378428|FG000|Overall Study|Termination of Study by Investigator|1|||
125206291|NCT03619902|450378428|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
125206292|NCT04506905|450378429|FG000|Overall Study|Lost to Follow-up|1|||
125206293|NCT04506905|450378430|FG001|Overall Study|Lost to Follow-up|0|||
125206294|NCT04506905|450378431|FG002|Overall Study|Lost to Follow-up|0|||
125206295|NCT04506905|450378432|FG003|Overall Study|Lost to Follow-up|1|||
125206296|NCT04506905|450378433|FG004|Overall Study|Lost to Follow-up|0|||
125206297|NCT04506905|450378434|FG005|Overall Study|Lost to Follow-up|0|||
125206298|NCT04506905|450378435|FG006|Overall Study|Lost to Follow-up|0|||
125206299|NCT04506905|450378436|FG007|Overall Study|Lost to Follow-up|0|||
125206300|NCT04506905|450378437|FG008|Overall Study|Lost to Follow-up|0|||
125206301|NCT04506905|450378429|FG000|Overall Study|Withdrawal by Subject|0|||
125206302|NCT04506905|450378430|FG001|Overall Study|Withdrawal by Subject|0|||
125206303|NCT04506905|450378431|FG002|Overall Study|Withdrawal by Subject|0|||
125206304|NCT04506905|450378432|FG003|Overall Study|Withdrawal by Subject|2|||
125206305|NCT04506905|450378433|FG004|Overall Study|Withdrawal by Subject|0|||
125206306|NCT04506905|450378434|FG005|Overall Study|Withdrawal by Subject|0|||
125206307|NCT04506905|450378435|FG006|Overall Study|Withdrawal by Subject|0|||
125206308|NCT04506905|450378436|FG007|Overall Study|Withdrawal by Subject|0|||
125206309|NCT04506905|450378437|FG008|Overall Study|Withdrawal by Subject|0|||
125206310|NCT05072106|450379719|FG000|Overall Study|Progressive disease|3|||
125206311|NCT05072106|450379720|FG001|Overall Study|Progressive disease|3|||
125206312|NCT05072106|450379719|FG000|Overall Study|Compassionate use|3|||
125206313|NCT05072106|450379720|FG001|Overall Study|Compassionate use|1|||
125206314|NCT05072106|450379719|FG000|Overall Study|Withdrawal by Subject|1|||
125206315|NCT05072106|450379720|FG001|Overall Study|Withdrawal by Subject|0|||
125206316|NCT03839459|450379721|FG000|Overall Study|Withdrawal by Subject|2|||
125206317|NCT03839459|450379721|FG000|Overall Study|progression of disease|3|||
125206318|NCT01371877|450379725|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
125206319|NCT01371877|450379726|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
125206320|NCT00869557|450379727|FG000|Randomized Phase|Lost to Follow-up|2|||
125206321|NCT00869557|450379728|FG001|Randomized Phase|Lost to Follow-up|1|||
125206322|NCT00869557|450379727|FG000|Randomized Phase|Investigator's Discretion|1|||
125206323|NCT00869557|450379728|FG001|Randomized Phase|Investigator's Discretion|0|||
125206324|NCT00869557|450379727|FG000|Randomized Phase|Withdrew Consent|0|||
125206325|NCT00869557|450379728|FG001|Randomized Phase|Withdrew Consent|1|||
125206326|NCT00869557|450379727|FG000|Extension Phase|Adverse Event|2|||
125206327|NCT00869557|450379728|FG001|Extension Phase|Adverse Event|2|||
125206328|NCT00869557|450379727|FG000|Extension Phase|Lack of Efficacy|1|||
125206329|NCT00869557|450379728|FG001|Extension Phase|Lack of Efficacy|0|||
125206330|NCT00869557|450379727|FG000|Extension Phase|Lost to Follow-up|3|||
125206331|NCT00869557|450379728|FG001|Extension Phase|Lost to Follow-up|1|||
125206332|NCT00869557|450379727|FG000|Extension Phase|Investigator's Discretion|2|||
125206333|NCT00869557|450379728|FG001|Extension Phase|Investigator's Discretion|0|||
125206334|NCT00869557|450379727|FG000|Extension Phase|Withdrew Consent|2|||
125206335|NCT00869557|450379728|FG001|Extension Phase|Withdrew Consent|0|||
125206336|NCT05940077|450379729|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
125206337|NCT02304380|450379730|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
125206338|NCT02304380|450379731|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
125206339|NCT02304380|450379732|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
125206340|NCT02304380|450379733|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
125206341|NCT02304380|450379734|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
125206342|NCT02304380|450379735|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
125206343|NCT04027075|450379736|FG000|Overall Study|Lost to Follow-up|41|||
125206344|NCT04027075|450379737|FG001|Overall Study|Lost to Follow-up|22|||
125206345|NCT02772276|450379741|FG000|Overall Study|Lost to Follow-up|0|||
125206346|NCT02772276|450379742|FG001|Overall Study|Lost to Follow-up|0|||
125206347|NCT02772276|450379743|FG002|Overall Study|Lost to Follow-up|0|||
125206348|NCT02772276|450379744|FG003|Overall Study|Lost to Follow-up|0|||
125206349|NCT02772276|450379745|FG004|Overall Study|Lost to Follow-up|0|||
125206350|NCT02772276|450379746|FG005|Overall Study|Lost to Follow-up|0|||
125206351|NCT02772276|450379747|FG006|Overall Study|Lost to Follow-up|1|||
125206352|NCT02772276|450379748|FG007|Overall Study|Lost to Follow-up|0|||
125206353|NCT02772276|450379749|FG008|Overall Study|Lost to Follow-up|0|||
125206354|NCT02772276|450379750|FG009|Overall Study|Lost to Follow-up|0|||
125206355|NCT02772276|450379751|FG010|Overall Study|Lost to Follow-up|0|||
125206356|NCT02772276|450379752|FG011|Overall Study|Lost to Follow-up|0|||
125206357|NCT02772276|450379753|FG012|Overall Study|Lost to Follow-up|0|||
125206358|NCT02772276|450379741|FG000|Overall Study|Withdrew consent|0|||
125206359|NCT02772276|450379742|FG001|Overall Study|Withdrew consent|0|||
125206360|NCT02772276|450379743|FG002|Overall Study|Withdrew consent|0|||
125206361|NCT02772276|450379744|FG003|Overall Study|Withdrew consent|0|||
125206362|NCT02772276|450379745|FG004|Overall Study|Withdrew consent|0|||
125206363|NCT02772276|450379746|FG005|Overall Study|Withdrew consent|0|||
125206364|NCT02772276|450379747|FG006|Overall Study|Withdrew consent|0|||
125206365|NCT02772276|450379748|FG007|Overall Study|Withdrew consent|1|||
125206366|NCT02772276|450379749|FG008|Overall Study|Withdrew consent|0|||
125206367|NCT02772276|450379750|FG009|Overall Study|Withdrew consent|0|||
125206368|NCT02772276|450379751|FG010|Overall Study|Withdrew consent|0|||
125206369|NCT02772276|450379752|FG011|Overall Study|Withdrew consent|0|||
125206370|NCT02772276|450379753|FG012|Overall Study|Withdrew consent|0|||
125206371|NCT00455520|450379754|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
125206372|NCT00455520|450379755|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
125206373|NCT00455520|450379754|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
125206374|NCT00455520|450379755|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
125206375|NCT00455520|450379754|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
125206376|NCT00455520|450379755|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
125206377|NCT00455520|450379754|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
125206378|NCT00455520|450379755|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
125206379|NCT00455520|450379754|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
125206380|NCT00455520|450379755|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
125206381|NCT00455520|450379754|FG000|Open Label Tapentadol Extended Release|All other|33|||
125206382|NCT00455520|450379755|FG001|Open Label Tapentadol Extended Release|All other|0|||
125206383|NCT00455520|450379754|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
125206384|NCT00455520|450379755|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
125206385|NCT00455520|450379754|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
125206386|NCT00455520|450379755|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
125206387|NCT00455520|450379754|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
125206388|NCT00455520|450379755|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
125206389|NCT00455520|450379754|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
125206390|NCT00455520|450379755|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
125206391|NCT00455520|450379754|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
125206392|NCT00455520|450379755|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
125206393|NCT00455520|450379754|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
125206394|NCT00455520|450379755|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
125206395|NCT02248974|450379757|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
125206396|NCT02248974|450379758|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
125206397|NCT02248974|450379757|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
125206398|NCT02248974|450379758|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
125206399|NCT02248974|450379757|FG000|1-Day Follow-Up|Enrolled in another study|1|||
125206400|NCT02248974|450379758|FG001|1-Day Follow-Up|Enrolled in another study|0|||
125206401|NCT02248974|450379757|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
125206402|NCT02248974|450379758|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
125206403|NCT02248974|450379757|FG000|1-Week Follow-Up|Enrolled in another study|1|||
125206404|NCT02248974|450379758|FG001|1-Week Follow-Up|Enrolled in another study|1|||
125206405|NCT02248974|450379757|FG000|1-Week Follow-Up|Transferred to another facility|1|||
125206406|NCT02248974|450379758|FG001|1-Week Follow-Up|Transferred to another facility|0|||
125206407|NCT02248974|450379757|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
125206408|NCT02248974|450379758|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
125206409|NCT02248974|450379757|FG000|1-Week Follow-Up|Death|1|||
125206410|NCT02248974|450379758|FG001|1-Week Follow-Up|Death|1|||
125206411|NCT02248974|450379757|FG000|1-Week Follow-Up|Excluded because of age|0|||
125206412|NCT02248974|450379758|FG001|1-Week Follow-Up|Excluded because of age|1|||
125206413|NCT02248974|450379757|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
125206414|NCT02248974|450379758|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
125206415|NCT02248974|450379757|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
125206416|NCT02248974|450379758|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
125206417|NCT02248974|450379757|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
125206418|NCT02248974|450379758|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
125206419|NCT02248974|450379757|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
125206420|NCT02248974|450379758|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
125206421|NCT02248974|450379757|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
125206422|NCT02248974|450379758|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
125206423|NCT03448939|450379759|FG000|Overall Study|Adverse Event|5|||
125206424|NCT03448939|450379760|FG001|Overall Study|Adverse Event|1|||
125206425|NCT03448939|450379759|FG000|Overall Study|Lost to Follow-up|6|||
125206426|NCT03448939|450379760|FG001|Overall Study|Lost to Follow-up|6|||
125206427|NCT03448939|450379759|FG000|Overall Study|Pregnancy|1|||
125206428|NCT03448939|450379760|FG001|Overall Study|Pregnancy|1|||
125206429|NCT03448939|450379759|FG000|Overall Study|Withdrawal by Subject|9|||
125206430|NCT03448939|450379760|FG001|Overall Study|Withdrawal by Subject|3|||
125206431|NCT01472965|450379761|FG000|Overall Study|Withdrawal by Subject|1|||
125206432|NCT01472965|450379762|FG001|Overall Study|Withdrawal by Subject|0|||
125206433|NCT00628095|450379763|FG000|Overall Study|Adverse Event|5|||
125206434|NCT00628095|450379764|FG001|Overall Study|Adverse Event|3|||
125206435|NCT00628095|450379763|FG000|Overall Study|Lack of Efficacy|0|||
125206436|NCT00628095|450379764|FG001|Overall Study|Lack of Efficacy|3|||
125206437|NCT00628095|450379763|FG000|Overall Study|Withdrawal by Subject|2|||
125206438|NCT00628095|450379764|FG001|Overall Study|Withdrawal by Subject|0|||
125206439|NCT00628095|450379763|FG000|Overall Study|Other|0|||
125206440|NCT00628095|450379764|FG001|Overall Study|Other|1|||
125206441|NCT03235115|450379768|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
125206442|NCT03235115|450379769|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
125206443|NCT03235115|450379770|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
125206444|NCT03235115|450379771|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
125206445|NCT03235115|450379772|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
125206446|NCT03235115|450379773|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
125206447|NCT00006305|450379776|FG000|Overall Study|Withdrawal by Subject|17|||
125206448|NCT00006305|450379777|FG001|Overall Study|Withdrawal by Subject|10|||
125206449|NCT00006305|450379778|FG002|Overall Study|Withdrawal by Subject|15|||
125206450|NCT00006305|450379779|FG003|Overall Study|Withdrawal by Subject|14|||
125206451|NCT00662558|450379780|FG000|Overall Study|Adverse Event|21|||
125206452|NCT00662558|450379781|FG001|Overall Study|Adverse Event|59|||
125206453|NCT00662558|450379780|FG000|Overall Study|Lack of Efficacy|4|||
125206454|NCT00662558|450379781|FG001|Overall Study|Lack of Efficacy|7|||
125206455|NCT00662558|450379780|FG000|Overall Study|Lost to Follow-up|13|||
125206456|NCT00662558|450379781|FG001|Overall Study|Lost to Follow-up|10|||
125206457|NCT00662558|450379780|FG000|Overall Study|Other|9|||
125206458|NCT00662558|450379781|FG001|Overall Study|Other|14|||
125206459|NCT00662558|450379780|FG000|Overall Study|Withdrawal by Subject|7|||
125206460|NCT00662558|450379781|FG001|Overall Study|Withdrawal by Subject|12|||
125206461|NCT00662558|450379780|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
125206462|NCT00662558|450379781|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
125206463|NCT00329641|450379782|FG000|Overall Study|Did not start treatment|1|||
125206464|NCT00329641|450379782|FG000|Overall Study|Not eligible|1|||
125206465|NCT00329641|450379782|FG000|Overall Study|Adverse Event|3|||
125206466|NCT00329641|450379782|FG000|Overall Study|Other reason, not protocol specified|1|||
125206467|NCT00783224|450379783|FG000|Overall Study|Adverse Event|0|||
125206468|NCT00783224|450379784|FG001|Overall Study|Adverse Event|0|||
125206469|NCT00783224|450379785|FG002|Overall Study|Adverse Event|1|||
125206470|NCT00783224|450379786|FG003|Overall Study|Adverse Event|0|||
125206471|NCT00783224|450379783|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
125206472|NCT00783224|450379784|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
125206473|NCT00783224|450379785|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
125206474|NCT00783224|450379786|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
125206475|NCT00783224|450379783|FG000|Overall Study|Inappropriate as a study subject|0|||
125206476|NCT00783224|450379784|FG001|Overall Study|Inappropriate as a study subject|0|||
125206477|NCT00783224|450379785|FG002|Overall Study|Inappropriate as a study subject|0|||
125206478|NCT00783224|450379786|FG003|Overall Study|Inappropriate as a study subject|1|||
125206479|NCT01711619|450379787|FG000|Overall Study|Early study termination|10|||
125206480|NCT01711619|450379788|FG001|Overall Study|Early study termination|14|||
125206481|NCT01711619|450379787|FG000|Overall Study|Withdrawal by Subject|3|||
125206482|NCT01711619|450379788|FG001|Overall Study|Withdrawal by Subject|7|||
125206483|NCT01711619|450379787|FG000|Overall Study|Protocol Violation|2|||
125206484|NCT01711619|450379788|FG001|Overall Study|Protocol Violation|3|||
125206485|NCT01711619|450379787|FG000|Overall Study|Adverse Event|2|||
125206486|NCT01711619|450379788|FG001|Overall Study|Adverse Event|0|||
125206487|NCT01711619|450379787|FG000|Overall Study|Lost to Follow-up|1|||
125206488|NCT01711619|450379788|FG001|Overall Study|Lost to Follow-up|0|||
125206489|NCT00401960|450379795|FG000|Overall Study|Lost to Follow-up|3|||
125206490|NCT00401960|450379796|FG001|Overall Study|Lost to Follow-up|0|||
125206491|NCT00401960|450379795|FG000|Overall Study|Death|2|||
125206492|NCT00401960|450379796|FG001|Overall Study|Death|0|||
125206493|NCT02649426|450379797|FG000|Overall Study|Follow-up on going|1|||
125206494|NCT02649426|450379798|FG001|Overall Study|Follow-up on going|26|||
125206495|NCT02649426|450379799|FG002|Overall Study|Follow-up on going|28|||
125206496|NCT02649426|450379800|FG003|Overall Study|Follow-up on going|31|||
125206497|NCT02584959|450379801|FG000|Period 1|Withdrawn from study|3|||
125206498|NCT02584959|450379802|FG001|Period 1|Withdrawn from study|4|||
125206499|NCT02584959|450379803|FG002|Period 1|Withdrawn from study|0|||
125206500|NCT02584959|450379801|FG000|Period 2|Withdrawn from study|6|||
125206501|NCT02584959|450379802|FG001|Period 2|Withdrawn from study|1|||
125206502|NCT02584959|450379803|FG002|Period 2|Withdrawn from study|2|||
125206503|NCT03008278|450379806|FG000|Overall Study|Progressive Disease|0|||
125206504|NCT03008278|450379807|FG001|Overall Study|Progressive Disease|0|||
125206505|NCT03008278|450379808|FG002|Overall Study|Progressive Disease|32|||
125206506|NCT03008278|450379806|FG000|Overall Study|Adverse Event|0|||
125206507|NCT03008278|450379807|FG001|Overall Study|Adverse Event|0|||
125206508|NCT03008278|450379808|FG002|Overall Study|Adverse Event|4|||
125206509|NCT03008278|450379806|FG000|Overall Study|Withdrawal by Subject|0|||
125206510|NCT03008278|450379807|FG001|Overall Study|Withdrawal by Subject|0|||
125206511|NCT03008278|450379808|FG002|Overall Study|Withdrawal by Subject|3|||
125206512|NCT03008278|450379806|FG000|Overall Study|Physician Decision|0|||
125206513|NCT03008278|450379807|FG001|Overall Study|Physician Decision|2|||
125206514|NCT03008278|450379808|FG002|Overall Study|Physician Decision|0|||
125206515|NCT00195494|450379809|FG000|Year 1|Adverse Event|0|||
125206516|NCT00195494|450379810|FG001|Year 1|Adverse Event|0|||
125206517|NCT00195494|450379811|FG002|Year 1|Adverse Event|0|||
125206518|NCT00195494|450379812|FG003|Year 1|Adverse Event|0|||
125206519|NCT00195494|450379813|FG004|Year 1|Adverse Event|34|||
125206520|NCT00195494|450379814|FG005|Year 1|Adverse Event|27|||
125206521|NCT00195494|450379809|FG000|Year 1|System Toxicity|0|||
125206522|NCT00195494|450379810|FG001|Year 1|System Toxicity|0|||
125206523|NCT00195494|450379811|FG002|Year 1|System Toxicity|0|||
125206524|NCT00195494|450379812|FG003|Year 1|System Toxicity|0|||
125206525|NCT00195494|450379813|FG004|Year 1|System Toxicity|0|||
125206526|NCT00195494|450379814|FG005|Year 1|System Toxicity|1|||
125206527|NCT00195494|450379809|FG000|Year 1|Lack of Efficacy|0|||
125206528|NCT00195494|450379810|FG001|Year 1|Lack of Efficacy|0|||
125206529|NCT00195494|450379811|FG002|Year 1|Lack of Efficacy|0|||
125206530|NCT00195494|450379812|FG003|Year 1|Lack of Efficacy|0|||
125206531|NCT00195494|450379813|FG004|Year 1|Lack of Efficacy|24|||
125206532|NCT00195494|450379814|FG005|Year 1|Lack of Efficacy|9|||
125206533|NCT00195494|450379809|FG000|Year 1|Compliance|0|||
125206534|NCT00195494|450379810|FG001|Year 1|Compliance|0|||
125206535|NCT00195494|450379811|FG002|Year 1|Compliance|0|||
125206536|NCT00195494|450379812|FG003|Year 1|Compliance|0|||
125206537|NCT00195494|450379813|FG004|Year 1|Compliance|5|||
125206538|NCT00195494|450379814|FG005|Year 1|Compliance|1|||
125206539|NCT00195494|450379809|FG000|Year 1|Lost to Follow-up|0|||
125206540|NCT00195494|450379810|FG001|Year 1|Lost to Follow-up|0|||
125206541|NCT00195494|450379811|FG002|Year 1|Lost to Follow-up|0|||
125206542|NCT00195494|450379812|FG003|Year 1|Lost to Follow-up|0|||
125206543|NCT00195494|450379813|FG004|Year 1|Lost to Follow-up|1|||
125206544|NCT00195494|450379814|FG005|Year 1|Lost to Follow-up|0|||
125206545|NCT00195494|450379809|FG000|Year 1|Missed >4 consecutive doses|0|||
125206546|NCT00195494|450379810|FG001|Year 1|Missed >4 consecutive doses|0|||
125206547|NCT00195494|450379811|FG002|Year 1|Missed >4 consecutive doses|0|||
125206548|NCT00195494|450379812|FG003|Year 1|Missed >4 consecutive doses|0|||
125206549|NCT00195494|450379813|FG004|Year 1|Missed >4 consecutive doses|3|||
125206550|NCT00195494|450379814|FG005|Year 1|Missed >4 consecutive doses|2|||
125206551|NCT00195494|450379809|FG000|Year 1|Protocol deviation|0|||
125206552|NCT00195494|450379810|FG001|Year 1|Protocol deviation|0|||
125206553|NCT00195494|450379811|FG002|Year 1|Protocol deviation|0|||
125206554|NCT00195494|450379812|FG003|Year 1|Protocol deviation|0|||
125206555|NCT00195494|450379813|FG004|Year 1|Protocol deviation|2|||
125206556|NCT00195494|450379814|FG005|Year 1|Protocol deviation|3|||
125206557|NCT00195494|450379809|FG000|Year 1|Physician Decision|0|||
125206558|NCT00195494|450379810|FG001|Year 1|Physician Decision|0|||
125206559|NCT00195494|450379811|FG002|Year 1|Physician Decision|0|||
125206560|NCT00195494|450379812|FG003|Year 1|Physician Decision|0|||
125206561|NCT00195494|450379813|FG004|Year 1|Physician Decision|1|||
125206562|NCT00195494|450379814|FG005|Year 1|Physician Decision|0|||
125206563|NCT00195494|450379809|FG000|Year 1|Withdrawal by Subject|0|||
125206564|NCT00195494|450379810|FG001|Year 1|Withdrawal by Subject|0|||
125206565|NCT00195494|450379811|FG002|Year 1|Withdrawal by Subject|0|||
125206566|NCT00195494|450379812|FG003|Year 1|Withdrawal by Subject|0|||
125206567|NCT00195494|450379813|FG004|Year 1|Withdrawal by Subject|8|||
125206568|NCT00195494|450379814|FG005|Year 1|Withdrawal by Subject|9|||
125206569|NCT00195494|450379809|FG000|Year 1|Protocol Violation|0|||
125206570|NCT00195494|450379810|FG001|Year 1|Protocol Violation|0|||
125206571|NCT00195494|450379811|FG002|Year 1|Protocol Violation|0|||
125206572|NCT00195494|450379812|FG003|Year 1|Protocol Violation|0|||
125206573|NCT00195494|450379813|FG004|Year 1|Protocol Violation|1|||
125206574|NCT00195494|450379814|FG005|Year 1|Protocol Violation|1|||
125206575|NCT00195494|450379809|FG000|Year 2|Adverse Event|3|||
125206576|NCT00195494|450379810|FG001|Year 2|Adverse Event|7|||
125206577|NCT00195494|450379811|FG002|Year 2|Adverse Event|5|||
125206578|NCT00195494|450379812|FG003|Year 2|Adverse Event|9|||
125206579|NCT00195494|450379813|FG004|Year 2|Adverse Event|0|||
125206580|NCT00195494|450379814|FG005|Year 2|Adverse Event|0|||
125206581|NCT00195494|450379809|FG000|Year 2|Lack of Efficacy|0|||
125206582|NCT00195494|450379810|FG001|Year 2|Lack of Efficacy|1|||
125206583|NCT00195494|450379811|FG002|Year 2|Lack of Efficacy|7|||
125206584|NCT00195494|450379812|FG003|Year 2|Lack of Efficacy|7|||
125206585|NCT00195494|450379813|FG004|Year 2|Lack of Efficacy|0|||
125206586|NCT00195494|450379814|FG005|Year 2|Lack of Efficacy|0|||
125206587|NCT00195494|450379809|FG000|Year 2|Compliance|1|||
125206588|NCT00195494|450379810|FG001|Year 2|Compliance|0|||
125206589|NCT00195494|450379811|FG002|Year 2|Compliance|0|||
125206590|NCT00195494|450379812|FG003|Year 2|Compliance|2|||
125206591|NCT00195494|450379813|FG004|Year 2|Compliance|0|||
125206592|NCT00195494|450379814|FG005|Year 2|Compliance|0|||
125206593|NCT00195494|450379809|FG000|Year 2|Lost to Follow-up|0|||
125206594|NCT00195494|450379810|FG001|Year 2|Lost to Follow-up|0|||
125206595|NCT00195494|450379811|FG002|Year 2|Lost to Follow-up|1|||
125206596|NCT00195494|450379812|FG003|Year 2|Lost to Follow-up|1|||
125206597|NCT00195494|450379813|FG004|Year 2|Lost to Follow-up|0|||
125206598|NCT00195494|450379814|FG005|Year 2|Lost to Follow-up|0|||
125206599|NCT00195494|450379809|FG000|Year 2|Missed >4 consecutive doses|1|||
125206600|NCT00195494|450379810|FG001|Year 2|Missed >4 consecutive doses|1|||
125206601|NCT00195494|450379811|FG002|Year 2|Missed >4 consecutive doses|1|||
125206602|NCT00195494|450379812|FG003|Year 2|Missed >4 consecutive doses|0|||
125206603|NCT00195494|450379813|FG004|Year 2|Missed >4 consecutive doses|0|||
125206604|NCT00195494|450379814|FG005|Year 2|Missed >4 consecutive doses|0|||
125206605|NCT00195494|450379809|FG000|Year 2|Protocol deviation|0|||
125206606|NCT00195494|450379810|FG001|Year 2|Protocol deviation|1|||
125206607|NCT00195494|450379811|FG002|Year 2|Protocol deviation|0|||
125206608|NCT00195494|450379812|FG003|Year 2|Protocol deviation|0|||
125206609|NCT00195494|450379813|FG004|Year 2|Protocol deviation|0|||
125206610|NCT00195494|450379814|FG005|Year 2|Protocol deviation|0|||
125206611|NCT00195494|450379809|FG000|Year 2|Physician Decision|1|||
125206612|NCT00195494|450379810|FG001|Year 2|Physician Decision|1|||
125206613|NCT00195494|450379811|FG002|Year 2|Physician Decision|0|||
125206614|NCT00195494|450379812|FG003|Year 2|Physician Decision|0|||
125206615|NCT00195494|450379813|FG004|Year 2|Physician Decision|0|||
125206616|NCT00195494|450379814|FG005|Year 2|Physician Decision|0|||
125206617|NCT00195494|450379809|FG000|Year 2|Withdrawal by Subject|1|||
124981409|NCT00586612|449557473|FG000|Primary Phase|Protocol Violation|1|||
124981410|NCT00586612|449557474|FG001|Primary Phase|Protocol Violation|0|||
124981411|NCT00586612|449557473|FG000|Primary Phase|Lost to Follow-up|0|||
125206618|NCT00195494|450379810|FG001|Year 2|Withdrawal by Subject|5|||
125206619|NCT00195494|450379811|FG002|Year 2|Withdrawal by Subject|4|||
125206620|NCT00195494|450379812|FG003|Year 2|Withdrawal by Subject|3|||
125206621|NCT00195494|450379813|FG004|Year 2|Withdrawal by Subject|0|||
125206622|NCT00195494|450379814|FG005|Year 2|Withdrawal by Subject|0|||
125206623|NCT00195494|450379809|FG000|Year 2|System toxicity|0|||
125206624|NCT00195494|450379810|FG001|Year 2|System toxicity|0|||
125206625|NCT00195494|450379811|FG002|Year 2|System toxicity|0|||
125206626|NCT00195494|450379812|FG003|Year 2|System toxicity|1|||
125206627|NCT00195494|450379813|FG004|Year 2|System toxicity|0|||
125206628|NCT00195494|450379814|FG005|Year 2|System toxicity|0|||
125206629|NCT00513357|450379815|FG000|Overall Study|did not receive allocated placebo|2|||
125206630|NCT00513357|450379816|FG001|Overall Study|did not receive allocated placebo|3|||
125206631|NCT00513357|450379815|FG000|Overall Study|Adverse Event|4|||
125206632|NCT00513357|450379816|FG001|Overall Study|Adverse Event|2|||
125206633|NCT00513357|450379815|FG000|Overall Study|Death|2|||
125206634|NCT00513357|450379816|FG001|Overall Study|Death|0|||
125206635|NCT00513357|450379815|FG000|Overall Study|Withdrawal by Subject|5|||
125206636|NCT00513357|450379816|FG001|Overall Study|Withdrawal by Subject|4|||
125206637|NCT00513357|450379815|FG000|Overall Study|Disease Progression|2|||
125206638|NCT00513357|450379816|FG001|Overall Study|Disease Progression|1|||
125206639|NCT01217385|450379821|FG000|Overall Study|Withdrawal by Subject|3|||
125206640|NCT01217385|450379821|FG000|Overall Study|DOSI not performed/not eval|12|||
125206641|NCT01217385|450379821|FG000|Overall Study|Central Path not Available|1|||
125206642|NCT01217385|450379821|FG000|Overall Study|Normal Breast TOI not available|10|||
125206643|NCT00090987|450379822|FG000|Overall Study|Adverse Event|5|||
125206644|NCT00090987|450379822|FG000|Overall Study|Lack of Efficacy|7|||
125206645|NCT00090987|450379822|FG000|Overall Study|Withdrawal by Subject|3|||
125206646|NCT00090987|450379822|FG000|Overall Study|alternative therapy|1|||
125206647|NCT00090987|450379822|FG000|Overall Study|Non-compliance|4|||
125206648|NCT00090987|450379822|FG000|Overall Study|Incarcerated|1|||
125206649|NCT00835679|450379824|FG000|Overall Study|Withdrawal by Subject|1|||
125206650|NCT00835679|450379825|FG001|Overall Study|Withdrawal by Subject|0|||
125206651|NCT00835679|450379826|FG002|Overall Study|Withdrawal by Subject|0|||
125206652|NCT00835679|450379827|FG003|Overall Study|Withdrawal by Subject|0|||
125206653|NCT04769739|450379829|FG000|Overall Study|Colorectal cancer obstruction|2|||
125206654|NCT04769739|450379830|FG001|Overall Study|Colorectal cancer obstruction|0|||
125206655|NCT04769739|450379831|FG002|Overall Study|Colorectal cancer obstruction|0|||
125206656|NCT04769739|450379832|FG003|Overall Study|Colorectal cancer obstruction|0|||
125206657|NCT04769739|450379829|FG000|Overall Study|Failed cecal intubation|1|||
125206658|NCT04769739|450379830|FG001|Overall Study|Failed cecal intubation|0|||
125206659|NCT04769739|450379831|FG002|Overall Study|Failed cecal intubation|0|||
125206660|NCT04769739|450379832|FG003|Overall Study|Failed cecal intubation|1|||
125206661|NCT04769739|450379829|FG000|Overall Study|Poor bowel preparation|0|||
125206662|NCT04769739|450379830|FG001|Overall Study|Poor bowel preparation|0|||
125206663|NCT04769739|450379831|FG002|Overall Study|Poor bowel preparation|0|||
125206664|NCT04769739|450379832|FG003|Overall Study|Poor bowel preparation|1|||
125206665|NCT03689543|450379834|FG000|Overall Study|Adverse Event|0|||
125206666|NCT03689543|450379835|FG001|Overall Study|Adverse Event|0|||
125206667|NCT03689543|450379836|FG002|Overall Study|Adverse Event|1|||
125206668|NCT01634659|450379854|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
125206669|NCT01634659|450379855|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
125206670|NCT01634659|450379854|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
125206671|NCT01634659|450379855|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
125206672|NCT02431806|450379856|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
125206673|NCT02431806|450379857|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
125206674|NCT02431806|450379858|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
125206675|NCT02431806|450379859|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
125206676|NCT02431806|450379856|FG000|Double-blind Treatment Period|Adverse Event|4|||
125206677|NCT02431806|450379857|FG001|Double-blind Treatment Period|Adverse Event|7|||
125206678|NCT02431806|450379858|FG002|Double-blind Treatment Period|Adverse Event|11|||
125206679|NCT02431806|450379859|FG003|Double-blind Treatment Period|Adverse Event|7|||
125206680|NCT02431806|450379856|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
125206681|NCT02431806|450379857|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
125206682|NCT02431806|450379858|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
125206683|NCT02431806|450379859|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
125206684|NCT02431806|450379856|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
125206685|NCT02431806|450379857|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
125206686|NCT02431806|450379858|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
125206687|NCT02431806|450379859|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
125206688|NCT02431806|450379856|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
125206689|NCT02431806|450379857|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
125206690|NCT02431806|450379858|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
125206691|NCT02431806|450379859|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
125206692|NCT02431806|450379856|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
125206693|NCT02431806|450379857|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
125206694|NCT02431806|450379858|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
125206695|NCT02431806|450379859|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
125206696|NCT02431806|450379856|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
125206697|NCT02431806|450379857|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
125206698|NCT02431806|450379858|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
125206699|NCT02431806|450379859|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
125206700|NCT03627416|450379860|FG000|Overall Study|Adverse Event|0|||
125206701|NCT03627416|450379861|FG001|Overall Study|Adverse Event|1|||
125206702|NCT02968433|450379862|FG000|Overall Study|Withdrawal by Subject|1|||
125206703|NCT02079636|450379863|FG000|Overall Study|Death|2|||
125206704|NCT02079636|450379864|FG001|Overall Study|Death|1|||
125206705|NCT02079636|450379865|FG002|Overall Study|Death|0|||
125206706|NCT02079636|450379866|FG003|Overall Study|Death|5|||
125206707|NCT02079636|450379867|FG004|Overall Study|Death|1|||
125206708|NCT02079636|450379868|FG005|Overall Study|Death|2|||
125206709|NCT02079636|450379869|FG006|Overall Study|Death|1|||
125206710|NCT02079636|450379870|FG007|Overall Study|Death|0|||
125206711|NCT02079636|450379871|FG008|Overall Study|Death|0|||
125206712|NCT02079636|450379872|FG009|Overall Study|Death|0|||
125206713|NCT02079636|450379873|FG010|Overall Study|Death|0|||
125206714|NCT02079636|450379874|FG011|Overall Study|Death|1|||
125206715|NCT02079636|450379875|FG012|Overall Study|Death|1|||
125206716|NCT02079636|450379876|FG013|Overall Study|Death|0|||
125206717|NCT02079636|450379877|FG014|Overall Study|Death|2|||
125206718|NCT02079636|450379863|FG000|Overall Study|Adverse Event|1|||
125206719|NCT02079636|450379864|FG001|Overall Study|Adverse Event|1|||
125206720|NCT02079636|450379865|FG002|Overall Study|Adverse Event|0|||
125206721|NCT02079636|450379866|FG003|Overall Study|Adverse Event|1|||
125206722|NCT02079636|450379867|FG004|Overall Study|Adverse Event|1|||
125206723|NCT02079636|450379868|FG005|Overall Study|Adverse Event|2|||
125206724|NCT02079636|450379869|FG006|Overall Study|Adverse Event|0|||
125206725|NCT02079636|450379870|FG007|Overall Study|Adverse Event|0|||
125206726|NCT02079636|450379871|FG008|Overall Study|Adverse Event|0|||
125206727|NCT02079636|450379872|FG009|Overall Study|Adverse Event|0|||
125206728|NCT02079636|450379873|FG010|Overall Study|Adverse Event|0|||
125206729|NCT02079636|450379874|FG011|Overall Study|Adverse Event|0|||
125206730|NCT02079636|450379875|FG012|Overall Study|Adverse Event|0|||
125206731|NCT02079636|450379876|FG013|Overall Study|Adverse Event|0|||
125206732|NCT02079636|450379877|FG014|Overall Study|Adverse Event|0|||
125206733|NCT02079636|450379863|FG000|Overall Study|Progressive disease|0|||
125206734|NCT02079636|450379864|FG001|Overall Study|Progressive disease|0|||
125206735|NCT02079636|450379865|FG002|Overall Study|Progressive disease|0|||
125206736|NCT02079636|450379866|FG003|Overall Study|Progressive disease|2|||
125206737|NCT02079636|450379867|FG004|Overall Study|Progressive disease|0|||
125206738|NCT02079636|450379868|FG005|Overall Study|Progressive disease|0|||
125206739|NCT02079636|450379869|FG006|Overall Study|Progressive disease|0|||
125206740|NCT02079636|450379870|FG007|Overall Study|Progressive disease|0|||
125206741|NCT02079636|450379871|FG008|Overall Study|Progressive disease|0|||
125206742|NCT02079636|450379872|FG009|Overall Study|Progressive disease|0|||
125206743|NCT02079636|450379873|FG010|Overall Study|Progressive disease|0|||
125206744|NCT02079636|450379874|FG011|Overall Study|Progressive disease|0|||
125206745|NCT02079636|450379875|FG012|Overall Study|Progressive disease|1|||
125206746|NCT02079636|450379876|FG013|Overall Study|Progressive disease|0|||
125206747|NCT02079636|450379877|FG014|Overall Study|Progressive disease|0|||
125206748|NCT02079636|450379863|FG000|Overall Study|Withdrawal by Subject|0|||
125206749|NCT02079636|450379864|FG001|Overall Study|Withdrawal by Subject|0|||
125206750|NCT02079636|450379865|FG002|Overall Study|Withdrawal by Subject|0|||
125206751|NCT02079636|450379866|FG003|Overall Study|Withdrawal by Subject|4|||
125206752|NCT02079636|450379867|FG004|Overall Study|Withdrawal by Subject|0|||
125206753|NCT02079636|450379868|FG005|Overall Study|Withdrawal by Subject|1|||
125206754|NCT02079636|450379869|FG006|Overall Study|Withdrawal by Subject|0|||
125206755|NCT02079636|450379870|FG007|Overall Study|Withdrawal by Subject|0|||
125206756|NCT02079636|450379871|FG008|Overall Study|Withdrawal by Subject|0|||
125206757|NCT02079636|450379872|FG009|Overall Study|Withdrawal by Subject|2|||
125206758|NCT02079636|450379873|FG010|Overall Study|Withdrawal by Subject|1|||
125206759|NCT02079636|450379874|FG011|Overall Study|Withdrawal by Subject|1|||
125206760|NCT02079636|450379875|FG012|Overall Study|Withdrawal by Subject|1|||
125206761|NCT02079636|450379876|FG013|Overall Study|Withdrawal by Subject|0|||
125206762|NCT02079636|450379877|FG014|Overall Study|Withdrawal by Subject|2|||
125206763|NCT02079636|450379863|FG000|Overall Study|Physician Decision|0|||
125206764|NCT02079636|450379864|FG001|Overall Study|Physician Decision|0|||
125206765|NCT02079636|450379865|FG002|Overall Study|Physician Decision|0|||
125206766|NCT02079636|450379866|FG003|Overall Study|Physician Decision|0|||
125206767|NCT02079636|450379867|FG004|Overall Study|Physician Decision|0|||
125206768|NCT02079636|450379868|FG005|Overall Study|Physician Decision|1|||
125206769|NCT02079636|450379869|FG006|Overall Study|Physician Decision|0|||
125206770|NCT02079636|450379870|FG007|Overall Study|Physician Decision|0|||
125206771|NCT02079636|450379871|FG008|Overall Study|Physician Decision|0|||
125206772|NCT02079636|450379872|FG009|Overall Study|Physician Decision|1|||
125206773|NCT02079636|450379873|FG010|Overall Study|Physician Decision|1|||
125206774|NCT02079636|450379874|FG011|Overall Study|Physician Decision|0|||
125206775|NCT02079636|450379875|FG012|Overall Study|Physician Decision|0|||
125206776|NCT02079636|450379876|FG013|Overall Study|Physician Decision|0|||
125206777|NCT02079636|450379877|FG014|Overall Study|Physician Decision|1|||
125206778|NCT02079636|450379863|FG000|Overall Study|Lost to Follow-up|0|||
125206779|NCT02079636|450379864|FG001|Overall Study|Lost to Follow-up|0|||
125206780|NCT02079636|450379865|FG002|Overall Study|Lost to Follow-up|0|||
125206781|NCT02079636|450379866|FG003|Overall Study|Lost to Follow-up|0|||
125206782|NCT02079636|450379867|FG004|Overall Study|Lost to Follow-up|0|||
125206783|NCT02079636|450379868|FG005|Overall Study|Lost to Follow-up|0|||
125206784|NCT02079636|450379869|FG006|Overall Study|Lost to Follow-up|0|||
125206785|NCT02079636|450379870|FG007|Overall Study|Lost to Follow-up|1|||
125206786|NCT02079636|450379871|FG008|Overall Study|Lost to Follow-up|0|||
125206787|NCT02079636|450379872|FG009|Overall Study|Lost to Follow-up|0|||
125206788|NCT02079636|450379873|FG010|Overall Study|Lost to Follow-up|0|||
125206789|NCT02079636|450379874|FG011|Overall Study|Lost to Follow-up|0|||
125206790|NCT02079636|450379875|FG012|Overall Study|Lost to Follow-up|0|||
125206791|NCT02079636|450379876|FG013|Overall Study|Lost to Follow-up|0|||
125206792|NCT02079636|450379877|FG014|Overall Study|Lost to Follow-up|0|||
125206793|NCT00875433|450379878|FG000|Overall Study|Progressive disease|41|||
125206794|NCT00875433|450379878|FG000|Overall Study|Other Adverse Event|14|||
125206795|NCT00875433|450379878|FG000|Overall Study|Withdrawal by Subject|2|||
125206796|NCT00875433|450379878|FG000|Overall Study|Other|3|||
125206797|NCT00622336|450379879|FG000|Treatment Phase|Progression of Disease|181|||
125206798|NCT00622336|450379879|FG000|Treatment Phase|Adverse Event|46|||
125206799|NCT00622336|450379879|FG000|Treatment Phase|Other|40|||
125206800|NCT00622336|450379879|FG000|Treatment Phase|Death|14|||
125206801|NCT00622336|450379879|FG000|Treatment Phase|Lack of therapeutic effect|13|||
125206802|NCT00622336|450379879|FG000|Treatment Phase|Withdrawal by Subject|13|||
125206803|NCT00622336|450379879|FG000|Treatment Phase|Lost to Follow-up|2|||
125206804|NCT00622336|450379879|FG000|Extension Phase|Adverse Event|2|||
125206805|NCT00622336|450379879|FG000|Extension Phase|Progressive Disease|6|||
125206806|NCT00622336|450379879|FG000|Extension Phase|Lack of therapeutic effect|2|||
125206807|NCT00622336|450379879|FG000|Extension Phase|Withdrawal by Subject|1|||
125206808|NCT00622336|450379879|FG000|Extension Phase|Lost to Follow-up|1|||
125206809|NCT00622336|450379879|FG000|Extension Phase|Other|9|||
125206810|NCT04148287|450379881|FG000|Overall Study|Death|2|||
125206811|NCT03912428|450379882|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
125206812|NCT03912428|450379883|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
125206813|NCT03912428|450379884|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
125206814|NCT03912428|450379885|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
125206815|NCT03912428|450379882|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
125206816|NCT03912428|450379883|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
125206817|NCT03912428|450379884|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
125206818|NCT03912428|450379885|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
125206819|NCT03912428|450379882|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
125206820|NCT03912428|450379883|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
125206821|NCT03912428|450379884|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
125206822|NCT03912428|450379885|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
125206823|NCT01777139|450381472|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
125206824|NCT01777139|450381473|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
125206825|NCT01777139|450381472|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
125206826|NCT01777139|450381473|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
125206827|NCT01777139|450381472|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
125206828|NCT01777139|450381473|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
125206829|NCT01777139|450381472|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
125206830|NCT01777139|450381473|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
125206831|NCT01777139|450381472|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
125206832|NCT01777139|450381473|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
125206833|NCT01777139|450381472|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
125206834|NCT01777139|450381473|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
125206835|NCT01777139|450381472|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
125206836|NCT01777139|450381473|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
125206837|NCT01777139|450381472|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
125206838|NCT01777139|450381473|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
125206839|NCT05625477|450381474|FG000|Overall Study|Lost to Follow-up|2|||
125206840|NCT05625477|450381475|FG001|Overall Study|Lost to Follow-up|2|||
125206841|NCT05625477|450381476|FG002|Overall Study|Lost to Follow-up|1|||
125206842|NCT05625477|450381477|FG003|Overall Study|Lost to Follow-up|1|||
125206843|NCT05625477|450381478|FG004|Overall Study|Lost to Follow-up|0|||
125206844|NCT05625477|450381474|FG000|Overall Study|Covid quarantine|1|||
125206845|NCT05625477|450381475|FG001|Overall Study|Covid quarantine|0|||
125206846|NCT05625477|450381476|FG002|Overall Study|Covid quarantine|0|||
125206847|NCT05625477|450381477|FG003|Overall Study|Covid quarantine|0|||
124981412|NCT00586612|449557474|FG001|Primary Phase|Lost to Follow-up|1|||
124981413|NCT00586612|449557473|FG000|Primary Phase|Withdrawal by Subject|0|||
125206848|NCT05625477|450381478|FG004|Overall Study|Covid quarantine|0|||
125206849|NCT02502266|450381479|FG000|Overall Study|Adverse Event|0|||
125206850|NCT02502266|450381480|FG001|Overall Study|Adverse Event|0|||
125206851|NCT02502266|450381481|FG002|Overall Study|Adverse Event|0|||
125206852|NCT02502266|450381482|FG003|Overall Study|Adverse Event|0|||
125206853|NCT02502266|450381483|FG004|Overall Study|Adverse Event|1|||
125206854|NCT02502266|450381484|FG005|Overall Study|Adverse Event|1|||
125206855|NCT02502266|450381485|FG006|Overall Study|Adverse Event|1|||
125206856|NCT02502266|450381479|FG000|Overall Study|Withdrawal by Subject|30|||
125206857|NCT02502266|450381480|FG001|Overall Study|Withdrawal by Subject|15|||
125206858|NCT02502266|450381481|FG002|Overall Study|Withdrawal by Subject|16|||
125206859|NCT02502266|450381482|FG003|Overall Study|Withdrawal by Subject|0|||
125206860|NCT02502266|450381483|FG004|Overall Study|Withdrawal by Subject|0|||
125206861|NCT02502266|450381484|FG005|Overall Study|Withdrawal by Subject|0|||
125206862|NCT02502266|450381485|FG006|Overall Study|Withdrawal by Subject|0|||
125206863|NCT02502266|450381479|FG000|Overall Study|Still on Treatment|0|||
125206864|NCT02502266|450381480|FG001|Overall Study|Still on Treatment|0|||
125206865|NCT02502266|450381481|FG002|Overall Study|Still on Treatment|1|||
125206866|NCT02502266|450381482|FG003|Overall Study|Still on Treatment|0|||
125206867|NCT02502266|450381483|FG004|Overall Study|Still on Treatment|0|||
125206868|NCT02502266|450381484|FG005|Overall Study|Still on Treatment|0|||
125206869|NCT02502266|450381485|FG006|Overall Study|Still on Treatment|0|||
125206870|NCT02502266|450381479|FG000|Overall Study|Other Reasons|19|||
125206871|NCT02502266|450381480|FG001|Overall Study|Other Reasons|6|||
125206872|NCT02502266|450381481|FG002|Overall Study|Other Reasons|14|||
125206873|NCT02502266|450381482|FG003|Overall Study|Other Reasons|0|||
125206874|NCT02502266|450381483|FG004|Overall Study|Other Reasons|1|||
125206875|NCT02502266|450381484|FG005|Overall Study|Other Reasons|1|||
125206876|NCT02502266|450381485|FG006|Overall Study|Other Reasons|0|||
125206877|NCT02502266|450381479|FG000|Overall Study|Arm 4 Discontinued|0|||
125206878|NCT02502266|450381480|FG001|Overall Study|Arm 4 Discontinued|0|||
125206879|NCT02502266|450381481|FG002|Overall Study|Arm 4 Discontinued|0|||
125206880|NCT02502266|450381482|FG003|Overall Study|Arm 4 Discontinued|52|||
125206881|NCT02502266|450381483|FG004|Overall Study|Arm 4 Discontinued|0|||
125206882|NCT02502266|450381484|FG005|Overall Study|Arm 4 Discontinued|0|||
125206883|NCT02502266|450381485|FG006|Overall Study|Arm 4 Discontinued|0|||
125206884|NCT02502266|450381479|FG000|Overall Study|Never treated|0|||
125206885|NCT02502266|450381480|FG001|Overall Study|Never treated|0|||
125206886|NCT02502266|450381481|FG002|Overall Study|Never treated|0|||
125206887|NCT02502266|450381482|FG003|Overall Study|Never treated|0|||
125206888|NCT02502266|450381483|FG004|Overall Study|Never treated|0|||
125206889|NCT02502266|450381484|FG005|Overall Study|Never treated|1|||
125206890|NCT02502266|450381485|FG006|Overall Study|Never treated|0|||
125206891|NCT02921750|450381486|FG000|Overall Study|Adverse Event|1|||
125206892|NCT02921750|450381487|FG001|Overall Study|Adverse Event|2|||
125206893|NCT02921750|450381486|FG000|Overall Study|Withdrawal by Subject|1|||
125206894|NCT02921750|450381487|FG001|Overall Study|Withdrawal by Subject|1|||
125206895|NCT02921750|450381486|FG000|Overall Study|Lost to Follow-up|3|||
125206896|NCT02921750|450381487|FG001|Overall Study|Lost to Follow-up|3|||
125206897|NCT02921750|450381486|FG000|Overall Study|Wound healed|3|||
125206898|NCT02921750|450381487|FG001|Overall Study|Wound healed|3|||
125206899|NCT02921750|450381486|FG000|Overall Study|Serious Adverse Event|1|||
125206900|NCT02921750|450381487|FG001|Overall Study|Serious Adverse Event|2|||
125206901|NCT03605849|450381488|FG000|Overall Study|Adverse Event|20|||
125206902|NCT03605849|450381489|FG001|Overall Study|Adverse Event|21|||
125206903|NCT03605849|450381490|FG002|Overall Study|Adverse Event|29|||
125206904|NCT03605849|450381491|FG003|Overall Study|Adverse Event|11|||
125206905|NCT03605849|450381488|FG000|Overall Study|Lack of Efficacy|4|||
125206906|NCT03605849|450381489|FG001|Overall Study|Lack of Efficacy|7|||
125206907|NCT03605849|450381490|FG002|Overall Study|Lack of Efficacy|9|||
125206908|NCT03605849|450381491|FG003|Overall Study|Lack of Efficacy|2|||
125206909|NCT03605849|450381488|FG000|Overall Study|Lost to Follow-up|8|||
125206910|NCT03605849|450381489|FG001|Overall Study|Lost to Follow-up|8|||
125206911|NCT03605849|450381490|FG002|Overall Study|Lost to Follow-up|14|||
125206912|NCT03605849|450381491|FG003|Overall Study|Lost to Follow-up|11|||
125206913|NCT03605849|450381488|FG000|Overall Study|Non-compliance With IMP|6|||
125206914|NCT03605849|450381489|FG001|Overall Study|Non-compliance With IMP|5|||
125206915|NCT03605849|450381490|FG002|Overall Study|Non-compliance With IMP|2|||
125089793|NCT01117428|449947025|FG002|Overall Study|Physician Decision|0|||
125089794|NCT01117428|449947026|FG003|Overall Study|Physician Decision|0|||
125089795|NCT01117428|449947027|FG004|Overall Study|Physician Decision|0|||
125089796|NCT01117428|449947028|FG005|Overall Study|Physician Decision|0|||
125089797|NCT01117428|449947023|FG000|Overall Study|Withdrawal by Subject|0|||
125089798|NCT01117428|449947024|FG001|Overall Study|Withdrawal by Subject|0|||
125206916|NCT03605849|450381491|FG003|Overall Study|Non-compliance With IMP|1|||
125206917|NCT03605849|450381488|FG000|Overall Study|Protocol Deviation|1|||
125206918|NCT03605849|450381489|FG001|Overall Study|Protocol Deviation|2|||
125206919|NCT03605849|450381490|FG002|Overall Study|Protocol Deviation|1|||
125206920|NCT03605849|450381491|FG003|Overall Study|Protocol Deviation|3|||
125206921|NCT03605849|450381488|FG000|Overall Study|Withdrawal by Subject|33|||
125206922|NCT03605849|450381489|FG001|Overall Study|Withdrawal by Subject|28|||
125206923|NCT03605849|450381490|FG002|Overall Study|Withdrawal by Subject|30|||
125206924|NCT03605849|450381491|FG003|Overall Study|Withdrawal by Subject|28|||
125206925|NCT03605849|450381488|FG000|Overall Study|Site Terminated by Sponsor|0|||
125206926|NCT03605849|450381489|FG001|Overall Study|Site Terminated by Sponsor|0|||
125206927|NCT03605849|450381490|FG002|Overall Study|Site Terminated by Sponsor|0|||
125089799|NCT01117428|449947025|FG002|Overall Study|Withdrawal by Subject|1|||
125089800|NCT01117428|449947026|FG003|Overall Study|Withdrawal by Subject|0|||
125206928|NCT03605849|450381491|FG003|Overall Study|Site Terminated by Sponsor|1|||
125206929|NCT03605849|450381488|FG000|Overall Study|Physician Decision|2|||
125206930|NCT03605849|450381489|FG001|Overall Study|Physician Decision|1|||
125206931|NCT03605849|450381490|FG002|Overall Study|Physician Decision|2|||
125206932|NCT03605849|450381491|FG003|Overall Study|Physician Decision|1|||
125206933|NCT03605849|450381488|FG000|Overall Study|Enrolled, but not Treated|2|||
125206934|NCT03605849|450381489|FG001|Overall Study|Enrolled, but not Treated|2|||
125206935|NCT03605849|450381490|FG002|Overall Study|Enrolled, but not Treated|3|||
125206936|NCT03605849|450381491|FG003|Overall Study|Enrolled, but not Treated|2|||
125206937|NCT03605849|450381488|FG000|Overall Study|Other (COVID-19 Related)|0|||
125206938|NCT03605849|450381489|FG001|Overall Study|Other (COVID-19 Related)|1|||
125206939|NCT03605849|450381490|FG002|Overall Study|Other (COVID-19 Related)|1|||
125206940|NCT03605849|450381491|FG003|Overall Study|Other (COVID-19 Related)|0|||
125206941|NCT03605849|450381488|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
125206942|NCT03605849|450381489|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
125206943|NCT03605849|450381490|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
125206944|NCT03605849|450381491|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
125206945|NCT00328094|450381494|FG000|Overall Study|Physician Decision|3|||
125206946|NCT00328094|450381495|FG001|Overall Study|Physician Decision|3|||
125206947|NCT00590538|450381496|FG000|Overall Study|Study terminated before completed|2|||
125206948|NCT02309723|450381497|FG000|Overall Study|Withdrawal by Subject|24|||
125206949|NCT02309723|450381498|FG001|Overall Study|Withdrawal by Subject|23|||
125206950|NCT02309723|450381499|FG002|Overall Study|Withdrawal by Subject|24|||
125206951|NCT01125813|450381500|FG000|Overall Study|Death|1|||
125206952|NCT01125813|450381500|FG000|Overall Study|Withdrawal by Subject|1|||
125206953|NCT01125813|450381500|FG000|Overall Study|Screen Failures|4|||
125206954|NCT00985426|450381501|FG000|Overall Study|Adverse Event|0|||
125206955|NCT00985426|450381502|FG001|Overall Study|Adverse Event|1|||
125206956|NCT00985426|450381501|FG000|Overall Study|Subject Non-Compliance|3|||
125206957|NCT00985426|450381502|FG001|Overall Study|Subject Non-Compliance|3|||
125206958|NCT00985426|450381501|FG000|Overall Study|Withdrawal by Subject|12|||
125206959|NCT00985426|450381502|FG001|Overall Study|Withdrawal by Subject|16|||
125206960|NCT00985426|450381501|FG000|Overall Study|Lost to Follow-up|8|||
125206961|NCT00985426|450381502|FG001|Overall Study|Lost to Follow-up|10|||
125206962|NCT00985426|450381501|FG000|Overall Study|Death|7|||
125206963|NCT00985426|450381502|FG001|Overall Study|Death|3|||
125206964|NCT00985426|450381501|FG000|Overall Study|Protocol Violation|2|||
125206965|NCT00985426|450381502|FG001|Overall Study|Protocol Violation|0|||
125206966|NCT00985426|450381501|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
125206967|NCT00985426|450381502|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
125206968|NCT02327013|450381503|FG000|Overall Study|Adverse Event|4|||
125206969|NCT02327013|450381504|FG001|Overall Study|Adverse Event|4|||
125206970|NCT02327013|450381505|FG002|Overall Study|Adverse Event|3|||
125206971|NCT02327013|450381506|FG003|Overall Study|Adverse Event|0|||
125206972|NCT02327013|450381507|FG004|Overall Study|Adverse Event|1|||
125206973|NCT02327013|450381503|FG000|Overall Study|Lack of Efficacy|2|||
125206974|NCT02327013|450381504|FG001|Overall Study|Lack of Efficacy|0|||
125206975|NCT02327013|450381505|FG002|Overall Study|Lack of Efficacy|5|||
125206976|NCT02327013|450381506|FG003|Overall Study|Lack of Efficacy|0|||
125206977|NCT02327013|450381507|FG004|Overall Study|Lack of Efficacy|1|||
125206978|NCT02327013|450381503|FG000|Overall Study|Non-compliance with IMP|1|||
125206979|NCT02327013|450381504|FG001|Overall Study|Non-compliance with IMP|2|||
125206980|NCT02327013|450381505|FG002|Overall Study|Non-compliance with IMP|7|||
125206981|NCT02327013|450381506|FG003|Overall Study|Non-compliance with IMP|0|||
125206982|NCT02327013|450381507|FG004|Overall Study|Non-compliance with IMP|0|||
125206983|NCT02327013|450381503|FG000|Overall Study|Withdrawal of Consent|1|||
125206984|NCT02327013|450381504|FG001|Overall Study|Withdrawal of Consent|0|||
125206985|NCT02327013|450381505|FG002|Overall Study|Withdrawal of Consent|3|||
125206986|NCT02327013|450381506|FG003|Overall Study|Withdrawal of Consent|0|||
125206987|NCT02327013|450381507|FG004|Overall Study|Withdrawal of Consent|0|||
125206988|NCT02327013|450381503|FG000|Overall Study|Lost to Follow-up|2|||
125206989|NCT02327013|450381504|FG001|Overall Study|Lost to Follow-up|4|||
125206990|NCT02327013|450381505|FG002|Overall Study|Lost to Follow-up|5|||
125206991|NCT02327013|450381506|FG003|Overall Study|Lost to Follow-up|0|||
125206992|NCT02327013|450381507|FG004|Overall Study|Lost to Follow-up|0|||
125206993|NCT02327013|450381503|FG000|Overall Study|Administrative or other reason(s)|1|||
125206994|NCT02327013|450381504|FG001|Overall Study|Administrative or other reason(s)|5|||
125206995|NCT02327013|450381505|FG002|Overall Study|Administrative or other reason(s)|11|||
124981414|NCT00586612|449557474|FG001|Primary Phase|Withdrawal by Subject|2|||
125206996|NCT02327013|450381506|FG003|Overall Study|Administrative or other reason(s)|1|||
125206997|NCT02327013|450381507|FG004|Overall Study|Administrative or other reason(s)|1|||
125206998|NCT02327013|450381503|FG000|Overall Study|Protocol Violation|0|||
125206999|NCT02327013|450381504|FG001|Overall Study|Protocol Violation|0|||
125207000|NCT02327013|450381505|FG002|Overall Study|Protocol Violation|3|||
125207001|NCT02327013|450381506|FG003|Overall Study|Protocol Violation|0|||
125207002|NCT02327013|450381507|FG004|Overall Study|Protocol Violation|1|||
125207003|NCT02327013|450381503|FG000|Overall Study|Withdrawal before treatment|2|||
125207004|NCT02327013|450381504|FG001|Overall Study|Withdrawal before treatment|1|||
125207005|NCT02327013|450381505|FG002|Overall Study|Withdrawal before treatment|5|||
125207006|NCT02327013|450381506|FG003|Overall Study|Withdrawal before treatment|0|||
125207007|NCT02327013|450381507|FG004|Overall Study|Withdrawal before treatment|0|||
125207008|NCT01565668|450381508|FG000|Overall Study|Death|2|||
125207009|NCT01565668|450381509|FG001|Overall Study|Death|1|||
125207010|NCT01565668|450381508|FG000|Overall Study|Lack of Efficacy|4|||
125207011|NCT01565668|450381509|FG001|Overall Study|Lack of Efficacy|2|||
125207012|NCT01565668|450381508|FG000|Overall Study|Participant went on Hospice Care|1|||
125207013|NCT01565668|450381509|FG001|Overall Study|Participant went on Hospice Care|0|||
125207014|NCT01565668|450381508|FG000|Overall Study|Adverse Event|6|||
125207015|NCT01565668|450381509|FG001|Overall Study|Adverse Event|1|||
125207016|NCT01565668|450381508|FG000|Overall Study|Randomized, but never received drug|0|||
125207017|NCT01565668|450381509|FG001|Overall Study|Randomized, but never received drug|2|||
125207018|NCT01565668|450381508|FG000|Overall Study|Progressive disease|13|||
125207019|NCT01565668|450381509|FG001|Overall Study|Progressive disease|14|||
125207020|NCT01565668|450381508|FG000|Overall Study|Withdrawal by Subject|1|||
125207021|NCT01565668|450381509|FG001|Overall Study|Withdrawal by Subject|3|||
125207022|NCT01565668|450381508|FG000|Overall Study|HSCT Transplant|11|||
125207023|NCT01565668|450381509|FG001|Overall Study|HSCT Transplant|15|||
125207024|NCT04258254|450381510|FG000|Overall Study|Withdrawal by Subject|0|||
125207025|NCT04258254|450381511|FG001|Overall Study|Withdrawal by Subject|1|||
125207026|NCT04258254|450381512|FG002|Overall Study|Withdrawal by Subject|0|||
125207027|NCT02255552|450381513|FG000|Overall Study|Participants enrolled into another study|0|||
125207028|NCT02255552|450381514|FG001|Overall Study|Participants enrolled into another study|11|||
125207029|NCT02255552|450381513|FG000|Overall Study|Withdrawal by Subject|1|||
125207030|NCT02255552|450381514|FG001|Overall Study|Withdrawal by Subject|4|||
125207031|NCT04829331|450381515|FG000|Overall Study|Lost to Follow-up|1|||
125207032|NCT04829331|450381516|FG001|Overall Study|Lost to Follow-up|0|||
125207033|NCT03570554|450381518|FG000|Overall Study|Non-compliance with study drug|0|||
125207034|NCT03570554|450381519|FG001|Overall Study|Non-compliance with study drug|0|||
125207035|NCT03570554|450381520|FG002|Overall Study|Non-compliance with study drug|1|||
125207036|NCT03570554|450381521|FG003|Overall Study|Non-compliance with study drug|0|||
125207037|NCT03570554|450381518|FG000|Overall Study|Adverse Event|0|||
125207038|NCT03570554|450381519|FG001|Overall Study|Adverse Event|0|||
125207039|NCT03570554|450381520|FG002|Overall Study|Adverse Event|0|||
125207040|NCT03570554|450381521|FG003|Overall Study|Adverse Event|1|||
125207041|NCT02223819|450381536|FG000|Overall Study|Lost to Follow-up|2|||
125207042|NCT02956057|450381538|FG000|Overall Study|Discontinued intervention|14|||
125207043|NCT02956057|450381539|FG001|Overall Study|Discontinued intervention|10|||
125207044|NCT02956057|450381540|FG002|Overall Study|Discontinued intervention|7|||
125207045|NCT02956057|450381541|FG003|Overall Study|Discontinued intervention|14|||
125207046|NCT02956057|450381542|FG004|Overall Study|Discontinued intervention|4|||
125207047|NCT02956057|450381543|FG005|Overall Study|Discontinued intervention|17|||
125207048|NCT02956057|450381538|FG000|Overall Study|Lost to Follow-up|0|||
125207049|NCT02956057|450381539|FG001|Overall Study|Lost to Follow-up|2|||
125207050|NCT02956057|450381540|FG002|Overall Study|Lost to Follow-up|1|||
125207051|NCT02956057|450381541|FG003|Overall Study|Lost to Follow-up|1|||
125207052|NCT02956057|450381542|FG004|Overall Study|Lost to Follow-up|1|||
125207053|NCT02956057|450381543|FG005|Overall Study|Lost to Follow-up|0|||
125207054|NCT03435224|450381546|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
125207055|NCT01420679|450381549|FG000|Overall Study|Disease Progression|3|||
125207056|NCT01420679|450381550|FG001|Overall Study|Disease Progression|2|||
125207057|NCT01420679|450381549|FG000|Overall Study|Adverse Event|4|||
125207058|NCT01420679|450381550|FG001|Overall Study|Adverse Event|0|||
125207059|NCT01420679|450381549|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
125207060|NCT01420679|450381550|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
125207061|NCT01420679|450381549|FG000|Overall Study|Patient Decision|1|||
125207062|NCT01420679|450381550|FG001|Overall Study|Patient Decision|0|||
125207063|NCT01420679|450381549|FG000|Overall Study|Investigator Decision|1|||
125207064|NCT01420679|450381550|FG001|Overall Study|Investigator Decision|2|||
125207065|NCT01420679|450381549|FG000|Overall Study|Sponsor Decision|3|||
125207066|NCT01420679|450381550|FG001|Overall Study|Sponsor Decision|3|||
125207067|NCT01420679|450381549|FG000|Overall Study|Other|1|||
125207068|NCT01420679|450381550|FG001|Overall Study|Other|0|||
125207069|NCT00367484|450381551|FG000|Overall Study|Adverse Event|7|||
125207070|NCT00367484|450381551|FG000|Overall Study|Withdrew informed consent|5|||
125207071|NCT00367484|450381551|FG000|Overall Study|Travel to USA|1|||
125207072|NCT00367484|450381551|FG000|Overall Study|Lost to Follow-up|1|||
125207073|NCT00367484|450381551|FG000|Overall Study|Protocol Violation|1|||
125207074|NCT00367484|450381551|FG000|Overall Study|The choice of the patient|1|||
125207075|NCT00367484|450381551|FG000|Overall Study|Lack of Efficacy|1|||
125207076|NCT02604550|450381554|FG000|Overall Study|Lost to Follow-up|7|||
125207077|NCT02604550|450381555|FG001|Overall Study|Lost to Follow-up|6|||
125207078|NCT02604550|450381554|FG000|Overall Study|Withdrawal by Subject|0|||
125207079|NCT02604550|450381555|FG001|Overall Study|Withdrawal by Subject|1|||
125207080|NCT02604550|450381554|FG000|Overall Study|Incomplete data using paper journal|18|||
125207081|NCT02604550|450381555|FG001|Overall Study|Incomplete data using paper journal|19|||
125207082|NCT04472026|450381556|FG000|Overall Study|Lost to Follow-up|5|||
125207083|NCT01404208|450381557|FG000|Overall Study|Discontinued|3|||
125207084|NCT01404208|450381558|FG001|Overall Study|Discontinued|0|||
125207085|NCT04007107|450381561|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
125207086|NCT04007107|450381562|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
125207087|NCT04007107|450381563|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
125207088|NCT04007107|450381564|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
125207089|NCT04068688|450381565|FG000|Overall Study|Lost to Follow-up|1|||
125207090|NCT04068688|450381566|FG001|Overall Study|Lost to Follow-up|1|||
125207091|NCT04068688|450381567|FG002|Overall Study|Lost to Follow-up|0|||
125207092|NCT04068688|450381568|FG003|Overall Study|Lost to Follow-up|0|||
125207093|NCT04068688|450381569|FG004|Overall Study|Lost to Follow-up|5|||
125207094|NCT04068688|450381570|FG005|Overall Study|Lost to Follow-up|5|||
125207095|NCT04068688|450381571|FG006|Overall Study|Lost to Follow-up|0|||
125207096|NCT04068688|450381572|FG007|Overall Study|Lost to Follow-up|0|||
125207097|NCT04068688|450381573|FG008|Overall Study|Lost to Follow-up|1|||
125207098|NCT04068688|450381574|FG009|Overall Study|Lost to Follow-up|0|||
125207099|NCT04068688|450381565|FG000|Overall Study|Withdrawal by Subject|1|||
125207100|NCT04068688|450381566|FG001|Overall Study|Withdrawal by Subject|1|||
125207101|NCT04068688|450381567|FG002|Overall Study|Withdrawal by Subject|0|||
125207102|NCT04068688|450381568|FG003|Overall Study|Withdrawal by Subject|0|||
125207103|NCT04068688|450381569|FG004|Overall Study|Withdrawal by Subject|0|||
125207104|NCT04068688|450381570|FG005|Overall Study|Withdrawal by Subject|0|||
125207105|NCT04068688|450381571|FG006|Overall Study|Withdrawal by Subject|0|||
125207106|NCT04068688|450381572|FG007|Overall Study|Withdrawal by Subject|0|||
125207107|NCT04068688|450381573|FG008|Overall Study|Withdrawal by Subject|0|||
125207108|NCT04068688|450381574|FG009|Overall Study|Withdrawal by Subject|0|||
125207109|NCT04068688|450381565|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
125207110|NCT04068688|450381566|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
125207111|NCT04068688|450381567|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
125207112|NCT04068688|450381568|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
125207113|NCT04068688|450381569|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
125207114|NCT04068688|450381570|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
124981415|NCT00586612|449557473|FG000|Booster Phase|Lost to Follow-up|3|||
125207115|NCT04068688|450381571|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
125207116|NCT04068688|450381572|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
125207117|NCT04068688|450381573|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
125207118|NCT04068688|450381574|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
125207119|NCT04679051|450381575|FG000|Overall Study|felt tired after restricted time in bed|3|||
125207120|NCT04679051|450381576|FG001|Overall Study|felt tired after restricted time in bed|0|||
125207121|NCT04679051|450381575|FG000|Overall Study|discomfort with blood pressure cuff|2|||
125207122|NCT04679051|450381576|FG001|Overall Study|discomfort with blood pressure cuff|0|||
125207123|NCT04679051|450381575|FG000|Overall Study|scheduling conflict|1|||
125207124|NCT04679051|450381576|FG001|Overall Study|scheduling conflict|1|||
125207125|NCT04679051|450381575|FG000|Overall Study|Protocol Violation|0|||
125207126|NCT04679051|450381576|FG001|Overall Study|Protocol Violation|4|||
125207127|NCT02332239|450381577|FG000|Overall Study|Lost to Follow-up|4|||
125207128|NCT02332239|450381578|FG001|Overall Study|Lost to Follow-up|6|||
125207129|NCT00115037|450381579|FG000|Phase1|Lost to Follow-up|16|||
125207130|NCT00115037|450381580|FG001|Phase1|Lost to Follow-up|23|||
125207131|NCT00115037|450381581|FG002|Phase1|Lost to Follow-up|0|||
125207132|NCT00115037|450381582|FG003|Phase1|Lost to Follow-up|0|||
125207133|NCT00115037|450381583|FG004|Phase1|Lost to Follow-up|0|||
125207134|NCT00115037|450381584|FG005|Phase1|Lost to Follow-up|0|||
125207135|NCT00115037|450381579|FG000|Phase1|Withdrawal by Subject|9|||
125207136|NCT00115037|450381580|FG001|Phase1|Withdrawal by Subject|4|||
125207137|NCT00115037|450381581|FG002|Phase1|Withdrawal by Subject|0|||
125207138|NCT00115037|450381582|FG003|Phase1|Withdrawal by Subject|0|||
125207139|NCT00115037|450381583|FG004|Phase1|Withdrawal by Subject|0|||
125207140|NCT00115037|450381584|FG005|Phase1|Withdrawal by Subject|0|||
125207141|NCT00115037|450381579|FG000|Phase2|Death|0|||
125207142|NCT00115037|450381580|FG001|Phase2|Death|0|||
125207143|NCT00115037|450381581|FG002|Phase2|Death|1|||
125207144|NCT00115037|450381582|FG003|Phase2|Death|0|||
125207145|NCT00115037|450381583|FG004|Phase2|Death|0|||
125207146|NCT00115037|450381584|FG005|Phase2|Death|1|||
125207147|NCT00115037|450381579|FG000|Phase2|Withdrawal by Subject|0|||
125207148|NCT00115037|450381580|FG001|Phase2|Withdrawal by Subject|0|||
125207149|NCT00115037|450381581|FG002|Phase2|Withdrawal by Subject|2|||
125207150|NCT00115037|450381582|FG003|Phase2|Withdrawal by Subject|1|||
125207151|NCT00115037|450381583|FG004|Phase2|Withdrawal by Subject|2|||
125207152|NCT00115037|450381584|FG005|Phase2|Withdrawal by Subject|1|||
125207153|NCT00115037|450381579|FG000|Phase2|Lost to Follow-up|0|||
125207154|NCT00115037|450381580|FG001|Phase2|Lost to Follow-up|0|||
125207155|NCT00115037|450381581|FG002|Phase2|Lost to Follow-up|12|||
125207156|NCT00115037|450381582|FG003|Phase2|Lost to Follow-up|14|||
125207157|NCT00115037|450381583|FG004|Phase2|Lost to Follow-up|4|||
125207158|NCT00115037|450381584|FG005|Phase2|Lost to Follow-up|10|||
125207159|NCT00396877|450381585|FG000|Overall Study|Lost to Follow-up|2|||
125207160|NCT00396877|450381586|FG001|Overall Study|Lost to Follow-up|1|||
125207161|NCT00396877|450381585|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
125207162|NCT00396877|450381586|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
125207163|NCT03422159|450381589|FG000|Overall Study|Exclusion due to terminal disease|2|||
125207164|NCT03422159|450381590|FG001|Overall Study|Exclusion due to terminal disease|1|||
125207165|NCT02631070|450381591|FG000|Overall Study|Withdrawal by Subject|35|||
125207166|NCT02631070|450381592|FG001|Overall Study|Withdrawal by Subject|13|||
125207167|NCT02631070|450381591|FG000|Overall Study|Death|45|||
125207168|NCT02631070|450381592|FG001|Overall Study|Death|24|||
125207169|NCT02631070|450381591|FG000|Overall Study|Lost to Follow-up|5|||
125207170|NCT02631070|450381592|FG001|Overall Study|Lost to Follow-up|1|||
125207171|NCT02631070|450381591|FG000|Overall Study|Transition to rollover protocol|52|||
125207172|NCT02631070|450381592|FG001|Overall Study|Transition to rollover protocol|21|||
125207173|NCT02631070|450381591|FG000|Overall Study|Other reasons|12|||
125207174|NCT02631070|450381592|FG001|Overall Study|Other reasons|5|||
125207175|NCT03769194|450381599|FG000|Overall Study|Withdrawal by Subject|0|||
125207176|NCT03769194|450381600|FG001|Overall Study|Withdrawal by Subject|7|||
125207177|NCT03769194|450381601|FG002|Overall Study|Withdrawal by Subject|4|||
125207178|NCT03769194|450381602|FG003|Overall Study|Withdrawal by Subject|1|||
125207179|NCT03769194|450381599|FG000|Overall Study|moved from study area|0|||
125207180|NCT03769194|450381600|FG001|Overall Study|moved from study area|2|||
125207181|NCT03769194|450381601|FG002|Overall Study|moved from study area|1|||
125207182|NCT03769194|450381602|FG003|Overall Study|moved from study area|1|||
125207183|NCT03769194|450381599|FG000|Overall Study|Lost to Follow-up|3|||
125207184|NCT03769194|450381600|FG001|Overall Study|Lost to Follow-up|6|||
125207185|NCT03769194|450381601|FG002|Overall Study|Lost to Follow-up|3|||
125207186|NCT03769194|450381602|FG003|Overall Study|Lost to Follow-up|6|||
125207187|NCT03769194|450381599|FG000|Overall Study|other|1|||
125207188|NCT03769194|450381600|FG001|Overall Study|other|3|||
125207189|NCT03769194|450381601|FG002|Overall Study|other|0|||
125207190|NCT03769194|450381602|FG003|Overall Study|other|1|||
125207191|NCT00087126|450381603|FG000|Overall Study|Ineligible - second primary|1|||
125207192|NCT00087126|450381603|FG000|Overall Study|Never treated|1|||
125207193|NCT00934856|450381610|FG000|Feasibility Part|Progressive disease|4|||
125207194|NCT00934856|450381611|FG001|Feasibility Part|Progressive disease|4|||
125207195|NCT00934856|450381612|FG002|Feasibility Part|Progressive disease|2|||
125207196|NCT00934856|450381613|FG003|Feasibility Part|Progressive disease|3|||
125207197|NCT00934856|450381614|FG004|Feasibility Part|Progressive disease|0|||
125207198|NCT00934856|450381615|FG005|Feasibility Part|Progressive disease|0|||
125207199|NCT00934856|450381610|FG000|Feasibility Part|Physician Decision|0|||
125207200|NCT00934856|450381611|FG001|Feasibility Part|Physician Decision|0|||
125207201|NCT00934856|450381612|FG002|Feasibility Part|Physician Decision|1|||
125207202|NCT00934856|450381613|FG003|Feasibility Part|Physician Decision|0|||
125207203|NCT00934856|450381614|FG004|Feasibility Part|Physician Decision|0|||
125207204|NCT00934856|450381615|FG005|Feasibility Part|Physician Decision|0|||
125207205|NCT00934856|450381610|FG000|Feasibility Part|Adverse Event|1|||
125207206|NCT00934856|450381611|FG001|Feasibility Part|Adverse Event|1|||
125207207|NCT00934856|450381612|FG002|Feasibility Part|Adverse Event|0|||
125207208|NCT00934856|450381613|FG003|Feasibility Part|Adverse Event|1|||
125207209|NCT00934856|450381614|FG004|Feasibility Part|Adverse Event|0|||
125207210|NCT00934856|450381615|FG005|Feasibility Part|Adverse Event|2|||
125207211|NCT00934856|450381610|FG000|Feasibility Part|Withdrawal by Subject|0|||
125207212|NCT00934856|450381611|FG001|Feasibility Part|Withdrawal by Subject|0|||
125207213|NCT00934856|450381612|FG002|Feasibility Part|Withdrawal by Subject|0|||
125207214|NCT00934856|450381613|FG003|Feasibility Part|Withdrawal by Subject|1|||
125207215|NCT00934856|450381614|FG004|Feasibility Part|Withdrawal by Subject|0|||
125207216|NCT00934856|450381615|FG005|Feasibility Part|Withdrawal by Subject|1|||
125207217|NCT00934856|450381610|FG000|Extension Part|Adverse Event|0|||
125207218|NCT00934856|450381611|FG001|Extension Part|Adverse Event|0|||
125207219|NCT00934856|450381612|FG002|Extension Part|Adverse Event|0|||
125207220|NCT00934856|450381613|FG003|Extension Part|Adverse Event|1|||
125207221|NCT00934856|450381614|FG004|Extension Part|Adverse Event|4|||
125207222|NCT00934856|450381615|FG005|Extension Part|Adverse Event|4|||
125207223|NCT00934856|450381610|FG000|Extension Part|Progressive disease|0|||
125207224|NCT00934856|450381611|FG001|Extension Part|Progressive disease|0|||
125207225|NCT00934856|450381612|FG002|Extension Part|Progressive disease|0|||
125207226|NCT00934856|450381613|FG003|Extension Part|Progressive disease|1|||
125207227|NCT00934856|450381614|FG004|Extension Part|Progressive disease|0|||
125207228|NCT00934856|450381615|FG005|Extension Part|Progressive disease|0|||
125207229|NCT00934856|450381610|FG000|Extension Part|Non-compliance with drug|0|||
125207230|NCT00934856|450381611|FG001|Extension Part|Non-compliance with drug|0|||
124981416|NCT00586612|449557474|FG001|Booster Phase|Lost to Follow-up|1|||
125207231|NCT00934856|450381612|FG002|Extension Part|Non-compliance with drug|0|||
125207232|NCT00934856|450381613|FG003|Extension Part|Non-compliance with drug|0|||
125207233|NCT00934856|450381614|FG004|Extension Part|Non-compliance with drug|0|||
125207234|NCT00934856|450381615|FG005|Extension Part|Non-compliance with drug|1|||
125207235|NCT01273155|450381616|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
125207236|NCT01273155|450381617|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
125207237|NCT01273155|450381618|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
125207238|NCT01273155|450381619|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
125207239|NCT01273155|450381620|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
125207240|NCT01273155|450381621|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
125207241|NCT01273155|450381622|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
125207242|NCT01273155|450381616|FG000|Overall Study|Change in liver function/no longer eval.|0|||
125207243|NCT01273155|450381617|FG001|Overall Study|Change in liver function/no longer eval.|1|||
125207244|NCT01273155|450381618|FG002|Overall Study|Change in liver function/no longer eval.|0|||
125207245|NCT01273155|450381619|FG003|Overall Study|Change in liver function/no longer eval.|0|||
125207246|NCT01273155|450381620|FG004|Overall Study|Change in liver function/no longer eval.|1|||
125207247|NCT01273155|450381621|FG005|Overall Study|Change in liver function/no longer eval.|0|||
125207248|NCT01273155|450381622|FG006|Overall Study|Change in liver function/no longer eval.|0|||
125207249|NCT01273155|450381616|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
125207250|NCT01273155|450381617|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
125207251|NCT01273155|450381618|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
125207252|NCT01273155|450381619|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
125207253|NCT01273155|450381620|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
125207254|NCT01273155|450381621|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
125207255|NCT01273155|450381622|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
125207256|NCT01273155|450381616|FG000|Overall Study|Died during Cycle 1|0|||
125207257|NCT01273155|450381617|FG001|Overall Study|Died during Cycle 1|0|||
125207258|NCT01273155|450381618|FG002|Overall Study|Died during Cycle 1|1|||
125207259|NCT01273155|450381619|FG003|Overall Study|Died during Cycle 1|1|||
125207260|NCT01273155|450381620|FG004|Overall Study|Died during Cycle 1|0|||
125207261|NCT01273155|450381621|FG005|Overall Study|Died during Cycle 1|2|||
125207262|NCT01273155|450381622|FG006|Overall Study|Died during Cycle 1|2|||
125207263|NCT01273155|450381616|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
125207264|NCT01273155|450381617|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
125207265|NCT01273155|450381618|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
125207266|NCT01273155|450381619|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
125207267|NCT01273155|450381620|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
125207268|NCT01273155|450381621|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
125207269|NCT01273155|450381622|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
125207270|NCT01256385|450381623|FG000|Overall Study|Physician Decision|1|||
125207271|NCT01256385|450381624|FG001|Overall Study|Physician Decision|1|||
125207272|NCT01256385|450381623|FG000|Overall Study|Withdrawal by Subject|2|||
125207273|NCT01256385|450381624|FG001|Overall Study|Withdrawal by Subject|2|||
125207274|NCT00725101|450381625|FG000|Overall Study|Death|3|||
125207275|NCT00725101|450381625|FG000|Overall Study|Lost to Follow-up|353|||
125207276|NCT00725101|450381625|FG000|Overall Study|Protocol Violation|1|||
125207277|NCT00725101|450381625|FG000|Overall Study|Withdrawal by Subject|127|||
125207278|NCT00725101|450381625|FG000|Overall Study|not specified/no reason given|11|||
125207279|NCT03164265|450381626|FG000|Overall Study|Physician Decision|3|||
125207280|NCT03233204|450381627|FG000|Overall Study|Adverse Event|1|||
125207281|NCT03233204|450381627|FG000|Overall Study|Death|1|||
125207282|NCT03233204|450381627|FG000|Overall Study|Withdrawal by Subject|1|||
125207283|NCT03233204|450381627|FG000|Overall Study|Progressive Disease|3|||
125207284|NCT03467763|450381628|FG000|Overall Study|Lost to Follow-up|1|||
125207285|NCT03467763|450381628|FG000|Overall Study|Protocol Violation|2|||
125207286|NCT02889835|450381629|FG000|Overall Study|Lost to Follow-up|13|||
125207287|NCT02889835|450381630|FG001|Overall Study|Lost to Follow-up|13|||
125207288|NCT02889835|450381631|FG002|Overall Study|Lost to Follow-up|13|||
125207289|NCT02889835|450381629|FG000|Overall Study|Withdrawal by Subject|2|||
125207290|NCT02889835|450381630|FG001|Overall Study|Withdrawal by Subject|2|||
125207291|NCT02889835|450381631|FG002|Overall Study|Withdrawal by Subject|2|||
125207292|NCT02889835|450381629|FG000|Overall Study|Protocol Violation|1|||
125207293|NCT02889835|450381630|FG001|Overall Study|Protocol Violation|1|||
125207294|NCT02889835|450381631|FG002|Overall Study|Protocol Violation|1|||
125207295|NCT02889835|450381629|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
125207296|NCT02889835|450381630|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
125207297|NCT02889835|450381631|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
125207298|NCT02889835|450381629|FG000|Overall Study|Death|1|||
125207299|NCT02889835|450381630|FG001|Overall Study|Death|1|||
125207300|NCT02889835|450381631|FG002|Overall Study|Death|1|||
125207301|NCT04918355|450381632|FG000|Overall Study|no qualifying health encounter|497|||
125207302|NCT04918355|450381633|FG001|Overall Study|no qualifying health encounter|192|||
125207303|NCT04918355|450381634|FG002|Overall Study|no qualifying health encounter|438|||
125207304|NCT04918355|450381635|FG003|Overall Study|no qualifying health encounter|424|||
125207305|NCT00577005|450383324|FG000|Overall Study|Lost to Follow-up|3|||
125207306|NCT00577005|450383325|FG001|Overall Study|Lost to Follow-up|2|||
125207307|NCT00577005|450383324|FG000|Overall Study|Withdrawal by Subject|2|||
125207308|NCT00577005|450383325|FG001|Overall Study|Withdrawal by Subject|1|||
125207309|NCT03738800|450383329|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
125207310|NCT03738800|450383330|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
125207311|NCT03738800|450383331|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
125207312|NCT03738800|450383329|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
125207313|NCT03738800|450383330|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
125207314|NCT03738800|450383331|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
125207315|NCT03738800|450383329|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
125207316|NCT03738800|450383330|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
125207317|NCT03738800|450383331|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
125207318|NCT01777295|450383332|FG000|Overall Study|Withdrawal by Subject|2|||
125207319|NCT01777295|450383333|FG001|Overall Study|Withdrawal by Subject|2|||
125207320|NCT01777295|450383332|FG000|Overall Study|Pregnancy|0|||
125207321|NCT01777295|450383333|FG001|Overall Study|Pregnancy|1|||
125207322|NCT01777295|450383332|FG000|Overall Study|Personal problem|1|||
125207323|NCT01777295|450383333|FG001|Overall Study|Personal problem|0|||
125207324|NCT01777295|450383332|FG000|Overall Study|Investigator call for AEs check|1|||
125207325|NCT01777295|450383333|FG001|Overall Study|Investigator call for AEs check|0|||
125207326|NCT02554318|450383334|FG000|Overall Study|Withdrawal by Subject|10|||
125207327|NCT02554318|450383335|FG001|Overall Study|Withdrawal by Subject|8|||
125207328|NCT00033657|450383336|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
125207329|NCT00033657|450383337|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
125207330|NCT00033657|450383336|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
125207331|NCT00033657|450383337|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
125207332|NCT00033657|450383336|FG000|Neoadjuvant Chemotherapy|Death|1|||
125207333|NCT00033657|450383337|FG001|Neoadjuvant Chemotherapy|Death|1|||
125207334|NCT00033657|450383336|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
125207335|NCT00033657|450383337|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
125207336|NCT00033657|450383336|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
125207337|NCT00033657|450383337|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
125207338|NCT00033657|450383336|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
125207339|NCT00033657|450383337|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
125207340|NCT00033657|450383336|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
125207341|NCT00033657|450383337|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
125207342|NCT00033657|450383336|FG000|Surgical Resection|not complete resection|0|||
125207343|NCT00033657|450383337|FG001|Surgical Resection|not complete resection|3|||
125207344|NCT00033657|450383336|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
125207345|NCT00033657|450383337|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
125207346|NCT00033657|450383336|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
125207347|NCT00033657|450383337|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
125207348|NCT00033657|450383336|FG000|Adjuvant Chemotherapy|Death|2|||
125207349|NCT00033657|450383337|FG001|Adjuvant Chemotherapy|Death|1|||
125207350|NCT00033657|450383336|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
125207351|NCT00033657|450383337|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
125207352|NCT00033657|450383336|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
125207353|NCT00033657|450383337|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
125207354|NCT00033657|450383336|FG000|Adjuvant Chemotherapy|Other|0|||
125207355|NCT00033657|450383337|FG001|Adjuvant Chemotherapy|Other|2|||
125207356|NCT02945254|450383338|FG000|Overall Study|Lost to Follow-up|1|||
125207357|NCT02945254|450383339|FG001|Overall Study|Lost to Follow-up|0|||
125207358|NCT02945254|450383338|FG000|Overall Study|Withdrawal by Subject|1|||
125207359|NCT02945254|450383339|FG001|Overall Study|Withdrawal by Subject|0|||
125207360|NCT03436199|450383344|FG000|Overall Study|Adverse Event|15|||
125207361|NCT03436199|450383345|FG001|Overall Study|Adverse Event|40|||
125207362|NCT03436199|450383346|FG002|Overall Study|Adverse Event|7|||
125207363|NCT03436199|450383344|FG000|Overall Study|Withdrawal by Subject|4|||
125207364|NCT03436199|450383345|FG001|Overall Study|Withdrawal by Subject|10|||
125207365|NCT03436199|450383346|FG002|Overall Study|Withdrawal by Subject|3|||
125207366|NCT03436199|450383344|FG000|Overall Study|Lost to Follow-up|1|||
125207367|NCT03436199|450383345|FG001|Overall Study|Lost to Follow-up|0|||
125207368|NCT03436199|450383346|FG002|Overall Study|Lost to Follow-up|2|||
124981417|NCT02001064|449557477|FG000|Overall Study|Withdrawal by Subject|2|||
124981418|NCT02001064|449557478|FG001|Overall Study|Withdrawal by Subject|1|||
125207369|NCT03436199|450383344|FG000|Overall Study|Protocol Violation|1|||
125207370|NCT03436199|450383345|FG001|Overall Study|Protocol Violation|1|||
125207371|NCT03436199|450383346|FG002|Overall Study|Protocol Violation|0|||
125207372|NCT03436199|450383344|FG000|Overall Study|Physician Decision|0|||
125207373|NCT03436199|450383345|FG001|Overall Study|Physician Decision|1|||
125207374|NCT03436199|450383346|FG002|Overall Study|Physician Decision|0|||
125207375|NCT03436199|450383344|FG000|Overall Study|Could not return to clinic|1|||
125207376|NCT03436199|450383345|FG001|Overall Study|Could not return to clinic|0|||
125207377|NCT03436199|450383346|FG002|Overall Study|Could not return to clinic|0|||
125207378|NCT03436199|450383344|FG000|Overall Study|Withdrawn per physician|0|||
125207379|NCT03436199|450383345|FG001|Overall Study|Withdrawn per physician|1|||
125207380|NCT03436199|450383346|FG002|Overall Study|Withdrawn per physician|0|||
125207381|NCT00085098|450383347|FG000|Overall Study|Withdrawal by Subject|0|||
125207382|NCT00085098|450383348|FG001|Overall Study|Withdrawal by Subject|1|||
125207383|NCT00085098|450383347|FG000|Overall Study|Ineligible|1|||
125207384|NCT00085098|450383348|FG001|Overall Study|Ineligible|1|||
125207385|NCT03515629|450383349|FG000|Overall Study|Death|0|||
125207386|NCT03515629|450383350|FG001|Overall Study|Death|1|||
125207387|NCT03515629|450383351|FG002|Overall Study|Death|1|||
125207388|NCT03515629|450383349|FG000|Overall Study|Progressive disease|0|||
125207389|NCT03515629|450383350|FG001|Overall Study|Progressive disease|1|||
125207390|NCT03515629|450383351|FG002|Overall Study|Progressive disease|0|||
125207391|NCT01886781|450383352|FG000|Overall Study|Protocol Violation|5|||
125207392|NCT01886781|450383353|FG001|Overall Study|Protocol Violation|0|||
125207393|NCT01886781|450383352|FG000|Overall Study|Adverse Event|1|||
125207394|NCT01886781|450383353|FG001|Overall Study|Adverse Event|0|||
125207395|NCT01886781|450383352|FG000|Overall Study|Lost to Follow-up|5|||
125207396|NCT01886781|450383353|FG001|Overall Study|Lost to Follow-up|0|||
125207397|NCT01886781|450383352|FG000|Overall Study|Withdrawal by Subject|2|||
125207398|NCT01886781|450383353|FG001|Overall Study|Withdrawal by Subject|1|||
125207399|NCT01886781|450383352|FG000|Overall Study|Worsening of symptoms|1|||
125207400|NCT01886781|450383353|FG001|Overall Study|Worsening of symptoms|1|||
125207401|NCT01522235|450383354|FG000|Overall Study|Physician Decision|1|||
125207402|NCT01522235|450383355|FG001|Overall Study|Physician Decision|1|||
125207403|NCT00980018|450383356|FG000|Overall Study|Adverse Event|8|||
125207404|NCT00980018|450383356|FG000|Overall Study|Patient withdrew consent|3|||
125207405|NCT00980018|450383356|FG000|Overall Study|Lost to Follow-up|1|||
125207406|NCT01832818|450383360|FG000|Overall Study|Lost to Follow-up|6|||
125207407|NCT01672294|450383361|FG000|Overall Study|Withdrawal by Subject|4|||
125207408|NCT01672294|450383362|FG001|Overall Study|Withdrawal by Subject|4|||
125207409|NCT01672294|450383363|FG002|Overall Study|Withdrawal by Subject|4|||
125207410|NCT01672294|450383364|FG003|Overall Study|Withdrawal by Subject|4|||
125207411|NCT01672294|450383361|FG000|Overall Study|Excluded by study|1|||
125207412|NCT01672294|450383362|FG001|Overall Study|Excluded by study|1|||
125207413|NCT01672294|450383363|FG002|Overall Study|Excluded by study|0|||
125207414|NCT01672294|450383364|FG003|Overall Study|Excluded by study|0|||
125207415|NCT01672294|450383361|FG000|Overall Study|Lost to Follow-up|1|||
125207416|NCT01672294|450383362|FG001|Overall Study|Lost to Follow-up|16|||
125207417|NCT01672294|450383363|FG002|Overall Study|Lost to Follow-up|7|||
125207418|NCT01672294|450383364|FG003|Overall Study|Lost to Follow-up|9|||
125207419|NCT01438814|450383370|FG000|Overall Study|Adverse Event|3|||
125207420|NCT01438814|450383371|FG001|Overall Study|Adverse Event|3|||
125207421|NCT01438814|450383370|FG000|Overall Study|Protocol Violation|1|||
125207422|NCT01438814|450383371|FG001|Overall Study|Protocol Violation|2|||
125207423|NCT01438814|450383370|FG000|Overall Study|Lost to Follow-up|4|||
125207424|NCT01438814|450383371|FG001|Overall Study|Lost to Follow-up|3|||
125207425|NCT01438814|450383370|FG000|Overall Study|Withdrawal by Subject|4|||
125207426|NCT01438814|450383371|FG001|Overall Study|Withdrawal by Subject|2|||
125207427|NCT01438814|450383370|FG000|Overall Study|Other|2|||
125207428|NCT01438814|450383371|FG001|Overall Study|Other|4|||
125207429|NCT01870297|450383376|FG000|Overall Study|Adverse Event|0|||
125207430|NCT01870297|450383377|FG001|Overall Study|Adverse Event|0|||
125207431|NCT01870297|450383378|FG002|Overall Study|Adverse Event|0|||
125207432|NCT01870297|450383379|FG003|Overall Study|Adverse Event|0|||
125207433|NCT01870297|450383380|FG004|Overall Study|Adverse Event|2|||
125207434|NCT01870297|450383381|FG005|Overall Study|Adverse Event|0|||
125207435|NCT01870297|450383382|FG006|Overall Study|Adverse Event|0|||
125207436|NCT01870297|450383376|FG000|Overall Study|Lost to Follow-up|0|||
125207437|NCT01870297|450383377|FG001|Overall Study|Lost to Follow-up|1|||
125207438|NCT01870297|450383378|FG002|Overall Study|Lost to Follow-up|1|||
125207439|NCT01870297|450383379|FG003|Overall Study|Lost to Follow-up|0|||
125207440|NCT01870297|450383380|FG004|Overall Study|Lost to Follow-up|0|||
125207441|NCT01870297|450383381|FG005|Overall Study|Lost to Follow-up|0|||
125207442|NCT01870297|450383382|FG006|Overall Study|Lost to Follow-up|0|||
125207443|NCT01870297|450383376|FG000|Overall Study|Withdrawal by Subject|0|||
125207444|NCT01870297|450383377|FG001|Overall Study|Withdrawal by Subject|0|||
125207445|NCT01870297|450383378|FG002|Overall Study|Withdrawal by Subject|0|||
125207446|NCT01870297|450383379|FG003|Overall Study|Withdrawal by Subject|0|||
125207447|NCT01870297|450383380|FG004|Overall Study|Withdrawal by Subject|1|||
125207448|NCT01870297|450383381|FG005|Overall Study|Withdrawal by Subject|1|||
125207449|NCT01870297|450383382|FG006|Overall Study|Withdrawal by Subject|1|||
125207450|NCT01870297|450383376|FG000|Overall Study|Sponsor Decision|0|||
125207451|NCT01870297|450383377|FG001|Overall Study|Sponsor Decision|6|||
125207452|NCT01870297|450383378|FG002|Overall Study|Sponsor Decision|0|||
125207453|NCT01870297|450383379|FG003|Overall Study|Sponsor Decision|0|||
125207454|NCT01870297|450383380|FG004|Overall Study|Sponsor Decision|0|||
125207455|NCT01870297|450383381|FG005|Overall Study|Sponsor Decision|0|||
125207456|NCT01870297|450383382|FG006|Overall Study|Sponsor Decision|1|||
125207457|NCT00337779|450383383|FG000|Overall Study|Withdrawal by Subject|10|||
125207458|NCT00337779|450383384|FG001|Overall Study|Withdrawal by Subject|12|||
125207459|NCT00337779|450383383|FG000|Overall Study|Sponsor decision|1|||
125207460|NCT00337779|450383384|FG001|Overall Study|Sponsor decision|1|||
125207461|NCT00337779|450383383|FG000|Overall Study|Physician Decision|3|||
125207462|NCT00337779|450383384|FG001|Overall Study|Physician Decision|6|||
125207463|NCT00337779|450383383|FG000|Overall Study|Protocol Violation|1|||
125207464|NCT00337779|450383384|FG001|Overall Study|Protocol Violation|1|||
125207465|NCT00337779|450383383|FG000|Overall Study|Lost to Follow-up|6|||
125207466|NCT00337779|450383384|FG001|Overall Study|Lost to Follow-up|5|||
125207467|NCT00337779|450383383|FG000|Overall Study|Adverse Event|28|||
125207468|NCT00337779|450383384|FG001|Overall Study|Adverse Event|51|||
125207469|NCT00337779|450383383|FG000|Overall Study|Pregnancy|3|||
125207470|NCT00337779|450383384|FG001|Overall Study|Pregnancy|2|||
125207471|NCT00337779|450383383|FG000|Overall Study|Death|0|||
125207472|NCT00337779|450383384|FG001|Overall Study|Death|1|||
125207473|NCT01162122|450383385|FG000|Overall Study|Withdrawal by Subject|52|||
125207474|NCT01162122|450383386|FG001|Overall Study|Withdrawal by Subject|43|||
125207475|NCT01162122|450383385|FG000|Overall Study|Lost to Follow-up|73|||
125207476|NCT01162122|450383386|FG001|Overall Study|Lost to Follow-up|91|||
125207477|NCT01162122|450383385|FG000|Overall Study|Adverse Event|3|||
125207478|NCT01162122|450383386|FG001|Overall Study|Adverse Event|2|||
125207479|NCT01162122|450383385|FG000|Overall Study|Death|51|||
125207480|NCT01162122|450383386|FG001|Overall Study|Death|46|||
125207481|NCT01162122|450383385|FG000|Overall Study|Protocol Violation|2|||
125207482|NCT01162122|450383386|FG001|Overall Study|Protocol Violation|2|||
125207483|NCT01162122|450383385|FG000|Overall Study|Inappropriate enrollment|5|||
125207484|NCT01162122|450383386|FG001|Overall Study|Inappropriate enrollment|4|||
125207485|NCT01162122|450383385|FG000|Overall Study|Administrative reason|1|||
125207486|NCT01162122|450383386|FG001|Overall Study|Administrative reason|1|||
125207487|NCT01162122|450383385|FG000|Overall Study|Unable to classify|3|||
125207488|NCT01162122|450383386|FG001|Overall Study|Unable to classify|7|||
125207489|NCT01162122|450383385|FG000|Overall Study|Missing primary reason|1|||
125207490|NCT01162122|450383386|FG001|Overall Study|Missing primary reason|0|||
125207491|NCT02020512|450383387|FG000|Overall Study|Adverse Event|1|||
125207492|NCT02020512|450383387|FG000|Overall Study|Lost to Follow-up|3|||
125207493|NCT02020512|450383387|FG000|Overall Study|Protocol Violation|4|||
125207494|NCT00422422|450383391|FG000|Overall Study|Lack of Efficacy|1|||
125207495|NCT00422422|450383391|FG000|Overall Study|Protocol Violation|1|||
125207496|NCT00422422|450383391|FG000|Overall Study|Withdrawal by Subject|2|||
125207497|NCT00422422|450383391|FG000|Overall Study|SAE, non-fatal|1|||
125207498|NCT00422422|450383391|FG000|Overall Study|AE, non-serious non-fatal|5|||
125207499|NCT03313310|450383392|FG000|Phase 2|Lost to Follow-up|4|||
125207500|NCT03313310|450383393|FG001|Phase 2|Lost to Follow-up|0|||
125207501|NCT03313310|450383392|FG000|Phase 3|Lost to Follow-up|0|||
125207502|NCT03313310|450383393|FG001|Phase 3|Lost to Follow-up|1|||
125207503|NCT00926536|450383394|FG000|Overall Study|Physician Decision|1|||
125207504|NCT00926536|450383395|FG001|Overall Study|Physician Decision|2|||
125207505|NCT00990665|450383396|FG000|Overall Study|Unsuccessful Implant|8|||
125207506|NCT00990665|450383396|FG000|Overall Study|Death|29|||
125207507|NCT00990665|450383396|FG000|Overall Study|Heart Transplant|1|||
125207508|NCT00990665|450383396|FG000|Overall Study|Withdrawal by Subject|6|||
125207509|NCT00990665|450383396|FG000|Overall Study|Lost to Follow-up|1|||
125207510|NCT00990665|450383396|FG000|Overall Study|System Explant|3|||
125207511|NCT01080391|450383399|FG000|Overall Study|Randomized but not treated|7|||
125207512|NCT01080391|450383400|FG001|Overall Study|Randomized but not treated|4|||
125207513|NCT01904903|450383401|FG000|Overall Study|Withdrawal by Subject|1|||
125207514|NCT00672841|450383402|FG000|Overall Study|Comfort care|1|||
125207515|NCT00672841|450383403|FG001|Overall Study|Comfort care|4|||
125207516|NCT00672841|450383402|FG000|Overall Study|icteric specimens|0|||
125207517|NCT00672841|450383403|FG001|Overall Study|icteric specimens|3|||
125207518|NCT00672841|450383402|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
125207519|NCT00672841|450383403|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
125207520|NCT00672841|450383402|FG000|Overall Study|Adverse Event|0|||
125207521|NCT00672841|450383403|FG001|Overall Study|Adverse Event|3|||
125207522|NCT00672841|450383402|FG000|Overall Study|Pregnancy|0|||
125207523|NCT00672841|450383403|FG001|Overall Study|Pregnancy|1|||
125207524|NCT03578146|450383404|FG000|Overall Study|Did Not Receive Treatment|1|||
125207525|NCT03578146|450383405|FG001|Overall Study|Did Not Receive Treatment|0|||
125207526|NCT03578146|450383406|FG002|Overall Study|Did Not Receive Treatment|0|||
125207527|NCT03578146|450383407|FG003|Overall Study|Did Not Receive Treatment|0|||
125207528|NCT03578146|450383408|FG004|Overall Study|Did Not Receive Treatment|0|||
125207529|NCT03578146|450383409|FG005|Overall Study|Did Not Receive Treatment|2|||
125207530|NCT03578146|450383404|FG000|Overall Study|Lost to Follow-up|0|||
125207531|NCT03578146|450383405|FG001|Overall Study|Lost to Follow-up|1|||
125207532|NCT03578146|450383406|FG002|Overall Study|Lost to Follow-up|1|||
125207533|NCT03578146|450383407|FG003|Overall Study|Lost to Follow-up|0|||
125207534|NCT03578146|450383408|FG004|Overall Study|Lost to Follow-up|0|||
125207535|NCT03578146|450383409|FG005|Overall Study|Lost to Follow-up|1|||
125207536|NCT01717391|450383410|FG000|Overall Study|Withdrawal by Subject|5|||
125207537|NCT01717391|450383410|FG000|Overall Study|Physician Decision|1|||
125207538|NCT01717391|450383410|FG000|Overall Study|FLT technical failure|3|||
125207539|NCT03677934|450383411|FG000|Overall Study|Adverse Event|1|||
125207540|NCT03677934|450383412|FG001|Overall Study|Adverse Event|1|||
125207541|NCT03677934|450383411|FG000|Overall Study|Death|8|||
125207542|NCT03677934|450383412|FG001|Overall Study|Death|4|||
125207543|NCT03677934|450383411|FG000|Overall Study|Lost to Follow-up|3|||
125207544|NCT03677934|450383412|FG001|Overall Study|Lost to Follow-up|0|||
125207545|NCT03677934|450383411|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125207546|NCT03677934|450383412|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125207547|NCT03677934|450383411|FG000|Overall Study|Physician Decision|0|||
125207548|NCT03677934|450383412|FG001|Overall Study|Physician Decision|1|||
125207549|NCT03677934|450383411|FG000|Overall Study|Withdrawal by Subject|1|||
125207550|NCT03677934|450383412|FG001|Overall Study|Withdrawal by Subject|7|||
125207551|NCT01260584|450383413|FG000|Period 1|Protocol Violation|0|||
125207552|NCT01260584|450383414|FG001|Period 1|Protocol Violation|0|||
125207553|NCT01260584|450383415|FG002|Period 1|Protocol Violation|1|||
125207554|NCT01260584|450383416|FG003|Period 1|Protocol Violation|1|||
125207555|NCT01260584|450383413|FG000|Period 1|Adverse Event|0|||
125207556|NCT01260584|450383414|FG001|Period 1|Adverse Event|0|||
125207557|NCT01260584|450383415|FG002|Period 1|Adverse Event|1|||
125207558|NCT01260584|450383416|FG003|Period 1|Adverse Event|0|||
125207559|NCT01260584|450383413|FG000|Period 2|Protocol Violation|0|||
125207560|NCT01260584|450383414|FG001|Period 2|Protocol Violation|2|||
125207561|NCT01260584|450383415|FG002|Period 2|Protocol Violation|3|||
125207562|NCT01260584|450383416|FG003|Period 2|Protocol Violation|1|||
125207563|NCT01260584|450383413|FG000|Period 2|Adverse Event|1|||
125207564|NCT01260584|450383414|FG001|Period 2|Adverse Event|0|||
125207565|NCT01260584|450383415|FG002|Period 2|Adverse Event|2|||
125207566|NCT01260584|450383416|FG003|Period 2|Adverse Event|0|||
124981419|NCT01609062|449557479|FG000|Extension Phase|Terminated by Sponsor|14|||
124981420|NCT01609062|449557480|FG001|Extension Phase|Terminated by Sponsor|9|||
124981421|NCT01609062|449557479|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
124981422|NCT01609062|449557480|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
124981423|NCT01609062|449557479|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
124981424|NCT01609062|449557480|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
125207567|NCT01260584|450383413|FG000|Period 2|Withdrawal by Subject|0|||
125207568|NCT01260584|450383414|FG001|Period 2|Withdrawal by Subject|1|||
125207569|NCT01260584|450383415|FG002|Period 2|Withdrawal by Subject|0|||
125207570|NCT01260584|450383416|FG003|Period 2|Withdrawal by Subject|0|||
125207571|NCT00932451|450383419|FG000|Overall Study|Withdrawal by Subject|69|||
125207572|NCT00932451|450383419|FG000|Overall Study|Lost to Follow-up|22|||
125207573|NCT00932451|450383419|FG000|Overall Study|Death|726|||
125207574|NCT00932451|450383419|FG000|Overall Study|Other reasons|5|||
125207575|NCT03434249|450383422|FG000|Overall Study|Adverse Event|1|||
125207576|NCT03434249|450383423|FG001|Overall Study|Adverse Event|0|||
125207577|NCT03434249|450383422|FG000|Overall Study|Lost to Follow-up|0|||
125207578|NCT03434249|450383423|FG001|Overall Study|Lost to Follow-up|1|||
125207579|NCT03434249|450383422|FG000|Overall Study|Non-compliance of family|2|||
125207580|NCT03434249|450383423|FG001|Overall Study|Non-compliance of family|1|||
125207581|NCT03434249|450383422|FG000|Overall Study|Difficulties in completing daily diary|2|||
125207582|NCT03434249|450383423|FG001|Overall Study|Difficulties in completing daily diary|1|||
125207583|NCT00561470|450383424|FG000|Overall Study|Adverse Event|74|||
125207584|NCT00561470|450383425|FG001|Overall Study|Adverse Event|163|||
125207585|NCT00561470|450383424|FG000|Overall Study|Disease progression|437|||
125207586|NCT00561470|450383425|FG001|Overall Study|Disease progression|305|||
125207587|NCT00561470|450383424|FG000|Overall Study|poor compliance to protocol|4|||
125207588|NCT00561470|450383425|FG001|Overall Study|poor compliance to protocol|4|||
125207589|NCT00561470|450383424|FG000|Overall Study|Lost to Follow-up|2|||
125207590|NCT00561470|450383425|FG001|Overall Study|Lost to Follow-up|0|||
125207591|NCT00561470|450383424|FG000|Overall Study|Physician Decision|21|||
125207592|NCT00561470|450383425|FG001|Overall Study|Physician Decision|20|||
125207593|NCT00561470|450383424|FG000|Overall Study|Consent Withdrawn|2|||
125207594|NCT00561470|450383425|FG001|Overall Study|Consent Withdrawn|6|||
125207595|NCT00561470|450383424|FG000|Overall Study|Subject request|43|||
125207596|NCT00561470|450383425|FG001|Overall Study|Subject request|77|||
125207597|NCT00561470|450383424|FG000|Overall Study|Metastatic surgery|10|||
125207598|NCT00561470|450383425|FG001|Overall Study|Metastatic surgery|12|||
125207599|NCT00561470|450383424|FG000|Overall Study|Unauthorized procedure|3|||
125207600|NCT00561470|450383425|FG001|Overall Study|Unauthorized procedure|1|||
125207601|NCT00561470|450383424|FG000|Overall Study|Randomized but not treated|5|||
125207602|NCT00561470|450383425|FG001|Overall Study|Randomized but not treated|5|||
124981425|NCT02738853|449557481|FG000|Enrollment|Inclusion/Exclusion not met|21|||
124981426|NCT02738853|449557481|FG000|Enrollment|Withdrawal by Subject|3|||
124981427|NCT02738853|449557481|FG000|Enrollment|Subject treated with commercially available device|6|||
124981428|NCT02738853|449557481|FG000|Enrollment|Study Enrollment Closed|3|||
124981429|NCT02738853|449557481|FG000|Procedure|Death|1|||
125207603|NCT00561470|450383424|FG000|Overall Study|Missed visit window|1|||
125207604|NCT00561470|450383425|FG001|Overall Study|Missed visit window|4|||
125207605|NCT00561470|450383424|FG000|Overall Study|Planning surgery|1|||
125207606|NCT00561470|450383425|FG001|Overall Study|Planning surgery|1|||
125207607|NCT00561470|450383424|FG000|Overall Study|Ongoing Treatment|11|||
125207608|NCT00561470|450383425|FG001|Overall Study|Ongoing Treatment|14|||
125207609|NCT00637806|450383426|FG000|Double-blind Phase|Study Discontinued|2|||
125207610|NCT00637806|450383427|FG001|Double-blind Phase|Study Discontinued|0|||
125207611|NCT00637806|450383428|FG002|Double-blind Phase|Study Discontinued|1|||
125207612|NCT00637806|450383429|FG003|Double-blind Phase|Study Discontinued|0|||
125207613|NCT00637806|450383426|FG000|Extension Phase|Study Discontinued|0|||
125207614|NCT00637806|450383427|FG001|Extension Phase|Study Discontinued|0|||
125207615|NCT00637806|450383428|FG002|Extension Phase|Study Discontinued|0|||
125207616|NCT00637806|450383429|FG003|Extension Phase|Study Discontinued|1|||
125207617|NCT02918552|450383430|FG000|Overall Study|Failed Pharmacokinetics|1|||
125207618|NCT02918552|450383431|FG001|Overall Study|Failed Pharmacokinetics|0|||
125207619|NCT02918552|450383430|FG000|Overall Study|Withdrawal by Subject|0|||
125207620|NCT02918552|450383431|FG001|Overall Study|Withdrawal by Subject|1|||
125207621|NCT02918552|450383430|FG000|Overall Study|Lost to Follow-up|0|||
125207622|NCT02918552|450383431|FG001|Overall Study|Lost to Follow-up|1|||
125207623|NCT01731470|450383432|FG000|Overall Study|Withdrawal by Subject|1|||
125207624|NCT01731470|450383432|FG000|Overall Study|Did not meet study criteria|1|||
125207625|NCT04395274|450383433|FG000|Overall Study|Lost to Follow-up|20|||
125207626|NCT04395274|450383434|FG001|Overall Study|Lost to Follow-up|11|||
125207627|NCT04395274|450383433|FG000|Overall Study|Withdrawal by Subject|13|||
125207628|NCT04395274|450383434|FG001|Overall Study|Withdrawal by Subject|10|||
125207629|NCT04395274|450383433|FG000|Overall Study|Moved Abroad|0|||
125207630|NCT04395274|450383434|FG001|Overall Study|Moved Abroad|1|||
125207631|NCT03325894|450383435|FG000|Overall Study|Adverse Event|2|||
125207632|NCT03325894|450383436|FG001|Overall Study|Adverse Event|3|||
125207633|NCT03325894|450383435|FG000|Overall Study|Protocol Violation|1|||
125207634|NCT03325894|450383436|FG001|Overall Study|Protocol Violation|2|||
125207635|NCT03325894|450383435|FG000|Overall Study|Withdrawal by Subject|10|||
125207636|NCT03325894|450383436|FG001|Overall Study|Withdrawal by Subject|6|||
125207637|NCT03325894|450383435|FG000|Overall Study|Lost to Follow-up|4|||
125207638|NCT03325894|450383436|FG001|Overall Study|Lost to Follow-up|9|||
125207639|NCT03325894|450383435|FG000|Overall Study|Lack of Efficacy|8|||
125207640|NCT03325894|450383436|FG001|Overall Study|Lack of Efficacy|14|||
125207641|NCT03325894|450383435|FG000|Overall Study|Study Terminated by Sponsor|38|||
125207642|NCT03325894|450383436|FG001|Overall Study|Study Terminated by Sponsor|43|||
125207643|NCT03325894|450383435|FG000|Overall Study|Other (Not received Treatment)|1|||
125207644|NCT03325894|450383436|FG001|Overall Study|Other (Not received Treatment)|0|||
125207645|NCT01592292|450383439|FG000|Overall Study|Follow-up loss|3|||
125207646|NCT01592292|450383440|FG001|Overall Study|Follow-up loss|3|||
125207647|NCT01592292|450383441|FG002|Overall Study|Follow-up loss|1|||
125207648|NCT01592292|450383442|FG003|Overall Study|Follow-up loss|0|||
125207649|NCT01592292|450383439|FG000|Overall Study|Withdrew consent|2|||
125207650|NCT01592292|450383440|FG001|Overall Study|Withdrew consent|1|||
125207651|NCT01592292|450383441|FG002|Overall Study|Withdrew consent|0|||
125207652|NCT01592292|450383442|FG003|Overall Study|Withdrew consent|0|||
125207653|NCT01592292|450383439|FG000|Overall Study|Other|1|||
125207654|NCT01592292|450383440|FG001|Overall Study|Other|1|||
125207655|NCT01592292|450383441|FG002|Overall Study|Other|2|||
125207656|NCT01592292|450383442|FG003|Overall Study|Other|1|||
125207657|NCT00335959|450383443|FG000|Overall Study|Adverse Event|2|||
125207658|NCT00335959|450383443|FG000|Overall Study|Ineligible|1|||
125207659|NCT02450552|450383444|FG000|Overall Study|Withdrawal by Subject|4|||
125207660|NCT02450552|450383445|FG001|Overall Study|Withdrawal by Subject|0|||
125207661|NCT02450552|450383446|FG002|Overall Study|Withdrawal by Subject|4|||
125207662|NCT02450552|450383444|FG000|Overall Study|Physician Decision|1|||
125207663|NCT02450552|450383445|FG001|Overall Study|Physician Decision|0|||
125207664|NCT02450552|450383446|FG002|Overall Study|Physician Decision|1|||
125207665|NCT01876979|450383448|FG000|Overall Study|Physician Decision|2|||
125207666|NCT01876979|450383449|FG001|Overall Study|Physician Decision|3|||
125207667|NCT00948506|450383450|FG000|Overall Study|Withdrawal by Subject|3|||
125207668|NCT00948506|450383451|FG001|Overall Study|Withdrawal by Subject|1|||
125207669|NCT00824382|450383455|FG000|Overall Study|Adverse Event|4|||
125207670|NCT00824382|450383456|FG001|Overall Study|Adverse Event|1|||
125207671|NCT00824382|450383457|FG002|Overall Study|Adverse Event|1|||
125207672|NCT00824382|450383458|FG003|Overall Study|Adverse Event|4|||
125207673|NCT00824382|450383455|FG000|Overall Study|Protocol Violation|1|||
125207674|NCT00824382|450383456|FG001|Overall Study|Protocol Violation|0|||
125207675|NCT00824382|450383457|FG002|Overall Study|Protocol Violation|0|||
125207676|NCT00824382|450383458|FG003|Overall Study|Protocol Violation|1|||
125207677|NCT00824382|450383455|FG000|Overall Study|Investigator's decision|0|||
125207678|NCT00824382|450383456|FG001|Overall Study|Investigator's decision|1|||
125207679|NCT00824382|450383457|FG002|Overall Study|Investigator's decision|2|||
125207680|NCT00824382|450383458|FG003|Overall Study|Investigator's decision|0|||
125207681|NCT00721279|450383459|FG000|Overall Study|Lack of Efficacy|6|||
125207682|NCT00721279|450383460|FG001|Overall Study|Lack of Efficacy|3|||
125207683|NCT00721279|450383459|FG000|Overall Study|Tolerability insufficient|5|||
125207684|NCT00721279|450383460|FG001|Overall Study|Tolerability insufficient|2|||
125207685|NCT00721279|450383459|FG000|Overall Study|Withdrawal by Subject|13|||
125207686|NCT00721279|450383460|FG001|Overall Study|Withdrawal by Subject|3|||
125207687|NCT00721279|450383459|FG000|Overall Study|Other|12|||
125207688|NCT00721279|450383460|FG001|Overall Study|Other|16|||
125207689|NCT02680834|450383461|FG000|Overall Study|Physician Decision|5|||
125207690|NCT02680834|450383462|FG001|Overall Study|Physician Decision|2|||
125207691|NCT02680834|450383461|FG000|Overall Study|Withdrawal by Subject|6|||
125207692|NCT02680834|450383462|FG001|Overall Study|Withdrawal by Subject|0|||
125207693|NCT02680834|450383461|FG000|Overall Study|Lost to Follow-up|0|||
125207694|NCT02680834|450383462|FG001|Overall Study|Lost to Follow-up|1|||
125207695|NCT01732471|450383463|FG000|Overall Study|Withdrawal by Subject|1|||
125207696|NCT00232596|450383464|FG000|6-Week Titration Phase|Adverse Event|6|||
125207697|NCT00232596|450383465|FG001|6-Week Titration Phase|Adverse Event|19|||
125207698|NCT00232596|450383464|FG000|6-Week Titration Phase|Failed to Return|2|||
125207699|NCT00232596|450383465|FG001|6-Week Titration Phase|Failed to Return|1|||
125207700|NCT00232596|450383464|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
125207701|NCT00232596|450383465|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
125207702|NCT00232596|450383464|FG000|6-Week Titration Phase|Protocol Violation|1|||
125207703|NCT00232596|450383465|FG001|6-Week Titration Phase|Protocol Violation|3|||
125207704|NCT00232596|450383464|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
125207705|NCT00232596|450383465|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
125207706|NCT00232596|450383464|FG000|6-Week Titration Phase|Other|3|||
125207707|NCT00232596|450383465|FG001|6-Week Titration Phase|Other|3|||
125207708|NCT00232596|450383464|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
125207709|NCT00232596|450383465|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
125207710|NCT00232596|450383464|FG000|12-Week Maintenance Phase|Adverse Event|7|||
125207711|NCT00232596|450383465|FG001|12-Week Maintenance Phase|Adverse Event|22|||
125207712|NCT00232596|450383464|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
125207713|NCT00232596|450383465|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
125207714|NCT00232596|450383464|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
125207715|NCT00232596|450383465|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
125207716|NCT00232596|450383464|FG000|12-Week Maintenance Phase|Other|1|||
125207717|NCT00232596|450383465|FG001|12-Week Maintenance Phase|Other|3|||
125207718|NCT01253174|450383466|FG000|Period 1|Randomized but not treated|0|||
125207719|NCT01253174|450383467|FG001|Period 1|Randomized but not treated|1|||
125207720|NCT01253174|450383468|FG002|Period 1|Randomized but not treated|1|||
125207721|NCT01253174|450383469|FG003|Period 1|Randomized but not treated|0|||
125207722|NCT01253174|450383470|FG004|Period 1|Randomized but not treated|1|||
125207723|NCT01253174|450383471|FG005|Period 1|Randomized but not treated|0|||
125207724|NCT01253174|450383466|FG000|Period 2|Adverse Event|0|||
125207725|NCT01253174|450383467|FG001|Period 2|Adverse Event|0|||
125207726|NCT01253174|450383468|FG002|Period 2|Adverse Event|1|||
125207727|NCT01253174|450383469|FG003|Period 2|Adverse Event|0|||
125207728|NCT01253174|450383470|FG004|Period 2|Adverse Event|0|||
125207729|NCT01253174|450383471|FG005|Period 2|Adverse Event|0|||
125207730|NCT01253174|450383466|FG000|Period 3|Withdrawal by Subject|0|||
125207731|NCT01253174|450383467|FG001|Period 3|Withdrawal by Subject|1|||
125207732|NCT01253174|450383468|FG002|Period 3|Withdrawal by Subject|0|||
125207733|NCT01253174|450383469|FG003|Period 3|Withdrawal by Subject|0|||
125207734|NCT01253174|450383470|FG004|Period 3|Withdrawal by Subject|1|||
125207735|NCT01253174|450383471|FG005|Period 3|Withdrawal by Subject|0|||
125207736|NCT01253174|450383466|FG000|Period 3|Pregnancy|0|||
125207737|NCT01253174|450383467|FG001|Period 3|Pregnancy|0|||
125207738|NCT01253174|450383468|FG002|Period 3|Pregnancy|1|||
125207739|NCT01253174|450383469|FG003|Period 3|Pregnancy|0|||
125207740|NCT01253174|450383470|FG004|Period 3|Pregnancy|0|||
125207741|NCT01253174|450383471|FG005|Period 3|Pregnancy|0|||
125207742|NCT04438499|450383472|FG000|Overall Study|Lack of Efficacy|3|||
125207743|NCT00224406|450385339|FG000|Overall Study|Re-transplant|0|||
125207744|NCT00224406|450385340|FG001|Overall Study|Re-transplant|2|||
125207745|NCT00224406|450385339|FG000|Overall Study|Death|0|||
125207746|NCT00224406|450385340|FG001|Overall Study|Death|1|||
125207747|NCT00224406|450385339|FG000|Overall Study|Transplant cancelled|0|||
125207748|NCT00224406|450385340|FG001|Overall Study|Transplant cancelled|4|||
125207749|NCT00224406|450385339|FG000|Overall Study|Drug not delivered|2|||
125207750|NCT00224406|450385340|FG001|Overall Study|Drug not delivered|0|||
125207751|NCT00224406|450385339|FG000|Overall Study|Other|4|||
125207752|NCT00224406|450385340|FG001|Overall Study|Other|0|||
125207753|NCT00224406|450385339|FG000|Overall Study|Transplant cancelled|3|||
125207754|NCT00224406|450385340|FG001|Overall Study|Transplant cancelled|0|||
125207755|NCT01556997|450385341|FG000|Overall Study|Adverse Event|10|||
125207756|NCT01556997|450385342|FG001|Overall Study|Adverse Event|12|||
125207757|NCT01556997|450385343|FG002|Overall Study|Adverse Event|12|||
125207758|NCT01556997|450385341|FG000|Overall Study|Lost to Follow-up|6|||
125207759|NCT01556997|450385342|FG001|Overall Study|Lost to Follow-up|6|||
125207760|NCT01556997|450385343|FG002|Overall Study|Lost to Follow-up|4|||
125207761|NCT01556997|450385341|FG000|Overall Study|Physician Decision|1|||
125207762|NCT01556997|450385342|FG001|Overall Study|Physician Decision|1|||
125207763|NCT01556997|450385343|FG002|Overall Study|Physician Decision|1|||
125207764|NCT01556997|450385341|FG000|Overall Study|Withdrawal by Subject|7|||
125207765|NCT01556997|450385342|FG001|Overall Study|Withdrawal by Subject|6|||
125207766|NCT01556997|450385343|FG002|Overall Study|Withdrawal by Subject|8|||
125207767|NCT01556997|450385341|FG000|Overall Study|Other|2|||
125207768|NCT01556997|450385342|FG001|Overall Study|Other|3|||
125207769|NCT01556997|450385343|FG002|Overall Study|Other|7|||
125207770|NCT01172808|450385344|FG000|Overall Study|Adverse Event|8|||
125207771|NCT01172808|450385345|FG001|Overall Study|Adverse Event|4|||
125207772|NCT01172808|450385346|FG002|Overall Study|Adverse Event|8|||
125207773|NCT01172808|450385347|FG003|Overall Study|Adverse Event|3|||
125207774|NCT01172808|450385344|FG000|Overall Study|Lack of Efficacy|1|||
125207775|NCT01172808|450385345|FG001|Overall Study|Lack of Efficacy|0|||
125207776|NCT01172808|450385346|FG002|Overall Study|Lack of Efficacy|0|||
125207777|NCT01172808|450385347|FG003|Overall Study|Lack of Efficacy|0|||
125207778|NCT01172808|450385344|FG000|Overall Study|Protocol Violation|2|||
125207779|NCT01172808|450385345|FG001|Overall Study|Protocol Violation|2|||
125207780|NCT01172808|450385346|FG002|Overall Study|Protocol Violation|2|||
125207781|NCT01172808|450385347|FG003|Overall Study|Protocol Violation|0|||
125207782|NCT01172808|450385344|FG000|Overall Study|Lost to Follow-up|0|||
125207783|NCT01172808|450385345|FG001|Overall Study|Lost to Follow-up|1|||
125207784|NCT01172808|450385346|FG002|Overall Study|Lost to Follow-up|1|||
125207785|NCT01172808|450385347|FG003|Overall Study|Lost to Follow-up|3|||
125207786|NCT01172808|450385344|FG000|Overall Study|Withdrawal by Subject|4|||
125207787|NCT01172808|450385345|FG001|Overall Study|Withdrawal by Subject|1|||
125207788|NCT01172808|450385346|FG002|Overall Study|Withdrawal by Subject|3|||
125207789|NCT01172808|450385347|FG003|Overall Study|Withdrawal by Subject|2|||
125207790|NCT01172808|450385344|FG000|Overall Study|Other|6|||
125207791|NCT01172808|450385345|FG001|Overall Study|Other|5|||
125207792|NCT01172808|450385346|FG002|Overall Study|Other|9|||
125207793|NCT01172808|450385347|FG003|Overall Study|Other|7|||
125207794|NCT01092637|450385355|FG000|Overall Study|Death|47|||
125207795|NCT01092637|450385356|FG001|Overall Study|Death|49|||
125207796|NCT02278367|450385357|FG000|Overall Study|Physician Decision|5|||
125207797|NCT02278367|450385358|FG001|Overall Study|Physician Decision|0|||
125207798|NCT02278367|450385357|FG000|Overall Study|Withdrawal by Subject|5|||
125207799|NCT02278367|450385358|FG001|Overall Study|Withdrawal by Subject|0|||
125207800|NCT05932225|450385360|FG000|Overall Study|Lost to Follow-up|0|||
125207801|NCT05932225|450385361|FG001|Overall Study|Lost to Follow-up|1|||
125207802|NCT05932225|450385362|FG002|Overall Study|Lost to Follow-up|0|||
125207803|NCT05932225|450385360|FG000|Overall Study|Withdrawal by Subject|1|||
125207804|NCT05932225|450385361|FG001|Overall Study|Withdrawal by Subject|0|||
125207805|NCT05932225|450385362|FG002|Overall Study|Withdrawal by Subject|0|||
125207806|NCT05932225|450385360|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
125207807|NCT05932225|450385361|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
125207808|NCT05932225|450385362|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
125207809|NCT02638129|450385363|FG000|Overall Study|Study terminated|28|||
125207810|NCT02638129|450385364|FG001|Overall Study|Study terminated|30|||
125207811|NCT02949908|450385367|FG000|Overall Study|Study termination|2|||
125207812|NCT02607280|450385372|FG000|Overall Study|Adverse Event|4|||
125207813|NCT02607280|450385373|FG001|Overall Study|Adverse Event|0|||
125207814|NCT02607280|450385372|FG000|Overall Study|Decrease in CrCl <15|0|||
125207815|NCT02607280|450385373|FG001|Overall Study|Decrease in CrCl <15|1|||
125207816|NCT01004432|450385374|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
125207817|NCT01004432|450385375|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
125207818|NCT01004432|450385376|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
125207819|NCT01004432|450385377|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
125207820|NCT01004432|450385378|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
125207821|NCT01004432|450385374|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
125207822|NCT01004432|450385375|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
125207823|NCT01004432|450385376|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
125207824|NCT01004432|450385377|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
125207825|NCT01004432|450385378|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
125207826|NCT01004432|450385374|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
125207827|NCT01004432|450385375|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
125207828|NCT01004432|450385376|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
125207829|NCT01004432|450385377|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
125207830|NCT01004432|450385378|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
125207831|NCT01004432|450385374|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
125207832|NCT01004432|450385375|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
125207833|NCT01004432|450385376|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
125207834|NCT01004432|450385377|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
125207835|NCT01004432|450385378|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
125207836|NCT01004432|450385374|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
125207837|NCT01004432|450385375|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
125207838|NCT01004432|450385376|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
125207839|NCT01004432|450385377|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
125207840|NCT01004432|450385378|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
125207841|NCT01004432|450385374|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
125207842|NCT01004432|450385375|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
125207843|NCT01004432|450385376|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
125207844|NCT01004432|450385377|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
125207845|NCT01004432|450385378|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
125207846|NCT01004432|450385374|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
125207847|NCT01004432|450385375|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
125207848|NCT01004432|450385376|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
125207849|NCT01004432|450385377|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
125207850|NCT01004432|450385378|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
125207851|NCT01004432|450385374|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
125207852|NCT01004432|450385375|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
125207853|NCT01004432|450385376|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
125207854|NCT01004432|450385377|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
125207855|NCT01004432|450385378|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
125207856|NCT01004432|450385374|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
125207857|NCT01004432|450385375|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
125207858|NCT01004432|450385376|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
125207859|NCT01004432|450385377|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
125207860|NCT01004432|450385378|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
125207861|NCT01004432|450385374|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
125207862|NCT01004432|450385375|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
125207863|NCT01004432|450385376|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
125207864|NCT01004432|450385377|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
125207865|NCT01004432|450385378|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
125207866|NCT01004432|450385374|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
125207867|NCT01004432|450385375|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
125207868|NCT01004432|450385376|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
125207869|NCT01004432|450385377|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
125207870|NCT01004432|450385378|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
125207871|NCT01004432|450385374|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
125207872|NCT01004432|450385375|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
125207873|NCT01004432|450385376|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
125207874|NCT01004432|450385377|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
125207875|NCT01004432|450385378|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
125207876|NCT01004432|450385374|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
125207877|NCT01004432|450385375|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
125207878|NCT01004432|450385376|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
125207879|NCT01004432|450385377|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
125207880|NCT01004432|450385378|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
125207881|NCT01004432|450385374|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
125207882|NCT01004432|450385375|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
125207883|NCT01004432|450385376|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
125207884|NCT01004432|450385377|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
125207885|NCT01004432|450385378|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
125207886|NCT01004432|450385374|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
125207887|NCT01004432|450385375|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
125207888|NCT01004432|450385376|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
125207889|NCT01004432|450385377|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
125207890|NCT01004432|450385378|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
125207891|NCT02667626|450385379|FG000|Overall Study|Withdrawal by Subject|0|||
125207892|NCT02667626|450385380|FG001|Overall Study|Withdrawal by Subject|1|||
125207893|NCT02696434|450385382|FG000|Overall Study|Adverse Event|3|||
125207894|NCT02696434|450385383|FG001|Overall Study|Adverse Event|1|||
125207895|NCT02696434|450385382|FG000|Overall Study|Lost to Follow-up|5|||
125207896|NCT02696434|450385383|FG001|Overall Study|Lost to Follow-up|4|||
125207897|NCT02696434|450385382|FG000|Overall Study|Withdrawal by Subject|14|||
125207898|NCT02696434|450385383|FG001|Overall Study|Withdrawal by Subject|12|||
125207899|NCT02696434|450385382|FG000|Overall Study|Physician Decision|0|||
125207900|NCT02696434|450385383|FG001|Overall Study|Physician Decision|1|||
125207901|NCT02539134|450385384|FG000|Overall Study|Lost to Follow-up|1|||
125207902|NCT02539134|450385385|FG001|Overall Study|Lost to Follow-up|0|||
125207903|NCT02539134|450385386|FG002|Overall Study|Lost to Follow-up|0|||
124981430|NCT02738853|449557481|FG000|1 Month|Death|2|||
125207904|NCT02539134|450385387|FG003|Overall Study|Lost to Follow-up|0|||
125207905|NCT02539134|450385388|FG004|Overall Study|Lost to Follow-up|0|||
124981431|NCT02738853|449557481|FG000|6 Month|Death|4|||
125207906|NCT02539134|450385389|FG005|Overall Study|Lost to Follow-up|0|||
125207907|NCT01149421|450385390|FG000|Overall Study|Adverse Event|22|||
125207908|NCT01149421|450385391|FG001|Overall Study|Adverse Event|6|||
125207909|NCT01149421|450385392|FG002|Overall Study|Adverse Event|11|||
125207910|NCT01149421|450385390|FG000|Overall Study|Withdrawal by Subject|20|||
125207911|NCT01149421|450385391|FG001|Overall Study|Withdrawal by Subject|12|||
125207912|NCT01149421|450385392|FG002|Overall Study|Withdrawal by Subject|13|||
125207913|NCT01149421|450385390|FG000|Overall Study|Sponsor Decision|0|||
125207914|NCT01149421|450385391|FG001|Overall Study|Sponsor Decision|1|||
125207915|NCT01149421|450385392|FG002|Overall Study|Sponsor Decision|1|||
125207916|NCT01149421|450385390|FG000|Overall Study|Lost to Follow-up|2|||
125207917|NCT01149421|450385391|FG001|Overall Study|Lost to Follow-up|4|||
125207918|NCT01149421|450385392|FG002|Overall Study|Lost to Follow-up|5|||
125207919|NCT01149421|450385390|FG000|Overall Study|Physician Decision|5|||
125207920|NCT01149421|450385391|FG001|Overall Study|Physician Decision|3|||
125207921|NCT01149421|450385392|FG002|Overall Study|Physician Decision|6|||
125207922|NCT01149421|450385390|FG000|Overall Study|Entry Criteria Not Met|1|||
125207923|NCT01149421|450385391|FG001|Overall Study|Entry Criteria Not Met|1|||
125207924|NCT01149421|450385392|FG002|Overall Study|Entry Criteria Not Met|2|||
125207925|NCT01149421|450385390|FG000|Overall Study|Protocol Violation|2|||
125207926|NCT01149421|450385391|FG001|Overall Study|Protocol Violation|2|||
125207927|NCT01149421|450385392|FG002|Overall Study|Protocol Violation|6|||
125207928|NCT00616603|450385393|FG000|Overall Study|Physician Decision|2|||
125207929|NCT00616603|450385394|FG001|Overall Study|Physician Decision|0|||
125207930|NCT00616603|450385395|FG002|Overall Study|Physician Decision|2|||
125207931|NCT00766467|450385397|FG000|Overall Study|Withdrawal by Subject|7|||
125207932|NCT00766467|450385398|FG001|Overall Study|Withdrawal by Subject|2|||
125207933|NCT00766467|450385397|FG000|Overall Study|Adverse Event|1|||
125207934|NCT00766467|450385398|FG001|Overall Study|Adverse Event|1|||
125207935|NCT00766467|450385397|FG000|Overall Study|Protocol Violation|2|||
125207936|NCT00766467|450385398|FG001|Overall Study|Protocol Violation|4|||
125207937|NCT00766467|450385397|FG000|Overall Study|Tumor Progression on Study|0|||
125207938|NCT00766467|450385398|FG001|Overall Study|Tumor Progression on Study|1|||
125207939|NCT00766467|450385397|FG000|Overall Study|Physician Decision|1|||
125207940|NCT00766467|450385398|FG001|Overall Study|Physician Decision|0|||
125207941|NCT00943670|450385408|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
125207942|NCT00943670|450385408|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
125207943|NCT00943670|450385408|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
125207944|NCT00943670|450385408|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
125207945|NCT00943670|450385408|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
125207946|NCT00943670|450385408|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
125207947|NCT00943670|450385408|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
125207948|NCT00943670|450385408|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
125207949|NCT00943670|450385408|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
125207950|NCT00943670|450385408|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
125207951|NCT03956615|450385409|FG000|Overall Study|No multiple myeloma confirmed|2|||
125207952|NCT03956615|450385409|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
125207953|NCT03956615|450385409|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
125207954|NCT03956615|450385409|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
125207955|NCT01069419|450385410|FG000|Overall Study|Adverse Event|233|||
125207956|NCT01069419|450385410|FG000|Overall Study|Lack of Efficacy|332|||
125207957|NCT01069419|450385410|FG000|Overall Study|Lost to Follow-up|49|||
125207958|NCT01069419|450385410|FG000|Overall Study|Remission of disease|11|||
125207959|NCT01069419|450385410|FG000|Overall Study|Withdrawal by Subject|34|||
125207960|NCT01069419|450385410|FG000|Overall Study|Other Reason|43|||
125207961|NCT01069419|450385410|FG000|Overall Study|Missing termination information|13|||
125207962|NCT00908076|450385411|FG000|Overall Study|Lack of Efficacy|1|||
125207963|NCT00908076|450385412|FG001|Overall Study|Lack of Efficacy|1|||
125207964|NCT02382796|450385413|FG000|Overall Study|Global deterioration of health status|1|||
125207965|NCT02382796|450385413|FG000|Overall Study|Objective progression or relapse|3|||
125207966|NCT02382796|450385413|FG000|Overall Study|Commercial dacomitinib became available|3|||
125207967|NCT00334802|450385420|FG000|Overall Study|Progressive Disease|2|||
125207968|NCT00334802|450385421|FG001|Overall Study|Progressive Disease|24|||
125207969|NCT00334802|450385420|FG000|Overall Study|Toxicity|1|||
125207970|NCT00334802|450385421|FG001|Overall Study|Toxicity|5|||
125207971|NCT00334802|450385420|FG000|Overall Study|Lack of Efficacy|1|||
125207972|NCT00334802|450385421|FG001|Overall Study|Lack of Efficacy|3|||
125207973|NCT00334802|450385420|FG000|Overall Study|Patient Condition Aggrevated|1|||
125207974|NCT00334802|450385421|FG001|Overall Study|Patient Condition Aggrevated|0|||
125207975|NCT00334802|450385420|FG000|Overall Study|Physician Decision|1|||
125207976|NCT00334802|450385421|FG001|Overall Study|Physician Decision|0|||
125207977|NCT00334802|450385420|FG000|Overall Study|Withdrawal by Subject|0|||
125207978|NCT00334802|450385421|FG001|Overall Study|Withdrawal by Subject|4|||
125207979|NCT00334802|450385420|FG000|Overall Study|Adverse Event|0|||
125207980|NCT00334802|450385421|FG001|Overall Study|Adverse Event|3|||
124981432|NCT02738853|449557481|FG000|6 Month|Withdrawal by Subject|2|||
124981433|NCT02738853|449557481|FG000|1 Year|Death|6|||
124981434|NCT02738853|449557481|FG000|1 Year|Withdrawal by Subject|1|||
124981435|NCT02738853|449557481|FG000|2 Year|Death|2|||
124981436|NCT02738853|449557481|FG000|2 Year|Lost to Follow-up|1|||
124981437|NCT02738853|449557481|FG000|3 Year|Death|2|||
124981438|NCT02738853|449557481|FG000|3 Year|Withdrawal by Subject|1|||
124981439|NCT02738853|449557481|FG000|4 Year|Death|9|||
124981440|NCT02738853|449557481|FG000|5 Year|Lost to Follow-up|4|||
124981441|NCT02626455|449557486|FG000|Overall Study|Other|1|||
125207981|NCT00334802|450385420|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
124981442|NCT02626455|449557487|FG001|Overall Study|Other|1|||
124981443|NCT02626455|449557488|FG002|Overall Study|Other|0|||
124981444|NCT02626455|449557489|FG003|Overall Study|Other|0|||
124981445|NCT02626455|449557490|FG004|Overall Study|Other|0|||
124981446|NCT02626455|449557491|FG005|Overall Study|Other|17|||
124981447|NCT02626455|449557492|FG006|Overall Study|Other|23|||
124981448|NCT02626455|449557486|FG000|Overall Study|Withdrawal by Subject|1|||
124981449|NCT02626455|449557487|FG001|Overall Study|Withdrawal by Subject|0|||
124981450|NCT02626455|449557488|FG002|Overall Study|Withdrawal by Subject|0|||
124981451|NCT02626455|449557489|FG003|Overall Study|Withdrawal by Subject|0|||
124981452|NCT02626455|449557490|FG004|Overall Study|Withdrawal by Subject|0|||
124981453|NCT02626455|449557491|FG005|Overall Study|Withdrawal by Subject|10|||
124981454|NCT02626455|449557492|FG006|Overall Study|Withdrawal by Subject|6|||
124981455|NCT02626455|449557486|FG000|Overall Study|Physician Decision|0|||
124981456|NCT02626455|449557487|FG001|Overall Study|Physician Decision|2|||
124981457|NCT02626455|449557488|FG002|Overall Study|Physician Decision|2|||
124981458|NCT02626455|449557489|FG003|Overall Study|Physician Decision|2|||
124981459|NCT02626455|449557490|FG004|Overall Study|Physician Decision|1|||
124981460|NCT02626455|449557491|FG005|Overall Study|Physician Decision|10|||
124981461|NCT02626455|449557492|FG006|Overall Study|Physician Decision|3|||
124981462|NCT02626455|449557486|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
124981463|NCT02626455|449557487|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
124981464|NCT02626455|449557488|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
124981465|NCT02626455|449557489|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
124981466|NCT02626455|449557490|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
124981467|NCT02626455|449557491|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
124981468|NCT02626455|449557492|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
124981469|NCT02626455|449557486|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
124981470|NCT02626455|449557487|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
124981471|NCT02626455|449557488|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
124981472|NCT02626455|449557489|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
124981473|NCT02626455|449557490|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
124981474|NCT02626455|449557491|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
124981475|NCT02626455|449557492|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
124981476|NCT02626455|449557486|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
124981477|NCT02626455|449557487|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
124981478|NCT02626455|449557488|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
124981479|NCT02626455|449557489|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
124981480|NCT02626455|449557490|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
124981481|NCT02626455|449557491|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
124981482|NCT02626455|449557492|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
124981483|NCT02626455|449557486|FG000|Overall Study|Patient decision|0|||
124981484|NCT02626455|449557487|FG001|Overall Study|Patient decision|1|||
124981485|NCT02626455|449557488|FG002|Overall Study|Patient decision|0|||
124981486|NCT02626455|449557489|FG003|Overall Study|Patient decision|0|||
125207982|NCT00334802|450385421|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
125207983|NCT03887117|450385422|FG000|Overall Study|Discontinued prematurely|0|||
125207984|NCT03887117|450385423|FG001|Overall Study|Discontinued prematurely|1|||
125207985|NCT03887117|450385424|FG002|Overall Study|Discontinued prematurely|1|||
125207986|NCT03887117|450385425|FG003|Overall Study|Discontinued prematurely|2|||
125207987|NCT01739764|450385426|FG000|Overall Study|Adverse Event|0|||
125207988|NCT01739764|450385427|FG001|Overall Study|Adverse Event|3|||
125207989|NCT01739764|450385428|FG002|Overall Study|Adverse Event|4|||
125207990|NCT01739764|450385426|FG000|Overall Study|Death|4|||
125207991|NCT01739764|450385427|FG001|Overall Study|Death|6|||
125207992|NCT01739764|450385428|FG002|Overall Study|Death|38|||
124981487|NCT02626455|449557490|FG004|Overall Study|Patient decision|1|||
124981488|NCT02626455|449557491|FG005|Overall Study|Patient decision|36|||
124981489|NCT02626455|449557492|FG006|Overall Study|Patient decision|22|||
124981490|NCT02626455|449557486|FG000|Overall Study|Protocol Violation|0|||
124981491|NCT02626455|449557487|FG001|Overall Study|Protocol Violation|0|||
125207993|NCT01739764|450385426|FG000|Overall Study|Lost to Follow-up|0|||
125207994|NCT01739764|450385427|FG001|Overall Study|Lost to Follow-up|0|||
125207995|NCT01739764|450385428|FG002|Overall Study|Lost to Follow-up|5|||
125207996|NCT01739764|450385426|FG000|Overall Study|Non-Compliance|0|||
125207997|NCT01739764|450385427|FG001|Overall Study|Non-Compliance|0|||
125207998|NCT01739764|450385428|FG002|Overall Study|Non-Compliance|1|||
125207999|NCT01739764|450385426|FG000|Overall Study|Multiple Reasons|3|||
125208000|NCT01739764|450385427|FG001|Overall Study|Multiple Reasons|2|||
125208001|NCT01739764|450385428|FG002|Overall Study|Multiple Reasons|3|||
125208002|NCT01739764|450385426|FG000|Overall Study|Physician Decision|2|||
125208003|NCT01739764|450385427|FG001|Overall Study|Physician Decision|2|||
125208004|NCT01739764|450385428|FG002|Overall Study|Physician Decision|4|||
125208005|NCT01739764|450385426|FG000|Overall Study|Progressive Disease|3|||
125208006|NCT01739764|450385427|FG001|Overall Study|Progressive Disease|5|||
125208007|NCT01739764|450385428|FG002|Overall Study|Progressive Disease|16|||
125208008|NCT01739764|450385426|FG000|Overall Study|Protocol Violation|0|||
125208009|NCT01739764|450385427|FG001|Overall Study|Protocol Violation|0|||
125208010|NCT01739764|450385428|FG002|Overall Study|Protocol Violation|2|||
125208011|NCT01739764|450385426|FG000|Overall Study|Study Terminated by Sponsor|8|||
125208012|NCT01739764|450385427|FG001|Overall Study|Study Terminated by Sponsor|13|||
125208013|NCT01739764|450385428|FG002|Overall Study|Study Terminated by Sponsor|26|||
125208014|NCT01739764|450385426|FG000|Overall Study|Withdrawal by Subject|6|||
125208015|NCT01739764|450385427|FG001|Overall Study|Withdrawal by Subject|5|||
125208016|NCT01739764|450385428|FG002|Overall Study|Withdrawal by Subject|27|||
125208017|NCT01389258|450385429|FG000|Overall Study|Lost to Follow-up|5|||
125208018|NCT01534208|450385430|FG000|Overall Study|Lost to Follow-up|19|||
125208019|NCT01534208|450385431|FG001|Overall Study|Lost to Follow-up|14|||
125208020|NCT01534208|450385430|FG000|Overall Study|Withdrawal by Subject|6|||
125208021|NCT01534208|450385431|FG001|Overall Study|Withdrawal by Subject|20|||
125208022|NCT01534208|450385430|FG000|Overall Study|Adverse Event|15|||
125208023|NCT01534208|450385431|FG001|Overall Study|Adverse Event|8|||
125208024|NCT01534208|450385430|FG000|Overall Study|Physician Decision|2|||
125208025|NCT01534208|450385431|FG001|Overall Study|Physician Decision|0|||
125208026|NCT01534208|450385430|FG000|Overall Study|Lack of Efficacy|0|||
125208027|NCT01534208|450385431|FG001|Overall Study|Lack of Efficacy|3|||
125208028|NCT01534208|450385430|FG000|Overall Study|Protocol Violation|2|||
125208029|NCT01534208|450385431|FG001|Overall Study|Protocol Violation|2|||
125208030|NCT01534208|450385430|FG000|Overall Study|Sponsor decision|4|||
125208031|NCT01534208|450385431|FG001|Overall Study|Sponsor decision|1|||
125208032|NCT01534208|450385430|FG000|Overall Study|Subject relocation|2|||
125208033|NCT01534208|450385431|FG001|Overall Study|Subject relocation|0|||
125208034|NCT01534208|450385430|FG000|Overall Study|Lab assessment|2|||
125208035|NCT01534208|450385431|FG001|Overall Study|Lab assessment|1|||
125208036|NCT01534208|450385430|FG000|Overall Study|Eligibility error|3|||
125208037|NCT01534208|450385431|FG001|Overall Study|Eligibility error|0|||
125208038|NCT01534208|450385430|FG000|Overall Study|PCP decision|1|||
125208039|NCT01534208|450385431|FG001|Overall Study|PCP decision|0|||
125208040|NCT01534208|450385430|FG000|Overall Study|Needed prohibited meds|1|||
125208041|NCT01534208|450385431|FG001|Overall Study|Needed prohibited meds|0|||
125208042|NCT03482167|450385434|FG000|Allocated to Intervention|Physician Decision|1|||
125208043|NCT03482167|450385435|FG001|Allocated to Intervention|Physician Decision|2|||
125208044|NCT03482167|450385434|FG000|Received Intervention|Adverse Event|3|||
125208045|NCT03482167|450385435|FG001|Received Intervention|Adverse Event|1|||
125208046|NCT03482167|450385434|FG000|Received Intervention|Physician Decision|1|||
125208047|NCT03482167|450385435|FG001|Received Intervention|Physician Decision|1|||
125208048|NCT03482167|450385434|FG000|Received Intervention|Withdrawal by Subject|1|||
125208049|NCT03482167|450385435|FG001|Received Intervention|Withdrawal by Subject|0|||
125208050|NCT01001598|450385440|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
125208051|NCT01001598|450385440|FG000|Overall Study|Adverse Event|1|||
125208052|NCT05079230|450385451|FG000|Overall Study|Study Terminated by Sponsor|101|||
125208053|NCT05079230|450385452|FG001|Overall Study|Study Terminated by Sponsor|102|||
125208054|NCT05079230|450385451|FG000|Overall Study|Death|72|||
125208055|NCT05079230|450385452|FG001|Overall Study|Death|66|||
125208056|NCT05079230|450385451|FG000|Overall Study|Withdrew Consent|16|||
125208057|NCT05079230|450385452|FG001|Overall Study|Withdrew Consent|18|||
125208058|NCT05079230|450385451|FG000|Overall Study|Lost to Follow-up|0|||
125208059|NCT05079230|450385452|FG001|Overall Study|Lost to Follow-up|3|||
125208060|NCT02920177|450385453|FG000|Overall Study|Withdrawal by Subject|1|||
125208061|NCT02920177|450385454|FG001|Overall Study|Withdrawal by Subject|1|||
125208062|NCT02920177|450385453|FG000|Overall Study|Physician Decision|1|||
125208063|NCT02920177|450385454|FG001|Overall Study|Physician Decision|0|||
125208064|NCT02920177|450385453|FG000|Overall Study|Lost to Follow-up|0|||
125208065|NCT02920177|450385454|FG001|Overall Study|Lost to Follow-up|1|||
125208066|NCT01362244|450385456|FG000|Overall Study|Adverse Event|3|||
125208067|NCT01362244|450385457|FG001|Overall Study|Adverse Event|5|||
125208068|NCT01362244|450385456|FG000|Overall Study|Lack of Efficacy|5|||
125208069|NCT01362244|450385457|FG001|Overall Study|Lack of Efficacy|11|||
125208070|NCT01362244|450385456|FG000|Overall Study|Lost to Follow-up|0|||
125208071|NCT01362244|450385457|FG001|Overall Study|Lost to Follow-up|2|||
125208072|NCT01362244|450385456|FG000|Overall Study|Protocol Violation|5|||
125208073|NCT01362244|450385457|FG001|Overall Study|Protocol Violation|1|||
125208074|NCT01362244|450385456|FG000|Overall Study|Withdrawal by Subject|2|||
125208075|NCT01362244|450385457|FG001|Overall Study|Withdrawal by Subject|1|||
125208076|NCT01362244|450385456|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
125208077|NCT01362244|450385457|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
125208078|NCT01362244|450385456|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
125208079|NCT01362244|450385457|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
125208080|NCT05153148|450385458|FG000|Overall Study|Adverse Event|1|||
125208081|NCT05153148|450385459|FG001|Overall Study|Adverse Event|0|||
124981492|NCT02626455|449557488|FG002|Overall Study|Protocol Violation|0|||
124981493|NCT02626455|449557489|FG003|Overall Study|Protocol Violation|0|||
124981494|NCT02626455|449557490|FG004|Overall Study|Protocol Violation|0|||
124981495|NCT02626455|449557491|FG005|Overall Study|Protocol Violation|0|||
124981496|NCT02626455|449557492|FG006|Overall Study|Protocol Violation|1|||
124981497|NCT02626455|449557486|FG000|Overall Study|Progressive disease - radiological progression|0|||
124981498|NCT02626455|449557487|FG001|Overall Study|Progressive disease - radiological progression|0|||
124981499|NCT02626455|449557488|FG002|Overall Study|Progressive disease - radiological progression|0|||
124981500|NCT02626455|449557489|FG003|Overall Study|Progressive disease - radiological progression|0|||
124981501|NCT02626455|449557490|FG004|Overall Study|Progressive disease - radiological progression|0|||
124981502|NCT02626455|449557491|FG005|Overall Study|Progressive disease - radiological progression|11|||
124981503|NCT02626455|449557492|FG006|Overall Study|Progressive disease - radiological progression|22|||
124981504|NCT02626455|449557486|FG000|Overall Study|Progressive disease - clinical progression|0|||
124981505|NCT02626455|449557487|FG001|Overall Study|Progressive disease - clinical progression|0|||
124981506|NCT02626455|449557488|FG002|Overall Study|Progressive disease - clinical progression|0|||
124981507|NCT02626455|449557489|FG003|Overall Study|Progressive disease - clinical progression|0|||
124981508|NCT02626455|449557490|FG004|Overall Study|Progressive disease - clinical progression|0|||
124981509|NCT02626455|449557491|FG005|Overall Study|Progressive disease - clinical progression|1|||
124981510|NCT02626455|449557492|FG006|Overall Study|Progressive disease - clinical progression|2|||
124981511|NCT02626455|449557486|FG000|Overall Study|Lost to Follow-up|0|||
124981512|NCT02626455|449557487|FG001|Overall Study|Lost to Follow-up|0|||
124981513|NCT02626455|449557488|FG002|Overall Study|Lost to Follow-up|0|||
124981514|NCT02626455|449557489|FG003|Overall Study|Lost to Follow-up|0|||
124981515|NCT02626455|449557490|FG004|Overall Study|Lost to Follow-up|0|||
124981516|NCT02626455|449557491|FG005|Overall Study|Lost to Follow-up|1|||
124981517|NCT02626455|449557492|FG006|Overall Study|Lost to Follow-up|0|||
124981518|NCT02626455|449557486|FG000|Overall Study|AE not associated with clinical disease progression|1|||
124981519|NCT02626455|449557487|FG001|Overall Study|AE not associated with clinical disease progression|1|||
124981520|NCT02626455|449557488|FG002|Overall Study|AE not associated with clinical disease progression|0|||
124981521|NCT02626455|449557489|FG003|Overall Study|AE not associated with clinical disease progression|2|||
124981522|NCT02626455|449557490|FG004|Overall Study|AE not associated with clinical disease progression|1|||
124981523|NCT02626455|449557491|FG005|Overall Study|AE not associated with clinical disease progression|65|||
124981524|NCT02626455|449557492|FG006|Overall Study|AE not associated with clinical disease progression|21|||
124981525|NCT02626455|449557486|FG000|Overall Study|AE associated with clinical disease progression|0|||
124981526|NCT02626455|449557487|FG001|Overall Study|AE associated with clinical disease progression|0|||
124981527|NCT02626455|449557488|FG002|Overall Study|AE associated with clinical disease progression|0|||
124981528|NCT02626455|449557489|FG003|Overall Study|AE associated with clinical disease progression|0|||
124981529|NCT02626455|449557490|FG004|Overall Study|AE associated with clinical disease progression|0|||
124981530|NCT02626455|449557491|FG005|Overall Study|AE associated with clinical disease progression|1|||
124981531|NCT02626455|449557492|FG006|Overall Study|AE associated with clinical disease progression|2|||
124981532|NCT02626455|449557486|FG000|Overall Study|Study intervention never administered|0|||
124981533|NCT02626455|449557487|FG001|Overall Study|Study intervention never administered|0|||
124981534|NCT02626455|449557488|FG002|Overall Study|Study intervention never administered|0|||
124981535|NCT02626455|449557489|FG003|Overall Study|Study intervention never administered|0|||
124981536|NCT02626455|449557490|FG004|Overall Study|Study intervention never administered|0|||
124981537|NCT02626455|449557491|FG005|Overall Study|Study intervention never administered|1|||
124981538|NCT02626455|449557492|FG006|Overall Study|Study intervention never administered|3|||
125208082|NCT05153148|450385460|FG002|Overall Study|Adverse Event|3|||
125208083|NCT05153148|450385461|FG003|Overall Study|Adverse Event|5|||
125208084|NCT05153148|450385458|FG000|Overall Study|Lost to Follow-up|1|||
125208085|NCT05153148|450385459|FG001|Overall Study|Lost to Follow-up|1|||
125208086|NCT05153148|450385460|FG002|Overall Study|Lost to Follow-up|2|||
125208087|NCT05153148|450385461|FG003|Overall Study|Lost to Follow-up|0|||
125208088|NCT05153148|450385458|FG000|Overall Study|Withdrawal by Subject|6|||
125208089|NCT05153148|450385459|FG001|Overall Study|Withdrawal by Subject|8|||
125208090|NCT05153148|450385460|FG002|Overall Study|Withdrawal by Subject|6|||
125208091|NCT05153148|450385461|FG003|Overall Study|Withdrawal by Subject|8|||
125208092|NCT05153148|450385458|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
125208093|NCT05153148|450385459|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
125208094|NCT05153148|450385460|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
125208095|NCT05153148|450385461|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
125208096|NCT05153148|450385458|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
125208097|NCT05153148|450385459|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
125208098|NCT05153148|450385460|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
125208099|NCT05153148|450385461|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
125208100|NCT05153148|450385458|FG000|Overall Study|Reason not Specified|1|||
125208101|NCT05153148|450385459|FG001|Overall Study|Reason not Specified|1|||
125208102|NCT05153148|450385460|FG002|Overall Study|Reason not Specified|1|||
125208103|NCT05153148|450385461|FG003|Overall Study|Reason not Specified|1|||
125208104|NCT01712334|450385462|FG000|Treatment Period 1|Randomized in Error|0|||
125208105|NCT01712334|450385463|FG001|Treatment Period 1|Randomized in Error|2|||
125208106|NCT02892513|450385466|FG000|Overall Study|Withdrawal by Subject|0|||
125208107|NCT02892513|450385467|FG001|Overall Study|Withdrawal by Subject|1|||
125208108|NCT03426436|450385468|FG000|Overall Study|Incorrect lead placement|12|||
125208109|NCT03426436|450385468|FG000|Overall Study|Withdrawal by Subject|2|||
125208110|NCT03426436|450385468|FG000|Overall Study|Consent issue|1|||
125208111|NCT03426436|450385468|FG000|Overall Study|ECGs not saved|4|||
125208112|NCT02919267|450385469|FG000|Overall Study|Protocol Violation|0|||
125208113|NCT02919267|450385470|FG001|Overall Study|Protocol Violation|3|||
125208114|NCT02919267|450385471|FG002|Overall Study|Protocol Violation|3|||
125208115|NCT02919267|450385472|FG003|Overall Study|Protocol Violation|4|||
125208116|NCT02407054|450385473|FG000|Overall Study|Adverse Event|1|||
125208117|NCT02407054|450385474|FG001|Overall Study|Adverse Event|4|||
125208118|NCT02407054|450385475|FG002|Overall Study|Adverse Event|1|||
125208119|NCT02407054|450385473|FG000|Overall Study|Non-compliance with Study|0|||
125208120|NCT02407054|450385474|FG001|Overall Study|Non-compliance with Study|2|||
125208121|NCT02407054|450385475|FG002|Overall Study|Non-compliance with Study|1|||
125208122|NCT02407054|450385473|FG000|Overall Study|Physician Decision|1|||
125208123|NCT02407054|450385474|FG001|Overall Study|Physician Decision|3|||
125208124|NCT02407054|450385475|FG002|Overall Study|Physician Decision|3|||
125208125|NCT02407054|450385473|FG000|Overall Study|Withdrawal by Subject|5|||
125208126|NCT02407054|450385474|FG001|Overall Study|Withdrawal by Subject|9|||
125208127|NCT02407054|450385475|FG002|Overall Study|Withdrawal by Subject|2|||
125208128|NCT00131365|450385476|FG000|Overall Study|Withdrawal by Subject|1|||
125208129|NCT00131365|450385476|FG000|Overall Study|Alternative treatment|3|||
125208130|NCT04608344|450385477|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
125208131|NCT04608344|450385478|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
125208132|NCT04608344|450385477|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
125208133|NCT04608344|450385478|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
125208134|NCT02044874|450385479|FG000|Overall Study|Adverse Event|5|||
125208135|NCT02044874|450385480|FG001|Overall Study|Adverse Event|6|||
125208136|NCT02044874|450385481|FG002|Overall Study|Adverse Event|6|||
125208137|NCT02044874|450385479|FG000|Overall Study|Withdrawal by Subject|8|||
125208138|NCT02044874|450385480|FG001|Overall Study|Withdrawal by Subject|16|||
125208139|NCT02044874|450385481|FG002|Overall Study|Withdrawal by Subject|23|||
125208140|NCT02044874|450385479|FG000|Overall Study|Physician Decision|0|||
125208141|NCT02044874|450385480|FG001|Overall Study|Physician Decision|2|||
125208142|NCT02044874|450385481|FG002|Overall Study|Physician Decision|1|||
125208143|NCT02044874|450385479|FG000|Overall Study|Lost to Follow-up|10|||
125208144|NCT02044874|450385480|FG001|Overall Study|Lost to Follow-up|27|||
125208145|NCT02044874|450385481|FG002|Overall Study|Lost to Follow-up|21|||
125208146|NCT02044874|450385479|FG000|Overall Study|Sponsor Decision|0|||
125208147|NCT02044874|450385480|FG001|Overall Study|Sponsor Decision|1|||
125208148|NCT02044874|450385481|FG002|Overall Study|Sponsor Decision|1|||
125208149|NCT02044874|450385479|FG000|Overall Study|Other|7|||
125208150|NCT02044874|450385480|FG001|Overall Study|Other|3|||
125208151|NCT02044874|450385481|FG002|Overall Study|Other|8|||
125208152|NCT00415597|450385482|FG000|Enrollment|Withdrawal by Subject|1|||
125208153|NCT00415597|450385482|FG000|Enrollment|Protocol Violation|1|||
125208154|NCT00415597|450385482|FG000|Treatment|Adverse Event|110|||
125208155|NCT00415597|450385482|FG000|Treatment|Lack of Efficacy|39|||
125208156|NCT00415597|450385482|FG000|Treatment|Protocol Violation|67|||
125208157|NCT00415597|450385482|FG000|Treatment|Physician Decision|3|||
125208158|NCT00415597|450385482|FG000|Treatment|Withdrawal by Subject|51|||
125208159|NCT00415597|450385482|FG000|Treatment|Lost to Follow-up|28|||
125208160|NCT00415597|450385482|FG000|Treatment|Drug Screen|2|||
125208161|NCT00415597|450385482|FG000|Treatment|Administrative|3|||
125208162|NCT00415597|450385482|FG000|Treatment|Sponsor Decision|1|||
125208163|NCT00415597|450385482|FG000|Treatment|Multiple Reasons|1|||
125208164|NCT01447927|450385483|FG000|Overall Study|Adverse Event|4|||
125208165|NCT01447927|450385484|FG001|Overall Study|Adverse Event|3|||
125208166|NCT01447927|450385483|FG000|Overall Study|Withdrawal by Subject|1|||
125208167|NCT01447927|450385484|FG001|Overall Study|Withdrawal by Subject|0|||
125208168|NCT04102865|450385486|FG000|Overall Study|Adverse Event|4|||
125208169|NCT04102865|450385487|FG001|Overall Study|Adverse Event|0|||
125208170|NCT04102865|450385486|FG000|Overall Study|Lost to Follow-up|1|||
125208171|NCT04102865|450385487|FG001|Overall Study|Lost to Follow-up|0|||
125208172|NCT04102865|450385486|FG000|Overall Study|Withdrawal by Subject|2|||
125208173|NCT04102865|450385487|FG001|Overall Study|Withdrawal by Subject|0|||
125208174|NCT01764997|450385488|FG000|Run-in Period|Adverse Event|15|||
125208175|NCT01764997|450385489|FG001|Run-in Period|Adverse Event|0|||
125208176|NCT01764997|450385490|FG002|Run-in Period|Adverse Event|0|||
125208177|NCT01764997|450385491|FG003|Run-in Period|Adverse Event|0|||
125208178|NCT01764997|450385492|FG004|Run-in Period|Adverse Event|0|||
125208179|NCT01764997|450385488|FG000|Run-in Period|Lack of Efficacy|5|||
125208180|NCT01764997|450385489|FG001|Run-in Period|Lack of Efficacy|0|||
125208181|NCT01764997|450385490|FG002|Run-in Period|Lack of Efficacy|0|||
125208182|NCT01764997|450385491|FG003|Run-in Period|Lack of Efficacy|0|||
125208183|NCT01764997|450385492|FG004|Run-in Period|Lack of Efficacy|0|||
125208184|NCT01764997|450385488|FG000|Run-in Period|Poor compliance to protocol|1|||
125208185|NCT01764997|450385489|FG001|Run-in Period|Poor compliance to protocol|0|||
125208186|NCT01764997|450385490|FG002|Run-in Period|Poor compliance to protocol|0|||
125208187|NCT01764997|450385491|FG003|Run-in Period|Poor compliance to protocol|0|||
125208188|NCT01764997|450385492|FG004|Run-in Period|Poor compliance to protocol|0|||
125208189|NCT01764997|450385488|FG000|Run-in Period|Other than specified above|17|||
125208190|NCT01764997|450385489|FG001|Run-in Period|Other than specified above|0|||
125208191|NCT01764997|450385490|FG002|Run-in Period|Other than specified above|0|||
125208192|NCT01764997|450385491|FG003|Run-in Period|Other than specified above|0|||
125208193|NCT01764997|450385492|FG004|Run-in Period|Other than specified above|0|||
125208194|NCT01764997|450385488|FG000|Study Drug Treatment Period|Adverse Event|0|||
125208195|NCT01764997|450385489|FG001|Study Drug Treatment Period|Adverse Event|1|||
125208196|NCT01764997|450385490|FG002|Study Drug Treatment Period|Adverse Event|0|||
125208197|NCT01764997|450385491|FG003|Study Drug Treatment Period|Adverse Event|0|||
125208198|NCT01764997|450385492|FG004|Study Drug Treatment Period|Adverse Event|24|||
125208199|NCT01764997|450385488|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
125208200|NCT01764997|450385489|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
125208201|NCT01764997|450385490|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
125208202|NCT01764997|450385491|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
125208203|NCT01764997|450385492|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
125208204|NCT01764997|450385488|FG000|Study Drug Treatment Period|Other than specified above|0|||
125208205|NCT01764997|450385489|FG001|Study Drug Treatment Period|Other than specified above|0|||
125208206|NCT01764997|450385490|FG002|Study Drug Treatment Period|Other than specified above|0|||
125208207|NCT01764997|450385491|FG003|Study Drug Treatment Period|Other than specified above|0|||
125208208|NCT01764997|450385492|FG004|Study Drug Treatment Period|Other than specified above|10|||
125208209|NCT01210352|450385501|FG000|Overall Study|Adverse Event|0|||
125208210|NCT01210352|450385502|FG001|Overall Study|Adverse Event|0|||
125208211|NCT01210352|450385503|FG002|Overall Study|Adverse Event|0|||
125208212|NCT01210352|450385504|FG003|Overall Study|Adverse Event|0|||
125208213|NCT01210352|450385505|FG004|Overall Study|Adverse Event|0|||
125208214|NCT01210352|450385506|FG005|Overall Study|Adverse Event|0|||
125208215|NCT01210352|450385507|FG006|Overall Study|Adverse Event|0|||
125208216|NCT01210352|450385508|FG007|Overall Study|Adverse Event|2|||
125208217|NCT01210352|450385509|FG008|Overall Study|Adverse Event|1|||
125208218|NCT01210352|450385501|FG000|Overall Study|Lack of Efficacy|0|||
125208219|NCT01210352|450385502|FG001|Overall Study|Lack of Efficacy|0|||
125208220|NCT01210352|450385503|FG002|Overall Study|Lack of Efficacy|0|||
125208221|NCT01210352|450385504|FG003|Overall Study|Lack of Efficacy|0|||
125208222|NCT01210352|450385505|FG004|Overall Study|Lack of Efficacy|0|||
125208223|NCT01210352|450385506|FG005|Overall Study|Lack of Efficacy|0|||
125208224|NCT01210352|450385507|FG006|Overall Study|Lack of Efficacy|1|||
125208225|NCT01210352|450385508|FG007|Overall Study|Lack of Efficacy|0|||
125208226|NCT01210352|450385509|FG008|Overall Study|Lack of Efficacy|0|||
125208227|NCT01210352|450385501|FG000|Overall Study|Physician Decision|0|||
125208228|NCT01210352|450385502|FG001|Overall Study|Physician Decision|0|||
125208229|NCT01210352|450385503|FG002|Overall Study|Physician Decision|0|||
125208230|NCT01210352|450385504|FG003|Overall Study|Physician Decision|0|||
125208231|NCT01210352|450385505|FG004|Overall Study|Physician Decision|0|||
125208232|NCT01210352|450385506|FG005|Overall Study|Physician Decision|0|||
125208233|NCT01210352|450385507|FG006|Overall Study|Physician Decision|0|||
125208234|NCT01210352|450385508|FG007|Overall Study|Physician Decision|1|||
125208235|NCT01210352|450385509|FG008|Overall Study|Physician Decision|2|||
125208236|NCT01210352|450385501|FG000|Overall Study|Withdrawal by Subject|0|||
125208237|NCT01210352|450385502|FG001|Overall Study|Withdrawal by Subject|0|||
125208238|NCT01210352|450385503|FG002|Overall Study|Withdrawal by Subject|1|||
125208239|NCT01210352|450385504|FG003|Overall Study|Withdrawal by Subject|0|||
125208240|NCT01210352|450385505|FG004|Overall Study|Withdrawal by Subject|0|||
125208241|NCT01210352|450385506|FG005|Overall Study|Withdrawal by Subject|0|||
125208242|NCT01210352|450385507|FG006|Overall Study|Withdrawal by Subject|1|||
125208243|NCT01210352|450385508|FG007|Overall Study|Withdrawal by Subject|0|||
124872052|NCT01338025|449152805|FG000|Overall Study|Found ineligible after starting|1|||
124872053|NCT01338025|449152806|FG001|Overall Study|Found ineligible after starting|0|||
125208244|NCT01210352|450385509|FG008|Overall Study|Withdrawal by Subject|1|||
125208245|NCT01210352|450385501|FG000|Overall Study|Patient Discharged Early|0|||
125208246|NCT01210352|450385502|FG001|Overall Study|Patient Discharged Early|0|||
125208247|NCT01210352|450385503|FG002|Overall Study|Patient Discharged Early|1|||
125208248|NCT01210352|450385504|FG003|Overall Study|Patient Discharged Early|0|||
125208249|NCT01210352|450385505|FG004|Overall Study|Patient Discharged Early|0|||
125208250|NCT01210352|450385506|FG005|Overall Study|Patient Discharged Early|0|||
125208251|NCT01210352|450385507|FG006|Overall Study|Patient Discharged Early|0|||
125208252|NCT01210352|450385508|FG007|Overall Study|Patient Discharged Early|0|||
125208253|NCT01210352|450385509|FG008|Overall Study|Patient Discharged Early|0|||
125208254|NCT01298141|450385510|FG000|Overall Study|Adverse Event|3|||
125208255|NCT01298141|450385510|FG000|Overall Study|Refusal of Required Study Procedures|1|||
125208256|NCT01298141|450385510|FG000|Overall Study|Withdrawal by Subject|6|||
125208257|NCT01298141|450385510|FG000|Overall Study|Termination of Study by the Investigator|5|||
125208258|NCT01298141|450385510|FG000|Overall Study|Other|5|||
125208259|NCT01298141|450385510|FG000|Overall Study|Lost to Follow-up|1|||
125208260|NCT01298141|450385510|FG000|Overall Study|Death|6|||
125208261|NCT01298141|450385510|FG000|Overall Study|Not treated|4|||
125208262|NCT02093390|450385514|FG000|Overall Study|Withdrawal by Subject|0|||
125208263|NCT02093390|450385515|FG001|Overall Study|Withdrawal by Subject|1|||
125208264|NCT01854879|450385516|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
125208265|NCT01854879|450385516|FG000|Overall Study|screen fail|3|||
125208266|NCT01854879|450385516|FG000|Overall Study|incomplete data set|1|||
125208267|NCT04683939|450385520|FG000|Overall Study|Study termination by the sponsor|0|||
125208268|NCT04683939|450385521|FG001|Overall Study|Study termination by the sponsor|1|||
125208269|NCT04683939|450385522|FG002|Overall Study|Study termination by the sponsor|2|||
125208270|NCT04683939|450385523|FG003|Overall Study|Study termination by the sponsor|2|||
125208271|NCT04683939|450385520|FG000|Overall Study|Death|1|||
125208272|NCT04683939|450385521|FG001|Overall Study|Death|1|||
125208273|NCT04683939|450385522|FG002|Overall Study|Death|2|||
125208274|NCT04683939|450385523|FG003|Overall Study|Death|1|||
125208275|NCT04683939|450385520|FG000|Overall Study|Withdrawal by Subject|1|||
125208276|NCT04683939|450385521|FG001|Overall Study|Withdrawal by Subject|0|||
125208277|NCT04683939|450385522|FG002|Overall Study|Withdrawal by Subject|0|||
125208278|NCT04683939|450385523|FG003|Overall Study|Withdrawal by Subject|0|||
125208279|NCT04683939|450385520|FG000|Overall Study|Physician Decision|1|||
125208280|NCT04683939|450385521|FG001|Overall Study|Physician Decision|0|||
125208281|NCT04683939|450385522|FG002|Overall Study|Physician Decision|0|||
125208282|NCT04683939|450385523|FG003|Overall Study|Physician Decision|0|||
125208283|NCT04683939|450385520|FG000|Overall Study|Lost to Follow-up|0|||
125208284|NCT04683939|450385521|FG001|Overall Study|Lost to Follow-up|1|||
125208285|NCT04683939|450385522|FG002|Overall Study|Lost to Follow-up|0|||
125208286|NCT04683939|450385523|FG003|Overall Study|Lost to Follow-up|0|||
125208287|NCT02000882|450387192|FG000|Overall Study|Adverse Event|3|||
125208288|NCT02000882|450387192|FG000|Overall Study|Physician Decision|2|||
125208289|NCT02000882|450387192|FG000|Overall Study|Withdrawal by Subject|1|||
125208290|NCT00549601|450387193|FG000|Randomized|Protocol Violation|0|||
125208291|NCT00549601|450387194|FG001|Randomized|Protocol Violation|0|||
125208292|NCT00549601|450387195|FG002|Randomized|Protocol Violation|1|||
125208293|NCT00549601|450387193|FG000|Randomized|Withdrawal by Subject|0|||
125208294|NCT00549601|450387194|FG001|Randomized|Withdrawal by Subject|1|||
125208295|NCT00549601|450387195|FG002|Randomized|Withdrawal by Subject|1|||
125208296|NCT00549601|450387193|FG000|Received Study Drug|Adverse Event|2|||
125208297|NCT00549601|450387194|FG001|Received Study Drug|Adverse Event|5|||
125208298|NCT00549601|450387195|FG002|Received Study Drug|Adverse Event|1|||
125208299|NCT00549601|450387193|FG000|Received Study Drug|Death|0|||
125208300|NCT00549601|450387194|FG001|Received Study Drug|Death|1|||
125208301|NCT00549601|450387195|FG002|Received Study Drug|Death|0|||
125208302|NCT00549601|450387193|FG000|Received Study Drug|Lost to Follow-up|0|||
125208303|NCT00549601|450387194|FG001|Received Study Drug|Lost to Follow-up|1|||
125208304|NCT00549601|450387195|FG002|Received Study Drug|Lost to Follow-up|1|||
125208305|NCT00549601|450387193|FG000|Received Study Drug|Protocol Violation|3|||
125208306|NCT00549601|450387194|FG001|Received Study Drug|Protocol Violation|4|||
125208307|NCT00549601|450387195|FG002|Received Study Drug|Protocol Violation|1|||
125208308|NCT00549601|450387193|FG000|Received Study Drug|Withdrawal by Subject|2|||
125208309|NCT00549601|450387194|FG001|Received Study Drug|Withdrawal by Subject|0|||
125208310|NCT00549601|450387195|FG002|Received Study Drug|Withdrawal by Subject|1|||
125208311|NCT00908596|450387199|FG000|Overall Study|Other reasons|46|||
125208312|NCT00908596|450387200|FG001|Overall Study|Other reasons|6|||
125208313|NCT00908596|450387201|FG002|Overall Study|Other reasons|2|||
125208314|NCT00908596|450387202|FG003|Overall Study|Other reasons|0|||
125208315|NCT00908596|450387199|FG000|Overall Study|Lost to Follow-up|0|||
125208316|NCT00908596|450387200|FG001|Overall Study|Lost to Follow-up|1|||
125208317|NCT00908596|450387201|FG002|Overall Study|Lost to Follow-up|12|||
125208318|NCT00908596|450387202|FG003|Overall Study|Lost to Follow-up|4|||
125208319|NCT00908596|450387199|FG000|Overall Study|Death|0|||
125208320|NCT00908596|450387200|FG001|Overall Study|Death|5|||
125208321|NCT00908596|450387201|FG002|Overall Study|Death|57|||
125208322|NCT00908596|450387202|FG003|Overall Study|Death|32|||
125208323|NCT00908596|450387199|FG000|Overall Study|Protocol Violation|1|||
125208324|NCT00908596|450387200|FG001|Overall Study|Protocol Violation|0|||
125208325|NCT00908596|450387201|FG002|Overall Study|Protocol Violation|0|||
125208326|NCT00908596|450387202|FG003|Overall Study|Protocol Violation|0|||
125208327|NCT00908596|450387199|FG000|Overall Study|Withdrawal by Subject|0|||
125208328|NCT00908596|450387200|FG001|Overall Study|Withdrawal by Subject|1|||
125089801|NCT01117428|449947027|FG004|Overall Study|Withdrawal by Subject|0|||
125089802|NCT01117428|449947028|FG005|Overall Study|Withdrawal by Subject|0|||
125089803|NCT01117428|449947023|FG000|Overall Study|Progressive disease|15|||
125089804|NCT01117428|449947024|FG001|Overall Study|Progressive disease|27|||
125089805|NCT01117428|449947025|FG002|Overall Study|Progressive disease|10|||
125089806|NCT01117428|449947026|FG003|Overall Study|Progressive disease|12|||
125089807|NCT01117428|449947027|FG004|Overall Study|Progressive disease|16|||
125089808|NCT01117428|449947028|FG005|Overall Study|Progressive disease|17|||
125089809|NCT02519777|449947030|FG000|Overall Study|Death|1|||
125089810|NCT02519777|449947031|FG001|Overall Study|Death|0|||
125089811|NCT02519777|449947032|FG002|Overall Study|Death|0|||
125089812|NCT02519777|449947030|FG000|Overall Study|Lost to Follow-up|0|||
125089813|NCT02519777|449947031|FG001|Overall Study|Lost to Follow-up|4|||
125089814|NCT02519777|449947032|FG002|Overall Study|Lost to Follow-up|2|||
125089815|NCT02519777|449947030|FG000|Overall Study|Withdrawal by Subject|3|||
125089816|NCT02519777|449947031|FG001|Overall Study|Withdrawal by Subject|1|||
125089817|NCT02519777|449947032|FG002|Overall Study|Withdrawal by Subject|0|||
125089818|NCT02519777|449947030|FG000|Overall Study|Severe Debilitation|1|||
125089819|NCT02519777|449947031|FG001|Overall Study|Severe Debilitation|1|||
125089820|NCT02519777|449947032|FG002|Overall Study|Severe Debilitation|1|||
125089821|NCT02519777|449947030|FG000|Overall Study|Not able to get to clinic|1|||
125089822|NCT02519777|449947031|FG001|Overall Study|Not able to get to clinic|2|||
125089823|NCT02519777|449947032|FG002|Overall Study|Not able to get to clinic|1|||
125089824|NCT02195531|449947033|FG000|Overall Study|Withdrawal by Subject|1|||
125089825|NCT02195531|449947034|FG001|Overall Study|Withdrawal by Subject|1|||
125089826|NCT02195531|449947035|FG002|Overall Study|Withdrawal by Subject|1|||
125089827|NCT00545740|449947040|FG000|Overall Study|Lack of Efficacy|34|||
125089828|NCT00545740|449947041|FG001|Overall Study|Lack of Efficacy|35|||
125089829|NCT00545740|449947042|FG002|Overall Study|Lack of Efficacy|47|||
125089830|NCT00545740|449947043|FG003|Overall Study|Lack of Efficacy|36|||
125089831|NCT00545740|449947040|FG000|Overall Study|Withdrawal by Subject|17|||
125089832|NCT00545740|449947041|FG001|Overall Study|Withdrawal by Subject|15|||
125089833|NCT00545740|449947042|FG002|Overall Study|Withdrawal by Subject|16|||
125089834|NCT00545740|449947043|FG003|Overall Study|Withdrawal by Subject|18|||
125089835|NCT00545740|449947040|FG000|Overall Study|Adverse Event|10|||
125089836|NCT00545740|449947041|FG001|Overall Study|Adverse Event|18|||
125089837|NCT00545740|449947042|FG002|Overall Study|Adverse Event|19|||
125089838|NCT00545740|449947043|FG003|Overall Study|Adverse Event|9|||
125089839|NCT00545740|449947040|FG000|Overall Study|Lost to Follow-up|7|||
125089840|NCT00545740|449947041|FG001|Overall Study|Lost to Follow-up|5|||
125089841|NCT00545740|449947042|FG002|Overall Study|Lost to Follow-up|5|||
125089842|NCT00545740|449947043|FG003|Overall Study|Lost to Follow-up|6|||
124872054|NCT03017079|449152807|FG000|Overall Study|Physician Decision|1|||
124872055|NCT03017079|449152808|FG001|Overall Study|Physician Decision|1|||
124872056|NCT03017079|449152807|FG000|Overall Study|Death|3|||
124872057|NCT03017079|449152808|FG001|Overall Study|Death|2|||
124872058|NCT03017079|449152807|FG000|Overall Study|Lack of Efficacy|2|||
124872059|NCT03017079|449152808|FG001|Overall Study|Lack of Efficacy|2|||
124872060|NCT03017079|449152807|FG000|Overall Study|Protocol Violation|0|||
124872061|NCT03017079|449152808|FG001|Overall Study|Protocol Violation|1|||
124872062|NCT03538951|449152809|FG000|Overall Study|Withdrawal by Subject|1|||
124872063|NCT03538951|449152810|FG001|Overall Study|Withdrawal by Subject|2|||
124872064|NCT04120233|449152815|FG000|Overall Study|Adverse Event|0|||
124872065|NCT04120233|449152816|FG001|Overall Study|Adverse Event|0|||
124872066|NCT04120233|449152817|FG002|Overall Study|Adverse Event|0|||
124872067|NCT04120233|449152818|FG003|Overall Study|Adverse Event|0|||
124872068|NCT04120233|449152819|FG004|Overall Study|Adverse Event|1|||
124872069|NCT04120233|449152820|FG005|Overall Study|Adverse Event|0|||
124872070|NCT03779906|449152822|FG000|Overall Study|Lost to Follow-up|7|||
124872071|NCT03779906|449152822|FG000|Overall Study|COVID pandemic|1|||
124872072|NCT02553460|449152825|FG000|Overall Study|Death|3|||
124872073|NCT02553460|449152825|FG000|Overall Study|Withdrawal by Subject|1|||
124872074|NCT02553460|449152825|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
124872075|NCT02553460|449152825|FG000|Overall Study|Relapse or Transplant|14|||
124872076|NCT02553460|449152825|FG000|Overall Study|No response to treatment|2|||
124872077|NCT02553460|449152825|FG000|Overall Study|CAR T cells|2|||
124872078|NCT04814368|449152826|FG000|Overall Study|Study Terminated by Sponsor|0|||
125089843|NCT00545740|449947040|FG000|Overall Study|Protocol Violation|1|||
125089844|NCT00545740|449947041|FG001|Overall Study|Protocol Violation|3|||
125089845|NCT00545740|449947042|FG002|Overall Study|Protocol Violation|1|||
125089846|NCT00545740|449947043|FG003|Overall Study|Protocol Violation|0|||
125089847|NCT00545740|449947040|FG000|Overall Study|Non-compliance|0|||
125089848|NCT00545740|449947041|FG001|Overall Study|Non-compliance|2|||
125089849|NCT00545740|449947042|FG002|Overall Study|Non-compliance|1|||
125089850|NCT00545740|449947043|FG003|Overall Study|Non-compliance|0|||
125089851|NCT00545740|449947040|FG000|Overall Study|Moved|2|||
125089852|NCT00545740|449947041|FG001|Overall Study|Moved|0|||
124981539|NCT03002220|449559682|FG000|Overall Study|Lack of Efficacy|2|||
124981540|NCT03002220|449559682|FG000|Overall Study|Withdrawal by Subject|3|||
124981541|NCT03002220|449559682|FG000|Overall Study|Adverse Event|2|||
124981542|NCT03002220|449559682|FG000|Overall Study|Disease progression|13|||
124981543|NCT03002220|449559682|FG000|Overall Study|Physician Decision|1|||
124981544|NCT01015560|449559683|FG000|Overall Study|Adverse Event|1|||
124981545|NCT01015560|449559683|FG000|Overall Study|Not protocol specified|1|||
124981546|NCT01015560|449559683|FG000|Overall Study|Withdrawal by Subject|1|||
125089853|NCT00545740|449947042|FG002|Overall Study|Moved|1|||
125089854|NCT00545740|449947043|FG003|Overall Study|Moved|0|||
125089855|NCT00545740|449947040|FG000|Overall Study|Diverticulitis attack|0|||
125089856|NCT00545740|449947041|FG001|Overall Study|Diverticulitis attack|0|||
125089857|NCT00545740|449947042|FG002|Overall Study|Diverticulitis attack|1|||
125089858|NCT00545740|449947043|FG003|Overall Study|Diverticulitis attack|1|||
125089859|NCT00545740|449947040|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
125089860|NCT00545740|449947041|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
125089861|NCT00545740|449947042|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
125089862|NCT00545740|449947043|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
124981547|NCT00640133|449559686|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
124981548|NCT00640133|449559687|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
124981549|NCT00640133|449559686|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
124981550|NCT00640133|449559687|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
124981551|NCT00640133|449559686|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
124981552|NCT00640133|449559687|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
124981553|NCT00128102|449559688|FG000|Overall Study|Site Discontinued|3|||
124981554|NCT00128102|449559689|FG001|Overall Study|Site Discontinued|6|||
124981555|NCT00128102|449559688|FG000|Overall Study|Other|0|||
124981556|NCT00128102|449559689|FG001|Overall Study|Other|1|||
124981557|NCT00128102|449559688|FG000|Overall Study|Progressive Disease|255|||
124981558|NCT00128102|449559689|FG001|Overall Study|Progressive Disease|285|||
124981559|NCT00128102|449559688|FG000|Overall Study|Adverse Event|34|||
124981560|NCT00128102|449559689|FG001|Overall Study|Adverse Event|11|||
124981561|NCT00128102|449559688|FG000|Overall Study|Death|12|||
124981562|NCT00128102|449559689|FG001|Overall Study|Death|13|||
124981563|NCT00128102|449559688|FG000|Overall Study|Physician Decision|3|||
124981564|NCT00128102|449559689|FG001|Overall Study|Physician Decision|3|||
124981565|NCT00128102|449559688|FG000|Overall Study|Withdrawal by Subject|19|||
124981566|NCT00128102|449559689|FG001|Overall Study|Withdrawal by Subject|11|||
124981567|NCT00128102|449559688|FG000|Overall Study|Protocol Violation|2|||
124981568|NCT00128102|449559689|FG001|Overall Study|Protocol Violation|2|||
124981569|NCT01202903|449559691|FG000|Overall Study|Administrative Probelms|1|||
124981570|NCT01202903|449559692|FG001|Overall Study|Administrative Probelms|4|||
124981571|NCT01202903|449559691|FG000|Overall Study|Protocol Violation|0|||
124981572|NCT01202903|449559692|FG001|Overall Study|Protocol Violation|1|||
124981573|NCT01202903|449559691|FG000|Overall Study|Death|1|||
124981574|NCT01202903|449559692|FG001|Overall Study|Death|0|||
124981575|NCT01202903|449559691|FG000|Overall Study|Lost to Follow-up|1|||
124981576|NCT01202903|449559692|FG001|Overall Study|Lost to Follow-up|1|||
124981577|NCT01202903|449559691|FG000|Overall Study|Lack of Efficacy|1|||
124981578|NCT01202903|449559692|FG001|Overall Study|Lack of Efficacy|3|||
124981579|NCT01202903|449559691|FG000|Overall Study|Adverse Event|3|||
124981580|NCT01202903|449559692|FG001|Overall Study|Adverse Event|3|||
124981581|NCT01202903|449559691|FG000|Overall Study|Withdrawal by Subject|4|||
124981582|NCT01202903|449559692|FG001|Overall Study|Withdrawal by Subject|4|||
124981583|NCT01302080|449559693|FG000|Overall Study|Withdrew Consent|92|||
124981584|NCT01302080|449559694|FG001|Overall Study|Withdrew Consent|39|||
124981585|NCT01302080|449559693|FG000|Overall Study|Patient/Family Moved|28|||
124981586|NCT01302080|449559694|FG001|Overall Study|Patient/Family Moved|3|||
124981587|NCT01302080|449559693|FG000|Overall Study|Lost to Follow-up|192|||
124981588|NCT01302080|449559694|FG001|Overall Study|Lost to Follow-up|93|||
124981589|NCT01302080|449559693|FG000|Overall Study|Death|1|||
124981590|NCT01302080|449559694|FG001|Overall Study|Death|0|||
124981591|NCT01302080|449559693|FG000|Overall Study|Other|52|||
124981592|NCT01302080|449559694|FG001|Overall Study|Other|8|||
124981593|NCT01302080|449559693|FG000|Overall Study|Reason Missing For Discontinuation|1|||
124981594|NCT01302080|449559694|FG001|Overall Study|Reason Missing For Discontinuation|0|||
125089863|NCT00545740|449947040|FG000|Overall Study|Site closure|1|||
124981595|NCT01076153|449559702|FG000|Overall Study|Symptoms improved/resolved|10|||
124981596|NCT01076153|449559702|FG000|Overall Study|Adverse Event|1|||
124981597|NCT01142232|449559706|FG000|Overall Study|Adverse Event|1|||
124981598|NCT01142232|449559707|FG001|Overall Study|Adverse Event|2|||
124981599|NCT01142232|449559708|FG002|Overall Study|Adverse Event|1|||
124981600|NCT01142232|449559709|FG003|Overall Study|Adverse Event|0|||
124981601|NCT01142232|449559710|FG004|Overall Study|Adverse Event|4|||
124981602|NCT01142232|449559706|FG000|Overall Study|Death|0|||
124981603|NCT01142232|449559707|FG001|Overall Study|Death|0|||
125089864|NCT00545740|449947041|FG001|Overall Study|Site closure|0|||
125089865|NCT00545740|449947042|FG002|Overall Study|Site closure|0|||
125089866|NCT00545740|449947043|FG003|Overall Study|Site closure|0|||
125089867|NCT00545740|449947040|FG000|Overall Study|Missed visit|1|||
125089868|NCT00545740|449947041|FG001|Overall Study|Missed visit|0|||
125089869|NCT00545740|449947042|FG002|Overall Study|Missed visit|0|||
125089870|NCT00545740|449947043|FG003|Overall Study|Missed visit|0|||
125089871|NCT00545740|449947040|FG000|Overall Study|Physician Decision|0|||
125089872|NCT00545740|449947041|FG001|Overall Study|Physician Decision|0|||
125089873|NCT00545740|449947042|FG002|Overall Study|Physician Decision|3|||
124981604|NCT01142232|449559708|FG002|Overall Study|Death|0|||
124981605|NCT01142232|449559709|FG003|Overall Study|Death|0|||
124981606|NCT01142232|449559710|FG004|Overall Study|Death|1|||
124981607|NCT01142232|449559706|FG000|Overall Study|Disease Progression|2|||
124981608|NCT01142232|449559707|FG001|Overall Study|Disease Progression|0|||
124981609|NCT01142232|449559708|FG002|Overall Study|Disease Progression|1|||
124981610|NCT01142232|449559709|FG003|Overall Study|Disease Progression|2|||
124981611|NCT01142232|449559710|FG004|Overall Study|Disease Progression|12|||
124981612|NCT01142232|449559706|FG000|Overall Study|Withdrawal by Subject|0|||
124981613|NCT01142232|449559707|FG001|Overall Study|Withdrawal by Subject|0|||
124981614|NCT01142232|449559708|FG002|Overall Study|Withdrawal by Subject|0|||
124981615|NCT01142232|449559709|FG003|Overall Study|Withdrawal by Subject|1|||
124981616|NCT01142232|449559710|FG004|Overall Study|Withdrawal by Subject|3|||
124981617|NCT01142232|449559706|FG000|Overall Study|Physician Decision|0|||
124981618|NCT01142232|449559707|FG001|Overall Study|Physician Decision|1|||
124981619|NCT01142232|449559708|FG002|Overall Study|Physician Decision|0|||
124981620|NCT01142232|449559709|FG003|Overall Study|Physician Decision|2|||
124981621|NCT01142232|449559710|FG004|Overall Study|Physician Decision|10|||
124981622|NCT01142232|449559706|FG000|Overall Study|Alternative Therapy|0|||
124981623|NCT01142232|449559707|FG001|Overall Study|Alternative Therapy|1|||
124981624|NCT01142232|449559708|FG002|Overall Study|Alternative Therapy|1|||
124981625|NCT01142232|449559709|FG003|Overall Study|Alternative Therapy|0|||
124981626|NCT01142232|449559710|FG004|Overall Study|Alternative Therapy|1|||
124981627|NCT01142232|449559706|FG000|Overall Study|Off Trt for other complicating disease|0|||
124981628|NCT01142232|449559707|FG001|Overall Study|Off Trt for other complicating disease|0|||
124981629|NCT01142232|449559708|FG002|Overall Study|Off Trt for other complicating disease|0|||
124981630|NCT01142232|449559709|FG003|Overall Study|Off Trt for other complicating disease|0|||
124981631|NCT01142232|449559710|FG004|Overall Study|Off Trt for other complicating disease|1|||
124981632|NCT01142232|449559706|FG000|Overall Study|Noncompliance|0|||
124981633|NCT01142232|449559707|FG001|Overall Study|Noncompliance|0|||
124981634|NCT01142232|449559708|FG002|Overall Study|Noncompliance|0|||
124981635|NCT01142232|449559709|FG003|Overall Study|Noncompliance|0|||
124981636|NCT01142232|449559710|FG004|Overall Study|Noncompliance|2|||
124981637|NCT00574873|449559713|FG000|Overall Study|Withdrawal by Subject|18|||
124981638|NCT00574873|449559714|FG001|Overall Study|Withdrawal by Subject|19|||
124981639|NCT00574873|449559713|FG000|Overall Study|Investigator request|18|||
124981640|NCT00574873|449559714|FG001|Overall Study|Investigator request|8|||
124981641|NCT00574873|449559713|FG000|Overall Study|Death|15|||
124981642|NCT00574873|449559714|FG001|Overall Study|Death|14|||
124981643|NCT00574873|449559713|FG000|Overall Study|Lost to Follow-up|14|||
124981644|NCT00574873|449559714|FG001|Overall Study|Lost to Follow-up|5|||
125089874|NCT00545740|449947043|FG003|Overall Study|Physician Decision|0|||
125089875|NCT00545740|449947040|FG000|Overall Study|Accepted only monthly telephone calls|1|||
125208329|NCT00908596|450387201|FG002|Overall Study|Withdrawal by Subject|3|||
125208330|NCT00908596|450387202|FG003|Overall Study|Withdrawal by Subject|1|||
125208331|NCT02437188|450387205|FG000|Overall Study|Randomized but did not receive surgery|4|||
125208332|NCT02437188|450387206|FG001|Overall Study|Randomized but did not receive surgery|8|||
125208333|NCT02437188|450387205|FG000|Overall Study|Adverse Event|0|||
125208334|NCT02437188|450387206|FG001|Overall Study|Adverse Event|1|||
125208335|NCT02661061|450387209|FG000|Overall Study|Lack of Efficacy|1|||
125208336|NCT02661061|450387210|FG001|Overall Study|Lack of Efficacy|1|||
125208337|NCT02661061|450387209|FG000|Overall Study|Withdrawal by Subject|1|||
125208338|NCT02661061|450387210|FG001|Overall Study|Withdrawal by Subject|1|||
125208339|NCT03246061|450387211|FG000|Overall Study|Still in follow-up|15|||
125208340|NCT03246061|450387212|FG001|Overall Study|Still in follow-up|21|||
125208341|NCT01937715|450387217|FG000|Overall Study|Death|0|||
125208342|NCT01937715|450387218|FG001|Overall Study|Death|0|||
125208343|NCT01937715|450387219|FG002|Overall Study|Death|0|||
125208344|NCT01937715|450387220|FG003|Overall Study|Death|1|||
125208345|NCT01937715|450387221|FG004|Overall Study|Death|0|||
125208346|NCT01937715|450387217|FG000|Overall Study|Withdrawal by Subject|0|||
125208347|NCT01937715|450387218|FG001|Overall Study|Withdrawal by Subject|1|||
125208348|NCT01937715|450387219|FG002|Overall Study|Withdrawal by Subject|0|||
124981645|NCT00574873|449559713|FG000|Overall Study|Other|40|||
124981646|NCT00574873|449559714|FG001|Overall Study|Other|4|||
124981647|NCT00574873|449559713|FG000|Overall Study|Discontinuation of study by sponsor|5|||
124981648|NCT00574873|449559714|FG001|Overall Study|Discontinuation of study by sponsor|199|||
125089876|NCT00545740|449947041|FG001|Overall Study|Accepted only monthly telephone calls|0|||
125208349|NCT01937715|450387220|FG003|Overall Study|Withdrawal by Subject|0|||
125208350|NCT01937715|450387221|FG004|Overall Study|Withdrawal by Subject|2|||
125208351|NCT01937715|450387217|FG000|Overall Study|Other|0|||
124981649|NCT00574873|449559713|FG000|Overall Study|Blank, site closed per local regulations|2|||
124981650|NCT00574873|449559714|FG001|Overall Study|Blank, site closed per local regulations|2|||
124981651|NCT00574873|449559713|FG000|Overall Study|Extension Study|126|||
124981652|NCT00574873|449559714|FG001|Overall Study|Extension Study|0|||
124981653|NCT00201643|449559716|FG000|Overall Study|Withdrawal by Subject|5|||
124981654|NCT00201643|449559717|FG001|Overall Study|Withdrawal by Subject|4|||
124981655|NCT02787044|449559724|FG000|Overall Study|Lost to Follow-up|15|||
124981656|NCT02787044|449559725|FG001|Overall Study|Lost to Follow-up|19|||
124981657|NCT00490490|449559728|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
124981658|NCT00490490|449559728|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
124981659|NCT03207451|449559730|FG000|Overall Study|scheduling conflict|1|||
124981660|NCT03207451|449559731|FG001|Overall Study|scheduling conflict|0|||
124981661|NCT03207451|449559732|FG002|Overall Study|scheduling conflict|2|||
124981662|NCT03207451|449559733|FG003|Overall Study|scheduling conflict|2|||
124981663|NCT03207451|449559730|FG000|Overall Study|Adverse Event|0|||
124981664|NCT03207451|449559731|FG001|Overall Study|Adverse Event|0|||
124981665|NCT03207451|449559732|FG002|Overall Study|Adverse Event|0|||
124981666|NCT03207451|449559733|FG003|Overall Study|Adverse Event|1|||
124981667|NCT02040584|449559734|FG000|Overall Study|Adverse Event|13|||
124981668|NCT02040584|449559735|FG001|Overall Study|Adverse Event|6|||
124981669|NCT02040584|449559734|FG000|Overall Study|Protocol Violation|9|||
124981670|NCT02040584|449559735|FG001|Overall Study|Protocol Violation|11|||
124981671|NCT02040584|449559734|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124981672|NCT02040584|449559735|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
124981673|NCT02040584|449559734|FG000|Overall Study|Death|6|||
124981674|NCT02040584|449559735|FG001|Overall Study|Death|3|||
124981675|NCT02040584|449559734|FG000|Overall Study|Transplant rejection/retransplant|0|||
124981676|NCT02040584|449559735|FG001|Overall Study|Transplant rejection/retransplant|1|||
124981677|NCT02040584|449559734|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
124981678|NCT02040584|449559735|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
124981679|NCT05540717|449559736|FG000|Overall Study|Lost to Follow-up|2|||
124981680|NCT05540717|449559737|FG001|Overall Study|Lost to Follow-up|5|||
124981681|NCT05540717|449559736|FG000|Overall Study|Withdrawal by Subject|6|||
124981682|NCT05540717|449559737|FG001|Overall Study|Withdrawal by Subject|6|||
124981683|NCT05540717|449559736|FG000|Overall Study|Sponsor request|1|||
124981684|NCT05540717|449559737|FG001|Overall Study|Sponsor request|0|||
124981685|NCT05540717|449559736|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
124981686|NCT05540717|449559737|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
125208352|NCT01937715|450387218|FG001|Overall Study|Other|0|||
125208353|NCT01937715|450387219|FG002|Overall Study|Other|0|||
125208354|NCT01937715|450387220|FG003|Overall Study|Other|3|||
125208355|NCT01937715|450387221|FG004|Overall Study|Other|0|||
125208356|NCT05459558|450387222|FG000|Overall Study|Adverse Event|1|||
125208357|NCT05459558|450387223|FG001|Overall Study|Adverse Event|0|||
125208358|NCT05459558|450387224|FG002|Overall Study|Adverse Event|0|||
125208359|NCT05459558|450387222|FG000|Overall Study|Scheduling issue|0|||
125208360|NCT05459558|450387223|FG001|Overall Study|Scheduling issue|1|||
125208361|NCT05459558|450387224|FG002|Overall Study|Scheduling issue|3|||
125208362|NCT05459558|450387222|FG000|Overall Study|Withdrawal by Subject|0|||
125208363|NCT05459558|450387223|FG001|Overall Study|Withdrawal by Subject|0|||
125208364|NCT05459558|450387224|FG002|Overall Study|Withdrawal by Subject|2|||
125208365|NCT03292458|450387227|FG000|Period 1|Adverse Event|2|||
125208366|NCT03292458|450387228|FG001|Period 1|Adverse Event|0|||
125208367|NCT00593606|450387229|FG000|Overall Study|Adverse Event|13|||
125208368|NCT00593606|450387229|FG000|Overall Study|Withdrawal by Subject|1|||
125208369|NCT00593606|450387229|FG000|Overall Study|Protocol Violation|3|||
125208370|NCT00593606|450387229|FG000|Overall Study|Lost to Follow-up|2|||
125208371|NCT00593606|450387229|FG000|Overall Study|Run-In Failure|5|||
125208372|NCT00593606|450387229|FG000|Overall Study|Screen Failure|3|||
125208373|NCT04643964|450387230|FG000|Overall Study|Lost to Follow-up|55|||
125208374|NCT04643964|450387231|FG001|Overall Study|Lost to Follow-up|59|||
124981687|NCT05540717|449559736|FG000|Overall Study|Other|0|||
124981688|NCT05540717|449559737|FG001|Overall Study|Other|1|||
124981689|NCT01940939|449559738|FG000|Overall Study|Withdrawal by Subject|2|||
124981690|NCT01940939|449559739|FG001|Overall Study|Withdrawal by Subject|8|||
124981691|NCT01470001|449559740|FG000|Overall Study|Lost to Follow-up|1|||
124981692|NCT01470001|449559741|FG001|Overall Study|Lost to Follow-up|1|||
124981693|NCT01470001|449559740|FG000|Overall Study|Physician Decision|2|||
124981694|NCT01470001|449559741|FG001|Overall Study|Physician Decision|0|||
124981695|NCT01470001|449559740|FG000|Overall Study|Withdrawal by Subject|2|||
124981696|NCT01470001|449559741|FG001|Overall Study|Withdrawal by Subject|1|||
124981697|NCT02591953|449559744|FG000|Overall Study|Lost to Follow-up|6|||
125208375|NCT04643964|450387232|FG002|Overall Study|Lost to Follow-up|54|||
125208376|NCT04643964|450387233|FG003|Overall Study|Lost to Follow-up|129|||
125208377|NCT04643964|450387234|FG004|Overall Study|Lost to Follow-up|48|||
125208378|NCT04643964|450387230|FG000|Overall Study|Failed attention check|1|||
125208379|NCT04643964|450387231|FG001|Overall Study|Failed attention check|8|||
125208380|NCT04643964|450387232|FG002|Overall Study|Failed attention check|2|||
124981698|NCT02591953|449559745|FG001|Overall Study|Lost to Follow-up|6|||
124981699|NCT03167359|449559748|FG000|Overall Study|Physician Decision|1|||
124981700|NCT03167359|449559748|FG000|Overall Study|Lost to Follow-up|1|||
124981701|NCT01896557|449559749|FG000|Clopidogrel Alone|Adverse Event|1|||
124981702|NCT01896557|449559750|FG001|Clopidogrel Alone|Adverse Event|0|||
124981703|NCT01896557|449559749|FG000|Clopidogrel + GI Protector|low adherence|1|||
124981704|NCT01896557|449559750|FG001|Clopidogrel + GI Protector|low adherence|1|||
124981705|NCT01896557|449559749|FG000|Clopidogrel + GI Protector|Reading error|1|||
124981706|NCT01896557|449559750|FG001|Clopidogrel + GI Protector|Reading error|3|||
124981707|NCT01517295|449559751|FG000|Overall Study|Physician Decision|1|||
124981708|NCT01517295|449559752|FG001|Overall Study|Physician Decision|0|||
124981709|NCT02182947|449559753|FG000|Overall Study|Withdrawal by Subject|7|||
124981710|NCT02182947|449559753|FG000|Overall Study|Lost to Follow-up|3|||
124981711|NCT02182947|449559753|FG000|Overall Study|Failed screening activities|8|||
124981712|NCT02236988|449559756|FG000|Overall Study|Lost to Follow-up|0|||
124981713|NCT02236988|449559757|FG001|Overall Study|Lost to Follow-up|0|||
124981714|NCT02236988|449559758|FG002|Overall Study|Lost to Follow-up|0|||
124981715|NCT02236988|449559759|FG003|Overall Study|Lost to Follow-up|1|||
124981716|NCT02236988|449559756|FG000|Overall Study|Unable to Comply with Study Visits|0|||
124981717|NCT02236988|449559757|FG001|Overall Study|Unable to Comply with Study Visits|0|||
124981718|NCT02236988|449559758|FG002|Overall Study|Unable to Comply with Study Visits|0|||
124981719|NCT02236988|449559759|FG003|Overall Study|Unable to Comply with Study Visits|2|||
124981720|NCT00730275|449559760|FG000|Overall Study|Withdrawal by Subject|0|||
124981721|NCT00730275|449559761|FG001|Overall Study|Withdrawal by Subject|0|||
124981722|NCT00730275|449559762|FG002|Overall Study|Withdrawal by Subject|0|||
124981723|NCT00730275|449559763|FG003|Overall Study|Withdrawal by Subject|1|||
124981724|NCT04032613|449559764|FG000|Overall Study|Did not complete post-program assessment|5|||
124981725|NCT04032613|449559765|FG001|Overall Study|Did not complete post-program assessment|2|||
124981726|NCT03053518|449559770|FG000|Overall Study|Withdrawal by Subject|3|||
124981727|NCT03053518|449559770|FG000|Overall Study|Lost to Follow-up|2|||
124981728|NCT03053518|449559770|FG000|Overall Study|Ineligible|5|||
124981729|NCT02071290|449559771|FG000|Overall Study|Death|1|||
124981730|NCT02071290|449559772|FG001|Overall Study|Death|0|||
124981731|NCT02071290|449559771|FG000|Overall Study|Withdrawal by Subject|0|||
124981732|NCT02071290|449559772|FG001|Overall Study|Withdrawal by Subject|1|||
124981733|NCT02071290|449559771|FG000|Overall Study|Protocol Violation|3|||
124981734|NCT02071290|449559772|FG001|Overall Study|Protocol Violation|5|||
124981735|NCT02071290|449559771|FG000|Overall Study|Physician Decision|0|||
124981736|NCT02071290|449559772|FG001|Overall Study|Physician Decision|1|||
124981737|NCT04488770|449559775|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981738|NCT04488770|449559776|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981739|NCT04488770|449559777|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981740|NCT04488770|449559778|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
124981741|NCT04488770|449559779|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981742|NCT04488770|449559780|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981743|NCT04488770|449559781|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981744|NCT04488770|449559782|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981745|NCT04488770|449559783|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981746|NCT04488770|449559784|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981747|NCT04488770|449559785|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981748|NCT04488770|449559786|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981749|NCT04488770|449559787|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981750|NCT04488770|449559775|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
124981751|NCT04488770|449559776|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981752|NCT04488770|449559777|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981753|NCT04488770|449559778|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981754|NCT04488770|449559779|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981755|NCT04488770|449559780|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981756|NCT04488770|449559781|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981757|NCT04488770|449559782|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981758|NCT04488770|449559783|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981759|NCT04488770|449559784|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981760|NCT04488770|449559785|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981761|NCT04488770|449559786|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981762|NCT04488770|449559787|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981763|NCT04488770|449559775|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981764|NCT04488770|449559776|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981765|NCT04488770|449559777|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981766|NCT04488770|449559778|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981767|NCT04488770|449559779|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981768|NCT04488770|449559780|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
124981769|NCT04488770|449559781|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
124981770|NCT04488770|449559782|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981771|NCT04488770|449559783|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981772|NCT04488770|449559784|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981773|NCT04488770|449559785|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981774|NCT04488770|449559786|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981775|NCT04488770|449559787|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981776|NCT04488770|449559775|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981777|NCT04488770|449559776|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981778|NCT04488770|449559777|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981779|NCT04488770|449559778|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981780|NCT04488770|449559779|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
124981781|NCT04488770|449559780|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981782|NCT04488770|449559781|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981783|NCT04488770|449559782|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981784|NCT04488770|449559783|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981785|NCT04488770|449559784|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981786|NCT04488770|449559785|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981787|NCT04488770|449559786|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981788|NCT04488770|449559787|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981789|NCT02075073|449559788|FG000|Overall Study|Withdrawal by Subject|0|||
124981790|NCT02075073|449559789|FG001|Overall Study|Withdrawal by Subject|1|||
124981791|NCT02075073|449559790|FG002|Overall Study|Withdrawal by Subject|0|||
124981792|NCT03361605|449559798|FG000|Overall Study|Analyzable data not available|3|||
124981793|NCT02770612|449559799|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
124981794|NCT00958841|449559802|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124981795|NCT00958841|449559802|FG000|Overall Study|Abnormal test procedure result(s)|3|||
124981796|NCT00958841|449559802|FG000|Overall Study|Administrative problems|1|||
124981797|NCT00958841|449559802|FG000|Overall Study|Adverse Event|8|||
124981798|NCT00958841|449559802|FG000|Overall Study|New cancer therapy|5|||
124981799|NCT00958841|449559802|FG000|Overall Study|Withdrawal by Subject|1|||
124981800|NCT00958841|449559802|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
124981801|NCT00958841|449559802|FG000|Overall Study|Completed M6/did not enter extension|27|||
124981802|NCT00958841|449559802|FG000|Overall Study|Discontinued prior to M*|28|||
124981803|NCT03014011|449559804|FG000|First Intervention|Withdrawal by Subject|1|||
124981804|NCT03014011|449559805|FG001|First Intervention|Withdrawal by Subject|0|||
124981805|NCT03014011|449559804|FG000|Washout|Withdrawal by Subject|1|||
124981806|NCT03014011|449559805|FG001|Washout|Withdrawal by Subject|0|||
124981807|NCT02416453|449559806|FG000|Overall Study|Adverse Event|0|||
124981808|NCT02416453|449559807|FG001|Overall Study|Adverse Event|0|||
124981809|NCT02416453|449559808|FG002|Overall Study|Adverse Event|0|||
124981810|NCT02416453|449559809|FG003|Overall Study|Adverse Event|2|||
124981811|NCT02416453|449559810|FG004|Overall Study|Adverse Event|0|||
124981812|NCT02416453|449559811|FG005|Overall Study|Adverse Event|1|||
124981813|NCT02416453|449559812|FG006|Overall Study|Adverse Event|0|||
124981814|NCT02416453|449559813|FG007|Overall Study|Adverse Event|0|||
124981815|NCT02416453|449559814|FG008|Overall Study|Adverse Event|0|||
124981816|NCT02416453|449559815|FG009|Overall Study|Adverse Event|0|||
124981817|NCT02416453|449559816|FG010|Overall Study|Adverse Event|0|||
124981818|NCT02416453|449559806|FG000|Overall Study|Lost to Follow-up|1|||
124981819|NCT02416453|449559807|FG001|Overall Study|Lost to Follow-up|3|||
124981820|NCT02416453|449559808|FG002|Overall Study|Lost to Follow-up|0|||
124981821|NCT02416453|449559809|FG003|Overall Study|Lost to Follow-up|8|||
124981822|NCT02416453|449559810|FG004|Overall Study|Lost to Follow-up|0|||
124981823|NCT02416453|449559811|FG005|Overall Study|Lost to Follow-up|5|||
124981824|NCT02416453|449559812|FG006|Overall Study|Lost to Follow-up|1|||
124981825|NCT02416453|449559813|FG007|Overall Study|Lost to Follow-up|3|||
124981826|NCT02416453|449559814|FG008|Overall Study|Lost to Follow-up|1|||
124981827|NCT02416453|449559815|FG009|Overall Study|Lost to Follow-up|0|||
124981828|NCT02416453|449559816|FG010|Overall Study|Lost to Follow-up|0|||
124981829|NCT02416453|449559806|FG000|Overall Study|Physician Decision|0|||
124981830|NCT02416453|449559807|FG001|Overall Study|Physician Decision|0|||
124981831|NCT02416453|449559808|FG002|Overall Study|Physician Decision|0|||
124981832|NCT02416453|449559809|FG003|Overall Study|Physician Decision|0|||
124981833|NCT02416453|449559810|FG004|Overall Study|Physician Decision|0|||
124981834|NCT02416453|449559811|FG005|Overall Study|Physician Decision|1|||
124981835|NCT02416453|449559812|FG006|Overall Study|Physician Decision|1|||
125208381|NCT04643964|450387233|FG003|Overall Study|Failed attention check|14|||
125208382|NCT04643964|450387234|FG004|Overall Study|Failed attention check|11|||
125208383|NCT01472939|450387235|FG000|Overall Study|Adverse Event|3|||
124981836|NCT02416453|449559813|FG007|Overall Study|Physician Decision|1|||
124981837|NCT02416453|449559814|FG008|Overall Study|Physician Decision|0|||
125208384|NCT01472939|450387236|FG001|Overall Study|Adverse Event|7|||
124981838|NCT02416453|449559815|FG009|Overall Study|Physician Decision|0|||
124981839|NCT02416453|449559816|FG010|Overall Study|Physician Decision|0|||
124981840|NCT02416453|449559806|FG000|Overall Study|Withdrawal by Subject|2|||
124981841|NCT02416453|449559807|FG001|Overall Study|Withdrawal by Subject|0|||
124981842|NCT02416453|449559808|FG002|Overall Study|Withdrawal by Subject|0|||
124981843|NCT02416453|449559809|FG003|Overall Study|Withdrawal by Subject|5|||
124981844|NCT02416453|449559810|FG004|Overall Study|Withdrawal by Subject|1|||
124981845|NCT02416453|449559811|FG005|Overall Study|Withdrawal by Subject|8|||
124981846|NCT02416453|449559812|FG006|Overall Study|Withdrawal by Subject|0|||
124981847|NCT02416453|449559813|FG007|Overall Study|Withdrawal by Subject|8|||
124981848|NCT02416453|449559814|FG008|Overall Study|Withdrawal by Subject|4|||
124981849|NCT02416453|449559815|FG009|Overall Study|Withdrawal by Subject|0|||
124981850|NCT02416453|449559816|FG010|Overall Study|Withdrawal by Subject|0|||
124981851|NCT02416453|449559806|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
124981852|NCT02416453|449559807|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
124981853|NCT02416453|449559808|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
124981854|NCT02416453|449559809|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
124981855|NCT02416453|449559810|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
124981856|NCT02416453|449559811|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
124981857|NCT02416453|449559812|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
124981858|NCT02416453|449559813|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
124981859|NCT02416453|449559814|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
124981860|NCT02416453|449559815|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
124981861|NCT02416453|449559816|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
124981862|NCT02416453|449559806|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
124981863|NCT02416453|449559807|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
124981864|NCT02416453|449559808|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
124981865|NCT02416453|449559809|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
124981866|NCT02416453|449559810|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
124981867|NCT02416453|449559811|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
124981868|NCT02416453|449559812|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
124981869|NCT02416453|449559813|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
124981870|NCT02416453|449559814|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
124981871|NCT02416453|449559815|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
124981872|NCT02416453|449559816|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
124981873|NCT00831129|449559824|FG000|Overall Study|Adverse Event|0|||
124981874|NCT00831129|449559825|FG001|Overall Study|Adverse Event|1|||
124981875|NCT00831129|449559824|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
124981876|NCT00831129|449559825|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
124981877|NCT01877239|449559826|FG000|Overall Study|Adverse Event|4|||
124981878|NCT01877239|449559826|FG000|Overall Study|Disease Remission|1|||
124981879|NCT01877239|449559826|FG000|Overall Study|Withdrawal by Subject|4|||
124981880|NCT01877239|449559826|FG000|Overall Study|Other|2|||
124981881|NCT01877239|449559826|FG000|Overall Study|Lack of Efficacy|4|||
124981882|NCT01877239|449559826|FG000|Overall Study|Data not available|35|||
124981883|NCT00743431|449559830|FG000|Overall Study|Toxicity|6|||
124981884|NCT00743431|449559830|FG000|Overall Study|Tumor progression|56|||
124981885|NCT00743431|449559830|FG000|Overall Study|Withdrawal by Subject|13|||
124981886|NCT00743431|449559830|FG000|Overall Study|Death|9|||
124981887|NCT00743431|449559830|FG000|Overall Study|Reason for discontinuation not specified|29|||
124981888|NCT00743431|449559830|FG000|Overall Study|No documentation available|13|||
124981889|NCT03291288|449559831|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
124981890|NCT03291288|449559832|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
124981891|NCT03291288|449559831|FG000|Drug-drug Interaction Phase|Disease progression|1|||
124981892|NCT03291288|449559832|FG001|Drug-drug Interaction Phase|Disease progression|0|||
124981893|NCT03291288|449559831|FG000|Drug-drug Interaction Phase|Other|3|||
124981894|NCT03291288|449559832|FG001|Drug-drug Interaction Phase|Other|0|||
125208385|NCT01472939|450387237|FG002|Overall Study|Adverse Event|7|||
125208386|NCT01472939|450387238|FG003|Overall Study|Adverse Event|14|||
124981895|NCT03291288|449559831|FG000|Pexidartinib Only|Ongoing|0|||
124981896|NCT03291288|449559832|FG001|Pexidartinib Only|Ongoing|2|||
125208387|NCT01472939|450387235|FG000|Overall Study|Lack of Efficacy|1|||
124981897|NCT04276415|449559833|FG000|Overall Study|Adverse Event|0|||
124981898|NCT04276415|449559834|FG001|Overall Study|Adverse Event|0|||
125208388|NCT01472939|450387236|FG001|Overall Study|Lack of Efficacy|0|||
125208389|NCT01472939|450387237|FG002|Overall Study|Lack of Efficacy|0|||
125208390|NCT01472939|450387238|FG003|Overall Study|Lack of Efficacy|1|||
124981899|NCT04276415|449559835|FG002|Overall Study|Adverse Event|0|||
124981900|NCT04276415|449559836|FG003|Overall Study|Adverse Event|3|||
124981901|NCT04276415|449559837|FG004|Overall Study|Adverse Event|0|||
124981902|NCT04276415|449559838|FG005|Overall Study|Adverse Event|0|||
125208391|NCT01472939|450387235|FG000|Overall Study|Lost to Follow-up|3|||
124981903|NCT04276415|449559833|FG000|Overall Study|Clinical progression|1|||
124981904|NCT04276415|449559834|FG001|Overall Study|Clinical progression|1|||
125208392|NCT01472939|450387236|FG001|Overall Study|Lost to Follow-up|0|||
125208393|NCT01472939|450387237|FG002|Overall Study|Lost to Follow-up|2|||
125208394|NCT01472939|450387238|FG003|Overall Study|Lost to Follow-up|0|||
125208395|NCT01472939|450387235|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
125208396|NCT01472939|450387236|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
125208397|NCT01472939|450387237|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
125208398|NCT01472939|450387238|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
125208399|NCT01472939|450387235|FG000|Overall Study|Prohibited Medication|0|||
125208400|NCT01472939|450387236|FG001|Overall Study|Prohibited Medication|1|||
125208401|NCT01472939|450387237|FG002|Overall Study|Prohibited Medication|0|||
125208402|NCT01472939|450387238|FG003|Overall Study|Prohibited Medication|0|||
125208403|NCT01472939|450387235|FG000|Overall Study|Withdrawal By PI|1|||
125208404|NCT01472939|450387236|FG001|Overall Study|Withdrawal By PI|0|||
125208405|NCT01472939|450387237|FG002|Overall Study|Withdrawal By PI|0|||
125208406|NCT01472939|450387238|FG003|Overall Study|Withdrawal By PI|0|||
125208407|NCT01472939|450387235|FG000|Overall Study|Protocol Violation|3|||
125208408|NCT01472939|450387236|FG001|Overall Study|Protocol Violation|3|||
125208409|NCT01472939|450387237|FG002|Overall Study|Protocol Violation|0|||
125208410|NCT01472939|450387238|FG003|Overall Study|Protocol Violation|1|||
125208411|NCT01472939|450387235|FG000|Overall Study|Withdrawal by Subject|9|||
125208412|NCT01472939|450387236|FG001|Overall Study|Withdrawal by Subject|3|||
125208413|NCT01472939|450387237|FG002|Overall Study|Withdrawal by Subject|1|||
125208414|NCT01472939|450387238|FG003|Overall Study|Withdrawal by Subject|4|||
125208415|NCT00114738|450387239|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
125208416|NCT00114738|450387240|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
125208417|NCT00114738|450387241|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
125208418|NCT00114738|450387239|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
125208419|NCT00114738|450387240|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
125208420|NCT00114738|450387241|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
125208421|NCT00114738|450387239|FG000|Screening for Randomization|Neuropathy|17|||
125208422|NCT00114738|450387240|FG001|Screening for Randomization|Neuropathy|0|||
125208423|NCT00114738|450387241|FG002|Screening for Randomization|Neuropathy|0|||
125208424|NCT00114738|450387239|FG000|Screening for Randomization|Progressive disease|2|||
125208425|NCT00114738|450387240|FG001|Screening for Randomization|Progressive disease|0|||
125208426|NCT00114738|450387241|FG002|Screening for Randomization|Progressive disease|0|||
125208427|NCT00114738|450387239|FG000|Screening for Randomization|CNS Hemorrhage|1|||
125208428|NCT00114738|450387240|FG001|Screening for Randomization|CNS Hemorrhage|0|||
125208429|NCT00114738|450387241|FG002|Screening for Randomization|CNS Hemorrhage|0|||
125208430|NCT00114738|450387239|FG000|Screening for Randomization|Other|1|||
125208431|NCT00114738|450387240|FG001|Screening for Randomization|Other|0|||
125208432|NCT00114738|450387241|FG002|Screening for Randomization|Other|0|||
125208433|NCT00308750|450387242|FG000|Overall Study|Adverse Event|9|||
125208434|NCT00308750|450387243|FG001|Overall Study|Adverse Event|9|||
125208435|NCT00308750|450387244|FG002|Overall Study|Adverse Event|13|||
125208436|NCT00308750|450387242|FG000|Overall Study|Withdrawal by Subject|6|||
124872079|NCT04814368|449152827|FG001|Overall Study|Study Terminated by Sponsor|3|||
124872080|NCT04814368|449152828|FG002|Overall Study|Study Terminated by Sponsor|0|||
125208437|NCT00308750|450387243|FG001|Overall Study|Withdrawal by Subject|2|||
125208438|NCT00308750|450387244|FG002|Overall Study|Withdrawal by Subject|3|||
125208439|NCT00308750|450387242|FG000|Overall Study|Physician Decision|3|||
125208440|NCT00308750|450387243|FG001|Overall Study|Physician Decision|4|||
125208441|NCT00308750|450387244|FG002|Overall Study|Physician Decision|3|||
125208442|NCT00308750|450387242|FG000|Overall Study|Sponsor Decision|1|||
125208443|NCT00308750|450387243|FG001|Overall Study|Sponsor Decision|0|||
125208444|NCT00308750|450387244|FG002|Overall Study|Sponsor Decision|0|||
125208445|NCT00308750|450387242|FG000|Overall Study|Disease Progression|47|||
125208446|NCT00308750|450387243|FG001|Overall Study|Disease Progression|24|||
125208447|NCT00308750|450387244|FG002|Overall Study|Disease Progression|28|||
125208448|NCT00308750|450387242|FG000|Overall Study|Unrelated Complication|3|||
125208449|NCT00308750|450387243|FG001|Overall Study|Unrelated Complication|0|||
125208450|NCT00308750|450387244|FG002|Overall Study|Unrelated Complication|1|||
125208451|NCT00308750|450387242|FG000|Overall Study|Death|1|||
125208452|NCT00308750|450387243|FG001|Overall Study|Death|0|||
125208453|NCT00308750|450387244|FG002|Overall Study|Death|1|||
125208454|NCT00308750|450387242|FG000|Overall Study|Protocol Violation|1|||
125208455|NCT00308750|450387243|FG001|Overall Study|Protocol Violation|0|||
125208456|NCT00308750|450387244|FG002|Overall Study|Protocol Violation|0|||
125208457|NCT00308750|450387242|FG000|Overall Study|New Primary Disease Identified|1|||
125208458|NCT00308750|450387243|FG001|Overall Study|New Primary Disease Identified|1|||
125208459|NCT00308750|450387244|FG002|Overall Study|New Primary Disease Identified|0|||
125208460|NCT01358578|450387245|FG000|Induction Period|Adverse Event|2|||
124872081|NCT04814368|449152829|FG003|Overall Study|Study Terminated by Sponsor|2|||
125208461|NCT01358578|450387246|FG001|Induction Period|Adverse Event|4|||
125208462|NCT01358578|450387247|FG002|Induction Period|Adverse Event|2|||
125208463|NCT01358578|450387248|FG003|Induction Period|Adverse Event|6|||
125208464|NCT01358578|450387249|FG004|Induction Period|Adverse Event|0|||
125208465|NCT01358578|450387250|FG005|Induction Period|Adverse Event|0|||
125208466|NCT01358578|450387245|FG000|Induction Period|Lack of Efficacy|0|||
125208467|NCT01358578|450387246|FG001|Induction Period|Lack of Efficacy|0|||
125208468|NCT01358578|450387247|FG002|Induction Period|Lack of Efficacy|9|||
125208469|NCT01358578|450387248|FG003|Induction Period|Lack of Efficacy|1|||
125208470|NCT01358578|450387249|FG004|Induction Period|Lack of Efficacy|0|||
125208471|NCT01358578|450387250|FG005|Induction Period|Lack of Efficacy|0|||
125208472|NCT01358578|450387245|FG000|Induction Period|Lost to Follow-up|0|||
125208473|NCT01358578|450387246|FG001|Induction Period|Lost to Follow-up|0|||
125208474|NCT01358578|450387247|FG002|Induction Period|Lost to Follow-up|1|||
125208475|NCT01358578|450387248|FG003|Induction Period|Lost to Follow-up|4|||
125208476|NCT01358578|450387249|FG004|Induction Period|Lost to Follow-up|0|||
125208477|NCT01358578|450387250|FG005|Induction Period|Lost to Follow-up|0|||
125208478|NCT01358578|450387245|FG000|Induction Period|Physician Decision|2|||
125208479|NCT01358578|450387246|FG001|Induction Period|Physician Decision|1|||
125208480|NCT01358578|450387247|FG002|Induction Period|Physician Decision|2|||
125208481|NCT01358578|450387248|FG003|Induction Period|Physician Decision|0|||
125208482|NCT01358578|450387249|FG004|Induction Period|Physician Decision|0|||
125208483|NCT01358578|450387250|FG005|Induction Period|Physician Decision|0|||
125208484|NCT01358578|450387245|FG000|Induction Period|Protocol Deviation|3|||
125208485|NCT01358578|450387246|FG001|Induction Period|Protocol Deviation|5|||
125208486|NCT01358578|450387247|FG002|Induction Period|Protocol Deviation|0|||
125208487|NCT01358578|450387248|FG003|Induction Period|Protocol Deviation|3|||
125208488|NCT01358578|450387249|FG004|Induction Period|Protocol Deviation|0|||
125208489|NCT01358578|450387250|FG005|Induction Period|Protocol Deviation|0|||
125208490|NCT01358578|450387245|FG000|Induction Period|technical problems|0|||
125208491|NCT01358578|450387246|FG001|Induction Period|technical problems|0|||
125208492|NCT01358578|450387247|FG002|Induction Period|technical problems|1|||
125208493|NCT01358578|450387248|FG003|Induction Period|technical problems|1|||
125208494|NCT01358578|450387249|FG004|Induction Period|technical problems|0|||
125208495|NCT01358578|450387250|FG005|Induction Period|technical problems|0|||
125208496|NCT01358578|450387245|FG000|Induction Period|Withdrawal by Subject|5|||
125208497|NCT01358578|450387246|FG001|Induction Period|Withdrawal by Subject|5|||
125208498|NCT01358578|450387247|FG002|Induction Period|Withdrawal by Subject|10|||
125208499|NCT01358578|450387248|FG003|Induction Period|Withdrawal by Subject|6|||
125208500|NCT01358578|450387249|FG004|Induction Period|Withdrawal by Subject|0|||
125208501|NCT01358578|450387250|FG005|Induction Period|Withdrawal by Subject|0|||
125208502|NCT01358578|450387245|FG000|Maintenance Period|Adverse Event|2|||
125208503|NCT01358578|450387246|FG001|Maintenance Period|Adverse Event|7|||
125208504|NCT01358578|450387247|FG002|Maintenance Period|Adverse Event|0|||
125208505|NCT01358578|450387248|FG003|Maintenance Period|Adverse Event|6|||
125208506|NCT01358578|450387249|FG004|Maintenance Period|Adverse Event|4|||
125208507|NCT01358578|450387250|FG005|Maintenance Period|Adverse Event|3|||
125208508|NCT01358578|450387245|FG000|Maintenance Period|Lack of Efficacy|10|||
125208509|NCT01358578|450387246|FG001|Maintenance Period|Lack of Efficacy|2|||
125208510|NCT01358578|450387247|FG002|Maintenance Period|Lack of Efficacy|0|||
125208511|NCT01358578|450387248|FG003|Maintenance Period|Lack of Efficacy|11|||
125208512|NCT01358578|450387249|FG004|Maintenance Period|Lack of Efficacy|3|||
125208513|NCT01358578|450387250|FG005|Maintenance Period|Lack of Efficacy|0|||
125208514|NCT01358578|450387245|FG000|Maintenance Period|Lost to Follow-up|4|||
125208515|NCT01358578|450387246|FG001|Maintenance Period|Lost to Follow-up|0|||
125208516|NCT01358578|450387247|FG002|Maintenance Period|Lost to Follow-up|0|||
125208517|NCT01358578|450387248|FG003|Maintenance Period|Lost to Follow-up|5|||
125208518|NCT01358578|450387249|FG004|Maintenance Period|Lost to Follow-up|1|||
125208519|NCT01358578|450387250|FG005|Maintenance Period|Lost to Follow-up|1|||
125208520|NCT01358578|450387245|FG000|Maintenance Period|Non-compliance with study treatment|3|||
125208521|NCT01358578|450387246|FG001|Maintenance Period|Non-compliance with study treatment|1|||
125208522|NCT01358578|450387247|FG002|Maintenance Period|Non-compliance with study treatment|0|||
125208523|NCT01358578|450387248|FG003|Maintenance Period|Non-compliance with study treatment|2|||
125208524|NCT01358578|450387249|FG004|Maintenance Period|Non-compliance with study treatment|1|||
125208525|NCT01358578|450387250|FG005|Maintenance Period|Non-compliance with study treatment|2|||
125208526|NCT01358578|450387245|FG000|Maintenance Period|Physician Decision|0|||
125208527|NCT01358578|450387246|FG001|Maintenance Period|Physician Decision|1|||
125208528|NCT01358578|450387247|FG002|Maintenance Period|Physician Decision|0|||
125208529|NCT01358578|450387248|FG003|Maintenance Period|Physician Decision|1|||
125208530|NCT01358578|450387249|FG004|Maintenance Period|Physician Decision|0|||
125208531|NCT01358578|450387250|FG005|Maintenance Period|Physician Decision|0|||
125208532|NCT01358578|450387245|FG000|Maintenance Period|Pregnancy|1|||
125208533|NCT01358578|450387246|FG001|Maintenance Period|Pregnancy|0|||
125208534|NCT01358578|450387247|FG002|Maintenance Period|Pregnancy|0|||
124872082|NCT04814368|449152826|FG000|Overall Study|Subject Decision|1|||
125208535|NCT01358578|450387248|FG003|Maintenance Period|Pregnancy|0|||
125208536|NCT01358578|450387249|FG004|Maintenance Period|Pregnancy|0|||
125208537|NCT01358578|450387250|FG005|Maintenance Period|Pregnancy|0|||
125208538|NCT01358578|450387245|FG000|Maintenance Period|Protocol deviation|7|||
125208539|NCT01358578|450387246|FG001|Maintenance Period|Protocol deviation|4|||
125208540|NCT01358578|450387247|FG002|Maintenance Period|Protocol deviation|0|||
124981905|NCT04276415|449559835|FG002|Overall Study|Clinical progression|0|||
124981906|NCT04276415|449559836|FG003|Overall Study|Clinical progression|0|||
124981907|NCT04276415|449559837|FG004|Overall Study|Clinical progression|1|||
124981908|NCT04276415|449559838|FG005|Overall Study|Clinical progression|0|||
124981909|NCT04276415|449559833|FG000|Overall Study|Other|0|||
124981910|NCT04276415|449559834|FG001|Overall Study|Other|0|||
125208541|NCT01358578|450387248|FG003|Maintenance Period|Protocol deviation|2|||
125208542|NCT01358578|450387249|FG004|Maintenance Period|Protocol deviation|2|||
125208543|NCT01358578|450387250|FG005|Maintenance Period|Protocol deviation|2|||
125208544|NCT01358578|450387245|FG000|Maintenance Period|Withdrawal by Subject|12|||
125208545|NCT01358578|450387246|FG001|Maintenance Period|Withdrawal by Subject|7|||
125208546|NCT01358578|450387247|FG002|Maintenance Period|Withdrawal by Subject|2|||
125208547|NCT01358578|450387248|FG003|Maintenance Period|Withdrawal by Subject|15|||
125208548|NCT01358578|450387249|FG004|Maintenance Period|Withdrawal by Subject|6|||
125208549|NCT01358578|450387250|FG005|Maintenance Period|Withdrawal by Subject|3|||
125208550|NCT01358578|450387245|FG000|Follow-up Period|Adverse Event|1|||
125208551|NCT01358578|450387246|FG001|Follow-up Period|Adverse Event|1|||
125208552|NCT01358578|450387247|FG002|Follow-up Period|Adverse Event|0|||
125208553|NCT01358578|450387248|FG003|Follow-up Period|Adverse Event|0|||
125208554|NCT01358578|450387249|FG004|Follow-up Period|Adverse Event|0|||
125208555|NCT01358578|450387250|FG005|Follow-up Period|Adverse Event|0|||
125208556|NCT01358578|450387245|FG000|Follow-up Period|Lack of Efficacy|3|||
125208557|NCT01358578|450387246|FG001|Follow-up Period|Lack of Efficacy|0|||
125208558|NCT01358578|450387247|FG002|Follow-up Period|Lack of Efficacy|4|||
125208559|NCT01358578|450387248|FG003|Follow-up Period|Lack of Efficacy|1|||
125208560|NCT01358578|450387249|FG004|Follow-up Period|Lack of Efficacy|0|||
125208561|NCT01358578|450387250|FG005|Follow-up Period|Lack of Efficacy|0|||
125208562|NCT01358578|450387245|FG000|Follow-up Period|Lost to Follow-up|0|||
125208563|NCT01358578|450387246|FG001|Follow-up Period|Lost to Follow-up|1|||
125208564|NCT01358578|450387247|FG002|Follow-up Period|Lost to Follow-up|0|||
125208565|NCT01358578|450387248|FG003|Follow-up Period|Lost to Follow-up|4|||
125208566|NCT01358578|450387249|FG004|Follow-up Period|Lost to Follow-up|0|||
125208567|NCT01358578|450387250|FG005|Follow-up Period|Lost to Follow-up|0|||
125208568|NCT01358578|450387245|FG000|Follow-up Period|non- compliance with study treatment|1|||
125208569|NCT01358578|450387246|FG001|Follow-up Period|non- compliance with study treatment|0|||
125208570|NCT01358578|450387247|FG002|Follow-up Period|non- compliance with study treatment|0|||
125208571|NCT01358578|450387248|FG003|Follow-up Period|non- compliance with study treatment|0|||
125208572|NCT01358578|450387249|FG004|Follow-up Period|non- compliance with study treatment|0|||
125208573|NCT01358578|450387250|FG005|Follow-up Period|non- compliance with study treatment|0|||
125208574|NCT01358578|450387245|FG000|Follow-up Period|Pregnancy|1|||
125208575|NCT01358578|450387246|FG001|Follow-up Period|Pregnancy|0|||
125208576|NCT01358578|450387247|FG002|Follow-up Period|Pregnancy|0|||
125208577|NCT01358578|450387248|FG003|Follow-up Period|Pregnancy|0|||
125208578|NCT01358578|450387249|FG004|Follow-up Period|Pregnancy|0|||
125208579|NCT01358578|450387250|FG005|Follow-up Period|Pregnancy|0|||
125208580|NCT01358578|450387245|FG000|Follow-up Period|Withdrawal by Subject|3|||
125208581|NCT01358578|450387246|FG001|Follow-up Period|Withdrawal by Subject|3|||
125208582|NCT01358578|450387247|FG002|Follow-up Period|Withdrawal by Subject|1|||
125208583|NCT01358578|450387248|FG003|Follow-up Period|Withdrawal by Subject|12|||
125208584|NCT01358578|450387249|FG004|Follow-up Period|Withdrawal by Subject|0|||
125208585|NCT01358578|450387250|FG005|Follow-up Period|Withdrawal by Subject|0|||
125208586|NCT01358578|450387245|FG000|Follow-up Period|Physician Decision|1|||
125208587|NCT01358578|450387246|FG001|Follow-up Period|Physician Decision|1|||
125208588|NCT01358578|450387247|FG002|Follow-up Period|Physician Decision|0|||
125208589|NCT01358578|450387248|FG003|Follow-up Period|Physician Decision|2|||
125208590|NCT01358578|450387249|FG004|Follow-up Period|Physician Decision|0|||
125208591|NCT01358578|450387250|FG005|Follow-up Period|Physician Decision|0|||
125208592|NCT00388297|450387251|FG000|Overall Study|Lost to Follow-up|16|||
125208593|NCT00388297|450387252|FG001|Overall Study|Lost to Follow-up|12|||
125208594|NCT00388297|450387253|FG002|Overall Study|Lost to Follow-up|11|||
125208595|NCT00388297|450387254|FG003|Overall Study|Lost to Follow-up|8|||
125208596|NCT01492101|450387256|FG000|Overall Study|Death|323|||
125208597|NCT01492101|450387257|FG001|Overall Study|Death|322|||
125208598|NCT01492101|450387256|FG000|Overall Study|Withdrawal by Subject|14|||
125208599|NCT01492101|450387257|FG001|Overall Study|Withdrawal by Subject|18|||
125208600|NCT01492101|450387256|FG000|Overall Study|Lost to Follow-up|0|||
125208601|NCT01492101|450387257|FG001|Overall Study|Lost to Follow-up|2|||
125208602|NCT01675154|450387258|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
124981911|NCT04276415|449559835|FG002|Overall Study|Other|0|||
125208603|NCT01675154|450387259|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
125208604|NCT01675154|450387260|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
125208605|NCT01675154|450387261|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
125208606|NCT02971800|450387264|FG000|Overall Study|Protocol Violation|1|||
125208607|NCT02971800|450387264|FG000|Overall Study|Withdrawal by Subject|1|||
125208608|NCT02971800|450387264|FG000|Overall Study|Exclusion criteria prior intervention|1|||
124981912|NCT04276415|449559836|FG003|Overall Study|Other|1|||
125208609|NCT02971800|450387264|FG000|Overall Study|Number evaluable participant already reached|4|||
125208610|NCT05323994|450387265|FG000|Overall Study|Protocol Violation|1|||
125208611|NCT00460265|450387266|FG000|Overall Study|Lost to Follow-up|14|||
125208612|NCT00460265|450387267|FG001|Overall Study|Lost to Follow-up|15|||
125208613|NCT00460265|450387266|FG000|Overall Study|Physician Decision|1|||
125208614|NCT00460265|450387267|FG001|Overall Study|Physician Decision|2|||
125208615|NCT00460265|450387266|FG000|Overall Study|Withdrawal by Subject|10|||
125208616|NCT00460265|450387267|FG001|Overall Study|Withdrawal by Subject|25|||
125208617|NCT00460265|450387266|FG000|Overall Study|Ongoing|60|||
125208618|NCT00460265|450387267|FG001|Overall Study|Ongoing|47|||
125208619|NCT02719353|450387269|FG000|First Intervention|Physician Decision|0|||
125208620|NCT02719353|450387270|FG001|First Intervention|Physician Decision|1|||
125208621|NCT01917344|450387274|FG000|Overall Study|Withdrawal by Subject|1|||
125208622|NCT04526574|450387279|FG000|Overall Study|Protocol Violation|3|||
125208623|NCT04526574|450387280|FG001|Overall Study|Protocol Violation|1|||
125208624|NCT04526574|450387279|FG000|Overall Study|Withdrawal by Subject|12|||
125208625|NCT04526574|450387280|FG001|Overall Study|Withdrawal by Subject|9|||
125208626|NCT04526574|450387279|FG000|Overall Study|Other|1|||
125208627|NCT04526574|450387280|FG001|Overall Study|Other|2|||
125208628|NCT04526574|450387279|FG000|Overall Study|Adverse Event|1|||
125208629|NCT04526574|450387280|FG001|Overall Study|Adverse Event|1|||
125208630|NCT04526574|450387279|FG000|Overall Study|Death|2|||
125208631|NCT04526574|450387280|FG001|Overall Study|Death|3|||
125208632|NCT04526574|450387279|FG000|Overall Study|Lost to Follow-up|9|||
125208633|NCT04526574|450387280|FG001|Overall Study|Lost to Follow-up|9|||
125208634|NCT04526574|450387279|FG000|Overall Study|No longer meets eligibility criteria|8|||
125208635|NCT04526574|450387280|FG001|Overall Study|No longer meets eligibility criteria|8|||
125208636|NCT00045734|450387288|FG000|Overall Study|Protocol Violation|1|||
125208637|NCT01524783|450387293|FG000|Blinded Period|Adverse Event|64|||
125208638|NCT01524783|450387294|FG001|Blinded Period|Adverse Event|7|||
125208639|NCT01524783|450387295|FG002|Blinded Period|Adverse Event|0|||
125208640|NCT01524783|450387293|FG000|Blinded Period|Disease Progression|89|||
125208641|NCT01524783|450387294|FG001|Blinded Period|Disease Progression|75|||
125208642|NCT01524783|450387295|FG002|Blinded Period|Disease Progression|0|||
125208643|NCT01524783|450387293|FG000|Blinded Period|Withdrawal by Subject|19|||
125208644|NCT01524783|450387294|FG001|Blinded Period|Withdrawal by Subject|6|||
125208645|NCT01524783|450387295|FG002|Blinded Period|Withdrawal by Subject|0|||
125208646|NCT01524783|450387293|FG000|Blinded Period|Protocol deviation|2|||
124981913|NCT04276415|449559837|FG004|Overall Study|Other|0|||
124981914|NCT04276415|449559838|FG005|Overall Study|Other|0|||
124981915|NCT04276415|449559833|FG000|Overall Study|Physician Decision|0|||
125208647|NCT01524783|450387294|FG001|Blinded Period|Protocol deviation|1|||
125208648|NCT01524783|450387295|FG002|Blinded Period|Protocol deviation|0|||
124981916|NCT04276415|449559834|FG001|Overall Study|Physician Decision|0|||
124981917|NCT04276415|449559835|FG002|Overall Study|Physician Decision|1|||
125208649|NCT01524783|450387293|FG000|Blinded Period|Death|5|||
125208650|NCT01524783|450387294|FG001|Blinded Period|Death|2|||
125208651|NCT01524783|450387295|FG002|Blinded Period|Death|0|||
125208652|NCT01524783|450387293|FG000|Open-label Period|Disease progression|13|||
125208653|NCT01524783|450387294|FG001|Open-label Period|Disease progression|0|||
125208654|NCT01524783|450387295|FG002|Open-label Period|Disease progression|2|||
125208655|NCT01524783|450387293|FG000|Open-label Period|Administrative problems|5|||
125208656|NCT01524783|450387294|FG001|Open-label Period|Administrative problems|0|||
125208657|NCT01524783|450387295|FG002|Open-label Period|Administrative problems|2|||
125208658|NCT01524783|450387293|FG000|Open-label Period|Adverse Event|5|||
125208659|NCT01524783|450387294|FG001|Open-label Period|Adverse Event|0|||
124981918|NCT04276415|449559836|FG003|Overall Study|Physician Decision|3|||
124981919|NCT04276415|449559837|FG004|Overall Study|Physician Decision|2|||
124981920|NCT04276415|449559838|FG005|Overall Study|Physician Decision|0|||
124981921|NCT04276415|449559833|FG000|Overall Study|Progressive disease|3|||
124981922|NCT04276415|449559834|FG001|Overall Study|Progressive disease|3|||
124981923|NCT04276415|449559835|FG002|Overall Study|Progressive disease|4|||
125208660|NCT01524783|450387295|FG002|Open-label Period|Adverse Event|1|||
125208661|NCT01524783|450387293|FG000|Open-label Period|Withdrawal by Subject|2|||
125208662|NCT01524783|450387294|FG001|Open-label Period|Withdrawal by Subject|0|||
125208663|NCT01524783|450387295|FG002|Open-label Period|Withdrawal by Subject|1|||
125208664|NCT01524783|450387293|FG000|Open-label Period|Protocol deviation|1|||
125208665|NCT01524783|450387294|FG001|Open-label Period|Protocol deviation|0|||
124981924|NCT04276415|449559836|FG003|Overall Study|Progressive disease|5|||
124981925|NCT04276415|449559837|FG004|Overall Study|Progressive disease|1|||
125208666|NCT01524783|450387295|FG002|Open-label Period|Protocol deviation|0|||
125208667|NCT02054910|450387297|FG000|Overall Study|Lost to Follow-up|4|||
125208668|NCT02054910|450387298|FG001|Overall Study|Lost to Follow-up|1|||
125208669|NCT01096589|450387304|FG000|Overall Study|Adverse Event|2|||
125208670|NCT01096589|450387305|FG001|Overall Study|Adverse Event|1|||
125208671|NCT01096589|450387306|FG002|Overall Study|Adverse Event|2|||
125208672|NCT01096589|450387307|FG003|Overall Study|Adverse Event|1|||
125208673|NCT01096589|450387304|FG000|Overall Study|Withdrawal by Subject|2|||
125208674|NCT01096589|450387305|FG001|Overall Study|Withdrawal by Subject|1|||
125208675|NCT01096589|450387306|FG002|Overall Study|Withdrawal by Subject|1|||
125208676|NCT01096589|450387307|FG003|Overall Study|Withdrawal by Subject|1|||
125208677|NCT01096589|450387304|FG000|Overall Study|Compliance with protocol|0|||
125208678|NCT01096589|450387305|FG001|Overall Study|Compliance with protocol|0|||
125208679|NCT01096589|450387306|FG002|Overall Study|Compliance with protocol|1|||
125208680|NCT01096589|450387307|FG003|Overall Study|Compliance with protocol|0|||
125208681|NCT01096589|450387304|FG000|Overall Study|found treatment exhausting|0|||
125208682|NCT01096589|450387305|FG001|Overall Study|found treatment exhausting|0|||
125208683|NCT01096589|450387306|FG002|Overall Study|found treatment exhausting|0|||
125208684|NCT01096589|450387307|FG003|Overall Study|found treatment exhausting|1|||
125208685|NCT03673345|450387308|FG000|Overall Study|Lost to Follow-up|1|||
125208686|NCT03673345|450387309|FG001|Overall Study|Lost to Follow-up|0|||
125208687|NCT03673345|450387310|FG002|Overall Study|Lost to Follow-up|3|||
125208688|NCT03673345|450387311|FG003|Overall Study|Lost to Follow-up|3|||
125208689|NCT03673345|450387312|FG004|Overall Study|Lost to Follow-up|2|||
125208690|NCT03673345|450387313|FG005|Overall Study|Lost to Follow-up|1|||
125208691|NCT03673345|450387314|FG006|Overall Study|Lost to Follow-up|0|||
125208692|NCT03673345|450387315|FG007|Overall Study|Lost to Follow-up|0|||
125208693|NCT03673345|450387308|FG000|Overall Study|Withdrawal by Subject|1|||
125208694|NCT03673345|450387309|FG001|Overall Study|Withdrawal by Subject|0|||
125208695|NCT03673345|450387310|FG002|Overall Study|Withdrawal by Subject|4|||
125208696|NCT03673345|450387311|FG003|Overall Study|Withdrawal by Subject|2|||
125208697|NCT03673345|450387312|FG004|Overall Study|Withdrawal by Subject|0|||
125208698|NCT03673345|450387313|FG005|Overall Study|Withdrawal by Subject|0|||
125208699|NCT03673345|450387314|FG006|Overall Study|Withdrawal by Subject|0|||
125208700|NCT03673345|450387315|FG007|Overall Study|Withdrawal by Subject|0|||
125208701|NCT03673345|450387308|FG000|Overall Study|Physician Decision|0|||
125208702|NCT03673345|450387309|FG001|Overall Study|Physician Decision|0|||
124872083|NCT04814368|449152827|FG001|Overall Study|Subject Decision|2|||
124872084|NCT04814368|449152828|FG002|Overall Study|Subject Decision|0|||
124872085|NCT04814368|449152829|FG003|Overall Study|Subject Decision|0|||
124872086|NCT01194570|449154007|FG000|Overall Study|Adverse Event|22|||
124872087|NCT01194570|449154008|FG001|Overall Study|Adverse Event|40|||
124872088|NCT01194570|449154007|FG000|Overall Study|Death|6|||
124872089|NCT01194570|449154008|FG001|Overall Study|Death|20|||
124872090|NCT01194570|449154007|FG000|Overall Study|Lack of Efficacy|32|||
124872091|NCT01194570|449154008|FG001|Overall Study|Lack of Efficacy|33|||
124872092|NCT01194570|449154007|FG000|Overall Study|Lost to Follow-up|4|||
124872093|NCT01194570|449154008|FG001|Overall Study|Lost to Follow-up|15|||
124872094|NCT01194570|449154007|FG000|Overall Study|Non-Compliance|2|||
124872095|NCT01194570|449154008|FG001|Overall Study|Non-Compliance|2|||
124872096|NCT01194570|449154007|FG000|Overall Study|Non-Compliance With Study Drug|2|||
124872097|NCT01194570|449154008|FG001|Overall Study|Non-Compliance With Study Drug|2|||
124872098|NCT01194570|449154007|FG000|Overall Study|Other|18|||
124872099|NCT01194570|449154008|FG001|Overall Study|Other|47|||
124872100|NCT01194570|449154007|FG000|Overall Study|Physician Decision|10|||
124872101|NCT01194570|449154008|FG001|Overall Study|Physician Decision|25|||
124872102|NCT01194570|449154007|FG000|Overall Study|Protocol Violation|1|||
124872103|NCT01194570|449154008|FG001|Overall Study|Protocol Violation|2|||
124872104|NCT01194570|449154007|FG000|Overall Study|Study Terminated By Sponsor|0|||
124872105|NCT01194570|449154008|FG001|Overall Study|Study Terminated By Sponsor|1|||
124872106|NCT01194570|449154007|FG000|Overall Study|Withdrawal by Subject|57|||
124872107|NCT01194570|449154008|FG001|Overall Study|Withdrawal by Subject|82|||
124872108|NCT01194570|449154007|FG000|Overall Study|Pregnancy|1|||
124872109|NCT01194570|449154008|FG001|Overall Study|Pregnancy|1|||
124872110|NCT01337674|449154009|FG000|Treatment Period 1|Adverse Event|0|||
124872111|NCT01337674|449154010|FG001|Treatment Period 1|Adverse Event|1|||
124872112|NCT01337674|449154011|FG002|Treatment Period 1|Adverse Event|0|||
124872113|NCT01337674|449154012|FG003|Treatment Period 1|Adverse Event|0|||
124872114|NCT01337674|449154009|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
124872115|NCT01337674|449154010|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
124872116|NCT01337674|449154011|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
124872117|NCT01337674|449154012|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
124872118|NCT01337674|449154009|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124872119|NCT01337674|449154010|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124872120|NCT01337674|449154011|FG002|Treatment Period 2|Withdrawal by Subject|1|||
124872121|NCT01337674|449154012|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124872122|NCT00939484|449154016|FG000|Overall Study|Progression/Relapse|8|||
124872123|NCT00939484|449154017|FG001|Overall Study|Progression/Relapse|20|||
124872124|NCT00939484|449154018|FG002|Overall Study|Progression/Relapse|3|||
124872125|NCT01224925|449154019|FG000|Overall Study|Lost to Follow-up|3|||
125208703|NCT03673345|450387310|FG002|Overall Study|Physician Decision|2|||
125208704|NCT03673345|450387311|FG003|Overall Study|Physician Decision|0|||
125208705|NCT03673345|450387312|FG004|Overall Study|Physician Decision|0|||
125208706|NCT03673345|450387313|FG005|Overall Study|Physician Decision|0|||
125208707|NCT03673345|450387314|FG006|Overall Study|Physician Decision|0|||
125208708|NCT03673345|450387315|FG007|Overall Study|Physician Decision|0|||
125208709|NCT02267135|450387316|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
125208710|NCT02267135|450387317|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
125208711|NCT02267135|450387316|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
125208712|NCT02267135|450387317|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
125208713|NCT02267135|450387316|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
125208714|NCT02267135|450387317|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
125208715|NCT02267135|450387316|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
125208716|NCT02267135|450387317|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
125208717|NCT02267135|450387316|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
125208718|NCT02267135|450387317|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
125208719|NCT00900731|450387318|FG000|Overall Study|Adverse Event|31|||
125208720|NCT00900731|450387319|FG001|Overall Study|Adverse Event|27|||
125208721|NCT00900731|450387318|FG000|Overall Study|Withdrawal by Subject|8|||
125208722|NCT00900731|450387319|FG001|Overall Study|Withdrawal by Subject|7|||
125208723|NCT00900731|450387318|FG000|Overall Study|Protocol Deviation|8|||
125208724|NCT00900731|450387319|FG001|Overall Study|Protocol Deviation|11|||
125208725|NCT00900731|450387318|FG000|Overall Study|Administrative Problems|5|||
125208726|NCT00900731|450387319|FG001|Overall Study|Administrative Problems|4|||
125208727|NCT00900731|450387318|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
125208728|NCT00900731|450387319|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
125208729|NCT00900731|450387318|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
125208730|NCT00900731|450387319|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
125208731|NCT00900731|450387318|FG000|Overall Study|Lost to Follow-up|2|||
125208732|NCT00900731|450387319|FG001|Overall Study|Lost to Follow-up|3|||
125208733|NCT00900731|450387318|FG000|Overall Study|Lack of Efficacy|1|||
125208734|NCT00900731|450387319|FG001|Overall Study|Lack of Efficacy|3|||
125208735|NCT00900731|450387318|FG000|Overall Study|Death|0|||
125208736|NCT00900731|450387319|FG001|Overall Study|Death|2|||
125208737|NCT03806231|450387320|FG000|Overall Study|Physician Decision|1|||
125208738|NCT03806231|450387321|FG001|Overall Study|Physician Decision|0|||
125208739|NCT03806231|450387320|FG000|Overall Study|Withdrawal by Subject|1|||
125208740|NCT03806231|450387321|FG001|Overall Study|Withdrawal by Subject|0|||
125208741|NCT00932698|450387322|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
125208742|NCT00932698|450387323|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
125208743|NCT00932698|450387324|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
125208744|NCT00932698|450387325|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
125208745|NCT00932698|450387326|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
125208746|NCT00932698|450387327|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
125208747|NCT00932698|450387328|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
125208748|NCT00932698|450387329|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
125208749|NCT00932698|450387330|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
125208750|NCT00932698|450387331|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
125208751|NCT00932698|450387332|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
125208752|NCT00932698|450387322|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
125208753|NCT00932698|450387323|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
125208754|NCT00932698|450387324|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
125208755|NCT00932698|450387325|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
125208756|NCT00932698|450387326|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
125208757|NCT00932698|450387327|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
125208758|NCT00932698|450387328|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
125208759|NCT00932698|450387329|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
125208760|NCT00932698|450387330|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
125208761|NCT00932698|450387331|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
125208762|NCT00932698|450387332|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
125208763|NCT00932698|450387322|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
125208764|NCT00932698|450387323|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
125208765|NCT00932698|450387324|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
125208766|NCT00932698|450387325|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
125208767|NCT00932698|450387326|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
125208768|NCT00932698|450387327|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
125208769|NCT00932698|450387328|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
125208770|NCT00932698|450387329|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
125208771|NCT00932698|450387330|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
125208772|NCT00932698|450387331|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
125208773|NCT00932698|450387332|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
125208774|NCT00932698|450387322|FG000|Part 1 (Dose Escalation)|Other|0|||
125208775|NCT00932698|450387323|FG001|Part 1 (Dose Escalation)|Other|0|||
125208776|NCT00932698|450387324|FG002|Part 1 (Dose Escalation)|Other|1|||
125208777|NCT00932698|450387325|FG003|Part 1 (Dose Escalation)|Other|0|||
125208778|NCT00932698|450387326|FG004|Part 1 (Dose Escalation)|Other|0|||
125208779|NCT00932698|450387327|FG005|Part 1 (Dose Escalation)|Other|0|||
125208780|NCT00932698|450387328|FG006|Part 1 (Dose Escalation)|Other|1|||
125208781|NCT00932698|450387329|FG007|Part 1 (Dose Escalation)|Other|0|||
125208782|NCT00932698|450387330|FG008|Part 1 (Dose Escalation)|Other|0|||
125208783|NCT00932698|450387331|FG009|Part 1 (Dose Escalation)|Other|0|||
125208784|NCT00932698|450387332|FG010|Part 1 (Dose Escalation)|Other|0|||
125208785|NCT00932698|450387322|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
125208786|NCT00932698|450387323|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
125208787|NCT00932698|450387324|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
125208788|NCT00932698|450387325|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
125208789|NCT00932698|450387326|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
125208790|NCT00932698|450387327|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
125208791|NCT00932698|450387328|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
125208792|NCT00932698|450387329|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
125208793|NCT00932698|450387330|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
125208794|NCT00932698|450387331|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
125208795|NCT00932698|450387332|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
125208796|NCT00932698|450387322|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
125208797|NCT00932698|450387323|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
125208798|NCT00932698|450387324|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
125208799|NCT00932698|450387325|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
125208800|NCT00932698|450387326|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
125208801|NCT00932698|450387327|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
125208802|NCT00932698|450387328|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
125208803|NCT00932698|450387329|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
125208804|NCT00932698|450387330|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
125208805|NCT00932698|450387331|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
125208806|NCT00932698|450387332|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
125208807|NCT00932698|450387322|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
125208808|NCT00932698|450387323|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
125208809|NCT00932698|450387324|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
125208810|NCT00932698|450387325|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
125208811|NCT00932698|450387326|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
125208812|NCT00932698|450387327|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
125208813|NCT00932698|450387328|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
125208814|NCT00932698|450387329|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
125208815|NCT00932698|450387330|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
125208816|NCT00932698|450387331|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
125208817|NCT00932698|450387332|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
125208818|NCT00655681|450387333|FG000|Overall Study|Lost to Follow-up|1|||
125208819|NCT00655681|450387334|FG001|Overall Study|Lost to Follow-up|1|||
125208820|NCT02429310|450387335|FG000|Overall Study|Lost to Follow-up|1|||
125208821|NCT02429310|450387336|FG001|Overall Study|Lost to Follow-up|2|||
125208822|NCT02429310|450387335|FG000|Overall Study|Protocol Violation|1|||
125208823|NCT02429310|450387336|FG001|Overall Study|Protocol Violation|1|||
125208824|NCT00394433|450387337|FG000|Overall Study|Adverse Event|2|||
125208825|NCT00394433|450387337|FG000|Overall Study|Alternative Therapy|1|||
125208826|NCT01554176|450387338|FG000|Treatment Phase|Protocol Violation|1|||
125208827|NCT01554176|450387339|FG001|Treatment Phase|Protocol Violation|2|||
125208828|NCT01554176|450387340|FG002|Treatment Phase|Protocol Violation|0|||
125208829|NCT01554176|450387341|FG003|Treatment Phase|Protocol Violation|0|||
125208830|NCT01554176|450387342|FG004|Treatment Phase|Protocol Violation|0|||
125208831|NCT01554176|450387338|FG000|Treatment Phase|Physician Decision|1|||
125208832|NCT01554176|450387339|FG001|Treatment Phase|Physician Decision|1|||
125208833|NCT01554176|450387340|FG002|Treatment Phase|Physician Decision|0|||
125208834|NCT01554176|450387341|FG003|Treatment Phase|Physician Decision|0|||
125208835|NCT01554176|450387342|FG004|Treatment Phase|Physician Decision|0|||
125208836|NCT01554176|450387338|FG000|Treatment Phase|Lack of Efficacy|0|||
125208837|NCT01554176|450387339|FG001|Treatment Phase|Lack of Efficacy|1|||
125208838|NCT01554176|450387340|FG002|Treatment Phase|Lack of Efficacy|0|||
125208839|NCT01554176|450387341|FG003|Treatment Phase|Lack of Efficacy|0|||
125208840|NCT01554176|450387342|FG004|Treatment Phase|Lack of Efficacy|0|||
125208841|NCT01554176|450387338|FG000|Treatment Phase|Adverse event, non-fatal|1|||
125208842|NCT01554176|450387339|FG001|Treatment Phase|Adverse event, non-fatal|1|||
125208843|NCT01554176|450387340|FG002|Treatment Phase|Adverse event, non-fatal|0|||
125208844|NCT01554176|450387341|FG003|Treatment Phase|Adverse event, non-fatal|0|||
125208845|NCT01554176|450387342|FG004|Treatment Phase|Adverse event, non-fatal|0|||
125208846|NCT01554176|450387338|FG000|Treatment Phase|Non-compliance with study drug|1|||
125208847|NCT01554176|450387339|FG001|Treatment Phase|Non-compliance with study drug|0|||
125208848|NCT01554176|450387340|FG002|Treatment Phase|Non-compliance with study drug|0|||
125208849|NCT01554176|450387341|FG003|Treatment Phase|Non-compliance with study drug|0|||
125208850|NCT01554176|450387342|FG004|Treatment Phase|Non-compliance with study drug|0|||
125208851|NCT01554176|450387338|FG000|Treatment Phase|Withdrawal by Subject|1|||
125208852|NCT01554176|450387339|FG001|Treatment Phase|Withdrawal by Subject|0|||
125208853|NCT01554176|450387340|FG002|Treatment Phase|Withdrawal by Subject|0|||
125208854|NCT01554176|450387341|FG003|Treatment Phase|Withdrawal by Subject|0|||
125208855|NCT01554176|450387342|FG004|Treatment Phase|Withdrawal by Subject|0|||
125208856|NCT01554176|450387338|FG000|Treatment Phase|Lost to Follow-up|3|||
124981926|NCT04276415|449559838|FG005|Overall Study|Progressive disease|2|||
125208857|NCT01554176|450387339|FG001|Treatment Phase|Lost to Follow-up|0|||
125208858|NCT01554176|450387340|FG002|Treatment Phase|Lost to Follow-up|0|||
125208859|NCT01554176|450387341|FG003|Treatment Phase|Lost to Follow-up|0|||
125208860|NCT01554176|450387342|FG004|Treatment Phase|Lost to Follow-up|0|||
125208861|NCT01554176|450387338|FG000|Run-out Phase|Protocol Violation|0|||
125208862|NCT01554176|450387339|FG001|Run-out Phase|Protocol Violation|0|||
125208863|NCT01554176|450387340|FG002|Run-out Phase|Protocol Violation|0|||
125208864|NCT01554176|450387341|FG003|Run-out Phase|Protocol Violation|1|||
125208865|NCT01554176|450387342|FG004|Run-out Phase|Protocol Violation|0|||
125208866|NCT01085136|450387343|FG000|Part A|Other Adverse event|223|||
125208867|NCT01085136|450387344|FG001|Part A|Other Adverse event|0|||
125208868|NCT01085136|450387345|FG002|Part A|Other Adverse event|0|||
125208869|NCT01085136|450387343|FG000|Part A|Protocol Violation|3|||
125208870|NCT01085136|450387344|FG001|Part A|Protocol Violation|0|||
125208871|NCT01085136|450387345|FG002|Part A|Protocol Violation|0|||
125208872|NCT01085136|450387343|FG000|Part A|Lost to Follow-up|3|||
125208873|NCT01085136|450387344|FG001|Part A|Lost to Follow-up|0|||
125208874|NCT01085136|450387345|FG002|Part A|Lost to Follow-up|0|||
125208875|NCT01085136|450387343|FG000|Part A|Refusal to continue trial medication|64|||
125208876|NCT01085136|450387344|FG001|Part A|Refusal to continue trial medication|0|||
125208877|NCT01085136|450387345|FG002|Part A|Refusal to continue trial medication|0|||
125208878|NCT01085136|450387343|FG000|Part A|Other reason not defined above|30|||
125208879|NCT01085136|450387344|FG001|Part A|Other reason not defined above|0|||
125208880|NCT01085136|450387345|FG002|Part A|Other reason not defined above|0|||
125208881|NCT01085136|450387343|FG000|Part B|Other AE|0|||
125208882|NCT01085136|450387344|FG001|Part B|Other AE|29|||
125208883|NCT01085136|450387345|FG002|Part B|Other AE|8|||
125208884|NCT01085136|450387343|FG000|Part B|Refusal to continue trial medication|0|||
125208885|NCT01085136|450387344|FG001|Part B|Refusal to continue trial medication|12|||
125208886|NCT01085136|450387345|FG002|Part B|Refusal to continue trial medication|7|||
125208887|NCT01085136|450387343|FG000|Part B|Not treated|0|||
125208888|NCT01085136|450387344|FG001|Part B|Not treated|4|||
125208889|NCT01085136|450387345|FG002|Part B|Not treated|8|||
125208890|NCT01085136|450387343|FG000|Part B|Other reason not defined above|0|||
125208891|NCT01085136|450387344|FG001|Part B|Other reason not defined above|6|||
125208892|NCT01085136|450387345|FG002|Part B|Other reason not defined above|3|||
125208893|NCT02678000|450387347|FG000|PART 2|Adverse Event|0|||
125208894|NCT02678000|450387348|FG001|PART 2|Adverse Event|0|||
125208895|NCT02678000|450387349|FG002|PART 2|Adverse Event|2|||
125208896|NCT02678000|450387350|FG003|PART 2|Adverse Event|1|||
125208897|NCT02678000|450387351|FG004|PART 2|Adverse Event|0|||
125208898|NCT02678000|450387347|FG000|PART 2|Withdrawal by Subject|0|||
125208899|NCT02678000|450387348|FG001|PART 2|Withdrawal by Subject|0|||
125208900|NCT02678000|450387349|FG002|PART 2|Withdrawal by Subject|1|||
125208901|NCT02678000|450387350|FG003|PART 2|Withdrawal by Subject|0|||
125208902|NCT02678000|450387351|FG004|PART 2|Withdrawal by Subject|0|||
125208903|NCT01764659|450387354|FG000|Overall Study|Death|1|||
125208904|NCT01764659|450387354|FG000|Overall Study|Physician Decision|1|||
125208905|NCT00628927|450387355|FG000|Overall Study|Problems performing blood draw|6|||
125208906|NCT00628927|450387356|FG001|Overall Study|Problems performing blood draw|0|||
125208907|NCT00628927|450387355|FG000|Overall Study|Lost to Follow-up|1|||
125208908|NCT00628927|450387356|FG001|Overall Study|Lost to Follow-up|0|||
125208909|NCT00628927|450387355|FG000|Overall Study|Equipment failure|1|||
125208910|NCT00628927|450387356|FG001|Overall Study|Equipment failure|0|||
125208911|NCT02440854|450387357|FG000|Overall Study|Relocation of patient|1|||
125208912|NCT02440854|450387357|FG000|Overall Study|Death|6|||
125208913|NCT02440854|450387357|FG000|Overall Study|Lost to Follow-up|10|||
125208914|NCT02440854|450387357|FG000|Overall Study|Afatinib discontinuation|46|||
124981927|NCT04276415|449559833|FG000|Overall Study|Withdrawal by patient|0|||
124981928|NCT04276415|449559834|FG001|Overall Study|Withdrawal by patient|0|||
124981929|NCT04276415|449559835|FG002|Overall Study|Withdrawal by patient|0|||
125208915|NCT02440854|450387357|FG000|Overall Study|stopped study at earlier timepoint|14|||
124981930|NCT04276415|449559836|FG003|Overall Study|Withdrawal by patient|1|||
124981931|NCT04276415|449559837|FG004|Overall Study|Withdrawal by patient|2|||
125208916|NCT02440854|450387357|FG000|Overall Study|Study medication not received|1|||
125208917|NCT02440854|450387357|FG000|Overall Study|Violation of inclusion criteria|2|||
125208918|NCT00316914|450389295|FG000|Overall Study|Withdrawal by Subject|5|||
125208919|NCT00316914|450389296|FG001|Overall Study|Withdrawal by Subject|3|||
125208920|NCT00316914|450389295|FG000|Overall Study|Adverse Event|8|||
124981932|NCT04276415|449559838|FG005|Overall Study|Withdrawal by patient|0|||
125208921|NCT00316914|450389296|FG001|Overall Study|Adverse Event|7|||
125208922|NCT00316914|450389295|FG000|Overall Study|Other Problems|6|||
125208923|NCT00316914|450389296|FG001|Overall Study|Other Problems|11|||
125208924|NCT00316914|450389295|FG000|Overall Study|Missing end of treatment documentation|14|||
125208925|NCT00316914|450389296|FG001|Overall Study|Missing end of treatment documentation|15|||
125208926|NCT04105010|450389297|FG000|Overall Study|Death|3|||
125208927|NCT04105010|450389298|FG001|Overall Study|Death|1|||
125208928|NCT04105010|450389299|FG002|Overall Study|Death|1|||
125208929|NCT04105010|450389300|FG003|Overall Study|Death|54|||
125208930|NCT04105010|450389297|FG000|Overall Study|Lost to Follow-up|0|||
125208931|NCT04105010|450389298|FG001|Overall Study|Lost to Follow-up|0|||
125208932|NCT04105010|450389299|FG002|Overall Study|Lost to Follow-up|0|||
125208933|NCT04105010|450389300|FG003|Overall Study|Lost to Follow-up|4|||
125208934|NCT04105010|450389297|FG000|Overall Study|Withdrawal by Subject|8|||
125208935|NCT04105010|450389298|FG001|Overall Study|Withdrawal by Subject|1|||
125208936|NCT04105010|450389299|FG002|Overall Study|Withdrawal by Subject|1|||
125208937|NCT04105010|450389300|FG003|Overall Study|Withdrawal by Subject|4|||
125208938|NCT04105010|450389297|FG000|Overall Study|Other reason|4|||
125208939|NCT04105010|450389298|FG001|Overall Study|Other reason|7|||
125208940|NCT04105010|450389299|FG002|Overall Study|Other reason|0|||
125208941|NCT04105010|450389300|FG003|Overall Study|Other reason|19|||
125208942|NCT01179737|450389303|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
125208943|NCT01179737|450389304|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
125208944|NCT01179737|450389305|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
125208945|NCT01179737|450389306|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
125208946|NCT01179737|450389303|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
125208947|NCT01179737|450389304|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
125208948|NCT01179737|450389305|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
125208949|NCT01179737|450389306|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
125208950|NCT01179737|450389303|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
125208951|NCT01179737|450389304|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
125208952|NCT01179737|450389305|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
125208953|NCT01179737|450389306|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
125208954|NCT01179737|450389303|FG000|Cohort 1 & Cohort 2|Death|0|||
125208955|NCT01179737|450389304|FG001|Cohort 1 & Cohort 2|Death|0|||
125208956|NCT01179737|450389305|FG002|Cohort 1 & Cohort 2|Death|1|||
125208957|NCT01179737|450389306|FG003|Cohort 1 & Cohort 2|Death|0|||
125208958|NCT01179737|450389303|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
125208959|NCT01179737|450389304|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
125208960|NCT01179737|450389305|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
125208961|NCT01179737|450389306|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
125208962|NCT01179737|450389303|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
125208963|NCT01179737|450389304|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
125208964|NCT01179737|450389305|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
125208965|NCT01179737|450389306|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
125208966|NCT01179737|450389303|FG000|Extension|The study was terminated|3|||
125208967|NCT01179737|450389304|FG001|Extension|The study was terminated|0|||
125208968|NCT01179737|450389305|FG002|Extension|The study was terminated|0|||
125208969|NCT01179737|450389306|FG003|Extension|The study was terminated|0|||
125208970|NCT00717275|450389307|FG000|Overall Study|Premature study termination.|3|||
125208971|NCT00424021|450389311|FG000|NCT00046319 Study Period|Adverse Event|1|||
125208972|NCT00424021|450389312|FG001|NCT00046319 Study Period|Adverse Event|0|||
125208973|NCT00424021|450389313|FG002|NCT00046319 Study Period|Adverse Event|1|||
125208974|NCT00424021|450389314|FG003|NCT00046319 Study Period|Adverse Event|1|||
125208975|NCT00424021|450389311|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
125208976|NCT00424021|450389312|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
125208977|NCT00424021|450389313|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
125208978|NCT00424021|450389314|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
125208979|NCT00424021|450389311|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
125208980|NCT00424021|450389312|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
125208981|NCT00424021|450389313|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
125208982|NCT00424021|450389314|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
125208983|NCT00424021|450389311|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
125208984|NCT00424021|450389312|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
125208985|NCT00424021|450389313|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
125208986|NCT00424021|450389314|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
125208987|NCT00424021|450389311|FG000|AMB-220-E Study Period|Adverse Event|1|||
125208988|NCT00424021|450389312|FG001|AMB-220-E Study Period|Adverse Event|1|||
125208989|NCT00424021|450389313|FG002|AMB-220-E Study Period|Adverse Event|3|||
125208990|NCT00424021|450389314|FG003|AMB-220-E Study Period|Adverse Event|7|||
125208991|NCT00424021|450389311|FG000|AMB-220-E Study Period|Death|0|||
125208992|NCT00424021|450389312|FG001|AMB-220-E Study Period|Death|0|||
125208993|NCT00424021|450389313|FG002|AMB-220-E Study Period|Death|1|||
125208994|NCT00424021|450389314|FG003|AMB-220-E Study Period|Death|1|||
125208995|NCT00424021|450389311|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
125208996|NCT00424021|450389312|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
125208997|NCT00424021|450389313|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
125208998|NCT00424021|450389314|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
125208999|NCT00424021|450389311|FG000|AMB-220-E Study Period|Physician Decision|0|||
125209000|NCT00424021|450389312|FG001|AMB-220-E Study Period|Physician Decision|0|||
125209001|NCT00424021|450389313|FG002|AMB-220-E Study Period|Physician Decision|0|||
125209002|NCT00424021|450389314|FG003|AMB-220-E Study Period|Physician Decision|1|||
125209003|NCT03000530|450389315|FG000|Overall Study|Adverse Event|0|||
125209004|NCT03000530|450389316|FG001|Overall Study|Adverse Event|0|||
125209005|NCT03000530|450389317|FG002|Overall Study|Adverse Event|2|||
125209006|NCT03000530|450389315|FG000|Overall Study|Lost to Follow-up|0|||
125209007|NCT03000530|450389316|FG001|Overall Study|Lost to Follow-up|3|||
125209008|NCT03000530|450389317|FG002|Overall Study|Lost to Follow-up|1|||
125209009|NCT03000530|450389315|FG000|Overall Study|Withdrawal by Subject|0|||
125209010|NCT03000530|450389316|FG001|Overall Study|Withdrawal by Subject|2|||
125209011|NCT03000530|450389317|FG002|Overall Study|Withdrawal by Subject|1|||
125209012|NCT03597022|450389321|FG000|Overall Study|Premature termination of the study|7|||
125209013|NCT03597022|450389322|FG001|Overall Study|Premature termination of the study|7|||
125209014|NCT03597022|450389323|FG002|Overall Study|Premature termination of the study|8|||
125209015|NCT03597022|450389321|FG000|Overall Study|Serious adverse event|1|||
125209016|NCT03597022|450389322|FG001|Overall Study|Serious adverse event|1|||
125209017|NCT03597022|450389323|FG002|Overall Study|Serious adverse event|0|||
125209018|NCT00312572|450389324|FG000|Overall Study|Adverse Event|10|||
125209019|NCT00312572|450389325|FG001|Overall Study|Adverse Event|16|||
125209020|NCT00312572|450389324|FG000|Overall Study|Lost to Follow-up|1|||
125209021|NCT00312572|450389325|FG001|Overall Study|Lost to Follow-up|1|||
125209022|NCT00312572|450389324|FG000|Overall Study|Administrative|4|||
125209023|NCT00312572|450389325|FG001|Overall Study|Administrative|2|||
125209024|NCT00312572|450389324|FG000|Overall Study|Lack of Efficacy|1|||
125209025|NCT00312572|450389325|FG001|Overall Study|Lack of Efficacy|2|||
125209026|NCT02614131|450389328|FG000|Overall Study|Withdrawal by Subject|1|||
125209027|NCT02614131|450389329|FG001|Overall Study|Withdrawal by Subject|0|||
124872126|NCT01224925|449154020|FG001|Overall Study|Lost to Follow-up|2|||
125209028|NCT02614131|450389330|FG002|Overall Study|Withdrawal by Subject|0|||
125209029|NCT02614131|450389331|FG003|Overall Study|Withdrawal by Subject|0|||
125209030|NCT02614131|450389332|FG004|Overall Study|Withdrawal by Subject|0|||
125209031|NCT02614131|450389333|FG005|Overall Study|Withdrawal by Subject|0|||
125209032|NCT02614131|450389334|FG006|Overall Study|Withdrawal by Subject|0|||
125209033|NCT02614131|450389328|FG000|Overall Study|Adverse Event|0|||
125209034|NCT02614131|450389329|FG001|Overall Study|Adverse Event|0|||
125209035|NCT02614131|450389330|FG002|Overall Study|Adverse Event|0|||
125209036|NCT02614131|450389331|FG003|Overall Study|Adverse Event|0|||
125209037|NCT02614131|450389332|FG004|Overall Study|Adverse Event|0|||
125209038|NCT02614131|450389333|FG005|Overall Study|Adverse Event|0|||
125209039|NCT02614131|450389334|FG006|Overall Study|Adverse Event|1|||
125209040|NCT01285492|450389339|FG000|Overall Study|Adverse Event|11|||
125209041|NCT01285492|450389340|FG001|Overall Study|Adverse Event|0|||
125209042|NCT01285492|450389339|FG000|Overall Study|Protocol Violation|3|||
125209043|NCT01285492|450389340|FG001|Overall Study|Protocol Violation|0|||
125209044|NCT01285492|450389339|FG000|Overall Study|Withdrawal by Subject|2|||
125209045|NCT01285492|450389340|FG001|Overall Study|Withdrawal by Subject|1|||
125209046|NCT01285492|450389339|FG000|Overall Study|Death|1|||
125209047|NCT01285492|450389340|FG001|Overall Study|Death|0|||
125209048|NCT01797094|450389341|FG000|Overall Study|Adverse Event|1|||
125209049|NCT01797094|450389342|FG001|Overall Study|Adverse Event|1|||
125209050|NCT01797094|450389341|FG000|Overall Study|Personal Reasons|4|||
125209051|NCT01797094|450389342|FG001|Overall Study|Personal Reasons|0|||
125209052|NCT01797094|450389341|FG000|Overall Study|Protocol Violation|0|||
125209053|NCT01797094|450389342|FG001|Overall Study|Protocol Violation|1|||
125209054|NCT01797094|450389341|FG000|Overall Study|Other Miscellaneous Reasons|1|||
125209055|NCT01797094|450389342|FG001|Overall Study|Other Miscellaneous Reasons|0|||
125209056|NCT03217968|450389345|FG000|Overall Study|Withdrawal by Subject|4|||
125209057|NCT03217968|450389345|FG000|Overall Study|Lost to Follow-up|1|||
125209058|NCT03217968|450389345|FG000|Overall Study|Protocol Violation|6|||
125209059|NCT00306787|450389349|FG000|Overall Study|Discontinued without taking study drug|208|||
125209060|NCT00306787|450389350|FG001|Overall Study|Discontinued without taking study drug|215|||
125209061|NCT00306787|450389349|FG000|Overall Study|Adverse Event|1|||
125209062|NCT00306787|450389350|FG001|Overall Study|Adverse Event|1|||
125209063|NCT00306787|450389349|FG000|Overall Study|Lack of Efficacy|1|||
125209064|NCT00306787|450389350|FG001|Overall Study|Lack of Efficacy|0|||
125209065|NCT00306787|450389349|FG000|Overall Study|Protocol Violation|8|||
125209066|NCT00306787|450389350|FG001|Overall Study|Protocol Violation|10|||
125209067|NCT00306787|450389349|FG000|Overall Study|Withdrawal by Subject|2|||
125209068|NCT00306787|450389350|FG001|Overall Study|Withdrawal by Subject|9|||
125209069|NCT00306787|450389349|FG000|Overall Study|Lost to Follow-up|9|||
125209070|NCT00306787|450389350|FG001|Overall Study|Lost to Follow-up|6|||
125209071|NCT00306787|450389349|FG000|Overall Study|Administrative problems|4|||
125209072|NCT00306787|450389350|FG001|Overall Study|Administrative problems|0|||
125209073|NCT00306787|450389349|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125209074|NCT00306787|450389350|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125209075|NCT01887678|450389353|FG000|Overall Study|Adverse Event|4|||
125209076|NCT01887678|450389354|FG001|Overall Study|Adverse Event|6|||
125209077|NCT01887678|450389353|FG000|Overall Study|Exceeded rescue medication dosage|4|||
125209078|NCT01887678|450389354|FG001|Overall Study|Exceeded rescue medication dosage|5|||
125209079|NCT01887678|450389353|FG000|Overall Study|Withdrawal of consent|3|||
125209080|NCT01887678|450389354|FG001|Overall Study|Withdrawal of consent|4|||
125209081|NCT01887678|450389353|FG000|Overall Study|Lost to Follow-up|4|||
125209082|NCT01887678|450389354|FG001|Overall Study|Lost to Follow-up|2|||
125209083|NCT01887678|450389353|FG000|Overall Study|Deterioration of clinical condition|0|||
125209084|NCT01887678|450389354|FG001|Overall Study|Deterioration of clinical condition|4|||
125209085|NCT01887678|450389353|FG000|Overall Study|Lack of Efficacy|1|||
125209086|NCT01887678|450389354|FG001|Overall Study|Lack of Efficacy|2|||
125209087|NCT01887678|450389353|FG000|Overall Study|Non-compliance|0|||
125209088|NCT01887678|450389354|FG001|Overall Study|Non-compliance|3|||
125209089|NCT01887678|450389353|FG000|Overall Study|Specified|1|||
125209090|NCT01887678|450389354|FG001|Overall Study|Specified|2|||
125209091|NCT03013985|450389355|FG000|Overall Study|Protocol Violation|2|||
125209092|NCT03013985|450389356|FG001|Overall Study|Protocol Violation|2|||
125209093|NCT03013985|450389355|FG000|Overall Study|Withdrawal by Subject|14|||
125209094|NCT03013985|450389356|FG001|Overall Study|Withdrawal by Subject|17|||
125209095|NCT00791492|450389359|FG000|Overall Study|Withdrawal by Subject|1|||
125209096|NCT00791492|450389360|FG001|Overall Study|Withdrawal by Subject|2|||
125209097|NCT00791492|450389359|FG000|Overall Study|Liver transplantation|5|||
125209098|NCT00791492|450389360|FG001|Overall Study|Liver transplantation|1|||
125209099|NCT00634049|450389377|FG000|Overall Study|Never received study drug|1|||
125209100|NCT00634049|450389377|FG000|Overall Study|Died prior to receiving study drug|1|||
125209101|NCT00634049|450389377|FG000|Overall Study|Screening failure|1|||
125209102|NCT00314132|450389378|FG000|Overall Study|Lost to Follow-up|3|||
125209103|NCT00314132|450389379|FG001|Overall Study|Lost to Follow-up|13|||
125209104|NCT00314132|450389378|FG000|Overall Study|Withdrawal by Subject|3|||
125209105|NCT00314132|450389379|FG001|Overall Study|Withdrawal by Subject|5|||
125209106|NCT00314132|450389378|FG000|Overall Study|Adverse Event|1|||
125209107|NCT00314132|450389379|FG001|Overall Study|Adverse Event|0|||
125209108|NCT00314132|450389378|FG000|Overall Study|Physician Decision|1|||
125209109|NCT00314132|450389379|FG001|Overall Study|Physician Decision|0|||
125209110|NCT01380691|450389382|FG000|Washout (7 Days)|Protocol Violation|0|||
125209111|NCT01380691|450389383|FG001|Washout (7 Days)|Protocol Violation|0|||
125209112|NCT01380691|450389384|FG002|Washout (7 Days)|Protocol Violation|0|||
125209113|NCT01380691|450389385|FG003|Washout (7 Days)|Protocol Violation|1|||
125209114|NCT01380691|450389382|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
125209115|NCT01380691|450389383|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
125209116|NCT01380691|450389384|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
125209117|NCT01380691|450389385|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
125209118|NCT01987232|450389388|FG000|Overall Study|Ongoing in Study|0|||
125209119|NCT01987232|450389389|FG001|Overall Study|Ongoing in Study|0|||
125209120|NCT01987232|450389390|FG002|Overall Study|Ongoing in Study|0|||
125209121|NCT01987232|450389391|FG003|Overall Study|Ongoing in Study|1|||
125209122|NCT01987232|450389392|FG004|Overall Study|Ongoing in Study|0|||
125209123|NCT00586508|450389393|FG000|Overall Study|Progressive disease|52|||
125209124|NCT00586508|450389394|FG001|Overall Study|Progressive disease|8|||
125209125|NCT00586508|450389393|FG000|Overall Study|Death|0|||
125209126|NCT00586508|450389394|FG001|Overall Study|Death|1|||
125209127|NCT00586508|450389393|FG000|Overall Study|Adverse Event|12|||
125209128|NCT00586508|450389394|FG001|Overall Study|Adverse Event|4|||
125209129|NCT00586508|450389393|FG000|Overall Study|Withdrawal by Subject|4|||
125209130|NCT00586508|450389394|FG001|Overall Study|Withdrawal by Subject|0|||
125209131|NCT03564795|450389395|FG000|Overall Study|Withdrawal by Subject|3|||
125209132|NCT03564795|450389395|FG000|Overall Study|Lost to Follow-up|6|||
125209133|NCT03564795|450389395|FG000|Overall Study|Physician Decision|2|||
125209134|NCT02906033|450389400|FG000|Baseline|Protocol Violation|37|||
125209135|NCT02906033|450389401|FG001|Baseline|Protocol Violation|33|||
125209136|NCT02906033|450389400|FG000|Follow-up|Lost to Follow-up|46|||
125209137|NCT02906033|450389401|FG001|Follow-up|Lost to Follow-up|62|||
125209138|NCT01333956|450389406|FG000|Overall Study|Lost to Follow-up|1|||
125209139|NCT01333956|450389407|FG001|Overall Study|Lost to Follow-up|2|||
125209140|NCT01333956|450389408|FG002|Overall Study|Lost to Follow-up|0|||
125209141|NCT01333956|450389409|FG003|Overall Study|Lost to Follow-up|1|||
125209142|NCT01333956|450389406|FG000|Overall Study|Unable to complete study procedure|1|||
125209143|NCT01333956|450389407|FG001|Overall Study|Unable to complete study procedure|0|||
125209144|NCT01333956|450389408|FG002|Overall Study|Unable to complete study procedure|0|||
125209145|NCT01333956|450389409|FG003|Overall Study|Unable to complete study procedure|1|||
125209146|NCT01333956|450389406|FG000|Overall Study|Withdrawal by Subject|0|||
124872127|NCT02178059|449154021|FG000|Washout|Physician Decision|1|||
125209147|NCT01333956|450389407|FG001|Overall Study|Withdrawal by Subject|2|||
125209148|NCT01333956|450389408|FG002|Overall Study|Withdrawal by Subject|1|||
125209149|NCT01333956|450389409|FG003|Overall Study|Withdrawal by Subject|0|||
125209150|NCT00432276|450389412|FG000|Overall Study|Hyperglycemic Rescue|44|||
125209151|NCT00432276|450389413|FG001|Overall Study|Hyperglycemic Rescue|87|||
125209152|NCT00432276|450389412|FG000|Overall Study|Adverse Event|13|||
125209153|NCT00432276|450389413|FG001|Overall Study|Adverse Event|16|||
125209154|NCT00432276|450389412|FG000|Overall Study|Protocol Violation|25|||
125209155|NCT00432276|450389413|FG001|Overall Study|Protocol Violation|20|||
125209156|NCT00432276|450389412|FG000|Overall Study|Lost to Follow-up|6|||
125209157|NCT00432276|450389413|FG001|Overall Study|Lost to Follow-up|2|||
125209158|NCT00432276|450389412|FG000|Overall Study|Withdrawal by Subject|25|||
124981933|NCT01989169|449559841|FG000|Period 2|Adverse Event|0|||
124981934|NCT01989169|449559842|FG001|Period 2|Adverse Event|1|||
124981935|NCT02406677|449559843|FG000|Overall Study|Death|16|||
124981936|NCT02406677|449559844|FG001|Overall Study|Death|8|||
124981937|NCT02406677|449559843|FG000|Overall Study|Discharged without P2Y12|1|||
124981938|NCT02406677|449559844|FG001|Overall Study|Discharged without P2Y12|3|||
124981939|NCT02406677|449559843|FG000|Overall Study|Discharged on prasugrel|283|||
124981940|NCT02406677|449559844|FG001|Overall Study|Discharged on prasugrel|587|||
124981941|NCT02406677|449559843|FG000|Overall Study|Withdrawal by Subject|1|||
124981942|NCT02406677|449559844|FG001|Overall Study|Withdrawal by Subject|0|||
124981943|NCT01114880|449559845|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
124981944|NCT01114880|449559846|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
124981945|NCT01114880|449559845|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
124981946|NCT01114880|449559846|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
124981947|NCT01114880|449559845|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
124981948|NCT01114880|449559846|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
124981949|NCT01114880|449559845|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
124981950|NCT01114880|449559846|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
124981951|NCT01114880|449559845|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
124981952|NCT01114880|449559846|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
124981953|NCT01114880|449559845|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
124981954|NCT01114880|449559846|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
124981955|NCT04531904|449559847|FG000|Overall Study|Lost to Follow-up|1|||
124981956|NCT04531904|449559847|FG000|Overall Study|Death|14|||
124981957|NCT00283244|449559848|FG000|Overall Study|Adverse Event|0|||
124981958|NCT00283244|449559849|FG001|Overall Study|Adverse Event|8|||
124981959|NCT00283244|449559850|FG002|Overall Study|Adverse Event|11|||
124981960|NCT00283244|449559848|FG000|Overall Study|Death|4|||
124981961|NCT00283244|449559849|FG001|Overall Study|Death|3|||
124981962|NCT00283244|449559850|FG002|Overall Study|Death|2|||
124981963|NCT00283244|449559848|FG000|Overall Study|Lack of Efficacy|8|||
124981964|NCT00283244|449559849|FG001|Overall Study|Lack of Efficacy|32|||
124981965|NCT00283244|449559850|FG002|Overall Study|Lack of Efficacy|26|||
124981966|NCT00283244|449559848|FG000|Overall Study|Withdrawal by Subject|1|||
124981967|NCT00283244|449559849|FG001|Overall Study|Withdrawal by Subject|2|||
124981968|NCT00283244|449559850|FG002|Overall Study|Withdrawal by Subject|2|||
124981969|NCT00283244|449559848|FG000|Overall Study|Physician Decision|0|||
124981970|NCT00283244|449559849|FG001|Overall Study|Physician Decision|0|||
124981971|NCT00283244|449559850|FG002|Overall Study|Physician Decision|1|||
124981972|NCT00283244|449559848|FG000|Overall Study|Medical illness (other complicating dz)|4|||
124981973|NCT00283244|449559849|FG001|Overall Study|Medical illness (other complicating dz)|3|||
124981974|NCT00283244|449559850|FG002|Overall Study|Medical illness (other complicating dz)|6|||
124981975|NCT00283244|449559848|FG000|Overall Study|Clinical deterioration|1|||
124981976|NCT00283244|449559849|FG001|Overall Study|Clinical deterioration|3|||
124981977|NCT00283244|449559850|FG002|Overall Study|Clinical deterioration|3|||
124981978|NCT04500769|449561218|FG000|Overall Study|Withdrawal by Subject|5|||
124981979|NCT01967147|449561219|FG000|Overall Study|Adverse Event|5|||
125209159|NCT00432276|450389413|FG001|Overall Study|Withdrawal by Subject|20|||
125209160|NCT00432276|450389412|FG000|Overall Study|Physician Decision|6|||
125209161|NCT00432276|450389413|FG001|Overall Study|Physician Decision|8|||
125209162|NCT00432276|450389412|FG000|Overall Study|Other|2|||
125209163|NCT00432276|450389413|FG001|Overall Study|Other|3|||
125209164|NCT05249127|450389414|FG000|Overall Study|Protocol Violation|13|||
125209165|NCT05249127|450389414|FG000|Overall Study|Physician Decision|4|||
125209166|NCT05249127|450389414|FG000|Overall Study|Withdrawal by Subject|2|||
125209167|NCT05249127|450389414|FG000|Overall Study|Participant Non-compliance|1|||
125209168|NCT02073565|450389415|FG000|Cohort A|Withdrawal by Subject|1|||
125209169|NCT02073565|450389416|FG001|Cohort A|Withdrawal by Subject|0|||
125209170|NCT02073565|450389415|FG000|Cohort B|Withdrawal by Subject|1|||
125209171|NCT02073565|450389416|FG001|Cohort B|Withdrawal by Subject|2|||
125209172|NCT02073565|450389415|FG000|Cohort C|Withdrawal by Subject|0|||
125209173|NCT02073565|450389416|FG001|Cohort C|Withdrawal by Subject|2|||
125209174|NCT02073565|450389415|FG000|Cohort C|Lost to Follow-up|0|||
125209175|NCT02073565|450389416|FG001|Cohort C|Lost to Follow-up|2|||
125209176|NCT03646305|450389417|FG000|Overall Study|Lost to Follow-up|4|||
125209177|NCT03646305|450389418|FG001|Overall Study|Lost to Follow-up|2|||
125209178|NCT03646305|450389419|FG002|Overall Study|Lost to Follow-up|2|||
125209179|NCT03646305|450389420|FG003|Overall Study|Lost to Follow-up|1|||
125209180|NCT03646305|450389417|FG000|Overall Study|Withdrawal by Subject|1|||
125209181|NCT03646305|450389418|FG001|Overall Study|Withdrawal by Subject|0|||
125209182|NCT03646305|450389419|FG002|Overall Study|Withdrawal by Subject|0|||
124981980|NCT01967147|449561220|FG001|Overall Study|Adverse Event|2|||
124981981|NCT01967147|449561219|FG000|Overall Study|Lack of Efficacy|1|||
125209183|NCT03646305|450389420|FG003|Overall Study|Withdrawal by Subject|1|||
125209184|NCT04015518|450389421|FG000|Overall Study|Adverse Event|6|||
125209185|NCT04015518|450389422|FG001|Overall Study|Adverse Event|1|||
125209186|NCT04015518|450389423|FG002|Overall Study|Adverse Event|1|||
125209187|NCT04015518|450389424|FG003|Overall Study|Adverse Event|3|||
125209188|NCT04015518|450389425|FG004|Overall Study|Adverse Event|3|||
125209189|NCT04015518|450389421|FG000|Overall Study|Lack of Efficacy|1|||
125209190|NCT04015518|450389422|FG001|Overall Study|Lack of Efficacy|0|||
125209191|NCT04015518|450389423|FG002|Overall Study|Lack of Efficacy|1|||
125209192|NCT04015518|450389424|FG003|Overall Study|Lack of Efficacy|0|||
125209193|NCT04015518|450389425|FG004|Overall Study|Lack of Efficacy|4|||
125209194|NCT04015518|450389421|FG000|Overall Study|Lost to Follow-up|0|||
125209195|NCT04015518|450389422|FG001|Overall Study|Lost to Follow-up|0|||
125209196|NCT04015518|450389423|FG002|Overall Study|Lost to Follow-up|0|||
125209197|NCT04015518|450389424|FG003|Overall Study|Lost to Follow-up|0|||
125209198|NCT04015518|450389425|FG004|Overall Study|Lost to Follow-up|1|||
125209199|NCT04015518|450389421|FG000|Overall Study|Withdrawal by Subject|0|||
125209200|NCT04015518|450389422|FG001|Overall Study|Withdrawal by Subject|1|||
125209201|NCT04015518|450389423|FG002|Overall Study|Withdrawal by Subject|0|||
125209202|NCT04015518|450389424|FG003|Overall Study|Withdrawal by Subject|1|||
125209203|NCT04015518|450389425|FG004|Overall Study|Withdrawal by Subject|1|||
125209204|NCT04015518|450389421|FG000|Overall Study|Patient did not come for consecutive visits|0|||
125209205|NCT04015518|450389422|FG001|Overall Study|Patient did not come for consecutive visits|1|||
125209206|NCT04015518|450389423|FG002|Overall Study|Patient did not come for consecutive visits|0|||
125209207|NCT04015518|450389424|FG003|Overall Study|Patient did not come for consecutive visits|0|||
125209208|NCT04015518|450389425|FG004|Overall Study|Patient did not come for consecutive visits|0|||
125209209|NCT04015518|450389421|FG000|Overall Study|not willing to travel due to Covid-19|0|||
125209210|NCT04015518|450389422|FG001|Overall Study|not willing to travel due to Covid-19|0|||
125209211|NCT04015518|450389423|FG002|Overall Study|not willing to travel due to Covid-19|1|||
125209212|NCT04015518|450389424|FG003|Overall Study|not willing to travel due to Covid-19|0|||
125209213|NCT04015518|450389425|FG004|Overall Study|not willing to travel due to Covid-19|0|||
125209214|NCT04015518|450389421|FG000|Overall Study|Patient wants to discontinue treatment|0|||
125209215|NCT04015518|450389422|FG001|Overall Study|Patient wants to discontinue treatment|0|||
125209216|NCT04015518|450389423|FG002|Overall Study|Patient wants to discontinue treatment|0|||
125209217|NCT04015518|450389424|FG003|Overall Study|Patient wants to discontinue treatment|1|||
125209218|NCT04015518|450389425|FG004|Overall Study|Patient wants to discontinue treatment|0|||
125209219|NCT04015518|450389421|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
125209220|NCT04015518|450389422|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
125209221|NCT04015518|450389423|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
125209222|NCT04015518|450389424|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
124872128|NCT02178059|449154022|FG001|Washout|Physician Decision|0|||
124872129|NCT05178121|449154023|FG000|Overall Study|Other|4|||
124872130|NCT05178121|449154023|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
124872131|NCT00245102|449154024|FG000|Overall Study|Not Treated|1|||
124872132|NCT00245102|449154025|FG001|Overall Study|Not Treated|0|||
124872133|NCT00245102|449154026|FG002|Overall Study|Not Treated|1|||
124872134|NCT00245102|449154027|FG003|Overall Study|Not Treated|0|||
124872135|NCT00245102|449154028|FG004|Overall Study|Not Treated|0|||
124872136|NCT00245102|449154029|FG005|Overall Study|Not Treated|0|||
124872137|NCT00245102|449154024|FG000|Overall Study|Protocol Violation|1|||
124872138|NCT00245102|449154025|FG001|Overall Study|Protocol Violation|0|||
124872139|NCT00245102|449154026|FG002|Overall Study|Protocol Violation|0|||
124872140|NCT00245102|449154027|FG003|Overall Study|Protocol Violation|0|||
124872141|NCT00245102|449154028|FG004|Overall Study|Protocol Violation|0|||
124872142|NCT00245102|449154029|FG005|Overall Study|Protocol Violation|0|||
124872143|NCT00245102|449154024|FG000|Overall Study|Death|0|||
124872144|NCT00245102|449154025|FG001|Overall Study|Death|0|||
124872145|NCT00245102|449154026|FG002|Overall Study|Death|0|||
124872146|NCT00245102|449154027|FG003|Overall Study|Death|1|||
124872147|NCT00245102|449154028|FG004|Overall Study|Death|0|||
124872148|NCT00245102|449154029|FG005|Overall Study|Death|0|||
124872149|NCT00245102|449154024|FG000|Overall Study|Adverse Event|4|||
124872150|NCT00245102|449154025|FG001|Overall Study|Adverse Event|2|||
124872151|NCT00245102|449154026|FG002|Overall Study|Adverse Event|5|||
124872152|NCT00245102|449154027|FG003|Overall Study|Adverse Event|1|||
124872153|NCT00245102|449154028|FG004|Overall Study|Adverse Event|0|||
124872154|NCT00245102|449154029|FG005|Overall Study|Adverse Event|2|||
124872155|NCT00245102|449154024|FG000|Overall Study|Decline in performance|0|||
124872156|NCT00245102|449154025|FG001|Overall Study|Decline in performance|2|||
124872157|NCT00245102|449154026|FG002|Overall Study|Decline in performance|0|||
124872158|NCT00245102|449154027|FG003|Overall Study|Decline in performance|1|||
124872159|NCT00245102|449154028|FG004|Overall Study|Decline in performance|0|||
124872160|NCT00245102|449154029|FG005|Overall Study|Decline in performance|2|||
124872161|NCT00245102|449154024|FG000|Overall Study|Participant needed surgery|0|||
124872162|NCT00245102|449154025|FG001|Overall Study|Participant needed surgery|0|||
125209223|NCT04015518|450389425|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
125209224|NCT04015518|450389421|FG000|Overall Study|Pregnancy|0|||
125209225|NCT04015518|450389422|FG001|Overall Study|Pregnancy|0|||
124872163|NCT00245102|449154026|FG002|Overall Study|Participant needed surgery|1|||
125209226|NCT04015518|450389423|FG002|Overall Study|Pregnancy|0|||
125209227|NCT04015518|450389424|FG003|Overall Study|Pregnancy|0|||
125209228|NCT04015518|450389425|FG004|Overall Study|Pregnancy|1|||
125209229|NCT04015518|450389421|FG000|Overall Study|Personal reasons|1|||
125209230|NCT04015518|450389422|FG001|Overall Study|Personal reasons|0|||
125209231|NCT04015518|450389423|FG002|Overall Study|Personal reasons|0|||
125209232|NCT04015518|450389424|FG003|Overall Study|Personal reasons|0|||
125209233|NCT04015518|450389425|FG004|Overall Study|Personal reasons|1|||
125209234|NCT04015518|450389421|FG000|Overall Study|Withdrew consent|1|||
125209235|NCT04015518|450389422|FG001|Overall Study|Withdrew consent|0|||
125209236|NCT04015518|450389423|FG002|Overall Study|Withdrew consent|0|||
125209237|NCT04015518|450389424|FG003|Overall Study|Withdrew consent|0|||
125209238|NCT04015518|450389425|FG004|Overall Study|Withdrew consent|0|||
125209239|NCT04015518|450389421|FG000|Overall Study|Prostate carcinoma|1|||
125209240|NCT04015518|450389422|FG001|Overall Study|Prostate carcinoma|0|||
125209241|NCT04015518|450389423|FG002|Overall Study|Prostate carcinoma|0|||
125209242|NCT04015518|450389424|FG003|Overall Study|Prostate carcinoma|0|||
125209243|NCT04015518|450389425|FG004|Overall Study|Prostate carcinoma|0|||
125209244|NCT04015518|450389421|FG000|Overall Study|Could not keep appointments due to work|1|||
125209245|NCT04015518|450389422|FG001|Overall Study|Could not keep appointments due to work|0|||
125209246|NCT04015518|450389423|FG002|Overall Study|Could not keep appointments due to work|0|||
125209247|NCT04015518|450389424|FG003|Overall Study|Could not keep appointments due to work|0|||
125209248|NCT04015518|450389425|FG004|Overall Study|Could not keep appointments due to work|0|||
125209249|NCT00386425|450389426|FG000|Overall Study|Physician Decision|3|||
125209250|NCT00386425|450389427|FG001|Overall Study|Physician Decision|0|||
125209251|NCT00386425|450389428|FG002|Overall Study|Physician Decision|0|||
125209252|NCT00386425|450389426|FG000|Overall Study|Withdrawal by Subject|0|||
125209253|NCT00386425|450389427|FG001|Overall Study|Withdrawal by Subject|1|||
125209254|NCT00386425|450389428|FG002|Overall Study|Withdrawal by Subject|0|||
125209255|NCT01324570|450389436|FG000|Overall Study|Adverse Event|4|||
125209256|NCT01324570|450389437|FG001|Overall Study|Adverse Event|7|||
125209257|NCT01324570|450389436|FG000|Overall Study|Withdrawal by Subject|0|||
125209258|NCT01324570|450389437|FG001|Overall Study|Withdrawal by Subject|3|||
125209259|NCT01324570|450389436|FG000|Overall Study|Lack of Efficacy|0|||
125209260|NCT01324570|450389437|FG001|Overall Study|Lack of Efficacy|1|||
125209261|NCT01324570|450389436|FG000|Overall Study|Confirmed or suspected diversion|0|||
125209262|NCT01324570|450389437|FG001|Overall Study|Confirmed or suspected diversion|1|||
125209263|NCT01324570|450389436|FG000|Overall Study|Administrative|0|||
125209264|NCT01324570|450389437|FG001|Overall Study|Administrative|2|||
125209265|NCT02360475|450389438|FG000|Overall Study|Lost to Follow-up|4|||
125209266|NCT02360475|450389439|FG001|Overall Study|Lost to Follow-up|12|||
125209267|NCT02360475|450389440|FG002|Overall Study|Lost to Follow-up|6|||
125209268|NCT02360475|450389441|FG003|Overall Study|Lost to Follow-up|4|||
125209269|NCT02360475|450389438|FG000|Overall Study|Withdrawal by Subject|0|||
125209270|NCT02360475|450389439|FG001|Overall Study|Withdrawal by Subject|1|||
125209271|NCT02360475|450389440|FG002|Overall Study|Withdrawal by Subject|2|||
125209272|NCT02360475|450389441|FG003|Overall Study|Withdrawal by Subject|0|||
125209273|NCT02360475|450389438|FG000|Overall Study|Migrated/moved from study area|0|||
125209274|NCT02360475|450389439|FG001|Overall Study|Migrated/moved from study area|0|||
125209275|NCT02360475|450389440|FG002|Overall Study|Migrated/moved from study area|0|||
125209276|NCT02360475|450389441|FG003|Overall Study|Migrated/moved from study area|1|||
125209277|NCT00207727|450389442|FG000|Overall Study|Withdrawal by Subject|0|||
125209278|NCT00207727|450389443|FG001|Overall Study|Withdrawal by Subject|0|||
125209279|NCT00207727|450389444|FG002|Overall Study|Withdrawal by Subject|0|||
125209280|NCT00207727|450389445|FG003|Overall Study|Withdrawal by Subject|0|||
125209281|NCT00207727|450389446|FG004|Overall Study|Withdrawal by Subject|1|||
125209282|NCT00207727|450389442|FG000|Overall Study|Lost to Follow-up|0|||
125209283|NCT00207727|450389443|FG001|Overall Study|Lost to Follow-up|1|||
125209284|NCT00207727|450389444|FG002|Overall Study|Lost to Follow-up|0|||
125209285|NCT00207727|450389445|FG003|Overall Study|Lost to Follow-up|0|||
125209286|NCT00207727|450389446|FG004|Overall Study|Lost to Follow-up|0|||
125209287|NCT00207727|450389442|FG000|Overall Study|Other|38|||
125209288|NCT00207727|450389443|FG001|Overall Study|Other|41|||
125209289|NCT00207727|450389444|FG002|Overall Study|Other|41|||
124981982|NCT01967147|449561220|FG001|Overall Study|Lack of Efficacy|4|||
125209290|NCT00207727|450389445|FG003|Overall Study|Other|37|||
125209291|NCT00207727|450389446|FG004|Overall Study|Other|33|||
125209292|NCT00539032|450389451|FG000|Overall Study|Withdrawal by Subject|2|||
125209293|NCT00539032|450389452|FG001|Overall Study|Withdrawal by Subject|1|||
125209294|NCT00435019|450389453|FG000|Overall Study|Adverse Event|1|||
125209295|NCT00435019|450389454|FG001|Overall Study|Adverse Event|0|||
125209296|NCT00435019|450389453|FG000|Overall Study|Lack of Efficacy|1|||
125209297|NCT00435019|450389454|FG001|Overall Study|Lack of Efficacy|2|||
125209298|NCT00435019|450389453|FG000|Overall Study|Protocol Violation|3|||
125209299|NCT00435019|450389454|FG001|Overall Study|Protocol Violation|1|||
125209300|NCT00435019|450389453|FG000|Overall Study|Personal reasons for withdrawal|8|||
125209301|NCT00435019|450389454|FG001|Overall Study|Personal reasons for withdrawal|7|||
125209302|NCT02669082|450389458|FG000|Overall Study|Adverse Event|1|||
125209303|NCT04852276|450389459|FG000|Overall Study|Death|2|||
125209304|NCT04852276|450389460|FG001|Overall Study|Death|0|||
125209305|NCT04852276|450389459|FG000|Overall Study|Lost to Follow-up|15|||
125209306|NCT04852276|450389460|FG001|Overall Study|Lost to Follow-up|9|||
125209307|NCT04852276|450389459|FG000|Overall Study|Withdrawal by Subject|26|||
125209308|NCT04852276|450389460|FG001|Overall Study|Withdrawal by Subject|6|||
125209309|NCT01709864|450391213|FG000|Overall Study|Physician Decision|0|||
125209310|NCT01709864|450391214|FG001|Overall Study|Physician Decision|1|||
125209311|NCT01709864|450391213|FG000|Overall Study|subject/guardian decision|5|||
125209312|NCT01709864|450391214|FG001|Overall Study|subject/guardian decision|6|||
125209313|NCT01709864|450391213|FG000|Overall Study|Lost to Follow-up|1|||
125209314|NCT01709864|450391214|FG001|Overall Study|Lost to Follow-up|0|||
125209315|NCT01709864|450391213|FG000|Overall Study|non-compliance with study treatment|1|||
125209316|NCT01709864|450391214|FG001|Overall Study|non-compliance with study treatment|1|||
125209317|NCT01709864|450391213|FG000|Overall Study|Adverse Event|0|||
125209318|NCT01709864|450391214|FG001|Overall Study|Adverse Event|2|||
125209319|NCT01709864|450391213|FG000|Overall Study|Death|0|||
124981983|NCT01967147|449561219|FG000|Overall Study|Lost to Follow-up|1|||
125209320|NCT01709864|450391214|FG001|Overall Study|Death|1|||
125209321|NCT00427999|450391215|FG000|Overall Study|Adverse Event|6|||
125209322|NCT00427999|450391215|FG000|Overall Study|Abnormal laboratory values|1|||
125209323|NCT00427999|450391215|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
125209324|NCT00427999|450391215|FG000|Overall Study|Protocol Violation|2|||
125209325|NCT00427999|450391215|FG000|Overall Study|Withdrawal by Subject|9|||
125209326|NCT00427999|450391215|FG000|Overall Study|Death|1|||
125209327|NCT02380859|450391216|FG000|Overall Study|Withdrawal by Subject|2|||
125209328|NCT02380859|450391217|FG001|Overall Study|Withdrawal by Subject|0|||
125209329|NCT02284568|450391218|FG000|Overall Study|Adverse Event|2|||
125209330|NCT02284568|450391219|FG001|Overall Study|Adverse Event|9|||
125209331|NCT02284568|450391220|FG002|Overall Study|Adverse Event|4|||
125209332|NCT02284568|450391218|FG000|Overall Study|Withdrawal by Subject|22|||
125209333|NCT02284568|450391219|FG001|Overall Study|Withdrawal by Subject|21|||
125209334|NCT02284568|450391220|FG002|Overall Study|Withdrawal by Subject|1|||
125209335|NCT02284568|450391218|FG000|Overall Study|Noncompliance with study drug admin|1|||
125209336|NCT02284568|450391219|FG001|Overall Study|Noncompliance with study drug admin|2|||
125209337|NCT02284568|450391220|FG002|Overall Study|Noncompliance with study drug admin|0|||
125209338|NCT02284568|450391218|FG000|Overall Study|Noncompliance|1|||
125209339|NCT02284568|450391219|FG001|Overall Study|Noncompliance|0|||
125209340|NCT02284568|450391220|FG002|Overall Study|Noncompliance|0|||
125209341|NCT02284568|450391218|FG000|Overall Study|Protocol Violation|0|||
125209342|NCT02284568|450391219|FG001|Overall Study|Protocol Violation|1|||
125209343|NCT02284568|450391220|FG002|Overall Study|Protocol Violation|0|||
125209344|NCT02284568|450391218|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
125209345|NCT02284568|450391219|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
125209346|NCT02284568|450391220|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
125209347|NCT02284568|450391218|FG000|Overall Study|Lost to Follow-up|0|||
125209348|NCT02284568|450391219|FG001|Overall Study|Lost to Follow-up|3|||
125209349|NCT02284568|450391220|FG002|Overall Study|Lost to Follow-up|0|||
125209350|NCT02284568|450391218|FG000|Overall Study|Lack of Efficacy|4|||
124981984|NCT01967147|449561220|FG001|Overall Study|Lost to Follow-up|2|||
124981985|NCT01967147|449561219|FG000|Overall Study|Withdrawal by Subject|2|||
124981986|NCT01967147|449561220|FG001|Overall Study|Withdrawal by Subject|4|||
124981987|NCT01967147|449561219|FG000|Overall Study|Non-compliance with Study Drug|0|||
124981988|NCT01967147|449561220|FG001|Overall Study|Non-compliance with Study Drug|3|||
124981989|NCT01967147|449561219|FG000|Overall Study|Other|4|||
124981990|NCT01967147|449561220|FG001|Overall Study|Other|5|||
124981991|NCT00166712|449561222|FG000|Overall Study|Death|0|||
124981992|NCT00166712|449561223|FG001|Overall Study|Death|1|||
124981993|NCT00166712|449561222|FG000|Overall Study|Adverse Event|1|||
124981994|NCT00166712|449561223|FG001|Overall Study|Adverse Event|0|||
124981995|NCT00166712|449561222|FG000|Overall Study|Withdrawal by Subject|1|||
124981996|NCT00166712|449561223|FG001|Overall Study|Withdrawal by Subject|2|||
124981997|NCT00166712|449561222|FG000|Overall Study|Physician Decision|0|||
124981998|NCT00166712|449561223|FG001|Overall Study|Physician Decision|2|||
124981999|NCT03986944|449561224|FG000|Overall Study|Adverse Event|1|||
125209351|NCT02284568|450391219|FG001|Overall Study|Lack of Efficacy|7|||
125209352|NCT02284568|450391220|FG002|Overall Study|Lack of Efficacy|0|||
125209353|NCT02284568|450391218|FG000|Overall Study|Other|1|||
125209354|NCT02284568|450391219|FG001|Overall Study|Other|2|||
125209355|NCT02284568|450391220|FG002|Overall Study|Other|0|||
125209356|NCT02284568|450391218|FG000|Overall Study|Withdrew before taking study drug|0|||
125209357|NCT02284568|450391219|FG001|Overall Study|Withdrew before taking study drug|1|||
125209358|NCT02284568|450391220|FG002|Overall Study|Withdrew before taking study drug|0|||
125209359|NCT00412217|450391221|FG000|Overall Study|Insufficient Data Available|8|||
125209360|NCT00412217|450391222|FG001|Overall Study|Insufficient Data Available|3|||
125209361|NCT00412217|450391221|FG000|Overall Study|Death|5|||
125209362|NCT00412217|450391222|FG001|Overall Study|Death|4|||
125209363|NCT00412217|450391221|FG000|Overall Study|Disease Progression|2|||
125209364|NCT00412217|450391222|FG001|Overall Study|Disease Progression|3|||
125209365|NCT00412217|450391221|FG000|Overall Study|Investigator Decision|1|||
125209366|NCT00412217|450391222|FG001|Overall Study|Investigator Decision|0|||
125209367|NCT00412217|450391221|FG000|Overall Study|Withdrawal by Subject|2|||
125209368|NCT00412217|450391222|FG001|Overall Study|Withdrawal by Subject|0|||
125209369|NCT00412217|450391221|FG000|Overall Study|Lost to Follow-up|1|||
125209370|NCT00412217|450391222|FG001|Overall Study|Lost to Follow-up|4|||
125209371|NCT00412217|450391221|FG000|Overall Study|Study Terminated by Sponsor|26|||
125209372|NCT00412217|450391222|FG001|Overall Study|Study Terminated by Sponsor|33|||
125209373|NCT00412217|450391221|FG000|Overall Study|Other|1|||
125209374|NCT00412217|450391222|FG001|Overall Study|Other|1|||
125209375|NCT03114657|450391223|FG000|Overall Study|Adverse Event|9|||
125209376|NCT03114657|450391224|FG001|Overall Study|Adverse Event|6|||
125209377|NCT03114657|450391223|FG000|Overall Study|Death|4|||
125209378|NCT03114657|450391224|FG001|Overall Study|Death|0|||
125209379|NCT03114657|450391223|FG000|Overall Study|Multiple Reasons|1|||
125209380|NCT03114657|450391224|FG001|Overall Study|Multiple Reasons|2|||
125209381|NCT03114657|450391223|FG000|Overall Study|Physician Decision|2|||
125209382|NCT03114657|450391224|FG001|Overall Study|Physician Decision|2|||
125209383|NCT03114657|450391223|FG000|Overall Study|Study Terminated By Sponsor|355|||
125209384|NCT03114657|450391224|FG001|Overall Study|Study Terminated By Sponsor|374|||
125209385|NCT03114657|450391223|FG000|Overall Study|Symptomatic Deterioration|0|||
125209386|NCT03114657|450391224|FG001|Overall Study|Symptomatic Deterioration|1|||
125209387|NCT03114657|450391223|FG000|Overall Study|Withdrawal by Subject|28|||
125209388|NCT03114657|450391224|FG001|Overall Study|Withdrawal by Subject|22|||
125209389|NCT01546038|450391225|FG000|Overall Study|Death|15|||
125209390|NCT01546038|450391226|FG001|Overall Study|Death|6|||
124982000|NCT03986944|449561225|FG001|Overall Study|Adverse Event|2|||
124982001|NCT03986944|449561226|FG002|Overall Study|Adverse Event|3|||
124982002|NCT03986944|449561224|FG000|Overall Study|Protocol Violation|0|||
124982003|NCT03986944|449561225|FG001|Overall Study|Protocol Violation|1|||
124982004|NCT03986944|449561226|FG002|Overall Study|Protocol Violation|1|||
124982005|NCT03986944|449561224|FG000|Overall Study|Withdrawal by Subject|3|||
124982006|NCT03986944|449561225|FG001|Overall Study|Withdrawal by Subject|5|||
124982007|NCT03986944|449561226|FG002|Overall Study|Withdrawal by Subject|5|||
124982008|NCT03986944|449561224|FG000|Overall Study|Study termination|10|||
124982009|NCT03986944|449561225|FG001|Overall Study|Study termination|10|||
125209391|NCT01546038|450391227|FG002|Overall Study|Death|4|||
125209392|NCT01546038|450391228|FG003|Overall Study|Death|2|||
125209393|NCT01546038|450391229|FG004|Overall Study|Death|9|||
125209394|NCT01546038|450391230|FG005|Overall Study|Death|3|||
125209395|NCT01546038|450391231|FG006|Overall Study|Death|46|||
125209396|NCT01546038|450391232|FG007|Overall Study|Death|76|||
125209397|NCT01546038|450391233|FG008|Overall Study|Death|39|||
125209398|NCT01546038|450391225|FG000|Overall Study|Lost to Follow-up|0|||
125209399|NCT01546038|450391226|FG001|Overall Study|Lost to Follow-up|0|||
125209400|NCT01546038|450391227|FG002|Overall Study|Lost to Follow-up|0|||
125209401|NCT01546038|450391228|FG003|Overall Study|Lost to Follow-up|0|||
125209402|NCT01546038|450391229|FG004|Overall Study|Lost to Follow-up|1|||
125209403|NCT01546038|450391230|FG005|Overall Study|Lost to Follow-up|0|||
125209404|NCT01546038|450391231|FG006|Overall Study|Lost to Follow-up|2|||
125209405|NCT01546038|450391232|FG007|Overall Study|Lost to Follow-up|1|||
125209406|NCT01546038|450391233|FG008|Overall Study|Lost to Follow-up|0|||
125209407|NCT01546038|450391225|FG000|Overall Study|Withdrawal by Subject|1|||
125209408|NCT01546038|450391226|FG001|Overall Study|Withdrawal by Subject|0|||
125209409|NCT01546038|450391227|FG002|Overall Study|Withdrawal by Subject|0|||
125209410|NCT01546038|450391228|FG003|Overall Study|Withdrawal by Subject|1|||
125209411|NCT01546038|450391229|FG004|Overall Study|Withdrawal by Subject|0|||
125209412|NCT01546038|450391230|FG005|Overall Study|Withdrawal by Subject|1|||
125209413|NCT01546038|450391231|FG006|Overall Study|Withdrawal by Subject|3|||
125209414|NCT01546038|450391232|FG007|Overall Study|Withdrawal by Subject|3|||
124982010|NCT03986944|449561226|FG002|Overall Study|Study termination|10|||
124982011|NCT03986944|449561224|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
125033579|NCT00408005|449743817|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
125209415|NCT01546038|450391233|FG008|Overall Study|Withdrawal by Subject|1|||
125209416|NCT01546038|450391225|FG000|Overall Study|: Randomized, not treated|0|||
125209417|NCT01546038|450391226|FG001|Overall Study|: Randomized, not treated|0|||
125209418|NCT01546038|450391227|FG002|Overall Study|: Randomized, not treated|0|||
125209419|NCT01546038|450391228|FG003|Overall Study|: Randomized, not treated|0|||
125209420|NCT01546038|450391229|FG004|Overall Study|: Randomized, not treated|0|||
125209421|NCT01546038|450391230|FG005|Overall Study|: Randomized, not treated|0|||
125209422|NCT01546038|450391231|FG006|Overall Study|: Randomized, not treated|2|||
125209423|NCT01546038|450391232|FG007|Overall Study|: Randomized, not treated|4|||
125209424|NCT01546038|450391233|FG008|Overall Study|: Randomized, not treated|3|||
125209425|NCT03329248|450391234|FG000|Overall Study|Progressive Disease|6|||
125209426|NCT00987402|450391235|FG000|Overall Study|Insufficient data entry|86|||
125209427|NCT00987402|450391236|FG001|Overall Study|Insufficient data entry|98|||
124982012|NCT03986944|449561225|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
124982013|NCT03986944|449561226|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
124982014|NCT03986944|449561224|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
124982015|NCT03986944|449561225|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
124982016|NCT03986944|449561226|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
124982017|NCT03339245|449561230|FG000|Overall Study|Adverse Event|1|||
124982018|NCT03339245|449561231|FG001|Overall Study|Adverse Event|1|||
124982019|NCT03339245|449561230|FG000|Overall Study|Withdrawal by Subject|1|||
124982020|NCT03339245|449561231|FG001|Overall Study|Withdrawal by Subject|0|||
124982021|NCT00837694|449561232|FG000|Overall Study|Lost to Follow-up|2|||
124982022|NCT00837694|449561233|FG001|Overall Study|Lost to Follow-up|0|||
124982023|NCT00837694|449561234|FG002|Overall Study|Lost to Follow-up|2|||
124982024|NCT00837694|449561235|FG003|Overall Study|Lost to Follow-up|1|||
124982025|NCT00837694|449561236|FG004|Overall Study|Lost to Follow-up|1|||
124982026|NCT00837694|449561237|FG005|Overall Study|Lost to Follow-up|1|||
124982027|NCT00306670|449561244|FG000|Overall Study|patients recruited; Genentech, the st|0|||
124982028|NCT00306670|449561245|FG001|Overall Study|patients recruited; Genentech, the st|2|||
124982029|NCT00503139|449561246|FG000|Overall Study|Case Report Forms were not collected|4|||
124982030|NCT00503139|449561246|FG000|Overall Study|Protocol Violation|4|||
124982031|NCT02735577|449561247|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
124982032|NCT02735577|449561247|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
124982033|NCT02731690|449561248|FG000|Overall Study|Adverse Event|1|||
125209428|NCT01254721|450391237|FG000|Overall Study|Lost to Follow-up|0|||
125209429|NCT01254721|450391238|FG001|Overall Study|Lost to Follow-up|4|||
125209430|NCT01254721|450391237|FG000|Overall Study|Lack of Efficacy|4|||
125209431|NCT01254721|450391238|FG001|Overall Study|Lack of Efficacy|2|||
125209432|NCT01254721|450391237|FG000|Overall Study|Death|0|||
125209433|NCT01254721|450391238|FG001|Overall Study|Death|1|||
125209434|NCT01254721|450391237|FG000|Overall Study|technical problum|1|||
125209435|NCT01254721|450391238|FG001|Overall Study|technical problum|0|||
125209436|NCT01254721|450391237|FG000|Overall Study|Adverse Event|2|||
125209437|NCT01254721|450391238|FG001|Overall Study|Adverse Event|3|||
125209438|NCT01254721|450391237|FG000|Overall Study|Withdrawal by Subject|8|||
125209439|NCT01254721|450391238|FG001|Overall Study|Withdrawal by Subject|11|||
125209440|NCT01254721|450391237|FG000|Overall Study|Wrongly randomization|0|||
125209441|NCT01254721|450391238|FG001|Overall Study|Wrongly randomization|1|||
125209442|NCT01362517|450391243|FG000|Overall Study|Protocol Violation|1|||
125209443|NCT01362517|450391243|FG000|Overall Study|Lost to Follow-up|1|||
125209444|NCT03209518|450391244|FG000|Overall Study|Case Report Forms Uncollected|1|||
125209445|NCT03209518|450391244|FG000|Overall Study|Protocol Deviation|1|||
125209446|NCT00236899|450391245|FG000|Overall Study|Adverse Event (Study Related)|1|||
125209447|NCT00236899|450391246|FG001|Overall Study|Adverse Event (Study Related)|1|||
125209448|NCT00236899|450391247|FG002|Overall Study|Adverse Event (Study Related)|2|||
125209449|NCT00236899|450391248|FG003|Overall Study|Adverse Event (Study Related)|1|||
125209450|NCT00236899|450391245|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
125209451|NCT00236899|450391246|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
125209452|NCT00236899|450391247|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
125209453|NCT00236899|450391248|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
125209454|NCT00236899|450391245|FG000|Overall Study|Death (Study Disease)|1|||
125209455|NCT00236899|450391246|FG001|Overall Study|Death (Study Disease)|4|||
125209456|NCT00236899|450391247|FG002|Overall Study|Death (Study Disease)|0|||
125209457|NCT00236899|450391248|FG003|Overall Study|Death (Study Disease)|0|||
125209458|NCT00236899|450391245|FG000|Overall Study|Death (Not Study Related)|2|||
125209459|NCT00236899|450391246|FG001|Overall Study|Death (Not Study Related)|0|||
125209460|NCT00236899|450391247|FG002|Overall Study|Death (Not Study Related)|0|||
125209461|NCT00236899|450391248|FG003|Overall Study|Death (Not Study Related)|0|||
125209462|NCT00236899|450391245|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
125209463|NCT00236899|450391246|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
125209464|NCT00236899|450391247|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
125209465|NCT00236899|450391248|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
125209466|NCT00236899|450391245|FG000|Overall Study|Lost to Follow-up|0|||
125209467|NCT00236899|450391246|FG001|Overall Study|Lost to Follow-up|1|||
125209468|NCT00236899|450391247|FG002|Overall Study|Lost to Follow-up|0|||
125209469|NCT00236899|450391248|FG003|Overall Study|Lost to Follow-up|0|||
125209470|NCT00236899|450391245|FG000|Overall Study|Entry Criteria Exclusion|0|||
125209471|NCT00236899|450391246|FG001|Overall Study|Entry Criteria Exclusion|1|||
125209472|NCT00236899|450391247|FG002|Overall Study|Entry Criteria Exclusion|1|||
125209473|NCT00236899|450391248|FG003|Overall Study|Entry Criteria Exclusion|0|||
125209474|NCT00236899|450391245|FG000|Overall Study|Protocol Violation|1|||
125209475|NCT00236899|450391246|FG001|Overall Study|Protocol Violation|0|||
125209476|NCT00236899|450391247|FG002|Overall Study|Protocol Violation|0|||
125209477|NCT00236899|450391248|FG003|Overall Study|Protocol Violation|0|||
125209478|NCT00236899|450391245|FG000|Overall Study|Withdrawal by Subject|6|||
125209479|NCT00236899|450391246|FG001|Overall Study|Withdrawal by Subject|4|||
124982034|NCT02731690|449561248|FG000|Overall Study|Withdrawal by Subject|3|||
124982035|NCT02731690|449561248|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
124982036|NCT00833833|449561249|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
124982037|NCT00833833|449561250|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
124982038|NCT00833833|449561251|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
124982039|NCT00833833|449561252|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
124982040|NCT00833833|449561253|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
124982041|NCT00833833|449561254|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
124982042|NCT00833833|449561249|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
124982043|NCT00833833|449561250|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
124982044|NCT00833833|449561251|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
124982045|NCT00833833|449561252|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
124982046|NCT00833833|449561253|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
124982047|NCT00833833|449561254|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
124982048|NCT00833833|449561249|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
124982049|NCT00833833|449561250|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
124982050|NCT00833833|449561251|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
124982051|NCT00833833|449561252|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
124982052|NCT00833833|449561253|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
124982053|NCT00833833|449561254|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
124982054|NCT00833833|449561249|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
124982055|NCT00833833|449561250|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
124982056|NCT00833833|449561251|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
124982057|NCT00833833|449561252|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
124982058|NCT00833833|449561253|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
124982059|NCT00833833|449561254|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
124982060|NCT00833833|449561249|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
124982061|NCT00833833|449561250|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
124982062|NCT00833833|449561251|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
124982063|NCT00833833|449561252|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
124982064|NCT00833833|449561253|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
124982065|NCT00833833|449561254|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
124982066|NCT00833833|449561249|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
124982067|NCT00833833|449561250|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
124982068|NCT00833833|449561251|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
124982069|NCT00833833|449561252|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
124982070|NCT00833833|449561253|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
124982071|NCT00833833|449561254|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
124982072|NCT00833833|449561249|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
124982073|NCT00833833|449561250|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
124982074|NCT00833833|449561251|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
124982075|NCT00833833|449561252|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
124982076|NCT00833833|449561253|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
124982077|NCT00833833|449561254|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
124982078|NCT00833833|449561249|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
124982079|NCT00833833|449561250|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
124982080|NCT00833833|449561251|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
124982081|NCT00833833|449561252|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
124982082|NCT00833833|449561253|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
124982083|NCT00833833|449561254|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
124982084|NCT00833833|449561249|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
124982085|NCT00833833|449561250|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
124982086|NCT00833833|449561251|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
124982087|NCT00833833|449561252|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
124982088|NCT00833833|449561253|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
124982089|NCT00833833|449561254|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
124982090|NCT00833833|449561249|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
124982091|NCT00833833|449561250|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
124982092|NCT00833833|449561251|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
124982093|NCT00833833|449561252|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
124982094|NCT00833833|449561253|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
124982095|NCT00833833|449561254|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
124982096|NCT00833833|449561249|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
124982097|NCT00833833|449561250|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
124982098|NCT00833833|449561251|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
124982099|NCT00833833|449561252|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
124982100|NCT00833833|449561253|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
124982101|NCT00833833|449561254|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
125209480|NCT00236899|450391247|FG002|Overall Study|Withdrawal by Subject|5|||
125209481|NCT00236899|450391248|FG003|Overall Study|Withdrawal by Subject|2|||
125209482|NCT00236899|450391245|FG000|Overall Study|Physician Decision|7|||
125209483|NCT00236899|450391246|FG001|Overall Study|Physician Decision|8|||
125209484|NCT00236899|450391247|FG002|Overall Study|Physician Decision|7|||
125209485|NCT00236899|450391248|FG003|Overall Study|Physician Decision|6|||
125209486|NCT00236899|450391245|FG000|Overall Study|Satisfactory Response|2|||
125209487|NCT00236899|450391246|FG001|Overall Study|Satisfactory Response|0|||
125209488|NCT00236899|450391247|FG002|Overall Study|Satisfactory Response|0|||
125209489|NCT00236899|450391248|FG003|Overall Study|Satisfactory Response|1|||
125209490|NCT00236899|450391245|FG000|Overall Study|Lack of Efficacy|18|||
125209491|NCT00236899|450391246|FG001|Overall Study|Lack of Efficacy|18|||
125209492|NCT00236899|450391247|FG002|Overall Study|Lack of Efficacy|25|||
125209493|NCT00236899|450391248|FG003|Overall Study|Lack of Efficacy|23|||
125209494|NCT03379792|450391250|FG000|Overall Study|Physician Decision|0|||
125209495|NCT03379792|450391251|FG001|Overall Study|Physician Decision|0|||
125209496|NCT03379792|450391252|FG002|Overall Study|Physician Decision|0|||
125209497|NCT03379792|450391253|FG003|Overall Study|Physician Decision|1|||
125209498|NCT03379792|450391254|FG004|Overall Study|Physician Decision|0|||
125209499|NCT03379792|450391255|FG005|Overall Study|Physician Decision|0|||
125209500|NCT03379792|450391250|FG000|Overall Study|Withdrawal by Subject|0|||
125209501|NCT03379792|450391251|FG001|Overall Study|Withdrawal by Subject|0|||
125209502|NCT03379792|450391252|FG002|Overall Study|Withdrawal by Subject|0|||
125209503|NCT03379792|450391253|FG003|Overall Study|Withdrawal by Subject|0|||
125209504|NCT03379792|450391254|FG004|Overall Study|Withdrawal by Subject|1|||
125209505|NCT03379792|450391255|FG005|Overall Study|Withdrawal by Subject|1|||
125209506|NCT01121536|450391256|FG000|Overall Study|Adverse Event|63|||
125209507|NCT01121536|450391256|FG000|Overall Study|Lack of Efficacy|35|||
125209508|NCT01121536|450391256|FG000|Overall Study|Withdrawal by Subject|65|||
125209509|NCT01121536|450391256|FG000|Overall Study|Protocol Violation|20|||
125209510|NCT01121536|450391256|FG000|Overall Study|Noncompliance with study medication|12|||
125209511|NCT01121536|450391256|FG000|Overall Study|Noncompliance with study procedures|9|||
125209512|NCT01121536|450391256|FG000|Overall Study|Lost to Follow-up|39|||
125209513|NCT01121536|450391256|FG000|Overall Study|Other|118|||
125209514|NCT02854605|450391257|FG000|Overall Study|Adverse Event|1|||
125209515|NCT02854605|450391258|FG001|Overall Study|Adverse Event|5|||
125209516|NCT02854605|450391259|FG002|Overall Study|Adverse Event|2|||
125209517|NCT02854605|450391257|FG000|Overall Study|Lost to Follow-up|0|||
125209518|NCT02854605|450391258|FG001|Overall Study|Lost to Follow-up|2|||
125209519|NCT02854605|450391259|FG002|Overall Study|Lost to Follow-up|0|||
125209520|NCT02854605|450391257|FG000|Overall Study|Withdrew Consent|1|||
125209521|NCT02854605|450391258|FG001|Overall Study|Withdrew Consent|0|||
125209522|NCT02854605|450391259|FG002|Overall Study|Withdrew Consent|1|||
125209523|NCT02854605|450391257|FG000|Overall Study|Investigator's Discretion|1|||
125209524|NCT02854605|450391258|FG001|Overall Study|Investigator's Discretion|0|||
124872164|NCT00245102|449154027|FG003|Overall Study|Participant needed surgery|0|||
124872165|NCT00245102|449154028|FG004|Overall Study|Participant needed surgery|0|||
124872166|NCT00245102|449154029|FG005|Overall Study|Participant needed surgery|0|||
124872167|NCT00245102|449154024|FG000|Overall Study|Clinical progression|1|||
124872168|NCT00245102|449154025|FG001|Overall Study|Clinical progression|0|||
124872169|NCT00245102|449154026|FG002|Overall Study|Clinical progression|0|||
124872170|NCT00245102|449154027|FG003|Overall Study|Clinical progression|0|||
124872171|NCT00245102|449154028|FG004|Overall Study|Clinical progression|0|||
124872172|NCT00245102|449154029|FG005|Overall Study|Clinical progression|0|||
124872173|NCT01953003|449154030|FG000|Overall Study|Not treated|0|||
124872174|NCT01953003|449154031|FG001|Overall Study|Not treated|1|||
124872175|NCT01953003|449154030|FG000|Overall Study|Progressive disease|35|||
124872176|NCT01953003|449154031|FG001|Overall Study|Progressive disease|45|||
124872177|NCT01953003|449154030|FG000|Overall Study|Related Adverse events|7|||
124872178|NCT01953003|449154031|FG001|Overall Study|Related Adverse events|2|||
124872179|NCT01953003|449154030|FG000|Overall Study|Non-related adverse events|0|||
124872180|NCT01953003|449154031|FG001|Overall Study|Non-related adverse events|2|||
124872181|NCT01953003|449154030|FG000|Overall Study|Protocol Violation|0|||
124872182|NCT01953003|449154031|FG001|Overall Study|Protocol Violation|1|||
124872183|NCT01953003|449154030|FG000|Overall Study|Withdrawal by Subject|14|||
124872184|NCT01953003|449154031|FG001|Overall Study|Withdrawal by Subject|4|||
124872185|NCT03092375|449154034|FG000|Overall Study|Lack of Efficacy|0|||
125209525|NCT02854605|450391259|FG002|Overall Study|Investigator's Discretion|0|||
125209526|NCT02854605|450391257|FG000|Overall Study|Protocol Violation|0|||
125209527|NCT02854605|450391258|FG001|Overall Study|Protocol Violation|0|||
125209528|NCT02854605|450391259|FG002|Overall Study|Protocol Violation|1|||
125209529|NCT00568334|450391264|FG000|Overall Study|Withdrawal by Subject|0|||
125209530|NCT00568334|450391265|FG001|Overall Study|Withdrawal by Subject|1|||
125209531|NCT00568334|450391264|FG000|Overall Study|Lost to Follow-up|1|||
125209532|NCT00568334|450391265|FG001|Overall Study|Lost to Follow-up|0|||
125209533|NCT01897571|450391266|FG000|Overall Study|Lost to Follow-up|3|||
125209534|NCT01897571|450391267|FG001|Overall Study|Lost to Follow-up|0|||
125209535|NCT01897571|450391268|FG002|Overall Study|Lost to Follow-up|0|||
125209536|NCT01897571|450391269|FG003|Overall Study|Lost to Follow-up|0|||
124982102|NCT00833833|449561249|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
124982103|NCT00833833|449561250|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
124982104|NCT00833833|449561251|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
124982105|NCT00833833|449561252|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
125209537|NCT01897571|450391270|FG004|Overall Study|Lost to Follow-up|2|||
125209538|NCT01897571|450391271|FG005|Overall Study|Lost to Follow-up|0|||
125209539|NCT01897571|450391272|FG006|Overall Study|Lost to Follow-up|0|||
125209540|NCT01897571|450391273|FG007|Overall Study|Lost to Follow-up|0|||
125209541|NCT01897571|450391274|FG008|Overall Study|Lost to Follow-up|1|||
125209542|NCT01897571|450391275|FG009|Overall Study|Lost to Follow-up|2|||
125209543|NCT01897571|450391276|FG010|Overall Study|Lost to Follow-up|4|||
125209544|NCT01897571|450391266|FG000|Overall Study|Withdrawal by Subject|0|||
125209545|NCT01897571|450391267|FG001|Overall Study|Withdrawal by Subject|0|||
125209546|NCT01897571|450391268|FG002|Overall Study|Withdrawal by Subject|0|||
125209547|NCT01897571|450391269|FG003|Overall Study|Withdrawal by Subject|0|||
125209548|NCT01897571|450391270|FG004|Overall Study|Withdrawal by Subject|0|||
125209549|NCT01897571|450391271|FG005|Overall Study|Withdrawal by Subject|0|||
125209550|NCT01897571|450391272|FG006|Overall Study|Withdrawal by Subject|0|||
125209551|NCT01897571|450391273|FG007|Overall Study|Withdrawal by Subject|1|||
125209552|NCT01897571|450391274|FG008|Overall Study|Withdrawal by Subject|4|||
125209553|NCT01897571|450391275|FG009|Overall Study|Withdrawal by Subject|3|||
125209554|NCT01897571|450391276|FG010|Overall Study|Withdrawal by Subject|1|||
125209555|NCT01897571|450391266|FG000|Overall Study|Other|1|||
125209556|NCT01897571|450391267|FG001|Overall Study|Other|0|||
125209557|NCT01897571|450391268|FG002|Overall Study|Other|0|||
125209558|NCT01897571|450391269|FG003|Overall Study|Other|3|||
125209559|NCT01897571|450391270|FG004|Overall Study|Other|3|||
125209560|NCT01897571|450391271|FG005|Overall Study|Other|4|||
125209561|NCT01897571|450391272|FG006|Overall Study|Other|7|||
125209562|NCT01897571|450391273|FG007|Overall Study|Other|0|||
125209563|NCT01897571|450391274|FG008|Overall Study|Other|0|||
125209564|NCT01897571|450391275|FG009|Overall Study|Other|0|||
125209565|NCT01897571|450391276|FG010|Overall Study|Other|0|||
125209566|NCT01897571|450391266|FG000|Overall Study|Enrolled in rollover study|0|||
125209567|NCT01897571|450391267|FG001|Overall Study|Enrolled in rollover study|0|||
125209568|NCT01897571|450391268|FG002|Overall Study|Enrolled in rollover study|0|||
125209569|NCT01897571|450391269|FG003|Overall Study|Enrolled in rollover study|0|||
125209570|NCT01897571|450391270|FG004|Overall Study|Enrolled in rollover study|0|||
125209571|NCT01897571|450391271|FG005|Overall Study|Enrolled in rollover study|0|||
125209572|NCT01897571|450391272|FG006|Overall Study|Enrolled in rollover study|0|||
125209573|NCT01897571|450391273|FG007|Overall Study|Enrolled in rollover study|9|||
125209574|NCT01897571|450391274|FG008|Overall Study|Enrolled in rollover study|7|||
125209575|NCT01897571|450391275|FG009|Overall Study|Enrolled in rollover study|9|||
125209576|NCT01897571|450391276|FG010|Overall Study|Enrolled in rollover study|1|||
125209577|NCT01897571|450391266|FG000|Overall Study|Death|2|||
125209578|NCT01897571|450391267|FG001|Overall Study|Death|2|||
125209579|NCT01897571|450391268|FG002|Overall Study|Death|3|||
125209580|NCT01897571|450391269|FG003|Overall Study|Death|6|||
125209581|NCT01897571|450391270|FG004|Overall Study|Death|7|||
125209582|NCT01897571|450391271|FG005|Overall Study|Death|9|||
125209583|NCT01897571|450391272|FG006|Overall Study|Death|5|||
124982106|NCT00833833|449561253|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
124982107|NCT00833833|449561254|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
124982108|NCT00833833|449561249|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
124982109|NCT00833833|449561250|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
124982110|NCT00833833|449561251|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
124982111|NCT00833833|449561252|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
124982112|NCT00833833|449561253|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
124982113|NCT00833833|449561254|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
124982114|NCT01994837|449561255|FG000|Overall Study|Progressive disease per protocol|23|||
124982115|NCT01994837|449561255|FG000|Overall Study|Adv event related to progressive disease|3|||
124982116|NCT01994837|449561255|FG000|Overall Study|Fatal progressive disease|2|||
124982117|NCT01994837|449561255|FG000|Overall Study|Adverse event not related to progression|1|||
124982118|NCT01994837|449561255|FG000|Overall Study|Chose palliative care|1|||
124982119|NCT01994837|449561255|FG000|Overall Study|Proceeded to transplant|1|||
124982120|NCT01994837|449561255|FG000|Overall Study|Removed from study due to no response|1|||
124982121|NCT01127893|449561256|FG000|Overall Study|Study Termination by the Sponsor|1|||
125209584|NCT01897571|450391273|FG007|Overall Study|Death|22|||
125209585|NCT01897571|450391274|FG008|Overall Study|Death|23|||
125209586|NCT01897571|450391275|FG009|Overall Study|Death|129|||
125209587|NCT01897571|450391276|FG010|Overall Study|Death|59|||
125209588|NCT05268016|450391279|FG000|Overall Study|Unacceptable toxicity or AE|2|||
125209589|NCT05268016|450391280|FG001|Overall Study|Unacceptable toxicity or AE|2|||
125209590|NCT05268016|450391281|FG002|Overall Study|Unacceptable toxicity or AE|4|||
125209591|NCT05268016|450391282|FG003|Overall Study|Unacceptable toxicity or AE|3|||
125209592|NCT05268016|450391283|FG004|Overall Study|Unacceptable toxicity or AE|1|||
125209593|NCT05268016|450391279|FG000|Overall Study|Withdrawal by Subject|1|||
124982122|NCT01262677|449561257|FG000|Overall Study|Does not meet entrance criteria|0|||
124982123|NCT01262677|449561258|FG001|Overall Study|Does not meet entrance criteria|2|||
124982124|NCT01262677|449561259|FG002|Overall Study|Does not meet entrance criteria|0|||
124982125|NCT01262677|449561257|FG000|Overall Study|Insufficient clinical response|0|||
124982126|NCT01262677|449561258|FG001|Overall Study|Insufficient clinical response|0|||
124982127|NCT01262677|449561259|FG002|Overall Study|Insufficient clinical response|1|||
124982128|NCT01262677|449561257|FG000|Overall Study|Lost to Follow-up|1|||
124982129|NCT01262677|449561258|FG001|Overall Study|Lost to Follow-up|0|||
124982130|NCT01262677|449561259|FG002|Overall Study|Lost to Follow-up|2|||
124982131|NCT01262677|449561257|FG000|Overall Study|No longer willing to participate|3|||
124982132|NCT01262677|449561258|FG001|Overall Study|No longer willing to participate|3|||
124982133|NCT01262677|449561259|FG002|Overall Study|No longer willing to participate|2|||
124982134|NCT01262677|449561257|FG000|Overall Study|Reason not provided|2|||
124982135|NCT01262677|449561258|FG001|Overall Study|Reason not provided|1|||
124982136|NCT01262677|449561259|FG002|Overall Study|Reason not provided|3|||
124982137|NCT01262677|449561257|FG000|Overall Study|Protocol Violation|0|||
124982138|NCT01262677|449561258|FG001|Overall Study|Protocol Violation|1|||
124982139|NCT01262677|449561259|FG002|Overall Study|Protocol Violation|1|||
124982140|NCT01262677|449561257|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
124982141|NCT01262677|449561258|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
124982142|NCT01262677|449561259|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
124982143|NCT03446781|449561265|FG000|Overall Study|Lost to Follow-up|11|||
124982144|NCT03446781|449561266|FG001|Overall Study|Lost to Follow-up|5|||
124982145|NCT03446781|449561265|FG000|Overall Study|Withdrawal by Subject|9|||
124982146|NCT03446781|449561266|FG001|Overall Study|Withdrawal by Subject|7|||
124982147|NCT03446781|449561265|FG000|Overall Study|Adverse Event|8|||
124982148|NCT03446781|449561266|FG001|Overall Study|Adverse Event|2|||
124982149|NCT03446781|449561265|FG000|Overall Study|Protocol Violation|0|||
124982150|NCT03446781|449561266|FG001|Overall Study|Protocol Violation|3|||
124982151|NCT01638429|449561273|FG000|Overall Study|Withdrawal by Subject|1|||
124982152|NCT00996476|449561275|FG000|Overall Study|Withdrawal by Subject|1|||
124982153|NCT00996476|449561276|FG001|Overall Study|Withdrawal by Subject|2|||
124982154|NCT00996476|449561277|FG002|Overall Study|Withdrawal by Subject|1|||
124982155|NCT00996476|449561278|FG003|Overall Study|Withdrawal by Subject|0|||
124982156|NCT00996476|449561279|FG004|Overall Study|Withdrawal by Subject|1|||
124982157|NCT00996476|449561275|FG000|Overall Study|Adverse Event|0|||
124982158|NCT00996476|449561276|FG001|Overall Study|Adverse Event|1|||
124982159|NCT00996476|449561277|FG002|Overall Study|Adverse Event|0|||
124982160|NCT00996476|449561278|FG003|Overall Study|Adverse Event|0|||
124982161|NCT00996476|449561279|FG004|Overall Study|Adverse Event|1|||
124982162|NCT00473265|449561280|FG000|Overall Study|Unrelated adverse event|5|||
124982163|NCT00473265|449561280|FG000|Overall Study|Off treatment early|15|||
124982164|NCT01802567|449561281|FG000|Overall Study|Withdrawal by Subject|2|||
124982165|NCT01802567|449561281|FG000|Overall Study|Physician Decision|1|||
124982166|NCT01802567|449561281|FG000|Overall Study|Lack of Efficacy|7|||
125209594|NCT05268016|450391280|FG001|Overall Study|Withdrawal by Subject|3|||
125209595|NCT05268016|450391281|FG002|Overall Study|Withdrawal by Subject|2|||
125209596|NCT05268016|450391282|FG003|Overall Study|Withdrawal by Subject|2|||
125209597|NCT05268016|450391283|FG004|Overall Study|Withdrawal by Subject|1|||
125209598|NCT05268016|450391279|FG000|Overall Study|Lost to Follow-up|4|||
125209599|NCT05268016|450391280|FG001|Overall Study|Lost to Follow-up|7|||
125209600|NCT05268016|450391281|FG002|Overall Study|Lost to Follow-up|1|||
125209601|NCT05268016|450391282|FG003|Overall Study|Lost to Follow-up|3|||
125209602|NCT05268016|450391283|FG004|Overall Study|Lost to Follow-up|5|||
125209603|NCT05268016|450391279|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
125209604|NCT05268016|450391280|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
125209605|NCT05268016|450391281|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
125209606|NCT05268016|450391282|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
125209607|NCT05268016|450391283|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
125209608|NCT05268016|450391279|FG000|Overall Study|Lack of Efficacy|0|||
125209609|NCT05268016|450391280|FG001|Overall Study|Lack of Efficacy|0|||
125209610|NCT05268016|450391281|FG002|Overall Study|Lack of Efficacy|0|||
125209611|NCT05268016|450391282|FG003|Overall Study|Lack of Efficacy|0|||
125209612|NCT05268016|450391283|FG004|Overall Study|Lack of Efficacy|4|||
125209613|NCT05268016|450391279|FG000|Overall Study|Physician Decision|0|||
125209614|NCT05268016|450391280|FG001|Overall Study|Physician Decision|0|||
125209615|NCT05268016|450391281|FG002|Overall Study|Physician Decision|0|||
125209616|NCT05268016|450391282|FG003|Overall Study|Physician Decision|1|||
125209617|NCT05268016|450391283|FG004|Overall Study|Physician Decision|0|||
125209618|NCT05268016|450391279|FG000|Overall Study|Other|1|||
125209619|NCT05268016|450391280|FG001|Overall Study|Other|0|||
125209620|NCT05268016|450391281|FG002|Overall Study|Other|1|||
124982167|NCT01802567|449561281|FG000|Overall Study|Consented but did not start therapy|7|||
124982168|NCT01802567|449561281|FG000|Overall Study|Protocol Violation|1|||
124982169|NCT01895101|449561286|FG000|Overall Study|OPCAB procedure|1|||
125209621|NCT05268016|450391282|FG003|Overall Study|Other|2|||
125209622|NCT05268016|450391283|FG004|Overall Study|Other|0|||
125209623|NCT02273908|450391284|FG000|Overall Study|Adverse Event|16|||
125209624|NCT02273908|450391285|FG001|Overall Study|Adverse Event|0|||
125209625|NCT02273908|450391284|FG000|Overall Study|Lost to Follow-up|10|||
125209626|NCT02273908|450391285|FG001|Overall Study|Lost to Follow-up|1|||
125209627|NCT02273908|450391284|FG000|Overall Study|Did not meet entrance criteria|3|||
125209628|NCT02273908|450391285|FG001|Overall Study|Did not meet entrance criteria|2|||
125209629|NCT02273908|450391284|FG000|Overall Study|Withdrawal by Subject|4|||
125209630|NCT02273908|450391285|FG001|Overall Study|Withdrawal by Subject|2|||
125209631|NCT04908475|450391286|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
125209632|NCT04908475|450391287|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125209633|NCT04908475|450391288|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125209634|NCT04908475|450391289|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125209635|NCT04908475|450391290|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125209636|NCT04908475|450391291|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125209637|NCT04908475|450391286|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
125209638|NCT04908475|450391287|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
125209639|NCT04908475|450391288|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
125209640|NCT04908475|450391289|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
125209641|NCT04908475|450391290|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
125209642|NCT04908475|450391291|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
125209643|NCT04908475|450391286|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
125209644|NCT04908475|450391287|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
125209645|NCT04908475|450391288|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
125209646|NCT04908475|450391289|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
125209647|NCT04908475|450391290|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
125209648|NCT04908475|450391291|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
125209649|NCT04908475|450391286|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
125209650|NCT04908475|450391287|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
125209651|NCT04908475|450391288|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
125209652|NCT04908475|450391289|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
125209653|NCT04908475|450391290|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
125209654|NCT04908475|450391291|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
125209655|NCT04908475|450391286|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
125209656|NCT04908475|450391287|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
125209657|NCT04908475|450391288|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
125209658|NCT04908475|450391289|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
125209659|NCT04908475|450391290|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
125209660|NCT04908475|450391291|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
125209661|NCT04908475|450391286|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
125209662|NCT04908475|450391287|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
125209663|NCT04908475|450391288|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
125209664|NCT04908475|450391289|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
125209665|NCT04908475|450391290|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
125209666|NCT04908475|450391291|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
125209667|NCT00404924|450391292|FG000|Overall Study|Adverse Event|75|||
125209668|NCT00404924|450391293|FG001|Overall Study|Adverse Event|16|||
125209669|NCT00404924|450391292|FG000|Overall Study|Condition under investigation worsened|475|||
125209670|NCT00404924|450391293|FG001|Overall Study|Condition under investigation worsened|264|||
125209671|NCT00404924|450391292|FG000|Overall Study|Lost to Follow-up|1|||
125209672|NCT00404924|450391293|FG001|Overall Study|Lost to Follow-up|1|||
125209673|NCT00404924|450391292|FG000|Overall Study|Withdrawal by Subject|26|||
125209674|NCT00404924|450391293|FG001|Overall Study|Withdrawal by Subject|13|||
125209675|NCT00404924|450391292|FG000|Overall Study|Other|25|||
125209676|NCT00404924|450391293|FG001|Overall Study|Other|11|||
125209677|NCT00404924|450391292|FG000|Overall Study|Randomised but not received treatment|1|||
125209678|NCT00404924|450391293|FG001|Overall Study|Randomised but not received treatment|1|||
125209679|NCT03913104|450391296|FG000|Overall Study|Lost to Follow-up|20|||
125209680|NCT03913104|450391296|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
125209681|NCT03913104|450391296|FG000|Overall Study|Withdrawal by Subject|2|||
125209682|NCT00089635|450391297|FG000|Overall Study|Adverse Event|2|||
125209683|NCT00089635|450391297|FG000|Overall Study|Death|17|||
125209684|NCT00089635|450391297|FG000|Overall Study|Disease Progression|12|||
125209685|NCT00089635|450391297|FG000|Overall Study|Lost to Follow-up|3|||
125209686|NCT00089635|450391297|FG000|Overall Study|Withdrawal by Subject|6|||
125209687|NCT00089635|450391297|FG000|Overall Study|Ineligibility determined|1|||
125209688|NCT00089635|450391297|FG000|Overall Study|Other|2|||
125209689|NCT00821015|450391299|FG000|Overall Study|Lost to Follow-up|12|||
125209690|NCT01593254|450391305|FG000|Overall Study|Disease progression|2|||
125209691|NCT01593254|450391306|FG001|Overall Study|Disease progression|7|||
125209692|NCT01593254|450391305|FG000|Overall Study|Study drug toxicity|6|||
125209693|NCT01593254|450391306|FG001|Overall Study|Study drug toxicity|20|||
125209694|NCT01593254|450391305|FG000|Overall Study|Death|3|||
125209695|NCT01593254|450391306|FG001|Overall Study|Death|3|||
125209696|NCT01593254|450391305|FG000|Overall Study|AE unrelated to study drug|0|||
125209697|NCT01593254|450391306|FG001|Overall Study|AE unrelated to study drug|1|||
125209698|NCT01593254|450391305|FG000|Overall Study|participant request to discontinue study treatment|1|||
125209699|NCT01593254|450391306|FG001|Overall Study|participant request to discontinue study treatment|3|||
125209700|NCT01593254|450391305|FG000|Overall Study|participant withdrew consent|0|||
125209701|NCT01593254|450391306|FG001|Overall Study|participant withdrew consent|9|||
124982170|NCT01895101|449561287|FG001|Overall Study|OPCAB procedure|1|||
124982171|NCT01895101|449561288|FG002|Overall Study|OPCAB procedure|3|||
124982172|NCT01895101|449561286|FG000|Overall Study|Withdrawal by Subject|0|||
124982173|NCT01895101|449561287|FG001|Overall Study|Withdrawal by Subject|1|||
124982174|NCT01895101|449561288|FG002|Overall Study|Withdrawal by Subject|2|||
124982175|NCT01895101|449561286|FG000|Overall Study|another study, enrolled in other study|0|||
124982176|NCT01895101|449561287|FG001|Overall Study|another study, enrolled in other study|1|||
124982177|NCT01895101|449561288|FG002|Overall Study|another study, enrolled in other study|0|||
124982178|NCT01895101|449561286|FG000|Overall Study|Death|0|||
124982179|NCT01895101|449561287|FG001|Overall Study|Death|1|||
124982180|NCT01895101|449561288|FG002|Overall Study|Death|0|||
124982181|NCT01895101|449561286|FG000|Overall Study|coagulation disorder|0|||
124982182|NCT01895101|449561287|FG001|Overall Study|coagulation disorder|1|||
124982183|NCT01895101|449561288|FG002|Overall Study|coagulation disorder|0|||
124982184|NCT03339583|449561289|FG000|First Intervention (14 Days)|Adverse Event|1|||
124982185|NCT03339583|449561290|FG001|First Intervention (14 Days)|Adverse Event|0|||
124982186|NCT03339583|449561289|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
124982187|NCT03339583|449561290|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
124982188|NCT03339583|449561289|FG000|Second Intervention (14 Days)|Adverse Event|0|||
124982189|NCT03339583|449561290|FG001|Second Intervention (14 Days)|Adverse Event|1|||
124982190|NCT03339583|449561289|FG000|Follow-up (14 Days)|Physician Decision|6|||
124982191|NCT03339583|449561290|FG001|Follow-up (14 Days)|Physician Decision|3|||
124982192|NCT00734591|449561291|FG000|Screening for Prospective Period|Site did not participate|1604|||
124982193|NCT00734591|449561292|FG001|Screening for Prospective Period|Site did not participate|1488|||
124982194|NCT00734591|449561291|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
124982195|NCT00734591|449561292|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
124982196|NCT00734591|449561291|FG000|Prospective Period|Withdrawal by Subject|11|||
124982197|NCT00734591|449561292|FG001|Prospective Period|Withdrawal by Subject|9|||
124982198|NCT00734591|449561291|FG000|Prospective Period|Lost to Follow-up|37|||
124982199|NCT00734591|449561292|FG001|Prospective Period|Lost to Follow-up|33|||
124982200|NCT00734591|449561291|FG000|Prospective Period|Study Terminated|1|||
124982201|NCT00734591|449561292|FG001|Prospective Period|Study Terminated|0|||
124982202|NCT00734591|449561291|FG000|Prospective Period|Other|2|||
124982203|NCT00734591|449561292|FG001|Prospective Period|Other|2|||
124982204|NCT01659853|449561293|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
124982205|NCT01659853|449561294|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
124982206|NCT01659853|449561293|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
124982207|NCT01659853|449561294|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
124982208|NCT05560243|449561298|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
124982209|NCT00939822|449561303|FG000|Overall Study|Lost to Follow-up|1|||
124982210|NCT00939822|449561304|FG001|Overall Study|Lost to Follow-up|0|||
124982211|NCT00939822|449561303|FG000|Overall Study|withdrew from study due to busy schedule|1|||
124982212|NCT00939822|449561304|FG001|Overall Study|withdrew from study due to busy schedule|1|||
124982213|NCT00939822|449561303|FG000|Overall Study|Mental health issues|0|||
124982214|NCT00939822|449561304|FG001|Overall Study|Mental health issues|2|||
124982215|NCT01072630|449561307|FG000|Overall Study|Adverse Event|11|||
124982216|NCT01072630|449561308|FG001|Overall Study|Adverse Event|19|||
124982217|NCT01072630|449561309|FG002|Overall Study|Adverse Event|2|||
124982218|NCT01072630|449561307|FG000|Overall Study|Lack of Efficacy|10|||
124982219|NCT01072630|449561308|FG001|Overall Study|Lack of Efficacy|10|||
124982220|NCT01072630|449561309|FG002|Overall Study|Lack of Efficacy|1|||
124982221|NCT01072630|449561307|FG000|Overall Study|Withdrawal by Subject|8|||
124982222|NCT01072630|449561308|FG001|Overall Study|Withdrawal by Subject|7|||
125209702|NCT01593254|450391305|FG000|Overall Study|lost to follow up|1|||
125209703|NCT01593254|450391306|FG001|Overall Study|lost to follow up|6|||
124982223|NCT01072630|449561309|FG002|Overall Study|Withdrawal by Subject|2|||
124982224|NCT01072630|449561307|FG000|Overall Study|Protocol Violation|10|||
124982225|NCT01072630|449561308|FG001|Overall Study|Protocol Violation|8|||
124982226|NCT01072630|449561309|FG002|Overall Study|Protocol Violation|4|||
124982227|NCT01072630|449561307|FG000|Overall Study|Lost to Follow-up|11|||
124982228|NCT01072630|449561308|FG001|Overall Study|Lost to Follow-up|11|||
124982229|NCT01072630|449561309|FG002|Overall Study|Lost to Follow-up|1|||
124982230|NCT01072630|449561307|FG000|Overall Study|Noncompliance with study medication|1|||
124982231|NCT01072630|449561308|FG001|Overall Study|Noncompliance with study medication|1|||
125209704|NCT01593254|450391305|FG000|Overall Study|maximum clinical benefit|1|||
125209705|NCT01593254|450391306|FG001|Overall Study|maximum clinical benefit|2|||
125209706|NCT01593254|450391305|FG000|Overall Study|Poor/non compliance|1|||
125209707|NCT01593254|450391306|FG001|Overall Study|Poor/non compliance|1|||
125209708|NCT01593254|450391305|FG000|Overall Study|Pregnancy|0|||
125209709|NCT01593254|450391306|FG001|Overall Study|Pregnancy|3|||
125209710|NCT01593254|450391305|FG000|Overall Study|participant no longer meets study criteria|1|||
125209711|NCT01593254|450391306|FG001|Overall Study|participant no longer meets study criteria|1|||
125209712|NCT01593254|450391305|FG000|Overall Study|Admin reason by sponsor|7|||
125209713|NCT01593254|450391306|FG001|Overall Study|Admin reason by sponsor|3|||
125209714|NCT01593254|450391305|FG000|Overall Study|Imatinib treatment failure|2|||
125209715|NCT01593254|450391306|FG001|Overall Study|Imatinib treatment failure|0|||
125209716|NCT01593254|450391305|FG000|Overall Study|Other Reasons|61|||
125209717|NCT01593254|450391306|FG001|Overall Study|Other Reasons|115|||
125209718|NCT00076999|450391313|FG000|Overall Study|Adverse Event|2|||
125209719|NCT00076999|450391314|FG001|Overall Study|Adverse Event|8|||
125209720|NCT00076999|450391315|FG002|Overall Study|Adverse Event|6|||
125209721|NCT00076999|450391316|FG003|Overall Study|Adverse Event|0|||
125209722|NCT00076999|450391317|FG004|Overall Study|Adverse Event|2|||
125209723|NCT00076999|450391313|FG000|Overall Study|Protocol Violation|0|||
125209724|NCT00076999|450391314|FG001|Overall Study|Protocol Violation|3|||
125209725|NCT00076999|450391315|FG002|Overall Study|Protocol Violation|4|||
125209726|NCT00076999|450391316|FG003|Overall Study|Protocol Violation|0|||
125209727|NCT00076999|450391317|FG004|Overall Study|Protocol Violation|9|||
125209728|NCT00076999|450391313|FG000|Overall Study|Lost to Follow-up|2|||
125209729|NCT00076999|450391314|FG001|Overall Study|Lost to Follow-up|1|||
125209730|NCT00076999|450391315|FG002|Overall Study|Lost to Follow-up|0|||
125209731|NCT00076999|450391316|FG003|Overall Study|Lost to Follow-up|0|||
125209732|NCT00076999|450391317|FG004|Overall Study|Lost to Follow-up|0|||
125209733|NCT00076999|450391313|FG000|Overall Study|Withdrawal by Subject|0|||
125209734|NCT00076999|450391314|FG001|Overall Study|Withdrawal by Subject|4|||
125209735|NCT00076999|450391315|FG002|Overall Study|Withdrawal by Subject|3|||
125209736|NCT00076999|450391316|FG003|Overall Study|Withdrawal by Subject|0|||
125209737|NCT00076999|450391317|FG004|Overall Study|Withdrawal by Subject|1|||
125209738|NCT00076999|450391313|FG000|Overall Study|Other reason (not specified)|8|||
125209739|NCT00076999|450391314|FG001|Overall Study|Other reason (not specified)|8|||
125209740|NCT00076999|450391315|FG002|Overall Study|Other reason (not specified)|4|||
125209741|NCT00076999|450391316|FG003|Overall Study|Other reason (not specified)|1|||
125209742|NCT00076999|450391317|FG004|Overall Study|Other reason (not specified)|13|||
125209743|NCT01857102|450391319|FG000|Period 1|No longer meets Eligibility Criteria|0|||
125209744|NCT01857102|450391320|FG001|Period 1|No longer meets Eligibility Criteria|2|||
125209745|NCT01857102|450391319|FG000|Period 1|Lost to Follow-up|0|||
125209746|NCT01857102|450391320|FG001|Period 1|Lost to Follow-up|3|||
125209747|NCT01857102|450391319|FG000|Period 1|Unsatisfactory Lens Fit|1|||
125209748|NCT01857102|450391320|FG001|Period 1|Unsatisfactory Lens Fit|0|||
125209749|NCT01857102|450391319|FG000|Period 1|Unsatisfactory Visual Response|1|||
125209750|NCT01857102|450391320|FG001|Period 1|Unsatisfactory Visual Response|0|||
125209751|NCT01857102|450391319|FG000|Period 1|Physician Decision|1|||
125209752|NCT01857102|450391320|FG001|Period 1|Physician Decision|0|||
125311752|NCT03566082|450768817|FG000|Overall Study|Failures (revision required)|2|||
124982232|NCT01072630|449561309|FG002|Overall Study|Noncompliance with study medication|1|||
124982233|NCT01072630|449561307|FG000|Overall Study|Noncompliance with study procedures|1|||
124982234|NCT01072630|449561308|FG001|Overall Study|Noncompliance with study procedures|2|||
124982235|NCT01072630|449561309|FG002|Overall Study|Noncompliance with study procedures|1|||
124982236|NCT01072630|449561307|FG000|Overall Study|Other|3|||
124982237|NCT01072630|449561308|FG001|Overall Study|Other|2|||
124982238|NCT01072630|449561309|FG002|Overall Study|Other|1|||
124982239|NCT01232738|449561310|FG000|Overall Study|Death|3|||
124982240|NCT01232738|449561310|FG000|Overall Study|Physician Decision|2|||
124982241|NCT01232738|449561310|FG000|Overall Study|Lost to Follow-up|1|||
124982242|NCT01232738|449561310|FG000|Overall Study|Withdrawal by Subject|2|||
124982243|NCT01232738|449561310|FG000|Overall Study|Adverse Event|5|||
124982244|NCT00338962|449561311|FG000|Overall Study|Lost to Follow-up|3|||
124982245|NCT00338962|449561312|FG001|Overall Study|Lost to Follow-up|3|||
124982246|NCT00338962|449561313|FG002|Overall Study|Lost to Follow-up|2|||
124982247|NCT00338962|449561314|FG003|Overall Study|Lost to Follow-up|3|||
124982248|NCT00338962|449561311|FG000|Overall Study|Withdrawal by Subject|1|||
124982249|NCT00338962|449561312|FG001|Overall Study|Withdrawal by Subject|0|||
124982250|NCT00338962|449561313|FG002|Overall Study|Withdrawal by Subject|0|||
124982251|NCT00338962|449561314|FG003|Overall Study|Withdrawal by Subject|0|||
124982252|NCT00338962|449561311|FG000|Overall Study|No Transportation|2|||
124982253|NCT00338962|449561312|FG001|Overall Study|No Transportation|0|||
124982254|NCT00338962|449561313|FG002|Overall Study|No Transportation|0|||
124982255|NCT00338962|449561314|FG003|Overall Study|No Transportation|0|||
124982256|NCT00338962|449561311|FG000|Overall Study|Time Constraint|2|||
125209753|NCT01857102|450391319|FG000|Period 2|Lens Discomfort|1|||
125209754|NCT01857102|450391320|FG001|Period 2|Lens Discomfort|0|||
125209755|NCT01857102|450391319|FG000|Period 2|Unsatisfactory Lens Fit|1|||
125209756|NCT01857102|450391320|FG001|Period 2|Unsatisfactory Lens Fit|0|||
125209757|NCT02603562|450391325|FG000|Overall Study|Lost to Follow-up|1|||
125209758|NCT02117713|450391346|FG000|Week 48|Adverse Event|4|||
125209759|NCT02117713|450391346|FG000|Week 48|Withdrawal by caregiver|2|||
125209760|NCT02117713|450391346|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
125209761|NCT02117713|450391346|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
125209762|NCT02117713|450391346|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
125209763|NCT02117713|450391346|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
125209764|NCT00574795|450391347|FG000|Infant Series|Withdrawal by Subject|2|||
125209765|NCT00574795|450391347|FG000|Infant Series|Protocol Violation|2|||
125209766|NCT00574795|450391347|FG000|Infant Series|Adverse Event|1|||
125209767|NCT00574795|450391347|FG000|After Infant Series|Withdrawal by Subject|1|||
125209768|NCT00574795|450391347|FG000|After Infant Series|Adverse Event|2|||
125209769|NCT00574795|450391347|FG000|Toddler Dose|Withdrawal by Subject|1|||
125209770|NCT00467961|450391351|FG000|Overall Study|Technical Failures|5|||
125209771|NCT00467961|450391351|FG000|Overall Study|Disease Progression|2|||
125209772|NCT03417024|450391352|FG000|Overall Study|Study Termination prior to follow-up|11|||
125209773|NCT03417024|450391352|FG000|Overall Study|Physician Decision|2|||
125209774|NCT03168919|450391353|FG000|Overall Study|Withdrawal by Subject|2|||
125209775|NCT02195427|450391354|FG000|Overall Study|Did not consent to study extension|13|||
124982257|NCT00338962|449561312|FG001|Overall Study|Time Constraint|0|||
124982258|NCT00338962|449561313|FG002|Overall Study|Time Constraint|0|||
124982259|NCT00338962|449561314|FG003|Overall Study|Time Constraint|0|||
124982260|NCT00338962|449561311|FG000|Overall Study|Moved|0|||
124982261|NCT00338962|449561312|FG001|Overall Study|Moved|1|||
124982262|NCT00338962|449561313|FG002|Overall Study|Moved|0|||
124982263|NCT00338962|449561314|FG003|Overall Study|Moved|0|||
124982264|NCT00338962|449561311|FG000|Overall Study|Adverse Event|0|||
124982265|NCT00338962|449561312|FG001|Overall Study|Adverse Event|0|||
124982266|NCT00338962|449561313|FG002|Overall Study|Adverse Event|2|||
124982267|NCT00338962|449561314|FG003|Overall Study|Adverse Event|0|||
124982268|NCT00338962|449561311|FG000|Overall Study|Poor Compliance|0|||
124982269|NCT00338962|449561312|FG001|Overall Study|Poor Compliance|0|||
124982270|NCT00338962|449561313|FG002|Overall Study|Poor Compliance|2|||
124982271|NCT00338962|449561314|FG003|Overall Study|Poor Compliance|0|||
124982272|NCT03046121|449561315|FG000|Overall Study|Death|32|||
124982273|NCT03046121|449561316|FG001|Overall Study|Death|60|||
124982274|NCT03046121|449561315|FG000|Overall Study|Withdrawal by Subject|14|||
124982275|NCT03046121|449561316|FG001|Overall Study|Withdrawal by Subject|12|||
124982276|NCT03214640|449561317|FG000|Overall Study|Protocol Violation|1|||
124982277|NCT03214640|449561318|FG001|Overall Study|Protocol Violation|2|||
124982278|NCT03214640|449561319|FG002|Overall Study|Protocol Violation|1|||
124982279|NCT03214640|449561320|FG003|Overall Study|Protocol Violation|4|||
124982280|NCT00910039|449561321|FG000|Overall Study|Physician Decision|1|||
124982281|NCT04155047|449561327|FG000|Overall Study|Adverse Event|1|||
124982282|NCT04155047|449561328|FG001|Overall Study|Adverse Event|0|||
124982283|NCT04155047|449561327|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
124982284|NCT04155047|449561328|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
124982285|NCT01280357|449561336|FG000|Overall Study|Excluded no internal monitoring|14|||
124982286|NCT01280357|449561336|FG000|Overall Study|IInsufficient data/No data supplied|12|||
124982287|NCT00886795|449561337|FG000|Overall Study|Lack of Efficacy|1|||
124982288|NCT01259089|449561342|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
124982289|NCT01259089|449561343|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
124982290|NCT01259089|449561344|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
124982291|NCT01259089|449561345|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
124982292|NCT01259089|449561346|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
124982293|NCT01259089|449561347|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
124982294|NCT01259089|449561342|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
124982295|NCT01259089|449561343|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
124982296|NCT01259089|449561344|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
124982297|NCT01259089|449561345|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
124982298|NCT01259089|449561346|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
124982299|NCT01259089|449561347|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
124982300|NCT01259089|449561342|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
124982301|NCT01259089|449561343|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
124982302|NCT01259089|449561344|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
124982303|NCT01259089|449561345|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
124982304|NCT01259089|449561346|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
124982305|NCT01259089|449561347|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
124982306|NCT01259089|449561342|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
124982307|NCT01259089|449561343|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
124982308|NCT01259089|449561344|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
125209776|NCT02195427|450391355|FG001|Overall Study|Did not consent to study extension|9|||
125209777|NCT02195427|450391354|FG000|Overall Study|Withdrawal by Subject|4|||
125209778|NCT02195427|450391355|FG001|Overall Study|Withdrawal by Subject|2|||
125209779|NCT02195427|450391354|FG000|Overall Study|Lost to Follow-up|0|||
125209780|NCT02195427|450391355|FG001|Overall Study|Lost to Follow-up|1|||
125209781|NCT02195427|450391354|FG000|Overall Study|Protocol Violation|7|||
125209782|NCT02195427|450391355|FG001|Overall Study|Protocol Violation|14|||
125209783|NCT02195427|450391354|FG000|Overall Study|Conditional re-treatment at W52|2|||
125209784|NCT02195427|450391355|FG001|Overall Study|Conditional re-treatment at W52|1|||
125209785|NCT03403621|450391359|FG000|Overall Study|Withdrawal by Subject|2|||
125209786|NCT03403621|450391360|FG001|Overall Study|Withdrawal by Subject|2|||
125209787|NCT00422292|450391365|FG000|Overall Study|Serious adverse events|1|||
125209788|NCT00422292|450391366|FG001|Overall Study|Serious adverse events|4|||
125209789|NCT00422292|450391367|FG002|Overall Study|Serious adverse events|0|||
125209790|NCT00422292|450391368|FG003|Overall Study|Serious adverse events|0|||
125209791|NCT00422292|450391365|FG000|Overall Study|Adverse Event|1|||
125209792|NCT00422292|450391366|FG001|Overall Study|Adverse Event|0|||
125209793|NCT00422292|450391367|FG002|Overall Study|Adverse Event|1|||
125209794|NCT00422292|450391368|FG003|Overall Study|Adverse Event|0|||
125209795|NCT00422292|450391365|FG000|Overall Study|Protocol Violation|4|||
125209796|NCT00422292|450391366|FG001|Overall Study|Protocol Violation|25|||
125209797|NCT00422292|450391367|FG002|Overall Study|Protocol Violation|8|||
125209798|NCT00422292|450391368|FG003|Overall Study|Protocol Violation|5|||
125209799|NCT00422292|450391365|FG000|Overall Study|Lost to Follow-up|6|||
125209800|NCT00422292|450391366|FG001|Overall Study|Lost to Follow-up|12|||
125209801|NCT00422292|450391367|FG002|Overall Study|Lost to Follow-up|6|||
125209802|NCT00422292|450391368|FG003|Overall Study|Lost to Follow-up|6|||
125209803|NCT00422292|450391365|FG000|Overall Study|Withdrawal by Subject|6|||
125209804|NCT00422292|450391366|FG001|Overall Study|Withdrawal by Subject|25|||
125209805|NCT00422292|450391367|FG002|Overall Study|Withdrawal by Subject|7|||
125209806|NCT00422292|450391368|FG003|Overall Study|Withdrawal by Subject|13|||
125209807|NCT04607980|450391369|FG000|Overall Study|Adverse Event|3|||
125209808|NCT04607980|450391370|FG001|Overall Study|Adverse Event|4|||
125209809|NCT04607980|450391369|FG000|Overall Study|Death|0|||
125209810|NCT04607980|450391370|FG001|Overall Study|Death|1|||
125209811|NCT04607980|450391369|FG000|Overall Study|Withdrawal by Subject|2|||
125209812|NCT04607980|450391370|FG001|Overall Study|Withdrawal by Subject|5|||
125209813|NCT04607980|450391369|FG000|Overall Study|Lost to Follow-up|4|||
125209814|NCT04607980|450391370|FG001|Overall Study|Lost to Follow-up|8|||
125209815|NCT04607980|450391369|FG000|Overall Study|Protocol Violation|0|||
125209816|NCT04607980|450391370|FG001|Overall Study|Protocol Violation|3|||
125209817|NCT04607980|450391369|FG000|Overall Study|Other|3|||
125209818|NCT04607980|450391370|FG001|Overall Study|Other|0|||
125209819|NCT02824562|450393670|FG000|Overall Study|Lost to Follow-up|3|||
125209820|NCT02824562|450393671|FG001|Overall Study|Lost to Follow-up|4|||
125209821|NCT02824562|450393670|FG000|Overall Study|Death|0|||
125209822|NCT02824562|450393671|FG001|Overall Study|Death|1|||
125209823|NCT02168777|450393672|FG000|Overall Study|Withdrawal by Subject|1|||
125209824|NCT02168777|450393673|FG001|Overall Study|Withdrawal by Subject|0|||
125209825|NCT02168777|450393674|FG002|Overall Study|Withdrawal by Subject|2|||
125209826|NCT02168777|450393672|FG000|Overall Study|Adverse Event|1|||
125209827|NCT02168777|450393673|FG001|Overall Study|Adverse Event|0|||
125209828|NCT02168777|450393674|FG002|Overall Study|Adverse Event|1|||
125209829|NCT02168777|450393672|FG000|Overall Study|Disease recurrence|0|||
125209830|NCT02168777|450393673|FG001|Overall Study|Disease recurrence|0|||
125209831|NCT02168777|450393674|FG002|Overall Study|Disease recurrence|1|||
125209832|NCT02168777|450393672|FG000|Overall Study|Radiological disease progression|0|||
125209833|NCT02168777|450393673|FG001|Overall Study|Radiological disease progression|5|||
125209834|NCT02168777|450393674|FG002|Overall Study|Radiological disease progression|5|||
125209835|NCT02168777|450393672|FG000|Overall Study|Clinical disease progression|0|||
125209836|NCT02168777|450393673|FG001|Overall Study|Clinical disease progression|1|||
125209837|NCT02168777|450393674|FG002|Overall Study|Clinical disease progression|2|||
125311753|NCT03566082|450768817|FG000|Overall Study|Lost to Follow-up|8|||
125311754|NCT00983385|450768820|FG000|Observation Period|Not eligible to be dosed|20|||
125311755|NCT00983385|450768820|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
125311756|NCT01279681|450768822|FG000|Overall Study|Disease Progression|9|||
125311757|NCT01279681|450768823|FG001|Overall Study|Disease Progression|6|||
125311758|NCT01279681|450768822|FG000|Overall Study|Withdrawal by Subject|3|||
125311759|NCT01279681|450768823|FG001|Overall Study|Withdrawal by Subject|4|||
125311760|NCT01279681|450768822|FG000|Overall Study|Adverse Event|2|||
125311761|NCT01279681|450768823|FG001|Overall Study|Adverse Event|3|||
125311762|NCT01279681|450768822|FG000|Overall Study|Death|0|||
125311763|NCT01279681|450768823|FG001|Overall Study|Death|1|||
124872186|NCT03092375|449154035|FG001|Overall Study|Lack of Efficacy|1|||
124872187|NCT03092375|449154036|FG002|Overall Study|Lack of Efficacy|1|||
124872188|NCT03092375|449154037|FG003|Overall Study|Lack of Efficacy|0|||
125209838|NCT02168777|450393672|FG000|Overall Study|Other reason|0|||
125209839|NCT02168777|450393673|FG001|Overall Study|Other reason|1|||
125209840|NCT02168777|450393674|FG002|Overall Study|Other reason|0|||
125209841|NCT05243563|450393675|FG000|Overall Study|Withdrawal by Subject|1|||
125209842|NCT05243563|450393676|FG001|Overall Study|Withdrawal by Subject|0|||
125209843|NCT05243563|450393675|FG000|Overall Study|Physician Decision|1|||
125209844|NCT05243563|450393676|FG001|Overall Study|Physician Decision|0|||
124982309|NCT01259089|449561345|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
125209845|NCT03774394|450393682|FG000|Overall Study|Withdrawal by Subject|2|||
125209846|NCT03774394|450393683|FG001|Overall Study|Withdrawal by Subject|0|||
124872189|NCT00553501|449154042|FG000|Overall Study|Adverse Event|2|||
124872190|NCT00553501|449154042|FG000|Overall Study|Death|1|||
124872191|NCT00553501|449154042|FG000|Overall Study|Progression|1|||
124872192|NCT02293395|449154043|FG000|Overall Study|Lost to Follow-up|1|||
124872193|NCT02293395|449154044|FG001|Overall Study|Lost to Follow-up|0|||
124872194|NCT02293395|449154043|FG000|Overall Study|Withdrawal by Subject|8|||
124872195|NCT02293395|449154044|FG001|Overall Study|Withdrawal by Subject|7|||
124872196|NCT00224770|449154048|FG000|Overall Study|Lost to Follow-up|4|||
124872197|NCT00224770|449154049|FG001|Overall Study|Lost to Follow-up|2|||
124872198|NCT00224770|449154050|FG002|Overall Study|Lost to Follow-up|0|||
124872199|NCT00861614|449154051|FG000|Overall Study|Disease Progression|182|||
124872200|NCT00861614|449154052|FG001|Overall Study|Disease Progression|263|||
124872201|NCT00861614|449154051|FG000|Overall Study|Study Drug Toxicity|79|||
124872202|NCT00861614|449154052|FG001|Overall Study|Study Drug Toxicity|6|||
124872203|NCT00861614|449154051|FG000|Overall Study|Death|32|||
124872204|NCT00861614|449154052|FG001|Overall Study|Death|19|||
124872205|NCT00861614|449154051|FG000|Overall Study|Adverse Event|27|||
124872206|NCT00861614|449154052|FG001|Overall Study|Adverse Event|23|||
124872207|NCT00861614|449154051|FG000|Overall Study|Withdrawal by Subject|34|||
124872208|NCT00861614|449154052|FG001|Overall Study|Withdrawal by Subject|35|||
124872209|NCT00861614|449154051|FG000|Overall Study|Other|17|||
124872210|NCT00861614|449154052|FG001|Overall Study|Other|22|||
124872211|NCT03391765|449154053|FG000|Overall Study|Adverse Event|2|||
124872212|NCT03391765|449154054|FG001|Overall Study|Adverse Event|0|||
124872213|NCT03391765|449154055|FG002|Overall Study|Adverse Event|0|||
124872214|NCT03391765|449154056|FG003|Overall Study|Adverse Event|2|||
124872215|NCT03391765|449154053|FG000|Overall Study|Withdrew consent|5|||
124872216|NCT03391765|449154054|FG001|Overall Study|Withdrew consent|7|||
124872217|NCT03391765|449154055|FG002|Overall Study|Withdrew consent|2|||
124872218|NCT03391765|449154056|FG003|Overall Study|Withdrew consent|5|||
124872219|NCT03391765|449154053|FG000|Overall Study|Other, not specified|44|||
124872220|NCT03391765|449154054|FG001|Overall Study|Other, not specified|38|||
124872221|NCT03391765|449154055|FG002|Overall Study|Other, not specified|21|||
124872222|NCT03391765|449154056|FG003|Overall Study|Other, not specified|16|||
124872223|NCT01255592|449154057|FG000|Overall Study|Adverse Event|5|||
124872224|NCT01255592|449154058|FG001|Overall Study|Adverse Event|0|||
124872225|NCT01255592|449154057|FG000|Overall Study|Withdrawal by Subject|1|||
124872226|NCT01255592|449154058|FG001|Overall Study|Withdrawal by Subject|0|||
124872227|NCT01255592|449154057|FG000|Overall Study|Other|0|||
124872228|NCT01255592|449154058|FG001|Overall Study|Other|1|||
124872229|NCT02035332|449154059|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
124872230|NCT00838682|449154061|FG000|Overall Study|Lost to Follow-up|21|||
124872231|NCT00838682|449154062|FG001|Overall Study|Lost to Follow-up|14|||
124872232|NCT00838682|449154061|FG000|Overall Study|detection of exclusion criteria|4|||
124872233|NCT00838682|449154062|FG001|Overall Study|detection of exclusion criteria|3|||
124872234|NCT00838682|449154061|FG000|Overall Study|Protocol Violation|0|||
124872235|NCT00838682|449154062|FG001|Overall Study|Protocol Violation|1|||
124872236|NCT00838682|449154061|FG000|Overall Study|Withdrawal by Subject|0|||
124872237|NCT00838682|449154062|FG001|Overall Study|Withdrawal by Subject|1|||
124872238|NCT03315143|449154068|FG000|Overall Study|Death|240|||
124872239|NCT03315143|449154069|FG001|Overall Study|Death|246|||
124872240|NCT03315143|449154068|FG000|Overall Study|Withdrawal by Subject|57|||
124872241|NCT03315143|449154069|FG001|Overall Study|Withdrawal by Subject|68|||
124872242|NCT03315143|449154068|FG000|Overall Study|Site Terminated by Sponsor|256|||
124872243|NCT03315143|449154069|FG001|Overall Study|Site Terminated by Sponsor|282|||
124872244|NCT03315143|449154068|FG000|Overall Study|Study Terminated by Sponsor|4723|||
124872245|NCT03315143|449154069|FG001|Overall Study|Study Terminated by Sponsor|4664|||
124872246|NCT03315143|449154068|FG000|Overall Study|Reason not Specified|16|||
124872247|NCT03315143|449154069|FG001|Overall Study|Reason not Specified|32|||
124872248|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
124872249|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
124872250|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
124872251|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
124872252|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
124872253|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
124872254|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
124872255|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
124872256|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
124872257|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
124872258|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
124872259|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
124872260|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
124982310|NCT01259089|449561346|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
124982311|NCT01259089|449561347|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
124982312|NCT01259089|449561342|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
124982313|NCT01259089|449561343|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
124982314|NCT01259089|449561344|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
124982315|NCT01259089|449561345|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
124982316|NCT01259089|449561346|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
124982317|NCT01259089|449561347|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
124982318|NCT01259089|449561342|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
124982319|NCT01259089|449561343|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
124982320|NCT01259089|449561344|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
124982321|NCT01259089|449561345|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
124982322|NCT01259089|449561346|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
124982323|NCT01259089|449561347|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
124982324|NCT01259089|449561342|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
124982325|NCT01259089|449561343|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
124982326|NCT01259089|449561344|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
124982327|NCT01259089|449561345|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
124982328|NCT01259089|449561346|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
124982329|NCT01259089|449561347|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
124982330|NCT01259089|449561342|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
124982331|NCT01259089|449561343|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
124982332|NCT01259089|449561344|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
124982333|NCT01259089|449561345|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
124982334|NCT01259089|449561346|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
124982335|NCT01259089|449561347|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
124982336|NCT01259089|449561342|FG000|Survival Follow up for Two Years|Death|3|||
124982337|NCT01259089|449561343|FG001|Survival Follow up for Two Years|Death|2|||
124982338|NCT01259089|449561344|FG002|Survival Follow up for Two Years|Death|2|||
124982339|NCT01259089|449561345|FG003|Survival Follow up for Two Years|Death|3|||
124982340|NCT01259089|449561346|FG004|Survival Follow up for Two Years|Death|6|||
124982341|NCT01259089|449561347|FG005|Survival Follow up for Two Years|Death|13|||
124982342|NCT01259089|449561342|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
124982343|NCT01259089|449561343|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
124982344|NCT01259089|449561344|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
124982345|NCT01259089|449561345|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
124982346|NCT01259089|449561346|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
124982347|NCT01259089|449561347|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
124982348|NCT01259089|449561342|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
124982349|NCT01259089|449561343|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
124982350|NCT01259089|449561344|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
124982351|NCT01259089|449561345|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
124982352|NCT01259089|449561346|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
124982353|NCT01259089|449561347|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
124982354|NCT02310100|449561348|FG000|Overall Study|Physician Decision|3|||
124982355|NCT02310100|449561348|FG000|Overall Study|Withdrawal by Subject|10|||
124982356|NCT02310100|449561348|FG000|Overall Study|Enrollment closure|1|||
124982357|NCT02310100|449561348|FG000|Overall Study|Unapproved ablation operator|1|||
124982358|NCT02310100|449561348|FG000|Overall Study|Visit compliance|1|||
124982359|NCT02310100|449561348|FG000|Overall Study|Lost to Follow-up|2|||
124982360|NCT00688870|449561349|FG000|Infant Series|Parent or legal guardian request|4|||
124982361|NCT00688870|449561350|FG001|Infant Series|Parent or legal guardian request|0|||
124982362|NCT01253018|449561361|FG000|Overall Study|Lost to Follow-up|1|||
124982363|NCT01253018|449561362|FG001|Overall Study|Lost to Follow-up|1|||
124982364|NCT01253018|449561361|FG000|Overall Study|Robot Repair Issues|2|||
124982365|NCT01253018|449561362|FG001|Overall Study|Robot Repair Issues|0|||
124982366|NCT01253018|449561361|FG000|Overall Study|Withdrawal by Subject|1|||
124982367|NCT01253018|449561362|FG001|Overall Study|Withdrawal by Subject|1|||
124982368|NCT03449901|449561363|FG000|Overall Study|Progression|57|||
124982369|NCT03449901|449561364|FG001|Overall Study|Progression|12|||
124982370|NCT03449901|449561363|FG000|Overall Study|Adverse Event|3|||
124982371|NCT03449901|449561364|FG001|Overall Study|Adverse Event|0|||
124982372|NCT03449901|449561363|FG000|Overall Study|Death|6|||
125209847|NCT02697916|450393684|FG000|Overall Study|Death|357|||
125209848|NCT02697916|450393685|FG001|Overall Study|Death|315|||
124982373|NCT03449901|449561364|FG001|Overall Study|Death|2|||
124982374|NCT03449901|449561363|FG000|Overall Study|Withdrawal by Subject|12|||
124982375|NCT03449901|449561364|FG001|Overall Study|Withdrawal by Subject|1|||
124982376|NCT03449901|449561363|FG000|Overall Study|Physician Decision|1|||
125209849|NCT02697916|450393684|FG000|Overall Study|Withdrawal by Subject|221|||
125209850|NCT02697916|450393685|FG001|Overall Study|Withdrawal by Subject|393|||
125209851|NCT03334422|450393686|FG000|Overall Study|Adverse Event|1|||
125209852|NCT03334422|450393687|FG001|Overall Study|Adverse Event|3|||
125209853|NCT03334422|450393688|FG002|Overall Study|Adverse Event|2|||
125209854|NCT03334422|450393689|FG003|Overall Study|Adverse Event|2|||
125209855|NCT03334422|450393686|FG000|Overall Study|Lack of Efficacy|10|||
125209856|NCT03334422|450393687|FG001|Overall Study|Lack of Efficacy|2|||
125209857|NCT03334422|450393688|FG002|Overall Study|Lack of Efficacy|7|||
125209858|NCT03334422|450393689|FG003|Overall Study|Lack of Efficacy|3|||
125209859|NCT03334422|450393686|FG000|Overall Study|Withdrawal by Subject|8|||
125209860|NCT03334422|450393687|FG001|Overall Study|Withdrawal by Subject|3|||
125209861|NCT03334422|450393688|FG002|Overall Study|Withdrawal by Subject|1|||
125209862|NCT03334422|450393689|FG003|Overall Study|Withdrawal by Subject|0|||
125209863|NCT03334422|450393686|FG000|Overall Study|Lost to Follow-up|0|||
125209864|NCT03334422|450393687|FG001|Overall Study|Lost to Follow-up|0|||
124982377|NCT03449901|449561364|FG001|Overall Study|Physician Decision|0|||
124982378|NCT03449901|449561363|FG000|Overall Study|Patient elected for surgical intervention|1|||
124982379|NCT03449901|449561364|FG001|Overall Study|Patient elected for surgical intervention|0|||
125209865|NCT03334422|450393688|FG002|Overall Study|Lost to Follow-up|0|||
125209866|NCT03334422|450393689|FG003|Overall Study|Lost to Follow-up|1|||
125209867|NCT03334422|450393686|FG000|Overall Study|Inability to obtain laboratory samples|0|||
125209868|NCT03334422|450393687|FG001|Overall Study|Inability to obtain laboratory samples|1|||
125209869|NCT03334422|450393688|FG002|Overall Study|Inability to obtain laboratory samples|0|||
125209870|NCT03334422|450393689|FG003|Overall Study|Inability to obtain laboratory samples|0|||
125209871|NCT03334422|450393686|FG000|Overall Study|Pregnancy|0|||
125209872|NCT03334422|450393687|FG001|Overall Study|Pregnancy|1|||
125209873|NCT03334422|450393688|FG002|Overall Study|Pregnancy|0|||
125209874|NCT03334422|450393689|FG003|Overall Study|Pregnancy|0|||
125209875|NCT01313221|450393692|FG000|Overall Study|Protocol Violation|0|||
125209876|NCT01313221|450393693|FG001|Overall Study|Protocol Violation|1|||
125209877|NCT01313221|450393694|FG002|Overall Study|Protocol Violation|1|||
125209878|NCT01313221|450393692|FG000|Overall Study|Non-compliance|3|||
125209879|NCT01313221|450393693|FG001|Overall Study|Non-compliance|0|||
125209880|NCT01313221|450393694|FG002|Overall Study|Non-compliance|2|||
125209881|NCT01313221|450393692|FG000|Overall Study|Withdrawal by Subject|2|||
125209882|NCT01313221|450393693|FG001|Overall Study|Withdrawal by Subject|3|||
125209883|NCT01313221|450393694|FG002|Overall Study|Withdrawal by Subject|5|||
125209884|NCT01313221|450393692|FG000|Overall Study|Requirement for alternative therapy|0|||
125209885|NCT01313221|450393693|FG001|Overall Study|Requirement for alternative therapy|1|||
125209886|NCT01313221|450393694|FG002|Overall Study|Requirement for alternative therapy|1|||
125209887|NCT01313221|450393692|FG000|Overall Study|Lost to Follow-up|6|||
125209888|NCT01313221|450393693|FG001|Overall Study|Lost to Follow-up|3|||
125209889|NCT01313221|450393694|FG002|Overall Study|Lost to Follow-up|1|||
125209890|NCT01313221|450393692|FG000|Overall Study|Other|1|||
125209891|NCT01313221|450393693|FG001|Overall Study|Other|0|||
125209892|NCT01313221|450393694|FG002|Overall Study|Other|0|||
125209893|NCT01313221|450393692|FG000|Overall Study|Adverse Event|0|||
125209894|NCT01313221|450393693|FG001|Overall Study|Adverse Event|0|||
125209895|NCT01313221|450393694|FG002|Overall Study|Adverse Event|7|||
125209896|NCT01313221|450393692|FG000|Overall Study|Disease progression|0|||
125209897|NCT01313221|450393693|FG001|Overall Study|Disease progression|0|||
125209898|NCT01313221|450393694|FG002|Overall Study|Disease progression|2|||
124982380|NCT03449901|449561363|FG000|Overall Study|Patient off for other complicating disease|1|||
124982381|NCT03449901|449561364|FG001|Overall Study|Patient off for other complicating disease|0|||
124982382|NCT03466073|449561365|FG000|Overall Study|Death|1|||
124982383|NCT03466073|449561366|FG001|Overall Study|Death|0|||
124982384|NCT03466073|449561367|FG002|Overall Study|Death|0|||
124982385|NCT03466073|449561368|FG003|Overall Study|Death|0|||
124982386|NCT03466073|449561369|FG004|Overall Study|Death|0|||
124982387|NCT03466073|449561370|FG005|Overall Study|Death|1|||
124982388|NCT00744757|449561371|FG000|Overall Study|Objective disease progression|7|||
124982389|NCT00744757|449561371|FG000|Overall Study|Physician Decision|5|||
124982390|NCT00744757|449561371|FG000|Overall Study|Withdrawal by Subject|1|||
124982391|NCT00744757|449561371|FG000|Overall Study|Death|6|||
125209899|NCT01313221|450393692|FG000|Overall Study|Physician Decision|0|||
124982392|NCT00744757|449561371|FG000|Overall Study|Adverse Event|2|||
124982393|NCT03682302|449561372|FG000|Overall Study|Lost to Follow-up|1|||
124982394|NCT03682302|449561373|FG001|Overall Study|Lost to Follow-up|2|||
124982395|NCT03682302|449561374|FG002|Overall Study|Lost to Follow-up|0|||
125209900|NCT01313221|450393693|FG001|Overall Study|Physician Decision|0|||
125209901|NCT01313221|450393694|FG002|Overall Study|Physician Decision|2|||
125209902|NCT01313221|450393692|FG000|Overall Study|Pregnancy|0|||
125209903|NCT01313221|450393693|FG001|Overall Study|Pregnancy|0|||
125209904|NCT01313221|450393694|FG002|Overall Study|Pregnancy|2|||
125209905|NCT00994214|450393695|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
125209906|NCT00994214|450393696|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
125209907|NCT00994214|450393697|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
125209908|NCT00994214|450393698|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
125209909|NCT00994214|450393695|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
125209910|NCT00994214|450393696|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
125209911|NCT00994214|450393697|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
125209912|NCT00994214|450393698|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
125209913|NCT00994214|450393695|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
125209914|NCT00994214|450393696|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
125209915|NCT00994214|450393697|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
125209916|NCT00994214|450393698|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
125209917|NCT00994214|450393695|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
125209918|NCT00994214|450393696|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
125209919|NCT00994214|450393697|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
125209920|NCT00994214|450393698|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
125209921|NCT00994214|450393695|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
125209922|NCT00994214|450393696|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
125209923|NCT00994214|450393697|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
125209924|NCT00994214|450393698|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
125209925|NCT00994214|450393695|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
125209926|NCT00994214|450393696|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
125209927|NCT00994214|450393697|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
125209928|NCT00994214|450393698|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
125209929|NCT01698268|450393702|FG000|Overall Study|Physician Decision|2|||
125209930|NCT01698268|450393703|FG001|Overall Study|Physician Decision|1|||
125209931|NCT02864316|450393704|FG000|Overall Study|Progressive Disease|2|||
125209932|NCT02864316|450393705|FG001|Overall Study|Progressive Disease|1|||
125209933|NCT02864316|450393704|FG000|Overall Study|Adverse Event|0|||
125209934|NCT02864316|450393705|FG001|Overall Study|Adverse Event|1|||
125209935|NCT00298363|450393706|FG000|Overall Study|Lost to Follow-up|0|||
125209936|NCT00298363|450393707|FG001|Overall Study|Lost to Follow-up|0|||
125209937|NCT00298363|450393708|FG002|Overall Study|Lost to Follow-up|1|||
125209938|NCT00298363|450393706|FG000|Overall Study|Physician Decision|4|||
125209939|NCT00298363|450393707|FG001|Overall Study|Physician Decision|1|||
125209940|NCT00298363|450393708|FG002|Overall Study|Physician Decision|0|||
125209941|NCT00298363|450393706|FG000|Overall Study|Protocol Violation|1|||
125209942|NCT00298363|450393707|FG001|Overall Study|Protocol Violation|1|||
125209943|NCT00298363|450393708|FG002|Overall Study|Protocol Violation|0|||
125209944|NCT00298363|450393706|FG000|Overall Study|Withdrawal by Subject|5|||
125209945|NCT00298363|450393707|FG001|Overall Study|Withdrawal by Subject|1|||
125209946|NCT00298363|450393708|FG002|Overall Study|Withdrawal by Subject|3|||
125209947|NCT00298363|450393706|FG000|Overall Study|Adverse Event|5|||
125209948|NCT00298363|450393707|FG001|Overall Study|Adverse Event|2|||
125209949|NCT00298363|450393708|FG002|Overall Study|Adverse Event|2|||
125209950|NCT00298363|450393706|FG000|Overall Study|Lack of Efficacy|2|||
125209951|NCT00298363|450393707|FG001|Overall Study|Lack of Efficacy|3|||
125209952|NCT00298363|450393708|FG002|Overall Study|Lack of Efficacy|0|||
125209953|NCT04710368|450393709|FG000|Overall Study|Withdrawal by Subject|9|||
125209954|NCT04710368|450393709|FG000|Overall Study|Lost to Follow-up|4|||
125209955|NCT04710368|450393709|FG000|Overall Study|Death|2|||
125209956|NCT04710368|450393709|FG000|Overall Study|Patient preference|11|||
125209957|NCT04710368|450393709|FG000|Overall Study|Treatment discontinuation|1|||
125209958|NCT00135356|450393710|FG000|Overall Study|Adverse Event|6|||
125209959|NCT00135356|450393711|FG001|Overall Study|Adverse Event|2|||
125209960|NCT00135356|450393710|FG000|Overall Study|Lack of Efficacy|2|||
125209961|NCT00135356|450393711|FG001|Overall Study|Lack of Efficacy|0|||
125209962|NCT00135356|450393710|FG000|Overall Study|Lost to Follow-up|3|||
125209963|NCT00135356|450393711|FG001|Overall Study|Lost to Follow-up|1|||
125209964|NCT00135356|450393710|FG000|Overall Study|Surgery for abdominal fat|1|||
125209965|NCT00135356|450393711|FG001|Overall Study|Surgery for abdominal fat|0|||
125209966|NCT00135356|450393710|FG000|Overall Study|Change in antiviral regimen|0|||
125209967|NCT00135356|450393711|FG001|Overall Study|Change in antiviral regimen|1|||
125209968|NCT00135356|450393710|FG000|Overall Study|Poor/noncompliance|1|||
125209969|NCT00135356|450393711|FG001|Overall Study|Poor/noncompliance|1|||
125209970|NCT00135356|450393710|FG000|Overall Study|No longer meets study criteria|2|||
125209971|NCT00135356|450393711|FG001|Overall Study|No longer meets study criteria|0|||
125209972|NCT00135356|450393710|FG000|Overall Study|Withdrawal by Subject|2|||
125209973|NCT00135356|450393711|FG001|Overall Study|Withdrawal by Subject|4|||
125209974|NCT00153816|450393712|FG000|Overall Study|Death|6|||
125209975|NCT00153816|450393713|FG001|Overall Study|Death|5|||
125209976|NCT00153816|450393714|FG002|Overall Study|Death|4|||
125209977|NCT00153816|450393715|FG003|Overall Study|Death|6|||
125209978|NCT00153816|450393716|FG004|Overall Study|Death|0|||
125209979|NCT00153816|450393717|FG005|Overall Study|Death|2|||
125209980|NCT00153816|450393712|FG000|Overall Study|Lost to Follow-up|7|||
125209981|NCT00153816|450393713|FG001|Overall Study|Lost to Follow-up|8|||
125209982|NCT00153816|450393714|FG002|Overall Study|Lost to Follow-up|5|||
124982396|NCT03682302|449561375|FG003|Overall Study|Lost to Follow-up|1|||
124982397|NCT03682302|449561372|FG000|Overall Study|Study drug was not administered|0|||
124982398|NCT03682302|449561373|FG001|Overall Study|Study drug was not administered|0|||
124982399|NCT03682302|449561374|FG002|Overall Study|Study drug was not administered|1|||
124982400|NCT03682302|449561375|FG003|Overall Study|Study drug was not administered|1|||
124982401|NCT03309813|449561378|FG000|Main Randomized Study|Withdrawal by Subject|1|||
124982402|NCT03309813|449561379|FG001|Main Randomized Study|Withdrawal by Subject|0|||
124982403|NCT00658788|449561380|FG000|Overall Study|Adverse Event|11|||
124982404|NCT00658788|449561380|FG000|Overall Study|Withdrawal by Subject|13|||
124982405|NCT00658788|449561380|FG000|Overall Study|Lost to Follow-up|18|||
124982406|NCT00658788|449561380|FG000|Overall Study|Treatment Discontinuation|32|||
124982407|NCT00653523|449561381|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
124982408|NCT00653523|449561381|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
124982409|NCT00653523|449561381|FG000|Overall Study|Adverse Event|7|||
124982410|NCT00653523|449561381|FG000|Overall Study|Withdrawal by Subject|6|||
124982411|NCT00653523|449561381|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
124982412|NCT00653523|449561381|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
124982413|NCT05384938|449561382|FG000|Overall Study|Withdrawal by Subject|8|||
124982414|NCT05384938|449561382|FG000|Overall Study|Lost to Follow-up|6|||
124982415|NCT05384938|449561382|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
125209983|NCT00153816|450393715|FG003|Overall Study|Lost to Follow-up|8|||
125209984|NCT00153816|450393716|FG004|Overall Study|Lost to Follow-up|7|||
125209985|NCT00153816|450393717|FG005|Overall Study|Lost to Follow-up|9|||
125209986|NCT00153816|450393712|FG000|Overall Study|Withdrawal by Subject|9|||
125209987|NCT00153816|450393713|FG001|Overall Study|Withdrawal by Subject|9|||
125209988|NCT00153816|450393714|FG002|Overall Study|Withdrawal by Subject|9|||
125209989|NCT00153816|450393715|FG003|Overall Study|Withdrawal by Subject|4|||
125209990|NCT00153816|450393716|FG004|Overall Study|Withdrawal by Subject|1|||
125209991|NCT00153816|450393717|FG005|Overall Study|Withdrawal by Subject|5|||
125209992|NCT00153816|450393712|FG000|Overall Study|Follow-up exam not done|8|||
125209993|NCT00153816|450393713|FG001|Overall Study|Follow-up exam not done|7|||
125209994|NCT00153816|450393714|FG002|Overall Study|Follow-up exam not done|11|||
125209995|NCT00153816|450393715|FG003|Overall Study|Follow-up exam not done|10|||
125209996|NCT00153816|450393716|FG004|Overall Study|Follow-up exam not done|8|||
125209997|NCT00153816|450393717|FG005|Overall Study|Follow-up exam not done|9|||
125209998|NCT00153816|450393712|FG000|Overall Study|Follow-up exam done, histology missing|2|||
125209999|NCT00153816|450393713|FG001|Overall Study|Follow-up exam done, histology missing|3|||
125210000|NCT00153816|450393714|FG002|Overall Study|Follow-up exam done, histology missing|3|||
125210001|NCT00153816|450393715|FG003|Overall Study|Follow-up exam done, histology missing|3|||
125210002|NCT00153816|450393716|FG004|Overall Study|Follow-up exam done, histology missing|1|||
125210003|NCT00153816|450393717|FG005|Overall Study|Follow-up exam done, histology missing|2|||
125210004|NCT01887288|450393722|FG000|Overall Study|The study was terminated and the PI has|16|||
125210005|NCT00253370|450393725|FG000|Overall Study|Adverse Event|18|||
125210006|NCT00253370|450393725|FG000|Overall Study|Disease progression|13|||
125210007|NCT00253370|450393725|FG000|Overall Study|Death|2|||
125210008|NCT00253370|450393725|FG000|Overall Study|Withdrawal by Subject|6|||
125210009|NCT00253370|450393725|FG000|Overall Study|Non-protocol therapy|1|||
125210010|NCT00253370|450393725|FG000|Overall Study|Physician Decision|1|||
125210011|NCT00253370|450393725|FG000|Overall Study|Protocol Violation|1|||
125210012|NCT00253370|450393725|FG000|Overall Study|Abdominal pain due to disease|1|||
125210013|NCT05916131|450393726|FG000|Overall Study|Lost to Follow-up|0|||
125210014|NCT05916131|450393727|FG001|Overall Study|Lost to Follow-up|0|||
125210015|NCT05916131|450393728|FG002|Overall Study|Lost to Follow-up|1|||
125210016|NCT05916131|450393729|FG003|Overall Study|Lost to Follow-up|0|||
125210017|NCT01211483|450393739|FG000|Phase 1b|Death|6|||
125210018|NCT01211483|450393740|FG001|Phase 1b|Death|0|||
125210019|NCT01211483|450393741|FG002|Phase 1b|Death|0|||
125210020|NCT01211483|450393742|FG003|Phase 1b|Death|0|||
125210021|NCT01211483|450393739|FG000|Phase 1b|Withdrawal by Subject|1|||
125210022|NCT01211483|450393740|FG001|Phase 1b|Withdrawal by Subject|0|||
125210023|NCT01211483|450393741|FG002|Phase 1b|Withdrawal by Subject|0|||
125210024|NCT01211483|450393742|FG003|Phase 1b|Withdrawal by Subject|0|||
125210025|NCT01211483|450393739|FG000|Phase 2|Lost to Follow-up|0|||
125210026|NCT01211483|450393740|FG001|Phase 2|Lost to Follow-up|1|||
125210027|NCT01211483|450393741|FG002|Phase 2|Lost to Follow-up|1|||
125210028|NCT01211483|450393742|FG003|Phase 2|Lost to Follow-up|2|||
125210029|NCT01211483|450393739|FG000|Phase 2|Death|0|||
125210030|NCT01211483|450393740|FG001|Phase 2|Death|64|||
125210031|NCT01211483|450393741|FG002|Phase 2|Death|53|||
125210032|NCT01211483|450393742|FG003|Phase 2|Death|53|||
125210033|NCT01211483|450393739|FG000|Phase 2|Withdrawal by Subject|0|||
125210034|NCT01211483|450393740|FG001|Phase 2|Withdrawal by Subject|1|||
125210035|NCT01211483|450393741|FG002|Phase 2|Withdrawal by Subject|10|||
125210036|NCT01211483|450393742|FG003|Phase 2|Withdrawal by Subject|5|||
125210037|NCT01211483|450393739|FG000|Phase 2|Study terminated by Sponsor|0|||
125210038|NCT01211483|450393740|FG001|Phase 2|Study terminated by Sponsor|6|||
125210039|NCT01211483|450393741|FG002|Phase 2|Study terminated by Sponsor|8|||
125210040|NCT01211483|450393742|FG003|Phase 2|Study terminated by Sponsor|11|||
125210041|NCT01398410|450393744|FG000|Overall Study|Adverse Event|12|||
125210042|NCT01398410|450393745|FG001|Overall Study|Adverse Event|16|||
125210043|NCT01398410|450393744|FG000|Overall Study|Participants Choice|8|||
125210044|NCT01398410|450393745|FG001|Overall Study|Participants Choice|11|||
125210045|NCT01398410|450393744|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
125210046|NCT01398410|450393745|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
125210047|NCT01398410|450393744|FG000|Overall Study|Other|36|||
125210048|NCT01398410|450393745|FG001|Overall Study|Other|29|||
125210049|NCT04245202|450393746|FG000|Overall Study|Lack of Efficacy|10|||
125210050|NCT04245202|450393747|FG001|Overall Study|Lack of Efficacy|1|||
125210051|NCT02470403|450393748|FG000|Overall Study|Adverse Event|1|||
125210052|NCT02470403|450393749|FG001|Overall Study|Adverse Event|0|||
125210053|NCT02470403|450393750|FG002|Overall Study|Adverse Event|0|||
125210054|NCT02470403|450393751|FG003|Overall Study|Adverse Event|0|||
125210055|NCT02470403|450393752|FG004|Overall Study|Adverse Event|0|||
125210056|NCT02470403|450393748|FG000|Overall Study|Lost to Follow-up|0|||
124872261|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
124872262|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
124872263|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
124872264|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
124872265|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
124872266|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
124872267|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
124872268|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
124872269|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
125210057|NCT02470403|450393749|FG001|Overall Study|Lost to Follow-up|1|||
125210058|NCT02470403|450393750|FG002|Overall Study|Lost to Follow-up|0|||
125210059|NCT02470403|450393751|FG003|Overall Study|Lost to Follow-up|0|||
125210060|NCT02470403|450393752|FG004|Overall Study|Lost to Follow-up|0|||
125210061|NCT02470403|450393748|FG000|Overall Study|Subject/guardian decision|1|||
125210062|NCT02470403|450393749|FG001|Overall Study|Subject/guardian decision|0|||
125210063|NCT02470403|450393750|FG002|Overall Study|Subject/guardian decision|0|||
125210064|NCT02470403|450393751|FG003|Overall Study|Subject/guardian decision|4|||
125210065|NCT02470403|450393752|FG004|Overall Study|Subject/guardian decision|0|||
125210066|NCT00904839|450393759|FG000|Overall Study|Adverse Event|0|||
125210067|NCT00904839|450393760|FG001|Overall Study|Adverse Event|5|||
125210068|NCT00904839|450393761|FG002|Overall Study|Adverse Event|4|||
125210069|NCT00904839|450393759|FG000|Overall Study|Protocol Violation|0|||
125210070|NCT00904839|450393760|FG001|Overall Study|Protocol Violation|1|||
125210071|NCT00904839|450393761|FG002|Overall Study|Protocol Violation|1|||
125210072|NCT00904839|450393759|FG000|Overall Study|Lost to Follow-up|0|||
125210073|NCT00904839|450393760|FG001|Overall Study|Lost to Follow-up|1|||
125210074|NCT00904839|450393761|FG002|Overall Study|Lost to Follow-up|2|||
125210075|NCT00904839|450393759|FG000|Overall Study|Withdrawal by Subject|0|||
125210076|NCT00904839|450393760|FG001|Overall Study|Withdrawal by Subject|2|||
125210077|NCT00904839|450393761|FG002|Overall Study|Withdrawal by Subject|0|||
125210078|NCT00904839|450393759|FG000|Overall Study|Not treated|1|||
125210079|NCT00904839|450393760|FG001|Overall Study|Not treated|0|||
125210080|NCT00904839|450393761|FG002|Overall Study|Not treated|1|||
125210081|NCT00904839|450393759|FG000|Overall Study|Other than above|0|||
125210082|NCT00904839|450393760|FG001|Overall Study|Other than above|9|||
125210083|NCT00904839|450393761|FG002|Overall Study|Other than above|7|||
125210084|NCT01430624|450393762|FG000|Overall Study|Lost to Follow-up|23|||
125210085|NCT01430624|450393763|FG001|Overall Study|Lost to Follow-up|29|||
125210086|NCT01430624|450393764|FG002|Overall Study|Lost to Follow-up|27|||
125210087|NCT01430624|450393762|FG000|Overall Study|technical or eligibility|5|||
125210088|NCT01430624|450393763|FG001|Overall Study|technical or eligibility|5|||
125210089|NCT01430624|450393764|FG002|Overall Study|technical or eligibility|2|||
125210090|NCT01167634|450393769|FG000|Overall Study|Lost to Follow-up|1|||
125210091|NCT01167634|450393770|FG001|Overall Study|Lost to Follow-up|3|||
125210092|NCT01167634|450393771|FG002|Overall Study|Lost to Follow-up|3|||
125210093|NCT01167634|450393772|FG003|Overall Study|Lost to Follow-up|4|||
125210094|NCT01167634|450393769|FG000|Overall Study|Withdrawal by Subject|1|||
125210095|NCT01167634|450393770|FG001|Overall Study|Withdrawal by Subject|1|||
125210096|NCT01167634|450393771|FG002|Overall Study|Withdrawal by Subject|0|||
125210097|NCT01167634|450393772|FG003|Overall Study|Withdrawal by Subject|0|||
125210098|NCT00553358|450393773|FG000|Overall Study|Randomized but did not receive treatment|3|||
125210099|NCT00553358|450393774|FG001|Overall Study|Randomized but did not receive treatment|3|||
125210100|NCT00553358|450393775|FG002|Overall Study|Randomized but did not receive treatment|1|||
125210101|NCT00553358|450393773|FG000|Overall Study|Lost to Follow-up|22|||
125210102|NCT00553358|450393774|FG001|Overall Study|Lost to Follow-up|26|||
125210103|NCT00553358|450393775|FG002|Overall Study|Lost to Follow-up|18|||
125210104|NCT00553358|450393773|FG000|Overall Study|Withdrew completely|23|||
125210105|NCT00553358|450393774|FG001|Overall Study|Withdrew completely|33|||
125210106|NCT00553358|450393775|FG002|Overall Study|Withdrew completely|34|||
125210107|NCT00553358|450393773|FG000|Overall Study|Died during clinical follow-up|25|||
125210108|NCT00553358|450393774|FG001|Overall Study|Died during clinical follow-up|29|||
125210109|NCT00553358|450393775|FG002|Overall Study|Died during clinical follow-up|32|||
125210110|NCT00553358|450393773|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
125210111|NCT00553358|450393774|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
125210112|NCT00553358|450393775|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
125210113|NCT00553358|450393773|FG000|Overall Study|Died after clinical follow-up ended|1|||
125210114|NCT00553358|450393774|FG001|Overall Study|Died after clinical follow-up ended|2|||
125210115|NCT00553358|450393775|FG002|Overall Study|Died after clinical follow-up ended|0|||
125210116|NCT00553358|450393773|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
125210117|NCT00553358|450393774|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
125210118|NCT00553358|450393775|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
125210119|NCT01074255|450393780|FG000|Overall Study|Did not receive EMEND|2|||
125210120|NCT02943785|450393781|FG000|Overall Study|Adverse Event|112|||
125210121|NCT02943785|450393782|FG001|Overall Study|Adverse Event|97|||
125210122|NCT02943785|450393781|FG000|Overall Study|Withdrawal by Subject|63|||
125210123|NCT02943785|450393782|FG001|Overall Study|Withdrawal by Subject|126|||
125210124|NCT02943785|450393781|FG000|Overall Study|Physician Decision|23|||
125210125|NCT02943785|450393782|FG001|Overall Study|Physician Decision|47|||
125210126|NCT02943785|450393781|FG000|Overall Study|Death|46|||
125210127|NCT02943785|450393782|FG001|Overall Study|Death|46|||
125210128|NCT02943785|450393781|FG000|Overall Study|Lost to Follow-up|1|||
125210129|NCT02943785|450393782|FG001|Overall Study|Lost to Follow-up|0|||
125210130|NCT02943785|450393781|FG000|Overall Study|Other|16|||
125210131|NCT02943785|450393782|FG001|Overall Study|Other|19|||
125210132|NCT02943785|450393781|FG000|Overall Study|Did not receive any study medication|21|||
125210133|NCT02943785|450393782|FG001|Overall Study|Did not receive any study medication|28|||
125210134|NCT01281956|450393785|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
125210135|NCT01281956|450393786|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
125210136|NCT03170609|450393787|FG000|Overall Study|Death|0|||
125210137|NCT03170609|450393788|FG001|Overall Study|Death|0|||
125210138|NCT03170609|450393789|FG002|Overall Study|Death|1|||
125210139|NCT03170609|450393790|FG003|Overall Study|Death|0|||
125210140|NCT03170609|450393791|FG004|Overall Study|Death|0|||
125210141|NCT03170609|450393792|FG005|Overall Study|Death|0|||
125210142|NCT03170609|450393793|FG006|Overall Study|Death|0|||
125210143|NCT03170609|450393787|FG000|Overall Study|Withdrawal by Subject|1|||
125210144|NCT03170609|450393788|FG001|Overall Study|Withdrawal by Subject|2|||
125210145|NCT03170609|450393789|FG002|Overall Study|Withdrawal by Subject|0|||
125210146|NCT03170609|450393790|FG003|Overall Study|Withdrawal by Subject|0|||
125210147|NCT03170609|450393791|FG004|Overall Study|Withdrawal by Subject|0|||
125210148|NCT03170609|450393792|FG005|Overall Study|Withdrawal by Subject|0|||
125210149|NCT03170609|450393793|FG006|Overall Study|Withdrawal by Subject|1|||
125210150|NCT03170609|450393787|FG000|Overall Study|Lost to Follow-up|1|||
125210151|NCT03170609|450393788|FG001|Overall Study|Lost to Follow-up|0|||
125210152|NCT03170609|450393789|FG002|Overall Study|Lost to Follow-up|5|||
125210153|NCT03170609|450393790|FG003|Overall Study|Lost to Follow-up|2|||
125210154|NCT03170609|450393791|FG004|Overall Study|Lost to Follow-up|1|||
125210155|NCT03170609|450393792|FG005|Overall Study|Lost to Follow-up|1|||
125210156|NCT03170609|450393793|FG006|Overall Study|Lost to Follow-up|0|||
125210157|NCT03170609|450393787|FG000|Overall Study|Other|1|||
125210158|NCT03170609|450393788|FG001|Overall Study|Other|0|||
125210159|NCT03170609|450393789|FG002|Overall Study|Other|0|||
125210160|NCT03170609|450393790|FG003|Overall Study|Other|0|||
125210161|NCT03170609|450393791|FG004|Overall Study|Other|0|||
125210162|NCT03170609|450393792|FG005|Overall Study|Other|1|||
125210163|NCT03170609|450393793|FG006|Overall Study|Other|0|||
125210164|NCT01490697|450393795|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
125210165|NCT01490697|450393796|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
125210166|NCT00090584|450393797|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
125210167|NCT00090584|450393798|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
125210168|NCT00090584|450393797|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
125210169|NCT00090584|450393798|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
125210170|NCT00270231|450393799|FG000|First Intervention|Lost to Follow-up|1|||
125210171|NCT00270231|450393800|FG001|First Intervention|Lost to Follow-up|1|||
125210172|NCT00270231|450393799|FG000|Washout Period|Lost to Follow-up|1|||
125210173|NCT00270231|450393800|FG001|Washout Period|Lost to Follow-up|0|||
125210174|NCT00270231|450393799|FG000|Second Intervention|Lost to Follow-up|0|||
125210175|NCT00270231|450393800|FG001|Second Intervention|Lost to Follow-up|1|||
125210176|NCT01969084|450393801|FG000|Overall Study|Adverse Event|0|||
125210177|NCT01969084|450393802|FG001|Overall Study|Adverse Event|1|||
125210178|NCT04776018|450393805|FG000|Overall Study|Death|0|||
125210179|NCT04776018|450393806|FG001|Overall Study|Death|1|||
125210180|NCT04776018|450393807|FG002|Overall Study|Death|4|||
125210181|NCT04776018|450393808|FG003|Overall Study|Death|1|||
125210182|NCT04776018|450393809|FG004|Overall Study|Death|4|||
125210183|NCT04776018|450393810|FG005|Overall Study|Death|0|||
125210184|NCT04776018|450393811|FG006|Overall Study|Death|0|||
125210185|NCT04776018|450393805|FG000|Overall Study|Study terminated by sponsor|2|||
125210186|NCT04776018|450393806|FG001|Overall Study|Study terminated by sponsor|1|||
125210187|NCT04776018|450393807|FG002|Overall Study|Study terminated by sponsor|4|||
125210188|NCT04776018|450393808|FG003|Overall Study|Study terminated by sponsor|0|||
125210189|NCT04776018|450393809|FG004|Overall Study|Study terminated by sponsor|3|||
125210190|NCT04776018|450393810|FG005|Overall Study|Study terminated by sponsor|0|||
125210191|NCT04776018|450393811|FG006|Overall Study|Study terminated by sponsor|0|||
125210192|NCT04776018|450393805|FG000|Overall Study|Withdrawal by Subject|1|||
125210193|NCT04776018|450393806|FG001|Overall Study|Withdrawal by Subject|0|||
125210194|NCT04776018|450393807|FG002|Overall Study|Withdrawal by Subject|0|||
125210195|NCT04776018|450393808|FG003|Overall Study|Withdrawal by Subject|2|||
125210196|NCT04776018|450393809|FG004|Overall Study|Withdrawal by Subject|1|||
125210197|NCT04776018|450393810|FG005|Overall Study|Withdrawal by Subject|0|||
125210198|NCT04776018|450393811|FG006|Overall Study|Withdrawal by Subject|0|||
125210199|NCT04776018|450393805|FG000|Overall Study|Other|0|||
125210200|NCT04776018|450393806|FG001|Overall Study|Other|1|||
125210201|NCT04776018|450393807|FG002|Overall Study|Other|1|||
125210202|NCT04776018|450393808|FG003|Overall Study|Other|0|||
125210203|NCT04776018|450393809|FG004|Overall Study|Other|0|||
125210204|NCT04776018|450393810|FG005|Overall Study|Other|0|||
125210205|NCT04776018|450393811|FG006|Overall Study|Other|0|||
125210206|NCT04776018|450393805|FG000|Overall Study|Lost to Follow-up|0|||
125210207|NCT04776018|450393806|FG001|Overall Study|Lost to Follow-up|0|||
125210208|NCT04776018|450393807|FG002|Overall Study|Lost to Follow-up|1|||
125210209|NCT04776018|450393808|FG003|Overall Study|Lost to Follow-up|0|||
125210210|NCT04776018|450393809|FG004|Overall Study|Lost to Follow-up|0|||
125210211|NCT04776018|450393810|FG005|Overall Study|Lost to Follow-up|0|||
125210212|NCT04776018|450393811|FG006|Overall Study|Lost to Follow-up|0|||
125210213|NCT02908074|450393813|FG000|Overall Study|sponsor/ICON decision|0|||
125210214|NCT02908074|450393814|FG001|Overall Study|sponsor/ICON decision|0|||
125210215|NCT02908074|450393815|FG002|Overall Study|sponsor/ICON decision|1|||
125210216|NCT02908074|450393816|FG003|Overall Study|sponsor/ICON decision|0|||
125210217|NCT02908074|450393817|FG004|Overall Study|sponsor/ICON decision|0|||
125210218|NCT02908074|450393818|FG005|Overall Study|sponsor/ICON decision|0|||
125210219|NCT02908074|450393813|FG000|Overall Study|Protocol Violation|0|||
125210220|NCT02908074|450393814|FG001|Overall Study|Protocol Violation|1|||
125210221|NCT02908074|450393815|FG002|Overall Study|Protocol Violation|0|||
125210222|NCT02908074|450393816|FG003|Overall Study|Protocol Violation|0|||
125210223|NCT02908074|450393817|FG004|Overall Study|Protocol Violation|0|||
125210224|NCT02908074|450393818|FG005|Overall Study|Protocol Violation|0|||
125210225|NCT02908074|450393813|FG000|Overall Study|Adverse Event|5|||
125210226|NCT02908074|450393814|FG001|Overall Study|Adverse Event|2|||
125210227|NCT02908074|450393815|FG002|Overall Study|Adverse Event|0|||
125210228|NCT02908074|450393816|FG003|Overall Study|Adverse Event|0|||
125210229|NCT02908074|450393817|FG004|Overall Study|Adverse Event|1|||
125210230|NCT02908074|450393818|FG005|Overall Study|Adverse Event|0|||
125210231|NCT02908074|450393813|FG000|Overall Study|AESI|1|||
125210232|NCT02908074|450393814|FG001|Overall Study|AESI|0|||
125210233|NCT02908074|450393815|FG002|Overall Study|AESI|1|||
125210234|NCT02908074|450393816|FG003|Overall Study|AESI|0|||
125210235|NCT02908074|450393817|FG004|Overall Study|AESI|1|||
125210236|NCT02908074|450393818|FG005|Overall Study|AESI|0|||
125210237|NCT02908074|450393813|FG000|Overall Study|Discontinuation criteria per protocol|0|||
125210238|NCT02908074|450393814|FG001|Overall Study|Discontinuation criteria per protocol|0|||
125210239|NCT02908074|450393815|FG002|Overall Study|Discontinuation criteria per protocol|1|||
125210240|NCT02908074|450393816|FG003|Overall Study|Discontinuation criteria per protocol|0|||
125210241|NCT02908074|450393817|FG004|Overall Study|Discontinuation criteria per protocol|0|||
125210242|NCT02908074|450393818|FG005|Overall Study|Discontinuation criteria per protocol|1|||
125210243|NCT02908074|450393813|FG000|Overall Study|Withdrawal by Subject|3|||
125210244|NCT02908074|450393814|FG001|Overall Study|Withdrawal by Subject|2|||
125210245|NCT02908074|450393815|FG002|Overall Study|Withdrawal by Subject|2|||
125210246|NCT02908074|450393816|FG003|Overall Study|Withdrawal by Subject|2|||
125210247|NCT02908074|450393817|FG004|Overall Study|Withdrawal by Subject|2|||
125210248|NCT02908074|450393818|FG005|Overall Study|Withdrawal by Subject|2|||
125210249|NCT02908074|450393813|FG000|Overall Study|Lost to Follow-up|0|||
125210250|NCT02908074|450393814|FG001|Overall Study|Lost to Follow-up|1|||
125210251|NCT02908074|450393815|FG002|Overall Study|Lost to Follow-up|1|||
125210252|NCT02908074|450393816|FG003|Overall Study|Lost to Follow-up|1|||
125210253|NCT02908074|450393817|FG004|Overall Study|Lost to Follow-up|0|||
125210254|NCT02908074|450393818|FG005|Overall Study|Lost to Follow-up|1|||
125210255|NCT02655419|450393823|FG000|Overall Study|Enrolled but not treated|1|||
125210256|NCT02655419|450393824|FG001|Overall Study|Enrolled but not treated|5|||
125210257|NCT02655419|450393823|FG000|Overall Study|Withdrawal by Subject|4|||
125210258|NCT02655419|450393824|FG001|Overall Study|Withdrawal by Subject|1|||
125210259|NCT02655419|450393823|FG000|Overall Study|Other|0|||
125210260|NCT02655419|450393824|FG001|Overall Study|Other|1|||
125210261|NCT03053427|450393825|FG000|Overall Study|Adverse Event|4|||
125210262|NCT03053427|450393826|FG001|Overall Study|Adverse Event|4|||
125210263|NCT03053427|450393825|FG000|Overall Study|Lack of Efficacy|1|||
125210264|NCT03053427|450393826|FG001|Overall Study|Lack of Efficacy|3|||
125210265|NCT03053427|450393825|FG000|Overall Study|Lost to Follow-up|2|||
125210266|NCT03053427|450393826|FG001|Overall Study|Lost to Follow-up|2|||
125210267|NCT03053427|450393825|FG000|Overall Study|Worsening of the target disease|0|||
125210268|NCT03053427|450393826|FG001|Overall Study|Worsening of the target disease|1|||
125210269|NCT03053427|450393825|FG000|Overall Study|Protocol Deviation|3|||
125210270|NCT03053427|450393826|FG001|Overall Study|Protocol Deviation|3|||
125210271|NCT03053427|450393825|FG000|Overall Study|Withdrawal by Subject|3|||
125210272|NCT03053427|450393826|FG001|Overall Study|Withdrawal by Subject|2|||
125210273|NCT03053427|450393825|FG000|Overall Study|Miscellaneous|0|||
125210274|NCT03053427|450393826|FG001|Overall Study|Miscellaneous|1|||
125210275|NCT02172040|450393827|FG000|Overall Study|Adverse Event|0|||
125210276|NCT02172040|450393828|FG001|Overall Study|Adverse Event|2|||
125210277|NCT02172040|450393829|FG002|Overall Study|Adverse Event|0|||
125210278|NCT02172040|450393830|FG003|Overall Study|Adverse Event|0|||
125210279|NCT02172040|450393827|FG000|Overall Study|Protocol Violation|0|||
125210280|NCT02172040|450393828|FG001|Overall Study|Protocol Violation|1|||
125210281|NCT02172040|450393829|FG002|Overall Study|Protocol Violation|0|||
125210282|NCT02172040|450393830|FG003|Overall Study|Protocol Violation|0|||
125210283|NCT02172040|450393827|FG000|Overall Study|Withdrawal by Subject|0|||
125210284|NCT02172040|450393828|FG001|Overall Study|Withdrawal by Subject|0|||
125210285|NCT02172040|450393829|FG002|Overall Study|Withdrawal by Subject|1|||
125210286|NCT02172040|450393830|FG003|Overall Study|Withdrawal by Subject|0|||
125210287|NCT02172040|450393827|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
125210288|NCT02172040|450393828|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
125210289|NCT02172040|450393829|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
125210290|NCT02172040|450393830|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
125210291|NCT02172040|450393827|FG000|Overall Study|Family emergency abroad|0|||
125210292|NCT02172040|450393828|FG001|Overall Study|Family emergency abroad|0|||
125210293|NCT02172040|450393829|FG002|Overall Study|Family emergency abroad|0|||
125210294|NCT02172040|450393830|FG003|Overall Study|Family emergency abroad|1|||
125210295|NCT02607306|450393833|FG000|Overall Study|Adverse Event|8|||
125210296|NCT02607306|450393834|FG001|Overall Study|Adverse Event|6|||
125210297|NCT02607306|450393835|FG002|Overall Study|Adverse Event|6|||
125210298|NCT02607306|450393833|FG000|Overall Study|Unclassified|1|||
125210299|NCT02607306|450393834|FG001|Overall Study|Unclassified|4|||
125210300|NCT02607306|450393835|FG002|Overall Study|Unclassified|0|||
124872270|NCT00549757|449154070|FG000|Extension Period (in Average 9 Months)|Death|143|||
124872271|NCT00549757|449154071|FG001|Extension Period (in Average 9 Months)|Death|136|||
124872272|NCT00549757|449154070|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
124872273|NCT00549757|449154071|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
124872274|NCT00549757|449154070|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
124872275|NCT00549757|449154071|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
124872276|NCT00549757|449154070|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
124872277|NCT00549757|449154071|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
124872278|NCT02641392|449154072|FG000|Overall Study|Lost to Follow-up|0|||
124872279|NCT02641392|449154073|FG001|Overall Study|Lost to Follow-up|0|||
124872280|NCT02641392|449154074|FG002|Overall Study|Lost to Follow-up|2|||
124872281|NCT02641392|449154072|FG000|Overall Study|Withdrawal by Subject|0|||
124872282|NCT02641392|449154073|FG001|Overall Study|Withdrawal by Subject|0|||
124872283|NCT02641392|449154074|FG002|Overall Study|Withdrawal by Subject|17|||
124872284|NCT02641392|449154072|FG000|Overall Study|Adverse Event|0|||
124872285|NCT02641392|449154073|FG001|Overall Study|Adverse Event|1|||
124872286|NCT02641392|449154074|FG002|Overall Study|Adverse Event|25|||
124872287|NCT02641392|449154072|FG000|Overall Study|Study Terminated by Sponsor|4|||
124872288|NCT02641392|449154073|FG001|Overall Study|Study Terminated by Sponsor|12|||
124872289|NCT02641392|449154074|FG002|Overall Study|Study Terminated by Sponsor|144|||
124872290|NCT02641392|449154072|FG000|Overall Study|Lack of Efficacy|0|||
124872291|NCT02641392|449154073|FG001|Overall Study|Lack of Efficacy|0|||
124872292|NCT02641392|449154074|FG002|Overall Study|Lack of Efficacy|101|||
124872293|NCT02641392|449154072|FG000|Overall Study|Miscellaneous|0|||
124872294|NCT02641392|449154073|FG001|Overall Study|Miscellaneous|0|||
124872295|NCT02641392|449154074|FG002|Overall Study|Miscellaneous|3|||
124872296|NCT02641392|449154072|FG000|Overall Study|Death|0|||
124872297|NCT02641392|449154073|FG001|Overall Study|Death|0|||
124872298|NCT02641392|449154074|FG002|Overall Study|Death|1|||
124872299|NCT04067401|449154075|FG000|Overall Study|Withdrawal by Subject|7|||
124872300|NCT04067401|449154076|FG001|Overall Study|Withdrawal by Subject|0|||
124872301|NCT04067401|449154075|FG000|Overall Study|no data provided|1|||
124872302|NCT04067401|449154076|FG001|Overall Study|no data provided|0|||
124872303|NCT01477853|449154077|FG000|Phase A|Adverse Event|1|||
124872304|NCT01477853|449154078|FG001|Phase A|Adverse Event|2|||
124872305|NCT01477853|449154079|FG002|Phase A|Adverse Event|2|||
125210301|NCT02607306|450393833|FG000|Overall Study|Withdrawal by Subject|8|||
125210302|NCT02607306|450393834|FG001|Overall Study|Withdrawal by Subject|10|||
125210303|NCT02607306|450393835|FG002|Overall Study|Withdrawal by Subject|2|||
125210304|NCT02607306|450393833|FG000|Overall Study|Lack of Efficacy|0|||
125210305|NCT02607306|450393834|FG001|Overall Study|Lack of Efficacy|1|||
125210306|NCT02607306|450393835|FG002|Overall Study|Lack of Efficacy|1|||
125210307|NCT02607306|450393833|FG000|Overall Study|Protocol Violation|4|||
125210308|NCT02607306|450393834|FG001|Overall Study|Protocol Violation|2|||
125210309|NCT02607306|450393835|FG002|Overall Study|Protocol Violation|1|||
125210310|NCT03759366|450393836|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
125210311|NCT03759366|450393836|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
125210312|NCT03759366|450393836|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
125210313|NCT03759366|450393836|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
125210314|NCT03759366|450393836|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
125210315|NCT03759366|450393836|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
125210316|NCT03759366|450393836|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
125210317|NCT00597012|450393837|FG000|Overall Study|Death|1|||
125210318|NCT00597012|450393838|FG001|Overall Study|Death|1|||
125210319|NCT00597012|450393837|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
125210320|NCT00597012|450393838|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
125210321|NCT00597012|450393837|FG000|Overall Study|Withdrawal by Subject|7|||
125210322|NCT00597012|450393838|FG001|Overall Study|Withdrawal by Subject|4|||
125210323|NCT00597012|450393837|FG000|Overall Study|Ineligible|2|||
125210324|NCT00597012|450393838|FG001|Overall Study|Ineligible|0|||
125210325|NCT00597012|450393837|FG000|Overall Study|Lost to Follow-up|0|||
125210326|NCT00597012|450393838|FG001|Overall Study|Lost to Follow-up|2|||
125210327|NCT04226495|450393839|FG000|Overall Study|Withdrawal by Subject|3|||
125210328|NCT04226495|450393840|FG001|Overall Study|Withdrawal by Subject|3|||
125210329|NCT04226495|450393839|FG000|Overall Study|PI discretion|3|||
125210330|NCT04226495|450393840|FG001|Overall Study|PI discretion|4|||
125210331|NCT00583102|450393841|FG000|Overall Study|Adverse Event|3|||
125210332|NCT00505661|450393844|FG000|Overall Study|Not Eligible|4|||
125210333|NCT03611582|450393845|FG000|Overall Study|Adverse Event|26|||
125210334|NCT03611582|450393846|FG001|Overall Study|Adverse Event|6|||
125210335|NCT03611582|450393845|FG000|Overall Study|Protocol Violation|0|||
125210336|NCT03611582|450393846|FG001|Overall Study|Protocol Violation|1|||
125210337|NCT03611582|450393845|FG000|Overall Study|Pregnancy|1|||
125210338|NCT03611582|450393846|FG001|Overall Study|Pregnancy|2|||
125210339|NCT03611582|450393845|FG000|Overall Study|Lack of Efficacy|0|||
125210340|NCT03611582|450393846|FG001|Overall Study|Lack of Efficacy|1|||
125210341|NCT03611582|450393845|FG000|Overall Study|At the discretion of the investigator|1|||
125210342|NCT03611582|450393846|FG001|Overall Study|At the discretion of the investigator|0|||
125210343|NCT03611582|450393845|FG000|Overall Study|Safety concern as judged by the investigator|1|||
125210344|NCT03611582|450393846|FG001|Overall Study|Safety concern as judged by the investigator|2|||
125210345|NCT03611582|450393845|FG000|Overall Study|Withdrawal by Subject|4|||
125210346|NCT03611582|450393846|FG001|Overall Study|Withdrawal by Subject|3|||
125210347|NCT03611582|450393845|FG000|Overall Study|Lost to Follow-up|18|||
125210348|NCT03611582|450393846|FG001|Overall Study|Lost to Follow-up|7|||
125210349|NCT03611582|450393845|FG000|Overall Study|other|17|||
125210350|NCT03611582|450393846|FG001|Overall Study|other|16|||
125210351|NCT04459598|450393847|FG000|Overall Study|Adverse Event|1|||
125210352|NCT04459598|450393848|FG001|Overall Study|Adverse Event|1|||
125210353|NCT01078298|450393849|FG000|Overall Study|Lost to Follow-up|12|||
125210354|NCT01078298|450393850|FG001|Overall Study|Lost to Follow-up|13|||
125210355|NCT01078298|450393849|FG000|Overall Study|Withdrawal by Subject|31|||
125210356|NCT01078298|450393850|FG001|Overall Study|Withdrawal by Subject|33|||
125210357|NCT01078298|450393849|FG000|Overall Study|Protocol Violation|6|||
125210358|NCT01078298|450393850|FG001|Overall Study|Protocol Violation|6|||
125210359|NCT01078298|450393849|FG000|Overall Study|Adverse Event|6|||
125210360|NCT01078298|450393850|FG001|Overall Study|Adverse Event|5|||
125210361|NCT01078298|450393849|FG000|Overall Study|Death|2|||
125210362|NCT01078298|450393850|FG001|Overall Study|Death|0|||
125210363|NCT01078298|450393849|FG000|Overall Study|Did not meet entrance criteria|0|||
125210364|NCT01078298|450393850|FG001|Overall Study|Did not meet entrance criteria|1|||
125210365|NCT01078298|450393849|FG000|Overall Study|Other|24|||
125210366|NCT01078298|450393850|FG001|Overall Study|Other|32|||
125210367|NCT00463840|450393851|FG000|Overall Study|Disease progression|7|||
125210368|NCT00463840|450393851|FG000|Overall Study|Withdrawal by Subject|2|||
125210369|NCT00463840|450393851|FG000|Overall Study|Adverse Event|3|||
125311764|NCT01279681|450768822|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
125311765|NCT01279681|450768823|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
125311766|NCT01279681|450768822|FG000|Overall Study|Physician Decision|1|||
125311767|NCT01279681|450768823|FG001|Overall Study|Physician Decision|0|||
125311768|NCT01279681|450768822|FG000|Overall Study|Other Reason|0|||
125311769|NCT01279681|450768823|FG001|Overall Study|Other Reason|2|||
125311770|NCT01467505|450770575|FG000|Overall Study|Adverse Event|1|||
125311771|NCT01467505|450770576|FG001|Overall Study|Adverse Event|0|||
125311772|NCT01467505|450770575|FG000|Overall Study|Withdrawal by Subject|4|||
125311773|NCT01467505|450770576|FG001|Overall Study|Withdrawal by Subject|0|||
125311774|NCT01467505|450770575|FG000|Overall Study|Study Terminated by Sponsor|28|||
125311775|NCT01467505|450770576|FG001|Overall Study|Study Terminated by Sponsor|3|||
125311776|NCT02807623|450770577|FG000|Overall Study|Lost to Follow-up|23|||
125311777|NCT02807623|450770578|FG001|Overall Study|Lost to Follow-up|18|||
125311778|NCT02807623|450770579|FG002|Overall Study|Lost to Follow-up|22|||
125311779|NCT02807623|450770577|FG000|Overall Study|Drug intolerance|0|||
125311780|NCT02807623|450770578|FG001|Overall Study|Drug intolerance|1|||
125311781|NCT02807623|450770579|FG002|Overall Study|Drug intolerance|0|||
125311782|NCT02807623|450770577|FG000|Overall Study|incomplete blood draw|0|||
125311783|NCT02807623|450770578|FG001|Overall Study|incomplete blood draw|2|||
125311784|NCT02807623|450770579|FG002|Overall Study|incomplete blood draw|1|||
125311785|NCT02098746|450770580|FG000|Overall Study|Changes of Investigator|2|||
125311786|NCT02098746|450770580|FG000|Overall Study|Other Miscellaneous Reasons|1|||
125311787|NCT02098746|450770580|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
125311788|NCT02098746|450770580|FG000|Overall Study|Data Not Available After Treatment|1|||
125311789|NCT00217425|450770581|FG000|Overall Study|Never started treatment|2|||
125311790|NCT00217425|450770581|FG000|Overall Study|Patient ineligible|5|||
125311791|NCT00217425|450770581|FG000|Overall Study|Lack of Efficacy|13|||
125311792|NCT00217425|450770581|FG000|Overall Study|Adverse Event|8|||
125311793|NCT00217425|450770581|FG000|Overall Study|Withdrawal by Subject|4|||
125311794|NCT00217425|450770581|FG000|Overall Study|Other complicating disease|1|||
125311795|NCT00217425|450770581|FG000|Overall Study|Other|4|||
125311796|NCT00086047|450770584|FG000|Overall Study|Lost to Follow-up|7|||
125311797|NCT00086047|450770585|FG001|Overall Study|Lost to Follow-up|6|||
125311798|NCT00086047|450770584|FG000|Overall Study|Physician Decision|0|||
125311799|NCT00086047|450770585|FG001|Overall Study|Physician Decision|1|||
125311800|NCT02471014|450770586|FG000|Overall Study|Lost to Follow-up|2|||
125311801|NCT02471014|450770587|FG001|Overall Study|Lost to Follow-up|2|||
125311802|NCT04640311|450770588|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
125311803|NCT04640311|450770589|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311804|NCT04640311|450770590|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311805|NCT04640311|450770591|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124872306|NCT01477853|449154077|FG000|Phase A|Lost to Follow-up|4|||
124872307|NCT01477853|449154078|FG001|Phase A|Lost to Follow-up|3|||
124872308|NCT01477853|449154079|FG002|Phase A|Lost to Follow-up|2|||
124872309|NCT01477853|449154077|FG000|Phase A|Physician Decision|1|||
124872310|NCT01477853|449154078|FG001|Phase A|Physician Decision|0|||
124872311|NCT01477853|449154079|FG002|Phase A|Physician Decision|1|||
124872312|NCT01477853|449154077|FG000|Phase A|Study terminated by sponsor|37|||
124872313|NCT01477853|449154078|FG001|Phase A|Study terminated by sponsor|40|||
124872314|NCT01477853|449154079|FG002|Phase A|Study terminated by sponsor|39|||
124872315|NCT01477853|449154077|FG000|Phase B|Lost to Follow-up|0|||
124872316|NCT01477853|449154078|FG001|Phase B|Lost to Follow-up|1|||
124872317|NCT01477853|449154079|FG002|Phase B|Lost to Follow-up|0|||
124872318|NCT01477853|449154077|FG000|Phase B|Study terminated by sponsor|12|||
124872319|NCT01477853|449154078|FG001|Phase B|Study terminated by sponsor|10|||
124872320|NCT01477853|449154079|FG002|Phase B|Study terminated by sponsor|11|||
124872321|NCT01050816|449154080|FG000|Overall Study|Lost to Follow-up|2|||
124872322|NCT01050816|449154080|FG000|Overall Study|patient's refusal|2|||
124872323|NCT00948974|449154086|FG000|Overall Study|Lost to Follow-up|23|||
124872324|NCT00948974|449154087|FG001|Overall Study|Lost to Follow-up|20|||
124872325|NCT00238433|449154089|FG000|Overall Study|Screen failure|1|||
124872326|NCT00238433|449154089|FG000|Overall Study|Lost to Follow-up|1|||
124872327|NCT00238433|449154089|FG000|Overall Study|Death|1|||
124872328|NCT01814748|449154092|FG000|Overall Study|Lost to Follow-up|1|||
124872329|NCT01814748|449154093|FG001|Overall Study|Lost to Follow-up|2|||
124872330|NCT01814748|449154092|FG000|Overall Study|Study site terminated by sponsor|1|||
124872331|NCT01814748|449154093|FG001|Overall Study|Study site terminated by sponsor|1|||
124872332|NCT01814748|449154092|FG000|Overall Study|Withdrawal by Subject|6|||
124872333|NCT01814748|449154093|FG001|Overall Study|Withdrawal by Subject|4|||
124872334|NCT04044456|449154094|FG000|Overall Study|Lost to Follow-up|4|||
124872335|NCT04044456|449154095|FG001|Overall Study|Lost to Follow-up|1|||
124872336|NCT04044456|449154094|FG000|Overall Study|Withdrawal by Subject|1|||
124872337|NCT04044456|449154095|FG001|Overall Study|Withdrawal by Subject|0|||
124872338|NCT01972529|449154096|FG000|Overall Study|Adverse Event|0|||
124872339|NCT01972529|449154097|FG001|Overall Study|Adverse Event|1|||
124872340|NCT01972529|449154098|FG002|Overall Study|Adverse Event|0|||
124872341|NCT01972529|449154099|FG003|Overall Study|Adverse Event|0|||
124872342|NCT01972529|449154096|FG000|Overall Study|Lost to Follow-up|1|||
124872343|NCT01972529|449154097|FG001|Overall Study|Lost to Follow-up|0|||
124872344|NCT01972529|449154098|FG002|Overall Study|Lost to Follow-up|0|||
124872345|NCT01972529|449154099|FG003|Overall Study|Lost to Follow-up|0|||
124872346|NCT01972529|449154096|FG000|Overall Study|Participant Choice|0|||
124872347|NCT01972529|449154097|FG001|Overall Study|Participant Choice|1|||
124872348|NCT01972529|449154098|FG002|Overall Study|Participant Choice|0|||
124872349|NCT01972529|449154099|FG003|Overall Study|Participant Choice|0|||
124872350|NCT01972529|449154096|FG000|Overall Study|Withdrawl of Consent|1|||
124872351|NCT01972529|449154097|FG001|Overall Study|Withdrawl of Consent|2|||
124872352|NCT01972529|449154098|FG002|Overall Study|Withdrawl of Consent|0|||
124872353|NCT01972529|449154099|FG003|Overall Study|Withdrawl of Consent|1|||
124872354|NCT01972529|449154096|FG000|Overall Study|Other|0|||
124872355|NCT01972529|449154097|FG001|Overall Study|Other|0|||
124872356|NCT01972529|449154098|FG002|Overall Study|Other|0|||
124872357|NCT01972529|449154099|FG003|Overall Study|Other|2|||
124872358|NCT01972529|449154096|FG000|Overall Study|Not treated|0|||
124872359|NCT01972529|449154097|FG001|Overall Study|Not treated|1|||
124872360|NCT01972529|449154098|FG002|Overall Study|Not treated|2|||
124872361|NCT01972529|449154099|FG003|Overall Study|Not treated|1|||
124872362|NCT02274857|449154100|FG000|Overall Study|Adverse Event|1|||
124872363|NCT02274857|449154101|FG001|Overall Study|Adverse Event|0|||
124872364|NCT02274857|449154100|FG000|Overall Study|Death|1|||
124872365|NCT02274857|449154101|FG001|Overall Study|Death|2|||
124872366|NCT02274857|449154100|FG000|Overall Study|Lost to Follow-up|3|||
124872367|NCT02274857|449154101|FG001|Overall Study|Lost to Follow-up|0|||
124872368|NCT02274857|449154100|FG000|Overall Study|Physician Decision|2|||
124872369|NCT02274857|449154101|FG001|Overall Study|Physician Decision|0|||
124872370|NCT02274857|449154100|FG000|Overall Study|Trial screen failure|0|||
124872371|NCT02274857|449154101|FG001|Overall Study|Trial screen failure|2|||
124872372|NCT02274857|449154100|FG000|Overall Study|Withdrawal by Subject|11|||
124872373|NCT02274857|449154101|FG001|Overall Study|Withdrawal by Subject|2|||
124872374|NCT02274857|449154100|FG000|Overall Study|Other|2|||
124872375|NCT02274857|449154101|FG001|Overall Study|Other|0|||
124872376|NCT00330174|449154105|FG000|Overall Study|Withdrawal by Subject|7|||
124872377|NCT00330174|449154106|FG001|Overall Study|Withdrawal by Subject|7|||
124872378|NCT00330174|449154105|FG000|Overall Study|Lost to Follow-up|4|||
125311806|NCT04640311|450770592|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311807|NCT04640311|450770593|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311808|NCT04640311|450770594|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311809|NCT04640311|450770595|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311810|NCT04640311|450770596|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311811|NCT04640311|450770597|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311812|NCT04640311|450770598|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311813|NCT04640311|450770599|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311814|NCT04640311|450770600|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311815|NCT04640311|450770588|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311816|NCT04640311|450770589|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
125311817|NCT04640311|450770590|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311818|NCT04640311|450770591|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311819|NCT04640311|450770592|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311820|NCT04640311|450770593|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311821|NCT04640311|450770594|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311822|NCT04640311|450770595|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311823|NCT04640311|450770596|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311824|NCT04640311|450770597|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311825|NCT04640311|450770598|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311826|NCT04640311|450770599|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311827|NCT04640311|450770600|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311828|NCT04640311|450770588|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124872379|NCT00330174|449154106|FG001|Overall Study|Lost to Follow-up|1|||
124872380|NCT00330174|449154105|FG000|Overall Study|Clinical deterioration|1|||
124872381|NCT00330174|449154106|FG001|Overall Study|Clinical deterioration|2|||
124872382|NCT00330174|449154105|FG000|Overall Study|Excessive missed visits|3|||
124872383|NCT00330174|449154106|FG001|Overall Study|Excessive missed visits|8|||
124872384|NCT00330174|449154105|FG000|Overall Study|Miscellaneous reasons|7|||
124872385|NCT00330174|449154106|FG001|Overall Study|Miscellaneous reasons|1|||
124872386|NCT02403180|449154107|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
124872387|NCT02403180|449154108|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
124872388|NCT02403180|449154107|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
124872389|NCT02403180|449154108|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
124872390|NCT00118716|449154111|FG000|Overall Study|Adverse Event|2|||
124872391|NCT00118716|449154112|FG001|Overall Study|Adverse Event|7|||
124872392|NCT00118716|449154111|FG000|Overall Study|Protocol Violation|5|||
124872393|NCT00118716|449154112|FG001|Overall Study|Protocol Violation|4|||
124872394|NCT00118716|449154111|FG000|Overall Study|Withdrawal by Subject|0|||
124872395|NCT00118716|449154112|FG001|Overall Study|Withdrawal by Subject|1|||
124872396|NCT00118716|449154111|FG000|Overall Study|Exacerbation|2|||
124872397|NCT00118716|449154112|FG001|Overall Study|Exacerbation|2|||
124872398|NCT00118716|449154111|FG000|Overall Study|Discontinued by sponsor|1|||
124872399|NCT00118716|449154112|FG001|Overall Study|Discontinued by sponsor|1|||
124872400|NCT00118716|449154111|FG000|Overall Study|Non-compliance|1|||
124872401|NCT00118716|449154112|FG001|Overall Study|Non-compliance|3|||
124872402|NCT00118716|449154111|FG000|Overall Study|misrandomized|1|||
124872403|NCT00118716|449154112|FG001|Overall Study|misrandomized|1|||
124872404|NCT00118716|449154111|FG000|Overall Study|Expired drug use|1|||
124872405|NCT00118716|449154112|FG001|Overall Study|Expired drug use|2|||
124872406|NCT00118716|449154111|FG000|Overall Study|Investigator discretion|0|||
124872407|NCT00118716|449154112|FG001|Overall Study|Investigator discretion|1|||
124872408|NCT01445652|449154114|FG000|Overall Study|Not comfortable in lenses|5|||
124872409|NCT01445652|449154115|FG001|Overall Study|Not comfortable in lenses|0|||
124872410|NCT01445652|449154114|FG000|Overall Study|Failed to attend scheduled visit|2|||
124872411|NCT01445652|449154115|FG001|Overall Study|Failed to attend scheduled visit|3|||
124872412|NCT01445652|449154114|FG000|Overall Study|Failed teach session|2|||
124872413|NCT01445652|449154115|FG001|Overall Study|Failed teach session|0|||
124872414|NCT01445652|449154114|FG000|Overall Study|Adverse Event|1|||
124872415|NCT01445652|449154115|FG001|Overall Study|Adverse Event|0|||
124872416|NCT00454571|449154116|FG000|Overall Study|Adverse Event|2|||
124872417|NCT00454571|449154117|FG001|Overall Study|Adverse Event|0|||
124872418|NCT00454571|449154116|FG000|Overall Study|Physician Decision|0|||
124872419|NCT00454571|449154117|FG001|Overall Study|Physician Decision|1|||
124872420|NCT00454571|449154116|FG000|Overall Study|Protocol Violation|1|||
124872421|NCT00454571|449154117|FG001|Overall Study|Protocol Violation|0|||
124872422|NCT00454571|449154116|FG000|Overall Study|Withdrawal by Subject|10|||
124872423|NCT00454571|449154117|FG001|Overall Study|Withdrawal by Subject|5|||
124872424|NCT02436811|449154118|FG000|Overall Study|Lost to Follow-up|2|||
124872425|NCT02436811|449154119|FG001|Overall Study|Lost to Follow-up|9|||
125311829|NCT04640311|450770589|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
125311830|NCT04640311|450770590|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311831|NCT04640311|450770591|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311832|NCT04640311|450770592|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311833|NCT04640311|450770593|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311834|NCT04640311|450770594|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311835|NCT04640311|450770595|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124982614|NCT03843554|449563233|FG000|Overall Study|Physician Decision|0|||
124982615|NCT03843554|449563234|FG001|Overall Study|Physician Decision|2|||
124982616|NCT04396366|449563235|FG000|Overall Study|Adverse Event|1|||
124982617|NCT04396366|449563236|FG001|Overall Study|Adverse Event|0|||
125311836|NCT04640311|450770596|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311837|NCT04640311|450770597|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311838|NCT04640311|450770598|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311839|NCT04640311|450770599|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311840|NCT04640311|450770600|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311841|NCT04640311|450770588|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
125311842|NCT04640311|450770589|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
125311843|NCT04640311|450770590|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
125311844|NCT04640311|450770591|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311845|NCT04640311|450770592|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311846|NCT04640311|450770593|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311847|NCT04640311|450770594|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311848|NCT04640311|450770595|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311849|NCT04640311|450770596|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311850|NCT04640311|450770597|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311851|NCT04640311|450770598|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311852|NCT04640311|450770599|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311853|NCT04640311|450770600|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311854|NCT04640311|450770588|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311855|NCT04640311|450770589|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311856|NCT04640311|450770590|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
125311857|NCT04640311|450770591|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311858|NCT04640311|450770592|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311859|NCT04640311|450770593|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311860|NCT04640311|450770594|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311861|NCT04640311|450770595|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311862|NCT04640311|450770596|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311863|NCT04640311|450770597|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311864|NCT04640311|450770598|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311865|NCT04640311|450770599|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311866|NCT04640311|450770600|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311867|NCT04640311|450770588|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311868|NCT04640311|450770589|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311869|NCT04640311|450770590|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311870|NCT04640311|450770591|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
125311871|NCT04640311|450770592|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311872|NCT04640311|450770593|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311873|NCT04640311|450770594|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
125311874|NCT04640311|450770595|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311875|NCT04640311|450770596|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311876|NCT04640311|450770597|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311877|NCT04640311|450770598|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311878|NCT04640311|450770599|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311879|NCT04640311|450770600|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311880|NCT04640311|450770588|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311881|NCT04640311|450770589|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311882|NCT04640311|450770590|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311883|NCT04640311|450770591|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311884|NCT04640311|450770592|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311885|NCT04640311|450770593|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
125311886|NCT04640311|450770594|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311887|NCT04640311|450770595|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311888|NCT04640311|450770596|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
125311889|NCT04640311|450770597|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311890|NCT04640311|450770598|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311891|NCT04640311|450770599|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311892|NCT04640311|450770600|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311893|NCT04640311|450770588|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311894|NCT04640311|450770589|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311895|NCT04640311|450770590|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311896|NCT04640311|450770591|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311897|NCT04640311|450770592|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311898|NCT04640311|450770593|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311899|NCT04640311|450770594|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
125311900|NCT04640311|450770595|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311901|NCT04640311|450770596|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311902|NCT04640311|450770597|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311903|NCT04640311|450770598|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
125311904|NCT04640311|450770599|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311905|NCT04640311|450770600|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311906|NCT04640311|450770588|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125311907|NCT04640311|450770589|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125311908|NCT04640311|450770590|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125311909|NCT04640311|450770591|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125311910|NCT04640311|450770592|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125311911|NCT04640311|450770593|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
124982652|NCT03568318|449563280|FG000|Overall Study|Adverse Event|3|||
124982653|NCT03568318|449563281|FG001|Overall Study|Adverse Event|1|||
124982654|NCT03568318|449563282|FG002|Overall Study|Adverse Event|1|||
124982655|NCT03568318|449563283|FG003|Overall Study|Adverse Event|0|||
125311912|NCT04640311|450770594|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125311913|NCT04640311|450770595|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125311914|NCT04640311|450770596|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125311915|NCT04640311|450770597|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
124982656|NCT03568318|449563284|FG004|Overall Study|Adverse Event|1|||
124982657|NCT03568318|449563285|FG005|Overall Study|Adverse Event|0|||
124982658|NCT03568318|449563280|FG000|Overall Study|Withdrawal by Subject|6|||
124982659|NCT03568318|449563281|FG001|Overall Study|Withdrawal by Subject|5|||
124982660|NCT03568318|449563282|FG002|Overall Study|Withdrawal by Subject|2|||
124982661|NCT03568318|449563283|FG003|Overall Study|Withdrawal by Subject|1|||
124982662|NCT03568318|449563284|FG004|Overall Study|Withdrawal by Subject|0|||
124982663|NCT03568318|449563285|FG005|Overall Study|Withdrawal by Subject|0|||
124982664|NCT03568318|449563280|FG000|Overall Study|Lost to Follow-up|3|||
124982665|NCT03568318|449563281|FG001|Overall Study|Lost to Follow-up|2|||
124982666|NCT03568318|449563282|FG002|Overall Study|Lost to Follow-up|2|||
124982667|NCT03568318|449563283|FG003|Overall Study|Lost to Follow-up|2|||
124982668|NCT03568318|449563284|FG004|Overall Study|Lost to Follow-up|1|||
124982669|NCT03568318|449563285|FG005|Overall Study|Lost to Follow-up|0|||
124982670|NCT03568318|449563280|FG000|Overall Study|Other|3|||
124982671|NCT03568318|449563281|FG001|Overall Study|Other|1|||
124982672|NCT03568318|449563282|FG002|Overall Study|Other|3|||
124982673|NCT03568318|449563283|FG003|Overall Study|Other|0|||
125311916|NCT04640311|450770598|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125311917|NCT04640311|450770599|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
125311918|NCT04640311|450770600|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125311919|NCT00592904|450770601|FG000|Overall Study|Adverse Event|15|||
125311920|NCT00592904|450770602|FG001|Overall Study|Adverse Event|25|||
125311921|NCT00592904|450770603|FG002|Overall Study|Adverse Event|13|||
125311922|NCT00592904|450770604|FG003|Overall Study|Adverse Event|5|||
125311923|NCT00592904|450770601|FG000|Overall Study|Protocol Violation|1|||
125311924|NCT00592904|450770602|FG001|Overall Study|Protocol Violation|1|||
125311925|NCT00592904|450770603|FG002|Overall Study|Protocol Violation|0|||
124982674|NCT03568318|449563284|FG004|Overall Study|Other|0|||
124982675|NCT03568318|449563285|FG005|Overall Study|Other|0|||
124982676|NCT03568318|449563280|FG000|Overall Study|Ongoing at Time of Analysis|5|||
124982677|NCT03568318|449563281|FG001|Overall Study|Ongoing at Time of Analysis|3|||
124982678|NCT03568318|449563282|FG002|Overall Study|Ongoing at Time of Analysis|2|||
124982679|NCT03568318|449563283|FG003|Overall Study|Ongoing at Time of Analysis|1|||
124982680|NCT03568318|449563284|FG004|Overall Study|Ongoing at Time of Analysis|0|||
124982681|NCT03568318|449563285|FG005|Overall Study|Ongoing at Time of Analysis|0|||
125311926|NCT00592904|450770604|FG003|Overall Study|Protocol Violation|1|||
125311927|NCT00592904|450770601|FG000|Overall Study|Withdrawal by Subject|4|||
125311928|NCT00592904|450770602|FG001|Overall Study|Withdrawal by Subject|16|||
125311929|NCT00592904|450770603|FG002|Overall Study|Withdrawal by Subject|1|||
125311930|NCT00592904|450770604|FG003|Overall Study|Withdrawal by Subject|2|||
125311931|NCT00592904|450770601|FG000|Overall Study|Lack of Efficacy|2|||
125311932|NCT00592904|450770602|FG001|Overall Study|Lack of Efficacy|7|||
125311933|NCT00592904|450770603|FG002|Overall Study|Lack of Efficacy|2|||
125311934|NCT00592904|450770604|FG003|Overall Study|Lack of Efficacy|3|||
125311935|NCT00592904|450770601|FG000|Overall Study|Physician Decision|0|||
125311936|NCT00592904|450770602|FG001|Overall Study|Physician Decision|3|||
125311937|NCT00592904|450770603|FG002|Overall Study|Physician Decision|1|||
125311938|NCT00592904|450770604|FG003|Overall Study|Physician Decision|0|||
125311939|NCT00592904|450770601|FG000|Overall Study|Other|3|||
125311940|NCT00592904|450770602|FG001|Overall Study|Other|3|||
125311941|NCT00592904|450770603|FG002|Overall Study|Other|0|||
125311942|NCT00592904|450770604|FG003|Overall Study|Other|0|||
125311943|NCT03191630|450770607|FG000|Overall Study|Lost to Follow-up|7|||
125311944|NCT03191630|450770608|FG001|Overall Study|Lost to Follow-up|7|||
125311945|NCT01367834|450770613|FG000|Overall Study|Withdrawal by Subject|2|||
125311946|NCT01367834|450770614|FG001|Overall Study|Withdrawal by Subject|2|||
125311947|NCT01367834|450770613|FG000|Overall Study|Study was ended.|0|||
125311948|NCT01367834|450770614|FG001|Overall Study|Study was ended.|1|||
125311949|NCT01020786|450770619|FG000|Induction Period|Entry Criteria Not Met|2|||
125311950|NCT01020786|450770619|FG000|Induction Period|Adverse Event|10|||
125311951|NCT01020786|450770619|FG000|Induction Period|Progressive Disease|31|||
125311952|NCT01020786|450770619|FG000|Induction Period|Investigator Decision|3|||
125311953|NCT01020786|450770619|FG000|Induction Period|Withdrawal by Subject|3|||
125311954|NCT01020786|450770619|FG000|Maintenance Period|Adverse Event|8|||
125311955|NCT01020786|450770619|FG000|Maintenance Period|Progressive Disease|43|||
125311956|NCT01020786|450770619|FG000|Maintenance Period|Withdrawal by Subject|8|||
125311957|NCT01020786|450770619|FG000|Maintenance Period|Sponsor Decision|1|||
125311958|NCT01818596|450770628|FG000|Overall Study|Enrolled but Not Treated|4|||
125311959|NCT01818596|450770629|FG001|Overall Study|Enrolled but Not Treated|0|||
125311960|NCT01818596|450770628|FG000|Overall Study|Adverse Event|7|||
125311961|NCT01818596|450770629|FG001|Overall Study|Adverse Event|0|||
125311962|NCT01818596|450770628|FG000|Overall Study|Death|3|||
125311963|NCT01818596|450770629|FG001|Overall Study|Death|0|||
125311964|NCT01818596|450770628|FG000|Overall Study|Investigator's Discretion|4|||
125311965|NCT01818596|450770629|FG001|Overall Study|Investigator's Discretion|0|||
125311966|NCT01818596|450770628|FG000|Overall Study|Protocol Violation|1|||
125311967|NCT01818596|450770629|FG001|Overall Study|Protocol Violation|0|||
125311968|NCT01818596|450770628|FG000|Overall Study|Withdrew Consent|5|||
125311969|NCT01818596|450770629|FG001|Overall Study|Withdrew Consent|0|||
125311970|NCT01818596|450770628|FG000|Overall Study|Lost to Follow-up|7|||
125311971|NCT01818596|450770629|FG001|Overall Study|Lost to Follow-up|0|||
125311972|NCT03801174|450770630|FG000|Overall Study|Withdrawal by Subject|14|||
125311973|NCT03801174|450770631|FG001|Overall Study|Withdrawal by Subject|15|||
125311974|NCT03801174|450770630|FG000|Overall Study|Death|1|||
125311975|NCT03801174|450770631|FG001|Overall Study|Death|0|||
125311976|NCT03801174|450770630|FG000|Overall Study|Pregnancy|2|||
125311977|NCT03801174|450770631|FG001|Overall Study|Pregnancy|2|||
125311978|NCT03801174|450770630|FG000|Overall Study|Lost to Follow-up|19|||
125311979|NCT03801174|450770631|FG001|Overall Study|Lost to Follow-up|10|||
125311980|NCT03801174|450770630|FG000|Overall Study|Other|4|||
125311981|NCT03801174|450770631|FG001|Overall Study|Other|3|||
125311982|NCT03801174|450770630|FG000|Overall Study|Lack of Efficacy|4|||
125311983|NCT03801174|450770631|FG001|Overall Study|Lack of Efficacy|0|||
125311984|NCT03801174|450770630|FG000|Overall Study|Unwilling to complete activities|5|||
125311985|NCT03801174|450770631|FG001|Overall Study|Unwilling to complete activities|6|||
125311986|NCT03801174|450770630|FG000|Overall Study|Moved out of area|3|||
125311987|NCT03801174|450770631|FG001|Overall Study|Moved out of area|0|||
125311988|NCT02915263|450770644|FG000|Overall Study|Covid|3|||
125311989|NCT02915263|450770645|FG001|Overall Study|Covid|2|||
125311990|NCT01879683|450770646|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
125311991|NCT01618669|450770647|FG000|Overall Study|Lost to Follow-up|1|||
125311992|NCT01618669|450770648|FG001|Overall Study|Lost to Follow-up|1|||
125311993|NCT01618669|450770647|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
125311994|NCT01618669|450770648|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
125311995|NCT01618669|450770647|FG000|Overall Study|Adverse Event|16|||
125311996|NCT01618669|450770648|FG001|Overall Study|Adverse Event|7|||
125311997|NCT01618669|450770647|FG000|Overall Study|Protocol Violation|5|||
125311998|NCT01618669|450770648|FG001|Overall Study|Protocol Violation|3|||
125311999|NCT01618669|450770647|FG000|Overall Study|Withdrawal by Subject|9|||
125312000|NCT01618669|450770648|FG001|Overall Study|Withdrawal by Subject|9|||
125312001|NCT01618669|450770647|FG000|Overall Study|Miscellaneous Reason|0|||
125312002|NCT01618669|450770648|FG001|Overall Study|Miscellaneous Reason|1|||
125312003|NCT01702558|450770651|FG000|Overall Study|Withdrawal by Subject|0|||
125312004|NCT01702558|450770652|FG001|Overall Study|Withdrawal by Subject|0|||
125312005|NCT01702558|450770653|FG002|Overall Study|Withdrawal by Subject|0|||
125312006|NCT01702558|450770654|FG003|Overall Study|Withdrawal by Subject|12|||
125312007|NCT01702558|450770655|FG004|Overall Study|Withdrawal by Subject|4|||
125312008|NCT01702558|450770651|FG000|Overall Study|Lost to Follow-up|0|||
125312009|NCT01702558|450770652|FG001|Overall Study|Lost to Follow-up|0|||
125312010|NCT01702558|450770653|FG002|Overall Study|Lost to Follow-up|0|||
125312011|NCT01702558|450770654|FG003|Overall Study|Lost to Follow-up|3|||
124982753|NCT05870228|449563320|FG000|Overall Study|Lost to Follow-up|2|||
124982754|NCT05870228|449563321|FG001|Overall Study|Lost to Follow-up|0|||
124982755|NCT05870228|449563320|FG000|Overall Study|Withdrawal by Subject|1|||
124982756|NCT05870228|449563321|FG001|Overall Study|Withdrawal by Subject|0|||
124872426|NCT02436811|449154120|FG002|Overall Study|Lost to Follow-up|7|||
124872427|NCT03595332|449154121|FG000|Overall Study|Lost to Follow-up|16|||
124872428|NCT03595332|449154122|FG001|Overall Study|Lost to Follow-up|22|||
124872429|NCT03595332|449154121|FG000|Overall Study|Unable to retrieve ID from school|0|||
124872430|NCT03595332|449154122|FG001|Overall Study|Unable to retrieve ID from school|2|||
124872431|NCT01201811|449154125|FG000|Overall Study|Adverse Event|6|||
124872432|NCT01201811|449154125|FG000|Overall Study|Disease progression|3|||
124872433|NCT01201811|449154125|FG000|Overall Study|Withdrawal by Subject|3|||
124872434|NCT01201811|449154125|FG000|Overall Study|Death|4|||
124872435|NCT01201811|449154125|FG000|Overall Study|Treatment Failure|2|||
124872436|NCT01201811|449154125|FG000|Overall Study|Physician Decision|1|||
124872437|NCT00117676|449154126|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
124872438|NCT00117676|449154127|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
124872439|NCT00117676|449154126|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
124872440|NCT00117676|449154127|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
124872441|NCT00117676|449154126|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
124982769|NCT03547739|449563326|FG000|Overall Study|Death|0|||
124982770|NCT03547739|449563327|FG001|Overall Study|Death|1|||
124982771|NCT03547739|449563328|FG002|Overall Study|Death|5|||
124982772|NCT03547739|449563326|FG000|Overall Study|Adverse Event|24|||
124982773|NCT03547739|449563327|FG001|Overall Study|Adverse Event|11|||
124982774|NCT03547739|449563328|FG002|Overall Study|Adverse Event|13|||
124982775|NCT03547739|449563326|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
124982776|NCT03547739|449563327|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
124982777|NCT03547739|449563328|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
124982778|NCT03547739|449563326|FG000|Overall Study|Lost to Follow-up|80|||
124982779|NCT03547739|449563327|FG001|Overall Study|Lost to Follow-up|84|||
124982780|NCT03547739|449563328|FG002|Overall Study|Lost to Follow-up|116|||
124982787|NCT04035499|449563336|FG000|Overall Study|Death|2|||
124982788|NCT04035499|449563336|FG000|Overall Study|Withdrawal by Subject|1|||
124982789|NCT02003222|449563337|FG000|Induction|Never started treatment|0|||
124982790|NCT02003222|449563338|FG001|Induction|Never started treatment|0|||
124982791|NCT02003222|449563339|FG002|Induction|Never started treatment|0|||
124982792|NCT02003222|449563340|FG003|Induction|Never started treatment|0|||
124982793|NCT02003222|449563341|FG004|Induction|Never started treatment|8|||
124982794|NCT02003222|449563337|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
124982795|NCT02003222|449563338|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
124982796|NCT02003222|449563339|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
124982797|NCT02003222|449563340|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
124982798|NCT02003222|449563341|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
124982799|NCT02003222|449563337|FG000|Induction|Adverse Event|0|||
124982800|NCT02003222|449563338|FG001|Induction|Adverse Event|0|||
124982801|NCT02003222|449563339|FG002|Induction|Adverse Event|0|||
124982802|NCT02003222|449563340|FG003|Induction|Adverse Event|0|||
124982803|NCT02003222|449563341|FG004|Induction|Adverse Event|13|||
124982804|NCT02003222|449563337|FG000|Induction|Alternative therapy|0|||
124982805|NCT02003222|449563338|FG001|Induction|Alternative therapy|0|||
124982806|NCT02003222|449563339|FG002|Induction|Alternative therapy|0|||
124982807|NCT02003222|449563340|FG003|Induction|Alternative therapy|0|||
124982808|NCT02003222|449563341|FG004|Induction|Alternative therapy|12|||
124982809|NCT02003222|449563337|FG000|Induction|Disease progression|0|||
124982810|NCT02003222|449563338|FG001|Induction|Disease progression|0|||
124982811|NCT02003222|449563339|FG002|Induction|Disease progression|0|||
124982812|NCT02003222|449563340|FG003|Induction|Disease progression|0|||
124982813|NCT02003222|449563341|FG004|Induction|Disease progression|22|||
124982814|NCT02003222|449563337|FG000|Induction|Death|0|||
124982815|NCT02003222|449563338|FG001|Induction|Death|0|||
124982816|NCT02003222|449563339|FG002|Induction|Death|0|||
124982817|NCT02003222|449563340|FG003|Induction|Death|0|||
124982818|NCT02003222|449563341|FG004|Induction|Death|3|||
124982819|NCT02003222|449563337|FG000|Induction|Withdrawal by Subject|0|||
125312012|NCT01702558|450770655|FG004|Overall Study|Lost to Follow-up|0|||
125312013|NCT01702558|450770651|FG000|Overall Study|Death|4|||
124982820|NCT02003222|449563338|FG001|Induction|Withdrawal by Subject|0|||
124982821|NCT02003222|449563339|FG002|Induction|Withdrawal by Subject|0|||
124982822|NCT02003222|449563340|FG003|Induction|Withdrawal by Subject|0|||
124982823|NCT02003222|449563341|FG004|Induction|Withdrawal by Subject|8|||
124982824|NCT02003222|449563337|FG000|Induction|Other reasons|0|||
124982825|NCT02003222|449563338|FG001|Induction|Other reasons|0|||
124982826|NCT02003222|449563339|FG002|Induction|Other reasons|0|||
124982827|NCT02003222|449563340|FG003|Induction|Other reasons|0|||
124982828|NCT02003222|449563341|FG004|Induction|Other reasons|22|||
124982829|NCT02003222|449563337|FG000|Intensification|Never started treatment|0|||
125312014|NCT01702558|450770652|FG001|Overall Study|Death|3|||
124982830|NCT02003222|449563338|FG001|Intensification|Never started treatment|0|||
124982831|NCT02003222|449563339|FG002|Intensification|Never started treatment|0|||
124982832|NCT02003222|449563340|FG003|Intensification|Never started treatment|0|||
124982833|NCT02003222|449563341|FG004|Intensification|Never started treatment|2|||
125312015|NCT01702558|450770653|FG002|Overall Study|Death|3|||
124982834|NCT02003222|449563337|FG000|Intensification|Adverse Event|0|||
124982835|NCT02003222|449563338|FG001|Intensification|Adverse Event|0|||
124982836|NCT02003222|449563339|FG002|Intensification|Adverse Event|0|||
124982837|NCT02003222|449563340|FG003|Intensification|Adverse Event|0|||
124982838|NCT02003222|449563341|FG004|Intensification|Adverse Event|6|||
124982839|NCT02003222|449563337|FG000|Intensification|Alternative therapy|0|||
125312016|NCT01702558|450770654|FG003|Overall Study|Death|16|||
124982840|NCT02003222|449563338|FG001|Intensification|Alternative therapy|0|||
124982841|NCT02003222|449563339|FG002|Intensification|Alternative therapy|0|||
124982842|NCT02003222|449563340|FG003|Intensification|Alternative therapy|0|||
124982843|NCT02003222|449563341|FG004|Intensification|Alternative therapy|8|||
124982844|NCT02003222|449563337|FG000|Intensification|Disease progression|0|||
124982845|NCT02003222|449563338|FG001|Intensification|Disease progression|0|||
124982846|NCT02003222|449563339|FG002|Intensification|Disease progression|0|||
124982847|NCT02003222|449563340|FG003|Intensification|Disease progression|0|||
124982848|NCT02003222|449563341|FG004|Intensification|Disease progression|18|||
124982849|NCT02003222|449563337|FG000|Intensification|Withdrawal by Subject|0|||
124982850|NCT02003222|449563338|FG001|Intensification|Withdrawal by Subject|0|||
124982851|NCT02003222|449563339|FG002|Intensification|Withdrawal by Subject|0|||
124982852|NCT02003222|449563340|FG003|Intensification|Withdrawal by Subject|0|||
124982853|NCT02003222|449563341|FG004|Intensification|Withdrawal by Subject|5|||
124982854|NCT02003222|449563337|FG000|Intensification|Other reasons|0|||
124982855|NCT02003222|449563338|FG001|Intensification|Other reasons|0|||
124982856|NCT02003222|449563339|FG002|Intensification|Other reasons|0|||
124982857|NCT02003222|449563340|FG003|Intensification|Other reasons|0|||
124982858|NCT02003222|449563341|FG004|Intensification|Other reasons|8|||
124982870|NCT04662931|449563351|FG000|Overall Study|Withdrawal by Subject|17|||
124982871|NCT04662931|449563351|FG000|Overall Study|Death|3|||
124982872|NCT04662931|449563351|FG000|Overall Study|Lost to Follow-up|3|||
124982873|NCT04662931|449563351|FG000|Overall Study|Guardian Decision|1|||
124982874|NCT05051462|449563355|FG000|Overall Study|Lost to Follow-up|1|||
124982875|NCT05051462|449563356|FG001|Overall Study|Lost to Follow-up|8|||
124982876|NCT05051462|449563355|FG000|Overall Study|Withdrawal by Subject|1|||
124982877|NCT05051462|449563356|FG001|Overall Study|Withdrawal by Subject|0|||
124982878|NCT05051462|449563355|FG000|Overall Study|Protocol Violation|0|||
124982879|NCT05051462|449563356|FG001|Overall Study|Protocol Violation|2|||
124982880|NCT02425904|449563357|FG000|Overall Study|Lost to Follow-up|1|||
124982881|NCT02425904|449563358|FG001|Overall Study|Lost to Follow-up|0|||
124982882|NCT02425904|449563357|FG000|Overall Study|Withdrawal by Subject|2|||
124982883|NCT02425904|449563358|FG001|Overall Study|Withdrawal by Subject|0|||
124982884|NCT02425904|449563357|FG000|Overall Study|Death|0|||
124982885|NCT02425904|449563358|FG001|Overall Study|Death|3|||
124982886|NCT05260021|449563364|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
124982887|NCT05260021|449563365|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
124982888|NCT05260021|449563366|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
124982889|NCT05260021|449563364|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
124982890|NCT05260021|449563365|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
124982891|NCT05260021|449563366|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
124982892|NCT05260021|449563364|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
124982893|NCT05260021|449563365|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
124982894|NCT05260021|449563366|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
124982895|NCT05260021|449563364|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
124982896|NCT05260021|449563365|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
124982897|NCT05260021|449563366|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
124982898|NCT05260021|449563364|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
124982899|NCT05260021|449563365|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
124982900|NCT05260021|449563366|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
124982901|NCT03842358|449564798|FG000|Overall Study|Poor DOT probe contact with breast|2|||
124982902|NCT03842358|449564798|FG000|Overall Study|DOT system problem|1|||
124982903|NCT03842358|449564798|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
124982904|NCT03842358|449564798|FG000|Overall Study|No biopsy after physician review|4|||
124982905|NCT03842358|449564798|FG000|Overall Study|Patient withdrew|2|||
125033580|NCT00408005|449743818|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
125312017|NCT01702558|450770655|FG004|Overall Study|Death|20|||
125312018|NCT01702558|450770651|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
125312019|NCT01702558|450770652|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
125312020|NCT01702558|450770653|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
125312021|NCT01702558|450770654|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
125312022|NCT01702558|450770655|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
125312023|NCT01702558|450770651|FG000|Overall Study|Study Terminated by Sponsor|0|||
125312024|NCT01702558|450770652|FG001|Overall Study|Study Terminated by Sponsor|1|||
125312025|NCT01702558|450770653|FG002|Overall Study|Study Terminated by Sponsor|0|||
125312026|NCT01702558|450770654|FG003|Overall Study|Study Terminated by Sponsor|0|||
125312027|NCT01702558|450770655|FG004|Overall Study|Study Terminated by Sponsor|1|||
125312028|NCT01702558|450770651|FG000|Overall Study|Other|0|||
125312029|NCT01702558|450770652|FG001|Overall Study|Other|0|||
125312030|NCT01702558|450770653|FG002|Overall Study|Other|0|||
125312031|NCT01702558|450770654|FG003|Overall Study|Other|16|||
125312032|NCT01702558|450770655|FG004|Overall Study|Other|17|||
125312033|NCT03259087|450770658|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
125312034|NCT03259087|450770659|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
125312035|NCT03259087|450770660|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
125312036|NCT03259087|450770661|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
125312037|NCT03259087|450770662|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
125312038|NCT03259087|450770658|FG000|Period 2 of Part 2|Adverse Event|0|||
125312039|NCT03259087|450770659|FG001|Period 2 of Part 2|Adverse Event|0|||
125312040|NCT03259087|450770660|FG002|Period 2 of Part 2|Adverse Event|0|||
125312041|NCT03259087|450770661|FG003|Period 2 of Part 2|Adverse Event|0|||
125312042|NCT03259087|450770662|FG004|Period 2 of Part 2|Adverse Event|1|||
125312043|NCT04950465|450770663|FG000|Overall Study|Lost to Follow-up|1|||
125312044|NCT04950465|450770664|FG001|Overall Study|Lost to Follow-up|0|||
125312045|NCT04950465|450770665|FG002|Overall Study|Lost to Follow-up|0|||
125312046|NCT01788566|450770666|FG000|Overall Study|Death|4|||
125312047|NCT01788566|450770666|FG000|Overall Study|Adverse Event|1|||
125312048|NCT01788566|450770666|FG000|Overall Study|Clinical Progressive Disease|3|||
125312049|NCT01620086|450770669|FG000|Overall Study|Withdrawal by Subject|3|||
125312050|NCT01620086|450770670|FG001|Overall Study|Withdrawal by Subject|3|||
125312051|NCT01620086|450770671|FG002|Overall Study|Withdrawal by Subject|0|||
125312052|NCT01620086|450770669|FG000|Overall Study|failed study criteria|1|||
125312053|NCT01620086|450770670|FG001|Overall Study|failed study criteria|4|||
125312054|NCT01620086|450770671|FG002|Overall Study|failed study criteria|0|||
125312055|NCT01620086|450770669|FG000|Overall Study|Physician Decision|1|||
125312056|NCT01620086|450770670|FG001|Overall Study|Physician Decision|0|||
125312057|NCT01620086|450770671|FG002|Overall Study|Physician Decision|0|||
125312058|NCT01695135|450770672|FG000|Double-blind Treatment Phase|Progressive disease|50|||
125312059|NCT01695135|450770673|FG001|Double-blind Treatment Phase|Progressive disease|110|||
125312060|NCT01695135|450770674|FG002|Double-blind Treatment Phase|Progressive disease|0|||
125312061|NCT01695135|450770675|FG003|Double-blind Treatment Phase|Progressive disease|0|||
125312062|NCT01695135|450770672|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
125312063|NCT01695135|450770673|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
125312064|NCT01695135|450770674|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125312065|NCT01695135|450770675|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125312066|NCT01695135|450770672|FG000|Double-blind Treatment Phase|Adverse Event|7|||
125312067|NCT01695135|450770673|FG001|Double-blind Treatment Phase|Adverse Event|7|||
125312068|NCT01695135|450770674|FG002|Double-blind Treatment Phase|Adverse Event|0|||
125312069|NCT01695135|450770675|FG003|Double-blind Treatment Phase|Adverse Event|0|||
125312070|NCT01695135|450770672|FG000|Double-blind Treatment Phase|Other|1|||
125312071|NCT01695135|450770673|FG001|Double-blind Treatment Phase|Other|3|||
125312072|NCT01695135|450770674|FG002|Double-blind Treatment Phase|Other|0|||
125312073|NCT01695135|450770675|FG003|Double-blind Treatment Phase|Other|0|||
125312074|NCT01695135|450770672|FG000|Double-blind Treatment Phase|Physician Decision|6|||
125312075|NCT01695135|450770673|FG001|Double-blind Treatment Phase|Physician Decision|3|||
125312076|NCT01695135|450770674|FG002|Double-blind Treatment Phase|Physician Decision|0|||
125312077|NCT01695135|450770675|FG003|Double-blind Treatment Phase|Physician Decision|0|||
125312078|NCT01695135|450770672|FG000|Double-blind Treatment Phase|Death|1|||
125312079|NCT01695135|450770673|FG001|Double-blind Treatment Phase|Death|1|||
125312080|NCT01695135|450770674|FG002|Double-blind Treatment Phase|Death|0|||
125312081|NCT01695135|450770675|FG003|Double-blind Treatment Phase|Death|0|||
125312082|NCT01695135|450770672|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
125312083|NCT01695135|450770673|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
125312084|NCT01695135|450770674|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
125312085|NCT01695135|450770675|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
125312086|NCT01695135|450770672|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
125312087|NCT01695135|450770673|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
125312088|NCT01695135|450770674|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
125312089|NCT01695135|450770675|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
125312090|NCT01695135|450770672|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
125312091|NCT01695135|450770673|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
125312092|NCT01695135|450770674|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
125312093|NCT01695135|450770675|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
125312094|NCT01695135|450770672|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
124982964|NCT06665919|449564823|FG000|Overall Study|Withdrawal by Subject|4|||
124982965|NCT06665919|449564824|FG001|Overall Study|Withdrawal by Subject|4|||
125312095|NCT01695135|450770673|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
124982966|NCT06665919|449564825|FG002|Overall Study|Withdrawal by Subject|4|||
124982967|NCT06665919|449564823|FG000|Overall Study|Non-compliance to Treatment|4|||
124982968|NCT06665919|449564824|FG001|Overall Study|Non-compliance to Treatment|1|||
124982969|NCT06665919|449564825|FG002|Overall Study|Non-compliance to Treatment|6|||
124982970|NCT06665919|449564823|FG000|Overall Study|Lost to Follow-up|3|||
124982971|NCT06665919|449564824|FG001|Overall Study|Lost to Follow-up|0|||
124982972|NCT06665919|449564825|FG002|Overall Study|Lost to Follow-up|2|||
124982973|NCT06665919|449564823|FG000|Overall Study|Physician Decision|4|||
124982974|NCT06665919|449564824|FG001|Overall Study|Physician Decision|0|||
124982975|NCT06665919|449564825|FG002|Overall Study|Physician Decision|1|||
124983009|NCT04150068|449564843|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
124983010|NCT04150068|449564844|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
124983011|NCT04150068|449564845|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
124983012|NCT04150068|449564843|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
124983013|NCT04150068|449564844|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
124983014|NCT04150068|449564845|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
124983015|NCT05316701|449564846|FG000|Overall Study|Adverse Event|0|||
124983016|NCT05316701|449564847|FG001|Overall Study|Adverse Event|1|||
124983017|NCT05316701|449564846|FG000|Overall Study|Death|3|||
124983018|NCT05316701|449564847|FG001|Overall Study|Death|9|||
124983019|NCT05316701|449564846|FG000|Overall Study|Lost to Follow-up|1|||
124983020|NCT05316701|449564847|FG001|Overall Study|Lost to Follow-up|0|||
124983021|NCT05316701|449564846|FG000|Overall Study|Physician Decision|1|||
124983022|NCT05316701|449564847|FG001|Overall Study|Physician Decision|4|||
124983023|NCT05316701|449564846|FG000|Overall Study|Withdrawal by Subject|3|||
124983024|NCT05316701|449564847|FG001|Overall Study|Withdrawal by Subject|5|||
124983025|NCT05316701|449564846|FG000|Overall Study|Progression/Relapse|14|||
124983026|NCT05316701|449564847|FG001|Overall Study|Progression/Relapse|9|||
124983027|NCT05316701|449564846|FG000|Overall Study|Received Standard of Care|1|||
124983028|NCT05316701|449564847|FG001|Overall Study|Received Standard of Care|0|||
124983029|NCT05316701|449564846|FG000|Overall Study|Ongoing|70|||
124983030|NCT05316701|449564847|FG001|Overall Study|Ongoing|64|||
124983031|NCT04696653|449564848|FG000|Overall Study|left organization|18|||
124983032|NCT04696653|449564848|FG000|Overall Study|Lost to Follow-up|3|||
124983038|NCT04625413|449564850|FG000|Overall Study|Hospice|2|||
124983039|NCT04625413|449564850|FG000|Overall Study|Distress|1|||
124983040|NCT04625413|449564850|FG000|Overall Study|Not feeling well|1|||
125312096|NCT01695135|450770674|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
125312097|NCT01695135|450770675|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
125312098|NCT01695135|450770672|FG000|Open Label Extension Treatment Phase|Other|0|||
124872442|NCT00117676|449154127|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
124872443|NCT00117676|449154126|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
124872444|NCT00117676|449154127|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
124872445|NCT00117676|449154126|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
124872446|NCT00117676|449154127|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
124872447|NCT00117676|449154126|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
124872448|NCT00117676|449154127|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
124872449|NCT00117676|449154126|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
124872450|NCT00117676|449154127|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
124872451|NCT00117676|449154126|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
124872452|NCT00117676|449154127|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
124872453|NCT00117676|449154126|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
124872454|NCT00117676|449154127|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
124872455|NCT00117676|449154126|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
124872456|NCT00117676|449154127|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
124872457|NCT00117676|449154126|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
124872458|NCT00117676|449154127|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
124872459|NCT00117676|449154126|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
124872460|NCT00117676|449154127|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
124872461|NCT00117676|449154126|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
124872462|NCT00117676|449154127|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
124872463|NCT00117676|449154126|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
124872464|NCT00117676|449154127|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
124872465|NCT00117676|449154126|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
124872466|NCT00117676|449154127|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
124872467|NCT00117676|449154126|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
124872468|NCT00117676|449154127|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
124872469|NCT00117676|449154126|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
124872470|NCT00117676|449154127|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
124872471|NCT00117676|449154126|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
124872472|NCT00117676|449154127|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
124872473|NCT00117676|449154126|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
124872474|NCT00117676|449154127|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
124872475|NCT00117676|449154126|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
124872476|NCT00117676|449154127|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
124872477|NCT00117676|449154126|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
124872478|NCT00117676|449154127|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
124872479|NCT00117676|449154126|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
124872480|NCT00117676|449154127|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
124872481|NCT00117676|449154126|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
124872482|NCT00117676|449154127|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
124872483|NCT00117676|449154126|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
124872484|NCT00117676|449154127|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
124872485|NCT00117676|449154126|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
124872486|NCT00117676|449154127|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
124872487|NCT00117676|449154126|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
124872488|NCT00117676|449154127|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
124872489|NCT00117676|449154126|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
124872490|NCT00117676|449154127|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
124872491|NCT00117676|449154126|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
124872492|NCT00117676|449154127|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
124872493|NCT00117676|449154126|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
124872494|NCT00117676|449154127|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
124872495|NCT00117676|449154126|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
124872496|NCT00117676|449154127|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
124872497|NCT00117676|449154126|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
124872498|NCT00117676|449154127|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
124872499|NCT00117676|449154126|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
124872500|NCT00117676|449154127|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
125312099|NCT01695135|450770673|FG001|Open Label Extension Treatment Phase|Other|0|||
124983059|NCT04679935|449564854|FG000|Overall Study|Death|0|||
124983060|NCT04679935|449564855|FG001|Overall Study|Death|1|||
125312100|NCT01695135|450770674|FG002|Open Label Extension Treatment Phase|Other|4|||
125312101|NCT01695135|450770675|FG003|Open Label Extension Treatment Phase|Other|7|||
125312102|NCT01695135|450770672|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
125312103|NCT01695135|450770673|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
125312104|NCT01695135|450770674|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
125312105|NCT01695135|450770675|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
125312106|NCT01695135|450770672|FG000|Open Label Extension Treatment Phase|Death|0|||
125312107|NCT01695135|450770673|FG001|Open Label Extension Treatment Phase|Death|0|||
125312108|NCT01695135|450770674|FG002|Open Label Extension Treatment Phase|Death|2|||
125312109|NCT01695135|450770675|FG003|Open Label Extension Treatment Phase|Death|7|||
125312110|NCT01695135|450770672|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
125312111|NCT01695135|450770673|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
125312112|NCT01695135|450770674|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
125312113|NCT01695135|450770675|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
125312114|NCT02562716|450770676|FG000|Overall Study|Adverse Event|7|||
125312115|NCT02562716|450770677|FG001|Overall Study|Adverse Event|14|||
125312116|NCT02562716|450770676|FG000|Overall Study|Withdrawal unrelated to AE|7|||
125312117|NCT02562716|450770677|FG001|Overall Study|Withdrawal unrelated to AE|1|||
125312118|NCT02562716|450770676|FG000|Overall Study|Progression|8|||
125312119|NCT02562716|450770677|FG001|Overall Study|Progression|10|||
125312120|NCT02562716|450770676|FG000|Overall Study|Death|2|||
125312121|NCT02562716|450770677|FG001|Overall Study|Death|1|||
125312122|NCT02562716|450770676|FG000|Overall Study|Not protocol specified|4|||
125312123|NCT02562716|450770677|FG001|Overall Study|Not protocol specified|2|||
125312124|NCT00684996|450770678|FG000|Overall Study|Adverse Event|1|||
125312125|NCT00684996|450770678|FG000|Overall Study|Refusal unrelated to adverse event|1|||
125312126|NCT00684996|450770678|FG000|Overall Study|Progression/relapse|2|||
125312127|NCT00684996|450770678|FG000|Overall Study|Other reasons not protocol specified|1|||
125312128|NCT01076959|450770681|FG000|Overall Study|Adverse Event|767|||
125312129|NCT01076959|450770681|FG000|Overall Study|Lack of Efficacy|849|||
125312130|NCT01076959|450770681|FG000|Overall Study|Non-compliance|274|||
125312131|NCT01076959|450770681|FG000|Overall Study|Lost to Follow-up|241|||
125312132|NCT01076959|450770681|FG000|Overall Study|Other|119|||
125312133|NCT01078441|450770682|FG000|Overall Study|Withdrawal by Subject|1|||
124983078|NCT02993146|449564872|FG000|Overall Study|Withdrawal by Subject|0|||
124983079|NCT02993146|449564873|FG001|Overall Study|Withdrawal by Subject|0|||
124983080|NCT02993146|449564874|FG002|Overall Study|Withdrawal by Subject|1|||
124983081|NCT02993146|449564875|FG003|Overall Study|Withdrawal by Subject|1|||
124983082|NCT04362189|449564876|FG000|Overall Study|Lost to Follow-up|0|||
124983083|NCT04362189|449564877|FG001|Overall Study|Lost to Follow-up|1|||
124983084|NCT04362189|449564876|FG000|Overall Study|Withdrawal by Subject|1|||
125312134|NCT01425801|450770683|FG000|Period 1|Withdrawal by Subject|0|||
125312135|NCT01425801|450770684|FG001|Period 1|Withdrawal by Subject|0|||
125312136|NCT01425801|450770685|FG002|Period 1|Withdrawal by Subject|0|||
124983085|NCT04362189|449564877|FG001|Overall Study|Withdrawal by Subject|0|||
124983086|NCT04362189|449564876|FG000|Overall Study|FDA Clinical Hold|7|||
124983087|NCT04362189|449564877|FG001|Overall Study|FDA Clinical Hold|2|||
125312137|NCT01425801|450770686|FG003|Period 1|Withdrawal by Subject|0|||
124983088|NCT04362189|449564876|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
124983089|NCT04362189|449564877|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
124983090|NCT04362189|449564876|FG000|Overall Study|Adverse Event|0|||
124983091|NCT04362189|449564877|FG001|Overall Study|Adverse Event|2|||
124983092|NCT04362189|449564876|FG000|Overall Study|Death|4|||
124983093|NCT04362189|449564877|FG001|Overall Study|Death|1|||
124983094|NCT02111681|449564878|FG000|Overall Study|Death|5|||
124983095|NCT02111681|449564878|FG000|Overall Study|Lack of Efficacy|2|||
124983096|NCT02111681|449564878|FG000|Overall Study|Progression of disease|4|||
125312138|NCT01425801|450770687|FG004|Period 1|Withdrawal by Subject|1|||
125312139|NCT01425801|450770688|FG005|Period 1|Withdrawal by Subject|0|||
125312140|NCT01425801|450770683|FG000|Period 2|Withdrawal by Subject|0|||
125312141|NCT01425801|450770684|FG001|Period 2|Withdrawal by Subject|0|||
125312142|NCT01425801|450770685|FG002|Period 2|Withdrawal by Subject|0|||
125312143|NCT01425801|450770686|FG003|Period 2|Withdrawal by Subject|0|||
125312144|NCT01425801|450770687|FG004|Period 2|Withdrawal by Subject|1|||
125312145|NCT01425801|450770688|FG005|Period 2|Withdrawal by Subject|0|||
125312146|NCT01425801|450770683|FG000|Period 3|Stability criteria not fullfilled|0|||
125312147|NCT01425801|450770684|FG001|Period 3|Stability criteria not fullfilled|0|||
125312148|NCT01425801|450770685|FG002|Period 3|Stability criteria not fullfilled|1|||
125312149|NCT01425801|450770686|FG003|Period 3|Stability criteria not fullfilled|0|||
125312150|NCT01425801|450770687|FG004|Period 3|Stability criteria not fullfilled|0|||
125312151|NCT01425801|450770688|FG005|Period 3|Stability criteria not fullfilled|0|||
125312152|NCT01425801|450770683|FG000|Period 4|Not able to maintain visit schedule|0|||
125312153|NCT01425801|450770684|FG001|Period 4|Not able to maintain visit schedule|0|||
125312154|NCT01425801|450770685|FG002|Period 4|Not able to maintain visit schedule|1|||
125312155|NCT01425801|450770686|FG003|Period 4|Not able to maintain visit schedule|0|||
125312156|NCT01425801|450770687|FG004|Period 4|Not able to maintain visit schedule|0|||
125312157|NCT01425801|450770688|FG005|Period 4|Not able to maintain visit schedule|0|||
125312158|NCT02868554|450770689|FG000|Overall Study|Lost to Follow-up|3|||
125312159|NCT02868554|450770690|FG001|Overall Study|Lost to Follow-up|0|||
125312160|NCT02868554|450770691|FG002|Overall Study|Lost to Follow-up|1|||
125312161|NCT02175017|450770692|FG000|Overall Study|Did not receive the investigational product|1|||
125312162|NCT02175017|450770693|FG001|Overall Study|Did not receive the investigational product|2|||
124983184|NCT04349631|449565182|FG000|Overall Study|Lost to Follow-up|3|||
124983185|NCT04349631|449565182|FG000|Overall Study|Withdrawal by Subject|7|||
125312163|NCT02175017|450770692|FG000|Overall Study|Withdrawal by Subject|6|||
125312164|NCT02175017|450770693|FG001|Overall Study|Withdrawal by Subject|3|||
124983216|NCT01982448|449565186|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
124983217|NCT01982448|449565187|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
124983218|NCT01982448|449565186|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
124983219|NCT01982448|449565187|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
124983220|NCT01982448|449565186|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
124983221|NCT01982448|449565187|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
124983222|NCT01982448|449565186|FG000|Preoperative Chemotherapy|Lost to Follow-up|1|||
124983223|NCT01982448|449565187|FG001|Preoperative Chemotherapy|Lost to Follow-up|0|||
125033581|NCT00408005|449743811|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
125033582|NCT00408005|449743812|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
125033583|NCT00408005|449743813|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
125033584|NCT00408005|449743814|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
125033585|NCT00408005|449743815|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
125033586|NCT00408005|449743816|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
125033587|NCT00408005|449743817|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
125033588|NCT00408005|449743818|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
125033589|NCT00408005|449743811|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
125033590|NCT00408005|449743812|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
125033591|NCT00408005|449743813|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
125033592|NCT00408005|449743814|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
125033593|NCT00408005|449743815|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
125033594|NCT00408005|449743816|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
125033595|NCT00408005|449743817|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
125033596|NCT00408005|449743818|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
125033597|NCT00408005|449743811|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
125033598|NCT00408005|449743812|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
125033599|NCT00408005|449743813|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
125033600|NCT00408005|449743814|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
125033601|NCT00408005|449743815|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
125033602|NCT00408005|449743816|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
125312165|NCT02175017|450770692|FG000|Overall Study|Met an exclusion criteria|0|||
125312166|NCT02175017|450770693|FG001|Overall Study|Met an exclusion criteria|1|||
125033603|NCT00408005|449743817|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
125033604|NCT00408005|449743818|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
125033605|NCT00408005|449743811|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
125033606|NCT00408005|449743812|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
125033607|NCT00408005|449743813|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
125033608|NCT00408005|449743814|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
125033609|NCT00408005|449743815|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
125033610|NCT00408005|449743816|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
125033611|NCT00408005|449743817|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
125033612|NCT00408005|449743818|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
125033613|NCT00408005|449743811|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
125033614|NCT00408005|449743812|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
125033615|NCT00408005|449743813|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
125033616|NCT00408005|449743814|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
125033617|NCT00408005|449743815|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
125033618|NCT00408005|449743816|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
125033619|NCT00408005|449743817|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
125312167|NCT02175017|450770692|FG000|Overall Study|Adverse Event|3|||
125312168|NCT02175017|450770693|FG001|Overall Study|Adverse Event|10|||
125312169|NCT02175017|450770692|FG000|Overall Study|Disease progression|20|||
125312170|NCT02175017|450770693|FG001|Overall Study|Disease progression|27|||
125312171|NCT02175017|450770692|FG000|Overall Study|Other than above reasons|3|||
125312172|NCT02175017|450770693|FG001|Overall Study|Other than above reasons|0|||
125312173|NCT04915729|450770694|FG000|Overall Study|Lost to Follow-up|20|||
125312174|NCT04915729|450770695|FG001|Overall Study|Lost to Follow-up|10|||
125312175|NCT04915729|450770694|FG000|Overall Study|Withdrawal by Subject|12|||
125312176|NCT04915729|450770695|FG001|Overall Study|Withdrawal by Subject|5|||
125312177|NCT04915729|450770694|FG000|Overall Study|Death|34|||
125312178|NCT04915729|450770695|FG001|Overall Study|Death|44|||
125312179|NCT04915729|450770694|FG000|Overall Study|not treated|3|||
124983224|NCT02898077|449567261|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
125312180|NCT04915729|450770695|FG001|Overall Study|not treated|6|||
125312181|NCT04915729|450770694|FG000|Overall Study|Investigator removed subject|1|||
125312182|NCT04915729|450770695|FG001|Overall Study|Investigator removed subject|2|||
125312183|NCT04915729|450770694|FG000|Overall Study|questionnaire result not evaluated|1|||
125312184|NCT04915729|450770695|FG001|Overall Study|questionnaire result not evaluated|0|||
125312185|NCT04915729|450770694|FG000|Overall Study|refuse of hospital visit|1|||
125312186|NCT04915729|450770695|FG001|Overall Study|refuse of hospital visit|3|||
125312187|NCT04915729|450770694|FG000|Overall Study|Subject withdrew|1|||
125312188|NCT04915729|450770695|FG001|Overall Study|Subject withdrew|0|||
125312189|NCT02294058|450770703|FG000|Overall Study|Adverse Event|16|||
125312190|NCT02294058|450770704|FG001|Overall Study|Adverse Event|7|||
125312191|NCT02294058|450770705|FG002|Overall Study|Adverse Event|13|||
125312192|NCT02294058|450770703|FG000|Overall Study|Lack of Efficacy|3|||
125312193|NCT02294058|450770704|FG001|Overall Study|Lack of Efficacy|3|||
125312194|NCT02294058|450770705|FG002|Overall Study|Lack of Efficacy|0|||
125312195|NCT02294058|450770703|FG000|Overall Study|Lost to Follow-up|1|||
125312196|NCT02294058|450770704|FG001|Overall Study|Lost to Follow-up|0|||
125312197|NCT02294058|450770705|FG002|Overall Study|Lost to Follow-up|2|||
125312198|NCT02294058|450770703|FG000|Overall Study|Withdrawal by Subject|10|||
125312199|NCT02294058|450770704|FG001|Overall Study|Withdrawal by Subject|14|||
125312200|NCT02294058|450770705|FG002|Overall Study|Withdrawal by Subject|13|||
125312201|NCT02294058|450770703|FG000|Overall Study|Physician Decision|2|||
125312202|NCT02294058|450770704|FG001|Overall Study|Physician Decision|1|||
125312203|NCT02294058|450770705|FG002|Overall Study|Physician Decision|0|||
125312204|NCT02294058|450770703|FG000|Overall Study|Miscellaneous|4|||
125312205|NCT02294058|450770704|FG001|Overall Study|Miscellaneous|1|||
125312206|NCT02294058|450770705|FG002|Overall Study|Miscellaneous|1|||
125312207|NCT03575403|450770707|FG000|Overall Study|Adverse Event|1|||
125312208|NCT03575403|450770708|FG001|Overall Study|Adverse Event|0|||
125312209|NCT03575403|450770709|FG002|Overall Study|Adverse Event|0|||
125312210|NCT03575403|450770707|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
125312211|NCT03575403|450770708|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
124983225|NCT02898077|449567262|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
124983226|NCT02898077|449567261|FG000|Overall Study|Lost to Follow-up|4|||
124983227|NCT02898077|449567262|FG001|Overall Study|Lost to Follow-up|3|||
124983228|NCT02898077|449567261|FG000|Overall Study|Physician Decision|0|||
124983229|NCT02898077|449567262|FG001|Overall Study|Physician Decision|2|||
124983230|NCT02898077|449567261|FG000|Overall Study|Sponsor Decision|32|||
124983231|NCT02898077|449567262|FG001|Overall Study|Sponsor Decision|13|||
124983232|NCT02898077|449567261|FG000|Overall Study|Withdrawal by Subject|6|||
124983233|NCT02898077|449567262|FG001|Overall Study|Withdrawal by Subject|3|||
124983234|NCT02898077|449567261|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
124983235|NCT02898077|449567262|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
124983236|NCT02898077|449567261|FG000|Overall Study|Ended extension period|3|||
124983237|NCT02898077|449567262|FG001|Overall Study|Ended extension period|0|||
124983238|NCT00621777|449567263|FG000|Open Phase|Adverse Event|20|||
124983239|NCT00621777|449567264|FG001|Open Phase|Adverse Event|0|||
124983240|NCT00621777|449567263|FG000|Open Phase|Did not abstain during open phase|56|||
124983241|NCT00621777|449567264|FG001|Open Phase|Did not abstain during open phase|0|||
124983242|NCT00621777|449567263|FG000|Open Phase|Withdrawal by Subject|17|||
124983243|NCT00621777|449567264|FG001|Open Phase|Withdrawal by Subject|0|||
124983244|NCT00621777|449567263|FG000|Open Phase|administrative|13|||
124983245|NCT00621777|449567264|FG001|Open Phase|administrative|0|||
124983246|NCT00621777|449567263|FG000|Open Phase|Lost to Follow-up|10|||
124983247|NCT00621777|449567264|FG001|Open Phase|Lost to Follow-up|0|||
124983248|NCT00621777|449567263|FG000|Randomized Phase|Adverse Event|3|||
124983249|NCT00621777|449567264|FG001|Randomized Phase|Adverse Event|3|||
124983250|NCT00621777|449567263|FG000|Randomized Phase|Lost to Follow-up|3|||
125312212|NCT03575403|450770709|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
125312213|NCT02330055|450770710|FG000|Overall Study|technical issues|2|||
125312214|NCT02330055|450770711|FG001|Overall Study|technical issues|0|||
124983251|NCT00621777|449567264|FG001|Randomized Phase|Lost to Follow-up|3|||
124983252|NCT00621777|449567263|FG000|Randomized Phase|Withdrawal by Subject|1|||
124983253|NCT00621777|449567264|FG001|Randomized Phase|Withdrawal by Subject|9|||
124983254|NCT00621777|449567263|FG000|Randomized Phase|administrative|0|||
124983255|NCT00621777|449567264|FG001|Randomized Phase|administrative|3|||
124983256|NCT00621777|449567263|FG000|Randomized Phase|Death|0|||
124983257|NCT00621777|449567264|FG001|Randomized Phase|Death|1|||
125312215|NCT02330055|450770710|FG000|Overall Study|participant forgot to wear device|5|||
125312216|NCT02330055|450770711|FG001|Overall Study|participant forgot to wear device|5|||
125312217|NCT02330055|450770710|FG000|Overall Study|data for less than 60 minutes|3|||
125312218|NCT02330055|450770711|FG001|Overall Study|data for less than 60 minutes|3|||
125312219|NCT02330055|450770710|FG000|Overall Study|participant did not sleep|0|||
125312220|NCT02330055|450770711|FG001|Overall Study|participant did not sleep|1|||
125312221|NCT03359174|450770714|FG000|Overall Study|Adverse Event|1|||
125312222|NCT01332994|450770718|FG000|Overall Study|Adverse Event|34|||
125312223|NCT01332994|450770718|FG000|Overall Study|Death|1|||
125312224|NCT01332994|450770718|FG000|Overall Study|Lack of Efficacy|1|||
125312225|NCT01332994|450770718|FG000|Overall Study|Lost to Follow-up|4|||
125312226|NCT01332994|450770718|FG000|Overall Study|Protocol Violation|6|||
125312227|NCT01332994|450770718|FG000|Overall Study|Withdrawal by Subject|15|||
125312228|NCT01332994|450770718|FG000|Overall Study|Administrative Problem|2|||
125312229|NCT01332994|450770718|FG000|Overall Study|Other|8|||
125312230|NCT02800863|450770719|FG000|Overall Study|Adverse Event|14|||
125312231|NCT02800863|450770719|FG000|Overall Study|Another Device Implanted|1|||
125312232|NCT02800863|450770719|FG000|Overall Study|Device Explanted|1|||
125312233|NCT02800863|450770719|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
125312234|NCT02800863|450770719|FG000|Overall Study|Health Issues|1|||
125312235|NCT02800863|450770719|FG000|Overall Study|Insurance Denial|8|||
125312236|NCT02800863|450770719|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
125312237|NCT02800863|450770719|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
125312238|NCT02800863|450770719|FG000|Overall Study|Screen Failure|1|||
124983258|NCT04410523|449567265|FG000|Overall Study|Study terminated by sponsor|1|||
124983259|NCT04410523|449567266|FG001|Overall Study|Study terminated by sponsor|3|||
124983260|NCT04410523|449567267|FG002|Overall Study|Study terminated by sponsor|2|||
124983261|NCT04410523|449567268|FG003|Overall Study|Study terminated by sponsor|6|||
124983262|NCT04410523|449567269|FG004|Overall Study|Study terminated by sponsor|3|||
124983263|NCT04410523|449567270|FG005|Overall Study|Study terminated by sponsor|4|||
124983264|NCT04410523|449567265|FG000|Overall Study|Adverse Event|1|||
124983265|NCT04410523|449567266|FG001|Overall Study|Adverse Event|0|||
124983266|NCT04410523|449567267|FG002|Overall Study|Adverse Event|0|||
124983267|NCT04410523|449567268|FG003|Overall Study|Adverse Event|0|||
124983268|NCT04410523|449567269|FG004|Overall Study|Adverse Event|0|||
124983269|NCT04410523|449567270|FG005|Overall Study|Adverse Event|2|||
124983270|NCT04410523|449567265|FG000|Overall Study|Lost to Follow-up|0|||
124983271|NCT04410523|449567266|FG001|Overall Study|Lost to Follow-up|1|||
124983272|NCT04410523|449567267|FG002|Overall Study|Lost to Follow-up|0|||
124983273|NCT04410523|449567268|FG003|Overall Study|Lost to Follow-up|0|||
124983274|NCT04410523|449567269|FG004|Overall Study|Lost to Follow-up|0|||
124983275|NCT04410523|449567270|FG005|Overall Study|Lost to Follow-up|0|||
124983276|NCT04410523|449567265|FG000|Overall Study|Physician Decision|0|||
124983277|NCT04410523|449567266|FG001|Overall Study|Physician Decision|1|||
124983278|NCT04410523|449567267|FG002|Overall Study|Physician Decision|0|||
124983279|NCT04410523|449567268|FG003|Overall Study|Physician Decision|0|||
124983280|NCT04410523|449567269|FG004|Overall Study|Physician Decision|0|||
124983281|NCT04410523|449567270|FG005|Overall Study|Physician Decision|0|||
124983282|NCT04410523|449567265|FG000|Overall Study|Pregnancy|0|||
124983283|NCT04410523|449567266|FG001|Overall Study|Pregnancy|0|||
124983284|NCT04410523|449567267|FG002|Overall Study|Pregnancy|0|||
124983285|NCT04410523|449567268|FG003|Overall Study|Pregnancy|0|||
124983286|NCT04410523|449567269|FG004|Overall Study|Pregnancy|0|||
124983287|NCT04410523|449567270|FG005|Overall Study|Pregnancy|1|||
124983288|NCT04410523|449567265|FG000|Overall Study|Protocol deviation|0|||
124983289|NCT04410523|449567266|FG001|Overall Study|Protocol deviation|0|||
124983290|NCT04410523|449567267|FG002|Overall Study|Protocol deviation|0|||
124983291|NCT04410523|449567268|FG003|Overall Study|Protocol deviation|0|||
124983292|NCT04410523|449567269|FG004|Overall Study|Protocol deviation|0|||
124983293|NCT04410523|449567270|FG005|Overall Study|Protocol deviation|2|||
124983294|NCT04410523|449567265|FG000|Overall Study|Subject decision|2|||
124983295|NCT04410523|449567266|FG001|Overall Study|Subject decision|0|||
124983296|NCT04410523|449567267|FG002|Overall Study|Subject decision|0|||
124983297|NCT04410523|449567268|FG003|Overall Study|Subject decision|1|||
124983298|NCT04410523|449567269|FG004|Overall Study|Subject decision|0|||
124983299|NCT04410523|449567270|FG005|Overall Study|Subject decision|1|||
124983300|NCT01239043|449567271|FG000|Overall Study|Protocol Violation|2|||
124983301|NCT01239043|449567272|FG001|Overall Study|Protocol Violation|1|||
125312239|NCT02800863|450770719|FG000|Overall Study|Sponsor Request|6|||
125312240|NCT02800863|450770719|FG000|Overall Study|Death|3|||
125312241|NCT02800863|450770719|FG000|Overall Study|Subject Implant at Another Facility|1|||
125312242|NCT02800863|450770719|FG000|Overall Study|Lost to Follow-up|26|||
125312243|NCT02800863|450770719|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
124983302|NCT01519089|449567273|FG000|Overall Study|Adverse Event|4|||
124983303|NCT01519089|449567274|FG001|Overall Study|Adverse Event|4|||
124983304|NCT01519089|449567273|FG000|Overall Study|Lack of Efficacy|0|||
124983305|NCT01519089|449567274|FG001|Overall Study|Lack of Efficacy|2|||
124983306|NCT01519089|449567273|FG000|Overall Study|Lost to Follow-up|1|||
124983307|NCT01519089|449567274|FG001|Overall Study|Lost to Follow-up|0|||
124983308|NCT01519089|449567273|FG000|Overall Study|Withdrawal by Subject|0|||
124983309|NCT01519089|449567274|FG001|Overall Study|Withdrawal by Subject|2|||
124983310|NCT01519089|449567273|FG000|Overall Study|Other|2|||
124983311|NCT01519089|449567274|FG001|Overall Study|Other|6|||
125312244|NCT02800863|450770719|FG000|Overall Study|Subject and/or Family Request|64|||
125312245|NCT02800863|450770719|FG000|Overall Study|Trial Failure|81|||
125312246|NCT02800863|450770719|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
125312247|NCT00279916|450770720|FG000|Overall Study|Withdrawal by Subject|4|||
125312248|NCT00279916|450770721|FG001|Overall Study|Withdrawal by Subject|3|||
125312249|NCT00279916|450770720|FG000|Overall Study|Lost to Follow-up|3|||
125312250|NCT00279916|450770721|FG001|Overall Study|Lost to Follow-up|2|||
125312251|NCT01807598|450770722|FG000|Overall Study|Withdrawal by Subject|4|||
125312252|NCT01807598|450770722|FG000|Overall Study|Adverse Event|1|||
125312253|NCT01807598|450770722|FG000|Overall Study|Other Physician Decision|1|||
125312254|NCT02717494|450770723|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
125312255|NCT02717494|450770724|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
125312256|NCT02717494|450770725|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
125312257|NCT02717494|450770723|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
125312258|NCT02717494|450770724|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
125312259|NCT02717494|450770725|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
125312260|NCT02717494|450770723|FG000|First Intervention (Step 1)|Death|0|||
125312261|NCT02717494|450770724|FG001|First Intervention (Step 1)|Death|0|||
125312262|NCT02717494|450770725|FG002|First Intervention (Step 1)|Death|1|||
125312263|NCT02717494|450770723|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
125312264|NCT02717494|450770724|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
125312265|NCT02717494|450770725|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
125312266|NCT00731679|450770726|FG000|Overall Study|Adverse Event|7|||
125312267|NCT00731679|450770727|FG001|Overall Study|Adverse Event|8|||
125312268|NCT00731679|450770726|FG000|Overall Study|Withdrawal by Subject|8|||
125312269|NCT00731679|450770727|FG001|Overall Study|Withdrawal by Subject|8|||
125312270|NCT00731679|450770726|FG000|Overall Study|Lost to Follow-up|7|||
125312271|NCT00731679|450770727|FG001|Overall Study|Lost to Follow-up|8|||
125312272|NCT00731679|450770726|FG000|Overall Study|Noncompliance|0|||
125312273|NCT00731679|450770727|FG001|Overall Study|Noncompliance|1|||
125312274|NCT00731679|450770726|FG000|Overall Study|Pregnancy|0|||
125312275|NCT00731679|450770727|FG001|Overall Study|Pregnancy|1|||
125312276|NCT02488005|450770730|FG000|Overall Study|Lost to Follow-up|2|||
125312277|NCT02326597|450770733|FG000|Overall Study|Lost to Follow-up|42|||
125312278|NCT02326597|450770734|FG001|Overall Study|Lost to Follow-up|32|||
125312279|NCT04089761|450770737|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
125312280|NCT04089761|450770737|FG000|"Run In Phase"|Lost to Follow-up|1|||
125312281|NCT04089761|450770737|FG000|"Treatment Phase"|No evaluable data|5|||
125312282|NCT04089761|450770737|FG000|"Treatment Phase"|Lost to Follow-up|1|||
125312283|NCT04739436|450770739|FG000|Overall Study|Lost to Follow-up|21|||
125312284|NCT04739436|450770740|FG001|Overall Study|Lost to Follow-up|23|||
125312285|NCT04739436|450770739|FG000|Overall Study|Withdrawal by Subject|4|||
125312286|NCT04739436|450770740|FG001|Overall Study|Withdrawal by Subject|6|||
125312287|NCT04739436|450770739|FG000|Overall Study|not randomized properly|1|||
125312288|NCT04739436|450770740|FG001|Overall Study|not randomized properly|0|||
125312289|NCT00428948|450770742|FG000|Overall Study|Lost to Follow-up|15|||
125312290|NCT00428948|450770743|FG001|Overall Study|Lost to Follow-up|8|||
125312291|NCT00428948|450770742|FG000|Overall Study|Adverse Event|148|||
125312292|NCT00428948|450770743|FG001|Overall Study|Adverse Event|24|||
125312293|NCT00428948|450770742|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
125312294|NCT00428948|450770743|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
125312295|NCT00428948|450770742|FG000|Overall Study|Investigator Withdrew Subject|3|||
125312296|NCT00428948|450770743|FG001|Overall Study|Investigator Withdrew Subject|4|||
125312297|NCT00428948|450770742|FG000|Overall Study|Subject Withdrew Consent|50|||
125312298|NCT00428948|450770743|FG001|Overall Study|Subject Withdrew Consent|30|||
125312299|NCT00428948|450770742|FG000|Overall Study|Protocol Deviation|1|||
125312300|NCT00428948|450770743|FG001|Overall Study|Protocol Deviation|1|||
125312301|NCT03449758|450772288|FG000|Overall Study|Major protocol deviation|1|||
125312302|NCT03449758|450772288|FG000|Overall Study|Treatment inefficacy|5|||
125312303|NCT03449758|450772288|FG000|Overall Study|Adverse Event|9|||
125312304|NCT03449758|450772288|FG000|Overall Study|Consent withdrawal|1|||
125312305|NCT03449758|450772288|FG000|Overall Study|Other unspecified reason|3|||
125312306|NCT00922623|450772292|FG000|Overall Study|Other|4|||
125312307|NCT00922623|450772292|FG000|Overall Study|Lost to Follow-up|1|||
125312308|NCT01402817|450772293|FG000|Overall Study|Withdrawal by Subject|3|||
125312309|NCT01402817|450772293|FG000|Overall Study|Study Suspended by FDA|8|||
125312310|NCT03310723|450772295|FG000|Overall Study|Withdrawal by Subject|0|||
125312311|NCT03310723|450772296|FG001|Overall Study|Withdrawal by Subject|1|||
125312312|NCT03310723|450772295|FG000|Overall Study|Protocol Violation|0|||
125312313|NCT03310723|450772296|FG001|Overall Study|Protocol Violation|2|||
125312314|NCT01410890|450772297|FG000|Overall Study|Withdrawal by Subject|0|||
125312315|NCT01410890|450772298|FG001|Overall Study|Withdrawal by Subject|1|||
125312316|NCT01121146|450772299|FG000|Overall Study|Death|17|||
125312317|NCT01121146|450772300|FG001|Overall Study|Death|15|||
125312318|NCT01121146|450772299|FG000|Overall Study|Adverse Event|2|||
125312319|NCT01121146|450772300|FG001|Overall Study|Adverse Event|11|||
125312320|NCT01121146|450772299|FG000|Overall Study|Lost to Follow-up|7|||
125312321|NCT01121146|450772300|FG001|Overall Study|Lost to Follow-up|16|||
125312322|NCT00997035|450772303|FG000|3-week Followup Visit|Lost to Follow-up|9|||
125312323|NCT00997035|450772304|FG001|3-week Followup Visit|Lost to Follow-up|6|||
125312324|NCT00997035|450772303|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
125312325|NCT00997035|450772304|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
125312326|NCT01380769|450772305|FG000|Overall Study|Withdrawal by Subject|7|||
125312327|NCT01380769|450772306|FG001|Overall Study|Withdrawal by Subject|11|||
125312328|NCT01380769|450772305|FG000|Overall Study|Physician Decision|1|||
125312329|NCT01380769|450772306|FG001|Overall Study|Physician Decision|1|||
125312330|NCT01380769|450772305|FG000|Overall Study|Adverse Event|1|||
125312331|NCT01380769|450772306|FG001|Overall Study|Adverse Event|1|||
125312332|NCT01380769|450772305|FG000|Overall Study|Protocol Violation|0|||
125312333|NCT01380769|450772306|FG001|Overall Study|Protocol Violation|1|||
125312334|NCT02640547|450772307|FG000|Overall Study|Failure to Return|1|||
125312335|NCT02640547|450772307|FG000|Overall Study|Withdrawal by Subject|1|||
125312336|NCT02640547|450772307|FG000|Overall Study|Death|6|||
125312337|NCT02640547|450772307|FG000|Overall Study|Miscellaneous|3|||
125312338|NCT02753946|450772321|FG000|Overall Study|Adverse Event|7|||
125312339|NCT02753946|450772322|FG001|Overall Study|Adverse Event|6|||
125312340|NCT02753946|450772321|FG000|Overall Study|Withdrawal by Subject|6|||
125312341|NCT02753946|450772322|FG001|Overall Study|Withdrawal by Subject|1|||
125312342|NCT02753946|450772321|FG000|Overall Study|Lack of Efficacy|1|||
125312343|NCT02753946|450772322|FG001|Overall Study|Lack of Efficacy|0|||
125312344|NCT02753946|450772321|FG000|Overall Study|Physician Decision|0|||
125312345|NCT02753946|450772322|FG001|Overall Study|Physician Decision|2|||
125312346|NCT02519439|450772323|FG000|Overall Study|Study Termination|19|||
125312347|NCT02519439|450772323|FG000|Overall Study|Withdrawal by Subject|1|||
125312348|NCT02519439|450772323|FG000|Overall Study|Adverse Event|1|||
125312349|NCT01539759|450772328|FG000|Overall Study|Lost to Follow-up|6|||
125312350|NCT01539759|450772329|FG001|Overall Study|Lost to Follow-up|8|||
125312351|NCT03901144|450772330|FG000|Overall Study|Lost to Follow-up|1|||
125312352|NCT03901144|450772331|FG001|Overall Study|Lost to Follow-up|1|||
125312353|NCT03901144|450772332|FG002|Overall Study|Lost to Follow-up|1|||
125312354|NCT03901144|450772333|FG003|Overall Study|Lost to Follow-up|1|||
125312355|NCT02491983|450772334|FG000|Overall Study|Physician Decision|1|||
125312356|NCT02491983|450772335|FG001|Overall Study|Physician Decision|0|||
125312357|NCT02491983|450772334|FG000|Overall Study|Not meet selection criteria|1|||
125312358|NCT02491983|450772335|FG001|Overall Study|Not meet selection criteria|0|||
125312359|NCT02491983|450772334|FG000|Overall Study|Withdrawal by Subject|0|||
125312360|NCT02491983|450772335|FG001|Overall Study|Withdrawal by Subject|1|||
125312361|NCT02714569|450772336|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
125312362|NCT02714569|450772337|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
125312363|NCT02714569|450772338|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
125312364|NCT02714569|450772339|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
125312365|NCT02714569|450772340|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
125312366|NCT02714569|450772341|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
125312367|NCT02714569|450772342|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
125312368|NCT02714569|450772343|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
125312369|NCT02714569|450772344|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
125312370|NCT02714569|450772345|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
125312371|NCT02714569|450772346|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
125312372|NCT02714569|450772336|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
125312373|NCT02714569|450772337|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
125312374|NCT02714569|450772338|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
125312375|NCT02714569|450772339|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
125312376|NCT02714569|450772340|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
125312377|NCT02714569|450772341|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
125312378|NCT02714569|450772342|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
125312379|NCT02714569|450772343|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
125312380|NCT02714569|450772344|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
125312381|NCT02714569|450772345|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
125312382|NCT02714569|450772346|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
125312383|NCT02714569|450772336|FG000|Part A Third Intervention|Adverse Event|0|||
125312384|NCT02714569|450772337|FG001|Part A Third Intervention|Adverse Event|0|||
125312385|NCT02714569|450772338|FG002|Part A Third Intervention|Adverse Event|1|||
125312386|NCT02714569|450772339|FG003|Part A Third Intervention|Adverse Event|0|||
125312387|NCT02714569|450772340|FG004|Part A Third Intervention|Adverse Event|0|||
125312388|NCT02714569|450772341|FG005|Part A Third Intervention|Adverse Event|0|||
125312389|NCT02714569|450772342|FG006|Part A Third Intervention|Adverse Event|0|||
125312390|NCT02714569|450772343|FG007|Part A Third Intervention|Adverse Event|0|||
125312391|NCT02714569|450772344|FG008|Part A Third Intervention|Adverse Event|0|||
125312392|NCT02714569|450772345|FG009|Part A Third Intervention|Adverse Event|0|||
125312393|NCT02714569|450772346|FG010|Part A Third Intervention|Adverse Event|0|||
125312394|NCT02714569|450772336|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
125312395|NCT02714569|450772337|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
125312396|NCT02714569|450772338|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
125312397|NCT02714569|450772339|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
125312398|NCT02714569|450772340|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
125312399|NCT02714569|450772341|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
125312400|NCT02714569|450772342|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
125312401|NCT02714569|450772343|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
125312402|NCT02714569|450772344|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
125312403|NCT02714569|450772345|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
125312404|NCT02714569|450772346|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
125312405|NCT02714569|450772336|FG000|Part B (Overall)|Lost to Follow-up|0|||
125312406|NCT02714569|450772337|FG001|Part B (Overall)|Lost to Follow-up|0|||
125312407|NCT02714569|450772338|FG002|Part B (Overall)|Lost to Follow-up|0|||
125312408|NCT02714569|450772339|FG003|Part B (Overall)|Lost to Follow-up|0|||
125312409|NCT02714569|450772340|FG004|Part B (Overall)|Lost to Follow-up|0|||
125312410|NCT02714569|450772341|FG005|Part B (Overall)|Lost to Follow-up|0|||
125312411|NCT02714569|450772342|FG006|Part B (Overall)|Lost to Follow-up|1|||
125312412|NCT02714569|450772343|FG007|Part B (Overall)|Lost to Follow-up|0|||
125312413|NCT02714569|450772344|FG008|Part B (Overall)|Lost to Follow-up|0|||
125312414|NCT02714569|450772345|FG009|Part B (Overall)|Lost to Follow-up|0|||
125312415|NCT02714569|450772346|FG010|Part B (Overall)|Lost to Follow-up|0|||
125312416|NCT02714569|450772336|FG000|Part B (Overall)|Withdrawal by Subject|0|||
125312417|NCT02714569|450772337|FG001|Part B (Overall)|Withdrawal by Subject|0|||
125312418|NCT02714569|450772338|FG002|Part B (Overall)|Withdrawal by Subject|0|||
125312419|NCT02714569|450772339|FG003|Part B (Overall)|Withdrawal by Subject|0|||
125312420|NCT02714569|450772340|FG004|Part B (Overall)|Withdrawal by Subject|0|||
125312421|NCT02714569|450772341|FG005|Part B (Overall)|Withdrawal by Subject|0|||
125312422|NCT02714569|450772342|FG006|Part B (Overall)|Withdrawal by Subject|0|||
125312423|NCT02714569|450772343|FG007|Part B (Overall)|Withdrawal by Subject|1|||
125312424|NCT02714569|450772344|FG008|Part B (Overall)|Withdrawal by Subject|0|||
125312425|NCT02714569|450772345|FG009|Part B (Overall)|Withdrawal by Subject|1|||
124983312|NCT01519089|449567273|FG000|Overall Study|Not received study drug|0|||
124983313|NCT01519089|449567274|FG001|Overall Study|Not received study drug|1|||
124983314|NCT00127205|449567275|FG000|Overall Study|Adverse Event|228|||
124983315|NCT00127205|449567276|FG001|Overall Study|Adverse Event|387|||
124983316|NCT00127205|449567277|FG002|Overall Study|Adverse Event|273|||
124983317|NCT00127205|449567275|FG000|Overall Study|Death|8|||
124983318|NCT00127205|449567276|FG001|Overall Study|Death|6|||
125312426|NCT02714569|450772346|FG010|Part B (Overall)|Withdrawal by Subject|0|||
125312427|NCT02714569|450772336|FG000|Part B (Overall)|Adverse Event|0|||
125312428|NCT02714569|450772337|FG001|Part B (Overall)|Adverse Event|0|||
125312429|NCT02714569|450772338|FG002|Part B (Overall)|Adverse Event|0|||
125312430|NCT02714569|450772339|FG003|Part B (Overall)|Adverse Event|0|||
125312431|NCT02714569|450772340|FG004|Part B (Overall)|Adverse Event|0|||
125312432|NCT02714569|450772341|FG005|Part B (Overall)|Adverse Event|0|||
125312433|NCT02714569|450772342|FG006|Part B (Overall)|Adverse Event|0|||
125312434|NCT02714569|450772343|FG007|Part B (Overall)|Adverse Event|0|||
125312435|NCT02714569|450772344|FG008|Part B (Overall)|Adverse Event|0|||
125312436|NCT02714569|450772345|FG009|Part B (Overall)|Adverse Event|1|||
125312437|NCT02714569|450772346|FG010|Part B (Overall)|Adverse Event|0|||
125312438|NCT00104650|450772350|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
125312439|NCT00104650|450772351|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
125312440|NCT00104650|450772352|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
125312441|NCT00104650|450772350|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
125312442|NCT00104650|450772351|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
124983319|NCT00127205|449567277|FG002|Overall Study|Death|5|||
124983320|NCT00127205|449567275|FG000|Overall Study|Withdrawal by Subject|318|||
124983321|NCT00127205|449567276|FG001|Overall Study|Withdrawal by Subject|310|||
124983322|NCT00127205|449567277|FG002|Overall Study|Withdrawal by Subject|172|||
125312443|NCT00104650|450772352|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
125312444|NCT00104650|450772350|FG000|Treatment Period (25 Weeks)|Death|7|||
125312445|NCT00104650|450772351|FG001|Treatment Period (25 Weeks)|Death|5|||
125312446|NCT00104650|450772352|FG002|Treatment Period (25 Weeks)|Death|6|||
125312447|NCT00104650|450772350|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
125312448|NCT00104650|450772351|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
125312449|NCT00104650|450772352|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
125312450|NCT00104650|450772350|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
125312451|NCT00104650|450772351|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
125312452|NCT00104650|450772352|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
124983323|NCT00127205|449567275|FG000|Overall Study|Other-non protocol specified|142|||
124983324|NCT00127205|449567276|FG001|Overall Study|Other-non protocol specified|129|||
124983325|NCT00127205|449567277|FG002|Overall Study|Other-non protocol specified|77|||
124983326|NCT00127205|449567275|FG000|Overall Study|Data not reported|6|||
124983327|NCT00127205|449567276|FG001|Overall Study|Data not reported|10|||
124983328|NCT00127205|449567277|FG002|Overall Study|Data not reported|1|||
124983329|NCT00127205|449567275|FG000|Overall Study|Progression|127|||
124983330|NCT00127205|449567276|FG001|Overall Study|Progression|131|||
124983331|NCT00127205|449567277|FG002|Overall Study|Progression|84|||
124983332|NCT00224887|449567281|FG000|Overall Study|Pregnancy|6|||
124983333|NCT00224887|449567282|FG001|Overall Study|Pregnancy|6|||
124983334|NCT03582943|449567287|FG000|Allocated to Groups|Withdrawal by Subject|1|||
124983335|NCT03582943|449567288|FG001|Allocated to Groups|Withdrawal by Subject|1|||
124983336|NCT03582943|449567287|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
124983337|NCT03582943|449567288|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
124983338|NCT03582943|449567287|FG000|Analyzed|Protocol Violation|4|||
124983339|NCT03582943|449567288|FG001|Analyzed|Protocol Violation|1|||
124983340|NCT05032872|449567289|FG000|Overall Study|Adverse Event|1|||
124983341|NCT05032872|449567290|FG001|Overall Study|Adverse Event|0|||
124983342|NCT05032872|449567289|FG000|Overall Study|Lost to Follow-up|2|||
124983343|NCT05032872|449567290|FG001|Overall Study|Lost to Follow-up|4|||
124983344|NCT05032872|449567289|FG000|Overall Study|Withdrawal by Subject|4|||
124983345|NCT05032872|449567290|FG001|Overall Study|Withdrawal by Subject|3|||
124983346|NCT00488475|449567291|FG000|Overall Study|Other|1754|||
124983347|NCT00798590|449567312|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
124983348|NCT00798590|449567313|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
124983349|NCT01163292|449567319|FG000|Overall Study|Lack of Efficacy|9|||
124983350|NCT01163292|449567320|FG001|Overall Study|Lack of Efficacy|0|||
124983351|NCT01163292|449567319|FG000|Overall Study|Adverse Event|6|||
124983352|NCT01163292|449567320|FG001|Overall Study|Adverse Event|0|||
124983353|NCT01163292|449567319|FG000|Overall Study|Initiation of biological therapy|0|||
124983354|NCT01163292|449567320|FG001|Overall Study|Initiation of biological therapy|15|||
124983355|NCT01163292|449567319|FG000|Overall Study|Sufficient response to adalimumab|8|||
124983356|NCT01163292|449567320|FG001|Overall Study|Sufficient response to adalimumab|0|||
124983357|NCT01163292|449567319|FG000|Overall Study|Refusal to receive adalimumab|7|||
124983358|NCT01163292|449567320|FG001|Overall Study|Refusal to receive adalimumab|0|||
124983359|NCT01163292|449567319|FG000|Overall Study|Economic reasons|6|||
124983360|NCT01163292|449567320|FG001|Overall Study|Economic reasons|0|||
124983361|NCT01163292|449567319|FG000|Overall Study|No further visits|5|||
124983362|NCT01163292|449567320|FG001|Overall Study|No further visits|7|||
124983363|NCT03223662|449567321|FG000|Overall Study|Physician Decision|1|||
124983364|NCT03223662|449567321|FG000|Overall Study|Study closure|1|||
124983365|NCT02217475|449567322|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
124983366|NCT02217475|449567323|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
124983367|NCT02217475|449567324|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
124983368|NCT02217475|449567322|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
124983369|NCT02217475|449567323|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
124983370|NCT02217475|449567324|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
124983371|NCT02217475|449567322|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
124983372|NCT02217475|449567323|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
124983373|NCT02217475|449567324|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
124983374|NCT02217475|449567322|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
124983375|NCT02217475|449567323|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
124983376|NCT02217475|449567324|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
124983377|NCT02217475|449567322|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
124983378|NCT02217475|449567323|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
124983379|NCT02217475|449567324|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
124983380|NCT02217475|449567322|FG000|Discontinued After Period 1|Adverse Event|1|||
124983381|NCT02217475|449567323|FG001|Discontinued After Period 1|Adverse Event|2|||
125312453|NCT00104650|450772350|FG000|Treatment Period (25 Weeks)|Other|1|||
124983382|NCT02217475|449567324|FG002|Discontinued After Period 1|Adverse Event|0|||
124983383|NCT02217475|449567322|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
124983384|NCT02217475|449567323|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
124983385|NCT02217475|449567324|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
124983386|NCT02217475|449567322|FG000|Discontinued After Period 1|Physician Decision|0|||
124983387|NCT02217475|449567323|FG001|Discontinued After Period 1|Physician Decision|0|||
124983388|NCT02217475|449567324|FG002|Discontinued After Period 1|Physician Decision|1|||
124983389|NCT02217475|449567322|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
124983390|NCT02217475|449567323|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
124983391|NCT02217475|449567324|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
124983392|NCT02217475|449567322|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
124983393|NCT02217475|449567323|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
124983394|NCT02217475|449567324|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
124983395|NCT02217475|449567322|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
124983396|NCT02217475|449567323|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
124983397|NCT02217475|449567324|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
125312454|NCT00104650|450772351|FG001|Treatment Period (25 Weeks)|Other|0|||
125312455|NCT00104650|450772352|FG002|Treatment Period (25 Weeks)|Other|0|||
125312456|NCT00104650|450772350|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
125312457|NCT00104650|450772351|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
125312458|NCT00104650|450772352|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
125312459|NCT00104650|450772350|FG000|Follow-up Period|Physician Decision|1|||
125312460|NCT00104650|450772351|FG001|Follow-up Period|Physician Decision|1|||
125312461|NCT00104650|450772352|FG002|Follow-up Period|Physician Decision|0|||
125312462|NCT00104650|450772350|FG000|Follow-up Period|Adverse Event|1|||
125312463|NCT00104650|450772351|FG001|Follow-up Period|Adverse Event|0|||
125312464|NCT00104650|450772352|FG002|Follow-up Period|Adverse Event|1|||
125312465|NCT00104650|450772350|FG000|Follow-up Period|Withdrawal by Subject|0|||
125312466|NCT00104650|450772351|FG001|Follow-up Period|Withdrawal by Subject|3|||
125312467|NCT00104650|450772352|FG002|Follow-up Period|Withdrawal by Subject|3|||
125312468|NCT00104650|450772350|FG000|Follow-up Period|Death|6|||
125312469|NCT00104650|450772351|FG001|Follow-up Period|Death|6|||
125312470|NCT00104650|450772352|FG002|Follow-up Period|Death|4|||
125312471|NCT00104650|450772350|FG000|Follow-up Period|Disease progression|3|||
125312472|NCT00104650|450772351|FG001|Follow-up Period|Disease progression|1|||
125312473|NCT00104650|450772352|FG002|Follow-up Period|Disease progression|0|||
125312474|NCT00104650|450772350|FG000|Follow-up Period|Lost to Follow-up|0|||
125312475|NCT00104650|450772351|FG001|Follow-up Period|Lost to Follow-up|1|||
125312476|NCT00104650|450772352|FG002|Follow-up Period|Lost to Follow-up|2|||
125312477|NCT00104650|450772350|FG000|Follow-up Period|Other|0|||
125312478|NCT00104650|450772351|FG001|Follow-up Period|Other|1|||
125312479|NCT00104650|450772352|FG002|Follow-up Period|Other|0|||
125312480|NCT02728089|450772354|FG000|Overall Study|Physician Decision|2|||
125312481|NCT02728089|450772354|FG000|Overall Study|Withdrawal by Subject|1|||
125312482|NCT03384940|450772360|FG000|Overall Study|Progressive disease|36|||
125312483|NCT03384940|450772361|FG001|Overall Study|Progressive disease|11|||
125312484|NCT03384940|450772362|FG002|Overall Study|Progressive disease|13|||
125312485|NCT03384940|450772360|FG000|Overall Study|Clinical progression|4|||
125312486|NCT03384940|450772361|FG001|Overall Study|Clinical progression|0|||
125312487|NCT03384940|450772362|FG002|Overall Study|Clinical progression|3|||
125312488|NCT03384940|450772360|FG000|Overall Study|Adverse Event|7|||
125312489|NCT03384940|450772361|FG001|Overall Study|Adverse Event|1|||
125312490|NCT03384940|450772362|FG002|Overall Study|Adverse Event|1|||
125312491|NCT03384940|450772360|FG000|Overall Study|Withdrawal by Subject|3|||
125312492|NCT03384940|450772361|FG001|Overall Study|Withdrawal by Subject|1|||
125312493|NCT03384940|450772362|FG002|Overall Study|Withdrawal by Subject|0|||
125312494|NCT03384940|450772360|FG000|Overall Study|Physician Decision|1|||
125312495|NCT03384940|450772361|FG001|Overall Study|Physician Decision|1|||
125312496|NCT03384940|450772362|FG002|Overall Study|Physician Decision|0|||
125312497|NCT03384940|450772360|FG000|Overall Study|Death|2|||
125312498|NCT03384940|450772361|FG001|Overall Study|Death|1|||
125312499|NCT03384940|450772362|FG002|Overall Study|Death|0|||
125312500|NCT03384940|450772360|FG000|Overall Study|Other|0|||
125312501|NCT03384940|450772361|FG001|Overall Study|Other|0|||
125312502|NCT03384940|450772362|FG002|Overall Study|Other|1|||
125312503|NCT03089580|450772368|FG000|Overall Study|Lost to Follow-up|2|||
125312504|NCT03087513|450772369|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
125312505|NCT00770601|450772370|FG000|Overall Study|Withdrawal by Subject|1|||
125312506|NCT04417361|450772372|FG000|Overall Study|Withdrawal by Subject|1|||
125312507|NCT04417361|450772373|FG001|Overall Study|Withdrawal by Subject|0|||
125312508|NCT04417361|450772372|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
125312509|NCT04417361|450772373|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
125312510|NCT04965688|450772379|FG000|Overall Study|Withdrawal by Subject|2|||
125312511|NCT05864586|450772380|FG000|Overall Study|Ineligible|4|||
125312512|NCT05864586|450772381|FG001|Overall Study|Ineligible|12|||
125312513|NCT05864586|450772380|FG000|Overall Study|Pregnancy|0|||
125312514|NCT05864586|450772381|FG001|Overall Study|Pregnancy|1|||
125312515|NCT05864586|450772380|FG000|Overall Study|Withdrawal by Subject|0|||
125312516|NCT05864586|450772381|FG001|Overall Study|Withdrawal by Subject|1|||
125312517|NCT00801216|450772382|FG000|Overall Study|Screening Failure|2|||
125312518|NCT00319254|450772386|FG000|Overall Study|Withdrawal by Subject|4|||
125312519|NCT00319254|450772386|FG000|Overall Study|Death|46|||
125312520|NCT00319254|450772386|FG000|Overall Study|Lost to Follow-up|2|||
125312521|NCT00319254|450772386|FG000|Overall Study|Enrolled, Not Treated|2|||
125312522|NCT01505374|450772387|FG000|Overall Study|Lost to Follow-up|1|||
125312523|NCT01505374|450772388|FG001|Overall Study|Lost to Follow-up|0|||
125312524|NCT02452424|450772391|FG000|Overall Study|Death|2|||
125312525|NCT02452424|450772392|FG001|Overall Study|Death|2|||
125312526|NCT02452424|450772393|FG002|Overall Study|Death|2|||
125312527|NCT02452424|450772394|FG003|Overall Study|Death|6|||
125312528|NCT02452424|450772395|FG004|Overall Study|Death|2|||
125312529|NCT02452424|450772396|FG005|Overall Study|Death|0|||
125312530|NCT02452424|450772397|FG006|Overall Study|Death|5|||
125312531|NCT02452424|450772398|FG007|Overall Study|Death|1|||
125312532|NCT02452424|450772399|FG008|Overall Study|Death|3|||
125312533|NCT02452424|450772400|FG009|Overall Study|Death|1|||
125312534|NCT02452424|450772401|FG010|Overall Study|Death|0|||
125312535|NCT02452424|450772391|FG000|Overall Study|Lost to Follow-up|0|||
125312536|NCT02452424|450772392|FG001|Overall Study|Lost to Follow-up|1|||
125312537|NCT02452424|450772393|FG002|Overall Study|Lost to Follow-up|1|||
125312538|NCT02452424|450772394|FG003|Overall Study|Lost to Follow-up|0|||
125312539|NCT02452424|450772395|FG004|Overall Study|Lost to Follow-up|0|||
125312540|NCT02452424|450772396|FG005|Overall Study|Lost to Follow-up|0|||
125312541|NCT02452424|450772397|FG006|Overall Study|Lost to Follow-up|0|||
125312542|NCT02452424|450772398|FG007|Overall Study|Lost to Follow-up|0|||
125312543|NCT02452424|450772399|FG008|Overall Study|Lost to Follow-up|0|||
125312544|NCT02452424|450772400|FG009|Overall Study|Lost to Follow-up|0|||
125312545|NCT02452424|450772401|FG010|Overall Study|Lost to Follow-up|0|||
125312546|NCT02452424|450772391|FG000|Overall Study|Withdrawal by Subject|0|||
125312547|NCT02452424|450772392|FG001|Overall Study|Withdrawal by Subject|0|||
125312548|NCT02452424|450772393|FG002|Overall Study|Withdrawal by Subject|3|||
125312549|NCT02452424|450772394|FG003|Overall Study|Withdrawal by Subject|2|||
125312550|NCT02452424|450772395|FG004|Overall Study|Withdrawal by Subject|0|||
125312551|NCT02452424|450772396|FG005|Overall Study|Withdrawal by Subject|0|||
125312552|NCT02452424|450772397|FG006|Overall Study|Withdrawal by Subject|1|||
125312553|NCT02452424|450772398|FG007|Overall Study|Withdrawal by Subject|0|||
125312554|NCT02452424|450772399|FG008|Overall Study|Withdrawal by Subject|1|||
125312555|NCT02452424|450772400|FG009|Overall Study|Withdrawal by Subject|1|||
125312556|NCT02452424|450772401|FG010|Overall Study|Withdrawal by Subject|0|||
125312557|NCT02452424|450772391|FG000|Overall Study|Other|0|||
125312558|NCT02452424|450772392|FG001|Overall Study|Other|0|||
125312559|NCT02452424|450772393|FG002|Overall Study|Other|1|||
125312560|NCT02452424|450772394|FG003|Overall Study|Other|0|||
125312561|NCT02452424|450772395|FG004|Overall Study|Other|0|||
125312562|NCT02452424|450772396|FG005|Overall Study|Other|1|||
125312563|NCT02452424|450772397|FG006|Overall Study|Other|4|||
125312564|NCT02452424|450772398|FG007|Overall Study|Other|3|||
125312565|NCT02452424|450772399|FG008|Overall Study|Other|0|||
125312566|NCT02452424|450772400|FG009|Overall Study|Other|0|||
125312567|NCT02452424|450772401|FG010|Overall Study|Other|1|||
125312568|NCT02452424|450772391|FG000|Overall Study|Progressive disease (per RECIST)|0|||
125312569|NCT02452424|450772392|FG001|Overall Study|Progressive disease (per RECIST)|0|||
125312570|NCT02452424|450772393|FG002|Overall Study|Progressive disease (per RECIST)|0|||
125312571|NCT02452424|450772394|FG003|Overall Study|Progressive disease (per RECIST)|0|||
125312572|NCT02452424|450772395|FG004|Overall Study|Progressive disease (per RECIST)|0|||
125312573|NCT02452424|450772396|FG005|Overall Study|Progressive disease (per RECIST)|0|||
125312574|NCT02452424|450772397|FG006|Overall Study|Progressive disease (per RECIST)|0|||
125312575|NCT02452424|450772398|FG007|Overall Study|Progressive disease (per RECIST)|0|||
125312576|NCT02452424|450772399|FG008|Overall Study|Progressive disease (per RECIST)|2|||
125312577|NCT02452424|450772400|FG009|Overall Study|Progressive disease (per RECIST)|0|||
125312578|NCT02452424|450772401|FG010|Overall Study|Progressive disease (per RECIST)|0|||
125312579|NCT02452424|450772391|FG000|Overall Study|Adverse Event|0|||
125312580|NCT02452424|450772392|FG001|Overall Study|Adverse Event|0|||
125312581|NCT02452424|450772393|FG002|Overall Study|Adverse Event|0|||
125312582|NCT02452424|450772394|FG003|Overall Study|Adverse Event|0|||
125312583|NCT02452424|450772395|FG004|Overall Study|Adverse Event|0|||
125312584|NCT02452424|450772396|FG005|Overall Study|Adverse Event|0|||
125312585|NCT02452424|450772397|FG006|Overall Study|Adverse Event|0|||
125312586|NCT02452424|450772398|FG007|Overall Study|Adverse Event|0|||
125312587|NCT02452424|450772399|FG008|Overall Study|Adverse Event|0|||
125312588|NCT02452424|450772400|FG009|Overall Study|Adverse Event|0|||
125312589|NCT02452424|450772401|FG010|Overall Study|Adverse Event|1|||
125312590|NCT01463306|450772402|FG000|Overall Study|Adverse Event|6|||
125312591|NCT01463306|450772403|FG001|Overall Study|Adverse Event|9|||
125312592|NCT01463306|450772404|FG002|Overall Study|Adverse Event|3|||
125312593|NCT01463306|450772402|FG000|Overall Study|Death|3|||
125312594|NCT01463306|450772403|FG001|Overall Study|Death|3|||
125312595|NCT01463306|450772404|FG002|Overall Study|Death|0|||
125312596|NCT01463306|450772402|FG000|Overall Study|Lack of Efficacy|22|||
125312597|NCT01463306|450772403|FG001|Overall Study|Lack of Efficacy|16|||
125312598|NCT01463306|450772404|FG002|Overall Study|Lack of Efficacy|1|||
125312599|NCT01463306|450772402|FG000|Overall Study|Lost to Follow-up|5|||
125312600|NCT01463306|450772403|FG001|Overall Study|Lost to Follow-up|2|||
125312601|NCT01463306|450772404|FG002|Overall Study|Lost to Follow-up|0|||
125312602|NCT01463306|450772402|FG000|Overall Study|Protocol Violation|4|||
125312603|NCT01463306|450772403|FG001|Overall Study|Protocol Violation|0|||
125312604|NCT01463306|450772404|FG002|Overall Study|Protocol Violation|0|||
125312605|NCT01463306|450772402|FG000|Overall Study|Withdrawal by Subject|19|||
125312606|NCT01463306|450772403|FG001|Overall Study|Withdrawal by Subject|9|||
125312607|NCT01463306|450772404|FG002|Overall Study|Withdrawal by Subject|1|||
125312608|NCT01463306|450772402|FG000|Overall Study|Other|26|||
125312609|NCT01463306|450772403|FG001|Overall Study|Other|13|||
125312610|NCT01463306|450772404|FG002|Overall Study|Other|0|||
125312611|NCT01463306|450772402|FG000|Overall Study|Approval expiry at site|1|||
125312612|NCT01463306|450772403|FG001|Overall Study|Approval expiry at site|0|||
125312613|NCT01463306|450772404|FG002|Overall Study|Approval expiry at site|0|||
125312614|NCT02679287|450772405|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
125312615|NCT02679287|450772406|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
124983398|NCT02217475|449567322|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
125312616|NCT02679287|450772405|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
125312617|NCT02679287|450772406|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
125312618|NCT02679287|450772405|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
125312619|NCT02679287|450772406|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
125312620|NCT02679287|450772405|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
125312621|NCT02679287|450772406|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
125312622|NCT02679287|450772405|FG000|Period 2|Work/Scheduling Conflict|1|||
125312623|NCT02679287|450772406|FG001|Period 2|Work/Scheduling Conflict|0|||
125312624|NCT02679287|450772405|FG000|Period 2|Disliked Mobile System|2|||
124983399|NCT02217475|449567323|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
124983400|NCT02217475|449567324|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
124983401|NCT02217475|449567322|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
124983402|NCT02217475|449567323|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
124983403|NCT02217475|449567324|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
124983404|NCT02643472|449567325|FG000|Overall Study|Death|2|||
124983405|NCT02643472|449567326|FG001|Overall Study|Death|5|||
124983406|NCT02643472|449567325|FG000|Overall Study|Withdrawal by Subject|3|||
124983407|NCT02643472|449567326|FG001|Overall Study|Withdrawal by Subject|2|||
124983408|NCT02643472|449567325|FG000|Overall Study|Protocol Violation|0|||
124983409|NCT02643472|449567326|FG001|Overall Study|Protocol Violation|1|||
124983410|NCT02643472|449567325|FG000|Overall Study|Lost to Follow-up|22|||
124983411|NCT02643472|449567326|FG001|Overall Study|Lost to Follow-up|26|||
124983412|NCT00506441|449567327|FG000|Period 1; Open-label Period|Adverse Event|21|||
124983413|NCT00506441|449567328|FG001|Period 1; Open-label Period|Adverse Event|0|||
124983414|NCT00506441|449567327|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
124983415|NCT00506441|449567328|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
124983416|NCT00506441|449567327|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
124983417|NCT00506441|449567328|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
124983418|NCT00506441|449567327|FG000|Period 1; Open-label Period|Physician Decision|5|||
124983419|NCT00506441|449567328|FG001|Period 1; Open-label Period|Physician Decision|0|||
124983420|NCT00506441|449567327|FG000|Period 1; Open-label Period|Protocol Violation|9|||
124983421|NCT00506441|449567328|FG001|Period 1; Open-label Period|Protocol Violation|0|||
124983422|NCT00506441|449567327|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
124983423|NCT00506441|449567328|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
124983424|NCT00506441|449567327|FG000|Period 1; Open-label Period|Other Reasons|13|||
124983425|NCT00506441|449567328|FG001|Period 1; Open-label Period|Other Reasons|0|||
124983426|NCT00506441|449567327|FG000|Period 2; Double-blind Period|Adverse Event|0|||
124983427|NCT00506441|449567328|FG001|Period 2; Double-blind Period|Adverse Event|1|||
124983428|NCT00506441|449567327|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
124983429|NCT00506441|449567328|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
124983430|NCT00506441|449567327|FG000|Period 2; Double-blind Period|Physician Decision|1|||
124983431|NCT00506441|449567328|FG001|Period 2; Double-blind Period|Physician Decision|1|||
124983432|NCT00506441|449567327|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
124983433|NCT00506441|449567328|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
124983434|NCT00506441|449567327|FG000|Period 2; Double-blind Period|Other Reason|1|||
125210370|NCT00866333|450393852|FG000|Overall Study|Withdrawal of consent|0|||
125210371|NCT00866333|450393853|FG001|Overall Study|Withdrawal of consent|1|||
125210372|NCT00866333|450393854|FG002|Overall Study|Withdrawal of consent|2|||
125210373|NCT00866333|450393852|FG000|Overall Study|Reason not Specified|3|||
125210374|NCT00866333|450393853|FG001|Overall Study|Reason not Specified|1|||
125210375|NCT00866333|450393854|FG002|Overall Study|Reason not Specified|1|||
125210376|NCT00866333|450393852|FG000|Overall Study|Study Terminated by Sponsor|2|||
125210377|NCT00866333|450393853|FG001|Overall Study|Study Terminated by Sponsor|5|||
125210378|NCT00866333|450393854|FG002|Overall Study|Study Terminated by Sponsor|9|||
124983435|NCT00506441|449567328|FG001|Period 2; Double-blind Period|Other Reason|1|||
124983436|NCT01215188|449567329|FG000|Overall Study|Lost to Follow-up|22|||
124983437|NCT01215188|449567330|FG001|Overall Study|Lost to Follow-up|22|||
124983438|NCT01215188|449567331|FG002|Overall Study|Lost to Follow-up|16|||
124983439|NCT01215188|449567329|FG000|Overall Study|Adverse Event|1|||
124983440|NCT01215188|449567330|FG001|Overall Study|Adverse Event|1|||
124983441|NCT01215188|449567331|FG002|Overall Study|Adverse Event|3|||
124983442|NCT01215188|449567329|FG000|Overall Study|Physician Decision|2|||
124983443|NCT01215188|449567330|FG001|Overall Study|Physician Decision|1|||
124983444|NCT01215188|449567331|FG002|Overall Study|Physician Decision|0|||
124983445|NCT01215188|449567329|FG000|Overall Study|Lack of Efficacy|0|||
124983446|NCT01215188|449567330|FG001|Overall Study|Lack of Efficacy|0|||
124983447|NCT01215188|449567331|FG002|Overall Study|Lack of Efficacy|1|||
125210379|NCT01653327|450393855|FG000|Overall Study|Withdrawal by Subject|1|||
125312625|NCT02679287|450772406|FG001|Period 2|Disliked Mobile System|0|||
125312626|NCT02679287|450772405|FG000|Period 3|Work/Scheduling Conflict|0|||
125312627|NCT02679287|450772406|FG001|Period 3|Work/Scheduling Conflict|1|||
125312628|NCT00992459|450772415|FG000|Overall Study|Withdrawal by Subject|0|||
125312629|NCT00992459|450772416|FG001|Overall Study|Withdrawal by Subject|1|||
125312630|NCT00992459|450772415|FG000|Overall Study|Adverse Event|1|||
125312631|NCT00992459|450772416|FG001|Overall Study|Adverse Event|0|||
125312632|NCT00543387|450772417|FG000|Panel 1 + Panel 2|Adverse Event|0|||
125312633|NCT00543387|450772418|FG001|Panel 1 + Panel 2|Adverse Event|1|||
125312634|NCT00543387|450772419|FG002|Panel 1 + Panel 2|Adverse Event|0|||
125312635|NCT00543387|450772420|FG003|Panel 1 + Panel 2|Adverse Event|0|||
125312636|NCT00543387|450772421|FG004|Panel 1 + Panel 2|Adverse Event|0|||
125312637|NCT00543387|450772422|FG005|Panel 1 + Panel 2|Adverse Event|0|||
125312638|NCT00543387|450772423|FG006|Panel 1 + Panel 2|Adverse Event|0|||
125312639|NCT00543387|450772424|FG007|Panel 1 + Panel 2|Adverse Event|1|||
125312640|NCT00543387|450772425|FG008|Panel 1 + Panel 2|Adverse Event|1|||
125312641|NCT00543387|450772426|FG009|Panel 1 + Panel 2|Adverse Event|0|||
125312642|NCT00543387|450772427|FG010|Panel 1 + Panel 2|Adverse Event|0|||
125312643|NCT00543387|450772417|FG000|Panel 1 + Panel 2|Physician Decision|0|||
125312644|NCT00543387|450772418|FG001|Panel 1 + Panel 2|Physician Decision|0|||
125312645|NCT00543387|450772419|FG002|Panel 1 + Panel 2|Physician Decision|1|||
125312646|NCT00543387|450772420|FG003|Panel 1 + Panel 2|Physician Decision|0|||
125312647|NCT00543387|450772421|FG004|Panel 1 + Panel 2|Physician Decision|0|||
125312648|NCT00543387|450772422|FG005|Panel 1 + Panel 2|Physician Decision|0|||
125312649|NCT00543387|450772423|FG006|Panel 1 + Panel 2|Physician Decision|0|||
125312650|NCT00543387|450772424|FG007|Panel 1 + Panel 2|Physician Decision|1|||
125312651|NCT00543387|450772425|FG008|Panel 1 + Panel 2|Physician Decision|0|||
125312652|NCT00543387|450772426|FG009|Panel 1 + Panel 2|Physician Decision|0|||
125312653|NCT00543387|450772427|FG010|Panel 1 + Panel 2|Physician Decision|0|||
125312654|NCT00543387|450772417|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
125312655|NCT00543387|450772418|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
125312656|NCT00543387|450772419|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
125312657|NCT00543387|450772420|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
125312658|NCT00543387|450772421|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
125312659|NCT00543387|450772422|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
125312660|NCT00543387|450772423|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
125312661|NCT00543387|450772424|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
125312662|NCT00543387|450772425|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
125312663|NCT00543387|450772426|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
125312664|NCT00543387|450772427|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
125312665|NCT00543387|450772417|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
125312666|NCT00543387|450772418|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
125312667|NCT00543387|450772419|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
125312668|NCT00543387|450772420|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
125312669|NCT00543387|450772421|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
125312670|NCT00543387|450772422|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
125312671|NCT00543387|450772423|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
125312672|NCT00543387|450772424|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
125312673|NCT00543387|450772425|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
125312674|NCT00543387|450772426|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
125312675|NCT00543387|450772427|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
125312676|NCT00543387|450772417|FG000|Crossover Participants|Progressive Disease|0|||
125312677|NCT00543387|450772418|FG001|Crossover Participants|Progressive Disease|0|||
125312678|NCT00543387|450772419|FG002|Crossover Participants|Progressive Disease|0|||
125312679|NCT00543387|450772420|FG003|Crossover Participants|Progressive Disease|0|||
125312680|NCT00543387|450772421|FG004|Crossover Participants|Progressive Disease|0|||
125312681|NCT00543387|450772422|FG005|Crossover Participants|Progressive Disease|0|||
125312682|NCT00543387|450772423|FG006|Crossover Participants|Progressive Disease|0|||
125312683|NCT00543387|450772424|FG007|Crossover Participants|Progressive Disease|0|||
124983448|NCT01215188|449567329|FG000|Overall Study|Protocol Violation|1|||
124983449|NCT01215188|449567330|FG001|Overall Study|Protocol Violation|1|||
124983450|NCT01215188|449567331|FG002|Overall Study|Protocol Violation|1|||
124983451|NCT01215188|449567329|FG000|Overall Study|Withdrawal by Subject|32|||
124983452|NCT01215188|449567330|FG001|Overall Study|Withdrawal by Subject|34|||
124983453|NCT01215188|449567331|FG002|Overall Study|Withdrawal by Subject|31|||
125312684|NCT00543387|450772425|FG008|Crossover Participants|Progressive Disease|0|||
124983454|NCT01012414|449567332|FG000|Overall Study|Withdrawal by Subject|2|||
124983455|NCT01012414|449567332|FG000|Overall Study|Lost to Follow-up|1|||
125312685|NCT00543387|450772426|FG009|Crossover Participants|Progressive Disease|1|||
125312686|NCT00543387|450772427|FG010|Crossover Participants|Progressive Disease|2|||
125312687|NCT00543387|450772417|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
124983456|NCT01012414|449567332|FG000|Overall Study|Trial was stopped before completed|7|||
125312688|NCT00543387|450772418|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
125312689|NCT00543387|450772419|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
124983457|NCT02601300|449567333|FG000|Induction Phase|Lack of Efficacy|2|||
124983458|NCT02601300|449567333|FG000|Induction Phase|Protocol Violation|1|||
124983459|NCT02601300|449567333|FG000|Extension Phase|Withdrawal by Subject|3|||
124983460|NCT02601300|449567333|FG000|Extension Phase|Adverse Event|4|||
124983461|NCT02601300|449567333|FG000|Extension Phase|Lack of Efficacy|10|||
124983462|NCT00528931|449567337|FG000|Overall Study|Lost to Follow-up|1|||
124983463|NCT00992225|449567338|FG000|Overall Study|Entry Criteria Not Met|8|||
124983464|NCT00992225|449567338|FG000|Overall Study|Adverse Event|2|||
124983465|NCT00291642|449567341|FG000|Overall Study|Adverse Event|1|||
124983466|NCT00291642|449567342|FG001|Overall Study|Adverse Event|0|||
124983467|NCT00291642|449567343|FG002|Overall Study|Adverse Event|1|||
124983468|NCT00291642|449567344|FG003|Overall Study|Adverse Event|0|||
124983469|NCT00291642|449567345|FG004|Overall Study|Adverse Event|1|||
124983470|NCT00291642|449567341|FG000|Overall Study|Patient missed visit|0|||
124983471|NCT00291642|449567342|FG001|Overall Study|Patient missed visit|0|||
124983472|NCT00291642|449567343|FG002|Overall Study|Patient missed visit|1|||
124983473|NCT00291642|449567344|FG003|Overall Study|Patient missed visit|0|||
124983474|NCT00291642|449567345|FG004|Overall Study|Patient missed visit|0|||
124983475|NCT00291642|449567341|FG000|Overall Study|Intake of prohibited medication|1|||
124983476|NCT00291642|449567342|FG001|Overall Study|Intake of prohibited medication|0|||
124983477|NCT00291642|449567343|FG002|Overall Study|Intake of prohibited medication|0|||
124983478|NCT00291642|449567344|FG003|Overall Study|Intake of prohibited medication|0|||
124983479|NCT00291642|449567345|FG004|Overall Study|Intake of prohibited medication|0|||
124983480|NCT02576587|449567350|FG000|Baseline|Equipment failure|0|||
124983481|NCT02576587|449567351|FG001|Baseline|Equipment failure|1|||
124983482|NCT02576587|449567350|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
124983483|NCT02576587|449567351|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
124983484|NCT02576587|449567350|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
124983485|NCT02576587|449567351|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
124983486|NCT02576587|449567350|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
124983487|NCT02576587|449567351|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
124983488|NCT00532493|449567352|FG000|Overall Study|Death|1|||
124983489|NCT00532493|449567353|FG001|Overall Study|Death|1|||
124983490|NCT00532493|449567352|FG000|Overall Study|Lost to Follow-up|10|||
124983491|NCT00532493|449567353|FG001|Overall Study|Lost to Follow-up|7|||
124983492|NCT00532493|449567352|FG000|Overall Study|Withdrawal by Subject|7|||
124983493|NCT00532493|449567353|FG001|Overall Study|Withdrawal by Subject|9|||
124983494|NCT00532493|449567352|FG000|Overall Study|Physician Decision|1|||
125312690|NCT00543387|450772420|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
125312691|NCT00543387|450772421|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
125312692|NCT00543387|450772422|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
125312693|NCT00543387|450772423|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
125312694|NCT00543387|450772424|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
125312695|NCT00543387|450772425|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
125312696|NCT00543387|450772426|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
125312697|NCT00543387|450772427|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
125312698|NCT00940498|450772428|FG000|Overall Study|Death|2|||
125312699|NCT00940498|450772429|FG001|Overall Study|Death|0|||
125312700|NCT00940498|450772430|FG002|Overall Study|Death|0|||
125312701|NCT00940498|450772431|FG003|Overall Study|Death|1|||
125312702|NCT00940498|450772432|FG004|Overall Study|Death|5|||
125312703|NCT00940498|450772433|FG005|Overall Study|Death|0|||
125312704|NCT00940498|450772434|FG006|Overall Study|Death|1|||
125312705|NCT00940498|450772435|FG007|Overall Study|Death|0|||
125312706|NCT00940498|450772428|FG000|Overall Study|Lost to Follow-up|1|||
125312707|NCT00940498|450772429|FG001|Overall Study|Lost to Follow-up|1|||
125312708|NCT00940498|450772430|FG002|Overall Study|Lost to Follow-up|2|||
125312709|NCT00940498|450772431|FG003|Overall Study|Lost to Follow-up|0|||
125312710|NCT00940498|450772432|FG004|Overall Study|Lost to Follow-up|1|||
125312711|NCT00940498|450772433|FG005|Overall Study|Lost to Follow-up|0|||
125312712|NCT00940498|450772434|FG006|Overall Study|Lost to Follow-up|0|||
125312713|NCT00940498|450772435|FG007|Overall Study|Lost to Follow-up|1|||
125312714|NCT00940498|450772428|FG000|Overall Study|Disease Progression|0|||
125312715|NCT00940498|450772429|FG001|Overall Study|Disease Progression|0|||
125312716|NCT00940498|450772430|FG002|Overall Study|Disease Progression|1|||
125312717|NCT00940498|450772431|FG003|Overall Study|Disease Progression|1|||
125312718|NCT00940498|450772432|FG004|Overall Study|Disease Progression|0|||
124983495|NCT00532493|449567353|FG001|Overall Study|Physician Decision|6|||
124983496|NCT00532493|449567352|FG000|Overall Study|Adverse Event|6|||
124983497|NCT00532493|449567353|FG001|Overall Study|Adverse Event|5|||
124983498|NCT00532493|449567352|FG000|Overall Study|Protocol Deviation|1|||
124983499|NCT00532493|449567353|FG001|Overall Study|Protocol Deviation|0|||
125312719|NCT00940498|450772433|FG005|Overall Study|Disease Progression|1|||
125312720|NCT00940498|450772434|FG006|Overall Study|Disease Progression|0|||
125312721|NCT00940498|450772435|FG007|Overall Study|Disease Progression|0|||
125312722|NCT00940498|450772428|FG000|Overall Study|Physician Decision|0|||
124983500|NCT00532493|449567352|FG000|Overall Study|Subject Moved Away|3|||
125312723|NCT00940498|450772429|FG001|Overall Study|Physician Decision|0|||
125312724|NCT00940498|450772430|FG002|Overall Study|Physician Decision|0|||
125312725|NCT00940498|450772431|FG003|Overall Study|Physician Decision|0|||
125312726|NCT00940498|450772432|FG004|Overall Study|Physician Decision|2|||
125312727|NCT00940498|450772433|FG005|Overall Study|Physician Decision|0|||
125312728|NCT00940498|450772434|FG006|Overall Study|Physician Decision|0|||
125312729|NCT00940498|450772435|FG007|Overall Study|Physician Decision|0|||
125312730|NCT00940498|450772428|FG000|Overall Study|Not treated due to disease related pain|0|||
125312731|NCT00940498|450772429|FG001|Overall Study|Not treated due to disease related pain|0|||
125312732|NCT00940498|450772430|FG002|Overall Study|Not treated due to disease related pain|0|||
125312733|NCT00940498|450772431|FG003|Overall Study|Not treated due to disease related pain|0|||
125312734|NCT00940498|450772432|FG004|Overall Study|Not treated due to disease related pain|1|||
125312735|NCT00940498|450772433|FG005|Overall Study|Not treated due to disease related pain|0|||
125312736|NCT00940498|450772434|FG006|Overall Study|Not treated due to disease related pain|0|||
125312737|NCT00940498|450772435|FG007|Overall Study|Not treated due to disease related pain|0|||
125312738|NCT01943591|450772436|FG000|Overall Study|Lost to Follow-up|3|||
125312739|NCT01943591|450772437|FG001|Overall Study|Lost to Follow-up|4|||
125312740|NCT01943591|450772436|FG000|Overall Study|Death|2|||
125312741|NCT01943591|450772437|FG001|Overall Study|Death|7|||
125312742|NCT00227721|450773714|FG000|Overall Study|On study, but never treated.|1|||
125312743|NCT01389882|450773723|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
125312744|NCT01389882|450773724|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
125312745|NCT01389882|450773723|FG000|Overall Study|Withdrawal by Subject|0|||
125312746|NCT01389882|450773724|FG001|Overall Study|Withdrawal by Subject|1|||
125312747|NCT00859547|450773736|FG000|Overall Study|Lost to Follow-up|1|||
125312748|NCT00859547|450773736|FG000|Overall Study|Parent withdrew consent|1|||
125312749|NCT01276639|450773747|FG000|Week 0 to 16|Death|1|||
125312750|NCT01276639|450773748|FG001|Week 0 to 16|Death|0|||
125312751|NCT01276639|450773749|FG002|Week 0 to 16|Death|0|||
125312752|NCT01276639|450773750|FG003|Week 0 to 16|Death|0|||
125312753|NCT01276639|450773751|FG004|Week 0 to 16|Death|0|||
125312754|NCT01276639|450773747|FG000|Week 0 to 16|Adverse Event|11|||
125312755|NCT01276639|450773748|FG001|Week 0 to 16|Adverse Event|8|||
125312756|NCT01276639|450773749|FG002|Week 0 to 16|Adverse Event|11|||
125312757|NCT01276639|450773750|FG003|Week 0 to 16|Adverse Event|0|||
125312758|NCT01276639|450773751|FG004|Week 0 to 16|Adverse Event|0|||
125312759|NCT01276639|450773747|FG000|Week 0 to 16|Lack of Efficacy|20|||
125312760|NCT01276639|450773748|FG001|Week 0 to 16|Lack of Efficacy|15|||
125312761|NCT01276639|450773749|FG002|Week 0 to 16|Lack of Efficacy|25|||
125312762|NCT01276639|450773750|FG003|Week 0 to 16|Lack of Efficacy|0|||
125312763|NCT01276639|450773751|FG004|Week 0 to 16|Lack of Efficacy|0|||
125312764|NCT01276639|450773747|FG000|Week 0 to 16|Lost to Follow-up|3|||
125312765|NCT01276639|450773748|FG001|Week 0 to 16|Lost to Follow-up|5|||
125312766|NCT01276639|450773749|FG002|Week 0 to 16|Lost to Follow-up|3|||
125312767|NCT01276639|450773750|FG003|Week 0 to 16|Lost to Follow-up|0|||
125312768|NCT01276639|450773751|FG004|Week 0 to 16|Lost to Follow-up|0|||
125312769|NCT01276639|450773747|FG000|Week 0 to 16|Withdrawal by Subject|8|||
125312770|NCT01276639|450773748|FG001|Week 0 to 16|Withdrawal by Subject|5|||
125312771|NCT01276639|450773749|FG002|Week 0 to 16|Withdrawal by Subject|4|||
125312772|NCT01276639|450773750|FG003|Week 0 to 16|Withdrawal by Subject|0|||
125312773|NCT01276639|450773751|FG004|Week 0 to 16|Withdrawal by Subject|0|||
125312774|NCT01276639|450773747|FG000|Week 0 to 16|Other|7|||
125312775|NCT01276639|450773748|FG001|Week 0 to 16|Other|7|||
125312776|NCT01276639|450773749|FG002|Week 0 to 16|Other|2|||
125312777|NCT01276639|450773750|FG003|Week 0 to 16|Other|0|||
125312778|NCT01276639|450773751|FG004|Week 0 to 16|Other|0|||
125312779|NCT01276639|450773747|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
125312780|NCT01276639|450773748|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
125312781|NCT01276639|450773749|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
125312782|NCT01276639|450773750|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
125312783|NCT01276639|450773751|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
125312784|NCT01276639|450773747|FG000|Week 16 to 52|Death|1|||
125312785|NCT01276639|450773748|FG001|Week 16 to 52|Death|0|||
125312786|NCT01276639|450773749|FG002|Week 16 to 52|Death|0|||
125312787|NCT01276639|450773750|FG003|Week 16 to 52|Death|0|||
125312788|NCT01276639|450773751|FG004|Week 16 to 52|Death|0|||
125312789|NCT01276639|450773747|FG000|Week 16 to 52|Adverse Event|10|||
125312790|NCT01276639|450773748|FG001|Week 16 to 52|Adverse Event|13|||
125312791|NCT01276639|450773749|FG002|Week 16 to 52|Adverse Event|0|||
125312792|NCT01276639|450773750|FG003|Week 16 to 52|Adverse Event|1|||
125312793|NCT01276639|450773751|FG004|Week 16 to 52|Adverse Event|3|||
125312794|NCT01276639|450773747|FG000|Week 16 to 52|Lack of Efficacy|99|||
125312795|NCT01276639|450773748|FG001|Week 16 to 52|Lack of Efficacy|71|||
125312796|NCT01276639|450773749|FG002|Week 16 to 52|Lack of Efficacy|0|||
125312797|NCT01276639|450773750|FG003|Week 16 to 52|Lack of Efficacy|14|||
125312798|NCT01276639|450773751|FG004|Week 16 to 52|Lack of Efficacy|13|||
125312799|NCT01276639|450773747|FG000|Week 16 to 52|Lost to Follow-up|3|||
125312800|NCT01276639|450773748|FG001|Week 16 to 52|Lost to Follow-up|1|||
125312801|NCT01276639|450773749|FG002|Week 16 to 52|Lost to Follow-up|0|||
125312802|NCT01276639|450773750|FG003|Week 16 to 52|Lost to Follow-up|0|||
125312803|NCT01276639|450773751|FG004|Week 16 to 52|Lost to Follow-up|1|||
125312804|NCT01276639|450773747|FG000|Week 16 to 52|Withdrawal by Subject|4|||
125312805|NCT01276639|450773748|FG001|Week 16 to 52|Withdrawal by Subject|4|||
125312806|NCT01276639|450773749|FG002|Week 16 to 52|Withdrawal by Subject|0|||
125312807|NCT01276639|450773750|FG003|Week 16 to 52|Withdrawal by Subject|0|||
125312808|NCT01276639|450773751|FG004|Week 16 to 52|Withdrawal by Subject|1|||
125312809|NCT01276639|450773747|FG000|Week 16 to 52|Other|10|||
125312810|NCT01276639|450773748|FG001|Week 16 to 52|Other|12|||
125312811|NCT01276639|450773749|FG002|Week 16 to 52|Other|0|||
125312812|NCT01276639|450773750|FG003|Week 16 to 52|Other|1|||
125312813|NCT01276639|450773751|FG004|Week 16 to 52|Other|3|||
125312814|NCT00330759|450773757|FG000|Overall Study|Death|316|||
125312815|NCT00330759|450773758|FG001|Overall Study|Death|310|||
125312816|NCT00330759|450773757|FG000|Overall Study|Disease progression|104|||
125312817|NCT00330759|450773758|FG001|Overall Study|Disease progression|126|||
125312818|NCT00330759|450773757|FG000|Overall Study|Withdrawal by Subject|143|||
125312819|NCT00330759|450773758|FG001|Overall Study|Withdrawal by Subject|124|||
125312820|NCT00330759|450773757|FG000|Overall Study|Adverse Event|48|||
125312821|NCT00330759|450773758|FG001|Overall Study|Adverse Event|36|||
125312822|NCT00330759|450773757|FG000|Overall Study|Participant request|31|||
125312823|NCT00330759|450773758|FG001|Overall Study|Participant request|22|||
125312824|NCT00330759|450773757|FG000|Overall Study|Lost to Follow-up|16|||
125312825|NCT00330759|450773758|FG001|Overall Study|Lost to Follow-up|22|||
125312826|NCT00330759|450773757|FG000|Overall Study|Noncompliance|15|||
125312827|NCT00330759|450773758|FG001|Overall Study|Noncompliance|17|||
125312828|NCT00330759|450773757|FG000|Overall Study|Physician Decision|1|||
125312829|NCT00330759|450773758|FG001|Overall Study|Physician Decision|2|||
125312830|NCT00330759|450773757|FG000|Overall Study|Protocol deviation|0|||
125312831|NCT00330759|450773758|FG001|Overall Study|Protocol deviation|2|||
125312832|NCT00330759|450773757|FG000|Overall Study|Ineligibility determined|2|||
125312833|NCT00330759|450773758|FG001|Overall Study|Ineligibility determined|1|||
125312834|NCT00330759|450773757|FG000|Overall Study|Other|36|||
125312835|NCT00330759|450773758|FG001|Overall Study|Other|44|||
125312836|NCT03654690|450773763|FG000|Overall Study|Withdrawal by Subject|1|||
125312837|NCT03654690|450773764|FG001|Overall Study|Withdrawal by Subject|0|||
125312838|NCT03654690|450773765|FG002|Overall Study|Withdrawal by Subject|0|||
125312839|NCT00742183|450773768|FG000|Overall Study|Adverse Event|2|||
125312840|NCT00742183|450773769|FG001|Overall Study|Adverse Event|2|||
125312841|NCT00742183|450773768|FG000|Overall Study|Death|1|||
125312842|NCT00742183|450773769|FG001|Overall Study|Death|0|||
125312843|NCT00742183|450773768|FG000|Overall Study|Physician Decision|0|||
125312844|NCT00742183|450773769|FG001|Overall Study|Physician Decision|2|||
125312845|NCT00742183|450773768|FG000|Overall Study|Lost to Follow-up|4|||
125312846|NCT00742183|450773769|FG001|Overall Study|Lost to Follow-up|4|||
125312847|NCT00742183|450773768|FG000|Overall Study|Required skin-graft|1|||
125312848|NCT00742183|450773769|FG001|Overall Study|Required skin-graft|1|||
125312849|NCT00742183|450773768|FG000|Overall Study|Withdrawal by Subject|1|||
125312850|NCT00742183|450773769|FG001|Overall Study|Withdrawal by Subject|0|||
125312851|NCT00742183|450773768|FG000|Overall Study|Lack of Efficacy|0|||
125312852|NCT00742183|450773769|FG001|Overall Study|Lack of Efficacy|3|||
125312853|NCT00786799|450773772|FG000|Overall Study|Lost to Follow-up|1|||
125312854|NCT00786799|450773773|FG001|Overall Study|Lost to Follow-up|1|||
125312855|NCT02544503|450773774|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
125312856|NCT02544503|450773775|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
125312857|NCT02544503|450773774|FG000|Overall Study|Lost to Follow-up|9|||
125312858|NCT02544503|450773775|FG001|Overall Study|Lost to Follow-up|0|||
125312859|NCT02544503|450773774|FG000|Overall Study|Withdrawal by Subject|1|||
125312860|NCT02544503|450773775|FG001|Overall Study|Withdrawal by Subject|0|||
125312861|NCT01080807|450773779|FG000|Overall Study|Adverse Event|9|||
125312862|NCT01080807|450773780|FG001|Overall Study|Adverse Event|1|||
125312863|NCT01080807|450773779|FG000|Overall Study|Lack of Efficacy|0|||
125312864|NCT01080807|450773780|FG001|Overall Study|Lack of Efficacy|1|||
125312865|NCT01080807|450773779|FG000|Overall Study|Withdrawal by Subject|7|||
125312866|NCT01080807|450773780|FG001|Overall Study|Withdrawal by Subject|2|||
125312867|NCT01080807|450773779|FG000|Overall Study|Protocol Violation|7|||
125312868|NCT01080807|450773780|FG001|Overall Study|Protocol Violation|6|||
125312869|NCT01080807|450773779|FG000|Overall Study|Lost to Follow-up|6|||
125312870|NCT01080807|450773780|FG001|Overall Study|Lost to Follow-up|4|||
125312871|NCT01080807|450773779|FG000|Overall Study|Noncompliance with drug administration|1|||
125312872|NCT01080807|450773780|FG001|Overall Study|Noncompliance with drug administration|1|||
125312873|NCT01080807|450773779|FG000|Overall Study|Noncompliance to study procedures|1|||
124983501|NCT00532493|449567353|FG001|Overall Study|Subject Moved Away|1|||
125312874|NCT01080807|450773780|FG001|Overall Study|Noncompliance to study procedures|1|||
125312875|NCT01080807|450773779|FG000|Overall Study|Began working day shift|0|||
125312876|NCT01080807|450773780|FG001|Overall Study|Began working day shift|2|||
125312877|NCT01080807|450773779|FG000|Overall Study|Laid off or terminated from job|1|||
125312878|NCT01080807|450773780|FG001|Overall Study|Laid off or terminated from job|2|||
125312879|NCT01080807|450773779|FG000|Overall Study|Stopped working consistent night shifts|0|||
125312880|NCT01080807|450773780|FG001|Overall Study|Stopped working consistent night shifts|1|||
125312881|NCT01080807|450773779|FG000|Overall Study|Work schedule changing|1|||
125312882|NCT01080807|450773780|FG001|Overall Study|Work schedule changing|1|||
125312883|NCT01080807|450773779|FG000|Overall Study|Work schedule and travel|0|||
125312884|NCT01080807|450773780|FG001|Overall Study|Work schedule and travel|1|||
125312885|NCT01080807|450773779|FG000|Overall Study|Switched to first shift|1|||
125312886|NCT01080807|450773780|FG001|Overall Study|Switched to first shift|0|||
125312887|NCT01080807|450773779|FG000|Overall Study|Moved away without notifying center|1|||
125312888|NCT01080807|450773780|FG001|Overall Study|Moved away without notifying center|0|||
125312889|NCT03922581|450773786|FG000|Overall Study|Lost to Follow-up|20|||
125312890|NCT03922581|450773787|FG001|Overall Study|Lost to Follow-up|9|||
125312891|NCT03922581|450773786|FG000|Overall Study|Physician Decision|1|||
125312892|NCT03922581|450773787|FG001|Overall Study|Physician Decision|1|||
125312893|NCT03922581|450773786|FG000|Overall Study|Withdrawal by Subject|1|||
125312894|NCT03922581|450773787|FG001|Overall Study|Withdrawal by Subject|0|||
125312895|NCT04685798|450773790|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
125312896|NCT02223715|450773791|FG000|Overall Study|Death|31|||
125312897|NCT02223715|450773791|FG000|Overall Study|Lost to Follow-up|73|||
125312898|NCT03956550|450773792|FG000|Overall Study|Sponsor decision|65|||
125312899|NCT03956550|450773793|FG001|Overall Study|Sponsor decision|66|||
125312900|NCT03956550|450773794|FG002|Overall Study|Sponsor decision|64|||
125312901|NCT03956550|450773792|FG000|Overall Study|Adverse Event|0|||
125312902|NCT03956550|450773793|FG001|Overall Study|Adverse Event|1|||
125312903|NCT03956550|450773794|FG002|Overall Study|Adverse Event|0|||
125312904|NCT03956550|450773792|FG000|Overall Study|Withdrawal by Subject|5|||
125312905|NCT03956550|450773793|FG001|Overall Study|Withdrawal by Subject|5|||
125312906|NCT03956550|450773794|FG002|Overall Study|Withdrawal by Subject|6|||
125312907|NCT01745367|450773797|FG000|Overall Study|Death|1|||
125312908|NCT01745367|450773798|FG001|Overall Study|Death|0|||
125312909|NCT01745367|450773797|FG000|Overall Study|Withdrawal by Subject|1|||
125312910|NCT01745367|450773798|FG001|Overall Study|Withdrawal by Subject|2|||
125312911|NCT01745367|450773797|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
125312912|NCT01745367|450773798|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
125312913|NCT01745367|450773797|FG000|Overall Study|Other Reasons Unspecified|0|||
125312914|NCT01745367|450773798|FG001|Overall Study|Other Reasons Unspecified|2|||
125312915|NCT00824473|450773802|FG000|Overall Study|Adverse Event|4|||
125312916|NCT00824473|450773803|FG001|Overall Study|Adverse Event|5|||
125312917|NCT00824473|450773802|FG000|Overall Study|Lack of Efficacy|2|||
125312918|NCT00824473|450773803|FG001|Overall Study|Lack of Efficacy|2|||
125312919|NCT00824473|450773802|FG000|Overall Study|Protocol Violation|2|||
125312920|NCT00824473|450773803|FG001|Overall Study|Protocol Violation|0|||
125312921|NCT00824473|450773802|FG000|Overall Study|Non-Compliance|4|||
125312922|NCT00824473|450773803|FG001|Overall Study|Non-Compliance|2|||
125312923|NCT00824473|450773802|FG000|Overall Study|Withdrawal by Subject|2|||
125312924|NCT00824473|450773803|FG001|Overall Study|Withdrawal by Subject|3|||
125312925|NCT00824473|450773802|FG000|Overall Study|Other|1|||
125312926|NCT00824473|450773803|FG001|Overall Study|Other|1|||
125312927|NCT01359904|450773804|FG000|Overall Study|Withdrawal by Subject|1|||
125312928|NCT01359904|450773805|FG001|Overall Study|Withdrawal by Subject|0|||
125312929|NCT02525588|450773807|FG000|Overall Study|Death|3|||
125312930|NCT02525588|450773808|FG001|Overall Study|Death|1|||
125312931|NCT02525588|450773807|FG000|Overall Study|Lost to Follow-up|2|||
125312932|NCT02525588|450773808|FG001|Overall Study|Lost to Follow-up|0|||
125312933|NCT02525588|450773807|FG000|Overall Study|Withdrawal by Subject|1|||
125312934|NCT02525588|450773808|FG001|Overall Study|Withdrawal by Subject|1|||
125312935|NCT02525588|450773807|FG000|Overall Study|Adverse Event|0|||
125312936|NCT02525588|450773808|FG001|Overall Study|Adverse Event|1|||
125312937|NCT03018691|450773811|FG000|Overall Study|Adverse Event|1|||
125312938|NCT03018691|450773812|FG001|Overall Study|Adverse Event|1|||
125312939|NCT03018691|450773813|FG002|Overall Study|Adverse Event|4|||
125312940|NCT03018691|450773811|FG000|Overall Study|Lack of Efficacy|0|||
125312941|NCT03018691|450773812|FG001|Overall Study|Lack of Efficacy|0|||
125312942|NCT03018691|450773813|FG002|Overall Study|Lack of Efficacy|1|||
125312943|NCT03018691|450773811|FG000|Overall Study|Withdrawal by Subject|0|||
125312944|NCT03018691|450773812|FG001|Overall Study|Withdrawal by Subject|0|||
125312945|NCT03018691|450773813|FG002|Overall Study|Withdrawal by Subject|1|||
125312946|NCT03018691|450773811|FG000|Overall Study|Withdrawal by parent/guardian|1|||
125312947|NCT03018691|450773812|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125312948|NCT03018691|450773813|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125312949|NCT03369418|450773815|FG000|Overall Study|Withdrawal by Subject|3|||
125312950|NCT03369418|450773816|FG001|Overall Study|Withdrawal by Subject|3|||
125312951|NCT00796666|450773818|FG000|Overall Study|Death|2|||
125312952|NCT00796666|450773819|FG001|Overall Study|Death|4|||
125312953|NCT00796666|450773818|FG000|Overall Study|Withdrawal by Subject|2|||
125312954|NCT00796666|450773819|FG001|Overall Study|Withdrawal by Subject|0|||
125312955|NCT00796666|450773818|FG000|Overall Study|Adverse Event|7|||
125312956|NCT00796666|450773819|FG001|Overall Study|Adverse Event|5|||
125312957|NCT00796666|450773818|FG000|Overall Study|Protocol Violation|1|||
125312958|NCT00796666|450773819|FG001|Overall Study|Protocol Violation|0|||
125312959|NCT00796666|450773818|FG000|Overall Study|Other|1|||
125312960|NCT00796666|450773819|FG001|Overall Study|Other|0|||
125312961|NCT00796666|450773818|FG000|Overall Study|Terminated by sponsor|53|||
125312962|NCT00796666|450773819|FG001|Overall Study|Terminated by sponsor|55|||
125312963|NCT00796666|450773818|FG000|Overall Study|Randomized and not treated|1|||
125312964|NCT00796666|450773819|FG001|Overall Study|Randomized and not treated|0|||
125312965|NCT00057863|450773821|FG000|Overall Study|Death|1|||
125312966|NCT00057863|450773821|FG000|Overall Study|Withdrawal by Subject|2|||
125312967|NCT01521507|450773822|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
125312968|NCT01521507|450773823|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
125312969|NCT01521507|450773822|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
125312970|NCT01521507|450773823|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
125312971|NCT01521507|450773822|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
125312972|NCT01521507|450773823|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
125312973|NCT01521507|450773822|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
125312974|NCT01521507|450773823|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
125312975|NCT01521507|450773822|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
125312976|NCT01521507|450773823|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
125312977|NCT01521507|450773822|FG000|Stage 2: Observational Design|Physician Decision|1|||
125312978|NCT01521507|450773823|FG001|Stage 2: Observational Design|Physician Decision|0|||
125312979|NCT01479868|450773824|FG000|Overall Study|Adverse Event|1|||
125312980|NCT01479868|450773824|FG000|Overall Study|Lost to Follow-up|4|||
125312981|NCT01479868|450773824|FG000|Overall Study|Protocol Violation|1|||
125312982|NCT01479868|450773824|FG000|Overall Study|Withdrawal by Subject|1|||
125312983|NCT01479868|450773824|FG000|Overall Study|Sponsor's Decision|1|||
125312984|NCT01479868|450773824|FG000|Overall Study|Initiation of new HCV Therapy|1|||
125312985|NCT01292187|450773825|FG000|Overall Study|Adverse Event|10|||
125312986|NCT01292187|450773826|FG001|Overall Study|Adverse Event|5|||
125312987|NCT01292187|450773825|FG000|Overall Study|Withdrawal by Subject|6|||
125312988|NCT01292187|450773826|FG001|Overall Study|Withdrawal by Subject|5|||
125312989|NCT01292187|450773825|FG000|Overall Study|All other reasons|1|||
125312990|NCT01292187|450773826|FG001|Overall Study|All other reasons|3|||
125312991|NCT00113841|450773828|FG000|Overall Study|Disease progression|0|||
125312992|NCT00113841|450773829|FG001|Overall Study|Disease progression|2|||
125312993|NCT00113841|450773828|FG000|Overall Study|Non-compliant|1|||
125312994|NCT00113841|450773829|FG001|Overall Study|Non-compliant|0|||
125312995|NCT02721875|450773831|FG000|Overall Study|Progressive disease/relapse|1|||
125312996|NCT02721875|450773832|FG001|Overall Study|Progressive disease/relapse|0|||
125312997|NCT00430716|450773833|FG000|Double Blind Phase|Death|1|||
125312998|NCT00430716|450773834|FG001|Double Blind Phase|Death|0|||
125312999|NCT00430716|450773835|FG002|Double Blind Phase|Death|0|||
125313000|NCT00430716|450773833|FG000|Double Blind Phase|No longer willing to participate|2|||
125313001|NCT00430716|450773834|FG001|Double Blind Phase|No longer willing to participate|1|||
125313002|NCT00430716|450773835|FG002|Double Blind Phase|No longer willing to participate|1|||
125313003|NCT00430716|450773833|FG000|Double Blind Phase|Other|0|||
125313004|NCT00430716|450773834|FG001|Double Blind Phase|Other|2|||
125313005|NCT00430716|450773835|FG002|Double Blind Phase|Other|0|||
125313006|NCT00430716|450773833|FG000|Double Blind Phase|Study terminated by sponsor|1|||
125313007|NCT00430716|450773834|FG001|Double Blind Phase|Study terminated by sponsor|1|||
125313008|NCT00430716|450773835|FG002|Double Blind Phase|Study terminated by sponsor|2|||
125313009|NCT00430716|450773833|FG000|Double Blind Phase|Adverse Event|1|||
125313010|NCT00430716|450773834|FG001|Double Blind Phase|Adverse Event|1|||
125313011|NCT00430716|450773835|FG002|Double Blind Phase|Adverse Event|3|||
125313012|NCT00430716|450773833|FG000|Double Blind Phase|Not treated|1|||
125313013|NCT00430716|450773834|FG001|Double Blind Phase|Not treated|0|||
125313014|NCT00430716|450773835|FG002|Double Blind Phase|Not treated|0|||
125313015|NCT00430716|450773833|FG000|Open Label Phase|Lost to Follow-up|1|||
125313016|NCT00430716|450773834|FG001|Open Label Phase|Lost to Follow-up|0|||
125313017|NCT00430716|450773835|FG002|Open Label Phase|Lost to Follow-up|1|||
125313018|NCT00430716|450773833|FG000|Open Label Phase|No longer willing to participate|0|||
125313019|NCT00430716|450773834|FG001|Open Label Phase|No longer willing to participate|1|||
125313020|NCT00430716|450773835|FG002|Open Label Phase|No longer willing to participate|1|||
125313021|NCT00430716|450773833|FG000|Open Label Phase|Other|3|||
125313022|NCT00430716|450773834|FG001|Open Label Phase|Other|1|||
125313023|NCT00430716|450773835|FG002|Open Label Phase|Other|1|||
125313024|NCT00430716|450773833|FG000|Open Label Phase|Protocol Violation|1|||
125313025|NCT00430716|450773834|FG001|Open Label Phase|Protocol Violation|0|||
125313026|NCT00430716|450773835|FG002|Open Label Phase|Protocol Violation|0|||
125313027|NCT00430716|450773833|FG000|Open Label Phase|Study terminated by sponsor|4|||
125313028|NCT00430716|450773834|FG001|Open Label Phase|Study terminated by sponsor|5|||
125313029|NCT00430716|450773835|FG002|Open Label Phase|Study terminated by sponsor|4|||
125313030|NCT01433172|450773836|FG000|Overall Study|Withdrawal by Subject|0|||
125313031|NCT01433172|450773837|FG001|Overall Study|Withdrawal by Subject|1|||
125313032|NCT01433172|450773838|FG002|Overall Study|Withdrawal by Subject|0|||
125313033|NCT01433172|450773836|FG000|Overall Study|Disease Progression|0|||
125313034|NCT01433172|450773837|FG001|Overall Study|Disease Progression|0|||
125313035|NCT01433172|450773838|FG002|Overall Study|Disease Progression|1|||
125313036|NCT01433172|450773836|FG000|Overall Study|Death|0|||
125313037|NCT01433172|450773837|FG001|Overall Study|Death|2|||
125313038|NCT01433172|450773838|FG002|Overall Study|Death|0|||
125313039|NCT00773513|450773839|FG000|Overall Study|Renal Transplant|254|||
125313040|NCT00773513|450773840|FG001|Overall Study|Renal Transplant|263|||
125313041|NCT00773513|450773839|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
125313042|NCT00773513|450773840|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
125313043|NCT00773513|450773839|FG000|Overall Study|Withdrew Consent|68|||
125313044|NCT00773513|450773840|FG001|Overall Study|Withdrew Consent|69|||
125313045|NCT00773513|450773839|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
125313046|NCT00773513|450773840|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
125313047|NCT00773513|450773839|FG000|Overall Study|Failure to Return|22|||
125313048|NCT00773513|450773840|FG001|Overall Study|Failure to Return|8|||
125313049|NCT00773513|450773839|FG000|Overall Study|Insufficient Therapeutic Response|1|||
125313050|NCT00773513|450773840|FG001|Overall Study|Insufficient Therapeutic Response|18|||
125313051|NCT00773513|450773839|FG000|Overall Study|Reason Not Specified|159|||
125313052|NCT00773513|450773840|FG001|Overall Study|Reason Not Specified|126|||
125313053|NCT00773513|450773839|FG000|Overall Study|Death|531|||
125313054|NCT00773513|450773840|FG001|Overall Study|Death|545|||
125313055|NCT03116685|450773845|FG000|Overall Study|Physician Decision|0|||
125313056|NCT03116685|450773846|FG001|Overall Study|Physician Decision|1|||
125313057|NCT01045694|450773847|FG000|Overall Study|Withdrawal by Subject|2|||
125313058|NCT02719171|450775101|FG000|Overall Study|Adverse Event|1|||
125313059|NCT02719171|450775102|FG001|Overall Study|Adverse Event|2|||
125313060|NCT02719171|450775103|FG002|Overall Study|Adverse Event|0|||
125313061|NCT02719171|450775104|FG003|Overall Study|Adverse Event|0|||
125313062|NCT02719171|450775105|FG004|Overall Study|Adverse Event|2|||
125313063|NCT02719171|450775101|FG000|Overall Study|Lost to Follow-up|0|||
125313064|NCT02719171|450775102|FG001|Overall Study|Lost to Follow-up|0|||
125313065|NCT02719171|450775103|FG002|Overall Study|Lost to Follow-up|1|||
125313066|NCT02719171|450775104|FG003|Overall Study|Lost to Follow-up|0|||
125313067|NCT02719171|450775105|FG004|Overall Study|Lost to Follow-up|0|||
125313068|NCT02719171|450775101|FG000|Overall Study|Subject Withdrawal|0|||
125313069|NCT02719171|450775102|FG001|Overall Study|Subject Withdrawal|2|||
125313070|NCT02719171|450775103|FG002|Overall Study|Subject Withdrawal|2|||
125313071|NCT02719171|450775104|FG003|Overall Study|Subject Withdrawal|1|||
125313072|NCT02719171|450775105|FG004|Overall Study|Subject Withdrawal|0|||
125313073|NCT02719171|450775101|FG000|Overall Study|Other|0|||
125313074|NCT02719171|450775102|FG001|Overall Study|Other|0|||
125313075|NCT02719171|450775103|FG002|Overall Study|Other|0|||
125313076|NCT02719171|450775104|FG003|Overall Study|Other|1|||
125313077|NCT02719171|450775105|FG004|Overall Study|Other|0|||
125313078|NCT02796677|450775106|FG000|Overall Study|Adverse Event|11|||
125313079|NCT02796677|450775107|FG001|Overall Study|Adverse Event|22|||
125313080|NCT02796677|450775108|FG002|Overall Study|Adverse Event|14|||
125313081|NCT02796677|450775109|FG003|Overall Study|Adverse Event|14|||
125313082|NCT02796677|450775106|FG000|Overall Study|Protocol Violation|7|||
125313083|NCT02796677|450775107|FG001|Overall Study|Protocol Violation|5|||
125313084|NCT02796677|450775108|FG002|Overall Study|Protocol Violation|4|||
125313085|NCT02796677|450775109|FG003|Overall Study|Protocol Violation|8|||
125313086|NCT02796677|450775106|FG000|Overall Study|Lost to Follow-up|1|||
125313087|NCT02796677|450775107|FG001|Overall Study|Lost to Follow-up|5|||
125313088|NCT02796677|450775108|FG002|Overall Study|Lost to Follow-up|2|||
125313089|NCT02796677|450775109|FG003|Overall Study|Lost to Follow-up|2|||
125313090|NCT02796677|450775106|FG000|Overall Study|Lack of Efficacy|7|||
125313091|NCT02796677|450775107|FG001|Overall Study|Lack of Efficacy|9|||
125313092|NCT02796677|450775108|FG002|Overall Study|Lack of Efficacy|14|||
125313093|NCT02796677|450775109|FG003|Overall Study|Lack of Efficacy|20|||
125313094|NCT02796677|450775106|FG000|Overall Study|Withdrawal by Subject|4|||
125313095|NCT02796677|450775107|FG001|Overall Study|Withdrawal by Subject|14|||
125313096|NCT02796677|450775108|FG002|Overall Study|Withdrawal by Subject|6|||
125313097|NCT02796677|450775109|FG003|Overall Study|Withdrawal by Subject|7|||
125313098|NCT02796677|450775106|FG000|Overall Study|Progressive disease|6|||
125313099|NCT02796677|450775107|FG001|Overall Study|Progressive disease|15|||
125313100|NCT02796677|450775108|FG002|Overall Study|Progressive disease|13|||
125313101|NCT02796677|450775109|FG003|Overall Study|Progressive disease|18|||
125313102|NCT02796677|450775106|FG000|Overall Study|Reason not mentioned|2|||
125313103|NCT02796677|450775107|FG001|Overall Study|Reason not mentioned|3|||
125313104|NCT02796677|450775108|FG002|Overall Study|Reason not mentioned|0|||
125313105|NCT02796677|450775109|FG003|Overall Study|Reason not mentioned|5|||
125313106|NCT00961181|450775110|FG000|Overall Study|Death|2|||
125313107|NCT00961181|450775110|FG000|Overall Study|Withdrawal by Subject|2|||
125313108|NCT00961181|450775110|FG000|Overall Study|Lost to Follow-up|1|||
125313109|NCT03811340|450775111|FG000|Overall Study|subjects did not complete the survey.|90|||
125313110|NCT01045967|450775112|FG000|Second Intervention|Protocol Violation|0|||
125313111|NCT01045967|450775113|FG001|Second Intervention|Protocol Violation|1|||
125313112|NCT01485094|450775123|FG000|Overall Study|Adverse Event|1|||
125313113|NCT01485094|450775124|FG001|Overall Study|Adverse Event|1|||
125313114|NCT01485094|450775125|FG002|Overall Study|Adverse Event|1|||
125313115|NCT01485094|450775123|FG000|Overall Study|Lost to Follow-up|1|||
125313116|NCT01485094|450775124|FG001|Overall Study|Lost to Follow-up|0|||
125313117|NCT01485094|450775125|FG002|Overall Study|Lost to Follow-up|0|||
125313118|NCT01485094|450775123|FG000|Overall Study|Withdrawal by Subject|1|||
125313119|NCT01485094|450775124|FG001|Overall Study|Withdrawal by Subject|1|||
125313120|NCT01485094|450775125|FG002|Overall Study|Withdrawal by Subject|0|||
125313121|NCT02576639|450775126|FG000|Overall Study|Withdrawal by Subject|1|||
125313122|NCT02576639|450775127|FG001|Overall Study|Withdrawal by Subject|2|||
125313123|NCT02576639|450775128|FG002|Overall Study|Withdrawal by Subject|1|||
125313124|NCT02576639|450775129|FG003|Overall Study|Withdrawal by Subject|0|||
125313125|NCT02576639|450775130|FG004|Overall Study|Withdrawal by Subject|1|||
125313126|NCT02576639|450775126|FG000|Overall Study|Adverse Event|1|||
125313127|NCT02576639|450775127|FG001|Overall Study|Adverse Event|0|||
125313128|NCT02576639|450775128|FG002|Overall Study|Adverse Event|1|||
125313129|NCT02576639|450775129|FG003|Overall Study|Adverse Event|1|||
125313130|NCT02576639|450775130|FG004|Overall Study|Adverse Event|2|||
125313131|NCT02576639|450775126|FG000|Overall Study|Physician Decision|0|||
125313132|NCT02576639|450775127|FG001|Overall Study|Physician Decision|0|||
125313133|NCT02576639|450775128|FG002|Overall Study|Physician Decision|0|||
125313134|NCT02576639|450775129|FG003|Overall Study|Physician Decision|0|||
125313135|NCT02576639|450775130|FG004|Overall Study|Physician Decision|1|||
125313136|NCT02079038|450775131|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
125313137|NCT02079038|450775132|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
125313138|NCT02079038|450775131|FG000|Modified Intent to Treat Population|Death|1|||
125313139|NCT02079038|450775132|FG001|Modified Intent to Treat Population|Death|0|||
125313140|NCT02079038|450775131|FG000|Completed 6 Months|Lost to Follow-up|2|||
125313141|NCT02079038|450775132|FG001|Completed 6 Months|Lost to Follow-up|1|||
125313142|NCT02478463|450775133|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
125313143|NCT02478463|450775133|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
125313144|NCT02478463|450775133|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
125313145|NCT01358825|450775136|FG000|Overall Study|Blood sample not drawn|0|||
125313146|NCT01358825|450775137|FG001|Overall Study|Blood sample not drawn|1|||
125313147|NCT01508169|450775141|FG000|Overall Study|Adverse Event|1|||
125313148|NCT01508169|450775142|FG001|Overall Study|Adverse Event|0|||
125313149|NCT01508169|450775141|FG000|Overall Study|Withdrawal by Subject|1|||
125313150|NCT01508169|450775142|FG001|Overall Study|Withdrawal by Subject|0|||
125313151|NCT01508169|450775141|FG000|Overall Study|Lost to Follow-up|1|||
125313152|NCT01508169|450775142|FG001|Overall Study|Lost to Follow-up|2|||
125313153|NCT03600740|450775143|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
125313154|NCT01814527|450775144|FG000|Overall Study|RTP greater than 30 days|6|||
125313155|NCT01814527|450775145|FG001|Overall Study|RTP greater than 30 days|1|||
125313156|NCT04524858|450775146|FG000|Overall Study|Adverse Event|1|||
125313157|NCT03571204|450775147|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
125313158|NCT03571204|450775148|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
125313159|NCT03571204|450775149|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
125313160|NCT03571204|450775147|FG000|Overall Study|Physician Decision|0|||
125313161|NCT03571204|450775148|FG001|Overall Study|Physician Decision|1|||
125313162|NCT03571204|450775149|FG002|Overall Study|Physician Decision|0|||
125313163|NCT02396212|450775150|FG000|Overall Study|Adverse Event|1|||
125313164|NCT02396212|450775150|FG000|Overall Study|Lack of Efficacy|2|||
125313165|NCT01363700|450775151|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
125313166|NCT01363700|450775152|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
125313167|NCT01363700|450775153|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
125313168|NCT01363700|450775154|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
125313169|NCT01363700|450775155|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
125313170|NCT05202418|450775163|FG000|Overall Study|Withdrawal by Subject|2|||
125313171|NCT05202418|450775164|FG001|Overall Study|Withdrawal by Subject|1|||
125313172|NCT05202418|450775163|FG000|Overall Study|Lost to Follow-up|1|||
125313173|NCT05202418|450775164|FG001|Overall Study|Lost to Follow-up|1|||
125313174|NCT01329978|450775168|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
125313175|NCT01329978|450775169|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
125313176|NCT01329978|450775170|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
125313177|NCT01329978|450775171|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
125313178|NCT01329978|450775172|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
125313179|NCT01329978|450775168|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
125313180|NCT01329978|450775169|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
125313181|NCT01329978|450775170|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
125313182|NCT01329978|450775171|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
125313183|NCT01329978|450775172|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
125313184|NCT01329978|450775168|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
125313185|NCT01329978|450775169|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
124983502|NCT00532493|449567352|FG000|Overall Study|Contraindicative Medication|1|||
124983503|NCT00532493|449567353|FG001|Overall Study|Contraindicative Medication|0|||
124983504|NCT00738894|449567356|FG000|Overall Study|Lost to Follow-up|23|||
124983505|NCT00738894|449567357|FG001|Overall Study|Lost to Follow-up|13|||
124983506|NCT00738894|449567356|FG000|Overall Study|Withdrawal by Subject|10|||
124983507|NCT00738894|449567357|FG001|Overall Study|Withdrawal by Subject|15|||
124983508|NCT00738894|449567356|FG000|Overall Study|Physician Decision|4|||
125313186|NCT01329978|450775170|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
125313187|NCT01329978|450775171|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
125313188|NCT01329978|450775172|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
125313189|NCT01329978|450775168|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
125313190|NCT01329978|450775169|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
125313191|NCT01329978|450775170|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
125313192|NCT01329978|450775171|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
125313193|NCT01329978|450775172|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
125313194|NCT01329978|450775168|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
125313195|NCT01329978|450775169|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
125313196|NCT01329978|450775170|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
125313197|NCT01329978|450775171|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
125313198|NCT01329978|450775172|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
125313199|NCT01329978|450775168|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
125313200|NCT01329978|450775169|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
125313201|NCT01329978|450775170|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
125313202|NCT01329978|450775171|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
125313203|NCT01329978|450775172|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
125313204|NCT01329978|450775168|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
125313205|NCT01329978|450775169|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
125313206|NCT01329978|450775170|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
125313207|NCT01329978|450775171|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
125313208|NCT01329978|450775172|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
125313209|NCT04170543|450775182|FG000|Overall Study|Death|1|||
125313210|NCT04170543|450775183|FG001|Overall Study|Death|1|||
125313211|NCT04170543|450775184|FG002|Overall Study|Death|1|||
125313212|NCT04170543|450775185|FG003|Overall Study|Death|1|||
125313213|NCT04170543|450775186|FG004|Overall Study|Death|1|||
125313214|NCT04170543|450775182|FG000|Overall Study|Lost to Follow-up|3|||
125313215|NCT04170543|450775183|FG001|Overall Study|Lost to Follow-up|3|||
125313216|NCT04170543|450775184|FG002|Overall Study|Lost to Follow-up|0|||
125313217|NCT04170543|450775185|FG003|Overall Study|Lost to Follow-up|3|||
125313218|NCT04170543|450775186|FG004|Overall Study|Lost to Follow-up|1|||
125313219|NCT04170543|450775182|FG000|Overall Study|Withdrawal by Subject|13|||
125313220|NCT04170543|450775183|FG001|Overall Study|Withdrawal by Subject|6|||
125313221|NCT04170543|450775184|FG002|Overall Study|Withdrawal by Subject|5|||
125313222|NCT04170543|450775185|FG003|Overall Study|Withdrawal by Subject|4|||
125313223|NCT04170543|450775186|FG004|Overall Study|Withdrawal by Subject|9|||
125313224|NCT04170543|450775182|FG000|Overall Study|Not able to transition to phase 2b|8|||
125313225|NCT04170543|450775183|FG001|Overall Study|Not able to transition to phase 2b|0|||
125313226|NCT04170543|450775184|FG002|Overall Study|Not able to transition to phase 2b|10|||
125313227|NCT04170543|450775185|FG003|Overall Study|Not able to transition to phase 2b|0|||
125313228|NCT04170543|450775186|FG004|Overall Study|Not able to transition to phase 2b|6|||
125313229|NCT04170543|450775182|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
125313230|NCT04170543|450775183|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
125313231|NCT04170543|450775184|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
125313232|NCT04170543|450775185|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
125313233|NCT04170543|450775186|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
125313234|NCT04170543|450775182|FG000|Overall Study|Not Treated|0|||
125313235|NCT04170543|450775183|FG001|Overall Study|Not Treated|0|||
125313236|NCT04170543|450775184|FG002|Overall Study|Not Treated|0|||
125313237|NCT04170543|450775185|FG003|Overall Study|Not Treated|0|||
125313238|NCT04170543|450775186|FG004|Overall Study|Not Treated|2|||
125313239|NCT04170543|450775182|FG000|Overall Study|(CRF)|16|||
125313240|NCT04170543|450775183|FG001|Overall Study|(CRF)|15|||
125313241|NCT04170543|450775184|FG002|Overall Study|(CRF)|12|||
125313242|NCT04170543|450775185|FG003|Overall Study|(CRF)|17|||
125313243|NCT04170543|450775186|FG004|Overall Study|(CRF)|17|||
125313244|NCT04170543|450775182|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
125313245|NCT04170543|450775183|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
125313246|NCT04170543|450775184|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
125313247|NCT04170543|450775185|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
125313248|NCT04170543|450775186|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
125313249|NCT04303559|450775187|FG000|Overall Study|Study closed due to poor enrollment.|1|||
125313250|NCT04037891|450775190|FG000|Open-label Period|Withdrawal by Subject|1|||
124983509|NCT00738894|449567357|FG001|Overall Study|Physician Decision|5|||
125313251|NCT04037891|450775191|FG001|Open-label Period|Withdrawal by Subject|0|||
125313252|NCT04037891|450775192|FG002|Open-label Period|Withdrawal by Subject|0|||
125313253|NCT04037891|450775190|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
125313254|NCT04037891|450775191|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
125313255|NCT04037891|450775192|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
124983510|NCT00738894|449567356|FG000|Overall Study|Death|2|||
124983511|NCT00738894|449567357|FG001|Overall Study|Death|0|||
124983512|NCT02546921|449567364|FG000|Overall Study|Adverse Event|0|||
124983513|NCT02546921|449567365|FG001|Overall Study|Adverse Event|5|||
124983514|NCT02546921|449567366|FG002|Overall Study|Adverse Event|2|||
124983515|NCT02546921|449567367|FG003|Overall Study|Adverse Event|0|||
124983516|NCT02546921|449567368|FG004|Overall Study|Adverse Event|0|||
124983517|NCT02546921|449567369|FG005|Overall Study|Adverse Event|0|||
124983518|NCT02546921|449567370|FG006|Overall Study|Adverse Event|0|||
124983519|NCT02546921|449567364|FG000|Overall Study|Evidence of Disease Progression|1|||
124983520|NCT02546921|449567365|FG001|Overall Study|Evidence of Disease Progression|0|||
124983521|NCT02546921|449567366|FG002|Overall Study|Evidence of Disease Progression|0|||
124983522|NCT02546921|449567367|FG003|Overall Study|Evidence of Disease Progression|0|||
124983523|NCT02546921|449567368|FG004|Overall Study|Evidence of Disease Progression|1|||
124983524|NCT02546921|449567369|FG005|Overall Study|Evidence of Disease Progression|0|||
124983525|NCT02546921|449567370|FG006|Overall Study|Evidence of Disease Progression|0|||
124983526|NCT02546921|449567364|FG000|Overall Study|Patient Choice|0|||
124983527|NCT02546921|449567365|FG001|Overall Study|Patient Choice|1|||
124983528|NCT02546921|449567366|FG002|Overall Study|Patient Choice|0|||
124983529|NCT02546921|449567367|FG003|Overall Study|Patient Choice|0|||
124983530|NCT02546921|449567368|FG004|Overall Study|Patient Choice|0|||
124983531|NCT02546921|449567369|FG005|Overall Study|Patient Choice|1|||
124983532|NCT02546921|449567370|FG006|Overall Study|Patient Choice|0|||
124983533|NCT00680992|449567374|FG000|Overall Study|Complete Resection (as per protocol)|25|||
124983534|NCT00680992|449567375|FG001|Overall Study|Complete Resection (as per protocol)|121|||
124983535|NCT00680992|449567376|FG002|Overall Study|Complete Resection (as per protocol)|0|||
124983536|NCT00680992|449567374|FG000|Overall Study|Administrative Decision|83|||
124983537|NCT00680992|449567375|FG001|Overall Study|Administrative Decision|42|||
124983538|NCT00680992|449567376|FG002|Overall Study|Administrative Decision|5|||
124983539|NCT00680992|449567374|FG000|Overall Study|End of Trial|32|||
124983540|NCT00680992|449567375|FG001|Overall Study|End of Trial|12|||
124983541|NCT00680992|449567376|FG002|Overall Study|End of Trial|3|||
124983542|NCT00680992|449567374|FG000|Overall Study|Withdrawal by Subject|33|||
124983543|NCT00680992|449567375|FG001|Overall Study|Withdrawal by Subject|11|||
124983544|NCT00680992|449567376|FG002|Overall Study|Withdrawal by Subject|1|||
124983545|NCT00680992|449567374|FG000|Overall Study|Adverse Event|21|||
124983546|NCT00680992|449567375|FG001|Overall Study|Adverse Event|19|||
124983547|NCT00680992|449567376|FG002|Overall Study|Adverse Event|1|||
124983548|NCT00680992|449567374|FG000|Overall Study|Other|19|||
124983549|NCT00680992|449567375|FG001|Overall Study|Other|14|||
124983550|NCT00680992|449567376|FG002|Overall Study|Other|1|||
124983551|NCT00680992|449567374|FG000|Overall Study|Disease Progression|21|||
124983552|NCT00680992|449567375|FG001|Overall Study|Disease Progression|9|||
124983553|NCT00680992|449567376|FG002|Overall Study|Disease Progression|0|||
124983554|NCT00680992|449567374|FG000|Overall Study|Lost to Follow-up|12|||
124983555|NCT00680992|449567375|FG001|Overall Study|Lost to Follow-up|14|||
124983556|NCT00680992|449567376|FG002|Overall Study|Lost to Follow-up|0|||
124983557|NCT00680992|449567374|FG000|Overall Study|Noncompliance|4|||
124983558|NCT00680992|449567375|FG001|Overall Study|Noncompliance|6|||
124983559|NCT00680992|449567376|FG002|Overall Study|Noncompliance|0|||
124983560|NCT00680992|449567374|FG000|Overall Study|Requirement for Alternative Therapy|8|||
124983561|NCT00680992|449567375|FG001|Overall Study|Requirement for Alternative Therapy|2|||
125313256|NCT03446313|450775193|FG000|Overall Study|Lost to Follow-up|1|||
125313257|NCT03446313|450775194|FG001|Overall Study|Lost to Follow-up|2|||
125313258|NCT03446313|450775193|FG000|Overall Study|Failed primary screening|3|||
124983562|NCT00680992|449567376|FG002|Overall Study|Requirement for Alternative Therapy|0|||
124983563|NCT00680992|449567374|FG000|Overall Study|Pregnancy|5|||
124983564|NCT00680992|449567375|FG001|Overall Study|Pregnancy|0|||
124983565|NCT00680992|449567376|FG002|Overall Study|Pregnancy|1|||
124983566|NCT00680992|449567374|FG000|Overall Study|Death|5|||
124983567|NCT00680992|449567375|FG001|Overall Study|Death|1|||
124983568|NCT00680992|449567376|FG002|Overall Study|Death|0|||
124983569|NCT00680992|449567374|FG000|Overall Study|Ineligibility Determined|0|||
124983570|NCT00680992|449567375|FG001|Overall Study|Ineligibility Determined|1|||
124983571|NCT00680992|449567376|FG002|Overall Study|Ineligibility Determined|0|||
124983572|NCT01585155|449567377|FG000|Overall Study|Adverse Event|1|||
125313259|NCT03446313|450775194|FG001|Overall Study|Failed primary screening|0|||
125313260|NCT03446313|450775193|FG000|Overall Study|Diagnosed with terminal cancer|1|||
125313261|NCT03446313|450775194|FG001|Overall Study|Diagnosed with terminal cancer|0|||
124983573|NCT01585155|449567377|FG000|Overall Study|Lack of Efficacy|2|||
124983574|NCT01585155|449567377|FG000|Overall Study|Worsening ulcerative colitis|2|||
125313262|NCT03446313|450775193|FG000|Overall Study|Excluded from analysis|1|||
125313263|NCT03446313|450775194|FG001|Overall Study|Excluded from analysis|1|||
125313264|NCT05274958|450775195|FG000|Overall Study|Only completed 1 set of PROMs|22|||
125313265|NCT05274958|450775196|FG001|Overall Study|Only completed 1 set of PROMs|35|||
125313266|NCT05481359|450775197|FG000|Overall Study|Lost to Follow-up|3|||
125313267|NCT05481359|450775197|FG000|Overall Study|Withdrawal by Subject|1|||
125313268|NCT04491136|450775202|FG000|Overall Study|Patient withdraw informed consent|9|||
125313269|NCT04491136|450775202|FG000|Overall Study|Adverse Event|2|||
125313270|NCT04491136|450775202|FG000|Overall Study|Death|3|||
125313271|NCT04491136|450775202|FG000|Overall Study|Lost to Follow-up|3|||
125313272|NCT04491136|450775202|FG000|Overall Study|Physician Decision|45|||
125313273|NCT04491136|450775202|FG000|Overall Study|sponsor terminated the study early|16|||
125313274|NCT04491136|450775202|FG000|Overall Study|Patient/guardian's decision|1|||
125313275|NCT01611194|450775203|FG000|Overall Study|Lost to Follow-up|0|||
125313276|NCT01611194|450775204|FG001|Overall Study|Lost to Follow-up|1|||
125313277|NCT01611194|450775203|FG000|Overall Study|Withdrawal by Subject|0|||
125313278|NCT01611194|450775204|FG001|Overall Study|Withdrawal by Subject|1|||
125313279|NCT01611194|450775203|FG000|Overall Study|drug use|0|||
125313280|NCT01611194|450775204|FG001|Overall Study|drug use|1|||
125313281|NCT00452790|450775207|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
125313282|NCT00452790|450775208|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
125313283|NCT00452790|450775207|FG000|Infant Series|Parent/legal guardian request|8|||
125313284|NCT00452790|450775208|FG001|Infant Series|Parent/legal guardian request|6|||
125313285|NCT00452790|450775207|FG000|Infant Series|Failed to return|4|||
125313286|NCT00452790|450775208|FG001|Infant Series|Failed to return|1|||
125313287|NCT00452790|450775207|FG000|Infant Series|Protocol Violation|1|||
125313288|NCT00452790|450775208|FG001|Infant Series|Protocol Violation|3|||
125313289|NCT00452790|450775207|FG000|Infant Series|Lost to Follow-up|2|||
125313290|NCT00452790|450775208|FG001|Infant Series|Lost to Follow-up|2|||
125313291|NCT00452790|450775207|FG000|Infant Series|Adverse Event|1|||
125313292|NCT00452790|450775208|FG001|Infant Series|Adverse Event|2|||
125313293|NCT00452790|450775207|FG000|Infant Series|Other reasons|1|||
125313294|NCT00452790|450775208|FG001|Infant Series|Other reasons|2|||
125313295|NCT00452790|450775207|FG000|Infant Series|Investigator request|0|||
125313296|NCT00452790|450775208|FG001|Infant Series|Investigator request|1|||
125313297|NCT00452790|450775207|FG000|Infant Series|Death|0|||
125313298|NCT00452790|450775208|FG001|Infant Series|Death|1|||
125313299|NCT00452790|450775207|FG000|After Infant Series|Investigator request|10|||
125313300|NCT00452790|450775208|FG001|After Infant Series|Investigator request|10|||
125313301|NCT00452790|450775207|FG000|After Infant Series|Adverse Event|4|||
125313302|NCT00452790|450775208|FG001|After Infant Series|Adverse Event|1|||
125313303|NCT00452790|450775207|FG000|After Infant Series|Parent/legal guardian request|1|||
125313304|NCT00452790|450775208|FG001|After Infant Series|Parent/legal guardian request|3|||
125313305|NCT00452790|450775207|FG000|After Infant Series|Lost to Follow-up|4|||
125313306|NCT00452790|450775208|FG001|After Infant Series|Lost to Follow-up|0|||
125313307|NCT00452790|450775207|FG000|After Infant Series|Failed to return|1|||
125313308|NCT00452790|450775208|FG001|After Infant Series|Failed to return|0|||
125313309|NCT00452790|450775207|FG000|After Infant Series|Other reasons|1|||
125313310|NCT00452790|450775208|FG001|After Infant Series|Other reasons|0|||
125313311|NCT00452790|450775207|FG000|Toddler Dose|Failed to return|0|||
125313312|NCT00452790|450775208|FG001|Toddler Dose|Failed to return|1|||
125313313|NCT00452790|450775207|FG000|Toddler Dose|Parent/legal guardian request|0|||
125313314|NCT00452790|450775208|FG001|Toddler Dose|Parent/legal guardian request|1|||
125313315|NCT00348673|450775210|FG000|Stage 1|Randomized but not Treated|0|||
125313316|NCT00348673|450775211|FG001|Stage 1|Randomized but not Treated|0|||
125313317|NCT00348673|450775212|FG002|Stage 1|Randomized but not Treated|1|||
125313318|NCT00348673|450775213|FG003|Stage 1|Randomized but not Treated|0|||
125313319|NCT00348673|450775214|FG004|Stage 1|Randomized but not Treated|0|||
125313320|NCT00348673|450775215|FG005|Stage 1|Randomized but not Treated|0|||
125313321|NCT00348673|450775216|FG006|Stage 1|Randomized but not Treated|0|||
125313322|NCT00348673|450775217|FG007|Stage 1|Randomized but not Treated|0|||
125313323|NCT00348673|450775218|FG008|Stage 1|Randomized but not Treated|0|||
125313324|NCT01712204|450775219|FG000|Overall Study|Adverse Event|3|||
125313325|NCT01712204|450775220|FG001|Overall Study|Adverse Event|1|||
125313326|NCT01712204|450775219|FG000|Overall Study|Withdrawal by Subject|3|||
125313327|NCT01712204|450775220|FG001|Overall Study|Withdrawal by Subject|3|||
125313328|NCT01712204|450775219|FG000|Overall Study|Lost to Follow-up|1|||
125313329|NCT01712204|450775220|FG001|Overall Study|Lost to Follow-up|0|||
125313330|NCT01712204|450775219|FG000|Overall Study|Protocol Violation|1|||
125313331|NCT01712204|450775220|FG001|Overall Study|Protocol Violation|1|||
125313332|NCT01150097|450775228|FG000|Months 24 to 36 Post-transplantation|Death|2|||
125313333|NCT01150097|450775229|FG001|Months 24 to 36 Post-transplantation|Death|0|||
125313334|NCT01150097|450775230|FG002|Months 24 to 36 Post-transplantation|Death|0|||
125313335|NCT01150097|450775228|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
125313336|NCT01150097|450775229|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
125313337|NCT01150097|450775230|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
125313338|NCT01150097|450775228|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
125313339|NCT01150097|450775229|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
125313340|NCT01150097|450775230|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
125313341|NCT01150097|450775228|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
125313342|NCT01150097|450775229|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
125313343|NCT01150097|450775230|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
125313344|NCT01150097|450775228|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
125313345|NCT01150097|450775229|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
125313346|NCT01150097|450775230|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
125313347|NCT01150097|450775228|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
125313348|NCT01150097|450775229|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
125313349|NCT01150097|450775230|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
125313350|NCT01150097|450775228|FG000|Months 24 to 48 Post-transplantation|Death|2|||
125313351|NCT01150097|450775229|FG001|Months 24 to 48 Post-transplantation|Death|0|||
125313352|NCT01150097|450775230|FG002|Months 24 to 48 Post-transplantation|Death|0|||
125313353|NCT01114828|450775233|FG000|Overall Study|Adverse Event|1|||
125313354|NCT01114828|450775234|FG001|Overall Study|Adverse Event|1|||
125313355|NCT01114828|450775233|FG000|Overall Study|Lack of Efficacy|0|||
125313356|NCT01114828|450775234|FG001|Overall Study|Lack of Efficacy|2|||
125313357|NCT01114828|450775233|FG000|Overall Study|Protocol Violation|2|||
125313358|NCT01114828|450775234|FG001|Overall Study|Protocol Violation|0|||
125313359|NCT01114828|450775233|FG000|Overall Study|Withdrawal by Subject|0|||
125313360|NCT01114828|450775234|FG001|Overall Study|Withdrawal by Subject|1|||
125313361|NCT00549445|450775235|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
125313362|NCT00549445|450775236|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
125313363|NCT03790111|450777273|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
125313364|NCT03798717|450777278|FG000|Overall Study|Failed Screening|0|||
125313365|NCT03798717|450777279|FG001|Overall Study|Failed Screening|0|||
125313366|NCT03798717|450777280|FG002|Overall Study|Failed Screening|0|||
125313367|NCT03798717|450777281|FG003|Overall Study|Failed Screening|0|||
125313368|NCT03798717|450777282|FG004|Overall Study|Failed Screening|0|||
125313369|NCT03798717|450777283|FG005|Overall Study|Failed Screening|1|||
125313370|NCT03798717|450777278|FG000|Overall Study|Physician Decision|1|||
125313371|NCT03798717|450777279|FG001|Overall Study|Physician Decision|0|||
125313372|NCT03798717|450777280|FG002|Overall Study|Physician Decision|1|||
125313373|NCT03798717|450777281|FG003|Overall Study|Physician Decision|0|||
125313374|NCT03798717|450777282|FG004|Overall Study|Physician Decision|0|||
125313375|NCT03798717|450777283|FG005|Overall Study|Physician Decision|0|||
125313376|NCT03798717|450777278|FG000|Overall Study|Withdrawal by Subject|0|||
125313377|NCT03798717|450777279|FG001|Overall Study|Withdrawal by Subject|0|||
125313378|NCT03798717|450777280|FG002|Overall Study|Withdrawal by Subject|0|||
125313379|NCT03798717|450777281|FG003|Overall Study|Withdrawal by Subject|1|||
125313380|NCT03798717|450777282|FG004|Overall Study|Withdrawal by Subject|0|||
125313381|NCT03798717|450777283|FG005|Overall Study|Withdrawal by Subject|0|||
125313382|NCT03798717|450777278|FG000|Overall Study|Lost to Follow-up|1|||
125313383|NCT03798717|450777279|FG001|Overall Study|Lost to Follow-up|0|||
125313384|NCT03798717|450777280|FG002|Overall Study|Lost to Follow-up|0|||
125313385|NCT03798717|450777281|FG003|Overall Study|Lost to Follow-up|1|||
125313386|NCT03798717|450777282|FG004|Overall Study|Lost to Follow-up|0|||
125313387|NCT03798717|450777283|FG005|Overall Study|Lost to Follow-up|0|||
125313388|NCT03798717|450777278|FG000|Overall Study|Adverse Event|0|||
125313389|NCT03798717|450777279|FG001|Overall Study|Adverse Event|1|||
125313390|NCT03798717|450777280|FG002|Overall Study|Adverse Event|0|||
125313391|NCT03798717|450777281|FG003|Overall Study|Adverse Event|0|||
125313392|NCT03798717|450777282|FG004|Overall Study|Adverse Event|0|||
125313393|NCT03798717|450777283|FG005|Overall Study|Adverse Event|0|||
125313394|NCT03798717|450777278|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
125313395|NCT03798717|450777279|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
125313396|NCT03798717|450777280|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
125313397|NCT03798717|450777281|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
125313398|NCT03798717|450777282|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
125313399|NCT03798717|450777283|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
125313400|NCT01777308|450777287|FG000|Overall Study|Withdrawal by Subject|5|||
125313401|NCT01777308|450777288|FG001|Overall Study|Withdrawal by Subject|1|||
125313402|NCT01777308|450777287|FG000|Overall Study|Migrated/moved from study area|1|||
125313403|NCT01777308|450777288|FG001|Overall Study|Migrated/moved from study area|0|||
125313404|NCT01777308|450777287|FG000|Overall Study|Lost to Follow-up|7|||
125313405|NCT01777308|450777288|FG001|Overall Study|Lost to Follow-up|2|||
125313406|NCT01777308|450777287|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
125313407|NCT01777308|450777288|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
125313408|NCT03212326|450777290|FG000|Overall Study|Physician Decision|4|||
125313409|NCT00985673|450777302|FG000|Overall Study|Lost to Follow-up|6|||
125313410|NCT00985673|450777303|FG001|Overall Study|Lost to Follow-up|7|||
125313411|NCT00985673|450777304|FG002|Overall Study|Lost to Follow-up|6|||
125313412|NCT00985673|450777305|FG003|Overall Study|Lost to Follow-up|10|||
124983575|NCT01397422|449567382|FG000|Overall Study|Adverse Event|0|||
124983576|NCT01397422|449567383|FG001|Overall Study|Adverse Event|3|||
124983577|NCT01397422|449567384|FG002|Overall Study|Adverse Event|3|||
124983578|NCT01397422|449567385|FG003|Overall Study|Adverse Event|8|||
124983579|NCT01397422|449567382|FG000|Overall Study|Withdrawal by Subject|1|||
124983580|NCT01397422|449567383|FG001|Overall Study|Withdrawal by Subject|0|||
124983581|NCT01397422|449567384|FG002|Overall Study|Withdrawal by Subject|0|||
124983582|NCT01397422|449567385|FG003|Overall Study|Withdrawal by Subject|0|||
125313413|NCT00985673|450777306|FG004|Overall Study|Lost to Follow-up|5|||
125313414|NCT00985673|450777307|FG005|Overall Study|Lost to Follow-up|3|||
125313415|NCT00985673|450777302|FG000|Overall Study|Withdrawal by Subject|0|||
125313416|NCT00985673|450777303|FG001|Overall Study|Withdrawal by Subject|4|||
125313417|NCT00985673|450777304|FG002|Overall Study|Withdrawal by Subject|5|||
125313418|NCT00985673|450777305|FG003|Overall Study|Withdrawal by Subject|2|||
125313419|NCT00985673|450777306|FG004|Overall Study|Withdrawal by Subject|2|||
125313420|NCT00985673|450777307|FG005|Overall Study|Withdrawal by Subject|3|||
125313421|NCT00985673|450777302|FG000|Overall Study|Other|1|||
125313422|NCT00985673|450777303|FG001|Overall Study|Other|0|||
125313423|NCT00985673|450777304|FG002|Overall Study|Other|1|||
125313424|NCT00985673|450777305|FG003|Overall Study|Other|0|||
125313425|NCT00985673|450777306|FG004|Overall Study|Other|1|||
125313426|NCT00985673|450777307|FG005|Overall Study|Other|0|||
125313427|NCT00984256|450777310|FG000|Overall Study|Withdrawal by Subject|0|||
125313428|NCT00984256|450777311|FG001|Overall Study|Withdrawal by Subject|1|||
125313429|NCT03057496|450777312|FG000|Overall Study|Withdrawal by Subject|8|||
125313430|NCT03057496|450777312|FG000|Overall Study|Lost to Follow-up|5|||
125313431|NCT03057496|450777312|FG000|Overall Study|Did not use device during home trial|3|||
125313432|NCT03057496|450777312|FG000|Overall Study|Device failure|2|||
125313433|NCT00280917|450777313|FG000|Overall Study|Adverse Event|1|||
125313434|NCT00280917|450777314|FG001|Overall Study|Adverse Event|1|||
125313435|NCT00280917|450777315|FG002|Overall Study|Adverse Event|4|||
125313436|NCT00280917|450777316|FG003|Overall Study|Adverse Event|1|||
125313437|NCT00280917|450777313|FG000|Overall Study|Change Therapy|1|||
125313438|NCT00280917|450777314|FG001|Overall Study|Change Therapy|2|||
125313439|NCT00280917|450777315|FG002|Overall Study|Change Therapy|0|||
125313440|NCT00280917|450777316|FG003|Overall Study|Change Therapy|0|||
125313441|NCT00280917|450777313|FG000|Overall Study|Withdrawal by Subject|0|||
125313442|NCT00280917|450777314|FG001|Overall Study|Withdrawal by Subject|2|||
125313443|NCT00280917|450777315|FG002|Overall Study|Withdrawal by Subject|0|||
125313444|NCT00280917|450777316|FG003|Overall Study|Withdrawal by Subject|1|||
125313445|NCT00280917|450777313|FG000|Overall Study|Noncompliance|0|||
125313446|NCT00280917|450777314|FG001|Overall Study|Noncompliance|1|||
125313447|NCT00280917|450777315|FG002|Overall Study|Noncompliance|2|||
125313448|NCT00280917|450777316|FG003|Overall Study|Noncompliance|0|||
125313449|NCT01307319|450777317|FG000|Overall Study|Adverse Event|2|||
125313450|NCT01307319|450777318|FG001|Overall Study|Adverse Event|2|||
125313451|NCT01307319|450777319|FG002|Overall Study|Adverse Event|1|||
125313452|NCT01307319|450777317|FG000|Overall Study|Lost to Follow-up|1|||
125313453|NCT01307319|450777318|FG001|Overall Study|Lost to Follow-up|0|||
125313454|NCT01307319|450777319|FG002|Overall Study|Lost to Follow-up|1|||
125313455|NCT01307319|450777317|FG000|Overall Study|Protocol Violation|1|||
125313456|NCT01307319|450777318|FG001|Overall Study|Protocol Violation|1|||
125313457|NCT01307319|450777319|FG002|Overall Study|Protocol Violation|0|||
125313458|NCT01307319|450777317|FG000|Overall Study|Withdrawal by Subject|0|||
125313459|NCT01307319|450777318|FG001|Overall Study|Withdrawal by Subject|1|||
125313460|NCT01307319|450777319|FG002|Overall Study|Withdrawal by Subject|2|||
125313461|NCT01307319|450777317|FG000|Overall Study|Other|0|||
125313462|NCT01307319|450777318|FG001|Overall Study|Other|4|||
125313463|NCT01307319|450777319|FG002|Overall Study|Other|3|||
124983583|NCT01397422|449567382|FG000|Overall Study|Increased bradykinesia related to PD|1|||
124983584|NCT01397422|449567383|FG001|Overall Study|Increased bradykinesia related to PD|0|||
124983585|NCT01397422|449567384|FG002|Overall Study|Increased bradykinesia related to PD|0|||
125313464|NCT01731912|450777322|FG000|Overall Study|noncompliance|2|||
125313465|NCT02222558|450777323|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
124983586|NCT01397422|449567385|FG003|Overall Study|Increased bradykinesia related to PD|0|||
125313466|NCT02222558|450777324|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
125313467|NCT02222558|450777325|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
125313468|NCT02222558|450777326|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
125313469|NCT02222558|450777327|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
125313470|NCT02222558|450777328|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
125313471|NCT02222558|450777323|FG000|Period 3|Withdrawal by Subject|0|||
125313472|NCT02222558|450777324|FG001|Period 3|Withdrawal by Subject|0|||
125313473|NCT02222558|450777325|FG002|Period 3|Withdrawal by Subject|0|||
125313474|NCT02222558|450777326|FG003|Period 3|Withdrawal by Subject|0|||
125313475|NCT02222558|450777327|FG004|Period 3|Withdrawal by Subject|0|||
125313476|NCT02222558|450777328|FG005|Period 3|Withdrawal by Subject|1|||
125313477|NCT03400852|450777329|FG000|Blinded Treatment Period|Physician Decision|0|||
125313478|NCT03400852|450777330|FG001|Blinded Treatment Period|Physician Decision|1|||
125313479|NCT03400852|450777331|FG002|Blinded Treatment Period|Physician Decision|0|||
125313480|NCT03400852|450777329|FG000|Blinded Treatment Period|Adverse Event|1|||
125313481|NCT03400852|450777330|FG001|Blinded Treatment Period|Adverse Event|1|||
125313482|NCT03400852|450777331|FG002|Blinded Treatment Period|Adverse Event|0|||
125313483|NCT03400852|450777329|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
125313484|NCT03400852|450777330|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
125313485|NCT03400852|450777331|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
125313486|NCT03400852|450777329|FG000|Open Label Period|Physician Decision|0|||
125313487|NCT03400852|450777330|FG001|Open Label Period|Physician Decision|0|||
125313488|NCT03400852|450777331|FG002|Open Label Period|Physician Decision|1|||
125313489|NCT03400852|450777329|FG000|Open Label Period|Study terminated by sponsor|0|||
125313490|NCT03400852|450777330|FG001|Open Label Period|Study terminated by sponsor|0|||
125313491|NCT03400852|450777331|FG002|Open Label Period|Study terminated by sponsor|21|||
125313492|NCT00936702|450777332|FG000|Overall Study|Disease progression|34|||
125313493|NCT00936702|450777332|FG000|Overall Study|Adverse Event|8|||
125313494|NCT00936702|450777332|FG000|Overall Study|Withdrawal by Subject|2|||
125313495|NCT00936702|450777332|FG000|Overall Study|Alternative Treatment|1|||
125313496|NCT00936702|450777332|FG000|Overall Study|Other|1|||
125313497|NCT02532465|450777333|FG000|Overall Study|Protocol Violation|1|||
125313498|NCT02532465|450777334|FG001|Overall Study|Protocol Violation|0|||
125313499|NCT02532465|450777333|FG000|Overall Study|Lack of Efficacy|0|||
125313500|NCT02532465|450777334|FG001|Overall Study|Lack of Efficacy|1|||
125313501|NCT00622505|450777335|FG000|Overall Study|Adverse Event|9|||
125313502|NCT00622505|450777336|FG001|Overall Study|Adverse Event|7|||
125313503|NCT00622505|450777335|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
125313504|NCT00622505|450777336|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
125313505|NCT00622505|450777335|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
125313506|NCT00622505|450777336|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
125313507|NCT00622505|450777335|FG000|Overall Study|Withdrawal by Subject|12|||
125313508|NCT00622505|450777336|FG001|Overall Study|Withdrawal by Subject|5|||
125313509|NCT00622505|450777335|FG000|Overall Study|Administrative Problems|2|||
125313510|NCT00622505|450777336|FG001|Overall Study|Administrative Problems|4|||
125313511|NCT00622505|450777335|FG000|Overall Study|Death|2|||
125313512|NCT00622505|450777336|FG001|Overall Study|Death|2|||
125313513|NCT00965081|450777339|FG000|Overall Study|Adverse Event|14|||
125313514|NCT00965081|450777340|FG001|Overall Study|Adverse Event|9|||
125313515|NCT00965081|450777339|FG000|Overall Study|Lack of Efficacy|2|||
125313516|NCT00965081|450777340|FG001|Overall Study|Lack of Efficacy|5|||
125313517|NCT00965081|450777339|FG000|Overall Study|Lost to Follow-up|4|||
125313518|NCT00965081|450777340|FG001|Overall Study|Lost to Follow-up|5|||
125313519|NCT00965081|450777339|FG000|Overall Study|Physician Decision|2|||
125313520|NCT00965081|450777340|FG001|Overall Study|Physician Decision|0|||
125313521|NCT00965081|450777339|FG000|Overall Study|Protocol Violation|2|||
125313522|NCT00965081|450777340|FG001|Overall Study|Protocol Violation|5|||
125313523|NCT00965081|450777339|FG000|Overall Study|Sponsor Decision|1|||
125313524|NCT00965081|450777340|FG001|Overall Study|Sponsor Decision|0|||
125313525|NCT00965081|450777339|FG000|Overall Study|Withdrawal by Subject|4|||
125313526|NCT00965081|450777340|FG001|Overall Study|Withdrawal by Subject|7|||
125313527|NCT00965081|450777339|FG000|Overall Study|Switched to Rescue Arm|5|||
125313528|NCT00965081|450777340|FG001|Overall Study|Switched to Rescue Arm|12|||
125313529|NCT02159066|450777345|FG000|Part I|Adverse Event|7|||
125313530|NCT02159066|450777346|FG001|Part I|Adverse Event|5|||
125313531|NCT02159066|450777347|FG002|Part I|Adverse Event|0|||
125313532|NCT02159066|450777348|FG003|Part I|Adverse Event|0|||
125313533|NCT02159066|450777349|FG004|Part I|Adverse Event|0|||
125313534|NCT02159066|450777350|FG005|Part I|Adverse Event|0|||
125313535|NCT02159066|450777345|FG000|Part I|Death|11|||
125313536|NCT02159066|450777346|FG001|Part I|Death|9|||
125313537|NCT02159066|450777347|FG002|Part I|Death|0|||
125313538|NCT02159066|450777348|FG003|Part I|Death|0|||
125313539|NCT02159066|450777349|FG004|Part I|Death|0|||
125313540|NCT02159066|450777350|FG005|Part I|Death|0|||
125313541|NCT02159066|450777345|FG000|Part I|Progressive Disease|37|||
125313542|NCT02159066|450777346|FG001|Part I|Progressive Disease|46|||
125313543|NCT02159066|450777347|FG002|Part I|Progressive Disease|0|||
125313544|NCT02159066|450777348|FG003|Part I|Progressive Disease|0|||
125313545|NCT02159066|450777349|FG004|Part I|Progressive Disease|0|||
125313546|NCT02159066|450777350|FG005|Part I|Progressive Disease|0|||
125313547|NCT02159066|450777345|FG000|Part I|New Therapy for Study Indication|5|||
125313548|NCT02159066|450777346|FG001|Part I|New Therapy for Study Indication|4|||
125313549|NCT02159066|450777347|FG002|Part I|New Therapy for Study Indication|0|||
125313550|NCT02159066|450777348|FG003|Part I|New Therapy for Study Indication|0|||
125313551|NCT02159066|450777349|FG004|Part I|New Therapy for Study Indication|0|||
125313552|NCT02159066|450777350|FG005|Part I|New Therapy for Study Indication|0|||
125313553|NCT02159066|450777345|FG000|Part I|Termination of participants from the study|3|||
125313554|NCT02159066|450777346|FG001|Part I|Termination of participants from the study|3|||
125313555|NCT02159066|450777347|FG002|Part I|Termination of participants from the study|0|||
125313556|NCT02159066|450777348|FG003|Part I|Termination of participants from the study|0|||
124983587|NCT03772587|449567386|FG000|Overall Study|COVID-19|0|||
124983588|NCT03772587|449567387|FG001|Overall Study|COVID-19|0|||
124983589|NCT03772587|449567388|FG002|Overall Study|COVID-19|1|||
124983590|NCT03772587|449567389|FG003|Overall Study|COVID-19|1|||
124983591|NCT03772587|449567390|FG004|Overall Study|COVID-19|0|||
125313557|NCT02159066|450777349|FG004|Part I|Termination of participants from the study|0|||
125313558|NCT02159066|450777350|FG005|Part I|Termination of participants from the study|0|||
124983592|NCT03772587|449567386|FG000|Overall Study|Withdrawal by Subject|1|||
124983593|NCT03772587|449567387|FG001|Overall Study|Withdrawal by Subject|0|||
124983594|NCT03772587|449567388|FG002|Overall Study|Withdrawal by Subject|0|||
124983595|NCT03772587|449567389|FG003|Overall Study|Withdrawal by Subject|0|||
124983596|NCT03772587|449567390|FG004|Overall Study|Withdrawal by Subject|0|||
124983597|NCT00513305|449567391|FG000|Overall Study|Adverse Event|6|||
124983598|NCT00513305|449567392|FG001|Overall Study|Adverse Event|2|||
124983599|NCT00513305|449567391|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
124983600|NCT00513305|449567392|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
124983601|NCT00513305|449567391|FG000|Overall Study|Lack of Efficacy|8|||
124983602|NCT00513305|449567392|FG001|Overall Study|Lack of Efficacy|13|||
124983603|NCT00513305|449567391|FG000|Overall Study|Withdrawal by Subject|1|||
124983604|NCT00513305|449567392|FG001|Overall Study|Withdrawal by Subject|2|||
124983605|NCT00513305|449567391|FG000|Overall Study|Disease progression|8|||
124983606|NCT00513305|449567392|FG001|Overall Study|Disease progression|5|||
124983607|NCT00513305|449567391|FG000|Overall Study|Eligible for stem cell transplant|1|||
124983608|NCT00513305|449567392|FG001|Overall Study|Eligible for stem cell transplant|0|||
124983609|NCT00513305|449567391|FG000|Overall Study|Hematologic counts did not recover|1|||
124983610|NCT00513305|449567392|FG001|Overall Study|Hematologic counts did not recover|0|||
124983611|NCT00513305|449567391|FG000|Overall Study|Physician Decision|1|||
124983612|NCT00513305|449567392|FG001|Overall Study|Physician Decision|0|||
124983613|NCT00513305|449567391|FG000|Overall Study|Persistent hypocellularity|0|||
124983614|NCT00513305|449567392|FG001|Overall Study|Persistent hypocellularity|1|||
124983615|NCT00513305|449567391|FG000|Overall Study|Sponsor Decision|0|||
124983616|NCT00513305|449567392|FG001|Overall Study|Sponsor Decision|2|||
124983617|NCT02297139|449567401|FG000|Overall Study|Disease progression|0|||
124983618|NCT02297139|449567402|FG001|Overall Study|Disease progression|1|||
124983619|NCT02297139|449567401|FG000|Overall Study|Study drug toxicity|0|||
124983620|NCT02297139|449567402|FG001|Overall Study|Study drug toxicity|4|||
124983621|NCT02297139|449567401|FG000|Overall Study|Participant request to discontinue study treatment|0|||
124983622|NCT02297139|449567402|FG001|Overall Study|Participant request to discontinue study treatment|1|||
124983623|NCT02297139|449567401|FG000|Overall Study|Maximum clinical benefit|1|||
124983624|NCT02297139|449567402|FG001|Overall Study|Maximum clinical benefit|0|||
124983625|NCT02297139|449567401|FG000|Overall Study|Administrative reason by sponsor|0|||
124983626|NCT02297139|449567402|FG001|Overall Study|Administrative reason by sponsor|2|||
124983627|NCT02297139|449567401|FG000|Overall Study|Other reasons|0|||
124983628|NCT02297139|449567402|FG001|Overall Study|Other reasons|8|||
124983629|NCT03798691|449567407|FG000|Overall Study|Lost to Follow-up|2|||
124983630|NCT03798691|449567408|FG001|Overall Study|Lost to Follow-up|2|||
124983631|NCT05148962|449567409|FG000|Overall Study|Withdrawal by Subject|1|||
124983632|NCT05148962|449567410|FG001|Overall Study|Withdrawal by Subject|1|||
124983633|NCT05148962|449567411|FG002|Overall Study|Withdrawal by Subject|0|||
124983634|NCT05148962|449567412|FG003|Overall Study|Withdrawal by Subject|1|||
124983635|NCT05148962|449567413|FG004|Overall Study|Withdrawal by Subject|0|||
124983636|NCT05148962|449567409|FG000|Overall Study|Participant was early terminated per protocol|0|||
124983637|NCT05148962|449567410|FG001|Overall Study|Participant was early terminated per protocol|0|||
124983638|NCT05148962|449567411|FG002|Overall Study|Participant was early terminated per protocol|3|||
124983639|NCT05148962|449567412|FG003|Overall Study|Participant was early terminated per protocol|5|||
124983640|NCT05148962|449567413|FG004|Overall Study|Participant was early terminated per protocol|2|||
124983641|NCT05148962|449567409|FG000|Overall Study|Miscellaneous|0|||
124983642|NCT05148962|449567410|FG001|Overall Study|Miscellaneous|0|||
124983643|NCT05148962|449567411|FG002|Overall Study|Miscellaneous|0|||
124983644|NCT05148962|449567412|FG003|Overall Study|Miscellaneous|1|||
124983645|NCT05148962|449567413|FG004|Overall Study|Miscellaneous|0|||
124983646|NCT01525238|449567418|FG000|Overall Study|Withdrawal by Subject|1|||
124983647|NCT01525238|449567419|FG001|Overall Study|Withdrawal by Subject|0|||
125313559|NCT02159066|450777345|FG000|Part I|Physician Decision|2|||
124983648|NCT01525238|449567420|FG002|Overall Study|Withdrawal by Subject|0|||
124983649|NCT00607724|449567421|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
124983650|NCT00607724|449567422|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
124983651|NCT00607724|449567423|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
124983652|NCT00607724|449567424|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
124983653|NCT00607724|449567425|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
124983654|NCT00607724|449567426|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
124983655|NCT00607724|449567427|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
124983656|NCT00607724|449567421|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
125313560|NCT02159066|450777346|FG001|Part I|Physician Decision|9|||
124983657|NCT00607724|449567422|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
124983658|NCT00607724|449567423|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
124983659|NCT00607724|449567424|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
124983660|NCT00607724|449567425|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
124983661|NCT00607724|449567426|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
124983662|NCT00607724|449567427|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
124983663|NCT00607724|449567421|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
124983664|NCT00607724|449567422|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
124983665|NCT00607724|449567423|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
124983666|NCT00607724|449567424|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
124983667|NCT00607724|449567425|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
124983668|NCT00607724|449567426|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
124983669|NCT00607724|449567427|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
124983670|NCT00607724|449567421|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
124983671|NCT00607724|449567422|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
124983672|NCT00607724|449567423|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
124983673|NCT00607724|449567424|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
124983674|NCT00607724|449567425|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
124983675|NCT00607724|449567426|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
124983676|NCT00607724|449567427|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
124983677|NCT00607724|449567421|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
124983678|NCT00607724|449567422|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
124983679|NCT00607724|449567423|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
124983680|NCT00607724|449567424|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
124983681|NCT00607724|449567425|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
124983682|NCT00607724|449567426|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
124983683|NCT00607724|449567427|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
124983684|NCT03738423|449567428|FG000|Overall Study|Withdrawal by Subject|9|||
124983685|NCT03738423|449567429|FG001|Overall Study|Withdrawal by Subject|12|||
124983686|NCT03738423|449567430|FG002|Overall Study|Withdrawal by Subject|9|||
124983687|NCT03738423|449567431|FG003|Overall Study|Withdrawal by Subject|12|||
124983688|NCT03738423|449567432|FG004|Overall Study|Withdrawal by Subject|10|||
124983689|NCT03738423|449567428|FG000|Overall Study|Lack of Efficacy|3|||
124983690|NCT03738423|449567429|FG001|Overall Study|Lack of Efficacy|1|||
124983691|NCT03738423|449567430|FG002|Overall Study|Lack of Efficacy|1|||
124983692|NCT03738423|449567431|FG003|Overall Study|Lack of Efficacy|1|||
124983693|NCT03738423|449567432|FG004|Overall Study|Lack of Efficacy|2|||
124983694|NCT03738423|449567428|FG000|Overall Study|Lost to Follow-up|1|||
124983695|NCT03738423|449567429|FG001|Overall Study|Lost to Follow-up|0|||
124983696|NCT03738423|449567430|FG002|Overall Study|Lost to Follow-up|1|||
124983697|NCT03738423|449567431|FG003|Overall Study|Lost to Follow-up|1|||
124983698|NCT03738423|449567432|FG004|Overall Study|Lost to Follow-up|0|||
124983699|NCT03738423|449567428|FG000|Overall Study|Protocol Violation|1|||
124983700|NCT03738423|449567429|FG001|Overall Study|Protocol Violation|0|||
124983701|NCT03738423|449567430|FG002|Overall Study|Protocol Violation|0|||
124983702|NCT03738423|449567431|FG003|Overall Study|Protocol Violation|0|||
125313561|NCT02159066|450777347|FG002|Part I|Physician Decision|0|||
125313562|NCT02159066|450777348|FG003|Part I|Physician Decision|0|||
125313563|NCT02159066|450777349|FG004|Part I|Physician Decision|0|||
125313564|NCT02159066|450777350|FG005|Part I|Physician Decision|0|||
125313565|NCT02159066|450777345|FG000|Part I|Participant/Guardian Decision|9|||
125313566|NCT02159066|450777346|FG001|Part I|Participant/Guardian Decision|3|||
125313567|NCT02159066|450777347|FG002|Part I|Participant/Guardian Decision|0|||
125313568|NCT02159066|450777348|FG003|Part I|Participant/Guardian Decision|0|||
125313569|NCT02159066|450777349|FG004|Part I|Participant/Guardian Decision|0|||
125313570|NCT02159066|450777350|FG005|Part I|Participant/Guardian Decision|0|||
125313571|NCT02159066|450777345|FG000|Part I|Missing Data|1|||
125313572|NCT02159066|450777346|FG001|Part I|Missing Data|0|||
125313573|NCT02159066|450777347|FG002|Part I|Missing Data|0|||
125313574|NCT02159066|450777348|FG003|Part I|Missing Data|0|||
125313575|NCT02159066|450777349|FG004|Part I|Missing Data|0|||
124983703|NCT03738423|449567432|FG004|Overall Study|Protocol Violation|1|||
124983704|NCT03738423|449567428|FG000|Overall Study|Physician Decision|0|||
124983705|NCT03738423|449567429|FG001|Overall Study|Physician Decision|0|||
124983706|NCT03738423|449567430|FG002|Overall Study|Physician Decision|1|||
124983707|NCT03738423|449567431|FG003|Overall Study|Physician Decision|0|||
124983708|NCT03738423|449567432|FG004|Overall Study|Physician Decision|1|||
125313576|NCT02159066|450777350|FG005|Part I|Missing Data|0|||
125313577|NCT02159066|450777345|FG000|Part II|Adverse Event|0|||
125313578|NCT02159066|450777346|FG001|Part II|Adverse Event|0|||
124983709|NCT03738423|449567428|FG000|Overall Study|Death|0|||
124983710|NCT03738423|449567429|FG001|Overall Study|Death|0|||
125313579|NCT02159066|450777347|FG002|Part II|Adverse Event|1|||
124983711|NCT03738423|449567430|FG002|Overall Study|Death|0|||
125313580|NCT02159066|450777348|FG003|Part II|Adverse Event|0|||
125313581|NCT02159066|450777349|FG004|Part II|Adverse Event|1|||
125313582|NCT02159066|450777350|FG005|Part II|Adverse Event|1|||
124983712|NCT03738423|449567431|FG003|Overall Study|Death|0|||
124983713|NCT03738423|449567432|FG004|Overall Study|Death|1|||
124983714|NCT03738423|449567428|FG000|Overall Study|Randomized but never treated|0|||
124983715|NCT03738423|449567429|FG001|Overall Study|Randomized but never treated|0|||
124983716|NCT03738423|449567430|FG002|Overall Study|Randomized but never treated|1|||
124983717|NCT03738423|449567431|FG003|Overall Study|Randomized but never treated|1|||
124983718|NCT03738423|449567432|FG004|Overall Study|Randomized but never treated|0|||
124983719|NCT01241604|449567433|FG000|Screening Period|Screen Failure|3|||
124983720|NCT01241604|449567434|FG001|Screening Period|Screen Failure|0|||
124983721|NCT01241604|449567435|FG002|Screening Period|Screen Failure|0|||
124983722|NCT01593787|449567436|FG000|Overall Study|Adverse Event|1|||
124983723|NCT01593787|449567437|FG001|Overall Study|Adverse Event|0|||
124983724|NCT01593787|449567438|FG002|Overall Study|Adverse Event|0|||
124983725|NCT00151281|449567439|FG000|Overall Study|Not evaluable|3|||
124983726|NCT01865747|449567440|FG000|Overall Study (ITT)|Adverse Event|32|||
124983727|NCT01865747|449567441|FG001|Overall Study (ITT)|Adverse Event|31|||
124983728|NCT01865747|449567440|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
124983729|NCT01865747|449567441|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
124983730|NCT01865747|449567440|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
124983731|NCT01865747|449567441|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
124983732|NCT01865747|449567440|FG000|Overall Study (ITT)|Protocol Violation|1|||
125313583|NCT02159066|450777345|FG000|Part II|Death|0|||
125313584|NCT02159066|450777346|FG001|Part II|Death|0|||
125313585|NCT02159066|450777347|FG002|Part II|Death|1|||
125313586|NCT02159066|450777348|FG003|Part II|Death|0|||
125313587|NCT02159066|450777349|FG004|Part II|Death|2|||
125313588|NCT02159066|450777350|FG005|Part II|Death|1|||
125313589|NCT02159066|450777345|FG000|Part II|Progressive Disease|0|||
125313590|NCT02159066|450777346|FG001|Part II|Progressive Disease|0|||
125313591|NCT02159066|450777347|FG002|Part II|Progressive Disease|35|||
125313592|NCT02159066|450777348|FG003|Part II|Progressive Disease|1|||
125313593|NCT02159066|450777349|FG004|Part II|Progressive Disease|7|||
125313594|NCT02159066|450777350|FG005|Part II|Progressive Disease|4|||
125313595|NCT02159066|450777345|FG000|Part II|New Therapy for Study Indication|0|||
125313596|NCT02159066|450777346|FG001|Part II|New Therapy for Study Indication|0|||
124983733|NCT01865747|449567441|FG001|Overall Study (ITT)|Protocol Violation|1|||
124983734|NCT01865747|449567440|FG000|Overall Study (ITT)|Physician Decision|5|||
124983735|NCT01865747|449567441|FG001|Overall Study (ITT)|Physician Decision|2|||
124983736|NCT01865747|449567440|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
124983737|NCT01865747|449567441|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
124983738|NCT01865747|449567440|FG000|Overall Study (ITT)|Sponsor Decision|0|||
125313597|NCT02159066|450777347|FG002|Part II|New Therapy for Study Indication|0|||
125313598|NCT02159066|450777348|FG003|Part II|New Therapy for Study Indication|0|||
125313599|NCT02159066|450777349|FG004|Part II|New Therapy for Study Indication|1|||
125313600|NCT02159066|450777350|FG005|Part II|New Therapy for Study Indication|0|||
124983739|NCT01865747|449567441|FG001|Overall Study (ITT)|Sponsor Decision|1|||
125210380|NCT01738191|450393856|FG000|Overall Study|Withdrawal by Subject|4|||
125210381|NCT01738191|450393857|FG001|Overall Study|Withdrawal by Subject|1|||
125210382|NCT02243046|450393858|FG000|Overall Study|Lost to Follow-up|1|||
125210383|NCT02243046|450393859|FG001|Overall Study|Lost to Follow-up|1|||
125210384|NCT02243046|450393860|FG002|Overall Study|Lost to Follow-up|4|||
125210385|NCT03338569|450393861|FG000|Overall Study|Physician Decision|8|||
125210386|NCT03338569|450393862|FG001|Overall Study|Physician Decision|3|||
125210387|NCT03338569|450393861|FG000|Overall Study|Withdrawal by Subject|0|||
125210388|NCT03338569|450393862|FG001|Overall Study|Withdrawal by Subject|1|||
125210389|NCT03338569|450393861|FG000|Overall Study|Lost to Follow-up|0|||
125210390|NCT03338569|450393862|FG001|Overall Study|Lost to Follow-up|1|||
125210391|NCT02109445|450393865|FG000|Overall Study|Symptomatic deterioration|2|||
125210392|NCT02109445|450393865|FG000|Overall Study|Adverse Event|1|||
125210393|NCT00441363|450395568|FG000|Overall Study|Adverse Event|4|||
125210394|NCT00441363|450395569|FG001|Overall Study|Adverse Event|2|||
125210395|NCT00441363|450395568|FG000|Overall Study|Withdrawal by Subject|3|||
125210396|NCT00441363|450395569|FG001|Overall Study|Withdrawal by Subject|4|||
125313601|NCT02159066|450777345|FG000|Part II|Physician Decision|0|||
125313602|NCT02159066|450777346|FG001|Part II|Physician Decision|0|||
125313603|NCT02159066|450777347|FG002|Part II|Physician Decision|1|||
124983740|NCT01865747|449567440|FG000|Overall Study (ITT)|Progressive Disease|122|||
124983741|NCT01865747|449567441|FG001|Overall Study (ITT)|Progressive Disease|158|||
124983742|NCT01865747|449567440|FG000|Overall Study (ITT)|Reason Not Provided|0|||
125210397|NCT00441363|450395568|FG000|Overall Study|Physician Decision|6|||
125210398|NCT00441363|450395569|FG001|Overall Study|Physician Decision|7|||
125210399|NCT00441363|450395568|FG000|Overall Study|Lost to Follow-up|2|||
125210400|NCT00441363|450395569|FG001|Overall Study|Lost to Follow-up|2|||
125313604|NCT02159066|450777348|FG003|Part II|Physician Decision|0|||
124983743|NCT01865747|449567441|FG001|Overall Study (ITT)|Reason Not Provided|1|||
125313605|NCT02159066|450777349|FG004|Part II|Physician Decision|0|||
125313606|NCT02159066|450777350|FG005|Part II|Physician Decision|0|||
125313607|NCT02159066|450777345|FG000|Part II|Participant/Guardian Decision|0|||
125313608|NCT02159066|450777346|FG001|Part II|Participant/Guardian Decision|0|||
125313609|NCT02159066|450777347|FG002|Part II|Participant/Guardian Decision|0|||
125313610|NCT02159066|450777348|FG003|Part II|Participant/Guardian Decision|0|||
125313611|NCT02159066|450777349|FG004|Part II|Participant/Guardian Decision|2|||
125313612|NCT02159066|450777350|FG005|Part II|Participant/Guardian Decision|0|||
125313613|NCT01147666|450777351|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
125313614|NCT01147666|450777352|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
125313615|NCT01147666|450777353|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
125313616|NCT01147666|450777354|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313617|NCT01147666|450777355|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313618|NCT01147666|450777356|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313619|NCT01147666|450777357|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313620|NCT01147666|450777358|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313621|NCT01147666|450777359|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313622|NCT01147666|450777360|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313623|NCT01147666|450777361|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313624|NCT01147666|450777362|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313625|NCT01147666|450777363|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
125313626|NCT01147666|450777364|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313627|NCT01147666|450777365|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313628|NCT01147666|450777351|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
125313629|NCT01147666|450777352|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
125313630|NCT01147666|450777353|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
125313631|NCT01147666|450777354|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
125313632|NCT01147666|450777355|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
125313633|NCT01147666|450777356|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
125313634|NCT01147666|450777357|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
125313635|NCT01147666|450777358|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
125313636|NCT01147666|450777359|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
125313637|NCT01147666|450777360|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
125313638|NCT01147666|450777361|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
125313639|NCT01147666|450777362|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
125313640|NCT01147666|450777363|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
125313641|NCT01147666|450777364|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
125313642|NCT01147666|450777365|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
125313643|NCT01147666|450777351|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
125313644|NCT01147666|450777352|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
125313645|NCT01147666|450777353|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
125313646|NCT01147666|450777354|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
125313647|NCT01147666|450777355|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
125313648|NCT01147666|450777356|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
125313649|NCT01147666|450777357|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
125313650|NCT01147666|450777358|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
125313651|NCT01147666|450777359|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
125313652|NCT01147666|450777360|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
125313653|NCT01147666|450777361|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
125313654|NCT01147666|450777362|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
125313655|NCT01147666|450777363|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
125313656|NCT01147666|450777364|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
125313657|NCT01147666|450777365|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
125313658|NCT01147666|450777351|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
125313659|NCT01147666|450777352|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313660|NCT01147666|450777353|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313661|NCT01147666|450777354|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
125313662|NCT01147666|450777355|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313663|NCT01147666|450777356|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313664|NCT01147666|450777357|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313665|NCT01147666|450777358|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313666|NCT01147666|450777359|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313667|NCT01147666|450777360|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313668|NCT01147666|450777361|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
125313669|NCT01147666|450777362|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313670|NCT01147666|450777363|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313671|NCT01147666|450777364|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313672|NCT01147666|450777365|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313673|NCT01147666|450777351|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
125313674|NCT01147666|450777352|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
125313675|NCT01147666|450777353|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
125313676|NCT01147666|450777354|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
125313677|NCT01147666|450777355|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
124983744|NCT01865747|449567440|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
124983745|NCT01865747|449567441|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
124983746|NCT01865747|449567440|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
124983747|NCT01865747|449567441|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
124983748|NCT01865747|449567440|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
124983749|NCT01865747|449567441|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
124983750|NCT01865747|449567440|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
124983751|NCT01865747|449567441|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
124983752|NCT01865747|449567440|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
124983753|NCT01865747|449567441|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
124983754|NCT01865747|449567440|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
124983755|NCT01865747|449567441|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
124983756|NCT01865747|449567440|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
124983757|NCT01865747|449567441|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
124983758|NCT01865747|449567440|FG000|Primary Intent to Treat (PITT)|Other|0|||
124983759|NCT01865747|449567441|FG001|Primary Intent to Treat (PITT)|Other|1|||
124983760|NCT02592876|449567442|FG000|Overall Study|Withdrawal by Subject|3|||
124983761|NCT02592876|449567443|FG001|Overall Study|Withdrawal by Subject|3|||
124983762|NCT02592876|449567442|FG000|Overall Study|Study Termination by Sponsor|32|||
124983763|NCT02592876|449567443|FG001|Overall Study|Study Termination by Sponsor|27|||
124983764|NCT02592876|449567442|FG000|Overall Study|Lost to Follow-up|0|||
124983765|NCT02592876|449567443|FG001|Overall Study|Lost to Follow-up|1|||
124983766|NCT02592876|449567442|FG000|Overall Study|Death|6|||
124983767|NCT02592876|449567443|FG001|Overall Study|Death|9|||
124983768|NCT01133418|449567446|FG000|Overall Study|Lost to Follow-up|5|||
124983769|NCT01133418|449567447|FG001|Overall Study|Lost to Follow-up|6|||
124983770|NCT00611975|449567448|FG000|Overall Study|Withdrawal by Subject|3|||
124983771|NCT00611975|449567449|FG001|Overall Study|Withdrawal by Subject|7|||
125313678|NCT01147666|450777356|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
125313679|NCT01147666|450777357|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
125313680|NCT01147666|450777358|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
125313681|NCT01147666|450777359|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
125313682|NCT01147666|450777360|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
125313683|NCT01147666|450777361|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
125313684|NCT01147666|450777362|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
125313685|NCT01147666|450777363|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
125313686|NCT01147666|450777364|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
125313687|NCT01147666|450777365|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
125313688|NCT01147666|450777351|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313689|NCT01147666|450777352|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313690|NCT01147666|450777353|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313691|NCT01147666|450777354|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
125313692|NCT01147666|450777355|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313693|NCT01147666|450777356|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313694|NCT01147666|450777357|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313695|NCT01147666|450777358|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313696|NCT01147666|450777359|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313697|NCT01147666|450777360|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313698|NCT01147666|450777361|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
125313699|NCT01147666|450777362|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313700|NCT01147666|450777363|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313701|NCT01147666|450777364|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313702|NCT01147666|450777365|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313703|NCT01147666|450777351|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313704|NCT01147666|450777352|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313705|NCT01147666|450777353|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313706|NCT01147666|450777354|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313707|NCT01147666|450777355|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313708|NCT01147666|450777356|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313709|NCT01147666|450777357|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313710|NCT01147666|450777358|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313711|NCT01147666|450777359|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313712|NCT01147666|450777360|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313713|NCT01147666|450777361|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
124983772|NCT00611975|449567448|FG000|Overall Study|Pregnancy|2|||
125313714|NCT01147666|450777362|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
124983773|NCT00611975|449567449|FG001|Overall Study|Pregnancy|1|||
124983774|NCT01077271|449569717|FG000|Overall Study|Parental desire|8|||
124983775|NCT01077271|449569717|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
124983776|NCT01077271|449569717|FG000|Overall Study|Noncompliance|2|||
124983777|NCT01077271|449569717|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
124983778|NCT01077271|449569717|FG000|Overall Study|Changed doctors|2|||
124983779|NCT01077271|449569717|FG000|Overall Study|Parents thought too many injections|2|||
124983780|NCT01077271|449569717|FG000|Overall Study|End of RSV season nearly reached|1|||
124983781|NCT01077271|449569717|FG000|Overall Study|Mother unconvinced of the necessity|1|||
124983782|NCT03333876|449569718|FG000|Screening Period|Screen Failure|4|||
124983783|NCT03333876|449569718|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
124983784|NCT03333876|449569718|FG000|Mandibular Advancement|Adverse Event|2|||
124983785|NCT03333876|449569718|FG000|Mandibular Advancement|Product Damage|2|||
124983786|NCT00095498|449569719|FG000|Overall Study|Physician Decision|9|||
124983787|NCT00095498|449569720|FG001|Overall Study|Physician Decision|10|||
124983788|NCT00095498|449569721|FG002|Overall Study|Physician Decision|8|||
124983789|NCT00095498|449569719|FG000|Overall Study|Adverse Event|1|||
124983790|NCT00095498|449569720|FG001|Overall Study|Adverse Event|0|||
124983791|NCT00095498|449569721|FG002|Overall Study|Adverse Event|1|||
124983792|NCT00095498|449569719|FG000|Overall Study|Withdrawal by Subject|15|||
124983793|NCT00095498|449569720|FG001|Overall Study|Withdrawal by Subject|16|||
124983794|NCT00095498|449569721|FG002|Overall Study|Withdrawal by Subject|15|||
124983795|NCT00095498|449569719|FG000|Overall Study|Disease progression|0|||
124983796|NCT00095498|449569720|FG001|Overall Study|Disease progression|1|||
124983797|NCT00095498|449569721|FG002|Overall Study|Disease progression|1|||
125313715|NCT01147666|450777363|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
125313716|NCT01147666|450777364|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313717|NCT01147666|450777365|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
125313718|NCT01147666|450777351|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
125313719|NCT01147666|450777352|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
125313720|NCT01147666|450777353|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
125313721|NCT01147666|450777354|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
125313722|NCT01147666|450777355|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
125313723|NCT01147666|450777356|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
125313724|NCT01147666|450777357|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
125313725|NCT01147666|450777358|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
125313726|NCT01147666|450777359|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
125313727|NCT01147666|450777360|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
125313728|NCT01147666|450777361|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
125313729|NCT01147666|450777362|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
125313730|NCT01147666|450777363|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
125313731|NCT01147666|450777364|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
125313732|NCT01147666|450777365|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
125313733|NCT01147666|450777351|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
125313734|NCT01147666|450777352|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
125313735|NCT01147666|450777353|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
125313736|NCT01147666|450777354|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
125313737|NCT01147666|450777355|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
125313738|NCT01147666|450777356|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
125313739|NCT01147666|450777357|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
125313740|NCT01147666|450777358|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
125313741|NCT01147666|450777359|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
125313742|NCT01147666|450777360|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
125313743|NCT01147666|450777361|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
125313744|NCT01147666|450777362|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
125313745|NCT01147666|450777363|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
125313746|NCT01147666|450777364|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
125313747|NCT01147666|450777365|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
124983798|NCT00095498|449569719|FG000|Overall Study|Ineligibility determined|3|||
124983799|NCT00095498|449569720|FG001|Overall Study|Ineligibility determined|0|||
125313748|NCT01147666|450777351|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313749|NCT01147666|450777352|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313750|NCT01147666|450777353|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313751|NCT01147666|450777354|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
125313752|NCT01147666|450777355|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
124983800|NCT00095498|449569721|FG002|Overall Study|Ineligibility determined|2|||
125313753|NCT01147666|450777356|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
124983801|NCT00095498|449569719|FG000|Overall Study|Lost to Follow-up|1|||
124983802|NCT00095498|449569720|FG001|Overall Study|Lost to Follow-up|1|||
124983803|NCT00095498|449569721|FG002|Overall Study|Lost to Follow-up|2|||
124983804|NCT00095498|449569719|FG000|Overall Study|Noncompliance|1|||
124983805|NCT00095498|449569720|FG001|Overall Study|Noncompliance|0|||
124983806|NCT00095498|449569721|FG002|Overall Study|Noncompliance|1|||
125313754|NCT01147666|450777357|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
124983807|NCT00095498|449569719|FG000|Overall Study|Other|6|||
124983808|NCT00095498|449569720|FG001|Overall Study|Other|7|||
124983809|NCT00095498|449569721|FG002|Overall Study|Other|6|||
124983810|NCT00095498|449569719|FG000|Overall Study|Protocol Violation|0|||
124983811|NCT00095498|449569720|FG001|Overall Study|Protocol Violation|0|||
124983812|NCT00095498|449569721|FG002|Overall Study|Protocol Violation|1|||
124983813|NCT00095498|449569719|FG000|Overall Study|Requirement for alternative therapy|1|||
124983814|NCT00095498|449569720|FG001|Overall Study|Requirement for alternative therapy|0|||
124983815|NCT00095498|449569721|FG002|Overall Study|Requirement for alternative therapy|2|||
124983816|NCT05020327|449569722|FG000|Overall Study|Physician Decision|3|||
124983817|NCT05020327|449569723|FG001|Overall Study|Physician Decision|0|||
124983818|NCT05020327|449569724|FG002|Overall Study|Physician Decision|0|||
124983819|NCT05020327|449569722|FG000|Overall Study|Withdrawal by Subject|1|||
124983820|NCT05020327|449569723|FG001|Overall Study|Withdrawal by Subject|1|||
124983821|NCT05020327|449569724|FG002|Overall Study|Withdrawal by Subject|0|||
124983822|NCT05020327|449569722|FG000|Overall Study|personal/cultural, ineligible|12|||
124983823|NCT05020327|449569723|FG001|Overall Study|personal/cultural, ineligible|0|||
124983824|NCT05020327|449569724|FG002|Overall Study|personal/cultural, ineligible|0|||
124983825|NCT04684394|449569725|FG000|Overall Study|Death|1|||
124983826|NCT04684394|449569726|FG001|Overall Study|Death|2|||
124983827|NCT04684394|449569725|FG000|Overall Study|Lost to Follow-up|1|||
124983828|NCT04684394|449569726|FG001|Overall Study|Lost to Follow-up|0|||
124983829|NCT04684394|449569725|FG000|Overall Study|Withdrawal by Subject|2|||
124983830|NCT04684394|449569726|FG001|Overall Study|Withdrawal by Subject|0|||
124983831|NCT04684394|449569725|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
124983832|NCT04684394|449569726|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
124983833|NCT00591370|449569728|FG000|Overall Study|Not Treated|2|||
124983834|NCT03439254|449569729|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
124983835|NCT03439254|449569730|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
124983836|NCT03439254|449569731|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
124983837|NCT03439254|449569732|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
124983838|NCT03439254|449569733|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
124983839|NCT03439254|449569734|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
124983840|NCT03439254|449569729|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
124983841|NCT03439254|449569730|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
124983842|NCT03439254|449569731|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
124983843|NCT03439254|449569732|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
124983844|NCT03439254|449569733|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
124983845|NCT03439254|449569734|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
124983846|NCT03439254|449569729|FG000|Double-blind Phase (18 Months)|Death|1|||
124983847|NCT03439254|449569730|FG001|Double-blind Phase (18 Months)|Death|2|||
124983848|NCT03439254|449569731|FG002|Double-blind Phase (18 Months)|Death|2|||
124983849|NCT03439254|449569732|FG003|Double-blind Phase (18 Months)|Death|0|||
124983850|NCT03439254|449569733|FG004|Double-blind Phase (18 Months)|Death|0|||
124983851|NCT03439254|449569734|FG005|Double-blind Phase (18 Months)|Death|0|||
124983852|NCT03439254|449569729|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
124983853|NCT03439254|449569730|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
124983854|NCT03439254|449569731|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
124983855|NCT03439254|449569732|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
124983856|NCT03439254|449569733|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
124983857|NCT03439254|449569734|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
124983858|NCT03439254|449569729|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
124983859|NCT03439254|449569730|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
124983860|NCT03439254|449569731|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
124983861|NCT03439254|449569732|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
124983862|NCT03439254|449569733|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
124983863|NCT03439254|449569734|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
124983864|NCT03439254|449569729|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
124983865|NCT03439254|449569730|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
124983866|NCT03439254|449569731|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
124983867|NCT03439254|449569732|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
124983868|NCT03439254|449569733|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
124983869|NCT03439254|449569734|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
124983870|NCT03439254|449569729|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
124983871|NCT03439254|449569730|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
124983872|NCT03439254|449569731|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
124983873|NCT03439254|449569732|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
124983874|NCT03439254|449569733|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
124983875|NCT03439254|449569734|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
124983876|NCT03439254|449569729|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
124983877|NCT03439254|449569730|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
124983878|NCT03439254|449569731|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
124983879|NCT03439254|449569732|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
124983880|NCT03439254|449569733|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
124983881|NCT03439254|449569734|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
124983882|NCT03439254|449569729|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
124983883|NCT03439254|449569730|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
124983884|NCT03439254|449569731|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
124983885|NCT03439254|449569732|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
124983886|NCT03439254|449569733|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
124983887|NCT03439254|449569734|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
124983888|NCT03439254|449569729|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
124983889|NCT03439254|449569730|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
124983890|NCT03439254|449569731|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
124983891|NCT03439254|449569732|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
124983892|NCT03439254|449569733|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
124983893|NCT03439254|449569734|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
124983894|NCT03439254|449569729|FG000|Double-blind Phase (18 Months)|Site closure|0|||
124983895|NCT03439254|449569730|FG001|Double-blind Phase (18 Months)|Site closure|0|||
124983896|NCT03439254|449569731|FG002|Double-blind Phase (18 Months)|Site closure|1|||
124983897|NCT03439254|449569732|FG003|Double-blind Phase (18 Months)|Site closure|0|||
124983898|NCT03439254|449569733|FG004|Double-blind Phase (18 Months)|Site closure|0|||
124983899|NCT03439254|449569734|FG005|Double-blind Phase (18 Months)|Site closure|0|||
124983900|NCT03439254|449569729|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
124983901|NCT03439254|449569730|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
124983902|NCT03439254|449569731|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
124983903|NCT03439254|449569732|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
124983904|NCT03439254|449569733|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
124983905|NCT03439254|449569734|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
124983906|NCT03439254|449569729|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
124983907|NCT03439254|449569730|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
124983908|NCT03439254|449569731|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
124983909|NCT03439254|449569732|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
124983910|NCT03439254|449569733|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
124983911|NCT03439254|449569734|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
124983912|NCT03439254|449569729|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
124983913|NCT03439254|449569730|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
124983914|NCT03439254|449569731|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
124983915|NCT03439254|449569732|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
124983916|NCT03439254|449569733|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
124983917|NCT03439254|449569734|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
124983918|NCT03439254|449569729|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
124983919|NCT03439254|449569730|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
124983920|NCT03439254|449569731|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
124983921|NCT03439254|449569732|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
124983922|NCT03439254|449569733|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
124983923|NCT03439254|449569734|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
124983924|NCT03439254|449569729|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
124983925|NCT03439254|449569730|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
124983926|NCT03439254|449569731|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
125313755|NCT01147666|450777358|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313756|NCT01147666|450777359|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313757|NCT01147666|450777360|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313758|NCT01147666|450777361|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313759|NCT01147666|450777362|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313760|NCT01147666|450777363|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313761|NCT01147666|450777364|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313762|NCT01147666|450777365|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313763|NCT01147666|450777351|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
125313764|NCT01147666|450777352|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
125313765|NCT01147666|450777353|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
125313766|NCT01147666|450777354|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
125313767|NCT01147666|450777355|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
125313768|NCT01147666|450777356|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
125313769|NCT01147666|450777357|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
125313770|NCT01147666|450777358|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
125313771|NCT01147666|450777359|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
125313772|NCT01147666|450777360|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
125313773|NCT01147666|450777361|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
125313774|NCT01147666|450777362|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
125313775|NCT01147666|450777363|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
125313776|NCT01147666|450777364|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
125313777|NCT01147666|450777365|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
125313778|NCT01147666|450777351|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313779|NCT01147666|450777352|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313780|NCT01147666|450777353|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313781|NCT01147666|450777354|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
125313782|NCT01147666|450777355|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313783|NCT01147666|450777356|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313784|NCT01147666|450777357|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313785|NCT01147666|450777358|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313786|NCT01147666|450777359|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313787|NCT01147666|450777360|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313788|NCT01147666|450777361|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
125313789|NCT01147666|450777362|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313790|NCT01147666|450777363|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313791|NCT01147666|450777364|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313792|NCT01147666|450777365|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313793|NCT01147666|450777351|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313794|NCT01147666|450777352|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313795|NCT01147666|450777353|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313796|NCT01147666|450777354|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313797|NCT01147666|450777355|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313798|NCT01147666|450777356|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313799|NCT01147666|450777357|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313800|NCT01147666|450777358|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313801|NCT01147666|450777359|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313802|NCT01147666|450777360|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313803|NCT01147666|450777361|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313804|NCT01147666|450777362|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313805|NCT01147666|450777363|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
125313806|NCT01147666|450777364|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313807|NCT01147666|450777365|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313808|NCT01147666|450777351|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313809|NCT01147666|450777352|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313810|NCT01147666|450777353|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313811|NCT01147666|450777354|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313812|NCT01147666|450777355|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313813|NCT01147666|450777356|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313814|NCT01147666|450777357|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313815|NCT01147666|450777358|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313816|NCT01147666|450777359|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313817|NCT01147666|450777360|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313818|NCT01147666|450777361|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313819|NCT01147666|450777362|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313820|NCT01147666|450777363|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
125313821|NCT01147666|450777364|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313822|NCT01147666|450777365|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
125313823|NCT00474955|450777366|FG000|Overall Study|Adverse Event|2|||
125313824|NCT00474955|450777366|FG000|Overall Study|Drug unavailability|1|||
125313825|NCT00474955|450777366|FG000|Overall Study|Personal reasons|5|||
125313826|NCT01135134|450777367|FG000|Overall Study|Adverse Event|1|||
125313827|NCT01135134|450777368|FG001|Overall Study|Adverse Event|1|||
125313828|NCT01135134|450777367|FG000|Overall Study|Did not meet protocol eligibility|1|||
125313829|NCT01135134|450777368|FG001|Overall Study|Did not meet protocol eligibility|0|||
125313830|NCT00256724|450777373|FG000|Overall Study|Physician Decision|2|||
125313831|NCT00256724|450777374|FG001|Overall Study|Physician Decision|5|||
124983927|NCT03439254|449569732|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
124983928|NCT03439254|449569733|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
124983929|NCT03439254|449569734|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
124983930|NCT03439254|449569729|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
124983931|NCT03439254|449569730|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
124983932|NCT03439254|449569731|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
124983933|NCT03439254|449569732|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
124983934|NCT03439254|449569733|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
124983935|NCT03439254|449569734|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
124983936|NCT03439254|449569729|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
124983937|NCT03439254|449569730|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
124983938|NCT03439254|449569731|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
124983939|NCT03439254|449569732|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
124983940|NCT03439254|449569733|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
124983941|NCT03439254|449569734|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
124983942|NCT03439254|449569729|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
124983943|NCT03439254|449569730|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
124983944|NCT03439254|449569731|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
124983945|NCT03439254|449569732|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
124983946|NCT03439254|449569733|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
124983947|NCT03439254|449569734|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
124983948|NCT03439254|449569729|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
124983949|NCT03439254|449569730|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
124983950|NCT03439254|449569731|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
124983951|NCT03439254|449569732|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
124983952|NCT03439254|449569733|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
124983953|NCT03439254|449569734|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
124983954|NCT03439254|449569729|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
124983955|NCT03439254|449569730|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
124983956|NCT03439254|449569731|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
124983957|NCT03439254|449569732|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
124983958|NCT03439254|449569733|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
124983959|NCT03439254|449569734|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
124983960|NCT03439254|449569729|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
124983961|NCT03439254|449569730|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
124983962|NCT03439254|449569731|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
124983963|NCT03439254|449569732|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
124983964|NCT03439254|449569733|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
124983965|NCT03439254|449569734|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
124983966|NCT03439254|449569729|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
124983967|NCT03439254|449569730|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
124983968|NCT03439254|449569731|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
124983969|NCT03439254|449569732|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
124983970|NCT03439254|449569733|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
124983971|NCT03439254|449569734|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
124983972|NCT02075476|449569736|FG000|Overall Study|Death|2|||
124983973|NCT02075476|449569737|FG001|Overall Study|Death|2|||
124983974|NCT02075476|449569736|FG000|Overall Study|Lost to Follow-up|1|||
124983975|NCT02075476|449569737|FG001|Overall Study|Lost to Follow-up|3|||
124983976|NCT00095056|449569738|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
124983977|NCT00095056|449569739|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
124983978|NCT00095056|449569738|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
124983979|NCT00095056|449569739|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
125313832|NCT00256724|450777373|FG000|Overall Study|Protocol Violation|3|||
125313833|NCT00256724|450777374|FG001|Overall Study|Protocol Violation|3|||
125313834|NCT01569841|450777383|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
125313835|NCT01569841|450777384|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
125313836|NCT01859923|450777385|FG000|Overall Study|Adverse Event|0|||
125313837|NCT01859923|450777386|FG001|Overall Study|Adverse Event|0|||
125313838|NCT01859923|450777387|FG002|Overall Study|Adverse Event|1|||
125313839|NCT01859923|450777388|FG003|Overall Study|Adverse Event|1|||
125313840|NCT00764361|450777394|FG000|Overall Study|Withdrawal by Subject|2|||
125313841|NCT00764361|450777395|FG001|Overall Study|Withdrawal by Subject|3|||
125313842|NCT00764361|450777394|FG000|Overall Study|Adverse Event|0|||
125313843|NCT00764361|450777395|FG001|Overall Study|Adverse Event|1|||
125313844|NCT02090426|450777396|FG000|Overall Study|Lost to Follow-up|12|||
125313845|NCT02090426|450777397|FG001|Overall Study|Lost to Follow-up|6|||
124983980|NCT00095056|449569738|FG000|Phase A (Weeks 0-12)|Death|1|||
124983981|NCT00095056|449569739|FG001|Phase A (Weeks 0-12)|Death|0|||
124983982|NCT00095056|449569738|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
124983983|NCT00095056|449569739|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
124983984|NCT00095056|449569738|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
124983985|NCT00095056|449569739|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
124983986|NCT00095056|449569738|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
124983987|NCT00095056|449569739|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
124983988|NCT00095056|449569738|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
124983989|NCT00095056|449569739|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
124983990|NCT00095056|449569738|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
124983991|NCT00095056|449569739|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
124983992|NCT00095056|449569738|FG000|Phase B (Weeks 12-54)|Death|3|||
124983993|NCT00095056|449569739|FG001|Phase B (Weeks 12-54)|Death|1|||
124983994|NCT00095056|449569738|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
124983995|NCT00095056|449569739|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
124983996|NCT00095056|449569738|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
124983997|NCT00095056|449569739|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
124983998|NCT00923260|449569745|FG000|Overall Study|Lost to Follow-up|1|||
124983999|NCT00923260|449569746|FG001|Overall Study|Lost to Follow-up|1|||
124984000|NCT00836745|449569750|FG000|Overall Study|Death|2|||
124984001|NCT00836745|449569750|FG000|Overall Study|Lost to Follow-up|10|||
124984002|NCT00836745|449569750|FG000|Overall Study|Adverse Event|3|||
124984003|NCT00836745|449569750|FG000|Overall Study|Objective progression or relapse|4|||
124984004|NCT00836745|449569750|FG000|Overall Study|Other|2|||
124984005|NCT02121301|449569752|FG000|Overall Study|Protocol Violation|1|||
124984006|NCT02121301|449569753|FG001|Overall Study|Protocol Violation|4|||
124984007|NCT02121301|449569754|FG002|Overall Study|Protocol Violation|1|||
124984008|NCT00436852|449569760|FG000|Overall Study|Death|23|||
124984009|NCT00436852|449569761|FG001|Overall Study|Death|34|||
124984010|NCT00436852|449569760|FG000|Overall Study|Lack of Efficacy|9|||
124984011|NCT00436852|449569761|FG001|Overall Study|Lack of Efficacy|7|||
124984012|NCT00436852|449569760|FG000|Overall Study|Withdrawal by Subject|2|||
124984013|NCT00436852|449569761|FG001|Overall Study|Withdrawal by Subject|4|||
124984014|NCT00436852|449569760|FG000|Overall Study|Ineligible|1|||
124984015|NCT00436852|449569761|FG001|Overall Study|Ineligible|0|||
124984016|NCT00370682|449569762|FG000|Overall Study|Moved from area|0|||
124984017|NCT00370682|449569763|FG001|Overall Study|Moved from area|2|||
124984018|NCT00370682|449569764|FG002|Overall Study|Moved from area|0|||
124984019|NCT00370682|449569762|FG000|Overall Study|Lost to Follow-up|0|||
124984020|NCT00370682|449569763|FG001|Overall Study|Lost to Follow-up|1|||
124984021|NCT00370682|449569764|FG002|Overall Study|Lost to Follow-up|1|||
124984022|NCT00943852|449569765|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
124984023|NCT00943852|449569766|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
124984024|NCT00943852|449569767|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
124984025|NCT00943852|449569768|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
124984026|NCT00943852|449569769|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
124984027|NCT00943852|449569770|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
124984028|NCT00943852|449569771|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
124984029|NCT00943852|449569772|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
124984030|NCT00943852|449569773|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
124984031|NCT00943852|449569774|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
124984032|NCT00943852|449569765|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
124984033|NCT00943852|449569766|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
124984034|NCT00943852|449569767|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
124984035|NCT00943852|449569768|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
124984036|NCT00943852|449569769|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
124984037|NCT00943852|449569770|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
124984038|NCT00943852|449569771|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
124984039|NCT00943852|449569772|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
125210401|NCT00441363|450395568|FG000|Overall Study|Other|2|||
125210402|NCT00441363|450395569|FG001|Overall Study|Other|0|||
125210403|NCT02474355|450395572|FG000|Overall Study|Other|43|||
125210404|NCT02474355|450395572|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
125210405|NCT02474355|450395572|FG000|Overall Study|Lost to Follow-up|98|||
125210406|NCT02474355|450395572|FG000|Overall Study|Withdrawal by Subject|124|||
125210407|NCT02474355|450395572|FG000|Overall Study|Death|1361|||
125210408|NCT01066793|450395573|FG000|Overall Study|Death|4|||
125210409|NCT01066793|450395574|FG001|Overall Study|Death|1|||
125210410|NCT01066793|450395575|FG002|Overall Study|Death|1|||
125210411|NCT01066793|450395576|FG003|Overall Study|Death|0|||
125210412|NCT01066793|450395577|FG004|Overall Study|Death|0|||
125210413|NCT01066793|450395578|FG005|Overall Study|Death|0|||
125313846|NCT01141712|450777401|FG000|Overall Study|Disease progression|3|||
125313847|NCT01308736|450777402|FG000|Overall Study|Did not attend a single session|6|||
125313848|NCT01308736|450777403|FG001|Overall Study|Did not attend a single session|5|||
125313849|NCT03634085|450777404|FG000|Overall Study|Adverse Event|1|||
125313850|NCT03634085|450777405|FG001|Overall Study|Adverse Event|0|||
125313851|NCT03634085|450777404|FG000|Overall Study|Withdrawal by Subject|0|||
125313852|NCT03634085|450777405|FG001|Overall Study|Withdrawal by Subject|2|||
125313853|NCT00296816|450777410|FG000|Overall Study|Disease Progression|37|||
125313854|NCT00296816|450777410|FG000|Overall Study|Adverse Event|18|||
125313855|NCT00296816|450777410|FG000|Overall Study|Investigator/Participant request|5|||
125313856|NCT00296816|450777410|FG000|Overall Study|Non-compliance|1|||
125313857|NCT00296816|450777410|FG000|Overall Study|Missing for end of treatment|4|||
125313858|NCT00296816|450777410|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
125313859|NCT00296816|450777410|FG000|Overall Study|Poor performance status|1|||
125313860|NCT00296816|450777410|FG000|Overall Study|Relocation to Florida|1|||
125313861|NCT00296816|450777410|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
125313862|NCT00296816|450777410|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
125313863|NCT00296816|450777410|FG000|Overall Study|Neuropathy/patient preference|1|||
125313864|NCT00296816|450777410|FG000|Overall Study|Proteinuria|1|||
125313865|NCT00296816|450777410|FG000|Overall Study|ineligibility due to radiation treatment|1|||
125313866|NCT00985465|450777416|FG000|Overall Study|Withdrawal by Subject|1|||
125313867|NCT00985465|450777417|FG001|Overall Study|Withdrawal by Subject|2|||
125313868|NCT00985465|450777416|FG000|Overall Study|Considered to be part of the other group|0|||
125313869|NCT00985465|450777417|FG001|Overall Study|Considered to be part of the other group|1|||
125313870|NCT04701333|450777418|FG000|Overall Study|Lost to Follow-up|3|||
125313871|NCT04701333|450777419|FG001|Overall Study|Lost to Follow-up|7|||
125313872|NCT04701333|450777418|FG000|Overall Study|Withdrawal by Subject|0|||
125313873|NCT04701333|450777419|FG001|Overall Study|Withdrawal by Subject|1|||
125313874|NCT01012258|450777420|FG000|Overall Study|Death|14|||
124984040|NCT00943852|449569773|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
124984041|NCT00943852|449569774|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
124984042|NCT00943852|449569765|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
125313875|NCT01012258|450777420|FG000|Overall Study|Lost to Follow-up|1|||
125313876|NCT01012258|450777420|FG000|Overall Study|Adverse Event|1|||
125313877|NCT01012258|450777420|FG000|Overall Study|Progressive Disease (PD)|18|||
125313878|NCT01012258|450777420|FG000|Overall Study|Symptomatic Deterioration|1|||
125313879|NCT01012258|450777420|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
124984043|NCT00943852|449569766|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
124984044|NCT00943852|449569767|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
124984045|NCT00943852|449569768|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
124984046|NCT00943852|449569769|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
124984047|NCT00943852|449569770|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
124984048|NCT00943852|449569771|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
124984049|NCT00943852|449569772|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
124984050|NCT00943852|449569773|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
124984051|NCT00943852|449569774|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
124984052|NCT00943852|449569765|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
124984053|NCT00943852|449569766|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
124984054|NCT00943852|449569767|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
124984055|NCT00943852|449569768|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
124984056|NCT00943852|449569769|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
124984057|NCT00943852|449569770|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
124984058|NCT00943852|449569771|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
124984059|NCT00943852|449569772|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
124984060|NCT00943852|449569773|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
124984061|NCT00943852|449569774|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
124984062|NCT00943852|449569765|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
124984063|NCT00943852|449569766|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
124984064|NCT00943852|449569767|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
125313880|NCT01012258|450777420|FG000|Overall Study|Another Tumor Discovered|1|||
125313881|NCT01012258|450777420|FG000|Overall Study|Ongoing|29|||
125313882|NCT00580723|450777430|FG000|Overall Study|Did not want to participate in extension|3|||
125313883|NCT00580723|450777430|FG000|Overall Study|Lost to Follow-up|5|||
125313884|NCT00148759|450777431|FG000|Overall Study|Withdrawal by Subject|1|||
125313885|NCT00148759|450777432|FG001|Overall Study|Withdrawal by Subject|1|||
125313886|NCT00148759|450777431|FG000|Overall Study|Lost to Follow-up|1|||
125313887|NCT00148759|450777432|FG001|Overall Study|Lost to Follow-up|0|||
124984065|NCT00943852|449569768|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
124984066|NCT00943852|449569769|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
124984067|NCT00943852|449569770|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
124984068|NCT00943852|449569771|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
124984069|NCT00943852|449569772|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
124984070|NCT00943852|449569773|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
124984071|NCT00943852|449569774|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
124984072|NCT02141620|449569775|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
124984073|NCT02141620|449569776|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
124984074|NCT03651622|449569777|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
124984075|NCT03651622|449569778|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
124984076|NCT03651622|449569779|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
124984077|NCT03651622|449569777|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
124984078|NCT03651622|449569778|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
124984079|NCT03651622|449569779|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
124984080|NCT03651622|449569777|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
124984081|NCT03651622|449569778|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
124984082|NCT03651622|449569779|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
124984083|NCT03651622|449569777|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
124984084|NCT03651622|449569778|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
124984085|NCT03651622|449569779|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
124984086|NCT03651622|449569777|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
124984087|NCT03651622|449569778|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
124984088|NCT03651622|449569779|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
124984089|NCT03377699|449569780|FG000|Overall Study|Withdrawal by Subject|2|||
124984090|NCT03377699|449569781|FG001|Overall Study|Withdrawal by Subject|9|||
124984091|NCT03377699|449569780|FG000|Overall Study|Lost to Follow-up|1|||
124984092|NCT03377699|449569781|FG001|Overall Study|Lost to Follow-up|1|||
124984093|NCT03377699|449569780|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
124984094|NCT03377699|449569781|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
124984095|NCT03377699|449569780|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
124984096|NCT03377699|449569781|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
124984097|NCT03377699|449569780|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
124984098|NCT03377699|449569781|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
124984099|NCT03377699|449569780|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
124984100|NCT03377699|449569781|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
124984101|NCT00307684|449569782|FG000|Open Label Phase|Lack of Efficacy|0|||
124984102|NCT00307684|449569783|FG001|Open Label Phase|Lack of Efficacy|0|||
124984103|NCT00307684|449569784|FG002|Open Label Phase|Lack of Efficacy|3|||
124984104|NCT00307684|449569782|FG000|Open Label Phase|Adverse Event|0|||
124984105|NCT00307684|449569783|FG001|Open Label Phase|Adverse Event|0|||
124984106|NCT00307684|449569784|FG002|Open Label Phase|Adverse Event|16|||
124984107|NCT00307684|449569782|FG000|Open Label Phase|Withdrawal by Subject|0|||
124984108|NCT00307684|449569783|FG001|Open Label Phase|Withdrawal by Subject|0|||
124984109|NCT00307684|449569784|FG002|Open Label Phase|Withdrawal by Subject|15|||
124984110|NCT00307684|449569782|FG000|Open Label Phase|Lost to Follow-up|0|||
124984111|NCT00307684|449569783|FG001|Open Label Phase|Lost to Follow-up|0|||
124984112|NCT00307684|449569784|FG002|Open Label Phase|Lost to Follow-up|11|||
124984113|NCT00307684|449569782|FG000|Open Label Phase|non compliance|0|||
124984114|NCT00307684|449569783|FG001|Open Label Phase|non compliance|0|||
124984115|NCT00307684|449569784|FG002|Open Label Phase|non compliance|5|||
124984116|NCT00307684|449569782|FG000|Open Label Phase|other|0|||
124984117|NCT00307684|449569783|FG001|Open Label Phase|other|0|||
124984118|NCT00307684|449569784|FG002|Open Label Phase|other|6|||
124984119|NCT00307684|449569782|FG000|Double Blind Phase|Lack of Efficacy|2|||
124984120|NCT00307684|449569783|FG001|Double Blind Phase|Lack of Efficacy|5|||
124984121|NCT00307684|449569784|FG002|Double Blind Phase|Lack of Efficacy|0|||
124984122|NCT02580305|449569785|FG000|Overall Study|Adverse Event|15|||
124984123|NCT02580305|449569786|FG001|Overall Study|Adverse Event|19|||
124984124|NCT02580305|449569787|FG002|Overall Study|Adverse Event|10|||
124984125|NCT02580305|449569785|FG000|Overall Study|Lack of Efficacy|5|||
125313888|NCT01454596|450777433|FG000|Overall Study|Death|0|||
125313889|NCT01454596|450777434|FG001|Overall Study|Death|0|||
124984126|NCT02580305|449569786|FG001|Overall Study|Lack of Efficacy|0|||
125313890|NCT01454596|450777435|FG002|Overall Study|Death|0|||
124984127|NCT02580305|449569787|FG002|Overall Study|Lack of Efficacy|2|||
124984128|NCT02580305|449569785|FG000|Overall Study|Protocol Violation|4|||
124984129|NCT02580305|449569786|FG001|Overall Study|Protocol Violation|9|||
125313891|NCT01454596|450777436|FG003|Overall Study|Death|0|||
125313892|NCT01454596|450777437|FG004|Overall Study|Death|0|||
125313893|NCT01454596|450777438|FG005|Overall Study|Death|0|||
124984130|NCT02580305|449569787|FG002|Overall Study|Protocol Violation|6|||
124984131|NCT02580305|449569785|FG000|Overall Study|Lost to Follow-up|4|||
124984132|NCT02580305|449569786|FG001|Overall Study|Lost to Follow-up|4|||
124984133|NCT02580305|449569787|FG002|Overall Study|Lost to Follow-up|2|||
124984134|NCT02580305|449569785|FG000|Overall Study|Withdrawal by Subject|11|||
124984135|NCT02580305|449569786|FG001|Overall Study|Withdrawal by Subject|9|||
124984136|NCT02580305|449569787|FG002|Overall Study|Withdrawal by Subject|7|||
124984137|NCT02580305|449569785|FG000|Overall Study|Randomized in error and never treated|4|||
124984138|NCT02580305|449569786|FG001|Overall Study|Randomized in error and never treated|8|||
124984139|NCT02580305|449569787|FG002|Overall Study|Randomized in error and never treated|5|||
124984140|NCT00941070|449569789|FG000|Overall Study|Patient non-compliant|1|||
124984141|NCT01416389|449569792|FG000|Overall Study|Lost to Follow-up|1|||
124984142|NCT01416389|449569793|FG001|Overall Study|Lost to Follow-up|0|||
124984143|NCT01416389|449569792|FG000|Overall Study|Started New Therapy|2|||
124984144|NCT01416389|449569793|FG001|Overall Study|Started New Therapy|0|||
124984145|NCT01125514|449569794|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
124984146|NCT01125514|449569794|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
124984147|NCT01125514|449569794|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
124984148|NCT01125514|449569794|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
124984149|NCT01125514|449569794|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
124984150|NCT01125514|449569794|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
124984151|NCT02755818|449569797|FG000|Overall Study|Withdrawal by Subject|0|||
124984152|NCT02755818|449569798|FG001|Overall Study|Withdrawal by Subject|0|||
124984153|NCT02755818|449569799|FG002|Overall Study|Withdrawal by Subject|0|||
124984154|NCT02755818|449569800|FG003|Overall Study|Withdrawal by Subject|2|||
124984155|NCT02755818|449569797|FG000|Overall Study|withdrawal by PI|0|||
124984156|NCT02755818|449569798|FG001|Overall Study|withdrawal by PI|0|||
124984157|NCT02755818|449569799|FG002|Overall Study|withdrawal by PI|1|||
124984158|NCT02755818|449569800|FG003|Overall Study|withdrawal by PI|1|||
124984159|NCT02535091|449569801|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
124984160|NCT02535091|449569802|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
124984161|NCT02535091|449569803|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
124984162|NCT02535091|449569801|FG000|Overall Study|Withdrawal by Subject|14|||
124984163|NCT02535091|449569802|FG001|Overall Study|Withdrawal by Subject|5|||
124984164|NCT02535091|449569803|FG002|Overall Study|Withdrawal by Subject|121|||
124984165|NCT02535091|449569801|FG000|Overall Study|Adverse Event|9|||
124984166|NCT02535091|449569802|FG001|Overall Study|Adverse Event|4|||
124984167|NCT02535091|449569803|FG002|Overall Study|Adverse Event|170|||
124984168|NCT02535091|449569801|FG000|Overall Study|Other|4|||
124984169|NCT02535091|449569802|FG001|Overall Study|Other|3|||
124984170|NCT02535091|449569803|FG002|Overall Study|Other|81|||
124984171|NCT02535091|449569801|FG000|Overall Study|Lost to Follow-up|0|||
124984172|NCT02535091|449569802|FG001|Overall Study|Lost to Follow-up|1|||
124984173|NCT02535091|449569803|FG002|Overall Study|Lost to Follow-up|19|||
124984174|NCT02535091|449569801|FG000|Overall Study|Protocol Violation|0|||
124984175|NCT02535091|449569802|FG001|Overall Study|Protocol Violation|1|||
124984176|NCT02535091|449569803|FG002|Overall Study|Protocol Violation|11|||
124984177|NCT02535091|449569801|FG000|Overall Study|Pregnancy|0|||
124984178|NCT02535091|449569802|FG001|Overall Study|Pregnancy|0|||
124984179|NCT02535091|449569803|FG002|Overall Study|Pregnancy|7|||
124984180|NCT01127763|449569804|FG000|Overall Study|Adverse Event|2|||
124984181|NCT01127763|449569804|FG000|Overall Study|Withdrawal by Subject|1|||
124984182|NCT01127763|449569804|FG000|Overall Study|Physician Decision|2|||
124984183|NCT01769326|449569805|FG000|Overall Study|Lost to Follow-up|1|||
124984184|NCT01769326|449569806|FG001|Overall Study|Lost to Follow-up|2|||
124984185|NCT01769326|449569807|FG002|Overall Study|Lost to Follow-up|0|||
124984186|NCT01769326|449569808|FG003|Overall Study|Lost to Follow-up|0|||
124984187|NCT01769326|449569805|FG000|Overall Study|unrelated injry|1|||
124984188|NCT01769326|449569806|FG001|Overall Study|unrelated injry|1|||
124984189|NCT01769326|449569807|FG002|Overall Study|unrelated injry|0|||
124984190|NCT01769326|449569808|FG003|Overall Study|unrelated injry|0|||
124984191|NCT01769326|449569805|FG000|Overall Study|got a job|0|||
124984192|NCT01769326|449569806|FG001|Overall Study|got a job|1|||
124984193|NCT01769326|449569807|FG002|Overall Study|got a job|0|||
124984194|NCT01769326|449569808|FG003|Overall Study|got a job|0|||
125210414|NCT01066793|450395573|FG000|Overall Study|Lack of Efficacy|2|||
125210415|NCT01066793|450395574|FG001|Overall Study|Lack of Efficacy|1|||
125210416|NCT01066793|450395575|FG002|Overall Study|Lack of Efficacy|0|||
125210417|NCT01066793|450395576|FG003|Overall Study|Lack of Efficacy|0|||
125210418|NCT01066793|450395577|FG004|Overall Study|Lack of Efficacy|0|||
125210419|NCT01066793|450395578|FG005|Overall Study|Lack of Efficacy|0|||
125210420|NCT01066793|450395573|FG000|Overall Study|Lost to Follow-up|180|||
125210421|NCT01066793|450395574|FG001|Overall Study|Lost to Follow-up|39|||
124984195|NCT01769326|449569805|FG000|Overall Study|Got sick and could not complete study|0|||
124984196|NCT01769326|449569806|FG001|Overall Study|Got sick and could not complete study|0|||
124984197|NCT01769326|449569807|FG002|Overall Study|Got sick and could not complete study|1|||
125210422|NCT01066793|450395575|FG002|Overall Study|Lost to Follow-up|82|||
124984198|NCT01769326|449569808|FG003|Overall Study|Got sick and could not complete study|0|||
124984199|NCT01036438|449569809|FG000|Overall Study|Adverse Event|7|||
124984200|NCT01036438|449569810|FG001|Overall Study|Adverse Event|8|||
124984201|NCT01036438|449569809|FG000|Overall Study|Death|0|||
124984202|NCT01036438|449569810|FG001|Overall Study|Death|1|||
124984203|NCT01036438|449569809|FG000|Overall Study|No effect of study treatment|3|||
124984204|NCT01036438|449569810|FG001|Overall Study|No effect of study treatment|1|||
124984205|NCT02153073|449569811|FG000|Overall Study|Case Report Forms Uncollected|230|||
124984206|NCT02153073|449569811|FG000|Overall Study|Protocol Deviation|68|||
124984207|NCT03702231|449569812|FG000|Overall Study|Withdrawal by Subject|1|||
124984208|NCT03702231|449569813|FG001|Overall Study|Withdrawal by Subject|0|||
124984209|NCT03702231|449569814|FG002|Overall Study|Withdrawal by Subject|0|||
124984210|NCT03702231|449569812|FG000|Overall Study|Protocol Violation|0|||
124984211|NCT03702231|449569813|FG001|Overall Study|Protocol Violation|0|||
124984212|NCT03702231|449569814|FG002|Overall Study|Protocol Violation|1|||
124984213|NCT03702231|449569812|FG000|Overall Study|Change in CLL Treatment|0|||
124984214|NCT03702231|449569813|FG001|Overall Study|Change in CLL Treatment|0|||
124984215|NCT03702231|449569814|FG002|Overall Study|Change in CLL Treatment|1|||
124984216|NCT03702231|449569812|FG000|Overall Study|COVID Pandemic|1|||
124984217|NCT03702231|449569813|FG001|Overall Study|COVID Pandemic|4|||
124984218|NCT03702231|449569814|FG002|Overall Study|COVID Pandemic|1|||
124984219|NCT03702231|449569812|FG000|Overall Study|Non-compliance|0|||
124984220|NCT03702231|449569813|FG001|Overall Study|Non-compliance|0|||
124984221|NCT03702231|449569814|FG002|Overall Study|Non-compliance|1|||
125210423|NCT01066793|450395576|FG003|Overall Study|Lost to Follow-up|16|||
125210424|NCT01066793|450395577|FG004|Overall Study|Lost to Follow-up|0|||
125210425|NCT01066793|450395578|FG005|Overall Study|Lost to Follow-up|1|||
125210426|NCT01066793|450395573|FG000|Overall Study|Physician Decision|3|||
125210427|NCT01066793|450395574|FG001|Overall Study|Physician Decision|0|||
125210428|NCT01066793|450395575|FG002|Overall Study|Physician Decision|0|||
125210429|NCT01066793|450395576|FG003|Overall Study|Physician Decision|0|||
125210430|NCT01066793|450395577|FG004|Overall Study|Physician Decision|0|||
125210431|NCT01066793|450395578|FG005|Overall Study|Physician Decision|0|||
125210432|NCT01066793|450395573|FG000|Overall Study|Protocol Violation|3|||
125210433|NCT01066793|450395574|FG001|Overall Study|Protocol Violation|2|||
125210434|NCT01066793|450395575|FG002|Overall Study|Protocol Violation|2|||
125210435|NCT01066793|450395576|FG003|Overall Study|Protocol Violation|0|||
125210436|NCT01066793|450395577|FG004|Overall Study|Protocol Violation|0|||
125210437|NCT01066793|450395578|FG005|Overall Study|Protocol Violation|0|||
125210438|NCT01066793|450395573|FG000|Overall Study|Withdrawal by Subject|7|||
125210439|NCT01066793|450395574|FG001|Overall Study|Withdrawal by Subject|4|||
125210440|NCT01066793|450395575|FG002|Overall Study|Withdrawal by Subject|1|||
125210441|NCT01066793|450395576|FG003|Overall Study|Withdrawal by Subject|0|||
125210442|NCT01066793|450395577|FG004|Overall Study|Withdrawal by Subject|0|||
125210443|NCT01066793|450395578|FG005|Overall Study|Withdrawal by Subject|0|||
125210444|NCT01066793|450395573|FG000|Overall Study|Early Termination|3|||
125210445|NCT01066793|450395574|FG001|Overall Study|Early Termination|0|||
125210446|NCT01066793|450395575|FG002|Overall Study|Early Termination|0|||
125210447|NCT01066793|450395576|FG003|Overall Study|Early Termination|0|||
125210448|NCT01066793|450395577|FG004|Overall Study|Early Termination|0|||
125210449|NCT01066793|450395578|FG005|Overall Study|Early Termination|0|||
125210450|NCT01066793|450395573|FG000|Overall Study|Lab test not done|7|||
125210451|NCT01066793|450395574|FG001|Overall Study|Lab test not done|0|||
125210452|NCT01066793|450395575|FG002|Overall Study|Lab test not done|0|||
125210453|NCT01066793|450395576|FG003|Overall Study|Lab test not done|1|||
125210454|NCT01066793|450395577|FG004|Overall Study|Lab test not done|0|||
125210455|NCT01066793|450395578|FG005|Overall Study|Lab test not done|0|||
125210456|NCT01066793|450395573|FG000|Overall Study|Miscellaneous|4|||
125210457|NCT01066793|450395574|FG001|Overall Study|Miscellaneous|5|||
125210458|NCT01066793|450395575|FG002|Overall Study|Miscellaneous|6|||
125210459|NCT01066793|450395576|FG003|Overall Study|Miscellaneous|0|||
125210460|NCT01066793|450395577|FG004|Overall Study|Miscellaneous|0|||
125210461|NCT01066793|450395578|FG005|Overall Study|Miscellaneous|0|||
125210462|NCT01066793|450395573|FG000|Overall Study|Non-responders|104|||
125210463|NCT01066793|450395574|FG001|Overall Study|Non-responders|5|||
125210464|NCT01066793|450395575|FG002|Overall Study|Non-responders|11|||
125210465|NCT01066793|450395576|FG003|Overall Study|Non-responders|25|||
125210466|NCT01066793|450395577|FG004|Overall Study|Non-responders|0|||
125210467|NCT01066793|450395578|FG005|Overall Study|Non-responders|0|||
125210468|NCT01066793|450395573|FG000|Overall Study|Other|15|||
125210469|NCT01066793|450395574|FG001|Overall Study|Other|5|||
125210470|NCT01066793|450395575|FG002|Overall Study|Other|6|||
125210471|NCT01066793|450395576|FG003|Overall Study|Other|2|||
125210472|NCT01066793|450395577|FG004|Overall Study|Other|0|||
125210473|NCT01066793|450395578|FG005|Overall Study|Other|0|||
125210474|NCT01066793|450395573|FG000|Overall Study|Relapse|20|||
125210475|NCT01066793|450395574|FG001|Overall Study|Relapse|8|||
125210476|NCT01066793|450395575|FG002|Overall Study|Relapse|2|||
124984222|NCT01278173|449569815|FG000|Overall Study|Lack of Efficacy|13|||
125210477|NCT01066793|450395576|FG003|Overall Study|Relapse|3|||
125210478|NCT01066793|450395577|FG004|Overall Study|Relapse|0|||
124984223|NCT01278173|449569815|FG000|Overall Study|Adverse Event|8|||
124984224|NCT01278173|449569815|FG000|Overall Study|Administrative or other reason|4|||
124984225|NCT01278173|449569815|FG000|Overall Study|Protocol Violation|1|||
124984226|NCT01278173|449569815|FG000|Overall Study|Withdrawal by Subject|1|||
124984227|NCT03590366|449569816|FG000|Overall Study|Adverse Event|0|||
124984228|NCT03590366|449569817|FG001|Overall Study|Adverse Event|3|||
124984229|NCT03590366|449569816|FG000|Overall Study|Lost to Follow-up|3|||
124984230|NCT03590366|449569817|FG001|Overall Study|Lost to Follow-up|3|||
124984231|NCT03590366|449569816|FG000|Overall Study|Withdrawal by Subject|0|||
124984232|NCT03590366|449569817|FG001|Overall Study|Withdrawal by Subject|2|||
124984233|NCT01373151|449569818|FG000|Period 1|Lack of Efficacy|3|||
124984234|NCT01373151|449569819|FG001|Period 1|Lack of Efficacy|0|||
124984235|NCT01373151|449569820|FG002|Period 1|Lack of Efficacy|0|||
124984236|NCT01373151|449569821|FG003|Period 1|Lack of Efficacy|0|||
124984237|NCT01373151|449569822|FG004|Period 1|Lack of Efficacy|1|||
124984238|NCT01373151|449569823|FG005|Period 1|Lack of Efficacy|0|||
124984239|NCT01373151|449569824|FG006|Period 1|Lack of Efficacy|0|||
124984240|NCT01373151|449569818|FG000|Period 1|Adverse Event|0|||
124984241|NCT01373151|449569819|FG001|Period 1|Adverse Event|0|||
124984242|NCT01373151|449569820|FG002|Period 1|Adverse Event|1|||
124984243|NCT01373151|449569821|FG003|Period 1|Adverse Event|0|||
124984244|NCT01373151|449569822|FG004|Period 1|Adverse Event|4|||
124984245|NCT01373151|449569823|FG005|Period 1|Adverse Event|3|||
124984246|NCT01373151|449569824|FG006|Period 1|Adverse Event|0|||
124984247|NCT01373151|449569818|FG000|Period 1|Withdrawal by Subject|2|||
124984248|NCT01373151|449569819|FG001|Period 1|Withdrawal by Subject|0|||
124984249|NCT01373151|449569820|FG002|Period 1|Withdrawal by Subject|3|||
124984250|NCT01373151|449569821|FG003|Period 1|Withdrawal by Subject|1|||
124984251|NCT01373151|449569822|FG004|Period 1|Withdrawal by Subject|0|||
124984252|NCT01373151|449569823|FG005|Period 1|Withdrawal by Subject|1|||
124984253|NCT01373151|449569824|FG006|Period 1|Withdrawal by Subject|0|||
124984254|NCT01373151|449569818|FG000|Period 2|Lack of Efficacy|9|||
124984255|NCT01373151|449569819|FG001|Period 2|Lack of Efficacy|0|||
124984256|NCT01373151|449569820|FG002|Period 2|Lack of Efficacy|0|||
124984257|NCT01373151|449569821|FG003|Period 2|Lack of Efficacy|1|||
124984258|NCT01373151|449569822|FG004|Period 2|Lack of Efficacy|2|||
124984259|NCT01373151|449569823|FG005|Period 2|Lack of Efficacy|0|||
124984260|NCT01373151|449569824|FG006|Period 2|Lack of Efficacy|3|||
124984261|NCT01373151|449569818|FG000|Period 2|Adverse Event|0|||
124984262|NCT01373151|449569819|FG001|Period 2|Adverse Event|0|||
124984263|NCT01373151|449569820|FG002|Period 2|Adverse Event|3|||
124984264|NCT01373151|449569821|FG003|Period 2|Adverse Event|3|||
124984265|NCT01373151|449569822|FG004|Period 2|Adverse Event|0|||
124984266|NCT01373151|449569823|FG005|Period 2|Adverse Event|0|||
124984267|NCT01373151|449569824|FG006|Period 2|Adverse Event|1|||
124984268|NCT01373151|449569818|FG000|Period 2|subject request to discontinue|0|||
124984269|NCT01373151|449569819|FG001|Period 2|subject request to discontinue|1|||
124984270|NCT01373151|449569820|FG002|Period 2|subject request to discontinue|0|||
124984271|NCT01373151|449569821|FG003|Period 2|subject request to discontinue|0|||
124984272|NCT01373151|449569822|FG004|Period 2|subject request to discontinue|0|||
124984273|NCT01373151|449569823|FG005|Period 2|subject request to discontinue|0|||
124984274|NCT01373151|449569824|FG006|Period 2|subject request to discontinue|0|||
124984275|NCT01373151|449569818|FG000|Period 2|Withdrawal by Subject|0|||
124984276|NCT01373151|449569819|FG001|Period 2|Withdrawal by Subject|0|||
124984277|NCT01373151|449569820|FG002|Period 2|Withdrawal by Subject|0|||
124984278|NCT01373151|449569821|FG003|Period 2|Withdrawal by Subject|1|||
124984279|NCT01373151|449569822|FG004|Period 2|Withdrawal by Subject|0|||
124984280|NCT01373151|449569823|FG005|Period 2|Withdrawal by Subject|0|||
124984281|NCT01373151|449569824|FG006|Period 2|Withdrawal by Subject|0|||
124984282|NCT01373151|449569818|FG000|Period 2|Other|0|||
124984283|NCT01373151|449569819|FG001|Period 2|Other|0|||
124984284|NCT01373151|449569820|FG002|Period 2|Other|1|||
124984285|NCT01373151|449569821|FG003|Period 2|Other|0|||
124984286|NCT01373151|449569822|FG004|Period 2|Other|0|||
124984287|NCT01373151|449569823|FG005|Period 2|Other|0|||
124984288|NCT01373151|449569824|FG006|Period 2|Other|1|||
124984289|NCT03026075|449569825|FG000|Overall Study|Physician Decision|1|||
124984290|NCT02712905|449569827|FG000|Monotherapy|Death|2|||
124984291|NCT02712905|449569828|FG001|Monotherapy|Death|5|||
124984292|NCT02712905|449569829|FG002|Monotherapy|Death|0|||
124984293|NCT02712905|449569830|FG003|Monotherapy|Death|3|||
124984294|NCT02712905|449569831|FG004|Monotherapy|Death|15|||
124984295|NCT02712905|449569832|FG005|Monotherapy|Death|1|||
124984296|NCT02712905|449569833|FG006|Monotherapy|Death|3|||
124984297|NCT02712905|449569834|FG007|Monotherapy|Death|3|||
124984298|NCT02712905|449569835|FG008|Monotherapy|Death|0|||
124984299|NCT02712905|449569836|FG009|Monotherapy|Death|27|||
124984300|NCT02712905|449569837|FG010|Monotherapy|Death|2|||
124984301|NCT02712905|449569838|FG011|Monotherapy|Death|5|||
124984302|NCT02712905|449569839|FG012|Monotherapy|Death|0|||
124984303|NCT02712905|449569840|FG013|Monotherapy|Death|0|||
124984304|NCT02712905|449569841|FG014|Monotherapy|Death|0|||
124984305|NCT02712905|449569842|FG015|Monotherapy|Death|0|||
124984306|NCT02712905|449569843|FG016|Monotherapy|Death|0|||
124984307|NCT02712905|449569844|FG017|Monotherapy|Death|0|||
124984308|NCT02712905|449569827|FG000|Monotherapy|Lost to Follow-up|0|||
124984309|NCT02712905|449569828|FG001|Monotherapy|Lost to Follow-up|1|||
124984310|NCT02712905|449569829|FG002|Monotherapy|Lost to Follow-up|0|||
124984311|NCT02712905|449569830|FG003|Monotherapy|Lost to Follow-up|1|||
124984312|NCT02712905|449569831|FG004|Monotherapy|Lost to Follow-up|0|||
124984313|NCT02712905|449569832|FG005|Monotherapy|Lost to Follow-up|0|||
124984314|NCT02712905|449569833|FG006|Monotherapy|Lost to Follow-up|0|||
124984315|NCT02712905|449569834|FG007|Monotherapy|Lost to Follow-up|0|||
124984316|NCT02712905|449569835|FG008|Monotherapy|Lost to Follow-up|0|||
124984317|NCT02712905|449569836|FG009|Monotherapy|Lost to Follow-up|2|||
124984318|NCT02712905|449569837|FG010|Monotherapy|Lost to Follow-up|0|||
124984319|NCT02712905|449569838|FG011|Monotherapy|Lost to Follow-up|0|||
124984320|NCT02712905|449569839|FG012|Monotherapy|Lost to Follow-up|0|||
124984321|NCT02712905|449569840|FG013|Monotherapy|Lost to Follow-up|0|||
124984322|NCT02712905|449569841|FG014|Monotherapy|Lost to Follow-up|0|||
124984323|NCT02712905|449569842|FG015|Monotherapy|Lost to Follow-up|0|||
124984324|NCT02712905|449569843|FG016|Monotherapy|Lost to Follow-up|0|||
124984325|NCT02712905|449569844|FG017|Monotherapy|Lost to Follow-up|0|||
124984326|NCT02712905|449569827|FG000|Monotherapy|Physician Decision|1|||
124984327|NCT02712905|449569828|FG001|Monotherapy|Physician Decision|0|||
124984328|NCT02712905|449569829|FG002|Monotherapy|Physician Decision|0|||
124984329|NCT02712905|449569830|FG003|Monotherapy|Physician Decision|1|||
124984330|NCT02712905|449569831|FG004|Monotherapy|Physician Decision|0|||
124984331|NCT02712905|449569832|FG005|Monotherapy|Physician Decision|0|||
124984332|NCT02712905|449569833|FG006|Monotherapy|Physician Decision|0|||
124984333|NCT02712905|449569834|FG007|Monotherapy|Physician Decision|0|||
124984334|NCT02712905|449569835|FG008|Monotherapy|Physician Decision|0|||
124984335|NCT02712905|449569836|FG009|Monotherapy|Physician Decision|1|||
124984336|NCT02712905|449569837|FG010|Monotherapy|Physician Decision|0|||
124984337|NCT02712905|449569838|FG011|Monotherapy|Physician Decision|0|||
124984338|NCT02712905|449569839|FG012|Monotherapy|Physician Decision|0|||
124984339|NCT02712905|449569840|FG013|Monotherapy|Physician Decision|0|||
124984340|NCT02712905|449569841|FG014|Monotherapy|Physician Decision|0|||
124984341|NCT02712905|449569842|FG015|Monotherapy|Physician Decision|0|||
124984342|NCT02712905|449569843|FG016|Monotherapy|Physician Decision|0|||
124984343|NCT02712905|449569844|FG017|Monotherapy|Physician Decision|0|||
124984344|NCT02712905|449569827|FG000|Monotherapy|Study Terminated by Sponsor|0|||
124984345|NCT02712905|449569828|FG001|Monotherapy|Study Terminated by Sponsor|0|||
124984346|NCT02712905|449569829|FG002|Monotherapy|Study Terminated by Sponsor|0|||
124984347|NCT02712905|449569830|FG003|Monotherapy|Study Terminated by Sponsor|0|||
124984348|NCT02712905|449569831|FG004|Monotherapy|Study Terminated by Sponsor|1|||
124984349|NCT02712905|449569832|FG005|Monotherapy|Study Terminated by Sponsor|0|||
124984350|NCT02712905|449569833|FG006|Monotherapy|Study Terminated by Sponsor|0|||
124984351|NCT02712905|449569834|FG007|Monotherapy|Study Terminated by Sponsor|0|||
124984352|NCT02712905|449569835|FG008|Monotherapy|Study Terminated by Sponsor|0|||
124984353|NCT02712905|449569836|FG009|Monotherapy|Study Terminated by Sponsor|2|||
124984354|NCT02712905|449569837|FG010|Monotherapy|Study Terminated by Sponsor|0|||
124984355|NCT02712905|449569838|FG011|Monotherapy|Study Terminated by Sponsor|0|||
124984356|NCT02712905|449569839|FG012|Monotherapy|Study Terminated by Sponsor|0|||
124984357|NCT02712905|449569840|FG013|Monotherapy|Study Terminated by Sponsor|0|||
124984358|NCT02712905|449569841|FG014|Monotherapy|Study Terminated by Sponsor|0|||
124984359|NCT02712905|449569842|FG015|Monotherapy|Study Terminated by Sponsor|0|||
124984360|NCT02712905|449569843|FG016|Monotherapy|Study Terminated by Sponsor|0|||
124984361|NCT02712905|449569844|FG017|Monotherapy|Study Terminated by Sponsor|0|||
124984362|NCT02712905|449569827|FG000|Monotherapy|Withdrawal by Subject|0|||
124984363|NCT02712905|449569828|FG001|Monotherapy|Withdrawal by Subject|0|||
124984364|NCT02712905|449569829|FG002|Monotherapy|Withdrawal by Subject|1|||
124984365|NCT02712905|449569830|FG003|Monotherapy|Withdrawal by Subject|0|||
124984366|NCT02712905|449569831|FG004|Monotherapy|Withdrawal by Subject|2|||
124984367|NCT02712905|449569832|FG005|Monotherapy|Withdrawal by Subject|0|||
124984368|NCT02712905|449569833|FG006|Monotherapy|Withdrawal by Subject|0|||
124984369|NCT02712905|449569834|FG007|Monotherapy|Withdrawal by Subject|0|||
125210479|NCT01066793|450395578|FG005|Overall Study|Relapse|0|||
125210480|NCT01066793|450395573|FG000|Overall Study|Result Not Available|1|||
124984370|NCT02712905|449569835|FG008|Monotherapy|Withdrawal by Subject|0|||
124984371|NCT02712905|449569836|FG009|Monotherapy|Withdrawal by Subject|4|||
124984372|NCT02712905|449569837|FG010|Monotherapy|Withdrawal by Subject|1|||
124984373|NCT02712905|449569838|FG011|Monotherapy|Withdrawal by Subject|2|||
124984374|NCT02712905|449569839|FG012|Monotherapy|Withdrawal by Subject|0|||
124984375|NCT02712905|449569840|FG013|Monotherapy|Withdrawal by Subject|0|||
124984376|NCT02712905|449569841|FG014|Monotherapy|Withdrawal by Subject|0|||
124984377|NCT02712905|449569842|FG015|Monotherapy|Withdrawal by Subject|0|||
124984378|NCT02712905|449569843|FG016|Monotherapy|Withdrawal by Subject|0|||
124984379|NCT02712905|449569844|FG017|Monotherapy|Withdrawal by Subject|0|||
124984380|NCT02712905|449569827|FG000|Monotherapy|Started New Cancer Drug|0|||
124984381|NCT02712905|449569828|FG001|Monotherapy|Started New Cancer Drug|0|||
124984382|NCT02712905|449569829|FG002|Monotherapy|Started New Cancer Drug|0|||
124984383|NCT02712905|449569830|FG003|Monotherapy|Started New Cancer Drug|0|||
124984384|NCT02712905|449569831|FG004|Monotherapy|Started New Cancer Drug|0|||
124984385|NCT02712905|449569832|FG005|Monotherapy|Started New Cancer Drug|1|||
124984386|NCT02712905|449569833|FG006|Monotherapy|Started New Cancer Drug|0|||
124984387|NCT02712905|449569834|FG007|Monotherapy|Started New Cancer Drug|0|||
124984388|NCT02712905|449569835|FG008|Monotherapy|Started New Cancer Drug|0|||
124984389|NCT02712905|449569836|FG009|Monotherapy|Started New Cancer Drug|0|||
124984390|NCT02712905|449569837|FG010|Monotherapy|Started New Cancer Drug|0|||
124984391|NCT02712905|449569838|FG011|Monotherapy|Started New Cancer Drug|0|||
124984392|NCT02712905|449569839|FG012|Monotherapy|Started New Cancer Drug|0|||
124984393|NCT02712905|449569840|FG013|Monotherapy|Started New Cancer Drug|0|||
124984394|NCT02712905|449569841|FG014|Monotherapy|Started New Cancer Drug|0|||
124984395|NCT02712905|449569842|FG015|Monotherapy|Started New Cancer Drug|0|||
124984396|NCT02712905|449569843|FG016|Monotherapy|Started New Cancer Drug|0|||
124984397|NCT02712905|449569844|FG017|Monotherapy|Started New Cancer Drug|0|||
124984398|NCT02712905|449569827|FG000|Monotherapy|Adverse Event|0|||
124984399|NCT02712905|449569828|FG001|Monotherapy|Adverse Event|0|||
124984400|NCT02712905|449569829|FG002|Monotherapy|Adverse Event|0|||
124984401|NCT02712905|449569830|FG003|Monotherapy|Adverse Event|0|||
124984402|NCT02712905|449569831|FG004|Monotherapy|Adverse Event|0|||
124984403|NCT02712905|449569832|FG005|Monotherapy|Adverse Event|0|||
124984404|NCT02712905|449569833|FG006|Monotherapy|Adverse Event|0|||
124984405|NCT02712905|449569834|FG007|Monotherapy|Adverse Event|0|||
124984406|NCT02712905|449569835|FG008|Monotherapy|Adverse Event|1|||
124984407|NCT02712905|449569836|FG009|Monotherapy|Adverse Event|0|||
124984408|NCT02712905|449569837|FG010|Monotherapy|Adverse Event|0|||
124984409|NCT02712905|449569838|FG011|Monotherapy|Adverse Event|0|||
124984410|NCT02712905|449569839|FG012|Monotherapy|Adverse Event|0|||
124984411|NCT02712905|449569840|FG013|Monotherapy|Adverse Event|0|||
124984412|NCT02712905|449569841|FG014|Monotherapy|Adverse Event|0|||
124984413|NCT02712905|449569842|FG015|Monotherapy|Adverse Event|0|||
124984414|NCT02712905|449569843|FG016|Monotherapy|Adverse Event|0|||
124984415|NCT02712905|449569844|FG017|Monotherapy|Adverse Event|0|||
124984416|NCT02712905|449569827|FG000|Combination Therapy|Death|0|||
124984417|NCT02712905|449569828|FG001|Combination Therapy|Death|0|||
124984418|NCT02712905|449569829|FG002|Combination Therapy|Death|0|||
124984419|NCT02712905|449569830|FG003|Combination Therapy|Death|0|||
124984420|NCT02712905|449569831|FG004|Combination Therapy|Death|0|||
124984421|NCT02712905|449569832|FG005|Combination Therapy|Death|0|||
124984422|NCT02712905|449569833|FG006|Combination Therapy|Death|0|||
124984423|NCT02712905|449569834|FG007|Combination Therapy|Death|0|||
124984424|NCT02712905|449569835|FG008|Combination Therapy|Death|0|||
124984425|NCT02712905|449569836|FG009|Combination Therapy|Death|0|||
124984426|NCT02712905|449569837|FG010|Combination Therapy|Death|0|||
124984427|NCT02712905|449569838|FG011|Combination Therapy|Death|0|||
124984428|NCT02712905|449569839|FG012|Combination Therapy|Death|5|||
124984429|NCT02712905|449569840|FG013|Combination Therapy|Death|6|||
124984430|NCT02712905|449569841|FG014|Combination Therapy|Death|1|||
124984431|NCT02712905|449569842|FG015|Combination Therapy|Death|3|||
124984432|NCT02712905|449569843|FG016|Combination Therapy|Death|1|||
125313894|NCT01454596|450777439|FG006|Overall Study|Death|0|||
125313895|NCT01454596|450777440|FG007|Overall Study|Death|0|||
125313896|NCT01454596|450777441|FG008|Overall Study|Death|0|||
125313897|NCT01454596|450777442|FG009|Overall Study|Death|1|||
125313898|NCT01454596|450777443|FG010|Overall Study|Death|1|||
124984433|NCT02712905|449569844|FG017|Combination Therapy|Death|3|||
124984434|NCT02712905|449569827|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
124984435|NCT02712905|449569828|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
124984436|NCT02712905|449569829|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
124984437|NCT02712905|449569830|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
124984438|NCT02712905|449569831|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
125210481|NCT01066793|450395574|FG001|Overall Study|Result Not Available|0|||
125210482|NCT01066793|450395575|FG002|Overall Study|Result Not Available|0|||
125210483|NCT01066793|450395576|FG003|Overall Study|Result Not Available|0|||
125210484|NCT01066793|450395577|FG004|Overall Study|Result Not Available|0|||
125210485|NCT01066793|450395578|FG005|Overall Study|Result Not Available|0|||
125210486|NCT01066793|450395573|FG000|Overall Study|Treatment Interrupted|1|||
125210487|NCT01066793|450395574|FG001|Overall Study|Treatment Interrupted|1|||
125210488|NCT01066793|450395575|FG002|Overall Study|Treatment Interrupted|0|||
125210489|NCT01066793|450395576|FG003|Overall Study|Treatment Interrupted|0|||
125313899|NCT01454596|450777444|FG011|Overall Study|Death|0|||
124984439|NCT02712905|449569832|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
124984440|NCT02712905|449569833|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
124984441|NCT02712905|449569834|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
124984442|NCT02712905|449569835|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
124984443|NCT02712905|449569836|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
124984444|NCT02712905|449569837|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
124984445|NCT02712905|449569838|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
124984446|NCT02712905|449569839|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
124984447|NCT02712905|449569840|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
124984448|NCT02712905|449569841|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
125210490|NCT01066793|450395577|FG004|Overall Study|Treatment Interrupted|0|||
124984449|NCT02712905|449569842|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
124984450|NCT02712905|449569843|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
124984451|NCT02712905|449569844|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
124984452|NCT02712905|449569827|FG000|Combination Therapy|Withdrawal by Subject|0|||
124984453|NCT02712905|449569828|FG001|Combination Therapy|Withdrawal by Subject|0|||
124984454|NCT02712905|449569829|FG002|Combination Therapy|Withdrawal by Subject|0|||
124984455|NCT02712905|449569830|FG003|Combination Therapy|Withdrawal by Subject|0|||
124984456|NCT02712905|449569831|FG004|Combination Therapy|Withdrawal by Subject|0|||
124984457|NCT02712905|449569832|FG005|Combination Therapy|Withdrawal by Subject|0|||
124984458|NCT02712905|449569833|FG006|Combination Therapy|Withdrawal by Subject|0|||
124984459|NCT02712905|449569834|FG007|Combination Therapy|Withdrawal by Subject|0|||
124984460|NCT02712905|449569835|FG008|Combination Therapy|Withdrawal by Subject|0|||
124984461|NCT02712905|449569836|FG009|Combination Therapy|Withdrawal by Subject|0|||
124984462|NCT02712905|449569837|FG010|Combination Therapy|Withdrawal by Subject|0|||
124984463|NCT02712905|449569838|FG011|Combination Therapy|Withdrawal by Subject|0|||
124984464|NCT02712905|449569839|FG012|Combination Therapy|Withdrawal by Subject|0|||
124984465|NCT02712905|449569840|FG013|Combination Therapy|Withdrawal by Subject|0|||
124984466|NCT02712905|449569841|FG014|Combination Therapy|Withdrawal by Subject|0|||
124984467|NCT02712905|449569842|FG015|Combination Therapy|Withdrawal by Subject|1|||
124984468|NCT02712905|449569843|FG016|Combination Therapy|Withdrawal by Subject|0|||
124984469|NCT02712905|449569844|FG017|Combination Therapy|Withdrawal by Subject|2|||
124984470|NCT02712905|449569827|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124984471|NCT02712905|449569828|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124984472|NCT02712905|449569829|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124984473|NCT02712905|449569830|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124984474|NCT02712905|449569831|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124984475|NCT02712905|449569832|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124984476|NCT02712905|449569833|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124984477|NCT02712905|449569834|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124984478|NCT02712905|449569835|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124984479|NCT02712905|449569836|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124984480|NCT02712905|449569837|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124984481|NCT02712905|449569838|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124984482|NCT02712905|449569839|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124984483|NCT02712905|449569840|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124984484|NCT02712905|449569841|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124984485|NCT02712905|449569842|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
124984486|NCT02712905|449569843|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124984487|NCT02712905|449569844|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124984488|NCT01468181|449569845|FG000|Overall Study|Adverse Event|8|||
124984489|NCT01468181|449569846|FG001|Overall Study|Adverse Event|1|||
124984490|NCT01468181|449569847|FG002|Overall Study|Adverse Event|6|||
124984491|NCT01468181|449569848|FG003|Overall Study|Adverse Event|2|||
124984492|NCT01468181|449569849|FG004|Overall Study|Adverse Event|2|||
124984493|NCT01468181|449569845|FG000|Overall Study|Protocol Violation|2|||
124984494|NCT01468181|449569846|FG001|Overall Study|Protocol Violation|0|||
124984495|NCT01468181|449569847|FG002|Overall Study|Protocol Violation|1|||
124984496|NCT01468181|449569848|FG003|Overall Study|Protocol Violation|0|||
124984497|NCT01468181|449569849|FG004|Overall Study|Protocol Violation|1|||
124984498|NCT01468181|449569845|FG000|Overall Study|Physician Decision|0|||
124984499|NCT01468181|449569846|FG001|Overall Study|Physician Decision|0|||
124984500|NCT01468181|449569847|FG002|Overall Study|Physician Decision|0|||
124984501|NCT01468181|449569848|FG003|Overall Study|Physician Decision|1|||
124984502|NCT01468181|449569849|FG004|Overall Study|Physician Decision|1|||
125210491|NCT01066793|450395578|FG005|Overall Study|Treatment Interrupted|0|||
125210492|NCT01066793|450395573|FG000|Overall Study|Treatment Never Started|18|||
125210493|NCT01066793|450395574|FG001|Overall Study|Treatment Never Started|5|||
125210494|NCT01066793|450395575|FG002|Overall Study|Treatment Never Started|4|||
124984503|NCT01468181|449569845|FG000|Overall Study|Lost to Follow-up|0|||
124984504|NCT01468181|449569846|FG001|Overall Study|Lost to Follow-up|0|||
125210495|NCT01066793|450395576|FG003|Overall Study|Treatment Never Started|1|||
124984505|NCT01468181|449569847|FG002|Overall Study|Lost to Follow-up|1|||
124984506|NCT01468181|449569848|FG003|Overall Study|Lost to Follow-up|0|||
124984507|NCT01468181|449569849|FG004|Overall Study|Lost to Follow-up|1|||
125210496|NCT01066793|450395577|FG004|Overall Study|Treatment Never Started|0|||
125210497|NCT01066793|450395578|FG005|Overall Study|Treatment Never Started|0|||
125210498|NCT01066793|450395573|FG000|Overall Study|Treatment Stopped|2|||
124984508|NCT01468181|449569845|FG000|Overall Study|Withdrawal by Subject|0|||
124984509|NCT01468181|449569846|FG001|Overall Study|Withdrawal by Subject|1|||
124984510|NCT01468181|449569847|FG002|Overall Study|Withdrawal by Subject|0|||
124984511|NCT01468181|449569848|FG003|Overall Study|Withdrawal by Subject|0|||
124984512|NCT01468181|449569849|FG004|Overall Study|Withdrawal by Subject|0|||
124984513|NCT01942785|449569856|FG000|Overall Study|Adverse Event|2|||
124984514|NCT01942785|449569856|FG000|Overall Study|Withdrawal by Subject|1|||
124984515|NCT01942785|449569856|FG000|Overall Study|Protocol Violation|1|||
124984516|NCT02227199|449569857|FG000|Overall Study|Physician Decision|0|||
124984517|NCT02227199|449569858|FG001|Overall Study|Physician Decision|0|||
124984518|NCT02227199|449569859|FG002|Overall Study|Physician Decision|1|||
124984519|NCT02227199|449569857|FG000|Overall Study|Adverse Event|0|||
124984520|NCT02227199|449569858|FG001|Overall Study|Adverse Event|0|||
124984521|NCT02227199|449569859|FG002|Overall Study|Adverse Event|3|||
124984522|NCT05597787|449569860|FG000|Overall Study|Withdrawal by Subject|0|||
124984523|NCT05597787|449569861|FG001|Overall Study|Withdrawal by Subject|0|||
124984524|NCT05597787|449569862|FG002|Overall Study|Withdrawal by Subject|1|||
124984525|NCT01934790|449569864|FG000|Treatment|Adverse Event|3|||
124984526|NCT01934790|449569864|FG000|Treatment|Clinical progression|6|||
124984527|NCT01934790|449569864|FG000|Treatment|Radiological progression|4|||
124984528|NCT01934790|449569864|FG000|Treatment|Withdrawal by Subject|2|||
124984529|NCT01934790|449569864|FG000|Treatment|Study drug never administered|1|||
124984530|NCT01934790|449569864|FG000|Active Follow up|Death|20|||
124984531|NCT01934790|449569864|FG000|Active Follow up|Physician Decision|2|||
124984532|NCT01934790|449569864|FG000|Active Follow up|Progressive disease|1|||
124984533|NCT01934790|449569864|FG000|Active Follow up|Other reason|1|||
124984534|NCT00552929|449569867|FG000|Overall Study|Lost to Follow-up|0|||
124984535|NCT00552929|449569868|FG001|Overall Study|Lost to Follow-up|0|||
124984536|NCT00552929|449569869|FG002|Overall Study|Lost to Follow-up|0|||
124984537|NCT00552929|449569870|FG003|Overall Study|Lost to Follow-up|0|||
124984538|NCT00552929|449569871|FG004|Overall Study|Lost to Follow-up|0|||
124984539|NCT00552929|449569872|FG005|Overall Study|Lost to Follow-up|0|||
124984540|NCT00552929|449569873|FG006|Overall Study|Lost to Follow-up|0|||
124984541|NCT00552929|449569874|FG007|Overall Study|Lost to Follow-up|0|||
124984542|NCT00552929|449569875|FG008|Overall Study|Lost to Follow-up|1|||
124984543|NCT00552929|449569876|FG009|Overall Study|Lost to Follow-up|0|||
124984544|NCT00552929|449569867|FG000|Overall Study|Not Eligible|0|||
124984545|NCT00552929|449569868|FG001|Overall Study|Not Eligible|0|||
124984546|NCT00552929|449569869|FG002|Overall Study|Not Eligible|0|||
124984547|NCT00552929|449569870|FG003|Overall Study|Not Eligible|0|||
124984548|NCT00552929|449569871|FG004|Overall Study|Not Eligible|0|||
124984549|NCT00552929|449569872|FG005|Overall Study|Not Eligible|1|||
124984550|NCT00552929|449569873|FG006|Overall Study|Not Eligible|0|||
124984551|NCT00552929|449569874|FG007|Overall Study|Not Eligible|0|||
124984552|NCT00552929|449569875|FG008|Overall Study|Not Eligible|0|||
124984553|NCT00552929|449569876|FG009|Overall Study|Not Eligible|0|||
124984554|NCT01200290|449569877|FG000|Treatment Period|Adverse Event|1|||
124984555|NCT01200290|449569877|FG000|Post-Treatment Follow-Up Period|Death|2|||
124984556|NCT01144377|449569882|FG000|52 Week Treatment Period|Adverse Event|0|||
124984557|NCT01144377|449569883|FG001|52 Week Treatment Period|Adverse Event|0|||
124984558|NCT01144377|449569884|FG002|52 Week Treatment Period|Adverse Event|3|||
124984559|NCT01144377|449569885|FG003|52 Week Treatment Period|Adverse Event|2|||
124984560|NCT01144377|449569886|FG004|52 Week Treatment Period|Adverse Event|1|||
124984561|NCT01144377|449569882|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
124984562|NCT01144377|449569883|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
124984563|NCT01144377|449569884|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
124984564|NCT01144377|449569885|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
124984565|NCT01144377|449569886|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
124984566|NCT01144377|449569882|FG000|52 Week Treatment Period|Protocol Violation|0|||
124984567|NCT01144377|449569883|FG001|52 Week Treatment Period|Protocol Violation|0|||
125313900|NCT00857285|450777445|FG000|Overall Study|Adverse Event|4|||
124984568|NCT01144377|449569884|FG002|52 Week Treatment Period|Protocol Violation|0|||
124984569|NCT01144377|449569885|FG003|52 Week Treatment Period|Protocol Violation|0|||
124984570|NCT01144377|449569886|FG004|52 Week Treatment Period|Protocol Violation|1|||
124984571|NCT01144377|449569882|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
124984572|NCT01144377|449569883|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
124984573|NCT01144377|449569884|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
124984574|NCT01144377|449569885|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
124984575|NCT01144377|449569886|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
124984576|NCT01144377|449569882|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
124984577|NCT01144377|449569883|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
124984578|NCT01144377|449569884|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
124984579|NCT01144377|449569885|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
124984580|NCT01144377|449569886|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
124984581|NCT01144377|449569882|FG000|52 Week Treatment Period|Sponsor Decision|0|||
124984582|NCT01144377|449569883|FG001|52 Week Treatment Period|Sponsor Decision|0|||
124984583|NCT01144377|449569884|FG002|52 Week Treatment Period|Sponsor Decision|0|||
124984584|NCT01144377|449569885|FG003|52 Week Treatment Period|Sponsor Decision|0|||
124984585|NCT01144377|449569886|FG004|52 Week Treatment Period|Sponsor Decision|1|||
124984586|NCT01144377|449569882|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
124984587|NCT01144377|449569883|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
124984588|NCT01144377|449569884|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
124984589|NCT01144377|449569885|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
124984590|NCT01144377|449569886|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
124984591|NCT01144377|449569882|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
124984592|NCT01144377|449569883|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
124984593|NCT01144377|449569884|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
124984594|NCT01144377|449569885|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
124984595|NCT01144377|449569886|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
124984596|NCT01144377|449569882|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
124984597|NCT01144377|449569883|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
124984598|NCT01144377|449569884|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
124984599|NCT01144377|449569885|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
124984600|NCT01144377|449569886|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
124984601|NCT02489968|449569888|FG000|Open-label Treatment Period|Adverse Event|14|||
124984602|NCT02489968|449569889|FG001|Open-label Treatment Period|Adverse Event|7|||
124984603|NCT02489968|449569890|FG002|Open-label Treatment Period|Adverse Event|0|||
124984604|NCT02489968|449569891|FG003|Open-label Treatment Period|Adverse Event|0|||
124984605|NCT02489968|449569892|FG004|Open-label Treatment Period|Adverse Event|0|||
124984606|NCT02489968|449569893|FG005|Open-label Treatment Period|Adverse Event|0|||
124984607|NCT02489968|449569888|FG000|Open-label Treatment Period|Protocol Violation|2|||
124984608|NCT02489968|449569889|FG001|Open-label Treatment Period|Protocol Violation|2|||
124984609|NCT02489968|449569890|FG002|Open-label Treatment Period|Protocol Violation|0|||
124984610|NCT02489968|449569891|FG003|Open-label Treatment Period|Protocol Violation|0|||
124984611|NCT02489968|449569892|FG004|Open-label Treatment Period|Protocol Violation|0|||
124984612|NCT02489968|449569893|FG005|Open-label Treatment Period|Protocol Violation|0|||
124984613|NCT02489968|449569888|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
124984614|NCT02489968|449569889|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
124984615|NCT02489968|449569890|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
124984616|NCT02489968|449569891|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
124984617|NCT02489968|449569892|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
124984618|NCT02489968|449569893|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
124984619|NCT02489968|449569888|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
124984620|NCT02489968|449569889|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
124984621|NCT02489968|449569890|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
124984622|NCT02489968|449569891|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
124984623|NCT02489968|449569892|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
124984624|NCT02489968|449569893|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
124984625|NCT02489968|449569888|FG000|Open-label Treatment Period|Other than specified above|204|||
124984626|NCT02489968|449569889|FG001|Open-label Treatment Period|Other than specified above|189|||
124984627|NCT02489968|449569890|FG002|Open-label Treatment Period|Other than specified above|0|||
124984628|NCT02489968|449569891|FG003|Open-label Treatment Period|Other than specified above|0|||
124984629|NCT02489968|449569892|FG004|Open-label Treatment Period|Other than specified above|0|||
124984630|NCT02489968|449569893|FG005|Open-label Treatment Period|Other than specified above|0|||
124984631|NCT02489968|449569888|FG000|Double-blind Treatment Period|Adverse Event|0|||
124984632|NCT02489968|449569889|FG001|Double-blind Treatment Period|Adverse Event|0|||
124984633|NCT02489968|449569890|FG002|Double-blind Treatment Period|Adverse Event|2|||
124984634|NCT02489968|449569891|FG003|Double-blind Treatment Period|Adverse Event|6|||
124984635|NCT02489968|449569892|FG004|Double-blind Treatment Period|Adverse Event|4|||
124984636|NCT02489968|449569893|FG005|Double-blind Treatment Period|Adverse Event|5|||
124984637|NCT02489968|449569888|FG000|Double-blind Treatment Period|Protocol Violation|0|||
124984638|NCT02489968|449569889|FG001|Double-blind Treatment Period|Protocol Violation|0|||
124984639|NCT02489968|449569890|FG002|Double-blind Treatment Period|Protocol Violation|0|||
124984640|NCT02489968|449569891|FG003|Double-blind Treatment Period|Protocol Violation|0|||
124984641|NCT02489968|449569892|FG004|Double-blind Treatment Period|Protocol Violation|1|||
124984642|NCT02489968|449569893|FG005|Double-blind Treatment Period|Protocol Violation|1|||
124984643|NCT02489968|449569888|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
124984644|NCT02489968|449569889|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
125210499|NCT01066793|450395574|FG001|Overall Study|Treatment Stopped|1|||
125210500|NCT01066793|450395575|FG002|Overall Study|Treatment Stopped|0|||
124984645|NCT02489968|449569890|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
124984646|NCT02489968|449569891|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
124984647|NCT02489968|449569892|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
124984648|NCT02489968|449569893|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
124984649|NCT02489968|449569888|FG000|Double-blind Treatment Period|Other than specified above|0|||
124984650|NCT02489968|449569889|FG001|Double-blind Treatment Period|Other than specified above|0|||
124984651|NCT02489968|449569890|FG002|Double-blind Treatment Period|Other than specified above|0|||
124984652|NCT02489968|449569891|FG003|Double-blind Treatment Period|Other than specified above|0|||
124984653|NCT02489968|449569892|FG004|Double-blind Treatment Period|Other than specified above|1|||
124984654|NCT02489968|449569893|FG005|Double-blind Treatment Period|Other than specified above|0|||
124984655|NCT01305200|449569894|FG000|Overall Study|Physician Decision|4|||
124984656|NCT01305200|449569895|FG001|Overall Study|Physician Decision|6|||
124984657|NCT01305200|449569896|FG002|Overall Study|Physician Decision|1|||
124984658|NCT01305200|449569894|FG000|Overall Study|Withdrawal by Subject|24|||
124984659|NCT01305200|449569895|FG001|Overall Study|Withdrawal by Subject|21|||
124984660|NCT01305200|449569896|FG002|Overall Study|Withdrawal by Subject|1|||
124984661|NCT01305200|449569894|FG000|Overall Study|Ineligible|1|||
124984662|NCT01305200|449569895|FG001|Overall Study|Ineligible|2|||
124984663|NCT01305200|449569896|FG002|Overall Study|Ineligible|1|||
124984664|NCT01305200|449569894|FG000|Overall Study|Death|0|||
124984665|NCT01305200|449569895|FG001|Overall Study|Death|2|||
124984666|NCT01305200|449569896|FG002|Overall Study|Death|0|||
124984667|NCT04075994|449571209|FG000|Overall Study|Withdrawal by Subject|8|||
124984668|NCT04075994|449571210|FG001|Overall Study|Withdrawal by Subject|9|||
124984669|NCT04075994|449571209|FG000|Overall Study|Adverse Event|2|||
124984670|NCT04075994|449571210|FG001|Overall Study|Adverse Event|2|||
124984671|NCT04075994|449571209|FG000|Overall Study|Investigator withdrew|3|||
124984672|NCT04075994|449571210|FG001|Overall Study|Investigator withdrew|1|||
124984673|NCT01941719|449571214|FG000|Overall Study|Lost to Follow-up|20|||
124984674|NCT01941719|449571215|FG001|Overall Study|Lost to Follow-up|19|||
124984675|NCT01744392|449571218|FG000|Overall Study|Physician Decision|1|||
124984676|NCT00858364|449571225|FG000|Overall Study|Administrative Decision|3|||
124984677|NCT00858364|449571226|FG001|Overall Study|Administrative Decision|2|||
124984678|NCT00858364|449571225|FG000|Overall Study|Adverse Event|5|||
124984679|NCT00858364|449571226|FG001|Overall Study|Adverse Event|2|||
124984680|NCT00858364|449571225|FG000|Overall Study|Withdrawal by Subject|44|||
124984681|NCT00858364|449571226|FG001|Overall Study|Withdrawal by Subject|118|||
124984682|NCT00858364|449571225|FG000|Overall Study|Ineligibility Determined|1|||
124984683|NCT00858364|449571226|FG001|Overall Study|Ineligibility Determined|10|||
124984684|NCT00858364|449571225|FG000|Overall Study|Lost to Follow-up|24|||
124984685|NCT00858364|449571226|FG001|Overall Study|Lost to Follow-up|54|||
124984686|NCT00858364|449571225|FG000|Overall Study|Noncompliance|3|||
124984687|NCT00858364|449571226|FG001|Overall Study|Noncompliance|4|||
124984688|NCT00858364|449571225|FG000|Overall Study|Protocol Deviation|0|||
124984689|NCT00858364|449571226|FG001|Overall Study|Protocol Deviation|2|||
124984690|NCT00858364|449571225|FG000|Overall Study|Other|9|||
124984691|NCT00858364|449571226|FG001|Overall Study|Other|17|||
124984692|NCT00858364|449571225|FG000|Overall Study|Missing|1|||
124984693|NCT00858364|449571226|FG001|Overall Study|Missing|1|||
124984694|NCT00858364|449571225|FG000|Overall Study|Still on-study|114|||
124984695|NCT00858364|449571226|FG001|Overall Study|Still on-study|247|||
124984696|NCT03980808|449571227|FG000|Overall Study|Lost to Follow-up|2|||
124984697|NCT03980808|449571228|FG001|Overall Study|Lost to Follow-up|2|||
124984698|NCT01655693|449571229|FG000|Overall Study|Progression of Disease|92|||
124984699|NCT01655693|449571230|FG001|Overall Study|Progression of Disease|76|||
124984700|NCT01655693|449571231|FG002|Overall Study|Progression of Disease|58|||
124984701|NCT01655693|449571229|FG000|Overall Study|Death|8|||
124984702|NCT01655693|449571230|FG001|Overall Study|Death|9|||
124984703|NCT01655693|449571231|FG002|Overall Study|Death|12|||
124984704|NCT01655693|449571229|FG000|Overall Study|Serious Adverse Event|3|||
124984705|NCT01655693|449571230|FG001|Overall Study|Serious Adverse Event|15|||
124984706|NCT01655693|449571231|FG002|Overall Study|Serious Adverse Event|11|||
124984707|NCT01655693|449571229|FG000|Overall Study|Withdrawal by Subject|3|||
124984708|NCT01655693|449571230|FG001|Overall Study|Withdrawal by Subject|2|||
124984709|NCT01655693|449571231|FG002|Overall Study|Withdrawal by Subject|20|||
124984710|NCT01655693|449571229|FG000|Overall Study|Adverse Event|3|||
124872501|NCT00117676|449154126|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
124872502|NCT00117676|449154127|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
124984711|NCT01655693|449571230|FG001|Overall Study|Adverse Event|11|||
124984712|NCT01655693|449571231|FG002|Overall Study|Adverse Event|3|||
124984713|NCT01655693|449571229|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
124984714|NCT01655693|449571230|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
124984715|NCT01655693|449571231|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
124984716|NCT01655693|449571229|FG000|Overall Study|Non-Compliance|0|||
124984717|NCT01655693|449571230|FG001|Overall Study|Non-Compliance|0|||
124984718|NCT01655693|449571231|FG002|Overall Study|Non-Compliance|7|||
124984719|NCT01655693|449571229|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
124984720|NCT01655693|449571230|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
124984721|NCT01655693|449571231|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
124984722|NCT01655693|449571229|FG000|Overall Study|Protocol Violation|1|||
124984723|NCT01655693|449571230|FG001|Overall Study|Protocol Violation|0|||
124984724|NCT01655693|449571231|FG002|Overall Study|Protocol Violation|3|||
124984725|NCT01655693|449571229|FG000|Overall Study|Lost to Follow-up|1|||
124984726|NCT01655693|449571230|FG001|Overall Study|Lost to Follow-up|0|||
124984727|NCT01655693|449571231|FG002|Overall Study|Lost to Follow-up|1|||
124984728|NCT01655693|449571229|FG000|Overall Study|Screening Failure|1|||
124984729|NCT01655693|449571230|FG001|Overall Study|Screening Failure|0|||
124984730|NCT01655693|449571231|FG002|Overall Study|Screening Failure|0|||
124984731|NCT01655693|449571229|FG000|Overall Study|Other|8|||
124984732|NCT01655693|449571230|FG001|Overall Study|Other|6|||
124984733|NCT01655693|449571231|FG002|Overall Study|Other|15|||
124984734|NCT00929110|449571236|FG000|Overall Study|Adverse Event|40|||
124984735|NCT00929110|449571237|FG001|Overall Study|Adverse Event|29|||
124984736|NCT00929110|449571238|FG002|Overall Study|Adverse Event|18|||
124984737|NCT00929110|449571236|FG000|Overall Study|Subject withdrew consent|40|||
124984738|NCT00929110|449571237|FG001|Overall Study|Subject withdrew consent|23|||
124984739|NCT00929110|449571238|FG002|Overall Study|Subject withdrew consent|26|||
124984740|NCT00929110|449571236|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
124984741|NCT00929110|449571237|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
124984742|NCT00929110|449571238|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
124984743|NCT00929110|449571236|FG000|Overall Study|Lost to Follow-up|7|||
124984744|NCT00929110|449571237|FG001|Overall Study|Lost to Follow-up|7|||
124984745|NCT00929110|449571238|FG002|Overall Study|Lost to Follow-up|3|||
124984746|NCT00929110|449571236|FG000|Overall Study|Protocol deviation|5|||
124984747|NCT00929110|449571237|FG001|Overall Study|Protocol deviation|2|||
124984748|NCT00929110|449571238|FG002|Overall Study|Protocol deviation|4|||
124984749|NCT00929110|449571236|FG000|Overall Study|Administrative problems|4|||
124984750|NCT00929110|449571237|FG001|Overall Study|Administrative problems|1|||
124984751|NCT00929110|449571238|FG002|Overall Study|Administrative problems|2|||
124984752|NCT00929110|449571236|FG000|Overall Study|Death|2|||
124984753|NCT00929110|449571237|FG001|Overall Study|Death|2|||
124984754|NCT00929110|449571238|FG002|Overall Study|Death|2|||
124984755|NCT00929110|449571236|FG000|Overall Study|Abnormal laboratory value(s)|0|||
124984756|NCT00929110|449571237|FG001|Overall Study|Abnormal laboratory value(s)|1|||
124984757|NCT00929110|449571238|FG002|Overall Study|Abnormal laboratory value(s)|0|||
124984758|NCT00929110|449571236|FG000|Overall Study|Abnormal test procedure result(s)|0|||
124984759|NCT00929110|449571237|FG001|Overall Study|Abnormal test procedure result(s)|1|||
124984760|NCT00929110|449571238|FG002|Overall Study|Abnormal test procedure result(s)|1|||
124984761|NCT00929110|449571236|FG000|Overall Study|Patient inability to use the device|0|||
124984762|NCT00929110|449571237|FG001|Overall Study|Patient inability to use the device|1|||
124984763|NCT00929110|449571238|FG002|Overall Study|Patient inability to use the device|0|||
124984764|NCT02703259|449571239|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
124984765|NCT02703259|449571240|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
124984766|NCT02703259|449571239|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
124984767|NCT02703259|449571240|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
124984768|NCT02703259|449571239|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
124984769|NCT02703259|449571240|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
124984770|NCT02285153|449571246|FG000|Overall Study|Adverse Event|1|||
124984771|NCT02285153|449571247|FG001|Overall Study|Adverse Event|0|||
124984772|NCT02544451|449571249|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
124984773|NCT02544451|449571250|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
124984774|NCT02544451|449571251|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
124984775|NCT02544451|449571252|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
124984776|NCT02544451|449571249|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
124984777|NCT02544451|449571250|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
124984778|NCT02544451|449571251|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
124984779|NCT02544451|449571252|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
124984780|NCT02544451|449571249|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
124984781|NCT02544451|449571250|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
124984782|NCT02544451|449571251|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
124984783|NCT02544451|449571252|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
124984784|NCT02544451|449571249|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
124984785|NCT02544451|449571250|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
124984786|NCT02544451|449571251|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
124984787|NCT02544451|449571252|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
125210501|NCT01066793|450395576|FG003|Overall Study|Treatment Stopped|1|||
124984788|NCT02544451|449571249|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
124984789|NCT02544451|449571250|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
124984790|NCT02544451|449571251|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
124984791|NCT02544451|449571252|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
124984792|NCT02544451|449571249|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
124984793|NCT02544451|449571250|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
124984794|NCT02544451|449571251|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
124984795|NCT02544451|449571252|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
124984796|NCT00998790|449571255|FG000|Overall Study|Withdrawal by Subject|21|||
124984797|NCT01489891|449571256|FG000|Overall Study|Endoscopy failure|1|||
124984798|NCT01489891|449571257|FG001|Overall Study|Endoscopy failure|0|||
124984799|NCT03001076|449571258|FG000|Overall Study|Withdrawal by patient|2|||
124984800|NCT03001076|449571259|FG001|Overall Study|Withdrawal by patient|0|||
124984801|NCT03001076|449571258|FG000|Overall Study|Other|1|||
124984802|NCT03001076|449571259|FG001|Overall Study|Other|0|||
124984803|NCT03001076|449571258|FG000|Overall Study|Adverse Event|3|||
124984804|NCT03001076|449571259|FG001|Overall Study|Adverse Event|3|||
124984805|NCT03001076|449571258|FG000|Overall Study|Sponsor decision|1|||
124984806|NCT03001076|449571259|FG001|Overall Study|Sponsor decision|0|||
124984807|NCT03001076|449571258|FG000|Overall Study|Lost to Follow-up|0|||
124984808|NCT03001076|449571259|FG001|Overall Study|Lost to Follow-up|2|||
124984809|NCT00948766|449571260|FG000|Core Study|Adverse Event|73|||
124984810|NCT00948766|449571261|FG001|Core Study|Adverse Event|51|||
124984811|NCT00948766|449571260|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
124984812|NCT00948766|449571261|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
124984813|NCT00948766|449571260|FG000|Core Study|Patient Withdrew Consent|27|||
124984814|NCT00948766|449571261|FG001|Core Study|Patient Withdrew Consent|46|||
124984815|NCT00948766|449571260|FG000|Core Study|Lost to Follow-up|3|||
124984816|NCT00948766|449571261|FG001|Core Study|Lost to Follow-up|2|||
124984817|NCT00948766|449571260|FG000|Core Study|Administrative Problems|2|||
124984818|NCT00948766|449571261|FG001|Core Study|Administrative Problems|2|||
124984819|NCT00948766|449571260|FG000|Core Study|Death|1|||
124984820|NCT00948766|449571261|FG001|Core Study|Death|1|||
124984821|NCT00948766|449571260|FG000|Core Study|Protocol Deviation|8|||
124984822|NCT00948766|449571261|FG001|Core Study|Protocol Deviation|10|||
124984823|NCT00948766|449571260|FG000|Extension Study|Adverse Event|43|||
124984824|NCT00948766|449571261|FG001|Extension Study|Adverse Event|0|||
124984825|NCT00948766|449571260|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
124984826|NCT00948766|449571261|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
124984827|NCT00948766|449571260|FG000|Extension Study|Study Drug No Longer Required|1|||
124984828|NCT00948766|449571261|FG001|Extension Study|Study Drug No Longer Required|0|||
124984829|NCT00948766|449571260|FG000|Extension Study|Patient Withdrew Consent|32|||
124984830|NCT00948766|449571261|FG001|Extension Study|Patient Withdrew Consent|0|||
124984831|NCT00948766|449571260|FG000|Extension Study|Lost to Follow-up|8|||
124984832|NCT00948766|449571261|FG001|Extension Study|Lost to Follow-up|0|||
124984833|NCT00948766|449571260|FG000|Extension Study|Administrative Problems|1|||
124984834|NCT00948766|449571261|FG001|Extension Study|Administrative Problems|0|||
124984835|NCT00948766|449571260|FG000|Extension Study|Death|4|||
124984836|NCT00948766|449571261|FG001|Extension Study|Death|0|||
124984837|NCT00888927|449571265|FG000|Overall Study|Adverse Event|0|||
124984838|NCT00888927|449571266|FG001|Overall Study|Adverse Event|0|||
124984839|NCT00888927|449571267|FG002|Overall Study|Adverse Event|0|||
124984840|NCT00888927|449571268|FG003|Overall Study|Adverse Event|1|||
124984841|NCT00888927|449571265|FG000|Overall Study|Withdrawal of consent|0|||
124984842|NCT00888927|449571266|FG001|Overall Study|Withdrawal of consent|0|||
124984843|NCT00888927|449571267|FG002|Overall Study|Withdrawal of consent|0|||
124984844|NCT00888927|449571268|FG003|Overall Study|Withdrawal of consent|1|||
124984845|NCT03459443|449571269|FG000|Overall Study|Lack of Efficacy|3|||
124984846|NCT03459443|449571269|FG000|Overall Study|Adverse Event|1|||
124984847|NCT03459443|449571269|FG000|Overall Study|Sponsor's decision to close the study|18|||
124984848|NCT01080716|449571270|FG000|Part 1|Physician Decision|1|||
124984849|NCT01080716|449571271|FG001|Part 1|Physician Decision|0|||
124984850|NCT01080716|449571272|FG002|Part 1|Physician Decision|0|||
124984851|NCT01080716|449571273|FG003|Part 1|Physician Decision|0|||
124984852|NCT00287690|449571274|FG000|Overall Study|Protocol Violation|20|||
124984853|NCT00287690|449571275|FG001|Overall Study|Protocol Violation|26|||
124984854|NCT03592745|449571276|FG000|Overall Study|Adverse Event|0|||
124984855|NCT03592745|449571277|FG001|Overall Study|Adverse Event|2|||
124984856|NCT03592745|449571276|FG000|Overall Study|Lost to Follow-up|2|||
124984857|NCT03592745|449571277|FG001|Overall Study|Lost to Follow-up|0|||
124984858|NCT03592745|449571276|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
125313901|NCT00857285|450777446|FG001|Overall Study|Adverse Event|2|||
125313902|NCT00857285|450777445|FG000|Overall Study|Lack of Efficacy|0|||
125313903|NCT00857285|450777446|FG001|Overall Study|Lack of Efficacy|2|||
124984859|NCT03592745|449571277|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
124984860|NCT05017103|449571278|FG000|Overall Study|Death|2|||
124984861|NCT01081665|449571279|FG000|Overall Study|Death|41|||
124984862|NCT01081665|449571279|FG000|Overall Study|Lost to Follow-up|18|||
124984863|NCT01081665|449571279|FG000|Overall Study|Withdrawal by Subject|17|||
124984864|NCT01081665|449571279|FG000|Overall Study|Change of dialysis unit|10|||
124984865|NCT01081665|449571279|FG000|Overall Study|Regulation of iPTH|5|||
124984866|NCT01081665|449571279|FG000|Overall Study|Change in renal replacement therapy|2|||
124984867|NCT01081665|449571279|FG000|Overall Study|Adverse Event|1|||
124984868|NCT01081665|449571279|FG000|Overall Study|Lack of Efficacy|1|||
124984869|NCT03406078|449571285|FG000|Overall Study|Death|1|||
124984870|NCT03406078|449571286|FG001|Overall Study|Death|0|||
124984871|NCT03406078|449571285|FG000|Overall Study|Lost to Follow-up|0|||
124984872|NCT03406078|449571286|FG001|Overall Study|Lost to Follow-up|1|||
124984873|NCT03406078|449571285|FG000|Overall Study|Withdrawal by Subject|5|||
124984874|NCT03406078|449571286|FG001|Overall Study|Withdrawal by Subject|2|||
124984875|NCT01413503|449571287|FG000|Overall Study|Lost to Follow-up|1|||
124984876|NCT03117998|449571292|FG000|Overall Study|Adverse Event|1|||
125313904|NCT00857285|450777445|FG000|Overall Study|Protocol Violation|3|||
125313905|NCT00857285|450777446|FG001|Overall Study|Protocol Violation|1|||
125313906|NCT00857285|450777445|FG000|Overall Study|Withdrawal by Subject|4|||
125313907|NCT00857285|450777446|FG001|Overall Study|Withdrawal by Subject|0|||
125313908|NCT00857285|450777445|FG000|Overall Study|Randomization criteria not met|1|||
125313909|NCT00857285|450777446|FG001|Overall Study|Randomization criteria not met|1|||
125313910|NCT01987102|450777450|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
125313911|NCT01987102|450777451|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
125313912|NCT01987102|450777450|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
125313913|NCT01987102|450777451|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
125313914|NCT01987102|450777450|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
125313915|NCT01987102|450777451|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
125313916|NCT01987102|450777450|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
125313917|NCT01987102|450777451|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
125313918|NCT01987102|450777450|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
125313919|NCT01987102|450777451|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
125313920|NCT01987102|450777450|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
125313921|NCT01987102|450777451|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
125313922|NCT01236521|450777452|FG000|Overall Study|Withdrawal by Subject|12|||
125313923|NCT01236521|450777453|FG001|Overall Study|Withdrawal by Subject|17|||
124984877|NCT03117998|449571293|FG001|Overall Study|Adverse Event|0|||
124984878|NCT03117998|449571294|FG002|Overall Study|Adverse Event|0|||
124984879|NCT03117998|449571295|FG003|Overall Study|Adverse Event|0|||
124984880|NCT03117998|449571296|FG004|Overall Study|Adverse Event|0|||
124984881|NCT03117998|449571297|FG005|Overall Study|Adverse Event|0|||
124984882|NCT03117998|449571292|FG000|Overall Study|Withdrawal by Subject|0|||
124984883|NCT03117998|449571293|FG001|Overall Study|Withdrawal by Subject|0|||
124984884|NCT03117998|449571294|FG002|Overall Study|Withdrawal by Subject|2|||
124984885|NCT03117998|449571295|FG003|Overall Study|Withdrawal by Subject|3|||
124984886|NCT03117998|449571296|FG004|Overall Study|Withdrawal by Subject|3|||
124984887|NCT03117998|449571297|FG005|Overall Study|Withdrawal by Subject|0|||
124984888|NCT03117998|449571292|FG000|Overall Study|Physician Decision|0|||
124984889|NCT03117998|449571293|FG001|Overall Study|Physician Decision|1|||
124984890|NCT03117998|449571294|FG002|Overall Study|Physician Decision|1|||
124984891|NCT03117998|449571295|FG003|Overall Study|Physician Decision|0|||
124984892|NCT03117998|449571296|FG004|Overall Study|Physician Decision|0|||
124984893|NCT03117998|449571297|FG005|Overall Study|Physician Decision|0|||
124984894|NCT03117998|449571292|FG000|Overall Study|Lost to Follow-up|0|||
124984895|NCT03117998|449571293|FG001|Overall Study|Lost to Follow-up|0|||
124984896|NCT03117998|449571294|FG002|Overall Study|Lost to Follow-up|0|||
124984897|NCT03117998|449571295|FG003|Overall Study|Lost to Follow-up|1|||
124984898|NCT03117998|449571296|FG004|Overall Study|Lost to Follow-up|4|||
124984899|NCT03117998|449571297|FG005|Overall Study|Lost to Follow-up|0|||
124984900|NCT03117998|449571292|FG000|Overall Study|Subject noncompliance|0|||
124984901|NCT03117998|449571293|FG001|Overall Study|Subject noncompliance|0|||
124984902|NCT03117998|449571294|FG002|Overall Study|Subject noncompliance|1|||
124984903|NCT03117998|449571295|FG003|Overall Study|Subject noncompliance|0|||
124984904|NCT03117998|449571296|FG004|Overall Study|Subject noncompliance|0|||
124984905|NCT03117998|449571297|FG005|Overall Study|Subject noncompliance|2|||
124984906|NCT03117998|449571292|FG000|Overall Study|Protocol Violation|0|||
124984907|NCT03117998|449571293|FG001|Overall Study|Protocol Violation|0|||
124984908|NCT03117998|449571294|FG002|Overall Study|Protocol Violation|0|||
124984909|NCT03117998|449571295|FG003|Overall Study|Protocol Violation|0|||
124984910|NCT03117998|449571296|FG004|Overall Study|Protocol Violation|0|||
124984911|NCT03117998|449571297|FG005|Overall Study|Protocol Violation|1|||
124984912|NCT00293059|449571298|FG000|Overall Study|Adverse Event|12|||
124984913|NCT00293059|449571299|FG001|Overall Study|Adverse Event|4|||
124984914|NCT00293059|449571298|FG000|Overall Study|Lack of Efficacy|2|||
124984915|NCT00293059|449571299|FG001|Overall Study|Lack of Efficacy|0|||
125313924|NCT01236521|450777452|FG000|Overall Study|Death|2|||
125313925|NCT01236521|450777453|FG001|Overall Study|Death|1|||
124984916|NCT00293059|449571298|FG000|Overall Study|Lost to Follow-up|2|||
124984917|NCT00293059|449571299|FG001|Overall Study|Lost to Follow-up|3|||
124984918|NCT00293059|449571298|FG000|Overall Study|Pregnancy|1|||
124984919|NCT00293059|449571299|FG001|Overall Study|Pregnancy|1|||
124984920|NCT00293059|449571298|FG000|Overall Study|Protocol Violation|2|||
124984921|NCT00293059|449571299|FG001|Overall Study|Protocol Violation|0|||
124984922|NCT00293059|449571298|FG000|Overall Study|Withdrawal by Subject|11|||
124984923|NCT00293059|449571299|FG001|Overall Study|Withdrawal by Subject|5|||
124984924|NCT00293059|449571298|FG000|Overall Study|Participant moved out of state|1|||
124984925|NCT00293059|449571299|FG001|Overall Study|Participant moved out of state|0|||
124984926|NCT00293059|449571298|FG000|Overall Study|Participant stopped study drug|1|||
124984927|NCT00293059|449571299|FG001|Overall Study|Participant stopped study drug|0|||
124984928|NCT00293059|449571298|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
124984929|NCT00293059|449571299|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
124984930|NCT00293059|449571298|FG000|Overall Study|missing|3|||
124984931|NCT00293059|449571299|FG001|Overall Study|missing|5|||
124984932|NCT00350103|449571300|FG000|Overall Study|Adverse Event|12|||
124984933|NCT00350103|449571301|FG001|Overall Study|Adverse Event|29|||
124984934|NCT00350103|449571302|FG002|Overall Study|Adverse Event|17|||
124984935|NCT00350103|449571300|FG000|Overall Study|Lack of Efficacy|5|||
124984936|NCT00350103|449571301|FG001|Overall Study|Lack of Efficacy|1|||
124984937|NCT00350103|449571302|FG002|Overall Study|Lack of Efficacy|3|||
124984938|NCT00350103|449571300|FG000|Overall Study|Withdrawal by Subject|6|||
124984939|NCT00350103|449571301|FG001|Overall Study|Withdrawal by Subject|6|||
124984940|NCT00350103|449571302|FG002|Overall Study|Withdrawal by Subject|8|||
124984941|NCT00350103|449571300|FG000|Overall Study|Protocol Violation|0|||
124984942|NCT00350103|449571301|FG001|Overall Study|Protocol Violation|0|||
124984943|NCT00350103|449571302|FG002|Overall Study|Protocol Violation|1|||
124984944|NCT00350103|449571300|FG000|Overall Study|Unsatisfactory Compliance|2|||
124984945|NCT00350103|449571301|FG001|Overall Study|Unsatisfactory Compliance|2|||
124984946|NCT00350103|449571302|FG002|Overall Study|Unsatisfactory Compliance|1|||
124984947|NCT00350103|449571300|FG000|Overall Study|Investigator´s decision|1|||
124984948|NCT00350103|449571301|FG001|Overall Study|Investigator´s decision|1|||
124984949|NCT00350103|449571302|FG002|Overall Study|Investigator´s decision|0|||
124984950|NCT00350103|449571300|FG000|Overall Study|Exclusion criteria met|0|||
124984951|NCT00350103|449571301|FG001|Overall Study|Exclusion criteria met|0|||
124984952|NCT00350103|449571302|FG002|Overall Study|Exclusion criteria met|1|||
124984953|NCT00350103|449571300|FG000|Overall Study|Patient relocated|0|||
124984954|NCT00350103|449571301|FG001|Overall Study|Patient relocated|0|||
124984955|NCT00350103|449571302|FG002|Overall Study|Patient relocated|1|||
124984956|NCT00350103|449571300|FG000|Overall Study|Need for prohibited medication|1|||
124984957|NCT00350103|449571301|FG001|Overall Study|Need for prohibited medication|0|||
124984958|NCT00350103|449571302|FG002|Overall Study|Need for prohibited medication|0|||
124984959|NCT00350103|449571300|FG000|Overall Study|Personal reasons|0|||
124984960|NCT00350103|449571301|FG001|Overall Study|Personal reasons|0|||
124984961|NCT00350103|449571302|FG002|Overall Study|Personal reasons|1|||
124984962|NCT00350103|449571300|FG000|Overall Study|Patient stopped feeling pain|1|||
124984963|NCT00350103|449571301|FG001|Overall Study|Patient stopped feeling pain|0|||
124984964|NCT00350103|449571302|FG002|Overall Study|Patient stopped feeling pain|0|||
124984965|NCT00350103|449571300|FG000|Overall Study|PR greater than 250ms|0|||
124984966|NCT00350103|449571301|FG001|Overall Study|PR greater than 250ms|0|||
124984967|NCT00350103|449571302|FG002|Overall Study|PR greater than 250ms|1|||
124984968|NCT00350103|449571300|FG000|Overall Study|Wrong calculation of QT interval|0|||
124984969|NCT00350103|449571301|FG001|Overall Study|Wrong calculation of QT interval|0|||
124984970|NCT00350103|449571302|FG002|Overall Study|Wrong calculation of QT interval|1|||
124984971|NCT00350103|449571300|FG000|Overall Study|Sponsor mistake|1|||
124984972|NCT00350103|449571301|FG001|Overall Study|Sponsor mistake|0|||
124984973|NCT00350103|449571302|FG002|Overall Study|Sponsor mistake|0|||
124984974|NCT00350103|449571300|FG000|Overall Study|Randomization mistake|0|||
124984975|NCT00350103|449571301|FG001|Overall Study|Randomization mistake|1|||
124984976|NCT00350103|449571302|FG002|Overall Study|Randomization mistake|1|||
124984977|NCT00350103|449571300|FG000|Overall Study|Sponsor´s decision|0|||
124984978|NCT00350103|449571301|FG001|Overall Study|Sponsor´s decision|1|||
124984979|NCT00350103|449571302|FG002|Overall Study|Sponsor´s decision|0|||
124984980|NCT00350103|449571300|FG000|Overall Study|Lost, Reason unknown|1|||
124984981|NCT00350103|449571301|FG001|Overall Study|Lost, Reason unknown|1|||
124984982|NCT00350103|449571302|FG002|Overall Study|Lost, Reason unknown|0|||
124984983|NCT00438672|449571303|FG000|Overall Study|Lost to Follow-up|7|||
124984984|NCT00438672|449571304|FG001|Overall Study|Lost to Follow-up|9|||
124984985|NCT04828837|449571305|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
124984986|NCT04828837|449571306|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
124984987|NCT04828837|449571305|FG000|Overall Study|Lost to Follow-up|2|||
124984988|NCT04828837|449571306|FG001|Overall Study|Lost to Follow-up|6|||
124984989|NCT04828837|449571305|FG000|Overall Study|Lack of Efficacy|1|||
124984990|NCT04828837|449571306|FG001|Overall Study|Lack of Efficacy|0|||
124984991|NCT04828837|449571305|FG000|Overall Study|Admitted due to pneumothorax.|1|||
124984992|NCT04828837|449571306|FG001|Overall Study|Admitted due to pneumothorax.|0|||
124984993|NCT04828837|449571305|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
124984994|NCT04828837|449571306|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
124984995|NCT00320528|449571307|FG000|Study Period II|Adverse Event|3|||
124984996|NCT00320528|449571308|FG001|Study Period II|Adverse Event|4|||
124984997|NCT00320528|449571309|FG002|Study Period II|Adverse Event|8|||
124984998|NCT00320528|449571307|FG000|Study Period II|Parent/Caregiver Decision|8|||
124984999|NCT00320528|449571308|FG001|Study Period II|Parent/Caregiver Decision|3|||
124985000|NCT00320528|449571309|FG002|Study Period II|Parent/Caregiver Decision|11|||
124985001|NCT00320528|449571307|FG000|Study Period II|Withdrawal by Subject|0|||
125313926|NCT01236521|450777452|FG000|Overall Study|Lost to Follow-up|9|||
125313927|NCT01236521|450777453|FG001|Overall Study|Lost to Follow-up|7|||
125313928|NCT02252146|450779319|FG000|Overall Study|Lack of Efficacy|4|||
125313929|NCT02252146|450779319|FG000|Overall Study|Entered hospice care|1|||
125313930|NCT02252146|450779319|FG000|Overall Study|Inability to travel to study site|1|||
124985002|NCT00320528|449571308|FG001|Study Period II|Withdrawal by Subject|1|||
124985003|NCT00320528|449571309|FG002|Study Period II|Withdrawal by Subject|1|||
124985004|NCT00320528|449571307|FG000|Study Period II|Entry Criteria Exclusion|0|||
124985005|NCT00320528|449571308|FG001|Study Period II|Entry Criteria Exclusion|2|||
124985006|NCT00320528|449571309|FG002|Study Period II|Entry Criteria Exclusion|2|||
124985007|NCT00320528|449571307|FG000|Study Period III|Adverse Event|1|||
124985008|NCT00320528|449571308|FG001|Study Period III|Adverse Event|0|||
124985009|NCT00320528|449571309|FG002|Study Period III|Adverse Event|0|||
124985010|NCT00320528|449571307|FG000|Study Period III|Lost to Follow-up|1|||
124985011|NCT00320528|449571308|FG001|Study Period III|Lost to Follow-up|0|||
124985012|NCT00320528|449571309|FG002|Study Period III|Lost to Follow-up|0|||
124985013|NCT00320528|449571307|FG000|Study Period III|Withdrawal by Subject|1|||
124985014|NCT00320528|449571308|FG001|Study Period III|Withdrawal by Subject|1|||
124985015|NCT00320528|449571309|FG002|Study Period III|Withdrawal by Subject|2|||
124985016|NCT00320528|449571307|FG000|Study Period III|Lack of Efficacy|2|||
124985017|NCT00320528|449571308|FG001|Study Period III|Lack of Efficacy|0|||
124985018|NCT00320528|449571309|FG002|Study Period III|Lack of Efficacy|0|||
124985019|NCT00320528|449571307|FG000|Study Period III|Parent/Caregiver Decision|14|||
124985020|NCT00320528|449571308|FG001|Study Period III|Parent/Caregiver Decision|3|||
124985021|NCT00320528|449571309|FG002|Study Period III|Parent/Caregiver Decision|11|||
124985022|NCT00320528|449571307|FG000|Study Period III|Protocol Violation|0|||
124985023|NCT00320528|449571308|FG001|Study Period III|Protocol Violation|1|||
124985024|NCT00320528|449571309|FG002|Study Period III|Protocol Violation|0|||
124985025|NCT00320528|449571307|FG000|Study Period III|Physician Decision|0|||
124985026|NCT00320528|449571308|FG001|Study Period III|Physician Decision|1|||
124985027|NCT00320528|449571309|FG002|Study Period III|Physician Decision|2|||
124985028|NCT00320528|449571307|FG000|Study Period III|Sponsor Decision|0|||
124985029|NCT00320528|449571308|FG001|Study Period III|Sponsor Decision|0|||
124985030|NCT00320528|449571309|FG002|Study Period III|Sponsor Decision|1|||
124985031|NCT00320528|449571307|FG000|Study Period III|Atomoxetine Commercially Available|68|||
124985032|NCT00320528|449571308|FG001|Study Period III|Atomoxetine Commercially Available|25|||
124985033|NCT00320528|449571309|FG002|Study Period III|Atomoxetine Commercially Available|90|||
124985034|NCT00545753|449571310|FG000|Overall Study|Withdrawal by Subject|0|||
124985035|NCT00545753|449571311|FG001|Overall Study|Withdrawal by Subject|1|||
124985036|NCT00545753|449571312|FG002|Overall Study|Withdrawal by Subject|10|||
124985037|NCT00545753|449571310|FG000|Overall Study|Lost to Follow-up|13|||
124985038|NCT00545753|449571311|FG001|Overall Study|Lost to Follow-up|3|||
124985039|NCT00545753|449571312|FG002|Overall Study|Lost to Follow-up|12|||
124985040|NCT00545753|449571310|FG000|Overall Study|Protocol Violation|3|||
124985041|NCT00545753|449571311|FG001|Overall Study|Protocol Violation|1|||
124985042|NCT00545753|449571312|FG002|Overall Study|Protocol Violation|4|||
124985043|NCT05453201|449571313|FG000|Overall Study|Withdrawal by Subject|1|||
124985044|NCT04577001|449571316|FG000|Overall Study|Subject became ineligible|0|||
124985045|NCT04577001|449571317|FG001|Overall Study|Subject became ineligible|1|||
124985046|NCT03465904|449571321|FG000|Overall Study|Withdrawal by Subject|9|||
124985047|NCT03465904|449571322|FG001|Overall Study|Withdrawal by Subject|5|||
124985048|NCT03465904|449571321|FG000|Overall Study|Lost to Follow-up|11|||
124985049|NCT03465904|449571322|FG001|Overall Study|Lost to Follow-up|9|||
124985050|NCT03465904|449571321|FG000|Overall Study|Protocol Violation|20|||
124985051|NCT03465904|449571322|FG001|Overall Study|Protocol Violation|15|||
124985052|NCT05618912|449571323|FG000|Overall Study|Lost to Follow-up|14|||
124985053|NCT05618912|449571324|FG001|Overall Study|Lost to Follow-up|19|||
124985054|NCT05110690|449571325|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
124985055|NCT05110690|449571325|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
124985056|NCT05110690|449571325|FG000|Completion of Intervention|Lost to Follow-up|1|||
124985057|NCT05110690|449571325|FG000|Completion of Intervention|Death|1|||
124985058|NCT05110690|449571325|FG000|Completion of Intervention|Withdrawal by Subject|2|||
124985059|NCT01022112|449571328|FG000|Overall Study|Adverse Event|1|||
124985060|NCT01022112|449571329|FG001|Overall Study|Adverse Event|2|||
124985061|NCT01022112|449571330|FG002|Overall Study|Adverse Event|0|||
124985062|NCT01022112|449571331|FG003|Overall Study|Adverse Event|1|||
124985063|NCT01022112|449571332|FG004|Overall Study|Adverse Event|0|||
124985064|NCT01022112|449571328|FG000|Overall Study|Lack of Efficacy|1|||
124985065|NCT01022112|449571329|FG001|Overall Study|Lack of Efficacy|0|||
124985066|NCT01022112|449571330|FG002|Overall Study|Lack of Efficacy|0|||
124985067|NCT01022112|449571331|FG003|Overall Study|Lack of Efficacy|0|||
124985068|NCT01022112|449571332|FG004|Overall Study|Lack of Efficacy|1|||
125313931|NCT00531284|450779320|FG000|Overall Study|Progressive Disease|1|||
125313932|NCT00531284|450779321|FG001|Overall Study|Progressive Disease|3|||
124985069|NCT01022112|449571328|FG000|Overall Study|Physician Decision|0|||
124985070|NCT01022112|449571329|FG001|Overall Study|Physician Decision|0|||
124985071|NCT01022112|449571330|FG002|Overall Study|Physician Decision|1|||
124985072|NCT01022112|449571331|FG003|Overall Study|Physician Decision|0|||
124985073|NCT01022112|449571332|FG004|Overall Study|Physician Decision|1|||
124985074|NCT01022112|449571328|FG000|Overall Study|Withdrawal by Subject|0|||
124985075|NCT01022112|449571329|FG001|Overall Study|Withdrawal by Subject|1|||
124985076|NCT01022112|449571330|FG002|Overall Study|Withdrawal by Subject|2|||
124985077|NCT01022112|449571331|FG003|Overall Study|Withdrawal by Subject|2|||
124985078|NCT01022112|449571332|FG004|Overall Study|Withdrawal by Subject|1|||
124985079|NCT01022112|449571328|FG000|Overall Study|Fasting plasma glucose level increased|1|||
124985080|NCT01022112|449571329|FG001|Overall Study|Fasting plasma glucose level increased|0|||
124985081|NCT01022112|449571330|FG002|Overall Study|Fasting plasma glucose level increased|0|||
124985082|NCT01022112|449571331|FG003|Overall Study|Fasting plasma glucose level increased|0|||
124985083|NCT01022112|449571332|FG004|Overall Study|Fasting plasma glucose level increased|7|||
124985084|NCT00925353|449571333|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
124985085|NCT01302067|449573115|FG000|Overall Study|Death|0|||
124985086|NCT01302067|449573116|FG001|Overall Study|Death|0|||
124985087|NCT01302067|449573117|FG002|Overall Study|Death|1|||
124985088|NCT01302067|449573115|FG000|Overall Study|Physician Decision|9|||
124985089|NCT01302067|449573116|FG001|Overall Study|Physician Decision|5|||
124985090|NCT01302067|449573117|FG002|Overall Study|Physician Decision|14|||
124985091|NCT01302067|449573115|FG000|Overall Study|Lack of Efficacy|8|||
124985092|NCT01302067|449573116|FG001|Overall Study|Lack of Efficacy|4|||
124985093|NCT01302067|449573117|FG002|Overall Study|Lack of Efficacy|2|||
124985094|NCT01302067|449573115|FG000|Overall Study|Lost to Follow-up|9|||
124985095|NCT01302067|449573116|FG001|Overall Study|Lost to Follow-up|4|||
124985096|NCT01302067|449573117|FG002|Overall Study|Lost to Follow-up|15|||
124985097|NCT01302067|449573115|FG000|Overall Study|Withdrawal by Subject|13|||
124985098|NCT01302067|449573116|FG001|Overall Study|Withdrawal by Subject|6|||
124985099|NCT01302067|449573117|FG002|Overall Study|Withdrawal by Subject|10|||
124985100|NCT01302067|449573115|FG000|Overall Study|Other|1|||
124985101|NCT01302067|449573116|FG001|Overall Study|Other|1|||
124985102|NCT01302067|449573117|FG002|Overall Study|Other|3|||
124985103|NCT01302067|449573115|FG000|Overall Study|Protocol Violation|11|||
124985104|NCT01302067|449573116|FG001|Overall Study|Protocol Violation|0|||
124985105|NCT01302067|449573117|FG002|Overall Study|Protocol Violation|8|||
124985106|NCT01302067|449573115|FG000|Overall Study|Adverse Event|27|||
124985107|NCT01302067|449573116|FG001|Overall Study|Adverse Event|14|||
124985108|NCT01302067|449573117|FG002|Overall Study|Adverse Event|45|||
124985109|NCT02738203|449573119|FG000|Overall Study|Failed IUD Insertion|2|||
124985110|NCT02738203|449573120|FG001|Overall Study|Failed IUD Insertion|2|||
124985111|NCT02738203|449573119|FG000|Overall Study|Protocol Violation|0|||
124985112|NCT02738203|449573120|FG001|Overall Study|Protocol Violation|1|||
124985113|NCT03241927|449573121|FG000|Overall Study|study terminated|1|||
124985114|NCT03241927|449573122|FG001|Overall Study|study terminated|0|||
124985115|NCT01198756|449573123|FG000|Overall Study|Adverse Event|0|||
124985116|NCT01198756|449573124|FG001|Overall Study|Adverse Event|0|||
124985117|NCT01198756|449573125|FG002|Overall Study|Adverse Event|0|||
124985118|NCT01198756|449573126|FG003|Overall Study|Adverse Event|1|||
124985119|NCT01198756|449573123|FG000|Overall Study|Protocol Violation|0|||
124985120|NCT01198756|449573124|FG001|Overall Study|Protocol Violation|0|||
124985121|NCT01198756|449573125|FG002|Overall Study|Protocol Violation|0|||
124985122|NCT01198756|449573126|FG003|Overall Study|Protocol Violation|2|||
124985123|NCT01198756|449573123|FG000|Overall Study|Withdrawal by Subject|9|||
124985124|NCT01198756|449573124|FG001|Overall Study|Withdrawal by Subject|4|||
124985125|NCT01198756|449573125|FG002|Overall Study|Withdrawal by Subject|7|||
124985126|NCT01198756|449573126|FG003|Overall Study|Withdrawal by Subject|5|||
124985127|NCT01198756|449573123|FG000|Overall Study|Lost to Follow-up|29|||
124985128|NCT01198756|449573124|FG001|Overall Study|Lost to Follow-up|36|||
124985129|NCT01198756|449573125|FG002|Overall Study|Lost to Follow-up|23|||
124985130|NCT01198756|449573126|FG003|Overall Study|Lost to Follow-up|18|||
124985131|NCT01290315|449573128|FG000|Overall Study|Adverse Event|0|||
124985132|NCT01290315|449573129|FG001|Overall Study|Adverse Event|0|||
124985133|NCT01290315|449573130|FG002|Overall Study|Adverse Event|0|||
124985134|NCT01290315|449573131|FG003|Overall Study|Adverse Event|3|||
124985135|NCT01290315|449573128|FG000|Overall Study|Selection criteria/compliance|2|||
124985136|NCT01290315|449573129|FG001|Overall Study|Selection criteria/compliance|1|||
124985137|NCT01290315|449573130|FG002|Overall Study|Selection criteria/compliance|0|||
124985138|NCT01290315|449573131|FG003|Overall Study|Selection criteria/compliance|2|||
124985139|NCT01290315|449573128|FG000|Overall Study|Lost to Follow-up|0|||
124985140|NCT01290315|449573129|FG001|Overall Study|Lost to Follow-up|1|||
124985141|NCT01290315|449573130|FG002|Overall Study|Lost to Follow-up|0|||
124985142|NCT01290315|449573131|FG003|Overall Study|Lost to Follow-up|0|||
124985143|NCT01290315|449573128|FG000|Overall Study|Withdrawal by Subject|1|||
124985144|NCT01290315|449573129|FG001|Overall Study|Withdrawal by Subject|1|||
124985145|NCT01290315|449573130|FG002|Overall Study|Withdrawal by Subject|0|||
124985146|NCT01290315|449573131|FG003|Overall Study|Withdrawal by Subject|0|||
125210502|NCT01066793|450395577|FG004|Overall Study|Treatment Stopped|0|||
124985147|NCT00591721|449573132|FG000|Overall Study|Withdrawal by Subject|10|||
125313933|NCT00531284|450779322|FG002|Overall Study|Progressive Disease|5|||
125313934|NCT00531284|450779323|FG003|Overall Study|Progressive Disease|42|||
125313935|NCT00531284|450779324|FG004|Overall Study|Progressive Disease|4|||
125313936|NCT00531284|450779325|FG005|Overall Study|Progressive Disease|4|||
125313937|NCT00531284|450779326|FG006|Overall Study|Progressive Disease|3|||
125313938|NCT00531284|450779327|FG007|Overall Study|Progressive Disease|8|||
125313939|NCT00531284|450779328|FG008|Overall Study|Progressive Disease|6|||
125313940|NCT00531284|450779329|FG009|Overall Study|Progressive Disease|3|||
125313941|NCT00531284|450779330|FG010|Overall Study|Progressive Disease|3|||
125313942|NCT00531284|450779331|FG011|Overall Study|Progressive Disease|14|||
125313943|NCT00531284|450779332|FG012|Overall Study|Progressive Disease|2|||
125313944|NCT00531284|450779333|FG013|Overall Study|Progressive Disease|1|||
125313945|NCT00531284|450779334|FG014|Overall Study|Progressive Disease|2|||
125313946|NCT00531284|450779335|FG015|Overall Study|Progressive Disease|11|||
125313947|NCT00531284|450779336|FG016|Overall Study|Progressive Disease|5|||
125313948|NCT00531284|450779320|FG000|Overall Study|Adverse Event|0|||
125313949|NCT00531284|450779321|FG001|Overall Study|Adverse Event|1|||
125313950|NCT00531284|450779322|FG002|Overall Study|Adverse Event|1|||
125313951|NCT00531284|450779323|FG003|Overall Study|Adverse Event|7|||
125313952|NCT00531284|450779324|FG004|Overall Study|Adverse Event|0|||
125313953|NCT00531284|450779325|FG005|Overall Study|Adverse Event|2|||
125313954|NCT00531284|450779326|FG006|Overall Study|Adverse Event|3|||
125313955|NCT00531284|450779327|FG007|Overall Study|Adverse Event|2|||
125313956|NCT00531284|450779328|FG008|Overall Study|Adverse Event|3|||
125313957|NCT00531284|450779329|FG009|Overall Study|Adverse Event|0|||
125313958|NCT00531284|450779330|FG010|Overall Study|Adverse Event|0|||
125313959|NCT00531284|450779331|FG011|Overall Study|Adverse Event|5|||
125313960|NCT00531284|450779332|FG012|Overall Study|Adverse Event|0|||
125313961|NCT00531284|450779333|FG013|Overall Study|Adverse Event|1|||
125313962|NCT00531284|450779334|FG014|Overall Study|Adverse Event|1|||
125313963|NCT00531284|450779335|FG015|Overall Study|Adverse Event|0|||
125313964|NCT00531284|450779336|FG016|Overall Study|Adverse Event|2|||
125313965|NCT00531284|450779320|FG000|Overall Study|Withdrawal by Subject|1|||
125313966|NCT00531284|450779321|FG001|Overall Study|Withdrawal by Subject|0|||
125313967|NCT00531284|450779322|FG002|Overall Study|Withdrawal by Subject|0|||
125313968|NCT00531284|450779323|FG003|Overall Study|Withdrawal by Subject|4|||
125313969|NCT00531284|450779324|FG004|Overall Study|Withdrawal by Subject|0|||
125313970|NCT00531284|450779325|FG005|Overall Study|Withdrawal by Subject|0|||
125313971|NCT00531284|450779326|FG006|Overall Study|Withdrawal by Subject|0|||
125313972|NCT00531284|450779327|FG007|Overall Study|Withdrawal by Subject|0|||
125313973|NCT00531284|450779328|FG008|Overall Study|Withdrawal by Subject|0|||
125313974|NCT00531284|450779329|FG009|Overall Study|Withdrawal by Subject|0|||
125313975|NCT00531284|450779330|FG010|Overall Study|Withdrawal by Subject|0|||
125313976|NCT00531284|450779331|FG011|Overall Study|Withdrawal by Subject|3|||
125313977|NCT00531284|450779332|FG012|Overall Study|Withdrawal by Subject|0|||
125313978|NCT00531284|450779333|FG013|Overall Study|Withdrawal by Subject|1|||
125313979|NCT00531284|450779334|FG014|Overall Study|Withdrawal by Subject|0|||
125313980|NCT00531284|450779335|FG015|Overall Study|Withdrawal by Subject|1|||
125313981|NCT00531284|450779336|FG016|Overall Study|Withdrawal by Subject|1|||
125313982|NCT00531284|450779320|FG000|Overall Study|Other|1|||
125313983|NCT00531284|450779321|FG001|Overall Study|Other|0|||
125313984|NCT00531284|450779322|FG002|Overall Study|Other|0|||
125313985|NCT00531284|450779323|FG003|Overall Study|Other|10|||
125313986|NCT00531284|450779324|FG004|Overall Study|Other|2|||
125313987|NCT00531284|450779325|FG005|Overall Study|Other|1|||
125313988|NCT00531284|450779326|FG006|Overall Study|Other|0|||
125313989|NCT00531284|450779327|FG007|Overall Study|Other|0|||
125313990|NCT00531284|450779328|FG008|Overall Study|Other|2|||
125313991|NCT00531284|450779329|FG009|Overall Study|Other|1|||
125313992|NCT00531284|450779330|FG010|Overall Study|Other|0|||
124985148|NCT00591721|449573133|FG001|Overall Study|Withdrawal by Subject|10|||
125313993|NCT00531284|450779331|FG011|Overall Study|Other|2|||
125313994|NCT00531284|450779332|FG012|Overall Study|Other|0|||
125313995|NCT00531284|450779333|FG013|Overall Study|Other|0|||
125313996|NCT00531284|450779334|FG014|Overall Study|Other|1|||
124985149|NCT00591721|449573132|FG000|Overall Study|Lost to Follow-up|1|||
124985150|NCT00591721|449573133|FG001|Overall Study|Lost to Follow-up|4|||
124985151|NCT00591721|449573132|FG000|Overall Study|Intervention not received|10|||
125313997|NCT00531284|450779335|FG015|Overall Study|Other|0|||
125313998|NCT00531284|450779336|FG016|Overall Study|Other|0|||
125313999|NCT02219464|450779338|FG000|Overall Study|Withdrawal by Subject|1|||
125314000|NCT02219464|450779339|FG001|Overall Study|Withdrawal by Subject|0|||
125314001|NCT02219464|450779338|FG000|Overall Study|case cancelled|1|||
125314002|NCT02219464|450779339|FG001|Overall Study|case cancelled|0|||
125314003|NCT02219464|450779338|FG000|Overall Study|catheter malfunction|1|||
125314004|NCT02219464|450779339|FG001|Overall Study|catheter malfunction|0|||
125314005|NCT02544321|450779351|FG000|Overall Study|Withdrawal by Subject|1|||
125314006|NCT02544321|450779352|FG001|Overall Study|Withdrawal by Subject|2|||
125314007|NCT02544321|450779351|FG000|Overall Study|Adverse Event|1|||
125314008|NCT02544321|450779352|FG001|Overall Study|Adverse Event|1|||
125314009|NCT02544321|450779351|FG000|Overall Study|Protocol Violation|0|||
124985152|NCT00591721|449573133|FG001|Overall Study|Intervention not received|8|||
124985153|NCT00423943|449573134|FG000|Overall Study|Withdrawal by Subject|3|||
124985154|NCT00423943|449573135|FG001|Overall Study|Withdrawal by Subject|1|||
124985155|NCT00901186|449573140|FG000|Overall Study|Lack of Efficacy|0|||
124985156|NCT00901186|449573141|FG001|Overall Study|Lack of Efficacy|1|||
124985157|NCT00901186|449573140|FG000|Overall Study|Abnormal laboratory values|0|||
124985158|NCT00901186|449573141|FG001|Overall Study|Abnormal laboratory values|1|||
124985159|NCT00901186|449573140|FG000|Overall Study|Lost to Follow-up|2|||
124985160|NCT00901186|449573141|FG001|Overall Study|Lost to Follow-up|0|||
124985161|NCT00901186|449573140|FG000|Overall Study|Adverse Event|2|||
124985162|NCT00901186|449573141|FG001|Overall Study|Adverse Event|4|||
124985163|NCT00901186|449573140|FG000|Overall Study|Administration problems|0|||
124985164|NCT00901186|449573141|FG001|Overall Study|Administration problems|1|||
124985165|NCT00901186|449573140|FG000|Overall Study|Protocol deviations|5|||
124985166|NCT00901186|449573141|FG001|Overall Study|Protocol deviations|4|||
124985167|NCT02383056|449573144|FG000|Overall Study|Adverse Event|1|||
124985168|NCT02383056|449573145|FG001|Overall Study|Adverse Event|0|||
124985169|NCT02383056|449573144|FG000|Overall Study|Lost to Follow-up|0|||
124985170|NCT02383056|449573145|FG001|Overall Study|Lost to Follow-up|2|||
124985171|NCT00581555|449573146|FG000|Overall Study|Adverse Event|4|||
124985172|NCT00581555|449573147|FG001|Overall Study|Adverse Event|3|||
124985173|NCT00581555|449573146|FG000|Overall Study|Physician Decision|3|||
124985174|NCT00581555|449573147|FG001|Overall Study|Physician Decision|2|||
124985175|NCT00581555|449573146|FG000|Overall Study|Withdrawal by Subject|18|||
124985176|NCT00581555|449573147|FG001|Overall Study|Withdrawal by Subject|9|||
124985177|NCT00581555|449573146|FG000|Overall Study|Lost to Follow-up|2|||
124985178|NCT00581555|449573147|FG001|Overall Study|Lost to Follow-up|2|||
124985179|NCT00581555|449573146|FG000|Overall Study|Other reasons|16|||
124985180|NCT00581555|449573147|FG001|Overall Study|Other reasons|4|||
125314010|NCT02544321|450779352|FG001|Overall Study|Protocol Violation|1|||
125314011|NCT01584232|450779353|FG000|Overall Study|Adverse Event|3|||
125314012|NCT01584232|450779354|FG001|Overall Study|Adverse Event|1|||
124985181|NCT03828747|449573148|FG000|Double-Blind Treatment Period|Adverse Event|6|||
124985182|NCT03828747|449573149|FG001|Double-Blind Treatment Period|Adverse Event|6|||
124985183|NCT03828747|449573148|FG000|Double-Blind Treatment Period|Death|1|||
124985184|NCT03828747|449573149|FG001|Double-Blind Treatment Period|Death|1|||
124985185|NCT03828747|449573148|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
124985186|NCT03828747|449573149|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
124985187|NCT03828747|449573148|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
124985188|NCT03828747|449573149|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
124985189|NCT03828747|449573148|FG000|Double-Blind Treatment Period|Physician Decision|1|||
124985190|NCT03828747|449573149|FG001|Double-Blind Treatment Period|Physician Decision|4|||
124985191|NCT03828747|449573148|FG000|Double-Blind Treatment Period|Various reasons|5|||
124985192|NCT03828747|449573149|FG001|Double-Blind Treatment Period|Various reasons|3|||
124985193|NCT03828747|449573148|FG000|Open-Label Extension|Adverse Event|9|||
124985194|NCT03828747|449573149|FG001|Open-Label Extension|Adverse Event|7|||
124985195|NCT03828747|449573148|FG000|Open-Label Extension|Death|0|||
124985196|NCT03828747|449573149|FG001|Open-Label Extension|Death|2|||
124985197|NCT03828747|449573148|FG000|Open-Label Extension|Lost to Follow-up|4|||
124985198|NCT03828747|449573149|FG001|Open-Label Extension|Lost to Follow-up|0|||
124985199|NCT03828747|449573148|FG000|Open-Label Extension|Withdrawal by Subject|31|||
124985200|NCT03828747|449573149|FG001|Open-Label Extension|Withdrawal by Subject|30|||
124985201|NCT03828747|449573148|FG000|Open-Label Extension|Various reasons|4|||
124985202|NCT03828747|449573149|FG001|Open-Label Extension|Various reasons|4|||
124985203|NCT03828747|449573148|FG000|Open-Label Extension|Physician Decision|6|||
124985204|NCT03828747|449573149|FG001|Open-Label Extension|Physician Decision|2|||
124985205|NCT05816330|449573150|FG000|Overall Study|Withdrawal by Subject|4|||
124985206|NCT05816330|449573151|FG001|Overall Study|Withdrawal by Subject|1|||
124985207|NCT03245151|449573152|FG000|Overall Study|Withdrawal by Subject|2|||
124985208|NCT03245151|449573153|FG001|Overall Study|Withdrawal by Subject|0|||
124985209|NCT03245151|449573154|FG002|Overall Study|Withdrawal by Subject|0|||
125314013|NCT01584232|450779353|FG000|Overall Study|Withdrawal by Subject|2|||
124985210|NCT03245151|449573155|FG003|Overall Study|Withdrawal by Subject|2|||
124985211|NCT03245151|449573156|FG004|Overall Study|Withdrawal by Subject|1|||
124985212|NCT03245151|449573152|FG000|Overall Study|Death|3|||
124985213|NCT03245151|449573153|FG001|Overall Study|Death|14|||
124985214|NCT03245151|449573154|FG002|Overall Study|Death|9|||
124985215|NCT03245151|449573155|FG003|Overall Study|Death|16|||
124985216|NCT03245151|449573156|FG004|Overall Study|Death|7|||
124985217|NCT03245151|449573152|FG000|Overall Study|Sponsor's decision|0|||
125314014|NCT01584232|450779354|FG001|Overall Study|Withdrawal by Subject|1|||
125314015|NCT01584232|450779353|FG000|Overall Study|Physician Decision|2|||
124985218|NCT03245151|449573153|FG001|Overall Study|Sponsor's decision|1|||
124985219|NCT03245151|449573154|FG002|Overall Study|Sponsor's decision|0|||
124985220|NCT03245151|449573155|FG003|Overall Study|Sponsor's decision|0|||
124985221|NCT03245151|449573156|FG004|Overall Study|Sponsor's decision|0|||
125314016|NCT01584232|450779354|FG001|Overall Study|Physician Decision|1|||
124985222|NCT03900416|449573157|FG000|Six Week Follow-up|Lost to Follow-up|1|||
124985223|NCT03900416|449573158|FG001|Six Week Follow-up|Lost to Follow-up|0|||
124985224|NCT03900416|449573157|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
124985225|NCT03900416|449573158|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
124985226|NCT03900416|449573157|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
124985227|NCT03900416|449573158|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
124985228|NCT03900416|449573157|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
124985229|NCT03900416|449573158|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
124985230|NCT03900416|449573157|FG000|Twelve Week Follow-up|Adverse Event|1|||
124985231|NCT03900416|449573158|FG001|Twelve Week Follow-up|Adverse Event|1|||
124985232|NCT03900416|449573157|FG000|Six Month Follow-up|Lost to Follow-up|4|||
124985233|NCT03900416|449573158|FG001|Six Month Follow-up|Lost to Follow-up|3|||
124985234|NCT03900416|449573157|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
124985235|NCT03900416|449573158|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
124985236|NCT02663518|449573166|FG000|Part 1: Phase 1a Escalation|Death|0|||
124985237|NCT02663518|449573167|FG001|Part 1: Phase 1a Escalation|Death|0|||
124985238|NCT02663518|449573168|FG002|Part 1: Phase 1a Escalation|Death|1|||
124985239|NCT02663518|449573169|FG003|Part 1: Phase 1a Escalation|Death|0|||
124985240|NCT02663518|449573170|FG004|Part 1: Phase 1a Escalation|Death|0|||
124985241|NCT02663518|449573171|FG005|Part 1: Phase 1a Escalation|Death|0|||
124985242|NCT02663518|449573172|FG006|Part 1: Phase 1a Escalation|Death|0|||
124985243|NCT02663518|449573173|FG007|Part 1: Phase 1a Escalation|Death|0|||
124985244|NCT02663518|449573174|FG008|Part 1: Phase 1a Escalation|Death|0|||
124985245|NCT02663518|449573175|FG009|Part 1: Phase 1a Escalation|Death|0|||
124985246|NCT02663518|449573176|FG010|Part 1: Phase 1a Escalation|Death|0|||
124985247|NCT02663518|449573177|FG011|Part 1: Phase 1a Escalation|Death|0|||
124985248|NCT02663518|449573178|FG012|Part 1: Phase 1a Escalation|Death|0|||
124985249|NCT02663518|449573179|FG013|Part 1: Phase 1a Escalation|Death|0|||
124985250|NCT02663518|449573166|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124985251|NCT02663518|449573167|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124985252|NCT02663518|449573168|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
124985253|NCT02663518|449573169|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124985254|NCT02663518|449573170|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124985255|NCT02663518|449573171|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124985256|NCT02663518|449573172|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124985257|NCT02663518|449573173|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124985258|NCT02663518|449573174|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124985259|NCT02663518|449573175|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124985260|NCT02663518|449573176|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124985261|NCT02663518|449573177|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124985262|NCT02663518|449573178|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124985263|NCT02663518|449573179|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124985264|NCT02663518|449573166|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
124985265|NCT02663518|449573167|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
124985266|NCT02663518|449573168|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
124985267|NCT02663518|449573169|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
124985268|NCT02663518|449573170|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
124985269|NCT02663518|449573171|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
124985270|NCT02663518|449573172|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
124985271|NCT02663518|449573173|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
124985272|NCT02663518|449573174|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
124985273|NCT02663518|449573175|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
124985274|NCT02663518|449573176|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
124985275|NCT02663518|449573177|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
124985276|NCT02663518|449573178|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
124985277|NCT02663518|449573179|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
124985278|NCT02663518|449573166|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
124985279|NCT02663518|449573167|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
124985280|NCT02663518|449573168|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
124985281|NCT02663518|449573169|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
124985282|NCT02663518|449573170|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
124985283|NCT02663518|449573171|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
124985284|NCT02663518|449573172|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
124985285|NCT02663518|449573173|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
124985286|NCT02663518|449573174|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
124985287|NCT02663518|449573175|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
124985288|NCT02663518|449573176|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
124985289|NCT02663518|449573177|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
124985290|NCT02663518|449573178|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
124985291|NCT02663518|449573179|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
125210503|NCT01066793|450395578|FG005|Overall Study|Treatment Stopped|0|||
125210504|NCT01911793|450395579|FG000|Overall Study|Physician Decision|1|||
124985292|NCT02663518|449573166|FG000|Part 1: Phase 1a Escalation|Other|0|||
124985293|NCT02663518|449573167|FG001|Part 1: Phase 1a Escalation|Other|0|||
124985294|NCT02663518|449573168|FG002|Part 1: Phase 1a Escalation|Other|2|||
124985295|NCT02663518|449573169|FG003|Part 1: Phase 1a Escalation|Other|0|||
124985296|NCT02663518|449573170|FG004|Part 1: Phase 1a Escalation|Other|0|||
124985297|NCT02663518|449573171|FG005|Part 1: Phase 1a Escalation|Other|0|||
124985298|NCT02663518|449573172|FG006|Part 1: Phase 1a Escalation|Other|0|||
124985299|NCT02663518|449573173|FG007|Part 1: Phase 1a Escalation|Other|0|||
124985300|NCT02663518|449573174|FG008|Part 1: Phase 1a Escalation|Other|0|||
124985301|NCT02663518|449573175|FG009|Part 1: Phase 1a Escalation|Other|0|||
124985302|NCT02663518|449573176|FG010|Part 1: Phase 1a Escalation|Other|0|||
124985303|NCT02663518|449573177|FG011|Part 1: Phase 1a Escalation|Other|0|||
124985304|NCT02663518|449573178|FG012|Part 1: Phase 1a Escalation|Other|0|||
124985305|NCT02663518|449573179|FG013|Part 1: Phase 1a Escalation|Other|0|||
124985306|NCT02663518|449573166|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
124985307|NCT02663518|449573167|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
124985308|NCT02663518|449573168|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
124985309|NCT02663518|449573169|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
124985310|NCT02663518|449573170|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
124985311|NCT02663518|449573171|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
124985312|NCT02663518|449573172|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
124985313|NCT02663518|449573173|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
124985314|NCT02663518|449573174|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
124985315|NCT02663518|449573175|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
124985316|NCT02663518|449573176|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
124985317|NCT02663518|449573177|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
124985318|NCT02663518|449573178|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
124985319|NCT02663518|449573179|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
124985320|NCT02663518|449573166|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124985321|NCT02663518|449573167|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124985322|NCT02663518|449573168|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124985323|NCT02663518|449573169|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124985324|NCT02663518|449573170|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
124985325|NCT02663518|449573171|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124985326|NCT02663518|449573172|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
124985327|NCT02663518|449573173|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
124985328|NCT02663518|449573174|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124985329|NCT02663518|449573175|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124985330|NCT02663518|449573176|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124985331|NCT02663518|449573177|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124985332|NCT02663518|449573178|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124985333|NCT02663518|449573179|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124985334|NCT02663518|449573166|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124985335|NCT02663518|449573167|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124985336|NCT02663518|449573168|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124985337|NCT02663518|449573169|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124985338|NCT02663518|449573170|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
124985339|NCT02663518|449573171|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124985340|NCT02663518|449573172|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124985341|NCT02663518|449573173|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124985342|NCT02663518|449573174|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124985343|NCT02663518|449573175|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124985344|NCT02663518|449573176|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124985345|NCT02663518|449573177|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124985346|NCT02663518|449573178|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124985347|NCT02663518|449573179|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124985348|NCT02663518|449573166|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
124985349|NCT02663518|449573167|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
124985350|NCT02663518|449573168|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
124985351|NCT02663518|449573169|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
124985352|NCT02663518|449573170|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
124985353|NCT02663518|449573171|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
124985354|NCT02663518|449573172|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
124985355|NCT02663518|449573173|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
124985356|NCT02663518|449573174|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
124985357|NCT02663518|449573175|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
124985358|NCT02663518|449573176|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
124985359|NCT02663518|449573177|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
124985360|NCT02663518|449573178|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
124985361|NCT02663518|449573179|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
124985362|NCT02663518|449573166|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
124985363|NCT02663518|449573167|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
124985364|NCT02663518|449573168|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
124985365|NCT02663518|449573169|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
124985366|NCT02663518|449573170|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
124985367|NCT02663518|449573171|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
124985368|NCT02663518|449573172|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
124985369|NCT02663518|449573173|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
124985370|NCT02663518|449573174|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
124985371|NCT02663518|449573175|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
124985372|NCT02663518|449573176|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
124985373|NCT02663518|449573177|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
124985374|NCT02663518|449573178|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
124985375|NCT02663518|449573179|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
124985376|NCT02663518|449573166|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124985377|NCT02663518|449573167|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124985378|NCT02663518|449573168|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124985379|NCT02663518|449573169|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124985380|NCT02663518|449573170|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124985381|NCT02663518|449573171|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124985382|NCT02663518|449573172|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
124985383|NCT02663518|449573173|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124985384|NCT02663518|449573174|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124985385|NCT02663518|449573175|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124985386|NCT02663518|449573176|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124985387|NCT02663518|449573177|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124985388|NCT02663518|449573178|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124985389|NCT02663518|449573179|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124985390|NCT02663518|449573166|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
124985391|NCT02663518|449573167|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
124985392|NCT02663518|449573168|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
124985393|NCT02663518|449573169|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
124985394|NCT02663518|449573170|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
124985395|NCT02663518|449573171|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
124985396|NCT02663518|449573172|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
124985397|NCT02663518|449573173|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
124985398|NCT02663518|449573174|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
124985399|NCT02663518|449573175|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
124985400|NCT02663518|449573176|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
124985401|NCT02663518|449573177|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
124985402|NCT02663518|449573178|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
124985403|NCT02663518|449573179|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
124985404|NCT02663518|449573166|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124985405|NCT02663518|449573167|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124985406|NCT02663518|449573168|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124985407|NCT02663518|449573169|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124985408|NCT02663518|449573170|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124985409|NCT02663518|449573171|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124985410|NCT02663518|449573172|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124985411|NCT02663518|449573173|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124985412|NCT02663518|449573174|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124985413|NCT02663518|449573175|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124985414|NCT02663518|449573176|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124985415|NCT02663518|449573177|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124985416|NCT02663518|449573178|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
124985417|NCT02663518|449573179|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124985418|NCT02663518|449573166|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124985419|NCT02663518|449573167|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124985420|NCT02663518|449573168|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124985421|NCT02663518|449573169|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124985422|NCT02663518|449573170|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124985423|NCT02663518|449573171|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124985424|NCT02663518|449573172|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124985425|NCT02663518|449573173|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124985426|NCT02663518|449573174|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124985427|NCT02663518|449573175|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
125314017|NCT01584232|450779353|FG000|Overall Study|Lost to Follow-up|1|||
125314018|NCT01584232|450779354|FG001|Overall Study|Lost to Follow-up|0|||
125314019|NCT03347123|450779355|FG000|Overall Study|Death|1|||
124985428|NCT02663518|449573176|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124985429|NCT02663518|449573177|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
124985430|NCT02663518|449573178|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124985431|NCT02663518|449573179|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124985432|NCT02663518|449573166|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
124985433|NCT02663518|449573167|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
124985434|NCT02663518|449573168|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
124985435|NCT02663518|449573169|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
124985436|NCT02663518|449573170|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
124985437|NCT02663518|449573171|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
124985438|NCT02663518|449573172|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
124985439|NCT02663518|449573173|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
124985440|NCT02663518|449573174|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
124985441|NCT02663518|449573175|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
124985442|NCT02663518|449573176|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
124985443|NCT02663518|449573177|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
124985444|NCT02663518|449573178|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
124985445|NCT02663518|449573179|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
124985446|NCT02663518|449573166|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
124985447|NCT02663518|449573167|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
124985448|NCT02663518|449573168|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
124985449|NCT02663518|449573169|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
124985450|NCT02663518|449573170|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
124985451|NCT02663518|449573171|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
124985452|NCT02663518|449573172|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
124985453|NCT02663518|449573173|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
124985454|NCT02663518|449573174|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
124985455|NCT02663518|449573175|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
124985456|NCT02663518|449573176|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
124985457|NCT02663518|449573177|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
124985458|NCT02663518|449573178|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
124985459|NCT02663518|449573179|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
124985460|NCT02663518|449573166|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124985461|NCT02663518|449573167|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124985462|NCT02663518|449573168|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124985463|NCT02663518|449573169|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124985464|NCT02663518|449573170|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124985465|NCT02663518|449573171|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124985466|NCT02663518|449573172|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124985467|NCT02663518|449573173|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124985468|NCT02663518|449573174|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124985469|NCT02663518|449573175|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124985470|NCT02663518|449573176|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124985471|NCT02663518|449573177|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124985472|NCT02663518|449573178|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
124985473|NCT02663518|449573179|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124985474|NCT03896152|449573180|FG000|Overall Study|Patient/guardian decision|1|||
124985475|NCT03896152|449573181|FG001|Overall Study|Patient/guardian decision|1|||
124985476|NCT03896152|449573180|FG000|Overall Study|Adverse Event|0|||
124985477|NCT03896152|449573181|FG001|Overall Study|Adverse Event|1|||
124985478|NCT03896152|449573180|FG000|Overall Study|Physician Decision|1|||
124985479|NCT03896152|449573181|FG001|Overall Study|Physician Decision|0|||
124985480|NCT03896152|449573180|FG000|Overall Study|Technical problems|1|||
124985481|NCT03896152|449573181|FG001|Overall Study|Technical problems|0|||
124985482|NCT00772330|449573182|FG000|Overall Study|Lost to Follow-up|3|||
124985483|NCT01353859|449573183|FG000|Overall Study|Adverse Event|3|||
124985484|NCT01353859|449573183|FG000|Overall Study|Lack of Efficacy|1|||
124985485|NCT00766363|449573190|FG000|Overall Study|Withdrawal by Subject|1|||
124985486|NCT00766363|449573191|FG001|Overall Study|Withdrawal by Subject|0|||
124985487|NCT00766363|449573192|FG002|Overall Study|Withdrawal by Subject|0|||
124985488|NCT00766363|449573193|FG003|Overall Study|Withdrawal by Subject|0|||
124985489|NCT00766363|449573190|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
124985490|NCT00766363|449573191|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
124985491|NCT00766363|449573192|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
124985492|NCT00766363|449573193|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
125314020|NCT03347123|450779356|FG001|Overall Study|Death|2|||
124985493|NCT01153321|449573194|FG000|Overall Study|Development of study withdrawal criteria|0|||
124985494|NCT01153321|449573195|FG001|Overall Study|Development of study withdrawal criteria|1|||
124985495|NCT01153321|449573194|FG000|Overall Study|Withdrawal by Subject|0|||
124985496|NCT01153321|449573195|FG001|Overall Study|Withdrawal by Subject|1|||
124985497|NCT01153321|449573194|FG000|Overall Study|Adverse Event|1|||
124985498|NCT01153321|449573195|FG001|Overall Study|Adverse Event|1|||
124985499|NCT00911937|449573196|FG000|Overall Study|Death|1|||
124985500|NCT00911937|449573197|FG001|Overall Study|Death|0|||
124985501|NCT00911937|449573196|FG000|Overall Study|Lost to Follow-up|8|||
124985502|NCT00911937|449573197|FG001|Overall Study|Lost to Follow-up|5|||
124985503|NCT00911937|449573196|FG000|Overall Study|Withdrawal by Subject|10|||
124985504|NCT00911937|449573197|FG001|Overall Study|Withdrawal by Subject|7|||
124985505|NCT00911937|449573196|FG000|Overall Study|Withdrawn due to pregnancy|1|||
124985506|NCT00911937|449573197|FG001|Overall Study|Withdrawn due to pregnancy|0|||
124985507|NCT00911937|449573196|FG000|Overall Study|Adverse Event|11|||
124985508|NCT00911937|449573197|FG001|Overall Study|Adverse Event|25|||
124985509|NCT00911937|449573196|FG000|Overall Study|Lack of Efficacy|11|||
124985510|NCT00911937|449573197|FG001|Overall Study|Lack of Efficacy|6|||
124985511|NCT00911937|449573196|FG000|Overall Study|Did not meet inclusion criteria|9|||
124985512|NCT00911937|449573197|FG001|Overall Study|Did not meet inclusion criteria|11|||
124985513|NCT00911937|449573196|FG000|Overall Study|Protocol Violation|14|||
124985514|NCT00911937|449573197|FG001|Overall Study|Protocol Violation|23|||
124985515|NCT00911937|449573196|FG000|Overall Study|Randomized but not treated|13|||
124985516|NCT00911937|449573197|FG001|Overall Study|Randomized but not treated|13|||
124985517|NCT00911937|449573196|FG000|Overall Study|Other|9|||
124985518|NCT00911937|449573197|FG001|Overall Study|Other|5|||
124985519|NCT00700427|449573202|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
124985520|NCT00700427|449573203|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
124985521|NCT00700427|449573204|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
124985522|NCT00700427|449573205|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
124985523|NCT00700427|449573206|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
124985524|NCT00700427|449573202|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
124985525|NCT00700427|449573203|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
124985526|NCT00700427|449573204|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
124985527|NCT00700427|449573205|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
124985528|NCT00700427|449573206|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
124985529|NCT00700427|449573202|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
124985530|NCT00700427|449573203|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
124985531|NCT00700427|449573204|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
124985532|NCT00700427|449573205|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
124985533|NCT00700427|449573206|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
124985534|NCT00700427|449573202|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
124985535|NCT00700427|449573203|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
124985536|NCT00700427|449573204|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
124985537|NCT00700427|449573205|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
124985538|NCT00700427|449573206|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
124985539|NCT00700427|449573202|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
124985540|NCT00700427|449573203|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
124985541|NCT00700427|449573204|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
124985542|NCT00700427|449573205|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
124985543|NCT00700427|449573206|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
124985544|NCT00700427|449573202|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
124985545|NCT00700427|449573203|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
124985546|NCT00700427|449573204|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
125314021|NCT03347123|450779357|FG002|Overall Study|Death|0|||
125314022|NCT03347123|450779358|FG003|Overall Study|Death|0|||
124985547|NCT00700427|449573205|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
124985548|NCT00700427|449573206|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
124985549|NCT00700427|449573202|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
124985550|NCT00700427|449573203|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
124985551|NCT00700427|449573204|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
124985552|NCT00700427|449573205|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
124985553|NCT00700427|449573206|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
124985554|NCT00700427|449573202|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
124985555|NCT00700427|449573203|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
124985556|NCT00700427|449573204|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
124985557|NCT00700427|449573205|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
124985558|NCT00700427|449573206|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
125314023|NCT03347123|450779359|FG004|Overall Study|Death|0|||
125314024|NCT03347123|450779360|FG005|Overall Study|Death|0|||
124985559|NCT00700427|449573202|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
124985560|NCT00700427|449573203|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
124985561|NCT00700427|449573204|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
124985562|NCT00700427|449573205|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
124985563|NCT00700427|449573206|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
124985564|NCT00700427|449573202|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
124985565|NCT00700427|449573203|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
124985566|NCT00700427|449573204|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
124985567|NCT00700427|449573205|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
124985568|NCT00700427|449573206|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
124985569|NCT00700427|449573202|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
124985570|NCT00700427|449573203|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
124985571|NCT00700427|449573204|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
124985572|NCT00700427|449573205|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
124985573|NCT00700427|449573206|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
124985574|NCT00700427|449573202|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
124985575|NCT00700427|449573203|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
124985576|NCT00700427|449573204|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
124985577|NCT00700427|449573205|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
124985578|NCT00700427|449573206|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
124985579|NCT00700427|449573202|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
124985580|NCT00700427|449573203|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
124985581|NCT00700427|449573204|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
124985582|NCT00700427|449573205|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
124985583|NCT00700427|449573206|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
124985584|NCT00700427|449573202|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
124985585|NCT00700427|449573203|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
124985586|NCT00700427|449573204|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
124985587|NCT00700427|449573205|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
124985588|NCT00700427|449573206|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
124985589|NCT00700427|449573202|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
124985590|NCT00700427|449573203|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
124985591|NCT00700427|449573204|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
124985592|NCT00700427|449573205|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
124985593|NCT00700427|449573206|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
124985594|NCT00700427|449573202|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
124985595|NCT00700427|449573203|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
124985596|NCT00700427|449573204|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
124985597|NCT00700427|449573205|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
124985598|NCT00700427|449573206|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
124985599|NCT00700427|449573202|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
124985600|NCT00700427|449573203|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
124985601|NCT00700427|449573204|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
124985602|NCT00700427|449573205|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
124985603|NCT00700427|449573206|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
124985604|NCT00700427|449573202|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
124985605|NCT00700427|449573203|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
124985606|NCT00700427|449573204|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
124985607|NCT00700427|449573205|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
124985608|NCT00700427|449573206|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
124985609|NCT00700427|449573202|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
124985610|NCT00700427|449573203|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
124985611|NCT00700427|449573204|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
124985612|NCT00700427|449573205|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
124985613|NCT00700427|449573206|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
124985614|NCT00700427|449573202|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
125314025|NCT03347123|450779361|FG006|Overall Study|Death|0|||
125314026|NCT03347123|450779355|FG000|Overall Study|Withdrawal by Subject|1|||
125314027|NCT03347123|450779356|FG001|Overall Study|Withdrawal by Subject|0|||
125314028|NCT03347123|450779357|FG002|Overall Study|Withdrawal by Subject|0|||
125314029|NCT03347123|450779358|FG003|Overall Study|Withdrawal by Subject|0|||
125314030|NCT03347123|450779359|FG004|Overall Study|Withdrawal by Subject|0|||
125314031|NCT03347123|450779360|FG005|Overall Study|Withdrawal by Subject|0|||
125314032|NCT03347123|450779361|FG006|Overall Study|Withdrawal by Subject|0|||
125314033|NCT03347123|450779355|FG000|Overall Study|Reason not Specified|3|||
124985615|NCT00700427|449573203|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
124985616|NCT00700427|449573204|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
124985617|NCT00700427|449573205|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
124985618|NCT00700427|449573206|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
124985619|NCT00700427|449573202|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
124985620|NCT00700427|449573203|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
124985621|NCT00700427|449573204|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
124985622|NCT00700427|449573205|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
124985623|NCT00700427|449573206|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
124985624|NCT00700427|449573202|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
124985625|NCT00700427|449573203|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
124985626|NCT00700427|449573204|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
124985627|NCT00700427|449573205|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
124985628|NCT00700427|449573206|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
124985629|NCT00700427|449573202|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
124985630|NCT00700427|449573203|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
124985631|NCT00700427|449573204|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
124985632|NCT00700427|449573205|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
124985633|NCT00700427|449573206|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
124985634|NCT00700427|449573202|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
124985635|NCT00700427|449573203|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
124985636|NCT00700427|449573204|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
124985637|NCT00700427|449573205|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
124985638|NCT00700427|449573206|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
124985639|NCT00700427|449573202|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
124985640|NCT00700427|449573203|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
124985641|NCT00700427|449573204|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
124985642|NCT00700427|449573205|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
124985643|NCT00700427|449573206|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
124985644|NCT00700427|449573202|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
124985645|NCT00700427|449573203|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
124985646|NCT00700427|449573204|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
124985647|NCT00700427|449573205|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
124985648|NCT00700427|449573206|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
124985649|NCT00700427|449573202|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
124985650|NCT00700427|449573203|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
124985651|NCT00700427|449573204|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
124985652|NCT00700427|449573205|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
124985653|NCT00700427|449573206|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
124985654|NCT00700427|449573202|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
124985655|NCT00700427|449573203|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
124985656|NCT00700427|449573204|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
124985657|NCT00700427|449573205|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
124985658|NCT00700427|449573206|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
124985659|NCT00700427|449573202|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
124985660|NCT00700427|449573203|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
124985661|NCT00700427|449573204|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
124985662|NCT00700427|449573205|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
124985663|NCT00700427|449573206|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
124985664|NCT00700427|449573202|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
124985665|NCT00700427|449573203|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
124985666|NCT00700427|449573204|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
124985667|NCT00700427|449573205|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
124985668|NCT00700427|449573206|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
124985669|NCT00700427|449573202|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
124985670|NCT00700427|449573203|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
124985671|NCT00700427|449573204|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
124985672|NCT00700427|449573205|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
124985673|NCT00700427|449573206|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
124985674|NCT00700427|449573202|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
124985675|NCT00700427|449573203|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
124985676|NCT00700427|449573204|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
125314034|NCT03347123|450779356|FG001|Overall Study|Reason not Specified|4|||
124985677|NCT00700427|449573205|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
124985678|NCT00700427|449573206|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
124985679|NCT00700427|449573202|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
124985680|NCT00700427|449573203|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
124985681|NCT00700427|449573204|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
124985682|NCT00700427|449573205|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
124985683|NCT00700427|449573206|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
124985684|NCT00700427|449573202|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
124985685|NCT00700427|449573203|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
124985686|NCT00700427|449573204|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
124985687|NCT00700427|449573205|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
124985688|NCT00700427|449573206|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
124985689|NCT00700427|449573202|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
124985690|NCT00700427|449573203|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
124985691|NCT00700427|449573204|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
124985692|NCT00700427|449573205|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
124985693|NCT00700427|449573206|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
124985694|NCT00700427|449573202|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
124985695|NCT00700427|449573203|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
124985696|NCT00700427|449573204|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
124985697|NCT00700427|449573205|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
124985698|NCT00700427|449573206|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
124985699|NCT00700427|449573202|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
124985700|NCT00700427|449573203|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
124985701|NCT00700427|449573204|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
124985702|NCT00700427|449573205|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
124985703|NCT00700427|449573206|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
124985704|NCT00700427|449573202|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
124985705|NCT00700427|449573203|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
124985706|NCT00700427|449573204|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
124985707|NCT00700427|449573205|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
124985708|NCT00700427|449573206|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
124985709|NCT00424385|449573207|FG000|Cohort 0|Withdrawal by Subject|5|||
124985710|NCT00424385|449573207|FG000|Cohort 0|Physician Decision|1|||
124985711|NCT00424385|449573207|FG000|Cohort 1|Withdrawal by Subject|1|||
124985712|NCT02683876|449573208|FG000|Overall Study|samples damaged during shipping|2|||
124985713|NCT02683876|449573209|FG001|Overall Study|samples damaged during shipping|0|||
124985714|NCT03231800|449573216|FG000|Overall Study|Lost to Follow-up|0|||
124985715|NCT03231800|449573217|FG001|Overall Study|Lost to Follow-up|2|||
124985716|NCT03231800|449573216|FG000|Overall Study|Protocol Violation|1|||
124985717|NCT03231800|449573217|FG001|Overall Study|Protocol Violation|1|||
124985718|NCT03231800|449573216|FG000|Overall Study|reason not provided|2|||
124985719|NCT03231800|449573217|FG001|Overall Study|reason not provided|0|||
124985720|NCT00859222|449573218|FG000|Overall Study|Adverse Event|2|||
124985721|NCT00859222|449573219|FG001|Overall Study|Adverse Event|3|||
124985722|NCT00859222|449573220|FG002|Overall Study|Adverse Event|6|||
124985723|NCT00859222|449573221|FG003|Overall Study|Adverse Event|24|||
124985724|NCT00859222|449573222|FG004|Overall Study|Adverse Event|15|||
124985725|NCT00859222|449573218|FG000|Overall Study|DLT|1|||
124985726|NCT00859222|449573219|FG001|Overall Study|DLT|0|||
124985727|NCT00859222|449573220|FG002|Overall Study|DLT|0|||
124985728|NCT00859222|449573221|FG003|Overall Study|DLT|0|||
124985729|NCT00859222|449573222|FG004|Overall Study|DLT|0|||
124985730|NCT00400725|449573233|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
124985731|NCT00400725|449573234|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
124985732|NCT00400725|449573235|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
124985733|NCT00400725|449573233|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
124985734|NCT00400725|449573234|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
124985735|NCT00400725|449573235|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
124985736|NCT00400725|449573233|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
124985737|NCT00400725|449573234|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
124985738|NCT00400725|449573235|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
124985739|NCT00400725|449573233|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
124985740|NCT00400725|449573234|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
124985741|NCT00400725|449573235|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
124985742|NCT00400725|449573233|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
124985743|NCT00400725|449573234|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
124985744|NCT00400725|449573235|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
124985745|NCT00400725|449573233|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
124985746|NCT00400725|449573234|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
124985747|NCT00400725|449573235|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
124985748|NCT00400725|449573233|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
125210505|NCT01911793|450395580|FG001|Overall Study|Physician Decision|5|||
124985749|NCT00400725|449573234|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
124985750|NCT00400725|449573235|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
124985751|NCT00400725|449573233|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
124985752|NCT00400725|449573234|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
124985753|NCT00400725|449573235|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
124985754|NCT00400725|449573233|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
124985755|NCT00400725|449573234|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
124985756|NCT00400725|449573235|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
124985757|NCT04738292|449573243|FG000|Overall Study|Death|1|||
124985758|NCT01056718|449573244|FG000|Overall Study|Withdrawal by Subject|2|||
124985759|NCT01056718|449573244|FG000|Overall Study|Ischemia on baseline stress test|1|||
124985760|NCT05086276|449573245|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
124985761|NCT05086276|449573246|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
124985762|NCT00777088|449573247|FG000|Overall Study|PED Treatment not attempted|1|||
124985763|NCT00760474|449573252|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
124985764|NCT00760474|449573253|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
124985765|NCT00760474|449573252|FG000|Placebo Washout Period|Other|0|||
124985766|NCT00760474|449573253|FG001|Placebo Washout Period|Other|1|||
124985767|NCT00760474|449573252|FG000|Period 2 (P2)|Lost to Follow-up|1|||
124985768|NCT00760474|449573253|FG001|Period 2 (P2)|Lost to Follow-up|0|||
124985769|NCT00760474|449573252|FG000|Period 2 (P2)|Adverse Event|0|||
124985770|NCT00760474|449573253|FG001|Period 2 (P2)|Adverse Event|1|||
124985771|NCT00515853|449573254|FG000|Overall Study|Lost to Follow-up|9|||
124985772|NCT00515853|449573255|FG001|Overall Study|Lost to Follow-up|13|||
124985773|NCT00515853|449573254|FG000|Overall Study|Withdrawal by Subject|6|||
124985774|NCT00515853|449573255|FG001|Overall Study|Withdrawal by Subject|4|||
125314035|NCT03347123|450779357|FG002|Overall Study|Reason not Specified|0|||
124985775|NCT01394978|449573256|FG000|Overall Study|Withdrawal by Subject|2|||
124985776|NCT01394978|449573257|FG001|Overall Study|Withdrawal by Subject|4|||
124985777|NCT01394978|449573256|FG000|Overall Study|Lost to Follow-up|13|||
124985778|NCT01394978|449573257|FG001|Overall Study|Lost to Follow-up|20|||
124985779|NCT01394978|449573256|FG000|Overall Study|Death|6|||
124985780|NCT01394978|449573257|FG001|Overall Study|Death|7|||
124985781|NCT01081132|449573258|FG000|Overall Study|Lack of Efficacy|25|||
124985782|NCT01081132|449573259|FG001|Overall Study|Lack of Efficacy|9|||
124985783|NCT01081132|449573258|FG000|Overall Study|Withdrawal by Subject|13|||
124985784|NCT01081132|449573259|FG001|Overall Study|Withdrawal by Subject|16|||
124985785|NCT01081132|449573258|FG000|Overall Study|Lost to Follow-up|4|||
124985786|NCT01081132|449573259|FG001|Overall Study|Lost to Follow-up|11|||
124985787|NCT01081132|449573258|FG000|Overall Study|Adverse Event|3|||
124985788|NCT01081132|449573259|FG001|Overall Study|Adverse Event|9|||
124985789|NCT01081132|449573258|FG000|Overall Study|Non Compliance|4|||
124985790|NCT01081132|449573259|FG001|Overall Study|Non Compliance|2|||
124985791|NCT01081132|449573258|FG000|Overall Study|Lack Of Compliance|0|||
124985792|NCT01081132|449573259|FG001|Overall Study|Lack Of Compliance|1|||
124985793|NCT01081132|449573258|FG000|Overall Study|Missed Visits|1|||
124985794|NCT01081132|449573259|FG001|Overall Study|Missed Visits|1|||
124985795|NCT01081132|449573258|FG000|Overall Study|Stopped Taking Meds|2|||
124985796|NCT01081132|449573259|FG001|Overall Study|Stopped Taking Meds|0|||
124985797|NCT01081132|449573258|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
124985798|NCT01081132|449573259|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
124985799|NCT01081132|449573258|FG000|Overall Study|Declined Taper Phase|0|||
124985800|NCT01081132|449573259|FG001|Overall Study|Declined Taper Phase|1|||
124985801|NCT01081132|449573258|FG000|Overall Study|Protocol Violation|3|||
124985802|NCT01081132|449573259|FG001|Overall Study|Protocol Violation|1|||
124985803|NCT02101385|449573262|FG000|Study Treatment|Disease Progression|9|||
125314036|NCT03347123|450779358|FG003|Overall Study|Reason not Specified|0|||
124985804|NCT02101385|449573263|FG001|Study Treatment|Disease Progression|3|||
124985805|NCT02101385|449573262|FG000|Study Treatment|Alternative therapy|0|||
124985806|NCT02101385|449573263|FG001|Study Treatment|Alternative therapy|1|||
124985807|NCT02101385|449573262|FG000|Study Treatment|No treatment, per protocol criteria|0|||
124985808|NCT02101385|449573263|FG001|Study Treatment|No treatment, per protocol criteria|4|||
124985809|NCT02101385|449573262|FG000|Study Treatment|Patient Non compliance|0|||
124985810|NCT02101385|449573263|FG001|Study Treatment|Patient Non compliance|2|||
124985811|NCT02101385|449573262|FG000|Study Treatment|Withdrawal by Subject|5|||
124985812|NCT02101385|449573263|FG001|Study Treatment|Withdrawal by Subject|2|||
124985813|NCT02101385|449573262|FG000|Study Treatment|screen failure|1|||
124985814|NCT02101385|449573263|FG001|Study Treatment|screen failure|0|||
124985815|NCT02101385|449573262|FG000|Study Treatment|AE/Side Effects/Complications|8|||
124985816|NCT02101385|449573263|FG001|Study Treatment|AE/Side Effects/Complications|0|||
124985817|NCT02101385|449573262|FG000|Study Treatment|Lost to Follow-up|1|||
124985818|NCT02101385|449573263|FG001|Study Treatment|Lost to Follow-up|0|||
124985819|NCT02101385|449573262|FG000|Study Treatment|Disease Progression before treatment|1|||
124985820|NCT02101385|449573263|FG001|Study Treatment|Disease Progression before treatment|0|||
124985821|NCT02101385|449573262|FG000|Study Treatment|Death|1|||
125314037|NCT03347123|450779359|FG004|Overall Study|Reason not Specified|0|||
124985822|NCT02101385|449573263|FG001|Study Treatment|Death|0|||
124985823|NCT02101385|449573262|FG000|Follow up|Lost to Follow-up|4|||
124985824|NCT02101385|449573263|FG001|Follow up|Lost to Follow-up|9|||
124985825|NCT02101385|449573262|FG000|Follow up|Refused to follow up|5|||
124985826|NCT02101385|449573263|FG001|Follow up|Refused to follow up|4|||
124985827|NCT02101385|449573262|FG000|Follow up|Death|21|||
124985828|NCT02101385|449573263|FG001|Follow up|Death|39|||
124985829|NCT02101385|449573262|FG000|Follow up|study completed|33|||
124985830|NCT02101385|449573263|FG001|Follow up|study completed|52|||
124985831|NCT02101385|449573262|FG000|Follow up|screen failure|2|||
124985832|NCT02101385|449573263|FG001|Follow up|screen failure|0|||
124985833|NCT02101385|449573262|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
124985834|NCT02101385|449573263|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
124985835|NCT02101385|449573262|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
124985836|NCT02101385|449573263|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
124985837|NCT02101385|449573262|FG000|Follow up|Withdrawal by Subject|2|||
124985838|NCT02101385|449573263|FG001|Follow up|Withdrawal by Subject|2|||
124985839|NCT02101385|449573262|FG000|Follow up|PI requested closure of site|0|||
124985840|NCT02101385|449573263|FG001|Follow up|PI requested closure of site|5|||
124985841|NCT02432196|449573264|FG000|Overall Study|Exit - did not receive study device|1|||
124985842|NCT02432196|449573264|FG000|Overall Study|Death|2|||
124985843|NCT02432196|449573264|FG000|Overall Study|Reoperation|3|||
124985844|NCT05038163|449573265|FG000|Stage 1|Did not complete survey|374|||
124985845|NCT05038163|449573266|FG001|Stage 1|Did not complete survey|0|||
124985846|NCT05038163|449573267|FG002|Stage 1|Did not complete survey|0|||
124985847|NCT05038163|449573268|FG003|Stage 1|Did not complete survey|0|||
124985848|NCT05038163|449573269|FG004|Stage 1|Did not complete survey|0|||
124985849|NCT05038163|449573270|FG005|Stage 1|Did not complete survey|0|||
124985850|NCT05038163|449573265|FG000|Stage 2|Did not complete Stage 2 survey|0|||
124985851|NCT05038163|449573266|FG001|Stage 2|Did not complete Stage 2 survey|29|||
124985852|NCT05038163|449573267|FG002|Stage 2|Did not complete Stage 2 survey|30|||
124985853|NCT05038163|449573268|FG003|Stage 2|Did not complete Stage 2 survey|24|||
124985854|NCT05038163|449573269|FG004|Stage 2|Did not complete Stage 2 survey|21|||
124985855|NCT05038163|449573270|FG005|Stage 2|Did not complete Stage 2 survey|100|||
124985856|NCT01905150|449573271|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
124985857|NCT01905150|449573272|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
124985858|NCT01147536|449573273|FG000|Overall Study|Administrative study close|2|||
124985859|NCT01147536|449573273|FG000|Overall Study|Death|1|||
124985860|NCT03762200|449573276|FG000|Overall Study|Death|2|||
124985861|NCT02631577|449573277|FG000|Overall Study|Death|1|||
124985862|NCT02631577|449573278|FG001|Overall Study|Death|7|||
124985863|NCT02631577|449573277|FG000|Overall Study|Withdrawal by Subject|0|||
124985864|NCT02631577|449573278|FG001|Overall Study|Withdrawal by Subject|3|||
124985865|NCT03973931|449573284|FG000|Overall Study|Lost to Follow-up|47|||
124985866|NCT03973931|449573285|FG001|Overall Study|Lost to Follow-up|63|||
124985867|NCT03973931|449573286|FG002|Overall Study|Lost to Follow-up|51|||
124985868|NCT03973931|449573287|FG003|Overall Study|Lost to Follow-up|54|||
124985869|NCT03973931|449573284|FG000|Overall Study|opted out|6|||
124985870|NCT03973931|449573285|FG001|Overall Study|opted out|5|||
124985871|NCT03973931|449573286|FG002|Overall Study|opted out|5|||
124985872|NCT03973931|449573287|FG003|Overall Study|opted out|1|||
124985873|NCT02516332|449574729|FG000|Overall Study|Withdrawal by Subject|2|||
124985874|NCT02516332|449574730|FG001|Overall Study|Withdrawal by Subject|1|||
124985875|NCT02516332|449574731|FG002|Overall Study|Withdrawal by Subject|2|||
124985876|NCT02704754|449574736|FG000|Overall Study|Lost to Follow-up|1|||
124985877|NCT02704754|449574737|FG001|Overall Study|Lost to Follow-up|1|||
124985878|NCT02704754|449574736|FG000|Overall Study|Lack of Efficacy|1|||
124985879|NCT02704754|449574737|FG001|Overall Study|Lack of Efficacy|0|||
124985880|NCT02704754|449574736|FG000|Overall Study|Withdrawal by Subject|1|||
124985881|NCT02704754|449574737|FG001|Overall Study|Withdrawal by Subject|0|||
124985882|NCT03809429|449574738|FG000|Overall Study|Withdrawal by Subject|7|||
124985883|NCT03809429|449574739|FG001|Overall Study|Withdrawal by Subject|3|||
124985884|NCT03809429|449574738|FG000|Overall Study|Adverse Event|6|||
124985885|NCT03809429|449574739|FG001|Overall Study|Adverse Event|9|||
125314038|NCT03347123|450779360|FG005|Overall Study|Reason not Specified|0|||
125314039|NCT03347123|450779361|FG006|Overall Study|Reason not Specified|0|||
125314040|NCT01132807|450779362|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
125314041|NCT01132807|450779363|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
124985886|NCT03809429|449574738|FG000|Overall Study|COVID-19|3|||
124985887|NCT03809429|449574739|FG001|Overall Study|COVID-19|1|||
124985888|NCT03809429|449574738|FG000|Overall Study|Participant was discontinued by investigator|12|||
124985889|NCT03809429|449574739|FG001|Overall Study|Participant was discontinued by investigator|7|||
124985890|NCT04214600|449574741|FG000|Overall Study|Lost to Follow-up|9|||
125314042|NCT01132807|450779364|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
125314043|NCT01132807|450779362|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
124985891|NCT04214600|449574742|FG001|Overall Study|Lost to Follow-up|14|||
124985892|NCT03507777|449574743|FG000|Overall Study|Lost to Follow-up|5|||
124985893|NCT03507777|449574744|FG001|Overall Study|Lost to Follow-up|7|||
124985894|NCT03507777|449574743|FG000|Overall Study|Withdrawal by Subject|6|||
124985895|NCT03507777|449574744|FG001|Overall Study|Withdrawal by Subject|11|||
124985896|NCT03507777|449574743|FG000|Overall Study|Death|30|||
124985897|NCT03507777|449574744|FG001|Overall Study|Death|44|||
124985898|NCT03507777|449574743|FG000|Overall Study|Other Reasons|3|||
124985899|NCT03507777|449574744|FG001|Overall Study|Other Reasons|8|||
124985900|NCT01552603|449574745|FG000|Overall Study|Physician Decision|1|||
124985901|NCT04797650|449574750|FG000|Overall Study|Reason Not Specified|5|||
124985902|NCT04797650|449574751|FG001|Overall Study|Reason Not Specified|12|||
124985903|NCT04797650|449574752|FG002|Overall Study|Reason Not Specified|5|||
124985904|NCT04797650|449574750|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
124985905|NCT04797650|449574751|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
124985906|NCT04797650|449574752|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
124985907|NCT04797650|449574750|FG000|Overall Study|Lack of Efficacy|1|||
124985908|NCT04797650|449574751|FG001|Overall Study|Lack of Efficacy|0|||
124985909|NCT04797650|449574752|FG002|Overall Study|Lack of Efficacy|1|||
124985910|NCT04797650|449574750|FG000|Overall Study|Non-compliance with Study Drug|0|||
124985911|NCT04797650|449574751|FG001|Overall Study|Non-compliance with Study Drug|0|||
124985912|NCT04797650|449574752|FG002|Overall Study|Non-compliance with Study Drug|2|||
124985913|NCT04797650|449574750|FG000|Overall Study|Lost to Follow-up|4|||
124985914|NCT04797650|449574751|FG001|Overall Study|Lost to Follow-up|6|||
124985915|NCT04797650|449574752|FG002|Overall Study|Lost to Follow-up|1|||
124985916|NCT00657020|449574753|FG000|PERIOD 1|Adverse Event|0|||
124985917|NCT00657020|449574754|FG001|PERIOD 1|Adverse Event|1|||
124985918|NCT01144052|449574755|FG000|Overall Study|Withdrawal by Subject|1|||
124985919|NCT01144052|449574756|FG001|Overall Study|Withdrawal by Subject|1|||
124985920|NCT00774930|449574760|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
124985921|NCT00774930|449574761|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
124985922|NCT00774930|449574760|FG000|DB Phase|Adverse Event|1|||
124985923|NCT00774930|449574761|FG001|DB Phase|Adverse Event|2|||
124985924|NCT00774930|449574760|FG000|DB Phase|Subject Decision|1|||
124985925|NCT00774930|449574761|FG001|DB Phase|Subject Decision|5|||
124985926|NCT00774930|449574760|FG000|DB Phase|Sponsor Decision|0|||
124985927|NCT00774930|449574761|FG001|DB Phase|Sponsor Decision|1|||
124985928|NCT00774930|449574760|FG000|DB Phase|Disease Progression|1|||
124985929|NCT00774930|449574761|FG001|DB Phase|Disease Progression|1|||
124985930|NCT00774930|449574760|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
124985931|NCT00774930|449574761|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
124985932|NCT00774930|449574760|FG000|IOL Phase|Adverse Event|1|||
124985933|NCT00774930|449574761|FG001|IOL Phase|Adverse Event|1|||
124985934|NCT00774930|449574760|FG000|IOL Phase|Subject Decision|4|||
124985935|NCT00774930|449574761|FG001|IOL Phase|Subject Decision|3|||
124985936|NCT00774930|449574760|FG000|IOL Phase|Physician Decision|3|||
124985937|NCT00774930|449574761|FG001|IOL Phase|Physician Decision|2|||
124985938|NCT00774930|449574760|FG000|IOL Phase|Sponsor Decision|1|||
124985939|NCT00774930|449574761|FG001|IOL Phase|Sponsor Decision|0|||
124985940|NCT00774930|449574760|FG000|IOL Phase|Disease Progression|2|||
124985941|NCT00774930|449574761|FG001|IOL Phase|Disease Progression|1|||
124985942|NCT00774930|449574760|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
124985943|NCT00774930|449574761|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
124985944|NCT00774930|449574760|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
124985945|NCT00774930|449574761|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
124985946|NCT00774930|449574760|FG000|IOL Phase|Other|1|||
124985947|NCT00774930|449574761|FG001|IOL Phase|Other|0|||
124985948|NCT00774930|449574760|FG000|IOL Phase|Brain radiation|0|||
125314044|NCT01132807|450779363|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
124985949|NCT00774930|449574761|FG001|IOL Phase|Brain radiation|1|||
124985950|NCT00774930|449574760|FG000|LTOLE Phase|Adverse Event|7|||
124985951|NCT00774930|449574761|FG001|LTOLE Phase|Adverse Event|3|||
124985952|NCT00774930|449574760|FG000|LTOLE Phase|Subject decision|0|||
124985953|NCT00774930|449574761|FG001|LTOLE Phase|Subject decision|5|||
124985954|NCT00774930|449574760|FG000|LTOLE Phase|Physician Decision|4|||
124985955|NCT00774930|449574761|FG001|LTOLE Phase|Physician Decision|1|||
124985956|NCT00774930|449574760|FG000|LTOLE Phase|Sponsor decision|2|||
125314045|NCT01132807|450779364|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
124985957|NCT00774930|449574761|FG001|LTOLE Phase|Sponsor decision|1|||
124985958|NCT00774930|449574760|FG000|LTOLE Phase|Disease Progression|2|||
124985959|NCT00774930|449574761|FG001|LTOLE Phase|Disease Progression|5|||
124985960|NCT00774930|449574760|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
124985961|NCT00774930|449574761|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
124985962|NCT00774930|449574760|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
124985963|NCT00774930|449574761|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
124985964|NCT01631227|449574762|FG000|Overall Study|withdrawn consent|27|||
124985965|NCT01631227|449574763|FG001|Overall Study|withdrawn consent|21|||
124985966|NCT01631227|449574762|FG000|Overall Study|Adverse Event|1|||
124985967|NCT01631227|449574763|FG001|Overall Study|Adverse Event|0|||
124985968|NCT01631227|449574762|FG000|Overall Study|administrative|2|||
124985969|NCT01631227|449574763|FG001|Overall Study|administrative|1|||
124985970|NCT03020576|449574764|FG000|Overall Study|Withdrawal by Subject|1|||
124985971|NCT03020576|449574765|FG001|Overall Study|Withdrawal by Subject|2|||
124985972|NCT01177800|449574767|FG000|Overall Study|Adverse Event|9|||
124985973|NCT01177800|449574768|FG001|Overall Study|Adverse Event|3|||
124985974|NCT01177800|449574767|FG000|Overall Study|Protocol Violation|0|||
124985975|NCT01177800|449574768|FG001|Overall Study|Protocol Violation|1|||
124985976|NCT01177800|449574767|FG000|Overall Study|Physician Decision|1|||
124985977|NCT01177800|449574768|FG001|Overall Study|Physician Decision|0|||
124985978|NCT01177800|449574767|FG000|Overall Study|Withdrawal of informed consent|0|||
124985979|NCT01177800|449574768|FG001|Overall Study|Withdrawal of informed consent|1|||
124985980|NCT03527550|449574769|FG000|Overall Study|Lost to Follow-up|4|||
124985981|NCT03527550|449574770|FG001|Overall Study|Lost to Follow-up|2|||
124985982|NCT03527550|449574769|FG000|Overall Study|Withdrawal by Subject|4|||
124985983|NCT03527550|449574770|FG001|Overall Study|Withdrawal by Subject|1|||
124985984|NCT03527550|449574769|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
124985985|NCT03527550|449574770|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
124985986|NCT01097707|449574771|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
124985987|NCT01097707|449574772|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
124985988|NCT01097707|449574773|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
124985989|NCT01097707|449574774|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
124985990|NCT01097707|449574775|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
124985991|NCT01097707|449574771|FG000|Overall Study|Adverse Event|4|||
124985992|NCT01097707|449574772|FG001|Overall Study|Adverse Event|2|||
124985993|NCT01097707|449574773|FG002|Overall Study|Adverse Event|3|||
124985994|NCT01097707|449574774|FG003|Overall Study|Adverse Event|1|||
124985995|NCT01097707|449574775|FG004|Overall Study|Adverse Event|3|||
124985996|NCT01097707|449574771|FG000|Overall Study|Entry Criteria Not Met|2|||
124985997|NCT01097707|449574772|FG001|Overall Study|Entry Criteria Not Met|1|||
124985998|NCT01097707|449574773|FG002|Overall Study|Entry Criteria Not Met|1|||
124985999|NCT01097707|449574774|FG003|Overall Study|Entry Criteria Not Met|0|||
124986000|NCT01097707|449574775|FG004|Overall Study|Entry Criteria Not Met|1|||
124986001|NCT01097707|449574771|FG000|Overall Study|Lack of Efficacy|1|||
124986002|NCT01097707|449574772|FG001|Overall Study|Lack of Efficacy|0|||
124986003|NCT01097707|449574773|FG002|Overall Study|Lack of Efficacy|0|||
124986004|NCT01097707|449574774|FG003|Overall Study|Lack of Efficacy|1|||
124986005|NCT01097707|449574775|FG004|Overall Study|Lack of Efficacy|0|||
124986006|NCT01097707|449574771|FG000|Overall Study|Lost to Follow-up|1|||
124986007|NCT01097707|449574772|FG001|Overall Study|Lost to Follow-up|1|||
124986008|NCT01097707|449574773|FG002|Overall Study|Lost to Follow-up|2|||
124986009|NCT01097707|449574774|FG003|Overall Study|Lost to Follow-up|0|||
124986010|NCT01097707|449574775|FG004|Overall Study|Lost to Follow-up|3|||
124986011|NCT01097707|449574771|FG000|Overall Study|Protocol Violation|2|||
124986012|NCT01097707|449574772|FG001|Overall Study|Protocol Violation|2|||
124986013|NCT01097707|449574773|FG002|Overall Study|Protocol Violation|3|||
124986014|NCT01097707|449574774|FG003|Overall Study|Protocol Violation|2|||
124986015|NCT01097707|449574775|FG004|Overall Study|Protocol Violation|2|||
124986016|NCT01097707|449574771|FG000|Overall Study|Sponsor Decision|31|||
124986017|NCT01097707|449574772|FG001|Overall Study|Sponsor Decision|31|||
124986018|NCT01097707|449574773|FG002|Overall Study|Sponsor Decision|34|||
124986019|NCT01097707|449574774|FG003|Overall Study|Sponsor Decision|35|||
124986020|NCT01097707|449574775|FG004|Overall Study|Sponsor Decision|36|||
124986021|NCT01097707|449574771|FG000|Overall Study|Withdrawal by Subject|3|||
124986022|NCT01097707|449574772|FG001|Overall Study|Withdrawal by Subject|6|||
124986023|NCT01097707|449574773|FG002|Overall Study|Withdrawal by Subject|1|||
124986024|NCT01097707|449574774|FG003|Overall Study|Withdrawal by Subject|4|||
124986025|NCT01097707|449574775|FG004|Overall Study|Withdrawal by Subject|3|||
124986026|NCT01097707|449574771|FG000|Overall Study|Reason unknown|0|||
124986027|NCT01097707|449574772|FG001|Overall Study|Reason unknown|0|||
124986028|NCT01097707|449574773|FG002|Overall Study|Reason unknown|0|||
124986029|NCT01097707|449574774|FG003|Overall Study|Reason unknown|0|||
124986030|NCT01097707|449574775|FG004|Overall Study|Reason unknown|1|||
124986031|NCT01498679|449574776|FG000|Overall Study|Adverse Event|1|||
125314046|NCT02043938|450779368|FG000|Overall Study|Withdrawal by Subject|7|||
124986032|NCT01498679|449574777|FG001|Overall Study|Adverse Event|4|||
124986033|NCT01498679|449574776|FG000|Overall Study|Lack of Efficacy|72|||
124986034|NCT01498679|449574777|FG001|Overall Study|Lack of Efficacy|12|||
124986035|NCT01498679|449574776|FG000|Overall Study|Protocol Violation|4|||
124986036|NCT01498679|449574777|FG001|Overall Study|Protocol Violation|0|||
124986037|NCT01498679|449574776|FG000|Overall Study|Physician Decision|0|||
124986038|NCT01498679|449574777|FG001|Overall Study|Physician Decision|2|||
124986039|NCT01498679|449574776|FG000|Overall Study|Withdrawal by Subject|12|||
124986040|NCT01498679|449574777|FG001|Overall Study|Withdrawal by Subject|4|||
124986041|NCT03212989|449574779|FG000|Overall Study|Physician Decision|8|||
124986042|NCT00252577|449574782|FG000|Overall Study|Lost to Follow-up|20|||
124986043|NCT01801735|449574785|FG000|Overall Study|Adverse Event|79|||
124986044|NCT01801735|449574785|FG000|Overall Study|Lack of Efficacy|28|||
124986045|NCT01801735|449574785|FG000|Overall Study|Withdrawal by Subject|27|||
124986046|NCT01801735|449574785|FG000|Overall Study|Protocol Violation|25|||
124986047|NCT01801735|449574785|FG000|Overall Study|Lost to Follow-up|15|||
124986048|NCT01801735|449574785|FG000|Overall Study|Non-compliance with Trial Drug|13|||
124986049|NCT01801735|449574785|FG000|Overall Study|Physician Decision|3|||
124986050|NCT01801735|449574785|FG000|Overall Study|Death|1|||
124986051|NCT01801735|449574785|FG000|Overall Study|Other, including site closure|19|||
124986052|NCT00560066|449574786|FG000|Overall Study|Death|2|||
124986053|NCT00560066|449574787|FG001|Overall Study|Death|1|||
124986054|NCT00560066|449574786|FG000|Overall Study|Withdrawal by Subject|0|||
124986055|NCT00560066|449574787|FG001|Overall Study|Withdrawal by Subject|3|||
124986056|NCT00560066|449574786|FG000|Overall Study|Lost to Follow-up|4|||
124986057|NCT00560066|449574787|FG001|Overall Study|Lost to Follow-up|10|||
124986058|NCT00560066|449574786|FG000|Overall Study|Protocol Violation|0|||
124986059|NCT00560066|449574787|FG001|Overall Study|Protocol Violation|1|||
124986060|NCT00560066|449574786|FG000|Overall Study|Administrative reason|0|||
124986061|NCT00560066|449574787|FG001|Overall Study|Administrative reason|5|||
124986062|NCT00560066|449574786|FG000|Overall Study|Missing primary reason|0|||
124986063|NCT00560066|449574787|FG001|Overall Study|Missing primary reason|2|||
124986064|NCT00620282|449574788|FG000|Overall Study|Adverse Event|0|||
124986065|NCT00620282|449574789|FG001|Overall Study|Adverse Event|1|||
124986066|NCT00620282|449574790|FG002|Overall Study|Adverse Event|0|||
124986067|NCT00620282|449574788|FG000|Overall Study|Arterial line unable to be placed|0|||
124986068|NCT00620282|449574789|FG001|Overall Study|Arterial line unable to be placed|0|||
124986069|NCT00620282|449574790|FG002|Overall Study|Arterial line unable to be placed|1|||
124986070|NCT00620282|449574788|FG000|Overall Study|Withdrawal by Subject|0|||
124986071|NCT00620282|449574789|FG001|Overall Study|Withdrawal by Subject|1|||
124986072|NCT00620282|449574790|FG002|Overall Study|Withdrawal by Subject|0|||
124986073|NCT01258595|449574791|FG000|Overall Study|Lost to Follow-up|1|||
124986074|NCT01258595|449574792|FG001|Overall Study|Lost to Follow-up|0|||
124986075|NCT01258595|449574791|FG000|Overall Study|Withdrawal by Subject|0|||
124986076|NCT01258595|449574792|FG001|Overall Study|Withdrawal by Subject|1|||
124986077|NCT01820585|449574793|FG000|Overall Study|Adverse Event|9|||
124986078|NCT01820585|449574794|FG001|Overall Study|Adverse Event|13|||
124986079|NCT01820585|449574795|FG002|Overall Study|Adverse Event|23|||
124986080|NCT01820585|449574796|FG003|Overall Study|Adverse Event|34|||
124986081|NCT01820585|449574793|FG000|Overall Study|Lack of Efficacy|9|||
124986082|NCT01820585|449574794|FG001|Overall Study|Lack of Efficacy|7|||
124986083|NCT01820585|449574795|FG002|Overall Study|Lack of Efficacy|5|||
124986084|NCT01820585|449574796|FG003|Overall Study|Lack of Efficacy|1|||
124986085|NCT01820585|449574793|FG000|Overall Study|Withdrawal by Subject|3|||
124986086|NCT01820585|449574794|FG001|Overall Study|Withdrawal by Subject|7|||
124986087|NCT01820585|449574795|FG002|Overall Study|Withdrawal by Subject|3|||
124986088|NCT01820585|449574796|FG003|Overall Study|Withdrawal by Subject|8|||
124986089|NCT01820585|449574793|FG000|Overall Study|Lost to Follow-up|3|||
124986090|NCT01820585|449574794|FG001|Overall Study|Lost to Follow-up|3|||
124986091|NCT01820585|449574795|FG002|Overall Study|Lost to Follow-up|0|||
124986092|NCT01820585|449574796|FG003|Overall Study|Lost to Follow-up|3|||
124986093|NCT01820585|449574793|FG000|Overall Study|Protocol Violation|3|||
124986094|NCT01820585|449574794|FG001|Overall Study|Protocol Violation|1|||
124986095|NCT01820585|449574795|FG002|Overall Study|Protocol Violation|1|||
124986096|NCT01820585|449574796|FG003|Overall Study|Protocol Violation|1|||
124986097|NCT01820585|449574793|FG000|Overall Study|Subject non-compliance|0|||
124986098|NCT01820585|449574794|FG001|Overall Study|Subject non-compliance|0|||
124986099|NCT01820585|449574795|FG002|Overall Study|Subject non-compliance|1|||
124986100|NCT01820585|449574796|FG003|Overall Study|Subject non-compliance|2|||
124986101|NCT01820585|449574793|FG000|Overall Study|at sponsor request|0|||
124986102|NCT01820585|449574794|FG001|Overall Study|at sponsor request|0|||
124986103|NCT01820585|449574795|FG002|Overall Study|at sponsor request|1|||
124986104|NCT01820585|449574796|FG003|Overall Study|at sponsor request|0|||
124986105|NCT01820585|449574793|FG000|Overall Study|Pregnancy|0|||
124986106|NCT01820585|449574794|FG001|Overall Study|Pregnancy|1|||
124986107|NCT01820585|449574795|FG002|Overall Study|Pregnancy|0|||
124986108|NCT01820585|449574796|FG003|Overall Study|Pregnancy|0|||
124986109|NCT00548262|449574797|FG000|Overall Study|Death|21|||
124986110|NCT00548262|449574797|FG000|Overall Study|Adverse Event|2|||
124986111|NCT00548262|449574797|FG000|Overall Study|Lack of Efficacy|4|||
124986112|NCT00548262|449574797|FG000|Overall Study|Lost to Follow-up|1|||
124986113|NCT00548262|449574797|FG000|Overall Study|Other|3|||
124986114|NCT00548262|449574797|FG000|Overall Study|Withdrawal by Subject|1|||
124986115|NCT01712659|449574798|FG000|Dose Escalation|Physician Decision|0|||
124986116|NCT01712659|449574799|FG001|Dose Escalation|Physician Decision|1|||
124986117|NCT01712659|449574800|FG002|Dose Escalation|Physician Decision|0|||
124986118|NCT01712659|449574801|FG003|Dose Escalation|Physician Decision|0|||
124986119|NCT01712659|449574802|FG004|Dose Escalation|Physician Decision|0|||
124986120|NCT01712659|449574798|FG000|Dose Escalation|Unable to take study drug|0|||
124986121|NCT01712659|449574799|FG001|Dose Escalation|Unable to take study drug|1|||
124986122|NCT01712659|449574800|FG002|Dose Escalation|Unable to take study drug|0|||
124986123|NCT01712659|449574801|FG003|Dose Escalation|Unable to take study drug|0|||
124986124|NCT01712659|449574802|FG004|Dose Escalation|Unable to take study drug|0|||
124986125|NCT01712659|449574798|FG000|Dose Expansion|Early disease progression|1|||
124986126|NCT01712659|449574799|FG001|Dose Expansion|Early disease progression|0|||
124986127|NCT01712659|449574800|FG002|Dose Expansion|Early disease progression|0|||
124986128|NCT01712659|449574801|FG003|Dose Expansion|Early disease progression|0|||
124986129|NCT01712659|449574802|FG004|Dose Expansion|Early disease progression|0|||
124986130|NCT01712659|449574798|FG000|Dose Expansion|Physician Decision|1|||
124986131|NCT01712659|449574799|FG001|Dose Expansion|Physician Decision|0|||
124986132|NCT01712659|449574800|FG002|Dose Expansion|Physician Decision|0|||
124986133|NCT01712659|449574801|FG003|Dose Expansion|Physician Decision|0|||
124986134|NCT01712659|449574802|FG004|Dose Expansion|Physician Decision|0|||
124986135|NCT02442336|449574805|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
124986136|NCT02442336|449574805|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
124986137|NCT02442336|449574805|FG000|Overall Study|Lost to Follow-up|11|||
124986138|NCT00844532|449574808|FG000|Overall Study|Death|16|||
124986139|NCT00844532|449574808|FG000|Overall Study|Withdrawal by Subject|16|||
124986140|NCT00844532|449574808|FG000|Overall Study|Lost to Follow-up|7|||
124986141|NCT03189745|449574809|FG000|Overall Study|Conflict in work schedule of participant|1|||
124986142|NCT03189745|449574810|FG001|Overall Study|Conflict in work schedule of participant|1|||
124986143|NCT01993927|449574811|FG000|Overall Study|Case Report Forms Uncollected|18|||
124986144|NCT01993927|449574811|FG000|Overall Study|Protocol Violation|11|||
124986145|NCT00895154|449574812|FG000|Overall Study|Lost to Follow-up|1|||
124986146|NCT00895154|449574813|FG001|Overall Study|Lost to Follow-up|1|||
124986147|NCT00895154|449574812|FG000|Overall Study|Withdrawal by Subject|0|||
124986148|NCT00895154|449574813|FG001|Overall Study|Withdrawal by Subject|1|||
124986149|NCT02729831|449574814|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
124986150|NCT02729831|449574815|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
124986151|NCT02729831|449574816|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
124986152|NCT02729831|449574817|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
124986153|NCT02729831|449574814|FG000|1 Week Post-visit|Lost to Follow-up|43|||
124986154|NCT02729831|449574815|FG001|1 Week Post-visit|Lost to Follow-up|40|||
124986155|NCT02729831|449574816|FG002|1 Week Post-visit|Lost to Follow-up|38|||
124986156|NCT02729831|449574817|FG003|1 Week Post-visit|Lost to Follow-up|36|||
124986157|NCT02729831|449574814|FG000|6 Month Follow-up|Lost to Follow-up|54|||
124986158|NCT02729831|449574815|FG001|6 Month Follow-up|Lost to Follow-up|51|||
124986159|NCT02729831|449574816|FG002|6 Month Follow-up|Lost to Follow-up|48|||
124986160|NCT02729831|449574817|FG003|6 Month Follow-up|Lost to Follow-up|42|||
124986161|NCT02729831|449574814|FG000|6 Month Follow-up|Death|1|||
124986162|NCT02729831|449574815|FG001|6 Month Follow-up|Death|3|||
124986163|NCT02729831|449574816|FG002|6 Month Follow-up|Death|0|||
124986164|NCT02729831|449574817|FG003|6 Month Follow-up|Death|1|||
124986165|NCT01747551|449574818|FG000|Overall Study|Progressive Disease|24|||
124986166|NCT01747551|449574819|FG001|Overall Study|Progressive Disease|17|||
124986167|NCT01747551|449574818|FG000|Overall Study|Death|3|||
124986168|NCT01747551|449574819|FG001|Overall Study|Death|1|||
124986169|NCT01747551|449574818|FG000|Overall Study|Adverse Event|7|||
124986170|NCT01747551|449574819|FG001|Overall Study|Adverse Event|1|||
124986171|NCT01747551|449574818|FG000|Overall Study|Prolonged Treatment Delay|2|||
124986172|NCT01747551|449574819|FG001|Overall Study|Prolonged Treatment Delay|0|||
124986173|NCT01747551|449574818|FG000|Overall Study|Withdrawal by Subject|3|||
124986174|NCT01747551|449574819|FG001|Overall Study|Withdrawal by Subject|1|||
124986175|NCT01747551|449574818|FG000|Overall Study|Physician Decision|2|||
124986176|NCT01747551|449574819|FG001|Overall Study|Physician Decision|1|||
124986177|NCT01747551|449574818|FG000|Overall Study|Other|2|||
124986178|NCT01747551|449574819|FG001|Overall Study|Other|0|||
124986179|NCT01142115|449574820|FG000|First Intervention|Lack of Efficacy|1|||
124986180|NCT01142115|449574821|FG001|First Intervention|Lack of Efficacy|1|||
124986181|NCT01142115|449574820|FG000|First Intervention|Adverse Event|1|||
124986182|NCT01142115|449574821|FG001|First Intervention|Adverse Event|0|||
125314047|NCT02043938|450779368|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
124986183|NCT03208036|449574822|FG000|Baseline Assessment|Withdrawal by Subject|1|||
124986184|NCT03208036|449574823|FG001|Baseline Assessment|Withdrawal by Subject|1|||
124986185|NCT03208036|449574822|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
124986186|NCT03208036|449574823|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
124986187|NCT03208036|449574822|FG000|Intervention|Withdrawal by Subject|3|||
124986188|NCT03208036|449574823|FG001|Intervention|Withdrawal by Subject|2|||
124986189|NCT03208036|449574822|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
124986190|NCT03208036|449574823|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
124986191|NCT02091206|449574824|FG000|Treatment Period|Adverse Event|0|||
124986192|NCT02091206|449574825|FG001|Treatment Period|Adverse Event|1|||
124986193|NCT02091206|449574826|FG002|Treatment Period|Adverse Event|0|||
124986194|NCT02091206|449574827|FG003|Treatment Period|Adverse Event|0|||
124986195|NCT02091206|449574824|FG000|Treatment Period|Met withdrawal criteria|0|||
124986196|NCT02091206|449574825|FG001|Treatment Period|Met withdrawal criteria|0|||
124986197|NCT02091206|449574826|FG002|Treatment Period|Met withdrawal criteria|1|||
124986198|NCT02091206|449574827|FG003|Treatment Period|Met withdrawal criteria|0|||
124986199|NCT02091206|449574824|FG000|Taper Period|Participant refused study drug|1|||
124986200|NCT02091206|449574825|FG001|Taper Period|Participant refused study drug|0|||
124986201|NCT02091206|449574826|FG002|Taper Period|Participant refused study drug|0|||
124986202|NCT02091206|449574827|FG003|Taper Period|Participant refused study drug|1|||
124986203|NCT02091206|449574824|FG000|Taper Period|Lost to Follow-up|0|||
124986204|NCT02091206|449574825|FG001|Taper Period|Lost to Follow-up|0|||
124986205|NCT02091206|449574826|FG002|Taper Period|Lost to Follow-up|0|||
124986206|NCT02091206|449574827|FG003|Taper Period|Lost to Follow-up|1|||
124986207|NCT00700778|449574828|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
124986208|NCT03381339|449574829|FG000|Overall Study|Protocol Violation|4|||
124986209|NCT03381339|449574830|FG001|Overall Study|Protocol Violation|3|||
124986210|NCT03381339|449574829|FG000|Overall Study|Lost to Follow-up|0|||
124986211|NCT03381339|449574830|FG001|Overall Study|Lost to Follow-up|1|||
124986212|NCT04927247|449574833|FG000|Overall Study|Other|2|||
124986213|NCT04927247|449574834|FG001|Overall Study|Other|1|||
124986214|NCT04927247|449574833|FG000|Overall Study|Physician Decision|0|||
124986215|NCT04927247|449574834|FG001|Overall Study|Physician Decision|1|||
124986216|NCT04927247|449574833|FG000|Overall Study|Adverse Event|1|||
124986217|NCT04927247|449574834|FG001|Overall Study|Adverse Event|0|||
124986218|NCT00591851|449574835|FG000|Overall Study|Withdrawal by Subject|3|||
124986219|NCT00591851|449574835|FG000|Overall Study|Adverse Event|2|||
124986220|NCT00591851|449574835|FG000|Overall Study|Progressive Disease|1|||
124986221|NCT04664400|449574836|FG000|Overall Study|Withdrawal by Subject|2|||
124986222|NCT01011153|449574841|FG000|Overall Study|Less than 78 cases completed|8|||
124986223|NCT01011153|449574842|FG001|Overall Study|Less than 78 cases completed|11|||
124986224|NCT01011153|449574843|FG002|Overall Study|Less than 78 cases completed|9|||
124986225|NCT03014479|449574844|FG000|Overall Study|Adverse Event|0|||
124986226|NCT03014479|449574845|FG001|Overall Study|Adverse Event|1|||
124986227|NCT03014479|449574844|FG000|Overall Study|Voluntary Withdrawal|0|||
124986228|NCT03014479|449574845|FG001|Overall Study|Voluntary Withdrawal|2|||
124986229|NCT03014479|449574844|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
124986230|NCT03014479|449574845|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
124986231|NCT02217501|449574854|FG000|Overall Study|Death|3|||
124986232|NCT02217501|449574855|FG001|Overall Study|Death|4|||
124986233|NCT02019667|449574856|FG000|First Intervention (6 Months)|Adverse Event|0|||
124986234|NCT02019667|449574857|FG001|First Intervention (6 Months)|Adverse Event|1|||
124986235|NCT02019667|449574856|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
124986236|NCT02019667|449574857|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
124986237|NCT02019667|449574856|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
124986238|NCT02019667|449574857|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
124986239|NCT03981861|449574861|FG000|Overall Study|Withdrawal by Subject|3|||
124986240|NCT00432666|449576601|FG000|Main Period|Adverse Event|1|||
124986241|NCT00432666|449576602|FG001|Main Period|Adverse Event|1|||
124986242|NCT00432666|449576601|FG000|Main Period|Consent Withdrawn|1|||
124986243|NCT00432666|449576602|FG001|Main Period|Consent Withdrawn|0|||
124986244|NCT00432666|449576601|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
124986245|NCT00432666|449576602|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
124986246|NCT00432666|449576601|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
124986247|NCT00432666|449576602|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
124986248|NCT00432666|449576601|FG000|Open-Label Extension Period|Adverse Event|5|||
124986249|NCT00432666|449576602|FG001|Open-Label Extension Period|Adverse Event|0|||
124986250|NCT00432666|449576601|FG000|Open-Label Extension Period|Consent withdrawn|10|||
124986251|NCT00432666|449576602|FG001|Open-Label Extension Period|Consent withdrawn|0|||
124986252|NCT00432666|449576601|FG000|Open-Label Extension Period|Physician Decision|3|||
124986253|NCT00432666|449576602|FG001|Open-Label Extension Period|Physician Decision|0|||
124986254|NCT00978627|449576603|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
124986255|NCT00978627|449576604|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
124986256|NCT00978627|449576603|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
124986257|NCT00978627|449576604|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
124986258|NCT00978627|449576603|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
124986259|NCT00978627|449576604|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
124986260|NCT00978627|449576603|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
124986261|NCT00978627|449576604|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
124986262|NCT00978627|449576603|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
124986263|NCT00978627|449576604|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
124986264|NCT00978627|449576603|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
124986265|NCT00978627|449576604|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
124986266|NCT00978627|449576603|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
124986267|NCT00978627|449576604|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
125314048|NCT02043938|450779368|FG000|Overall Study|No show by subject|1|||
124986268|NCT00978627|449576603|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
124986269|NCT00978627|449576604|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
124986270|NCT00978627|449576603|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
124986271|NCT00978627|449576604|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
124986272|NCT03037931|449576607|FG000|Overall Study|Death|354|||
124986273|NCT03037931|449576608|FG001|Overall Study|Death|367|||
124986274|NCT03037931|449576607|FG000|Overall Study|Lost to Follow-up|7|||
124986275|NCT03037931|449576608|FG001|Overall Study|Lost to Follow-up|4|||
124986276|NCT03037931|449576607|FG000|Overall Study|Withdrawal by Subject|48|||
124986277|NCT03037931|449576608|FG001|Overall Study|Withdrawal by Subject|41|||
124986278|NCT00605215|449576609|FG000|Overall Study|Death|0|||
124986279|NCT00605215|449576610|FG001|Overall Study|Death|0|||
124986280|NCT00605215|449576611|FG002|Overall Study|Death|1|||
124986281|NCT00605215|449576609|FG000|Overall Study|Adverse Event|19|||
124986282|NCT00605215|449576610|FG001|Overall Study|Adverse Event|21|||
124986283|NCT00605215|449576611|FG002|Overall Study|Adverse Event|26|||
124986284|NCT00605215|449576609|FG000|Overall Study|Refusal to sign the re-consent form|8|||
124986285|NCT00605215|449576610|FG001|Overall Study|Refusal to sign the re-consent form|3|||
124986286|NCT00605215|449576611|FG002|Overall Study|Refusal to sign the re-consent form|3|||
124986287|NCT00605215|449576609|FG000|Overall Study|Withdrawal by Subject|39|||
124986288|NCT00605215|449576610|FG001|Overall Study|Withdrawal by Subject|37|||
124986289|NCT00605215|449576611|FG002|Overall Study|Withdrawal by Subject|27|||
124986290|NCT00605215|449576609|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
124986291|NCT00605215|449576610|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
124986292|NCT00605215|449576611|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
124986293|NCT00605215|449576609|FG000|Overall Study|Protocol Violation|3|||
124986294|NCT00605215|449576610|FG001|Overall Study|Protocol Violation|4|||
124986295|NCT00605215|449576611|FG002|Overall Study|Protocol Violation|1|||
124986296|NCT00605215|449576609|FG000|Overall Study|Pregnancy|8|||
124986297|NCT00605215|449576610|FG001|Overall Study|Pregnancy|5|||
124986298|NCT00605215|449576611|FG002|Overall Study|Pregnancy|4|||
124986299|NCT00605215|449576609|FG000|Overall Study|Lost to Follow-up|8|||
124986300|NCT00605215|449576610|FG001|Overall Study|Lost to Follow-up|5|||
124986301|NCT00605215|449576611|FG002|Overall Study|Lost to Follow-up|2|||
124986302|NCT00605215|449576609|FG000|Overall Study|Other than specified|0|||
124986303|NCT00605215|449576610|FG001|Overall Study|Other than specified|2|||
124986304|NCT00605215|449576611|FG002|Overall Study|Other than specified|1|||
124986305|NCT02914275|449576612|FG000|Overall Study|Lost to Follow-up|84|||
124986306|NCT02914275|449576613|FG001|Overall Study|Lost to Follow-up|29|||
124986307|NCT02914275|449576612|FG000|Overall Study|Withdrawal by Subject|26|||
124986308|NCT02914275|449576613|FG001|Overall Study|Withdrawal by Subject|10|||
124986309|NCT02914275|449576612|FG000|Overall Study|Protocol Violation|1|||
124986310|NCT02914275|449576613|FG001|Overall Study|Protocol Violation|1|||
124986311|NCT02914275|449576612|FG000|Overall Study|Physician Decision|3|||
124986312|NCT02914275|449576613|FG001|Overall Study|Physician Decision|1|||
124986313|NCT02914275|449576612|FG000|Overall Study|Other|4|||
124986314|NCT02914275|449576613|FG001|Overall Study|Other|1|||
124986315|NCT02914275|449576612|FG000|Overall Study|Excluded due to invalid informed consent|3|||
124986316|NCT02914275|449576613|FG001|Overall Study|Excluded due to invalid informed consent|0|||
124986317|NCT02366468|449576617|FG000|Overall Study|Adverse Event|2|||
124986318|NCT02366468|449576618|FG001|Overall Study|Adverse Event|0|||
124986319|NCT02366468|449576617|FG000|Overall Study|Withdrawal by Subject|1|||
124986320|NCT02366468|449576618|FG001|Overall Study|Withdrawal by Subject|5|||
124986321|NCT02366468|449576617|FG000|Overall Study|Lost to Follow-up|2|||
124986322|NCT02366468|449576618|FG001|Overall Study|Lost to Follow-up|0|||
124986323|NCT02366468|449576617|FG000|Overall Study|Death|1|||
124986324|NCT02366468|449576618|FG001|Overall Study|Death|2|||
124986325|NCT02366468|449576617|FG000|Overall Study|Other|0|||
124986326|NCT02366468|449576618|FG001|Overall Study|Other|2|||
124986327|NCT00446043|449576619|FG000|Overall Study|Adverse Event|9|||
125314049|NCT02043938|450779368|FG000|Overall Study|Investigator decision|1|||
125314050|NCT00248495|450779369|FG000|Overall Study|Withdrawal by Subject|1|||
125314051|NCT03812380|450779370|FG000|Overall Study|Protocol Violation|3|||
125314052|NCT03812380|450779371|FG001|Overall Study|Protocol Violation|3|||
124986328|NCT00446043|449576619|FG000|Overall Study|Withdrawal by Subject|70|||
124986329|NCT00446043|449576619|FG000|Overall Study|Protocol Violation|2|||
124986330|NCT00446043|449576619|FG000|Overall Study|Lost to Follow-up|42|||
124986331|NCT00446043|449576619|FG000|Overall Study|Pregnancy|2|||
125314053|NCT03812380|450779370|FG000|Overall Study|Withdrawal by Subject|5|||
124986332|NCT04772898|449576620|FG000|Overall Study|Withdrawal by Subject|0|||
124986333|NCT04772898|449576621|FG001|Overall Study|Withdrawal by Subject|1|||
124986334|NCT02947087|449576622|FG000|Overall Study|Withdrawal by Subject|3|||
124986335|NCT02947087|449576623|FG001|Overall Study|Withdrawal by Subject|2|||
124986336|NCT01879722|449576627|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
124986337|NCT01879722|449576628|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
124986338|NCT01879722|449576629|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
124986339|NCT01879722|449576630|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
124986340|NCT01879722|449576631|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
124986341|NCT01879722|449576632|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
124986342|NCT01879722|449576633|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
124986343|NCT01879722|449576634|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
124986344|NCT01879722|449576635|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
124986345|NCT01879722|449576636|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
124986346|NCT01879722|449576627|FG000|Overall Study|Voluntary Withdrawal|0|||
124986347|NCT01879722|449576628|FG001|Overall Study|Voluntary Withdrawal|0|||
124986348|NCT01879722|449576629|FG002|Overall Study|Voluntary Withdrawal|0|||
124986349|NCT01879722|449576630|FG003|Overall Study|Voluntary Withdrawal|0|||
124986350|NCT01879722|449576631|FG004|Overall Study|Voluntary Withdrawal|0|||
124986351|NCT01879722|449576632|FG005|Overall Study|Voluntary Withdrawal|0|||
124986352|NCT01879722|449576633|FG006|Overall Study|Voluntary Withdrawal|0|||
124986353|NCT01879722|449576634|FG007|Overall Study|Voluntary Withdrawal|0|||
124986354|NCT01879722|449576635|FG008|Overall Study|Voluntary Withdrawal|1|||
124986355|NCT01879722|449576636|FG009|Overall Study|Voluntary Withdrawal|0|||
124986356|NCT01253304|449576639|FG000|Overall Study|Adverse Event|0|||
124986357|NCT01253304|449576640|FG001|Overall Study|Adverse Event|0|||
124986358|NCT01253304|449576641|FG002|Overall Study|Adverse Event|0|||
124986359|NCT01253304|449576642|FG003|Overall Study|Adverse Event|1|||
124986360|NCT01327495|449576643|FG000|Overall Study|Adverse Event|2|||
124986361|NCT01327495|449576644|FG001|Overall Study|Adverse Event|1|||
124986362|NCT01327495|449576645|FG002|Overall Study|Adverse Event|1|||
124986363|NCT01327495|449576646|FG003|Overall Study|Adverse Event|0|||
124986364|NCT01327495|449576647|FG004|Overall Study|Adverse Event|0|||
124986365|NCT01327495|449576648|FG005|Overall Study|Adverse Event|2|||
124986366|NCT01327495|449576643|FG000|Overall Study|Withdrawal by Subject|0|||
124986367|NCT01327495|449576644|FG001|Overall Study|Withdrawal by Subject|1|||
124986368|NCT01327495|449576645|FG002|Overall Study|Withdrawal by Subject|1|||
124986369|NCT01327495|449576646|FG003|Overall Study|Withdrawal by Subject|0|||
124986370|NCT01327495|449576647|FG004|Overall Study|Withdrawal by Subject|1|||
124986371|NCT01327495|449576648|FG005|Overall Study|Withdrawal by Subject|0|||
124986372|NCT01327495|449576643|FG000|Overall Study|Physician Decision|0|||
124986373|NCT01327495|449576644|FG001|Overall Study|Physician Decision|0|||
124986374|NCT01327495|449576645|FG002|Overall Study|Physician Decision|0|||
124986375|NCT01327495|449576646|FG003|Overall Study|Physician Decision|0|||
124986376|NCT01327495|449576647|FG004|Overall Study|Physician Decision|2|||
124986377|NCT01327495|449576648|FG005|Overall Study|Physician Decision|0|||
124986378|NCT00006011|449576650|FG000|Overall Study|Disease progression|13|||
124986379|NCT00006011|449576651|FG001|Overall Study|Disease progression|6|||
124986380|NCT00006011|449576652|FG002|Overall Study|Disease progression|26|||
124986381|NCT00006011|449576650|FG000|Overall Study|Refused further treatment|15|||
124986382|NCT00006011|449576651|FG001|Overall Study|Refused further treatment|13|||
124986383|NCT00006011|449576652|FG002|Overall Study|Refused further treatment|26|||
124986384|NCT00006011|449576650|FG000|Overall Study|Adverse Event|15|||
124986385|NCT00006011|449576651|FG001|Overall Study|Adverse Event|39|||
124986386|NCT00006011|449576652|FG002|Overall Study|Adverse Event|5|||
124986387|NCT00006011|449576650|FG000|Overall Study|Death|0|||
124986388|NCT00006011|449576651|FG001|Overall Study|Death|1|||
124986389|NCT00006011|449576652|FG002|Overall Study|Death|2|||
124986390|NCT00006011|449576650|FG000|Overall Study|Other|4|||
124986391|NCT00006011|449576651|FG001|Overall Study|Other|2|||
124986392|NCT00006011|449576652|FG002|Overall Study|Other|5|||
124986393|NCT00006011|449576650|FG000|Overall Study|Ineligible|18|||
124986394|NCT00006011|449576651|FG001|Overall Study|Ineligible|16|||
124986395|NCT00006011|449576652|FG002|Overall Study|Ineligible|9|||
124986396|NCT02207569|449576658|FG000|1-Month|Death|6|||
124986397|NCT02207569|449576658|FG000|1-Month|Withdrawal by Subject|2|||
124986398|NCT02207569|449576658|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
124986399|NCT02207569|449576658|FG000|6-Month|Death|8|||
124986400|NCT02207569|449576658|FG000|6-Month|Withdrawal by Subject|2|||
124986401|NCT02207569|449576658|FG000|12-Month|Death|14|||
124986402|NCT02207569|449576658|FG000|12-Month|Withdrawal by Subject|2|||
124986403|NCT02207569|449576658|FG000|24-Month|Death|23|||
124986404|NCT02207569|449576658|FG000|24-Month|Withdrawal by Subject|3|||
124986405|NCT02207569|449576658|FG000|36-Month|Death|23|||
124986406|NCT02207569|449576658|FG000|36-Month|Withdrawal by Subject|4|||
124986407|NCT02207569|449576658|FG000|48-Month|Death|25|||
124986408|NCT02207569|449576658|FG000|48-Month|Withdrawal by Subject|2|||
124986409|NCT02207569|449576658|FG000|48-Month|Lost to Follow-up|4|||
124986410|NCT02207569|449576658|FG000|60-Month|Death|1|||
124986411|NCT02207569|449576658|FG000|60-Month|Lost to Follow-up|1|||
124986412|NCT02207569|449576658|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
124986413|NCT02207569|449576658|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
124986414|NCT01844687|449576659|FG000|Visit 1|Protocol Violation|3|||
124986415|NCT01844687|449576659|FG000|Visit 1|Lost to Follow-up|5|||
124986416|NCT01844687|449576659|FG000|Visit 2|Withdrawal by Subject|1|||
124986417|NCT01844687|449576659|FG000|Visit 2|Protocol Violation|1|||
124986418|NCT01844687|449576659|FG000|Visit 3|Lost to Follow-up|1|||
125314054|NCT03812380|450779371|FG001|Overall Study|Withdrawal by Subject|4|||
125314055|NCT03812380|450779370|FG000|Overall Study|Early termination of study|14|||
125314056|NCT03812380|450779371|FG001|Overall Study|Early termination of study|14|||
125314057|NCT01285401|450779372|FG000|Overall Study|Prematurely withdrawn from the study|17|||
125314058|NCT01285401|450779373|FG001|Overall Study|Prematurely withdrawn from the study|29|||
124872503|NCT00117676|449154126|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
124872504|NCT00117676|449154127|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
124872505|NCT00117676|449154126|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
124872506|NCT00117676|449154127|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
124872507|NCT00952822|449154128|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
124872508|NCT00952822|449154129|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
124872509|NCT00952822|449154130|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
124872510|NCT00952822|449154131|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
124872511|NCT00952822|449154128|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
124872512|NCT00952822|449154129|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
124872513|NCT00952822|449154130|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
124872514|NCT00952822|449154131|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
124872515|NCT04555096|449154135|FG000|Overall Study|Death|4|||
124872516|NCT04555096|449154136|FG001|Overall Study|Death|4|||
124872517|NCT04555096|449154135|FG000|Overall Study|Withdrawal by Subject|1|||
124872518|NCT04555096|449154136|FG001|Overall Study|Withdrawal by Subject|0|||
124872519|NCT04555096|449154135|FG000|Overall Study|Other|0|||
124872520|NCT04555096|449154136|FG001|Overall Study|Other|1|||
124872521|NCT01464021|449155651|FG000|Overall Study|Withdrawal by Subject|13|||
124872522|NCT01464021|449155651|FG000|Overall Study|Lost to Follow-up|1|||
124872523|NCT01464021|449155651|FG000|Overall Study|Lack of Efficacy|1|||
124872524|NCT01464021|449155651|FG000|Overall Study|various|11|||
124872525|NCT01106430|449155654|FG000|Overall Study|Adverse Event|8|||
124872526|NCT01106430|449155655|FG001|Overall Study|Adverse Event|10|||
124872527|NCT01106430|449155654|FG000|Overall Study|Lack of Efficacy|2|||
124872528|NCT01106430|449155655|FG001|Overall Study|Lack of Efficacy|13|||
124872529|NCT01106430|449155654|FG000|Overall Study|Lost to Follow-up|5|||
124872530|NCT01106430|449155655|FG001|Overall Study|Lost to Follow-up|1|||
124872531|NCT01106430|449155654|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
124872532|NCT01106430|449155655|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
124872533|NCT01106430|449155654|FG000|Overall Study|Moved Out Of State|0|||
124872534|NCT01106430|449155655|FG001|Overall Study|Moved Out Of State|1|||
124872535|NCT01106430|449155654|FG000|Overall Study|Refused To Take Medication|0|||
124872536|NCT01106430|449155655|FG001|Overall Study|Refused To Take Medication|1|||
124872537|NCT01106430|449155654|FG000|Overall Study|Noncompliance|0|||
124872538|NCT01106430|449155655|FG001|Overall Study|Noncompliance|1|||
124872539|NCT01106430|449155654|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
124872540|NCT01106430|449155655|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
124872541|NCT01106430|449155654|FG000|Overall Study|Previous Use Of Marijuana|1|||
124872542|NCT01106430|449155655|FG001|Overall Study|Previous Use Of Marijuana|0|||
124872543|NCT01106430|449155654|FG000|Overall Study|Protocol Violation|7|||
124872544|NCT01106430|449155655|FG001|Overall Study|Protocol Violation|2|||
124872545|NCT01106430|449155654|FG000|Overall Study|Withdrawal by Subject|8|||
124872546|NCT01106430|449155655|FG001|Overall Study|Withdrawal by Subject|4|||
124872547|NCT01424930|449155660|FG000|Overall Study|Adverse Event|0|||
124872548|NCT01424930|449155661|FG001|Overall Study|Adverse Event|1|||
124872549|NCT01424930|449155660|FG000|Overall Study|Death|1|||
124872550|NCT01424930|449155661|FG001|Overall Study|Death|0|||
124872551|NCT01424930|449155660|FG000|Overall Study|Progressive Disease|3|||
124872552|NCT01424930|449155661|FG001|Overall Study|Progressive Disease|6|||
124872553|NCT01424930|449155660|FG000|Overall Study|Screen Failure|0|||
124872554|NCT01424930|449155661|FG001|Overall Study|Screen Failure|1|||
124872555|NCT01424930|449155660|FG000|Overall Study|Reason not specified|0|||
124872556|NCT01424930|449155661|FG001|Overall Study|Reason not specified|6|||
124872557|NCT01078155|449155662|FG000|Overall Study|Adverse Event|7|||
124872558|NCT01078155|449155662|FG000|Overall Study|Lack of Efficacy|16|||
124872559|NCT01078155|449155662|FG000|Overall Study|Participant's Decision|6|||
124872560|NCT01078155|449155662|FG000|Overall Study|Lost to Follow-up|15|||
124872561|NCT03286751|449155663|FG000|Washout Period 1|Withdrawal by Subject|0|||
124872562|NCT03286751|449155664|FG001|Washout Period 1|Withdrawal by Subject|0|||
124872563|NCT03286751|449155665|FG002|Washout Period 1|Withdrawal by Subject|0|||
124872564|NCT03286751|449155666|FG003|Washout Period 1|Withdrawal by Subject|0|||
124986419|NCT01844687|449576659|FG000|Visit 3|Withdrawal by Subject|3|||
125314059|NCT02366312|450779383|FG000|Overall Study|Lost to Follow-up|0|||
125314060|NCT02366312|450779384|FG001|Overall Study|Lost to Follow-up|1|||
124872565|NCT03286751|449155667|FG004|Washout Period 1|Withdrawal by Subject|1|||
124872566|NCT03286751|449155668|FG005|Washout Period 1|Withdrawal by Subject|0|||
124872567|NCT03286751|449155663|FG000|Washout Period 2|Personal Reasons|0|||
124872568|NCT03286751|449155664|FG001|Washout Period 2|Personal Reasons|1|||
124986420|NCT01844687|449576659|FG000|Visit 3|child care problems|1|||
124986421|NCT01844687|449576659|FG000|Visit 4|Pregnancy|1|||
124986422|NCT01844687|449576659|FG000|Visit 4|Lost to Follow-up|1|||
124986423|NCT01844687|449576659|FG000|Visit 4|Withdrawal by Subject|2|||
124986424|NCT05383508|449576662|FG000|Overall Study|Withdrawal by Subject|1|||
124986425|NCT05383508|449576663|FG001|Overall Study|Withdrawal by Subject|0|||
124986426|NCT05383508|449576664|FG002|Overall Study|Withdrawal by Subject|1|||
124986427|NCT05383508|449576665|FG003|Overall Study|Withdrawal by Subject|1|||
124986428|NCT05383508|449576666|FG004|Overall Study|Withdrawal by Subject|2|||
124986429|NCT05383508|449576667|FG005|Overall Study|Withdrawal by Subject|0|||
124986430|NCT03047395|449576668|FG000|Overall Study|Adverse Event|142|||
124986431|NCT03047395|449576668|FG000|Overall Study|Withdrawal by Subject|155|||
124986432|NCT03047395|449576668|FG000|Overall Study|Lost to Follow-up|144|||
124986433|NCT03047395|449576668|FG000|Overall Study|COVID-19 Infection|2|||
124986434|NCT03047395|449576668|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
124986435|NCT03047395|449576668|FG000|Overall Study|Other, Not Specified|117|||
124986436|NCT01859988|449576669|FG000|Overall Study|Withdrawal by Subject|6|||
124986437|NCT01859988|449576670|FG001|Overall Study|Withdrawal by Subject|3|||
124986438|NCT01859988|449576671|FG002|Overall Study|Withdrawal by Subject|4|||
124986439|NCT01859988|449576672|FG003|Overall Study|Withdrawal by Subject|3|||
124986440|NCT01859988|449576673|FG004|Overall Study|Withdrawal by Subject|2|||
124986441|NCT01859988|449576674|FG005|Overall Study|Withdrawal by Subject|2|||
124986442|NCT01859988|449576669|FG000|Overall Study|Lack of Efficacy|1|||
124986443|NCT01859988|449576670|FG001|Overall Study|Lack of Efficacy|1|||
124986444|NCT01859988|449576671|FG002|Overall Study|Lack of Efficacy|5|||
124986445|NCT01859988|449576672|FG003|Overall Study|Lack of Efficacy|0|||
124986446|NCT01859988|449576673|FG004|Overall Study|Lack of Efficacy|7|||
124986447|NCT01859988|449576674|FG005|Overall Study|Lack of Efficacy|9|||
124986448|NCT01859988|449576669|FG000|Overall Study|Physician Decision|1|||
124986449|NCT01859988|449576670|FG001|Overall Study|Physician Decision|3|||
124986450|NCT01859988|449576671|FG002|Overall Study|Physician Decision|1|||
124986451|NCT01859988|449576672|FG003|Overall Study|Physician Decision|3|||
124986452|NCT01859988|449576673|FG004|Overall Study|Physician Decision|4|||
124986453|NCT01859988|449576674|FG005|Overall Study|Physician Decision|1|||
124986454|NCT01859988|449576669|FG000|Overall Study|Adverse Event|2|||
124986455|NCT01859988|449576670|FG001|Overall Study|Adverse Event|1|||
124986456|NCT01859988|449576671|FG002|Overall Study|Adverse Event|3|||
124986457|NCT01859988|449576672|FG003|Overall Study|Adverse Event|1|||
124986458|NCT01859988|449576673|FG004|Overall Study|Adverse Event|2|||
124986459|NCT01859988|449576674|FG005|Overall Study|Adverse Event|2|||
124986460|NCT01859988|449576669|FG000|Overall Study|Lost to Follow-up|1|||
124986461|NCT01859988|449576670|FG001|Overall Study|Lost to Follow-up|2|||
124986462|NCT01859988|449576671|FG002|Overall Study|Lost to Follow-up|3|||
124986463|NCT01859988|449576672|FG003|Overall Study|Lost to Follow-up|0|||
124986464|NCT01859988|449576673|FG004|Overall Study|Lost to Follow-up|3|||
124986465|NCT01859988|449576674|FG005|Overall Study|Lost to Follow-up|2|||
124986466|NCT01859988|449576669|FG000|Overall Study|Protocol Violation|0|||
124986467|NCT01859988|449576670|FG001|Overall Study|Protocol Violation|0|||
124986468|NCT01859988|449576671|FG002|Overall Study|Protocol Violation|1|||
124986469|NCT01859988|449576672|FG003|Overall Study|Protocol Violation|0|||
124986470|NCT01859988|449576673|FG004|Overall Study|Protocol Violation|0|||
124986471|NCT01859988|449576674|FG005|Overall Study|Protocol Violation|0|||
124986472|NCT01859988|449576669|FG000|Overall Study|Other than specified above|0|||
124986473|NCT01859988|449576670|FG001|Overall Study|Other than specified above|2|||
124986474|NCT01859988|449576671|FG002|Overall Study|Other than specified above|11|||
124986475|NCT01859988|449576672|FG003|Overall Study|Other than specified above|3|||
124986476|NCT01859988|449576673|FG004|Overall Study|Other than specified above|5|||
124986477|NCT01859988|449576674|FG005|Overall Study|Other than specified above|3|||
124986478|NCT00635427|449576679|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
124986479|NCT00635427|449576680|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
124986480|NCT00635427|449576681|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
125314061|NCT00354679|450779389|FG000|Overall Study|Patient Not Treated|1|||
125314062|NCT03719131|450779391|FG000|Overall Study|Death|1|||
125314063|NCT03719131|450779392|FG001|Overall Study|Death|2|||
125314064|NCT01544920|450779393|FG000|Overall Study|Adverse Event|0|||
125314065|NCT01544920|450779394|FG001|Overall Study|Adverse Event|3|||
125314066|NCT01544920|450779393|FG000|Overall Study|Death|0|||
125314067|NCT01544920|450779394|FG001|Overall Study|Death|1|||
125314068|NCT01544920|450779393|FG000|Overall Study|Lost to Follow-up|11|||
125314069|NCT01544920|450779394|FG001|Overall Study|Lost to Follow-up|12|||
125314070|NCT01544920|450779393|FG000|Overall Study|Protocol Violation|0|||
125314071|NCT01544920|450779394|FG001|Overall Study|Protocol Violation|2|||
125314072|NCT01544920|450779393|FG000|Overall Study|Physician Decision|4|||
125314073|NCT01544920|450779394|FG001|Overall Study|Physician Decision|1|||
125314074|NCT01544920|450779393|FG000|Overall Study|Withdrawal by Subject|4|||
125314075|NCT01544920|450779394|FG001|Overall Study|Withdrawal by Subject|4|||
125314076|NCT00466440|450779395|FG000|Overall Study|Adverse Event|0|||
125314077|NCT00466440|450779396|FG001|Overall Study|Adverse Event|3|||
125314078|NCT00466440|450779397|FG002|Overall Study|Adverse Event|1|||
125314079|NCT00466440|450779395|FG000|Overall Study|Death|1|||
125314080|NCT00466440|450779396|FG001|Overall Study|Death|1|||
124986481|NCT00635427|449576682|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
124986482|NCT00635427|449576683|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
124986483|NCT00635427|449576679|FG000|Overall Study|Death|0|||
124986484|NCT00635427|449576680|FG001|Overall Study|Death|0|||
124986485|NCT00635427|449576681|FG002|Overall Study|Death|0|||
124986486|NCT00635427|449576682|FG003|Overall Study|Death|1|||
124986487|NCT00635427|449576683|FG004|Overall Study|Death|0|||
124986488|NCT00635427|449576679|FG000|Overall Study|Termination Of Study By Sponsor|12|||
124986489|NCT00635427|449576680|FG001|Overall Study|Termination Of Study By Sponsor|6|||
124986490|NCT00635427|449576681|FG002|Overall Study|Termination Of Study By Sponsor|10|||
124986491|NCT00635427|449576682|FG003|Overall Study|Termination Of Study By Sponsor|6|||
124986492|NCT00635427|449576683|FG004|Overall Study|Termination Of Study By Sponsor|6|||
124986493|NCT00635427|449576679|FG000|Overall Study|Withdrawal Of Consent|0|||
124986494|NCT00635427|449576680|FG001|Overall Study|Withdrawal Of Consent|0|||
124986495|NCT00635427|449576681|FG002|Overall Study|Withdrawal Of Consent|0|||
124986496|NCT00635427|449576682|FG003|Overall Study|Withdrawal Of Consent|2|||
124986497|NCT00635427|449576683|FG004|Overall Study|Withdrawal Of Consent|2|||
124986498|NCT03484273|449576686|FG000|Overall Study|Equipment Malfunction|1|||
124986499|NCT03484273|449576686|FG000|Overall Study|Data excluded from analysis|1|||
124986500|NCT02081417|449576687|FG000|Overall Study|Lost to Follow-up|26|||
124986501|NCT02081417|449576688|FG001|Overall Study|Lost to Follow-up|23|||
124986502|NCT02081417|449576687|FG000|Overall Study|Moved Away|1|||
124986503|NCT02081417|449576688|FG001|Overall Study|Moved Away|2|||
124986504|NCT02081417|449576687|FG000|Overall Study|Incarcerated|2|||
124986505|NCT02081417|449576688|FG001|Overall Study|Incarcerated|2|||
124986506|NCT02081417|449576687|FG000|Overall Study|Death|4|||
124986507|NCT02081417|449576688|FG001|Overall Study|Death|3|||
124986508|NCT02081417|449576687|FG000|Overall Study|Withdrawal by Subject|4|||
124986509|NCT02081417|449576688|FG001|Overall Study|Withdrawal by Subject|0|||
124986510|NCT02081417|449576687|FG000|Overall Study|Admitted to Residential Treatment|2|||
124986511|NCT02081417|449576688|FG001|Overall Study|Admitted to Residential Treatment|0|||
124986512|NCT02081417|449576687|FG000|Overall Study|Did not start treatment|17|||
124986513|NCT02081417|449576688|FG001|Overall Study|Did not start treatment|21|||
124986514|NCT01157676|449576691|FG000|Randomization|Death|1|||
124986515|NCT01157676|449576692|FG001|Randomization|Death|1|||
124986516|NCT01157676|449576691|FG000|Randomization|unresectable|2|||
124986517|NCT01157676|449576692|FG001|Randomization|unresectable|3|||
124986518|NCT01157676|449576691|FG000|Randomization|Withdrawal by Subject|17|||
124986519|NCT01157676|449576692|FG001|Randomization|Withdrawal by Subject|13|||
124986520|NCT01157676|449576691|FG000|Randomization|Physician Decision|1|||
124986521|NCT01157676|449576692|FG001|Randomization|Physician Decision|0|||
124986522|NCT01157676|449576691|FG000|Surgery|underwent open cystectomy|0|||
124986523|NCT01157676|449576692|FG001|Surgery|underwent open cystectomy|4|||
124986524|NCT01157676|449576691|FG000|Surgery|converted to open procedure|0|||
124986525|NCT01157676|449576692|FG001|Surgery|converted to open procedure|5|||
124986526|NCT01157676|449576691|FG000|Surgery|underwent robotic cystectomy|1|||
124986527|NCT01157676|449576692|FG001|Surgery|underwent robotic cystectomy|0|||
124986528|NCT01263665|449576696|FG000|Overall Study|Withdrew Consent|1|||
124986529|NCT01263665|449576696|FG000|Overall Study|Lost to Follow-up|3|||
124986530|NCT01263665|449576696|FG000|Overall Study|Death|2|||
124986531|NCT01263665|449576696|FG000|Overall Study|Amputation above the ankle|1|||
124986532|NCT01263665|449576696|FG000|Overall Study|Surgical Bypass|2|||
124986533|NCT02706899|449576700|FG000|Overall Study|Withdrawal by Subject|1|||
124986534|NCT02706899|449576701|FG001|Overall Study|Withdrawal by Subject|0|||
124986535|NCT02706899|449576700|FG000|Overall Study|Death|8|||
124986536|NCT02706899|449576701|FG001|Overall Study|Death|0|||
124986537|NCT02706899|449576700|FG000|Overall Study|Study Termination by Sponsor|4|||
124986538|NCT02706899|449576701|FG001|Overall Study|Study Termination by Sponsor|6|||
124986539|NCT00324675|449576702|FG000|Overall Study|Adverse Event|1|||
124986540|NCT00324675|449576703|FG001|Overall Study|Adverse Event|0|||
124986541|NCT01435616|449576704|FG000|Overall Study|Adverse Event|39|||
124986542|NCT01435616|449576705|FG001|Overall Study|Adverse Event|21|||
125314081|NCT00466440|450779397|FG002|Overall Study|Death|0|||
125314082|NCT00466440|450779395|FG000|Overall Study|Progressive disease|13|||
125314083|NCT00466440|450779396|FG001|Overall Study|Progressive disease|5|||
125314084|NCT00466440|450779397|FG002|Overall Study|Progressive disease|4|||
124986543|NCT01435616|449576704|FG000|Overall Study|Death|7|||
124986544|NCT01435616|449576705|FG001|Overall Study|Death|2|||
125314085|NCT00466440|450779395|FG000|Overall Study|Lost to Follow-up|0|||
124986545|NCT01435616|449576704|FG000|Overall Study|Lost to Follow-up|22|||
125314086|NCT00466440|450779396|FG001|Overall Study|Lost to Follow-up|1|||
124986546|NCT01435616|449576705|FG001|Overall Study|Lost to Follow-up|13|||
124986547|NCT01435616|449576704|FG000|Overall Study|Protocol Violation|16|||
124986548|NCT01435616|449576705|FG001|Overall Study|Protocol Violation|13|||
124986549|NCT01435616|449576704|FG000|Overall Study|Withdrawal by Subject|66|||
124986550|NCT01435616|449576705|FG001|Overall Study|Withdrawal by Subject|24|||
124986551|NCT01435616|449576704|FG000|Overall Study|Physician Decision|20|||
125314087|NCT00466440|450779397|FG002|Overall Study|Lost to Follow-up|0|||
125314088|NCT00466440|450779395|FG000|Overall Study|Physician Decision|0|||
124986552|NCT01435616|449576705|FG001|Overall Study|Physician Decision|7|||
124986553|NCT01435616|449576704|FG000|Overall Study|Sponsor Decision|1|||
124986554|NCT01435616|449576705|FG001|Overall Study|Sponsor Decision|0|||
124986555|NCT00371683|449576706|FG000|DB Treatment Period-Randomized Patients|Death|1|||
124986556|NCT00371683|449576707|FG001|DB Treatment Period-Randomized Patients|Death|1|||
124986557|NCT00371683|449576706|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
124986558|NCT00371683|449576707|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
124986559|NCT00371683|449576706|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
124986560|NCT00371683|449576707|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
124986561|NCT00371683|449576706|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
124986562|NCT00371683|449576707|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
124986563|NCT00371683|449576706|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
124986564|NCT00371683|449576707|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
124986565|NCT00371683|449576706|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
124986566|NCT00371683|449576707|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
124986567|NCT00371683|449576706|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
124986568|NCT00371683|449576707|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
124986569|NCT00371683|449576706|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
124986570|NCT00371683|449576707|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
124986571|NCT00371683|449576706|FG000|Follow-Up Period - Randomized Patients|Death|0|||
124986572|NCT00371683|449576707|FG001|Follow-Up Period - Randomized Patients|Death|2|||
124986573|NCT00371683|449576706|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
124986574|NCT00371683|449576707|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
124986575|NCT00371683|449576706|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
124986576|NCT00371683|449576707|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
124986577|NCT03122223|449576708|FG000|Overall Study|Withdrawal by Subject|2|||
124986578|NCT03122223|449576709|FG001|Overall Study|Withdrawal by Subject|2|||
124986579|NCT03122223|449576710|FG002|Overall Study|Withdrawal by Subject|1|||
124986580|NCT03122223|449576711|FG003|Overall Study|Withdrawal by Subject|0|||
125314089|NCT00466440|450779396|FG001|Overall Study|Physician Decision|1|||
125314090|NCT00466440|450779397|FG002|Overall Study|Physician Decision|2|||
125314091|NCT00466440|450779395|FG000|Overall Study|Protocol entry criteria not met|0|||
125314092|NCT00466440|450779396|FG001|Overall Study|Protocol entry criteria not met|0|||
125314093|NCT00466440|450779397|FG002|Overall Study|Protocol entry criteria not met|4|||
125314094|NCT00466440|450779395|FG000|Overall Study|Withdrawal by Subject|0|||
125314095|NCT00466440|450779396|FG001|Overall Study|Withdrawal by Subject|1|||
125314096|NCT00466440|450779397|FG002|Overall Study|Withdrawal by Subject|0|||
125314097|NCT00466440|450779395|FG000|Overall Study|Sponsor decision|0|||
125314098|NCT00466440|450779396|FG001|Overall Study|Sponsor decision|0|||
125314099|NCT00466440|450779397|FG002|Overall Study|Sponsor decision|1|||
125314100|NCT03294590|450779400|FG000|Overall Study|Lost to Follow-up|105|||
125314101|NCT03294590|450779401|FG001|Overall Study|Lost to Follow-up|107|||
125314102|NCT00255190|450779404|FG000|Overall Study|Adverse Event|17|||
125314103|NCT00255190|450779405|FG001|Overall Study|Adverse Event|36|||
125314104|NCT00255190|450779404|FG000|Overall Study|Protocol Violation|2|||
125314105|NCT00255190|450779405|FG001|Overall Study|Protocol Violation|2|||
125314106|NCT00255190|450779404|FG000|Overall Study|Lost to Follow-up|10|||
125314107|NCT00255190|450779405|FG001|Overall Study|Lost to Follow-up|27|||
125314108|NCT00255190|450779404|FG000|Overall Study|Withdrew Consent|17|||
125314109|NCT00255190|450779405|FG001|Overall Study|Withdrew Consent|48|||
125314110|NCT00255190|450779404|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
125314111|NCT00255190|450779405|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
125314112|NCT00255190|450779404|FG000|Overall Study|Erosive esophagitis not healed|0|||
125314113|NCT00255190|450779405|FG001|Overall Study|Erosive esophagitis not healed|20|||
125314114|NCT00255190|450779404|FG000|Overall Study|Various|4|||
125314115|NCT00255190|450779405|FG001|Overall Study|Various|23|||
125314116|NCT03367858|450779410|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
125314117|NCT03367858|450779411|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
125314118|NCT03367858|450779410|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
125314119|NCT03367858|450779411|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
125314120|NCT03367858|450779410|FG000|3 Month Follow Up|Lost to Follow-up|8|||
125314121|NCT03367858|450779411|FG001|3 Month Follow Up|Lost to Follow-up|3|||
125314122|NCT03367858|450779410|FG000|3 Month Follow Up|Moved out of study area|2|||
125314123|NCT03367858|450779411|FG001|3 Month Follow Up|Moved out of study area|6|||
125314124|NCT03367858|450779410|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
125314125|NCT03367858|450779411|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
125314126|NCT03367858|450779410|FG000|3 Month Follow Up|MRI contraindication|2|||
125314127|NCT03367858|450779411|FG001|3 Month Follow Up|MRI contraindication|1|||
125314128|NCT03367858|450779410|FG000|3 Month Follow Up|Incarcerated|0|||
125314129|NCT03367858|450779411|FG001|3 Month Follow Up|Incarcerated|1|||
125314130|NCT03367858|450779410|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
124986581|NCT03122223|449576708|FG000|Overall Study|Lost to Follow-up|0|||
124986582|NCT03122223|449576709|FG001|Overall Study|Lost to Follow-up|2|||
124986583|NCT03122223|449576710|FG002|Overall Study|Lost to Follow-up|2|||
124986584|NCT03122223|449576711|FG003|Overall Study|Lost to Follow-up|0|||
124986585|NCT03122223|449576708|FG000|Overall Study|Participant unable to adhere|1|||
124986586|NCT03122223|449576709|FG001|Overall Study|Participant unable to adhere|1|||
124986587|NCT03122223|449576710|FG002|Overall Study|Participant unable to adhere|1|||
124986588|NCT03122223|449576711|FG003|Overall Study|Participant unable to adhere|0|||
124986589|NCT03181789|449576712|FG000|Overall Study|Withdrawal by Subject|0|||
124986590|NCT03181789|449576713|FG001|Overall Study|Withdrawal by Subject|1|||
124986591|NCT03181789|449576714|FG002|Overall Study|Withdrawal by Subject|1|||
124986592|NCT03181789|449576715|FG003|Overall Study|Withdrawal by Subject|0|||
124986593|NCT03181789|449576712|FG000|Overall Study|Lost to Follow-up|7|||
124986594|NCT03181789|449576713|FG001|Overall Study|Lost to Follow-up|1|||
124986595|NCT03181789|449576714|FG002|Overall Study|Lost to Follow-up|0|||
124986596|NCT03181789|449576715|FG003|Overall Study|Lost to Follow-up|0|||
124986597|NCT03181789|449576712|FG000|Overall Study|Participant unable to adhere to visit|0|||
124986598|NCT03181789|449576713|FG001|Overall Study|Participant unable to adhere to visit|1|||
124986599|NCT03181789|449576714|FG002|Overall Study|Participant unable to adhere to visit|0|||
124986600|NCT03181789|449576715|FG003|Overall Study|Participant unable to adhere to visit|0|||
124986601|NCT01151410|449576716|FG000|Overall Study|Withdrawal by Subject|3|||
124986602|NCT01151410|449576717|FG001|Overall Study|Withdrawal by Subject|5|||
124986603|NCT01151410|449576716|FG000|Overall Study|Lost to Follow-up|3|||
124986604|NCT01151410|449576717|FG001|Overall Study|Lost to Follow-up|4|||
124986605|NCT01151410|449576716|FG000|Overall Study|Adverse Event|1|||
124986606|NCT01151410|449576717|FG001|Overall Study|Adverse Event|2|||
124986607|NCT01151410|449576716|FG000|Overall Study|Protocol deviation|2|||
125314131|NCT03367858|450779411|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
125314132|NCT03367858|450779410|FG000|6 Month Follow Up|Lost to Follow-up|5|||
125314133|NCT03367858|450779411|FG001|6 Month Follow Up|Lost to Follow-up|2|||
125314134|NCT03367858|450779410|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
125314135|NCT03367858|450779411|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
124986608|NCT01151410|449576717|FG001|Overall Study|Protocol deviation|1|||
124986609|NCT01151410|449576716|FG000|Overall Study|Administrative problems|1|||
124986610|NCT01151410|449576717|FG001|Overall Study|Administrative problems|1|||
124986611|NCT01151410|449576716|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124986612|NCT01151410|449576717|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
124986613|NCT01151410|449576716|FG000|Overall Study|Abnormal laboratory value(s)|0|||
124986614|NCT01151410|449576717|FG001|Overall Study|Abnormal laboratory value(s)|1|||
124986615|NCT04602221|449576718|FG000|Overall Study|Discontinuation of trial treatment|0|||
124986616|NCT04602221|449576719|FG001|Overall Study|Discontinuation of trial treatment|0|||
124986617|NCT04602221|449576720|FG002|Overall Study|Discontinuation of trial treatment|1|||
124986618|NCT04602221|449576721|FG003|Overall Study|Discontinuation of trial treatment|0|||
124986619|NCT04602221|449576722|FG004|Overall Study|Discontinuation of trial treatment|0|||
124986620|NCT04602221|449576723|FG005|Overall Study|Discontinuation of trial treatment|0|||
124986621|NCT04602221|449576724|FG006|Overall Study|Discontinuation of trial treatment|0|||
124986622|NCT04602221|449576725|FG007|Overall Study|Discontinuation of trial treatment|0|||
124986623|NCT04602221|449576726|FG008|Overall Study|Discontinuation of trial treatment|0|||
125314136|NCT03367858|450779410|FG000|12 Month Follow Up|Lost to Follow-up|3|||
125314137|NCT03367858|450779411|FG001|12 Month Follow Up|Lost to Follow-up|3|||
125314138|NCT03367858|450779410|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
125314139|NCT03367858|450779411|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
125314140|NCT01217463|450779414|FG000|Overall Study|Adverse Event|8|||
125314141|NCT01217463|450779415|FG001|Overall Study|Adverse Event|5|||
125314142|NCT01217463|450779414|FG000|Overall Study|Physician Decision|0|||
125314143|NCT01217463|450779415|FG001|Overall Study|Physician Decision|1|||
125314144|NCT01217463|450779414|FG000|Overall Study|Withdrawal by Subject|3|||
125314145|NCT01217463|450779415|FG001|Overall Study|Withdrawal by Subject|0|||
125314146|NCT01217463|450779414|FG000|Overall Study|Surgery on the Target Limb|0|||
125314147|NCT01217463|450779415|FG001|Overall Study|Surgery on the Target Limb|1|||
125314148|NCT01217463|450779414|FG000|Overall Study|Patient Non-compliant|1|||
125314149|NCT01217463|450779415|FG001|Overall Study|Patient Non-compliant|0|||
125314150|NCT01217463|450779414|FG000|Overall Study|Other|1|||
124986624|NCT04602221|449576727|FG009|Overall Study|Discontinuation of trial treatment|0|||
124986625|NCT04602221|449576728|FG010|Overall Study|Discontinuation of trial treatment|0|||
124986626|NCT04602221|449576729|FG011|Overall Study|Discontinuation of trial treatment|0|||
125314151|NCT01217463|450779415|FG001|Overall Study|Other|1|||
125314152|NCT01623115|450779416|FG000|Overall Study|Randomized but not treated|0|||
124986627|NCT04602221|449576730|FG012|Overall Study|Discontinuation of trial treatment|0|||
124986628|NCT04602221|449576731|FG013|Overall Study|Discontinuation of trial treatment|0|||
125314153|NCT01623115|450779417|FG001|Overall Study|Randomized but not treated|1|||
125314154|NCT01623115|450779416|FG000|Overall Study|Physician Decision|1|||
125314155|NCT01623115|450779417|FG001|Overall Study|Physician Decision|0|||
124986629|NCT04602221|449576732|FG014|Overall Study|Discontinuation of trial treatment|0|||
125314156|NCT01623115|450779416|FG000|Overall Study|Participants moved|1|||
125314157|NCT01623115|450779417|FG001|Overall Study|Participants moved|5|||
125314158|NCT01623115|450779416|FG000|Overall Study|Adverse Event|10|||
125314159|NCT01623115|450779417|FG001|Overall Study|Adverse Event|13|||
125314160|NCT01623115|450779416|FG000|Overall Study|Poor compliance to protocol|4|||
125314161|NCT01623115|450779417|FG001|Overall Study|Poor compliance to protocol|10|||
125314162|NCT01623115|450779416|FG000|Overall Study|Consent withdrawn by participant|2|||
125314163|NCT01623115|450779417|FG001|Overall Study|Consent withdrawn by participant|6|||
125314164|NCT01623115|450779416|FG000|Overall Study|Related to study drug administration|0|||
125314165|NCT01623115|450779417|FG001|Overall Study|Related to study drug administration|2|||
125314166|NCT01623115|450779416|FG000|Overall Study|Last visit outside protocol visit window|14|||
125314167|NCT01623115|450779417|FG001|Overall Study|Last visit outside protocol visit window|26|||
125314168|NCT01623115|450779416|FG000|Overall Study|Site closure|1|||
125314169|NCT01623115|450779417|FG001|Overall Study|Site closure|7|||
125314170|NCT01623115|450779416|FG000|Overall Study|Death|0|||
125314171|NCT01623115|450779417|FG001|Overall Study|Death|4|||
125314172|NCT01623115|450779416|FG000|Overall Study|Other than specified above|0|||
125314173|NCT01623115|450779417|FG001|Overall Study|Other than specified above|3|||
125314174|NCT03827655|450779418|FG000|Overall Study|Death|0|||
125314175|NCT03827655|450779419|FG001|Overall Study|Death|0|||
125314176|NCT03827655|450779420|FG002|Overall Study|Death|0|||
125314177|NCT03827655|450779421|FG003|Overall Study|Death|0|||
125314178|NCT03827655|450779422|FG004|Overall Study|Death|1|||
125314179|NCT03827655|450779418|FG000|Overall Study|Protocol Deviation|1|||
125314180|NCT03827655|450779419|FG001|Overall Study|Protocol Deviation|0|||
125314181|NCT03827655|450779420|FG002|Overall Study|Protocol Deviation|1|||
125314182|NCT03827655|450779421|FG003|Overall Study|Protocol Deviation|1|||
125314183|NCT03827655|450779422|FG004|Overall Study|Protocol Deviation|0|||
125314184|NCT03827655|450779418|FG000|Overall Study|Withdrawal by Subject|3|||
125314185|NCT03827655|450779419|FG001|Overall Study|Withdrawal by Subject|2|||
125314186|NCT03827655|450779420|FG002|Overall Study|Withdrawal by Subject|2|||
125314187|NCT03827655|450779421|FG003|Overall Study|Withdrawal by Subject|0|||
125314188|NCT03827655|450779422|FG004|Overall Study|Withdrawal by Subject|1|||
125314189|NCT03827655|450779418|FG000|Overall Study|Reason not Specified|3|||
125314190|NCT03827655|450779419|FG001|Overall Study|Reason not Specified|1|||
125314191|NCT03827655|450779420|FG002|Overall Study|Reason not Specified|1|||
125314192|NCT03827655|450779421|FG003|Overall Study|Reason not Specified|1|||
125314193|NCT03827655|450779422|FG004|Overall Study|Reason not Specified|1|||
125314194|NCT01721161|450779424|FG000|Overall Study|Adverse Event|2|||
125314195|NCT01721161|450779425|FG001|Overall Study|Adverse Event|3|||
125314196|NCT01721161|450779424|FG000|Overall Study|Lost to Follow-up|1|||
125314197|NCT01721161|450779425|FG001|Overall Study|Lost to Follow-up|2|||
125314198|NCT01721161|450779424|FG000|Overall Study|Withdrawal by Subject|1|||
125314199|NCT01721161|450779425|FG001|Overall Study|Withdrawal by Subject|1|||
125314200|NCT01721161|450779424|FG000|Overall Study|Other|0|||
125314201|NCT01721161|450779425|FG001|Overall Study|Other|1|||
125314202|NCT02888106|450779429|FG000|Overall Study|Withdrawal by Subject|1|||
125314203|NCT02888106|450779430|FG001|Overall Study|Withdrawal by Subject|2|||
125314204|NCT02888106|450779431|FG002|Overall Study|Withdrawal by Subject|0|||
125314205|NCT02888106|450779432|FG003|Overall Study|Withdrawal by Subject|1|||
125314206|NCT02888106|450779433|FG004|Overall Study|Withdrawal by Subject|0|||
125314207|NCT02888106|450779434|FG005|Overall Study|Withdrawal by Subject|0|||
125314208|NCT02888106|450779429|FG000|Overall Study|Lost to Follow-up|1|||
125314209|NCT02888106|450779430|FG001|Overall Study|Lost to Follow-up|0|||
125314210|NCT02888106|450779431|FG002|Overall Study|Lost to Follow-up|0|||
125314211|NCT02888106|450779432|FG003|Overall Study|Lost to Follow-up|1|||
125314212|NCT02888106|450779433|FG004|Overall Study|Lost to Follow-up|0|||
125314213|NCT02888106|450779434|FG005|Overall Study|Lost to Follow-up|1|||
125314214|NCT02888106|450779429|FG000|Overall Study|Adverse Event|2|||
125314215|NCT02888106|450779430|FG001|Overall Study|Adverse Event|0|||
124986630|NCT04602221|449576733|FG015|Overall Study|Discontinuation of trial treatment|0|||
124986631|NCT04602221|449576734|FG016|Overall Study|Discontinuation of trial treatment|0|||
124986632|NCT04602221|449576735|FG017|Overall Study|Discontinuation of trial treatment|0|||
124986633|NCT04602221|449576718|FG000|Overall Study|Other than listed|0|||
125314216|NCT02888106|450779431|FG002|Overall Study|Adverse Event|0|||
125314217|NCT02888106|450779432|FG003|Overall Study|Adverse Event|0|||
125314218|NCT02888106|450779433|FG004|Overall Study|Adverse Event|0|||
124986634|NCT04602221|449576719|FG001|Overall Study|Other than listed|0|||
124986635|NCT04602221|449576720|FG002|Overall Study|Other than listed|0|||
124986636|NCT04602221|449576721|FG003|Overall Study|Other than listed|0|||
125314219|NCT02888106|450779434|FG005|Overall Study|Adverse Event|0|||
125314220|NCT02888106|450779429|FG000|Overall Study|Withdrawal of consent|0|||
125314221|NCT02888106|450779430|FG001|Overall Study|Withdrawal of consent|0|||
125314222|NCT02888106|450779431|FG002|Overall Study|Withdrawal of consent|0|||
125314223|NCT02888106|450779432|FG003|Overall Study|Withdrawal of consent|0|||
125314224|NCT02888106|450779433|FG004|Overall Study|Withdrawal of consent|1|||
125314225|NCT02888106|450779434|FG005|Overall Study|Withdrawal of consent|0|||
125314226|NCT02888106|450779429|FG000|Overall Study|Pregnancy|1|||
125314227|NCT02888106|450779430|FG001|Overall Study|Pregnancy|0|||
124986637|NCT04602221|449576722|FG004|Overall Study|Other than listed|0|||
124986638|NCT04602221|449576723|FG005|Overall Study|Other than listed|0|||
124986639|NCT04602221|449576724|FG006|Overall Study|Other than listed|0|||
124986640|NCT04602221|449576725|FG007|Overall Study|Other than listed|0|||
124986641|NCT04602221|449576726|FG008|Overall Study|Other than listed|0|||
124986642|NCT04602221|449576727|FG009|Overall Study|Other than listed|0|||
124986643|NCT04602221|449576728|FG010|Overall Study|Other than listed|0|||
124986644|NCT04602221|449576729|FG011|Overall Study|Other than listed|0|||
124986645|NCT04602221|449576730|FG012|Overall Study|Other than listed|0|||
124986646|NCT04602221|449576731|FG013|Overall Study|Other than listed|0|||
124986647|NCT04602221|449576732|FG014|Overall Study|Other than listed|0|||
124986648|NCT04602221|449576733|FG015|Overall Study|Other than listed|1|||
124986649|NCT04602221|449576734|FG016|Overall Study|Other than listed|0|||
124986650|NCT04602221|449576735|FG017|Overall Study|Other than listed|1|||
124986651|NCT04602221|449576718|FG000|Overall Study|Withdrawal by Subject|0|||
124986652|NCT04602221|449576719|FG001|Overall Study|Withdrawal by Subject|0|||
124986653|NCT04602221|449576720|FG002|Overall Study|Withdrawal by Subject|0|||
124986654|NCT04602221|449576721|FG003|Overall Study|Withdrawal by Subject|0|||
124986655|NCT04602221|449576722|FG004|Overall Study|Withdrawal by Subject|0|||
124986656|NCT04602221|449576723|FG005|Overall Study|Withdrawal by Subject|0|||
124986657|NCT04602221|449576724|FG006|Overall Study|Withdrawal by Subject|0|||
124986658|NCT04602221|449576725|FG007|Overall Study|Withdrawal by Subject|0|||
124986659|NCT04602221|449576726|FG008|Overall Study|Withdrawal by Subject|0|||
124986660|NCT04602221|449576727|FG009|Overall Study|Withdrawal by Subject|0|||
124986661|NCT04602221|449576728|FG010|Overall Study|Withdrawal by Subject|0|||
124986662|NCT04602221|449576729|FG011|Overall Study|Withdrawal by Subject|0|||
124986663|NCT04602221|449576730|FG012|Overall Study|Withdrawal by Subject|1|||
124986664|NCT04602221|449576731|FG013|Overall Study|Withdrawal by Subject|0|||
124986665|NCT04602221|449576732|FG014|Overall Study|Withdrawal by Subject|0|||
124986666|NCT04602221|449576733|FG015|Overall Study|Withdrawal by Subject|0|||
124986667|NCT04602221|449576734|FG016|Overall Study|Withdrawal by Subject|0|||
124986668|NCT04602221|449576735|FG017|Overall Study|Withdrawal by Subject|0|||
124986669|NCT04602221|449576718|FG000|Overall Study|Lost to Follow-up|0|||
124986670|NCT04602221|449576719|FG001|Overall Study|Lost to Follow-up|0|||
124986671|NCT04602221|449576720|FG002|Overall Study|Lost to Follow-up|0|||
124986672|NCT04602221|449576721|FG003|Overall Study|Lost to Follow-up|0|||
124986673|NCT04602221|449576722|FG004|Overall Study|Lost to Follow-up|0|||
124986674|NCT04602221|449576723|FG005|Overall Study|Lost to Follow-up|1|||
124986675|NCT04602221|449576724|FG006|Overall Study|Lost to Follow-up|0|||
124986676|NCT04602221|449576725|FG007|Overall Study|Lost to Follow-up|0|||
124986677|NCT04602221|449576726|FG008|Overall Study|Lost to Follow-up|0|||
124986678|NCT04602221|449576727|FG009|Overall Study|Lost to Follow-up|0|||
124986679|NCT04602221|449576728|FG010|Overall Study|Lost to Follow-up|0|||
124986680|NCT04602221|449576729|FG011|Overall Study|Lost to Follow-up|0|||
124986681|NCT04602221|449576730|FG012|Overall Study|Lost to Follow-up|0|||
124986682|NCT04602221|449576731|FG013|Overall Study|Lost to Follow-up|0|||
124986683|NCT04602221|449576732|FG014|Overall Study|Lost to Follow-up|0|||
124986684|NCT04602221|449576733|FG015|Overall Study|Lost to Follow-up|0|||
124986685|NCT04602221|449576734|FG016|Overall Study|Lost to Follow-up|0|||
124986686|NCT04602221|449576735|FG017|Overall Study|Lost to Follow-up|0|||
124986687|NCT01237587|449576741|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
124986688|NCT01237587|449576742|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
124986689|NCT01237587|449576741|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
124986690|NCT01237587|449576742|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
124986691|NCT01237587|449576741|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
124986692|NCT01237587|449576742|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
124986693|NCT01237587|449576741|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
124986694|NCT01237587|449576742|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
124986695|NCT01237587|449576741|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
124986696|NCT01237587|449576742|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
124986697|NCT01237587|449576741|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
124986698|NCT01237587|449576742|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
125314228|NCT02888106|450779431|FG002|Overall Study|Pregnancy|0|||
125314229|NCT02888106|450779432|FG003|Overall Study|Pregnancy|0|||
124986699|NCT01237587|449576741|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
124986700|NCT01237587|449576742|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
124986701|NCT01237587|449576741|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
125314230|NCT02888106|450779433|FG004|Overall Study|Pregnancy|0|||
124872569|NCT03286751|449155665|FG002|Washout Period 2|Personal Reasons|0|||
124986702|NCT01237587|449576742|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
124986703|NCT01237587|449576741|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
124986704|NCT01237587|449576742|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
124986705|NCT01237587|449576741|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
125314231|NCT02888106|450779434|FG005|Overall Study|Pregnancy|0|||
125314232|NCT01894607|450779435|FG000|Overall Study|Ineligible|1|||
125314233|NCT03259555|450779450|FG000|Overall Study|Adverse Event|6|||
125314234|NCT03259555|450779451|FG001|Overall Study|Adverse Event|4|||
125314235|NCT03259555|450779450|FG000|Overall Study|Lack of Efficacy|6|||
125314236|NCT03259555|450779451|FG001|Overall Study|Lack of Efficacy|4|||
125314237|NCT03259555|450779450|FG000|Overall Study|Lost to Follow-up|0|||
125314238|NCT03259555|450779451|FG001|Overall Study|Lost to Follow-up|2|||
125314239|NCT03259555|450779450|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125314240|NCT03259555|450779451|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125314241|NCT03259555|450779450|FG000|Overall Study|Progressive Disease|0|||
125314242|NCT03259555|450779451|FG001|Overall Study|Progressive Disease|2|||
125314243|NCT03259555|450779450|FG000|Overall Study|Withdrawal by Subject|19|||
125314244|NCT03259555|450779451|FG001|Overall Study|Withdrawal by Subject|16|||
125314245|NCT03259555|450779450|FG000|Overall Study|Physician Decision|1|||
125314246|NCT03259555|450779451|FG001|Overall Study|Physician Decision|2|||
125314247|NCT03259555|450779450|FG000|Overall Study|Other|1|||
125314248|NCT03259555|450779451|FG001|Overall Study|Other|0|||
125314249|NCT04393493|450779452|FG000|First 4 Days of Intervention|Early improvement|5|||
125314250|NCT04393493|450779453|FG001|First 4 Days of Intervention|Early improvement|7|||
125314251|NCT01125800|450779454|FG000|Phase I|Protocol Violation|0|||
124986706|NCT01237587|449576742|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
124986707|NCT01237587|449576741|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
124986708|NCT01237587|449576742|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
124986709|NCT01237587|449576741|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
124986710|NCT01237587|449576742|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
124986711|NCT01237587|449576741|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
124986712|NCT01237587|449576742|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
125314252|NCT01125800|450779455|FG001|Phase I|Protocol Violation|3|||
125314253|NCT01125800|450779456|FG002|Phase I|Protocol Violation|1|||
124986713|NCT01237587|449576741|FG000|Taper Phase|Adverse Event|0|||
125314254|NCT01125800|450779457|FG003|Phase I|Protocol Violation|1|||
125314255|NCT01125800|450779458|FG004|Phase I|Protocol Violation|0|||
125314256|NCT01125800|450779454|FG000|Phase I|Adverse Event|2|||
125314257|NCT01125800|450779455|FG001|Phase I|Adverse Event|2|||
125314258|NCT01125800|450779456|FG002|Phase I|Adverse Event|1|||
125314259|NCT01125800|450779457|FG003|Phase I|Adverse Event|7|||
125314260|NCT01125800|450779458|FG004|Phase I|Adverse Event|0|||
125314261|NCT01125800|450779454|FG000|Phase I|Administrative problems|1|||
125314262|NCT01125800|450779455|FG001|Phase I|Administrative problems|0|||
125314263|NCT01125800|450779456|FG002|Phase I|Administrative problems|0|||
125314264|NCT01125800|450779457|FG003|Phase I|Administrative problems|0|||
125314265|NCT01125800|450779458|FG004|Phase I|Administrative problems|0|||
125314266|NCT01125800|450779454|FG000|Phase I|Withdrawal by Subject|0|||
125314267|NCT01125800|450779455|FG001|Phase I|Withdrawal by Subject|0|||
124986714|NCT01237587|449576742|FG001|Taper Phase|Adverse Event|2|||
124986715|NCT01237587|449576741|FG000|Taper Phase|Protocol Violation|2|||
124986716|NCT01237587|449576742|FG001|Taper Phase|Protocol Violation|0|||
124986717|NCT01237587|449576741|FG000|Taper Phase|Lack of Efficacy|2|||
124986718|NCT01237587|449576742|FG001|Taper Phase|Lack of Efficacy|5|||
124986719|NCT01237587|449576741|FG000|Taper Phase|Parent/Guardian Decision|0|||
124986720|NCT01237587|449576742|FG001|Taper Phase|Parent/Guardian Decision|2|||
124986721|NCT01237587|449576741|FG000|Taper Phase|Sponsor Decision|1|||
124986722|NCT01237587|449576742|FG001|Taper Phase|Sponsor Decision|0|||
124986723|NCT01237587|449576741|FG000|Taper Phase|Withdrawal by Subject|0|||
124986724|NCT01237587|449576742|FG001|Taper Phase|Withdrawal by Subject|1|||
124986725|NCT02656329|449576743|FG000|Overall Study|Lost to Follow-up|2|||
124986726|NCT02656329|449576744|FG001|Overall Study|Lost to Follow-up|3|||
124986727|NCT02656329|449576743|FG000|Overall Study|Withdrawal by Subject|7|||
124986728|NCT02656329|449576744|FG001|Overall Study|Withdrawal by Subject|6|||
124986729|NCT02656329|449576743|FG000|Overall Study|Study termination by Sponsor|150|||
124986730|NCT02656329|449576744|FG001|Overall Study|Study termination by Sponsor|142|||
125314268|NCT01125800|450779456|FG002|Phase I|Withdrawal by Subject|1|||
125314269|NCT01125800|450779457|FG003|Phase I|Withdrawal by Subject|0|||
125314270|NCT01125800|450779458|FG004|Phase I|Withdrawal by Subject|0|||
124986731|NCT02656329|449576743|FG000|Overall Study|Other than specified above|5|||
124986732|NCT02656329|449576744|FG001|Overall Study|Other than specified above|6|||
124986733|NCT01139580|449576745|FG000|Overall Study|Adverse Event|5|||
124986734|NCT01139580|449576746|FG001|Overall Study|Adverse Event|4|||
124986735|NCT01139580|449576745|FG000|Overall Study|Lost to Follow-up|9|||
124986736|NCT01139580|449576746|FG001|Overall Study|Lost to Follow-up|1|||
125314271|NCT01125800|450779454|FG000|Phase I|Disease progression|5|||
125314272|NCT01125800|450779455|FG001|Phase I|Disease progression|4|||
125314273|NCT01125800|450779456|FG002|Phase I|Disease progression|1|||
125314274|NCT01125800|450779457|FG003|Phase I|Disease progression|3|||
125314275|NCT01125800|450779458|FG004|Phase I|Disease progression|0|||
125314276|NCT01125800|450779454|FG000|Phase II|Protocol Violation|0|||
125314277|NCT01125800|450779455|FG001|Phase II|Protocol Violation|0|||
125314278|NCT01125800|450779456|FG002|Phase II|Protocol Violation|0|||
125314279|NCT01125800|450779457|FG003|Phase II|Protocol Violation|0|||
124986737|NCT01139580|449576745|FG000|Overall Study|Lack of Efficacy|0|||
124986738|NCT01139580|449576746|FG001|Overall Study|Lack of Efficacy|2|||
124986739|NCT01139580|449576745|FG000|Overall Study|Withdrawal by Subject|6|||
124986740|NCT01139580|449576746|FG001|Overall Study|Withdrawal by Subject|9|||
124986741|NCT01139580|449576745|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
124986742|NCT01139580|449576746|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
124986743|NCT01139580|449576745|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
124986744|NCT01139580|449576746|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
124986745|NCT01139580|449576745|FG000|Overall Study|Misrandomized|1|||
124986746|NCT01139580|449576746|FG001|Overall Study|Misrandomized|0|||
124986747|NCT01139580|449576745|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
124986748|NCT01139580|449576746|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
124986749|NCT01139580|449576745|FG000|Overall Study|Participant Randomization in Error|0|||
124986750|NCT01139580|449576746|FG001|Overall Study|Participant Randomization in Error|1|||
124986751|NCT00633880|449576751|FG000|Open Label Titration|Lack of Efficacy|1|||
124986752|NCT00633880|449576752|FG001|Open Label Titration|Lack of Efficacy|0|||
124986753|NCT00633880|449576753|FG002|Open Label Titration|Lack of Efficacy|0|||
124986754|NCT00633880|449576751|FG000|Open Label Titration|Adverse Event|13|||
124986755|NCT00633880|449576752|FG001|Open Label Titration|Adverse Event|0|||
124986756|NCT00633880|449576753|FG002|Open Label Titration|Adverse Event|0|||
124986757|NCT00633880|449576751|FG000|Open Label Titration|Treatment Failure|55|||
124986758|NCT00633880|449576752|FG001|Open Label Titration|Treatment Failure|0|||
124986759|NCT00633880|449576753|FG002|Open Label Titration|Treatment Failure|0|||
124986760|NCT00633880|449576751|FG000|Open Label Titration|Protocol Violation|6|||
124986761|NCT00633880|449576752|FG001|Open Label Titration|Protocol Violation|0|||
124986762|NCT00633880|449576753|FG002|Open Label Titration|Protocol Violation|0|||
124986763|NCT00633880|449576751|FG000|Open Label Titration|Physician Decision|1|||
124986764|NCT00633880|449576752|FG001|Open Label Titration|Physician Decision|0|||
124986765|NCT00633880|449576753|FG002|Open Label Titration|Physician Decision|0|||
124986766|NCT00633880|449576751|FG000|Open Label Titration|Withdrawal by Subject|4|||
124986767|NCT00633880|449576752|FG001|Open Label Titration|Withdrawal by Subject|0|||
124986768|NCT00633880|449576753|FG002|Open Label Titration|Withdrawal by Subject|0|||
124986769|NCT00847808|449576760|FG000|Overall Study|Adverse Event|7|||
124986770|NCT00847808|449576760|FG000|Overall Study|Protocol Violation|1|||
124986771|NCT00847808|449576760|FG000|Overall Study|Lost to Follow-up|1|||
124986772|NCT00847808|449576760|FG000|Overall Study|Withdrawal by Subject|4|||
124986773|NCT00847808|449576760|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
124986774|NCT00847808|449576760|FG000|Overall Study|Participant Took Excluded Medication|1|||
124986775|NCT05172050|449576767|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
124986776|NCT05172050|449576768|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
124986777|NCT05172050|449576769|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
124986778|NCT05172050|449576767|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
124986779|NCT05172050|449576768|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
124986780|NCT05172050|449576769|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
124986781|NCT05172050|449576767|FG000|Overall Study|Other|2|||
124986782|NCT05172050|449576768|FG001|Overall Study|Other|2|||
124986783|NCT05172050|449576769|FG002|Overall Study|Other|1|||
124986784|NCT00969709|449578270|FG000|Overall Study|Adverse Event|3|||
124986785|NCT00969709|449578271|FG001|Overall Study|Adverse Event|13|||
124986786|NCT00969709|449578272|FG002|Overall Study|Adverse Event|26|||
124986787|NCT00969709|449578273|FG003|Overall Study|Adverse Event|12|||
124986788|NCT00969709|449578270|FG000|Overall Study|Lack of Efficacy|7|||
124986789|NCT00969709|449578271|FG001|Overall Study|Lack of Efficacy|4|||
124986790|NCT00969709|449578272|FG002|Overall Study|Lack of Efficacy|1|||
124986791|NCT00969709|449578273|FG003|Overall Study|Lack of Efficacy|3|||
124986792|NCT00969709|449578270|FG000|Overall Study|Protocol Violation|9|||
124986793|NCT00969709|449578271|FG001|Overall Study|Protocol Violation|5|||
125210506|NCT01533688|450395581|FG000|Overall Study|Withdrawal by Subject|5|||
125210507|NCT01533688|450395582|FG001|Overall Study|Withdrawal by Subject|4|||
125210508|NCT01533688|450395583|FG002|Overall Study|Withdrawal by Subject|3|||
125210509|NCT01533688|450395581|FG000|Overall Study|Medically unstable|1|||
125210510|NCT01533688|450395582|FG001|Overall Study|Medically unstable|3|||
125210511|NCT01533688|450395583|FG002|Overall Study|Medically unstable|3|||
125210512|NCT01533688|450395581|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
125210513|NCT01533688|450395582|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
125210514|NCT01533688|450395583|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
125210515|NCT04591015|450395584|FG000|Overall Study|Death|6|||
124986794|NCT00969709|449578272|FG002|Overall Study|Protocol Violation|9|||
124986795|NCT00969709|449578273|FG003|Overall Study|Protocol Violation|10|||
124986796|NCT00969709|449578270|FG000|Overall Study|Withdrawal by Subject|9|||
124986797|NCT00969709|449578271|FG001|Overall Study|Withdrawal by Subject|12|||
124986798|NCT00969709|449578272|FG002|Overall Study|Withdrawal by Subject|11|||
124986799|NCT00969709|449578273|FG003|Overall Study|Withdrawal by Subject|23|||
124986800|NCT00969709|449578270|FG000|Overall Study|Lost to Follow-up|10|||
124986801|NCT00969709|449578271|FG001|Overall Study|Lost to Follow-up|14|||
125210516|NCT04591015|450395585|FG001|Overall Study|Death|4|||
124986802|NCT00969709|449578272|FG002|Overall Study|Lost to Follow-up|8|||
124986803|NCT00969709|449578273|FG003|Overall Study|Lost to Follow-up|15|||
124986804|NCT00969709|449578270|FG000|Overall Study|Other reasons|0|||
124986805|NCT00969709|449578271|FG001|Overall Study|Other reasons|0|||
124986806|NCT00969709|449578272|FG002|Overall Study|Other reasons|3|||
124986807|NCT00969709|449578273|FG003|Overall Study|Other reasons|0|||
124986808|NCT02980731|449578274|FG000|Overall Study|Death|63|||
124986809|NCT02980731|449578274|FG000|Overall Study|Withdrawal by Subject|6|||
124986810|NCT02980731|449578274|FG000|Overall Study|Lost to Follow-up|5|||
124986811|NCT02980731|449578274|FG000|Overall Study|Study terminated by Sponsor|4|||
124986812|NCT02980731|449578274|FG000|Overall Study|Completed survival follow-up period|65|||
124986813|NCT02980731|449578274|FG000|Overall Study|COVID-19 infection|1|||
124986814|NCT02980731|449578274|FG000|Overall Study|Other, not specified|66|||
124986815|NCT01342341|449578275|FG000|Overall Study|Lost to Follow-up|4|||
124986816|NCT01342341|449578276|FG001|Overall Study|Lost to Follow-up|4|||
124986817|NCT01238900|449578277|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
124986818|NCT01238900|449578277|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
124986819|NCT00616902|449578278|FG000|Overall Study|Termination of study|6|||
124986820|NCT00616902|449578279|FG001|Overall Study|Termination of study|6|||
124986821|NCT03725085|449578280|FG000|Overall Study|Lost to Follow-up|2|||
124986822|NCT01119105|449578281|FG000|Overall Study|Withdrawal by Subject|1|||
124986823|NCT01119105|449578282|FG001|Overall Study|Withdrawal by Subject|1|||
124986824|NCT01119105|449578283|FG002|Overall Study|Withdrawal by Subject|1|||
124986825|NCT01119105|449578281|FG000|Overall Study|Lost to Follow-up|0|||
124986826|NCT01119105|449578282|FG001|Overall Study|Lost to Follow-up|2|||
125314280|NCT01125800|450779458|FG004|Phase II|Protocol Violation|1|||
125314281|NCT01125800|450779454|FG000|Phase II|Adverse Event|0|||
125314282|NCT01125800|450779455|FG001|Phase II|Adverse Event|0|||
125314283|NCT01125800|450779456|FG002|Phase II|Adverse Event|0|||
125314284|NCT01125800|450779457|FG003|Phase II|Adverse Event|0|||
124986827|NCT01119105|449578283|FG002|Overall Study|Lost to Follow-up|5|||
124986828|NCT01119105|449578281|FG000|Overall Study|Adverse Event|1|||
124986829|NCT01119105|449578282|FG001|Overall Study|Adverse Event|0|||
124986830|NCT01119105|449578283|FG002|Overall Study|Adverse Event|1|||
124986831|NCT01119105|449578281|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
124986832|NCT01119105|449578282|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
124986833|NCT01119105|449578283|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
124986834|NCT01119105|449578281|FG000|Overall Study|Other|1|||
124986835|NCT01119105|449578282|FG001|Overall Study|Other|1|||
124986836|NCT01119105|449578283|FG002|Overall Study|Other|0|||
124986837|NCT01775475|449578284|FG000|Overall Study|Death|3|||
124986838|NCT01775475|449578285|FG001|Overall Study|Death|3|||
124986839|NCT02245737|449578292|FG000|Overall Study|Adverse Event|23|||
125314285|NCT01125800|450779458|FG004|Phase II|Adverse Event|2|||
125314286|NCT01125800|450779454|FG000|Phase II|Disease progression|0|||
125314287|NCT01125800|450779455|FG001|Phase II|Disease progression|0|||
125314288|NCT01125800|450779456|FG002|Phase II|Disease progression|0|||
125314289|NCT01125800|450779457|FG003|Phase II|Disease progression|1|||
125314290|NCT01125800|450779458|FG004|Phase II|Disease progression|8|||
125314291|NCT04332107|450779463|FG000|Day 3|Lost to Follow-up|23|||
125314292|NCT04332107|450779464|FG001|Day 3|Lost to Follow-up|14|||
125314293|NCT04332107|450779463|FG000|Day 3|Missing outcome data|3|||
125314294|NCT04332107|450779464|FG001|Day 3|Missing outcome data|6|||
125314295|NCT04332107|450779463|FG000|Day 14|Lost to Follow-up|13|||
125314296|NCT04332107|450779464|FG001|Day 14|Lost to Follow-up|4|||
125314297|NCT04332107|450779463|FG000|Day 14|Missing outcome data|4|||
125314298|NCT04332107|450779464|FG001|Day 14|Missing outcome data|4|||
125314299|NCT04332107|450779463|FG000|Day 21|Lost to Follow-up|10|||
125314300|NCT04332107|450779464|FG001|Day 21|Lost to Follow-up|2|||
124986840|NCT02245737|449578293|FG001|Overall Study|Adverse Event|26|||
124986841|NCT02245737|449578294|FG002|Overall Study|Adverse Event|33|||
124986842|NCT02245737|449578292|FG000|Overall Study|Condition Worsened|9|||
124986843|NCT02245737|449578293|FG001|Overall Study|Condition Worsened|10|||
124986844|NCT02245737|449578294|FG002|Overall Study|Condition Worsened|9|||
124986845|NCT02245737|449578292|FG000|Overall Study|Death|2|||
124986846|NCT02245737|449578293|FG001|Overall Study|Death|4|||
124986847|NCT02245737|449578294|FG002|Overall Study|Death|4|||
125314301|NCT01670721|450779469|FG000|Overall Study|Participant's decision|15|||
125314302|NCT01670721|450779469|FG000|Overall Study|Other than specified above|38|||
125314303|NCT04970654|450779472|FG000|Overall Study|Withdrawal by parents/guardian|1|||
125314304|NCT04970654|450779473|FG001|Overall Study|Withdrawal by parents/guardian|2|||
124986848|NCT02245737|449578292|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
124986849|NCT02245737|449578293|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
124986850|NCT02245737|449578294|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
124986851|NCT02245737|449578292|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
124986852|NCT02245737|449578293|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
124986853|NCT02245737|449578294|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
125314305|NCT04970654|450779472|FG000|Overall Study|Unclassified|2|||
125314306|NCT04970654|450779473|FG001|Overall Study|Unclassified|1|||
124986854|NCT02245737|449578292|FG000|Overall Study|Lost to Follow-up|2|||
124986855|NCT02245737|449578293|FG001|Overall Study|Lost to Follow-up|5|||
124986856|NCT02245737|449578294|FG002|Overall Study|Lost to Follow-up|4|||
124986857|NCT02245737|449578292|FG000|Overall Study|Other-determined by Investigator|9|||
124986858|NCT02245737|449578293|FG001|Overall Study|Other-determined by Investigator|10|||
124986859|NCT02245737|449578294|FG002|Overall Study|Other-determined by Investigator|10|||
125314307|NCT04970654|450779472|FG000|Overall Study|Lost to Follow-up|1|||
125314308|NCT04970654|450779473|FG001|Overall Study|Lost to Follow-up|0|||
125314309|NCT05579977|450779481|FG000|Treatment Phase|Other|0|||
125314310|NCT05579977|450779482|FG001|Treatment Phase|Other|0|||
125314311|NCT05579977|450779483|FG002|Treatment Phase|Other|0|||
125314312|NCT05579977|450779484|FG003|Treatment Phase|Other|2|||
125314313|NCT05579977|450779485|FG004|Treatment Phase|Other|1|||
125314314|NCT05579977|450779486|FG005|Treatment Phase|Other|2|||
125314315|NCT05579977|450779487|FG006|Treatment Phase|Other|1|||
125314316|NCT05579977|450779488|FG007|Treatment Phase|Other|2|||
125314317|NCT05579977|450779489|FG008|Treatment Phase|Other|2|||
125314318|NCT05579977|450779490|FG009|Treatment Phase|Other|1|||
125314319|NCT05579977|450779491|FG010|Treatment Phase|Other|0|||
125314320|NCT05579977|450779492|FG011|Treatment Phase|Other|0|||
125314321|NCT05579977|450779493|FG012|Treatment Phase|Other|3|||
125314322|NCT05579977|450779481|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
125314323|NCT05579977|450779482|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
125314324|NCT05579977|450779483|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
125314325|NCT05579977|450779484|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
125314326|NCT05579977|450779485|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
125314327|NCT05579977|450779486|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
125314328|NCT05579977|450779487|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
125314329|NCT05579977|450779488|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
125314330|NCT05579977|450779489|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
125314331|NCT05579977|450779490|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
125314332|NCT05579977|450779491|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
125314333|NCT05579977|450779492|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
125314334|NCT05579977|450779493|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
125314335|NCT05579977|450779481|FG000|Treatment Phase|Withdrawal by Subject|2|||
125314336|NCT05579977|450779482|FG001|Treatment Phase|Withdrawal by Subject|0|||
125314337|NCT05579977|450779483|FG002|Treatment Phase|Withdrawal by Subject|0|||
125314338|NCT05579977|450779484|FG003|Treatment Phase|Withdrawal by Subject|1|||
125314339|NCT05579977|450779485|FG004|Treatment Phase|Withdrawal by Subject|2|||
125314340|NCT05579977|450779486|FG005|Treatment Phase|Withdrawal by Subject|0|||
125314341|NCT05579977|450779487|FG006|Treatment Phase|Withdrawal by Subject|1|||
125314342|NCT05579977|450779488|FG007|Treatment Phase|Withdrawal by Subject|8|||
125314343|NCT05579977|450779489|FG008|Treatment Phase|Withdrawal by Subject|3|||
125314344|NCT05579977|450779490|FG009|Treatment Phase|Withdrawal by Subject|3|||
125314345|NCT05579977|450779491|FG010|Treatment Phase|Withdrawal by Subject|5|||
125314346|NCT05579977|450779492|FG011|Treatment Phase|Withdrawal by Subject|1|||
125314347|NCT05579977|450779493|FG012|Treatment Phase|Withdrawal by Subject|3|||
125314348|NCT05579977|450779481|FG000|Treatment Phase|Study terminated by sponsor|70|||
125314349|NCT05579977|450779482|FG001|Treatment Phase|Study terminated by sponsor|70|||
125314350|NCT05579977|450779483|FG002|Treatment Phase|Study terminated by sponsor|61|||
125314351|NCT05579977|450779484|FG003|Treatment Phase|Study terminated by sponsor|59|||
125314352|NCT05579977|450779485|FG004|Treatment Phase|Study terminated by sponsor|63|||
125314353|NCT05579977|450779486|FG005|Treatment Phase|Study terminated by sponsor|53|||
125314354|NCT05579977|450779487|FG006|Treatment Phase|Study terminated by sponsor|66|||
125314355|NCT05579977|450779488|FG007|Treatment Phase|Study terminated by sponsor|48|||
125314356|NCT05579977|450779489|FG008|Treatment Phase|Study terminated by sponsor|47|||
125314357|NCT05579977|450779490|FG009|Treatment Phase|Study terminated by sponsor|37|||
125314358|NCT05579977|450779491|FG010|Treatment Phase|Study terminated by sponsor|44|||
125314359|NCT05579977|450779492|FG011|Treatment Phase|Study terminated by sponsor|36|||
125314360|NCT05579977|450779493|FG012|Treatment Phase|Study terminated by sponsor|32|||
124986860|NCT02245737|449578292|FG000|Overall Study|Physician Decision|6|||
124986861|NCT02245737|449578293|FG001|Overall Study|Physician Decision|3|||
125314361|NCT05579977|450779481|FG000|Treatment Phase|Pregnancy|0|||
124986862|NCT02245737|449578294|FG002|Overall Study|Physician Decision|6|||
125314362|NCT05579977|450779482|FG001|Treatment Phase|Pregnancy|0|||
124986863|NCT02245737|449578292|FG000|Overall Study|Protocol Violation|3|||
124986864|NCT02245737|449578293|FG001|Overall Study|Protocol Violation|2|||
124986865|NCT02245737|449578294|FG002|Overall Study|Protocol Violation|3|||
125314363|NCT05579977|450779483|FG002|Treatment Phase|Pregnancy|0|||
125314364|NCT05579977|450779484|FG003|Treatment Phase|Pregnancy|0|||
125314365|NCT05579977|450779485|FG004|Treatment Phase|Pregnancy|0|||
125314366|NCT05579977|450779486|FG005|Treatment Phase|Pregnancy|0|||
125314367|NCT05579977|450779487|FG006|Treatment Phase|Pregnancy|0|||
124986866|NCT02245737|449578292|FG000|Overall Study|Withdrawal by Subject|40|||
124986867|NCT02245737|449578293|FG001|Overall Study|Withdrawal by Subject|41|||
125314368|NCT05579977|450779488|FG007|Treatment Phase|Pregnancy|0|||
125314369|NCT05579977|450779489|FG008|Treatment Phase|Pregnancy|0|||
125314370|NCT05579977|450779490|FG009|Treatment Phase|Pregnancy|1|||
125314371|NCT05579977|450779491|FG010|Treatment Phase|Pregnancy|0|||
125314372|NCT05579977|450779492|FG011|Treatment Phase|Pregnancy|0|||
125314373|NCT05579977|450779493|FG012|Treatment Phase|Pregnancy|0|||
125314374|NCT05579977|450779481|FG000|Treatment Phase|Physician Decision|0|||
125314375|NCT05579977|450779482|FG001|Treatment Phase|Physician Decision|0|||
125314376|NCT05579977|450779483|FG002|Treatment Phase|Physician Decision|0|||
125314377|NCT05579977|450779484|FG003|Treatment Phase|Physician Decision|0|||
125314378|NCT05579977|450779485|FG004|Treatment Phase|Physician Decision|0|||
125314379|NCT05579977|450779486|FG005|Treatment Phase|Physician Decision|0|||
125314380|NCT05579977|450779487|FG006|Treatment Phase|Physician Decision|0|||
125314381|NCT05579977|450779488|FG007|Treatment Phase|Physician Decision|0|||
125314382|NCT05579977|450779489|FG008|Treatment Phase|Physician Decision|0|||
125314383|NCT05579977|450779490|FG009|Treatment Phase|Physician Decision|0|||
125314384|NCT05579977|450779491|FG010|Treatment Phase|Physician Decision|0|||
125314385|NCT05579977|450779492|FG011|Treatment Phase|Physician Decision|1|||
125314386|NCT05579977|450779493|FG012|Treatment Phase|Physician Decision|0|||
125314387|NCT05579977|450779481|FG000|Treatment Phase|Lost to Follow-up|0|||
125314388|NCT05579977|450779482|FG001|Treatment Phase|Lost to Follow-up|0|||
125314389|NCT05579977|450779483|FG002|Treatment Phase|Lost to Follow-up|0|||
125314390|NCT05579977|450779484|FG003|Treatment Phase|Lost to Follow-up|1|||
125314391|NCT05579977|450779485|FG004|Treatment Phase|Lost to Follow-up|1|||
125314392|NCT05579977|450779486|FG005|Treatment Phase|Lost to Follow-up|1|||
125314393|NCT05579977|450779487|FG006|Treatment Phase|Lost to Follow-up|0|||
125314394|NCT05579977|450779488|FG007|Treatment Phase|Lost to Follow-up|1|||
125314395|NCT05579977|450779489|FG008|Treatment Phase|Lost to Follow-up|2|||
125314396|NCT05579977|450779490|FG009|Treatment Phase|Lost to Follow-up|2|||
125314397|NCT05579977|450779491|FG010|Treatment Phase|Lost to Follow-up|1|||
125314398|NCT05579977|450779492|FG011|Treatment Phase|Lost to Follow-up|4|||
125314399|NCT05579977|450779493|FG012|Treatment Phase|Lost to Follow-up|3|||
125314400|NCT05579977|450779481|FG000|Treatment Phase|Death|1|||
125314401|NCT05579977|450779482|FG001|Treatment Phase|Death|0|||
125314402|NCT05579977|450779483|FG002|Treatment Phase|Death|0|||
125314403|NCT05579977|450779484|FG003|Treatment Phase|Death|0|||
125314404|NCT05579977|450779485|FG004|Treatment Phase|Death|0|||
125314405|NCT05579977|450779486|FG005|Treatment Phase|Death|0|||
125314406|NCT05579977|450779487|FG006|Treatment Phase|Death|0|||
125314407|NCT05579977|450779488|FG007|Treatment Phase|Death|0|||
125314408|NCT05579977|450779489|FG008|Treatment Phase|Death|0|||
125314409|NCT05579977|450779490|FG009|Treatment Phase|Death|0|||
125314410|NCT05579977|450779491|FG010|Treatment Phase|Death|0|||
125314411|NCT05579977|450779492|FG011|Treatment Phase|Death|0|||
125314412|NCT05579977|450779493|FG012|Treatment Phase|Death|0|||
125314413|NCT05579977|450779481|FG000|Treatment Phase|Adverse Event|0|||
125314414|NCT05579977|450779482|FG001|Treatment Phase|Adverse Event|3|||
125314415|NCT05579977|450779483|FG002|Treatment Phase|Adverse Event|11|||
125314416|NCT05579977|450779484|FG003|Treatment Phase|Adverse Event|10|||
125314417|NCT05579977|450779485|FG004|Treatment Phase|Adverse Event|5|||
125314418|NCT05579977|450779486|FG005|Treatment Phase|Adverse Event|17|||
125314419|NCT05579977|450779487|FG006|Treatment Phase|Adverse Event|5|||
125314420|NCT05579977|450779488|FG007|Treatment Phase|Adverse Event|5|||
125314421|NCT05579977|450779489|FG008|Treatment Phase|Adverse Event|12|||
125314422|NCT05579977|450779490|FG009|Treatment Phase|Adverse Event|20|||
125314423|NCT05579977|450779491|FG010|Treatment Phase|Adverse Event|15|||
125314424|NCT05579977|450779492|FG011|Treatment Phase|Adverse Event|24|||
125314425|NCT05579977|450779493|FG012|Treatment Phase|Adverse Event|23|||
125314426|NCT05579977|450779481|FG000|Treatment Phase|Randomized not treated|0|||
125314427|NCT05579977|450779482|FG001|Treatment Phase|Randomized not treated|0|||
125314428|NCT05579977|450779483|FG002|Treatment Phase|Randomized not treated|0|||
125314429|NCT05579977|450779484|FG003|Treatment Phase|Randomized not treated|0|||
125314430|NCT05579977|450779485|FG004|Treatment Phase|Randomized not treated|1|||
125314431|NCT05579977|450779486|FG005|Treatment Phase|Randomized not treated|0|||
125314432|NCT05579977|450779487|FG006|Treatment Phase|Randomized not treated|0|||
125314433|NCT05579977|450779488|FG007|Treatment Phase|Randomized not treated|0|||
125314434|NCT05579977|450779489|FG008|Treatment Phase|Randomized not treated|0|||
125314435|NCT05579977|450779490|FG009|Treatment Phase|Randomized not treated|0|||
125314436|NCT05579977|450779491|FG010|Treatment Phase|Randomized not treated|0|||
125314437|NCT05579977|450779492|FG011|Treatment Phase|Randomized not treated|0|||
125314438|NCT05579977|450779493|FG012|Treatment Phase|Randomized not treated|0|||
125314439|NCT05579977|450779481|FG000|Follow up|Death|1|||
125314440|NCT05579977|450779482|FG001|Follow up|Death|0|||
125314441|NCT05579977|450779483|FG002|Follow up|Death|0|||
125314442|NCT05579977|450779484|FG003|Follow up|Death|0|||
125314443|NCT05579977|450779485|FG004|Follow up|Death|0|||
125314444|NCT05579977|450779486|FG005|Follow up|Death|0|||
125314445|NCT05579977|450779487|FG006|Follow up|Death|0|||
125314446|NCT05579977|450779488|FG007|Follow up|Death|0|||
125314447|NCT05579977|450779489|FG008|Follow up|Death|0|||
125314448|NCT05579977|450779490|FG009|Follow up|Death|0|||
125314449|NCT05579977|450779491|FG010|Follow up|Death|0|||
125314450|NCT05579977|450779492|FG011|Follow up|Death|0|||
124986868|NCT02245737|449578294|FG002|Overall Study|Withdrawal by Subject|44|||
124986869|NCT02245737|449578292|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
124986870|NCT02245737|449578293|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
124986871|NCT02245737|449578294|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
124986872|NCT02245737|449578292|FG000|Overall Study|Sponsor Decision|445|||
124986873|NCT02245737|449578293|FG001|Overall Study|Sponsor Decision|430|||
124986874|NCT02245737|449578294|FG002|Overall Study|Sponsor Decision|432|||
124986875|NCT00618618|449578295|FG000|Overall Study|Patient Request|0|||
124986876|NCT00618618|449578296|FG001|Overall Study|Patient Request|0|||
124986877|NCT00618618|449578297|FG002|Overall Study|Patient Request|2|||
124986878|NCT00618618|449578298|FG003|Overall Study|Patient Request|0|||
124986879|NCT00618618|449578295|FG000|Overall Study|Inability to Complete Study Procedures|0|||
124986880|NCT00618618|449578296|FG001|Overall Study|Inability to Complete Study Procedures|1|||
124986881|NCT00618618|449578297|FG002|Overall Study|Inability to Complete Study Procedures|0|||
124986882|NCT00618618|449578298|FG003|Overall Study|Inability to Complete Study Procedures|0|||
124986883|NCT00618618|449578295|FG000|Overall Study|Lost to Follow-up|3|||
124986884|NCT00618618|449578296|FG001|Overall Study|Lost to Follow-up|0|||
124986885|NCT00618618|449578297|FG002|Overall Study|Lost to Follow-up|0|||
124986886|NCT00618618|449578298|FG003|Overall Study|Lost to Follow-up|1|||
124986887|NCT00618618|449578295|FG000|Overall Study|Non-compliance|1|||
124986888|NCT00618618|449578296|FG001|Overall Study|Non-compliance|1|||
124986889|NCT00618618|449578297|FG002|Overall Study|Non-compliance|0|||
124986890|NCT00618618|449578298|FG003|Overall Study|Non-compliance|0|||
124986891|NCT00618618|449578295|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
124986892|NCT00618618|449578296|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
124986893|NCT00618618|449578297|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
124986894|NCT00618618|449578298|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
124986895|NCT00618618|449578295|FG000|Overall Study|Death|0|||
124986896|NCT00618618|449578296|FG001|Overall Study|Death|1|||
124986897|NCT00618618|449578297|FG002|Overall Study|Death|0|||
124986898|NCT00618618|449578298|FG003|Overall Study|Death|0|||
124986899|NCT02929329|449578301|FG000|Overall Study|Withdrawal by Subject|24|||
124986900|NCT02929329|449578302|FG001|Overall Study|Withdrawal by Subject|21|||
124986901|NCT02929329|449578301|FG000|Overall Study|Lost to Follow-up|26|||
124986902|NCT02929329|449578302|FG001|Overall Study|Lost to Follow-up|20|||
124986903|NCT02929329|449578301|FG000|Overall Study|Death|1054|||
124986904|NCT02929329|449578302|FG001|Overall Study|Death|1051|||
124986905|NCT00309959|449578309|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
124986906|NCT03836716|449578313|FG000|Overall Study|Adverse Event|3|||
124986907|NCT03836716|449578313|FG000|Overall Study|Death|22|||
124986908|NCT03836716|449578313|FG000|Overall Study|Withdrawal by Subject|8|||
124986909|NCT03836716|449578313|FG000|Overall Study|Study terminated by sponsor|87|||
124986910|NCT01983254|449578314|FG000|Overall Study|Death|6|||
124986911|NCT01983254|449578315|FG001|Overall Study|Death|6|||
124986912|NCT01983254|449578314|FG000|Overall Study|Lost to Follow-up|17|||
124986913|NCT01983254|449578315|FG001|Overall Study|Lost to Follow-up|16|||
124986914|NCT01983254|449578314|FG000|Overall Study|too ill|11|||
124986915|NCT01983254|449578315|FG001|Overall Study|too ill|8|||
124986916|NCT00434213|449578316|FG000|Overall Study|Adverse Event|12|||
124986917|NCT00434213|449578316|FG000|Overall Study|Lack of Efficacy|9|||
124986918|NCT00434213|449578316|FG000|Overall Study|Lost to Follow-up|14|||
124986919|NCT00434213|449578316|FG000|Overall Study|Withdrawal by Subject|7|||
124986920|NCT00434213|449578316|FG000|Overall Study|Protocol Violation|3|||
125210517|NCT04591015|450395584|FG000|Overall Study|Withdrawal by Subject|6|||
125210518|NCT04591015|450395585|FG001|Overall Study|Withdrawal by Subject|3|||
125210519|NCT04591015|450395584|FG000|Overall Study|Lost to Follow-up|16|||
125210520|NCT04591015|450395585|FG001|Overall Study|Lost to Follow-up|11|||
125210521|NCT02509078|450395586|FG000|Overall Study|Protocol Violation|1|||
125210522|NCT02509078|450395587|FG001|Overall Study|Protocol Violation|1|||
125210523|NCT02686814|450395588|FG000|Overall Study|Physician Decision|14|||
125210524|NCT02686814|450395588|FG000|Overall Study|Withdrawal by Subject|4|||
125210525|NCT02686814|450395588|FG000|Overall Study|Death|1|||
125210526|NCT00290693|450395589|FG000|Overall Study|Withdrawal by Subject|2|||
125210527|NCT02907619|450395590|FG000|Overall Study|Study terminated by sponsor|18|||
125210528|NCT02907619|450395591|FG001|Overall Study|Study terminated by sponsor|18|||
125210529|NCT02907619|450395592|FG002|Overall Study|Study terminated by sponsor|19|||
125210530|NCT02907619|450395590|FG000|Overall Study|Death|0|||
125210531|NCT02907619|450395591|FG001|Overall Study|Death|0|||
125210532|NCT02907619|450395592|FG002|Overall Study|Death|1|||
125210533|NCT02907619|450395590|FG000|Overall Study|Withdrawal by Subject|1|||
125210534|NCT02907619|450395591|FG001|Overall Study|Withdrawal by Subject|1|||
125210535|NCT02907619|450395592|FG002|Overall Study|Withdrawal by Subject|0|||
124986921|NCT00434213|449578316|FG000|Overall Study|Unable to comply with study visit window|2|||
124986922|NCT00434213|449578316|FG000|Overall Study|Application site reaction|1|||
124986923|NCT00434213|449578316|FG000|Overall Study|Non-compliant to study schedule|1|||
124986924|NCT00768079|449578317|FG000|Overall Study|Lost to Follow-up|2|||
125210536|NCT02907619|450395590|FG000|Overall Study|Other|0|||
124986925|NCT00768079|449578318|FG001|Overall Study|Lost to Follow-up|0|||
124986926|NCT00768079|449578319|FG002|Overall Study|Lost to Follow-up|4|||
125314451|NCT05579977|450779493|FG012|Follow up|Death|0|||
125314452|NCT05579977|450779481|FG000|Follow up|Lost to Follow-up|0|||
125314453|NCT05579977|450779482|FG001|Follow up|Lost to Follow-up|0|||
125314454|NCT05579977|450779483|FG002|Follow up|Lost to Follow-up|0|||
125314455|NCT05579977|450779484|FG003|Follow up|Lost to Follow-up|1|||
125314456|NCT05579977|450779485|FG004|Follow up|Lost to Follow-up|1|||
125314457|NCT05579977|450779486|FG005|Follow up|Lost to Follow-up|2|||
125314458|NCT05579977|450779487|FG006|Follow up|Lost to Follow-up|1|||
125314459|NCT05579977|450779488|FG007|Follow up|Lost to Follow-up|1|||
125314460|NCT05579977|450779489|FG008|Follow up|Lost to Follow-up|3|||
125314461|NCT05579977|450779490|FG009|Follow up|Lost to Follow-up|2|||
125314462|NCT05579977|450779491|FG010|Follow up|Lost to Follow-up|2|||
125314463|NCT05579977|450779492|FG011|Follow up|Lost to Follow-up|4|||
125314464|NCT05579977|450779493|FG012|Follow up|Lost to Follow-up|4|||
125314465|NCT05579977|450779481|FG000|Follow up|Withdrawal by Subject|2|||
125314466|NCT05579977|450779482|FG001|Follow up|Withdrawal by Subject|0|||
125314467|NCT05579977|450779483|FG002|Follow up|Withdrawal by Subject|0|||
125314468|NCT05579977|450779484|FG003|Follow up|Withdrawal by Subject|0|||
125314469|NCT05579977|450779485|FG004|Follow up|Withdrawal by Subject|1|||
125314470|NCT05579977|450779486|FG005|Follow up|Withdrawal by Subject|0|||
125314471|NCT05579977|450779487|FG006|Follow up|Withdrawal by Subject|1|||
125314472|NCT05579977|450779488|FG007|Follow up|Withdrawal by Subject|4|||
125314473|NCT05579977|450779489|FG008|Follow up|Withdrawal by Subject|2|||
125314474|NCT05579977|450779490|FG009|Follow up|Withdrawal by Subject|3|||
125314475|NCT05579977|450779491|FG010|Follow up|Withdrawal by Subject|3|||
125314476|NCT05579977|450779492|FG011|Follow up|Withdrawal by Subject|1|||
125314477|NCT05579977|450779493|FG012|Follow up|Withdrawal by Subject|3|||
125314478|NCT00350844|450779494|FG000|Overall Study|Lost to Follow-up|1|||
125314479|NCT01420926|450779495|FG000|Overall Study|Adverse Event|6|||
125314480|NCT01420926|450779496|FG001|Overall Study|Adverse Event|4|||
125314481|NCT01420926|450779495|FG000|Overall Study|Death|18|||
125314482|NCT01420926|450779496|FG001|Overall Study|Death|17|||
125314483|NCT01420926|450779495|FG000|Overall Study|Withdrawal by Subject|11|||
125314484|NCT01420926|450779496|FG001|Overall Study|Withdrawal by Subject|17|||
125314485|NCT01420926|450779495|FG000|Overall Study|Non-protocol treatment|17|||
125314486|NCT01420926|450779496|FG001|Overall Study|Non-protocol treatment|20|||
125314487|NCT01420926|450779495|FG000|Overall Study|Physician Decision|8|||
125314488|NCT01420926|450779496|FG001|Overall Study|Physician Decision|5|||
125314489|NCT02775916|450779499|FG000|Overall Study|Adverse Event|1|||
125314490|NCT02775916|450779500|FG001|Overall Study|Adverse Event|0|||
125314491|NCT02775916|450779499|FG000|Overall Study|Subject/Guardian Decision|2|||
125314492|NCT02775916|450779500|FG001|Overall Study|Subject/Guardian Decision|0|||
125314493|NCT02614729|450781637|FG000|Overall Study|Withdrawal by Subject|1|||
125314494|NCT02614729|450781638|FG001|Overall Study|Withdrawal by Subject|0|||
125314495|NCT01232868|450781639|FG000|Overall Study|Lost to Follow-up|2|||
125314496|NCT01232868|450781640|FG001|Overall Study|Lost to Follow-up|4|||
125314497|NCT02539797|450781641|FG000|Overall Study|Lost to Follow-up|0|||
125314498|NCT02539797|450781642|FG001|Overall Study|Lost to Follow-up|1|||
125314499|NCT02539797|450781643|FG002|Overall Study|Lost to Follow-up|0|||
125314500|NCT04002960|450781645|FG000|Overall Study|Withdrawn prior to Completion|2|||
125314501|NCT00865345|450781648|FG000|Overall Study|Withdrawal by Subject|2|||
125314502|NCT00383786|450781649|FG000|Overall Study|Protocol Violation|2|||
125314503|NCT00383786|450781650|FG001|Overall Study|Protocol Violation|6|||
125314504|NCT00383786|450781649|FG000|Overall Study|Withdrawal by Subject|2|||
125314505|NCT00383786|450781650|FG001|Overall Study|Withdrawal by Subject|5|||
125314506|NCT00383786|450781649|FG000|Overall Study|Physician Decision|0|||
125314507|NCT00383786|450781650|FG001|Overall Study|Physician Decision|1|||
125314508|NCT01517750|450781653|FG000|Overall Study|Lost to Follow-up|1|||
125314509|NCT01517750|450781654|FG001|Overall Study|Lost to Follow-up|2|||
125314510|NCT01517750|450781655|FG002|Overall Study|Lost to Follow-up|4|||
125314511|NCT01517750|450781656|FG003|Overall Study|Lost to Follow-up|1|||
125314512|NCT02723773|450781657|FG000|Overall Study|Adverse Event|934|||
125314513|NCT02723773|450781658|FG001|Overall Study|Adverse Event|3|||
125314514|NCT02723773|450781659|FG002|Overall Study|Adverse Event|1|||
125314515|NCT02723773|450781660|FG003|Overall Study|Adverse Event|9|||
125314516|NCT02723773|450781657|FG000|Overall Study|Protocol Violation|1|||
125314517|NCT02723773|450781658|FG001|Overall Study|Protocol Violation|0|||
125314518|NCT02723773|450781659|FG002|Overall Study|Protocol Violation|0|||
125314519|NCT02723773|450781660|FG003|Overall Study|Protocol Violation|0|||
125314520|NCT02723773|450781657|FG000|Overall Study|Withdrawal by Subject|360|||
125314521|NCT02723773|450781658|FG001|Overall Study|Withdrawal by Subject|5|||
125314522|NCT02723773|450781659|FG002|Overall Study|Withdrawal by Subject|6|||
125314523|NCT02723773|450781660|FG003|Overall Study|Withdrawal by Subject|10|||
125314524|NCT02723773|450781657|FG000|Overall Study|Migrated/moved from study area|37|||
125314525|NCT02723773|450781658|FG001|Overall Study|Migrated/moved from study area|0|||
125314526|NCT02723773|450781659|FG002|Overall Study|Migrated/moved from study area|0|||
125314527|NCT02723773|450781660|FG003|Overall Study|Migrated/moved from study area|1|||
125314528|NCT02723773|450781657|FG000|Overall Study|Lost to Follow-up|198|||
125314529|NCT02723773|450781658|FG001|Overall Study|Lost to Follow-up|0|||
125314530|NCT02723773|450781659|FG002|Overall Study|Lost to Follow-up|0|||
124986927|NCT00768079|449578317|FG000|Overall Study|Participant incarcerated|0|||
124986928|NCT00768079|449578318|FG001|Overall Study|Participant incarcerated|1|||
124986929|NCT00768079|449578319|FG002|Overall Study|Participant incarcerated|0|||
124986930|NCT04860297|449578328|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
124986931|NCT04860297|449578329|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
124986932|NCT04860297|449578330|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
124986933|NCT04860297|449578331|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
124986934|NCT04860297|449578332|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
124986935|NCT04860297|449578333|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
124986936|NCT04860297|449578334|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
124986937|NCT04860297|449578335|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
124986938|NCT04860297|449578328|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
124986939|NCT04860297|449578329|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
124986940|NCT04860297|449578330|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
124986941|NCT04860297|449578331|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
124986942|NCT04860297|449578332|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
124986943|NCT04860297|449578333|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
124986944|NCT04860297|449578334|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
124986945|NCT04860297|449578335|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
124986946|NCT04860297|449578328|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
124986947|NCT04860297|449578329|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
124986948|NCT04860297|449578330|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
124986949|NCT04860297|449578331|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
124986950|NCT04860297|449578332|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
124986951|NCT04860297|449578333|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
124986952|NCT04860297|449578334|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
124986953|NCT04860297|449578335|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
124986954|NCT04860297|449578328|FG000|Part B (Booster Dose)|Other Than Specified|0|||
124986955|NCT04860297|449578329|FG001|Part B (Booster Dose)|Other Than Specified|0|||
124986956|NCT04860297|449578330|FG002|Part B (Booster Dose)|Other Than Specified|0|||
124986957|NCT04860297|449578331|FG003|Part B (Booster Dose)|Other Than Specified|0|||
124986958|NCT04860297|449578332|FG004|Part B (Booster Dose)|Other Than Specified|0|||
124986959|NCT04860297|449578333|FG005|Part B (Booster Dose)|Other Than Specified|1|||
124986960|NCT04860297|449578334|FG006|Part B (Booster Dose)|Other Than Specified|1|||
124986961|NCT04860297|449578335|FG007|Part B (Booster Dose)|Other Than Specified|0|||
124986962|NCT04860297|449578328|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
124986963|NCT04860297|449578329|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
124986964|NCT04860297|449578330|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
124986965|NCT04860297|449578331|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
124986966|NCT04860297|449578332|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
124986967|NCT04860297|449578333|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
124986968|NCT04860297|449578334|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
124986969|NCT04860297|449578335|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
124986970|NCT04860297|449578328|FG000|Part B (Booster Dose)|Death|0|||
124986971|NCT04860297|449578329|FG001|Part B (Booster Dose)|Death|0|||
124986972|NCT04860297|449578330|FG002|Part B (Booster Dose)|Death|0|||
124986973|NCT04860297|449578331|FG003|Part B (Booster Dose)|Death|0|||
124986974|NCT04860297|449578332|FG004|Part B (Booster Dose)|Death|1|||
124986975|NCT04860297|449578333|FG005|Part B (Booster Dose)|Death|2|||
124986976|NCT04860297|449578334|FG006|Part B (Booster Dose)|Death|1|||
124986977|NCT04860297|449578335|FG007|Part B (Booster Dose)|Death|0|||
124986978|NCT04860297|449578328|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
124986979|NCT04860297|449578329|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
124986980|NCT04860297|449578330|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
124986981|NCT04860297|449578331|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
124986982|NCT04860297|449578332|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
124986983|NCT04860297|449578333|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
125314531|NCT02723773|450781660|FG003|Overall Study|Lost to Follow-up|0|||
125314532|NCT02723773|450781657|FG000|Overall Study|Other|189|||
125314533|NCT02723773|450781658|FG001|Overall Study|Other|1|||
125314534|NCT02723773|450781659|FG002|Overall Study|Other|2|||
125314535|NCT02723773|450781660|FG003|Overall Study|Other|2|||
125314536|NCT03629886|450781661|FG000|Overall Study|Migrated / moved from the study area|0|||
124986984|NCT04860297|449578334|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
124986985|NCT04860297|449578335|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
124986986|NCT04811131|449578339|FG000|Overall Study|Adverse Event|0|||
124986987|NCT04811131|449578340|FG001|Overall Study|Adverse Event|0|||
124986988|NCT04811131|449578341|FG002|Overall Study|Adverse Event|1|||
124986989|NCT04811131|449578342|FG003|Overall Study|Adverse Event|0|||
124986990|NCT04811131|449578339|FG000|Overall Study|Lack of Efficacy|0|||
124986991|NCT04811131|449578340|FG001|Overall Study|Lack of Efficacy|0|||
124986992|NCT04811131|449578341|FG002|Overall Study|Lack of Efficacy|0|||
125314537|NCT03629886|450781662|FG001|Overall Study|Migrated / moved from the study area|55|||
124986993|NCT04811131|449578342|FG003|Overall Study|Lack of Efficacy|1|||
125314538|NCT03629886|450781661|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
124986994|NCT04811131|449578339|FG000|Overall Study|Lost to Follow-up|0|||
124986995|NCT04811131|449578340|FG001|Overall Study|Lost to Follow-up|1|||
124986996|NCT04811131|449578341|FG002|Overall Study|Lost to Follow-up|0|||
124986997|NCT04811131|449578342|FG003|Overall Study|Lost to Follow-up|0|||
124986998|NCT04811131|449578339|FG000|Overall Study|Sponsor request|31|||
124986999|NCT04811131|449578340|FG001|Overall Study|Sponsor request|35|||
124987000|NCT04811131|449578341|FG002|Overall Study|Sponsor request|27|||
124987001|NCT04811131|449578342|FG003|Overall Study|Sponsor request|10|||
124987002|NCT04811131|449578339|FG000|Overall Study|Withdrawal by Subject|3|||
124987003|NCT04811131|449578340|FG001|Overall Study|Withdrawal by Subject|1|||
124987004|NCT04811131|449578341|FG002|Overall Study|Withdrawal by Subject|3|||
124987005|NCT04811131|449578342|FG003|Overall Study|Withdrawal by Subject|1|||
124987006|NCT01528345|449578344|FG000|Overall Study|Adverse Event|10|||
124987007|NCT01528345|449578345|FG001|Overall Study|Adverse Event|1|||
124987008|NCT01528345|449578344|FG000|Overall Study|Death|1|||
124987009|NCT01528345|449578345|FG001|Overall Study|Death|1|||
124987010|NCT01528345|449578344|FG000|Overall Study|Non-compliance with study treatment|1|||
124987011|NCT01528345|449578345|FG001|Overall Study|Non-compliance with study treatment|0|||
124987012|NCT01528345|449578344|FG000|Overall Study|Progressive Disease|26|||
124987013|NCT01528345|449578345|FG001|Overall Study|Progressive Disease|40|||
124987014|NCT01528345|449578344|FG000|Overall Study|Study Terminated by Sponsor|4|||
124987015|NCT01528345|449578345|FG001|Overall Study|Study Terminated by Sponsor|8|||
124987016|NCT01528345|449578344|FG000|Overall Study|Subject/Guardian Decision|5|||
124987017|NCT01528345|449578345|FG001|Overall Study|Subject/Guardian Decision|0|||
124987018|NCT02624791|449578347|FG000|Overall Study|Withdrawal by Subject|2|||
124987019|NCT02624791|449578348|FG001|Overall Study|Withdrawal by Subject|0|||
124987020|NCT02624791|449578349|FG002|Overall Study|Withdrawal by Subject|0|||
124987021|NCT02624791|449578350|FG003|Overall Study|Withdrawal by Subject|0|||
124987022|NCT02624791|449578351|FG004|Overall Study|Withdrawal by Subject|0|||
124987023|NCT02624791|449578352|FG005|Overall Study|Withdrawal by Subject|0|||
124987024|NCT01131182|449578353|FG000|Overall Study|Withdrawal by Subject|1|||
124987025|NCT01131182|449578354|FG001|Overall Study|Withdrawal by Subject|1|||
124987026|NCT01131182|449578353|FG000|Overall Study|Lost to Follow-up|14|||
124987027|NCT01131182|449578354|FG001|Overall Study|Lost to Follow-up|15|||
124987028|NCT01131182|449578353|FG000|Overall Study|Other Reason|1|||
124987029|NCT01131182|449578354|FG001|Overall Study|Other Reason|0|||
124987030|NCT00735475|449578355|FG000|Overall Study|Adverse Event|0|||
124987031|NCT00735475|449578356|FG001|Overall Study|Adverse Event|1|||
124987032|NCT00735475|449578355|FG000|Overall Study|Death|1|||
124987033|NCT00735475|449578356|FG001|Overall Study|Death|1|||
124987034|NCT00735475|449578355|FG000|Overall Study|Lost to Follow-up|3|||
124987035|NCT00735475|449578356|FG001|Overall Study|Lost to Follow-up|3|||
124987036|NCT00735475|449578355|FG000|Overall Study|Physician Decision|0|||
124987037|NCT00735475|449578356|FG001|Overall Study|Physician Decision|1|||
124987038|NCT00735475|449578355|FG000|Overall Study|Withdrawal by Subject|4|||
124987039|NCT00735475|449578356|FG001|Overall Study|Withdrawal by Subject|5|||
124987040|NCT01146782|449578359|FG000|Screening Cohort|Screen Failure|187|||
124987041|NCT01146782|449578359|FG000|Screening Cohort|Lost to Follow-up|4|||
124987042|NCT01146782|449578359|FG000|Screening Cohort|Physician Decision|1|||
124987043|NCT01146782|449578359|FG000|Screening Cohort|Withdrawal by Subject|29|||
124987044|NCT01146782|449578359|FG000|Safety Cohort|Screen Failure|61|||
124987045|NCT01146782|449578359|FG000|Safety Cohort|Withdrawal by Subject|4|||
124987046|NCT01146782|449578359|FG000|Safety Cohort|Control AHI <5|4|||
124987047|NCT01146782|449578359|FG000|Safety Cohort|TST <4 hrs|14|||
124987048|NCT01146782|449578359|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
124987049|NCT01146782|449578359|FG000|Primary Endpoint Cohort|Physician Decision|1|||
124987050|NCT02270515|449578360|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
124987051|NCT02270515|449578360|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
124987052|NCT02270515|449578360|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
124987053|NCT02270515|449578360|FG000|Intervention Period 1: 0-6 Months|Death|7|||
124987054|NCT02270515|449578360|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
124987055|NCT02270515|449578360|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
124987056|NCT02270515|449578360|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
125314539|NCT03629886|450781662|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
125314540|NCT03629886|450781661|FG000|Overall Study|Study vaccine not administrated|0|||
124987057|NCT02270515|449578360|FG000|Intervention Period 2: 6-12 Months|Death|5|||
124987058|NCT02270515|449578360|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
124987059|NCT02270515|449578360|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
124987060|NCT02270515|449578360|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
124987061|NCT02270515|449578360|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
124987062|NCT02270515|449578360|FG000|Intervention Period 3: 12-18 Months|Death|3|||
124987063|NCT02270515|449578360|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
124987064|NCT00911768|449578361|FG000|Overall Study|Protocol Violation|5|||
124987065|NCT00911768|449578362|FG001|Overall Study|Protocol Violation|4|||
124987066|NCT00911768|449578361|FG000|Overall Study|Withdrawal by Subject|1|||
124987067|NCT00911768|449578362|FG001|Overall Study|Withdrawal by Subject|0|||
124987068|NCT01758900|449578363|FG000|Overall Study|difficulty for further intubation|7|||
124987069|NCT01758900|449578364|FG001|Overall Study|difficulty for further intubation|8|||
124987070|NCT00935818|449578366|FG000|Overall Study|Withdrawal by Subject|45|||
124987071|NCT00935818|449578367|FG001|Overall Study|Withdrawal by Subject|50|||
124987072|NCT00935818|449578366|FG000|Overall Study|Lost to Follow-up|40|||
124987073|NCT00935818|449578367|FG001|Overall Study|Lost to Follow-up|42|||
124987074|NCT00935818|449578366|FG000|Overall Study|Adverse Event|6|||
124987075|NCT00935818|449578367|FG001|Overall Study|Adverse Event|7|||
124987076|NCT00935818|449578366|FG000|Overall Study|Physician Decision|0|||
124987077|NCT00935818|449578367|FG001|Overall Study|Physician Decision|1|||
124987078|NCT01370590|449578368|FG000|Period 1|Adverse Event|8|||
125314541|NCT03629886|450781662|FG001|Overall Study|Study vaccine not administrated|3|||
125314542|NCT03629886|450781661|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
125314543|NCT03629886|450781662|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
125314544|NCT03629886|450781661|FG000|Overall Study|Refused vaccination step of the study|0|||
125314545|NCT03629886|450781662|FG001|Overall Study|Refused vaccination step of the study|44|||
125314546|NCT00404651|450781663|FG000|Overall Study|Serious Adverse Event|0|||
125314547|NCT00404651|450781664|FG001|Overall Study|Serious Adverse Event|0|||
125314548|NCT00404651|450781665|FG002|Overall Study|Serious Adverse Event|2|||
125314549|NCT00404651|450781666|FG003|Overall Study|Serious Adverse Event|0|||
125314550|NCT00404651|450781663|FG000|Overall Study|Protocol Violation|10|||
125314551|NCT00404651|450781664|FG001|Overall Study|Protocol Violation|5|||
125314552|NCT00404651|450781665|FG002|Overall Study|Protocol Violation|14|||
125314553|NCT00404651|450781666|FG003|Overall Study|Protocol Violation|5|||
125314554|NCT00404651|450781663|FG000|Overall Study|Lost to Follow-up|15|||
125314555|NCT00404651|450781664|FG001|Overall Study|Lost to Follow-up|11|||
125314556|NCT00404651|450781665|FG002|Overall Study|Lost to Follow-up|13|||
125314557|NCT00404651|450781666|FG003|Overall Study|Lost to Follow-up|10|||
125314558|NCT00404651|450781663|FG000|Overall Study|Withdrawal by Subject|14|||
125314559|NCT00404651|450781664|FG001|Overall Study|Withdrawal by Subject|12|||
125314560|NCT00404651|450781665|FG002|Overall Study|Withdrawal by Subject|16|||
125314561|NCT00404651|450781666|FG003|Overall Study|Withdrawal by Subject|6|||
125314562|NCT00346216|450781668|FG000|Overall Study|Other|181|||
125314563|NCT00346216|450781669|FG001|Overall Study|Other|231|||
125314564|NCT00346216|450781670|FG002|Overall Study|Other|205|||
125314565|NCT00346216|450781668|FG000|Overall Study|No longer willing to participate|600|||
125314566|NCT00346216|450781669|FG001|Overall Study|No longer willing to participate|606|||
125314567|NCT00346216|450781670|FG002|Overall Study|No longer willing to participate|585|||
125314568|NCT00346216|450781668|FG000|Overall Study|Withdrawal by Subject|661|||
125314569|NCT00346216|450781669|FG001|Overall Study|Withdrawal by Subject|692|||
125314570|NCT00346216|450781670|FG002|Overall Study|Withdrawal by Subject|651|||
125314571|NCT00346216|450781668|FG000|Overall Study|Lost to Follow-up|611|||
125314572|NCT00346216|450781669|FG001|Overall Study|Lost to Follow-up|588|||
125314573|NCT00346216|450781670|FG002|Overall Study|Lost to Follow-up|542|||
125314574|NCT00346216|450781668|FG000|Overall Study|Physician Decision|80|||
125314575|NCT00346216|450781669|FG001|Overall Study|Physician Decision|76|||
125314576|NCT00346216|450781670|FG002|Overall Study|Physician Decision|59|||
125314577|NCT00346216|450781668|FG000|Overall Study|Does not meet entrance criteria|13|||
125314578|NCT00346216|450781669|FG001|Overall Study|Does not meet entrance criteria|10|||
125314579|NCT00346216|450781670|FG002|Overall Study|Does not meet entrance criteria|8|||
125314580|NCT00346216|450781668|FG000|Overall Study|Death|189|||
125314581|NCT00346216|450781669|FG001|Overall Study|Death|192|||
125314582|NCT00346216|450781670|FG002|Overall Study|Death|228|||
125314583|NCT00346216|450781668|FG000|Overall Study|Study terminated by sponsor|11|||
125314584|NCT00346216|450781669|FG001|Overall Study|Study terminated by sponsor|4|||
125314585|NCT00346216|450781670|FG002|Overall Study|Study terminated by sponsor|8|||
125314586|NCT00346216|450781668|FG000|Overall Study|Missing Subject Summary Status|62|||
125314587|NCT00346216|450781669|FG001|Overall Study|Missing Subject Summary Status|61|||
125314588|NCT00346216|450781670|FG002|Overall Study|Missing Subject Summary Status|62|||
125314589|NCT01220167|450781676|FG000|Period 3|Urine positive for substance abuse|0|||
125314590|NCT01220167|450781677|FG001|Period 3|Urine positive for substance abuse|1|||
124987079|NCT01370590|449578369|FG001|Period 1|Adverse Event|4|||
124987080|NCT01370590|449578368|FG000|Period 1|Lost to Follow-up|2|||
124987081|NCT01370590|449578369|FG001|Period 1|Lost to Follow-up|2|||
124987082|NCT01370590|449578368|FG000|Period 1|Protocol Violation|2|||
125314591|NCT01220167|450781678|FG002|Period 3|Urine positive for substance abuse|0|||
125314592|NCT00619515|450781682|FG000|Overall Study|Study Termination by IRB|73|||
125314593|NCT02420093|450781686|FG000|Overall Study|Withdrawal by Subject|1|||
125314594|NCT02420093|450781687|FG001|Overall Study|Withdrawal by Subject|1|||
125314595|NCT04862065|450781688|FG000|Screening|Protocol Violation|54|||
124987083|NCT01370590|449578369|FG001|Period 1|Protocol Violation|2|||
124987084|NCT01370590|449578368|FG000|Period 1|Withdrawal by Subject|4|||
125314596|NCT04862065|450781689|FG001|Screening|Protocol Violation|0|||
125314597|NCT04862065|450781690|FG002|Screening|Protocol Violation|0|||
124987085|NCT01370590|449578369|FG001|Period 1|Withdrawal by Subject|2|||
124987086|NCT01370590|449578368|FG000|Period 1|Could not access randomization system|0|||
124987087|NCT01370590|449578369|FG001|Period 1|Could not access randomization system|1|||
125314598|NCT04862065|450781688|FG000|Screening|Insufficient Sample|1|||
125314599|NCT04862065|450781689|FG001|Screening|Insufficient Sample|0|||
125314600|NCT04862065|450781690|FG002|Screening|Insufficient Sample|0|||
125314601|NCT04862065|450781688|FG000|Follow-Up|Lost to Follow-up|3|||
125314602|NCT04862065|450781689|FG001|Follow-Up|Lost to Follow-up|0|||
125314603|NCT04862065|450781690|FG002|Follow-Up|Lost to Follow-up|0|||
125314604|NCT03244917|450781694|FG000|Overall Study|Lost to Follow-up|2|||
125314605|NCT03244917|450781695|FG001|Overall Study|Lost to Follow-up|2|||
125314606|NCT03001557|450781696|FG000|Core Phase|Randomized but not treated|0|||
125314607|NCT03001557|450781697|FG001|Core Phase|Randomized but not treated|0|||
125314608|NCT03001557|450781698|FG002|Core Phase|Randomized but not treated|1|||
125314609|NCT03001557|450781699|FG003|Core Phase|Randomized but not treated|0|||
125314610|NCT03001557|450781700|FG004|Core Phase|Randomized but not treated|0|||
124987088|NCT01370590|449578368|FG000|Crossover Washout Period|Adverse Event|1|||
124987089|NCT01370590|449578369|FG001|Crossover Washout Period|Adverse Event|4|||
124987090|NCT01370590|449578368|FG000|Crossover Washout Period|Lost to Follow-up|2|||
124987091|NCT01370590|449578369|FG001|Crossover Washout Period|Lost to Follow-up|0|||
124987092|NCT01370590|449578368|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
124987093|NCT01370590|449578369|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
124987094|NCT01370590|449578368|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
124987095|NCT01370590|449578369|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
124987096|NCT01370590|449578368|FG000|Period 2|Adverse Event|0|||
124987097|NCT01370590|449578369|FG001|Period 2|Adverse Event|1|||
124987098|NCT01370590|449578368|FG000|Period 2|Withdrawal by Subject|1|||
124987099|NCT01370590|449578369|FG001|Period 2|Withdrawal by Subject|1|||
124987100|NCT00604825|449578370|FG000|Overall Study|Adverse Event|2|||
124987101|NCT00604825|449578371|FG001|Overall Study|Adverse Event|6|||
124987102|NCT00604825|449578372|FG002|Overall Study|Adverse Event|7|||
124987103|NCT00604825|449578373|FG003|Overall Study|Adverse Event|4|||
124987104|NCT00604825|449578370|FG000|Overall Study|Lost to Follow-up|0|||
124987105|NCT00604825|449578371|FG001|Overall Study|Lost to Follow-up|3|||
124987106|NCT00604825|449578372|FG002|Overall Study|Lost to Follow-up|1|||
124987107|NCT00604825|449578373|FG003|Overall Study|Lost to Follow-up|0|||
124987108|NCT00604825|449578370|FG000|Overall Study|Protocol Violation|0|||
124987109|NCT00604825|449578371|FG001|Overall Study|Protocol Violation|1|||
124987110|NCT00604825|449578372|FG002|Overall Study|Protocol Violation|0|||
124987111|NCT00604825|449578373|FG003|Overall Study|Protocol Violation|0|||
124987112|NCT00604825|449578370|FG000|Overall Study|Withdrawal by Subject|4|||
124987113|NCT00604825|449578371|FG001|Overall Study|Withdrawal by Subject|3|||
124987114|NCT00604825|449578372|FG002|Overall Study|Withdrawal by Subject|5|||
124987115|NCT00604825|449578373|FG003|Overall Study|Withdrawal by Subject|5|||
124987116|NCT00604825|449578370|FG000|Overall Study|Lack of Efficacy|3|||
124987117|NCT00604825|449578371|FG001|Overall Study|Lack of Efficacy|2|||
124987118|NCT00604825|449578372|FG002|Overall Study|Lack of Efficacy|1|||
124987119|NCT00604825|449578373|FG003|Overall Study|Lack of Efficacy|0|||
124987120|NCT00604825|449578370|FG000|Overall Study|Did not meet eligibility criteria|0|||
124987121|NCT00604825|449578371|FG001|Overall Study|Did not meet eligibility criteria|0|||
124987122|NCT00604825|449578372|FG002|Overall Study|Did not meet eligibility criteria|2|||
124987123|NCT00604825|449578373|FG003|Overall Study|Did not meet eligibility criteria|0|||
124987124|NCT00604825|449578370|FG000|Overall Study|Physician Decision|0|||
124987125|NCT00604825|449578371|FG001|Overall Study|Physician Decision|0|||
124987126|NCT00604825|449578372|FG002|Overall Study|Physician Decision|0|||
124987127|NCT00604825|449578373|FG003|Overall Study|Physician Decision|1|||
124987128|NCT00604825|449578370|FG000|Overall Study|Exclusion criterion met|0|||
124987129|NCT00604825|449578371|FG001|Overall Study|Exclusion criterion met|0|||
124987130|NCT00604825|449578372|FG002|Overall Study|Exclusion criterion met|0|||
124987131|NCT00604825|449578373|FG003|Overall Study|Exclusion criterion met|1|||
124987132|NCT04617275|449578374|FG000|Treatment Period|Adverse Event|1|||
124987133|NCT04617275|449578375|FG001|Treatment Period|Adverse Event|6|||
124987134|NCT04617275|449578376|FG002|Treatment Period|Adverse Event|4|||
124987135|NCT04617275|449578377|FG003|Treatment Period|Adverse Event|6|||
124987136|NCT04617275|449578378|FG004|Treatment Period|Adverse Event|7|||
124987137|NCT04617275|449578379|FG005|Treatment Period|Adverse Event|8|||
124987138|NCT04617275|449578380|FG006|Treatment Period|Adverse Event|0|||
124987139|NCT04617275|449578381|FG007|Treatment Period|Adverse Event|12|||
125314611|NCT03001557|450781701|FG005|Core Phase|Randomized but not treated|0|||
124987140|NCT04617275|449578374|FG000|Treatment Period|Lost to Follow-up|0|||
124987141|NCT04617275|449578375|FG001|Treatment Period|Lost to Follow-up|0|||
124987142|NCT04617275|449578376|FG002|Treatment Period|Lost to Follow-up|2|||
124987143|NCT04617275|449578377|FG003|Treatment Period|Lost to Follow-up|0|||
124987144|NCT04617275|449578378|FG004|Treatment Period|Lost to Follow-up|0|||
124987145|NCT04617275|449578379|FG005|Treatment Period|Lost to Follow-up|3|||
124987146|NCT04617275|449578380|FG006|Treatment Period|Lost to Follow-up|0|||
124987147|NCT04617275|449578381|FG007|Treatment Period|Lost to Follow-up|2|||
124987148|NCT04617275|449578374|FG000|Treatment Period|No longer meets eligibility criteria|0|||
125314612|NCT03001557|450781702|FG006|Core Phase|Randomized but not treated|0|||
124987149|NCT04617275|449578375|FG001|Treatment Period|No longer meets eligibility criteria|0|||
124987150|NCT04617275|449578376|FG002|Treatment Period|No longer meets eligibility criteria|0|||
124987151|NCT04617275|449578377|FG003|Treatment Period|No longer meets eligibility criteria|1|||
124987152|NCT04617275|449578378|FG004|Treatment Period|No longer meets eligibility criteria|0|||
124987153|NCT04617275|449578379|FG005|Treatment Period|No longer meets eligibility criteria|0|||
124987154|NCT04617275|449578380|FG006|Treatment Period|No longer meets eligibility criteria|0|||
124987155|NCT04617275|449578381|FG007|Treatment Period|No longer meets eligibility criteria|0|||
124987156|NCT04617275|449578374|FG000|Treatment Period|Other|0|||
124987157|NCT04617275|449578375|FG001|Treatment Period|Other|1|||
124987158|NCT04617275|449578376|FG002|Treatment Period|Other|0|||
124987159|NCT04617275|449578377|FG003|Treatment Period|Other|0|||
124987160|NCT04617275|449578378|FG004|Treatment Period|Other|0|||
124987161|NCT04617275|449578379|FG005|Treatment Period|Other|0|||
124987162|NCT04617275|449578380|FG006|Treatment Period|Other|0|||
124987163|NCT04617275|449578381|FG007|Treatment Period|Other|0|||
124987164|NCT04617275|449578374|FG000|Treatment Period|Withdrawal by Subject|2|||
124987165|NCT04617275|449578375|FG001|Treatment Period|Withdrawal by Subject|0|||
124987166|NCT04617275|449578376|FG002|Treatment Period|Withdrawal by Subject|0|||
124987167|NCT04617275|449578377|FG003|Treatment Period|Withdrawal by Subject|2|||
124987168|NCT04617275|449578378|FG004|Treatment Period|Withdrawal by Subject|2|||
124987169|NCT04617275|449578379|FG005|Treatment Period|Withdrawal by Subject|0|||
124987170|NCT04617275|449578380|FG006|Treatment Period|Withdrawal by Subject|1|||
124987171|NCT04617275|449578381|FG007|Treatment Period|Withdrawal by Subject|2|||
124987172|NCT04617275|449578374|FG000|Follow-up Period|Adverse Event|1|||
124987173|NCT04617275|449578375|FG001|Follow-up Period|Adverse Event|1|||
124987174|NCT04617275|449578376|FG002|Follow-up Period|Adverse Event|2|||
124987175|NCT04617275|449578377|FG003|Follow-up Period|Adverse Event|3|||
124987176|NCT04617275|449578378|FG004|Follow-up Period|Adverse Event|4|||
124987177|NCT04617275|449578379|FG005|Follow-up Period|Adverse Event|3|||
124987178|NCT04617275|449578380|FG006|Follow-up Period|Adverse Event|0|||
124987179|NCT04617275|449578381|FG007|Follow-up Period|Adverse Event|3|||
124987180|NCT04617275|449578374|FG000|Follow-up Period|Lost to Follow-up|0|||
124987181|NCT04617275|449578375|FG001|Follow-up Period|Lost to Follow-up|1|||
124987182|NCT04617275|449578376|FG002|Follow-up Period|Lost to Follow-up|2|||
124987183|NCT04617275|449578377|FG003|Follow-up Period|Lost to Follow-up|0|||
124987184|NCT04617275|449578378|FG004|Follow-up Period|Lost to Follow-up|0|||
124987185|NCT04617275|449578379|FG005|Follow-up Period|Lost to Follow-up|4|||
124987186|NCT04617275|449578380|FG006|Follow-up Period|Lost to Follow-up|0|||
124987187|NCT04617275|449578381|FG007|Follow-up Period|Lost to Follow-up|3|||
124987188|NCT04617275|449578374|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
124987189|NCT04617275|449578375|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
124987190|NCT04617275|449578376|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
124987191|NCT04617275|449578377|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
124987192|NCT04617275|449578378|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
124987193|NCT04617275|449578379|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
124987194|NCT04617275|449578380|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
124987195|NCT04617275|449578381|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
124987196|NCT04617275|449578374|FG000|Follow-up Period|Other|0|||
124987197|NCT04617275|449578375|FG001|Follow-up Period|Other|1|||
124987198|NCT04617275|449578376|FG002|Follow-up Period|Other|0|||
124987199|NCT04617275|449578377|FG003|Follow-up Period|Other|0|||
124987200|NCT04617275|449578378|FG004|Follow-up Period|Other|0|||
124987201|NCT04617275|449578379|FG005|Follow-up Period|Other|0|||
124987202|NCT04617275|449578380|FG006|Follow-up Period|Other|0|||
124987203|NCT04617275|449578381|FG007|Follow-up Period|Other|0|||
124987204|NCT04617275|449578374|FG000|Follow-up Period|Withdrawal by Subject|2|||
124987205|NCT04617275|449578375|FG001|Follow-up Period|Withdrawal by Subject|0|||
124987206|NCT04617275|449578376|FG002|Follow-up Period|Withdrawal by Subject|0|||
124987207|NCT04617275|449578377|FG003|Follow-up Period|Withdrawal by Subject|2|||
124987208|NCT04617275|449578378|FG004|Follow-up Period|Withdrawal by Subject|2|||
124987209|NCT04617275|449578379|FG005|Follow-up Period|Withdrawal by Subject|0|||
125314613|NCT03001557|450781703|FG007|Core Phase|Randomized but not treated|0|||
124987210|NCT04617275|449578380|FG006|Follow-up Period|Withdrawal by Subject|1|||
125314614|NCT03001557|450781696|FG000|Extension Phase|Adverse Event|0|||
125314615|NCT03001557|450781697|FG001|Extension Phase|Adverse Event|0|||
124987211|NCT04617275|449578381|FG007|Follow-up Period|Withdrawal by Subject|2|||
125314616|NCT03001557|450781698|FG002|Extension Phase|Adverse Event|0|||
125314617|NCT03001557|450781699|FG003|Extension Phase|Adverse Event|0|||
124987212|NCT04927884|449578389|FG000|Overall Study|Progressive Disease|2|||
124987213|NCT05593445|449578392|FG000|12-Week DBVC Period|Adverse Event|1|||
124987214|NCT05593445|449578393|FG001|12-Week DBVC Period|Adverse Event|0|||
124987215|NCT05593445|449578394|FG002|12-Week DBVC Period|Adverse Event|0|||
124987216|NCT05593445|449578395|FG003|12-Week DBVC Period|Adverse Event|0|||
124987217|NCT05593445|449578392|FG000|12-Week DBVC Period|Physician Decision|0|||
124987218|NCT05593445|449578393|FG001|12-Week DBVC Period|Physician Decision|1|||
124987219|NCT05593445|449578394|FG002|12-Week DBVC Period|Physician Decision|0|||
125314618|NCT03001557|450781700|FG004|Extension Phase|Adverse Event|0|||
124987220|NCT05593445|449578395|FG003|12-Week DBVC Period|Physician Decision|0|||
124987221|NCT05593445|449578392|FG000|12-Week DBVC Period|Protocol Violation|0|||
124987222|NCT05593445|449578393|FG001|12-Week DBVC Period|Protocol Violation|1|||
124987223|NCT05593445|449578394|FG002|12-Week DBVC Period|Protocol Violation|0|||
124987224|NCT05593445|449578395|FG003|12-Week DBVC Period|Protocol Violation|0|||
124987225|NCT05593445|449578392|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
124987226|NCT05593445|449578393|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
124987227|NCT05593445|449578394|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
124987228|NCT05593445|449578395|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
124987229|NCT05593445|449578392|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
124987230|NCT05593445|449578393|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
124987231|NCT05593445|449578394|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
124987232|NCT05593445|449578395|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
124987233|NCT05593445|449578392|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
124987234|NCT05593445|449578393|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
124987235|NCT05593445|449578394|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
124987236|NCT05593445|449578395|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
124987237|NCT05593445|449578392|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
124987238|NCT05593445|449578393|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
124987239|NCT05593445|449578394|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
124987240|NCT05593445|449578395|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
124987241|NCT05593445|449578392|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
124987242|NCT05593445|449578393|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
124987243|NCT05593445|449578394|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
124987244|NCT05593445|449578395|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
124987245|NCT05559476|449578396|FG000|Overall Study|Adverse Event|2|||
124987246|NCT05559476|449578397|FG001|Overall Study|Adverse Event|0|||
124987247|NCT05559476|449578396|FG000|Overall Study|Lost to Follow-up|13|||
124987248|NCT05559476|449578397|FG001|Overall Study|Lost to Follow-up|12|||
124987249|NCT05559476|449578396|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
124987250|NCT05559476|449578397|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
124987251|NCT05559476|449578396|FG000|Overall Study|Other|0|||
124987252|NCT05559476|449578397|FG001|Overall Study|Other|2|||
124987253|NCT00727311|449578398|FG000|Overall Study|Did not receive drug|316|||
124987254|NCT00727311|449578398|FG000|Overall Study|Missing end of therapy data|205|||
124987255|NCT00727311|449578398|FG000|Overall Study|Adverse Event|58|||
124987256|NCT00727311|449578398|FG000|Overall Study|Lack of Efficacy|242|||
124987257|NCT00727311|449578398|FG000|Overall Study|Lost to Follow-up|73|||
124987258|NCT00727311|449578398|FG000|Overall Study|Withdrawal by Subject|77|||
124987259|NCT00727311|449578398|FG000|Overall Study|Other|97|||
124987260|NCT00727311|449578398|FG000|Overall Study|Multiple reasons|39|||
124987261|NCT00266227|449579770|FG000|Initial Treatment|Adverse Event|0|||
124987262|NCT00266227|449579771|FG001|Initial Treatment|Adverse Event|0|||
124987263|NCT00266227|449579772|FG002|Initial Treatment|Adverse Event|13|||
124987264|NCT00266227|449579770|FG000|Initial Treatment|Lost to Follow-up|0|||
124987265|NCT00266227|449579771|FG001|Initial Treatment|Lost to Follow-up|0|||
124987266|NCT00266227|449579772|FG002|Initial Treatment|Lost to Follow-up|6|||
124987267|NCT00266227|449579770|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
124987268|NCT00266227|449579771|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
124987269|NCT00266227|449579772|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
124987270|NCT00266227|449579770|FG000|Initial Treatment|Physician decision to withdraw|0|||
124987271|NCT00266227|449579771|FG001|Initial Treatment|Physician decision to withdraw|0|||
124987272|NCT00266227|449579772|FG002|Initial Treatment|Physician decision to withdraw|12|||
124987273|NCT00266227|449579770|FG000|Initial Treatment|Pregnancy|0|||
124987274|NCT00266227|449579771|FG001|Initial Treatment|Pregnancy|0|||
124987275|NCT00266227|449579772|FG002|Initial Treatment|Pregnancy|1|||
124987276|NCT00266227|449579770|FG000|Retreatment: Up to Week 48|Death|1|||
124987277|NCT00266227|449579771|FG001|Retreatment: Up to Week 48|Death|0|||
124987278|NCT00266227|449579772|FG002|Retreatment: Up to Week 48|Death|0|||
124987279|NCT00266227|449579770|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
124987280|NCT00266227|449579771|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
124987281|NCT00266227|449579772|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
124987282|NCT00266227|449579770|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
124987283|NCT00266227|449579771|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
124987284|NCT00266227|449579772|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
124987285|NCT00266227|449579770|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
124987286|NCT00266227|449579771|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
124987287|NCT00266227|449579772|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
124987288|NCT00266227|449579770|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
124987289|NCT00266227|449579771|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
124987290|NCT00266227|449579772|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
124987291|NCT00266227|449579770|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
124987292|NCT00266227|449579771|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
124987293|NCT00266227|449579772|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
124987294|NCT00266227|449579770|FG000|Retreatment: Week 48 to Week 72|Death|1|||
124987295|NCT00266227|449579771|FG001|Retreatment: Week 48 to Week 72|Death|1|||
124987296|NCT00266227|449579772|FG002|Retreatment: Week 48 to Week 72|Death|0|||
124987297|NCT00266227|449579770|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
124987298|NCT00266227|449579771|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
124987299|NCT00266227|449579772|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
124987300|NCT00266227|449579770|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
124987301|NCT00266227|449579771|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
124987302|NCT00266227|449579772|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
124987303|NCT00266227|449579770|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
124987304|NCT00266227|449579771|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
124987305|NCT00266227|449579772|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
125314619|NCT03001557|450781701|FG005|Extension Phase|Adverse Event|2|||
125314620|NCT03001557|450781702|FG006|Extension Phase|Adverse Event|0|||
125314621|NCT03001557|450781703|FG007|Extension Phase|Adverse Event|0|||
125314622|NCT03001557|450781696|FG000|Extension Phase|Withdrawal by Subject|0|||
125314623|NCT03001557|450781697|FG001|Extension Phase|Withdrawal by Subject|0|||
125314624|NCT03001557|450781698|FG002|Extension Phase|Withdrawal by Subject|0|||
125314625|NCT03001557|450781699|FG003|Extension Phase|Withdrawal by Subject|0|||
125314626|NCT03001557|450781700|FG004|Extension Phase|Withdrawal by Subject|0|||
125314627|NCT03001557|450781701|FG005|Extension Phase|Withdrawal by Subject|1|||
125314628|NCT03001557|450781702|FG006|Extension Phase|Withdrawal by Subject|5|||
125314629|NCT03001557|450781703|FG007|Extension Phase|Withdrawal by Subject|2|||
125314630|NCT03001557|450781696|FG000|Extension Phase|Lost to Follow-up|0|||
125314631|NCT03001557|450781697|FG001|Extension Phase|Lost to Follow-up|0|||
125314632|NCT03001557|450781698|FG002|Extension Phase|Lost to Follow-up|0|||
125314633|NCT03001557|450781699|FG003|Extension Phase|Lost to Follow-up|0|||
125314634|NCT03001557|450781700|FG004|Extension Phase|Lost to Follow-up|0|||
125314635|NCT03001557|450781701|FG005|Extension Phase|Lost to Follow-up|0|||
125314636|NCT03001557|450781702|FG006|Extension Phase|Lost to Follow-up|2|||
125314637|NCT03001557|450781703|FG007|Extension Phase|Lost to Follow-up|1|||
125314638|NCT03001557|450781696|FG000|Extension Phase|Administrative Reason|0|||
125314639|NCT03001557|450781697|FG001|Extension Phase|Administrative Reason|0|||
125314640|NCT03001557|450781698|FG002|Extension Phase|Administrative Reason|0|||
125314641|NCT03001557|450781699|FG003|Extension Phase|Administrative Reason|0|||
125314642|NCT03001557|450781700|FG004|Extension Phase|Administrative Reason|0|||
125314643|NCT03001557|450781701|FG005|Extension Phase|Administrative Reason|1|||
125314644|NCT03001557|450781702|FG006|Extension Phase|Administrative Reason|3|||
125314645|NCT03001557|450781703|FG007|Extension Phase|Administrative Reason|3|||
125314646|NCT03001557|450781696|FG000|Extension Phase|Loss of caregiver|0|||
125314647|NCT03001557|450781697|FG001|Extension Phase|Loss of caregiver|0|||
125314648|NCT03001557|450781698|FG002|Extension Phase|Loss of caregiver|0|||
125314649|NCT03001557|450781699|FG003|Extension Phase|Loss of caregiver|0|||
125314650|NCT03001557|450781700|FG004|Extension Phase|Loss of caregiver|0|||
125314651|NCT03001557|450781701|FG005|Extension Phase|Loss of caregiver|0|||
125314652|NCT03001557|450781702|FG006|Extension Phase|Loss of caregiver|1|||
125314653|NCT03001557|450781703|FG007|Extension Phase|Loss of caregiver|0|||
125314654|NCT03001557|450781696|FG000|Extension Phase|Others|0|||
125314655|NCT03001557|450781697|FG001|Extension Phase|Others|0|||
125314656|NCT03001557|450781698|FG002|Extension Phase|Others|0|||
125314657|NCT03001557|450781699|FG003|Extension Phase|Others|0|||
125314658|NCT03001557|450781700|FG004|Extension Phase|Others|0|||
125314659|NCT03001557|450781701|FG005|Extension Phase|Others|1|||
125314660|NCT03001557|450781702|FG006|Extension Phase|Others|3|||
125314661|NCT03001557|450781703|FG007|Extension Phase|Others|0|||
125314662|NCT01272232|450781704|FG000|Weeks 0-56|Adverse Event|39|||
125314663|NCT01272232|450781705|FG001|Weeks 0-56|Adverse Event|18|||
125314664|NCT01272232|450781706|FG002|Weeks 0-56|Adverse Event|7|||
125314665|NCT01272232|450781704|FG000|Weeks 0-56|Lack of Efficacy|0|||
125314666|NCT01272232|450781705|FG001|Weeks 0-56|Lack of Efficacy|0|||
125314667|NCT01272232|450781706|FG002|Weeks 0-56|Lack of Efficacy|3|||
125314668|NCT01272232|450781704|FG000|Weeks 0-56|Protocol Violation|12|||
125314669|NCT01272232|450781705|FG001|Weeks 0-56|Protocol Violation|8|||
125314670|NCT01272232|450781706|FG002|Weeks 0-56|Protocol Violation|13|||
124987306|NCT00266227|449579770|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
125314671|NCT01272232|450781704|FG000|Weeks 0-56|Withdrawal criteria|32|||
125314672|NCT01272232|450781705|FG001|Weeks 0-56|Withdrawal criteria|14|||
125314673|NCT01272232|450781706|FG002|Weeks 0-56|Withdrawal criteria|37|||
125314674|NCT01272232|450781704|FG000|Weeks 0-56|Unclassified|16|||
125314675|NCT01272232|450781705|FG001|Weeks 0-56|Unclassified|7|||
124987307|NCT00266227|449579771|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
125314676|NCT01272232|450781706|FG002|Weeks 0-56|Unclassified|12|||
125314677|NCT01272232|450781704|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
125314678|NCT01272232|450781705|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
125314679|NCT01272232|450781706|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
124987308|NCT00266227|449579772|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
124987309|NCT04988867|449579779|FG000|Overall Study|Study terminated by Sponsor|12|||
124987310|NCT04988867|449579779|FG000|Overall Study|Adverse Event|2|||
124987311|NCT04988867|449579779|FG000|Overall Study|Study drug noncompliance|1|||
124987312|NCT00037830|449579780|FG000|Overall Study|Adverse Event|2|||
124987313|NCT00037830|449579781|FG001|Overall Study|Adverse Event|0|||
124987314|NCT00037830|449579782|FG002|Overall Study|Adverse Event|0|||
124987315|NCT00037830|449579780|FG000|Overall Study|Withdrawal by Subject|4|||
124987316|NCT00037830|449579781|FG001|Overall Study|Withdrawal by Subject|5|||
124987317|NCT00037830|449579782|FG002|Overall Study|Withdrawal by Subject|1|||
124987318|NCT00037830|449579780|FG000|Overall Study|Protocol Violation|2|||
124987319|NCT00037830|449579781|FG001|Overall Study|Protocol Violation|2|||
124987320|NCT00037830|449579782|FG002|Overall Study|Protocol Violation|0|||
124987321|NCT00037830|449579780|FG000|Overall Study|Unrelated Medical Problem|2|||
124987322|NCT00037830|449579781|FG001|Overall Study|Unrelated Medical Problem|0|||
124987323|NCT00037830|449579782|FG002|Overall Study|Unrelated Medical Problem|0|||
124987324|NCT01699503|449579785|FG000|Overall Study|Death|31|||
124987325|NCT01699503|449579786|FG001|Overall Study|Death|40|||
124987326|NCT01699503|449579785|FG000|Overall Study|Withdrawal by Subject|65|||
124987327|NCT01699503|449579786|FG001|Overall Study|Withdrawal by Subject|57|||
124987328|NCT01699503|449579785|FG000|Overall Study|Lost to Follow-up|121|||
124987329|NCT01699503|449579786|FG001|Overall Study|Lost to Follow-up|117|||
124987330|NCT01699503|449579785|FG000|Overall Study|Excluded due to quality|783|||
124987331|NCT01699503|449579786|FG001|Overall Study|Excluded due to quality|791|||
124987332|NCT01004848|449579788|FG000|Overall Study|Lost to Follow-up|55|||
124987333|NCT01004848|449579789|FG001|Overall Study|Lost to Follow-up|45|||
124987334|NCT01160289|449579790|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
124987335|NCT01160289|449579791|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
124987336|NCT01160289|449579792|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
124987337|NCT01160289|449579793|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
124987338|NCT01160289|449579794|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
124987339|NCT01160289|449579795|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
124987340|NCT01160289|449579790|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
124987341|NCT01160289|449579791|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
124987342|NCT01160289|449579792|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
124987343|NCT01160289|449579793|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
124987344|NCT01160289|449579794|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
124987345|NCT01160289|449579795|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
124987346|NCT01160289|449579790|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
124987347|NCT01160289|449579791|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
124987348|NCT01160289|449579792|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
124987349|NCT01160289|449579793|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
124987350|NCT01160289|449579794|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
124987351|NCT01160289|449579795|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
124987352|NCT01160289|449579790|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
124987353|NCT01160289|449579791|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
124987354|NCT01160289|449579792|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
124987355|NCT01160289|449579793|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
124987356|NCT01160289|449579794|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
124987357|NCT01160289|449579795|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
124987358|NCT01160289|449579790|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
124987359|NCT01160289|449579791|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
124987360|NCT01160289|449579792|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
124987361|NCT01160289|449579793|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
124987362|NCT01160289|449579794|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
124987363|NCT01160289|449579795|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
124987364|NCT01160289|449579790|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
124987365|NCT01160289|449579791|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
124987366|NCT01160289|449579792|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
124987367|NCT01160289|449579793|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
124987368|NCT01160289|449579794|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
124987369|NCT01160289|449579795|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
124987370|NCT01160289|449579790|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
124987371|NCT01160289|449579791|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
124987372|NCT01160289|449579792|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
124987373|NCT01160289|449579793|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
124987374|NCT01160289|449579794|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
124987375|NCT01160289|449579795|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
125210537|NCT02907619|450395591|FG001|Overall Study|Other|1|||
124987376|NCT01160289|449579790|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
124987377|NCT01160289|449579791|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
124987378|NCT01160289|449579792|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
124987379|NCT01160289|449579793|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
124987380|NCT01160289|449579794|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
124987381|NCT01160289|449579795|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
124987382|NCT01160289|449579790|FG000|Post-Randomization Period|Adverse Event|0|||
124987383|NCT01160289|449579791|FG001|Post-Randomization Period|Adverse Event|4|||
124987384|NCT01160289|449579792|FG002|Post-Randomization Period|Adverse Event|4|||
124987385|NCT01160289|449579793|FG003|Post-Randomization Period|Adverse Event|2|||
124987386|NCT01160289|449579794|FG004|Post-Randomization Period|Adverse Event|0|||
124987387|NCT01160289|449579795|FG005|Post-Randomization Period|Adverse Event|0|||
124987388|NCT01160289|449579790|FG000|Post-Randomization Period|Death|0|||
124987389|NCT01160289|449579791|FG001|Post-Randomization Period|Death|0|||
124987390|NCT01160289|449579792|FG002|Post-Randomization Period|Death|0|||
124987391|NCT01160289|449579793|FG003|Post-Randomization Period|Death|1|||
124987392|NCT01160289|449579794|FG004|Post-Randomization Period|Death|0|||
124987393|NCT01160289|449579795|FG005|Post-Randomization Period|Death|0|||
124987394|NCT01160289|449579790|FG000|Post-Randomization Period|Lack of Efficacy|0|||
124987395|NCT01160289|449579791|FG001|Post-Randomization Period|Lack of Efficacy|1|||
124987396|NCT01160289|449579792|FG002|Post-Randomization Period|Lack of Efficacy|0|||
124987397|NCT01160289|449579793|FG003|Post-Randomization Period|Lack of Efficacy|3|||
124987398|NCT01160289|449579794|FG004|Post-Randomization Period|Lack of Efficacy|0|||
124987399|NCT01160289|449579795|FG005|Post-Randomization Period|Lack of Efficacy|0|||
124987400|NCT01160289|449579790|FG000|Post-Randomization Period|Lost to Follow-up|0|||
124987401|NCT01160289|449579791|FG001|Post-Randomization Period|Lost to Follow-up|3|||
124987402|NCT01160289|449579792|FG002|Post-Randomization Period|Lost to Follow-up|2|||
124987403|NCT01160289|449579793|FG003|Post-Randomization Period|Lost to Follow-up|5|||
124987404|NCT01160289|449579794|FG004|Post-Randomization Period|Lost to Follow-up|3|||
124987405|NCT01160289|449579795|FG005|Post-Randomization Period|Lost to Follow-up|4|||
124987406|NCT01160289|449579790|FG000|Post-Randomization Period|Physician Decision|0|||
124987407|NCT01160289|449579791|FG001|Post-Randomization Period|Physician Decision|0|||
124987408|NCT01160289|449579792|FG002|Post-Randomization Period|Physician Decision|1|||
124987409|NCT01160289|449579793|FG003|Post-Randomization Period|Physician Decision|0|||
124987410|NCT01160289|449579794|FG004|Post-Randomization Period|Physician Decision|0|||
124987411|NCT01160289|449579795|FG005|Post-Randomization Period|Physician Decision|0|||
124987412|NCT01160289|449579790|FG000|Post-Randomization Period|Protocol Violation|0|||
124987413|NCT01160289|449579791|FG001|Post-Randomization Period|Protocol Violation|4|||
124987414|NCT01160289|449579792|FG002|Post-Randomization Period|Protocol Violation|2|||
124987415|NCT01160289|449579793|FG003|Post-Randomization Period|Protocol Violation|0|||
124987416|NCT01160289|449579794|FG004|Post-Randomization Period|Protocol Violation|1|||
124987417|NCT01160289|449579795|FG005|Post-Randomization Period|Protocol Violation|3|||
124987418|NCT01160289|449579790|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
124987419|NCT01160289|449579791|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
124987420|NCT01160289|449579792|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
124987421|NCT01160289|449579793|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
124987422|NCT01160289|449579794|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
124987423|NCT01160289|449579795|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
124987424|NCT01160289|449579790|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
124987425|NCT01160289|449579791|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
124987426|NCT01160289|449579792|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
124987427|NCT01160289|449579793|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
124987428|NCT01160289|449579794|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
124987429|NCT01160289|449579795|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
124987430|NCT01160289|449579790|FG000|Post-Randomization Period|Sponsor Decision|0|||
124987431|NCT01160289|449579791|FG001|Post-Randomization Period|Sponsor Decision|1|||
124987432|NCT01160289|449579792|FG002|Post-Randomization Period|Sponsor Decision|0|||
124987433|NCT01160289|449579793|FG003|Post-Randomization Period|Sponsor Decision|0|||
124987434|NCT01160289|449579794|FG004|Post-Randomization Period|Sponsor Decision|0|||
124987435|NCT01160289|449579795|FG005|Post-Randomization Period|Sponsor Decision|0|||
124987436|NCT03292432|449579802|FG000|Overall Study|Lost to Follow-up|11|||
124987437|NCT03292432|449579803|FG001|Overall Study|Lost to Follow-up|8|||
124987438|NCT03292432|449579802|FG000|Overall Study|Death|2|||
124987439|NCT03292432|449579803|FG001|Overall Study|Death|1|||
124987440|NCT03292432|449579802|FG000|Overall Study|Withdrawal by Subject|1|||
124987441|NCT03292432|449579803|FG001|Overall Study|Withdrawal by Subject|2|||
124987442|NCT03292432|449579802|FG000|Overall Study|Site closed before any data collected|1|||
124987443|NCT03292432|449579803|FG001|Overall Study|Site closed before any data collected|0|||
124987444|NCT01236534|449579804|FG000|Overall Study|Adverse Event|3|||
124987445|NCT01236534|449579805|FG001|Overall Study|Adverse Event|0|||
124987446|NCT01014143|449579806|FG000|Second Intervention|Lost to Follow-up|2|||
125314680|NCT01272232|450781704|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
125314681|NCT01272232|450781705|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
125314682|NCT01272232|450781706|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
125314683|NCT01272232|450781704|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
125314684|NCT01272232|450781705|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
125314685|NCT01272232|450781706|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
125314686|NCT01272232|450781704|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
125314687|NCT01272232|450781705|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
125314688|NCT01272232|450781706|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
125314689|NCT01272232|450781704|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
125314690|NCT01272232|450781705|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
125314691|NCT01272232|450781706|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
125314692|NCT01960140|450781710|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
125314693|NCT00628030|450781711|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
125314694|NCT00628030|450781712|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
125314695|NCT00628030|450781711|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
125314696|NCT00628030|450781712|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
125314697|NCT00628030|450781711|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
125314698|NCT00628030|450781712|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
125314699|NCT01156480|450781714|FG000|Overall Study|change in diagnosis|0|||
125314700|NCT01156480|450781715|FG001|Overall Study|change in diagnosis|1|||
125314701|NCT01176058|450781716|FG000|Overall Study|Adverse Event|1|||
125314702|NCT01176058|450781717|FG001|Overall Study|Adverse Event|0|||
125314703|NCT01176058|450781716|FG000|Overall Study|Insufficient clinical response|2|||
125314704|NCT01176058|450781717|FG001|Overall Study|Insufficient clinical response|2|||
125314705|NCT01176058|450781716|FG000|Overall Study|Insufficient mycological response|0|||
125314706|NCT01176058|450781717|FG001|Overall Study|Insufficient mycological response|1|||
125314707|NCT01176058|450781716|FG000|Overall Study|Withdrawal by Subject|1|||
125314708|NCT01176058|450781717|FG001|Overall Study|Withdrawal by Subject|0|||
125314709|NCT04276233|450781718|FG000|Overall Study|Adverse Event|1|||
125314710|NCT04276233|450781718|FG000|Overall Study|Lost to Follow-up|3|||
125314711|NCT04276233|450781718|FG000|Overall Study|Physician Decision|4|||
125314712|NCT04276233|450781718|FG000|Overall Study|Withdrawal by Subject|2|||
125314713|NCT01946139|450781719|FG000|Overall Study|Withdrawal by Subject|8|||
125314714|NCT01946139|450781719|FG000|Overall Study|ineligible|8|||
125314715|NCT01946139|450781719|FG000|Overall Study|Specimens not available|4|||
125314716|NCT02525471|450781726|FG000|Overall Study|Screen Failure|6|||
125314717|NCT02525471|450781726|FG000|Overall Study|Withdrawal by Subject|4|||
125314718|NCT02525471|450781726|FG000|Overall Study|Death|1|||
125314719|NCT00890825|450781727|FG000|Overall Study|Withdrawal by Subject|1|||
125314720|NCT00890825|450781728|FG001|Overall Study|Withdrawal by Subject|0|||
125314721|NCT00890825|450781727|FG000|Overall Study|Alive at data cut off (DCO)|13|||
125314722|NCT00890825|450781728|FG001|Overall Study|Alive at data cut off (DCO)|14|||
125314723|NCT02336607|450781729|FG000|Overall Study|Physician Decision|1|||
125314724|NCT02336607|450781730|FG001|Overall Study|Physician Decision|4|||
125314725|NCT02336607|450781731|FG002|Overall Study|Physician Decision|3|||
125314726|NCT02336607|450781732|FG003|Overall Study|Physician Decision|15|||
125314727|NCT02336607|450781729|FG000|Overall Study|Lack of Efficacy|1|||
125314728|NCT02336607|450781730|FG001|Overall Study|Lack of Efficacy|0|||
125314729|NCT02336607|450781731|FG002|Overall Study|Lack of Efficacy|0|||
125314730|NCT02336607|450781732|FG003|Overall Study|Lack of Efficacy|2|||
125314731|NCT02336607|450781729|FG000|Overall Study|Lost to Follow-up|2|||
125314732|NCT02336607|450781730|FG001|Overall Study|Lost to Follow-up|1|||
125314733|NCT02336607|450781731|FG002|Overall Study|Lost to Follow-up|0|||
125314734|NCT02336607|450781732|FG003|Overall Study|Lost to Follow-up|21|||
125314735|NCT02336607|450781729|FG000|Overall Study|Protocol Violation|0|||
125314736|NCT02336607|450781730|FG001|Overall Study|Protocol Violation|1|||
125314737|NCT02336607|450781731|FG002|Overall Study|Protocol Violation|1|||
125314738|NCT02336607|450781732|FG003|Overall Study|Protocol Violation|3|||
125314739|NCT02336607|450781729|FG000|Overall Study|Adverse Event|0|||
125314740|NCT02336607|450781730|FG001|Overall Study|Adverse Event|2|||
125314741|NCT02336607|450781731|FG002|Overall Study|Adverse Event|2|||
124987447|NCT01014143|449579807|FG001|Second Intervention|Lost to Follow-up|0|||
124987448|NCT01014143|449579808|FG002|Second Intervention|Lost to Follow-up|0|||
125314742|NCT02336607|450781732|FG003|Overall Study|Adverse Event|26|||
125314743|NCT02336607|450781729|FG000|Overall Study|Withdrawal by Subject|0|||
125314744|NCT02336607|450781730|FG001|Overall Study|Withdrawal by Subject|2|||
125314745|NCT02336607|450781731|FG002|Overall Study|Withdrawal by Subject|0|||
125314746|NCT02336607|450781732|FG003|Overall Study|Withdrawal by Subject|20|||
125314747|NCT01216202|450781735|FG000|Overall Study|Withdrawal by Subject|8|||
125314748|NCT01216202|450781736|FG001|Overall Study|Withdrawal by Subject|0|||
125314749|NCT01216202|450781735|FG000|Overall Study|Death|0|||
125314750|NCT01216202|450781736|FG001|Overall Study|Death|2|||
125314751|NCT01216202|450781735|FG000|Overall Study|Lost to Follow-up|14|||
124987449|NCT02038543|449579815|FG000|Overall Study|Screen Failure|0|||
124987450|NCT02038543|449579816|FG001|Overall Study|Screen Failure|0|||
124987451|NCT02038543|449579817|FG002|Overall Study|Screen Failure|0|||
124987452|NCT02038543|449579818|FG003|Overall Study|Screen Failure|1|||
124987453|NCT02038543|449579815|FG000|Overall Study|Withdrawal by Subject|0|||
124987454|NCT02038543|449579816|FG001|Overall Study|Withdrawal by Subject|0|||
124987455|NCT02038543|449579817|FG002|Overall Study|Withdrawal by Subject|0|||
124987456|NCT02038543|449579818|FG003|Overall Study|Withdrawal by Subject|1|||
124987457|NCT04638920|449579819|FG000|Overall Study|Withdrawal by Subject|5|||
124987458|NCT03775434|449579820|FG000|Overall Study|Adverse Event|2|||
124987459|NCT03775434|449579820|FG000|Overall Study|Withdrawal by Subject|1|||
124987460|NCT02334423|449579821|FG000|Overall Study|Protocol Violation|10|||
124987461|NCT02334423|449579822|FG001|Overall Study|Protocol Violation|3|||
124987462|NCT02930226|449579823|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
124987463|NCT02930226|449579824|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
124987464|NCT02930226|449579825|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
124987465|NCT02930226|449579826|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
124987466|NCT02930226|449579827|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
124987467|NCT02930226|449579828|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
124987468|NCT00652327|449579831|FG000|Overall Study|Adverse Event|0|||
124987469|NCT00652327|449579832|FG001|Overall Study|Adverse Event|2|||
124987470|NCT00652327|449579831|FG000|Overall Study|Lost to Follow-up|0|||
124987471|NCT00652327|449579832|FG001|Overall Study|Lost to Follow-up|3|||
125314752|NCT01216202|450781736|FG001|Overall Study|Lost to Follow-up|0|||
124987472|NCT01076647|449579833|FG000|Overall Study|Adverse Event|4|||
124987473|NCT01076647|449579834|FG001|Overall Study|Adverse Event|1|||
124987474|NCT01076647|449579833|FG000|Overall Study|Lack of Efficacy|0|||
124987475|NCT01076647|449579834|FG001|Overall Study|Lack of Efficacy|1|||
124987476|NCT01076647|449579833|FG000|Overall Study|Protocol Violation|7|||
124987477|NCT01076647|449579834|FG001|Overall Study|Protocol Violation|9|||
124987478|NCT01076647|449579833|FG000|Overall Study|Withdrawal criteria|2|||
124987479|NCT01076647|449579834|FG001|Overall Study|Withdrawal criteria|2|||
124987480|NCT01076647|449579833|FG000|Overall Study|Unclassified|12|||
124987481|NCT01076647|449579834|FG001|Overall Study|Unclassified|12|||
124987482|NCT01871805|449579838|FG000|Phase I|Death|7|||
124987483|NCT01871805|449579839|FG001|Phase I|Death|4|||
124987484|NCT01871805|449579840|FG002|Phase I|Death|6|||
124987485|NCT01871805|449579841|FG003|Phase I|Death|2|||
124987486|NCT01871805|449579842|FG004|Phase I|Death|9|||
124987487|NCT01871805|449579843|FG005|Phase I|Death|0|||
124987488|NCT01871805|449579838|FG000|Phase I|Alive in Survival Follow-up|0|||
125314753|NCT02365649|450781747|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
125314754|NCT02365649|450781748|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
125314755|NCT02365649|450781749|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
125314756|NCT02365649|450781750|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
125314757|NCT02365649|450781751|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
125314758|NCT02365649|450781752|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
125314759|NCT02365649|450781753|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
125314760|NCT02365649|450781754|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
125314761|NCT02365649|450781755|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
125314762|NCT02365649|450781756|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
125314763|NCT02365649|450781747|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
125314764|NCT02365649|450781748|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
125314765|NCT02365649|450781749|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
125314766|NCT02365649|450781750|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
125314767|NCT02365649|450781751|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
125314768|NCT02365649|450781752|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
125314769|NCT02365649|450781753|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
125314770|NCT02365649|450781754|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
125314771|NCT02365649|450781755|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
125314772|NCT02365649|450781756|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
125314773|NCT02365649|450781747|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
125314774|NCT02365649|450781748|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
124987489|NCT01871805|449579839|FG001|Phase I|Alive in Survival Follow-up|2|||
124987490|NCT01871805|449579840|FG002|Phase I|Alive in Survival Follow-up|4|||
124987491|NCT01871805|449579841|FG003|Phase I|Alive in Survival Follow-up|5|||
124987492|NCT01871805|449579842|FG004|Phase I|Alive in Survival Follow-up|4|||
124987493|NCT01871805|449579843|FG005|Phase I|Alive in Survival Follow-up|0|||
124987494|NCT01871805|449579838|FG000|Phase I|Lost to Follow-up|0|||
124987495|NCT01871805|449579839|FG001|Phase I|Lost to Follow-up|1|||
124987496|NCT01871805|449579840|FG002|Phase I|Lost to Follow-up|3|||
124987497|NCT01871805|449579841|FG003|Phase I|Lost to Follow-up|0|||
124987498|NCT01871805|449579842|FG004|Phase I|Lost to Follow-up|0|||
124987499|NCT01871805|449579843|FG005|Phase I|Lost to Follow-up|0|||
124987500|NCT01871805|449579838|FG000|Phase II|Death|0|||
124987501|NCT01871805|449579839|FG001|Phase II|Death|0|||
124987502|NCT01871805|449579840|FG002|Phase II|Death|0|||
124987503|NCT01871805|449579841|FG003|Phase II|Death|0|||
124987504|NCT01871805|449579842|FG004|Phase II|Death|0|||
124987505|NCT01871805|449579843|FG005|Phase II|Death|45|||
124987506|NCT01871805|449579838|FG000|Phase II|Alive in Survival Follow-up|0|||
124987507|NCT01871805|449579839|FG001|Phase II|Alive in Survival Follow-up|0|||
124987508|NCT01871805|449579840|FG002|Phase II|Alive in Survival Follow-up|0|||
124987509|NCT01871805|449579841|FG003|Phase II|Alive in Survival Follow-up|0|||
124987510|NCT01871805|449579842|FG004|Phase II|Alive in Survival Follow-up|0|||
124987511|NCT01871805|449579843|FG005|Phase II|Alive in Survival Follow-up|29|||
124987512|NCT01871805|449579838|FG000|Phase II|Lost to Follow-up|0|||
124987513|NCT01871805|449579839|FG001|Phase II|Lost to Follow-up|0|||
124987514|NCT01871805|449579840|FG002|Phase II|Lost to Follow-up|0|||
124987515|NCT01871805|449579841|FG003|Phase II|Lost to Follow-up|0|||
124987516|NCT01871805|449579842|FG004|Phase II|Lost to Follow-up|0|||
124987517|NCT01871805|449579843|FG005|Phase II|Lost to Follow-up|13|||
124987518|NCT03412747|449579846|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
124987519|NCT03412747|449579847|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
124987520|NCT03412747|449579848|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
124987521|NCT03412747|449579846|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
124987522|NCT03412747|449579847|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
124987523|NCT03412747|449579848|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
124987524|NCT03412747|449579846|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
124987525|NCT03412747|449579847|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
124987526|NCT03412747|449579848|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
124987527|NCT03412747|449579846|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
124987528|NCT03412747|449579847|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
124987529|NCT03412747|449579848|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
124987530|NCT03412747|449579846|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
124987531|NCT03412747|449579847|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
124987532|NCT03412747|449579848|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
124987533|NCT03412747|449579846|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
124987534|NCT03412747|449579847|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
124987535|NCT03412747|449579848|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
124987536|NCT03412747|449579846|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
124987537|NCT03412747|449579847|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
124987538|NCT03412747|449579848|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
124987539|NCT03412747|449579846|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
124987540|NCT03412747|449579847|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
124987541|NCT03412747|449579848|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
124987542|NCT03412747|449579846|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
124987543|NCT03412747|449579847|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
124987544|NCT03412747|449579848|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
124987545|NCT03412747|449579846|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
124987546|NCT03412747|449579847|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
124987547|NCT03412747|449579848|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
124987548|NCT03412747|449579846|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
124987549|NCT03412747|449579847|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
124987550|NCT03412747|449579848|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
124987551|NCT03412747|449579846|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
124987552|NCT03412747|449579847|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
124987553|NCT03412747|449579848|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
124987554|NCT03412747|449579846|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
124987555|NCT03412747|449579847|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
124987556|NCT03412747|449579848|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
124987557|NCT03412747|449579846|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
124987558|NCT03412747|449579847|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
124987559|NCT03412747|449579848|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
124987560|NCT03412747|449579846|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
124987561|NCT03412747|449579847|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
124987562|NCT03412747|449579848|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
124987563|NCT03412747|449579846|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
124987564|NCT03412747|449579847|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
124987565|NCT03412747|449579848|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
124987566|NCT00468104|449579851|FG000|First Intervention|Protocol Violation|2|||
124987567|NCT00468104|449579852|FG001|First Intervention|Protocol Violation|1|||
124987568|NCT00468104|449579851|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
124987569|NCT00468104|449579852|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
124987570|NCT00468104|449579851|FG000|First Intervention|died within 3 weeks|1|||
124987571|NCT00468104|449579852|FG001|First Intervention|died within 3 weeks|0|||
124987572|NCT00468104|449579851|FG000|First Intervention|malposition/blocked chest tube tube|2|||
124987573|NCT00468104|449579852|FG001|First Intervention|malposition/blocked chest tube tube|0|||
124987574|NCT00468104|449579851|FG000|First Intervention|large lung mass with minimal effusion|1|||
124987575|NCT00468104|449579852|FG001|First Intervention|large lung mass with minimal effusion|0|||
124987576|NCT00468104|449579851|FG000|First Intervention|associated prolonged pneumothorax|1|||
124987577|NCT00468104|449579852|FG001|First Intervention|associated prolonged pneumothorax|0|||
124987578|NCT00468104|449579851|FG000|First Intervention|trapped lung|1|||
124987579|NCT00468104|449579852|FG001|First Intervention|trapped lung|0|||
124987580|NCT00468104|449579851|FG000|Second Intervention|Withdrawal by Subject|5|||
124987581|NCT00468104|449579852|FG001|Second Intervention|Withdrawal by Subject|2|||
124987582|NCT00468104|449579851|FG000|Second Intervention|discarded for malposition of chest tube|0|||
124987583|NCT00468104|449579852|FG001|Second Intervention|discarded for malposition of chest tube|2|||
124987584|NCT00141219|449579853|FG000|Overall Study|Protocol violations|5|||
124987585|NCT00141219|449579854|FG001|Overall Study|Protocol violations|4|||
124987586|NCT00141219|449579853|FG000|Overall Study|Adverse Event|8|||
124987587|NCT00141219|449579854|FG001|Overall Study|Adverse Event|6|||
124987588|NCT00141219|449579853|FG000|Overall Study|Lack of Efficacy|5|||
124987589|NCT00141219|449579854|FG001|Overall Study|Lack of Efficacy|4|||
124987590|NCT00141219|449579853|FG000|Overall Study|Withdrawal by Subject|6|||
124987591|NCT00141219|449579854|FG001|Overall Study|Withdrawal by Subject|2|||
124987592|NCT02224690|449579855|FG000|Overall Study|Adverse Event|8|||
124987593|NCT02224690|449579856|FG001|Overall Study|Adverse Event|1|||
124987594|NCT02224690|449579855|FG000|Overall Study|Met Withdrawal Criteria|4|||
125314775|NCT02365649|450781749|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
124987595|NCT02224690|449579856|FG001|Overall Study|Met Withdrawal Criteria|0|||
124987596|NCT02224690|449579855|FG000|Overall Study|Use of G-tube|1|||
124987597|NCT02224690|449579856|FG001|Overall Study|Use of G-tube|0|||
124987598|NCT02224690|449579855|FG000|Overall Study|Did not meet eligibility criteria|1|||
124987599|NCT02224690|449579856|FG001|Overall Study|Did not meet eligibility criteria|0|||
124987600|NCT00122460|449579858|FG000|Overall Study|investigational study phase ongoing|7|||
124987601|NCT00122460|449579859|FG001|Overall Study|investigational study phase ongoing|1|||
124987602|NCT01506609|449579860|FG000|Overall Study|Adverse Event Related to Progression|0|||
124987603|NCT01506609|449579861|FG001|Overall Study|Adverse Event Related to Progression|0|||
124987604|NCT01506609|449579862|FG002|Overall Study|Adverse Event Related to Progression|0|||
124987605|NCT01506609|449579863|FG003|Overall Study|Adverse Event Related to Progression|3|||
124987606|NCT01506609|449579864|FG004|Overall Study|Adverse Event Related to Progression|7|||
124987607|NCT01506609|449579865|FG005|Overall Study|Adverse Event Related to Progression|3|||
124987608|NCT01506609|449579860|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
124987609|NCT01506609|449579861|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
124987610|NCT01506609|449579862|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
124987611|NCT01506609|449579863|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
124987612|NCT01506609|449579864|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
124987613|NCT01506609|449579865|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
124987614|NCT01506609|449579860|FG000|Overall Study|Withdrawal by Subject|0|||
124987615|NCT01506609|449579861|FG001|Overall Study|Withdrawal by Subject|0|||
124987616|NCT01506609|449579862|FG002|Overall Study|Withdrawal by Subject|0|||
124987617|NCT01506609|449579863|FG003|Overall Study|Withdrawal by Subject|9|||
124987618|NCT01506609|449579864|FG004|Overall Study|Withdrawal by Subject|7|||
124987619|NCT01506609|449579865|FG005|Overall Study|Withdrawal by Subject|7|||
125314776|NCT02365649|450781750|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
125314777|NCT02365649|450781751|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
125314778|NCT02365649|450781752|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
125314779|NCT02365649|450781753|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
125314780|NCT02365649|450781754|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
125314781|NCT02365649|450781755|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
125314782|NCT02365649|450781756|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
125314783|NCT02365649|450781747|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
125314784|NCT02365649|450781748|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
125314785|NCT02365649|450781749|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
125314786|NCT02365649|450781750|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
125314787|NCT02365649|450781751|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
125314788|NCT02365649|450781752|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
125314789|NCT02365649|450781753|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
125314790|NCT02365649|450781754|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
125314791|NCT02365649|450781755|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
124872570|NCT03286751|449155666|FG003|Washout Period 2|Personal Reasons|0|||
124987620|NCT01506609|449579860|FG000|Overall Study|Lost to Follow-up|0|||
124987621|NCT01506609|449579861|FG001|Overall Study|Lost to Follow-up|0|||
124987622|NCT01506609|449579862|FG002|Overall Study|Lost to Follow-up|0|||
125314792|NCT02365649|450781756|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
124987623|NCT01506609|449579863|FG003|Overall Study|Lost to Follow-up|1|||
124987624|NCT01506609|449579864|FG004|Overall Study|Lost to Follow-up|2|||
124987625|NCT01506609|449579865|FG005|Overall Study|Lost to Follow-up|0|||
124987626|NCT01506609|449579860|FG000|Overall Study|Sponsor Discontinued Study|0|||
124987627|NCT01506609|449579861|FG001|Overall Study|Sponsor Discontinued Study|0|||
124987628|NCT01506609|449579862|FG002|Overall Study|Sponsor Discontinued Study|0|||
124987629|NCT01506609|449579863|FG003|Overall Study|Sponsor Discontinued Study|2|||
124987630|NCT01506609|449579864|FG004|Overall Study|Sponsor Discontinued Study|2|||
124987631|NCT01506609|449579865|FG005|Overall Study|Sponsor Discontinued Study|0|||
124987632|NCT01506609|449579860|FG000|Overall Study|Progressive Disease per Protocol|1|||
124987633|NCT01506609|449579861|FG001|Overall Study|Progressive Disease per Protocol|0|||
124987634|NCT01506609|449579862|FG002|Overall Study|Progressive Disease per Protocol|0|||
124987635|NCT01506609|449579863|FG003|Overall Study|Progressive Disease per Protocol|64|||
124987636|NCT01506609|449579864|FG004|Overall Study|Progressive Disease per Protocol|57|||
124987637|NCT01506609|449579865|FG005|Overall Study|Progressive Disease per Protocol|74|||
124987638|NCT01506609|449579860|FG000|Overall Study|Other, Not Specified|0|||
124987639|NCT01506609|449579861|FG001|Overall Study|Other, Not Specified|0|||
124987640|NCT01506609|449579862|FG002|Overall Study|Other, Not Specified|0|||
124987641|NCT01506609|449579863|FG003|Overall Study|Other, Not Specified|10|||
124987642|NCT01506609|449579864|FG004|Overall Study|Other, Not Specified|7|||
124987643|NCT01506609|449579865|FG005|Overall Study|Other, Not Specified|3|||
124987644|NCT01506609|449579860|FG000|Overall Study|Missing / Unknown Reason|1|||
124987645|NCT01506609|449579861|FG001|Overall Study|Missing / Unknown Reason|0|||
124987646|NCT01506609|449579862|FG002|Overall Study|Missing / Unknown Reason|1|||
124987647|NCT01506609|449579863|FG003|Overall Study|Missing / Unknown Reason|4|||
124987648|NCT01506609|449579864|FG004|Overall Study|Missing / Unknown Reason|4|||
124987649|NCT01506609|449579865|FG005|Overall Study|Missing / Unknown Reason|2|||
124987650|NCT00381615|449579868|FG000|Overall Study|Withdrawal by Subject|1|||
124987651|NCT00381615|449579869|FG001|Overall Study|Withdrawal by Subject|3|||
124987652|NCT00381615|449579870|FG002|Overall Study|Withdrawal by Subject|0|||
124987653|NCT00381615|449579871|FG003|Overall Study|Withdrawal by Subject|1|||
124987654|NCT00381615|449579868|FG000|Overall Study|Lost to Follow-up|3|||
124987655|NCT00381615|449579869|FG001|Overall Study|Lost to Follow-up|2|||
124987656|NCT00381615|449579870|FG002|Overall Study|Lost to Follow-up|0|||
124987657|NCT00381615|449579871|FG003|Overall Study|Lost to Follow-up|1|||
124987658|NCT00381615|449579868|FG000|Overall Study|Protocol Violation|0|||
124987659|NCT00381615|449579869|FG001|Overall Study|Protocol Violation|0|||
124987660|NCT00381615|449579870|FG002|Overall Study|Protocol Violation|1|||
124987661|NCT00381615|449579871|FG003|Overall Study|Protocol Violation|0|||
124987662|NCT02595073|449579872|FG000|Overall Study|Progressive Disease|0|||
124987663|NCT02595073|449579873|FG001|Overall Study|Progressive Disease|1|||
124987664|NCT02595073|449579872|FG000|Overall Study|Protocol Violation|2|||
124987665|NCT02595073|449579873|FG001|Overall Study|Protocol Violation|0|||
124987666|NCT02962960|449579874|FG000|Overall Study|Withdrawal by Subject|1|||
124987667|NCT02962960|449579875|FG001|Overall Study|Withdrawal by Subject|1|||
124987668|NCT02962960|449579876|FG002|Overall Study|Withdrawal by Subject|0|||
124987669|NCT02962960|449579874|FG000|Overall Study|Adverse Event|1|||
124987670|NCT02962960|449579875|FG001|Overall Study|Adverse Event|1|||
124987671|NCT02962960|449579876|FG002|Overall Study|Adverse Event|0|||
124987672|NCT02962960|449579874|FG000|Overall Study|Protocol Violation|1|||
124987673|NCT02962960|449579875|FG001|Overall Study|Protocol Violation|0|||
124987674|NCT02962960|449579876|FG002|Overall Study|Protocol Violation|0|||
124987675|NCT00468559|449579882|FG000|Open-label Treatment Phase|Adverse Event|5|||
124987676|NCT00468559|449579883|FG001|Open-label Treatment Phase|Adverse Event|0|||
124987677|NCT00468559|449579884|FG002|Open-label Treatment Phase|Adverse Event|0|||
124987678|NCT00468559|449579882|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
124987679|NCT00468559|449579883|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
124987680|NCT00468559|449579884|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
124987681|NCT00468559|449579882|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
124987682|NCT00468559|449579883|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
125314793|NCT02365649|450781747|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
125314794|NCT02365649|450781748|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
124987683|NCT00468559|449579884|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
125314795|NCT02365649|450781749|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
124987684|NCT00468559|449579882|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
125314796|NCT02365649|450781750|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
124987685|NCT00468559|449579883|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
124987686|NCT00468559|449579884|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
124987687|NCT00468559|449579882|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
124987688|NCT00468559|449579883|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
124987689|NCT00468559|449579884|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
124987690|NCT03538301|449579888|FG000|Overall Study|Adverse Event|1|||
124987691|NCT03538301|449579889|FG001|Overall Study|Adverse Event|4|||
124987692|NCT03538301|449579890|FG002|Overall Study|Adverse Event|4|||
124987693|NCT03538301|449579888|FG000|Overall Study|Death|1|||
124987694|NCT03538301|449579889|FG001|Overall Study|Death|1|||
124987695|NCT03538301|449579890|FG002|Overall Study|Death|0|||
124987696|NCT03538301|449579888|FG000|Overall Study|Physician Decision|0|||
124987697|NCT03538301|449579889|FG001|Overall Study|Physician Decision|1|||
124987698|NCT03538301|449579890|FG002|Overall Study|Physician Decision|0|||
124987699|NCT03538301|449579888|FG000|Overall Study|Protocol Violation|0|||
124987700|NCT03538301|449579889|FG001|Overall Study|Protocol Violation|0|||
124987701|NCT03538301|449579890|FG002|Overall Study|Protocol Violation|1|||
124987702|NCT03538301|449579888|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
124987703|NCT03538301|449579889|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
124987704|NCT03538301|449579890|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
124987705|NCT02842151|449579893|FG000|Overall Study|Adverse Event|1|||
124987706|NCT02842151|449579893|FG000|Overall Study|Subject moved too far away|1|||
124987707|NCT01879553|449579894|FG000|Overall Study|Withdrawal by Subject|1|||
124987708|NCT01879553|449579895|FG001|Overall Study|Withdrawal by Subject|0|||
124987709|NCT02559895|449579897|FG000|Overall Study|Adverse Event|3|||
124987710|NCT02559895|449579898|FG001|Overall Study|Adverse Event|3|||
124987711|NCT02559895|449579899|FG002|Overall Study|Adverse Event|2|||
124987712|NCT02559895|449579900|FG003|Overall Study|Adverse Event|1|||
124987713|NCT02559895|449579897|FG000|Overall Study|Lack of Efficacy|2|||
124987714|NCT02559895|449579898|FG001|Overall Study|Lack of Efficacy|3|||
124987715|NCT02559895|449579899|FG002|Overall Study|Lack of Efficacy|2|||
124987716|NCT02559895|449579900|FG003|Overall Study|Lack of Efficacy|8|||
124987717|NCT02559895|449579897|FG000|Overall Study|Lost to Follow-up|22|||
124987718|NCT02559895|449579898|FG001|Overall Study|Lost to Follow-up|16|||
124987719|NCT02559895|449579899|FG002|Overall Study|Lost to Follow-up|12|||
124987720|NCT02559895|449579900|FG003|Overall Study|Lost to Follow-up|17|||
124987721|NCT02559895|449579897|FG000|Overall Study|Physician Decision|1|||
124987722|NCT02559895|449579898|FG001|Overall Study|Physician Decision|1|||
124987723|NCT02559895|449579899|FG002|Overall Study|Physician Decision|3|||
124987724|NCT02559895|449579900|FG003|Overall Study|Physician Decision|0|||
124987725|NCT02559895|449579897|FG000|Overall Study|Withdrawal by Subject|16|||
124987726|NCT02559895|449579898|FG001|Overall Study|Withdrawal by Subject|9|||
124987727|NCT02559895|449579899|FG002|Overall Study|Withdrawal by Subject|20|||
124987728|NCT02559895|449579900|FG003|Overall Study|Withdrawal by Subject|9|||
124987729|NCT02559895|449579897|FG000|Overall Study|Study Burden|10|||
124987730|NCT02559895|449579898|FG001|Overall Study|Study Burden|16|||
124987731|NCT02559895|449579899|FG002|Overall Study|Study Burden|12|||
124987732|NCT02559895|449579900|FG003|Overall Study|Study Burden|22|||
124987733|NCT02559895|449579897|FG000|Overall Study|Other|1|||
124987734|NCT02559895|449579898|FG001|Overall Study|Other|5|||
124987735|NCT02559895|449579899|FG002|Overall Study|Other|3|||
124987736|NCT02559895|449579900|FG003|Overall Study|Other|3|||
124987737|NCT04540887|449579906|FG000|Overall Study|Withdrawal by Subject|2|||
124987738|NCT01262027|449579907|FG000|Overall Study|Adverse Event|1|||
124987739|NCT01262027|449579907|FG000|Overall Study|Withdrawal by Subject|3|||
124987740|NCT01262027|449579907|FG000|Overall Study|Protocol Violation|1|||
124987741|NCT02665338|449579912|FG000|Overall Study|Withdrawal by Subject|0|||
124987742|NCT02665338|449579913|FG001|Overall Study|Withdrawal by Subject|1|||
124987743|NCT00589121|449579914|FG000|Overall Study|Protocol Violation|2|||
124987744|NCT00589121|449579915|FG001|Overall Study|Protocol Violation|6|||
124987745|NCT00589121|449579914|FG000|Overall Study|No protocol treatment received|0|||
124987746|NCT00589121|449579915|FG001|Overall Study|No protocol treatment received|1|||
124987747|NCT01892540|449579916|FG000|Overall Study|Did not complete PET/MRI|0|||
124987748|NCT01892540|449579917|FG001|Overall Study|Did not complete PET/MRI|0|||
124987749|NCT01892540|449579918|FG002|Overall Study|Did not complete PET/MRI|2|||
125314797|NCT02365649|450781751|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
125314798|NCT02365649|450781752|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
125314799|NCT02365649|450781753|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
125314800|NCT02365649|450781754|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
124987750|NCT01892540|449579916|FG000|Overall Study|Did not fit in scanner|0|||
124987751|NCT01892540|449579917|FG001|Overall Study|Did not fit in scanner|0|||
124987752|NCT01892540|449579918|FG002|Overall Study|Did not fit in scanner|1|||
124987753|NCT02317432|449579919|FG000|Overall Study|Death|4|||
124987754|NCT02317432|449579920|FG001|Overall Study|Death|1|||
124987755|NCT02317432|449579919|FG000|Overall Study|Lost to Follow-up|0|||
124987756|NCT02317432|449579920|FG001|Overall Study|Lost to Follow-up|5|||
124987757|NCT02317432|449579919|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
124987758|NCT02317432|449579920|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
124987759|NCT03992846|449579923|FG000|Overall Study|Adverse Event|8|||
124987760|NCT03992846|449579924|FG001|Overall Study|Adverse Event|6|||
124987761|NCT03992846|449579925|FG002|Overall Study|Adverse Event|3|||
124987762|NCT03992846|449579923|FG000|Overall Study|Lost to Follow-up|0|||
124987763|NCT03992846|449579924|FG001|Overall Study|Lost to Follow-up|1|||
124987764|NCT03992846|449579925|FG002|Overall Study|Lost to Follow-up|1|||
124987765|NCT03992846|449579923|FG000|Overall Study|Pregnancy|2|||
124987766|NCT03992846|449579924|FG001|Overall Study|Pregnancy|0|||
124987767|NCT03992846|449579925|FG002|Overall Study|Pregnancy|1|||
124987768|NCT03992846|449579923|FG000|Overall Study|Protocol Violation|1|||
124987769|NCT03992846|449579924|FG001|Overall Study|Protocol Violation|2|||
124987770|NCT03992846|449579925|FG002|Overall Study|Protocol Violation|0|||
124987771|NCT03992846|449579923|FG000|Overall Study|Withdrawal by Subject|8|||
124987772|NCT03992846|449579924|FG001|Overall Study|Withdrawal by Subject|10|||
124987773|NCT03992846|449579925|FG002|Overall Study|Withdrawal by Subject|20|||
124987774|NCT03992846|449579923|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
124987775|NCT03992846|449579924|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
124987776|NCT03992846|449579925|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
124987777|NCT03647488|449581439|FG000|Overall Study|Progressive disease|10|||
124987778|NCT03647488|449581440|FG001|Overall Study|Progressive disease|0|||
124987779|NCT03647488|449581441|FG002|Overall Study|Progressive disease|0|||
124987780|NCT03647488|449581439|FG000|Overall Study|Adverse Event|5|||
124987781|NCT03647488|449581440|FG001|Overall Study|Adverse Event|0|||
124987782|NCT03647488|449581441|FG002|Overall Study|Adverse Event|0|||
124987783|NCT03647488|449581439|FG000|Overall Study|Clinical progression|2|||
124987784|NCT03647488|449581440|FG001|Overall Study|Clinical progression|0|||
124987785|NCT03647488|449581441|FG002|Overall Study|Clinical progression|0|||
124987786|NCT03647488|449581439|FG000|Overall Study|Participant refused to take investigational product|1|||
124987787|NCT03647488|449581440|FG001|Overall Study|Participant refused to take investigational product|0|||
124987788|NCT03647488|449581441|FG002|Overall Study|Participant refused to take investigational product|0|||
124987789|NCT00565851|449581442|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
124987790|NCT00565851|449581443|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
124987791|NCT00565851|449581444|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
124987792|NCT00565851|449581445|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
124987793|NCT00565851|449581446|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
124987794|NCT00565851|449581447|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
124987795|NCT00565851|449581448|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
124987796|NCT00565851|449581449|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
124987797|NCT00565851|449581442|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
124987798|NCT00565851|449581443|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
124987799|NCT00565851|449581444|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
124987800|NCT00565851|449581445|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
124987801|NCT00565851|449581446|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
124987802|NCT00565851|449581447|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
124987803|NCT00565851|449581448|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
124987804|NCT00565851|449581449|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
124987805|NCT00775463|449581450|FG000|Overall Study|Withdrawal by Subject|0|||
124987806|NCT00775463|449581451|FG001|Overall Study|Withdrawal by Subject|1|||
124987807|NCT00775463|449581450|FG000|Overall Study|Adverse Event|7|||
124987808|NCT00775463|449581451|FG001|Overall Study|Adverse Event|9|||
124987809|NCT00775463|449581450|FG000|Overall Study|Protocol Violation|2|||
124987810|NCT00775463|449581451|FG001|Overall Study|Protocol Violation|2|||
124987811|NCT00775463|449581450|FG000|Overall Study|Lost to Follow-up|1|||
124987812|NCT00775463|449581451|FG001|Overall Study|Lost to Follow-up|0|||
124987813|NCT00775463|449581450|FG000|Overall Study|Lack of Efficacy|1|||
124987814|NCT00775463|449581451|FG001|Overall Study|Lack of Efficacy|1|||
124987815|NCT03695237|449581452|FG000|Overall Study|Withdrawal by Subject|1|||
124987816|NCT03695237|449581453|FG001|Overall Study|Withdrawal by Subject|3|||
124987817|NCT03695237|449581452|FG000|Overall Study|Lost to Follow-up|1|||
124987818|NCT03695237|449581453|FG001|Overall Study|Lost to Follow-up|2|||
124987819|NCT03695237|449581452|FG000|Overall Study|Other, Not Specified|8|||
124987820|NCT03695237|449581453|FG001|Overall Study|Other, Not Specified|2|||
124987821|NCT01789567|449581456|FG000|Overall Study|Death|6|||
124987822|NCT00091169|449581457|FG000|Overall Study|Disease progression|3|||
124987823|NCT00091169|449581458|FG001|Overall Study|Disease progression|1|||
124987824|NCT00091169|449581457|FG000|Overall Study|Adverse Event|11|||
124987825|NCT00091169|449581458|FG001|Overall Study|Adverse Event|17|||
124987826|NCT00091169|449581457|FG000|Overall Study|Death|4|||
124987827|NCT00091169|449581458|FG001|Overall Study|Death|1|||
124987828|NCT00091169|449581457|FG000|Overall Study|Withdrawal by Subject|10|||
124987829|NCT00091169|449581458|FG001|Overall Study|Withdrawal by Subject|13|||
124987830|NCT00091169|449581457|FG000|Overall Study|Other|3|||
124987831|NCT00091169|449581458|FG001|Overall Study|Other|4|||
124987832|NCT00091169|449581457|FG000|Overall Study|Not start protocol therapy|26|||
124987833|NCT00091169|449581458|FG001|Overall Study|Not start protocol therapy|17|||
124987834|NCT00872989|449581459|FG000|Overall Study|Adverse Event|7|||
124987835|NCT00872989|449581460|FG001|Overall Study|Adverse Event|15|||
124987836|NCT00872989|449581459|FG000|Overall Study|Withdrawal by Subject|8|||
124987837|NCT00872989|449581460|FG001|Overall Study|Withdrawal by Subject|5|||
124987838|NCT00872989|449581459|FG000|Overall Study|Progression/relapse|47|||
124987839|NCT00872989|449581460|FG001|Overall Study|Progression/relapse|35|||
125210538|NCT02907619|450395592|FG002|Overall Study|Other|0|||
124987840|NCT00872989|449581459|FG000|Overall Study|Not protocol specified|3|||
124987841|NCT00872989|449581460|FG001|Overall Study|Not protocol specified|8|||
124987842|NCT02407990|449581461|FG000|Overall Study|Death|2|||
124987843|NCT02407990|449581462|FG001|Overall Study|Death|22|||
124987844|NCT02407990|449581463|FG002|Overall Study|Death|23|||
124987845|NCT02407990|449581464|FG003|Overall Study|Death|7|||
124987846|NCT02407990|449581465|FG004|Overall Study|Death|17|||
124987847|NCT02407990|449581466|FG005|Overall Study|Death|16|||
124987848|NCT02407990|449581467|FG006|Overall Study|Death|10|||
124987849|NCT02407990|449581468|FG007|Overall Study|Death|248|||
124987850|NCT02407990|449581461|FG000|Overall Study|Lost to Follow-up|0|||
124987851|NCT02407990|449581462|FG001|Overall Study|Lost to Follow-up|1|||
124987852|NCT02407990|449581463|FG002|Overall Study|Lost to Follow-up|0|||
124987853|NCT02407990|449581464|FG003|Overall Study|Lost to Follow-up|0|||
124987854|NCT02407990|449581465|FG004|Overall Study|Lost to Follow-up|0|||
124987855|NCT02407990|449581466|FG005|Overall Study|Lost to Follow-up|0|||
124987856|NCT02407990|449581467|FG006|Overall Study|Lost to Follow-up|0|||
124987857|NCT02407990|449581468|FG007|Overall Study|Lost to Follow-up|17|||
124987858|NCT02407990|449581461|FG000|Overall Study|Progressive Disease|0|||
124987859|NCT02407990|449581462|FG001|Overall Study|Progressive Disease|0|||
124987860|NCT02407990|449581463|FG002|Overall Study|Progressive Disease|0|||
124987861|NCT02407990|449581464|FG003|Overall Study|Progressive Disease|0|||
124987862|NCT02407990|449581465|FG004|Overall Study|Progressive Disease|0|||
124987863|NCT02407990|449581466|FG005|Overall Study|Progressive Disease|0|||
124987864|NCT02407990|449581467|FG006|Overall Study|Progressive Disease|0|||
124987865|NCT02407990|449581468|FG007|Overall Study|Progressive Disease|1|||
124987866|NCT02407990|449581461|FG000|Overall Study|Withdrawal by Subject|0|||
124987867|NCT02407990|449581462|FG001|Overall Study|Withdrawal by Subject|0|||
124987868|NCT02407990|449581463|FG002|Overall Study|Withdrawal by Subject|0|||
124987869|NCT02407990|449581464|FG003|Overall Study|Withdrawal by Subject|0|||
124987870|NCT02407990|449581465|FG004|Overall Study|Withdrawal by Subject|1|||
124987871|NCT02407990|449581466|FG005|Overall Study|Withdrawal by Subject|0|||
124987872|NCT02407990|449581467|FG006|Overall Study|Withdrawal by Subject|0|||
124987873|NCT02407990|449581468|FG007|Overall Study|Withdrawal by Subject|30|||
124987874|NCT02407990|449581461|FG000|Overall Study|Study Terminated by Sponsor|1|||
124987875|NCT02407990|449581462|FG001|Overall Study|Study Terminated by Sponsor|3|||
124987876|NCT02407990|449581463|FG002|Overall Study|Study Terminated by Sponsor|3|||
124987877|NCT02407990|449581464|FG003|Overall Study|Study Terminated by Sponsor|0|||
124987878|NCT02407990|449581465|FG004|Overall Study|Study Terminated by Sponsor|3|||
124987879|NCT02407990|449581466|FG005|Overall Study|Study Terminated by Sponsor|4|||
124987880|NCT02407990|449581467|FG006|Overall Study|Study Terminated by Sponsor|3|||
124987881|NCT02407990|449581468|FG007|Overall Study|Study Terminated by Sponsor|37|||
124987882|NCT02407990|449581461|FG000|Overall Study|Logistics|0|||
124987883|NCT02407990|449581462|FG001|Overall Study|Logistics|0|||
124987884|NCT02407990|449581463|FG002|Overall Study|Logistics|0|||
124987885|NCT02407990|449581464|FG003|Overall Study|Logistics|0|||
124987886|NCT02407990|449581465|FG004|Overall Study|Logistics|0|||
124987887|NCT02407990|449581466|FG005|Overall Study|Logistics|0|||
124987888|NCT02407990|449581467|FG006|Overall Study|Logistics|0|||
124987889|NCT02407990|449581468|FG007|Overall Study|Logistics|1|||
124987890|NCT02407990|449581461|FG000|Overall Study|Rolled into long-term extension study|0|||
124987891|NCT02407990|449581462|FG001|Overall Study|Rolled into long-term extension study|0|||
124987892|NCT02407990|449581463|FG002|Overall Study|Rolled into long-term extension study|0|||
124987893|NCT02407990|449581464|FG003|Overall Study|Rolled into long-term extension study|0|||
124987894|NCT02407990|449581465|FG004|Overall Study|Rolled into long-term extension study|0|||
124987895|NCT02407990|449581466|FG005|Overall Study|Rolled into long-term extension study|0|||
124987896|NCT02407990|449581467|FG006|Overall Study|Rolled into long-term extension study|0|||
124987897|NCT02407990|449581468|FG007|Overall Study|Rolled into long-term extension study|1|||
124987898|NCT00734097|449581469|FG000|Screening|Protocol Violation|12|||
124987899|NCT00734097|449581469|FG000|Screening|Withdrawal by Subject|5|||
124987900|NCT00734097|449581469|FG000|Screening|Lost to Follow-up|2|||
124987901|NCT00734097|449581469|FG000|Screening|Unconfirmed pregnancy|1|||
124987902|NCT00734097|449581469|FG000|Open Label|Lost to Follow-up|7|||
124987903|NCT00734097|449581469|FG000|Open Label|Withdrawal by Subject|5|||
124987904|NCT00734097|449581469|FG000|Open Label|Protocol Violation|4|||
124987905|NCT02233543|449581476|FG000|Period 1|Withdrawal by Subject|1|||
124987906|NCT02233543|449581477|FG001|Period 1|Withdrawal by Subject|0|||
124987907|NCT02233543|449581476|FG000|Period 1|Participants required other treatment.|2|||
124987908|NCT02233543|449581477|FG001|Period 1|Participants required other treatment.|3|||
124987909|NCT02233543|449581476|FG000|Period 2|Adverse Event|1|||
124987910|NCT02233543|449581477|FG001|Period 2|Adverse Event|0|||
124987911|NCT02233543|449581476|FG000|Period 2|Participant required other treatment.|0|||
124987912|NCT02233543|449581477|FG001|Period 2|Participant required other treatment.|1|||
124987913|NCT02233543|449581476|FG000|Period 2|COPD exacerbation|1|||
124987914|NCT02233543|449581477|FG001|Period 2|COPD exacerbation|0|||
124987915|NCT03573583|449581478|FG000|Overall Study|Lost to Follow-up|1|||
124987916|NCT03573583|449581479|FG001|Overall Study|Lost to Follow-up|0|||
124987917|NCT03573583|449581478|FG000|Overall Study|Withdrawal by Subject|1|||
125314801|NCT02365649|450781755|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
124987918|NCT03573583|449581479|FG001|Overall Study|Withdrawal by Subject|1|||
124987919|NCT03730480|449581484|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
124987920|NCT01227577|449581485|FG000|Overall Study|Protocol deviation|3|||
124987921|NCT01227577|449581485|FG000|Overall Study|Death|3|||
124987922|NCT01227577|449581485|FG000|Overall Study|Administrative problems|2|||
124987923|NCT01227577|449581485|FG000|Overall Study|Lost to Follow-up|1|||
124987924|NCT01227577|449581485|FG000|Overall Study|Withdrawal by Subject|4|||
124987925|NCT01227577|449581485|FG000|Overall Study|Lack of Efficacy|5|||
124987926|NCT01227577|449581485|FG000|Overall Study|Adverse Event|17|||
124987927|NCT00852540|449581486|FG000|Overall Study|Adverse Event|10|||
124987928|NCT00852540|449581487|FG001|Overall Study|Adverse Event|3|||
124987929|NCT00852540|449581486|FG000|Overall Study|Lack of Efficacy|15|||
124987930|NCT00852540|449581487|FG001|Overall Study|Lack of Efficacy|3|||
124987931|NCT00852540|449581486|FG000|Overall Study|Protocol Violation|1|||
124987932|NCT00852540|449581487|FG001|Overall Study|Protocol Violation|2|||
124987933|NCT00852540|449581486|FG000|Overall Study|Lost to Follow-up|2|||
124987934|NCT00852540|449581487|FG001|Overall Study|Lost to Follow-up|3|||
124987935|NCT00852540|449581486|FG000|Overall Study|Investigator Discretion|2|||
124987936|NCT00852540|449581487|FG001|Overall Study|Investigator Discretion|3|||
124987937|NCT00852540|449581486|FG000|Overall Study|Withdrawal by Subject|3|||
124987938|NCT00852540|449581487|FG001|Overall Study|Withdrawal by Subject|1|||
124987939|NCT00852540|449581486|FG000|Overall Study|Did Not Receive Study Drug|3|||
124987940|NCT00852540|449581487|FG001|Overall Study|Did Not Receive Study Drug|3|||
124987941|NCT01639495|449581488|FG000|Overall Study|Lost to Follow-up|6|||
124987942|NCT01639495|449581488|FG000|Overall Study|Consented but didn't have study catheter|4|||
124987943|NCT01639495|449581488|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
124987944|NCT01639495|449581488|FG000|Overall Study|No radiofrequency energy applied|2|||
124987945|NCT01183234|449581489|FG000|First Intervention|Adverse Event|1|||
124987946|NCT01183234|449581490|FG001|First Intervention|Adverse Event|0|||
124987947|NCT01639560|449581493|FG000|Overall Study|Withdrawal by Subject|9|||
124987948|NCT01639560|449581494|FG001|Overall Study|Withdrawal by Subject|14|||
124987949|NCT01639560|449581493|FG000|Overall Study|Lack of Efficacy|1|||
124987950|NCT01639560|449581494|FG001|Overall Study|Lack of Efficacy|2|||
124987951|NCT01639560|449581493|FG000|Overall Study|Lost to Follow-up|9|||
124987952|NCT01639560|449581494|FG001|Overall Study|Lost to Follow-up|11|||
124987953|NCT01639560|449581493|FG000|Overall Study|Adverse Event|0|||
124987954|NCT01639560|449581494|FG001|Overall Study|Adverse Event|2|||
124987955|NCT01156792|449581498|FG000|Overall Study|Adverse Event|1|||
124987956|NCT01156792|449581498|FG000|Overall Study|Lack of Efficacy|36|||
124987957|NCT01156792|449581498|FG000|Overall Study|Protocol Violation|6|||
124987958|NCT01156792|449581498|FG000|Overall Study|Lost to Follow-up|3|||
124987959|NCT01156792|449581498|FG000|Overall Study|Physician Decision|3|||
124987960|NCT01156792|449581498|FG000|Overall Study|Withdrawal by Subject|9|||
124987961|NCT01156792|449581498|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
124987962|NCT01474434|449581499|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
124987963|NCT01474434|449581500|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
124987964|NCT01474434|449581501|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
124987965|NCT01474434|449581502|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
124987966|NCT01474434|449581499|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
124987967|NCT01474434|449581500|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
124987968|NCT01474434|449581501|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
124987969|NCT01474434|449581502|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
124987970|NCT01474434|449581499|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
124987971|NCT01474434|449581500|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
124987972|NCT01474434|449581501|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
124987973|NCT01474434|449581502|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
124987974|NCT00495586|449581506|FG000|Overall Study|Withdrawal by Subject|4|||
124987975|NCT00495586|449581507|FG001|Overall Study|Withdrawal by Subject|4|||
124987976|NCT00158860|449581508|FG000|Overall Study|Adverse Event|3|||
125314802|NCT02365649|450781756|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
125314803|NCT02365649|450781747|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
125314804|NCT02365649|450781748|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
124987977|NCT00158860|449581509|FG001|Overall Study|Adverse Event|6|||
124987978|NCT00158860|449581508|FG000|Overall Study|Lost to Follow-up|11|||
124987979|NCT00158860|449581509|FG001|Overall Study|Lost to Follow-up|17|||
124987980|NCT00158860|449581508|FG000|Overall Study|Protocol Violation|8|||
124987981|NCT00158860|449581509|FG001|Overall Study|Protocol Violation|23|||
124987982|NCT00158860|449581508|FG000|Overall Study|Withdrawal by Subject|7|||
124987983|NCT00158860|449581509|FG001|Overall Study|Withdrawal by Subject|17|||
124987984|NCT00158860|449581508|FG000|Overall Study|MOVING OUT OF STATE|1|||
124987985|NCT00158860|449581509|FG001|Overall Study|MOVING OUT OF STATE|0|||
124987986|NCT00158860|449581508|FG000|Overall Study|Pregnancy|3|||
124987987|NCT00158860|449581509|FG001|Overall Study|Pregnancy|3|||
124987988|NCT00158860|449581508|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
124987989|NCT00158860|449581509|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
124987990|NCT00158860|449581508|FG000|Overall Study|SPONSOR REQUEST|0|||
124987991|NCT00158860|449581509|FG001|Overall Study|SPONSOR REQUEST|1|||
124987992|NCT00158860|449581508|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
124987993|NCT00158860|449581509|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
125314805|NCT02365649|450781749|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
125314806|NCT02365649|450781750|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
125314807|NCT02365649|450781751|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
125314808|NCT02365649|450781752|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
125314809|NCT02365649|450781753|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
125314810|NCT02365649|450781754|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
124987994|NCT00158860|449581508|FG000|Overall Study|Closed per sponsor|0|||
124987995|NCT00158860|449581509|FG001|Overall Study|Closed per sponsor|1|||
124987996|NCT01029652|449581510|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
124987997|NCT01029652|449581511|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
124987998|NCT01029652|449581510|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
124987999|NCT01029652|449581511|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
124988000|NCT01029652|449581510|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
124988001|NCT01029652|449581511|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
124988002|NCT01029652|449581510|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
124988003|NCT01029652|449581511|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
124988004|NCT01029652|449581510|FG000|Core Study (0-12 Weeks)|Death|0|||
124988005|NCT01029652|449581511|FG001|Core Study (0-12 Weeks)|Death|1|||
124988006|NCT01029652|449581510|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
124988007|NCT01029652|449581511|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
124988008|NCT01029652|449581510|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
124988009|NCT01029652|449581511|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
124988010|NCT01029652|449581510|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
124988011|NCT01029652|449581511|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
124988012|NCT01029652|449581510|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
124988013|NCT01029652|449581511|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
124988014|NCT01029652|449581510|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
124988015|NCT01029652|449581511|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
124988016|NCT01029652|449581510|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
124988017|NCT01029652|449581511|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
124988018|NCT01029652|449581510|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
124988019|NCT01029652|449581511|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
125314811|NCT02365649|450781755|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
125314812|NCT02365649|450781756|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
125314813|NCT02365649|450781747|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
125314814|NCT02365649|450781748|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
125314815|NCT02365649|450781749|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
125314816|NCT02365649|450781750|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
125314817|NCT02365649|450781751|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
125314818|NCT02365649|450781752|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
125314819|NCT02365649|450781753|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
125314820|NCT02365649|450781754|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
125314821|NCT02365649|450781755|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
125314822|NCT02365649|450781756|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
125314823|NCT02365649|450781747|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
125314824|NCT02365649|450781748|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
125314825|NCT02365649|450781749|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
125314826|NCT02365649|450781750|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
125314827|NCT02365649|450781751|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
125314828|NCT02365649|450781752|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
124872571|NCT03286751|449155667|FG004|Washout Period 2|Personal Reasons|0|||
124988020|NCT02095951|449581512|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
124988021|NCT02095951|449581513|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
124988022|NCT03618823|449581514|FG000|Overall Study|Lost to Follow-up|63|||
124988023|NCT03618823|449581515|FG001|Overall Study|Lost to Follow-up|61|||
124988024|NCT00964886|449581516|FG000|Overall Study|Lost to Follow-up|2|||
124872572|NCT03286751|449155668|FG005|Washout Period 2|Personal Reasons|0|||
124988025|NCT00964886|449581517|FG001|Overall Study|Lost to Follow-up|2|||
124988026|NCT00964886|449581518|FG002|Overall Study|Lost to Follow-up|6|||
124988027|NCT00964886|449581519|FG003|Overall Study|Lost to Follow-up|4|||
124988028|NCT00964886|449581516|FG000|Overall Study|Withdrawal by Subject|6|||
124988029|NCT00964886|449581517|FG001|Overall Study|Withdrawal by Subject|2|||
125314829|NCT02365649|450781753|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
125314830|NCT02365649|450781754|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
125314831|NCT02365649|450781755|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
125314832|NCT02365649|450781756|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
124988030|NCT00964886|449581518|FG002|Overall Study|Withdrawal by Subject|5|||
124988031|NCT00964886|449581519|FG003|Overall Study|Withdrawal by Subject|3|||
124988032|NCT00964886|449581516|FG000|Overall Study|Adverse Event|3|||
124988033|NCT00964886|449581517|FG001|Overall Study|Adverse Event|1|||
124988034|NCT00964886|449581518|FG002|Overall Study|Adverse Event|5|||
124988035|NCT00964886|449581519|FG003|Overall Study|Adverse Event|2|||
124988036|NCT00964886|449581516|FG000|Overall Study|Protocol Violation|0|||
124988037|NCT00964886|449581517|FG001|Overall Study|Protocol Violation|2|||
124988038|NCT00964886|449581518|FG002|Overall Study|Protocol Violation|0|||
124988039|NCT00964886|449581519|FG003|Overall Study|Protocol Violation|0|||
124988040|NCT00523640|449581521|FG000|Overall Study|Death|1|||
124988041|NCT01621568|449581524|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
124988042|NCT01621568|449581525|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
124988043|NCT01621568|449581524|FG000|Week 5-6 No Treatment|Death|1|||
124988044|NCT01621568|449581525|FG001|Week 5-6 No Treatment|Death|0|||
124988045|NCT02399254|449581526|FG000|Overall Study|Physician Decision|2|||
124988046|NCT03500159|449581529|FG000|Overall Study|Study Terminated|2|||
124988047|NCT03500159|449581530|FG001|Overall Study|Study Terminated|1|||
124988048|NCT02292927|449581535|FG000|Overall Study|Protocol Violation|13|||
124988049|NCT02292927|449581536|FG001|Overall Study|Protocol Violation|7|||
124988050|NCT02971761|449581538|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
124988051|NCT01605916|449581539|FG000|Overall Study|Adverse Event|1|||
124988052|NCT01605916|449581540|FG001|Overall Study|Adverse Event|0|||
124988053|NCT01605916|449581541|FG002|Overall Study|Adverse Event|0|||
124988054|NCT01605916|449581542|FG003|Overall Study|Adverse Event|1|||
124988055|NCT01605916|449581543|FG004|Overall Study|Adverse Event|0|||
124988056|NCT01605916|449581539|FG000|Overall Study|Lack of Efficacy|2|||
124988057|NCT01605916|449581540|FG001|Overall Study|Lack of Efficacy|3|||
124988058|NCT01605916|449581541|FG002|Overall Study|Lack of Efficacy|3|||
124988059|NCT01605916|449581542|FG003|Overall Study|Lack of Efficacy|5|||
124988060|NCT01605916|449581543|FG004|Overall Study|Lack of Efficacy|4|||
124988061|NCT01605916|449581539|FG000|Overall Study|Withdrawal by Subject|1|||
124988062|NCT01605916|449581540|FG001|Overall Study|Withdrawal by Subject|1|||
124988063|NCT01605916|449581541|FG002|Overall Study|Withdrawal by Subject|0|||
124988064|NCT01605916|449581542|FG003|Overall Study|Withdrawal by Subject|0|||
124988065|NCT01605916|449581543|FG004|Overall Study|Withdrawal by Subject|2|||
124988066|NCT02549196|449581553|FG000|Overall Study|Protocol Violation|0|||
124988067|NCT02549196|449581554|FG001|Overall Study|Protocol Violation|0|||
124988068|NCT02549196|449581555|FG002|Overall Study|Protocol Violation|0|||
124988069|NCT02549196|449581556|FG003|Overall Study|Protocol Violation|1|||
124988070|NCT02549196|449581553|FG000|Overall Study|Withdrawal by Subject|1|||
125314833|NCT02365649|450781747|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
125314834|NCT02365649|450781748|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
125314835|NCT02365649|450781749|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
125314836|NCT02365649|450781750|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
125314837|NCT02365649|450781751|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
125314838|NCT02365649|450781752|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
125314839|NCT02365649|450781753|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
125314840|NCT02365649|450781754|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
125314841|NCT02365649|450781755|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
125314842|NCT02365649|450781756|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
125314843|NCT02365649|450781747|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
125314844|NCT02365649|450781748|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
125314845|NCT02365649|450781749|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
125314846|NCT02365649|450781750|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
125314847|NCT02365649|450781751|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
125314848|NCT02365649|450781752|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
124988071|NCT02549196|449581554|FG001|Overall Study|Withdrawal by Subject|0|||
124988072|NCT02549196|449581555|FG002|Overall Study|Withdrawal by Subject|1|||
124988073|NCT02549196|449581556|FG003|Overall Study|Withdrawal by Subject|0|||
124988074|NCT01103362|449581559|FG000|Overall Study|study terminated|596|||
124988075|NCT03265938|449581561|FG000|Overall Study|Withdrawal by Subject|1|||
124988076|NCT03265938|449581561|FG000|Overall Study|Physician Decision|1|||
124988077|NCT03265938|449581561|FG000|Overall Study|friable mass|6|||
124988078|NCT02679508|449581562|FG000|Healing Phase|Protocol Violation|1|||
124988079|NCT02679508|449581563|FG001|Healing Phase|Protocol Violation|1|||
124988080|NCT02679508|449581562|FG000|Healing Phase|Lost to Follow-up|1|||
124988081|NCT02679508|449581563|FG001|Healing Phase|Lost to Follow-up|0|||
124988082|NCT02679508|449581562|FG000|Maintenance Phase|Adverse Event|12|||
125314849|NCT02365649|450781753|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
125314850|NCT02365649|450781754|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
125314851|NCT02365649|450781755|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
125314852|NCT02365649|450781756|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
125314853|NCT02365649|450781747|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
125314854|NCT02365649|450781748|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
125314855|NCT02365649|450781749|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
125314856|NCT02365649|450781750|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
125314857|NCT02365649|450781751|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
125314858|NCT02365649|450781752|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
125314859|NCT02365649|450781753|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
125314860|NCT02365649|450781754|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
125314861|NCT02365649|450781755|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
125314862|NCT02365649|450781756|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
125314863|NCT02365649|450781747|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
125314864|NCT02365649|450781748|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
125314865|NCT02365649|450781749|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
125314866|NCT02365649|450781750|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
125314867|NCT02365649|450781751|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
125314868|NCT02365649|450781752|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
125314869|NCT02365649|450781753|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
125314870|NCT02365649|450781754|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
125314871|NCT02365649|450781755|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
125314872|NCT02365649|450781756|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
124988083|NCT02679508|449581563|FG001|Maintenance Phase|Adverse Event|2|||
124988084|NCT02679508|449581562|FG000|Maintenance Phase|Lost to Follow-up|0|||
124988085|NCT02679508|449581563|FG001|Maintenance Phase|Lost to Follow-up|1|||
124988086|NCT02679508|449581562|FG000|Maintenance Phase|Withdrawal by Subject|15|||
124988087|NCT02679508|449581563|FG001|Maintenance Phase|Withdrawal by Subject|8|||
124988088|NCT02679508|449581562|FG000|Maintenance Phase|Other|5|||
124988089|NCT02679508|449581563|FG001|Maintenance Phase|Other|4|||
124988090|NCT03143166|449581564|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
124988091|NCT01028027|449581565|FG000|Overall Study|Lost to Follow-up|4|||
124988092|NCT01028027|449581566|FG001|Overall Study|Lost to Follow-up|1|||
124988093|NCT01028027|449581565|FG000|Overall Study|Withdrawal by Subject|5|||
124988094|NCT01028027|449581566|FG001|Overall Study|Withdrawal by Subject|3|||
124988095|NCT01028027|449581565|FG000|Overall Study|Adverse Event|4|||
124988096|NCT01028027|449581566|FG001|Overall Study|Adverse Event|7|||
124988097|NCT01028027|449581565|FG000|Overall Study|Protocol Violation|3|||
124988098|NCT01028027|449581566|FG001|Overall Study|Protocol Violation|1|||
124988099|NCT01028027|449581565|FG000|Overall Study|Lack of Efficacy|0|||
124988100|NCT01028027|449581566|FG001|Overall Study|Lack of Efficacy|1|||
124988101|NCT05000931|449581575|FG000|Overall Study|Lost to Follow-up|1|||
124988102|NCT03562975|449581576|FG000|Overall Study|Death|1|||
124988103|NCT03562975|449581576|FG000|Overall Study|Lost to Follow-up|1|||
124988104|NCT03562975|449581576|FG000|Overall Study|Withdrawal by Subject|1|||
124988105|NCT00979134|449581577|FG000|Overall Study|Disease progression|18|||
124988106|NCT00979134|449581578|FG001|Overall Study|Disease progression|2|||
124988107|NCT00979134|449581579|FG002|Overall Study|Disease progression|5|||
124988108|NCT00979134|449581577|FG000|Overall Study|Adverse Event|0|||
124988109|NCT00979134|449581578|FG001|Overall Study|Adverse Event|0|||
124988110|NCT00979134|449581579|FG002|Overall Study|Adverse Event|2|||
124988111|NCT00979134|449581577|FG000|Overall Study|Withdrawal by Subject|1|||
124988112|NCT00979134|449581578|FG001|Overall Study|Withdrawal by Subject|1|||
124988113|NCT00979134|449581579|FG002|Overall Study|Withdrawal by Subject|2|||
124988114|NCT00979134|449581577|FG000|Overall Study|Lost to Follow-up|2|||
124988115|NCT00979134|449581578|FG001|Overall Study|Lost to Follow-up|2|||
124988116|NCT00979134|449581579|FG002|Overall Study|Lost to Follow-up|0|||
124988117|NCT00979134|449581577|FG000|Overall Study|Death|4|||
124988118|NCT00979134|449581578|FG001|Overall Study|Death|0|||
124988119|NCT00979134|449581579|FG002|Overall Study|Death|26|||
124988120|NCT00979134|449581577|FG000|Overall Study|Other|8|||
124988121|NCT00979134|449581578|FG001|Overall Study|Other|1|||
124988122|NCT00979134|449581579|FG002|Overall Study|Other|5|||
124988123|NCT05180500|449581582|FG000|Overall Study|Adverse Event|1|||
124988124|NCT05180500|449581583|FG001|Overall Study|Adverse Event|0|||
124988125|NCT05180500|449581582|FG000|Overall Study|Withdrawal by Subject|2|||
124988126|NCT05180500|449581583|FG001|Overall Study|Withdrawal by Subject|0|||
124988127|NCT00867308|449581584|FG000|Overall Study|Death|1|||
124988128|NCT00867308|449581585|FG001|Overall Study|Death|0|||
124988129|NCT00867308|449581584|FG000|Overall Study|Adverse Event|1|||
124988130|NCT00867308|449581585|FG001|Overall Study|Adverse Event|4|||
124988131|NCT00867308|449581584|FG000|Overall Study|Lack of Efficacy|6|||
124988132|NCT00867308|449581585|FG001|Overall Study|Lack of Efficacy|12|||
124988133|NCT00867308|449581584|FG000|Overall Study|Withdrawal by Subject|1|||
124988134|NCT00867308|449581585|FG001|Overall Study|Withdrawal by Subject|2|||
124988135|NCT05917470|449581591|FG000|Overall Study|Progressive Disease|1|||
124988136|NCT05917470|449581592|FG001|Overall Study|Progressive Disease|1|||
124988137|NCT05917470|449581593|FG002|Overall Study|Progressive Disease|2|||
124988138|NCT05917470|449581594|FG003|Overall Study|Progressive Disease|3|||
124988139|NCT05917470|449581595|FG004|Overall Study|Progressive Disease|1|||
124988140|NCT05917470|449581596|FG005|Overall Study|Progressive Disease|1|||
124988141|NCT05917470|449581597|FG006|Overall Study|Progressive Disease|0|||
124988142|NCT05917470|449581598|FG007|Overall Study|Progressive Disease|0|||
124988143|NCT05917470|449581591|FG000|Overall Study|Withdrawal by Subject|0|||
124988144|NCT05917470|449581592|FG001|Overall Study|Withdrawal by Subject|0|||
124988145|NCT05917470|449581593|FG002|Overall Study|Withdrawal by Subject|1|||
124988146|NCT05917470|449581594|FG003|Overall Study|Withdrawal by Subject|0|||
124988147|NCT05917470|449581595|FG004|Overall Study|Withdrawal by Subject|0|||
124988148|NCT05917470|449581596|FG005|Overall Study|Withdrawal by Subject|0|||
124988149|NCT05917470|449581597|FG006|Overall Study|Withdrawal by Subject|0|||
124988150|NCT05917470|449581598|FG007|Overall Study|Withdrawal by Subject|0|||
124988151|NCT05917470|449581591|FG000|Overall Study|Sponsor Decision|0|||
124988152|NCT05917470|449581592|FG001|Overall Study|Sponsor Decision|0|||
124988153|NCT05917470|449581593|FG002|Overall Study|Sponsor Decision|1|||
124988154|NCT05917470|449581594|FG003|Overall Study|Sponsor Decision|0|||
124988155|NCT05917470|449581595|FG004|Overall Study|Sponsor Decision|2|||
124988156|NCT05917470|449581596|FG005|Overall Study|Sponsor Decision|1|||
124988157|NCT05917470|449581597|FG006|Overall Study|Sponsor Decision|3|||
124988158|NCT05917470|449581598|FG007|Overall Study|Sponsor Decision|3|||
124988159|NCT05917470|449581591|FG000|Overall Study|Adverse Event|0|||
124988160|NCT05917470|449581592|FG001|Overall Study|Adverse Event|0|||
124988161|NCT05917470|449581593|FG002|Overall Study|Adverse Event|0|||
124988162|NCT05917470|449581594|FG003|Overall Study|Adverse Event|0|||
124988163|NCT05917470|449581595|FG004|Overall Study|Adverse Event|0|||
124988164|NCT05917470|449581596|FG005|Overall Study|Adverse Event|1|||
124988165|NCT05917470|449581597|FG006|Overall Study|Adverse Event|0|||
124988166|NCT05917470|449581598|FG007|Overall Study|Adverse Event|0|||
124988167|NCT03694275|449584074|FG000|Overall Study|Adverse Event|0|||
124988168|NCT03694275|449584075|FG001|Overall Study|Adverse Event|1|||
124988169|NCT03694275|449584074|FG000|Overall Study|Reason not Specified|0|||
124988170|NCT03694275|449584075|FG001|Overall Study|Reason not Specified|1|||
124988171|NCT03541174|449584076|FG000|Part 1 Double-Blind|Adverse Event|6|||
124988172|NCT03541174|449584077|FG001|Part 1 Double-Blind|Adverse Event|5|||
124988173|NCT03541174|449584078|FG002|Part 1 Double-Blind|Adverse Event|2|||
124988174|NCT03541174|449584079|FG003|Part 1 Double-Blind|Adverse Event|0|||
124988175|NCT03541174|449584080|FG004|Part 1 Double-Blind|Adverse Event|0|||
124988176|NCT03541174|449584081|FG005|Part 1 Double-Blind|Adverse Event|0|||
124988177|NCT03541174|449584076|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
124988178|NCT03541174|449584077|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
124988179|NCT03541174|449584078|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
124988180|NCT03541174|449584079|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
124988181|NCT03541174|449584080|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
124988182|NCT03541174|449584081|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
124988183|NCT03541174|449584076|FG000|Part 1 Double-Blind|Other reasons|3|||
124988184|NCT03541174|449584077|FG001|Part 1 Double-Blind|Other reasons|2|||
124988185|NCT03541174|449584078|FG002|Part 1 Double-Blind|Other reasons|3|||
124988186|NCT03541174|449584079|FG003|Part 1 Double-Blind|Other reasons|0|||
124988187|NCT03541174|449584080|FG004|Part 1 Double-Blind|Other reasons|0|||
124988188|NCT03541174|449584081|FG005|Part 1 Double-Blind|Other reasons|0|||
124988189|NCT03541174|449584076|FG000|Part 2 Single-Blind|Adverse Event|0|||
124988190|NCT03541174|449584077|FG001|Part 2 Single-Blind|Adverse Event|0|||
124988191|NCT03541174|449584078|FG002|Part 2 Single-Blind|Adverse Event|0|||
124988192|NCT03541174|449584079|FG003|Part 2 Single-Blind|Adverse Event|25|||
124988193|NCT03541174|449584080|FG004|Part 2 Single-Blind|Adverse Event|0|||
124988194|NCT03541174|449584081|FG005|Part 2 Single-Blind|Adverse Event|0|||
124988195|NCT03541174|449584076|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
124988196|NCT03541174|449584077|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
124988197|NCT03541174|449584078|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
124988198|NCT03541174|449584079|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
124988199|NCT03541174|449584080|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
124988200|NCT03541174|449584081|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
124988201|NCT03541174|449584076|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
124988202|NCT03541174|449584077|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
124988203|NCT03541174|449584078|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
124988204|NCT03541174|449584079|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
124988205|NCT03541174|449584080|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
124988206|NCT03541174|449584081|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
124988207|NCT03541174|449584076|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
124988208|NCT03541174|449584077|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
124988209|NCT03541174|449584078|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
124988210|NCT03541174|449584079|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
124988211|NCT03541174|449584080|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
124988212|NCT03541174|449584081|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
124988213|NCT03541174|449584076|FG000|Part 2 Single-Blind|Death|0|||
124988214|NCT03541174|449584077|FG001|Part 2 Single-Blind|Death|0|||
124988215|NCT03541174|449584078|FG002|Part 2 Single-Blind|Death|0|||
124988216|NCT03541174|449584079|FG003|Part 2 Single-Blind|Death|5|||
124988217|NCT03541174|449584080|FG004|Part 2 Single-Blind|Death|0|||
124988218|NCT03541174|449584081|FG005|Part 2 Single-Blind|Death|0|||
124988219|NCT03541174|449584076|FG000|Part 2 Single-Blind|Pregnancy|0|||
124988220|NCT03541174|449584077|FG001|Part 2 Single-Blind|Pregnancy|0|||
124988221|NCT03541174|449584078|FG002|Part 2 Single-Blind|Pregnancy|0|||
124988222|NCT03541174|449584079|FG003|Part 2 Single-Blind|Pregnancy|1|||
124988223|NCT03541174|449584080|FG004|Part 2 Single-Blind|Pregnancy|0|||
124988224|NCT03541174|449584081|FG005|Part 2 Single-Blind|Pregnancy|0|||
124988225|NCT03541174|449584076|FG000|Part 2 Single-Blind|Other reasons|0|||
124988226|NCT03541174|449584077|FG001|Part 2 Single-Blind|Other reasons|0|||
124988227|NCT03541174|449584078|FG002|Part 2 Single-Blind|Other reasons|0|||
124988228|NCT03541174|449584079|FG003|Part 2 Single-Blind|Other reasons|32|||
124988229|NCT03541174|449584080|FG004|Part 2 Single-Blind|Other reasons|0|||
124988230|NCT03541174|449584081|FG005|Part 2 Single-Blind|Other reasons|0|||
124988231|NCT03541174|449584076|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
124988232|NCT03541174|449584077|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
124988233|NCT03541174|449584078|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
124988234|NCT03541174|449584079|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
124988235|NCT03541174|449584080|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
124988236|NCT03541174|449584081|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
124988237|NCT03541174|449584076|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
124988238|NCT03541174|449584077|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
124988239|NCT03541174|449584078|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
124988240|NCT03541174|449584079|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
124988241|NCT03541174|449584080|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
124988242|NCT03541174|449584081|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
124988243|NCT03541174|449584076|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
124988244|NCT03541174|449584077|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
124988245|NCT03541174|449584078|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
124988246|NCT03541174|449584079|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
124988247|NCT03541174|449584080|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
124988248|NCT03541174|449584081|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
124988249|NCT03541174|449584076|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
124988250|NCT03541174|449584077|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
124988251|NCT03541174|449584078|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
124988252|NCT03541174|449584079|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
124988253|NCT03541174|449584080|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
124988254|NCT03541174|449584081|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
124988255|NCT03541174|449584076|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
124988256|NCT03541174|449584077|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
124988257|NCT03541174|449584078|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
124988258|NCT03541174|449584079|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
124988259|NCT03541174|449584080|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
124988260|NCT03541174|449584081|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
124988261|NCT02217332|449584084|FG000|Overall Study|Adverse Event|3|||
124988262|NCT02217332|449584084|FG000|Overall Study|Dose interruption >1 month|1|||
124988263|NCT02217332|449584084|FG000|Overall Study|Protocol Violation (eligibility)|1|||
124988264|NCT02217332|449584084|FG000|Overall Study|Withdrawal by Subject|1|||
124988265|NCT02217332|449584084|FG000|Overall Study|Lost to Follow-up|1|||
124988266|NCT04058366|449584085|FG000|Overall Study|Adverse Event|14|||
124988267|NCT04058366|449584085|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
124988268|NCT04058366|449584085|FG000|Overall Study|Commercial drug is available for participants|6|||
124988269|NCT04058366|449584085|FG000|Overall Study|Death|1|||
124988270|NCT04058366|449584085|FG000|Overall Study|Other non-compliance|2|||
124988271|NCT04058366|449584085|FG000|Overall Study|Other|6|||
124988272|NCT00603304|449584086|FG000|Overall Study|Lost to Follow-up|5|||
124988273|NCT00603304|449584087|FG001|Overall Study|Lost to Follow-up|7|||
124988274|NCT00603304|449584086|FG000|Overall Study|Withdrawal by Subject|8|||
124872573|NCT03286751|449155663|FG000|Washout Period 5|Adverse Event|0|||
124872574|NCT03286751|449155664|FG001|Washout Period 5|Adverse Event|0|||
124872575|NCT03286751|449155665|FG002|Washout Period 5|Adverse Event|0|||
124872576|NCT03286751|449155666|FG003|Washout Period 5|Adverse Event|0|||
124872577|NCT03286751|449155667|FG004|Washout Period 5|Adverse Event|1|||
124872578|NCT03286751|449155668|FG005|Washout Period 5|Adverse Event|0|||
124872579|NCT01621880|449155669|FG000|Overall Study|Adverse Event|5|||
124872580|NCT01621880|449155670|FG001|Overall Study|Adverse Event|1|||
124988275|NCT00603304|449584087|FG001|Overall Study|Withdrawal by Subject|5|||
124988276|NCT00603304|449584086|FG000|Overall Study|Protocol Violation|1|||
124988277|NCT00603304|449584087|FG001|Overall Study|Protocol Violation|0|||
124988278|NCT00603304|449584086|FG000|Overall Study|Adverse Event|4|||
124988279|NCT00603304|449584087|FG001|Overall Study|Adverse Event|2|||
124988280|NCT00603304|449584086|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
124988281|NCT00603304|449584087|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
124988282|NCT00603304|449584086|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
124988283|NCT00603304|449584087|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
124988284|NCT00603304|449584086|FG000|Overall Study|Exclusionary Medication|2|||
124988285|NCT00603304|449584087|FG001|Overall Study|Exclusionary Medication|3|||
124988286|NCT00603304|449584086|FG000|Overall Study|Non-Compliant|0|||
124988287|NCT00603304|449584087|FG001|Overall Study|Non-Compliant|1|||
124988288|NCT00603304|449584086|FG000|Overall Study|Moved Away|0|||
124988289|NCT00603304|449584087|FG001|Overall Study|Moved Away|2|||
124988290|NCT00603304|449584086|FG000|Overall Study|Other|2|||
124988291|NCT00603304|449584087|FG001|Overall Study|Other|0|||
124988292|NCT00603304|449584086|FG000|Overall Study|Patient Decision|2|||
124988293|NCT00603304|449584087|FG001|Overall Study|Patient Decision|0|||
124988294|NCT02480153|449584088|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
124988295|NCT02480153|449584089|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
124988296|NCT02480153|449584090|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
124988297|NCT02480153|449584088|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
124988298|NCT02480153|449584089|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
124988299|NCT02480153|449584090|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
124988300|NCT02480153|449584088|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
124988301|NCT02480153|449584089|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
125314873|NCT01188772|450781763|FG000|Overall Study|Randomized but Not Treated|0|||
125314874|NCT01188772|450781764|FG001|Overall Study|Randomized but Not Treated|1|||
125314875|NCT01188772|450781765|FG002|Overall Study|Randomized but Not Treated|0|||
125314876|NCT01188772|450781766|FG003|Overall Study|Randomized but Not Treated|0|||
125314877|NCT01188772|450781763|FG000|Overall Study|Adverse Event|0|||
125314878|NCT01188772|450781764|FG001|Overall Study|Adverse Event|1|||
125314879|NCT01188772|450781765|FG002|Overall Study|Adverse Event|2|||
125314880|NCT01188772|450781766|FG003|Overall Study|Adverse Event|0|||
125314881|NCT01188772|450781763|FG000|Overall Study|Lost to Follow-up|4|||
125314882|NCT01188772|450781764|FG001|Overall Study|Lost to Follow-up|1|||
125314883|NCT01188772|450781765|FG002|Overall Study|Lost to Follow-up|1|||
125314884|NCT01188772|450781766|FG003|Overall Study|Lost to Follow-up|1|||
125314885|NCT01188772|450781763|FG000|Overall Study|Non-responder|0|||
125314886|NCT01188772|450781764|FG001|Overall Study|Non-responder|0|||
125314887|NCT01188772|450781765|FG002|Overall Study|Non-responder|3|||
125314888|NCT01188772|450781766|FG003|Overall Study|Non-responder|0|||
125314889|NCT01188772|450781763|FG000|Overall Study|Physician Decision|0|||
125314890|NCT01188772|450781764|FG001|Overall Study|Physician Decision|0|||
125314891|NCT01188772|450781765|FG002|Overall Study|Physician Decision|1|||
125314892|NCT01188772|450781766|FG003|Overall Study|Physician Decision|0|||
125314893|NCT01188772|450781763|FG000|Overall Study|Terminated by Sponsor|0|||
125314894|NCT01188772|450781764|FG001|Overall Study|Terminated by Sponsor|0|||
125314895|NCT01188772|450781765|FG002|Overall Study|Terminated by Sponsor|1|||
125314896|NCT01188772|450781766|FG003|Overall Study|Terminated by Sponsor|0|||
125314897|NCT01188772|450781763|FG000|Overall Study|Treatment Failure|0|||
125314898|NCT01188772|450781764|FG001|Overall Study|Treatment Failure|0|||
125314899|NCT01188772|450781765|FG002|Overall Study|Treatment Failure|1|||
125314900|NCT01188772|450781766|FG003|Overall Study|Treatment Failure|0|||
125314901|NCT01188772|450781763|FG000|Overall Study|Virologic Failure|1|||
125314902|NCT01188772|450781764|FG001|Overall Study|Virologic Failure|0|||
125314903|NCT01188772|450781765|FG002|Overall Study|Virologic Failure|0|||
125314904|NCT01188772|450781766|FG003|Overall Study|Virologic Failure|0|||
125314905|NCT01188772|450781763|FG000|Overall Study|Withdrawal by Subject|0|||
125314906|NCT01188772|450781764|FG001|Overall Study|Withdrawal by Subject|0|||
125314907|NCT01188772|450781765|FG002|Overall Study|Withdrawal by Subject|2|||
125314908|NCT01188772|450781766|FG003|Overall Study|Withdrawal by Subject|0|||
125314909|NCT03370718|450781773|FG000|Overall Study|Withdrawal by Subject|1|||
125314910|NCT03863509|450781776|FG000|Overall Study|COVID-19 shutdown period|0|||
125314911|NCT03863509|450781777|FG001|Overall Study|COVID-19 shutdown period|4|||
124988302|NCT02480153|449584090|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
124988303|NCT02480153|449584088|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
125314912|NCT03863509|450781778|FG002|Overall Study|COVID-19 shutdown period|0|||
125314913|NCT03863509|450781776|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
125314914|NCT03863509|450781777|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
125314915|NCT03863509|450781778|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
125314916|NCT03863509|450781776|FG000|Overall Study|Lost to Follow-up|8|||
125314917|NCT03863509|450781777|FG001|Overall Study|Lost to Follow-up|0|||
125314918|NCT03863509|450781778|FG002|Overall Study|Lost to Follow-up|2|||
125314919|NCT03863509|450781776|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
124988304|NCT02480153|449584089|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
124988305|NCT02480153|449584090|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
124988306|NCT02480153|449584088|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
124988307|NCT02480153|449584089|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
124988308|NCT02480153|449584090|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
124988309|NCT02480153|449584088|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
124988310|NCT02480153|449584089|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
124988311|NCT02480153|449584090|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
124988312|NCT02480153|449584088|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
124988313|NCT02480153|449584089|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
124988314|NCT02480153|449584090|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
124988315|NCT02480153|449584088|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
124988316|NCT02480153|449584089|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
124988317|NCT02480153|449584090|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
124988318|NCT02480153|449584088|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
124988319|NCT02480153|449584089|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
124988320|NCT02480153|449584090|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
124988321|NCT02480153|449584088|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
124988322|NCT02480153|449584089|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
124988323|NCT02480153|449584090|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
124988324|NCT02480153|449584088|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
124988325|NCT02480153|449584089|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
124988326|NCT02480153|449584090|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
124988327|NCT02480153|449584088|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
124988328|NCT02480153|449584089|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
124988329|NCT02480153|449584090|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
124988330|NCT02480153|449584088|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
124988331|NCT02480153|449584089|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
124988332|NCT02480153|449584090|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
124988333|NCT02480153|449584088|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
124988334|NCT02480153|449584089|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
124988335|NCT02480153|449584090|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
124988336|NCT02480153|449584088|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
124988337|NCT02480153|449584089|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
124988338|NCT02480153|449584090|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
124988339|NCT02480153|449584088|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
124988340|NCT02480153|449584089|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
124988341|NCT02480153|449584090|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
124988342|NCT02480153|449584088|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
124988343|NCT02480153|449584089|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
124988344|NCT02480153|449584090|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
124988345|NCT02480153|449584088|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
124988346|NCT02480153|449584089|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
124988347|NCT02480153|449584090|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
124988348|NCT00512317|449584091|FG000|Overall Study|Insufficient clinical response|36|||
124988349|NCT00512317|449584091|FG000|Overall Study|Withdrawal by Subject|23|||
124988350|NCT00512317|449584091|FG000|Overall Study|Sponsor closure of study|21|||
124988351|NCT00512317|449584091|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
124988352|NCT00512317|449584091|FG000|Overall Study|Adverse Event|13|||
124988353|NCT00512317|449584091|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
124988354|NCT00512317|449584091|FG000|Overall Study|Lost to Follow-up|2|||
125314920|NCT03863509|450781777|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
125314921|NCT03863509|450781778|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
125314922|NCT03863509|450781776|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
125314923|NCT03863509|450781777|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
125314924|NCT03863509|450781778|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
125314925|NCT01572480|450781781|FG000|Participants Enrolled|Withdrawal by Subject|1|||
125314926|NCT01572480|450781781|FG000|Drug Administration|Discontinued drug/Off Study|1|||
125314927|NCT01572480|450781781|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
125314928|NCT01572480|450781781|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
125314929|NCT06172348|450781782|FG000|Treatment Period 2|Adverse Event|0|||
125314930|NCT06172348|450781783|FG001|Treatment Period 2|Adverse Event|0|||
125314931|NCT06172348|450781784|FG002|Treatment Period 2|Adverse Event|1|||
124988355|NCT00512317|449584091|FG000|Overall Study|Other|2|||
124988356|NCT04433585|449584092|FG000|Overall Study|Withdrawal by Subject|15|||
124988357|NCT04433585|449584093|FG001|Overall Study|Withdrawal by Subject|3|||
124988358|NCT04433585|449584094|FG002|Overall Study|Withdrawal by Subject|15|||
124988359|NCT04433585|449584095|FG003|Overall Study|Withdrawal by Subject|6|||
124988360|NCT04433585|449584092|FG000|Overall Study|Adverse Event|10|||
124988361|NCT04433585|449584093|FG001|Overall Study|Adverse Event|4|||
124988362|NCT04433585|449584094|FG002|Overall Study|Adverse Event|1|||
124988363|NCT04433585|449584095|FG003|Overall Study|Adverse Event|0|||
124988364|NCT04433585|449584092|FG000|Overall Study|Due to the conflict in Ukraine|2|||
124988365|NCT04433585|449584093|FG001|Overall Study|Due to the conflict in Ukraine|1|||
124988366|NCT04433585|449584094|FG002|Overall Study|Due to the conflict in Ukraine|1|||
124988367|NCT04433585|449584095|FG003|Overall Study|Due to the conflict in Ukraine|2|||
124988368|NCT04433585|449584092|FG000|Overall Study|Physician Decision|1|||
124988369|NCT04433585|449584093|FG001|Overall Study|Physician Decision|2|||
124988370|NCT04433585|449584094|FG002|Overall Study|Physician Decision|0|||
124988371|NCT04433585|449584095|FG003|Overall Study|Physician Decision|0|||
124988372|NCT04433585|449584092|FG000|Overall Study|Lost to Follow-up|1|||
124988373|NCT04433585|449584093|FG001|Overall Study|Lost to Follow-up|1|||
124988374|NCT04433585|449584094|FG002|Overall Study|Lost to Follow-up|1|||
124988375|NCT04433585|449584095|FG003|Overall Study|Lost to Follow-up|0|||
124988376|NCT04433585|449584092|FG000|Overall Study|Lack of Efficacy|0|||
124988377|NCT04433585|449584093|FG001|Overall Study|Lack of Efficacy|1|||
124988378|NCT04433585|449584094|FG002|Overall Study|Lack of Efficacy|1|||
124988379|NCT04433585|449584095|FG003|Overall Study|Lack of Efficacy|1|||
124988380|NCT04433585|449584092|FG000|Overall Study|Death|0|||
124988381|NCT04433585|449584093|FG001|Overall Study|Death|1|||
124988382|NCT04433585|449584094|FG002|Overall Study|Death|0|||
124988383|NCT04433585|449584095|FG003|Overall Study|Death|0|||
124988384|NCT02630693|449584098|FG000|Overall Study|No receive treatment|0|||
124988385|NCT02630693|449584099|FG001|Overall Study|No receive treatment|1|||
124988386|NCT00993668|449584100|FG000|Single-Blind Period|Adverse Event|1|||
124988387|NCT00993668|449584101|FG001|Single-Blind Period|Adverse Event|1|||
124988388|NCT00993668|449584100|FG000|Single-Blind Period|Lack of Efficacy|0|||
124988389|NCT00993668|449584101|FG001|Single-Blind Period|Lack of Efficacy|1|||
124988390|NCT00993668|449584100|FG000|Single-Blind Period|Lost to Follow-up|3|||
124988391|NCT00993668|449584101|FG001|Single-Blind Period|Lost to Follow-up|1|||
124988392|NCT00993668|449584100|FG000|Open-Label Period|Adverse Event|9|||
124988393|NCT00993668|449584101|FG001|Open-Label Period|Adverse Event|8|||
124988394|NCT00993668|449584100|FG000|Open-Label Period|Lack of Efficacy|4|||
124988395|NCT00993668|449584101|FG001|Open-Label Period|Lack of Efficacy|3|||
124988396|NCT00993668|449584100|FG000|Open-Label Period|Withdrawal by Subject|4|||
124988397|NCT00993668|449584101|FG001|Open-Label Period|Withdrawal by Subject|3|||
124988398|NCT00993668|449584100|FG000|Open-Label Period|Lost to Follow-up|6|||
124988399|NCT00993668|449584101|FG001|Open-Label Period|Lost to Follow-up|1|||
124988400|NCT03606668|449584104|FG000|Overall Study|Screen Failure|1|||
124988401|NCT03606668|449584104|FG000|Overall Study|Lost to Follow-up|1|||
124988402|NCT02057523|449584108|FG000|Overall Study|Withdrawal by Subject|1|||
124988403|NCT02057523|449584108|FG000|Overall Study|Lack of Efficacy|1|||
124988404|NCT02313233|449584112|FG000|Overall Study|Withdrawal by Subject|1|||
125314932|NCT06172348|450781785|FG003|Treatment Period 2|Adverse Event|0|||
125314933|NCT06172348|450781786|FG004|Treatment Period 2|Adverse Event|0|||
125314934|NCT06172348|450781787|FG005|Treatment Period 2|Adverse Event|0|||
125314935|NCT00191334|450781788|FG000|Overall Study|Adverse Event|4|||
125314936|NCT00191334|450781788|FG000|Overall Study|Disease Progression or Relapse|8|||
125314937|NCT00191334|450781788|FG000|Overall Study|Physician Decision|1|||
125314938|NCT00191334|450781788|FG000|Overall Study|Withdrawal by Subject|4|||
125314939|NCT00866814|450781789|FG000|Overall Study|Lost to Follow-up|12|||
125314940|NCT00866814|450781789|FG000|Overall Study|Adverse Event|2|||
125314941|NCT00866814|450781789|FG000|Overall Study|Physician Decision|1|||
125314942|NCT00866814|450781789|FG000|Overall Study|Death|1|||
125314943|NCT00866814|450781789|FG000|Overall Study|No longer wished to participate|1|||
125314944|NCT00866814|450781789|FG000|Overall Study|Unable to meet follow-up requirements|2|||
125314945|NCT00866814|450781789|FG000|Overall Study|Moved to area without study site|1|||
125314946|NCT01063153|450781790|FG000|Overall Study|Found Ineligible During Screening|2|||
125314947|NCT01063153|450781791|FG001|Overall Study|Found Ineligible During Screening|0|||
124988405|NCT02313233|449584113|FG001|Overall Study|Withdrawal by Subject|2|||
124988406|NCT02313233|449584112|FG000|Overall Study|Administrative reason|1|||
124988407|NCT02313233|449584113|FG001|Overall Study|Administrative reason|1|||
125314948|NCT01063153|450781790|FG000|Overall Study|Lost to Follow-up|0|||
125314949|NCT01063153|450781791|FG001|Overall Study|Lost to Follow-up|7|||
124988408|NCT00564889|449584116|FG000|Overall Study|Death|7|||
124988409|NCT00564889|449584116|FG000|Overall Study|Adverse Event|12|||
124988410|NCT00564889|449584116|FG000|Overall Study|Alternative treatment|3|||
124988411|NCT00564889|449584116|FG000|Overall Study|Disease progression|3|||
124988412|NCT00564889|449584116|FG000|Overall Study|Other, not specified|4|||
125314950|NCT01063153|450781790|FG000|Overall Study|Withdrawal by Subject|0|||
125314951|NCT01063153|450781791|FG001|Overall Study|Withdrawal by Subject|1|||
124988413|NCT00682890|449584124|FG000|Overall Study|Lost to Follow-up|1|||
124988414|NCT00682890|449584125|FG001|Overall Study|Lost to Follow-up|1|||
124988415|NCT00682890|449584124|FG000|Overall Study|subject moved away|0|||
124988416|NCT00682890|449584125|FG001|Overall Study|subject moved away|1|||
124988417|NCT00682890|449584124|FG000|Overall Study|heavy menstrual bleeding|1|||
124988418|NCT00682890|449584125|FG001|Overall Study|heavy menstrual bleeding|0|||
124988419|NCT03545503|449584126|FG000|Overall Study|Protocol Violation|14|||
124988420|NCT03545503|449584127|FG001|Overall Study|Protocol Violation|16|||
124988421|NCT02884908|449584130|FG000|Overall Study|Lost to Follow-up|13|||
124988422|NCT02884908|449584131|FG001|Overall Study|Lost to Follow-up|18|||
124988423|NCT01605019|449584134|FG000|Overall Study|pt did not meet transplant endpoint|3|||
124988424|NCT01605019|449584135|FG001|Overall Study|pt did not meet transplant endpoint|0|||
124988425|NCT00862719|449584136|FG000|Overall Study|Disease Progression|5|||
124988426|NCT00862719|449584137|FG001|Overall Study|Disease Progression|0|||
124988427|NCT00862719|449584138|FG002|Overall Study|Disease Progression|1|||
124988428|NCT00862719|449584139|FG003|Overall Study|Disease Progression|0|||
124988429|NCT00862719|449584136|FG000|Overall Study|Death|5|||
124988430|NCT00862719|449584137|FG001|Overall Study|Death|6|||
124988431|NCT00862719|449584138|FG002|Overall Study|Death|1|||
124988432|NCT00862719|449584139|FG003|Overall Study|Death|1|||
124988433|NCT00862719|449584136|FG000|Overall Study|Engraftment failure|0|||
124988434|NCT00862719|449584137|FG001|Overall Study|Engraftment failure|0|||
124988435|NCT00862719|449584138|FG002|Overall Study|Engraftment failure|1|||
124988436|NCT00862719|449584139|FG003|Overall Study|Engraftment failure|0|||
124988437|NCT00862719|449584136|FG000|Overall Study|Veno-Occlusive Disease|0|||
124988438|NCT00862719|449584137|FG001|Overall Study|Veno-Occlusive Disease|0|||
124988439|NCT00862719|449584138|FG002|Overall Study|Veno-Occlusive Disease|1|||
124988440|NCT00862719|449584139|FG003|Overall Study|Veno-Occlusive Disease|0|||
125314952|NCT01063153|450781790|FG000|Overall Study|Physician Decision|0|||
125314953|NCT01063153|450781791|FG001|Overall Study|Physician Decision|4|||
125314954|NCT02831764|450784128|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
125314955|NCT02831764|450784129|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
125314956|NCT02831764|450784130|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
125314957|NCT02831764|450784131|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
125314958|NCT02831764|450784132|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
125314959|NCT02831764|450784128|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
125314960|NCT02831764|450784129|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
125314961|NCT02831764|450784130|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
125314962|NCT02831764|450784131|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
125314963|NCT02831764|450784132|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
125314964|NCT02831764|450784128|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
125314965|NCT02831764|450784129|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
125314966|NCT02831764|450784130|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
125314967|NCT02831764|450784131|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
125314968|NCT02831764|450784132|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
125314969|NCT02831764|450784128|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
125314970|NCT02831764|450784129|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
125314971|NCT02831764|450784130|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
125314972|NCT02831764|450784131|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
125314973|NCT02831764|450784132|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
125314974|NCT02831764|450784128|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
125314975|NCT02831764|450784129|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
125314976|NCT02831764|450784130|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
125314977|NCT02831764|450784131|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
125314978|NCT02831764|450784132|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
125314979|NCT02831764|450784128|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
125314980|NCT02831764|450784129|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
125314981|NCT02831764|450784130|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
124988441|NCT00470366|449584140|FG000|Overall Study|Adverse Event|3|||
124988442|NCT00470366|449584140|FG000|Overall Study|Poor compliance|1|||
124988443|NCT04493502|449584141|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
124988444|NCT04493502|449584142|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
125314982|NCT02831764|450784131|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
124988445|NCT04493502|449584141|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
124988446|NCT04493502|449584142|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
124988447|NCT04493502|449584141|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
124988448|NCT04493502|449584142|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
124988449|NCT04493502|449584141|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
124988450|NCT04493502|449584142|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
124988451|NCT04493502|449584141|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
124988452|NCT04493502|449584142|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
124988453|NCT04493502|449584141|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
124988454|NCT04493502|449584142|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
124988455|NCT04493502|449584141|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
124988456|NCT04493502|449584142|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
124988457|NCT04493502|449584141|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
124988458|NCT04493502|449584142|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
124988459|NCT04493502|449584141|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
124988460|NCT04493502|449584142|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
124988461|NCT04493502|449584141|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
124988462|NCT04493502|449584142|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
124988463|NCT04493502|449584141|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
124988464|NCT04493502|449584142|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
124988465|NCT04493502|449584141|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
124988466|NCT04493502|449584142|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
124988467|NCT04493502|449584141|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
124988468|NCT04493502|449584142|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
124988469|NCT01021215|449584143|FG000|Overall Study|Lost to Follow-up|3|||
124988470|NCT01021215|449584144|FG001|Overall Study|Lost to Follow-up|0|||
124988471|NCT02751320|449584145|FG000|Overall Study|Adverse Event|2|||
124988472|NCT02751320|449584145|FG000|Overall Study|Withdrawal by Subject|1|||
124988473|NCT01014533|449584146|FG000|Overall Study|Protocol Violation|3|||
124988474|NCT01014533|449584147|FG001|Overall Study|Protocol Violation|2|||
124988475|NCT01014533|449584146|FG000|Overall Study|Withdrawal by Subject|2|||
124988476|NCT01014533|449584147|FG001|Overall Study|Withdrawal by Subject|0|||
124988477|NCT01014533|449584146|FG000|Overall Study|unable to come to appointment|0|||
124988478|NCT01014533|449584147|FG001|Overall Study|unable to come to appointment|3|||
124988479|NCT00296400|449584148|FG000|Overall Study|Adverse Event|7|||
124988480|NCT00296400|449584149|FG001|Overall Study|Adverse Event|7|||
124988481|NCT00296400|449584150|FG002|Overall Study|Adverse Event|7|||
124988482|NCT00296400|449584148|FG000|Overall Study|Withdrawal by Subject|5|||
124988483|NCT00296400|449584149|FG001|Overall Study|Withdrawal by Subject|6|||
124988484|NCT00296400|449584150|FG002|Overall Study|Withdrawal by Subject|2|||
124988485|NCT00296400|449584148|FG000|Overall Study|Incorrect enrollment|2|||
124988486|NCT00296400|449584149|FG001|Overall Study|Incorrect enrollment|0|||
124988487|NCT00296400|449584150|FG002|Overall Study|Incorrect enrollment|0|||
124988488|NCT00296400|449584148|FG000|Overall Study|Protocol Violation|1|||
124988489|NCT00296400|449584149|FG001|Overall Study|Protocol Violation|1|||
124988490|NCT00296400|449584150|FG002|Overall Study|Protocol Violation|1|||
124988491|NCT00296400|449584148|FG000|Overall Study|Lost to Follow-up|1|||
124988492|NCT00296400|449584149|FG001|Overall Study|Lost to Follow-up|1|||
124988493|NCT00296400|449584150|FG002|Overall Study|Lost to Follow-up|2|||
124988494|NCT00296400|449584148|FG000|Overall Study|Study specific discontinuation criteria|0|||
124988495|NCT00296400|449584149|FG001|Overall Study|Study specific discontinuation criteria|0|||
124988496|NCT00296400|449584150|FG002|Overall Study|Study specific discontinuation criteria|1|||
124988497|NCT00296400|449584148|FG000|Overall Study|Visit 10 was performed earlier|0|||
124988498|NCT00296400|449584149|FG001|Overall Study|Visit 10 was performed earlier|1|||
124988499|NCT00296400|449584150|FG002|Overall Study|Visit 10 was performed earlier|0|||
124988500|NCT00296400|449584148|FG000|Overall Study|Pregnancy|1|||
124988501|NCT00296400|449584149|FG001|Overall Study|Pregnancy|2|||
124988502|NCT00296400|449584150|FG002|Overall Study|Pregnancy|0|||
124988503|NCT00412061|449584151|FG000|Double Blind Phase|Disease Progression|101|||
124988504|NCT00412061|449584152|FG001|Double Blind Phase|Disease Progression|154|||
124988505|NCT00412061|449584151|FG000|Double Blind Phase|Adverse Event|61|||
124988506|NCT00412061|449584152|FG001|Double Blind Phase|Adverse Event|16|||
124988507|NCT00412061|449584151|FG000|Double Blind Phase|Final Primary Analysis|26|||
124988508|NCT00412061|449584152|FG001|Double Blind Phase|Final Primary Analysis|14|||
124988509|NCT00412061|449584151|FG000|Double Blind Phase|Withdrawal by Subject|18|||
124988510|NCT00412061|449584152|FG001|Double Blind Phase|Withdrawal by Subject|20|||
124988511|NCT00412061|449584151|FG000|Double Blind Phase|Death|6|||
124988512|NCT00412061|449584152|FG001|Double Blind Phase|Death|3|||
124988513|NCT00412061|449584151|FG000|Double Blind Phase|Protocol Violation|3|||
124988514|NCT00412061|449584152|FG001|Double Blind Phase|Protocol Violation|4|||
124988515|NCT00412061|449584151|FG000|Double Blind Phase|New Cander Therapy|1|||
124988516|NCT00412061|449584152|FG001|Double Blind Phase|New Cander Therapy|1|||
124988517|NCT00412061|449584151|FG000|Double Blind Phase|Lost to Follow-up|0|||
124988518|NCT00412061|449584152|FG001|Double Blind Phase|Lost to Follow-up|1|||
124988519|NCT00412061|449584151|FG000|Open Label Phase|Disease Progression|0|||
124988520|NCT00412061|449584152|FG001|Open Label Phase|Disease Progression|86|||
124988521|NCT00412061|449584151|FG000|Open Label Phase|Adverse Event|0|||
124988522|NCT00412061|449584152|FG001|Open Label Phase|Adverse Event|46|||
124988523|NCT00412061|449584151|FG000|Open Label Phase|Withdrawal by Subject|0|||
124988524|NCT00412061|449584152|FG001|Open Label Phase|Withdrawal by Subject|15|||
124988525|NCT00412061|449584151|FG000|Open Label Phase|Administrative Problems|0|||
124988526|NCT00412061|449584152|FG001|Open Label Phase|Administrative Problems|13|||
124988527|NCT00412061|449584151|FG000|Open Label Phase|Death|0|||
124988528|NCT00412061|449584152|FG001|Open Label Phase|Death|7|||
124988529|NCT00412061|449584151|FG000|Open Label Phase|Lost to Follow-up|0|||
124988530|NCT00412061|449584152|FG001|Open Label Phase|Lost to Follow-up|2|||
124988531|NCT00412061|449584151|FG000|Open Label Phase|New Cancer Therapy|0|||
124988532|NCT00412061|449584152|FG001|Open Label Phase|New Cancer Therapy|1|||
124988533|NCT01942590|449584154|FG000|Overall Study|Withdrawal by Subject|0|||
124988534|NCT01942590|449584155|FG001|Overall Study|Withdrawal by Subject|1|||
124988535|NCT01942590|449584154|FG000|Overall Study|Adverse Event|1|||
124988536|NCT01942590|449584155|FG001|Overall Study|Adverse Event|0|||
124988537|NCT01011387|449584159|FG000|Overall Study|Withdrawal by Subject|3|||
124988538|NCT01011387|449584159|FG000|Overall Study|Adverse Event|2|||
124988539|NCT01011387|449584159|FG000|Overall Study|Protocol Violation|1|||
124988540|NCT02433340|449584160|FG000|Overall Study|Adverse Event|0|||
124988541|NCT02433340|449584161|FG001|Overall Study|Adverse Event|0|||
124988542|NCT02433340|449584162|FG002|Overall Study|Adverse Event|1|||
124988543|NCT02433340|449584163|FG003|Overall Study|Adverse Event|0|||
124988544|NCT02433340|449584160|FG000|Overall Study|Withdrawal by Subject|1|||
124988545|NCT02433340|449584161|FG001|Overall Study|Withdrawal by Subject|0|||
124988546|NCT02433340|449584162|FG002|Overall Study|Withdrawal by Subject|1|||
124988547|NCT02433340|449584163|FG003|Overall Study|Withdrawal by Subject|2|||
124988548|NCT02433340|449584160|FG000|Overall Study|Lost to Follow-up|0|||
124988549|NCT02433340|449584161|FG001|Overall Study|Lost to Follow-up|1|||
124988550|NCT02433340|449584162|FG002|Overall Study|Lost to Follow-up|0|||
124988551|NCT02433340|449584163|FG003|Overall Study|Lost to Follow-up|0|||
124988552|NCT02433340|449584160|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
124988553|NCT02433340|449584161|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
124988554|NCT02433340|449584162|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
124988555|NCT02433340|449584163|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
124988556|NCT02433340|449584160|FG000|Overall Study|Other|0|||
124988557|NCT02433340|449584161|FG001|Overall Study|Other|1|||
124988558|NCT02433340|449584162|FG002|Overall Study|Other|0|||
124988559|NCT02433340|449584163|FG003|Overall Study|Other|0|||
124988560|NCT01178385|449584164|FG000|Overall Study|Withdrawal by Subject|2|||
124988561|NCT01178385|449584165|FG001|Overall Study|Withdrawal by Subject|0|||
124988562|NCT01226095|449584166|FG000|Overall Study|Poor compliance|1|||
124988563|NCT01688830|449584169|FG000|Overall Study|Lost to Follow-up|0|||
124988564|NCT01688830|449584170|FG001|Overall Study|Lost to Follow-up|0|||
124988565|NCT01688830|449584171|FG002|Overall Study|Lost to Follow-up|0|||
124988566|NCT01688830|449584172|FG003|Overall Study|Lost to Follow-up|0|||
124988567|NCT01688830|449584173|FG004|Overall Study|Lost to Follow-up|0|||
124988568|NCT01688830|449584174|FG005|Overall Study|Lost to Follow-up|0|||
124988569|NCT01688830|449584175|FG006|Overall Study|Lost to Follow-up|0|||
124988570|NCT01688830|449584176|FG007|Overall Study|Lost to Follow-up|0|||
124988571|NCT01688830|449584177|FG008|Overall Study|Lost to Follow-up|0|||
124988572|NCT01688830|449584178|FG009|Overall Study|Lost to Follow-up|0|||
124988573|NCT01688830|449584179|FG010|Overall Study|Lost to Follow-up|1|||
124988574|NCT01688830|449584180|FG011|Overall Study|Lost to Follow-up|0|||
124988575|NCT01688830|449584181|FG012|Overall Study|Lost to Follow-up|0|||
124988576|NCT01688830|449584182|FG013|Overall Study|Lost to Follow-up|0|||
125314983|NCT02831764|450784132|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
125314984|NCT02831764|450784128|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
125314985|NCT02831764|450784129|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
125314986|NCT02831764|450784130|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
124988577|NCT01688830|449584183|FG014|Overall Study|Lost to Follow-up|0|||
124988578|NCT01688830|449584184|FG015|Overall Study|Lost to Follow-up|0|||
124988579|NCT01688830|449584185|FG016|Overall Study|Lost to Follow-up|0|||
124988580|NCT01688830|449584186|FG017|Overall Study|Lost to Follow-up|0|||
124988581|NCT01688830|449584187|FG018|Overall Study|Lost to Follow-up|0|||
124988582|NCT01688830|449584188|FG019|Overall Study|Lost to Follow-up|0|||
124988583|NCT01688830|449584189|FG020|Overall Study|Lost to Follow-up|0|||
124988584|NCT04822597|449584190|FG000|Overall Study|Withdrawal by Subject|0|||
124988585|NCT04822597|449584191|FG001|Overall Study|Withdrawal by Subject|1|||
124988586|NCT04822597|449584192|FG002|Overall Study|Withdrawal by Subject|1|||
124988587|NCT04822597|449584193|FG003|Overall Study|Withdrawal by Subject|0|||
124988588|NCT04822597|449584190|FG000|Overall Study|Physician Decision|0|||
124988589|NCT04822597|449584191|FG001|Overall Study|Physician Decision|0|||
124988590|NCT04822597|449584192|FG002|Overall Study|Physician Decision|1|||
124988591|NCT04822597|449584193|FG003|Overall Study|Physician Decision|1|||
124988592|NCT04822597|449584190|FG000|Overall Study|Subject withdrawn after enrollment|0|||
124988593|NCT04822597|449584191|FG001|Overall Study|Subject withdrawn after enrollment|1|||
124988594|NCT04822597|449584192|FG002|Overall Study|Subject withdrawn after enrollment|0|||
124988595|NCT04822597|449584193|FG003|Overall Study|Subject withdrawn after enrollment|1|||
124988596|NCT04822597|449584190|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
124988597|NCT04822597|449584191|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
124988598|NCT04822597|449584192|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
124988599|NCT04822597|449584193|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
125314987|NCT02831764|450784131|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
125314988|NCT02831764|450784132|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
125314989|NCT02831764|450784128|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
125314990|NCT02831764|450784129|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
125314991|NCT02831764|450784130|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
125314992|NCT02831764|450784131|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
125314993|NCT02831764|450784132|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
125314994|NCT02831764|450784128|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
125314995|NCT02831764|450784129|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
125314996|NCT02831764|450784130|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
125314997|NCT02831764|450784131|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
125314998|NCT02831764|450784132|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
125314999|NCT02831764|450784128|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
125315000|NCT02831764|450784129|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
125315001|NCT02831764|450784130|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
125315002|NCT02831764|450784131|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
125315003|NCT02831764|450784132|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
125315004|NCT02831764|450784128|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
125315005|NCT02831764|450784129|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
125315006|NCT02831764|450784130|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
125315007|NCT02831764|450784131|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
125315008|NCT02831764|450784132|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
125315009|NCT02831764|450784128|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
125315010|NCT02831764|450784129|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
125315011|NCT02831764|450784130|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
125315012|NCT02831764|450784131|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
125315013|NCT02831764|450784132|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
125315014|NCT02831764|450784128|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
125315015|NCT02831764|450784129|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
125315016|NCT02831764|450784130|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
125315017|NCT02831764|450784131|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
125315018|NCT02831764|450784132|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
125315019|NCT02831764|450784128|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
125315020|NCT02831764|450784129|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
125315021|NCT02831764|450784130|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
125315022|NCT02831764|450784131|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
125315023|NCT02831764|450784132|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
125315024|NCT02831764|450784128|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
125315025|NCT02831764|450784129|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
125315026|NCT02831764|450784130|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
125315027|NCT02831764|450784131|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
125315028|NCT02831764|450784132|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
125315029|NCT02831764|450784128|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
125315030|NCT02831764|450784129|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
125315031|NCT02831764|450784130|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
125315032|NCT02831764|450784131|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
124988600|NCT01285609|449584194|FG000|Randomized|Progressive Disease|41|||
124988601|NCT01285609|449584195|FG001|Randomized|Progressive Disease|61|||
124988602|NCT01285609|449584194|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
124988603|NCT01285609|449584195|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
124988604|NCT01285609|449584194|FG000|Randomized|Study Drug Toxicity|13|||
124988605|NCT01285609|449584195|FG001|Randomized|Study Drug Toxicity|14|||
124988606|NCT01285609|449584194|FG000|Randomized|Death|5|||
124988607|NCT01285609|449584195|FG001|Randomized|Death|7|||
124988608|NCT01285609|449584194|FG000|Randomized|Withdrawal by Subject|8|||
124988609|NCT01285609|449584195|FG001|Randomized|Withdrawal by Subject|11|||
124988610|NCT01285609|449584194|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
124988611|NCT01285609|449584195|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
124988612|NCT01285609|449584194|FG000|Randomized|Undisclosed Reasons|1|||
124988613|NCT01285609|449584195|FG001|Randomized|Undisclosed Reasons|0|||
124988614|NCT01285609|449584194|FG000|Randomized|Randomized but not Treated|4|||
124988615|NCT01285609|449584195|FG001|Randomized|Randomized but not Treated|4|||
124988616|NCT01285609|449584194|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
124988617|NCT01285609|449584195|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
124988618|NCT01285609|449584194|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
125315033|NCT02831764|450784132|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
125315034|NCT02831764|450784128|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
125315035|NCT02831764|450784129|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
125315036|NCT02831764|450784130|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
125315037|NCT02831764|450784131|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
125315038|NCT02831764|450784132|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
125315039|NCT02831764|450784128|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
125315040|NCT02831764|450784129|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
125315041|NCT02831764|450784130|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
125315042|NCT02831764|450784131|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
125315043|NCT02831764|450784132|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
125315044|NCT02831764|450784128|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
125315045|NCT02831764|450784129|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
125315046|NCT02831764|450784130|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
125315047|NCT02831764|450784131|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
125315048|NCT02831764|450784132|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
125315049|NCT04564846|450784133|FG000|Overall Study|Withdrawal by Subject|2|||
125315050|NCT04564846|450784134|FG001|Overall Study|Withdrawal by Subject|1|||
125315051|NCT04564846|450784133|FG000|Overall Study|Physician Decision|0|||
125315052|NCT04564846|450784134|FG001|Overall Study|Physician Decision|1|||
125315053|NCT04564846|450784133|FG000|Overall Study|Lost to Follow-up|0|||
125315054|NCT04564846|450784134|FG001|Overall Study|Lost to Follow-up|1|||
125315055|NCT04564846|450784133|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
125315056|NCT04564846|450784134|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
125315057|NCT04564846|450784133|FG000|Overall Study|Subject non-compliance|1|||
125315058|NCT04564846|450784134|FG001|Overall Study|Subject non-compliance|0|||
125315059|NCT02735239|450784135|FG000|Overall Study|Adverse Event|0|||
125315060|NCT02735239|450784136|FG001|Overall Study|Adverse Event|0|||
125315061|NCT02735239|450784137|FG002|Overall Study|Adverse Event|4|||
125315062|NCT02735239|450784138|FG003|Overall Study|Adverse Event|0|||
125315063|NCT02735239|450784139|FG004|Overall Study|Adverse Event|0|||
125315064|NCT02735239|450784140|FG005|Overall Study|Adverse Event|0|||
125315065|NCT02735239|450784135|FG000|Overall Study|Death|1|||
125315066|NCT02735239|450784136|FG001|Overall Study|Death|1|||
125315067|NCT02735239|450784137|FG002|Overall Study|Death|0|||
125315068|NCT02735239|450784138|FG003|Overall Study|Death|0|||
125315069|NCT02735239|450784139|FG004|Overall Study|Death|0|||
125315070|NCT02735239|450784140|FG005|Overall Study|Death|0|||
125315071|NCT02735239|450784135|FG000|Overall Study|Physician Decision|0|||
125315072|NCT02735239|450784136|FG001|Overall Study|Physician Decision|0|||
125315073|NCT02735239|450784137|FG002|Overall Study|Physician Decision|1|||
125315074|NCT02735239|450784138|FG003|Overall Study|Physician Decision|0|||
125315075|NCT02735239|450784139|FG004|Overall Study|Physician Decision|0|||
125315076|NCT02735239|450784140|FG005|Overall Study|Physician Decision|0|||
125315077|NCT02735239|450784135|FG000|Overall Study|Progressive disease|3|||
125315078|NCT02735239|450784136|FG001|Overall Study|Progressive disease|1|||
125315079|NCT02735239|450784137|FG002|Overall Study|Progressive disease|3|||
125315080|NCT02735239|450784138|FG003|Overall Study|Progressive disease|0|||
125315081|NCT02735239|450784139|FG004|Overall Study|Progressive disease|0|||
125315082|NCT02735239|450784140|FG005|Overall Study|Progressive disease|2|||
125315083|NCT02735239|450784135|FG000|Overall Study|Withdrawal by Subject|0|||
125315084|NCT02735239|450784136|FG001|Overall Study|Withdrawal by Subject|1|||
125315085|NCT02735239|450784137|FG002|Overall Study|Withdrawal by Subject|0|||
125315086|NCT02735239|450784138|FG003|Overall Study|Withdrawal by Subject|0|||
125315087|NCT02735239|450784139|FG004|Overall Study|Withdrawal by Subject|0|||
125315088|NCT02735239|450784140|FG005|Overall Study|Withdrawal by Subject|0|||
125315089|NCT02038153|450784143|FG000|Overall Study|Withdrawal by Subject|1|||
125315090|NCT03016312|450784144|FG000|Overall Study|discontinued before the treatment started|0|||
125315091|NCT03016312|450784145|FG001|Overall Study|discontinued before the treatment started|1|||
125315092|NCT03016312|450784144|FG000|Overall Study|Withdrawal by Subject|37|||
125315093|NCT03016312|450784145|FG001|Overall Study|Withdrawal by Subject|44|||
125315094|NCT03016312|450784144|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
125315095|NCT03016312|450784145|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
124988619|NCT01285609|449584195|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
125315096|NCT03016312|450784144|FG000|Overall Study|Physician Decision|1|||
125315097|NCT03016312|450784145|FG001|Overall Study|Physician Decision|3|||
125315098|NCT03016312|450784144|FG000|Overall Study|Lost to Follow-up|12|||
125315099|NCT03016312|450784145|FG001|Overall Study|Lost to Follow-up|12|||
125315100|NCT03016312|450784144|FG000|Overall Study|Death|210|||
125315101|NCT03016312|450784145|FG001|Overall Study|Death|184|||
125315102|NCT03016312|450784144|FG000|Overall Study|loss to contact|1|||
125315103|NCT03016312|450784145|FG001|Overall Study|loss to contact|0|||
124988620|NCT01285609|449584194|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
124988621|NCT01285609|449584195|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
124988622|NCT01285609|449584194|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
124988623|NCT01285609|449584195|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
124988624|NCT01285609|449584194|FG000|Treated With Blinded Therapy|Death|11|||
124988625|NCT01285609|449584195|FG001|Treated With Blinded Therapy|Death|3|||
124988626|NCT01285609|449584194|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
124988627|NCT01285609|449584195|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
124988628|NCT01285609|449584194|FG000|Treated With Blinded Therapy|Not Reported|0|||
124988629|NCT01285609|449584195|FG001|Treated With Blinded Therapy|Not Reported|2|||
124988630|NCT01285609|449584194|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
124988631|NCT01285609|449584195|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
125315104|NCT03016312|450784144|FG000|Overall Study|started a new cancer therapy|1|||
125315105|NCT03016312|450784145|FG001|Overall Study|started a new cancer therapy|0|||
125315106|NCT01050634|450784146|FG000|Overall Study|Enrolled, but Not Treated|56|||
125315107|NCT01050634|450784146|FG000|Overall Study|Death|2|||
125315108|NCT01050634|450784146|FG000|Overall Study|Adverse Event|42|||
125315109|NCT01050634|450784146|FG000|Overall Study|Lost to Follow-up|2|||
124988632|NCT01285609|449584194|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
124988633|NCT01285609|449584195|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
124988634|NCT01285609|449584194|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
124988635|NCT01285609|449584195|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
124988636|NCT01285609|449584194|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
124988637|NCT01285609|449584195|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
124988638|NCT01285609|449584194|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
124988639|NCT01285609|449584195|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
124988640|NCT01285609|449584194|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
124988641|NCT01285609|449584195|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
125315110|NCT01050634|450784146|FG000|Overall Study|Other|21|||
125315111|NCT01050634|450784146|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
125315112|NCT00496015|450784147|FG000|Overall Study|Other|1|||
125315113|NCT00496015|450784148|FG001|Overall Study|Other|0|||
125315114|NCT00496015|450784149|FG002|Overall Study|Other|0|||
125315115|NCT00496015|450784150|FG003|Overall Study|Other|1|||
125315116|NCT00496015|450784151|FG004|Overall Study|Other|0|||
125315117|NCT00527735|450784152|FG000|Overall Study|Disease progression|47|||
125315118|NCT00527735|450784153|FG001|Overall Study|Disease progression|61|||
125315119|NCT00527735|450784154|FG002|Overall Study|Disease progression|53|||
125315120|NCT00527735|450784152|FG000|Overall Study|Death|23|||
125315121|NCT00527735|450784153|FG001|Overall Study|Death|13|||
125315122|NCT00527735|450784154|FG002|Overall Study|Death|15|||
125315123|NCT00527735|450784152|FG000|Overall Study|Completed treatment in treatment phase|14|||
125315124|NCT00527735|450784153|FG001|Overall Study|Completed treatment in treatment phase|13|||
125315125|NCT00527735|450784154|FG002|Overall Study|Completed treatment in treatment phase|18|||
125315126|NCT00527735|450784152|FG000|Overall Study|Adverse Event|10|||
125315127|NCT00527735|450784153|FG001|Overall Study|Adverse Event|6|||
125315128|NCT00527735|450784154|FG002|Overall Study|Adverse Event|7|||
125315129|NCT00527735|450784152|FG000|Overall Study|Not identified|5|||
125315130|NCT00527735|450784153|FG001|Overall Study|Not identified|5|||
125315131|NCT00527735|450784154|FG002|Overall Study|Not identified|5|||
125315132|NCT00527735|450784152|FG000|Overall Study|Withdrawal by Subject|5|||
125315133|NCT00527735|450784153|FG001|Overall Study|Withdrawal by Subject|4|||
125315134|NCT00527735|450784154|FG002|Overall Study|Withdrawal by Subject|3|||
125315135|NCT00527735|450784152|FG000|Overall Study|No longer met study criteria|2|||
125315136|NCT00527735|450784153|FG001|Overall Study|No longer met study criteria|2|||
125315137|NCT00527735|450784154|FG002|Overall Study|No longer met study criteria|1|||
124988642|NCT01285609|449584194|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
124988643|NCT01285609|449584195|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
124988644|NCT01285609|449584194|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
124988645|NCT01285609|449584195|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
124988646|NCT01285609|449584194|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
124988647|NCT01285609|449584195|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
124988648|NCT01285609|449584194|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
124988649|NCT01285609|449584195|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
124988650|NCT02412371|449584207|FG000|Overall Study|Withdrawal by Subject|0|||
125315138|NCT00527735|450784152|FG000|Overall Study|Lost to Follow-up|0|||
125315139|NCT00527735|450784153|FG001|Overall Study|Lost to Follow-up|0|||
125315140|NCT00527735|450784154|FG002|Overall Study|Lost to Follow-up|3|||
125315141|NCT00527735|450784152|FG000|Overall Study|Poor compliance or noncompliance|0|||
125315142|NCT00527735|450784153|FG001|Overall Study|Poor compliance or noncompliance|1|||
125315143|NCT00527735|450784154|FG002|Overall Study|Poor compliance or noncompliance|1|||
125315144|NCT00527735|450784152|FG000|Overall Study|Completed treatment during maintenance|2|||
125315145|NCT00527735|450784153|FG001|Overall Study|Completed treatment during maintenance|2|||
125315146|NCT00527735|450784154|FG002|Overall Study|Completed treatment during maintenance|1|||
125315147|NCT01535807|450784155|FG000|Overall Study|Withdrawal by Subject|1|||
125315148|NCT01535807|450784156|FG001|Overall Study|Withdrawal by Subject|1|||
125315149|NCT01535807|450784155|FG000|Overall Study|Data collection error|1|||
125315150|NCT01535807|450784156|FG001|Overall Study|Data collection error|1|||
125315151|NCT02730728|450784159|FG000|Overall Study|Withdrawal by Subject|0|||
125315152|NCT02730728|450784160|FG001|Overall Study|Withdrawal by Subject|1|||
125315153|NCT02730728|450784161|FG002|Overall Study|Withdrawal by Subject|0|||
125315154|NCT02730728|450784159|FG000|Overall Study|Lack of Efficacy|0|||
125315155|NCT02730728|450784160|FG001|Overall Study|Lack of Efficacy|1|||
125315156|NCT02730728|450784161|FG002|Overall Study|Lack of Efficacy|1|||
125315157|NCT01855412|450784162|FG000|Overall Study|Death|77|||
125315158|NCT01855412|450784163|FG001|Overall Study|Death|123|||
125315159|NCT01855412|450784164|FG002|Overall Study|Death|30|||
125315160|NCT01855412|450784162|FG000|Overall Study|Lost to Follow-up|28|||
125315161|NCT01855412|450784163|FG001|Overall Study|Lost to Follow-up|46|||
125315162|NCT01855412|450784164|FG002|Overall Study|Lost to Follow-up|15|||
125315163|NCT01855412|450784162|FG000|Overall Study|Withdrawal by Subject|77|||
125315164|NCT01855412|450784163|FG001|Overall Study|Withdrawal by Subject|123|||
125315165|NCT01855412|450784164|FG002|Overall Study|Withdrawal by Subject|24|||
125315166|NCT01855412|450784162|FG000|Overall Study|Physician Decision|25|||
125315167|NCT01855412|450784163|FG001|Overall Study|Physician Decision|31|||
125315168|NCT01855412|450784164|FG002|Overall Study|Physician Decision|3|||
125315169|NCT01855412|450784162|FG000|Overall Study|Site Closure|4|||
125315170|NCT01855412|450784163|FG001|Overall Study|Site Closure|18|||
125315171|NCT01855412|450784164|FG002|Overall Study|Site Closure|1|||
125315172|NCT01855412|450784162|FG000|Overall Study|Reason not Specified|1|||
125315173|NCT01855412|450784163|FG001|Overall Study|Reason not Specified|2|||
125315174|NCT01855412|450784164|FG002|Overall Study|Reason not Specified|3|||
125315175|NCT01702844|450784179|FG000|Overall Study|Adverse Event|9|||
125315176|NCT01702844|450784179|FG000|Overall Study|Death|1|||
125315177|NCT01702844|450784179|FG000|Overall Study|Withdrawal by Subject|3|||
125315178|NCT01702844|450784179|FG000|Overall Study|Physician Decision|6|||
125315179|NCT02123134|450784180|FG000|Overall Study|Withdrawal of consent|3|||
125315180|NCT02123134|450784181|FG001|Overall Study|Withdrawal of consent|2|||
125315181|NCT02123134|450784180|FG000|Overall Study|Administrative decision|0|||
125315182|NCT02123134|450784181|FG001|Overall Study|Administrative decision|1|||
125315183|NCT03431441|450784182|FG000|Overall Study|Withdrawal by Subject|2|||
125315184|NCT03431441|450784182|FG000|Overall Study|Adverse Event|2|||
125315185|NCT03431441|450784182|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
125315186|NCT00764699|450784196|FG000|Overall Study|PI left and study terminated|3|||
125315187|NCT03985761|450784198|FG000|Overall Study|Withdrawal by Subject|2|||
125315188|NCT03985761|450784199|FG001|Overall Study|Withdrawal by Subject|3|||
125315189|NCT02322281|450784202|FG000|Overall Study|Progressive Disease|42|||
125315190|NCT02322281|450784203|FG001|Overall Study|Progressive Disease|14|||
125315191|NCT02322281|450784204|FG002|Overall Study|Progressive Disease|49|||
125315192|NCT02322281|450784202|FG000|Overall Study|Adverse Event|3|||
125315193|NCT02322281|450784203|FG001|Overall Study|Adverse Event|4|||
125315194|NCT02322281|450784204|FG002|Overall Study|Adverse Event|6|||
125315195|NCT02322281|450784202|FG000|Overall Study|Death|3|||
125315196|NCT02322281|450784203|FG001|Overall Study|Death|3|||
125315197|NCT02322281|450784204|FG002|Overall Study|Death|3|||
125315198|NCT02322281|450784202|FG000|Overall Study|Withdrawal by Subject|1|||
125315199|NCT02322281|450784203|FG001|Overall Study|Withdrawal by Subject|1|||
125315200|NCT02322281|450784204|FG002|Overall Study|Withdrawal by Subject|6|||
125315201|NCT02322281|450784202|FG000|Overall Study|Physician Decision|2|||
125315202|NCT02322281|450784203|FG001|Overall Study|Physician Decision|0|||
125315203|NCT02322281|450784204|FG002|Overall Study|Physician Decision|5|||
125315204|NCT02322281|450784202|FG000|Overall Study|Study Terminated by Sponsor|2|||
125315205|NCT02322281|450784203|FG001|Overall Study|Study Terminated by Sponsor|0|||
125315206|NCT02322281|450784204|FG002|Overall Study|Study Terminated by Sponsor|0|||
125315207|NCT02322281|450784202|FG000|Overall Study|Missing|0|||
125315208|NCT02322281|450784203|FG001|Overall Study|Missing|0|||
125315209|NCT02322281|450784204|FG002|Overall Study|Missing|1|||
125315210|NCT02322281|450784202|FG000|Overall Study|Miscellaneous|0|||
125315211|NCT02322281|450784203|FG001|Overall Study|Miscellaneous|0|||
125315212|NCT02322281|450784204|FG002|Overall Study|Miscellaneous|4|||
125315213|NCT05789745|450784208|FG000|Overall Study|Withdrawal by Subject|0|||
125315214|NCT05789745|450784209|FG001|Overall Study|Withdrawal by Subject|0|||
125315215|NCT05789745|450784210|FG002|Overall Study|Withdrawal by Subject|0|||
125315216|NCT05789745|450784211|FG003|Overall Study|Withdrawal by Subject|0|||
125315217|NCT05789745|450784212|FG004|Overall Study|Withdrawal by Subject|1|||
125315218|NCT05470387|450784216|FG000|Overall Study|Protocol Violation|0|||
125315219|NCT05470387|450784217|FG001|Overall Study|Protocol Violation|3|||
125315220|NCT03275740|450784218|FG000|Overall Study|Adverse Event|0|||
125315221|NCT03275740|450784219|FG001|Overall Study|Adverse Event|0|||
125315222|NCT03275740|450784220|FG002|Overall Study|Adverse Event|0|||
125315223|NCT03275740|450784221|FG003|Overall Study|Adverse Event|0|||
125315224|NCT03275740|450784222|FG004|Overall Study|Adverse Event|1|||
125315225|NCT03275740|450784223|FG005|Overall Study|Adverse Event|0|||
125315226|NCT03275740|450784224|FG006|Overall Study|Adverse Event|0|||
125315227|NCT03275740|450784225|FG007|Overall Study|Adverse Event|0|||
125315228|NCT03275740|450784226|FG008|Overall Study|Adverse Event|0|||
125315229|NCT03275740|450784227|FG009|Overall Study|Adverse Event|0|||
125315230|NCT03275740|450784228|FG010|Overall Study|Adverse Event|0|||
125315231|NCT03275740|450784229|FG011|Overall Study|Adverse Event|0|||
124988651|NCT02412371|449584208|FG001|Overall Study|Withdrawal by Subject|2|||
124988652|NCT02412371|449584209|FG002|Overall Study|Withdrawal by Subject|0|||
124988653|NCT02412371|449584210|FG003|Overall Study|Withdrawal by Subject|1|||
124988654|NCT02412371|449584211|FG004|Overall Study|Withdrawal by Subject|1|||
124988655|NCT02412371|449584212|FG005|Overall Study|Withdrawal by Subject|0|||
125315232|NCT03275740|450784218|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315233|NCT03275740|450784219|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315234|NCT03275740|450784220|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315235|NCT03275740|450784221|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315236|NCT03275740|450784222|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315237|NCT03275740|450784223|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
125315238|NCT03275740|450784224|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315239|NCT03275740|450784225|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315240|NCT03275740|450784226|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315241|NCT03275740|450784227|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315242|NCT03275740|450784228|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315243|NCT03275740|450784229|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315244|NCT03275740|450784218|FG000|Overall Study|Withdrawal by Subject|0|||
125315245|NCT03275740|450784219|FG001|Overall Study|Withdrawal by Subject|0|||
125315246|NCT03275740|450784220|FG002|Overall Study|Withdrawal by Subject|0|||
125315247|NCT03275740|450784221|FG003|Overall Study|Withdrawal by Subject|0|||
125315248|NCT03275740|450784222|FG004|Overall Study|Withdrawal by Subject|0|||
125315249|NCT03275740|450784223|FG005|Overall Study|Withdrawal by Subject|0|||
125315250|NCT03275740|450784224|FG006|Overall Study|Withdrawal by Subject|0|||
125315251|NCT03275740|450784225|FG007|Overall Study|Withdrawal by Subject|0|||
125315252|NCT03275740|450784226|FG008|Overall Study|Withdrawal by Subject|1|||
125315253|NCT03275740|450784227|FG009|Overall Study|Withdrawal by Subject|1|||
125315254|NCT03275740|450784228|FG010|Overall Study|Withdrawal by Subject|0|||
125315255|NCT03275740|450784229|FG011|Overall Study|Withdrawal by Subject|0|||
125315256|NCT00687401|450784231|FG000|Overall Study|Protocol Violation|7|||
125315257|NCT00687401|450784231|FG000|Overall Study|Adverse Event|6|||
125315258|NCT00687401|450784231|FG000|Overall Study|Lack of Efficacy|6|||
125315259|NCT00687401|450784231|FG000|Overall Study|Withdrawal by Subject|4|||
125315260|NCT00687401|450784231|FG000|Overall Study|Did not return for visit|3|||
124988656|NCT02412371|449584207|FG000|Overall Study|Sponsor Discontinued Study|1|||
125315261|NCT00687401|450784231|FG000|Overall Study|For reasons different from those above|4|||
125315262|NCT02920892|450784232|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
125315263|NCT02920892|450784233|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
125315264|NCT02920892|450784234|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
125315265|NCT02920892|450784232|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
125315266|NCT02920892|450784233|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
125315267|NCT02920892|450784234|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
125315268|NCT02920892|450784232|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
124988657|NCT02412371|449584208|FG001|Overall Study|Sponsor Discontinued Study|4|||
124988658|NCT02412371|449584209|FG002|Overall Study|Sponsor Discontinued Study|6|||
124988659|NCT02412371|449584210|FG003|Overall Study|Sponsor Discontinued Study|4|||
124988660|NCT02412371|449584211|FG004|Overall Study|Sponsor Discontinued Study|5|||
124988661|NCT02412371|449584212|FG005|Overall Study|Sponsor Discontinued Study|0|||
124988662|NCT02412371|449584207|FG000|Overall Study|Death|4|||
124988663|NCT02412371|449584208|FG001|Overall Study|Death|2|||
124988664|NCT02412371|449584209|FG002|Overall Study|Death|1|||
124988665|NCT02412371|449584210|FG003|Overall Study|Death|3|||
124988666|NCT02412371|449584211|FG004|Overall Study|Death|5|||
124988667|NCT02412371|449584212|FG005|Overall Study|Death|2|||
124988668|NCT02412371|449584207|FG000|Overall Study|Other|2|||
124988669|NCT02412371|449584208|FG001|Overall Study|Other|1|||
124988670|NCT02412371|449584209|FG002|Overall Study|Other|0|||
124988671|NCT02412371|449584210|FG003|Overall Study|Other|0|||
125315269|NCT02920892|450784233|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
124988672|NCT02412371|449584211|FG004|Overall Study|Other|1|||
124988673|NCT02412371|449584212|FG005|Overall Study|Other|3|||
124988674|NCT02053792|449584213|FG000|Overall Study|Physician Decision|0|||
124988675|NCT02053792|449584214|FG001|Overall Study|Physician Decision|1|||
124988676|NCT02053792|449584213|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
124988677|NCT02053792|449584214|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
124988678|NCT02053792|449584213|FG000|Overall Study|Lack of Efficacy|1|||
125315270|NCT02920892|450784234|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
125315271|NCT02920892|450784232|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
125315272|NCT02920892|450784233|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
125315273|NCT02920892|450784234|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
125315274|NCT02920892|450784232|FG000|Placebo-Controlled Period|Physician Decision|0|||
125315275|NCT02920892|450784233|FG001|Placebo-Controlled Period|Physician Decision|0|||
125315276|NCT02920892|450784234|FG002|Placebo-Controlled Period|Physician Decision|1|||
125315277|NCT02920892|450784232|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
125315278|NCT02920892|450784233|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
125315279|NCT02920892|450784234|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
125315280|NCT02920892|450784232|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
125315281|NCT02920892|450784233|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
125315282|NCT02920892|450784234|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
125315283|NCT02920892|450784232|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
125315284|NCT02920892|450784233|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
125315285|NCT02920892|450784234|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
125315286|NCT04486235|450784235|FG000|Overall Study|Pregnancy|1|||
125315287|NCT04486235|450784236|FG001|Overall Study|Pregnancy|0|||
125315288|NCT04486235|450784235|FG000|Overall Study|Lost to Follow-up|1|||
125315289|NCT04486235|450784236|FG001|Overall Study|Lost to Follow-up|0|||
125315290|NCT03935126|450784237|FG000|Overall Study|Study termination by sponsor|3|||
125315291|NCT02520726|450784238|FG000|Overall Study|Lost to Follow-up|3|||
125315292|NCT02520726|450784239|FG001|Overall Study|Lost to Follow-up|2|||
125315293|NCT03649217|450784240|FG000|Overall Study|subject had severe ataxia not initially found|1|||
125315294|NCT03649217|450784240|FG000|Overall Study|subject had cognitive issues not initially found|1|||
125315295|NCT01092728|450784241|FG000|Overall Study|Withdrawal by Subject|2|||
125315296|NCT01092728|450784242|FG001|Overall Study|Withdrawal by Subject|0|||
125315297|NCT01092728|450784241|FG000|Overall Study|Adverse Event|0|||
125315298|NCT01092728|450784242|FG001|Overall Study|Adverse Event|1|||
125315299|NCT01092728|450784241|FG000|Overall Study|Disease Progression|1|||
125315300|NCT01092728|450784242|FG001|Overall Study|Disease Progression|13|||
125315301|NCT01092728|450784241|FG000|Overall Study|Prohibited Concomitant Medications|1|||
125315302|NCT01092728|450784242|FG001|Overall Study|Prohibited Concomitant Medications|0|||
125315303|NCT02552966|450784243|FG000|Overall Study|Lost to Follow-up|2|||
125315304|NCT02552966|450784243|FG000|Overall Study|Withdrawal by Subject|3|||
125315305|NCT00721396|450784244|FG000|Overall Study|Adverse Event|4|||
125315306|NCT00721396|450784245|FG001|Overall Study|Adverse Event|7|||
125315307|NCT00721396|450784246|FG002|Overall Study|Adverse Event|2|||
125315308|NCT00721396|450784247|FG003|Overall Study|Adverse Event|0|||
125315309|NCT00721396|450784244|FG000|Overall Study|Withdrawal by Subject|12|||
125315310|NCT00721396|450784245|FG001|Overall Study|Withdrawal by Subject|15|||
125315311|NCT00721396|450784246|FG002|Overall Study|Withdrawal by Subject|3|||
125315312|NCT00721396|450784247|FG003|Overall Study|Withdrawal by Subject|7|||
125315313|NCT00721396|450784244|FG000|Overall Study|Lost to Follow-up|7|||
125315314|NCT00721396|450784245|FG001|Overall Study|Lost to Follow-up|9|||
125315315|NCT00721396|450784246|FG002|Overall Study|Lost to Follow-up|3|||
125315316|NCT00721396|450784247|FG003|Overall Study|Lost to Follow-up|3|||
125315317|NCT00721396|450784244|FG000|Overall Study|Protocol Violation|4|||
125315318|NCT00721396|450784245|FG001|Overall Study|Protocol Violation|3|||
125315319|NCT00721396|450784246|FG002|Overall Study|Protocol Violation|1|||
125315320|NCT00721396|450784247|FG003|Overall Study|Protocol Violation|0|||
125315321|NCT00721396|450784244|FG000|Overall Study|Inappropriate enrollment|0|||
125315322|NCT00721396|450784245|FG001|Overall Study|Inappropriate enrollment|2|||
125315323|NCT00721396|450784246|FG002|Overall Study|Inappropriate enrollment|0|||
125315324|NCT00721396|450784247|FG003|Overall Study|Inappropriate enrollment|0|||
125315325|NCT00721396|450784244|FG000|Overall Study|Administrative reason|3|||
125315326|NCT00721396|450784245|FG001|Overall Study|Administrative reason|0|||
125315327|NCT00721396|450784246|FG002|Overall Study|Administrative reason|1|||
125315328|NCT00721396|450784247|FG003|Overall Study|Administrative reason|0|||
125315329|NCT01091675|450784249|FG000|Overall Study|Adverse Event|7|||
125315330|NCT01091675|450784249|FG000|Overall Study|Lack of Efficacy|27|||
125315331|NCT00614380|450784250|FG000|Overall Study|Adverse Event|14|||
125315332|NCT00614380|450784251|FG001|Overall Study|Adverse Event|4|||
125315333|NCT00614380|450784252|FG002|Overall Study|Adverse Event|0|||
125315334|NCT00614380|450784253|FG003|Overall Study|Adverse Event|0|||
125315335|NCT00614380|450784250|FG000|Overall Study|Lost to Follow-up|6|||
125315336|NCT00614380|450784251|FG001|Overall Study|Lost to Follow-up|1|||
125315337|NCT00614380|450784252|FG002|Overall Study|Lost to Follow-up|0|||
125315338|NCT00614380|450784253|FG003|Overall Study|Lost to Follow-up|0|||
125315339|NCT00614380|450784250|FG000|Overall Study|Non compliant with the protocol|12|||
125315340|NCT00614380|450784251|FG001|Overall Study|Non compliant with the protocol|2|||
125315341|NCT00614380|450784252|FG002|Overall Study|Non compliant with the protocol|1|||
125315342|NCT00614380|450784253|FG003|Overall Study|Non compliant with the protocol|2|||
125315343|NCT00614380|450784250|FG000|Overall Study|Consent withdrawn|3|||
125315344|NCT00614380|450784251|FG001|Overall Study|Consent withdrawn|1|||
125315345|NCT00614380|450784252|FG002|Overall Study|Consent withdrawn|0|||
125315346|NCT00614380|450784253|FG003|Overall Study|Consent withdrawn|0|||
125315347|NCT02021565|450784267|FG000|Baseline Through Intervention|Death|0|||
125315348|NCT02021565|450784268|FG001|Baseline Through Intervention|Death|1|||
125315349|NCT02021565|450784267|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
125315350|NCT02021565|450784268|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
125315351|NCT02021565|450784267|FG000|Baseline Through Intervention|Protocol Violation|0|||
125315352|NCT02021565|450784268|FG001|Baseline Through Intervention|Protocol Violation|7|||
125315353|NCT02021565|450784267|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
125315354|NCT02021565|450784268|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
125315355|NCT02021565|450784267|FG000|3-month Follow-up|Death|3|||
125315356|NCT02021565|450784268|FG001|3-month Follow-up|Death|0|||
125315357|NCT02021565|450784267|FG000|3-month Follow-up|Withdrawal by Subject|4|||
125315358|NCT02021565|450784268|FG001|3-month Follow-up|Withdrawal by Subject|0|||
125315359|NCT02021565|450784267|FG000|3-month Follow-up|Protocol Violation|3|||
125315360|NCT02021565|450784268|FG001|3-month Follow-up|Protocol Violation|2|||
125315361|NCT03318549|450784269|FG000|Overall Study|Withdrawal by Subject|5|||
125315362|NCT03318549|450784270|FG001|Overall Study|Withdrawal by Subject|19|||
125315363|NCT03318549|450784271|FG002|Overall Study|Withdrawal by Subject|2|||
125315364|NCT03318549|450784272|FG003|Overall Study|Withdrawal by Subject|0|||
125315365|NCT03318549|450784273|FG004|Overall Study|Withdrawal by Subject|0|||
125315366|NCT03318549|450784274|FG005|Overall Study|Withdrawal by Subject|0|||
125315367|NCT03318549|450784275|FG006|Overall Study|Withdrawal by Subject|0|||
125315368|NCT03318549|450784269|FG000|Overall Study|Physician Decision|0|||
125315369|NCT03318549|450784270|FG001|Overall Study|Physician Decision|4|||
125315370|NCT03318549|450784271|FG002|Overall Study|Physician Decision|1|||
125315371|NCT03318549|450784272|FG003|Overall Study|Physician Decision|0|||
125315372|NCT03318549|450784273|FG004|Overall Study|Physician Decision|0|||
125315373|NCT03318549|450784274|FG005|Overall Study|Physician Decision|0|||
125315374|NCT03318549|450784275|FG006|Overall Study|Physician Decision|0|||
125315375|NCT03318549|450784269|FG000|Overall Study|Lost to Follow-up|0|||
125315376|NCT03318549|450784270|FG001|Overall Study|Lost to Follow-up|3|||
125315377|NCT03318549|450784271|FG002|Overall Study|Lost to Follow-up|3|||
125315378|NCT03318549|450784272|FG003|Overall Study|Lost to Follow-up|0|||
125315379|NCT03318549|450784273|FG004|Overall Study|Lost to Follow-up|0|||
125315380|NCT03318549|450784274|FG005|Overall Study|Lost to Follow-up|0|||
125315381|NCT03318549|450784275|FG006|Overall Study|Lost to Follow-up|0|||
125315382|NCT00510835|450784278|FG000|Overall Study|Withdrawal by Subject|6|||
125315383|NCT00510835|450784279|FG001|Overall Study|Withdrawal by Subject|2|||
125315384|NCT00510835|450784280|FG002|Overall Study|Withdrawal by Subject|2|||
125315385|NCT00607087|450784284|FG000|Overall Study|Withdrawal by Subject|9|||
125315386|NCT00607087|450784285|FG001|Overall Study|Withdrawal by Subject|4|||
125315387|NCT00607087|450784286|FG002|Overall Study|Withdrawal by Subject|4|||
125315388|NCT00607087|450784284|FG000|Overall Study|Adverse Event|3|||
125315389|NCT00607087|450784285|FG001|Overall Study|Adverse Event|2|||
125315390|NCT00607087|450784286|FG002|Overall Study|Adverse Event|3|||
125315391|NCT00607087|450784284|FG000|Overall Study|Other reason|1|||
125315392|NCT00607087|450784285|FG001|Overall Study|Other reason|5|||
125315393|NCT00607087|450784286|FG002|Overall Study|Other reason|2|||
125315394|NCT00607087|450784284|FG000|Overall Study|Poor compliance to protocol|1|||
125315395|NCT00607087|450784285|FG001|Overall Study|Poor compliance to protocol|0|||
125315396|NCT00607087|450784286|FG002|Overall Study|Poor compliance to protocol|1|||
125315397|NCT00607087|450784284|FG000|Overall Study|Lost to Follow-up|1|||
125315398|NCT00607087|450784285|FG001|Overall Study|Lost to Follow-up|0|||
125315399|NCT00607087|450784286|FG002|Overall Study|Lost to Follow-up|0|||
125315400|NCT00607087|450784284|FG000|Period 1|Withdrawal by Subject|7|||
125315401|NCT00607087|450784285|FG001|Period 1|Withdrawal by Subject|2|||
125315402|NCT00607087|450784286|FG002|Period 1|Withdrawal by Subject|3|||
125315403|NCT00607087|450784284|FG000|Period 1|Adverse Event|3|||
125315404|NCT00607087|450784285|FG001|Period 1|Adverse Event|0|||
125315405|NCT00607087|450784286|FG002|Period 1|Adverse Event|0|||
125315406|NCT00607087|450784284|FG000|Period 1|Poor compliance to protocol|1|||
125315407|NCT00607087|450784285|FG001|Period 1|Poor compliance to protocol|0|||
125315408|NCT00607087|450784286|FG002|Period 1|Poor compliance to protocol|0|||
125315409|NCT00607087|450784284|FG000|Period 1|Lost to Follow-up|1|||
125315410|NCT00607087|450784285|FG001|Period 1|Lost to Follow-up|0|||
125315411|NCT00607087|450784286|FG002|Period 1|Lost to Follow-up|0|||
125315412|NCT00607087|450784284|FG000|Period 1|Other reason|0|||
125315413|NCT00607087|450784285|FG001|Period 1|Other reason|4|||
125315414|NCT00607087|450784286|FG002|Period 1|Other reason|2|||
125315415|NCT00607087|450784284|FG000|Period 2|Withdrawal by Subject|0|||
125315416|NCT00607087|450784285|FG001|Period 2|Withdrawal by Subject|1|||
125315417|NCT00607087|450784286|FG002|Period 2|Withdrawal by Subject|1|||
125315418|NCT00607087|450784284|FG000|Period 2|Other reason|1|||
125315419|NCT00607087|450784285|FG001|Period 2|Other reason|1|||
125315420|NCT00607087|450784286|FG002|Period 2|Other reason|0|||
125315421|NCT00607087|450784284|FG000|Period 2|Adverse Event|0|||
125315422|NCT00607087|450784285|FG001|Period 2|Adverse Event|1|||
125315423|NCT00607087|450784286|FG002|Period 2|Adverse Event|3|||
125315424|NCT00607087|450784284|FG000|Period 2|Poor compliance to protocol|0|||
125315425|NCT00607087|450784285|FG001|Period 2|Poor compliance to protocol|0|||
125315426|NCT00607087|450784286|FG002|Period 2|Poor compliance to protocol|1|||
125315427|NCT00607087|450784284|FG000|Period 3|Withdrawal by Subject|2|||
125315428|NCT00607087|450784285|FG001|Period 3|Withdrawal by Subject|1|||
125315429|NCT00607087|450784286|FG002|Period 3|Withdrawal by Subject|0|||
125315430|NCT00607087|450784284|FG000|Period 3|Adverse Event|0|||
125315431|NCT00607087|450784285|FG001|Period 3|Adverse Event|1|||
125315432|NCT00607087|450784286|FG002|Period 3|Adverse Event|0|||
125315433|NCT00650767|450784288|FG000|Overall Study|Adverse Event|0|||
125315434|NCT00650767|450784289|FG001|Overall Study|Adverse Event|3|||
125315435|NCT00650767|450784290|FG002|Overall Study|Adverse Event|10|||
125315436|NCT00650767|450784291|FG003|Overall Study|Adverse Event|8|||
125315437|NCT00650767|450784288|FG000|Overall Study|Death|1|||
125315438|NCT00650767|450784289|FG001|Overall Study|Death|0|||
125315439|NCT00650767|450784290|FG002|Overall Study|Death|0|||
125315440|NCT00650767|450784291|FG003|Overall Study|Death|0|||
125315441|NCT00650767|450784288|FG000|Overall Study|Withdrawal by Subject|2|||
125315442|NCT00650767|450784289|FG001|Overall Study|Withdrawal by Subject|4|||
125315443|NCT00650767|450784290|FG002|Overall Study|Withdrawal by Subject|3|||
125315444|NCT00650767|450784291|FG003|Overall Study|Withdrawal by Subject|3|||
125315445|NCT00650767|450784288|FG000|Overall Study|Lost to Follow-up|1|||
124988679|NCT02053792|449584214|FG001|Overall Study|Lack of Efficacy|0|||
124988680|NCT02053792|449584213|FG000|Overall Study|Adverse Event|1|||
124988681|NCT02053792|449584214|FG001|Overall Study|Adverse Event|0|||
124988682|NCT02053792|449584213|FG000|Overall Study|Withdrawal by Subject|2|||
124988683|NCT02053792|449584214|FG001|Overall Study|Withdrawal by Subject|2|||
124988684|NCT02053792|449584213|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
124988685|NCT02053792|449584214|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
124988686|NCT02053792|449584213|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
124988687|NCT02053792|449584214|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
124988688|NCT05326815|449584216|FG000|Overall Study|Withdrawal by Subject|3|||
124988689|NCT05326815|449584216|FG000|Overall Study|Did not complete required labs|6|||
124988690|NCT05326815|449584216|FG000|Overall Study|Screen fail- abnormal labs|5|||
124988691|NCT00925132|449584217|FG000|Overall Study|Withdrawal by Subject|2|||
124988692|NCT00925132|449584218|FG001|Overall Study|Withdrawal by Subject|0|||
124988693|NCT00925132|449584219|FG002|Overall Study|Withdrawal by Subject|0|||
124988694|NCT00925132|449584220|FG003|Overall Study|Withdrawal by Subject|0|||
124988695|NCT00925132|449584221|FG004|Overall Study|Withdrawal by Subject|1|||
124988696|NCT00925132|449584217|FG000|Overall Study|Removed due to disease progression|0|||
124988697|NCT00925132|449584218|FG001|Overall Study|Removed due to disease progression|0|||
124988698|NCT00925132|449584219|FG002|Overall Study|Removed due to disease progression|0|||
124988699|NCT00925132|449584220|FG003|Overall Study|Removed due to disease progression|0|||
124988700|NCT00925132|449584221|FG004|Overall Study|Removed due to disease progression|4|||
124988701|NCT02545933|449584222|FG000|Overall Study|Adverse Event|3|||
124988702|NCT02545933|449584223|FG001|Overall Study|Adverse Event|0|||
124988703|NCT02545933|449584224|FG002|Overall Study|Adverse Event|0|||
124988704|NCT02545933|449584222|FG000|Overall Study|Withdrawal by Subject|2|||
124988705|NCT02545933|449584223|FG001|Overall Study|Withdrawal by Subject|3|||
124988706|NCT02545933|449584224|FG002|Overall Study|Withdrawal by Subject|3|||
124988707|NCT02545933|449584222|FG000|Overall Study|Protocol Violation|1|||
124988708|NCT02545933|449584223|FG001|Overall Study|Protocol Violation|0|||
124988709|NCT02545933|449584224|FG002|Overall Study|Protocol Violation|1|||
124988710|NCT03149549|449584225|FG000|Study Discontinuation--Treatment Period|Death|0|||
124988711|NCT03149549|449584226|FG001|Study Discontinuation--Treatment Period|Death|0|||
124988712|NCT03149549|449584227|FG002|Study Discontinuation--Treatment Period|Death|0|||
124988713|NCT03149549|449584228|FG003|Study Discontinuation--Treatment Period|Death|1|||
124988714|NCT03149549|449584229|FG004|Study Discontinuation--Treatment Period|Death|2|||
124988715|NCT03149549|449584230|FG005|Study Discontinuation--Treatment Period|Death|1|||
124988716|NCT03149549|449584231|FG006|Study Discontinuation--Treatment Period|Death|1|||
124988717|NCT03149549|449584232|FG007|Study Discontinuation--Treatment Period|Death|2|||
124988718|NCT03149549|449584233|FG008|Study Discontinuation--Treatment Period|Death|4|||
124988719|NCT03149549|449584234|FG009|Study Discontinuation--Treatment Period|Death|1|||
125315446|NCT00650767|450784289|FG001|Overall Study|Lost to Follow-up|1|||
125315447|NCT00650767|450784290|FG002|Overall Study|Lost to Follow-up|1|||
125315448|NCT00650767|450784291|FG003|Overall Study|Lost to Follow-up|0|||
125315449|NCT00650767|450784288|FG000|Overall Study|Other|1|||
125315450|NCT00650767|450784289|FG001|Overall Study|Other|1|||
124988720|NCT03149549|449584235|FG010|Study Discontinuation--Treatment Period|Death|0|||
124988721|NCT03149549|449584236|FG011|Study Discontinuation--Treatment Period|Death|0|||
124988722|NCT03149549|449584237|FG012|Study Discontinuation--Treatment Period|Death|1|||
124988723|NCT03149549|449584225|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
125315451|NCT00650767|450784290|FG002|Overall Study|Other|0|||
125315452|NCT00650767|450784291|FG003|Overall Study|Other|0|||
125315453|NCT01774799|450784292|FG000|Overall Study|Lost to Follow-up|1|||
124988724|NCT03149549|449584226|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
124988725|NCT03149549|449584227|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
124988726|NCT03149549|449584228|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
124988727|NCT03149549|449584229|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
124988728|NCT03149549|449584230|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
125315454|NCT01774799|450784293|FG001|Overall Study|Lost to Follow-up|1|||
124988729|NCT03149549|449584231|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
124988730|NCT03149549|449584232|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
124988731|NCT03149549|449584233|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
124988732|NCT03149549|449584234|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
124988733|NCT03149549|449584235|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
124988734|NCT03149549|449584236|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
124988735|NCT03149549|449584237|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
124988736|NCT03149549|449584225|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
124988737|NCT03149549|449584226|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
124988738|NCT03149549|449584227|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
124988739|NCT03149549|449584228|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
124988740|NCT03149549|449584229|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
124988741|NCT03149549|449584230|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
124988742|NCT03149549|449584231|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
124988743|NCT03149549|449584232|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
124988744|NCT03149549|449584233|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
124988745|NCT03149549|449584234|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
124988746|NCT03149549|449584235|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
124988747|NCT03149549|449584236|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
124988748|NCT03149549|449584237|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
124988749|NCT03149549|449584225|FG000|Study Discontinuation--Treatment Period|Other|0|||
124988750|NCT03149549|449584226|FG001|Study Discontinuation--Treatment Period|Other|0|||
124988751|NCT03149549|449584227|FG002|Study Discontinuation--Treatment Period|Other|0|||
124988752|NCT03149549|449584228|FG003|Study Discontinuation--Treatment Period|Other|0|||
124988753|NCT03149549|449584229|FG004|Study Discontinuation--Treatment Period|Other|0|||
124988754|NCT03149549|449584230|FG005|Study Discontinuation--Treatment Period|Other|0|||
124988755|NCT03149549|449584231|FG006|Study Discontinuation--Treatment Period|Other|0|||
124988756|NCT03149549|449584232|FG007|Study Discontinuation--Treatment Period|Other|1|||
124988757|NCT03149549|449584233|FG008|Study Discontinuation--Treatment Period|Other|0|||
124988758|NCT03149549|449584234|FG009|Study Discontinuation--Treatment Period|Other|1|||
124988759|NCT03149549|449584235|FG010|Study Discontinuation--Treatment Period|Other|0|||
124988760|NCT03149549|449584236|FG011|Study Discontinuation--Treatment Period|Other|0|||
124988761|NCT03149549|449584237|FG012|Study Discontinuation--Treatment Period|Other|0|||
124988762|NCT03149549|449584225|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
124988763|NCT03149549|449584226|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
124988764|NCT03149549|449584227|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
124988765|NCT03149549|449584228|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
125315455|NCT01774799|450784294|FG002|Overall Study|Lost to Follow-up|0|||
125315456|NCT01774799|450784295|FG003|Overall Study|Lost to Follow-up|0|||
125315457|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
125315458|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
125315459|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
125315460|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
125315461|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
125315462|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
125315463|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
125315464|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
125315465|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
125315466|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
125315467|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
125315468|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
125315469|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
125315470|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
125315471|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
124988766|NCT03149549|449584229|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
125315472|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
124988767|NCT03149549|449584230|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
124988768|NCT03149549|449584231|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
125315473|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
125315474|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
125315475|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
125315476|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
125315477|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
125315478|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
125315479|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
125315480|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
125315481|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
125315482|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
125315483|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
125315484|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
125315485|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
125315486|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
125315487|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
125315488|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
125315489|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
125315490|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
125315491|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
125315492|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
125315493|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
125315494|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
125315495|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
125315496|NCT02586623|450784296|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
125315497|NCT02586623|450784297|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
125315498|NCT02586623|450784298|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
125315499|NCT02586623|450784296|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
125315500|NCT02586623|450784297|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
125315501|NCT02586623|450784298|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
125315502|NCT02586623|450784296|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
125315503|NCT02586623|450784297|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
125315504|NCT02586623|450784298|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
125315505|NCT02586623|450784296|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
125315506|NCT02586623|450784297|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
125315507|NCT02586623|450784298|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
125315508|NCT02586623|450784296|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
125315509|NCT02586623|450784297|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
125315510|NCT02586623|450784298|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
125315511|NCT02586623|450784296|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
125315512|NCT02586623|450784297|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
125315513|NCT02586623|450784298|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
125315514|NCT02586623|450784296|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
125315515|NCT02586623|450784297|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
125315516|NCT02586623|450784298|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
125315517|NCT02586623|450784296|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
125315518|NCT02586623|450784297|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
125315519|NCT02586623|450784298|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
125315520|NCT02910466|450784299|FG000|Overall Study|Adverse Event|1|||
125315521|NCT02910466|450784299|FG000|Overall Study|Withdrawal by Subject|3|||
125315522|NCT02910466|450784299|FG000|Overall Study|Lost to Follow-up|5|||
125315523|NCT02910466|450784299|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
125315524|NCT02910466|450784299|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
125315525|NCT01808196|450784306|FG000|Overall Study|Lost to Follow-up|1|||
125315526|NCT00479713|450784307|FG000|Overall Study|Adverse Event|8|||
125315527|NCT00479713|450784308|FG001|Overall Study|Adverse Event|6|||
125315528|NCT00479713|450784307|FG000|Overall Study|Death|1|||
125315529|NCT00479713|450784308|FG001|Overall Study|Death|0|||
125315530|NCT00479713|450784307|FG000|Overall Study|Lost to Follow-up|0|||
125315531|NCT00479713|450784308|FG001|Overall Study|Lost to Follow-up|1|||
125315532|NCT00479713|450784307|FG000|Overall Study|Protocol Violation|0|||
125315533|NCT00479713|450784308|FG001|Overall Study|Protocol Violation|1|||
125315534|NCT00479713|450784307|FG000|Overall Study|Withdrawal by Subject|4|||
125315535|NCT00479713|450784308|FG001|Overall Study|Withdrawal by Subject|1|||
125315536|NCT00141102|450784309|FG000|Overall Study|Adverse Event|233|||
125315537|NCT00141102|450784310|FG001|Overall Study|Adverse Event|305|||
125315538|NCT00141102|450784309|FG000|Overall Study|Laboratory Abnormality|9|||
125315539|NCT00141102|450784310|FG001|Overall Study|Laboratory Abnormality|33|||
125315540|NCT00141102|450784309|FG000|Overall Study|Lack of Efficacy|21|||
125315541|NCT00141102|450784310|FG001|Overall Study|Lack of Efficacy|26|||
125315542|NCT00141102|450784309|FG000|Overall Study|Lost to Follow-up|29|||
125315543|NCT00141102|450784310|FG001|Overall Study|Lost to Follow-up|32|||
125315544|NCT00141102|450784309|FG000|Overall Study|Other|87|||
125315545|NCT00141102|450784310|FG001|Overall Study|Other|76|||
125315546|NCT00141102|450784309|FG000|Overall Study|Withdrawal by Subject|112|||
125315547|NCT00141102|450784310|FG001|Overall Study|Withdrawal by Subject|142|||
125315548|NCT00141102|450784309|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
125315549|NCT00141102|450784310|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
125315550|NCT00141102|450784309|FG000|Overall Study|Death|2|||
125315551|NCT00141102|450784310|FG001|Overall Study|Death|2|||
125315552|NCT01871519|450784315|FG000|Overall Study|Death|26|||
125315553|NCT01871519|450784315|FG000|Overall Study|Lost to Follow-up|15|||
125315554|NCT01871519|450784315|FG000|Overall Study|Withdrawal by Subject|49|||
125315555|NCT00794950|450784316|FG000|BCG Induction|Withdrawal by Subject|2|||
125315556|NCT00794950|450784316|FG000|BCG Induction|ineligible|3|||
125315557|NCT00794950|450784316|FG000|BCG Induction|noncompliant w. BCG|1|||
125315558|NCT00794950|450784316|FG000|BCG Induction|Adverse Event|1|||
125315559|NCT00794950|450784316|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
125315560|NCT00794950|450784316|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
125315561|NCT00794950|450784316|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
125315562|NCT00794950|450784316|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
125315563|NCT02485704|450784317|FG000|Overall Study|Lost to Follow-up|4|||
125315564|NCT02485704|450784318|FG001|Overall Study|Lost to Follow-up|5|||
125315565|NCT02485704|450784317|FG000|Overall Study|Withdrawal by Subject|0|||
125315566|NCT02485704|450784318|FG001|Overall Study|Withdrawal by Subject|3|||
125315567|NCT02485704|450784317|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
125315568|NCT02485704|450784318|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
125315569|NCT04481243|450786042|FG000|Overall Study|Withdrawal by Subject|4|||
125315570|NCT02173769|450786044|FG000|Overall Study|Protocol Violation|4|||
125315571|NCT04388111|450786045|FG000|Overall Study|Lost to Follow-up|5|||
125315572|NCT04388111|450786046|FG001|Overall Study|Lost to Follow-up|3|||
125315573|NCT04388111|450786045|FG000|Overall Study|Adverse Event|1|||
125315574|NCT04388111|450786046|FG001|Overall Study|Adverse Event|1|||
125315575|NCT04388111|450786045|FG000|Overall Study|Protocol Violation|2|||
125315576|NCT04388111|450786046|FG001|Overall Study|Protocol Violation|4|||
125315577|NCT04388111|450786045|FG000|Overall Study|Withdrawal by Subject|1|||
125315578|NCT04388111|450786046|FG001|Overall Study|Withdrawal by Subject|0|||
125315579|NCT00928486|450786047|FG000|Overall Study|Adverse Event|2|||
125315580|NCT00928486|450786047|FG000|Overall Study|Disease Progression|7|||
124988769|NCT03149549|449584232|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
124988770|NCT03149549|449584233|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
125315581|NCT00928486|450786047|FG000|Overall Study|Withdrawal by Subject|1|||
125315582|NCT01342913|450786048|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
125315583|NCT01342913|450786049|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
125315584|NCT01342913|450786050|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
125315585|NCT01342913|450786048|FG000|2-week Run-in Period|Physician Decision|6|||
125315586|NCT01342913|450786049|FG001|2-week Run-in Period|Physician Decision|0|||
125315587|NCT01342913|450786050|FG002|2-week Run-in Period|Physician Decision|0|||
125315588|NCT01342913|450786048|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
125315589|NCT01342913|450786049|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
125315590|NCT01342913|450786050|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
125315591|NCT01342913|450786048|FG000|2-week Run-in Period|Adverse Event|2|||
125315592|NCT01342913|450786049|FG001|2-week Run-in Period|Adverse Event|0|||
125315593|NCT01342913|450786050|FG002|2-week Run-in Period|Adverse Event|0|||
125315594|NCT01342913|450786048|FG000|2-week Run-in Period|Protocol Violation|5|||
125315595|NCT01342913|450786049|FG001|2-week Run-in Period|Protocol Violation|0|||
125315596|NCT01342913|450786050|FG002|2-week Run-in Period|Protocol Violation|0|||
125315597|NCT01342913|450786048|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
125315598|NCT01342913|450786049|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
125315599|NCT01342913|450786050|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
125315600|NCT01342913|450786048|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125315601|NCT01342913|450786049|FG001|Double-Blind Treatment Period|Adverse Event|3|||
125315602|NCT01342913|450786050|FG002|Double-Blind Treatment Period|Adverse Event|6|||
125315603|NCT01342913|450786048|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
125315604|NCT01342913|450786049|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
125315605|NCT01342913|450786050|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
125315606|NCT01342913|450786048|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
125315607|NCT01342913|450786049|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
125315608|NCT01342913|450786050|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
125315609|NCT01342913|450786048|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
125315610|NCT01342913|450786049|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
125315611|NCT01342913|450786050|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
124988771|NCT03149549|449584234|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
125315612|NCT01342913|450786048|FG000|Double-Blind Treatment Period|Physician Decision|0|||
125315613|NCT01342913|450786049|FG001|Double-Blind Treatment Period|Physician Decision|2|||
125315614|NCT01342913|450786050|FG002|Double-Blind Treatment Period|Physician Decision|0|||
125315615|NCT01342913|450786048|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125315616|NCT01342913|450786049|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
125315617|NCT01342913|450786050|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
125315618|NCT00387881|450786055|FG000|Overall Study|Lost to Follow-up|23|||
125315619|NCT00387881|450786056|FG001|Overall Study|Lost to Follow-up|23|||
125315620|NCT00387881|450786055|FG000|Overall Study|Protocol Violation|2|||
125315621|NCT00387881|450786056|FG001|Overall Study|Protocol Violation|12|||
125315622|NCT00387881|450786055|FG000|Overall Study|Withdrawal by Subject|15|||
125315623|NCT00387881|450786056|FG001|Overall Study|Withdrawal by Subject|18|||
125315624|NCT00387881|450786055|FG000|Overall Study|Sponsor terminated Study|0|||
125315625|NCT00387881|450786056|FG001|Overall Study|Sponsor terminated Study|1|||
125315626|NCT00387881|450786055|FG000|Overall Study|Not eligible|6|||
125315627|NCT00387881|450786056|FG001|Overall Study|Not eligible|7|||
125315628|NCT00387881|450786055|FG000|Overall Study|No opportunity to treat headache|32|||
125315629|NCT00387881|450786056|FG001|Overall Study|No opportunity to treat headache|34|||
125315630|NCT00387881|450786055|FG000|Overall Study|Not otherwise specified|11|||
125315631|NCT00387881|450786056|FG001|Overall Study|Not otherwise specified|7|||
125315632|NCT00453154|450786057|FG000|Double BIind Maintenance|Adverse Event|0|||
125315633|NCT00453154|450786058|FG001|Double BIind Maintenance|Adverse Event|0|||
125315634|NCT00453154|450786059|FG002|Double BIind Maintenance|Adverse Event|3|||
125315635|NCT00453154|450786060|FG003|Double BIind Maintenance|Adverse Event|12|||
125315636|NCT00453154|450786057|FG000|Double BIind Maintenance|Death|0|||
125315637|NCT00453154|450786058|FG001|Double BIind Maintenance|Death|0|||
125315638|NCT00453154|450786059|FG002|Double BIind Maintenance|Death|2|||
125315639|NCT00453154|450786060|FG003|Double BIind Maintenance|Death|1|||
125315640|NCT00453154|450786057|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
125315641|NCT00453154|450786058|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
125315642|NCT00453154|450786059|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
125315643|NCT00453154|450786060|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
125315644|NCT00453154|450786057|FG000|Double BIind Maintenance|Progression|0|||
125315645|NCT00453154|450786058|FG001|Double BIind Maintenance|Progression|0|||
125315646|NCT00453154|450786059|FG002|Double BIind Maintenance|Progression|29|||
125315647|NCT00453154|450786060|FG003|Double BIind Maintenance|Progression|26|||
125315648|NCT00453154|450786057|FG000|Double BIind Maintenance|Medical Issues|0|||
125315649|NCT00453154|450786058|FG001|Double BIind Maintenance|Medical Issues|0|||
125315650|NCT00453154|450786059|FG002|Double BIind Maintenance|Medical Issues|3|||
125315651|NCT00453154|450786060|FG003|Double BIind Maintenance|Medical Issues|1|||
125315652|NCT00453154|450786057|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
125315653|NCT00453154|450786058|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
125315654|NCT00453154|450786059|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
125315655|NCT00453154|450786060|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
125315656|NCT01790594|450786061|FG000|Overall Study|Death|1|||
125315657|NCT01790594|450786062|FG001|Overall Study|Death|0|||
125315658|NCT01790594|450786063|FG002|Overall Study|Death|0|||
125315659|NCT01790594|450786061|FG000|Overall Study|Physician Decision|2|||
125315660|NCT01790594|450786062|FG001|Overall Study|Physician Decision|1|||
125315661|NCT01790594|450786063|FG002|Overall Study|Physician Decision|0|||
125315662|NCT01790594|450786061|FG000|Overall Study|Withdrawal by Subject|2|||
125315663|NCT01790594|450786062|FG001|Overall Study|Withdrawal by Subject|0|||
125315664|NCT01790594|450786063|FG002|Overall Study|Withdrawal by Subject|0|||
125315665|NCT01790594|450786061|FG000|Overall Study|Transplant was not done|0|||
125315666|NCT01790594|450786062|FG001|Overall Study|Transplant was not done|0|||
125315667|NCT01790594|450786063|FG002|Overall Study|Transplant was not done|3|||
125315668|NCT01790594|450786061|FG000|Overall Study|Terminated prior to week 76|0|||
125315669|NCT01790594|450786062|FG001|Overall Study|Terminated prior to week 76|2|||
125315670|NCT01790594|450786063|FG002|Overall Study|Terminated prior to week 76|0|||
125315671|NCT03291067|450786065|FG000|Overall Study|Adverse Event|0|||
125315672|NCT03291067|450786066|FG001|Overall Study|Adverse Event|2|||
125315673|NCT03291067|450786067|FG002|Overall Study|Adverse Event|17|||
125315674|NCT03291067|450786068|FG003|Overall Study|Adverse Event|3|||
125315675|NCT03291067|450786065|FG000|Overall Study|Lost to Follow-up|2|||
125315676|NCT03291067|450786066|FG001|Overall Study|Lost to Follow-up|1|||
125315677|NCT03291067|450786067|FG002|Overall Study|Lost to Follow-up|0|||
125315678|NCT03291067|450786068|FG003|Overall Study|Lost to Follow-up|1|||
125315679|NCT03291067|450786065|FG000|Overall Study|Physician Decision|0|||
125315680|NCT03291067|450786066|FG001|Overall Study|Physician Decision|0|||
125315681|NCT03291067|450786067|FG002|Overall Study|Physician Decision|1|||
125315682|NCT03291067|450786068|FG003|Overall Study|Physician Decision|0|||
125315683|NCT03291067|450786065|FG000|Overall Study|Protocol Violation|5|||
125315684|NCT03291067|450786066|FG001|Overall Study|Protocol Violation|3|||
125315685|NCT03291067|450786067|FG002|Overall Study|Protocol Violation|4|||
125315686|NCT03291067|450786068|FG003|Overall Study|Protocol Violation|2|||
125315687|NCT03291067|450786065|FG000|Overall Study|Withdrawal by Subject|3|||
125315688|NCT03291067|450786066|FG001|Overall Study|Withdrawal by Subject|4|||
125315689|NCT03291067|450786067|FG002|Overall Study|Withdrawal by Subject|7|||
125315690|NCT03291067|450786068|FG003|Overall Study|Withdrawal by Subject|5|||
125315691|NCT03291067|450786065|FG000|Overall Study|Other|0|||
125315692|NCT03291067|450786066|FG001|Overall Study|Other|4|||
125315693|NCT03291067|450786067|FG002|Overall Study|Other|4|||
125315694|NCT03291067|450786068|FG003|Overall Study|Other|6|||
125315695|NCT02152631|450786069|FG000|Overall Study|Adverse Event|32|||
125315696|NCT02152631|450786070|FG001|Overall Study|Adverse Event|4|||
125315697|NCT02152631|450786069|FG000|Overall Study|Withdrawal by Subject|13|||
125315698|NCT02152631|450786070|FG001|Overall Study|Withdrawal by Subject|16|||
125315699|NCT02152631|450786069|FG000|Overall Study|Noncompliance with study drug|1|||
125315700|NCT02152631|450786070|FG001|Overall Study|Noncompliance with study drug|0|||
125315701|NCT02152631|450786069|FG000|Overall Study|Physician Decision|1|||
125315702|NCT02152631|450786070|FG001|Overall Study|Physician Decision|2|||
125315703|NCT02152631|450786069|FG000|Overall Study|Lost to Follow-up|0|||
125315704|NCT02152631|450786070|FG001|Overall Study|Lost to Follow-up|1|||
125315705|NCT02152631|450786069|FG000|Overall Study|On Treatment|19|||
125315706|NCT02152631|450786070|FG001|Overall Study|On Treatment|3|||
125315707|NCT05473026|450786071|FG000|Overall Study|Lost to Follow-up|5|||
125315708|NCT05473026|450786072|FG001|Overall Study|Lost to Follow-up|2|||
125315709|NCT03683173|450786083|FG000|Completed Follow-up|Unavailable|235|||
124988772|NCT03149549|449584235|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
124988773|NCT03149549|449584236|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
124988774|NCT03149549|449584237|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
124988775|NCT03149549|449584225|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
124988776|NCT03149549|449584226|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
124988777|NCT03149549|449584227|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
124988778|NCT03149549|449584228|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
124988779|NCT03149549|449584229|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
124988780|NCT03149549|449584230|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
124988781|NCT03149549|449584231|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
124988782|NCT03149549|449584232|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
124988783|NCT03149549|449584233|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
124988784|NCT03149549|449584234|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
124988785|NCT03149549|449584235|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
124988786|NCT03149549|449584236|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
124988787|NCT03149549|449584237|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
124988788|NCT03149549|449584225|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
124988789|NCT03149549|449584226|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
124988790|NCT03149549|449584227|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
124988791|NCT03149549|449584228|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
125315710|NCT03683173|450786084|FG001|Completed Follow-up|Unavailable|217|||
125315711|NCT03683173|450786083|FG000|Completed Follow-up|Refused|69|||
125315712|NCT03683173|450786084|FG001|Completed Follow-up|Refused|59|||
125315713|NCT03683173|450786083|FG000|Completed Follow-up|Disconnected phone|65|||
125315714|NCT03683173|450786084|FG001|Completed Follow-up|Disconnected phone|95|||
125315715|NCT03683173|450786083|FG000|Completed Follow-up|Health issue/deceased|10|||
125315716|NCT03683173|450786084|FG001|Completed Follow-up|Health issue/deceased|4|||
125315717|NCT03683173|450786083|FG000|Completed Follow-up|Moved away|8|||
125315718|NCT03683173|450786084|FG001|Completed Follow-up|Moved away|1|||
125315719|NCT02210000|450786085|FG000|Overall Study|Study Terminated|11|||
125315720|NCT02210000|450786086|FG001|Overall Study|Study Terminated|12|||
125315721|NCT02210000|450786085|FG000|Overall Study|Withdrawal by Subject|7|||
125315722|NCT02210000|450786086|FG001|Overall Study|Withdrawal by Subject|1|||
125315723|NCT02210000|450786085|FG000|Overall Study|Adverse Event|1|||
125315724|NCT02210000|450786086|FG001|Overall Study|Adverse Event|5|||
125315725|NCT02210000|450786085|FG000|Overall Study|Lost to Follow-up|0|||
125315726|NCT02210000|450786086|FG001|Overall Study|Lost to Follow-up|2|||
125315727|NCT02210000|450786085|FG000|Overall Study|Physician Decision|0|||
125315728|NCT02210000|450786086|FG001|Overall Study|Physician Decision|1|||
125315729|NCT01329263|450786089|FG000|Overall Study|Lost to Follow-up|4|||
125315730|NCT01329263|450786090|FG001|Overall Study|Lost to Follow-up|21|||
125315731|NCT01329263|450786089|FG000|Overall Study|Withdrawal by Subject|1|||
124988792|NCT03149549|449584229|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
125315732|NCT01329263|450786090|FG001|Overall Study|Withdrawal by Subject|2|||
125315733|NCT00308139|450786092|FG000|Overall Study|Adverse Event|20|||
125315734|NCT00308139|450786093|FG001|Overall Study|Adverse Event|14|||
125315735|NCT00308139|450786092|FG000|Overall Study|Lost to Follow-up|13|||
125315736|NCT00308139|450786093|FG001|Overall Study|Lost to Follow-up|8|||
125315737|NCT00308139|450786092|FG000|Overall Study|Protocol Violation|3|||
125315738|NCT00308139|450786093|FG001|Overall Study|Protocol Violation|2|||
125315739|NCT00308139|450786092|FG000|Overall Study|Withdrawal of Consent|40|||
124872581|NCT01621880|449155669|FG000|Overall Study|Withdrawal by Subject|5|||
125315740|NCT00308139|450786093|FG001|Overall Study|Withdrawal of Consent|42|||
125315741|NCT00308139|450786092|FG000|Overall Study|Investigator Decision|11|||
125315742|NCT00308139|450786093|FG001|Overall Study|Investigator Decision|10|||
124988793|NCT03149549|449584230|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
124988794|NCT03149549|449584231|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
124988795|NCT03149549|449584232|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
124988796|NCT03149549|449584233|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
124988797|NCT03149549|449584234|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
124988798|NCT03149549|449584235|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
124988799|NCT03149549|449584236|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
124988800|NCT03149549|449584237|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
124988801|NCT03149549|449584225|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
124988802|NCT03149549|449584226|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
124988803|NCT03149549|449584227|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
124988804|NCT03149549|449584228|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
124988805|NCT03149549|449584229|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
124988806|NCT03149549|449584230|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
124988807|NCT03149549|449584231|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
124988808|NCT03149549|449584232|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
124988809|NCT03149549|449584233|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
124988810|NCT03149549|449584234|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
124988811|NCT03149549|449584235|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
124988812|NCT03149549|449584236|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
124988813|NCT03149549|449584237|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
124988814|NCT03149549|449584225|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
124988815|NCT03149549|449584226|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
124988816|NCT03149549|449584227|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
124988817|NCT03149549|449584228|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
124988818|NCT03149549|449584229|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
124988819|NCT03149549|449584230|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
124988820|NCT03149549|449584231|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
124988821|NCT03149549|449584232|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
124988822|NCT03149549|449584233|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
124988823|NCT03149549|449584234|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
124988824|NCT03149549|449584235|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
124988825|NCT03149549|449584236|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
124988826|NCT03149549|449584237|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
124988827|NCT01034176|449586024|FG000|Overall Study|Physician Decision|2|||
124988828|NCT01034176|449586025|FG001|Overall Study|Physician Decision|0|||
124988829|NCT01034176|449586024|FG000|Overall Study|Withdrawal by Subject|0|||
124988830|NCT01034176|449586025|FG001|Overall Study|Withdrawal by Subject|1|||
124988831|NCT01034176|449586024|FG000|Overall Study|Lost to Follow-up|0|||
124988832|NCT01034176|449586025|FG001|Overall Study|Lost to Follow-up|1|||
124988833|NCT03207009|449586028|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
124988834|NCT04343872|449586029|FG000|Overall Study|Lost to Follow-up|6|||
124988835|NCT04343872|449586030|FG001|Overall Study|Lost to Follow-up|3|||
124988836|NCT03241225|449586033|FG000|Overall Study|Lost to Follow-up|2|||
124988837|NCT03241225|449586034|FG001|Overall Study|Lost to Follow-up|1|||
124988838|NCT03241225|449586033|FG000|Overall Study|Protocol Violation|4|||
124988839|NCT03241225|449586034|FG001|Overall Study|Protocol Violation|1|||
124988840|NCT03241225|449586033|FG000|Overall Study|Withdrawal by Subject|1|||
124988841|NCT03241225|449586034|FG001|Overall Study|Withdrawal by Subject|0|||
124988842|NCT01635920|449586037|FG000|Overall Study|Adverse Event|1|||
124988843|NCT01635920|449586038|FG001|Overall Study|Adverse Event|0|||
124988844|NCT01635920|449586037|FG000|Overall Study|Lost to Follow-up|0|||
124988845|NCT01635920|449586038|FG001|Overall Study|Lost to Follow-up|1|||
124988846|NCT01635920|449586037|FG000|Overall Study|Subject decision|2|||
124988847|NCT01635920|449586038|FG001|Overall Study|Subject decision|0|||
124988848|NCT00007345|449586039|FG000|Overall Study|Refused further treatment|0|||
124988849|NCT00007345|449586040|FG001|Overall Study|Refused further treatment|7|||
124988850|NCT00007345|449586039|FG000|Overall Study|Switched to alternative treatment|0|||
124988851|NCT00007345|449586040|FG001|Overall Study|Switched to alternative treatment|3|||
125315743|NCT00308139|450786092|FG000|Overall Study|Loss of Glucose Control|5|||
125315744|NCT00308139|450786093|FG001|Overall Study|Loss of Glucose Control|7|||
125315745|NCT00308139|450786092|FG000|Overall Study|Administrative|1|||
125315746|NCT00308139|450786093|FG001|Overall Study|Administrative|4|||
125315747|NCT00308139|450786092|FG000|Overall Study|Other|1|||
124988852|NCT00007345|449586039|FG000|Overall Study|Intercurrent illness|1|||
124988853|NCT00007345|449586040|FG001|Overall Study|Intercurrent illness|0|||
124988854|NCT00007345|449586039|FG000|Overall Study|Death on study|1|||
124988855|NCT00007345|449586040|FG001|Overall Study|Death on study|1|||
124988856|NCT02074553|449586041|FG000|Intervention Period 1|Family Emergency|0|||
125315748|NCT00308139|450786093|FG001|Overall Study|Other|0|||
125315749|NCT00833040|450786096|FG000|Overall Study|Adverse Event|0|||
125315750|NCT00833040|450786097|FG001|Overall Study|Adverse Event|0|||
125315751|NCT00833040|450786098|FG002|Overall Study|Adverse Event|0|||
125315752|NCT00833040|450786099|FG003|Overall Study|Adverse Event|0|||
125315753|NCT00833040|450786100|FG004|Overall Study|Adverse Event|0|||
125315754|NCT00833040|450786101|FG005|Overall Study|Adverse Event|1|||
125315755|NCT02313766|450786102|FG000|Overall Study|surgery cancelled|1|||
124988857|NCT02074553|449586042|FG001|Intervention Period 1|Family Emergency|0|||
124988858|NCT02074553|449586043|FG002|Intervention Period 1|Family Emergency|0|||
124988859|NCT02074553|449586044|FG003|Intervention Period 1|Family Emergency|1|||
124988860|NCT02074553|449586045|FG004|Intervention Period 1|Family Emergency|0|||
124988861|NCT02074553|449586046|FG005|Intervention Period 1|Family Emergency|0|||
124988862|NCT02074553|449586047|FG006|Intervention Period 1|Family Emergency|0|||
124988863|NCT02074553|449586048|FG007|Intervention Period 1|Family Emergency|0|||
124988864|NCT02074553|449586041|FG000|Washout Period 1|Adverse Event|1|||
124988865|NCT02074553|449586042|FG001|Washout Period 1|Adverse Event|0|||
124988866|NCT02074553|449586043|FG002|Washout Period 1|Adverse Event|0|||
124988867|NCT02074553|449586044|FG003|Washout Period 1|Adverse Event|0|||
124988868|NCT02074553|449586045|FG004|Washout Period 1|Adverse Event|0|||
124988869|NCT02074553|449586046|FG005|Washout Period 1|Adverse Event|0|||
124988870|NCT02074553|449586047|FG006|Washout Period 1|Adverse Event|0|||
124988871|NCT02074553|449586048|FG007|Washout Period 1|Adverse Event|0|||
124988872|NCT02074553|449586041|FG000|Washout Period 1|Physician Decision|0|||
124988873|NCT02074553|449586042|FG001|Washout Period 1|Physician Decision|0|||
124988874|NCT02074553|449586043|FG002|Washout Period 1|Physician Decision|0|||
124988875|NCT02074553|449586044|FG003|Washout Period 1|Physician Decision|1|||
124988876|NCT02074553|449586045|FG004|Washout Period 1|Physician Decision|0|||
124988877|NCT02074553|449586046|FG005|Washout Period 1|Physician Decision|0|||
124988878|NCT02074553|449586047|FG006|Washout Period 1|Physician Decision|0|||
124988879|NCT02074553|449586048|FG007|Washout Period 1|Physician Decision|0|||
124988880|NCT02074553|449586041|FG000|Washout Period 1|Other|0|||
124988881|NCT02074553|449586042|FG001|Washout Period 1|Other|0|||
124988882|NCT02074553|449586043|FG002|Washout Period 1|Other|0|||
124988883|NCT02074553|449586044|FG003|Washout Period 1|Other|0|||
124988884|NCT02074553|449586045|FG004|Washout Period 1|Other|0|||
124988885|NCT02074553|449586046|FG005|Washout Period 1|Other|1|||
124988886|NCT02074553|449586047|FG006|Washout Period 1|Other|0|||
124988887|NCT02074553|449586048|FG007|Washout Period 1|Other|0|||
124988888|NCT02074553|449586041|FG000|Washout Period 2|Adverse Event|0|||
124988889|NCT02074553|449586042|FG001|Washout Period 2|Adverse Event|0|||
124988890|NCT02074553|449586043|FG002|Washout Period 2|Adverse Event|0|||
124988891|NCT02074553|449586044|FG003|Washout Period 2|Adverse Event|0|||
124988892|NCT02074553|449586045|FG004|Washout Period 2|Adverse Event|0|||
124988893|NCT02074553|449586046|FG005|Washout Period 2|Adverse Event|0|||
124988894|NCT02074553|449586047|FG006|Washout Period 2|Adverse Event|1|||
124988895|NCT02074553|449586048|FG007|Washout Period 2|Adverse Event|0|||
124988896|NCT02074553|449586041|FG000|Washout Period 2|Physician Decision|0|||
125315756|NCT02313766|450786103|FG001|Overall Study|surgery cancelled|0|||
125315757|NCT02313766|450786104|FG002|Overall Study|surgery cancelled|0|||
124988897|NCT02074553|449586042|FG001|Washout Period 2|Physician Decision|0|||
124988898|NCT02074553|449586043|FG002|Washout Period 2|Physician Decision|0|||
124988899|NCT02074553|449586044|FG003|Washout Period 2|Physician Decision|0|||
124988900|NCT02074553|449586045|FG004|Washout Period 2|Physician Decision|0|||
124988901|NCT02074553|449586046|FG005|Washout Period 2|Physician Decision|1|||
124988902|NCT02074553|449586047|FG006|Washout Period 2|Physician Decision|0|||
124988903|NCT02074553|449586048|FG007|Washout Period 2|Physician Decision|0|||
124988904|NCT02074553|449586041|FG000|Washout Period 2|Lost to Follow-up|0|||
125315758|NCT02313766|450786102|FG000|Overall Study|Lost to Follow-up|0|||
125315759|NCT02313766|450786103|FG001|Overall Study|Lost to Follow-up|2|||
125315760|NCT02313766|450786104|FG002|Overall Study|Lost to Follow-up|0|||
125315761|NCT02313766|450786102|FG000|Overall Study|Adverse Event|0|||
125315762|NCT02313766|450786103|FG001|Overall Study|Adverse Event|1|||
125315763|NCT02313766|450786104|FG002|Overall Study|Adverse Event|0|||
124988905|NCT02074553|449586042|FG001|Washout Period 2|Lost to Follow-up|0|||
125315764|NCT02193776|450786106|FG000|Overall Study|Consent withdrawn|1|||
125315765|NCT02193776|450786107|FG001|Overall Study|Consent withdrawn|0|||
125315766|NCT02193776|450786108|FG002|Overall Study|Consent withdrawn|0|||
125315767|NCT02193776|450786109|FG003|Overall Study|Consent withdrawn|0|||
124872582|NCT01621880|449155670|FG001|Overall Study|Withdrawal by Subject|4|||
124988906|NCT02074553|449586043|FG002|Washout Period 2|Lost to Follow-up|1|||
124988907|NCT02074553|449586044|FG003|Washout Period 2|Lost to Follow-up|0|||
124988908|NCT02074553|449586045|FG004|Washout Period 2|Lost to Follow-up|0|||
124988909|NCT02074553|449586046|FG005|Washout Period 2|Lost to Follow-up|0|||
124988910|NCT02074553|449586047|FG006|Washout Period 2|Lost to Follow-up|0|||
124988911|NCT02074553|449586048|FG007|Washout Period 2|Lost to Follow-up|0|||
124988912|NCT02074553|449586041|FG000|Washout Period 3|Physician Decision|0|||
124988913|NCT02074553|449586042|FG001|Washout Period 3|Physician Decision|0|||
124988914|NCT02074553|449586043|FG002|Washout Period 3|Physician Decision|0|||
124988915|NCT02074553|449586044|FG003|Washout Period 3|Physician Decision|0|||
125315768|NCT02193776|450786106|FG000|Overall Study|Failure to comply with protocol|0|||
125315769|NCT02193776|450786107|FG001|Overall Study|Failure to comply with protocol|1|||
125315770|NCT02193776|450786108|FG002|Overall Study|Failure to comply with protocol|0|||
125315771|NCT02193776|450786109|FG003|Overall Study|Failure to comply with protocol|0|||
125315772|NCT02193776|450786106|FG000|Overall Study|Investigator/Sponsor decision|1|||
125315773|NCT02193776|450786107|FG001|Overall Study|Investigator/Sponsor decision|1|||
125315774|NCT02193776|450786108|FG002|Overall Study|Investigator/Sponsor decision|0|||
125315775|NCT02193776|450786109|FG003|Overall Study|Investigator/Sponsor decision|0|||
125315776|NCT02193776|450786106|FG000|Overall Study|Death|1|||
125315777|NCT02193776|450786107|FG001|Overall Study|Death|0|||
125315778|NCT02193776|450786108|FG002|Overall Study|Death|0|||
125315779|NCT02193776|450786109|FG003|Overall Study|Death|0|||
125315780|NCT02193776|450786106|FG000|Overall Study|Adverse event/Specific toxicity|5|||
125315781|NCT02193776|450786107|FG001|Overall Study|Adverse event/Specific toxicity|5|||
125315782|NCT02193776|450786108|FG002|Overall Study|Adverse event/Specific toxicity|2|||
125315783|NCT02193776|450786109|FG003|Overall Study|Adverse event/Specific toxicity|2|||
125315784|NCT01458639|450786110|FG000|Overall Study|Physician Decision|4|||
125315785|NCT01458639|450786110|FG000|Overall Study|Equipment issue|1|||
125315786|NCT01458639|450786110|FG000|Overall Study|Inability to obtain subject blood sample|1|||
125315787|NCT01884077|450786111|FG000|Overall Study|screen fail|0|||
125315788|NCT01884077|450786112|FG001|Overall Study|screen fail|2|||
125315789|NCT01884077|450786111|FG000|Overall Study|canceled surgery|2|||
125315790|NCT01884077|450786112|FG001|Overall Study|canceled surgery|0|||
125315791|NCT01884077|450786111|FG000|Overall Study|Lost to Follow-up|0|||
125315792|NCT01884077|450786112|FG001|Overall Study|Lost to Follow-up|4|||
124988916|NCT02074553|449586045|FG004|Washout Period 3|Physician Decision|0|||
124988917|NCT02074553|449586046|FG005|Washout Period 3|Physician Decision|0|||
124988918|NCT02074553|449586047|FG006|Washout Period 3|Physician Decision|0|||
124988919|NCT02074553|449586048|FG007|Washout Period 3|Physician Decision|1|||
124988920|NCT00194987|449586049|FG000|Overall Study|Withdrawal by Subject|0|||
124988921|NCT00194987|449586050|FG001|Overall Study|Withdrawal by Subject|3|||
124988922|NCT01664598|449586051|FG000|Overall Study|Sponsor Decision|1|||
124988923|NCT01664598|449586051|FG000|Overall Study|Withdrawal of Informed Consent|4|||
124988924|NCT01664598|449586051|FG000|Overall Study|Adverse Event|1|||
124988925|NCT01658150|449586052|FG000|Overall Study|Withdrawal by Subject|1|||
124988926|NCT02342743|449586053|FG000|Baseline Period|Withdrawal by Subject|3|||
124988927|NCT02342743|449586053|FG000|Baseline Period|Lost to Follow-up|2|||
124988928|NCT02342743|449586053|FG000|Baseline Period|Change in prophylactic medication|3|||
124988929|NCT02342743|449586053|FG000|Baseline Period|Screening failure regarding baseline|7|||
124988930|NCT02342743|449586053|FG000|Treatment Period|Withdrawal by Subject|2|||
124988931|NCT02342743|449586053|FG000|Treatment Period|Lost to Follow-up|8|||
124988932|NCT02342743|449586053|FG000|Treatment Period|Change in prophylactic medication|1|||
124988933|NCT04875676|449586054|FG000|Overall Study|Lost to Follow-up|1|||
124988934|NCT04875676|449586055|FG001|Overall Study|Lost to Follow-up|0|||
124988935|NCT04875676|449586056|FG002|Overall Study|Lost to Follow-up|0|||
124988936|NCT04187989|449586057|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
124988937|NCT04187989|449586058|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
124988938|NCT04187989|449586057|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
124988939|NCT04187989|449586058|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
124988940|NCT03646656|449586059|FG000|Overall Study|Lost to Follow-up|1|||
124988941|NCT03646656|449586060|FG001|Overall Study|Lost to Follow-up|0|||
124988942|NCT03646656|449586059|FG000|Overall Study|Withdrawal by Subject|2|||
124988943|NCT03646656|449586060|FG001|Overall Study|Withdrawal by Subject|0|||
124988944|NCT03602066|449586061|FG000|Overall Study|Withdrawal by Subject|2|||
124988945|NCT03602066|449586062|FG001|Overall Study|Withdrawal by Subject|0|||
124988946|NCT03602066|449586061|FG000|Overall Study|Physician Decision|1|||
124988947|NCT03602066|449586062|FG001|Overall Study|Physician Decision|0|||
124988948|NCT00092495|449586063|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
124988949|NCT00092495|449586064|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
124988950|NCT00092495|449586065|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
124988951|NCT00092495|449586066|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
124988952|NCT00092495|449586067|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
124988953|NCT00092495|449586063|FG000|Base Study Vaccination Period|Extended|0|||
124988954|NCT00092495|449586064|FG001|Base Study Vaccination Period|Extended|0|||
124988955|NCT00092495|449586065|FG002|Base Study Vaccination Period|Extended|0|||
124988956|NCT00092495|449586066|FG003|Base Study Vaccination Period|Extended|1|||
125315793|NCT01884077|450786111|FG000|Overall Study|study closed|6|||
125315794|NCT01884077|450786112|FG001|Overall Study|study closed|4|||
124988957|NCT00092495|449586067|FG004|Base Study Vaccination Period|Extended|0|||
124988958|NCT00092495|449586063|FG000|Base Study Vaccination Period|*Clinical AE|1|||
124988959|NCT00092495|449586064|FG001|Base Study Vaccination Period|*Clinical AE|0|||
124988960|NCT00092495|449586065|FG002|Base Study Vaccination Period|*Clinical AE|1|||
124988961|NCT00092495|449586066|FG003|Base Study Vaccination Period|*Clinical AE|2|||
124988962|NCT00092495|449586067|FG004|Base Study Vaccination Period|*Clinical AE|0|||
125315795|NCT01755234|450786113|FG000|Overall Study|Lost to Follow-up|11|||
125315796|NCT01755234|450786114|FG001|Overall Study|Lost to Follow-up|6|||
125315797|NCT01755234|450786113|FG000|Overall Study|Change in surgical case|2|||
125315798|NCT01755234|450786114|FG001|Overall Study|Change in surgical case|1|||
125315799|NCT01755234|450786113|FG000|Overall Study|case cancelled|1|||
125315800|NCT01755234|450786114|FG001|Overall Study|case cancelled|0|||
125315801|NCT01755234|450786113|FG000|Overall Study|Withdrawal by Subject|0|||
125315802|NCT01755234|450786114|FG001|Overall Study|Withdrawal by Subject|1|||
125315803|NCT01755234|450786113|FG000|Overall Study|unblinded|1|||
125315804|NCT01755234|450786114|FG001|Overall Study|unblinded|0|||
125315805|NCT00981149|450786115|FG000|Overall Study|Lost to Follow-up|1|||
125315806|NCT00981149|450786116|FG001|Overall Study|Lost to Follow-up|2|||
125315807|NCT00981149|450786115|FG000|Overall Study|Withdrawal by Subject|1|||
125315808|NCT00981149|450786116|FG001|Overall Study|Withdrawal by Subject|1|||
125315809|NCT02648204|450786117|FG000|Overall Study|Withdrawal by Subject|12|||
125315810|NCT02648204|450786118|FG001|Overall Study|Withdrawal by Subject|8|||
125315811|NCT02648204|450786119|FG002|Overall Study|Withdrawal by Subject|2|||
125315812|NCT02648204|450786120|FG003|Overall Study|Withdrawal by Subject|6|||
125315813|NCT02648204|450786117|FG000|Overall Study|Lost to Follow-up|5|||
125315814|NCT02648204|450786118|FG001|Overall Study|Lost to Follow-up|8|||
125315815|NCT02648204|450786119|FG002|Overall Study|Lost to Follow-up|4|||
125315816|NCT02648204|450786120|FG003|Overall Study|Lost to Follow-up|6|||
125315817|NCT02648204|450786117|FG000|Overall Study|Missing follow-up information|4|||
125315818|NCT02648204|450786118|FG001|Overall Study|Missing follow-up information|4|||
124988963|NCT00092495|449586063|FG000|Base Study Vaccination Period|*Other reasons|1|||
124988964|NCT00092495|449586064|FG001|Base Study Vaccination Period|*Other reasons|0|||
124988965|NCT00092495|449586065|FG002|Base Study Vaccination Period|*Other reasons|0|||
124988966|NCT00092495|449586066|FG003|Base Study Vaccination Period|*Other reasons|1|||
124988967|NCT00092495|449586067|FG004|Base Study Vaccination Period|*Other reasons|0|||
124988968|NCT00092495|449586063|FG000|Base Study Vaccination Period|*Pregnancy|0|||
124988969|NCT00092495|449586064|FG001|Base Study Vaccination Period|*Pregnancy|2|||
124988970|NCT00092495|449586065|FG002|Base Study Vaccination Period|*Pregnancy|5|||
124988971|NCT00092495|449586066|FG003|Base Study Vaccination Period|*Pregnancy|7|||
124988972|NCT00092495|449586067|FG004|Base Study Vaccination Period|*Pregnancy|0|||
124988973|NCT00092495|449586063|FG000|Base Study Vaccination Period|Adverse Event|1|||
124988974|NCT00092495|449586064|FG001|Base Study Vaccination Period|Adverse Event|0|||
124988975|NCT00092495|449586065|FG002|Base Study Vaccination Period|Adverse Event|0|||
124988976|NCT00092495|449586066|FG003|Base Study Vaccination Period|Adverse Event|3|||
124988977|NCT00092495|449586067|FG004|Base Study Vaccination Period|Adverse Event|0|||
124988978|NCT00092495|449586063|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
124988979|NCT00092495|449586064|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
124988980|NCT00092495|449586065|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
124988981|NCT00092495|449586066|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
124988982|NCT00092495|449586067|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
124988983|NCT00092495|449586063|FG000|Base Study Vaccination Period|Moved|3|||
124988984|NCT00092495|449586064|FG001|Base Study Vaccination Period|Moved|1|||
124988985|NCT00092495|449586065|FG002|Base Study Vaccination Period|Moved|2|||
124988986|NCT00092495|449586066|FG003|Base Study Vaccination Period|Moved|2|||
124988987|NCT00092495|449586067|FG004|Base Study Vaccination Period|Moved|0|||
124988988|NCT00092495|449586063|FG000|Base Study Vaccination Period|Other|1|||
124988989|NCT00092495|449586064|FG001|Base Study Vaccination Period|Other|1|||
124988990|NCT00092495|449586065|FG002|Base Study Vaccination Period|Other|0|||
124988991|NCT00092495|449586066|FG003|Base Study Vaccination Period|Other|2|||
124988992|NCT00092495|449586067|FG004|Base Study Vaccination Period|Other|0|||
124988993|NCT00092495|449586063|FG000|Base Study Vaccination Period|Pregnancy|2|||
124988994|NCT00092495|449586064|FG001|Base Study Vaccination Period|Pregnancy|0|||
124988995|NCT00092495|449586065|FG002|Base Study Vaccination Period|Pregnancy|0|||
124988996|NCT00092495|449586066|FG003|Base Study Vaccination Period|Pregnancy|0|||
124988997|NCT00092495|449586067|FG004|Base Study Vaccination Period|Pregnancy|0|||
124988998|NCT00092495|449586063|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
124988999|NCT00092495|449586064|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
124989000|NCT00092495|449586065|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
124989001|NCT00092495|449586066|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
124989002|NCT00092495|449586067|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
124989003|NCT00092495|449586063|FG000|Base Study Vaccination Period|Protocol Violation|1|||
125315819|NCT02648204|450786119|FG002|Overall Study|Missing follow-up information|4|||
124989004|NCT00092495|449586064|FG001|Base Study Vaccination Period|Protocol Violation|0|||
124989005|NCT00092495|449586065|FG002|Base Study Vaccination Period|Protocol Violation|0|||
124989006|NCT00092495|449586066|FG003|Base Study Vaccination Period|Protocol Violation|0|||
124989007|NCT00092495|449586067|FG004|Base Study Vaccination Period|Protocol Violation|0|||
124989008|NCT00092495|449586063|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
125315820|NCT02648204|450786120|FG003|Overall Study|Missing follow-up information|2|||
125315821|NCT02648204|450786117|FG000|Overall Study|Death|1|||
125315822|NCT02648204|450786118|FG001|Overall Study|Death|1|||
125315823|NCT02648204|450786119|FG002|Overall Study|Death|2|||
124989009|NCT00092495|449586064|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
124989010|NCT00092495|449586065|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
124989011|NCT00092495|449586066|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
124989012|NCT00092495|449586067|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
124989013|NCT00092495|449586063|FG000|Base Study Follow-up Period|Extended|0|||
124989014|NCT00092495|449586064|FG001|Base Study Follow-up Period|Extended|0|||
124989015|NCT00092495|449586065|FG002|Base Study Follow-up Period|Extended|1|||
124989016|NCT00092495|449586066|FG003|Base Study Follow-up Period|Extended|2|||
124989017|NCT00092495|449586067|FG004|Base Study Follow-up Period|Extended|0|||
124989018|NCT00092495|449586063|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
124989019|NCT00092495|449586064|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
124989020|NCT00092495|449586065|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
124989021|NCT00092495|449586066|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
124989022|NCT00092495|449586067|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
124989023|NCT00092495|449586063|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
124989024|NCT00092495|449586064|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
124989025|NCT00092495|449586065|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
124989026|NCT00092495|449586066|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
124989027|NCT00092495|449586067|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
124989028|NCT00938470|449586072|FG000|Overall Study|Disease Progression|3|||
124989029|NCT00938470|449586073|FG001|Overall Study|Disease Progression|0|||
124989030|NCT00938470|449586072|FG000|Overall Study|Alternate Treatment|1|||
124989031|NCT00938470|449586073|FG001|Overall Study|Alternate Treatment|0|||
124989032|NCT00938470|449586072|FG000|Overall Study|Death|3|||
124989033|NCT00938470|449586073|FG001|Overall Study|Death|2|||
124989034|NCT00938470|449586072|FG000|Overall Study|Other Reason|0|||
124989035|NCT00938470|449586073|FG001|Overall Study|Other Reason|1|||
124989036|NCT04279392|449586077|FG000|Overall Study|Physician Decision|1|||
124989037|NCT04279392|449586078|FG001|Overall Study|Physician Decision|0|||
124989038|NCT01171807|449586079|FG000|Overall Study|Treatment failure|2|||
124989039|NCT01171807|449586080|FG001|Overall Study|Treatment failure|4|||
124989040|NCT01171807|449586079|FG000|Overall Study|Non compliance|1|||
124989041|NCT01171807|449586080|FG001|Overall Study|Non compliance|0|||
124989042|NCT01171807|449586079|FG000|Overall Study|Lost to Follow-up|3|||
124989043|NCT01171807|449586080|FG001|Overall Study|Lost to Follow-up|0|||
124989044|NCT04289051|449586085|FG000|Overall Study|Lost to Follow-up|0|||
124989045|NCT04289051|449586086|FG001|Overall Study|Lost to Follow-up|0|||
124989046|NCT04289051|449586087|FG002|Overall Study|Lost to Follow-up|2|||
124989047|NCT01901341|449586088|FG000|Overall Study|Adverse Event|4|||
124989048|NCT01901341|449586089|FG001|Overall Study|Adverse Event|2|||
124989049|NCT01901341|449586088|FG000|Overall Study|Lack of Efficacy|0|||
124989050|NCT01901341|449586089|FG001|Overall Study|Lack of Efficacy|2|||
124989051|NCT01901341|449586088|FG000|Overall Study|Lost to Follow-up|0|||
124989052|NCT01901341|449586089|FG001|Overall Study|Lost to Follow-up|1|||
124989053|NCT01901341|449586088|FG000|Overall Study|Protocol Violation|2|||
124989054|NCT01901341|449586089|FG001|Overall Study|Protocol Violation|0|||
124989055|NCT01901341|449586088|FG000|Overall Study|Study Terminated by Sponsor|13|||
124989056|NCT01901341|449586089|FG001|Overall Study|Study Terminated by Sponsor|15|||
124989057|NCT01901341|449586088|FG000|Overall Study|Withdrawal by Subject|1|||
124989058|NCT01901341|449586089|FG001|Overall Study|Withdrawal by Subject|1|||
124989059|NCT00822172|449586093|FG000|Overall Study|Adverse Event|10|||
124989060|NCT00822172|449586094|FG001|Overall Study|Adverse Event|12|||
124989061|NCT00822172|449586093|FG000|Overall Study|Death|1|||
124989062|NCT00822172|449586094|FG001|Overall Study|Death|0|||
124989063|NCT00822172|449586093|FG000|Overall Study|Lost to Follow-up|3|||
124989064|NCT00822172|449586094|FG001|Overall Study|Lost to Follow-up|1|||
124989065|NCT00822172|449586093|FG000|Overall Study|Withdrawal by Subject|1|||
125315824|NCT02648204|450786120|FG003|Overall Study|Death|2|||
125315825|NCT02648204|450786117|FG000|Overall Study|Adverse Event|0|||
125315826|NCT02648204|450786118|FG001|Overall Study|Adverse Event|0|||
125315827|NCT02648204|450786119|FG002|Overall Study|Adverse Event|1|||
125315828|NCT02648204|450786120|FG003|Overall Study|Adverse Event|0|||
125315829|NCT02634333|450786121|FG000|Overall Study|Completed out of Window|3|||
125315830|NCT02634333|450786122|FG001|Overall Study|Completed out of Window|2|||
125315831|NCT02634333|450786121|FG000|Overall Study|Missed Visit|5|||
124989066|NCT00822172|449586094|FG001|Overall Study|Withdrawal by Subject|4|||
124989067|NCT00822172|449586093|FG000|Overall Study|site closed|0|||
124989068|NCT00822172|449586094|FG001|Overall Study|site closed|1|||
124989069|NCT00822172|449586093|FG000|Overall Study|Other|0|||
124989070|NCT00822172|449586094|FG001|Overall Study|Other|1|||
124989071|NCT01981473|449586095|FG000|Overall Study|Incorrect diagnosis of RA|0|||
124989072|NCT01981473|449586096|FG001|Overall Study|Incorrect diagnosis of RA|0|||
124989073|NCT01981473|449586097|FG002|Overall Study|Incorrect diagnosis of RA|1|||
124989074|NCT01981473|449586095|FG000|Overall Study|Received treatment for < 6 months|0|||
124989075|NCT01981473|449586096|FG001|Overall Study|Received treatment for < 6 months|0|||
124989076|NCT01981473|449586097|FG002|Overall Study|Received treatment for < 6 months|1|||
125315832|NCT02634333|450786122|FG001|Overall Study|Missed Visit|2|||
125315833|NCT02634333|450786121|FG000|Overall Study|Lost to Follow-up|12|||
124989077|NCT01981473|449586095|FG000|Overall Study|Received treatment for >24 months|2|||
124989078|NCT01981473|449586096|FG001|Overall Study|Received treatment for >24 months|0|||
124989079|NCT01981473|449586097|FG002|Overall Study|Received treatment for >24 months|6|||
124989080|NCT02937454|449586099|FG000|Overall Study|Adverse Event|0|||
124989081|NCT02937454|449586100|FG001|Overall Study|Adverse Event|1|||
124989082|NCT02937454|449586099|FG000|Overall Study|Death|98|||
124989083|NCT02937454|449586100|FG001|Overall Study|Death|95|||
124989084|NCT02937454|449586099|FG000|Overall Study|Lost to Follow-up|1|||
124989085|NCT02937454|449586100|FG001|Overall Study|Lost to Follow-up|1|||
124989086|NCT02937454|449586099|FG000|Overall Study|Physician Decision|0|||
124989087|NCT02937454|449586100|FG001|Overall Study|Physician Decision|1|||
124989088|NCT02937454|449586099|FG000|Overall Study|Protocol Violation|6|||
124989089|NCT02937454|449586100|FG001|Overall Study|Protocol Violation|10|||
124989090|NCT02937454|449586099|FG000|Overall Study|Withdrawal by Subject|27|||
124989091|NCT02937454|449586100|FG001|Overall Study|Withdrawal by Subject|15|||
124989092|NCT02937454|449586099|FG000|Overall Study|Other|8|||
124989093|NCT02937454|449586100|FG001|Overall Study|Other|5|||
124989094|NCT01888900|449586106|FG000|Overall Study|failed treatment|0|||
124989095|NCT01888900|449586107|FG001|Overall Study|failed treatment|2|||
124989096|NCT03932812|449586108|FG000|Overall Study|Lost to Follow-up|12|||
124989097|NCT03932812|449586109|FG001|Overall Study|Lost to Follow-up|14|||
124989098|NCT03932812|449586108|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
124989099|NCT03932812|449586109|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
124989100|NCT02585232|449586113|FG000|Overall Study|Lost to Follow-up|8|||
124989101|NCT02585232|449586114|FG001|Overall Study|Lost to Follow-up|8|||
124989102|NCT02585232|449586113|FG000|Overall Study|Withdrawal by Subject|4|||
124989103|NCT02585232|449586114|FG001|Overall Study|Withdrawal by Subject|8|||
124989104|NCT02257567|449586115|FG000|Overall Study|Adverse Event|0|||
124989105|NCT02257567|449586116|FG001|Overall Study|Adverse Event|0|||
124989106|NCT02257567|449586117|FG002|Overall Study|Adverse Event|0|||
124989107|NCT02257567|449586118|FG003|Overall Study|Adverse Event|1|||
124989108|NCT02257567|449586119|FG004|Overall Study|Adverse Event|1|||
124989109|NCT02257567|449586120|FG005|Overall Study|Adverse Event|0|||
124989110|NCT02257567|449586121|FG006|Overall Study|Adverse Event|0|||
124989111|NCT02257567|449586122|FG007|Overall Study|Adverse Event|0|||
124989112|NCT02257567|449586123|FG008|Overall Study|Adverse Event|1|||
124989113|NCT02257567|449586124|FG009|Overall Study|Adverse Event|0|||
124989114|NCT02257567|449586125|FG010|Overall Study|Adverse Event|0|||
124989115|NCT02257567|449586115|FG000|Overall Study|Death|2|||
124989116|NCT02257567|449586116|FG001|Overall Study|Death|2|||
124989117|NCT02257567|449586117|FG002|Overall Study|Death|2|||
124989118|NCT02257567|449586118|FG003|Overall Study|Death|4|||
124989119|NCT02257567|449586119|FG004|Overall Study|Death|15|||
125315834|NCT02634333|450786122|FG001|Overall Study|Lost to Follow-up|7|||
125315835|NCT02634333|450786121|FG000|Overall Study|Withdrawal by Subject|9|||
125315836|NCT02634333|450786122|FG001|Overall Study|Withdrawal by Subject|13|||
125315837|NCT02634333|450786121|FG000|Overall Study|Death|11|||
125315838|NCT02634333|450786122|FG001|Overall Study|Death|8|||
125315839|NCT01794000|450786123|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
125315840|NCT01794000|450786124|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
125315841|NCT01794000|450786123|FG000|Double-Blind Phase (DBP)|Death|1|||
125315842|NCT01794000|450786124|FG001|Double-Blind Phase (DBP)|Death|2|||
125315843|NCT01794000|450786123|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
125315844|NCT01794000|450786124|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
125315845|NCT01794000|450786123|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
125315846|NCT01794000|450786124|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
125315847|NCT01794000|450786123|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
125315848|NCT01794000|450786124|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
125315849|NCT01794000|450786123|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
125315850|NCT01794000|450786124|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
125315851|NCT01794000|450786123|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
125315852|NCT01794000|450786124|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
125315853|NCT01794000|450786123|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
125315854|NCT01794000|450786124|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
124989120|NCT02257567|449586120|FG005|Overall Study|Death|11|||
124989121|NCT02257567|449586121|FG006|Overall Study|Death|26|||
124872583|NCT01127646|449155671|FG000|Overall Study|Entry Criteria Not Met|1|||
124989122|NCT02257567|449586122|FG007|Overall Study|Death|30|||
124989123|NCT02257567|449586123|FG008|Overall Study|Death|2|||
125315855|NCT02748863|450786125|FG000|Treatment Period 1|Adverse Event|0|||
124872584|NCT01127646|449155672|FG001|Overall Study|Entry Criteria Not Met|0|||
124989124|NCT02257567|449586124|FG009|Overall Study|Death|18|||
124989125|NCT02257567|449586125|FG010|Overall Study|Death|65|||
124989126|NCT02257567|449586115|FG000|Overall Study|Lost to Follow-up|0|||
124989127|NCT02257567|449586116|FG001|Overall Study|Lost to Follow-up|0|||
124989128|NCT02257567|449586117|FG002|Overall Study|Lost to Follow-up|0|||
125315856|NCT02748863|450786126|FG001|Treatment Period 1|Adverse Event|1|||
125315857|NCT02748863|450786127|FG002|Treatment Period 1|Adverse Event|0|||
125315858|NCT02748863|450786128|FG003|Treatment Period 1|Adverse Event|0|||
125315859|NCT02748863|450786129|FG004|Treatment Period 1|Adverse Event|0|||
125315860|NCT02748863|450786125|FG000|Treatment Period 1|Lack of Efficacy|0|||
125315861|NCT02748863|450786126|FG001|Treatment Period 1|Lack of Efficacy|0|||
125315862|NCT02748863|450786127|FG002|Treatment Period 1|Lack of Efficacy|1|||
125315863|NCT02748863|450786128|FG003|Treatment Period 1|Lack of Efficacy|0|||
125315864|NCT02748863|450786129|FG004|Treatment Period 1|Lack of Efficacy|0|||
125315865|NCT02748863|450786125|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125315866|NCT02748863|450786126|FG001|Treatment Period 1|Withdrawal by Subject|1|||
125315867|NCT02748863|450786127|FG002|Treatment Period 1|Withdrawal by Subject|1|||
125315868|NCT02748863|450786128|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125315869|NCT02748863|450786129|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125315870|NCT02748863|450786125|FG000|Treatment Period 2|Lost to Follow-up|2|||
125315871|NCT02748863|450786126|FG001|Treatment Period 2|Lost to Follow-up|0|||
125315872|NCT02748863|450786127|FG002|Treatment Period 2|Lost to Follow-up|0|||
125315873|NCT02748863|450786128|FG003|Treatment Period 2|Lost to Follow-up|0|||
125315874|NCT02748863|450786129|FG004|Treatment Period 2|Lost to Follow-up|0|||
125315875|NCT02748863|450786125|FG000|Treatment Period 2|Adverse Event|3|||
125315876|NCT02748863|450786126|FG001|Treatment Period 2|Adverse Event|2|||
125315877|NCT02748863|450786127|FG002|Treatment Period 2|Adverse Event|0|||
125315878|NCT02748863|450786128|FG003|Treatment Period 2|Adverse Event|2|||
125315879|NCT02748863|450786129|FG004|Treatment Period 2|Adverse Event|0|||
125315880|NCT02748863|450786125|FG000|Treatment Period 2|Lack of Efficacy|0|||
125315881|NCT02748863|450786126|FG001|Treatment Period 2|Lack of Efficacy|1|||
125315882|NCT02748863|450786127|FG002|Treatment Period 2|Lack of Efficacy|0|||
125315883|NCT02748863|450786128|FG003|Treatment Period 2|Lack of Efficacy|0|||
125315884|NCT02748863|450786129|FG004|Treatment Period 2|Lack of Efficacy|0|||
125315885|NCT02748863|450786125|FG000|Treatment Period 2|Pregnancy|0|||
125315886|NCT02748863|450786126|FG001|Treatment Period 2|Pregnancy|0|||
125315887|NCT02748863|450786127|FG002|Treatment Period 2|Pregnancy|0|||
125315888|NCT02748863|450786128|FG003|Treatment Period 2|Pregnancy|0|||
125315889|NCT02748863|450786129|FG004|Treatment Period 2|Pregnancy|1|||
125315890|NCT04537793|450786130|FG000|Part B (24 Weeks)|Adverse Event|0|||
125315891|NCT04537793|450786131|FG001|Part B (24 Weeks)|Adverse Event|1|||
125315892|NCT01255423|450786132|FG000|Overall Study|Abnormal Laboratory value|3|||
125315893|NCT01255423|450786133|FG001|Overall Study|Abnormal Laboratory value|2|||
125315894|NCT01255423|450786132|FG000|Overall Study|Use of prohibited medications|0|||
125315895|NCT01255423|450786133|FG001|Overall Study|Use of prohibited medications|1|||
125315896|NCT00657046|450786135|FG000|Overall Study|Adverse Event|1|||
125315897|NCT00657046|450786136|FG001|Overall Study|Adverse Event|1|||
125315898|NCT00657046|450786137|FG002|Overall Study|Adverse Event|0|||
125315899|NCT00657046|450786135|FG000|Overall Study|Protocol Violation|2|||
125315900|NCT00657046|450786136|FG001|Overall Study|Protocol Violation|2|||
125315901|NCT00657046|450786137|FG002|Overall Study|Protocol Violation|0|||
125315902|NCT00657046|450786135|FG000|Overall Study|Withdrawal by Subject|1|||
125315903|NCT00657046|450786136|FG001|Overall Study|Withdrawal by Subject|0|||
125315904|NCT00657046|450786137|FG002|Overall Study|Withdrawal by Subject|0|||
125315905|NCT00657046|450786135|FG000|Overall Study|Death|0|||
125315906|NCT00657046|450786136|FG001|Overall Study|Death|0|||
125315907|NCT00657046|450786137|FG002|Overall Study|Death|1|||
125315908|NCT00657046|450786135|FG000|Overall Study|Surgery|0|||
125315909|NCT00657046|450786136|FG001|Overall Study|Surgery|0|||
125315910|NCT00657046|450786137|FG002|Overall Study|Surgery|1|||
125315911|NCT01858363|450786138|FG000|Overall Study|Death|35|||
125315912|NCT01858363|450786139|FG001|Overall Study|Death|9|||
125315913|NCT01858363|450786138|FG000|Overall Study|Withdrawal by Subject|28|||
125315914|NCT01858363|450786139|FG001|Overall Study|Withdrawal by Subject|14|||
125315915|NCT01858363|450786138|FG000|Overall Study|Lost to Follow-up|13|||
125315916|NCT01858363|450786139|FG001|Overall Study|Lost to Follow-up|3|||
125315917|NCT03480152|450786149|FG000|Phase I|Signed consent. Died before treatment.|1|||
125315918|NCT03480152|450786150|FG001|Phase I|Signed consent. Died before treatment.|0|||
125315919|NCT03480152|450786151|FG002|Phase I|Signed consent. Died before treatment.|0|||
125315920|NCT00101686|450786152|FG000|Overall Study|Progressive Disease|37|||
125315921|NCT00101686|450786153|FG001|Overall Study|Progressive Disease|28|||
125315922|NCT00101686|450786154|FG002|Overall Study|Progressive Disease|37|||
125315923|NCT00101686|450786155|FG003|Overall Study|Progressive Disease|38|||
125315924|NCT00101686|450786156|FG004|Overall Study|Progressive Disease|28|||
125315925|NCT00101686|450786157|FG005|Overall Study|Progressive Disease|25|||
125315926|NCT00101686|450786158|FG006|Overall Study|Progressive Disease|5|||
125315927|NCT00101686|450786159|FG007|Overall Study|Progressive Disease|7|||
125315928|NCT00101686|450786160|FG008|Overall Study|Progressive Disease|10|||
125315929|NCT00101686|450786161|FG009|Overall Study|Progressive Disease|8|||
125315930|NCT00101686|450786152|FG000|Overall Study|initiation other anti-cancer treatment|4|||
125315931|NCT00101686|450786153|FG001|Overall Study|initiation other anti-cancer treatment|3|||
125315932|NCT00101686|450786154|FG002|Overall Study|initiation other anti-cancer treatment|4|||
125315933|NCT00101686|450786155|FG003|Overall Study|initiation other anti-cancer treatment|3|||
125315934|NCT00101686|450786156|FG004|Overall Study|initiation other anti-cancer treatment|1|||
125315935|NCT00101686|450786157|FG005|Overall Study|initiation other anti-cancer treatment|1|||
125315936|NCT00101686|450786158|FG006|Overall Study|initiation other anti-cancer treatment|2|||
125315937|NCT00101686|450786159|FG007|Overall Study|initiation other anti-cancer treatment|2|||
125315938|NCT00101686|450786160|FG008|Overall Study|initiation other anti-cancer treatment|3|||
125315939|NCT00101686|450786161|FG009|Overall Study|initiation other anti-cancer treatment|3|||
125315940|NCT00101686|450786152|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
125315941|NCT00101686|450786153|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
125315942|NCT00101686|450786154|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
125315943|NCT00101686|450786155|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
125315944|NCT00101686|450786156|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
125315945|NCT00101686|450786157|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
125315946|NCT00101686|450786158|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
125315947|NCT00101686|450786159|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
125315948|NCT00101686|450786160|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
125315949|NCT00101686|450786161|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
125315950|NCT00101686|450786152|FG000|Overall Study|unacceptable toxicity|3|||
125315951|NCT00101686|450786153|FG001|Overall Study|unacceptable toxicity|9|||
125315952|NCT00101686|450786154|FG002|Overall Study|unacceptable toxicity|10|||
125315953|NCT00101686|450786155|FG003|Overall Study|unacceptable toxicity|6|||
125315954|NCT00101686|450786156|FG004|Overall Study|unacceptable toxicity|16|||
125315955|NCT00101686|450786157|FG005|Overall Study|unacceptable toxicity|10|||
125315956|NCT00101686|450786158|FG006|Overall Study|unacceptable toxicity|4|||
125315957|NCT00101686|450786159|FG007|Overall Study|unacceptable toxicity|2|||
125315958|NCT00101686|450786160|FG008|Overall Study|unacceptable toxicity|1|||
125315959|NCT00101686|450786161|FG009|Overall Study|unacceptable toxicity|4|||
125315960|NCT00101686|450786152|FG000|Overall Study|Randomized but did not receive treament|1|||
125315961|NCT00101686|450786153|FG001|Overall Study|Randomized but did not receive treament|6|||
125315962|NCT00101686|450786154|FG002|Overall Study|Randomized but did not receive treament|2|||
125315963|NCT00101686|450786155|FG003|Overall Study|Randomized but did not receive treament|2|||
125315964|NCT00101686|450786156|FG004|Overall Study|Randomized but did not receive treament|2|||
125315965|NCT00101686|450786157|FG005|Overall Study|Randomized but did not receive treament|2|||
125315966|NCT00101686|450786158|FG006|Overall Study|Randomized but did not receive treament|0|||
125315967|NCT00101686|450786159|FG007|Overall Study|Randomized but did not receive treament|1|||
124989129|NCT02257567|449586118|FG003|Overall Study|Lost to Follow-up|0|||
124989130|NCT02257567|449586119|FG004|Overall Study|Lost to Follow-up|2|||
124989131|NCT02257567|449586120|FG005|Overall Study|Lost to Follow-up|2|||
124989132|NCT02257567|449586121|FG006|Overall Study|Lost to Follow-up|0|||
124989133|NCT02257567|449586122|FG007|Overall Study|Lost to Follow-up|0|||
125315968|NCT00101686|450786160|FG008|Overall Study|Randomized but did not receive treament|0|||
125315969|NCT00101686|450786161|FG009|Overall Study|Randomized but did not receive treament|1|||
125315970|NCT00101686|450786152|FG000|Overall Study|intercurrent non-cancer related illness|0|||
125315971|NCT00101686|450786153|FG001|Overall Study|intercurrent non-cancer related illness|0|||
125315972|NCT00101686|450786154|FG002|Overall Study|intercurrent non-cancer related illness|2|||
125315973|NCT00101686|450786155|FG003|Overall Study|intercurrent non-cancer related illness|0|||
125315974|NCT00101686|450786156|FG004|Overall Study|intercurrent non-cancer related illness|1|||
125315975|NCT00101686|450786157|FG005|Overall Study|intercurrent non-cancer related illness|3|||
125315976|NCT00101686|450786158|FG006|Overall Study|intercurrent non-cancer related illness|1|||
125315977|NCT00101686|450786159|FG007|Overall Study|intercurrent non-cancer related illness|0|||
125315978|NCT00101686|450786160|FG008|Overall Study|intercurrent non-cancer related illness|1|||
125315979|NCT00101686|450786161|FG009|Overall Study|intercurrent non-cancer related illness|1|||
125315980|NCT00101686|450786152|FG000|Overall Study|Physician Decision|10|||
125315981|NCT00101686|450786153|FG001|Overall Study|Physician Decision|13|||
125315982|NCT00101686|450786154|FG002|Overall Study|Physician Decision|6|||
125315983|NCT00101686|450786155|FG003|Overall Study|Physician Decision|7|||
125315984|NCT00101686|450786156|FG004|Overall Study|Physician Decision|8|||
125315985|NCT00101686|450786157|FG005|Overall Study|Physician Decision|9|||
125315986|NCT00101686|450786158|FG006|Overall Study|Physician Decision|5|||
125315987|NCT00101686|450786159|FG007|Overall Study|Physician Decision|5|||
125315988|NCT00101686|450786160|FG008|Overall Study|Physician Decision|1|||
125315989|NCT00101686|450786161|FG009|Overall Study|Physician Decision|1|||
125315990|NCT00101686|450786152|FG000|Overall Study|Other|1|||
125315991|NCT00101686|450786153|FG001|Overall Study|Other|4|||
125315992|NCT00101686|450786154|FG002|Overall Study|Other|1|||
125315993|NCT00101686|450786155|FG003|Overall Study|Other|6|||
125315994|NCT00101686|450786156|FG004|Overall Study|Other|2|||
125315995|NCT00101686|450786157|FG005|Overall Study|Other|12|||
124989134|NCT02257567|449586123|FG008|Overall Study|Lost to Follow-up|0|||
125315996|NCT00101686|450786158|FG006|Overall Study|Other|1|||
125315997|NCT00101686|450786159|FG007|Overall Study|Other|5|||
125315998|NCT00101686|450786160|FG008|Overall Study|Other|3|||
124872585|NCT01127646|449155671|FG000|Overall Study|Protocol Violation|0|||
125315999|NCT00101686|450786161|FG009|Overall Study|Other|3|||
124872586|NCT01127646|449155672|FG001|Overall Study|Protocol Violation|1|||
124989135|NCT02257567|449586124|FG009|Overall Study|Lost to Follow-up|1|||
124989136|NCT02257567|449586125|FG010|Overall Study|Lost to Follow-up|1|||
124989137|NCT02257567|449586115|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
124989138|NCT02257567|449586116|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
124989139|NCT02257567|449586117|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
124989140|NCT02257567|449586118|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
124989141|NCT02257567|449586119|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
124989142|NCT02257567|449586120|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
124989143|NCT02257567|449586121|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
124989144|NCT02257567|449586122|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
124989145|NCT02257567|449586123|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
124989146|NCT02257567|449586124|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
124989147|NCT02257567|449586125|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
124989148|NCT02257567|449586115|FG000|Overall Study|Physician Decision|0|||
124989149|NCT02257567|449586116|FG001|Overall Study|Physician Decision|0|||
124989150|NCT02257567|449586117|FG002|Overall Study|Physician Decision|0|||
124989151|NCT02257567|449586118|FG003|Overall Study|Physician Decision|0|||
124989152|NCT02257567|449586119|FG004|Overall Study|Physician Decision|0|||
124989153|NCT02257567|449586120|FG005|Overall Study|Physician Decision|0|||
124989154|NCT02257567|449586121|FG006|Overall Study|Physician Decision|0|||
124989155|NCT02257567|449586122|FG007|Overall Study|Physician Decision|2|||
124989156|NCT02257567|449586123|FG008|Overall Study|Physician Decision|0|||
124989157|NCT02257567|449586124|FG009|Overall Study|Physician Decision|1|||
124989158|NCT02257567|449586125|FG010|Overall Study|Physician Decision|0|||
124989159|NCT02257567|449586115|FG000|Overall Study|Withdrawal by Subject|0|||
124989160|NCT02257567|449586116|FG001|Overall Study|Withdrawal by Subject|0|||
124989161|NCT02257567|449586117|FG002|Overall Study|Withdrawal by Subject|2|||
124989162|NCT02257567|449586118|FG003|Overall Study|Withdrawal by Subject|0|||
124989163|NCT02257567|449586119|FG004|Overall Study|Withdrawal by Subject|0|||
124989164|NCT02257567|449586120|FG005|Overall Study|Withdrawal by Subject|6|||
124989165|NCT02257567|449586121|FG006|Overall Study|Withdrawal by Subject|6|||
124989166|NCT02257567|449586122|FG007|Overall Study|Withdrawal by Subject|6|||
124989167|NCT02257567|449586123|FG008|Overall Study|Withdrawal by Subject|1|||
124989168|NCT02257567|449586124|FG009|Overall Study|Withdrawal by Subject|1|||
124989169|NCT02257567|449586125|FG010|Overall Study|Withdrawal by Subject|10|||
124989170|NCT03215810|449586126|FG000|Overall Study|Still responding to nivolumab|1|||
124989171|NCT03215810|449586126|FG000|Overall Study|Insufficient TIL growth|1|||
124989172|NCT03215810|449586126|FG000|Overall Study|Decline in performance status|1|||
124989173|NCT03215810|449586126|FG000|Overall Study|Withdrawal by Subject|1|||
124989174|NCT02679573|449586129|FG000|Overall Study|Adverse Event|13|||
124989175|NCT02679573|449586130|FG001|Overall Study|Adverse Event|6|||
124989176|NCT02679573|449586129|FG000|Overall Study|Lack of Efficacy|12|||
124989177|NCT02679573|449586130|FG001|Overall Study|Lack of Efficacy|15|||
124989178|NCT02679573|449586129|FG000|Overall Study|Could not complete required study visits|6|||
124989179|NCT02679573|449586130|FG001|Overall Study|Could not complete required study visits|2|||
124989180|NCT02679573|449586129|FG000|Overall Study|Withdrawal by Subject|2|||
124989181|NCT02679573|449586130|FG001|Overall Study|Withdrawal by Subject|9|||
124989182|NCT02679573|449586129|FG000|Overall Study|Death|2|||
124989183|NCT02679573|449586130|FG001|Overall Study|Death|0|||
124989184|NCT02679573|449586129|FG000|Overall Study|Physician Decision|2|||
124989185|NCT02679573|449586130|FG001|Overall Study|Physician Decision|4|||
124989186|NCT02679573|449586129|FG000|Overall Study|Lost to Follow-up|0|||
124989187|NCT02679573|449586130|FG001|Overall Study|Lost to Follow-up|3|||
124989188|NCT00324116|449586132|FG000|Overall Study|Adverse Event|5|||
124989189|NCT00324116|449586132|FG000|Overall Study|Lack of Efficacy|17|||
124989190|NCT00324116|449586132|FG000|Overall Study|Withdrawal by Subject|5|||
124989191|NCT00324116|449586132|FG000|Overall Study|Other|5|||
124989192|NCT01806623|449586133|FG000|Overall Study|Withdrawal by Subject|1|||
124989193|NCT01806623|449586133|FG000|Overall Study|Adverse Event|1|||
124989194|NCT01806623|449586133|FG000|Overall Study|Did not meet the inclusion criteria|56|||
124989195|NCT01737827|449586134|FG000|Overall Study|Adverse Event|3|||
124989196|NCT01737827|449586135|FG001|Overall Study|Adverse Event|6|||
124989197|NCT01737827|449586136|FG002|Overall Study|Adverse Event|0|||
124989198|NCT01737827|449586134|FG000|Overall Study|Lost to Follow-up|0|||
124989199|NCT01737827|449586135|FG001|Overall Study|Lost to Follow-up|1|||
124989200|NCT01737827|449586136|FG002|Overall Study|Lost to Follow-up|0|||
125316000|NCT00101686|450786152|FG000|Overall Study|Withdrawal by Subject|9|||
125316001|NCT00101686|450786153|FG001|Overall Study|Withdrawal by Subject|8|||
125316002|NCT00101686|450786154|FG002|Overall Study|Withdrawal by Subject|6|||
125316003|NCT00101686|450786155|FG003|Overall Study|Withdrawal by Subject|8|||
125316004|NCT00101686|450786156|FG004|Overall Study|Withdrawal by Subject|8|||
125316005|NCT00101686|450786157|FG005|Overall Study|Withdrawal by Subject|7|||
125316006|NCT00101686|450786158|FG006|Overall Study|Withdrawal by Subject|7|||
125316007|NCT00101686|450786159|FG007|Overall Study|Withdrawal by Subject|7|||
125316008|NCT00101686|450786160|FG008|Overall Study|Withdrawal by Subject|8|||
124989201|NCT01737827|449586134|FG000|Overall Study|Physician Decision|0|||
124989202|NCT01737827|449586135|FG001|Overall Study|Physician Decision|2|||
124989203|NCT01737827|449586136|FG002|Overall Study|Physician Decision|0|||
124989204|NCT01737827|449586134|FG000|Overall Study|Progressive Disease|5|||
124989205|NCT01737827|449586135|FG001|Overall Study|Progressive Disease|16|||
124989206|NCT01737827|449586136|FG002|Overall Study|Progressive Disease|2|||
124989207|NCT01737827|449586134|FG000|Overall Study|Study Terminated by Sponsor|0|||
124989208|NCT01737827|449586135|FG001|Overall Study|Study Terminated by Sponsor|1|||
124989209|NCT01737827|449586136|FG002|Overall Study|Study Terminated by Sponsor|0|||
124989210|NCT01737827|449586134|FG000|Overall Study|Subject/Guardian Decision|0|||
124989211|NCT01737827|449586135|FG001|Overall Study|Subject/Guardian Decision|2|||
124989212|NCT01737827|449586136|FG002|Overall Study|Subject/Guardian Decision|0|||
124989213|NCT01451827|449586137|FG000|Overall Study|Adverse Event|2|||
124989214|NCT01451827|449586138|FG001|Overall Study|Adverse Event|0|||
124989215|NCT01451827|449586139|FG002|Overall Study|Adverse Event|1|||
124989216|NCT01451827|449586140|FG003|Overall Study|Adverse Event|1|||
124989217|NCT01451827|449586137|FG000|Overall Study|Protocol deviation|1|||
124989218|NCT01451827|449586138|FG001|Overall Study|Protocol deviation|0|||
124989219|NCT01451827|449586139|FG002|Overall Study|Protocol deviation|0|||
124989220|NCT01451827|449586140|FG003|Overall Study|Protocol deviation|0|||
124989221|NCT01451827|449586137|FG000|Overall Study|Lost to Follow-up|0|||
124989222|NCT01451827|449586138|FG001|Overall Study|Lost to Follow-up|3|||
124989223|NCT01451827|449586139|FG002|Overall Study|Lost to Follow-up|0|||
124989224|NCT01451827|449586140|FG003|Overall Study|Lost to Follow-up|2|||
124989225|NCT01451827|449586137|FG000|Overall Study|Participant met withdrawal criteria|0|||
124989226|NCT01451827|449586138|FG001|Overall Study|Participant met withdrawal criteria|2|||
124989227|NCT01451827|449586139|FG002|Overall Study|Participant met withdrawal criteria|0|||
124989228|NCT01451827|449586140|FG003|Overall Study|Participant met withdrawal criteria|0|||
124989229|NCT01451827|449586137|FG000|Overall Study|Withdrawal by Subject|0|||
124989230|NCT01451827|449586138|FG001|Overall Study|Withdrawal by Subject|0|||
124989231|NCT01451827|449586139|FG002|Overall Study|Withdrawal by Subject|1|||
124989232|NCT01451827|449586140|FG003|Overall Study|Withdrawal by Subject|1|||
124989233|NCT01034163|449586143|FG000|Overall Study|Treatment completed as per protocol|8|||
124989234|NCT01034163|449586144|FG001|Overall Study|Treatment completed as per protocol|7|||
124989235|NCT01034163|449586143|FG000|Overall Study|Withdrawal by Subject|8|||
124989236|NCT01034163|449586144|FG001|Overall Study|Withdrawal by Subject|2|||
124989237|NCT01034163|449586143|FG000|Overall Study|Protocol deviation|1|||
124989238|NCT01034163|449586144|FG001|Overall Study|Protocol deviation|0|||
124989239|NCT01034163|449586143|FG000|Overall Study|Disease progression|3|||
124989240|NCT01034163|449586144|FG001|Overall Study|Disease progression|4|||
124989241|NCT01034163|449586143|FG000|Overall Study|Adverse Event|6|||
124989242|NCT01034163|449586144|FG001|Overall Study|Adverse Event|0|||
124989243|NCT01034163|449586143|FG000|Overall Study|Administrative problems|0|||
124989244|NCT01034163|449586144|FG001|Overall Study|Administrative problems|1|||
124989245|NCT01034163|449586143|FG000|Overall Study|Abnormal laboratory value|1|||
124989246|NCT01034163|449586144|FG001|Overall Study|Abnormal laboratory value|0|||
124989247|NCT02424734|449586145|FG000|Overall Study|Treatment stopped to be discharged home|2|||
124989248|NCT02424734|449586146|FG001|Overall Study|Treatment stopped to be discharged home|2|||
124989249|NCT02424734|449586147|FG002|Overall Study|Treatment stopped to be discharged home|0|||
124989250|NCT00528645|449586148|FG000|Overall Study|Adverse Event|3|||
124989251|NCT00116753|449586149|FG000|Overall Study|Adverse Event|16|||
124989252|NCT00116753|449586150|FG001|Overall Study|Adverse Event|10|||
124989253|NCT00116753|449586151|FG002|Overall Study|Adverse Event|7|||
124989254|NCT00116753|449586149|FG000|Overall Study|Withdrawal by Subject|11|||
124989255|NCT00116753|449586150|FG001|Overall Study|Withdrawal by Subject|12|||
124989256|NCT00116753|449586151|FG002|Overall Study|Withdrawal by Subject|8|||
124989257|NCT00116753|449586149|FG000|Overall Study|Lost to Follow-up|0|||
125316009|NCT00101686|450786161|FG009|Overall Study|Withdrawal by Subject|9|||
125316010|NCT00867165|450786162|FG000|Overall Study|Adverse Event|3|||
124989258|NCT00116753|449586150|FG001|Overall Study|Lost to Follow-up|2|||
124989259|NCT00116753|449586151|FG002|Overall Study|Lost to Follow-up|1|||
124989260|NCT00116753|449586149|FG000|Overall Study|Protocol Violation|0|||
124989261|NCT00116753|449586150|FG001|Overall Study|Protocol Violation|0|||
124989262|NCT00116753|449586151|FG002|Overall Study|Protocol Violation|1|||
124989263|NCT00116753|449586149|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
124989264|NCT00116753|449586150|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
124989265|NCT00116753|449586151|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
124989266|NCT00116753|449586149|FG000|Overall Study|Disease Progression|3|||
124989267|NCT00116753|449586150|FG001|Overall Study|Disease Progression|4|||
124989268|NCT00116753|449586151|FG002|Overall Study|Disease Progression|3|||
124989269|NCT00116753|449586149|FG000|Overall Study|Abnormal Echocardiogram|0|||
124989270|NCT00116753|449586150|FG001|Overall Study|Abnormal Echocardiogram|0|||
124989271|NCT00116753|449586151|FG002|Overall Study|Abnormal Echocardiogram|1|||
124989272|NCT00116753|449586149|FG000|Overall Study|Progressive Parkinson's Disease|1|||
124989273|NCT00116753|449586150|FG001|Overall Study|Progressive Parkinson's Disease|0|||
124989274|NCT00116753|449586151|FG002|Overall Study|Progressive Parkinson's Disease|0|||
124989275|NCT00116753|449586149|FG000|Overall Study|Dosing Error|0|||
124989276|NCT00116753|449586150|FG001|Overall Study|Dosing Error|1|||
124989277|NCT00116753|449586151|FG002|Overall Study|Dosing Error|0|||
124989278|NCT01642251|449586152|FG000|Overall Study|Progressive disease|0|||
124989279|NCT01642251|449586153|FG001|Overall Study|Progressive disease|0|||
124989280|NCT01642251|449586154|FG002|Overall Study|Progressive disease|3|||
124989281|NCT01642251|449586155|FG003|Overall Study|Progressive disease|3|||
124989282|NCT01642251|449586152|FG000|Overall Study|Adverse Event|0|||
124989283|NCT01642251|449586153|FG001|Overall Study|Adverse Event|0|||
124989284|NCT01642251|449586154|FG002|Overall Study|Adverse Event|5|||
124989285|NCT01642251|449586155|FG003|Overall Study|Adverse Event|4|||
124989286|NCT01642251|449586152|FG000|Overall Study|Death|0|||
124989287|NCT01642251|449586153|FG001|Overall Study|Death|0|||
125316011|NCT00867165|450786163|FG001|Overall Study|Adverse Event|0|||
125316012|NCT00867165|450786162|FG000|Overall Study|Withdrawal by Subject|1|||
125316013|NCT00867165|450786163|FG001|Overall Study|Withdrawal by Subject|0|||
125316014|NCT02738008|450786164|FG000|Overall Study|Study Terminated by Sponsor|1|||
125316015|NCT02738008|450786165|FG001|Overall Study|Study Terminated by Sponsor|5|||
125316016|NCT02738008|450786166|FG002|Overall Study|Study Terminated by Sponsor|3|||
125316017|NCT02738008|450786164|FG000|Overall Study|Adverse Event|0|||
125316018|NCT02738008|450786165|FG001|Overall Study|Adverse Event|1|||
125316019|NCT02738008|450786166|FG002|Overall Study|Adverse Event|2|||
125316020|NCT03550378|450786169|FG000|Overall Study|Death|0|||
125316021|NCT03550378|450786170|FG001|Overall Study|Death|1|||
125316022|NCT00468299|450786171|FG000|Overall Study|Withdrawal by Subject|0|||
125316023|NCT00468299|450786172|FG001|Overall Study|Withdrawal by Subject|1|||
125316024|NCT03546621|450786173|FG000|Overall Study|Withdrawal by Subject|0|||
125316025|NCT03546621|450786174|FG001|Overall Study|Withdrawal by Subject|1|||
125316026|NCT03546621|450786175|FG002|Overall Study|Withdrawal by Subject|2|||
125316027|NCT03546621|450786176|FG003|Overall Study|Withdrawal by Subject|1|||
125316028|NCT03546621|450786173|FG000|Overall Study|Lost to Follow-up|0|||
125316029|NCT03546621|450786174|FG001|Overall Study|Lost to Follow-up|1|||
125316030|NCT03546621|450786175|FG002|Overall Study|Lost to Follow-up|0|||
125316031|NCT03546621|450786176|FG003|Overall Study|Lost to Follow-up|0|||
125316032|NCT03546621|450786173|FG000|Overall Study|Adverse Event|0|||
125316033|NCT03546621|450786174|FG001|Overall Study|Adverse Event|1|||
125316034|NCT03546621|450786175|FG002|Overall Study|Adverse Event|0|||
125316035|NCT03546621|450786176|FG003|Overall Study|Adverse Event|1|||
125316036|NCT03546621|450786173|FG000|Overall Study|Progressive disease|0|||
125316037|NCT03546621|450786174|FG001|Overall Study|Progressive disease|0|||
125316038|NCT03546621|450786175|FG002|Overall Study|Progressive disease|0|||
125316039|NCT03546621|450786176|FG003|Overall Study|Progressive disease|1|||
125316040|NCT00377520|450786181|FG000|Overall Study|Ineligible (Prior radiation)|1|||
125316041|NCT00462306|450786188|FG000|Overall Study|insufficient data|0|||
125316042|NCT00462306|450786189|FG001|Overall Study|insufficient data|13|||
125316043|NCT00154297|450786191|FG000|Overall Study|Death|5|||
125316044|NCT00154297|450786192|FG001|Overall Study|Death|2|||
125316045|NCT00154297|450786191|FG000|Overall Study|Withdrawal by Subject|0|||
125316046|NCT00154297|450786192|FG001|Overall Study|Withdrawal by Subject|5|||
125316047|NCT00154297|450786191|FG000|Overall Study|Lost to Follow-up|3|||
125316048|NCT00154297|450786192|FG001|Overall Study|Lost to Follow-up|0|||
125316049|NCT05051579|450786194|FG000|Overall Study|Withdrawal by Subject|3|||
125316050|NCT05051579|450786195|FG001|Overall Study|Withdrawal by Subject|5|||
125316051|NCT05051579|450786196|FG002|Overall Study|Withdrawal by Subject|2|||
124989288|NCT01642251|449586154|FG002|Overall Study|Death|1|||
124989289|NCT01642251|449586155|FG003|Overall Study|Death|3|||
124989290|NCT01642251|449586152|FG000|Overall Study|Withdrawal by Subject|0|||
124989291|NCT01642251|449586153|FG001|Overall Study|Withdrawal by Subject|0|||
124989292|NCT01642251|449586154|FG002|Overall Study|Withdrawal by Subject|1|||
125316052|NCT05051579|450786197|FG003|Overall Study|Withdrawal by Subject|1|||
125316053|NCT05051579|450786198|FG004|Overall Study|Withdrawal by Subject|4|||
125316054|NCT05051579|450786199|FG005|Overall Study|Withdrawal by Subject|0|||
125316055|NCT05051579|450786200|FG006|Overall Study|Withdrawal by Subject|4|||
124989293|NCT01642251|449586155|FG003|Overall Study|Withdrawal by Subject|3|||
124989294|NCT01642251|449586152|FG000|Overall Study|Alternative therapy|0|||
124989295|NCT01642251|449586153|FG001|Overall Study|Alternative therapy|0|||
124989296|NCT01642251|449586154|FG002|Overall Study|Alternative therapy|0|||
124989297|NCT01642251|449586155|FG003|Overall Study|Alternative therapy|2|||
124989298|NCT01642251|449586152|FG000|Overall Study|Other complicating disease|0|||
124989299|NCT01642251|449586153|FG001|Overall Study|Other complicating disease|0|||
125316056|NCT05051579|450786194|FG000|Overall Study|Lost to Follow-up|1|||
125316057|NCT05051579|450786195|FG001|Overall Study|Lost to Follow-up|0|||
125316058|NCT05051579|450786196|FG002|Overall Study|Lost to Follow-up|0|||
125316059|NCT05051579|450786197|FG003|Overall Study|Lost to Follow-up|0|||
125316060|NCT05051579|450786198|FG004|Overall Study|Lost to Follow-up|1|||
124989300|NCT01642251|449586154|FG002|Overall Study|Other complicating disease|1|||
124989301|NCT01642251|449586155|FG003|Overall Study|Other complicating disease|0|||
124989302|NCT01642251|449586152|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
124989303|NCT01642251|449586153|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
124989304|NCT01642251|449586154|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
124989305|NCT01642251|449586155|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
124989306|NCT01445301|449586156|FG000|Overall Study|Adverse Event|15|||
124989307|NCT01445301|449586157|FG001|Overall Study|Adverse Event|25|||
124989308|NCT01445301|449586158|FG002|Overall Study|Adverse Event|4|||
124989309|NCT01445301|449586156|FG000|Overall Study|Lack of Efficacy|0|||
124989310|NCT01445301|449586157|FG001|Overall Study|Lack of Efficacy|1|||
124989311|NCT01445301|449586158|FG002|Overall Study|Lack of Efficacy|0|||
124989312|NCT01445301|449586156|FG000|Overall Study|Protocol Violation|1|||
124989313|NCT01445301|449586157|FG001|Overall Study|Protocol Violation|0|||
124989314|NCT01445301|449586158|FG002|Overall Study|Protocol Violation|0|||
124989315|NCT01445301|449586156|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
125316061|NCT05051579|450786199|FG005|Overall Study|Lost to Follow-up|0|||
125316062|NCT05051579|450786200|FG006|Overall Study|Lost to Follow-up|1|||
125316063|NCT05051579|450786194|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
125316064|NCT05051579|450786195|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
125316065|NCT05051579|450786196|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
125316066|NCT05051579|450786197|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
125316067|NCT05051579|450786198|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
125316068|NCT05051579|450786199|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
125316069|NCT05051579|450786200|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
125316070|NCT05051579|450786194|FG000|Overall Study|Adverse Event|2|||
125316071|NCT05051579|450786195|FG001|Overall Study|Adverse Event|1|||
125316072|NCT05051579|450786196|FG002|Overall Study|Adverse Event|0|||
125316073|NCT05051579|450786197|FG003|Overall Study|Adverse Event|4|||
125316074|NCT05051579|450786198|FG004|Overall Study|Adverse Event|1|||
125316075|NCT05051579|450786199|FG005|Overall Study|Adverse Event|2|||
125316076|NCT05051579|450786200|FG006|Overall Study|Adverse Event|0|||
125316077|NCT05051579|450786194|FG000|Overall Study|Inadvertent Enrollment|0|||
125316078|NCT05051579|450786195|FG001|Overall Study|Inadvertent Enrollment|0|||
125316079|NCT05051579|450786196|FG002|Overall Study|Inadvertent Enrollment|0|||
125316080|NCT05051579|450786197|FG003|Overall Study|Inadvertent Enrollment|0|||
125316081|NCT05051579|450786198|FG004|Overall Study|Inadvertent Enrollment|0|||
125316082|NCT05051579|450786199|FG005|Overall Study|Inadvertent Enrollment|0|||
125316083|NCT05051579|450786200|FG006|Overall Study|Inadvertent Enrollment|1|||
125316084|NCT05051579|450786194|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
125316085|NCT05051579|450786195|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
125316086|NCT05051579|450786196|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
125316087|NCT05051579|450786197|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
125316088|NCT05051579|450786198|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
125316089|NCT05051579|450786199|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
125316090|NCT05051579|450786200|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
125316091|NCT05051579|450786194|FG000|Overall Study|Sponsor Decision|0|||
125316092|NCT05051579|450786195|FG001|Overall Study|Sponsor Decision|0|||
125316093|NCT05051579|450786196|FG002|Overall Study|Sponsor Decision|0|||
125316094|NCT05051579|450786197|FG003|Overall Study|Sponsor Decision|0|||
125316095|NCT05051579|450786198|FG004|Overall Study|Sponsor Decision|1|||
125316096|NCT05051579|450786199|FG005|Overall Study|Sponsor Decision|0|||
125316097|NCT05051579|450786200|FG006|Overall Study|Sponsor Decision|0|||
125316098|NCT05051579|450786194|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
125316099|NCT05051579|450786195|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
125316100|NCT05051579|450786196|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
125316101|NCT05051579|450786197|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
125316102|NCT05051579|450786198|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
125316103|NCT05051579|450786199|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
125316104|NCT05051579|450786200|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
125316105|NCT00990106|450786201|FG000|Overall Study|"too busy to continue"|1|||
125316106|NCT00990106|450786202|FG001|Overall Study|"too busy to continue"|2|||
124989316|NCT01445301|449586157|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
124989317|NCT01445301|449586158|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
124989318|NCT01445301|449586156|FG000|Overall Study|Physician Decision|0|||
124989319|NCT01445301|449586157|FG001|Overall Study|Physician Decision|2|||
124989320|NCT01445301|449586158|FG002|Overall Study|Physician Decision|0|||
125316107|NCT00990106|450786201|FG000|Overall Study|Lost to Follow-up|1|||
125316108|NCT00990106|450786202|FG001|Overall Study|Lost to Follow-up|3|||
125316109|NCT00990106|450786201|FG000|Overall Study|Withdrawal by Subject|2|||
125316110|NCT00990106|450786202|FG001|Overall Study|Withdrawal by Subject|1|||
125316111|NCT00990106|450786201|FG000|Overall Study|opted for open label prazosin|1|||
125316112|NCT00990106|450786202|FG001|Overall Study|opted for open label prazosin|1|||
125316113|NCT00990106|450786201|FG000|Overall Study|relocation/deployment|4|||
124989321|NCT01445301|449586156|FG000|Overall Study|Withdrawal by Subject|5|||
124989322|NCT01445301|449586157|FG001|Overall Study|Withdrawal by Subject|6|||
124989323|NCT01445301|449586158|FG002|Overall Study|Withdrawal by Subject|4|||
124989324|NCT00752557|449586159|FG000|Overall Study|Withdrawal by Subject|4|||
124989325|NCT00752557|449586160|FG001|Overall Study|Withdrawal by Subject|3|||
124989326|NCT00752557|449586161|FG002|Overall Study|Withdrawal by Subject|3|||
124989327|NCT00752557|449586159|FG000|Overall Study|Unspecified resaons|0|||
124989328|NCT00752557|449586160|FG001|Overall Study|Unspecified resaons|2|||
124989329|NCT00752557|449586161|FG002|Overall Study|Unspecified resaons|2|||
124989330|NCT00752557|449586159|FG000|Overall Study|Lost to Follow-up|1|||
124989331|NCT00752557|449586160|FG001|Overall Study|Lost to Follow-up|0|||
124989332|NCT00752557|449586161|FG002|Overall Study|Lost to Follow-up|1|||
124989333|NCT02413333|449586162|FG000|Period 1|Adverse Event|1|||
124989334|NCT02413333|449586163|FG001|Period 1|Adverse Event|0|||
124989335|NCT02413333|449586162|FG000|Period 1|Reason Not Specified|0|||
124989336|NCT02413333|449586163|FG001|Period 1|Reason Not Specified|1|||
124989337|NCT02413333|449586162|FG000|Period 2|Protocol Deviation|1|||
124989338|NCT02413333|449586163|FG001|Period 2|Protocol Deviation|0|||
124989339|NCT02996474|449586164|FG000|Overall Study|Physician Decision|5|||
124989340|NCT00540046|449586165|FG000|Overall Study|Lost to Follow-up|33|||
124989341|NCT00540046|449586166|FG001|Overall Study|Lost to Follow-up|23|||
124989342|NCT02891837|449586167|FG000|Overall Study|Lost to Follow-up|2|||
124989343|NCT02891837|449586168|FG001|Overall Study|Lost to Follow-up|0|||
124989344|NCT02891837|449586167|FG000|Overall Study|Withdrawal by Subject|1|||
124989345|NCT02891837|449586168|FG001|Overall Study|Withdrawal by Subject|0|||
124989346|NCT00185965|449586169|FG000|Overall Study|Adverse Event|0|||
124989347|NCT00185965|449586170|FG001|Overall Study|Adverse Event|1|||
124989348|NCT02533531|449586171|FG000|Overall Study|Device did not turn on|1|||
124989349|NCT02047903|449586172|FG000|Overall Study|Adverse Event|14|||
124989350|NCT02047903|449586172|FG000|Overall Study|Serious adverse event|10|||
124989351|NCT02047903|449586172|FG000|Overall Study|Withdrawal by Subject|16|||
124989352|NCT02047903|449586172|FG000|Overall Study|Lost to Follow-up|4|||
124989353|NCT02047903|449586172|FG000|Overall Study|Reason not listed|6|||
124989354|NCT02047903|449586172|FG000|Overall Study|Not Treated|9|||
124989355|NCT03616977|449586176|FG000|Period 1|Physician Decision|0|||
124989356|NCT03616977|449586177|FG001|Period 1|Physician Decision|1|||
124989357|NCT03616977|449586176|FG000|Period 3|Adverse Event|1|||
124989358|NCT03616977|449586177|FG001|Period 3|Adverse Event|1|||
124989359|NCT01323972|449586179|FG000|Overall Study|Withdrawal by Subject|1|||
124989360|NCT01323972|449586180|FG001|Overall Study|Withdrawal by Subject|0|||
124989361|NCT01323972|449586181|FG002|Overall Study|Withdrawal by Subject|1|||
124989362|NCT01323972|449586182|FG003|Overall Study|Withdrawal by Subject|0|||
124989363|NCT01323972|449586179|FG000|Overall Study|Migrated/moved from study area|1|||
124989364|NCT01323972|449586180|FG001|Overall Study|Migrated/moved from study area|2|||
124989365|NCT01323972|449586181|FG002|Overall Study|Migrated/moved from study area|0|||
124989366|NCT01323972|449586182|FG003|Overall Study|Migrated/moved from study area|0|||
124989367|NCT01323972|449586179|FG000|Overall Study|Lost to Follow-up|0|||
124989368|NCT01323972|449586180|FG001|Overall Study|Lost to Follow-up|1|||
124989369|NCT01323972|449586181|FG002|Overall Study|Lost to Follow-up|1|||
124989370|NCT01323972|449586182|FG003|Overall Study|Lost to Follow-up|1|||
124989371|NCT02008877|449586183|FG000|Overall Study|Inevaluable|0|||
124989372|NCT02008877|449586184|FG001|Overall Study|Inevaluable|1|||
124989373|NCT02008877|449586185|FG002|Overall Study|Inevaluable|0|||
124989374|NCT01049217|449586186|FG000|Overall Study|Adverse Event|2|||
125316114|NCT00990106|450786202|FG001|Overall Study|relocation/deployment|1|||
125316115|NCT00990106|450786201|FG000|Overall Study|started exclusionary medication|0|||
125316116|NCT00990106|450786202|FG001|Overall Study|started exclusionary medication|1|||
125316117|NCT00990106|450786201|FG000|Overall Study|planned major surgery|0|||
125316118|NCT00990106|450786202|FG001|Overall Study|planned major surgery|1|||
125316119|NCT00990106|450786201|FG000|Overall Study|scheduling conflicts|0|||
124989375|NCT01049217|449586187|FG001|Overall Study|Adverse Event|1|||
124989376|NCT01049217|449586186|FG000|Overall Study|Lack of Efficacy|1|||
124989377|NCT01049217|449586187|FG001|Overall Study|Lack of Efficacy|1|||
124989378|NCT01049217|449586186|FG000|Overall Study|Lost to Follow-up|3|||
125316120|NCT00990106|450786202|FG001|Overall Study|scheduling conflicts|2|||
124989379|NCT01049217|449586187|FG001|Overall Study|Lost to Follow-up|8|||
124989380|NCT01049217|449586186|FG000|Overall Study|Withdrawal by Subject|4|||
124989381|NCT01049217|449586187|FG001|Overall Study|Withdrawal by Subject|3|||
124989382|NCT01049217|449586186|FG000|Overall Study|Protocol Violation|1|||
124989383|NCT01049217|449586187|FG001|Overall Study|Protocol Violation|3|||
124989384|NCT01049217|449586186|FG000|Overall Study|Pregnancy|1|||
125316121|NCT00410956|450786203|FG000|Overall Study|Adverse Event|1|||
125316122|NCT00410956|450786203|FG000|Overall Study|Death|2|||
125316123|NCT00410956|450786203|FG000|Overall Study|Lack of Efficacy|10|||
125316124|NCT00410956|450786203|FG000|Overall Study|Physician Decision|6|||
125316125|NCT01650194|450786204|FG000|Overall Study|Progressive Disease (PD)|35|||
125316126|NCT01650194|450786204|FG000|Overall Study|Withdrawal by Subject|2|||
125316127|NCT01650194|450786204|FG000|Overall Study|Miscellaneous|10|||
125316128|NCT00880698|450786207|FG000|Overall Study|Death|0|||
125316129|NCT00880698|450786208|FG001|Overall Study|Death|0|||
125316130|NCT00880698|450786209|FG002|Overall Study|Death|1|||
125316131|NCT00880698|450786210|FG003|Overall Study|Death|2|||
125316132|NCT00880698|450786207|FG000|Overall Study|Lost to Follow-up|1|||
125316133|NCT00880698|450786208|FG001|Overall Study|Lost to Follow-up|3|||
125316134|NCT00880698|450786209|FG002|Overall Study|Lost to Follow-up|0|||
125316135|NCT00880698|450786210|FG003|Overall Study|Lost to Follow-up|1|||
125316136|NCT04158583|450786213|FG000|Overall Study|Withdrawal by Subject|1|||
125316137|NCT04158583|450786214|FG001|Overall Study|Withdrawal by Subject|1|||
125316138|NCT04158583|450786215|FG002|Overall Study|Withdrawal by Subject|0|||
125316139|NCT04158583|450786216|FG003|Overall Study|Withdrawal by Subject|0|||
125316140|NCT04158583|450786217|FG004|Overall Study|Withdrawal by Subject|1|||
125316141|NCT04158583|450786218|FG005|Overall Study|Withdrawal by Subject|0|||
125316142|NCT04158583|450786219|FG006|Overall Study|Withdrawal by Subject|0|||
125316143|NCT04158583|450786220|FG007|Overall Study|Withdrawal by Subject|0|||
125316144|NCT04158583|450786221|FG008|Overall Study|Withdrawal by Subject|2|||
125316145|NCT04158583|450786222|FG009|Overall Study|Withdrawal by Subject|0|||
125316146|NCT04158583|450786213|FG000|Overall Study|Study Terminated by Sponsor|0|||
125316147|NCT04158583|450786214|FG001|Overall Study|Study Terminated by Sponsor|0|||
125316148|NCT04158583|450786215|FG002|Overall Study|Study Terminated by Sponsor|0|||
125316149|NCT04158583|450786216|FG003|Overall Study|Study Terminated by Sponsor|1|||
125316150|NCT04158583|450786217|FG004|Overall Study|Study Terminated by Sponsor|0|||
125316151|NCT04158583|450786218|FG005|Overall Study|Study Terminated by Sponsor|0|||
125316152|NCT04158583|450786219|FG006|Overall Study|Study Terminated by Sponsor|0|||
125316153|NCT04158583|450786220|FG007|Overall Study|Study Terminated by Sponsor|0|||
125316154|NCT04158583|450786221|FG008|Overall Study|Study Terminated by Sponsor|0|||
125316155|NCT04158583|450786222|FG009|Overall Study|Study Terminated by Sponsor|0|||
125316156|NCT04158583|450786213|FG000|Overall Study|Progressive Disease|1|||
125316157|NCT04158583|450786214|FG001|Overall Study|Progressive Disease|0|||
125316158|NCT04158583|450786215|FG002|Overall Study|Progressive Disease|3|||
125316159|NCT04158583|450786216|FG003|Overall Study|Progressive Disease|5|||
125316160|NCT04158583|450786217|FG004|Overall Study|Progressive Disease|0|||
125316161|NCT04158583|450786218|FG005|Overall Study|Progressive Disease|1|||
125316162|NCT04158583|450786219|FG006|Overall Study|Progressive Disease|6|||
125316163|NCT04158583|450786220|FG007|Overall Study|Progressive Disease|2|||
125316164|NCT04158583|450786221|FG008|Overall Study|Progressive Disease|1|||
125316165|NCT04158583|450786222|FG009|Overall Study|Progressive Disease|2|||
125316166|NCT04158583|450786213|FG000|Overall Study|Lost to Follow-up|0|||
125316167|NCT04158583|450786214|FG001|Overall Study|Lost to Follow-up|0|||
125316168|NCT04158583|450786215|FG002|Overall Study|Lost to Follow-up|1|||
125316169|NCT04158583|450786216|FG003|Overall Study|Lost to Follow-up|1|||
125316170|NCT04158583|450786217|FG004|Overall Study|Lost to Follow-up|1|||
125316171|NCT04158583|450786218|FG005|Overall Study|Lost to Follow-up|0|||
125316172|NCT04158583|450786219|FG006|Overall Study|Lost to Follow-up|0|||
125316173|NCT04158583|450786220|FG007|Overall Study|Lost to Follow-up|0|||
125316174|NCT04158583|450786221|FG008|Overall Study|Lost to Follow-up|0|||
125316175|NCT04158583|450786222|FG009|Overall Study|Lost to Follow-up|0|||
125316176|NCT04158583|450786213|FG000|Overall Study|Due To Patient Status|0|||
125316177|NCT04158583|450786214|FG001|Overall Study|Due To Patient Status|0|||
125316178|NCT04158583|450786215|FG002|Overall Study|Due To Patient Status|0|||
125316179|NCT04158583|450786216|FG003|Overall Study|Due To Patient Status|0|||
124989385|NCT01049217|449586187|FG001|Overall Study|Pregnancy|0|||
124989386|NCT01049217|449586186|FG000|Overall Study|Study Terminated by Sponsor|43|||
124989387|NCT01049217|449586187|FG001|Overall Study|Study Terminated by Sponsor|43|||
124989388|NCT01049217|449586186|FG000|Overall Study|Other|1|||
124989389|NCT01049217|449586187|FG001|Overall Study|Other|2|||
124989390|NCT01049217|449586186|FG000|Overall Study|Randomized but not Treated|0|||
125316180|NCT04158583|450786217|FG004|Overall Study|Due To Patient Status|0|||
125316181|NCT04158583|450786218|FG005|Overall Study|Due To Patient Status|0|||
125316182|NCT04158583|450786219|FG006|Overall Study|Due To Patient Status|0|||
125316183|NCT04158583|450786220|FG007|Overall Study|Due To Patient Status|0|||
125316184|NCT04158583|450786221|FG008|Overall Study|Due To Patient Status|1|||
124989391|NCT01049217|449586187|FG001|Overall Study|Randomized but not Treated|2|||
125316185|NCT04158583|450786222|FG009|Overall Study|Due To Patient Status|0|||
125316186|NCT04158583|450786213|FG000|Overall Study|Death|3|||
125316187|NCT04158583|450786214|FG001|Overall Study|Death|4|||
125316188|NCT04158583|450786215|FG002|Overall Study|Death|2|||
125316189|NCT04158583|450786216|FG003|Overall Study|Death|2|||
125316190|NCT04158583|450786217|FG004|Overall Study|Death|4|||
124989392|NCT00903682|449586188|FG000|Overall Study|Adverse Event|6|||
125316191|NCT04158583|450786218|FG005|Overall Study|Death|3|||
125316192|NCT04158583|450786219|FG006|Overall Study|Death|5|||
125316193|NCT04158583|450786220|FG007|Overall Study|Death|2|||
124989393|NCT00903682|449586189|FG001|Overall Study|Adverse Event|13|||
124989394|NCT00903682|449586188|FG000|Overall Study|Lost to Follow-up|1|||
124989395|NCT00903682|449586189|FG001|Overall Study|Lost to Follow-up|0|||
124989396|NCT00903682|449586188|FG000|Overall Study|Withdrawal by Subject|5|||
124989397|NCT00903682|449586189|FG001|Overall Study|Withdrawal by Subject|0|||
124989398|NCT00903682|449586188|FG000|Overall Study|Pregnancy|0|||
124989399|NCT00903682|449586189|FG001|Overall Study|Pregnancy|1|||
124989400|NCT00903682|449586188|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
124989401|NCT00903682|449586189|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
124989402|NCT00903682|449586188|FG000|Overall Study|Subject Non-Compliant|1|||
124989403|NCT00903682|449586189|FG001|Overall Study|Subject Non-Compliant|0|||
124989404|NCT00903682|449586188|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
124989405|NCT00903682|449586189|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
124989406|NCT00903682|449586188|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
124989407|NCT00903682|449586189|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
124989408|NCT02495792|449586190|FG000|Overall Study|Lost to Follow-up|5|||
124989409|NCT02495792|449586191|FG001|Overall Study|Lost to Follow-up|9|||
124989410|NCT02495792|449586190|FG000|Overall Study|Protocol Violation|32|||
124989411|NCT02495792|449586191|FG001|Overall Study|Protocol Violation|31|||
124989412|NCT03141905|449586194|FG000|Overall Study|Death|3|||
124989413|NCT03141905|449586195|FG001|Overall Study|Death|2|||
124989414|NCT03141905|449586194|FG000|Overall Study|Withdrawal by Subject|1|||
124989415|NCT03141905|449586195|FG001|Overall Study|Withdrawal by Subject|0|||
124989416|NCT03141905|449586194|FG000|Overall Study|Lost to Follow-up|3|||
124989417|NCT03141905|449586195|FG001|Overall Study|Lost to Follow-up|7|||
124989418|NCT03141905|449586194|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
124989419|NCT03141905|449586195|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
124989420|NCT02502799|449588200|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
124989421|NCT02502799|449588201|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
124989422|NCT02502799|449588202|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
124989423|NCT02502799|449588203|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
124989424|NCT02502799|449588200|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
124989425|NCT02502799|449588201|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
124989426|NCT02502799|449588202|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
124989427|NCT02502799|449588203|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
124989428|NCT02502799|449588200|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
124989429|NCT02502799|449588201|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
124989430|NCT02502799|449588202|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
124989431|NCT02502799|449588203|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
124989432|NCT02502799|449588200|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
124989433|NCT02502799|449588201|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
124989434|NCT02502799|449588202|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
124989435|NCT02502799|449588203|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
124989436|NCT02502799|449588200|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
124989437|NCT02502799|449588201|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
124989438|NCT02502799|449588202|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
124989439|NCT02502799|449588203|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
124989440|NCT01076192|449588217|FG000|Overall Study|Other|197|||
124989441|NCT05087979|449588218|FG000|Overall Study|Converted to general anesthesia|1|||
124989442|NCT05087979|449588219|FG001|Overall Study|Converted to general anesthesia|0|||
124989443|NCT02924428|449588220|FG000|Overall Study|Adverse Event|1|||
124989444|NCT02924428|449588221|FG001|Overall Study|Adverse Event|0|||
124989445|NCT02924428|449588220|FG000|Overall Study|Physician Decision|1|||
124989446|NCT02924428|449588221|FG001|Overall Study|Physician Decision|0|||
124989447|NCT02924428|449588220|FG000|Overall Study|Lost to Follow-up|2|||
124989448|NCT02924428|449588221|FG001|Overall Study|Lost to Follow-up|4|||
124989449|NCT02924428|449588220|FG000|Overall Study|Pregnancy|0|||
124989450|NCT02924428|449588221|FG001|Overall Study|Pregnancy|1|||
124989451|NCT01850446|449588222|FG000|Overall Study|Lack of Efficacy|1|||
124989452|NCT01850446|449588223|FG001|Overall Study|Lack of Efficacy|0|||
124989453|NCT01850446|449588222|FG000|Overall Study|Withdrawal by Subject|4|||
124989454|NCT01850446|449588223|FG001|Overall Study|Withdrawal by Subject|0|||
124989455|NCT01850446|449588222|FG000|Overall Study|Protocol Violation|0|||
124989456|NCT01850446|449588223|FG001|Overall Study|Protocol Violation|2|||
124989457|NCT02680002|449588224|FG000|Overall Study|Lost to Follow-up|5|||
124989458|NCT02680002|449588225|FG001|Overall Study|Lost to Follow-up|1|||
124989459|NCT02680002|449588226|FG002|Overall Study|Lost to Follow-up|4|||
124989460|NCT02680002|449588227|FG003|Overall Study|Lost to Follow-up|2|||
124989461|NCT02680002|449588228|FG004|Overall Study|Lost to Follow-up|0|||
124989462|NCT02680002|449588229|FG005|Overall Study|Lost to Follow-up|2|||
124989463|NCT02680002|449588224|FG000|Overall Study|Physician Decision|5|||
124989464|NCT02680002|449588225|FG001|Overall Study|Physician Decision|1|||
124989465|NCT02680002|449588226|FG002|Overall Study|Physician Decision|1|||
125316194|NCT04158583|450786221|FG008|Overall Study|Death|0|||
125316195|NCT04158583|450786222|FG009|Overall Study|Death|1|||
125316196|NCT04158583|450786213|FG000|Overall Study|Clinical Progression Disease|0|||
124989466|NCT02680002|449588227|FG003|Overall Study|Physician Decision|1|||
124989467|NCT02680002|449588228|FG004|Overall Study|Physician Decision|1|||
124989468|NCT02680002|449588229|FG005|Overall Study|Physician Decision|1|||
124989469|NCT02680002|449588224|FG000|Overall Study|Protocol Violation|1|||
124989470|NCT02680002|449588225|FG001|Overall Study|Protocol Violation|0|||
124989471|NCT02680002|449588226|FG002|Overall Study|Protocol Violation|1|||
124989472|NCT02680002|449588227|FG003|Overall Study|Protocol Violation|0|||
124989473|NCT02680002|449588228|FG004|Overall Study|Protocol Violation|1|||
124989474|NCT02680002|449588229|FG005|Overall Study|Protocol Violation|2|||
124989475|NCT02680002|449588224|FG000|Overall Study|Withdrawal by Subject|0|||
124989476|NCT02680002|449588225|FG001|Overall Study|Withdrawal by Subject|0|||
124989477|NCT02680002|449588226|FG002|Overall Study|Withdrawal by Subject|1|||
124989478|NCT02680002|449588227|FG003|Overall Study|Withdrawal by Subject|0|||
124989479|NCT02680002|449588228|FG004|Overall Study|Withdrawal by Subject|2|||
124989480|NCT02680002|449588229|FG005|Overall Study|Withdrawal by Subject|2|||
124989481|NCT02680002|449588224|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
124989482|NCT02680002|449588225|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
124989483|NCT02680002|449588226|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
124989484|NCT02680002|449588227|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
124989485|NCT02680002|449588228|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
124989486|NCT02680002|449588229|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
124989487|NCT02680002|449588224|FG000|Overall Study|Other|0|||
124989488|NCT02680002|449588225|FG001|Overall Study|Other|1|||
124989489|NCT02680002|449588226|FG002|Overall Study|Other|0|||
124989490|NCT02680002|449588227|FG003|Overall Study|Other|0|||
124989491|NCT02680002|449588228|FG004|Overall Study|Other|1|||
124989492|NCT02680002|449588229|FG005|Overall Study|Other|0|||
124989493|NCT02680002|449588224|FG000|Overall Study|Adverse Event|0|||
124989494|NCT02680002|449588225|FG001|Overall Study|Adverse Event|0|||
124989495|NCT02680002|449588226|FG002|Overall Study|Adverse Event|0|||
124989496|NCT02680002|449588227|FG003|Overall Study|Adverse Event|0|||
124989497|NCT02680002|449588228|FG004|Overall Study|Adverse Event|1|||
124989498|NCT02680002|449588229|FG005|Overall Study|Adverse Event|2|||
124989499|NCT00759915|449588230|FG000|Overall Study|Withdrawal by Subject|1|||
124989500|NCT00759915|449588231|FG001|Overall Study|Withdrawal by Subject|0|||
124989501|NCT00759915|449588230|FG000|Overall Study|Adverse Event|0|||
124989502|NCT00759915|449588231|FG001|Overall Study|Adverse Event|1|||
124989503|NCT03527173|449588234|FG000|Overall Study|Lost to Follow-up|4|||
124989504|NCT03527173|449588235|FG001|Overall Study|Lost to Follow-up|2|||
124989505|NCT03527173|449588234|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
124989506|NCT03527173|449588235|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
124989507|NCT03527173|449588234|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
124989508|NCT03527173|449588235|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
124989509|NCT03527173|449588234|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
124989510|NCT03527173|449588235|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
124989511|NCT01248780|449588240|FG000|Overall Study|Lack of Efficacy|2|||
124989512|NCT01248780|449588241|FG001|Overall Study|Lack of Efficacy|0|||
124989513|NCT01248780|449588240|FG000|Overall Study|Lost to Follow-up|0|||
124989514|NCT01248780|449588241|FG001|Overall Study|Lost to Follow-up|1|||
124989515|NCT01248780|449588240|FG000|Overall Study|Death|0|||
124989516|NCT01248780|449588241|FG001|Overall Study|Death|1|||
124989517|NCT01248780|449588240|FG000|Overall Study|Adverse Event|2|||
124989518|NCT01248780|449588241|FG001|Overall Study|Adverse Event|7|||
124989519|NCT01248780|449588240|FG000|Overall Study|Protocol Violation|1|||
124989520|NCT01248780|449588241|FG001|Overall Study|Protocol Violation|1|||
124989521|NCT01248780|449588240|FG000|Overall Study|Withdrawal by Subject|4|||
124989522|NCT01248780|449588241|FG001|Overall Study|Withdrawal by Subject|4|||
124989523|NCT01248780|449588240|FG000|Overall Study|Not treated|0|||
124989524|NCT01248780|449588241|FG001|Overall Study|Not treated|1|||
124989525|NCT04097301|449588242|FG000|Overall Study|Death|1|||
124989526|NCT04097301|449588242|FG000|Overall Study|Withdrawal by Subject|1|||
125316197|NCT04158583|450786214|FG001|Overall Study|Clinical Progression Disease|0|||
125316198|NCT04158583|450786215|FG002|Overall Study|Clinical Progression Disease|0|||
124989527|NCT04097301|449588242|FG000|Overall Study|Screening Failure|5|||
124989528|NCT00203476|449588243|FG000|Overall Study|Lost to Follow-up|1|||
124989529|NCT00203476|449588244|FG001|Overall Study|Lost to Follow-up|0|||
124989530|NCT00203476|449588245|FG002|Overall Study|Lost to Follow-up|0|||
124989531|NCT00203476|449588243|FG000|Overall Study|Withdrawal by Subject|0|||
124989532|NCT00203476|449588244|FG001|Overall Study|Withdrawal by Subject|1|||
124989533|NCT00203476|449588245|FG002|Overall Study|Withdrawal by Subject|0|||
124989534|NCT01190514|449588246|FG000|First Intervention (Period 1)|Adverse Event|1|||
124989535|NCT01190514|449588247|FG001|First Intervention (Period 1)|Adverse Event|0|||
124989536|NCT01190514|449588248|FG002|First Intervention (Period 1)|Adverse Event|0|||
124989537|NCT01190514|449588249|FG003|First Intervention (Period 1)|Adverse Event|0|||
124989538|NCT01190514|449588246|FG000|Third Intervention (Period 3)|Adverse Event|1|||
124989539|NCT01190514|449588247|FG001|Third Intervention (Period 3)|Adverse Event|0|||
124989540|NCT01190514|449588248|FG002|Third Intervention (Period 3)|Adverse Event|0|||
124989541|NCT01190514|449588249|FG003|Third Intervention (Period 3)|Adverse Event|0|||
124989542|NCT01813929|449588250|FG000|Overall Study|Withdrawal by Subject|0|||
124989543|NCT01813929|449588251|FG001|Overall Study|Withdrawal by Subject|1|||
124989544|NCT04101318|449588252|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
124989545|NCT04101318|449588253|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
124989546|NCT04101318|449588252|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
124989547|NCT04101318|449588253|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
124989548|NCT04101318|449588252|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
124989549|NCT04101318|449588253|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
124989550|NCT01874431|449588254|FG000|Overall Study|Physician Decision|0|||
124989551|NCT01874431|449588255|FG001|Overall Study|Physician Decision|0|||
124989552|NCT01874431|449588256|FG002|Overall Study|Physician Decision|1|||
124989553|NCT01874431|449588257|FG003|Overall Study|Physician Decision|0|||
124989554|NCT01874431|449588258|FG004|Overall Study|Physician Decision|0|||
124989555|NCT01874431|449588259|FG005|Overall Study|Physician Decision|0|||
125316199|NCT04158583|450786216|FG003|Overall Study|Clinical Progression Disease|1|||
125316200|NCT04158583|450786217|FG004|Overall Study|Clinical Progression Disease|0|||
125316201|NCT04158583|450786218|FG005|Overall Study|Clinical Progression Disease|0|||
125316202|NCT04158583|450786219|FG006|Overall Study|Clinical Progression Disease|0|||
125316203|NCT04158583|450786220|FG007|Overall Study|Clinical Progression Disease|0|||
125316204|NCT04158583|450786221|FG008|Overall Study|Clinical Progression Disease|0|||
125316205|NCT04158583|450786222|FG009|Overall Study|Clinical Progression Disease|0|||
125316206|NCT04158583|450786213|FG000|Overall Study|Clinical Progression|0|||
124989556|NCT01874431|449588260|FG006|Overall Study|Physician Decision|0|||
124989557|NCT01874431|449588261|FG007|Overall Study|Physician Decision|0|||
124989558|NCT01874431|449588254|FG000|Overall Study|Adverse Event|5|||
124989559|NCT01874431|449588255|FG001|Overall Study|Adverse Event|4|||
125316207|NCT04158583|450786214|FG001|Overall Study|Clinical Progression|0|||
125316208|NCT04158583|450786215|FG002|Overall Study|Clinical Progression|0|||
125316209|NCT04158583|450786216|FG003|Overall Study|Clinical Progression|0|||
125316210|NCT04158583|450786217|FG004|Overall Study|Clinical Progression|1|||
125316211|NCT04158583|450786218|FG005|Overall Study|Clinical Progression|0|||
125316212|NCT04158583|450786219|FG006|Overall Study|Clinical Progression|2|||
125316213|NCT04158583|450786220|FG007|Overall Study|Clinical Progression|0|||
125316214|NCT04158583|450786221|FG008|Overall Study|Clinical Progression|0|||
125316215|NCT04158583|450786222|FG009|Overall Study|Clinical Progression|0|||
125316216|NCT04158583|450786213|FG000|Overall Study|Clinical Deterioration|0|||
125316217|NCT04158583|450786214|FG001|Overall Study|Clinical Deterioration|0|||
125316218|NCT04158583|450786215|FG002|Overall Study|Clinical Deterioration|0|||
125316219|NCT04158583|450786216|FG003|Overall Study|Clinical Deterioration|1|||
125316220|NCT04158583|450786217|FG004|Overall Study|Clinical Deterioration|0|||
125316221|NCT04158583|450786218|FG005|Overall Study|Clinical Deterioration|0|||
125316222|NCT04158583|450786219|FG006|Overall Study|Clinical Deterioration|0|||
125316223|NCT04158583|450786220|FG007|Overall Study|Clinical Deterioration|0|||
125316224|NCT04158583|450786221|FG008|Overall Study|Clinical Deterioration|0|||
125316225|NCT04158583|450786222|FG009|Overall Study|Clinical Deterioration|1|||
125316226|NCT00320515|450786223|FG000|Overall Study|Death|33|||
125316227|NCT00320515|450786223|FG000|Overall Study|Lost to Follow-up|6|||
125316228|NCT00320515|450786223|FG000|Overall Study|Physician Decision|2|||
125316229|NCT00320515|450786223|FG000|Overall Study|Withdrawal by Subject|8|||
125316230|NCT01777776|450786224|FG000|Overall Study|Adverse Event|2|||
125316231|NCT01777776|450786225|FG001|Overall Study|Adverse Event|4|||
125316232|NCT01777776|450786226|FG002|Overall Study|Adverse Event|0|||
125316233|NCT01777776|450786227|FG003|Overall Study|Adverse Event|0|||
125316234|NCT01777776|450786224|FG000|Overall Study|Disease Progression|4|||
125316235|NCT01777776|450786225|FG001|Overall Study|Disease Progression|8|||
125316236|NCT01777776|450786226|FG002|Overall Study|Disease Progression|6|||
125316237|NCT01777776|450786227|FG003|Overall Study|Disease Progression|3|||
125316238|NCT01777776|450786224|FG000|Overall Study|Withdrawal by Subject|0|||
125316239|NCT01777776|450786225|FG001|Overall Study|Withdrawal by Subject|0|||
124989560|NCT01874431|449588256|FG002|Overall Study|Adverse Event|6|||
124989561|NCT01874431|449588257|FG003|Overall Study|Adverse Event|5|||
124989562|NCT01874431|449588258|FG004|Overall Study|Adverse Event|2|||
124989563|NCT01874431|449588259|FG005|Overall Study|Adverse Event|8|||
124989564|NCT01874431|449588260|FG006|Overall Study|Adverse Event|2|||
124989565|NCT01874431|449588261|FG007|Overall Study|Adverse Event|3|||
124989566|NCT01874431|449588254|FG000|Overall Study|Protocol Violation|1|||
124989567|NCT01874431|449588255|FG001|Overall Study|Protocol Violation|1|||
125316240|NCT01777776|450786226|FG002|Overall Study|Withdrawal by Subject|0|||
125316241|NCT01777776|450786227|FG003|Overall Study|Withdrawal by Subject|1|||
125316242|NCT00851786|450786228|FG000|Overall Study|Withdrawal by Subject|0|||
125316243|NCT00851786|450786229|FG001|Overall Study|Withdrawal by Subject|1|||
125316244|NCT00851786|450786228|FG000|Overall Study|Protocol Violation|0|||
124989568|NCT01874431|449588256|FG002|Overall Study|Protocol Violation|1|||
124989569|NCT01874431|449588257|FG003|Overall Study|Protocol Violation|0|||
124989570|NCT01874431|449588258|FG004|Overall Study|Protocol Violation|3|||
124989571|NCT01874431|449588259|FG005|Overall Study|Protocol Violation|2|||
124989572|NCT01874431|449588260|FG006|Overall Study|Protocol Violation|1|||
124989573|NCT01874431|449588261|FG007|Overall Study|Protocol Violation|1|||
124989574|NCT01874431|449588254|FG000|Overall Study|Non-compliance|0|||
124989575|NCT01874431|449588255|FG001|Overall Study|Non-compliance|0|||
124989576|NCT01874431|449588256|FG002|Overall Study|Non-compliance|0|||
124989577|NCT01874431|449588257|FG003|Overall Study|Non-compliance|0|||
124989578|NCT01874431|449588258|FG004|Overall Study|Non-compliance|1|||
124989579|NCT01874431|449588259|FG005|Overall Study|Non-compliance|0|||
124989580|NCT01874431|449588260|FG006|Overall Study|Non-compliance|1|||
124989581|NCT01874431|449588261|FG007|Overall Study|Non-compliance|0|||
124989582|NCT01874431|449588254|FG000|Overall Study|Logistical difficulties|0|||
124989583|NCT01874431|449588255|FG001|Overall Study|Logistical difficulties|0|||
124989584|NCT01874431|449588256|FG002|Overall Study|Logistical difficulties|0|||
124989585|NCT01874431|449588257|FG003|Overall Study|Logistical difficulties|0|||
124989586|NCT01874431|449588258|FG004|Overall Study|Logistical difficulties|0|||
124989587|NCT01874431|449588259|FG005|Overall Study|Logistical difficulties|0|||
124989588|NCT01874431|449588260|FG006|Overall Study|Logistical difficulties|1|||
124989589|NCT01874431|449588261|FG007|Overall Study|Logistical difficulties|0|||
124989590|NCT01874431|449588254|FG000|Overall Study|Withdrawal by Subject|0|||
124989591|NCT01874431|449588255|FG001|Overall Study|Withdrawal by Subject|0|||
124989592|NCT01874431|449588256|FG002|Overall Study|Withdrawal by Subject|1|||
124989593|NCT01874431|449588257|FG003|Overall Study|Withdrawal by Subject|2|||
124989594|NCT01874431|449588258|FG004|Overall Study|Withdrawal by Subject|1|||
124989595|NCT01874431|449588259|FG005|Overall Study|Withdrawal by Subject|1|||
124989596|NCT01874431|449588260|FG006|Overall Study|Withdrawal by Subject|3|||
124989597|NCT01874431|449588261|FG007|Overall Study|Withdrawal by Subject|0|||
124989598|NCT01874431|449588254|FG000|Overall Study|Sponsor decision|0|||
124989599|NCT01874431|449588255|FG001|Overall Study|Sponsor decision|0|||
124989600|NCT01874431|449588256|FG002|Overall Study|Sponsor decision|0|||
124989601|NCT01874431|449588257|FG003|Overall Study|Sponsor decision|0|||
124989602|NCT01874431|449588258|FG004|Overall Study|Sponsor decision|1|||
124989603|NCT01874431|449588259|FG005|Overall Study|Sponsor decision|0|||
124989604|NCT01874431|449588260|FG006|Overall Study|Sponsor decision|0|||
124989605|NCT01874431|449588261|FG007|Overall Study|Sponsor decision|0|||
124989606|NCT01874431|449588254|FG000|Overall Study|Lost to Follow-up|0|||
124989607|NCT01874431|449588255|FG001|Overall Study|Lost to Follow-up|0|||
124989608|NCT01874431|449588256|FG002|Overall Study|Lost to Follow-up|1|||
124989609|NCT01874431|449588257|FG003|Overall Study|Lost to Follow-up|0|||
124989610|NCT01874431|449588258|FG004|Overall Study|Lost to Follow-up|0|||
124989611|NCT01874431|449588259|FG005|Overall Study|Lost to Follow-up|0|||
124989612|NCT01874431|449588260|FG006|Overall Study|Lost to Follow-up|0|||
124989613|NCT01874431|449588261|FG007|Overall Study|Lost to Follow-up|0|||
124989614|NCT00642772|449588262|FG000|Overall Study|Lost to Follow-up|3|||
124989615|NCT00642772|449588262|FG000|Overall Study|Withdrawal by Subject|7|||
124989616|NCT00757588|449588263|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
124989617|NCT00757588|449588264|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
124989618|NCT00757588|449588263|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
124989619|NCT00757588|449588264|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
124989620|NCT00757588|449588263|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
124989621|NCT00757588|449588264|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
124989622|NCT00757588|449588263|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
124989623|NCT00757588|449588264|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
124989624|NCT00757588|449588263|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
124989625|NCT00757588|449588264|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
124989626|NCT00757588|449588263|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
124989627|NCT00757588|449588264|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
124989628|NCT00757588|449588263|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
124989629|NCT00757588|449588264|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
124989630|NCT00757588|449588263|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
124989631|NCT00757588|449588264|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
124989632|NCT00757588|449588263|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
124989633|NCT00757588|449588264|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
124989634|NCT00757588|449588263|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
124989635|NCT00757588|449588264|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
124989636|NCT00757588|449588263|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
124989637|NCT00757588|449588264|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
124989638|NCT00757588|449588263|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
124989639|NCT00757588|449588264|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
124989640|NCT00757588|449588263|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
125316245|NCT00851786|450786229|FG001|Overall Study|Protocol Violation|1|||
125316246|NCT00851786|450786228|FG000|Overall Study|Lost to Follow-up|1|||
125316247|NCT00851786|450786229|FG001|Overall Study|Lost to Follow-up|0|||
125316248|NCT00851786|450786228|FG000|Overall Study|Incarceration|1|||
125316249|NCT00851786|450786229|FG001|Overall Study|Incarceration|0|||
125316250|NCT00851786|450786228|FG000|Overall Study|Site Closure|1|||
125316251|NCT00851786|450786229|FG001|Overall Study|Site Closure|0|||
125316252|NCT00851786|450786228|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
125316253|NCT00851786|450786229|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
125316254|NCT03737123|450788374|FG000|Study Treatment|Adverse Event|2|||
125316255|NCT03737123|450788375|FG001|Study Treatment|Adverse Event|0|||
125316256|NCT03737123|450788374|FG000|Study Treatment|Disease Progression|2|||
125316257|NCT03737123|450788375|FG001|Study Treatment|Disease Progression|0|||
125316258|NCT03737123|450788374|FG000|Study Treatment|Withdrawal by Subject|2|||
125316259|NCT03737123|450788375|FG001|Study Treatment|Withdrawal by Subject|0|||
125316260|NCT03737123|450788374|FG000|Follow up|Death|1|||
125316261|NCT03737123|450788375|FG001|Follow up|Death|0|||
125316262|NCT03737123|450788374|FG000|Follow up|Withdrawal by Subject|1|||
125316263|NCT03737123|450788375|FG001|Follow up|Withdrawal by Subject|0|||
125316264|NCT03737123|450788374|FG000|Follow up|Termination of study|4|||
125316265|NCT03737123|450788375|FG001|Follow up|Termination of study|0|||
125316266|NCT04233801|450788387|FG000|Overall Study|Other than listed|0|||
125316267|NCT04233801|450788388|FG001|Overall Study|Other than listed|0|||
125316268|NCT04233801|450788389|FG002|Overall Study|Other than listed|1|||
125316269|NCT04233801|450788387|FG000|Overall Study|Withdrawal by Subject|0|||
125316270|NCT04233801|450788388|FG001|Overall Study|Withdrawal by Subject|2|||
125316271|NCT04233801|450788389|FG002|Overall Study|Withdrawal by Subject|3|||
125316272|NCT01169103|450788391|FG000|Overall Study|Lost to Follow-up|3|||
125316273|NCT01169103|450788392|FG001|Overall Study|Lost to Follow-up|3|||
125316274|NCT01169103|450788391|FG000|Overall Study|Withdrawal by Subject|3|||
125316275|NCT01169103|450788392|FG001|Overall Study|Withdrawal by Subject|1|||
125316276|NCT02792231|450788397|FG000|Overall Study|Patient/guardian decision|32|||
125316277|NCT02792231|450788398|FG001|Overall Study|Patient/guardian decision|42|||
125316278|NCT02792231|450788397|FG000|Overall Study|Adverse Event|15|||
125316279|NCT02792231|450788398|FG001|Overall Study|Adverse Event|11|||
125316280|NCT02792231|450788397|FG000|Overall Study|Physician Decision|14|||
125316281|NCT02792231|450788398|FG001|Overall Study|Physician Decision|12|||
125316282|NCT02792231|450788397|FG000|Overall Study|Lack of Efficacy|7|||
125316283|NCT02792231|450788398|FG001|Overall Study|Lack of Efficacy|9|||
125316284|NCT02792231|450788397|FG000|Overall Study|Lost to Follow-up|9|||
125316285|NCT02792231|450788398|FG001|Overall Study|Lost to Follow-up|5|||
125316286|NCT02792231|450788397|FG000|Overall Study|Pregnancy|1|||
125316287|NCT02792231|450788398|FG001|Overall Study|Pregnancy|3|||
125316288|NCT02792231|450788397|FG000|Overall Study|Non-compliance with study treatment|2|||
125316289|NCT02792231|450788398|FG001|Overall Study|Non-compliance with study treatment|1|||
125316290|NCT02792231|450788397|FG000|Overall Study|Protocol deviation|2|||
125316291|NCT02792231|450788398|FG001|Overall Study|Protocol deviation|0|||
125316292|NCT02792231|450788397|FG000|Overall Study|Technical problems|0|||
125316293|NCT02792231|450788398|FG001|Overall Study|Technical problems|1|||
125316294|NCT05196828|450788399|FG000|Overall Study|Withdrawal by Subject|2|||
125316295|NCT05196828|450788400|FG001|Overall Study|Withdrawal by Subject|0|||
125316296|NCT05196828|450788399|FG000|Overall Study|Lost to Follow-up|0|||
125316297|NCT05196828|450788400|FG001|Overall Study|Lost to Follow-up|4|||
125316298|NCT05196828|450788399|FG000|Overall Study|Adverse Event|1|||
125316299|NCT05196828|450788400|FG001|Overall Study|Adverse Event|0|||
124989641|NCT00757588|449588264|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
124989642|NCT00757588|449588263|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
124989643|NCT00757588|449588264|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
124989644|NCT00757588|449588263|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
124989645|NCT00757588|449588264|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
124989646|NCT00757588|449588263|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
124989647|NCT00757588|449588264|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
124989648|NCT05398237|449588265|FG000|Overall Study|Withdrawal by Subject|1|||
124989649|NCT03271021|449588271|FG000|Overall Study|Adverse Event|3|||
124989650|NCT03271021|449588272|FG001|Overall Study|Adverse Event|2|||
124989651|NCT03271021|449588271|FG000|Overall Study|Withdrawal by Subject|36|||
124989652|NCT03271021|449588272|FG001|Overall Study|Withdrawal by Subject|53|||
124989653|NCT03271021|449588271|FG000|Overall Study|Lost to Follow-up|34|||
124989654|NCT03271021|449588272|FG001|Overall Study|Lost to Follow-up|39|||
124989655|NCT03271021|449588271|FG000|Overall Study|Protocol Violation|6|||
125316300|NCT02469623|450788401|FG000|Overall Study|Not consented for long-term follow-up|4|||
125316301|NCT02469623|450788401|FG000|Overall Study|Lost to Follow-up|4|||
125316302|NCT02469623|450788401|FG000|Overall Study|Withdrawal by Subject|2|||
125316303|NCT02469623|450788401|FG000|Overall Study|Death|3|||
125316304|NCT04073186|450788402|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
125316305|NCT04073186|450788402|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
125316306|NCT04073186|450788402|FG000|First Wearing Cycle|Protocol Violation|1|||
125316307|NCT04073186|450788402|FG000|First Wearing Cycle|Lens Discomfort|2|||
124989656|NCT03271021|449588272|FG001|Overall Study|Protocol Violation|4|||
124989657|NCT03271021|449588271|FG000|Overall Study|Abnormal Lab Results|1|||
124989658|NCT03271021|449588272|FG001|Overall Study|Abnormal Lab Results|0|||
124989659|NCT03271021|449588271|FG000|Overall Study|Miscellaneous|9|||
124989660|NCT03271021|449588272|FG001|Overall Study|Miscellaneous|8|||
124989661|NCT01383499|449588273|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
124989662|NCT01383499|449588274|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
124989663|NCT01383499|449588275|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
124989664|NCT01383499|449588276|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
124989665|NCT04275089|449588277|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
124989666|NCT00297232|449588279|FG000|Overall Study|Lack of Efficacy|7|||
124989667|NCT00297232|449588279|FG000|Overall Study|Lost to Follow-up|10|||
124989668|NCT00297232|449588279|FG000|Overall Study|Adverse Event|63|||
124989669|NCT00297232|449588279|FG000|Overall Study|Voluntary Withdrawal|120|||
124989670|NCT00297232|449588279|FG000|Overall Study|Subject was Noncompliant|9|||
124989671|NCT00297232|449588279|FG000|Overall Study|Death|9|||
124989672|NCT00297232|449588279|FG000|Overall Study|Anti-natalizumab Positive|8|||
124989673|NCT00297232|449588279|FG000|Overall Study|Switched to Commercial Tysabri|22|||
124989674|NCT00297232|449588279|FG000|Overall Study|Disease Progression|8|||
124989675|NCT00297232|449588279|FG000|Overall Study|Fear of PML|10|||
124989676|NCT00297232|449588279|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
124989677|NCT00297232|449588279|FG000|Overall Study|Miscellaneous|5|||
124989678|NCT00297232|449588279|FG000|Overall Study|Sponsor Decision|34|||
124989679|NCT00297232|449588279|FG000|Overall Study|Subject Relocated|7|||
124989680|NCT00297232|449588279|FG000|Overall Study|Subject Withdrew Consent|37|||
124989681|NCT00297232|449588279|FG000|Overall Study|Persistently Positive Antibodies|11|||
124989682|NCT00297232|449588279|FG000|Overall Study|Investigator Withdrew From Program|19|||
124989683|NCT00297232|449588279|FG000|Overall Study|Did Not Enroll to Week 264|34|||
124989684|NCT00297232|449588279|FG000|Overall Study|Did Not Enroll to Week 480|17|||
124989685|NCT00297232|449588279|FG000|Overall Study|No data available after Week 264|161|||
124989686|NCT00297232|449588279|FG000|Overall Study|Other|1|||
124989687|NCT03038438|449588282|FG000|Overall Study|Death|3|||
124989688|NCT03038438|449588282|FG000|Overall Study|Lost to Follow-up|8|||
124989689|NCT03038438|449588282|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
124989690|NCT03038438|449588282|FG000|Overall Study|Withdrawal by Subject|5|||
124989691|NCT03038438|449588282|FG000|Overall Study|No 36-Month Follow-Up|18|||
124989692|NCT01656733|449588285|FG000|Overall Study|No permission to collect birth outcomes|0|||
124989693|NCT01656733|449588286|FG001|Overall Study|No permission to collect birth outcomes|1|||
124989694|NCT01656733|449588285|FG000|Overall Study|Delivery at another hospital|0|||
124989695|NCT01656733|449588286|FG001|Overall Study|Delivery at another hospital|2|||
124989696|NCT01656733|449588285|FG000|Overall Study|Spontaneous abortion|0|||
124989697|NCT01656733|449588286|FG001|Overall Study|Spontaneous abortion|1|||
124989698|NCT03625895|449588287|FG000|Overall Study|Protocol Violation|585|||
124989699|NCT01065844|449588288|FG000|Overall Study|Adverse Event|5|||
124989700|NCT02476279|449588289|FG000|Overall Study|Lost to Follow-up|1|||
124989701|NCT02476279|449588290|FG001|Overall Study|Lost to Follow-up|1|||
124989702|NCT00577473|449588293|FG000|Overall Study|Protocol Violation|1|||
124989703|NCT00577473|449588294|FG001|Overall Study|Protocol Violation|4|||
124989704|NCT00577473|449588293|FG000|Overall Study|Adverse Event|8|||
124989705|NCT00577473|449588294|FG001|Overall Study|Adverse Event|5|||
124989706|NCT00577473|449588293|FG000|Overall Study|Withdrawal by Subject|2|||
124989707|NCT00577473|449588294|FG001|Overall Study|Withdrawal by Subject|6|||
124989708|NCT00577473|449588293|FG000|Overall Study|Physician Decision|2|||
124989709|NCT00577473|449588294|FG001|Overall Study|Physician Decision|2|||
124989710|NCT00577473|449588293|FG000|Overall Study|Lack of Efficacy|8|||
124989711|NCT00577473|449588294|FG001|Overall Study|Lack of Efficacy|7|||
124989712|NCT01502631|449588297|FG000|Overall Study|Adverse Event|5|||
124989713|NCT01502631|449588298|FG001|Overall Study|Adverse Event|8|||
124989714|NCT01502631|449588297|FG000|Overall Study|Lost to Follow-up|2|||
124989715|NCT01502631|449588298|FG001|Overall Study|Lost to Follow-up|2|||
124989716|NCT01502631|449588297|FG000|Overall Study|Participant withdrew consent|2|||
124989717|NCT01502631|449588298|FG001|Overall Study|Participant withdrew consent|4|||
124989718|NCT01502631|449588297|FG000|Overall Study|Participant non-compliant|1|||
124989719|NCT01502631|449588298|FG001|Overall Study|Participant non-compliant|0|||
124989720|NCT01502631|449588297|FG000|Overall Study|Investigator's decision|0|||
124989721|NCT01502631|449588298|FG001|Overall Study|Investigator's decision|1|||
124989722|NCT01502631|449588297|FG000|Overall Study|Other|10|||
124989723|NCT01502631|449588298|FG001|Overall Study|Other|5|||
124989724|NCT02084056|449588299|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
124989725|NCT02084056|449588300|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
124989726|NCT02084056|449588301|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
124989727|NCT02084056|449588302|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
124989728|NCT02084056|449588299|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
124989729|NCT02084056|449588300|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
124989730|NCT02084056|449588301|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
124989731|NCT02084056|449588302|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
124989732|NCT01293487|449588303|FG000|Overall Study|Lost to Follow-up|0|||
124989733|NCT01293487|449588304|FG001|Overall Study|Lost to Follow-up|0|||
124989734|NCT01293487|449588305|FG002|Overall Study|Lost to Follow-up|0|||
124989735|NCT01293487|449588306|FG003|Overall Study|Lost to Follow-up|1|||
124989736|NCT01293487|449588307|FG004|Overall Study|Lost to Follow-up|0|||
124989737|NCT01293487|449588308|FG005|Overall Study|Lost to Follow-up|0|||
124989738|NCT01293487|449588309|FG006|Overall Study|Lost to Follow-up|0|||
124989739|NCT01293487|449588310|FG007|Overall Study|Lost to Follow-up|0|||
124989740|NCT01293487|449588303|FG000|Overall Study|Withdrawal by Subject|0|||
124989741|NCT01293487|449588304|FG001|Overall Study|Withdrawal by Subject|0|||
124989742|NCT01293487|449588305|FG002|Overall Study|Withdrawal by Subject|0|||
124989743|NCT01293487|449588306|FG003|Overall Study|Withdrawal by Subject|0|||
124989744|NCT01293487|449588307|FG004|Overall Study|Withdrawal by Subject|0|||
124989745|NCT01293487|449588308|FG005|Overall Study|Withdrawal by Subject|0|||
124989746|NCT01293487|449588309|FG006|Overall Study|Withdrawal by Subject|0|||
124989747|NCT01293487|449588310|FG007|Overall Study|Withdrawal by Subject|2|||
124989748|NCT00395460|449588311|FG000|Overall Study|Withdrawal by Subject|1|||
124989749|NCT00395460|449588312|FG001|Overall Study|Withdrawal by Subject|0|||
124989750|NCT04223830|449588319|FG000|Overall Study|Lost to Follow-up|9|||
124989751|NCT04223830|449588319|FG000|Overall Study|Adverse Event|1|||
124989752|NCT01964924|449588320|FG000|Trametinib Monotherapy|Progression|19|||
124989753|NCT01964924|449588321|FG001|Trametinib Monotherapy|Progression|0|||
124989754|NCT00577577|449588323|FG000|Overall Study|Adverse Event|3|||
124989755|NCT00577577|449588324|FG001|Overall Study|Adverse Event|2|||
124989756|NCT00577577|449588323|FG000|Overall Study|Lost to Follow-up|1|||
124989757|NCT00577577|449588324|FG001|Overall Study|Lost to Follow-up|0|||
124989758|NCT00577577|449588323|FG000|Overall Study|Protocol Violation|0|||
124989759|NCT00577577|449588324|FG001|Overall Study|Protocol Violation|3|||
124989760|NCT00577577|449588323|FG000|Overall Study|Transportation|1|||
124989761|NCT00577577|449588324|FG001|Overall Study|Transportation|0|||
124989762|NCT01153958|449588325|FG000|Overall Study|Study Terminated|36|||
124989763|NCT01153958|449588326|FG001|Overall Study|Study Terminated|32|||
124989764|NCT02150343|449588333|FG000|Overall Study|Adverse Event|2|||
124989765|NCT02150343|449588334|FG001|Overall Study|Adverse Event|0|||
124989766|NCT02150343|449588335|FG002|Overall Study|Adverse Event|1|||
124989767|NCT02150343|449588336|FG003|Overall Study|Adverse Event|1|||
124989768|NCT02150343|449588333|FG000|Overall Study|Withdrawal by Subject|13|||
124989769|NCT02150343|449588334|FG001|Overall Study|Withdrawal by Subject|10|||
124989770|NCT02150343|449588335|FG002|Overall Study|Withdrawal by Subject|9|||
124989771|NCT02150343|449588336|FG003|Overall Study|Withdrawal by Subject|4|||
124989772|NCT02150343|449588333|FG000|Overall Study|Lost to Follow-up|4|||
124989773|NCT02150343|449588334|FG001|Overall Study|Lost to Follow-up|4|||
124989774|NCT02150343|449588335|FG002|Overall Study|Lost to Follow-up|2|||
124989775|NCT02150343|449588336|FG003|Overall Study|Lost to Follow-up|3|||
124989776|NCT02150343|449588333|FG000|Overall Study|Other|2|||
124989777|NCT02150343|449588334|FG001|Overall Study|Other|6|||
124989778|NCT02150343|449588335|FG002|Overall Study|Other|0|||
124989779|NCT02150343|449588336|FG003|Overall Study|Other|2|||
124989780|NCT02729753|449588337|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
124989781|NCT02729753|449588338|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
124989782|NCT00190749|449588339|FG000|Overall Study|Lost to Follow-up|8|||
124989783|NCT00190749|449588340|FG001|Overall Study|Lost to Follow-up|11|||
124989784|NCT00190749|449588339|FG000|Overall Study|Withdrawal by Subject|10|||
124989785|NCT00190749|449588340|FG001|Overall Study|Withdrawal by Subject|6|||
124989786|NCT00190749|449588339|FG000|Overall Study|Protocol Violation|5|||
124989787|NCT00190749|449588340|FG001|Overall Study|Protocol Violation|4|||
124989788|NCT00190749|449588339|FG000|Overall Study|Adverse Event|0|||
124989789|NCT00190749|449588340|FG001|Overall Study|Adverse Event|5|||
124989790|NCT00190749|449588339|FG000|Overall Study|Lack of Efficacy|2|||
124989791|NCT00190749|449588340|FG001|Overall Study|Lack of Efficacy|3|||
124989792|NCT00190749|449588339|FG000|Overall Study|Reason Not Specified|0|||
124989793|NCT00190749|449588340|FG001|Overall Study|Reason Not Specified|2|||
124989794|NCT00190749|449588339|FG000|Overall Study|Sponsor Decision|1|||
124989795|NCT00190749|449588340|FG001|Overall Study|Sponsor Decision|0|||
124989796|NCT01200589|449588341|FG000|Overall Study|Withdrawal by Subject|13|||
124989797|NCT01200589|449588342|FG001|Overall Study|Withdrawal by Subject|11|||
124989798|NCT01200589|449588341|FG000|Overall Study|Physician Decision|2|||
124989799|NCT01200589|449588342|FG001|Overall Study|Physician Decision|2|||
124989800|NCT01200589|449588341|FG000|Overall Study|Lost to Follow-up|5|||
124989801|NCT01200589|449588342|FG001|Overall Study|Lost to Follow-up|4|||
124989802|NCT01200589|449588341|FG000|Overall Study|Study terminated|170|||
124989803|NCT01200589|449588342|FG001|Overall Study|Study terminated|172|||
124989804|NCT01090427|449588343|FG000|After Controlled Period|Death|0|||
124989805|NCT01090427|449588344|FG001|After Controlled Period|Death|0|||
124989806|NCT01090427|449588345|FG002|After Controlled Period|Death|0|||
124989807|NCT01090427|449588346|FG003|After Controlled Period|Death|0|||
124989808|NCT01090427|449588347|FG004|After Controlled Period|Death|0|||
124989809|NCT01090427|449588348|FG005|After Controlled Period|Death|1|||
124989810|NCT01090427|449588349|FG006|After Controlled Period|Death|0|||
125316308|NCT04073186|450788402|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
125316309|NCT04073186|450788402|FG000|Second Wearing Cycle|Adverse Event|1|||
125316310|NCT01096316|450788403|FG000|Overall Study|Lost to Follow-up|15|||
125316311|NCT01096316|450788404|FG001|Overall Study|Lost to Follow-up|9|||
125316312|NCT02763644|450788405|FG000|Overall Study|Patient/guardian decision|1|||
125316313|NCT02763644|450788406|FG001|Overall Study|Patient/guardian decision|0|||
125316314|NCT02763644|450788405|FG000|Overall Study|Death|1|||
125316315|NCT02763644|450788406|FG001|Overall Study|Death|1|||
125316316|NCT02763644|450788405|FG000|Overall Study|Adverse Event|1|||
124989811|NCT01090427|449588343|FG000|After Controlled Period|Lack of Efficacy|0|||
124989812|NCT01090427|449588344|FG001|After Controlled Period|Lack of Efficacy|0|||
124989813|NCT01090427|449588345|FG002|After Controlled Period|Lack of Efficacy|0|||
124989814|NCT01090427|449588346|FG003|After Controlled Period|Lack of Efficacy|0|||
124989815|NCT01090427|449588347|FG004|After Controlled Period|Lack of Efficacy|0|||
124989816|NCT01090427|449588348|FG005|After Controlled Period|Lack of Efficacy|3|||
124989817|NCT01090427|449588349|FG006|After Controlled Period|Lack of Efficacy|2|||
124989818|NCT01090427|449588343|FG000|After Controlled Period|Adverse Event|0|||
124989819|NCT01090427|449588344|FG001|After Controlled Period|Adverse Event|0|||
124989820|NCT01090427|449588345|FG002|After Controlled Period|Adverse Event|0|||
124989821|NCT01090427|449588346|FG003|After Controlled Period|Adverse Event|2|||
124989822|NCT01090427|449588347|FG004|After Controlled Period|Adverse Event|0|||
124989823|NCT01090427|449588348|FG005|After Controlled Period|Adverse Event|1|||
124989824|NCT01090427|449588349|FG006|After Controlled Period|Adverse Event|0|||
124989825|NCT01154010|449588350|FG000|Overall Study|Lost to Follow-up|0|||
124989826|NCT01154010|449588351|FG001|Overall Study|Lost to Follow-up|1|||
124989827|NCT00439231|449588352|FG000|Overall Study|Lack of Efficacy|28|||
124989828|NCT03683823|449588357|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
124989829|NCT03683823|449588358|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
124989830|NCT03683823|449588357|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
124989831|NCT03683823|449588358|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
124989832|NCT03683823|449588357|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
124989833|NCT03683823|449588358|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
124989834|NCT03965351|449588359|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
124989835|NCT03965351|449588360|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
124989836|NCT03965351|449588359|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
124989837|NCT03965351|449588360|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
124989838|NCT00490724|449588361|FG000|Period I|Physician Decision|0|||
124989839|NCT00490724|449588362|FG001|Period I|Physician Decision|0|||
124989840|NCT00490724|449588363|FG002|Period I|Physician Decision|1|||
124989841|NCT00490724|449588361|FG000|Period II|Treatment Discontinuation|3|||
124989842|NCT00490724|449588362|FG001|Period II|Treatment Discontinuation|1|||
124989843|NCT00490724|449588363|FG002|Period II|Treatment Discontinuation|3|||
124989844|NCT00994682|449588364|FG000|Double Bilnd|Withdrawal by Subject|5|||
124989845|NCT00994682|449588365|FG001|Double Bilnd|Withdrawal by Subject|6|||
124989846|NCT00994682|449588364|FG000|Double Bilnd|Lost to Follow-up|3|||
124989847|NCT00994682|449588365|FG001|Double Bilnd|Lost to Follow-up|3|||
124989848|NCT00994682|449588364|FG000|Double Bilnd|Adverse Event|1|||
124989849|NCT00994682|449588365|FG001|Double Bilnd|Adverse Event|0|||
124989850|NCT00994682|449588364|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
124989851|NCT00994682|449588365|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
124989852|NCT00994682|449588364|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
124989853|NCT00994682|449588365|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
124989854|NCT00994682|449588364|FG000|Pioglitazone Open Label|Physician Decision|6|||
124989855|NCT00994682|449588365|FG001|Pioglitazone Open Label|Physician Decision|1|||
124989856|NCT02859324|449588368|FG000|Overall Study|Death|4|||
124989857|NCT02859324|449588369|FG001|Overall Study|Death|6|||
124989858|NCT02859324|449588370|FG002|Overall Study|Death|5|||
124989859|NCT02859324|449588368|FG000|Overall Study|Other reasons|3|||
124989860|NCT02859324|449588369|FG001|Overall Study|Other reasons|3|||
124989861|NCT02859324|449588370|FG002|Overall Study|Other reasons|0|||
124989862|NCT02134977|449590508|FG000|Overall Study|Protocol Deviation|102|||
124989863|NCT01773291|449590509|FG000|Overall Study|Protocol Violation|1|||
124989864|NCT01773291|449590510|FG001|Overall Study|Protocol Violation|0|||
124989865|NCT01773291|449590511|FG002|Overall Study|Protocol Violation|0|||
125316317|NCT02763644|450788406|FG001|Overall Study|Adverse Event|1|||
124989866|NCT01773291|449590509|FG000|Overall Study|Withdrawal by Subject|0|||
124989867|NCT01773291|449590510|FG001|Overall Study|Withdrawal by Subject|0|||
124989868|NCT01773291|449590511|FG002|Overall Study|Withdrawal by Subject|1|||
124989869|NCT00107120|449590513|FG000|Overall Study|Adverse Event|4|||
124989870|NCT00107120|449590514|FG001|Overall Study|Adverse Event|1|||
124989871|NCT00107120|449590513|FG000|Overall Study|Lack of Efficacy|5|||
124989872|NCT00107120|449590514|FG001|Overall Study|Lack of Efficacy|5|||
124989873|NCT00107120|449590513|FG000|Overall Study|Protocol Violation|3|||
124989874|NCT00107120|449590514|FG001|Overall Study|Protocol Violation|0|||
124989875|NCT00107120|449590513|FG000|Overall Study|Withdrawal by Subject|8|||
124989876|NCT00107120|449590514|FG001|Overall Study|Withdrawal by Subject|9|||
125316318|NCT02836652|450788407|FG000|Overall Study|Death|3|||
124989877|NCT00107120|449590513|FG000|Overall Study|Lost to Follow-up|8|||
125316319|NCT02836652|450788408|FG001|Overall Study|Death|3|||
125316320|NCT02836652|450788407|FG000|Overall Study|Transplant/Explant|3|||
124989878|NCT00107120|449590514|FG001|Overall Study|Lost to Follow-up|6|||
124989879|NCT00107120|449590513|FG000|Overall Study|Pregnancy|0|||
124989880|NCT00107120|449590514|FG001|Overall Study|Pregnancy|1|||
124989881|NCT00107120|449590513|FG000|Overall Study|moving away from site|1|||
124989882|NCT00107120|449590514|FG001|Overall Study|moving away from site|1|||
124989883|NCT00107120|449590513|FG000|Overall Study|death of parent|0|||
124989884|NCT00107120|449590514|FG001|Overall Study|death of parent|1|||
124989885|NCT00896051|449590518|FG000|Overall Study|Adverse Event|2|||
124989886|NCT00896051|449590519|FG001|Overall Study|Adverse Event|1|||
124989887|NCT00896051|449590518|FG000|Overall Study|Lost to Follow-up|3|||
124989888|NCT00896051|449590519|FG001|Overall Study|Lost to Follow-up|2|||
124989889|NCT00896051|449590518|FG000|Overall Study|Withdrawal by Subject|3|||
124989890|NCT00896051|449590519|FG001|Overall Study|Withdrawal by Subject|2|||
124989891|NCT00896051|449590518|FG000|Overall Study|Subject noncompliant|1|||
124989892|NCT00896051|449590519|FG001|Overall Study|Subject noncompliant|3|||
124989893|NCT00896051|449590518|FG000|Overall Study|Other|1|||
124989894|NCT00896051|449590519|FG001|Overall Study|Other|1|||
124989895|NCT02935452|449590520|FG000|Overall Study|work and life commintment|3|||
124989896|NCT02935452|449590521|FG001|Overall Study|work and life commintment|1|||
124989897|NCT00876928|449590522|FG000|Overall Study|Lost to Follow-up|2|||
124989898|NCT00876928|449590523|FG001|Overall Study|Lost to Follow-up|5|||
124989899|NCT00876928|449590522|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
124989900|NCT00876928|449590523|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
124989901|NCT03103763|449590526|FG000|Overall Study|Death|15|||
124989902|NCT03103763|449590527|FG001|Overall Study|Death|5|||
124989903|NCT03103763|449590528|FG002|Overall Study|Death|5|||
124989904|NCT03103763|449590526|FG000|Overall Study|Withdrawal by Subject|0|||
124989905|NCT03103763|449590527|FG001|Overall Study|Withdrawal by Subject|3|||
124989906|NCT03103763|449590528|FG002|Overall Study|Withdrawal by Subject|2|||
124989907|NCT01970345|449590529|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
124989908|NCT01970345|449590530|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
124989909|NCT01970345|449590529|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
124989910|NCT01970345|449590530|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
124989911|NCT01346475|449590533|FG000|First Intervention|Lost to Follow-up|4|||
124989912|NCT01346475|449590534|FG001|First Intervention|Lost to Follow-up|3|||
124989913|NCT00558259|449590537|FG000|Overall Study|Adverse Event|50|||
125316321|NCT02836652|450788408|FG001|Overall Study|Transplant/Explant|4|||
125316322|NCT02836652|450788407|FG000|Overall Study|Withdrawn|9|||
125316323|NCT02836652|450788408|FG001|Overall Study|Withdrawn|9|||
125316324|NCT02836652|450788407|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
125316325|NCT02836652|450788408|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
125316326|NCT00473434|450788409|FG000|Overall Study|Physician Decision|3|||
125316327|NCT00473434|450788409|FG000|Overall Study|Withdrawal by Subject|9|||
125316328|NCT00473434|450788409|FG000|Overall Study|Compliance|3|||
125316329|NCT00473434|450788409|FG000|Overall Study|Lack of Efficacy|3|||
125316330|NCT00473434|450788409|FG000|Overall Study|Adverse Event|3|||
125316331|NCT00473434|450788409|FG000|Overall Study|Patient was selling medication to others|1|||
125316332|NCT00473434|450788409|FG000|Overall Study|Safety evaluation|1|||
125316333|NCT00473434|450788409|FG000|Overall Study|Reason not specified|6|||
125316334|NCT00473434|450788409|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
125316335|NCT00473434|450788409|FG000|Overall Study|Switching to trial medication|1|||
125316336|NCT00473434|450788409|FG000|Overall Study|No longer required|1|||
125316337|NCT02349633|450788410|FG000|Overall Study|Death|0|||
125316338|NCT02349633|450788411|FG001|Overall Study|Death|1|||
125316339|NCT02349633|450788412|FG002|Overall Study|Death|0|||
125316340|NCT02349633|450788413|FG003|Overall Study|Death|0|||
125316341|NCT02349633|450788414|FG004|Overall Study|Death|0|||
125316342|NCT02349633|450788415|FG005|Overall Study|Death|1|||
125316343|NCT02349633|450788416|FG006|Overall Study|Death|1|||
125316344|NCT02349633|450788417|FG007|Overall Study|Death|1|||
125316345|NCT02349633|450788418|FG008|Overall Study|Death|0|||
125316346|NCT02349633|450788419|FG009|Overall Study|Death|1|||
124989914|NCT00558259|449590538|FG001|Overall Study|Adverse Event|81|||
125316347|NCT02349633|450788420|FG010|Overall Study|Death|0|||
125316348|NCT02349633|450788421|FG011|Overall Study|Death|0|||
125316349|NCT02349633|450788422|FG012|Overall Study|Death|0|||
124989915|NCT00558259|449590537|FG000|Overall Study|Protocol Violation|9|||
124989916|NCT00558259|449590538|FG001|Overall Study|Protocol Violation|5|||
124989917|NCT00558259|449590537|FG000|Overall Study|Withdrawal by Subject|12|||
124989918|NCT00558259|449590538|FG001|Overall Study|Withdrawal by Subject|13|||
125316350|NCT02349633|450788423|FG013|Overall Study|Death|0|||
125316351|NCT02349633|450788410|FG000|Overall Study|Withdrawal by Subject|0|||
125316352|NCT02349633|450788411|FG001|Overall Study|Withdrawal by Subject|0|||
125316353|NCT02349633|450788412|FG002|Overall Study|Withdrawal by Subject|0|||
124989919|NCT02874924|449590539|FG000|Overall Study|Adverse Event|2|||
124989920|NCT02874924|449590540|FG001|Overall Study|Adverse Event|0|||
125316354|NCT02349633|450788413|FG003|Overall Study|Withdrawal by Subject|1|||
125316355|NCT02349633|450788414|FG004|Overall Study|Withdrawal by Subject|0|||
125316356|NCT02349633|450788415|FG005|Overall Study|Withdrawal by Subject|0|||
125316357|NCT02349633|450788416|FG006|Overall Study|Withdrawal by Subject|0|||
125316358|NCT02349633|450788417|FG007|Overall Study|Withdrawal by Subject|2|||
125316359|NCT02349633|450788418|FG008|Overall Study|Withdrawal by Subject|2|||
125316360|NCT02349633|450788419|FG009|Overall Study|Withdrawal by Subject|1|||
125316361|NCT02349633|450788420|FG010|Overall Study|Withdrawal by Subject|0|||
125316362|NCT02349633|450788421|FG011|Overall Study|Withdrawal by Subject|0|||
125316363|NCT02349633|450788422|FG012|Overall Study|Withdrawal by Subject|0|||
125316364|NCT02349633|450788423|FG013|Overall Study|Withdrawal by Subject|0|||
125316365|NCT02349633|450788410|FG000|Overall Study|Withdrawal of informed consent|0|||
125316366|NCT02349633|450788411|FG001|Overall Study|Withdrawal of informed consent|0|||
125316367|NCT02349633|450788412|FG002|Overall Study|Withdrawal of informed consent|0|||
125316368|NCT02349633|450788413|FG003|Overall Study|Withdrawal of informed consent|1|||
125316369|NCT02349633|450788414|FG004|Overall Study|Withdrawal of informed consent|1|||
125316370|NCT02349633|450788415|FG005|Overall Study|Withdrawal of informed consent|0|||
125316371|NCT02349633|450788416|FG006|Overall Study|Withdrawal of informed consent|0|||
125316372|NCT02349633|450788417|FG007|Overall Study|Withdrawal of informed consent|3|||
125316373|NCT02349633|450788418|FG008|Overall Study|Withdrawal of informed consent|0|||
125316374|NCT02349633|450788419|FG009|Overall Study|Withdrawal of informed consent|0|||
125316375|NCT02349633|450788420|FG010|Overall Study|Withdrawal of informed consent|0|||
125316376|NCT02349633|450788421|FG011|Overall Study|Withdrawal of informed consent|0|||
125316377|NCT02349633|450788422|FG012|Overall Study|Withdrawal of informed consent|0|||
125316378|NCT02349633|450788423|FG013|Overall Study|Withdrawal of informed consent|0|||
125316379|NCT02349633|450788410|FG000|Overall Study|Transition to compassionate use|0|||
125316380|NCT02349633|450788411|FG001|Overall Study|Transition to compassionate use|0|||
125316381|NCT02349633|450788412|FG002|Overall Study|Transition to compassionate use|0|||
125316382|NCT02349633|450788413|FG003|Overall Study|Transition to compassionate use|0|||
125316383|NCT02349633|450788414|FG004|Overall Study|Transition to compassionate use|1|||
125316384|NCT02349633|450788415|FG005|Overall Study|Transition to compassionate use|0|||
125316385|NCT02349633|450788416|FG006|Overall Study|Transition to compassionate use|0|||
125316386|NCT02349633|450788417|FG007|Overall Study|Transition to compassionate use|3|||
125316387|NCT02349633|450788418|FG008|Overall Study|Transition to compassionate use|0|||
125316388|NCT02349633|450788419|FG009|Overall Study|Transition to compassionate use|1|||
125316389|NCT02349633|450788420|FG010|Overall Study|Transition to compassionate use|0|||
125316390|NCT02349633|450788421|FG011|Overall Study|Transition to compassionate use|0|||
125316391|NCT02349633|450788422|FG012|Overall Study|Transition to compassionate use|0|||
125316392|NCT02349633|450788423|FG013|Overall Study|Transition to compassionate use|0|||
125316393|NCT02349633|450788410|FG000|Overall Study|Early termination of survival follow-up|0|||
125316394|NCT02349633|450788411|FG001|Overall Study|Early termination of survival follow-up|0|||
125316395|NCT02349633|450788412|FG002|Overall Study|Early termination of survival follow-up|0|||
125316396|NCT02349633|450788413|FG003|Overall Study|Early termination of survival follow-up|0|||
125316397|NCT02349633|450788414|FG004|Overall Study|Early termination of survival follow-up|0|||
125316398|NCT02349633|450788415|FG005|Overall Study|Early termination of survival follow-up|0|||
125316399|NCT02349633|450788416|FG006|Overall Study|Early termination of survival follow-up|0|||
124989921|NCT02874924|449590541|FG002|Overall Study|Adverse Event|0|||
124989922|NCT02874924|449590539|FG000|Overall Study|Withdrawal by Subject|1|||
124989923|NCT02874924|449590540|FG001|Overall Study|Withdrawal by Subject|0|||
124989924|NCT02874924|449590541|FG002|Overall Study|Withdrawal by Subject|0|||
124989925|NCT02029846|449590544|FG000|Overall Study|n=1 each arm|1|||
124989926|NCT02029846|449590545|FG001|Overall Study|n=1 each arm|1|||
124989927|NCT02966301|449590546|FG000|Overall Study|Death|2|||
124989928|NCT02966301|449590546|FG000|Overall Study|Withdrawal by Subject|1|||
124989929|NCT00700258|449590547|FG000|Overall Study|Premature discontinuation of documentation|136|||
124989930|NCT00700258|449590547|FG000|Overall Study|Type of study end not documented|1|||
124989931|NCT00700258|449590547|FG000|Overall Study|Lost to Follow-up|81|||
124989932|NCT00700258|449590547|FG000|Overall Study|Premature discontinuation of therapy|1013|||
124989933|NCT00370331|449590549|FG000|Overall Study|Adverse Event|4|||
124989934|NCT00370331|449590550|FG001|Overall Study|Adverse Event|13|||
124989935|NCT00370331|449590549|FG000|Overall Study|Withdrawal by Subject|2|||
124989936|NCT00370331|449590550|FG001|Overall Study|Withdrawal by Subject|4|||
125316400|NCT02349633|450788417|FG007|Overall Study|Early termination of survival follow-up|4|||
125316401|NCT02349633|450788418|FG008|Overall Study|Early termination of survival follow-up|0|||
125316402|NCT02349633|450788419|FG009|Overall Study|Early termination of survival follow-up|0|||
125316403|NCT02349633|450788420|FG010|Overall Study|Early termination of survival follow-up|0|||
125316404|NCT02349633|450788421|FG011|Overall Study|Early termination of survival follow-up|0|||
125316405|NCT02349633|450788422|FG012|Overall Study|Early termination of survival follow-up|0|||
124989937|NCT00370331|449590549|FG000|Overall Study|Lost to Follow-up|0|||
124989938|NCT00370331|449590550|FG001|Overall Study|Lost to Follow-up|3|||
124989939|NCT00370331|449590549|FG000|Overall Study|Lack of Efficacy|0|||
125316406|NCT02349633|450788423|FG013|Overall Study|Early termination of survival follow-up|0|||
125316407|NCT02349633|450788410|FG000|Overall Study|Termination by sponsor|0|||
125316408|NCT02349633|450788411|FG001|Overall Study|Termination by sponsor|0|||
125316409|NCT02349633|450788412|FG002|Overall Study|Termination by sponsor|0|||
125316410|NCT02349633|450788413|FG003|Overall Study|Termination by sponsor|0|||
125316411|NCT02349633|450788414|FG004|Overall Study|Termination by sponsor|0|||
125316412|NCT02349633|450788415|FG005|Overall Study|Termination by sponsor|0|||
125316413|NCT02349633|450788416|FG006|Overall Study|Termination by sponsor|0|||
125316414|NCT02349633|450788417|FG007|Overall Study|Termination by sponsor|1|||
125316415|NCT02349633|450788418|FG008|Overall Study|Termination by sponsor|0|||
125316416|NCT02349633|450788419|FG009|Overall Study|Termination by sponsor|2|||
125316417|NCT02349633|450788420|FG010|Overall Study|Termination by sponsor|0|||
125316418|NCT02349633|450788421|FG011|Overall Study|Termination by sponsor|0|||
125316419|NCT02349633|450788422|FG012|Overall Study|Termination by sponsor|0|||
125316420|NCT02349633|450788423|FG013|Overall Study|Termination by sponsor|0|||
125316421|NCT02349633|450788410|FG000|Overall Study|Other|0|||
125316422|NCT02349633|450788411|FG001|Overall Study|Other|0|||
125316423|NCT02349633|450788412|FG002|Overall Study|Other|0|||
125316424|NCT02349633|450788413|FG003|Overall Study|Other|0|||
125316425|NCT02349633|450788414|FG004|Overall Study|Other|0|||
125316426|NCT02349633|450788415|FG005|Overall Study|Other|0|||
125316427|NCT02349633|450788416|FG006|Overall Study|Other|0|||
125316428|NCT02349633|450788417|FG007|Overall Study|Other|2|||
125316429|NCT02349633|450788418|FG008|Overall Study|Other|0|||
125316430|NCT02349633|450788419|FG009|Overall Study|Other|0|||
125316431|NCT02349633|450788420|FG010|Overall Study|Other|0|||
125316432|NCT02349633|450788421|FG011|Overall Study|Other|0|||
125316433|NCT02349633|450788422|FG012|Overall Study|Other|0|||
124989940|NCT00370331|449590550|FG001|Overall Study|Lack of Efficacy|1|||
124989941|NCT00370331|449590549|FG000|Overall Study|Non-compliance|0|||
124989942|NCT00370331|449590550|FG001|Overall Study|Non-compliance|1|||
124989943|NCT00370331|449590549|FG000|Overall Study|Protocol Violation|1|||
124989944|NCT00370331|449590550|FG001|Overall Study|Protocol Violation|1|||
124989945|NCT00738582|449590553|FG000|Combination Therapy|Completed Combination Therapy|1|||
124989946|NCT00738582|449590554|FG001|Combination Therapy|Completed Combination Therapy|0|||
124989947|NCT00738582|449590553|FG000|Combination Therapy|Physician Decision|1|||
124989948|NCT00738582|449590554|FG001|Combination Therapy|Physician Decision|0|||
124989949|NCT00738582|449590553|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
124989950|NCT00738582|449590554|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
124989951|NCT00738582|449590553|FG000|Combination Therapy|Other|5|||
124989952|NCT00738582|449590554|FG001|Combination Therapy|Other|0|||
124989953|NCT00738582|449590553|FG000|Combination Therapy|Adverse Event|16|||
124989954|NCT00738582|449590554|FG001|Combination Therapy|Adverse Event|0|||
124989955|NCT00738582|449590553|FG000|Combination Therapy|Progressive Disease|9|||
124989956|NCT00738582|449590554|FG001|Combination Therapy|Progressive Disease|0|||
124989957|NCT00738582|449590553|FG000|Maintenance Therapy|Other|0|||
124989958|NCT00738582|449590554|FG001|Maintenance Therapy|Other|2|||
124989959|NCT00738582|449590553|FG000|Maintenance Therapy|Adverse Event|0|||
124989960|NCT00738582|449590554|FG001|Maintenance Therapy|Adverse Event|6|||
124989961|NCT00738582|449590553|FG000|Maintenance Therapy|Progressive Disease|0|||
124989962|NCT00738582|449590554|FG001|Maintenance Therapy|Progressive Disease|47|||
124989963|NCT00738582|449590553|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
124989964|NCT00738582|449590554|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
124989965|NCT01052103|449590555|FG000|Overall Study|Adverse Event|10|||
124989966|NCT01052103|449590556|FG001|Overall Study|Adverse Event|6|||
124989967|NCT01052103|449590555|FG000|Overall Study|Entry Criteria Not Met|3|||
124989968|NCT01052103|449590556|FG001|Overall Study|Entry Criteria Not Met|1|||
124989969|NCT01052103|449590555|FG000|Overall Study|Lost to Follow-up|3|||
124989970|NCT01052103|449590556|FG001|Overall Study|Lost to Follow-up|5|||
124989971|NCT01052103|449590555|FG000|Overall Study|Protocol Violation|10|||
124989972|NCT01052103|449590556|FG001|Overall Study|Protocol Violation|4|||
124989973|NCT01052103|449590555|FG000|Overall Study|Scheduling conflict|2|||
124989974|NCT01052103|449590556|FG001|Overall Study|Scheduling conflict|1|||
125316434|NCT02349633|450788423|FG013|Overall Study|Other|0|||
125316435|NCT01008943|450788425|FG000|Overall Study|Withdrawal by Subject|1|||
125316436|NCT01453140|450788428|FG000|Overall Study|Adverse Event|3|||
125316437|NCT02611479|450788429|FG000|Baseline Enrollment|Exited study|13|||
125316438|NCT02611479|450788429|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
125316439|NCT02611479|450788429|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
125316440|NCT02611479|450788429|FG000|Data Cleaning|No baseline function or pain metrics|2|||
124989975|NCT01052103|449590555|FG000|Overall Study|Sponsor Decision|2|||
124989976|NCT01052103|449590556|FG001|Overall Study|Sponsor Decision|0|||
124989977|NCT01052103|449590555|FG000|Overall Study|Withdrawal by Subject|3|||
124989978|NCT01052103|449590556|FG001|Overall Study|Withdrawal by Subject|6|||
124989979|NCT01052103|449590555|FG000|Overall Study|Perceived Lack of Efficacy|1|||
124989980|NCT01052103|449590556|FG001|Overall Study|Perceived Lack of Efficacy|0|||
124989981|NCT00545051|449590560|FG000|Overall Study|Adverse Event|7|||
124989982|NCT00545051|449590561|FG001|Overall Study|Adverse Event|3|||
124989983|NCT00545051|449590560|FG000|Overall Study|Death|1|||
125316441|NCT00743249|450788430|FG000|Overall Study|Adverse Event|0|||
125316442|NCT00743249|450788431|FG001|Overall Study|Adverse Event|4|||
125316443|NCT00743249|450788430|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
125316444|NCT00743249|450788431|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
125316445|NCT00743249|450788430|FG000|Overall Study|Unsuccessful insertion of stent|2|||
125316446|NCT00743249|450788431|FG001|Overall Study|Unsuccessful insertion of stent|1|||
124989984|NCT00545051|449590561|FG001|Overall Study|Death|0|||
124989985|NCT00545051|449590560|FG000|Overall Study|Violation of inclusion/exclusion|0|||
124989986|NCT00545051|449590561|FG001|Overall Study|Violation of inclusion/exclusion|2|||
124989987|NCT00545051|449590560|FG000|Overall Study|Protocol Violation|1|||
124989988|NCT00545051|449590561|FG001|Overall Study|Protocol Violation|0|||
124989989|NCT00545051|449590560|FG000|Overall Study|Withdrawal by Subject|0|||
124989990|NCT00545051|449590561|FG001|Overall Study|Withdrawal by Subject|1|||
124989991|NCT00545051|449590560|FG000|Overall Study|Administrative reasons|0|||
124989992|NCT00545051|449590561|FG001|Overall Study|Administrative reasons|1|||
124989993|NCT00903006|449590562|FG000|Overall Study|Withdrawal by Subject|2|||
124989994|NCT00903006|449590563|FG001|Overall Study|Withdrawal by Subject|0|||
124989995|NCT00903006|449590564|FG002|Overall Study|Withdrawal by Subject|0|||
124989996|NCT00903006|449590565|FG003|Overall Study|Withdrawal by Subject|0|||
124989997|NCT00903006|449590562|FG000|Overall Study|Progressive Disease|0|||
124989998|NCT00903006|449590563|FG001|Overall Study|Progressive Disease|3|||
124989999|NCT00903006|449590564|FG002|Overall Study|Progressive Disease|1|||
124990000|NCT00903006|449590565|FG003|Overall Study|Progressive Disease|0|||
124990001|NCT01079663|449590568|FG000|Overall Study|Adverse Event|0|||
124990002|NCT01079663|449590569|FG001|Overall Study|Adverse Event|2|||
124990003|NCT01079663|449590568|FG000|Overall Study|Protocol Violation|0|||
124990004|NCT01079663|449590569|FG001|Overall Study|Protocol Violation|2|||
124990005|NCT01236339|449590574|FG000|Overall Study|Termination of study by sponsor|11|||
124990006|NCT01236339|449590575|FG001|Overall Study|Termination of study by sponsor|13|||
124990007|NCT02054741|449590576|FG000|Overall Study|Protocol Violation|13|||
124990008|NCT02054741|449590577|FG001|Overall Study|Protocol Violation|2|||
125316447|NCT00423657|450788435|FG000|Overall Study|Withdrew consent|10|||
125316448|NCT00423657|450788436|FG001|Overall Study|Withdrew consent|8|||
125316449|NCT00423657|450788435|FG000|Overall Study|Non-compliance|0|||
125316450|NCT00423657|450788436|FG001|Overall Study|Non-compliance|1|||
125316451|NCT00423657|450788435|FG000|Overall Study|Other|15|||
125316452|NCT00423657|450788436|FG001|Overall Study|Other|16|||
125316453|NCT00423657|450788435|FG000|Overall Study|Request of sponsor/investigator|1|||
125316454|NCT00423657|450788436|FG001|Overall Study|Request of sponsor/investigator|0|||
125316455|NCT02653326|450788440|FG000|Overall Study|Lost to Follow-up|10|||
125316456|NCT02653326|450788441|FG001|Overall Study|Lost to Follow-up|7|||
125316457|NCT02422498|450788442|FG000|Overall Study|Inevaluable|4|||
125316458|NCT03206216|450788443|FG000|Overall Study|Withdrawal by Subject|0|||
125316459|NCT03206216|450788444|FG001|Overall Study|Withdrawal by Subject|1|||
125316460|NCT01054456|450788447|FG000|Overall Study|Other|1|||
125316461|NCT04621448|450788448|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
125316462|NCT04621448|450788449|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
125316463|NCT04621448|450788450|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
125316464|NCT04621448|450788451|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
125316465|NCT04621448|450788448|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
125316466|NCT04621448|450788449|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
125316467|NCT04621448|450788450|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
125316468|NCT04621448|450788451|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
125316469|NCT04621448|450788448|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
125316470|NCT04621448|450788449|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
125316471|NCT04621448|450788450|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
125316472|NCT04621448|450788451|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
125316473|NCT04621448|450788448|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
125316474|NCT04621448|450788449|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
125316475|NCT04621448|450788450|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
125316476|NCT04621448|450788451|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
125316477|NCT04590014|450788454|FG000|Overall Study|Withdrawal by Subject|1|||
124990009|NCT02054741|449590576|FG000|Overall Study|Withdrawal by Subject|10|||
125316478|NCT04590014|450788455|FG001|Overall Study|Withdrawal by Subject|0|||
125316479|NCT01506271|450788456|FG000|Overall Study|Progressive disease|0|||
125316480|NCT01506271|450788457|FG001|Overall Study|Progressive disease|1|||
125316481|NCT01506271|450788458|FG002|Overall Study|Progressive disease|0|||
125316482|NCT01506271|450788456|FG000|Overall Study|Protocol Violation|3|||
125316483|NCT01506271|450788457|FG001|Overall Study|Protocol Violation|1|||
125316484|NCT01506271|450788458|FG002|Overall Study|Protocol Violation|0|||
125316485|NCT01506271|450788456|FG000|Overall Study|Death|0|||
124990010|NCT02054741|449590577|FG001|Overall Study|Withdrawal by Subject|5|||
124990011|NCT02054741|449590576|FG000|Overall Study|Death|94|||
124990012|NCT02054741|449590577|FG001|Overall Study|Death|90|||
124990013|NCT02054741|449590576|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
124990014|NCT02054741|449590577|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
125316486|NCT01506271|450788457|FG001|Overall Study|Death|1|||
125316487|NCT01506271|450788458|FG002|Overall Study|Death|0|||
125316488|NCT01506271|450788456|FG000|Overall Study|Adverse Event|0|||
125316489|NCT01506271|450788457|FG001|Overall Study|Adverse Event|2|||
125316490|NCT01506271|450788458|FG002|Overall Study|Adverse Event|0|||
125316491|NCT01506271|450788456|FG000|Overall Study|Insufficient supply of study drug|1|||
125316492|NCT01506271|450788457|FG001|Overall Study|Insufficient supply of study drug|0|||
125316493|NCT01506271|450788458|FG002|Overall Study|Insufficient supply of study drug|0|||
125316494|NCT01506271|450788456|FG000|Overall Study|Withdrawal by Subject|0|||
125316495|NCT01506271|450788457|FG001|Overall Study|Withdrawal by Subject|1|||
125316496|NCT01506271|450788458|FG002|Overall Study|Withdrawal by Subject|1|||
125316497|NCT01506271|450788456|FG000|Overall Study|Lost to Follow-up|0|||
125316498|NCT01506271|450788457|FG001|Overall Study|Lost to Follow-up|1|||
125316499|NCT01506271|450788458|FG002|Overall Study|Lost to Follow-up|2|||
125316500|NCT03040141|450788459|FG000|Overall Study|Death|1|||
125316501|NCT03040141|450788460|FG001|Overall Study|Death|2|||
125316502|NCT03040141|450788461|FG002|Overall Study|Death|3|||
125316503|NCT03040141|450788459|FG000|Overall Study|Withdrawal by Subject|3|||
125316504|NCT03040141|450788460|FG001|Overall Study|Withdrawal by Subject|1|||
125316505|NCT03040141|450788461|FG002|Overall Study|Withdrawal by Subject|1|||
125316506|NCT03040141|450788459|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
125316507|NCT03040141|450788460|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
125316508|NCT03040141|450788461|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
125316509|NCT03040141|450788459|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
125316510|NCT03040141|450788460|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
125316511|NCT03040141|450788461|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
125316512|NCT01391663|450788462|FG000|Overall Study|Withdrawal by Subject|0|||
125316513|NCT01391663|450788463|FG001|Overall Study|Withdrawal by Subject|0|||
125316514|NCT01391663|450788464|FG002|Overall Study|Withdrawal by Subject|1|||
125316515|NCT01391663|450788465|FG003|Overall Study|Withdrawal by Subject|0|||
125316516|NCT03515824|450788466|FG000|Overall Study|Death|3|||
125316517|NCT03515824|450788467|FG001|Overall Study|Death|2|||
125316518|NCT03515824|450788468|FG002|Overall Study|Death|6|||
125316519|NCT03515824|450788469|FG003|Overall Study|Death|0|||
125316520|NCT03515824|450788466|FG000|Overall Study|Lost to Follow-up|0|||
125316521|NCT03515824|450788467|FG001|Overall Study|Lost to Follow-up|1|||
125316522|NCT03515824|450788468|FG002|Overall Study|Lost to Follow-up|1|||
125316523|NCT03515824|450788469|FG003|Overall Study|Lost to Follow-up|0|||
125316524|NCT03515824|450788466|FG000|Overall Study|Study terminated by sponsor|0|||
125316525|NCT03515824|450788467|FG001|Overall Study|Study terminated by sponsor|1|||
125316526|NCT03515824|450788468|FG002|Overall Study|Study terminated by sponsor|6|||
125316527|NCT03515824|450788469|FG003|Overall Study|Study terminated by sponsor|0|||
125316528|NCT03515824|450788466|FG000|Overall Study|Status not recorded|0|||
125316529|NCT03515824|450788467|FG001|Overall Study|Status not recorded|0|||
125316530|NCT03515824|450788468|FG002|Overall Study|Status not recorded|2|||
125316531|NCT03515824|450788469|FG003|Overall Study|Status not recorded|0|||
125316532|NCT00920855|450788470|FG000|Overall Study|Adverse Event|1|||
125316533|NCT00920855|450788471|FG001|Overall Study|Adverse Event|1|||
125316534|NCT00920855|450788472|FG002|Overall Study|Adverse Event|4|||
125316535|NCT00920855|450788470|FG000|Overall Study|Withdrawal by Subject|2|||
125316536|NCT00920855|450788471|FG001|Overall Study|Withdrawal by Subject|1|||
125316537|NCT00920855|450788472|FG002|Overall Study|Withdrawal by Subject|6|||
125316538|NCT00920855|450788470|FG000|Overall Study|Disease progression|2|||
125316539|NCT00920855|450788471|FG001|Overall Study|Disease progression|1|||
125316540|NCT00920855|450788472|FG002|Overall Study|Disease progression|10|||
125316541|NCT00920855|450788470|FG000|Overall Study|Noncompliance to study medication|0|||
125316542|NCT00920855|450788471|FG001|Overall Study|Noncompliance to study medication|0|||
125316543|NCT00920855|450788472|FG002|Overall Study|Noncompliance to study medication|1|||
125316544|NCT00920855|450788470|FG000|Overall Study|Response plateau; started maintenance|0|||
125316545|NCT00920855|450788471|FG001|Overall Study|Response plateau; started maintenance|0|||
124990015|NCT01945060|449590581|FG000|Overall Study|Lost to follow up|1|||
124990016|NCT01945060|449590582|FG001|Overall Study|Lost to follow up|0|||
124990017|NCT01945060|449590581|FG000|Overall Study|Distress related to IV access|0|||
124990018|NCT01945060|449590582|FG001|Overall Study|Distress related to IV access|1|||
124990019|NCT00402597|449590585|FG000|Overall Study|Death|15|||
124990020|NCT00402597|449590586|FG001|Overall Study|Death|7|||
124990021|NCT00402597|449590587|FG002|Overall Study|Death|6|||
124990022|NCT00402597|449590588|FG003|Overall Study|Death|4|||
124990023|NCT00402597|449590589|FG004|Overall Study|Death|6|||
124990024|NCT00402597|449590585|FG000|Overall Study|Adverse Event|81|||
124990025|NCT00402597|449590586|FG001|Overall Study|Adverse Event|18|||
124990026|NCT00402597|449590587|FG002|Overall Study|Adverse Event|106|||
124990027|NCT00402597|449590588|FG003|Overall Study|Adverse Event|39|||
124990028|NCT00402597|449590589|FG004|Overall Study|Adverse Event|71|||
124990029|NCT00402597|449590585|FG000|Overall Study|Lost to Follow-up|8|||
125316546|NCT00920855|450788472|FG002|Overall Study|Response plateau; started maintenance|1|||
125316547|NCT01384734|450788473|FG000|Overall Study|Adverse Event|0|||
125316548|NCT01384734|450788474|FG001|Overall Study|Adverse Event|3|||
125316549|NCT01384734|450788475|FG002|Overall Study|Adverse Event|0|||
124990030|NCT00402597|449590586|FG001|Overall Study|Lost to Follow-up|1|||
124990031|NCT00402597|449590587|FG002|Overall Study|Lost to Follow-up|8|||
124990032|NCT00402597|449590588|FG003|Overall Study|Lost to Follow-up|2|||
124990033|NCT00402597|449590589|FG004|Overall Study|Lost to Follow-up|3|||
124990034|NCT00402597|449590585|FG000|Overall Study|Withdrawal by Subject|57|||
124990035|NCT00402597|449590586|FG001|Overall Study|Withdrawal by Subject|16|||
124990036|NCT00402597|449590587|FG002|Overall Study|Withdrawal by Subject|65|||
124990037|NCT00402597|449590588|FG003|Overall Study|Withdrawal by Subject|15|||
124990038|NCT00402597|449590589|FG004|Overall Study|Withdrawal by Subject|24|||
124990039|NCT00402597|449590585|FG000|Overall Study|reason not specified|30|||
124990040|NCT00402597|449590586|FG001|Overall Study|reason not specified|4|||
125316550|NCT01384734|450788476|FG003|Overall Study|Adverse Event|2|||
125316551|NCT01384734|450788477|FG004|Overall Study|Adverse Event|7|||
125316552|NCT01384734|450788473|FG000|Overall Study|Death|1|||
125316553|NCT01384734|450788474|FG001|Overall Study|Death|0|||
125316554|NCT01384734|450788475|FG002|Overall Study|Death|1|||
125316555|NCT01384734|450788476|FG003|Overall Study|Death|0|||
125316556|NCT01384734|450788477|FG004|Overall Study|Death|0|||
125316557|NCT01384734|450788473|FG000|Overall Study|Continuation criteria not met|0|||
125316558|NCT01384734|450788474|FG001|Overall Study|Continuation criteria not met|0|||
125316559|NCT01384734|450788475|FG002|Overall Study|Continuation criteria not met|1|||
125316560|NCT01384734|450788476|FG003|Overall Study|Continuation criteria not met|1|||
125316561|NCT01384734|450788477|FG004|Overall Study|Continuation criteria not met|0|||
125316562|NCT01384734|450788473|FG000|Overall Study|Lack of Efficacy|3|||
125316563|NCT01384734|450788474|FG001|Overall Study|Lack of Efficacy|7|||
125316564|NCT01384734|450788475|FG002|Overall Study|Lack of Efficacy|4|||
125316565|NCT01384734|450788476|FG003|Overall Study|Lack of Efficacy|4|||
125316566|NCT01384734|450788477|FG004|Overall Study|Lack of Efficacy|2|||
125316567|NCT01384734|450788473|FG000|Overall Study|Lost to Follow-up|5|||
125316568|NCT01384734|450788474|FG001|Overall Study|Lost to Follow-up|3|||
124990041|NCT00402597|449590587|FG002|Overall Study|reason not specified|27|||
124990042|NCT00402597|449590588|FG003|Overall Study|reason not specified|14|||
124990043|NCT00402597|449590589|FG004|Overall Study|reason not specified|20|||
124990044|NCT00986973|449590593|FG000|Overall Study|Withdrawn by study team|1|||
124990045|NCT00598273|449590594|FG000|Overall Study|Adverse Event|4|||
124990046|NCT00598273|449590595|FG001|Overall Study|Adverse Event|5|||
124990047|NCT00598273|449590596|FG002|Overall Study|Adverse Event|2|||
124990048|NCT00598273|449590594|FG000|Overall Study|Death|6|||
124990049|NCT00598273|449590595|FG001|Overall Study|Death|12|||
124990050|NCT00598273|449590596|FG002|Overall Study|Death|8|||
124990051|NCT00598273|449590594|FG000|Overall Study|Lost to Follow-up|8|||
124990052|NCT00598273|449590595|FG001|Overall Study|Lost to Follow-up|3|||
124990053|NCT00598273|449590596|FG002|Overall Study|Lost to Follow-up|5|||
124990054|NCT00598273|449590594|FG000|Overall Study|Physician Decision|0|||
124990055|NCT00598273|449590595|FG001|Overall Study|Physician Decision|0|||
124990056|NCT00598273|449590596|FG002|Overall Study|Physician Decision|1|||
124990057|NCT00598273|449590594|FG000|Overall Study|Withdrawal by Subject|12|||
124990058|NCT00598273|449590595|FG001|Overall Study|Withdrawal by Subject|10|||
124990059|NCT00598273|449590596|FG002|Overall Study|Withdrawal by Subject|10|||
124990060|NCT00598273|449590594|FG000|Overall Study|Noncompliance|3|||
124990061|NCT00598273|449590595|FG001|Overall Study|Noncompliance|2|||
124990062|NCT00598273|449590596|FG002|Overall Study|Noncompliance|3|||
124990063|NCT00598273|449590594|FG000|Overall Study|Relocation|0|||
124990064|NCT00598273|449590595|FG001|Overall Study|Relocation|2|||
124990065|NCT00598273|449590596|FG002|Overall Study|Relocation|4|||
124990066|NCT00598273|449590594|FG000|Overall Study|Renal transplant|1|||
124990067|NCT00598273|449590595|FG001|Overall Study|Renal transplant|0|||
124990068|NCT00598273|449590596|FG002|Overall Study|Renal transplant|1|||
124990069|NCT00598273|449590594|FG000|Overall Study|Site elected to close|1|||
124990070|NCT00598273|449590595|FG001|Overall Study|Site elected to close|0|||
124990071|NCT00598273|449590596|FG002|Overall Study|Site elected to close|0|||
124990072|NCT00598273|449590594|FG000|Overall Study|Started dialysis|6|||
124990073|NCT00598273|449590595|FG001|Overall Study|Started dialysis|4|||
124990074|NCT00598273|449590596|FG002|Overall Study|Started dialysis|5|||
125316569|NCT01384734|450788475|FG002|Overall Study|Lost to Follow-up|3|||
125316570|NCT01384734|450788476|FG003|Overall Study|Lost to Follow-up|8|||
125316571|NCT01384734|450788477|FG004|Overall Study|Lost to Follow-up|5|||
124990075|NCT01465347|449590597|FG000|Overall Study|Withdrawal by Subject|1|||
124990076|NCT01465347|449590598|FG001|Overall Study|Withdrawal by Subject|1|||
124990077|NCT01465347|449590597|FG000|Overall Study|Physician Decision|0|||
124990078|NCT01465347|449590598|FG001|Overall Study|Physician Decision|1|||
124990079|NCT01465347|449590597|FG000|Overall Study|Admitted to hospice|0|||
124990080|NCT01465347|449590598|FG001|Overall Study|Admitted to hospice|1|||
125316572|NCT01384734|450788473|FG000|Overall Study|Non-compliance with study drug|1|||
125316573|NCT01384734|450788474|FG001|Overall Study|Non-compliance with study drug|2|||
125316574|NCT01384734|450788475|FG002|Overall Study|Non-compliance with study drug|6|||
125316575|NCT01384734|450788476|FG003|Overall Study|Non-compliance with study drug|0|||
125316576|NCT01384734|450788477|FG004|Overall Study|Non-compliance with study drug|2|||
125316577|NCT01384734|450788473|FG000|Overall Study|Pregnancy|0|||
125316578|NCT01384734|450788474|FG001|Overall Study|Pregnancy|1|||
125316579|NCT01384734|450788475|FG002|Overall Study|Pregnancy|0|||
125316580|NCT01384734|450788476|FG003|Overall Study|Pregnancy|0|||
125316581|NCT01384734|450788477|FG004|Overall Study|Pregnancy|1|||
125316582|NCT01384734|450788473|FG000|Overall Study|Sponsor terminated|0|||
125316583|NCT01384734|450788474|FG001|Overall Study|Sponsor terminated|0|||
125316584|NCT01384734|450788475|FG002|Overall Study|Sponsor terminated|0|||
125316585|NCT01384734|450788476|FG003|Overall Study|Sponsor terminated|0|||
125316586|NCT01384734|450788477|FG004|Overall Study|Sponsor terminated|1|||
125316587|NCT01384734|450788473|FG000|Overall Study|Withdrawal by Subject|5|||
125316588|NCT01384734|450788474|FG001|Overall Study|Withdrawal by Subject|5|||
125316589|NCT01384734|450788475|FG002|Overall Study|Withdrawal by Subject|6|||
125316590|NCT01384734|450788476|FG003|Overall Study|Withdrawal by Subject|7|||
125316591|NCT01384734|450788477|FG004|Overall Study|Withdrawal by Subject|9|||
125316592|NCT01384734|450788473|FG000|Overall Study|Investigator relocating|0|||
125316593|NCT01384734|450788474|FG001|Overall Study|Investigator relocating|2|||
125316594|NCT01384734|450788475|FG002|Overall Study|Investigator relocating|0|||
125316595|NCT01384734|450788476|FG003|Overall Study|Investigator relocating|3|||
125316596|NCT01384734|450788477|FG004|Overall Study|Investigator relocating|1|||
125316597|NCT01384734|450788473|FG000|Overall Study|Unable to come back for visit|1|||
125316598|NCT01384734|450788474|FG001|Overall Study|Unable to come back for visit|0|||
125316599|NCT01384734|450788475|FG002|Overall Study|Unable to come back for visit|1|||
125316600|NCT01384734|450788476|FG003|Overall Study|Unable to come back for visit|1|||
125316601|NCT01384734|450788477|FG004|Overall Study|Unable to come back for visit|0|||
125316602|NCT01384734|450788473|FG000|Overall Study|Prison|0|||
125316603|NCT01384734|450788474|FG001|Overall Study|Prison|0|||
125316604|NCT01384734|450788475|FG002|Overall Study|Prison|1|||
125316605|NCT01384734|450788476|FG003|Overall Study|Prison|0|||
125316606|NCT01384734|450788477|FG004|Overall Study|Prison|0|||
125316607|NCT01384734|450788473|FG000|Overall Study|As per Exclusion criteria|0|||
125316608|NCT01384734|450788474|FG001|Overall Study|As per Exclusion criteria|1|||
125316609|NCT01384734|450788475|FG002|Overall Study|As per Exclusion criteria|0|||
125316610|NCT01384734|450788476|FG003|Overall Study|As per Exclusion criteria|0|||
124990081|NCT01590082|449590599|FG000|Overall Study|Withdrawal by Subject|1|||
124990082|NCT01590082|449590600|FG001|Overall Study|Withdrawal by Subject|0|||
124990083|NCT01590082|449590599|FG000|Overall Study|Ineligible|1|||
124990084|NCT01590082|449590600|FG001|Overall Study|Ineligible|0|||
124990085|NCT02414932|449590601|FG000|Overall Study|Withdrawal by Subject|2|||
124990086|NCT02414932|449590602|FG001|Overall Study|Withdrawal by Subject|3|||
124990087|NCT02414932|449590601|FG000|Overall Study|Adverse Event|1|||
124990088|NCT02414932|449590602|FG001|Overall Study|Adverse Event|0|||
124990089|NCT00906945|449590603|FG000|Overall Study|Found to be not eligible|0|||
124990090|NCT00906945|449590604|FG001|Overall Study|Found to be not eligible|0|||
124990091|NCT00906945|449590605|FG002|Overall Study|Found to be not eligible|0|||
124990092|NCT00906945|449590606|FG003|Overall Study|Found to be not eligible|1|||
124990093|NCT00906945|449590607|FG004|Overall Study|Found to be not eligible|1|||
124990094|NCT00906945|449590608|FG005|Overall Study|Found to be not eligible|1|||
124990095|NCT00906945|449590603|FG000|Overall Study|Physician Decision|0|||
124990096|NCT00906945|449590604|FG001|Overall Study|Physician Decision|0|||
124990097|NCT00906945|449590605|FG002|Overall Study|Physician Decision|0|||
124990098|NCT00906945|449590606|FG003|Overall Study|Physician Decision|0|||
124990099|NCT00906945|449590607|FG004|Overall Study|Physician Decision|0|||
124990100|NCT00906945|449590608|FG005|Overall Study|Physician Decision|1|||
124990101|NCT01210664|449590610|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
124990102|NCT01210664|449590611|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
124990103|NCT01210664|449590612|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
125316611|NCT01384734|450788477|FG004|Overall Study|As per Exclusion criteria|0|||
124990104|NCT01210664|449590613|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
124990105|NCT01210664|449590610|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
124990106|NCT01210664|449590611|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
124990107|NCT01210664|449590612|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
124990108|NCT01210664|449590613|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
124990109|NCT01210664|449590610|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
125316612|NCT01384734|450788473|FG000|Overall Study|Missed End of treatment visit|0|||
125316613|NCT01384734|450788474|FG001|Overall Study|Missed End of treatment visit|0|||
125316614|NCT01384734|450788475|FG002|Overall Study|Missed End of treatment visit|0|||
125316615|NCT01384734|450788476|FG003|Overall Study|Missed End of treatment visit|1|||
125316616|NCT01384734|450788477|FG004|Overall Study|Missed End of treatment visit|0|||
125316617|NCT01384734|450788473|FG000|Overall Study|Adhesion problem|0|||
125316618|NCT01384734|450788474|FG001|Overall Study|Adhesion problem|0|||
125316619|NCT01384734|450788475|FG002|Overall Study|Adhesion problem|0|||
125316620|NCT01384734|450788476|FG003|Overall Study|Adhesion problem|1|||
124990110|NCT01210664|449590611|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
124990111|NCT01210664|449590612|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
124990112|NCT01210664|449590613|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
124990113|NCT01853644|449590614|FG000|Registration and Treatment Start|Did not start treatment|1|||
124990114|NCT01853644|449590614|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
124990115|NCT01853644|449590614|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
124990116|NCT01853644|449590614|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
125316621|NCT01384734|450788477|FG004|Overall Study|Adhesion problem|0|||
125316622|NCT01384734|450788473|FG000|Overall Study|Early termination|0|||
125316623|NCT01384734|450788474|FG001|Overall Study|Early termination|0|||
125316624|NCT01384734|450788475|FG002|Overall Study|Early termination|0|||
125316625|NCT01384734|450788476|FG003|Overall Study|Early termination|0|||
125316626|NCT01384734|450788477|FG004|Overall Study|Early termination|1|||
125316627|NCT01384734|450788473|FG000|Overall Study|Physician Decision|1|||
125316628|NCT01384734|450788474|FG001|Overall Study|Physician Decision|0|||
125316629|NCT01384734|450788475|FG002|Overall Study|Physician Decision|0|||
125316630|NCT01384734|450788476|FG003|Overall Study|Physician Decision|0|||
125316631|NCT01384734|450788477|FG004|Overall Study|Physician Decision|0|||
125316632|NCT01290523|450788478|FG000|Overall Study|Death|3|||
125316633|NCT00539994|450788479|FG000|Overall Study|Lost to Follow-up|2|||
125316634|NCT00539994|450788480|FG001|Overall Study|Lost to Follow-up|1|||
125316635|NCT00539994|450788481|FG002|Overall Study|Lost to Follow-up|0|||
125316636|NCT00539994|450788479|FG000|Overall Study|Withdrawal by Subject|1|||
125316637|NCT00539994|450788480|FG001|Overall Study|Withdrawal by Subject|0|||
125316638|NCT00539994|450788481|FG002|Overall Study|Withdrawal by Subject|1|||
125316639|NCT00539994|450788479|FG000|Overall Study|Physician Decision|0|||
125316640|NCT00539994|450788480|FG001|Overall Study|Physician Decision|0|||
125316641|NCT00539994|450788481|FG002|Overall Study|Physician Decision|1|||
125316642|NCT03071263|450788482|FG000|Overall Study|Adverse Event|1|||
125316643|NCT03071263|450788483|FG001|Overall Study|Adverse Event|3|||
125316644|NCT03071263|450788482|FG000|Overall Study|Withdrawal by Subject|1|||
125316645|NCT03071263|450788483|FG001|Overall Study|Withdrawal by Subject|3|||
125316646|NCT03071263|450788482|FG000|Overall Study|Physician Decision|1|||
125316647|NCT03071263|450788483|FG001|Overall Study|Physician Decision|0|||
125316648|NCT03071263|450788482|FG000|Overall Study|Participant moved to another city|0|||
125316649|NCT03071263|450788483|FG001|Overall Study|Participant moved to another city|1|||
125316650|NCT03084796|450788484|FG000|Overall Study|Adverse Event|4|||
125316651|NCT03084796|450788485|FG001|Overall Study|Adverse Event|5|||
125316652|NCT03084796|450788486|FG002|Overall Study|Adverse Event|6|||
125316653|NCT03084796|450788487|FG003|Overall Study|Adverse Event|2|||
125316654|NCT03084796|450788488|FG004|Overall Study|Adverse Event|3|||
125316655|NCT03084796|450788489|FG005|Overall Study|Adverse Event|5|||
125316656|NCT03084796|450788484|FG000|Overall Study|Withdrawal by Subject|3|||
125316657|NCT03084796|450788485|FG001|Overall Study|Withdrawal by Subject|5|||
125316658|NCT03084796|450788486|FG002|Overall Study|Withdrawal by Subject|2|||
125316659|NCT03084796|450788487|FG003|Overall Study|Withdrawal by Subject|1|||
125316660|NCT03084796|450788488|FG004|Overall Study|Withdrawal by Subject|3|||
125316661|NCT03084796|450788489|FG005|Overall Study|Withdrawal by Subject|0|||
125316662|NCT03084796|450788484|FG000|Overall Study|Protocol Violation|0|||
125316663|NCT03084796|450788485|FG001|Overall Study|Protocol Violation|0|||
125316664|NCT03084796|450788486|FG002|Overall Study|Protocol Violation|1|||
125316665|NCT03084796|450788487|FG003|Overall Study|Protocol Violation|0|||
125316666|NCT03084796|450788488|FG004|Overall Study|Protocol Violation|1|||
125316667|NCT03084796|450788489|FG005|Overall Study|Protocol Violation|1|||
125316668|NCT03084796|450788484|FG000|Overall Study|Lack of Efficacy|0|||
125316669|NCT03084796|450788485|FG001|Overall Study|Lack of Efficacy|0|||
125316670|NCT03084796|450788486|FG002|Overall Study|Lack of Efficacy|1|||
125316671|NCT03084796|450788487|FG003|Overall Study|Lack of Efficacy|0|||
125316672|NCT03084796|450788488|FG004|Overall Study|Lack of Efficacy|1|||
125316673|NCT03084796|450788489|FG005|Overall Study|Lack of Efficacy|0|||
125316674|NCT03084796|450788484|FG000|Overall Study|Lost to Follow-up|0|||
124990117|NCT01853644|449590614|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
124990118|NCT01853644|449590614|FG000|Continued Treatment After First Response|Adverse Event|2|||
124990119|NCT01853644|449590614|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
125316675|NCT03084796|450788485|FG001|Overall Study|Lost to Follow-up|0|||
125316676|NCT03084796|450788486|FG002|Overall Study|Lost to Follow-up|1|||
124990120|NCT02891408|449590615|FG000|Overall Study|Lost to Follow-up|0|||
125316677|NCT03084796|450788487|FG003|Overall Study|Lost to Follow-up|1|||
125316678|NCT03084796|450788488|FG004|Overall Study|Lost to Follow-up|3|||
125316679|NCT03084796|450788489|FG005|Overall Study|Lost to Follow-up|1|||
125316680|NCT03084796|450788484|FG000|Overall Study|Randomization error|0|||
125316681|NCT03084796|450788485|FG001|Overall Study|Randomization error|0|||
125316682|NCT03084796|450788486|FG002|Overall Study|Randomization error|1|||
125316683|NCT03084796|450788487|FG003|Overall Study|Randomization error|0|||
125316684|NCT03084796|450788488|FG004|Overall Study|Randomization error|0|||
125316685|NCT03084796|450788489|FG005|Overall Study|Randomization error|0|||
125316686|NCT05470985|450788490|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
124990121|NCT02891408|449590616|FG001|Overall Study|Lost to Follow-up|0|||
124990122|NCT02891408|449590617|FG002|Overall Study|Lost to Follow-up|1|||
124990123|NCT02891408|449590618|FG003|Overall Study|Lost to Follow-up|0|||
124990124|NCT02891408|449590619|FG004|Overall Study|Lost to Follow-up|0|||
124990125|NCT02891408|449590620|FG005|Overall Study|Lost to Follow-up|0|||
124990126|NCT02891408|449590621|FG006|Overall Study|Lost to Follow-up|0|||
124990127|NCT01054170|449590622|FG000|Overall Study|Protocol Violation|1|||
124990128|NCT01054170|449590623|FG001|Overall Study|Protocol Violation|0|||
124990129|NCT01054170|449590622|FG000|Overall Study|Withdrawal by Subject|3|||
124990130|NCT01054170|449590623|FG001|Overall Study|Withdrawal by Subject|2|||
124990131|NCT01054170|449590622|FG000|Overall Study|Adverse Event|0|||
124990132|NCT01054170|449590623|FG001|Overall Study|Adverse Event|4|||
124990133|NCT00709852|449590624|FG000|Period 1|Adverse Event|2|||
124990134|NCT00709852|449590625|FG001|Period 1|Adverse Event|0|||
124990135|NCT00709852|449590624|FG000|Period 1|Withdrawal by Subject|4|||
124990136|NCT00709852|449590625|FG001|Period 1|Withdrawal by Subject|2|||
124990137|NCT00709852|449590624|FG000|Period 1|Protocol Violation|1|||
124990138|NCT00709852|449590625|FG001|Period 1|Protocol Violation|0|||
124990139|NCT00709852|449590624|FG000|Period 1|Defective scanner|0|||
124990140|NCT00709852|449590625|FG001|Period 1|Defective scanner|1|||
124990141|NCT00709852|449590624|FG000|Period 1|Lost to Follow-up|1|||
124990142|NCT00709852|449590625|FG001|Period 1|Lost to Follow-up|0|||
124990143|NCT00709852|449590624|FG000|Period 2|Protocol Violation|4|||
124990144|NCT00709852|449590625|FG001|Period 2|Protocol Violation|1|||
124990145|NCT00709852|449590624|FG000|Period 2|Adverse Event|1|||
124990146|NCT00709852|449590625|FG001|Period 2|Adverse Event|1|||
124990147|NCT00709852|449590624|FG000|Period 2|Lost to Follow-up|1|||
124990148|NCT00709852|449590625|FG001|Period 2|Lost to Follow-up|0|||
125316687|NCT05470985|450788491|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
125316688|NCT05470985|450788490|FG000|Double Blind Treatment Period|Physician Decision|0|||
125316689|NCT05470985|450788491|FG001|Double Blind Treatment Period|Physician Decision|1|||
125316690|NCT05470985|450788490|FG000|Long Term Extension|Adverse Event|0|||
125316691|NCT05470985|450788491|FG001|Long Term Extension|Adverse Event|1|||
125316692|NCT05470985|450788490|FG000|Long Term Extension|Study terminated by sponsor|2|||
125316693|NCT05470985|450788491|FG001|Long Term Extension|Study terminated by sponsor|0|||
125316694|NCT01917747|450788492|FG000|Overall Study|Withdrawal by Subject|1|||
125316695|NCT01917747|450788493|FG001|Overall Study|Withdrawal by Subject|2|||
125316696|NCT01917747|450788492|FG000|Overall Study|Lost to Follow-up|18|||
125316697|NCT01917747|450788493|FG001|Overall Study|Lost to Follow-up|9|||
125316698|NCT02741245|450788494|FG000|Overall Study|Adverse Event|0|||
125316699|NCT02741245|450788495|FG001|Overall Study|Adverse Event|0|||
125316700|NCT02741245|450788496|FG002|Overall Study|Adverse Event|0|||
125316701|NCT02741245|450788497|FG003|Overall Study|Adverse Event|2|||
125316702|NCT02741245|450788498|FG004|Overall Study|Adverse Event|2|||
125316703|NCT02741245|450788494|FG000|Overall Study|Protocol Violation|0|||
125316704|NCT02741245|450788495|FG001|Overall Study|Protocol Violation|1|||
125316705|NCT02741245|450788496|FG002|Overall Study|Protocol Violation|0|||
125316706|NCT02741245|450788497|FG003|Overall Study|Protocol Violation|1|||
125316707|NCT02741245|450788498|FG004|Overall Study|Protocol Violation|0|||
125316708|NCT02741245|450788494|FG000|Overall Study|Withdrawal by Subject|0|||
125316709|NCT02741245|450788495|FG001|Overall Study|Withdrawal by Subject|0|||
125316710|NCT02741245|450788496|FG002|Overall Study|Withdrawal by Subject|0|||
125316711|NCT02741245|450788497|FG003|Overall Study|Withdrawal by Subject|1|||
125316712|NCT02741245|450788498|FG004|Overall Study|Withdrawal by Subject|0|||
125316713|NCT00152503|450788501|FG000|Overall Study|Adverse Event|4|||
125316714|NCT02922725|450788502|FG000|Overall Study|Withdrawal by Subject|1|||
125316715|NCT02922725|450788503|FG001|Overall Study|Withdrawal by Subject|0|||
125316716|NCT02922725|450788504|FG002|Overall Study|Withdrawal by Subject|0|||
125316717|NCT01300234|450788505|FG000|Overall Study|Adverse Event|1|||
125316718|NCT01300234|450788506|FG001|Overall Study|Adverse Event|1|||
125316719|NCT01300234|450788505|FG000|Overall Study|Protocol Violation|2|||
124990149|NCT00709852|449590624|FG000|Period 2|No 72-hour follow-up|3|||
124990150|NCT00709852|449590625|FG001|Period 2|No 72-hour follow-up|0|||
124990151|NCT02951767|449590626|FG000|Overall Study|Study Terminated By Sponsor|9|||
124990152|NCT02951767|449590626|FG000|Overall Study|Withdrawal by Subject|11|||
124990153|NCT02951767|449590626|FG000|Overall Study|Death|96|||
124990154|NCT02951767|449590626|FG000|Overall Study|Lost to Follow-up|2|||
124990155|NCT02951767|449590626|FG000|Overall Study|Physician Decision|1|||
124990156|NCT01442779|449590627|FG000|Overall Study|Withdrawal by Subject|3|||
124990157|NCT01442779|449590627|FG000|Overall Study|Death|3|||
125316720|NCT01300234|450788506|FG001|Overall Study|Protocol Violation|3|||
125316721|NCT01300234|450788505|FG000|Overall Study|Withdrawal by Subject|5|||
125316722|NCT01300234|450788506|FG001|Overall Study|Withdrawal by Subject|9|||
125316723|NCT01300234|450788505|FG000|Overall Study|Lost to Follow-up|14|||
125316724|NCT01300234|450788506|FG001|Overall Study|Lost to Follow-up|12|||
125316725|NCT01300234|450788505|FG000|Overall Study|Pregnancy|2|||
125316726|NCT01300234|450788506|FG001|Overall Study|Pregnancy|1|||
124990158|NCT01442779|449590627|FG000|Overall Study|Non-compliance|1|||
124990159|NCT01048671|449590628|FG000|Overall Study|Protocol Violation|0|||
124990160|NCT01048671|449590629|FG001|Overall Study|Protocol Violation|1|||
124990161|NCT01048671|449590630|FG002|Overall Study|Protocol Violation|1|||
124990162|NCT03814187|449590631|FG000|Overall Study|Sponsor's Administrative Decision|0|||
124990163|NCT03814187|449590632|FG001|Overall Study|Sponsor's Administrative Decision|0|||
124990164|NCT03814187|449590633|FG002|Overall Study|Sponsor's Administrative Decision|272|||
124990165|NCT03814187|449590631|FG000|Overall Study|Death|80|||
124990166|NCT03814187|449590632|FG001|Overall Study|Death|81|||
124990167|NCT03814187|449590633|FG002|Overall Study|Death|4|||
124990168|NCT03814187|449590631|FG000|Overall Study|Withdrew Consent|77|||
124990169|NCT03814187|449590632|FG001|Overall Study|Withdrew Consent|78|||
124990170|NCT03814187|449590633|FG002|Overall Study|Withdrew Consent|2|||
124990171|NCT03814187|449590631|FG000|Overall Study|Lost to Follow-up|47|||
124990172|NCT03814187|449590632|FG001|Overall Study|Lost to Follow-up|52|||
124990173|NCT03814187|449590633|FG002|Overall Study|Lost to Follow-up|1|||
124990174|NCT03814187|449590631|FG000|Overall Study|Adverse Event|22|||
124990175|NCT03814187|449590632|FG001|Overall Study|Adverse Event|23|||
124990176|NCT03814187|449590633|FG002|Overall Study|Adverse Event|0|||
124990177|NCT03814187|449590631|FG000|Overall Study|Physician Decision|7|||
124990178|NCT03814187|449590632|FG001|Overall Study|Physician Decision|4|||
124990179|NCT03814187|449590633|FG002|Overall Study|Physician Decision|2|||
124990180|NCT03814187|449590631|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
124990181|NCT03814187|449590632|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
124990182|NCT03814187|449590633|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
124990183|NCT03814187|449590631|FG000|Overall Study|Other reasons|34|||
124990184|NCT03814187|449590632|FG001|Overall Study|Other reasons|40|||
124990185|NCT03814187|449590633|FG002|Overall Study|Other reasons|2|||
124990186|NCT00513604|449590634|FG000|Overall Study|Not treated|2|||
124990187|NCT00513604|449590635|FG001|Overall Study|Not treated|0|||
124990188|NCT00513604|449590636|FG002|Overall Study|Not treated|1|||
124990189|NCT00513604|449590637|FG003|Overall Study|Not treated|0|||
124990190|NCT00513604|449590638|FG004|Overall Study|Not treated|0|||
124990191|NCT00513604|449590634|FG000|Overall Study|Death during treatment|0|||
124990192|NCT00513604|449590635|FG001|Overall Study|Death during treatment|3|||
124990193|NCT00513604|449590636|FG002|Overall Study|Death during treatment|2|||
124990194|NCT00513604|449590637|FG003|Overall Study|Death during treatment|0|||
124990195|NCT00513604|449590638|FG004|Overall Study|Death during treatment|0|||
124990196|NCT00196976|449590639|FG000|Primary Study|Migrated from study area|0|||
124990197|NCT00196976|449590640|FG001|Primary Study|Migrated from study area|0|||
124990198|NCT00196976|449590641|FG002|Primary Study|Migrated from study area|0|||
124990199|NCT00196976|449590642|FG003|Primary Study|Migrated from study area|0|||
124990200|NCT00196976|449590643|FG004|Primary Study|Migrated from study area|0|||
124990201|NCT00196976|449590644|FG005|Primary Study|Migrated from study area|0|||
124990202|NCT00196976|449590645|FG006|Primary Study|Migrated from study area|0|||
124990203|NCT00196976|449590646|FG007|Primary Study|Migrated from study area|1|||
124990204|NCT00196976|449590647|FG008|Primary Study|Migrated from study area|0|||
124990205|NCT00196976|449590648|FG009|Primary Study|Migrated from study area|0|||
124990206|NCT00196976|449590649|FG010|Primary Study|Migrated from study area|0|||
124990207|NCT00196976|449590650|FG011|Primary Study|Migrated from study area|0|||
124990208|NCT00196976|449590651|FG012|Primary Study|Migrated from study area|0|||
124990209|NCT00196976|449590652|FG013|Primary Study|Migrated from study area|0|||
124990210|NCT00196976|449590639|FG000|Primary Study|Protocol Violation|0|||
124990211|NCT00196976|449590640|FG001|Primary Study|Protocol Violation|1|||
124990212|NCT00196976|449590641|FG002|Primary Study|Protocol Violation|1|||
124990213|NCT00196976|449590642|FG003|Primary Study|Protocol Violation|0|||
124990214|NCT00196976|449590643|FG004|Primary Study|Protocol Violation|0|||
124990215|NCT00196976|449590644|FG005|Primary Study|Protocol Violation|0|||
124990216|NCT00196976|449590645|FG006|Primary Study|Protocol Violation|0|||
124990217|NCT00196976|449590646|FG007|Primary Study|Protocol Violation|0|||
124990218|NCT00196976|449590647|FG008|Primary Study|Protocol Violation|0|||
124990219|NCT00196976|449590648|FG009|Primary Study|Protocol Violation|0|||
124990220|NCT00196976|449590649|FG010|Primary Study|Protocol Violation|0|||
124990221|NCT00196976|449590650|FG011|Primary Study|Protocol Violation|0|||
124990222|NCT00196976|449590651|FG012|Primary Study|Protocol Violation|0|||
124990223|NCT00196976|449590652|FG013|Primary Study|Protocol Violation|0|||
124990224|NCT00196976|449590639|FG000|Primary Study|Withdrawal by Subject|1|||
124990225|NCT00196976|449590640|FG001|Primary Study|Withdrawal by Subject|0|||
124990226|NCT00196976|449590641|FG002|Primary Study|Withdrawal by Subject|1|||
124990227|NCT00196976|449590642|FG003|Primary Study|Withdrawal by Subject|1|||
124990228|NCT00196976|449590643|FG004|Primary Study|Withdrawal by Subject|2|||
124990229|NCT00196976|449590644|FG005|Primary Study|Withdrawal by Subject|1|||
124990230|NCT00196976|449590645|FG006|Primary Study|Withdrawal by Subject|0|||
124990231|NCT00196976|449590646|FG007|Primary Study|Withdrawal by Subject|0|||
124990232|NCT00196976|449590647|FG008|Primary Study|Withdrawal by Subject|0|||
124990233|NCT00196976|449590648|FG009|Primary Study|Withdrawal by Subject|1|||
124990234|NCT00196976|449590649|FG010|Primary Study|Withdrawal by Subject|0|||
124990235|NCT00196976|449590650|FG011|Primary Study|Withdrawal by Subject|0|||
124990236|NCT00196976|449590651|FG012|Primary Study|Withdrawal by Subject|0|||
124990237|NCT00196976|449590652|FG013|Primary Study|Withdrawal by Subject|0|||
124990238|NCT00196976|449590639|FG000|Primary Study|Lost to Follow-up|0|||
125316727|NCT01300234|450788505|FG000|Overall Study|Participant reached stopping critera|2|||
125316728|NCT01300234|450788506|FG001|Overall Study|Participant reached stopping critera|0|||
125316729|NCT01300234|450788505|FG000|Overall Study|Participant stopped medication|1|||
125316730|NCT01300234|450788506|FG001|Overall Study|Participant stopped medication|1|||
125316731|NCT01300234|450788505|FG000|Overall Study|Participant refused return to hospital|1|||
125316732|NCT01300234|450788506|FG001|Overall Study|Participant refused return to hospital|0|||
125316733|NCT03253679|450788507|FG000|Overall Study|Screen Failure|1|||
125316734|NCT04816214|450788508|FG000|Overall Study|Progressive Disease|4|||
125316735|NCT04816214|450788509|FG001|Overall Study|Progressive Disease|0|||
125316736|NCT04816214|450788510|FG002|Overall Study|Progressive Disease|0|||
125316737|NCT04816214|450788508|FG000|Overall Study|Death|1|||
125316738|NCT04816214|450788509|FG001|Overall Study|Death|0|||
125316739|NCT04816214|450788510|FG002|Overall Study|Death|0|||
125316740|NCT04816214|450788508|FG000|Overall Study|Study Terminated by Sponsor|1|||
125316741|NCT04816214|450788509|FG001|Overall Study|Study Terminated by Sponsor|0|||
125316742|NCT04816214|450788510|FG002|Overall Study|Study Terminated by Sponsor|0|||
125316743|NCT00550407|450788511|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
125316744|NCT00550407|450788512|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
125316745|NCT00550407|450788513|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
125316746|NCT00550407|450788511|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
125316747|NCT00550407|450788512|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
125316748|NCT00550407|450788513|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
125316749|NCT00550407|450788511|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
125316750|NCT00550407|450788512|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
125316751|NCT00550407|450788513|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
125316752|NCT00550407|450788511|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
125316753|NCT00550407|450788512|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
125316754|NCT00550407|450788513|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
125316755|NCT00550407|450788511|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
125316756|NCT00550407|450788512|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
125316757|NCT00550407|450788513|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
125316758|NCT00550407|450788511|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
125316759|NCT00550407|450788512|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
125316760|NCT00550407|450788513|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
125316761|NCT00550407|450788511|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
125316762|NCT00550407|450788512|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
125316763|NCT00550407|450788513|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
125316764|NCT00550407|450788511|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
125316765|NCT00550407|450788512|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
125316766|NCT00550407|450788513|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
125316767|NCT00550407|450788511|FG000|26-Week Randomized Phase|Adverse Event|0|||
125316768|NCT00550407|450788512|FG001|26-Week Randomized Phase|Adverse Event|5|||
125316769|NCT00550407|450788513|FG002|26-Week Randomized Phase|Adverse Event|2|||
125316770|NCT00550407|450788511|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
125316771|NCT00550407|450788512|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
125316772|NCT00550407|450788513|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
125316773|NCT00550407|450788511|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
125316774|NCT00550407|450788512|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
125316775|NCT00550407|450788513|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
125316776|NCT00550407|450788511|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
125316777|NCT00550407|450788512|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
125316778|NCT00550407|450788513|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
125316779|NCT00584415|450788514|FG000|Overall Study|Adverse Event|7|||
125316780|NCT00717249|450788517|FG000|Overall Study|Lens Discomfort|4|||
125316781|NCT00717249|450788518|FG001|Overall Study|Lens Discomfort|1|||
125316782|NCT00717249|450788517|FG000|Overall Study|Unsatisfactory visual Response|0|||
125316783|NCT00717249|450788518|FG001|Overall Study|Unsatisfactory visual Response|2|||
125316784|NCT00717249|450788517|FG000|Overall Study|Adverse Event|4|||
125316785|NCT00717249|450788518|FG001|Overall Study|Adverse Event|2|||
125316786|NCT00717249|450788517|FG000|Overall Study|Lost to Follow-up|2|||
125316787|NCT00717249|450788518|FG001|Overall Study|Lost to Follow-up|0|||
125316788|NCT00717249|450788517|FG000|Overall Study|Withdrawal by Subject|1|||
125316789|NCT00717249|450788518|FG001|Overall Study|Withdrawal by Subject|2|||
125316790|NCT00717249|450788517|FG000|Overall Study|Pregnancy|6|||
125316791|NCT00717249|450788518|FG001|Overall Study|Pregnancy|3|||
125316792|NCT00717249|450788517|FG000|Overall Study|Protocol Violation|0|||
125316793|NCT00717249|450788518|FG001|Overall Study|Protocol Violation|2|||
125316794|NCT00717249|450788517|FG000|Overall Study|Subject became Ineligible|1|||
125316795|NCT00717249|450788518|FG001|Overall Study|Subject became Ineligible|1|||
125316796|NCT00717249|450788517|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
125316797|NCT00717249|450788518|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
125316798|NCT00717249|450788517|FG000|Overall Study|Gastric Surgery|0|||
124990239|NCT00196976|449590640|FG001|Primary Study|Lost to Follow-up|0|||
124990240|NCT00196976|449590641|FG002|Primary Study|Lost to Follow-up|0|||
124990241|NCT00196976|449590642|FG003|Primary Study|Lost to Follow-up|0|||
125316799|NCT00717249|450788518|FG001|Overall Study|Gastric Surgery|1|||
125316800|NCT00717249|450788517|FG000|Overall Study|Diagnosed with Diabetes|1|||
124990242|NCT00196976|449590643|FG004|Primary Study|Lost to Follow-up|1|||
124990243|NCT00196976|449590644|FG005|Primary Study|Lost to Follow-up|1|||
124990244|NCT00196976|449590645|FG006|Primary Study|Lost to Follow-up|0|||
124990245|NCT00196976|449590646|FG007|Primary Study|Lost to Follow-up|2|||
124990246|NCT00196976|449590647|FG008|Primary Study|Lost to Follow-up|0|||
124990247|NCT00196976|449590648|FG009|Primary Study|Lost to Follow-up|0|||
124990248|NCT00196976|449590649|FG010|Primary Study|Lost to Follow-up|0|||
124990249|NCT00196976|449590650|FG011|Primary Study|Lost to Follow-up|0|||
124990250|NCT00196976|449590651|FG012|Primary Study|Lost to Follow-up|0|||
124990251|NCT00196976|449590652|FG013|Primary Study|Lost to Follow-up|0|||
124990252|NCT00196976|449590639|FG000|Primary Study|Other|0|||
124990253|NCT00196976|449590640|FG001|Primary Study|Other|0|||
124990254|NCT00196976|449590641|FG002|Primary Study|Other|2|||
124990255|NCT00196976|449590642|FG003|Primary Study|Other|0|||
124990256|NCT00196976|449590643|FG004|Primary Study|Other|0|||
124990257|NCT00196976|449590644|FG005|Primary Study|Other|0|||
124990258|NCT00196976|449590645|FG006|Primary Study|Other|0|||
124990259|NCT00196976|449590646|FG007|Primary Study|Other|0|||
124990260|NCT00196976|449590647|FG008|Primary Study|Other|0|||
124990261|NCT00196976|449590648|FG009|Primary Study|Other|0|||
124990262|NCT00196976|449590649|FG010|Primary Study|Other|0|||
124990263|NCT00196976|449590650|FG011|Primary Study|Other|0|||
124990264|NCT00196976|449590651|FG012|Primary Study|Other|0|||
124990265|NCT00196976|449590652|FG013|Primary Study|Other|0|||
124990266|NCT00196976|449590639|FG000|Booster Study|Withdrawal by Subject|0|||
124990267|NCT00196976|449590640|FG001|Booster Study|Withdrawal by Subject|0|||
124990268|NCT00196976|449590641|FG002|Booster Study|Withdrawal by Subject|0|||
124990269|NCT00196976|449590642|FG003|Booster Study|Withdrawal by Subject|0|||
124990270|NCT00196976|449590643|FG004|Booster Study|Withdrawal by Subject|0|||
124990271|NCT00196976|449590644|FG005|Booster Study|Withdrawal by Subject|0|||
124990272|NCT00196976|449590645|FG006|Booster Study|Withdrawal by Subject|0|||
124990273|NCT00196976|449590646|FG007|Booster Study|Withdrawal by Subject|0|||
124990274|NCT00196976|449590647|FG008|Booster Study|Withdrawal by Subject|0|||
124990275|NCT00196976|449590648|FG009|Booster Study|Withdrawal by Subject|0|||
124990276|NCT00196976|449590649|FG010|Booster Study|Withdrawal by Subject|1|||
124990277|NCT00196976|449590650|FG011|Booster Study|Withdrawal by Subject|0|||
124990278|NCT00196976|449590651|FG012|Booster Study|Withdrawal by Subject|0|||
124990279|NCT00196976|449590652|FG013|Booster Study|Withdrawal by Subject|0|||
124990280|NCT00196976|449590639|FG000|Booster Study|Lost to Follow-up|0|||
124990281|NCT00196976|449590640|FG001|Booster Study|Lost to Follow-up|0|||
124990282|NCT00196976|449590641|FG002|Booster Study|Lost to Follow-up|0|||
124990283|NCT00196976|449590642|FG003|Booster Study|Lost to Follow-up|0|||
124990284|NCT00196976|449590643|FG004|Booster Study|Lost to Follow-up|0|||
124990285|NCT00196976|449590644|FG005|Booster Study|Lost to Follow-up|0|||
124990286|NCT00196976|449590645|FG006|Booster Study|Lost to Follow-up|0|||
124990287|NCT00196976|449590646|FG007|Booster Study|Lost to Follow-up|0|||
124990288|NCT00196976|449590647|FG008|Booster Study|Lost to Follow-up|0|||
124990289|NCT00196976|449590648|FG009|Booster Study|Lost to Follow-up|0|||
124990290|NCT00196976|449590649|FG010|Booster Study|Lost to Follow-up|1|||
124990291|NCT00196976|449590650|FG011|Booster Study|Lost to Follow-up|2|||
124990292|NCT00196976|449590651|FG012|Booster Study|Lost to Follow-up|0|||
124990293|NCT00196976|449590652|FG013|Booster Study|Lost to Follow-up|0|||
124990294|NCT02689518|449590653|FG000|Overall Study|Withdrawal by Subject|3|||
124990295|NCT00825825|449590654|FG000|First Medication Period (14 Days)|Adverse Event|1|||
125316801|NCT00717249|450788518|FG001|Overall Study|Diagnosed with Diabetes|0|||
124990296|NCT00825825|449590655|FG001|First Medication Period (14 Days)|Adverse Event|0|||
124990297|NCT00825825|449590656|FG002|First Medication Period (14 Days)|Adverse Event|0|||
125316802|NCT00717249|450788517|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
125316803|NCT00717249|450788518|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
124990298|NCT00825825|449590657|FG003|First Medication Period (14 Days)|Adverse Event|0|||
124990299|NCT00825825|449590658|FG004|First Medication Period (14 Days)|Adverse Event|0|||
124990300|NCT00825825|449590659|FG005|First Medication Period (14 Days)|Adverse Event|1|||
124990301|NCT00825825|449590654|FG000|First Medication Period (14 Days)|Physician Decision|2|||
124990302|NCT00825825|449590655|FG001|First Medication Period (14 Days)|Physician Decision|0|||
124990303|NCT00825825|449590656|FG002|First Medication Period (14 Days)|Physician Decision|1|||
124990304|NCT00825825|449590657|FG003|First Medication Period (14 Days)|Physician Decision|0|||
124990305|NCT00825825|449590658|FG004|First Medication Period (14 Days)|Physician Decision|0|||
124990306|NCT00825825|449590659|FG005|First Medication Period (14 Days)|Physician Decision|1|||
124990307|NCT00825825|449590654|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
124990308|NCT00825825|449590655|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
125316804|NCT00717249|450788517|FG000|Overall Study|Subject relocated|1|||
124990309|NCT00825825|449590656|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
125316805|NCT00717249|450788518|FG001|Overall Study|Subject relocated|0|||
125316806|NCT00717249|450788517|FG000|Overall Study|Headaches|1|||
125316807|NCT00717249|450788518|FG001|Overall Study|Headaches|0|||
125316808|NCT00360412|450788519|FG000|Overall Study|Adverse Event|37|||
125316809|NCT00360412|450788520|FG001|Overall Study|Adverse Event|65|||
125316810|NCT00360412|450788519|FG000|Overall Study|Protocol Violation|2|||
125316811|NCT00360412|450788520|FG001|Overall Study|Protocol Violation|5|||
125316812|NCT00360412|450788519|FG000|Overall Study|Patient withdrew consent|27|||
125316813|NCT00360412|450788520|FG001|Overall Study|Patient withdrew consent|52|||
124990310|NCT00825825|449590657|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
124990311|NCT00825825|449590658|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
124990312|NCT00825825|449590659|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
124990313|NCT00825825|449590654|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
124990314|NCT00825825|449590655|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
124990315|NCT00825825|449590656|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
124990316|NCT00825825|449590657|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
124990317|NCT00825825|449590658|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
124990318|NCT00825825|449590659|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
124990319|NCT00825825|449590654|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
124990320|NCT00825825|449590655|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
124990321|NCT00825825|449590656|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
124990322|NCT00825825|449590657|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
124990323|NCT00825825|449590658|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
124990324|NCT00825825|449590659|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
124990325|NCT00825825|449590654|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
124990326|NCT00825825|449590655|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
124990327|NCT00825825|449590656|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
124990328|NCT00825825|449590657|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
124990329|NCT00825825|449590658|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
124990330|NCT00825825|449590659|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
124990331|NCT00825825|449590654|FG000|Third Medication Period (14 Days)|poor data quality|0|||
124990332|NCT00825825|449590655|FG001|Third Medication Period (14 Days)|poor data quality|1|||
124990333|NCT00825825|449590656|FG002|Third Medication Period (14 Days)|poor data quality|0|||
124990334|NCT00825825|449590657|FG003|Third Medication Period (14 Days)|poor data quality|0|||
124990335|NCT00825825|449590658|FG004|Third Medication Period (14 Days)|poor data quality|0|||
124990336|NCT00825825|449590659|FG005|Third Medication Period (14 Days)|poor data quality|0|||
124990337|NCT01920854|449590660|FG000|Overall Study|Withdrawal by Subject|1|||
124990338|NCT01920854|449590661|FG001|Overall Study|Withdrawal by Subject|0|||
124990339|NCT01920854|449590662|FG002|Overall Study|Withdrawal by Subject|0|||
124990340|NCT01920854|449590663|FG003|Overall Study|Withdrawal by Subject|0|||
124990341|NCT01920854|449590664|FG004|Overall Study|Withdrawal by Subject|1|||
124990342|NCT01920854|449590665|FG005|Overall Study|Withdrawal by Subject|0|||
124990343|NCT01920854|449590666|FG006|Overall Study|Withdrawal by Subject|1|||
124990344|NCT00757783|449590667|FG000|Overall Study|Adverse Event|0|||
124990345|NCT00757783|449590668|FG001|Overall Study|Adverse Event|2|||
124990346|NCT00757783|449590667|FG000|Overall Study|Lost to Follow-up|1|||
124990347|NCT00757783|449590668|FG001|Overall Study|Lost to Follow-up|1|||
124990348|NCT00757783|449590667|FG000|Overall Study|Protocol Violation|1|||
124990349|NCT00757783|449590668|FG001|Overall Study|Protocol Violation|0|||
124990350|NCT00757783|449590667|FG000|Overall Study|Withdrawal by Subject|2|||
124990351|NCT00757783|449590668|FG001|Overall Study|Withdrawal by Subject|1|||
124990352|NCT00757783|449590667|FG000|Overall Study|Other|1|||
124990353|NCT00757783|449590668|FG001|Overall Study|Other|2|||
124990354|NCT02054520|449590669|FG000|Overall Study|Adverse Event|1|||
124990355|NCT02054520|449590670|FG001|Overall Study|Adverse Event|4|||
124990356|NCT02054520|449590671|FG002|Overall Study|Adverse Event|2|||
124990357|NCT02054520|449590672|FG003|Overall Study|Adverse Event|1|||
124990358|NCT02054520|449590673|FG004|Overall Study|Adverse Event|1|||
124990359|NCT02054520|449590674|FG005|Overall Study|Adverse Event|0|||
124990360|NCT02054520|449590669|FG000|Overall Study|Lack of Efficacy|7|||
125316814|NCT00360412|450788519|FG000|Overall Study|Lack of therapeutic efficacy|46|||
125316815|NCT00360412|450788520|FG001|Overall Study|Lack of therapeutic efficacy|61|||
124990361|NCT02054520|449590670|FG001|Overall Study|Lack of Efficacy|0|||
124990362|NCT02054520|449590671|FG002|Overall Study|Lack of Efficacy|2|||
124990363|NCT02054520|449590672|FG003|Overall Study|Lack of Efficacy|1|||
125316816|NCT00360412|450788519|FG000|Overall Study|Physician Decision|2|||
125316817|NCT00360412|450788520|FG001|Overall Study|Physician Decision|4|||
124990364|NCT02054520|449590673|FG004|Overall Study|Lack of Efficacy|3|||
124990365|NCT02054520|449590674|FG005|Overall Study|Lack of Efficacy|2|||
124990366|NCT02054520|449590669|FG000|Overall Study|Withdrawal by Subject|1|||
124990367|NCT02054520|449590670|FG001|Overall Study|Withdrawal by Subject|0|||
124990368|NCT02054520|449590671|FG002|Overall Study|Withdrawal by Subject|0|||
124990369|NCT02054520|449590672|FG003|Overall Study|Withdrawal by Subject|2|||
125316818|NCT00360412|450788519|FG000|Overall Study|Other|5|||
125316819|NCT00360412|450788520|FG001|Overall Study|Other|6|||
125316820|NCT00360412|450788519|FG000|Overall Study|Study termination by Sponsor|214|||
125316821|NCT00360412|450788520|FG001|Overall Study|Study termination by Sponsor|469|||
125316822|NCT00871871|450788521|FG000|Part I|Adverse Event|0|||
125316823|NCT00871871|450788522|FG001|Part I|Adverse Event|2|||
125316824|NCT00871871|450788523|FG002|Part I|Adverse Event|0|||
125316825|NCT00871871|450788524|FG003|Part I|Adverse Event|0|||
125316826|NCT00871871|450788521|FG000|Part I|Withdrawal by Subject|3|||
125316827|NCT00871871|450788522|FG001|Part I|Withdrawal by Subject|0|||
125316828|NCT00871871|450788523|FG002|Part I|Withdrawal by Subject|0|||
125316829|NCT00871871|450788524|FG003|Part I|Withdrawal by Subject|0|||
125316830|NCT00871871|450788521|FG000|Part I|Laboratory abnormality|0|||
125316831|NCT00871871|450788522|FG001|Part I|Laboratory abnormality|1|||
125316832|NCT00871871|450788523|FG002|Part I|Laboratory abnormality|0|||
125316833|NCT00871871|450788524|FG003|Part I|Laboratory abnormality|0|||
124990370|NCT02054520|449590673|FG004|Overall Study|Withdrawal by Subject|1|||
124990371|NCT02054520|449590674|FG005|Overall Study|Withdrawal by Subject|0|||
124990372|NCT02054520|449590669|FG000|Overall Study|Physician Decision|0|||
124990373|NCT02054520|449590670|FG001|Overall Study|Physician Decision|1|||
124990374|NCT02054520|449590671|FG002|Overall Study|Physician Decision|0|||
124990375|NCT02054520|449590672|FG003|Overall Study|Physician Decision|1|||
124990376|NCT02054520|449590673|FG004|Overall Study|Physician Decision|0|||
124990377|NCT02054520|449590674|FG005|Overall Study|Physician Decision|1|||
124990378|NCT02054520|449590669|FG000|Overall Study|Study terminated by Sponsor|0|||
124990379|NCT02054520|449590670|FG001|Overall Study|Study terminated by Sponsor|0|||
124990380|NCT02054520|449590671|FG002|Overall Study|Study terminated by Sponsor|2|||
124990381|NCT02054520|449590672|FG003|Overall Study|Study terminated by Sponsor|1|||
124990382|NCT02054520|449590673|FG004|Overall Study|Study terminated by Sponsor|0|||
124990383|NCT02054520|449590674|FG005|Overall Study|Study terminated by Sponsor|0|||
124990384|NCT02372136|449590679|FG000|Overall Study|Death|3|||
124990385|NCT02372136|449590680|FG001|Overall Study|Death|1|||
124990386|NCT00985946|449590681|FG000|Overall Study|Lost to Follow-up|6|||
124990387|NCT00985946|449590681|FG000|Overall Study|Withdrawal by Subject|1|||
124990388|NCT02471833|449590682|FG000|Overall Study|Lost to Follow-up|1|||
124990389|NCT02471833|449590683|FG001|Overall Study|Lost to Follow-up|0|||
124990390|NCT02471833|449590684|FG002|Overall Study|Lost to Follow-up|0|||
124990391|NCT02471833|449590682|FG000|Overall Study|Withdrawal by Subject|2|||
124990392|NCT02471833|449590683|FG001|Overall Study|Withdrawal by Subject|1|||
124990393|NCT02471833|449590684|FG002|Overall Study|Withdrawal by Subject|5|||
124990394|NCT00112047|449590687|FG000|Randomized Phase|Lost to Follow-up|26|||
124990395|NCT00112047|449590688|FG001|Randomized Phase|Lost to Follow-up|33|||
124990396|NCT00112047|449590687|FG000|Randomized Phase|Adverse Event|10|||
124990397|NCT00112047|449590688|FG001|Randomized Phase|Adverse Event|10|||
124990398|NCT00112047|449590687|FG000|Randomized Phase|Withrawal of consent|10|||
124990399|NCT00112047|449590688|FG001|Randomized Phase|Withrawal of consent|18|||
124990400|NCT00112047|449590687|FG000|Randomized Phase|Sub-optimal virological response|3|||
124990401|NCT00112047|449590688|FG001|Randomized Phase|Sub-optimal virological response|13|||
124990402|NCT00112047|449590687|FG000|Randomized Phase|Noncompliance|8|||
124990403|NCT00112047|449590688|FG001|Randomized Phase|Noncompliance|4|||
124990404|NCT00112047|449590687|FG000|Randomized Phase|Protocol Violation|2|||
124990405|NCT00112047|449590688|FG001|Randomized Phase|Protocol Violation|0|||
124990406|NCT00112047|449590687|FG000|Randomized Phase|Pregnancy|3|||
124990407|NCT00112047|449590688|FG001|Randomized Phase|Pregnancy|1|||
124990408|NCT00112047|449590687|FG000|Randomized Phase|Death|1|||
124990409|NCT00112047|449590688|FG001|Randomized Phase|Death|3|||
124990410|NCT00112047|449590687|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
124990411|NCT00112047|449590688|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
124990412|NCT00112047|449590687|FG000|Randomized Phase|Inability to swallow pills|0|||
124990413|NCT00112047|449590688|FG001|Randomized Phase|Inability to swallow pills|1|||
124990414|NCT00112047|449590687|FG000|Randomized Phase|Incarceration|3|||
124990415|NCT00112047|449590688|FG001|Randomized Phase|Incarceration|2|||
124990416|NCT00112047|449590687|FG000|Randomized Phase|Moved out of State|0|||
125316834|NCT00871871|450788521|FG000|Part II|Lack of Efficacy|0|||
125316835|NCT00871871|450788522|FG001|Part II|Lack of Efficacy|0|||
125316836|NCT00871871|450788523|FG002|Part II|Lack of Efficacy|1|||
125316837|NCT00871871|450788524|FG003|Part II|Lack of Efficacy|0|||
124990417|NCT00112047|449590688|FG001|Randomized Phase|Moved out of State|1|||
124990418|NCT00112047|449590687|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
124990419|NCT00112047|449590688|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
125316838|NCT00871871|450788521|FG000|Part II|Withdrawal by Subject|0|||
125316839|NCT00871871|450788522|FG001|Part II|Withdrawal by Subject|0|||
125316840|NCT00871871|450788523|FG002|Part II|Withdrawal by Subject|2|||
124990420|NCT00112047|449590687|FG000|Randomized Phase|High Hepatitis B DNA|0|||
124990421|NCT00112047|449590688|FG001|Randomized Phase|High Hepatitis B DNA|1|||
124990422|NCT00112047|449590687|FG000|Atripla Phase|Adverse Event|2|||
125316841|NCT00871871|450788524|FG003|Part II|Withdrawal by Subject|1|||
125316842|NCT00871871|450788521|FG000|Part II|Adverse Event|0|||
125316843|NCT00871871|450788522|FG001|Part II|Adverse Event|0|||
125316844|NCT00871871|450788523|FG002|Part II|Adverse Event|1|||
125316845|NCT00871871|450788524|FG003|Part II|Adverse Event|2|||
125316846|NCT00871871|450788521|FG000|Part II|Protocol Violation|0|||
125316847|NCT00871871|450788522|FG001|Part II|Protocol Violation|0|||
125316848|NCT00871871|450788523|FG002|Part II|Protocol Violation|0|||
125316849|NCT00871871|450788524|FG003|Part II|Protocol Violation|1|||
124990423|NCT00112047|449590688|FG001|Atripla Phase|Adverse Event|1|||
124990424|NCT00112047|449590687|FG000|Atripla Phase|Lost to Follow-up|5|||
124990425|NCT00112047|449590688|FG001|Atripla Phase|Lost to Follow-up|7|||
124990426|NCT00112047|449590687|FG000|Atripla Phase|Pregnancy|0|||
124990427|NCT00112047|449590688|FG001|Atripla Phase|Pregnancy|1|||
124990428|NCT00112047|449590687|FG000|Atripla Phase|Death|0|||
124990429|NCT00112047|449590688|FG001|Atripla Phase|Death|2|||
125316850|NCT03064490|450788530|FG000|Overall Study|Physician Decision|5|||
124990430|NCT00112047|449590687|FG000|Atripla Phase|Withdrew consent|7|||
124990431|NCT00112047|449590688|FG001|Atripla Phase|Withdrew consent|7|||
124990432|NCT00112047|449590687|FG000|Atripla Phase|Sub-optimal virological response|0|||
124990433|NCT00112047|449590688|FG001|Atripla Phase|Sub-optimal virological response|1|||
124990434|NCT00112047|449590687|FG000|Atripla Phase|Non-compliance|1|||
124990435|NCT00112047|449590688|FG001|Atripla Phase|Non-compliance|0|||
124990436|NCT00112047|449590687|FG000|Atripla Phase|Other|3|||
124990437|NCT00112047|449590688|FG001|Atripla Phase|Other|1|||
124990438|NCT01307579|449590689|FG000|Overall Study|Death|3|||
124990439|NCT01307579|449590690|FG001|Overall Study|Death|6|||
124990440|NCT01307579|449590689|FG000|Overall Study|Physician Decision|26|||
124990441|NCT01307579|449590690|FG001|Overall Study|Physician Decision|29|||
125316851|NCT01928927|450788531|FG000|Overall Study|Lost to Follow-up|1|||
124990442|NCT01307579|449590689|FG000|Overall Study|Withdrawal by Subject|7|||
124990443|NCT01307579|449590690|FG001|Overall Study|Withdrawal by Subject|3|||
124990444|NCT01307579|449590689|FG000|Overall Study|Institutional diagnosis of IFD|21|||
124990445|NCT01307579|449590690|FG001|Overall Study|Institutional diagnosis of IFD|36|||
124990446|NCT01307579|449590689|FG000|Overall Study|Begin conditioning for HSCT|42|||
124990447|NCT01307579|449590690|FG001|Overall Study|Begin conditioning for HSCT|44|||
124990448|NCT01307579|449590689|FG000|Overall Study|Refractory or relapsed AML|38|||
124990449|NCT01307579|449590690|FG001|Overall Study|Refractory or relapsed AML|23|||
124990450|NCT01307579|449590689|FG000|Overall Study|Ineligible|3|||
124990451|NCT01307579|449590690|FG001|Overall Study|Ineligible|4|||
124990452|NCT00812331|449592630|FG000|Overall Study|Adverse Event|1|||
124990453|NCT00812331|449592631|FG001|Overall Study|Adverse Event|0|||
124990454|NCT00812331|449592632|FG002|Overall Study|Adverse Event|0|||
124990455|NCT00812331|449592633|FG003|Overall Study|Adverse Event|0|||
124990456|NCT00812331|449592634|FG004|Overall Study|Adverse Event|0|||
124990457|NCT01506453|449592635|FG000|Overall Study|Withdrawal prior to treatment|0|||
124990458|NCT01506453|449592636|FG001|Overall Study|Withdrawal prior to treatment|2|||
124990459|NCT00055601|449592644|FG000|Overall Study|Protocol Violation|1|||
124990460|NCT00055601|449592645|FG001|Overall Study|Protocol Violation|1|||
124990461|NCT00055601|449592644|FG000|Overall Study|No protocol treatment received|1|||
124990462|NCT00055601|449592645|FG001|Overall Study|No protocol treatment received|1|||
124990463|NCT00117845|449592646|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
124990464|NCT00910689|449592647|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
124990465|NCT00910689|449592648|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
124990466|NCT00910689|449592649|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
124990467|NCT00910689|449592650|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
124990468|NCT00910689|449592647|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
125316852|NCT01928927|450788532|FG001|Overall Study|Lost to Follow-up|0|||
125316853|NCT01928927|450788531|FG000|Overall Study|Withdrawal by Subject|1|||
125316854|NCT01928927|450788532|FG001|Overall Study|Withdrawal by Subject|1|||
125316855|NCT02421172|450790416|FG000|Period 1|Adverse Event|1|||
125316856|NCT02421172|450790417|FG001|Period 1|Adverse Event|0|||
125316857|NCT02421172|450790418|FG002|Period 1|Adverse Event|0|||
125316858|NCT02421172|450790419|FG003|Period 1|Adverse Event|0|||
125316859|NCT02421172|450790420|FG004|Period 1|Adverse Event|0|||
125316860|NCT02421172|450790416|FG000|Period 1|Lost to Follow-up|3|||
125316861|NCT02421172|450790417|FG001|Period 1|Lost to Follow-up|1|||
125316862|NCT02421172|450790418|FG002|Period 1|Lost to Follow-up|0|||
124990469|NCT00910689|449592648|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
124990470|NCT00910689|449592649|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
124990471|NCT00910689|449592650|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
124990472|NCT00910689|449592647|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
124990473|NCT00910689|449592648|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
124990474|NCT00910689|449592649|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
124990475|NCT00910689|449592650|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
124990476|NCT00910689|449592647|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
124990477|NCT00910689|449592648|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
125316863|NCT02421172|450790419|FG003|Period 1|Lost to Follow-up|0|||
125316864|NCT02421172|450790420|FG004|Period 1|Lost to Follow-up|0|||
125316865|NCT02421172|450790416|FG000|Period 1|Patient/guardian decision|0|||
125316866|NCT02421172|450790417|FG001|Period 1|Patient/guardian decision|1|||
125316867|NCT02421172|450790418|FG002|Period 1|Patient/guardian decision|0|||
124990478|NCT00910689|449592649|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
124990479|NCT00910689|449592650|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
124990480|NCT00910689|449592647|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
124990481|NCT00910689|449592648|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
124990482|NCT00910689|449592649|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
124990483|NCT00910689|449592650|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
124990484|NCT00910689|449592647|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
124990485|NCT00910689|449592648|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
124990486|NCT00910689|449592649|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
124990487|NCT00910689|449592650|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
124990488|NCT00910689|449592647|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
124990489|NCT00910689|449592648|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
124990490|NCT00910689|449592649|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
124990491|NCT00910689|449592650|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
124990492|NCT00910689|449592647|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
124990493|NCT00910689|449592648|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
124990494|NCT00910689|449592649|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
124990495|NCT00910689|449592650|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
124990496|NCT00910689|449592647|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
124990497|NCT00910689|449592648|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
124990498|NCT00910689|449592649|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
124990499|NCT00910689|449592650|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
124990500|NCT00910689|449592647|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
124990501|NCT00910689|449592648|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
124990502|NCT00910689|449592649|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
124990503|NCT00910689|449592650|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
124990504|NCT00910689|449592647|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
124990505|NCT00910689|449592648|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
124990506|NCT00910689|449592649|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
124990507|NCT00910689|449592650|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
124990508|NCT00910689|449592647|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
124990509|NCT00910689|449592648|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
124990510|NCT00910689|449592649|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
124990511|NCT00910689|449592650|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
124990512|NCT00910689|449592647|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
124990513|NCT00910689|449592648|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
124990514|NCT00910689|449592649|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
124990515|NCT00910689|449592650|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
124990516|NCT00910689|449592647|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
125316868|NCT02421172|450790419|FG003|Period 1|Patient/guardian decision|0|||
125316869|NCT02421172|450790420|FG004|Period 1|Patient/guardian decision|0|||
125316870|NCT02421172|450790416|FG000|Period 2|Adverse Event|0|||
125316871|NCT02421172|450790417|FG001|Period 2|Adverse Event|0|||
124990517|NCT00910689|449592648|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
124990518|NCT00910689|449592649|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
124990519|NCT00910689|449592650|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
124990520|NCT00910689|449592647|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
124990521|NCT00910689|449592648|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
124990522|NCT00910689|449592649|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
124990523|NCT00910689|449592650|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
124990524|NCT00910689|449592647|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
124990525|NCT00910689|449592648|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
125316872|NCT02421172|450790418|FG002|Period 2|Adverse Event|4|||
125316873|NCT02421172|450790419|FG003|Period 2|Adverse Event|0|||
125316874|NCT02421172|450790420|FG004|Period 2|Adverse Event|0|||
125316875|NCT02421172|450790416|FG000|Period 2|Lost to Follow-up|0|||
125316876|NCT02421172|450790417|FG001|Period 2|Lost to Follow-up|0|||
125316877|NCT02421172|450790418|FG002|Period 2|Lost to Follow-up|0|||
125316878|NCT02421172|450790419|FG003|Period 2|Lost to Follow-up|1|||
125316879|NCT02421172|450790420|FG004|Period 2|Lost to Follow-up|0|||
125316880|NCT02421172|450790416|FG000|Period 2|Patient/guardian decision|0|||
124990526|NCT00910689|449592649|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
124990527|NCT00910689|449592650|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
124990528|NCT00910689|449592647|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
124990529|NCT00910689|449592648|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
124990530|NCT00910689|449592649|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
124990531|NCT00910689|449592650|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
125316881|NCT02421172|450790417|FG001|Period 2|Patient/guardian decision|0|||
125316882|NCT02421172|450790418|FG002|Period 2|Patient/guardian decision|3|||
125316883|NCT02421172|450790419|FG003|Period 2|Patient/guardian decision|2|||
124990532|NCT00910689|449592647|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
124990533|NCT00910689|449592648|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
124990534|NCT00910689|449592649|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
124990535|NCT00910689|449592650|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
124990536|NCT00910689|449592647|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
124990537|NCT00910689|449592648|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
124990538|NCT00910689|449592649|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
124990539|NCT00910689|449592650|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
124990540|NCT00910689|449592647|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
124990541|NCT00910689|449592648|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
124990542|NCT00910689|449592649|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
124990543|NCT00910689|449592650|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
124990544|NCT00910689|449592647|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
124990545|NCT00910689|449592648|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
124990546|NCT00910689|449592649|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
124990547|NCT00910689|449592650|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
124990548|NCT00484289|449592656|FG000|Long Term Phase|Adverse Event|1|||
124990549|NCT00484289|449592657|FG001|Long Term Phase|Adverse Event|17|||
124990550|NCT00484289|449592658|FG002|Long Term Phase|Adverse Event|5|||
124990551|NCT00484289|449592656|FG000|Long Term Phase|Withdrawal by Subject|0|||
124990552|NCT00484289|449592657|FG001|Long Term Phase|Withdrawal by Subject|7|||
124990553|NCT00484289|449592658|FG002|Long Term Phase|Withdrawal by Subject|6|||
124990554|NCT00484289|449592656|FG000|Long Term Phase|Inadequate response|2|||
125316884|NCT02421172|450790420|FG004|Period 2|Patient/guardian decision|1|||
125316885|NCT00683878|450790424|FG000|Overall Study|Lack of Efficacy|3|||
125316886|NCT00683878|450790425|FG001|Overall Study|Lack of Efficacy|0|||
125316887|NCT00683878|450790426|FG002|Overall Study|Lack of Efficacy|1|||
125316888|NCT00683878|450790424|FG000|Overall Study|Adverse Event|4|||
125316889|NCT00683878|450790425|FG001|Overall Study|Adverse Event|3|||
124990555|NCT00484289|449592657|FG001|Long Term Phase|Inadequate response|7|||
124990556|NCT00484289|449592658|FG002|Long Term Phase|Inadequate response|4|||
125316890|NCT00683878|450790426|FG002|Overall Study|Adverse Event|3|||
125316891|NCT00683878|450790424|FG000|Overall Study|Withdrawal by Subject|9|||
125316892|NCT00683878|450790425|FG001|Overall Study|Withdrawal by Subject|8|||
125316893|NCT00683878|450790426|FG002|Overall Study|Withdrawal by Subject|6|||
125316894|NCT00683878|450790424|FG000|Overall Study|Death|0|||
125316895|NCT00683878|450790425|FG001|Overall Study|Death|1|||
125316896|NCT00683878|450790426|FG002|Overall Study|Death|0|||
125316897|NCT00683878|450790424|FG000|Overall Study|Lost to Follow-up|4|||
125316898|NCT00683878|450790425|FG001|Overall Study|Lost to Follow-up|2|||
125316899|NCT00683878|450790426|FG002|Overall Study|Lost to Follow-up|4|||
125316900|NCT00683878|450790424|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
125316901|NCT00683878|450790425|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
125316902|NCT00683878|450790426|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
125316903|NCT02869633|450790430|FG000|Overall Study|Death|2|||
125316904|NCT02869633|450790431|FG001|Overall Study|Death|1|||
125316905|NCT02869633|450790430|FG000|Overall Study|Patient refused follow-up|1|||
125316906|NCT02869633|450790431|FG001|Overall Study|Patient refused follow-up|0|||
125316907|NCT02869633|450790430|FG000|Overall Study|Provider discretion|1|||
125316908|NCT02869633|450790431|FG001|Overall Study|Provider discretion|0|||
125316909|NCT02869633|450790430|FG000|Overall Study|Investigator decision|1|||
125316910|NCT02869633|450790431|FG001|Overall Study|Investigator decision|0|||
125316911|NCT02869633|450790430|FG000|Overall Study|Lost to Follow-up|0|||
125316912|NCT02869633|450790431|FG001|Overall Study|Lost to Follow-up|1|||
125316913|NCT02869633|450790430|FG000|Overall Study|Not eligible|6|||
125316914|NCT02869633|450790431|FG001|Overall Study|Not eligible|1|||
125316915|NCT02869633|450790430|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
125316916|NCT02869633|450790431|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
125316917|NCT02869633|450790430|FG000|Overall Study|Withdrawal by Subject|0|||
125316918|NCT02869633|450790431|FG001|Overall Study|Withdrawal by Subject|1|||
125316919|NCT04024891|450790432|FG000|Overall Study|Pregnancy|0|||
125316920|NCT04024891|450790433|FG001|Overall Study|Pregnancy|1|||
124990557|NCT00484289|449592656|FG000|Long Term Phase|Other Reason|0|||
124990558|NCT00484289|449592657|FG001|Long Term Phase|Other Reason|5|||
124990559|NCT00484289|449592658|FG002|Long Term Phase|Other Reason|1|||
124990560|NCT00484289|449592656|FG000|Post Marketing Phase|Adverse Event|0|||
124990561|NCT00484289|449592657|FG001|Post Marketing Phase|Adverse Event|1|||
125316921|NCT01421017|450790434|FG000|Overall Study|Withdrawal by Subject|2|||
125316922|NCT01421017|450790435|FG001|Overall Study|Withdrawal by Subject|0|||
125316923|NCT01421017|450790436|FG002|Overall Study|Withdrawal by Subject|0|||
125316924|NCT01421017|450790434|FG000|Overall Study|POD|0|||
125316925|NCT01421017|450790435|FG001|Overall Study|POD|6|||
125316926|NCT01421017|450790436|FG002|Overall Study|POD|3|||
125316927|NCT03489863|450790437|FG000|Overall Study|Withdrawal by Subject|0|||
125316928|NCT03489863|450790438|FG001|Overall Study|Withdrawal by Subject|1|||
125316929|NCT00962208|450790440|FG000|Overall Study|Could not achieve good vision|9|||
125316930|NCT00962208|450790441|FG001|Overall Study|Could not achieve good vision|0|||
125316931|NCT00962208|450790440|FG000|Overall Study|Contraindicated to continue study|5|||
125316932|NCT00962208|450790441|FG001|Overall Study|Contraindicated to continue study|1|||
125316933|NCT00962208|450790440|FG000|Overall Study|Lost to Follow-up|0|||
125316934|NCT00962208|450790441|FG001|Overall Study|Lost to Follow-up|9|||
125316935|NCT00791388|450790442|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
125316936|NCT00791388|450790443|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
125316937|NCT00791388|450790444|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
125316938|NCT00791388|450790445|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
125316939|NCT00791388|450790446|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
125316940|NCT00791388|450790442|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
125316941|NCT00791388|450790443|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
125316942|NCT00791388|450790444|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
125316943|NCT00791388|450790445|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
124990562|NCT00484289|449592658|FG002|Post Marketing Phase|Adverse Event|0|||
124990563|NCT02349425|449592659|FG000|Period 1|Adverse Event|1|||
124990564|NCT02349425|449592660|FG001|Period 1|Adverse Event|1|||
124990565|NCT02349425|449592661|FG002|Period 1|Adverse Event|0|||
124990566|NCT02349425|449592662|FG003|Period 1|Adverse Event|0|||
125316944|NCT00791388|450790446|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
125316945|NCT00791388|450790442|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
125316946|NCT00791388|450790443|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
125316947|NCT00791388|450790444|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
125316948|NCT00791388|450790445|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
124990567|NCT02349425|449592659|FG000|Period 2|Adverse Event|0|||
124990568|NCT02349425|449592660|FG001|Period 2|Adverse Event|1|||
124990569|NCT02349425|449592661|FG002|Period 2|Adverse Event|1|||
124990570|NCT02349425|449592662|FG003|Period 2|Adverse Event|0|||
124990571|NCT01403610|449592663|FG000|Overall Study|Withdrawal by Subject|2|||
124990572|NCT01403610|449592664|FG001|Overall Study|Withdrawal by Subject|0|||
124990573|NCT01403610|449592665|FG002|Overall Study|Withdrawal by Subject|0|||
124990574|NCT01403610|449592666|FG003|Overall Study|Withdrawal by Subject|0|||
124990575|NCT01403610|449592663|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
124990576|NCT01403610|449592664|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
124990577|NCT01403610|449592665|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
124990578|NCT01403610|449592666|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
124990579|NCT00686725|449592669|FG000|Overall Study|Adverse Event|1|||
124990580|NCT00686725|449592670|FG001|Overall Study|Adverse Event|1|||
124990581|NCT00686725|449592669|FG000|Overall Study|Progressive Disease|17|||
124990582|NCT00686725|449592670|FG001|Overall Study|Progressive Disease|23|||
124990583|NCT00686725|449592669|FG000|Overall Study|Lost to Follow-up|7|||
124990584|NCT00686725|449592670|FG001|Overall Study|Lost to Follow-up|5|||
124990585|NCT00686725|449592669|FG000|Overall Study|Death|6|||
124990586|NCT00686725|449592670|FG001|Overall Study|Death|3|||
124990587|NCT00686725|449592669|FG000|Overall Study|Withdrawal by Subject|13|||
124990588|NCT00686725|449592670|FG001|Overall Study|Withdrawal by Subject|4|||
124990589|NCT00686725|449592669|FG000|Overall Study|Protocol Violation|1|||
124990590|NCT00686725|449592670|FG001|Overall Study|Protocol Violation|3|||
124990591|NCT00686725|449592669|FG000|Overall Study|Other|1|||
124990592|NCT00686725|449592670|FG001|Overall Study|Other|3|||
124990593|NCT03064035|449592673|FG000|Overall Study|Did not receive allocated intervention|4|||
124990594|NCT03064035|449592674|FG001|Overall Study|Did not receive allocated intervention|2|||
124990595|NCT03064035|449592673|FG000|Overall Study|Lost to Follow-up|1|||
124990596|NCT03064035|449592674|FG001|Overall Study|Lost to Follow-up|1|||
124990597|NCT01143038|449592675|FG000|Overall Study|Withdrawal by Subject|4|||
124990598|NCT01143038|449592675|FG000|Overall Study|Requirement for alternative therapy|5|||
124990599|NCT01143038|449592675|FG000|Overall Study|Adverse Event|3|||
124990600|NCT01143038|449592675|FG000|Overall Study|Lost to Follow-up|2|||
124990601|NCT01143038|449592675|FG000|Overall Study|Protocol Deviation|1|||
124990602|NCT01143038|449592675|FG000|Overall Study|Death|1|||
124990603|NCT01248065|449592678|FG000|Overall Study|Lost to Follow-up|3|||
124990604|NCT01248065|449592679|FG001|Overall Study|Lost to Follow-up|5|||
124990605|NCT01248065|449592678|FG000|Overall Study|Withdrawal by Subject|14|||
124990606|NCT01248065|449592679|FG001|Overall Study|Withdrawal by Subject|11|||
124990607|NCT01248065|449592678|FG000|Overall Study|Adverse Event|3|||
124990608|NCT01248065|449592679|FG001|Overall Study|Adverse Event|0|||
124990609|NCT01248065|449592678|FG000|Overall Study|Third treatment failure event|3|||
124990610|NCT01248065|449592679|FG001|Overall Study|Third treatment failure event|1|||
124990611|NCT01248065|449592678|FG000|Overall Study|Other|3|||
124990612|NCT01248065|449592679|FG001|Overall Study|Other|5|||
125316949|NCT00791388|450790446|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
125316950|NCT02995980|450790447|FG000|Overall Study|Lost to Follow-up|14|||
124990613|NCT03010176|449592682|FG000|Overall Study|Death|21|||
124990614|NCT03010176|449592683|FG001|Overall Study|Death|35|||
124990615|NCT03010176|449592684|FG002|Overall Study|Death|19|||
125316951|NCT00657540|450790449|FG000|Overall Study|Lost to Follow-up|1|||
125316952|NCT00657540|450790450|FG001|Overall Study|Lost to Follow-up|4|||
125316953|NCT03010527|450790452|FG000|Overall Study|Death|0|||
125316954|NCT03010527|450790453|FG001|Overall Study|Death|0|||
125316955|NCT03010527|450790454|FG002|Overall Study|Death|1|||
125316956|NCT03010527|450790452|FG000|Overall Study|Adverse Event|0|||
125316957|NCT03010527|450790453|FG001|Overall Study|Adverse Event|4|||
125316958|NCT03010527|450790454|FG002|Overall Study|Adverse Event|2|||
125316959|NCT03010527|450790452|FG000|Overall Study|Protocol Violation|0|||
124990616|NCT03010176|449592685|FG003|Overall Study|Death|19|||
124990617|NCT03010176|449592686|FG004|Overall Study|Death|14|||
124990618|NCT03010176|449592687|FG005|Overall Study|Death|0|||
124990619|NCT03010176|449592682|FG000|Overall Study|Lost to Follow-up|0|||
124990620|NCT03010176|449592683|FG001|Overall Study|Lost to Follow-up|0|||
124990621|NCT03010176|449592684|FG002|Overall Study|Lost to Follow-up|0|||
124990622|NCT03010176|449592685|FG003|Overall Study|Lost to Follow-up|0|||
124990623|NCT03010176|449592686|FG004|Overall Study|Lost to Follow-up|1|||
124990624|NCT03010176|449592687|FG005|Overall Study|Lost to Follow-up|0|||
124990625|NCT03010176|449592682|FG000|Overall Study|Physician Decision|0|||
124990626|NCT03010176|449592683|FG001|Overall Study|Physician Decision|4|||
124990627|NCT03010176|449592684|FG002|Overall Study|Physician Decision|0|||
124990628|NCT03010176|449592685|FG003|Overall Study|Physician Decision|1|||
124990629|NCT03010176|449592686|FG004|Overall Study|Physician Decision|0|||
124990630|NCT03010176|449592687|FG005|Overall Study|Physician Decision|0|||
124990631|NCT03010176|449592682|FG000|Overall Study|Sponsor Decision|0|||
124990632|NCT03010176|449592683|FG001|Overall Study|Sponsor Decision|4|||
124990633|NCT03010176|449592684|FG002|Overall Study|Sponsor Decision|4|||
124990634|NCT03010176|449592685|FG003|Overall Study|Sponsor Decision|1|||
124990635|NCT03010176|449592686|FG004|Overall Study|Sponsor Decision|6|||
124990636|NCT03010176|449592687|FG005|Overall Study|Sponsor Decision|0|||
124990637|NCT03010176|449592682|FG000|Overall Study|Withdrawal by Subject|11|||
124990638|NCT03010176|449592683|FG001|Overall Study|Withdrawal by Subject|9|||
124990639|NCT03010176|449592684|FG002|Overall Study|Withdrawal by Subject|3|||
124990640|NCT03010176|449592685|FG003|Overall Study|Withdrawal by Subject|0|||
124990641|NCT03010176|449592686|FG004|Overall Study|Withdrawal by Subject|4|||
124990642|NCT03010176|449592687|FG005|Overall Study|Withdrawal by Subject|0|||
124990643|NCT00321373|449592690|FG000|Overall Study|Adverse Event|0|||
124990644|NCT00321373|449592691|FG001|Overall Study|Adverse Event|0|||
124990645|NCT00321373|449592692|FG002|Overall Study|Adverse Event|1|||
124990646|NCT00321373|449592690|FG000|Overall Study|Lost to Follow-up|1|||
124990647|NCT00321373|449592691|FG001|Overall Study|Lost to Follow-up|0|||
124990648|NCT00321373|449592692|FG002|Overall Study|Lost to Follow-up|1|||
124990649|NCT00321373|449592690|FG000|Overall Study|Withdrawal by Subject|1|||
125316960|NCT03010527|450790453|FG001|Overall Study|Protocol Violation|1|||
125316961|NCT03010527|450790454|FG002|Overall Study|Protocol Violation|0|||
125316962|NCT03010527|450790452|FG000|Overall Study|Lost to Follow-up|0|||
125316963|NCT03010527|450790453|FG001|Overall Study|Lost to Follow-up|2|||
124990650|NCT00321373|449592691|FG001|Overall Study|Withdrawal by Subject|0|||
124990651|NCT00321373|449592692|FG002|Overall Study|Withdrawal by Subject|0|||
124990652|NCT00321373|449592690|FG000|Overall Study|Other|0|||
124990653|NCT00321373|449592691|FG001|Overall Study|Other|0|||
124990654|NCT00321373|449592692|FG002|Overall Study|Other|1|||
124990655|NCT01774487|449592693|FG000|Overall Study|Did not tolerate taste|4|||
124990656|NCT01774487|449592694|FG001|Overall Study|Did not tolerate taste|4|||
124990657|NCT00461032|449592695|FG000|Overall Study|Adverse Event|5|||
124990658|NCT00461032|449592696|FG001|Overall Study|Adverse Event|6|||
124990659|NCT00461032|449592695|FG000|Overall Study|Lack of Efficacy|5|||
124990660|NCT00461032|449592696|FG001|Overall Study|Lack of Efficacy|1|||
124990661|NCT00461032|449592695|FG000|Overall Study|Lost to Follow-up|7|||
124990662|NCT00461032|449592696|FG001|Overall Study|Lost to Follow-up|12|||
124990663|NCT00461032|449592695|FG000|Overall Study|Protocol Violation|4|||
124990664|NCT00461032|449592696|FG001|Overall Study|Protocol Violation|4|||
124990665|NCT00461032|449592695|FG000|Overall Study|Withdrawal by Subject|7|||
124990666|NCT00461032|449592696|FG001|Overall Study|Withdrawal by Subject|15|||
125316964|NCT03010527|450790454|FG002|Overall Study|Lost to Follow-up|1|||
125316965|NCT03010527|450790452|FG000|Overall Study|Withdrawal by Subject|0|||
125316966|NCT03010527|450790453|FG001|Overall Study|Withdrawal by Subject|3|||
124990667|NCT00461032|449592695|FG000|Overall Study|Patient Moved or Relocated|2|||
124990668|NCT00461032|449592696|FG001|Overall Study|Patient Moved or Relocated|1|||
124990669|NCT00461032|449592695|FG000|Overall Study|Other|7|||
124990670|NCT00461032|449592696|FG001|Overall Study|Other|5|||
124990671|NCT04447846|449592697|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
124990672|NCT01878214|449592698|FG000|Overall Study|Withdrawal by Subject|18|||
124990673|NCT01878214|449592699|FG001|Overall Study|Withdrawal by Subject|7|||
124990674|NCT01878214|449592698|FG000|Overall Study|Death|0|||
124990675|NCT01878214|449592699|FG001|Overall Study|Death|1|||
125316967|NCT03010527|450790454|FG002|Overall Study|Withdrawal by Subject|4|||
125316968|NCT03010527|450790452|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
124990676|NCT01878214|449592698|FG000|Overall Study|Lost to Follow-up|35|||
124990677|NCT01878214|449592699|FG001|Overall Study|Lost to Follow-up|36|||
124990678|NCT00946101|449592700|FG000|Overall Study|Lost to Follow-up|2|||
125316969|NCT03010527|450790453|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
124990679|NCT00946101|449592701|FG001|Overall Study|Lost to Follow-up|1|||
124990680|NCT00946101|449592700|FG000|Overall Study|Withdrawal of consent|2|||
124990681|NCT00946101|449592701|FG001|Overall Study|Withdrawal of consent|0|||
124990682|NCT00946101|449592700|FG000|Overall Study|Physician Decision|0|||
124990683|NCT00946101|449592701|FG001|Overall Study|Physician Decision|1|||
124990684|NCT00552240|449592710|FG000|Overall Study|Adverse Event|9|||
124990685|NCT00552240|449592711|FG001|Overall Study|Adverse Event|9|||
124990686|NCT00552240|449592710|FG000|Overall Study|Protocol Violation|1|||
124990687|NCT00552240|449592711|FG001|Overall Study|Protocol Violation|1|||
124990688|NCT00552240|449592710|FG000|Overall Study|Lost to Follow-up|5|||
124990689|NCT00552240|449592711|FG001|Overall Study|Lost to Follow-up|6|||
124990690|NCT00552240|449592710|FG000|Overall Study|Withdrawal by Subject|2|||
124990691|NCT00552240|449592711|FG001|Overall Study|Withdrawal by Subject|2|||
124990692|NCT00552240|449592710|FG000|Overall Study|Lack of Efficacy|6|||
124990693|NCT00552240|449592711|FG001|Overall Study|Lack of Efficacy|0|||
124990694|NCT00552240|449592710|FG000|Overall Study|Other|1|||
124990695|NCT00552240|449592711|FG001|Overall Study|Other|0|||
124990696|NCT02783768|449592712|FG000|Overall Study|Lost to Follow-up|1|||
124990697|NCT02783768|449592713|FG001|Overall Study|Lost to Follow-up|0|||
124990698|NCT01323647|449592714|FG000|Overall Study|Migrated/moved from study area|2|||
124990699|NCT01323647|449592715|FG001|Overall Study|Migrated/moved from study area|0|||
124990700|NCT01323647|449592714|FG000|Overall Study|Withdrawal by Subject|5|||
124990701|NCT01323647|449592715|FG001|Overall Study|Withdrawal by Subject|0|||
124990702|NCT01323647|449592714|FG000|Overall Study|Lost to Follow-up|2|||
124990703|NCT01323647|449592715|FG001|Overall Study|Lost to Follow-up|0|||
124990704|NCT02319525|449592722|FG000|Overall Study|Withdrawal by Subject|2|||
124990705|NCT02319525|449592723|FG001|Overall Study|Withdrawal by Subject|1|||
124990706|NCT00938860|449592724|FG000|Overall Study|Adverse Event|2|||
124990707|NCT00938860|449592725|FG001|Overall Study|Adverse Event|1|||
124990708|NCT00938860|449592724|FG000|Overall Study|Abnormal laboratory values|2|||
124990709|NCT00938860|449592725|FG001|Overall Study|Abnormal laboratory values|2|||
124990710|NCT00938860|449592724|FG000|Overall Study|Withdrawal by Subject|11|||
124990711|NCT00938860|449592725|FG001|Overall Study|Withdrawal by Subject|8|||
124990712|NCT00938860|449592724|FG000|Overall Study|Lost to Follow-up|4|||
124990713|NCT00938860|449592725|FG001|Overall Study|Lost to Follow-up|4|||
124990714|NCT00938860|449592724|FG000|Overall Study|Administration problems|2|||
124990715|NCT00938860|449592725|FG001|Overall Study|Administration problems|0|||
124990716|NCT00938860|449592724|FG000|Overall Study|Death|1|||
124990717|NCT00938860|449592725|FG001|Overall Study|Death|1|||
124990718|NCT00938860|449592724|FG000|Overall Study|Protocol Violation|3|||
124990719|NCT00938860|449592725|FG001|Overall Study|Protocol Violation|1|||
124990720|NCT00232544|449592726|FG000|Overall Study|Lost to Follow-up|20|||
124990721|NCT00232544|449592727|FG001|Overall Study|Lost to Follow-up|15|||
124990722|NCT00336895|449592728|FG000|Overall Study|diarrhea|1|||
124990723|NCT00336895|449592728|FG000|Overall Study|nausea and upset stomach|1|||
124990724|NCT00336895|449592728|FG000|Overall Study|Physician Decision|1|||
124990725|NCT00336895|449592728|FG000|Overall Study|screen failed|1|||
124990726|NCT03426605|449592729|FG000|Overall Study|AML relapse or progression|2|||
124990727|NCT03426605|449592730|FG001|Overall Study|AML relapse or progression|1|||
124990728|NCT03426605|449592731|FG002|Overall Study|AML relapse or progression|2|||
124990729|NCT03426605|449592732|FG003|Overall Study|AML relapse or progression|2|||
124990730|NCT03426605|449592729|FG000|Overall Study|Treatment failure|3|||
124990731|NCT03426605|449592730|FG001|Overall Study|Treatment failure|2|||
124990732|NCT03426605|449592731|FG002|Overall Study|Treatment failure|0|||
124990733|NCT03426605|449592732|FG003|Overall Study|Treatment failure|0|||
124990734|NCT03426605|449592729|FG000|Overall Study|Adverse Event|1|||
124990735|NCT03426605|449592730|FG001|Overall Study|Adverse Event|0|||
124990736|NCT03426605|449592731|FG002|Overall Study|Adverse Event|1|||
124990737|NCT03426605|449592732|FG003|Overall Study|Adverse Event|1|||
124990738|NCT03426605|449592729|FG000|Overall Study|Withdrawal by Subject|0|||
124990739|NCT03426605|449592730|FG001|Overall Study|Withdrawal by Subject|0|||
124990740|NCT03426605|449592731|FG002|Overall Study|Withdrawal by Subject|1|||
124990741|NCT03426605|449592732|FG003|Overall Study|Withdrawal by Subject|1|||
124990742|NCT01535560|449592736|FG000|Overall Study|Adverse Event|12|||
124990743|NCT01535560|449592737|FG001|Overall Study|Adverse Event|7|||
125316970|NCT03010527|450790454|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
124990744|NCT01535560|449592736|FG000|Overall Study|Lost to Follow-up|1|||
124990745|NCT01535560|449592737|FG001|Overall Study|Lost to Follow-up|3|||
124990746|NCT01535560|449592736|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
124990747|NCT01535560|449592737|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
124990748|NCT01535560|449592736|FG000|Overall Study|Treatment Failure|21|||
124990749|NCT01535560|449592737|FG001|Overall Study|Treatment Failure|83|||
125316971|NCT03010527|450790452|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
124990750|NCT01535560|449592736|FG000|Overall Study|Other|0|||
124990751|NCT01535560|449592737|FG001|Overall Study|Other|1|||
124990752|NCT01535560|449592736|FG000|Overall Study|Randomized in Error|0|||
124990753|NCT01535560|449592737|FG001|Overall Study|Randomized in Error|1|||
124990754|NCT02009761|449592738|FG000|Overall Study|Adverse Event|4|||
124990755|NCT01047293|449592748|FG000|Overall Study|DLT criteria not fulfilled|1|||
125316972|NCT03010527|450790453|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
125316973|NCT03010527|450790454|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
125316974|NCT03010527|450790452|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
125316975|NCT03010527|450790453|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
125316976|NCT03010527|450790454|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
125316977|NCT02656017|450790455|FG000|Overall Study|Study burden|3|||
125316978|NCT02656017|450790456|FG001|Overall Study|Study burden|3|||
125316979|NCT02656017|450790455|FG000|Overall Study|Adverse Event|2|||
124990756|NCT01047293|449592749|FG001|Overall Study|DLT criteria not fulfilled|1|||
124990757|NCT01047293|449592750|FG002|Overall Study|DLT criteria not fulfilled|0|||
124990758|NCT01047293|449592751|FG003|Overall Study|DLT criteria not fulfilled|0|||
124990759|NCT01272804|449592755|FG000|Overall Study|Adverse Event|1|||
124990760|NCT01272804|449592756|FG001|Overall Study|Adverse Event|0|||
124990761|NCT01272804|449592757|FG002|Overall Study|Adverse Event|0|||
124990762|NCT01272804|449592758|FG003|Overall Study|Adverse Event|0|||
124990763|NCT01272804|449592759|FG004|Overall Study|Adverse Event|2|||
124990764|NCT01272804|449592760|FG005|Overall Study|Adverse Event|1|||
125316980|NCT02656017|450790456|FG001|Overall Study|Adverse Event|1|||
125316981|NCT02656017|450790455|FG000|Overall Study|Unable/unwilling to take study medication|2|||
125316982|NCT02656017|450790456|FG001|Overall Study|Unable/unwilling to take study medication|1|||
125316983|NCT02656017|450790455|FG000|Overall Study|Began Tolvaptan|1|||
125316984|NCT02656017|450790456|FG001|Overall Study|Began Tolvaptan|1|||
125316985|NCT02656017|450790455|FG000|Overall Study|Withdrawal by Subject|1|||
125316986|NCT02656017|450790456|FG001|Overall Study|Withdrawal by Subject|0|||
125316987|NCT04245111|450790457|FG000|Overall Study|Lost to Follow-up|5|||
125316988|NCT04245111|450790458|FG001|Overall Study|Lost to Follow-up|1|||
125316989|NCT04245111|450790459|FG002|Overall Study|Lost to Follow-up|1|||
125316990|NCT03309878|450790460|FG000|Overall Study|Adverse Event|1|||
124990765|NCT02318797|449592761|FG000|Overall Study|Death|3|||
124990766|NCT02318797|449592762|FG001|Overall Study|Death|6|||
124990767|NCT02318797|449592761|FG000|Overall Study|Lost to Follow-up|85|||
124990768|NCT02318797|449592762|FG001|Overall Study|Lost to Follow-up|96|||
124990769|NCT02112708|449592764|FG000|Baseline|Physician Decision|16|||
124990770|NCT02112708|449592765|FG001|Baseline|Physician Decision|11|||
124990771|NCT02112708|449592764|FG000|Baseline|Lost to Follow-up|12|||
124990772|NCT02112708|449592765|FG001|Baseline|Lost to Follow-up|0|||
124990773|NCT02112708|449592764|FG000|4 Month|Death|0|||
124990774|NCT02112708|449592765|FG001|4 Month|Death|1|||
124990775|NCT02112708|449592764|FG000|4 Month|Withdrawal by Subject|12|||
124990776|NCT02112708|449592765|FG001|4 Month|Withdrawal by Subject|0|||
124990777|NCT02673515|449592766|FG000|Overall Study|Lack of motivation|2|||
124990778|NCT02673515|449592767|FG001|Overall Study|Lack of motivation|1|||
124990779|NCT01796548|449592768|FG000|Overall Study|Lost to Follow-up|1|||
124990780|NCT01796548|449592768|FG000|Overall Study|Other|2|||
124990781|NCT04227704|449592772|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
124990782|NCT04227704|449592773|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
124990783|NCT04227704|449592774|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
124990784|NCT04227704|449592772|FG000|Overall Study|due to C/S being cancelled|1|||
124990785|NCT04227704|449592773|FG001|Overall Study|due to C/S being cancelled|0|||
124990786|NCT04227704|449592774|FG002|Overall Study|due to C/S being cancelled|0|||
124990787|NCT03432260|449592785|FG000|Overall Study|Lost to Follow-up|1|||
124990788|NCT03432260|449592786|FG001|Overall Study|Lost to Follow-up|1|||
124990789|NCT03432260|449592787|FG002|Overall Study|Lost to Follow-up|0|||
124990790|NCT03432260|449592788|FG003|Overall Study|Lost to Follow-up|0|||
124990791|NCT03432260|449592789|FG004|Overall Study|Lost to Follow-up|1|||
124990792|NCT01775124|449592791|FG000|Core Period|Disease Progression|0|||
124990793|NCT01775124|449592792|FG001|Core Period|Disease Progression|1|||
124990794|NCT01775124|449592791|FG000|Core Period|Physician Decision|1|||
124990795|NCT01775124|449592792|FG001|Core Period|Physician Decision|1|||
124990796|NCT01775124|449592791|FG000|Core Period|Death|0|||
124990797|NCT01775124|449592792|FG001|Core Period|Death|1|||
124990798|NCT01775124|449592791|FG000|Core Period|Administrative problems|1|||
124990799|NCT01775124|449592792|FG001|Core Period|Administrative problems|0|||
125316991|NCT03309878|450790461|FG001|Overall Study|Adverse Event|0|||
124990800|NCT01775124|449592791|FG000|Core Period|Withdrawal by Subject|4|||
124990801|NCT01775124|449592792|FG001|Core Period|Withdrawal by Subject|2|||
124990802|NCT01775124|449592791|FG000|Core Period|Adverse Event|5|||
124990803|NCT01775124|449592792|FG001|Core Period|Adverse Event|5|||
124990804|NCT01775124|449592791|FG000|Extension Period|Adverse Event|3|||
124990805|NCT01775124|449592792|FG001|Extension Period|Adverse Event|2|||
124990806|NCT01775124|449592791|FG000|Extension Period|Physician Decision|0|||
125316992|NCT03309878|450790462|FG002|Overall Study|Adverse Event|0|||
125316993|NCT03309878|450790463|FG003|Overall Study|Adverse Event|0|||
125316994|NCT03309878|450790460|FG000|Overall Study|Did not maintain eligibility|2|||
125316995|NCT03309878|450790461|FG001|Overall Study|Did not maintain eligibility|1|||
124990807|NCT01775124|449592792|FG001|Extension Period|Physician Decision|2|||
124990808|NCT01775124|449592791|FG000|Extension Period|Administrative problems|0|||
124990809|NCT01775124|449592792|FG001|Extension Period|Administrative problems|1|||
124990810|NCT01775124|449592791|FG000|Extension Period|Lost to Follow-up|0|||
124990811|NCT01775124|449592792|FG001|Extension Period|Lost to Follow-up|1|||
124990812|NCT01775124|449592791|FG000|Extension Period|Withdrawal by Subject|9|||
124990813|NCT01775124|449592792|FG001|Extension Period|Withdrawal by Subject|12|||
124990814|NCT01589237|449594280|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
124990815|NCT01589237|449594281|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
124990816|NCT01589237|449594282|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
124990817|NCT01589237|449594283|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
124990818|NCT01589237|449594280|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
124990819|NCT01589237|449594281|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
124990820|NCT01589237|449594282|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
124990821|NCT01589237|449594283|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
124990822|NCT01589237|449594280|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
124990823|NCT01589237|449594281|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
124990824|NCT01589237|449594282|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
124990825|NCT01589237|449594283|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
124990826|NCT01589237|449594280|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
124990827|NCT01589237|449594281|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
124990828|NCT01589237|449594282|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
124990829|NCT01589237|449594283|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
124990830|NCT02594163|449594284|FG000|Treatment Period|Progressive disease|2|||
124990831|NCT02594163|449594285|FG001|Treatment Period|Progressive disease|3|||
124990832|NCT02594163|449594284|FG000|Treatment Period|Adverse Event|1|||
124990833|NCT02594163|449594285|FG001|Treatment Period|Adverse Event|5|||
124990834|NCT02594163|449594284|FG000|Treatment Period|Physician Decision|1|||
124990835|NCT02594163|449594285|FG001|Treatment Period|Physician Decision|3|||
124990836|NCT02594163|449594284|FG000|Treatment Period|Study termination by sponsor|2|||
124990837|NCT02594163|449594285|FG001|Treatment Period|Study termination by sponsor|1|||
124990838|NCT02594163|449594284|FG000|Treatment Period|Other, Non-AE|1|||
124990839|NCT02594163|449594285|FG001|Treatment Period|Other, Non-AE|0|||
124990840|NCT02594163|449594284|FG000|Follow-up Period|Withdrawal by Subject|0|||
124990841|NCT02594163|449594285|FG001|Follow-up Period|Withdrawal by Subject|1|||
124990842|NCT02594163|449594284|FG000|Follow-up Period|Study Termination by Sponsor|6|||
124990843|NCT02594163|449594285|FG001|Follow-up Period|Study Termination by Sponsor|4|||
124990844|NCT02594163|449594284|FG000|Follow-up Period|Lost to Follow-up|1|||
124990845|NCT02594163|449594285|FG001|Follow-up Period|Lost to Follow-up|0|||
124990846|NCT02594163|449594284|FG000|Follow-up Period|Death|2|||
124990847|NCT02594163|449594285|FG001|Follow-up Period|Death|5|||
124990848|NCT02594163|449594284|FG000|Follow-up Period|Adverse Event|0|||
124990849|NCT02594163|449594285|FG001|Follow-up Period|Adverse Event|1|||
124990850|NCT02594163|449594284|FG000|Follow-up Period|Progressive Disease|2|||
124990851|NCT02594163|449594285|FG001|Follow-up Period|Progressive Disease|0|||
124990852|NCT02594163|449594284|FG000|Follow-up Period|Physician Decision|0|||
124990853|NCT02594163|449594285|FG001|Follow-up Period|Physician Decision|1|||
124990854|NCT01022268|449594288|FG000|Overall Study|Withdrawal by Subject|1|||
124990855|NCT01022268|449594289|FG001|Overall Study|Withdrawal by Subject|0|||
124990856|NCT01022268|449594288|FG000|Overall Study|Withdrawal by Subject|1|||
125316996|NCT03309878|450790462|FG002|Overall Study|Did not maintain eligibility|0|||
125316997|NCT03309878|450790463|FG003|Overall Study|Did not maintain eligibility|0|||
125316998|NCT03309878|450790460|FG000|Overall Study|Withdrawal by Subject|0|||
125316999|NCT03309878|450790461|FG001|Overall Study|Withdrawal by Subject|1|||
125317000|NCT03309878|450790462|FG002|Overall Study|Withdrawal by Subject|0|||
125317001|NCT03309878|450790463|FG003|Overall Study|Withdrawal by Subject|0|||
125317002|NCT03192176|450790465|FG000|Overall Study|Adverse Event|1|||
125317003|NCT03192176|450790466|FG001|Overall Study|Adverse Event|0|||
125317004|NCT03192176|450790467|FG002|Overall Study|Adverse Event|4|||
125317005|NCT03192176|450790468|FG003|Overall Study|Adverse Event|5|||
125317006|NCT03192176|450790469|FG004|Overall Study|Adverse Event|3|||
125317007|NCT03192176|450790470|FG005|Overall Study|Adverse Event|2|||
125317008|NCT03192176|450790471|FG006|Overall Study|Adverse Event|3|||
124990857|NCT01022268|449594289|FG001|Overall Study|Withdrawal by Subject|0|||
124990858|NCT00189488|449594290|FG000|Overall Study|Ineligibility determined|1|||
124990859|NCT00189488|449594291|FG001|Overall Study|Ineligibility determined|0|||
124990860|NCT00189488|449594290|FG000|Overall Study|Protocol deviation|2|||
125317009|NCT03192176|450790472|FG007|Overall Study|Adverse Event|3|||
125317010|NCT03192176|450790465|FG000|Overall Study|Lost to Follow-up|0|||
125317011|NCT03192176|450790466|FG001|Overall Study|Lost to Follow-up|0|||
125317012|NCT03192176|450790467|FG002|Overall Study|Lost to Follow-up|1|||
125317013|NCT03192176|450790468|FG003|Overall Study|Lost to Follow-up|2|||
125317014|NCT03192176|450790469|FG004|Overall Study|Lost to Follow-up|3|||
124990861|NCT00189488|449594291|FG001|Overall Study|Protocol deviation|1|||
124990862|NCT00189488|449594290|FG000|Overall Study|Adverse Event|2|||
124990863|NCT00189488|449594291|FG001|Overall Study|Adverse Event|1|||
124990864|NCT00189488|449594290|FG000|Overall Study|Withdrawal by Subject|2|||
124990865|NCT00189488|449594291|FG001|Overall Study|Withdrawal by Subject|6|||
124990866|NCT00189488|449594290|FG000|Overall Study|Disease progression|2|||
124990867|NCT00189488|449594291|FG001|Overall Study|Disease progression|4|||
124990868|NCT00189488|449594290|FG000|Overall Study|Administrative Decision|0|||
124990869|NCT00189488|449594291|FG001|Overall Study|Administrative Decision|2|||
124990870|NCT00189488|449594290|FG000|Overall Study|Death|5|||
124990871|NCT00189488|449594291|FG001|Overall Study|Death|8|||
124990872|NCT00189488|449594290|FG000|Overall Study|Other|1|||
124990873|NCT00189488|449594291|FG001|Overall Study|Other|0|||
124990874|NCT02831387|449594292|FG000|Overall Study|Withdrawal by Subject|1|||
124990875|NCT02831387|449594293|FG001|Overall Study|Withdrawal by Subject|1|||
124990876|NCT02831387|449594292|FG000|Overall Study|Discontinued due to stock recovery|0|||
124990877|NCT02831387|449594293|FG001|Overall Study|Discontinued due to stock recovery|1|||
124990878|NCT00192647|449594294|FG000|Overall Study|Death|1|||
124990879|NCT00192647|449594295|FG001|Overall Study|Death|1|||
124990880|NCT00192647|449594294|FG000|Overall Study|Adverse Event|35|||
124990881|NCT00192647|449594295|FG001|Overall Study|Adverse Event|29|||
124990882|NCT00192647|449594294|FG000|Overall Study|Laboratory Test Abnormality|4|||
124990883|NCT00192647|449594295|FG001|Overall Study|Laboratory Test Abnormality|2|||
124990884|NCT00192647|449594294|FG000|Overall Study|Insufficient Therapeutic Response|53|||
124990885|NCT00192647|449594295|FG001|Overall Study|Insufficient Therapeutic Response|83|||
124990886|NCT00192647|449594294|FG000|Overall Study|Entry Criteria Violation|6|||
124990887|NCT00192647|449594295|FG001|Overall Study|Entry Criteria Violation|6|||
124990888|NCT00192647|449594294|FG000|Overall Study|Protocol Violation|3|||
124990889|NCT00192647|449594295|FG001|Overall Study|Protocol Violation|1|||
124990890|NCT00192647|449594294|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
124990891|NCT00192647|449594295|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
124990892|NCT00192647|449594294|FG000|Overall Study|Failure to Return|11|||
124990893|NCT00192647|449594295|FG001|Overall Study|Failure to Return|13|||
124990894|NCT00192647|449594294|FG000|Overall Study|Other/Administrative|5|||
124990895|NCT00192647|449594295|FG001|Overall Study|Other/Administrative|3|||
124990896|NCT01828073|449594296|FG000|Overall Study|Lost to Follow-up|1|||
124990897|NCT01828073|449594297|FG001|Overall Study|Lost to Follow-up|2|||
124990898|NCT02915302|449594298|FG000|Overall Study|Adverse Event|3|||
125317015|NCT03192176|450790470|FG005|Overall Study|Lost to Follow-up|1|||
125317016|NCT03192176|450790471|FG006|Overall Study|Lost to Follow-up|1|||
124990899|NCT02915302|449594299|FG001|Overall Study|Adverse Event|0|||
124990900|NCT02915302|449594298|FG000|Overall Study|Protocol Violation|20|||
124990901|NCT02915302|449594299|FG001|Overall Study|Protocol Violation|27|||
125317017|NCT03192176|450790472|FG007|Overall Study|Lost to Follow-up|1|||
125317018|NCT03192176|450790465|FG000|Overall Study|Physician Decision|1|||
125317019|NCT03192176|450790466|FG001|Overall Study|Physician Decision|0|||
125317020|NCT03192176|450790467|FG002|Overall Study|Physician Decision|0|||
125317021|NCT03192176|450790468|FG003|Overall Study|Physician Decision|0|||
125317022|NCT03192176|450790469|FG004|Overall Study|Physician Decision|0|||
125317023|NCT03192176|450790470|FG005|Overall Study|Physician Decision|2|||
125317024|NCT03192176|450790471|FG006|Overall Study|Physician Decision|1|||
125317025|NCT03192176|450790472|FG007|Overall Study|Physician Decision|0|||
125317026|NCT03192176|450790465|FG000|Overall Study|Protocol Deviation|1|||
125317027|NCT03192176|450790466|FG001|Overall Study|Protocol Deviation|1|||
125317028|NCT03192176|450790467|FG002|Overall Study|Protocol Deviation|0|||
125317029|NCT03192176|450790468|FG003|Overall Study|Protocol Deviation|0|||
125317030|NCT03192176|450790469|FG004|Overall Study|Protocol Deviation|2|||
125317031|NCT03192176|450790470|FG005|Overall Study|Protocol Deviation|0|||
125317032|NCT03192176|450790471|FG006|Overall Study|Protocol Deviation|0|||
125317033|NCT03192176|450790472|FG007|Overall Study|Protocol Deviation|0|||
125317034|NCT03192176|450790465|FG000|Overall Study|Withdrawal by Subject|3|||
125317035|NCT03192176|450790466|FG001|Overall Study|Withdrawal by Subject|4|||
125317036|NCT03192176|450790467|FG002|Overall Study|Withdrawal by Subject|0|||
125317037|NCT03192176|450790468|FG003|Overall Study|Withdrawal by Subject|4|||
125317038|NCT03192176|450790469|FG004|Overall Study|Withdrawal by Subject|3|||
125317039|NCT03192176|450790470|FG005|Overall Study|Withdrawal by Subject|4|||
125317040|NCT03192176|450790471|FG006|Overall Study|Withdrawal by Subject|4|||
125317041|NCT03192176|450790472|FG007|Overall Study|Withdrawal by Subject|2|||
125317042|NCT03192176|450790465|FG000|Overall Study|Miscellaneous|1|||
124990902|NCT02915302|449594298|FG000|Overall Study|Lost to Follow-up|19|||
124990903|NCT02915302|449594299|FG001|Overall Study|Lost to Follow-up|22|||
124990904|NCT02915302|449594298|FG000|Overall Study|Withdrawal by Subject|22|||
124990905|NCT02915302|449594299|FG001|Overall Study|Withdrawal by Subject|29|||
124990906|NCT02915302|449594298|FG000|Overall Study|Other|1|||
124990907|NCT02915302|449594299|FG001|Overall Study|Other|0|||
125317043|NCT03192176|450790466|FG001|Overall Study|Miscellaneous|0|||
125317044|NCT03192176|450790467|FG002|Overall Study|Miscellaneous|1|||
125317045|NCT03192176|450790468|FG003|Overall Study|Miscellaneous|1|||
125317046|NCT03192176|450790469|FG004|Overall Study|Miscellaneous|1|||
125317047|NCT03192176|450790470|FG005|Overall Study|Miscellaneous|2|||
124990908|NCT00690443|449594300|FG000|Overall Study|Adverse Event|1|||
124990909|NCT00690443|449594301|FG001|Overall Study|Adverse Event|2|||
125317048|NCT03192176|450790471|FG006|Overall Study|Miscellaneous|0|||
125317049|NCT03192176|450790472|FG007|Overall Study|Miscellaneous|1|||
125317050|NCT00667628|450790473|FG000|Overall Study|Lost to Follow-up|1|||
125317051|NCT00667628|450790474|FG001|Overall Study|Lost to Follow-up|0|||
125317052|NCT00667628|450790473|FG000|Overall Study|Death|6|||
125317053|NCT00667628|450790474|FG001|Overall Study|Death|6|||
125317054|NCT00667628|450790473|FG000|Overall Study|Investigator Considers in Best Interest|1|||
125317055|NCT00667628|450790474|FG001|Overall Study|Investigator Considers in Best Interest|0|||
125317056|NCT00667628|450790473|FG000|Overall Study|Sponsor Terminated Study|17|||
125317057|NCT00667628|450790474|FG001|Overall Study|Sponsor Terminated Study|21|||
125317058|NCT04244253|450790475|FG000|Overall Study|Adverse Event|2|||
125317059|NCT04244253|450790476|FG001|Overall Study|Adverse Event|2|||
124990910|NCT01877837|449594302|FG000|Overall Study|Lost to Follow-up|1|||
124990911|NCT01877837|449594302|FG000|Overall Study|Ineligible|4|||
124990912|NCT00645801|449594304|FG000|Overall Study|unclear if patient took all the medication.|1|||
125317060|NCT04244253|450790477|FG002|Overall Study|Adverse Event|4|||
125317061|NCT04244253|450790475|FG000|Overall Study|Protocol Violation|1|||
125317062|NCT04244253|450790476|FG001|Overall Study|Protocol Violation|2|||
125317063|NCT04244253|450790477|FG002|Overall Study|Protocol Violation|1|||
125317064|NCT04244253|450790475|FG000|Overall Study|Withdrawal by Subject|0|||
125317065|NCT04244253|450790476|FG001|Overall Study|Withdrawal by Subject|1|||
125317066|NCT04244253|450790477|FG002|Overall Study|Withdrawal by Subject|6|||
125317067|NCT04244253|450790475|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125317068|NCT04244253|450790476|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125317069|NCT04244253|450790477|FG002|Overall Study|Non-Compliance With Study Drug|1|||
125317070|NCT04663321|450790478|FG000|Overall Study|Study terminated by Sponsor|2|||
125317071|NCT04663321|450790479|FG001|Overall Study|Study terminated by Sponsor|1|||
125317072|NCT04663321|450790480|FG002|Overall Study|Study terminated by Sponsor|2|||
125317073|NCT04663321|450790478|FG000|Overall Study|Withdrawal by Subject|10|||
125317074|NCT04663321|450790479|FG001|Overall Study|Withdrawal by Subject|3|||
125317075|NCT04663321|450790480|FG002|Overall Study|Withdrawal by Subject|2|||
125317076|NCT04663321|450790478|FG000|Overall Study|Not provided|0|||
125317077|NCT04663321|450790479|FG001|Overall Study|Not provided|0|||
125317078|NCT04663321|450790480|FG002|Overall Study|Not provided|1|||
125317079|NCT03532542|450790483|FG000|Overall Study|Death|1|||
125317080|NCT03532542|450790484|FG001|Overall Study|Death|0|||
125317081|NCT03532542|450790483|FG000|Overall Study|Study Terminated by Sponsor|41|||
125317082|NCT03532542|450790484|FG001|Overall Study|Study Terminated by Sponsor|65|||
125317083|NCT03532542|450790483|FG000|Overall Study|Withdrawal by Subject|6|||
125317084|NCT03532542|450790484|FG001|Overall Study|Withdrawal by Subject|5|||
125317085|NCT01962441|450790485|FG000|Randomized Period|Randomized but Never Treated|4|||
125317086|NCT01962441|450790486|FG001|Randomized Period|Randomized but Never Treated|2|||
125317087|NCT01962441|450790487|FG002|Randomized Period|Randomized but Never Treated|3|||
125317088|NCT01962441|450790485|FG000|Randomized Period|Lost to Follow-up|2|||
125317089|NCT01962441|450790486|FG001|Randomized Period|Lost to Follow-up|4|||
125317090|NCT01962441|450790487|FG002|Randomized Period|Lost to Follow-up|4|||
125317091|NCT01962441|450790485|FG000|Randomized Period|Withdrew Consent|3|||
125317092|NCT01962441|450790486|FG001|Randomized Period|Withdrew Consent|3|||
125317093|NCT01962441|450790487|FG002|Randomized Period|Withdrew Consent|2|||
125317094|NCT01962441|450790485|FG000|Randomized Period|Adverse Event|1|||
125317095|NCT01962441|450790486|FG001|Randomized Period|Adverse Event|1|||
125317096|NCT01962441|450790487|FG002|Randomized Period|Adverse Event|0|||
125317097|NCT01962441|450790485|FG000|Randomized Period|Death|0|||
125317098|NCT01962441|450790486|FG001|Randomized Period|Death|0|||
125317099|NCT01962441|450790487|FG002|Randomized Period|Death|2|||
125317100|NCT01962441|450790485|FG000|Randomized Period|Protocol Violation|0|||
124990913|NCT00645801|449594305|FG001|Overall Study|unclear if patient took all the medication.|0|||
124990914|NCT00645801|449594304|FG000|Overall Study|Lost to Follow-up|19|||
125317101|NCT01962441|450790486|FG001|Randomized Period|Protocol Violation|1|||
125317102|NCT01962441|450790487|FG002|Randomized Period|Protocol Violation|0|||
125317103|NCT01962441|450790485|FG000|Retreatment Substudy|Lack of Efficacy|1|||
125317104|NCT01962441|450790486|FG001|Retreatment Substudy|Lack of Efficacy|0|||
125317105|NCT01962441|450790487|FG002|Retreatment Substudy|Lack of Efficacy|0|||
124990915|NCT00645801|449594305|FG001|Overall Study|Lost to Follow-up|15|||
124990916|NCT00705679|449594306|FG000|Overall Study|Adverse Event|1|||
124990917|NCT00705679|449594307|FG001|Overall Study|Adverse Event|1|||
124990918|NCT00705679|449594308|FG002|Overall Study|Adverse Event|0|||
125317106|NCT01962441|450790485|FG000|Retreatment Substudy|Lost to Follow-up|1|||
125317107|NCT01962441|450790486|FG001|Retreatment Substudy|Lost to Follow-up|0|||
125317108|NCT01962441|450790487|FG002|Retreatment Substudy|Lost to Follow-up|0|||
125317109|NCT02055898|450790488|FG000|First Intervention (5 Days)|Physician Decision|2|||
125317110|NCT02055898|450790489|FG001|First Intervention (5 Days)|Physician Decision|0|||
125317111|NCT02055898|450790488|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
125317112|NCT02055898|450790489|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
125317113|NCT02314052|450790493|FG000|Cycle One|Adverse Event|0|||
125317114|NCT02314052|450790494|FG001|Cycle One|Adverse Event|0|||
125317115|NCT02314052|450790495|FG002|Cycle One|Adverse Event|0|||
125317116|NCT02314052|450790496|FG003|Cycle One|Adverse Event|1|||
125317117|NCT02314052|450790497|FG004|Cycle One|Adverse Event|0|||
125317118|NCT02314052|450790498|FG005|Cycle One|Adverse Event|0|||
125317119|NCT00117637|450790499|FG000|First Intervention (Period 1)|Adverse Event|11|||
125317120|NCT00117637|450790500|FG001|First Intervention (Period 1)|Adverse Event|16|||
125317121|NCT00117637|450790499|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
125317122|NCT00117637|450790500|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
125317123|NCT00117637|450790499|FG000|First Intervention (Period 1)|Protocol Violation|1|||
125317124|NCT00117637|450790500|FG001|First Intervention (Period 1)|Protocol Violation|0|||
125317125|NCT00117637|450790499|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
125317126|NCT00117637|450790500|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
125317127|NCT00117637|450790499|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
125317128|NCT00117637|450790500|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
125317129|NCT00117637|450790499|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
125317130|NCT00117637|450790500|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
125317131|NCT00117637|450790499|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
125317132|NCT00117637|450790500|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
125317133|NCT00117637|450790499|FG000|First Intervention (Period 1)|reason not reported|0|||
125317134|NCT00117637|450790500|FG001|First Intervention (Period 1)|reason not reported|1|||
125317135|NCT00117637|450790499|FG000|Second Intervention (Period 2)|Adverse Event|0|||
125317136|NCT00117637|450790500|FG001|Second Intervention (Period 2)|Adverse Event|9|||
125317137|NCT00117637|450790499|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
125317138|NCT00117637|450790500|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
125317139|NCT00117637|450790499|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
125317140|NCT00117637|450790500|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
124990919|NCT00705679|449594309|FG003|Overall Study|Adverse Event|0|||
124990920|NCT00705679|449594310|FG004|Overall Study|Adverse Event|0|||
124990921|NCT00705679|449594306|FG000|Overall Study|Death|0|||
124990922|NCT00705679|449594307|FG001|Overall Study|Death|0|||
124990923|NCT00705679|449594308|FG002|Overall Study|Death|3|||
124990924|NCT00705679|449594309|FG003|Overall Study|Death|2|||
124990925|NCT00705679|449594310|FG004|Overall Study|Death|1|||
124990926|NCT00705679|449594306|FG000|Overall Study|Lost to Follow-up|32|||
124990927|NCT00705679|449594307|FG001|Overall Study|Lost to Follow-up|60|||
124990928|NCT00705679|449594308|FG002|Overall Study|Lost to Follow-up|44|||
124990929|NCT00705679|449594309|FG003|Overall Study|Lost to Follow-up|30|||
124990930|NCT00705679|449594310|FG004|Overall Study|Lost to Follow-up|35|||
124990931|NCT00705679|449594306|FG000|Overall Study|Physician Decision|0|||
124990932|NCT00705679|449594307|FG001|Overall Study|Physician Decision|1|||
124990933|NCT00705679|449594308|FG002|Overall Study|Physician Decision|0|||
124990934|NCT00705679|449594309|FG003|Overall Study|Physician Decision|1|||
124990935|NCT00705679|449594310|FG004|Overall Study|Physician Decision|0|||
124990936|NCT00705679|449594306|FG000|Overall Study|Withdrawal by Subject|32|||
124990937|NCT00705679|449594307|FG001|Overall Study|Withdrawal by Subject|77|||
124990938|NCT00705679|449594308|FG002|Overall Study|Withdrawal by Subject|68|||
124990939|NCT00705679|449594309|FG003|Overall Study|Withdrawal by Subject|47|||
124990940|NCT00705679|449594310|FG004|Overall Study|Withdrawal by Subject|33|||
124990941|NCT00932113|449594311|FG000|Overall Study|Lost to Follow-up|1|||
124990942|NCT00932113|449594312|FG001|Overall Study|Lost to Follow-up|0|||
124990943|NCT01776541|449594316|FG000|Overall Study|Administrative Reason|6|||
124990944|NCT01776541|449594317|FG001|Overall Study|Administrative Reason|2|||
124990945|NCT01776541|449594316|FG000|Overall Study|Death|4|||
124990946|NCT01776541|449594317|FG001|Overall Study|Death|0|||
124990947|NCT01776541|449594316|FG000|Overall Study|Lost to Follow-up|27|||
124990948|NCT01776541|449594317|FG001|Overall Study|Lost to Follow-up|48|||
124990949|NCT01776541|449594316|FG000|Overall Study|Unclassified|5|||
124990950|NCT01776541|449594317|FG001|Overall Study|Unclassified|4|||
124990951|NCT01776541|449594316|FG000|Overall Study|Protocol Violation|2|||
124990952|NCT01776541|449594317|FG001|Overall Study|Protocol Violation|1|||
124990953|NCT01776541|449594316|FG000|Overall Study|Withdrawal by Subject|12|||
124990954|NCT01776541|449594317|FG001|Overall Study|Withdrawal by Subject|20|||
124990955|NCT00156819|449594318|FG000|Overall Study|Lost to Follow-up|1|||
124990956|NCT00156819|449594319|FG001|Overall Study|Lost to Follow-up|1|||
124990957|NCT00156819|449594320|FG002|Overall Study|Lost to Follow-up|3|||
124990958|NCT02090959|449594321|FG000|Overall Study|Withdrawal by Subject|10|||
124990959|NCT02090959|449594321|FG000|Overall Study|Adverse Event|1|||
124990960|NCT02090959|449594321|FG000|Overall Study|Investigator decision|2|||
124990961|NCT02090959|449594321|FG000|Overall Study|Study termination|6|||
124990962|NCT02090959|449594321|FG000|Overall Study|Enrolled but not treated|1|||
124990963|NCT02090959|449594321|FG000|Overall Study|Transfer for compassionate use medicine|4|||
124990964|NCT02090959|449594321|FG000|Overall Study|Move to medical need program|3|||
125317141|NCT00117637|450790499|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
125317142|NCT00117637|450790500|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
125317143|NCT00117637|450790499|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
125317144|NCT00117637|450790500|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
124990965|NCT02090959|449594321|FG000|Overall Study|Entered in to other study|34|||
124990966|NCT02090959|449594321|FG000|Overall Study|Switched to commercial supply|88|||
124990967|NCT02090959|449594321|FG000|Overall Study|Other than specified|2|||
124990968|NCT00522873|449594324|FG000|Overall Study|Adverse Event|41|||
124990969|NCT00522873|449594325|FG001|Overall Study|Adverse Event|26|||
124990970|NCT00522873|449594324|FG000|Overall Study|Withdrawal by Subject|20|||
124990971|NCT00522873|449594325|FG001|Overall Study|Withdrawal by Subject|9|||
124990972|NCT00522873|449594324|FG000|Overall Study|Protocol Violation|14|||
124990973|NCT00522873|449594325|FG001|Overall Study|Protocol Violation|4|||
124990974|NCT00522873|449594324|FG000|Overall Study|Lost to Follow-up|11|||
124990975|NCT00522873|449594325|FG001|Overall Study|Lost to Follow-up|3|||
124990976|NCT00522873|449594324|FG000|Overall Study|Personal Reasons|8|||
124990977|NCT00522873|449594325|FG001|Overall Study|Personal Reasons|1|||
124990978|NCT00522873|449594324|FG000|Overall Study|Medication Errors|1|||
124990979|NCT00522873|449594325|FG001|Overall Study|Medication Errors|1|||
124990980|NCT00522873|449594324|FG000|Overall Study|Never Received Medication|1|||
124990981|NCT00522873|449594325|FG001|Overall Study|Never Received Medication|0|||
124990982|NCT04256629|449594333|FG000|Overall Study|Adverse Event|0|||
124990983|NCT04256629|449594334|FG001|Overall Study|Adverse Event|0|||
124990984|NCT04256629|449594335|FG002|Overall Study|Adverse Event|0|||
124990985|NCT04256629|449594336|FG003|Overall Study|Adverse Event|0|||
124990986|NCT04256629|449594337|FG004|Overall Study|Adverse Event|0|||
124990987|NCT04256629|449594338|FG005|Overall Study|Adverse Event|1|||
124990988|NCT04256629|449594333|FG000|Overall Study|Protocol Violation|0|||
124990989|NCT04256629|449594334|FG001|Overall Study|Protocol Violation|1|||
124990990|NCT04256629|449594335|FG002|Overall Study|Protocol Violation|0|||
124990991|NCT04256629|449594336|FG003|Overall Study|Protocol Violation|0|||
124990992|NCT04256629|449594337|FG004|Overall Study|Protocol Violation|0|||
124990993|NCT04256629|449594338|FG005|Overall Study|Protocol Violation|0|||
124990994|NCT02647866|449594339|FG000|Overall Study|Adverse Event|0|||
124990995|NCT02647866|449594340|FG001|Overall Study|Adverse Event|0|||
124990996|NCT02647866|449594341|FG002|Overall Study|Adverse Event|2|||
124990997|NCT02647866|449594342|FG003|Overall Study|Adverse Event|2|||
124990998|NCT02647866|449594343|FG004|Overall Study|Adverse Event|1|||
124990999|NCT02647866|449594339|FG000|Overall Study|Disease Worsening|3|||
124991000|NCT02647866|449594340|FG001|Overall Study|Disease Worsening|1|||
124991001|NCT02647866|449594341|FG002|Overall Study|Disease Worsening|0|||
124991002|NCT02647866|449594342|FG003|Overall Study|Disease Worsening|0|||
124991003|NCT02647866|449594343|FG004|Overall Study|Disease Worsening|1|||
124991004|NCT02647866|449594339|FG000|Overall Study|Withdrawal by Subject|1|||
124991005|NCT02647866|449594340|FG001|Overall Study|Withdrawal by Subject|1|||
124991006|NCT02647866|449594341|FG002|Overall Study|Withdrawal by Subject|2|||
124991007|NCT02647866|449594342|FG003|Overall Study|Withdrawal by Subject|4|||
124991008|NCT02647866|449594343|FG004|Overall Study|Withdrawal by Subject|4|||
124991009|NCT02647866|449594339|FG000|Overall Study|Physician Decision|0|||
124991010|NCT02647866|449594340|FG001|Overall Study|Physician Decision|1|||
124991011|NCT02647866|449594341|FG002|Overall Study|Physician Decision|1|||
124991012|NCT02647866|449594342|FG003|Overall Study|Physician Decision|0|||
125317145|NCT00117637|450790499|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
125317146|NCT00117637|450790500|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
125317147|NCT00117637|450790499|FG000|Second Intervention (Period 2)|reason not reported|1|||
125317148|NCT00117637|450790500|FG001|Second Intervention (Period 2)|reason not reported|0|||
125317149|NCT01620060|450790501|FG000|Overall Study|Adverse Event|9|||
125317150|NCT01620060|450790501|FG000|Overall Study|Protocol Violation|1|||
125317151|NCT01620060|450790501|FG000|Overall Study|Withdrawal by Subject|1|||
125317152|NCT01620060|450790501|FG000|Overall Study|Did not comply with Study Produre|1|||
125317153|NCT01620060|450790501|FG000|Overall Study|Family emergency|1|||
125317154|NCT01620060|450790501|FG000|Overall Study|Per Sponsor Decision|2|||
125317155|NCT01582061|450790502|FG000|Overall Study|Lack of Efficacy|3|||
125317156|NCT01582061|450790503|FG001|Overall Study|Lack of Efficacy|23|||
125317157|NCT01582061|450790502|FG000|Overall Study|Adverse Event|12|||
124991013|NCT02647866|449594343|FG004|Overall Study|Physician Decision|2|||
124991014|NCT02647866|449594339|FG000|Overall Study|Death|0|||
124991015|NCT02647866|449594340|FG001|Overall Study|Death|1|||
124991016|NCT02647866|449594341|FG002|Overall Study|Death|0|||
124991017|NCT02647866|449594342|FG003|Overall Study|Death|0|||
124991018|NCT02647866|449594343|FG004|Overall Study|Death|0|||
124991019|NCT02647866|449594339|FG000|Overall Study|Subject moved to different country|1|||
124991020|NCT02647866|449594340|FG001|Overall Study|Subject moved to different country|0|||
124991021|NCT02647866|449594341|FG002|Overall Study|Subject moved to different country|0|||
124991022|NCT02647866|449594342|FG003|Overall Study|Subject moved to different country|0|||
124991023|NCT02647866|449594343|FG004|Overall Study|Subject moved to different country|0|||
124991024|NCT00069108|449594344|FG000|Overall Study|Withdrawal by Subject|5|||
124991025|NCT00069108|449594345|FG001|Overall Study|Withdrawal by Subject|9|||
125317158|NCT01582061|450790503|FG001|Overall Study|Adverse Event|8|||
125317159|NCT01582061|450790502|FG000|Overall Study|Withdrawal by Subject|10|||
125317160|NCT01582061|450790503|FG001|Overall Study|Withdrawal by Subject|4|||
125317161|NCT01582061|450790502|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124991026|NCT00069108|449594344|FG000|Overall Study|Adverse Event|64|||
124991027|NCT00069108|449594345|FG001|Overall Study|Adverse Event|42|||
124991028|NCT00069108|449594344|FG000|Overall Study|Death|6|||
124991029|NCT00069108|449594345|FG001|Overall Study|Death|6|||
124991030|NCT00069108|449594344|FG000|Overall Study|Administration|15|||
124991031|NCT00069108|449594345|FG001|Overall Study|Administration|4|||
124991032|NCT00069108|449594344|FG000|Overall Study|Insufficient therapy|117|||
124991033|NCT00069108|449594345|FG001|Overall Study|Insufficient therapy|144|||
124991034|NCT00069108|449594344|FG000|Overall Study|Violation criteria|1|||
124991035|NCT00069108|449594345|FG001|Overall Study|Violation criteria|4|||
124991036|NCT00069108|449594344|FG000|Overall Study|Refused treatment|5|||
124991037|NCT00069108|449594345|FG001|Overall Study|Refused treatment|10|||
124991038|NCT01415531|449594347|FG000|Overall Study|Adverse Event|7|||
124991039|NCT01415531|449594348|FG001|Overall Study|Adverse Event|10|||
124991040|NCT01415531|449594347|FG000|Overall Study|Lack of Efficacy|3|||
124991041|NCT01415531|449594348|FG001|Overall Study|Lack of Efficacy|2|||
124991042|NCT01415531|449594347|FG000|Overall Study|Protocol Violation|0|||
124991043|NCT01415531|449594348|FG001|Overall Study|Protocol Violation|1|||
124991044|NCT01415531|449594347|FG000|Overall Study|Withdrawal by Subject|5|||
124991045|NCT01415531|449594348|FG001|Overall Study|Withdrawal by Subject|4|||
124991046|NCT01415531|449594347|FG000|Overall Study|Lost to Follow-up|6|||
124991047|NCT01415531|449594348|FG001|Overall Study|Lost to Follow-up|14|||
124991048|NCT01415531|449594347|FG000|Overall Study|Lack of Compliance|1|||
124991049|NCT01415531|449594348|FG001|Overall Study|Lack of Compliance|4|||
124991050|NCT01415531|449594347|FG000|Overall Study|Other Reasons|3|||
124991051|NCT01415531|449594348|FG001|Overall Study|Other Reasons|2|||
124991052|NCT00394082|449594351|FG000|Overall Study|Unacceptable toxicity|15|||
124991053|NCT00394082|449594351|FG000|Overall Study|Adverse Event|4|||
124991054|NCT00394082|449594351|FG000|Overall Study|Physician Decision|4|||
124991055|NCT00394082|449594351|FG000|Overall Study|Withdrawal by Subject|2|||
124991056|NCT00394082|449594351|FG000|Overall Study|Other|1|||
124991057|NCT02344004|449594353|FG000|Overall Study|Adverse Event|11|||
124991058|NCT02344004|449594354|FG001|Overall Study|Adverse Event|1|||
124991059|NCT02344004|449594353|FG000|Overall Study|Death|9|||
124991060|NCT02344004|449594354|FG001|Overall Study|Death|7|||
124991061|NCT02344004|449594353|FG000|Overall Study|Physician Decision|4|||
124991062|NCT02344004|449594354|FG001|Overall Study|Physician Decision|1|||
124991063|NCT02344004|449594353|FG000|Overall Study|Withdrawal by Subject|22|||
124991064|NCT02344004|449594354|FG001|Overall Study|Withdrawal by Subject|5|||
125317162|NCT01582061|450790503|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125317163|NCT01582061|450790502|FG000|Overall Study|Death|0|||
125317164|NCT01582061|450790503|FG001|Overall Study|Death|1|||
125317165|NCT01582061|450790502|FG000|Overall Study|condition no longer requires study drug|1|||
125317166|NCT01582061|450790503|FG001|Overall Study|condition no longer requires study drug|0|||
125317167|NCT01582061|450790502|FG000|Overall Study|Lost to Follow-up|1|||
124991065|NCT02344004|449594353|FG000|Overall Study|Rescue Medication|2|||
124991066|NCT02344004|449594354|FG001|Overall Study|Rescue Medication|0|||
124991067|NCT02344004|449594353|FG000|Overall Study|Other Not Specified|12|||
124991068|NCT02344004|449594354|FG001|Overall Study|Other Not Specified|0|||
124991069|NCT02344004|449594353|FG000|Overall Study|Protocol Violation|1|||
124991070|NCT02344004|449594354|FG001|Overall Study|Protocol Violation|0|||
124991071|NCT02481947|449594355|FG000|Overall Study|Withdrawal by Subject|24|||
124991072|NCT02481947|449594356|FG001|Overall Study|Withdrawal by Subject|10|||
124991073|NCT02481947|449594355|FG000|Overall Study|Lost to Follow-up|11|||
124991074|NCT02481947|449594356|FG001|Overall Study|Lost to Follow-up|5|||
124991075|NCT02481947|449594355|FG000|Overall Study|Adverse Event|6|||
124991076|NCT02481947|449594356|FG001|Overall Study|Adverse Event|11|||
124991077|NCT02481947|449594355|FG000|Overall Study|Physician Decision|4|||
124991078|NCT02481947|449594356|FG001|Overall Study|Physician Decision|5|||
124991079|NCT02481947|449594355|FG000|Overall Study|Protocol Violation|1|||
124991080|NCT02481947|449594356|FG001|Overall Study|Protocol Violation|5|||
124991081|NCT05249829|449594357|FG000|Overall Study|Participant Relocation|0|||
124991082|NCT05249829|449594358|FG001|Overall Study|Participant Relocation|1|||
124991083|NCT05249829|449594359|FG002|Overall Study|Participant Relocation|2|||
124991084|NCT05249829|449594360|FG003|Overall Study|Participant Relocation|2|||
124991085|NCT05249829|449594357|FG000|Overall Study|Withdrawal by Subject|9|||
124991086|NCT05249829|449594358|FG001|Overall Study|Withdrawal by Subject|17|||
124991087|NCT05249829|449594359|FG002|Overall Study|Withdrawal by Subject|40|||
124991088|NCT05249829|449594360|FG003|Overall Study|Withdrawal by Subject|35|||
124991089|NCT05249829|449594357|FG000|Overall Study|Physician Decision|1|||
124991090|NCT05249829|449594358|FG001|Overall Study|Physician Decision|0|||
124991091|NCT05249829|449594359|FG002|Overall Study|Physician Decision|0|||
124991092|NCT05249829|449594360|FG003|Overall Study|Physician Decision|0|||
124991093|NCT05249829|449594357|FG000|Overall Study|Lost to Follow-up|16|||
124991094|NCT05249829|449594358|FG001|Overall Study|Lost to Follow-up|16|||
124991095|NCT05249829|449594359|FG002|Overall Study|Lost to Follow-up|57|||
124991096|NCT05249829|449594360|FG003|Overall Study|Lost to Follow-up|60|||
124991097|NCT05249829|449594357|FG000|Overall Study|Adverse Event|2|||
125317168|NCT01582061|450790503|FG001|Overall Study|Lost to Follow-up|0|||
125317169|NCT00231777|450790504|FG000|Overall Study|Lost to Follow-up|3|||
124991098|NCT05249829|449594358|FG001|Overall Study|Adverse Event|2|||
124991099|NCT05249829|449594359|FG002|Overall Study|Adverse Event|2|||
124991100|NCT05249829|449594360|FG003|Overall Study|Adverse Event|2|||
125317170|NCT00231777|450790505|FG001|Overall Study|Lost to Follow-up|0|||
125317171|NCT00231777|450790504|FG000|Overall Study|Other|3|||
125317172|NCT00231777|450790505|FG001|Overall Study|Other|2|||
125317173|NCT04551989|450790508|FG000|Overall Study|Adverse Event|4|||
125317174|NCT04551989|450790508|FG000|Overall Study|Protocol Violation|3|||
125317175|NCT04551989|450790508|FG000|Overall Study|Lost to Follow-up|1|||
125317176|NCT04551989|450790508|FG000|Overall Study|Physician Decision|3|||
125317177|NCT04698343|450790509|FG000|Overall Study|Withdrawal by Subject|6|||
125317178|NCT04698343|450790509|FG000|Overall Study|Physician Decision|2|||
125317179|NCT04698343|450790509|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
125317180|NCT04698343|450790509|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
125317181|NCT04698343|450790509|FG000|Overall Study|Personal reasons|3|||
125317182|NCT04698343|450790509|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
125317183|NCT02756338|450790510|FG000|Overall Study|Withdrawn by Investigator|1|||
125317184|NCT02756338|450790510|FG000|Overall Study|Device Replaced with Pacemaker|4|||
125317185|NCT00088530|450790513|FG000|Overall Study|Progressive/Relapsed Disease|28|||
125317186|NCT00088530|450790514|FG001|Overall Study|Progressive/Relapsed Disease|39|||
125317187|NCT00088530|450790513|FG000|Overall Study|Adverse Event|15|||
125317188|NCT00088530|450790514|FG001|Overall Study|Adverse Event|9|||
125317189|NCT00088530|450790513|FG000|Overall Study|Withdrawal by Subject|2|||
125317190|NCT00088530|450790514|FG001|Overall Study|Withdrawal by Subject|5|||
125317191|NCT00088530|450790513|FG000|Overall Study|Lost to Follow-up|2|||
125317192|NCT00088530|450790514|FG001|Overall Study|Lost to Follow-up|0|||
125317193|NCT00088530|450790513|FG000|Overall Study|Physician Decision|2|||
125317194|NCT00088530|450790514|FG001|Overall Study|Physician Decision|0|||
125317195|NCT00088530|450790513|FG000|Overall Study|Sponsor decision|0|||
125317196|NCT00088530|450790514|FG001|Overall Study|Sponsor decision|1|||
125317197|NCT00088530|450790513|FG000|Overall Study|Patient never treated|1|||
125317198|NCT00088530|450790514|FG001|Overall Study|Patient never treated|0|||
125317199|NCT00300755|450790517|FG000|Overall Study|Adverse Event|1|||
125317200|NCT00300755|450790518|FG001|Overall Study|Adverse Event|2|||
125317201|NCT00300755|450790519|FG002|Overall Study|Adverse Event|1|||
125317202|NCT00300755|450790517|FG000|Overall Study|Withdrawal by Subject|0|||
125317203|NCT00300755|450790518|FG001|Overall Study|Withdrawal by Subject|2|||
125317204|NCT00300755|450790519|FG002|Overall Study|Withdrawal by Subject|0|||
125317205|NCT00300755|450790517|FG000|Overall Study|Protocol Violation|0|||
125317206|NCT00300755|450790518|FG001|Overall Study|Protocol Violation|0|||
125317207|NCT00300755|450790519|FG002|Overall Study|Protocol Violation|1|||
125317208|NCT02694744|450790523|FG000|Overall Study|Adverse Event|2|||
125317209|NCT02694744|450790524|FG001|Overall Study|Adverse Event|1|||
125317210|NCT02694744|450790523|FG000|Overall Study|Withdrawal by Subject|2|||
125317211|NCT02694744|450790524|FG001|Overall Study|Withdrawal by Subject|1|||
125317212|NCT02694744|450790523|FG000|Overall Study|Physician Decision|1|||
125317213|NCT02694744|450790524|FG001|Overall Study|Physician Decision|2|||
125317214|NCT02694744|450790523|FG000|Overall Study|Lost to Follow-up|1|||
125317215|NCT02694744|450790524|FG001|Overall Study|Lost to Follow-up|0|||
125317216|NCT02694744|450790523|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
125317217|NCT02694744|450790524|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
125317218|NCT00686777|450790525|FG000|Overall Study|Adverse Event|2|||
125317219|NCT00686777|450790525|FG000|Overall Study|Pregnancy|1|||
125317220|NCT00686777|450790525|FG000|Overall Study|Withdrawal by Subject|2|||
125317221|NCT00686777|450790525|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
125317222|NCT00686777|450790525|FG000|Overall Study|No Visit|1|||
124991101|NCT05249829|449594357|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
124991102|NCT05249829|449594358|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
124991103|NCT05249829|449594359|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
124991104|NCT05249829|449594360|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
124991105|NCT05249829|449594357|FG000|Overall Study|Protocol Violation|2|||
124991106|NCT05249829|449594358|FG001|Overall Study|Protocol Violation|0|||
124991107|NCT05249829|449594359|FG002|Overall Study|Protocol Violation|5|||
124991108|NCT05249829|449594360|FG003|Overall Study|Protocol Violation|3|||
124991109|NCT05249829|449594357|FG000|Overall Study|Death|0|||
124991110|NCT05249829|449594358|FG001|Overall Study|Death|1|||
125317223|NCT01945021|450790526|FG000|Overall Study|Adverse Event|1|||
125317224|NCT01945021|450790526|FG000|Overall Study|Withdrawal of consent|12|||
125317225|NCT01945021|450790526|FG000|Overall Study|Lost to Follow-up|5|||
125317226|NCT01945021|450790526|FG000|Overall Study|Death|65|||
125317227|NCT03582215|450790527|FG000|Overall Study|Adverse Event|1|||
125317228|NCT03582215|450790528|FG001|Overall Study|Adverse Event|0|||
125317229|NCT03582215|450790529|FG002|Overall Study|Adverse Event|0|||
125317230|NCT03582215|450790530|FG003|Overall Study|Adverse Event|0|||
125317231|NCT03582215|450790531|FG004|Overall Study|Adverse Event|0|||
125317232|NCT03582215|450790532|FG005|Overall Study|Adverse Event|0|||
125317233|NCT03582215|450790533|FG006|Overall Study|Adverse Event|2|||
124991111|NCT05249829|449594359|FG002|Overall Study|Death|2|||
124991112|NCT05249829|449594360|FG003|Overall Study|Death|4|||
124991113|NCT02842827|449594362|FG000|Overall Study|Adverse Event|0|||
124991114|NCT02842827|449594363|FG001|Overall Study|Adverse Event|1|||
124991115|NCT02842827|449594364|FG002|Overall Study|Adverse Event|0|||
124991116|NCT02842827|449594365|FG003|Overall Study|Adverse Event|1|||
124991117|NCT02842827|449594366|FG004|Overall Study|Adverse Event|0|||
124991118|NCT02842827|449594367|FG005|Overall Study|Adverse Event|1|||
124991119|NCT02842827|449594368|FG006|Overall Study|Adverse Event|0|||
124991120|NCT02842827|449594369|FG007|Overall Study|Adverse Event|0|||
124991121|NCT02842827|449594362|FG000|Overall Study|Death|1|||
124991122|NCT02842827|449594363|FG001|Overall Study|Death|0|||
124991123|NCT02842827|449594364|FG002|Overall Study|Death|2|||
124991124|NCT02842827|449594365|FG003|Overall Study|Death|3|||
124991125|NCT02842827|449594366|FG004|Overall Study|Death|2|||
124991126|NCT02842827|449594367|FG005|Overall Study|Death|1|||
124991127|NCT02842827|449594368|FG006|Overall Study|Death|0|||
124991128|NCT02842827|449594369|FG007|Overall Study|Death|4|||
124991129|NCT02842827|449594362|FG000|Overall Study|Physician Decision|1|||
124991130|NCT02842827|449594363|FG001|Overall Study|Physician Decision|3|||
124991131|NCT02842827|449594364|FG002|Overall Study|Physician Decision|0|||
124991132|NCT02842827|449594365|FG003|Overall Study|Physician Decision|0|||
124991133|NCT02842827|449594366|FG004|Overall Study|Physician Decision|1|||
124991134|NCT02842827|449594367|FG005|Overall Study|Physician Decision|4|||
124991135|NCT02842827|449594368|FG006|Overall Study|Physician Decision|2|||
124991136|NCT02842827|449594369|FG007|Overall Study|Physician Decision|1|||
124991137|NCT02842827|449594362|FG000|Overall Study|Protocol Defined Disease Progression|0|||
124991138|NCT02842827|449594363|FG001|Overall Study|Protocol Defined Disease Progression|0|||
124991139|NCT02842827|449594364|FG002|Overall Study|Protocol Defined Disease Progression|0|||
124991140|NCT02842827|449594365|FG003|Overall Study|Protocol Defined Disease Progression|0|||
124991141|NCT02842827|449594366|FG004|Overall Study|Protocol Defined Disease Progression|0|||
124991142|NCT02842827|449594367|FG005|Overall Study|Protocol Defined Disease Progression|1|||
124991143|NCT02842827|449594368|FG006|Overall Study|Protocol Defined Disease Progression|0|||
124991144|NCT02842827|449594369|FG007|Overall Study|Protocol Defined Disease Progression|0|||
125317234|NCT03582215|450790534|FG007|Overall Study|Adverse Event|2|||
125317235|NCT02163902|450790535|FG000|Overall Study|Subject's Request|3|||
124991145|NCT02842827|449594362|FG000|Overall Study|Participant Withdrawal of Consent|1|||
124991146|NCT02842827|449594363|FG001|Overall Study|Participant Withdrawal of Consent|2|||
124991147|NCT02842827|449594364|FG002|Overall Study|Participant Withdrawal of Consent|2|||
124991148|NCT02842827|449594365|FG003|Overall Study|Participant Withdrawal of Consent|2|||
124991149|NCT02842827|449594366|FG004|Overall Study|Participant Withdrawal of Consent|2|||
124991150|NCT02842827|449594367|FG005|Overall Study|Participant Withdrawal of Consent|1|||
124991151|NCT02842827|449594368|FG006|Overall Study|Participant Withdrawal of Consent|2|||
124991152|NCT02842827|449594369|FG007|Overall Study|Participant Withdrawal of Consent|1|||
124991153|NCT01815138|449594370|FG000|Overall Study|Withdrawal by Subject|0|||
124991154|NCT01815138|449594371|FG001|Overall Study|Withdrawal by Subject|1|||
124991155|NCT01815138|449594370|FG000|Overall Study|Physician Decision|8|||
124991156|NCT01815138|449594371|FG001|Overall Study|Physician Decision|5|||
124991157|NCT03426267|449594372|FG000|Overall Study|Physician Decision|1|||
124991158|NCT03426267|449594373|FG001|Overall Study|Physician Decision|4|||
124991159|NCT03426267|449594372|FG000|Overall Study|Lost to Follow-up|1|||
124991160|NCT03426267|449594373|FG001|Overall Study|Lost to Follow-up|0|||
124991161|NCT03426267|449594372|FG000|Overall Study|Withdrawal by Subject|4|||
124991162|NCT03426267|449594373|FG001|Overall Study|Withdrawal by Subject|10|||
124991163|NCT03426267|449594372|FG000|Overall Study|Protocol Violation|1|||
124991164|NCT03426267|449594373|FG001|Overall Study|Protocol Violation|3|||
124991165|NCT03426267|449594372|FG000|Overall Study|Adverse Event|9|||
124991166|NCT03426267|449594373|FG001|Overall Study|Adverse Event|27|||
124991167|NCT03426267|449594372|FG000|Overall Study|Prohibited Treatment Intake|2|||
124991168|NCT03426267|449594373|FG001|Overall Study|Prohibited Treatment Intake|3|||
124991169|NCT03426267|449594372|FG000|Overall Study|Lack of Efficacy|0|||
124991170|NCT03426267|449594373|FG001|Overall Study|Lack of Efficacy|25|||
124991171|NCT03426267|449594372|FG000|Overall Study|other|3|||
124991172|NCT03426267|449594373|FG001|Overall Study|other|0|||
124991173|NCT00609765|449594376|FG000|Overall Study|Study ended prior to 12 months|1|||
124991174|NCT02649946|449594383|FG000|Overall Study|Withdrawal by Subject|1|||
124991175|NCT02649946|449594384|FG001|Overall Study|Withdrawal by Subject|1|||
124991176|NCT02649946|449594383|FG000|Overall Study|Death|7|||
124991177|NCT02649946|449594384|FG001|Overall Study|Death|9|||
124991178|NCT02649946|449594383|FG000|Overall Study|Physician Decision|1|||
124991179|NCT02649946|449594384|FG001|Overall Study|Physician Decision|0|||
124991180|NCT02649946|449594383|FG000|Overall Study|Lost to Follow-up|2|||
125317236|NCT02163902|450790536|FG001|Overall Study|Subject's Request|4|||
124991181|NCT02649946|449594384|FG001|Overall Study|Lost to Follow-up|1|||
124991182|NCT02649946|449594383|FG000|Overall Study|Erroneously enrolled|1|||
125317237|NCT02163902|450790535|FG000|Overall Study|Lost to Follow-up|6|||
124991183|NCT02649946|449594384|FG001|Overall Study|Erroneously enrolled|0|||
125317238|NCT02163902|450790536|FG001|Overall Study|Lost to Follow-up|7|||
124991184|NCT02649946|449594383|FG000|Overall Study|Missed 6-month follow-up visit|0|||
124991185|NCT02649946|449594384|FG001|Overall Study|Missed 6-month follow-up visit|4|||
124991186|NCT00950950|449594385|FG000|Overall Study|Adverse Event|1|||
124991187|NCT00950950|449594386|FG001|Overall Study|Adverse Event|0|||
124991188|NCT00950950|449594385|FG000|Overall Study|Withdrawal by Subject|0|||
124991189|NCT00950950|449594386|FG001|Overall Study|Withdrawal by Subject|1|||
124991190|NCT02232243|449594394|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
124991191|NCT02232243|449594395|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
124991192|NCT02232243|449594396|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
124991193|NCT00704405|449594397|FG000|Overall Study (NC Population)|Adverse Event|1|||
124991194|NCT00704405|449594398|FG001|Overall Study (NC Population)|Adverse Event|0|||
124991195|NCT00704405|449594399|FG002|Overall Study (NC Population)|Adverse Event|0|||
124991196|NCT00704405|449594400|FG003|Overall Study (NC Population)|Adverse Event|0|||
124991197|NCT00704405|449594401|FG004|Overall Study (NC Population)|Adverse Event|0|||
124991198|NCT00704405|449594397|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
124991199|NCT00704405|449594398|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
124991200|NCT00704405|449594399|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
124991201|NCT00704405|449594400|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
124991202|NCT00704405|449594401|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
124991203|NCT00704405|449594397|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
124991204|NCT00704405|449594398|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
124991205|NCT00704405|449594399|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
124991206|NCT00704405|449594400|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
124991207|NCT00704405|449594401|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
124991208|NCT00704405|449594397|FG000|Overall Study (NC Population)|Other|0|||
124991209|NCT00704405|449594398|FG001|Overall Study (NC Population)|Other|0|||
124991210|NCT00704405|449594399|FG002|Overall Study (NC Population)|Other|0|||
124991211|NCT00704405|449594400|FG003|Overall Study (NC Population)|Other|0|||
124991212|NCT00704405|449594401|FG004|Overall Study (NC Population)|Other|1|||
124991213|NCT00704405|449594397|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
124991214|NCT00704405|449594398|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
124991215|NCT00704405|449594399|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
124991216|NCT00704405|449594400|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
124991217|NCT00704405|449594401|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
124991218|NCT00704405|449594397|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
124991219|NCT00704405|449594398|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
124991220|NCT00704405|449594399|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
124991221|NCT00704405|449594400|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
124991222|NCT00704405|449594401|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
125317239|NCT02163902|450790535|FG000|Overall Study|Administrative Decision|2|||
125317240|NCT02163902|450790536|FG001|Overall Study|Administrative Decision|2|||
125317241|NCT03119259|450790537|FG000|Overall Study|Withdrawn as no longer eligible|1|||
125317242|NCT03119259|450790538|FG001|Overall Study|Withdrawn as no longer eligible|0|||
125317243|NCT03119259|450790537|FG000|Overall Study|Withdrawal by Subject|4|||
125317244|NCT03119259|450790538|FG001|Overall Study|Withdrawal by Subject|2|||
125317245|NCT03119259|450790537|FG000|Overall Study|Lost to Follow-up|0|||
125317246|NCT03119259|450790538|FG001|Overall Study|Lost to Follow-up|1|||
125317247|NCT02903160|450790541|FG000|Overall Study|Adverse Event|2|||
125317248|NCT02903160|450790541|FG000|Overall Study|Death|1|||
125317249|NCT02903160|450790541|FG000|Overall Study|Lost to Follow-up|2|||
124991223|NCT00928018|449594402|FG000|Overall Study|Withdrawal by Subject|1|||
124991224|NCT00928018|449594403|FG001|Overall Study|Withdrawal by Subject|0|||
124991225|NCT03218397|449594404|FG000|Overall Study|Prior positive blood culture|8|||
124991226|NCT03218397|449594405|FG001|Overall Study|Prior positive blood culture|13|||
124991227|NCT03218397|449594404|FG000|Overall Study|Comfort care|8|||
124991228|NCT03218397|449594405|FG001|Overall Study|Comfort care|5|||
124991229|NCT03218397|449594404|FG000|Overall Study|Comfort care and positive blood culture|1|||
124991230|NCT03218397|449594405|FG001|Overall Study|Comfort care and positive blood culture|0|||
124991231|NCT03218397|449594404|FG000|Overall Study|Comfort care and mixed culture|0|||
124991232|NCT03218397|449594405|FG001|Overall Study|Comfort care and mixed culture|1|||
124991233|NCT03218397|449594404|FG000|Overall Study|Mixed culture|2|||
124991234|NCT03218397|449594405|FG001|Overall Study|Mixed culture|2|||
124991235|NCT03218397|449594404|FG000|Overall Study|Inaccessible hospital records|2|||
125317250|NCT02903160|450790541|FG000|Overall Study|Withdrawal by Subject|1|||
124991236|NCT03218397|449594405|FG001|Overall Study|Inaccessible hospital records|5|||
124991237|NCT03218397|449594404|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
124991238|NCT03218397|449594405|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
124991239|NCT03218397|449594404|FG000|Overall Study|Randomized during laboratory off hours|2|||
125317251|NCT02903160|450790541|FG000|Overall Study|Medical Insurance Barriers|1|||
125317252|NCT01664910|450790544|FG000|Overall Study|Adverse Event|0|||
125317253|NCT01664910|450790545|FG001|Overall Study|Adverse Event|0|||
125317254|NCT01664910|450790546|FG002|Overall Study|Adverse Event|1|||
124991240|NCT03218397|449594405|FG001|Overall Study|Randomized during laboratory off hours|1|||
124991241|NCT00943111|449594406|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
124991242|NCT00943111|449594407|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
124991243|NCT00943111|449594408|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
124991244|NCT00943111|449594406|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
124991245|NCT00943111|449594407|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
124991246|NCT00943111|449594408|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
124991247|NCT00943111|449594406|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
124991248|NCT00943111|449594407|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
124991249|NCT00943111|449594408|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
124991250|NCT00943111|449594406|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
124991251|NCT00943111|449594407|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
124991252|NCT00943111|449594408|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
124991253|NCT00943111|449594406|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
124991254|NCT00943111|449594407|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
124991255|NCT00943111|449594408|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
124991256|NCT00943111|449594406|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
124991257|NCT00943111|449594407|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
124991258|NCT00943111|449594408|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
124991259|NCT00943111|449594406|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
124991260|NCT00943111|449594407|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
124991261|NCT00943111|449594408|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
124991262|NCT00943111|449594406|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
124991263|NCT00943111|449594407|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
124991264|NCT00943111|449594408|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
124991265|NCT01946438|449594409|FG000|Overall Study|Adverse Event|0|||
124991266|NCT01946438|449594410|FG001|Overall Study|Adverse Event|0|||
124991267|NCT01946438|449594411|FG002|Overall Study|Adverse Event|0|||
124991268|NCT01946438|449594412|FG003|Overall Study|Adverse Event|1|||
124991269|NCT01946438|449594409|FG000|Overall Study|Serious Adverse event|1|||
124991270|NCT01946438|449594410|FG001|Overall Study|Serious Adverse event|0|||
124991271|NCT01946438|449594411|FG002|Overall Study|Serious Adverse event|0|||
124991272|NCT01946438|449594412|FG003|Overall Study|Serious Adverse event|0|||
124991273|NCT01946438|449594409|FG000|Overall Study|Protocol Violation|0|||
124991274|NCT01946438|449594410|FG001|Overall Study|Protocol Violation|0|||
124991275|NCT01946438|449594411|FG002|Overall Study|Protocol Violation|1|||
124991276|NCT01946438|449594412|FG003|Overall Study|Protocol Violation|0|||
124991277|NCT01946438|449594409|FG000|Overall Study|Withdrawal by Subject|1|||
124991278|NCT01946438|449594410|FG001|Overall Study|Withdrawal by Subject|0|||
124991279|NCT01946438|449594411|FG002|Overall Study|Withdrawal by Subject|0|||
124991280|NCT01946438|449594412|FG003|Overall Study|Withdrawal by Subject|0|||
124991281|NCT02457559|449594414|FG000|Overall Study|Progressive Disease|1|||
124991282|NCT02457559|449594415|FG001|Overall Study|Progressive Disease|2|||
124991283|NCT02457559|449594416|FG002|Overall Study|Progressive Disease|3|||
124991284|NCT02457559|449594417|FG003|Overall Study|Progressive Disease|0|||
124991285|NCT02457559|449594418|FG004|Overall Study|Progressive Disease|0|||
124991286|NCT02457559|449594419|FG005|Overall Study|Progressive Disease|2|||
124991287|NCT02457559|449594420|FG006|Overall Study|Progressive Disease|1|||
124991288|NCT02457559|449594421|FG007|Overall Study|Progressive Disease|0|||
124991289|NCT02457559|449594422|FG008|Overall Study|Progressive Disease|1|||
124991290|NCT02457559|449594423|FG009|Overall Study|Progressive Disease|1|||
124991291|NCT02457559|449594424|FG010|Overall Study|Progressive Disease|1|||
124991292|NCT02457559|449594414|FG000|Overall Study|Investigator's Discretion|0|||
124991293|NCT02457559|449594415|FG001|Overall Study|Investigator's Discretion|0|||
124991294|NCT02457559|449594416|FG002|Overall Study|Investigator's Discretion|2|||
124991295|NCT02457559|449594417|FG003|Overall Study|Investigator's Discretion|0|||
124991296|NCT02457559|449594418|FG004|Overall Study|Investigator's Discretion|1|||
124991297|NCT02457559|449594419|FG005|Overall Study|Investigator's Discretion|0|||
124991298|NCT02457559|449594420|FG006|Overall Study|Investigator's Discretion|1|||
124991299|NCT02457559|449594421|FG007|Overall Study|Investigator's Discretion|0|||
124991300|NCT02457559|449594422|FG008|Overall Study|Investigator's Discretion|1|||
124991301|NCT02457559|449594423|FG009|Overall Study|Investigator's Discretion|0|||
124991302|NCT02457559|449594424|FG010|Overall Study|Investigator's Discretion|1|||
124991303|NCT02457559|449594414|FG000|Overall Study|Adverse Event|0|||
124991304|NCT02457559|449594415|FG001|Overall Study|Adverse Event|1|||
124991305|NCT02457559|449594416|FG002|Overall Study|Adverse Event|2|||
124991306|NCT02457559|449594417|FG003|Overall Study|Adverse Event|0|||
124991307|NCT02457559|449594418|FG004|Overall Study|Adverse Event|0|||
124991308|NCT02457559|449594419|FG005|Overall Study|Adverse Event|0|||
124991309|NCT02457559|449594420|FG006|Overall Study|Adverse Event|0|||
124991310|NCT02457559|449594421|FG007|Overall Study|Adverse Event|0|||
124991311|NCT02457559|449594422|FG008|Overall Study|Adverse Event|0|||
124991312|NCT02457559|449594423|FG009|Overall Study|Adverse Event|0|||
125317255|NCT00730158|450790550|FG000|Overall Study|Withdrawal by Subject|1|||
125317256|NCT00730158|450790551|FG001|Overall Study|Withdrawal by Subject|1|||
125317257|NCT04678115|450790552|FG000|Overall Study|Lost to Follow-up|1|||
125317258|NCT04678115|450790553|FG001|Overall Study|Lost to Follow-up|0|||
125317259|NCT01168349|450790554|FG000|Overall Study|Death|157|||
125317260|NCT01168349|450790554|FG000|Overall Study|Lost to Follow-up|34|||
125317261|NCT01168349|450790554|FG000|Overall Study|Withdrawal by Subject|9|||
125317262|NCT01168349|450790554|FG000|Overall Study|Kidney transplantation|3|||
125317263|NCT01168349|450790554|FG000|Overall Study|Other|22|||
125317264|NCT01168349|450790554|FG000|Overall Study|Protocol Violation|76|||
125317265|NCT04059549|450790555|FG000|Overall Study|Withdrawal by Subject|2|||
125317266|NCT04059549|450790556|FG001|Overall Study|Withdrawal by Subject|0|||
125317267|NCT00988884|450790558|FG000|Overall Study|Adverse Event|0|||
125317268|NCT00988884|450790559|FG001|Overall Study|Adverse Event|1|||
125317269|NCT00988884|450790558|FG000|Overall Study|Lost to Follow-up|20|||
125317270|NCT00988884|450790559|FG001|Overall Study|Lost to Follow-up|16|||
125317271|NCT00988884|450790558|FG000|Overall Study|Protocol Violation|0|||
125317272|NCT00988884|450790559|FG001|Overall Study|Protocol Violation|1|||
125317273|NCT00988884|450790558|FG000|Overall Study|Withdrawal by Subject|15|||
125317274|NCT00988884|450790559|FG001|Overall Study|Withdrawal by Subject|18|||
125317275|NCT01632020|450790560|FG000|Overall Study|Withdrawal by Subject|1|||
125317276|NCT01632020|450790561|FG001|Overall Study|Withdrawal by Subject|0|||
124991313|NCT02457559|449594424|FG010|Overall Study|Adverse Event|0|||
124991314|NCT02457559|449594414|FG000|Overall Study|Reason not Specified|1|||
124991315|NCT02457559|449594415|FG001|Overall Study|Reason not Specified|0|||
124991316|NCT02457559|449594416|FG002|Overall Study|Reason not Specified|0|||
124991317|NCT02457559|449594417|FG003|Overall Study|Reason not Specified|0|||
124991318|NCT02457559|449594418|FG004|Overall Study|Reason not Specified|0|||
124991319|NCT02457559|449594419|FG005|Overall Study|Reason not Specified|0|||
124991320|NCT02457559|449594420|FG006|Overall Study|Reason not Specified|0|||
124991321|NCT02457559|449594421|FG007|Overall Study|Reason not Specified|0|||
124991322|NCT02457559|449594422|FG008|Overall Study|Reason not Specified|0|||
124991323|NCT02457559|449594423|FG009|Overall Study|Reason not Specified|2|||
124991324|NCT02457559|449594424|FG010|Overall Study|Reason not Specified|0|||
124991325|NCT02457559|449594414|FG000|Overall Study|Death|0|||
124991326|NCT02457559|449594415|FG001|Overall Study|Death|0|||
124991327|NCT02457559|449594416|FG002|Overall Study|Death|0|||
124991328|NCT02457559|449594417|FG003|Overall Study|Death|0|||
124991329|NCT02457559|449594418|FG004|Overall Study|Death|0|||
124991330|NCT02457559|449594419|FG005|Overall Study|Death|0|||
124991331|NCT02457559|449594420|FG006|Overall Study|Death|0|||
124991332|NCT02457559|449594421|FG007|Overall Study|Death|0|||
124991333|NCT02457559|449594422|FG008|Overall Study|Death|1|||
124991334|NCT02457559|449594423|FG009|Overall Study|Death|1|||
124991335|NCT02457559|449594424|FG010|Overall Study|Death|0|||
124991336|NCT00998335|449594429|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
124991337|NCT00998335|449594430|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
124991338|NCT03169101|449594432|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
124991339|NCT03169101|449594433|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
124991340|NCT03169101|449594434|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
124872587|NCT01662063|449155673|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
124872588|NCT01662063|449155674|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
124872589|NCT01662063|449155675|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
124872590|NCT01662063|449155673|FG000|Overall Study|Lack of Efficacy|1|||
124872591|NCT01662063|449155674|FG001|Overall Study|Lack of Efficacy|6|||
124872592|NCT01662063|449155675|FG002|Overall Study|Lack of Efficacy|0|||
124872593|NCT01662063|449155673|FG000|Overall Study|Lost to Follow-up|0|||
124991341|NCT03169101|449594435|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
124991342|NCT01078454|449594437|FG000|Overall Study|Adverse Event|1|||
124991343|NCT01078454|449594438|FG001|Overall Study|Adverse Event|1|||
124991344|NCT01078454|449594437|FG000|Overall Study|Death|0|||
124991345|NCT01078454|449594438|FG001|Overall Study|Death|1|||
124991346|NCT00031551|449596498|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
124991347|NCT00031551|449596499|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
124991348|NCT00409773|449596500|FG000|Overall Study|Adverse Event|3|||
125317277|NCT01632020|450790560|FG000|Overall Study|Adverse Event|1|||
124872594|NCT01662063|449155674|FG001|Overall Study|Lost to Follow-up|4|||
124872595|NCT01662063|449155675|FG002|Overall Study|Lost to Follow-up|0|||
124991349|NCT00409773|449596501|FG001|Overall Study|Adverse Event|4|||
124991350|NCT00409773|449596502|FG002|Overall Study|Adverse Event|4|||
124991351|NCT00409773|449596503|FG003|Overall Study|Adverse Event|2|||
124991352|NCT00409773|449596504|FG004|Overall Study|Adverse Event|6|||
124991353|NCT00409773|449596500|FG000|Overall Study|Lost to Follow-up|6|||
125317278|NCT01632020|450790561|FG001|Overall Study|Adverse Event|0|||
125317279|NCT01362348|450790563|FG000|Overall Study|Protocol-defined stopping criteria|9|||
125317280|NCT01362348|450790563|FG000|Overall Study|Study closed/terminated|5|||
125317281|NCT00647296|450790566|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
125317282|NCT00647296|450790567|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
125317283|NCT00647296|450790568|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
125317284|NCT00647296|450790569|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
124991354|NCT00409773|449596501|FG001|Overall Study|Lost to Follow-up|1|||
124991355|NCT00409773|449596502|FG002|Overall Study|Lost to Follow-up|2|||
125317285|NCT00647296|450790566|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
125317286|NCT00647296|450790567|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
125317287|NCT00647296|450790568|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
124991356|NCT00409773|449596503|FG003|Overall Study|Lost to Follow-up|3|||
124991357|NCT00409773|449596504|FG004|Overall Study|Lost to Follow-up|1|||
124991358|NCT00409773|449596500|FG000|Overall Study|Physician Decision|0|||
124991359|NCT00409773|449596501|FG001|Overall Study|Physician Decision|0|||
125317288|NCT00647296|450790569|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
125317289|NCT00647296|450790566|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
125317290|NCT00647296|450790567|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
125317291|NCT00647296|450790568|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
125317292|NCT00647296|450790569|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
125317293|NCT00647296|450790566|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
125317294|NCT00647296|450790567|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
124991360|NCT00409773|449596502|FG002|Overall Study|Physician Decision|0|||
124991361|NCT00409773|449596503|FG003|Overall Study|Physician Decision|2|||
124991362|NCT00409773|449596504|FG004|Overall Study|Physician Decision|0|||
124991363|NCT00409773|449596500|FG000|Overall Study|Protocol Violation|0|||
124991364|NCT00409773|449596501|FG001|Overall Study|Protocol Violation|2|||
124991365|NCT00409773|449596502|FG002|Overall Study|Protocol Violation|3|||
124991366|NCT00409773|449596503|FG003|Overall Study|Protocol Violation|3|||
124991367|NCT00409773|449596504|FG004|Overall Study|Protocol Violation|1|||
125317295|NCT00647296|450790568|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
125317296|NCT00647296|450790569|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
125317297|NCT00647296|450790566|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
125317298|NCT00647296|450790567|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
125317299|NCT00647296|450790568|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
125317300|NCT00647296|450790569|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
124991368|NCT00409773|449596500|FG000|Overall Study|Withdrawal by Subject|0|||
124991369|NCT00409773|449596501|FG001|Overall Study|Withdrawal by Subject|0|||
124991370|NCT00409773|449596502|FG002|Overall Study|Withdrawal by Subject|0|||
124991371|NCT00409773|449596503|FG003|Overall Study|Withdrawal by Subject|2|||
124991372|NCT00409773|449596504|FG004|Overall Study|Withdrawal by Subject|1|||
124991373|NCT00409773|449596500|FG000|Overall Study|Lack of Eligibility|0|||
124991374|NCT00409773|449596501|FG001|Overall Study|Lack of Eligibility|0|||
124991375|NCT00409773|449596502|FG002|Overall Study|Lack of Eligibility|0|||
124991376|NCT00409773|449596503|FG003|Overall Study|Lack of Eligibility|0|||
124991377|NCT00409773|449596504|FG004|Overall Study|Lack of Eligibility|1|||
124991378|NCT00153062|449596505|FG000|Overall Study|Death|360|||
124991379|NCT00153062|449596506|FG001|Overall Study|Death|352|||
124991380|NCT00153062|449596507|FG002|Overall Study|Death|369|||
124991381|NCT00153062|449596508|FG003|Overall Study|Death|365|||
124991382|NCT00153062|449596505|FG000|Overall Study|Withdrawal by Subject|14|||
124991383|NCT00153062|449596506|FG001|Overall Study|Withdrawal by Subject|30|||
124991384|NCT00153062|449596507|FG002|Overall Study|Withdrawal by Subject|27|||
124991385|NCT00153062|449596508|FG003|Overall Study|Withdrawal by Subject|28|||
124991386|NCT00153062|449596505|FG000|Overall Study|Lost to Follow-up|12|||
124991387|NCT00153062|449596506|FG001|Overall Study|Lost to Follow-up|20|||
124991388|NCT00153062|449596507|FG002|Overall Study|Lost to Follow-up|15|||
124991389|NCT00153062|449596508|FG003|Overall Study|Lost to Follow-up|16|||
124991390|NCT00153062|449596505|FG000|Overall Study|Adverse Event|0|||
124991391|NCT00153062|449596506|FG001|Overall Study|Adverse Event|1|||
124991392|NCT00153062|449596507|FG002|Overall Study|Adverse Event|1|||
124991393|NCT00153062|449596508|FG003|Overall Study|Adverse Event|0|||
124991394|NCT00153062|449596505|FG000|Overall Study|Protocol Violation|0|||
124991395|NCT00153062|449596506|FG001|Overall Study|Protocol Violation|2|||
124991396|NCT00153062|449596507|FG002|Overall Study|Protocol Violation|1|||
124991397|NCT00153062|449596508|FG003|Overall Study|Protocol Violation|1|||
125317301|NCT00647296|450790566|FG000|Part 2: 4-week Placebo Washout|Death|3|||
125317302|NCT00647296|450790567|FG001|Part 2: 4-week Placebo Washout|Death|0|||
124991398|NCT00153062|449596505|FG000|Overall Study|No disposition data available|1|||
124991399|NCT00153062|449596506|FG001|Overall Study|No disposition data available|1|||
124991400|NCT00153062|449596507|FG002|Overall Study|No disposition data available|1|||
124991401|NCT00153062|449596508|FG003|Overall Study|No disposition data available|1|||
124991402|NCT00153062|449596505|FG000|Overall Study|Other|0|||
125317303|NCT00647296|450790568|FG002|Part 2: 4-week Placebo Washout|Death|0|||
125317304|NCT00647296|450790569|FG003|Part 2: 4-week Placebo Washout|Death|0|||
124991403|NCT00153062|449596506|FG001|Overall Study|Other|0|||
124991404|NCT00153062|449596507|FG002|Overall Study|Other|1|||
124991405|NCT00153062|449596508|FG003|Overall Study|Other|0|||
124991406|NCT02359877|449596509|FG000|Overall Study|Withdrawal by Subject|1|||
125317305|NCT00647296|450790566|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
124991407|NCT02359877|449596510|FG001|Overall Study|Withdrawal by Subject|0|||
124991408|NCT02359877|449596511|FG002|Overall Study|Withdrawal by Subject|0|||
124991409|NCT02359877|449596512|FG003|Overall Study|Withdrawal by Subject|2|||
124991410|NCT02359877|449596509|FG000|Overall Study|Adverse Event|0|||
124991411|NCT02359877|449596510|FG001|Overall Study|Adverse Event|0|||
124991412|NCT02359877|449596511|FG002|Overall Study|Adverse Event|0|||
124991413|NCT02359877|449596512|FG003|Overall Study|Adverse Event|1|||
124991414|NCT01919814|449596519|FG000|Overall Study|Adverse Event|1|||
124991415|NCT01919814|449596520|FG001|Overall Study|Adverse Event|0|||
124991416|NCT01919814|449596519|FG000|Overall Study|Protocol Violation|1|||
124991417|NCT01919814|449596520|FG001|Overall Study|Protocol Violation|0|||
124991418|NCT01919814|449596519|FG000|Overall Study|Withdrawal by Subject|1|||
124991419|NCT01919814|449596520|FG001|Overall Study|Withdrawal by Subject|0|||
124991420|NCT00275262|449596521|FG000|Overall Study|Adverse Event|2|||
124991421|NCT00275262|449596522|FG001|Overall Study|Adverse Event|0|||
124991422|NCT00275262|449596521|FG000|Overall Study|Disease progression|2|||
124991423|NCT00275262|449596522|FG001|Overall Study|Disease progression|5|||
124991424|NCT00275262|449596521|FG000|Overall Study|Lost to Follow-up|0|||
124991425|NCT00275262|449596522|FG001|Overall Study|Lost to Follow-up|2|||
124991426|NCT00275262|449596521|FG000|Overall Study|Protocol Violation|0|||
124991427|NCT00275262|449596522|FG001|Overall Study|Protocol Violation|2|||
124991428|NCT00275262|449596521|FG000|Overall Study|Death|1|||
124991429|NCT00275262|449596522|FG001|Overall Study|Death|0|||
124991430|NCT00275262|449596521|FG000|Overall Study|Started Chemotherapy|1|||
124991431|NCT00275262|449596522|FG001|Overall Study|Started Chemotherapy|0|||
124991432|NCT02164383|449596525|FG000|Overall Study|Lost to Follow-up|1|||
124991433|NCT02164383|449596526|FG001|Overall Study|Lost to Follow-up|0|||
124991434|NCT01290029|449596537|FG000|Overall Study|Other|2|||
124991435|NCT02336178|449596541|FG000|Overall Study|Lost to Follow-up|1|||
124991436|NCT02336178|449596541|FG000|Overall Study|Protocol Violation|1|||
124991437|NCT02336178|449596541|FG000|Overall Study|Withdrawal by Subject|1|||
124991438|NCT02336178|449596541|FG000|Overall Study|Other|1|||
124991439|NCT00618982|449596542|FG000|Overall Study|Adverse Event|23|||
124991440|NCT00618982|449596542|FG000|Overall Study|Withdrawal by Subject|1|||
124991441|NCT00618982|449596542|FG000|Overall Study|Protocol Violation|1|||
124991442|NCT00618982|449596542|FG000|Overall Study|ongoing, still treated with study med.|25|||
124991443|NCT00799513|449596545|FG000|Overall Study|Physician Decision|1|||
124991444|NCT00799513|449596545|FG000|Overall Study|Adverse Event|1|||
124991445|NCT00666679|449596546|FG000|First Intervention|Lost to Follow-up|1|||
124991446|NCT00666679|449596547|FG001|First Intervention|Lost to Follow-up|0|||
124991447|NCT00666679|449596546|FG000|First Intervention|Protocol Violation|1|||
124991448|NCT00666679|449596547|FG001|First Intervention|Protocol Violation|0|||
124991449|NCT00666679|449596546|FG000|First Intervention|Withdrawal by Subject|1|||
124991450|NCT00666679|449596547|FG001|First Intervention|Withdrawal by Subject|0|||
124991451|NCT00666679|449596546|FG000|First Intervention|Randomized did not start treatment|1|||
124991452|NCT00666679|449596547|FG001|First Intervention|Randomized did not start treatment|1|||
124991453|NCT00666679|449596546|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
124991454|NCT00666679|449596547|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
124991455|NCT00666679|449596546|FG000|Washout Period of 1 Week|Protocol Violation|0|||
124991456|NCT00666679|449596547|FG001|Washout Period of 1 Week|Protocol Violation|1|||
124991457|NCT00666679|449596546|FG000|Second Intervention|Adverse Event|1|||
124991458|NCT00666679|449596547|FG001|Second Intervention|Adverse Event|0|||
124991459|NCT00666679|449596546|FG000|Second Intervention|Death|0|||
124991460|NCT00666679|449596547|FG001|Second Intervention|Death|1|||
124991461|NCT05062759|449596550|FG000|Overall Study|Death|0|||
124991462|NCT05062759|449596551|FG001|Overall Study|Death|1|||
124991463|NCT05062759|449596550|FG000|Overall Study|Lost to Follow-up|1|||
124991464|NCT05062759|449596551|FG001|Overall Study|Lost to Follow-up|0|||
124991465|NCT02781844|449596552|FG000|Treatment Period 1|Adverse Event|0|||
124991466|NCT02781844|449596553|FG001|Treatment Period 1|Adverse Event|0|||
124991467|NCT02781844|449596554|FG002|Treatment Period 1|Adverse Event|0|||
124991468|NCT02781844|449596555|FG003|Treatment Period 1|Adverse Event|0|||
124991469|NCT02781844|449596556|FG004|Treatment Period 1|Adverse Event|0|||
124991470|NCT02781844|449596557|FG005|Treatment Period 1|Adverse Event|1|||
124991471|NCT02781844|449596558|FG006|Treatment Period 1|Adverse Event|0|||
124991472|NCT02781844|449596559|FG007|Treatment Period 1|Adverse Event|0|||
124991473|NCT02518490|449596560|FG000|Overall Study|Withdrawal by Subject|1|||
124991474|NCT02518490|449596561|FG001|Overall Study|Withdrawal by Subject|1|||
124991475|NCT00346632|449596562|FG000|Overall Study|Progressive Disease|2|||
124991476|NCT00346632|449596563|FG001|Overall Study|Progressive Disease|2|||
124991477|NCT00346632|449596564|FG002|Overall Study|Progressive Disease|4|||
124991478|NCT00346632|449596565|FG003|Overall Study|Progressive Disease|3|||
124991479|NCT00346632|449596566|FG004|Overall Study|Progressive Disease|3|||
124991480|NCT00346632|449596567|FG005|Overall Study|Progressive Disease|1|||
124991481|NCT00346632|449596568|FG006|Overall Study|Progressive Disease|2|||
124991482|NCT00346632|449596569|FG007|Overall Study|Progressive Disease|2|||
124991483|NCT00346632|449596570|FG008|Overall Study|Progressive Disease|2|||
124991484|NCT00346632|449596571|FG009|Overall Study|Progressive Disease|2|||
124991485|NCT00346632|449596562|FG000|Overall Study|Adverse Event|0|||
124991486|NCT00346632|449596563|FG001|Overall Study|Adverse Event|0|||
124991487|NCT00346632|449596564|FG002|Overall Study|Adverse Event|0|||
124991488|NCT00346632|449596565|FG003|Overall Study|Adverse Event|0|||
124991489|NCT00346632|449596566|FG004|Overall Study|Adverse Event|1|||
124991490|NCT00346632|449596567|FG005|Overall Study|Adverse Event|1|||
124991491|NCT00346632|449596568|FG006|Overall Study|Adverse Event|1|||
124991492|NCT00346632|449596569|FG007|Overall Study|Adverse Event|0|||
124991493|NCT00346632|449596570|FG008|Overall Study|Adverse Event|0|||
124991494|NCT00346632|449596571|FG009|Overall Study|Adverse Event|0|||
124991495|NCT00346632|449596562|FG000|Overall Study|Death|0|||
124991496|NCT00346632|449596563|FG001|Overall Study|Death|0|||
124991497|NCT00346632|449596564|FG002|Overall Study|Death|1|||
124991498|NCT00346632|449596565|FG003|Overall Study|Death|0|||
124991499|NCT00346632|449596566|FG004|Overall Study|Death|0|||
124991500|NCT00346632|449596567|FG005|Overall Study|Death|0|||
124991501|NCT00346632|449596568|FG006|Overall Study|Death|0|||
124991502|NCT00346632|449596569|FG007|Overall Study|Death|0|||
124991503|NCT00346632|449596570|FG008|Overall Study|Death|0|||
124991504|NCT00346632|449596571|FG009|Overall Study|Death|0|||
124991505|NCT00346632|449596562|FG000|Overall Study|Protocol Violation|0|||
124991506|NCT00346632|449596563|FG001|Overall Study|Protocol Violation|0|||
124991507|NCT00346632|449596564|FG002|Overall Study|Protocol Violation|0|||
124991508|NCT00346632|449596565|FG003|Overall Study|Protocol Violation|0|||
124991509|NCT00346632|449596566|FG004|Overall Study|Protocol Violation|0|||
124991510|NCT00346632|449596567|FG005|Overall Study|Protocol Violation|0|||
124991511|NCT00346632|449596568|FG006|Overall Study|Protocol Violation|1|||
124991512|NCT00346632|449596569|FG007|Overall Study|Protocol Violation|0|||
124991513|NCT00346632|449596570|FG008|Overall Study|Protocol Violation|0|||
124991514|NCT00346632|449596571|FG009|Overall Study|Protocol Violation|0|||
124991515|NCT00346632|449596562|FG000|Overall Study|Withdrawal by Subject|0|||
124991516|NCT00346632|449596563|FG001|Overall Study|Withdrawal by Subject|0|||
124991517|NCT00346632|449596564|FG002|Overall Study|Withdrawal by Subject|0|||
124991518|NCT00346632|449596565|FG003|Overall Study|Withdrawal by Subject|0|||
124991519|NCT00346632|449596566|FG004|Overall Study|Withdrawal by Subject|0|||
124991520|NCT00346632|449596567|FG005|Overall Study|Withdrawal by Subject|0|||
124991521|NCT00346632|449596568|FG006|Overall Study|Withdrawal by Subject|1|||
124991522|NCT00346632|449596569|FG007|Overall Study|Withdrawal by Subject|0|||
124991523|NCT00346632|449596570|FG008|Overall Study|Withdrawal by Subject|0|||
124991524|NCT00346632|449596571|FG009|Overall Study|Withdrawal by Subject|0|||
124991525|NCT00346632|449596562|FG000|Overall Study|Switched to alternative treatment|0|||
124991526|NCT00346632|449596563|FG001|Overall Study|Switched to alternative treatment|0|||
124991527|NCT00346632|449596564|FG002|Overall Study|Switched to alternative treatment|1|||
124991528|NCT00346632|449596565|FG003|Overall Study|Switched to alternative treatment|0|||
124991529|NCT00346632|449596566|FG004|Overall Study|Switched to alternative treatment|0|||
124991530|NCT00346632|449596567|FG005|Overall Study|Switched to alternative treatment|0|||
124991531|NCT00346632|449596568|FG006|Overall Study|Switched to alternative treatment|0|||
124991532|NCT00346632|449596569|FG007|Overall Study|Switched to alternative treatment|0|||
125317306|NCT00647296|450790567|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
125317307|NCT00647296|450790568|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
125317308|NCT00647296|450790569|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
125317309|NCT00647296|450790566|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
125317310|NCT00647296|450790567|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
125317311|NCT00647296|450790568|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
125317312|NCT00647296|450790569|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
125317313|NCT00647296|450790566|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
125317314|NCT00647296|450790567|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
125317315|NCT00647296|450790568|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
125317316|NCT00647296|450790569|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
125317317|NCT00647296|450790566|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
125317318|NCT00647296|450790567|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
125317319|NCT00647296|450790568|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
124991533|NCT00346632|449596570|FG008|Overall Study|Switched to alternative treatment|0|||
124991534|NCT00346632|449596571|FG009|Overall Study|Switched to alternative treatment|0|||
124991535|NCT00346632|449596562|FG000|Overall Study|Not Stated|1|||
124991536|NCT00346632|449596563|FG001|Overall Study|Not Stated|1|||
124991537|NCT00346632|449596564|FG002|Overall Study|Not Stated|0|||
124991538|NCT00346632|449596565|FG003|Overall Study|Not Stated|0|||
124991539|NCT00346632|449596566|FG004|Overall Study|Not Stated|0|||
124991540|NCT00346632|449596567|FG005|Overall Study|Not Stated|0|||
125317320|NCT00647296|450790569|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
124991541|NCT00346632|449596568|FG006|Overall Study|Not Stated|0|||
124991542|NCT00346632|449596569|FG007|Overall Study|Not Stated|2|||
124991543|NCT00346632|449596570|FG008|Overall Study|Not Stated|2|||
124991544|NCT00346632|449596571|FG009|Overall Study|Not Stated|1|||
124991545|NCT00918580|449596572|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
124991546|NCT00918580|449596572|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
125317321|NCT00647296|450790566|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
125317322|NCT00647296|450790567|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
125317323|NCT00647296|450790568|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
125317324|NCT00647296|450790569|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
125317325|NCT01787461|450790570|FG000|Overall Study|Adverse Event|4|||
125317326|NCT01787461|450790571|FG001|Overall Study|Adverse Event|3|||
125317327|NCT01787461|450790570|FG000|Overall Study|Lost to Follow-up|3|||
125317328|NCT01787461|450790571|FG001|Overall Study|Lost to Follow-up|2|||
125317329|NCT01787461|450790570|FG000|Overall Study|No longer met eligibility criteria|1|||
125317330|NCT01787461|450790571|FG001|Overall Study|No longer met eligibility criteria|0|||
125317331|NCT01787461|450790570|FG000|Overall Study|Withdrawal by Subject|3|||
125317332|NCT01787461|450790571|FG001|Overall Study|Withdrawal by Subject|4|||
125317333|NCT01787461|450790570|FG000|Overall Study|Protocol Violation|3|||
125317334|NCT01787461|450790571|FG001|Overall Study|Protocol Violation|0|||
125317335|NCT01519323|450792296|FG000|Overall Study|Death|3|||
125317336|NCT01519323|450792297|FG001|Overall Study|Death|2|||
125317337|NCT01519323|450792296|FG000|Overall Study|Study terminated by sponsor|0|||
125317338|NCT01519323|450792297|FG001|Overall Study|Study terminated by sponsor|1|||
125317339|NCT00383552|450792300|FG000|Overall Study|Adverse Event|7|||
125317340|NCT00383552|450792301|FG001|Overall Study|Adverse Event|6|||
125317341|NCT00383552|450792302|FG002|Overall Study|Adverse Event|9|||
125317342|NCT00383552|450792303|FG003|Overall Study|Adverse Event|6|||
125317343|NCT00383552|450792300|FG000|Overall Study|Lack of Efficacy|4|||
125317344|NCT00383552|450792301|FG001|Overall Study|Lack of Efficacy|13|||
125317345|NCT00383552|450792302|FG002|Overall Study|Lack of Efficacy|29|||
125317346|NCT00383552|450792303|FG003|Overall Study|Lack of Efficacy|42|||
125317347|NCT00383552|450792300|FG000|Overall Study|Lost to Follow-up|0|||
125317348|NCT00383552|450792301|FG001|Overall Study|Lost to Follow-up|1|||
125317349|NCT00383552|450792302|FG002|Overall Study|Lost to Follow-up|5|||
125317350|NCT00383552|450792303|FG003|Overall Study|Lost to Follow-up|1|||
125317351|NCT00383552|450792300|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
125317352|NCT00383552|450792301|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
125317353|NCT00383552|450792302|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
125317354|NCT00383552|450792303|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
125317355|NCT00383552|450792300|FG000|Overall Study|Did not wish to continue (related)|1|||
125317356|NCT00383552|450792301|FG001|Overall Study|Did not wish to continue (related)|0|||
125317357|NCT00383552|450792302|FG002|Overall Study|Did not wish to continue (related)|2|||
125317358|NCT00383552|450792303|FG003|Overall Study|Did not wish to continue (related)|3|||
125317359|NCT00383552|450792300|FG000|Overall Study|Noncompliance with the protocol|11|||
125317360|NCT00383552|450792301|FG001|Overall Study|Noncompliance with the protocol|6|||
125317361|NCT00383552|450792302|FG002|Overall Study|Noncompliance with the protocol|8|||
125317362|NCT00383552|450792303|FG003|Overall Study|Noncompliance with the protocol|10|||
125317363|NCT00383552|450792300|FG000|Overall Study|Did not meet protocol eligibility|8|||
125317364|NCT00383552|450792301|FG001|Overall Study|Did not meet protocol eligibility|6|||
125317365|NCT00383552|450792302|FG002|Overall Study|Did not meet protocol eligibility|2|||
125317366|NCT00383552|450792303|FG003|Overall Study|Did not meet protocol eligibility|3|||
125317367|NCT00383552|450792300|FG000|Overall Study|Administrative|1|||
125317368|NCT00383552|450792301|FG001|Overall Study|Administrative|0|||
125317369|NCT00383552|450792302|FG002|Overall Study|Administrative|1|||
125317370|NCT00383552|450792303|FG003|Overall Study|Administrative|1|||
125317371|NCT03096834|450792304|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
125317372|NCT03096834|450792305|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
125317373|NCT03096834|450792306|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
125317374|NCT03096834|450792307|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
125317375|NCT03096834|450792304|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
125317376|NCT03096834|450792305|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
125317377|NCT03096834|450792306|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
125317378|NCT03096834|450792307|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
125317379|NCT03096834|450792304|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
125317380|NCT03096834|450792305|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
124991547|NCT00918580|449596572|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
124991548|NCT00918580|449596572|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
124991549|NCT00918580|449596572|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
124991550|NCT00918580|449596572|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
125317381|NCT03096834|450792306|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
125317382|NCT03096834|450792307|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
125317383|NCT03096834|450792304|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
125317384|NCT03096834|450792305|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
125317385|NCT03096834|450792306|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
125317386|NCT03096834|450792307|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
125317387|NCT03096834|450792304|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
125317388|NCT03096834|450792305|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
125317389|NCT03096834|450792306|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
125317390|NCT03096834|450792307|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
125317391|NCT03096834|450792304|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
125317392|NCT03096834|450792305|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
125317393|NCT03096834|450792306|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
125317394|NCT03096834|450792307|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
125317395|NCT03096834|450792304|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
125317396|NCT03096834|450792305|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
125317397|NCT03096834|450792306|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
125317398|NCT03096834|450792307|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
125317399|NCT03096834|450792304|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
125317400|NCT03096834|450792305|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
124991551|NCT00918580|449596572|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
124991552|NCT04882995|449596573|FG000|Overall Study|Withdrawal by Subject|1|||
124991553|NCT04882995|449596574|FG001|Overall Study|Withdrawal by Subject|2|||
124991554|NCT04882995|449596573|FG000|Overall Study|Protocol Violation|4|||
124991555|NCT04882995|449596574|FG001|Overall Study|Protocol Violation|4|||
124991556|NCT04882995|449596573|FG000|Overall Study|Surgery postponed due to COVID|1|||
125317401|NCT03096834|450792306|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
125317402|NCT03096834|450792307|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
125317403|NCT03096834|450792304|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
125317404|NCT03096834|450792305|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
125317405|NCT03096834|450792306|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
125317406|NCT03096834|450792307|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
125317407|NCT03096834|450792304|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
125317408|NCT03096834|450792305|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
124991557|NCT04882995|449596574|FG001|Overall Study|Surgery postponed due to COVID|1|||
124991558|NCT00477334|449596575|FG000|Overall Study|Discontinued prior to taking study drug|106|||
124991559|NCT00477334|449596576|FG001|Overall Study|Discontinued prior to taking study drug|53|||
124991560|NCT00477334|449596575|FG000|Overall Study|Adverse Event|1|||
124991561|NCT00477334|449596576|FG001|Overall Study|Adverse Event|2|||
124991562|NCT00477334|449596575|FG000|Overall Study|Withdrawal by Subject|2|||
124991563|NCT00477334|449596576|FG001|Overall Study|Withdrawal by Subject|1|||
124991564|NCT00477334|449596575|FG000|Overall Study|Lost to Follow-up|15|||
124991565|NCT00477334|449596576|FG001|Overall Study|Lost to Follow-up|4|||
124991566|NCT00477334|449596575|FG000|Overall Study|Administrative Problems|39|||
124991567|NCT00477334|449596576|FG001|Overall Study|Administrative Problems|15|||
124991568|NCT00477334|449596575|FG000|Overall Study|Protocol Violation|7|||
124991569|NCT00477334|449596576|FG001|Overall Study|Protocol Violation|1|||
124991570|NCT03587974|449596580|FG000|Overall Study|caregiver demented, care recipient died|3|||
124991571|NCT03587974|449596581|FG001|Overall Study|caregiver demented, care recipient died|3|||
124991572|NCT03587974|449596580|FG000|Overall Study|Withdrawal by Subject|2|||
124991573|NCT03587974|449596581|FG001|Overall Study|Withdrawal by Subject|1|||
124991574|NCT04371198|449596583|FG000|Overall Study|inadequate sample|4|||
124991575|NCT03486457|449596586|FG000|Up to Month 3|Adverse Event|2|||
124991576|NCT03486457|449596587|FG001|Up to Month 3|Adverse Event|5|||
124991577|NCT03486457|449596586|FG000|Up to Month 3|Lack of Efficacy|1|||
124991578|NCT03486457|449596587|FG001|Up to Month 3|Lack of Efficacy|0|||
124991579|NCT03486457|449596586|FG000|Up to Month 3|Withdrawal by Subject|1|||
124991580|NCT03486457|449596587|FG001|Up to Month 3|Withdrawal by Subject|0|||
124991581|NCT03486457|449596586|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
124991582|NCT03486457|449596587|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
124991583|NCT03486457|449596586|FG000|Up to Month 3|Other|1|||
124991584|NCT03486457|449596587|FG001|Up to Month 3|Other|0|||
124991585|NCT03486457|449596586|FG000|Month 3 to Month 6|Adverse Event|2|||
124991586|NCT03486457|449596587|FG001|Month 3 to Month 6|Adverse Event|0|||
124991587|NCT03486457|449596586|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
124991588|NCT03486457|449596587|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
124991589|NCT03486457|449596586|FG000|Month 3 to Month 6|Pregnancy|0|||
124991590|NCT03486457|449596587|FG001|Month 3 to Month 6|Pregnancy|1|||
124991591|NCT03486457|449596586|FG000|Month 3 to Month 6|Other|1|||
124991592|NCT03486457|449596587|FG001|Month 3 to Month 6|Other|0|||
124991593|NCT00372229|449596588|FG000|Study Phase|Graft loss|0|||
124991594|NCT00372229|449596589|FG001|Study Phase|Graft loss|3|||
124991595|NCT00372229|449596588|FG000|Study Phase|Protocol Violation|3|||
124991596|NCT00372229|449596589|FG001|Study Phase|Protocol Violation|4|||
124991597|NCT00372229|449596588|FG000|Study Phase|Consent withdrawn|16|||
125317409|NCT03096834|450792306|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
125317410|NCT03096834|450792307|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
125317411|NCT03096834|450792304|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
124991598|NCT00372229|449596589|FG001|Study Phase|Consent withdrawn|14|||
124991599|NCT00372229|449596588|FG000|Study Phase|Refused treatment/did not cooperate|3|||
124991600|NCT00372229|449596589|FG001|Study Phase|Refused treatment/did not cooperate|1|||
124991601|NCT00372229|449596588|FG000|Study Phase|Death|3|||
125317412|NCT03096834|450792305|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
125317413|NCT03096834|450792306|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
125317414|NCT03096834|450792307|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
125317415|NCT03096834|450792304|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
125317416|NCT03096834|450792305|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
125317417|NCT03096834|450792306|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
125317418|NCT03096834|450792307|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
125317419|NCT00966654|450792308|FG000|Overall Study|Study was terminated,PI left institution|12|||
125317420|NCT04416204|450792311|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
125317421|NCT04416204|450792312|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
125317422|NCT04416204|450792313|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
125317423|NCT04416204|450792314|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
125317424|NCT03858049|450792315|FG000|Overall Study|Adverse Event|16|||
125317425|NCT03858049|450792316|FG001|Overall Study|Adverse Event|9|||
125317426|NCT03858049|450792315|FG000|Overall Study|Other|1|||
125317427|NCT03858049|450792316|FG001|Overall Study|Other|1|||
125317428|NCT04456504|450792317|FG000|Overall Study|Lost to Follow-up|2|||
124991602|NCT00372229|449596589|FG001|Study Phase|Death|2|||
124991603|NCT00372229|449596588|FG000|Study Phase|Reason not specified|3|||
124991604|NCT00372229|449596589|FG001|Study Phase|Reason not specified|2|||
124991605|NCT00372229|449596588|FG000|Study Phase|Lost to Follow-up|3|||
124991606|NCT00372229|449596589|FG001|Study Phase|Lost to Follow-up|3|||
125317429|NCT04617782|450792318|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
125317430|NCT04617782|450792318|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
125317431|NCT04617782|450792318|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
125317432|NCT04617782|450792318|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
125317433|NCT04617782|450792318|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
125317434|NCT04617782|450792318|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
125317435|NCT01405768|450792319|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
125317436|NCT01405768|450792320|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
125317437|NCT01690052|450792323|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
125317438|NCT01690052|450792324|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
125317439|NCT01474317|450792334|FG000|Overall Study|Adverse Event|1|||
125317440|NCT01474317|450792334|FG000|Overall Study|Subject ineligible for study|1|||
125317441|NCT01381016|450792337|FG000|Overall Study|Lost to Follow-up|1|||
125317442|NCT01381016|450792338|FG001|Overall Study|Lost to Follow-up|1|||
125317443|NCT01381016|450792337|FG000|Overall Study|Screen Failure|2|||
125317444|NCT01381016|450792338|FG001|Overall Study|Screen Failure|2|||
125317445|NCT01381016|450792337|FG000|Overall Study|Withdrawal by Subject|0|||
125317446|NCT01381016|450792338|FG001|Overall Study|Withdrawal by Subject|1|||
125317447|NCT01381016|450792337|FG000|Overall Study|Physician Decision|0|||
125317448|NCT01381016|450792338|FG001|Overall Study|Physician Decision|2|||
125317449|NCT01693029|450792339|FG000|Overall Study|Withdrawal by Subject|15|||
125317450|NCT01693029|450792340|FG001|Overall Study|Withdrawal by Subject|22|||
125317451|NCT01693029|450792339|FG000|Overall Study|Kidney transplantation|7|||
125317452|NCT01693029|450792340|FG001|Overall Study|Kidney transplantation|7|||
125317453|NCT01693029|450792339|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
125317454|NCT01693029|450792340|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
125317455|NCT01693029|450792339|FG000|Overall Study|Protocol Violation|6|||
125317456|NCT01693029|450792340|FG001|Overall Study|Protocol Violation|7|||
125317457|NCT01693029|450792339|FG000|Overall Study|Change in dialysis modality|2|||
125317458|NCT01693029|450792340|FG001|Overall Study|Change in dialysis modality|1|||
125317459|NCT01693029|450792339|FG000|Overall Study|Physician Decision|0|||
125317460|NCT01693029|450792340|FG001|Overall Study|Physician Decision|2|||
125317461|NCT01693029|450792339|FG000|Overall Study|Lost to Follow-up|0|||
125317462|NCT01693029|450792340|FG001|Overall Study|Lost to Follow-up|1|||
125317463|NCT01693029|450792339|FG000|Overall Study|Adverse Event|1|||
125317464|NCT01693029|450792340|FG001|Overall Study|Adverse Event|6|||
125317465|NCT01693029|450792339|FG000|Overall Study|Death|5|||
125317466|NCT01693029|450792340|FG001|Overall Study|Death|8|||
125317467|NCT01693029|450792339|FG000|Overall Study|Non-compliance|2|||
125317468|NCT01693029|450792340|FG001|Overall Study|Non-compliance|1|||
125317469|NCT02647281|450792341|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
125317470|NCT02647281|450792342|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
125317471|NCT02647281|450792343|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
125317472|NCT02647281|450792344|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
125317473|NCT02647281|450792345|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
125317474|NCT02647281|450792346|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
125317475|NCT02647281|450792347|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
125317476|NCT02647281|450792348|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
125317477|NCT02647281|450792349|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
125317478|NCT05801991|450792350|FG000|Overall Study|Lost to Follow-up|1|||
124991607|NCT00372229|449596588|FG000|Follow-Up Phase|Graft loss|8|||
124991608|NCT00372229|449596589|FG001|Follow-Up Phase|Graft loss|7|||
124991609|NCT00372229|449596588|FG000|Follow-Up Phase|Consent withdrawn|13|||
125317479|NCT05801991|450792351|FG001|Overall Study|Lost to Follow-up|0|||
125317480|NCT01451723|450792353|FG000|Overall Study|study halted|6|||
125317481|NCT01451723|450792354|FG001|Overall Study|study halted|5|||
125317482|NCT01631435|450792355|FG000|Overall Study|Adverse Event|2|||
125317483|NCT01631435|450792355|FG000|Overall Study|Withdrawal by Subject|2|||
125317484|NCT01631435|450792355|FG000|Overall Study|incomplete study procedure|5|||
125317485|NCT01005251|450792364|FG000|Overall Study|Withdrawal by Subject|2|||
125317486|NCT01005251|450792365|FG001|Overall Study|Withdrawal by Subject|5|||
125317487|NCT01005251|450792366|FG002|Overall Study|Withdrawal by Subject|3|||
125317488|NCT01005251|450792367|FG003|Overall Study|Withdrawal by Subject|4|||
125317489|NCT01005251|450792368|FG004|Overall Study|Withdrawal by Subject|9|||
125317490|NCT01005251|450792364|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
125317491|NCT01005251|450792365|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125317492|NCT01005251|450792366|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
125317493|NCT01005251|450792367|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
125317494|NCT01005251|450792368|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
125317495|NCT01005251|450792364|FG000|Overall Study|Adverse Event|2|||
125317496|NCT01005251|450792365|FG001|Overall Study|Adverse Event|6|||
125317497|NCT01005251|450792366|FG002|Overall Study|Adverse Event|8|||
125317498|NCT01005251|450792367|FG003|Overall Study|Adverse Event|5|||
125317499|NCT01005251|450792368|FG004|Overall Study|Adverse Event|4|||
125317500|NCT01005251|450792364|FG000|Overall Study|Protocol Violation|1|||
125317501|NCT01005251|450792365|FG001|Overall Study|Protocol Violation|0|||
125317502|NCT01005251|450792366|FG002|Overall Study|Protocol Violation|0|||
125317503|NCT01005251|450792367|FG003|Overall Study|Protocol Violation|0|||
125317504|NCT01005251|450792368|FG004|Overall Study|Protocol Violation|2|||
125317505|NCT01005251|450792364|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
125317506|NCT01005251|450792365|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
125317507|NCT01005251|450792366|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
125317508|NCT01005251|450792367|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
125317509|NCT01005251|450792368|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
125317510|NCT01005251|450792364|FG000|Overall Study|Lost to Follow-up|1|||
125317511|NCT01005251|450792365|FG001|Overall Study|Lost to Follow-up|4|||
125317512|NCT01005251|450792366|FG002|Overall Study|Lost to Follow-up|2|||
125317513|NCT01005251|450792367|FG003|Overall Study|Lost to Follow-up|0|||
125317514|NCT01005251|450792368|FG004|Overall Study|Lost to Follow-up|0|||
125317515|NCT01005251|450792364|FG000|Overall Study|Physician Decision|0|||
125317516|NCT01005251|450792365|FG001|Overall Study|Physician Decision|0|||
125317517|NCT01005251|450792366|FG002|Overall Study|Physician Decision|0|||
125317518|NCT01005251|450792367|FG003|Overall Study|Physician Decision|0|||
125317519|NCT01005251|450792368|FG004|Overall Study|Physician Decision|2|||
125317520|NCT01005251|450792364|FG000|Overall Study|Patient moved|1|||
125317521|NCT01005251|450792365|FG001|Overall Study|Patient moved|0|||
125317522|NCT01005251|450792366|FG002|Overall Study|Patient moved|0|||
124872596|NCT01662063|449155673|FG000|Overall Study|Protocol Violation|1|||
124872597|NCT01662063|449155674|FG001|Overall Study|Protocol Violation|0|||
124872598|NCT01662063|449155675|FG002|Overall Study|Protocol Violation|0|||
124872599|NCT01662063|449155673|FG000|Overall Study|Withdrawal by Subject|2|||
124872600|NCT01662063|449155674|FG001|Overall Study|Withdrawal by Subject|4|||
124872601|NCT01662063|449155675|FG002|Overall Study|Withdrawal by Subject|1|||
125317523|NCT01005251|450792367|FG003|Overall Study|Patient moved|0|||
125317524|NCT01005251|450792368|FG004|Overall Study|Patient moved|0|||
125317525|NCT01005251|450792364|FG000|Overall Study|Wrong drug dispensed|0|||
125317526|NCT01005251|450792365|FG001|Overall Study|Wrong drug dispensed|1|||
125317527|NCT01005251|450792366|FG002|Overall Study|Wrong drug dispensed|0|||
125317528|NCT01005251|450792367|FG003|Overall Study|Wrong drug dispensed|0|||
125317529|NCT01005251|450792368|FG004|Overall Study|Wrong drug dispensed|0|||
125317530|NCT01005251|450792364|FG000|Overall Study|Randomized in error|0|||
125317531|NCT01005251|450792365|FG001|Overall Study|Randomized in error|0|||
125317532|NCT01005251|450792366|FG002|Overall Study|Randomized in error|1|||
125317533|NCT01005251|450792367|FG003|Overall Study|Randomized in error|1|||
125317534|NCT01005251|450792368|FG004|Overall Study|Randomized in error|0|||
125317535|NCT01005251|450792364|FG000|Overall Study|Lack of Efficacy|0|||
125317536|NCT01005251|450792365|FG001|Overall Study|Lack of Efficacy|0|||
125317537|NCT01005251|450792366|FG002|Overall Study|Lack of Efficacy|1|||
125317538|NCT01005251|450792367|FG003|Overall Study|Lack of Efficacy|1|||
125317539|NCT01005251|450792368|FG004|Overall Study|Lack of Efficacy|0|||
125317540|NCT00443040|450792369|FG000|Overall Study|Withdrawal by Subject|1|||
125317541|NCT00443040|450792370|FG001|Overall Study|Withdrawal by Subject|0|||
125317542|NCT00443040|450792371|FG002|Overall Study|Withdrawal by Subject|0|||
125317543|NCT00443040|450792369|FG000|Overall Study|Converted to an open laparotomy|3|||
125317544|NCT00443040|450792370|FG001|Overall Study|Converted to an open laparotomy|0|||
125317545|NCT00443040|450792371|FG002|Overall Study|Converted to an open laparotomy|1|||
125317546|NCT00435409|450792375|FG000|Overall Study|Protocol Violation|1|||
124872602|NCT01662063|449155673|FG000|Overall Study|Physician Decision|0|||
124872603|NCT01662063|449155674|FG001|Overall Study|Physician Decision|2|||
124872604|NCT01662063|449155675|FG002|Overall Study|Physician Decision|0|||
125317547|NCT00435409|450792376|FG001|Overall Study|Protocol Violation|2|||
125317548|NCT00435409|450792377|FG002|Overall Study|Protocol Violation|0|||
125317549|NCT00435409|450792375|FG000|Overall Study|Lost to Follow-up|1|||
125317550|NCT00435409|450792376|FG001|Overall Study|Lost to Follow-up|2|||
125317551|NCT00435409|450792377|FG002|Overall Study|Lost to Follow-up|0|||
125317552|NCT00435409|450792375|FG000|Overall Study|Death|8|||
125317553|NCT00435409|450792376|FG001|Overall Study|Death|6|||
125317554|NCT00435409|450792377|FG002|Overall Study|Death|6|||
125317555|NCT00435409|450792375|FG000|Overall Study|Objective progression or relapse|158|||
125317556|NCT00435409|450792376|FG001|Overall Study|Objective progression or relapse|93|||
125317557|NCT00435409|450792377|FG002|Overall Study|Objective progression or relapse|58|||
125317558|NCT00435409|450792375|FG000|Overall Study|Global deterioration of health status|0|||
125317559|NCT00435409|450792376|FG001|Overall Study|Global deterioration of health status|0|||
125317560|NCT00435409|450792377|FG002|Overall Study|Global deterioration of health status|4|||
125317561|NCT00435409|450792375|FG000|Overall Study|Withdrawal by Subject|8|||
125317562|NCT00435409|450792376|FG001|Overall Study|Withdrawal by Subject|7|||
125317563|NCT00435409|450792377|FG002|Overall Study|Withdrawal by Subject|1|||
125317564|NCT00435409|450792375|FG000|Overall Study|Other|45|||
125317565|NCT00435409|450792376|FG001|Overall Study|Other|30|||
125317566|NCT00435409|450792377|FG002|Overall Study|Other|1|||
125317567|NCT00435409|450792375|FG000|Overall Study|Adverse Event|0|||
125317568|NCT00435409|450792376|FG001|Overall Study|Adverse Event|0|||
125317569|NCT00435409|450792377|FG002|Overall Study|Adverse Event|8|||
125317570|NCT00435409|450792375|FG000|Overall Study|Sponsor decision|0|||
125317571|NCT00435409|450792376|FG001|Overall Study|Sponsor decision|3|||
125317572|NCT00435409|450792377|FG002|Overall Study|Sponsor decision|0|||
125317573|NCT03661723|450792379|FG000|Overall Study|Disease Progression|4|||
125317574|NCT03661723|450792380|FG001|Overall Study|Disease Progression|24|||
125317575|NCT03661723|450792381|FG002|Overall Study|Disease Progression|4|||
125317576|NCT03661723|450792382|FG003|Overall Study|Disease Progression|19|||
125317577|NCT03661723|450792379|FG000|Overall Study|Withdrawal by Subject|1|||
125317578|NCT03661723|450792380|FG001|Overall Study|Withdrawal by Subject|0|||
125317579|NCT03661723|450792381|FG002|Overall Study|Withdrawal by Subject|2|||
125317580|NCT03661723|450792382|FG003|Overall Study|Withdrawal by Subject|4|||
125317581|NCT03661723|450792379|FG000|Overall Study|Physician Decision|1|||
125317582|NCT03661723|450792380|FG001|Overall Study|Physician Decision|0|||
125317583|NCT03661723|450792381|FG002|Overall Study|Physician Decision|0|||
125317584|NCT03661723|450792382|FG003|Overall Study|Physician Decision|0|||
125317585|NCT03661723|450792379|FG000|Overall Study|Clinical Deterioration|0|||
125317586|NCT03661723|450792380|FG001|Overall Study|Clinical Deterioration|0|||
125317587|NCT03661723|450792381|FG002|Overall Study|Clinical Deterioration|0|||
125317588|NCT03661723|450792382|FG003|Overall Study|Clinical Deterioration|1|||
125317589|NCT00883779|450792385|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
125317590|NCT00883779|450792386|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
125317591|NCT00883779|450792385|FG000|Primary Study Treatment Phase|Disease progression|75|||
125317592|NCT00883779|450792386|FG001|Primary Study Treatment Phase|Disease progression|59|||
125317593|NCT00883779|450792385|FG000|Primary Study Treatment Phase|Adverse Event|16|||
125317594|NCT00883779|450792386|FG001|Primary Study Treatment Phase|Adverse Event|16|||
125317595|NCT00883779|450792385|FG000|Primary Study Treatment Phase|Death|2|||
125317596|NCT00883779|450792386|FG001|Primary Study Treatment Phase|Death|3|||
125317597|NCT00883779|450792385|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
125317598|NCT00883779|450792386|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
125317599|NCT00883779|450792385|FG000|Primary Study Treatment Phase|Other|3|||
125317600|NCT00883779|450792386|FG001|Primary Study Treatment Phase|Other|0|||
125317601|NCT00883779|450792385|FG000|Post-Study Treatment Phase|Adverse Event|2|||
125317602|NCT00883779|450792386|FG001|Post-Study Treatment Phase|Adverse Event|3|||
125317603|NCT00883779|450792385|FG000|Post-Study Treatment Phase|Death|1|||
125317604|NCT00883779|450792386|FG001|Post-Study Treatment Phase|Death|3|||
125317605|NCT00883779|450792385|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
125317606|NCT00883779|450792386|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
125317607|NCT00883779|450792385|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
125317608|NCT00883779|450792386|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
125317609|NCT00883779|450792385|FG000|Post-Study Treatment Phase|Disease progression|103|||
124991610|NCT00372229|449596589|FG001|Follow-Up Phase|Consent withdrawn|19|||
125317610|NCT00883779|450792386|FG001|Post-Study Treatment Phase|Disease progression|122|||
125317611|NCT00883779|450792385|FG000|Post-Study Treatment Phase|Other|3|||
125317612|NCT00883779|450792386|FG001|Post-Study Treatment Phase|Other|0|||
125317613|NCT00883779|450792385|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
125317614|NCT00883779|450792386|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
125317615|NCT00883779|450792385|FG000|Off-study Phase|Death|185|||
125317616|NCT00883779|450792386|FG001|Off-study Phase|Death|174|||
125317617|NCT00883779|450792385|FG000|Off-study Phase|Refused treatment|1|||
125317618|NCT00883779|450792386|FG001|Off-study Phase|Refused treatment|1|||
125317619|NCT00883779|450792385|FG000|Off-study Phase|Failure to return|5|||
125317620|NCT00883779|450792386|FG001|Off-study Phase|Failure to return|6|||
125317621|NCT00883779|450792385|FG000|Off-study Phase|Other|18|||
125317622|NCT00883779|450792386|FG001|Off-study Phase|Other|21|||
125317623|NCT00499681|450792387|FG000|Overall Study|toxicity|0|||
125317624|NCT00499681|450792388|FG001|Overall Study|toxicity|1|||
125317625|NCT00499681|450792387|FG000|Overall Study|disease progression|0|||
125317626|NCT00499681|450792388|FG001|Overall Study|disease progression|1|||
125317627|NCT02174731|450792389|FG000|Overall Study|Participant decision|67|||
125317628|NCT02174731|450792390|FG001|Overall Study|Participant decision|64|||
125317629|NCT02174731|450792389|FG000|Overall Study|Incorrect enrolment before randomization|0|||
125317630|NCT02174731|450792390|FG001|Overall Study|Incorrect enrolment before randomization|1|||
125317631|NCT02174731|450792389|FG000|Overall Study|Missing|2|||
125317632|NCT02174731|450792390|FG001|Overall Study|Missing|0|||
125317633|NCT00079040|450792391|FG000|Overall Study|Withdrew before treatment|1|||
125317634|NCT00079040|450792391|FG000|Overall Study|Ineligible|1|||
125317635|NCT00739401|450792394|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
125317636|NCT00739401|450792394|FG000|Overall Study|Death|3|||
125317637|NCT00739401|450792394|FG000|Overall Study|Withdrawal by Subject|4|||
125317638|NCT04575155|450792395|FG000|2 Month|Withdrawal by Subject|1|||
125317639|NCT04575155|450792396|FG001|2 Month|Withdrawal by Subject|1|||
125317640|NCT04575155|450792395|FG000|2 Month|Lost to Follow-up|5|||
125317641|NCT04575155|450792396|FG001|2 Month|Lost to Follow-up|3|||
125317642|NCT04575155|450792395|FG000|2 Month|Ineligible|1|||
125317643|NCT04575155|450792396|FG001|2 Month|Ineligible|0|||
125317644|NCT00467740|450792399|FG000|Overall Study|Adverse Event|0|||
125317645|NCT00467740|450792400|FG001|Overall Study|Adverse Event|0|||
125317646|NCT00467740|450792401|FG002|Overall Study|Adverse Event|1|||
125317647|NCT00467740|450792402|FG003|Overall Study|Adverse Event|0|||
125317648|NCT00467740|450792403|FG004|Overall Study|Adverse Event|0|||
125317649|NCT00467740|450792399|FG000|Overall Study|Protocol Violation|0|||
125317650|NCT00467740|450792400|FG001|Overall Study|Protocol Violation|0|||
125317651|NCT00467740|450792401|FG002|Overall Study|Protocol Violation|1|||
125317652|NCT00467740|450792402|FG003|Overall Study|Protocol Violation|0|||
125317653|NCT00467740|450792403|FG004|Overall Study|Protocol Violation|0|||
125317654|NCT00467740|450792399|FG000|Overall Study|Lost to Follow-up|0|||
125317655|NCT00467740|450792400|FG001|Overall Study|Lost to Follow-up|1|||
125317656|NCT00467740|450792401|FG002|Overall Study|Lost to Follow-up|0|||
125317657|NCT00467740|450792402|FG003|Overall Study|Lost to Follow-up|0|||
125317658|NCT00467740|450792403|FG004|Overall Study|Lost to Follow-up|0|||
125317659|NCT00467740|450792399|FG000|Overall Study|Withdrawal by Subject|1|||
125317660|NCT00467740|450792400|FG001|Overall Study|Withdrawal by Subject|1|||
125317661|NCT00467740|450792401|FG002|Overall Study|Withdrawal by Subject|0|||
125317662|NCT00467740|450792402|FG003|Overall Study|Withdrawal by Subject|1|||
125317663|NCT00467740|450792403|FG004|Overall Study|Withdrawal by Subject|0|||
125317664|NCT00467740|450792399|FG000|Overall Study|Lack of Efficacy|0|||
125317665|NCT00467740|450792400|FG001|Overall Study|Lack of Efficacy|1|||
125317666|NCT00467740|450792401|FG002|Overall Study|Lack of Efficacy|0|||
125317667|NCT00467740|450792402|FG003|Overall Study|Lack of Efficacy|0|||
125317668|NCT00467740|450792403|FG004|Overall Study|Lack of Efficacy|0|||
125317669|NCT03535974|450792404|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
125317670|NCT03535974|450792405|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
125317671|NCT03535974|450792406|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
125317672|NCT03535974|450792404|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
125317673|NCT03535974|450792405|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
125317674|NCT03535974|450792406|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
125317675|NCT02678351|450792407|FG000|Overall Study|Withdrawal by Subject|1|||
125317676|NCT01919229|450792408|FG000|Overall Study|Subject/guardian decision|0|||
125317677|NCT01919229|450792409|FG001|Overall Study|Subject/guardian decision|0|||
125317678|NCT01919229|450792410|FG002|Overall Study|Subject/guardian decision|1|||
125317679|NCT04999839|450792419|FG000|Overall Study|Adverse Event|1|||
125317680|NCT04999839|450792420|FG001|Overall Study|Adverse Event|1|||
125317681|NCT04999839|450792421|FG002|Overall Study|Adverse Event|1|||
125317682|NCT04999839|450792422|FG003|Overall Study|Adverse Event|1|||
125317683|NCT04999839|450792423|FG004|Overall Study|Adverse Event|1|||
125317684|NCT04999839|450792419|FG000|Overall Study|Lost to Follow-up|2|||
125317685|NCT04999839|450792420|FG001|Overall Study|Lost to Follow-up|0|||
125317686|NCT04999839|450792421|FG002|Overall Study|Lost to Follow-up|2|||
125317687|NCT04999839|450792422|FG003|Overall Study|Lost to Follow-up|4|||
125317688|NCT04999839|450792423|FG004|Overall Study|Lost to Follow-up|1|||
125317689|NCT04999839|450792419|FG000|Overall Study|Withdrawal by Subject|6|||
125317690|NCT04999839|450792420|FG001|Overall Study|Withdrawal by Subject|5|||
124991611|NCT00372229|449596588|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
125317691|NCT04999839|450792421|FG002|Overall Study|Withdrawal by Subject|3|||
125317692|NCT04999839|450792422|FG003|Overall Study|Withdrawal by Subject|2|||
124991612|NCT00372229|449596589|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
125317693|NCT04999839|450792423|FG004|Overall Study|Withdrawal by Subject|2|||
125317694|NCT04999839|450792419|FG000|Overall Study|Lack of Efficacy|0|||
125317695|NCT04999839|450792420|FG001|Overall Study|Lack of Efficacy|1|||
125317696|NCT04999839|450792421|FG002|Overall Study|Lack of Efficacy|0|||
125317697|NCT04999839|450792422|FG003|Overall Study|Lack of Efficacy|0|||
125317698|NCT04999839|450792423|FG004|Overall Study|Lack of Efficacy|0|||
125317699|NCT04999839|450792419|FG000|Overall Study|Physician Decision|0|||
125317700|NCT04999839|450792420|FG001|Overall Study|Physician Decision|0|||
125317701|NCT04999839|450792421|FG002|Overall Study|Physician Decision|0|||
125317702|NCT04999839|450792422|FG003|Overall Study|Physician Decision|0|||
125317703|NCT04999839|450792423|FG004|Overall Study|Physician Decision|1|||
125317704|NCT04999839|450792419|FG000|Overall Study|Sponsor request|0|||
125317705|NCT04999839|450792420|FG001|Overall Study|Sponsor request|1|||
125317706|NCT04999839|450792421|FG002|Overall Study|Sponsor request|0|||
125317707|NCT04999839|450792422|FG003|Overall Study|Sponsor request|0|||
125317708|NCT04999839|450792423|FG004|Overall Study|Sponsor request|0|||
125317709|NCT04999839|450792419|FG000|Overall Study|Other|0|||
125317710|NCT04999839|450792420|FG001|Overall Study|Other|0|||
125317711|NCT04999839|450792421|FG002|Overall Study|Other|1|||
125317712|NCT04999839|450792422|FG003|Overall Study|Other|0|||
125317713|NCT04999839|450792423|FG004|Overall Study|Other|0|||
125317714|NCT00399516|450792424|FG000|Overall Study|Lost to Follow-up|2|||
125317715|NCT00982735|450792425|FG000|Overall Study|Lost to Follow-up|6|||
125317716|NCT00982735|450792425|FG000|Overall Study|Patient ineligible for trial|224|||
125317717|NCT00539981|450792435|FG000|Overall Study|Adverse events (AE)|3|||
125317718|NCT00539981|450792436|FG001|Overall Study|Adverse events (AE)|3|||
125317719|NCT00539981|450792435|FG000|Overall Study|Lost to Follow-up|260|||
125317720|NCT00539981|450792436|FG001|Overall Study|Lost to Follow-up|251|||
125317721|NCT00539981|450792435|FG000|Overall Study|Withdrew consent|22|||
125317722|NCT00539981|450792436|FG001|Overall Study|Withdrew consent|14|||
125317723|NCT00539981|450792435|FG000|Overall Study|Death|1|||
125317724|NCT00539981|450792436|FG001|Overall Study|Death|1|||
125317725|NCT00539981|450792435|FG000|Overall Study|Other reason-unspecified|9|||
125317726|NCT00539981|450792436|FG001|Overall Study|Other reason-unspecified|13|||
125317727|NCT02675907|450792437|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
125317728|NCT02675907|450792438|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
125317729|NCT02675907|450792437|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
125317730|NCT02675907|450792438|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
125317731|NCT02675907|450792437|FG000|Study Overall|Lack of Efficacy|1|||
125317732|NCT02675907|450792438|FG001|Study Overall|Lack of Efficacy|0|||
125317733|NCT02675907|450792437|FG000|Study Overall|Withdrawal by Subject|2|||
125317734|NCT02675907|450792438|FG001|Study Overall|Withdrawal by Subject|2|||
125317735|NCT02675907|450792437|FG000|Study Overall|Lost to Follow-up|0|||
125317736|NCT02675907|450792438|FG001|Study Overall|Lost to Follow-up|2|||
125317737|NCT01611792|450792439|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
125317738|NCT01611792|450792440|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
125317739|NCT01611792|450792439|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
125317740|NCT01611792|450792440|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
125317741|NCT02898454|450792443|FG000|Overall Study|Adverse Event|4|||
125317742|NCT02898454|450792444|FG001|Overall Study|Adverse Event|1|||
125317743|NCT02898454|450792445|FG002|Overall Study|Adverse Event|2|||
125317744|NCT02898454|450792443|FG000|Overall Study|Protocol Violation|1|||
125317745|NCT02898454|450792444|FG001|Overall Study|Protocol Violation|0|||
125317746|NCT02898454|450792445|FG002|Overall Study|Protocol Violation|1|||
125317747|NCT02898454|450792443|FG000|Overall Study|Lack of Efficacy|4|||
125317748|NCT02898454|450792444|FG001|Overall Study|Lack of Efficacy|1|||
125317749|NCT02898454|450792445|FG002|Overall Study|Lack of Efficacy|0|||
125317750|NCT02898454|450792443|FG000|Overall Study|Withdrawal by Subject|6|||
125317751|NCT02898454|450792444|FG001|Overall Study|Withdrawal by Subject|3|||
125317752|NCT02898454|450792445|FG002|Overall Study|Withdrawal by Subject|3|||
125317753|NCT02898454|450792443|FG000|Overall Study|Lost to Follow-up|1|||
125317754|NCT02898454|450792444|FG001|Overall Study|Lost to Follow-up|0|||
125317755|NCT02898454|450792445|FG002|Overall Study|Lost to Follow-up|0|||
125317756|NCT02898454|450792443|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
125317757|NCT02898454|450792444|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
125317758|NCT02898454|450792445|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
124991613|NCT00372229|449596588|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
124991614|NCT00372229|449596589|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
125317759|NCT01601535|450792446|FG000|Phase 1|Adverse Event|1|||
125317760|NCT01601535|450792447|FG001|Phase 1|Adverse Event|0|||
125317761|NCT01601535|450792448|FG002|Phase 1|Adverse Event|2|||
125317762|NCT01601535|450792449|FG003|Phase 1|Adverse Event|1|||
125317763|NCT01601535|450792450|FG004|Phase 1|Adverse Event|0|||
125317764|NCT01601535|450792451|FG005|Phase 1|Adverse Event|0|||
125317765|NCT01601535|450792446|FG000|Phase 1|Withdrawal by Subject|2|||
125317766|NCT01601535|450792447|FG001|Phase 1|Withdrawal by Subject|1|||
125317767|NCT01601535|450792448|FG002|Phase 1|Withdrawal by Subject|1|||
124872605|NCT01662063|449155673|FG000|Overall Study|Other|0|||
124991615|NCT00372229|449596588|FG000|Follow-Up Phase|Death|9|||
124991616|NCT00372229|449596589|FG001|Follow-Up Phase|Death|12|||
125317768|NCT01601535|450792449|FG003|Phase 1|Withdrawal by Subject|2|||
125317769|NCT01601535|450792450|FG004|Phase 1|Withdrawal by Subject|0|||
125317770|NCT01601535|450792451|FG005|Phase 1|Withdrawal by Subject|0|||
125317771|NCT01601535|450792446|FG000|Phase 1|Progressive Disease|2|||
125317772|NCT01601535|450792447|FG001|Phase 1|Progressive Disease|3|||
125317773|NCT01601535|450792448|FG002|Phase 1|Progressive Disease|2|||
125317774|NCT01601535|450792449|FG003|Phase 1|Progressive Disease|1|||
125317775|NCT01601535|450792450|FG004|Phase 1|Progressive Disease|0|||
125317776|NCT01601535|450792451|FG005|Phase 1|Progressive Disease|0|||
125317777|NCT01601535|450792446|FG000|Phase 1|Started Another Treatment|1|||
125317778|NCT01601535|450792447|FG001|Phase 1|Started Another Treatment|2|||
125317779|NCT01601535|450792448|FG002|Phase 1|Started Another Treatment|0|||
125317780|NCT01601535|450792449|FG003|Phase 1|Started Another Treatment|0|||
125317781|NCT01601535|450792450|FG004|Phase 1|Started Another Treatment|0|||
125317782|NCT01601535|450792451|FG005|Phase 1|Started Another Treatment|0|||
125317783|NCT01601535|450792446|FG000|Phase 2|Adverse Event|0|||
125317784|NCT01601535|450792447|FG001|Phase 2|Adverse Event|0|||
125317785|NCT01601535|450792448|FG002|Phase 2|Adverse Event|0|||
125317786|NCT01601535|450792449|FG003|Phase 2|Adverse Event|0|||
125317787|NCT01601535|450792450|FG004|Phase 2|Adverse Event|5|||
125317788|NCT01601535|450792451|FG005|Phase 2|Adverse Event|1|||
125317789|NCT01601535|450792446|FG000|Phase 2|Withdrawal by Subject|0|||
125317790|NCT01601535|450792447|FG001|Phase 2|Withdrawal by Subject|0|||
125317791|NCT01601535|450792448|FG002|Phase 2|Withdrawal by Subject|0|||
125317792|NCT01601535|450792449|FG003|Phase 2|Withdrawal by Subject|0|||
125317793|NCT01601535|450792450|FG004|Phase 2|Withdrawal by Subject|8|||
125317794|NCT01601535|450792451|FG005|Phase 2|Withdrawal by Subject|2|||
125317795|NCT01601535|450792446|FG000|Phase 2|Progressive Disease|0|||
125317796|NCT01601535|450792447|FG001|Phase 2|Progressive Disease|0|||
125317797|NCT01601535|450792448|FG002|Phase 2|Progressive Disease|0|||
125317798|NCT01601535|450792449|FG003|Phase 2|Progressive Disease|0|||
125317799|NCT01601535|450792450|FG004|Phase 2|Progressive Disease|5|||
125317800|NCT01601535|450792451|FG005|Phase 2|Progressive Disease|7|||
125317801|NCT01601535|450792446|FG000|Phase 2|Started Another Treatment|0|||
125317802|NCT01601535|450792447|FG001|Phase 2|Started Another Treatment|0|||
125317803|NCT01601535|450792448|FG002|Phase 2|Started Another Treatment|0|||
125317804|NCT01601535|450792449|FG003|Phase 2|Started Another Treatment|0|||
125317805|NCT01601535|450792450|FG004|Phase 2|Started Another Treatment|1|||
125317806|NCT01601535|450792451|FG005|Phase 2|Started Another Treatment|2|||
125317807|NCT03649074|450792452|FG000|Overall Study|Lost to Follow-up|2|||
125317808|NCT03649074|450792453|FG001|Overall Study|Lost to Follow-up|1|||
125317809|NCT03649074|450792452|FG000|Overall Study|Adverse Event|1|||
125317810|NCT03649074|450792453|FG001|Overall Study|Adverse Event|0|||
125317811|NCT03649074|450792452|FG000|Overall Study|Physician Decision|1|||
125317812|NCT03649074|450792453|FG001|Overall Study|Physician Decision|0|||
125317813|NCT03649074|450792452|FG000|Overall Study|Withdrawal by Subject|0|||
125317814|NCT03649074|450792453|FG001|Overall Study|Withdrawal by Subject|2|||
125317815|NCT03649074|450792452|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
125317816|NCT03649074|450792453|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
125317817|NCT03649074|450792452|FG000|Overall Study|Other|1|||
125317818|NCT03649074|450792453|FG001|Overall Study|Other|0|||
125317819|NCT00795704|450792454|FG000|Overall Study|Withdrawal by Subject|3|||
125317820|NCT00795704|450792455|FG001|Overall Study|Withdrawal by Subject|2|||
125317821|NCT00795704|450792454|FG000|Overall Study|Adverse Event|1|||
125317822|NCT00795704|450792455|FG001|Overall Study|Adverse Event|1|||
125317823|NCT03980730|450792456|FG000|Overall Study|Study Terminated by Sponsor|0|||
125317824|NCT03980730|450792457|FG001|Overall Study|Study Terminated by Sponsor|3|||
125317825|NCT03980730|450792456|FG000|Overall Study|Adverse Event|2|||
125317826|NCT03980730|450792457|FG001|Overall Study|Adverse Event|0|||
125317827|NCT03980730|450792456|FG000|Overall Study|Sponsor Request|0|||
125317828|NCT03980730|450792457|FG001|Overall Study|Sponsor Request|1|||
125317829|NCT00556894|450792458|FG000|Overall Study|Adverse Event|2|||
125317830|NCT00556894|450792459|FG001|Overall Study|Adverse Event|3|||
125317831|NCT00556894|450792460|FG002|Overall Study|Adverse Event|3|||
125317832|NCT00556894|450792458|FG000|Overall Study|Death|1|||
125317833|NCT00556894|450792459|FG001|Overall Study|Death|0|||
125317834|NCT00556894|450792460|FG002|Overall Study|Death|0|||
125317835|NCT00556894|450792458|FG000|Overall Study|regulatory decision in Bulgaria|10|||
125317836|NCT00556894|450792459|FG001|Overall Study|regulatory decision in Bulgaria|14|||
125317837|NCT00556894|450792460|FG002|Overall Study|regulatory decision in Bulgaria|13|||
125317838|NCT00556894|450792458|FG000|Overall Study|Change in therapy|2|||
124991617|NCT00372229|449596588|FG000|Follow-Up Phase|Administrative|1|||
124991618|NCT00372229|449596589|FG001|Follow-Up Phase|Administrative|0|||
125317839|NCT00556894|450792459|FG001|Overall Study|Change in therapy|1|||
125317840|NCT00556894|450792460|FG002|Overall Study|Change in therapy|2|||
125317841|NCT00556894|450792458|FG000|Overall Study|Withdrawal by Subject|1|||
125317842|NCT00556894|450792459|FG001|Overall Study|Withdrawal by Subject|1|||
125317843|NCT00556894|450792460|FG002|Overall Study|Withdrawal by Subject|1|||
125317844|NCT00880620|450792461|FG000|Overall Study|Adverse Event|4|||
125317845|NCT00880620|450792462|FG001|Overall Study|Adverse Event|5|||
125317846|NCT00880620|450792463|FG002|Overall Study|Adverse Event|15|||
125317847|NCT00880620|450792464|FG003|Overall Study|Adverse Event|15|||
125317848|NCT00880620|450792461|FG000|Overall Study|Death|0|||
125317849|NCT00880620|450792462|FG001|Overall Study|Death|0|||
125317850|NCT00880620|450792463|FG002|Overall Study|Death|1|||
125317851|NCT00880620|450792464|FG003|Overall Study|Death|0|||
125317852|NCT00880620|450792461|FG000|Overall Study|Lack of Efficacy|12|||
125317853|NCT00880620|450792462|FG001|Overall Study|Lack of Efficacy|4|||
125317854|NCT00880620|450792463|FG002|Overall Study|Lack of Efficacy|0|||
125317855|NCT00880620|450792464|FG003|Overall Study|Lack of Efficacy|1|||
125317856|NCT00880620|450792461|FG000|Overall Study|Lost to Follow-up|0|||
125317857|NCT00880620|450792462|FG001|Overall Study|Lost to Follow-up|1|||
125317858|NCT00880620|450792463|FG002|Overall Study|Lost to Follow-up|1|||
125317859|NCT00880620|450792464|FG003|Overall Study|Lost to Follow-up|0|||
125317860|NCT00880620|450792461|FG000|Overall Study|Protocol Violation|0|||
125317861|NCT00880620|450792462|FG001|Overall Study|Protocol Violation|1|||
125317862|NCT00880620|450792463|FG002|Overall Study|Protocol Violation|0|||
125317863|NCT00880620|450792464|FG003|Overall Study|Protocol Violation|2|||
125317864|NCT00880620|450792461|FG000|Overall Study|Withdrawal by Subject|4|||
125317865|NCT00880620|450792462|FG001|Overall Study|Withdrawal by Subject|3|||
125317866|NCT00880620|450792463|FG002|Overall Study|Withdrawal by Subject|1|||
125317867|NCT00880620|450792464|FG003|Overall Study|Withdrawal by Subject|3|||
125317868|NCT00880620|450792461|FG000|Overall Study|Noncompliance|0|||
125317869|NCT00880620|450792462|FG001|Overall Study|Noncompliance|0|||
125317870|NCT00880620|450792463|FG002|Overall Study|Noncompliance|1|||
125317871|NCT00880620|450792464|FG003|Overall Study|Noncompliance|1|||
125317872|NCT00880620|450792461|FG000|Overall Study|Other|1|||
125317873|NCT00880620|450792462|FG001|Overall Study|Other|1|||
125317874|NCT00880620|450792463|FG002|Overall Study|Other|2|||
125317875|NCT00880620|450792464|FG003|Overall Study|Other|2|||
125317876|NCT03883581|450792466|FG000|Overall Study|Withdrawal by Subject|4|||
125317877|NCT04612725|450792467|FG000|Overall Study|Adverse Event|1|||
125317878|NCT04612725|450792468|FG001|Overall Study|Adverse Event|3|||
125317879|NCT04612725|450792469|FG002|Overall Study|Adverse Event|1|||
125317880|NCT04612725|450792470|FG003|Overall Study|Adverse Event|0|||
125317881|NCT04612725|450792471|FG004|Overall Study|Adverse Event|1|||
125317882|NCT04612725|450792467|FG000|Overall Study|Lost to Follow-up|0|||
125317883|NCT04612725|450792468|FG001|Overall Study|Lost to Follow-up|1|||
125317884|NCT04612725|450792469|FG002|Overall Study|Lost to Follow-up|0|||
125317885|NCT04612725|450792470|FG003|Overall Study|Lost to Follow-up|0|||
125317886|NCT04612725|450792471|FG004|Overall Study|Lost to Follow-up|0|||
125317887|NCT04612725|450792467|FG000|Overall Study|Physician Decision|2|||
125317888|NCT04612725|450792468|FG001|Overall Study|Physician Decision|0|||
125317889|NCT04612725|450792469|FG002|Overall Study|Physician Decision|0|||
125317890|NCT04612725|450792470|FG003|Overall Study|Physician Decision|0|||
125317891|NCT04612725|450792471|FG004|Overall Study|Physician Decision|0|||
125317892|NCT04612725|450792467|FG000|Overall Study|Study terminated by sponsor|3|||
125317893|NCT04612725|450792468|FG001|Overall Study|Study terminated by sponsor|1|||
125317894|NCT04612725|450792469|FG002|Overall Study|Study terminated by sponsor|2|||
125317895|NCT04612725|450792470|FG003|Overall Study|Study terminated by sponsor|4|||
125317896|NCT04612725|450792471|FG004|Overall Study|Study terminated by sponsor|5|||
125317897|NCT04612725|450792467|FG000|Overall Study|Withdrawal by Subject|8|||
125317898|NCT04612725|450792468|FG001|Overall Study|Withdrawal by Subject|3|||
125317899|NCT04612725|450792469|FG002|Overall Study|Withdrawal by Subject|5|||
125317900|NCT04612725|450792470|FG003|Overall Study|Withdrawal by Subject|1|||
125317901|NCT04612725|450792471|FG004|Overall Study|Withdrawal by Subject|9|||
125317902|NCT04612725|450792467|FG000|Overall Study|Other|0|||
125317903|NCT04612725|450792468|FG001|Overall Study|Other|0|||
125317904|NCT04612725|450792469|FG002|Overall Study|Other|0|||
125317905|NCT04612725|450792470|FG003|Overall Study|Other|0|||
125317906|NCT04612725|450792471|FG004|Overall Study|Other|1|||
125317907|NCT02354235|450792472|FG000|Overall Study|Adverse Event|2|||
125317908|NCT02354235|450792473|FG001|Overall Study|Adverse Event|2|||
125317909|NCT02354235|450792472|FG000|Overall Study|Physician Decision|0|||
125317910|NCT02354235|450792473|FG001|Overall Study|Physician Decision|1|||
125317911|NCT02354235|450792472|FG000|Overall Study|Withdrawal by Subject|1|||
125317912|NCT02354235|450792473|FG001|Overall Study|Withdrawal by Subject|3|||
125317913|NCT02354235|450792472|FG000|Overall Study|Conflict with the stopping criteria|0|||
125317914|NCT02354235|450792473|FG001|Overall Study|Conflict with the stopping criteria|1|||
125317915|NCT04750642|450792476|FG000|Overall Study|Adverse Event|1|||
125317916|NCT04750642|450792477|FG001|Overall Study|Adverse Event|0|||
125317917|NCT04750642|450792476|FG000|Overall Study|Withdrawal by Subject|0|||
125317918|NCT04750642|450792477|FG001|Overall Study|Withdrawal by Subject|1|||
125317919|NCT04750642|450792476|FG000|Overall Study|Protocol Violation|0|||
125317920|NCT04750642|450792477|FG001|Overall Study|Protocol Violation|1|||
125317921|NCT02926638|450792478|FG000|Overall Study|Progression|2|||
125317922|NCT02926638|450792479|FG001|Overall Study|Progression|5|||
125317923|NCT02926638|450792478|FG000|Overall Study|Ineligible|1|||
125317924|NCT02926638|450792479|FG001|Overall Study|Ineligible|0|||
125317925|NCT02926638|450792478|FG000|Overall Study|Not protocol specified|1|||
125317926|NCT02926638|450792479|FG001|Overall Study|Not protocol specified|0|||
125317927|NCT00644423|450793888|FG000|Overall Study|Lost to Follow-up|1|||
125317928|NCT00644423|450793889|FG001|Overall Study|Lost to Follow-up|1|||
125317929|NCT02426580|450793890|FG000|Overall Study|Death|2|||
125317930|NCT02426580|450793891|FG001|Overall Study|Death|2|||
124991619|NCT00372229|449596588|FG000|Follow-Up Phase|Reason not specified|2|||
124991620|NCT00372229|449596589|FG001|Follow-Up Phase|Reason not specified|3|||
124991621|NCT00372229|449596588|FG000|Follow-Up Phase|Lost to Follow-up|12|||
124991622|NCT00372229|449596589|FG001|Follow-Up Phase|Lost to Follow-up|10|||
124991623|NCT00262951|449596595|FG000|Overall Study|Progressive disease/relapse|3|||
124991624|NCT00262951|449596595|FG000|Overall Study|Adverse Event|7|||
124991625|NCT00262951|449596595|FG000|Overall Study|Death|1|||
125317931|NCT02426580|450793890|FG000|Overall Study|Lost to Follow-up|0|||
125317932|NCT02426580|450793891|FG001|Overall Study|Lost to Follow-up|9|||
125317933|NCT02426580|450793890|FG000|Overall Study|transfer to hemodialysis|5|||
125317934|NCT02426580|450793891|FG001|Overall Study|transfer to hemodialysis|5|||
125317935|NCT02426580|450793890|FG000|Overall Study|Kidney transplant|3|||
125317936|NCT02426580|450793891|FG001|Overall Study|Kidney transplant|0|||
125317937|NCT02426580|450793890|FG000|Overall Study|Allergic to egg white|1|||
125317938|NCT02426580|450793891|FG001|Overall Study|Allergic to egg white|0|||
125317939|NCT00445549|450793892|FG000|Overall Study|progressive disease|12|||
125317940|NCT00768989|450793895|FG000|Prior to Week 24|Withdrawal by Subject|1|||
125317941|NCT00768989|450793896|FG001|Prior to Week 24|Withdrawal by Subject|0|||
125317942|NCT00768989|450793895|FG000|Prior to Week 24|Adverse Event|3|||
125317943|NCT00768989|450793896|FG001|Prior to Week 24|Adverse Event|0|||
125317944|NCT00768989|450793895|FG000|Prior to Week 24|Lost to Follow-up|0|||
125317945|NCT00768989|450793896|FG001|Prior to Week 24|Lost to Follow-up|1|||
125317946|NCT00768989|450793895|FG000|Prior to Week 24|Protocol Violation|0|||
125317947|NCT00768989|450793896|FG001|Prior to Week 24|Protocol Violation|2|||
125317948|NCT00768989|450793895|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
125317949|NCT00768989|450793896|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
125317950|NCT00768989|450793895|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
125317951|NCT00768989|450793896|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
125317952|NCT00768989|450793895|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
125317953|NCT00768989|450793896|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
125317954|NCT00768989|450793895|FG000|On or After Week 36|Lack of Efficacy|1|||
125317955|NCT00768989|450793896|FG001|On or After Week 36|Lack of Efficacy|0|||
125317956|NCT00768989|450793895|FG000|On or After Week 36|Adverse Event|0|||
125317957|NCT00768989|450793896|FG001|On or After Week 36|Adverse Event|1|||
125317958|NCT00768989|450793895|FG000|On or After Week 36|Lost to Follow-up|1|||
125317959|NCT00768989|450793896|FG001|On or After Week 36|Lost to Follow-up|0|||
125317960|NCT00768989|450793895|FG000|On or After Week 36|Poor Compliance|1|||
125317961|NCT00768989|450793896|FG001|On or After Week 36|Poor Compliance|0|||
125317962|NCT00768989|450793895|FG000|On or After Week 36|Protocol Violation|1|||
125317963|NCT00768989|450793896|FG001|On or After Week 36|Protocol Violation|0|||
125317964|NCT00768989|450793895|FG000|On or After Week 36|Did not attend termination visit|2|||
125317965|NCT00768989|450793896|FG001|On or After Week 36|Did not attend termination visit|0|||
125317966|NCT00768989|450793895|FG000|On or After Week 36|Sponsor Termination|45|||
125317967|NCT00768989|450793896|FG001|On or After Week 36|Sponsor Termination|26|||
125317968|NCT00718510|450793905|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
125317969|NCT00718510|450793906|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
125317970|NCT00718510|450793905|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
125317971|NCT00718510|450793906|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
125317972|NCT00844376|450793912|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
125317973|NCT00844376|450793913|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
125317974|NCT01011673|450793914|FG000|Randomized|Secondary headache|2|||
125317975|NCT01011673|450793915|FG001|Randomized|Secondary headache|1|||
125317976|NCT01011673|450793914|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
125317977|NCT01011673|450793915|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
125317978|NCT00549640|450793916|FG000|Overall Study|Withdrawal by Subject|6|||
125317979|NCT00549640|450793917|FG001|Overall Study|Withdrawal by Subject|12|||
125317980|NCT00549640|450793916|FG000|Overall Study|Adverse Event|5|||
125317981|NCT00549640|450793917|FG001|Overall Study|Adverse Event|0|||
125317982|NCT00549640|450793916|FG000|Overall Study|Lost to Follow-up|7|||
125317983|NCT00549640|450793917|FG001|Overall Study|Lost to Follow-up|4|||
125317984|NCT00660192|450793918|FG000|Overall Study|Lost to Follow-up|2|||
125317985|NCT00660192|450793919|FG001|Overall Study|Lost to Follow-up|3|||
125317986|NCT02734693|450793920|FG000|Overall Study|Adverse Event|1|||
125317987|NCT02734693|450793921|FG001|Overall Study|Adverse Event|3|||
125317988|NCT02734693|450793922|FG002|Overall Study|Adverse Event|3|||
125317989|NCT02734693|450793920|FG000|Overall Study|Lack of Efficacy|1|||
125317990|NCT02734693|450793921|FG001|Overall Study|Lack of Efficacy|0|||
125317991|NCT02734693|450793922|FG002|Overall Study|Lack of Efficacy|0|||
125317992|NCT02734693|450793920|FG000|Overall Study|Lost to Follow-up|2|||
125317993|NCT02734693|450793921|FG001|Overall Study|Lost to Follow-up|0|||
125317994|NCT02734693|450793922|FG002|Overall Study|Lost to Follow-up|0|||
125317995|NCT02734693|450793920|FG000|Overall Study|Protocol Violation|1|||
124991626|NCT00262951|449596595|FG000|Overall Study|Withdrawal by Subject|1|||
125317996|NCT02734693|450793921|FG001|Overall Study|Protocol Violation|0|||
125317997|NCT02734693|450793922|FG002|Overall Study|Protocol Violation|0|||
125317998|NCT02734693|450793920|FG000|Overall Study|Withdrawal by Subject|1|||
125317999|NCT02734693|450793921|FG001|Overall Study|Withdrawal by Subject|0|||
125318000|NCT02734693|450793922|FG002|Overall Study|Withdrawal by Subject|0|||
125318001|NCT03740048|450793924|FG000|Overall Study|Withdrawal by Subject|1|||
125318002|NCT03740048|450793925|FG001|Overall Study|Withdrawal by Subject|1|||
125318003|NCT03740048|450793924|FG000|Overall Study|Death|1|||
125318004|NCT03740048|450793925|FG001|Overall Study|Death|6|||
125318005|NCT03740048|450793924|FG000|Overall Study|Switched to thrice-weekly HD|2|||
125318006|NCT03740048|450793925|FG001|Overall Study|Switched to thrice-weekly HD|0|||
125318007|NCT03740048|450793924|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
125318008|NCT03740048|450793925|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
125318009|NCT03740048|450793924|FG000|Overall Study|Lost to Follow-up|0|||
125318010|NCT03740048|450793925|FG001|Overall Study|Lost to Follow-up|1|||
125318011|NCT03740048|450793924|FG000|Overall Study|Non-compliance with HD|0|||
125318012|NCT03740048|450793925|FG001|Overall Study|Non-compliance with HD|1|||
125318013|NCT01476722|450793926|FG000|Overall Study|Adverse Event|1|||
125318014|NCT03261336|450793927|FG000|Overall Study|Adverse Event|1|||
125318015|NCT01069484|450793929|FG000|Overall Study|Death-in-near-family|1|||
125318016|NCT01069484|450793930|FG001|Overall Study|Death-in-near-family|0|||
125318017|NCT01069484|450793929|FG000|Overall Study|No specific reason|8|||
125318018|NCT01069484|450793930|FG001|Overall Study|No specific reason|2|||
125318019|NCT01069484|450793929|FG000|Overall Study|Illness mother or child|3|||
125318020|NCT01069484|450793930|FG001|Overall Study|Illness mother or child|1|||
125318021|NCT00292942|450793932|FG000|Overall Study|Withdrawal by Subject|0|||
125318022|NCT00292942|450793933|FG001|Overall Study|Withdrawal by Subject|0|||
125318023|NCT00292942|450793934|FG002|Overall Study|Withdrawal by Subject|1|||
125318024|NCT00292942|450793935|FG003|Overall Study|Withdrawal by Subject|0|||
125318025|NCT00292942|450793932|FG000|Overall Study|Adverse Event|0|||
125318026|NCT00292942|450793933|FG001|Overall Study|Adverse Event|0|||
125318027|NCT00292942|450793934|FG002|Overall Study|Adverse Event|0|||
125318028|NCT00292942|450793935|FG003|Overall Study|Adverse Event|1|||
125318029|NCT00644358|450793936|FG000|Overall Study|Adverse Event|124|||
125318030|NCT00644358|450793936|FG000|Overall Study|Lost to Follow-up|105|||
125318031|NCT00644358|450793936|FG000|Overall Study|Consent Withdrawal|64|||
125318032|NCT00644358|450793936|FG000|Overall Study|Lack of Effectiveness|39|||
125318033|NCT00644358|450793936|FG000|Overall Study|Protocol Violation|5|||
125318034|NCT00644358|450793936|FG000|Overall Study|Noncompliance|14|||
125318035|NCT00644358|450793936|FG000|Overall Study|Other Unspecified|11|||
125318036|NCT00651924|450793943|FG000|Overall Study|Withdrawal by PI|0|||
125318037|NCT00651924|450793944|FG001|Overall Study|Withdrawal by PI|2|||
125318038|NCT00651924|450793943|FG000|Overall Study|Withdrawal by Subject|0|||
125318039|NCT00651924|450793944|FG001|Overall Study|Withdrawal by Subject|5|||
125318040|NCT00758771|450793945|FG000|Overall Study|Withdrawal by Subject|1|||
125318041|NCT00758771|450793946|FG001|Overall Study|Withdrawal by Subject|1|||
125318042|NCT00758771|450793945|FG000|Overall Study|Did not meet eligibility criteria|2|||
125318043|NCT00758771|450793946|FG001|Overall Study|Did not meet eligibility criteria|4|||
125318044|NCT00960063|450793947|FG000|Overall Study|Adverse Event|1|||
125318045|NCT00960063|450793948|FG001|Overall Study|Adverse Event|0|||
125318046|NCT00960063|450793949|FG002|Overall Study|Adverse Event|0|||
125318047|NCT00960063|450793947|FG000|Overall Study|Progression of Disease|0|||
125318048|NCT00960063|450793948|FG001|Overall Study|Progression of Disease|0|||
125318049|NCT00960063|450793949|FG002|Overall Study|Progression of Disease|3|||
125318050|NCT00771914|450793950|FG000|Overall Study|Physician Decision|0|||
125318051|NCT00771914|450793951|FG001|Overall Study|Physician Decision|0|||
125318052|NCT00771914|450793952|FG002|Overall Study|Physician Decision|0|||
125318053|NCT00771914|450793953|FG003|Overall Study|Physician Decision|1|||
125318054|NCT00771914|450793950|FG000|Overall Study|Lost to Follow-up|0|||
125318055|NCT00771914|450793951|FG001|Overall Study|Lost to Follow-up|0|||
125318056|NCT00771914|450793952|FG002|Overall Study|Lost to Follow-up|0|||
125318057|NCT00771914|450793953|FG003|Overall Study|Lost to Follow-up|1|||
125318058|NCT02978417|450793957|FG000|Overall Study|Lost to Follow-up|2|||
125318059|NCT02978417|450793958|FG001|Overall Study|Lost to Follow-up|2|||
125318060|NCT05083351|450793963|FG000|Overall Study|Adverse Event|3|||
125318061|NCT05083351|450793963|FG000|Overall Study|Did not meet data inclusion criteria|8|||
125318062|NCT05083351|450793963|FG000|Overall Study|Did not meet eligibility criteria|19|||
125318063|NCT05083351|450793963|FG000|Overall Study|Study Staff Decision|19|||
125318064|NCT01759420|450793969|FG000|Overall Study|Screen failure|5|||
125318065|NCT01759420|450793969|FG000|Overall Study|Inaccurate EKG machine readings|1|||
125318066|NCT01129622|450793972|FG000|Overall Study|Withdrawal by Subject|2|||
125318067|NCT00960375|450793975|FG000|Overall Study|Lost to Follow-up|20|||
125318068|NCT00960375|450793976|FG001|Overall Study|Lost to Follow-up|22|||
125318069|NCT00591006|450793977|FG000|Overall Study|Withdrawal by Subject|0|||
124991627|NCT00262951|449596595|FG000|Overall Study|Alternative treatment|3|||
125318070|NCT00591006|450793978|FG001|Overall Study|Withdrawal by Subject|0|||
125318071|NCT00591006|450793979|FG002|Overall Study|Withdrawal by Subject|0|||
125318072|NCT00591006|450793980|FG003|Overall Study|Withdrawal by Subject|0|||
125318073|NCT00591006|450793981|FG004|Overall Study|Withdrawal by Subject|0|||
125318074|NCT00591006|450793982|FG005|Overall Study|Withdrawal by Subject|0|||
125318075|NCT00591006|450793983|FG006|Overall Study|Withdrawal by Subject|0|||
125318076|NCT00591006|450793984|FG007|Overall Study|Withdrawal by Subject|0|||
125318077|NCT00591006|450793985|FG008|Overall Study|Withdrawal by Subject|0|||
125318078|NCT00591006|450793986|FG009|Overall Study|Withdrawal by Subject|0|||
125318079|NCT00591006|450793987|FG010|Overall Study|Withdrawal by Subject|0|||
125318080|NCT00591006|450793988|FG011|Overall Study|Withdrawal by Subject|0|||
125318081|NCT00591006|450793989|FG012|Overall Study|Withdrawal by Subject|0|||
125318082|NCT00591006|450793990|FG013|Overall Study|Withdrawal by Subject|0|||
125318083|NCT00591006|450793991|FG014|Overall Study|Withdrawal by Subject|0|||
125318084|NCT00591006|450793992|FG015|Overall Study|Withdrawal by Subject|1|||
125318085|NCT00591006|450793993|FG016|Overall Study|Withdrawal by Subject|0|||
125318086|NCT00591006|450793994|FG017|Overall Study|Withdrawal by Subject|0|||
125318087|NCT00591006|450793995|FG018|Overall Study|Withdrawal by Subject|0|||
125318088|NCT00591006|450793996|FG019|Overall Study|Withdrawal by Subject|0|||
125318089|NCT00591006|450793997|FG020|Overall Study|Withdrawal by Subject|0|||
125318090|NCT00591006|450793998|FG021|Overall Study|Withdrawal by Subject|0|||
125318091|NCT00591006|450793999|FG022|Overall Study|Withdrawal by Subject|0|||
125318092|NCT00591006|450794000|FG023|Overall Study|Withdrawal by Subject|1|||
125318093|NCT00591006|450793977|FG000|Overall Study|Adverse Event|0|||
125318094|NCT00591006|450793978|FG001|Overall Study|Adverse Event|0|||
125318095|NCT00591006|450793979|FG002|Overall Study|Adverse Event|0|||
125318096|NCT00591006|450793980|FG003|Overall Study|Adverse Event|0|||
125318097|NCT00591006|450793981|FG004|Overall Study|Adverse Event|0|||
125318098|NCT00591006|450793982|FG005|Overall Study|Adverse Event|0|||
125318099|NCT00591006|450793983|FG006|Overall Study|Adverse Event|0|||
125318100|NCT00591006|450793984|FG007|Overall Study|Adverse Event|0|||
125318101|NCT00591006|450793985|FG008|Overall Study|Adverse Event|0|||
125318102|NCT00591006|450793986|FG009|Overall Study|Adverse Event|0|||
125318103|NCT00591006|450793987|FG010|Overall Study|Adverse Event|0|||
125318104|NCT00591006|450793988|FG011|Overall Study|Adverse Event|0|||
125318105|NCT00591006|450793989|FG012|Overall Study|Adverse Event|0|||
125318106|NCT00591006|450793990|FG013|Overall Study|Adverse Event|0|||
125318107|NCT00591006|450793991|FG014|Overall Study|Adverse Event|0|||
125318108|NCT00591006|450793992|FG015|Overall Study|Adverse Event|0|||
125318109|NCT00591006|450793993|FG016|Overall Study|Adverse Event|0|||
125318110|NCT00591006|450793994|FG017|Overall Study|Adverse Event|0|||
125318111|NCT00591006|450793995|FG018|Overall Study|Adverse Event|0|||
125318112|NCT00591006|450793996|FG019|Overall Study|Adverse Event|0|||
125318113|NCT00591006|450793997|FG020|Overall Study|Adverse Event|0|||
125318114|NCT00591006|450793998|FG021|Overall Study|Adverse Event|0|||
125318115|NCT00591006|450793999|FG022|Overall Study|Adverse Event|1|||
125318116|NCT00591006|450794000|FG023|Overall Study|Adverse Event|0|||
125318117|NCT00689390|450794001|FG000|Overall Study|Adverse Event|19|||
125318118|NCT00689390|450794002|FG001|Overall Study|Adverse Event|0|||
125318119|NCT00689390|450794001|FG000|Overall Study|Lost to Follow-up|179|||
125318120|NCT00689390|450794002|FG001|Overall Study|Lost to Follow-up|7|||
125318121|NCT00689390|450794001|FG000|Overall Study|Withdrawal by Subject|117|||
125318122|NCT00689390|450794002|FG001|Overall Study|Withdrawal by Subject|3|||
125318123|NCT00689390|450794001|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
125318124|NCT00689390|450794002|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
125318125|NCT00689390|450794001|FG000|Overall Study|Non-Compliance With Protocol|21|||
124991628|NCT00262951|449596595|FG000|Overall Study|Off treatment for other disease|1|||
124991629|NCT01577745|449596596|FG000|Overall Study|Withdrawal by Subject|0|||
124991630|NCT01577745|449596597|FG001|Overall Study|Withdrawal by Subject|1|||
124991631|NCT01577745|449596598|FG002|Overall Study|Withdrawal by Subject|0|||
124991632|NCT01577745|449596599|FG003|Overall Study|Withdrawal by Subject|3|||
124991633|NCT01577745|449596600|FG004|Overall Study|Withdrawal by Subject|2|||
124991634|NCT01577745|449596601|FG005|Overall Study|Withdrawal by Subject|0|||
124991635|NCT01577745|449596596|FG000|Overall Study|Death|3|||
124991636|NCT01577745|449596597|FG001|Overall Study|Death|2|||
124991637|NCT01577745|449596598|FG002|Overall Study|Death|2|||
124991638|NCT01577745|449596599|FG003|Overall Study|Death|1|||
124991639|NCT01577745|449596600|FG004|Overall Study|Death|1|||
124991640|NCT01577745|449596601|FG005|Overall Study|Death|3|||
124991641|NCT01577745|449596596|FG000|Overall Study|Physician Decision|0|||
124991642|NCT01577745|449596597|FG001|Overall Study|Physician Decision|0|||
124991643|NCT01577745|449596598|FG002|Overall Study|Physician Decision|0|||
124991644|NCT01577745|449596599|FG003|Overall Study|Physician Decision|1|||
124991645|NCT01577745|449596600|FG004|Overall Study|Physician Decision|1|||
124991646|NCT01577745|449596601|FG005|Overall Study|Physician Decision|0|||
124991647|NCT01577745|449596596|FG000|Overall Study|Lost to Follow-up|0|||
124991648|NCT01577745|449596597|FG001|Overall Study|Lost to Follow-up|0|||
124991649|NCT01577745|449596598|FG002|Overall Study|Lost to Follow-up|0|||
124991650|NCT01577745|449596599|FG003|Overall Study|Lost to Follow-up|0|||
124991651|NCT01577745|449596600|FG004|Overall Study|Lost to Follow-up|0|||
125318126|NCT00689390|450794002|FG001|Overall Study|Non-Compliance With Protocol|0|||
124991652|NCT01577745|449596601|FG005|Overall Study|Lost to Follow-up|1|||
124991653|NCT01577745|449596596|FG000|Overall Study|Alternative Therapy|0|||
124991654|NCT01577745|449596597|FG001|Overall Study|Alternative Therapy|0|||
124991655|NCT01577745|449596598|FG002|Overall Study|Alternative Therapy|0|||
124991656|NCT01577745|449596599|FG003|Overall Study|Alternative Therapy|1|||
124991657|NCT01577745|449596600|FG004|Overall Study|Alternative Therapy|1|||
124991658|NCT01577745|449596601|FG005|Overall Study|Alternative Therapy|0|||
124991659|NCT01136772|449596602|FG000|Overall Study|Adverse Event|15|||
124991660|NCT01136772|449596603|FG001|Overall Study|Adverse Event|14|||
124991661|NCT01136772|449596602|FG000|Overall Study|Lack of Efficacy|42|||
124991662|NCT01136772|449596603|FG001|Overall Study|Lack of Efficacy|39|||
124991663|NCT01136772|449596602|FG000|Overall Study|Administrative|14|||
124991664|NCT01136772|449596603|FG001|Overall Study|Administrative|12|||
124991665|NCT01136772|449596602|FG000|Overall Study|Withdrawal by Subject|33|||
124991666|NCT01136772|449596603|FG001|Overall Study|Withdrawal by Subject|36|||
124991667|NCT01136772|449596602|FG000|Overall Study|Did not receive injection|10|||
124991668|NCT01136772|449596603|FG001|Overall Study|Did not receive injection|7|||
124991669|NCT01136772|449596602|FG000|Overall Study|Did not follow up after first injection|2|||
124991670|NCT01136772|449596603|FG001|Overall Study|Did not follow up after first injection|2|||
124991671|NCT01602562|449596609|FG000|Overall Study|Adverse Event|3|||
124991672|NCT01602562|449596610|FG001|Overall Study|Adverse Event|1|||
124991673|NCT01602562|449596609|FG000|Overall Study|Physician Decision|1|||
124991674|NCT01602562|449596610|FG001|Overall Study|Physician Decision|1|||
124991675|NCT01602562|449596609|FG000|Overall Study|Withdrawal by Subject|1|||
124991676|NCT01602562|449596610|FG001|Overall Study|Withdrawal by Subject|1|||
124991677|NCT03881553|449596611|FG000|Overall Study|Discharged prior to participation|1|||
124991678|NCT03881553|449596612|FG001|Overall Study|Discharged prior to participation|1|||
124991679|NCT03881553|449596613|FG002|Overall Study|Discharged prior to participation|0|||
124991680|NCT03881553|449596611|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
124991681|NCT03881553|449596612|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
124991682|NCT03881553|449596613|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
124991683|NCT01959516|449596614|FG000|Epoch 1|Adverse Event|4|||
124991684|NCT01959516|449596615|FG001|Epoch 1|Adverse Event|1|||
124991685|NCT01959516|449596614|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
124991686|NCT01959516|449596615|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
124991687|NCT01959516|449596614|FG000|Epoch 1|Subject withdrew consent|3|||
124991688|NCT01959516|449596615|FG001|Epoch 1|Subject withdrew consent|2|||
124991689|NCT01959516|449596614|FG000|Epoch 1|Administrative problems|1|||
124991690|NCT01959516|449596615|FG001|Epoch 1|Administrative problems|0|||
124991691|NCT01959516|449596614|FG000|Epoch 1|Use of prohibited treatment|1|||
124991692|NCT01959516|449596615|FG001|Epoch 1|Use of prohibited treatment|0|||
124991693|NCT01959516|449596614|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
124991694|NCT01959516|449596615|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
124991695|NCT01959516|449596614|FG000|Epoch 1|Protocol deviation|0|||
124991696|NCT01959516|449596615|FG001|Epoch 1|Protocol deviation|1|||
124991697|NCT01959516|449596614|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
124991698|NCT01959516|449596615|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
124991699|NCT01959516|449596614|FG000|Epoch 2|Subject withdrew consent|1|||
124991700|NCT01959516|449596615|FG001|Epoch 2|Subject withdrew consent|0|||
124991701|NCT01959516|449596614|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
124991702|NCT01959516|449596615|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
124991703|NCT01477333|449596616|FG000|Overall Study|Adverse Event|1|||
124991704|NCT01477333|449596616|FG000|Overall Study|Withdrawal by Subject|1|||
124991705|NCT01477333|449596616|FG000|Overall Study|Clinical Deterioration|1|||
124991706|NCT03801915|449596621|FG000|Overall Study|Screen failure|0|||
124991707|NCT03801915|449596622|FG001|Overall Study|Screen failure|0|||
124991708|NCT03801915|449596623|FG002|Overall Study|Screen failure|1|||
124991709|NCT03801915|449596621|FG000|Overall Study|Ineligible|1|||
124991710|NCT03801915|449596622|FG001|Overall Study|Ineligible|0|||
124991711|NCT03801915|449596623|FG002|Overall Study|Ineligible|0|||
124991712|NCT03801915|449596621|FG000|Overall Study|Physician Decision|2|||
124991713|NCT03801915|449596622|FG001|Overall Study|Physician Decision|1|||
124991714|NCT03801915|449596623|FG002|Overall Study|Physician Decision|0|||
124991715|NCT02308020|449596626|FG000|Overall Study|Lost to Follow-up|1|||
124991716|NCT02308020|449596627|FG001|Overall Study|Lost to Follow-up|7|||
124991717|NCT02308020|449596628|FG002|Overall Study|Lost to Follow-up|0|||
124991718|NCT02308020|449596629|FG003|Overall Study|Lost to Follow-up|0|||
124991719|NCT02308020|449596630|FG004|Overall Study|Lost to Follow-up|1|||
124991720|NCT02308020|449596631|FG005|Overall Study|Lost to Follow-up|2|||
124991721|NCT02308020|449596626|FG000|Overall Study|Sponsor Decision|0|||
124991722|NCT02308020|449596627|FG001|Overall Study|Sponsor Decision|8|||
124991723|NCT02308020|449596628|FG002|Overall Study|Sponsor Decision|0|||
124991724|NCT02308020|449596629|FG003|Overall Study|Sponsor Decision|2|||
124991725|NCT02308020|449596630|FG004|Overall Study|Sponsor Decision|2|||
124991726|NCT02308020|449596631|FG005|Overall Study|Sponsor Decision|1|||
124991727|NCT02308020|449596626|FG000|Overall Study|Withdrawal by Subject|3|||
124991728|NCT02308020|449596627|FG001|Overall Study|Withdrawal by Subject|5|||
124991729|NCT02308020|449596628|FG002|Overall Study|Withdrawal by Subject|3|||
124991730|NCT02308020|449596629|FG003|Overall Study|Withdrawal by Subject|2|||
124991731|NCT02308020|449596630|FG004|Overall Study|Withdrawal by Subject|1|||
124991732|NCT02308020|449596631|FG005|Overall Study|Withdrawal by Subject|2|||
124991733|NCT01211288|449596632|FG000|Overall Study|Lost to Follow-up|1|||
124991734|NCT01211288|449596633|FG001|Overall Study|Lost to Follow-up|1|||
124991735|NCT04217590|449596634|FG000|Overall Study|Other|1|||
124991736|NCT04217590|449596635|FG001|Overall Study|Other|1|||
124991737|NCT04217590|449596634|FG000|Overall Study|Withdrawal by Subject|3|||
124991738|NCT04217590|449596635|FG001|Overall Study|Withdrawal by Subject|1|||
124991739|NCT04217590|449596634|FG000|Overall Study|Death|0|||
124991740|NCT04217590|449596635|FG001|Overall Study|Death|1|||
124991741|NCT02003573|449596647|FG000|Overall Study|Progressive disease|2|||
124991742|NCT02003573|449596648|FG001|Overall Study|Progressive disease|0|||
124991743|NCT02003573|449596649|FG002|Overall Study|Progressive disease|1|||
124991744|NCT02003573|449596647|FG000|Overall Study|Other Adverse event|0|||
124991745|NCT02003573|449596648|FG001|Overall Study|Other Adverse event|1|||
124991746|NCT02003573|449596649|FG002|Overall Study|Other Adverse event|1|||
124991747|NCT02003573|449596647|FG000|Overall Study|Refuse to take trial medication|0|||
124991748|NCT02003573|449596648|FG001|Overall Study|Refuse to take trial medication|1|||
124991749|NCT02003573|449596649|FG002|Overall Study|Refuse to take trial medication|1|||
124991750|NCT02003573|449596647|FG000|Overall Study|Other than specified|1|||
124991751|NCT02003573|449596648|FG001|Overall Study|Other than specified|2|||
124991752|NCT02003573|449596649|FG002|Overall Study|Other than specified|3|||
124991753|NCT01242800|449596654|FG000|Overall Study|Patient refusal|0|||
124991754|NCT01242800|449596655|FG001|Overall Study|Patient refusal|10|||
124991755|NCT01242800|449596654|FG000|Overall Study|Physician Decision|0|||
124991756|NCT01242800|449596655|FG001|Overall Study|Physician Decision|1|||
124991757|NCT01242800|449596654|FG000|Overall Study|Disease progression|0|||
124991758|NCT01242800|449596655|FG001|Overall Study|Disease progression|3|||
124991759|NCT01242800|449596654|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
124991760|NCT01242800|449596655|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
124991761|NCT01242800|449596654|FG000|Overall Study|Reasons not reported|0|||
124991762|NCT01242800|449596655|FG001|Overall Study|Reasons not reported|4|||
124991763|NCT00953745|449596656|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
124991764|NCT00953745|449596657|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
124991765|NCT00953745|449596656|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
124991766|NCT00953745|449596657|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
124991767|NCT00953745|449596656|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
124991768|NCT00953745|449596657|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
124991769|NCT00953745|449596656|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
124991770|NCT00953745|449596657|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
124991771|NCT00953745|449596656|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
124991772|NCT00953745|449596657|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
124991773|NCT00953745|449596656|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
124991774|NCT00953745|449596657|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
124991775|NCT01395888|449596660|FG000|2-week Run-in Period|Adverse Event|2|||
124991776|NCT01395888|449596661|FG001|2-week Run-in Period|Adverse Event|0|||
124991777|NCT01395888|449596662|FG002|2-week Run-in Period|Adverse Event|0|||
124991778|NCT01395888|449596660|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
124991779|NCT01395888|449596661|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
124991780|NCT01395888|449596662|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
124991781|NCT01395888|449596660|FG000|2-week Run-in Period|Lost to Follow-up|1|||
124991782|NCT01395888|449596661|FG001|2-week Run-in Period|Lost to Follow-up|0|||
124991783|NCT01395888|449596662|FG002|2-week Run-in Period|Lost to Follow-up|0|||
124991784|NCT01395888|449596660|FG000|2-week Run-in Period|Protocol Violation|2|||
124991785|NCT01395888|449596661|FG001|2-week Run-in Period|Protocol Violation|0|||
124991786|NCT01395888|449596662|FG002|2-week Run-in Period|Protocol Violation|0|||
124991787|NCT01395888|449596660|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
124991788|NCT01395888|449596661|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
124991789|NCT01395888|449596662|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
124991790|NCT01395888|449596660|FG000|Treatment Period (TP)|Adverse Event|0|||
124991791|NCT01395888|449596661|FG001|Treatment Period (TP)|Adverse Event|7|||
124991792|NCT01395888|449596662|FG002|Treatment Period (TP)|Adverse Event|6|||
124991793|NCT01395888|449596660|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
124991794|NCT01395888|449596661|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
124991795|NCT01395888|449596662|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
124991796|NCT01395888|449596660|FG000|Treatment Period (TP)|Protocol Violation|0|||
124991797|NCT01395888|449596661|FG001|Treatment Period (TP)|Protocol Violation|1|||
124991798|NCT01395888|449596662|FG002|Treatment Period (TP)|Protocol Violation|5|||
124991799|NCT01395888|449596660|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
124991800|NCT01395888|449596661|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
124991801|NCT01395888|449596662|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
124991802|NCT01395888|449596660|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
124872606|NCT01662063|449155674|FG001|Overall Study|Other|1|||
124991803|NCT01395888|449596661|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
124991804|NCT01395888|449596662|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
124991805|NCT02640157|449596664|FG000|Overall Study|Adverse Event|2|||
124991806|NCT02640157|449596665|FG001|Overall Study|Adverse Event|2|||
124991807|NCT02640157|449596666|FG002|Overall Study|Adverse Event|1|||
124991808|NCT02640157|449596664|FG000|Overall Study|Withdrew consent|2|||
124991809|NCT02640157|449596665|FG001|Overall Study|Withdrew consent|0|||
124991810|NCT02640157|449596666|FG002|Overall Study|Withdrew consent|2|||
124991811|NCT02640157|449596664|FG000|Overall Study|Lost to Follow-up|9|||
124991812|NCT02640157|449596665|FG001|Overall Study|Lost to Follow-up|2|||
124991813|NCT02640157|449596666|FG002|Overall Study|Lost to Follow-up|7|||
124991814|NCT02640157|449596664|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
124991815|NCT02640157|449596665|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
124991816|NCT02640157|449596666|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
124991817|NCT01679405|449596668|FG000|Overall Study|Death|2|||
124991818|NCT01679405|449596669|FG001|Overall Study|Death|5|||
124991819|NCT00126503|449596670|FG000|Overall Study|disease progression|23|||
124991820|NCT00126503|449596671|FG001|Overall Study|disease progression|14|||
124991821|NCT00126503|449596670|FG000|Overall Study|Withdrawal by Subject|0|||
124991822|NCT00126503|449596671|FG001|Overall Study|Withdrawal by Subject|1|||
124991823|NCT00126503|449596670|FG000|Overall Study|alternative therapy|1|||
124991824|NCT00126503|449596671|FG001|Overall Study|alternative therapy|1|||
124991825|NCT00126503|449596670|FG000|Overall Study|other complicating disease|4|||
124991826|NCT00126503|449596671|FG001|Overall Study|other complicating disease|1|||
124991827|NCT00126503|449596670|FG000|Overall Study|Death|3|||
124991828|NCT00126503|449596671|FG001|Overall Study|Death|0|||
124991829|NCT00126503|449596670|FG000|Overall Study|Adverse Event|13|||
124991830|NCT00126503|449596671|FG001|Overall Study|Adverse Event|3|||
124991831|NCT00126503|449596670|FG000|Overall Study|non-compliant|1|||
124991832|NCT00126503|449596671|FG001|Overall Study|non-compliant|0|||
125318127|NCT00689390|450794001|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
125318128|NCT00689390|450794002|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
124991833|NCT00126503|449596670|FG000|Overall Study|Physician Decision|2|||
124991834|NCT00126503|449596671|FG001|Overall Study|Physician Decision|1|||
124991835|NCT04677179|449596672|FG000|Induction Treatment Period|Adverse Event|1|||
124991836|NCT04677179|449596673|FG001|Induction Treatment Period|Adverse Event|0|||
124991837|NCT04677179|449596674|FG002|Induction Treatment Period|Adverse Event|0|||
124991838|NCT04677179|449596675|FG003|Induction Treatment Period|Adverse Event|0|||
124991839|NCT04677179|449596676|FG004|Induction Treatment Period|Adverse Event|0|||
124991840|NCT04677179|449596677|FG005|Induction Treatment Period|Adverse Event|0|||
124991841|NCT04677179|449596678|FG006|Induction Treatment Period|Adverse Event|0|||
124991842|NCT04677179|449596679|FG007|Induction Treatment Period|Adverse Event|0|||
124991843|NCT04677179|449596680|FG008|Induction Treatment Period|Adverse Event|0|||
124991844|NCT04677179|449596681|FG009|Induction Treatment Period|Adverse Event|0|||
124991845|NCT04677179|449596672|FG000|Induction Treatment Period|Physician Decision|1|||
124991846|NCT04677179|449596673|FG001|Induction Treatment Period|Physician Decision|0|||
124991847|NCT04677179|449596674|FG002|Induction Treatment Period|Physician Decision|1|||
124991848|NCT04677179|449596675|FG003|Induction Treatment Period|Physician Decision|0|||
124991849|NCT04677179|449596676|FG004|Induction Treatment Period|Physician Decision|0|||
124991850|NCT04677179|449596677|FG005|Induction Treatment Period|Physician Decision|0|||
124991851|NCT04677179|449596678|FG006|Induction Treatment Period|Physician Decision|0|||
124991852|NCT04677179|449596679|FG007|Induction Treatment Period|Physician Decision|0|||
124991853|NCT04677179|449596680|FG008|Induction Treatment Period|Physician Decision|0|||
124991854|NCT04677179|449596681|FG009|Induction Treatment Period|Physician Decision|0|||
124991855|NCT04677179|449596672|FG000|Induction Treatment Period|Protocol Violation|0|||
124991856|NCT04677179|449596673|FG001|Induction Treatment Period|Protocol Violation|1|||
124991857|NCT04677179|449596674|FG002|Induction Treatment Period|Protocol Violation|0|||
124991858|NCT04677179|449596675|FG003|Induction Treatment Period|Protocol Violation|0|||
124991859|NCT04677179|449596676|FG004|Induction Treatment Period|Protocol Violation|0|||
124991860|NCT04677179|449596677|FG005|Induction Treatment Period|Protocol Violation|0|||
124991861|NCT04677179|449596678|FG006|Induction Treatment Period|Protocol Violation|0|||
124991862|NCT04677179|449596679|FG007|Induction Treatment Period|Protocol Violation|0|||
124991863|NCT04677179|449596680|FG008|Induction Treatment Period|Protocol Violation|0|||
124991864|NCT04677179|449596681|FG009|Induction Treatment Period|Protocol Violation|0|||
124991865|NCT04677179|449596672|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
124991866|NCT04677179|449596673|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
124991867|NCT04677179|449596674|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
124991868|NCT04677179|449596675|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
124991869|NCT04677179|449596676|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
124991870|NCT04677179|449596677|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
124991871|NCT04677179|449596678|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
124991872|NCT04677179|449596679|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
124991873|NCT04677179|449596680|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
124991874|NCT04677179|449596681|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
124991875|NCT04677179|449596672|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
124991876|NCT04677179|449596673|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
124991877|NCT04677179|449596674|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
124991878|NCT04677179|449596675|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
124991879|NCT04677179|449596676|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
124991880|NCT04677179|449596677|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
124991881|NCT04677179|449596678|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
124991882|NCT04677179|449596679|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
124991883|NCT04677179|449596680|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
124991884|NCT04677179|449596681|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
124991885|NCT04677179|449596672|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
124991886|NCT04677179|449596673|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
124991887|NCT04677179|449596674|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
124991888|NCT04677179|449596675|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
124991889|NCT04677179|449596676|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
124991890|NCT04677179|449596677|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
124991891|NCT04677179|449596678|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
124991892|NCT04677179|449596679|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
124991893|NCT04677179|449596680|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
124991894|NCT04677179|449596681|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
124991895|NCT04677179|449596672|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
124991896|NCT04677179|449596673|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
124991897|NCT04677179|449596674|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
124991898|NCT04677179|449596675|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
124991899|NCT04677179|449596676|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
124991900|NCT04677179|449596677|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
124991901|NCT04677179|449596678|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
124991902|NCT04677179|449596679|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
124991903|NCT04677179|449596680|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
124991904|NCT04677179|449596681|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
124991905|NCT04677179|449596672|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
124991906|NCT04677179|449596673|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
124991907|NCT04677179|449596674|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
124991908|NCT04677179|449596675|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
124991909|NCT04677179|449596676|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
124991910|NCT04677179|449596677|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
124991911|NCT04677179|449596678|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
124991912|NCT04677179|449596679|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
124991913|NCT04677179|449596680|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
124991914|NCT04677179|449596681|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
124991915|NCT04677179|449596672|FG000|Extension Treatment Period|Lack of Efficacy|0|||
124991916|NCT04677179|449596673|FG001|Extension Treatment Period|Lack of Efficacy|0|||
124991917|NCT04677179|449596674|FG002|Extension Treatment Period|Lack of Efficacy|0|||
124991918|NCT04677179|449596675|FG003|Extension Treatment Period|Lack of Efficacy|0|||
124991919|NCT04677179|449596676|FG004|Extension Treatment Period|Lack of Efficacy|0|||
124991920|NCT04677179|449596677|FG005|Extension Treatment Period|Lack of Efficacy|0|||
124991921|NCT04677179|449596678|FG006|Extension Treatment Period|Lack of Efficacy|6|||
124991922|NCT04677179|449596679|FG007|Extension Treatment Period|Lack of Efficacy|0|||
124991923|NCT04677179|449596680|FG008|Extension Treatment Period|Lack of Efficacy|0|||
124991924|NCT04677179|449596681|FG009|Extension Treatment Period|Lack of Efficacy|0|||
124991925|NCT04677179|449596672|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
124991926|NCT04677179|449596673|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
124991927|NCT04677179|449596674|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
124991928|NCT04677179|449596675|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
124991929|NCT04677179|449596676|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
124991930|NCT04677179|449596677|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
124991931|NCT04677179|449596678|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
124991932|NCT04677179|449596679|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
124991933|NCT04677179|449596680|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
124991934|NCT04677179|449596681|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
124991935|NCT04677179|449596672|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
124991936|NCT04677179|449596673|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
124991937|NCT04677179|449596674|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
124991938|NCT04677179|449596675|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
124991939|NCT04677179|449596676|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
124991940|NCT04677179|449596677|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
124991941|NCT04677179|449596678|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
125318129|NCT00689390|450794001|FG000|Overall Study|Administrative|37|||
124991942|NCT04677179|449596679|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
124991943|NCT04677179|449596680|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
124991944|NCT04677179|449596681|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
124991945|NCT04677179|449596672|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
124991946|NCT04677179|449596673|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
124991947|NCT04677179|449596674|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
124991948|NCT04677179|449596675|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
124991949|NCT04677179|449596676|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
124991950|NCT04677179|449596677|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
124991951|NCT04677179|449596678|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
124991952|NCT04677179|449596679|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
124991953|NCT04677179|449596680|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
124991954|NCT04677179|449596681|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
124991955|NCT04677179|449596672|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
124991956|NCT04677179|449596673|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
124991957|NCT04677179|449596674|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
124991958|NCT04677179|449596675|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
124991959|NCT04677179|449596676|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
124991960|NCT04677179|449596677|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
124991961|NCT04677179|449596678|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
124991962|NCT04677179|449596679|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
124991963|NCT04677179|449596680|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
124991964|NCT04677179|449596681|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
124991965|NCT04677179|449596672|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
124991966|NCT04677179|449596673|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
124991967|NCT04677179|449596674|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
124991968|NCT04677179|449596675|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
124991969|NCT04677179|449596676|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
124991970|NCT04677179|449596677|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
124991971|NCT04677179|449596678|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
124991972|NCT04677179|449596679|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
124991973|NCT04677179|449596680|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
124991974|NCT04677179|449596681|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
124991975|NCT04677179|449596672|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
124991976|NCT04677179|449596673|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
124991977|NCT04677179|449596674|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
124991978|NCT04677179|449596675|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
124991979|NCT04677179|449596676|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
124991980|NCT04677179|449596677|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
124991981|NCT04677179|449596678|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
124991982|NCT04677179|449596679|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
124991983|NCT04677179|449596680|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
124991984|NCT04677179|449596681|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
124991985|NCT04677179|449596672|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
124991986|NCT04677179|449596673|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
124991987|NCT04677179|449596674|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
124991988|NCT04677179|449596675|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
124991989|NCT04677179|449596676|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
124991990|NCT04677179|449596677|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
124991991|NCT04677179|449596678|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
124991992|NCT04677179|449596679|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
124991993|NCT04677179|449596680|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
124991994|NCT04677179|449596681|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
124991995|NCT02641496|449596682|FG000|Overall Study|Lost to Follow-up|13|||
124991996|NCT02641496|449596683|FG001|Overall Study|Lost to Follow-up|12|||
124991997|NCT02641496|449596682|FG000|Overall Study|Withdrawal by Subject|1|||
124991998|NCT02641496|449596683|FG001|Overall Study|Withdrawal by Subject|0|||
124991999|NCT03075410|449596686|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
124992000|NCT03075410|449596687|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
124992001|NCT03075410|449596688|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
124992002|NCT03075410|449596689|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
124992003|NCT03075410|449596690|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
124992004|NCT03075410|449596691|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
124992005|NCT03075410|449596692|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
124992006|NCT03075410|449596693|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
124992007|NCT03075410|449596694|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
124992008|NCT03075410|449596686|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
124992009|NCT03075410|449596687|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
124992010|NCT03075410|449596688|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
124992011|NCT03075410|449596689|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
124992012|NCT03075410|449596690|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
124992013|NCT03075410|449596691|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
124992014|NCT03075410|449596692|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
124992015|NCT03075410|449596693|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
124992016|NCT03075410|449596694|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
124992017|NCT00790751|449596697|FG000|Overall Study|Protocol non-compliance|16|||
124992018|NCT00790751|449596698|FG001|Overall Study|Protocol non-compliance|16|||
124992019|NCT00790751|449596699|FG002|Overall Study|Protocol non-compliance|10|||
124992020|NCT00790751|449596700|FG003|Overall Study|Protocol non-compliance|11|||
124992021|NCT00790751|449596697|FG000|Overall Study|Lost to Follow-up|4|||
124992022|NCT00790751|449596698|FG001|Overall Study|Lost to Follow-up|9|||
124992023|NCT00790751|449596699|FG002|Overall Study|Lost to Follow-up|4|||
124992024|NCT00790751|449596700|FG003|Overall Study|Lost to Follow-up|5|||
124992025|NCT00790751|449596697|FG000|Overall Study|Adverse Event|5|||
124992026|NCT00790751|449596698|FG001|Overall Study|Adverse Event|3|||
124992027|NCT00790751|449596699|FG002|Overall Study|Adverse Event|5|||
124992028|NCT00790751|449596700|FG003|Overall Study|Adverse Event|4|||
124992029|NCT00790751|449596697|FG000|Overall Study|Requirement for restricted medication|0|||
124992030|NCT00790751|449596698|FG001|Overall Study|Requirement for restricted medication|2|||
124992031|NCT00790751|449596699|FG002|Overall Study|Requirement for restricted medication|0|||
124992032|NCT00790751|449596700|FG003|Overall Study|Requirement for restricted medication|0|||
124992033|NCT00790751|449596697|FG000|Overall Study|Death|0|||
124992034|NCT00790751|449596698|FG001|Overall Study|Death|0|||
124992035|NCT00790751|449596699|FG002|Overall Study|Death|1|||
124992036|NCT00790751|449596700|FG003|Overall Study|Death|0|||
124992037|NCT00790751|449596697|FG000|Overall Study|Physician Decision|0|||
124992038|NCT00790751|449596698|FG001|Overall Study|Physician Decision|0|||
124992039|NCT00790751|449596699|FG002|Overall Study|Physician Decision|0|||
124992040|NCT00790751|449596700|FG003|Overall Study|Physician Decision|1|||
124992041|NCT00346268|449598535|FG000|Overall Study|Adverse Event|1|||
124992042|NCT00346268|449598536|FG001|Overall Study|Adverse Event|0|||
124992043|NCT00346268|449598535|FG000|Overall Study|Protocol Violation|1|||
124992044|NCT00346268|449598536|FG001|Overall Study|Protocol Violation|0|||
124992045|NCT00346268|449598535|FG000|Overall Study|Participant refused|0|||
124992046|NCT00346268|449598536|FG001|Overall Study|Participant refused|3|||
124992047|NCT00743275|449598537|FG000|Overall Study|Protocol Violation|0|||
124992048|NCT00743275|449598538|FG001|Overall Study|Protocol Violation|1|||
124992049|NCT03938545|449598543|FG000|Overall Study|Lost to Follow-up|0|||
124992050|NCT03938545|449598544|FG001|Overall Study|Lost to Follow-up|0|||
124992051|NCT03938545|449598545|FG002|Overall Study|Lost to Follow-up|0|||
124992052|NCT03938545|449598546|FG003|Overall Study|Lost to Follow-up|1|||
124992053|NCT03938545|449598543|FG000|Overall Study|Non-compliance with study drug|0|||
124992054|NCT03938545|449598544|FG001|Overall Study|Non-compliance with study drug|0|||
124992055|NCT03938545|449598545|FG002|Overall Study|Non-compliance with study drug|1|||
124992056|NCT03938545|449598546|FG003|Overall Study|Non-compliance with study drug|0|||
124992057|NCT03938545|449598543|FG000|Overall Study|Pregnancy|1|||
124992058|NCT03938545|449598544|FG001|Overall Study|Pregnancy|0|||
124992059|NCT03938545|449598545|FG002|Overall Study|Pregnancy|0|||
124992060|NCT03938545|449598546|FG003|Overall Study|Pregnancy|0|||
124992061|NCT03938545|449598543|FG000|Overall Study|Study terminated by sponsor|6|||
124992062|NCT03938545|449598544|FG001|Overall Study|Study terminated by sponsor|4|||
124992063|NCT03938545|449598545|FG002|Overall Study|Study terminated by sponsor|2|||
124992064|NCT03938545|449598546|FG003|Overall Study|Study terminated by sponsor|4|||
124992065|NCT03938545|449598543|FG000|Overall Study|Withdrawal by Subject|0|||
124992066|NCT03938545|449598544|FG001|Overall Study|Withdrawal by Subject|1|||
124992067|NCT03938545|449598545|FG002|Overall Study|Withdrawal by Subject|0|||
124992068|NCT03938545|449598546|FG003|Overall Study|Withdrawal by Subject|0|||
124992069|NCT03938545|449598543|FG000|Overall Study|Adverse Event|1|||
124992070|NCT03938545|449598544|FG001|Overall Study|Adverse Event|0|||
124992071|NCT03938545|449598545|FG002|Overall Study|Adverse Event|0|||
124992072|NCT03938545|449598546|FG003|Overall Study|Adverse Event|0|||
124992073|NCT02186223|449598551|FG000|Overall Study|Not eligible for device placement|6|||
124992074|NCT02186223|449598551|FG000|Overall Study|Unable to obtain femoral access|3|||
124992075|NCT02186223|449598551|FG000|Overall Study|Death|3|||
124992076|NCT02186223|449598551|FG000|Overall Study|Device in place less than 48 hours|9|||
124992077|NCT02079610|449598555|FG000|Overall Study|Withdrawal by Subject|1|||
124992078|NCT02079610|449598556|FG001|Overall Study|Withdrawal by Subject|1|||
124992079|NCT01111474|449598557|FG000|Overall Study|Lost to Follow-up|12|||
124992080|NCT01016977|449598558|FG000|Overall Study|Lost to Follow-up|1|||
124992081|NCT01016977|449598559|FG001|Overall Study|Lost to Follow-up|0|||
124992082|NCT01016977|449598558|FG000|Overall Study|Withdrawal by Subject|2|||
124992083|NCT01016977|449598559|FG001|Overall Study|Withdrawal by Subject|2|||
124992084|NCT01236365|449598560|FG000|Overall Study|Lost to Follow-up|0|||
124992085|NCT01236365|449598561|FG001|Overall Study|Lost to Follow-up|2|||
124992086|NCT01236365|449598560|FG000|Overall Study|Moved Out of State|1|||
124992087|NCT01236365|449598561|FG001|Overall Study|Moved Out of State|0|||
124992088|NCT01236365|449598560|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
124992089|NCT01236365|449598561|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
124992090|NCT00717067|449598562|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
124992091|NCT00717067|449598563|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
124992092|NCT00717067|449598564|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
124992093|NCT00717067|449598565|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
124992094|NCT00717067|449598566|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
124992095|NCT01689337|449598567|FG000|Overall Study|Study Discontinuation|1|||
124992096|NCT00824161|449598568|FG000|Overall Study|Withdrawal by Subject|1|||
124992097|NCT00824161|449598568|FG000|Overall Study|Screen Failure|1|||
124992098|NCT02572882|449598569|FG000|Overall Study|Withdrawal by Subject|1|||
124992099|NCT02572882|449598569|FG000|Overall Study|Participant received kidney transplant|1|||
124992100|NCT02354508|449598570|FG000|Period 1: Core Phase|Adverse Event|1|||
124992101|NCT02354508|449598571|FG001|Period 1: Core Phase|Adverse Event|1|||
124992102|NCT02354508|449598572|FG002|Period 1: Core Phase|Adverse Event|2|||
124992103|NCT02354508|449598570|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
124992104|NCT02354508|449598571|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
124992105|NCT02354508|449598572|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
124992106|NCT02354508|449598570|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
124992107|NCT02354508|449598571|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
124992108|NCT02354508|449598572|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
124992109|NCT02354508|449598570|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
124992110|NCT02354508|449598571|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
124992111|NCT02354508|449598572|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
124992112|NCT02354508|449598570|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
124992113|NCT02354508|449598571|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
124992114|NCT02354508|449598572|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
124992115|NCT02354508|449598570|FG000|Period 2: Extension Phase|Physician Decision|5|||
124992116|NCT02354508|449598571|FG001|Period 2: Extension Phase|Physician Decision|0|||
124992117|NCT02354508|449598572|FG002|Period 2: Extension Phase|Physician Decision|1|||
124992118|NCT02354508|449598570|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
124992119|NCT02354508|449598571|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
124992120|NCT02354508|449598572|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
124992121|NCT02354508|449598570|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
124992122|NCT02354508|449598571|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
124992123|NCT02354508|449598572|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
124992124|NCT02354508|449598570|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
124992125|NCT02354508|449598571|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
124992126|NCT02354508|449598572|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
124992127|NCT03536143|449598573|FG000|Overall Study|Early termination, Sponsor decision|1|||
124992128|NCT04754477|449598574|FG000|Overall Study|Withdrawal by Subject|1|||
124992129|NCT01347762|449598575|FG000|Overall Study|Lost to Follow-up|0|||
124992130|NCT01347762|449598576|FG001|Overall Study|Lost to Follow-up|1|||
124992131|NCT01347762|449598577|FG002|Overall Study|Lost to Follow-up|6|||
124992132|NCT01347762|449598578|FG003|Overall Study|Lost to Follow-up|5|||
124992133|NCT01347762|449598575|FG000|Overall Study|Withdrawal by Subject|4|||
124992134|NCT01347762|449598576|FG001|Overall Study|Withdrawal by Subject|1|||
124992135|NCT01347762|449598577|FG002|Overall Study|Withdrawal by Subject|3|||
124992136|NCT01347762|449598578|FG003|Overall Study|Withdrawal by Subject|3|||
124992137|NCT01590017|449598579|FG000|Overall Study|Adverse Event|1|||
124992138|NCT01590017|449598579|FG000|Overall Study|Withdrawal by Subject|1|||
124992139|NCT01590017|449598579|FG000|Overall Study|Lack of Efficacy|1|||
124992140|NCT01590017|449598579|FG000|Overall Study|Physician Decision|1|||
124992141|NCT00093808|449598580|FG000|Overall Study|Cancel participation before receiving tx|1|||
124992142|NCT00093808|449598580|FG000|Overall Study|Protocol Violation|1|||
124992143|NCT00871780|449598581|FG000|Overall Study|Enrolled But Not Treated|6|||
124992144|NCT00871780|449598581|FG000|Overall Study|Withdrawal by Subject|9|||
124992145|NCT00871780|449598581|FG000|Overall Study|Adverse Event|6|||
124992146|NCT00871780|449598581|FG000|Overall Study|Voluntary Discontinuation|4|||
124992147|NCT00871780|449598581|FG000|Overall Study|Death|1|||
124992148|NCT00871780|449598581|FG000|Overall Study|Physician Decision|1|||
124992149|NCT03406260|449598582|FG000|Period 1|Adverse Event|0|||
124992150|NCT03406260|449598583|FG001|Period 1|Adverse Event|0|||
124992151|NCT03406260|449598584|FG002|Period 1|Adverse Event|0|||
124992152|NCT03406260|449598585|FG003|Period 1|Adverse Event|0|||
124992153|NCT03406260|449598586|FG004|Period 1|Adverse Event|1|||
124992154|NCT03406260|449598587|FG005|Period 1|Adverse Event|0|||
124992155|NCT02527343|449598588|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
124992156|NCT02527343|449598589|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
124992157|NCT02527343|449598590|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
124992158|NCT02527343|449598591|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
124992159|NCT02527343|449598592|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
124992160|NCT02527343|449598593|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
124992161|NCT02527343|449598588|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
124992162|NCT02527343|449598589|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
124992163|NCT02527343|449598590|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
124992164|NCT02527343|449598591|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
124992165|NCT02527343|449598592|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
124992166|NCT02527343|449598593|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
124992167|NCT02527343|449598588|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
124992168|NCT02527343|449598589|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
124992169|NCT02527343|449598590|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
124992170|NCT02527343|449598591|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
124992171|NCT02527343|449598592|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
124992172|NCT02527343|449598593|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
124992173|NCT02527343|449598588|FG000|RT Period: Weeks 1 to 52|Other|4|||
124992174|NCT02527343|449598589|FG001|RT Period: Weeks 1 to 52|Other|3|||
124992175|NCT02527343|449598590|FG002|RT Period: Weeks 1 to 52|Other|0|||
124992176|NCT02527343|449598591|FG003|RT Period: Weeks 1 to 52|Other|0|||
125318130|NCT00689390|450794002|FG001|Overall Study|Administrative|0|||
125318131|NCT02343263|450794003|FG000|Overall Study|Physician Decision|5|||
124992177|NCT02527343|449598592|FG004|RT Period: Weeks 1 to 52|Other|0|||
124992178|NCT02527343|449598593|FG005|RT Period: Weeks 1 to 52|Other|0|||
124992179|NCT02527343|449598588|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
124992180|NCT02527343|449598589|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
124992181|NCT02527343|449598590|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
124992182|NCT02527343|449598591|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
124992183|NCT02527343|449598592|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
124992184|NCT02527343|449598593|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
124992185|NCT02527343|449598588|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
125318132|NCT02343263|450794004|FG001|Overall Study|Physician Decision|3|||
125318133|NCT02343263|450794005|FG002|Overall Study|Physician Decision|1|||
125318134|NCT00525512|450794023|FG000|Double-Blind Phase|Adverse Event|48|||
125318135|NCT00525512|450794024|FG001|Double-Blind Phase|Adverse Event|28|||
125318136|NCT00525512|450794025|FG002|Double-Blind Phase|Adverse Event|0|||
125318137|NCT00525512|450794026|FG003|Double-Blind Phase|Adverse Event|0|||
125318138|NCT00525512|450794023|FG000|Double-Blind Phase|Protocol Violation|3|||
125318139|NCT00525512|450794024|FG001|Double-Blind Phase|Protocol Violation|1|||
125318140|NCT00525512|450794025|FG002|Double-Blind Phase|Protocol Violation|0|||
125318141|NCT00525512|450794026|FG003|Double-Blind Phase|Protocol Violation|0|||
125318142|NCT00525512|450794023|FG000|Double-Blind Phase|Lost to Follow-up|3|||
125318143|NCT00525512|450794024|FG001|Double-Blind Phase|Lost to Follow-up|7|||
125318144|NCT00525512|450794025|FG002|Double-Blind Phase|Lost to Follow-up|0|||
125318145|NCT00525512|450794026|FG003|Double-Blind Phase|Lost to Follow-up|0|||
125318146|NCT00525512|450794023|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
125318147|NCT00525512|450794024|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
125318148|NCT00525512|450794025|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
125318149|NCT00525512|450794026|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
125318150|NCT00525512|450794023|FG000|Double-Blind Phase|Lack of Efficacy|13|||
125318151|NCT00525512|450794024|FG001|Double-Blind Phase|Lack of Efficacy|5|||
125318152|NCT00525512|450794025|FG002|Double-Blind Phase|Lack of Efficacy|0|||
125318153|NCT00525512|450794026|FG003|Double-Blind Phase|Lack of Efficacy|0|||
125318154|NCT00525512|450794023|FG000|Double-Blind Phase|Other reason (not specified)|12|||
125318155|NCT00525512|450794024|FG001|Double-Blind Phase|Other reason (not specified)|13|||
125318156|NCT00525512|450794025|FG002|Double-Blind Phase|Other reason (not specified)|0|||
125318157|NCT00525512|450794026|FG003|Double-Blind Phase|Other reason (not specified)|0|||
125318158|NCT00525512|450794023|FG000|Open-Label Phase|Adverse Event|0|||
125318159|NCT00525512|450794024|FG001|Open-Label Phase|Adverse Event|0|||
125318160|NCT00525512|450794025|FG002|Open-Label Phase|Adverse Event|1|||
125318161|NCT00525512|450794026|FG003|Open-Label Phase|Adverse Event|0|||
125318162|NCT00525512|450794023|FG000|Open-Label Phase|Lost to Follow-up|0|||
125318163|NCT00525512|450794024|FG001|Open-Label Phase|Lost to Follow-up|0|||
125318164|NCT00525512|450794025|FG002|Open-Label Phase|Lost to Follow-up|1|||
125318165|NCT00525512|450794026|FG003|Open-Label Phase|Lost to Follow-up|0|||
125318166|NCT00525512|450794023|FG000|Open-Label Phase|Other reason (not specified)|0|||
125318167|NCT00525512|450794024|FG001|Open-Label Phase|Other reason (not specified)|0|||
125318168|NCT00525512|450794025|FG002|Open-Label Phase|Other reason (not specified)|4|||
125318169|NCT00525512|450794026|FG003|Open-Label Phase|Other reason (not specified)|5|||
125318170|NCT03289208|450794027|FG000|Overall Study|Adverse Event|1|||
125318171|NCT03289208|450794028|FG001|Overall Study|Adverse Event|0|||
124992186|NCT02527343|449598589|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
124992187|NCT02527343|449598590|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
124992188|NCT02527343|449598591|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
124992189|NCT02527343|449598592|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
125318172|NCT03289208|450794029|FG002|Overall Study|Adverse Event|0|||
125318173|NCT03353675|450794033|FG000|Overall Study|Adverse Event|4|||
125318174|NCT02025179|450794036|FG000|Overall Study|Lost to Follow-up|0|||
125318175|NCT02025179|450794037|FG001|Overall Study|Lost to Follow-up|0|||
125318176|NCT02025179|450794038|FG002|Overall Study|Lost to Follow-up|1|||
125318177|NCT02362724|450794039|FG000|Overall Study|Withdrawal by Subject|3|||
125318178|NCT02362724|450794040|FG001|Overall Study|Withdrawal by Subject|1|||
124992190|NCT02527343|449598593|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
124992191|NCT02527343|449598588|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
124992192|NCT02527343|449598589|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
124992193|NCT02527343|449598590|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
124992194|NCT02527343|449598591|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
125318179|NCT02362724|450794039|FG000|Overall Study|Adverse Event|3|||
125318180|NCT02362724|450794040|FG001|Overall Study|Adverse Event|0|||
125318181|NCT00402168|450794041|FG000|Randomized|Lost to Follow-up|1|||
125318182|NCT00402168|450794042|FG001|Randomized|Lost to Follow-up|0|||
125318183|NCT00402168|450794041|FG000|Randomized|Withdrawal by Subject|0|||
125318184|NCT00402168|450794042|FG001|Randomized|Withdrawal by Subject|1|||
125318185|NCT00402168|450794041|FG000|Treatment (up to 12 Months)|Death|0|||
125318186|NCT00402168|450794042|FG001|Treatment (up to 12 Months)|Death|1|||
124992195|NCT02527343|449598592|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
124992196|NCT02527343|449598593|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
124992197|NCT02527343|449598588|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
124992198|NCT02527343|449598589|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
125318187|NCT00402168|450794041|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
125318188|NCT00402168|450794042|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
125318189|NCT00402168|450794041|FG000|Treatment (up to 12 Months)|non-specified|0|||
125318190|NCT00402168|450794042|FG001|Treatment (up to 12 Months)|non-specified|1|||
124992199|NCT02527343|449598590|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
124992200|NCT02527343|449598591|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
124992201|NCT02527343|449598592|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
124992202|NCT02527343|449598593|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
124992203|NCT02527343|449598588|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
125318191|NCT00402168|450794041|FG000|Long Term (LT)|Adverse Event|1|||
125318192|NCT00402168|450794042|FG001|Long Term (LT)|Adverse Event|5|||
125318193|NCT00402168|450794041|FG000|Long Term (LT)|Withdrawal by Subject|4|||
124992204|NCT02527343|449598589|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
124992205|NCT02527343|449598590|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
124992206|NCT02527343|449598591|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
124992207|NCT02527343|449598592|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
124992208|NCT02527343|449598593|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
124992209|NCT02527343|449598588|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
124992210|NCT02527343|449598589|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
124992211|NCT02527343|449598590|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
124992212|NCT02527343|449598591|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
124992213|NCT02527343|449598592|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
124992214|NCT02527343|449598593|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
124992215|NCT02527343|449598588|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
124992216|NCT02527343|449598589|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
124992217|NCT02527343|449598590|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
124992218|NCT02527343|449598591|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
124992219|NCT02527343|449598592|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
124992220|NCT02527343|449598593|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
124992221|NCT02527343|449598588|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
124992222|NCT02527343|449598589|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
124992223|NCT02527343|449598590|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
124992224|NCT02527343|449598591|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
124992225|NCT02527343|449598592|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
124992226|NCT02527343|449598593|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
124992227|NCT02527343|449598588|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
124992228|NCT02527343|449598589|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
124992229|NCT02527343|449598590|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
125318194|NCT00402168|450794042|FG001|Long Term (LT)|Withdrawal by Subject|7|||
125318195|NCT00402168|450794041|FG000|Long Term (LT)|Pregnancy|0|||
125318196|NCT00402168|450794042|FG001|Long Term (LT)|Pregnancy|1|||
124992230|NCT02527343|449598591|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
124992231|NCT02527343|449598592|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
124992232|NCT02527343|449598593|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
124992233|NCT00701220|449598594|FG000|Overall Study|Withdrawal by Subject|0|||
124992234|NCT00701220|449598595|FG001|Overall Study|Withdrawal by Subject|2|||
125318197|NCT00402168|450794041|FG000|Long Term (LT)|Lost to Follow-up|1|||
124992235|NCT00701220|449598594|FG000|Overall Study|Protocol Violation|2|||
124992236|NCT00701220|449598595|FG001|Overall Study|Protocol Violation|0|||
124992237|NCT03235284|449598596|FG000|Overall Study|Adverse Event|1|||
124992238|NCT03235284|449598597|FG001|Overall Study|Adverse Event|2|||
124992239|NCT03235284|449598598|FG002|Overall Study|Adverse Event|1|||
124992240|NCT00440999|449598601|FG000|Overall Study|Adverse Event|0|||
124992241|NCT00440999|449598602|FG001|Overall Study|Adverse Event|2|||
124992242|NCT00440999|449598601|FG000|Overall Study|Lack of Efficacy|6|||
124992243|NCT00440999|449598602|FG001|Overall Study|Lack of Efficacy|7|||
124992244|NCT00440999|449598601|FG000|Overall Study|Lost to Follow-up|19|||
124992245|NCT00440999|449598602|FG001|Overall Study|Lost to Follow-up|12|||
124992246|NCT00440999|449598601|FG000|Overall Study|Protocol Violation|1|||
124992247|NCT00440999|449598602|FG001|Overall Study|Protocol Violation|0|||
124992248|NCT00440999|449598601|FG000|Overall Study|Withdrawal by Subject|2|||
124992249|NCT00440999|449598602|FG001|Overall Study|Withdrawal by Subject|5|||
124992250|NCT00440999|449598601|FG000|Overall Study|Subjets missed the visit|1|||
124992251|NCT00440999|449598602|FG001|Overall Study|Subjets missed the visit|0|||
124992252|NCT00440999|449598601|FG000|Overall Study|Mixed infection at entry|1|||
124992253|NCT00440999|449598602|FG001|Overall Study|Mixed infection at entry|0|||
124992254|NCT00440999|449598601|FG000|Overall Study|P. falciparum malaria|5|||
124992255|NCT00440999|449598602|FG001|Overall Study|P. falciparum malaria|14|||
124992256|NCT00440999|449598601|FG000|Overall Study|Subj left hosp without inform staff|0|||
124992257|NCT00440999|449598602|FG001|Overall Study|Subj left hosp without inform staff|1|||
124992258|NCT04745026|449598603|FG000|Overall Study|Physician Decision|1|||
124992259|NCT04745026|449598604|FG001|Overall Study|Physician Decision|0|||
124992260|NCT04745026|449598603|FG000|Overall Study|Adverse Event|2|||
124992261|NCT04745026|449598604|FG001|Overall Study|Adverse Event|2|||
124992262|NCT04745026|449598603|FG000|Overall Study|Protocol Violation|1|||
124992263|NCT04745026|449598604|FG001|Overall Study|Protocol Violation|3|||
124992264|NCT04745026|449598603|FG000|Overall Study|Lost to Follow-up|4|||
124992265|NCT04745026|449598604|FG001|Overall Study|Lost to Follow-up|3|||
124992266|NCT04745026|449598603|FG000|Overall Study|Withdrawal by Subject|5|||
124992267|NCT04745026|449598604|FG001|Overall Study|Withdrawal by Subject|5|||
124992268|NCT01205152|449598605|FG000|Overall Study|Death|1|||
124992269|NCT03256851|449598606|FG000|Overall Study|Withdrawal by Subject|1|||
124992270|NCT03256851|449598607|FG001|Overall Study|Withdrawal by Subject|0|||
124992271|NCT00249002|449598608|FG000|Overall Study|Adverse Event|2|||
124992272|NCT00249002|449598608|FG000|Overall Study|Study cancellation|3|||
124992273|NCT00249002|449598608|FG000|Overall Study|Other|2|||
124992274|NCT02208999|449598609|FG000|Overall Study|Lost to Follow-up|1|||
124992275|NCT00319839|449598610|FG000|Overall Study|Adverse Event|5|||
124992276|NCT00319839|449598610|FG000|Overall Study|Withdrawal by Subject|1|||
124992277|NCT02483585|449598611|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
124992278|NCT02483585|449598612|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
124992279|NCT02483585|449598611|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
124992280|NCT02483585|449598612|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
124992281|NCT02483585|449598611|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
124992282|NCT02483585|449598612|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
124992283|NCT02483585|449598611|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
124992284|NCT02483585|449598612|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
124992285|NCT02483585|449598611|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
124992286|NCT02483585|449598612|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
124992287|NCT02483585|449598611|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
124992288|NCT02483585|449598612|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
124992289|NCT02483585|449598611|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
124992290|NCT02483585|449598612|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
124992291|NCT01324440|449598617|FG000|Overall Study|Subject moved|0|||
124992292|NCT01324440|449598618|FG001|Overall Study|Subject moved|1|||
124992293|NCT00903630|449598619|FG000|Phase 2|Adverse Event|0|||
124992294|NCT00903630|449598620|FG001|Phase 2|Adverse Event|0|||
124992295|NCT00903630|449598621|FG002|Phase 2|Adverse Event|1|||
124992296|NCT04025580|449598622|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
124992297|NCT04025580|449598623|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
124992298|NCT04025580|449598624|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
124992299|NCT02325557|449598625|FG000|Overall Study|Progressive disease|1|||
124992300|NCT02325557|449598626|FG001|Overall Study|Progressive disease|0|||
124992301|NCT02325557|449598627|FG002|Overall Study|Progressive disease|0|||
124992302|NCT02325557|449598628|FG003|Overall Study|Progressive disease|0|||
124992303|NCT02325557|449598625|FG000|Overall Study|Withdrawal by Subject|4|||
124992304|NCT02325557|449598626|FG001|Overall Study|Withdrawal by Subject|0|||
124992305|NCT02325557|449598627|FG002|Overall Study|Withdrawal by Subject|0|||
124992306|NCT02325557|449598628|FG003|Overall Study|Withdrawal by Subject|15|||
124992307|NCT02325557|449598625|FG000|Overall Study|Death|5|||
124992308|NCT02325557|449598626|FG001|Overall Study|Death|1|||
124992309|NCT02325557|449598627|FG002|Overall Study|Death|1|||
124992310|NCT02325557|449598628|FG003|Overall Study|Death|16|||
124992311|NCT02325557|449598625|FG000|Overall Study|Lost to Follow-up|0|||
124992312|NCT02325557|449598626|FG001|Overall Study|Lost to Follow-up|0|||
124992313|NCT02325557|449598627|FG002|Overall Study|Lost to Follow-up|1|||
124992314|NCT02325557|449598628|FG003|Overall Study|Lost to Follow-up|1|||
124992315|NCT02325557|449598625|FG000|Overall Study|Other|0|||
124992316|NCT02325557|449598626|FG001|Overall Study|Other|0|||
124992317|NCT02325557|449598627|FG002|Overall Study|Other|0|||
124992318|NCT02325557|449598628|FG003|Overall Study|Other|5|||
124992319|NCT00138671|449598629|FG000|Overall Study|Death|0|||
124992320|NCT00138671|449598630|FG001|Overall Study|Death|3|||
124992321|NCT00138671|449598629|FG000|Overall Study|Adverse Event|6|||
124992322|NCT00138671|449598630|FG001|Overall Study|Adverse Event|3|||
124992323|NCT00138671|449598629|FG000|Overall Study|Lost to Follow-up|1|||
124992324|NCT00138671|449598630|FG001|Overall Study|Lost to Follow-up|2|||
124992325|NCT00138671|449598629|FG000|Overall Study|Withdrawal by Subject|3|||
124992326|NCT00138671|449598630|FG001|Overall Study|Withdrawal by Subject|5|||
124992327|NCT00138671|449598629|FG000|Overall Study|Other|3|||
124992328|NCT00138671|449598630|FG001|Overall Study|Other|3|||
124992329|NCT01488487|449598633|FG000|Overall Study|Adverse Event|6|||
124992330|NCT01488487|449598633|FG000|Overall Study|Death|1|||
124992331|NCT01488487|449598633|FG000|Overall Study|Withdrawal by Subject|2|||
124992332|NCT00928746|449598637|FG000|Overall Study|Adverse Event|2|||
124992333|NCT00928746|449598637|FG000|Overall Study|Protocol Violation|1|||
124872607|NCT01662063|449155675|FG002|Overall Study|Other|0|||
124872608|NCT02313909|449155677|FG000|Overall Study|Consent withdrawn by participant|33|||
124872609|NCT02313909|449155678|FG001|Overall Study|Consent withdrawn by participant|33|||
124872610|NCT02313909|449155677|FG000|Overall Study|Lost to Follow-up|24|||
124872611|NCT02313909|449155678|FG001|Overall Study|Lost to Follow-up|17|||
124872612|NCT00293267|449155684|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
124872613|NCT00293267|449155685|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
124872614|NCT00293267|449155684|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
124872615|NCT00293267|449155685|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
124872616|NCT00293267|449155684|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
124872617|NCT00293267|449155685|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
124872618|NCT00293267|449155684|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
124872619|NCT00293267|449155685|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
124872620|NCT00293267|449155684|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
124872621|NCT00293267|449155685|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
124872622|NCT00293267|449155684|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
124872623|NCT00293267|449155685|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
124872624|NCT00293267|449155684|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
124872625|NCT00293267|449155685|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
124872626|NCT00293267|449155684|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
124872627|NCT00293267|449155685|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
124872628|NCT00293267|449155684|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
124872629|NCT00293267|449155685|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
124872630|NCT00293267|449155684|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
124872631|NCT00293267|449155685|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
124872632|NCT00293267|449155684|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
124872633|NCT00293267|449155685|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
124872634|NCT00293267|449155684|FG000|Extension - Double-Blind Week 49-156|Death|3|||
124872635|NCT00293267|449155685|FG001|Extension - Double-Blind Week 49-156|Death|0|||
124872636|NCT00293267|449155684|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
124872637|NCT00293267|449155685|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
124872638|NCT00293267|449155684|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
124872639|NCT00293267|449155685|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
124872640|NCT00293267|449155684|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
124872641|NCT00293267|449155685|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
124872642|NCT00293267|449155684|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
124872643|NCT00293267|449155685|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
124872644|NCT00293267|449155684|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
124872645|NCT00293267|449155685|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
124872646|NCT00293267|449155684|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
124872647|NCT00293267|449155685|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
124872648|NCT00293267|449155684|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
124872649|NCT00293267|449155685|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
124992334|NCT00928746|449598637|FG000|Overall Study|Withdrawal by Subject|1|||
124992335|NCT00928746|449598637|FG000|Overall Study|Other|2|||
124992336|NCT02004353|449598643|FG000|Overall Study|Voluntary participation|1334|||
124992337|NCT01691768|449598644|FG000|Overall Study|Death|0|||
124992338|NCT01691768|449598645|FG001|Overall Study|Death|2|||
124992339|NCT01691768|449598644|FG000|Overall Study|Lost to Follow-up|4|||
124992340|NCT01691768|449598645|FG001|Overall Study|Lost to Follow-up|3|||
124992341|NCT01691768|449598644|FG000|Overall Study|Withdrawal by Subject|10|||
124992342|NCT01691768|449598645|FG001|Overall Study|Withdrawal by Subject|9|||
124992343|NCT01691768|449598644|FG000|Overall Study|Relocated|0|||
124992344|NCT01691768|449598645|FG001|Overall Study|Relocated|1|||
124992345|NCT01691768|449598644|FG000|Overall Study|Investigator decision|1|||
124992346|NCT01691768|449598645|FG001|Overall Study|Investigator decision|1|||
124992347|NCT02581631|449598646|FG000|Overall Study|Disease progression|29|||
124992348|NCT02581631|449598647|FG001|Overall Study|Disease progression|19|||
124992349|NCT02581631|449598648|FG002|Overall Study|Disease progression|13|||
124992350|NCT02581631|449598649|FG003|Overall Study|Disease progression|5|||
124992351|NCT02581631|449598650|FG004|Overall Study|Disease progression|8|||
124992352|NCT02581631|449598646|FG000|Overall Study|Study drug toxicity|4|||
124992353|NCT02581631|449598647|FG001|Overall Study|Study drug toxicity|6|||
124992354|NCT02581631|449598648|FG002|Overall Study|Study drug toxicity|7|||
124992355|NCT02581631|449598649|FG003|Overall Study|Study drug toxicity|0|||
124992356|NCT02581631|449598650|FG004|Overall Study|Study drug toxicity|3|||
124992357|NCT02581631|449598646|FG000|Overall Study|AE unrelated to study drug|3|||
124992358|NCT02581631|449598647|FG001|Overall Study|AE unrelated to study drug|1|||
124992359|NCT02581631|449598648|FG002|Overall Study|AE unrelated to study drug|1|||
124872650|NCT00293267|449155684|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
124872651|NCT00293267|449155685|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
124872652|NCT00293267|449155684|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
124872653|NCT00293267|449155685|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
124872654|NCT00293267|449155684|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
124872655|NCT00293267|449155685|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
124872656|NCT00293267|449155684|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
124872657|NCT00293267|449155685|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
124872658|NCT00293267|449155684|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
124872659|NCT00293267|449155685|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
124872660|NCT00293267|449155684|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
124872661|NCT00293267|449155685|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
124872662|NCT00293267|449155684|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
124872663|NCT00293267|449155685|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
124872664|NCT00293267|449155684|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
124872665|NCT00293267|449155685|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
124872666|NCT00293267|449155684|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
124872667|NCT00293267|449155685|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
124872668|NCT03086330|449155686|FG000|Overall Study|Withdrawal by Subject|3|||
124872669|NCT03086330|449155687|FG001|Overall Study|Withdrawal by Subject|2|||
124872670|NCT03086330|449155686|FG000|Overall Study|Lost to Follow-up|1|||
124872671|NCT03086330|449155687|FG001|Overall Study|Lost to Follow-up|2|||
124872672|NCT04899245|449155707|FG000|Overall Study|Withdrawal by Subject|3|||
124872673|NCT04899245|449155708|FG001|Overall Study|Withdrawal by Subject|5|||
124872674|NCT04899245|449155709|FG002|Overall Study|Withdrawal by Subject|2|||
124872675|NCT04899245|449155707|FG000|Overall Study|No longer eligible - Left staff position|0|||
124872676|NCT04899245|449155708|FG001|Overall Study|No longer eligible - Left staff position|0|||
124872677|NCT04899245|449155709|FG002|Overall Study|No longer eligible - Left staff position|1|||
124872678|NCT04899245|449155707|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
124872679|NCT04899245|449155708|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
124872680|NCT04899245|449155709|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
124872681|NCT04899245|449155707|FG000|Overall Study|No longer eligible - Moved away from area|2|||
124872682|NCT04899245|449155708|FG001|Overall Study|No longer eligible - Moved away from area|2|||
124872683|NCT04899245|449155709|FG002|Overall Study|No longer eligible - Moved away from area|0|||
124872684|NCT03371940|449155721|FG000|Overall Study|Withdrawal by Subject|8|||
124872685|NCT03371940|449155722|FG001|Overall Study|Withdrawal by Subject|1|||
124872686|NCT03371940|449155723|FG002|Overall Study|Withdrawal by Subject|3|||
124872687|NCT03371940|449155724|FG003|Overall Study|Withdrawal by Subject|4|||
124872688|NCT05099926|449155730|FG000|Overall Study|Lost to Follow-up|1|||
124872689|NCT00724152|449155733|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
124872690|NCT00724152|449155734|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
124872691|NCT00724152|449155735|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
124872692|NCT00724152|449155733|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
124872693|NCT00724152|449155734|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
124872694|NCT00724152|449155735|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
124872695|NCT00031486|449155741|FG000|Overall Study|Adverse Event|1|||
124992360|NCT02581631|449598649|FG003|Overall Study|AE unrelated to study drug|0|||
124992361|NCT02581631|449598650|FG004|Overall Study|AE unrelated to study drug|2|||
124992362|NCT02581631|449598646|FG000|Overall Study|Request to discontinue|1|||
124992363|NCT02581631|449598647|FG001|Overall Study|Request to discontinue|0|||
124992364|NCT02581631|449598648|FG002|Overall Study|Request to discontinue|3|||
124992365|NCT02581631|449598649|FG003|Overall Study|Request to discontinue|0|||
124992366|NCT02581631|449598650|FG004|Overall Study|Request to discontinue|1|||
124992367|NCT02581631|449598646|FG000|Overall Study|participant withdrew consent|3|||
124992368|NCT02581631|449598647|FG001|Overall Study|participant withdrew consent|0|||
124992369|NCT02581631|449598648|FG002|Overall Study|participant withdrew consent|1|||
124992370|NCT02581631|449598649|FG003|Overall Study|participant withdrew consent|0|||
124992371|NCT02581631|449598650|FG004|Overall Study|participant withdrew consent|0|||
124992372|NCT02581631|449598646|FG000|Overall Study|Maximum clinical benefit|1|||
124992373|NCT02581631|449598647|FG001|Overall Study|Maximum clinical benefit|7|||
124992374|NCT02581631|449598648|FG002|Overall Study|Maximum clinical benefit|1|||
124992375|NCT02581631|449598649|FG003|Overall Study|Maximum clinical benefit|3|||
124992376|NCT02581631|449598650|FG004|Overall Study|Maximum clinical benefit|13|||
124992377|NCT02581631|449598646|FG000|Overall Study|Other Reasons|1|||
124992378|NCT02581631|449598647|FG001|Overall Study|Other Reasons|0|||
124992379|NCT02581631|449598648|FG002|Overall Study|Other Reasons|2|||
124992380|NCT02581631|449598649|FG003|Overall Study|Other Reasons|2|||
124992381|NCT02581631|449598650|FG004|Overall Study|Other Reasons|3|||
124992382|NCT02581631|449598646|FG000|Overall Study|Poor/Non-Compliance|0|||
124992383|NCT02581631|449598647|FG001|Overall Study|Poor/Non-Compliance|0|||
124992384|NCT02581631|449598648|FG002|Overall Study|Poor/Non-Compliance|1|||
124992385|NCT02581631|449598649|FG003|Overall Study|Poor/Non-Compliance|0|||
124992386|NCT02581631|449598650|FG004|Overall Study|Poor/Non-Compliance|0|||
124992387|NCT00819390|449598651|FG000|Overall Study|Lost to Follow-up|1|||
124992388|NCT00819390|449598652|FG001|Overall Study|Lost to Follow-up|1|||
124992389|NCT00819390|449598653|FG002|Overall Study|Lost to Follow-up|0|||
124992390|NCT00819390|449598654|FG003|Overall Study|Lost to Follow-up|0|||
124992391|NCT00819390|449598651|FG000|Overall Study|Withdrawal by Subject|2|||
124992392|NCT00819390|449598652|FG001|Overall Study|Withdrawal by Subject|0|||
124992393|NCT00819390|449598653|FG002|Overall Study|Withdrawal by Subject|0|||
124992394|NCT00819390|449598654|FG003|Overall Study|Withdrawal by Subject|0|||
124992395|NCT00819390|449598651|FG000|Overall Study|Adverse Event|0|||
124992396|NCT00819390|449598652|FG001|Overall Study|Adverse Event|0|||
124992397|NCT00819390|449598653|FG002|Overall Study|Adverse Event|1|||
124992398|NCT00819390|449598654|FG003|Overall Study|Adverse Event|0|||
124992399|NCT01759368|449598661|FG000|Overall Study|Lost to Follow-up|1|||
124992400|NCT01759368|449598662|FG001|Overall Study|Lost to Follow-up|0|||
124992401|NCT01191268|449598663|FG000|Overall Study|Withdrawal by Subject|19|||
124992402|NCT01191268|449598664|FG001|Overall Study|Withdrawal by Subject|25|||
124992403|NCT01191268|449598665|FG002|Overall Study|Withdrawal by Subject|21|||
124992404|NCT01191268|449598663|FG000|Overall Study|Adverse Event|21|||
124992405|NCT01191268|449598664|FG001|Overall Study|Adverse Event|13|||
124992406|NCT01191268|449598665|FG002|Overall Study|Adverse Event|8|||
124992407|NCT01191268|449598663|FG000|Overall Study|Physician Decision|6|||
124992408|NCT01191268|449598664|FG001|Overall Study|Physician Decision|8|||
124992409|NCT01191268|449598665|FG002|Overall Study|Physician Decision|9|||
124992410|NCT01191268|449598663|FG000|Overall Study|Lost to Follow-up|8|||
124992411|NCT01191268|449598664|FG001|Overall Study|Lost to Follow-up|5|||
124992412|NCT01191268|449598665|FG002|Overall Study|Lost to Follow-up|9|||
124992413|NCT01191268|449598663|FG000|Overall Study|Entry Criteria Not Met|3|||
124992414|NCT01191268|449598664|FG001|Overall Study|Entry Criteria Not Met|1|||
124992415|NCT01191268|449598665|FG002|Overall Study|Entry Criteria Not Met|1|||
124992416|NCT01191268|449598663|FG000|Overall Study|Death|0|||
124992417|NCT01191268|449598664|FG001|Overall Study|Death|1|||
124992418|NCT01191268|449598665|FG002|Overall Study|Death|3|||
124992419|NCT01191268|449598663|FG000|Overall Study|Protocol Violation|1|||
124992420|NCT01191268|449598664|FG001|Overall Study|Protocol Violation|0|||
124992421|NCT01191268|449598665|FG002|Overall Study|Protocol Violation|1|||
124992422|NCT01191268|449598663|FG000|Overall Study|Sponsor Decision|0|||
124992423|NCT01191268|449598664|FG001|Overall Study|Sponsor Decision|2|||
124992424|NCT01191268|449598665|FG002|Overall Study|Sponsor Decision|0|||
124992425|NCT01270971|449598668|FG000|Overall Study|Withdrawal by Subject|24|||
124992426|NCT01270971|449598669|FG001|Overall Study|Withdrawal by Subject|11|||
124992427|NCT01270971|449598668|FG000|Overall Study|Lost to Follow-up|18|||
124992428|NCT01270971|449598669|FG001|Overall Study|Lost to Follow-up|5|||
124992429|NCT01270971|449598668|FG000|Overall Study|Adverse Event|1|||
124992430|NCT01270971|449598669|FG001|Overall Study|Adverse Event|2|||
124992431|NCT01270971|449598668|FG000|Overall Study|Non compliance|2|||
124992432|NCT01270971|449598669|FG001|Overall Study|Non compliance|2|||
124992433|NCT01270971|449598668|FG000|Overall Study|Non-specific|7|||
124992434|NCT01270971|449598669|FG001|Overall Study|Non-specific|3|||
124992435|NCT01588496|449598673|FG000|Overall Study|Withdrawal by Subject|0|||
124992436|NCT01588496|449598674|FG001|Overall Study|Withdrawal by Subject|1|||
124992437|NCT01588496|449598675|FG002|Overall Study|Withdrawal by Subject|0|||
124992438|NCT03333837|449598678|FG000|Overall Study|Adverse Event|2|||
124992439|NCT03333837|449598679|FG001|Overall Study|Adverse Event|1|||
124992440|NCT03333837|449598680|FG002|Overall Study|Adverse Event|1|||
124872696|NCT00031486|449155742|FG001|Overall Study|Adverse Event|0|||
124992441|NCT03333837|449598681|FG003|Overall Study|Adverse Event|1|||
124992442|NCT03333837|449598682|FG004|Overall Study|Adverse Event|0|||
124992443|NCT03333837|449598678|FG000|Overall Study|Caregiver withdrew|0|||
124992444|NCT03333837|449598679|FG001|Overall Study|Caregiver withdrew|2|||
124992445|NCT03333837|449598680|FG002|Overall Study|Caregiver withdrew|1|||
124992446|NCT03333837|449598681|FG003|Overall Study|Caregiver withdrew|0|||
124992447|NCT03333837|449598682|FG004|Overall Study|Caregiver withdrew|0|||
124992448|NCT03333837|449598678|FG000|Overall Study|Withdrawal by Subject|0|||
124992449|NCT03333837|449598679|FG001|Overall Study|Withdrawal by Subject|0|||
124992450|NCT03333837|449598680|FG002|Overall Study|Withdrawal by Subject|1|||
124992451|NCT03333837|449598681|FG003|Overall Study|Withdrawal by Subject|1|||
124992452|NCT03333837|449598682|FG004|Overall Study|Withdrawal by Subject|3|||
124992453|NCT03333837|449598678|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
124992454|NCT03333837|449598679|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
124992455|NCT03333837|449598680|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
124992456|NCT03333837|449598681|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
124992457|NCT03333837|449598682|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
124992458|NCT00705523|449598683|FG000|Overall Study|Lost to Follow-up|2|||
124992459|NCT00705523|449598684|FG001|Overall Study|Lost to Follow-up|3|||
124992460|NCT01013285|449598685|FG000|Overall Study|Death|48|||
124992461|NCT01013285|449598686|FG001|Overall Study|Death|89|||
124992462|NCT02374671|449598689|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
124992463|NCT02374671|449598690|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
124992464|NCT02374671|449598691|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
124992465|NCT02374671|449598689|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
124992466|NCT02374671|449598690|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
124992467|NCT02374671|449598691|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
124992468|NCT02374671|449598689|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
124992469|NCT02374671|449598690|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
124992470|NCT02374671|449598691|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
124992471|NCT02374671|449598689|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
124992472|NCT02374671|449598690|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
124992473|NCT02374671|449598691|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
124992474|NCT02374671|449598689|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
124992475|NCT02374671|449598690|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
124992476|NCT02374671|449598691|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
124992477|NCT03866473|449598694|FG000|Phase 1|Death|1|||
124992478|NCT03866473|449598695|FG001|Phase 1|Death|0|||
124992479|NCT03866473|449598694|FG000|Phase 2|Death|0|||
124992480|NCT03866473|449598695|FG001|Phase 2|Death|2|||
124992481|NCT03866473|449598694|FG000|Phase 2|Dropped|1|||
124992482|NCT03866473|449598695|FG001|Phase 2|Dropped|1|||
124992483|NCT03866473|449598694|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
124992484|NCT03866473|449598695|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
124992485|NCT03110185|449598696|FG000|Overall Study|Death|0|||
124992486|NCT03110185|449598697|FG001|Overall Study|Death|1|||
124992487|NCT03110185|449598696|FG000|Overall Study|Withdrawal by Subject|2|||
124992488|NCT03110185|449598697|FG001|Overall Study|Withdrawal by Subject|7|||
124992489|NCT03110185|449598696|FG000|Overall Study|Time Constraints|0|||
124992490|NCT03110185|449598697|FG001|Overall Study|Time Constraints|6|||
124992491|NCT03110185|449598696|FG000|Overall Study|Conflict with care|5|||
124992492|NCT03110185|449598697|FG001|Overall Study|Conflict with care|12|||
124992493|NCT03110185|449598696|FG000|Overall Study|Protocol Violation|1|||
124992494|NCT03110185|449598697|FG001|Overall Study|Protocol Violation|4|||
124992495|NCT03110185|449598696|FG000|Overall Study|MRI Incompatible|2|||
124992496|NCT03110185|449598697|FG001|Overall Study|MRI Incompatible|0|||
124992497|NCT03110185|449598696|FG000|Overall Study|Patient Refusal|0|||
124992498|NCT03110185|449598697|FG001|Overall Study|Patient Refusal|1|||
124992499|NCT00600886|449598698|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
124992500|NCT00600886|449598699|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
124992501|NCT00600886|449598698|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
124992502|NCT00600886|449598699|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
124992503|NCT00600886|449598698|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
124992504|NCT00600886|449598699|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
124992505|NCT00600886|449598698|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
124992506|NCT00600886|449598699|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
124992507|NCT00600886|449598698|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
124992508|NCT00600886|449598699|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
124992509|NCT00600886|449598698|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
124992510|NCT00600886|449598699|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
124992511|NCT00600886|449598698|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
124992512|NCT00600886|449598699|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
124992513|NCT00600886|449598698|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
124992514|NCT00600886|449598699|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
124992515|NCT00600886|449598698|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
124992516|NCT00600886|449598699|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
124992517|NCT00600886|449598698|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
124992518|NCT00600886|449598699|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
124992519|NCT00600886|449598698|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
124992520|NCT00600886|449598699|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
124992521|NCT00600886|449598698|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
124992522|NCT00600886|449598699|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
124992523|NCT00600886|449598698|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
124992524|NCT00600886|449598699|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
124992525|NCT00600886|449598698|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
124992526|NCT00600886|449598699|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
124992527|NCT00600886|449598698|FG000|Extension - Same Treatment (FAS)|Death|1|||
124992528|NCT00600886|449598699|FG001|Extension - Same Treatment (FAS)|Death|1|||
124992529|NCT00600886|449598698|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
124992530|NCT00600886|449598699|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
124992531|NCT00600886|449598698|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
124992532|NCT00600886|449598699|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
124992533|NCT00600886|449598698|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
124992534|NCT00600886|449598699|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
124992535|NCT00600886|449598698|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
124992536|NCT00600886|449598699|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
124992537|NCT00600886|449598698|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
124992538|NCT00600886|449598699|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
124992539|NCT00600886|449598698|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
124992540|NCT00600886|449598699|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
124992541|NCT00600886|449598698|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
124992542|NCT00600886|449598699|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
124992543|NCT00600886|449598698|FG000|Extension - After Crossover (CAS)|Death|1|||
124992544|NCT00600886|449598699|FG001|Extension - After Crossover (CAS)|Death|0|||
124992545|NCT02523599|449598700|FG000|Overall Study|Adverse Event|1|||
124992546|NCT02523599|449598701|FG001|Overall Study|Adverse Event|0|||
124992547|NCT02523599|449598700|FG000|Overall Study|Physician Decision|1|||
124992548|NCT02523599|449598701|FG001|Overall Study|Physician Decision|0|||
124992549|NCT02523599|449598700|FG000|Overall Study|Lost to Follow-up|4|||
124992550|NCT02523599|449598701|FG001|Overall Study|Lost to Follow-up|1|||
124992551|NCT02523599|449598700|FG000|Overall Study|Did not return for Day 30 visit|2|||
124992552|NCT02523599|449598701|FG001|Overall Study|Did not return for Day 30 visit|0|||
124992553|NCT01427751|449598702|FG000|Overall Study|Adverse Event|18|||
124992554|NCT01427751|449598703|FG001|Overall Study|Adverse Event|2|||
124992555|NCT01427751|449598702|FG000|Overall Study|No further treatment benefit expected|5|||
124992556|NCT01427751|449598703|FG001|Overall Study|No further treatment benefit expected|1|||
124992557|NCT01427751|449598702|FG000|Overall Study|Lost to Follow-up|3|||
124992558|NCT01427751|449598703|FG001|Overall Study|Lost to Follow-up|1|||
124992559|NCT01427751|449598702|FG000|Overall Study|Withdrawal of consent|2|||
124992560|NCT01427751|449598703|FG001|Overall Study|Withdrawal of consent|2|||
124992561|NCT01427751|449598702|FG000|Overall Study|Protocol Violation|6|||
124992562|NCT01427751|449598703|FG001|Overall Study|Protocol Violation|4|||
124992563|NCT01427751|449598702|FG000|Overall Study|Death|2|||
124992564|NCT01427751|449598703|FG001|Overall Study|Death|0|||
124992565|NCT01427751|449598702|FG000|Overall Study|Other miscellaneous reasons|6|||
124992566|NCT01427751|449598703|FG001|Overall Study|Other miscellaneous reasons|4|||
124992567|NCT05330312|449598704|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
124992568|NCT05330312|449598705|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
124992569|NCT05330312|449598706|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
124992570|NCT05330312|449598704|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
124992571|NCT05330312|449598705|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
124992572|NCT05330312|449598706|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
124992573|NCT05330312|449598704|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
124992574|NCT05330312|449598705|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
124992575|NCT05330312|449598706|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
124992576|NCT05330312|449598704|FG000|Pivotal Investigation - Part 2|Death|1|||
124992577|NCT05330312|449598705|FG001|Pivotal Investigation - Part 2|Death|4|||
124992578|NCT05330312|449598706|FG002|Pivotal Investigation - Part 2|Death|0|||
124992579|NCT03319849|449598707|FG000|Overall Study|Adverse Event|1|||
124992580|NCT03319849|449598708|FG001|Overall Study|Adverse Event|0|||
124992581|NCT03319849|449598707|FG000|Overall Study|Physician Decision|0|||
124992582|NCT03319849|449598708|FG001|Overall Study|Physician Decision|1|||
124992583|NCT03319849|449598707|FG000|Overall Study|Withdrawal by Subject|0|||
124992584|NCT03319849|449598708|FG001|Overall Study|Withdrawal by Subject|1|||
124992585|NCT03319849|449598707|FG000|Overall Study|COVID-19|0|||
124992586|NCT03319849|449598708|FG001|Overall Study|COVID-19|1|||
124992587|NCT03319849|449598707|FG000|Overall Study|Other|1|||
124992588|NCT03319849|449598708|FG001|Overall Study|Other|2|||
124992589|NCT03319849|449598707|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
124992590|NCT03319849|449598708|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
124992591|NCT03319849|449598707|FG000|Overall Study|Lost to Follow-up|0|||
124992592|NCT03319849|449598708|FG001|Overall Study|Lost to Follow-up|2|||
124992593|NCT01060540|449600619|FG000|Overall Study|Withdrawal by Subject|10|||
124992594|NCT01060540|449600620|FG001|Overall Study|Withdrawal by Subject|20|||
124992595|NCT01060540|449600619|FG000|Overall Study|Lost to Follow-up|52|||
124992596|NCT01060540|449600620|FG001|Overall Study|Lost to Follow-up|43|||
124992597|NCT01060540|449600619|FG000|Overall Study|Death|2|||
124992598|NCT01060540|449600620|FG001|Overall Study|Death|1|||
124992599|NCT01060540|449600619|FG000|Overall Study|Physician Decision|0|||
124992600|NCT01060540|449600620|FG001|Overall Study|Physician Decision|1|||
124992601|NCT02502097|449600621|FG000|Period 1|Adverse Event|0|||
124992602|NCT02502097|449600622|FG001|Period 1|Adverse Event|0|||
124992603|NCT02502097|449600623|FG002|Period 1|Adverse Event|1|||
124992604|NCT02502097|449600624|FG003|Period 1|Adverse Event|0|||
124992605|NCT02502097|449600621|FG000|Wash Out Period|Adverse Event|0|||
124992606|NCT02502097|449600622|FG001|Wash Out Period|Adverse Event|1|||
124992607|NCT02502097|449600623|FG002|Wash Out Period|Adverse Event|1|||
124992608|NCT02502097|449600624|FG003|Wash Out Period|Adverse Event|1|||
124992609|NCT02502097|449600621|FG000|Period 2|Adverse Event|0|||
124992610|NCT02502097|449600622|FG001|Period 2|Adverse Event|0|||
124992611|NCT02502097|449600623|FG002|Period 2|Adverse Event|1|||
124992612|NCT02502097|449600624|FG003|Period 2|Adverse Event|0|||
124992613|NCT01201317|449600625|FG000|Overall Study|Withdrawal by Subject|5|||
124992614|NCT01201317|449600626|FG001|Overall Study|Withdrawal by Subject|0|||
124992615|NCT01201317|449600627|FG002|Overall Study|Withdrawal by Subject|3|||
124992616|NCT01201317|449600625|FG000|Overall Study|Adverse Event|2|||
124992617|NCT01201317|449600626|FG001|Overall Study|Adverse Event|2|||
124992618|NCT01201317|449600627|FG002|Overall Study|Adverse Event|2|||
124992619|NCT01201317|449600625|FG000|Overall Study|Screen failure|1|||
124992620|NCT01201317|449600626|FG001|Overall Study|Screen failure|1|||
124992621|NCT01201317|449600627|FG002|Overall Study|Screen failure|0|||
124992622|NCT01201317|449600625|FG000|Overall Study|Protocol Violation|0|||
124992623|NCT01201317|449600626|FG001|Overall Study|Protocol Violation|1|||
124992624|NCT01201317|449600627|FG002|Overall Study|Protocol Violation|1|||
124992625|NCT01201317|449600625|FG000|Overall Study|Death|0|||
124992626|NCT01201317|449600626|FG001|Overall Study|Death|1|||
124992627|NCT01201317|449600627|FG002|Overall Study|Death|0|||
124992628|NCT01201317|449600625|FG000|Overall Study|Study-specific withdrawal criteria|0|||
124992629|NCT01201317|449600626|FG001|Overall Study|Study-specific withdrawal criteria|0|||
124992630|NCT01201317|449600627|FG002|Overall Study|Study-specific withdrawal criteria|1|||
124992631|NCT01201317|449600625|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
124992632|NCT01201317|449600626|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
124992633|NCT01201317|449600627|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
124992634|NCT01201317|449600625|FG000|Overall Study|Decrease in renal function|0|||
124992635|NCT01201317|449600626|FG001|Overall Study|Decrease in renal function|1|||
124992636|NCT01201317|449600627|FG002|Overall Study|Decrease in renal function|0|||
124992637|NCT01201317|449600625|FG000|Overall Study|Lack of Efficacy|1|||
124992638|NCT01201317|449600626|FG001|Overall Study|Lack of Efficacy|0|||
124992639|NCT01201317|449600627|FG002|Overall Study|Lack of Efficacy|0|||
124992640|NCT01201317|449600625|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
124992641|NCT01201317|449600626|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
124992642|NCT01201317|449600627|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
124992643|NCT00252733|449600628|FG000|Overall Study|Withdrawal by Subject|73|||
124992644|NCT00252733|449600629|FG001|Overall Study|Withdrawal by Subject|67|||
124992645|NCT00252733|449600628|FG000|Overall Study|Death|7|||
124992646|NCT00252733|449600629|FG001|Overall Study|Death|5|||
124992647|NCT00252733|449600628|FG000|Overall Study|Lost to Follow-up|12|||
124992648|NCT00252733|449600629|FG001|Overall Study|Lost to Follow-up|6|||
124992649|NCT00252733|449600628|FG000|Overall Study|Multiple Reasons|14|||
124992650|NCT00252733|449600629|FG001|Overall Study|Multiple Reasons|14|||
124992651|NCT01350336|449600630|FG000|Overall Study|Lost to Follow-up|31|||
124992652|NCT01350336|449600630|FG000|Overall Study|Withdrawal by Subject|14|||
124992653|NCT01350336|449600630|FG000|Overall Study|Physician Decision|8|||
124992654|NCT01350336|449600630|FG000|Overall Study|Death|4|||
124992655|NCT01491672|449600631|FG000|Overall Study|Lost to Follow-up|0|||
124992656|NCT01491672|449600632|FG001|Overall Study|Lost to Follow-up|4|||
124992657|NCT01491672|449600633|FG002|Overall Study|Lost to Follow-up|1|||
124992658|NCT01491672|449600631|FG000|Overall Study|Withdrawal by Subject|6|||
124992659|NCT01491672|449600632|FG001|Overall Study|Withdrawal by Subject|7|||
124872697|NCT00031486|449155741|FG000|Overall Study|Lost to Follow-up|0|||
124992660|NCT01491672|449600633|FG002|Overall Study|Withdrawal by Subject|0|||
124992661|NCT01491672|449600631|FG000|Overall Study|Adverse Event|8|||
124992662|NCT01491672|449600632|FG001|Overall Study|Adverse Event|10|||
124992663|NCT01491672|449600633|FG002|Overall Study|Adverse Event|4|||
124992664|NCT01491672|449600631|FG000|Overall Study|Disease progression|42|||
124992665|NCT01491672|449600632|FG001|Overall Study|Disease progression|34|||
124992666|NCT01491672|449600633|FG002|Overall Study|Disease progression|6|||
124992667|NCT01491672|449600631|FG000|Overall Study|Protocol deviation|0|||
124992668|NCT01491672|449600632|FG001|Overall Study|Protocol deviation|1|||
124992669|NCT01491672|449600633|FG002|Overall Study|Protocol deviation|0|||
124992670|NCT01491672|449600631|FG000|Overall Study|Death|0|||
124992671|NCT01491672|449600632|FG001|Overall Study|Death|4|||
124992672|NCT01491672|449600633|FG002|Overall Study|Death|0|||
124992673|NCT02795429|449600634|FG000|Overall Study|Adverse Event|1|||
124992674|NCT02795429|449600635|FG001|Overall Study|Adverse Event|2|||
124992675|NCT02795429|449600636|FG002|Overall Study|Adverse Event|1|||
124992676|NCT02795429|449600637|FG003|Overall Study|Adverse Event|2|||
124992677|NCT02795429|449600638|FG004|Overall Study|Adverse Event|1|||
124992678|NCT02795429|449600634|FG000|Overall Study|Death|1|||
124992679|NCT02795429|449600635|FG001|Overall Study|Death|0|||
124992680|NCT02795429|449600636|FG002|Overall Study|Death|1|||
124992681|NCT02795429|449600637|FG003|Overall Study|Death|2|||
124992682|NCT02795429|449600638|FG004|Overall Study|Death|1|||
124992683|NCT02795429|449600634|FG000|Overall Study|Physician Decision|0|||
124992684|NCT02795429|449600635|FG001|Overall Study|Physician Decision|0|||
124992685|NCT02795429|449600636|FG002|Overall Study|Physician Decision|2|||
124992686|NCT02795429|449600637|FG003|Overall Study|Physician Decision|1|||
124992687|NCT02795429|449600638|FG004|Overall Study|Physician Decision|5|||
124992688|NCT02795429|449600634|FG000|Overall Study|Progressive disease|3|||
124992689|NCT02795429|449600635|FG001|Overall Study|Progressive disease|7|||
124992690|NCT02795429|449600636|FG002|Overall Study|Progressive disease|6|||
124992691|NCT02795429|449600637|FG003|Overall Study|Progressive disease|26|||
124992692|NCT02795429|449600638|FG004|Overall Study|Progressive disease|20|||
124992693|NCT02795429|449600634|FG000|Overall Study|Subject/guardian decision|1|||
124992694|NCT02795429|449600635|FG001|Overall Study|Subject/guardian decision|1|||
124992695|NCT02795429|449600636|FG002|Overall Study|Subject/guardian decision|1|||
124992696|NCT02795429|449600637|FG003|Overall Study|Subject/guardian decision|1|||
124992697|NCT02795429|449600638|FG004|Overall Study|Subject/guardian decision|3|||
124992698|NCT03310268|449600639|FG000|Overall Study|(Not specified)|1|||
124992699|NCT03310268|449600640|FG001|Overall Study|(Not specified)|5|||
124992700|NCT03310268|449600641|FG002|Overall Study|(Not specified)|0|||
124992701|NCT00706433|449600644|FG000|Overall Study|Lost to Follow-up|3|||
124992702|NCT00706433|449600645|FG001|Overall Study|Lost to Follow-up|1|||
124992703|NCT00706433|449600646|FG002|Overall Study|Lost to Follow-up|6|||
124992704|NCT00706433|449600647|FG003|Overall Study|Lost to Follow-up|0|||
124992705|NCT00706433|449600644|FG000|Overall Study|Withdrawal by Subject|1|||
124992706|NCT00706433|449600645|FG001|Overall Study|Withdrawal by Subject|2|||
124992707|NCT00706433|449600646|FG002|Overall Study|Withdrawal by Subject|3|||
124992708|NCT00706433|449600647|FG003|Overall Study|Withdrawal by Subject|1|||
124992709|NCT00706433|449600644|FG000|Overall Study|Adverse Event|0|||
124992710|NCT00706433|449600645|FG001|Overall Study|Adverse Event|0|||
124992711|NCT00706433|449600646|FG002|Overall Study|Adverse Event|1|||
124992712|NCT00706433|449600647|FG003|Overall Study|Adverse Event|0|||
124992713|NCT00706433|449600644|FG000|Overall Study|Protocol Violation|1|||
124992714|NCT00706433|449600645|FG001|Overall Study|Protocol Violation|0|||
124992715|NCT00706433|449600646|FG002|Overall Study|Protocol Violation|0|||
124992716|NCT00706433|449600647|FG003|Overall Study|Protocol Violation|0|||
124992717|NCT00706433|449600644|FG000|Overall Study|new job|0|||
124992718|NCT00706433|449600645|FG001|Overall Study|new job|0|||
124992719|NCT00706433|449600646|FG002|Overall Study|new job|0|||
124992720|NCT00706433|449600647|FG003|Overall Study|new job|1|||
124992721|NCT05041101|449600648|FG000|Overall Study|Adverse Event|1|||
124992722|NCT05041101|449600649|FG001|Overall Study|Adverse Event|0|||
124992723|NCT05041101|449600650|FG002|Overall Study|Adverse Event|0|||
124992724|NCT05041101|449600648|FG000|Overall Study|Diease Progression|5|||
124992725|NCT05041101|449600649|FG001|Overall Study|Diease Progression|0|||
124992726|NCT05041101|449600650|FG002|Overall Study|Diease Progression|0|||
124992727|NCT04426851|449600651|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
124992728|NCT04426851|449600652|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
124992729|NCT04426851|449600651|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
124992730|NCT04426851|449600652|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
124992731|NCT00986674|449600653|FG000|Overall Study|Lack of Efficacy|28|||
124992732|NCT00986674|449600654|FG001|Overall Study|Lack of Efficacy|25|||
124992733|NCT00986674|449600655|FG002|Overall Study|Lack of Efficacy|23|||
124992734|NCT00986674|449600653|FG000|Overall Study|Adverse Event|4|||
124992735|NCT00986674|449600654|FG001|Overall Study|Adverse Event|8|||
124992736|NCT00986674|449600655|FG002|Overall Study|Adverse Event|9|||
124992737|NCT00986674|449600653|FG000|Overall Study|Death|5|||
124992738|NCT00986674|449600654|FG001|Overall Study|Death|0|||
124992739|NCT00986674|449600655|FG002|Overall Study|Death|4|||
124992740|NCT00986674|449600653|FG000|Overall Study|Withdrawal by Subject|6|||
124992741|NCT00986674|449600654|FG001|Overall Study|Withdrawal by Subject|2|||
124992742|NCT00986674|449600655|FG002|Overall Study|Withdrawal by Subject|1|||
124992743|NCT00986674|449600653|FG000|Overall Study|alternative therapy|0|||
124992744|NCT00986674|449600654|FG001|Overall Study|alternative therapy|0|||
124992745|NCT00986674|449600655|FG002|Overall Study|alternative therapy|1|||
124992746|NCT00986674|449600653|FG000|Overall Study|not start protocol therapy|4|||
124992747|NCT00986674|449600654|FG001|Overall Study|not start protocol therapy|3|||
124992748|NCT00986674|449600655|FG002|Overall Study|not start protocol therapy|1|||
124992749|NCT00986674|449600653|FG000|Overall Study|unknown/not specify|0|||
124992750|NCT00986674|449600654|FG001|Overall Study|unknown/not specify|7|||
124992751|NCT00986674|449600655|FG002|Overall Study|unknown/not specify|9|||
124992752|NCT02128542|449600656|FG000|Overall Study|Lost to Follow-up|3|||
124992753|NCT02128542|449600657|FG001|Overall Study|Lost to Follow-up|0|||
124992754|NCT02128542|449600656|FG000|Overall Study|Withdrew Consent|1|||
124992755|NCT02128542|449600657|FG001|Overall Study|Withdrew Consent|0|||
124992756|NCT01853137|449600658|FG000|Overall Study|Lost to Follow-up|4|||
124992757|NCT01853137|449600659|FG001|Overall Study|Lost to Follow-up|1|||
124992758|NCT00825916|449600660|FG000|Overall Study|Lost to Follow-up|4|||
124992759|NCT00825916|449600661|FG001|Overall Study|Lost to Follow-up|2|||
124992760|NCT00825916|449600662|FG002|Overall Study|Lost to Follow-up|1|||
124992761|NCT01778023|449600663|FG000|Overall Study|Withdrawal by Subject|0|||
124992762|NCT01778023|449600664|FG001|Overall Study|Withdrawal by Subject|3|||
124992763|NCT01990560|449600665|FG000|Overall Study|Withdrawal by Subject|1|||
124992764|NCT01098097|449600666|FG000|Overall Study|Adverse Event|17|||
124992765|NCT01098097|449600666|FG000|Overall Study|Lost to Follow-up|18|||
124992766|NCT01098097|449600666|FG000|Overall Study|Status unknown|16|||
124992767|NCT01098097|449600666|FG000|Overall Study|No reason reported|31|||
124992768|NCT01411215|449600667|FG000|Overall Study|Adverse Event|1|||
124992769|NCT01411215|449600668|FG001|Overall Study|Adverse Event|2|||
124992770|NCT01411215|449600667|FG000|Overall Study|Lack of Efficacy|2|||
124992771|NCT01411215|449600668|FG001|Overall Study|Lack of Efficacy|4|||
124992772|NCT01411215|449600667|FG000|Overall Study|Lost to Follow-up|12|||
124992773|NCT01411215|449600668|FG001|Overall Study|Lost to Follow-up|18|||
124992774|NCT01411215|449600667|FG000|Overall Study|Did not meet entrance criteria|0|||
124992775|NCT01411215|449600668|FG001|Overall Study|Did not meet entrance criteria|1|||
124992776|NCT01411215|449600667|FG000|Overall Study|Study terminated by sponsor|2|||
124992777|NCT01411215|449600668|FG001|Overall Study|Study terminated by sponsor|15|||
124992778|NCT01411215|449600667|FG000|Overall Study|Protocol Violation|3|||
124992779|NCT01411215|449600668|FG001|Overall Study|Protocol Violation|5|||
124992780|NCT01411215|449600667|FG000|Overall Study|Withdrawal by Subject|34|||
124992781|NCT01411215|449600668|FG001|Overall Study|Withdrawal by Subject|21|||
124992782|NCT01411215|449600667|FG000|Overall Study|Other|12|||
124992783|NCT01411215|449600668|FG001|Overall Study|Other|17|||
124992784|NCT01411215|449600667|FG000|Overall Study|Screen failure|0|||
124992785|NCT01411215|449600668|FG001|Overall Study|Screen failure|1|||
124992786|NCT00848926|449600669|FG000|Treatment Period|Progressive disease|45|||
124992787|NCT00848926|449600669|FG000|Treatment Period|Adverse Event|20|||
124992788|NCT00848926|449600669|FG000|Treatment Period|Physician Decision|12|||
124992789|NCT00848926|449600669|FG000|Treatment Period|Withdrawal by Subject|7|||
124992790|NCT00848926|449600669|FG000|Follow-up Period|Lost to Follow-up|7|||
124992791|NCT00848926|449600669|FG000|Follow-up Period|Withdrawal by Subject|3|||
124992792|NCT00848926|449600669|FG000|Follow-up Period|Other|2|||
124992793|NCT02924064|449600672|FG000|Overall Study|Adverse Event|2|||
124992794|NCT02924064|449600673|FG001|Overall Study|Adverse Event|2|||
124992795|NCT02924064|449600672|FG000|Overall Study|Lost to Follow-up|0|||
124992796|NCT02924064|449600673|FG001|Overall Study|Lost to Follow-up|2|||
124992797|NCT02924064|449600672|FG000|Overall Study|Physician Decision|0|||
124992798|NCT02924064|449600673|FG001|Overall Study|Physician Decision|2|||
124992799|NCT02924064|449600672|FG000|Overall Study|Protocol Violation|1|||
124992800|NCT02924064|449600673|FG001|Overall Study|Protocol Violation|3|||
124992801|NCT02924064|449600672|FG000|Overall Study|Withdrawal by Subject|4|||
124992802|NCT02924064|449600673|FG001|Overall Study|Withdrawal by Subject|5|||
124992803|NCT02924064|449600672|FG000|Overall Study|Other|17|||
124992804|NCT02924064|449600673|FG001|Overall Study|Other|29|||
124992805|NCT04507126|449600674|FG000|Overall Study|Withdrawal by Subject|1|||
124992806|NCT04507126|449600674|FG000|Overall Study|Protocol Violation|2|||
124992807|NCT04507126|449600674|FG000|Overall Study|Physician Decision|1|||
124992808|NCT00966277|449600677|FG000|Overall Study|Withdrawal by Subject|3|||
124992809|NCT00966277|449600678|FG001|Overall Study|Withdrawal by Subject|0|||
124992810|NCT00966277|449600677|FG000|Overall Study|Ineligible|1|||
124992811|NCT00966277|449600678|FG001|Overall Study|Ineligible|3|||
124992812|NCT00966277|449600677|FG000|Overall Study|Treatment Plan Changed|0|||
124992813|NCT00966277|449600678|FG001|Overall Study|Treatment Plan Changed|1|||
124992814|NCT01100034|449600679|FG000|Overall Study|Lost to Follow-up|11|||
124992815|NCT01100034|449600679|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
124992816|NCT01100034|449600679|FG000|Overall Study|Withdrawal by Subject|4|||
124992817|NCT01100034|449600679|FG000|Overall Study|Sponsor decision|21|||
124992818|NCT01100034|449600679|FG000|Overall Study|Participated in another clinical trial|1|||
124992819|NCT01100034|449600679|FG000|Overall Study|Participants moved to another hospital|4|||
124992820|NCT01100034|449600679|FG000|Overall Study|Site closed due to non-responsiveness|1|||
124992821|NCT01831856|449600680|FG000|Overall Study|Adverse Event|5|||
124992822|NCT01831856|449600681|FG001|Overall Study|Adverse Event|8|||
124992823|NCT01831856|449600680|FG000|Overall Study|Lack of Efficacy|13|||
124992824|NCT01831856|449600681|FG001|Overall Study|Lack of Efficacy|11|||
124992825|NCT01831856|449600680|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
124992826|NCT01831856|449600681|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
124992827|NCT00455325|449600682|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
124992828|NCT00455325|449600683|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
124992829|NCT00455325|449600684|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
124992830|NCT00455325|449600685|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
124992831|NCT00455325|449600682|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
124992832|NCT00455325|449600683|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
124992833|NCT00455325|449600684|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
124992834|NCT00455325|449600685|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
124992835|NCT00455325|449600682|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
124992836|NCT00455325|449600683|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
124992837|NCT00455325|449600684|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
124992838|NCT00455325|449600685|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
124992839|NCT00455325|449600682|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
124992840|NCT00455325|449600683|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
124992841|NCT00455325|449600684|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
124992842|NCT00455325|449600685|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
124992843|NCT00455325|449600682|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
124992844|NCT00455325|449600683|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
124992845|NCT00455325|449600684|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
124992846|NCT00455325|449600685|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
124992847|NCT00455325|449600682|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
124992848|NCT00455325|449600683|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
124992849|NCT00455325|449600684|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
124992850|NCT00455325|449600685|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
124992851|NCT00455325|449600682|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
124992852|NCT00455325|449600683|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
124992853|NCT00455325|449600684|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
124992854|NCT00455325|449600685|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
124992855|NCT04620811|449600686|FG000|Overall Study|Withdrawal by Subject|18|||
124992856|NCT04620811|449600687|FG001|Overall Study|Withdrawal by Subject|15|||
124992857|NCT04620811|449600686|FG000|Overall Study|Adverse Event|6|||
124992858|NCT04620811|449600687|FG001|Overall Study|Adverse Event|11|||
124992859|NCT04620811|449600686|FG000|Overall Study|Lost to Follow-up|4|||
124992860|NCT04620811|449600687|FG001|Overall Study|Lost to Follow-up|8|||
124992861|NCT04620811|449600686|FG000|Overall Study|Physician Decision|1|||
124992862|NCT04620811|449600687|FG001|Overall Study|Physician Decision|4|||
124992863|NCT04620811|449600686|FG000|Overall Study|Sponsor Decision|0|||
124992864|NCT04620811|449600687|FG001|Overall Study|Sponsor Decision|1|||
124992865|NCT04620811|449600686|FG000|Overall Study|Elevation of ALT or AST|1|||
124992866|NCT04620811|449600687|FG001|Overall Study|Elevation of ALT or AST|0|||
124992867|NCT04620811|449600686|FG000|Overall Study|Other|3|||
124872698|NCT00031486|449155742|FG001|Overall Study|Lost to Follow-up|1|||
124872699|NCT00031486|449155741|FG000|Overall Study|Withdrawal by Subject|3|||
124872700|NCT00031486|449155742|FG001|Overall Study|Withdrawal by Subject|2|||
124872701|NCT00031486|449155741|FG000|Overall Study|Death|0|||
124872702|NCT00031486|449155742|FG001|Overall Study|Death|3|||
124872703|NCT00031486|449155741|FG000|Overall Study|Non-compliant|0|||
124872704|NCT00031486|449155742|FG001|Overall Study|Non-compliant|4|||
124872705|NCT00031486|449155741|FG000|Overall Study|Did not meet eligibility requirement|2|||
124872706|NCT00031486|449155742|FG001|Overall Study|Did not meet eligibility requirement|1|||
124872707|NCT00031486|449155741|FG000|Overall Study|Other|1|||
124872708|NCT00031486|449155742|FG001|Overall Study|Other|1|||
124872709|NCT03685591|449155743|FG000|Overall Study|Global Deterioration of Health Status|0|||
124872710|NCT03685591|449155744|FG001|Overall Study|Global Deterioration of Health Status|0|||
124872711|NCT03685591|449155745|FG002|Overall Study|Global Deterioration of Health Status|0|||
124872712|NCT03685591|449155746|FG003|Overall Study|Global Deterioration of Health Status|1|||
124872713|NCT03685591|449155747|FG004|Overall Study|Global Deterioration of Health Status|2|||
124872714|NCT03685591|449155748|FG005|Overall Study|Global Deterioration of Health Status|4|||
124872715|NCT03685591|449155749|FG006|Overall Study|Global Deterioration of Health Status|1|||
124872716|NCT03685591|449155750|FG007|Overall Study|Global Deterioration of Health Status|1|||
124872717|NCT03685591|449155751|FG008|Overall Study|Global Deterioration of Health Status|0|||
124872718|NCT03685591|449155743|FG000|Overall Study|Progressive Disease|1|||
124872719|NCT03685591|449155744|FG001|Overall Study|Progressive Disease|1|||
124872720|NCT03685591|449155745|FG002|Overall Study|Progressive Disease|0|||
124872721|NCT03685591|449155746|FG003|Overall Study|Progressive Disease|3|||
124872722|NCT03685591|449155747|FG004|Overall Study|Progressive Disease|5|||
124872723|NCT03685591|449155748|FG005|Overall Study|Progressive Disease|4|||
124872724|NCT03685591|449155749|FG006|Overall Study|Progressive Disease|3|||
124872725|NCT03685591|449155750|FG007|Overall Study|Progressive Disease|2|||
124992868|NCT04620811|449600687|FG001|Overall Study|Other|5|||
124992869|NCT01959334|449600688|FG000|Second Dose|Adverse Event|1|||
124992870|NCT01959334|449600689|FG001|Second Dose|Adverse Event|0|||
124992871|NCT01959334|449600688|FG000|Third Dose|Adverse Event|0|||
124992872|NCT01959334|449600689|FG001|Third Dose|Adverse Event|1|||
124992873|NCT02294227|449600690|FG000|Overall Study|Death|0|||
124992874|NCT02294227|449600691|FG001|Overall Study|Death|0|||
124992875|NCT02294227|449600692|FG002|Overall Study|Death|1|||
124992876|NCT02294227|449600690|FG000|Overall Study|Subject/Guardian Decision|6|||
124992877|NCT02294227|449600691|FG001|Overall Study|Subject/Guardian Decision|3|||
124992878|NCT02294227|449600692|FG002|Overall Study|Subject/Guardian Decision|7|||
124992879|NCT02294227|449600690|FG000|Overall Study|Physician Decision|1|||
124992880|NCT02294227|449600691|FG001|Overall Study|Physician Decision|2|||
124992881|NCT02294227|449600692|FG002|Overall Study|Physician Decision|1|||
124992882|NCT02294227|449600690|FG000|Overall Study|Lost to Follow-up|1|||
124992883|NCT02294227|449600691|FG001|Overall Study|Lost to Follow-up|0|||
124992884|NCT02294227|449600692|FG002|Overall Study|Lost to Follow-up|0|||
124992885|NCT02294227|449600690|FG000|Overall Study|Lack of Efficacy|11|||
124992886|NCT02294227|449600691|FG001|Overall Study|Lack of Efficacy|12|||
124992887|NCT02294227|449600692|FG002|Overall Study|Lack of Efficacy|8|||
124992888|NCT02294227|449600690|FG000|Overall Study|Adverse Event|6|||
124992889|NCT02294227|449600691|FG001|Overall Study|Adverse Event|8|||
124992890|NCT02294227|449600692|FG002|Overall Study|Adverse Event|2|||
124992891|NCT01768637|449600693|FG000|Overall Study|Lost to Follow-up|2|||
124992892|NCT01768637|449600694|FG001|Overall Study|Lost to Follow-up|7|||
124992893|NCT01768637|449600693|FG000|Overall Study|Difficult blood draw|1|||
124992894|NCT01768637|449600694|FG001|Overall Study|Difficult blood draw|0|||
124992895|NCT00887432|449600695|FG000|Overall Study|Start Excluded Therapy|3|||
124992896|NCT00887432|449600696|FG001|Overall Study|Start Excluded Therapy|0|||
124992897|NCT00887432|449600695|FG000|Overall Study|Did not complete treatment|6|||
124992898|NCT00887432|449600696|FG001|Overall Study|Did not complete treatment|8|||
124992899|NCT00887432|449600695|FG000|Overall Study|Protocol Violation|2|||
124992900|NCT00887432|449600696|FG001|Overall Study|Protocol Violation|3|||
124992901|NCT00887432|449600695|FG000|Overall Study|Withdrawal by Subject|3|||
124992902|NCT00887432|449600696|FG001|Overall Study|Withdrawal by Subject|2|||
124992903|NCT00887432|449600695|FG000|Overall Study|Lost to Follow-up|1|||
124992904|NCT00887432|449600696|FG001|Overall Study|Lost to Follow-up|0|||
124992905|NCT00887432|449600695|FG000|Overall Study|No reason provided|0|||
124992906|NCT00887432|449600696|FG001|Overall Study|No reason provided|1|||
124992907|NCT01636960|449600699|FG000|Induction Phase|Adverse Event|2|||
124992908|NCT01636960|449600699|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
124992909|NCT01636960|449600699|FG000|Maintenance Phase|Adverse Event|3|||
124992910|NCT01636960|449600699|FG000|Maintenance Phase|Progressive disease|1|||
124992911|NCT01580969|449600700|FG000|Overall Study|Physician Decision|3|||
124992912|NCT01580969|449600701|FG001|Overall Study|Physician Decision|0|||
124992913|NCT01580969|449600702|FG002|Overall Study|Physician Decision|0|||
124992914|NCT01209780|449600703|FG000|Overall Study|Adverse Event|0|||
124992915|NCT01209780|449600704|FG001|Overall Study|Adverse Event|1|||
124992916|NCT01209780|449600705|FG002|Overall Study|Adverse Event|0|||
124992917|NCT01209780|449600706|FG003|Overall Study|Adverse Event|0|||
124992918|NCT01209780|449600707|FG004|Overall Study|Adverse Event|0|||
124992919|NCT01209780|449600703|FG000|Overall Study|Withdrawal by Subject|9|||
124992920|NCT01209780|449600704|FG001|Overall Study|Withdrawal by Subject|2|||
124992921|NCT01209780|449600705|FG002|Overall Study|Withdrawal by Subject|1|||
124992922|NCT01209780|449600706|FG003|Overall Study|Withdrawal by Subject|1|||
124992923|NCT01209780|449600707|FG004|Overall Study|Withdrawal by Subject|0|||
124992924|NCT01209780|449600703|FG000|Overall Study|Lost to Follow-up|17|||
124992925|NCT01209780|449600704|FG001|Overall Study|Lost to Follow-up|12|||
124992926|NCT01209780|449600705|FG002|Overall Study|Lost to Follow-up|3|||
124992927|NCT01209780|449600706|FG003|Overall Study|Lost to Follow-up|9|||
124992928|NCT01209780|449600707|FG004|Overall Study|Lost to Follow-up|4|||
124992929|NCT01209780|449600703|FG000|Overall Study|Protocol Violation|0|||
124992930|NCT01209780|449600704|FG001|Overall Study|Protocol Violation|1|||
124992931|NCT01209780|449600705|FG002|Overall Study|Protocol Violation|0|||
124992932|NCT01209780|449600706|FG003|Overall Study|Protocol Violation|0|||
124992933|NCT01209780|449600707|FG004|Overall Study|Protocol Violation|0|||
124992934|NCT01209780|449600703|FG000|Overall Study|Inappropriate enrollment|0|||
124992935|NCT01209780|449600704|FG001|Overall Study|Inappropriate enrollment|2|||
124992936|NCT01209780|449600705|FG002|Overall Study|Inappropriate enrollment|0|||
124992937|NCT01209780|449600706|FG003|Overall Study|Inappropriate enrollment|0|||
124992938|NCT01209780|449600707|FG004|Overall Study|Inappropriate enrollment|1|||
124992939|NCT02709096|449600713|FG000|Overall Study|non-compliance|1|||
124992940|NCT02709096|449600714|FG001|Overall Study|non-compliance|1|||
124992941|NCT00511472|449600715|FG000|Overall Study|Clinical Adverse Event|1|||
124992942|NCT00511472|449600716|FG001|Overall Study|Clinical Adverse Event|2|||
124992943|NCT00511472|449600715|FG000|Overall Study|Laboratory Adverse Event|0|||
124992944|NCT00511472|449600716|FG001|Overall Study|Laboratory Adverse Event|2|||
124992945|NCT00511472|449600715|FG000|Overall Study|Not reported|2|||
124992946|NCT00511472|449600716|FG001|Overall Study|Not reported|2|||
124992947|NCT00505284|449600717|FG000|Overall Study|Adverse Event|3|||
124992948|NCT00505284|449600718|FG001|Overall Study|Adverse Event|7|||
124992949|NCT00505284|449600719|FG002|Overall Study|Adverse Event|9|||
124992950|NCT00505284|449600720|FG003|Overall Study|Adverse Event|14|||
124992951|NCT00505284|449600721|FG004|Overall Study|Adverse Event|22|||
124992952|NCT00505284|449600717|FG000|Overall Study|Protocol Violation|0|||
124992953|NCT00505284|449600718|FG001|Overall Study|Protocol Violation|1|||
124992954|NCT00505284|449600719|FG002|Overall Study|Protocol Violation|1|||
124992955|NCT00505284|449600720|FG003|Overall Study|Protocol Violation|0|||
124992956|NCT00505284|449600721|FG004|Overall Study|Protocol Violation|0|||
124992957|NCT00505284|449600717|FG000|Overall Study|Withdrawal by Subject|2|||
124992958|NCT00505284|449600718|FG001|Overall Study|Withdrawal by Subject|6|||
124992959|NCT00505284|449600719|FG002|Overall Study|Withdrawal by Subject|1|||
124992960|NCT00505284|449600720|FG003|Overall Study|Withdrawal by Subject|0|||
124992961|NCT00505284|449600721|FG004|Overall Study|Withdrawal by Subject|6|||
124992962|NCT00505284|449600717|FG000|Overall Study|Lack of Efficacy|0|||
124992963|NCT00505284|449600718|FG001|Overall Study|Lack of Efficacy|1|||
124992964|NCT00505284|449600719|FG002|Overall Study|Lack of Efficacy|1|||
124992965|NCT00505284|449600720|FG003|Overall Study|Lack of Efficacy|1|||
124992966|NCT00505284|449600721|FG004|Overall Study|Lack of Efficacy|1|||
124992967|NCT00505284|449600717|FG000|Overall Study|Physician Decision|0|||
124992968|NCT00505284|449600718|FG001|Overall Study|Physician Decision|1|||
124992969|NCT00505284|449600719|FG002|Overall Study|Physician Decision|0|||
124992970|NCT00505284|449600720|FG003|Overall Study|Physician Decision|0|||
124992971|NCT00505284|449600721|FG004|Overall Study|Physician Decision|0|||
124992972|NCT00505284|449600717|FG000|Overall Study|Other|5|||
124992973|NCT00505284|449600718|FG001|Overall Study|Other|0|||
124992974|NCT00505284|449600719|FG002|Overall Study|Other|0|||
124992975|NCT00505284|449600720|FG003|Overall Study|Other|4|||
124992976|NCT00505284|449600721|FG004|Overall Study|Other|4|||
124992977|NCT00731120|449600722|FG000|Overall Study|Adverse Event|7|||
124992978|NCT00731120|449600723|FG001|Overall Study|Adverse Event|6|||
124992979|NCT00731120|449600724|FG002|Overall Study|Adverse Event|8|||
124992980|NCT00731120|449600722|FG000|Overall Study|Lack of Efficacy|4|||
124992981|NCT00731120|449600723|FG001|Overall Study|Lack of Efficacy|5|||
124992982|NCT00731120|449600724|FG002|Overall Study|Lack of Efficacy|4|||
124992983|NCT00731120|449600722|FG000|Overall Study|Noncompliance with Study Drug|3|||
124992984|NCT00731120|449600723|FG001|Overall Study|Noncompliance with Study Drug|3|||
124992985|NCT00731120|449600724|FG002|Overall Study|Noncompliance with Study Drug|1|||
124992986|NCT00731120|449600722|FG000|Overall Study|Protocol Deviations|1|||
124992987|NCT00731120|449600723|FG001|Overall Study|Protocol Deviations|6|||
124992988|NCT00731120|449600724|FG002|Overall Study|Protocol Deviations|1|||
124992989|NCT00731120|449600722|FG000|Overall Study|Withdrawal of Consent|13|||
124992990|NCT00731120|449600723|FG001|Overall Study|Withdrawal of Consent|8|||
124992991|NCT00731120|449600724|FG002|Overall Study|Withdrawal of Consent|4|||
124992992|NCT00731120|449600722|FG000|Overall Study|Lost to Follow-up|10|||
124992993|NCT00731120|449600723|FG001|Overall Study|Lost to Follow-up|15|||
124992994|NCT00731120|449600724|FG002|Overall Study|Lost to Follow-up|17|||
124992995|NCT00731120|449600722|FG000|Overall Study|Other|4|||
124992996|NCT00731120|449600723|FG001|Overall Study|Other|0|||
124992997|NCT00731120|449600724|FG002|Overall Study|Other|1|||
124992998|NCT01551212|449600725|FG000|Overall Study|Graft loss/Retransplantation|0|||
124992999|NCT01551212|449600726|FG001|Overall Study|Graft loss/Retransplantation|1|||
124993000|NCT01551212|449600725|FG000|Overall Study|Administrative problems|1|||
124993001|NCT01551212|449600726|FG001|Overall Study|Administrative problems|2|||
124993002|NCT01551212|449600725|FG000|Overall Study|Lost to Follow-up|0|||
124993003|NCT01551212|449600726|FG001|Overall Study|Lost to Follow-up|1|||
124993004|NCT01551212|449600725|FG000|Overall Study|Protocol Violation|0|||
124993005|NCT01551212|449600726|FG001|Overall Study|Protocol Violation|1|||
124993006|NCT01551212|449600725|FG000|Overall Study|Withdrawal by Subject|0|||
124993007|NCT01551212|449600726|FG001|Overall Study|Withdrawal by Subject|7|||
124993008|NCT01551212|449600725|FG000|Overall Study|Death|2|||
124993009|NCT01551212|449600726|FG001|Overall Study|Death|4|||
124993010|NCT01551212|449600725|FG000|Overall Study|Never Received Study Treatment|2|||
124993011|NCT01551212|449600726|FG001|Overall Study|Never Received Study Treatment|4|||
124993012|NCT01575028|449600727|FG000|Overall Study|Physician Decision|0|||
124993013|NCT01575028|449600728|FG001|Overall Study|Physician Decision|1|||
124993014|NCT00529958|449600729|FG000|2-Year Follow-up|Lost to Follow-up|1|||
124993015|NCT00529958|449600730|FG001|2-Year Follow-up|Lost to Follow-up|2|||
124993016|NCT00529958|449600731|FG002|2-Year Follow-up|Lost to Follow-up|2|||
124993017|NCT00529958|449600729|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
124993018|NCT00529958|449600730|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
124993019|NCT00529958|449600731|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
124993020|NCT00529958|449600729|FG000|5-Year Follow-up|Lost to Follow-up|2|||
124993021|NCT00529958|449600730|FG001|5-Year Follow-up|Lost to Follow-up|3|||
124993022|NCT00529958|449600731|FG002|5-Year Follow-up|Lost to Follow-up|1|||
124993023|NCT00529958|449600729|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
124993024|NCT00529958|449600730|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
124993025|NCT00529958|449600731|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
124993026|NCT03534284|449600733|FG000|Overall Study|Death|2|||
124993027|NCT03534284|449600734|FG001|Overall Study|Death|3|||
124993028|NCT03534284|449600735|FG002|Overall Study|Death|3|||
124993029|NCT03534284|449600733|FG000|Overall Study|Withdrawal by Subject|5|||
124993030|NCT03534284|449600734|FG001|Overall Study|Withdrawal by Subject|0|||
124993031|NCT03534284|449600735|FG002|Overall Study|Withdrawal by Subject|0|||
124993032|NCT03316300|449600736|FG000|Overall Study|Withdrawal by Subject|3|||
124993033|NCT03316300|449600737|FG001|Overall Study|Withdrawal by Subject|2|||
124993034|NCT03316300|449600736|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
124993035|NCT03316300|449600737|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
124993036|NCT03316300|449600736|FG000|Overall Study|Adverse Event|1|||
124993037|NCT03316300|449600737|FG001|Overall Study|Adverse Event|0|||
124993038|NCT03316300|449600736|FG000|Overall Study|COVID-19|0|||
124993039|NCT03316300|449600737|FG001|Overall Study|COVID-19|1|||
124993040|NCT04737187|449600738|FG000|Overall Study|Switched to marketed drug|32|||
124993041|NCT04737187|449600739|FG001|Overall Study|Switched to marketed drug|4|||
124993042|NCT04737187|449600738|FG000|Overall Study|Radiological Progressive Disease|145|||
124993043|NCT04737187|449600739|FG001|Overall Study|Radiological Progressive Disease|146|||
124993044|NCT04737187|449600738|FG000|Overall Study|Clinical Progressive Disease|20|||
124993045|NCT04737187|449600739|FG001|Overall Study|Clinical Progressive Disease|20|||
124993046|NCT04737187|449600738|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
124993047|NCT04737187|449600739|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
124993048|NCT04737187|449600738|FG000|Overall Study|Adverse Event|16|||
124993049|NCT04737187|449600739|FG001|Overall Study|Adverse Event|16|||
124993050|NCT04737187|449600738|FG000|Overall Study|Physician Decision|2|||
124993051|NCT04737187|449600739|FG001|Overall Study|Physician Decision|0|||
124993052|NCT04737187|449600738|FG000|Overall Study|Withdrawal by Subject|5|||
124993053|NCT04737187|449600739|FG001|Overall Study|Withdrawal by Subject|8|||
124993054|NCT03756129|449600740|FG000|Overall Study|Adverse Event|1|||
124993055|NCT03756129|449600741|FG001|Overall Study|Adverse Event|1|||
124993056|NCT03756129|449600742|FG002|Overall Study|Adverse Event|0|||
124993057|NCT03756129|449600743|FG003|Overall Study|Adverse Event|2|||
124993058|NCT03756129|449600744|FG004|Overall Study|Adverse Event|0|||
124993059|NCT03756129|449600745|FG005|Overall Study|Adverse Event|0|||
124993060|NCT03756129|449600740|FG000|Overall Study|Withdrawal by Subject|2|||
124993061|NCT03756129|449600741|FG001|Overall Study|Withdrawal by Subject|1|||
124993062|NCT03756129|449600742|FG002|Overall Study|Withdrawal by Subject|3|||
124993063|NCT03756129|449600743|FG003|Overall Study|Withdrawal by Subject|1|||
124993064|NCT03756129|449600744|FG004|Overall Study|Withdrawal by Subject|1|||
124993065|NCT03756129|449600745|FG005|Overall Study|Withdrawal by Subject|3|||
124993066|NCT03756129|449600740|FG000|Overall Study|Lost to Follow-up|0|||
124993067|NCT03756129|449600741|FG001|Overall Study|Lost to Follow-up|0|||
124993068|NCT03756129|449600742|FG002|Overall Study|Lost to Follow-up|0|||
124993069|NCT03756129|449600743|FG003|Overall Study|Lost to Follow-up|0|||
124993070|NCT03756129|449600744|FG004|Overall Study|Lost to Follow-up|0|||
124993071|NCT03756129|449600745|FG005|Overall Study|Lost to Follow-up|1|||
124993072|NCT03756129|449600740|FG000|Overall Study|Physician Decision|0|||
124993073|NCT03756129|449600741|FG001|Overall Study|Physician Decision|0|||
124993074|NCT03756129|449600742|FG002|Overall Study|Physician Decision|0|||
124993075|NCT03756129|449600743|FG003|Overall Study|Physician Decision|0|||
124993076|NCT03756129|449600744|FG004|Overall Study|Physician Decision|0|||
124993077|NCT03756129|449600745|FG005|Overall Study|Physician Decision|1|||
124993078|NCT03035201|449600746|FG000|Overall Study|Death|9|||
124993079|NCT03035201|449600747|FG001|Overall Study|Death|12|||
124993080|NCT03035201|449600748|FG002|Overall Study|Death|9|||
124993081|NCT03035201|449600749|FG003|Overall Study|Death|10|||
124993082|NCT03035201|449600746|FG000|Overall Study|Withdrawal by Subject|51|||
124993083|NCT03035201|449600747|FG001|Overall Study|Withdrawal by Subject|49|||
124993084|NCT03035201|449600748|FG002|Overall Study|Withdrawal by Subject|37|||
124993085|NCT03035201|449600749|FG003|Overall Study|Withdrawal by Subject|46|||
124993086|NCT03035201|449600746|FG000|Overall Study|Lost to Follow-up|67|||
124993087|NCT03035201|449600747|FG001|Overall Study|Lost to Follow-up|51|||
124993088|NCT03035201|449600748|FG002|Overall Study|Lost to Follow-up|64|||
124993089|NCT03035201|449600749|FG003|Overall Study|Lost to Follow-up|69|||
124993090|NCT03705832|449600750|FG000|Overall Study|Physician Decision|0|||
124993091|NCT03705832|449600751|FG001|Overall Study|Physician Decision|1|||
124993092|NCT03705832|449600750|FG000|Overall Study|Withdrawal by Subject|1|||
124993093|NCT03705832|449600751|FG001|Overall Study|Withdrawal by Subject|0|||
124993094|NCT01050790|449600752|FG000|Overall Study|Adverse Event|1|||
124993095|NCT01880528|449600753|FG000|Overall Study|Other|1|||
124993096|NCT01880528|449600754|FG001|Overall Study|Other|1|||
124993097|NCT01439360|449600755|FG000|Overall Study|Adverse Event|4|||
124993098|NCT01439360|449600756|FG001|Overall Study|Adverse Event|16|||
124993099|NCT01439360|449600755|FG000|Overall Study|Lost to Follow-up|43|||
124993100|NCT01439360|449600756|FG001|Overall Study|Lost to Follow-up|58|||
124993101|NCT01439360|449600755|FG000|Overall Study|Others|10|||
124993102|NCT01439360|449600756|FG001|Overall Study|Others|5|||
124993103|NCT01439360|449600755|FG000|Overall Study|Protocol Violation|1|||
124993104|NCT01439360|449600756|FG001|Overall Study|Protocol Violation|0|||
124993105|NCT01439360|449600755|FG000|Overall Study|Withdrawal by Subject|140|||
124993106|NCT01439360|449600756|FG001|Overall Study|Withdrawal by Subject|129|||
124993107|NCT01912456|449602157|FG000|Period 1|Physician Decision|0|||
124993108|NCT01912456|449602158|FG001|Period 1|Physician Decision|0|||
124993109|NCT01912456|449602159|FG002|Period 1|Physician Decision|1|||
124993110|NCT01912456|449602160|FG003|Period 1|Physician Decision|0|||
124993111|NCT01912456|449602157|FG000|Period 1|non-compliance|1|||
124993112|NCT01912456|449602158|FG001|Period 1|non-compliance|0|||
124993113|NCT01912456|449602159|FG002|Period 1|non-compliance|0|||
124993114|NCT01912456|449602160|FG003|Period 1|non-compliance|1|||
124993115|NCT01912456|449602157|FG000|Period 1|Adverse Event|1|||
124993116|NCT01912456|449602158|FG001|Period 1|Adverse Event|0|||
124993117|NCT01912456|449602159|FG002|Period 1|Adverse Event|0|||
124993118|NCT01912456|449602160|FG003|Period 1|Adverse Event|1|||
124993119|NCT01912456|449602157|FG000|Period 1|Withdrawal by Subject|0|||
124993120|NCT01912456|449602158|FG001|Period 1|Withdrawal by Subject|1|||
124993121|NCT01912456|449602159|FG002|Period 1|Withdrawal by Subject|1|||
124993122|NCT01912456|449602160|FG003|Period 1|Withdrawal by Subject|1|||
124993123|NCT01912456|449602157|FG000|Period 2|Lack of Efficacy|0|||
124993124|NCT01912456|449602158|FG001|Period 2|Lack of Efficacy|2|||
124993125|NCT01912456|449602159|FG002|Period 2|Lack of Efficacy|0|||
124993126|NCT01912456|449602160|FG003|Period 2|Lack of Efficacy|0|||
124993127|NCT01912456|449602157|FG000|Period 2|Adverse Event|0|||
124993128|NCT01912456|449602158|FG001|Period 2|Adverse Event|0|||
124993129|NCT01912456|449602159|FG002|Period 2|Adverse Event|0|||
124993130|NCT01912456|449602160|FG003|Period 2|Adverse Event|1|||
124993131|NCT01201343|449602161|FG000|Overall Study|Adverse Event|6|||
124993132|NCT01201343|449602161|FG000|Overall Study|Withdrawal by Subject|5|||
124993133|NCT01201343|449602161|FG000|Overall Study|Lost to Follow-up|2|||
124993134|NCT01201343|449602161|FG000|Overall Study|Lack of Efficacy|2|||
124993135|NCT01201343|449602161|FG000|Overall Study|Participant wrongly included in trial|1|||
124993136|NCT01201343|449602161|FG000|Overall Study|Randomized, not treated|3|||
124993137|NCT00001962|449602165|FG000|Overall Study|Lack of Efficacy|18|||
124993138|NCT00001962|449602165|FG000|Overall Study|Lack of Accrual|6|||
124993139|NCT00001962|449602165|FG000|Overall Study|Death|1|||
124993140|NCT00001962|449602165|FG000|Overall Study|Lost to Follow-up|2|||
124993141|NCT00001962|449602165|FG000|Overall Study|Adverse Event|1|||
124993142|NCT01036763|449602166|FG000|Overall Study|Adverse Event|25|||
124993143|NCT01036763|449602166|FG000|Overall Study|Lost to Follow-up|28|||
124993144|NCT01036763|449602166|FG000|Overall Study|Other reason (not specified)|40|||
124993145|NCT01672723|449602167|FG000|First Intervention|Adverse Event|3|||
124993146|NCT01672723|449602168|FG001|First Intervention|Adverse Event|0|||
124993147|NCT01177722|449602171|FG000|Overall Study|Serious Adverse Event|0|||
124993148|NCT01177722|449602172|FG001|Overall Study|Serious Adverse Event|0|||
124993149|NCT01177722|449602173|FG002|Overall Study|Serious Adverse Event|1|||
124993150|NCT01177722|449602174|FG003|Overall Study|Serious Adverse Event|0|||
124993151|NCT01177722|449602171|FG000|Overall Study|Protocol Violation|0|||
124993152|NCT01177722|449602172|FG001|Overall Study|Protocol Violation|0|||
124993153|NCT01177722|449602173|FG002|Overall Study|Protocol Violation|1|||
124993154|NCT01177722|449602174|FG003|Overall Study|Protocol Violation|0|||
124993155|NCT01177722|449602171|FG000|Overall Study|Lost to Follow-up|3|||
124993156|NCT01177722|449602172|FG001|Overall Study|Lost to Follow-up|4|||
124993157|NCT01177722|449602173|FG002|Overall Study|Lost to Follow-up|3|||
124993158|NCT01177722|449602174|FG003|Overall Study|Lost to Follow-up|1|||
124993159|NCT01177722|449602171|FG000|Overall Study|Withdrawal by Subject|10|||
124993160|NCT01177722|449602172|FG001|Overall Study|Withdrawal by Subject|6|||
124993161|NCT01177722|449602173|FG002|Overall Study|Withdrawal by Subject|4|||
124993162|NCT01177722|449602174|FG003|Overall Study|Withdrawal by Subject|6|||
124993163|NCT00596427|449602178|FG000|Overall Study|Withdrawal by Subject|2|||
124993164|NCT00596427|449602179|FG001|Overall Study|Withdrawal by Subject|2|||
124993165|NCT00596427|449602178|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
124993166|NCT00596427|449602179|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
124993167|NCT00596427|449602178|FG000|Overall Study|Protocol Violation|1|||
124993168|NCT00596427|449602179|FG001|Overall Study|Protocol Violation|0|||
124993169|NCT00320541|449602180|FG000|Overall Study|Adverse Event|21|||
124993170|NCT00320541|449602181|FG001|Overall Study|Adverse Event|19|||
124993171|NCT00320541|449602180|FG000|Overall Study|Protocol Violation|0|||
124993172|NCT00320541|449602181|FG001|Overall Study|Protocol Violation|1|||
124993173|NCT00320541|449602180|FG000|Overall Study|Withdrawal by Subject|12|||
124993174|NCT00320541|449602181|FG001|Overall Study|Withdrawal by Subject|16|||
124993175|NCT00320541|449602180|FG000|Overall Study|Physician Decision|9|||
124993176|NCT00320541|449602181|FG001|Overall Study|Physician Decision|13|||
124993177|NCT00320541|449602180|FG000|Overall Study|Other|3|||
124993178|NCT00320541|449602181|FG001|Overall Study|Other|4|||
124993179|NCT00320541|449602180|FG000|Overall Study|Sponsor Decision|2|||
124993180|NCT00320541|449602181|FG001|Overall Study|Sponsor Decision|1|||
124993181|NCT00320541|449602180|FG000|Overall Study|Death due to Study Disease|1|||
124993182|NCT00320541|449602181|FG001|Overall Study|Death due to Study Disease|3|||
124993183|NCT00320541|449602180|FG000|Overall Study|Death due to Adverse Event(s)|1|||
124993184|NCT00320541|449602181|FG001|Overall Study|Death due to Adverse Event(s)|0|||
124993185|NCT00320541|449602180|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
124993186|NCT00320541|449602181|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
124993187|NCT03057977|449602184|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
124993188|NCT03057977|449602185|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
124993189|NCT03057977|449602184|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
124993190|NCT03057977|449602185|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
124993191|NCT03057977|449602184|FG000|Discontinuation From Treatment|Protocol Violation|6|||
124993192|NCT03057977|449602185|FG001|Discontinuation From Treatment|Protocol Violation|5|||
124993193|NCT03057977|449602184|FG000|Discontinuation From Treatment|Not treated|4|||
124993194|NCT03057977|449602185|FG001|Discontinuation From Treatment|Not treated|0|||
124993195|NCT03057977|449602184|FG000|Discontinuation From Treatment|Adverse Event|343|||
124993196|NCT03057977|449602185|FG001|Discontinuation From Treatment|Adverse Event|337|||
124993197|NCT03057977|449602184|FG000|Discontinuation From Treatment|Reason Unknown|0|||
124993198|NCT03057977|449602185|FG001|Discontinuation From Treatment|Reason Unknown|1|||
124993199|NCT03057977|449602184|FG000|Discontinuation From Treatment|Personal Reasons|1|||
124993200|NCT03057977|449602185|FG001|Discontinuation From Treatment|Personal Reasons|1|||
124993201|NCT03057977|449602184|FG000|Discontinuation From Treatment|Unblinded medication|1|||
124993202|NCT03057977|449602185|FG001|Discontinuation From Treatment|Unblinded medication|0|||
124993203|NCT03057977|449602184|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
124993204|NCT03057977|449602185|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
124993205|NCT03057977|449602184|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
124993206|NCT03057977|449602185|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
124993207|NCT03057977|449602184|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
124993208|NCT03057977|449602185|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
124993209|NCT03057977|449602184|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
124993210|NCT03057977|449602185|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
124993211|NCT03057977|449602184|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
124993212|NCT03057977|449602185|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
124993213|NCT03057977|449602184|FG000|Discontinuation From Treatment|Not attending study visit|3|||
124993214|NCT03057977|449602185|FG001|Discontinuation From Treatment|Not attending study visit|10|||
124993215|NCT03057977|449602184|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
124993216|NCT03057977|449602185|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
124993217|NCT03057977|449602184|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
124993218|NCT03057977|449602185|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
124993219|NCT03057977|449602184|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
124993220|NCT03057977|449602185|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
124993221|NCT03057977|449602184|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
124993222|NCT03057977|449602185|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
124993223|NCT03057977|449602184|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
124993224|NCT03057977|449602185|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
124993225|NCT02401867|449602186|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
124993226|NCT02401867|449602186|FG000|Analysis|Cervical assay could not be conducted|9|||
124993227|NCT01640054|449602189|FG000|Overall Study|Study-specific disc criteria|1|||
124993228|NCT01640054|449602189|FG000|Overall Study|Lack of Efficacy|3|||
124993229|NCT01640054|449602189|FG000|Overall Study|Adverse Event|2|||
124993230|NCT02080221|449602191|FG000|Overall Study|Withdrawal by Subject|1|||
124993231|NCT02080221|449602191|FG000|Overall Study|Clinical Progression of Disease|1|||
124993232|NCT01386788|449602194|FG000|Overall Study|Lost to Follow-up|2|||
124993233|NCT00120406|449602197|FG000|Overall Study|Death|9|||
124993234|NCT00120406|449602198|FG001|Overall Study|Death|4|||
124993235|NCT00120406|449602197|FG000|Overall Study|Withdrawal by Subject|5|||
124993236|NCT00120406|449602198|FG001|Overall Study|Withdrawal by Subject|7|||
124993237|NCT00120406|449602197|FG000|Overall Study|Lost to Follow-up|5|||
124993238|NCT00120406|449602198|FG001|Overall Study|Lost to Follow-up|2|||
124993239|NCT00120406|449602197|FG000|Overall Study|received non-study stent|0|||
124993240|NCT00120406|449602198|FG001|Overall Study|received non-study stent|2|||
124993241|NCT00120406|449602197|FG000|Overall Study|patient moved but has not withdrawn|0|||
124993242|NCT00120406|449602198|FG001|Overall Study|patient moved but has not withdrawn|1|||
124993243|NCT02808143|449602199|FG000|Maintenance Phase|Disease recurrence|1|||
124993244|NCT02808143|449602200|FG001|Maintenance Phase|Disease recurrence|3|||
124993245|NCT02808143|449602199|FG000|Maintenance Phase|Disease progression|1|||
124993246|NCT02808143|449602200|FG001|Maintenance Phase|Disease progression|2|||
124993247|NCT02808143|449602199|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
124993248|NCT02808143|449602200|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
124993249|NCT02808143|449602199|FG000|Survival Follow-Up|Disease recurrence|0|||
124993250|NCT02808143|449602200|FG001|Survival Follow-Up|Disease recurrence|2|||
124993251|NCT02808143|449602199|FG000|Survival Follow-Up|Adverse Event|0|||
124993252|NCT02808143|449602200|FG001|Survival Follow-Up|Adverse Event|1|||
124993253|NCT02808143|449602199|FG000|Survival Follow-Up|Death|1|||
124993254|NCT02808143|449602200|FG001|Survival Follow-Up|Death|0|||
124993255|NCT04964388|449602201|FG000|Overall Study|Lost to Follow-up|3|||
124993256|NCT04964388|449602202|FG001|Overall Study|Lost to Follow-up|2|||
124993257|NCT00250679|449602203|FG000|Overall Study|Adverse Event|12|||
124993258|NCT00250679|449602204|FG001|Overall Study|Adverse Event|15|||
124993259|NCT00250679|449602205|FG002|Overall Study|Adverse Event|16|||
124993260|NCT00250679|449602203|FG000|Overall Study|Protocol Violation|2|||
124993261|NCT00250679|449602204|FG001|Overall Study|Protocol Violation|4|||
124993262|NCT00250679|449602205|FG002|Overall Study|Protocol Violation|3|||
124872726|NCT03685591|449155751|FG008|Overall Study|Progressive Disease|1|||
124872727|NCT03685591|449155743|FG000|Overall Study|Other|0|||
124872728|NCT03685591|449155744|FG001|Overall Study|Other|0|||
124872729|NCT03685591|449155745|FG002|Overall Study|Other|1|||
124872730|NCT03685591|449155746|FG003|Overall Study|Other|0|||
124872731|NCT03685591|449155747|FG004|Overall Study|Other|2|||
124872732|NCT03685591|449155748|FG005|Overall Study|Other|3|||
124872733|NCT03685591|449155749|FG006|Overall Study|Other|0|||
124872734|NCT03685591|449155750|FG007|Overall Study|Other|0|||
124872735|NCT03685591|449155751|FG008|Overall Study|Other|0|||
124872736|NCT03685591|449155743|FG000|Overall Study|Withdrawal by Subject|0|||
124872737|NCT03685591|449155744|FG001|Overall Study|Withdrawal by Subject|0|||
124872738|NCT03685591|449155745|FG002|Overall Study|Withdrawal by Subject|0|||
124872739|NCT03685591|449155746|FG003|Overall Study|Withdrawal by Subject|0|||
124872740|NCT03685591|449155747|FG004|Overall Study|Withdrawal by Subject|3|||
124872741|NCT03685591|449155748|FG005|Overall Study|Withdrawal by Subject|2|||
124872742|NCT03685591|449155749|FG006|Overall Study|Withdrawal by Subject|0|||
124872743|NCT03685591|449155750|FG007|Overall Study|Withdrawal by Subject|0|||
124872744|NCT03685591|449155751|FG008|Overall Study|Withdrawal by Subject|1|||
124872745|NCT03685591|449155743|FG000|Overall Study|Adverse Event|0|||
124872746|NCT03685591|449155744|FG001|Overall Study|Adverse Event|0|||
124872747|NCT03685591|449155745|FG002|Overall Study|Adverse Event|0|||
124872748|NCT03685591|449155746|FG003|Overall Study|Adverse Event|1|||
124872749|NCT03685591|449155747|FG004|Overall Study|Adverse Event|1|||
124872750|NCT03685591|449155748|FG005|Overall Study|Adverse Event|4|||
124872751|NCT03685591|449155749|FG006|Overall Study|Adverse Event|0|||
124872752|NCT03685591|449155750|FG007|Overall Study|Adverse Event|1|||
124872753|NCT03685591|449155751|FG008|Overall Study|Adverse Event|1|||
124872754|NCT01685138|449155754|FG000|Overall Study|Lost to Follow-up|1|||
124872755|NCT01685138|449155754|FG000|Overall Study|Protocol Violation|1|||
124872756|NCT01685138|449155754|FG000|Overall Study|No longer requires treatment|1|||
124872757|NCT01685138|449155754|FG000|Overall Study|Subject/guardian decision|2|||
124872758|NCT01685138|449155754|FG000|Overall Study|Physician Decision|6|||
124872759|NCT01685138|449155754|FG000|Overall Study|Death|10|||
124872760|NCT01685138|449155754|FG000|Overall Study|Adverse Event|18|||
124872761|NCT01685138|449155754|FG000|Overall Study|Progressive disease|53|||
124872762|NCT02068495|449155757|FG000|Overall Study|Case Report Forms Uncollected|60|||
124872763|NCT02068495|449155757|FG000|Overall Study|Protocol Deviation|49|||
124872764|NCT00689026|449155758|FG000|Overall Study|Withdrawal by Subject|13|||
124872765|NCT00689026|449155759|FG001|Overall Study|Withdrawal by Subject|6|||
124872766|NCT02703922|449155762|FG000|Overall Study|Death|5|||
124872767|NCT02703922|449155763|FG001|Overall Study|Death|8|||
124872768|NCT02703922|449155762|FG000|Overall Study|Lost to Follow-up|10|||
124872769|NCT02703922|449155763|FG001|Overall Study|Lost to Follow-up|10|||
124872770|NCT00394355|449155765|FG000|Overall Study|Adverse Event|10|||
124872771|NCT00394355|449155766|FG001|Overall Study|Adverse Event|6|||
124872772|NCT00394355|449155767|FG002|Overall Study|Adverse Event|7|||
124872773|NCT00394355|449155768|FG003|Overall Study|Adverse Event|8|||
124872774|NCT00394355|449155765|FG000|Overall Study|Did not meet protocol eligibility|1|||
124872775|NCT00394355|449155766|FG001|Overall Study|Did not meet protocol eligibility|5|||
124872776|NCT00394355|449155767|FG002|Overall Study|Did not meet protocol eligibility|4|||
124872777|NCT00394355|449155768|FG003|Overall Study|Did not meet protocol eligibility|2|||
124872778|NCT00394355|449155765|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
124872779|NCT00394355|449155766|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
124872780|NCT00394355|449155767|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
124872781|NCT00394355|449155768|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
124872782|NCT00394355|449155765|FG000|Overall Study|Subject withdrawal - related to drug|1|||
124872783|NCT00394355|449155766|FG001|Overall Study|Subject withdrawal - related to drug|0|||
124872784|NCT00394355|449155767|FG002|Overall Study|Subject withdrawal - related to drug|0|||
124872785|NCT00394355|449155768|FG003|Overall Study|Subject withdrawal - related to drug|0|||
124993263|NCT00250679|449602203|FG000|Overall Study|Withdrawal by Subject|15|||
124872786|NCT00394355|449155765|FG000|Overall Study|Lost to Follow-up|7|||
124872787|NCT00394355|449155766|FG001|Overall Study|Lost to Follow-up|5|||
124872788|NCT00394355|449155767|FG002|Overall Study|Lost to Follow-up|4|||
124872789|NCT00394355|449155768|FG003|Overall Study|Lost to Follow-up|3|||
124872790|NCT00394355|449155765|FG000|Overall Study|Noncompliance with protocol|4|||
124872791|NCT00394355|449155766|FG001|Overall Study|Noncompliance with protocol|3|||
124993264|NCT00250679|449602204|FG001|Overall Study|Withdrawal by Subject|18|||
124993265|NCT00250679|449602205|FG002|Overall Study|Withdrawal by Subject|15|||
124993266|NCT00250679|449602203|FG000|Overall Study|Lost to Follow-up|3|||
124993267|NCT00250679|449602204|FG001|Overall Study|Lost to Follow-up|4|||
124993268|NCT00250679|449602205|FG002|Overall Study|Lost to Follow-up|2|||
124993269|NCT00250679|449602203|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
124993270|NCT00250679|449602204|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
124993271|NCT00250679|449602205|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
124993272|NCT00250679|449602203|FG000|Overall Study|Lack of Efficacy|0|||
124993273|NCT00250679|449602204|FG001|Overall Study|Lack of Efficacy|1|||
124993274|NCT00250679|449602205|FG002|Overall Study|Lack of Efficacy|3|||
124993275|NCT00250679|449602203|FG000|Overall Study|Technical Holter issues|1|||
124993276|NCT00250679|449602204|FG001|Overall Study|Technical Holter issues|0|||
124993277|NCT00250679|449602205|FG002|Overall Study|Technical Holter issues|2|||
124993278|NCT00250679|449602203|FG000|Overall Study|Moved|1|||
124993279|NCT00250679|449602204|FG001|Overall Study|Moved|1|||
124993280|NCT00250679|449602205|FG002|Overall Study|Moved|0|||
124993281|NCT00250679|449602203|FG000|Overall Study|Non-compliance|1|||
124993282|NCT00250679|449602204|FG001|Overall Study|Non-compliance|1|||
124993283|NCT00250679|449602205|FG002|Overall Study|Non-compliance|0|||
124993284|NCT00250679|449602203|FG000|Overall Study|various single events: hip surgery,diary|3|||
124993285|NCT00250679|449602204|FG001|Overall Study|various single events: hip surgery,diary|1|||
124993286|NCT00250679|449602205|FG002|Overall Study|various single events: hip surgery,diary|1|||
124993287|NCT00448279|449602207|FG000|Overall Study|Lost to Follow-up|2|||
124993288|NCT00448279|449602208|FG001|Overall Study|Lost to Follow-up|2|||
124993289|NCT00448279|449602207|FG000|Overall Study|Adverse Event|1|||
124993290|NCT00448279|449602208|FG001|Overall Study|Adverse Event|1|||
124993291|NCT00448279|449602207|FG000|Overall Study|Disease progression|16|||
124993292|NCT00448279|449602208|FG001|Overall Study|Disease progression|18|||
124993293|NCT00448279|449602207|FG000|Overall Study|Withdrawal by Subject|4|||
124993294|NCT00448279|449602208|FG001|Overall Study|Withdrawal by Subject|3|||
124993295|NCT00448279|449602207|FG000|Overall Study|Other|6|||
124993296|NCT00448279|449602208|FG001|Overall Study|Other|4|||
124993297|NCT00448279|449602207|FG000|Overall Study|Protocol Violation|0|||
124993298|NCT00448279|449602208|FG001|Overall Study|Protocol Violation|1|||
124993299|NCT03907410|449602209|FG000|Overall Study|Lost to Follow-up|4|||
124993300|NCT03907410|449602210|FG001|Overall Study|Lost to Follow-up|1|||
124993301|NCT03907410|449602211|FG002|Overall Study|Lost to Follow-up|1|||
124993302|NCT03907410|449602209|FG000|Overall Study|Lost to follow-up and research burden|0|||
124993303|NCT03907410|449602210|FG001|Overall Study|Lost to follow-up and research burden|0|||
124993304|NCT03907410|449602211|FG002|Overall Study|Lost to follow-up and research burden|1|||
124993305|NCT03718533|449602212|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
124993306|NCT03718533|449602212|FG000|Overall Study|Protocol deviation|1|||
124993307|NCT03718533|449602212|FG000|Overall Study|Disease progression|1|||
124993308|NCT03718533|449602212|FG000|Overall Study|Relapse|1|||
124993309|NCT03718533|449602212|FG000|Overall Study|Physician Decision|2|||
124993310|NCT03718533|449602212|FG000|Overall Study|Physician Decision and Adverse Event|1|||
124993311|NCT01295034|449602213|FG000|Overall Study|Lost to Follow-up|5|||
124993312|NCT01295034|449602214|FG001|Overall Study|Lost to Follow-up|5|||
124993313|NCT01174160|449602217|FG000|Overall Study|Adverse Event|1|||
124993314|NCT01174160|449602218|FG001|Overall Study|Adverse Event|0|||
124993315|NCT01174160|449602217|FG000|Overall Study|Lost to Follow-up|1|||
124993316|NCT01174160|449602218|FG001|Overall Study|Lost to Follow-up|0|||
124993317|NCT01174160|449602217|FG000|Overall Study|Physician Decision|1|||
124993318|NCT01174160|449602218|FG001|Overall Study|Physician Decision|0|||
124993319|NCT01174160|449602217|FG000|Overall Study|Protocol Violation|4|||
124993320|NCT01174160|449602218|FG001|Overall Study|Protocol Violation|6|||
124993321|NCT01174160|449602217|FG000|Overall Study|Withdrawal by Subject|1|||
124993322|NCT01174160|449602218|FG001|Overall Study|Withdrawal by Subject|0|||
124993323|NCT04218084|449602219|FG000|Overall Study|Adverse Event|7|||
124993324|NCT04218084|449602220|FG001|Overall Study|Adverse Event|2|||
124993325|NCT04218084|449602219|FG000|Overall Study|Withdrawal of Consent|4|||
124993326|NCT04218084|449602220|FG001|Overall Study|Withdrawal of Consent|5|||
124993327|NCT04218084|449602219|FG000|Overall Study|Physician Decision|1|||
124993328|NCT04218084|449602220|FG001|Overall Study|Physician Decision|1|||
124993329|NCT04218084|449602219|FG000|Overall Study|Lost to Follow-up|1|||
124993330|NCT04218084|449602220|FG001|Overall Study|Lost to Follow-up|1|||
124993331|NCT04218084|449602219|FG000|Overall Study|Non-compliance with study drug|1|||
124993332|NCT04218084|449602220|FG001|Overall Study|Non-compliance with study drug|1|||
124993333|NCT04218084|449602219|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
124993334|NCT04218084|449602220|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
124993335|NCT04218084|449602219|FG000|Overall Study|Other|0|||
124993336|NCT04218084|449602220|FG001|Overall Study|Other|1|||
124993337|NCT04218084|449602219|FG000|Overall Study|Ongoing at data cut-off date|62|||
124993338|NCT04218084|449602220|FG001|Overall Study|Ongoing at data cut-off date|58|||
124993339|NCT05580588|449602221|FG000|Overall Study|Lack of Efficacy|12|||
124993340|NCT00211185|449602224|FG000|Overall Study|Death|2|||
124993341|NCT00211185|449602224|FG000|Overall Study|Disease progression|7|||
124993342|NCT00211185|449602224|FG000|Overall Study|Withdrawal by Subject|6|||
124993343|NCT00211185|449602224|FG000|Overall Study|Physician Decision|5|||
124993344|NCT00712673|449602225|FG000|Overall Study|Adverse Event|3|||
124993345|NCT00712673|449602226|FG001|Overall Study|Adverse Event|3|||
124993346|NCT00712673|449602227|FG002|Overall Study|Adverse Event|21|||
124993347|NCT00712673|449602228|FG003|Overall Study|Adverse Event|26|||
124993348|NCT00712673|449602225|FG000|Overall Study|Lack of Efficacy|2|||
124993349|NCT00712673|449602226|FG001|Overall Study|Lack of Efficacy|8|||
124993350|NCT00712673|449602227|FG002|Overall Study|Lack of Efficacy|8|||
124993351|NCT00712673|449602228|FG003|Overall Study|Lack of Efficacy|6|||
124993352|NCT00712673|449602225|FG000|Overall Study|Poor Compliance to Protocol|3|||
124993353|NCT00712673|449602226|FG001|Overall Study|Poor Compliance to Protocol|3|||
124993354|NCT00712673|449602227|FG002|Overall Study|Poor Compliance to Protocol|4|||
124993355|NCT00712673|449602228|FG003|Overall Study|Poor Compliance to Protocol|16|||
124993356|NCT00712673|449602225|FG000|Overall Study|Lost to Follow-up|1|||
124993357|NCT00712673|449602226|FG001|Overall Study|Lost to Follow-up|0|||
124993358|NCT00712673|449602227|FG002|Overall Study|Lost to Follow-up|2|||
124993359|NCT00712673|449602228|FG003|Overall Study|Lost to Follow-up|0|||
124993360|NCT00712673|449602225|FG000|Overall Study|Withdrawal by Subject|6|||
124993361|NCT00712673|449602226|FG001|Overall Study|Withdrawal by Subject|7|||
124993362|NCT00712673|449602227|FG002|Overall Study|Withdrawal by Subject|15|||
124993363|NCT00712673|449602228|FG003|Overall Study|Withdrawal by Subject|20|||
124993364|NCT00712673|449602225|FG000|Overall Study|Familial and Personal Reasons|5|||
124993365|NCT00712673|449602226|FG001|Overall Study|Familial and Personal Reasons|0|||
124993366|NCT00712673|449602227|FG002|Overall Study|Familial and Personal Reasons|5|||
124993367|NCT00712673|449602228|FG003|Overall Study|Familial and Personal Reasons|2|||
124993368|NCT00712673|449602225|FG000|Overall Study|Investigator's Decision|1|||
124993369|NCT00712673|449602226|FG001|Overall Study|Investigator's Decision|0|||
124993370|NCT00712673|449602227|FG002|Overall Study|Investigator's Decision|0|||
124993371|NCT00712673|449602228|FG003|Overall Study|Investigator's Decision|0|||
124993372|NCT00712673|449602225|FG000|Overall Study|Protocol Violation|0|||
124993373|NCT00712673|449602226|FG001|Overall Study|Protocol Violation|0|||
124993374|NCT00712673|449602227|FG002|Overall Study|Protocol Violation|2|||
124993375|NCT00712673|449602228|FG003|Overall Study|Protocol Violation|0|||
124993376|NCT03305731|449602229|FG000|Overall Study|Protocol Violation|1|||
124993377|NCT03658668|449602230|FG000|Overall Study|Time Commitment|1|||
124993378|NCT03658668|449602231|FG001|Overall Study|Time Commitment|1|||
124993379|NCT01952054|449602232|FG000|Overall Study|Physician Decision|1|||
124993380|NCT01127139|449602233|FG000|Overall Study|Adverse Event|40|||
124993381|NCT01127139|449602233|FG000|Overall Study|Incompliance|12|||
124993382|NCT01127139|449602233|FG000|Overall Study|Lack of Efficacy|4|||
124993383|NCT01127139|449602233|FG000|Overall Study|Reason not specified|1|||
124993384|NCT01498653|449602234|FG000|Overall Study|Adverse Event|2|||
124993385|NCT01498653|449602235|FG001|Overall Study|Adverse Event|2|||
124993386|NCT01498653|449602234|FG000|Overall Study|Lack of Efficacy|12|||
124993387|NCT01498653|449602235|FG001|Overall Study|Lack of Efficacy|26|||
124993388|NCT01498653|449602234|FG000|Overall Study|Protocol Violation|0|||
124993389|NCT01498653|449602235|FG001|Overall Study|Protocol Violation|4|||
124993390|NCT01498653|449602234|FG000|Overall Study|Lost to Follow-up|1|||
124993391|NCT01498653|449602235|FG001|Overall Study|Lost to Follow-up|0|||
124993392|NCT01498653|449602234|FG000|Overall Study|Physician Decision|2|||
124993393|NCT01498653|449602235|FG001|Overall Study|Physician Decision|0|||
124993394|NCT01498653|449602234|FG000|Overall Study|Withdrawal by Subject|2|||
124993395|NCT01498653|449602235|FG001|Overall Study|Withdrawal by Subject|3|||
124993396|NCT05208866|449602236|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
124993397|NCT02070588|449602237|FG000|Overall Study|Withdrawal by Subject|29|||
124993398|NCT02070588|449602238|FG001|Overall Study|Withdrawal by Subject|1|||
124993399|NCT02070588|449602239|FG002|Overall Study|Withdrawal by Subject|0|||
124993400|NCT02070588|449602237|FG000|Overall Study|Writhdrawal due to early termination|9|||
124993401|NCT02070588|449602238|FG001|Overall Study|Writhdrawal due to early termination|0|||
124993402|NCT02070588|449602239|FG002|Overall Study|Writhdrawal due to early termination|0|||
124993403|NCT02070588|449602237|FG000|Overall Study|Adverse Event|1|||
124993404|NCT02070588|449602238|FG001|Overall Study|Adverse Event|0|||
124993405|NCT02070588|449602239|FG002|Overall Study|Adverse Event|0|||
124993406|NCT01718353|449602243|FG000|Overall Study|Lost to Follow-up|0|||
124993407|NCT01718353|449602244|FG001|Overall Study|Lost to Follow-up|1|||
124993408|NCT01718353|449602243|FG000|Overall Study|Principal Investigator's Decision|10|||
124993409|NCT01718353|449602244|FG001|Overall Study|Principal Investigator's Decision|4|||
124993410|NCT01718353|449602243|FG000|Overall Study|Randomized but not treated|2|||
124993411|NCT01718353|449602244|FG001|Overall Study|Randomized but not treated|0|||
124993412|NCT01078675|449602245|FG000|Overall Study|Withdrawal by Subject|7|||
124993413|NCT01078675|449602246|FG001|Overall Study|Withdrawal by Subject|3|||
124993414|NCT01078675|449602245|FG000|Overall Study|Protocol Violation|56|||
124993415|NCT01078675|449602246|FG001|Overall Study|Protocol Violation|0|||
124993416|NCT01078675|449602245|FG000|Overall Study|Provided in CRF for specific reasons|2|||
124993417|NCT01078675|449602246|FG001|Overall Study|Provided in CRF for specific reasons|3|||
124993418|NCT01078675|449602245|FG000|Overall Study|Adverse Event|3|||
124993419|NCT01078675|449602246|FG001|Overall Study|Adverse Event|0|||
124993420|NCT02745392|449602252|FG000|Overall Study|Lost to Follow-up|0|||
124993421|NCT02745392|449602253|FG001|Overall Study|Lost to Follow-up|1|||
124993422|NCT02745392|449602254|FG002|Overall Study|Lost to Follow-up|0|||
124993423|NCT02745392|449602255|FG003|Overall Study|Lost to Follow-up|0|||
124993424|NCT00899548|449602258|FG000|Overall Study|Physician Decision|3|||
124993425|NCT04781387|449602259|FG000|Overall Study|Withdrawal by Subject|1|||
124993426|NCT04781387|449602260|FG001|Overall Study|Withdrawal by Subject|0|||
124993427|NCT04781387|449602261|FG002|Overall Study|Withdrawal by Subject|1|||
124993428|NCT04781387|449602259|FG000|Overall Study|Lost to Follow-up|1|||
124993429|NCT04781387|449602260|FG001|Overall Study|Lost to Follow-up|0|||
124993430|NCT04781387|449602261|FG002|Overall Study|Lost to Follow-up|0|||
124993431|NCT00710021|449602262|FG000|Overall Study|Lost to Follow-up|1|||
124993432|NCT00710021|449602263|FG001|Overall Study|Lost to Follow-up|0|||
124993433|NCT00710021|449602264|FG002|Overall Study|Lost to Follow-up|0|||
124993434|NCT00710021|449602262|FG000|Overall Study|Subject's Decision|0|||
124993435|NCT00710021|449602263|FG001|Overall Study|Subject's Decision|1|||
124993436|NCT00710021|449602264|FG002|Overall Study|Subject's Decision|0|||
124993437|NCT00710021|449602262|FG000|Overall Study|Subject misrandomized|0|||
124993438|NCT00710021|449602263|FG001|Overall Study|Subject misrandomized|1|||
124993439|NCT00710021|449602264|FG002|Overall Study|Subject misrandomized|1|||
124993440|NCT00710021|449602262|FG000|Overall Study|Physician Decision|0|||
124993441|NCT00710021|449602263|FG001|Overall Study|Physician Decision|1|||
124993442|NCT00710021|449602264|FG002|Overall Study|Physician Decision|0|||
124993443|NCT04002401|449602270|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
124993444|NCT04002401|449602270|FG000|Overall Study|Death|10|||
124993445|NCT04002401|449602270|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
124993446|NCT04002401|449602270|FG000|Overall Study|Enrolled but Never Treated|1|||
124993447|NCT04002401|449602270|FG000|Overall Study|Lost to Follow-up|1|||
124993448|NCT00423930|449602271|FG000|Overall Study|Withdrawal by Subject|2|||
124993449|NCT01315353|449602275|FG000|Overall Study|Death|2|||
124993450|NCT01315353|449602276|FG001|Overall Study|Death|1|||
124993451|NCT01315353|449602277|FG002|Overall Study|Death|0|||
124993452|NCT01315353|449602275|FG000|Overall Study|Withdrawal by Subject|2|||
124993453|NCT01315353|449602276|FG001|Overall Study|Withdrawal by Subject|6|||
124993454|NCT01315353|449602277|FG002|Overall Study|Withdrawal by Subject|1|||
124993455|NCT01315353|449602275|FG000|Overall Study|Lost to Follow-up|13|||
124993456|NCT01315353|449602276|FG001|Overall Study|Lost to Follow-up|6|||
124993457|NCT01315353|449602277|FG002|Overall Study|Lost to Follow-up|6|||
124993458|NCT01315353|449602275|FG000|Overall Study|Unwilling to adhere to requirements|5|||
124993459|NCT01315353|449602276|FG001|Overall Study|Unwilling to adhere to requirements|5|||
124993460|NCT01315353|449602277|FG002|Overall Study|Unwilling to adhere to requirements|4|||
124993461|NCT01315353|449602275|FG000|Overall Study|Site closing|7|||
124993462|NCT01315353|449602276|FG001|Overall Study|Site closing|4|||
124993463|NCT01315353|449602277|FG002|Overall Study|Site closing|0|||
124993464|NCT01315353|449602275|FG000|Overall Study|Taken off study by site in error|0|||
124993465|NCT01315353|449602276|FG001|Overall Study|Taken off study by site in error|1|||
124993466|NCT01315353|449602277|FG002|Overall Study|Taken off study by site in error|0|||
124993467|NCT01315353|449602275|FG000|Overall Study|Inadvertent randomization/assignment|0|||
124993468|NCT01315353|449602276|FG001|Overall Study|Inadvertent randomization/assignment|0|||
124993469|NCT01315353|449602277|FG002|Overall Study|Inadvertent randomization/assignment|2|||
124993470|NCT03567434|449602278|FG000|Overall Study|Lost to Follow-up|1|||
124993471|NCT03567434|449602279|FG001|Overall Study|Lost to Follow-up|3|||
124993472|NCT01009580|449602281|FG000|Overall Study|Adverse Event|4|||
124993473|NCT01009580|449602282|FG001|Overall Study|Adverse Event|4|||
124993474|NCT01009580|449602281|FG000|Overall Study|Lack of Efficacy|0|||
124993475|NCT01009580|449602282|FG001|Overall Study|Lack of Efficacy|1|||
124993476|NCT01009580|449602281|FG000|Overall Study|Protocol Violation|2|||
124993477|NCT01009580|449602282|FG001|Overall Study|Protocol Violation|3|||
124993478|NCT01009580|449602281|FG000|Overall Study|Withdrawal Criteria|4|||
124993479|NCT01009580|449602282|FG001|Overall Study|Withdrawal Criteria|6|||
124993480|NCT01009580|449602281|FG000|Overall Study|Unclassified|17|||
124993481|NCT01009580|449602282|FG001|Overall Study|Unclassified|21|||
124993482|NCT02390245|449602284|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
124993483|NCT02390245|449602285|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
124993484|NCT02390245|449602286|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
124993485|NCT02390245|449602284|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
124993486|NCT02390245|449602285|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
124993487|NCT02390245|449602286|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
124993488|NCT03727438|449602287|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
124993489|NCT03727438|449602288|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
124993490|NCT03727438|449602287|FG000|Intervention Period|Excluded (health)|1|||
124993491|NCT03727438|449602288|FG001|Intervention Period|Excluded (health)|0|||
124993492|NCT03727438|449602287|FG000|Intervention Period|Withdrawal by Subject|3|||
124993493|NCT03727438|449602288|FG001|Intervention Period|Withdrawal by Subject|1|||
124993494|NCT03727438|449602287|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
124993495|NCT03727438|449602288|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
124993496|NCT03727438|449602287|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
124993497|NCT03727438|449602288|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
124993498|NCT03727438|449602287|FG000|8 Week Assessment|Withdrawal by Subject|6|||
124993499|NCT03727438|449602288|FG001|8 Week Assessment|Withdrawal by Subject|1|||
124993500|NCT03727438|449602287|FG000|6 mo Assessment|did not complete assessment|10|||
124993501|NCT03727438|449602288|FG001|6 mo Assessment|did not complete assessment|11|||
124993502|NCT01222507|449603967|FG000|Overall Study|Physician Decision|1|||
124993503|NCT01222507|449603967|FG000|Overall Study|Withdrawal by Subject|1|||
124993504|NCT02647320|449603968|FG000|Overall Study|Adverse Event|0|||
124993505|NCT02647320|449603969|FG001|Overall Study|Adverse Event|1|||
124993506|NCT02647320|449603970|FG002|Overall Study|Adverse Event|3|||
124993507|NCT02647320|449603971|FG003|Overall Study|Adverse Event|2|||
124993508|NCT02647320|449603972|FG004|Overall Study|Adverse Event|1|||
124993509|NCT02647320|449603968|FG000|Overall Study|Protocol Violation|0|||
124993510|NCT02647320|449603969|FG001|Overall Study|Protocol Violation|0|||
124993511|NCT02647320|449603970|FG002|Overall Study|Protocol Violation|3|||
124993512|NCT02647320|449603971|FG003|Overall Study|Protocol Violation|0|||
124993513|NCT02647320|449603972|FG004|Overall Study|Protocol Violation|0|||
124993514|NCT02647320|449603968|FG000|Overall Study|Withdrawal by Subject|7|||
124993515|NCT02647320|449603969|FG001|Overall Study|Withdrawal by Subject|4|||
124993516|NCT02647320|449603970|FG002|Overall Study|Withdrawal by Subject|2|||
124993517|NCT02647320|449603971|FG003|Overall Study|Withdrawal by Subject|2|||
124993518|NCT02647320|449603972|FG004|Overall Study|Withdrawal by Subject|7|||
124993519|NCT02647320|449603968|FG000|Overall Study|Persistent hyperglycemia|0|||
124993520|NCT02647320|449603969|FG001|Overall Study|Persistent hyperglycemia|1|||
124993521|NCT02647320|449603970|FG002|Overall Study|Persistent hyperglycemia|1|||
124993522|NCT02647320|449603971|FG003|Overall Study|Persistent hyperglycemia|1|||
124993523|NCT02647320|449603972|FG004|Overall Study|Persistent hyperglycemia|1|||
124993524|NCT02647320|449603968|FG000|Overall Study|Study terminated by sponsor|1|||
124993525|NCT02647320|449603969|FG001|Overall Study|Study terminated by sponsor|1|||
124993526|NCT02647320|449603970|FG002|Overall Study|Study terminated by sponsor|1|||
124993527|NCT02647320|449603971|FG003|Overall Study|Study terminated by sponsor|1|||
124993528|NCT02647320|449603972|FG004|Overall Study|Study terminated by sponsor|2|||
124993529|NCT02647320|449603968|FG000|Overall Study|Reason not provided|0|||
124993530|NCT02647320|449603969|FG001|Overall Study|Reason not provided|0|||
124993531|NCT02647320|449603970|FG002|Overall Study|Reason not provided|1|||
124993532|NCT02647320|449603971|FG003|Overall Study|Reason not provided|0|||
124993533|NCT02647320|449603972|FG004|Overall Study|Reason not provided|2|||
124993534|NCT02647320|449603968|FG000|Overall Study|Lost to Follow-up|1|||
124993535|NCT02647320|449603969|FG001|Overall Study|Lost to Follow-up|1|||
124993536|NCT02647320|449603970|FG002|Overall Study|Lost to Follow-up|0|||
124993537|NCT02647320|449603971|FG003|Overall Study|Lost to Follow-up|0|||
124993538|NCT02647320|449603972|FG004|Overall Study|Lost to Follow-up|0|||
124993539|NCT02647320|449603968|FG000|Overall Study|Develop anemia|1|||
124993540|NCT02647320|449603969|FG001|Overall Study|Develop anemia|0|||
124993541|NCT02647320|449603970|FG002|Overall Study|Develop anemia|0|||
124993542|NCT02647320|449603971|FG003|Overall Study|Develop anemia|0|||
124993543|NCT02647320|449603972|FG004|Overall Study|Develop anemia|0|||
124993544|NCT02647320|449603968|FG000|Overall Study|Lack of Efficacy|0|||
124993545|NCT02647320|449603969|FG001|Overall Study|Lack of Efficacy|0|||
124993546|NCT02647320|449603970|FG002|Overall Study|Lack of Efficacy|0|||
124993547|NCT02647320|449603971|FG003|Overall Study|Lack of Efficacy|1|||
124993548|NCT02647320|449603972|FG004|Overall Study|Lack of Efficacy|0|||
124993549|NCT02647320|449603968|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
124993550|NCT02647320|449603969|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
124993551|NCT02647320|449603970|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
124993552|NCT02647320|449603971|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
124993553|NCT02647320|449603972|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
124993554|NCT01650246|449603975|FG000|Overall Study|Adverse Event|23|||
124993555|NCT01650246|449603975|FG000|Overall Study|Protocol Violation|5|||
124993556|NCT01650246|449603975|FG000|Overall Study|Sponsor terminated study|53|||
124993557|NCT01650246|449603975|FG000|Overall Study|Lost to Follow-up|5|||
124993558|NCT01650246|449603975|FG000|Overall Study|Withdrawal by Subject|26|||
124993559|NCT01650246|449603975|FG000|Overall Study|Death|1|||
124993560|NCT01650246|449603975|FG000|Overall Study|Lack of Efficacy|30|||
124993561|NCT00953407|449603976|FG000|Overall Study|Failed inclusion criteria|1|||
124993562|NCT00953407|449603977|FG001|Overall Study|Failed inclusion criteria|1|||
124993563|NCT00953407|449603978|FG002|Overall Study|Failed inclusion criteria|1|||
124993564|NCT00953407|449603979|FG003|Overall Study|Failed inclusion criteria|1|||
124993565|NCT00953407|449603980|FG004|Overall Study|Failed inclusion criteria|1|||
124993566|NCT00953407|449603976|FG000|Overall Study|Lost to Follow-up|0|||
124993567|NCT00953407|449603977|FG001|Overall Study|Lost to Follow-up|0|||
124993568|NCT00953407|449603978|FG002|Overall Study|Lost to Follow-up|0|||
124993569|NCT00953407|449603979|FG003|Overall Study|Lost to Follow-up|1|||
124993570|NCT00953407|449603980|FG004|Overall Study|Lost to Follow-up|0|||
124993571|NCT03435497|449603982|FG000|Overall Study|Lost to Follow-up|1|||
124993572|NCT03435497|449603983|FG001|Overall Study|Lost to Follow-up|0|||
124993573|NCT03435497|449603982|FG000|Overall Study|Death|1|||
124993574|NCT03435497|449603983|FG001|Overall Study|Death|0|||
124993575|NCT03435497|449603982|FG000|Overall Study|Withdrawal by Subject|0|||
124993576|NCT03435497|449603983|FG001|Overall Study|Withdrawal by Subject|4|||
124993577|NCT03435497|449603982|FG000|Overall Study|Wrong survey administered|0|||
124993578|NCT03435497|449603983|FG001|Overall Study|Wrong survey administered|2|||
124993579|NCT05220254|449603984|FG000|Overall Study|Withdrawal by Subject|4|||
124993580|NCT05220254|449603984|FG000|Overall Study|Removed due to ineligibility|1|||
124993581|NCT05220254|449603984|FG000|Overall Study|Lost to Follow-up|7|||
124993582|NCT01557283|449603985|FG000|Overall Study|Lost to Follow-up|7|||
124993583|NCT01557283|449603985|FG000|Overall Study|Non-responder|19|||
124993584|NCT01557283|449603985|FG000|Overall Study|Adverse Event|7|||
124993585|NCT01557283|449603985|FG000|Overall Study|Lack of Efficacy|1|||
124993586|NCT01557283|449603985|FG000|Overall Study|Non-compliance|1|||
124993587|NCT01557283|449603985|FG000|Overall Study|Withdrawal by Subject|1|||
124993588|NCT01557283|449603985|FG000|Overall Study|Participant's weight too high for dose|1|||
124993589|NCT01557283|449603985|FG000|Overall Study|Worsening of psoriasis|1|||
124993590|NCT01557283|449603985|FG000|Overall Study|Other|6|||
124993591|NCT03603028|449603986|FG000|Overall Study|Withdrawal by Subject|1|||
124993592|NCT00842985|449603991|FG000|Screening|Did not meet entrance requirements|27|||
124993593|NCT00842985|449603991|FG000|First Intervention|Withdrawal by Subject|3|||
124993594|NCT00842985|449603991|FG000|First Intervention|Protocol Violation|3|||
124993595|NCT00842985|449603991|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
124993596|NCT00842985|449603991|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
124993597|NCT01037244|449603992|FG000|Overall Study|Adverse Event|3|||
124993598|NCT01037244|449603993|FG001|Overall Study|Adverse Event|2|||
124993599|NCT01037244|449603994|FG002|Overall Study|Adverse Event|6|||
124993600|NCT01037244|449603995|FG003|Overall Study|Adverse Event|3|||
124993601|NCT01037244|449603992|FG000|Overall Study|Lack of Efficacy|1|||
124993602|NCT01037244|449603993|FG001|Overall Study|Lack of Efficacy|1|||
124993603|NCT01037244|449603994|FG002|Overall Study|Lack of Efficacy|0|||
124993604|NCT01037244|449603995|FG003|Overall Study|Lack of Efficacy|1|||
124993605|NCT01037244|449603992|FG000|Overall Study|Lost to Follow-up|3|||
124993606|NCT01037244|449603993|FG001|Overall Study|Lost to Follow-up|3|||
124993607|NCT01037244|449603994|FG002|Overall Study|Lost to Follow-up|4|||
124993608|NCT01037244|449603995|FG003|Overall Study|Lost to Follow-up|4|||
124993609|NCT01037244|449603992|FG000|Overall Study|Withdrawal by Subject|1|||
124993610|NCT01037244|449603993|FG001|Overall Study|Withdrawal by Subject|5|||
124993611|NCT01037244|449603994|FG002|Overall Study|Withdrawal by Subject|3|||
124993612|NCT01037244|449603995|FG003|Overall Study|Withdrawal by Subject|5|||
124993613|NCT01037244|449603992|FG000|Overall Study|Partner Withdrew Consent|2|||
124993614|NCT01037244|449603993|FG001|Overall Study|Partner Withdrew Consent|1|||
124993615|NCT01037244|449603994|FG002|Overall Study|Partner Withdrew Consent|0|||
124993616|NCT01037244|449603995|FG003|Overall Study|Partner Withdrew Consent|0|||
124993617|NCT01037244|449603992|FG000|Overall Study|Various|3|||
124993618|NCT01037244|449603993|FG001|Overall Study|Various|2|||
124993619|NCT01037244|449603994|FG002|Overall Study|Various|1|||
124993620|NCT01037244|449603995|FG003|Overall Study|Various|1|||
124993621|NCT00690820|449603996|FG000|Period 1|Withdrawal by Subject|0|||
124993622|NCT00690820|449603997|FG001|Period 1|Withdrawal by Subject|1|||
124993623|NCT01768117|449603999|FG000|Overall Study|Lost to Follow-up|1|||
124993624|NCT01768117|449603999|FG000|Overall Study|Withdrawal by Subject|2|||
124993625|NCT01768117|449603999|FG000|Overall Study|Protocol Violation|3|||
124993626|NCT01249274|449604002|FG000|Overall Study|Lost to Follow-up|3|||
124993627|NCT01249274|449604003|FG001|Overall Study|Lost to Follow-up|4|||
124993628|NCT01249274|449604002|FG000|Overall Study|Received inpatient substance treatment|1|||
124993629|NCT01249274|449604003|FG001|Overall Study|Received inpatient substance treatment|2|||
124993630|NCT01000636|449604004|FG000|Overall Study|Withdrawal by Subject|1|||
124993631|NCT01000636|449604004|FG000|Overall Study|Adverse Event|1|||
124993632|NCT03451162|449604005|FG000|Overall Study|Lost to Follow-up|1|||
124993633|NCT03451162|449604006|FG001|Overall Study|Lost to Follow-up|0|||
124993634|NCT03451162|449604007|FG002|Overall Study|Lost to Follow-up|0|||
124993635|NCT03451162|449604008|FG003|Overall Study|Lost to Follow-up|0|||
124993636|NCT03451162|449604009|FG004|Overall Study|Lost to Follow-up|0|||
124993637|NCT03451162|449604005|FG000|Overall Study|Physician Decision|0|||
124993638|NCT03451162|449604006|FG001|Overall Study|Physician Decision|1|||
124993639|NCT03451162|449604007|FG002|Overall Study|Physician Decision|0|||
124993640|NCT03451162|449604008|FG003|Overall Study|Physician Decision|0|||
124993641|NCT03451162|449604009|FG004|Overall Study|Physician Decision|0|||
124993642|NCT03451162|449604005|FG000|Overall Study|Withdrawal by Subject|1|||
124993643|NCT03451162|449604006|FG001|Overall Study|Withdrawal by Subject|1|||
124993644|NCT03451162|449604007|FG002|Overall Study|Withdrawal by Subject|0|||
124993645|NCT03451162|449604008|FG003|Overall Study|Withdrawal by Subject|0|||
124993646|NCT03451162|449604009|FG004|Overall Study|Withdrawal by Subject|0|||
124993647|NCT02216357|449604012|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
124993648|NCT02216357|449604013|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
124993649|NCT00836095|449604014|FG000|Overall Study|Physician Decision|0|||
124993650|NCT00836095|449604015|FG001|Overall Study|Physician Decision|3|||
124993651|NCT04964414|449604017|FG000|Overall Study|Lost to Follow-up|10|||
124993652|NCT04964414|449604018|FG001|Overall Study|Lost to Follow-up|8|||
124993653|NCT04964414|449604017|FG000|Overall Study|Withdrawal by Subject|1|||
124993654|NCT04964414|449604018|FG001|Overall Study|Withdrawal by Subject|1|||
124993655|NCT05116046|449604021|FG000|Overall Study|Withdrawal by parent/guardian|2|||
124993656|NCT05116046|449604022|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124993657|NCT05116046|449604023|FG002|Overall Study|Withdrawal by parent/guardian|1|||
124993658|NCT05116046|449604021|FG000|Overall Study|Study terminated by sponsor|14|||
124993659|NCT05116046|449604022|FG001|Overall Study|Study terminated by sponsor|16|||
124993660|NCT05116046|449604023|FG002|Overall Study|Study terminated by sponsor|1|||
124993661|NCT01745848|449604032|FG000|Overall Study|Adverse Event|6|||
124993662|NCT00679627|449604033|FG000|Overall Study|Death|41|||
124993663|NCT00679627|449604034|FG001|Overall Study|Death|29|||
124993664|NCT00679627|449604033|FG000|Overall Study|Adverse Event|43|||
124993665|NCT00679627|449604034|FG001|Overall Study|Adverse Event|53|||
124993666|NCT00679627|449604033|FG000|Overall Study|Withdrawal by Subject|168|||
124993667|NCT00679627|449604034|FG001|Overall Study|Withdrawal by Subject|172|||
124993668|NCT00679627|449604033|FG000|Overall Study|Lost to Follow-up|22|||
124993669|NCT00679627|449604034|FG001|Overall Study|Lost to Follow-up|26|||
124993670|NCT00679627|449604033|FG000|Overall Study|Early Study Closure|425|||
124993671|NCT00679627|449604034|FG001|Overall Study|Early Study Closure|405|||
124993672|NCT01886378|449604035|FG000|Overall Study|Adverse Event|1|||
124993673|NCT01886378|449604035|FG000|Overall Study|Withdrawal by Subject|4|||
124993674|NCT01079741|449604041|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
124993675|NCT01079741|449604042|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
124993676|NCT01079741|449604043|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
124993677|NCT01079741|449604044|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
124993678|NCT01079741|449604045|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
124993679|NCT01079741|449604041|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
124993680|NCT01079741|449604042|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
124993681|NCT01079741|449604043|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
124993682|NCT01079741|449604044|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
124993683|NCT01079741|449604045|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
124993684|NCT00446992|449604046|FG000|Overall Study|Adverse Event|11|||
124993685|NCT00446992|449604046|FG000|Overall Study|Lost to Follow-up|5|||
124993686|NCT01275131|449604047|FG000|Period 1|Withdrawal by Subject|1|||
124993687|NCT01275131|449604048|FG001|Period 1|Withdrawal by Subject|0|||
124993688|NCT01275131|449604049|FG002|Period 1|Withdrawal by Subject|3|||
124993689|NCT01275131|449604050|FG003|Period 1|Withdrawal by Subject|2|||
124993690|NCT01275131|449604047|FG000|Period 1|Physician Decision|1|||
124993691|NCT01275131|449604048|FG001|Period 1|Physician Decision|0|||
124993692|NCT01275131|449604049|FG002|Period 1|Physician Decision|0|||
124993693|NCT01275131|449604050|FG003|Period 1|Physician Decision|0|||
124993694|NCT01275131|449604047|FG000|Period 2 (Crossover)|Adverse Event|0|||
124993695|NCT01275131|449604048|FG001|Period 2 (Crossover)|Adverse Event|1|||
124993696|NCT01275131|449604049|FG002|Period 2 (Crossover)|Adverse Event|0|||
124993697|NCT01275131|449604050|FG003|Period 2 (Crossover)|Adverse Event|0|||
124993698|NCT01275131|449604047|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
124993699|NCT01275131|449604048|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
124993700|NCT01275131|449604049|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
124993701|NCT01275131|449604050|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
124993702|NCT02076178|449604051|FG000|Oral Phase|Adverse Event|0|||
124993703|NCT02076178|449604052|FG001|Oral Phase|Adverse Event|7|||
124993704|NCT02076178|449604051|FG000|Oral Phase|Withdrawal by Subject|0|||
124993705|NCT02076178|449604052|FG001|Oral Phase|Withdrawal by Subject|4|||
124993706|NCT02076178|449604051|FG000|Oral Phase|Physician Decision|0|||
124993707|NCT02076178|449604052|FG001|Oral Phase|Physician Decision|1|||
124993708|NCT02076178|449604051|FG000|Injection Phase|Protocol defined stopping criteria|1|||
124993709|NCT02076178|449604052|FG001|Injection Phase|Protocol defined stopping criteria|0|||
124993710|NCT02076178|449604051|FG000|Injection Phase|Withdrawal by Subject|0|||
124993711|NCT02076178|449604052|FG001|Injection Phase|Withdrawal by Subject|3|||
124993712|NCT02076178|449604051|FG000|Injection Phase|Physician Decision|0|||
124993713|NCT02076178|449604052|FG001|Injection Phase|Physician Decision|3|||
124993714|NCT02076178|449604051|FG000|Injection Phase|Lost to Follow-up|0|||
124993715|NCT02076178|449604052|FG001|Injection Phase|Lost to Follow-up|1|||
124993716|NCT02434939|449604060|FG000|Overall Study|Lack of Efficacy|34|||
124993717|NCT02434939|449604061|FG001|Overall Study|Lack of Efficacy|48|||
124993718|NCT02434939|449604060|FG000|Overall Study|Withdrawal by Subject|3|||
124993719|NCT02434939|449604061|FG001|Overall Study|Withdrawal by Subject|0|||
124993720|NCT02434939|449604060|FG000|Overall Study|Adverse Event|0|||
124993721|NCT02434939|449604061|FG001|Overall Study|Adverse Event|1|||
124993722|NCT00585195|449604077|FG000|Overall Study|Adverse Event|0|||
124993723|NCT00585195|449604078|FG001|Overall Study|Adverse Event|0|||
124993724|NCT00585195|449604079|FG002|Overall Study|Adverse Event|0|||
124993725|NCT00585195|449604080|FG003|Overall Study|Adverse Event|0|||
124993726|NCT00585195|449604081|FG004|Overall Study|Adverse Event|2|||
124993727|NCT00585195|449604082|FG005|Overall Study|Adverse Event|1|||
124993728|NCT00585195|449604083|FG006|Overall Study|Adverse Event|0|||
124993729|NCT00585195|449604084|FG007|Overall Study|Adverse Event|1|||
124993730|NCT00585195|449604085|FG008|Overall Study|Adverse Event|0|||
124993731|NCT00585195|449604086|FG009|Overall Study|Adverse Event|0|||
124993732|NCT00585195|449604087|FG010|Overall Study|Adverse Event|3|||
124993733|NCT00585195|449604088|FG011|Overall Study|Adverse Event|0|||
124993734|NCT00585195|449604089|FG012|Overall Study|Adverse Event|8|||
124993735|NCT00585195|449604090|FG013|Overall Study|Adverse Event|6|||
124993736|NCT00585195|449604091|FG014|Overall Study|Adverse Event|4|||
124993737|NCT00585195|449604092|FG015|Overall Study|Adverse Event|1|||
124993738|NCT00585195|449604093|FG016|Overall Study|Adverse Event|14|||
124993739|NCT00585195|449604094|FG017|Overall Study|Adverse Event|9|||
124993740|NCT00585195|449604095|FG018|Overall Study|Adverse Event|2|||
124993741|NCT00585195|449604096|FG019|Overall Study|Adverse Event|3|||
124993742|NCT00585195|449604097|FG020|Overall Study|Adverse Event|1|||
124993743|NCT00585195|449604077|FG000|Overall Study|Progressive Disease|2|||
124993744|NCT00585195|449604078|FG001|Overall Study|Progressive Disease|2|||
124993745|NCT00585195|449604079|FG002|Overall Study|Progressive Disease|5|||
124993746|NCT00585195|449604080|FG003|Overall Study|Progressive Disease|4|||
124993747|NCT00585195|449604081|FG004|Overall Study|Progressive Disease|6|||
124993748|NCT00585195|449604082|FG005|Overall Study|Progressive Disease|4|||
124993749|NCT00585195|449604083|FG006|Overall Study|Progressive Disease|6|||
124993750|NCT00585195|449604084|FG007|Overall Study|Progressive Disease|3|||
124993751|NCT00585195|449604085|FG008|Overall Study|Progressive Disease|0|||
124993752|NCT00585195|449604086|FG009|Overall Study|Progressive Disease|5|||
124993753|NCT00585195|449604087|FG010|Overall Study|Progressive Disease|2|||
124993754|NCT00585195|449604088|FG011|Overall Study|Progressive Disease|25|||
124993755|NCT00585195|449604089|FG012|Overall Study|Progressive Disease|29|||
124993756|NCT00585195|449604090|FG013|Overall Study|Progressive Disease|26|||
124993757|NCT00585195|449604091|FG014|Overall Study|Progressive Disease|21|||
124993758|NCT00585195|449604092|FG015|Overall Study|Progressive Disease|12|||
124993759|NCT00585195|449604093|FG016|Overall Study|Progressive Disease|94|||
124993760|NCT00585195|449604094|FG017|Overall Study|Progressive Disease|42|||
124993761|NCT00585195|449604095|FG018|Overall Study|Progressive Disease|4|||
124993762|NCT00585195|449604096|FG019|Overall Study|Progressive Disease|9|||
124993763|NCT00585195|449604097|FG020|Overall Study|Progressive Disease|8|||
124993764|NCT00585195|449604077|FG000|Overall Study|Withdrawal by Subject|1|||
124993765|NCT00585195|449604078|FG001|Overall Study|Withdrawal by Subject|1|||
124993766|NCT00585195|449604079|FG002|Overall Study|Withdrawal by Subject|2|||
124993767|NCT00585195|449604080|FG003|Overall Study|Withdrawal by Subject|2|||
124993768|NCT00585195|449604081|FG004|Overall Study|Withdrawal by Subject|0|||
124993769|NCT00585195|449604082|FG005|Overall Study|Withdrawal by Subject|0|||
124993770|NCT00585195|449604083|FG006|Overall Study|Withdrawal by Subject|0|||
124993771|NCT00585195|449604084|FG007|Overall Study|Withdrawal by Subject|1|||
124993772|NCT00585195|449604085|FG008|Overall Study|Withdrawal by Subject|0|||
124993773|NCT00585195|449604086|FG009|Overall Study|Withdrawal by Subject|0|||
124993774|NCT00585195|449604087|FG010|Overall Study|Withdrawal by Subject|3|||
124993775|NCT00585195|449604088|FG011|Overall Study|Withdrawal by Subject|8|||
124993776|NCT00585195|449604089|FG012|Overall Study|Withdrawal by Subject|15|||
124993777|NCT00585195|449604090|FG013|Overall Study|Withdrawal by Subject|0|||
124993778|NCT00585195|449604091|FG014|Overall Study|Withdrawal by Subject|3|||
124993779|NCT00585195|449604092|FG015|Overall Study|Withdrawal by Subject|0|||
124993780|NCT00585195|449604093|FG016|Overall Study|Withdrawal by Subject|7|||
124993781|NCT00585195|449604094|FG017|Overall Study|Withdrawal by Subject|1|||
124993782|NCT00585195|449604095|FG018|Overall Study|Withdrawal by Subject|2|||
124993783|NCT00585195|449604096|FG019|Overall Study|Withdrawal by Subject|2|||
124993784|NCT00585195|449604097|FG020|Overall Study|Withdrawal by Subject|0|||
124993785|NCT00585195|449604077|FG000|Overall Study|Other|0|||
124993786|NCT00585195|449604078|FG001|Overall Study|Other|1|||
124993787|NCT00585195|449604079|FG002|Overall Study|Other|1|||
124993788|NCT00585195|449604080|FG003|Overall Study|Other|1|||
124993789|NCT00585195|449604081|FG004|Overall Study|Other|0|||
124993790|NCT00585195|449604082|FG005|Overall Study|Other|1|||
124993791|NCT00585195|449604083|FG006|Overall Study|Other|0|||
124993792|NCT00585195|449604084|FG007|Overall Study|Other|0|||
124993793|NCT00585195|449604085|FG008|Overall Study|Other|2|||
124993794|NCT00585195|449604086|FG009|Overall Study|Other|1|||
124993795|NCT00585195|449604087|FG010|Overall Study|Other|0|||
124993796|NCT00585195|449604088|FG011|Overall Study|Other|19|||
124993797|NCT00585195|449604089|FG012|Overall Study|Other|24|||
124993798|NCT00585195|449604090|FG013|Overall Study|Other|7|||
124993799|NCT00585195|449604091|FG014|Overall Study|Other|11|||
124993800|NCT00585195|449604092|FG015|Overall Study|Other|3|||
124993801|NCT00585195|449604093|FG016|Overall Study|Other|28|||
124993802|NCT00585195|449604094|FG017|Overall Study|Other|12|||
124993803|NCT00585195|449604095|FG018|Overall Study|Other|10|||
124993804|NCT00585195|449604096|FG019|Overall Study|Other|4|||
124993805|NCT00585195|449604097|FG020|Overall Study|Other|2|||
124993806|NCT00585195|449604077|FG000|Overall Study|Randomized not treated|0|||
124993807|NCT00585195|449604078|FG001|Overall Study|Randomized not treated|0|||
124993808|NCT00585195|449604079|FG002|Overall Study|Randomized not treated|1|||
124993809|NCT00585195|449604080|FG003|Overall Study|Randomized not treated|0|||
124993810|NCT00585195|449604081|FG004|Overall Study|Randomized not treated|1|||
124993811|NCT00585195|449604082|FG005|Overall Study|Randomized not treated|0|||
124993812|NCT00585195|449604083|FG006|Overall Study|Randomized not treated|1|||
124993813|NCT00585195|449604084|FG007|Overall Study|Randomized not treated|0|||
124993814|NCT00585195|449604085|FG008|Overall Study|Randomized not treated|0|||
124993815|NCT00585195|449604086|FG009|Overall Study|Randomized not treated|0|||
124993816|NCT00585195|449604087|FG010|Overall Study|Randomized not treated|2|||
124993817|NCT00585195|449604088|FG011|Overall Study|Randomized not treated|0|||
124993818|NCT00585195|449604089|FG012|Overall Study|Randomized not treated|0|||
124993819|NCT00585195|449604090|FG013|Overall Study|Randomized not treated|0|||
124993820|NCT00585195|449604091|FG014|Overall Study|Randomized not treated|0|||
124993821|NCT00585195|449604092|FG015|Overall Study|Randomized not treated|1|||
124993822|NCT00585195|449604093|FG016|Overall Study|Randomized not treated|0|||
124993823|NCT00585195|449604094|FG017|Overall Study|Randomized not treated|1|||
124993824|NCT00585195|449604095|FG018|Overall Study|Randomized not treated|3|||
124993825|NCT00585195|449604096|FG019|Overall Study|Randomized not treated|0|||
124993826|NCT00585195|449604097|FG020|Overall Study|Randomized not treated|2|||
124993827|NCT00585195|449604077|FG000|Overall Study|Death|0|||
124993828|NCT00585195|449604078|FG001|Overall Study|Death|0|||
124993829|NCT00585195|449604079|FG002|Overall Study|Death|0|||
124993830|NCT00585195|449604080|FG003|Overall Study|Death|0|||
124993831|NCT00585195|449604081|FG004|Overall Study|Death|0|||
124993832|NCT00585195|449604082|FG005|Overall Study|Death|0|||
124993833|NCT00585195|449604083|FG006|Overall Study|Death|0|||
124993834|NCT00585195|449604084|FG007|Overall Study|Death|0|||
124993835|NCT00585195|449604085|FG008|Overall Study|Death|1|||
124993836|NCT00585195|449604086|FG009|Overall Study|Death|0|||
124993837|NCT00585195|449604087|FG010|Overall Study|Death|1|||
124993838|NCT00585195|449604088|FG011|Overall Study|Death|1|||
124993839|NCT00585195|449604089|FG012|Overall Study|Death|7|||
124993840|NCT00585195|449604090|FG013|Overall Study|Death|2|||
124993841|NCT00585195|449604091|FG014|Overall Study|Death|8|||
124993842|NCT00585195|449604092|FG015|Overall Study|Death|2|||
124993843|NCT00585195|449604093|FG016|Overall Study|Death|11|||
124993844|NCT00585195|449604094|FG017|Overall Study|Death|0|||
124993845|NCT00585195|449604095|FG018|Overall Study|Death|0|||
124993846|NCT00585195|449604096|FG019|Overall Study|Death|0|||
124993847|NCT00585195|449604097|FG020|Overall Study|Death|1|||
124993848|NCT00585195|449604077|FG000|Overall Study|Lost to Follow-up|0|||
124993849|NCT00585195|449604078|FG001|Overall Study|Lost to Follow-up|0|||
124993850|NCT00585195|449604079|FG002|Overall Study|Lost to Follow-up|0|||
124993851|NCT00585195|449604080|FG003|Overall Study|Lost to Follow-up|0|||
124993852|NCT00585195|449604081|FG004|Overall Study|Lost to Follow-up|0|||
124993853|NCT00585195|449604082|FG005|Overall Study|Lost to Follow-up|0|||
124993854|NCT00585195|449604083|FG006|Overall Study|Lost to Follow-up|0|||
124993855|NCT00585195|449604084|FG007|Overall Study|Lost to Follow-up|0|||
124993856|NCT00585195|449604085|FG008|Overall Study|Lost to Follow-up|0|||
124993857|NCT00585195|449604086|FG009|Overall Study|Lost to Follow-up|0|||
124993858|NCT00585195|449604087|FG010|Overall Study|Lost to Follow-up|0|||
124993859|NCT00585195|449604088|FG011|Overall Study|Lost to Follow-up|0|||
124993860|NCT00585195|449604089|FG012|Overall Study|Lost to Follow-up|1|||
124993861|NCT00585195|449604090|FG013|Overall Study|Lost to Follow-up|0|||
124993862|NCT00585195|449604091|FG014|Overall Study|Lost to Follow-up|0|||
124993863|NCT00585195|449604092|FG015|Overall Study|Lost to Follow-up|0|||
124993864|NCT00585195|449604093|FG016|Overall Study|Lost to Follow-up|0|||
124993865|NCT00585195|449604094|FG017|Overall Study|Lost to Follow-up|2|||
124993866|NCT00585195|449604095|FG018|Overall Study|Lost to Follow-up|0|||
124993867|NCT00585195|449604096|FG019|Overall Study|Lost to Follow-up|0|||
124993868|NCT00585195|449604097|FG020|Overall Study|Lost to Follow-up|0|||
124993869|NCT00585195|449604077|FG000|Overall Study|Site Terminated by Sponsor|0|||
124993870|NCT00585195|449604078|FG001|Overall Study|Site Terminated by Sponsor|0|||
124993871|NCT00585195|449604079|FG002|Overall Study|Site Terminated by Sponsor|0|||
124993872|NCT00585195|449604080|FG003|Overall Study|Site Terminated by Sponsor|0|||
124993873|NCT00585195|449604081|FG004|Overall Study|Site Terminated by Sponsor|0|||
124993874|NCT00585195|449604082|FG005|Overall Study|Site Terminated by Sponsor|0|||
124993875|NCT00585195|449604083|FG006|Overall Study|Site Terminated by Sponsor|0|||
124993876|NCT00585195|449604084|FG007|Overall Study|Site Terminated by Sponsor|0|||
124993877|NCT00585195|449604085|FG008|Overall Study|Site Terminated by Sponsor|0|||
124993878|NCT00585195|449604086|FG009|Overall Study|Site Terminated by Sponsor|0|||
124993879|NCT00585195|449604087|FG010|Overall Study|Site Terminated by Sponsor|0|||
124993880|NCT00585195|449604088|FG011|Overall Study|Site Terminated by Sponsor|0|||
124993881|NCT00585195|449604089|FG012|Overall Study|Site Terminated by Sponsor|1|||
124993882|NCT00585195|449604090|FG013|Overall Study|Site Terminated by Sponsor|0|||
124993883|NCT00585195|449604091|FG014|Overall Study|Site Terminated by Sponsor|0|||
124993884|NCT00585195|449604092|FG015|Overall Study|Site Terminated by Sponsor|0|||
124993885|NCT00585195|449604093|FG016|Overall Study|Site Terminated by Sponsor|0|||
124993886|NCT00585195|449604094|FG017|Overall Study|Site Terminated by Sponsor|0|||
124993887|NCT00585195|449604095|FG018|Overall Study|Site Terminated by Sponsor|0|||
124993888|NCT00585195|449604096|FG019|Overall Study|Site Terminated by Sponsor|0|||
124993889|NCT00585195|449604097|FG020|Overall Study|Site Terminated by Sponsor|0|||
124993890|NCT00585195|449604077|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
124993891|NCT00585195|449604078|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
124993892|NCT00585195|449604079|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
124993893|NCT00585195|449604080|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
124993894|NCT00585195|449604081|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
124993895|NCT00585195|449604082|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
124993896|NCT00585195|449604083|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
124993897|NCT00585195|449604084|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
124993898|NCT00585195|449604085|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
124993899|NCT00585195|449604086|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
124993900|NCT00585195|449604087|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
124993901|NCT00585195|449604088|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
124993902|NCT00585195|449604089|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
124993903|NCT00585195|449604090|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
124993904|NCT00585195|449604091|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
124993905|NCT00585195|449604092|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
124993906|NCT00585195|449604093|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
124993907|NCT00585195|449604094|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
124993908|NCT00585195|449604095|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
124993909|NCT00585195|449604096|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
124993910|NCT00585195|449604097|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
124993911|NCT02796560|449604098|FG000|Overall Study|Adverse Event|2|||
124993912|NCT02796560|449604099|FG001|Overall Study|Adverse Event|0|||
125318198|NCT00402168|450794042|FG001|Long Term (LT)|Lost to Follow-up|0|||
125318199|NCT00402168|450794041|FG000|Long Term (LT)|Death|4|||
125318200|NCT00402168|450794042|FG001|Long Term (LT)|Death|0|||
125318201|NCT00402168|450794041|FG000|Long Term (LT)|Lack of Efficacy|0|||
124993913|NCT02796560|449604098|FG000|Overall Study|Withdrawal by Subject|2|||
124993914|NCT02796560|449604099|FG001|Overall Study|Withdrawal by Subject|2|||
124993915|NCT02881957|449604104|FG000|Overall Study|Comfort care|0|||
124993916|NCT02881957|449604105|FG001|Overall Study|Comfort care|1|||
124993917|NCT02881957|449604104|FG000|Overall Study|Concurrent trial enrollment|0|||
124993918|NCT02881957|449604105|FG001|Overall Study|Concurrent trial enrollment|1|||
124993919|NCT02881957|449604104|FG000|Overall Study|Discharged within 48 hours|0|||
124993920|NCT02881957|449604105|FG001|Overall Study|Discharged within 48 hours|1|||
124993921|NCT02881957|449604104|FG000|Overall Study|Withdrawal by Subject|2|||
124993922|NCT02881957|449604105|FG001|Overall Study|Withdrawal by Subject|1|||
124993923|NCT02881957|449604104|FG000|Overall Study|Protocol Violation|1|||
124993924|NCT02881957|449604105|FG001|Overall Study|Protocol Violation|0|||
124993925|NCT00345293|449604106|FG000|Overall Study|Unable to access line for sample|1|||
124993926|NCT00345293|449604107|FG001|Overall Study|Unable to access line for sample|0|||
124993927|NCT00345293|449604106|FG000|Overall Study|Withdrawal by Subject|1|||
124993928|NCT00345293|449604107|FG001|Overall Study|Withdrawal by Subject|0|||
124993929|NCT01440374|449605102|FG000|Part 1: Open-label Phase|Adverse Event|5|||
124993930|NCT01440374|449605103|FG001|Part 1: Open-label Phase|Adverse Event|0|||
124993931|NCT01440374|449605104|FG002|Part 1: Open-label Phase|Adverse Event|0|||
124993932|NCT01440374|449605105|FG003|Part 1: Open-label Phase|Adverse Event|0|||
124993933|NCT01440374|449605102|FG000|Part 1: Open-label Phase|Physician Decision|1|||
124993934|NCT01440374|449605103|FG001|Part 1: Open-label Phase|Physician Decision|0|||
124993935|NCT01440374|449605104|FG002|Part 1: Open-label Phase|Physician Decision|0|||
124993936|NCT01440374|449605105|FG003|Part 1: Open-label Phase|Physician Decision|0|||
124993937|NCT01440374|449605102|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
124993938|NCT01440374|449605103|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
124993939|NCT01440374|449605104|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
124993940|NCT01440374|449605105|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
124993941|NCT01440374|449605102|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
124993942|NCT01440374|449605103|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
124993943|NCT01440374|449605104|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
124993944|NCT01440374|449605105|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
124993945|NCT01440374|449605102|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
124993946|NCT01440374|449605103|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
124993947|NCT01440374|449605104|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
124993948|NCT01440374|449605105|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
124993949|NCT01440374|449605102|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
124993950|NCT01440374|449605103|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
124993951|NCT01440374|449605104|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
124993952|NCT01440374|449605105|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
124993953|NCT01440374|449605102|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
124993954|NCT01440374|449605103|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
124993955|NCT01440374|449605104|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
125318202|NCT00402168|450794042|FG001|Long Term (LT)|Lack of Efficacy|2|||
125318203|NCT00402168|450794041|FG000|Long Term (LT)|non-specified|1|||
125318204|NCT00402168|450794042|FG001|Long Term (LT)|non-specified|2|||
124993956|NCT01440374|449605105|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
124993957|NCT01440374|449605102|FG000|Part 2; Double-blind Phase|Not treated|0|||
124993958|NCT01440374|449605103|FG001|Part 2; Double-blind Phase|Not treated|0|||
124993959|NCT01440374|449605104|FG002|Part 2; Double-blind Phase|Not treated|1|||
124993960|NCT01440374|449605105|FG003|Part 2; Double-blind Phase|Not treated|0|||
124993961|NCT01440374|449605102|FG000|Part 3: Extension|Withdrawal by Subject|0|||
124993962|NCT01440374|449605103|FG001|Part 3: Extension|Withdrawal by Subject|0|||
124993963|NCT01440374|449605104|FG002|Part 3: Extension|Withdrawal by Subject|0|||
124993964|NCT01440374|449605105|FG003|Part 3: Extension|Withdrawal by Subject|5|||
124993965|NCT01440374|449605102|FG000|Part 3: Extension|Adverse Event|0|||
124993966|NCT01440374|449605103|FG001|Part 3: Extension|Adverse Event|0|||
124993967|NCT01440374|449605104|FG002|Part 3: Extension|Adverse Event|0|||
124993968|NCT01440374|449605105|FG003|Part 3: Extension|Adverse Event|13|||
124993969|NCT01440374|449605102|FG000|Part 3: Extension|Physician Decision|0|||
124993970|NCT01440374|449605103|FG001|Part 3: Extension|Physician Decision|0|||
124993971|NCT01440374|449605104|FG002|Part 3: Extension|Physician Decision|0|||
124993972|NCT01440374|449605105|FG003|Part 3: Extension|Physician Decision|14|||
124993973|NCT04281004|449605114|FG000|Overall Study|Physician Decision|1|||
124993974|NCT04281004|449605115|FG001|Overall Study|Physician Decision|0|||
124993975|NCT00701779|449605116|FG000|Overall Study|Adverse Event|6|||
124993976|NCT00701779|449605116|FG000|Overall Study|Lost to Follow-up|1|||
124993977|NCT00701779|449605116|FG000|Overall Study|Withdrawal by Subject|2|||
124993978|NCT03628898|449605117|FG000|Overall Study|Device deficiency|1|||
124993979|NCT01217957|449605118|FG000|Phase 1|Withdrawal by Patient|1|||
124993980|NCT01217957|449605119|FG001|Phase 1|Withdrawal by Patient|0|||
124993981|NCT01217957|449605120|FG002|Phase 1|Withdrawal by Patient|1|||
124993982|NCT01217957|449605121|FG003|Phase 1|Withdrawal by Patient|1|||
124993983|NCT01217957|449605122|FG004|Phase 1|Withdrawal by Patient|0|||
124993984|NCT01217957|449605118|FG000|Phase 2|Withdrawal by Patient|0|||
124993985|NCT01217957|449605119|FG001|Phase 2|Withdrawal by Patient|0|||
124993986|NCT01217957|449605120|FG002|Phase 2|Withdrawal by Patient|0|||
124993987|NCT01217957|449605121|FG003|Phase 2|Withdrawal by Patient|0|||
124993988|NCT01217957|449605122|FG004|Phase 2|Withdrawal by Patient|1|||
124993989|NCT01873495|449605125|FG000|Overall Study|Withdrawal by Subject|1|||
124993990|NCT01873495|449605125|FG000|Overall Study|Physician Decision|3|||
124993991|NCT01873495|449605125|FG000|Overall Study|Adverse Event|1|||
124993992|NCT01873495|449605125|FG000|Overall Study|Removed for Transplantation|1|||
124993993|NCT01873495|449605125|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
124993994|NCT01206777|449605126|FG000|Overall Study|Death|1|||
125318205|NCT00402168|450794041|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
125318206|NCT00402168|450794042|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
125318207|NCT00402168|450794041|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
125318208|NCT00402168|450794042|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
125318209|NCT00395746|450794048|FG000|Overall Study|Adverse Event|5|||
125318210|NCT00395746|450794049|FG001|Overall Study|Adverse Event|2|||
125318211|NCT00395746|450794050|FG002|Overall Study|Adverse Event|2|||
125318212|NCT00395746|450794048|FG000|Overall Study|Protocol Violation|0|||
125318213|NCT00395746|450794049|FG001|Overall Study|Protocol Violation|1|||
125318214|NCT00395746|450794050|FG002|Overall Study|Protocol Violation|0|||
125318215|NCT00395746|450794048|FG000|Overall Study|Lack of Efficacy|2|||
124993995|NCT01206777|449605126|FG000|Overall Study|Adverse Event|1|||
124993996|NCT02986334|449605127|FG000|Overall Study|Withdrawal by Subject|0|||
124993997|NCT02986334|449605128|FG001|Overall Study|Withdrawal by Subject|1|||
124993998|NCT02986334|449605129|FG002|Overall Study|Withdrawal by Subject|2|||
124993999|NCT02986334|449605127|FG000|Overall Study|Lost to Follow-up|1|||
124994000|NCT02986334|449605128|FG001|Overall Study|Lost to Follow-up|2|||
124994001|NCT02986334|449605129|FG002|Overall Study|Lost to Follow-up|1|||
124994002|NCT02986334|449605127|FG000|Overall Study|Adverse Event|0|||
124994003|NCT02986334|449605128|FG001|Overall Study|Adverse Event|2|||
124994004|NCT02986334|449605129|FG002|Overall Study|Adverse Event|1|||
124994005|NCT02986334|449605127|FG000|Overall Study|non compliance in phone ratings|2|||
124994006|NCT02986334|449605128|FG001|Overall Study|non compliance in phone ratings|1|||
124994007|NCT02986334|449605129|FG002|Overall Study|non compliance in phone ratings|2|||
124994008|NCT02986334|449605127|FG000|Overall Study|undisclosed comorbidities|0|||
124994009|NCT02986334|449605128|FG001|Overall Study|undisclosed comorbidities|1|||
124994010|NCT02986334|449605129|FG002|Overall Study|undisclosed comorbidities|1|||
124994011|NCT03864146|449605130|FG000|Overall Study|Lost to Follow-up|14|||
125318216|NCT00395746|450794049|FG001|Overall Study|Lack of Efficacy|0|||
124994012|NCT03864146|449605131|FG001|Overall Study|Lost to Follow-up|23|||
124994013|NCT03864146|449605130|FG000|Overall Study|Withdrawal by Subject|3|||
124994014|NCT03864146|449605131|FG001|Overall Study|Withdrawal by Subject|2|||
124994015|NCT01313637|449605137|FG000|Overall Study|Adverse Event|17|||
124994016|NCT01313637|449605138|FG001|Overall Study|Adverse Event|24|||
124994017|NCT01313637|449605139|FG002|Overall Study|Adverse Event|25|||
124994018|NCT01313637|449605140|FG003|Overall Study|Adverse Event|18|||
124994019|NCT01313637|449605137|FG000|Overall Study|Lack of Efficacy|44|||
124994020|NCT01313637|449605138|FG001|Overall Study|Lack of Efficacy|38|||
124994021|NCT01313637|449605139|FG002|Overall Study|Lack of Efficacy|37|||
124994022|NCT01313637|449605140|FG003|Overall Study|Lack of Efficacy|24|||
124994023|NCT01313637|449605137|FG000|Overall Study|Protocol Violation|4|||
124994024|NCT01313637|449605138|FG001|Overall Study|Protocol Violation|3|||
124994025|NCT01313637|449605139|FG002|Overall Study|Protocol Violation|11|||
124994026|NCT01313637|449605140|FG003|Overall Study|Protocol Violation|5|||
124994027|NCT01313637|449605137|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
124994028|NCT01313637|449605138|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
124994029|NCT01313637|449605139|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
124994030|NCT01313637|449605140|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
124994031|NCT01313637|449605137|FG000|Overall Study|Lost to Follow-up|0|||
124994032|NCT01313637|449605138|FG001|Overall Study|Lost to Follow-up|2|||
124994033|NCT01313637|449605139|FG002|Overall Study|Lost to Follow-up|1|||
124994034|NCT01313637|449605140|FG003|Overall Study|Lost to Follow-up|3|||
124994035|NCT01313637|449605137|FG000|Overall Study|Withdrawal by Subject|11|||
124994036|NCT01313637|449605138|FG001|Overall Study|Withdrawal by Subject|13|||
124994037|NCT01313637|449605139|FG002|Overall Study|Withdrawal by Subject|18|||
124994038|NCT01313637|449605140|FG003|Overall Study|Withdrawal by Subject|15|||
124994039|NCT00846391|449605142|FG000|Overall Study|Physician Decision|0|||
124994040|NCT00846391|449605143|FG001|Overall Study|Physician Decision|0|||
124994041|NCT00846391|449605144|FG002|Overall Study|Physician Decision|1|||
124994042|NCT00846391|449605142|FG000|Overall Study|Study Terminated by Sponsor|1|||
124994043|NCT00846391|449605143|FG001|Overall Study|Study Terminated by Sponsor|2|||
124994044|NCT00846391|449605144|FG002|Overall Study|Study Terminated by Sponsor|2|||
124994045|NCT04634825|449605146|FG000|Overall Study|Death|10|||
124994046|NCT04634825|449605147|FG001|Overall Study|Death|3|||
124994047|NCT04634825|449605146|FG000|Overall Study|Lost to Follow-up|1|||
125318217|NCT00395746|450794050|FG002|Overall Study|Lack of Efficacy|17|||
125318218|NCT00395746|450794048|FG000|Overall Study|Hypoglycaemia|2|||
124994048|NCT04634825|449605147|FG001|Overall Study|Lost to Follow-up|0|||
124994049|NCT04634825|449605146|FG000|Overall Study|Study terminated by sponsor|35|||
124994050|NCT04634825|449605147|FG001|Overall Study|Study terminated by sponsor|11|||
124994051|NCT04634825|449605146|FG000|Overall Study|Withdrawal by Subject|2|||
124994052|NCT04634825|449605147|FG001|Overall Study|Withdrawal by Subject|0|||
124994053|NCT03021954|449605156|FG000|Overall Study|Lost to Follow-up|10|||
124994054|NCT03021954|449605157|FG001|Overall Study|Lost to Follow-up|43|||
124994055|NCT03021954|449605156|FG000|Overall Study|Subjects had avulsion trauma|4|||
124994056|NCT03021954|449605157|FG001|Overall Study|Subjects had avulsion trauma|1|||
124994057|NCT00069238|449605158|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
124994058|NCT00069238|449605159|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
124994059|NCT00069238|449605160|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
124994060|NCT00069238|449605158|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
124994061|NCT00069238|449605159|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
124994062|NCT00069238|449605160|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
124994063|NCT00069238|449605158|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
124994064|NCT00069238|449605159|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
124994065|NCT00069238|449605160|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
124994066|NCT01001832|449605161|FG000|Short-term Period|Adverse Event|2|||
124994067|NCT01001832|449605162|FG001|Short-term Period|Adverse Event|3|||
124994068|NCT01001832|449605161|FG000|Long-term Period|Adverse Event|2|||
124994069|NCT01001832|449605162|FG001|Long-term Period|Adverse Event|1|||
124994070|NCT01001832|449605161|FG000|Long-term Period|Withdrawal by Subject|1|||
124994071|NCT01001832|449605162|FG001|Long-term Period|Withdrawal by Subject|0|||
124994072|NCT01001832|449605161|FG000|Long-term Period|Lack of Efficacy|0|||
124994073|NCT01001832|449605162|FG001|Long-term Period|Lack of Efficacy|2|||
124994074|NCT01001832|449605161|FG000|Long-term Period|Other|1|||
124994075|NCT01001832|449605162|FG001|Long-term Period|Other|2|||
124994076|NCT01001832|449605161|FG000|Follow-up Period|Withdrawal by Subject|1|||
124994077|NCT01001832|449605162|FG001|Follow-up Period|Withdrawal by Subject|0|||
124994078|NCT01001832|449605161|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
124994079|NCT01001832|449605162|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
124994080|NCT01001832|449605161|FG000|Follow-up Period|Other|2|||
124994081|NCT01001832|449605162|FG001|Follow-up Period|Other|1|||
124994082|NCT00807235|449605169|FG000|Overall Study|Adverse Event|1|||
124994083|NCT00807235|449605170|FG001|Overall Study|Adverse Event|0|||
124994084|NCT01765179|449605171|FG000|Overall Study|Adverse Event|3|||
124994085|NCT01765179|449605171|FG000|Overall Study|Lost to Follow-up|5|||
124994086|NCT01765179|449605171|FG000|Overall Study|Non-compliance with study drug|2|||
124994087|NCT01765179|449605171|FG000|Overall Study|Protocol Violation|1|||
124994088|NCT01765179|449605171|FG000|Overall Study|Withdrawal by Subject|8|||
124994089|NCT01765179|449605171|FG000|Overall Study|Hematocrit >54%|3|||
124994090|NCT01765179|449605171|FG000|Overall Study|prohibited med|1|||
124994091|NCT01765179|449605171|FG000|Overall Study|Out of country unable to finish study|1|||
124994092|NCT01765179|449605171|FG000|Overall Study|lack of venous access|1|||
124994093|NCT01765179|449605171|FG000|Overall Study|work conflict|1|||
124994094|NCT01765179|449605171|FG000|Overall Study|Ca elevated 10.6|1|||
125318219|NCT00395746|450794049|FG001|Overall Study|Hypoglycaemia|1|||
124994095|NCT01536015|449605172|FG000|Overall Study|Adverse Event|1|||
124994096|NCT01536015|449605173|FG001|Overall Study|Adverse Event|4|||
124994097|NCT01536015|449605172|FG000|Overall Study|Lost to Follow-up|0|||
124994098|NCT01536015|449605173|FG001|Overall Study|Lost to Follow-up|1|||
124994099|NCT01536015|449605172|FG000|Overall Study|Inclusion Criterion not met|2|||
124994100|NCT01536015|449605173|FG001|Overall Study|Inclusion Criterion not met|0|||
124994101|NCT01536015|449605172|FG000|Overall Study|Study closure|5|||
124994102|NCT01536015|449605173|FG001|Overall Study|Study closure|5|||
124994103|NCT03581825|449605175|FG000|Period 1|Lens Discomfort|1|||
124994104|NCT03581825|449605176|FG001|Period 1|Lens Discomfort|0|||
124994105|NCT03581825|449605175|FG000|Period 2|Unsatisfactory Vision to Test|0|||
124994106|NCT03581825|449605176|FG001|Period 2|Unsatisfactory Vision to Test|1|||
124994107|NCT01668667|449605177|FG000|Overall Study|Adverse Event|3|||
124994108|NCT01668667|449605178|FG001|Overall Study|Adverse Event|6|||
124994109|NCT01668667|449605179|FG002|Overall Study|Adverse Event|4|||
124994110|NCT01668667|449605180|FG003|Overall Study|Adverse Event|4|||
124994111|NCT01668667|449605177|FG000|Overall Study|Lack of Efficacy|3|||
124994112|NCT01668667|449605178|FG001|Overall Study|Lack of Efficacy|2|||
124994113|NCT01668667|449605179|FG002|Overall Study|Lack of Efficacy|2|||
124994114|NCT01668667|449605180|FG003|Overall Study|Lack of Efficacy|3|||
124994115|NCT01668667|449605177|FG000|Overall Study|Protocol Violation|6|||
124994116|NCT01668667|449605178|FG001|Overall Study|Protocol Violation|10|||
124994117|NCT01668667|449605179|FG002|Overall Study|Protocol Violation|12|||
124994118|NCT01668667|449605180|FG003|Overall Study|Protocol Violation|5|||
124994119|NCT01668667|449605177|FG000|Overall Study|Lost to Follow-up|9|||
124994120|NCT01668667|449605178|FG001|Overall Study|Lost to Follow-up|4|||
124994121|NCT01668667|449605179|FG002|Overall Study|Lost to Follow-up|7|||
124994122|NCT01668667|449605180|FG003|Overall Study|Lost to Follow-up|6|||
124994123|NCT01668667|449605177|FG000|Overall Study|Physician Decision|3|||
124994124|NCT01668667|449605178|FG001|Overall Study|Physician Decision|0|||
124994125|NCT01668667|449605179|FG002|Overall Study|Physician Decision|1|||
124994126|NCT01668667|449605180|FG003|Overall Study|Physician Decision|0|||
124994127|NCT01668667|449605177|FG000|Overall Study|Withdrawal by Subject|7|||
124994128|NCT01668667|449605178|FG001|Overall Study|Withdrawal by Subject|4|||
124994129|NCT01668667|449605179|FG002|Overall Study|Withdrawal by Subject|5|||
124994130|NCT01668667|449605180|FG003|Overall Study|Withdrawal by Subject|5|||
124994131|NCT00511901|449605181|FG000|Overall Study|Withdrawal by Subject|1|||
124994132|NCT00511901|449605182|FG001|Overall Study|Withdrawal by Subject|3|||
124994133|NCT00178126|449605183|FG000|Overall Study|Lost to Follow-up|21|||
124994134|NCT00178126|449605184|FG001|Overall Study|Lost to Follow-up|21|||
124994135|NCT00178126|449605183|FG000|Overall Study|did not receive intervention|4|||
124994136|NCT00178126|449605184|FG001|Overall Study|did not receive intervention|6|||
124994137|NCT02447172|449605185|FG000|Overall Study|Adverse Event|11|||
124994138|NCT02447172|449605186|FG001|Overall Study|Adverse Event|8|||
124994139|NCT02447172|449605187|FG002|Overall Study|Adverse Event|7|||
124994140|NCT02447172|449605185|FG000|Overall Study|Death|3|||
124994141|NCT02447172|449605186|FG001|Overall Study|Death|1|||
124994142|NCT02447172|449605187|FG002|Overall Study|Death|0|||
124994143|NCT02447172|449605185|FG000|Overall Study|Protocol Violation|2|||
124994144|NCT02447172|449605186|FG001|Overall Study|Protocol Violation|1|||
124994145|NCT02447172|449605187|FG002|Overall Study|Protocol Violation|2|||
124994146|NCT02447172|449605185|FG000|Overall Study|Lost to Follow-up|7|||
124994147|NCT02447172|449605186|FG001|Overall Study|Lost to Follow-up|4|||
124994148|NCT02447172|449605187|FG002|Overall Study|Lost to Follow-up|4|||
124994149|NCT02447172|449605185|FG000|Overall Study|Withdrawal by Subject|5|||
124994150|NCT02447172|449605186|FG001|Overall Study|Withdrawal by Subject|1|||
124994151|NCT02447172|449605187|FG002|Overall Study|Withdrawal by Subject|3|||
124994152|NCT02447172|449605185|FG000|Overall Study|protocol specific treatment unrelated|3|||
124994153|NCT02447172|449605186|FG001|Overall Study|protocol specific treatment unrelated|0|||
124994154|NCT02447172|449605187|FG002|Overall Study|protocol specific treatment unrelated|2|||
124994155|NCT03562247|449605188|FG000|Overall Study|Lost to Follow-up|3|||
124994156|NCT03562247|449605189|FG001|Overall Study|Lost to Follow-up|1|||
124994157|NCT03562247|449605190|FG002|Overall Study|Lost to Follow-up|1|||
124994158|NCT01182194|449605192|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
124994159|NCT01182194|449605193|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
124994160|NCT03343301|449605194|FG000|Overall Study|Withdrawal by Subject|1|||
124994161|NCT03343301|449605195|FG001|Overall Study|Withdrawal by Subject|1|||
124994162|NCT03343301|449605194|FG000|Overall Study|Death|0|||
124994163|NCT03343301|449605195|FG001|Overall Study|Death|2|||
124994164|NCT03343301|449605194|FG000|Overall Study|Other|0|||
124994165|NCT03343301|449605195|FG001|Overall Study|Other|6|||
124994166|NCT03343301|449605194|FG000|Overall Study|Missing|2|||
124994167|NCT03343301|449605195|FG001|Overall Study|Missing|0|||
124994168|NCT00368992|449605196|FG000|Overall Study|Ineligible|5|||
124994169|NCT00368992|449605196|FG000|Overall Study|Refused treatment|3|||
124994170|NCT00368992|449605196|FG000|Overall Study|Lack of Efficacy|63|||
124994171|NCT00368992|449605196|FG000|Overall Study|Adverse Event|26|||
124994172|NCT00368992|449605196|FG000|Overall Study|Death|4|||
124994173|NCT00368992|449605196|FG000|Overall Study|Other|9|||
124994174|NCT01013597|449605197|FG000|Overall Study|Withdrawal by Subject|1|||
124994175|NCT00427895|449605198|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
124994176|NCT00427895|449605199|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
124994177|NCT00427895|449605200|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
124994178|NCT00427895|449605201|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
124994179|NCT00427895|449605202|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
124994180|NCT00427895|449605203|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
124994181|NCT00427895|449605204|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
124994182|NCT00427895|449605205|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
124994183|NCT00427895|449605198|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
124994184|NCT00427895|449605199|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
124994185|NCT00427895|449605200|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
124994186|NCT00427895|449605201|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
124994187|NCT00427895|449605202|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
124994188|NCT00427895|449605203|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
124994189|NCT00427895|449605204|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
124994190|NCT00427895|449605205|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
124994191|NCT00427895|449605198|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
124994192|NCT00427895|449605199|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
124994193|NCT00427895|449605200|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
124994194|NCT00427895|449605201|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
124994195|NCT00427895|449605202|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
124994196|NCT00427895|449605203|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
124994197|NCT00427895|449605204|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
124994198|NCT00427895|449605205|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
124994199|NCT00427895|449605198|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
124994200|NCT00427895|449605199|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
124994201|NCT00427895|449605200|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
125318220|NCT00395746|450794050|FG002|Overall Study|Hypoglycaemia|0|||
125318221|NCT00395746|450794048|FG000|Overall Study|Subject decision|0|||
125318222|NCT00395746|450794049|FG001|Overall Study|Subject decision|0|||
125318223|NCT00395746|450794050|FG002|Overall Study|Subject decision|1|||
125318224|NCT00395746|450794048|FG000|Overall Study|Withdrawal of consent|0|||
125318225|NCT00395746|450794049|FG001|Overall Study|Withdrawal of consent|0|||
125318226|NCT00395746|450794050|FG002|Overall Study|Withdrawal of consent|1|||
125318227|NCT00395746|450794048|FG000|Overall Study|Difficultulty in use of device|0|||
125318228|NCT00395746|450794049|FG001|Overall Study|Difficultulty in use of device|0|||
125318229|NCT00395746|450794050|FG002|Overall Study|Difficultulty in use of device|1|||
125318230|NCT00395746|450794048|FG000|Overall Study|Unable to visit site on schedule|1|||
124994202|NCT00427895|449605201|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
124994203|NCT00427895|449605202|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
124994204|NCT00427895|449605203|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
124994205|NCT00427895|449605204|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
124994206|NCT00427895|449605205|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
124994207|NCT00427895|449605198|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
124994208|NCT00427895|449605199|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
124994209|NCT00427895|449605200|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
124994210|NCT00427895|449605201|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
124994211|NCT00427895|449605202|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
124994212|NCT00427895|449605203|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
124994213|NCT00427895|449605204|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
124994214|NCT00427895|449605205|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
124994215|NCT00427895|449605198|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
124994216|NCT00427895|449605199|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
124994217|NCT00427895|449605200|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
124994218|NCT00427895|449605201|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
124994219|NCT00427895|449605202|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
125318231|NCT00395746|450794049|FG001|Overall Study|Unable to visit site on schedule|0|||
125318232|NCT00395746|450794050|FG002|Overall Study|Unable to visit site on schedule|0|||
125318233|NCT03137992|450794055|FG000|Washout Period 1|Adverse Event|1|||
124994220|NCT00427895|449605203|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
124994221|NCT00427895|449605204|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
124994222|NCT00427895|449605205|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
124994223|NCT00427895|449605198|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
124994224|NCT00427895|449605199|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
124994225|NCT00427895|449605200|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
124994226|NCT00427895|449605201|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
125318234|NCT03137992|450794056|FG001|Washout Period 1|Adverse Event|1|||
125318235|NCT03137992|450794057|FG002|Washout Period 1|Adverse Event|0|||
125318236|NCT03137992|450794058|FG003|Washout Period 1|Adverse Event|0|||
125318237|NCT03137992|450794059|FG004|Washout Period 1|Adverse Event|0|||
124994227|NCT00427895|449605202|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
125318238|NCT03137992|450794060|FG005|Washout Period 1|Adverse Event|1|||
125318239|NCT03137992|450794055|FG000|Washout Period 1|Withdrawal by Subject|0|||
125318240|NCT03137992|450794056|FG001|Washout Period 1|Withdrawal by Subject|1|||
125318241|NCT03137992|450794057|FG002|Washout Period 1|Withdrawal by Subject|1|||
125318242|NCT03137992|450794058|FG003|Washout Period 1|Withdrawal by Subject|0|||
125318243|NCT03137992|450794059|FG004|Washout Period 1|Withdrawal by Subject|0|||
125318244|NCT03137992|450794060|FG005|Washout Period 1|Withdrawal by Subject|0|||
125318245|NCT03137992|450794055|FG000|Washout Period 1|Principal Investigator Discretion|0|||
125318246|NCT03137992|450794056|FG001|Washout Period 1|Principal Investigator Discretion|1|||
124994228|NCT00427895|449605203|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
124994229|NCT00427895|449605204|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
124994230|NCT00427895|449605205|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
124994231|NCT00427895|449605198|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
124994232|NCT00427895|449605199|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
124994233|NCT00427895|449605200|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
124994234|NCT00427895|449605201|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
124994235|NCT00427895|449605202|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
124994236|NCT00427895|449605203|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
124994237|NCT00427895|449605204|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
124994238|NCT00427895|449605205|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
124994239|NCT00427895|449605198|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
124994240|NCT00427895|449605199|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
124994241|NCT00427895|449605200|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
124994242|NCT00427895|449605201|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
124994243|NCT00427895|449605202|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
124994244|NCT00427895|449605203|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
124994245|NCT00427895|449605204|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
124994246|NCT00427895|449605205|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
124994247|NCT00427895|449605198|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
124994248|NCT00427895|449605199|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
124994249|NCT00427895|449605200|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
124994250|NCT00427895|449605201|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
124994251|NCT00427895|449605202|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
124994252|NCT00427895|449605203|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
124994253|NCT00427895|449605204|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
124994254|NCT00427895|449605205|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
124994255|NCT00427895|449605198|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
124994256|NCT00427895|449605199|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
124994257|NCT00427895|449605200|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
124994258|NCT00427895|449605201|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
124994259|NCT00427895|449605202|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
124994260|NCT00427895|449605203|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
124994261|NCT00427895|449605204|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
124994262|NCT00427895|449605205|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
124994263|NCT00427895|449605198|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
124994264|NCT00427895|449605199|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
124994265|NCT00427895|449605200|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
124994266|NCT00427895|449605201|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
124994267|NCT00427895|449605202|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
124994268|NCT00427895|449605203|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
124994269|NCT00427895|449605204|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
124994270|NCT00427895|449605205|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
124994271|NCT00427895|449605198|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
124994272|NCT00427895|449605199|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
124994273|NCT00427895|449605200|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
124994274|NCT00427895|449605201|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
124994275|NCT00427895|449605202|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
124994276|NCT00427895|449605203|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
124994277|NCT00427895|449605204|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
124994278|NCT00427895|449605205|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
124994279|NCT00427895|449605198|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
124994280|NCT00427895|449605199|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
124994281|NCT00427895|449605200|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
124994282|NCT00427895|449605201|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
124994283|NCT00427895|449605202|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
124994284|NCT00427895|449605203|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
124994285|NCT00427895|449605204|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
125318247|NCT03137992|450794057|FG002|Washout Period 1|Principal Investigator Discretion|0|||
125318248|NCT03137992|450794058|FG003|Washout Period 1|Principal Investigator Discretion|0|||
124994286|NCT00427895|449605205|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
124994287|NCT00427895|449605198|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
124994288|NCT00427895|449605199|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
124994289|NCT00427895|449605200|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
124994290|NCT00427895|449605201|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
124994291|NCT00427895|449605202|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
124994292|NCT00427895|449605203|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
124994293|NCT00427895|449605204|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
124994294|NCT00427895|449605205|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
124994295|NCT00427895|449605198|FG000|Vax 1/Year 1 Follow-up|Death|1|||
124994296|NCT00427895|449605199|FG001|Vax 1/Year 1 Follow-up|Death|0|||
124994297|NCT00427895|449605200|FG002|Vax 1/Year 1 Follow-up|Death|0|||
124994298|NCT00427895|449605201|FG003|Vax 1/Year 1 Follow-up|Death|0|||
124994299|NCT00427895|449605202|FG004|Vax 1/Year 1 Follow-up|Death|0|||
124994300|NCT00427895|449605203|FG005|Vax 1/Year 1 Follow-up|Death|0|||
124994301|NCT00427895|449605204|FG006|Vax 1/Year 1 Follow-up|Death|0|||
124994302|NCT00427895|449605205|FG007|Vax 1/Year 1 Follow-up|Death|0|||
124994303|NCT00427895|449605198|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
124994304|NCT00427895|449605199|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
124994305|NCT00427895|449605200|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
124994306|NCT00427895|449605201|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
124994307|NCT00427895|449605202|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
124994308|NCT00427895|449605203|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
124994309|NCT00427895|449605204|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
124994310|NCT00427895|449605205|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
124994311|NCT00427895|449605198|FG000|Vax 1/Year 1 Follow-up|Other|0|||
124994312|NCT00427895|449605199|FG001|Vax 1/Year 1 Follow-up|Other|0|||
124994313|NCT00427895|449605200|FG002|Vax 1/Year 1 Follow-up|Other|0|||
124994314|NCT00427895|449605201|FG003|Vax 1/Year 1 Follow-up|Other|2|||
124994315|NCT00427895|449605202|FG004|Vax 1/Year 1 Follow-up|Other|0|||
124994316|NCT00427895|449605203|FG005|Vax 1/Year 1 Follow-up|Other|0|||
124994317|NCT00427895|449605204|FG006|Vax 1/Year 1 Follow-up|Other|0|||
124994318|NCT00427895|449605205|FG007|Vax 1/Year 1 Follow-up|Other|0|||
124994319|NCT00427895|449605198|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
124994320|NCT00427895|449605199|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
124994321|NCT00427895|449605200|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
124994322|NCT00427895|449605201|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
124994323|NCT00427895|449605202|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
124994324|NCT00427895|449605203|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
124994325|NCT00427895|449605204|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
124994326|NCT00427895|449605205|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
124994327|NCT02533570|449605211|FG000|Overall Study|Adverse Event|0|||
124994328|NCT02533570|449605212|FG001|Overall Study|Adverse Event|1|||
124994329|NCT02533570|449605213|FG002|Overall Study|Adverse Event|1|||
124994330|NCT00960531|449605214|FG000|Overall Study|Lack of Efficacy|1|||
124994331|NCT00960531|449605215|FG001|Overall Study|Lack of Efficacy|0|||
124994332|NCT00960531|449605216|FG002|Overall Study|Lack of Efficacy|0|||
124994333|NCT00960531|449605217|FG003|Overall Study|Lack of Efficacy|0|||
124994334|NCT00960531|449605218|FG004|Overall Study|Lack of Efficacy|0|||
124994335|NCT00960531|449605219|FG005|Overall Study|Lack of Efficacy|0|||
124994336|NCT00960531|449605220|FG006|Overall Study|Lack of Efficacy|0|||
124994337|NCT00960531|449605221|FG007|Overall Study|Lack of Efficacy|0|||
124994338|NCT00960531|449605222|FG008|Overall Study|Lack of Efficacy|0|||
124994339|NCT00960531|449605223|FG009|Overall Study|Lack of Efficacy|0|||
124994340|NCT00960531|449605214|FG000|Overall Study|Withdrawal by Subject|1|||
124994341|NCT00960531|449605215|FG001|Overall Study|Withdrawal by Subject|0|||
124994342|NCT00960531|449605216|FG002|Overall Study|Withdrawal by Subject|5|||
124994343|NCT00960531|449605217|FG003|Overall Study|Withdrawal by Subject|2|||
124994344|NCT00960531|449605218|FG004|Overall Study|Withdrawal by Subject|0|||
124994345|NCT00960531|449605219|FG005|Overall Study|Withdrawal by Subject|0|||
124994346|NCT00960531|449605220|FG006|Overall Study|Withdrawal by Subject|2|||
124994347|NCT00960531|449605221|FG007|Overall Study|Withdrawal by Subject|0|||
124994348|NCT00960531|449605222|FG008|Overall Study|Withdrawal by Subject|1|||
124994349|NCT00960531|449605223|FG009|Overall Study|Withdrawal by Subject|0|||
124994350|NCT00960531|449605214|FG000|Overall Study|Caregiver Request|2|||
124994351|NCT00960531|449605215|FG001|Overall Study|Caregiver Request|0|||
124994352|NCT00960531|449605216|FG002|Overall Study|Caregiver Request|6|||
124994353|NCT00960531|449605217|FG003|Overall Study|Caregiver Request|5|||
124994354|NCT00960531|449605218|FG004|Overall Study|Caregiver Request|0|||
124994355|NCT00960531|449605219|FG005|Overall Study|Caregiver Request|2|||
124994356|NCT00960531|449605220|FG006|Overall Study|Caregiver Request|3|||
124994357|NCT00960531|449605221|FG007|Overall Study|Caregiver Request|1|||
124994358|NCT00960531|449605222|FG008|Overall Study|Caregiver Request|3|||
124994359|NCT00960531|449605223|FG009|Overall Study|Caregiver Request|0|||
124994360|NCT00960531|449605214|FG000|Overall Study|Investigator Request|0|||
124994361|NCT00960531|449605215|FG001|Overall Study|Investigator Request|0|||
124994362|NCT00960531|449605216|FG002|Overall Study|Investigator Request|1|||
124994363|NCT00960531|449605217|FG003|Overall Study|Investigator Request|0|||
124994364|NCT00960531|449605218|FG004|Overall Study|Investigator Request|0|||
124994365|NCT00960531|449605219|FG005|Overall Study|Investigator Request|0|||
124994366|NCT00960531|449605220|FG006|Overall Study|Investigator Request|0|||
124994367|NCT00960531|449605221|FG007|Overall Study|Investigator Request|0|||
124994368|NCT00960531|449605222|FG008|Overall Study|Investigator Request|0|||
124994369|NCT00960531|449605223|FG009|Overall Study|Investigator Request|0|||
124994370|NCT00960531|449605214|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
124994371|NCT00960531|449605215|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
124994372|NCT00960531|449605216|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
124994373|NCT00960531|449605217|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
124994374|NCT00960531|449605218|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
124994375|NCT00960531|449605219|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
124994376|NCT00960531|449605220|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
124994377|NCT00960531|449605221|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
124994378|NCT00960531|449605222|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
124994379|NCT00960531|449605223|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
124994380|NCT00960531|449605214|FG000|Overall Study|Lost to Follow-up|0|||
124994381|NCT00960531|449605215|FG001|Overall Study|Lost to Follow-up|0|||
124994382|NCT00960531|449605216|FG002|Overall Study|Lost to Follow-up|1|||
124994383|NCT00960531|449605217|FG003|Overall Study|Lost to Follow-up|0|||
124994384|NCT00960531|449605218|FG004|Overall Study|Lost to Follow-up|0|||
124994385|NCT00960531|449605219|FG005|Overall Study|Lost to Follow-up|0|||
124994386|NCT00960531|449605220|FG006|Overall Study|Lost to Follow-up|1|||
124994387|NCT00960531|449605221|FG007|Overall Study|Lost to Follow-up|0|||
124994388|NCT00960531|449605222|FG008|Overall Study|Lost to Follow-up|0|||
124994389|NCT00960531|449605223|FG009|Overall Study|Lost to Follow-up|0|||
124994390|NCT00960531|449605214|FG000|Overall Study|Failed to Return|2|||
124994391|NCT00960531|449605215|FG001|Overall Study|Failed to Return|0|||
124994392|NCT00960531|449605216|FG002|Overall Study|Failed to Return|0|||
124994393|NCT00960531|449605217|FG003|Overall Study|Failed to Return|0|||
124994394|NCT00960531|449605218|FG004|Overall Study|Failed to Return|0|||
124994395|NCT00960531|449605219|FG005|Overall Study|Failed to Return|0|||
124994396|NCT00960531|449605220|FG006|Overall Study|Failed to Return|0|||
124994397|NCT00960531|449605221|FG007|Overall Study|Failed to Return|2|||
124994398|NCT00960531|449605222|FG008|Overall Study|Failed to Return|0|||
124994399|NCT00960531|449605223|FG009|Overall Study|Failed to Return|0|||
124994400|NCT00960531|449605214|FG000|Overall Study|Adverse Event (AE)|2|||
124994401|NCT00960531|449605215|FG001|Overall Study|Adverse Event (AE)|0|||
124994402|NCT00960531|449605216|FG002|Overall Study|Adverse Event (AE)|0|||
124994403|NCT00960531|449605217|FG003|Overall Study|Adverse Event (AE)|0|||
124994404|NCT00960531|449605218|FG004|Overall Study|Adverse Event (AE)|0|||
124994405|NCT00960531|449605219|FG005|Overall Study|Adverse Event (AE)|1|||
124994406|NCT00960531|449605220|FG006|Overall Study|Adverse Event (AE)|2|||
124994407|NCT00960531|449605221|FG007|Overall Study|Adverse Event (AE)|0|||
124994408|NCT00960531|449605222|FG008|Overall Study|Adverse Event (AE)|2|||
124994409|NCT00960531|449605223|FG009|Overall Study|Adverse Event (AE)|0|||
124994410|NCT00960531|449605214|FG000|Overall Study|Reason not Specified|2|||
124994411|NCT00960531|449605215|FG001|Overall Study|Reason not Specified|1|||
124994412|NCT00960531|449605216|FG002|Overall Study|Reason not Specified|13|||
124994413|NCT00960531|449605217|FG003|Overall Study|Reason not Specified|1|||
124994414|NCT00960531|449605218|FG004|Overall Study|Reason not Specified|2|||
124994415|NCT00960531|449605219|FG005|Overall Study|Reason not Specified|0|||
125318249|NCT03137992|450794059|FG004|Washout Period 1|Principal Investigator Discretion|0|||
125318250|NCT03137992|450794060|FG005|Washout Period 1|Principal Investigator Discretion|0|||
125318251|NCT03137992|450794055|FG000|Washout Period 1|COPD Exacerbation|1|||
124994416|NCT00960531|449605220|FG006|Overall Study|Reason not Specified|16|||
124994417|NCT00960531|449605221|FG007|Overall Study|Reason not Specified|0|||
124994418|NCT00960531|449605222|FG008|Overall Study|Reason not Specified|8|||
124994419|NCT00960531|449605223|FG009|Overall Study|Reason not Specified|1|||
124994420|NCT02656823|449605229|FG000|Overall Study|Adverse Event|3|||
124994421|NCT02656823|449605229|FG000|Overall Study|Lost to Follow-up|2|||
124994422|NCT05269355|449605231|FG000|Overall Study|Progressive Disease|104|||
124994423|NCT05269355|449605232|FG001|Overall Study|Progressive Disease|68|||
124994424|NCT05269355|449605231|FG000|Overall Study|Study Terminated by Sponsor|87|||
124994425|NCT05269355|449605232|FG001|Overall Study|Study Terminated by Sponsor|29|||
124994426|NCT05269355|449605231|FG000|Overall Study|Adverse Event|15|||
124994427|NCT05269355|449605232|FG001|Overall Study|Adverse Event|8|||
124994428|NCT05269355|449605231|FG000|Overall Study|Withdrawal by Subject|18|||
124994429|NCT05269355|449605232|FG001|Overall Study|Withdrawal by Subject|5|||
124994430|NCT05269355|449605231|FG000|Overall Study|Physician Decision|6|||
124994431|NCT05269355|449605232|FG001|Overall Study|Physician Decision|4|||
124994432|NCT05269355|449605231|FG000|Overall Study|Death|3|||
125318252|NCT03137992|450794056|FG001|Washout Period 1|COPD Exacerbation|1|||
124994433|NCT05269355|449605232|FG001|Overall Study|Death|5|||
124994434|NCT05269355|449605231|FG000|Overall Study|Other Than Specified|5|||
124994435|NCT05269355|449605232|FG001|Overall Study|Other Than Specified|1|||
124994436|NCT05269355|449605231|FG000|Overall Study|Randomized But Not Treated|1|||
124994437|NCT05269355|449605232|FG001|Overall Study|Randomized But Not Treated|0|||
124994438|NCT00081497|449605233|FG000|Overall Study|Adverse Event|2|||
124994439|NCT00081497|449605234|FG001|Overall Study|Adverse Event|0|||
124994440|NCT00081497|449605233|FG000|Overall Study|Death|0|||
124994441|NCT00081497|449605234|FG001|Overall Study|Death|1|||
124994442|NCT00081497|449605233|FG000|Overall Study|Withdrawal by Subject|1|||
124994443|NCT00081497|449605234|FG001|Overall Study|Withdrawal by Subject|0|||
124994444|NCT00081497|449605233|FG000|Overall Study|Non-compliance|0|||
124994445|NCT00081497|449605234|FG001|Overall Study|Non-compliance|1|||
124994446|NCT00959647|449605235|FG000|Overall Study|Adverse Event|2|||
124994447|NCT00959647|449605235|FG000|Overall Study|Progressive disease|6|||
124994448|NCT00959647|449605235|FG000|Overall Study|Study terminated by sponsor|4|||
124994449|NCT00959647|449605235|FG000|Overall Study|Withdrawal by Subject|7|||
124994450|NCT01786174|449607204|FG000|Overall Study|Discontinued Study Drug|2|||
124994451|NCT01786174|449607205|FG001|Overall Study|Discontinued Study Drug|0|||
124994452|NCT03442985|449607214|FG000|Overall Study|Sponsor Request|55|||
124994453|NCT03442985|449607215|FG001|Overall Study|Sponsor Request|60|||
124994454|NCT03442985|449607216|FG002|Overall Study|Sponsor Request|54|||
124994455|NCT03442985|449607214|FG000|Overall Study|Lost to Follow-up|5|||
124994456|NCT03442985|449607215|FG001|Overall Study|Lost to Follow-up|2|||
124994457|NCT03442985|449607216|FG002|Overall Study|Lost to Follow-up|7|||
124994458|NCT03442985|449607214|FG000|Overall Study|Withdrawal by Subject|2|||
124994459|NCT03442985|449607215|FG001|Overall Study|Withdrawal by Subject|3|||
124994460|NCT03442985|449607216|FG002|Overall Study|Withdrawal by Subject|4|||
124994461|NCT03442985|449607214|FG000|Overall Study|Adverse Event|0|||
124994462|NCT03442985|449607215|FG001|Overall Study|Adverse Event|1|||
124994463|NCT03442985|449607216|FG002|Overall Study|Adverse Event|0|||
124994464|NCT01716117|449607220|FG000|Overall Study|Death|5|||
124994465|NCT01716117|449607221|FG001|Overall Study|Death|2|||
124994466|NCT01716117|449607220|FG000|Overall Study|Withdrawal by Subject|2|||
124994467|NCT01716117|449607221|FG001|Overall Study|Withdrawal by Subject|0|||
124994468|NCT03645057|449607222|FG000|Randomization to Baseline|Lost to Follow-up|1|||
124994469|NCT03645057|449607223|FG001|Randomization to Baseline|Lost to Follow-up|0|||
124994470|NCT03645057|449607224|FG002|Randomization to Baseline|Lost to Follow-up|1|||
124994471|NCT03645057|449607225|FG003|Randomization to Baseline|Lost to Follow-up|0|||
124994472|NCT03645057|449607222|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
124994473|NCT03645057|449607223|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
124994474|NCT03645057|449607224|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
124994475|NCT03645057|449607225|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
124994476|NCT03645057|449607222|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
124994477|NCT03645057|449607223|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
124994478|NCT03645057|449607224|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
124994479|NCT03645057|449607225|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
124994480|NCT03645057|449607222|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
124994481|NCT03645057|449607223|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
124994482|NCT03645057|449607224|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
124994483|NCT03645057|449607225|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
124994484|NCT00288509|449607226|FG000|Treatment Cycle 1|Adverse Event|1|||
124994485|NCT00288509|449607226|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
124994486|NCT00288509|449607226|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
124994487|NCT00288509|449607226|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
124994488|NCT00288509|449607226|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
124994489|NCT00288509|449607226|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
124994490|NCT00288509|449607226|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
124994491|NCT00288509|449607226|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
124994492|NCT00288509|449607226|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
124994493|NCT00288509|449607226|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
124994494|NCT00288509|449607226|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
124994495|NCT00288509|449607226|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
124994496|NCT00288509|449607226|FG000|Treatment Cycle 4|Physician Decision|4|||
124994497|NCT00288509|449607226|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
124994498|NCT00762970|449607233|FG000|Overall Study|Withdrawal by Subject|7|||
124994499|NCT00762970|449607234|FG001|Overall Study|Withdrawal by Subject|4|||
124994500|NCT00762970|449607235|FG002|Overall Study|Withdrawal by Subject|0|||
124994501|NCT00762970|449607233|FG000|Overall Study|Protocol Violation|3|||
124994502|NCT00762970|449607234|FG001|Overall Study|Protocol Violation|1|||
124994503|NCT00762970|449607235|FG002|Overall Study|Protocol Violation|1|||
124994504|NCT00762970|449607233|FG000|Overall Study|Lost to Follow-up|1|||
124994505|NCT00762970|449607234|FG001|Overall Study|Lost to Follow-up|2|||
124994506|NCT00762970|449607235|FG002|Overall Study|Lost to Follow-up|0|||
124994507|NCT00762970|449607233|FG000|Overall Study|Difficulty of handling lens|1|||
124994508|NCT00762970|449607234|FG001|Overall Study|Difficulty of handling lens|2|||
124994509|NCT00762970|449607235|FG002|Overall Study|Difficulty of handling lens|0|||
124994510|NCT01480674|449607236|FG000|Overall Study|Death|23|||
124994511|NCT01480674|449607236|FG000|Overall Study|Lost to Follow-up|2|||
124994512|NCT01480674|449607236|FG000|Overall Study|visit not done|10|||
124994513|NCT03818204|449607237|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124994514|NCT03818204|449607238|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124994515|NCT03818204|449607239|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124994516|NCT03818204|449607240|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124994517|NCT03818204|449607241|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
124994518|NCT03818204|449607242|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124994519|NCT03818204|449607243|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124994520|NCT03818204|449607244|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124994521|NCT03818204|449607245|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124994522|NCT03818204|449607246|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
125318253|NCT03137992|450794057|FG002|Washout Period 1|COPD Exacerbation|1|||
125318254|NCT03137992|450794058|FG003|Washout Period 1|COPD Exacerbation|0|||
125318255|NCT03137992|450794059|FG004|Washout Period 1|COPD Exacerbation|1|||
125318256|NCT03137992|450794060|FG005|Washout Period 1|COPD Exacerbation|1|||
125318257|NCT03137992|450794055|FG000|Washout Period 1|Subject Noncompliance|1|||
125318258|NCT03137992|450794056|FG001|Washout Period 1|Subject Noncompliance|0|||
125318259|NCT03137992|450794057|FG002|Washout Period 1|Subject Noncompliance|0|||
125318260|NCT03137992|450794058|FG003|Washout Period 1|Subject Noncompliance|0|||
125318261|NCT03137992|450794059|FG004|Washout Period 1|Subject Noncompliance|1|||
125318262|NCT03137992|450794060|FG005|Washout Period 1|Subject Noncompliance|0|||
125318263|NCT03137992|450794055|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
125318264|NCT03137992|450794056|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
125318265|NCT03137992|450794057|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
125318266|NCT03137992|450794058|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
125318267|NCT03137992|450794059|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
125318268|NCT03137992|450794060|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
125318269|NCT03137992|450794055|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
125318270|NCT03137992|450794056|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
124994523|NCT03818204|449607247|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124994524|NCT03818204|449607248|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124994525|NCT03818204|449607249|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124994526|NCT03818204|449607250|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
124994527|NCT03818204|449607251|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124994528|NCT03818204|449607252|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124994529|NCT03818204|449607253|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124994530|NCT03818204|449607254|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124994531|NCT03818204|449607255|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124994532|NCT03818204|449607237|FG000|Overall Study|Physician Decision|0|||
124994533|NCT03818204|449607238|FG001|Overall Study|Physician Decision|0|||
124994534|NCT03818204|449607239|FG002|Overall Study|Physician Decision|0|||
124994535|NCT03818204|449607240|FG003|Overall Study|Physician Decision|0|||
124994536|NCT03818204|449607241|FG004|Overall Study|Physician Decision|0|||
124994537|NCT03818204|449607242|FG005|Overall Study|Physician Decision|0|||
124994538|NCT03818204|449607243|FG006|Overall Study|Physician Decision|0|||
124994539|NCT03818204|449607244|FG007|Overall Study|Physician Decision|0|||
124994540|NCT03818204|449607245|FG008|Overall Study|Physician Decision|0|||
124994541|NCT03818204|449607246|FG009|Overall Study|Physician Decision|0|||
124994542|NCT03818204|449607247|FG010|Overall Study|Physician Decision|0|||
124994543|NCT03818204|449607248|FG011|Overall Study|Physician Decision|0|||
124994544|NCT03818204|449607249|FG012|Overall Study|Physician Decision|0|||
124994545|NCT03818204|449607250|FG013|Overall Study|Physician Decision|0|||
124994546|NCT03818204|449607251|FG014|Overall Study|Physician Decision|1|||
124994547|NCT03818204|449607252|FG015|Overall Study|Physician Decision|0|||
124994548|NCT03818204|449607253|FG016|Overall Study|Physician Decision|0|||
124994549|NCT03818204|449607254|FG017|Overall Study|Physician Decision|0|||
124994550|NCT03818204|449607255|FG018|Overall Study|Physician Decision|0|||
124994551|NCT00795951|449607256|FG000|Overall Study|Lost to Follow-up|1|||
124994552|NCT00795951|449607256|FG000|Overall Study|Withdrawal by Subject|1|||
124994553|NCT01211197|449607258|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124994554|NCT01211197|449607259|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124994555|NCT01211197|449607260|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
124994556|NCT01211197|449607261|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124994557|NCT01211197|449607262|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124994558|NCT01211197|449607263|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124994559|NCT01211197|449607258|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
124994560|NCT01211197|449607259|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
124994561|NCT01211197|449607260|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
124994562|NCT01211197|449607261|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
124994563|NCT01211197|449607262|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
124994564|NCT01211197|449607263|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
124994565|NCT00261846|449607264|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
124994566|NCT00261846|449607265|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
124994567|NCT00261846|449607266|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
124994568|NCT00261846|449607267|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
124994569|NCT00261846|449607268|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
124994570|NCT00261846|449607269|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
124994571|NCT00261846|449607270|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
124994572|NCT00261846|449607271|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
124994573|NCT00261846|449607272|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
124994574|NCT00261846|449607273|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
124994575|NCT00261846|449607274|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
124994576|NCT00261846|449607275|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
124994577|NCT00261846|449607264|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
124994578|NCT00261846|449607265|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
124994579|NCT00261846|449607266|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
124994580|NCT00261846|449607267|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
124994581|NCT00261846|449607268|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
124994582|NCT00261846|449607269|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
124994583|NCT00261846|449607270|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
124994584|NCT00261846|449607271|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
124994585|NCT00261846|449607272|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
124994586|NCT00261846|449607273|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
124994587|NCT00261846|449607274|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
124994588|NCT00261846|449607275|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
124994589|NCT00261846|449607264|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
124994590|NCT00261846|449607265|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
124994591|NCT00261846|449607266|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
124994592|NCT00261846|449607267|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
124994593|NCT00261846|449607268|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
124994594|NCT00261846|449607269|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
124994595|NCT00261846|449607270|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
124994596|NCT00261846|449607271|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
124994597|NCT00261846|449607272|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
124994598|NCT00261846|449607273|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
124994599|NCT00261846|449607274|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
124994600|NCT00261846|449607275|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
124994601|NCT00261846|449607264|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
124994602|NCT00261846|449607265|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
124994603|NCT00261846|449607266|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
124994604|NCT00261846|449607267|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
124994605|NCT00261846|449607268|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
124994606|NCT00261846|449607269|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
124994607|NCT00261846|449607270|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
124994608|NCT00261846|449607271|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
124994609|NCT00261846|449607272|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
124994610|NCT00261846|449607273|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
124994611|NCT00261846|449607274|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
124994612|NCT00261846|449607275|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
124994613|NCT00261846|449607264|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
124994614|NCT00261846|449607265|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
124994615|NCT00261846|449607266|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
124994616|NCT00261846|449607267|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
124994617|NCT00261846|449607268|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
124994618|NCT00261846|449607269|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
124994619|NCT00261846|449607270|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
124994620|NCT00261846|449607271|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
124994621|NCT00261846|449607272|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
124994622|NCT00261846|449607273|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
124994623|NCT00261846|449607274|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
124994624|NCT00261846|449607275|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
124994625|NCT00261846|449607264|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
124994626|NCT00261846|449607265|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
124994627|NCT00261846|449607266|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
124994628|NCT00261846|449607267|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
125318271|NCT03137992|450794057|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
124994629|NCT00261846|449607268|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
124994630|NCT00261846|449607269|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
124994631|NCT00261846|449607270|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
124994632|NCT00261846|449607271|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
124994633|NCT00261846|449607272|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
124994634|NCT00261846|449607273|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
124994635|NCT00261846|449607274|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
125318272|NCT03137992|450794058|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
125318273|NCT03137992|450794059|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
125318274|NCT03137992|450794060|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
125318275|NCT03137992|450794055|FG000|Period 2 (Visit 3)|Adverse Event|0|||
125318276|NCT03137992|450794056|FG001|Period 2 (Visit 3)|Adverse Event|1|||
125318277|NCT03137992|450794057|FG002|Period 2 (Visit 3)|Adverse Event|0|||
124994636|NCT00261846|449607275|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
124994637|NCT00261846|449607264|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
124994638|NCT00261846|449607265|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
124994639|NCT00261846|449607266|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
124994640|NCT00261846|449607267|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
124994641|NCT00261846|449607268|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
124994642|NCT00261846|449607269|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
124994643|NCT00261846|449607270|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
124994644|NCT00261846|449607271|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
125318278|NCT03137992|450794058|FG003|Period 2 (Visit 3)|Adverse Event|0|||
125318279|NCT03137992|450794059|FG004|Period 2 (Visit 3)|Adverse Event|0|||
125318280|NCT03137992|450794060|FG005|Period 2 (Visit 3)|Adverse Event|0|||
125318281|NCT03137992|450794055|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
124994645|NCT00261846|449607272|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
124994646|NCT00261846|449607273|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
124994647|NCT00261846|449607274|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
124994648|NCT00261846|449607275|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
124994649|NCT01009203|449607276|FG000|Overall Study|Withdrawal by Subject|1|||
124994650|NCT01009203|449607276|FG000|Overall Study|Adverse Event|5|||
124994651|NCT01009203|449607276|FG000|Overall Study|Treatment-unrelated death|1|||
124994652|NCT00892723|449607277|FG000|Overall Study|Lost to Follow-up|1|||
124994653|NCT00892723|449607278|FG001|Overall Study|Lost to Follow-up|3|||
124994654|NCT00892723|449607279|FG002|Overall Study|Lost to Follow-up|1|||
124994655|NCT00892723|449607277|FG000|Overall Study|Withdrawal by Subject|1|||
124994656|NCT00892723|449607278|FG001|Overall Study|Withdrawal by Subject|1|||
124994657|NCT00892723|449607279|FG002|Overall Study|Withdrawal by Subject|1|||
124994658|NCT00150969|449607280|FG000|24 Month Main Study|Adverse Event|3|||
124994659|NCT00150969|449607281|FG001|24 Month Main Study|Adverse Event|4|||
124994660|NCT00150969|449607280|FG000|24 Month Main Study|Death|1|||
124994661|NCT00150969|449607281|FG001|24 Month Main Study|Death|1|||
124994662|NCT00150969|449607280|FG000|24 Month Main Study|Lack of Efficacy|1|||
124994663|NCT00150969|449607281|FG001|24 Month Main Study|Lack of Efficacy|8|||
124994664|NCT00150969|449607280|FG000|24 Month Main Study|Lost to Follow-up|3|||
124994665|NCT00150969|449607281|FG001|24 Month Main Study|Lost to Follow-up|2|||
124994666|NCT00150969|449607280|FG000|24 Month Main Study|Protocol Violation|4|||
124994667|NCT00150969|449607281|FG001|24 Month Main Study|Protocol Violation|2|||
124994668|NCT00150969|449607280|FG000|24 Month Main Study|Withdrawal by Subject|7|||
125318282|NCT03137992|450794056|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
125318283|NCT03137992|450794057|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
125318284|NCT03137992|450794058|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
124994669|NCT00150969|449607281|FG001|24 Month Main Study|Withdrawal by Subject|4|||
124994670|NCT00150969|449607280|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
124994671|NCT00150969|449607281|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
124994672|NCT00150969|449607280|FG000|24-48 Month Extension|Lack of Efficacy|0|||
124994673|NCT00150969|449607281|FG001|24-48 Month Extension|Lack of Efficacy|1|||
124994674|NCT00150969|449607280|FG000|24-48 Month Extension|Adverse Event|1|||
124994675|NCT00150969|449607281|FG001|24-48 Month Extension|Adverse Event|3|||
124994676|NCT00150969|449607280|FG000|24-48 Month Extension|Other Reason|81|||
124994677|NCT00150969|449607281|FG001|24-48 Month Extension|Other Reason|91|||
124994678|NCT00615836|449607282|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
124994679|NCT00615836|449607283|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
124994680|NCT00615836|449607284|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
124994681|NCT00615836|449607285|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
124994682|NCT00615836|449607286|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
124994683|NCT00615836|449607282|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
125318285|NCT03137992|450794059|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
125318286|NCT03137992|450794060|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
125318287|NCT03137992|450794055|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
125318288|NCT03137992|450794056|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
125318289|NCT03137992|450794057|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
125318290|NCT03137992|450794058|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
125318291|NCT03137992|450794059|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
125318292|NCT03137992|450794060|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
125318293|NCT03137992|450794055|FG000|Washout Period 2|COPD Exacerbation|1|||
125318294|NCT03137992|450794056|FG001|Washout Period 2|COPD Exacerbation|1|||
124994684|NCT00615836|449607283|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
124994685|NCT00615836|449607284|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
124994686|NCT00615836|449607285|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
125318295|NCT03137992|450794057|FG002|Washout Period 2|COPD Exacerbation|0|||
125318296|NCT03137992|450794058|FG003|Washout Period 2|COPD Exacerbation|0|||
125318297|NCT03137992|450794059|FG004|Washout Period 2|COPD Exacerbation|1|||
125318298|NCT03137992|450794060|FG005|Washout Period 2|COPD Exacerbation|0|||
124994687|NCT00615836|449607286|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
124994688|NCT00615836|449607282|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
124994689|NCT00615836|449607283|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
124994690|NCT00615836|449607284|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
124994691|NCT00615836|449607285|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
124994692|NCT00615836|449607286|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
124994693|NCT00615836|449607282|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
124994694|NCT00615836|449607283|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
124994695|NCT00615836|449607284|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
124994696|NCT00615836|449607285|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
124994697|NCT00615836|449607286|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
124994698|NCT00615836|449607282|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
124994699|NCT00615836|449607283|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
124994700|NCT00615836|449607284|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
124994701|NCT00615836|449607285|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
124994702|NCT00615836|449607286|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
124994703|NCT00615836|449607282|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
124994704|NCT00615836|449607283|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
124994705|NCT00615836|449607284|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
124994706|NCT00615836|449607285|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
124994707|NCT00615836|449607286|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
124994708|NCT00615836|449607282|FG000|Extension Study (FE992026 CS31)|Other|10|||
124994709|NCT00615836|449607283|FG001|Extension Study (FE992026 CS31)|Other|7|||
124994710|NCT00615836|449607284|FG002|Extension Study (FE992026 CS31)|Other|8|||
124994711|NCT00615836|449607285|FG003|Extension Study (FE992026 CS31)|Other|8|||
124994712|NCT00615836|449607286|FG004|Extension Study (FE992026 CS31)|Other|0|||
124994713|NCT00615836|449607282|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
124994714|NCT00615836|449607283|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
124994715|NCT00615836|449607284|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
124994716|NCT00615836|449607285|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
124994717|NCT00615836|449607286|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
124994718|NCT00615836|449607282|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
124994719|NCT00615836|449607283|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
124994720|NCT00615836|449607284|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
124994721|NCT00615836|449607285|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
124994722|NCT00615836|449607286|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
124994723|NCT01313689|449607287|FG000|24-Week Randomization 1|Adverse Event|10|||
124994724|NCT01313689|449607288|FG001|24-Week Randomization 1|Adverse Event|5|||
124994725|NCT01313689|449607289|FG002|24-Week Randomization 1|Adverse Event|0|||
124994726|NCT01313689|449607290|FG003|24-Week Randomization 1|Adverse Event|0|||
124994727|NCT01313689|449607291|FG004|24-Week Randomization 1|Adverse Event|0|||
124994728|NCT01313689|449607287|FG000|24-Week Randomization 1|Physician Decision|4|||
124994729|NCT01313689|449607288|FG001|24-Week Randomization 1|Physician Decision|5|||
124994730|NCT01313689|449607289|FG002|24-Week Randomization 1|Physician Decision|0|||
124994731|NCT01313689|449607290|FG003|24-Week Randomization 1|Physician Decision|0|||
124994732|NCT01313689|449607291|FG004|24-Week Randomization 1|Physician Decision|0|||
124994733|NCT01313689|449607287|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
124994734|NCT01313689|449607288|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
124994735|NCT01313689|449607289|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
124994736|NCT01313689|449607290|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
124994737|NCT01313689|449607291|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
125318299|NCT03137992|450794055|FG000|Washout Period 2|Subject Non-compliance|0|||
125318300|NCT03137992|450794056|FG001|Washout Period 2|Subject Non-compliance|1|||
125318301|NCT03137992|450794057|FG002|Washout Period 2|Subject Non-compliance|0|||
125318302|NCT03137992|450794058|FG003|Washout Period 2|Subject Non-compliance|0|||
125318303|NCT03137992|450794059|FG004|Washout Period 2|Subject Non-compliance|0|||
125318304|NCT03137992|450794060|FG005|Washout Period 2|Subject Non-compliance|0|||
125318305|NCT03137992|450794055|FG000|Washout Period 2|Adverse Event|0|||
125318306|NCT03137992|450794056|FG001|Washout Period 2|Adverse Event|0|||
124994738|NCT01313689|449607287|FG000|24-Week Randomization 2|Adverse Event|0|||
124994739|NCT01313689|449607288|FG001|24-Week Randomization 2|Adverse Event|0|||
124994740|NCT01313689|449607289|FG002|24-Week Randomization 2|Adverse Event|2|||
125318307|NCT03137992|450794057|FG002|Washout Period 2|Adverse Event|0|||
125318308|NCT03137992|450794058|FG003|Washout Period 2|Adverse Event|1|||
125318309|NCT03137992|450794059|FG004|Washout Period 2|Adverse Event|1|||
125318310|NCT03137992|450794060|FG005|Washout Period 2|Adverse Event|0|||
124994741|NCT01313689|449607290|FG003|24-Week Randomization 2|Adverse Event|0|||
124994742|NCT01313689|449607291|FG004|24-Week Randomization 2|Adverse Event|8|||
124994743|NCT01313689|449607287|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
124994744|NCT01313689|449607288|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
124994745|NCT01313689|449607289|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
124994746|NCT01313689|449607290|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
124994747|NCT01313689|449607291|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
124994748|NCT01313689|449607287|FG000|24-Week Randomization 2|Physician Decision|0|||
124994749|NCT01313689|449607288|FG001|24-Week Randomization 2|Physician Decision|0|||
124994750|NCT01313689|449607289|FG002|24-Week Randomization 2|Physician Decision|0|||
124994751|NCT01313689|449607290|FG003|24-Week Randomization 2|Physician Decision|0|||
124994752|NCT01313689|449607291|FG004|24-Week Randomization 2|Physician Decision|4|||
124994753|NCT01007448|449607293|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
124994754|NCT01007448|449607294|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
124994755|NCT01007448|449607293|FG000|Overall Study|Staph Skin Infection Flare|1|||
124994756|NCT01007448|449607294|FG001|Overall Study|Staph Skin Infection Flare|0|||
124994757|NCT01007448|449607293|FG000|Overall Study|Participant Leaving the Country|1|||
124994758|NCT01007448|449607294|FG001|Overall Study|Participant Leaving the Country|0|||
124994759|NCT01007448|449607293|FG000|Overall Study|Participant Given Prohibited Medication|1|||
124994760|NCT01007448|449607294|FG001|Overall Study|Participant Given Prohibited Medication|0|||
124994761|NCT01007448|449607293|FG000|Overall Study|Progressive Disease|1|||
124994762|NCT01007448|449607294|FG001|Overall Study|Progressive Disease|2|||
124994763|NCT01007448|449607293|FG000|Overall Study|Lack of Efficacy|2|||
124994764|NCT01007448|449607294|FG001|Overall Study|Lack of Efficacy|0|||
124994765|NCT01007448|449607293|FG000|Overall Study|Withdrawal by Subject|2|||
124994766|NCT01007448|449607294|FG001|Overall Study|Withdrawal by Subject|3|||
124994767|NCT01007448|449607293|FG000|Overall Study|Adverse Event|1|||
124994768|NCT01007448|449607294|FG001|Overall Study|Adverse Event|4|||
124994769|NCT01337115|449607295|FG000|Overall Study|Protocol Violation|2|||
124994770|NCT01337115|449607296|FG001|Overall Study|Protocol Violation|0|||
124994771|NCT00448123|449607297|FG000|Overall Study|Lost to Follow-up|9|||
124994772|NCT00448123|449607298|FG001|Overall Study|Lost to Follow-up|6|||
124994773|NCT00448123|449607297|FG000|Overall Study|Physician Decision|6|||
124994774|NCT00448123|449607298|FG001|Overall Study|Physician Decision|6|||
124994775|NCT02027623|449607300|FG000|Overall Study|Lost to Follow-up|3|||
124994776|NCT02027623|449607301|FG001|Overall Study|Lost to Follow-up|3|||
124994777|NCT02027623|449607300|FG000|Overall Study|Withdrawal by Subject|6|||
124994778|NCT02027623|449607301|FG001|Overall Study|Withdrawal by Subject|9|||
124994779|NCT00406653|449607305|FG000|Induction Period|Adverse Event|1|||
124994780|NCT00406653|449607306|FG001|Induction Period|Adverse Event|10|||
124994781|NCT00406653|449607307|FG002|Induction Period|Adverse Event|4|||
124994782|NCT00406653|449607308|FG003|Induction Period|Adverse Event|11|||
124994783|NCT00406653|449607309|FG004|Induction Period|Adverse Event|0|||
124994784|NCT00406653|449607310|FG005|Induction Period|Adverse Event|0|||
124994785|NCT00406653|449607311|FG006|Induction Period|Adverse Event|0|||
124994786|NCT00406653|449607305|FG000|Induction Period|Lack of Efficacy|11|||
124994787|NCT00406653|449607306|FG001|Induction Period|Lack of Efficacy|14|||
124994788|NCT00406653|449607307|FG002|Induction Period|Lack of Efficacy|8|||
124994789|NCT00406653|449607308|FG003|Induction Period|Lack of Efficacy|10|||
124994790|NCT00406653|449607309|FG004|Induction Period|Lack of Efficacy|0|||
124994791|NCT00406653|449607310|FG005|Induction Period|Lack of Efficacy|0|||
124994792|NCT00406653|449607311|FG006|Induction Period|Lack of Efficacy|0|||
124994793|NCT00406653|449607305|FG000|Induction Period|Lost to Follow-up|0|||
124994794|NCT00406653|449607306|FG001|Induction Period|Lost to Follow-up|2|||
124994795|NCT00406653|449607307|FG002|Induction Period|Lost to Follow-up|0|||
124994796|NCT00406653|449607308|FG003|Induction Period|Lost to Follow-up|0|||
124994797|NCT00406653|449607309|FG004|Induction Period|Lost to Follow-up|0|||
124994798|NCT00406653|449607310|FG005|Induction Period|Lost to Follow-up|0|||
124994799|NCT00406653|449607311|FG006|Induction Period|Lost to Follow-up|0|||
124994800|NCT00406653|449607305|FG000|Induction Period|Withdrawal of Consent|2|||
124994801|NCT00406653|449607306|FG001|Induction Period|Withdrawal of Consent|5|||
124994802|NCT00406653|449607307|FG002|Induction Period|Withdrawal of Consent|1|||
124994803|NCT00406653|449607308|FG003|Induction Period|Withdrawal of Consent|2|||
124994804|NCT00406653|449607309|FG004|Induction Period|Withdrawal of Consent|0|||
124994805|NCT00406653|449607310|FG005|Induction Period|Withdrawal of Consent|0|||
124994806|NCT00406653|449607311|FG006|Induction Period|Withdrawal of Consent|0|||
124994807|NCT00406653|449607305|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
124994808|NCT00406653|449607306|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
124994809|NCT00406653|449607307|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
124994810|NCT00406653|449607308|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
124994811|NCT00406653|449607309|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
124994812|NCT00406653|449607310|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
124994813|NCT00406653|449607311|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
124994814|NCT00406653|449607305|FG000|Induction Period|Pregnancy|1|||
124994815|NCT00406653|449607306|FG001|Induction Period|Pregnancy|0|||
124994816|NCT00406653|449607307|FG002|Induction Period|Pregnancy|0|||
124994817|NCT00406653|449607308|FG003|Induction Period|Pregnancy|0|||
124994818|NCT00406653|449607309|FG004|Induction Period|Pregnancy|0|||
124994819|NCT00406653|449607310|FG005|Induction Period|Pregnancy|0|||
124994820|NCT00406653|449607311|FG006|Induction Period|Pregnancy|0|||
124994821|NCT00406653|449607305|FG000|Induction Period|Declined participation but followup done|0|||
124994822|NCT00406653|449607306|FG001|Induction Period|Declined participation but followup done|2|||
124994823|NCT00406653|449607307|FG002|Induction Period|Declined participation but followup done|1|||
124994824|NCT00406653|449607308|FG003|Induction Period|Declined participation but followup done|1|||
124994825|NCT00406653|449607309|FG004|Induction Period|Declined participation but followup done|0|||
124994826|NCT00406653|449607310|FG005|Induction Period|Declined participation but followup done|0|||
124994827|NCT00406653|449607311|FG006|Induction Period|Declined participation but followup done|0|||
124994828|NCT00406653|449607305|FG000|Induction Period|Given prohibited drug|0|||
124994829|NCT00406653|449607306|FG001|Induction Period|Given prohibited drug|1|||
124994830|NCT00406653|449607307|FG002|Induction Period|Given prohibited drug|2|||
124994831|NCT00406653|449607308|FG003|Induction Period|Given prohibited drug|0|||
124994832|NCT00406653|449607309|FG004|Induction Period|Given prohibited drug|0|||
124994833|NCT00406653|449607310|FG005|Induction Period|Given prohibited drug|0|||
124994834|NCT00406653|449607311|FG006|Induction Period|Given prohibited drug|0|||
125318311|NCT03137992|450794055|FG000|Washout Period 2|Withdrawal by Subject|1|||
125318312|NCT03137992|450794056|FG001|Washout Period 2|Withdrawal by Subject|0|||
125318313|NCT03137992|450794057|FG002|Washout Period 2|Withdrawal by Subject|0|||
125318314|NCT03137992|450794058|FG003|Washout Period 2|Withdrawal by Subject|0|||
125318315|NCT03137992|450794059|FG004|Washout Period 2|Withdrawal by Subject|1|||
125318316|NCT03137992|450794060|FG005|Washout Period 2|Withdrawal by Subject|0|||
124994835|NCT00406653|449607305|FG000|Induction Period|Incarcerated|0|||
124994836|NCT00406653|449607306|FG001|Induction Period|Incarcerated|0|||
124994837|NCT00406653|449607307|FG002|Induction Period|Incarcerated|1|||
124994838|NCT00406653|449607308|FG003|Induction Period|Incarcerated|0|||
125318317|NCT03137992|450794055|FG000|Washout Period 2|Sponsor Decision|0|||
125318318|NCT03137992|450794056|FG001|Washout Period 2|Sponsor Decision|0|||
125318319|NCT03137992|450794057|FG002|Washout Period 2|Sponsor Decision|0|||
124994839|NCT00406653|449607309|FG004|Induction Period|Incarcerated|0|||
124994840|NCT00406653|449607310|FG005|Induction Period|Incarcerated|0|||
124994841|NCT00406653|449607311|FG006|Induction Period|Incarcerated|0|||
125318320|NCT03137992|450794058|FG003|Washout Period 2|Sponsor Decision|0|||
125318321|NCT03137992|450794059|FG004|Washout Period 2|Sponsor Decision|0|||
125318322|NCT03137992|450794060|FG005|Washout Period 2|Sponsor Decision|1|||
125318323|NCT03137992|450794055|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
125318324|NCT03137992|450794056|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
125318325|NCT03137992|450794057|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
125318326|NCT03137992|450794058|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
125318327|NCT03137992|450794059|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
124994842|NCT00406653|449607305|FG000|Induction Period|Patient relocated|0|||
124994843|NCT00406653|449607306|FG001|Induction Period|Patient relocated|0|||
124994844|NCT00406653|449607307|FG002|Induction Period|Patient relocated|1|||
124994845|NCT00406653|449607308|FG003|Induction Period|Patient relocated|0|||
124994846|NCT00406653|449607309|FG004|Induction Period|Patient relocated|0|||
124994847|NCT00406653|449607310|FG005|Induction Period|Patient relocated|0|||
124994848|NCT00406653|449607311|FG006|Induction Period|Patient relocated|0|||
124994849|NCT00406653|449607305|FG000|Maintenance Period|Adverse Event|0|||
124994850|NCT00406653|449607306|FG001|Maintenance Period|Adverse Event|0|||
124994851|NCT00406653|449607307|FG002|Maintenance Period|Adverse Event|0|||
124994852|NCT00406653|449607308|FG003|Maintenance Period|Adverse Event|0|||
124994853|NCT00406653|449607309|FG004|Maintenance Period|Adverse Event|1|||
124994854|NCT00406653|449607310|FG005|Maintenance Period|Adverse Event|1|||
124994855|NCT00406653|449607311|FG006|Maintenance Period|Adverse Event|0|||
124994856|NCT00406653|449607305|FG000|Maintenance Period|Lack of Efficacy|0|||
124994857|NCT00406653|449607306|FG001|Maintenance Period|Lack of Efficacy|0|||
124994858|NCT00406653|449607307|FG002|Maintenance Period|Lack of Efficacy|0|||
124994859|NCT00406653|449607308|FG003|Maintenance Period|Lack of Efficacy|0|||
124994860|NCT00406653|449607309|FG004|Maintenance Period|Lack of Efficacy|20|||
124994861|NCT00406653|449607310|FG005|Maintenance Period|Lack of Efficacy|26|||
124994862|NCT00406653|449607311|FG006|Maintenance Period|Lack of Efficacy|0|||
124994863|NCT00406653|449607305|FG000|Maintenance Period|Lost to Follow-up|0|||
124994864|NCT00406653|449607306|FG001|Maintenance Period|Lost to Follow-up|0|||
124994865|NCT00406653|449607307|FG002|Maintenance Period|Lost to Follow-up|0|||
124994866|NCT00406653|449607308|FG003|Maintenance Period|Lost to Follow-up|0|||
124994867|NCT00406653|449607309|FG004|Maintenance Period|Lost to Follow-up|2|||
124994868|NCT00406653|449607310|FG005|Maintenance Period|Lost to Follow-up|1|||
125318328|NCT03137992|450794060|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
124994869|NCT00406653|449607311|FG006|Maintenance Period|Lost to Follow-up|0|||
124994870|NCT00406653|449607305|FG000|Maintenance Period|Withdrawal of Consent|0|||
124994871|NCT00406653|449607306|FG001|Maintenance Period|Withdrawal of Consent|0|||
124994872|NCT00406653|449607307|FG002|Maintenance Period|Withdrawal of Consent|0|||
125318329|NCT03137992|450794055|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
125318330|NCT03137992|450794056|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
125318331|NCT03137992|450794057|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
125318332|NCT03137992|450794058|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
125318333|NCT03137992|450794059|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
125318334|NCT03137992|450794060|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
124994873|NCT00406653|449607308|FG003|Maintenance Period|Withdrawal of Consent|0|||
124994874|NCT00406653|449607309|FG004|Maintenance Period|Withdrawal of Consent|2|||
125318335|NCT03137992|450794055|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
125318336|NCT03137992|450794056|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
125318337|NCT03137992|450794057|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
124994875|NCT00406653|449607310|FG005|Maintenance Period|Withdrawal of Consent|0|||
124994876|NCT00406653|449607311|FG006|Maintenance Period|Withdrawal of Consent|0|||
124994877|NCT00406653|449607305|FG000|Maintenance Period|Pregnancy|0|||
124994878|NCT00406653|449607306|FG001|Maintenance Period|Pregnancy|0|||
124994879|NCT00406653|449607307|FG002|Maintenance Period|Pregnancy|0|||
124994880|NCT00406653|449607308|FG003|Maintenance Period|Pregnancy|0|||
124994881|NCT00406653|449607309|FG004|Maintenance Period|Pregnancy|0|||
124994882|NCT00406653|449607310|FG005|Maintenance Period|Pregnancy|1|||
124994883|NCT00406653|449607311|FG006|Maintenance Period|Pregnancy|0|||
124994884|NCT00406653|449607305|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
124994885|NCT00406653|449607306|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
124994886|NCT00406653|449607307|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
124994887|NCT00406653|449607308|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
124994888|NCT00406653|449607309|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
124994889|NCT00406653|449607310|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
124994890|NCT00406653|449607311|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
124994891|NCT00406653|449607305|FG000|Maintenance Period|Error in disease score evaluation|0|||
124994892|NCT00406653|449607306|FG001|Maintenance Period|Error in disease score evaluation|0|||
124994893|NCT00406653|449607307|FG002|Maintenance Period|Error in disease score evaluation|0|||
124994894|NCT00406653|449607308|FG003|Maintenance Period|Error in disease score evaluation|0|||
124994895|NCT00406653|449607309|FG004|Maintenance Period|Error in disease score evaluation|1|||
124994896|NCT00406653|449607310|FG005|Maintenance Period|Error in disease score evaluation|0|||
124994897|NCT00406653|449607311|FG006|Maintenance Period|Error in disease score evaluation|0|||
124994898|NCT00406653|449607305|FG000|Open-Label Period|Death|0|||
124994899|NCT00406653|449607306|FG001|Open-Label Period|Death|0|||
124994900|NCT00406653|449607307|FG002|Open-Label Period|Death|0|||
124994901|NCT00406653|449607308|FG003|Open-Label Period|Death|0|||
124994902|NCT00406653|449607309|FG004|Open-Label Period|Death|0|||
124994903|NCT00406653|449607310|FG005|Open-Label Period|Death|0|||
124994904|NCT00406653|449607311|FG006|Open-Label Period|Death|1|||
124994905|NCT00406653|449607305|FG000|Open-Label Period|Adverse Event|0|||
124994906|NCT00406653|449607306|FG001|Open-Label Period|Adverse Event|0|||
124994907|NCT00406653|449607307|FG002|Open-Label Period|Adverse Event|0|||
124994908|NCT00406653|449607308|FG003|Open-Label Period|Adverse Event|0|||
124994909|NCT00406653|449607309|FG004|Open-Label Period|Adverse Event|0|||
124994910|NCT00406653|449607310|FG005|Open-Label Period|Adverse Event|0|||
124994911|NCT00406653|449607311|FG006|Open-Label Period|Adverse Event|18|||
124994912|NCT00406653|449607305|FG000|Open-Label Period|Lack of Efficacy|0|||
124994913|NCT00406653|449607306|FG001|Open-Label Period|Lack of Efficacy|0|||
124994914|NCT00406653|449607307|FG002|Open-Label Period|Lack of Efficacy|0|||
124994915|NCT00406653|449607308|FG003|Open-Label Period|Lack of Efficacy|0|||
124994916|NCT00406653|449607309|FG004|Open-Label Period|Lack of Efficacy|0|||
124994917|NCT00406653|449607310|FG005|Open-Label Period|Lack of Efficacy|0|||
124994918|NCT00406653|449607311|FG006|Open-Label Period|Lack of Efficacy|160|||
124994919|NCT00406653|449607305|FG000|Open-Label Period|Lost to Follow-up|0|||
124994920|NCT00406653|449607306|FG001|Open-Label Period|Lost to Follow-up|0|||
124994921|NCT00406653|449607307|FG002|Open-Label Period|Lost to Follow-up|0|||
124994922|NCT00406653|449607308|FG003|Open-Label Period|Lost to Follow-up|0|||
124994923|NCT00406653|449607309|FG004|Open-Label Period|Lost to Follow-up|0|||
124994924|NCT00406653|449607310|FG005|Open-Label Period|Lost to Follow-up|0|||
124994925|NCT00406653|449607311|FG006|Open-Label Period|Lost to Follow-up|6|||
124994926|NCT00406653|449607305|FG000|Open-Label Period|Withdrawal of Consent|0|||
124994927|NCT00406653|449607306|FG001|Open-Label Period|Withdrawal of Consent|0|||
124994928|NCT00406653|449607307|FG002|Open-Label Period|Withdrawal of Consent|0|||
124994929|NCT00406653|449607308|FG003|Open-Label Period|Withdrawal of Consent|0|||
124994930|NCT00406653|449607309|FG004|Open-Label Period|Withdrawal of Consent|0|||
124994931|NCT00406653|449607310|FG005|Open-Label Period|Withdrawal of Consent|0|||
124994932|NCT00406653|449607311|FG006|Open-Label Period|Withdrawal of Consent|11|||
124994933|NCT00406653|449607305|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
124994934|NCT00406653|449607306|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
124994935|NCT00406653|449607307|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
124994936|NCT00406653|449607308|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
124994937|NCT00406653|449607309|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
124994938|NCT00406653|449607310|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
124994939|NCT00406653|449607311|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
124994940|NCT00406653|449607305|FG000|Open-Label Period|Pregnancy|0|||
124994941|NCT00406653|449607306|FG001|Open-Label Period|Pregnancy|0|||
124994942|NCT00406653|449607307|FG002|Open-Label Period|Pregnancy|0|||
124994943|NCT00406653|449607308|FG003|Open-Label Period|Pregnancy|0|||
124994944|NCT00406653|449607309|FG004|Open-Label Period|Pregnancy|0|||
124994945|NCT00406653|449607310|FG005|Open-Label Period|Pregnancy|0|||
124994946|NCT00406653|449607311|FG006|Open-Label Period|Pregnancy|2|||
124994947|NCT00406653|449607305|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
124994948|NCT00406653|449607306|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
124994949|NCT00406653|449607307|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
124994950|NCT00406653|449607308|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
125318338|NCT03137992|450794058|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
124994951|NCT00406653|449607309|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
124994952|NCT00406653|449607310|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
125318339|NCT03137992|450794059|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
124994953|NCT00406653|449607311|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
124994954|NCT00406653|449607305|FG000|Open-Label Period|Declined participation but followup done|0|||
124994955|NCT00406653|449607306|FG001|Open-Label Period|Declined participation but followup done|0|||
124994956|NCT00406653|449607307|FG002|Open-Label Period|Declined participation but followup done|0|||
124994957|NCT00406653|449607308|FG003|Open-Label Period|Declined participation but followup done|0|||
124994958|NCT00406653|449607309|FG004|Open-Label Period|Declined participation but followup done|0|||
124994959|NCT00406653|449607310|FG005|Open-Label Period|Declined participation but followup done|0|||
124994960|NCT00406653|449607311|FG006|Open-Label Period|Declined participation but followup done|8|||
124994961|NCT00406653|449607305|FG000|Open-Label Period|Discontinued by Sponsor|0|||
124994962|NCT00406653|449607306|FG001|Open-Label Period|Discontinued by Sponsor|0|||
124994963|NCT00406653|449607307|FG002|Open-Label Period|Discontinued by Sponsor|0|||
124994964|NCT00406653|449607308|FG003|Open-Label Period|Discontinued by Sponsor|0|||
125318340|NCT03137992|450794060|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
125318341|NCT03137992|450794055|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
124994965|NCT00406653|449607309|FG004|Open-Label Period|Discontinued by Sponsor|0|||
124994966|NCT00406653|449607310|FG005|Open-Label Period|Discontinued by Sponsor|0|||
124994967|NCT00406653|449607311|FG006|Open-Label Period|Discontinued by Sponsor|1|||
124994968|NCT00406653|449607305|FG000|Open-Label Period|Refused followup|0|||
124994969|NCT00406653|449607306|FG001|Open-Label Period|Refused followup|0|||
124994970|NCT00406653|449607307|FG002|Open-Label Period|Refused followup|0|||
124994971|NCT00406653|449607308|FG003|Open-Label Period|Refused followup|0|||
124994972|NCT00406653|449607309|FG004|Open-Label Period|Refused followup|0|||
124994973|NCT00406653|449607310|FG005|Open-Label Period|Refused followup|0|||
125318342|NCT03137992|450794056|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
125318343|NCT03137992|450794057|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
125318344|NCT03137992|450794058|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
125318345|NCT03137992|450794059|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
125318346|NCT03137992|450794060|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
125318347|NCT03137992|450794055|FG000|Part 2 (Open-label Extension)|Per study team|1|||
125318348|NCT03137992|450794056|FG001|Part 2 (Open-label Extension)|Per study team|0|||
125318349|NCT03137992|450794057|FG002|Part 2 (Open-label Extension)|Per study team|0|||
125318350|NCT03137992|450794058|FG003|Part 2 (Open-label Extension)|Per study team|0|||
125318351|NCT03137992|450794059|FG004|Part 2 (Open-label Extension)|Per study team|0|||
125318352|NCT03137992|450794060|FG005|Part 2 (Open-label Extension)|Per study team|0|||
125318353|NCT03137992|450794055|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
124994974|NCT00406653|449607311|FG006|Open-Label Period|Refused followup|1|||
124994975|NCT00818649|449607312|FG000|Overall Study|Declining performance status|2|||
124994976|NCT00818649|449607312|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
124994977|NCT00818649|449607312|FG000|Overall Study|Adverse Event|1|||
124994978|NCT03513588|449607313|FG000|Overall Study|Lost to Follow-up|0|||
124994979|NCT03513588|449607314|FG001|Overall Study|Lost to Follow-up|1|||
124994980|NCT03513588|449607315|FG002|Overall Study|Lost to Follow-up|1|||
124994981|NCT03513588|449607313|FG000|Overall Study|Study dosing paused by sponsor|1|||
125318354|NCT03137992|450794056|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
124994982|NCT03513588|449607314|FG001|Overall Study|Study dosing paused by sponsor|1|||
125318355|NCT03137992|450794057|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
124994983|NCT03513588|449607315|FG002|Overall Study|Study dosing paused by sponsor|0|||
124994984|NCT03513588|449607313|FG000|Overall Study|Death|0|||
124994985|NCT03513588|449607314|FG001|Overall Study|Death|0|||
124994986|NCT03513588|449607315|FG002|Overall Study|Death|1|||
124994987|NCT00940108|449607316|FG000|Overall Study|Adverse Event|2|||
124994988|NCT00940108|449607317|FG001|Overall Study|Adverse Event|4|||
124994989|NCT00940108|449607318|FG002|Overall Study|Adverse Event|0|||
124994990|NCT00940108|449607319|FG003|Overall Study|Adverse Event|2|||
124994991|NCT00940108|449607316|FG000|Overall Study|Withdrew Consent|2|||
125318356|NCT03137992|450794058|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
125318357|NCT03137992|450794059|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
125318358|NCT03137992|450794060|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
125318359|NCT02370420|450794061|FG000|Overall Study|Physician Decision|3|||
125318360|NCT02370420|450794062|FG001|Overall Study|Physician Decision|3|||
125318361|NCT02370420|450794061|FG000|Overall Study|Lost to Follow-up|11|||
125318362|NCT02370420|450794062|FG001|Overall Study|Lost to Follow-up|9|||
125318363|NCT03077542|450794063|FG000|Overall Study|Death|4|||
125318364|NCT03077542|450794064|FG001|Overall Study|Death|0|||
125318365|NCT03077542|450794063|FG000|Overall Study|Physician Decision|6|||
125318366|NCT03077542|450794064|FG001|Overall Study|Physician Decision|1|||
125318367|NCT03077542|450794063|FG000|Overall Study|Withdrawal by Subject|0|||
125318368|NCT03077542|450794064|FG001|Overall Study|Withdrawal by Subject|1|||
125318369|NCT01300728|450794065|FG000|Overall Study|Withdrawal by Subject|1|||
125318370|NCT01300728|450794066|FG001|Overall Study|Withdrawal by Subject|1|||
125318371|NCT01300728|450794065|FG000|Overall Study|Physician Decision|1|||
125318372|NCT01300728|450794066|FG001|Overall Study|Physician Decision|0|||
125318373|NCT00301808|450794069|FG000|Overall Study|Adverse Event|5|||
125318374|NCT00301808|450794069|FG000|Overall Study|Death|3|||
124994992|NCT00940108|449607317|FG001|Overall Study|Withdrew Consent|1|||
124994993|NCT00940108|449607318|FG002|Overall Study|Withdrew Consent|0|||
125318375|NCT00301808|450794069|FG000|Overall Study|Lack of Efficacy|4|||
125318376|NCT05893862|450794073|FG000|Overall Study|Physician Decision|0|||
125318377|NCT05893862|450794074|FG001|Overall Study|Physician Decision|1|||
125318378|NCT05893862|450794075|FG002|Overall Study|Physician Decision|0|||
125318379|NCT05893862|450794076|FG003|Overall Study|Physician Decision|0|||
125318380|NCT05893862|450794077|FG004|Overall Study|Physician Decision|1|||
125318381|NCT05893862|450794078|FG005|Overall Study|Physician Decision|0|||
125318382|NCT05893862|450794073|FG000|Overall Study|Withdrawal by Subject|1|||
125318383|NCT05893862|450794074|FG001|Overall Study|Withdrawal by Subject|7|||
125318384|NCT05893862|450794075|FG002|Overall Study|Withdrawal by Subject|1|||
125318385|NCT05893862|450794076|FG003|Overall Study|Withdrawal by Subject|3|||
125318386|NCT05893862|450794077|FG004|Overall Study|Withdrawal by Subject|3|||
125318387|NCT05893862|450794078|FG005|Overall Study|Withdrawal by Subject|2|||
125318388|NCT05893862|450794073|FG000|Overall Study|Adverse Event|1|||
125318389|NCT05893862|450794074|FG001|Overall Study|Adverse Event|4|||
125318390|NCT05893862|450794075|FG002|Overall Study|Adverse Event|2|||
125318391|NCT05893862|450794076|FG003|Overall Study|Adverse Event|2|||
125318392|NCT05893862|450794077|FG004|Overall Study|Adverse Event|1|||
125318393|NCT05893862|450794078|FG005|Overall Study|Adverse Event|0|||
125318394|NCT02429830|450794079|FG000|Overall Study|Lost to Follow-up|1|||
125318395|NCT02429830|450794079|FG000|Overall Study|Device Explant|2|||
125318396|NCT01908426|450796243|FG000|Overall Study|Adverse Event|98|||
125318397|NCT01908426|450796244|FG001|Overall Study|Adverse Event|11|||
125318398|NCT01908426|450796243|FG000|Overall Study|Clinical Deterioration|72|||
125318399|NCT01908426|450796244|FG001|Overall Study|Clinical Deterioration|38|||
125318400|NCT01908426|450796243|FG000|Overall Study|Lack of Efficacy|3|||
125318401|NCT01908426|450796244|FG001|Overall Study|Lack of Efficacy|0|||
125318402|NCT01908426|450796243|FG000|Overall Study|Lost to Follow-up|0|||
125318403|NCT01908426|450796244|FG001|Overall Study|Lost to Follow-up|1|||
125318404|NCT01908426|450796243|FG000|Overall Study|Physician Decision|3|||
125318405|NCT01908426|450796244|FG001|Overall Study|Physician Decision|3|||
124994994|NCT00940108|449607319|FG003|Overall Study|Withdrew Consent|1|||
124994995|NCT00940108|449607316|FG000|Overall Study|Dose 2 contraindicated|1|||
124994996|NCT00940108|449607317|FG001|Overall Study|Dose 2 contraindicated|1|||
124994997|NCT00940108|449607318|FG002|Overall Study|Dose 2 contraindicated|0|||
124994998|NCT00940108|449607319|FG003|Overall Study|Dose 2 contraindicated|1|||
125318406|NCT01908426|450796243|FG000|Overall Study|Withdrawal by Subject|11|||
125318407|NCT01908426|450796244|FG001|Overall Study|Withdrawal by Subject|6|||
125318408|NCT01908426|450796243|FG000|Overall Study|Progressive Disease|206|||
125318409|NCT01908426|450796244|FG001|Overall Study|Progressive Disease|152|||
125318410|NCT01908426|450796243|FG000|Overall Study|Protocol Violation|1|||
125318411|NCT01908426|450796244|FG001|Overall Study|Protocol Violation|0|||
125318412|NCT01908426|450796243|FG000|Overall Study|No Study Treatment Given|3|||
124994999|NCT00940108|449607316|FG000|Overall Study|Declined further vaccination|0|||
125318413|NCT01908426|450796244|FG001|Overall Study|No Study Treatment Given|0|||
125318414|NCT03346434|450796245|FG000|Overall Study|Randomized in Error|0|||
125318415|NCT03346434|450796246|FG001|Overall Study|Randomized in Error|0|||
125318416|NCT03346434|450796247|FG002|Overall Study|Randomized in Error|0|||
125318417|NCT03346434|450796248|FG003|Overall Study|Randomized in Error|0|||
125318418|NCT03346434|450796249|FG004|Overall Study|Randomized in Error|1|||
125318419|NCT03346434|450796250|FG005|Overall Study|Randomized in Error|0|||
125318420|NCT03346434|450796245|FG000|Overall Study|Withdrawal by Subject|0|||
125318421|NCT03346434|450796246|FG001|Overall Study|Withdrawal by Subject|0|||
125318422|NCT03346434|450796247|FG002|Overall Study|Withdrawal by Subject|1|||
125318423|NCT03346434|450796248|FG003|Overall Study|Withdrawal by Subject|0|||
125318424|NCT03346434|450796249|FG004|Overall Study|Withdrawal by Subject|1|||
124995000|NCT00940108|449607317|FG001|Overall Study|Declined further vaccination|1|||
124995001|NCT00940108|449607318|FG002|Overall Study|Declined further vaccination|3|||
124995002|NCT00940108|449607319|FG003|Overall Study|Declined further vaccination|0|||
124995003|NCT00940108|449607316|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
124995004|NCT00940108|449607317|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
124995005|NCT00940108|449607318|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
124995006|NCT00940108|449607319|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
124995007|NCT00940108|449607316|FG000|Overall Study|Viral illness after Dose 1|0|||
124995008|NCT00940108|449607317|FG001|Overall Study|Viral illness after Dose 1|1|||
124995009|NCT00940108|449607318|FG002|Overall Study|Viral illness after Dose 1|0|||
124995010|NCT00940108|449607319|FG003|Overall Study|Viral illness after Dose 1|0|||
124995011|NCT00940108|449607316|FG000|Overall Study|Diagnosed with H1N1|0|||
125318425|NCT03346434|450796250|FG005|Overall Study|Withdrawal by Subject|0|||
125318426|NCT03346434|450796245|FG000|Overall Study|Lost to Follow-up|0|||
125318427|NCT03346434|450796246|FG001|Overall Study|Lost to Follow-up|0|||
125318428|NCT03346434|450796247|FG002|Overall Study|Lost to Follow-up|0|||
125318429|NCT03346434|450796248|FG003|Overall Study|Lost to Follow-up|0|||
125318430|NCT03346434|450796249|FG004|Overall Study|Lost to Follow-up|1|||
125318431|NCT03346434|450796250|FG005|Overall Study|Lost to Follow-up|1|||
125318432|NCT03346434|450796245|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
125318433|NCT03346434|450796246|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
125318434|NCT03346434|450796247|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
125318435|NCT03346434|450796248|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
125318436|NCT03346434|450796249|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
125318437|NCT03346434|450796250|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
125318438|NCT01419236|450796266|FG000|Overall Study|Adverse Event|1|||
125318439|NCT01419236|450796267|FG001|Overall Study|Adverse Event|0|||
125318440|NCT01419236|450796266|FG000|Overall Study|Lack of Efficacy|0|||
125318441|NCT01419236|450796267|FG001|Overall Study|Lack of Efficacy|1|||
125318442|NCT01419236|450796266|FG000|Overall Study|Lost to Follow-up|1|||
125318443|NCT01419236|450796267|FG001|Overall Study|Lost to Follow-up|0|||
125318444|NCT01419236|450796266|FG000|Overall Study|Physician Decision|1|||
125318445|NCT01419236|450796267|FG001|Overall Study|Physician Decision|0|||
125318446|NCT01419236|450796266|FG000|Overall Study|Withdrawal by Subject|1|||
125318447|NCT01419236|450796267|FG001|Overall Study|Withdrawal by Subject|4|||
125318448|NCT01419236|450796266|FG000|Overall Study|Entry Criteria Not Met|1|||
125318449|NCT01419236|450796267|FG001|Overall Study|Entry Criteria Not Met|0|||
125318450|NCT00762359|450796274|FG000|Overall Study|Adverse Event|20|||
125318451|NCT00762359|450796275|FG001|Overall Study|Adverse Event|23|||
125318452|NCT00762359|450796274|FG000|Overall Study|Protocol Violation|21|||
125318453|NCT00762359|450796275|FG001|Overall Study|Protocol Violation|13|||
125318454|NCT00762359|450796274|FG000|Overall Study|Withdrawal by Subject|13|||
125318455|NCT00762359|450796275|FG001|Overall Study|Withdrawal by Subject|10|||
125318456|NCT00762359|450796274|FG000|Overall Study|Lack of Efficacy|0|||
125318457|NCT00762359|450796275|FG001|Overall Study|Lack of Efficacy|4|||
125318458|NCT00762359|450796274|FG000|Overall Study|Institution closed|2|||
125318459|NCT00762359|450796275|FG001|Overall Study|Institution closed|3|||
125318460|NCT00762359|450796274|FG000|Overall Study|Physician Decision|2|||
125318461|NCT00762359|450796275|FG001|Overall Study|Physician Decision|3|||
125318462|NCT00762359|450796274|FG000|Overall Study|Removal|0|||
125318463|NCT00762359|450796275|FG001|Overall Study|Removal|1|||
125318464|NCT00762359|450796274|FG000|Overall Study|Withdrew consent|1|||
125318465|NCT00762359|450796275|FG001|Overall Study|Withdrew consent|0|||
125318466|NCT01453049|450796276|FG000|Overall Study|Protocol Violation|2|||
125318467|NCT01453049|450796277|FG001|Overall Study|Protocol Violation|5|||
125318468|NCT01453049|450796276|FG000|Overall Study|Lost to Follow-up|2|||
125318469|NCT01453049|450796277|FG001|Overall Study|Lost to Follow-up|1|||
125318470|NCT01453049|450796276|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
125318471|NCT01453049|450796277|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
125318472|NCT01453049|450796276|FG000|Overall Study|Withdrawal by Subject|1|||
125318473|NCT01453049|450796277|FG001|Overall Study|Withdrawal by Subject|0|||
125318474|NCT01453049|450796276|FG000|Overall Study|Randomized in Error|1|||
125318475|NCT01453049|450796277|FG001|Overall Study|Randomized in Error|0|||
125318476|NCT00882440|450796278|FG000|Overall Study|Adverse Event|2|||
125318477|NCT00882440|450796279|FG001|Overall Study|Adverse Event|2|||
125318478|NCT00882440|450796280|FG002|Overall Study|Adverse Event|2|||
125318479|NCT00882440|450796281|FG003|Overall Study|Adverse Event|1|||
124995012|NCT00940108|449607317|FG001|Overall Study|Diagnosed with H1N1|0|||
125318480|NCT00882440|450796282|FG004|Overall Study|Adverse Event|1|||
125318481|NCT00882440|450796283|FG005|Overall Study|Adverse Event|4|||
125318482|NCT00882440|450796284|FG006|Overall Study|Adverse Event|2|||
125318483|NCT00882440|450796278|FG000|Overall Study|Lack of Efficacy|3|||
125318484|NCT00882440|450796279|FG001|Overall Study|Lack of Efficacy|5|||
125318485|NCT00882440|450796280|FG002|Overall Study|Lack of Efficacy|2|||
124995013|NCT00940108|449607318|FG002|Overall Study|Diagnosed with H1N1|0|||
125318486|NCT00882440|450796281|FG003|Overall Study|Lack of Efficacy|0|||
125318487|NCT00882440|450796282|FG004|Overall Study|Lack of Efficacy|0|||
125318488|NCT00882440|450796283|FG005|Overall Study|Lack of Efficacy|3|||
125318489|NCT00882440|450796284|FG006|Overall Study|Lack of Efficacy|0|||
125318490|NCT00882440|450796278|FG000|Overall Study|Lost to Follow-up|2|||
125318491|NCT00882440|450796279|FG001|Overall Study|Lost to Follow-up|0|||
125318492|NCT00882440|450796280|FG002|Overall Study|Lost to Follow-up|1|||
125318493|NCT00882440|450796281|FG003|Overall Study|Lost to Follow-up|1|||
125318494|NCT00882440|450796282|FG004|Overall Study|Lost to Follow-up|1|||
125318495|NCT00882440|450796283|FG005|Overall Study|Lost to Follow-up|0|||
125318496|NCT00882440|450796284|FG006|Overall Study|Lost to Follow-up|1|||
125318497|NCT00882440|450796278|FG000|Overall Study|Protocol Violation|0|||
125318498|NCT00882440|450796279|FG001|Overall Study|Protocol Violation|0|||
125318499|NCT00882440|450796280|FG002|Overall Study|Protocol Violation|1|||
125318500|NCT00882440|450796281|FG003|Overall Study|Protocol Violation|1|||
125318501|NCT00882440|450796282|FG004|Overall Study|Protocol Violation|1|||
125318502|NCT00882440|450796283|FG005|Overall Study|Protocol Violation|0|||
125318503|NCT00882440|450796284|FG006|Overall Study|Protocol Violation|0|||
125318504|NCT00882440|450796278|FG000|Overall Study|Withdrawal by Subject|2|||
125318505|NCT00882440|450796279|FG001|Overall Study|Withdrawal by Subject|1|||
125318506|NCT00882440|450796280|FG002|Overall Study|Withdrawal by Subject|1|||
125318507|NCT00882440|450796281|FG003|Overall Study|Withdrawal by Subject|0|||
125318508|NCT00882440|450796282|FG004|Overall Study|Withdrawal by Subject|6|||
125318509|NCT00882440|450796283|FG005|Overall Study|Withdrawal by Subject|0|||
125318510|NCT00882440|450796284|FG006|Overall Study|Withdrawal by Subject|1|||
125318511|NCT00882440|450796278|FG000|Overall Study|Patient Uncooperative|2|||
125318512|NCT00882440|450796279|FG001|Overall Study|Patient Uncooperative|0|||
125318513|NCT00882440|450796280|FG002|Overall Study|Patient Uncooperative|0|||
125318514|NCT00882440|450796281|FG003|Overall Study|Patient Uncooperative|0|||
125318515|NCT00882440|450796282|FG004|Overall Study|Patient Uncooperative|1|||
125318516|NCT00882440|450796283|FG005|Overall Study|Patient Uncooperative|0|||
125318517|NCT00882440|450796284|FG006|Overall Study|Patient Uncooperative|0|||
124995014|NCT00940108|449607319|FG003|Overall Study|Diagnosed with H1N1|1|||
124995015|NCT02075541|449607323|FG000|Overall Study|Serious Adverse Event|1|||
124995016|NCT02075541|449607324|FG001|Overall Study|Serious Adverse Event|4|||
124995017|NCT02075541|449607323|FG000|Overall Study|Protocol Violation|1|||
124995018|NCT02075541|449607324|FG001|Overall Study|Protocol Violation|0|||
124995019|NCT02075541|449607323|FG000|Overall Study|Withdrawal by Subject|1|||
124995020|NCT02075541|449607324|FG001|Overall Study|Withdrawal by Subject|3|||
124995021|NCT02075541|449607323|FG000|Overall Study|Sponsor study termination|0|||
124995022|NCT02075541|449607324|FG001|Overall Study|Sponsor study termination|1|||
124995023|NCT02075541|449607323|FG000|Overall Study|Other- unable to perform study procedure|1|||
124995024|NCT02075541|449607324|FG001|Overall Study|Other- unable to perform study procedure|0|||
124995025|NCT01142596|449607326|FG000|Overall Study|Withdrawal by Subject|9|||
124995026|NCT01142596|449607327|FG001|Overall Study|Withdrawal by Subject|35|||
124995027|NCT01142596|449607326|FG000|Overall Study|Adverse Event|8|||
124995028|NCT01142596|449607327|FG001|Overall Study|Adverse Event|35|||
124995029|NCT01142596|449607326|FG000|Overall Study|Lack of Efficacy|5|||
124995030|NCT01142596|449607327|FG001|Overall Study|Lack of Efficacy|9|||
124995031|NCT01142596|449607326|FG000|Overall Study|Lost to Follow-up|2|||
124995032|NCT01142596|449607327|FG001|Overall Study|Lost to Follow-up|3|||
124995033|NCT01142596|449607326|FG000|Overall Study|Other reason (not specified)|5|||
124995034|NCT01142596|449607327|FG001|Overall Study|Other reason (not specified)|4|||
124995035|NCT01054846|449607328|FG000|Overall Study|Lost to Follow-up|76|||
124995036|NCT01054846|449607329|FG001|Overall Study|Lost to Follow-up|17|||
124995037|NCT02446886|449607330|FG000|Overall Study|Adverse Event|1|||
124995038|NCT02446886|449607331|FG001|Overall Study|Adverse Event|3|||
124995039|NCT02446886|449607330|FG000|Overall Study|Withdrawal by Subject|1|||
124995040|NCT02446886|449607331|FG001|Overall Study|Withdrawal by Subject|1|||
124995041|NCT00928447|449607332|FG000|Overall Study|Withdrawal by Subject|1|||
124995042|NCT00928447|449607332|FG000|Overall Study|Investigator's decision|1|||
124995043|NCT01259284|449607333|FG000|Overall Study|Study Termination|2|||
124995044|NCT01259284|449607334|FG001|Overall Study|Study Termination|0|||
124995045|NCT01259284|449607335|FG002|Overall Study|Study Termination|0|||
124995046|NCT02988622|449607336|FG000|Overall Study|Lost to Follow-up|17|||
124995047|NCT00421707|449607337|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
124995048|NCT00421707|449607338|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
125318518|NCT03287791|450796285|FG000|Overall Study|Insufficient Therapeutic Response|0|||
125318519|NCT03287791|450796286|FG001|Overall Study|Insufficient Therapeutic Response|0|||
125318520|NCT03287791|450796287|FG002|Overall Study|Insufficient Therapeutic Response|1|||
125318521|NCT03287791|450796285|FG000|Overall Study|Adverse Event|0|||
125318522|NCT03287791|450796286|FG001|Overall Study|Adverse Event|4|||
125318523|NCT03287791|450796287|FG002|Overall Study|Adverse Event|3|||
124995049|NCT00421707|449607337|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
124995050|NCT00421707|449607338|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
124995051|NCT00421707|449607337|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
124995052|NCT00421707|449607338|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
124995053|NCT00421707|449607337|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
125318524|NCT03287791|450796285|FG000|Overall Study|Withdrawal by Subject|12|||
125318525|NCT03287791|450796286|FG001|Overall Study|Withdrawal by Subject|12|||
125318526|NCT03287791|450796287|FG002|Overall Study|Withdrawal by Subject|17|||
125318527|NCT03287791|450796285|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
125318528|NCT03287791|450796286|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
125318529|NCT03287791|450796287|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
125318530|NCT03287791|450796285|FG000|Overall Study|Lost to Follow-up|8|||
125318531|NCT03287791|450796286|FG001|Overall Study|Lost to Follow-up|14|||
125318532|NCT03287791|450796287|FG002|Overall Study|Lost to Follow-up|11|||
125318533|NCT03287791|450796285|FG000|Overall Study|Protocol Violation|7|||
125318534|NCT03287791|450796286|FG001|Overall Study|Protocol Violation|2|||
125318535|NCT03287791|450796287|FG002|Overall Study|Protocol Violation|1|||
125318536|NCT03287791|450796285|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
125318537|NCT03287791|450796286|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
125318538|NCT03287791|450796287|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
125318539|NCT03287791|450796285|FG000|Overall Study|Too much time between 2 visits|0|||
125318540|NCT03287791|450796286|FG001|Overall Study|Too much time between 2 visits|1|||
125318541|NCT03287791|450796287|FG002|Overall Study|Too much time between 2 visits|0|||
125318542|NCT03287791|450796285|FG000|Overall Study|Non-compliance|0|||
125318543|NCT03287791|450796286|FG001|Overall Study|Non-compliance|1|||
125318544|NCT03287791|450796287|FG002|Overall Study|Non-compliance|0|||
125318545|NCT03287791|450796285|FG000|Overall Study|Did not meet inclusion criteria|1|||
125318546|NCT03287791|450796286|FG001|Overall Study|Did not meet inclusion criteria|0|||
125318547|NCT03287791|450796287|FG002|Overall Study|Did not meet inclusion criteria|0|||
125318548|NCT05482308|450796292|FG000|Overall Study|Withdrawal by Subject|1|||
125318549|NCT05482308|450796293|FG001|Overall Study|Withdrawal by Subject|0|||
125318550|NCT05482308|450796292|FG000|Overall Study|No longer meets eligibility criteria|0|||
125318551|NCT05482308|450796293|FG001|Overall Study|No longer meets eligibility criteria|1|||
124995054|NCT00421707|449607338|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
124995055|NCT00421707|449607337|FG000|Period 2: Washout|Adverse Event|1|||
124995056|NCT00421707|449607338|FG001|Period 2: Washout|Adverse Event|1|||
124995057|NCT00421707|449607337|FG000|Period 2: Washout|Withdrawal by Subject|0|||
124995058|NCT00421707|449607338|FG001|Period 2: Washout|Withdrawal by Subject|1|||
124995059|NCT00421707|449607337|FG000|Period 2: Washout|Lost to Follow-up|0|||
124995060|NCT00421707|449607338|FG001|Period 2: Washout|Lost to Follow-up|1|||
124995061|NCT00421707|449607337|FG000|Period 2: Washout|Other: Pregnancy|0|||
124995062|NCT00421707|449607338|FG001|Period 2: Washout|Other: Pregnancy|1|||
124995063|NCT00421707|449607337|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
124995064|NCT00421707|449607338|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
124995065|NCT00421707|449607337|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
124995066|NCT00421707|449607338|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
124995067|NCT00421707|449607337|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
124995068|NCT00421707|449607338|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
124995069|NCT03261700|449607342|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
124995070|NCT03261700|449607343|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
124995071|NCT01204398|449607344|FG000|Overall Study|Adverse Event|1|||
124995072|NCT00983931|449607345|FG000|14 Day Washout Period|Physician Decision|1|||
124995073|NCT01281969|449607348|FG000|Overall Study|not randomized didn't meet criteria|0|||
124995074|NCT01281969|449607349|FG001|Overall Study|not randomized didn't meet criteria|0|||
124995075|NCT01281969|449607350|FG002|Overall Study|not randomized didn't meet criteria|7|||
124995076|NCT01281969|449607348|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
124995077|NCT01281969|449607349|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
124995078|NCT01281969|449607350|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
124995079|NCT01281969|449607348|FG000|Overall Study|not randomized, child consent not given|0|||
124995080|NCT01281969|449607349|FG001|Overall Study|not randomized, child consent not given|0|||
124995081|NCT01281969|449607350|FG002|Overall Study|not randomized, child consent not given|2|||
124995082|NCT01723254|449607352|FG000|Overall Study|Conflict with work schedule|0|||
124995083|NCT01723254|449607353|FG001|Overall Study|Conflict with work schedule|0|||
124995084|NCT01723254|449607354|FG002|Overall Study|Conflict with work schedule|0|||
124995085|NCT01723254|449607355|FG003|Overall Study|Conflict with work schedule|0|||
124995086|NCT01723254|449607356|FG004|Overall Study|Conflict with work schedule|0|||
124995087|NCT01723254|449607357|FG005|Overall Study|Conflict with work schedule|0|||
124995088|NCT01723254|449607358|FG006|Overall Study|Conflict with work schedule|0|||
124995089|NCT01723254|449607359|FG007|Overall Study|Conflict with work schedule|1|||
124995090|NCT01723254|449607352|FG000|Overall Study|Personal issues|0|||
124995091|NCT01723254|449607353|FG001|Overall Study|Personal issues|0|||
124995092|NCT01723254|449607354|FG002|Overall Study|Personal issues|0|||
124995093|NCT01723254|449607355|FG003|Overall Study|Personal issues|0|||
124995094|NCT01723254|449607356|FG004|Overall Study|Personal issues|0|||
124995095|NCT01723254|449607357|FG005|Overall Study|Personal issues|1|||
124995096|NCT01723254|449607358|FG006|Overall Study|Personal issues|0|||
124995097|NCT01723254|449607359|FG007|Overall Study|Personal issues|0|||
124995098|NCT01723254|449607352|FG000|Overall Study|No longer have time to participate|0|||
124995099|NCT01723254|449607353|FG001|Overall Study|No longer have time to participate|0|||
124995100|NCT01723254|449607354|FG002|Overall Study|No longer have time to participate|0|||
124995101|NCT01723254|449607355|FG003|Overall Study|No longer have time to participate|1|||
124995102|NCT01723254|449607356|FG004|Overall Study|No longer have time to participate|0|||
124995103|NCT01723254|449607357|FG005|Overall Study|No longer have time to participate|0|||
124995104|NCT01723254|449607358|FG006|Overall Study|No longer have time to participate|0|||
124995105|NCT01723254|449607359|FG007|Overall Study|No longer have time to participate|0|||
124995106|NCT01723254|449607352|FG000|Overall Study|Move/Left to another country/city|0|||
124995107|NCT01723254|449607353|FG001|Overall Study|Move/Left to another country/city|0|||
124872792|NCT00394355|449155767|FG002|Overall Study|Noncompliance with protocol|10|||
124872793|NCT00394355|449155768|FG003|Overall Study|Noncompliance with protocol|8|||
124872794|NCT00394355|449155765|FG000|Overall Study|Administrative|0|||
124872795|NCT00394355|449155766|FG001|Overall Study|Administrative|1|||
124872796|NCT00394355|449155767|FG002|Overall Study|Administrative|1|||
124872797|NCT00394355|449155768|FG003|Overall Study|Administrative|1|||
124995108|NCT01723254|449607354|FG002|Overall Study|Move/Left to another country/city|2|||
124995109|NCT01723254|449607355|FG003|Overall Study|Move/Left to another country/city|1|||
124995110|NCT01723254|449607356|FG004|Overall Study|Move/Left to another country/city|1|||
124995111|NCT01723254|449607357|FG005|Overall Study|Move/Left to another country/city|0|||
124995112|NCT01723254|449607358|FG006|Overall Study|Move/Left to another country/city|0|||
124995113|NCT01723254|449607359|FG007|Overall Study|Move/Left to another country/city|0|||
124995114|NCT01723254|449607352|FG000|Overall Study|Protocol Violation|0|||
124995115|NCT01723254|449607353|FG001|Overall Study|Protocol Violation|1|||
124995116|NCT01723254|449607354|FG002|Overall Study|Protocol Violation|0|||
124995117|NCT01723254|449607355|FG003|Overall Study|Protocol Violation|0|||
124872798|NCT00394355|449155765|FG000|Overall Study|Lack of Efficacy|0|||
124872799|NCT00394355|449155766|FG001|Overall Study|Lack of Efficacy|0|||
124872800|NCT00394355|449155767|FG002|Overall Study|Lack of Efficacy|2|||
124872801|NCT00394355|449155768|FG003|Overall Study|Lack of Efficacy|3|||
124872802|NCT00500903|449155769|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
124872803|NCT00500903|449155770|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
124872804|NCT00500903|449155771|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
124872805|NCT00500903|449155769|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
124872806|NCT00500903|449155770|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
124872807|NCT00500903|449155771|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
124872808|NCT00500903|449155769|FG000|Overall Study|Progressive Disease|41|||
124872809|NCT00500903|449155770|FG001|Overall Study|Progressive Disease|2|||
124872810|NCT00500903|449155771|FG002|Overall Study|Progressive Disease|15|||
124872811|NCT00500903|449155769|FG000|Overall Study|Patient Declined Further Treatment|0|||
125318636|NCT02250326|450796309|FG000|Treatment|Death|1|||
125318637|NCT02250326|450796310|FG001|Treatment|Death|13|||
125318638|NCT02250326|450796311|FG002|Treatment|Death|2|||
125318639|NCT02250326|450796309|FG000|Treatment|Adverse Event|8|||
125318640|NCT02250326|450796310|FG001|Treatment|Adverse Event|8|||
125318641|NCT02250326|450796311|FG002|Treatment|Adverse Event|9|||
125318642|NCT02250326|450796309|FG000|Treatment|Progressive Disease|42|||
125318643|NCT02250326|450796310|FG001|Treatment|Progressive Disease|40|||
125318644|NCT02250326|450796311|FG002|Treatment|Progressive Disease|47|||
125318645|NCT02250326|450796309|FG000|Treatment|Symptomatic Deterioration|9|||
125318646|NCT02250326|450796310|FG001|Treatment|Symptomatic Deterioration|4|||
125318647|NCT02250326|450796311|FG002|Treatment|Symptomatic Deterioration|10|||
125318648|NCT02250326|450796309|FG000|Treatment|Withdrawal by Subject|11|||
125318649|NCT02250326|450796310|FG001|Treatment|Withdrawal by Subject|6|||
125318650|NCT02250326|450796311|FG002|Treatment|Withdrawal by Subject|4|||
125318651|NCT02250326|450796309|FG000|Treatment|Other reasons|8|||
125318652|NCT02250326|450796310|FG001|Treatment|Other reasons|7|||
125318653|NCT02250326|450796311|FG002|Treatment|Other reasons|7|||
125318654|NCT02250326|450796309|FG000|Extension Period|Progressive Disease|0|||
125318655|NCT02250326|450796310|FG001|Extension Period|Progressive Disease|2|||
125318656|NCT02250326|450796311|FG002|Extension Period|Progressive Disease|0|||
125318657|NCT02250326|450796309|FG000|Extension Period|Withdrawal by Subject|0|||
125318658|NCT02250326|450796310|FG001|Extension Period|Withdrawal by Subject|1|||
125318659|NCT02250326|450796311|FG002|Extension Period|Withdrawal by Subject|0|||
125318660|NCT02250326|450796309|FG000|Extension Period|Withdrawal by investigator|0|||
125318661|NCT02250326|450796310|FG001|Extension Period|Withdrawal by investigator|1|||
124872812|NCT00500903|449155770|FG001|Overall Study|Patient Declined Further Treatment|0|||
125318662|NCT02250326|450796311|FG002|Extension Period|Withdrawal by investigator|0|||
125318663|NCT00416624|450796312|FG000|Overall Study|Withdrawal by Subject|1|||
125318664|NCT00416624|450796313|FG001|Overall Study|Withdrawal by Subject|6|||
125318665|NCT00416624|450796314|FG002|Overall Study|Withdrawal by Subject|4|||
125318666|NCT00416624|450796315|FG003|Overall Study|Withdrawal by Subject|9|||
125318667|NCT00416624|450796312|FG000|Overall Study|Death|4|||
125318668|NCT00416624|450796313|FG001|Overall Study|Death|7|||
125318669|NCT00416624|450796314|FG002|Overall Study|Death|7|||
125318670|NCT00416624|450796315|FG003|Overall Study|Death|1|||
125318671|NCT00416624|450796312|FG000|Overall Study|Adverse Event|8|||
125318672|NCT00416624|450796313|FG001|Overall Study|Adverse Event|3|||
125318673|NCT00416624|450796314|FG002|Overall Study|Adverse Event|2|||
125318674|NCT00416624|450796315|FG003|Overall Study|Adverse Event|2|||
125318675|NCT00416624|450796312|FG000|Overall Study|Other|8|||
125318676|NCT00416624|450796313|FG001|Overall Study|Other|11|||
125318677|NCT00416624|450796314|FG002|Overall Study|Other|5|||
125318678|NCT00416624|450796315|FG003|Overall Study|Other|5|||
125318679|NCT00416624|450796312|FG000|Overall Study|Cancel|1|||
125318680|NCT00416624|450796313|FG001|Overall Study|Cancel|0|||
125318681|NCT00416624|450796314|FG002|Overall Study|Cancel|0|||
125318682|NCT00416624|450796315|FG003|Overall Study|Cancel|0|||
125318683|NCT03924622|450796316|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
125318684|NCT03924622|450796317|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
125318685|NCT03924622|450796318|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
125318686|NCT03924622|450796319|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
125318687|NCT03924622|450796320|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
125318688|NCT03924622|450796321|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
125318689|NCT00141453|450796324|FG000|Overall Study|Protocol Violation|6|||
125318690|NCT00141453|450796325|FG001|Overall Study|Protocol Violation|5|||
125318691|NCT00866177|450796330|FG000|Overall Study|Withdrawal by Subject|1|||
125318692|NCT00866177|450796330|FG000|Overall Study|Not Treated|151|||
125318693|NCT03585660|450796331|FG000|Overall Study|operator error|1|||
125318694|NCT03585660|450796331|FG000|Overall Study|technical error|2|||
125318695|NCT03585660|450796331|FG000|Overall Study|hip prosthesis|2|||
125318696|NCT03585660|450796331|FG000|Overall Study|did not undergo biopsy|8|||
125318697|NCT03585660|450796331|FG000|Overall Study|scanner problem|2|||
125318698|NCT05635461|450796336|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
125318699|NCT05635461|450796337|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
125318700|NCT05635461|450796338|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
125318701|NCT05635461|450796339|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
125318702|NCT05635461|450796340|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
125318703|NCT05635461|450796341|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
125318704|NCT05635461|450796336|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
125318705|NCT05635461|450796337|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
125318706|NCT05635461|450796338|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
125318707|NCT05635461|450796339|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
125318708|NCT05635461|450796340|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
125318709|NCT05635461|450796341|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
125318710|NCT05635461|450796336|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
125318711|NCT05635461|450796337|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
125318712|NCT05635461|450796338|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
125318713|NCT05635461|450796339|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
125318714|NCT05635461|450796340|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
125318715|NCT05635461|450796341|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
125318716|NCT03760029|450796344|FG000|Overall Study|Death|1|||
125318717|NCT03760029|450796345|FG001|Overall Study|Death|0|||
125318718|NCT03760029|450796346|FG002|Overall Study|Death|0|||
125318719|NCT03760029|450796344|FG000|Overall Study|Lost to Follow-up|0|||
125318720|NCT03760029|450796345|FG001|Overall Study|Lost to Follow-up|2|||
125318721|NCT03760029|450796346|FG002|Overall Study|Lost to Follow-up|1|||
125318722|NCT03760029|450796344|FG000|Overall Study|Withdrawal by Subject|1|||
125318723|NCT03760029|450796345|FG001|Overall Study|Withdrawal by Subject|4|||
125318724|NCT03760029|450796346|FG002|Overall Study|Withdrawal by Subject|1|||
125318725|NCT03760029|450796344|FG000|Overall Study|Withdrawal by parent/guardian|4|||
124995118|NCT01723254|449607356|FG004|Overall Study|Protocol Violation|0|||
124995119|NCT01723254|449607357|FG005|Overall Study|Protocol Violation|0|||
125318726|NCT03760029|450796345|FG001|Overall Study|Withdrawal by parent/guardian|4|||
125318727|NCT03760029|450796346|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125318728|NCT03760029|450796344|FG000|Overall Study|Other|2|||
125318729|NCT03760029|450796345|FG001|Overall Study|Other|1|||
125318730|NCT03760029|450796346|FG002|Overall Study|Other|0|||
125318731|NCT04890652|450796350|FG000|Overall Study|Withdrawal by Subject|2|||
125318732|NCT00524485|450796351|FG000|Overall Study|Withdrawal by Subject|5|||
125318733|NCT00667888|450796356|FG000|Overall Study|Death|1|||
125318734|NCT00667888|450796357|FG001|Overall Study|Death|1|||
125318735|NCT00667888|450796356|FG000|Overall Study|Withdrawal by Subject|6|||
125318736|NCT00667888|450796357|FG001|Overall Study|Withdrawal by Subject|3|||
125318737|NCT00667888|450796356|FG000|Overall Study|Proceed with other treatment|3|||
124995120|NCT01723254|449607358|FG006|Overall Study|Protocol Violation|0|||
124995121|NCT01723254|449607359|FG007|Overall Study|Protocol Violation|0|||
124995122|NCT01723254|449607352|FG000|Overall Study|Withdrawal by Subject|1|||
124995123|NCT01723254|449607353|FG001|Overall Study|Withdrawal by Subject|2|||
124995124|NCT01723254|449607354|FG002|Overall Study|Withdrawal by Subject|1|||
125318738|NCT00667888|450796357|FG001|Overall Study|Proceed with other treatment|3|||
125318739|NCT00667888|450796356|FG000|Overall Study|Ineligible after SIM|0|||
125318740|NCT00667888|450796357|FG001|Overall Study|Ineligible after SIM|2|||
125318741|NCT02140047|450796358|FG000|Overall Study|Withdrawal by parent/guardian|1|||
125318742|NCT02140047|450796359|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125318743|NCT02140047|450796360|FG002|Overall Study|Withdrawal by parent/guardian|0|||
125318744|NCT00659061|450796361|FG000|Overall Study|Migration due to political unrest|21|||
125318745|NCT00659061|450796362|FG001|Overall Study|Migration due to political unrest|15|||
125318746|NCT01277744|450796363|FG000|Overall Study|Physician Decision|2|||
125318747|NCT00325897|450796364|FG000|Overall Study|Lost to Follow-up|12|||
125318748|NCT00325897|450796365|FG001|Overall Study|Lost to Follow-up|13|||
125318749|NCT03915717|450796366|FG000|Overall Study|EchoMark Not Implanted|6|||
125318750|NCT03748823|450796368|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
125318751|NCT03748823|450796369|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
125318752|NCT03748823|450796368|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
125318753|NCT03748823|450796369|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
125318754|NCT03748823|450796368|FG000|Extension Period|Withdrawal by Subject|9|||
125318755|NCT03748823|450796369|FG001|Extension Period|Withdrawal by Subject|12|||
125318756|NCT03748823|450796368|FG000|Extension Period|Death|2|||
125318757|NCT03748823|450796369|FG001|Extension Period|Death|2|||
125318758|NCT03748823|450796368|FG000|Extension Period|Other than Specified|0|||
125318759|NCT03748823|450796369|FG001|Extension Period|Other than Specified|1|||
125318760|NCT03748823|450796368|FG000|Extension Period|Protocol Violation|1|||
125318761|NCT03748823|450796369|FG001|Extension Period|Protocol Violation|0|||
125318762|NCT03748823|450796368|FG000|Extension Period|Lost to Follow-up|0|||
125318763|NCT03748823|450796369|FG001|Extension Period|Lost to Follow-up|1|||
125318764|NCT03748823|450796368|FG000|Extension Period|Lack of Efficacy|0|||
125318765|NCT03748823|450796369|FG001|Extension Period|Lack of Efficacy|1|||
125318766|NCT03748823|450796368|FG000|Extension Period|Physician Decision|1|||
125318767|NCT03748823|450796369|FG001|Extension Period|Physician Decision|2|||
125318768|NCT00626275|450796370|FG000|Part A - Treatment Period 1|Adverse Event|1|||
125318769|NCT00626275|450796371|FG001|Part A - Treatment Period 1|Adverse Event|0|||
125318770|NCT00626275|450796372|FG002|Part A - Treatment Period 1|Adverse Event|0|||
125318771|NCT00626275|450796373|FG003|Part A - Treatment Period 1|Adverse Event|0|||
125318772|NCT00626275|450796374|FG004|Part A - Treatment Period 1|Adverse Event|0|||
125318773|NCT00626275|450796375|FG005|Part A - Treatment Period 1|Adverse Event|0|||
125318774|NCT00626275|450796376|FG006|Part A - Treatment Period 1|Adverse Event|0|||
125318775|NCT00626275|450796377|FG007|Part A - Treatment Period 1|Adverse Event|0|||
125318776|NCT00626275|450796370|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
125318777|NCT00626275|450796371|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
125318778|NCT00626275|450796372|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
125318779|NCT00626275|450796373|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
125318780|NCT00626275|450796374|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
125318781|NCT00626275|450796375|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
125318782|NCT00626275|450796376|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
125318783|NCT00626275|450796377|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
125318784|NCT00626275|450796370|FG000|Part B|Lost to Follow-up|0|||
125318785|NCT00626275|450796371|FG001|Part B|Lost to Follow-up|0|||
125318786|NCT00626275|450796372|FG002|Part B|Lost to Follow-up|0|||
125318787|NCT00626275|450796373|FG003|Part B|Lost to Follow-up|0|||
125318788|NCT00626275|450796374|FG004|Part B|Lost to Follow-up|0|||
125318789|NCT00626275|450796375|FG005|Part B|Lost to Follow-up|0|||
125318790|NCT00626275|450796376|FG006|Part B|Lost to Follow-up|1|||
125318791|NCT00626275|450796377|FG007|Part B|Lost to Follow-up|0|||
125318792|NCT00626275|450796370|FG000|Part B|Withdrawal by Subject|0|||
125318793|NCT00626275|450796371|FG001|Part B|Withdrawal by Subject|0|||
125318794|NCT00626275|450796372|FG002|Part B|Withdrawal by Subject|0|||
125318795|NCT00626275|450796373|FG003|Part B|Withdrawal by Subject|0|||
125318796|NCT00626275|450796374|FG004|Part B|Withdrawal by Subject|0|||
125318797|NCT00626275|450796375|FG005|Part B|Withdrawal by Subject|0|||
125318798|NCT00626275|450796376|FG006|Part B|Withdrawal by Subject|0|||
125318799|NCT00626275|450796377|FG007|Part B|Withdrawal by Subject|1|||
125318800|NCT01046565|450796378|FG000|Overall Study|Adverse Event|2|||
125318801|NCT01046565|450796378|FG000|Overall Study|Withdrawal by Subject|7|||
125318802|NCT01650558|450796379|FG000|Overall Study|Migration out of study area|61|||
125318803|NCT01650558|450796380|FG001|Overall Study|Migration out of study area|71|||
125318804|NCT01650558|450796381|FG002|Overall Study|Migration out of study area|56|||
125318805|NCT01650558|450796379|FG000|Overall Study|Lost to Follow-up|10|||
125318806|NCT01650558|450796380|FG001|Overall Study|Lost to Follow-up|13|||
125318807|NCT01650558|450796381|FG002|Overall Study|Lost to Follow-up|6|||
125318808|NCT01650558|450796379|FG000|Overall Study|Death|10|||
125318809|NCT01650558|450796380|FG001|Overall Study|Death|6|||
125318810|NCT01650558|450796381|FG002|Overall Study|Death|8|||
125318811|NCT01650558|450796379|FG000|Overall Study|Withdrawal by Subject|1|||
125318812|NCT01650558|450796380|FG001|Overall Study|Withdrawal by Subject|1|||
125318813|NCT01650558|450796381|FG002|Overall Study|Withdrawal by Subject|3|||
125318814|NCT01650558|450796379|FG000|Overall Study|Non-compliant participant|1|||
124995125|NCT01723254|449607355|FG003|Overall Study|Withdrawal by Subject|0|||
124995126|NCT01723254|449607356|FG004|Overall Study|Withdrawal by Subject|1|||
124995127|NCT01723254|449607357|FG005|Overall Study|Withdrawal by Subject|1|||
124995128|NCT01723254|449607358|FG006|Overall Study|Withdrawal by Subject|1|||
125318815|NCT01650558|450796380|FG001|Overall Study|Non-compliant participant|0|||
125318816|NCT01650558|450796381|FG002|Overall Study|Non-compliant participant|2|||
124995129|NCT01723254|449607359|FG007|Overall Study|Withdrawal by Subject|2|||
124995130|NCT01201265|449607363|FG000|Overall Study|Death|14|||
124995131|NCT01201265|449607363|FG000|Overall Study|Insufficient Therapeutic Response|3|||
124995132|NCT01201265|449607363|FG000|Overall Study|Lost to Follow-up|10|||
124995133|NCT01201265|449607363|FG000|Overall Study|Withdrawal by Subject|7|||
124995134|NCT01201265|449607363|FG000|Overall Study|Disease Progression|4|||
124995135|NCT04640077|449607364|FG000|Period 1|Withdrawal by Subject|4|||
124995136|NCT04640077|449607365|FG001|Period 1|Withdrawal by Subject|5|||
124995137|NCT04640077|449607366|FG002|Period 1|Withdrawal by Subject|0|||
124995138|NCT04640077|449607364|FG000|Period 1|Adverse Event|1|||
124995139|NCT04640077|449607365|FG001|Period 1|Adverse Event|1|||
124995140|NCT04640077|449607366|FG002|Period 1|Adverse Event|0|||
124995141|NCT04640077|449607364|FG000|Period 1|Screen Failure|2|||
124995142|NCT04640077|449607365|FG001|Period 1|Screen Failure|0|||
124995143|NCT04640077|449607366|FG002|Period 1|Screen Failure|0|||
124995144|NCT04640077|449607364|FG000|Period 2|Withdrawal by Subject|0|||
124995145|NCT04640077|449607365|FG001|Period 2|Withdrawal by Subject|0|||
124995146|NCT04640077|449607366|FG002|Period 2|Withdrawal by Subject|18|||
124995147|NCT04640077|449607364|FG000|Period 2|Adverse Event|0|||
124995148|NCT04640077|449607365|FG001|Period 2|Adverse Event|0|||
124995149|NCT04640077|449607366|FG002|Period 2|Adverse Event|6|||
125318817|NCT01650558|450796379|FG000|Overall Study|Physician Decision|0|||
124995150|NCT04640077|449607364|FG000|Period 2|Lost to Follow-up|0|||
124995151|NCT04640077|449607365|FG001|Period 2|Lost to Follow-up|0|||
124995152|NCT04640077|449607366|FG002|Period 2|Lost to Follow-up|2|||
124995153|NCT04640077|449607364|FG000|Period 2|Death|0|||
124995154|NCT04640077|449607365|FG001|Period 2|Death|0|||
125318818|NCT01650558|450796380|FG001|Overall Study|Physician Decision|1|||
125318819|NCT01650558|450796381|FG002|Overall Study|Physician Decision|0|||
125318820|NCT00528957|450796384|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
125318821|NCT00528957|450796385|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
125318822|NCT00528957|450796384|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
125318823|NCT00528957|450796385|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
125318824|NCT00528957|450796384|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
125318825|NCT00528957|450796385|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
125318826|NCT00528957|450796384|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
125318827|NCT00528957|450796385|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
125318828|NCT00528957|450796384|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
125318829|NCT00528957|450796385|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
125318830|NCT00528957|450796384|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
125318831|NCT00528957|450796385|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
125318832|NCT00528957|450796384|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
125318833|NCT00528957|450796385|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
125318834|NCT00528957|450796384|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
125318835|NCT00528957|450796385|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
125318836|NCT00528957|450796384|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
125318837|NCT00528957|450796385|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
125318838|NCT00528957|450796384|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
125318839|NCT00528957|450796385|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
125318840|NCT00528957|450796384|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
125318841|NCT00528957|450796385|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
125318842|NCT00528957|450796384|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
125318843|NCT00528957|450796385|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
125318844|NCT00528957|450796384|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
124995155|NCT04640077|449607366|FG002|Period 2|Death|2|||
124995156|NCT04640077|449607364|FG000|Period 2|Progressive Disease|0|||
124995157|NCT04640077|449607365|FG001|Period 2|Progressive Disease|0|||
124995158|NCT04640077|449607366|FG002|Period 2|Progressive Disease|1|||
124995159|NCT04640077|449607364|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
124995160|NCT04640077|449607365|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
124995161|NCT04640077|449607366|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
124995162|NCT01257425|449607367|FG000|Overall Study|Lack of Efficacy|3|||
124995163|NCT01257425|449607368|FG001|Overall Study|Lack of Efficacy|3|||
124995164|NCT01257425|449607367|FG000|Overall Study|Adverse Event|1|||
124995165|NCT01257425|449607368|FG001|Overall Study|Adverse Event|1|||
124995166|NCT01257425|449607367|FG000|Overall Study|Protocol Violation|1|||
125318845|NCT00528957|450796385|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
125318846|NCT00528957|450796384|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
125318847|NCT00528957|450796385|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
125318848|NCT00528957|450796384|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
125318849|NCT00528957|450796385|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
125318850|NCT00528957|450796384|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
125318851|NCT00528957|450796385|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
125318852|NCT03624881|450796386|FG000|Overall Study|Screen Failure|14|||
125318853|NCT03624881|450796387|FG001|Overall Study|Screen Failure|0|||
125318854|NCT03624881|450796386|FG000|Overall Study|No Catheter Inserted|6|||
125318855|NCT03624881|450796387|FG001|Overall Study|No Catheter Inserted|1|||
125318856|NCT03624881|450796386|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
125318857|NCT03624881|450796387|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
125318858|NCT03624881|450796386|FG000|Overall Study|Death|2|||
125318859|NCT03624881|450796387|FG001|Overall Study|Death|0|||
125318860|NCT03624881|450796386|FG000|Overall Study|Lost to Follow-up|10|||
125318861|NCT03624881|450796387|FG001|Overall Study|Lost to Follow-up|4|||
125318862|NCT03624881|450796386|FG000|Overall Study|Withdrawal by Subject|12|||
125318863|NCT03624881|450796387|FG001|Overall Study|Withdrawal by Subject|1|||
125318864|NCT04258423|450796390|FG000|Overall Study|Study Closure|2|||
125318865|NCT04258423|450796391|FG001|Overall Study|Study Closure|2|||
125318866|NCT03284710|450797801|FG000|Overall Study|Withdrawal by Subject|1|||
125318867|NCT03284710|450797802|FG001|Overall Study|Withdrawal by Subject|0|||
125318868|NCT03284710|450797803|FG002|Overall Study|Withdrawal by Subject|1|||
125318869|NCT03284710|450797804|FG003|Overall Study|Withdrawal by Subject|6|||
125318870|NCT03284710|450797801|FG000|Overall Study|Lost to Follow-up|3|||
125318871|NCT03284710|450797802|FG001|Overall Study|Lost to Follow-up|3|||
125318872|NCT03284710|450797803|FG002|Overall Study|Lost to Follow-up|1|||
125318873|NCT03284710|450797804|FG003|Overall Study|Lost to Follow-up|0|||
125318874|NCT03284710|450797801|FG000|Overall Study|Physician Decision|1|||
125318875|NCT03284710|450797802|FG001|Overall Study|Physician Decision|0|||
125318876|NCT03284710|450797803|FG002|Overall Study|Physician Decision|0|||
125318877|NCT03284710|450797804|FG003|Overall Study|Physician Decision|0|||
125318878|NCT03284710|450797801|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
125318879|NCT03284710|450797802|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
125318880|NCT03284710|450797803|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
125318881|NCT03284710|450797804|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
125318882|NCT03284710|450797801|FG000|Overall Study|HIV Infection|0|||
125318883|NCT03284710|450797802|FG001|Overall Study|HIV Infection|2|||
125318884|NCT03284710|450797803|FG002|Overall Study|HIV Infection|2|||
125318885|NCT03284710|450797804|FG003|Overall Study|HIV Infection|1|||
125318886|NCT02412306|450797807|FG000|Overall Study|Lost to Follow-up|0|||
125318887|NCT02412306|450797808|FG001|Overall Study|Lost to Follow-up|1|||
125318888|NCT02412306|450797809|FG002|Overall Study|Lost to Follow-up|0|||
125318889|NCT02412306|450797810|FG003|Overall Study|Lost to Follow-up|0|||
125318890|NCT02412306|450797811|FG004|Overall Study|Lost to Follow-up|0|||
125318891|NCT02412306|450797807|FG000|Overall Study|Withdrawal by Subject|0|||
125318892|NCT02412306|450797808|FG001|Overall Study|Withdrawal by Subject|0|||
125318893|NCT02412306|450797809|FG002|Overall Study|Withdrawal by Subject|1|||
125318894|NCT02412306|450797810|FG003|Overall Study|Withdrawal by Subject|0|||
125318895|NCT02412306|450797811|FG004|Overall Study|Withdrawal by Subject|0|||
125318896|NCT02412306|450797807|FG000|Overall Study|Death|5|||
125318897|NCT02412306|450797808|FG001|Overall Study|Death|7|||
125318898|NCT02412306|450797809|FG002|Overall Study|Death|15|||
125318899|NCT02412306|450797810|FG003|Overall Study|Death|0|||
125318900|NCT02412306|450797811|FG004|Overall Study|Death|2|||
125318901|NCT01706458|450797815|FG000|Overall Study|Physician Decision|3|||
125318902|NCT01706458|450797816|FG001|Overall Study|Physician Decision|4|||
125318903|NCT04349891|450797822|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
125318904|NCT04349891|450797823|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
125318905|NCT04349891|450797822|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
125318906|NCT04349891|450797823|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
125318907|NCT04349891|450797822|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
125318908|NCT04349891|450797823|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
125318909|NCT04349891|450797822|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
125318910|NCT04349891|450797823|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
125318911|NCT02927301|450797826|FG000|Overall Study|Death|39|||
125318912|NCT02927301|450797826|FG000|Overall Study|Lost to Follow-up|8|||
125318913|NCT02927301|450797826|FG000|Overall Study|Physician Decision|2|||
125318914|NCT02927301|450797826|FG000|Overall Study|Withdrawal by Subject|12|||
125318915|NCT02927301|450797826|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
125318916|NCT04247347|450797831|FG000|Overall Study|Withdrawal by Subject|2|||
125318917|NCT04247347|450797832|FG001|Overall Study|Withdrawal by Subject|3|||
125318918|NCT04247347|450797833|FG002|Overall Study|Withdrawal by Subject|3|||
125318919|NCT04247347|450797831|FG000|Overall Study|Lost to Follow-up|1|||
125318920|NCT04247347|450797832|FG001|Overall Study|Lost to Follow-up|1|||
125318921|NCT04247347|450797833|FG002|Overall Study|Lost to Follow-up|1|||
125318922|NCT03562195|450797834|FG000|Overall Study|Adverse Event|0|||
125318923|NCT03562195|450797835|FG001|Overall Study|Adverse Event|6|||
125318924|NCT03562195|450797834|FG000|Overall Study|Lack of Efficacy|0|||
125318925|NCT03562195|450797835|FG001|Overall Study|Lack of Efficacy|5|||
125318926|NCT03562195|450797834|FG000|Overall Study|Protocol Violation|0|||
125318927|NCT03562195|450797835|FG001|Overall Study|Protocol Violation|1|||
125318928|NCT03562195|450797834|FG000|Overall Study|Lost to Follow-up|0|||
125318929|NCT03562195|450797835|FG001|Overall Study|Lost to Follow-up|1|||
125318930|NCT03562195|450797834|FG000|Overall Study|Physician Decision|1|||
125318931|NCT03562195|450797835|FG001|Overall Study|Physician Decision|0|||
125318932|NCT03562195|450797834|FG000|Overall Study|Withdrawal by Subject|3|||
125318933|NCT03562195|450797835|FG001|Overall Study|Withdrawal by Subject|0|||
125318934|NCT02529852|450797836|FG000|Overall Study|Withdrawal by Subject|2|||
125318935|NCT02269124|450797842|FG000|Overall Study|Lost to Follow-up|1|||
125318936|NCT02269124|450797843|FG001|Overall Study|Lost to Follow-up|0|||
125318937|NCT02269124|450797842|FG000|Overall Study|Withdrawal by Subject|0|||
125318938|NCT02269124|450797843|FG001|Overall Study|Withdrawal by Subject|2|||
125318939|NCT00614575|450797845|FG000|Overall Study|Adverse Event|106|||
125318940|NCT00614575|450797845|FG000|Overall Study|Lost to Follow-up|55|||
125318941|NCT00614575|450797845|FG000|Overall Study|Lack of Efficacy|14|||
125318942|NCT00614575|450797845|FG000|Overall Study|Withdrawal by Subject|6|||
125318943|NCT00614575|450797845|FG000|Overall Study|Death|3|||
125318944|NCT00614575|450797845|FG000|Overall Study|Physician Decision|2|||
125318945|NCT00614575|450797845|FG000|Overall Study|No data were collected.|18|||
125318946|NCT00614575|450797845|FG000|Overall Study|Irregularly enrolled patients|23|||
125318947|NCT00614575|450797845|FG000|Overall Study|No treatment|1|||
125318948|NCT03452540|450797846|FG000|Overall Study|Adverse Event|1|||
125318949|NCT03452540|450797846|FG000|Overall Study|Withdrawal by Subject|1|||
125318950|NCT03452540|450797846|FG000|Overall Study|Other SAE and AE|2|||
125318951|NCT04664153|450797849|FG000|Overall Study|Lack of Efficacy|0|||
125318952|NCT04664153|450797850|FG001|Overall Study|Lack of Efficacy|0|||
125318953|NCT04664153|450797851|FG002|Overall Study|Lack of Efficacy|1|||
125318954|NCT04664153|450797852|FG003|Overall Study|Lack of Efficacy|0|||
125318955|NCT04664153|450797849|FG000|Overall Study|Physician Decision|0|||
125318956|NCT04664153|450797850|FG001|Overall Study|Physician Decision|0|||
125318957|NCT04664153|450797851|FG002|Overall Study|Physician Decision|1|||
125318958|NCT04664153|450797852|FG003|Overall Study|Physician Decision|0|||
125318959|NCT04664153|450797849|FG000|Overall Study|Withdrawal by Subject|3|||
125318960|NCT04664153|450797850|FG001|Overall Study|Withdrawal by Subject|2|||
125318961|NCT04664153|450797851|FG002|Overall Study|Withdrawal by Subject|1|||
125318962|NCT04664153|450797852|FG003|Overall Study|Withdrawal by Subject|2|||
125318963|NCT04664153|450797849|FG000|Overall Study|Other|0|||
125318964|NCT04664153|450797850|FG001|Overall Study|Other|1|||
125318965|NCT04664153|450797851|FG002|Overall Study|Other|0|||
125318966|NCT04664153|450797852|FG003|Overall Study|Other|0|||
125318967|NCT04664153|450797849|FG000|Overall Study|Adverse Event|4|||
125318968|NCT04664153|450797850|FG001|Overall Study|Adverse Event|0|||
125318969|NCT04664153|450797851|FG002|Overall Study|Adverse Event|1|||
125318970|NCT04664153|450797852|FG003|Overall Study|Adverse Event|0|||
125318971|NCT01045460|450797853|FG000|Overall Study|Physician Decision|3|||
125318972|NCT01045460|450797854|FG001|Overall Study|Physician Decision|2|||
125318973|NCT01045460|450797853|FG000|Overall Study|Lost to Follow-up|0|||
125318974|NCT01045460|450797854|FG001|Overall Study|Lost to Follow-up|1|||
125318975|NCT01045460|450797853|FG000|Overall Study|Lack of Efficacy|3|||
125318976|NCT01045460|450797854|FG001|Overall Study|Lack of Efficacy|0|||
125318977|NCT00097500|450797855|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
125318978|NCT00097500|450797856|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
125318979|NCT00097500|450797855|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
125318980|NCT00097500|450797856|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
125318981|NCT00097500|450797855|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
125318982|NCT00097500|450797856|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
125318983|NCT00097500|450797855|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
125318984|NCT00097500|450797856|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
125318985|NCT00097500|450797855|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
125318986|NCT00097500|450797856|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
125318987|NCT00097500|450797855|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
125318988|NCT00097500|450797856|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
124872813|NCT00500903|449155771|FG002|Overall Study|Patient Declined Further Treatment|3|||
124872814|NCT00500903|449155769|FG000|Overall Study|Symptomatic Deterioration|2|||
125318989|NCT00097500|450797855|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
125318990|NCT00097500|450797856|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
125318991|NCT01600885|450797860|FG000|First Period|Adverse Event|1|||
125318992|NCT01600885|450797861|FG001|First Period|Adverse Event|1|||
125318993|NCT01600885|450797860|FG000|First Period|moved out of area|1|||
125318994|NCT01600885|450797861|FG001|First Period|moved out of area|0|||
125318995|NCT00436332|450797862|FG000|Overall Study|Adverse Event|9|||
125318996|NCT00436332|450797862|FG000|Overall Study|Withdrawal by Subject|2|||
125318997|NCT00436332|450797862|FG000|Overall Study|Progression|59|||
125318998|NCT00436332|450797862|FG000|Overall Study|Death|2|||
125318999|NCT00436332|450797862|FG000|Overall Study|Not Protocol Specified|6|||
125319000|NCT00436332|450797862|FG000|Overall Study|Ineligible|2|||
125319001|NCT00436332|450797862|FG000|Overall Study|Never Received Treatment|3|||
125319002|NCT00472108|450797863|FG000|Overall Study|Lost to Follow-up|0|||
125319003|NCT00472108|450797864|FG001|Overall Study|Lost to Follow-up|1|||
125319004|NCT00642356|450797871|FG000|Overall Study|Adverse Event|1|||
125319005|NCT00642356|450797872|FG001|Overall Study|Adverse Event|0|||
125319006|NCT00642356|450797871|FG000|Overall Study|Protocol Violation|0|||
125319007|NCT00642356|450797872|FG001|Overall Study|Protocol Violation|3|||
125319008|NCT00642356|450797871|FG000|Overall Study|Lack of Efficacy|1|||
125319009|NCT00642356|450797872|FG001|Overall Study|Lack of Efficacy|0|||
125319010|NCT01009060|450797873|FG000|Overall Study|Adverse Event|1|||
125319011|NCT01009060|450797874|FG001|Overall Study|Adverse Event|2|||
125319012|NCT01009060|450797873|FG000|Overall Study|Protocol Violation|0|||
125319013|NCT01009060|450797874|FG001|Overall Study|Protocol Violation|1|||
125319014|NCT01009060|450797873|FG000|Overall Study|Lost to Follow-up|1|||
125319015|NCT01009060|450797874|FG001|Overall Study|Lost to Follow-up|0|||
125319016|NCT01009060|450797873|FG000|Overall Study|Physician Decision|1|||
125319017|NCT01009060|450797874|FG001|Overall Study|Physician Decision|1|||
125319018|NCT01009060|450797873|FG000|Overall Study|Withdrawal by Subject|1|||
125319019|NCT01009060|450797874|FG001|Overall Study|Withdrawal by Subject|1|||
125319020|NCT00005906|450797875|FG000|Overall Study|Lack of Efficacy|3|||
125319021|NCT00286442|450797880|FG000|Overall Study|Hyperglycemic Rescue|19|||
125319022|NCT00286442|450797881|FG001|Overall Study|Hyperglycemic Rescue|17|||
125319023|NCT00286442|450797882|FG002|Overall Study|Hyperglycemic Rescue|25|||
125319024|NCT00286442|450797880|FG000|Overall Study|Adverse Event|7|||
125319025|NCT00286442|450797881|FG001|Overall Study|Adverse Event|6|||
125319026|NCT00286442|450797882|FG002|Overall Study|Adverse Event|1|||
125319027|NCT00286442|450797880|FG000|Overall Study|Protocol Violation|2|||
125319028|NCT00286442|450797881|FG001|Overall Study|Protocol Violation|4|||
125319029|NCT00286442|450797882|FG002|Overall Study|Protocol Violation|2|||
125319030|NCT00286442|450797880|FG000|Overall Study|Lost to Follow-up|5|||
125319031|NCT00286442|450797881|FG001|Overall Study|Lost to Follow-up|2|||
125319032|NCT00286442|450797882|FG002|Overall Study|Lost to Follow-up|1|||
125319033|NCT00286442|450797880|FG000|Overall Study|Physician Decision|1|||
125319034|NCT00286442|450797881|FG001|Overall Study|Physician Decision|1|||
125319035|NCT00286442|450797882|FG002|Overall Study|Physician Decision|1|||
125319036|NCT00286442|450797880|FG000|Overall Study|Administrative Error|1|||
125319037|NCT00286442|450797881|FG001|Overall Study|Administrative Error|1|||
125319038|NCT00286442|450797882|FG002|Overall Study|Administrative Error|0|||
125319039|NCT00286442|450797880|FG000|Overall Study|Withdrawal by Subject|2|||
125319040|NCT00286442|450797881|FG001|Overall Study|Withdrawal by Subject|14|||
125319041|NCT00286442|450797882|FG002|Overall Study|Withdrawal by Subject|2|||
125319042|NCT02542865|450797885|FG000|Overall Study|Identified as screen failure|1|||
125319043|NCT02542865|450797886|FG001|Overall Study|Identified as screen failure|0|||
125319044|NCT02542865|450797885|FG000|Overall Study|Withdrawal by Subject|16|||
125319045|NCT02542865|450797886|FG001|Overall Study|Withdrawal by Subject|0|||
125319046|NCT01339689|450797889|FG000|Overall Study|Adverse Event|1|||
125319047|NCT01339689|450797890|FG001|Overall Study|Adverse Event|2|||
125319048|NCT01339689|450797889|FG000|Overall Study|Lost to Follow-up|9|||
125319049|NCT01339689|450797890|FG001|Overall Study|Lost to Follow-up|3|||
125319050|NCT01339689|450797889|FG000|Overall Study|Withdrawal by Subject|3|||
125319051|NCT01339689|450797890|FG001|Overall Study|Withdrawal by Subject|0|||
125319052|NCT01339689|450797889|FG000|Overall Study|Noncompliance|1|||
125319053|NCT01339689|450797890|FG001|Overall Study|Noncompliance|0|||
125319054|NCT01339689|450797889|FG000|Overall Study|Relocated out of area|0|||
125319055|NCT01339689|450797890|FG001|Overall Study|Relocated out of area|1|||
125319056|NCT01339689|450797889|FG000|Overall Study|Other|2|||
125319057|NCT01339689|450797890|FG001|Overall Study|Other|2|||
125319058|NCT01339689|450797889|FG000|Overall Study|multiple reasons|1|||
125319059|NCT01339689|450797890|FG001|Overall Study|multiple reasons|1|||
125319060|NCT04571944|450797891|FG000|Overall Study|Death|1|||
125319061|NCT04571944|450797892|FG001|Overall Study|Death|0|||
125319062|NCT04571944|450797891|FG000|Overall Study|Withdrawal by Subject|3|||
125319063|NCT04571944|450797892|FG001|Overall Study|Withdrawal by Subject|0|||
125319064|NCT04571944|450797891|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
125319065|NCT04571944|450797892|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
125319066|NCT04913610|450797895|FG000|Randomized Participants|Did Not Receive Treatment|0|||
125319067|NCT04913610|450797896|FG001|Randomized Participants|Did Not Receive Treatment|0|||
125319068|NCT04913610|450797897|FG002|Randomized Participants|Did Not Receive Treatment|1|||
125319069|NCT04913610|450797898|FG003|Randomized Participants|Did Not Receive Treatment|1|||
125319070|NCT04913610|450797899|FG004|Randomized Participants|Did Not Receive Treatment|0|||
125319071|NCT04913610|450797895|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
125319072|NCT04913610|450797896|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
125319073|NCT04913610|450797897|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
125319074|NCT04913610|450797898|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
125319075|NCT04913610|450797899|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
125319076|NCT02358473|450797904|FG000|Overall Study|Disease Progession|6|||
125319077|NCT02358473|450797904|FG000|Overall Study|Adverse Event|3|||
125319078|NCT02358473|450797904|FG000|Overall Study|Withdrawal by Subject|2|||
125319079|NCT02358473|450797904|FG000|Overall Study|Physician Decision|2|||
125319080|NCT02051764|450797905|FG000|Overall Study|Study terminated by sponsor|0|||
125319081|NCT02051764|450797906|FG001|Overall Study|Study terminated by sponsor|7|||
125319082|NCT03557970|450797907|FG000|Overall Study|Study closure|1|||
125319083|NCT03557970|450797908|FG001|Overall Study|Study closure|0|||
125319084|NCT03557970|450797907|FG000|Overall Study|Physician Decision|0|||
125319085|NCT03557970|450797908|FG001|Overall Study|Physician Decision|1|||
125319086|NCT03557970|450797907|FG000|Overall Study|Death|0|||
125319087|NCT03557970|450797908|FG001|Overall Study|Death|1|||
125319088|NCT03155724|450797909|FG000|Overall Study|Death|3|||
125319089|NCT03155724|450797909|FG000|Overall Study|Physician Decision|1|||
125319090|NCT03155724|450797909|FG000|Overall Study|Study closure|7|||
125319091|NCT00321789|450797913|FG000|Overall Study|Lost to Follow-up|4|||
125319092|NCT00321789|450797914|FG001|Overall Study|Lost to Follow-up|7|||
125319093|NCT00321789|450797913|FG000|Overall Study|Withdrawal by Subject|6|||
125319094|NCT00321789|450797914|FG001|Overall Study|Withdrawal by Subject|6|||
125319095|NCT00321789|450797913|FG000|Overall Study|Protocol Violation|5|||
125319096|NCT00321789|450797914|FG001|Overall Study|Protocol Violation|3|||
125319097|NCT03309020|450797916|FG000|Overall Study|Death|1|||
125319098|NCT03309020|450797917|FG001|Overall Study|Death|0|||
125319099|NCT03309020|450797916|FG000|Overall Study|Did not undergo surgery|2|||
125319100|NCT03309020|450797917|FG001|Overall Study|Did not undergo surgery|1|||
125319101|NCT02919761|450797920|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
125319102|NCT02919761|450797921|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
125319103|NCT02919761|450797922|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
125319104|NCT02919761|450797920|FG000|Part 1: Open Label|Adverse Event|1|||
125319105|NCT02919761|450797921|FG001|Part 1: Open Label|Adverse Event|0|||
125319106|NCT02919761|450797922|FG002|Part 1: Open Label|Adverse Event|0|||
125319107|NCT02919761|450797920|FG000|Part 1: Open Label|Lost to Follow-up|1|||
125319108|NCT02919761|450797921|FG001|Part 1: Open Label|Lost to Follow-up|0|||
125319109|NCT02919761|450797922|FG002|Part 1: Open Label|Lost to Follow-up|0|||
125319110|NCT02919761|450797920|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
125319111|NCT02919761|450797921|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
125319112|NCT02919761|450797922|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
125319113|NCT02919761|450797920|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
125319114|NCT02919761|450797921|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
125319115|NCT02919761|450797922|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
125319116|NCT02919761|450797920|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
125319117|NCT02919761|450797921|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
125319118|NCT02919761|450797922|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
125319119|NCT02919761|450797920|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
125319120|NCT02919761|450797921|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
125319121|NCT02919761|450797922|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
125319122|NCT02919761|450797920|FG000|Part 1: Open Label|Termination by Sponsor|1|||
125319123|NCT02919761|450797921|FG001|Part 1: Open Label|Termination by Sponsor|0|||
125319124|NCT02919761|450797922|FG002|Part 1: Open Label|Termination by Sponsor|0|||
125319125|NCT02919761|450797920|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
125319126|NCT02919761|450797921|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
125319127|NCT02919761|450797922|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
125319128|NCT02919761|450797920|FG000|Part 2: Double-blind|Adverse Event|0|||
125319129|NCT02919761|450797921|FG001|Part 2: Double-blind|Adverse Event|1|||
125319130|NCT02919761|450797922|FG002|Part 2: Double-blind|Adverse Event|0|||
125319131|NCT02919761|450797920|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
125319132|NCT02919761|450797921|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
125319133|NCT02919761|450797922|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
125319134|NCT02919761|450797920|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
125319135|NCT02919761|450797921|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
125319136|NCT02919761|450797922|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
125319137|NCT02919761|450797920|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
125319138|NCT02919761|450797921|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
125319139|NCT02919761|450797922|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
125319140|NCT02919761|450797920|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
125319141|NCT02919761|450797921|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
125319142|NCT02919761|450797922|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
125319143|NCT02919761|450797920|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
125319144|NCT02919761|450797921|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
124995167|NCT01257425|449607368|FG001|Overall Study|Protocol Violation|1|||
124995168|NCT01257425|449607367|FG000|Overall Study|Withdrawal by Subject|0|||
124995169|NCT01257425|449607368|FG001|Overall Study|Withdrawal by Subject|1|||
124995170|NCT01257425|449607367|FG000|Overall Study|Death|1|||
124995171|NCT01257425|449607368|FG001|Overall Study|Death|0|||
124995172|NCT02668185|449607369|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
124995173|NCT02668185|449607370|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
124995174|NCT02668185|449607369|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
124995175|NCT02668185|449607370|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
124995176|NCT02668185|449607369|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
124995177|NCT02668185|449607370|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
124995178|NCT02668185|449607369|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
124995179|NCT02668185|449607370|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
124995180|NCT00723021|449607375|FG000|Intervention Period 4|Adverse Event|0|||
124995181|NCT00723021|449607376|FG001|Intervention Period 4|Adverse Event|0|||
124995182|NCT00723021|449607377|FG002|Intervention Period 4|Adverse Event|0|||
124995183|NCT00723021|449607378|FG003|Intervention Period 4|Adverse Event|0|||
124995184|NCT00723021|449607379|FG004|Intervention Period 4|Adverse Event|1|||
124995185|NCT00770341|449607380|FG000|Overall Study|Did not meet eligibility criteria|1|||
124995186|NCT00770341|449607381|FG001|Overall Study|Did not meet eligibility criteria|0|||
124995187|NCT00770341|449607382|FG002|Overall Study|Did not meet eligibility criteria|0|||
124995188|NCT00770341|449607380|FG000|Overall Study|Withdrawal by Subject|0|||
125319145|NCT02919761|450797922|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
125319146|NCT02919761|450797920|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
125319147|NCT02919761|450797921|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
125319148|NCT02919761|450797922|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
125319149|NCT03409796|450800098|FG000|Overall Study|Adverse Event|2|||
125319150|NCT03409796|450800099|FG001|Overall Study|Adverse Event|0|||
125319151|NCT03409796|450800098|FG000|Overall Study|Other|0|||
125319152|NCT03409796|450800099|FG001|Overall Study|Other|1|||
125319153|NCT00740220|450800100|FG000|Overall Study|screen failures (non-COPD patients)|9|||
125319154|NCT01602224|450800101|FG000|Overall Study|Adverse Event|0|||
125319155|NCT01602224|450800102|FG001|Overall Study|Adverse Event|1|||
125319156|NCT01602224|450800103|FG002|Overall Study|Adverse Event|0|||
125319157|NCT01602224|450800101|FG000|Overall Study|Investigator Decison|1|||
125319158|NCT01602224|450800102|FG001|Overall Study|Investigator Decison|0|||
125319159|NCT01602224|450800103|FG002|Overall Study|Investigator Decison|0|||
125319160|NCT01602224|450800101|FG000|Overall Study|Lost to Follow-up|0|||
125319161|NCT01602224|450800102|FG001|Overall Study|Lost to Follow-up|0|||
125319162|NCT01602224|450800103|FG002|Overall Study|Lost to Follow-up|1|||
125319163|NCT01602224|450800101|FG000|Overall Study|Protocol Violation|0|||
125319164|NCT01602224|450800102|FG001|Overall Study|Protocol Violation|1|||
125319165|NCT01602224|450800103|FG002|Overall Study|Protocol Violation|0|||
125319166|NCT01602224|450800101|FG000|Overall Study|Sponsor Decision|2|||
125319167|NCT01602224|450800102|FG001|Overall Study|Sponsor Decision|3|||
125319168|NCT01602224|450800103|FG002|Overall Study|Sponsor Decision|2|||
125319169|NCT01602224|450800101|FG000|Overall Study|Withdrawal by Subject|5|||
125319170|NCT01602224|450800102|FG001|Overall Study|Withdrawal by Subject|3|||
125319171|NCT01602224|450800103|FG002|Overall Study|Withdrawal by Subject|3|||
125319172|NCT01352117|450800104|FG000|Overall Study|Death|15|||
125319173|NCT01352117|450800105|FG001|Overall Study|Death|16|||
125319174|NCT01352117|450800104|FG000|Overall Study|Withdrawal by Subject|1|||
125319175|NCT01352117|450800105|FG001|Overall Study|Withdrawal by Subject|0|||
125319176|NCT01352117|450800104|FG000|Overall Study|Lost to Follow-up|2|||
125319177|NCT01352117|450800105|FG001|Overall Study|Lost to Follow-up|7|||
125319178|NCT01352117|450800104|FG000|Overall Study|Non-adherent to study requirements|1|||
125319179|NCT01352117|450800105|FG001|Overall Study|Non-adherent to study requirements|1|||
125319180|NCT01352117|450800104|FG000|Overall Study|Did not initiate study treatment|1|||
125319181|NCT01352117|450800105|FG001|Overall Study|Did not initiate study treatment|0|||
125319182|NCT01352117|450800104|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
125319183|NCT01352117|450800105|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
125319184|NCT00633477|450800106|FG000|Overall Study|Death|1|||
125319185|NCT00633477|450800107|FG001|Overall Study|Death|0|||
125319186|NCT00633477|450800106|FG000|Overall Study|Randomized but not treated|1|||
125319187|NCT00633477|450800107|FG001|Overall Study|Randomized but not treated|0|||
124995189|NCT00770341|449607381|FG001|Overall Study|Withdrawal by Subject|1|||
124995190|NCT00770341|449607382|FG002|Overall Study|Withdrawal by Subject|0|||
124995191|NCT00770341|449607380|FG000|Overall Study|Clinical Adverse Event|3|||
124995192|NCT00770341|449607381|FG001|Overall Study|Clinical Adverse Event|1|||
125319188|NCT00770653|450800111|FG000|Overall Study|Adverse Event|13|||
125319189|NCT00770653|450800112|FG001|Overall Study|Adverse Event|5|||
125319190|NCT00770653|450800111|FG000|Overall Study|Protocol Violation|8|||
125319191|NCT00770653|450800112|FG001|Overall Study|Protocol Violation|6|||
125319192|NCT00770653|450800111|FG000|Overall Study|Withdrawal by Subject|4|||
125319193|NCT00770653|450800112|FG001|Overall Study|Withdrawal by Subject|7|||
125319194|NCT00770653|450800111|FG000|Overall Study|Lack of Compliance|1|||
125319195|NCT00770653|450800112|FG001|Overall Study|Lack of Compliance|4|||
125319196|NCT00770653|450800111|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
125319197|NCT00770653|450800112|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
125319198|NCT00770653|450800111|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
125319199|NCT00770653|450800112|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
125319200|NCT00770653|450800111|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
125319201|NCT00770653|450800112|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
125319202|NCT00770653|450800111|FG000|Overall Study|Lost to Follow-up|1|||
125319203|NCT00770653|450800112|FG001|Overall Study|Lost to Follow-up|2|||
125319204|NCT00770653|450800111|FG000|Overall Study|Physician Decision|1|||
125319205|NCT00770653|450800112|FG001|Overall Study|Physician Decision|0|||
125319206|NCT04906499|450800117|FG000|Overall Study|Lack of time|1|||
125319207|NCT03525444|450800123|FG000|Overall Study|Adverse Event|0|||
125319208|NCT03525444|450800124|FG001|Overall Study|Adverse Event|1|||
125319209|NCT03525444|450800123|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
125319210|NCT03525444|450800124|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
125319211|NCT03525444|450800123|FG000|Overall Study|Other|0|||
125319212|NCT03525444|450800124|FG001|Overall Study|Other|1|||
125319213|NCT00262860|450800125|FG000|Overall Study|Adverse Event|2|||
125319214|NCT02741128|450800126|FG000|Overall Study|Protocol Violation|4|||
125319215|NCT02741128|450800127|FG001|Overall Study|Protocol Violation|1|||
125319216|NCT02741128|450800126|FG000|Overall Study|Withdrawal by Subject|2|||
125319217|NCT02741128|450800127|FG001|Overall Study|Withdrawal by Subject|0|||
125319218|NCT02741128|450800126|FG000|Overall Study|Lost to Follow-up|1|||
125319219|NCT02741128|450800127|FG001|Overall Study|Lost to Follow-up|0|||
125319220|NCT01419769|450800128|FG000|Overall Study|Did not receive the AXIOS stent|3|||
125319221|NCT01419769|450800128|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
125319222|NCT00878501|450800129|FG000|Overall Study|Adverse Event|11|||
125319223|NCT00878501|450800130|FG001|Overall Study|Adverse Event|3|||
125319224|NCT00878501|450800131|FG002|Overall Study|Adverse Event|3|||
125319225|NCT00878501|450800129|FG000|Overall Study|Lack of Efficacy|2|||
125319226|NCT00878501|450800130|FG001|Overall Study|Lack of Efficacy|1|||
125319227|NCT00878501|450800131|FG002|Overall Study|Lack of Efficacy|0|||
125319228|NCT00878501|450800129|FG000|Overall Study|Withdrawal by Subject|2|||
125319229|NCT00878501|450800130|FG001|Overall Study|Withdrawal by Subject|1|||
125319230|NCT00878501|450800131|FG002|Overall Study|Withdrawal by Subject|2|||
125319231|NCT00878501|450800129|FG000|Overall Study|Protocol Violation|0|||
125319232|NCT00878501|450800130|FG001|Overall Study|Protocol Violation|0|||
125319233|NCT00878501|450800131|FG002|Overall Study|Protocol Violation|1|||
125319234|NCT00878501|450800129|FG000|Overall Study|Incorrect enrolment|1|||
125319235|NCT00878501|450800130|FG001|Overall Study|Incorrect enrolment|2|||
125319236|NCT00878501|450800131|FG002|Overall Study|Incorrect enrolment|0|||
125319237|NCT00878501|450800129|FG000|Overall Study|Intake of prohibited concom. medication|0|||
125319238|NCT00878501|450800130|FG001|Overall Study|Intake of prohibited concom. medication|0|||
125319239|NCT00878501|450800131|FG002|Overall Study|Intake of prohibited concom. medication|1|||
125319240|NCT00878501|450800129|FG000|Overall Study|Mis-randomisation of patient|1|||
125319241|NCT00878501|450800130|FG001|Overall Study|Mis-randomisation of patient|0|||
125319242|NCT00878501|450800131|FG002|Overall Study|Mis-randomisation of patient|0|||
125319243|NCT00878501|450800129|FG000|Overall Study|Administrative|0|||
125319244|NCT00878501|450800130|FG001|Overall Study|Administrative|0|||
125319245|NCT00878501|450800131|FG002|Overall Study|Administrative|1|||
125319246|NCT00812708|450800132|FG000|Overall Study|Device could not be implanted|2|||
125319247|NCT00812708|450800132|FG000|Overall Study|Lack of medical insurance|1|||
125319248|NCT00812708|450800132|FG000|Overall Study|Switched to another study|1|||
125319249|NCT00812708|450800132|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
125319250|NCT00812708|450800132|FG000|Overall Study|Signed consent but later withdrew|3|||
125319251|NCT01959503|450800133|FG000|Overall Study|Death|2|||
125319252|NCT01959503|450800134|FG001|Overall Study|Death|1|||
125319253|NCT01959503|450800133|FG000|Overall Study|Randomized but not treated|1|||
125319254|NCT01959503|450800134|FG001|Overall Study|Randomized but not treated|1|||
125319255|NCT01600326|450800135|FG000|Overall Study|Lost to Follow-up|1|||
125319256|NCT01600326|450800136|FG001|Overall Study|Lost to Follow-up|1|||
124995193|NCT00770341|449607382|FG002|Overall Study|Clinical Adverse Event|2|||
124995194|NCT00770341|449607380|FG000|Overall Study|Laboratory adverse event|3|||
124995195|NCT00770341|449607381|FG001|Overall Study|Laboratory adverse event|3|||
125319257|NCT01131507|450800138|FG000|Overall Study|Adverse Event|1|||
125319258|NCT01131507|450800138|FG000|Overall Study|Lost to Follow-up|1|||
125319259|NCT01131507|450800138|FG000|Overall Study|Withdrawal by Subject|1|||
125319260|NCT01393158|450800139|FG000|Overall Study|Adverse Event|1|||
125319261|NCT01393158|450800140|FG001|Overall Study|Adverse Event|0|||
125319262|NCT03224130|450800141|FG000|Overall Study|consent issue|0|||
125319263|NCT03224130|450800142|FG001|Overall Study|consent issue|1|||
125319264|NCT03095651|450800145|FG000|Overall Study|Lost to Follow-up|1|||
125319265|NCT03095651|450800146|FG001|Overall Study|Lost to Follow-up|1|||
125319266|NCT03095651|450800147|FG002|Overall Study|Lost to Follow-up|0|||
125319267|NCT03095651|450800148|FG003|Overall Study|Lost to Follow-up|1|||
125319268|NCT03095651|450800149|FG004|Overall Study|Lost to Follow-up|0|||
125319269|NCT03095651|450800150|FG005|Overall Study|Lost to Follow-up|0|||
125319270|NCT03095651|450800151|FG006|Overall Study|Lost to Follow-up|0|||
125319271|NCT03095651|450800152|FG007|Overall Study|Lost to Follow-up|0|||
125319272|NCT03095651|450800145|FG000|Overall Study|Withdrawal by Subject|0|||
125319273|NCT03095651|450800146|FG001|Overall Study|Withdrawal by Subject|0|||
125319274|NCT03095651|450800147|FG002|Overall Study|Withdrawal by Subject|0|||
125319275|NCT03095651|450800148|FG003|Overall Study|Withdrawal by Subject|0|||
125319276|NCT03095651|450800149|FG004|Overall Study|Withdrawal by Subject|0|||
125319277|NCT03095651|450800150|FG005|Overall Study|Withdrawal by Subject|1|||
125319278|NCT03095651|450800151|FG006|Overall Study|Withdrawal by Subject|0|||
125319279|NCT03095651|450800152|FG007|Overall Study|Withdrawal by Subject|0|||
125319280|NCT02587520|450800158|FG000|Overall Study|Protocol Violation|2|||
125319281|NCT02587520|450800159|FG001|Overall Study|Protocol Violation|0|||
125319282|NCT02587520|450800160|FG002|Overall Study|Protocol Violation|0|||
125319283|NCT02587520|450800161|FG003|Overall Study|Protocol Violation|2|||
125319284|NCT02587520|450800162|FG004|Overall Study|Protocol Violation|0|||
125319285|NCT02587520|450800163|FG005|Overall Study|Protocol Violation|1|||
125319286|NCT02587520|450800164|FG006|Overall Study|Protocol Violation|1|||
125319287|NCT02587520|450800165|FG007|Overall Study|Protocol Violation|1|||
125319288|NCT02587520|450800166|FG008|Overall Study|Protocol Violation|3|||
125319289|NCT02587520|450800167|FG009|Overall Study|Protocol Violation|3|||
125319290|NCT02587520|450800168|FG010|Overall Study|Protocol Violation|1|||
125319291|NCT02587520|450800169|FG011|Overall Study|Protocol Violation|2|||
125319292|NCT02587520|450800170|FG012|Overall Study|Protocol Violation|0|||
125319293|NCT02587520|450800171|FG013|Overall Study|Protocol Violation|0|||
125319294|NCT02587520|450800172|FG014|Overall Study|Protocol Violation|0|||
125319295|NCT02587520|450800173|FG015|Overall Study|Protocol Violation|0|||
125319296|NCT02587520|450800174|FG016|Overall Study|Protocol Violation|0|||
125319297|NCT02587520|450800175|FG017|Overall Study|Protocol Violation|0|||
125319298|NCT02587520|450800158|FG000|Overall Study|Adverse Event|0|||
125319299|NCT02587520|450800159|FG001|Overall Study|Adverse Event|0|||
125319300|NCT02587520|450800160|FG002|Overall Study|Adverse Event|0|||
125319301|NCT02587520|450800161|FG003|Overall Study|Adverse Event|0|||
125319302|NCT02587520|450800162|FG004|Overall Study|Adverse Event|0|||
125319303|NCT02587520|450800163|FG005|Overall Study|Adverse Event|0|||
125319304|NCT02587520|450800164|FG006|Overall Study|Adverse Event|0|||
125319305|NCT02587520|450800165|FG007|Overall Study|Adverse Event|0|||
125319306|NCT02587520|450800166|FG008|Overall Study|Adverse Event|0|||
125319307|NCT02587520|450800167|FG009|Overall Study|Adverse Event|0|||
125319308|NCT02587520|450800168|FG010|Overall Study|Adverse Event|0|||
125319309|NCT02587520|450800169|FG011|Overall Study|Adverse Event|1|||
125319310|NCT02587520|450800170|FG012|Overall Study|Adverse Event|0|||
125319311|NCT02587520|450800171|FG013|Overall Study|Adverse Event|0|||
125319312|NCT02587520|450800172|FG014|Overall Study|Adverse Event|0|||
125319313|NCT02587520|450800173|FG015|Overall Study|Adverse Event|0|||
125319314|NCT02587520|450800174|FG016|Overall Study|Adverse Event|0|||
125319315|NCT02587520|450800175|FG017|Overall Study|Adverse Event|0|||
125319316|NCT02587520|450800158|FG000|Overall Study|Withdrawal by Subject|0|||
125319317|NCT02587520|450800159|FG001|Overall Study|Withdrawal by Subject|0|||
125319318|NCT02587520|450800160|FG002|Overall Study|Withdrawal by Subject|1|||
125319319|NCT02587520|450800161|FG003|Overall Study|Withdrawal by Subject|1|||
125319320|NCT02587520|450800162|FG004|Overall Study|Withdrawal by Subject|0|||
125319321|NCT02587520|450800163|FG005|Overall Study|Withdrawal by Subject|1|||
125319322|NCT02587520|450800164|FG006|Overall Study|Withdrawal by Subject|1|||
125319323|NCT02587520|450800165|FG007|Overall Study|Withdrawal by Subject|0|||
125319324|NCT02587520|450800166|FG008|Overall Study|Withdrawal by Subject|0|||
125319325|NCT02587520|450800167|FG009|Overall Study|Withdrawal by Subject|0|||
125319326|NCT02587520|450800168|FG010|Overall Study|Withdrawal by Subject|0|||
125319327|NCT02587520|450800169|FG011|Overall Study|Withdrawal by Subject|0|||
124995196|NCT00770341|449607382|FG002|Overall Study|Laboratory adverse event|0|||
124995197|NCT00770341|449607380|FG000|Overall Study|Lack of Efficacy|3|||
124995198|NCT00770341|449607381|FG001|Overall Study|Lack of Efficacy|0|||
124995199|NCT00770341|449607382|FG002|Overall Study|Lack of Efficacy|1|||
124995200|NCT00770341|449607380|FG000|Overall Study|Other|1|||
124995201|NCT00770341|449607381|FG001|Overall Study|Other|0|||
124995202|NCT00770341|449607382|FG002|Overall Study|Other|0|||
124995203|NCT00770341|449607380|FG000|Overall Study|Not treated|1|||
124995204|NCT00770341|449607381|FG001|Overall Study|Not treated|0|||
125319328|NCT02587520|450800170|FG012|Overall Study|Withdrawal by Subject|0|||
125319329|NCT02587520|450800171|FG013|Overall Study|Withdrawal by Subject|1|||
125319330|NCT02587520|450800172|FG014|Overall Study|Withdrawal by Subject|0|||
125319331|NCT02587520|450800173|FG015|Overall Study|Withdrawal by Subject|0|||
125319332|NCT02587520|450800174|FG016|Overall Study|Withdrawal by Subject|0|||
125319333|NCT02587520|450800175|FG017|Overall Study|Withdrawal by Subject|0|||
125319334|NCT02587520|450800158|FG000|Overall Study|Lost to Follow-up|0|||
125319335|NCT02587520|450800159|FG001|Overall Study|Lost to Follow-up|2|||
125319336|NCT02587520|450800160|FG002|Overall Study|Lost to Follow-up|0|||
125319337|NCT02587520|450800161|FG003|Overall Study|Lost to Follow-up|2|||
124995205|NCT00770341|449607382|FG002|Overall Study|Not treated|0|||
124995206|NCT01163916|449607383|FG000|Overall Study|Withdrawal by Subject|2|||
124995207|NCT01163916|449607384|FG001|Overall Study|Withdrawal by Subject|0|||
124995208|NCT01163916|449607385|FG002|Overall Study|Withdrawal by Subject|2|||
124995209|NCT01163916|449607383|FG000|Overall Study|Adverse Event|2|||
124995210|NCT01163916|449607384|FG001|Overall Study|Adverse Event|0|||
124995211|NCT01163916|449607385|FG002|Overall Study|Adverse Event|1|||
124995212|NCT01163916|449607383|FG000|Overall Study|Lack of Efficacy|2|||
124995213|NCT01163916|449607384|FG001|Overall Study|Lack of Efficacy|0|||
124995214|NCT01163916|449607385|FG002|Overall Study|Lack of Efficacy|1|||
124995215|NCT01163916|449607383|FG000|Overall Study|Other|24|||
124995216|NCT01163916|449607384|FG001|Overall Study|Other|4|||
125210539|NCT02636699|450395599|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
125210540|NCT02636699|450395600|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
125210541|NCT02636699|450395601|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
125210542|NCT02636699|450395599|FG000|Screening Period|Withdrawal by Subject|0|||
125210543|NCT02636699|450395600|FG001|Screening Period|Withdrawal by Subject|0|||
125210544|NCT02636699|450395601|FG002|Screening Period|Withdrawal by Subject|23|||
125210545|NCT02636699|450395599|FG000|Screening Period|Adverse Event|0|||
125210546|NCT02636699|450395600|FG001|Screening Period|Adverse Event|0|||
125210547|NCT02636699|450395601|FG002|Screening Period|Adverse Event|1|||
125210548|NCT02636699|450395599|FG000|Screening Period|Other not specified|0|||
125210549|NCT02636699|450395600|FG001|Screening Period|Other not specified|0|||
125210550|NCT02636699|450395601|FG002|Screening Period|Other not specified|3|||
125210551|NCT02636699|450395599|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
125210552|NCT02636699|450395600|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
125210553|NCT02636699|450395601|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
125210554|NCT02636699|450395599|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
125210555|NCT02636699|450395600|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
125210556|NCT02636699|450395601|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
125210557|NCT02636699|450395599|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
125210558|NCT02636699|450395600|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
125210559|NCT02636699|450395601|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
125210560|NCT02636699|450395599|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
125210561|NCT02636699|450395600|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
125210562|NCT02636699|450395601|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
125210563|NCT02636699|450395599|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
125210564|NCT02636699|450395600|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
125210565|NCT02636699|450395601|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
125210566|NCT02636699|450395599|FG000|Treatment and Follow-up Periods|Other|3|||
125210567|NCT02636699|450395600|FG001|Treatment and Follow-up Periods|Other|1|||
125210568|NCT02636699|450395601|FG002|Treatment and Follow-up Periods|Other|0|||
125210569|NCT01636947|450395606|FG000|Overall Study|Not Treated|2|||
125210570|NCT01636947|450395607|FG001|Overall Study|Not Treated|2|||
125210571|NCT01636947|450395606|FG000|Overall Study|Lost to Follow-up|4|||
125210572|NCT01636947|450395607|FG001|Overall Study|Lost to Follow-up|0|||
125210573|NCT01636947|450395606|FG000|Overall Study|Protocol Violation|1|||
125210574|NCT01636947|450395607|FG001|Overall Study|Protocol Violation|1|||
125210575|NCT01636947|450395606|FG000|Overall Study|Withdrawal by Subject|3|||
125210576|NCT01636947|450395607|FG001|Overall Study|Withdrawal by Subject|3|||
125210577|NCT01636947|450395606|FG000|Overall Study|Adverse Event|1|||
125210578|NCT01636947|450395607|FG001|Overall Study|Adverse Event|1|||
125210579|NCT01636947|450395606|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
125210580|NCT01636947|450395607|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
125210581|NCT00369161|450395608|FG000|Overall Study|Adverse Event|15|||
125210582|NCT00369161|450395609|FG001|Overall Study|Adverse Event|13|||
125210583|NCT00369161|450395608|FG000|Overall Study|Abnormal laboratory value|0|||
125210584|NCT00369161|450395609|FG001|Overall Study|Abnormal laboratory value|1|||
125210585|NCT00369161|450395608|FG000|Overall Study|Lack of Efficacy|3|||
125210586|NCT00369161|450395609|FG001|Overall Study|Lack of Efficacy|1|||
125210587|NCT00369161|450395608|FG000|Overall Study|Protocol Violation|0|||
125210588|NCT00369161|450395609|FG001|Overall Study|Protocol Violation|2|||
125210589|NCT00369161|450395608|FG000|Overall Study|Withdrawal by Subject|2|||
125210590|NCT00369161|450395609|FG001|Overall Study|Withdrawal by Subject|3|||
125210591|NCT00369161|450395608|FG000|Overall Study|Death|1|||
125210592|NCT00369161|450395609|FG001|Overall Study|Death|2|||
125210593|NCT00369161|450395608|FG000|Overall Study|Graft loss|4|||
125210594|NCT00369161|450395609|FG001|Overall Study|Graft loss|0|||
125210595|NCT00369161|450395608|FG000|Overall Study|Administrative Problem|2|||
125210596|NCT00369161|450395609|FG001|Overall Study|Administrative Problem|2|||
125210597|NCT02147067|450395610|FG000|Overall Study|Withdrawal by Subject|2|||
125210598|NCT02147067|450395611|FG001|Overall Study|Withdrawal by Subject|2|||
125210599|NCT02603107|450395612|FG000|Randomized Phase|Withdrew consent|8|||
125210600|NCT02603107|450395613|FG001|Randomized Phase|Withdrew consent|15|||
125210601|NCT02603107|450395612|FG000|Randomized Phase|Lost to Follow-up|1|||
125210602|NCT02603107|450395613|FG001|Randomized Phase|Lost to Follow-up|3|||
125210603|NCT02603107|450395612|FG000|Randomized Phase|Adverse Event|2|||
125319338|NCT02587520|450800162|FG004|Overall Study|Lost to Follow-up|0|||
125319339|NCT02587520|450800163|FG005|Overall Study|Lost to Follow-up|1|||
125319340|NCT02587520|450800164|FG006|Overall Study|Lost to Follow-up|1|||
125319341|NCT02587520|450800165|FG007|Overall Study|Lost to Follow-up|1|||
125319342|NCT02587520|450800166|FG008|Overall Study|Lost to Follow-up|0|||
125319343|NCT02587520|450800167|FG009|Overall Study|Lost to Follow-up|2|||
125319344|NCT02587520|450800168|FG010|Overall Study|Lost to Follow-up|2|||
125319345|NCT02587520|450800169|FG011|Overall Study|Lost to Follow-up|1|||
125319346|NCT02587520|450800170|FG012|Overall Study|Lost to Follow-up|0|||
125319347|NCT02587520|450800171|FG013|Overall Study|Lost to Follow-up|0|||
125319348|NCT02587520|450800172|FG014|Overall Study|Lost to Follow-up|0|||
125319349|NCT02587520|450800173|FG015|Overall Study|Lost to Follow-up|0|||
125319350|NCT02587520|450800174|FG016|Overall Study|Lost to Follow-up|0|||
125319351|NCT02587520|450800175|FG017|Overall Study|Lost to Follow-up|0|||
125319352|NCT01751061|450800176|FG000|Overall Study|Death|1|||
125319353|NCT01751061|450800177|FG001|Overall Study|Death|0|||
125319354|NCT01751061|450800176|FG000|Overall Study|patient death|5|||
125319355|NCT01751061|450800177|FG001|Overall Study|patient death|0|||
125319356|NCT01751061|450800176|FG000|Overall Study|Lost to Follow-up|40|||
125319357|NCT01751061|450800177|FG001|Overall Study|Lost to Follow-up|25|||
125319358|NCT01751061|450800176|FG000|Overall Study|patient regained decisional capacity|4|||
125319359|NCT01751061|450800177|FG001|Overall Study|patient regained decisional capacity|8|||
125319360|NCT01751061|450800176|FG000|Overall Study|Withdrawal by Subject|4|||
125319361|NCT01751061|450800177|FG001|Overall Study|Withdrawal by Subject|1|||
125319362|NCT01751061|450800176|FG000|Overall Study|Physician Decision|2|||
125319363|NCT01751061|450800177|FG001|Overall Study|Physician Decision|0|||
125319364|NCT01194830|450800179|FG000|Overall Study|Adverse Event|3|||
125319365|NCT01194830|450800180|FG001|Overall Study|Adverse Event|2|||
125319366|NCT01194830|450800179|FG000|Overall Study|Protocol Violation|5|||
125319367|NCT01194830|450800180|FG001|Overall Study|Protocol Violation|4|||
125319368|NCT01194830|450800179|FG000|Overall Study|Lost to Follow-up|9|||
125319369|NCT01194830|450800180|FG001|Overall Study|Lost to Follow-up|7|||
125319370|NCT01194830|450800179|FG000|Overall Study|Withdrawal by Subject|2|||
125319371|NCT01194830|450800180|FG001|Overall Study|Withdrawal by Subject|1|||
125319372|NCT01194830|450800179|FG000|Overall Study|Lack of Efficacy|1|||
125319373|NCT01194830|450800180|FG001|Overall Study|Lack of Efficacy|1|||
125319374|NCT01194830|450800179|FG000|Overall Study|Non-compliance issues|4|||
125319375|NCT01194830|450800180|FG001|Overall Study|Non-compliance issues|4|||
125319376|NCT01194830|450800179|FG000|Overall Study|Other Reason|12|||
125319377|NCT01194830|450800180|FG001|Overall Study|Other Reason|8|||
125319378|NCT01815918|450800183|FG000|Overall Study|Patient samples not analyzable|3|||
125319379|NCT01815918|450800184|FG001|Overall Study|Patient samples not analyzable|4|||
125319380|NCT01815918|450800183|FG000|Overall Study|Lack of Efficacy|15|||
125319381|NCT01815918|450800184|FG001|Overall Study|Lack of Efficacy|15|||
125319382|NCT02814916|450800187|FG000|Overall Study|Withdrawal of consent|0|||
125319383|NCT02814916|450800188|FG001|Overall Study|Withdrawal of consent|2|||
125319384|NCT02814916|450800189|FG002|Overall Study|Withdrawal of consent|0|||
125319385|NCT02814916|450800187|FG000|Overall Study|Lost to Follow-up|0|||
125319386|NCT02814916|450800188|FG001|Overall Study|Lost to Follow-up|1|||
125319387|NCT02814916|450800189|FG002|Overall Study|Lost to Follow-up|0|||
125319388|NCT02814916|450800187|FG000|Overall Study|Other, not specified|0|||
125319389|NCT02814916|450800188|FG001|Overall Study|Other, not specified|1|||
125319390|NCT02814916|450800189|FG002|Overall Study|Other, not specified|0|||
125319391|NCT04739982|450800200|FG000|Overall Study|Lost to Follow-up|176|||
125319392|NCT04739982|450800201|FG001|Overall Study|Lost to Follow-up|65|||
125319393|NCT04739982|450800200|FG000|Overall Study|Withdrawal by Subject|19|||
125319394|NCT04739982|450800201|FG001|Overall Study|Withdrawal by Subject|0|||
125319395|NCT04739982|450800200|FG000|Overall Study|Protocol Violation|0|||
125319396|NCT04739982|450800201|FG001|Overall Study|Protocol Violation|5|||
125319397|NCT00702702|450800202|FG000|Overall Study|Study prematurely terminated|56|||
125319398|NCT02240485|450800203|FG000|3 Months Post-admission|Lost to Follow-up|1|||
125319399|NCT02240485|450800204|FG001|3 Months Post-admission|Lost to Follow-up|5|||
125319400|NCT02240485|450800203|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
125319401|NCT02240485|450800204|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
125319402|NCT02240485|450800203|FG000|9 Months Post-admission|Lost to Follow-up|3|||
125319403|NCT02240485|450800204|FG001|9 Months Post-admission|Lost to Follow-up|1|||
125319404|NCT02240485|450800203|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
125319405|NCT02240485|450800204|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
125319406|NCT02240485|450800203|FG000|18 Months Post-admission|Lost to Follow-up|1|||
125319407|NCT02240485|450800204|FG001|18 Months Post-admission|Lost to Follow-up|1|||
125319408|NCT02240485|450800203|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
125319409|NCT02240485|450800204|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
125319410|NCT00953667|450800205|FG000|Overall Study|Lost to Follow-up|11|||
125319411|NCT00953667|450800205|FG000|Overall Study|Physician Decision|35|||
125319412|NCT00953667|450800205|FG000|Overall Study|Withdrawal by Subject|63|||
125319413|NCT00953667|450800205|FG000|Overall Study|Adverse Event|10|||
125319414|NCT00953667|450800205|FG000|Overall Study|poor venous access,unable to draw blood|4|||
125319415|NCT04819945|450800206|FG000|Overall Study|Lost to Follow-up|1|||
125319416|NCT00475670|450800207|FG000|Overall Study|Death|0|||
125319417|NCT00475670|450800208|FG001|Overall Study|Death|1|||
125319418|NCT00475670|450800207|FG000|Overall Study|Lack of Efficacy|3|||
125319419|NCT00475670|450800208|FG001|Overall Study|Lack of Efficacy|34|||
125319420|NCT00475670|450800207|FG000|Overall Study|Refused treatment|0|||
125319421|NCT00475670|450800208|FG001|Overall Study|Refused treatment|2|||
125319422|NCT00475670|450800207|FG000|Overall Study|Failure to Return|0|||
125319423|NCT00475670|450800208|FG001|Overall Study|Failure to Return|1|||
125319424|NCT00475670|450800207|FG000|Overall Study|Other|0|||
125319425|NCT00475670|450800208|FG001|Overall Study|Other|3|||
125319426|NCT04949191|450800209|FG000|Overall Study|Non-compliance with Study Drug|1|||
125319427|NCT04949191|450800210|FG001|Overall Study|Non-compliance with Study Drug|0|||
125319428|NCT04949191|450800211|FG002|Overall Study|Non-compliance with Study Drug|0|||
125319429|NCT04949191|450800212|FG003|Overall Study|Non-compliance with Study Drug|0|||
125319430|NCT04949191|450800209|FG000|Overall Study|Progressive Disease|0|||
125319431|NCT04949191|450800210|FG001|Overall Study|Progressive Disease|1|||
125319432|NCT04949191|450800211|FG002|Overall Study|Progressive Disease|0|||
125319433|NCT04949191|450800212|FG003|Overall Study|Progressive Disease|0|||
125319434|NCT04949191|450800209|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
125319435|NCT04949191|450800210|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
125319436|NCT04949191|450800211|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
125319437|NCT04949191|450800212|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
125319438|NCT04949191|450800209|FG000|Overall Study|Sponsor Terminated Study|0|||
125319439|NCT04949191|450800210|FG001|Overall Study|Sponsor Terminated Study|0|||
125319440|NCT04949191|450800211|FG002|Overall Study|Sponsor Terminated Study|1|||
125319441|NCT04949191|450800212|FG003|Overall Study|Sponsor Terminated Study|1|||
125319442|NCT02913482|450800213|FG000|Overall Study|Death|0|||
125319443|NCT02913482|450800214|FG001|Overall Study|Death|2|||
125319444|NCT02913482|450800215|FG002|Overall Study|Death|2|||
125319445|NCT02913482|450800213|FG000|Overall Study|Progressive Disease|1|||
125319446|NCT02913482|450800214|FG001|Overall Study|Progressive Disease|1|||
125319447|NCT02913482|450800215|FG002|Overall Study|Progressive Disease|1|||
125319448|NCT02913482|450800213|FG000|Overall Study|Reason not specified|0|||
125319449|NCT02913482|450800214|FG001|Overall Study|Reason not specified|0|||
125319450|NCT02913482|450800215|FG002|Overall Study|Reason not specified|1|||
125319451|NCT02913482|450800213|FG000|Overall Study|Withdrawal by Subject|0|||
125319452|NCT02913482|450800214|FG001|Overall Study|Withdrawal by Subject|1|||
125319453|NCT02913482|450800215|FG002|Overall Study|Withdrawal by Subject|1|||
125319454|NCT00918385|450800218|FG000|Monotherapy|Adverse Event|1|||
125319455|NCT00918385|450800219|FG001|Monotherapy|Adverse Event|6|||
125319456|NCT00918385|450800218|FG000|Monotherapy|Complicating illness|1|||
125319457|NCT00918385|450800219|FG001|Monotherapy|Complicating illness|0|||
125319458|NCT00918385|450800218|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
125319459|NCT00918385|450800219|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
125319460|NCT00918385|450800218|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
125319461|NCT00918385|450800219|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
125319462|NCT00918385|450800218|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
125319463|NCT00918385|450800219|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
125319464|NCT00918385|450800218|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
125319465|NCT00918385|450800219|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
125319466|NCT00317473|450800221|FG000|Overall Study|Withdrawal by Subject|2|||
125319467|NCT00317473|450800222|FG001|Overall Study|Withdrawal by Subject|1|||
125319468|NCT00317473|450800223|FG002|Overall Study|Withdrawal by Subject|2|||
125319469|NCT00317473|450800224|FG003|Overall Study|Withdrawal by Subject|1|||
125319470|NCT00317473|450800225|FG004|Overall Study|Withdrawal by Subject|3|||
125319471|NCT00317473|450800226|FG005|Overall Study|Withdrawal by Subject|1|||
125319472|NCT00317473|450800221|FG000|Overall Study|Relocation|1|||
125319473|NCT00317473|450800222|FG001|Overall Study|Relocation|0|||
125319474|NCT00317473|450800223|FG002|Overall Study|Relocation|1|||
125319475|NCT00317473|450800224|FG003|Overall Study|Relocation|1|||
125319476|NCT00317473|450800225|FG004|Overall Study|Relocation|5|||
125319477|NCT00317473|450800226|FG005|Overall Study|Relocation|2|||
125319478|NCT00317473|450800221|FG000|Overall Study|Death|1|||
125319479|NCT00317473|450800222|FG001|Overall Study|Death|0|||
125319480|NCT00317473|450800223|FG002|Overall Study|Death|0|||
125319481|NCT00317473|450800224|FG003|Overall Study|Death|0|||
125319482|NCT00317473|450800225|FG004|Overall Study|Death|0|||
125319483|NCT00317473|450800226|FG005|Overall Study|Death|0|||
125319484|NCT00317473|450800221|FG000|Overall Study|Other|0|||
125319485|NCT00317473|450800222|FG001|Overall Study|Other|2|||
125319486|NCT00317473|450800223|FG002|Overall Study|Other|0|||
125319487|NCT00317473|450800224|FG003|Overall Study|Other|0|||
124872815|NCT00500903|449155770|FG001|Overall Study|Symptomatic Deterioration|0|||
125319488|NCT00317473|450800225|FG004|Overall Study|Other|0|||
125319489|NCT00317473|450800226|FG005|Overall Study|Other|0|||
125319490|NCT03416868|450800230|FG000|Overall Study|Withdrawal by Subject|2|||
125319491|NCT03416868|450800230|FG000|Overall Study|Lost to Follow-up|1|||
125210604|NCT02603107|450395613|FG001|Randomized Phase|Adverse Event|0|||
125210605|NCT02603107|450395612|FG000|Randomized Phase|Death|1|||
125210606|NCT02603107|450395613|FG001|Randomized Phase|Death|1|||
125210607|NCT02603107|450395612|FG000|Randomized Phase|Non-compliance with study drug|1|||
125210608|NCT02603107|450395613|FG001|Randomized Phase|Non-compliance with study drug|1|||
125210609|NCT02603107|450395612|FG000|Randomized Phase|Investigator's discretion|0|||
125210610|NCT02603107|450395613|FG001|Randomized Phase|Investigator's discretion|1|||
125210611|NCT02603107|450395612|FG000|Randomized Phase|Lack of Efficacy|1|||
125210612|NCT02603107|450395613|FG001|Randomized Phase|Lack of Efficacy|0|||
125319492|NCT01323582|450800231|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
125319493|NCT01323582|450800232|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
125319494|NCT01323582|450800231|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
124995217|NCT01163916|449607385|FG002|Overall Study|Other|16|||
124995218|NCT00883051|449607386|FG000|Overall Study|Lost to Follow-up|0|||
124995219|NCT00883051|449607387|FG001|Overall Study|Lost to Follow-up|0|||
124995220|NCT00883051|449607388|FG002|Overall Study|Lost to Follow-up|0|||
124995221|NCT00883051|449607389|FG003|Overall Study|Lost to Follow-up|0|||
124995222|NCT00883051|449607390|FG004|Overall Study|Lost to Follow-up|1|||
124995223|NCT00883051|449607386|FG000|Overall Study|Did not use study medication|24|||
124995224|NCT00883051|449607387|FG001|Overall Study|Did not use study medication|22|||
124995225|NCT00883051|449607388|FG002|Overall Study|Did not use study medication|29|||
124995226|NCT00883051|449607389|FG003|Overall Study|Did not use study medication|29|||
124995227|NCT00883051|449607390|FG004|Overall Study|Did not use study medication|17|||
124995228|NCT02337751|449607391|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
124995229|NCT02337751|449607392|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
124995230|NCT02337751|449607391|FG000|Overall Study|Voluntary Withdrawal|6|||
124995231|NCT02337751|449607392|FG001|Overall Study|Voluntary Withdrawal|8|||
124995232|NCT02337751|449607391|FG000|Overall Study|Lack of Efficacy|2|||
124995233|NCT02337751|449607392|FG001|Overall Study|Lack of Efficacy|5|||
124995234|NCT02337751|449607391|FG000|Overall Study|Investigator's Judgement|1|||
124995235|NCT02337751|449607392|FG001|Overall Study|Investigator's Judgement|0|||
124995236|NCT01910181|449607397|FG000|Overall Study|Death|37|||
124995237|NCT01910181|449607397|FG000|Overall Study|Lost to Follow-up|3|||
125319495|NCT01323582|450800232|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
125319496|NCT01323582|450800231|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
125319497|NCT01323582|450800232|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
125319498|NCT00083889|450800233|FG000|Overall Study|Adverse Event|76|||
125319499|NCT00083889|450800234|FG001|Overall Study|Adverse Event|86|||
125319500|NCT00083889|450800233|FG000|Overall Study|Protocol Violation|2|||
125319501|NCT00083889|450800234|FG001|Overall Study|Protocol Violation|2|||
125319502|NCT00083889|450800233|FG000|Overall Study|Withdrawal by Subject|22|||
125319503|NCT00083889|450800234|FG001|Overall Study|Withdrawal by Subject|24|||
125319504|NCT00083889|450800233|FG000|Overall Study|Lack of Efficacy|240|||
125319505|NCT00083889|450800234|FG001|Overall Study|Lack of Efficacy|219|||
125319506|NCT00083889|450800233|FG000|Overall Study|Decision of sponsor|32|||
125319507|NCT00083889|450800234|FG001|Overall Study|Decision of sponsor|4|||
125319508|NCT00083889|450800233|FG000|Overall Study|Randomized: did not take study drug|0|||
125319509|NCT00083889|450800234|FG001|Overall Study|Randomized: did not take study drug|15|||
125319510|NCT00083889|450800233|FG000|Overall Study|Completed on marketed sunitinub|3|||
125319511|NCT00083889|450800234|FG001|Overall Study|Completed on marketed sunitinub|0|||
125319512|NCT00083889|450800233|FG000|Overall Study|Crossover to SU011248|0|||
125319513|NCT00083889|450800234|FG001|Overall Study|Crossover to SU011248|25|||
125319514|NCT00388349|450800235|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
125319515|NCT00388349|450800236|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
125319516|NCT00112736|450800237|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
125319517|NCT00112736|450800238|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
125319518|NCT05435339|450800239|FG000|Overall Study|Death|1|||
125319519|NCT05435339|450800240|FG001|Overall Study|Death|0|||
125319520|NCT05435339|450800241|FG002|Overall Study|Death|3|||
125319521|NCT05435339|450800242|FG003|Overall Study|Death|1|||
125319522|NCT05435339|450800243|FG004|Overall Study|Death|3|||
125319523|NCT05435339|450800244|FG005|Overall Study|Death|2|||
125319524|NCT05435339|450800245|FG006|Overall Study|Death|4|||
125319525|NCT05435339|450800246|FG007|Overall Study|Death|6|||
125319526|NCT05435339|450800239|FG000|Overall Study|Sponsor Decision|0|||
124995238|NCT01910181|449607397|FG000|Overall Study|Study Terminated by Sponsor|6|||
124995239|NCT01328717|449609276|FG000|Overall Study|Adverse Event|1|||
124995240|NCT03440320|449609277|FG000|Overall Study|Withdrawal by Subject|0|||
124995241|NCT03440320|449609278|FG001|Overall Study|Withdrawal by Subject|1|||
124995242|NCT01620255|449609281|FG000|Overall Study|Withdrawal by Subject|4|||
124995243|NCT01620255|449609282|FG001|Overall Study|Withdrawal by Subject|1|||
124995244|NCT01620255|449609283|FG002|Overall Study|Withdrawal by Subject|1|||
125210613|NCT02603107|450395612|FG000|Randomized Phase|Protocol Violation|1|||
125210614|NCT02603107|450395613|FG001|Randomized Phase|Protocol Violation|0|||
125210615|NCT02603107|450395612|FG000|Optional Extension Phase|Lost to Follow-up|3|||
125319527|NCT05435339|450800240|FG001|Overall Study|Sponsor Decision|1|||
125319528|NCT05435339|450800241|FG002|Overall Study|Sponsor Decision|0|||
125319529|NCT05435339|450800242|FG003|Overall Study|Sponsor Decision|0|||
125319530|NCT05435339|450800243|FG004|Overall Study|Sponsor Decision|2|||
125319531|NCT05435339|450800244|FG005|Overall Study|Sponsor Decision|1|||
125319532|NCT05435339|450800245|FG006|Overall Study|Sponsor Decision|2|||
125319533|NCT05435339|450800246|FG007|Overall Study|Sponsor Decision|2|||
125319534|NCT05435339|450800239|FG000|Overall Study|Withdrawal by Subject|0|||
125319535|NCT05435339|450800240|FG001|Overall Study|Withdrawal by Subject|0|||
125319536|NCT05435339|450800241|FG002|Overall Study|Withdrawal by Subject|0|||
125319537|NCT05435339|450800242|FG003|Overall Study|Withdrawal by Subject|0|||
125319538|NCT05435339|450800243|FG004|Overall Study|Withdrawal by Subject|1|||
125319539|NCT05435339|450800244|FG005|Overall Study|Withdrawal by Subject|0|||
125319540|NCT05435339|450800245|FG006|Overall Study|Withdrawal by Subject|1|||
125319541|NCT05435339|450800246|FG007|Overall Study|Withdrawal by Subject|1|||
125319542|NCT00537394|450800249|FG000|First Year of Follow-up|Death|7|||
125319543|NCT00537394|450800250|FG001|First Year of Follow-up|Death|0|||
125319544|NCT00537394|450800251|FG002|First Year of Follow-up|Death|0|||
125319545|NCT00537394|450800249|FG000|First Year of Follow-up|Severe debilitation|1|||
125319546|NCT00537394|450800250|FG001|First Year of Follow-up|Severe debilitation|0|||
125319547|NCT00537394|450800251|FG002|First Year of Follow-up|Severe debilitation|1|||
125319548|NCT00537394|450800249|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
125319549|NCT00537394|450800250|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
125319550|NCT00537394|450800251|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
125319551|NCT00537394|450800249|FG000|First Year of Follow-up|Lost to Follow-up|1|||
125319552|NCT00537394|450800250|FG001|First Year of Follow-up|Lost to Follow-up|5|||
125319553|NCT00537394|450800251|FG002|First Year of Follow-up|Lost to Follow-up|1|||
125319554|NCT00537394|450800249|FG000|2nd Year of Follow-up|Death|4|||
125319555|NCT00537394|450800250|FG001|2nd Year of Follow-up|Death|1|||
125319556|NCT00537394|450800251|FG002|2nd Year of Follow-up|Death|2|||
125319557|NCT00537394|450800249|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
125319558|NCT00537394|450800250|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
125319559|NCT00537394|450800251|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
125319560|NCT00537394|450800249|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
125319561|NCT00537394|450800250|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
125319562|NCT00537394|450800251|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
125319563|NCT00537394|450800249|FG000|2nd Year of Follow-up|Clinic site closure|1|||
125319564|NCT00537394|450800250|FG001|2nd Year of Follow-up|Clinic site closure|0|||
125319565|NCT00537394|450800251|FG002|2nd Year of Follow-up|Clinic site closure|0|||
125319566|NCT03473236|450800255|FG000|Overall Study|Withdrawal by Subject|0|||
125319567|NCT03473236|450800256|FG001|Overall Study|Withdrawal by Subject|0|||
125319568|NCT03473236|450800257|FG002|Overall Study|Withdrawal by Subject|0|||
125319569|NCT03473236|450800258|FG003|Overall Study|Withdrawal by Subject|0|||
125319570|NCT03473236|450800259|FG004|Overall Study|Withdrawal by Subject|0|||
125319571|NCT03473236|450800260|FG005|Overall Study|Withdrawal by Subject|1|||
125319572|NCT03473236|450800261|FG006|Overall Study|Withdrawal by Subject|0|||
125319573|NCT03473236|450800262|FG007|Overall Study|Withdrawal by Subject|0|||
125319574|NCT03473236|450800263|FG008|Overall Study|Withdrawal by Subject|1|||
125319575|NCT03473236|450800264|FG009|Overall Study|Withdrawal by Subject|0|||
125319576|NCT00685165|450800265|FG000|Washout Period of 14 Days|Adverse Event|1|||
125319577|NCT00685165|450800266|FG001|Washout Period of 14 Days|Adverse Event|0|||
125319578|NCT05135871|450800267|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
125319579|NCT05135871|450800268|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
125319580|NCT05135871|450800269|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
125319581|NCT05135871|450800270|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
125319582|NCT04886154|450800276|FG000|Overall Study|Adverse Event|0|||
125319583|NCT04886154|450800277|FG001|Overall Study|Adverse Event|0|||
125319584|NCT04886154|450800278|FG002|Overall Study|Adverse Event|0|||
125319585|NCT04886154|450800279|FG003|Overall Study|Adverse Event|0|||
125319586|NCT04886154|450800280|FG004|Overall Study|Adverse Event|1|||
125319587|NCT04886154|450800281|FG005|Overall Study|Adverse Event|0|||
125319588|NCT04886154|450800282|FG006|Overall Study|Adverse Event|0|||
125319589|NCT04886154|450800283|FG007|Overall Study|Adverse Event|1|||
125319590|NCT04886154|450800284|FG008|Overall Study|Adverse Event|1|||
125319591|NCT04886154|450800285|FG009|Overall Study|Adverse Event|0|||
125319592|NCT04886154|450800286|FG010|Overall Study|Adverse Event|0|||
125319593|NCT04886154|450800287|FG011|Overall Study|Adverse Event|1|||
125319594|NCT04886154|450800288|FG012|Overall Study|Adverse Event|0|||
125319595|NCT04886154|450800289|FG013|Overall Study|Adverse Event|0|||
125319596|NCT04886154|450800290|FG014|Overall Study|Adverse Event|3|||
125319597|NCT04886154|450800276|FG000|Overall Study|Lost to Follow-up|1|||
125319598|NCT04886154|450800277|FG001|Overall Study|Lost to Follow-up|0|||
125319599|NCT04886154|450800278|FG002|Overall Study|Lost to Follow-up|2|||
125319600|NCT04886154|450800279|FG003|Overall Study|Lost to Follow-up|0|||
125319601|NCT04886154|450800280|FG004|Overall Study|Lost to Follow-up|17|||
125319602|NCT04886154|450800281|FG005|Overall Study|Lost to Follow-up|7|||
125319603|NCT04886154|450800282|FG006|Overall Study|Lost to Follow-up|8|||
125319604|NCT04886154|450800283|FG007|Overall Study|Lost to Follow-up|7|||
125319605|NCT04886154|450800284|FG008|Overall Study|Lost to Follow-up|8|||
125319606|NCT04886154|450800285|FG009|Overall Study|Lost to Follow-up|0|||
125319607|NCT04886154|450800286|FG010|Overall Study|Lost to Follow-up|2|||
125319608|NCT04886154|450800287|FG011|Overall Study|Lost to Follow-up|0|||
125319609|NCT04886154|450800288|FG012|Overall Study|Lost to Follow-up|0|||
125319610|NCT04886154|450800289|FG013|Overall Study|Lost to Follow-up|0|||
125319611|NCT04886154|450800290|FG014|Overall Study|Lost to Follow-up|0|||
125319612|NCT04886154|450800276|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319613|NCT04886154|450800277|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319614|NCT04886154|450800278|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319615|NCT04886154|450800279|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319616|NCT04886154|450800280|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319617|NCT04886154|450800281|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319618|NCT04886154|450800282|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
125319619|NCT04886154|450800283|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319620|NCT04886154|450800284|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319621|NCT04886154|450800285|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319622|NCT04886154|450800286|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319623|NCT04886154|450800287|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319624|NCT04886154|450800288|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319625|NCT04886154|450800289|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319626|NCT04886154|450800290|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319627|NCT04886154|450800276|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319628|NCT04886154|450800277|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319629|NCT04886154|450800278|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319630|NCT04886154|450800279|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319631|NCT04886154|450800280|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125319632|NCT04886154|450800281|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319633|NCT04886154|450800282|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
125319634|NCT04886154|450800283|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125319635|NCT04886154|450800284|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319636|NCT04886154|450800285|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319637|NCT04886154|450800286|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319638|NCT04886154|450800287|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319639|NCT04886154|450800288|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319640|NCT04886154|450800289|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319641|NCT04886154|450800290|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125319642|NCT04886154|450800276|FG000|Overall Study|Other, Not Specified|0|||
125319643|NCT04886154|450800277|FG001|Overall Study|Other, Not Specified|0|||
125319644|NCT04886154|450800278|FG002|Overall Study|Other, Not Specified|0|||
125319645|NCT04886154|450800279|FG003|Overall Study|Other, Not Specified|0|||
125319646|NCT04886154|450800280|FG004|Overall Study|Other, Not Specified|11|||
125319647|NCT04886154|450800281|FG005|Overall Study|Other, Not Specified|8|||
125319648|NCT04886154|450800282|FG006|Overall Study|Other, Not Specified|9|||
125319649|NCT04886154|450800283|FG007|Overall Study|Other, Not Specified|10|||
125319650|NCT04886154|450800284|FG008|Overall Study|Other, Not Specified|6|||
125319651|NCT04886154|450800285|FG009|Overall Study|Other, Not Specified|1|||
125319652|NCT04886154|450800286|FG010|Overall Study|Other, Not Specified|1|||
125319653|NCT04886154|450800287|FG011|Overall Study|Other, Not Specified|2|||
125319654|NCT04886154|450800288|FG012|Overall Study|Other, Not Specified|1|||
125319655|NCT04886154|450800289|FG013|Overall Study|Other, Not Specified|2|||
125319656|NCT04886154|450800290|FG014|Overall Study|Other, Not Specified|3|||
125319657|NCT01400698|450800292|FG000|Overall Study|Lost to Follow-up|2|||
125319658|NCT01400698|450800293|FG001|Overall Study|Lost to Follow-up|5|||
125319659|NCT01400698|450800294|FG002|Overall Study|Lost to Follow-up|2|||
125319660|NCT01400698|450800295|FG003|Overall Study|Lost to Follow-up|1|||
125319661|NCT01400698|450800296|FG004|Overall Study|Lost to Follow-up|4|||
125319662|NCT01400698|450800297|FG005|Overall Study|Lost to Follow-up|3|||
125319663|NCT01400698|450800292|FG000|Overall Study|Withdrawal by Subject|8|||
125319664|NCT01400698|450800293|FG001|Overall Study|Withdrawal by Subject|2|||
125319665|NCT01400698|450800294|FG002|Overall Study|Withdrawal by Subject|0|||
125319666|NCT01400698|450800295|FG003|Overall Study|Withdrawal by Subject|4|||
125319667|NCT01400698|450800296|FG004|Overall Study|Withdrawal by Subject|1|||
125319668|NCT01400698|450800297|FG005|Overall Study|Withdrawal by Subject|3|||
125319669|NCT01400698|450800292|FG000|Overall Study|Protocol Violation|0|||
124995245|NCT01620255|449609284|FG003|Overall Study|Withdrawal by Subject|2|||
125319670|NCT01400698|450800293|FG001|Overall Study|Protocol Violation|1|||
125319671|NCT01400698|450800294|FG002|Overall Study|Protocol Violation|0|||
125319672|NCT01400698|450800295|FG003|Overall Study|Protocol Violation|0|||
124995246|NCT01620255|449609285|FG004|Overall Study|Withdrawal by Subject|4|||
125319673|NCT01400698|450800296|FG004|Overall Study|Protocol Violation|1|||
125319674|NCT01400698|450800297|FG005|Overall Study|Protocol Violation|0|||
125319675|NCT01400698|450800292|FG000|Overall Study|Non-compliance|0|||
125319676|NCT01400698|450800293|FG001|Overall Study|Non-compliance|1|||
125319677|NCT01400698|450800294|FG002|Overall Study|Non-compliance|0|||
125319678|NCT01400698|450800295|FG003|Overall Study|Non-compliance|1|||
125319679|NCT01400698|450800296|FG004|Overall Study|Non-compliance|0|||
125319680|NCT01400698|450800297|FG005|Overall Study|Non-compliance|0|||
125319681|NCT01400698|450800292|FG000|Overall Study|Adverse Event|1|||
125319682|NCT01400698|450800293|FG001|Overall Study|Adverse Event|0|||
125319683|NCT01400698|450800294|FG002|Overall Study|Adverse Event|0|||
125319684|NCT01400698|450800295|FG003|Overall Study|Adverse Event|0|||
125319685|NCT01400698|450800296|FG004|Overall Study|Adverse Event|0|||
125319686|NCT01400698|450800297|FG005|Overall Study|Adverse Event|0|||
125319687|NCT01400698|450800292|FG000|Overall Study|Other|4|||
125319688|NCT01400698|450800293|FG001|Overall Study|Other|2|||
125319689|NCT01400698|450800294|FG002|Overall Study|Other|0|||
125319690|NCT01400698|450800295|FG003|Overall Study|Other|2|||
125319691|NCT01400698|450800296|FG004|Overall Study|Other|1|||
125319692|NCT01400698|450800297|FG005|Overall Study|Other|0|||
125319693|NCT00948064|450801990|FG000|Phase I|No treatment received|1|||
125319694|NCT00948064|450801991|FG001|Phase I|No treatment received|0|||
125319695|NCT00948064|450801992|FG002|Phase I|No treatment received|0|||
125319696|NCT00948064|450801990|FG000|Phase II|Physician Decision|0|||
125319697|NCT00948064|450801991|FG001|Phase II|Physician Decision|0|||
125319698|NCT00948064|450801992|FG002|Phase II|Physician Decision|1|||
125319699|NCT00948064|450801990|FG000|Phase II|Withdrawal by Subject|0|||
125319700|NCT00948064|450801991|FG001|Phase II|Withdrawal by Subject|1|||
125319701|NCT00948064|450801992|FG002|Phase II|Withdrawal by Subject|0|||
125319702|NCT00179621|450801994|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
125319703|NCT00179621|450801995|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
125319704|NCT00179621|450801996|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
125319705|NCT00179621|450801997|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
125319706|NCT00179621|450801994|FG000|Double-Blind Period|Adverse Event|2|||
125319707|NCT00179621|450801995|FG001|Double-Blind Period|Adverse Event|7|||
125319708|NCT00179621|450801996|FG002|Double-Blind Period|Adverse Event|4|||
125319709|NCT00179621|450801997|FG003|Double-Blind Period|Adverse Event|0|||
125319710|NCT00179621|450801994|FG000|Double-Blind Period|Withdrawal by Subject|2|||
125319711|NCT00179621|450801995|FG001|Double-Blind Period|Withdrawal by Subject|1|||
125319712|NCT00179621|450801996|FG002|Double-Blind Period|Withdrawal by Subject|3|||
125319713|NCT00179621|450801997|FG003|Double-Blind Period|Withdrawal by Subject|0|||
125319714|NCT00179621|450801994|FG000|Double-Blind Period|Death|0|||
125319715|NCT00179621|450801995|FG001|Double-Blind Period|Death|1|||
125319716|NCT00179621|450801996|FG002|Double-Blind Period|Death|2|||
125319717|NCT00179621|450801997|FG003|Double-Blind Period|Death|0|||
125319718|NCT00179621|450801994|FG000|Double-Blind Period|Protocol Violation|1|||
125319719|NCT00179621|450801995|FG001|Double-Blind Period|Protocol Violation|0|||
125319720|NCT00179621|450801996|FG002|Double-Blind Period|Protocol Violation|0|||
125319721|NCT00179621|450801997|FG003|Double-Blind Period|Protocol Violation|0|||
125319722|NCT00179621|450801994|FG000|Double-Blind Period|Other|0|||
125319723|NCT00179621|450801995|FG001|Double-Blind Period|Other|2|||
125319724|NCT00179621|450801996|FG002|Double-Blind Period|Other|2|||
125319725|NCT00179621|450801997|FG003|Double-Blind Period|Other|0|||
125319726|NCT00179621|450801994|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
125319727|NCT00179621|450801995|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
125319728|NCT00179621|450801996|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
125319729|NCT00179621|450801997|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
125319730|NCT00179621|450801994|FG000|Open-Label Period|Adverse Event|0|||
125319731|NCT00179621|450801995|FG001|Open-Label Period|Adverse Event|6|||
125319732|NCT00179621|450801996|FG002|Open-Label Period|Adverse Event|5|||
125319733|NCT00179621|450801997|FG003|Open-Label Period|Adverse Event|6|||
125319734|NCT00179621|450801994|FG000|Open-Label Period|Withdrawal by Subject|0|||
125319735|NCT00179621|450801995|FG001|Open-Label Period|Withdrawal by Subject|2|||
125319736|NCT00179621|450801996|FG002|Open-Label Period|Withdrawal by Subject|2|||
125319737|NCT00179621|450801997|FG003|Open-Label Period|Withdrawal by Subject|2|||
125319738|NCT00179621|450801994|FG000|Open-Label Period|Death|0|||
125319739|NCT00179621|450801995|FG001|Open-Label Period|Death|0|||
125319740|NCT00179621|450801996|FG002|Open-Label Period|Death|1|||
125319741|NCT00179621|450801997|FG003|Open-Label Period|Death|2|||
125319742|NCT00179621|450801994|FG000|Open-Label Period|Other|0|||
125319743|NCT00179621|450801995|FG001|Open-Label Period|Other|1|||
125319744|NCT00179621|450801996|FG002|Open-Label Period|Other|1|||
125319745|NCT00179621|450801997|FG003|Open-Label Period|Other|2|||
125319746|NCT02973100|450801999|FG000|Overall Study|Adverse Event|1|||
125319747|NCT02973100|450802000|FG001|Overall Study|Adverse Event|2|||
125319748|NCT02973100|450802001|FG002|Overall Study|Adverse Event|1|||
125319749|NCT02973100|450802002|FG003|Overall Study|Adverse Event|2|||
125319750|NCT02973100|450801999|FG000|Overall Study|Lost to Follow-up|3|||
125319751|NCT02973100|450802000|FG001|Overall Study|Lost to Follow-up|1|||
125319752|NCT02973100|450802001|FG002|Overall Study|Lost to Follow-up|1|||
125319753|NCT02973100|450802002|FG003|Overall Study|Lost to Follow-up|0|||
125319754|NCT02973100|450801999|FG000|Overall Study|Withdrawal by Subject|3|||
125319755|NCT02973100|450802000|FG001|Overall Study|Withdrawal by Subject|5|||
125319756|NCT02973100|450802001|FG002|Overall Study|Withdrawal by Subject|1|||
125319757|NCT02973100|450802002|FG003|Overall Study|Withdrawal by Subject|4|||
125319758|NCT02973100|450801999|FG000|Overall Study|Notification of change in address|0|||
125319759|NCT02973100|450802000|FG001|Overall Study|Notification of change in address|0|||
125319760|NCT02973100|450802001|FG002|Overall Study|Notification of change in address|0|||
125319761|NCT02973100|450802002|FG003|Overall Study|Notification of change in address|1|||
125319762|NCT02973100|450801999|FG000|Overall Study|Failed to attend Safety followup period|0|||
125319763|NCT02973100|450802000|FG001|Overall Study|Failed to attend Safety followup period|0|||
125319764|NCT02973100|450802001|FG002|Overall Study|Failed to attend Safety followup period|1|||
125319765|NCT02973100|450802002|FG003|Overall Study|Failed to attend Safety followup period|0|||
125319766|NCT04516746|450802013|FG000|Overall Study|Randomized but not Treated|51|||
125319767|NCT04516746|450802014|FG001|Overall Study|Randomized but not Treated|19|||
125319768|NCT04516746|450802013|FG000|Overall Study|Adverse Event|0|||
125319769|NCT04516746|450802014|FG001|Overall Study|Adverse Event|1|||
125319770|NCT04516746|450802013|FG000|Overall Study|Death|62|||
125319771|NCT04516746|450802014|FG001|Overall Study|Death|32|||
125319772|NCT04516746|450802013|FG000|Overall Study|Lost to Follow-up|3431|||
125319773|NCT04516746|450802014|FG001|Overall Study|Lost to Follow-up|1831|||
125319774|NCT04516746|450802013|FG000|Overall Study|Withdrawal by Subject|1946|||
125319775|NCT04516746|450802014|FG001|Overall Study|Withdrawal by Subject|1696|||
125319776|NCT04516746|450802013|FG000|Overall Study|Physician Decision|10|||
125319777|NCT04516746|450802014|FG001|Overall Study|Physician Decision|8|||
125319778|NCT04516746|450802013|FG000|Overall Study|Other|35|||
125319779|NCT04516746|450802014|FG001|Overall Study|Other|16|||
125319780|NCT03115359|450802017|FG000|Overall Study|Withdrawal by Subject|29|||
125319781|NCT03115359|450802018|FG001|Overall Study|Withdrawal by Subject|39|||
125319782|NCT03115359|450802017|FG000|Overall Study|Scheduling conflict|25|||
125319783|NCT03115359|450802018|FG001|Overall Study|Scheduling conflict|23|||
125319784|NCT03115359|450802017|FG000|Overall Study|Personal reasons including health|12|||
125319785|NCT03115359|450802018|FG001|Overall Study|Personal reasons including health|9|||
125319786|NCT03115359|450802017|FG000|Overall Study|Transportation barriers|3|||
125319787|NCT03115359|450802018|FG001|Overall Study|Transportation barriers|0|||
125319788|NCT03115359|450802017|FG000|Overall Study|No longer interested|5|||
125319789|NCT03115359|450802018|FG001|Overall Study|No longer interested|4|||
125319790|NCT03115359|450802017|FG000|Overall Study|No reason provided|45|||
125319791|NCT03115359|450802018|FG001|Overall Study|No reason provided|47|||
125319792|NCT05543265|450802024|FG000|Overall Study|Lost to Follow-up|3|||
125319793|NCT05543265|450802025|FG001|Overall Study|Lost to Follow-up|3|||
125319794|NCT05543265|450802024|FG000|Overall Study|Withdrawal by Subject|0|||
125319795|NCT05543265|450802025|FG001|Overall Study|Withdrawal by Subject|1|||
125319796|NCT05316597|450802026|FG000|First Session|Withdrawal by Subject|0|||
125319797|NCT05316597|450802027|FG001|First Session|Withdrawal by Subject|1|||
125319798|NCT05316597|450802026|FG000|Washout Period|Lost to Follow-up|1|||
125319799|NCT05316597|450802027|FG001|Washout Period|Lost to Follow-up|2|||
125319800|NCT05316597|450802026|FG000|Washout Period|Physician Decision|1|||
125319801|NCT05316597|450802027|FG001|Washout Period|Physician Decision|1|||
125319802|NCT05316597|450802026|FG000|Washout Period|Excluded before second session|1|||
125319803|NCT05316597|450802027|FG001|Washout Period|Excluded before second session|1|||
125319804|NCT05316597|450802026|FG000|Washout Period|Withdrawal by Subject|0|||
125319805|NCT05316597|450802027|FG001|Washout Period|Withdrawal by Subject|4|||
125319806|NCT05526716|450802028|FG000|Overall Study|Death|1|||
125319807|NCT05526716|450802029|FG001|Overall Study|Death|2|||
125319808|NCT05526716|450802028|FG000|Overall Study|Lost to Follow-up|17|||
125319809|NCT05526716|450802029|FG001|Overall Study|Lost to Follow-up|15|||
125319810|NCT05526716|450802028|FG000|Overall Study|Physician Decision|0|||
125319811|NCT05526716|450802029|FG001|Overall Study|Physician Decision|1|||
125319812|NCT05526716|450802028|FG000|Overall Study|Randomized by mistake without study treatment|0|||
125319813|NCT05526716|450802029|FG001|Overall Study|Randomized by mistake without study treatment|1|||
125319814|NCT05526716|450802028|FG000|Overall Study|Withdrawal by Subject|12|||
125319815|NCT05526716|450802029|FG001|Overall Study|Withdrawal by Subject|12|||
125319816|NCT05526716|450802028|FG000|Overall Study|Not reported|0|||
125319817|NCT05526716|450802029|FG001|Overall Study|Not reported|2|||
125319818|NCT04750824|450802030|FG000|Overall Study|Toxicity/intolerability|3|||
125319819|NCT04750824|450802031|FG001|Overall Study|Toxicity/intolerability|1|||
125319820|NCT04750824|450802030|FG000|Overall Study|Death|1|||
125319821|NCT04750824|450802031|FG001|Overall Study|Death|3|||
125319822|NCT04750824|450802030|FG000|Overall Study|Scheduled duration of therapy complete|1|||
125319823|NCT04750824|450802031|FG001|Overall Study|Scheduled duration of therapy complete|9|||
125319824|NCT04750824|450802030|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
124995247|NCT01620255|449609281|FG000|Overall Study|Participant underwent fecal transplant|0|||
125319825|NCT04750824|450802031|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
125319826|NCT03547518|450802039|FG000|Overall Study|Lost to Follow-up|2|||
125319827|NCT03547518|450802040|FG001|Overall Study|Lost to Follow-up|0|||
125319828|NCT02384551|450802042|FG000|Overall Study|Lost to Follow-up|13|||
125319829|NCT02384551|450802043|FG001|Overall Study|Lost to Follow-up|14|||
125319830|NCT02384551|450802044|FG002|Overall Study|Lost to Follow-up|14|||
125319831|NCT02384551|450802045|FG003|Overall Study|Lost to Follow-up|14|||
125319832|NCT04742556|450802046|FG000|Overall Study|Withdrawal by Subject|0|||
125319833|NCT04742556|450802047|FG001|Overall Study|Withdrawal by Subject|1|||
125319834|NCT04742556|450802048|FG002|Overall Study|Withdrawal by Subject|0|||
125319835|NCT04742556|450802046|FG000|Overall Study|Adverse Event|0|||
125319836|NCT04742556|450802047|FG001|Overall Study|Adverse Event|0|||
125319837|NCT04742556|450802048|FG002|Overall Study|Adverse Event|2|||
125319838|NCT04742556|450802046|FG000|Overall Study|Clinical disease progression|0|||
125319839|NCT04742556|450802047|FG001|Overall Study|Clinical disease progression|1|||
125319840|NCT04742556|450802048|FG002|Overall Study|Clinical disease progression|2|||
125319841|NCT04742556|450802046|FG000|Overall Study|Objective disease progression|3|||
125319842|NCT04742556|450802047|FG001|Overall Study|Objective disease progression|2|||
125319843|NCT04742556|450802048|FG002|Overall Study|Objective disease progression|4|||
125319844|NCT03035032|450802049|FG000|Overall Study|Adverse Event|2|||
125319845|NCT03035032|450802049|FG000|Overall Study|Death|9|||
125319846|NCT03035032|450802049|FG000|Overall Study|Lost to Follow-up|1|||
125319847|NCT03035032|450802049|FG000|Overall Study|Progressive Disease|22|||
125319848|NCT03035032|450802049|FG000|Overall Study|Protocol Violation|2|||
125319849|NCT03035032|450802049|FG000|Overall Study|Withdrawal by Subject|2|||
125319850|NCT03035032|450802049|FG000|Overall Study|Physician Decision|5|||
125319851|NCT02201524|450802050|FG000|Overall Study|Adverse Event|0|||
125319852|NCT02201524|450802051|FG001|Overall Study|Adverse Event|2|||
125319853|NCT02201524|450802052|FG002|Overall Study|Adverse Event|1|||
125319854|NCT02201524|450802053|FG003|Overall Study|Adverse Event|0|||
125319855|NCT02201524|450802050|FG000|Overall Study|Insufficient clinical response|1|||
125319856|NCT02201524|450802051|FG001|Overall Study|Insufficient clinical response|0|||
125319857|NCT02201524|450802052|FG002|Overall Study|Insufficient clinical response|0|||
125319858|NCT02201524|450802053|FG003|Overall Study|Insufficient clinical response|0|||
125319859|NCT02201524|450802050|FG000|Overall Study|Lost to Follow-up|0|||
125319860|NCT02201524|450802051|FG001|Overall Study|Lost to Follow-up|0|||
125319861|NCT02201524|450802052|FG002|Overall Study|Lost to Follow-up|2|||
125319862|NCT02201524|450802053|FG003|Overall Study|Lost to Follow-up|0|||
125319863|NCT02201524|450802050|FG000|Overall Study|No longer meets eligibility criteria|0|||
125319864|NCT02201524|450802051|FG001|Overall Study|No longer meets eligibility criteria|0|||
125319865|NCT02201524|450802052|FG002|Overall Study|No longer meets eligibility criteria|0|||
125319866|NCT02201524|450802053|FG003|Overall Study|No longer meets eligibility criteria|2|||
125319867|NCT02201524|450802050|FG000|Overall Study|Protocol Violation|0|||
125319868|NCT02201524|450802051|FG001|Overall Study|Protocol Violation|0|||
125319869|NCT02201524|450802052|FG002|Overall Study|Protocol Violation|0|||
125319870|NCT02201524|450802053|FG003|Overall Study|Protocol Violation|1|||
125319871|NCT02201524|450802050|FG000|Overall Study|Withdrawal by Subject|0|||
125319872|NCT02201524|450802051|FG001|Overall Study|Withdrawal by Subject|0|||
125319873|NCT02201524|450802052|FG002|Overall Study|Withdrawal by Subject|1|||
125319874|NCT02201524|450802053|FG003|Overall Study|Withdrawal by Subject|1|||
125319875|NCT02201524|450802050|FG000|Overall Study|Other|1|||
125319876|NCT02201524|450802051|FG001|Overall Study|Other|1|||
125319877|NCT02201524|450802052|FG002|Overall Study|Other|0|||
125319878|NCT02201524|450802053|FG003|Overall Study|Other|0|||
125319879|NCT02914639|450802055|FG000|Overall Study|Withdrawal by Subject|0|||
125319880|NCT02914639|450802056|FG001|Overall Study|Withdrawal by Subject|2|||
125319881|NCT01018030|450802058|FG000|Overall Study|Adverse Event|10|||
125319882|NCT01018030|450802059|FG001|Overall Study|Adverse Event|5|||
125319883|NCT01018030|450802060|FG002|Overall Study|Adverse Event|5|||
125319884|NCT01018030|450802058|FG000|Overall Study|Withdrawal by Subject|2|||
125319885|NCT01018030|450802059|FG001|Overall Study|Withdrawal by Subject|2|||
125319886|NCT01018030|450802060|FG002|Overall Study|Withdrawal by Subject|4|||
125319887|NCT01018030|450802058|FG000|Overall Study|Lost to Follow-up|2|||
125319888|NCT01018030|450802059|FG001|Overall Study|Lost to Follow-up|0|||
125319889|NCT01018030|450802060|FG002|Overall Study|Lost to Follow-up|3|||
125319890|NCT01018030|450802058|FG000|Overall Study|Protocol Violation|2|||
125319891|NCT01018030|450802059|FG001|Overall Study|Protocol Violation|1|||
125319892|NCT01018030|450802060|FG002|Overall Study|Protocol Violation|0|||
125319893|NCT01018030|450802058|FG000|Overall Study|Physician Decision|1|||
125319894|NCT01018030|450802059|FG001|Overall Study|Physician Decision|0|||
125319895|NCT01018030|450802060|FG002|Overall Study|Physician Decision|1|||
125319896|NCT01018030|450802058|FG000|Overall Study|Lack of Efficacy|1|||
124995248|NCT01620255|449609282|FG001|Overall Study|Participant underwent fecal transplant|0|||
125319897|NCT01018030|450802059|FG001|Overall Study|Lack of Efficacy|0|||
125319898|NCT01018030|450802060|FG002|Overall Study|Lack of Efficacy|0|||
125319899|NCT01018030|450802058|FG000|Overall Study|Did Not Receive Study Drug|1|||
125319900|NCT01018030|450802059|FG001|Overall Study|Did Not Receive Study Drug|3|||
125319901|NCT01018030|450802060|FG002|Overall Study|Did Not Receive Study Drug|0|||
125319902|NCT03617172|450802063|FG000|Overall Study|Lost to Follow-up|1|||
125319903|NCT03617172|450802064|FG001|Overall Study|Lost to Follow-up|0|||
125319904|NCT01089504|450802065|FG000|Overall Study|Lost to Follow-up|1|||
125319905|NCT01089504|450802066|FG001|Overall Study|Lost to Follow-up|1|||
125319906|NCT01089504|450802065|FG000|Overall Study|Withdrawal by Subject|2|||
125319907|NCT01089504|450802066|FG001|Overall Study|Withdrawal by Subject|0|||
125319908|NCT01924845|450802067|FG000|Overall Study|Adverse Event|3|||
125319909|NCT01924845|450802067|FG000|Overall Study|Withdrawal by Subject|2|||
125319910|NCT01924845|450802067|FG000|Overall Study|Protocol Violation|1|||
125319911|NCT00062439|450802068|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
125319912|NCT00062439|450802068|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
125319913|NCT00062439|450802068|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
125319914|NCT00062439|450802068|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
125319915|NCT00062439|450802068|FG000|Post Chemoradiation Assessment|Death|1|||
125319916|NCT00062439|450802068|FG000|Post Chemoradiation Assessment|Disease progression|2|||
125319917|NCT00062439|450802068|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
125319918|NCT00062439|450802068|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
125319919|NCT00062439|450802068|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
125319920|NCT00062439|450802068|FG000|Surgery|Physician Decision|4|||
125319921|NCT00062439|450802068|FG000|Surgery|Death|1|||
125319922|NCT00062439|450802068|FG000|Surgery|Adverse Event|2|||
125319923|NCT00062439|450802068|FG000|Consolidation Chemotherapy|Adverse Event|2|||
125319924|NCT00001832|450802072|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
125319925|NCT00001832|450802073|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
125319926|NCT00001832|450802074|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
125319927|NCT00001832|450802075|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
125319928|NCT00001832|450802076|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
125319929|NCT00001832|450802077|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
125319930|NCT00001832|450802078|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
125319931|NCT00001832|450802079|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
125319932|NCT00001832|450802080|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
125319933|NCT00001832|450802081|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
125319934|NCT00001832|450802082|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
125319935|NCT00001832|450802083|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
125319936|NCT00001832|450802084|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
125319937|NCT00001832|450802085|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
125319938|NCT00001832|450802086|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
125319939|NCT00001832|450802072|FG000|Treatment Period|Death during treatment|0|||
125319940|NCT00001832|450802073|FG001|Treatment Period|Death during treatment|0|||
125319941|NCT00001832|450802074|FG002|Treatment Period|Death during treatment|0|||
125319942|NCT00001832|450802075|FG003|Treatment Period|Death during treatment|0|||
125319943|NCT00001832|450802076|FG004|Treatment Period|Death during treatment|0|||
125319944|NCT00001832|450802077|FG005|Treatment Period|Death during treatment|1|||
125319945|NCT00001832|450802078|FG006|Treatment Period|Death during treatment|0|||
125319946|NCT00001832|450802079|FG007|Treatment Period|Death during treatment|0|||
125319947|NCT00001832|450802080|FG008|Treatment Period|Death during treatment|0|||
125319948|NCT00001832|450802081|FG009|Treatment Period|Death during treatment|0|||
125319949|NCT00001832|450802082|FG010|Treatment Period|Death during treatment|0|||
125319950|NCT00001832|450802083|FG011|Treatment Period|Death during treatment|0|||
125319951|NCT00001832|450802084|FG012|Treatment Period|Death during treatment|0|||
125319952|NCT00001832|450802085|FG013|Treatment Period|Death during treatment|0|||
125319953|NCT00001832|450802086|FG014|Treatment Period|Death during treatment|0|||
125319954|NCT00001832|450802072|FG000|Treatment Period|Not treated|0|||
125319955|NCT00001832|450802073|FG001|Treatment Period|Not treated|0|||
125319956|NCT00001832|450802074|FG002|Treatment Period|Not treated|0|||
125319957|NCT00001832|450802075|FG003|Treatment Period|Not treated|0|||
125319958|NCT00001832|450802076|FG004|Treatment Period|Not treated|0|||
125319959|NCT00001832|450802077|FG005|Treatment Period|Not treated|0|||
125319960|NCT00001832|450802078|FG006|Treatment Period|Not treated|0|||
125319961|NCT00001832|450802079|FG007|Treatment Period|Not treated|1|||
125319962|NCT00001832|450802080|FG008|Treatment Period|Not treated|0|||
125319963|NCT00001832|450802081|FG009|Treatment Period|Not treated|0|||
125319964|NCT00001832|450802082|FG010|Treatment Period|Not treated|0|||
125319965|NCT00001832|450802083|FG011|Treatment Period|Not treated|0|||
125319966|NCT00001832|450802084|FG012|Treatment Period|Not treated|0|||
125319967|NCT00001832|450802085|FG013|Treatment Period|Not treated|0|||
125319968|NCT00001832|450802086|FG014|Treatment Period|Not treated|0|||
125319969|NCT01546857|450802088|FG000|Overall Study|Withdrawal by Subject|2|||
125319970|NCT01546857|450802089|FG001|Overall Study|Withdrawal by Subject|3|||
125319971|NCT01469221|450802090|FG000|Double Blind Phase|Protocol Violation|1|||
125319972|NCT01469221|450802091|FG001|Double Blind Phase|Protocol Violation|0|||
125319973|NCT01469221|450802092|FG002|Double Blind Phase|Protocol Violation|0|||
125319974|NCT01469221|450802090|FG000|Double Blind Phase|Physician Decision|1|||
125319975|NCT01469221|450802091|FG001|Double Blind Phase|Physician Decision|1|||
125319976|NCT01469221|450802092|FG002|Double Blind Phase|Physician Decision|0|||
125319977|NCT01469221|450802090|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
124872816|NCT00500903|449155771|FG002|Overall Study|Symptomatic Deterioration|0|||
125319978|NCT01469221|450802091|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
125319979|NCT01469221|450802092|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
125319980|NCT02004236|450802100|FG000|Overall Study|Lack of Efficacy|0|||
125319981|NCT02004236|450802101|FG001|Overall Study|Lack of Efficacy|0|||
125319982|NCT02004236|450802102|FG002|Overall Study|Lack of Efficacy|16|||
125319983|NCT00918281|450802105|FG000|Overall Study|Physician Decision|29|||
125319984|NCT00168844|450802106|FG000|Overall Study|Adverse Event|31|||
125319985|NCT00168844|450802107|FG001|Overall Study|Adverse Event|32|||
125319986|NCT00168844|450802108|FG002|Overall Study|Adverse Event|48|||
125319987|NCT00168844|450802106|FG000|Overall Study|Lost to Follow-up|4|||
125319988|NCT00168844|450802107|FG001|Overall Study|Lost to Follow-up|5|||
125319989|NCT00168844|450802108|FG002|Overall Study|Lost to Follow-up|11|||
125319990|NCT00168844|450802106|FG000|Overall Study|Withdrawal by Subject|12|||
125319991|NCT00168844|450802107|FG001|Overall Study|Withdrawal by Subject|9|||
125319992|NCT00168844|450802108|FG002|Overall Study|Withdrawal by Subject|19|||
125319993|NCT00168844|450802106|FG000|Overall Study|Protocol Violation|2|||
125319994|NCT00168844|450802107|FG001|Overall Study|Protocol Violation|2|||
125319995|NCT00168844|450802108|FG002|Overall Study|Protocol Violation|4|||
125319996|NCT00168844|450802106|FG000|Overall Study|Other|6|||
125319997|NCT00168844|450802107|FG001|Overall Study|Other|7|||
125319998|NCT00168844|450802108|FG002|Overall Study|Other|9|||
125319999|NCT00849940|450802117|FG000|Overall Study|Physician Decision|4|||
125320000|NCT00601835|450802118|FG000|Overall Study|Withdrawal by Subject|9|||
125320001|NCT00601835|450802119|FG001|Overall Study|Withdrawal by Subject|6|||
125320002|NCT00601835|450802118|FG000|Overall Study|Physician Decision|1|||
125320003|NCT00601835|450802119|FG001|Overall Study|Physician Decision|0|||
125320004|NCT00601835|450802118|FG000|Overall Study|Lost to Follow-up|37|||
125320005|NCT00601835|450802119|FG001|Overall Study|Lost to Follow-up|5|||
125320006|NCT00601835|450802118|FG000|Overall Study|Adverse Event|1|||
125320007|NCT00601835|450802119|FG001|Overall Study|Adverse Event|1|||
125320008|NCT00601835|450802118|FG000|Overall Study|Relocate|12|||
125320009|NCT00601835|450802119|FG001|Overall Study|Relocate|2|||
125320010|NCT01927497|450802120|FG000|Overall Study|Death|0|||
125320011|NCT01927497|450802121|FG001|Overall Study|Death|1|||
125320012|NCT01927497|450802120|FG000|Overall Study|Protocol Violation|2|||
125320013|NCT01927497|450802121|FG001|Overall Study|Protocol Violation|0|||
125320014|NCT03914417|450802122|FG000|Overall Study|Withdrawal by Subject|2|||
125320015|NCT03361137|450802123|FG000|Overall Study|Reason not specified|1|||
125320016|NCT03361137|450802124|FG001|Overall Study|Reason not specified|0|||
125320017|NCT03361137|450802125|FG002|Overall Study|Reason not specified|0|||
125320018|NCT03361137|450802126|FG003|Overall Study|Reason not specified|0|||
125320019|NCT03361137|450802127|FG004|Overall Study|Reason not specified|0|||
125320020|NCT03009058|450802128|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
125320021|NCT01486966|450802131|FG000|Overall Study|Adverse Event|0|||
125320022|NCT01486966|450802132|FG001|Overall Study|Adverse Event|1|||
125320023|NCT01486966|450802131|FG000|Overall Study|Withdrawal by Subject|0|||
125320024|NCT01486966|450802132|FG001|Overall Study|Withdrawal by Subject|1|||
125320025|NCT00506350|450802133|FG000|Overall Study|Serious Adverse Event|1|||
125320026|NCT00506350|450802134|FG001|Overall Study|Serious Adverse Event|0|||
125320027|NCT00506350|450802135|FG002|Overall Study|Serious Adverse Event|0|||
125320028|NCT00506350|450802136|FG003|Overall Study|Serious Adverse Event|0|||
125320029|NCT00506350|450802137|FG004|Overall Study|Serious Adverse Event|0|||
125320030|NCT00506350|450802138|FG005|Overall Study|Serious Adverse Event|0|||
125320031|NCT00506350|450802139|FG006|Overall Study|Serious Adverse Event|0|||
125320032|NCT00506350|450802140|FG007|Overall Study|Serious Adverse Event|0|||
125320033|NCT00506350|450802141|FG008|Overall Study|Serious Adverse Event|0|||
125320034|NCT00506350|450802133|FG000|Overall Study|Adverse Event|0|||
125320035|NCT00506350|450802134|FG001|Overall Study|Adverse Event|0|||
125320036|NCT00506350|450802135|FG002|Overall Study|Adverse Event|0|||
125320037|NCT00506350|450802136|FG003|Overall Study|Adverse Event|0|||
125320038|NCT00506350|450802137|FG004|Overall Study|Adverse Event|0|||
125320039|NCT00506350|450802138|FG005|Overall Study|Adverse Event|0|||
125320040|NCT00506350|450802139|FG006|Overall Study|Adverse Event|0|||
125320041|NCT00506350|450802140|FG007|Overall Study|Adverse Event|1|||
125320042|NCT00506350|450802141|FG008|Overall Study|Adverse Event|1|||
125320043|NCT00506350|450802133|FG000|Overall Study|Protocol Violation|0|||
125320044|NCT00506350|450802134|FG001|Overall Study|Protocol Violation|0|||
125320045|NCT00506350|450802135|FG002|Overall Study|Protocol Violation|1|||
125320046|NCT00506350|450802136|FG003|Overall Study|Protocol Violation|0|||
125320047|NCT00506350|450802137|FG004|Overall Study|Protocol Violation|0|||
125320048|NCT00506350|450802138|FG005|Overall Study|Protocol Violation|0|||
125320049|NCT00506350|450802139|FG006|Overall Study|Protocol Violation|1|||
125320050|NCT00506350|450802140|FG007|Overall Study|Protocol Violation|0|||
125320051|NCT00506350|450802141|FG008|Overall Study|Protocol Violation|0|||
125320052|NCT00506350|450802133|FG000|Overall Study|Withdrawal by Subject|0|||
125320053|NCT00506350|450802134|FG001|Overall Study|Withdrawal by Subject|1|||
125320054|NCT00506350|450802135|FG002|Overall Study|Withdrawal by Subject|1|||
125320055|NCT00506350|450802136|FG003|Overall Study|Withdrawal by Subject|1|||
125320056|NCT00506350|450802137|FG004|Overall Study|Withdrawal by Subject|4|||
125320057|NCT00506350|450802138|FG005|Overall Study|Withdrawal by Subject|1|||
125320058|NCT00506350|450802139|FG006|Overall Study|Withdrawal by Subject|1|||
125320059|NCT00506350|450802140|FG007|Overall Study|Withdrawal by Subject|2|||
125320060|NCT00506350|450802141|FG008|Overall Study|Withdrawal by Subject|0|||
125320061|NCT00506350|450802133|FG000|Overall Study|Lost to Follow-up|1|||
125320062|NCT00506350|450802134|FG001|Overall Study|Lost to Follow-up|1|||
125320063|NCT00506350|450802135|FG002|Overall Study|Lost to Follow-up|1|||
125320064|NCT00506350|450802136|FG003|Overall Study|Lost to Follow-up|1|||
125320065|NCT00506350|450802137|FG004|Overall Study|Lost to Follow-up|2|||
125320066|NCT00506350|450802138|FG005|Overall Study|Lost to Follow-up|1|||
125320067|NCT00506350|450802139|FG006|Overall Study|Lost to Follow-up|0|||
125320068|NCT00506350|450802140|FG007|Overall Study|Lost to Follow-up|0|||
125320069|NCT00506350|450802141|FG008|Overall Study|Lost to Follow-up|2|||
125320070|NCT00506350|450802133|FG000|Overall Study|Medical Reason|0|||
125320071|NCT00506350|450802134|FG001|Overall Study|Medical Reason|0|||
125320072|NCT00506350|450802135|FG002|Overall Study|Medical Reason|0|||
125320073|NCT00506350|450802136|FG003|Overall Study|Medical Reason|0|||
125320074|NCT00506350|450802137|FG004|Overall Study|Medical Reason|1|||
125320075|NCT00506350|450802138|FG005|Overall Study|Medical Reason|0|||
125320076|NCT00506350|450802139|FG006|Overall Study|Medical Reason|0|||
125320077|NCT00506350|450802140|FG007|Overall Study|Medical Reason|0|||
125320078|NCT00506350|450802141|FG008|Overall Study|Medical Reason|0|||
125320079|NCT00506350|450802133|FG000|Overall Study|Other|1|||
125320080|NCT00506350|450802134|FG001|Overall Study|Other|1|||
125320081|NCT00506350|450802135|FG002|Overall Study|Other|3|||
125320082|NCT00506350|450802136|FG003|Overall Study|Other|0|||
125320083|NCT00506350|450802137|FG004|Overall Study|Other|3|||
125320084|NCT00506350|450802138|FG005|Overall Study|Other|0|||
125320085|NCT00506350|450802139|FG006|Overall Study|Other|0|||
125320086|NCT00506350|450802140|FG007|Overall Study|Other|2|||
125320087|NCT00506350|450802141|FG008|Overall Study|Other|2|||
125320088|NCT01691794|450802142|FG000|Overall Study|Poor/Non-Compliance|1|||
125320089|NCT01691794|450802143|FG001|Overall Study|Poor/Non-Compliance|4|||
125320090|NCT01691794|450802144|FG002|Overall Study|Poor/Non-Compliance|1|||
125320091|NCT01691794|450802142|FG000|Overall Study|Death|0|||
125320092|NCT01691794|450802143|FG001|Overall Study|Death|0|||
125320093|NCT01691794|450802144|FG002|Overall Study|Death|1|||
125320094|NCT01691794|450802142|FG000|Overall Study|Lack of Efficacy|0|||
125320095|NCT01691794|450802143|FG001|Overall Study|Lack of Efficacy|7|||
125320096|NCT01691794|450802144|FG002|Overall Study|Lack of Efficacy|1|||
125320097|NCT01691794|450802142|FG000|Overall Study|Participant request to discontinue|0|||
125320098|NCT01691794|450802143|FG001|Overall Study|Participant request to discontinue|1|||
125320099|NCT01691794|450802144|FG002|Overall Study|Participant request to discontinue|0|||
125320100|NCT01691794|450802142|FG000|Overall Study|Adverse Event|0|||
125320101|NCT01691794|450802143|FG001|Overall Study|Adverse Event|1|||
125320102|NCT01691794|450802144|FG002|Overall Study|Adverse Event|1|||
125320103|NCT01691794|450802142|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
125320104|NCT01691794|450802143|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
125320105|NCT01691794|450802144|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
125320106|NCT01691794|450802142|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
125320107|NCT01691794|450802143|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
125320108|NCT01691794|450802144|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
125320109|NCT04972786|450802145|FG000|First Intervention (1 Day)|Adverse Event|1|||
125320110|NCT04972786|450802146|FG001|First Intervention (1 Day)|Adverse Event|0|||
125320111|NCT00844844|450802147|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
125320112|NCT00844844|450802147|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
125320113|NCT00844844|450802147|FG000|Extension Treatment Period|Adverse Event|2|||
125320114|NCT00844844|450802147|FG000|Post Treatment Period|Withdrawal by Subject|1|||
125320115|NCT05472090|450802150|FG000|Overall Study|Adverse Event|2|||
125320116|NCT05472090|450802151|FG001|Overall Study|Adverse Event|3|||
125320117|NCT05472090|450802150|FG000|Overall Study|Lack of Efficacy|1|||
125320118|NCT05472090|450802151|FG001|Overall Study|Lack of Efficacy|0|||
125320119|NCT05472090|450802150|FG000|Overall Study|Physician Decision|1|||
125320120|NCT05472090|450802151|FG001|Overall Study|Physician Decision|0|||
125320121|NCT05472090|450802150|FG000|Overall Study|Withdrawal by Subject|2|||
125320122|NCT05472090|450802151|FG001|Overall Study|Withdrawal by Subject|0|||
125320123|NCT05472090|450802150|FG000|Overall Study|Lost to Follow-up|0|||
125320124|NCT05472090|450802151|FG001|Overall Study|Lost to Follow-up|3|||
125320125|NCT01350999|450802153|FG000|Overall Study|Adverse Event|4|||
125320126|NCT01350999|450802154|FG001|Overall Study|Adverse Event|9|||
125320127|NCT01350999|450802155|FG002|Overall Study|Adverse Event|10|||
125320128|NCT01350999|450802153|FG000|Overall Study|Voluntary withdrawal|3|||
125320129|NCT01350999|450802154|FG001|Overall Study|Voluntary withdrawal|4|||
125320130|NCT01350999|450802155|FG002|Overall Study|Voluntary withdrawal|6|||
125320131|NCT01350999|450802153|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
125320132|NCT01350999|450802154|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
125320133|NCT01350999|450802155|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
125320134|NCT02891174|450804254|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
125320135|NCT02891174|450804255|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
125320136|NCT02891174|450804254|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
125320137|NCT02891174|450804255|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
125320138|NCT02891174|450804254|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
125320139|NCT02891174|450804255|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
125320140|NCT02891174|450804254|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
125320141|NCT02891174|450804255|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
125320142|NCT02891174|450804254|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
125320143|NCT02891174|450804255|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
125320144|NCT02891174|450804254|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
125320145|NCT02891174|450804255|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
125320146|NCT02891174|450804254|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
125320147|NCT02891174|450804255|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
125320148|NCT04124939|450804256|FG000|Overall Study|Lost to Follow-up|1|||
125320149|NCT04124939|450804257|FG001|Overall Study|Lost to Follow-up|3|||
125320150|NCT04235140|450804258|FG000|Overall Study|Adverse Event|2|||
125320151|NCT04235140|450804258|FG000|Overall Study|Lost to Follow-up|1|||
125320152|NCT04235140|450804258|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
125320153|NCT04235140|450804258|FG000|Overall Study|Commercial drug is available for participants|7|||
125320154|NCT02177695|450804260|FG000|ITT Analysis|Ineligible|5|||
125320155|NCT02177695|450804261|FG001|ITT Analysis|Ineligible|5|||
125320156|NCT02177695|450804260|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
125320157|NCT02177695|450804261|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
125320158|NCT02177695|450804260|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
125320159|NCT02177695|450804261|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
125320160|NCT02177695|450804260|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
125320161|NCT02177695|450804261|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
125320162|NCT00419393|450804262|FG000|Overall Study|Adverse Event|5|||
125320163|NCT00419393|450804262|FG000|Overall Study|Protocol Violation|5|||
125320164|NCT00419393|450804262|FG000|Overall Study|Withdrawal by Subject|7|||
125320165|NCT00419393|450804262|FG000|Overall Study|Other: Sponsor request|3|||
125320166|NCT00419393|450804262|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
125320167|NCT00419393|450804262|FG000|Overall Study|Other: Site closure|1|||
125320168|NCT00419393|450804262|FG000|Overall Study|Other: Other health problems|1|||
125320169|NCT00419393|450804262|FG000|Overall Study|Other: Investigator decision|1|||
125320170|NCT00979901|450804263|FG000|Overall Study|Adverse Event|1|||
125320171|NCT00979901|450804264|FG001|Overall Study|Adverse Event|3|||
125320172|NCT00979901|450804265|FG002|Overall Study|Adverse Event|9|||
125320173|NCT00979901|450804266|FG003|Overall Study|Adverse Event|2|||
125320174|NCT00979901|450804263|FG000|Overall Study|Lack of Efficacy|8|||
125320175|NCT00979901|450804264|FG001|Overall Study|Lack of Efficacy|4|||
125320176|NCT00979901|450804265|FG002|Overall Study|Lack of Efficacy|9|||
125320177|NCT00979901|450804266|FG003|Overall Study|Lack of Efficacy|0|||
125320178|NCT00979901|450804263|FG000|Overall Study|Lost to Follow-up|1|||
125320179|NCT00979901|450804264|FG001|Overall Study|Lost to Follow-up|1|||
125320180|NCT00979901|450804265|FG002|Overall Study|Lost to Follow-up|2|||
125320181|NCT00979901|450804266|FG003|Overall Study|Lost to Follow-up|0|||
125320182|NCT00979901|450804263|FG000|Overall Study|Protocol Violation|2|||
125320183|NCT00979901|450804264|FG001|Overall Study|Protocol Violation|2|||
125320184|NCT00979901|450804265|FG002|Overall Study|Protocol Violation|7|||
125320185|NCT00979901|450804266|FG003|Overall Study|Protocol Violation|1|||
125320186|NCT00979901|450804263|FG000|Overall Study|Withdrawal by Subject|2|||
125320187|NCT00979901|450804264|FG001|Overall Study|Withdrawal by Subject|1|||
125320188|NCT00979901|450804265|FG002|Overall Study|Withdrawal by Subject|1|||
125320189|NCT00979901|450804266|FG003|Overall Study|Withdrawal by Subject|1|||
125320190|NCT00979901|450804263|FG000|Overall Study|Noncompliance|1|||
125320191|NCT00979901|450804264|FG001|Overall Study|Noncompliance|0|||
125320192|NCT00979901|450804265|FG002|Overall Study|Noncompliance|0|||
125320193|NCT00979901|450804266|FG003|Overall Study|Noncompliance|0|||
125320194|NCT00979901|450804263|FG000|Overall Study|out-of-state|1|||
125320195|NCT00979901|450804264|FG001|Overall Study|out-of-state|0|||
125320196|NCT00979901|450804265|FG002|Overall Study|out-of-state|0|||
125320197|NCT00979901|450804266|FG003|Overall Study|out-of-state|0|||
125320198|NCT00979901|450804263|FG000|Overall Study|vacation|1|||
125320199|NCT00979901|450804264|FG001|Overall Study|vacation|0|||
125320200|NCT00979901|450804265|FG002|Overall Study|vacation|0|||
125320201|NCT00979901|450804266|FG003|Overall Study|vacation|0|||
125320202|NCT00979901|450804263|FG000|Overall Study|elevated lab values pre-randomization|1|||
125320203|NCT00979901|450804264|FG001|Overall Study|elevated lab values pre-randomization|0|||
125320204|NCT00979901|450804265|FG002|Overall Study|elevated lab values pre-randomization|0|||
125320205|NCT00979901|450804266|FG003|Overall Study|elevated lab values pre-randomization|0|||
125320206|NCT00979901|450804263|FG000|Overall Study|Discontinued in Error|0|||
125320207|NCT00979901|450804264|FG001|Overall Study|Discontinued in Error|1|||
125320208|NCT00979901|450804265|FG002|Overall Study|Discontinued in Error|0|||
125320209|NCT00979901|450804266|FG003|Overall Study|Discontinued in Error|0|||
125320210|NCT00979901|450804263|FG000|Overall Study|Left Country|0|||
125320211|NCT00979901|450804264|FG001|Overall Study|Left Country|0|||
125320212|NCT00979901|450804265|FG002|Overall Study|Left Country|1|||
125320213|NCT00979901|450804266|FG003|Overall Study|Left Country|0|||
125320214|NCT00979901|450804263|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
125320215|NCT00979901|450804264|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
125320216|NCT00979901|450804265|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
125320217|NCT00979901|450804266|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
125320218|NCT01317472|450804268|FG000|Overall Study|Withdrawal by Subject|1|||
125320219|NCT01317472|450804269|FG001|Overall Study|Withdrawal by Subject|0|||
125320220|NCT01317472|450804268|FG000|Overall Study|Unrelated hospitalization|1|||
125320221|NCT01317472|450804269|FG001|Overall Study|Unrelated hospitalization|0|||
125320222|NCT02182895|450804272|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
125320223|NCT02182895|450804273|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
125320224|NCT00836589|450804280|FG000|Overall Study|Lost to Follow-up|246|||
125320225|NCT00836589|450804280|FG000|Overall Study|Death|429|||
125320226|NCT00836589|450804280|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
125320227|NCT02399215|450804302|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
125320228|NCT02399215|450804302|FG000|Overall Study|Withdrawal by Subject|1|||
125320229|NCT00772538|450804303|FG000|Overall Study|Adverse Event|6|||
125320230|NCT00772538|450804304|FG001|Overall Study|Adverse Event|6|||
125320231|NCT00772538|450804303|FG000|Overall Study|Protocol Violation|3|||
125320232|NCT00772538|450804304|FG001|Overall Study|Protocol Violation|3|||
125320233|NCT00772538|450804303|FG000|Overall Study|Lost to Follow-up|1|||
125320234|NCT00772538|450804304|FG001|Overall Study|Lost to Follow-up|1|||
125320235|NCT00772538|450804303|FG000|Overall Study|Withdrawal by Subject|3|||
125320236|NCT00772538|450804304|FG001|Overall Study|Withdrawal by Subject|8|||
125320237|NCT00772538|450804303|FG000|Overall Study|Lack of Efficacy|0|||
125320238|NCT00772538|450804304|FG001|Overall Study|Lack of Efficacy|1|||
125320239|NCT00772538|450804303|FG000|Overall Study|Other|7|||
125320240|NCT00772538|450804304|FG001|Overall Study|Other|7|||
125320241|NCT00189540|450804305|FG000|Overall Study|Withdrawal by Subject|3|||
125320242|NCT00189540|450804306|FG001|Overall Study|Withdrawal by Subject|0|||
125320243|NCT00189540|450804305|FG000|Overall Study|Death|4|||
125320244|NCT00189540|450804306|FG001|Overall Study|Death|1|||
125320245|NCT00713609|450804307|FG000|Overall Study|Adverse Event|2|||
125320246|NCT00713609|450804308|FG001|Overall Study|Adverse Event|0|||
125320247|NCT00713609|450804309|FG002|Overall Study|Adverse Event|2|||
125320248|NCT00713609|450804310|FG003|Overall Study|Adverse Event|2|||
125320249|NCT00713609|450804311|FG004|Overall Study|Adverse Event|3|||
125320250|NCT00713609|450804312|FG005|Overall Study|Adverse Event|1|||
125320251|NCT00713609|450804307|FG000|Overall Study|Lost to Follow-up|5|||
125320252|NCT00713609|450804308|FG001|Overall Study|Lost to Follow-up|7|||
125320253|NCT00713609|450804309|FG002|Overall Study|Lost to Follow-up|5|||
125320254|NCT00713609|450804310|FG003|Overall Study|Lost to Follow-up|5|||
125320255|NCT00713609|450804311|FG004|Overall Study|Lost to Follow-up|7|||
125320256|NCT00713609|450804312|FG005|Overall Study|Lost to Follow-up|0|||
125320257|NCT00713609|450804307|FG000|Overall Study|Lack of Efficacy|1|||
125320258|NCT00713609|450804308|FG001|Overall Study|Lack of Efficacy|3|||
125320259|NCT00713609|450804309|FG002|Overall Study|Lack of Efficacy|0|||
125320260|NCT00713609|450804310|FG003|Overall Study|Lack of Efficacy|0|||
125320261|NCT00713609|450804311|FG004|Overall Study|Lack of Efficacy|1|||
125320262|NCT00713609|450804312|FG005|Overall Study|Lack of Efficacy|0|||
125320263|NCT00713609|450804307|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
125320264|NCT00713609|450804308|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
125320265|NCT00713609|450804309|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
125320266|NCT00713609|450804310|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
125320267|NCT00713609|450804311|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
125320268|NCT00713609|450804312|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
125320269|NCT00713609|450804307|FG000|Overall Study|Withdrawal by Subject|6|||
125320270|NCT00713609|450804308|FG001|Overall Study|Withdrawal by Subject|1|||
125320271|NCT00713609|450804309|FG002|Overall Study|Withdrawal by Subject|5|||
124995249|NCT01620255|449609283|FG002|Overall Study|Participant underwent fecal transplant|1|||
125320272|NCT00713609|450804310|FG003|Overall Study|Withdrawal by Subject|1|||
125320273|NCT00713609|450804311|FG004|Overall Study|Withdrawal by Subject|5|||
125320274|NCT00713609|450804312|FG005|Overall Study|Withdrawal by Subject|7|||
125320275|NCT00713609|450804307|FG000|Overall Study|Protocol Violation|6|||
125320276|NCT00713609|450804308|FG001|Overall Study|Protocol Violation|3|||
125320277|NCT00713609|450804309|FG002|Overall Study|Protocol Violation|1|||
125320278|NCT00713609|450804310|FG003|Overall Study|Protocol Violation|1|||
125320279|NCT00713609|450804311|FG004|Overall Study|Protocol Violation|2|||
125320280|NCT00713609|450804312|FG005|Overall Study|Protocol Violation|0|||
125320281|NCT01903356|450804313|FG000|Overall Study|Lost to Follow-up|7|||
125320282|NCT01903356|450804313|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
125320283|NCT01903356|450804313|FG000|Overall Study|Violated the dosage and administration|3|||
125320284|NCT04529083|450804314|FG000|Overall Study|Withdrawal by Subject|3|||
125320285|NCT03305666|450804315|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
125320286|NCT03305666|450804316|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
125320287|NCT04196686|450804318|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
125320288|NCT04196686|450804319|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
125320289|NCT02587221|450804323|FG000|Overall Study|Adverse Event|3|||
125320290|NCT02587221|450804324|FG001|Overall Study|Adverse Event|3|||
125320291|NCT02587221|450804323|FG000|Overall Study|Death|33|||
125320292|NCT02587221|450804324|FG001|Overall Study|Death|34|||
125320293|NCT02587221|450804323|FG000|Overall Study|Withdrawal by Subject|66|||
125320294|NCT02587221|450804324|FG001|Overall Study|Withdrawal by Subject|61|||
125320295|NCT02587221|450804323|FG000|Overall Study|Lost to Follow-up|21|||
125320296|NCT02587221|450804324|FG001|Overall Study|Lost to Follow-up|19|||
125320297|NCT02587221|450804323|FG000|Overall Study|Protocol Violation|6|||
125320298|NCT02587221|450804324|FG001|Overall Study|Protocol Violation|5|||
125320299|NCT02587221|450804323|FG000|Overall Study|Other Reason or Unspecified|2|||
125320300|NCT02587221|450804324|FG001|Overall Study|Other Reason or Unspecified|1|||
125320301|NCT02546609|450804325|FG000|Overall Study|Withdrawal by Subject|0|||
125320302|NCT02546609|450804326|FG001|Overall Study|Withdrawal by Subject|1|||
125320303|NCT02546609|450804327|FG002|Overall Study|Withdrawal by Subject|2|||
125320304|NCT02546609|450804325|FG000|Overall Study|Adverse Event|0|||
125320305|NCT02546609|450804326|FG001|Overall Study|Adverse Event|6|||
125320306|NCT02546609|450804327|FG002|Overall Study|Adverse Event|1|||
125320307|NCT02546609|450804325|FG000|Overall Study|Protocol Violation|0|||
125320308|NCT02546609|450804326|FG001|Overall Study|Protocol Violation|1|||
125320309|NCT02546609|450804327|FG002|Overall Study|Protocol Violation|1|||
125320310|NCT02546609|450804325|FG000|Overall Study|Lost to Follow-up|2|||
125320311|NCT02546609|450804326|FG001|Overall Study|Lost to Follow-up|3|||
125320312|NCT02546609|450804327|FG002|Overall Study|Lost to Follow-up|1|||
125320313|NCT02546609|450804325|FG000|Overall Study|travel or work schedule restriction|0|||
125320314|NCT02546609|450804326|FG001|Overall Study|travel or work schedule restriction|0|||
125320315|NCT02546609|450804327|FG002|Overall Study|travel or work schedule restriction|2|||
125320316|NCT00914849|450804328|FG000|Overall Study|Withdrawal by Subject|1|||
125320317|NCT00914849|450804329|FG001|Overall Study|Withdrawal by Subject|0|||
125320318|NCT00914849|450804328|FG000|Overall Study|Not eligible|0|||
125320319|NCT00914849|450804329|FG001|Overall Study|Not eligible|1|||
125320320|NCT01001221|450804330|FG000|Overall Study|Adverse Event|1|||
125320321|NCT01001221|450804331|FG001|Overall Study|Adverse Event|2|||
125320322|NCT01001221|450804332|FG002|Overall Study|Adverse Event|0|||
125320323|NCT01001221|450804333|FG003|Overall Study|Adverse Event|2|||
125320324|NCT01001221|450804334|FG004|Overall Study|Adverse Event|0|||
125320325|NCT01001221|450804330|FG000|Overall Study|Disease progression|3|||
125320326|NCT01001221|450804331|FG001|Overall Study|Disease progression|2|||
125320327|NCT01001221|450804332|FG002|Overall Study|Disease progression|2|||
125320328|NCT01001221|450804333|FG003|Overall Study|Disease progression|4|||
125320329|NCT01001221|450804334|FG004|Overall Study|Disease progression|0|||
125320330|NCT01001221|450804330|FG000|Overall Study|Other|1|||
125320331|NCT01001221|450804331|FG001|Overall Study|Other|1|||
125320332|NCT01001221|450804332|FG002|Overall Study|Other|0|||
125320333|NCT01001221|450804333|FG003|Overall Study|Other|0|||
125320334|NCT01001221|450804334|FG004|Overall Study|Other|0|||
125320335|NCT01001221|450804330|FG000|Overall Study|Not treated; protocol exclusion|0|||
125320336|NCT01001221|450804331|FG001|Overall Study|Not treated; protocol exclusion|0|||
125320337|NCT01001221|450804332|FG002|Overall Study|Not treated; protocol exclusion|1|||
125320338|NCT01001221|450804333|FG003|Overall Study|Not treated; protocol exclusion|0|||
125320339|NCT01001221|450804334|FG004|Overall Study|Not treated; protocol exclusion|0|||
125320340|NCT05106959|450804335|FG000|Overall Study|Lost to Follow-up|1|||
125320341|NCT01292486|450804336|FG000|Overall Study|Protocol Violation|2|||
125320342|NCT01292486|450804336|FG000|Overall Study|Did not meet screening criteria|2|||
125320343|NCT01292486|450804336|FG000|Overall Study|Adverse Event|1|||
125320344|NCT01292486|450804336|FG000|Overall Study|Physician Decision|1|||
125320345|NCT04602390|450804341|FG000|Overall Study|Withdrawal by Subject|0|||
125320346|NCT04602390|450804342|FG001|Overall Study|Withdrawal by Subject|0|||
125320347|NCT04602390|450804343|FG002|Overall Study|Withdrawal by Subject|0|||
125320348|NCT04602390|450804344|FG003|Overall Study|Withdrawal by Subject|0|||
125320349|NCT04602390|450804345|FG004|Overall Study|Withdrawal by Subject|1|||
125320350|NCT04602390|450804346|FG005|Overall Study|Withdrawal by Subject|0|||
125320351|NCT04602390|450804341|FG000|Overall Study|Adverse Event|0|||
125320352|NCT04602390|450804342|FG001|Overall Study|Adverse Event|0|||
125320353|NCT04602390|450804343|FG002|Overall Study|Adverse Event|0|||
125320354|NCT04602390|450804344|FG003|Overall Study|Adverse Event|0|||
125320355|NCT04602390|450804345|FG004|Overall Study|Adverse Event|0|||
125320356|NCT04602390|450804346|FG005|Overall Study|Adverse Event|1|||
125320357|NCT00265564|450804347|FG000|Overall Study|Lost to Follow-up|5|||
125320358|NCT00265564|450804348|FG001|Overall Study|Lost to Follow-up|7|||
125320359|NCT00265564|450804347|FG000|Overall Study|met exclusion criteria|5|||
125320360|NCT00265564|450804348|FG001|Overall Study|met exclusion criteria|2|||
125320361|NCT01553084|450804349|FG000|Overall Study|Withdrawal by Subject|15|||
125320362|NCT01553084|450804350|FG001|Overall Study|Withdrawal by Subject|13|||
125320363|NCT01553084|450804351|FG002|Overall Study|Withdrawal by Subject|35|||
125320364|NCT03988400|450804352|FG000|Overall Study|Adverse Event|1|||
125320365|NCT03988400|450804353|FG001|Overall Study|Adverse Event|0|||
125320366|NCT03988400|450804352|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
125320367|NCT03988400|450804353|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
125320368|NCT03988400|450804352|FG000|Overall Study|Lost to Follow-up|0|||
125320369|NCT03988400|450804353|FG001|Overall Study|Lost to Follow-up|1|||
125320370|NCT04201431|450804354|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
125320371|NCT04201431|450804355|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
125320372|NCT04201431|450804356|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
125320373|NCT01176032|450804357|FG000|Overall Study|Adverse Event|1|||
125320374|NCT01176032|450804358|FG001|Overall Study|Adverse Event|0|||
125320375|NCT01176032|450804357|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125320376|NCT01176032|450804358|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125320377|NCT01176032|450804357|FG000|Overall Study|Protocol Violation|1|||
125320378|NCT01176032|450804358|FG001|Overall Study|Protocol Violation|0|||
125320379|NCT01176032|450804357|FG000|Overall Study|Informed consent withdrawn|3|||
125320380|NCT01176032|450804358|FG001|Overall Study|Informed consent withdrawn|0|||
125320381|NCT01176032|450804357|FG000|Overall Study|Other|1|||
125320382|NCT01176032|450804358|FG001|Overall Study|Other|0|||
125320383|NCT01791244|450804361|FG000|Overall Study|Adverse Event|5|||
125320384|NCT01791244|450804362|FG001|Overall Study|Adverse Event|7|||
125320385|NCT01791244|450804361|FG000|Overall Study|Insufficient clinical response|10|||
125320386|NCT01791244|450804362|FG001|Overall Study|Insufficient clinical response|10|||
125320387|NCT01791244|450804361|FG000|Overall Study|Laboratory Abnormality|0|||
125320388|NCT01791244|450804362|FG001|Overall Study|Laboratory Abnormality|1|||
125320389|NCT01149096|450804363|FG000|Overall Study|Lost to Follow-up|0|||
125320390|NCT01149096|450804364|FG001|Overall Study|Lost to Follow-up|1|||
125320391|NCT04079296|450804365|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
125320392|NCT04079296|450804366|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
125320393|NCT04079296|450804367|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
125320394|NCT04079296|450804368|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
125320395|NCT04079296|450804369|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
125320396|NCT04079296|450804365|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
125320397|NCT04079296|450804366|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
125320398|NCT04079296|450804367|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
125320399|NCT04079296|450804368|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
125320400|NCT04079296|450804369|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
125320401|NCT04079296|450804365|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
125320402|NCT04079296|450804366|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
125320403|NCT04079296|450804367|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
125320404|NCT04079296|450804368|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
125320405|NCT04079296|450804369|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
125320406|NCT04079296|450804365|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
125320407|NCT04079296|450804366|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
125320408|NCT04079296|450804367|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
125320409|NCT04079296|450804368|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
124995250|NCT01620255|449609284|FG003|Overall Study|Participant underwent fecal transplant|0|||
124995251|NCT01620255|449609285|FG004|Overall Study|Participant underwent fecal transplant|0|||
124995252|NCT01620255|449609281|FG000|Overall Study|Non-compliance|0|||
124995253|NCT01620255|449609282|FG001|Overall Study|Non-compliance|1|||
125320410|NCT04079296|450804369|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
125320411|NCT04079296|450804365|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
125320412|NCT04079296|450804366|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
125320413|NCT04079296|450804367|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
125320414|NCT04079296|450804368|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
125320415|NCT04079296|450804369|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
125320416|NCT04079296|450804365|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
125320417|NCT04079296|450804366|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
125320418|NCT04079296|450804367|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
125320419|NCT04079296|450804368|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
125320420|NCT04079296|450804369|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
125320421|NCT04079296|450804365|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
125320422|NCT04079296|450804366|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
125320423|NCT04079296|450804367|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
125320424|NCT04079296|450804368|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
125320425|NCT04079296|450804369|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
125320426|NCT04079296|450804365|FG000|Dose Expansion Phase (168 Days)|Death|0|||
125320427|NCT04079296|450804366|FG001|Dose Expansion Phase (168 Days)|Death|0|||
125320428|NCT04079296|450804367|FG002|Dose Expansion Phase (168 Days)|Death|0|||
125320429|NCT04079296|450804368|FG003|Dose Expansion Phase (168 Days)|Death|1|||
125320430|NCT04079296|450804369|FG004|Dose Expansion Phase (168 Days)|Death|0|||
125320431|NCT01346358|450804382|FG000|Overall Study|Withdrawal by Subject|1|||
125320432|NCT01346358|450804383|FG001|Overall Study|Withdrawal by Subject|0|||
125320433|NCT01346358|450804384|FG002|Overall Study|Withdrawal by Subject|1|||
125320434|NCT01346358|450804385|FG003|Overall Study|Withdrawal by Subject|1|||
125320435|NCT01346358|450804386|FG004|Overall Study|Withdrawal by Subject|0|||
125320436|NCT01346358|450804387|FG005|Overall Study|Withdrawal by Subject|2|||
125320437|NCT01346358|450804388|FG006|Overall Study|Withdrawal by Subject|1|||
125320438|NCT01346358|450804389|FG007|Overall Study|Withdrawal by Subject|1|||
125320439|NCT01346358|450804390|FG008|Overall Study|Withdrawal by Subject|1|||
125320440|NCT01346358|450804382|FG000|Overall Study|Adverse Event|1|||
125320441|NCT01346358|450804383|FG001|Overall Study|Adverse Event|0|||
125320442|NCT01346358|450804384|FG002|Overall Study|Adverse Event|0|||
125320443|NCT01346358|450804385|FG003|Overall Study|Adverse Event|0|||
125320444|NCT01346358|450804386|FG004|Overall Study|Adverse Event|1|||
125320445|NCT01346358|450804387|FG005|Overall Study|Adverse Event|0|||
125320446|NCT01346358|450804388|FG006|Overall Study|Adverse Event|0|||
125320447|NCT01346358|450804389|FG007|Overall Study|Adverse Event|0|||
125320448|NCT01346358|450804390|FG008|Overall Study|Adverse Event|1|||
125320449|NCT01346358|450804382|FG000|Overall Study|Non-Compliance|0|||
125320450|NCT01346358|450804383|FG001|Overall Study|Non-Compliance|0|||
125320451|NCT01346358|450804384|FG002|Overall Study|Non-Compliance|0|||
125320452|NCT01346358|450804385|FG003|Overall Study|Non-Compliance|0|||
125320453|NCT01346358|450804386|FG004|Overall Study|Non-Compliance|0|||
125320454|NCT01346358|450804387|FG005|Overall Study|Non-Compliance|0|||
125320455|NCT01346358|450804388|FG006|Overall Study|Non-Compliance|0|||
125320456|NCT01346358|450804389|FG007|Overall Study|Non-Compliance|2|||
125320457|NCT01346358|450804390|FG008|Overall Study|Non-Compliance|0|||
125320458|NCT01346358|450804382|FG000|Overall Study|Physician Decision|0|||
125320459|NCT01346358|450804383|FG001|Overall Study|Physician Decision|1|||
125320460|NCT01346358|450804384|FG002|Overall Study|Physician Decision|0|||
125320461|NCT01346358|450804385|FG003|Overall Study|Physician Decision|0|||
125320462|NCT01346358|450804386|FG004|Overall Study|Physician Decision|0|||
125320463|NCT01346358|450804387|FG005|Overall Study|Physician Decision|0|||
125320464|NCT01346358|450804388|FG006|Overall Study|Physician Decision|0|||
125320465|NCT01346358|450804389|FG007|Overall Study|Physician Decision|1|||
125320466|NCT01346358|450804390|FG008|Overall Study|Physician Decision|1|||
125320467|NCT05058365|450804393|FG000|Overall Study|Migration|1|||
125320468|NCT05058365|450804394|FG001|Overall Study|Migration|1|||
125320469|NCT04038359|450804395|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
125320470|NCT04038359|450804396|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
125320471|NCT04038359|450804395|FG000|Overall Study|Death|8|||
125320472|NCT04038359|450804396|FG001|Overall Study|Death|7|||
125320473|NCT04038359|450804395|FG000|Overall Study|Lost to Follow-up|3|||
125320474|NCT04038359|450804396|FG001|Overall Study|Lost to Follow-up|0|||
125320475|NCT04038359|450804395|FG000|Overall Study|Participant Moved|1|||
125320476|NCT04038359|450804396|FG001|Overall Study|Participant Moved|0|||
125320477|NCT04038359|450804395|FG000|Overall Study|Withdrawal by Subject|4|||
125320478|NCT04038359|450804396|FG001|Overall Study|Withdrawal by Subject|3|||
125320479|NCT04038359|450804395|FG000|Overall Study|Physician Decision|3|||
125320480|NCT04038359|450804396|FG001|Overall Study|Physician Decision|2|||
125320481|NCT04038359|450804395|FG000|Overall Study|Adverse Event|0|||
125320482|NCT04038359|450804396|FG001|Overall Study|Adverse Event|2|||
125320483|NCT04038359|450804395|FG000|Overall Study|Progressive Disease|0|||
125320484|NCT04038359|450804396|FG001|Overall Study|Progressive Disease|1|||
125320485|NCT00703014|450804397|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
125320486|NCT00703014|450804398|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
125320487|NCT00703014|450804399|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
125320488|NCT00703014|450804400|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
125320489|NCT00703014|450804397|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
125320490|NCT00703014|450804398|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
125320491|NCT00703014|450804399|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
125320492|NCT00703014|450804400|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
125320493|NCT05121766|450804401|FG000|Overall Study|Covid reinfection|3|||
125320494|NCT05121766|450804402|FG001|Overall Study|Covid reinfection|0|||
125320495|NCT05121766|450804401|FG000|Overall Study|Withdrawal by Subject|3|||
125320496|NCT05121766|450804402|FG001|Overall Study|Withdrawal by Subject|1|||
125320497|NCT05121766|450804401|FG000|Overall Study|Adverse Event|2|||
125320498|NCT05121766|450804402|FG001|Overall Study|Adverse Event|4|||
125320499|NCT05121766|450804401|FG000|Overall Study|Lost to Follow-up|0|||
125320500|NCT05121766|450804402|FG001|Overall Study|Lost to Follow-up|1|||
125320501|NCT01033240|450804406|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
124995254|NCT01620255|449609283|FG002|Overall Study|Non-compliance|0|||
125320502|NCT01033240|450804407|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
125320503|NCT01033240|450804408|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
125320504|NCT01033240|450804406|FG000|Overall Study|Death|2|||
125320505|NCT01033240|450804407|FG001|Overall Study|Death|0|||
125320506|NCT01033240|450804408|FG002|Overall Study|Death|0|||
125320507|NCT01033240|450804406|FG000|Overall Study|Withdrew Consent|2|||
125320508|NCT01033240|450804407|FG001|Overall Study|Withdrew Consent|9|||
125320509|NCT01033240|450804408|FG002|Overall Study|Withdrew Consent|2|||
125320510|NCT01033240|450804406|FG000|Overall Study|Disease Progression|35|||
125320511|NCT01033240|450804407|FG001|Overall Study|Disease Progression|32|||
125320512|NCT01033240|450804408|FG002|Overall Study|Disease Progression|41|||
125320513|NCT01033240|450804406|FG000|Overall Study|Investigator Discretion|0|||
125320514|NCT01033240|450804407|FG001|Overall Study|Investigator Discretion|0|||
125320515|NCT01033240|450804408|FG002|Overall Study|Investigator Discretion|2|||
125320516|NCT01033240|450804406|FG000|Overall Study|Other|0|||
125320517|NCT01033240|450804407|FG001|Overall Study|Other|1|||
125320518|NCT01033240|450804408|FG002|Overall Study|Other|2|||
125320519|NCT05468814|450804409|FG000|Overall Study|Lost to Follow-up|5|||
125320520|NCT05468814|450804410|FG001|Overall Study|Lost to Follow-up|6|||
125320521|NCT04716426|450804412|FG000|Overall Study|Vaccination|1|||
125320522|NCT04716426|450804413|FG001|Overall Study|Vaccination|1|||
125320523|NCT04716426|450804412|FG000|Overall Study|Contamination|1|||
125320524|NCT04716426|450804413|FG001|Overall Study|Contamination|0|||
125320525|NCT00551759|450804414|FG000|Overall Study|Adverse Event|7|||
125320526|NCT00551759|450804414|FG000|Overall Study|Death|5|||
125320527|NCT00551759|450804414|FG000|Overall Study|Ineligible|1|||
125320528|NCT02960217|450804415|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
125320529|NCT02960217|450804416|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
125320530|NCT02960217|450804415|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
125320531|NCT02960217|450804416|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
125320532|NCT02960217|450804415|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
125320533|NCT02960217|450804416|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
125320534|NCT02960217|450804415|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
125320535|NCT02960217|450804416|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
125320536|NCT02960217|450804415|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
125320537|NCT02960217|450804416|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
125320538|NCT02960217|450804415|FG000|Open-Label Extension Phase|Adverse Event|1|||
125320539|NCT02960217|450804416|FG001|Open-Label Extension Phase|Adverse Event|0|||
125320540|NCT02960217|450804415|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
125320541|NCT02960217|450804416|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
125320542|NCT02960217|450804415|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
125320543|NCT02960217|450804416|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
125320544|NCT02960217|450804415|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
125320545|NCT02960217|450804416|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
125320546|NCT00625131|450804419|FG000|Overall Study|Lost to Follow-up|3|||
125320547|NCT00625131|450804420|FG001|Overall Study|Lost to Follow-up|2|||
125320548|NCT00625131|450804421|FG002|Overall Study|Lost to Follow-up|0|||
125320549|NCT00625131|450804419|FG000|Overall Study|Withdrawal by Subject|1|||
125320550|NCT00625131|450804420|FG001|Overall Study|Withdrawal by Subject|0|||
125320551|NCT00625131|450804421|FG002|Overall Study|Withdrawal by Subject|5|||
125320552|NCT00668148|450804437|FG000|Overall Study|Adverse Event|5|||
125320553|NCT00668148|450804437|FG000|Overall Study|Subject Non-compliance|1|||
125320554|NCT00668148|450804437|FG000|Overall Study|Progressive Disease Before Treatment|2|||
125320555|NCT00668148|450804437|FG000|Overall Study|Withdrawal of Consent|2|||
125320556|NCT01766050|450806297|FG000|Overall Study|Adverse Event|1|||
125320557|NCT01766050|450806297|FG000|Overall Study|Lost to Follow-up|1|||
125320558|NCT01766050|450806297|FG000|Overall Study|Withdrawal by Subject|2|||
125320559|NCT00089297|450806300|FG000|Overall Study|Adverse Event|9|||
125320560|NCT00089297|450806300|FG000|Overall Study|Death|1|||
125320561|NCT00089297|450806300|FG000|Overall Study|Withdrawal by Subject|12|||
125320562|NCT00089297|450806300|FG000|Overall Study|Disease progression|2|||
125320563|NCT00089297|450806300|FG000|Overall Study|Ineligible|11|||
125320564|NCT00089297|450806300|FG000|Overall Study|Secondary malignancy|1|||
125320565|NCT00089297|450806300|FG000|Overall Study|IRB approval not ready|1|||
125320566|NCT00089297|450806300|FG000|Overall Study|Non-compliance|1|||
125320567|NCT01910298|450806305|FG000|Overall Study|Adverse Event|1|||
125320568|NCT01910298|450806306|FG001|Overall Study|Adverse Event|0|||
125320569|NCT01910298|450806305|FG000|Overall Study|Withdrawal by Subject|2|||
125320570|NCT01910298|450806306|FG001|Overall Study|Withdrawal by Subject|7|||
125320571|NCT01910298|450806305|FG000|Overall Study|Protocol Deviation|0|||
125320572|NCT01910298|450806306|FG001|Overall Study|Protocol Deviation|5|||
125320573|NCT01910298|450806305|FG000|Overall Study|Lost to Follow-up|1|||
124995255|NCT01620255|449609284|FG003|Overall Study|Non-compliance|0|||
125320574|NCT01910298|450806306|FG001|Overall Study|Lost to Follow-up|1|||
125320575|NCT01910298|450806305|FG000|Overall Study|Study Terminated by Sponsor|1|||
125320576|NCT01910298|450806306|FG001|Overall Study|Study Terminated by Sponsor|17|||
125320577|NCT01910298|450806305|FG000|Overall Study|Other Miscellaneous Reasons|0|||
125320578|NCT01910298|450806306|FG001|Overall Study|Other Miscellaneous Reasons|2|||
125320579|NCT03037385|450806310|FG000|Overall Study|Adverse Event|0|||
125320580|NCT03037385|450806311|FG001|Overall Study|Adverse Event|0|||
125320581|NCT03037385|450806312|FG002|Overall Study|Adverse Event|1|||
125320582|NCT03037385|450806313|FG003|Overall Study|Adverse Event|0|||
125320583|NCT03037385|450806314|FG004|Overall Study|Adverse Event|0|||
125320584|NCT03037385|450806315|FG005|Overall Study|Adverse Event|0|||
125320585|NCT03037385|450806316|FG006|Overall Study|Adverse Event|0|||
125320586|NCT03037385|450806317|FG007|Overall Study|Adverse Event|0|||
125320587|NCT03037385|450806318|FG008|Overall Study|Adverse Event|0|||
125320588|NCT03037385|450806319|FG009|Overall Study|Adverse Event|6|||
125320589|NCT03037385|450806310|FG000|Overall Study|Death|1|||
125320590|NCT03037385|450806311|FG001|Overall Study|Death|4|||
125320591|NCT03037385|450806312|FG002|Overall Study|Death|2|||
125320592|NCT03037385|450806313|FG003|Overall Study|Death|2|||
125320593|NCT03037385|450806314|FG004|Overall Study|Death|5|||
125320594|NCT03037385|450806315|FG005|Overall Study|Death|2|||
125320595|NCT03037385|450806316|FG006|Overall Study|Death|1|||
125320596|NCT03037385|450806317|FG007|Overall Study|Death|4|||
125320597|NCT03037385|450806318|FG008|Overall Study|Death|3|||
125320598|NCT03037385|450806319|FG009|Overall Study|Death|240|||
125320599|NCT03037385|450806310|FG000|Overall Study|Initiation of Another Therapy|1|||
125320600|NCT03037385|450806311|FG001|Overall Study|Initiation of Another Therapy|0|||
125320601|NCT03037385|450806312|FG002|Overall Study|Initiation of Another Therapy|0|||
125320602|NCT03037385|450806313|FG003|Overall Study|Initiation of Another Therapy|0|||
125320603|NCT03037385|450806314|FG004|Overall Study|Initiation of Another Therapy|0|||
125320604|NCT03037385|450806315|FG005|Overall Study|Initiation of Another Therapy|0|||
125320605|NCT03037385|450806316|FG006|Overall Study|Initiation of Another Therapy|0|||
125320606|NCT03037385|450806317|FG007|Overall Study|Initiation of Another Therapy|1|||
125320607|NCT03037385|450806318|FG008|Overall Study|Initiation of Another Therapy|0|||
125320608|NCT03037385|450806319|FG009|Overall Study|Initiation of Another Therapy|2|||
125320609|NCT03037385|450806310|FG000|Overall Study|Lost to Follow-up|0|||
125320610|NCT03037385|450806311|FG001|Overall Study|Lost to Follow-up|0|||
125320611|NCT03037385|450806312|FG002|Overall Study|Lost to Follow-up|0|||
125320612|NCT03037385|450806313|FG003|Overall Study|Lost to Follow-up|0|||
125320613|NCT03037385|450806314|FG004|Overall Study|Lost to Follow-up|0|||
125320614|NCT03037385|450806315|FG005|Overall Study|Lost to Follow-up|1|||
125320615|NCT03037385|450806316|FG006|Overall Study|Lost to Follow-up|0|||
125320616|NCT03037385|450806317|FG007|Overall Study|Lost to Follow-up|0|||
125320617|NCT03037385|450806318|FG008|Overall Study|Lost to Follow-up|0|||
125320618|NCT03037385|450806319|FG009|Overall Study|Lost to Follow-up|16|||
125320619|NCT03037385|450806310|FG000|Overall Study|Physician Decision|0|||
125320620|NCT03037385|450806311|FG001|Overall Study|Physician Decision|0|||
125320621|NCT03037385|450806312|FG002|Overall Study|Physician Decision|0|||
125320622|NCT03037385|450806313|FG003|Overall Study|Physician Decision|0|||
125320623|NCT03037385|450806314|FG004|Overall Study|Physician Decision|0|||
125320624|NCT03037385|450806315|FG005|Overall Study|Physician Decision|0|||
125320625|NCT03037385|450806316|FG006|Overall Study|Physician Decision|0|||
125320626|NCT03037385|450806317|FG007|Overall Study|Physician Decision|0|||
125320627|NCT03037385|450806318|FG008|Overall Study|Physician Decision|0|||
125320628|NCT03037385|450806319|FG009|Overall Study|Physician Decision|1|||
125320629|NCT03037385|450806310|FG000|Overall Study|Progressive Disease|0|||
125320630|NCT03037385|450806311|FG001|Overall Study|Progressive Disease|1|||
125320631|NCT03037385|450806312|FG002|Overall Study|Progressive Disease|1|||
125320632|NCT03037385|450806313|FG003|Overall Study|Progressive Disease|5|||
125320633|NCT03037385|450806314|FG004|Overall Study|Progressive Disease|2|||
125320634|NCT03037385|450806315|FG005|Overall Study|Progressive Disease|0|||
125320635|NCT03037385|450806316|FG006|Overall Study|Progressive Disease|1|||
125320636|NCT03037385|450806317|FG007|Overall Study|Progressive Disease|0|||
125320637|NCT03037385|450806318|FG008|Overall Study|Progressive Disease|0|||
125320638|NCT03037385|450806319|FG009|Overall Study|Progressive Disease|30|||
125320639|NCT03037385|450806310|FG000|Overall Study|Withdrawal by Subject|0|||
125320640|NCT03037385|450806311|FG001|Overall Study|Withdrawal by Subject|0|||
125320641|NCT03037385|450806312|FG002|Overall Study|Withdrawal by Subject|1|||
125320642|NCT03037385|450806313|FG003|Overall Study|Withdrawal by Subject|2|||
125320643|NCT03037385|450806314|FG004|Overall Study|Withdrawal by Subject|1|||
125320644|NCT03037385|450806315|FG005|Overall Study|Withdrawal by Subject|3|||
125320645|NCT03037385|450806316|FG006|Overall Study|Withdrawal by Subject|0|||
125320646|NCT03037385|450806317|FG007|Overall Study|Withdrawal by Subject|0|||
125320647|NCT03037385|450806318|FG008|Overall Study|Withdrawal by Subject|0|||
125320648|NCT03037385|450806319|FG009|Overall Study|Withdrawal by Subject|52|||
125320649|NCT03037385|450806310|FG000|Overall Study|Reason Not Specified|0|||
124995256|NCT01620255|449609285|FG004|Overall Study|Non-compliance|0|||
125320650|NCT03037385|450806311|FG001|Overall Study|Reason Not Specified|1|||
125320651|NCT03037385|450806312|FG002|Overall Study|Reason Not Specified|0|||
125320652|NCT03037385|450806313|FG003|Overall Study|Reason Not Specified|4|||
125320653|NCT03037385|450806314|FG004|Overall Study|Reason Not Specified|3|||
125320654|NCT03037385|450806315|FG005|Overall Study|Reason Not Specified|6|||
125320655|NCT03037385|450806316|FG006|Overall Study|Reason Not Specified|2|||
125320656|NCT03037385|450806317|FG007|Overall Study|Reason Not Specified|0|||
125320657|NCT03037385|450806318|FG008|Overall Study|Reason Not Specified|1|||
125320658|NCT03037385|450806319|FG009|Overall Study|Reason Not Specified|181|||
125320659|NCT01838694|450806324|FG000|Overall Study|Adverse Event|0|||
125320660|NCT01838694|450806325|FG001|Overall Study|Adverse Event|1|||
125320661|NCT00672555|450806326|FG000|Overall Study|Lost to Follow-up|4|||
125320662|NCT00672555|450806326|FG000|Overall Study|Did not want to answer questionnaire|2|||
125320663|NCT03623243|450806327|FG000|Overall Study|Adverse Event|15|||
125320664|NCT03623243|450806327|FG000|Overall Study|Guardian Decision|1|||
125320665|NCT03623243|450806327|FG000|Overall Study|New Therapy for Study Indication|1|||
125320666|NCT03623243|450806327|FG000|Overall Study|Protocol Deviation|3|||
125320667|NCT03623243|450806327|FG000|Overall Study|Physician Decision|4|||
125320668|NCT03623243|450806327|FG000|Overall Study|Patient Decision|15|||
125320669|NCT02153086|450806330|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
125320670|NCT02153086|450806330|FG000|Overall Study|Other|2|||
125320671|NCT00446849|450806331|FG000|Acute Phase|Lack of Efficacy|64|||
125320672|NCT00446849|450806331|FG000|Acute Phase|Protocol Violation|10|||
125320673|NCT00446849|450806331|FG000|Acute Phase|Consent withdrawn|4|||
125320674|NCT00446849|450806331|FG000|Acute Phase|Lost to Follow-up|2|||
125320675|NCT00446849|450806331|FG000|Acute Phase|Physician Decision|1|||
125320676|NCT00446849|450806331|FG000|Acute Phase|noncompliance|1|||
125320677|NCT00446849|450806331|FG000|Maintenance Phase|Lack of Efficacy|40|||
125320678|NCT00446849|450806331|FG000|Maintenance Phase|Protocol Violation|7|||
125320679|NCT00446849|450806331|FG000|Maintenance Phase|Adverse Event|6|||
125320680|NCT00446849|450806331|FG000|Maintenance Phase|Consent withdrawn|5|||
125320681|NCT00446849|450806331|FG000|Maintenance Phase|Lost to Follow-up|3|||
125320682|NCT00446849|450806331|FG000|Maintenance Phase|Pregnancy|1|||
125320683|NCT00446849|450806331|FG000|Maintenance Phase|noncompliance|2|||
125320684|NCT00446849|450806331|FG000|Maintenance Phase|prohibited medication use|2|||
125320685|NCT00446849|450806331|FG000|Maintenance Phase|antibiotic use|1|||
125320686|NCT00446849|450806331|FG000|Maintenance Phase|study closure|1|||
125320687|NCT00446849|450806331|FG000|Maintenance Phase|hydrocodone use|1|||
125320688|NCT00446849|450806331|FG000|Maintenance Phase|concomitant medication use|1|||
125320689|NCT05546476|450806334|FG000|Period 1: Part A|Adverse Event|2|||
125320690|NCT05546476|450806335|FG001|Period 1: Part A|Adverse Event|0|||
125320691|NCT05546476|450806336|FG002|Period 1: Part A|Adverse Event|0|||
125320692|NCT05546476|450806337|FG003|Period 1: Part A|Adverse Event|1|||
125320693|NCT05546476|450806334|FG000|Period 1: Part A|Death|4|||
125320694|NCT05546476|450806335|FG001|Period 1: Part A|Death|4|||
125320695|NCT05546476|450806336|FG002|Period 1: Part A|Death|5|||
125320696|NCT05546476|450806337|FG003|Period 1: Part A|Death|6|||
125320697|NCT05546476|450806334|FG000|Period 1: Part A|Lack of Efficacy|0|||
125320698|NCT05546476|450806335|FG001|Period 1: Part A|Lack of Efficacy|0|||
125320699|NCT05546476|450806336|FG002|Period 1: Part A|Lack of Efficacy|0|||
125320700|NCT05546476|450806337|FG003|Period 1: Part A|Lack of Efficacy|1|||
125320701|NCT05546476|450806334|FG000|Period 1: Part A|Lost to Follow-up|0|||
125320702|NCT05546476|450806335|FG001|Period 1: Part A|Lost to Follow-up|0|||
125320703|NCT05546476|450806336|FG002|Period 1: Part A|Lost to Follow-up|0|||
125320704|NCT05546476|450806337|FG003|Period 1: Part A|Lost to Follow-up|1|||
125320705|NCT05546476|450806334|FG000|Period 1: Part A|Physician Decision|1|||
125320706|NCT05546476|450806335|FG001|Period 1: Part A|Physician Decision|0|||
125320707|NCT05546476|450806336|FG002|Period 1: Part A|Physician Decision|0|||
125320708|NCT05546476|450806337|FG003|Period 1: Part A|Physician Decision|0|||
125320709|NCT05546476|450806334|FG000|Period 1: Part A|Progressive disease|3|||
125320710|NCT05546476|450806335|FG001|Period 1: Part A|Progressive disease|5|||
125320711|NCT05546476|450806336|FG002|Period 1: Part A|Progressive disease|0|||
125320712|NCT05546476|450806337|FG003|Period 1: Part A|Progressive disease|1|||
125320713|NCT05546476|450806334|FG000|Period 1: Part A|Withdrawal by Subject|1|||
125320714|NCT05546476|450806335|FG001|Period 1: Part A|Withdrawal by Subject|1|||
125320715|NCT05546476|450806336|FG002|Period 1: Part A|Withdrawal by Subject|1|||
125320716|NCT05546476|450806337|FG003|Period 1: Part A|Withdrawal by Subject|2|||
125320717|NCT05546476|450806334|FG000|Period 1: Part A|Global deterioration of health status|2|||
125320718|NCT05546476|450806335|FG001|Period 1: Part A|Global deterioration of health status|2|||
125320719|NCT05546476|450806336|FG002|Period 1: Part A|Global deterioration of health status|1|||
125320720|NCT05546476|450806337|FG003|Period 1: Part A|Global deterioration of health status|4|||
125320721|NCT05546476|450806334|FG000|Period 1: Part A|Other: Unspecified|0|||
125320722|NCT05546476|450806335|FG001|Period 1: Part A|Other: Unspecified|2|||
125320723|NCT05546476|450806336|FG002|Period 1: Part A|Other: Unspecified|0|||
125320724|NCT05546476|450806337|FG003|Period 1: Part A|Other: Unspecified|0|||
125320725|NCT05546476|450806334|FG000|Period 2: Part B|Ongoing|26|||
125320726|NCT05546476|450806335|FG001|Period 2: Part B|Ongoing|27|||
125320727|NCT05546476|450806336|FG002|Period 2: Part B|Ongoing|35|||
125320728|NCT05546476|450806337|FG003|Period 2: Part B|Ongoing|29|||
124995257|NCT01620255|449609281|FG000|Overall Study|Adverse Event|0|||
125320729|NCT00807911|450806340|FG000|Overall Study|Withdrawal by Subject|12|||
125320730|NCT00807911|450806341|FG001|Overall Study|Withdrawal by Subject|10|||
125320731|NCT00807911|450806340|FG000|Overall Study|Ineligible|0|||
125320732|NCT00807911|450806341|FG001|Overall Study|Ineligible|4|||
125320733|NCT02953652|450806342|FG000|Overall Study|Adverse Event|18|||
125320734|NCT02953652|450806342|FG000|Overall Study|Withdrawal by Subject|6|||
125320735|NCT02953652|450806342|FG000|Overall Study|Protocol Violation|1|||
125320736|NCT02953652|450806342|FG000|Overall Study|Disease Progression|27|||
125320737|NCT03780452|450806346|FG000|Overall Study|Screening failure|2|||
125320738|NCT03796728|450806352|FG000|Overall Study|Lost to Follow-up|8|||
125320739|NCT03796728|450806352|FG000|Overall Study|Reason not Specified|16|||
125320740|NCT00333775|450806353|FG000|Overall Study|Death|144|||
125320741|NCT00333775|450806354|FG001|Overall Study|Death|149|||
125320742|NCT00333775|450806355|FG002|Overall Study|Death|143|||
125320743|NCT00333775|450806353|FG000|Overall Study|In Follow-up When Study Stopped|87|||
125320744|NCT00333775|450806354|FG001|Overall Study|In Follow-up When Study Stopped|92|||
125320745|NCT00333775|450806355|FG002|Overall Study|In Follow-up When Study Stopped|96|||
125320746|NCT00333775|450806353|FG000|Overall Study|Lost to Follow-up|10|||
125320747|NCT00333775|450806354|FG001|Overall Study|Lost to Follow-up|7|||
125320748|NCT00333775|450806355|FG002|Overall Study|Lost to Follow-up|8|||
125320749|NCT01383928|450806359|FG000|Overall Study|Initiation of ASCT|2|||
125320750|NCT01383928|450806360|FG001|Overall Study|Initiation of ASCT|1|||
125320751|NCT01383928|450806361|FG002|Overall Study|Initiation of ASCT|18|||
125320752|NCT01383928|450806359|FG000|Overall Study|Adverse Event|1|||
125320753|NCT01383928|450806360|FG001|Overall Study|Adverse Event|2|||
125320754|NCT01383928|450806361|FG002|Overall Study|Adverse Event|8|||
125320755|NCT01383928|450806359|FG000|Overall Study|Other|1|||
125320756|NCT01383928|450806360|FG001|Overall Study|Other|3|||
125320757|NCT01383928|450806361|FG002|Overall Study|Other|4|||
125320758|NCT01383928|450806359|FG000|Overall Study|Progressive Disease|1|||
125320759|NCT01383928|450806360|FG001|Overall Study|Progressive Disease|1|||
125320760|NCT01383928|450806361|FG002|Overall Study|Progressive Disease|5|||
125320761|NCT01383928|450806359|FG000|Overall Study|Withdrawal by Subject|0|||
125320762|NCT01383928|450806360|FG001|Overall Study|Withdrawal by Subject|0|||
125320763|NCT01383928|450806361|FG002|Overall Study|Withdrawal by Subject|4|||
125320764|NCT01383928|450806359|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
125320765|NCT01383928|450806360|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
125320766|NCT01383928|450806361|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
125320767|NCT03651765|450806364|FG000|Overall Study|Adverse Event|6|||
125320768|NCT03651765|450806364|FG000|Overall Study|Lack of Efficacy|18|||
125320769|NCT03651765|450806364|FG000|Overall Study|Lost to Follow-up|5|||
125320770|NCT03651765|450806364|FG000|Overall Study|Non-Compliance with Study Drug|4|||
125320771|NCT03651765|450806364|FG000|Overall Study|Physician Decision|6|||
125320772|NCT03651765|450806364|FG000|Overall Study|Pregnancy|1|||
125320773|NCT03651765|450806364|FG000|Overall Study|Discontinued by Sponsor|40|||
125320774|NCT03651765|450806364|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
125320775|NCT03651765|450806364|FG000|Overall Study|Withdrawal by Subject|24|||
125320776|NCT03651765|450806364|FG000|Overall Study|Miscellaneous|6|||
125320777|NCT04842747|450806376|FG000|Overall Study|Withdrawal by Subject|6|||
125320778|NCT04842747|450806377|FG001|Overall Study|Withdrawal by Subject|2|||
125320779|NCT04842747|450806376|FG000|Overall Study|Lost to Follow-up|1|||
125320780|NCT04842747|450806377|FG001|Overall Study|Lost to Follow-up|2|||
125320781|NCT04842747|450806376|FG000|Overall Study|Physician Decision|1|||
125320782|NCT04842747|450806377|FG001|Overall Study|Physician Decision|0|||
125320783|NCT04842747|450806376|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
125320784|NCT04842747|450806377|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
125320785|NCT01743469|450806378|FG000|Active Treatment Phase|Adverse Event|10|||
125320786|NCT01743469|450806379|FG001|Active Treatment Phase|Adverse Event|5|||
125320787|NCT01743469|450806380|FG002|Active Treatment Phase|Adverse Event|8|||
125320788|NCT01743469|450806381|FG003|Active Treatment Phase|Adverse Event|1|||
124995258|NCT01620255|449609282|FG001|Overall Study|Adverse Event|4|||
124995259|NCT01620255|449609283|FG002|Overall Study|Adverse Event|0|||
124995260|NCT01620255|449609284|FG003|Overall Study|Adverse Event|1|||
124995261|NCT01620255|449609285|FG004|Overall Study|Adverse Event|1|||
124995262|NCT01620255|449609281|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
124995263|NCT01620255|449609282|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
124995264|NCT01620255|449609283|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
124995265|NCT01620255|449609284|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
124995266|NCT01620255|449609285|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
125320789|NCT01743469|450806378|FG000|Active Treatment Phase|Disease Progression|40|||
125320790|NCT01743469|450806379|FG001|Active Treatment Phase|Disease Progression|47|||
125320791|NCT01743469|450806380|FG002|Active Treatment Phase|Disease Progression|30|||
125320792|NCT01743469|450806381|FG003|Active Treatment Phase|Disease Progression|20|||
125320793|NCT01743469|450806378|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
125320794|NCT01743469|450806379|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
125320795|NCT01743469|450806380|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
125320796|NCT01743469|450806381|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
125320797|NCT01743469|450806378|FG000|Active Treatment Phase|Missing|1|||
125320798|NCT01743469|450806379|FG001|Active Treatment Phase|Missing|0|||
125320799|NCT01743469|450806380|FG002|Active Treatment Phase|Missing|0|||
125320800|NCT01743469|450806381|FG003|Active Treatment Phase|Missing|0|||
125320801|NCT01743469|450806378|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
125320802|NCT01743469|450806379|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
125320803|NCT01743469|450806380|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
125320804|NCT01743469|450806381|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
125320805|NCT01743469|450806378|FG000|Follow-up Period - Post-Treatment|Death|43|||
125320806|NCT01743469|450806379|FG001|Follow-up Period - Post-Treatment|Death|47|||
125320807|NCT01743469|450806380|FG002|Follow-up Period - Post-Treatment|Death|22|||
125320808|NCT01743469|450806381|FG003|Follow-up Period - Post-Treatment|Death|16|||
125320809|NCT01743469|450806378|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
125320810|NCT01743469|450806379|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
125320811|NCT01743469|450806380|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
125320812|NCT01743469|450806381|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
125320813|NCT01451606|450806382|FG000|Overall Study|Withdrawal by Subject|4|||
125320814|NCT01451606|450806383|FG001|Overall Study|Withdrawal by Subject|3|||
125320815|NCT04011540|450806389|FG000|Overall Study|Lost to Follow-up|9|||
125320816|NCT04011540|450806390|FG001|Overall Study|Lost to Follow-up|6|||
125320817|NCT02138890|450806395|FG000|Overall Study|Adverse Event|1|||
125320818|NCT02138890|450806396|FG001|Overall Study|Adverse Event|0|||
125320819|NCT01446159|450806397|FG000|Overall Study|Withdrawal by Subject|1|||
125320820|NCT01446159|450806398|FG001|Overall Study|Withdrawal by Subject|0|||
125320821|NCT01446159|450806399|FG002|Overall Study|Withdrawal by Subject|14|||
125320822|NCT01446159|450806400|FG003|Overall Study|Withdrawal by Subject|11|||
125320823|NCT01446159|450806397|FG000|Overall Study|Lost to Follow-up|0|||
125320824|NCT01446159|450806398|FG001|Overall Study|Lost to Follow-up|0|||
125320825|NCT01446159|450806399|FG002|Overall Study|Lost to Follow-up|1|||
125320826|NCT01446159|450806400|FG003|Overall Study|Lost to Follow-up|2|||
125320827|NCT01446159|450806397|FG000|Overall Study|Death|2|||
125320828|NCT01446159|450806398|FG001|Overall Study|Death|3|||
125320829|NCT01446159|450806399|FG002|Overall Study|Death|43|||
125320830|NCT01446159|450806400|FG003|Overall Study|Death|36|||
125320831|NCT01446159|450806397|FG000|Overall Study|Other|0|||
125320832|NCT01446159|450806398|FG001|Overall Study|Other|0|||
125320833|NCT01446159|450806399|FG002|Overall Study|Other|13|||
125320834|NCT01446159|450806400|FG003|Overall Study|Other|13|||
125320835|NCT03668873|450806401|FG000|Overall Study|Lost to Follow-up|6|||
125320836|NCT03668873|450806402|FG001|Overall Study|Lost to Follow-up|3|||
125320837|NCT02183675|450806403|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
125320838|NCT02183675|450806404|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
125320839|NCT02183675|450806405|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
125320840|NCT02183675|450806406|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
125320841|NCT02183675|450806407|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
125320842|NCT02183675|450806408|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
125320843|NCT01521117|450806409|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
125320844|NCT01521117|450806410|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
125320845|NCT01521117|450806409|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
125320846|NCT01521117|450806410|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
125320847|NCT01521117|450806409|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
125320848|NCT01521117|450806410|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
125320849|NCT00795535|450806415|FG000|Overall Study|incomplete data and technical problems|20|||
125320850|NCT04576988|450806416|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
125320851|NCT04576988|450806417|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
125320852|NCT04576988|450806416|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
125320853|NCT04576988|450806417|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
125320854|NCT04576988|450806416|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
125320855|NCT04576988|450806417|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
125320856|NCT04576988|450806416|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
125320857|NCT04576988|450806417|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
125320858|NCT04576988|450806416|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
125320859|NCT04576988|450806417|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
125320860|NCT04576988|450806416|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
125320861|NCT04576988|450806417|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
125320862|NCT04576988|450806416|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
125320863|NCT04576988|450806417|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
125320864|NCT04576988|450806416|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
125320865|NCT04576988|450806417|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
125320866|NCT04576988|450806416|FG000|Long Term Double Blind (LTDB)|Death|2|||
125320867|NCT04576988|450806417|FG001|Long Term Double Blind (LTDB)|Death|1|||
125320868|NCT04576988|450806416|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
125320869|NCT04576988|450806417|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
125320870|NCT00617734|450806418|FG000|Overall Study|Withdrew Consent|2|||
124995267|NCT01155375|449609293|FG000|Overall Study|Adverse Event|1|||
124995268|NCT01155375|449609294|FG001|Overall Study|Adverse Event|0|||
124995269|NCT01933113|449609295|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
124995270|NCT04981366|449609296|FG000|Overall Study|Withdrawal by Subject|5|||
124995271|NCT04981366|449609297|FG001|Overall Study|Withdrawal by Subject|4|||
124995272|NCT04981366|449609298|FG002|Overall Study|Withdrawal by Subject|8|||
124995273|NCT04981366|449609296|FG000|Overall Study|Health issues unrelated to the trial|1|||
124995274|NCT04981366|449609297|FG001|Overall Study|Health issues unrelated to the trial|2|||
124995275|NCT04981366|449609298|FG002|Overall Study|Health issues unrelated to the trial|0|||
124995276|NCT01122862|449609310|FG000|Period 1|Protocol Violation|0|||
124995277|NCT01122862|449609311|FG001|Period 1|Protocol Violation|1|||
124995278|NCT01122862|449609312|FG002|Period 1|Protocol Violation|0|||
124995279|NCT01122862|449609310|FG000|Period 2|Adverse Event|0|||
124995280|NCT01122862|449609311|FG001|Period 2|Adverse Event|0|||
125210616|NCT02603107|450395613|FG001|Optional Extension Phase|Lost to Follow-up|3|||
125210617|NCT02603107|450395612|FG000|Optional Extension Phase|Withdrew consent|3|||
125210618|NCT02603107|450395613|FG001|Optional Extension Phase|Withdrew consent|2|||
125210619|NCT02603107|450395612|FG000|Optional Extension Phase|Investigator's discretion|2|||
125210620|NCT02603107|450395613|FG001|Optional Extension Phase|Investigator's discretion|2|||
125210621|NCT02603107|450395612|FG000|Optional Extension Phase|Pregnancy|0|||
125210622|NCT02603107|450395613|FG001|Optional Extension Phase|Pregnancy|3|||
125210623|NCT02603107|450395612|FG000|Optional Extension Phase|Adverse Event|0|||
125210624|NCT02603107|450395613|FG001|Optional Extension Phase|Adverse Event|2|||
125210625|NCT02603107|450395612|FG000|Optional Extension Phase|Not treated in extension phase|0|||
125210626|NCT02603107|450395613|FG001|Optional Extension Phase|Not treated in extension phase|1|||
125210627|NCT02603107|450395612|FG000|Optional Extension Phase|Protocol Violation|1|||
125210628|NCT02603107|450395613|FG001|Optional Extension Phase|Protocol Violation|0|||
125210629|NCT03411902|450395614|FG000|Overall Study|Lost to Follow-up|3|||
125210630|NCT03411902|450395615|FG001|Overall Study|Lost to Follow-up|0|||
125210631|NCT00419159|450395616|FG000|Overall Study|Adverse Event|7|||
125210632|NCT00419159|450395617|FG001|Overall Study|Adverse Event|15|||
125210633|NCT00419159|450395616|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125210634|NCT00419159|450395617|FG001|Overall Study|Abnormal laboratory value(s)|2|||
125210635|NCT00419159|450395616|FG000|Overall Study|Subject's no longer requires study drug|0|||
125210636|NCT00419159|450395617|FG001|Overall Study|Subject's no longer requires study drug|1|||
125210637|NCT00419159|450395616|FG000|Overall Study|Protocol Violation|1|||
125210638|NCT00419159|450395617|FG001|Overall Study|Protocol Violation|0|||
125210639|NCT00419159|450395616|FG000|Overall Study|Withdrawal by Subject|10|||
125210640|NCT00419159|450395617|FG001|Overall Study|Withdrawal by Subject|3|||
125210641|NCT00419159|450395616|FG000|Overall Study|Lost to Follow-up|0|||
125210642|NCT00419159|450395617|FG001|Overall Study|Lost to Follow-up|1|||
125210643|NCT00419159|450395616|FG000|Overall Study|Death|2|||
125210644|NCT00419159|450395617|FG001|Overall Study|Death|2|||
125210645|NCT00419159|450395616|FG000|Overall Study|Disease progression|79|||
125210646|NCT00419159|450395617|FG001|Overall Study|Disease progression|76|||
125210647|NCT01017601|450395618|FG000|Overall Study|Disease Progression|12|||
125210648|NCT01017601|450395619|FG001|Overall Study|Disease Progression|12|||
125210649|NCT01017601|450395618|FG000|Overall Study|Withdrawal by Subject|0|||
125210650|NCT01017601|450395619|FG001|Overall Study|Withdrawal by Subject|1|||
125210651|NCT00187278|450395624|FG000|Overall Study|Protocol Violation|10|||
125210652|NCT00187278|450395625|FG001|Overall Study|Protocol Violation|13|||
125210653|NCT00803205|450395626|FG000|Overall Study|Adverse Event|7|||
125210654|NCT00803205|450395627|FG001|Overall Study|Adverse Event|2|||
125210655|NCT00803205|450395626|FG000|Overall Study|Lost to Follow-up|1|||
125210656|NCT00803205|450395627|FG001|Overall Study|Lost to Follow-up|0|||
125210657|NCT00803205|450395626|FG000|Overall Study|Withdrawal by Subject|9|||
125210658|NCT00803205|450395627|FG001|Overall Study|Withdrawal by Subject|9|||
125210659|NCT00803205|450395626|FG000|Overall Study|Physician Decision|1|||
125210660|NCT00803205|450395627|FG001|Overall Study|Physician Decision|0|||
125210661|NCT00803205|450395626|FG000|Overall Study|Protocol Violation|1|||
125210662|NCT00803205|450395627|FG001|Overall Study|Protocol Violation|1|||
125210663|NCT00803205|450395626|FG000|Overall Study|Medical Monitor Decision|1|||
125210664|NCT00803205|450395627|FG001|Overall Study|Medical Monitor Decision|0|||
125210665|NCT00803205|450395626|FG000|Overall Study|Acquired a Lung Infection|0|||
125210666|NCT00803205|450395627|FG001|Overall Study|Acquired a Lung Infection|1|||
125210667|NCT00803205|450395626|FG000|Overall Study|Sponsor Decision|0|||
125210668|NCT00803205|450395627|FG001|Overall Study|Sponsor Decision|1|||
125210669|NCT02735096|450395628|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
125210670|NCT00379808|450395629|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
125210671|NCT00379808|450395630|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
125210672|NCT02638259|450395634|FG000|Treatment Period 1|Adverse Event|1|||
125210673|NCT02638259|450395635|FG001|Treatment Period 1|Adverse Event|5|||
125210674|NCT02638259|450395634|FG000|Treatment Period 1|Death|0|||
125210675|NCT02638259|450395635|FG001|Treatment Period 1|Death|1|||
125210676|NCT02638259|450395634|FG000|Treatment Period 1|Lack of Efficacy|0|||
125210677|NCT02638259|450395635|FG001|Treatment Period 1|Lack of Efficacy|1|||
125320871|NCT00617734|450806419|FG001|Overall Study|Withdrew Consent|0|||
125320872|NCT00617734|450806418|FG000|Overall Study|Adverse Event|4|||
125320873|NCT00617734|450806419|FG001|Overall Study|Adverse Event|1|||
125320874|NCT00617734|450806418|FG000|Overall Study|Protocol Violation|1|||
125320875|NCT00617734|450806419|FG001|Overall Study|Protocol Violation|0|||
125320876|NCT00617734|450806418|FG000|Overall Study|Found Ineligible After Randomization|1|||
125320877|NCT00617734|450806419|FG001|Overall Study|Found Ineligible After Randomization|4|||
125320878|NCT00617734|450806418|FG000|Overall Study|Lost to Follow-up|0|||
125320879|NCT00617734|450806419|FG001|Overall Study|Lost to Follow-up|1|||
125320880|NCT01844765|450806420|FG000|Overall Study|Adverse Event|6|||
125320881|NCT01844765|450806421|FG001|Overall Study|Adverse Event|8|||
125320882|NCT01844765|450806420|FG000|Overall Study|Withdrawal by Subject|2|||
125320883|NCT01844765|450806421|FG001|Overall Study|Withdrawal by Subject|3|||
125320884|NCT01844765|450806420|FG000|Overall Study|Disease progression|1|||
125320885|NCT01844765|450806421|FG001|Overall Study|Disease progression|0|||
125320886|NCT01844765|450806420|FG000|Overall Study|Administrative problems|3|||
125320887|NCT01844765|450806421|FG001|Overall Study|Administrative problems|4|||
125320888|NCT01844765|450806420|FG000|Overall Study|Protocol deviation|2|||
125320889|NCT01844765|450806421|FG001|Overall Study|Protocol deviation|0|||
125320890|NCT01844765|450806420|FG000|Overall Study|Untreated|1|||
125320891|NCT01844765|450806421|FG001|Overall Study|Untreated|0|||
125320892|NCT00556075|450806427|FG000|Overall Study|Lost to Follow-up|3|||
125320893|NCT00556075|450806428|FG001|Overall Study|Lost to Follow-up|0|||
125320894|NCT00556075|450806429|FG002|Overall Study|Lost to Follow-up|3|||
125320895|NCT00556075|450806427|FG000|Overall Study|Withdrawal by Subject|3|||
125320896|NCT00556075|450806428|FG001|Overall Study|Withdrawal by Subject|3|||
125320897|NCT00556075|450806429|FG002|Overall Study|Withdrawal by Subject|0|||
125320898|NCT00556075|450806427|FG000|Overall Study|Protocol Violation|1|||
125320899|NCT00556075|450806428|FG001|Overall Study|Protocol Violation|1|||
125320900|NCT00556075|450806429|FG002|Overall Study|Protocol Violation|3|||
125320901|NCT00556075|450806427|FG000|Overall Study|Not eligible|1|||
125320902|NCT00556075|450806428|FG001|Overall Study|Not eligible|1|||
125320903|NCT00556075|450806429|FG002|Overall Study|Not eligible|2|||
125320904|NCT00556075|450806427|FG000|Overall Study|Adverse Event|1|||
125320905|NCT00556075|450806428|FG001|Overall Study|Adverse Event|2|||
125320906|NCT00556075|450806429|FG002|Overall Study|Adverse Event|0|||
125320907|NCT00556075|450806427|FG000|Overall Study|Personal issues|4|||
125320908|NCT00556075|450806428|FG001|Overall Study|Personal issues|1|||
125320909|NCT00556075|450806429|FG002|Overall Study|Personal issues|0|||
125320910|NCT00556075|450806427|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
125320911|NCT00556075|450806428|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
125320912|NCT00556075|450806429|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
125320913|NCT02485691|450806430|FG000|Overall Study|Adverse Event|25|||
125320914|NCT02485691|450806431|FG001|Overall Study|Adverse Event|11|||
125320915|NCT02485691|450806430|FG000|Overall Study|Poor compliance to protocol|0|||
125320916|NCT02485691|450806431|FG001|Overall Study|Poor compliance to protocol|1|||
125320917|NCT02485691|450806430|FG000|Overall Study|Disease progression|57|||
125320918|NCT02485691|450806431|FG001|Overall Study|Disease progression|92|||
125320919|NCT02485691|450806430|FG000|Overall Study|Investigator's decision|23|||
125320920|NCT02485691|450806431|FG001|Overall Study|Investigator's decision|5|||
125320921|NCT02485691|450806430|FG000|Overall Study|Participant's request|13|||
125320922|NCT02485691|450806431|FG001|Overall Study|Participant's request|6|||
125320923|NCT02485691|450806430|FG000|Overall Study|Other reason|8|||
125320924|NCT02485691|450806431|FG001|Overall Study|Other reason|9|||
125320925|NCT02485691|450806430|FG000|Overall Study|Randomized and not treated|3|||
125320926|NCT02485691|450806431|FG001|Overall Study|Randomized and not treated|2|||
125320927|NCT00604565|450806432|FG000|Overall Study|Study terminated|0|||
125320928|NCT00604565|450806433|FG001|Overall Study|Study terminated|3|||
125320929|NCT04292535|450806434|FG000|Overall Study|Withdrawal by Subject|0|||
125320930|NCT04292535|450806435|FG001|Overall Study|Withdrawal by Subject|0|||
125320931|NCT04292535|450806436|FG002|Overall Study|Withdrawal by Subject|0|||
125320932|NCT04292535|450806437|FG003|Overall Study|Withdrawal by Subject|0|||
125320933|NCT04292535|450806438|FG004|Overall Study|Withdrawal by Subject|0|||
125320934|NCT04292535|450806439|FG005|Overall Study|Withdrawal by Subject|0|||
125320935|NCT04292535|450806440|FG006|Overall Study|Withdrawal by Subject|0|||
125320936|NCT04292535|450806441|FG007|Overall Study|Withdrawal by Subject|1|||
125320937|NCT04292535|450806442|FG008|Overall Study|Withdrawal by Subject|0|||
125320938|NCT04292535|450806443|FG009|Overall Study|Withdrawal by Subject|0|||
125320939|NCT04292535|450806444|FG010|Overall Study|Withdrawal by Subject|0|||
125320940|NCT04292535|450806445|FG011|Overall Study|Withdrawal by Subject|0|||
125320941|NCT04292535|450806446|FG012|Overall Study|Withdrawal by Subject|0|||
125320942|NCT04292535|450806447|FG013|Overall Study|Withdrawal by Subject|0|||
125320943|NCT04292535|450806434|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125320944|NCT04292535|450806435|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125320945|NCT04292535|450806436|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
124995281|NCT01122862|449609312|FG002|Period 2|Adverse Event|1|||
125320946|NCT04292535|450806437|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125320947|NCT04292535|450806438|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125320948|NCT04292535|450806439|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125320949|NCT04292535|450806440|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125320950|NCT04292535|450806441|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
125320951|NCT04292535|450806442|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125320952|NCT04292535|450806443|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125320953|NCT04292535|450806444|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125320954|NCT04292535|450806445|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125320955|NCT04292535|450806446|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
125320956|NCT04292535|450806447|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
125320957|NCT04292535|450806434|FG000|Overall Study|Report of Dizziness|0|||
125320958|NCT04292535|450806435|FG001|Overall Study|Report of Dizziness|0|||
125320959|NCT04292535|450806436|FG002|Overall Study|Report of Dizziness|0|||
125320960|NCT04292535|450806437|FG003|Overall Study|Report of Dizziness|0|||
125320961|NCT04292535|450806438|FG004|Overall Study|Report of Dizziness|0|||
125320962|NCT04292535|450806439|FG005|Overall Study|Report of Dizziness|0|||
125320963|NCT04292535|450806440|FG006|Overall Study|Report of Dizziness|0|||
125320964|NCT04292535|450806441|FG007|Overall Study|Report of Dizziness|0|||
125320965|NCT04292535|450806442|FG008|Overall Study|Report of Dizziness|0|||
125320966|NCT04292535|450806443|FG009|Overall Study|Report of Dizziness|0|||
125320967|NCT04292535|450806444|FG010|Overall Study|Report of Dizziness|0|||
125320968|NCT04292535|450806445|FG011|Overall Study|Report of Dizziness|0|||
124995282|NCT02699983|449609314|FG000|Overall Study|Withdrawal by Subject|1|||
125320969|NCT04292535|450806446|FG012|Overall Study|Report of Dizziness|0|||
125320970|NCT04292535|450806447|FG013|Overall Study|Report of Dizziness|1|||
125320971|NCT04292535|450806434|FG000|Overall Study|Equipment Failure|0|||
125320972|NCT04292535|450806435|FG001|Overall Study|Equipment Failure|0|||
125320973|NCT04292535|450806436|FG002|Overall Study|Equipment Failure|0|||
125320974|NCT04292535|450806437|FG003|Overall Study|Equipment Failure|0|||
125320975|NCT04292535|450806438|FG004|Overall Study|Equipment Failure|0|||
125320976|NCT04292535|450806439|FG005|Overall Study|Equipment Failure|0|||
125320977|NCT04292535|450806440|FG006|Overall Study|Equipment Failure|0|||
125320978|NCT04292535|450806441|FG007|Overall Study|Equipment Failure|0|||
125320979|NCT04292535|450806442|FG008|Overall Study|Equipment Failure|0|||
125320980|NCT04292535|450806443|FG009|Overall Study|Equipment Failure|0|||
125320981|NCT04292535|450806444|FG010|Overall Study|Equipment Failure|0|||
125320982|NCT04292535|450806445|FG011|Overall Study|Equipment Failure|1|||
125320983|NCT04292535|450806446|FG012|Overall Study|Equipment Failure|0|||
125320984|NCT04292535|450806447|FG013|Overall Study|Equipment Failure|0|||
125320985|NCT03836625|450806448|FG000|Overall Study|Lost to Follow-up|9|||
125320986|NCT03836625|450806449|FG001|Overall Study|Lost to Follow-up|9|||
125320987|NCT03836625|450806448|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
125320988|NCT03836625|450806449|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
125320989|NCT03836625|450806448|FG000|Overall Study|Death|0|||
125320990|NCT03836625|450806449|FG001|Overall Study|Death|1|||
125320991|NCT03836625|450806448|FG000|Overall Study|Refused follow-up|0|||
125320992|NCT03836625|450806449|FG001|Overall Study|Refused follow-up|1|||
125320993|NCT01420861|450806454|FG000|Overall Study|Adverse Event|2|||
125320994|NCT01420861|450806454|FG000|Overall Study|Study terminated by Sponsor|7|||
125320995|NCT01420861|450806454|FG000|Overall Study|Screen failure|7|||
125320996|NCT01420861|450806454|FG000|Overall Study|Randomized not Treated|2|||
125320997|NCT01247324|450806455|FG000|Overall Study|Death|6|||
125320998|NCT01247324|450806456|FG001|Overall Study|Death|10|||
125320999|NCT01247324|450806455|FG000|Overall Study|Physician Decision|2|||
125321000|NCT01247324|450806456|FG001|Overall Study|Physician Decision|3|||
125321001|NCT01247324|450806455|FG000|Overall Study|Non-compliance with study drug|3|||
125321002|NCT01247324|450806456|FG001|Overall Study|Non-compliance with study drug|0|||
125321003|NCT01247324|450806455|FG000|Overall Study|Lack of Efficacy|24|||
125321004|NCT01247324|450806456|FG001|Overall Study|Lack of Efficacy|14|||
125321005|NCT01247324|450806455|FG000|Overall Study|Non-compliance|3|||
125321006|NCT01247324|450806456|FG001|Overall Study|Non-compliance|2|||
125321007|NCT01247324|450806455|FG000|Overall Study|Pregnancy|5|||
125321008|NCT01247324|450806456|FG001|Overall Study|Pregnancy|10|||
125321009|NCT01247324|450806455|FG000|Overall Study|Protocol Violation|1|||
125321010|NCT01247324|450806456|FG001|Overall Study|Protocol Violation|1|||
125321011|NCT01247324|450806455|FG000|Overall Study|Reason not specified|42|||
125321012|NCT01247324|450806456|FG001|Overall Study|Reason not specified|32|||
125321013|NCT01247324|450806455|FG000|Overall Study|Consent withdrawn by participant|41|||
125321014|NCT01247324|450806456|FG001|Overall Study|Consent withdrawn by participant|56|||
125321015|NCT01247324|450806455|FG000|Overall Study|Adverse Event|49|||
125321016|NCT01247324|450806456|FG001|Overall Study|Adverse Event|35|||
125321017|NCT01247324|450806455|FG000|Overall Study|Lost to Follow-up|3|||
125321018|NCT01247324|450806456|FG001|Overall Study|Lost to Follow-up|6|||
125321019|NCT01247324|450806455|FG000|Overall Study|Study Terminated by Sponsor|4|||
125321020|NCT01247324|450806456|FG001|Overall Study|Study Terminated by Sponsor|1|||
125321021|NCT01247324|450806455|FG000|Overall Study|Missing|2|||
125321022|NCT01247324|450806456|FG001|Overall Study|Missing|1|||
125321023|NCT01253291|450806457|FG000|Overall Study|Withdrawal by Subject|1|||
125321024|NCT01253291|450806458|FG001|Overall Study|Withdrawal by Subject|1|||
125321025|NCT01253291|450806459|FG002|Overall Study|Withdrawal by Subject|0|||
125321026|NCT01253291|450806460|FG003|Overall Study|Withdrawal by Subject|0|||
125321027|NCT01253291|450806461|FG004|Overall Study|Withdrawal by Subject|0|||
125321028|NCT01253291|450806457|FG000|Overall Study|Adverse Event|0|||
125321029|NCT01253291|450806458|FG001|Overall Study|Adverse Event|1|||
125321030|NCT01253291|450806459|FG002|Overall Study|Adverse Event|0|||
125321031|NCT01253291|450806460|FG003|Overall Study|Adverse Event|0|||
125321032|NCT01253291|450806461|FG004|Overall Study|Adverse Event|0|||
125321033|NCT01253291|450806457|FG000|Overall Study|Lack of Efficacy|1|||
125321034|NCT01253291|450806458|FG001|Overall Study|Lack of Efficacy|0|||
125321035|NCT01253291|450806459|FG002|Overall Study|Lack of Efficacy|0|||
125321036|NCT01253291|450806460|FG003|Overall Study|Lack of Efficacy|0|||
125321037|NCT01253291|450806461|FG004|Overall Study|Lack of Efficacy|0|||
125321038|NCT01253291|450806457|FG000|Overall Study|Physician Decision|2|||
125321039|NCT01253291|450806458|FG001|Overall Study|Physician Decision|0|||
125321040|NCT01253291|450806459|FG002|Overall Study|Physician Decision|0|||
125321041|NCT01253291|450806460|FG003|Overall Study|Physician Decision|0|||
125321042|NCT01253291|450806461|FG004|Overall Study|Physician Decision|2|||
125321043|NCT01021020|450808033|FG000|Period I|Protocol Violation|1|||
125321044|NCT01021020|450808033|FG000|Period I|Withdrawal by Subject|1|||
125321045|NCT01021020|450808033|FG000|14 Day Washout Period A|Physician Decision|1|||
125321046|NCT03598036|450808036|FG000|Overall Study|Withdrawal by Subject|1|||
125321047|NCT03598036|450808037|FG001|Overall Study|Withdrawal by Subject|0|||
125321048|NCT04607668|450808039|FG000|Overall Study|Death|49|||
125321049|NCT04607668|450808040|FG001|Overall Study|Death|26|||
125321050|NCT04607668|450808039|FG000|Overall Study|Lost to Follow-up|3|||
125321051|NCT04607668|450808040|FG001|Overall Study|Lost to Follow-up|4|||
125321052|NCT04607668|450808039|FG000|Overall Study|Study terminated by Sponsor|92|||
125321053|NCT04607668|450808040|FG001|Overall Study|Study terminated by Sponsor|114|||
125321054|NCT04607668|450808039|FG000|Overall Study|Withdrawal by Subject|12|||
125321055|NCT04607668|450808040|FG001|Overall Study|Withdrawal by Subject|11|||
125321056|NCT04607668|450808039|FG000|Overall Study|Other, unspecified|8|||
125321057|NCT04607668|450808040|FG001|Overall Study|Other, unspecified|7|||
125321058|NCT01488045|450808041|FG000|Overall Study|Withdrawal by Subject|6|||
125321059|NCT01488045|450808042|FG001|Overall Study|Withdrawal by Subject|11|||
125321060|NCT01488045|450808041|FG000|Overall Study|Failure to present for colonoscopy|3|||
125321061|NCT01488045|450808042|FG001|Overall Study|Failure to present for colonoscopy|6|||
125321062|NCT01488045|450808041|FG000|Overall Study|Failure to report exclusion criteria|0|||
125321063|NCT01488045|450808042|FG001|Overall Study|Failure to report exclusion criteria|1|||
125321064|NCT02230410|450808049|FG000|Overall Study|Screen Failure|3|||
125321065|NCT02388269|450808056|FG000|Overall Study|Adverse Event|2|||
125321066|NCT02388269|450808057|FG001|Overall Study|Adverse Event|0|||
125321067|NCT02388269|450808058|FG002|Overall Study|Adverse Event|0|||
125321068|NCT02388269|450808056|FG000|Overall Study|Withdrawal by Subject|1|||
125321069|NCT02388269|450808057|FG001|Overall Study|Withdrawal by Subject|2|||
125321070|NCT02388269|450808058|FG002|Overall Study|Withdrawal by Subject|0|||
125321071|NCT02388269|450808056|FG000|Overall Study|less than 50% stimulations|1|||
125321072|NCT02388269|450808057|FG001|Overall Study|less than 50% stimulations|0|||
125321073|NCT02388269|450808058|FG002|Overall Study|less than 50% stimulations|0|||
125321074|NCT02388269|450808056|FG000|Overall Study|no diary data|3|||
125321075|NCT02388269|450808057|FG001|Overall Study|no diary data|0|||
125321076|NCT02388269|450808058|FG002|Overall Study|no diary data|0|||
125321077|NCT02388269|450808056|FG000|Overall Study|Protocol Violation|2|||
125321078|NCT02388269|450808057|FG001|Overall Study|Protocol Violation|0|||
125321079|NCT02388269|450808058|FG002|Overall Study|Protocol Violation|0|||
125321080|NCT02388269|450808056|FG000|Overall Study|Screen Failure|0|||
125321081|NCT02388269|450808057|FG001|Overall Study|Screen Failure|0|||
125321082|NCT02388269|450808058|FG002|Overall Study|Screen Failure|10|||
125321083|NCT03448406|450808059|FG000|Overall Study|Noncompliance of scheduled visits|1|||
125321084|NCT03448406|450808060|FG001|Overall Study|Noncompliance of scheduled visits|2|||
125321085|NCT03448406|450808059|FG000|Overall Study|Withdrawal by Subject|1|||
125321086|NCT03448406|450808060|FG001|Overall Study|Withdrawal by Subject|2|||
125321087|NCT03448406|450808059|FG000|Overall Study|Protocol Violation|1|||
125321088|NCT03448406|450808060|FG001|Overall Study|Protocol Violation|0|||
125321089|NCT03448406|450808059|FG000|Overall Study|Adverse Event|8|||
125321090|NCT03448406|450808060|FG001|Overall Study|Adverse Event|9|||
125321091|NCT03405792|450808061|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
125321092|NCT03405792|450808062|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
125321093|NCT03405792|450808061|FG000|Overall Study|o Did not receive pembrolizumab|1|||
124995283|NCT02699983|449609315|FG001|Overall Study|Withdrawal by Subject|0|||
124995284|NCT03421431|449609316|FG000|Overall Study|Adverse Event|2|||
125321094|NCT03405792|450808062|FG001|Overall Study|o Did not receive pembrolizumab|0|||
124995285|NCT03421431|449609317|FG001|Overall Study|Adverse Event|1|||
125321095|NCT03962491|450808063|FG000|Overall Study|Lost to Follow-up|4|||
125321096|NCT03962491|450808064|FG001|Overall Study|Lost to Follow-up|5|||
125321097|NCT03882021|450808065|FG000|Enrollment|Procedure aborted/cancelled|2|||
124995286|NCT03421431|449609318|FG002|Overall Study|Adverse Event|12|||
124995287|NCT03421431|449609316|FG000|Overall Study|Lost to Follow-up|1|||
124995288|NCT03421431|449609317|FG001|Overall Study|Lost to Follow-up|1|||
124995289|NCT03421431|449609318|FG002|Overall Study|Lost to Follow-up|1|||
124995290|NCT03421431|449609316|FG000|Overall Study|Withdrawal by Subject|3|||
124995291|NCT03421431|449609317|FG001|Overall Study|Withdrawal by Subject|2|||
125321098|NCT03882021|450808065|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
125321099|NCT03882021|450808065|FG000|Enrollment to 3-Month|Death|1|||
125321100|NCT03882021|450808065|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
125321101|NCT03882021|450808065|FG000|Enrollment to 3-Month|Missed Visit|4|||
125321102|NCT03882021|450808065|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
125321103|NCT03882021|450808065|FG000|6-Month to 12-Month Visit|Death|1|||
125321104|NCT03882021|450808065|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
125321105|NCT03186209|450808066|FG000|Overall Study|Withdrawal by Subject|11|||
125321106|NCT03186209|450808067|FG001|Overall Study|Withdrawal by Subject|22|||
125321107|NCT03186209|450808066|FG000|Overall Study|Pregnancy|1|||
125321108|NCT03186209|450808067|FG001|Overall Study|Pregnancy|0|||
125321109|NCT03186209|450808066|FG000|Overall Study|Adverse Event|4|||
125321110|NCT03186209|450808067|FG001|Overall Study|Adverse Event|0|||
125321111|NCT03186209|450808066|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
125321112|NCT03186209|450808067|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
125321113|NCT03186209|450808066|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
125321114|NCT03186209|450808067|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
125321115|NCT03186209|450808066|FG000|Overall Study|Fail to meet randomization criteria|0|||
125321116|NCT03186209|450808067|FG001|Overall Study|Fail to meet randomization criteria|1|||
125321117|NCT03186209|450808066|FG000|Overall Study|Lost to Follow-up|0|||
125321118|NCT03186209|450808067|FG001|Overall Study|Lost to Follow-up|1|||
125321119|NCT02559622|450808072|FG000|Overall Study|Progressive disease|0|||
125321120|NCT02559622|450808073|FG001|Overall Study|Progressive disease|1|||
125321121|NCT02559622|450808074|FG002|Overall Study|Progressive disease|0|||
125321122|NCT02559622|450808075|FG003|Overall Study|Progressive disease|0|||
125321123|NCT02559622|450808072|FG000|Overall Study|Adverse Event|0|||
125321124|NCT02559622|450808073|FG001|Overall Study|Adverse Event|2|||
125321125|NCT02559622|450808074|FG002|Overall Study|Adverse Event|2|||
125321126|NCT02559622|450808075|FG003|Overall Study|Adverse Event|2|||
125321127|NCT02559622|450808072|FG000|Overall Study|Patient/guardian decision|1|||
125321128|NCT02559622|450808073|FG001|Overall Study|Patient/guardian decision|2|||
125321129|NCT02559622|450808074|FG002|Overall Study|Patient/guardian decision|0|||
125321130|NCT02559622|450808075|FG003|Overall Study|Patient/guardian decision|1|||
125321131|NCT02163538|450808076|FG000|Overall Study|Protocol Violation|1|||
125321132|NCT02163538|450808077|FG001|Overall Study|Protocol Violation|0|||
125321133|NCT02163538|450808076|FG000|Overall Study|Physician Decision|0|||
125321134|NCT02163538|450808077|FG001|Overall Study|Physician Decision|1|||
125321135|NCT01339832|450808080|FG000|Overall Study|Lost to Follow-up|3|||
125321136|NCT01339832|450808080|FG000|Overall Study|Death|11|||
125321137|NCT01126749|450808081|FG000|Phase 1b|Other|0|||
125321138|NCT01126749|450808082|FG001|Phase 1b|Other|1|||
125321139|NCT01126749|450808083|FG002|Phase 1b|Other|0|||
125321140|NCT01126749|450808084|FG003|Phase 1b|Other|0|||
125321141|NCT01126749|450808081|FG000|Phase 1b|Withdrawal by Subject|0|||
125321142|NCT01126749|450808082|FG001|Phase 1b|Withdrawal by Subject|1|||
125321143|NCT01126749|450808083|FG002|Phase 1b|Withdrawal by Subject|0|||
125321144|NCT01126749|450808084|FG003|Phase 1b|Withdrawal by Subject|0|||
125321145|NCT01126749|450808081|FG000|Phase 1b|Death|3|||
125321146|NCT01126749|450808082|FG001|Phase 1b|Death|4|||
125321147|NCT01126749|450808083|FG002|Phase 1b|Death|0|||
125321148|NCT01126749|450808084|FG003|Phase 1b|Death|0|||
125321149|NCT01126749|450808081|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
125321150|NCT01126749|450808082|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
125321151|NCT01126749|450808083|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
125321152|NCT01126749|450808084|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
125321153|NCT01126749|450808081|FG000|Phase 2|Study Termination by Sponsor|0|||
124995292|NCT03421431|449609318|FG002|Overall Study|Withdrawal by Subject|1|||
125321154|NCT01126749|450808082|FG001|Phase 2|Study Termination by Sponsor|0|||
124995293|NCT03421431|449609316|FG000|Overall Study|Protocol Violation|0|||
125321155|NCT01126749|450808083|FG002|Phase 2|Study Termination by Sponsor|12|||
125321156|NCT01126749|450808084|FG003|Phase 2|Study Termination by Sponsor|6|||
125321157|NCT01126749|450808081|FG000|Phase 2|Other|0|||
125321158|NCT01126749|450808082|FG001|Phase 2|Other|0|||
125321159|NCT01126749|450808083|FG002|Phase 2|Other|4|||
125321160|NCT01126749|450808084|FG003|Phase 2|Other|2|||
125321161|NCT01126749|450808081|FG000|Phase 2|Withdrawal by Subject|0|||
125321162|NCT01126749|450808082|FG001|Phase 2|Withdrawal by Subject|0|||
125321163|NCT01126749|450808083|FG002|Phase 2|Withdrawal by Subject|0|||
124995294|NCT03421431|449609317|FG001|Overall Study|Protocol Violation|1|||
125321164|NCT01126749|450808084|FG003|Phase 2|Withdrawal by Subject|2|||
125321165|NCT01126749|450808081|FG000|Phase 2|Lost to Follow-up|0|||
125321166|NCT01126749|450808082|FG001|Phase 2|Lost to Follow-up|0|||
124995295|NCT03421431|449609318|FG002|Overall Study|Protocol Violation|0|||
124995296|NCT03421431|449609316|FG000|Overall Study|Participant met Stopping Rules|0|||
124995297|NCT03421431|449609317|FG001|Overall Study|Participant met Stopping Rules|1|||
124995298|NCT03421431|449609318|FG002|Overall Study|Participant met Stopping Rules|0|||
124995299|NCT00141726|449609319|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
124995300|NCT00235326|449609327|FG000|Overall Study|Lost to Follow-up|746|||
124995301|NCT00235326|449609328|FG001|Overall Study|Lost to Follow-up|1400|||
124995302|NCT01790126|449609329|FG000|Overall Study|PSA Progression|12|||
124995303|NCT01790126|449609330|FG001|Overall Study|PSA Progression|16|||
124995304|NCT01790126|449609331|FG002|Overall Study|PSA Progression|16|||
124995305|NCT01790126|449609329|FG000|Overall Study|Other|5|||
124995306|NCT01790126|449609330|FG001|Overall Study|Other|4|||
124995307|NCT01790126|449609331|FG002|Overall Study|Other|8|||
124995308|NCT01790126|449609329|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
124995309|NCT01790126|449609330|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
124995310|NCT01790126|449609331|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
124995311|NCT01790126|449609329|FG000|Overall Study|Withdrawal by Physician|1|||
124995312|NCT01790126|449609330|FG001|Overall Study|Withdrawal by Physician|1|||
124995313|NCT01790126|449609331|FG002|Overall Study|Withdrawal by Physician|2|||
124995314|NCT01790126|449609329|FG000|Overall Study|Withdrawal by Subject|3|||
124995315|NCT01790126|449609330|FG001|Overall Study|Withdrawal by Subject|1|||
124995316|NCT01790126|449609331|FG002|Overall Study|Withdrawal by Subject|2|||
124995317|NCT01790126|449609329|FG000|Overall Study|Lost to Follow-up|1|||
124995318|NCT01790126|449609330|FG001|Overall Study|Lost to Follow-up|0|||
124995319|NCT01790126|449609331|FG002|Overall Study|Lost to Follow-up|1|||
124995320|NCT01790126|449609329|FG000|Overall Study|Adverse Event|0|||
124995321|NCT01790126|449609330|FG001|Overall Study|Adverse Event|2|||
124995322|NCT01790126|449609331|FG002|Overall Study|Adverse Event|0|||
124995323|NCT01790126|449609329|FG000|Overall Study|Death|2|||
124995324|NCT01790126|449609330|FG001|Overall Study|Death|0|||
124995325|NCT01790126|449609331|FG002|Overall Study|Death|0|||
124995326|NCT01790126|449609329|FG000|Overall Study|Radiographic Progression|3|||
124995327|NCT01790126|449609330|FG001|Overall Study|Radiographic Progression|1|||
124995328|NCT01790126|449609331|FG002|Overall Study|Radiographic Progression|0|||
124995329|NCT01128738|449609332|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
124995330|NCT01128738|449609333|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
124995331|NCT01128738|449609332|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
124995332|NCT01128738|449609333|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
124995333|NCT01128738|449609332|FG000|Second TP|Lost to Follow-up|0|||
124995334|NCT01128738|449609333|FG001|Second TP|Lost to Follow-up|1|||
124995335|NCT01128738|449609332|FG000|Second TP|Withdrawal by Subject|0|||
124995336|NCT01128738|449609333|FG001|Second TP|Withdrawal by Subject|2|||
124995337|NCT01178671|449609334|FG000|Overall Study|Adverse Event|4|||
124995338|NCT01178671|449609335|FG001|Overall Study|Adverse Event|6|||
124995339|NCT01178671|449609334|FG000|Overall Study|Protocol Violation|1|||
124995340|NCT01178671|449609335|FG001|Overall Study|Protocol Violation|1|||
124995341|NCT01178671|449609334|FG000|Overall Study|Lack of Efficacy|0|||
124995342|NCT01178671|449609335|FG001|Overall Study|Lack of Efficacy|1|||
124995343|NCT01178671|449609334|FG000|Overall Study|Lost to Follow-up|3|||
124995344|NCT01178671|449609335|FG001|Overall Study|Lost to Follow-up|1|||
124995345|NCT01178671|449609334|FG000|Overall Study|Physician Decision|4|||
124995346|NCT01178671|449609335|FG001|Overall Study|Physician Decision|6|||
124995347|NCT02349451|449609339|FG000|Overall Study|Withdrawal by Subject|0|||
124995348|NCT02349451|449609340|FG001|Overall Study|Withdrawal by Subject|1|||
124995349|NCT02349451|449609341|FG002|Overall Study|Withdrawal by Subject|2|||
124995350|NCT02349451|449609342|FG003|Overall Study|Withdrawal by Subject|1|||
124995351|NCT02683941|449609343|FG000|Double-blind Phase|Adverse Event|0|||
124995352|NCT02683941|449609344|FG001|Double-blind Phase|Adverse Event|1|||
124995353|NCT02683941|449609343|FG000|Double-blind Phase|Withdrawal by Subject|4|||
124995354|NCT02683941|449609344|FG001|Double-blind Phase|Withdrawal by Subject|2|||
124995355|NCT02683941|449609343|FG000|Double-blind Phase|Lost to Follow-up|1|||
124995356|NCT02683941|449609344|FG001|Double-blind Phase|Lost to Follow-up|0|||
124995357|NCT02683941|449609343|FG000|Double-blind Phase|Disease Progression|5|||
124995358|NCT02683941|449609344|FG001|Double-blind Phase|Disease Progression|2|||
124995359|NCT02683941|449609343|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
124995360|NCT02683941|449609344|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
124995361|NCT02683941|449609343|FG000|Open-label Treatment Phase|Disease Progression|1|||
124995362|NCT02683941|449609344|FG001|Open-label Treatment Phase|Disease Progression|2|||
124995363|NCT02683941|449609343|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
124995364|NCT02683941|449609344|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
124995365|NCT02683941|449609343|FG000|Open-label Treatment Phase|Other|1|||
124995366|NCT02683941|449609344|FG001|Open-label Treatment Phase|Other|0|||
124995367|NCT02683941|449609343|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
124995368|NCT02683941|449609344|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
124995369|NCT02683941|449609343|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
124995370|NCT02683941|449609344|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
125321167|NCT01126749|450808083|FG002|Phase 2|Lost to Follow-up|0|||
125321168|NCT01126749|450808084|FG003|Phase 2|Lost to Follow-up|1|||
125321169|NCT01126749|450808081|FG000|Phase 2|Death|0|||
125321170|NCT01126749|450808082|FG001|Phase 2|Death|0|||
125321171|NCT01126749|450808083|FG002|Phase 2|Death|22|||
125321172|NCT01126749|450808084|FG003|Phase 2|Death|22|||
125321173|NCT01126749|450808081|FG000|Phase 2|Adverse Event|0|||
125321174|NCT01126749|450808082|FG001|Phase 2|Adverse Event|0|||
125321175|NCT01126749|450808083|FG002|Phase 2|Adverse Event|0|||
125321176|NCT01126749|450808084|FG003|Phase 2|Adverse Event|1|||
125321177|NCT00627393|450808087|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
125321178|NCT00627393|450808088|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
125321179|NCT00627393|450808087|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
125321180|NCT00627393|450808088|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
125321181|NCT00627393|450808087|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
125321182|NCT00627393|450808088|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
125321183|NCT00627393|450808087|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
125321184|NCT00627393|450808088|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
125321185|NCT01056822|450808089|FG000|Overall Study|Adverse Event|0|||
125321186|NCT01056822|450808090|FG001|Overall Study|Adverse Event|1|||
125321187|NCT01056822|450808089|FG000|Overall Study|Protocol Violation|6|||
125321188|NCT01056822|450808090|FG001|Overall Study|Protocol Violation|5|||
125321189|NCT01056822|450808089|FG000|Overall Study|Withdrawal by Subject|1|||
125321190|NCT01056822|450808090|FG001|Overall Study|Withdrawal by Subject|1|||
125321191|NCT01056822|450808089|FG000|Overall Study|Lost to Follow-up|1|||
125321192|NCT01056822|450808090|FG001|Overall Study|Lost to Follow-up|0|||
125321193|NCT05498649|450808091|FG000|Overall Study|Lost to Follow-up|1|||
125321194|NCT02761330|450808096|FG000|Treatment Week 1|Withdrawal by Subject|0|||
125321195|NCT02761330|450808097|FG001|Treatment Week 1|Withdrawal by Subject|0|||
125321196|NCT02761330|450808098|FG002|Treatment Week 1|Withdrawal by Subject|0|||
125321197|NCT02761330|450808099|FG003|Treatment Week 1|Withdrawal by Subject|1|||
125321198|NCT02761330|450808100|FG004|Treatment Week 1|Withdrawal by Subject|0|||
125321199|NCT02761330|450808101|FG005|Treatment Week 1|Withdrawal by Subject|1|||
125321200|NCT03043313|450808104|FG000|Overall Study|Withdrawal by Subject|5|||
125321201|NCT03043313|450808105|FG001|Overall Study|Withdrawal by Subject|1|||
125321202|NCT03043313|450808106|FG002|Overall Study|Withdrawal by Subject|1|||
125321203|NCT03043313|450808104|FG000|Overall Study|Lost to Follow-up|1|||
125321204|NCT03043313|450808105|FG001|Overall Study|Lost to Follow-up|1|||
125321205|NCT03043313|450808106|FG002|Overall Study|Lost to Follow-up|0|||
125321206|NCT03043313|450808104|FG000|Overall Study|Death|28|||
125321207|NCT03043313|450808105|FG001|Overall Study|Death|26|||
125321208|NCT03043313|450808106|FG002|Overall Study|Death|17|||
125321209|NCT03043313|450808104|FG000|Overall Study|Participation terminated by sponsor|11|||
125321210|NCT03043313|450808105|FG001|Overall Study|Participation terminated by sponsor|13|||
125321211|NCT03043313|450808106|FG002|Overall Study|Participation terminated by sponsor|13|||
125321212|NCT00980954|450808107|FG000|Overall Study|Protocol Violation|9|||
125321213|NCT00980954|450808108|FG001|Overall Study|Protocol Violation|15|||
125321214|NCT02657889|450808109|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
125321215|NCT02657889|450808110|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
125321216|NCT02657889|450808111|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
125321217|NCT02657889|450808112|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
125321218|NCT02657889|450808109|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
125321219|NCT02657889|450808110|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
125321220|NCT02657889|450808111|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
125321221|NCT02657889|450808112|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
125321222|NCT02657889|450808109|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
125321223|NCT02657889|450808110|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
125321224|NCT02657889|450808111|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
125321225|NCT02657889|450808112|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
125321226|NCT02657889|450808109|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
125321227|NCT02657889|450808110|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
125321228|NCT02657889|450808111|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
125321229|NCT02657889|450808112|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
125321230|NCT02657889|450808109|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
125321231|NCT02657889|450808110|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
125321232|NCT02657889|450808111|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
125321233|NCT02657889|450808112|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
125321234|NCT02657889|450808109|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
125321235|NCT02657889|450808110|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
125321236|NCT02657889|450808111|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
125321237|NCT02657889|450808112|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
125321238|NCT02657889|450808109|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
124995371|NCT02683941|449609343|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
124995372|NCT02683941|449609344|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
124995373|NCT02683941|449609343|FG000|Open-label Follow-up Phase|Other|8|||
124995374|NCT02683941|449609344|FG001|Open-label Follow-up Phase|Other|1|||
124995375|NCT02121834|449609346|FG000|Overall Study|Protocol Violation|0|||
124995376|NCT02121834|449609347|FG001|Overall Study|Protocol Violation|1|||
124995377|NCT02121834|449609348|FG002|Overall Study|Protocol Violation|0|||
124995378|NCT02121834|449609349|FG003|Overall Study|Protocol Violation|0|||
124995379|NCT02121834|449609350|FG004|Overall Study|Protocol Violation|0|||
124995380|NCT02121834|449609351|FG005|Overall Study|Protocol Violation|0|||
124995381|NCT02121834|449609352|FG006|Overall Study|Protocol Violation|0|||
124995382|NCT02121834|449609346|FG000|Overall Study|Withdrawal by Subject|0|||
125321239|NCT02657889|450808110|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
125321240|NCT02657889|450808111|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
125321241|NCT02657889|450808112|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
125321242|NCT02657889|450808109|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
125321243|NCT02657889|450808110|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
125321244|NCT02657889|450808111|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
125321245|NCT02657889|450808112|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
125321246|NCT02657889|450808109|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
125321247|NCT02657889|450808110|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
125321248|NCT02657889|450808111|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
125321249|NCT02657889|450808112|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
125321250|NCT02657889|450808109|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
125321251|NCT02657889|450808110|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
125321252|NCT02657889|450808111|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
125321253|NCT02657889|450808112|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
125321254|NCT02657889|450808109|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
125321255|NCT02657889|450808110|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
125321256|NCT02657889|450808111|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
125321257|NCT02657889|450808112|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
125321258|NCT02657889|450808109|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
125321259|NCT02657889|450808110|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
125321260|NCT02657889|450808111|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
125321261|NCT02657889|450808112|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
125321262|NCT00374140|450808113|FG000|Overall Study|Lost to Follow-up|1|||
125321263|NCT00374140|450808113|FG000|Overall Study|Protocol Violation|1|||
125321264|NCT01576341|450808114|FG000|Overall Study|Withdrawal by Subject|24|||
125321265|NCT01576341|450808114|FG000|Overall Study|Adverse Event|10|||
125321266|NCT01576341|450808114|FG000|Overall Study|Death|21|||
125321267|NCT01576341|450808114|FG000|Overall Study|Physician Decision|2|||
125321268|NCT01576341|450808114|FG000|Overall Study|Lost to Follow-up|2|||
125321269|NCT01576341|450808114|FG000|Overall Study|Kidney transplantation|10|||
125321270|NCT01576341|450808114|FG000|Overall Study|Protocol Violation|12|||
125321271|NCT01576341|450808114|FG000|Overall Study|Other|12|||
125321272|NCT00517296|450808118|FG000|Overall Study|Withdrawal by Subject|1|||
125321273|NCT00517296|450808119|FG001|Overall Study|Withdrawal by Subject|0|||
125321274|NCT04366349|450808120|FG000|Overall Study|Withdrawal by Subject|1|||
125321275|NCT04366349|450808121|FG001|Overall Study|Withdrawal by Subject|0|||
125321276|NCT04366349|450808122|FG002|Overall Study|Withdrawal by Subject|0|||
125321277|NCT04366349|450808123|FG003|Overall Study|Withdrawal by Subject|0|||
125321278|NCT04366349|450808124|FG004|Overall Study|Withdrawal by Subject|0|||
125321279|NCT04366349|450808125|FG005|Overall Study|Withdrawal by Subject|0|||
125321280|NCT03413891|450808130|FG000|Overall Study|Lost to Follow-up|2|||
125321281|NCT03413891|450808131|FG001|Overall Study|Lost to Follow-up|1|||
125321282|NCT03413891|450808130|FG000|Overall Study|Protocol Violation|0|||
125321283|NCT03413891|450808131|FG001|Overall Study|Protocol Violation|1|||
125321284|NCT04905134|450808135|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
125321285|NCT04905134|450808135|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
124995383|NCT02121834|449609347|FG001|Overall Study|Withdrawal by Subject|1|||
124995384|NCT02121834|449609348|FG002|Overall Study|Withdrawal by Subject|1|||
124995385|NCT02121834|449609349|FG003|Overall Study|Withdrawal by Subject|0|||
124995386|NCT02121834|449609350|FG004|Overall Study|Withdrawal by Subject|0|||
125321286|NCT03642873|450808136|FG000|Third Intervention (1 Day)|Screen failure|0|||
125321287|NCT03642873|450808137|FG001|Third Intervention (1 Day)|Screen failure|0|||
125321288|NCT03642873|450808138|FG002|Third Intervention (1 Day)|Screen failure|0|||
125321289|NCT03642873|450808139|FG003|Third Intervention (1 Day)|Screen failure|0|||
124995387|NCT02121834|449609351|FG005|Overall Study|Withdrawal by Subject|0|||
124995388|NCT02121834|449609352|FG006|Overall Study|Withdrawal by Subject|0|||
124995389|NCT02121834|449609346|FG000|Overall Study|Lost to Follow-up|0|||
125321290|NCT03642873|450808140|FG004|Third Intervention (1 Day)|Screen failure|1|||
125321291|NCT03642873|450808141|FG005|Third Intervention (1 Day)|Screen failure|0|||
124995390|NCT02121834|449609347|FG001|Overall Study|Lost to Follow-up|0|||
124995391|NCT02121834|449609348|FG002|Overall Study|Lost to Follow-up|1|||
124995392|NCT02121834|449609349|FG003|Overall Study|Lost to Follow-up|0|||
124995393|NCT02121834|449609350|FG004|Overall Study|Lost to Follow-up|0|||
124995394|NCT02121834|449609351|FG005|Overall Study|Lost to Follow-up|0|||
124995395|NCT02121834|449609352|FG006|Overall Study|Lost to Follow-up|0|||
124995396|NCT00551460|449609353|FG000|Overall Study|Adverse Event|1|||
124995397|NCT00551460|449609353|FG000|Overall Study|Withdrawal by Subject|1|||
124995398|NCT00551460|449609353|FG000|Overall Study|Physician Decision|1|||
124995399|NCT00551460|449609353|FG000|Overall Study|Death|7|||
124995400|NCT00551460|449609353|FG000|Overall Study|Ineligible|4|||
124995401|NCT00551460|449609353|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
124995402|NCT01971203|449609354|FG000|Overall Study|Protocol Violation|3|||
124995403|NCT01971203|449609355|FG001|Overall Study|Protocol Violation|2|||
124995404|NCT01971203|449609354|FG000|Overall Study|Withdrawal by Subject|5|||
125321292|NCT05556265|450808142|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
125321293|NCT05556265|450808143|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
125321294|NCT05556265|450808144|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
125321295|NCT05556265|450808145|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
125321296|NCT05556265|450808146|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
125321297|NCT05556265|450808142|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
125321298|NCT05556265|450808143|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
125321299|NCT05556265|450808144|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
125321300|NCT05556265|450808145|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
125321301|NCT05556265|450808146|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
125321302|NCT05556265|450808142|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
125321303|NCT05556265|450808143|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
125321304|NCT05556265|450808144|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
125321305|NCT05556265|450808145|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
125321306|NCT05556265|450808146|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
125321307|NCT05556265|450808142|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
125321308|NCT05556265|450808143|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
125321309|NCT05556265|450808144|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
125321310|NCT05556265|450808145|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
125321311|NCT05556265|450808146|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
125321312|NCT05556265|450808142|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
125321313|NCT05556265|450808143|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
125321314|NCT05556265|450808144|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
125321315|NCT05556265|450808145|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
125321316|NCT05556265|450808146|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
125321317|NCT05556265|450808142|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
125321318|NCT05556265|450808143|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
125321319|NCT05556265|450808144|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
125321320|NCT05556265|450808145|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
125321321|NCT05556265|450808146|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
125321322|NCT05556265|450808142|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
125321323|NCT05556265|450808143|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
125321324|NCT05556265|450808144|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
125321325|NCT05556265|450808145|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
125321326|NCT05556265|450808146|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
125321327|NCT05556265|450808142|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
125321328|NCT05556265|450808143|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
125321329|NCT05556265|450808144|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
125321330|NCT05556265|450808145|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
125321331|NCT05556265|450808146|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
125321332|NCT05556265|450808142|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
125321333|NCT05556265|450808143|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
125321334|NCT05556265|450808144|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
125321335|NCT05556265|450808145|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
125321336|NCT05556265|450808146|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
125321337|NCT03221556|450808149|FG000|Allocation|post-randomization exclusion|0|||
124995405|NCT01971203|449609355|FG001|Overall Study|Withdrawal by Subject|6|||
124995406|NCT01971203|449609354|FG000|Overall Study|Adverse Event|1|||
125321338|NCT03221556|450808150|FG001|Allocation|post-randomization exclusion|1|||
125321339|NCT03221556|450808149|FG000|Follow-Up|Withdrawal by Subject|0|||
125321340|NCT03221556|450808150|FG001|Follow-Up|Withdrawal by Subject|1|||
125321341|NCT02234843|450808153|FG000|Overall Study|Death|1|||
125321342|NCT02234843|450808154|FG001|Overall Study|Death|0|||
125321343|NCT02234843|450808155|FG002|Overall Study|Death|0|||
125321344|NCT02234843|450808156|FG003|Overall Study|Death|0|||
125321345|NCT02234843|450808157|FG004|Overall Study|Death|0|||
125321346|NCT02234843|450808158|FG005|Overall Study|Death|0|||
125321347|NCT02234843|450808159|FG006|Overall Study|Death|0|||
125321348|NCT02234843|450808160|FG007|Overall Study|Death|0|||
125321349|NCT02234843|450808161|FG008|Overall Study|Death|0|||
125321350|NCT02234843|450808162|FG009|Overall Study|Death|0|||
125321351|NCT02234843|450808153|FG000|Overall Study|Protocol Violation|1|||
125321352|NCT02234843|450808154|FG001|Overall Study|Protocol Violation|0|||
125321353|NCT02234843|450808155|FG002|Overall Study|Protocol Violation|1|||
125321354|NCT02234843|450808156|FG003|Overall Study|Protocol Violation|0|||
125321355|NCT02234843|450808157|FG004|Overall Study|Protocol Violation|0|||
125321356|NCT02234843|450808158|FG005|Overall Study|Protocol Violation|0|||
125321357|NCT02234843|450808159|FG006|Overall Study|Protocol Violation|0|||
125321358|NCT02234843|450808160|FG007|Overall Study|Protocol Violation|0|||
125321359|NCT02234843|450808161|FG008|Overall Study|Protocol Violation|0|||
125321360|NCT02234843|450808162|FG009|Overall Study|Protocol Violation|0|||
125321361|NCT02234843|450808153|FG000|Overall Study|Efficacy outcome reached|2|||
125321362|NCT02234843|450808154|FG001|Overall Study|Efficacy outcome reached|0|||
125321363|NCT02234843|450808155|FG002|Overall Study|Efficacy outcome reached|0|||
125321364|NCT02234843|450808156|FG003|Overall Study|Efficacy outcome reached|0|||
125321365|NCT02234843|450808157|FG004|Overall Study|Efficacy outcome reached|0|||
125321366|NCT02234843|450808158|FG005|Overall Study|Efficacy outcome reached|2|||
125321367|NCT02234843|450808159|FG006|Overall Study|Efficacy outcome reached|0|||
125321368|NCT02234843|450808160|FG007|Overall Study|Efficacy outcome reached|0|||
125321369|NCT02234843|450808161|FG008|Overall Study|Efficacy outcome reached|0|||
125321370|NCT02234843|450808162|FG009|Overall Study|Efficacy outcome reached|0|||
125321371|NCT02234843|450808153|FG000|Overall Study|Patient convenience|2|||
125321372|NCT02234843|450808154|FG001|Overall Study|Patient convenience|0|||
125321373|NCT02234843|450808155|FG002|Overall Study|Patient convenience|0|||
125321374|NCT02234843|450808156|FG003|Overall Study|Patient convenience|0|||
125321375|NCT02234843|450808157|FG004|Overall Study|Patient convenience|0|||
125321376|NCT02234843|450808158|FG005|Overall Study|Patient convenience|1|||
125321377|NCT02234843|450808159|FG006|Overall Study|Patient convenience|0|||
125321378|NCT02234843|450808160|FG007|Overall Study|Patient convenience|0|||
125321379|NCT02234843|450808161|FG008|Overall Study|Patient convenience|0|||
125321380|NCT02234843|450808162|FG009|Overall Study|Patient convenience|0|||
125321381|NCT02234843|450808153|FG000|Overall Study|Withdrawal by Subject|5|||
125321382|NCT02234843|450808154|FG001|Overall Study|Withdrawal by Subject|1|||
125321383|NCT02234843|450808155|FG002|Overall Study|Withdrawal by Subject|1|||
125321384|NCT02234843|450808156|FG003|Overall Study|Withdrawal by Subject|0|||
125321385|NCT02234843|450808157|FG004|Overall Study|Withdrawal by Subject|0|||
125321386|NCT02234843|450808158|FG005|Overall Study|Withdrawal by Subject|7|||
125321387|NCT02234843|450808159|FG006|Overall Study|Withdrawal by Subject|0|||
125321388|NCT02234843|450808160|FG007|Overall Study|Withdrawal by Subject|0|||
125321389|NCT02234843|450808161|FG008|Overall Study|Withdrawal by Subject|0|||
125321390|NCT02234843|450808162|FG009|Overall Study|Withdrawal by Subject|0|||
125321391|NCT02234843|450808153|FG000|Overall Study|Recovery|1|||
125321392|NCT02234843|450808154|FG001|Overall Study|Recovery|0|||
124995407|NCT01971203|449609355|FG001|Overall Study|Adverse Event|0|||
124995408|NCT03353350|449609356|FG000|30-week Core Treatment Period|Protocol Violation|1|||
124995409|NCT03353350|449609357|FG001|30-week Core Treatment Period|Protocol Violation|1|||
124995410|NCT03353350|449609358|FG002|30-week Core Treatment Period|Protocol Violation|1|||
124995411|NCT03353350|449609359|FG003|30-week Core Treatment Period|Protocol Violation|0|||
124995412|NCT03353350|449609356|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
124995413|NCT03353350|449609357|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
124995414|NCT03353350|449609358|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
125321393|NCT02234843|450808155|FG002|Overall Study|Recovery|0|||
125321394|NCT02234843|450808156|FG003|Overall Study|Recovery|0|||
125321395|NCT02234843|450808157|FG004|Overall Study|Recovery|0|||
125321396|NCT02234843|450808158|FG005|Overall Study|Recovery|0|||
125321397|NCT02234843|450808159|FG006|Overall Study|Recovery|0|||
125321398|NCT02234843|450808160|FG007|Overall Study|Recovery|0|||
125321399|NCT02234843|450808161|FG008|Overall Study|Recovery|0|||
125321400|NCT02234843|450808162|FG009|Overall Study|Recovery|0|||
125321401|NCT02234843|450808153|FG000|Overall Study|Other|0|||
125321402|NCT02234843|450808154|FG001|Overall Study|Other|2|||
125321403|NCT02234843|450808155|FG002|Overall Study|Other|0|||
125321404|NCT02234843|450808156|FG003|Overall Study|Other|1|||
125321405|NCT02234843|450808157|FG004|Overall Study|Other|0|||
125321406|NCT02234843|450808158|FG005|Overall Study|Other|1|||
125321407|NCT02234843|450808159|FG006|Overall Study|Other|0|||
125321408|NCT02234843|450808160|FG007|Overall Study|Other|1|||
125321409|NCT02234843|450808161|FG008|Overall Study|Other|0|||
125321410|NCT02234843|450808162|FG009|Overall Study|Other|0|||
125321411|NCT02234843|450808153|FG000|Overall Study|Physician Decision|4|||
125321412|NCT02234843|450808154|FG001|Overall Study|Physician Decision|1|||
125321413|NCT02234843|450808155|FG002|Overall Study|Physician Decision|0|||
125321414|NCT02234843|450808156|FG003|Overall Study|Physician Decision|1|||
125321415|NCT02234843|450808157|FG004|Overall Study|Physician Decision|0|||
125321416|NCT02234843|450808158|FG005|Overall Study|Physician Decision|0|||
125321417|NCT02234843|450808159|FG006|Overall Study|Physician Decision|0|||
125321418|NCT02234843|450808160|FG007|Overall Study|Physician Decision|1|||
125321419|NCT02234843|450808161|FG008|Overall Study|Physician Decision|0|||
125321420|NCT02234843|450808162|FG009|Overall Study|Physician Decision|0|||
125321421|NCT02234843|450808153|FG000|Overall Study|Adverse Event|5|||
125321422|NCT02234843|450808154|FG001|Overall Study|Adverse Event|1|||
125321423|NCT02234843|450808155|FG002|Overall Study|Adverse Event|1|||
125321424|NCT02234843|450808156|FG003|Overall Study|Adverse Event|3|||
125321425|NCT02234843|450808157|FG004|Overall Study|Adverse Event|2|||
125321426|NCT02234843|450808158|FG005|Overall Study|Adverse Event|1|||
125321427|NCT02234843|450808159|FG006|Overall Study|Adverse Event|0|||
125321428|NCT02234843|450808160|FG007|Overall Study|Adverse Event|0|||
125321429|NCT02234843|450808161|FG008|Overall Study|Adverse Event|1|||
125321430|NCT02234843|450808162|FG009|Overall Study|Adverse Event|0|||
125321431|NCT02234843|450808153|FG000|Overall Study|Non-compliance with study drug|1|||
125321432|NCT02234843|450808154|FG001|Overall Study|Non-compliance with study drug|0|||
125321433|NCT02234843|450808155|FG002|Overall Study|Non-compliance with study drug|0|||
125321434|NCT02234843|450808156|FG003|Overall Study|Non-compliance with study drug|0|||
125321435|NCT02234843|450808157|FG004|Overall Study|Non-compliance with study drug|0|||
125321436|NCT02234843|450808158|FG005|Overall Study|Non-compliance with study drug|1|||
125321437|NCT02234843|450808159|FG006|Overall Study|Non-compliance with study drug|1|||
125321438|NCT02234843|450808160|FG007|Overall Study|Non-compliance with study drug|0|||
125321439|NCT02234843|450808161|FG008|Overall Study|Non-compliance with study drug|0|||
125321440|NCT02234843|450808162|FG009|Overall Study|Non-compliance with study drug|0|||
125321441|NCT02234843|450808153|FG000|Overall Study|Lost to Follow-up|0|||
125321442|NCT02234843|450808154|FG001|Overall Study|Lost to Follow-up|1|||
125321443|NCT02234843|450808155|FG002|Overall Study|Lost to Follow-up|0|||
125321444|NCT02234843|450808156|FG003|Overall Study|Lost to Follow-up|0|||
125321445|NCT02234843|450808157|FG004|Overall Study|Lost to Follow-up|0|||
125321446|NCT02234843|450808158|FG005|Overall Study|Lost to Follow-up|0|||
125321447|NCT02234843|450808159|FG006|Overall Study|Lost to Follow-up|1|||
125321448|NCT02234843|450808160|FG007|Overall Study|Lost to Follow-up|0|||
125321449|NCT02234843|450808161|FG008|Overall Study|Lost to Follow-up|0|||
125321450|NCT02234843|450808162|FG009|Overall Study|Lost to Follow-up|0|||
125321451|NCT03905096|450808163|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
125321452|NCT03905096|450808164|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
125321453|NCT02016781|450808165|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
125321454|NCT02016781|450808166|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
125321455|NCT02016781|450808165|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
125321456|NCT02016781|450808166|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
125321457|NCT02016781|450808165|FG000|Final Database Lock|Withdrawal by Subject|2|||
125321458|NCT02016781|450808166|FG001|Final Database Lock|Withdrawal by Subject|1|||
124995415|NCT03353350|449609359|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
125321459|NCT02016781|450808165|FG000|Final Database Lock|Lost to Follow-up|11|||
125321460|NCT02016781|450808166|FG001|Final Database Lock|Lost to Follow-up|4|||
125321461|NCT02016781|450808165|FG000|Final Database Lock|Missing data|0|||
125321462|NCT02016781|450808166|FG001|Final Database Lock|Missing data|3|||
125321463|NCT02336282|450808167|FG000|Overall Study|Unrelated illness|1|||
125321464|NCT02336282|450808167|FG000|Overall Study|Uncomfortable with technology|1|||
125321465|NCT02336282|450808167|FG000|Overall Study|Lost to Follow-up|1|||
125321466|NCT02336282|450808167|FG000|Overall Study|Not enough time to complete sessions|2|||
125321467|NCT03724942|450808169|FG000|Overall Study|Adverse Event|20|||
125321468|NCT03724942|450808170|FG001|Overall Study|Adverse Event|14|||
125321469|NCT03724942|450808169|FG000|Overall Study|Lack of Efficacy|0|||
125321470|NCT03724942|450808170|FG001|Overall Study|Lack of Efficacy|1|||
125321471|NCT03724942|450808169|FG000|Overall Study|Physician Decision|5|||
125321472|NCT03724942|450808170|FG001|Overall Study|Physician Decision|2|||
125321473|NCT03724942|450808169|FG000|Overall Study|Protocol Violation|1|||
125321474|NCT03724942|450808170|FG001|Overall Study|Protocol Violation|0|||
125321475|NCT03724942|450808169|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
124995416|NCT03353350|449609356|FG000|30-week Core Treatment Period|Adverse Event|0|||
125321476|NCT03724942|450808170|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
125321477|NCT03724942|450808169|FG000|Overall Study|Withdrawal by Legal Representative|3|||
125321478|NCT03724942|450808170|FG001|Overall Study|Withdrawal by Legal Representative|0|||
125321479|NCT04875975|450808171|FG000|Overall Study|Adverse Event|1|||
125321480|NCT04875975|450808172|FG001|Overall Study|Adverse Event|2|||
124995417|NCT03353350|449609357|FG001|30-week Core Treatment Period|Adverse Event|4|||
125321481|NCT04875975|450808171|FG000|Overall Study|Lack of Efficacy|2|||
124995418|NCT03353350|449609358|FG002|30-week Core Treatment Period|Adverse Event|2|||
124995419|NCT03353350|449609359|FG003|30-week Core Treatment Period|Adverse Event|3|||
125321482|NCT04875975|450808172|FG001|Overall Study|Lack of Efficacy|2|||
125321483|NCT04875975|450808171|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
125321484|NCT04875975|450808172|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
125321485|NCT04875975|450808171|FG000|Overall Study|Relapse With Insults|0|||
125321486|NCT04875975|450808172|FG001|Overall Study|Relapse With Insults|1|||
125321487|NCT04875975|450808171|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
125321488|NCT04875975|450808172|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
125321489|NCT03253393|450808173|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
125321490|NCT03253393|450808174|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
125321491|NCT03253393|450808175|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
125321492|NCT04515771|450809939|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
125321493|NCT04515771|450809940|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
125321494|NCT04515771|450809939|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
125321495|NCT04515771|450809940|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
125321496|NCT04515771|450809939|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
125321497|NCT04515771|450809940|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
125321498|NCT00948246|450809941|FG000|Overall Study|Lost to Follow-up|11|||
125321499|NCT00948246|450809941|FG000|Overall Study|Adverse Event|11|||
125321500|NCT00948246|450809941|FG000|Overall Study|Death|1|||
125321501|NCT00948246|450809941|FG000|Overall Study|Withdrawal by Subject|1|||
125321502|NCT04199351|450809944|FG000|Overall Study|Decision by sponsor|0|||
125321503|NCT04199351|450809945|FG001|Overall Study|Decision by sponsor|0|||
125321504|NCT04199351|450809946|FG002|Overall Study|Decision by sponsor|0|||
125321505|NCT04199351|450809947|FG003|Overall Study|Decision by sponsor|2|||
125321506|NCT04199351|450809948|FG004|Overall Study|Decision by sponsor|0|||
125321507|NCT04199351|450809949|FG005|Overall Study|Decision by sponsor|0|||
125321508|NCT04199351|450809950|FG006|Overall Study|Decision by sponsor|0|||
125321509|NCT04199351|450809951|FG007|Overall Study|Decision by sponsor|0|||
125321510|NCT04199351|450809952|FG008|Overall Study|Decision by sponsor|0|||
125321511|NCT04199351|450809953|FG009|Overall Study|Decision by sponsor|6|||
125321512|NCT04199351|450809944|FG000|Overall Study|Lost to Follow-up|0|||
125321513|NCT04199351|450809945|FG001|Overall Study|Lost to Follow-up|0|||
125321514|NCT04199351|450809946|FG002|Overall Study|Lost to Follow-up|1|||
125321515|NCT04199351|450809947|FG003|Overall Study|Lost to Follow-up|0|||
125321516|NCT04199351|450809948|FG004|Overall Study|Lost to Follow-up|0|||
125321517|NCT04199351|450809949|FG005|Overall Study|Lost to Follow-up|1|||
125321518|NCT04199351|450809950|FG006|Overall Study|Lost to Follow-up|0|||
124995420|NCT03353350|449609356|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
124995421|NCT03353350|449609357|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
124995422|NCT03353350|449609358|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
124995423|NCT03353350|449609359|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
124995424|NCT03353350|449609356|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
124995425|NCT03353350|449609357|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
124995426|NCT03353350|449609358|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
124995427|NCT03353350|449609359|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
124995428|NCT03353350|449609356|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
124995429|NCT03353350|449609357|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
124995430|NCT03353350|449609358|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
124995431|NCT03353350|449609359|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
124995432|NCT03353350|449609356|FG000|26-week Treatment Extension Period|Adverse Event|1|||
124995433|NCT03353350|449609357|FG001|26-week Treatment Extension Period|Adverse Event|0|||
124995434|NCT03353350|449609358|FG002|26-week Treatment Extension Period|Adverse Event|0|||
124995435|NCT03353350|449609359|FG003|26-week Treatment Extension Period|Adverse Event|1|||
124995436|NCT03353350|449609356|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
124995437|NCT03353350|449609357|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
124995438|NCT03353350|449609358|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
124995439|NCT03353350|449609359|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
124995440|NCT00147823|449609365|FG000|Overall Study|Lost to Follow-up|6|||
124995441|NCT00147823|449609366|FG001|Overall Study|Lost to Follow-up|12|||
124995442|NCT00147823|449609365|FG000|Overall Study|Physician Decision|1|||
124995443|NCT00147823|449609366|FG001|Overall Study|Physician Decision|0|||
124995444|NCT00147823|449609365|FG000|Overall Study|Withdrawal by Subject|0|||
124995445|NCT00147823|449609366|FG001|Overall Study|Withdrawal by Subject|1|||
124995446|NCT00147823|449609365|FG000|Overall Study|Did not receive vitoss due to infection|6|||
125321519|NCT04199351|450809951|FG007|Overall Study|Lost to Follow-up|0|||
125321520|NCT04199351|450809952|FG008|Overall Study|Lost to Follow-up|0|||
124995447|NCT00147823|449609366|FG001|Overall Study|Did not receive vitoss due to infection|2|||
124995448|NCT01012713|449609367|FG000|Overall Study|Lack of Efficacy|3|||
125321521|NCT04199351|450809953|FG009|Overall Study|Lost to Follow-up|0|||
125321522|NCT04199351|450809944|FG000|Overall Study|Withdrawal by Subject|0|||
125321523|NCT04199351|450809945|FG001|Overall Study|Withdrawal by Subject|1|||
125321524|NCT04199351|450809946|FG002|Overall Study|Withdrawal by Subject|0|||
125321525|NCT04199351|450809947|FG003|Overall Study|Withdrawal by Subject|0|||
125321526|NCT04199351|450809948|FG004|Overall Study|Withdrawal by Subject|1|||
125321527|NCT04199351|450809949|FG005|Overall Study|Withdrawal by Subject|4|||
125321528|NCT04199351|450809950|FG006|Overall Study|Withdrawal by Subject|2|||
125321529|NCT04199351|450809951|FG007|Overall Study|Withdrawal by Subject|0|||
125321530|NCT04199351|450809952|FG008|Overall Study|Withdrawal by Subject|3|||
125321531|NCT04199351|450809953|FG009|Overall Study|Withdrawal by Subject|0|||
124995449|NCT02571049|449609368|FG000|Screening|Did not meet entry criteria|2|||
124995450|NCT02571049|449609369|FG001|Screening|Did not meet entry criteria|2|||
124995451|NCT02571049|449609368|FG000|Randomization|No migraine attack|0|||
124995452|NCT02571049|449609369|FG001|Randomization|No migraine attack|1|||
124995453|NCT02571049|449609368|FG000|Randomization|Adverse Event|0|||
124995454|NCT02571049|449609369|FG001|Randomization|Adverse Event|1|||
124995455|NCT01055262|449609370|FG000|Overall Study|Adverse Event|5|||
124995456|NCT01055262|449609370|FG000|Overall Study|Protocol Violation|3|||
124995457|NCT01055262|449609370|FG000|Overall Study|Uncooperativeness|1|||
124995458|NCT03370471|449609371|FG000|Overall Study|Withdrawal by Subject|6|||
124995459|NCT03370471|449609372|FG001|Overall Study|Withdrawal by Subject|1|||
124995460|NCT03370471|449609371|FG000|Overall Study|Unable to access veins for blood draw|0|||
124995461|NCT03370471|449609372|FG001|Overall Study|Unable to access veins for blood draw|1|||
124995462|NCT03370471|449609371|FG000|Overall Study|Screen fail|1|||
124995463|NCT03370471|449609372|FG001|Overall Study|Screen fail|0|||
124995464|NCT00561951|449609373|FG000|Overall Study|Adverse Event|11|||
124995465|NCT00561951|449609374|FG001|Overall Study|Adverse Event|14|||
124995466|NCT00561951|449609375|FG002|Overall Study|Adverse Event|14|||
124995467|NCT00561951|449609373|FG000|Overall Study|Lack of Efficacy|5|||
124995468|NCT00561951|449609374|FG001|Overall Study|Lack of Efficacy|3|||
124995469|NCT00561951|449609375|FG002|Overall Study|Lack of Efficacy|2|||
124995470|NCT00561951|449609373|FG000|Overall Study|Lost to Follow-up|1|||
124995471|NCT00561951|449609374|FG001|Overall Study|Lost to Follow-up|1|||
124995472|NCT00561951|449609375|FG002|Overall Study|Lost to Follow-up|0|||
124995473|NCT00561951|449609373|FG000|Overall Study|Withdrawal by Subject|10|||
124995474|NCT00561951|449609374|FG001|Overall Study|Withdrawal by Subject|9|||
124995475|NCT00561951|449609375|FG002|Overall Study|Withdrawal by Subject|10|||
124995476|NCT00561951|449609373|FG000|Overall Study|Protocol Violation|4|||
124995477|NCT00561951|449609374|FG001|Overall Study|Protocol Violation|3|||
124995478|NCT00561951|449609375|FG002|Overall Study|Protocol Violation|4|||
124995479|NCT00561951|449609373|FG000|Overall Study|Physician Decision|1|||
124995480|NCT00561951|449609374|FG001|Overall Study|Physician Decision|0|||
124995481|NCT00561951|449609375|FG002|Overall Study|Physician Decision|0|||
124995482|NCT00561951|449609373|FG000|Overall Study|Pregnancy|0|||
124995483|NCT00561951|449609374|FG001|Overall Study|Pregnancy|1|||
124995484|NCT00561951|449609375|FG002|Overall Study|Pregnancy|0|||
124995485|NCT00561951|449609373|FG000|Overall Study|Meet Withdrawal Criterion|0|||
124995486|NCT00561951|449609374|FG001|Overall Study|Meet Withdrawal Criterion|1|||
124995487|NCT00561951|449609375|FG002|Overall Study|Meet Withdrawal Criterion|1|||
124995488|NCT00561951|449609373|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
124995489|NCT00561951|449609374|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
124995490|NCT00561951|449609375|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
124995491|NCT00392327|449609387|FG000|Overall Study|Death|1|||
124995492|NCT00392327|449609388|FG001|Overall Study|Death|0|||
124995493|NCT00392327|449609389|FG002|Overall Study|Death|1|||
124995494|NCT00392327|449609390|FG003|Overall Study|Death|0|||
124995495|NCT00392327|449609391|FG004|Overall Study|Death|0|||
124995496|NCT00392327|449609392|FG005|Overall Study|Death|0|||
124995497|NCT00392327|449609393|FG006|Overall Study|Death|0|||
124995498|NCT00392327|449609394|FG007|Overall Study|Death|0|||
124995499|NCT00392327|449609387|FG000|Overall Study|Lack of Efficacy|8|||
124995500|NCT00392327|449609388|FG001|Overall Study|Lack of Efficacy|8|||
124995501|NCT00392327|449609389|FG002|Overall Study|Lack of Efficacy|9|||
124995502|NCT00392327|449609390|FG003|Overall Study|Lack of Efficacy|6|||
124995503|NCT00392327|449609391|FG004|Overall Study|Lack of Efficacy|3|||
124995504|NCT00392327|449609392|FG005|Overall Study|Lack of Efficacy|3|||
124995505|NCT00392327|449609393|FG006|Overall Study|Lack of Efficacy|3|||
124995506|NCT00392327|449609394|FG007|Overall Study|Lack of Efficacy|3|||
124995507|NCT00392327|449609387|FG000|Overall Study|Physician Decision|3|||
124995508|NCT00392327|449609388|FG001|Overall Study|Physician Decision|5|||
125321532|NCT00474487|450809957|FG000|Overall Study|Withdrawal by Subject|6|||
124995509|NCT00392327|449609389|FG002|Overall Study|Physician Decision|2|||
124995510|NCT00392327|449609390|FG003|Overall Study|Physician Decision|2|||
124995511|NCT00392327|449609391|FG004|Overall Study|Physician Decision|0|||
124995512|NCT00392327|449609392|FG005|Overall Study|Physician Decision|1|||
124995513|NCT00392327|449609393|FG006|Overall Study|Physician Decision|5|||
124995514|NCT00392327|449609394|FG007|Overall Study|Physician Decision|3|||
124995515|NCT00392327|449609387|FG000|Overall Study|Protocol Violation|0|||
124995516|NCT00392327|449609388|FG001|Overall Study|Protocol Violation|0|||
124995517|NCT00392327|449609389|FG002|Overall Study|Protocol Violation|1|||
124995518|NCT00392327|449609390|FG003|Overall Study|Protocol Violation|0|||
124995519|NCT00392327|449609391|FG004|Overall Study|Protocol Violation|0|||
124995520|NCT00392327|449609392|FG005|Overall Study|Protocol Violation|0|||
124995521|NCT00392327|449609393|FG006|Overall Study|Protocol Violation|0|||
124995522|NCT00392327|449609394|FG007|Overall Study|Protocol Violation|0|||
124995523|NCT00392327|449609387|FG000|Overall Study|Withdrawal by Subject|3|||
124995524|NCT00392327|449609388|FG001|Overall Study|Withdrawal by Subject|2|||
125321533|NCT00474487|450809958|FG001|Overall Study|Withdrawal by Subject|0|||
125321534|NCT00474487|450809959|FG002|Overall Study|Withdrawal by Subject|0|||
125321535|NCT00474487|450809960|FG003|Overall Study|Withdrawal by Subject|0|||
125321536|NCT00474487|450809957|FG000|Overall Study|Lost to Follow-up|20|||
125321537|NCT00474487|450809958|FG001|Overall Study|Lost to Follow-up|1|||
124995525|NCT00392327|449609389|FG002|Overall Study|Withdrawal by Subject|4|||
124995526|NCT00392327|449609390|FG003|Overall Study|Withdrawal by Subject|6|||
124995527|NCT00392327|449609391|FG004|Overall Study|Withdrawal by Subject|0|||
124995528|NCT00392327|449609392|FG005|Overall Study|Withdrawal by Subject|1|||
124995529|NCT00392327|449609393|FG006|Overall Study|Withdrawal by Subject|1|||
124995530|NCT00392327|449609394|FG007|Overall Study|Withdrawal by Subject|5|||
124995531|NCT00392327|449609387|FG000|Overall Study|Ineligible|0|||
124995532|NCT00392327|449609388|FG001|Overall Study|Ineligible|4|||
124995533|NCT00392327|449609389|FG002|Overall Study|Ineligible|3|||
124995534|NCT00392327|449609390|FG003|Overall Study|Ineligible|2|||
125321538|NCT00474487|450809959|FG002|Overall Study|Lost to Follow-up|7|||
125321539|NCT00474487|450809960|FG003|Overall Study|Lost to Follow-up|0|||
125321540|NCT00474487|450809957|FG000|Overall Study|Inappropriate enrollment|4|||
124995535|NCT00392327|449609391|FG004|Overall Study|Ineligible|0|||
124995536|NCT00392327|449609392|FG005|Overall Study|Ineligible|0|||
124995537|NCT00392327|449609393|FG006|Overall Study|Ineligible|0|||
125321541|NCT00474487|450809958|FG001|Overall Study|Inappropriate enrollment|0|||
125321542|NCT00474487|450809959|FG002|Overall Study|Inappropriate enrollment|7|||
125321543|NCT00474487|450809960|FG003|Overall Study|Inappropriate enrollment|0|||
125321544|NCT00474487|450809957|FG000|Overall Study|Death|0|||
125321545|NCT00474487|450809958|FG001|Overall Study|Death|1|||
125321546|NCT00474487|450809959|FG002|Overall Study|Death|0|||
125321547|NCT00474487|450809960|FG003|Overall Study|Death|0|||
125321548|NCT02443688|450809963|FG000|Overall Study|Adverse Event|2|||
125321549|NCT02443688|450809964|FG001|Overall Study|Adverse Event|3|||
125321550|NCT02443688|450809965|FG002|Overall Study|Adverse Event|2|||
125321551|NCT02443688|450809963|FG000|Overall Study|Lost to Follow-up|1|||
125321552|NCT02443688|450809964|FG001|Overall Study|Lost to Follow-up|0|||
125321553|NCT02443688|450809965|FG002|Overall Study|Lost to Follow-up|0|||
125321554|NCT02443688|450809963|FG000|Overall Study|Physician Decision|3|||
125321555|NCT02443688|450809964|FG001|Overall Study|Physician Decision|0|||
125321556|NCT02443688|450809965|FG002|Overall Study|Physician Decision|1|||
125321557|NCT02443688|450809963|FG000|Overall Study|Pregnancy|0|||
125321558|NCT02443688|450809964|FG001|Overall Study|Pregnancy|0|||
125321559|NCT02443688|450809965|FG002|Overall Study|Pregnancy|1|||
125321560|NCT02443688|450809963|FG000|Overall Study|Withdrawal by Subject|3|||
125321561|NCT02443688|450809964|FG001|Overall Study|Withdrawal by Subject|3|||
125321562|NCT02443688|450809965|FG002|Overall Study|Withdrawal by Subject|4|||
125321563|NCT02443688|450809963|FG000|Overall Study|Non-compliance with study drug|1|||
125321564|NCT02443688|450809964|FG001|Overall Study|Non-compliance with study drug|2|||
125321565|NCT02443688|450809965|FG002|Overall Study|Non-compliance with study drug|4|||
125321566|NCT02443688|450809963|FG000|Overall Study|Sponsor Request|2|||
125321567|NCT02443688|450809964|FG001|Overall Study|Sponsor Request|1|||
125321568|NCT02443688|450809965|FG002|Overall Study|Sponsor Request|0|||
125321569|NCT03182374|450809966|FG000|Overall Study|Lost to Follow-up|3|||
125321570|NCT03182374|450809967|FG001|Overall Study|Lost to Follow-up|2|||
125321571|NCT03182374|450809966|FG000|Overall Study|Lack of Efficacy|8|||
125321572|NCT03182374|450809967|FG001|Overall Study|Lack of Efficacy|14|||
125321573|NCT03182374|450809966|FG000|Overall Study|Withdrawal by Subject|1|||
125321574|NCT03182374|450809967|FG001|Overall Study|Withdrawal by Subject|1|||
125321575|NCT03182374|450809966|FG000|Overall Study|exit for non-compliance|1|||
125321576|NCT03182374|450809967|FG001|Overall Study|exit for non-compliance|1|||
124995538|NCT00392327|449609394|FG007|Overall Study|Ineligible|0|||
124995539|NCT04508023|449609395|FG000|Overall Study|Withdrawal by Subject|1|||
124995540|NCT04508023|449609396|FG001|Overall Study|Withdrawal by Subject|2|||
124995541|NCT01074216|449609403|FG000|Overall Study|Physician Decision|1|||
124995542|NCT01074216|449609403|FG000|Overall Study|Not Treated|12|||
124995543|NCT01323634|449609404|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
124995544|NCT01323634|449609405|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
125321577|NCT03182374|450809966|FG000|Overall Study|one subject was randomized but not treated|1|||
125321578|NCT03182374|450809967|FG001|Overall Study|one subject was randomized but not treated|0|||
124995545|NCT01323634|449609406|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
124995546|NCT01323634|449609404|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
125321579|NCT03182374|450809966|FG000|Overall Study|Other reasons|0|||
125321580|NCT03182374|450809967|FG001|Overall Study|Other reasons|3|||
125321581|NCT03198715|450809975|FG000|Overall Study|Death|0|||
125321582|NCT03198715|450809976|FG001|Overall Study|Death|0|||
125321583|NCT03198715|450809977|FG002|Overall Study|Death|1|||
125321584|NCT03198715|450809978|FG003|Overall Study|Death|0|||
125321585|NCT03198715|450809979|FG004|Overall Study|Death|2|||
125321586|NCT03198715|450809975|FG000|Overall Study|Other|0|||
125321587|NCT03198715|450809976|FG001|Overall Study|Other|1|||
125321588|NCT03198715|450809977|FG002|Overall Study|Other|1|||
125321589|NCT03198715|450809978|FG003|Overall Study|Other|0|||
125321590|NCT03198715|450809979|FG004|Overall Study|Other|0|||
125321591|NCT00616759|450809980|FG000|Overall Study|Physician Decision|2|||
125321592|NCT00616759|450809981|FG001|Overall Study|Physician Decision|0|||
125321593|NCT00616759|450809980|FG000|Overall Study|Withdrawal by Subject|1|||
125321594|NCT00616759|450809981|FG001|Overall Study|Withdrawal by Subject|2|||
125321595|NCT02007096|450809982|FG000|Overall Study|medication not available|2|||
125321596|NCT02007096|450809983|FG001|Overall Study|medication not available|0|||
125321597|NCT02007096|450809982|FG000|Overall Study|did not inject saline|0|||
125321598|NCT02007096|450809983|FG001|Overall Study|did not inject saline|3|||
125321599|NCT02007096|450809982|FG000|Overall Study|did not follow postoperative protocol|8|||
125321600|NCT02007096|450809983|FG001|Overall Study|did not follow postoperative protocol|11|||
125321601|NCT02007096|450809982|FG000|Overall Study|converted to open surgery|1|||
125321602|NCT02007096|450809983|FG001|Overall Study|converted to open surgery|1|||
125321603|NCT02007096|450809982|FG000|Overall Study|no mesh placed|0|||
125321604|NCT02007096|450809983|FG001|Overall Study|no mesh placed|1|||
125321605|NCT02558894|450809988|FG000|Overall Study|Death; any cause, entire study duration|28|||
125321606|NCT02558894|450809989|FG001|Overall Study|Death; any cause, entire study duration|31|||
125321607|NCT02558894|450809988|FG000|Overall Study|Withdrawal by Subject|2|||
125321608|NCT02558894|450809989|FG001|Overall Study|Withdrawal by Subject|1|||
125321609|NCT02558894|450809988|FG000|Overall Study|Closure of Part A|2|||
125321610|NCT02558894|450809989|FG001|Overall Study|Closure of Part A|1|||
125321611|NCT02476617|450809995|FG000|Overall Study|Adverse Event|1|||
125321612|NCT02476617|450809995|FG000|Overall Study|Lost to Follow-up|1|||
125321613|NCT03486912|450809996|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
125321614|NCT03486912|450809997|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
125321615|NCT03486912|450809998|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
125321616|NCT03486912|450809999|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
125321617|NCT03486912|450809996|FG000|Treatment Period|Withdrawal by Subject|3|||
125321618|NCT03486912|450809997|FG001|Treatment Period|Withdrawal by Subject|3|||
125321619|NCT03486912|450809998|FG002|Treatment Period|Withdrawal by Subject|3|||
125321620|NCT03486912|450809999|FG003|Treatment Period|Withdrawal by Subject|2|||
125321621|NCT03486912|450809996|FG000|Treatment Period|Other Reasons|0|||
125321622|NCT03486912|450809997|FG001|Treatment Period|Other Reasons|2|||
125321623|NCT03486912|450809998|FG002|Treatment Period|Other Reasons|1|||
125321624|NCT03486912|450809999|FG003|Treatment Period|Other Reasons|1|||
125321625|NCT03486912|450809996|FG000|Treatment Period|Adverse Event|0|||
125321626|NCT03486912|450809997|FG001|Treatment Period|Adverse Event|1|||
125321627|NCT03486912|450809998|FG002|Treatment Period|Adverse Event|1|||
125321628|NCT03486912|450809999|FG003|Treatment Period|Adverse Event|0|||
125321629|NCT03486912|450809996|FG000|Treatment Period|Lost to Follow-up|1|||
125321630|NCT03486912|450809997|FG001|Treatment Period|Lost to Follow-up|0|||
125321631|NCT03486912|450809998|FG002|Treatment Period|Lost to Follow-up|0|||
125321632|NCT03486912|450809999|FG003|Treatment Period|Lost to Follow-up|2|||
125321633|NCT02491684|450810000|FG000|Treatment Phase|Adverse Event|2|||
125321634|NCT02491684|450810001|FG001|Treatment Phase|Adverse Event|2|||
125321635|NCT02491684|450810000|FG000|Treatment Phase|Incorrect randomisation|1|||
125321636|NCT02491684|450810001|FG001|Treatment Phase|Incorrect randomisation|0|||
125321637|NCT02491684|450810000|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
125321638|NCT02491684|450810001|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
125321639|NCT01263769|450810003|FG000|Overall Study|Non-Compliant with treatment|1|||
125321640|NCT02242942|450810006|FG000|Overall Study|Death|17|||
125321641|NCT02242942|450810007|FG001|Overall Study|Death|20|||
125321642|NCT02242942|450810008|FG002|Overall Study|Death|2|||
125321643|NCT02242942|450810006|FG000|Overall Study|Physician Decision|1|||
125321644|NCT02242942|450810007|FG001|Overall Study|Physician Decision|0|||
125321645|NCT02242942|450810008|FG002|Overall Study|Physician Decision|0|||
125321646|NCT02242942|450810006|FG000|Overall Study|Withdrawal by Subject|8|||
125321647|NCT02242942|450810007|FG001|Overall Study|Withdrawal by Subject|10|||
125321648|NCT02242942|450810008|FG002|Overall Study|Withdrawal by Subject|0|||
125321649|NCT02242942|450810006|FG000|Overall Study|On-going in Study|190|||
125321650|NCT02242942|450810007|FG001|Overall Study|On-going in Study|186|||
125321651|NCT02242942|450810008|FG002|Overall Study|On-going in Study|11|||
125321652|NCT03259230|450810009|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
125321653|NCT03259230|450810010|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
125321654|NCT00561652|450810011|FG000|Overall Study|Withdrawal by Subject|0|||
125321655|NCT00561652|450810012|FG001|Overall Study|Withdrawal by Subject|1|||
125321656|NCT03019406|450810016|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
125321657|NCT03019406|450810017|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
125321658|NCT03019406|450810018|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
125321659|NCT03019406|450810019|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
125321660|NCT00231816|450810022|FG000|Overall Study|Adverse Event|1|||
125321661|NCT00231816|450810023|FG001|Overall Study|Adverse Event|0|||
125321662|NCT00231816|450810022|FG000|Overall Study|Lost to Follow-up|8|||
125321663|NCT00231816|450810023|FG001|Overall Study|Lost to Follow-up|5|||
125321664|NCT00231816|450810022|FG000|Overall Study|Protocol Violation|2|||
125321665|NCT00231816|450810023|FG001|Overall Study|Protocol Violation|3|||
125321666|NCT00231816|450810022|FG000|Overall Study|Withdrawal by Subject|3|||
125321667|NCT00231816|450810023|FG001|Overall Study|Withdrawal by Subject|3|||
125321668|NCT00231816|450810022|FG000|Overall Study|Other|2|||
125321669|NCT00231816|450810023|FG001|Overall Study|Other|1|||
125321670|NCT00468169|450810024|FG000|Overall Study|Withdrawal by Subject|1|||
125321671|NCT00468169|450810025|FG001|Overall Study|Withdrawal by Subject|0|||
125321672|NCT01283139|450810031|FG000|Overall Study|Lost to Follow-up|5|||
125321673|NCT01283139|450810032|FG001|Overall Study|Lost to Follow-up|2|||
125321674|NCT01283139|450810033|FG002|Overall Study|Lost to Follow-up|3|||
125321675|NCT01283139|450810034|FG003|Overall Study|Lost to Follow-up|1|||
125321676|NCT01283139|450810031|FG000|Overall Study|Withdrawal by Subject|8|||
124995547|NCT01323634|449609405|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
124995548|NCT01323634|449609406|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
124995549|NCT01323634|449609404|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
124995550|NCT01323634|449609405|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
124995551|NCT01323634|449609406|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
124995552|NCT01323634|449609404|FG000|2-week Run-in Period|Physician Decision|5|||
124995553|NCT01323634|449609405|FG001|2-week Run-in Period|Physician Decision|0|||
124995554|NCT01323634|449609406|FG002|2-week Run-in Period|Physician Decision|0|||
125321677|NCT01283139|450810032|FG001|Overall Study|Withdrawal by Subject|8|||
125321678|NCT01283139|450810033|FG002|Overall Study|Withdrawal by Subject|6|||
125321679|NCT01283139|450810034|FG003|Overall Study|Withdrawal by Subject|8|||
125321680|NCT01283139|450810031|FG000|Overall Study|Death|2|||
125321681|NCT01283139|450810032|FG001|Overall Study|Death|0|||
125321682|NCT01283139|450810033|FG002|Overall Study|Death|2|||
125321683|NCT01283139|450810034|FG003|Overall Study|Death|2|||
125321684|NCT01283139|450810031|FG000|Overall Study|Lack of Efficacy|1|||
125321685|NCT01283139|450810032|FG001|Overall Study|Lack of Efficacy|2|||
125321686|NCT01283139|450810033|FG002|Overall Study|Lack of Efficacy|2|||
125321687|NCT01283139|450810034|FG003|Overall Study|Lack of Efficacy|1|||
125321688|NCT01283139|450810031|FG000|Overall Study|Early termination due to AE/SAE|1|||
125321689|NCT01283139|450810032|FG001|Overall Study|Early termination due to AE/SAE|1|||
125321690|NCT01283139|450810033|FG002|Overall Study|Early termination due to AE/SAE|0|||
125321691|NCT01283139|450810034|FG003|Overall Study|Early termination due to AE/SAE|0|||
125321692|NCT01283139|450810031|FG000|Overall Study|Participant's refusal to continue|0|||
125321693|NCT01283139|450810032|FG001|Overall Study|Participant's refusal to continue|3|||
125321694|NCT01283139|450810033|FG002|Overall Study|Participant's refusal to continue|1|||
125321695|NCT01283139|450810034|FG003|Overall Study|Participant's refusal to continue|1|||
125321696|NCT01283139|450810031|FG000|Overall Study|Pregnancy|0|||
125321697|NCT01283139|450810032|FG001|Overall Study|Pregnancy|1|||
125321698|NCT01283139|450810033|FG002|Overall Study|Pregnancy|1|||
125321699|NCT01283139|450810034|FG003|Overall Study|Pregnancy|0|||
125321700|NCT01283139|450810031|FG000|Overall Study|Missed follow-up visit|0|||
125321701|NCT01283139|450810032|FG001|Overall Study|Missed follow-up visit|1|||
125321702|NCT01283139|450810033|FG002|Overall Study|Missed follow-up visit|2|||
125321703|NCT01283139|450810034|FG003|Overall Study|Missed follow-up visit|2|||
125321704|NCT01283139|450810031|FG000|Overall Study|Participant randomized in error|0|||
125321705|NCT01283139|450810032|FG001|Overall Study|Participant randomized in error|0|||
125321706|NCT01283139|450810033|FG002|Overall Study|Participant randomized in error|1|||
125321707|NCT01283139|450810034|FG003|Overall Study|Participant randomized in error|0|||
125321708|NCT00976274|450810035|FG000|Overall Study|Lost to Follow-up|5|||
125321709|NCT00976274|450810036|FG001|Overall Study|Lost to Follow-up|5|||
125321710|NCT00976274|450810035|FG000|Overall Study|Withdrawal by Subject|1|||
125321711|NCT00976274|450810036|FG001|Overall Study|Withdrawal by Subject|1|||
125321712|NCT00976274|450810035|FG000|Overall Study|Physician Decision|1|||
125321713|NCT00976274|450810036|FG001|Overall Study|Physician Decision|2|||
124995555|NCT01323634|449609404|FG000|2-week Run-in Period|Protocol Violation|1|||
124995556|NCT01323634|449609405|FG001|2-week Run-in Period|Protocol Violation|0|||
124995557|NCT01323634|449609406|FG002|2-week Run-in Period|Protocol Violation|0|||
125321714|NCT01075243|450810037|FG000|Overall Study|Lost to Follow-up|5|||
125321715|NCT01075243|450810038|FG001|Overall Study|Lost to Follow-up|2|||
125321716|NCT01075243|450810039|FG002|Overall Study|Lost to Follow-up|0|||
125321717|NCT01075243|450810037|FG000|Overall Study|Withdrawal by Subject|1|||
125321718|NCT01075243|450810038|FG001|Overall Study|Withdrawal by Subject|1|||
125321719|NCT01075243|450810039|FG002|Overall Study|Withdrawal by Subject|0|||
125321720|NCT00784563|450810042|FG000|Years 1 & 2|Withdrawal by Subject|3|||
125321721|NCT00784563|450810043|FG001|Years 1 & 2|Withdrawal by Subject|2|||
125321722|NCT00784563|450810044|FG002|Years 1 & 2|Withdrawal by Subject|0|||
125321723|NCT00784563|450810042|FG000|Years 1 & 2|Adverse Event|0|||
125321724|NCT00784563|450810043|FG001|Years 1 & 2|Adverse Event|3|||
125321725|NCT00784563|450810044|FG002|Years 1 & 2|Adverse Event|0|||
125321726|NCT00784563|450810042|FG000|Year 3|Withdrawal by Subject|0|||
125321727|NCT00784563|450810043|FG001|Year 3|Withdrawal by Subject|0|||
125321728|NCT00784563|450810044|FG002|Year 3|Withdrawal by Subject|2|||
125321729|NCT00784563|450810042|FG000|Year 3|Adverse Event|0|||
125321730|NCT00784563|450810043|FG001|Year 3|Adverse Event|0|||
125321731|NCT00784563|450810044|FG002|Year 3|Adverse Event|1|||
125321732|NCT01614249|450810045|FG000|Overall Study|Lost to Follow-up|11|||
125321733|NCT01614249|450810046|FG001|Overall Study|Lost to Follow-up|23|||
125321734|NCT02954536|450810047|FG000|Overall Study|Adverse Event|2|||
125321735|NCT02954536|450810047|FG000|Overall Study|Death|12|||
125321736|NCT02946580|450810048|FG000|Overall Study|Withdrawal by Subject|1|||
125321737|NCT02946580|450810049|FG001|Overall Study|Withdrawal by Subject|2|||
125321738|NCT02946580|450810048|FG000|Overall Study|Adverse Event|0|||
125321739|NCT02946580|450810049|FG001|Overall Study|Adverse Event|2|||
125321740|NCT02946580|450810048|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
125321741|NCT02946580|450810049|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
125321742|NCT04764162|450810053|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
125321743|NCT04764162|450810054|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
125321744|NCT00791934|450810055|FG000|Overall Study|Withdrawal by Subject|2|||
124995558|NCT01323634|449609404|FG000|2-week Run-in Period|Adverse Event|1|||
124995559|NCT01323634|449609405|FG001|2-week Run-in Period|Adverse Event|0|||
124995560|NCT01323634|449609406|FG002|2-week Run-in Period|Adverse Event|0|||
124995561|NCT01323634|449609404|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
124995562|NCT01323634|449609405|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
124995563|NCT01323634|449609406|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
124995564|NCT01323634|449609404|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
124995565|NCT01323634|449609405|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
124995566|NCT01323634|449609406|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
124995567|NCT01323634|449609404|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
124995568|NCT01323634|449609405|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
124995569|NCT01323634|449609406|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
124995570|NCT01323634|449609404|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
124995571|NCT01323634|449609405|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
124995572|NCT01323634|449609406|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
124995573|NCT01323634|449609404|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
124995574|NCT01323634|449609405|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
124995575|NCT01323634|449609406|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
124995576|NCT01323634|449609404|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
124995577|NCT01323634|449609405|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
124995578|NCT01323634|449609406|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
124995579|NCT01323634|449609404|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
124995580|NCT01323634|449609405|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
124995581|NCT01323634|449609406|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
124995582|NCT05056987|449609407|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
124995583|NCT05056987|449609408|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
124995584|NCT05056987|449609407|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
124995585|NCT05056987|449609408|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
124995586|NCT00753272|449609410|FG000|Overall Study|Adverse Event|878|||
124995587|NCT00753272|449609411|FG001|Overall Study|Adverse Event|869|||
124995588|NCT00753272|449609410|FG000|Overall Study|Protocol Violation|28|||
124995589|NCT00753272|449609411|FG001|Overall Study|Protocol Violation|46|||
124995590|NCT00753272|449609410|FG000|Overall Study|Withdrawal by Subject|2481|||
124995591|NCT00753272|449609411|FG001|Overall Study|Withdrawal by Subject|2407|||
124995592|NCT00753272|449609410|FG000|Overall Study|Lost to Follow-up|491|||
124995593|NCT00753272|449609411|FG001|Overall Study|Lost to Follow-up|497|||
124995594|NCT00753272|449609410|FG000|Overall Study|Other|1104|||
124995595|NCT00753272|449609411|FG001|Overall Study|Other|1088|||
124995596|NCT03604523|449609412|FG000|Overall Study|Physician Decision|1|||
124995597|NCT03604523|449609413|FG001|Overall Study|Physician Decision|0|||
124995598|NCT01675479|449609417|FG000|Overall Study|Lost to Follow-up|11|||
124995599|NCT04223856|449609421|FG000|Overall Study|Progressive disease|153|||
124995600|NCT04223856|449609422|FG001|Overall Study|Progressive disease|73|||
124995601|NCT04223856|449609421|FG000|Overall Study|Adverse Event|97|||
124995602|NCT04223856|449609422|FG001|Overall Study|Adverse Event|62|||
124995603|NCT04223856|449609421|FG000|Overall Study|Physician Decision|9|||
125321745|NCT00791934|450810055|FG000|Overall Study|Did not consent for extended follow-up|13|||
125321746|NCT02018562|450810056|FG000|Overall Study|Withdrawal by Subject|2|||
124995604|NCT04223856|449609422|FG001|Overall Study|Physician Decision|28|||
124995605|NCT04223856|449609421|FG000|Overall Study|Withdrawal by Subject|22|||
124995606|NCT04223856|449609422|FG001|Overall Study|Withdrawal by Subject|24|||
124995607|NCT04223856|449609421|FG000|Overall Study|Other|7|||
125321747|NCT02018562|450810057|FG001|Overall Study|Withdrawal by Subject|0|||
125321748|NCT02018562|450810056|FG000|Overall Study|Discharged prior to study completion|1|||
125321749|NCT02018562|450810057|FG001|Overall Study|Discharged prior to study completion|0|||
125321750|NCT05194124|450810058|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125321751|NCT05194124|450810059|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125321752|NCT05194124|450810060|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125321753|NCT05194124|450810061|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
125321754|NCT05194124|450810062|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125321755|NCT05194124|450810063|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
125321756|NCT05194124|450810064|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125321757|NCT05194124|450810065|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125321758|NCT05194124|450810066|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125321759|NCT05194124|450810067|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125321760|NCT05194124|450810058|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125321761|NCT05194124|450810059|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125321762|NCT05194124|450810060|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125321763|NCT05194124|450810061|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125321764|NCT05194124|450810062|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125321765|NCT05194124|450810063|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125321766|NCT05194124|450810064|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125321767|NCT05194124|450810065|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125321768|NCT05194124|450810066|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125321769|NCT05194124|450810067|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
125321770|NCT04609319|450810068|FG000|Overall Study|Death|64|||
125321771|NCT04609319|450810069|FG001|Overall Study|Death|49|||
125321772|NCT04609319|450810070|FG002|Overall Study|Death|1|||
125321773|NCT04609319|450810068|FG000|Overall Study|Withdrawal of consent|15|||
125321774|NCT04609319|450810069|FG001|Overall Study|Withdrawal of consent|3|||
125321775|NCT04609319|450810070|FG002|Overall Study|Withdrawal of consent|0|||
125321776|NCT04609319|450810068|FG000|Overall Study|Lost to Follow-up|20|||
125321777|NCT04609319|450810069|FG001|Overall Study|Lost to Follow-up|33|||
125321778|NCT04609319|450810070|FG002|Overall Study|Lost to Follow-up|0|||
125321779|NCT04609319|450810068|FG000|Overall Study|Alive until end of follow-up|60|||
125321780|NCT04609319|450810069|FG001|Overall Study|Alive until end of follow-up|53|||
125321781|NCT04609319|450810070|FG002|Overall Study|Alive until end of follow-up|1|||
125321782|NCT03474588|450810081|FG000|Overall Study|Withdrawal by Subject|4|||
125321783|NCT03474588|450810082|FG001|Overall Study|Withdrawal by Subject|3|||
125321784|NCT03474588|450810081|FG000|Overall Study|Death|0|||
125321785|NCT03474588|450810082|FG001|Overall Study|Death|1|||
125321786|NCT03804528|450810084|FG000|Overall Study|Time Commitment|18|||
125321787|NCT03804528|450810084|FG000|Overall Study|Health Reasons|5|||
125321788|NCT01607957|450810085|FG000|Overall Study|Not treated|1|||
125321789|NCT01607957|450810086|FG001|Overall Study|Not treated|1|||
125321790|NCT01607957|450810085|FG000|Overall Study|Death|367|||
125321791|NCT01607957|450810086|FG001|Overall Study|Death|211|||
125321792|NCT01607957|450810085|FG000|Overall Study|Lost to Follow-up|3|||
125321793|NCT01607957|450810086|FG001|Overall Study|Lost to Follow-up|3|||
125321794|NCT01607957|450810085|FG000|Overall Study|Participant refusal|1|||
125321795|NCT01607957|450810086|FG001|Overall Study|Participant refusal|0|||
125321796|NCT03589859|450810095|FG000|Overall Study|Withdrawal by Subject|0|||
125321797|NCT03589859|450810096|FG001|Overall Study|Withdrawal by Subject|6|||
125321798|NCT02331134|450810097|FG000|Overall Study|Withdrawal by Subject|1|||
125321799|NCT04966013|450810098|FG000|Overall Study|Withdrawal by Subject|0|||
125321800|NCT04966013|450810099|FG001|Overall Study|Withdrawal by Subject|2|||
125321801|NCT04966013|450810100|FG002|Overall Study|Withdrawal by Subject|1|||
125321802|NCT04966013|450810098|FG000|Overall Study|Adverse Event|2|||
125321803|NCT04966013|450810099|FG001|Overall Study|Adverse Event|1|||
125321804|NCT04966013|450810100|FG002|Overall Study|Adverse Event|1|||
125321805|NCT03518086|450810104|FG000|Overall Study|Adverse Event|23|||
125321806|NCT03518086|450810105|FG001|Overall Study|Adverse Event|15|||
125321807|NCT03518086|450810106|FG002|Overall Study|Adverse Event|3|||
125321808|NCT03518086|450810107|FG003|Overall Study|Adverse Event|2|||
125321809|NCT03518086|450810104|FG000|Overall Study|Withdrawal by Subject|8|||
125321810|NCT03518086|450810105|FG001|Overall Study|Withdrawal by Subject|5|||
125321811|NCT03518086|450810106|FG002|Overall Study|Withdrawal by Subject|1|||
125321812|NCT03518086|450810107|FG003|Overall Study|Withdrawal by Subject|0|||
124995608|NCT04223856|449609422|FG001|Overall Study|Other|2|||
124995609|NCT04223856|449609421|FG000|Overall Study|Randomized but not treated|2|||
124995610|NCT04223856|449609422|FG001|Overall Study|Randomized but not treated|11|||
125321813|NCT03518086|450810104|FG000|Overall Study|Lack of Efficacy|5|||
125321814|NCT03518086|450810105|FG001|Overall Study|Lack of Efficacy|5|||
125321815|NCT03518086|450810106|FG002|Overall Study|Lack of Efficacy|0|||
125321816|NCT03518086|450810107|FG003|Overall Study|Lack of Efficacy|2|||
125321817|NCT03518086|450810104|FG000|Overall Study|Protocol Violation|1|||
125321818|NCT03518086|450810105|FG001|Overall Study|Protocol Violation|5|||
125321819|NCT03518086|450810106|FG002|Overall Study|Protocol Violation|1|||
125321820|NCT03518086|450810107|FG003|Overall Study|Protocol Violation|3|||
125321821|NCT03518086|450810104|FG000|Overall Study|Lost to Follow-up|0|||
125321822|NCT03518086|450810105|FG001|Overall Study|Lost to Follow-up|3|||
125321823|NCT03518086|450810106|FG002|Overall Study|Lost to Follow-up|0|||
125321824|NCT03518086|450810107|FG003|Overall Study|Lost to Follow-up|0|||
125321825|NCT03518086|450810104|FG000|Overall Study|Insufficient Diary Data|0|||
125321826|NCT03518086|450810105|FG001|Overall Study|Insufficient Diary Data|2|||
125321827|NCT03518086|450810106|FG002|Overall Study|Insufficient Diary Data|0|||
125321828|NCT03518086|450810107|FG003|Overall Study|Insufficient Diary Data|0|||
125321829|NCT03518086|450810104|FG000|Overall Study|Non- compliance to Protocol|0|||
125321830|NCT03518086|450810105|FG001|Overall Study|Non- compliance to Protocol|1|||
125321831|NCT03518086|450810106|FG002|Overall Study|Non- compliance to Protocol|0|||
125321832|NCT03518086|450810107|FG003|Overall Study|Non- compliance to Protocol|0|||
125321833|NCT03518086|450810104|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
125321834|NCT03518086|450810105|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
125321835|NCT03518086|450810106|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
125321836|NCT03518086|450810107|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
125321837|NCT03518086|450810104|FG000|Overall Study|Site Terminated by Sponsor|0|||
125321838|NCT03518086|450810105|FG001|Overall Study|Site Terminated by Sponsor|1|||
125321839|NCT03518086|450810106|FG002|Overall Study|Site Terminated by Sponsor|0|||
125321840|NCT03518086|450810107|FG003|Overall Study|Site Terminated by Sponsor|0|||
125321841|NCT03518086|450810104|FG000|Overall Study|Pregnancy|0|||
125321842|NCT03518086|450810105|FG001|Overall Study|Pregnancy|0|||
125321843|NCT03518086|450810106|FG002|Overall Study|Pregnancy|0|||
125321844|NCT03518086|450810107|FG003|Overall Study|Pregnancy|2|||
125321845|NCT05967260|450810108|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
125321846|NCT05967260|450810109|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
125321847|NCT00626106|450810110|FG000|Overall Study|Withdrawal by Subject|2|||
125321848|NCT00626106|450810111|FG001|Overall Study|Withdrawal by Subject|1|||
125321849|NCT00626106|450810110|FG000|Overall Study|Lost to Follow-up|1|||
125321850|NCT00626106|450810111|FG001|Overall Study|Lost to Follow-up|4|||
125321851|NCT00626106|450810110|FG000|Overall Study|Death|64|||
125321852|NCT00626106|450810111|FG001|Overall Study|Death|19|||
125321853|NCT03007966|450811707|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
125321854|NCT03007966|450811708|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
125321855|NCT01428258|450811709|FG000|Intervention 1|Withdrawal by Subject|2|||
125321856|NCT01428258|450811710|FG001|Intervention 1|Withdrawal by Subject|0|||
125321857|NCT00248625|450811711|FG000|Overall Study|Withdrawal by Subject|0|||
125321858|NCT00248625|450811712|FG001|Overall Study|Withdrawal by Subject|2|||
125321859|NCT03085095|450811713|FG000|Overall Study|Adverse Event|23|||
125321860|NCT03085095|450811714|FG001|Overall Study|Adverse Event|8|||
125321861|NCT03085095|450811713|FG000|Overall Study|Protocol Violation|0|||
125321862|NCT03085095|450811714|FG001|Overall Study|Protocol Violation|1|||
125321863|NCT03085095|450811713|FG000|Overall Study|Lost to Follow-up|2|||
125321864|NCT03085095|450811714|FG001|Overall Study|Lost to Follow-up|1|||
125321865|NCT03085095|450811713|FG000|Overall Study|Withdrawal by Subject|17|||
125321866|NCT03085095|450811714|FG001|Overall Study|Withdrawal by Subject|6|||
125321867|NCT03085095|450811713|FG000|Overall Study|Physician Decision|9|||
125321868|NCT03085095|450811714|FG001|Overall Study|Physician Decision|3|||
125321869|NCT03085095|450811713|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
125321870|NCT03085095|450811714|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
125321871|NCT03085095|450811713|FG000|Overall Study|Did not Receive Study Drug|2|||
125321872|NCT03085095|450811714|FG001|Overall Study|Did not Receive Study Drug|2|||
125321873|NCT03085095|450811713|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
125321874|NCT03085095|450811714|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
125321875|NCT00408317|450811715|FG000|First Intervention Period|Adverse Event|0|||
125321876|NCT00408317|450811716|FG001|First Intervention Period|Adverse Event|1|||
125321877|NCT00408317|450811715|FG000|Second Intervention Period|Adverse Event|2|||
125321878|NCT00408317|450811716|FG001|Second Intervention Period|Adverse Event|0|||
125321879|NCT00408317|450811715|FG000|Second Intervention Period|Protocol Violation|0|||
125321880|NCT00408317|450811716|FG001|Second Intervention Period|Protocol Violation|1|||
125321881|NCT00408317|450811715|FG000|Second Intervention Period|Withdrawal of consent|0|||
125321882|NCT00408317|450811716|FG001|Second Intervention Period|Withdrawal of consent|1|||
124995611|NCT04223856|449609421|FG000|Overall Study|On-treatment|144|||
125321883|NCT00286468|450811717|FG000|Overall Study|Hyperglycemic Rescue|28|||
125321884|NCT00286468|450811718|FG001|Overall Study|Hyperglycemic Rescue|30|||
125321885|NCT00286468|450811719|FG002|Overall Study|Hyperglycemic Rescue|31|||
125321886|NCT00286468|450811717|FG000|Overall Study|Adverse Event|2|||
125321887|NCT00286468|450811718|FG001|Overall Study|Adverse Event|6|||
125321888|NCT00286468|450811719|FG002|Overall Study|Adverse Event|4|||
125321889|NCT00286468|450811717|FG000|Overall Study|Protocol Violation|0|||
125321890|NCT00286468|450811718|FG001|Overall Study|Protocol Violation|3|||
125321891|NCT00286468|450811719|FG002|Overall Study|Protocol Violation|1|||
125321892|NCT00286468|450811717|FG000|Overall Study|Lost to Follow-up|1|||
125321893|NCT00286468|450811718|FG001|Overall Study|Lost to Follow-up|1|||
125321894|NCT00286468|450811719|FG002|Overall Study|Lost to Follow-up|2|||
125321895|NCT00286468|450811717|FG000|Overall Study|Withdrawal by Subject|3|||
125321896|NCT00286468|450811718|FG001|Overall Study|Withdrawal by Subject|8|||
125321897|NCT00286468|450811719|FG002|Overall Study|Withdrawal by Subject|11|||
125321898|NCT00286468|450811717|FG000|Overall Study|Physician Decision|3|||
125321899|NCT00286468|450811718|FG001|Overall Study|Physician Decision|2|||
125321900|NCT00286468|450811719|FG002|Overall Study|Physician Decision|1|||
125321901|NCT02923726|450811720|FG000|Overall Study|Death|196|||
125321902|NCT02923726|450811721|FG001|Overall Study|Death|175|||
125321903|NCT02923726|450811720|FG000|Overall Study|Withdrawal by Subject|337|||
125321904|NCT02923726|450811721|FG001|Overall Study|Withdrawal by Subject|307|||
125321905|NCT00074711|450811723|FG000|Overall Study|Withdrawal by Subject|1|||
125321906|NCT00074711|450811724|FG001|Overall Study|Withdrawal by Subject|1|||
125321907|NCT00074711|450811723|FG000|Overall Study|Lost to Follow-up|10|||
125321908|NCT00074711|450811724|FG001|Overall Study|Lost to Follow-up|8|||
125321909|NCT00074711|450811723|FG000|Overall Study|Participant stopped study drug|4|||
125321910|NCT00074711|450811724|FG001|Overall Study|Participant stopped study drug|6|||
125321911|NCT03466658|450811725|FG000|Overall Study|Withdrawal by Subject|3|||
125321912|NCT05365217|450811726|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125321913|NCT05365217|450811727|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125321914|NCT00129402|450811730|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
125321915|NCT00129402|450811731|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
125321916|NCT00129402|450811732|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
125321917|NCT00129402|450811733|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
125321918|NCT00129402|450811734|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
125321919|NCT00129402|450811735|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
125321920|NCT00129402|450811736|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
125321921|NCT00129402|450811730|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
125321922|NCT00129402|450811731|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
125321923|NCT00129402|450811732|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
125321924|NCT00129402|450811733|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
125321925|NCT00129402|450811734|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
125321926|NCT00129402|450811735|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
125321927|NCT00129402|450811736|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
125321928|NCT00129402|450811730|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
125321929|NCT00129402|450811731|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
125321930|NCT00129402|450811732|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
125321931|NCT00129402|450811733|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
125321932|NCT00129402|450811734|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
125321933|NCT00129402|450811735|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
125321934|NCT00129402|450811736|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
125321935|NCT00129402|450811730|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
125321936|NCT00129402|450811731|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
125321937|NCT00129402|450811732|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
124995612|NCT04223856|449609422|FG001|Overall Study|On-treatment|0|||
124995613|NCT03226275|449609423|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
124995614|NCT03226275|449609424|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
124995615|NCT03226275|449609425|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
124995616|NCT03226275|449609426|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
124995617|NCT03226275|449609423|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
124995618|NCT03226275|449609424|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
124995619|NCT03226275|449609425|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
124995620|NCT03226275|449609426|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
124995621|NCT01340196|449611306|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
124995622|NCT00887250|449611310|FG000|Overall Study|Adverse Event|3|||
124995623|NCT00887250|449611311|FG001|Overall Study|Adverse Event|0|||
124995624|NCT00887250|449611312|FG002|Overall Study|Adverse Event|7|||
124995625|NCT00887250|449611310|FG000|Overall Study|Lack of Efficacy|9|||
124995626|NCT00887250|449611311|FG001|Overall Study|Lack of Efficacy|6|||
124995627|NCT00887250|449611312|FG002|Overall Study|Lack of Efficacy|1|||
124995628|NCT00887250|449611310|FG000|Overall Study|Lost to Follow-up|2|||
124995629|NCT00887250|449611311|FG001|Overall Study|Lost to Follow-up|3|||
124995630|NCT00887250|449611312|FG002|Overall Study|Lost to Follow-up|1|||
124995631|NCT00887250|449611310|FG000|Overall Study|Protocol Violation|2|||
124995632|NCT00887250|449611311|FG001|Overall Study|Protocol Violation|2|||
125321938|NCT00129402|450811733|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
125321939|NCT00129402|450811734|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
124995633|NCT00887250|449611312|FG002|Overall Study|Protocol Violation|1|||
124995634|NCT00887250|449611310|FG000|Overall Study|Withdrawal by Subject|2|||
124995635|NCT00887250|449611311|FG001|Overall Study|Withdrawal by Subject|1|||
125321940|NCT00129402|450811735|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
125321941|NCT00129402|450811736|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
125321942|NCT00129402|450811730|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
125321943|NCT00129402|450811731|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
125321944|NCT00129402|450811732|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
125321945|NCT00129402|450811733|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
125321946|NCT00129402|450811734|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
125321947|NCT00129402|450811735|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
125321948|NCT00129402|450811736|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
125321949|NCT00129402|450811730|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
125321950|NCT00129402|450811731|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
125321951|NCT00129402|450811732|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
125321952|NCT00129402|450811733|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
125321953|NCT00129402|450811734|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
125321954|NCT00129402|450811735|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
125321955|NCT00129402|450811736|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
125321956|NCT00129402|450811730|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
125321957|NCT00129402|450811731|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
125321958|NCT00129402|450811732|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
125321959|NCT00129402|450811733|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
125321960|NCT00129402|450811734|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
125321961|NCT00129402|450811735|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
125321962|NCT00129402|450811736|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
125321963|NCT00129402|450811730|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
125321964|NCT00129402|450811731|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
125321965|NCT00129402|450811732|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
125321966|NCT00129402|450811733|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
125321967|NCT00129402|450811734|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
125321968|NCT00129402|450811735|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
125321969|NCT00129402|450811736|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
125321970|NCT00129402|450811730|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
125321971|NCT00129402|450811731|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
125321972|NCT00129402|450811732|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
125321973|NCT00129402|450811733|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
125321974|NCT00129402|450811734|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
125321975|NCT00129402|450811735|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
125321976|NCT00129402|450811736|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
125321977|NCT00129402|450811730|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
125321978|NCT00129402|450811731|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
125321979|NCT00129402|450811732|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
125321980|NCT00129402|450811733|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
125321981|NCT00129402|450811734|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
125321982|NCT00129402|450811735|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
125321983|NCT00129402|450811736|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
125321984|NCT00129402|450811730|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
125321985|NCT00129402|450811731|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
125321986|NCT00129402|450811732|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
125321987|NCT00129402|450811733|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
125321988|NCT00129402|450811734|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
125321989|NCT00129402|450811735|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
125321990|NCT00129402|450811736|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
125321991|NCT00129402|450811730|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
125321992|NCT00129402|450811731|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
125321993|NCT00129402|450811732|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
125321994|NCT00129402|450811733|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
125321995|NCT00129402|450811734|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
125321996|NCT00129402|450811735|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
125321997|NCT00129402|450811736|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
125321998|NCT00129402|450811730|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
125321999|NCT00129402|450811731|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
124872817|NCT00500903|449155769|FG000|Overall Study|Reason Not Specified|10|||
124995636|NCT00887250|449611312|FG002|Overall Study|Withdrawal by Subject|2|||
125322000|NCT00129402|450811732|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
125322001|NCT00129402|450811733|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
125322002|NCT00129402|450811734|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
125322003|NCT00129402|450811735|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
125322004|NCT00129402|450811736|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
125322005|NCT01527149|450811737|FG000|Overall Study|Death|2|||
125322006|NCT01680341|450811738|FG000|Overall Study|Adverse Event|3|||
125322007|NCT01680341|450811739|FG001|Overall Study|Adverse Event|2|||
125322008|NCT01680341|450811738|FG000|Overall Study|Unclassified|18|||
125322009|NCT01680341|450811739|FG001|Overall Study|Unclassified|15|||
125322010|NCT00481832|450811740|FG000|Enrollment|Physician Decision|8|||
125322011|NCT00481832|450811740|FG000|Enrollment|Unable to collect enough stem cells|2|||
125322012|NCT00481832|450811740|FG000|Inter-transplant Period|Adverse Event|4|||
125322013|NCT00481832|450811740|FG000|Inter-transplant Period|Death|3|||
125322014|NCT00481832|450811740|FG000|Inter-transplant Period|Physician Decision|4|||
125322015|NCT00481832|450811740|FG000|Inter-transplant Period|Disease relapse|11|||
125322016|NCT00481832|450811740|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
125322017|NCT02992288|450811741|FG000|Overall Study|Adverse Event|8|||
125322018|NCT02992288|450811742|FG001|Overall Study|Adverse Event|2|||
125322019|NCT02992288|450811743|FG002|Overall Study|Adverse Event|2|||
125322020|NCT02992288|450811744|FG003|Overall Study|Adverse Event|2|||
125322021|NCT02992288|450811745|FG004|Overall Study|Adverse Event|2|||
125322022|NCT02992288|450811746|FG005|Overall Study|Adverse Event|7|||
125322023|NCT02992288|450811741|FG000|Overall Study|Non-compliance with study drug|0|||
125322024|NCT02992288|450811742|FG001|Overall Study|Non-compliance with study drug|1|||
125322025|NCT02992288|450811743|FG002|Overall Study|Non-compliance with study drug|1|||
125322026|NCT02992288|450811744|FG003|Overall Study|Non-compliance with study drug|0|||
125322027|NCT02992288|450811745|FG004|Overall Study|Non-compliance with study drug|1|||
125322028|NCT02992288|450811746|FG005|Overall Study|Non-compliance with study drug|0|||
125322029|NCT02992288|450811741|FG000|Overall Study|Physician Decision|3|||
125322030|NCT02992288|450811742|FG001|Overall Study|Physician Decision|0|||
125322031|NCT02992288|450811743|FG002|Overall Study|Physician Decision|1|||
125322032|NCT02992288|450811744|FG003|Overall Study|Physician Decision|0|||
125322033|NCT02992288|450811745|FG004|Overall Study|Physician Decision|0|||
125322034|NCT02992288|450811746|FG005|Overall Study|Physician Decision|1|||
125322035|NCT02992288|450811741|FG000|Overall Study|Death|2|||
125322036|NCT02992288|450811742|FG001|Overall Study|Death|0|||
125322037|NCT02992288|450811743|FG002|Overall Study|Death|2|||
125322038|NCT02992288|450811744|FG003|Overall Study|Death|1|||
125322039|NCT02992288|450811745|FG004|Overall Study|Death|2|||
125322040|NCT02992288|450811746|FG005|Overall Study|Death|0|||
125322041|NCT02992288|450811741|FG000|Overall Study|Lost to Follow-up|0|||
125322042|NCT02992288|450811742|FG001|Overall Study|Lost to Follow-up|0|||
125322043|NCT02992288|450811743|FG002|Overall Study|Lost to Follow-up|0|||
125322044|NCT02992288|450811744|FG003|Overall Study|Lost to Follow-up|1|||
125322045|NCT02992288|450811745|FG004|Overall Study|Lost to Follow-up|0|||
125322046|NCT02992288|450811746|FG005|Overall Study|Lost to Follow-up|0|||
125322047|NCT02992288|450811741|FG000|Overall Study|Protocol Violation|0|||
125322048|NCT02992288|450811742|FG001|Overall Study|Protocol Violation|0|||
125322049|NCT02992288|450811743|FG002|Overall Study|Protocol Violation|0|||
125322050|NCT02992288|450811744|FG003|Overall Study|Protocol Violation|0|||
125322051|NCT02992288|450811745|FG004|Overall Study|Protocol Violation|0|||
125322052|NCT02992288|450811746|FG005|Overall Study|Protocol Violation|1|||
125322053|NCT02992288|450811741|FG000|Overall Study|Withdrawal by Subject|4|||
125322054|NCT02992288|450811742|FG001|Overall Study|Withdrawal by Subject|2|||
125322055|NCT02992288|450811743|FG002|Overall Study|Withdrawal by Subject|1|||
125322056|NCT02992288|450811744|FG003|Overall Study|Withdrawal by Subject|5|||
125322057|NCT02992288|450811745|FG004|Overall Study|Withdrawal by Subject|3|||
125322058|NCT02992288|450811746|FG005|Overall Study|Withdrawal by Subject|4|||
125322059|NCT02006472|450811750|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
125322060|NCT02006472|450811751|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
125322061|NCT02006472|450811752|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
125322062|NCT02006472|450811753|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
125322063|NCT02006472|450811754|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
125322064|NCT02006472|450811750|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
125322065|NCT02006472|450811751|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
125322066|NCT02006472|450811752|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
125322067|NCT02006472|450811753|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
125322068|NCT02006472|450811754|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
125322069|NCT02006472|450811750|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
125322070|NCT02006472|450811751|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
125322071|NCT02006472|450811752|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
125322072|NCT02006472|450811753|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
125322073|NCT02006472|450811754|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
125322074|NCT02006472|450811750|FG000|Period 1 (Through Week 26)|Other|1|||
125322075|NCT02006472|450811751|FG001|Period 1 (Through Week 26)|Other|5|||
125322076|NCT02006472|450811752|FG002|Period 1 (Through Week 26)|Other|0|||
125322077|NCT02006472|450811753|FG003|Period 1 (Through Week 26)|Other|2|||
125322078|NCT02006472|450811754|FG004|Period 1 (Through Week 26)|Other|3|||
125322079|NCT02006472|450811750|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
125322080|NCT02006472|450811751|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
125322081|NCT02006472|450811752|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
125322082|NCT02006472|450811753|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
125322083|NCT02006472|450811754|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
125322084|NCT02006472|450811750|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
125322085|NCT02006472|450811751|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
125322086|NCT02006472|450811752|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
125322087|NCT02006472|450811753|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
125322088|NCT02006472|450811754|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
125322089|NCT02006472|450811750|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
125322090|NCT02006472|450811751|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
125322091|NCT02006472|450811752|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
125322092|NCT02006472|450811753|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
125322093|NCT02006472|450811754|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
125322094|NCT02006472|450811750|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
125322095|NCT02006472|450811751|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
125322096|NCT02006472|450811752|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
125322097|NCT02006472|450811753|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
125322098|NCT02006472|450811754|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
125322099|NCT02006472|450811750|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
125322100|NCT02006472|450811751|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
125322101|NCT02006472|450811752|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
125322102|NCT02006472|450811753|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
125322103|NCT02006472|450811754|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
125322104|NCT02006472|450811750|FG000|Period 2 (Through Week 52)|Other|0|||
125322105|NCT02006472|450811751|FG001|Period 2 (Through Week 52)|Other|1|||
125322106|NCT02006472|450811752|FG002|Period 2 (Through Week 52)|Other|0|||
125322107|NCT02006472|450811753|FG003|Period 2 (Through Week 52)|Other|1|||
125322108|NCT02006472|450811754|FG004|Period 2 (Through Week 52)|Other|0|||
125322109|NCT02006472|450811750|FG000|Period 2 (Through Week 52)|Not treated|0|||
125322110|NCT02006472|450811751|FG001|Period 2 (Through Week 52)|Not treated|0|||
125322111|NCT02006472|450811752|FG002|Period 2 (Through Week 52)|Not treated|2|||
125322112|NCT02006472|450811753|FG003|Period 2 (Through Week 52)|Not treated|0|||
125322113|NCT02006472|450811754|FG004|Period 2 (Through Week 52)|Not treated|0|||
125322114|NCT02006472|450811750|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
125322115|NCT02006472|450811751|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
125322116|NCT02006472|450811752|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
125322117|NCT02006472|450811753|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
125322118|NCT02006472|450811754|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
125322119|NCT02006472|450811750|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
125322120|NCT02006472|450811751|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
125322121|NCT02006472|450811752|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
125322122|NCT02006472|450811753|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
125322123|NCT02006472|450811754|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
125322124|NCT00499486|450811755|FG000|Overall Study|Withdrawal by Subject|16|||
125322125|NCT00656513|450811756|FG000|Overall Study|Protocol Violation|1|||
125322126|NCT00656513|450811757|FG001|Overall Study|Protocol Violation|0|||
125322127|NCT00656513|450811758|FG002|Overall Study|Protocol Violation|2|||
125322128|NCT00656513|450811756|FG000|Overall Study|Withdrawal by Subject|0|||
125322129|NCT00656513|450811757|FG001|Overall Study|Withdrawal by Subject|11|||
125322130|NCT00656513|450811758|FG002|Overall Study|Withdrawal by Subject|4|||
125322131|NCT00656513|450811756|FG000|Overall Study|Death|0|||
125322132|NCT00656513|450811757|FG001|Overall Study|Death|0|||
125322133|NCT00656513|450811758|FG002|Overall Study|Death|1|||
125322134|NCT00656513|450811756|FG000|Overall Study|Missing data|0|||
125322135|NCT00656513|450811757|FG001|Overall Study|Missing data|11|||
125322136|NCT00656513|450811758|FG002|Overall Study|Missing data|9|||
125322137|NCT00656513|450811756|FG000|Overall Study|Incomplete treatment|3|||
125322138|NCT00656513|450811757|FG001|Overall Study|Incomplete treatment|0|||
125322139|NCT00656513|450811758|FG002|Overall Study|Incomplete treatment|0|||
125322140|NCT00656513|450811756|FG000|Overall Study|Treatment completed outside of timeframe|0|||
125322141|NCT00656513|450811757|FG001|Overall Study|Treatment completed outside of timeframe|3|||
125322142|NCT00656513|450811758|FG002|Overall Study|Treatment completed outside of timeframe|1|||
125322143|NCT00656513|450811756|FG000|Overall Study|Missing baseline form|0|||
125322144|NCT00656513|450811757|FG001|Overall Study|Missing baseline form|5|||
125322145|NCT00656513|450811758|FG002|Overall Study|Missing baseline form|5|||
125322146|NCT00087152|450811759|FG000|Overall Study|Ineligible|6|||
125322147|NCT01436149|450811763|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
125322148|NCT01436149|450811764|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
125322149|NCT01436149|450811765|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
125322150|NCT01436149|450811763|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
125322151|NCT01436149|450811764|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
125322152|NCT01436149|450811765|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
125322153|NCT01436149|450811763|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
125322154|NCT01436149|450811764|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
125322155|NCT01436149|450811765|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
125322156|NCT01436149|450811763|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
125322157|NCT01436149|450811764|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
125322158|NCT01436149|450811765|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
125322159|NCT01436149|450811763|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
125322160|NCT01436149|450811764|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
125322161|NCT01436149|450811765|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
125322162|NCT01436149|450811763|FG000|Antidepressant Lead-in Phase|Other|119|||
125322163|NCT01436149|450811764|FG001|Antidepressant Lead-in Phase|Other|0|||
125322164|NCT01436149|450811765|FG002|Antidepressant Lead-in Phase|Other|0|||
125322165|NCT01436149|450811763|FG000|Randomized Phase|Adverse Event|9|||
125322166|NCT01436149|450811764|FG001|Randomized Phase|Adverse Event|10|||
125322167|NCT01436149|450811765|FG002|Randomized Phase|Adverse Event|11|||
125322168|NCT01436149|450811763|FG000|Randomized Phase|Protocol Violation|4|||
125322169|NCT01436149|450811764|FG001|Randomized Phase|Protocol Violation|5|||
125322170|NCT01436149|450811765|FG002|Randomized Phase|Protocol Violation|0|||
125322171|NCT01436149|450811763|FG000|Randomized Phase|Withdrawal by Subject|16|||
125322172|NCT01436149|450811764|FG001|Randomized Phase|Withdrawal by Subject|10|||
125322173|NCT01436149|450811765|FG002|Randomized Phase|Withdrawal by Subject|10|||
125322174|NCT01436149|450811763|FG000|Randomized Phase|Lost to Follow-up|34|||
125322175|NCT01436149|450811764|FG001|Randomized Phase|Lost to Follow-up|5|||
125322176|NCT01436149|450811765|FG002|Randomized Phase|Lost to Follow-up|6|||
125322177|NCT01436149|450811763|FG000|Randomized Phase|Lack of Efficacy|0|||
125322178|NCT01436149|450811764|FG001|Randomized Phase|Lack of Efficacy|0|||
125322179|NCT01436149|450811765|FG002|Randomized Phase|Lack of Efficacy|1|||
125322180|NCT01436149|450811763|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
125322181|NCT01436149|450811764|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
125322182|NCT01436149|450811765|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
125322183|NCT01436149|450811763|FG000|Randomized Phase|Other|12|||
125322184|NCT01436149|450811764|FG001|Randomized Phase|Other|5|||
125322185|NCT01436149|450811765|FG002|Randomized Phase|Other|11|||
125322186|NCT01643668|450811769|FG000|Overall Study|Death|1|||
125322187|NCT00322881|450811770|FG000|Overall Study|Death|2|||
125322188|NCT00322881|450811770|FG000|Overall Study|Adverse Event|1|||
125322189|NCT00322881|450811770|FG000|Overall Study|Disease Progression|2|||
125322190|NCT02285855|450811773|FG000|Overall Study|Withdrawal by Subject|2|||
125322191|NCT02285855|450811774|FG001|Overall Study|Withdrawal by Subject|1|||
125322192|NCT03253796|450811775|FG000|Period 1: Run-In|Adverse Event|4|||
125322193|NCT03253796|450811776|FG001|Period 1: Run-In|Adverse Event|0|||
125322194|NCT03253796|450811777|FG002|Period 1: Run-In|Adverse Event|0|||
125322195|NCT03253796|450811778|FG003|Period 1: Run-In|Adverse Event|0|||
125322196|NCT03253796|450811779|FG004|Period 1: Run-In|Adverse Event|0|||
125322197|NCT03253796|450811775|FG000|Period 1: Run-In|Lack of Efficacy|1|||
125322198|NCT03253796|450811776|FG001|Period 1: Run-In|Lack of Efficacy|0|||
125322199|NCT03253796|450811777|FG002|Period 1: Run-In|Lack of Efficacy|0|||
125322200|NCT03253796|450811778|FG003|Period 1: Run-In|Lack of Efficacy|0|||
125322201|NCT03253796|450811779|FG004|Period 1: Run-In|Lack of Efficacy|0|||
125322202|NCT03253796|450811775|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
125322203|NCT03253796|450811776|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
125322204|NCT03253796|450811777|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
125322205|NCT03253796|450811778|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
125322206|NCT03253796|450811779|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
125322207|NCT03253796|450811775|FG000|Period 1: Run-In|Protocol Violation|5|||
125322208|NCT03253796|450811776|FG001|Period 1: Run-In|Protocol Violation|0|||
125322209|NCT03253796|450811777|FG002|Period 1: Run-In|Protocol Violation|0|||
125322210|NCT03253796|450811778|FG003|Period 1: Run-In|Protocol Violation|0|||
125322211|NCT03253796|450811779|FG004|Period 1: Run-In|Protocol Violation|0|||
125322212|NCT03253796|450811775|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
125322213|NCT03253796|450811776|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
125322214|NCT03253796|450811777|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
125322215|NCT03253796|450811778|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
125322216|NCT03253796|450811779|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
125322217|NCT03253796|450811775|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
125322218|NCT03253796|450811776|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
125322219|NCT03253796|450811777|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
125322220|NCT03253796|450811778|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
125322221|NCT03253796|450811779|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
125322222|NCT03253796|450811775|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
125322223|NCT03253796|450811776|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
125322224|NCT03253796|450811777|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
125322225|NCT03253796|450811778|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
125322226|NCT03253796|450811779|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
125322227|NCT03253796|450811775|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
125322228|NCT03253796|450811776|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
125322229|NCT03253796|450811777|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
125322230|NCT03253796|450811778|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
125322231|NCT03253796|450811779|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
125322232|NCT03253796|450811775|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
125322233|NCT03253796|450811776|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
125322234|NCT03253796|450811777|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
125322235|NCT03253796|450811778|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
125322236|NCT03253796|450811779|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
125322237|NCT03253796|450811775|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
125322238|NCT03253796|450811776|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
125322239|NCT03253796|450811777|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
125322240|NCT03253796|450811778|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
125322241|NCT03253796|450811779|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
125322242|NCT03253796|450811775|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
125322243|NCT03253796|450811776|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
125322244|NCT03253796|450811777|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
125322245|NCT03253796|450811778|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
125322246|NCT03253796|450811779|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
125322247|NCT00528112|450811780|FG000|Treatment up to 3 Years|Adverse Event|313|||
125322248|NCT00528112|450811781|FG001|Treatment up to 3 Years|Adverse Event|278|||
125322249|NCT00528112|450811780|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
125322250|NCT00528112|450811781|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
125322251|NCT00528112|450811780|FG000|Treatment up to 3 Years|Protocol Violation|16|||
125322252|NCT00528112|450811781|FG001|Treatment up to 3 Years|Protocol Violation|16|||
125322253|NCT00528112|450811780|FG000|Treatment up to 3 Years|Death|0|||
125322254|NCT00528112|450811781|FG001|Treatment up to 3 Years|Death|1|||
125322255|NCT00528112|450811780|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
125322256|NCT00528112|450811781|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
125322257|NCT00528112|450811780|FG000|Treatment up to 3 Years|Pregnancy|9|||
125322258|NCT00528112|450811781|FG001|Treatment up to 3 Years|Pregnancy|10|||
125322259|NCT00528112|450811780|FG000|Treatment up to 3 Years|Other reasons|186|||
125322260|NCT00528112|450811781|FG001|Treatment up to 3 Years|Other reasons|186|||
125322261|NCT00528112|450811780|FG000|Extension Phase|Withdrawal by Subject|0|||
125322262|NCT00528112|450811781|FG001|Extension Phase|Withdrawal by Subject|3|||
125322263|NCT00528112|450811780|FG000|Extension Phase|Other reasons|0|||
125322264|NCT00528112|450811781|FG001|Extension Phase|Other reasons|100|||
125322265|NCT00528112|450811780|FG000|Extension Phase|Pregnancy|0|||
125322266|NCT00528112|450811781|FG001|Extension Phase|Pregnancy|3|||
125322267|NCT00528112|450811780|FG000|Extension Phase|Lost to Follow-up|0|||
125322268|NCT00528112|450811781|FG001|Extension Phase|Lost to Follow-up|12|||
125322269|NCT00528112|450811780|FG000|Extension Phase|Death|0|||
125322270|NCT00528112|450811781|FG001|Extension Phase|Death|1|||
125322271|NCT00528112|450811780|FG000|Extension Phase|Adverse Event|0|||
125322272|NCT00528112|450811781|FG001|Extension Phase|Adverse Event|36|||
125322273|NCT00528112|450811780|FG000|Extension Phase|Protocol Violation|0|||
125322274|NCT00528112|450811781|FG001|Extension Phase|Protocol Violation|2|||
125322275|NCT02718898|450811782|FG000|Blinded Treatment Period|Adverse Event|5|||
125322276|NCT02718898|450811783|FG001|Blinded Treatment Period|Adverse Event|1|||
125322277|NCT02718898|450811784|FG002|Blinded Treatment Period|Adverse Event|0|||
125322278|NCT02718898|450811785|FG003|Blinded Treatment Period|Adverse Event|0|||
125322279|NCT02718898|450811786|FG004|Blinded Treatment Period|Adverse Event|0|||
125322280|NCT02718898|450811787|FG005|Blinded Treatment Period|Adverse Event|0|||
125322281|NCT02718898|450811788|FG006|Blinded Treatment Period|Adverse Event|0|||
125322282|NCT02718898|450811782|FG000|Blinded Treatment Period|Physician Decision|1|||
125322283|NCT02718898|450811783|FG001|Blinded Treatment Period|Physician Decision|0|||
125322284|NCT02718898|450811784|FG002|Blinded Treatment Period|Physician Decision|0|||
125322285|NCT02718898|450811785|FG003|Blinded Treatment Period|Physician Decision|0|||
125322286|NCT02718898|450811786|FG004|Blinded Treatment Period|Physician Decision|0|||
125322287|NCT02718898|450811787|FG005|Blinded Treatment Period|Physician Decision|0|||
125322288|NCT02718898|450811788|FG006|Blinded Treatment Period|Physician Decision|0|||
125322289|NCT02718898|450811782|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
125322290|NCT02718898|450811783|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
125322291|NCT02718898|450811784|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
125322292|NCT02718898|450811785|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
125322293|NCT02718898|450811786|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
125322294|NCT02718898|450811787|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
125322295|NCT02718898|450811788|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
125322296|NCT02718898|450811782|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
125322297|NCT02718898|450811783|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
125322298|NCT02718898|450811784|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
125322299|NCT02718898|450811785|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
125322300|NCT02718898|450811786|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
125322301|NCT02718898|450811787|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
125322302|NCT02718898|450811788|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
125322303|NCT02718898|450811782|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
125322304|NCT02718898|450811783|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
125322305|NCT02718898|450811784|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
125322306|NCT02718898|450811785|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
125322307|NCT02718898|450811786|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
125322308|NCT02718898|450811787|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
125322309|NCT02718898|450811788|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
125322310|NCT02718898|450811782|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
125322311|NCT02718898|450811783|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
125322312|NCT02718898|450811784|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
125322313|NCT02718898|450811785|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
125322314|NCT02718898|450811786|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
125322315|NCT02718898|450811787|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
125322316|NCT02718898|450811788|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
125322317|NCT02718898|450811782|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125322318|NCT02718898|450811783|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125322319|NCT02718898|450811784|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
125322320|NCT02718898|450811785|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
125322321|NCT02718898|450811786|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125322322|NCT02718898|450811787|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125322323|NCT02718898|450811788|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125322324|NCT02718898|450811782|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
125322325|NCT02718898|450811783|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
125322326|NCT02718898|450811784|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
125322327|NCT02718898|450811785|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
125322328|NCT02718898|450811786|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
125322329|NCT02718898|450811787|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
125322330|NCT02718898|450811788|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
125322331|NCT02718898|450811782|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
125322332|NCT02718898|450811783|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
125322333|NCT02718898|450811784|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
125322334|NCT02718898|450811785|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
125322335|NCT02718898|450811786|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
125322336|NCT02718898|450811787|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
125322337|NCT02718898|450811788|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
125322338|NCT02718898|450811782|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
125322339|NCT02718898|450811783|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
125322340|NCT02718898|450811784|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
125322341|NCT02718898|450811785|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
125322342|NCT02718898|450811786|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
125322343|NCT02718898|450811787|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
125322344|NCT02718898|450811788|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
125322345|NCT02718898|450811782|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
125322346|NCT02718898|450811783|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
125322347|NCT02718898|450811784|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
125322348|NCT02718898|450811785|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
125322349|NCT02718898|450811786|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
125322350|NCT02718898|450811787|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
125322351|NCT02718898|450811788|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
125322352|NCT02718898|450811782|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
125322353|NCT02718898|450811783|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
125322354|NCT02718898|450811784|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
125322355|NCT02718898|450811785|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
125322356|NCT02718898|450811786|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
125322357|NCT02718898|450811787|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
124872818|NCT00500903|449155770|FG001|Overall Study|Reason Not Specified|0|||
125322358|NCT02718898|450811788|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
125322359|NCT02718898|450811782|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125322360|NCT02718898|450811783|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125322361|NCT02718898|450811784|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125322362|NCT02718898|450811785|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125322363|NCT02718898|450811786|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125322364|NCT02718898|450811787|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
125322365|NCT02718898|450811788|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
125322366|NCT00894803|450811789|FG000|Overall Study|Death|20|||
125322367|NCT00894803|450811790|FG001|Overall Study|Death|4|||
125322368|NCT00894803|450811789|FG000|Overall Study|Lost to Follow-up|0|||
125322369|NCT00894803|450811790|FG001|Overall Study|Lost to Follow-up|1|||
125322370|NCT04484961|450811791|FG000|Overall Study|Lost to Follow-up|9|||
125322371|NCT04484961|450811792|FG001|Overall Study|Lost to Follow-up|9|||
125322372|NCT01667900|450811793|FG000|Part B|Death|0|||
125322373|NCT01667900|450811794|FG001|Part B|Death|0|||
125322374|NCT01667900|450811795|FG002|Part B|Death|0|||
125322375|NCT01667900|450811796|FG003|Part B|Death|0|||
125322376|NCT01667900|450811797|FG004|Part B|Death|0|||
125322377|NCT01667900|450811798|FG005|Part B|Death|0|||
125322378|NCT01667900|450811799|FG006|Part B|Death|0|||
125322379|NCT01667900|450811800|FG007|Part B|Death|0|||
125322380|NCT01667900|450811801|FG008|Part B|Death|0|||
125322381|NCT01667900|450811802|FG009|Part B|Death|0|||
125322382|NCT01667900|450811803|FG010|Part B|Death|0|||
125322383|NCT01667900|450811804|FG011|Part B|Death|0|||
125322384|NCT01667900|450811805|FG012|Part B|Death|0|||
125322385|NCT01667900|450811806|FG013|Part B|Death|0|||
125322386|NCT01667900|450811807|FG014|Part B|Death|0|||
125322387|NCT01667900|450811808|FG015|Part B|Death|0|||
125322388|NCT01667900|450811809|FG016|Part B|Death|1|||
125322389|NCT01667900|450811810|FG017|Part B|Death|0|||
125322390|NCT01667900|450811811|FG018|Part B|Death|0|||
125322391|NCT01667900|450811812|FG019|Part B|Death|0|||
125322392|NCT00004563|450811817|FG000|Overall Study|Withdrawal by Subject|20|||
125322393|NCT00004563|450811818|FG001|Overall Study|Withdrawal by Subject|16|||
125322394|NCT00004563|450811817|FG000|Overall Study|Lack of Efficacy|3|||
125322395|NCT00004563|450811818|FG001|Overall Study|Lack of Efficacy|5|||
125322396|NCT00004563|450811817|FG000|Overall Study|Death|2|||
125322397|NCT00004563|450811818|FG001|Overall Study|Death|3|||
125322398|NCT03337308|450811819|FG000|Overall Study|Adverse Event|2|||
125322399|NCT03337308|450811820|FG001|Overall Study|Adverse Event|3|||
125322400|NCT03337308|450811821|FG002|Overall Study|Adverse Event|3|||
125322401|NCT03337308|450811822|FG003|Overall Study|Adverse Event|1|||
125322402|NCT03337308|450811819|FG000|Overall Study|Lost to Follow-up|1|||
125322403|NCT03337308|450811820|FG001|Overall Study|Lost to Follow-up|2|||
125322404|NCT03337308|450811821|FG002|Overall Study|Lost to Follow-up|0|||
125322405|NCT03337308|450811822|FG003|Overall Study|Lost to Follow-up|0|||
125322406|NCT03337308|450811819|FG000|Overall Study|Withdrawal by Subject|2|||
125322407|NCT03337308|450811820|FG001|Overall Study|Withdrawal by Subject|1|||
125322408|NCT03337308|450811821|FG002|Overall Study|Withdrawal by Subject|2|||
125322409|NCT03337308|450811822|FG003|Overall Study|Withdrawal by Subject|1|||
125322410|NCT03337308|450811819|FG000|Overall Study|Protocol Violation|0|||
125322411|NCT03337308|450811820|FG001|Overall Study|Protocol Violation|1|||
125322412|NCT03337308|450811821|FG002|Overall Study|Protocol Violation|0|||
125322413|NCT03337308|450811822|FG003|Overall Study|Protocol Violation|0|||
125322414|NCT00762164|450811825|FG000|Overall Study|Lost to Follow-up|1|||
125322415|NCT00762164|450811826|FG001|Overall Study|Lost to Follow-up|1|||
125322416|NCT00762164|450811825|FG000|Overall Study|Discontinued medication|2|||
125322417|NCT00762164|450811826|FG001|Overall Study|Discontinued medication|0|||
125322418|NCT00762164|450811825|FG000|Overall Study|Withdrawal by Subject|0|||
125322419|NCT00762164|450811826|FG001|Overall Study|Withdrawal by Subject|1|||
125322420|NCT03094416|450811829|FG000|Run-in|Screening failure|8|||
124995637|NCT00887250|449611310|FG000|Overall Study|Patient uncooperative|0|||
125322421|NCT03094416|450811829|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
125322422|NCT03094416|450811829|FG000|Run-in|Withdrawal by Subject|3|||
125322423|NCT03094416|450811829|FG000|Treatment Period|Withdrawal by Subject|2|||
125322424|NCT04528641|450811831|FG000|Overall Study|Withdrawal by Subject|0|||
125322425|NCT04528641|450811832|FG001|Overall Study|Withdrawal by Subject|0|||
125322426|NCT04528641|450811833|FG002|Overall Study|Withdrawal by Subject|0|||
125322427|NCT04528641|450811834|FG003|Overall Study|Withdrawal by Subject|1|||
125322428|NCT04528641|450811835|FG004|Overall Study|Withdrawal by Subject|0|||
125322429|NCT04528641|450811836|FG005|Overall Study|Withdrawal by Subject|1|||
125322430|NCT03341299|450811837|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
125322431|NCT03341299|450811838|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
125322432|NCT03341299|450811839|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
125322433|NCT03341299|450811840|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
125322434|NCT00945009|450811843|FG000|Overall Study|Lack of Efficacy|10|||
125322435|NCT00945009|450811844|FG001|Overall Study|Lack of Efficacy|0|||
125322436|NCT00945009|450811845|FG002|Overall Study|Lack of Efficacy|0|||
125322437|NCT00945009|450811843|FG000|Overall Study|Physician Decision|21|||
125322438|NCT00945009|450811844|FG001|Overall Study|Physician Decision|4|||
125322439|NCT00945009|450811845|FG002|Overall Study|Physician Decision|3|||
125322440|NCT00945009|450811843|FG000|Overall Study|Protocol Violation|6|||
125322441|NCT00945009|450811844|FG001|Overall Study|Protocol Violation|1|||
125322442|NCT00945009|450811845|FG002|Overall Study|Protocol Violation|0|||
125322443|NCT00945009|450811843|FG000|Overall Study|Withdrawal by Subject|1|||
125322444|NCT00945009|450811844|FG001|Overall Study|Withdrawal by Subject|0|||
125322445|NCT00945009|450811845|FG002|Overall Study|Withdrawal by Subject|0|||
125322446|NCT00945009|450811843|FG000|Overall Study|Ineligible|6|||
125322447|NCT00945009|450811844|FG001|Overall Study|Ineligible|1|||
125322448|NCT00945009|450811845|FG002|Overall Study|Ineligible|0|||
125322449|NCT00945009|450811843|FG000|Overall Study|Inevaluable|0|||
125322450|NCT00945009|450811844|FG001|Overall Study|Inevaluable|1|||
125322451|NCT00945009|450811845|FG002|Overall Study|Inevaluable|0|||
125322452|NCT00945009|450811843|FG000|Overall Study|Refusal of further protocol|1|||
125322453|NCT00945009|450811844|FG001|Overall Study|Refusal of further protocol|0|||
125322454|NCT00945009|450811845|FG002|Overall Study|Refusal of further protocol|0|||
125322455|NCT04607005|450811846|FG000|Overall Study|Adverse Event|0|||
125322456|NCT04607005|450811847|FG001|Overall Study|Adverse Event|1|||
125322457|NCT04607005|450811846|FG000|Overall Study|Lack of Efficacy|1|||
125322458|NCT04607005|450811847|FG001|Overall Study|Lack of Efficacy|6|||
125322459|NCT04607005|450811846|FG000|Overall Study|Withdrawal by Subject|4|||
125322460|NCT04607005|450811847|FG001|Overall Study|Withdrawal by Subject|9|||
125322461|NCT04607005|450811846|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
125322462|NCT04607005|450811847|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
125322463|NCT03919773|450811856|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
125322464|NCT03919773|450811857|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
125322465|NCT03919773|450811856|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
125322466|NCT03919773|450811857|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
125322467|NCT04659044|450811860|FG000|Induction|Physician Decision|1|||
125322468|NCT04659044|450811860|FG000|Induction|Adverse Event|2|||
125322469|NCT05417438|450811862|FG000|Overall Study|Withdrawal by Subject|3|||
125322470|NCT02994108|450813732|FG000|Intervention Messages|Withdrawal by Subject|2|||
125322471|NCT02994108|450813733|FG001|Intervention Messages|Withdrawal by Subject|0|||
125322472|NCT02994108|450813732|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
125322473|NCT02994108|450813733|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
125322474|NCT02994108|450813732|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
125322475|NCT02994108|450813733|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
125322476|NCT02994108|450813732|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
125322477|NCT02994108|450813733|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
125322478|NCT00781768|450813734|FG000|Overall Study|Not transplanted.|0|||
125322479|NCT00781768|450813735|FG001|Overall Study|Not transplanted.|2|||
125322480|NCT00079417|450813744|FG000|Overall Study|Physician Decision|2|||
125322481|NCT00079417|450813744|FG000|Overall Study|Ineligible|7|||
125322482|NCT02458313|450813745|FG000|Overall Study|Withdrawal by Subject|6|||
125322483|NCT02458313|450813746|FG001|Overall Study|Withdrawal by Subject|8|||
125322484|NCT02458313|450813745|FG000|Overall Study|Excluded for motion during MRI|1|||
125322485|NCT02458313|450813746|FG001|Overall Study|Excluded for motion during MRI|2|||
125322486|NCT02081677|450813747|FG000|Overall Study|Adverse Event|0|||
125322487|NCT02081677|450813748|FG001|Overall Study|Adverse Event|0|||
125322488|NCT02081677|450813749|FG002|Overall Study|Adverse Event|1|||
125322489|NCT02081677|450813750|FG003|Overall Study|Adverse Event|0|||
125322490|NCT02081677|450813747|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
125322491|NCT02081677|450813748|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
125322492|NCT02081677|450813749|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
125322493|NCT02081677|450813750|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
125322494|NCT02081677|450813747|FG000|Overall Study|Not comfortable with lens care system|1|||
125322495|NCT02081677|450813748|FG001|Overall Study|Not comfortable with lens care system|0|||
125322496|NCT02081677|450813749|FG002|Overall Study|Not comfortable with lens care system|0|||
125322497|NCT02081677|450813750|FG003|Overall Study|Not comfortable with lens care system|0|||
125322498|NCT02081677|450813747|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
125322499|NCT02081677|450813748|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
125322500|NCT02081677|450813749|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
125322501|NCT02081677|450813750|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
125322502|NCT00904969|450813751|FG000|Overall Study|Lost to Follow-up|4|||
125322503|NCT00904969|450813751|FG000|Overall Study|Withdrawal by Subject|3|||
125322504|NCT00904969|450813751|FG000|Overall Study|Additional Treatments|11|||
125322505|NCT00904969|450813751|FG000|Overall Study|Case Aborted; Subject Exited|1|||
125322506|NCT01097668|450813752|FG000|Overall Study|Withdrawal by Subject|1|||
125322507|NCT01097668|450813753|FG001|Overall Study|Withdrawal by Subject|2|||
125322508|NCT01097668|450813752|FG000|Overall Study|Lost to Follow-up|1|||
125322509|NCT01097668|450813753|FG001|Overall Study|Lost to Follow-up|0|||
125322510|NCT00199381|450813760|FG000|Overall Study|Withdrawal by Subject|38|||
125322511|NCT00199381|450813760|FG000|Overall Study|Adverse Event|73|||
125322512|NCT00199381|450813760|FG000|Overall Study|Protocol Violation|6|||
125322513|NCT00199381|450813760|FG000|Overall Study|Lack of Efficacy|27|||
125322514|NCT00199381|450813760|FG000|Overall Study|Not including due to early termination|37|||
125322515|NCT00199381|450813760|FG000|Overall Study|Study termination by Sponsor|323|||
125322516|NCT00385671|450813762|FG000|Overall Study|Adverse Event|14|||
125322517|NCT00385671|450813763|FG001|Overall Study|Adverse Event|27|||
125322518|NCT00385671|450813764|FG002|Overall Study|Adverse Event|18|||
125322519|NCT00385671|450813762|FG000|Overall Study|Lack of Efficacy|5|||
125322520|NCT00385671|450813763|FG001|Overall Study|Lack of Efficacy|9|||
125322521|NCT00385671|450813764|FG002|Overall Study|Lack of Efficacy|5|||
125322522|NCT00385671|450813762|FG000|Overall Study|Lost to Follow-up|6|||
125322523|NCT00385671|450813763|FG001|Overall Study|Lost to Follow-up|6|||
125322524|NCT00385671|450813764|FG002|Overall Study|Lost to Follow-up|5|||
125322525|NCT00385671|450813762|FG000|Overall Study|Physician Decision|2|||
125322526|NCT00385671|450813763|FG001|Overall Study|Physician Decision|1|||
125322527|NCT00385671|450813764|FG002|Overall Study|Physician Decision|2|||
125322528|NCT00385671|450813762|FG000|Overall Study|Protocol Violation|5|||
125322529|NCT00385671|450813763|FG001|Overall Study|Protocol Violation|2|||
125322530|NCT00385671|450813764|FG002|Overall Study|Protocol Violation|1|||
125322531|NCT00385671|450813762|FG000|Overall Study|Sponsor Decision|2|||
125322532|NCT00385671|450813763|FG001|Overall Study|Sponsor Decision|2|||
125322533|NCT00385671|450813764|FG002|Overall Study|Sponsor Decision|1|||
125322534|NCT00385671|450813762|FG000|Overall Study|Withdrawal by Subject|4|||
125322535|NCT00385671|450813763|FG001|Overall Study|Withdrawal by Subject|4|||
125322536|NCT00385671|450813764|FG002|Overall Study|Withdrawal by Subject|4|||
125322537|NCT04944992|450813765|FG000|Overall Study|Lost to Follow-up|1|||
125322538|NCT04944992|450813766|FG001|Overall Study|Lost to Follow-up|1|||
125322539|NCT04944992|450813765|FG000|Overall Study|Physician Decision|1|||
125322540|NCT04944992|450813766|FG001|Overall Study|Physician Decision|0|||
125322541|NCT04944992|450813765|FG000|Overall Study|Withdrawal by Subject|6|||
125322542|NCT04944992|450813766|FG001|Overall Study|Withdrawal by Subject|1|||
125322543|NCT01295814|450813767|FG000|Overall Study|Lack of Efficacy|0|||
125322544|NCT01295814|450813768|FG001|Overall Study|Lack of Efficacy|2|||
125322545|NCT01295814|450813767|FG000|Overall Study|Withdrawal by Subject|2|||
125322546|NCT01295814|450813768|FG001|Overall Study|Withdrawal by Subject|0|||
125322547|NCT03414983|450813769|FG000|Pre-Treatment|Other reasons|1|||
125322548|NCT03414983|450813770|FG001|Pre-Treatment|Other reasons|0|||
125322549|NCT03414983|450813769|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
125322550|NCT03414983|450813770|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
125322551|NCT03414983|450813769|FG000|Pre-Treatment|Participant withdrew consent|1|||
125322552|NCT03414983|450813770|FG001|Pre-Treatment|Participant withdrew consent|3|||
125322553|NCT03414983|450813769|FG000|Treatment|Participant withdrew consent|4|||
125322554|NCT03414983|450813770|FG001|Treatment|Participant withdrew consent|3|||
125322555|NCT03414983|450813769|FG000|Treatment|Participant request to discontinue study treatment|8|||
125322556|NCT03414983|450813770|FG001|Treatment|Participant request to discontinue study treatment|10|||
125322557|NCT03414983|450813769|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
125322558|NCT03414983|450813770|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
125322559|NCT03414983|450813769|FG000|Treatment|Death|0|||
125322560|NCT03414983|450813770|FG001|Treatment|Death|1|||
125322561|NCT03414983|450813769|FG000|Treatment|Study Drug Toxicity|10|||
125322562|NCT03414983|450813770|FG001|Treatment|Study Drug Toxicity|5|||
125322563|NCT03414983|450813769|FG000|Treatment|Disease Progression|75|||
125322564|NCT03414983|450813770|FG001|Treatment|Disease Progression|29|||
125322565|NCT03414983|450813769|FG000|Treatment|Not reported|1|||
125322566|NCT03414983|450813770|FG001|Treatment|Not reported|0|||
125322567|NCT03414983|450813769|FG000|Treatment|Other reasons|3|||
125322568|NCT03414983|450813770|FG001|Treatment|Other reasons|2|||
125322569|NCT03414983|450813769|FG000|Treatment|Poor/non-compliance|2|||
125322570|NCT03414983|450813770|FG001|Treatment|Poor/non-compliance|0|||
125322571|NCT03414983|450813769|FG000|Treatment|Maximum clinical benefit|5|||
125322572|NCT03414983|450813770|FG001|Treatment|Maximum clinical benefit|9|||
125322573|NCT03414983|450813769|FG000|Treatment|Lost to Follow-up|0|||
125322574|NCT03414983|450813770|FG001|Treatment|Lost to Follow-up|1|||
125322575|NCT03414983|450813769|FG000|Treatment|Administrative reasons by sponsor|1|||
125322576|NCT03414983|450813770|FG001|Treatment|Administrative reasons by sponsor|0|||
125322577|NCT01775501|450813773|FG000|Overall Study|Discontinued prior to treatment|1|||
124995638|NCT00887250|449611311|FG001|Overall Study|Patient uncooperative|0|||
125322578|NCT03780244|450813781|FG000|Overall Study|Lost to Follow-up|1|||
125322579|NCT03780244|450813782|FG001|Overall Study|Lost to Follow-up|0|||
125322580|NCT00804908|450813785|FG000|Overall Study|Other|115|||
125322581|NCT00804908|450813786|FG001|Overall Study|Other|116|||
125322582|NCT00804908|450813787|FG002|Overall Study|Other|114|||
125322583|NCT01280903|450813788|FG000|Overall Study|Lost to Follow-up|23|||
125322584|NCT01280903|450813789|FG001|Overall Study|Lost to Follow-up|16|||
125322585|NCT03453164|450813790|FG000|Overall Study|Lack of Efficacy|16|||
125322586|NCT03453164|450813790|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
125322587|NCT03822117|450813792|FG000|Overall Study|Death|18|||
125322588|NCT03822117|450813793|FG001|Overall Study|Death|17|||
125322589|NCT03822117|450813794|FG002|Overall Study|Death|12|||
125322590|NCT03822117|450813795|FG003|Overall Study|Death|4|||
125322591|NCT03822117|450813792|FG000|Overall Study|Lost to Follow-up|1|||
125322592|NCT03822117|450813793|FG001|Overall Study|Lost to Follow-up|2|||
125322593|NCT03822117|450813794|FG002|Overall Study|Lost to Follow-up|3|||
125322594|NCT03822117|450813795|FG003|Overall Study|Lost to Follow-up|0|||
125322595|NCT03822117|450813792|FG000|Overall Study|Study Terminated by Sponsor|25|||
125322596|NCT03822117|450813793|FG001|Overall Study|Study Terminated by Sponsor|11|||
125322597|NCT03822117|450813794|FG002|Overall Study|Study Terminated by Sponsor|6|||
125322598|NCT03822117|450813795|FG003|Overall Study|Study Terminated by Sponsor|0|||
125322599|NCT03822117|450813792|FG000|Overall Study|Withdrawal by Subject|4|||
125322600|NCT03822117|450813793|FG001|Overall Study|Withdrawal by Subject|0|||
125322601|NCT03822117|450813794|FG002|Overall Study|Withdrawal by Subject|3|||
125322602|NCT03822117|450813795|FG003|Overall Study|Withdrawal by Subject|0|||
125322603|NCT03822117|450813792|FG000|Overall Study|Disease Progression|1|||
125322604|NCT03822117|450813793|FG001|Overall Study|Disease Progression|2|||
125322605|NCT03822117|450813794|FG002|Overall Study|Disease Progression|1|||
125322606|NCT03822117|450813795|FG003|Overall Study|Disease Progression|0|||
125322607|NCT03822117|450813792|FG000|Overall Study|Never Returned to Hospital|0|||
125322608|NCT03822117|450813793|FG001|Overall Study|Never Returned to Hospital|0|||
125322609|NCT03822117|450813794|FG002|Overall Study|Never Returned to Hospital|1|||
125322610|NCT03822117|450813795|FG003|Overall Study|Never Returned to Hospital|0|||
125322611|NCT01074502|450813796|FG000|Overall Study|Withdrawal by Subject|1|||
125322612|NCT03459079|450813797|FG000|Overall Study|Adverse Event|4|||
125322613|NCT03459079|450813798|FG001|Overall Study|Adverse Event|2|||
125322614|NCT03459079|450813799|FG002|Overall Study|Adverse Event|0|||
125322615|NCT03459079|450813797|FG000|Overall Study|Withdrawal by Subject|2|||
125322616|NCT03459079|450813798|FG001|Overall Study|Withdrawal by Subject|2|||
125322617|NCT03459079|450813799|FG002|Overall Study|Withdrawal by Subject|0|||
125322618|NCT00726063|450813803|FG000|Overall Study|Adverse Event|9|||
125322619|NCT00726063|450813804|FG001|Overall Study|Adverse Event|7|||
125322620|NCT05176314|450813806|FG000|Overall Study|Lost to Follow-up|2|||
125322621|NCT05176314|450813806|FG000|Overall Study|Physician Decision|1|||
125322622|NCT05176314|450813806|FG000|Overall Study|Adverse Event|1|||
125322623|NCT01231984|450813807|FG000|Study Period 1|Withdrawal by Subject|0|||
125322624|NCT01231984|450813808|FG001|Study Period 1|Withdrawal by Subject|0|||
125322625|NCT01231984|450813809|FG002|Study Period 1|Withdrawal by Subject|0|||
125322626|NCT01231984|450813810|FG003|Study Period 1|Withdrawal by Subject|1|||
125322627|NCT01231984|450813807|FG000|Study Period 1|Lost to Follow-up|1|||
125322628|NCT01231984|450813808|FG001|Study Period 1|Lost to Follow-up|1|||
125322629|NCT01231984|450813809|FG002|Study Period 1|Lost to Follow-up|1|||
125322630|NCT01231984|450813810|FG003|Study Period 1|Lost to Follow-up|0|||
125322631|NCT01231984|450813807|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
125322632|NCT01231984|450813808|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
125322633|NCT01231984|450813809|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
125322634|NCT01231984|450813810|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
125322635|NCT01231984|450813807|FG000|Study Period 1|Screen Failure|0|||
125322636|NCT01231984|450813808|FG001|Study Period 1|Screen Failure|0|||
125322637|NCT01231984|450813809|FG002|Study Period 1|Screen Failure|0|||
125322638|NCT01231984|450813810|FG003|Study Period 1|Screen Failure|1|||
125322639|NCT01231984|450813807|FG000|Study Period 1|Non-compliance with study requirements|5|||
125322640|NCT01231984|450813808|FG001|Study Period 1|Non-compliance with study requirements|0|||
125322641|NCT01231984|450813809|FG002|Study Period 1|Non-compliance with study requirements|2|||
125322642|NCT01231984|450813810|FG003|Study Period 1|Non-compliance with study requirements|1|||
125322643|NCT01231984|450813807|FG000|Study Period 1|Protocol Violation|3|||
125322644|NCT01231984|450813808|FG001|Study Period 1|Protocol Violation|4|||
125322645|NCT01231984|450813809|FG002|Study Period 1|Protocol Violation|2|||
125322646|NCT01231984|450813810|FG003|Study Period 1|Protocol Violation|3|||
125322647|NCT01231984|450813807|FG000|Study Period 1|Adverse Event|1|||
125322648|NCT01231984|450813808|FG001|Study Period 1|Adverse Event|0|||
125322649|NCT01231984|450813809|FG002|Study Period 1|Adverse Event|0|||
125322650|NCT01231984|450813810|FG003|Study Period 1|Adverse Event|0|||
125322651|NCT01231984|450813807|FG000|Study Period 1|Other|0|||
125322652|NCT01231984|450813808|FG001|Study Period 1|Other|0|||
125322653|NCT01231984|450813809|FG002|Study Period 1|Other|0|||
125322654|NCT01231984|450813810|FG003|Study Period 1|Other|1|||
125322655|NCT01231984|450813807|FG000|Study Period 2|Withdrawal by Subject|1|||
125322656|NCT01231984|450813808|FG001|Study Period 2|Withdrawal by Subject|1|||
125322657|NCT01231984|450813809|FG002|Study Period 2|Withdrawal by Subject|0|||
125322658|NCT01231984|450813810|FG003|Study Period 2|Withdrawal by Subject|0|||
125322659|NCT01231984|450813807|FG000|Study Period 2|Lost to Follow-up|1|||
125322660|NCT01231984|450813808|FG001|Study Period 2|Lost to Follow-up|0|||
125322661|NCT01231984|450813809|FG002|Study Period 2|Lost to Follow-up|0|||
125322662|NCT01231984|450813810|FG003|Study Period 2|Lost to Follow-up|3|||
125322663|NCT01231984|450813807|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
125322664|NCT01231984|450813808|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
125322665|NCT01231984|450813809|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
125322666|NCT01231984|450813810|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
125322667|NCT02766023|450813813|FG000|Overall Study|Lost to Follow-up|23|||
125322668|NCT02766023|450813814|FG001|Overall Study|Lost to Follow-up|11|||
125322669|NCT02766023|450813813|FG000|Overall Study|Pregnancy|1|||
125322670|NCT02766023|450813814|FG001|Overall Study|Pregnancy|0|||
125322671|NCT02766023|450813813|FG000|Overall Study|Adverse Event|1|||
125322672|NCT02766023|450813814|FG001|Overall Study|Adverse Event|0|||
125322673|NCT02766023|450813813|FG000|Overall Study|Withdrawal by Subject|4|||
125322674|NCT02766023|450813814|FG001|Overall Study|Withdrawal by Subject|5|||
125322675|NCT02766023|450813813|FG000|Overall Study|Physician Decision|1|||
125322676|NCT02766023|450813814|FG001|Overall Study|Physician Decision|0|||
125322677|NCT02766023|450813813|FG000|Overall Study|Not Eligible at Enrollment|0|||
125322678|NCT02766023|450813814|FG001|Overall Study|Not Eligible at Enrollment|1|||
125322679|NCT06271993|450813815|FG000|Overall Study|Not reactive to histamine|5|||
125322680|NCT06271993|450813816|FG001|Overall Study|Not reactive to histamine|5|||
125322681|NCT06271993|450813817|FG002|Overall Study|Not reactive to histamine|5|||
125322682|NCT04026113|450813822|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
125322683|NCT04026113|450813823|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
125322684|NCT04026113|450813824|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
125322685|NCT04026113|450813825|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
125322686|NCT04026113|450813822|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
125322687|NCT04026113|450813823|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
125322688|NCT04026113|450813824|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
125322689|NCT04026113|450813825|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
125322690|NCT04026113|450813822|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
125322691|NCT04026113|450813823|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
125322692|NCT04026113|450813824|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
125322693|NCT04026113|450813825|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
125322694|NCT04026113|450813822|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
125322695|NCT04026113|450813823|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
125322696|NCT04026113|450813824|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
125322697|NCT04026113|450813825|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
125322698|NCT04026113|450813822|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
125322699|NCT04026113|450813823|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
125322700|NCT04026113|450813824|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
125322701|NCT04026113|450813825|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
125322702|NCT04026113|450813822|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
125322703|NCT04026113|450813823|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
125322704|NCT04026113|450813824|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
125322705|NCT04026113|450813825|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
125322706|NCT04026113|450813822|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
124995639|NCT00887250|449611312|FG002|Overall Study|Patient uncooperative|1|||
124995640|NCT00879762|449611313|FG000|Overall Study|Lost to Follow-up|3|||
124995641|NCT00879762|449611314|FG001|Overall Study|Lost to Follow-up|1|||
124995642|NCT00881608|449611315|FG000|Overall Study|Study prematurely terminated|11|||
124995643|NCT03214094|449611316|FG000|Overall Study|Case Report Forms Uncollected|14|||
124995644|NCT03214094|449611316|FG000|Overall Study|Protocol Deviation|46|||
124995645|NCT00655486|449611326|FG000|Overall Study|Adverse Event|10|||
124995646|NCT00655486|449611326|FG000|Overall Study|Lack of Efficacy|8|||
124995647|NCT00655486|449611326|FG000|Overall Study|Withdrawal by Subject|4|||
124995648|NCT00655486|449611326|FG000|Overall Study|Protocol Violation|1|||
124995649|NCT00655486|449611326|FG000|Overall Study|Unsatisfactory compliance|2|||
124995650|NCT00655486|449611326|FG000|Overall Study|Other: Pregnancy|1|||
124995651|NCT00655486|449611326|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
124995652|NCT00655486|449611326|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
124995653|NCT03840486|449611327|FG000|Overall Study|Withdrawal by Subject|0|||
124995654|NCT03840486|449611328|FG001|Overall Study|Withdrawal by Subject|1|||
124995655|NCT03840486|449611329|FG002|Overall Study|Withdrawal by Subject|0|||
124995656|NCT03840486|449611330|FG003|Overall Study|Withdrawal by Subject|0|||
124995657|NCT03840486|449611331|FG004|Overall Study|Withdrawal by Subject|0|||
124995658|NCT03840486|449611332|FG005|Overall Study|Withdrawal by Subject|0|||
124995659|NCT03840486|449611333|FG006|Overall Study|Withdrawal by Subject|0|||
124995660|NCT03840486|449611334|FG007|Overall Study|Withdrawal by Subject|0|||
124995661|NCT03840486|449611335|FG008|Overall Study|Withdrawal by Subject|0|||
124995662|NCT03840486|449611336|FG009|Overall Study|Withdrawal by Subject|0|||
124995663|NCT03840486|449611337|FG010|Overall Study|Withdrawal by Subject|0|||
124995664|NCT03840486|449611338|FG011|Overall Study|Withdrawal by Subject|0|||
125322707|NCT04026113|450813823|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
124995665|NCT02768870|449611339|FG000|Overall Study|Death|1|||
124995666|NCT02768870|449611339|FG000|Overall Study|Reoperation|6|||
124995667|NCT02768870|449611339|FG000|Overall Study|Lost to Follow-up|1|||
124995668|NCT02768870|449611339|FG000|Overall Study|Exit|4|||
125322708|NCT04026113|450813824|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
125322709|NCT04026113|450813825|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
125322710|NCT04026113|450813822|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
125322711|NCT04026113|450813823|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
125322712|NCT04026113|450813824|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
125322713|NCT04026113|450813825|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
125322714|NCT04026113|450813822|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
125322715|NCT04026113|450813823|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
125322716|NCT04026113|450813824|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
125322717|NCT04026113|450813825|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
125322718|NCT04613362|450813827|FG000|3 Month Follow-up|Lost to Follow-up|1|||
125322719|NCT04613362|450813828|FG001|3 Month Follow-up|Lost to Follow-up|2|||
125322720|NCT04613362|450813827|FG000|6 Month Follow-up|Lost to Follow-up|0|||
125322721|NCT04613362|450813828|FG001|6 Month Follow-up|Lost to Follow-up|1|||
125322722|NCT02218372|450813829|FG000|Overall Study|Adverse Event|1|||
125322723|NCT02218372|450813830|FG001|Overall Study|Adverse Event|1|||
125322724|NCT02218372|450813829|FG000|Overall Study|Miscellaneous|2|||
125322725|NCT02218372|450813830|FG001|Overall Study|Miscellaneous|1|||
125322726|NCT02218372|450813829|FG000|Overall Study|Randomized but did not receive treatment|2|||
125322727|NCT02218372|450813830|FG001|Overall Study|Randomized but did not receive treatment|3|||
125322728|NCT02218372|450813829|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125322729|NCT02218372|450813830|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
125322730|NCT00671658|450813839|FG000|Overall Study|Physician Decision|5|||
125322731|NCT01921205|450813840|FG000|Overall Study|Adverse Event|12|||
125322732|NCT01921205|450813841|FG001|Overall Study|Adverse Event|7|||
125322733|NCT01921205|450813840|FG000|Overall Study|Lack of Efficacy|1|||
125322734|NCT01921205|450813841|FG001|Overall Study|Lack of Efficacy|0|||
125322735|NCT01921205|450813840|FG000|Overall Study|Protocol Violation|1|||
125322736|NCT01921205|450813841|FG001|Overall Study|Protocol Violation|3|||
125322737|NCT01921205|450813840|FG000|Overall Study|Lost to Follow-up|1|||
125322738|NCT01921205|450813841|FG001|Overall Study|Lost to Follow-up|1|||
125322739|NCT01921205|450813840|FG000|Overall Study|Withdrawal by Subject|6|||
125322740|NCT01921205|450813841|FG001|Overall Study|Withdrawal by Subject|5|||
125322741|NCT01921205|450813840|FG000|Overall Study|Use Of Prohibited Medication|0|||
125322742|NCT01921205|450813841|FG001|Overall Study|Use Of Prohibited Medication|1|||
125322743|NCT01921205|450813840|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
125322744|NCT01921205|450813841|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
125322745|NCT01921205|450813840|FG000|Overall Study|Non Compliance Of The Parent|0|||
125322746|NCT01921205|450813841|FG001|Overall Study|Non Compliance Of The Parent|1|||
125322747|NCT01921205|450813840|FG000|Overall Study|Non Compliance Of Child|0|||
125322748|NCT01921205|450813841|FG001|Overall Study|Non Compliance Of Child|1|||
125322749|NCT00456846|450813843|FG000|Overall Study|Adverse Event|2|||
125322750|NCT00456846|450813844|FG001|Overall Study|Adverse Event|15|||
125322751|NCT00456846|450813843|FG000|Overall Study|Physician Decision|11|||
125322752|NCT00456846|450813844|FG001|Overall Study|Physician Decision|6|||
125322753|NCT00456846|450813843|FG000|Overall Study|Protocol Deviation|2|||
125322754|NCT00456846|450813844|FG001|Overall Study|Protocol Deviation|0|||
125322755|NCT00456846|450813843|FG000|Overall Study|Participant Discretion|1|||
125322756|NCT00456846|450813844|FG001|Overall Study|Participant Discretion|5|||
125322757|NCT00456846|450813843|FG000|Overall Study|Other|0|||
125322758|NCT00456846|450813844|FG001|Overall Study|Other|2|||
125322759|NCT03125395|450813846|FG000|Overall Study|Adverse Event|2|||
125322760|NCT03125395|450813846|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
125322761|NCT03125395|450813846|FG000|Overall Study|Physician Decision|2|||
125322762|NCT03125395|450813846|FG000|Overall Study|Commercial drug is available|5|||
125322763|NCT01668784|450813847|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
125322764|NCT01668784|450813848|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
125322765|NCT01668784|450813847|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
125322766|NCT01668784|450813848|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
125322767|NCT01668784|450813847|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
125322768|NCT01668784|450813848|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
125322769|NCT01668784|450813847|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
125322770|NCT01668784|450813848|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
125322771|NCT01668784|450813847|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
125322772|NCT01668784|450813848|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
125322773|NCT01668784|450813847|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
125322774|NCT01668784|450813848|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
125322775|NCT01668784|450813847|FG000|Treatment Period|Disease Progression|316|||
125322776|NCT01668784|450813848|FG001|Treatment Period|Disease Progression|293|||
125322777|NCT01668784|450813847|FG000|Treatment Period|Study Drug Toxicity|46|||
125322778|NCT01668784|450813848|FG001|Treatment Period|Study Drug Toxicity|53|||
125322779|NCT01668784|450813847|FG000|Treatment Period|Death|1|||
125322780|NCT01668784|450813848|FG001|Treatment Period|Death|1|||
125322781|NCT01668784|450813847|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
125322782|NCT01668784|450813848|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
125322783|NCT01668784|450813847|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
125322784|NCT01668784|450813848|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
125322785|NCT01668784|450813847|FG000|Treatment Period|Withdrawal by Subject|5|||
125322786|NCT01668784|450813848|FG001|Treatment Period|Withdrawal by Subject|3|||
125322787|NCT01668784|450813847|FG000|Treatment Period|Maximal Clinical Benefit|3|||
125322788|NCT01668784|450813848|FG001|Treatment Period|Maximal Clinical Benefit|3|||
125322789|NCT01668784|450813847|FG000|Treatment Period|Other|2|||
125322790|NCT01668784|450813848|FG001|Treatment Period|Other|8|||
125322791|NCT01668784|450813847|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
125322792|NCT01668784|450813848|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
125322793|NCT02783690|450813856|FG000|Overall Study|Withdrawal by Subject|3|||
125322794|NCT02783690|450813857|FG001|Overall Study|Withdrawal by Subject|3|||
125322795|NCT03157830|450813861|FG000|Overall Study|Lost to Follow-up|1|||
125322796|NCT03157830|450813861|FG000|Overall Study|Withdrawal by Subject|1|||
125322797|NCT05138653|450813864|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
125322798|NCT05138653|450813865|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322799|NCT05138653|450813866|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322800|NCT05138653|450813867|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322801|NCT05138653|450813868|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322802|NCT05138653|450813869|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322803|NCT05138653|450813870|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322804|NCT05138653|450813871|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322805|NCT05138653|450813872|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322806|NCT05138653|450813873|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322807|NCT05138653|450813874|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322808|NCT05138653|450813875|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322809|NCT05138653|450813876|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322810|NCT05138653|450813877|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322811|NCT05138653|450813878|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322812|NCT05138653|450813879|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322813|NCT05138653|450813864|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322814|NCT05138653|450813865|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
125322815|NCT05138653|450813866|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322816|NCT05138653|450813867|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322817|NCT05138653|450813868|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322818|NCT05138653|450813869|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322819|NCT05138653|450813870|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322820|NCT05138653|450813871|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322821|NCT05138653|450813872|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
125322822|NCT05138653|450813873|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322823|NCT05138653|450813874|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322824|NCT05138653|450813875|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322825|NCT05138653|450813876|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322826|NCT05138653|450813877|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322827|NCT05138653|450813878|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322828|NCT05138653|450813879|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322829|NCT05138653|450813864|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322830|NCT05138653|450813865|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
125322831|NCT05138653|450813866|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322832|NCT05138653|450813867|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322833|NCT05138653|450813868|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
125322834|NCT05138653|450813869|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322835|NCT05138653|450813870|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322836|NCT05138653|450813871|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322837|NCT05138653|450813872|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322838|NCT05138653|450813873|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322839|NCT05138653|450813874|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322840|NCT05138653|450813875|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322841|NCT05138653|450813876|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322842|NCT05138653|450813877|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322843|NCT05138653|450813878|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322844|NCT05138653|450813879|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322845|NCT05138653|450813864|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322846|NCT05138653|450813865|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322847|NCT05138653|450813866|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322848|NCT05138653|450813867|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322849|NCT05138653|450813868|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322850|NCT05138653|450813869|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322851|NCT05138653|450813870|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
125322852|NCT05138653|450813871|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322853|NCT05138653|450813872|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322854|NCT05138653|450813873|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322855|NCT05138653|450813874|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322856|NCT05138653|450813875|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322857|NCT05138653|450813876|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322858|NCT05138653|450813877|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322859|NCT05138653|450813878|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322860|NCT05138653|450813879|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322861|NCT05138653|450813864|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322862|NCT05138653|450813865|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322863|NCT05138653|450813866|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322864|NCT05138653|450813867|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322865|NCT05138653|450813868|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322866|NCT05138653|450813869|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322867|NCT05138653|450813870|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322868|NCT05138653|450813871|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322869|NCT05138653|450813872|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322870|NCT05138653|450813873|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322871|NCT05138653|450813874|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
125322872|NCT05138653|450813875|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322873|NCT05138653|450813876|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
125322874|NCT05138653|450813877|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322875|NCT05138653|450813878|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
125322876|NCT05138653|450813879|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322877|NCT05138653|450813864|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322878|NCT05138653|450813865|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322879|NCT05138653|450813866|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322880|NCT05138653|450813867|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322881|NCT05138653|450813868|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322882|NCT05138653|450813869|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322883|NCT05138653|450813870|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322884|NCT05138653|450813871|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322885|NCT05138653|450813872|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322886|NCT05138653|450813873|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322887|NCT05138653|450813874|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322888|NCT05138653|450813875|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322889|NCT05138653|450813876|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322890|NCT05138653|450813877|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322891|NCT05138653|450813878|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322892|NCT05138653|450813879|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
125322893|NCT05138653|450813864|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322894|NCT05138653|450813865|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322895|NCT05138653|450813866|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322896|NCT05138653|450813867|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322897|NCT05138653|450813868|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322898|NCT05138653|450813869|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322899|NCT05138653|450813870|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322900|NCT05138653|450813871|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322901|NCT05138653|450813872|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322902|NCT05138653|450813873|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322903|NCT05138653|450813874|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322904|NCT05138653|450813875|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322905|NCT05138653|450813876|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322906|NCT05138653|450813877|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
125322907|NCT05138653|450813878|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322908|NCT05138653|450813879|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322909|NCT04272242|450813880|FG000|Overall Study|Withdrawal by Subject|3|||
125322910|NCT04272242|450813880|FG000|Overall Study|Lost to Follow-up|1|||
125322911|NCT04272242|450813880|FG000|Overall Study|Adverse Event|1|||
125322912|NCT02702492|450813881|FG000|Overall Study|Disease progression|3|||
125322913|NCT02702492|450813882|FG001|Overall Study|Disease progression|3|||
125322914|NCT02702492|450813883|FG002|Overall Study|Disease progression|2|||
125322915|NCT02702492|450813884|FG003|Overall Study|Disease progression|4|||
125322916|NCT02702492|450813885|FG004|Overall Study|Disease progression|4|||
125322917|NCT02702492|450813886|FG005|Overall Study|Disease progression|1|||
125322918|NCT02702492|450813887|FG006|Overall Study|Disease progression|2|||
125322919|NCT02702492|450813888|FG007|Overall Study|Disease progression|8|||
125322920|NCT02702492|450813889|FG008|Overall Study|Disease progression|5|||
125322921|NCT02702492|450813890|FG009|Overall Study|Disease progression|1|||
125322922|NCT02702492|450813891|FG010|Overall Study|Disease progression|0|||
125322923|NCT02702492|450813892|FG011|Overall Study|Disease progression|3|||
125322924|NCT02702492|450813893|FG012|Overall Study|Disease progression|2|||
125322925|NCT02702492|450813881|FG000|Overall Study|Clinical progression|0|||
125322926|NCT02702492|450813882|FG001|Overall Study|Clinical progression|0|||
125322927|NCT02702492|450813883|FG002|Overall Study|Clinical progression|2|||
125322928|NCT02702492|450813884|FG003|Overall Study|Clinical progression|1|||
125322929|NCT02702492|450813885|FG004|Overall Study|Clinical progression|0|||
125322930|NCT02702492|450813886|FG005|Overall Study|Clinical progression|2|||
125322931|NCT02702492|450813887|FG006|Overall Study|Clinical progression|1|||
125322932|NCT02702492|450813888|FG007|Overall Study|Clinical progression|4|||
125322933|NCT02702492|450813889|FG008|Overall Study|Clinical progression|0|||
125322934|NCT02702492|450813890|FG009|Overall Study|Clinical progression|0|||
125322935|NCT02702492|450813891|FG010|Overall Study|Clinical progression|1|||
125322936|NCT02702492|450813892|FG011|Overall Study|Clinical progression|2|||
125322937|NCT02702492|450813893|FG012|Overall Study|Clinical progression|0|||
125322938|NCT02702492|450813881|FG000|Overall Study|Adverse Event|0|||
125322939|NCT02702492|450813882|FG001|Overall Study|Adverse Event|0|||
125322940|NCT02702492|450813883|FG002|Overall Study|Adverse Event|1|||
125322941|NCT02702492|450813884|FG003|Overall Study|Adverse Event|2|||
125322942|NCT02702492|450813885|FG004|Overall Study|Adverse Event|1|||
125322943|NCT02702492|450813886|FG005|Overall Study|Adverse Event|0|||
125322944|NCT02702492|450813887|FG006|Overall Study|Adverse Event|1|||
125322945|NCT02702492|450813888|FG007|Overall Study|Adverse Event|0|||
125322946|NCT02702492|450813889|FG008|Overall Study|Adverse Event|2|||
125322947|NCT02702492|450813890|FG009|Overall Study|Adverse Event|0|||
125322948|NCT02702492|450813891|FG010|Overall Study|Adverse Event|0|||
125322949|NCT02702492|450813892|FG011|Overall Study|Adverse Event|0|||
125322950|NCT02702492|450813893|FG012|Overall Study|Adverse Event|1|||
125322951|NCT02702492|450813881|FG000|Overall Study|Other|0|||
125322952|NCT02702492|450813882|FG001|Overall Study|Other|0|||
125322953|NCT02702492|450813883|FG002|Overall Study|Other|0|||
125322954|NCT02702492|450813884|FG003|Overall Study|Other|0|||
125322955|NCT02702492|450813885|FG004|Overall Study|Other|0|||
125322956|NCT02702492|450813886|FG005|Overall Study|Other|0|||
125322957|NCT02702492|450813887|FG006|Overall Study|Other|0|||
125322958|NCT02702492|450813888|FG007|Overall Study|Other|0|||
125322959|NCT02702492|450813889|FG008|Overall Study|Other|0|||
125322960|NCT02702492|450813890|FG009|Overall Study|Other|0|||
125322961|NCT02702492|450813891|FG010|Overall Study|Other|0|||
125322962|NCT02702492|450813892|FG011|Overall Study|Other|0|||
125322963|NCT02702492|450813893|FG012|Overall Study|Other|1|||
125322964|NCT01824836|450813894|FG000|Overall Study|Adverse Event|48|||
125322965|NCT01824836|450813894|FG000|Overall Study|Withdrawal by Subject|63|||
125322966|NCT01824836|450813894|FG000|Overall Study|Other complicating disease|116|||
125322967|NCT01824836|450813894|FG000|Overall Study|Disease progression|5|||
125322968|NCT01824836|450813894|FG000|Overall Study|Alternative therapy|2|||
125322969|NCT01824836|450813894|FG000|Overall Study|Depression|1|||
125322970|NCT01824836|450813894|FG000|Overall Study|Non-compliance|3|||
125322971|NCT01824836|450813894|FG000|Overall Study|Patient regained ovarian function|3|||
125322972|NCT01824836|450813894|FG000|Overall Study|Lost to Follow-up|8|||
125322973|NCT01824836|450813894|FG000|Overall Study|Physician Decision|2|||
125322974|NCT01824836|450813894|FG000|Overall Study|Research office was closed|3|||
125322975|NCT01824836|450813894|FG000|Overall Study|Relocation|3|||
125322976|NCT01824836|450813894|FG000|Overall Study|Insurance-related issue|1|||
125322977|NCT01824836|450813894|FG000|Overall Study|Transportation issue|1|||
125322978|NCT01824836|450813894|FG000|Overall Study|Patient transferred care|1|||
125322979|NCT01824836|450813894|FG000|Overall Study|Unknown reasons|4|||
125322980|NCT01824836|450813894|FG000|Overall Study|Never started treatment|16|||
125322981|NCT00751296|450816069|FG000|Overall Study|Adverse Event|2|||
125322982|NCT01972217|450816070|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
125322983|NCT01972217|450816071|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
125322984|NCT01972217|450816072|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
125322985|NCT01972217|450816073|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
125322986|NCT01972217|450816070|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
125322987|NCT01972217|450816071|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
125322988|NCT01972217|450816072|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
125322989|NCT01972217|450816073|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
125322990|NCT01972217|450816070|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
125322991|NCT01972217|450816071|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
125322992|NCT01972217|450816072|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
125322993|NCT01972217|450816073|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
125322994|NCT01972217|450816070|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
125322995|NCT01972217|450816071|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
125322996|NCT01972217|450816072|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
125322997|NCT01972217|450816073|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
125322998|NCT01972217|450816070|FG000|Part B Double-blind, Randomised Period|Death|0|||
125322999|NCT01972217|450816071|FG001|Part B Double-blind, Randomised Period|Death|0|||
125323000|NCT01972217|450816072|FG002|Part B Double-blind, Randomised Period|Death|43|||
125323001|NCT01972217|450816073|FG003|Part B Double-blind, Randomised Period|Death|44|||
125323002|NCT01972217|450816070|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
125323003|NCT01972217|450816071|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
125323004|NCT01972217|450816072|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
125323005|NCT01972217|450816073|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
125323006|NCT01972217|450816070|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
125323007|NCT01972217|450816071|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
125323008|NCT01972217|450816072|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
125323009|NCT01972217|450816073|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
125323010|NCT01972217|450816070|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
125323011|NCT01972217|450816071|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
125323012|NCT01972217|450816072|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
125323013|NCT01972217|450816073|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
125323014|NCT01972217|450816070|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
125323015|NCT01972217|450816071|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
125323016|NCT01972217|450816072|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
125323017|NCT01972217|450816073|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
125323018|NCT04106557|450816075|FG000|Overall Study|Physician Decision|0|||
125323019|NCT04106557|450816076|FG001|Overall Study|Physician Decision|1|||
125323020|NCT04106557|450816077|FG002|Overall Study|Physician Decision|0|||
125323021|NCT04106557|450816075|FG000|Overall Study|Protocol Violation|0|||
125323022|NCT04106557|450816076|FG001|Overall Study|Protocol Violation|1|||
125323023|NCT04106557|450816077|FG002|Overall Study|Protocol Violation|0|||
125323024|NCT03175367|450816078|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
125323025|NCT03175367|450816079|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
125323026|NCT03175367|450816080|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
125323027|NCT03175367|450816081|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
125323028|NCT03175367|450816082|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
125323029|NCT03175367|450816083|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
125323030|NCT03175367|450816084|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
125323031|NCT03175367|450816078|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
125323032|NCT03175367|450816079|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
125323033|NCT03175367|450816080|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
125323034|NCT03175367|450816081|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
125323035|NCT03175367|450816082|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
125323036|NCT03175367|450816083|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
125323037|NCT03175367|450816084|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
125323038|NCT03175367|450816078|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
125323039|NCT03175367|450816079|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
125323040|NCT03175367|450816080|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
125323041|NCT03175367|450816081|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
125323042|NCT03175367|450816082|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
125323043|NCT03175367|450816083|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
125323044|NCT03175367|450816084|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
125323045|NCT03175367|450816078|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
125323046|NCT03175367|450816079|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
125323047|NCT03175367|450816080|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
125323048|NCT03175367|450816081|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
125323049|NCT03175367|450816082|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
125323050|NCT03175367|450816083|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
125323051|NCT03175367|450816084|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
125323052|NCT03175367|450816078|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125323053|NCT03175367|450816079|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125323054|NCT03175367|450816080|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
125323055|NCT03175367|450816081|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125323056|NCT03175367|450816082|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
125323057|NCT03175367|450816083|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125323058|NCT03175367|450816084|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125323059|NCT03175367|450816078|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
125323060|NCT03175367|450816079|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
125323061|NCT03175367|450816080|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
125323062|NCT03175367|450816081|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
125323063|NCT03175367|450816082|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
125323064|NCT03175367|450816083|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
125323065|NCT03175367|450816084|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
125323066|NCT03175367|450816078|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125323067|NCT03175367|450816079|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125323068|NCT03175367|450816080|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125323069|NCT03175367|450816081|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125323070|NCT03175367|450816082|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125323071|NCT03175367|450816083|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
125323072|NCT03175367|450816084|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
125323073|NCT02151058|450816085|FG000|Overall Study|Withdrawal by Subject|1|||
125323074|NCT02151058|450816086|FG001|Overall Study|Withdrawal by Subject|1|||
125323075|NCT02151058|450816087|FG002|Overall Study|Withdrawal by Subject|3|||
125323076|NCT02151058|450816085|FG000|Overall Study|Lost to Follow-up|1|||
125323077|NCT02151058|450816086|FG001|Overall Study|Lost to Follow-up|0|||
125323078|NCT02151058|450816087|FG002|Overall Study|Lost to Follow-up|2|||
125323079|NCT00674817|450816089|FG000|Period 1|Withdrawal by Subject|2|||
125323080|NCT00674817|450816089|FG000|Period 1|Protocol Violation|1|||
125323081|NCT00674817|450816089|FG000|Period 3|Adverse Event|1|||
125323082|NCT00674817|450816089|FG000|Period 3|Protocol Violation|1|||
125323083|NCT00674817|450816089|FG000|Period 4|Adverse Event|1|||
125323084|NCT03379818|450816090|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
125323085|NCT03379818|450816091|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
125323086|NCT03379818|450816090|FG000|Overall Study|Withdrawal by Subject|2|||
125323087|NCT03379818|450816091|FG001|Overall Study|Withdrawal by Subject|3|||
125323088|NCT03379818|450816090|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
125323089|NCT03379818|450816091|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
125323090|NCT03199976|450816092|FG000|Overall Study|Lack of Efficacy|3|||
125323091|NCT03199976|450816093|FG001|Overall Study|Lack of Efficacy|6|||
125323092|NCT03199976|450816094|FG002|Overall Study|Lack of Efficacy|13|||
125323093|NCT03199976|450816092|FG000|Overall Study|Withdrawal by Subject|1|||
125323094|NCT03199976|450816093|FG001|Overall Study|Withdrawal by Subject|0|||
125323095|NCT03199976|450816094|FG002|Overall Study|Withdrawal by Subject|0|||
125323096|NCT03199976|450816092|FG000|Overall Study|Lost to Follow-up|0|||
125323097|NCT03199976|450816093|FG001|Overall Study|Lost to Follow-up|1|||
125323098|NCT03199976|450816094|FG002|Overall Study|Lost to Follow-up|1|||
125323099|NCT01780506|450816101|FG000|Double-Blind Phase|Randomized but not Treated|3|||
125323100|NCT01780506|450816102|FG001|Double-Blind Phase|Randomized but not Treated|2|||
125323101|NCT01780506|450816101|FG000|Double-Blind Phase|Adverse Event|4|||
125323102|NCT01780506|450816102|FG001|Double-Blind Phase|Adverse Event|14|||
125323103|NCT01780506|450816101|FG000|Double-Blind Phase|Death|1|||
125323104|NCT01780506|450816102|FG001|Double-Blind Phase|Death|2|||
125323105|NCT01780506|450816101|FG000|Double-Blind Phase|Pregnancy|2|||
125323106|NCT01780506|450816102|FG001|Double-Blind Phase|Pregnancy|1|||
125323107|NCT01780506|450816101|FG000|Double-Blind Phase|Lack of Efficacy|1|||
125323108|NCT01780506|450816102|FG001|Double-Blind Phase|Lack of Efficacy|1|||
125323109|NCT01780506|450816101|FG000|Double-Blind Phase|Investigator's Discretion|5|||
125323110|NCT01780506|450816102|FG001|Double-Blind Phase|Investigator's Discretion|2|||
125323111|NCT01780506|450816101|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
125323112|NCT01780506|450816102|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
125323113|NCT01780506|450816101|FG000|Double-Blind Phase|Protocol Violation|4|||
125323114|NCT01780506|450816102|FG001|Double-Blind Phase|Protocol Violation|3|||
125323115|NCT01780506|450816101|FG000|Double-Blind Phase|Withdrew Consent|23|||
125323116|NCT01780506|450816102|FG001|Double-Blind Phase|Withdrew Consent|24|||
125323117|NCT01780506|450816101|FG000|Double-Blind Phase|Lost to Follow-up|23|||
125323118|NCT01780506|450816102|FG001|Double-Blind Phase|Lost to Follow-up|26|||
125323119|NCT01780506|450816101|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
125323120|NCT01780506|450816102|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
125323121|NCT05236270|450816103|FG000|Overall Study|Lost to Follow-up|3|||
125323122|NCT05236270|450816104|FG001|Overall Study|Lost to Follow-up|2|||
125323123|NCT05236270|450816105|FG002|Overall Study|Lost to Follow-up|0|||
125323124|NCT05236270|450816106|FG003|Overall Study|Lost to Follow-up|0|||
125323125|NCT05236270|450816107|FG004|Overall Study|Lost to Follow-up|2|||
125323126|NCT05236270|450816108|FG005|Overall Study|Lost to Follow-up|0|||
125323127|NCT05236270|450816109|FG006|Overall Study|Lost to Follow-up|1|||
125323128|NCT05236270|450816110|FG007|Overall Study|Lost to Follow-up|3|||
125323129|NCT04030143|450816111|FG000|Overall Study|Adverse Event|5|||
125323130|NCT04030143|450816112|FG001|Overall Study|Adverse Event|10|||
125323131|NCT04030143|450816111|FG000|Overall Study|Lost to Follow-up|3|||
125323132|NCT04030143|450816112|FG001|Overall Study|Lost to Follow-up|7|||
125323133|NCT04030143|450816111|FG000|Overall Study|Protocol Deviation|2|||
125323134|NCT04030143|450816112|FG001|Overall Study|Protocol Deviation|2|||
125323135|NCT04030143|450816111|FG000|Overall Study|Withdrawal by Subject|16|||
125323136|NCT04030143|450816112|FG001|Overall Study|Withdrawal by Subject|18|||
125323137|NCT04030143|450816111|FG000|Overall Study|Physician Decision|1|||
125323138|NCT04030143|450816112|FG001|Overall Study|Physician Decision|1|||
125323139|NCT04030143|450816111|FG000|Overall Study|Due to Covid-19|2|||
125323140|NCT04030143|450816112|FG001|Overall Study|Due to Covid-19|3|||
125323141|NCT04030143|450816111|FG000|Overall Study|Not Due to Covid-19|1|||
125323142|NCT04030143|450816112|FG001|Overall Study|Not Due to Covid-19|1|||
125323143|NCT01499940|450816113|FG000|Overall Study|Study was withdrawn before completion.|9|||
125323144|NCT00412984|450816114|FG000|Overall Study|Death|331|||
125323145|NCT00412984|450816115|FG001|Overall Study|Death|349|||
125323146|NCT00412984|450816114|FG000|Overall Study|Adverse Event|679|||
125323147|NCT00412984|450816115|FG001|Overall Study|Adverse Event|738|||
125323148|NCT00412984|450816114|FG000|Overall Study|Withdrawal by Subject|921|||
125323149|NCT00412984|450816115|FG001|Overall Study|Withdrawal by Subject|989|||
125323150|NCT00412984|450816114|FG000|Overall Study|Lost to Follow-up|51|||
125323151|NCT00412984|450816115|FG001|Overall Study|Lost to Follow-up|39|||
125323152|NCT00412984|450816114|FG000|Overall Study|Poor/Noncompliance|57|||
125323153|NCT00412984|450816115|FG001|Overall Study|Poor/Noncompliance|77|||
125323154|NCT00412984|450816114|FG000|Overall Study|Pregnancy|1|||
125323155|NCT00412984|450816115|FG001|Overall Study|Pregnancy|0|||
125323156|NCT00412984|450816114|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
125323157|NCT00412984|450816115|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
125323158|NCT00412984|450816114|FG000|Overall Study|Administrative Reason by Sponsor|11|||
125323159|NCT00412984|450816115|FG001|Overall Study|Administrative Reason by Sponsor|8|||
125323160|NCT00412984|450816114|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
125323161|NCT00412984|450816115|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
125323162|NCT00412984|450816114|FG000|Overall Study|Other Reason|80|||
125323163|NCT00412984|450816115|FG001|Overall Study|Other Reason|92|||
125323164|NCT00412984|450816114|FG000|Overall Study|Not Reported|11|||
125323165|NCT00412984|450816115|FG001|Overall Study|Not Reported|12|||
125323166|NCT04218240|450816116|FG000|Overall Study|Withdrawal by Subject|6|||
125323167|NCT04218240|450816117|FG001|Overall Study|Withdrawal by Subject|0|||
125323168|NCT04218240|450816116|FG000|Overall Study|Lack of Efficacy|24|||
125323169|NCT04218240|450816117|FG001|Overall Study|Lack of Efficacy|19|||
125323170|NCT04218240|450816116|FG000|Overall Study|Physician Decision|0|||
125323171|NCT04218240|450816117|FG001|Overall Study|Physician Decision|1|||
125323172|NCT04218240|450816116|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
125323173|NCT04218240|450816117|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
125323174|NCT04914364|450816118|FG000|Overall Study|No longer eligible for study|1|||
125323175|NCT04914364|450816118|FG000|Overall Study|Lost to Follow-up|2|||
125323176|NCT04097678|450816119|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
125323177|NCT04097678|450816120|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
124995669|NCT03401229|449611340|FG000|Overall Study|Lost to Follow-up|2|||
124995670|NCT03401229|449611341|FG001|Overall Study|Lost to Follow-up|1|||
124995671|NCT03401229|449611340|FG000|Overall Study|Other|1|||
124995672|NCT03401229|449611341|FG001|Overall Study|Other|3|||
124995673|NCT03401229|449611340|FG000|Overall Study|Adverse Event|8|||
124995674|NCT03401229|449611341|FG001|Overall Study|Adverse Event|6|||
124995675|NCT03401229|449611340|FG000|Overall Study|Withdrawal by Subject|29|||
124995676|NCT03401229|449611341|FG001|Overall Study|Withdrawal by Subject|26|||
124995677|NCT03401229|449611340|FG000|Overall Study|COVID-19|0|||
124995678|NCT03401229|449611341|FG001|Overall Study|COVID-19|1|||
124995679|NCT01774110|449611342|FG000|Overall Study|Lost to Follow-up|7|||
124995680|NCT00640016|449611343|FG000|Overall Study|Withdrawal by Subject|0|||
125323178|NCT03694678|450816121|FG000|Overall Study|Withdrawal by Subject|2|||
125323179|NCT03694678|450816122|FG001|Overall Study|Withdrawal by Subject|0|||
125323180|NCT03694678|450816121|FG000|Overall Study|Lost to Follow-up|2|||
125323181|NCT03694678|450816122|FG001|Overall Study|Lost to Follow-up|3|||
124995681|NCT00640016|449611344|FG001|Overall Study|Withdrawal by Subject|1|||
125323182|NCT02435212|450816123|FG000|Core Phase|Adverse Event|8|||
125323183|NCT02435212|450816124|FG001|Core Phase|Adverse Event|5|||
125323184|NCT02435212|450816123|FG000|Core Phase|Withdrawal by Subject|3|||
125323185|NCT02435212|450816124|FG001|Core Phase|Withdrawal by Subject|0|||
125323186|NCT02435212|450816123|FG000|Core Phase|Withdrawal by parent/guardian|9|||
125323187|NCT02435212|450816124|FG001|Core Phase|Withdrawal by parent/guardian|4|||
124995682|NCT00640016|449611345|FG002|Overall Study|Withdrawal by Subject|0|||
125210678|NCT02638259|450395634|FG000|Treatment Period 1|Protocol Violation|0|||
125323188|NCT02435212|450816123|FG000|Core Phase|Protocol Violation|1|||
125323189|NCT02435212|450816124|FG001|Core Phase|Protocol Violation|2|||
125323190|NCT02435212|450816123|FG000|Core Phase|Physician Decision|3|||
125323191|NCT02435212|450816124|FG001|Core Phase|Physician Decision|0|||
125323192|NCT02435212|450816123|FG000|Core Phase|Lost to Follow-up|0|||
125323193|NCT02435212|450816124|FG001|Core Phase|Lost to Follow-up|1|||
125323194|NCT02435212|450816123|FG000|Core Phase|Lack of Efficacy|0|||
125323195|NCT02435212|450816124|FG001|Core Phase|Lack of Efficacy|1|||
125323196|NCT02435212|450816123|FG000|Core Phase|Recovery|1|||
125323197|NCT02435212|450816124|FG001|Core Phase|Recovery|0|||
125323198|NCT02435212|450816123|FG000|Optional Extension Phase|Adverse Event|3|||
125323199|NCT02435212|450816124|FG001|Optional Extension Phase|Adverse Event|9|||
125323200|NCT02435212|450816123|FG000|Optional Extension Phase|Physician Decision|6|||
125323201|NCT02435212|450816124|FG001|Optional Extension Phase|Physician Decision|8|||
125323202|NCT02435212|450816123|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
125323203|NCT02435212|450816124|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
125323204|NCT02435212|450816123|FG000|Optional Extension Phase|Lack of Efficacy|2|||
125323205|NCT02435212|450816124|FG001|Optional Extension Phase|Lack of Efficacy|3|||
125323206|NCT02435212|450816123|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
125323207|NCT02435212|450816124|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
125323208|NCT02435212|450816123|FG000|Optional Extension Phase|Protocol Violation|0|||
125323209|NCT02435212|450816124|FG001|Optional Extension Phase|Protocol Violation|1|||
125323210|NCT02435212|450816123|FG000|Optional Extension Phase|Recovery|1|||
125323211|NCT02435212|450816124|FG001|Optional Extension Phase|Recovery|1|||
125323212|NCT02435212|450816123|FG000|Optional Extension Phase|Death|1|||
125323213|NCT02435212|450816124|FG001|Optional Extension Phase|Death|0|||
125323214|NCT02435212|450816123|FG000|Optional Extension Phase|Technical problems|2|||
125323215|NCT02435212|450816124|FG001|Optional Extension Phase|Technical problems|0|||
125323216|NCT05966142|450816134|FG000|Overall Study|Death|3|||
125323217|NCT05966142|450816135|FG001|Overall Study|Death|3|||
125323218|NCT05966142|450816134|FG000|Overall Study|Lost to Follow-up|55|||
125323219|NCT05966142|450816135|FG001|Overall Study|Lost to Follow-up|52|||
125323220|NCT05966142|450816134|FG000|Overall Study|Physician Decision|1|||
125323221|NCT05966142|450816135|FG001|Overall Study|Physician Decision|0|||
125323222|NCT05966142|450816134|FG000|Overall Study|Withdrawal by Subject|9|||
125323223|NCT05966142|450816135|FG001|Overall Study|Withdrawal by Subject|8|||
125323224|NCT05966142|450816134|FG000|Overall Study|Duplicate Enrollment|1|||
125323225|NCT05966142|450816135|FG001|Overall Study|Duplicate Enrollment|0|||
125323226|NCT05966142|450816134|FG000|Overall Study|Study Logistical Reason|1|||
125323227|NCT05966142|450816135|FG001|Overall Study|Study Logistical Reason|0|||
125323228|NCT05966142|450816134|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
125323229|NCT05966142|450816135|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
125323230|NCT04852302|450816141|FG000|Overall Study|Withdrawal by Subject|2|||
125323231|NCT04852302|450816141|FG000|Overall Study|Did not complete CALM therapy.|2|||
125323232|NCT03267277|450816142|FG000|Overall Study|Withdrawal by Subject|1|||
125323233|NCT04849364|450816143|FG000|Overall Study|Eligibility criteria not meet|0|||
125323234|NCT04849364|450816144|FG001|Overall Study|Eligibility criteria not meet|1|||
125323235|NCT04849364|450816145|FG002|Overall Study|Eligibility criteria not meet|0|||
125323236|NCT03521570|450816147|FG000|Overall Study|Not eligible|11|||
125323237|NCT04531176|450816150|FG000|Overall Study|Study was stopped early|24|||
125323238|NCT04531176|450816151|FG001|Overall Study|Study was stopped early|26|||
125323239|NCT04531176|450816152|FG002|Overall Study|Study was stopped early|24|||
125323240|NCT01345240|450816165|FG000|Overall Study|Adverse Event|3|||
125323241|NCT01345240|450816166|FG001|Overall Study|Adverse Event|5|||
125323242|NCT01345240|450816167|FG002|Overall Study|Adverse Event|4|||
125323243|NCT01345240|450816168|FG003|Overall Study|Adverse Event|2|||
125323244|NCT01345240|450816169|FG004|Overall Study|Adverse Event|1|||
125323245|NCT01345240|450816165|FG000|Overall Study|Lost to Follow-up|8|||
125323246|NCT01345240|450816166|FG001|Overall Study|Lost to Follow-up|9|||
125323247|NCT01345240|450816167|FG002|Overall Study|Lost to Follow-up|14|||
125323248|NCT01345240|450816168|FG003|Overall Study|Lost to Follow-up|7|||
125323249|NCT01345240|450816169|FG004|Overall Study|Lost to Follow-up|9|||
125323250|NCT04298697|450816170|FG000|Overall Study|Lost to Follow-up|5|||
125323251|NCT04298697|450816171|FG001|Overall Study|Lost to Follow-up|5|||
125323252|NCT04298697|450816172|FG002|Overall Study|Lost to Follow-up|1|||
125323253|NCT04298697|450816173|FG003|Overall Study|Lost to Follow-up|0|||
125323254|NCT04298697|450816170|FG000|Overall Study|Withdrawal by Subject|0|||
125323255|NCT04298697|450816171|FG001|Overall Study|Withdrawal by Subject|3|||
125323256|NCT04298697|450816172|FG002|Overall Study|Withdrawal by Subject|2|||
125323257|NCT04298697|450816173|FG003|Overall Study|Withdrawal by Subject|3|||
124995683|NCT00640016|449611346|FG003|Overall Study|Withdrawal by Subject|0|||
125323258|NCT00449696|450816174|FG000|Overall Study|Other Treatment Required|6|||
125323259|NCT00449696|450816175|FG001|Overall Study|Other Treatment Required|1|||
125323260|NCT00449696|450816174|FG000|Overall Study|Withdrawal by Subject|5|||
125323261|NCT00449696|450816175|FG001|Overall Study|Withdrawal by Subject|5|||
125323262|NCT00449696|450816174|FG000|Overall Study|Lost to Follow-up|2|||
125323263|NCT00449696|450816175|FG001|Overall Study|Lost to Follow-up|3|||
125323264|NCT00449696|450816174|FG000|Overall Study|Others|7|||
125323265|NCT00449696|450816175|FG001|Overall Study|Others|0|||
125323266|NCT01903460|450816180|FG000|Overall Study|Adverse Event|0|||
125323267|NCT01903460|450816181|FG001|Overall Study|Adverse Event|0|||
125323268|NCT01903460|450816182|FG002|Overall Study|Adverse Event|0|||
125323269|NCT01903460|450816183|FG003|Overall Study|Adverse Event|1|||
125323270|NCT02246530|450816184|FG000|Overall Study|Lost to Follow-up|4|||
125323271|NCT02246530|450816185|FG001|Overall Study|Lost to Follow-up|0|||
125323272|NCT00888173|450816186|FG000|Overall Study|Wrong Primary|1|||
125323273|NCT00888173|450816186|FG000|Overall Study|Ineligible: required test not done|1|||
125323274|NCT01488890|450816187|FG000|Overall Study|Serious adverse event|2|||
125323275|NCT01488890|450816188|FG001|Overall Study|Serious adverse event|0|||
125323276|NCT01488890|450816189|FG002|Overall Study|Serious adverse event|0|||
125323277|NCT01488890|450816190|FG003|Overall Study|Serious adverse event|0|||
125323278|NCT01488890|450816187|FG000|Overall Study|Protocol Violation|3|||
125323279|NCT01488890|450816188|FG001|Overall Study|Protocol Violation|0|||
125323280|NCT01488890|450816189|FG002|Overall Study|Protocol Violation|4|||
125323281|NCT01488890|450816190|FG003|Overall Study|Protocol Violation|0|||
125323282|NCT01488890|450816187|FG000|Overall Study|Lost to Follow-up|13|||
125323283|NCT01488890|450816188|FG001|Overall Study|Lost to Follow-up|10|||
125323284|NCT01488890|450816189|FG002|Overall Study|Lost to Follow-up|20|||
125323285|NCT01488890|450816190|FG003|Overall Study|Lost to Follow-up|3|||
125323286|NCT01488890|450816187|FG000|Overall Study|Withdrawal by Subject|14|||
124995684|NCT00640016|449611343|FG000|Overall Study|Study termination|2|||
124995685|NCT00640016|449611344|FG001|Overall Study|Study termination|1|||
124995686|NCT00640016|449611345|FG002|Overall Study|Study termination|3|||
124995687|NCT00640016|449611346|FG003|Overall Study|Study termination|2|||
124995688|NCT00640016|449611343|FG000|Overall Study|Adverse Event|0|||
124995689|NCT00640016|449611344|FG001|Overall Study|Adverse Event|0|||
124995690|NCT00640016|449611345|FG002|Overall Study|Adverse Event|0|||
124995691|NCT00640016|449611346|FG003|Overall Study|Adverse Event|1|||
124995692|NCT03575143|449611347|FG000|Overall Study|Lost to Follow-up|0|||
124995693|NCT03575143|449611348|FG001|Overall Study|Lost to Follow-up|0|||
124995694|NCT03575143|449611349|FG002|Overall Study|Lost to Follow-up|4|||
124995695|NCT03575143|449611347|FG000|Overall Study|Withdrawal by Subject|0|||
125323287|NCT01488890|450816188|FG001|Overall Study|Withdrawal by Subject|10|||
125323288|NCT01488890|450816189|FG002|Overall Study|Withdrawal by Subject|11|||
125323289|NCT01488890|450816190|FG003|Overall Study|Withdrawal by Subject|2|||
125323290|NCT05712460|450816191|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125323291|NCT05712460|450816192|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125323292|NCT05712460|450816193|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
124995696|NCT03575143|449611348|FG001|Overall Study|Withdrawal by Subject|0|||
125323293|NCT05712460|450816194|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125323294|NCT05712460|450816195|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125323295|NCT05712460|450816196|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125323296|NCT05712460|450816197|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125323297|NCT05712460|450816198|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
125323298|NCT05712460|450816199|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125323299|NCT05712460|450816200|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125323300|NCT05712460|450816201|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125323301|NCT05712460|450816202|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125323302|NCT00829426|450816206|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
125323303|NCT00829426|450816207|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
125323304|NCT05135767|450816210|FG000|Baseline|Lost to Follow-up|1|||
125323305|NCT05135767|450816211|FG001|Baseline|Lost to Follow-up|1|||
125323306|NCT05135767|450816210|FG000|Baseline|Withdrawal by Subject|0|||
125323307|NCT05135767|450816211|FG001|Baseline|Withdrawal by Subject|2|||
124995697|NCT03575143|449611349|FG002|Overall Study|Withdrawal by Subject|5|||
124995698|NCT03575143|449611347|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
125323308|NCT05135767|450816210|FG000|Active Study Phase|Lost to Follow-up|2|||
125323309|NCT05135767|450816211|FG001|Active Study Phase|Lost to Follow-up|0|||
125323310|NCT02260934|450816215|FG000|Overall Study|Lost to Follow-up|2|||
125323311|NCT02260934|450816216|FG001|Overall Study|Lost to Follow-up|1|||
125323312|NCT02260934|450816215|FG000|Overall Study|Withdrawal by Subject|0|||
125323313|NCT02260934|450816216|FG001|Overall Study|Withdrawal by Subject|2|||
125323314|NCT02260934|450816215|FG000|Overall Study|Participant Relocated|1|||
125323315|NCT02260934|450816216|FG001|Overall Study|Participant Relocated|0|||
125323316|NCT02260934|450816215|FG000|Overall Study|Site error|0|||
125323317|NCT02260934|450816216|FG001|Overall Study|Site error|1|||
125323318|NCT03605667|450816217|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
125323319|NCT03605667|450816218|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
125323320|NCT03605667|450816217|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
125210679|NCT02638259|450395635|FG001|Treatment Period 1|Protocol Violation|3|||
125210680|NCT02638259|450395634|FG000|Treatment Period 1|Withdrawal by Subject|4|||
125323321|NCT03605667|450816218|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
125323322|NCT03605667|450816217|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
125323323|NCT03605667|450816218|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
125323324|NCT03605667|450816217|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
125323325|NCT03605667|450816218|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
125323326|NCT03605667|450816217|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
125323327|NCT03605667|450816218|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
124995699|NCT03575143|449611348|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
125323328|NCT03605667|450816217|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
125323329|NCT03605667|450816218|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
125323330|NCT03605667|450816217|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
125323331|NCT03605667|450816218|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
125323332|NCT03605667|450816217|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
125323333|NCT03605667|450816218|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
125323334|NCT03605667|450816217|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
125323335|NCT03605667|450816218|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
125323336|NCT03605667|450816217|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
125323337|NCT03605667|450816218|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
125323338|NCT03605667|450816217|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
125323339|NCT03605667|450816218|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
125323340|NCT03605667|450816217|FG000|OLE Phase (48 Weeks)|Other|6|||
125323341|NCT03605667|450816218|FG001|OLE Phase (48 Weeks)|Other|8|||
125323342|NCT03605667|450816217|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
125323343|NCT03605667|450816218|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
125323344|NCT03605667|450816217|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
125323345|NCT03605667|450816218|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
125323346|NCT03605667|450816217|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
125323347|NCT03605667|450816218|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
125323348|NCT03605667|450816217|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
125323349|NCT03605667|450816218|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
125323350|NCT03605667|450816217|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
125323351|NCT03605667|450816218|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
125323352|NCT03605667|450816217|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
125323353|NCT03605667|450816218|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
125323354|NCT03605667|450816217|FG000|OLE Phase (48 Weeks)|Death|0|||
125323355|NCT03605667|450816218|FG001|OLE Phase (48 Weeks)|Death|2|||
125323356|NCT03605667|450816217|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
125323357|NCT03605667|450816218|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
125323358|NCT03597347|450816221|FG000|Overall Study|Withdrawal by Subject|1|||
125323359|NCT03597347|450816222|FG001|Overall Study|Withdrawal by Subject|1|||
125323360|NCT03597347|450816223|FG002|Overall Study|Withdrawal by Subject|0|||
125323361|NCT03597347|450816221|FG000|Overall Study|Withdrawal due to Covid-19|3|||
125323362|NCT03597347|450816222|FG001|Overall Study|Withdrawal due to Covid-19|0|||
125323363|NCT03597347|450816223|FG002|Overall Study|Withdrawal due to Covid-19|0|||
125323364|NCT03597347|450816221|FG000|Overall Study|Sponsor decision to terminate study|3|||
125323365|NCT03597347|450816222|FG001|Overall Study|Sponsor decision to terminate study|2|||
125323366|NCT03597347|450816223|FG002|Overall Study|Sponsor decision to terminate study|4|||
125323367|NCT02532517|450816229|FG000|Overall Study|Did not complete 24-Month visit|4|||
125323368|NCT02532517|450816229|FG000|Overall Study|Failed Angiographic eligibility|1|||
125323369|NCT02532517|450816229|FG000|Overall Study|Lost to Follow-up|4|||
124995700|NCT03575143|449611349|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
124995701|NCT01287065|449611350|FG000|Treatment Period 1|Adverse Event|0|||
124995702|NCT01287065|449611351|FG001|Treatment Period 1|Adverse Event|0|||
124995703|NCT01287065|449611352|FG002|Treatment Period 1|Adverse Event|0|||
124995704|NCT01287065|449611353|FG003|Treatment Period 1|Adverse Event|0|||
124995705|NCT01287065|449611354|FG004|Treatment Period 1|Adverse Event|1|||
124995706|NCT01287065|449611355|FG005|Treatment Period 1|Adverse Event|0|||
124995707|NCT01287065|449611350|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124995708|NCT01287065|449611351|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124995709|NCT01287065|449611352|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124995710|NCT01287065|449611353|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125323370|NCT02532517|450816229|FG000|Overall Study|Withdrawal by Subject|4|||
125323371|NCT02532517|450816229|FG000|Overall Study|Death|4|||
125323372|NCT03312231|450816230|FG000|Overall Study|Lost to Follow-up|2|||
125323373|NCT03312231|450816231|FG001|Overall Study|Lost to Follow-up|6|||
124995711|NCT01287065|449611354|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124995712|NCT01287065|449611355|FG005|Treatment Period 1|Withdrawal by Subject|1|||
125323374|NCT03312231|450816232|FG002|Overall Study|Lost to Follow-up|1|||
125323375|NCT03312231|450816233|FG003|Overall Study|Lost to Follow-up|3|||
125323376|NCT03312231|450816234|FG004|Overall Study|Lost to Follow-up|1|||
124995713|NCT02875977|449611356|FG000|Overall Study|Lost to Follow-up|42|||
124995714|NCT02875977|449611357|FG001|Overall Study|Lost to Follow-up|29|||
125323377|NCT03312231|450816230|FG000|Overall Study|Withdrawal by Subject|0|||
125323378|NCT03312231|450816231|FG001|Overall Study|Withdrawal by Subject|3|||
125323379|NCT03312231|450816232|FG002|Overall Study|Withdrawal by Subject|1|||
125323380|NCT03312231|450816233|FG003|Overall Study|Withdrawal by Subject|0|||
125323381|NCT03312231|450816234|FG004|Overall Study|Withdrawal by Subject|0|||
125323382|NCT03312231|450816230|FG000|Overall Study|Death|0|||
125323383|NCT03312231|450816231|FG001|Overall Study|Death|1|||
125323384|NCT03312231|450816232|FG002|Overall Study|Death|1|||
125323385|NCT03312231|450816233|FG003|Overall Study|Death|0|||
125323386|NCT03312231|450816234|FG004|Overall Study|Death|0|||
125323387|NCT03312231|450816230|FG000|Overall Study|Study Vaccination not Received|1|||
125323388|NCT03312231|450816231|FG001|Overall Study|Study Vaccination not Received|1|||
125323389|NCT03312231|450816232|FG002|Overall Study|Study Vaccination not Received|1|||
125323390|NCT03312231|450816233|FG003|Overall Study|Study Vaccination not Received|0|||
125323391|NCT03312231|450816234|FG004|Overall Study|Study Vaccination not Received|0|||
125323392|NCT05720897|450816235|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
125323393|NCT05720897|450816236|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
125323394|NCT00400179|450816237|FG000|Overall Study|Adverse Event|2|||
125323395|NCT00400179|450816238|FG001|Overall Study|Adverse Event|2|||
125323396|NCT00400179|450816237|FG000|Overall Study|Death|1|||
125323397|NCT00400179|450816238|FG001|Overall Study|Death|2|||
125323398|NCT00400179|450816237|FG000|Overall Study|Withdrew Consent|1|||
125323399|NCT00400179|450816238|FG001|Overall Study|Withdrew Consent|5|||
125323400|NCT00400179|450816237|FG000|Overall Study|Disease progression|1|||
125323401|NCT00400179|450816238|FG001|Overall Study|Disease progression|1|||
125323402|NCT00400179|450816237|FG000|Overall Study|Intercurrent illness|0|||
125323403|NCT00400179|450816238|FG001|Overall Study|Intercurrent illness|1|||
125323404|NCT00400179|450816237|FG000|Overall Study|Investigator judgment|0|||
125323405|NCT00400179|450816238|FG001|Overall Study|Investigator judgment|1|||
125323406|NCT00400179|450816237|FG000|Overall Study|Randomization error/patient ineligible|1|||
125323407|NCT00400179|450816238|FG001|Overall Study|Randomization error/patient ineligible|6|||
125323408|NCT04780061|450816239|FG000|Overall Study|Withdrawal by Subject|5|||
125323409|NCT04780061|450816240|FG001|Overall Study|Withdrawal by Subject|8|||
125323410|NCT04780061|450816239|FG000|Overall Study|Adverse Event|2|||
125323411|NCT04780061|450816240|FG001|Overall Study|Adverse Event|2|||
125323412|NCT04780061|450816239|FG000|Overall Study|Lost to Follow-up|1|||
125323413|NCT04780061|450816240|FG001|Overall Study|Lost to Follow-up|5|||
125323414|NCT04825574|450816241|FG000|Overall Study|Commercial treatment became available|1|||
125323415|NCT04825574|450816241|FG000|Overall Study|Disease progression|1|||
125323416|NCT00303069|450817686|FG000|Overall Study|Lost to Follow-up|1|||
125323417|NCT00303069|450817687|FG001|Overall Study|Lost to Follow-up|0|||
125323418|NCT00303069|450817688|FG002|Overall Study|Lost to Follow-up|0|||
125323419|NCT00303069|450817689|FG003|Overall Study|Lost to Follow-up|2|||
125323420|NCT00303069|450817686|FG000|Overall Study|subject moved|1|||
125323421|NCT00303069|450817687|FG001|Overall Study|subject moved|0|||
125323422|NCT00303069|450817688|FG002|Overall Study|subject moved|0|||
125323423|NCT00303069|450817689|FG003|Overall Study|subject moved|0|||
125323424|NCT00303069|450817686|FG000|Overall Study|Recruitment into Army Reserves|0|||
125323425|NCT00303069|450817687|FG001|Overall Study|Recruitment into Army Reserves|0|||
125323426|NCT00303069|450817688|FG002|Overall Study|Recruitment into Army Reserves|1|||
125323427|NCT00303069|450817689|FG003|Overall Study|Recruitment into Army Reserves|0|||
125323428|NCT00092417|450817690|FG000|Overall Study|Lost to Follow-up|2|||
125323429|NCT00092417|450817691|FG001|Overall Study|Lost to Follow-up|0|||
125323430|NCT00092417|450817690|FG000|Overall Study|Withdrawal by Subject|2|||
125323431|NCT00092417|450817691|FG001|Overall Study|Withdrawal by Subject|1|||
125323432|NCT00092417|450817690|FG000|Overall Study|Other|1|||
125323433|NCT00092417|450817691|FG001|Overall Study|Other|0|||
125323434|NCT02318706|450817695|FG000|Double-blind Phase|Adverse Event|7|||
125323435|NCT02318706|450817696|FG001|Double-blind Phase|Adverse Event|4|||
125323436|NCT02318706|450817697|FG002|Double-blind Phase|Adverse Event|3|||
125323437|NCT02318706|450817698|FG003|Double-blind Phase|Adverse Event|10|||
125323438|NCT02318706|450817699|FG004|Double-blind Phase|Adverse Event|0|||
125323439|NCT02318706|450817695|FG000|Double-blind Phase|Lost to Follow-up|1|||
125323440|NCT02318706|450817696|FG001|Double-blind Phase|Lost to Follow-up|0|||
125323441|NCT02318706|450817697|FG002|Double-blind Phase|Lost to Follow-up|0|||
125323442|NCT02318706|450817698|FG003|Double-blind Phase|Lost to Follow-up|0|||
125323443|NCT02318706|450817699|FG004|Double-blind Phase|Lost to Follow-up|0|||
125323444|NCT02318706|450817695|FG000|Double-blind Phase|Protocol Violation|4|||
125323445|NCT02318706|450817696|FG001|Double-blind Phase|Protocol Violation|2|||
125323446|NCT02318706|450817697|FG002|Double-blind Phase|Protocol Violation|4|||
125323447|NCT02318706|450817698|FG003|Double-blind Phase|Protocol Violation|3|||
125323448|NCT02318706|450817699|FG004|Double-blind Phase|Protocol Violation|0|||
125323449|NCT02318706|450817695|FG000|Double-blind Phase|Withdrawal by Subject|9|||
125323450|NCT02318706|450817696|FG001|Double-blind Phase|Withdrawal by Subject|5|||
125323451|NCT02318706|450817697|FG002|Double-blind Phase|Withdrawal by Subject|7|||
125323452|NCT02318706|450817698|FG003|Double-blind Phase|Withdrawal by Subject|10|||
125323453|NCT02318706|450817699|FG004|Double-blind Phase|Withdrawal by Subject|0|||
125323454|NCT02318706|450817695|FG000|Double-blind Phase|Other|4|||
125323455|NCT02318706|450817696|FG001|Double-blind Phase|Other|1|||
125323456|NCT02318706|450817697|FG002|Double-blind Phase|Other|2|||
125323457|NCT02318706|450817698|FG003|Double-blind Phase|Other|1|||
125323458|NCT02318706|450817699|FG004|Double-blind Phase|Other|0|||
125323459|NCT02318706|450817695|FG000|Double-blind Phase|Death|0|||
125323460|NCT02318706|450817696|FG001|Double-blind Phase|Death|0|||
125323461|NCT02318706|450817697|FG002|Double-blind Phase|Death|2|||
125323462|NCT02318706|450817698|FG003|Double-blind Phase|Death|0|||
125323463|NCT02318706|450817699|FG004|Double-blind Phase|Death|0|||
125323464|NCT02318706|450817695|FG000|Open-label Extension Phase|Adverse Event|0|||
125323465|NCT02318706|450817696|FG001|Open-label Extension Phase|Adverse Event|0|||
125323466|NCT02318706|450817697|FG002|Open-label Extension Phase|Adverse Event|0|||
125323467|NCT02318706|450817698|FG003|Open-label Extension Phase|Adverse Event|0|||
125323468|NCT02318706|450817699|FG004|Open-label Extension Phase|Adverse Event|21|||
125323469|NCT02318706|450817695|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
125323470|NCT02318706|450817696|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
125323471|NCT02318706|450817697|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
125323472|NCT02318706|450817698|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
125323473|NCT02318706|450817699|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
125323474|NCT02318706|450817695|FG000|Open-label Extension Phase|Death|0|||
125323475|NCT02318706|450817696|FG001|Open-label Extension Phase|Death|0|||
125323476|NCT02318706|450817697|FG002|Open-label Extension Phase|Death|0|||
125323477|NCT02318706|450817698|FG003|Open-label Extension Phase|Death|0|||
125323478|NCT02318706|450817699|FG004|Open-label Extension Phase|Death|1|||
125323479|NCT02318706|450817695|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
125323480|NCT02318706|450817696|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
125323481|NCT02318706|450817697|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
125323482|NCT02318706|450817698|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
125323483|NCT02318706|450817699|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
125323484|NCT01456039|450817700|FG000|Phase 1 (First Step)|Disease Progression|1|||
125323485|NCT01456039|450817701|FG001|Phase 1 (First Step)|Disease Progression|1|||
125323486|NCT01456039|450817702|FG002|Phase 1 (First Step)|Disease Progression|0|||
125323487|NCT01456039|450817700|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
125323488|NCT01456039|450817701|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
125323489|NCT01456039|450817702|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
125323490|NCT01456039|450817700|FG000|Phase 1 (First Step)|Adverse Event|0|||
125323491|NCT01456039|450817701|FG001|Phase 1 (First Step)|Adverse Event|3|||
125323492|NCT01456039|450817702|FG002|Phase 1 (First Step)|Adverse Event|0|||
125323493|NCT01456039|450817700|FG000|Phase 1 (First Step)|Other|0|||
125323494|NCT01456039|450817701|FG001|Phase 1 (First Step)|Other|1|||
125323495|NCT01456039|450817702|FG002|Phase 1 (First Step)|Other|0|||
125323496|NCT01456039|450817700|FG000|Phase 2 (Second Step)|Disease Progression|0|||
125323497|NCT01456039|450817701|FG001|Phase 2 (Second Step)|Disease Progression|0|||
125323498|NCT01456039|450817702|FG002|Phase 2 (Second Step)|Disease Progression|17|||
125323499|NCT01456039|450817700|FG000|Phase 2 (Second Step)|Adverse Event|0|||
125323500|NCT01456039|450817701|FG001|Phase 2 (Second Step)|Adverse Event|0|||
125323501|NCT01456039|450817702|FG002|Phase 2 (Second Step)|Adverse Event|10|||
125323502|NCT01456039|450817700|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
125323503|NCT01456039|450817701|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
125323504|NCT01456039|450817702|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
125323505|NCT01456039|450817700|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
125323506|NCT01456039|450817701|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
125323507|NCT01456039|450817702|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
125323508|NCT01456039|450817700|FG000|Phase 2 (Second Step)|Other|0|||
125323509|NCT01456039|450817701|FG001|Phase 2 (Second Step)|Other|0|||
125323510|NCT01456039|450817702|FG002|Phase 2 (Second Step)|Other|1|||
125323511|NCT00335777|450817706|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
125323512|NCT00335777|450817706|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
125323513|NCT00335777|450817706|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
125323514|NCT00335777|450817706|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
125323515|NCT00335777|450817706|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
125323516|NCT00992108|450817709|FG000|Overall Study|Lost to Follow-up|0|||
125323517|NCT00992108|450817710|FG001|Overall Study|Lost to Follow-up|1|||
125323518|NCT04639245|450817715|FG000|Overall Study|Death|1|||
125323519|NCT01702311|450817716|FG000|Overall Study|Withdrawal by Subject|3|||
125323520|NCT01702311|450817717|FG001|Overall Study|Withdrawal by Subject|2|||
125323521|NCT01702311|450817716|FG000|Overall Study|Discharge less than 24 hours|10|||
125323522|NCT01702311|450817717|FG001|Overall Study|Discharge less than 24 hours|7|||
125323523|NCT01702311|450817716|FG000|Overall Study|Physician Decision|3|||
125323524|NCT01702311|450817717|FG001|Overall Study|Physician Decision|4|||
125323525|NCT01209689|450817720|FG000|Overall Study|Insufficient Therapeutic Response|7|||
125323526|NCT01209689|450817721|FG001|Overall Study|Insufficient Therapeutic Response|2|||
125323527|NCT01209689|450817720|FG000|Overall Study|Refused Treatment|8|||
125323528|NCT01209689|450817721|FG001|Overall Study|Refused Treatment|3|||
125323529|NCT01209689|450817720|FG000|Overall Study|Adverse Event|4|||
125323530|NCT01209689|450817721|FG001|Overall Study|Adverse Event|0|||
125323531|NCT01209689|450817720|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
125323532|NCT01209689|450817721|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
125323533|NCT01209689|450817720|FG000|Overall Study|Failure to Return|3|||
125323534|NCT01209689|450817721|FG001|Overall Study|Failure to Return|0|||
125323535|NCT01209689|450817720|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
125323536|NCT01209689|450817721|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
125323537|NCT03337477|450817722|FG000|Overall Study|not categorized into the listed ones|11|||
125323538|NCT03337477|450817723|FG001|Overall Study|not categorized into the listed ones|9|||
125323539|NCT03337477|450817722|FG000|Overall Study|Withdrawal by Subject|0|||
125323540|NCT03337477|450817723|FG001|Overall Study|Withdrawal by Subject|1|||
125323541|NCT03337477|450817722|FG000|Overall Study|Death|0|||
125323542|NCT03337477|450817723|FG001|Overall Study|Death|1|||
125323543|NCT03337477|450817722|FG000|Overall Study|Lost to Follow-up|0|||
125323544|NCT03337477|450817723|FG001|Overall Study|Lost to Follow-up|2|||
125323545|NCT03181932|450817724|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
125323546|NCT03181932|450817725|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
125323547|NCT03181932|450817724|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
125323548|NCT03181932|450817725|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
125323549|NCT03181932|450817724|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
125323550|NCT03181932|450817725|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
125323551|NCT03181932|450817724|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
125323552|NCT03181932|450817725|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
125323553|NCT03181932|450817724|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
125323554|NCT03181932|450817725|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
125323555|NCT03181932|450817724|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
125323556|NCT03181932|450817725|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
125323557|NCT03181932|450817724|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
125323558|NCT03181932|450817725|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
125323559|NCT03181932|450817724|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
125323560|NCT03181932|450817725|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
125323561|NCT03181932|450817724|FG000|Period 2 (Open-label Period)|Reason missing|2|||
125323562|NCT03181932|450817725|FG001|Period 2 (Open-label Period)|Reason missing|0|||
125323563|NCT02220920|450817726|FG000|Overall Study|Adverse Event|1|||
125323564|NCT02220920|450817727|FG001|Overall Study|Adverse Event|0|||
125323565|NCT02220920|450817726|FG000|Overall Study|Lack of Efficacy|0|||
125323566|NCT02220920|450817727|FG001|Overall Study|Lack of Efficacy|1|||
125323567|NCT02220920|450817726|FG000|Overall Study|Withdrawal by Subject|1|||
125323568|NCT02220920|450817727|FG001|Overall Study|Withdrawal by Subject|0|||
125323569|NCT02220920|450817726|FG000|Overall Study|Conflict with the stopping criteria|1|||
125323570|NCT02220920|450817727|FG001|Overall Study|Conflict with the stopping criteria|2|||
125323571|NCT00853307|450817728|FG000|Overall Study|Adverse Event|1|||
125323572|NCT00853307|450817729|FG001|Overall Study|Adverse Event|2|||
125323573|NCT00853307|450817728|FG000|Overall Study|Withdrawal by Subject|1|||
125323574|NCT00853307|450817729|FG001|Overall Study|Withdrawal by Subject|2|||
125323575|NCT00853307|450817728|FG000|Overall Study|Reason Not Specified|0|||
125323576|NCT00853307|450817729|FG001|Overall Study|Reason Not Specified|1|||
125323577|NCT00473564|450817730|FG000|Overall Study|robot surgery aborted in OR|23|||
125323578|NCT01112917|450817731|FG000|Overall Study|Death|2|||
125323579|NCT01112917|450817732|FG001|Overall Study|Death|11|||
125323580|NCT01112917|450817731|FG000|Overall Study|Lost to Follow-up|1|||
125323581|NCT01112917|450817732|FG001|Overall Study|Lost to Follow-up|1|||
125323582|NCT01112917|450817731|FG000|Overall Study|Withdrawal by Subject|1|||
125323583|NCT01112917|450817732|FG001|Overall Study|Withdrawal by Subject|3|||
125323584|NCT01112917|450817731|FG000|Overall Study|Unable to Convert Filter|3|||
125323585|NCT01112917|450817732|FG001|Overall Study|Unable to Convert Filter|0|||
125323586|NCT02177123|450817733|FG000|Overall Study|Lost to Follow-up|6|||
125323587|NCT02177123|450817733|FG000|Overall Study|Withdrawal by Subject|4|||
125323588|NCT02177123|450817733|FG000|Overall Study|Adverse Event|4|||
125323589|NCT02177123|450817733|FG000|Overall Study|Physician Decision|3|||
125323590|NCT02177123|450817733|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
125323591|NCT02177123|450817733|FG000|Overall Study|Excluded for medical reasons|2|||
125323592|NCT02177123|450817733|FG000|Overall Study|Death|1|||
125323593|NCT02177123|450817733|FG000|Overall Study|Other|1|||
125323594|NCT02177123|450817733|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
125323595|NCT02118584|450817737|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
125323596|NCT02118584|450817738|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
125323597|NCT02118584|450817739|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
125323598|NCT02118584|450817737|FG000|Part 1: Open Label Extension Period|Death|9|||
125323599|NCT02118584|450817738|FG001|Part 1: Open Label Extension Period|Death|0|||
125323600|NCT02118584|450817739|FG002|Part 1: Open Label Extension Period|Death|0|||
125323601|NCT02118584|450817737|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
125323602|NCT02118584|450817738|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
125323603|NCT02118584|450817739|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
125323604|NCT02118584|450817737|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
125323605|NCT02118584|450817738|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
125323606|NCT02118584|450817739|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
125323607|NCT02118584|450817737|FG000|Part 1: Open Label Extension Period|Other|135|||
125323608|NCT02118584|450817738|FG001|Part 1: Open Label Extension Period|Other|0|||
125323609|NCT02118584|450817739|FG002|Part 1: Open Label Extension Period|Other|0|||
125323610|NCT02118584|450817737|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
125323611|NCT02118584|450817738|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
125323612|NCT02118584|450817739|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
125323613|NCT02118584|450817737|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
125323614|NCT02118584|450817738|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
125323615|NCT02118584|450817739|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
125323616|NCT02118584|450817737|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
125323617|NCT02118584|450817738|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
125323618|NCT02118584|450817739|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
125323619|NCT02118584|450817737|FG000|Part 1: Open Label Extension Period|Other|3|||
125323620|NCT02118584|450817738|FG001|Part 1: Open Label Extension Period|Other|0|||
125323621|NCT02118584|450817739|FG002|Part 1: Open Label Extension Period|Other|0|||
125323622|NCT02118584|450817737|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
125323623|NCT02118584|450817738|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
125323624|NCT02118584|450817739|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
125323625|NCT02118584|450817737|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
125323626|NCT02118584|450817738|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
125323627|NCT02118584|450817739|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
125323628|NCT02118584|450817737|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
125323629|NCT02118584|450817738|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
125323630|NCT02118584|450817739|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
125323631|NCT02118584|450817737|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
125323632|NCT02118584|450817738|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
125323633|NCT02118584|450817739|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
125323634|NCT02118584|450817737|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
125323635|NCT02118584|450817738|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
125323636|NCT02118584|450817739|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
125323637|NCT02118584|450817737|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
125323638|NCT02118584|450817738|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
125323639|NCT02118584|450817739|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
125323640|NCT02118584|450817737|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
125323641|NCT02118584|450817738|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
125323642|NCT02118584|450817739|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
125323643|NCT02118584|450817737|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
125323644|NCT02118584|450817738|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
125323645|NCT02118584|450817739|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
125323646|NCT02118584|450817737|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
125323647|NCT02118584|450817738|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
125323648|NCT02118584|450817739|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
125323649|NCT03103542|450817742|FG000|Overall Study|Physician Decision|2|||
125323650|NCT03103542|450817742|FG000|Overall Study|Adverse Event|2|||
125323651|NCT03103542|450817742|FG000|Overall Study|Other|2|||
125323652|NCT03103542|450817742|FG000|Overall Study|Withdrawal by Subject|1|||
125323653|NCT03406780|450817743|FG000|Overall Study|Withdrawal by Subject|1|||
125323654|NCT03406780|450817744|FG001|Overall Study|Withdrawal by Subject|1|||
125323655|NCT03406780|450817743|FG000|Overall Study|Other|0|||
125323656|NCT03406780|450817744|FG001|Overall Study|Other|2|||
125323657|NCT00837434|450817745|FG000|Overall Study|Physician Decision|3|||
125323658|NCT00837434|450817746|FG001|Overall Study|Physician Decision|0|||
125323659|NCT00837434|450817745|FG000|Overall Study|Lost to Follow-up|1|||
125323660|NCT00837434|450817746|FG001|Overall Study|Lost to Follow-up|1|||
125323661|NCT00837434|450817745|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
125323662|NCT00837434|450817746|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
125323663|NCT00837434|450817745|FG000|Overall Study|Noncompliant|2|||
125323664|NCT00837434|450817746|FG001|Overall Study|Noncompliant|0|||
125323665|NCT00837434|450817745|FG000|Overall Study|Baseline assessments not done in time|1|||
125323666|NCT00837434|450817746|FG001|Overall Study|Baseline assessments not done in time|0|||
125323667|NCT00837434|450817745|FG000|Overall Study|Unable to obtain study drug|1|||
125323668|NCT00837434|450817746|FG001|Overall Study|Unable to obtain study drug|0|||
125323669|NCT03041038|450817763|FG000|Overall Study|Withdrawal by Subject|4|||
125323670|NCT03041038|450817764|FG001|Overall Study|Withdrawal by Subject|0|||
125323671|NCT03041038|450817763|FG000|Overall Study|Lost to Follow-up|1|||
125323672|NCT03041038|450817764|FG001|Overall Study|Lost to Follow-up|1|||
125323673|NCT03041038|450817763|FG000|Overall Study|Protocol Violation|1|||
125323674|NCT03041038|450817764|FG001|Overall Study|Protocol Violation|1|||
125323675|NCT00360230|450817765|FG000|Overall Study|Withdrawal by Subject|1|||
125323676|NCT00360230|450817766|FG001|Overall Study|Withdrawal by Subject|1|||
125323677|NCT00360230|450817767|FG002|Overall Study|Withdrawal by Subject|0|||
125323678|NCT00360230|450817768|FG003|Overall Study|Withdrawal by Subject|1|||
125323679|NCT00360230|450817769|FG004|Overall Study|Withdrawal by Subject|1|||
125323680|NCT00360230|450817770|FG005|Overall Study|Withdrawal by Subject|1|||
125323681|NCT00360230|450817771|FG006|Overall Study|Withdrawal by Subject|0|||
125323682|NCT00360230|450817765|FG000|Overall Study|Migrated|4|||
125323683|NCT00360230|450817766|FG001|Overall Study|Migrated|1|||
125323684|NCT00360230|450817767|FG002|Overall Study|Migrated|3|||
125323685|NCT00360230|450817768|FG003|Overall Study|Migrated|1|||
125323686|NCT00360230|450817769|FG004|Overall Study|Migrated|4|||
125323687|NCT00360230|450817770|FG005|Overall Study|Migrated|1|||
125323688|NCT00360230|450817771|FG006|Overall Study|Migrated|1|||
125323689|NCT00360230|450817765|FG000|Overall Study|Other|1|||
125323690|NCT00360230|450817766|FG001|Overall Study|Other|0|||
125323691|NCT00360230|450817767|FG002|Overall Study|Other|0|||
125323692|NCT00360230|450817768|FG003|Overall Study|Other|0|||
125323693|NCT00360230|450817769|FG004|Overall Study|Other|0|||
125323694|NCT00360230|450817770|FG005|Overall Study|Other|0|||
125323695|NCT00360230|450817771|FG006|Overall Study|Other|0|||
125323696|NCT00360230|450817765|FG000|Overall Study|Protocol Violation|0|||
125323697|NCT00360230|450817766|FG001|Overall Study|Protocol Violation|0|||
125323698|NCT00360230|450817767|FG002|Overall Study|Protocol Violation|0|||
125323699|NCT00360230|450817768|FG003|Overall Study|Protocol Violation|0|||
125323700|NCT00360230|450817769|FG004|Overall Study|Protocol Violation|0|||
125323701|NCT00360230|450817770|FG005|Overall Study|Protocol Violation|1|||
125323702|NCT00360230|450817771|FG006|Overall Study|Protocol Violation|0|||
125323703|NCT00360230|450817765|FG000|Overall Study|Death|0|||
125323704|NCT00360230|450817766|FG001|Overall Study|Death|1|||
125323705|NCT00360230|450817767|FG002|Overall Study|Death|0|||
125323706|NCT00360230|450817768|FG003|Overall Study|Death|0|||
125323707|NCT00360230|450817769|FG004|Overall Study|Death|0|||
125323708|NCT00360230|450817770|FG005|Overall Study|Death|1|||
125323709|NCT00360230|450817771|FG006|Overall Study|Death|1|||
125323710|NCT00581308|450817772|FG000|Pre Discharge|Lost to Follow-up|1|||
125323711|NCT00581308|450817772|FG000|Pre Discharge|Device Removed|1|||
125323712|NCT00581308|450817772|FG000|Month 1|Lost to Follow-up|3|||
125323713|NCT00581308|450817772|FG000|Month 1|Withdrawal by Subject|2|||
125323714|NCT00581308|450817772|FG000|Month 1|Device Removed|2|||
125323715|NCT00581308|450817772|FG000|Month 1|Uknown|1|||
125323716|NCT00581308|450817772|FG000|Month 6|Lost to Follow-up|1|||
125323717|NCT00581308|450817772|FG000|Month 6|Withdrawal by Subject|2|||
125323718|NCT00581308|450817772|FG000|Month 12|Death|1|||
125323719|NCT00581308|450817772|FG000|Month 12|Lost to Follow-up|14|||
125323720|NCT00581308|450817772|FG000|Month 12|Withdrawal by Subject|3|||
125323721|NCT00581308|450817772|FG000|Month 12|Device Removed|1|||
125323722|NCT00581308|450817772|FG000|Month 12|Other|1|||
125323723|NCT00886379|450817773|FG000|Overall Study|Transferred Schools|0|||
125323724|NCT00886379|450817774|FG001|Overall Study|Transferred Schools|0|||
125323725|NCT00886379|450817775|FG002|Overall Study|Transferred Schools|2|||
125323726|NCT00886379|450817776|FG003|Overall Study|Transferred Schools|1|||
125323727|NCT00886379|450817777|FG004|Overall Study|Transferred Schools|1|||
125323728|NCT00886379|450817773|FG000|Overall Study|Final blood draw not obtained|3|||
125323729|NCT00886379|450817774|FG001|Overall Study|Final blood draw not obtained|3|||
125323730|NCT00886379|450817775|FG002|Overall Study|Final blood draw not obtained|4|||
125323731|NCT00886379|450817776|FG003|Overall Study|Final blood draw not obtained|2|||
125323732|NCT00886379|450817777|FG004|Overall Study|Final blood draw not obtained|2|||
125323733|NCT04558125|450817778|FG000|Overall Study|Death|1|||
125323734|NCT01614886|450817779|FG000|Overall Study|Adverse Event|15|||
125323735|NCT01614886|450817780|FG001|Overall Study|Adverse Event|20|||
125323736|NCT01614886|450817779|FG000|Overall Study|Withdrawal by Subject|4|||
125323737|NCT01614886|450817780|FG001|Overall Study|Withdrawal by Subject|4|||
125323738|NCT01614886|450817779|FG000|Overall Study|Death|1|||
125323739|NCT01614886|450817780|FG001|Overall Study|Death|0|||
125323740|NCT01614886|450817779|FG000|Overall Study|Protocol deviation|0|||
125323741|NCT01614886|450817780|FG001|Overall Study|Protocol deviation|2|||
125323742|NCT01207414|450817782|FG000|Overall Study|Adverse Event|25|||
125323743|NCT01207414|450817783|FG001|Overall Study|Adverse Event|39|||
125323744|NCT01207414|450817782|FG000|Overall Study|Abnormal test procedure results|0|||
125323745|NCT01207414|450817783|FG001|Overall Study|Abnormal test procedure results|1|||
125323746|NCT01207414|450817782|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
125323747|NCT01207414|450817783|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
125323748|NCT01207414|450817782|FG000|Overall Study|Patient withdrew consent|14|||
125323749|NCT01207414|450817783|FG001|Overall Study|Patient withdrew consent|11|||
125323750|NCT01207414|450817782|FG000|Overall Study|Lost to Follow-up|15|||
125323751|NCT01207414|450817783|FG001|Overall Study|Lost to Follow-up|17|||
125323752|NCT01207414|450817782|FG000|Overall Study|Administrative problems|1|||
125323753|NCT01207414|450817783|FG001|Overall Study|Administrative problems|1|||
125323754|NCT01207414|450817782|FG000|Overall Study|Protocol deviation|12|||
125323755|NCT01207414|450817783|FG001|Overall Study|Protocol deviation|9|||
125323756|NCT01207414|450817782|FG000|Overall Study|Randomized in error|1|||
125323757|NCT01207414|450817783|FG001|Overall Study|Randomized in error|0|||
125323758|NCT01527370|450817784|FG000|Overall Study|Withdrawal by Subject|4|||
125323759|NCT01527370|450817784|FG000|Overall Study|Physician Decision|1|||
125323760|NCT01527370|450817784|FG000|Overall Study|Death|1|||
125323761|NCT01748292|450817787|FG000|Overall Study|Adverse Event|2|||
125323762|NCT01748292|450817788|FG001|Overall Study|Adverse Event|4|||
125323763|NCT01748292|450817787|FG000|Overall Study|Lost to Follow-up|0|||
125323764|NCT01748292|450817788|FG001|Overall Study|Lost to Follow-up|3|||
125323765|NCT01748292|450817787|FG000|Overall Study|Death|0|||
125323766|NCT01748292|450817788|FG001|Overall Study|Death|3|||
125323767|NCT01748292|450817787|FG000|Overall Study|Withdrawal by Subject|0|||
125323768|NCT01748292|450817788|FG001|Overall Study|Withdrawal by Subject|2|||
125323769|NCT02224560|450817789|FG000|Overall Study|Protocol Deviation|1|||
125323770|NCT02224560|450817790|FG001|Overall Study|Protocol Deviation|0|||
125323771|NCT02224560|450817791|FG002|Overall Study|Protocol Deviation|0|||
125323772|NCT02224560|450817789|FG000|Overall Study|Withdrawal by Subject|2|||
125323773|NCT02224560|450817790|FG001|Overall Study|Withdrawal by Subject|0|||
125323774|NCT02224560|450817791|FG002|Overall Study|Withdrawal by Subject|1|||
125323775|NCT02224560|450817789|FG000|Overall Study|Met Withdrawal Criteria|1|||
125323776|NCT02224560|450817790|FG001|Overall Study|Met Withdrawal Criteria|0|||
125323777|NCT02224560|450817791|FG002|Overall Study|Met Withdrawal Criteria|0|||
125323778|NCT02224560|450817789|FG000|Overall Study|Adverse Event|4|||
125323779|NCT02224560|450817790|FG001|Overall Study|Adverse Event|1|||
125323780|NCT02224560|450817791|FG002|Overall Study|Adverse Event|1|||
125323781|NCT02224560|450817789|FG000|Overall Study|Withdrawn by Investigator|1|||
125323782|NCT02224560|450817790|FG001|Overall Study|Withdrawn by Investigator|1|||
125323783|NCT02224560|450817791|FG002|Overall Study|Withdrawn by Investigator|0|||
125323784|NCT02340026|450817794|FG000|Treatment Phase|Withdrawal by Subject|2|||
125323785|NCT02340026|450817795|FG001|Treatment Phase|Withdrawal by Subject|2|||
125323786|NCT02340026|450817794|FG000|Follow-up Phase|Lost to Follow-up|1|||
125323787|NCT02340026|450817795|FG001|Follow-up Phase|Lost to Follow-up|0|||
125323788|NCT02738801|450817808|FG000|Overall Study|Adverse Event|1|||
125323789|NCT02738801|450817809|FG001|Overall Study|Adverse Event|1|||
125323790|NCT02738801|450817808|FG000|Overall Study|Withdrawal by Subject|0|||
125323791|NCT02738801|450817809|FG001|Overall Study|Withdrawal by Subject|1|||
125323792|NCT03279081|450817810|FG000|Overall Study|Withdrawal by Subject|12|||
125323793|NCT03279081|450817811|FG001|Overall Study|Withdrawal by Subject|20|||
125323794|NCT03279081|450817810|FG000|Overall Study|Physician Decision|4|||
125323795|NCT03279081|450817811|FG001|Overall Study|Physician Decision|1|||
125323796|NCT03279081|450817810|FG000|Overall Study|Lost to Follow-up|8|||
125323797|NCT03279081|450817811|FG001|Overall Study|Lost to Follow-up|8|||
125323798|NCT03279081|450817810|FG000|Overall Study|Death|0|||
125323799|NCT03279081|450817811|FG001|Overall Study|Death|1|||
125323800|NCT03279081|450817810|FG000|Overall Study|Adverse Event|1|||
125323801|NCT03279081|450817811|FG001|Overall Study|Adverse Event|0|||
125323802|NCT03279081|450817810|FG000|Overall Study|Reason not Specified|14|||
125323803|NCT03279081|450817811|FG001|Overall Study|Reason not Specified|4|||
125323804|NCT01210313|450817820|FG000|Overall Study|Withdrawal by Subject|3|||
125323805|NCT01210313|450817820|FG000|Overall Study|Adverse Event|2|||
125323806|NCT01210313|450817820|FG000|Overall Study|Distant recurrence|4|||
125323807|NCT01210313|450817820|FG000|Overall Study|Non-compliance|7|||
125323808|NCT01710345|450817821|FG000|Overall Study|Adverse Event|0|||
125323809|NCT01710345|450817822|FG001|Overall Study|Adverse Event|2|||
124995715|NCT01259726|449611358|FG000|Overall Study|Death|1|||
124995716|NCT01259726|449611359|FG001|Overall Study|Death|0|||
124995717|NCT01259726|449611360|FG002|Overall Study|Death|0|||
124995718|NCT01259726|449611361|FG003|Overall Study|Death|0|||
124995719|NCT01259726|449611358|FG000|Overall Study|Physician Decision|2|||
124995720|NCT01259726|449611359|FG001|Overall Study|Physician Decision|0|||
124995721|NCT01259726|449611360|FG002|Overall Study|Physician Decision|1|||
124995722|NCT01259726|449611361|FG003|Overall Study|Physician Decision|1|||
124995723|NCT01259726|449611358|FG000|Overall Study|Withdrawal by Subject|1|||
124995724|NCT01259726|449611359|FG001|Overall Study|Withdrawal by Subject|3|||
124995725|NCT01259726|449611360|FG002|Overall Study|Withdrawal by Subject|2|||
125323810|NCT01710345|450817823|FG002|Overall Study|Adverse Event|0|||
124995726|NCT01259726|449611361|FG003|Overall Study|Withdrawal by Subject|1|||
124995727|NCT01259726|449611358|FG000|Overall Study|Lost to Follow-up|1|||
124995728|NCT01259726|449611359|FG001|Overall Study|Lost to Follow-up|1|||
125323811|NCT01710345|450817821|FG000|Overall Study|Lack of Efficacy|2|||
125323812|NCT01710345|450817822|FG001|Overall Study|Lack of Efficacy|3|||
125323813|NCT01710345|450817823|FG002|Overall Study|Lack of Efficacy|1|||
125323814|NCT01710345|450817821|FG000|Overall Study|Drug Dosing Error|1|||
125323815|NCT01710345|450817822|FG001|Overall Study|Drug Dosing Error|0|||
125323816|NCT01710345|450817823|FG002|Overall Study|Drug Dosing Error|0|||
125323817|NCT01502293|450817826|FG000|Overall Study|Progressive Disease|20|||
125323818|NCT01502293|450817827|FG001|Overall Study|Progressive Disease|12|||
125323819|NCT01502293|450817828|FG002|Overall Study|Progressive Disease|2|||
125323820|NCT01502293|450817826|FG000|Overall Study|Withdrawal by Subject|3|||
125323821|NCT01502293|450817827|FG001|Overall Study|Withdrawal by Subject|3|||
125323822|NCT01502293|450817828|FG002|Overall Study|Withdrawal by Subject|1|||
125323823|NCT01502293|450817826|FG000|Overall Study|Adverse Event|0|||
125323824|NCT01502293|450817827|FG001|Overall Study|Adverse Event|2|||
125323825|NCT01502293|450817828|FG002|Overall Study|Adverse Event|0|||
125323826|NCT01502293|450817826|FG000|Overall Study|Reason Not Specified|2|||
125323827|NCT01502293|450817827|FG001|Overall Study|Reason Not Specified|0|||
125323828|NCT01502293|450817828|FG002|Overall Study|Reason Not Specified|0|||
125323829|NCT01502293|450817826|FG000|Overall Study|Physician Decision|0|||
125323830|NCT01502293|450817827|FG001|Overall Study|Physician Decision|0|||
125323831|NCT01502293|450817828|FG002|Overall Study|Physician Decision|1|||
125323832|NCT00107653|450817838|FG000|Overall Study|Adverse Event|24|||
125323833|NCT00107653|450817839|FG001|Overall Study|Adverse Event|43|||
125323834|NCT00107653|450817838|FG000|Overall Study|Insufficient Therapeutic Response|25|||
125323835|NCT00107653|450817839|FG001|Overall Study|Insufficient Therapeutic Response|11|||
125323836|NCT00107653|450817838|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
125323837|NCT00107653|450817839|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
125323838|NCT00107653|450817838|FG000|Overall Study|Protocol Violation|1|||
125323839|NCT00107653|450817839|FG001|Overall Study|Protocol Violation|0|||
125323840|NCT00107653|450817838|FG000|Overall Study|Withdrawal by Subject|12|||
125323841|NCT00107653|450817839|FG001|Overall Study|Withdrawal by Subject|13|||
125323842|NCT00107653|450817838|FG000|Overall Study|Lost to Follow-up|13|||
125323843|NCT00107653|450817839|FG001|Overall Study|Lost to Follow-up|5|||
125323844|NCT00107653|450817838|FG000|Overall Study|Administrative Reasons|3|||
125323845|NCT00107653|450817839|FG001|Overall Study|Administrative Reasons|3|||
125323846|NCT01838395|450817840|FG000|Overall Study|Withdrawal by Subject|0|||
125323847|NCT01838395|450817841|FG001|Overall Study|Withdrawal by Subject|0|||
125323848|NCT01838395|450817842|FG002|Overall Study|Withdrawal by Subject|0|||
125323849|NCT01838395|450817843|FG003|Overall Study|Withdrawal by Subject|0|||
125323850|NCT01838395|450817844|FG004|Overall Study|Withdrawal by Subject|1|||
125323851|NCT01838395|450817845|FG005|Overall Study|Withdrawal by Subject|0|||
125323852|NCT01838395|450817840|FG000|Overall Study|Death|0|||
125323853|NCT01838395|450817841|FG001|Overall Study|Death|0|||
125323854|NCT01838395|450817842|FG002|Overall Study|Death|1|||
125323855|NCT01838395|450817843|FG003|Overall Study|Death|0|||
125323856|NCT01838395|450817844|FG004|Overall Study|Death|0|||
125323857|NCT01838395|450817845|FG005|Overall Study|Death|0|||
125323858|NCT01838395|450817840|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
125323859|NCT01838395|450817841|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
125323860|NCT01838395|450817842|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
125323861|NCT01838395|450817843|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
125323862|NCT01838395|450817844|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
125323863|NCT01838395|450817845|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
125323864|NCT03694353|450817847|FG000|Overall Study|Withdrawal by Subject|1|||
125323865|NCT03694353|450817847|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
125323866|NCT00651742|450817848|FG000|Overall Study|Objective Disease Progression|22|||
125323867|NCT00651742|450817848|FG000|Overall Study|Toxicity|3|||
125323868|NCT00651742|450817848|FG000|Overall Study|Investigator Judgment|1|||
125323869|NCT00651742|450817848|FG000|Overall Study|Withdrawal of Consent|1|||
125323870|NCT00651742|450817848|FG000|Overall Study|Enrolled but not treated|1|||
125323871|NCT01535040|450817849|FG000|Overall Study|Physician Decision|0|||
125323872|NCT01535040|450817850|FG001|Overall Study|Physician Decision|1|||
125323873|NCT01535040|450817849|FG000|Overall Study|Withdrawal by Subject|13|||
125323874|NCT01535040|450817850|FG001|Overall Study|Withdrawal by Subject|10|||
125323875|NCT01535040|450817849|FG000|Overall Study|Never Started|9|||
125323876|NCT01535040|450817850|FG001|Overall Study|Never Started|4|||
125323877|NCT01535040|450817849|FG000|Overall Study|Toxicity|7|||
125323878|NCT01535040|450817850|FG001|Overall Study|Toxicity|5|||
125323879|NCT01535040|450817849|FG000|Overall Study|Multiple Reasons|1|||
125323880|NCT01535040|450817850|FG001|Overall Study|Multiple Reasons|1|||
124995729|NCT01259726|449611360|FG002|Overall Study|Lost to Follow-up|1|||
124995730|NCT01259726|449611361|FG003|Overall Study|Lost to Follow-up|3|||
124995731|NCT01978262|449611362|FG000|Overall Study|Withdrawal by Subject|9|||
124995732|NCT01978262|449611362|FG000|Overall Study|Lost to Follow-up|2|||
124995733|NCT02435966|449611370|FG000|Overall Study|Withdrawal by Subject|0|||
124995734|NCT02435966|449611371|FG001|Overall Study|Withdrawal by Subject|1|||
124995735|NCT02435966|449611372|FG002|Overall Study|Withdrawal by Subject|0|||
125323881|NCT05430854|450817851|FG000|Overall Study|Trial terminated by Sponsor|39|||
125323882|NCT05430854|450817852|FG001|Overall Study|Trial terminated by Sponsor|50|||
125323883|NCT05430854|450817853|FG002|Overall Study|Trial terminated by Sponsor|46|||
125323884|NCT05430854|450817851|FG000|Overall Study|Withdrawal by Subject|0|||
125323885|NCT05430854|450817852|FG001|Overall Study|Withdrawal by Subject|3|||
125323886|NCT05430854|450817853|FG002|Overall Study|Withdrawal by Subject|0|||
125323887|NCT04314284|450817854|FG000|Overall Study|Withdrawal by Subject|4|||
125323888|NCT04314284|450817855|FG001|Overall Study|Withdrawal by Subject|7|||
125323889|NCT04314284|450817854|FG000|Overall Study|Consented but did not complete survey|0|||
125323890|NCT04314284|450817855|FG001|Overall Study|Consented but did not complete survey|6|||
125323891|NCT01652235|450817856|FG000|Overall Study|Death|9|||
125323892|NCT01652235|450817856|FG000|Overall Study|Lost to Follow-up|5|||
125323893|NCT01652235|450817856|FG000|Overall Study|Withdrawal by Subject|2|||
125323894|NCT02023086|450817857|FG000|Overall Study|Withdrawal by Subject|2|||
125323895|NCT02023086|450817858|FG001|Overall Study|Withdrawal by Subject|0|||
125323896|NCT02608684|450819405|FG000|Overall Study|Physician Decision|2|||
125323897|NCT02608684|450819405|FG000|Overall Study|Withdrawal by Subject|1|||
125323898|NCT00755183|450819407|FG000|Overall Study|Adverse Event|5|||
125323899|NCT00755183|450819408|FG001|Overall Study|Adverse Event|2|||
125323900|NCT00755183|450819407|FG000|Overall Study|Protocol Violation|0|||
125323901|NCT00755183|450819408|FG001|Overall Study|Protocol Violation|1|||
125323902|NCT00755183|450819407|FG000|Overall Study|Withdrawal by Subject|0|||
125323903|NCT00755183|450819408|FG001|Overall Study|Withdrawal by Subject|2|||
125323904|NCT00755183|450819407|FG000|Overall Study|Administrative|2|||
125323905|NCT00755183|450819408|FG001|Overall Study|Administrative|1|||
125323906|NCT00148317|450819409|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
125323907|NCT00148317|450819409|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
125323908|NCT00148317|450819409|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
125323909|NCT00124943|450819410|FG000|Phase II|Adverse Event|0|||
125323910|NCT00124943|450819411|FG001|Phase II|Adverse Event|2|||
125323911|NCT00124943|450819412|FG002|Phase II|Adverse Event|0|||
125323912|NCT00124943|450819413|FG003|Phase II|Adverse Event|1|||
125323913|NCT00124943|450819410|FG000|Phase II|Protocol Violation|0|||
125323914|NCT00124943|450819411|FG001|Phase II|Protocol Violation|0|||
125323915|NCT00124943|450819412|FG002|Phase II|Protocol Violation|0|||
125323916|NCT00124943|450819413|FG003|Phase II|Protocol Violation|1|||
125323917|NCT00124943|450819410|FG000|Phase II|Lost to Follow-up|0|||
125323918|NCT00124943|450819411|FG001|Phase II|Lost to Follow-up|0|||
125323919|NCT00124943|450819412|FG002|Phase II|Lost to Follow-up|0|||
125323920|NCT00124943|450819413|FG003|Phase II|Lost to Follow-up|1|||
125323921|NCT00124943|450819410|FG000|Phase II|Withdrawal by Subject|0|||
125323922|NCT00124943|450819411|FG001|Phase II|Withdrawal by Subject|0|||
125323923|NCT00124943|450819412|FG002|Phase II|Withdrawal by Subject|0|||
125323924|NCT00124943|450819413|FG003|Phase II|Withdrawal by Subject|2|||
125323925|NCT02939287|450819415|FG000|Overall Study|met exclusion criteria|1|||
125323926|NCT02939287|450819416|FG001|Overall Study|met exclusion criteria|1|||
125323927|NCT02939287|450819417|FG002|Overall Study|met exclusion criteria|1|||
125323928|NCT02939287|450819415|FG000|Overall Study|Did not complete survey|2|||
125323929|NCT02939287|450819416|FG001|Overall Study|Did not complete survey|2|||
125323930|NCT02939287|450819417|FG002|Overall Study|Did not complete survey|0|||
125323931|NCT02939287|450819415|FG000|Overall Study|Withdrawal by Subject|1|||
125323932|NCT02939287|450819416|FG001|Overall Study|Withdrawal by Subject|1|||
125323933|NCT02939287|450819417|FG002|Overall Study|Withdrawal by Subject|0|||
125323934|NCT02903771|450819418|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
125323935|NCT02903771|450819419|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
125323936|NCT02903771|450819420|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
125323937|NCT02903771|450819421|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
125323938|NCT02903771|450819422|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
125323939|NCT02903771|450819423|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
125323940|NCT02903771|450819424|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
125323941|NCT02903771|450819418|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
125323942|NCT02903771|450819419|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
125323943|NCT02903771|450819420|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
125323944|NCT02903771|450819421|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
125323945|NCT02903771|450819422|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
125323946|NCT02903771|450819423|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
125323947|NCT02903771|450819424|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
125323948|NCT02903771|450819418|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
125323949|NCT02903771|450819419|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
125323950|NCT02903771|450819420|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
125323951|NCT02903771|450819421|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
125323952|NCT02903771|450819422|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
125323953|NCT02903771|450819423|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
125323954|NCT02903771|450819424|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
125323955|NCT02903771|450819418|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
125323956|NCT02903771|450819419|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
125323957|NCT02903771|450819420|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
125323958|NCT02903771|450819421|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
125323959|NCT02903771|450819422|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
125323960|NCT02903771|450819423|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
124995736|NCT02168842|449611374|FG000|Overall Study|Withdrawal by Subject|5|||
125323961|NCT02903771|450819424|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
125323962|NCT02903771|450819418|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
125323963|NCT02903771|450819419|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
125323964|NCT02903771|450819420|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
125323965|NCT02903771|450819421|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
125323966|NCT02903771|450819422|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
125323967|NCT02903771|450819423|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
125323968|NCT02903771|450819424|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
125323969|NCT02903771|450819418|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
125323970|NCT02903771|450819419|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
125323971|NCT02903771|450819420|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
125323972|NCT02903771|450819421|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
125323973|NCT02903771|450819422|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
125323974|NCT02903771|450819423|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
124995737|NCT02168842|449611375|FG001|Overall Study|Withdrawal by Subject|3|||
125323975|NCT02903771|450819424|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
125323976|NCT02903771|450819418|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
125323977|NCT02903771|450819419|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
125323978|NCT02903771|450819420|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
125323979|NCT02903771|450819421|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
125323980|NCT02903771|450819422|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
124995738|NCT02168842|449611374|FG000|Overall Study|Lost to Follow-up|0|||
124995739|NCT02168842|449611375|FG001|Overall Study|Lost to Follow-up|2|||
124995740|NCT02168842|449611374|FG000|Overall Study|Death|2|||
124995741|NCT02168842|449611375|FG001|Overall Study|Death|1|||
124995742|NCT02168842|449611374|FG000|Overall Study|Physician Decision|1|||
124995743|NCT02168842|449611375|FG001|Overall Study|Physician Decision|2|||
124995744|NCT00325039|449611376|FG000|Overall Study|Lost to Follow-up|18|||
124995745|NCT00325039|449611377|FG001|Overall Study|Lost to Follow-up|14|||
124995746|NCT02974088|449611378|FG000|Overall Study|Lost to Follow-up|0|||
124995747|NCT02974088|449611379|FG001|Overall Study|Lost to Follow-up|2|||
124995748|NCT02974088|449611378|FG000|Overall Study|Adverse Event|0|||
124995749|NCT02974088|449611379|FG001|Overall Study|Adverse Event|1|||
124995750|NCT00687973|449611385|FG000|Overall Study|Adverse Event|18|||
124995751|NCT00687973|449611386|FG001|Overall Study|Adverse Event|28|||
124995752|NCT00687973|449611385|FG000|Overall Study|Lack of Efficacy|2|||
124995753|NCT00687973|449611386|FG001|Overall Study|Lack of Efficacy|3|||
124995754|NCT00687973|449611385|FG000|Overall Study|Protocol Violation|1|||
124995755|NCT00687973|449611386|FG001|Overall Study|Protocol Violation|2|||
124995756|NCT00687973|449611385|FG000|Overall Study|Administrative Reasons|0|||
124995757|NCT00687973|449611386|FG001|Overall Study|Administrative Reasons|2|||
124995758|NCT00687973|449611385|FG000|Overall Study|Withdrawal by Subject|3|||
124995759|NCT00687973|449611386|FG001|Overall Study|Withdrawal by Subject|3|||
124995760|NCT00343252|449611387|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
124995761|NCT00343252|449611388|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
124995762|NCT00343252|449611387|FG000|6 Months (All Treated Participants)|Death|0|||
124995763|NCT00343252|449611388|FG001|6 Months (All Treated Participants)|Death|2|||
124995764|NCT00343252|449611387|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
124995765|NCT00343252|449611388|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
124995766|NCT00343252|449611387|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
124995767|NCT00343252|449611388|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
124995768|NCT00343252|449611387|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
124995769|NCT00343252|449611388|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
124995770|NCT00343252|449611387|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
124995771|NCT00343252|449611388|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
124995772|NCT00343252|449611387|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
124995773|NCT00343252|449611388|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
124995774|NCT00343252|449611387|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
124995775|NCT00343252|449611388|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
124995776|NCT00343252|449611387|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
124995777|NCT00343252|449611388|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
124995778|NCT00343252|449611387|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
124995779|NCT00343252|449611388|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
124995780|NCT00343252|449611387|FG000|12 Months (All Treated Participants)|Death|3|||
124995781|NCT00343252|449611388|FG001|12 Months (All Treated Participants)|Death|3|||
124995782|NCT00343252|449611387|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
124995783|NCT00343252|449611388|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
124995784|NCT00343252|449611387|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
124995785|NCT00343252|449611388|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
124995786|NCT00343252|449611387|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
124995787|NCT00343252|449611388|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
124995788|NCT00343252|449611387|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
124995789|NCT00343252|449611388|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
124995790|NCT00343252|449611387|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
124995791|NCT00343252|449611388|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
124995792|NCT00343252|449611387|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
124995793|NCT00343252|449611388|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
124995794|NCT00343252|449611387|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
124995795|NCT00343252|449611388|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
124995796|NCT00343252|449611387|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
124995797|NCT00343252|449611388|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
124995798|NCT00343252|449611387|FG000|18 Months (All Treated Participants)|Death|4|||
124995799|NCT00343252|449611388|FG001|18 Months (All Treated Participants)|Death|5|||
125323981|NCT02903771|450819423|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
125323982|NCT02903771|450819424|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
125323983|NCT02903771|450819418|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
125323984|NCT02903771|450819419|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
125323985|NCT02903771|450819420|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
125323986|NCT02903771|450819421|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
125323987|NCT02903771|450819422|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
125323988|NCT02903771|450819423|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
125323989|NCT02903771|450819424|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
125323990|NCT02903771|450819418|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
125323991|NCT02903771|450819419|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
125323992|NCT02903771|450819420|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
125323993|NCT02903771|450819421|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
125323994|NCT02903771|450819422|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
125323995|NCT02903771|450819423|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
125323996|NCT02903771|450819424|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
125323997|NCT02903771|450819418|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
125323998|NCT02903771|450819419|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
125323999|NCT02903771|450819420|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
125324000|NCT02903771|450819421|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
125324001|NCT02903771|450819422|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
125324002|NCT02903771|450819423|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
125324003|NCT02903771|450819424|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
125324004|NCT02903771|450819418|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
125324005|NCT02903771|450819419|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
125324006|NCT02903771|450819420|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
125324007|NCT02903771|450819421|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
125324008|NCT02903771|450819422|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
125324009|NCT02903771|450819423|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
125324010|NCT02903771|450819424|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
125324011|NCT01435382|450819432|FG000|Overall Study|Lost to Follow-up|1|||
125324012|NCT01435382|450819433|FG001|Overall Study|Lost to Follow-up|0|||
125324013|NCT01435382|450819434|FG002|Overall Study|Lost to Follow-up|1|||
125324014|NCT01435382|450819435|FG003|Overall Study|Lost to Follow-up|0|||
125324015|NCT01435382|450819432|FG000|Overall Study|Withdrawal by Subject|0|||
125324016|NCT01435382|450819433|FG001|Overall Study|Withdrawal by Subject|2|||
125324017|NCT01435382|450819434|FG002|Overall Study|Withdrawal by Subject|0|||
125324018|NCT01435382|450819435|FG003|Overall Study|Withdrawal by Subject|1|||
125324019|NCT00910650|450819436|FG000|Overall Study|Death|2|||
125324020|NCT03367793|450819437|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
125324021|NCT03367793|450819438|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
125324022|NCT03367793|450819439|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
125324023|NCT03367793|450819440|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
125324024|NCT03367793|450819441|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
125324025|NCT03367793|450819442|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
125324026|NCT02435992|450819443|FG000|Overall Study|non compliance with protocol|2|||
125324027|NCT02435992|450819444|FG001|Overall Study|non compliance with protocol|0|||
124995800|NCT00343252|449611387|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
124995801|NCT00343252|449611388|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
124995802|NCT00343252|449611387|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
124995803|NCT00343252|449611388|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
124995804|NCT00343252|449611387|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
124995805|NCT00343252|449611388|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
125324028|NCT02435992|450819445|FG002|Overall Study|non compliance with protocol|1|||
125324029|NCT02435992|450819446|FG003|Overall Study|non compliance with protocol|0|||
125324030|NCT02435992|450819447|FG004|Overall Study|non compliance with protocol|0|||
125324031|NCT02435992|450819443|FG000|Overall Study|Adverse Event|11|||
125324032|NCT02435992|450819444|FG001|Overall Study|Adverse Event|6|||
125324033|NCT02435992|450819445|FG002|Overall Study|Adverse Event|12|||
125324034|NCT02435992|450819446|FG003|Overall Study|Adverse Event|0|||
125324035|NCT02435992|450819447|FG004|Overall Study|Adverse Event|0|||
125324036|NCT02435992|450819443|FG000|Overall Study|Lack of Efficacy|4|||
125324037|NCT02435992|450819444|FG001|Overall Study|Lack of Efficacy|10|||
125324038|NCT02435992|450819445|FG002|Overall Study|Lack of Efficacy|9|||
125324039|NCT02435992|450819446|FG003|Overall Study|Lack of Efficacy|0|||
125324040|NCT02435992|450819447|FG004|Overall Study|Lack of Efficacy|0|||
125324041|NCT02435992|450819443|FG000|Overall Study|Withdrawal by Subject|10|||
125324042|NCT02435992|450819444|FG001|Overall Study|Withdrawal by Subject|8|||
125324043|NCT02435992|450819445|FG002|Overall Study|Withdrawal by Subject|20|||
125324044|NCT02435992|450819446|FG003|Overall Study|Withdrawal by Subject|0|||
125324045|NCT02435992|450819447|FG004|Overall Study|Withdrawal by Subject|0|||
125324046|NCT02435992|450819443|FG000|Overall Study|Other Reason|1|||
125324047|NCT02435992|450819444|FG001|Overall Study|Other Reason|0|||
125324048|NCT02435992|450819445|FG002|Overall Study|Other Reason|0|||
125324049|NCT02435992|450819446|FG003|Overall Study|Other Reason|0|||
125324050|NCT02435992|450819447|FG004|Overall Study|Other Reason|0|||
125324051|NCT02435992|450819443|FG000|Overall Study|Physician Decision|0|||
125324052|NCT02435992|450819444|FG001|Overall Study|Physician Decision|0|||
125324053|NCT02435992|450819445|FG002|Overall Study|Physician Decision|1|||
125324054|NCT02435992|450819446|FG003|Overall Study|Physician Decision|0|||
125324055|NCT02435992|450819447|FG004|Overall Study|Physician Decision|0|||
125324056|NCT00260533|450819448|FG000|Overall Study|Other|3|||
125324057|NCT00260533|450819449|FG001|Overall Study|Other|3|||
125324058|NCT01761877|450819450|FG000|Overall Study|Adverse Event|7|||
125324059|NCT01761877|450819451|FG001|Overall Study|Adverse Event|0|||
125324060|NCT01761877|450819450|FG000|Overall Study|Withdrawal by Subject|6|||
125324061|NCT01761877|450819451|FG001|Overall Study|Withdrawal by Subject|4|||
125324062|NCT01761877|450819450|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
125324063|NCT01761877|450819451|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
125324064|NCT01761877|450819450|FG000|Overall Study|Death|0|||
125324065|NCT01761877|450819451|FG001|Overall Study|Death|1|||
125324066|NCT01761877|450819450|FG000|Overall Study|MRI intolerant|1|||
125324067|NCT01761877|450819451|FG001|Overall Study|MRI intolerant|6|||
125324068|NCT01310777|450819453|FG000|Overall Study|Adverse Event|23|||
125324069|NCT01310777|450819454|FG001|Overall Study|Adverse Event|1|||
125324070|NCT01310777|450819455|FG002|Overall Study|Adverse Event|15|||
125324071|NCT01310777|450819453|FG000|Overall Study|Lost to Follow-up|0|||
125324072|NCT01310777|450819454|FG001|Overall Study|Lost to Follow-up|4|||
125324073|NCT01310777|450819455|FG002|Overall Study|Lost to Follow-up|1|||
125324074|NCT01310777|450819453|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
125324075|NCT01310777|450819454|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
125324076|NCT01310777|450819455|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
125324077|NCT01310777|450819453|FG000|Overall Study|Inadequate Control of IOP|5|||
125324078|NCT01310777|450819454|FG001|Overall Study|Inadequate Control of IOP|7|||
125324079|NCT01310777|450819455|FG002|Overall Study|Inadequate Control of IOP|10|||
125324080|NCT01310777|450819453|FG000|Overall Study|Other|4|||
125324081|NCT01310777|450819454|FG001|Overall Study|Other|1|||
125324082|NCT01310777|450819455|FG002|Overall Study|Other|2|||
125324083|NCT03697252|450819456|FG000|Overall Study|Adverse Event|3|||
125324084|NCT03697252|450819457|FG001|Overall Study|Adverse Event|2|||
125324085|NCT03697252|450819456|FG000|Overall Study|Withdrawal by Subject|14|||
125324086|NCT03697252|450819457|FG001|Overall Study|Withdrawal by Subject|14|||
125324087|NCT03697252|450819456|FG000|Overall Study|Lost to Follow-up|0|||
125324088|NCT03697252|450819457|FG001|Overall Study|Lost to Follow-up|1|||
125324089|NCT03697252|450819456|FG000|Overall Study|Physician Decision|1|||
125324090|NCT03697252|450819457|FG001|Overall Study|Physician Decision|1|||
125324091|NCT03697252|450819456|FG000|Overall Study|Other|0|||
125324092|NCT03697252|450819457|FG001|Overall Study|Other|1|||
125324093|NCT02383576|450819458|FG000|Overall Study|Death|53|||
125324094|NCT02383576|450819459|FG001|Overall Study|Death|33|||
125324095|NCT02383576|450819458|FG000|Overall Study|Lost to Follow-up|7|||
125324096|NCT02383576|450819459|FG001|Overall Study|Lost to Follow-up|1|||
125324097|NCT02383576|450819458|FG000|Overall Study|Withdrew Consent|1|||
125324098|NCT02383576|450819459|FG001|Overall Study|Withdrew Consent|6|||
125324099|NCT02383576|450819458|FG000|Overall Study|Investigator's Decision|0|||
125324100|NCT02383576|450819459|FG001|Overall Study|Investigator's Decision|1|||
125324101|NCT02383576|450819458|FG000|Overall Study|Administrative/Other|2|||
125324102|NCT02383576|450819459|FG001|Overall Study|Administrative/Other|4|||
125324103|NCT04711850|450819460|FG000|Overall Study|Graft loss|2|||
125324104|NCT04711850|450819461|FG001|Overall Study|Graft loss|1|||
125324105|NCT04711850|450819460|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
125324106|NCT04711850|450819461|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
124995806|NCT00343252|449611387|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
124995807|NCT00343252|449611388|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
124995808|NCT00343252|449611387|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
124995809|NCT00343252|449611388|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
124995810|NCT00343252|449611387|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
124995811|NCT00343252|449611388|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
125324107|NCT04711850|450819460|FG000|Overall Study|Study terminated by sponsor|5|||
125324108|NCT04711850|450819461|FG001|Overall Study|Study terminated by sponsor|3|||
125324109|NCT04711850|450819460|FG000|Overall Study|Sponsor decision|0|||
125324110|NCT04711850|450819461|FG001|Overall Study|Sponsor decision|2|||
125324111|NCT00774046|450819462|FG000|Screening|Not eligible|56|||
125324112|NCT00774046|450819462|FG000|Enrollment|Desired other therapy/refused|28|||
125324113|NCT00774046|450819462|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
125324114|NCT01353898|450819474|FG000|Overall Study|Study site terminated|0|||
125324115|NCT01353898|450819475|FG001|Overall Study|Study site terminated|0|||
125324116|NCT01353898|450819476|FG002|Overall Study|Study site terminated|0|||
125324117|NCT01353898|450819477|FG003|Overall Study|Study site terminated|0|||
125324118|NCT01353898|450819478|FG004|Overall Study|Study site terminated|0|||
125324119|NCT01353898|450819479|FG005|Overall Study|Study site terminated|1|||
124995812|NCT00343252|449611387|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
124995813|NCT00343252|449611388|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
124995814|NCT01740323|449611389|FG000|Overall Study|Adverse Event|1|||
124995815|NCT01740323|449611390|FG001|Overall Study|Adverse Event|0|||
124995816|NCT01740323|449611389|FG000|Overall Study|Randomized but did not take study drug|1|||
125324120|NCT03558737|450819480|FG000|Overall Study|Death|1|||
125324121|NCT03558737|450819481|FG001|Overall Study|Death|1|||
125324122|NCT03041181|450819484|FG000|Overall Study|Disease Progression|1|||
125324123|NCT03041181|450819485|FG001|Overall Study|Disease Progression|2|||
125324124|NCT03050801|450819492|FG000|Experiment 1|Lost to Follow-up|0|||
125324125|NCT03050801|450819493|FG001|Experiment 1|Lost to Follow-up|1|||
125324126|NCT03050801|450819494|FG002|Experiment 1|Lost to Follow-up|0|||
125324127|NCT03050801|450819495|FG003|Experiment 1|Lost to Follow-up|0|||
125324128|NCT03050801|450819496|FG004|Experiment 1|Lost to Follow-up|0|||
125324129|NCT03050801|450819497|FG005|Experiment 1|Lost to Follow-up|0|||
125324130|NCT03050801|450819492|FG000|Experiment 1|Physician Decision|0|||
125324131|NCT03050801|450819493|FG001|Experiment 1|Physician Decision|3|||
125324132|NCT03050801|450819494|FG002|Experiment 1|Physician Decision|0|||
125324133|NCT03050801|450819495|FG003|Experiment 1|Physician Decision|0|||
125324134|NCT03050801|450819496|FG004|Experiment 1|Physician Decision|0|||
125324135|NCT03050801|450819497|FG005|Experiment 1|Physician Decision|0|||
125324136|NCT03050801|450819492|FG000|Experiment 1|Change of experimental design|0|||
125324137|NCT03050801|450819493|FG001|Experiment 1|Change of experimental design|3|||
125324138|NCT03050801|450819494|FG002|Experiment 1|Change of experimental design|0|||
125324139|NCT03050801|450819495|FG003|Experiment 1|Change of experimental design|0|||
125324140|NCT03050801|450819496|FG004|Experiment 1|Change of experimental design|0|||
125324141|NCT03050801|450819497|FG005|Experiment 1|Change of experimental design|0|||
125324142|NCT03050801|450819492|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
125324143|NCT03050801|450819493|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
125324144|NCT03050801|450819494|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
125324145|NCT03050801|450819495|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
125324146|NCT03050801|450819496|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
125324147|NCT03050801|450819497|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
125324148|NCT03050801|450819492|FG000|Experiment 2|Lost to Follow-up|0|||
125324149|NCT03050801|450819493|FG001|Experiment 2|Lost to Follow-up|0|||
125324150|NCT03050801|450819494|FG002|Experiment 2|Lost to Follow-up|0|||
125324151|NCT03050801|450819495|FG003|Experiment 2|Lost to Follow-up|1|||
125324152|NCT03050801|450819496|FG004|Experiment 2|Lost to Follow-up|1|||
125324153|NCT03050801|450819497|FG005|Experiment 2|Lost to Follow-up|0|||
125324154|NCT03050801|450819492|FG000|Experiment 2|Physician Decision|0|||
125324155|NCT03050801|450819493|FG001|Experiment 2|Physician Decision|0|||
125324156|NCT03050801|450819494|FG002|Experiment 2|Physician Decision|0|||
125324157|NCT03050801|450819495|FG003|Experiment 2|Physician Decision|0|||
125324158|NCT03050801|450819496|FG004|Experiment 2|Physician Decision|1|||
125324159|NCT03050801|450819497|FG005|Experiment 2|Physician Decision|0|||
125324160|NCT03050801|450819492|FG000|Experiment 2|Pregnancy|0|||
125324161|NCT03050801|450819493|FG001|Experiment 2|Pregnancy|0|||
125324162|NCT03050801|450819494|FG002|Experiment 2|Pregnancy|0|||
125324163|NCT03050801|450819495|FG003|Experiment 2|Pregnancy|0|||
125324164|NCT03050801|450819496|FG004|Experiment 2|Pregnancy|1|||
125324165|NCT03050801|450819497|FG005|Experiment 2|Pregnancy|0|||
125324166|NCT03050801|450819492|FG000|Experiment 2|Withdrawal by Subject|0|||
125324167|NCT03050801|450819493|FG001|Experiment 2|Withdrawal by Subject|0|||
125324168|NCT03050801|450819494|FG002|Experiment 2|Withdrawal by Subject|0|||
125324169|NCT03050801|450819495|FG003|Experiment 2|Withdrawal by Subject|1|||
125324170|NCT03050801|450819496|FG004|Experiment 2|Withdrawal by Subject|0|||
125324171|NCT03050801|450819497|FG005|Experiment 2|Withdrawal by Subject|0|||
125324172|NCT03050801|450819492|FG000|Experiment 2|Poor data quality|0|||
125324173|NCT03050801|450819493|FG001|Experiment 2|Poor data quality|0|||
125324174|NCT03050801|450819494|FG002|Experiment 2|Poor data quality|0|||
125324175|NCT03050801|450819495|FG003|Experiment 2|Poor data quality|4|||
125324176|NCT03050801|450819496|FG004|Experiment 2|Poor data quality|1|||
125324177|NCT03050801|450819497|FG005|Experiment 2|Poor data quality|0|||
125324178|NCT03050801|450819492|FG000|Experiment 2|Discomfort during stimulation|0|||
125324179|NCT03050801|450819493|FG001|Experiment 2|Discomfort during stimulation|0|||
125324180|NCT03050801|450819494|FG002|Experiment 2|Discomfort during stimulation|0|||
125324181|NCT03050801|450819495|FG003|Experiment 2|Discomfort during stimulation|0|||
125324182|NCT03050801|450819496|FG004|Experiment 2|Discomfort during stimulation|0|||
125324183|NCT03050801|450819497|FG005|Experiment 2|Discomfort during stimulation|2|||
125324184|NCT03600909|450819498|FG000|Overall Study|Not treated|0|||
125324185|NCT03600909|450819499|FG001|Overall Study|Not treated|3|||
125324186|NCT03600909|450819500|FG002|Overall Study|Not treated|0|||
125324187|NCT04973449|450819501|FG000|Overall Study|Withdrawal by Subject|3|||
125324188|NCT04973449|450819502|FG001|Overall Study|Withdrawal by Subject|3|||
125324189|NCT04973449|450819503|FG002|Overall Study|Withdrawal by Subject|2|||
125324190|NCT04973449|450819504|FG003|Overall Study|Withdrawal by Subject|5|||
125324191|NCT04973449|450819505|FG004|Overall Study|Withdrawal by Subject|5|||
125324192|NCT04973449|450819506|FG005|Overall Study|Withdrawal by Subject|4|||
125324193|NCT04973449|450819507|FG006|Overall Study|Withdrawal by Subject|7|||
125324194|NCT04973449|450819508|FG007|Overall Study|Withdrawal by Subject|5|||
125324195|NCT04973449|450819501|FG000|Overall Study|Lost to Follow-up|15|||
125324196|NCT04973449|450819502|FG001|Overall Study|Lost to Follow-up|16|||
124995817|NCT01740323|449611390|FG001|Overall Study|Randomized but did not take study drug|0|||
124995818|NCT02019927|449611393|FG000|Overall Study|Lost to Follow-up|2|||
124995819|NCT02019927|449611394|FG001|Overall Study|Lost to Follow-up|4|||
125324197|NCT04973449|450819503|FG002|Overall Study|Lost to Follow-up|16|||
125324198|NCT04973449|450819504|FG003|Overall Study|Lost to Follow-up|13|||
125324199|NCT04973449|450819505|FG004|Overall Study|Lost to Follow-up|5|||
125324200|NCT04973449|450819506|FG005|Overall Study|Lost to Follow-up|6|||
125324201|NCT04973449|450819507|FG006|Overall Study|Lost to Follow-up|10|||
125324202|NCT04973449|450819508|FG007|Overall Study|Lost to Follow-up|6|||
125324203|NCT04973449|450819501|FG000|Overall Study|Death|1|||
125324204|NCT04973449|450819502|FG001|Overall Study|Death|0|||
125324205|NCT04973449|450819503|FG002|Overall Study|Death|0|||
125324206|NCT04973449|450819504|FG003|Overall Study|Death|0|||
125324207|NCT04973449|450819505|FG004|Overall Study|Death|0|||
125324208|NCT04973449|450819506|FG005|Overall Study|Death|1|||
125324209|NCT04973449|450819507|FG006|Overall Study|Death|0|||
125324210|NCT04973449|450819508|FG007|Overall Study|Death|0|||
125324211|NCT04973449|450819501|FG000|Overall Study|Other|1|||
125324212|NCT04973449|450819502|FG001|Overall Study|Other|1|||
125324213|NCT04973449|450819503|FG002|Overall Study|Other|2|||
125324214|NCT04973449|450819504|FG003|Overall Study|Other|1|||
125324215|NCT04973449|450819505|FG004|Overall Study|Other|4|||
125324216|NCT04973449|450819506|FG005|Overall Study|Other|0|||
125324217|NCT04973449|450819507|FG006|Overall Study|Other|2|||
125324218|NCT04973449|450819508|FG007|Overall Study|Other|2|||
125324219|NCT00521079|450819509|FG000|Overall Study|Adverse Event|7|||
125324220|NCT00521079|450819510|FG001|Overall Study|Adverse Event|1|||
125324221|NCT00521079|450819509|FG000|Overall Study|Lost to Follow-up|2|||
125324222|NCT00521079|450819510|FG001|Overall Study|Lost to Follow-up|1|||
125324223|NCT00521079|450819509|FG000|Overall Study|Withdrawal by Subject|5|||
125324224|NCT00521079|450819510|FG001|Overall Study|Withdrawal by Subject|3|||
125324225|NCT02651675|450819511|FG000|Overall Study|Death|0|||
125324226|NCT02651675|450819512|FG001|Overall Study|Death|0|||
125324227|NCT02651675|450819513|FG002|Overall Study|Death|1|||
125324228|NCT03674411|450819514|FG000|Overall Study|Non-treatment|4|||
125324229|NCT01506596|450819515|FG000|Overall Study|ineligible pathology|1|||
125324230|NCT04606134|450819523|FG000|Overall Study|Adverse Event|0|||
124995820|NCT02019927|449611395|FG002|Overall Study|Lost to Follow-up|1|||
124995821|NCT02019927|449611396|FG003|Overall Study|Lost to Follow-up|2|||
124995822|NCT02019927|449611397|FG004|Overall Study|Lost to Follow-up|3|||
124995823|NCT02019927|449611398|FG005|Overall Study|Lost to Follow-up|1|||
124995824|NCT03945825|449611401|FG000|Overall Study|Enrolled but treatment not administered|0|||
125324231|NCT04606134|450819524|FG001|Overall Study|Adverse Event|1|||
125324232|NCT01099267|450819525|FG000|MDS-003 Study|Adverse Event|37|||
125324233|NCT01099267|450819525|FG000|MDS-003 Study|Lack of Efficacy|52|||
125324234|NCT01099267|450819525|FG000|MDS-003 Study|Withdrawal by Subject|8|||
124995825|NCT03945825|449611402|FG001|Overall Study|Enrolled but treatment not administered|0|||
124995826|NCT03945825|449611403|FG002|Overall Study|Enrolled but treatment not administered|0|||
125324235|NCT01099267|450819525|FG000|MDS-003 Study|Lost to Follow-up|1|||
125324236|NCT01099267|450819525|FG000|MDS-003 Study|Death|11|||
125324237|NCT01099267|450819525|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
125324238|NCT01099267|450819525|FG000|MDS-003 Study|Disease Progression|7|||
125324239|NCT01099267|450819525|FG000|MDS-003 Study|Investigator Decision|2|||
125324240|NCT01099267|450819525|FG000|MDS-003 Study|Non-Compliance|2|||
125324241|NCT01099267|450819525|FG000|MDS-003 Study|Loss of Response|1|||
125324242|NCT01099267|450819525|FG000|MDS-003 Study|Secondary Malign Disease|1|||
125324243|NCT04050553|450819534|FG000|Period 1|Physician Decision|2|||
125324244|NCT04050553|450819535|FG001|Period 1|Physician Decision|2|||
125324245|NCT04050553|450819534|FG000|Period 1|Adverse Event|1|||
125324246|NCT04050553|450819535|FG001|Period 1|Adverse Event|1|||
125324247|NCT04050553|450819534|FG000|Period 1|Withdrawal by Subject|0|||
125324248|NCT04050553|450819535|FG001|Period 1|Withdrawal by Subject|1|||
125324249|NCT04050553|450819534|FG000|Wash-out|Adverse Event|0|||
125324250|NCT04050553|450819535|FG001|Wash-out|Adverse Event|1|||
125324251|NCT04050553|450819534|FG000|Wash-out|Withdrawal by Subject|0|||
125324252|NCT04050553|450819535|FG001|Wash-out|Withdrawal by Subject|1|||
125324253|NCT03472885|450819538|FG000|24-Week Treatment Period|Adverse Event|1|||
125324254|NCT02201953|450819539|FG000|Overall Study|Randomized but Never Treated|1|||
125324255|NCT02201953|450819540|FG001|Overall Study|Randomized but Never Treated|5|||
125324256|NCT02201953|450819539|FG000|Overall Study|Lack of Efficacy|9|||
125324257|NCT02201953|450819540|FG001|Overall Study|Lack of Efficacy|30|||
125324258|NCT02201953|450819539|FG000|Overall Study|Lost to Follow-up|8|||
125324259|NCT02201953|450819540|FG001|Overall Study|Lost to Follow-up|8|||
125324260|NCT02201953|450819539|FG000|Overall Study|Withdrew Consent|2|||
125324261|NCT02201953|450819540|FG001|Overall Study|Withdrew Consent|5|||
125324262|NCT02201953|450819539|FG000|Overall Study|Adverse Event|0|||
125324263|NCT02201953|450819540|FG001|Overall Study|Adverse Event|5|||
125324264|NCT02201953|450819539|FG000|Overall Study|Death|0|||
125324265|NCT02201953|450819540|FG001|Overall Study|Death|3|||
125324266|NCT01615939|450821372|FG000|Overall Study|Lost to Follow-up|5|||
125324267|NCT01615939|450821373|FG001|Overall Study|Lost to Follow-up|0|||
125324268|NCT02892344|450821377|FG000|Overall Study|Protocol deviation|3|||
125324269|NCT02892344|450821378|FG001|Overall Study|Protocol deviation|4|||
125324270|NCT02892344|450821377|FG000|Overall Study|Adverse Event|1|||
125324271|NCT02892344|450821378|FG001|Overall Study|Adverse Event|8|||
125324272|NCT02892344|450821377|FG000|Overall Study|Lost to Follow-up|0|||
125324273|NCT02892344|450821378|FG001|Overall Study|Lost to Follow-up|1|||
125324274|NCT02892344|450821377|FG000|Overall Study|Non-compliance with study treatment|0|||
125324275|NCT02892344|450821378|FG001|Overall Study|Non-compliance with study treatment|1|||
125324276|NCT02892344|450821377|FG000|Overall Study|Physician Decision|0|||
125324277|NCT02892344|450821378|FG001|Overall Study|Physician Decision|2|||
125324278|NCT02892344|450821377|FG000|Overall Study|Subject/guardian decision|0|||
125324279|NCT02892344|450821378|FG001|Overall Study|Subject/guardian decision|4|||
125324280|NCT02892344|450821377|FG000|Overall Study|Technical problems|0|||
125324281|NCT02892344|450821378|FG001|Overall Study|Technical problems|1|||
125324282|NCT01520506|450821379|FG000|Overall Study|Missed Visit|4|||
125324283|NCT01520506|450821379|FG000|Overall Study|Lost to Follow-up|1|||
125324284|NCT01520506|450821379|FG000|Overall Study|Withdrawal by Subject|1|||
125324285|NCT00425269|450821380|FG000|Overall Study|Pregnancy|5|||
125324286|NCT00425269|450821381|FG001|Overall Study|Pregnancy|7|||
125324287|NCT00425269|450821380|FG000|Overall Study|Lost to Follow-up|9|||
125324288|NCT00425269|450821381|FG001|Overall Study|Lost to Follow-up|9|||
125324289|NCT00425269|450821380|FG000|Overall Study|moved or medical reason|5|||
125324290|NCT00425269|450821381|FG001|Overall Study|moved or medical reason|4|||
125324291|NCT01084655|450821386|FG000|Overall Study|Radiographic disease progression|3|||
125324292|NCT01084655|450821387|FG001|Overall Study|Radiographic disease progression|2|||
125324293|NCT01084655|450821388|FG002|Overall Study|Radiographic disease progression|8|||
125324294|NCT01084655|450821386|FG000|Overall Study|Withdrawal by Subject|1|||
125324295|NCT01084655|450821387|FG001|Overall Study|Withdrawal by Subject|0|||
125324296|NCT01084655|450821388|FG002|Overall Study|Withdrawal by Subject|4|||
125324297|NCT01084655|450821386|FG000|Overall Study|Adverse Event|2|||
125324298|NCT01084655|450821387|FG001|Overall Study|Adverse Event|1|||
125324299|NCT01084655|450821388|FG002|Overall Study|Adverse Event|2|||
125324300|NCT01084655|450821386|FG000|Overall Study|Other|0|||
125324301|NCT01084655|450821387|FG001|Overall Study|Other|3|||
125324302|NCT01084655|450821388|FG002|Overall Study|Other|2|||
125324303|NCT01084655|450821386|FG000|Overall Study|Symptomatic deterioration|0|||
125324304|NCT01084655|450821387|FG001|Overall Study|Symptomatic deterioration|0|||
125324305|NCT01084655|450821388|FG002|Overall Study|Symptomatic deterioration|2|||
125324306|NCT01084655|450821386|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
125324307|NCT01084655|450821387|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
125324308|NCT01084655|450821388|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
125324309|NCT00535496|450821389|FG000|Overall Study|Lost to Follow-up|0|||
125324310|NCT00535496|450821390|FG001|Overall Study|Lost to Follow-up|1|||
125324311|NCT00535496|450821391|FG002|Overall Study|Lost to Follow-up|0|||
125324312|NCT00535496|450821392|FG003|Overall Study|Lost to Follow-up|0|||
125324313|NCT00535496|450821389|FG000|Overall Study|Not treated with sugammadex|0|||
125324314|NCT00535496|450821390|FG001|Overall Study|Not treated with sugammadex|1|||
125324315|NCT00535496|450821391|FG002|Overall Study|Not treated with sugammadex|0|||
125324316|NCT00535496|450821392|FG003|Overall Study|Not treated with sugammadex|0|||
125324317|NCT02326155|450821394|FG000|Overall Study|Adverse Event|21|||
125324318|NCT02326155|450821395|FG001|Overall Study|Adverse Event|5|||
125324319|NCT02326155|450821394|FG000|Overall Study|Death|3|||
125324320|NCT02326155|450821395|FG001|Overall Study|Death|0|||
124995827|NCT03945825|449611404|FG003|Overall Study|Enrolled but treatment not administered|0|||
124995828|NCT03945825|449611405|FG004|Overall Study|Enrolled but treatment not administered|1|||
124995829|NCT03945825|449611406|FG005|Overall Study|Enrolled but treatment not administered|0|||
124995830|NCT03945825|449611401|FG000|Overall Study|Lost to Follow-up|1|||
124995831|NCT03945825|449611402|FG001|Overall Study|Lost to Follow-up|5|||
124995832|NCT03945825|449611403|FG002|Overall Study|Lost to Follow-up|0|||
124995833|NCT03945825|449611404|FG003|Overall Study|Lost to Follow-up|1|||
124995834|NCT03945825|449611405|FG004|Overall Study|Lost to Follow-up|2|||
124995835|NCT03945825|449611406|FG005|Overall Study|Lost to Follow-up|2|||
124995836|NCT03945825|449611401|FG000|Overall Study|Withdrawal by Subject|1|||
124995837|NCT03945825|449611402|FG001|Overall Study|Withdrawal by Subject|0|||
125324321|NCT02326155|450821394|FG000|Overall Study|Lack of Efficacy|49|||
125324322|NCT02326155|450821395|FG001|Overall Study|Lack of Efficacy|5|||
125324323|NCT02326155|450821394|FG000|Overall Study|Lost to Follow-up|14|||
125324324|NCT02326155|450821395|FG001|Overall Study|Lost to Follow-up|3|||
125324325|NCT02326155|450821394|FG000|Overall Study|Protocol Violation|2|||
125324326|NCT02326155|450821395|FG001|Overall Study|Protocol Violation|0|||
125324327|NCT02326155|450821394|FG000|Overall Study|Withdrawal by Subject|34|||
125324328|NCT02326155|450821395|FG001|Overall Study|Withdrawal by Subject|11|||
125324329|NCT02326155|450821394|FG000|Overall Study|Disease progression|37|||
125324330|NCT02326155|450821395|FG001|Overall Study|Disease progression|4|||
125324331|NCT02326155|450821394|FG000|Overall Study|Study close|188|||
125324332|NCT02326155|450821395|FG001|Overall Study|Study close|21|||
125324333|NCT02326155|450821394|FG000|Overall Study|except for study close|46|||
125324334|NCT02326155|450821395|FG001|Overall Study|except for study close|13|||
125324335|NCT05024032|450821396|FG000|Overall Study|Withdrawal by Subject|0|||
125324336|NCT05024032|450821397|FG001|Overall Study|Withdrawal by Subject|3|||
125324337|NCT05024032|450821398|FG002|Overall Study|Withdrawal by Subject|4|||
125324338|NCT05024032|450821396|FG000|Overall Study|Adverse Event|0|||
125324339|NCT05024032|450821397|FG001|Overall Study|Adverse Event|1|||
125324340|NCT05024032|450821398|FG002|Overall Study|Adverse Event|0|||
125324341|NCT05024032|450821396|FG000|Overall Study|Protocol Deviation|1|||
125324342|NCT05024032|450821397|FG001|Overall Study|Protocol Deviation|0|||
125324343|NCT05024032|450821398|FG002|Overall Study|Protocol Deviation|0|||
125324344|NCT03591406|450821401|FG000|Overall Study|Adverse Event|5|||
125324345|NCT03591406|450821402|FG001|Overall Study|Adverse Event|3|||
125324346|NCT03591406|450821401|FG000|Overall Study|Protocol Violation|2|||
125324347|NCT03591406|450821402|FG001|Overall Study|Protocol Violation|1|||
124995838|NCT03945825|449611403|FG002|Overall Study|Withdrawal by Subject|1|||
124995839|NCT03945825|449611404|FG003|Overall Study|Withdrawal by Subject|1|||
124995840|NCT03945825|449611405|FG004|Overall Study|Withdrawal by Subject|0|||
124995841|NCT03945825|449611406|FG005|Overall Study|Withdrawal by Subject|1|||
124995842|NCT01423253|449611414|FG000|Overall Study|Adverse Event|2|||
124995843|NCT01423253|449611414|FG000|Overall Study|Lack of Efficacy|2|||
124995844|NCT01423253|449611414|FG000|Overall Study|Lost to Follow-up|1|||
124995845|NCT01423253|449611414|FG000|Overall Study|Protocol Violation|2|||
124995846|NCT01423253|449611414|FG000|Overall Study|Withdrawal by Subject|2|||
124995847|NCT00307125|449611415|FG000|Screening Phase|Adverse Event|1|||
124995848|NCT00307125|449611416|FG001|Screening Phase|Adverse Event|0|||
124995849|NCT00307125|449611417|FG002|Screening Phase|Adverse Event|0|||
124995850|NCT00307125|449611415|FG000|Screening Phase|Protocol Violation|27|||
124995851|NCT00307125|449611416|FG001|Screening Phase|Protocol Violation|0|||
124995852|NCT00307125|449611417|FG002|Screening Phase|Protocol Violation|0|||
124995853|NCT00307125|449611415|FG000|Screening Phase|Lost to Follow-up|87|||
124995854|NCT00307125|449611416|FG001|Screening Phase|Lost to Follow-up|0|||
124995855|NCT00307125|449611417|FG002|Screening Phase|Lost to Follow-up|0|||
124995856|NCT00307125|449611415|FG000|Screening Phase|Death|10|||
124995857|NCT00307125|449611416|FG001|Screening Phase|Death|0|||
124995858|NCT00307125|449611417|FG002|Screening Phase|Death|0|||
124995859|NCT00307125|449611415|FG000|Screening Phase|Withdrawal by Subject|77|||
124995860|NCT00307125|449611416|FG001|Screening Phase|Withdrawal by Subject|0|||
124995861|NCT00307125|449611417|FG002|Screening Phase|Withdrawal by Subject|0|||
125324348|NCT03591406|450821401|FG000|Overall Study|Withdrawal by Subject|0|||
125324349|NCT03591406|450821402|FG001|Overall Study|Withdrawal by Subject|5|||
125324350|NCT01083771|450821403|FG000|Overall Study|non-compliant|2|||
124995862|NCT00307125|449611415|FG000|Screening Phase|Physician Decision|26|||
124995863|NCT00307125|449611416|FG001|Screening Phase|Physician Decision|0|||
124995864|NCT00307125|449611417|FG002|Screening Phase|Physician Decision|0|||
124995865|NCT00307125|449611415|FG000|Screening Phase|Sponsor Decision|4|||
124995866|NCT00307125|449611416|FG001|Screening Phase|Sponsor Decision|0|||
124995867|NCT00307125|449611417|FG002|Screening Phase|Sponsor Decision|0|||
124995868|NCT00307125|449611415|FG000|Screening Phase|Study Terminated|17|||
124995869|NCT00307125|449611416|FG001|Screening Phase|Study Terminated|0|||
124995870|NCT00307125|449611417|FG002|Screening Phase|Study Terminated|0|||
124995871|NCT00307125|449611415|FG000|Screening Phase|Graft Loss|3|||
124995872|NCT00307125|449611416|FG001|Screening Phase|Graft Loss|0|||
125324351|NCT01083771|450821403|FG000|Overall Study|Withdrawal by Subject|3|||
124995873|NCT00307125|449611417|FG002|Screening Phase|Graft Loss|0|||
125324352|NCT02066181|450821404|FG000|Overall Study|Withdrawal by Subject|1|||
125324353|NCT02066181|450821405|FG001|Overall Study|Withdrawal by Subject|1|||
125324354|NCT00939393|450821408|FG000|Overall Study|Withdrawal by Subject|1|||
125324355|NCT00939393|450821409|FG001|Overall Study|Withdrawal by Subject|0|||
125324356|NCT00939393|450821408|FG000|Overall Study|Lost to Follow-up|3|||
125324357|NCT00939393|450821409|FG001|Overall Study|Lost to Follow-up|0|||
125324358|NCT02851615|450821410|FG000|Overall Study|Cognitive Issue|1|||
125324359|NCT02851615|450821411|FG001|Overall Study|Cognitive Issue|0|||
125324360|NCT02851615|450821410|FG000|Overall Study|Lost to Follow-up|0|||
125324361|NCT02851615|450821411|FG001|Overall Study|Lost to Follow-up|4|||
125324362|NCT00371150|450821420|FG000|Overall Study|Lost to Follow-up|3|||
125324363|NCT00371150|450821421|FG001|Overall Study|Lost to Follow-up|2|||
125324364|NCT03714672|450821422|FG000|Overall Study|Adverse Event|0|||
125324365|NCT03714672|450821423|FG001|Overall Study|Adverse Event|0|||
125324366|NCT03714672|450821424|FG002|Overall Study|Adverse Event|3|||
125324367|NCT03714672|450821425|FG003|Overall Study|Adverse Event|0|||
125324368|NCT03714672|450821422|FG000|Overall Study|Physician Decision|0|||
125324369|NCT03714672|450821423|FG001|Overall Study|Physician Decision|1|||
125324370|NCT03714672|450821424|FG002|Overall Study|Physician Decision|0|||
125324371|NCT03714672|450821425|FG003|Overall Study|Physician Decision|0|||
125324372|NCT03714672|450821422|FG000|Overall Study|Other Reason|1|||
125324373|NCT03714672|450821423|FG001|Overall Study|Other Reason|2|||
125324374|NCT03714672|450821424|FG002|Overall Study|Other Reason|1|||
125324375|NCT03714672|450821425|FG003|Overall Study|Other Reason|1|||
125324376|NCT03714672|450821422|FG000|Overall Study|Lost to Follow-up|1|||
125324377|NCT03714672|450821423|FG001|Overall Study|Lost to Follow-up|1|||
125324378|NCT03714672|450821424|FG002|Overall Study|Lost to Follow-up|0|||
125324379|NCT03714672|450821425|FG003|Overall Study|Lost to Follow-up|0|||
125324380|NCT02345070|450821427|FG000|Overall Study|Adverse Event|12|||
125324381|NCT02345070|450821428|FG001|Overall Study|Adverse Event|8|||
125324382|NCT02345070|450821429|FG002|Overall Study|Adverse Event|16|||
125324383|NCT02345070|450821427|FG000|Overall Study|Poor compliance to protocol|2|||
125324384|NCT02345070|450821428|FG001|Overall Study|Poor compliance to protocol|0|||
125324385|NCT02345070|450821429|FG002|Overall Study|Poor compliance to protocol|0|||
125324386|NCT02345070|450821427|FG000|Overall Study|Other than specified above|6|||
125324387|NCT02345070|450821428|FG001|Overall Study|Other than specified above|3|||
125324388|NCT02345070|450821429|FG002|Overall Study|Other than specified above|7|||
125324389|NCT00321620|450821435|FG000|Overall Study|Death|269|||
125324390|NCT00321620|450821436|FG001|Overall Study|Death|294|||
125324391|NCT00321620|450821435|FG000|Overall Study|Withdrawal by Subject|164|||
125324392|NCT00321620|450821436|FG001|Overall Study|Withdrawal by Subject|147|||
125324393|NCT00321620|450821435|FG000|Overall Study|Disease progression|113|||
125324394|NCT00321620|450821436|FG001|Overall Study|Disease progression|117|||
125324395|NCT00321620|450821435|FG000|Overall Study|Adverse Event|43|||
125324396|NCT00321620|450821436|FG001|Overall Study|Adverse Event|56|||
125324397|NCT00321620|450821435|FG000|Overall Study|Lost to Follow-up|13|||
125324398|NCT00321620|450821436|FG001|Overall Study|Lost to Follow-up|9|||
125324399|NCT00321620|450821435|FG000|Overall Study|Physician Decision|4|||
125324400|NCT00321620|450821436|FG001|Overall Study|Physician Decision|1|||
125324401|NCT00321620|450821435|FG000|Overall Study|Noncompliance|14|||
125324402|NCT00321620|450821436|FG001|Overall Study|Noncompliance|7|||
125324403|NCT00321620|450821435|FG000|Overall Study|Protocol deviation|4|||
125324404|NCT00321620|450821436|FG001|Overall Study|Protocol deviation|3|||
125324405|NCT00321620|450821435|FG000|Overall Study|Ineligibility determined|2|||
125324406|NCT00321620|450821436|FG001|Overall Study|Ineligibility determined|3|||
125324407|NCT00321620|450821435|FG000|Overall Study|Participant request|75|||
125324408|NCT00321620|450821436|FG001|Overall Study|Participant request|52|||
125324409|NCT00321620|450821435|FG000|Overall Study|Other|42|||
125324410|NCT00321620|450821436|FG001|Overall Study|Other|33|||
125324411|NCT03829228|450821437|FG000|Overall Study|Protocol Violation|1|||
125324412|NCT03304626|450821440|FG000|Overall Study|Adverse Event|1|||
125324413|NCT03304626|450821441|FG001|Overall Study|Adverse Event|0|||
125324414|NCT03304626|450821440|FG000|Overall Study|Lack of Efficacy|1|||
125324415|NCT03304626|450821441|FG001|Overall Study|Lack of Efficacy|1|||
125324416|NCT01462370|450821448|FG000|Overall Study|Lack of Qualifying Event|1|||
125324417|NCT01462370|450821449|FG001|Overall Study|Lack of Qualifying Event|1|||
125324418|NCT01462370|450821448|FG000|Overall Study|Physician Decision|0|||
125324419|NCT01462370|450821449|FG001|Overall Study|Physician Decision|1|||
125324420|NCT01462370|450821448|FG000|Overall Study|Withdrawal by Subject|0|||
125324421|NCT01462370|450821449|FG001|Overall Study|Withdrawal by Subject|3|||
125324422|NCT04385277|450821452|FG000|Overall Study|Physician Decision|2|||
125324423|NCT04385277|450821452|FG000|Overall Study|Ineligible|1|||
125324424|NCT04385277|450821452|FG000|Overall Study|Patient/Parent Refusal|2|||
125324425|NCT03566511|450821453|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
125324426|NCT03566511|450821454|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
125324427|NCT00981656|450821463|FG000|Overall Study|Protocol Violation|1|||
125324428|NCT00981656|450821463|FG000|Overall Study|Did not start protocol treatment|2|||
125324429|NCT00687596|450821464|FG000|Overall Study|Adverse Event (AE)|10|||
125324430|NCT00687596|450821465|FG001|Overall Study|Adverse Event (AE)|3|||
125324431|NCT00687596|450821464|FG000|Overall Study|Radiological Disease Progression|6|||
125324432|NCT00687596|450821465|FG001|Overall Study|Radiological Disease Progression|2|||
125324433|NCT00687596|450821464|FG000|Overall Study|Clinical Disease Progression|1|||
125324434|NCT00687596|450821465|FG001|Overall Study|Clinical Disease Progression|3|||
125324435|NCT00687596|450821464|FG000|Overall Study|Investigator Discretion|3|||
125324436|NCT00687596|450821465|FG001|Overall Study|Investigator Discretion|1|||
125324437|NCT00687596|450821464|FG000|Overall Study|Sponsor Terminated Study|6|||
125324438|NCT00687596|450821465|FG001|Overall Study|Sponsor Terminated Study|17|||
125324439|NCT03331315|450821470|FG000|Overall Study|Physician Decision|18|||
125324440|NCT03331315|450821471|FG001|Overall Study|Physician Decision|14|||
125324441|NCT02461758|450821475|FG000|Overall Study|Lost to Follow-up|0|||
125324442|NCT02461758|450821476|FG001|Overall Study|Lost to Follow-up|1|||
125324443|NCT02461758|450821477|FG002|Overall Study|Lost to Follow-up|1|||
125324444|NCT02461758|450821478|FG003|Overall Study|Lost to Follow-up|0|||
125324445|NCT03773978|450821490|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
125324446|NCT03773978|450821491|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
125324447|NCT03773978|450821490|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
125324448|NCT03773978|450821491|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
125324449|NCT03773978|450821490|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
125324450|NCT03773978|450821491|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
125324451|NCT03773978|450821490|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
125324452|NCT03773978|450821491|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
125324453|NCT03773978|450821490|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
125324454|NCT03773978|450821491|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
125324455|NCT03773978|450821490|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
125324456|NCT03773978|450821491|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
125324457|NCT03773978|450821490|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
125324458|NCT03773978|450821491|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
125324459|NCT03773978|450821490|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
125324460|NCT03773978|450821491|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
125324461|NCT03773978|450821490|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
125324462|NCT03773978|450821491|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
125324463|NCT03773978|450821490|FG000|DBW Period|Adverse Event|2|||
125324464|NCT03773978|450821491|FG001|DBW Period|Adverse Event|2|||
125324465|NCT03773978|450821490|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
125324466|NCT03773978|450821491|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
125324467|NCT03773978|450821490|FG000|DBW Period|Withdrawal by Subject|2|||
125324468|NCT03773978|450821491|FG001|DBW Period|Withdrawal by Subject|1|||
125324469|NCT03773978|450821490|FG000|DBW Period|Due to epidemic or pandemic|5|||
125324470|NCT03773978|450821491|FG001|DBW Period|Due to epidemic or pandemic|6|||
125324471|NCT03773978|450821490|FG000|DBW Period|Study team decision|1|||
125324472|NCT03773978|450821491|FG001|DBW Period|Study team decision|0|||
125324473|NCT01033019|450821492|FG000|Overall Study|Withdrawal by Subject|1|||
125324474|NCT01033019|450821493|FG001|Overall Study|Withdrawal by Subject|0|||
125324475|NCT00888134|450821497|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
125324476|NCT00888134|450821497|FG000|Follow-up|being followed for long-term survival|1|||
125324477|NCT03224819|450821499|FG000|Overall Study|Withdrawal by Subject|0|||
125324478|NCT03224819|450821500|FG001|Overall Study|Withdrawal by Subject|0|||
125324479|NCT03224819|450821501|FG002|Overall Study|Withdrawal by Subject|0|||
125324480|NCT03224819|450821502|FG003|Overall Study|Withdrawal by Subject|0|||
125324481|NCT03224819|450821503|FG004|Overall Study|Withdrawal by Subject|0|||
125324482|NCT03224819|450821504|FG005|Overall Study|Withdrawal by Subject|0|||
125324483|NCT03224819|450821505|FG006|Overall Study|Withdrawal by Subject|0|||
125324484|NCT03224819|450821506|FG007|Overall Study|Withdrawal by Subject|0|||
125324485|NCT03224819|450821507|FG008|Overall Study|Withdrawal by Subject|0|||
125324486|NCT03224819|450821508|FG009|Overall Study|Withdrawal by Subject|0|||
125324487|NCT03224819|450821509|FG010|Overall Study|Withdrawal by Subject|0|||
125324488|NCT03224819|450821510|FG011|Overall Study|Withdrawal by Subject|0|||
125324489|NCT03224819|450821511|FG012|Overall Study|Withdrawal by Subject|1|||
125324490|NCT03224819|450821512|FG013|Overall Study|Withdrawal by Subject|0|||
125324491|NCT03224819|450821499|FG000|Overall Study|Sponsor Decision|0|||
125324492|NCT03224819|450821500|FG001|Overall Study|Sponsor Decision|0|||
125324493|NCT03224819|450821501|FG002|Overall Study|Sponsor Decision|0|||
125324494|NCT03224819|450821502|FG003|Overall Study|Sponsor Decision|1|||
125324495|NCT03224819|450821503|FG004|Overall Study|Sponsor Decision|1|||
125324496|NCT03224819|450821504|FG005|Overall Study|Sponsor Decision|2|||
125324497|NCT03224819|450821505|FG006|Overall Study|Sponsor Decision|1|||
125324498|NCT03224819|450821506|FG007|Overall Study|Sponsor Decision|1|||
125324499|NCT03224819|450821507|FG008|Overall Study|Sponsor Decision|1|||
125324500|NCT03224819|450821508|FG009|Overall Study|Sponsor Decision|2|||
125324501|NCT03224819|450821509|FG010|Overall Study|Sponsor Decision|1|||
125324502|NCT03224819|450821510|FG011|Overall Study|Sponsor Decision|1|||
125324503|NCT03224819|450821511|FG012|Overall Study|Sponsor Decision|1|||
125324504|NCT03224819|450821512|FG013|Overall Study|Sponsor Decision|0|||
125324505|NCT03224819|450821499|FG000|Overall Study|Lost to Follow-up|0|||
125324506|NCT03224819|450821500|FG001|Overall Study|Lost to Follow-up|0|||
125324507|NCT03224819|450821501|FG002|Overall Study|Lost to Follow-up|0|||
125324508|NCT03224819|450821502|FG003|Overall Study|Lost to Follow-up|0|||
125324509|NCT03224819|450821503|FG004|Overall Study|Lost to Follow-up|0|||
125324510|NCT03224819|450821504|FG005|Overall Study|Lost to Follow-up|0|||
125324511|NCT03224819|450821505|FG006|Overall Study|Lost to Follow-up|0|||
125324512|NCT03224819|450821506|FG007|Overall Study|Lost to Follow-up|0|||
125324513|NCT03224819|450821507|FG008|Overall Study|Lost to Follow-up|1|||
125324514|NCT03224819|450821508|FG009|Overall Study|Lost to Follow-up|0|||
125324515|NCT03224819|450821509|FG010|Overall Study|Lost to Follow-up|0|||
125324516|NCT03224819|450821510|FG011|Overall Study|Lost to Follow-up|0|||
125324517|NCT03224819|450821511|FG012|Overall Study|Lost to Follow-up|0|||
125324518|NCT03224819|450821512|FG013|Overall Study|Lost to Follow-up|0|||
125324519|NCT03224819|450821499|FG000|Overall Study|Death|0|||
125324520|NCT03224819|450821500|FG001|Overall Study|Death|1|||
125324521|NCT03224819|450821501|FG002|Overall Study|Death|0|||
125324522|NCT03224819|450821502|FG003|Overall Study|Death|0|||
125324523|NCT03224819|450821503|FG004|Overall Study|Death|0|||
125324524|NCT03224819|450821504|FG005|Overall Study|Death|0|||
125324525|NCT03224819|450821505|FG006|Overall Study|Death|0|||
125324526|NCT03224819|450821506|FG007|Overall Study|Death|1|||
125324527|NCT03224819|450821507|FG008|Overall Study|Death|0|||
125324528|NCT03224819|450821508|FG009|Overall Study|Death|0|||
125324529|NCT03224819|450821509|FG010|Overall Study|Death|0|||
125324530|NCT03224819|450821510|FG011|Overall Study|Death|1|||
125324531|NCT03224819|450821511|FG012|Overall Study|Death|0|||
125324532|NCT03224819|450821512|FG013|Overall Study|Death|0|||
125324533|NCT03104868|450821513|FG000|6 Week Follow up|Lost to Follow-up|5|||
125324534|NCT03104868|450821514|FG001|6 Week Follow up|Lost to Follow-up|8|||
125324535|NCT03104868|450821513|FG000|6 Week Follow up|Death|1|||
125324536|NCT03104868|450821514|FG001|6 Week Follow up|Death|1|||
125324537|NCT03104868|450821513|FG000|6 Week Follow up|Withdrawal by Subject|7|||
125324538|NCT03104868|450821514|FG001|6 Week Follow up|Withdrawal by Subject|6|||
125324539|NCT03104868|450821513|FG000|6 Week Follow up|Completed Later Timepoint|24|||
125324540|NCT03104868|450821514|FG001|6 Week Follow up|Completed Later Timepoint|22|||
125324541|NCT03104868|450821513|FG000|6 Month Follow up|Lost to Follow-up|2|||
125324542|NCT03104868|450821514|FG001|6 Month Follow up|Lost to Follow-up|2|||
125324543|NCT03104868|450821513|FG000|6 Month Follow up|Death|0|||
125324544|NCT03104868|450821514|FG001|6 Month Follow up|Death|1|||
125324545|NCT03104868|450821513|FG000|6 Month Follow up|Completed Later Timepoint|22|||
125324546|NCT03104868|450821514|FG001|6 Month Follow up|Completed Later Timepoint|32|||
125324547|NCT03104868|450821513|FG000|12 Month Follow up|Lost to Follow-up|1|||
125324548|NCT03104868|450821514|FG001|12 Month Follow up|Lost to Follow-up|2|||
125324549|NCT03104868|450821513|FG000|12 Month Follow up|Death|0|||
125324550|NCT03104868|450821514|FG001|12 Month Follow up|Death|1|||
125324551|NCT03104868|450821513|FG000|12 Month Follow up|Withdrawal by Subject|0|||
125324552|NCT03104868|450821514|FG001|12 Month Follow up|Withdrawal by Subject|3|||
125324553|NCT03104868|450821513|FG000|12 Month Follow up|Completed Later Timepoint|32|||
125324554|NCT03104868|450821514|FG001|12 Month Follow up|Completed Later Timepoint|29|||
125324555|NCT03104868|450821513|FG000|18 Month Follow up|Lost to Follow-up|7|||
125324556|NCT03104868|450821514|FG001|18 Month Follow up|Lost to Follow-up|11|||
125324557|NCT03104868|450821513|FG000|18 Month Follow up|Death|2|||
125324558|NCT03104868|450821514|FG001|18 Month Follow up|Death|1|||
125324559|NCT03104868|450821513|FG000|18 Month Follow up|Withdrawal by Subject|1|||
125324560|NCT03104868|450821514|FG001|18 Month Follow up|Withdrawal by Subject|2|||
125324561|NCT03104868|450821513|FG000|18 Month Follow up|Graft Loss|1|||
125324562|NCT03104868|450821514|FG001|18 Month Follow up|Graft Loss|1|||
125324563|NCT03104868|450821513|FG000|18 Month Follow up|Completed Later Timepoint|19|||
125324564|NCT03104868|450821514|FG001|18 Month Follow up|Completed Later Timepoint|20|||
125324565|NCT03104868|450821513|FG000|24 Month Follow up|Lost to Follow-up|15|||
125324566|NCT03104868|450821514|FG001|24 Month Follow up|Lost to Follow-up|16|||
124995874|NCT00307125|449611415|FG000|Screening Phase|Graft Failure|8|||
124995875|NCT00307125|449611416|FG001|Screening Phase|Graft Failure|0|||
124995876|NCT00307125|449611417|FG002|Screening Phase|Graft Failure|0|||
124995877|NCT00307125|449611415|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
125324567|NCT03104868|450821513|FG000|24 Month Follow up|Death|3|||
125324568|NCT03104868|450821514|FG001|24 Month Follow up|Death|2|||
125324569|NCT03104868|450821513|FG000|24 Month Follow up|Withdrawal by Subject|1|||
125324570|NCT03104868|450821514|FG001|24 Month Follow up|Withdrawal by Subject|0|||
124995878|NCT00307125|449611416|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
125324571|NCT03104868|450821513|FG000|24 Month Follow up|Graft Loss|2|||
125324572|NCT03104868|450821514|FG001|24 Month Follow up|Graft Loss|0|||
125324573|NCT00005780|450821515|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
125324574|NCT04408989|450821516|FG000|Overall Study|Lost to Follow-up|0|||
125324575|NCT04408989|450821517|FG001|Overall Study|Lost to Follow-up|0|||
125324576|NCT04408989|450821518|FG002|Overall Study|Lost to Follow-up|1|||
125324577|NCT04408989|450821516|FG000|Overall Study|Withdrawal by Subject|0|||
125324578|NCT04408989|450821517|FG001|Overall Study|Withdrawal by Subject|0|||
125324579|NCT04408989|450821518|FG002|Overall Study|Withdrawal by Subject|2|||
125324580|NCT05082857|450821519|FG000|Overall Study|participants relocated and could not continue|2|||
125324581|NCT05082857|450821520|FG001|Overall Study|participants relocated and could not continue|1|||
125324582|NCT05082857|450821519|FG000|Overall Study|Lost to Follow-up|1|||
125324583|NCT05082857|450821520|FG001|Overall Study|Lost to Follow-up|3|||
125324584|NCT04672239|450821521|FG000|Week 2 Survey|Failed survey check items|1|||
125324585|NCT04672239|450821522|FG001|Week 2 Survey|Failed survey check items|2|||
125324586|NCT04672239|450821523|FG002|Week 2 Survey|Failed survey check items|3|||
125324587|NCT04672239|450821521|FG000|Week 2 Survey|Partially completed survey|7|||
125324588|NCT04672239|450821522|FG001|Week 2 Survey|Partially completed survey|1|||
125324589|NCT04672239|450821523|FG002|Week 2 Survey|Partially completed survey|4|||
125324590|NCT04672239|450821521|FG000|Week 2 Survey|Withdrawal by Subject|0|||
125324591|NCT04672239|450821522|FG001|Week 2 Survey|Withdrawal by Subject|1|||
125324592|NCT04672239|450821523|FG002|Week 2 Survey|Withdrawal by Subject|0|||
125324593|NCT04672239|450821521|FG000|Week 2 Survey|Lost to Follow-up|3|||
125324594|NCT04672239|450821522|FG001|Week 2 Survey|Lost to Follow-up|2|||
124995879|NCT00307125|449611417|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
124995880|NCT00307125|449611415|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
124995881|NCT00307125|449611416|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
124995882|NCT00307125|449611417|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
124995883|NCT00307125|449611415|FG000|Screening Phase|Moved or transferred facilities|34|||
124995884|NCT00307125|449611416|FG001|Screening Phase|Moved or transferred facilities|0|||
124995885|NCT00307125|449611417|FG002|Screening Phase|Moved or transferred facilities|0|||
124995886|NCT00307125|449611415|FG000|Screening Phase|Received Pancreas Transplant|8|||
124995887|NCT00307125|449611416|FG001|Screening Phase|Received Pancreas Transplant|0|||
124995888|NCT00307125|449611417|FG002|Screening Phase|Received Pancreas Transplant|0|||
124995889|NCT00307125|449611415|FG000|Screening Phase|Ineligible for pilot|4|||
124995890|NCT00307125|449611416|FG001|Screening Phase|Ineligible for pilot|0|||
124995891|NCT00307125|449611417|FG002|Screening Phase|Ineligible for pilot|0|||
124995892|NCT00307125|449611415|FG000|Screening Phase|Try to get pregnant|1|||
124995893|NCT00307125|449611416|FG001|Screening Phase|Try to get pregnant|0|||
124995894|NCT00307125|449611417|FG002|Screening Phase|Try to get pregnant|0|||
124995895|NCT00307125|449611415|FG000|Screening Phase|Developed acute leukemia|1|||
124995896|NCT00307125|449611416|FG001|Screening Phase|Developed acute leukemia|0|||
124995897|NCT00307125|449611417|FG002|Screening Phase|Developed acute leukemia|0|||
124995898|NCT00307125|449611415|FG000|Screening Phase|Metastatic colon cancer|1|||
124995899|NCT00307125|449611416|FG001|Screening Phase|Metastatic colon cancer|0|||
124995900|NCT00307125|449611417|FG002|Screening Phase|Metastatic colon cancer|0|||
124995901|NCT00307125|449611415|FG000|Screening Phase|Malignancy|1|||
124995902|NCT00307125|449611416|FG001|Screening Phase|Malignancy|0|||
124995903|NCT00307125|449611417|FG002|Screening Phase|Malignancy|0|||
124995904|NCT00307125|449611415|FG000|Screening Phase|PAK|1|||
124995905|NCT00307125|449611416|FG001|Screening Phase|PAK|0|||
124995906|NCT00307125|449611417|FG002|Screening Phase|PAK|0|||
124995907|NCT00307125|449611415|FG000|Screening Phase|Ineligible|1|||
124995908|NCT00307125|449611416|FG001|Screening Phase|Ineligible|0|||
124995909|NCT00307125|449611417|FG002|Screening Phase|Ineligible|0|||
124995910|NCT00307125|449611415|FG000|Screening Phase|Screen Error|1|||
124995911|NCT00307125|449611416|FG001|Screening Phase|Screen Error|0|||
124995912|NCT00307125|449611417|FG002|Screening Phase|Screen Error|0|||
124995913|NCT00307125|449611415|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
124995914|NCT00307125|449611416|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
124995915|NCT00307125|449611417|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
124995916|NCT00307125|449611415|FG000|Screening Phase|AMR and treated with rituximab|1|||
124995917|NCT00307125|449611416|FG001|Screening Phase|AMR and treated with rituximab|0|||
124995918|NCT00307125|449611417|FG002|Screening Phase|AMR and treated with rituximab|0|||
124995919|NCT00307125|449611415|FG000|Screening Phase|Coronary artery bypass|1|||
124995920|NCT00307125|449611416|FG001|Screening Phase|Coronary artery bypass|0|||
124995921|NCT00307125|449611417|FG002|Screening Phase|Coronary artery bypass|0|||
124995922|NCT00307125|449611415|FG000|Pilot Phase|Lost to Follow-up|0|||
124995923|NCT00307125|449611416|FG001|Pilot Phase|Lost to Follow-up|1|||
124995924|NCT00307125|449611417|FG002|Pilot Phase|Lost to Follow-up|0|||
124995925|NCT00307125|449611415|FG000|Pilot Phase|Withdrawal by Subject|0|||
124995926|NCT00307125|449611416|FG001|Pilot Phase|Withdrawal by Subject|1|||
124995927|NCT00307125|449611417|FG002|Pilot Phase|Withdrawal by Subject|1|||
124995928|NCT00051363|449611418|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
124995929|NCT00051363|449611419|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
125324595|NCT04672239|450821523|FG002|Week 2 Survey|Lost to Follow-up|5|||
124995930|NCT00051363|449611418|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
124995931|NCT00051363|449611419|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
125324596|NCT04672239|450821521|FG000|Week 6 Survey|Failed survey check items|2|||
125324597|NCT04672239|450821522|FG001|Week 6 Survey|Failed survey check items|2|||
124995932|NCT00051363|449611418|FG000|Overall Study|Death|2|||
124995933|NCT00051363|449611419|FG001|Overall Study|Death|2|||
124995934|NCT00051363|449611418|FG000|Overall Study|Excluded Pre-Randomization|2|||
125324598|NCT04672239|450821523|FG002|Week 6 Survey|Failed survey check items|2|||
125324599|NCT04672239|450821521|FG000|Week 6 Survey|Partially completed survey|3|||
125324600|NCT04672239|450821522|FG001|Week 6 Survey|Partially completed survey|3|||
125324601|NCT04672239|450821523|FG002|Week 6 Survey|Partially completed survey|2|||
125324602|NCT04672239|450821521|FG000|Week 6 Survey|Withdrawal by Subject|1|||
125324603|NCT04672239|450821522|FG001|Week 6 Survey|Withdrawal by Subject|1|||
125324604|NCT04672239|450821523|FG002|Week 6 Survey|Withdrawal by Subject|1|||
125324605|NCT04672239|450821521|FG000|Week 6 Survey|Withdrawn by PI|0|||
125324606|NCT04672239|450821522|FG001|Week 6 Survey|Withdrawn by PI|1|||
125324607|NCT04672239|450821523|FG002|Week 6 Survey|Withdrawn by PI|0|||
125324608|NCT04672239|450821521|FG000|Week 6 Survey|Lost to Follow-up|12|||
125324609|NCT04672239|450821522|FG001|Week 6 Survey|Lost to Follow-up|2|||
125324610|NCT04672239|450821523|FG002|Week 6 Survey|Lost to Follow-up|5|||
125324611|NCT04672239|450821521|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
125324612|NCT04672239|450821522|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
125324613|NCT04672239|450821523|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
125324614|NCT04672239|450821521|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
125324615|NCT04672239|450821522|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
125324616|NCT04672239|450821523|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
125324617|NCT04672239|450821521|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
125324618|NCT04672239|450821522|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
125324619|NCT04672239|450821523|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
125324620|NCT04672239|450821521|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
125324621|NCT04672239|450821522|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
125324622|NCT04672239|450821523|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
125324623|NCT04672239|450821521|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
125324624|NCT04672239|450821522|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
125324625|NCT04672239|450821523|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
125324626|NCT04672239|450821521|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
125324627|NCT04672239|450821522|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
125324628|NCT04672239|450821523|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
125324629|NCT04672239|450821521|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
125324630|NCT04672239|450821522|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
125324631|NCT04672239|450821523|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
125324632|NCT05408429|450821529|FG000|Overall Study|Lost to Follow-up|1|||
125324633|NCT05408429|450821530|FG001|Overall Study|Lost to Follow-up|1|||
125324634|NCT05408429|450821531|FG002|Overall Study|Lost to Follow-up|0|||
125324635|NCT05408429|450821529|FG000|Overall Study|Withdrawal by Subject|5|||
125324636|NCT05408429|450821530|FG001|Overall Study|Withdrawal by Subject|0|||
125324637|NCT05408429|450821531|FG002|Overall Study|Withdrawal by Subject|1|||
125324638|NCT01074970|450821533|FG000|Overall Study|Never Treated|0|||
125324639|NCT01074970|450821534|FG001|Overall Study|Never Treated|0|||
125324640|NCT01074970|450821535|FG002|Overall Study|Never Treated|8|||
125324641|NCT01074970|450821536|FG003|Overall Study|Never Treated|1|||
125324642|NCT01074970|450821533|FG000|Overall Study|Adverse Event|1|||
125324643|NCT01074970|450821534|FG001|Overall Study|Adverse Event|0|||
125324644|NCT01074970|450821535|FG002|Overall Study|Adverse Event|4|||
125324645|NCT01074970|450821536|FG003|Overall Study|Adverse Event|3|||
125324646|NCT01074970|450821533|FG000|Overall Study|Disease progression during treatment|3|||
125324647|NCT01074970|450821534|FG001|Overall Study|Disease progression during treatment|1|||
125324648|NCT01074970|450821535|FG002|Overall Study|Disease progression during treatment|2|||
125324649|NCT01074970|450821536|FG003|Overall Study|Disease progression during treatment|9|||
125324650|NCT01074970|450821533|FG000|Overall Study|Lost to Follow-up|0|||
125324651|NCT01074970|450821534|FG001|Overall Study|Lost to Follow-up|0|||
125324652|NCT01074970|450821535|FG002|Overall Study|Lost to Follow-up|1|||
125324653|NCT01074970|450821536|FG003|Overall Study|Lost to Follow-up|0|||
125324654|NCT01074970|450821533|FG000|Overall Study|Withdrawal by Subject|0|||
125324655|NCT01074970|450821534|FG001|Overall Study|Withdrawal by Subject|0|||
125324656|NCT01074970|450821535|FG002|Overall Study|Withdrawal by Subject|6|||
125324657|NCT01074970|450821536|FG003|Overall Study|Withdrawal by Subject|4|||
125324658|NCT05565742|450821541|FG000|Overall Study|Withdrawal by Subject|0|||
125324659|NCT05565742|450821542|FG001|Overall Study|Withdrawal by Subject|0|||
125324660|NCT05565742|450821543|FG002|Overall Study|Withdrawal by Subject|2|||
125324661|NCT05565742|450821544|FG003|Overall Study|Withdrawal by Subject|2|||
125324662|NCT05565742|450821545|FG004|Overall Study|Withdrawal by Subject|2|||
125324663|NCT05565742|450821541|FG000|Overall Study|Death|1|||
125324664|NCT05565742|450821542|FG001|Overall Study|Death|0|||
125324665|NCT05565742|450821543|FG002|Overall Study|Death|0|||
125324666|NCT05565742|450821544|FG003|Overall Study|Death|0|||
125324667|NCT05565742|450821545|FG004|Overall Study|Death|0|||
125324668|NCT05565742|450821541|FG000|Overall Study|Participant Travelled Abroad|0|||
125324669|NCT05565742|450821542|FG001|Overall Study|Participant Travelled Abroad|0|||
125324670|NCT05565742|450821543|FG002|Overall Study|Participant Travelled Abroad|0|||
125324671|NCT05565742|450821544|FG003|Overall Study|Participant Travelled Abroad|0|||
125324672|NCT05565742|450821545|FG004|Overall Study|Participant Travelled Abroad|1|||
125324673|NCT02855125|450821546|FG000|Overall Study|Withdrawal by Subject|2|||
125324674|NCT02855125|450821547|FG001|Overall Study|Withdrawal by Subject|2|||
125324675|NCT02855125|450821546|FG000|Overall Study|Clinical Disease Progression|5|||
125324676|NCT02855125|450821547|FG001|Overall Study|Clinical Disease Progression|4|||
125324677|NCT02855125|450821546|FG000|Overall Study|Radiologic Disease Progression|36|||
125324678|NCT02855125|450821547|FG001|Overall Study|Radiologic Disease Progression|39|||
125324679|NCT02855125|450821546|FG000|Overall Study|Adverse Event|11|||
125324680|NCT02855125|450821547|FG001|Overall Study|Adverse Event|7|||
124995935|NCT00051363|449611419|FG001|Overall Study|Excluded Pre-Randomization|5|||
124995936|NCT00985153|449611420|FG000|Overall Study|Lost to Follow-up|16|||
125324681|NCT02855125|450821546|FG000|Overall Study|Physician Decision|1|||
125324682|NCT02855125|450821547|FG001|Overall Study|Physician Decision|0|||
125324683|NCT02855125|450821546|FG000|Overall Study|On Treatment|9|||
125324684|NCT02855125|450821547|FG001|Overall Study|On Treatment|11|||
125324685|NCT02855125|450821546|FG000|Overall Study|Randomized but not treated|0|||
125324686|NCT02855125|450821547|FG001|Overall Study|Randomized but not treated|1|||
125324687|NCT04467905|450821548|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
125324688|NCT04467905|450821549|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
125324689|NCT04467905|450821550|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
125324690|NCT04467905|450821548|FG000|Overall Study|Conversion to SR|0|||
125324691|NCT04467905|450821549|FG001|Overall Study|Conversion to SR|0|||
125324692|NCT04467905|450821550|FG002|Overall Study|Conversion to SR|3|||
125324693|NCT04467905|450821548|FG000|Overall Study|Technical issue with Holter ECG|0|||
125324694|NCT04467905|450821549|FG001|Overall Study|Technical issue with Holter ECG|0|||
125324695|NCT04467905|450821550|FG002|Overall Study|Technical issue with Holter ECG|3|||
125324696|NCT04467905|450821548|FG000|Overall Study|Hemodynamic instability|0|||
125324697|NCT04467905|450821549|FG001|Overall Study|Hemodynamic instability|0|||
125324698|NCT04467905|450821550|FG002|Overall Study|Hemodynamic instability|1|||
125324699|NCT04467905|450821548|FG000|Overall Study|Site misinterpretation of protocol|0|||
125324700|NCT04467905|450821549|FG001|Overall Study|Site misinterpretation of protocol|0|||
125324701|NCT04467905|450821550|FG002|Overall Study|Site misinterpretation of protocol|1|||
125324702|NCT02419001|450822568|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
125324703|NCT02419001|450822569|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
125324704|NCT00744497|450822570|FG000|Overall Study|Withdrawal by Subject|21|||
125324705|NCT00744497|450822571|FG001|Overall Study|Withdrawal by Subject|18|||
125324706|NCT00744497|450822570|FG000|Overall Study|Death|11|||
125324707|NCT00744497|450822571|FG001|Overall Study|Death|9|||
125324708|NCT00744497|450822570|FG000|Overall Study|Lost to Follow-up|4|||
125324709|NCT00744497|450822571|FG001|Overall Study|Lost to Follow-up|2|||
125324710|NCT00744497|450822570|FG000|Overall Study|Poor compliance/noncompliance|9|||
125324711|NCT00744497|450822571|FG001|Overall Study|Poor compliance/noncompliance|5|||
125324712|NCT00744497|450822570|FG000|Overall Study|No longer meets study criteria|7|||
125324713|NCT00744497|450822571|FG001|Overall Study|No longer meets study criteria|3|||
125324714|NCT00744497|450822570|FG000|Overall Study|Administrative Reason By Sponsor|25|||
125324715|NCT00744497|450822571|FG001|Overall Study|Administrative Reason By Sponsor|8|||
125324716|NCT00744497|450822570|FG000|Overall Study|Disease progression|312|||
125324717|NCT00744497|450822571|FG001|Overall Study|Disease progression|219|||
125324718|NCT00744497|450822570|FG000|Overall Study|Study drug toxicity|68|||
125324719|NCT00744497|450822571|FG001|Overall Study|Study drug toxicity|141|||
125324720|NCT00744497|450822570|FG000|Overall Study|Adverse event unrelated to study drug|78|||
125324721|NCT00744497|450822571|FG001|Overall Study|Adverse event unrelated to study drug|122|||
125324722|NCT00744497|450822570|FG000|Overall Study|Patient requested to stop study drug|65|||
125324723|NCT00744497|450822571|FG001|Overall Study|Patient requested to stop study drug|80|||
125324724|NCT00744497|450822570|FG000|Overall Study|Maximum clinical benefit|141|||
124995937|NCT00985153|449611421|FG001|Overall Study|Lost to Follow-up|19|||
124995938|NCT00985153|449611422|FG002|Overall Study|Lost to Follow-up|17|||
124995939|NCT00985153|449611423|FG003|Overall Study|Lost to Follow-up|20|||
124995940|NCT00985153|449611420|FG000|Overall Study|Protocol Violation|3|||
124995941|NCT00985153|449611421|FG001|Overall Study|Protocol Violation|2|||
124995942|NCT00985153|449611422|FG002|Overall Study|Protocol Violation|4|||
124995943|NCT00985153|449611423|FG003|Overall Study|Protocol Violation|3|||
124995944|NCT00985153|449611420|FG000|Overall Study|Withdrawal by Subject|6|||
124995945|NCT00985153|449611421|FG001|Overall Study|Withdrawal by Subject|11|||
124995946|NCT00985153|449611422|FG002|Overall Study|Withdrawal by Subject|11|||
124995947|NCT00985153|449611423|FG003|Overall Study|Withdrawal by Subject|10|||
124995948|NCT00985153|449611420|FG000|Overall Study|Missed One or More Bleeds|7|||
124995949|NCT00985153|449611421|FG001|Overall Study|Missed One or More Bleeds|7|||
124995950|NCT00985153|449611422|FG002|Overall Study|Missed One or More Bleeds|8|||
124995951|NCT00985153|449611423|FG003|Overall Study|Missed One or More Bleeds|10|||
125324725|NCT00744497|450822571|FG001|Overall Study|Maximum clinical benefit|142|||
125324726|NCT00744497|450822570|FG000|Overall Study|Not defined|19|||
125324727|NCT00744497|450822571|FG001|Overall Study|Not defined|13|||
125324728|NCT03819114|450822574|FG000|Overall Study|Protocol Violation|0|||
125324729|NCT03819114|450822575|FG001|Overall Study|Protocol Violation|1|||
125324730|NCT03819114|450822576|FG002|Overall Study|Protocol Violation|1|||
125324731|NCT03819114|450822577|FG003|Overall Study|Protocol Violation|0|||
125324732|NCT03819114|450822574|FG000|Overall Study|Lost to Follow-up|0|||
125324733|NCT03819114|450822575|FG001|Overall Study|Lost to Follow-up|0|||
125324734|NCT03819114|450822576|FG002|Overall Study|Lost to Follow-up|1|||
125324735|NCT03819114|450822577|FG003|Overall Study|Lost to Follow-up|0|||
125324736|NCT02379728|450822578|FG000|Overall Study|Lost to Follow-up|1|||
125324737|NCT02379728|450822579|FG001|Overall Study|Lost to Follow-up|0|||
125324738|NCT02379728|450822580|FG002|Overall Study|Lost to Follow-up|3|||
125324739|NCT02379728|450822581|FG003|Overall Study|Lost to Follow-up|0|||
125324740|NCT02379728|450822578|FG000|Overall Study|Withdrawal by Subject|5|||
125324741|NCT02379728|450822579|FG001|Overall Study|Withdrawal by Subject|0|||
125324742|NCT02379728|450822580|FG002|Overall Study|Withdrawal by Subject|5|||
125324743|NCT02379728|450822581|FG003|Overall Study|Withdrawal by Subject|3|||
125324744|NCT02379728|450822578|FG000|Overall Study|Protocol Violation|0|||
125324745|NCT02379728|450822579|FG001|Overall Study|Protocol Violation|0|||
125324746|NCT02379728|450822580|FG002|Overall Study|Protocol Violation|2|||
125324747|NCT02379728|450822581|FG003|Overall Study|Protocol Violation|0|||
125324748|NCT05101122|450822585|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
125324749|NCT05101122|450822585|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
125324750|NCT05101122|450822585|FG000|AD313 80/5|Withdrawal by Subject|1|||
125324751|NCT05101122|450822585|FG000|AD313 80/10|Physician Decision|1|||
125324752|NCT03131219|450822586|FG000|Initial Evaluation Period|Adverse Event|2|||
125324753|NCT03131219|450822587|FG001|Initial Evaluation Period|Adverse Event|0|||
125324754|NCT03131219|450822586|FG000|Initial Evaluation Period|Protocol Violation|1|||
125324755|NCT03131219|450822587|FG001|Initial Evaluation Period|Protocol Violation|0|||
125324756|NCT03131219|450822586|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
125324757|NCT03131219|450822587|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
125324758|NCT03131219|450822586|FG000|Initial Evaluation Period|Physician Decision|1|||
125324759|NCT03131219|450822587|FG001|Initial Evaluation Period|Physician Decision|0|||
125324760|NCT03131219|450822586|FG000|Extension Period|Physician Decision|1|||
125324761|NCT03131219|450822587|FG001|Extension Period|Physician Decision|0|||
125324762|NCT04945733|450822590|FG000|Overall Study|Physician Decision|1|||
125324763|NCT04945733|450822591|FG001|Overall Study|Physician Decision|3|||
125324764|NCT04945733|450822592|FG002|Overall Study|Physician Decision|0|||
125324765|NCT04945733|450822590|FG000|Overall Study|Withdrawal by Subject|3|||
124995952|NCT00985153|449611420|FG000|Overall Study|Incomplete Safety Follow-up|3|||
124995953|NCT00985153|449611421|FG001|Overall Study|Incomplete Safety Follow-up|5|||
124995954|NCT00985153|449611422|FG002|Overall Study|Incomplete Safety Follow-up|4|||
124995955|NCT00985153|449611423|FG003|Overall Study|Incomplete Safety Follow-up|4|||
124995956|NCT01596621|449611425|FG000|Overall Study|Death|4|||
124995957|NCT01596621|449611425|FG000|Overall Study|Withdrawal by Subject|9|||
124995958|NCT01596621|449611425|FG000|Overall Study|Disease Progression|49|||
124995959|NCT01596621|449611425|FG000|Overall Study|Lost to Follow-up|3|||
124995960|NCT01596621|449611425|FG000|Overall Study|Other than specified|13|||
124995961|NCT02678247|449611430|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
124995962|NCT02678247|449611431|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
124995963|NCT02678247|449611430|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
124995964|NCT02678247|449611431|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
124995965|NCT02678247|449611430|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
124995966|NCT02678247|449611431|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
124995967|NCT02678247|449611430|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
124995968|NCT02678247|449611431|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
124995969|NCT02678247|449611430|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
124995970|NCT02678247|449611431|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
124995971|NCT02678247|449611430|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
124995972|NCT02678247|449611431|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
124995973|NCT00971243|449611434|FG000|Double Blind Period|Adverse Event|2|||
124995974|NCT00971243|449611435|FG001|Double Blind Period|Adverse Event|3|||
124995975|NCT00971243|449611436|FG002|Double Blind Period|Adverse Event|2|||
124995976|NCT00971243|449611437|FG003|Double Blind Period|Adverse Event|2|||
124995977|NCT00971243|449611438|FG004|Double Blind Period|Adverse Event|3|||
124995978|NCT00971243|449611434|FG000|Double Blind Period|Lost to Follow-up|0|||
124995979|NCT00971243|449611435|FG001|Double Blind Period|Lost to Follow-up|1|||
124995980|NCT00971243|449611436|FG002|Double Blind Period|Lost to Follow-up|1|||
124995981|NCT00971243|449611437|FG003|Double Blind Period|Lost to Follow-up|0|||
124995982|NCT00971243|449611438|FG004|Double Blind Period|Lost to Follow-up|1|||
124995983|NCT00971243|449611434|FG000|Double Blind Period|Physician Decision|10|||
124995984|NCT00971243|449611435|FG001|Double Blind Period|Physician Decision|6|||
125324766|NCT04945733|450822591|FG001|Overall Study|Withdrawal by Subject|3|||
125324767|NCT04945733|450822592|FG002|Overall Study|Withdrawal by Subject|0|||
125324768|NCT01709721|450822595|FG000|Open Label Phase|Withdrawal by Subject|0|||
125324769|NCT01709721|450822596|FG001|Open Label Phase|Withdrawal by Subject|0|||
125324770|NCT01709721|450822597|FG002|Open Label Phase|Withdrawal by Subject|5|||
124995985|NCT00971243|449611436|FG002|Double Blind Period|Physician Decision|7|||
125324771|NCT01709721|450822595|FG000|Open Label Phase|Adverse Event|0|||
124995986|NCT00971243|449611437|FG003|Double Blind Period|Physician Decision|6|||
124995987|NCT00971243|449611438|FG004|Double Blind Period|Physician Decision|7|||
124995988|NCT00971243|449611434|FG000|Double Blind Period|Protocol Violation|2|||
124995989|NCT00971243|449611435|FG001|Double Blind Period|Protocol Violation|0|||
125324772|NCT01709721|450822596|FG001|Open Label Phase|Adverse Event|0|||
125324773|NCT01709721|450822597|FG002|Open Label Phase|Adverse Event|8|||
125324774|NCT01709721|450822595|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
125324775|NCT01709721|450822596|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
125324776|NCT01709721|450822597|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
125324777|NCT01709721|450822595|FG000|Open Label Phase|Investigator Decision|0|||
125324778|NCT01709721|450822596|FG001|Open Label Phase|Investigator Decision|0|||
125324779|NCT01709721|450822597|FG002|Open Label Phase|Investigator Decision|1|||
125324780|NCT01709721|450822595|FG000|Open Label Phase|Sponsor Decision|0|||
125324781|NCT01709721|450822596|FG001|Open Label Phase|Sponsor Decision|0|||
125324782|NCT01709721|450822597|FG002|Open Label Phase|Sponsor Decision|2|||
125324783|NCT01709721|450822595|FG000|Open Label Phase|Protocol Violation|0|||
125324784|NCT01709721|450822596|FG001|Open Label Phase|Protocol Violation|0|||
125324785|NCT01709721|450822597|FG002|Open Label Phase|Protocol Violation|1|||
125324786|NCT01709721|450822595|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
125324787|NCT01709721|450822596|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
125324788|NCT01709721|450822597|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
125324789|NCT01709721|450822595|FG000|Open Label Phase|Inadequate Pain Control|0|||
125324790|NCT01709721|450822596|FG001|Open Label Phase|Inadequate Pain Control|0|||
125324791|NCT01709721|450822597|FG002|Open Label Phase|Inadequate Pain Control|37|||
125324792|NCT01709721|450822595|FG000|Open Label Phase|Other, Specify in text field in database|0|||
125324793|NCT01709721|450822596|FG001|Open Label Phase|Other, Specify in text field in database|0|||
125324794|NCT01709721|450822597|FG002|Open Label Phase|Other, Specify in text field in database|14|||
125324795|NCT01709721|450822595|FG000|Randomized Phase|Adverse Event|0|||
125324796|NCT01709721|450822596|FG001|Randomized Phase|Adverse Event|1|||
125324797|NCT01709721|450822597|FG002|Randomized Phase|Adverse Event|0|||
125324798|NCT01709721|450822595|FG000|Randomized Phase|Lost to Follow-up|1|||
125324799|NCT01709721|450822596|FG001|Randomized Phase|Lost to Follow-up|0|||
125324800|NCT01709721|450822597|FG002|Randomized Phase|Lost to Follow-up|0|||
125324801|NCT01709721|450822595|FG000|Randomized Phase|Inadequate Pain Control|1|||
125324802|NCT01709721|450822596|FG001|Randomized Phase|Inadequate Pain Control|2|||
125324803|NCT01709721|450822597|FG002|Randomized Phase|Inadequate Pain Control|0|||
125324804|NCT01709721|450822595|FG000|Randomized Phase|Other, Specify text field in database|1|||
125324805|NCT01709721|450822596|FG001|Randomized Phase|Other, Specify text field in database|3|||
125324806|NCT01709721|450822597|FG002|Randomized Phase|Other, Specify text field in database|0|||
125324807|NCT00763035|450822598|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
125324808|NCT00763035|450822599|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
125324809|NCT00763035|450822598|FG000|First Intervention|Adverse Event|0|||
125324810|NCT00763035|450822599|FG001|First Intervention|Adverse Event|1|||
125324811|NCT00763035|450822598|FG000|Second Intervention|Adverse Event|1|||
125324812|NCT00763035|450822599|FG001|Second Intervention|Adverse Event|0|||
125324813|NCT00763035|450822598|FG000|Second Intervention|Physician Decision|2|||
125324814|NCT00763035|450822599|FG001|Second Intervention|Physician Decision|0|||
125324815|NCT02131259|450822600|FG000|Overall Study|Progressive disease|751|||
125324816|NCT02131259|450822600|FG000|Overall Study|Adverse Event|341|||
125324817|NCT02131259|450822600|FG000|Overall Study|Lost to Follow-up|7|||
125324818|NCT02131259|450822600|FG000|Overall Study|Relocation|32|||
125324819|NCT02131259|450822600|FG000|Overall Study|Other|63|||
125324820|NCT02131259|450822600|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
125324821|NCT02131259|450822600|FG000|Overall Study|Progressive disease/relocation|1|||
125324822|NCT02131259|450822600|FG000|Overall Study|Progressive disease/other|2|||
125324823|NCT02131259|450822600|FG000|Overall Study|AE/lost to follow-up|1|||
125324824|NCT02131259|450822600|FG000|Overall Study|AE/other|1|||
125324825|NCT02131259|450822600|FG000|Overall Study|Progressive disease/AE/other|1|||
124995990|NCT00971243|449611436|FG002|Double Blind Period|Protocol Violation|3|||
124995991|NCT00971243|449611437|FG003|Double Blind Period|Protocol Violation|2|||
124995992|NCT00971243|449611438|FG004|Double Blind Period|Protocol Violation|2|||
124995993|NCT00971243|449611434|FG000|Double Blind Period|Withdrawal by Subject|4|||
124995994|NCT00971243|449611435|FG001|Double Blind Period|Withdrawal by Subject|1|||
124995995|NCT00971243|449611436|FG002|Double Blind Period|Withdrawal by Subject|4|||
124995996|NCT00971243|449611437|FG003|Double Blind Period|Withdrawal by Subject|4|||
124995997|NCT00971243|449611438|FG004|Double Blind Period|Withdrawal by Subject|4|||
124995998|NCT00971243|449611434|FG000|Double Blind Period|Other reasons|1|||
124995999|NCT00971243|449611435|FG001|Double Blind Period|Other reasons|0|||
125324826|NCT02131259|450822600|FG000|Overall Study|Missing|3|||
125324827|NCT03219723|450822601|FG000|Overall Study|Case Report Forms Uncollected|6|||
125324828|NCT03219723|450822601|FG000|Overall Study|Protocol Deviation|4|||
125324829|NCT03137381|450822602|FG000|Overall Study|Adverse Event|3|||
125324830|NCT03137381|450822603|FG001|Overall Study|Adverse Event|0|||
124996000|NCT00971243|449611436|FG002|Double Blind Period|Other reasons|2|||
125324831|NCT03137381|450822604|FG002|Overall Study|Adverse Event|2|||
125324832|NCT03137381|450822605|FG003|Overall Study|Adverse Event|0|||
125324833|NCT03137381|450822602|FG000|Overall Study|Lost to Follow-up|2|||
125324834|NCT03137381|450822603|FG001|Overall Study|Lost to Follow-up|1|||
125324835|NCT03137381|450822604|FG002|Overall Study|Lost to Follow-up|1|||
125324836|NCT03137381|450822605|FG003|Overall Study|Lost to Follow-up|0|||
125324837|NCT03137381|450822602|FG000|Overall Study|Protocol deviation|1|||
125324838|NCT03137381|450822603|FG001|Overall Study|Protocol deviation|1|||
125324839|NCT03137381|450822604|FG002|Overall Study|Protocol deviation|0|||
125324840|NCT03137381|450822605|FG003|Overall Study|Protocol deviation|1|||
125324841|NCT03137381|450822602|FG000|Overall Study|Withdrawal by Investigator|0|||
125324842|NCT03137381|450822603|FG001|Overall Study|Withdrawal by Investigator|1|||
125324843|NCT03137381|450822604|FG002|Overall Study|Withdrawal by Investigator|1|||
125324844|NCT03137381|450822605|FG003|Overall Study|Withdrawal by Investigator|0|||
125324845|NCT03137381|450822602|FG000|Overall Study|Withdrawal by Subject|3|||
125324846|NCT03137381|450822603|FG001|Overall Study|Withdrawal by Subject|4|||
125324847|NCT03137381|450822604|FG002|Overall Study|Withdrawal by Subject|3|||
125324848|NCT03137381|450822605|FG003|Overall Study|Withdrawal by Subject|0|||
125324849|NCT03137381|450822602|FG000|Overall Study|Pregnancy|0|||
125324850|NCT03137381|450822603|FG001|Overall Study|Pregnancy|0|||
125324851|NCT03137381|450822604|FG002|Overall Study|Pregnancy|1|||
125324852|NCT03137381|450822605|FG003|Overall Study|Pregnancy|0|||
125324853|NCT00459316|450822610|FG000|Steps 1 & 2|Other eligibility failure|1|||
125324854|NCT00459316|450822611|FG001|Steps 1 & 2|Other eligibility failure|1|||
125324855|NCT00459316|450822612|FG002|Steps 1 & 2|Other eligibility failure|0|||
125324856|NCT00459316|450822610|FG000|Steps 1 & 2|Death|1|||
125324857|NCT00459316|450822611|FG001|Steps 1 & 2|Death|1|||
125324858|NCT00459316|450822612|FG002|Steps 1 & 2|Death|0|||
125324859|NCT00459316|450822610|FG000|Steps 1 & 2|Not able to get to clinic|7|||
125324860|NCT00459316|450822611|FG001|Steps 1 & 2|Not able to get to clinic|4|||
125324861|NCT00459316|450822612|FG002|Steps 1 & 2|Not able to get to clinic|0|||
125324862|NCT00459316|450822610|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
125324863|NCT00459316|450822611|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
125324864|NCT00459316|450822612|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
125324865|NCT00459316|450822610|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
125324866|NCT00459316|450822611|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
125324867|NCT00459316|450822612|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
125324868|NCT00459316|450822610|FG000|Steps 1 & 2|Lost to Follow-up|5|||
125324869|NCT00459316|450822611|FG001|Steps 1 & 2|Lost to Follow-up|0|||
125324870|NCT00459316|450822612|FG002|Steps 1 & 2|Lost to Follow-up|2|||
125324871|NCT00459316|450822610|FG000|Step 3|Withdrawal by Subject|3|||
125324872|NCT00459316|450822611|FG001|Step 3|Withdrawal by Subject|0|||
125324873|NCT00459316|450822612|FG002|Step 3|Withdrawal by Subject|1|||
124996001|NCT00971243|449611437|FG003|Double Blind Period|Other reasons|0|||
124996002|NCT00971243|449611438|FG004|Double Blind Period|Other reasons|1|||
124996003|NCT00971243|449611434|FG000|Open-label Period|Adverse Event|1|||
124996004|NCT00971243|449611435|FG001|Open-label Period|Adverse Event|0|||
124996005|NCT00971243|449611436|FG002|Open-label Period|Adverse Event|1|||
124996006|NCT00971243|449611437|FG003|Open-label Period|Adverse Event|1|||
124996007|NCT00971243|449611438|FG004|Open-label Period|Adverse Event|0|||
124996008|NCT00971243|449611434|FG000|Open-label Period|Physician Decision|5|||
124996009|NCT00971243|449611435|FG001|Open-label Period|Physician Decision|9|||
124996010|NCT00971243|449611436|FG002|Open-label Period|Physician Decision|3|||
124996011|NCT00971243|449611437|FG003|Open-label Period|Physician Decision|7|||
124996012|NCT00971243|449611438|FG004|Open-label Period|Physician Decision|2|||
124996013|NCT00971243|449611434|FG000|Open-label Period|Protocol Violation|1|||
124996014|NCT00971243|449611435|FG001|Open-label Period|Protocol Violation|1|||
124996015|NCT00971243|449611436|FG002|Open-label Period|Protocol Violation|1|||
124996016|NCT00971243|449611437|FG003|Open-label Period|Protocol Violation|0|||
124996017|NCT00971243|449611438|FG004|Open-label Period|Protocol Violation|1|||
124996018|NCT00971243|449611434|FG000|Open-label Period|Withdrawal by Subject|1|||
124996019|NCT00971243|449611435|FG001|Open-label Period|Withdrawal by Subject|0|||
124996020|NCT00971243|449611436|FG002|Open-label Period|Withdrawal by Subject|0|||
124996021|NCT00971243|449611437|FG003|Open-label Period|Withdrawal by Subject|2|||
124996022|NCT00971243|449611438|FG004|Open-label Period|Withdrawal by Subject|1|||
125324874|NCT01980017|450822613|FG000|Overall Study|Lost to Follow-up|30|||
125324875|NCT01980017|450822614|FG001|Overall Study|Lost to Follow-up|21|||
125324876|NCT01980017|450822613|FG000|Overall Study|Death|0|||
125324877|NCT01980017|450822614|FG001|Overall Study|Death|1|||
125324878|NCT03044106|450822615|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
125324879|NCT03044106|450822616|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
125324880|NCT02057250|450822617|FG000|AID Assessment Phase|Adverse Event|3|||
125324881|NCT02057250|450822618|FG001|AID Assessment Phase|Adverse Event|2|||
125324882|NCT02057250|450822619|FG002|AID Assessment Phase|Adverse Event|6|||
124996023|NCT00971243|449611434|FG000|Open-label Period|Other reason|0|||
124996024|NCT00971243|449611435|FG001|Open-label Period|Other reason|0|||
124996025|NCT00971243|449611436|FG002|Open-label Period|Other reason|0|||
125324883|NCT02057250|450822620|FG003|AID Assessment Phase|Adverse Event|1|||
125324884|NCT02057250|450822621|FG004|AID Assessment Phase|Adverse Event|0|||
125324885|NCT02057250|450822617|FG000|AID Assessment Phase|Other than specified above|1|||
125324886|NCT02057250|450822618|FG001|AID Assessment Phase|Other than specified above|1|||
125324887|NCT02057250|450822619|FG002|AID Assessment Phase|Other than specified above|1|||
125324888|NCT02057250|450822620|FG003|AID Assessment Phase|Other than specified above|1|||
125324889|NCT02057250|450822621|FG004|AID Assessment Phase|Other than specified above|0|||
125324890|NCT02057250|450822617|FG000|Extension Phase|Adverse Event|0|||
125324891|NCT02057250|450822618|FG001|Extension Phase|Adverse Event|0|||
125324892|NCT02057250|450822619|FG002|Extension Phase|Adverse Event|0|||
125324893|NCT02057250|450822620|FG003|Extension Phase|Adverse Event|0|||
125324894|NCT02057250|450822621|FG004|Extension Phase|Adverse Event|15|||
125324895|NCT02057250|450822617|FG000|Extension Phase|Lack of Efficacy|0|||
125324896|NCT02057250|450822618|FG001|Extension Phase|Lack of Efficacy|0|||
125324897|NCT02057250|450822619|FG002|Extension Phase|Lack of Efficacy|0|||
125324898|NCT02057250|450822620|FG003|Extension Phase|Lack of Efficacy|0|||
125324899|NCT02057250|450822621|FG004|Extension Phase|Lack of Efficacy|10|||
125324900|NCT02057250|450822617|FG000|Extension Phase|Entered in this period but not treated|0|||
125324901|NCT02057250|450822618|FG001|Extension Phase|Entered in this period but not treated|0|||
124996026|NCT00971243|449611437|FG003|Open-label Period|Other reason|0|||
124996027|NCT00971243|449611438|FG004|Open-label Period|Other reason|2|||
124996028|NCT02092220|449611441|FG000|Period 1|Unrelated Illness|0|||
124996029|NCT02092220|449611442|FG001|Period 1|Unrelated Illness|2|||
124996030|NCT02092220|449611441|FG000|Period 2|Severe Hypoglycaemia|1|||
124996031|NCT02092220|449611442|FG001|Period 2|Severe Hypoglycaemia|0|||
124996032|NCT02092220|449611441|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
124996033|NCT02092220|449611442|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
124996034|NCT01231516|449611445|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
124996035|NCT01231516|449611446|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
124996036|NCT01231516|449611445|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
125324902|NCT02057250|450822619|FG002|Extension Phase|Entered in this period but not treated|0|||
125324903|NCT02057250|450822620|FG003|Extension Phase|Entered in this period but not treated|0|||
125324904|NCT02057250|450822621|FG004|Extension Phase|Entered in this period but not treated|4|||
125324905|NCT02057250|450822617|FG000|Extension Phase|Other than specified above|0|||
125324906|NCT02057250|450822618|FG001|Extension Phase|Other than specified above|0|||
125324907|NCT02057250|450822619|FG002|Extension Phase|Other than specified above|0|||
125324908|NCT02057250|450822620|FG003|Extension Phase|Other than specified above|0|||
125324909|NCT02057250|450822621|FG004|Extension Phase|Other than specified above|7|||
125324910|NCT00423579|450822625|FG000|Overall Study|Lost to Follow-up|3|||
125324911|NCT00423579|450822626|FG001|Overall Study|Lost to Follow-up|0|||
125324912|NCT00423579|450822625|FG000|Overall Study|Protocol Violation|1|||
125324913|NCT00423579|450822626|FG001|Overall Study|Protocol Violation|3|||
125324914|NCT00423579|450822625|FG000|Overall Study|Diagnosis of diabetes|0|||
125324915|NCT00423579|450822626|FG001|Overall Study|Diagnosis of diabetes|1|||
125324916|NCT02161016|450822629|FG000|Overall Study|withdrawn by IRB|1|||
125324917|NCT00003475|450822630|FG000|Overall Study|Not evaluable|13|||
125324918|NCT03675126|450822634|FG000|Overall Study|Study Terminated by Sponsor|9|||
125324919|NCT03675126|450822634|FG000|Overall Study|Death|2|||
125324920|NCT03675126|450822634|FG000|Overall Study|Withdrawal by Subject|4|||
125324921|NCT00001959|450822635|FG000|Overall Study|newly diagnosed colon cancer|1|||
125324922|NCT00001959|450822635|FG000|Overall Study|disabling sedation|1|||
125324923|NCT00001959|450822635|FG000|Overall Study|non-compliance|1|||
125324924|NCT04189952|450822640|FG000|Follow-up Period|Death|1|||
125324925|NCT04189952|450822640|FG000|Follow-up Period|Withdrawal by Subject|1|||
125324926|NCT01052493|450822641|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
125324927|NCT01052493|450822642|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
125324928|NCT01052493|450822643|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
125324929|NCT01498068|450822644|FG000|Overall Study|Withdrawal by Subject|1|||
125324930|NCT01498068|450822645|FG001|Overall Study|Withdrawal by Subject|1|||
125324931|NCT01318915|450822648|FG000|Overall Study|Lost to Follow-up|1|||
125324932|NCT00453206|450822650|FG000|Overall Study|Death|1|||
125324933|NCT05523089|450822654|FG000|Overall Study|Withdrawal by Subject|1|||
125324934|NCT05523089|450822655|FG001|Overall Study|Withdrawal by Subject|0|||
124996037|NCT01231516|449611446|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
124996038|NCT01231516|449611445|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
125324935|NCT05523089|450822656|FG002|Overall Study|Withdrawal by Subject|0|||
124996039|NCT01231516|449611446|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
124996040|NCT01231516|449611445|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
125324936|NCT05523089|450822654|FG000|Overall Study|Lost to Follow-up|1|||
125324937|NCT05523089|450822655|FG001|Overall Study|Lost to Follow-up|0|||
125324938|NCT05523089|450822656|FG002|Overall Study|Lost to Follow-up|0|||
125324939|NCT02681523|450822657|FG000|Overall Study|Adverse Event|1|||
125324940|NCT02681523|450822657|FG000|Overall Study|Patient Non-compliance|1|||
125324941|NCT01899040|450822658|FG000|Overall Study|Randomized in error|0|||
125324942|NCT01899040|450822659|FG001|Overall Study|Randomized in error|1|||
125324943|NCT01899040|450822660|FG002|Overall Study|Randomized in error|1|||
125324944|NCT01899040|450822658|FG000|Overall Study|Adverse Event|3|||
125324945|NCT01899040|450822659|FG001|Overall Study|Adverse Event|1|||
125324946|NCT01899040|450822660|FG002|Overall Study|Adverse Event|2|||
125324947|NCT01899040|450822658|FG000|Overall Study|Unspecified reasons|4|||
125324948|NCT01899040|450822659|FG001|Overall Study|Unspecified reasons|4|||
125324949|NCT01899040|450822660|FG002|Overall Study|Unspecified reasons|0|||
125324950|NCT01899040|450822658|FG000|Overall Study|Compliance issues|1|||
125324951|NCT01899040|450822659|FG001|Overall Study|Compliance issues|2|||
125324952|NCT01899040|450822660|FG002|Overall Study|Compliance issues|0|||
125324953|NCT02638220|450822666|FG000|Overall Study|Lost to Follow-up|6|||
125324954|NCT02638220|450822666|FG000|Overall Study|Withdrawal by Subject|3|||
125324955|NCT02638220|450822666|FG000|Overall Study|Physician Decision|1|||
125324956|NCT02638220|450822666|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
125324957|NCT03204188|450822667|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
125324958|NCT03204188|450822667|FG000|Immunotherapy Phase (1 Year)|Death|1|||
125324959|NCT03204188|450822667|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
125324960|NCT03204188|450822667|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
125324961|NCT01198795|450824248|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
125324962|NCT01198795|450824248|FG000|Overall Study|Withdrawal by Subject|17|||
125324963|NCT01198795|450824248|FG000|Overall Study|Lost to Follow-up|15|||
125324964|NCT01198795|450824248|FG000|Overall Study|Adverse Event|9|||
125324965|NCT01198795|450824248|FG000|Overall Study|Lack of Efficacy|5|||
125324966|NCT01198795|450824248|FG000|Overall Study|Protocol Violation|2|||
125324967|NCT01198795|450824248|FG000|Overall Study|Other Reason|4|||
125324968|NCT00936715|450824281|FG000|Overall Study|Investigators Discretion|1|||
125324969|NCT00936715|450824281|FG000|Overall Study|Protocol Violation|1|||
125324970|NCT00936715|450824281|FG000|Overall Study|Safety or Tolerability Reasons|4|||
125324971|NCT02492763|450824282|FG000|Overall Study|Withdrawal by Subject|0|||
125324972|NCT02492763|450824283|FG001|Overall Study|Withdrawal by Subject|2|||
125324973|NCT02492763|450824284|FG002|Overall Study|Withdrawal by Subject|1|||
125324974|NCT02492763|450824285|FG003|Overall Study|Withdrawal by Subject|0|||
125324975|NCT02492763|450824282|FG000|Overall Study|Adverse Event|3|||
125324976|NCT02492763|450824283|FG001|Overall Study|Adverse Event|1|||
125324977|NCT02492763|450824284|FG002|Overall Study|Adverse Event|1|||
125324978|NCT02492763|450824285|FG003|Overall Study|Adverse Event|2|||
125324979|NCT02492763|450824282|FG000|Overall Study|Death|0|||
125324980|NCT02492763|450824283|FG001|Overall Study|Death|0|||
125324981|NCT02492763|450824284|FG002|Overall Study|Death|1|||
125324982|NCT02492763|450824285|FG003|Overall Study|Death|0|||
125324983|NCT02492763|450824282|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
125324984|NCT02492763|450824283|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
125324985|NCT02492763|450824284|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
125324986|NCT02492763|450824285|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
125324987|NCT02492763|450824282|FG000|Overall Study|Lost to Follow-up|0|||
125324988|NCT02492763|450824283|FG001|Overall Study|Lost to Follow-up|0|||
125324989|NCT02492763|450824284|FG002|Overall Study|Lost to Follow-up|1|||
125324990|NCT02492763|450824285|FG003|Overall Study|Lost to Follow-up|0|||
125324991|NCT02492763|450824282|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125324992|NCT02492763|450824283|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125324993|NCT02492763|450824284|FG002|Overall Study|Non-Compliance With Study Drug|0|||
125324994|NCT02492763|450824285|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125324995|NCT02492763|450824282|FG000|Overall Study|Screen Failure|0|||
125324996|NCT02492763|450824283|FG001|Overall Study|Screen Failure|0|||
125324997|NCT02492763|450824284|FG002|Overall Study|Screen Failure|0|||
125324998|NCT02492763|450824285|FG003|Overall Study|Screen Failure|1|||
125324999|NCT02492763|450824282|FG000|Overall Study|Study Terminated by Sponsor|13|||
125325000|NCT02492763|450824283|FG001|Overall Study|Study Terminated by Sponsor|10|||
125325001|NCT02492763|450824284|FG002|Overall Study|Study Terminated by Sponsor|6|||
125325002|NCT02492763|450824285|FG003|Overall Study|Study Terminated by Sponsor|10|||
125325003|NCT01337960|450824286|FG000|Overall Study|Lost to Follow-up|1|||
125325004|NCT01337960|450824287|FG001|Overall Study|Lost to Follow-up|0|||
125325005|NCT01337960|450824288|FG002|Overall Study|Lost to Follow-up|0|||
125325006|NCT01337960|450824286|FG000|Overall Study|Withdrawal by Subject|1|||
125325007|NCT01337960|450824287|FG001|Overall Study|Withdrawal by Subject|0|||
125325008|NCT01337960|450824288|FG002|Overall Study|Withdrawal by Subject|0|||
125325009|NCT01772316|450824289|FG000|Overall Study|Serious adverse event|1|||
125325010|NCT01772316|450824289|FG000|Overall Study|Inform consent withdrawn|1|||
125325011|NCT01772316|450824289|FG000|Overall Study|Withdrawn by sponsor decision|5|||
125325012|NCT01747876|450824291|FG000|Overall Study|Adverse Event|1|||
125325013|NCT01747876|450824292|FG001|Overall Study|Adverse Event|0|||
125325014|NCT01747876|450824293|FG002|Overall Study|Adverse Event|2|||
125325015|NCT01747876|450824291|FG000|Overall Study|Withdrawal by Subject|0|||
125325016|NCT01747876|450824292|FG001|Overall Study|Withdrawal by Subject|1|||
125325017|NCT01747876|450824293|FG002|Overall Study|Withdrawal by Subject|1|||
125325018|NCT01747876|450824291|FG000|Overall Study|Disease progression|4|||
125325019|NCT01747876|450824292|FG001|Overall Study|Disease progression|13|||
125325020|NCT01747876|450824293|FG002|Overall Study|Disease progression|8|||
125325021|NCT01747876|450824291|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
125325022|NCT01747876|450824292|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
125325023|NCT01747876|450824293|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
125325024|NCT00914316|450824296|FG000|Phase 1|Physician Decision|4|||
125325025|NCT00914316|450824297|FG001|Phase 1|Physician Decision|0|||
125325026|NCT00914316|450824298|FG002|Phase 1|Physician Decision|1|||
125325027|NCT00914316|450824299|FG003|Phase 1|Physician Decision|2|||
125325028|NCT00914316|450824296|FG000|Phase 1|Withdrawal by Subject|0|||
125325029|NCT00914316|450824297|FG001|Phase 1|Withdrawal by Subject|2|||
125325030|NCT00914316|450824298|FG002|Phase 1|Withdrawal by Subject|4|||
125325031|NCT00914316|450824299|FG003|Phase 1|Withdrawal by Subject|0|||
125325032|NCT00914316|450824296|FG000|Phase 1|Adverse Event|1|||
125325033|NCT00914316|450824297|FG001|Phase 1|Adverse Event|0|||
125325034|NCT00914316|450824298|FG002|Phase 1|Adverse Event|0|||
125325035|NCT00914316|450824299|FG003|Phase 1|Adverse Event|0|||
125325036|NCT00914316|450824296|FG000|Phase 2|Withdrawal by Subject|1|||
125325037|NCT00914316|450824297|FG001|Phase 2|Withdrawal by Subject|0|||
125325038|NCT00914316|450824298|FG002|Phase 2|Withdrawal by Subject|1|||
125325039|NCT00914316|450824299|FG003|Phase 2|Withdrawal by Subject|0|||
125325040|NCT05660577|450824308|FG000|Overall Study|Discontinued|9|||
125325041|NCT03363841|450824311|FG000|Overall Study|Adverse Event|1|||
125325042|NCT03363841|450824311|FG000|Overall Study|Withdrawal by Subject|1|||
125325043|NCT03363841|450824311|FG000|Overall Study|Death|7|||
125325044|NCT03363841|450824311|FG000|Overall Study|Physician Decision|1|||
125325045|NCT01744977|450824312|FG000|Overall Study|Withdrawal by Subject|1|||
125325046|NCT01744977|450824313|FG001|Overall Study|Withdrawal by Subject|2|||
125325047|NCT01744977|450824312|FG000|Overall Study|Death|2|||
125325048|NCT01744977|450824313|FG001|Overall Study|Death|3|||
125210681|NCT02638259|450395635|FG001|Treatment Period 1|Withdrawal by Subject|6|||
125325049|NCT01744977|450824312|FG000|Overall Study|Lost to Follow-up|2|||
125325050|NCT01744977|450824313|FG001|Overall Study|Lost to Follow-up|0|||
125325051|NCT01744977|450824312|FG000|Overall Study|No longer meets inclusion|6|||
125325052|NCT01744977|450824313|FG001|Overall Study|No longer meets inclusion|0|||
125325053|NCT03879772|450824322|FG000|Overall Study|Adverse Event|2|||
125325054|NCT03879772|450824323|FG001|Overall Study|Adverse Event|2|||
125325055|NCT03879772|450824324|FG002|Overall Study|Adverse Event|3|||
125325056|NCT03879772|450824325|FG003|Overall Study|Adverse Event|4|||
125325057|NCT03879772|450824326|FG004|Overall Study|Adverse Event|3|||
125325058|NCT03879772|450824322|FG000|Overall Study|Treatment Failure|1|||
125325059|NCT03879772|450824323|FG001|Overall Study|Treatment Failure|0|||
125325060|NCT03879772|450824324|FG002|Overall Study|Treatment Failure|0|||
125325061|NCT03879772|450824325|FG003|Overall Study|Treatment Failure|2|||
125325062|NCT03879772|450824326|FG004|Overall Study|Treatment Failure|1|||
125325063|NCT03879772|450824322|FG000|Overall Study|Lost to Follow-up|0|||
125325064|NCT03879772|450824323|FG001|Overall Study|Lost to Follow-up|0|||
125325065|NCT03879772|450824324|FG002|Overall Study|Lost to Follow-up|0|||
125325066|NCT03879772|450824325|FG003|Overall Study|Lost to Follow-up|0|||
125325067|NCT03879772|450824326|FG004|Overall Study|Lost to Follow-up|1|||
125325068|NCT03879772|450824322|FG000|Overall Study|Withdrawal by Subject|0|||
125325069|NCT03879772|450824323|FG001|Overall Study|Withdrawal by Subject|1|||
125325070|NCT03879772|450824324|FG002|Overall Study|Withdrawal by Subject|3|||
125325071|NCT03879772|450824325|FG003|Overall Study|Withdrawal by Subject|1|||
125325072|NCT03879772|450824326|FG004|Overall Study|Withdrawal by Subject|1|||
125325073|NCT03879772|450824322|FG000|Overall Study|Protocol Violation|0|||
125325074|NCT03879772|450824323|FG001|Overall Study|Protocol Violation|0|||
125325075|NCT03879772|450824324|FG002|Overall Study|Protocol Violation|3|||
125325076|NCT03879772|450824325|FG003|Overall Study|Protocol Violation|1|||
125325077|NCT03879772|450824326|FG004|Overall Study|Protocol Violation|2|||
125325078|NCT03879772|450824322|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
125325079|NCT03879772|450824323|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
125325080|NCT03879772|450824324|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
125325081|NCT03879772|450824325|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
125325082|NCT03879772|450824326|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
125325083|NCT03818321|450824329|FG000|Overall Study|Withdrawal by Subject|1|||
125325084|NCT03818321|450824330|FG001|Overall Study|Withdrawal by Subject|2|||
125325085|NCT00106704|450824331|FG000|Overall Study|Adverse Event|10|||
125325086|NCT00106704|450824332|FG001|Overall Study|Adverse Event|7|||
125325087|NCT00106704|450824331|FG000|Overall Study|Death|2|||
125325088|NCT00106704|450824332|FG001|Overall Study|Death|1|||
125325089|NCT00106704|450824331|FG000|Overall Study|Lack of Efficacy|67|||
125325090|NCT00106704|450824332|FG001|Overall Study|Lack of Efficacy|69|||
125325091|NCT00106704|450824331|FG000|Overall Study|Lost to Follow-up|7|||
125325092|NCT00106704|450824332|FG001|Overall Study|Lost to Follow-up|3|||
125325093|NCT00106704|450824331|FG000|Overall Study|Pregnancy|1|||
125325094|NCT00106704|450824332|FG001|Overall Study|Pregnancy|0|||
125325095|NCT00106704|450824331|FG000|Overall Study|Protocol Violation|4|||
125325096|NCT00106704|450824332|FG001|Overall Study|Protocol Violation|7|||
125325097|NCT00106704|450824331|FG000|Overall Study|Withdrawal by Subject|14|||
125325098|NCT00106704|450824332|FG001|Overall Study|Withdrawal by Subject|21|||
125325099|NCT00106704|450824331|FG000|Overall Study|Patient moved|1|||
125325100|NCT00106704|450824332|FG001|Overall Study|Patient moved|0|||
124996041|NCT01231516|449611446|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
124996042|NCT01231516|449611445|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
124996043|NCT01231516|449611446|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
124996044|NCT01231516|449611445|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
124996045|NCT01231516|449611446|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
124996046|NCT01231516|449611445|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
124996047|NCT01231516|449611446|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
125325101|NCT00106704|450824331|FG000|Overall Study|Site terminated|0|||
125325102|NCT00106704|450824332|FG001|Overall Study|Site terminated|1|||
125325103|NCT00106704|450824331|FG000|Overall Study|Planned major surgery|1|||
125325104|NCT00106704|450824332|FG001|Overall Study|Planned major surgery|0|||
124996048|NCT01231516|449611445|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
124996049|NCT01231516|449611446|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
124996050|NCT01231516|449611445|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
124996051|NCT01231516|449611446|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
124996052|NCT01231516|449611445|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
124996053|NCT01231516|449611446|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
124996054|NCT01231516|449611445|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
124996055|NCT01231516|449611446|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
124996056|NCT01231516|449611445|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
124996057|NCT01231516|449611446|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
124996058|NCT01231516|449611445|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
124996059|NCT01231516|449611446|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
124996060|NCT01231516|449611445|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
124996061|NCT01231516|449611446|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
124996062|NCT01231516|449611445|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
124996063|NCT01231516|449611446|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
124996064|NCT01231516|449611445|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
124996065|NCT01231516|449611446|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
124996066|NCT00026208|449611447|FG000|Overall Study|Complications of auto accident|1|||
124996067|NCT00026208|449611448|FG001|Overall Study|Complications of auto accident|0|||
124996068|NCT02225353|449611449|FG000|Overall Study|Lost to Follow-up|0|||
124996069|NCT02225353|449611450|FG001|Overall Study|Lost to Follow-up|1|||
124996070|NCT02225353|449611451|FG002|Overall Study|Lost to Follow-up|3|||
124996071|NCT02225353|449611449|FG000|Overall Study|Protocol Violation|4|||
124996072|NCT02225353|449611450|FG001|Overall Study|Protocol Violation|5|||
124996073|NCT02225353|449611451|FG002|Overall Study|Protocol Violation|12|||
124996074|NCT01117857|449611452|FG000|Overall Study|Lost to Follow-up|4|||
124996075|NCT01117857|449611452|FG000|Overall Study|Withdrawal by Subject|4|||
124996076|NCT01117857|449611452|FG000|Overall Study|Physician Decision|1|||
124996077|NCT02730598|449611453|FG000|Overall Study|Withdrawal by Subject|3|||
124996078|NCT02730598|449611454|FG001|Overall Study|Withdrawal by Subject|3|||
125325105|NCT00106704|450824331|FG000|Overall Study|Patient Received Glycemic Medication|22|||
125325106|NCT00106704|450824332|FG001|Overall Study|Patient Received Glycemic Medication|41|||
125325107|NCT00106704|450824331|FG000|Overall Study|Unable to re-enter US|1|||
125325108|NCT00106704|450824332|FG001|Overall Study|Unable to re-enter US|0|||
125325109|NCT00106704|450824331|FG000|Overall Study|Laboratory test|1|||
125325110|NCT00106704|450824332|FG001|Overall Study|Laboratory test|1|||
125325111|NCT03216226|450824335|FG000|Overall Study|Adverse Event|3|||
125325112|NCT03216226|450824336|FG001|Overall Study|Adverse Event|0|||
125325113|NCT03216226|450824335|FG000|Overall Study|Protocol Violation|1|||
125325114|NCT03216226|450824336|FG001|Overall Study|Protocol Violation|3|||
125325115|NCT03216226|450824335|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
125325116|NCT03216226|450824336|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
125325117|NCT03216226|450824335|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
125325118|NCT03216226|450824336|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
125325119|NCT03216226|450824335|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
125325120|NCT03216226|450824336|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
125325121|NCT00871975|450824339|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
125325122|NCT00871975|450824339|FG000|Overall Study|Catheters could not be inserted|1|||
125325123|NCT00871975|450824339|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
125325124|NCT00871975|450824339|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
125325125|NCT05249582|450824340|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
124996079|NCT02730598|449611453|FG000|Overall Study|Protocol Violation|0|||
124996080|NCT02730598|449611454|FG001|Overall Study|Protocol Violation|1|||
124996081|NCT02730598|449611453|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
125325126|NCT05249582|450824341|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
125325127|NCT05249582|450824340|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
125325128|NCT05249582|450824341|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
125325129|NCT05249582|450824340|FG000|Overall Study|Declined to use virtual reality headset|1|||
125325130|NCT05249582|450824341|FG001|Overall Study|Declined to use virtual reality headset|0|||
125325131|NCT00283296|450824342|FG000|Overall Study|in-home trial not completed|5|||
125325132|NCT02668653|450824343|FG000|Overall Study|Refractory disease|41|||
125325133|NCT02668653|450824344|FG001|Overall Study|Refractory disease|70|||
125325134|NCT02668653|450824343|FG000|Overall Study|Relapse|44|||
125325135|NCT02668653|450824344|FG001|Overall Study|Relapse|65|||
125325136|NCT02668653|450824343|FG000|Overall Study|Adverse Event|58|||
125325137|NCT02668653|450824344|FG001|Overall Study|Adverse Event|23|||
125325138|NCT02668653|450824343|FG000|Overall Study|Subject decision to stop study drug|25|||
125325139|NCT02668653|450824344|FG001|Overall Study|Subject decision to stop study drug|23|||
125325140|NCT02668653|450824343|FG000|Overall Study|Other reasons not specified|16|||
125325141|NCT02668653|450824344|FG001|Overall Study|Other reasons not specified|11|||
125325142|NCT02668653|450824343|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
125325143|NCT02668653|450824344|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
125325144|NCT02668653|450824343|FG000|Overall Study|Investigator decision|10|||
125325145|NCT02668653|450824344|FG001|Overall Study|Investigator decision|7|||
125325146|NCT02668653|450824343|FG000|Overall Study|Failure to meet continuation criteria|5|||
125325147|NCT02668653|450824344|FG001|Overall Study|Failure to meet continuation criteria|12|||
125325148|NCT02668653|450824343|FG000|Overall Study|Lost to Follow-up|1|||
125325149|NCT02668653|450824344|FG001|Overall Study|Lost to Follow-up|0|||
125325150|NCT02668653|450824343|FG000|Overall Study|Pregnancy|0|||
125325151|NCT02668653|450824344|FG001|Overall Study|Pregnancy|1|||
125325152|NCT02668653|450824343|FG000|Overall Study|Death|0|||
125325153|NCT02668653|450824344|FG001|Overall Study|Death|1|||
125325154|NCT02158442|450824347|FG000|Overall Study|Withdrawal by Subject|1|||
125325155|NCT02158442|450824348|FG001|Overall Study|Withdrawal by Subject|0|||
125325156|NCT02158442|450824347|FG000|Overall Study|Perfusion staff not available|1|||
125325157|NCT02158442|450824348|FG001|Overall Study|Perfusion staff not available|0|||
125325158|NCT01294553|450824349|FG000|Overall Study|Duplicated Participants|1|||
125325159|NCT01294553|450824349|FG000|Overall Study|Protocol Violation|268|||
125325160|NCT00926237|450824352|FG000|Overall Study|Withdrawal by Subject|2|||
125325161|NCT00926237|450824353|FG001|Overall Study|Withdrawal by Subject|1|||
125325162|NCT00632229|450824359|FG000|Overall Study|Adverse Event|6|||
125325163|NCT00632229|450824360|FG001|Overall Study|Adverse Event|0|||
125325164|NCT00632229|450824359|FG000|Overall Study|Lost to Follow-up|0|||
125325165|NCT00632229|450824360|FG001|Overall Study|Lost to Follow-up|3|||
125325166|NCT00632229|450824359|FG000|Overall Study|Lack of Efficacy|0|||
125325167|NCT00632229|450824360|FG001|Overall Study|Lack of Efficacy|2|||
125325168|NCT00632229|450824359|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
125325169|NCT00632229|450824360|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
125325170|NCT05386329|450824361|FG000|Overall Study|Lost to Follow-up|3|||
125325171|NCT00577889|450824362|FG000|Overall Study|Withdrawal by Subject|1|||
125325172|NCT00577889|450824363|FG001|Overall Study|Withdrawal by Subject|0|||
125325173|NCT00577889|450824364|FG002|Overall Study|Withdrawal by Subject|0|||
125325174|NCT02667119|450824368|FG000|Overall Study|Lost to Follow-up|3|||
125325175|NCT02667119|450824369|FG001|Overall Study|Lost to Follow-up|0|||
125325176|NCT03783078|450824370|FG000|Overall Study|Death|31|||
125325177|NCT03783078|450824370|FG000|Overall Study|Sponsor Decision|23|||
125325178|NCT03783078|450824370|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
125325179|NCT02059278|450824372|FG000|Overall Study|Adverse Event|1|||
125325180|NCT02059278|450824373|FG001|Overall Study|Adverse Event|1|||
125325181|NCT02059278|450824372|FG000|Overall Study|Lost to Follow-up|1|||
125325182|NCT02059278|450824373|FG001|Overall Study|Lost to Follow-up|0|||
125325183|NCT02059278|450824372|FG000|Overall Study|Withdrawal by Subject|0|||
125325184|NCT02059278|450824373|FG001|Overall Study|Withdrawal by Subject|3|||
125325185|NCT02059278|450824372|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
125325186|NCT02059278|450824373|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
125325187|NCT00737672|450824376|FG000|Overall Study|Graft Abandonment|48|||
125325188|NCT00737672|450824377|FG001|Overall Study|Graft Abandonment|56|||
124996082|NCT02730598|449611454|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
125325189|NCT00737672|450824376|FG000|Overall Study|Death|23|||
124996083|NCT02146326|449611455|FG000|Overall Study|Lost to Follow-up|3|||
125325190|NCT00737672|450824377|FG001|Overall Study|Death|22|||
125325191|NCT00737672|450824376|FG000|Overall Study|Withdrawal by Subject|1|||
125325192|NCT00737672|450824377|FG001|Overall Study|Withdrawal by Subject|2|||
125325193|NCT00737672|450824376|FG000|Overall Study|Lost to Follow-up|1|||
125325194|NCT00737672|450824377|FG001|Overall Study|Lost to Follow-up|0|||
125325195|NCT00737672|450824376|FG000|Overall Study|Miscellaneous|7|||
125325196|NCT00737672|450824377|FG001|Overall Study|Miscellaneous|1|||
125325197|NCT00737672|450824376|FG000|Overall Study|Physician Decision|0|||
125325198|NCT00737672|450824377|FG001|Overall Study|Physician Decision|2|||
125325199|NCT02694185|450824378|FG000|Overall Study|Withdrawal by Subject|45|||
125325200|NCT02694185|450824379|FG001|Overall Study|Withdrawal by Subject|0|||
125325201|NCT05972993|450824391|FG000|Overall Study|Lost to Follow-up|2|||
125325202|NCT05972993|450824392|FG001|Overall Study|Lost to Follow-up|0|||
125325203|NCT05972993|450824393|FG002|Overall Study|Lost to Follow-up|1|||
125325204|NCT05972993|450824394|FG003|Overall Study|Lost to Follow-up|0|||
125325205|NCT05972993|450824395|FG004|Overall Study|Lost to Follow-up|0|||
125325206|NCT05972993|450824396|FG005|Overall Study|Lost to Follow-up|0|||
125325207|NCT05972993|450824397|FG006|Overall Study|Lost to Follow-up|0|||
125325208|NCT05972993|450824398|FG007|Overall Study|Lost to Follow-up|2|||
125325209|NCT05972993|450824399|FG008|Overall Study|Lost to Follow-up|0|||
125325210|NCT03866577|450824402|FG000|Overall Study|Protocol Violation|0|||
125325211|NCT03866577|450824403|FG001|Overall Study|Protocol Violation|0|||
125325212|NCT03866577|450824404|FG002|Overall Study|Protocol Violation|0|||
125325213|NCT03866577|450824405|FG003|Overall Study|Protocol Violation|0|||
125325214|NCT03866577|450824406|FG004|Overall Study|Protocol Violation|0|||
125325215|NCT03866577|450824407|FG005|Overall Study|Protocol Violation|0|||
125325216|NCT03866577|450824408|FG006|Overall Study|Protocol Violation|0|||
125325217|NCT03866577|450824409|FG007|Overall Study|Protocol Violation|0|||
125325218|NCT03866577|450824410|FG008|Overall Study|Protocol Violation|0|||
125325219|NCT03866577|450824411|FG009|Overall Study|Protocol Violation|0|||
125325220|NCT03866577|450824412|FG010|Overall Study|Protocol Violation|0|||
125325221|NCT03866577|450824413|FG011|Overall Study|Protocol Violation|1|||
125325222|NCT03866577|450824414|FG012|Overall Study|Protocol Violation|0|||
125325223|NCT03866577|450824402|FG000|Overall Study|Withdrawal by Subject|0|||
125325224|NCT03866577|450824403|FG001|Overall Study|Withdrawal by Subject|0|||
125325225|NCT03866577|450824404|FG002|Overall Study|Withdrawal by Subject|0|||
125325226|NCT03866577|450824405|FG003|Overall Study|Withdrawal by Subject|0|||
125325227|NCT03866577|450824406|FG004|Overall Study|Withdrawal by Subject|0|||
125325228|NCT03866577|450824407|FG005|Overall Study|Withdrawal by Subject|0|||
125325229|NCT03866577|450824408|FG006|Overall Study|Withdrawal by Subject|0|||
125325230|NCT03866577|450824409|FG007|Overall Study|Withdrawal by Subject|0|||
125325231|NCT03866577|450824410|FG008|Overall Study|Withdrawal by Subject|1|||
125325232|NCT03866577|450824411|FG009|Overall Study|Withdrawal by Subject|1|||
125325233|NCT03866577|450824412|FG010|Overall Study|Withdrawal by Subject|0|||
125325234|NCT03866577|450824413|FG011|Overall Study|Withdrawal by Subject|0|||
125325235|NCT03866577|450824414|FG012|Overall Study|Withdrawal by Subject|0|||
125325236|NCT03866577|450824402|FG000|Overall Study|Not qualified for IVIg infusion|0|||
125325237|NCT03866577|450824403|FG001|Overall Study|Not qualified for IVIg infusion|0|||
125325238|NCT03866577|450824404|FG002|Overall Study|Not qualified for IVIg infusion|0|||
125325239|NCT03866577|450824405|FG003|Overall Study|Not qualified for IVIg infusion|0|||
125325240|NCT03866577|450824406|FG004|Overall Study|Not qualified for IVIg infusion|0|||
125325241|NCT03866577|450824407|FG005|Overall Study|Not qualified for IVIg infusion|0|||
125325242|NCT03866577|450824408|FG006|Overall Study|Not qualified for IVIg infusion|0|||
125325243|NCT03866577|450824409|FG007|Overall Study|Not qualified for IVIg infusion|0|||
125325244|NCT03866577|450824410|FG008|Overall Study|Not qualified for IVIg infusion|0|||
125325245|NCT03866577|450824411|FG009|Overall Study|Not qualified for IVIg infusion|1|||
125325246|NCT03866577|450824412|FG010|Overall Study|Not qualified for IVIg infusion|0|||
125325247|NCT03866577|450824413|FG011|Overall Study|Not qualified for IVIg infusion|0|||
125325248|NCT03866577|450824414|FG012|Overall Study|Not qualified for IVIg infusion|0|||
125325249|NCT04825678|450824415|FG000|Overall Study|Decision by Sponsor|2|||
125325250|NCT04825678|450824416|FG001|Overall Study|Decision by Sponsor|3|||
125325251|NCT04825678|450824415|FG000|Overall Study|Withdrawal of Consent From Study|7|||
125325252|NCT04825678|450824416|FG001|Overall Study|Withdrawal of Consent From Study|9|||
125325253|NCT04825678|450824415|FG000|Overall Study|Lost to Follow-up|3|||
125325254|NCT04825678|450824416|FG001|Overall Study|Lost to Follow-up|4|||
125325255|NCT04825678|450824415|FG000|Overall Study|Never Received Investigational Product|1|||
125325256|NCT04825678|450824416|FG001|Overall Study|Never Received Investigational Product|1|||
125325257|NCT03818256|450824417|FG000|Overall Study|Withdrawal by Subject|2|||
125325258|NCT03818256|450824418|FG001|Overall Study|Withdrawal by Subject|2|||
125325259|NCT03818256|450824417|FG000|Overall Study|Adverse Event|3|||
125325260|NCT03818256|450824418|FG001|Overall Study|Adverse Event|1|||
125325261|NCT03818256|450824417|FG000|Overall Study|Lost to Follow-up|0|||
125325262|NCT03818256|450824418|FG001|Overall Study|Lost to Follow-up|5|||
125325263|NCT03818256|450824417|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
125325264|NCT03818256|450824418|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
125325265|NCT03818256|450824417|FG000|Overall Study|Not reporting for scheduled visits|1|||
125325266|NCT03818256|450824418|FG001|Overall Study|Not reporting for scheduled visits|0|||
125325267|NCT03818256|450824417|FG000|Overall Study|Non-compliant with investigational product|1|||
125325268|NCT03818256|450824418|FG001|Overall Study|Non-compliant with investigational product|0|||
125325269|NCT00734149|450824420|FG000|Overall Study|Withdrawal by Subject|1|||
125325270|NCT03043794|450824424|FG000|Overall Study|Lost to Follow-up|1|||
125325271|NCT04323124|450824427|FG000|Overall Study|Adverse Event|0|||
125325272|NCT04323124|450824428|FG001|Overall Study|Adverse Event|0|||
125325273|NCT04323124|450824429|FG002|Overall Study|Adverse Event|0|||
125325274|NCT04323124|450824430|FG003|Overall Study|Adverse Event|0|||
125325275|NCT04323124|450824431|FG004|Overall Study|Adverse Event|0|||
125325276|NCT04323124|450824432|FG005|Overall Study|Adverse Event|1|||
125325277|NCT04323124|450824433|FG006|Overall Study|Adverse Event|0|||
125325278|NCT04323124|450824434|FG007|Overall Study|Adverse Event|1|||
125325279|NCT04323124|450824435|FG008|Overall Study|Adverse Event|1|||
125325280|NCT04323124|450824436|FG009|Overall Study|Adverse Event|0|||
125325281|NCT04323124|450824437|FG010|Overall Study|Adverse Event|0|||
125325282|NCT04323124|450824438|FG011|Overall Study|Adverse Event|0|||
125325283|NCT04323124|450824439|FG012|Overall Study|Adverse Event|0|||
125325284|NCT04323124|450824440|FG013|Overall Study|Adverse Event|0|||
125325285|NCT04323124|450824441|FG014|Overall Study|Adverse Event|0|||
125325286|NCT04323124|450824427|FG000|Overall Study|Other|0|||
125325287|NCT04323124|450824428|FG001|Overall Study|Other|0|||
124996084|NCT02146326|449611456|FG001|Overall Study|Lost to Follow-up|3|||
124996085|NCT02146326|449611457|FG002|Overall Study|Lost to Follow-up|11|||
124996086|NCT02146326|449611458|FG003|Overall Study|Lost to Follow-up|19|||
124996087|NCT02146326|449611455|FG000|Overall Study|Withdrawal by Subject|2|||
124996088|NCT02146326|449611456|FG001|Overall Study|Withdrawal by Subject|1|||
124996089|NCT02146326|449611457|FG002|Overall Study|Withdrawal by Subject|15|||
124996090|NCT02146326|449611458|FG003|Overall Study|Withdrawal by Subject|11|||
124996091|NCT02146326|449611455|FG000|Overall Study|Separated from mental health center|23|||
124996092|NCT02146326|449611456|FG001|Overall Study|Separated from mental health center|33|||
124996093|NCT02146326|449611457|FG002|Overall Study|Separated from mental health center|0|||
124996094|NCT02146326|449611458|FG003|Overall Study|Separated from mental health center|0|||
124996095|NCT02146326|449611455|FG000|Overall Study|Incarcerated|0|||
124996096|NCT02146326|449611456|FG001|Overall Study|Incarcerated|0|||
124996097|NCT02146326|449611457|FG002|Overall Study|Incarcerated|3|||
124996098|NCT02146326|449611458|FG003|Overall Study|Incarcerated|8|||
124996099|NCT02146326|449611455|FG000|Overall Study|Death|0|||
124996100|NCT02146326|449611456|FG001|Overall Study|Death|0|||
124996101|NCT02146326|449611457|FG002|Overall Study|Death|4|||
124996102|NCT02146326|449611458|FG003|Overall Study|Death|4|||
124996103|NCT02146326|449611455|FG000|Overall Study|Unable to complete interview|0|||
124996104|NCT02146326|449611456|FG001|Overall Study|Unable to complete interview|0|||
124996105|NCT02146326|449611457|FG002|Overall Study|Unable to complete interview|10|||
124996106|NCT02146326|449611458|FG003|Overall Study|Unable to complete interview|6|||
124996107|NCT02910739|449611459|FG000|Overall Study|Adverse Event|1|||
124996108|NCT02910739|449611460|FG001|Overall Study|Adverse Event|0|||
124996109|NCT02910739|449611461|FG002|Overall Study|Adverse Event|0|||
124996110|NCT02910739|449611462|FG003|Overall Study|Adverse Event|0|||
124996111|NCT01340651|449611463|FG000|Overall Study|Adverse Event|3|||
124996112|NCT01340651|449611463|FG000|Overall Study|Consent Withdrawn|2|||
124996113|NCT01340651|449611463|FG000|Overall Study|Commercial Supply per Sponsor|12|||
124996114|NCT01696942|449611466|FG000|Overall Study|Withdrawal by Subject|1|||
124996115|NCT01696942|449611467|FG001|Overall Study|Withdrawal by Subject|0|||
124996116|NCT01696942|449611466|FG000|Overall Study|Protocol Violation|1|||
124996117|NCT01696942|449611467|FG001|Overall Study|Protocol Violation|2|||
124996118|NCT01696942|449611466|FG000|Overall Study|screen failure|0|||
124996119|NCT01696942|449611467|FG001|Overall Study|screen failure|1|||
124996120|NCT01313117|449611472|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
124996121|NCT01313117|449611472|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
124996122|NCT03442114|449611475|FG000|Overall Study|Lost to Follow-up|13|||
124996123|NCT03442114|449611476|FG001|Overall Study|Lost to Follow-up|13|||
124996124|NCT03442114|449611475|FG000|Overall Study|Physician Decision|2|||
124996125|NCT03442114|449611476|FG001|Overall Study|Physician Decision|2|||
124996126|NCT03442114|449611475|FG000|Overall Study|Protocol Violation|0|||
124996127|NCT03442114|449611476|FG001|Overall Study|Protocol Violation|2|||
124996128|NCT03442114|449611475|FG000|Overall Study|Withdrawal by Subject|1|||
124996129|NCT03442114|449611476|FG001|Overall Study|Withdrawal by Subject|3|||
124996130|NCT03442114|449611475|FG000|Overall Study|Guardianship Change|0|||
124996131|NCT03442114|449611476|FG001|Overall Study|Guardianship Change|1|||
124996132|NCT02903368|449611477|FG000|Part 1|Adverse Event|3|||
124996133|NCT02903368|449611478|FG001|Part 1|Adverse Event|0|||
124996134|NCT02903368|449611479|FG002|Part 1|Adverse Event|0|||
124996135|NCT02903368|449611480|FG003|Part 1|Adverse Event|0|||
124996136|NCT02903368|449611477|FG000|Part 1|Withdrawal by Subject|1|||
124996137|NCT02903368|449611478|FG001|Part 1|Withdrawal by Subject|0|||
124996138|NCT02903368|449611479|FG002|Part 1|Withdrawal by Subject|0|||
124996139|NCT02903368|449611480|FG003|Part 1|Withdrawal by Subject|0|||
124996140|NCT02903368|449611477|FG000|Part 2|Adverse Event|0|||
124996141|NCT02903368|449611478|FG001|Part 2|Adverse Event|0|||
124996142|NCT02903368|449611479|FG002|Part 2|Adverse Event|5|||
124996143|NCT02903368|449611480|FG003|Part 2|Adverse Event|0|||
124996144|NCT02903368|449611477|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
124996145|NCT02903368|449611478|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
124996146|NCT02903368|449611479|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
124996147|NCT02903368|449611480|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
125325288|NCT04323124|450824429|FG002|Overall Study|Other|0|||
125325289|NCT04323124|450824430|FG003|Overall Study|Other|0|||
125325290|NCT04323124|450824431|FG004|Overall Study|Other|1|||
125325291|NCT04323124|450824432|FG005|Overall Study|Other|0|||
125325292|NCT04323124|450824433|FG006|Overall Study|Other|0|||
125325293|NCT04323124|450824434|FG007|Overall Study|Other|0|||
125325294|NCT04323124|450824435|FG008|Overall Study|Other|1|||
125325295|NCT04323124|450824436|FG009|Overall Study|Other|0|||
125325296|NCT04323124|450824437|FG010|Overall Study|Other|0|||
125325297|NCT04323124|450824438|FG011|Overall Study|Other|0|||
125325298|NCT04323124|450824439|FG012|Overall Study|Other|0|||
125325299|NCT04323124|450824440|FG013|Overall Study|Other|0|||
125325300|NCT04323124|450824441|FG014|Overall Study|Other|0|||
125325301|NCT04323124|450824427|FG000|Overall Study|Coming from a red zone (COVID)|0|||
125325302|NCT04323124|450824428|FG001|Overall Study|Coming from a red zone (COVID)|0|||
125325303|NCT04323124|450824429|FG002|Overall Study|Coming from a red zone (COVID)|0|||
125325304|NCT04323124|450824430|FG003|Overall Study|Coming from a red zone (COVID)|0|||
125325305|NCT04323124|450824431|FG004|Overall Study|Coming from a red zone (COVID)|1|||
125325306|NCT04323124|450824432|FG005|Overall Study|Coming from a red zone (COVID)|1|||
125325307|NCT04323124|450824433|FG006|Overall Study|Coming from a red zone (COVID)|0|||
125325308|NCT04323124|450824434|FG007|Overall Study|Coming from a red zone (COVID)|0|||
125325309|NCT04323124|450824435|FG008|Overall Study|Coming from a red zone (COVID)|0|||
125325310|NCT04323124|450824436|FG009|Overall Study|Coming from a red zone (COVID)|0|||
125325311|NCT04323124|450824437|FG010|Overall Study|Coming from a red zone (COVID)|0|||
125325312|NCT04323124|450824438|FG011|Overall Study|Coming from a red zone (COVID)|0|||
125325313|NCT04323124|450824439|FG012|Overall Study|Coming from a red zone (COVID)|0|||
125325314|NCT04323124|450824440|FG013|Overall Study|Coming from a red zone (COVID)|0|||
125325315|NCT04323124|450824441|FG014|Overall Study|Coming from a red zone (COVID)|0|||
125325316|NCT04323124|450824427|FG000|Overall Study|No longer meets eligibility criteria|0|||
125325317|NCT04323124|450824428|FG001|Overall Study|No longer meets eligibility criteria|0|||
125325318|NCT04323124|450824429|FG002|Overall Study|No longer meets eligibility criteria|0|||
125325319|NCT04323124|450824430|FG003|Overall Study|No longer meets eligibility criteria|0|||
125325320|NCT04323124|450824431|FG004|Overall Study|No longer meets eligibility criteria|0|||
125325321|NCT04323124|450824432|FG005|Overall Study|No longer meets eligibility criteria|0|||
125325322|NCT04323124|450824433|FG006|Overall Study|No longer meets eligibility criteria|0|||
125325323|NCT04323124|450824434|FG007|Overall Study|No longer meets eligibility criteria|1|||
125325324|NCT04323124|450824435|FG008|Overall Study|No longer meets eligibility criteria|0|||
125325325|NCT04323124|450824436|FG009|Overall Study|No longer meets eligibility criteria|0|||
125325326|NCT04323124|450824437|FG010|Overall Study|No longer meets eligibility criteria|0|||
125325327|NCT04323124|450824438|FG011|Overall Study|No longer meets eligibility criteria|0|||
125325328|NCT04323124|450824439|FG012|Overall Study|No longer meets eligibility criteria|0|||
125325329|NCT04323124|450824440|FG013|Overall Study|No longer meets eligibility criteria|1|||
125325330|NCT04323124|450824441|FG014|Overall Study|No longer meets eligibility criteria|1|||
125325331|NCT04323124|450824427|FG000|Overall Study|Study terminated by sponsor|0|||
125325332|NCT04323124|450824428|FG001|Overall Study|Study terminated by sponsor|0|||
125325333|NCT04323124|450824429|FG002|Overall Study|Study terminated by sponsor|0|||
125325334|NCT04323124|450824430|FG003|Overall Study|Study terminated by sponsor|0|||
125325335|NCT04323124|450824431|FG004|Overall Study|Study terminated by sponsor|0|||
125325336|NCT04323124|450824432|FG005|Overall Study|Study terminated by sponsor|0|||
125325337|NCT04323124|450824433|FG006|Overall Study|Study terminated by sponsor|0|||
125325338|NCT04323124|450824434|FG007|Overall Study|Study terminated by sponsor|0|||
125325339|NCT04323124|450824435|FG008|Overall Study|Study terminated by sponsor|0|||
125325340|NCT04323124|450824436|FG009|Overall Study|Study terminated by sponsor|0|||
125325341|NCT04323124|450824437|FG010|Overall Study|Study terminated by sponsor|0|||
125325342|NCT04323124|450824438|FG011|Overall Study|Study terminated by sponsor|2|||
125325343|NCT04323124|450824439|FG012|Overall Study|Study terminated by sponsor|1|||
125325344|NCT04323124|450824440|FG013|Overall Study|Study terminated by sponsor|0|||
125325345|NCT04323124|450824441|FG014|Overall Study|Study terminated by sponsor|0|||
125325346|NCT00489307|450824442|FG000|Overall Study|Death|1|||
125325347|NCT00489307|450824443|FG001|Overall Study|Death|1|||
125325348|NCT00489307|450824442|FG000|Overall Study|Lost to Follow-up|2|||
125325349|NCT00489307|450824443|FG001|Overall Study|Lost to Follow-up|2|||
125325350|NCT00489307|450824442|FG000|Overall Study|Physician Decision|1|||
125325351|NCT00489307|450824443|FG001|Overall Study|Physician Decision|0|||
125325352|NCT00489307|450824442|FG000|Overall Study|Withdrawal by Subject|2|||
125325353|NCT00489307|450824443|FG001|Overall Study|Withdrawal by Subject|4|||
125325354|NCT00489307|450824442|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
125325355|NCT00489307|450824443|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
125325356|NCT00489307|450824442|FG000|Overall Study|Surgery after assignment|1|||
125325357|NCT00489307|450824443|FG001|Overall Study|Surgery after assignment|0|||
125325358|NCT00489307|450824442|FG000|Overall Study|Did not fill up the forms|2|||
125325359|NCT00489307|450824443|FG001|Overall Study|Did not fill up the forms|1|||
125325360|NCT00489307|450824442|FG000|Overall Study|Patient or family refusal|5|||
125325361|NCT00489307|450824443|FG001|Overall Study|Patient or family refusal|9|||
125325362|NCT04586205|450824444|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
125325363|NCT04586205|450824445|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
125325364|NCT01586364|450827070|FG000|Overall Study|Withdrawal by Subject|40|||
125325365|NCT01586364|450827070|FG000|Overall Study|Adverse Event|37|||
125325366|NCT01586364|450827070|FG000|Overall Study|Lost to Follow-up|17|||
125325367|NCT01586364|450827070|FG000|Overall Study|Protocol Violation|16|||
125325368|NCT01586364|450827070|FG000|Overall Study|Lack of Efficacy|1|||
125325369|NCT01586364|450827070|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
125325370|NCT01586364|450827070|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
125325371|NCT01586364|450827070|FG000|Overall Study|Other-Site closure due to PI illness|1|||
125325372|NCT01586364|450827070|FG000|Overall Study|Other-PI discretion, site closing|2|||
125325373|NCT01586364|450827070|FG000|Overall Study|Other-Not specified|1|||
125325374|NCT02121535|450827071|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
125325375|NCT02121535|450827072|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
125325376|NCT02121535|450827071|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
125325377|NCT02121535|450827072|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
125325378|NCT00091949|450827073|FG000|Overall Study|Withdrawal by Subject|117|||
125325379|NCT00091949|450827074|FG001|Overall Study|Withdrawal by Subject|110|||
125325380|NCT00091949|450827073|FG000|Overall Study|Lost to Follow-up|58|||
125325381|NCT00091949|450827074|FG001|Overall Study|Lost to Follow-up|41|||
125325382|NCT01256788|450827075|FG000|Overall Study|Lost to Follow-up|5|||
125325383|NCT01256788|450827076|FG001|Overall Study|Lost to Follow-up|8|||
125325384|NCT01256788|450827077|FG002|Overall Study|Lost to Follow-up|3|||
125325385|NCT02083354|450827078|FG000|Overall Study|Withdrawal by Subject|9|||
125325386|NCT02083354|450827078|FG000|Overall Study|Lost to Follow-up|1|||
125325387|NCT02083354|450827078|FG000|Overall Study|Adverse Event|3|||
125325388|NCT02083354|450827078|FG000|Overall Study|Disease progression|46|||
125325389|NCT02083354|450827078|FG000|Overall Study|Study closed/terminated|5|||
125325390|NCT03312634|450827079|FG000|Overall Study|Adverse Event|11|||
125325391|NCT03312634|450827080|FG001|Overall Study|Adverse Event|0|||
125325392|NCT03312634|450827079|FG000|Overall Study|Sponsor request|2|||
125325393|NCT03312634|450827080|FG001|Overall Study|Sponsor request|0|||
125325394|NCT03312634|450827079|FG000|Overall Study|Withdrawal by Subject|31|||
125325395|NCT03312634|450827080|FG001|Overall Study|Withdrawal by Subject|9|||
125325396|NCT03312634|450827079|FG000|Overall Study|Enrolled in an interventional study|0|||
125325397|NCT03312634|450827080|FG001|Overall Study|Enrolled in an interventional study|52|||
125325398|NCT03312634|450827079|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
125325399|NCT03312634|450827080|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
125325400|NCT03312634|450827079|FG000|Overall Study|Death|0|||
125325401|NCT03312634|450827080|FG001|Overall Study|Death|1|||
125325402|NCT03312634|450827079|FG000|Overall Study|Non-compliance|0|||
125325403|NCT03312634|450827080|FG001|Overall Study|Non-compliance|2|||
125325404|NCT03312634|450827079|FG000|Overall Study|Lost to Follow-up|0|||
125325405|NCT03312634|450827080|FG001|Overall Study|Lost to Follow-up|1|||
125325406|NCT03312634|450827079|FG000|Overall Study|Enrolled into non-interventional study|0|||
125325407|NCT03312634|450827080|FG001|Overall Study|Enrolled into non-interventional study|5|||
125325408|NCT03312634|450827079|FG000|Overall Study|Worsening clinical condition|0|||
125325409|NCT03312634|450827080|FG001|Overall Study|Worsening clinical condition|1|||
125325410|NCT03312634|450827079|FG000|Overall Study|Participant did not want to travel|0|||
125325411|NCT03312634|450827080|FG001|Overall Study|Participant did not want to travel|1|||
125325412|NCT03312634|450827079|FG000|Overall Study|Physician Decision|1|||
125325413|NCT03312634|450827080|FG001|Overall Study|Physician Decision|0|||
125325414|NCT03312634|450827079|FG000|Overall Study|Other|13|||
125325415|NCT03312634|450827080|FG001|Overall Study|Other|0|||
125325416|NCT00906204|450827081|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
125325417|NCT00906204|450827082|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
125325418|NCT00906204|450827081|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
125325419|NCT00906204|450827082|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
125325420|NCT00906204|450827081|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
125325421|NCT00906204|450827082|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
125325422|NCT00906204|450827081|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
125325423|NCT00906204|450827082|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
125325424|NCT00906204|450827081|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
125325425|NCT00906204|450827082|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
125325426|NCT04328077|450827083|FG000|Overall Study|Lost to Follow-up|0|||
125325427|NCT04328077|450827084|FG001|Overall Study|Lost to Follow-up|1|||
125325428|NCT04328077|450827085|FG002|Overall Study|Lost to Follow-up|0|||
125325429|NCT04328077|450827086|FG003|Overall Study|Lost to Follow-up|0|||
125325430|NCT04328077|450827083|FG000|Overall Study|Withdrawal by Subject|0|||
125325431|NCT04328077|450827084|FG001|Overall Study|Withdrawal by Subject|1|||
125325432|NCT04328077|450827085|FG002|Overall Study|Withdrawal by Subject|1|||
125325433|NCT04328077|450827086|FG003|Overall Study|Withdrawal by Subject|3|||
125325434|NCT05291520|450827087|FG000|Overall Study|Lost to Follow-up|0|||
125325435|NCT05291520|450827088|FG001|Overall Study|Lost to Follow-up|0|||
125325436|NCT05291520|450827089|FG002|Overall Study|Lost to Follow-up|1|||
125325437|NCT01347112|450827090|FG000|Overall Study|Withdrawal by Subject|1|||
125325438|NCT01347112|450827091|FG001|Overall Study|Withdrawal by Subject|7|||
125325439|NCT01347112|450827090|FG000|Overall Study|Lost to Follow-up|3|||
125325440|NCT01347112|450827091|FG001|Overall Study|Lost to Follow-up|5|||
125325441|NCT00696072|450827096|FG000|Overall Study|continuing active treatment|10|||
125325442|NCT00696072|450827097|FG001|Overall Study|continuing active treatment|13|||
125325443|NCT00696072|450827096|FG000|Overall Study|Adverse Event|10|||
125325444|NCT00696072|450827097|FG001|Overall Study|Adverse Event|6|||
125325445|NCT00696072|450827096|FG000|Overall Study|Patient Request|3|||
125325446|NCT00696072|450827097|FG001|Overall Study|Patient Request|7|||
125325447|NCT00696072|450827096|FG000|Overall Study|Investigator Request|1|||
125325448|NCT00696072|450827097|FG001|Overall Study|Investigator Request|4|||
125325449|NCT00696072|450827096|FG000|Overall Study|Sponsor Request|0|||
125325450|NCT00696072|450827097|FG001|Overall Study|Sponsor Request|1|||
125325451|NCT00696072|450827096|FG000|Overall Study|Disease Progression|32|||
125325452|NCT00696072|450827097|FG001|Overall Study|Disease Progression|30|||
125325453|NCT00696072|450827096|FG000|Overall Study|Non-specified|1|||
125325454|NCT00696072|450827097|FG001|Overall Study|Non-specified|2|||
125325455|NCT01597596|450827098|FG000|Overall Study|Study terminated by sponsor|1|||
125325456|NCT01597596|450827099|FG001|Overall Study|Study terminated by sponsor|0|||
125325457|NCT01597596|450827098|FG000|Overall Study|Physician Decision|0|||
125325458|NCT01597596|450827099|FG001|Overall Study|Physician Decision|1|||
125325459|NCT00313014|450827120|FG000|Overall Study|Withdrawal by Subject|11|||
125325460|NCT00313014|450827121|FG001|Overall Study|Withdrawal by Subject|7|||
125325461|NCT00313014|450827122|FG002|Overall Study|Withdrawal by Subject|5|||
125325462|NCT00313014|450827120|FG000|Overall Study|Adverse Event|14|||
125325463|NCT00313014|450827121|FG001|Overall Study|Adverse Event|29|||
125325464|NCT00313014|450827122|FG002|Overall Study|Adverse Event|16|||
125325465|NCT00313014|450827120|FG000|Overall Study|Lost to Follow-up|7|||
125325466|NCT00313014|450827121|FG001|Overall Study|Lost to Follow-up|6|||
125325467|NCT00313014|450827122|FG002|Overall Study|Lost to Follow-up|10|||
125325468|NCT00313014|450827120|FG000|Overall Study|Administrative|9|||
125325469|NCT00313014|450827121|FG001|Overall Study|Administrative|6|||
125325470|NCT00313014|450827122|FG002|Overall Study|Administrative|14|||
125325471|NCT00313014|450827120|FG000|Overall Study|Lack of Efficacy|52|||
125325472|NCT00313014|450827121|FG001|Overall Study|Lack of Efficacy|25|||
125325473|NCT00313014|450827122|FG002|Overall Study|Lack of Efficacy|16|||
125325474|NCT01054885|450827123|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
125325475|NCT01054885|450827124|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125325476|NCT01054885|450827125|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125325477|NCT01054885|450827126|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125325478|NCT01054885|450827127|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125325479|NCT01054885|450827128|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125325480|NCT01054885|450827129|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125325481|NCT01054885|450827123|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
125325482|NCT01054885|450827124|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
125325483|NCT01054885|450827125|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
125325484|NCT01054885|450827126|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
125325485|NCT01054885|450827127|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
125325486|NCT01054885|450827128|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
125325487|NCT01054885|450827129|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
125325488|NCT01054885|450827123|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
125325489|NCT01054885|450827124|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125325490|NCT01054885|450827125|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125325491|NCT01054885|450827126|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125325492|NCT01054885|450827127|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125325493|NCT01054885|450827128|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125325494|NCT01054885|450827129|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125325495|NCT01054885|450827123|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
125325496|NCT01054885|450827124|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125325497|NCT01054885|450827125|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125325498|NCT01054885|450827126|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125325499|NCT01054885|450827127|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125325500|NCT01054885|450827128|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125325501|NCT01054885|450827129|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125325502|NCT01054885|450827123|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
125325503|NCT01054885|450827124|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
125325504|NCT01054885|450827125|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
125325505|NCT01054885|450827126|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
125325506|NCT01054885|450827127|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
125210682|NCT02638259|450395634|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
125325507|NCT01054885|450827128|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
125325508|NCT01054885|450827129|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
125325509|NCT01054885|450827123|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
125325510|NCT01054885|450827124|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125325511|NCT01054885|450827125|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125325512|NCT01054885|450827126|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125325513|NCT01054885|450827127|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125325514|NCT01054885|450827128|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125325515|NCT01054885|450827129|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125325516|NCT01054885|450827123|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
125325517|NCT01054885|450827124|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
125325518|NCT01054885|450827125|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
125325519|NCT01054885|450827126|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
125325520|NCT01054885|450827127|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
125325521|NCT01054885|450827128|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
125325522|NCT01054885|450827129|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
125325523|NCT01054885|450827123|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125325524|NCT01054885|450827124|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125325525|NCT01054885|450827125|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
125325526|NCT01054885|450827126|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
125325527|NCT01054885|450827127|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125325528|NCT01054885|450827128|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
125325529|NCT01054885|450827129|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125325530|NCT01054885|450827123|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
125325531|NCT01054885|450827124|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
125325532|NCT01054885|450827125|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
125325533|NCT01054885|450827126|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
125325534|NCT01054885|450827127|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
125325535|NCT01054885|450827128|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
125325536|NCT01054885|450827129|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
125325537|NCT01054885|450827123|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
125325538|NCT01054885|450827124|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
125325539|NCT01054885|450827125|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
125325540|NCT01054885|450827126|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
125325541|NCT01054885|450827127|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
125325542|NCT01054885|450827128|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
125325543|NCT01054885|450827129|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
125325544|NCT01054885|450827123|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
125325545|NCT01054885|450827124|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
125325546|NCT01054885|450827125|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
125325547|NCT01054885|450827126|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
125325548|NCT01054885|450827127|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
125325549|NCT01054885|450827128|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
125325550|NCT01054885|450827129|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
124996148|NCT02903368|449611477|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
124996149|NCT02903368|449611478|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
124996150|NCT02903368|449611479|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
124996151|NCT02903368|449611480|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
124996152|NCT02903368|449611477|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
124996153|NCT02903368|449611478|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
124996154|NCT02903368|449611479|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
124996155|NCT02903368|449611480|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
124996156|NCT00171704|449613976|FG000|Overall Study|Adverse Event|24|||
124996157|NCT00171704|449613977|FG001|Overall Study|Adverse Event|33|||
124996158|NCT00171704|449613976|FG000|Overall Study|Disease Progression|14|||
124996159|NCT00171704|449613977|FG001|Overall Study|Disease Progression|9|||
124996160|NCT00171704|449613976|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
124996161|NCT00171704|449613977|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
124996162|NCT00171704|449613976|FG000|Overall Study|Administrative Problems|2|||
124996163|NCT00171704|449613977|FG001|Overall Study|Administrative Problems|1|||
124996164|NCT00171704|449613976|FG000|Overall Study|Death|2|||
124996165|NCT00171704|449613977|FG001|Overall Study|Death|2|||
125325551|NCT01054885|450827123|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
125325552|NCT01054885|450827124|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
125325553|NCT01054885|450827125|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
125325554|NCT01054885|450827126|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
125325555|NCT01054885|450827127|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
125325556|NCT01054885|450827128|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
125325557|NCT01054885|450827129|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
125325558|NCT01054885|450827123|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125325559|NCT01054885|450827124|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
125325560|NCT01054885|450827125|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
125325561|NCT01054885|450827126|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125325562|NCT01054885|450827127|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125325563|NCT01054885|450827128|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
125325564|NCT01054885|450827129|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
125325565|NCT01054885|450827123|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
125325566|NCT01054885|450827124|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
125325567|NCT01054885|450827125|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
125325568|NCT01054885|450827126|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
125325569|NCT01054885|450827127|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
125325570|NCT01054885|450827128|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
125325571|NCT01054885|450827129|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
125325572|NCT01054885|450827123|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
125325573|NCT01054885|450827124|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
125325574|NCT01054885|450827125|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
125325575|NCT01054885|450827126|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
125325576|NCT01054885|450827127|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
125325577|NCT01054885|450827128|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
125325578|NCT01054885|450827129|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
125325579|NCT01421719|450827132|FG000|Overall Study|Withdrawal by Subject|4|||
125325580|NCT01942837|450827133|FG000|Overall Study|Death|1|||
125325581|NCT01942837|450827133|FG000|Overall Study|Symptomatic or radiographic progression|49|||
125325582|NCT01942837|450827133|FG000|Overall Study|Adverse Event|6|||
125325583|NCT01942837|450827133|FG000|Overall Study|Physician Decision|3|||
124996166|NCT00171704|449613976|FG000|Overall Study|Withdrawal by Subject|1|||
124996167|NCT00171704|449613977|FG001|Overall Study|Withdrawal by Subject|3|||
124996168|NCT00171704|449613976|FG000|Overall Study|Protocol Violation|0|||
124996169|NCT00171704|449613977|FG001|Overall Study|Protocol Violation|1|||
124996170|NCT02141984|449613978|FG000|Overall Study|Lack of Efficacy|2|||
124996171|NCT00816400|449613982|FG000|Overall Study|Death|2|||
124996172|NCT00816400|449613983|FG001|Overall Study|Death|3|||
124996173|NCT00816400|449613984|FG002|Overall Study|Death|3|||
124996174|NCT00816400|449613985|FG003|Overall Study|Death|3|||
124996175|NCT00816400|449613986|FG004|Overall Study|Death|2|||
124996176|NCT00816400|449613987|FG005|Overall Study|Death|3|||
124996177|NCT00816400|449613988|FG006|Overall Study|Death|2|||
124996178|NCT00816400|449613989|FG007|Overall Study|Death|5|||
124996179|NCT00816400|449613990|FG008|Overall Study|Death|6|||
124996180|NCT00816400|449613982|FG000|Overall Study|In hospice care at the end of the study|0|||
124996181|NCT00816400|449613983|FG001|Overall Study|In hospice care at the end of the study|0|||
124996182|NCT00816400|449613984|FG002|Overall Study|In hospice care at the end of the study|2|||
124996183|NCT00816400|449613985|FG003|Overall Study|In hospice care at the end of the study|0|||
124996184|NCT00816400|449613986|FG004|Overall Study|In hospice care at the end of the study|0|||
124996185|NCT00816400|449613987|FG005|Overall Study|In hospice care at the end of the study|0|||
124996186|NCT00816400|449613988|FG006|Overall Study|In hospice care at the end of the study|0|||
124996187|NCT00816400|449613989|FG007|Overall Study|In hospice care at the end of the study|0|||
124996188|NCT00816400|449613990|FG008|Overall Study|In hospice care at the end of the study|0|||
124996189|NCT00081770|449613991|FG000|Overall Study|Adverse Event|130|||
124996190|NCT00081770|449613992|FG001|Overall Study|Adverse Event|98|||
124996191|NCT00081770|449613993|FG002|Overall Study|Adverse Event|136|||
124996192|NCT00081770|449613991|FG000|Overall Study|Lack of Efficacy|262|||
125325584|NCT01942837|450827133|FG000|Overall Study|Withdrawal by Subject|2|||
125325585|NCT01942837|450827133|FG000|Overall Study|Intercurrent Illness|1|||
124996193|NCT00081770|449613992|FG001|Overall Study|Lack of Efficacy|357|||
124996194|NCT00081770|449613993|FG002|Overall Study|Lack of Efficacy|211|||
124996195|NCT00081770|449613991|FG000|Overall Study|Lost to Follow-up|45|||
124996196|NCT00081770|449613992|FG001|Overall Study|Lost to Follow-up|34|||
124996197|NCT00081770|449613993|FG002|Overall Study|Lost to Follow-up|45|||
124996198|NCT00081770|449613991|FG000|Overall Study|Protocol Violation|15|||
124996199|NCT00081770|449613992|FG001|Overall Study|Protocol Violation|10|||
125210683|NCT02638259|450395635|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
124996200|NCT00081770|449613993|FG002|Overall Study|Protocol Violation|10|||
125325586|NCT01942837|450827133|FG000|Overall Study|On treatment|3|||
125325587|NCT01942837|450827133|FG000|Overall Study|Never initiate the treatment|2|||
125325588|NCT03250273|450827145|FG000|Overall Study|Disease Progression|2|||
125325589|NCT03250273|450827146|FG001|Overall Study|Disease Progression|11|||
125325590|NCT03250273|450827145|FG000|Overall Study|Death|0|||
125325591|NCT03250273|450827146|FG001|Overall Study|Death|1|||
125325592|NCT04226742|450827147|FG000|Overall Study|Lost to Follow-up|16|||
125325593|NCT04226742|450827148|FG001|Overall Study|Lost to Follow-up|13|||
125325594|NCT04226742|450827147|FG000|Overall Study|Withdrawal by Subject|5|||
125325595|NCT04226742|450827148|FG001|Overall Study|Withdrawal by Subject|3|||
125325596|NCT01759446|450827150|FG000|Overall Study|Protocol Violation|1|||
125325597|NCT01759446|450827151|FG001|Overall Study|Protocol Violation|0|||
125325598|NCT01759446|450827152|FG002|Overall Study|Protocol Violation|1|||
125325599|NCT01759446|450827153|FG003|Overall Study|Protocol Violation|0|||
125325600|NCT01759446|450827154|FG004|Overall Study|Protocol Violation|0|||
125325601|NCT01759446|450827150|FG000|Overall Study|Withdrawal by Subject|0|||
125325602|NCT01759446|450827151|FG001|Overall Study|Withdrawal by Subject|1|||
125325603|NCT01759446|450827152|FG002|Overall Study|Withdrawal by Subject|0|||
125325604|NCT01759446|450827153|FG003|Overall Study|Withdrawal by Subject|1|||
125325605|NCT01759446|450827154|FG004|Overall Study|Withdrawal by Subject|0|||
125325606|NCT04646044|450827156|FG000|Overall Study|Lost to Follow-up|0|||
125325607|NCT04646044|450827157|FG001|Overall Study|Lost to Follow-up|0|||
125325608|NCT04646044|450827158|FG002|Overall Study|Lost to Follow-up|1|||
124996201|NCT00081770|449613991|FG000|Overall Study|Withdrawal by Subject|45|||
124996202|NCT00081770|449613992|FG001|Overall Study|Withdrawal by Subject|40|||
124996203|NCT00081770|449613993|FG002|Overall Study|Withdrawal by Subject|42|||
124996204|NCT00081770|449613991|FG000|Overall Study|Did not meet protocol eligibility|2|||
124996205|NCT00081770|449613992|FG001|Overall Study|Did not meet protocol eligibility|0|||
124996206|NCT00081770|449613993|FG002|Overall Study|Did not meet protocol eligibility|3|||
124996207|NCT00081770|449613991|FG000|Overall Study|Administrative|1|||
124996208|NCT00081770|449613992|FG001|Overall Study|Administrative|0|||
124996209|NCT00081770|449613993|FG002|Overall Study|Administrative|1|||
124996210|NCT00081770|449613991|FG000|Overall Study|Other|2|||
124996211|NCT00081770|449613992|FG001|Overall Study|Other|7|||
124996212|NCT00081770|449613993|FG002|Overall Study|Other|8|||
124996213|NCT00601419|449613994|FG000|Overall Study|Lost to Follow-up|3|||
124996214|NCT00601419|449613994|FG000|Overall Study|Missed Visits|1|||
124996215|NCT01614197|449613995|FG000|Overall Study|Withdrawal by Subject|0|||
124996216|NCT01614197|449613996|FG001|Overall Study|Withdrawal by Subject|1|||
124996217|NCT01614197|449613997|FG002|Overall Study|Withdrawal by Subject|0|||
124996218|NCT01614197|449613998|FG003|Overall Study|Withdrawal by Subject|0|||
124996219|NCT02245672|449613999|FG000|Overall Study|Adverse Event|4|||
124996220|NCT02245672|449614000|FG001|Overall Study|Adverse Event|4|||
124996221|NCT02245672|449614001|FG002|Overall Study|Adverse Event|4|||
124996222|NCT02245672|449613999|FG000|Overall Study|Lost to Follow-up|3|||
124996223|NCT02245672|449614000|FG001|Overall Study|Lost to Follow-up|5|||
124996224|NCT02245672|449614001|FG002|Overall Study|Lost to Follow-up|1|||
124996225|NCT02245672|449613999|FG000|Overall Study|Withdrawal by Subject|6|||
124996226|NCT02245672|449614000|FG001|Overall Study|Withdrawal by Subject|3|||
124996227|NCT02245672|449614001|FG002|Overall Study|Withdrawal by Subject|0|||
124996228|NCT02245672|449613999|FG000|Overall Study|Randomized in error (not treated)|0|||
124996229|NCT02245672|449614000|FG001|Overall Study|Randomized in error (not treated)|1|||
124996230|NCT02245672|449614001|FG002|Overall Study|Randomized in error (not treated)|0|||
124996231|NCT00971932|449614002|FG000|Overall Study|Withdrawal by Subject|1|||
124996232|NCT00971932|449614002|FG000|Overall Study|Investigator's decision|2|||
124996233|NCT00971932|449614002|FG000|Overall Study|Ongoing|4|||
124996234|NCT01765192|449614005|FG000|Treatment Period 1|Adverse Event|0|||
124996235|NCT01765192|449614006|FG001|Treatment Period 1|Adverse Event|1|||
124996236|NCT01765192|449614005|FG000|Washout Period|Voluntary Withdrawal|1|||
124996237|NCT01765192|449614006|FG001|Washout Period|Voluntary Withdrawal|1|||
124996238|NCT01765192|449614005|FG000|Washout Period|Reason not specified|1|||
124996239|NCT01765192|449614006|FG001|Washout Period|Reason not specified|0|||
124996240|NCT01765192|449614005|FG000|Treatment Period 2|Reason not specified|0|||
124996241|NCT01765192|449614006|FG001|Treatment Period 2|Reason not specified|2|||
124996242|NCT01765192|449614005|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
124996243|NCT01765192|449614006|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
124996244|NCT00876694|449614011|FG000|Overall Study|Adverse Event|10|||
124996245|NCT00876694|449614012|FG001|Overall Study|Adverse Event|7|||
125325609|NCT04646044|450827159|FG003|Overall Study|Lost to Follow-up|0|||
125325610|NCT04646044|450827156|FG000|Overall Study|Withdrawal by Subject|0|||
124996246|NCT00876694|449614011|FG000|Overall Study|Subject withdrew consent|6|||
124996247|NCT00876694|449614012|FG001|Overall Study|Subject withdrew consent|4|||
125325611|NCT04646044|450827157|FG001|Overall Study|Withdrawal by Subject|1|||
124996248|NCT00876694|449614011|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125325612|NCT04646044|450827158|FG002|Overall Study|Withdrawal by Subject|0|||
124996249|NCT00876694|449614012|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124996250|NCT00876694|449614011|FG000|Overall Study|Abnormal test procedure result(s)|1|||
124996251|NCT00876694|449614012|FG001|Overall Study|Abnormal test procedure result(s)|0|||
124996252|NCT00876694|449614011|FG000|Overall Study|Administrative problems|1|||
124996253|NCT00876694|449614012|FG001|Overall Study|Administrative problems|1|||
125325613|NCT04646044|450827159|FG003|Overall Study|Withdrawal by Subject|0|||
125325614|NCT01391546|450827160|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
125325615|NCT01391546|450827161|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
125325616|NCT02156076|450827163|FG000|Treatment Period|no longer meets study criteria|0|||
125325617|NCT02156076|450827164|FG001|Treatment Period|no longer meets study criteria|0|||
125325618|NCT02156076|450827165|FG002|Treatment Period|no longer meets study criteria|1|||
125325619|NCT02156076|450827166|FG003|Treatment Period|no longer meets study criteria|0|||
125325620|NCT02156076|450827163|FG000|Treatment Period|Poor/non-compliance|0|||
125325621|NCT02156076|450827164|FG001|Treatment Period|Poor/non-compliance|1|||
125325622|NCT02156076|450827165|FG002|Treatment Period|Poor/non-compliance|0|||
125325623|NCT02156076|450827166|FG003|Treatment Period|Poor/non-compliance|0|||
125325624|NCT02156076|450827163|FG000|Treatment Period|Lost to Follow-up|0|||
124996254|NCT00876694|449614011|FG000|Overall Study|Death|1|||
124996255|NCT00876694|449614012|FG001|Overall Study|Death|0|||
124996256|NCT01215422|449614017|FG000|Overall Study|Relocation|1|||
124996257|NCT01215422|449614018|FG001|Overall Study|Relocation|0|||
124996258|NCT01215422|449614019|FG002|Overall Study|Relocation|0|||
124996259|NCT01215422|449614020|FG003|Overall Study|Relocation|0|||
124996260|NCT01215422|449614017|FG000|Overall Study|Failed intubations|0|||
124996261|NCT01215422|449614018|FG001|Overall Study|Failed intubations|0|||
124996262|NCT01215422|449614019|FG002|Overall Study|Failed intubations|3|||
124996263|NCT01215422|449614020|FG003|Overall Study|Failed intubations|8|||
124996264|NCT01215422|449614017|FG000|Overall Study|Did not complete all intubations|7|||
124996265|NCT01215422|449614018|FG001|Overall Study|Did not complete all intubations|0|||
124996266|NCT01215422|449614019|FG002|Overall Study|Did not complete all intubations|0|||
124996267|NCT01215422|449614020|FG003|Overall Study|Did not complete all intubations|0|||
124996268|NCT00294554|449614023|FG000|Overall Study|Lack of Efficacy|0|||
124996269|NCT00294554|449614024|FG001|Overall Study|Lack of Efficacy|1|||
124996270|NCT00294554|449614023|FG000|Overall Study|Physician Decision|0|||
124996271|NCT00294554|449614024|FG001|Overall Study|Physician Decision|1|||
124996272|NCT00462865|449614025|FG000|Overall Study|Adverse Event|1|||
124996273|NCT02864381|449614026|FG000|Overall Study|Death|58|||
124996274|NCT02864381|449614027|FG001|Overall Study|Death|61|||
124996275|NCT02864381|449614026|FG000|Overall Study|Withdrew Consent|5|||
124996276|NCT02864381|449614027|FG001|Overall Study|Withdrew Consent|6|||
124996277|NCT02864381|449614026|FG000|Overall Study|Reason Unknown|7|||
124996278|NCT02864381|449614027|FG001|Overall Study|Reason Unknown|3|||
124996279|NCT02864381|449614026|FG000|Overall Study|Lost to Follow-up|1|||
124996280|NCT02864381|449614027|FG001|Overall Study|Lost to Follow-up|1|||
124996281|NCT02864381|449614026|FG000|Overall Study|Investigator's Discretion|1|||
124996282|NCT02864381|449614027|FG001|Overall Study|Investigator's Discretion|0|||
124996283|NCT02864381|449614026|FG000|Overall Study|Protocol Violation|0|||
124996284|NCT02864381|449614027|FG001|Overall Study|Protocol Violation|1|||
124996285|NCT04142450|449614028|FG000|Overall Study|Screen Failure|1|||
124996286|NCT04142450|449614028|FG000|Overall Study|Lost to Follow-up|1|||
124996287|NCT02544217|449614029|FG000|Overall Study|Withdrawal by Subject|1|||
124996288|NCT02544217|449614030|FG001|Overall Study|Withdrawal by Subject|1|||
124996289|NCT02544217|449614031|FG002|Overall Study|Withdrawal by Subject|0|||
124996290|NCT02544217|449614032|FG003|Overall Study|Withdrawal by Subject|0|||
124996291|NCT02544217|449614033|FG004|Overall Study|Withdrawal by Subject|0|||
124996292|NCT02544217|449614034|FG005|Overall Study|Withdrawal by Subject|0|||
124996293|NCT01146054|449614037|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
124996294|NCT01146054|449614037|FG000|Overall Study|Rapid tumor progression|2|||
124996295|NCT01146054|449614037|FG000|Overall Study|Other illness precluded treatment|2|||
124996296|NCT01146054|449614037|FG000|Overall Study|Lost to Follow-up|1|||
124996297|NCT04335812|449614038|FG000|Overall Study|Withdrawal by Subject|1|||
124996298|NCT04335812|449614039|FG001|Overall Study|Withdrawal by Subject|3|||
124996299|NCT04335812|449614038|FG000|Overall Study|Lost to Follow-up|12|||
124996300|NCT04335812|449614039|FG001|Overall Study|Lost to Follow-up|12|||
124996301|NCT04335812|449614038|FG000|Overall Study|Did not engage in the intervention|22|||
124996302|NCT04335812|449614039|FG001|Overall Study|Did not engage in the intervention|18|||
124996303|NCT02901041|449614050|FG000|Overall Study|Withdrawal by PI|4|||
124996304|NCT02901041|449614051|FG001|Overall Study|Withdrawal by PI|8|||
124996305|NCT02901041|449614050|FG000|Overall Study|Withdrawal by Subject|7|||
124996306|NCT02901041|449614051|FG001|Overall Study|Withdrawal by Subject|3|||
124996307|NCT00975507|449614052|FG000|Overall Study|Adverse Event|1|||
124996308|NCT00975507|449614053|FG001|Overall Study|Adverse Event|0|||
124996309|NCT00975507|449614052|FG000|Overall Study|Lost to Follow-up|7|||
125325625|NCT02156076|450827164|FG001|Treatment Period|Lost to Follow-up|0|||
124996310|NCT00975507|449614053|FG001|Overall Study|Lost to Follow-up|1|||
124996311|NCT00975507|449614052|FG000|Overall Study|Protocol Violation|2|||
124996312|NCT00975507|449614053|FG001|Overall Study|Protocol Violation|0|||
124996313|NCT00975507|449614052|FG000|Overall Study|Withdrawal by Subject|10|||
124996314|NCT00975507|449614053|FG001|Overall Study|Withdrawal by Subject|3|||
125325626|NCT02156076|450827165|FG002|Treatment Period|Lost to Follow-up|0|||
125325627|NCT02156076|450827166|FG003|Treatment Period|Lost to Follow-up|1|||
125325628|NCT02156076|450827163|FG000|Treatment Period|Withdrawal by Subject|0|||
125325629|NCT02156076|450827164|FG001|Treatment Period|Withdrawal by Subject|0|||
125325630|NCT02156076|450827165|FG002|Treatment Period|Withdrawal by Subject|1|||
125325631|NCT02156076|450827166|FG003|Treatment Period|Withdrawal by Subject|0|||
125325632|NCT02156076|450827163|FG000|Treatment Period|Subject request to discontinue treatment|0|||
125325633|NCT02156076|450827164|FG001|Treatment Period|Subject request to discontinue treatment|1|||
125325634|NCT02156076|450827165|FG002|Treatment Period|Subject request to discontinue treatment|0|||
125325635|NCT02156076|450827166|FG003|Treatment Period|Subject request to discontinue treatment|0|||
125325636|NCT02156076|450827163|FG000|Treatment Period|Adverse Event|0|||
125325637|NCT02156076|450827164|FG001|Treatment Period|Adverse Event|0|||
125325638|NCT02156076|450827165|FG002|Treatment Period|Adverse Event|0|||
125325639|NCT02156076|450827166|FG003|Treatment Period|Adverse Event|1|||
125325640|NCT02156076|450827163|FG000|Follow-up Period|Withdrawal by Subject|1|||
125325641|NCT02156076|450827164|FG001|Follow-up Period|Withdrawal by Subject|0|||
125325642|NCT02156076|450827165|FG002|Follow-up Period|Withdrawal by Subject|0|||
125325643|NCT02156076|450827166|FG003|Follow-up Period|Withdrawal by Subject|0|||
125325644|NCT01213472|450827169|FG000|Overall Study|Recurrence/Progressive disease|25|||
125325645|NCT01213472|450827169|FG000|Overall Study|Withdrawal by Subject|1|||
125325646|NCT01213472|450827169|FG000|Overall Study|Physician Decision|1|||
125325647|NCT04225897|450827170|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325648|NCT04225897|450827171|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
125325649|NCT04225897|450827172|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325650|NCT04225897|450827173|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325651|NCT04225897|450827174|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325652|NCT04225897|450827175|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325653|NCT04225897|450827176|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325654|NCT04225897|450827177|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325655|NCT04225897|450827178|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325656|NCT04225897|450827179|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325657|NCT04225897|450827180|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325658|NCT04225897|450827181|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325659|NCT04225897|450827170|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325660|NCT04225897|450827171|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325661|NCT04225897|450827172|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
125325662|NCT04225897|450827173|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325663|NCT04225897|450827174|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325664|NCT04225897|450827175|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325665|NCT04225897|450827176|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325666|NCT04225897|450827177|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325667|NCT04225897|450827178|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325668|NCT04225897|450827179|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325669|NCT04225897|450827180|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325670|NCT04225897|450827181|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325671|NCT04225897|450827170|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325672|NCT04225897|450827171|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325673|NCT04225897|450827172|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
125325674|NCT04225897|450827173|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325675|NCT04225897|450827174|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325676|NCT04225897|450827175|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325677|NCT04225897|450827176|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325678|NCT04225897|450827177|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325679|NCT04225897|450827178|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325680|NCT04225897|450827179|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325681|NCT04225897|450827180|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325682|NCT04225897|450827181|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325683|NCT04225897|450827170|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125325684|NCT04225897|450827171|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125325685|NCT04225897|450827172|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125325686|NCT04225897|450827173|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125325687|NCT04225897|450827174|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125325688|NCT04225897|450827175|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125325689|NCT04225897|450827176|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125325690|NCT04225897|450827177|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
125325691|NCT04225897|450827178|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125210684|NCT02638259|450395634|FG000|Treatment Period 2|Adverse Event|5|||
125325692|NCT04225897|450827179|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125325693|NCT04225897|450827180|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125325694|NCT04225897|450827181|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125325695|NCT02085460|450827182|FG000|Overall Study|Adverse Event|2|||
125325696|NCT02085460|450827183|FG001|Overall Study|Adverse Event|2|||
125325697|NCT02085460|450827184|FG002|Overall Study|Adverse Event|1|||
125325698|NCT02085460|450827182|FG000|Overall Study|Physician Decision|1|||
125325699|NCT02085460|450827183|FG001|Overall Study|Physician Decision|1|||
125325700|NCT02085460|450827184|FG002|Overall Study|Physician Decision|2|||
125325701|NCT02085460|450827182|FG000|Overall Study|Withdrawal by Subject|11|||
125325702|NCT02085460|450827183|FG001|Overall Study|Withdrawal by Subject|5|||
125325703|NCT02085460|450827184|FG002|Overall Study|Withdrawal by Subject|7|||
125325704|NCT01285323|450827185|FG000|Overall Study|Adverse Event|9|||
125325705|NCT01285323|450827186|FG001|Overall Study|Adverse Event|8|||
125325706|NCT01285323|450827185|FG000|Overall Study|Lack of Efficacy|4|||
125325707|NCT01285323|450827186|FG001|Overall Study|Lack of Efficacy|2|||
125325708|NCT01285323|450827185|FG000|Overall Study|Withdrawal by Subject|15|||
125325709|NCT01285323|450827186|FG001|Overall Study|Withdrawal by Subject|11|||
125325710|NCT01285323|450827185|FG000|Overall Study|Protocol Violation|1|||
125325711|NCT01285323|450827186|FG001|Overall Study|Protocol Violation|2|||
125325712|NCT01285323|450827185|FG000|Overall Study|Non-compliance with study procedures|2|||
125325713|NCT01285323|450827186|FG001|Overall Study|Non-compliance with study procedures|3|||
125325714|NCT01285323|450827185|FG000|Overall Study|Lost to Follow-up|1|||
125325715|NCT01285323|450827186|FG001|Overall Study|Lost to Follow-up|1|||
125325716|NCT01285323|450827185|FG000|Overall Study|Other|1|||
125325717|NCT01285323|450827186|FG001|Overall Study|Other|3|||
125325718|NCT02703597|450827187|FG000|Assignment to Baseline|Lost to Follow-up|17|||
125325719|NCT02703597|450827188|FG001|Assignment to Baseline|Lost to Follow-up|16|||
125325720|NCT02703597|450827187|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
125325721|NCT02703597|450827188|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
125325722|NCT02703597|450827187|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
125325723|NCT02703597|450827188|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
125325724|NCT02703597|450827187|FG000|First Post-test to First Follow-up|Site drop out|0|||
125325725|NCT02703597|450827188|FG001|First Post-test to First Follow-up|Site drop out|58|||
125325726|NCT02703597|450827187|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
125325727|NCT02703597|450827188|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
125325728|NCT02703597|450827187|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
125325729|NCT02703597|450827188|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
125325730|NCT02703597|450827187|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
125325731|NCT02703597|450827188|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
125325732|NCT02606643|450827189|FG000|Overall Study|did not meet inclusion criteria|1|||
125325733|NCT02606643|450827190|FG001|Overall Study|did not meet inclusion criteria|3|||
125325734|NCT02796170|450827192|FG000|Overall Study|Lost to Follow-up|3|||
125325735|NCT02796170|450827193|FG001|Overall Study|Lost to Follow-up|0|||
125325736|NCT04313244|450827197|FG000|Overall Study|Withdrawal of Consent|3|||
125325737|NCT04313244|450827198|FG001|Overall Study|Withdrawal of Consent|3|||
125325738|NCT04313244|450827197|FG000|Overall Study|Met Exclusion Criteria|1|||
125325739|NCT04313244|450827198|FG001|Overall Study|Met Exclusion Criteria|0|||
125325740|NCT04313244|450827197|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
125325741|NCT04313244|450827198|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
125325742|NCT01472289|450827201|FG000|Overall Study|Death|2|||
125325743|NCT00907335|450827202|FG000|Overall Study|Withdrawal by Subject|2|||
125325744|NCT00907335|450827203|FG001|Overall Study|Withdrawal by Subject|0|||
125325745|NCT00907335|450827202|FG000|Overall Study|Adverse Event|4|||
125325746|NCT00907335|450827203|FG001|Overall Study|Adverse Event|1|||
125325747|NCT00907335|450827202|FG000|Overall Study|Lost to Follow-up|2|||
125325748|NCT00907335|450827203|FG001|Overall Study|Lost to Follow-up|0|||
125325749|NCT03873116|450827204|FG000|Part 1|Study drug discontinuation due to rash|0|||
125325750|NCT03873116|450827205|FG001|Part 1|Study drug discontinuation due to rash|0|||
125325751|NCT03873116|450827206|FG002|Part 1|Study drug discontinuation due to rash|0|||
125325752|NCT03873116|450827207|FG003|Part 1|Study drug discontinuation due to rash|0|||
125325753|NCT03873116|450827208|FG004|Part 1|Study drug discontinuation due to rash|0|||
125325754|NCT03873116|450827209|FG005|Part 1|Study drug discontinuation due to rash|1|||
125325755|NCT03873116|450827204|FG000|Part 2|Withdrawal by Subject|0|||
125325756|NCT03873116|450827205|FG001|Part 2|Withdrawal by Subject|0|||
125325757|NCT03873116|450827206|FG002|Part 2|Withdrawal by Subject|1|||
125325758|NCT03873116|450827207|FG003|Part 2|Withdrawal by Subject|0|||
125325759|NCT03873116|450827208|FG004|Part 2|Withdrawal by Subject|0|||
125325760|NCT03873116|450827209|FG005|Part 2|Withdrawal by Subject|0|||
125325761|NCT03873116|450827204|FG000|Part 2|Lab abnormality or AE|0|||
125325762|NCT03873116|450827205|FG001|Part 2|Lab abnormality or AE|0|||
125325763|NCT03873116|450827206|FG002|Part 2|Lab abnormality or AE|0|||
125325764|NCT03873116|450827207|FG003|Part 2|Lab abnormality or AE|0|||
125325765|NCT03873116|450827208|FG004|Part 2|Lab abnormality or AE|1|||
125325766|NCT03873116|450827209|FG005|Part 2|Lab abnormality or AE|0|||
125325767|NCT03873116|450827204|FG000|Part 3|Withdrawal by Subject|0|||
125325768|NCT03873116|450827205|FG001|Part 3|Withdrawal by Subject|0|||
125325769|NCT03873116|450827206|FG002|Part 3|Withdrawal by Subject|0|||
125325770|NCT03873116|450827207|FG003|Part 3|Withdrawal by Subject|0|||
125325771|NCT03873116|450827208|FG004|Part 3|Withdrawal by Subject|1|||
125325772|NCT03873116|450827209|FG005|Part 3|Withdrawal by Subject|0|||
125325773|NCT00912808|450827210|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
125325774|NCT00912808|450827211|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
125325775|NCT00912808|450827210|FG000|Washout|Withdrawal by Subject|0|||
125325776|NCT00912808|450827211|FG001|Washout|Withdrawal by Subject|1|||
125325777|NCT00912808|450827210|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
125325778|NCT00912808|450827211|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
125325779|NCT00912808|450827210|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
125325780|NCT00912808|450827211|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
125325781|NCT00474812|450827223|FG000|Overall Study|Withdrawal by Subject|5|||
125325782|NCT00474812|450827223|FG000|Overall Study|No Initiation of treatment|2|||
125325783|NCT03955146|450827231|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
125325784|NCT03955146|450827232|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
125325785|NCT03955146|450827233|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
125325786|NCT03955146|450827234|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
125325787|NCT03955146|450827231|FG000|DB Period (48 Weeks)|Adverse Event|2|||
125325788|NCT03955146|450827232|FG001|DB Period (48 Weeks)|Adverse Event|5|||
125325789|NCT03955146|450827233|FG002|DB Period (48 Weeks)|Adverse Event|1|||
125325790|NCT03955146|450827234|FG003|DB Period (48 Weeks)|Adverse Event|2|||
125325791|NCT03955146|450827231|FG000|DB Period (48 Weeks)|Death|13|||
125325792|NCT03955146|450827232|FG001|DB Period (48 Weeks)|Death|17|||
125325793|NCT03955146|450827233|FG002|DB Period (48 Weeks)|Death|1|||
125325794|NCT03955146|450827234|FG003|DB Period (48 Weeks)|Death|0|||
125325795|NCT03955146|450827231|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
125325796|NCT03955146|450827232|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
125325797|NCT03955146|450827233|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
125325798|NCT03955146|450827234|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
125325799|NCT03955146|450827231|FG000|DB Period (48 Weeks)|Disease Progression|2|||
125325800|NCT03955146|450827232|FG001|DB Period (48 Weeks)|Disease Progression|0|||
125325801|NCT03955146|450827233|FG002|DB Period (48 Weeks)|Disease Progression|0|||
125325802|NCT03955146|450827234|FG003|DB Period (48 Weeks)|Disease Progression|0|||
125325803|NCT03955146|450827231|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
125325804|NCT03955146|450827232|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
125325805|NCT03955146|450827233|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
125325806|NCT03955146|450827234|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
125325807|NCT03955146|450827231|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
125325808|NCT03955146|450827232|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
125325809|NCT03955146|450827233|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
125325810|NCT03955146|450827234|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
125325811|NCT03955146|450827231|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
125325812|NCT03955146|450827232|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
125325813|NCT03955146|450827233|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
125325814|NCT03955146|450827234|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
125325815|NCT03955146|450827231|FG000|DB Period (48 Weeks)|Participant Decision|9|||
125325816|NCT03955146|450827232|FG001|DB Period (48 Weeks)|Participant Decision|12|||
125325817|NCT03955146|450827233|FG002|DB Period (48 Weeks)|Participant Decision|1|||
125325818|NCT03955146|450827234|FG003|DB Period (48 Weeks)|Participant Decision|1|||
124996315|NCT03249714|449614054|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
124996316|NCT03249714|449614055|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
124996317|NCT03249714|449614054|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
124996318|NCT03249714|449614055|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
124996319|NCT03249714|449614054|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
124996320|NCT03249714|449614055|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
124996321|NCT03249714|449614054|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
124996322|NCT03249714|449614055|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
124996323|NCT01112306|449614061|FG000|Overall Study|Death|175|||
125325819|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
125325820|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
125325821|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
125325822|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
125325823|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
125325824|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
125325825|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
125325826|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
125325827|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
125325828|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
125325829|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
125325830|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
125325831|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
125325832|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
124996324|NCT01112306|449614061|FG000|Overall Study|Lost to Follow-up|9|||
124996325|NCT01112306|449614061|FG000|Overall Study|Withdrawal by Subject|31|||
124996326|NCT01112306|449614061|FG000|Overall Study|Other|70|||
124996327|NCT01607554|449614065|FG000|Overall Study|Disease progression|2|||
124996328|NCT03952806|449614066|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
125325833|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
125325834|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
125325835|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
125325836|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
124996329|NCT03952806|449614067|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
124996330|NCT03952806|449614066|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
124996331|NCT03952806|449614067|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
125325837|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
125325838|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
125325839|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
125325840|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
125325841|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
125325842|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
125325843|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
125325844|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
125325845|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
125325846|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
125325847|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
125325848|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
125325849|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
125325850|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
125325851|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
125325852|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
125325853|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
125325854|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
125325855|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
125325856|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
125325857|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
125325858|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
125325859|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
125325860|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
125325861|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
125325862|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
125325863|NCT04363320|450827237|FG000|Overall Study|Lost to Follow-up|43|||
125325864|NCT04363320|450827238|FG001|Overall Study|Lost to Follow-up|42|||
125325865|NCT04363320|450827239|FG002|Overall Study|Lost to Follow-up|24|||
125325866|NCT04363320|450827240|FG003|Overall Study|Lost to Follow-up|29|||
125325867|NCT04363320|450827237|FG000|Overall Study|Death|0|||
125325868|NCT04363320|450827238|FG001|Overall Study|Death|0|||
125325869|NCT04363320|450827239|FG002|Overall Study|Death|1|||
125325870|NCT04363320|450827240|FG003|Overall Study|Death|0|||
125325871|NCT02002598|450827241|FG000|Dose Level 1|Withdrawal by Subject|1|||
125325872|NCT02002598|450827242|FG001|Dose Level 1|Withdrawal by Subject|0|||
125325873|NCT02002598|450827243|FG002|Dose Level 1|Withdrawal by Subject|0|||
125325874|NCT02002598|450827244|FG003|Dose Level 1|Withdrawal by Subject|0|||
125325875|NCT02002598|450827245|FG004|Dose Level 1|Withdrawal by Subject|0|||
125325876|NCT05632211|450827246|FG000|Overall Study|Withdrawal by Subject|2|||
125325877|NCT05632211|450827247|FG001|Overall Study|Withdrawal by Subject|0|||
125325878|NCT05632211|450827248|FG002|Overall Study|Withdrawal by Subject|2|||
125325879|NCT05632211|450827246|FG000|Overall Study|Other reasons|1|||
125325880|NCT05632211|450827247|FG001|Overall Study|Other reasons|1|||
125325881|NCT05632211|450827248|FG002|Overall Study|Other reasons|1|||
125325882|NCT02628873|450827249|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
125325883|NCT02628873|450827250|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
125325884|NCT02628873|450827249|FG000|Second Test (1 Hour)|Physician Decision|1|||
125325885|NCT02628873|450827250|FG001|Second Test (1 Hour)|Physician Decision|0|||
124996332|NCT03952806|449614066|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
125325886|NCT00541658|450827251|FG000|Overall Study|Adverse Event|28|||
125325887|NCT00541658|450827252|FG001|Overall Study|Adverse Event|37|||
125325888|NCT00541658|450827253|FG002|Overall Study|Adverse Event|25|||
125325889|NCT00541658|450827251|FG000|Overall Study|Physician Decision|0|||
125325890|NCT00541658|450827252|FG001|Overall Study|Physician Decision|0|||
125325891|NCT00541658|450827253|FG002|Overall Study|Physician Decision|4|||
125325892|NCT00541658|450827251|FG000|Overall Study|Lost to Follow-up|3|||
125325893|NCT00541658|450827252|FG001|Overall Study|Lost to Follow-up|3|||
125325894|NCT00541658|450827253|FG002|Overall Study|Lost to Follow-up|6|||
125325895|NCT00541658|450827251|FG000|Overall Study|Protocol Violation|0|||
125325896|NCT00541658|450827252|FG001|Overall Study|Protocol Violation|1|||
125325897|NCT00541658|450827253|FG002|Overall Study|Protocol Violation|1|||
125325898|NCT00541658|450827251|FG000|Overall Study|Withdrawal by Subject|28|||
125325899|NCT00541658|450827252|FG001|Overall Study|Withdrawal by Subject|32|||
125325900|NCT00541658|450827253|FG002|Overall Study|Withdrawal by Subject|32|||
125325901|NCT00541658|450827251|FG000|Overall Study|Took No Study Drug|1|||
125325902|NCT00541658|450827252|FG001|Overall Study|Took No Study Drug|0|||
125325903|NCT00541658|450827253|FG002|Overall Study|Took No Study Drug|0|||
125325904|NCT04123470|450827254|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
125325905|NCT04123470|450827255|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
125325906|NCT04123470|450827254|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
125325907|NCT04123470|450827255|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
125325908|NCT04123470|450827254|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
125325909|NCT04123470|450827255|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
125325910|NCT04123470|450827254|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
125325911|NCT04123470|450827255|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
125325912|NCT02195518|450827256|FG000|Overall Study|Adverse Event|1|||
125325913|NCT02195518|450827256|FG000|Overall Study|Protocol Violation|4|||
125325914|NCT02195518|450827256|FG000|Overall Study|Pregnancy|2|||
125325915|NCT02195518|450827256|FG000|Overall Study|Withdrawal by Subject|1|||
125325916|NCT02195518|450827256|FG000|Overall Study|Lost to Follow-up|1|||
125325917|NCT05530252|450827257|FG000|Overall Study|Lost to Follow-up|1|||
125325918|NCT05530252|450827258|FG001|Overall Study|Lost to Follow-up|1|||
125325919|NCT05530252|450827259|FG002|Overall Study|Lost to Follow-up|1|||
125325920|NCT00911170|450827265|FG000|Treatment Period|Randomized in error|1|||
125325921|NCT00911170|450827266|FG001|Treatment Period|Randomized in error|1|||
125325922|NCT00911170|450827265|FG000|Treatment Period|Ineligibility determined|1|||
125325923|NCT00911170|450827266|FG001|Treatment Period|Ineligibility determined|3|||
125325924|NCT00911170|450827265|FG000|Treatment Period|Protocol deviation|1|||
125325925|NCT00911170|450827266|FG001|Treatment Period|Protocol deviation|2|||
125325926|NCT00911170|450827265|FG000|Treatment Period|Adverse Event|9|||
125325927|NCT00911170|450827266|FG001|Treatment Period|Adverse Event|10|||
125325928|NCT00911170|450827265|FG000|Treatment Period|Withdrawal by Subject|4|||
125325929|NCT00911170|450827266|FG001|Treatment Period|Withdrawal by Subject|4|||
125325930|NCT00911170|450827265|FG000|Treatment Period|Disease progression|0|||
125325931|NCT00911170|450827266|FG001|Treatment Period|Disease progression|2|||
125325932|NCT00911170|450827265|FG000|Treatment Period|Physician Decision|5|||
125325933|NCT00911170|450827266|FG001|Treatment Period|Physician Decision|5|||
125325934|NCT00911170|450827265|FG000|Treatment Period|Lost to Follow-up|0|||
125325935|NCT00911170|450827266|FG001|Treatment Period|Lost to Follow-up|1|||
125325936|NCT00911170|450827265|FG000|Treatment Period|Death|6|||
125325937|NCT00911170|450827266|FG001|Treatment Period|Death|9|||
125325938|NCT00911170|450827265|FG000|Long Term Follow-Up|Continuing in study|274|||
125325939|NCT00911170|450827266|FG001|Long Term Follow-Up|Continuing in study|269|||
125325940|NCT00911170|450827265|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
125325941|NCT00911170|450827266|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
125325942|NCT00911170|450827265|FG000|Long Term Follow-Up|Physician Decision|5|||
125325943|NCT00911170|450827266|FG001|Long Term Follow-Up|Physician Decision|4|||
125325944|NCT00911170|450827265|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
125325945|NCT00911170|450827266|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
125325946|NCT00911170|450827265|FG000|Long Term Follow-Up|Death|116|||
125325947|NCT00911170|450827266|FG001|Long Term Follow-Up|Death|121|||
125325948|NCT02594124|450827267|FG000|Overall Study|Adverse Event|0|||
125325949|NCT02594124|450827268|FG001|Overall Study|Adverse Event|5|||
125325950|NCT02594124|450827269|FG002|Overall Study|Adverse Event|8|||
125325951|NCT02594124|450827270|FG003|Overall Study|Adverse Event|1|||
125325952|NCT02594124|450827271|FG004|Overall Study|Adverse Event|0|||
125325953|NCT02594124|450827272|FG005|Overall Study|Adverse Event|0|||
124996333|NCT03952806|449614067|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
124996334|NCT03952806|449614066|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
124996335|NCT03952806|449614067|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
124996336|NCT03952806|449614066|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
125325954|NCT02594124|450827273|FG006|Overall Study|Adverse Event|2|||
125325955|NCT02594124|450827274|FG007|Overall Study|Adverse Event|2|||
125325956|NCT02594124|450827275|FG008|Overall Study|Adverse Event|0|||
124996337|NCT03952806|449614067|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
125325957|NCT02594124|450827267|FG000|Overall Study|Withdrawal by Subject|2|||
125325958|NCT02594124|450827268|FG001|Overall Study|Withdrawal by Subject|3|||
125325959|NCT02594124|450827269|FG002|Overall Study|Withdrawal by Subject|5|||
125325960|NCT02594124|450827270|FG003|Overall Study|Withdrawal by Subject|1|||
125325961|NCT02594124|450827271|FG004|Overall Study|Withdrawal by Subject|8|||
125325962|NCT02594124|450827272|FG005|Overall Study|Withdrawal by Subject|4|||
125325963|NCT02594124|450827273|FG006|Overall Study|Withdrawal by Subject|13|||
125325964|NCT02594124|450827274|FG007|Overall Study|Withdrawal by Subject|19|||
125325965|NCT02594124|450827275|FG008|Overall Study|Withdrawal by Subject|0|||
125325966|NCT02594124|450827267|FG000|Overall Study|Physician Decision|0|||
125325967|NCT02594124|450827268|FG001|Overall Study|Physician Decision|2|||
125325968|NCT02594124|450827269|FG002|Overall Study|Physician Decision|0|||
125325969|NCT02594124|450827270|FG003|Overall Study|Physician Decision|0|||
125325970|NCT02594124|450827271|FG004|Overall Study|Physician Decision|0|||
125325971|NCT02594124|450827272|FG005|Overall Study|Physician Decision|0|||
125325972|NCT02594124|450827273|FG006|Overall Study|Physician Decision|0|||
125325973|NCT02594124|450827274|FG007|Overall Study|Physician Decision|1|||
125325974|NCT02594124|450827275|FG008|Overall Study|Physician Decision|0|||
125325975|NCT02594124|450827267|FG000|Overall Study|Commercial drug|0|||
125325976|NCT02594124|450827268|FG001|Overall Study|Commercial drug|1|||
125325977|NCT02594124|450827269|FG002|Overall Study|Commercial drug|6|||
125325978|NCT02594124|450827270|FG003|Overall Study|Commercial drug|3|||
125325979|NCT02594124|450827271|FG004|Overall Study|Commercial drug|0|||
125325980|NCT02594124|450827272|FG005|Overall Study|Commercial drug|0|||
125325981|NCT02594124|450827273|FG006|Overall Study|Commercial drug|7|||
125325982|NCT02594124|450827274|FG007|Overall Study|Commercial drug|11|||
125325983|NCT02594124|450827275|FG008|Overall Study|Commercial drug|2|||
125325984|NCT02594124|450827267|FG000|Overall Study|Reason Not Specified|1|||
125325985|NCT02594124|450827268|FG001|Overall Study|Reason Not Specified|3|||
125325986|NCT02594124|450827269|FG002|Overall Study|Reason Not Specified|4|||
125325987|NCT02594124|450827270|FG003|Overall Study|Reason Not Specified|0|||
125325988|NCT02594124|450827271|FG004|Overall Study|Reason Not Specified|0|||
125325989|NCT02594124|450827272|FG005|Overall Study|Reason Not Specified|1|||
125325990|NCT02594124|450827273|FG006|Overall Study|Reason Not Specified|1|||
125325991|NCT02594124|450827274|FG007|Overall Study|Reason Not Specified|6|||
125325992|NCT02594124|450827275|FG008|Overall Study|Reason Not Specified|1|||
125325993|NCT02514083|450827280|FG000|Overall Study|Adverse Event|1|||
125325994|NCT02141295|450828915|FG000|Overall Study|Adverse Event|1|||
125325995|NCT02141295|450828916|FG001|Overall Study|Adverse Event|18|||
125325996|NCT02141295|450828917|FG002|Overall Study|Adverse Event|11|||
125325997|NCT02141295|450828915|FG000|Overall Study|Physician Decision|2|||
125325998|NCT02141295|450828916|FG001|Overall Study|Physician Decision|19|||
125325999|NCT02141295|450828917|FG002|Overall Study|Physician Decision|14|||
125326000|NCT02141295|450828915|FG000|Overall Study|Study terminated by sponsor|0|||
125326001|NCT02141295|450828916|FG001|Overall Study|Study terminated by sponsor|6|||
125326002|NCT02141295|450828917|FG002|Overall Study|Study terminated by sponsor|6|||
125326003|NCT02141295|450828915|FG000|Overall Study|Non-compliance|0|||
125326004|NCT02141295|450828916|FG001|Overall Study|Non-compliance|1|||
125326005|NCT02141295|450828917|FG002|Overall Study|Non-compliance|0|||
125326006|NCT02141295|450828915|FG000|Overall Study|Progressive disease|3|||
125326007|NCT02141295|450828916|FG001|Overall Study|Progressive disease|32|||
125326008|NCT02141295|450828917|FG002|Overall Study|Progressive disease|50|||
125326009|NCT02141295|450828915|FG000|Overall Study|Reason not specified|0|||
125326010|NCT02141295|450828916|FG001|Overall Study|Reason not specified|9|||
125326011|NCT02141295|450828917|FG002|Overall Study|Reason not specified|10|||
125326012|NCT02141295|450828915|FG000|Overall Study|Withdrawal by Subject|0|||
125326013|NCT02141295|450828916|FG001|Overall Study|Withdrawal by Subject|9|||
125326014|NCT02141295|450828917|FG002|Overall Study|Withdrawal by Subject|4|||
125326015|NCT01710501|450828918|FG000|Overall Study|Lost to Follow-up|2|||
125326016|NCT01710501|450828919|FG001|Overall Study|Lost to Follow-up|0|||
125326017|NCT01710501|450828920|FG002|Overall Study|Lost to Follow-up|0|||
125326018|NCT02536976|450828921|FG000|Overall Study|Physician Decision|0|||
125326019|NCT02536976|450828922|FG001|Overall Study|Physician Decision|1|||
125326020|NCT01671319|450828925|FG000|Overall Study|Withdrawal by Subject|1|||
125326021|NCT01709084|450828926|FG000|Overall Study|Lost to Follow-up|4|||
125326022|NCT01709084|450828927|FG001|Overall Study|Lost to Follow-up|7|||
125326023|NCT01709084|450828926|FG000|Overall Study|Withdrawal by Subject|2|||
125326024|NCT01709084|450828927|FG001|Overall Study|Withdrawal by Subject|2|||
125326025|NCT01709084|450828926|FG000|Overall Study|Adverse Event|5|||
125326026|NCT01709084|450828927|FG001|Overall Study|Adverse Event|0|||
125326027|NCT01709084|450828926|FG000|Overall Study|Other|5|||
125326028|NCT01709084|450828927|FG001|Overall Study|Other|3|||
125326029|NCT01709084|450828926|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
125326030|NCT01709084|450828927|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
125326031|NCT01709084|450828926|FG000|Overall Study|Not Treated|0|||
125326032|NCT01709084|450828927|FG001|Overall Study|Not Treated|2|||
125326033|NCT02144610|450828928|FG000|Overall Study|Physician Decision|1|||
125326034|NCT02144610|450828929|FG001|Overall Study|Physician Decision|0|||
125326035|NCT02144610|450828928|FG000|Overall Study|Withdrawal by Subject|1|||
125326036|NCT02144610|450828929|FG001|Overall Study|Withdrawal by Subject|5|||
125326037|NCT02144610|450828928|FG000|Overall Study|Death|2|||
125326038|NCT02144610|450828929|FG001|Overall Study|Death|2|||
125326039|NCT02144610|450828928|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
125326040|NCT02144610|450828929|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
124996338|NCT03952806|449614066|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
124996339|NCT03952806|449614067|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
124996340|NCT03952806|449614066|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
124996341|NCT03952806|449614067|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
125326041|NCT02144610|450828928|FG000|Overall Study|Other|0|||
125326042|NCT02144610|450828929|FG001|Overall Study|Other|1|||
125326043|NCT00214201|450828931|FG000|Overall Study|Withdrawal by Subject|2|||
125326044|NCT00214201|450828932|FG001|Overall Study|Withdrawal by Subject|0|||
125326045|NCT00214201|450828931|FG000|Overall Study|Death|0|||
125326046|NCT00214201|450828932|FG001|Overall Study|Death|2|||
125326047|NCT01399372|450828933|FG000|Overall Study|Protocol Violation|3|||
125326048|NCT01399372|450828934|FG001|Overall Study|Protocol Violation|1|||
125326049|NCT01432730|450828935|FG000|Period 1|Adverse Event|2|||
125326050|NCT01432730|450828936|FG001|Period 1|Adverse Event|0|||
125326051|NCT01432730|450828935|FG000|Period 2|Adverse Event|0|||
125326052|NCT01432730|450828936|FG001|Period 2|Adverse Event|4|||
125326053|NCT01712399|450828939|FG000|Overall Study|Lost to Follow-up|1|||
125326054|NCT01712399|450828939|FG000|Overall Study|Withdrawal by Subject|39|||
125326055|NCT01712399|450828939|FG000|Overall Study|Death|1|||
125326056|NCT01712399|450828939|FG000|Overall Study|Adverse Event|11|||
125326057|NCT01712399|450828939|FG000|Overall Study|Study closure|345|||
125326058|NCT01298648|450828940|FG000|Overall Study|Withdrawal by Subject|2|||
125326059|NCT01298648|450828940|FG000|Overall Study|Lost to Follow-up|21|||
125326060|NCT02038933|450828945|FG000|Overall Study|Disease progression|104|||
125326061|NCT02038933|450828945|FG000|Overall Study|Study drug toxicity|6|||
125326062|NCT02038933|450828945|FG000|Overall Study|Adverse event unrelated to study drug|6|||
125326063|NCT02038933|450828945|FG000|Overall Study|Participant request to discontinue treatment|2|||
125326064|NCT02038933|450828945|FG000|Overall Study|Lost to Follow-up|1|||
125326065|NCT02038933|450828945|FG000|Overall Study|Other reasons|2|||
125326066|NCT04154904|450828946|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
125326067|NCT04154904|450828947|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
125326068|NCT04154904|450828948|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
125326069|NCT02085161|450828950|FG000|Overall Study|Not Treated|1|||
125326070|NCT02085161|450828951|FG001|Overall Study|Not Treated|0|||
125326071|NCT02085161|450828952|FG002|Overall Study|Not Treated|0|||
125326072|NCT02085161|450828953|FG003|Overall Study|Not Treated|0|||
125326073|NCT02085161|450828950|FG000|Overall Study|Adverse Event|8|||
125326074|NCT02085161|450828951|FG001|Overall Study|Adverse Event|5|||
125326075|NCT02085161|450828952|FG002|Overall Study|Adverse Event|4|||
125326076|NCT02085161|450828953|FG003|Overall Study|Adverse Event|5|||
125326077|NCT02085161|450828950|FG000|Overall Study|Protocol Violation|0|||
125326078|NCT02085161|450828951|FG001|Overall Study|Protocol Violation|1|||
125326079|NCT02085161|450828952|FG002|Overall Study|Protocol Violation|0|||
125326080|NCT02085161|450828953|FG003|Overall Study|Protocol Violation|1|||
125326081|NCT02085161|450828950|FG000|Overall Study|Withdrawal by Subject|2|||
125326082|NCT02085161|450828951|FG001|Overall Study|Withdrawal by Subject|4|||
125326083|NCT02085161|450828952|FG002|Overall Study|Withdrawal by Subject|0|||
125326084|NCT02085161|450828953|FG003|Overall Study|Withdrawal by Subject|3|||
125326085|NCT02085161|450828950|FG000|Overall Study|Other Reason|1|||
125326086|NCT02085161|450828951|FG001|Overall Study|Other Reason|0|||
125326087|NCT02085161|450828952|FG002|Overall Study|Other Reason|1|||
125326088|NCT02085161|450828953|FG003|Overall Study|Other Reason|1|||
125326089|NCT01936870|450828958|FG000|Overall Study|No Visit After Treatment|176|||
125326090|NCT01936870|450828958|FG000|Overall Study|Protocol Violation|12|||
125326091|NCT01936870|450828958|FG000|Overall Study|No Drug Administration|1|||
125326092|NCT02399163|450828962|FG000|Overall Study|Adverse Event|2|||
125326093|NCT02399163|450828962|FG000|Overall Study|Protocol Deviation|2|||
125326094|NCT02399163|450828962|FG000|Overall Study|Withdrawal by Participant|5|||
125326095|NCT03910244|450828963|FG000|Overall Study|Adverse Event|14|||
124996342|NCT03952806|449614066|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
125326096|NCT03910244|450828964|FG001|Overall Study|Adverse Event|0|||
125326097|NCT03910244|450828963|FG000|Overall Study|Death|1|||
125326098|NCT03910244|450828964|FG001|Overall Study|Death|0|||
124996343|NCT03952806|449614067|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
125326099|NCT03910244|450828963|FG000|Overall Study|Lost to Follow-up|0|||
125326100|NCT03910244|450828964|FG001|Overall Study|Lost to Follow-up|2|||
125326101|NCT03910244|450828963|FG000|Overall Study|Joint withdrawal decision|1|||
125326102|NCT03910244|450828964|FG001|Overall Study|Joint withdrawal decision|0|||
125326103|NCT03910244|450828963|FG000|Overall Study|Study Terminated by Sponsor|7|||
124996344|NCT03952806|449614066|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
125210685|NCT02638259|450395635|FG001|Treatment Period 2|Adverse Event|4|||
125326104|NCT03910244|450828964|FG001|Overall Study|Study Terminated by Sponsor|4|||
125326105|NCT03910244|450828963|FG000|Overall Study|Physician Decision|1|||
125326106|NCT03910244|450828964|FG001|Overall Study|Physician Decision|0|||
125326107|NCT03910244|450828963|FG000|Overall Study|Protocol Violation|1|||
125326108|NCT03910244|450828964|FG001|Overall Study|Protocol Violation|0|||
125326109|NCT03910244|450828963|FG000|Overall Study|Withdrawal by Subject|7|||
125326110|NCT03910244|450828964|FG001|Overall Study|Withdrawal by Subject|2|||
125326111|NCT00803569|450828967|FG000|Overall Study|Progressive Disease|3|||
125326112|NCT00803569|450828967|FG000|Overall Study|Noncompliance|1|||
125326113|NCT03345784|450828968|FG000|Overall Study|Withdrawal by Subject|2|||
125326114|NCT03345784|450828969|FG001|Overall Study|Withdrawal by Subject|1|||
125326115|NCT04798196|450828970|FG000|Overall Study|Lost to Follow-up|3|||
125326116|NCT04798196|450828971|FG001|Overall Study|Lost to Follow-up|1|||
125326117|NCT04798196|450828972|FG002|Overall Study|Lost to Follow-up|3|||
125326118|NCT00728689|450828978|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
125326119|NCT00728689|450828979|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
125326120|NCT00929695|450828980|FG000|Overall Study|Death|2|||
125326121|NCT00929695|450828981|FG001|Overall Study|Death|1|||
125326122|NCT00929695|450828980|FG000|Overall Study|Withdrawal by Subject|0|||
125326123|NCT00929695|450828981|FG001|Overall Study|Withdrawal by Subject|2|||
125326124|NCT00929695|450828980|FG000|Overall Study|discharge home|4|||
125326125|NCT00929695|450828981|FG001|Overall Study|discharge home|3|||
125326126|NCT00929695|450828980|FG000|Overall Study|incorrect stratification|2|||
125326127|NCT00929695|450828981|FG001|Overall Study|incorrect stratification|0|||
125326128|NCT00887809|450828983|FG000|Overall Study|Patient Not Treated|3|||
125326129|NCT00887809|450828984|FG001|Overall Study|Patient Not Treated|0|||
125326130|NCT00887809|450828983|FG000|Overall Study|Death|1|||
125326131|NCT00887809|450828984|FG001|Overall Study|Death|0|||
125326132|NCT01690143|450828989|FG000|Overall Study|Withdrawal by Subject|1|||
125326133|NCT03777982|450828990|FG000|Overall Study|Physician Decision|0|||
125326134|NCT03777982|450828991|FG001|Overall Study|Physician Decision|1|||
125326135|NCT00870740|450828992|FG000|Overall Study|Adverse Event|2|||
125326136|NCT00870740|450828993|FG001|Overall Study|Adverse Event|1|||
125326137|NCT00870740|450828994|FG002|Overall Study|Adverse Event|3|||
125326138|NCT00870740|450828995|FG003|Overall Study|Adverse Event|2|||
125326139|NCT00870740|450828996|FG004|Overall Study|Adverse Event|1|||
125326140|NCT00870740|450828997|FG005|Overall Study|Adverse Event|6|||
125326141|NCT00870740|450828992|FG000|Overall Study|Consent Withdrawn|6|||
125326142|NCT00870740|450828993|FG001|Overall Study|Consent Withdrawn|3|||
125326143|NCT00870740|450828994|FG002|Overall Study|Consent Withdrawn|4|||
125326144|NCT00870740|450828995|FG003|Overall Study|Consent Withdrawn|6|||
125326145|NCT00870740|450828996|FG004|Overall Study|Consent Withdrawn|6|||
125326146|NCT00870740|450828997|FG005|Overall Study|Consent Withdrawn|5|||
125326147|NCT00870740|450828992|FG000|Overall Study|Investigator Decision|2|||
125326148|NCT00870740|450828993|FG001|Overall Study|Investigator Decision|0|||
125326149|NCT00870740|450828994|FG002|Overall Study|Investigator Decision|1|||
125326150|NCT00870740|450828995|FG003|Overall Study|Investigator Decision|0|||
125326151|NCT00870740|450828996|FG004|Overall Study|Investigator Decision|0|||
125326152|NCT00870740|450828997|FG005|Overall Study|Investigator Decision|0|||
125326153|NCT00870740|450828992|FG000|Overall Study|Subject Non-compliance|0|||
125326154|NCT00870740|450828993|FG001|Overall Study|Subject Non-compliance|0|||
125326155|NCT00870740|450828994|FG002|Overall Study|Subject Non-compliance|0|||
125326156|NCT00870740|450828995|FG003|Overall Study|Subject Non-compliance|0|||
125326157|NCT00870740|450828996|FG004|Overall Study|Subject Non-compliance|0|||
125326158|NCT00870740|450828997|FG005|Overall Study|Subject Non-compliance|1|||
125326159|NCT00870740|450828992|FG000|Overall Study|Death|0|||
125326160|NCT00870740|450828993|FG001|Overall Study|Death|0|||
125326161|NCT00870740|450828994|FG002|Overall Study|Death|0|||
125326162|NCT00870740|450828995|FG003|Overall Study|Death|0|||
125326163|NCT00870740|450828996|FG004|Overall Study|Death|1|||
125326164|NCT00870740|450828997|FG005|Overall Study|Death|0|||
125326165|NCT00870740|450828992|FG000|Overall Study|Other|2|||
125326166|NCT00870740|450828993|FG001|Overall Study|Other|5|||
125326167|NCT00870740|450828994|FG002|Overall Study|Other|2|||
125326168|NCT00870740|450828995|FG003|Overall Study|Other|4|||
125326169|NCT00870740|450828996|FG004|Overall Study|Other|3|||
125326170|NCT00870740|450828997|FG005|Overall Study|Other|5|||
125326171|NCT03755934|450829000|FG000|Overall Study|Adverse Event|4|||
125326172|NCT03755934|450829001|FG001|Overall Study|Adverse Event|1|||
125326173|NCT03755934|450829002|FG002|Overall Study|Adverse Event|1|||
125326174|NCT03755934|450829003|FG003|Overall Study|Adverse Event|3|||
125326175|NCT03755934|450829000|FG000|Overall Study|Physician Decision|2|||
125326176|NCT03755934|450829001|FG001|Overall Study|Physician Decision|0|||
125326177|NCT03755934|450829002|FG002|Overall Study|Physician Decision|0|||
125326178|NCT03755934|450829003|FG003|Overall Study|Physician Decision|1|||
125326179|NCT03755934|450829000|FG000|Overall Study|Withdrawal by Subject|5|||
125326180|NCT03755934|450829001|FG001|Overall Study|Withdrawal by Subject|0|||
125326181|NCT03755934|450829002|FG002|Overall Study|Withdrawal by Subject|0|||
125326182|NCT03755934|450829003|FG003|Overall Study|Withdrawal by Subject|1|||
125326183|NCT03755934|450829000|FG000|Overall Study|Other|3|||
125326184|NCT03755934|450829001|FG001|Overall Study|Other|1|||
125326185|NCT03755934|450829002|FG002|Overall Study|Other|3|||
125326186|NCT03755934|450829003|FG003|Overall Study|Other|1|||
125326187|NCT00307801|450829004|FG000|Overall Study|Adverse Event|12|||
125326188|NCT00307801|450829005|FG001|Overall Study|Adverse Event|4|||
125326189|NCT00307801|450829004|FG000|Overall Study|Withdrawal by Subject|9|||
125326190|NCT00307801|450829005|FG001|Overall Study|Withdrawal by Subject|4|||
125326191|NCT00307801|450829004|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
125326192|NCT00307801|450829005|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
125326193|NCT00307801|450829004|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
125326194|NCT00307801|450829005|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
125326195|NCT00307801|450829004|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
125326196|NCT00307801|450829005|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
125326197|NCT00307801|450829004|FG000|Overall Study|Wrong Randomization|1|||
125326198|NCT00307801|450829005|FG001|Overall Study|Wrong Randomization|0|||
125326199|NCT00307801|450829004|FG000|Overall Study|Lack of Efficacy|0|||
125326200|NCT00307801|450829005|FG001|Overall Study|Lack of Efficacy|2|||
125326201|NCT00307801|450829004|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
125326202|NCT00307801|450829005|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
125326203|NCT00307801|450829004|FG000|Overall Study|Frustration with e-diary|1|||
125326204|NCT00307801|450829005|FG001|Overall Study|Frustration with e-diary|0|||
125326205|NCT00307801|450829004|FG000|Overall Study|Protocol Violation|3|||
125326206|NCT00307801|450829005|FG001|Overall Study|Protocol Violation|2|||
125326207|NCT00307801|450829004|FG000|Overall Study|No reason specified|2|||
125326208|NCT00307801|450829005|FG001|Overall Study|No reason specified|0|||
125326209|NCT00307801|450829004|FG000|Overall Study|Pregnancy|0|||
125326210|NCT00307801|450829005|FG001|Overall Study|Pregnancy|1|||
125326211|NCT00551642|450829011|FG000|Treatment Period|Protocol Deviation|6|||
125326212|NCT00551642|450829012|FG001|Treatment Period|Protocol Deviation|11|||
125326213|NCT00551642|450829011|FG000|Treatment Period|Delivery device failure|1|||
125326214|NCT00551642|450829012|FG001|Treatment Period|Delivery device failure|3|||
125326215|NCT00551642|450829011|FG000|Treatment Period|Physician Decision|0|||
125326216|NCT00551642|450829012|FG001|Treatment Period|Physician Decision|1|||
125326217|NCT00551642|450829011|FG000|Treatment Period|Death|33|||
125326218|NCT00551642|450829012|FG001|Treatment Period|Death|31|||
125326219|NCT00551642|450829011|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
125326220|NCT00551642|450829012|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
125326221|NCT00551642|450829011|FG000|Treatment Period|Adverse Event|15|||
125326222|NCT00551642|450829012|FG001|Treatment Period|Adverse Event|12|||
125326223|NCT00551642|450829011|FG000|Treatment Period|Withdrawal by Subject|2|||
125326224|NCT00551642|450829012|FG001|Treatment Period|Withdrawal by Subject|1|||
125326225|NCT00361296|450829014|FG000|Overall Study|Physician Decision|1|||
125326226|NCT00361296|450829014|FG000|Overall Study|Lack of Efficacy|2|||
125326227|NCT00198822|450829015|FG000|Overall Study|Lost to Follow-up|14|||
125326228|NCT00198822|450829016|FG001|Overall Study|Lost to Follow-up|20|||
125326229|NCT00198822|450829017|FG002|Overall Study|Lost to Follow-up|21|||
125326230|NCT03011099|450829018|FG000|Overall Study|Withdrawal by Subject|0|||
125326231|NCT03011099|450829019|FG001|Overall Study|Withdrawal by Subject|2|||
125326232|NCT02072668|450829023|FG000|Second Intervention|Lost to Follow-up|1|||
125326233|NCT02072668|450829024|FG001|Second Intervention|Lost to Follow-up|0|||
125326234|NCT04482647|450829025|FG000|Overall Study|Time constraints|2|||
125326235|NCT04482647|450829025|FG000|Overall Study|Health issues|1|||
125326236|NCT04482647|450829025|FG000|Overall Study|Death in the family|1|||
125326237|NCT04482647|450829025|FG000|Overall Study|Disliked the intervention|1|||
125326238|NCT04482647|450829025|FG000|Overall Study|No reasons specified|7|||
124996345|NCT03952806|449614067|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
124996346|NCT03952806|449614066|FG000|OLE Phase (48 Weeks)|Other|16|||
124996347|NCT03952806|449614067|FG001|OLE Phase (48 Weeks)|Other|13|||
124996348|NCT01138007|449614068|FG000|Overall Study|Adverse Event|4|||
124996349|NCT01138007|449614069|FG001|Overall Study|Adverse Event|12|||
125326251|NCT04163341|450829030|FG000|Overall Study|Withdrawal by Subject|2|||
125326252|NCT04163341|450829031|FG001|Overall Study|Withdrawal by Subject|0|||
125326253|NCT04163341|450829030|FG000|Overall Study|Lost to Follow-up|3|||
125326254|NCT04163341|450829031|FG001|Overall Study|Lost to Follow-up|4|||
125326255|NCT02484391|450829033|FG000|Overall Study|Lack of Efficacy|15|||
125326256|NCT02484391|450829034|FG001|Overall Study|Lack of Efficacy|14|||
125326257|NCT02484391|450829035|FG002|Overall Study|Lack of Efficacy|3|||
125326258|NCT02484391|450829033|FG000|Overall Study|Lost to Follow-up|0|||
125326259|NCT02484391|450829034|FG001|Overall Study|Lost to Follow-up|0|||
125326260|NCT02484391|450829035|FG002|Overall Study|Lost to Follow-up|2|||
125326261|NCT02484391|450829033|FG000|Overall Study|Physician Decision|1|||
125326262|NCT02484391|450829034|FG001|Overall Study|Physician Decision|3|||
125326263|NCT02484391|450829035|FG002|Overall Study|Physician Decision|0|||
125326264|NCT02484391|450829033|FG000|Overall Study|Went to Transplant|5|||
125326265|NCT02484391|450829034|FG001|Overall Study|Went to Transplant|3|||
125326266|NCT02484391|450829035|FG002|Overall Study|Went to Transplant|2|||
125326267|NCT00905164|450829038|FG000|Period 1|Protocol Violation|0|||
125326268|NCT00905164|450829039|FG001|Period 1|Protocol Violation|1|||
125326269|NCT04730804|450829044|FG000|Overall Study|Physician Decision|0|||
125326270|NCT04730804|450829045|FG001|Overall Study|Physician Decision|0|||
125326271|NCT04730804|450829046|FG002|Overall Study|Physician Decision|0|||
125326272|NCT04730804|450829047|FG003|Overall Study|Physician Decision|0|||
125326273|NCT04730804|450829048|FG004|Overall Study|Physician Decision|0|||
125326274|NCT04730804|450829049|FG005|Overall Study|Physician Decision|1|||
125326275|NCT04730804|450829044|FG000|Overall Study|Withdrawal by Subject|0|||
125326276|NCT04730804|450829045|FG001|Overall Study|Withdrawal by Subject|0|||
125326277|NCT04730804|450829046|FG002|Overall Study|Withdrawal by Subject|0|||
125326278|NCT04730804|450829047|FG003|Overall Study|Withdrawal by Subject|0|||
125326279|NCT04730804|450829048|FG004|Overall Study|Withdrawal by Subject|1|||
125326280|NCT04730804|450829049|FG005|Overall Study|Withdrawal by Subject|2|||
125326281|NCT05366738|450831351|FG000|Overall Study|Adverse Event|0|||
125326282|NCT05366738|450831352|FG001|Overall Study|Adverse Event|1|||
125326283|NCT05366738|450831353|FG002|Overall Study|Adverse Event|0|||
125326284|NCT01389596|450831354|FG000|Overall Study|Protocol Violation|3|||
125326285|NCT01389596|450831355|FG001|Overall Study|Protocol Violation|4|||
125326286|NCT01389596|450831356|FG002|Overall Study|Protocol Violation|3|||
125326287|NCT01389596|450831354|FG000|Overall Study|Withdrawal by Subject|1|||
125326288|NCT01389596|450831355|FG001|Overall Study|Withdrawal by Subject|2|||
125326289|NCT01389596|450831356|FG002|Overall Study|Withdrawal by Subject|2|||
125326290|NCT01389596|450831354|FG000|Overall Study|Insufficient Clinical Response|3|||
125326291|NCT01389596|450831355|FG001|Overall Study|Insufficient Clinical Response|4|||
125326292|NCT01389596|450831356|FG002|Overall Study|Insufficient Clinical Response|5|||
125326293|NCT01389596|450831354|FG000|Overall Study|Adverse Event|1|||
125326294|NCT01389596|450831355|FG001|Overall Study|Adverse Event|4|||
125326295|NCT01389596|450831356|FG002|Overall Study|Adverse Event|0|||
125326296|NCT01389596|450831354|FG000|Overall Study|Death|0|||
125326297|NCT01389596|450831355|FG001|Overall Study|Death|1|||
125326298|NCT01389596|450831356|FG002|Overall Study|Death|0|||
125326299|NCT01389596|450831354|FG000|Overall Study|Other Unspecified|2|||
125326300|NCT01389596|450831355|FG001|Overall Study|Other Unspecified|1|||
125326301|NCT01389596|450831356|FG002|Overall Study|Other Unspecified|0|||
125326302|NCT01124006|450831360|FG000|Overall Study|Withdrawal by Subject|2|||
125326303|NCT01124006|450831361|FG001|Overall Study|Withdrawal by Subject|2|||
125326304|NCT01124006|450831362|FG002|Overall Study|Withdrawal by Subject|0|||
125326305|NCT01124006|450831360|FG000|Overall Study|Lost to Follow-up|1|||
125326306|NCT01124006|450831361|FG001|Overall Study|Lost to Follow-up|0|||
125326307|NCT01124006|450831362|FG002|Overall Study|Lost to Follow-up|1|||
125326308|NCT01124006|450831360|FG000|Overall Study|Other|0|||
125326309|NCT01124006|450831361|FG001|Overall Study|Other|0|||
125326310|NCT01124006|450831362|FG002|Overall Study|Other|1|||
125326311|NCT03841604|450831370|FG000|Overall Study|Withdrawal by Subject|3|||
125326312|NCT03841604|450831371|FG001|Overall Study|Withdrawal by Subject|1|||
125326313|NCT03841604|450831370|FG000|Overall Study|Adverse Event|4|||
125326314|NCT03841604|450831371|FG001|Overall Study|Adverse Event|2|||
125326315|NCT03841604|450831370|FG000|Overall Study|Physician Decision|1|||
125326316|NCT03841604|450831371|FG001|Overall Study|Physician Decision|0|||
125326317|NCT03877510|450831374|FG000|Overall Study|Death|6|||
125326318|NCT03877510|450831374|FG000|Overall Study|Lost to Follow-up|2|||
125326319|NCT03877510|450831374|FG000|Overall Study|Non-compliance with study drug|2|||
125326320|NCT03877510|450831374|FG000|Overall Study|Lack of Efficacy|14|||
125326321|NCT03877510|450831374|FG000|Overall Study|Adverse Event|20|||
125326322|NCT03877510|450831374|FG000|Overall Study|Withdrawal by Subject|22|||
125326323|NCT03877510|450831374|FG000|Overall Study|Miscellaneous|1|||
125326324|NCT01417377|450831375|FG000|Overall Study|Lost to Follow-up|12|||
125326325|NCT01417377|450831375|FG000|Overall Study|Enrolled, but not treated|1|||
125326326|NCT02113982|450831376|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
125326327|NCT02113982|450831377|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
125326328|NCT02113982|450831378|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
125326329|NCT02113982|450831379|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
125326330|NCT02113982|450831380|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
125326331|NCT02113982|450831381|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
125326332|NCT02113982|450831382|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
125326333|NCT02113982|450831383|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
125326334|NCT02113982|450831384|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
125326335|NCT02113982|450831385|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
125326336|NCT02113982|450831386|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
125326337|NCT02113982|450831387|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
125326338|NCT02113982|450831388|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
125326339|NCT02113982|450831389|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
125326340|NCT02113982|450831376|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
125326341|NCT02113982|450831377|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
125326342|NCT02113982|450831378|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
125326343|NCT02113982|450831379|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
124996350|NCT01138007|449614070|FG002|Overall Study|Adverse Event|9|||
124996351|NCT01138007|449614068|FG000|Overall Study|Lack of Efficacy|2|||
124996352|NCT01138007|449614069|FG001|Overall Study|Lack of Efficacy|0|||
124996353|NCT01138007|449614070|FG002|Overall Study|Lack of Efficacy|6|||
124996354|NCT01138007|449614068|FG000|Overall Study|Protocol Violation|2|||
124996355|NCT01138007|449614069|FG001|Overall Study|Protocol Violation|3|||
124996356|NCT01138007|449614070|FG002|Overall Study|Protocol Violation|2|||
124996357|NCT01138007|449614068|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
124996358|NCT01138007|449614069|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
124996359|NCT01138007|449614070|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
124996360|NCT01138007|449614068|FG000|Overall Study|Lost to Follow-up|3|||
124996361|NCT01138007|449614069|FG001|Overall Study|Lost to Follow-up|3|||
124996362|NCT01138007|449614070|FG002|Overall Study|Lost to Follow-up|5|||
124996363|NCT01138007|449614068|FG000|Overall Study|Physician Decision|0|||
124996364|NCT01138007|449614069|FG001|Overall Study|Physician Decision|5|||
124996365|NCT01138007|449614070|FG002|Overall Study|Physician Decision|3|||
124996366|NCT01138007|449614068|FG000|Overall Study|Withdrawal by Subject|5|||
124996367|NCT01138007|449614069|FG001|Overall Study|Withdrawal by Subject|6|||
124996368|NCT01138007|449614070|FG002|Overall Study|Withdrawal by Subject|15|||
124996369|NCT04661878|449614071|FG000|Overall Study|Lost to Follow-up|6|||
124996370|NCT04661878|449614072|FG001|Overall Study|Lost to Follow-up|5|||
124996371|NCT00744523|449614075|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
124996372|NCT00744523|449614076|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
124996373|NCT01139021|449614079|FG000|Overall Study|Adverse Event|0|||
124996374|NCT01139021|449614080|FG001|Overall Study|Adverse Event|0|||
124996375|NCT01139021|449614081|FG002|Overall Study|Adverse Event|0|||
124996376|NCT01139021|449614082|FG003|Overall Study|Adverse Event|0|||
124996377|NCT01139021|449614083|FG004|Overall Study|Adverse Event|1|||
124996378|NCT01139021|449614084|FG005|Overall Study|Adverse Event|0|||
124996379|NCT01139021|449614079|FG000|Overall Study|Lost to Follow-up|0|||
124996380|NCT01139021|449614080|FG001|Overall Study|Lost to Follow-up|0|||
124996381|NCT01139021|449614081|FG002|Overall Study|Lost to Follow-up|0|||
124996382|NCT01139021|449614082|FG003|Overall Study|Lost to Follow-up|0|||
124996383|NCT01139021|449614083|FG004|Overall Study|Lost to Follow-up|2|||
124996384|NCT01139021|449614084|FG005|Overall Study|Lost to Follow-up|0|||
124996385|NCT01139021|449614079|FG000|Overall Study|Protocol Violation|1|||
124996386|NCT01139021|449614080|FG001|Overall Study|Protocol Violation|0|||
124996387|NCT01139021|449614081|FG002|Overall Study|Protocol Violation|0|||
124996388|NCT01139021|449614082|FG003|Overall Study|Protocol Violation|0|||
124996389|NCT01139021|449614083|FG004|Overall Study|Protocol Violation|2|||
124996390|NCT01139021|449614084|FG005|Overall Study|Protocol Violation|0|||
124996391|NCT01139021|449614079|FG000|Overall Study|Withdrawal by Subject|0|||
124996392|NCT01139021|449614080|FG001|Overall Study|Withdrawal by Subject|0|||
124996393|NCT01139021|449614081|FG002|Overall Study|Withdrawal by Subject|0|||
124996394|NCT01139021|449614082|FG003|Overall Study|Withdrawal by Subject|1|||
124996395|NCT01139021|449614083|FG004|Overall Study|Withdrawal by Subject|4|||
124996396|NCT01139021|449614084|FG005|Overall Study|Withdrawal by Subject|0|||
124996397|NCT02963610|449614085|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
124996398|NCT05333224|449614086|FG000|Overall Study - Infants|Lost to Follow-up|1|||
124996399|NCT05333224|449614087|FG001|Overall Study - Infants|Lost to Follow-up|1|||
124996400|NCT00063154|449614088|FG000|Overall Study|Disease progression|27|||
124996401|NCT00063154|449614088|FG000|Overall Study|Adverse Event|2|||
124996402|NCT00063154|449614088|FG000|Overall Study|Physician Decision|10|||
124996403|NCT00063154|449614088|FG000|Overall Study|Death|3|||
124996404|NCT00063154|449614088|FG000|Overall Study|Reason unspecified|1|||
124996405|NCT00063154|449614088|FG000|Overall Study|Did not receive treatment|8|||
124996406|NCT02027701|449614089|FG000|Overall Study|Adverse Event|3|||
124996407|NCT02027701|449614089|FG000|Overall Study|Lack of Efficacy|8|||
124996408|NCT02027701|449614089|FG000|Overall Study|Physician Decision|2|||
124996409|NCT02027701|449614089|FG000|Overall Study|Withdrawal by Subject|3|||
124996410|NCT02893930|449614094|FG000|Overall Study|Adverse Event|3|||
124996411|NCT02893930|449614094|FG000|Overall Study|Death|1|||
124996412|NCT02893930|449614094|FG000|Overall Study|Disease progression|5|||
124996413|NCT02893930|449614094|FG000|Overall Study|Withdrawal by Subject|2|||
124996414|NCT02893930|449614094|FG000|Overall Study|Physician Decision|1|||
124996415|NCT02893930|449614094|FG000|Overall Study|Ineligible|1|||
124996416|NCT02349360|449614095|FG000|Overall Study|Withdrawal by Subject|0|||
124996417|NCT02349360|449614096|FG001|Overall Study|Withdrawal by Subject|1|||
124996418|NCT00394953|449614097|FG000|First Treatment Period|Adverse Event|1|||
124996419|NCT00394953|449614098|FG001|First Treatment Period|Adverse Event|2|||
124996420|NCT00394953|449614097|FG000|First Treatment Period|Death|6|||
124996421|NCT00394953|449614098|FG001|First Treatment Period|Death|7|||
124996422|NCT00394953|449614097|FG000|First Treatment Period|Lack of Efficacy|1|||
124996423|NCT00394953|449614098|FG001|First Treatment Period|Lack of Efficacy|1|||
124996424|NCT00394953|449614097|FG000|First Treatment Period|Withdrawal by Subject|6|||
124996425|NCT00394953|449614098|FG001|First Treatment Period|Withdrawal by Subject|3|||
125326344|NCT02113982|450831380|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
125326345|NCT02113982|450831381|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
125326346|NCT02113982|450831382|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
125326347|NCT02113982|450831383|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
125326348|NCT02113982|450831384|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
125326349|NCT02113982|450831385|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
125326350|NCT02113982|450831386|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
125326351|NCT02113982|450831387|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
125326352|NCT02113982|450831388|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
125326353|NCT02113982|450831389|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
125326354|NCT02113982|450831376|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125326355|NCT02113982|450831377|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125326356|NCT02113982|450831378|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125326357|NCT02113982|450831379|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
124996426|NCT00394953|449614097|FG000|First Treatment Period|Lost to Follow-up|0|||
124996427|NCT00394953|449614098|FG001|First Treatment Period|Lost to Follow-up|1|||
125326358|NCT02113982|450831380|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125326359|NCT02113982|450831381|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125326360|NCT02113982|450831382|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
125326361|NCT02113982|450831383|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125326362|NCT02113982|450831384|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125326363|NCT02113982|450831385|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125326364|NCT02113982|450831386|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
124996428|NCT00394953|449614097|FG000|First Treatment Period|Renal transplant|11|||
124996429|NCT00394953|449614098|FG001|First Treatment Period|Renal transplant|7|||
125326365|NCT02113982|450831387|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125326366|NCT02113982|450831388|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125326367|NCT02113982|450831389|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
124996430|NCT00394953|449614097|FG000|First Treatment Period|Not defined|4|||
124996431|NCT00394953|449614098|FG001|First Treatment Period|Not defined|1|||
124996432|NCT00394953|449614097|FG000|Second Treatment Period|Adverse Event|2|||
124996433|NCT00394953|449614098|FG001|Second Treatment Period|Adverse Event|5|||
124996434|NCT00394953|449614097|FG000|Second Treatment Period|Death|8|||
124996435|NCT00394953|449614098|FG001|Second Treatment Period|Death|4|||
124996436|NCT00394953|449614097|FG000|Second Treatment Period|Lack of Efficacy|9|||
124996437|NCT00394953|449614098|FG001|Second Treatment Period|Lack of Efficacy|47|||
124996438|NCT00394953|449614097|FG000|Second Treatment Period|Withdrawal by Subject|3|||
124996439|NCT00394953|449614098|FG001|Second Treatment Period|Withdrawal by Subject|3|||
124996440|NCT00394953|449614097|FG000|Second Treatment Period|Lost to Follow-up|0|||
124996441|NCT00394953|449614098|FG001|Second Treatment Period|Lost to Follow-up|1|||
124996442|NCT00394953|449614097|FG000|Second Treatment Period|Renal transplant|4|||
124996443|NCT00394953|449614098|FG001|Second Treatment Period|Renal transplant|6|||
124996444|NCT00394953|449614097|FG000|Second Treatment Period|Not defined|3|||
124996445|NCT00394953|449614098|FG001|Second Treatment Period|Not defined|8|||
124996446|NCT04079803|449614104|FG000|Overall Study|Withdrawal by Subject|0|||
124996447|NCT04079803|449614105|FG001|Overall Study|Withdrawal by Subject|0|||
124996448|NCT04079803|449614106|FG002|Overall Study|Withdrawal by Subject|1|||
124996449|NCT01294683|449614109|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
124996450|NCT01294683|449614110|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
124996451|NCT01294683|449614109|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
124996452|NCT01294683|449614110|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
124996453|NCT01294683|449614109|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
124996454|NCT01294683|449614110|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
124996455|NCT01294683|449614109|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
124996456|NCT01294683|449614110|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
124996457|NCT01294683|449614109|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
124996458|NCT01294683|449614110|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
124996459|NCT01294683|449614109|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
124996460|NCT01294683|449614110|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
124996461|NCT01294683|449614109|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
124996462|NCT01294683|449614110|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
124996463|NCT01294683|449614109|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
124996464|NCT01294683|449614110|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
124996465|NCT01294683|449614109|FG000|Post Crossover (Period III)|Adverse Event|6|||
125326368|NCT02113982|450831376|FG000|Stage 1: Dose Escalation|Transplant|0|||
125326369|NCT02113982|450831377|FG001|Stage 1: Dose Escalation|Transplant|1|||
125326370|NCT02113982|450831378|FG002|Stage 1: Dose Escalation|Transplant|0|||
125326371|NCT02113982|450831379|FG003|Stage 1: Dose Escalation|Transplant|0|||
125326372|NCT02113982|450831380|FG004|Stage 1: Dose Escalation|Transplant|0|||
125326373|NCT02113982|450831381|FG005|Stage 1: Dose Escalation|Transplant|1|||
125326374|NCT02113982|450831382|FG006|Stage 1: Dose Escalation|Transplant|0|||
124996466|NCT01294683|449614110|FG001|Post Crossover (Period III)|Adverse Event|6|||
125326375|NCT02113982|450831383|FG007|Stage 1: Dose Escalation|Transplant|0|||
125326376|NCT02113982|450831384|FG008|Stage 1: Dose Escalation|Transplant|0|||
125326377|NCT02113982|450831385|FG009|Stage 1: Dose Escalation|Transplant|0|||
125326378|NCT02113982|450831386|FG010|Stage 1: Dose Escalation|Transplant|0|||
125326379|NCT02113982|450831387|FG011|Stage 1: Dose Escalation|Transplant|0|||
125326380|NCT02113982|450831388|FG012|Stage 1: Dose Escalation|Transplant|0|||
125326381|NCT02113982|450831389|FG013|Stage 1: Dose Escalation|Transplant|0|||
125326382|NCT02113982|450831376|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
125326383|NCT02113982|450831377|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
125326384|NCT02113982|450831378|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
125326385|NCT02113982|450831379|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
125326386|NCT02113982|450831380|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
125326387|NCT02113982|450831381|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
125326388|NCT02113982|450831382|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
125326389|NCT02113982|450831383|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
125326390|NCT02113982|450831384|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
125326391|NCT02113982|450831385|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
125326392|NCT02113982|450831386|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
125326393|NCT02113982|450831387|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
125326394|NCT02113982|450831388|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
125326395|NCT02113982|450831389|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
125326396|NCT02113982|450831376|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
125326397|NCT02113982|450831377|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
125326398|NCT02113982|450831378|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
125326399|NCT02113982|450831379|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
125326400|NCT02113982|450831380|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
125326401|NCT02113982|450831381|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
125326402|NCT02113982|450831382|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
125326403|NCT02113982|450831383|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
125326404|NCT02113982|450831384|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
125326405|NCT02113982|450831385|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
125326406|NCT02113982|450831386|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
125326407|NCT02113982|450831387|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
125326408|NCT02113982|450831388|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
125326409|NCT02113982|450831389|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
125326410|NCT02113982|450831376|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
125326411|NCT02113982|450831377|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
125326412|NCT02113982|450831378|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
125326413|NCT02113982|450831379|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
125326414|NCT02113982|450831380|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
125326415|NCT02113982|450831381|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
125326416|NCT02113982|450831382|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
125326417|NCT02113982|450831383|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
125326418|NCT02113982|450831384|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
125326419|NCT02113982|450831385|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
125326420|NCT02113982|450831386|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
125326421|NCT02113982|450831387|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
125326422|NCT02113982|450831388|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
125326423|NCT02113982|450831389|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
125326424|NCT02113982|450831376|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
125326425|NCT02113982|450831377|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
125326426|NCT02113982|450831378|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
125326427|NCT02113982|450831379|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
125326428|NCT02113982|450831380|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
125326429|NCT02113982|450831381|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
125326430|NCT02113982|450831382|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
125326431|NCT02113982|450831383|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
125326432|NCT02113982|450831384|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
125326433|NCT02113982|450831385|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
125326434|NCT02113982|450831386|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
125326435|NCT02113982|450831387|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
125326436|NCT02113982|450831388|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
125326437|NCT02113982|450831389|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
125326438|NCT02113982|450831376|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326439|NCT02113982|450831377|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326440|NCT02113982|450831378|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326441|NCT02113982|450831379|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326442|NCT02113982|450831380|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326443|NCT02113982|450831381|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326444|NCT02113982|450831382|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326445|NCT02113982|450831383|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
125326446|NCT02113982|450831384|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326447|NCT02113982|450831385|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
125326448|NCT02113982|450831386|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
125326449|NCT02113982|450831387|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326450|NCT02113982|450831388|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326451|NCT02113982|450831389|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326452|NCT02113982|450831376|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326453|NCT02113982|450831377|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326454|NCT02113982|450831378|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326455|NCT02113982|450831379|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326456|NCT02113982|450831380|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326457|NCT02113982|450831381|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326458|NCT02113982|450831382|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326459|NCT02113982|450831383|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
125326460|NCT02113982|450831384|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326461|NCT02113982|450831385|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
125326462|NCT02113982|450831386|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326463|NCT02113982|450831387|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326464|NCT02113982|450831388|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326465|NCT02113982|450831389|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326466|NCT02113982|450831376|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326467|NCT02113982|450831377|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326468|NCT02113982|450831378|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326469|NCT02113982|450831379|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326470|NCT02113982|450831380|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326471|NCT02113982|450831381|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326472|NCT02113982|450831382|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326473|NCT02113982|450831383|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
125326474|NCT02113982|450831384|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326475|NCT02113982|450831385|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326476|NCT02113982|450831386|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326477|NCT02113982|450831387|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326478|NCT02113982|450831388|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326479|NCT02113982|450831389|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326480|NCT02113982|450831376|FG000|Stage 2: Cohort Expansion|Transplant|0|||
125326481|NCT02113982|450831377|FG001|Stage 2: Cohort Expansion|Transplant|0|||
125326482|NCT02113982|450831378|FG002|Stage 2: Cohort Expansion|Transplant|0|||
125326483|NCT02113982|450831379|FG003|Stage 2: Cohort Expansion|Transplant|0|||
125326484|NCT02113982|450831380|FG004|Stage 2: Cohort Expansion|Transplant|0|||
125326485|NCT02113982|450831381|FG005|Stage 2: Cohort Expansion|Transplant|0|||
124996467|NCT01294683|449614109|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
124996468|NCT01294683|449614110|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
124996469|NCT01294683|449614109|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
124996470|NCT01294683|449614110|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
124996471|NCT01294683|449614109|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
124996472|NCT01294683|449614110|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
124996473|NCT01032382|449614112|FG000|Overall Study|Disease dissemination|1|||
124996474|NCT01032382|449614113|FG001|Overall Study|Disease dissemination|1|||
124996475|NCT01032382|449614112|FG000|Overall Study|Treatment failure|3|||
124996476|NCT01032382|449614113|FG001|Overall Study|Treatment failure|1|||
124996477|NCT01032382|449614112|FG000|Overall Study|Index lesion relapse|1|||
124996478|NCT01032382|449614113|FG001|Overall Study|Index lesion relapse|3|||
124996479|NCT00412971|449614114|FG000|Overall Study|Lost to Follow-up|17|||
124996480|NCT00412971|449614115|FG001|Overall Study|Lost to Follow-up|9|||
124996481|NCT00412971|449614114|FG000|Overall Study|Protocol Violation|13|||
124996482|NCT00412971|449614115|FG001|Overall Study|Protocol Violation|1|||
124996483|NCT02409368|449614116|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
124996484|NCT02409368|449614117|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
124996485|NCT02409368|449614118|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
124996486|NCT02409368|449614119|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
124996487|NCT02409368|449614116|FG000|ECOG Reclassification|Death|1|||
124996488|NCT02409368|449614117|FG001|ECOG Reclassification|Death|5|||
124996489|NCT02409368|449614118|FG002|ECOG Reclassification|Death|0|||
124996490|NCT02409368|449614119|FG003|ECOG Reclassification|Death|0|||
124996491|NCT02409368|449614116|FG000|ECOG Reclassification|Disease Progression|113|||
124996492|NCT02409368|449614117|FG001|ECOG Reclassification|Disease Progression|382|||
124996493|NCT02409368|449614118|FG002|ECOG Reclassification|Disease Progression|70|||
124996494|NCT02409368|449614119|FG003|ECOG Reclassification|Disease Progression|1|||
124996495|NCT02409368|449614116|FG000|ECOG Reclassification|Lost to Follow-up|1|||
125326486|NCT02113982|450831382|FG006|Stage 2: Cohort Expansion|Transplant|0|||
125326487|NCT02113982|450831383|FG007|Stage 2: Cohort Expansion|Transplant|0|||
124996496|NCT02409368|449614117|FG001|ECOG Reclassification|Lost to Follow-up|5|||
124996497|NCT02409368|449614118|FG002|ECOG Reclassification|Lost to Follow-up|0|||
125326488|NCT02113982|450831384|FG008|Stage 2: Cohort Expansion|Transplant|0|||
125326489|NCT02113982|450831385|FG009|Stage 2: Cohort Expansion|Transplant|4|||
125326490|NCT02113982|450831386|FG010|Stage 2: Cohort Expansion|Transplant|2|||
125326491|NCT02113982|450831387|FG011|Stage 2: Cohort Expansion|Transplant|0|||
125326492|NCT02113982|450831388|FG012|Stage 2: Cohort Expansion|Transplant|0|||
125326493|NCT02113982|450831389|FG013|Stage 2: Cohort Expansion|Transplant|0|||
125326494|NCT02113982|450831376|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
125326495|NCT02113982|450831377|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
125326496|NCT02113982|450831378|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
125326497|NCT02113982|450831379|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
125326498|NCT02113982|450831380|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
125326499|NCT02113982|450831381|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
125326500|NCT02113982|450831382|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
125326501|NCT02113982|450831383|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
125326502|NCT02113982|450831384|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
125326503|NCT02113982|450831385|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
125326504|NCT02113982|450831386|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
125326505|NCT02113982|450831387|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
125326506|NCT02113982|450831388|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
125326507|NCT02113982|450831389|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
125326508|NCT02113982|450831376|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
125326509|NCT02113982|450831377|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
125326510|NCT02113982|450831378|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
125326511|NCT02113982|450831379|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
125326512|NCT02113982|450831380|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
125326513|NCT02113982|450831381|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
125326514|NCT02113982|450831382|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
125326515|NCT02113982|450831383|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
125326516|NCT02113982|450831384|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
125326517|NCT02113982|450831385|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
125326518|NCT02113982|450831386|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
125326519|NCT02113982|450831387|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
125326520|NCT02113982|450831388|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
125326521|NCT02113982|450831389|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
125326522|NCT02113982|450831376|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326523|NCT02113982|450831377|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326524|NCT02113982|450831378|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326525|NCT02113982|450831379|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326526|NCT02113982|450831380|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326527|NCT02113982|450831381|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326528|NCT02113982|450831382|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326529|NCT02113982|450831383|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326530|NCT02113982|450831384|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326531|NCT02113982|450831385|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326532|NCT02113982|450831386|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326533|NCT02113982|450831387|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
125326534|NCT02113982|450831388|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
124996498|NCT02409368|449614119|FG003|ECOG Reclassification|Lost to Follow-up|0|||
124996499|NCT02409368|449614116|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
124996500|NCT02409368|449614117|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
124996501|NCT02409368|449614118|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
124996502|NCT02409368|449614119|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
124996503|NCT02409368|449614116|FG000|ECOG Reclassification|Poor/non-compliance|0|||
124996504|NCT02409368|449614117|FG001|ECOG Reclassification|Poor/non-compliance|3|||
124996505|NCT02409368|449614118|FG002|ECOG Reclassification|Poor/non-compliance|2|||
124996506|NCT02409368|449614119|FG003|ECOG Reclassification|Poor/non-compliance|0|||
124996507|NCT02409368|449614116|FG000|ECOG Reclassification|Study drug toxicity|17|||
124996508|NCT02409368|449614117|FG001|ECOG Reclassification|Study drug toxicity|42|||
124996509|NCT02409368|449614118|FG002|ECOG Reclassification|Study drug toxicity|7|||
124996510|NCT02409368|449614119|FG003|ECOG Reclassification|Study drug toxicity|0|||
124996511|NCT02409368|449614116|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
124996512|NCT02409368|449614117|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
124996513|NCT02409368|449614118|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
125326535|NCT02113982|450831389|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326536|NCT02113982|450831376|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326537|NCT02113982|450831377|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326538|NCT02113982|450831378|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326539|NCT02113982|450831379|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326540|NCT02113982|450831380|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326541|NCT02113982|450831381|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326542|NCT02113982|450831382|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326543|NCT02113982|450831383|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326544|NCT02113982|450831384|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326545|NCT02113982|450831385|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326546|NCT02113982|450831386|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326547|NCT02113982|450831387|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
125326548|NCT02113982|450831388|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326549|NCT02113982|450831389|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326550|NCT02113982|450831376|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326551|NCT02113982|450831377|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326552|NCT02113982|450831378|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326553|NCT02113982|450831379|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326554|NCT02113982|450831380|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326555|NCT02113982|450831381|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326556|NCT02113982|450831382|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326557|NCT02113982|450831383|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326558|NCT02113982|450831384|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326559|NCT02113982|450831385|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326560|NCT02113982|450831386|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326561|NCT02113982|450831387|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
125326562|NCT02113982|450831388|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326563|NCT02113982|450831389|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326564|NCT02113982|450831376|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
125326565|NCT02113982|450831377|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
125326566|NCT02113982|450831378|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
125326567|NCT02113982|450831379|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
125326568|NCT02113982|450831380|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
125326569|NCT02113982|450831381|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
125326570|NCT02113982|450831382|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
125326571|NCT02113982|450831383|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
125326572|NCT02113982|450831384|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
124996514|NCT02409368|449614119|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
124996515|NCT02409368|449614116|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
124996516|NCT02409368|449614117|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
124996517|NCT02409368|449614118|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
124996518|NCT02409368|449614119|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
125326573|NCT02113982|450831385|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
125326574|NCT02113982|450831386|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
125326575|NCT02113982|450831387|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
124996519|NCT02409368|449614116|FG000|ECOG Reclassification|Participant withdrew consent|2|||
124996520|NCT02409368|449614117|FG001|ECOG Reclassification|Participant withdrew consent|3|||
124996521|NCT02409368|449614118|FG002|ECOG Reclassification|Participant withdrew consent|4|||
124996522|NCT02409368|449614119|FG003|ECOG Reclassification|Participant withdrew consent|0|||
124996523|NCT02409368|449614116|FG000|ECOG Reclassification|Other Reasons|5|||
124996524|NCT02409368|449614117|FG001|ECOG Reclassification|Other Reasons|26|||
124996525|NCT02409368|449614118|FG002|ECOG Reclassification|Other Reasons|2|||
124996526|NCT02409368|449614119|FG003|ECOG Reclassification|Other Reasons|0|||
124996527|NCT02409368|449614116|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
124996528|NCT02409368|449614117|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
124996529|NCT02409368|449614118|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
124996530|NCT02409368|449614119|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
124996531|NCT01296347|449614120|FG000|Allocation|Withdrawal by Subject|1|||
124996532|NCT01296347|449614121|FG001|Allocation|Withdrawal by Subject|2|||
124996533|NCT01296347|449614120|FG000|Allocation|Lack of Efficacy|1|||
124996534|NCT01296347|449614121|FG001|Allocation|Lack of Efficacy|2|||
124996535|NCT01296347|449614120|FG000|Allocation|not received infusion|1|||
124996536|NCT01296347|449614121|FG001|Allocation|not received infusion|0|||
124996537|NCT01296347|449614120|FG000|6 Week Follow up|Death|0|||
124996538|NCT01296347|449614121|FG001|6 Week Follow up|Death|1|||
124996539|NCT01296347|449614120|FG000|3 Month Follow up|Death|1|||
124996540|NCT01296347|449614121|FG001|3 Month Follow up|Death|0|||
124996541|NCT01296347|449614120|FG000|3 Month Follow up|Lost to Follow-up|0|||
124996542|NCT01296347|449614121|FG001|3 Month Follow up|Lost to Follow-up|1|||
124996543|NCT01296347|449614120|FG000|6 Month Follow up|Death|2|||
124996544|NCT01296347|449614121|FG001|6 Month Follow up|Death|1|||
124996545|NCT01296347|449614120|FG000|6 Month Follow up|Lost to Follow-up|0|||
124996546|NCT01296347|449614121|FG001|6 Month Follow up|Lost to Follow-up|1|||
125326576|NCT02113982|450831388|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
125326577|NCT02113982|450831389|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
125326578|NCT02113982|450831376|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326579|NCT02113982|450831377|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
124996547|NCT01296347|449614120|FG000|12 Month Follow up|Lost to Follow-up|3|||
125326580|NCT02113982|450831378|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
124996548|NCT01296347|449614121|FG001|12 Month Follow up|Lost to Follow-up|1|||
125326581|NCT02113982|450831379|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326582|NCT02113982|450831380|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326583|NCT02113982|450831381|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326584|NCT02113982|450831382|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326585|NCT02113982|450831383|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326586|NCT02113982|450831384|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326587|NCT02113982|450831385|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326588|NCT02113982|450831386|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326589|NCT02113982|450831387|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326590|NCT02113982|450831388|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
125326591|NCT02113982|450831389|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326592|NCT02113982|450831376|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326593|NCT02113982|450831377|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326594|NCT02113982|450831378|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326595|NCT02113982|450831379|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326596|NCT02113982|450831380|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326597|NCT02113982|450831381|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326598|NCT02113982|450831382|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326599|NCT02113982|450831383|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326600|NCT02113982|450831384|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326601|NCT02113982|450831385|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326602|NCT02113982|450831386|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326603|NCT02113982|450831387|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326604|NCT02113982|450831388|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
125326605|NCT02113982|450831389|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
125326606|NCT02113982|450831376|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326607|NCT02113982|450831377|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326608|NCT02113982|450831378|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326609|NCT02113982|450831379|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326610|NCT02113982|450831380|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326611|NCT02113982|450831381|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326612|NCT02113982|450831382|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326613|NCT02113982|450831383|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326614|NCT02113982|450831384|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326615|NCT02113982|450831385|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326616|NCT02113982|450831386|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326617|NCT02113982|450831387|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326618|NCT02113982|450831388|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
125326619|NCT02113982|450831389|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
125326620|NCT02113982|450831376|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326621|NCT02113982|450831377|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326622|NCT02113982|450831378|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326623|NCT02113982|450831379|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326624|NCT02113982|450831380|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326625|NCT02113982|450831381|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326626|NCT02113982|450831382|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326627|NCT02113982|450831383|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326628|NCT02113982|450831384|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326629|NCT02113982|450831385|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326630|NCT02113982|450831386|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326631|NCT02113982|450831387|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326632|NCT02113982|450831388|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
125326633|NCT02113982|450831389|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
125326634|NCT02113982|450831376|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326635|NCT02113982|450831377|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326636|NCT02113982|450831378|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326637|NCT02113982|450831379|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326638|NCT02113982|450831380|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326639|NCT02113982|450831381|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326640|NCT02113982|450831382|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326641|NCT02113982|450831383|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326642|NCT02113982|450831384|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326643|NCT02113982|450831385|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326644|NCT02113982|450831386|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326645|NCT02113982|450831387|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326646|NCT02113982|450831388|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
125326647|NCT02113982|450831389|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326648|NCT02113982|450831376|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326649|NCT02113982|450831377|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326650|NCT02113982|450831378|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326651|NCT02113982|450831379|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326652|NCT02113982|450831380|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326653|NCT02113982|450831381|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326654|NCT02113982|450831382|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326655|NCT02113982|450831383|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326656|NCT02113982|450831384|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326657|NCT02113982|450831385|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326658|NCT02113982|450831386|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326659|NCT02113982|450831387|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326660|NCT02113982|450831388|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
125326661|NCT02113982|450831389|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326662|NCT02113982|450831376|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326663|NCT02113982|450831377|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326664|NCT02113982|450831378|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326665|NCT02113982|450831379|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326666|NCT02113982|450831380|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326667|NCT02113982|450831381|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326668|NCT02113982|450831382|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326669|NCT02113982|450831383|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326670|NCT02113982|450831384|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326671|NCT02113982|450831385|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326672|NCT02113982|450831386|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326673|NCT02113982|450831387|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326674|NCT02113982|450831388|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
125326675|NCT02113982|450831389|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326676|NCT01774721|450831390|FG000|Overall Study|Death|133|||
125326677|NCT01774721|450831391|FG001|Overall Study|Death|152|||
125326678|NCT01774721|450831390|FG000|Overall Study|Withdrawal by Subject|20|||
125326679|NCT01774721|450831391|FG001|Overall Study|Withdrawal by Subject|14|||
125326680|NCT01774721|450831390|FG000|Overall Study|Lost to Follow-up|6|||
125326681|NCT01774721|450831391|FG001|Overall Study|Lost to Follow-up|7|||
125326682|NCT01774721|450831390|FG000|Overall Study|Did not meet eligibility criteria|0|||
125326683|NCT01774721|450831391|FG001|Overall Study|Did not meet eligibility criteria|3|||
125326684|NCT01774721|450831390|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
125326685|NCT01774721|450831391|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
125326686|NCT01774721|450831390|FG000|Overall Study|Study terminated by sponsor|5|||
125326687|NCT01774721|450831391|FG001|Overall Study|Study terminated by sponsor|0|||
125326688|NCT01774721|450831390|FG000|Overall Study|Disease progression|5|||
125326689|NCT01774721|450831391|FG001|Overall Study|Disease progression|0|||
125326690|NCT03594110|450831392|FG000|Interventional Part|Participant concerned about study treatment|23|||
125326691|NCT03594110|450831393|FG001|Interventional Part|Participant concerned about study treatment|28|||
125326692|NCT03594110|450831392|FG000|Interventional Part|Doctor advice|38|||
125326693|NCT03594110|450831393|FG001|Interventional Part|Doctor advice|40|||
125326694|NCT03594110|450831392|FG000|Interventional Part|Participants' wish|89|||
125326695|NCT03594110|450831393|FG001|Interventional Part|Participants' wish|68|||
125326696|NCT03594110|450831392|FG000|Interventional Part|Adverse event-non-fatal events|119|||
125326697|NCT03594110|450831393|FG001|Interventional Part|Adverse event-non-fatal events|116|||
125326698|NCT03594110|450831392|FG000|Interventional Part|Study drug stopped, reason missing|336|||
125326699|NCT03594110|450831393|FG001|Interventional Part|Study drug stopped, reason missing|294|||
125326700|NCT03594110|450831392|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
125326701|NCT03594110|450831393|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
125326702|NCT03594110|450831392|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
125326703|NCT03594110|450831393|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
125326704|NCT03594110|450831392|FG000|Interventional Part|Contraindicated drug started|32|||
125326705|NCT03594110|450831393|FG001|Interventional Part|Contraindicated drug started|18|||
125326706|NCT03594110|450831392|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
125326707|NCT03594110|450831393|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
125326708|NCT03594110|450831392|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
125326709|NCT03594110|450831393|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
125326710|NCT03594110|450831392|FG000|Non-interventional Part|Withdrawal by Subject|3|||
125326711|NCT03594110|450831393|FG001|Non-interventional Part|Withdrawal by Subject|4|||
125326712|NCT03594110|450831392|FG000|Non-interventional Part|Lost to Follow-up|45|||
125326713|NCT03594110|450831393|FG001|Non-interventional Part|Lost to Follow-up|41|||
124996549|NCT01296347|449614120|FG000|12 Month Follow up|Death|1|||
125326714|NCT02351817|450831394|FG000|Period 1|Adverse Event|1|||
125326715|NCT02351817|450831395|FG001|Period 1|Adverse Event|2|||
125326716|NCT02351817|450831394|FG000|Period 1|Lack of Efficacy|0|||
125326717|NCT02351817|450831395|FG001|Period 1|Lack of Efficacy|1|||
125326718|NCT02351817|450831394|FG000|Period 2|Adverse Event|0|||
125326719|NCT02351817|450831395|FG001|Period 2|Adverse Event|2|||
125326720|NCT02351817|450831394|FG000|Period 2|Protocol Violation|1|||
125326721|NCT02351817|450831395|FG001|Period 2|Protocol Violation|0|||
125326722|NCT02488915|450831398|FG000|Overall Study|Death|21|||
125326723|NCT02488915|450831398|FG000|Overall Study|Lost to Follow-up|4|||
125326724|NCT02488915|450831398|FG000|Overall Study|Withdrawal by Subject|1|||
125326725|NCT00684021|450831401|FG000|Overall Study|MRI Contraindicated|1|||
125326726|NCT00684021|450831402|FG001|Overall Study|MRI Contraindicated|1|||
125326727|NCT00684021|450831403|FG002|Overall Study|MRI Contraindicated|1|||
125326728|NCT00684021|450831404|FG003|Overall Study|MRI Contraindicated|0|||
125326729|NCT00684021|450831401|FG000|Overall Study|MRI not performed|0|||
125326730|NCT00684021|450831402|FG001|Overall Study|MRI not performed|1|||
125326731|NCT00684021|450831403|FG002|Overall Study|MRI not performed|1|||
125326732|NCT00684021|450831404|FG003|Overall Study|MRI not performed|2|||
125326733|NCT00684021|450831401|FG000|Overall Study|Death|1|||
125326734|NCT00684021|450831402|FG001|Overall Study|Death|0|||
125326735|NCT00684021|450831403|FG002|Overall Study|Death|0|||
125326736|NCT00684021|450831404|FG003|Overall Study|Death|0|||
125326737|NCT00927953|450831405|FG000|Overall Study|Death|2|||
125326738|NCT00927953|450831406|FG001|Overall Study|Death|1|||
125326739|NCT02976038|450831407|FG000|Overall Study|Physician Decision|22|||
125326740|NCT02976038|450831407|FG000|Overall Study|Withdrawal by Subject|3|||
125326741|NCT02976038|450831407|FG000|Overall Study|Lost to Follow-up|2|||
125326742|NCT02976038|450831407|FG000|Overall Study|Adverse Event|1|||
125326743|NCT01046396|450831408|FG000|Overall Study|Withdrawal by Subject|5|||
125326744|NCT01208207|450831409|FG000|Part I|Adverse Event|19|||
125326745|NCT01208207|450831410|FG001|Part I|Adverse Event|2|||
125326746|NCT01208207|450831411|FG002|Part I|Adverse Event|6|||
125326747|NCT01208207|450831412|FG003|Part I|Adverse Event|0|||
125326748|NCT01208207|450831413|FG004|Part I|Adverse Event|0|||
125326749|NCT01208207|450831414|FG005|Part I|Adverse Event|0|||
125326750|NCT01208207|450831415|FG006|Part I|Adverse Event|0|||
125326751|NCT01208207|450831409|FG000|Part I|Lack of Efficacy|21|||
125326752|NCT01208207|450831410|FG001|Part I|Lack of Efficacy|3|||
125326753|NCT01208207|450831411|FG002|Part I|Lack of Efficacy|2|||
125326754|NCT01208207|450831412|FG003|Part I|Lack of Efficacy|0|||
125326755|NCT01208207|450831413|FG004|Part I|Lack of Efficacy|0|||
125326756|NCT01208207|450831414|FG005|Part I|Lack of Efficacy|0|||
125326757|NCT01208207|450831415|FG006|Part I|Lack of Efficacy|0|||
125326758|NCT01208207|450831409|FG000|Part I|Lost to Follow-up|6|||
125326759|NCT01208207|450831410|FG001|Part I|Lost to Follow-up|1|||
125326760|NCT01208207|450831411|FG002|Part I|Lost to Follow-up|0|||
125326761|NCT01208207|450831412|FG003|Part I|Lost to Follow-up|0|||
125326762|NCT01208207|450831413|FG004|Part I|Lost to Follow-up|0|||
125326763|NCT01208207|450831414|FG005|Part I|Lost to Follow-up|0|||
125326764|NCT01208207|450831415|FG006|Part I|Lost to Follow-up|0|||
124996550|NCT01296347|449614121|FG001|12 Month Follow up|Death|1|||
124996551|NCT01296347|449614120|FG000|12 Month Follow up|Withdrawal by Subject|0|||
124996552|NCT01296347|449614121|FG001|12 Month Follow up|Withdrawal by Subject|1|||
124996553|NCT01585987|449614122|FG000|Randomized|Withdrawal by Subject|0|||
124996554|NCT01585987|449614123|FG001|Randomized|Withdrawal by Subject|4|||
124996555|NCT01585987|449614122|FG000|Randomized|No longer met criteria|0|||
124996556|NCT01585987|449614123|FG001|Randomized|No longer met criteria|2|||
124996557|NCT01585987|449614122|FG000|Treated|Disease Progression|39|||
124996558|NCT01585987|449614123|FG001|Treated|Disease Progression|36|||
125326765|NCT01208207|450831409|FG000|Part I|Non-Compliance With Study Drug|1|||
125326766|NCT01208207|450831410|FG001|Part I|Non-Compliance With Study Drug|0|||
125326767|NCT01208207|450831411|FG002|Part I|Non-Compliance With Study Drug|1|||
125326768|NCT01208207|450831412|FG003|Part I|Non-Compliance With Study Drug|0|||
125326769|NCT01208207|450831413|FG004|Part I|Non-Compliance With Study Drug|0|||
125326770|NCT01208207|450831414|FG005|Part I|Non-Compliance With Study Drug|0|||
125326771|NCT01208207|450831415|FG006|Part I|Non-Compliance With Study Drug|0|||
125326772|NCT01208207|450831409|FG000|Part I|Physician Decision|0|||
125326773|NCT01208207|450831410|FG001|Part I|Physician Decision|1|||
125326774|NCT01208207|450831411|FG002|Part I|Physician Decision|0|||
125326775|NCT01208207|450831412|FG003|Part I|Physician Decision|0|||
125326776|NCT01208207|450831413|FG004|Part I|Physician Decision|0|||
125326777|NCT01208207|450831414|FG005|Part I|Physician Decision|0|||
125326778|NCT01208207|450831415|FG006|Part I|Physician Decision|0|||
125326779|NCT01208207|450831409|FG000|Part I|Progressive Disease|1|||
125326780|NCT01208207|450831410|FG001|Part I|Progressive Disease|0|||
125326781|NCT01208207|450831411|FG002|Part I|Progressive Disease|0|||
125326782|NCT01208207|450831412|FG003|Part I|Progressive Disease|0|||
124996559|NCT01585987|449614122|FG000|Treated|Study Drug Toxicity|9|||
125326783|NCT01208207|450831413|FG004|Part I|Progressive Disease|0|||
125326784|NCT01208207|450831414|FG005|Part I|Progressive Disease|0|||
125326785|NCT01208207|450831415|FG006|Part I|Progressive Disease|0|||
125326786|NCT01208207|450831409|FG000|Part I|Protocol Violation|8|||
125326787|NCT01208207|450831410|FG001|Part I|Protocol Violation|0|||
125326788|NCT01208207|450831411|FG002|Part I|Protocol Violation|2|||
125326789|NCT01208207|450831412|FG003|Part I|Protocol Violation|0|||
125326790|NCT01208207|450831413|FG004|Part I|Protocol Violation|0|||
125326791|NCT01208207|450831414|FG005|Part I|Protocol Violation|0|||
125326792|NCT01208207|450831415|FG006|Part I|Protocol Violation|0|||
125326793|NCT01208207|450831409|FG000|Part I|Withdrawal by Subject|14|||
125326794|NCT01208207|450831410|FG001|Part I|Withdrawal by Subject|4|||
125326795|NCT01208207|450831411|FG002|Part I|Withdrawal by Subject|4|||
125326796|NCT01208207|450831412|FG003|Part I|Withdrawal by Subject|0|||
125326797|NCT01208207|450831413|FG004|Part I|Withdrawal by Subject|0|||
125326798|NCT01208207|450831414|FG005|Part I|Withdrawal by Subject|0|||
125326799|NCT01208207|450831415|FG006|Part I|Withdrawal by Subject|0|||
125326800|NCT01208207|450831409|FG000|Part II|Withdrawal by Subject|0|||
125326801|NCT01208207|450831410|FG001|Part II|Withdrawal by Subject|0|||
125326802|NCT01208207|450831411|FG002|Part II|Withdrawal by Subject|0|||
125326803|NCT01208207|450831412|FG003|Part II|Withdrawal by Subject|10|||
125326804|NCT01208207|450831413|FG004|Part II|Withdrawal by Subject|9|||
125326805|NCT01208207|450831414|FG005|Part II|Withdrawal by Subject|3|||
125326806|NCT01208207|450831415|FG006|Part II|Withdrawal by Subject|5|||
125326807|NCT01208207|450831409|FG000|Part II|Adverse Event|0|||
125326808|NCT01208207|450831410|FG001|Part II|Adverse Event|0|||
125326809|NCT01208207|450831411|FG002|Part II|Adverse Event|0|||
125326810|NCT01208207|450831412|FG003|Part II|Adverse Event|5|||
125326811|NCT01208207|450831413|FG004|Part II|Adverse Event|9|||
125326812|NCT01208207|450831414|FG005|Part II|Adverse Event|4|||
125326813|NCT01208207|450831415|FG006|Part II|Adverse Event|2|||
125326814|NCT01208207|450831409|FG000|Part II|Lack of Efficacy|0|||
125326815|NCT01208207|450831410|FG001|Part II|Lack of Efficacy|0|||
125326816|NCT01208207|450831411|FG002|Part II|Lack of Efficacy|0|||
125326817|NCT01208207|450831412|FG003|Part II|Lack of Efficacy|6|||
125326818|NCT01208207|450831413|FG004|Part II|Lack of Efficacy|4|||
125326819|NCT01208207|450831414|FG005|Part II|Lack of Efficacy|3|||
125326820|NCT01208207|450831415|FG006|Part II|Lack of Efficacy|3|||
125326821|NCT01208207|450831409|FG000|Part II|Lost to Follow-up|0|||
125326822|NCT01208207|450831410|FG001|Part II|Lost to Follow-up|0|||
125326823|NCT01208207|450831411|FG002|Part II|Lost to Follow-up|0|||
125326824|NCT01208207|450831412|FG003|Part II|Lost to Follow-up|4|||
125326825|NCT01208207|450831413|FG004|Part II|Lost to Follow-up|0|||
125326826|NCT01208207|450831414|FG005|Part II|Lost to Follow-up|2|||
125326827|NCT01208207|450831415|FG006|Part II|Lost to Follow-up|1|||
125326828|NCT01208207|450831409|FG000|Part II|Non-Compliance With Study Drug|0|||
125326829|NCT01208207|450831410|FG001|Part II|Non-Compliance With Study Drug|0|||
125326830|NCT01208207|450831411|FG002|Part II|Non-Compliance With Study Drug|0|||
125326831|NCT01208207|450831412|FG003|Part II|Non-Compliance With Study Drug|4|||
125326832|NCT01208207|450831413|FG004|Part II|Non-Compliance With Study Drug|1|||
125326833|NCT01208207|450831414|FG005|Part II|Non-Compliance With Study Drug|1|||
125326834|NCT01208207|450831415|FG006|Part II|Non-Compliance With Study Drug|0|||
125326835|NCT01208207|450831409|FG000|Part II|Physician Decision|0|||
125326836|NCT01208207|450831410|FG001|Part II|Physician Decision|0|||
125326837|NCT01208207|450831411|FG002|Part II|Physician Decision|0|||
125326838|NCT01208207|450831412|FG003|Part II|Physician Decision|1|||
125326839|NCT01208207|450831413|FG004|Part II|Physician Decision|0|||
125326840|NCT01208207|450831414|FG005|Part II|Physician Decision|2|||
125326841|NCT01208207|450831415|FG006|Part II|Physician Decision|0|||
125326842|NCT01208207|450831409|FG000|Part II|Protocol Violation|0|||
125326843|NCT01208207|450831410|FG001|Part II|Protocol Violation|0|||
125326844|NCT01208207|450831411|FG002|Part II|Protocol Violation|0|||
125326845|NCT01208207|450831412|FG003|Part II|Protocol Violation|1|||
125326846|NCT01208207|450831413|FG004|Part II|Protocol Violation|0|||
125326847|NCT01208207|450831414|FG005|Part II|Protocol Violation|0|||
125326848|NCT01208207|450831415|FG006|Part II|Protocol Violation|0|||
125326849|NCT01208207|450831409|FG000|Part II|Technical Problems|0|||
125326850|NCT01208207|450831410|FG001|Part II|Technical Problems|0|||
125326851|NCT01208207|450831411|FG002|Part II|Technical Problems|0|||
125326852|NCT01208207|450831412|FG003|Part II|Technical Problems|1|||
125326853|NCT01208207|450831413|FG004|Part II|Technical Problems|0|||
125326854|NCT01208207|450831414|FG005|Part II|Technical Problems|1|||
125326855|NCT01208207|450831415|FG006|Part II|Technical Problems|0|||
125326856|NCT04041414|450831416|FG000|Overall Study|Lost to Follow-up|1|||
125326857|NCT04041414|450831417|FG001|Overall Study|Lost to Follow-up|2|||
125326858|NCT04004988|450831418|FG000|Period 1|Physician Decision|2|||
125326859|NCT04004988|450831419|FG001|Period 1|Physician Decision|0|||
125326860|NCT04004988|450831418|FG000|Period 1|Withdrawal by Subject|0|||
125326861|NCT04004988|450831419|FG001|Period 1|Withdrawal by Subject|1|||
125326862|NCT04004988|450831418|FG000|Period 1|Adverse Event|1|||
125326863|NCT04004988|450831419|FG001|Period 1|Adverse Event|2|||
125326864|NCT00930046|450831420|FG000|Overall Study|Wound catheter malfunctioned|1|||
125326865|NCT00930046|450831421|FG001|Overall Study|Wound catheter malfunctioned|2|||
125326866|NCT01598532|450831422|FG000|Overall Study|Lost to Follow-up|3|||
125326867|NCT01598532|450831422|FG000|Overall Study|Did not meet inclusion criteria|8|||
125326868|NCT04682366|450831423|FG000|Overall Study|Lost to Follow-up|1|||
125326869|NCT04682366|450831424|FG001|Overall Study|Lost to Follow-up|1|||
125326870|NCT00702221|450831425|FG000|Overall Study|Adverse Event|4|||
125326871|NCT00702221|450831426|FG001|Overall Study|Adverse Event|3|||
125326872|NCT01867671|450831430|FG000|Overall Study|Adverse Event|5|||
125326873|NCT01867671|450831431|FG001|Overall Study|Adverse Event|3|||
125326874|NCT01867671|450831430|FG000|Overall Study|Anaphylaxis|0|||
125326875|NCT01867671|450831431|FG001|Overall Study|Anaphylaxis|1|||
125326876|NCT01867671|450831430|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
125326877|NCT01867671|450831431|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
125326878|NCT01867671|450831430|FG000|Overall Study|Lost to Follow-up|0|||
125326879|NCT01867671|450831431|FG001|Overall Study|Lost to Follow-up|1|||
125326880|NCT01867671|450831430|FG000|Overall Study|Non-compliance with Study Drug|1|||
125326881|NCT01867671|450831431|FG001|Overall Study|Non-compliance with Study Drug|2|||
125326882|NCT01867671|450831430|FG000|Overall Study|Withdrawal by Subject|21|||
125326883|NCT01867671|450831431|FG001|Overall Study|Withdrawal by Subject|21|||
125326884|NCT01523366|450831432|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125326885|NCT01523366|450831433|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125326886|NCT01523366|450831432|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
125326887|NCT01523366|450831433|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
125326888|NCT04543279|450831434|FG000|Overall Study|Withdrawal by Subject|1|||
125326889|NCT04543279|450831435|FG001|Overall Study|Withdrawal by Subject|0|||
125326890|NCT04543279|450831434|FG000|Overall Study|Adverse Event|1|||
125326891|NCT04543279|450831435|FG001|Overall Study|Adverse Event|0|||
125326892|NCT04543279|450831434|FG000|Overall Study|Physician Decision|1|||
125326893|NCT04543279|450831435|FG001|Overall Study|Physician Decision|0|||
125326894|NCT01352715|450831436|FG000|Overall Study|Death|3|||
125326895|NCT01352715|450831437|FG001|Overall Study|Death|3|||
125326896|NCT01352715|450831436|FG000|Overall Study|Lost to Follow-up|5|||
125326897|NCT01352715|450831437|FG001|Overall Study|Lost to Follow-up|7|||
125326898|NCT01352715|450831436|FG000|Overall Study|Withdrawal by Subject|4|||
125326899|NCT01352715|450831437|FG001|Overall Study|Withdrawal by Subject|8|||
125326900|NCT01352715|450831436|FG000|Overall Study|site closure|16|||
125326901|NCT01352715|450831437|FG001|Overall Study|site closure|15|||
125326902|NCT01352715|450831436|FG000|Overall Study|no final visit in closeout period|15|||
125326903|NCT01352715|450831437|FG001|Overall Study|no final visit in closeout period|12|||
125326904|NCT01352715|450831436|FG000|Overall Study|major ineligibility|2|||
125326905|NCT01352715|450831437|FG001|Overall Study|major ineligibility|1|||
125326906|NCT04596267|450831438|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
125326907|NCT04596267|450831439|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
125326908|NCT04596267|450831438|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
125326909|NCT04596267|450831439|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
125326910|NCT00071058|450831440|FG000|Overall Study|brain tumor-removed from study|1|||
125326911|NCT02000440|450831441|FG000|Overall Study|Adverse Event|3|||
125326912|NCT02000440|450831441|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
125326913|NCT04109547|450831442|FG000|Overall Study|Withdrawal by Subject|3|||
125326914|NCT04109547|450831443|FG001|Overall Study|Withdrawal by Subject|2|||
125326915|NCT04109547|450831444|FG002|Overall Study|Withdrawal by Subject|6|||
125326916|NCT04109547|450831445|FG003|Overall Study|Withdrawal by Subject|6|||
125326917|NCT04109547|450831442|FG000|Overall Study|Lost to Follow-up|0|||
125326918|NCT04109547|450831443|FG001|Overall Study|Lost to Follow-up|0|||
125326919|NCT04109547|450831444|FG002|Overall Study|Lost to Follow-up|0|||
125326920|NCT04109547|450831445|FG003|Overall Study|Lost to Follow-up|1|||
125326921|NCT04109547|450831442|FG000|Overall Study|Physician Decision|1|||
125326922|NCT04109547|450831443|FG001|Overall Study|Physician Decision|2|||
125326923|NCT04109547|450831444|FG002|Overall Study|Physician Decision|0|||
125326924|NCT04109547|450831445|FG003|Overall Study|Physician Decision|0|||
125326925|NCT01550003|450831446|FG000|Overall Study|Adverse Event|0|||
125326926|NCT01550003|450831447|FG001|Overall Study|Adverse Event|9|||
125326927|NCT01550003|450831448|FG002|Overall Study|Adverse Event|15|||
125326928|NCT01550003|450831446|FG000|Overall Study|Lack of Efficacy|4|||
125326929|NCT01550003|450831447|FG001|Overall Study|Lack of Efficacy|11|||
125326930|NCT01550003|450831448|FG002|Overall Study|Lack of Efficacy|15|||
125326931|NCT01550003|450831446|FG000|Overall Study|Protocol Violation|0|||
125326932|NCT01550003|450831447|FG001|Overall Study|Protocol Violation|3|||
125326933|NCT01550003|450831448|FG002|Overall Study|Protocol Violation|2|||
125326934|NCT01550003|450831446|FG000|Overall Study|Lost to Follow-up|1|||
125326935|NCT01550003|450831447|FG001|Overall Study|Lost to Follow-up|4|||
125326936|NCT01550003|450831448|FG002|Overall Study|Lost to Follow-up|8|||
125326937|NCT01550003|450831446|FG000|Overall Study|Consent withdrawn|2|||
125326938|NCT01550003|450831447|FG001|Overall Study|Consent withdrawn|11|||
125326939|NCT01550003|450831448|FG002|Overall Study|Consent withdrawn|23|||
125326940|NCT01550003|450831446|FG000|Overall Study|Missing|1|||
125326941|NCT01550003|450831447|FG001|Overall Study|Missing|0|||
125326942|NCT01550003|450831448|FG002|Overall Study|Missing|2|||
125326943|NCT01550003|450831446|FG000|Overall Study|Study closure as announced by sponsor|7|||
125326944|NCT01550003|450831447|FG001|Overall Study|Study closure as announced by sponsor|6|||
125326945|NCT01550003|450831448|FG002|Overall Study|Study closure as announced by sponsor|24|||
125326946|NCT01550003|450831446|FG000|Overall Study|Protocol Noncompliance|1|||
125326947|NCT01550003|450831447|FG001|Overall Study|Protocol Noncompliance|0|||
125326948|NCT01550003|450831448|FG002|Overall Study|Protocol Noncompliance|0|||
125326949|NCT01550003|450831446|FG000|Overall Study|Study closure|0|||
125326950|NCT01550003|450831447|FG001|Overall Study|Study closure|1|||
125326951|NCT01550003|450831448|FG002|Overall Study|Study closure|1|||
125326952|NCT01550003|450831446|FG000|Overall Study|Patient reached adulthood|0|||
125326953|NCT01550003|450831447|FG001|Overall Study|Patient reached adulthood|1|||
125326954|NCT01550003|450831448|FG002|Overall Study|Patient reached adulthood|0|||
125326955|NCT01550003|450831446|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
125326956|NCT01550003|450831447|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
125326957|NCT01550003|450831448|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
125326958|NCT01550003|450831446|FG000|Overall Study|Sponsor's order|0|||
125326959|NCT01550003|450831447|FG001|Overall Study|Sponsor's order|3|||
125326960|NCT01550003|450831448|FG002|Overall Study|Sponsor's order|3|||
125326961|NCT01550003|450831446|FG000|Overall Study|Sponsor's decision|1|||
125326962|NCT01550003|450831447|FG001|Overall Study|Sponsor's decision|5|||
125326963|NCT01550003|450831448|FG002|Overall Study|Sponsor's decision|4|||
125326964|NCT01550003|450831446|FG000|Overall Study|Subject mother passed away|0|||
125326965|NCT01550003|450831447|FG001|Overall Study|Subject mother passed away|1|||
125326966|NCT01550003|450831448|FG002|Overall Study|Subject mother passed away|0|||
125326967|NCT01550003|450831446|FG000|Overall Study|Discontinuation|0|||
125326968|NCT01550003|450831447|FG001|Overall Study|Discontinuation|1|||
125326969|NCT01550003|450831448|FG002|Overall Study|Discontinuation|0|||
125326970|NCT01550003|450831446|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
125326971|NCT01550003|450831447|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
125326972|NCT01550003|450831448|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
125326973|NCT01550003|450831446|FG000|Overall Study|Site closure|0|||
125326974|NCT01550003|450831447|FG001|Overall Study|Site closure|2|||
125326975|NCT01550003|450831448|FG002|Overall Study|Site closure|0|||
125326976|NCT01550003|450831446|FG000|Overall Study|Pregnancy|0|||
125326977|NCT01550003|450831447|FG001|Overall Study|Pregnancy|1|||
125326978|NCT01550003|450831448|FG002|Overall Study|Pregnancy|0|||
125326979|NCT01550003|450831446|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
125326980|NCT01550003|450831447|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
125326981|NCT01550003|450831448|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
125326982|NCT01550003|450831446|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
125326983|NCT01550003|450831447|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
125326984|NCT01550003|450831448|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
125326985|NCT01550003|450831446|FG000|Overall Study|Switching to adult rheumatologist|0|||
125326986|NCT01550003|450831447|FG001|Overall Study|Switching to adult rheumatologist|0|||
125326987|NCT01550003|450831448|FG002|Overall Study|Switching to adult rheumatologist|1|||
125326988|NCT01550003|450831446|FG000|Overall Study|Patient transition to adult care|0|||
125326989|NCT01550003|450831447|FG001|Overall Study|Patient transition to adult care|0|||
125326990|NCT01550003|450831448|FG002|Overall Study|Patient transition to adult care|1|||
125326991|NCT01550003|450831446|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
125326992|NCT01550003|450831447|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
125326993|NCT01550003|450831448|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
125326994|NCT01550003|450831446|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
125326995|NCT01550003|450831447|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
125326996|NCT01550003|450831448|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
125326997|NCT01550003|450831446|FG000|Overall Study|Per Sponsor request|1|||
125326998|NCT01550003|450831447|FG001|Overall Study|Per Sponsor request|0|||
125326999|NCT01550003|450831448|FG002|Overall Study|Per Sponsor request|1|||
125327000|NCT01550003|450831446|FG000|Overall Study|Patient not compliance|0|||
125327001|NCT01550003|450831447|FG001|Overall Study|Patient not compliance|0|||
125327002|NCT01550003|450831448|FG002|Overall Study|Patient not compliance|1|||
125327003|NCT01550003|450831446|FG000|Overall Study|Non-compliance|0|||
125327004|NCT01550003|450831447|FG001|Overall Study|Non-compliance|0|||
125327005|NCT01550003|450831448|FG002|Overall Study|Non-compliance|1|||
125327006|NCT01550003|450831446|FG000|Overall Study|Study closed|0|||
125327007|NCT01550003|450831447|FG001|Overall Study|Study closed|1|||
125327008|NCT01550003|450831448|FG002|Overall Study|Study closed|0|||
125327009|NCT01550003|450831446|FG000|Overall Study|Transitioned to adult rheumatology|0|||
125327010|NCT01550003|450831447|FG001|Overall Study|Transitioned to adult rheumatology|0|||
125327011|NCT01550003|450831448|FG002|Overall Study|Transitioned to adult rheumatology|1|||
125327012|NCT01656408|450831449|FG000|Overall Study|Adverse Event|0|||
125327013|NCT01656408|450831450|FG001|Overall Study|Adverse Event|0|||
125327014|NCT01656408|450831451|FG002|Overall Study|Adverse Event|1|||
125327015|NCT01656408|450831452|FG003|Overall Study|Adverse Event|0|||
125327016|NCT01656408|450831453|FG004|Overall Study|Adverse Event|0|||
125327017|NCT01656408|450831454|FG005|Overall Study|Adverse Event|1|||
125327018|NCT01656408|450831455|FG006|Overall Study|Adverse Event|1|||
125327019|NCT01656408|450831456|FG007|Overall Study|Adverse Event|0|||
125327020|NCT01656408|450831457|FG008|Overall Study|Adverse Event|1|||
125327021|NCT01656408|450831458|FG009|Overall Study|Adverse Event|0|||
125327022|NCT01656408|450831449|FG000|Overall Study|Physician Decision|1|||
125327023|NCT01656408|450831450|FG001|Overall Study|Physician Decision|0|||
125327024|NCT01656408|450831451|FG002|Overall Study|Physician Decision|1|||
125327025|NCT01656408|450831452|FG003|Overall Study|Physician Decision|0|||
125327026|NCT01656408|450831453|FG004|Overall Study|Physician Decision|1|||
125327027|NCT01656408|450831454|FG005|Overall Study|Physician Decision|1|||
125327028|NCT01656408|450831455|FG006|Overall Study|Physician Decision|0|||
125327029|NCT01656408|450831456|FG007|Overall Study|Physician Decision|1|||
125327030|NCT01656408|450831457|FG008|Overall Study|Physician Decision|1|||
125327031|NCT01656408|450831458|FG009|Overall Study|Physician Decision|3|||
125327032|NCT03995368|450831459|FG000|Overall Study|Lost to Follow-up|1|||
125327033|NCT03995368|450831460|FG001|Overall Study|Lost to Follow-up|4|||
125327034|NCT03995368|450831461|FG002|Overall Study|Lost to Follow-up|1|||
125327035|NCT03995368|450831459|FG000|Overall Study|Did not meet inclusion criteria|1|||
125327036|NCT03995368|450831460|FG001|Overall Study|Did not meet inclusion criteria|6|||
125327037|NCT03995368|450831461|FG002|Overall Study|Did not meet inclusion criteria|3|||
125327038|NCT03995368|450831459|FG000|Overall Study|Withdrawal by Subject|0|||
125327039|NCT03995368|450831460|FG001|Overall Study|Withdrawal by Subject|1|||
125327040|NCT03995368|450831461|FG002|Overall Study|Withdrawal by Subject|1|||
125327041|NCT03592186|450831462|FG000|Overall Study|Withdrawal by Subject|1|||
125327042|NCT03592186|450831463|FG001|Overall Study|Withdrawal by Subject|0|||
125327043|NCT03592186|450831462|FG000|Overall Study|Lost to Follow-up|16|||
125327044|NCT03592186|450831463|FG001|Overall Study|Lost to Follow-up|11|||
125327045|NCT01409707|450831466|FG000|Overall Study|Withdrawal by Subject|5|||
125327046|NCT01409707|450831467|FG001|Overall Study|Withdrawal by Subject|17|||
125327047|NCT01409707|450831468|FG002|Overall Study|Withdrawal by Subject|16|||
125327048|NCT01658436|450831469|FG000|Overall Study|Adverse Event|6|||
125327049|NCT01658436|450831470|FG001|Overall Study|Adverse Event|5|||
125327050|NCT01658436|450831469|FG000|Overall Study|Physician Decision|1|||
125327051|NCT01658436|450831470|FG001|Overall Study|Physician Decision|0|||
125327052|NCT01658436|450831469|FG000|Overall Study|Progressive disease|12|||
125327053|NCT01658436|450831470|FG001|Overall Study|Progressive disease|4|||
125327054|NCT01658436|450831469|FG000|Overall Study|Study terminated by sponsor|0|||
125327055|NCT01658436|450831470|FG001|Overall Study|Study terminated by sponsor|1|||
125327056|NCT01658436|450831469|FG000|Overall Study|Subject/guardian decision|0|||
125327057|NCT01658436|450831470|FG001|Overall Study|Subject/guardian decision|1|||
125327058|NCT01658436|450831469|FG000|Overall Study|Death|1|||
125327059|NCT01658436|450831470|FG001|Overall Study|Death|0|||
125327060|NCT01217229|450831471|FG000|Overall Study|Adverse Event|1|||
125327061|NCT01217229|450831471|FG000|Overall Study|Disease progression, deterioration|2|||
125327062|NCT01217229|450831471|FG000|Overall Study|Disease progression, Cheson criteria|14|||
125327063|NCT01217229|450831471|FG000|Overall Study|Protocol Violation|1|||
125327064|NCT01217229|450831471|FG000|Overall Study|Disease progression not confirmed|2|||
125327065|NCT03987503|450831472|FG000|Overall Study|Lost to Follow-up|20|||
125327066|NCT03987503|450831472|FG000|Overall Study|Withdrawal by Subject|2|||
125327067|NCT01929317|450831480|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
125327068|NCT01929317|450831481|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
125327069|NCT01929317|450831480|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
125327070|NCT01929317|450831481|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
125327071|NCT01929317|450831480|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
125327072|NCT01929317|450831481|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
125327073|NCT01929317|450831480|FG000|Long-term Phase|Adverse Event|5|||
125327074|NCT01929317|450831481|FG001|Long-term Phase|Adverse Event|1|||
125327075|NCT01929317|450831480|FG000|Long-term Phase|Physician Decision|3|||
125327076|NCT01929317|450831481|FG001|Long-term Phase|Physician Decision|0|||
125327077|NCT01929317|450831480|FG000|Long-term Phase|Withdrawal by Subject|4|||
125327078|NCT01929317|450831481|FG001|Long-term Phase|Withdrawal by Subject|0|||
125327079|NCT01929317|450831480|FG000|Long-term Phase|Protocol Violation|1|||
125327080|NCT01929317|450831481|FG001|Long-term Phase|Protocol Violation|0|||
125327081|NCT01929317|450831480|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
125327082|NCT01929317|450831481|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
125327083|NCT01929317|450831480|FG000|Long-term Phase|Study Closed/Terminated|5|||
125327084|NCT01929317|450831481|FG001|Long-term Phase|Study Closed/Terminated|3|||
125327085|NCT04322526|450831484|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
125327086|NCT04322526|450831485|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
125327087|NCT04322526|450831484|FG000|Washout (1 Week)|Lost to Follow-up|1|||
125327088|NCT04322526|450831485|FG001|Washout (1 Week)|Lost to Follow-up|2|||
125327089|NCT01523756|450831486|FG000|Baseline Period|Adverse Event|0|||
125327090|NCT01523756|450831487|FG001|Baseline Period|Adverse Event|1|||
124996560|NCT01585987|449614123|FG001|Treated|Study Drug Toxicity|5|||
125327091|NCT01523756|450831486|FG000|Test Period 1|Adverse Event|1|||
125327092|NCT01523756|450831487|FG001|Test Period 1|Adverse Event|0|||
125327093|NCT01523756|450831486|FG000|Test Period 2|Withdrawal by Subject|0|||
125327094|NCT01523756|450831487|FG001|Test Period 2|Withdrawal by Subject|1|||
124996561|NCT01585987|449614122|FG000|Treated|Adverse Event|3|||
125327095|NCT00993967|450831488|FG000|Overall Study|Adverse Event|8|||
125327096|NCT00993967|450831488|FG000|Overall Study|Death|1|||
125327097|NCT00993967|450831488|FG000|Overall Study|Lost to Follow-up|14|||
125327098|NCT00993967|450831488|FG000|Overall Study|Withdrawal by Subject|36|||
125327099|NCT00993967|450831488|FG000|Overall Study|Protocol Violation|2|||
125327100|NCT02760498|450831489|FG000|Overall Study|Adverse Event|3|||
125327101|NCT02760498|450831490|FG001|Overall Study|Adverse Event|3|||
125327102|NCT02760498|450831491|FG002|Overall Study|Adverse Event|1|||
125327103|NCT02760498|450831492|FG003|Overall Study|Adverse Event|1|||
125327104|NCT02760498|450831493|FG004|Overall Study|Adverse Event|0|||
125327105|NCT02760498|450831494|FG005|Overall Study|Adverse Event|6|||
125327106|NCT02760498|450831489|FG000|Overall Study|Death|7|||
125327107|NCT02760498|450831490|FG001|Overall Study|Death|5|||
125327108|NCT02760498|450831491|FG002|Overall Study|Death|5|||
125327109|NCT02760498|450831492|FG003|Overall Study|Death|7|||
125327110|NCT02760498|450831493|FG004|Overall Study|Death|0|||
125327111|NCT02760498|450831494|FG005|Overall Study|Death|23|||
125327112|NCT02760498|450831489|FG000|Overall Study|Lost to Follow-up|0|||
125327113|NCT02760498|450831490|FG001|Overall Study|Lost to Follow-up|0|||
125327114|NCT02760498|450831491|FG002|Overall Study|Lost to Follow-up|0|||
125327115|NCT02760498|450831492|FG003|Overall Study|Lost to Follow-up|0|||
125327116|NCT02760498|450831493|FG004|Overall Study|Lost to Follow-up|0|||
125327117|NCT02760498|450831494|FG005|Overall Study|Lost to Follow-up|3|||
125327118|NCT02760498|450831489|FG000|Overall Study|Non-compliance with study drug|0|||
125327119|NCT02760498|450831490|FG001|Overall Study|Non-compliance with study drug|2|||
125327120|NCT02760498|450831491|FG002|Overall Study|Non-compliance with study drug|0|||
125327121|NCT02760498|450831492|FG003|Overall Study|Non-compliance with study drug|0|||
125327122|NCT02760498|450831493|FG004|Overall Study|Non-compliance with study drug|0|||
125327123|NCT02760498|450831494|FG005|Overall Study|Non-compliance with study drug|0|||
125327124|NCT02760498|450831489|FG000|Overall Study|Participant decision|1|||
125327125|NCT02760498|450831490|FG001|Overall Study|Participant decision|4|||
125327126|NCT02760498|450831491|FG002|Overall Study|Participant decision|2|||
125327127|NCT02760498|450831492|FG003|Overall Study|Participant decision|2|||
125327128|NCT02760498|450831493|FG004|Overall Study|Participant decision|1|||
125327129|NCT02760498|450831494|FG005|Overall Study|Participant decision|6|||
125327130|NCT02760498|450831489|FG000|Overall Study|Sponsor decision|0|||
125327131|NCT02760498|450831490|FG001|Overall Study|Sponsor decision|0|||
125327132|NCT02760498|450831491|FG002|Overall Study|Sponsor decision|0|||
125327133|NCT02760498|450831492|FG003|Overall Study|Sponsor decision|3|||
125327134|NCT02760498|450831493|FG004|Overall Study|Sponsor decision|0|||
124996562|NCT01585987|449614123|FG001|Treated|Adverse Event|0|||
124996563|NCT01585987|449614122|FG000|Treated|Withdrawal by Subject|1|||
124996564|NCT01585987|449614123|FG001|Treated|Withdrawal by Subject|2|||
124996565|NCT01585987|449614122|FG000|Treated|Death|1|||
124996566|NCT01585987|449614123|FG001|Treated|Death|0|||
124996567|NCT01585987|449614122|FG000|Treated|Lost to Follow-up|0|||
124996568|NCT01585987|449614123|FG001|Treated|Lost to Follow-up|1|||
124996569|NCT01585987|449614122|FG000|Treated|Maximum Clinical Benefit|0|||
124996570|NCT01585987|449614123|FG001|Treated|Maximum Clinical Benefit|1|||
124996571|NCT01585987|449614122|FG000|Treated|Non-Specified|1|||
125327135|NCT02760498|450831494|FG005|Overall Study|Sponsor decision|0|||
125327136|NCT02760498|450831489|FG000|Overall Study|Physician Decision|3|||
125327137|NCT02760498|450831490|FG001|Overall Study|Physician Decision|4|||
125327138|NCT02760498|450831491|FG002|Overall Study|Physician Decision|1|||
125327139|NCT02760498|450831492|FG003|Overall Study|Physician Decision|4|||
125327140|NCT02760498|450831493|FG004|Overall Study|Physician Decision|0|||
125327141|NCT02760498|450831494|FG005|Overall Study|Physician Decision|2|||
125327142|NCT02760498|450831489|FG000|Overall Study|Disease progression|21|||
125327143|NCT02760498|450831490|FG001|Overall Study|Disease progression|19|||
125327144|NCT02760498|450831491|FG002|Overall Study|Disease progression|20|||
125327145|NCT02760498|450831492|FG003|Overall Study|Disease progression|18|||
125327146|NCT02760498|450831493|FG004|Overall Study|Disease progression|4|||
125327147|NCT02760498|450831494|FG005|Overall Study|Disease progression|55|||
125327148|NCT02760498|450831489|FG000|Overall Study|Withdrawal by Subject|4|||
125327149|NCT02760498|450831490|FG001|Overall Study|Withdrawal by Subject|7|||
125327150|NCT02760498|450831491|FG002|Overall Study|Withdrawal by Subject|5|||
125327151|NCT02760498|450831492|FG003|Overall Study|Withdrawal by Subject|1|||
125327152|NCT02760498|450831493|FG004|Overall Study|Withdrawal by Subject|0|||
125327153|NCT02760498|450831494|FG005|Overall Study|Withdrawal by Subject|6|||
125327154|NCT02760498|450831489|FG000|Overall Study|Other than specified|1|||
125327155|NCT02760498|450831490|FG001|Overall Study|Other than specified|6|||
125327156|NCT02760498|450831491|FG002|Overall Study|Other than specified|0|||
125327157|NCT02760498|450831492|FG003|Overall Study|Other than specified|3|||
125327158|NCT02760498|450831493|FG004|Overall Study|Other than specified|1|||
125327159|NCT02760498|450831494|FG005|Overall Study|Other than specified|0|||
125327160|NCT02760498|450831489|FG000|Overall Study|Not treated|0|||
125327161|NCT02760498|450831490|FG001|Overall Study|Not treated|0|||
125327162|NCT02760498|450831491|FG002|Overall Study|Not treated|0|||
125327163|NCT02760498|450831492|FG003|Overall Study|Not treated|0|||
124996572|NCT01585987|449614123|FG001|Treated|Non-Specified|2|||
125327164|NCT02760498|450831493|FG004|Overall Study|Not treated|0|||
125327165|NCT02760498|450831494|FG005|Overall Study|Not treated|2|||
125327166|NCT00935584|450831497|FG000|Overall Study|Withdrawal by Subject|9|||
125327167|NCT00935584|450831498|FG001|Overall Study|Withdrawal by Subject|0|||
125327168|NCT00935584|450831497|FG000|Overall Study|Death|3|||
125327169|NCT00935584|450831498|FG001|Overall Study|Death|0|||
125327170|NCT00935584|450831497|FG000|Overall Study|Lost to Follow-up|8|||
125327171|NCT00935584|450831498|FG001|Overall Study|Lost to Follow-up|0|||
125327172|NCT00935584|450831497|FG000|Overall Study|No show|9|||
125327173|NCT00935584|450831498|FG001|Overall Study|No show|0|||
125327174|NCT00935584|450831497|FG000|Overall Study|Relocated|3|||
125327175|NCT00935584|450831498|FG001|Overall Study|Relocated|0|||
125327176|NCT00935584|450831497|FG000|Overall Study|Patient changed provider|3|||
125327177|NCT00935584|450831498|FG001|Overall Study|Patient changed provider|0|||
125327178|NCT00935584|450831497|FG000|Overall Study|Provider dropped out of study|14|||
125327179|NCT00935584|450831498|FG001|Overall Study|Provider dropped out of study|4|||
125327180|NCT00687193|450831499|FG000|Overall Study|Adverse Event|0|||
125327181|NCT00687193|450831500|FG001|Overall Study|Adverse Event|1|||
125327182|NCT00687193|450831501|FG002|Overall Study|Adverse Event|2|||
125327183|NCT00687193|450831502|FG003|Overall Study|Adverse Event|3|||
125327184|NCT00687193|450831503|FG004|Overall Study|Adverse Event|0|||
125327185|NCT00687193|450831504|FG005|Overall Study|Adverse Event|2|||
125327186|NCT00687193|450831499|FG000|Overall Study|Lack of Efficacy|1|||
125327187|NCT00687193|450831500|FG001|Overall Study|Lack of Efficacy|1|||
125327188|NCT00687193|450831501|FG002|Overall Study|Lack of Efficacy|0|||
125327189|NCT00687193|450831502|FG003|Overall Study|Lack of Efficacy|0|||
125327190|NCT00687193|450831503|FG004|Overall Study|Lack of Efficacy|0|||
125327191|NCT00687193|450831504|FG005|Overall Study|Lack of Efficacy|2|||
125327192|NCT00687193|450831499|FG000|Overall Study|Protocol Violation|1|||
125327193|NCT00687193|450831500|FG001|Overall Study|Protocol Violation|2|||
125327194|NCT00687193|450831501|FG002|Overall Study|Protocol Violation|0|||
125327195|NCT00687193|450831502|FG003|Overall Study|Protocol Violation|1|||
125327196|NCT00687193|450831503|FG004|Overall Study|Protocol Violation|2|||
125327197|NCT00687193|450831504|FG005|Overall Study|Protocol Violation|0|||
125327198|NCT03534804|450831505|FG000|Overall Study|Withdrawal by Subject|1|||
125327199|NCT04986904|450831506|FG000|Overall Study|Lost to Follow-up|11|||
125327200|NCT04986904|450831506|FG000|Overall Study|Withdrawal by Subject|1|||
125327201|NCT00174187|450831507|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
125327202|NCT00174187|450831508|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
125327203|NCT00174187|450831509|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
125327204|NCT00174187|450831507|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
125327205|NCT00174187|450831508|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
125327206|NCT00174187|450831509|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
125327207|NCT00174187|450831507|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
125327208|NCT00174187|450831508|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
125327209|NCT00174187|450831509|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
125327210|NCT00174187|450831507|FG000|Period 1 (up to 3 Years)|Other|0|||
125327211|NCT00174187|450831508|FG001|Period 1 (up to 3 Years)|Other|1|||
125327212|NCT00174187|450831509|FG002|Period 1 (up to 3 Years)|Other|0|||
125327213|NCT00174187|450831507|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
125327214|NCT00174187|450831508|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
125327215|NCT00174187|450831509|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
125327216|NCT00174187|450831507|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
125327217|NCT00174187|450831508|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
125327218|NCT00174187|450831509|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
125327219|NCT00174187|450831507|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
125327220|NCT00174187|450831508|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
125327221|NCT00174187|450831509|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
125327222|NCT00174187|450831507|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
125327223|NCT00174187|450831508|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
125327224|NCT00174187|450831509|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
125327225|NCT00174187|450831507|FG000|Period 2 (After 3 Years)|Other|0|||
125327226|NCT00174187|450831508|FG001|Period 2 (After 3 Years)|Other|0|||
125327227|NCT00174187|450831509|FG002|Period 2 (After 3 Years)|Other|5|||
125327228|NCT03435211|450831510|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
125327229|NCT00759941|450831511|FG000|Overall Study|Use of medication|1|||
125327230|NCT00759941|450831512|FG001|Overall Study|Use of medication|0|||
125327231|NCT00759941|450831511|FG000|Overall Study|Adverse Event|1|||
125327232|NCT00759941|450831512|FG001|Overall Study|Adverse Event|0|||
125327233|NCT00759941|450831511|FG000|Overall Study|Exited in error by site|1|||
124996573|NCT01585987|449614122|FG000|Treated|Subject Request|0|||
125327234|NCT00759941|450831512|FG001|Overall Study|Exited in error by site|1|||
125327235|NCT03863080|450831513|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
125327236|NCT03863080|450831514|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
125327237|NCT03863080|450831515|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
125327238|NCT03863080|450831516|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
125327239|NCT03863080|450831513|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
125327240|NCT03863080|450831514|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
125327241|NCT03863080|450831515|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
125327242|NCT03863080|450831516|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
125327243|NCT03863080|450831513|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
125327244|NCT03863080|450831514|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
125327245|NCT03863080|450831515|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
125327246|NCT03863080|450831516|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
125327247|NCT01342211|450831517|FG000|Overall Study|Lost to Follow-up|0|||
125327248|NCT01342211|450831518|FG001|Overall Study|Lost to Follow-up|0|||
125327249|NCT01342211|450831519|FG002|Overall Study|Lost to Follow-up|0|||
125327250|NCT01342211|450831520|FG003|Overall Study|Lost to Follow-up|1|||
125327251|NCT01342211|450831521|FG004|Overall Study|Lost to Follow-up|0|||
125327252|NCT01342211|450831517|FG000|Overall Study|Adverse Event|0|||
125327253|NCT01342211|450831518|FG001|Overall Study|Adverse Event|0|||
125327254|NCT01342211|450831519|FG002|Overall Study|Adverse Event|0|||
125327255|NCT01342211|450831520|FG003|Overall Study|Adverse Event|0|||
125327256|NCT01342211|450831521|FG004|Overall Study|Adverse Event|1|||
125327257|NCT01342211|450831517|FG000|Overall Study|Withdrawal by Subject|0|||
125327258|NCT01342211|450831518|FG001|Overall Study|Withdrawal by Subject|0|||
125327259|NCT01342211|450831519|FG002|Overall Study|Withdrawal by Subject|0|||
125327260|NCT01342211|450831520|FG003|Overall Study|Withdrawal by Subject|1|||
125327261|NCT01342211|450831521|FG004|Overall Study|Withdrawal by Subject|0|||
125327262|NCT01342211|450831517|FG000|Overall Study|Randomized, but not Treated|0|||
125327263|NCT01342211|450831518|FG001|Overall Study|Randomized, but not Treated|2|||
125327264|NCT01342211|450831519|FG002|Overall Study|Randomized, but not Treated|0|||
125327265|NCT01342211|450831520|FG003|Overall Study|Randomized, but not Treated|0|||
125327266|NCT01342211|450831521|FG004|Overall Study|Randomized, but not Treated|1|||
125327267|NCT01588522|450831533|FG000|Overall Study|Withdrawal by Subject|1|||
125327268|NCT01588522|450831534|FG001|Overall Study|Withdrawal by Subject|5|||
125327269|NCT01588522|450831535|FG002|Overall Study|Withdrawal by Subject|3|||
125327270|NCT01588522|450831536|FG003|Overall Study|Withdrawal by Subject|1|||
125327271|NCT01588522|450831537|FG004|Overall Study|Withdrawal by Subject|2|||
125327272|NCT01588522|450831538|FG005|Overall Study|Withdrawal by Subject|0|||
125327273|NCT01588522|450831533|FG000|Overall Study|Lack of Efficacy|0|||
125327274|NCT01588522|450831534|FG001|Overall Study|Lack of Efficacy|0|||
125327275|NCT01588522|450831535|FG002|Overall Study|Lack of Efficacy|0|||
125327276|NCT01588522|450831536|FG003|Overall Study|Lack of Efficacy|0|||
125327277|NCT01588522|450831537|FG004|Overall Study|Lack of Efficacy|1|||
125327278|NCT01588522|450831538|FG005|Overall Study|Lack of Efficacy|0|||
125327279|NCT01588522|450831533|FG000|Overall Study|Adverse Event|0|||
125327280|NCT01588522|450831534|FG001|Overall Study|Adverse Event|0|||
125327281|NCT01588522|450831535|FG002|Overall Study|Adverse Event|0|||
125327282|NCT01588522|450831536|FG003|Overall Study|Adverse Event|1|||
125327283|NCT01588522|450831537|FG004|Overall Study|Adverse Event|0|||
125327284|NCT01588522|450831538|FG005|Overall Study|Adverse Event|0|||
125327285|NCT01588522|450831533|FG000|Overall Study|Grade 2 alopecia|1|||
125327286|NCT01588522|450831534|FG001|Overall Study|Grade 2 alopecia|0|||
125327287|NCT01588522|450831535|FG002|Overall Study|Grade 2 alopecia|0|||
125327288|NCT01588522|450831536|FG003|Overall Study|Grade 2 alopecia|0|||
125327289|NCT01588522|450831537|FG004|Overall Study|Grade 2 alopecia|0|||
125327290|NCT01588522|450831538|FG005|Overall Study|Grade 2 alopecia|0|||
125327291|NCT01588522|450831533|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
125327292|NCT01588522|450831534|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
125327293|NCT01588522|450831535|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
125327294|NCT01588522|450831536|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
125327295|NCT01588522|450831537|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
125327296|NCT01588522|450831538|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
124996574|NCT01585987|449614123|FG001|Treated|Subject Request|1|||
124996575|NCT01585987|449614122|FG000|Treated|Poor/Non-Compliance|0|||
124996576|NCT01585987|449614123|FG001|Treated|Poor/Non-Compliance|1|||
124996577|NCT02041520|449614124|FG000|Overall Study|Adverse Event|2|||
124996578|NCT02041520|449614125|FG001|Overall Study|Adverse Event|1|||
125327297|NCT01588522|450831533|FG000|Overall Study|Taken off taxane-based regimen|0|||
125327298|NCT01588522|450831534|FG001|Overall Study|Taken off taxane-based regimen|0|||
125327299|NCT01588522|450831535|FG002|Overall Study|Taken off taxane-based regimen|0|||
125327300|NCT01588522|450831536|FG003|Overall Study|Taken off taxane-based regimen|1|||
125327301|NCT01588522|450831537|FG004|Overall Study|Taken off taxane-based regimen|0|||
125327302|NCT01588522|450831538|FG005|Overall Study|Taken off taxane-based regimen|0|||
125327303|NCT01588522|450831533|FG000|Overall Study|Did not initiate chemotherapy|0|||
125327304|NCT01588522|450831534|FG001|Overall Study|Did not initiate chemotherapy|0|||
125327305|NCT01588522|450831535|FG002|Overall Study|Did not initiate chemotherapy|0|||
125327306|NCT01588522|450831536|FG003|Overall Study|Did not initiate chemotherapy|0|||
125327307|NCT01588522|450831537|FG004|Overall Study|Did not initiate chemotherapy|1|||
125327308|NCT01588522|450831538|FG005|Overall Study|Did not initiate chemotherapy|0|||
124996579|NCT02041520|449614124|FG000|Overall Study|Withdrawal by Subject|3|||
124996580|NCT02041520|449614125|FG001|Overall Study|Withdrawal by Subject|4|||
124996581|NCT02041520|449614124|FG000|Overall Study|Protocol Violation|1|||
124996582|NCT02041520|449614125|FG001|Overall Study|Protocol Violation|0|||
124996583|NCT02041520|449614124|FG000|Overall Study|Lost to Follow-up|0|||
124996584|NCT02041520|449614125|FG001|Overall Study|Lost to Follow-up|1|||
124996585|NCT02041520|449614124|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
124996586|NCT02041520|449614125|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
124996587|NCT01759407|449614126|FG000|Overall Study|Protocol Violation|0|||
124996588|NCT01759407|449614127|FG001|Overall Study|Protocol Violation|2|||
124996589|NCT03737474|449614128|FG000|Overall Study|Adverse Event|18|||
124996590|NCT03737474|449614129|FG001|Overall Study|Adverse Event|48|||
124996591|NCT03737474|449614128|FG000|Overall Study|Lack of Efficacy|1|||
124996592|NCT03737474|449614129|FG001|Overall Study|Lack of Efficacy|3|||
124996593|NCT03737474|449614128|FG000|Overall Study|Protocol Violation|0|||
124996594|NCT03737474|449614129|FG001|Overall Study|Protocol Violation|8|||
124996595|NCT03737474|449614128|FG000|Overall Study|Withdrawal by Subject|5|||
125327309|NCT03205423|450831541|FG000|Overall Study|Personal|1|||
125327310|NCT03205423|450831542|FG001|Overall Study|Personal|1|||
125327311|NCT03205423|450831541|FG000|Overall Study|Physician Decision|0|||
125327312|NCT03205423|450831542|FG001|Overall Study|Physician Decision|2|||
125327313|NCT05786651|450831545|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
125327314|NCT04390763|450831546|FG000|Safety run-in Part|Adverse Event|4|||
125327315|NCT04390763|450831547|FG001|Safety run-in Part|Adverse Event|0|||
125327316|NCT04390763|450831548|FG002|Safety run-in Part|Adverse Event|0|||
125327317|NCT04390763|450831549|FG003|Safety run-in Part|Adverse Event|0|||
125327318|NCT04390763|450831546|FG000|Safety run-in Part|Physician Decision|1|||
125327319|NCT04390763|450831547|FG001|Safety run-in Part|Physician Decision|0|||
125327320|NCT04390763|450831548|FG002|Safety run-in Part|Physician Decision|0|||
125327321|NCT04390763|450831549|FG003|Safety run-in Part|Physician Decision|0|||
125327322|NCT04390763|450831546|FG000|Safety run-in Part|Progressive Disease|6|||
125327323|NCT04390763|450831547|FG001|Safety run-in Part|Progressive Disease|0|||
125327324|NCT04390763|450831548|FG002|Safety run-in Part|Progressive Disease|0|||
125327325|NCT04390763|450831549|FG003|Safety run-in Part|Progressive Disease|0|||
125327326|NCT04390763|450831546|FG000|Randomized Part|Adverse Event|0|||
125327327|NCT04390763|450831547|FG001|Randomized Part|Adverse Event|11|||
125327328|NCT04390763|450831548|FG002|Randomized Part|Adverse Event|5|||
125327329|NCT04390763|450831549|FG003|Randomized Part|Adverse Event|5|||
125327330|NCT04390763|450831546|FG000|Randomized Part|Death|0|||
125327331|NCT04390763|450831547|FG001|Randomized Part|Death|3|||
125327332|NCT04390763|450831548|FG002|Randomized Part|Death|4|||
125327333|NCT04390763|450831549|FG003|Randomized Part|Death|2|||
125327334|NCT04390763|450831546|FG000|Randomized Part|Physician Decision|0|||
125327335|NCT04390763|450831547|FG001|Randomized Part|Physician Decision|2|||
125327336|NCT04390763|450831548|FG002|Randomized Part|Physician Decision|2|||
125327337|NCT04390763|450831549|FG003|Randomized Part|Physician Decision|9|||
125327338|NCT04390763|450831546|FG000|Randomized Part|Progressive Disease|0|||
125327339|NCT04390763|450831547|FG001|Randomized Part|Progressive Disease|24|||
125327340|NCT04390763|450831548|FG002|Randomized Part|Progressive Disease|31|||
125327341|NCT04390763|450831549|FG003|Randomized Part|Progressive Disease|23|||
125327342|NCT04390763|450831546|FG000|Randomized Part|Study terminated by sponsor|0|||
125327343|NCT04390763|450831547|FG001|Randomized Part|Study terminated by sponsor|1|||
125327344|NCT04390763|450831548|FG002|Randomized Part|Study terminated by sponsor|0|||
125327345|NCT04390763|450831549|FG003|Randomized Part|Study terminated by sponsor|0|||
125327346|NCT04390763|450831546|FG000|Randomized Part|Participant Decision|0|||
125327347|NCT04390763|450831547|FG001|Randomized Part|Participant Decision|5|||
125327348|NCT04390763|450831548|FG002|Randomized Part|Participant Decision|7|||
125327349|NCT04390763|450831549|FG003|Randomized Part|Participant Decision|6|||
125327350|NCT04390763|450831546|FG000|Randomized Part|Not treated|0|||
125327351|NCT04390763|450831547|FG001|Randomized Part|Not treated|4|||
125327352|NCT04390763|450831548|FG002|Randomized Part|Not treated|2|||
125327353|NCT04390763|450831549|FG003|Randomized Part|Not treated|7|||
125327354|NCT01803607|450833143|FG000|Overall Study|Adverse Event|5|||
125327355|NCT01803607|450833144|FG001|Overall Study|Adverse Event|3|||
125327356|NCT01803607|450833143|FG000|Overall Study|Lack of Efficacy|0|||
125327357|NCT01803607|450833144|FG001|Overall Study|Lack of Efficacy|1|||
125327358|NCT01803607|450833143|FG000|Overall Study|Protocol Violation|3|||
124996596|NCT03737474|449614129|FG001|Overall Study|Withdrawal by Subject|20|||
124996597|NCT03737474|449614128|FG000|Overall Study|Non-compliance With Study Drug|0|||
125327359|NCT01803607|450833144|FG001|Overall Study|Protocol Violation|2|||
125327360|NCT01803607|450833143|FG000|Overall Study|Study terminated by sponsor|54|||
125327361|NCT01803607|450833144|FG001|Overall Study|Study terminated by sponsor|56|||
125327362|NCT01803607|450833143|FG000|Overall Study|Withdrawal by Subject|6|||
125327363|NCT01803607|450833144|FG001|Overall Study|Withdrawal by Subject|5|||
125327364|NCT03077412|450833145|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
125327365|NCT03077412|450833146|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
125327366|NCT03077412|450833147|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
125327367|NCT03077412|450833145|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
125327368|NCT03077412|450833146|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
125327369|NCT03077412|450833147|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
125327370|NCT03077412|450833145|FG000|Overall Study|Adverse Event|1|||
125327371|NCT03077412|450833146|FG001|Overall Study|Adverse Event|2|||
125327372|NCT03077412|450833147|FG002|Overall Study|Adverse Event|2|||
125327373|NCT03077412|450833145|FG000|Overall Study|Investigator's Discretion|0|||
125327374|NCT03077412|450833146|FG001|Overall Study|Investigator's Discretion|1|||
125327375|NCT03077412|450833147|FG002|Overall Study|Investigator's Discretion|1|||
125327376|NCT03077412|450833145|FG000|Overall Study|Withdrew Consent|0|||
125327377|NCT03077412|450833146|FG001|Overall Study|Withdrew Consent|2|||
125327378|NCT03077412|450833147|FG002|Overall Study|Withdrew Consent|0|||
125327379|NCT02266888|450833151|FG000|Overall Study|Death|2|||
125327380|NCT02266888|450833152|FG001|Overall Study|Death|2|||
125327381|NCT02266888|450833153|FG002|Overall Study|Death|4|||
125327382|NCT02266888|450833154|FG003|Overall Study|Death|2|||
125327383|NCT02266888|450833151|FG000|Overall Study|Physician Decision|0|||
125327384|NCT02266888|450833152|FG001|Overall Study|Physician Decision|1|||
125327385|NCT02266888|450833153|FG002|Overall Study|Physician Decision|2|||
125327386|NCT02266888|450833154|FG003|Overall Study|Physician Decision|2|||
125327387|NCT02266888|450833151|FG000|Overall Study|Study Terminated|5|||
125327388|NCT02266888|450833152|FG001|Overall Study|Study Terminated|1|||
125327389|NCT02266888|450833153|FG002|Overall Study|Study Terminated|0|||
125327390|NCT02266888|450833154|FG003|Overall Study|Study Terminated|0|||
125327391|NCT02266888|450833151|FG000|Overall Study|No Longer Eligible|0|||
125327392|NCT02266888|450833152|FG001|Overall Study|No Longer Eligible|0|||
125327393|NCT02266888|450833153|FG002|Overall Study|No Longer Eligible|0|||
125327394|NCT02266888|450833154|FG003|Overall Study|No Longer Eligible|2|||
125327395|NCT02266888|450833151|FG000|Overall Study|Randomization Closed|0|||
125327396|NCT02266888|450833152|FG001|Overall Study|Randomization Closed|0|||
125327397|NCT02266888|450833153|FG002|Overall Study|Randomization Closed|4|||
125327398|NCT02266888|450833154|FG003|Overall Study|Randomization Closed|0|||
125327399|NCT02266888|450833151|FG000|Overall Study|Personnel unavailable at transplant|0|||
125327400|NCT02266888|450833152|FG001|Overall Study|Personnel unavailable at transplant|0|||
125327401|NCT02266888|450833153|FG002|Overall Study|Personnel unavailable at transplant|0|||
125327402|NCT02266888|450833154|FG003|Overall Study|Personnel unavailable at transplant|1|||
125327403|NCT02266888|450833151|FG000|Overall Study|Transfer of care|0|||
125327404|NCT02266888|450833152|FG001|Overall Study|Transfer of care|0|||
125327405|NCT02266888|450833153|FG002|Overall Study|Transfer of care|1|||
125327406|NCT02266888|450833154|FG003|Overall Study|Transfer of care|0|||
125327407|NCT02351856|450833155|FG000|Overall Study|Adverse Event|2|||
125327408|NCT02351856|450833155|FG000|Overall Study|Physician Decision|5|||
125327409|NCT02351856|450833155|FG000|Overall Study|Study terminated by sponsor|1|||
125327410|NCT01281124|450833158|FG000|Overall Study|Death|1|||
125327411|NCT03038100|450833159|FG000|Overall Study|Death|289|||
125327412|NCT03038100|450833160|FG001|Overall Study|Death|272|||
125327413|NCT03038100|450833159|FG000|Overall Study|Lost to Follow-up|9|||
125327414|NCT03038100|450833160|FG001|Overall Study|Lost to Follow-up|10|||
125327415|NCT03038100|450833159|FG000|Overall Study|Protocol Deviation|1|||
125327416|NCT03038100|450833160|FG001|Overall Study|Protocol Deviation|4|||
125327417|NCT03038100|450833159|FG000|Overall Study|Withdrawal by Subject|45|||
125327418|NCT03038100|450833160|FG001|Overall Study|Withdrawal by Subject|51|||
125327419|NCT03038100|450833159|FG000|Overall Study|Study Terminated By Sponsor|305|||
125327420|NCT03038100|450833160|FG001|Overall Study|Study Terminated By Sponsor|311|||
125327421|NCT03038100|450833159|FG000|Overall Study|Physician Decision|1|||
125327422|NCT03038100|450833160|FG001|Overall Study|Physician Decision|3|||
125327423|NCT00918255|450833161|FG000|Overall Study|Adverse Event|1|||
125327424|NCT00918255|450833162|FG001|Overall Study|Adverse Event|0|||
124996598|NCT03737474|449614129|FG001|Overall Study|Non-compliance With Study Drug|1|||
124996599|NCT03737474|449614128|FG000|Overall Study|Physician Decision|1|||
125327425|NCT00918255|450833163|FG002|Overall Study|Adverse Event|0|||
125327426|NCT00918255|450833161|FG000|Overall Study|Withdrawal by Subject|1|||
125327427|NCT00918255|450833162|FG001|Overall Study|Withdrawal by Subject|0|||
125327428|NCT00918255|450833163|FG002|Overall Study|Withdrawal by Subject|2|||
125327429|NCT00918255|450833161|FG000|Overall Study|Lack of Efficacy|1|||
125327430|NCT00918255|450833162|FG001|Overall Study|Lack of Efficacy|0|||
125327431|NCT00918255|450833163|FG002|Overall Study|Lack of Efficacy|0|||
125327432|NCT00918255|450833161|FG000|Overall Study|Lost to Follow-up|1|||
125327433|NCT00918255|450833162|FG001|Overall Study|Lost to Follow-up|0|||
125327434|NCT00918255|450833163|FG002|Overall Study|Lost to Follow-up|2|||
125327435|NCT00918255|450833161|FG000|Overall Study|Exceeded allowed number of interventions|0|||
125327436|NCT00918255|450833162|FG001|Overall Study|Exceeded allowed number of interventions|0|||
125327437|NCT00918255|450833163|FG002|Overall Study|Exceeded allowed number of interventions|1|||
125327438|NCT00918255|450833161|FG000|Overall Study|Non-compliance|1|||
125327439|NCT00918255|450833162|FG001|Overall Study|Non-compliance|0|||
125327440|NCT00918255|450833163|FG002|Overall Study|Non-compliance|0|||
125327441|NCT00918255|450833161|FG000|Overall Study|Investigator discretion|1|||
125327442|NCT00918255|450833162|FG001|Overall Study|Investigator discretion|0|||
125327443|NCT00918255|450833163|FG002|Overall Study|Investigator discretion|0|||
125327444|NCT02392624|450833164|FG000|Overall Study|Withdrawal by Subject|15|||
125327445|NCT02392624|450833165|FG001|Overall Study|Withdrawal by Subject|12|||
125327446|NCT02392624|450833166|FG002|Overall Study|Withdrawal by Subject|9|||
125327447|NCT02392624|450833164|FG000|Overall Study|Adverse Event|4|||
125327448|NCT02392624|450833165|FG001|Overall Study|Adverse Event|1|||
125327449|NCT02392624|450833166|FG002|Overall Study|Adverse Event|2|||
125327450|NCT02392624|450833164|FG000|Overall Study|Pregnancy|1|||
125327451|NCT02392624|450833165|FG001|Overall Study|Pregnancy|0|||
125327452|NCT02392624|450833166|FG002|Overall Study|Pregnancy|0|||
125327453|NCT02392624|450833164|FG000|Overall Study|Protocol Violation|0|||
125327454|NCT02392624|450833165|FG001|Overall Study|Protocol Violation|0|||
125327455|NCT02392624|450833166|FG002|Overall Study|Protocol Violation|1|||
125327456|NCT02392624|450833164|FG000|Overall Study|Sponsor/Investigator Decision|2|||
125327457|NCT02392624|450833165|FG001|Overall Study|Sponsor/Investigator Decision|1|||
125327458|NCT02392624|450833166|FG002|Overall Study|Sponsor/Investigator Decision|0|||
125327459|NCT02392624|450833164|FG000|Overall Study|Other|49|||
125327460|NCT02392624|450833165|FG001|Overall Study|Other|1|||
125327461|NCT02392624|450833166|FG002|Overall Study|Other|1|||
124996600|NCT03737474|449614129|FG001|Overall Study|Physician Decision|4|||
124996601|NCT02513745|449614130|FG000|Overall Study|Criteria at time of surgery not met.|3|||
124996602|NCT02513745|449614131|FG001|Overall Study|Criteria at time of surgery not met.|3|||
124996603|NCT01209143|449614132|FG000|Overall Study|Adverse Event|2|||
124996604|NCT01209143|449614133|FG001|Overall Study|Adverse Event|1|||
124996605|NCT01209143|449614132|FG000|Overall Study|Death|0|||
124996606|NCT01209143|449614133|FG001|Overall Study|Death|1|||
124996607|NCT01209143|449614132|FG000|Overall Study|Physician Decision|3|||
124996608|NCT01209143|449614133|FG001|Overall Study|Physician Decision|1|||
124996609|NCT01209143|449614132|FG000|Overall Study|Lost to Follow-up|1|||
124996610|NCT01209143|449614133|FG001|Overall Study|Lost to Follow-up|0|||
124996611|NCT01209143|449614132|FG000|Overall Study|Withdrawal by Subject|2|||
124996612|NCT01209143|449614133|FG001|Overall Study|Withdrawal by Subject|1|||
124996613|NCT01209143|449614132|FG000|Overall Study|Disease progression|11|||
124996614|NCT01209143|449614133|FG001|Overall Study|Disease progression|16|||
124996615|NCT01145755|449614134|FG000|Overall Study|Adverse Event|2|||
124996616|NCT01145755|449614135|FG001|Overall Study|Adverse Event|4|||
124996617|NCT01145755|449614136|FG002|Overall Study|Adverse Event|2|||
124996618|NCT01145755|449614134|FG000|Overall Study|Withdrawal by Subject|2|||
124996619|NCT01145755|449614135|FG001|Overall Study|Withdrawal by Subject|2|||
124996620|NCT01145755|449614136|FG002|Overall Study|Withdrawal by Subject|2|||
124996621|NCT01145755|449614134|FG000|Overall Study|Lost to Follow-up|2|||
124996622|NCT01145755|449614135|FG001|Overall Study|Lost to Follow-up|3|||
124996623|NCT01145755|449614136|FG002|Overall Study|Lost to Follow-up|1|||
124996624|NCT01145755|449614134|FG000|Overall Study|Protocol Violation|0|||
124996625|NCT01145755|449614135|FG001|Overall Study|Protocol Violation|3|||
124996626|NCT01145755|449614136|FG002|Overall Study|Protocol Violation|1|||
124996627|NCT01145755|449614134|FG000|Overall Study|Study Closure|14|||
124996628|NCT01145755|449614135|FG001|Overall Study|Study Closure|14|||
124996629|NCT01145755|449614136|FG002|Overall Study|Study Closure|17|||
124996630|NCT01145755|449614134|FG000|Overall Study|Lack of Efficacy|0|||
124996631|NCT01145755|449614135|FG001|Overall Study|Lack of Efficacy|1|||
124996632|NCT01145755|449614136|FG002|Overall Study|Lack of Efficacy|0|||
124996633|NCT01145755|449614134|FG000|Overall Study|Patient could not swollow medication|0|||
124996634|NCT01145755|449614135|FG001|Overall Study|Patient could not swollow medication|0|||
124996635|NCT01145755|449614136|FG002|Overall Study|Patient could not swollow medication|1|||
124996636|NCT01145755|449614134|FG000|Overall Study|Withdrawal by Subject|0|||
124996637|NCT01145755|449614135|FG001|Overall Study|Withdrawal by Subject|0|||
124996638|NCT01145755|449614136|FG002|Overall Study|Withdrawal by Subject|1|||
124996639|NCT01145755|449614134|FG000|Overall Study|Positive urine ethanol|0|||
124996640|NCT01145755|449614135|FG001|Overall Study|Positive urine ethanol|1|||
124996641|NCT01145755|449614136|FG002|Overall Study|Positive urine ethanol|0|||
124996642|NCT02739360|449614142|FG000|Overall Study|Adverse Event|1|||
124996643|NCT02739360|449614142|FG000|Overall Study|Study terminated by Sponsor|2|||
124996644|NCT01193920|449614143|FG000|Overall Study|Withdrawal by Subject|1|||
124996645|NCT01193920|449614144|FG001|Overall Study|Withdrawal by Subject|0|||
124996646|NCT01193920|449614145|FG002|Overall Study|Withdrawal by Subject|5|||
124996647|NCT01193920|449614146|FG003|Overall Study|Withdrawal by Subject|1|||
125327462|NCT00706238|450833167|FG000|Overall Study|Disease progression|4|||
125327463|NCT00706238|450833167|FG000|Overall Study|Other|1|||
125327464|NCT01193244|450833170|FG000|Overall Study|Withdrawal by Subject|79|||
125327465|NCT01193244|450833171|FG001|Overall Study|Withdrawal by Subject|97|||
125327466|NCT01193244|450833170|FG000|Overall Study|Other|303|||
125327467|NCT01193244|450833171|FG001|Overall Study|Other|278|||
125327468|NCT01193244|450833170|FG000|Overall Study|Lost to Follow-up|6|||
125327469|NCT01193244|450833171|FG001|Overall Study|Lost to Follow-up|15|||
124996648|NCT01193920|449614147|FG004|Overall Study|Withdrawal by Subject|3|||
124996649|NCT01193920|449614148|FG005|Overall Study|Withdrawal by Subject|1|||
124996650|NCT01193920|449614149|FG006|Overall Study|Withdrawal by Subject|3|||
124996651|NCT01193920|449614150|FG007|Overall Study|Withdrawal by Subject|0|||
124996652|NCT01193920|449614151|FG008|Overall Study|Withdrawal by Subject|1|||
124996653|NCT01193920|449614152|FG009|Overall Study|Withdrawal by Subject|0|||
124996654|NCT01193920|449614143|FG000|Overall Study|Lost to Follow-up|1|||
124996655|NCT01193920|449614144|FG001|Overall Study|Lost to Follow-up|0|||
125327470|NCT03763877|450833173|FG000|Overall Study|Withdrawal by Subject|3|||
125327471|NCT03763877|450833174|FG001|Overall Study|Withdrawal by Subject|1|||
124996656|NCT01193920|449614145|FG002|Overall Study|Lost to Follow-up|1|||
124996657|NCT01193920|449614146|FG003|Overall Study|Lost to Follow-up|1|||
124996658|NCT01193920|449614147|FG004|Overall Study|Lost to Follow-up|3|||
124996659|NCT01193920|449614148|FG005|Overall Study|Lost to Follow-up|3|||
124996660|NCT01193920|449614149|FG006|Overall Study|Lost to Follow-up|1|||
124996661|NCT01193920|449614150|FG007|Overall Study|Lost to Follow-up|0|||
124996662|NCT01193920|449614151|FG008|Overall Study|Lost to Follow-up|2|||
125327472|NCT03763877|450833175|FG002|Overall Study|Withdrawal by Subject|3|||
125327473|NCT03763877|450833176|FG003|Overall Study|Withdrawal by Subject|4|||
125327474|NCT03763877|450833173|FG000|Overall Study|Adverse Event|1|||
125327475|NCT03763877|450833174|FG001|Overall Study|Adverse Event|1|||
125327476|NCT03763877|450833175|FG002|Overall Study|Adverse Event|3|||
125327477|NCT03763877|450833176|FG003|Overall Study|Adverse Event|1|||
125327478|NCT03763877|450833173|FG000|Overall Study|Protocol Violation|1|||
125327479|NCT03763877|450833174|FG001|Overall Study|Protocol Violation|1|||
125327480|NCT03763877|450833175|FG002|Overall Study|Protocol Violation|0|||
125327481|NCT03763877|450833176|FG003|Overall Study|Protocol Violation|0|||
125327482|NCT03763877|450833173|FG000|Overall Study|Lost to Follow-up|0|||
125327483|NCT03763877|450833174|FG001|Overall Study|Lost to Follow-up|1|||
125327484|NCT03763877|450833175|FG002|Overall Study|Lost to Follow-up|1|||
125327485|NCT03763877|450833176|FG003|Overall Study|Lost to Follow-up|0|||
125327486|NCT03040336|450833177|FG000|Overall Study|Death|1|||
125327487|NCT03040336|450833178|FG001|Overall Study|Death|0|||
125327488|NCT03040336|450833177|FG000|Overall Study|Withdrawal by Subject|2|||
125327489|NCT03040336|450833178|FG001|Overall Study|Withdrawal by Subject|3|||
125327490|NCT00068692|450833183|FG000|Step 1: Registration|Disese progression/relapse|5|||
125327491|NCT00068692|450833184|FG001|Step 1: Registration|Disese progression/relapse|0|||
125327492|NCT00068692|450833185|FG002|Step 1: Registration|Disese progression/relapse|0|||
125327493|NCT00068692|450833186|FG003|Step 1: Registration|Disese progression/relapse|0|||
125327494|NCT00068692|450833187|FG004|Step 1: Registration|Disese progression/relapse|0|||
125327495|NCT00068692|450833188|FG005|Step 1: Registration|Disese progression/relapse|0|||
125327496|NCT00068692|450833189|FG006|Step 1: Registration|Disese progression/relapse|0|||
125327497|NCT00068692|450833190|FG007|Step 1: Registration|Disese progression/relapse|0|||
125327498|NCT00068692|450833183|FG000|Step 1: Registration|Adverse Event|7|||
125327499|NCT00068692|450833184|FG001|Step 1: Registration|Adverse Event|0|||
125327500|NCT00068692|450833185|FG002|Step 1: Registration|Adverse Event|0|||
125327501|NCT00068692|450833186|FG003|Step 1: Registration|Adverse Event|0|||
125327502|NCT00068692|450833187|FG004|Step 1: Registration|Adverse Event|0|||
125327503|NCT00068692|450833188|FG005|Step 1: Registration|Adverse Event|0|||
125327504|NCT00068692|450833189|FG006|Step 1: Registration|Adverse Event|0|||
125327505|NCT00068692|450833190|FG007|Step 1: Registration|Adverse Event|0|||
125327506|NCT00068692|450833183|FG000|Step 1: Registration|Death|1|||
125327507|NCT00068692|450833184|FG001|Step 1: Registration|Death|0|||
125327508|NCT00068692|450833185|FG002|Step 1: Registration|Death|0|||
125327509|NCT00068692|450833186|FG003|Step 1: Registration|Death|0|||
125327510|NCT00068692|450833187|FG004|Step 1: Registration|Death|0|||
125327511|NCT00068692|450833188|FG005|Step 1: Registration|Death|0|||
125327512|NCT00068692|450833189|FG006|Step 1: Registration|Death|0|||
125327513|NCT00068692|450833190|FG007|Step 1: Registration|Death|0|||
125327514|NCT00068692|450833183|FG000|Step 1: Registration|Withdrawal by Subject|11|||
125327515|NCT00068692|450833184|FG001|Step 1: Registration|Withdrawal by Subject|0|||
125327516|NCT00068692|450833185|FG002|Step 1: Registration|Withdrawal by Subject|0|||
125327517|NCT00068692|450833186|FG003|Step 1: Registration|Withdrawal by Subject|0|||
125327518|NCT00068692|450833187|FG004|Step 1: Registration|Withdrawal by Subject|0|||
124996663|NCT01193920|449614152|FG009|Overall Study|Lost to Follow-up|3|||
124996664|NCT01193920|449614143|FG000|Overall Study|Protocol Violation|1|||
124996665|NCT01193920|449614144|FG001|Overall Study|Protocol Violation|0|||
124996666|NCT01193920|449614145|FG002|Overall Study|Protocol Violation|0|||
125327519|NCT00068692|450833188|FG005|Step 1: Registration|Withdrawal by Subject|0|||
125327520|NCT00068692|450833189|FG006|Step 1: Registration|Withdrawal by Subject|0|||
125327521|NCT00068692|450833190|FG007|Step 1: Registration|Withdrawal by Subject|0|||
125327522|NCT00068692|450833183|FG000|Step 1: Registration|Alternative therapy|2|||
125327523|NCT00068692|450833184|FG001|Step 1: Registration|Alternative therapy|0|||
125327524|NCT00068692|450833185|FG002|Step 1: Registration|Alternative therapy|0|||
125327525|NCT00068692|450833186|FG003|Step 1: Registration|Alternative therapy|0|||
125327526|NCT00068692|450833187|FG004|Step 1: Registration|Alternative therapy|0|||
125327527|NCT00068692|450833188|FG005|Step 1: Registration|Alternative therapy|0|||
125327528|NCT00068692|450833189|FG006|Step 1: Registration|Alternative therapy|0|||
125327529|NCT00068692|450833190|FG007|Step 1: Registration|Alternative therapy|0|||
125327530|NCT00068692|450833183|FG000|Step 1: Registration|Complicating disease|2|||
125327531|NCT00068692|450833184|FG001|Step 1: Registration|Complicating disease|0|||
125327532|NCT00068692|450833185|FG002|Step 1: Registration|Complicating disease|0|||
125327533|NCT00068692|450833186|FG003|Step 1: Registration|Complicating disease|0|||
125327534|NCT00068692|450833187|FG004|Step 1: Registration|Complicating disease|0|||
125327535|NCT00068692|450833188|FG005|Step 1: Registration|Complicating disease|0|||
125327536|NCT00068692|450833189|FG006|Step 1: Registration|Complicating disease|0|||
125327537|NCT00068692|450833190|FG007|Step 1: Registration|Complicating disease|0|||
125327538|NCT00068692|450833183|FG000|Step 1: Registration|Protocol Violation|1|||
125327539|NCT00068692|450833184|FG001|Step 1: Registration|Protocol Violation|0|||
125327540|NCT00068692|450833185|FG002|Step 1: Registration|Protocol Violation|0|||
125327541|NCT00068692|450833186|FG003|Step 1: Registration|Protocol Violation|0|||
125327542|NCT00068692|450833187|FG004|Step 1: Registration|Protocol Violation|0|||
125327543|NCT00068692|450833188|FG005|Step 1: Registration|Protocol Violation|0|||
125327544|NCT00068692|450833189|FG006|Step 1: Registration|Protocol Violation|0|||
125327545|NCT00068692|450833190|FG007|Step 1: Registration|Protocol Violation|0|||
125327546|NCT00068692|450833183|FG000|Step 1: Registration|Not eligible|6|||
125327547|NCT00068692|450833184|FG001|Step 1: Registration|Not eligible|0|||
125327548|NCT00068692|450833185|FG002|Step 1: Registration|Not eligible|0|||
125327549|NCT00068692|450833186|FG003|Step 1: Registration|Not eligible|0|||
125327550|NCT00068692|450833187|FG004|Step 1: Registration|Not eligible|0|||
125327551|NCT00068692|450833188|FG005|Step 1: Registration|Not eligible|0|||
125327552|NCT00068692|450833189|FG006|Step 1: Registration|Not eligible|0|||
125327553|NCT00068692|450833190|FG007|Step 1: Registration|Not eligible|0|||
125327554|NCT00068692|450833183|FG000|Step 1: Registration|Other|2|||
125327555|NCT00068692|450833184|FG001|Step 1: Registration|Other|0|||
125327556|NCT00068692|450833185|FG002|Step 1: Registration|Other|0|||
125327557|NCT00068692|450833186|FG003|Step 1: Registration|Other|0|||
125327558|NCT00068692|450833187|FG004|Step 1: Registration|Other|0|||
125327559|NCT00068692|450833188|FG005|Step 1: Registration|Other|0|||
125327560|NCT00068692|450833189|FG006|Step 1: Registration|Other|0|||
125327561|NCT00068692|450833190|FG007|Step 1: Registration|Other|0|||
125327562|NCT00068692|450833183|FG000|Step 1: Registration|Not start protocol therapy|3|||
125327563|NCT00068692|450833184|FG001|Step 1: Registration|Not start protocol therapy|0|||
125327564|NCT00068692|450833185|FG002|Step 1: Registration|Not start protocol therapy|0|||
125327565|NCT00068692|450833186|FG003|Step 1: Registration|Not start protocol therapy|0|||
125327566|NCT00068692|450833187|FG004|Step 1: Registration|Not start protocol therapy|0|||
125327567|NCT00068692|450833188|FG005|Step 1: Registration|Not start protocol therapy|0|||
125327568|NCT00068692|450833189|FG006|Step 1: Registration|Not start protocol therapy|0|||
125327569|NCT00068692|450833190|FG007|Step 1: Registration|Not start protocol therapy|0|||
125327570|NCT00068692|450833183|FG000|Step 1: Registration|Registered but not randomized|0|||
125327571|NCT00068692|450833184|FG001|Step 1: Registration|Registered but not randomized|1|||
125327572|NCT00068692|450833185|FG002|Step 1: Registration|Registered but not randomized|0|||
125327573|NCT00068692|450833186|FG003|Step 1: Registration|Registered but not randomized|0|||
125327574|NCT00068692|450833187|FG004|Step 1: Registration|Registered but not randomized|0|||
125327575|NCT00068692|450833188|FG005|Step 1: Registration|Registered but not randomized|0|||
125327576|NCT00068692|450833189|FG006|Step 1: Registration|Registered but not randomized|0|||
125327577|NCT00068692|450833190|FG007|Step 1: Registration|Registered but not randomized|0|||
125327578|NCT00068692|450833183|FG000|Step 2: Randomization|Disesae progression/replase|0|||
125327579|NCT00068692|450833184|FG001|Step 2: Randomization|Disesae progression/replase|0|||
125327580|NCT00068692|450833185|FG002|Step 2: Randomization|Disesae progression/replase|1|||
125327581|NCT00068692|450833186|FG003|Step 2: Randomization|Disesae progression/replase|1|||
125327582|NCT00068692|450833187|FG004|Step 2: Randomization|Disesae progression/replase|0|||
125327583|NCT00068692|450833188|FG005|Step 2: Randomization|Disesae progression/replase|0|||
125327584|NCT00068692|450833189|FG006|Step 2: Randomization|Disesae progression/replase|0|||
125327585|NCT00068692|450833190|FG007|Step 2: Randomization|Disesae progression/replase|0|||
125327586|NCT00068692|450833183|FG000|Step 2: Randomization|Adverse Event|0|||
125327587|NCT00068692|450833184|FG001|Step 2: Randomization|Adverse Event|0|||
125327588|NCT00068692|450833185|FG002|Step 2: Randomization|Adverse Event|4|||
125327589|NCT00068692|450833186|FG003|Step 2: Randomization|Adverse Event|2|||
125327590|NCT00068692|450833187|FG004|Step 2: Randomization|Adverse Event|2|||
125327591|NCT00068692|450833188|FG005|Step 2: Randomization|Adverse Event|3|||
124996667|NCT01193920|449614146|FG003|Overall Study|Protocol Violation|0|||
125327592|NCT00068692|450833189|FG006|Step 2: Randomization|Adverse Event|4|||
125327593|NCT00068692|450833190|FG007|Step 2: Randomization|Adverse Event|4|||
125327594|NCT00068692|450833183|FG000|Step 2: Randomization|Death|0|||
125327595|NCT00068692|450833184|FG001|Step 2: Randomization|Death|0|||
125327596|NCT00068692|450833185|FG002|Step 2: Randomization|Death|0|||
125327597|NCT00068692|450833186|FG003|Step 2: Randomization|Death|0|||
125327598|NCT00068692|450833187|FG004|Step 2: Randomization|Death|1|||
125327599|NCT00068692|450833188|FG005|Step 2: Randomization|Death|0|||
125327600|NCT00068692|450833189|FG006|Step 2: Randomization|Death|0|||
125327601|NCT00068692|450833190|FG007|Step 2: Randomization|Death|1|||
125327602|NCT00068692|450833183|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
125327603|NCT00068692|450833184|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
125327604|NCT00068692|450833185|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
125327605|NCT00068692|450833186|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
125327606|NCT00068692|450833187|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
125327607|NCT00068692|450833188|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
125327608|NCT00068692|450833189|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
125327609|NCT00068692|450833190|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
125327610|NCT00068692|450833183|FG000|Step 2: Randomization|alternative therapy|0|||
125327611|NCT00068692|450833184|FG001|Step 2: Randomization|alternative therapy|0|||
125327612|NCT00068692|450833185|FG002|Step 2: Randomization|alternative therapy|0|||
125327613|NCT00068692|450833186|FG003|Step 2: Randomization|alternative therapy|1|||
125327614|NCT00068692|450833187|FG004|Step 2: Randomization|alternative therapy|1|||
125327615|NCT00068692|450833188|FG005|Step 2: Randomization|alternative therapy|0|||
125327616|NCT00068692|450833189|FG006|Step 2: Randomization|alternative therapy|0|||
125327617|NCT00068692|450833190|FG007|Step 2: Randomization|alternative therapy|0|||
125327618|NCT00068692|450833183|FG000|Step 2: Randomization|Physician Decision|0|||
125327619|NCT00068692|450833184|FG001|Step 2: Randomization|Physician Decision|0|||
125327620|NCT00068692|450833185|FG002|Step 2: Randomization|Physician Decision|0|||
125327621|NCT00068692|450833186|FG003|Step 2: Randomization|Physician Decision|1|||
125327622|NCT00068692|450833187|FG004|Step 2: Randomization|Physician Decision|1|||
125327623|NCT00068692|450833188|FG005|Step 2: Randomization|Physician Decision|0|||
125327624|NCT00068692|450833189|FG006|Step 2: Randomization|Physician Decision|0|||
125327625|NCT00068692|450833190|FG007|Step 2: Randomization|Physician Decision|0|||
125327626|NCT00068692|450833183|FG000|Step 2: Randomization|Other|0|||
125327627|NCT00068692|450833184|FG001|Step 2: Randomization|Other|0|||
125327628|NCT00068692|450833185|FG002|Step 2: Randomization|Other|0|||
125327629|NCT00068692|450833186|FG003|Step 2: Randomization|Other|1|||
125327630|NCT00068692|450833187|FG004|Step 2: Randomization|Other|0|||
125327631|NCT00068692|450833188|FG005|Step 2: Randomization|Other|1|||
125327632|NCT00068692|450833189|FG006|Step 2: Randomization|Other|0|||
125327633|NCT00068692|450833190|FG007|Step 2: Randomization|Other|0|||
125327634|NCT00068692|450833183|FG000|Step 2: Randomization|never start protocol therapy|0|||
125327635|NCT00068692|450833184|FG001|Step 2: Randomization|never start protocol therapy|0|||
125327636|NCT00068692|450833185|FG002|Step 2: Randomization|never start protocol therapy|1|||
125327637|NCT00068692|450833186|FG003|Step 2: Randomization|never start protocol therapy|0|||
125327638|NCT00068692|450833187|FG004|Step 2: Randomization|never start protocol therapy|1|||
125327639|NCT00068692|450833188|FG005|Step 2: Randomization|never start protocol therapy|0|||
125327640|NCT00068692|450833189|FG006|Step 2: Randomization|never start protocol therapy|0|||
125327641|NCT00068692|450833190|FG007|Step 2: Randomization|never start protocol therapy|0|||
125327642|NCT00248040|450833195|FG000|Overall Study|transplantectomy|2|||
125327643|NCT00248040|450833196|FG001|Overall Study|transplantectomy|1|||
125327644|NCT00248040|450833197|FG002|Overall Study|transplantectomy|3|||
125327645|NCT00248040|450833195|FG000|Overall Study|transplant cancelled post treat start|1|||
125327646|NCT00248040|450833196|FG001|Overall Study|transplant cancelled post treat start|0|||
125327647|NCT00248040|450833197|FG002|Overall Study|transplant cancelled post treat start|0|||
125327648|NCT00248040|450833195|FG000|Overall Study|Death|0|||
125327649|NCT00248040|450833196|FG001|Overall Study|Death|0|||
125327650|NCT00248040|450833197|FG002|Overall Study|Death|1|||
125327651|NCT00628108|450833208|FG000|Overall Study|Adverse Event|0|||
125327652|NCT00628108|450833209|FG001|Overall Study|Adverse Event|3|||
125327653|NCT00628108|450833208|FG000|Overall Study|Withdrawal by Subject|1|||
125327654|NCT00628108|450833209|FG001|Overall Study|Withdrawal by Subject|0|||
125327655|NCT03848832|450833210|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
125327656|NCT03848832|450833211|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
125327657|NCT03848832|450833212|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
125327658|NCT03848832|450833210|FG000|Overall Study|Withdrawal by Subject|0|||
125327659|NCT03848832|450833211|FG001|Overall Study|Withdrawal by Subject|0|||
125327660|NCT03848832|450833212|FG002|Overall Study|Withdrawal by Subject|1|||
125327661|NCT03848832|450833210|FG000|Overall Study|Withdrawal (Covid-19)|0|||
125327662|NCT03848832|450833211|FG001|Overall Study|Withdrawal (Covid-19)|2|||
125327663|NCT03848832|450833212|FG002|Overall Study|Withdrawal (Covid-19)|0|||
125327664|NCT03848832|450833210|FG000|Overall Study|Physician Decision|2|||
125327665|NCT03848832|450833211|FG001|Overall Study|Physician Decision|1|||
125327666|NCT03848832|450833212|FG002|Overall Study|Physician Decision|3|||
125327667|NCT03848832|450833210|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
125327668|NCT03848832|450833211|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
125327669|NCT03848832|450833212|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
125327670|NCT03848832|450833210|FG000|Overall Study|Adverse Event|1|||
125327671|NCT03848832|450833211|FG001|Overall Study|Adverse Event|0|||
125327672|NCT03848832|450833212|FG002|Overall Study|Adverse Event|0|||
125327673|NCT01760733|450833213|FG000|Waiting List|Death|18|||
125327674|NCT01760733|450833213|FG000|Waiting List|Removed from waiting list|41|||
125327675|NCT01760733|450833213|FG000|Waiting List|Not received a transplant yet|13|||
124996668|NCT01193920|449614147|FG004|Overall Study|Protocol Violation|0|||
124996669|NCT01193920|449614148|FG005|Overall Study|Protocol Violation|0|||
124996670|NCT01193920|449614149|FG006|Overall Study|Protocol Violation|0|||
124996671|NCT01193920|449614150|FG007|Overall Study|Protocol Violation|0|||
124996672|NCT01193920|449614151|FG008|Overall Study|Protocol Violation|0|||
124996673|NCT01193920|449614152|FG009|Overall Study|Protocol Violation|0|||
124996674|NCT01193920|449614143|FG000|Overall Study|Death|0|||
124996675|NCT01193920|449614144|FG001|Overall Study|Death|0|||
124996676|NCT01193920|449614145|FG002|Overall Study|Death|0|||
124996677|NCT01193920|449614146|FG003|Overall Study|Death|1|||
124996678|NCT01193920|449614147|FG004|Overall Study|Death|0|||
124996679|NCT01193920|449614148|FG005|Overall Study|Death|0|||
124996680|NCT01193920|449614149|FG006|Overall Study|Death|2|||
124996681|NCT01193920|449614150|FG007|Overall Study|Death|3|||
125327676|NCT01760733|450833213|FG000|Transplanted|Not reached 10 years post transplant|184|||
125327677|NCT01760733|450833213|FG000|Transplanted|Death|26|||
125327678|NCT01760733|450833213|FG000|Transplanted|Graft loss|7|||
125327679|NCT02404025|450833214|FG000|Overall Study|Adverse Event|1|||
125327680|NCT02404025|450833214|FG000|Overall Study|Lack of Efficacy|3|||
125327681|NCT01524796|450833215|FG000|Overall Study|Adverse Event|13|||
125327682|NCT01524796|450833215|FG000|Overall Study|Lack of Efficacy|3|||
125327683|NCT01524796|450833215|FG000|Overall Study|Lost to Follow-up|1|||
124996682|NCT01193920|449614151|FG008|Overall Study|Death|2|||
124996683|NCT01193920|449614152|FG009|Overall Study|Death|4|||
124996684|NCT01193920|449614143|FG000|Overall Study|Unable to classify|0|||
124996685|NCT01193920|449614144|FG001|Overall Study|Unable to classify|0|||
124996686|NCT01193920|449614145|FG002|Overall Study|Unable to classify|0|||
124996687|NCT01193920|449614146|FG003|Overall Study|Unable to classify|1|||
124996688|NCT01193920|449614147|FG004|Overall Study|Unable to classify|0|||
124996689|NCT01193920|449614148|FG005|Overall Study|Unable to classify|0|||
125327684|NCT01524796|450833215|FG000|Overall Study|The price|1|||
125327685|NCT01524796|450833215|FG000|Overall Study|Withdrawal by Subject|4|||
125327686|NCT01524796|450833215|FG000|Overall Study|Move|1|||
125327687|NCT01524796|450833215|FG000|Overall Study|Deterioration of pains|1|||
125327688|NCT01524796|450833215|FG000|Overall Study|Gall stone surgery|1|||
125327689|NCT01524796|450833215|FG000|Overall Study|Nervous about confidentiality|1|||
125327690|NCT01524796|450833215|FG000|Overall Study|Switch to carbamazapine|1|||
125327691|NCT01524796|450833215|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
125327692|NCT03938259|450833219|FG000|Overall Study|unable to establish baseline for ventilation|1|||
125327693|NCT03938259|450833220|FG001|Overall Study|unable to establish baseline for ventilation|1|||
125327694|NCT01002339|450833221|FG000|Overall Study|Withdrawal by Subject|0|||
125327695|NCT01002339|450833222|FG001|Overall Study|Withdrawal by Subject|1|||
125327696|NCT01002339|450833223|FG002|Overall Study|Withdrawal by Subject|0|||
125327697|NCT01002339|450833221|FG000|Overall Study|Incorrect treatment assignment|0|||
125327698|NCT01002339|450833222|FG001|Overall Study|Incorrect treatment assignment|0|||
125327699|NCT01002339|450833223|FG002|Overall Study|Incorrect treatment assignment|1|||
125327700|NCT01002339|450833221|FG000|Overall Study|Protocol Violation|0|||
125327701|NCT01002339|450833222|FG001|Overall Study|Protocol Violation|0|||
125327702|NCT01002339|450833223|FG002|Overall Study|Protocol Violation|2|||
125327703|NCT01002339|450833221|FG000|Overall Study|Lung cancer detected before transplant|0|||
125327704|NCT01002339|450833222|FG001|Overall Study|Lung cancer detected before transplant|0|||
125327705|NCT01002339|450833223|FG002|Overall Study|Lung cancer detected before transplant|1|||
125327706|NCT01002339|450833221|FG000|Overall Study|Randomized. Not transplanted|0|||
125327707|NCT01002339|450833222|FG001|Overall Study|Randomized. Not transplanted|0|||
125327708|NCT01002339|450833223|FG002|Overall Study|Randomized. Not transplanted|1|||
125327709|NCT01907854|450833224|FG000|Overall Study|Protocol Violation|1|||
125327710|NCT01907854|450833225|FG001|Overall Study|Protocol Violation|1|||
125327711|NCT01907854|450833224|FG000|Overall Study|Withdrawal by Subject|9|||
125327712|NCT01907854|450833225|FG001|Overall Study|Withdrawal by Subject|7|||
125327713|NCT01907854|450833224|FG000|Overall Study|Lost to Follow-up|2|||
125327714|NCT01907854|450833225|FG001|Overall Study|Lost to Follow-up|2|||
125327715|NCT01907854|450833224|FG000|Overall Study|Unclassified|4|||
125327716|NCT01907854|450833225|FG001|Overall Study|Unclassified|3|||
125327717|NCT02215252|450833228|FG000|Overall Study|Adverse Event|1|||
125327718|NCT02215252|450833229|FG001|Overall Study|Adverse Event|5|||
125327719|NCT02215252|450833230|FG002|Overall Study|Adverse Event|2|||
125327720|NCT02215252|450833228|FG000|Overall Study|Lost to Follow-up|0|||
125327721|NCT02215252|450833229|FG001|Overall Study|Lost to Follow-up|0|||
125327722|NCT02215252|450833230|FG002|Overall Study|Lost to Follow-up|1|||
125327723|NCT02215252|450833228|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
124996690|NCT01193920|449614149|FG006|Overall Study|Unable to classify|0|||
124996691|NCT01193920|449614150|FG007|Overall Study|Unable to classify|1|||
124996692|NCT01193920|449614151|FG008|Overall Study|Unable to classify|0|||
124996693|NCT01193920|449614152|FG009|Overall Study|Unable to classify|0|||
124996694|NCT03170154|449614153|FG000|Overall Study|Lost to Follow-up|4|||
124996695|NCT03170154|449614153|FG000|Overall Study|Death|2|||
124996696|NCT03170154|449614153|FG000|Overall Study|Withdrawal by Subject|2|||
124996697|NCT05266586|449614154|FG000|Overall Study|Adverse Event|2|||
125327724|NCT02215252|450833229|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
125327725|NCT02215252|450833230|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
125327726|NCT02215252|450833228|FG000|Overall Study|Protocol Violation|0|||
125327727|NCT02215252|450833229|FG001|Overall Study|Protocol Violation|1|||
125327728|NCT02215252|450833230|FG002|Overall Study|Protocol Violation|0|||
125327729|NCT02215252|450833228|FG000|Overall Study|Withdrawal by Subject|1|||
125327730|NCT02215252|450833229|FG001|Overall Study|Withdrawal by Subject|0|||
125327731|NCT02215252|450833230|FG002|Overall Study|Withdrawal by Subject|0|||
125327732|NCT02215252|450833228|FG000|Overall Study|Other|0|||
125327733|NCT02215252|450833229|FG001|Overall Study|Other|1|||
125327734|NCT02215252|450833230|FG002|Overall Study|Other|1|||
125327735|NCT03774576|450833231|FG000|Period 2|Adverse Event|1|||
125327736|NCT01716234|450833232|FG000|Overall Study|Protocol Violation|0|||
125327737|NCT01716234|450833233|FG001|Overall Study|Protocol Violation|0|||
125327738|NCT01716234|450833234|FG002|Overall Study|Protocol Violation|0|||
125327739|NCT01716234|450833235|FG003|Overall Study|Protocol Violation|1|||
125327740|NCT01716234|450833236|FG004|Overall Study|Protocol Violation|1|||
125327741|NCT01716234|450833237|FG005|Overall Study|Protocol Violation|1|||
125327742|NCT01716234|450833238|FG006|Overall Study|Protocol Violation|0|||
125327743|NCT01716234|450833232|FG000|Overall Study|Lack of Efficacy|0|||
125327744|NCT01716234|450833233|FG001|Overall Study|Lack of Efficacy|0|||
125327745|NCT01716234|450833234|FG002|Overall Study|Lack of Efficacy|0|||
125327746|NCT01716234|450833235|FG003|Overall Study|Lack of Efficacy|1|||
125327747|NCT01716234|450833236|FG004|Overall Study|Lack of Efficacy|0|||
125327748|NCT01716234|450833237|FG005|Overall Study|Lack of Efficacy|0|||
125327749|NCT01716234|450833238|FG006|Overall Study|Lack of Efficacy|0|||
125327750|NCT01716234|450833232|FG000|Overall Study|Did not meet protocol eligibility|0|||
125327751|NCT01716234|450833233|FG001|Overall Study|Did not meet protocol eligibility|0|||
125327752|NCT01716234|450833234|FG002|Overall Study|Did not meet protocol eligibility|1|||
125327753|NCT01716234|450833235|FG003|Overall Study|Did not meet protocol eligibility|0|||
125327754|NCT01716234|450833236|FG004|Overall Study|Did not meet protocol eligibility|0|||
125327755|NCT01716234|450833237|FG005|Overall Study|Did not meet protocol eligibility|4|||
125327756|NCT01716234|450833238|FG006|Overall Study|Did not meet protocol eligibility|0|||
125327757|NCT01716234|450833232|FG000|Overall Study|Adverse Event|7|||
125327758|NCT01716234|450833233|FG001|Overall Study|Adverse Event|10|||
125327759|NCT01716234|450833234|FG002|Overall Study|Adverse Event|2|||
125327760|NCT01716234|450833235|FG003|Overall Study|Adverse Event|8|||
125327761|NCT01716234|450833236|FG004|Overall Study|Adverse Event|3|||
125327762|NCT01716234|450833237|FG005|Overall Study|Adverse Event|6|||
125327763|NCT01716234|450833238|FG006|Overall Study|Adverse Event|0|||
125327764|NCT01716234|450833232|FG000|Overall Study|Withdrawal by Subject|3|||
125327765|NCT01716234|450833233|FG001|Overall Study|Withdrawal by Subject|0|||
125327766|NCT01716234|450833234|FG002|Overall Study|Withdrawal by Subject|2|||
125327767|NCT01716234|450833235|FG003|Overall Study|Withdrawal by Subject|2|||
125327768|NCT01716234|450833236|FG004|Overall Study|Withdrawal by Subject|1|||
125327769|NCT01716234|450833237|FG005|Overall Study|Withdrawal by Subject|3|||
125327770|NCT01716234|450833238|FG006|Overall Study|Withdrawal by Subject|0|||
125327771|NCT00515619|450833240|FG000|Overall Study|Adverse Event|34|||
125327772|NCT00515619|450833240|FG000|Overall Study|Lack of Efficacy|92|||
125327773|NCT00515619|450833240|FG000|Overall Study|Withdrawal by Subject|66|||
125327774|NCT00515619|450833240|FG000|Overall Study|Protocol Violation|3|||
125327775|NCT00515619|450833240|FG000|Overall Study|Lost to Follow-up|4|||
125327776|NCT00515619|450833240|FG000|Overall Study|Unsatisfactory compliance|6|||
125327777|NCT00515619|450833240|FG000|Overall Study|Other: Site discontinuing trials|2|||
125327778|NCT00515619|450833240|FG000|Overall Study|Other: Subject cannot attend visits|2|||
125327779|NCT00515619|450833240|FG000|Overall Study|Other: Subject required surgery|1|||
125327780|NCT00515619|450833240|FG000|Overall Study|Other: Subject moved to another country|1|||
125327781|NCT00515619|450833240|FG000|Overall Study|Other: Investigator decision|1|||
125327782|NCT00515619|450833240|FG000|Overall Study|Other: Subject became pregnant|1|||
125327783|NCT00515619|450833240|FG000|Overall Study|Other: Request from sponsor|1|||
125327784|NCT00515619|450833240|FG000|Overall Study|Other: Drug available on license|1|||
125327785|NCT00515619|450833240|FG000|Overall Study|Other: Subject interested in other AED|1|||
125327786|NCT03815929|450833241|FG000|Overall Study|Lost to Follow-up|2|||
125327787|NCT03815929|450833242|FG001|Overall Study|Lost to Follow-up|1|||
125327788|NCT03815929|450833243|FG002|Overall Study|Lost to Follow-up|0|||
125327789|NCT03815929|450833241|FG000|Overall Study|Physician Decision|2|||
125327790|NCT03815929|450833242|FG001|Overall Study|Physician Decision|2|||
125327791|NCT03815929|450833243|FG002|Overall Study|Physician Decision|0|||
125327792|NCT03815929|450833241|FG000|Overall Study|Withdrawal by Subject|0|||
125327793|NCT03815929|450833242|FG001|Overall Study|Withdrawal by Subject|0|||
125327794|NCT03815929|450833243|FG002|Overall Study|Withdrawal by Subject|1|||
125327795|NCT01467960|450833244|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
125327796|NCT01467960|450833245|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
125327797|NCT01467960|450833246|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
125327798|NCT01467960|450833247|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
125327799|NCT01467960|450833248|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
125327800|NCT01467960|450833249|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
125327801|NCT00771758|450833250|FG000|Overall Study|Adverse Event|2|||
125327802|NCT00771758|450833251|FG001|Overall Study|Adverse Event|8|||
125327803|NCT00771758|450833252|FG002|Overall Study|Adverse Event|1|||
125327804|NCT00771758|450833250|FG000|Overall Study|Lack of Efficacy|0|||
125327805|NCT00771758|450833251|FG001|Overall Study|Lack of Efficacy|2|||
125327806|NCT00771758|450833252|FG002|Overall Study|Lack of Efficacy|1|||
125327807|NCT00771758|450833250|FG000|Overall Study|Lost to Follow-up|1|||
125327808|NCT00771758|450833251|FG001|Overall Study|Lost to Follow-up|0|||
125327809|NCT00771758|450833252|FG002|Overall Study|Lost to Follow-up|0|||
125327810|NCT00771758|450833250|FG000|Overall Study|Protocol Violation|1|||
125327811|NCT00771758|450833251|FG001|Overall Study|Protocol Violation|0|||
125327812|NCT00771758|450833252|FG002|Overall Study|Protocol Violation|0|||
125327813|NCT00771758|450833250|FG000|Overall Study|Withdrawal by Subject|1|||
125327814|NCT00771758|450833251|FG001|Overall Study|Withdrawal by Subject|0|||
125327815|NCT00771758|450833252|FG002|Overall Study|Withdrawal by Subject|0|||
125327816|NCT00771758|450833250|FG000|Overall Study|Other|3|||
125327817|NCT00771758|450833251|FG001|Overall Study|Other|2|||
125327818|NCT00771758|450833252|FG002|Overall Study|Other|0|||
125327819|NCT03067077|450833253|FG000|Overall Study|Did not receive surgery|4|||
125327820|NCT03067077|450833254|FG001|Overall Study|Did not receive surgery|5|||
125327821|NCT03067077|450833253|FG000|Overall Study|Lost to Follow-up|3|||
125327822|NCT03067077|450833254|FG001|Overall Study|Lost to Follow-up|2|||
125327823|NCT01394016|450833256|FG000|Overall Study|Progressive Disease|2|||
125327824|NCT01394016|450833257|FG001|Overall Study|Progressive Disease|0|||
125327825|NCT01394016|450833258|FG002|Overall Study|Progressive Disease|0|||
125327826|NCT01394016|450833259|FG003|Overall Study|Progressive Disease|0|||
125327827|NCT01394016|450833260|FG004|Overall Study|Progressive Disease|0|||
125327828|NCT01394016|450833261|FG005|Overall Study|Progressive Disease|0|||
125327829|NCT01394016|450833262|FG006|Overall Study|Progressive Disease|0|||
125327830|NCT01394016|450833263|FG007|Overall Study|Progressive Disease|0|||
125327831|NCT01394016|450833264|FG008|Overall Study|Progressive Disease|0|||
125327832|NCT01394016|450833265|FG009|Overall Study|Progressive Disease|0|||
125327833|NCT01394016|450833266|FG010|Overall Study|Progressive Disease|0|||
125327834|NCT01394016|450833267|FG011|Overall Study|Progressive Disease|0|||
125327835|NCT01394016|450833268|FG012|Overall Study|Progressive Disease|0|||
125327836|NCT01394016|450833269|FG013|Overall Study|Progressive Disease|0|||
125327837|NCT01394016|450833270|FG014|Overall Study|Progressive Disease|0|||
125327838|NCT01394016|450833271|FG015|Overall Study|Progressive Disease|0|||
125327839|NCT01394016|450833272|FG016|Overall Study|Progressive Disease|0|||
125327840|NCT01394016|450833273|FG017|Overall Study|Progressive Disease|0|||
125327841|NCT01394016|450833274|FG018|Overall Study|Progressive Disease|0|||
125327842|NCT01394016|450833256|FG000|Overall Study|Withdrawal by Subject|0|||
125327843|NCT01394016|450833257|FG001|Overall Study|Withdrawal by Subject|0|||
125327844|NCT01394016|450833258|FG002|Overall Study|Withdrawal by Subject|0|||
125327845|NCT01394016|450833259|FG003|Overall Study|Withdrawal by Subject|0|||
125327846|NCT01394016|450833260|FG004|Overall Study|Withdrawal by Subject|0|||
125327847|NCT01394016|450833261|FG005|Overall Study|Withdrawal by Subject|0|||
125327848|NCT01394016|450833262|FG006|Overall Study|Withdrawal by Subject|0|||
125327849|NCT01394016|450833263|FG007|Overall Study|Withdrawal by Subject|1|||
125327850|NCT01394016|450833264|FG008|Overall Study|Withdrawal by Subject|1|||
125327851|NCT01394016|450833265|FG009|Overall Study|Withdrawal by Subject|1|||
125327852|NCT01394016|450833266|FG010|Overall Study|Withdrawal by Subject|4|||
125327853|NCT01394016|450833267|FG011|Overall Study|Withdrawal by Subject|0|||
125327854|NCT01394016|450833268|FG012|Overall Study|Withdrawal by Subject|0|||
125327855|NCT01394016|450833269|FG013|Overall Study|Withdrawal by Subject|3|||
125327856|NCT01394016|450833270|FG014|Overall Study|Withdrawal by Subject|1|||
125327857|NCT01394016|450833271|FG015|Overall Study|Withdrawal by Subject|3|||
125327858|NCT01394016|450833272|FG016|Overall Study|Withdrawal by Subject|1|||
125327859|NCT01394016|450833273|FG017|Overall Study|Withdrawal by Subject|1|||
125327860|NCT01394016|450833274|FG018|Overall Study|Withdrawal by Subject|2|||
125327861|NCT01394016|450833256|FG000|Overall Study|Adverse Event|0|||
125327862|NCT01394016|450833257|FG001|Overall Study|Adverse Event|0|||
125327863|NCT01394016|450833258|FG002|Overall Study|Adverse Event|0|||
125327864|NCT01394016|450833259|FG003|Overall Study|Adverse Event|0|||
125327865|NCT01394016|450833260|FG004|Overall Study|Adverse Event|0|||
125327866|NCT01394016|450833261|FG005|Overall Study|Adverse Event|0|||
125327867|NCT01394016|450833262|FG006|Overall Study|Adverse Event|0|||
125327868|NCT01394016|450833263|FG007|Overall Study|Adverse Event|0|||
125327869|NCT01394016|450833264|FG008|Overall Study|Adverse Event|0|||
125327870|NCT01394016|450833265|FG009|Overall Study|Adverse Event|1|||
125327871|NCT01394016|450833266|FG010|Overall Study|Adverse Event|0|||
125327872|NCT01394016|450833267|FG011|Overall Study|Adverse Event|0|||
125327873|NCT01394016|450833268|FG012|Overall Study|Adverse Event|0|||
125327874|NCT01394016|450833269|FG013|Overall Study|Adverse Event|0|||
125327875|NCT01394016|450833270|FG014|Overall Study|Adverse Event|0|||
125327876|NCT01394016|450833271|FG015|Overall Study|Adverse Event|0|||
125327877|NCT01394016|450833272|FG016|Overall Study|Adverse Event|1|||
125327878|NCT01394016|450833273|FG017|Overall Study|Adverse Event|1|||
124996698|NCT05266586|449614155|FG001|Overall Study|Adverse Event|2|||
124996699|NCT05266586|449614156|FG002|Overall Study|Adverse Event|1|||
124996700|NCT05266586|449614154|FG000|Overall Study|Withdrawal by Subject|1|||
124996701|NCT05266586|449614155|FG001|Overall Study|Withdrawal by Subject|0|||
124996702|NCT05266586|449614156|FG002|Overall Study|Withdrawal by Subject|1|||
124996703|NCT05266586|449614154|FG000|Overall Study|Non-compliance with study drug|0|||
124996704|NCT05266586|449614155|FG001|Overall Study|Non-compliance with study drug|1|||
124996705|NCT05266586|449614156|FG002|Overall Study|Non-compliance with study drug|0|||
124996706|NCT05266586|449614154|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
124996707|NCT05266586|449614155|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
124996708|NCT05266586|449614156|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
124996709|NCT03282240|449614157|FG000|Overall Study|Adverse Event|2|||
124996710|NCT03282240|449614158|FG001|Overall Study|Adverse Event|2|||
124996711|NCT03282240|449614159|FG002|Overall Study|Adverse Event|0|||
124996712|NCT03282240|449614157|FG000|Overall Study|Lost to Follow-up|3|||
124996713|NCT03282240|449614158|FG001|Overall Study|Lost to Follow-up|0|||
124996714|NCT03282240|449614159|FG002|Overall Study|Lost to Follow-up|0|||
124996715|NCT03282240|449614157|FG000|Overall Study|Protocol Deviation|4|||
125327879|NCT01394016|450833274|FG018|Overall Study|Adverse Event|0|||
124996716|NCT03282240|449614158|FG001|Overall Study|Protocol Deviation|1|||
124996717|NCT03282240|449614159|FG002|Overall Study|Protocol Deviation|2|||
124996718|NCT03282240|449614157|FG000|Overall Study|Withdrawal by Subject|1|||
124996719|NCT03282240|449614158|FG001|Overall Study|Withdrawal by Subject|0|||
124996720|NCT03282240|449614159|FG002|Overall Study|Withdrawal by Subject|1|||
124996721|NCT01101477|449615982|FG000|Overall Study|Protocol Violation|5|||
124996722|NCT01101477|449615983|FG001|Overall Study|Protocol Violation|3|||
124996723|NCT01101477|449615984|FG002|Overall Study|Protocol Violation|1|||
124996724|NCT02382016|449615985|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
124996725|NCT02382016|449615986|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
124996726|NCT02382016|449615985|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
124996727|NCT02382016|449615986|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
124996728|NCT02382016|449615985|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
124996729|NCT02382016|449615986|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
124996730|NCT02382016|449615985|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
124996731|NCT02382016|449615986|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
124996732|NCT02382016|449615985|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
124996733|NCT02382016|449615986|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
124996734|NCT02382016|449615985|FG000|Open-label (OL) Treatment Period|Death|4|||
124996735|NCT02382016|449615986|FG001|Open-label (OL) Treatment Period|Death|0|||
124996736|NCT02382016|449615985|FG000|OL Extension Period|Physician Decision|3|||
124996737|NCT02382016|449615986|FG001|OL Extension Period|Physician Decision|0|||
124996738|NCT02382016|449615985|FG000|OL Extension Period|Death|2|||
124996739|NCT02382016|449615986|FG001|OL Extension Period|Death|0|||
124996740|NCT02382016|449615985|FG000|OL Extension Period|Withdrawal by Subject|1|||
124996741|NCT02382016|449615986|FG001|OL Extension Period|Withdrawal by Subject|0|||
124996742|NCT00084266|449615987|FG000|Overall Study|Death|42|||
125327880|NCT01394016|450833256|FG000|Overall Study|Sponsor Decision|0|||
125327881|NCT01394016|450833257|FG001|Overall Study|Sponsor Decision|0|||
125327882|NCT01394016|450833258|FG002|Overall Study|Sponsor Decision|0|||
125327883|NCT01394016|450833259|FG003|Overall Study|Sponsor Decision|0|||
125327884|NCT01394016|450833260|FG004|Overall Study|Sponsor Decision|0|||
125327885|NCT01394016|450833261|FG005|Overall Study|Sponsor Decision|0|||
125327886|NCT01394016|450833262|FG006|Overall Study|Sponsor Decision|0|||
125327887|NCT01394016|450833263|FG007|Overall Study|Sponsor Decision|0|||
125327888|NCT01394016|450833264|FG008|Overall Study|Sponsor Decision|0|||
125327889|NCT01394016|450833265|FG009|Overall Study|Sponsor Decision|0|||
125327890|NCT01394016|450833266|FG010|Overall Study|Sponsor Decision|0|||
125327891|NCT01394016|450833267|FG011|Overall Study|Sponsor Decision|0|||
125327892|NCT01394016|450833268|FG012|Overall Study|Sponsor Decision|1|||
125327893|NCT01394016|450833269|FG013|Overall Study|Sponsor Decision|0|||
125327894|NCT01394016|450833270|FG014|Overall Study|Sponsor Decision|0|||
125327895|NCT01394016|450833271|FG015|Overall Study|Sponsor Decision|0|||
125327896|NCT01394016|450833272|FG016|Overall Study|Sponsor Decision|0|||
125327897|NCT01394016|450833273|FG017|Overall Study|Sponsor Decision|0|||
125327898|NCT01394016|450833274|FG018|Overall Study|Sponsor Decision|0|||
125327899|NCT01394016|450833256|FG000|Overall Study|Lost to Follow-up|0|||
125327900|NCT01394016|450833257|FG001|Overall Study|Lost to Follow-up|0|||
125327901|NCT01394016|450833258|FG002|Overall Study|Lost to Follow-up|0|||
124996743|NCT00084266|449615988|FG001|Overall Study|Death|39|||
124996744|NCT00084266|449615987|FG000|Overall Study|Adverse Event|8|||
124996745|NCT00084266|449615988|FG001|Overall Study|Adverse Event|5|||
124996746|NCT00084266|449615987|FG000|Overall Study|Lack of Efficacy|2|||
124996747|NCT00084266|449615988|FG001|Overall Study|Lack of Efficacy|4|||
124996748|NCT00084266|449615987|FG000|Overall Study|Lost to Follow-up|5|||
124996749|NCT00084266|449615988|FG001|Overall Study|Lost to Follow-up|3|||
125327902|NCT01394016|450833259|FG003|Overall Study|Lost to Follow-up|0|||
125327903|NCT01394016|450833260|FG004|Overall Study|Lost to Follow-up|0|||
125327904|NCT01394016|450833261|FG005|Overall Study|Lost to Follow-up|0|||
125327905|NCT01394016|450833262|FG006|Overall Study|Lost to Follow-up|0|||
125327906|NCT01394016|450833263|FG007|Overall Study|Lost to Follow-up|0|||
125327907|NCT01394016|450833264|FG008|Overall Study|Lost to Follow-up|0|||
125327908|NCT01394016|450833265|FG009|Overall Study|Lost to Follow-up|0|||
125327909|NCT01394016|450833266|FG010|Overall Study|Lost to Follow-up|0|||
124996750|NCT00084266|449615987|FG000|Overall Study|Participant not willing to participate|3|||
125327910|NCT01394016|450833267|FG011|Overall Study|Lost to Follow-up|0|||
125327911|NCT01394016|450833268|FG012|Overall Study|Lost to Follow-up|0|||
125327912|NCT01394016|450833269|FG013|Overall Study|Lost to Follow-up|0|||
125327913|NCT01394016|450833270|FG014|Overall Study|Lost to Follow-up|0|||
125327914|NCT01394016|450833271|FG015|Overall Study|Lost to Follow-up|0|||
125327915|NCT01394016|450833272|FG016|Overall Study|Lost to Follow-up|0|||
125327916|NCT01394016|450833273|FG017|Overall Study|Lost to Follow-up|0|||
125327917|NCT01394016|450833274|FG018|Overall Study|Lost to Follow-up|1|||
125327918|NCT04949490|450833282|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
125327919|NCT04949490|450833283|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
125327920|NCT04949490|450833284|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
125327921|NCT04949490|450833285|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
125327922|NCT04949490|450833286|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
125327923|NCT04949490|450833287|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
125327924|NCT04949490|450833282|FG000|Group A and Group B|Withdrawal by Subject|0|||
125327925|NCT04949490|450833283|FG001|Group A and Group B|Withdrawal by Subject|0|||
125327926|NCT04949490|450833284|FG002|Group A and Group B|Withdrawal by Subject|1|||
125327927|NCT04949490|450833285|FG003|Group A and Group B|Withdrawal by Subject|0|||
125327928|NCT04949490|450833286|FG004|Group A and Group B|Withdrawal by Subject|0|||
125327929|NCT04949490|450833287|FG005|Group A and Group B|Withdrawal by Subject|0|||
125327930|NCT04949490|450833282|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
125327931|NCT04949490|450833283|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
125327932|NCT04949490|450833284|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
125327933|NCT04949490|450833285|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
125327934|NCT04949490|450833286|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
125327935|NCT04949490|450833287|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
125327936|NCT04949490|450833282|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
125327937|NCT04949490|450833283|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
125327938|NCT04949490|450833284|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
124996751|NCT00084266|449615988|FG001|Overall Study|Participant not willing to participate|8|||
124996752|NCT00084266|449615987|FG000|Overall Study|Other|360|||
124996753|NCT00084266|449615988|FG001|Overall Study|Other|344|||
124996754|NCT00084266|449615987|FG000|Overall Study|Randomized not treated|21|||
124996755|NCT00084266|449615988|FG001|Overall Study|Randomized not treated|20|||
124996756|NCT00730171|449615989|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
124996757|NCT00730171|449615989|FG000|Overall Study|Adverse Event|193|||
124996758|NCT00730171|449615989|FG000|Overall Study|Protocol Violation|48|||
124996759|NCT00730171|449615989|FG000|Overall Study|Withdrawal by Subject|202|||
124996760|NCT00730171|449615989|FG000|Overall Study|Lost to Follow-up|121|||
124996761|NCT00730171|449615989|FG000|Overall Study|Insufficient Therapeutic Response|141|||
124996762|NCT00730171|449615989|FG000|Overall Study|Other|61|||
124996763|NCT01729156|449615990|FG000|Overall Study|Withdrawal by Subject|1|||
124996764|NCT01729156|449615991|FG001|Overall Study|Withdrawal by Subject|0|||
124996765|NCT01729156|449615992|FG002|Overall Study|Withdrawal by Subject|0|||
124996766|NCT00655863|449615993|FG000|Overall Study|Lost to Follow-up|0|||
124996767|NCT00655863|449615994|FG001|Overall Study|Lost to Follow-up|0|||
124996768|NCT00655863|449615995|FG002|Overall Study|Lost to Follow-up|1|||
124996769|NCT04442737|449615998|FG000|Overall Study|Lost to Follow-up|1|||
124996770|NCT04442737|449615999|FG001|Overall Study|Lost to Follow-up|3|||
124996771|NCT04442737|449615998|FG000|Overall Study|Withdrawal by Subject|3|||
124996772|NCT04442737|449615999|FG001|Overall Study|Withdrawal by Subject|2|||
124996773|NCT04442737|449615998|FG000|Overall Study|Adverse Event|3|||
124996774|NCT04442737|449615999|FG001|Overall Study|Adverse Event|2|||
124996775|NCT04442737|449615998|FG000|Overall Study|Death|0|||
124996776|NCT04442737|449615999|FG001|Overall Study|Death|1|||
124996777|NCT04442737|449615998|FG000|Overall Study|Protocol Violation|0|||
124996778|NCT04442737|449615999|FG001|Overall Study|Protocol Violation|2|||
124996779|NCT04442737|449615998|FG000|Overall Study|Other|1|||
124996780|NCT04442737|449615999|FG001|Overall Study|Other|1|||
124996781|NCT03588728|449616001|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
124996782|NCT03588728|449616002|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
124996783|NCT03588728|449616003|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
124996784|NCT03588728|449616004|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
125327939|NCT04949490|450833285|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
124996785|NCT03588728|449616001|FG000|Overall Study|Lab shut down due to COVID-19|0|||
125327940|NCT04949490|450833286|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
125327941|NCT04949490|450833287|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
125327942|NCT02017405|450833288|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
125327943|NCT02017405|450833289|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
125327944|NCT02017405|450833290|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
125327945|NCT02017405|450833291|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
125327946|NCT02017405|450833292|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
125327947|NCT02017405|450833293|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
125327948|NCT02017405|450833288|FG000|Open-label Phase|Adverse Event|1|||
125327949|NCT02017405|450833289|FG001|Open-label Phase|Adverse Event|1|||
125327950|NCT02017405|450833290|FG002|Open-label Phase|Adverse Event|0|||
125327951|NCT02017405|450833291|FG003|Open-label Phase|Adverse Event|0|||
125327952|NCT02017405|450833292|FG004|Open-label Phase|Adverse Event|0|||
125327953|NCT02017405|450833293|FG005|Open-label Phase|Adverse Event|0|||
125327954|NCT02864394|450833295|FG000|Overall Study|Death|184|||
125327955|NCT02864394|450833296|FG001|Overall Study|Death|189|||
125327956|NCT02864394|450833295|FG000|Overall Study|Lost to Follow-up|0|||
125327957|NCT02864394|450833296|FG001|Overall Study|Lost to Follow-up|2|||
125327958|NCT02864394|450833295|FG000|Overall Study|Sponsor Decision|26|||
125327959|NCT02864394|450833296|FG001|Overall Study|Sponsor Decision|11|||
125327960|NCT02864394|450833295|FG000|Overall Study|Withdrawal by Subject|3|||
125327961|NCT02864394|450833296|FG001|Overall Study|Withdrawal by Subject|10|||
125327962|NCT00777153|450835409|FG000|Overall Study|Lost to Follow-up|1|||
125327963|NCT00777153|450835410|FG001|Overall Study|Lost to Follow-up|1|||
125327964|NCT00777153|450835411|FG002|Overall Study|Lost to Follow-up|0|||
125327965|NCT00777153|450835409|FG000|Overall Study|Death|85|||
125327966|NCT00777153|450835410|FG001|Overall Study|Death|73|||
125327967|NCT00777153|450835411|FG002|Overall Study|Death|33|||
125327968|NCT00777153|450835409|FG000|Overall Study|Withdrawal by Subject|3|||
125327969|NCT00777153|450835410|FG001|Overall Study|Withdrawal by Subject|4|||
125327970|NCT00777153|450835411|FG002|Overall Study|Withdrawal by Subject|3|||
125327971|NCT00777153|450835409|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
125327972|NCT00777153|450835410|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
125327973|NCT00777153|450835411|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
125327974|NCT00554216|450835413|FG000|Overall Study|Lost to Follow-up|92|||
125327975|NCT00554216|450835414|FG001|Overall Study|Lost to Follow-up|31|||
125327976|NCT00554216|450835415|FG002|Overall Study|Lost to Follow-up|63|||
125327977|NCT00554216|450835413|FG000|Overall Study|Adverse Event|16|||
125327978|NCT00554216|450835414|FG001|Overall Study|Adverse Event|16|||
125327979|NCT00554216|450835415|FG002|Overall Study|Adverse Event|36|||
125327980|NCT00554216|450835413|FG000|Overall Study|Withdrawal by Subject|92|||
125327981|NCT00554216|450835414|FG001|Overall Study|Withdrawal by Subject|31|||
125327982|NCT00554216|450835415|FG002|Overall Study|Withdrawal by Subject|43|||
125327983|NCT00554216|450835413|FG000|Overall Study|Non compliance|10|||
125327984|NCT00554216|450835414|FG001|Overall Study|Non compliance|4|||
125327985|NCT00554216|450835415|FG002|Overall Study|Non compliance|5|||
125327986|NCT00554216|450835413|FG000|Overall Study|Pregnancy|2|||
125327987|NCT00554216|450835414|FG001|Overall Study|Pregnancy|1|||
125327988|NCT00554216|450835415|FG002|Overall Study|Pregnancy|14|||
125327989|NCT00554216|450835413|FG000|Overall Study|Restricted med|3|||
125327990|NCT00554216|450835414|FG001|Overall Study|Restricted med|1|||
125327991|NCT00554216|450835415|FG002|Overall Study|Restricted med|1|||
125327992|NCT00554216|450835413|FG000|Overall Study|Other|12|||
125327993|NCT00554216|450835414|FG001|Overall Study|Other|7|||
125327994|NCT00554216|450835415|FG002|Overall Study|Other|10|||
125327995|NCT00554216|450835413|FG000|Overall Study|Lack of Efficacy|15|||
125327996|NCT00554216|450835414|FG001|Overall Study|Lack of Efficacy|3|||
125327997|NCT00554216|450835415|FG002|Overall Study|Lack of Efficacy|0|||
125327998|NCT02079246|450835416|FG000|OLEX|Withdrawal before treatment|1|||
125327999|NCT02079246|450835417|FG001|OLEX|Withdrawal before treatment|0|||
125328000|NCT02079246|450835416|FG000|OLEX|Death|11|||
125328001|NCT02079246|450835417|FG001|OLEX|Death|0|||
125328002|NCT02079246|450835416|FG000|OLEX|Adverse Event|66|||
125328003|NCT02079246|450835417|FG001|OLEX|Adverse Event|0|||
125328004|NCT02079246|450835416|FG000|OLEX|Withdrawal by Subject|60|||
125328005|NCT02079246|450835417|FG001|OLEX|Withdrawal by Subject|0|||
125328006|NCT02079246|450835416|FG000|OLEX|Lost to Follow-up|6|||
125328007|NCT02079246|450835417|FG001|OLEX|Lost to Follow-up|0|||
125328008|NCT02079246|450835416|FG000|OLEX|Protocol Violation|6|||
125328009|NCT02079246|450835417|FG001|OLEX|Protocol Violation|0|||
125328010|NCT02079246|450835416|FG000|OLEX|Lack of Efficacy|3|||
125328011|NCT02079246|450835417|FG001|OLEX|Lack of Efficacy|0|||
125328012|NCT02079246|450835416|FG000|OLEX|Results of the lead-in studies|58|||
125328013|NCT02079246|450835417|FG001|OLEX|Results of the lead-in studies|0|||
125328014|NCT02079246|450835416|FG000|OLEX|Other: Disallowed medication|8|||
125328015|NCT02079246|450835417|FG001|OLEX|Other: Disallowed medication|0|||
125328016|NCT02079246|450835416|FG000|OLEX|Other: Insufficient compliance|2|||
125328017|NCT02079246|450835417|FG001|OLEX|Other: Insufficient compliance|0|||
125328018|NCT02079246|450835416|FG000|OLEX|Other: Caregiver unavailable|3|||
125328019|NCT02079246|450835417|FG001|OLEX|Other: Caregiver unavailable|0|||
125328020|NCT02079246|450835416|FG000|OLEX|Other: Coordinator decision|1|||
125328021|NCT02079246|450835417|FG001|OLEX|Other: Coordinator decision|0|||
125328022|NCT02079246|450835416|FG000|OLEX|Other: Worsening of condition|1|||
125328023|NCT02079246|450835417|FG001|OLEX|Other: Worsening of condition|0|||
125328024|NCT02079246|450835416|FG000|OLEX|Other: Moved to nursing home|1|||
125328025|NCT02079246|450835417|FG001|OLEX|Other: Moved to nursing home|0|||
125328026|NCT02079246|450835416|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
125328027|NCT02079246|450835417|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
125328028|NCT02079246|450835416|FG000|OLEX-MEM|Adverse Event|0|||
125328029|NCT02079246|450835417|FG001|OLEX-MEM|Adverse Event|6|||
125328030|NCT02079246|450835416|FG000|OLEX-MEM|Withdrawal by Subject|0|||
125328031|NCT02079246|450835417|FG001|OLEX-MEM|Withdrawal by Subject|7|||
125328032|NCT02079246|450835416|FG000|OLEX-MEM|Protocol Violation|0|||
125328033|NCT02079246|450835417|FG001|OLEX-MEM|Protocol Violation|2|||
125328034|NCT02079246|450835416|FG000|OLEX-MEM|Lost to Follow-up|0|||
125328035|NCT02079246|450835417|FG001|OLEX-MEM|Lost to Follow-up|1|||
125328036|NCT02079246|450835416|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
125328037|NCT02079246|450835417|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
125328038|NCT00463567|450835418|FG000|Overall Study|Adverse Event|29|||
125328039|NCT00463567|450835419|FG001|Overall Study|Adverse Event|26|||
125328040|NCT00463567|450835420|FG002|Overall Study|Adverse Event|17|||
125328041|NCT00463567|450835421|FG003|Overall Study|Adverse Event|46|||
125328042|NCT00463567|450835422|FG004|Overall Study|Adverse Event|10|||
125328043|NCT00463567|450835423|FG005|Overall Study|Adverse Event|10|||
125328044|NCT00463567|450835424|FG006|Overall Study|Adverse Event|4|||
125328045|NCT00463567|450835418|FG000|Overall Study|Withdrawal by Subject|29|||
125328046|NCT00463567|450835419|FG001|Overall Study|Withdrawal by Subject|22|||
125328047|NCT00463567|450835420|FG002|Overall Study|Withdrawal by Subject|20|||
125328048|NCT00463567|450835421|FG003|Overall Study|Withdrawal by Subject|37|||
125328049|NCT00463567|450835422|FG004|Overall Study|Withdrawal by Subject|6|||
125328050|NCT00463567|450835423|FG005|Overall Study|Withdrawal by Subject|5|||
125328051|NCT00463567|450835424|FG006|Overall Study|Withdrawal by Subject|1|||
125328052|NCT00463567|450835418|FG000|Overall Study|Protocol Deviation|13|||
125328053|NCT00463567|450835419|FG001|Overall Study|Protocol Deviation|9|||
125328054|NCT00463567|450835420|FG002|Overall Study|Protocol Deviation|14|||
125328055|NCT00463567|450835421|FG003|Overall Study|Protocol Deviation|11|||
125328056|NCT00463567|450835422|FG004|Overall Study|Protocol Deviation|1|||
125328057|NCT00463567|450835423|FG005|Overall Study|Protocol Deviation|1|||
125328058|NCT00463567|450835424|FG006|Overall Study|Protocol Deviation|2|||
125328059|NCT00463567|450835418|FG000|Overall Study|Lost to Follow-up|12|||
125328060|NCT00463567|450835419|FG001|Overall Study|Lost to Follow-up|6|||
125328061|NCT00463567|450835420|FG002|Overall Study|Lost to Follow-up|13|||
125328062|NCT00463567|450835421|FG003|Overall Study|Lost to Follow-up|8|||
125328063|NCT00463567|450835422|FG004|Overall Study|Lost to Follow-up|1|||
125328064|NCT00463567|450835423|FG005|Overall Study|Lost to Follow-up|1|||
125328065|NCT00463567|450835424|FG006|Overall Study|Lost to Follow-up|1|||
125328066|NCT00463567|450835418|FG000|Overall Study|Administrative problems|5|||
125328067|NCT00463567|450835419|FG001|Overall Study|Administrative problems|3|||
125328068|NCT00463567|450835420|FG002|Overall Study|Administrative problems|6|||
125328069|NCT00463567|450835421|FG003|Overall Study|Administrative problems|9|||
125328070|NCT00463567|450835422|FG004|Overall Study|Administrative problems|3|||
125328071|NCT00463567|450835423|FG005|Overall Study|Administrative problems|2|||
125328072|NCT00463567|450835424|FG006|Overall Study|Administrative problems|2|||
125328073|NCT00463567|450835418|FG000|Overall Study|Lack of Efficacy|4|||
125328074|NCT00463567|450835419|FG001|Overall Study|Lack of Efficacy|9|||
125328075|NCT00463567|450835420|FG002|Overall Study|Lack of Efficacy|9|||
125328076|NCT00463567|450835421|FG003|Overall Study|Lack of Efficacy|17|||
124996786|NCT03588728|449616002|FG001|Overall Study|Lab shut down due to COVID-19|0|||
124996787|NCT03588728|449616003|FG002|Overall Study|Lab shut down due to COVID-19|0|||
124996788|NCT03588728|449616004|FG003|Overall Study|Lab shut down due to COVID-19|1|||
124996789|NCT03588728|449616001|FG000|Overall Study|multiple technical issues|1|||
124996790|NCT03588728|449616002|FG001|Overall Study|multiple technical issues|0|||
124996791|NCT03588728|449616003|FG002|Overall Study|multiple technical issues|0|||
125328077|NCT00463567|450835422|FG004|Overall Study|Lack of Efficacy|1|||
125328078|NCT00463567|450835423|FG005|Overall Study|Lack of Efficacy|0|||
124996792|NCT03588728|449616004|FG003|Overall Study|multiple technical issues|0|||
124996793|NCT03588728|449616001|FG000|Overall Study|Hospitalized for COVID|1|||
124996794|NCT03588728|449616002|FG001|Overall Study|Hospitalized for COVID|0|||
124996795|NCT03588728|449616003|FG002|Overall Study|Hospitalized for COVID|0|||
125328079|NCT00463567|450835424|FG006|Overall Study|Lack of Efficacy|1|||
125328080|NCT00463567|450835418|FG000|Overall Study|Abnormal lab value(s)|1|||
125328081|NCT00463567|450835419|FG001|Overall Study|Abnormal lab value(s)|1|||
125328082|NCT00463567|450835420|FG002|Overall Study|Abnormal lab value(s)|2|||
125328083|NCT00463567|450835421|FG003|Overall Study|Abnormal lab value(s)|1|||
125328084|NCT00463567|450835422|FG004|Overall Study|Abnormal lab value(s)|1|||
125328085|NCT00463567|450835423|FG005|Overall Study|Abnormal lab value(s)|0|||
125328086|NCT00463567|450835424|FG006|Overall Study|Abnormal lab value(s)|0|||
124996796|NCT03588728|449616004|FG003|Overall Study|Hospitalized for COVID|0|||
124996797|NCT03588728|449616001|FG000|Overall Study|Schedule change unable to attend sessions|1|||
125328087|NCT00463567|450835418|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125328088|NCT00463567|450835419|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125328089|NCT00463567|450835420|FG002|Overall Study|Abnormal test procedure result(s)|6|||
125328090|NCT00463567|450835421|FG003|Overall Study|Abnormal test procedure result(s)|2|||
125328091|NCT00463567|450835422|FG004|Overall Study|Abnormal test procedure result(s)|0|||
125328092|NCT00463567|450835423|FG005|Overall Study|Abnormal test procedure result(s)|2|||
125328093|NCT00463567|450835424|FG006|Overall Study|Abnormal test procedure result(s)|0|||
125328094|NCT00463567|450835418|FG000|Overall Study|Death|1|||
125328095|NCT00463567|450835419|FG001|Overall Study|Death|0|||
125328096|NCT00463567|450835420|FG002|Overall Study|Death|2|||
125328097|NCT00463567|450835421|FG003|Overall Study|Death|0|||
125328098|NCT00463567|450835422|FG004|Overall Study|Death|0|||
125328099|NCT00463567|450835423|FG005|Overall Study|Death|0|||
125328100|NCT00463567|450835424|FG006|Overall Study|Death|0|||
125328101|NCT02633306|450835425|FG000|Overall Study|Withdrawal by Subject|3|||
125328102|NCT00956007|450835426|FG000|Overall Study|Protocol Violation|27|||
125328103|NCT00956007|450835427|FG001|Overall Study|Protocol Violation|23|||
125328104|NCT01746901|450835428|FG000|Naloxone Challenge Phase|Adverse Event|2|||
125328105|NCT01746901|450835429|FG001|Naloxone Challenge Phase|Adverse Event|0|||
125328106|NCT01746901|450835430|FG002|Naloxone Challenge Phase|Adverse Event|0|||
125328107|NCT01746901|450835431|FG003|Naloxone Challenge Phase|Adverse Event|0|||
125328108|NCT01746901|450835432|FG004|Naloxone Challenge Phase|Adverse Event|0|||
125328109|NCT01746901|450835433|FG005|Naloxone Challenge Phase|Adverse Event|0|||
125328110|NCT01746901|450835434|FG006|Naloxone Challenge Phase|Adverse Event|0|||
124996798|NCT03588728|449616002|FG001|Overall Study|Schedule change unable to attend sessions|0|||
124996799|NCT03588728|449616003|FG002|Overall Study|Schedule change unable to attend sessions|0|||
124996800|NCT03588728|449616004|FG003|Overall Study|Schedule change unable to attend sessions|0|||
124996801|NCT03285178|449616005|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
124996802|NCT03285178|449616006|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
124996803|NCT03285178|449616007|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
124996804|NCT03285178|449616008|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
124996805|NCT03285178|449616009|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
124996806|NCT03285178|449616010|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
124996807|NCT03285178|449616011|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
124996808|NCT03285178|449616005|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
124996809|NCT03285178|449616006|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
124996810|NCT03285178|449616007|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
124996811|NCT03285178|449616008|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
124996812|NCT03285178|449616009|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
124996813|NCT03285178|449616010|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
124996814|NCT03285178|449616011|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
124996815|NCT03285178|449616005|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
124996816|NCT03285178|449616006|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
124996817|NCT03285178|449616007|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
124996818|NCT03285178|449616008|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
124996819|NCT03285178|449616009|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
124996820|NCT03285178|449616010|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
124996821|NCT03285178|449616011|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
124996822|NCT03285178|449616005|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
124996823|NCT03285178|449616006|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
124996824|NCT03285178|449616007|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
124996825|NCT03285178|449616008|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
124996826|NCT03285178|449616009|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
124996827|NCT03285178|449616010|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
124996828|NCT03285178|449616011|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
124996829|NCT03285178|449616005|FG000|Single-Blind Run-In Period|Physician Decision|2|||
124996830|NCT03285178|449616006|FG001|Single-Blind Run-In Period|Physician Decision|0|||
124996831|NCT03285178|449616007|FG002|Single-Blind Run-In Period|Physician Decision|0|||
125328111|NCT01746901|450835435|FG007|Naloxone Challenge Phase|Adverse Event|0|||
125328112|NCT01746901|450835436|FG008|Naloxone Challenge Phase|Adverse Event|0|||
125328113|NCT01746901|450835428|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
125328114|NCT01746901|450835429|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
125328115|NCT01746901|450835430|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
125328116|NCT01746901|450835431|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
124996832|NCT03285178|449616008|FG003|Single-Blind Run-In Period|Physician Decision|0|||
124996833|NCT03285178|449616009|FG004|Single-Blind Run-In Period|Physician Decision|0|||
124996834|NCT03285178|449616010|FG005|Single-Blind Run-In Period|Physician Decision|0|||
124996835|NCT03285178|449616011|FG006|Single-Blind Run-In Period|Physician Decision|0|||
124996836|NCT03285178|449616005|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
124996837|NCT03285178|449616006|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
125328117|NCT01746901|450835432|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
125328118|NCT01746901|450835433|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
125328119|NCT01746901|450835434|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
125328120|NCT01746901|450835435|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
125328121|NCT01746901|450835436|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
125328122|NCT01746901|450835428|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125328123|NCT01746901|450835429|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
125328124|NCT01746901|450835430|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125328125|NCT01746901|450835431|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125328126|NCT01746901|450835432|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125328127|NCT01746901|450835433|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125328128|NCT01746901|450835434|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125328129|NCT01746901|450835435|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125328130|NCT01746901|450835436|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125328131|NCT01746901|450835428|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
125328132|NCT01746901|450835429|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
125328133|NCT01746901|450835430|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
125328134|NCT01746901|450835431|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
125328135|NCT01746901|450835432|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
125328136|NCT01746901|450835433|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
125328137|NCT01746901|450835434|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
125328138|NCT01746901|450835435|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
125328139|NCT01746901|450835436|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
125328140|NCT01746901|450835428|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
125328141|NCT01746901|450835429|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
125328142|NCT01746901|450835430|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
125328143|NCT01746901|450835431|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
125328144|NCT01746901|450835432|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
125328145|NCT01746901|450835433|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
125328146|NCT01746901|450835434|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
125328147|NCT01746901|450835435|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
125328148|NCT01746901|450835436|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
125328149|NCT01746901|450835428|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125328150|NCT01746901|450835429|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
125328151|NCT01746901|450835430|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
125328152|NCT01746901|450835431|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125328153|NCT01746901|450835432|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125328154|NCT01746901|450835433|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125328155|NCT01746901|450835434|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125328156|NCT01746901|450835435|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125328157|NCT01746901|450835436|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125328158|NCT01746901|450835428|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
125328159|NCT01746901|450835429|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
125328160|NCT01746901|450835430|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
125328161|NCT01746901|450835431|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
125328162|NCT01746901|450835432|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
125328163|NCT01746901|450835433|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
125328164|NCT01746901|450835434|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
125328165|NCT01746901|450835435|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
125328166|NCT01746901|450835436|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
125328167|NCT01746901|450835428|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125328168|NCT01746901|450835429|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125328169|NCT01746901|450835430|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125328170|NCT01746901|450835431|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125328171|NCT01746901|450835432|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125328172|NCT01746901|450835433|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125328173|NCT01746901|450835434|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125328174|NCT01746901|450835435|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
125328175|NCT01746901|450835436|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
124996838|NCT03285178|449616007|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
124996839|NCT03285178|449616008|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
124996840|NCT03285178|449616009|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
124996841|NCT03285178|449616010|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
124996842|NCT03285178|449616011|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
124996843|NCT03285178|449616005|FG000|Double-Blind Treatment Period|Adverse Event|0|||
124996844|NCT03285178|449616006|FG001|Double-Blind Treatment Period|Adverse Event|0|||
124996845|NCT03285178|449616007|FG002|Double-Blind Treatment Period|Adverse Event|0|||
124996846|NCT03285178|449616008|FG003|Double-Blind Treatment Period|Adverse Event|0|||
124996847|NCT03285178|449616009|FG004|Double-Blind Treatment Period|Adverse Event|0|||
124996848|NCT03285178|449616010|FG005|Double-Blind Treatment Period|Adverse Event|0|||
124996849|NCT03285178|449616011|FG006|Double-Blind Treatment Period|Adverse Event|2|||
124996850|NCT03285178|449616005|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
124996851|NCT03285178|449616006|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
124996852|NCT03285178|449616007|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
124996853|NCT03285178|449616008|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
124996854|NCT03285178|449616009|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
124996855|NCT03285178|449616010|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
124996856|NCT03285178|449616011|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
124996857|NCT03285178|449616005|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124996858|NCT03285178|449616006|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124996859|NCT03285178|449616007|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125328176|NCT01746901|450835428|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
125328177|NCT01746901|450835429|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
125328178|NCT01746901|450835430|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
125328179|NCT01746901|450835431|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
124996860|NCT03285178|449616008|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
124996861|NCT03285178|449616009|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124996862|NCT03285178|449616010|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
124996863|NCT03285178|449616011|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
124996864|NCT03285178|449616005|FG000|Double-Blind Treatment Period|COVID-19|0|||
124996865|NCT03285178|449616006|FG001|Double-Blind Treatment Period|COVID-19|0|||
124996866|NCT03285178|449616007|FG002|Double-Blind Treatment Period|COVID-19|1|||
124996867|NCT03285178|449616008|FG003|Double-Blind Treatment Period|COVID-19|0|||
124996868|NCT03285178|449616009|FG004|Double-Blind Treatment Period|COVID-19|0|||
124996869|NCT03285178|449616010|FG005|Double-Blind Treatment Period|COVID-19|0|||
124996870|NCT03285178|449616011|FG006|Double-Blind Treatment Period|COVID-19|0|||
124996871|NCT01388790|449616012|FG000|Overall Study|Ongoing at data cut-off date|8|||
124996872|NCT01128894|449616013|FG000|Overall Study|Adverse Event|31|||
124996873|NCT01128894|449616014|FG001|Overall Study|Adverse Event|41|||
124996874|NCT01128894|449616013|FG000|Overall Study|Protocol Violation|2|||
124996875|NCT01128894|449616014|FG001|Overall Study|Protocol Violation|1|||
124996876|NCT01128894|449616013|FG000|Overall Study|Noncompliance|4|||
124996877|NCT01128894|449616014|FG001|Overall Study|Noncompliance|5|||
124996878|NCT01128894|449616013|FG000|Overall Study|Lost to Follow-up|8|||
124996879|NCT01128894|449616014|FG001|Overall Study|Lost to Follow-up|8|||
124996880|NCT01128894|449616013|FG000|Overall Study|Withdrawal by Subject|10|||
124996881|NCT01128894|449616014|FG001|Overall Study|Withdrawal by Subject|12|||
124996882|NCT01128894|449616013|FG000|Overall Study|Physician Decision|2|||
124996883|NCT01128894|449616014|FG001|Overall Study|Physician Decision|1|||
124996884|NCT01128894|449616013|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
124996885|NCT01128894|449616014|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
124996886|NCT00195507|449616015|FG000|Overall Study|Adverse Event|24|||
124996887|NCT00195507|449616016|FG001|Overall Study|Adverse Event|13|||
124996888|NCT00195507|449616015|FG000|Overall Study|Death|0|||
124996889|NCT00195507|449616016|FG001|Overall Study|Death|1|||
124996890|NCT00195507|449616015|FG000|Overall Study|Failed to Return|4|||
124996891|NCT00195507|449616016|FG001|Overall Study|Failed to Return|3|||
124996892|NCT00195507|449616015|FG000|Overall Study|Physician Decision|1|||
124996893|NCT00195507|449616016|FG001|Overall Study|Physician Decision|2|||
124996894|NCT00195507|449616015|FG000|Overall Study|Lost to Follow-up|3|||
124996895|NCT00195507|449616016|FG001|Overall Study|Lost to Follow-up|2|||
124996896|NCT00195507|449616015|FG000|Overall Study|Protocol Violation|5|||
124996897|NCT00195507|449616016|FG001|Overall Study|Protocol Violation|4|||
124996898|NCT00195507|449616015|FG000|Overall Study|Lack of Efficacy|40|||
124996899|NCT00195507|449616016|FG001|Overall Study|Lack of Efficacy|67|||
124996900|NCT00195507|449616015|FG000|Overall Study|Withdrawal by Subject|16|||
124996901|NCT00195507|449616016|FG001|Overall Study|Withdrawal by Subject|23|||
125328180|NCT01746901|450835432|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
124996902|NCT00195507|449616015|FG000|Overall Study|Protocol Deviation|6|||
124996903|NCT00195507|449616016|FG001|Overall Study|Protocol Deviation|3|||
125328181|NCT01746901|450835433|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
125328182|NCT01746901|450835434|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
125328183|NCT01746901|450835435|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
125328184|NCT01746901|450835436|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
125328185|NCT01746901|450835428|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125328186|NCT01746901|450835429|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125328187|NCT01746901|450835430|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125328188|NCT01746901|450835431|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
124996904|NCT00973362|449616017|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
124996905|NCT00973362|449616018|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
124996906|NCT00973362|449616017|FG000|Baseline Evaluation|No colposcopy visit|62|||
125328189|NCT01746901|450835432|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125328190|NCT01746901|450835433|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125328191|NCT01746901|450835434|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125328192|NCT01746901|450835435|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125328193|NCT01746901|450835436|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125328194|NCT01746901|450835428|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
125328195|NCT01746901|450835429|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
125328196|NCT01746901|450835430|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
125328197|NCT01746901|450835431|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
125328198|NCT01746901|450835432|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
125328199|NCT01746901|450835433|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
125328200|NCT01746901|450835434|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
125328201|NCT01746901|450835435|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
125328202|NCT01746901|450835436|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
125328203|NCT01746901|450835428|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
125328204|NCT01746901|450835429|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
125328205|NCT01746901|450835430|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
124996907|NCT00973362|449616018|FG001|Baseline Evaluation|No colposcopy visit|0|||
124996908|NCT00973362|449616017|FG000|Baseline Evaluation|Inevaluable|686|||
124996909|NCT00973362|449616018|FG001|Baseline Evaluation|Inevaluable|223|||
124996910|NCT00973362|449616017|FG000|3-Year Follow-up|Lost to Follow-up|17|||
124996911|NCT00973362|449616018|FG001|3-Year Follow-up|Lost to Follow-up|0|||
124996912|NCT00887679|449616019|FG000|Overall Study|Withdrawal by Subject|1|||
124996913|NCT00887679|449616019|FG000|Overall Study|Lost to Follow-up|4|||
124996914|NCT00887679|449616019|FG000|Overall Study|Physician Decision|5|||
124996915|NCT01630434|449616026|FG000|Overall Study|Donor lungs turned down|1|||
124996916|NCT01630434|449616027|FG001|Overall Study|Donor lungs turned down|0|||
124996917|NCT01630434|449616026|FG000|Overall Study|Protocol Violation|9|||
124996918|NCT01630434|449616027|FG001|Overall Study|Protocol Violation|4|||
124996919|NCT01630434|449616026|FG000|Overall Study|Death|20|||
124996920|NCT01630434|449616027|FG001|Overall Study|Death|26|||
124996921|NCT02578862|449616028|FG000|Overall Study|Withdrawal by Subject|0|||
124996922|NCT02578862|449616029|FG001|Overall Study|Withdrawal by Subject|1|||
124996923|NCT02578862|449616028|FG000|Overall Study|Unplanned unilateral procedure|0|||
124996924|NCT02578862|449616029|FG001|Overall Study|Unplanned unilateral procedure|1|||
124996925|NCT01026454|449616030|FG000|Second Intervention|Pregnancy|1|||
124996926|NCT01026454|449616031|FG001|Second Intervention|Pregnancy|1|||
124996927|NCT01176773|449616032|FG000|Overall Study|Screen Failure|2|||
124996928|NCT01176773|449616032|FG000|Overall Study|Withdrew consent|1|||
124996929|NCT02196714|449616038|FG000|Overall Study|Protocol Violation|0|||
124996930|NCT02196714|449616039|FG001|Overall Study|Protocol Violation|0|||
124996931|NCT02196714|449616040|FG002|Overall Study|Protocol Violation|1|||
124996932|NCT02196714|449616041|FG003|Overall Study|Protocol Violation|0|||
124996933|NCT01592864|449616043|FG000|Overall Study|Withdrawal by Subject|0|||
124996934|NCT01592864|449616044|FG001|Overall Study|Withdrawal by Subject|1|||
124996935|NCT01881750|449616048|FG000|Overall Study|Changes in concomitant therapies|2|||
124996936|NCT01881750|449616049|FG001|Overall Study|Changes in concomitant therapies|3|||
124996937|NCT01881750|449616048|FG000|Overall Study|Lost to Follow-up|0|||
124996938|NCT01881750|449616049|FG001|Overall Study|Lost to Follow-up|1|||
124996939|NCT02804178|449616054|FG000|Overall Study|Adverse Event|1|||
124996940|NCT01106404|449616055|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
124996941|NCT01106404|449616056|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
124996942|NCT01106404|449616055|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
125328206|NCT01746901|450835431|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
124996943|NCT01106404|449616056|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
124996944|NCT01106404|449616055|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
124996945|NCT01106404|449616056|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
124996946|NCT01106404|449616055|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
124996947|NCT01106404|449616056|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
124996948|NCT01290601|449616057|FG000|Overall Study|Adverse Event|0|||
124996949|NCT01290601|449616058|FG001|Overall Study|Adverse Event|2|||
124996950|NCT01290601|449616059|FG002|Overall Study|Adverse Event|0|||
124996951|NCT01290601|449616060|FG003|Overall Study|Adverse Event|0|||
124996952|NCT01290601|449616057|FG000|Overall Study|Lack of Efficacy|2|||
124996953|NCT01290601|449616058|FG001|Overall Study|Lack of Efficacy|1|||
124996954|NCT01290601|449616059|FG002|Overall Study|Lack of Efficacy|0|||
124996955|NCT01290601|449616060|FG003|Overall Study|Lack of Efficacy|0|||
124996956|NCT01290601|449616057|FG000|Overall Study|Lost to Follow-up|7|||
124996957|NCT01290601|449616058|FG001|Overall Study|Lost to Follow-up|2|||
124996958|NCT01290601|449616059|FG002|Overall Study|Lost to Follow-up|0|||
124996959|NCT01290601|449616060|FG003|Overall Study|Lost to Follow-up|0|||
124996960|NCT01290601|449616057|FG000|Overall Study|Other|1|||
124996961|NCT01290601|449616058|FG001|Overall Study|Other|0|||
124996962|NCT01290601|449616059|FG002|Overall Study|Other|0|||
124996963|NCT01290601|449616060|FG003|Overall Study|Other|0|||
124996964|NCT01290601|449616057|FG000|Overall Study|Protocol Violation|1|||
124996965|NCT01290601|449616058|FG001|Overall Study|Protocol Violation|0|||
124996966|NCT01290601|449616059|FG002|Overall Study|Protocol Violation|0|||
124996967|NCT01290601|449616060|FG003|Overall Study|Protocol Violation|0|||
124996968|NCT00775450|449616061|FG000|Overall Study|Serious Adverse Event|2|||
124996969|NCT00775450|449616062|FG001|Overall Study|Serious Adverse Event|0|||
124996970|NCT00775450|449616063|FG002|Overall Study|Serious Adverse Event|0|||
124996971|NCT00775450|449616064|FG003|Overall Study|Serious Adverse Event|0|||
124996972|NCT00775450|449616065|FG004|Overall Study|Serious Adverse Event|0|||
124996973|NCT00775450|449616061|FG000|Overall Study|Protocol Violation|0|||
124996974|NCT00775450|449616062|FG001|Overall Study|Protocol Violation|0|||
124996975|NCT00775450|449616063|FG002|Overall Study|Protocol Violation|0|||
124996976|NCT00775450|449616064|FG003|Overall Study|Protocol Violation|0|||
124996977|NCT00775450|449616065|FG004|Overall Study|Protocol Violation|1|||
124996978|NCT00775450|449616061|FG000|Overall Study|Withdrawal by Subject|1|||
124996979|NCT00775450|449616062|FG001|Overall Study|Withdrawal by Subject|0|||
124996980|NCT00775450|449616063|FG002|Overall Study|Withdrawal by Subject|0|||
124996981|NCT00775450|449616064|FG003|Overall Study|Withdrawal by Subject|0|||
124996982|NCT00775450|449616065|FG004|Overall Study|Withdrawal by Subject|1|||
124996983|NCT01749540|449616072|FG000|Overall Study|Protocol Violation|0|||
124996984|NCT01749540|449616073|FG001|Overall Study|Protocol Violation|0|||
124996985|NCT01749540|449616074|FG002|Overall Study|Protocol Violation|0|||
124996986|NCT01749540|449616075|FG003|Overall Study|Protocol Violation|0|||
124996987|NCT01749540|449616076|FG004|Overall Study|Protocol Violation|0|||
124996988|NCT01749540|449616077|FG005|Overall Study|Protocol Violation|1|||
124996989|NCT01749540|449616078|FG006|Overall Study|Protocol Violation|1|||
124996990|NCT01749540|449616072|FG000|Overall Study|Withdrawal by Subject|0|||
124996991|NCT01749540|449616073|FG001|Overall Study|Withdrawal by Subject|0|||
124996992|NCT01749540|449616074|FG002|Overall Study|Withdrawal by Subject|0|||
124996993|NCT01749540|449616075|FG003|Overall Study|Withdrawal by Subject|1|||
124996994|NCT01749540|449616076|FG004|Overall Study|Withdrawal by Subject|0|||
124996995|NCT01749540|449616077|FG005|Overall Study|Withdrawal by Subject|0|||
124996996|NCT01749540|449616078|FG006|Overall Study|Withdrawal by Subject|0|||
124996997|NCT01749540|449616072|FG000|Overall Study|Initiated into extension study A536-06|0|||
124996998|NCT01749540|449616073|FG001|Overall Study|Initiated into extension study A536-06|0|||
124996999|NCT01749540|449616074|FG002|Overall Study|Initiated into extension study A536-06|0|||
124997000|NCT01749540|449616075|FG003|Overall Study|Initiated into extension study A536-06|0|||
124997001|NCT01749540|449616076|FG004|Overall Study|Initiated into extension study A536-06|0|||
124997002|NCT01749540|449616077|FG005|Overall Study|Initiated into extension study A536-06|2|||
124997003|NCT01749540|449616078|FG006|Overall Study|Initiated into extension study A536-06|24|||
124997004|NCT00954421|449616079|FG000|Screening|screen failures|3|||
124997005|NCT00954421|449616079|FG000|6 Months of DBS|Withdrawal by Subject|1|||
125328207|NCT01746901|450835432|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
125328208|NCT01746901|450835433|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
125328209|NCT01746901|450835434|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
125328210|NCT01746901|450835435|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
125328211|NCT01746901|450835436|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
125328212|NCT02968004|450835440|FG000|Main Study Phase|Adverse Event|1|||
124997006|NCT00954421|449616079|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
124997007|NCT00633061|449616080|FG000|Overall Study|Study closed|86|||
124997008|NCT00633061|449616081|FG001|Overall Study|Study closed|0|||
124997009|NCT05245097|449616082|FG000|Overall Study|Adverse Event|13|||
125328213|NCT02968004|450835441|FG001|Main Study Phase|Adverse Event|0|||
124997010|NCT05245097|449616083|FG001|Overall Study|Adverse Event|2|||
124997011|NCT05245097|449616082|FG000|Overall Study|Protocol Violation|8|||
124997012|NCT05245097|449616083|FG001|Overall Study|Protocol Violation|6|||
124997013|NCT05245097|449616082|FG000|Overall Study|Withdrawal by Subject|18|||
124997014|NCT05245097|449616083|FG001|Overall Study|Withdrawal by Subject|0|||
124997015|NCT05245097|449616082|FG000|Overall Study|Death|6|||
124997016|NCT05245097|449616083|FG001|Overall Study|Death|7|||
124997017|NCT05245097|449616082|FG000|Overall Study|Physician Decision|6|||
124997018|NCT05245097|449616083|FG001|Overall Study|Physician Decision|0|||
124997019|NCT05245097|449616082|FG000|Overall Study|Relocation|4|||
125328214|NCT02968004|450835440|FG000|Main Study Phase|Withdrawal by Subject|0|||
125328215|NCT02968004|450835441|FG001|Main Study Phase|Withdrawal by Subject|1|||
125328216|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
125328217|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
125328218|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
125328219|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
125328220|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
125328221|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
125328222|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
125328223|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
125328224|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
125328225|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
125328226|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
125328227|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
125328228|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
125328229|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
125328230|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
125328231|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
125328232|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
125328233|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
125328234|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
125328235|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
125328236|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
125328237|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
125328238|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
125328239|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
125328240|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
125328241|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
125328242|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
125328243|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
125328244|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
125328245|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
125328246|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
125328247|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
125328248|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
125328249|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
125328250|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
125328251|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
125328252|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
125328253|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
125328254|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
125328255|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
125328256|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
125328257|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
125328258|NCT05029362|450835442|FG000|Overall Study|Lost to Follow-up|9|||
125328259|NCT00419952|450835445|FG000|Overall Study|Adverse Event|8|||
125328260|NCT00419952|450835446|FG001|Overall Study|Adverse Event|10|||
125328261|NCT00419952|450835445|FG000|Overall Study|Withdrawal by Subject|44|||
125328262|NCT00419952|450835446|FG001|Overall Study|Withdrawal by Subject|43|||
125328263|NCT00419952|450835445|FG000|Overall Study|Lost to Follow-up|43|||
125328264|NCT00419952|450835446|FG001|Overall Study|Lost to Follow-up|34|||
125328265|NCT00419952|450835445|FG000|Overall Study|Protocol Violation|32|||
125328266|NCT00419952|450835446|FG001|Overall Study|Protocol Violation|24|||
125328267|NCT00419952|450835445|FG000|Overall Study|Pregnancy|4|||
125328268|NCT00419952|450835446|FG001|Overall Study|Pregnancy|2|||
125328269|NCT00419952|450835445|FG000|Overall Study|Physician Decision|1|||
125328270|NCT00419952|450835446|FG001|Overall Study|Physician Decision|3|||
125328271|NCT00419952|450835445|FG000|Overall Study|Incorrectly enrolled|10|||
125328272|NCT00419952|450835446|FG001|Overall Study|Incorrectly enrolled|3|||
125328273|NCT00419952|450835445|FG000|Overall Study|Intake of prohibited medication|2|||
125328274|NCT00419952|450835446|FG001|Overall Study|Intake of prohibited medication|2|||
125328275|NCT00419952|450835445|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
125328276|NCT00419952|450835446|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
125328277|NCT00419952|450835445|FG000|Overall Study|Diary or medication non-compliance|2|||
125328278|NCT00419952|450835446|FG001|Overall Study|Diary or medication non-compliance|4|||
125328279|NCT00419952|450835445|FG000|Overall Study|Abnormal ECG|1|||
125328280|NCT00419952|450835446|FG001|Overall Study|Abnormal ECG|0|||
125328281|NCT03126591|450835447|FG000|Overall Study|Death|6|||
125328282|NCT03126591|450835448|FG001|Overall Study|Death|3|||
125328283|NCT03126591|450835449|FG002|Overall Study|Death|17|||
124997020|NCT05245097|449616083|FG001|Overall Study|Relocation|3|||
124997021|NCT00607022|449616089|FG000|Overall Study|Withdrawal by Subject|1|||
124997022|NCT00607022|449616090|FG001|Overall Study|Withdrawal by Subject|0|||
124997023|NCT00607022|449616091|FG002|Overall Study|Withdrawal by Subject|0|||
125328284|NCT03126591|450835447|FG000|Overall Study|Progressive Disease|0|||
125328285|NCT03126591|450835448|FG001|Overall Study|Progressive Disease|1|||
125328286|NCT03126591|450835449|FG002|Overall Study|Progressive Disease|2|||
125328287|NCT03126591|450835447|FG000|Overall Study|Terminated by Sponsor|0|||
125328288|NCT03126591|450835448|FG001|Overall Study|Terminated by Sponsor|1|||
125328289|NCT03126591|450835449|FG002|Overall Study|Terminated by Sponsor|4|||
125328290|NCT03126591|450835447|FG000|Overall Study|Withdrawal by Subject|1|||
125328291|NCT03126591|450835448|FG001|Overall Study|Withdrawal by Subject|1|||
125328292|NCT03126591|450835449|FG002|Overall Study|Withdrawal by Subject|4|||
125328293|NCT02158546|450835450|FG000|Overall Study|Physician Decision|0|||
125328294|NCT02158546|450835451|FG001|Overall Study|Physician Decision|1|||
125328295|NCT02158546|450835452|FG002|Overall Study|Physician Decision|0|||
125328296|NCT02158546|450835453|FG003|Overall Study|Physician Decision|0|||
125328297|NCT02158546|450835450|FG000|Overall Study|Non-compliance|0|||
125328298|NCT02158546|450835451|FG001|Overall Study|Non-compliance|1|||
125328299|NCT02158546|450835452|FG002|Overall Study|Non-compliance|0|||
125328300|NCT02158546|450835453|FG003|Overall Study|Non-compliance|1|||
125328301|NCT02158546|450835450|FG000|Overall Study|Failure to meet eligibility criteria|0|||
125328302|NCT02158546|450835451|FG001|Overall Study|Failure to meet eligibility criteria|1|||
125328303|NCT02158546|450835452|FG002|Overall Study|Failure to meet eligibility criteria|0|||
125328304|NCT02158546|450835453|FG003|Overall Study|Failure to meet eligibility criteria|0|||
125328305|NCT02158546|450835450|FG000|Overall Study|Lack of Efficacy|1|||
125328306|NCT02158546|450835451|FG001|Overall Study|Lack of Efficacy|1|||
125328307|NCT02158546|450835452|FG002|Overall Study|Lack of Efficacy|0|||
125328308|NCT02158546|450835453|FG003|Overall Study|Lack of Efficacy|0|||
125328309|NCT02158546|450835450|FG000|Overall Study|Adverse Event|2|||
125328310|NCT02158546|450835451|FG001|Overall Study|Adverse Event|2|||
125328311|NCT02158546|450835452|FG002|Overall Study|Adverse Event|0|||
125328312|NCT02158546|450835453|FG003|Overall Study|Adverse Event|0|||
125328313|NCT02158546|450835450|FG000|Overall Study|Withdrawal by Subject|6|||
125328314|NCT02158546|450835451|FG001|Overall Study|Withdrawal by Subject|2|||
125328315|NCT02158546|450835452|FG002|Overall Study|Withdrawal by Subject|1|||
125328316|NCT02158546|450835453|FG003|Overall Study|Withdrawal by Subject|0|||
125328317|NCT02158546|450835450|FG000|Overall Study|Lost to Follow-up|5|||
125328318|NCT02158546|450835451|FG001|Overall Study|Lost to Follow-up|4|||
125328319|NCT02158546|450835452|FG002|Overall Study|Lost to Follow-up|0|||
125328320|NCT02158546|450835453|FG003|Overall Study|Lost to Follow-up|1|||
125328321|NCT02158546|450835450|FG000|Overall Study|Site Excluded|5|||
125328322|NCT02158546|450835451|FG001|Overall Study|Site Excluded|5|||
125328323|NCT02158546|450835452|FG002|Overall Study|Site Excluded|3|||
125328324|NCT02158546|450835453|FG003|Overall Study|Site Excluded|4|||
125328325|NCT02900378|450835454|FG000|Randomization (Visit 2)|Adverse Event|14|||
125328326|NCT02900378|450835455|FG001|Randomization (Visit 2)|Adverse Event|11|||
125328327|NCT02900378|450835454|FG000|Randomization (Visit 2)|Death|1|||
125328328|NCT02900378|450835455|FG001|Randomization (Visit 2)|Death|4|||
125328329|NCT02900378|450835454|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
125328330|NCT02900378|450835455|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
125328331|NCT02900378|450835454|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
125328332|NCT02900378|450835455|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
125328333|NCT02900378|450835454|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
125328334|NCT02900378|450835455|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
125328335|NCT02900378|450835454|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
125328336|NCT02900378|450835455|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
125328337|NCT02900378|450835454|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
125328338|NCT02900378|450835455|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
125328339|NCT02531802|450835457|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
125328340|NCT02531802|450835458|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
125328341|NCT02531802|450835459|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
125328342|NCT02531802|450835460|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
125328343|NCT02531802|450835461|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
125328344|NCT02531802|450835462|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
125328345|NCT02531802|450835463|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
125328346|NCT02531802|450835464|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
125328347|NCT02531802|450835465|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
125328348|NCT02531802|450835466|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
125328349|NCT02531802|450835467|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
125328350|NCT02531802|450835468|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
125328351|NCT02531802|450835469|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
124997024|NCT03254485|449616094|FG000|Overall Study|Adverse Event|3|||
125328352|NCT02531802|450835470|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
125328353|NCT02531802|450835471|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
125328354|NCT02531802|450835472|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
125328355|NCT02531802|450835473|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
125328356|NCT02531802|450835474|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
125328357|NCT02531802|450835475|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
125328358|NCT02531802|450835476|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
125328359|NCT02531802|450835477|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
125328360|NCT02531802|450835457|FG000|Received Vaccination 2|Physician Decision|0|||
125328361|NCT02531802|450835458|FG001|Received Vaccination 2|Physician Decision|0|||
125328362|NCT02531802|450835459|FG002|Received Vaccination 2|Physician Decision|0|||
125328363|NCT02531802|450835460|FG003|Received Vaccination 2|Physician Decision|0|||
125328364|NCT02531802|450835461|FG004|Received Vaccination 2|Physician Decision|0|||
125328365|NCT02531802|450835462|FG005|Received Vaccination 2|Physician Decision|1|||
125328366|NCT02531802|450835463|FG006|Received Vaccination 2|Physician Decision|0|||
125328367|NCT02531802|450835464|FG007|Received Vaccination 2|Physician Decision|0|||
125328368|NCT02531802|450835465|FG008|Received Vaccination 2|Physician Decision|0|||
125328369|NCT02531802|450835466|FG009|Received Vaccination 2|Physician Decision|2|||
125328370|NCT02531802|450835467|FG010|Received Vaccination 2|Physician Decision|0|||
125328371|NCT02531802|450835468|FG011|Received Vaccination 2|Physician Decision|0|||
125328372|NCT02531802|450835469|FG012|Received Vaccination 2|Physician Decision|0|||
125328373|NCT02531802|450835470|FG013|Received Vaccination 2|Physician Decision|1|||
125328374|NCT02531802|450835471|FG014|Received Vaccination 2|Physician Decision|0|||
125328375|NCT02531802|450835472|FG015|Received Vaccination 2|Physician Decision|0|||
125328376|NCT02531802|450835473|FG016|Received Vaccination 2|Physician Decision|0|||
125328377|NCT02531802|450835474|FG017|Received Vaccination 2|Physician Decision|1|||
125328378|NCT02531802|450835475|FG018|Received Vaccination 2|Physician Decision|0|||
125328379|NCT02531802|450835476|FG019|Received Vaccination 2|Physician Decision|0|||
125328380|NCT02531802|450835477|FG020|Received Vaccination 2|Physician Decision|0|||
125328381|NCT02531802|450835457|FG000|Received Vaccination 2|Adverse Event|0|||
125328382|NCT02531802|450835458|FG001|Received Vaccination 2|Adverse Event|0|||
125328383|NCT02531802|450835459|FG002|Received Vaccination 2|Adverse Event|0|||
125328384|NCT02531802|450835460|FG003|Received Vaccination 2|Adverse Event|0|||
125328385|NCT02531802|450835461|FG004|Received Vaccination 2|Adverse Event|0|||
125328386|NCT02531802|450835462|FG005|Received Vaccination 2|Adverse Event|2|||
125328387|NCT02531802|450835463|FG006|Received Vaccination 2|Adverse Event|0|||
125328388|NCT02531802|450835464|FG007|Received Vaccination 2|Adverse Event|0|||
125328389|NCT02531802|450835465|FG008|Received Vaccination 2|Adverse Event|0|||
125328390|NCT02531802|450835466|FG009|Received Vaccination 2|Adverse Event|0|||
125328391|NCT02531802|450835467|FG010|Received Vaccination 2|Adverse Event|0|||
125328392|NCT02531802|450835468|FG011|Received Vaccination 2|Adverse Event|0|||
125328393|NCT02531802|450835469|FG012|Received Vaccination 2|Adverse Event|0|||
125328394|NCT02531802|450835470|FG013|Received Vaccination 2|Adverse Event|0|||
125328395|NCT02531802|450835471|FG014|Received Vaccination 2|Adverse Event|0|||
125328396|NCT02531802|450835472|FG015|Received Vaccination 2|Adverse Event|0|||
125328397|NCT02531802|450835473|FG016|Received Vaccination 2|Adverse Event|0|||
125328398|NCT02531802|450835474|FG017|Received Vaccination 2|Adverse Event|2|||
125328399|NCT02531802|450835475|FG018|Received Vaccination 2|Adverse Event|1|||
125328400|NCT02531802|450835476|FG019|Received Vaccination 2|Adverse Event|0|||
125328401|NCT02531802|450835477|FG020|Received Vaccination 2|Adverse Event|1|||
125328402|NCT02531802|450835457|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
125328403|NCT02531802|450835458|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
125328404|NCT02531802|450835459|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
125328405|NCT02531802|450835460|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
125328406|NCT02531802|450835461|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
125328407|NCT02531802|450835462|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
125328408|NCT02531802|450835463|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
125328409|NCT02531802|450835464|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
125328410|NCT02531802|450835465|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
125328411|NCT02531802|450835466|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
124997025|NCT03254485|449616095|FG001|Overall Study|Adverse Event|0|||
124997026|NCT03254485|449616096|FG002|Overall Study|Adverse Event|0|||
124997027|NCT03254485|449616097|FG003|Overall Study|Adverse Event|6|||
124997028|NCT03254485|449616094|FG000|Overall Study|Protocol Violation|6|||
125328412|NCT02531802|450835467|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
125328413|NCT02531802|450835468|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
125328414|NCT02531802|450835469|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
125328415|NCT02531802|450835470|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
125328416|NCT02531802|450835471|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
125328417|NCT02531802|450835472|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
124997029|NCT03254485|449616095|FG001|Overall Study|Protocol Violation|0|||
124997030|NCT03254485|449616096|FG002|Overall Study|Protocol Violation|0|||
124997031|NCT03254485|449616097|FG003|Overall Study|Protocol Violation|2|||
124997032|NCT03254485|449616094|FG000|Overall Study|Withdrawal by Subject|1|||
124997033|NCT03254485|449616095|FG001|Overall Study|Withdrawal by Subject|0|||
124997034|NCT03254485|449616096|FG002|Overall Study|Withdrawal by Subject|0|||
124997035|NCT03254485|449616097|FG003|Overall Study|Withdrawal by Subject|4|||
124997036|NCT03254485|449616094|FG000|Overall Study|Death|0|||
124997037|NCT03254485|449616095|FG001|Overall Study|Death|0|||
124997038|NCT03254485|449616096|FG002|Overall Study|Death|0|||
124997039|NCT03254485|449616097|FG003|Overall Study|Death|1|||
124997040|NCT03254485|449616094|FG000|Overall Study|Lost to Follow-up|1|||
124997041|NCT03254485|449616095|FG001|Overall Study|Lost to Follow-up|0|||
124997042|NCT03254485|449616096|FG002|Overall Study|Lost to Follow-up|0|||
124997043|NCT03254485|449616097|FG003|Overall Study|Lost to Follow-up|0|||
124997044|NCT03254485|449616094|FG000|Overall Study|Other|1|||
124997045|NCT03254485|449616095|FG001|Overall Study|Other|0|||
124997046|NCT03254485|449616096|FG002|Overall Study|Other|0|||
124997047|NCT03254485|449616097|FG003|Overall Study|Other|2|||
124997048|NCT00467285|449616098|FG000|Overall Study|Lost to Follow-up|4|||
124997049|NCT00467285|449616099|FG001|Overall Study|Lost to Follow-up|4|||
124997050|NCT00777946|449616100|FG000|Overall Study|Adverse Event|11|||
124997051|NCT00777946|449616101|FG001|Overall Study|Adverse Event|1|||
124997052|NCT00777946|449616102|FG002|Overall Study|Adverse Event|3|||
124997053|NCT00777946|449616100|FG000|Overall Study|Lack of Efficacy|0|||
124997054|NCT00777946|449616101|FG001|Overall Study|Lack of Efficacy|0|||
124997055|NCT00777946|449616102|FG002|Overall Study|Lack of Efficacy|9|||
124997056|NCT00777946|449616100|FG000|Overall Study|Condition no longer required study drug|1|||
124997057|NCT00777946|449616101|FG001|Overall Study|Condition no longer required study drug|0|||
124997058|NCT00777946|449616102|FG002|Overall Study|Condition no longer required study drug|0|||
124997059|NCT00777946|449616100|FG000|Overall Study|Patient withdrew consent|3|||
124997060|NCT00777946|449616101|FG001|Overall Study|Patient withdrew consent|2|||
124997061|NCT00777946|449616102|FG002|Overall Study|Patient withdrew consent|3|||
124997062|NCT00777946|449616100|FG000|Overall Study|Lost to Follow-up|3|||
124997063|NCT00777946|449616101|FG001|Overall Study|Lost to Follow-up|1|||
124997064|NCT00777946|449616102|FG002|Overall Study|Lost to Follow-up|0|||
124997065|NCT00777946|449616100|FG000|Overall Study|Protocol deviation|2|||
124997066|NCT00777946|449616101|FG001|Overall Study|Protocol deviation|1|||
124997067|NCT00777946|449616102|FG002|Overall Study|Protocol deviation|1|||
124997068|NCT00777946|449616100|FG000|Overall Study|Randomized in error|1|||
124997069|NCT00777946|449616101|FG001|Overall Study|Randomized in error|1|||
124997070|NCT00777946|449616102|FG002|Overall Study|Randomized in error|0|||
124997071|NCT04675151|449616103|FG000|Overall Study|Protocol Violation|1|||
124997072|NCT04675151|449616104|FG001|Overall Study|Protocol Violation|0|||
124997073|NCT04675151|449616105|FG002|Overall Study|Protocol Violation|0|||
124997074|NCT04675151|449616106|FG003|Overall Study|Protocol Violation|1|||
124997075|NCT01658826|449616110|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
124997076|NCT01658826|449616111|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
124997077|NCT01658826|449616110|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
124997078|NCT01658826|449616111|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
125328418|NCT02531802|450835473|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
125328419|NCT02531802|450835474|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
125328420|NCT02531802|450835475|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
125328421|NCT02531802|450835476|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
125328422|NCT02531802|450835477|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
125328423|NCT01249261|450835483|FG000|Overall Study|Withdrawal by Subject|1|||
125328424|NCT01249261|450835484|FG001|Overall Study|Withdrawal by Subject|0|||
125328425|NCT02819804|450835485|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
125328426|NCT00482053|450835489|FG000|Inter-treatment Period|Disease progression|1|||
125328427|NCT00346697|450835492|FG000|Overall Study|Lost to Follow-up|0|||
125328428|NCT00346697|450835493|FG001|Overall Study|Lost to Follow-up|1|||
125328429|NCT01055197|450835495|FG000|Overall Study|Protocol Violation|7|||
125328430|NCT01055197|450835496|FG001|Overall Study|Protocol Violation|2|||
125328431|NCT01055197|450835495|FG000|Overall Study|Withdrawal by Subject|2|||
125328432|NCT01055197|450835496|FG001|Overall Study|Withdrawal by Subject|0|||
125328433|NCT03739203|450835497|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
125328434|NCT03739203|450835498|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
124997079|NCT01658826|449616110|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
124997080|NCT01658826|449616111|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
124997081|NCT01658826|449616110|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
124997082|NCT01658826|449616111|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
124997083|NCT01658826|449616110|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
124997084|NCT01658826|449616111|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
124997085|NCT01658826|449616110|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
125328435|NCT03739203|450835499|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
125328436|NCT03739203|450835497|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
125328437|NCT03739203|450835498|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
125328438|NCT03739203|450835499|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
125328439|NCT03739203|450835497|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
125328440|NCT03739203|450835498|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
125328441|NCT03739203|450835499|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
125328442|NCT03739203|450835497|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
125328443|NCT03739203|450835498|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
125328444|NCT03739203|450835499|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
125328445|NCT03739203|450835497|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
125328446|NCT03739203|450835498|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
125328447|NCT03739203|450835499|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
125328448|NCT03739203|450835497|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
125328449|NCT03739203|450835498|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
125328450|NCT03739203|450835499|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
125328451|NCT03739203|450835497|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
125328452|NCT03739203|450835498|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
125328453|NCT03739203|450835499|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
125328454|NCT03739203|450835497|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
125328455|NCT03739203|450835498|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
125328456|NCT03739203|450835499|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
125328457|NCT03739203|450835497|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
125328458|NCT03739203|450835498|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
125328459|NCT03739203|450835499|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
125328460|NCT03739203|450835497|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
125328461|NCT03739203|450835498|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
125328462|NCT03739203|450835499|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
125328463|NCT03739203|450835497|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
125328464|NCT03739203|450835498|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
125328465|NCT03739203|450835499|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
125328466|NCT03131570|450835500|FG000|Overall Study|Adverse Event|1|||
125328467|NCT03131570|450835501|FG001|Overall Study|Adverse Event|0|||
125328468|NCT01782378|450835502|FG000|First Series|Lost to Follow-up|7|||
125328469|NCT01782378|450835503|FG001|First Series|Lost to Follow-up|8|||
125328470|NCT01782378|450835502|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
124997086|NCT01658826|449616111|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
124997087|NCT01658826|449616110|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
124997088|NCT01658826|449616111|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
124997089|NCT01658826|449616110|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
124997090|NCT01658826|449616111|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
124997091|NCT01658826|449616110|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
124997092|NCT01658826|449616111|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
124997093|NCT01598311|449616114|FG000|Overall Study|Physician Decision|4|||
124997094|NCT01598311|449616115|FG001|Overall Study|Physician Decision|5|||
124997095|NCT01598311|449616114|FG000|Overall Study|Adverse Event|9|||
124997096|NCT01598311|449616115|FG001|Overall Study|Adverse Event|13|||
124997097|NCT01598311|449616114|FG000|Overall Study|Lost to Follow-up|7|||
124997098|NCT01598311|449616115|FG001|Overall Study|Lost to Follow-up|12|||
124997099|NCT01598311|449616114|FG000|Overall Study|Withdrawal by Subject|9|||
124997100|NCT01598311|449616115|FG001|Overall Study|Withdrawal by Subject|13|||
124997101|NCT01598311|449616114|FG000|Overall Study|No reason provided.|0|||
124997102|NCT01598311|449616115|FG001|Overall Study|No reason provided.|5|||
124997103|NCT01598311|449616114|FG000|Overall Study|Randomized but never treated|8|||
124997104|NCT01598311|449616115|FG001|Overall Study|Randomized but never treated|5|||
124997105|NCT01598311|449616114|FG000|Overall Study|Treated but no confirmed CDAD|9|||
124997106|NCT01598311|449616115|FG001|Overall Study|Treated but no confirmed CDAD|8|||
124997107|NCT01598311|449616114|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
124997108|NCT01598311|449616115|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
124997109|NCT00658684|449616116|FG000|Overall Study|Adverse Event|10|||
124997110|NCT00658684|449616117|FG001|Overall Study|Adverse Event|8|||
124997111|NCT00658684|449616118|FG002|Overall Study|Adverse Event|2|||
124997112|NCT00658684|449616119|FG003|Overall Study|Adverse Event|0|||
124997113|NCT00658684|449616116|FG000|Overall Study|Withdrawal by Subject|6|||
124997114|NCT00658684|449616117|FG001|Overall Study|Withdrawal by Subject|4|||
124997115|NCT00658684|449616118|FG002|Overall Study|Withdrawal by Subject|1|||
124997116|NCT00658684|449616119|FG003|Overall Study|Withdrawal by Subject|1|||
124997117|NCT00658684|449616116|FG000|Overall Study|Lack of Efficacy|1|||
124997118|NCT00658684|449616117|FG001|Overall Study|Lack of Efficacy|1|||
124997119|NCT00658684|449616118|FG002|Overall Study|Lack of Efficacy|0|||
125328471|NCT01782378|450835503|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
125328472|NCT01782378|450835502|FG000|Second Series|Lost to Follow-up|8|||
125328473|NCT01782378|450835503|FG001|Second Series|Lost to Follow-up|7|||
125328474|NCT01782378|450835502|FG000|Second Series|Did not choose to complete S2 Optional|18|||
124997120|NCT00658684|449616119|FG003|Overall Study|Lack of Efficacy|0|||
124997121|NCT00658684|449616116|FG000|Overall Study|Protocol Violation|1|||
124997122|NCT00658684|449616117|FG001|Overall Study|Protocol Violation|1|||
124997123|NCT00658684|449616118|FG002|Overall Study|Protocol Violation|0|||
124997124|NCT00658684|449616119|FG003|Overall Study|Protocol Violation|0|||
124997125|NCT00658684|449616116|FG000|Overall Study|Pregnancy|1|||
124997126|NCT00658684|449616117|FG001|Overall Study|Pregnancy|1|||
124997127|NCT00658684|449616118|FG002|Overall Study|Pregnancy|0|||
124997128|NCT00658684|449616119|FG003|Overall Study|Pregnancy|0|||
124997129|NCT00688103|449616120|FG000|Overall Study|Adverse Event|4|||
124997130|NCT00688103|449616121|FG001|Overall Study|Adverse Event|1|||
124997131|NCT00688103|449616120|FG000|Overall Study|Lack of Efficacy|11|||
124997132|NCT00688103|449616121|FG001|Overall Study|Lack of Efficacy|1|||
124997133|NCT00688103|449616120|FG000|Overall Study|Withdrawal by Subject|4|||
124997134|NCT00688103|449616121|FG001|Overall Study|Withdrawal by Subject|2|||
124997135|NCT00688103|449616120|FG000|Overall Study|complex reasons|11|||
124997136|NCT00688103|449616121|FG001|Overall Study|complex reasons|9|||
124997137|NCT03602261|449616124|FG000|Overall Study|Adverse Event|5|||
124997138|NCT03602261|449616125|FG001|Overall Study|Adverse Event|1|||
124997139|NCT03602261|449616124|FG000|Overall Study|Physician Decision|1|||
124997140|NCT03602261|449616125|FG001|Overall Study|Physician Decision|0|||
124997141|NCT03602261|449616124|FG000|Overall Study|Withdrawal by Subject|1|||
124997142|NCT03602261|449616125|FG001|Overall Study|Withdrawal by Subject|1|||
124997143|NCT03602261|449616124|FG000|Overall Study|Lack of Efficacy|0|||
124997144|NCT03602261|449616125|FG001|Overall Study|Lack of Efficacy|1|||
124997145|NCT03602261|449616124|FG000|Overall Study|Subject moving out of state|1|||
125328475|NCT01782378|450835503|FG001|Second Series|Did not choose to complete S2 Optional|0|||
125328476|NCT00830440|450835504|FG000|Overall Study|Protocol Violation|1|||
125328477|NCT00830440|450835505|FG001|Overall Study|Protocol Violation|0|||
125328478|NCT00830440|450835504|FG000|Overall Study|Withdrawal by Subject|1|||
125328479|NCT00830440|450835505|FG001|Overall Study|Withdrawal by Subject|0|||
125328480|NCT00830440|450835504|FG000|Overall Study|unsuccessful procedure|4|||
125328481|NCT00830440|450835505|FG001|Overall Study|unsuccessful procedure|0|||
125328482|NCT00830440|450835504|FG000|Overall Study|Adverse Event|2|||
125328483|NCT00830440|450835505|FG001|Overall Study|Adverse Event|0|||
125328484|NCT00391586|450835508|FG000|Overall Study|Progressive disease|13|||
125328485|NCT00391586|450835508|FG000|Overall Study|Adverse Event|5|||
125328486|NCT00391586|450835508|FG000|Overall Study|Physician Decision|2|||
125328487|NCT00391586|450835508|FG000|Overall Study|Death|4|||
125328488|NCT00904982|450835509|FG000|Overall Study|Withdrawal by Subject|2|||
125328489|NCT00904982|450835510|FG001|Overall Study|Withdrawal by Subject|0|||
125328490|NCT00904982|450835511|FG002|Overall Study|Withdrawal by Subject|0|||
125328491|NCT00904982|450835512|FG003|Overall Study|Withdrawal by Subject|0|||
125328492|NCT02420821|450835517|FG000|Overall Study|Lost to Follow-up|6|||
125328493|NCT02420821|450835518|FG001|Overall Study|Lost to Follow-up|6|||
125328494|NCT02420821|450835517|FG000|Overall Study|Non-compliance|0|||
125328495|NCT02420821|450835518|FG001|Overall Study|Non-compliance|2|||
125328496|NCT02420821|450835517|FG000|Overall Study|Physician Decision|6|||
125328497|NCT02420821|450835518|FG001|Overall Study|Physician Decision|2|||
125328498|NCT02420821|450835517|FG000|Overall Study|Withdrawal by Subject|32|||
125328499|NCT02420821|450835518|FG001|Overall Study|Withdrawal by Subject|25|||
125328500|NCT02420821|450835517|FG000|Overall Study|Death|270|||
125328501|NCT02420821|450835518|FG001|Overall Study|Death|263|||
125328502|NCT02420821|450835517|FG000|Overall Study|Study Terminated By Sponsor|145|||
125328503|NCT02420821|450835518|FG001|Overall Study|Study Terminated By Sponsor|149|||
125328504|NCT02420821|450835517|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
125328505|NCT02420821|450835518|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
125328506|NCT02420821|450835517|FG000|Overall Study|Adverse Event|0|||
125328507|NCT02420821|450835518|FG001|Overall Study|Adverse Event|1|||
124997146|NCT03602261|449616125|FG001|Overall Study|Subject moving out of state|0|||
124997147|NCT05677893|449617643|FG000|Overall Study|Withdrawal by Subject|0|||
125328508|NCT02420821|450835517|FG000|Overall Study|Protinuria|0|||
125328509|NCT02420821|450835518|FG001|Overall Study|Protinuria|1|||
124997148|NCT05677893|449617644|FG001|Overall Study|Withdrawal by Subject|0|||
124997149|NCT05677893|449617645|FG002|Overall Study|Withdrawal by Subject|0|||
124997150|NCT05677893|449617646|FG003|Overall Study|Withdrawal by Subject|0|||
124997151|NCT05677893|449617647|FG004|Overall Study|Withdrawal by Subject|1|||
124997152|NCT05677893|449617648|FG005|Overall Study|Withdrawal by Subject|1|||
124997153|NCT05677893|449617649|FG006|Overall Study|Withdrawal by Subject|0|||
124997154|NCT05677893|449617643|FG000|Overall Study|Others|1|||
125328510|NCT02420821|450835517|FG000|Overall Study|Progressive Disease|1|||
125328511|NCT02420821|450835518|FG001|Overall Study|Progressive Disease|1|||
125328512|NCT02420821|450835517|FG000|Overall Study|Disease Progression|0|||
124997155|NCT05677893|449617644|FG001|Overall Study|Others|0|||
125328513|NCT02420821|450835518|FG001|Overall Study|Disease Progression|1|||
125328514|NCT02420821|450835517|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
125328515|NCT02420821|450835518|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
125328516|NCT00686712|450835519|FG000|Overall Study|Protocol Violation|8|||
125328517|NCT00686712|450835520|FG001|Overall Study|Protocol Violation|8|||
125328518|NCT00686712|450835521|FG002|Overall Study|Protocol Violation|10|||
125328519|NCT00686712|450835519|FG000|Overall Study|Lost to Follow-up|1|||
125328520|NCT00686712|450835520|FG001|Overall Study|Lost to Follow-up|2|||
125328521|NCT00686712|450835521|FG002|Overall Study|Lost to Follow-up|3|||
125328522|NCT00686712|450835519|FG000|Overall Study|Adverse Event|1|||
125328523|NCT00686712|450835520|FG001|Overall Study|Adverse Event|1|||
124997156|NCT05677893|449617645|FG002|Overall Study|Others|0|||
124997157|NCT05677893|449617646|FG003|Overall Study|Others|0|||
124997158|NCT05677893|449617647|FG004|Overall Study|Others|0|||
124997159|NCT05677893|449617648|FG005|Overall Study|Others|0|||
124997160|NCT05677893|449617649|FG006|Overall Study|Others|0|||
124997161|NCT01485354|449617650|FG000|Overall Study|Withdrawal by Subject|5|||
124997162|NCT02101034|449617651|FG000|Overall Study|Enrolled but did not start treatment|0|||
124997163|NCT02101034|449617652|FG001|Overall Study|Enrolled but did not start treatment|0|||
124997164|NCT02101034|449617653|FG002|Overall Study|Enrolled but did not start treatment|1|||
124997165|NCT02101034|449617654|FG003|Overall Study|Enrolled but did not start treatment|0|||
124997166|NCT02101034|449617655|FG004|Overall Study|Enrolled but did not start treatment|0|||
124997167|NCT00604279|449617661|FG000|Overall Study|Lack of Efficacy|22|||
124997168|NCT00604279|449617662|FG001|Overall Study|Lack of Efficacy|9|||
124997169|NCT00604279|449617661|FG000|Overall Study|Lost to Follow-up|9|||
124997170|NCT00604279|449617662|FG001|Overall Study|Lost to Follow-up|14|||
124997171|NCT00604279|449617661|FG000|Overall Study|Pregnancy|2|||
124997172|NCT00604279|449617662|FG001|Overall Study|Pregnancy|0|||
124997173|NCT00604279|449617661|FG000|Overall Study|Protocol Violation|3|||
124997174|NCT00604279|449617662|FG001|Overall Study|Protocol Violation|1|||
125328524|NCT00686712|450835521|FG002|Overall Study|Adverse Event|0|||
125328525|NCT03058146|450835522|FG000|Overall Study|Withdrawal by Subject|4|||
125328526|NCT03058146|450835523|FG001|Overall Study|Withdrawal by Subject|1|||
125328527|NCT03058146|450835522|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
125328528|NCT03058146|450835523|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
125328529|NCT01352793|450835526|FG000|Overall Study|Lost to Follow-up|289|||
125328530|NCT01352793|450835527|FG001|Overall Study|Lost to Follow-up|125|||
125328531|NCT01352793|450835526|FG000|Overall Study|Withdrawal by Subject|120|||
125328532|NCT01352793|450835527|FG001|Overall Study|Withdrawal by Subject|55|||
125328533|NCT01352793|450835526|FG000|Overall Study|Protocol Violation|44|||
125328534|NCT01352793|450835527|FG001|Overall Study|Protocol Violation|23|||
125328535|NCT01352793|450835526|FG000|Overall Study|Adverse Event|44|||
125328536|NCT01352793|450835527|FG001|Overall Study|Adverse Event|10|||
125328537|NCT01352793|450835526|FG000|Overall Study|Physician Decision|1|||
125328538|NCT01352793|450835527|FG001|Overall Study|Physician Decision|0|||
125328539|NCT01352793|450835526|FG000|Overall Study|Pregnancy|26|||
125328540|NCT01352793|450835527|FG001|Overall Study|Pregnancy|8|||
125328541|NCT01352793|450835526|FG000|Overall Study|Other|25|||
125328542|NCT01352793|450835527|FG001|Overall Study|Other|7|||
125328543|NCT01352793|450835526|FG000|Overall Study|Medication error|2|||
125328544|NCT01352793|450835527|FG001|Overall Study|Medication error|2|||
125328545|NCT01352793|450835526|FG000|Overall Study|Death|1|||
125328546|NCT01352793|450835527|FG001|Overall Study|Death|0|||
125328547|NCT01352793|450835526|FG000|Overall Study|Randomized but not vaccinated|8|||
125328548|NCT01352793|450835527|FG001|Overall Study|Randomized but not vaccinated|0|||
125328549|NCT01352793|450835526|FG000|Overall Study|No longer meets eligibility criteria|25|||
125328550|NCT01352793|450835527|FG001|Overall Study|No longer meets eligibility criteria|15|||
125328551|NCT02839200|450835530|FG000|Overall Study|Withdrawal by Subject|2|||
125328552|NCT02839200|450835531|FG001|Overall Study|Withdrawal by Subject|0|||
124997175|NCT00604279|449617661|FG000|Overall Study|Withdrawal by Subject|16|||
124997176|NCT00604279|449617662|FG001|Overall Study|Withdrawal by Subject|5|||
124997177|NCT00604279|449617661|FG000|Overall Study|Adverse Event|4|||
124997178|NCT00604279|449617662|FG001|Overall Study|Adverse Event|5|||
124997179|NCT00604279|449617661|FG000|Overall Study|Other|8|||
124997180|NCT00604279|449617662|FG001|Overall Study|Other|4|||
125328553|NCT02839200|450835532|FG002|Overall Study|Withdrawal by Subject|1|||
125328554|NCT02839200|450835533|FG003|Overall Study|Withdrawal by Subject|0|||
125328555|NCT02839200|450835534|FG004|Overall Study|Withdrawal by Subject|0|||
125328556|NCT02839200|450835535|FG005|Overall Study|Withdrawal by Subject|1|||
124997181|NCT00995020|449617668|FG000|Overall Study|margin analysis not performed|2|||
124997182|NCT00995020|449617669|FG001|Overall Study|margin analysis not performed|5|||
124997183|NCT00995020|449617668|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
125328557|NCT02839200|450835530|FG000|Overall Study|Lost to Follow-up|2|||
125328558|NCT02839200|450835531|FG001|Overall Study|Lost to Follow-up|0|||
124997184|NCT00995020|449617669|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
125328559|NCT02839200|450835532|FG002|Overall Study|Lost to Follow-up|0|||
125328560|NCT02839200|450835533|FG003|Overall Study|Lost to Follow-up|0|||
124997185|NCT00719563|449617677|FG000|Overall Study|Adverse Event|16|||
124997186|NCT00719563|449617678|FG001|Overall Study|Adverse Event|13|||
124997187|NCT00719563|449617677|FG000|Overall Study|Medical condition changed|3|||
124997188|NCT00719563|449617678|FG001|Overall Study|Medical condition changed|5|||
124997189|NCT00719563|449617677|FG000|Overall Study|Lack of Efficacy|3|||
124997190|NCT00719563|449617678|FG001|Overall Study|Lack of Efficacy|7|||
125328561|NCT02839200|450835534|FG004|Overall Study|Lost to Follow-up|1|||
125328562|NCT02839200|450835535|FG005|Overall Study|Lost to Follow-up|0|||
124997191|NCT00719563|449617677|FG000|Overall Study|Personal reasons|6|||
124997192|NCT00719563|449617678|FG001|Overall Study|Personal reasons|7|||
124997193|NCT00719563|449617677|FG000|Overall Study|Unknown reasons|4|||
124997194|NCT00719563|449617678|FG001|Overall Study|Unknown reasons|6|||
124997195|NCT00719563|449617677|FG000|Overall Study|Noncompliant|1|||
125328563|NCT02839200|450835530|FG000|Overall Study|Adverse Event|0|||
125328564|NCT02839200|450835531|FG001|Overall Study|Adverse Event|0|||
125328565|NCT02839200|450835532|FG002|Overall Study|Adverse Event|0|||
125328566|NCT02839200|450835533|FG003|Overall Study|Adverse Event|0|||
125328567|NCT02839200|450835534|FG004|Overall Study|Adverse Event|1|||
125328568|NCT02839200|450835535|FG005|Overall Study|Adverse Event|0|||
125328569|NCT02839200|450835530|FG000|Overall Study|Randomized in error|0|||
125328570|NCT02839200|450835531|FG001|Overall Study|Randomized in error|1|||
125328571|NCT02839200|450835532|FG002|Overall Study|Randomized in error|0|||
125328572|NCT02839200|450835533|FG003|Overall Study|Randomized in error|0|||
125328573|NCT02839200|450835534|FG004|Overall Study|Randomized in error|0|||
125328574|NCT02839200|450835535|FG005|Overall Study|Randomized in error|0|||
125328575|NCT01094119|450835538|FG000|Overall Study|Lack of Efficacy|2|||
125328576|NCT01094119|450835539|FG001|Overall Study|Lack of Efficacy|4|||
125328577|NCT02205736|450835542|FG000|Overall Study|Lost to Follow-up|106|||
125328578|NCT03326713|450835543|FG000|Overall Study|Death|2|||
125328579|NCT03326713|450835544|FG001|Overall Study|Death|1|||
125328580|NCT03326713|450835545|FG002|Overall Study|Death|0|||
125328581|NCT03326713|450835543|FG000|Overall Study|Lost to Follow-up|20|||
125328582|NCT03326713|450835544|FG001|Overall Study|Lost to Follow-up|21|||
125328583|NCT03326713|450835545|FG002|Overall Study|Lost to Follow-up|33|||
125328584|NCT03326713|450835543|FG000|Overall Study|Withdrawal by Subject|1|||
125328585|NCT03326713|450835544|FG001|Overall Study|Withdrawal by Subject|2|||
125328586|NCT03326713|450835545|FG002|Overall Study|Withdrawal by Subject|11|||
125328587|NCT03326713|450835543|FG000|Overall Study|Found Ineligible|11|||
125328588|NCT03326713|450835544|FG001|Overall Study|Found Ineligible|11|||
125328589|NCT03326713|450835545|FG002|Overall Study|Found Ineligible|8|||
125328590|NCT06078124|450835551|FG000|Overall Study|Lost to Follow-up|14|||
125328591|NCT06078124|450835552|FG001|Overall Study|Lost to Follow-up|14|||
125328592|NCT01198977|450835553|FG000|Overall Study|Lost to Follow-up|1|||
125328593|NCT01198977|450835554|FG001|Overall Study|Lost to Follow-up|0|||
125328594|NCT01285557|450835555|FG000|Overall Study|Death|173|||
125328595|NCT01285557|450835556|FG001|Overall Study|Death|90|||
125328596|NCT01285557|450835555|FG000|Overall Study|Lost to Follow-up|6|||
125328597|NCT01285557|450835556|FG001|Overall Study|Lost to Follow-up|2|||
125328598|NCT01285557|450835555|FG000|Overall Study|Withdrew Consent|6|||
125328599|NCT01285557|450835556|FG001|Overall Study|Withdrew Consent|1|||
124997196|NCT00719563|449617678|FG001|Overall Study|Noncompliant|1|||
124997197|NCT00719563|449617677|FG000|Overall Study|Lost to Follow-up|5|||
124997198|NCT00719563|449617678|FG001|Overall Study|Lost to Follow-up|3|||
124997199|NCT00567268|449617679|FG000|Overall Study|Protocol Violation|7|||
124997200|NCT00567268|449617679|FG000|Overall Study|Lost to Follow-up|36|||
124997201|NCT00567268|449617679|FG000|Overall Study|No Visit After First Day of Treatment|2|||
124997202|NCT00567268|449617679|FG000|Overall Study|No Drug Administration|4|||
124997203|NCT00567268|449617679|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
124997204|NCT01717989|449617682|FG000|Overall Study|Ineligibility determined|6|||
124997205|NCT01717989|449617682|FG000|Overall Study|Protocol deviation|6|||
124997206|NCT01717989|449617682|FG000|Overall Study|Withdrawal by Subject|11|||
124997207|NCT01717989|449617682|FG000|Overall Study|Physician Decision|2|||
124997208|NCT01717989|449617682|FG000|Overall Study|Lost to Follow-up|11|||
125328600|NCT01285557|450835555|FG000|Overall Study|Sponsor Study Termination|23|||
125328601|NCT01285557|450835556|FG001|Overall Study|Sponsor Study Termination|13|||
125328602|NCT01285557|450835555|FG000|Overall Study|Randomized but not treated|1|||
125328603|NCT01285557|450835556|FG001|Overall Study|Randomized but not treated|1|||
125328604|NCT01285557|450835555|FG000|Overall Study|Study follow-up ongoing|28|||
125328605|NCT01285557|450835556|FG001|Overall Study|Study follow-up ongoing|14|||
124997209|NCT01717989|449617682|FG000|Overall Study|Death|439|||
124997210|NCT01717989|449617682|FG000|Overall Study|Protocol-specified criteria|551|||
124997211|NCT01717989|449617682|FG000|Overall Study|Other|40|||
125328606|NCT01285557|450835555|FG000|Overall Study|Sponsor Decision|2|||
124997212|NCT00792805|449617683|FG000|Overall Study|Adverse Event|12|||
124997213|NCT00792805|449617684|FG001|Overall Study|Adverse Event|10|||
125328607|NCT01285557|450835556|FG001|Overall Study|Sponsor Decision|1|||
125328608|NCT05615922|450835558|FG000|Overall Study|Lost to Follow-up|1|||
125328609|NCT03173248|450835562|FG000|Overall Study|Death|28|||
125328610|NCT03173248|450835563|FG001|Overall Study|Death|46|||
125328611|NCT03173248|450835562|FG000|Overall Study|Lost to Follow-up|0|||
125328612|NCT03173248|450835563|FG001|Overall Study|Lost to Follow-up|1|||
125328613|NCT03173248|450835562|FG000|Overall Study|Withdrawal by Subject|6|||
125328614|NCT03173248|450835563|FG001|Overall Study|Withdrawal by Subject|4|||
125328615|NCT03173248|450835562|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
125328616|NCT03173248|450835563|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
125328617|NCT01648751|450835566|FG000|Overall Study|Withdrawal by Subject|2|||
125328618|NCT01648751|450835567|FG001|Overall Study|Withdrawal by Subject|3|||
125328619|NCT02991768|450835571|FG000|Overall Study|Physician Decision|4|||
125328620|NCT03467750|450835572|FG000|Overall Study|Surgery canceled|1|||
125328621|NCT03467750|450835573|FG001|Overall Study|Surgery canceled|0|||
125328622|NCT03467750|450835572|FG000|Overall Study|Protocol Violation|1|||
125328623|NCT03467750|450835573|FG001|Overall Study|Protocol Violation|1|||
125328624|NCT03467750|450835572|FG000|Overall Study|Withdrawal by Subject|0|||
125328625|NCT03467750|450835573|FG001|Overall Study|Withdrawal by Subject|1|||
125328626|NCT05673876|450835574|FG000|Overall Study|Death|3|||
125328627|NCT05673876|450835575|FG001|Overall Study|Death|1|||
125328628|NCT05673876|450835574|FG000|Overall Study|Study Terminated by Sponsor|0|||
125328629|NCT05673876|450835575|FG001|Overall Study|Study Terminated by Sponsor|1|||
125328630|NCT05673876|450835574|FG000|Overall Study|Physician Decision|0|||
125328631|NCT05673876|450835575|FG001|Overall Study|Physician Decision|1|||
125328632|NCT04500158|450835578|FG000|Overall Study|Physician Decision|17|||
125328633|NCT04500158|450835579|FG001|Overall Study|Physician Decision|11|||
125328634|NCT02749422|450835582|FG000|Overall Study|Lost to Follow-up|0|||
125328635|NCT02749422|450835583|FG001|Overall Study|Lost to Follow-up|2|||
125328636|NCT02749422|450835582|FG000|Overall Study|Ineligible|0|||
125328637|NCT02749422|450835583|FG001|Overall Study|Ineligible|1|||
125328638|NCT04988477|450835589|FG000|Overall Study|Death|1|||
125328639|NCT04988477|450835590|FG001|Overall Study|Death|0|||
125328640|NCT04988477|450835591|FG002|Overall Study|Death|0|||
125328641|NCT04988477|450835589|FG000|Overall Study|Lost to Follow-up|5|||
125328642|NCT04988477|450835590|FG001|Overall Study|Lost to Follow-up|2|||
125328643|NCT04988477|450835591|FG002|Overall Study|Lost to Follow-up|0|||
125328644|NCT04988477|450835589|FG000|Overall Study|Withdrawal by Subject|2|||
125328645|NCT04988477|450835590|FG001|Overall Study|Withdrawal by Subject|0|||
125328646|NCT04988477|450835591|FG002|Overall Study|Withdrawal by Subject|0|||
125328647|NCT04610281|450837267|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
125328648|NCT04610281|450837268|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
125328649|NCT01458392|450837270|FG000|Overall Study|Death|2|||
125328650|NCT01458392|450837271|FG001|Overall Study|Death|11|||
125328651|NCT01458392|450837272|FG002|Overall Study|Death|22|||
125328652|NCT01458392|450837270|FG000|Overall Study|At the discretion of the sponsor|0|||
125328653|NCT01458392|450837271|FG001|Overall Study|At the discretion of the sponsor|2|||
125328654|NCT01458392|450837272|FG002|Overall Study|At the discretion of the sponsor|7|||
125328655|NCT01458392|450837270|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
125328656|NCT01458392|450837271|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
125328657|NCT01458392|450837272|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
125328658|NCT00753506|450837275|FG000|Overall Study|Withdrawal by Subject|4|||
125328659|NCT00753506|450837276|FG001|Overall Study|Withdrawal by Subject|1|||
125328660|NCT00753506|450837275|FG000|Overall Study|Lost to Follow-up|2|||
125328661|NCT00753506|450837276|FG001|Overall Study|Lost to Follow-up|0|||
125328662|NCT00753506|450837275|FG000|Overall Study|Other reason|1|||
125328663|NCT00753506|450837276|FG001|Overall Study|Other reason|1|||
125328664|NCT03557034|450837285|FG000|Overall Study|Withdrawal by Subject|1|||
125328665|NCT03557034|450837286|FG001|Overall Study|Withdrawal by Subject|0|||
125328666|NCT00790842|450837288|FG000|Dose Level 1|Adverse Event|1|||
125328667|NCT00790842|450837289|FG001|Dose Level 1|Adverse Event|0|||
125328668|NCT00790842|450837290|FG002|Dose Level 1|Adverse Event|0|||
125328669|NCT00790842|450837291|FG003|Dose Level 1|Adverse Event|2|||
125328670|NCT00790842|450837292|FG004|Dose Level 1|Adverse Event|0|||
125328671|NCT00790842|450837293|FG005|Dose Level 1|Adverse Event|0|||
125328672|NCT00790842|450837294|FG006|Dose Level 1|Adverse Event|0|||
125328673|NCT00790842|450837295|FG007|Dose Level 1|Adverse Event|1|||
125328674|NCT00790842|450837296|FG008|Dose Level 1|Adverse Event|0|||
125328675|NCT00790842|450837297|FG009|Dose Level 1|Adverse Event|0|||
125328676|NCT00790842|450837298|FG010|Dose Level 1|Adverse Event|0|||
125328677|NCT00790842|450837288|FG000|Dose Level 1|Physician Decision|1|||
125328678|NCT00790842|450837289|FG001|Dose Level 1|Physician Decision|0|||
125328679|NCT00790842|450837290|FG002|Dose Level 1|Physician Decision|0|||
125328680|NCT00790842|450837291|FG003|Dose Level 1|Physician Decision|0|||
125328681|NCT00790842|450837292|FG004|Dose Level 1|Physician Decision|0|||
125328682|NCT00790842|450837293|FG005|Dose Level 1|Physician Decision|0|||
125328683|NCT00790842|450837294|FG006|Dose Level 1|Physician Decision|0|||
125328684|NCT00790842|450837295|FG007|Dose Level 1|Physician Decision|1|||
125328685|NCT00790842|450837296|FG008|Dose Level 1|Physician Decision|0|||
125328686|NCT00790842|450837297|FG009|Dose Level 1|Physician Decision|0|||
125328687|NCT00790842|450837298|FG010|Dose Level 1|Physician Decision|0|||
125328688|NCT00790842|450837288|FG000|Dose Level 1|Withdrawal by Subject|1|||
125328689|NCT00790842|450837289|FG001|Dose Level 1|Withdrawal by Subject|0|||
124997214|NCT00792805|449617685|FG002|Overall Study|Adverse Event|10|||
124997215|NCT00792805|449617683|FG000|Overall Study|Subject withdrew consent|5|||
124997216|NCT00792805|449617684|FG001|Overall Study|Subject withdrew consent|6|||
124997217|NCT00792805|449617685|FG002|Overall Study|Subject withdrew consent|5|||
124997218|NCT00792805|449617683|FG000|Overall Study|Administrative problems|2|||
124997219|NCT00792805|449617684|FG001|Overall Study|Administrative problems|0|||
125328690|NCT00790842|450837290|FG002|Dose Level 1|Withdrawal by Subject|0|||
125328691|NCT00790842|450837291|FG003|Dose Level 1|Withdrawal by Subject|0|||
125328692|NCT00790842|450837292|FG004|Dose Level 1|Withdrawal by Subject|0|||
125328693|NCT00790842|450837293|FG005|Dose Level 1|Withdrawal by Subject|0|||
125328694|NCT00790842|450837294|FG006|Dose Level 1|Withdrawal by Subject|0|||
125328695|NCT00790842|450837295|FG007|Dose Level 1|Withdrawal by Subject|0|||
125328696|NCT00790842|450837296|FG008|Dose Level 1|Withdrawal by Subject|0|||
125328697|NCT00790842|450837297|FG009|Dose Level 1|Withdrawal by Subject|0|||
125328698|NCT00790842|450837298|FG010|Dose Level 1|Withdrawal by Subject|0|||
125328699|NCT00790842|450837288|FG000|Dose Level 2|Death|0|||
125328700|NCT00790842|450837289|FG001|Dose Level 2|Death|1|||
125328701|NCT00790842|450837290|FG002|Dose Level 2|Death|0|||
125328702|NCT00790842|450837291|FG003|Dose Level 2|Death|0|||
125328703|NCT00790842|450837292|FG004|Dose Level 2|Death|1|||
125328704|NCT00790842|450837293|FG005|Dose Level 2|Death|0|||
125328705|NCT00790842|450837294|FG006|Dose Level 2|Death|0|||
125328706|NCT00790842|450837295|FG007|Dose Level 2|Death|0|||
125328707|NCT00790842|450837296|FG008|Dose Level 2|Death|0|||
125328708|NCT00790842|450837297|FG009|Dose Level 2|Death|0|||
125328709|NCT00790842|450837298|FG010|Dose Level 2|Death|0|||
125328710|NCT00790842|450837288|FG000|Dose Level 2|Physician Decision|0|||
125328711|NCT00790842|450837289|FG001|Dose Level 2|Physician Decision|1|||
125328712|NCT00790842|450837290|FG002|Dose Level 2|Physician Decision|0|||
125328713|NCT00790842|450837291|FG003|Dose Level 2|Physician Decision|0|||
125328714|NCT00790842|450837292|FG004|Dose Level 2|Physician Decision|0|||
125328715|NCT00790842|450837293|FG005|Dose Level 2|Physician Decision|0|||
125328716|NCT00790842|450837294|FG006|Dose Level 2|Physician Decision|0|||
125328717|NCT00790842|450837295|FG007|Dose Level 2|Physician Decision|0|||
125328718|NCT00790842|450837296|FG008|Dose Level 2|Physician Decision|0|||
125328719|NCT00790842|450837297|FG009|Dose Level 2|Physician Decision|0|||
125328720|NCT00790842|450837298|FG010|Dose Level 2|Physician Decision|0|||
125328721|NCT00790842|450837288|FG000|Dose Level 2|Withdrawal by Subject|0|||
125328722|NCT00790842|450837289|FG001|Dose Level 2|Withdrawal by Subject|1|||
125328723|NCT00790842|450837290|FG002|Dose Level 2|Withdrawal by Subject|0|||
125328724|NCT00790842|450837291|FG003|Dose Level 2|Withdrawal by Subject|0|||
125328725|NCT00790842|450837292|FG004|Dose Level 2|Withdrawal by Subject|0|||
125328726|NCT00790842|450837293|FG005|Dose Level 2|Withdrawal by Subject|0|||
125328727|NCT00790842|450837294|FG006|Dose Level 2|Withdrawal by Subject|0|||
125328728|NCT00790842|450837295|FG007|Dose Level 2|Withdrawal by Subject|0|||
125328729|NCT00790842|450837296|FG008|Dose Level 2|Withdrawal by Subject|0|||
125328730|NCT00790842|450837297|FG009|Dose Level 2|Withdrawal by Subject|0|||
125328731|NCT00790842|450837298|FG010|Dose Level 2|Withdrawal by Subject|0|||
125328732|NCT00790842|450837288|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125328733|NCT00790842|450837289|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125328734|NCT00790842|450837290|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125328735|NCT00790842|450837291|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125328736|NCT00790842|450837292|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125328737|NCT00790842|450837293|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125328738|NCT00790842|450837294|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125328739|NCT00790842|450837295|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125328740|NCT00790842|450837296|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
125328741|NCT00790842|450837297|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125328742|NCT00790842|450837298|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125328743|NCT00790842|450837288|FG000|Dose Level 3|Adverse Event|0|||
125328744|NCT00790842|450837289|FG001|Dose Level 3|Adverse Event|0|||
125328745|NCT00790842|450837290|FG002|Dose Level 3|Adverse Event|1|||
125328746|NCT00790842|450837291|FG003|Dose Level 3|Adverse Event|0|||
125328747|NCT00790842|450837292|FG004|Dose Level 3|Adverse Event|0|||
125328748|NCT00790842|450837293|FG005|Dose Level 3|Adverse Event|0|||
125328749|NCT00790842|450837294|FG006|Dose Level 3|Adverse Event|0|||
125328750|NCT00790842|450837295|FG007|Dose Level 3|Adverse Event|0|||
125328751|NCT00790842|450837296|FG008|Dose Level 3|Adverse Event|0|||
125328752|NCT00790842|450837297|FG009|Dose Level 3|Adverse Event|0|||
125328753|NCT00790842|450837298|FG010|Dose Level 3|Adverse Event|0|||
125328754|NCT00790842|450837288|FG000|Dose Level 3|Withdrawal by Subject|0|||
125328755|NCT00790842|450837289|FG001|Dose Level 3|Withdrawal by Subject|0|||
125328756|NCT00790842|450837290|FG002|Dose Level 3|Withdrawal by Subject|3|||
125328757|NCT00790842|450837291|FG003|Dose Level 3|Withdrawal by Subject|0|||
125328758|NCT00790842|450837292|FG004|Dose Level 3|Withdrawal by Subject|0|||
125328759|NCT00790842|450837293|FG005|Dose Level 3|Withdrawal by Subject|0|||
125328760|NCT00790842|450837294|FG006|Dose Level 3|Withdrawal by Subject|0|||
125328761|NCT00790842|450837295|FG007|Dose Level 3|Withdrawal by Subject|0|||
125328762|NCT00790842|450837296|FG008|Dose Level 3|Withdrawal by Subject|0|||
125328763|NCT00790842|450837297|FG009|Dose Level 3|Withdrawal by Subject|2|||
125328764|NCT00790842|450837298|FG010|Dose Level 3|Withdrawal by Subject|0|||
125328765|NCT00790842|450837288|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125328766|NCT00790842|450837289|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125328767|NCT00790842|450837290|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125328768|NCT00790842|450837291|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125328769|NCT00790842|450837292|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125328770|NCT00790842|450837293|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
125328771|NCT00790842|450837294|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125328772|NCT00790842|450837295|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125328773|NCT00790842|450837296|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125328774|NCT00790842|450837297|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125328775|NCT00790842|450837298|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125328776|NCT00790842|450837288|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125328777|NCT00790842|450837289|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125328778|NCT00790842|450837290|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
125328779|NCT00790842|450837291|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125328780|NCT00790842|450837292|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125328781|NCT00790842|450837293|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125328782|NCT00790842|450837294|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125328783|NCT00790842|450837295|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125328784|NCT00790842|450837296|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125328785|NCT00790842|450837297|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125328786|NCT00790842|450837298|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125328787|NCT00790842|450837288|FG000|Dose Level 4|Adverse Event|0|||
125328788|NCT00790842|450837289|FG001|Dose Level 4|Adverse Event|0|||
125328789|NCT00790842|450837290|FG002|Dose Level 4|Adverse Event|0|||
125328790|NCT00790842|450837291|FG003|Dose Level 4|Adverse Event|0|||
125328791|NCT00790842|450837292|FG004|Dose Level 4|Adverse Event|0|||
125328792|NCT00790842|450837293|FG005|Dose Level 4|Adverse Event|0|||
125328793|NCT00790842|450837294|FG006|Dose Level 4|Adverse Event|1|||
125328794|NCT00790842|450837295|FG007|Dose Level 4|Adverse Event|0|||
125328795|NCT00790842|450837296|FG008|Dose Level 4|Adverse Event|0|||
125328796|NCT00790842|450837297|FG009|Dose Level 4|Adverse Event|0|||
125328797|NCT00790842|450837298|FG010|Dose Level 4|Adverse Event|0|||
125328798|NCT00790842|450837288|FG000|Dose Level 4|Physician Decision|0|||
125328799|NCT00790842|450837289|FG001|Dose Level 4|Physician Decision|0|||
125328800|NCT00790842|450837290|FG002|Dose Level 4|Physician Decision|0|||
125328801|NCT00790842|450837291|FG003|Dose Level 4|Physician Decision|0|||
125328802|NCT00790842|450837292|FG004|Dose Level 4|Physician Decision|0|||
125328803|NCT00790842|450837293|FG005|Dose Level 4|Physician Decision|0|||
125328804|NCT00790842|450837294|FG006|Dose Level 4|Physician Decision|1|||
125328805|NCT00790842|450837295|FG007|Dose Level 4|Physician Decision|0|||
125328806|NCT00790842|450837296|FG008|Dose Level 4|Physician Decision|0|||
125328807|NCT00790842|450837297|FG009|Dose Level 4|Physician Decision|0|||
125328808|NCT00790842|450837298|FG010|Dose Level 4|Physician Decision|1|||
125328809|NCT00790842|450837288|FG000|Dose Level 4|Withdrawal by Subject|0|||
125328810|NCT00790842|450837289|FG001|Dose Level 4|Withdrawal by Subject|0|||
125328811|NCT00790842|450837290|FG002|Dose Level 4|Withdrawal by Subject|0|||
125328812|NCT00790842|450837291|FG003|Dose Level 4|Withdrawal by Subject|0|||
125328813|NCT00790842|450837292|FG004|Dose Level 4|Withdrawal by Subject|0|||
125328814|NCT00790842|450837293|FG005|Dose Level 4|Withdrawal by Subject|0|||
125328815|NCT00790842|450837294|FG006|Dose Level 4|Withdrawal by Subject|0|||
125328816|NCT00790842|450837295|FG007|Dose Level 4|Withdrawal by Subject|0|||
125328817|NCT00790842|450837296|FG008|Dose Level 4|Withdrawal by Subject|0|||
125328818|NCT00790842|450837297|FG009|Dose Level 4|Withdrawal by Subject|0|||
125328819|NCT00790842|450837298|FG010|Dose Level 4|Withdrawal by Subject|1|||
125328820|NCT00790842|450837288|FG000|Expansion Cohort|Adverse Event|0|||
125328821|NCT00790842|450837289|FG001|Expansion Cohort|Adverse Event|0|||
125328822|NCT00790842|450837290|FG002|Expansion Cohort|Adverse Event|0|||
125328823|NCT00790842|450837291|FG003|Expansion Cohort|Adverse Event|0|||
125328824|NCT00790842|450837292|FG004|Expansion Cohort|Adverse Event|0|||
125328825|NCT00790842|450837293|FG005|Expansion Cohort|Adverse Event|0|||
125328826|NCT00790842|450837294|FG006|Expansion Cohort|Adverse Event|1|||
125328827|NCT00790842|450837295|FG007|Expansion Cohort|Adverse Event|0|||
125328828|NCT00790842|450837296|FG008|Expansion Cohort|Adverse Event|0|||
125328829|NCT00790842|450837297|FG009|Expansion Cohort|Adverse Event|0|||
125328830|NCT00790842|450837298|FG010|Expansion Cohort|Adverse Event|0|||
125328831|NCT00790842|450837288|FG000|Expansion Cohort|Death|0|||
125328832|NCT00790842|450837289|FG001|Expansion Cohort|Death|0|||
125328833|NCT00790842|450837290|FG002|Expansion Cohort|Death|2|||
125328834|NCT00790842|450837291|FG003|Expansion Cohort|Death|0|||
125328835|NCT00790842|450837292|FG004|Expansion Cohort|Death|0|||
125328836|NCT00790842|450837293|FG005|Expansion Cohort|Death|0|||
125328837|NCT00790842|450837294|FG006|Expansion Cohort|Death|0|||
124997220|NCT00792805|449617685|FG002|Overall Study|Administrative problems|4|||
124997221|NCT00792805|449617683|FG000|Overall Study|Abnormal test procedure result(s)|1|||
124997222|NCT00792805|449617684|FG001|Overall Study|Abnormal test procedure result(s)|2|||
124997223|NCT00792805|449617685|FG002|Overall Study|Abnormal test procedure result(s)|0|||
124997224|NCT00792805|449617683|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124997225|NCT00792805|449617684|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
124997226|NCT00792805|449617685|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
124997227|NCT00792805|449617683|FG000|Overall Study|Lost to Follow-up|1|||
124997228|NCT00792805|449617684|FG001|Overall Study|Lost to Follow-up|1|||
124997229|NCT00792805|449617685|FG002|Overall Study|Lost to Follow-up|6|||
124997230|NCT00792805|449617683|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125328838|NCT00790842|450837295|FG007|Expansion Cohort|Death|0|||
125328839|NCT00790842|450837296|FG008|Expansion Cohort|Death|0|||
125328840|NCT00790842|450837297|FG009|Expansion Cohort|Death|0|||
125328841|NCT00790842|450837298|FG010|Expansion Cohort|Death|0|||
125328842|NCT00790842|450837288|FG000|Expansion Cohort|Physician Decision|0|||
125328843|NCT00790842|450837289|FG001|Expansion Cohort|Physician Decision|0|||
125328844|NCT00790842|450837290|FG002|Expansion Cohort|Physician Decision|1|||
125328845|NCT00790842|450837291|FG003|Expansion Cohort|Physician Decision|0|||
125328846|NCT00790842|450837292|FG004|Expansion Cohort|Physician Decision|0|||
125328847|NCT00790842|450837293|FG005|Expansion Cohort|Physician Decision|0|||
125328848|NCT00790842|450837294|FG006|Expansion Cohort|Physician Decision|0|||
125328849|NCT00790842|450837295|FG007|Expansion Cohort|Physician Decision|0|||
125328850|NCT00790842|450837296|FG008|Expansion Cohort|Physician Decision|0|||
125328851|NCT00790842|450837297|FG009|Expansion Cohort|Physician Decision|0|||
125328852|NCT00790842|450837298|FG010|Expansion Cohort|Physician Decision|0|||
125328853|NCT00790842|450837288|FG000|Expansion Cohort|Withdrawal by Subject|0|||
125328854|NCT00790842|450837289|FG001|Expansion Cohort|Withdrawal by Subject|0|||
125328855|NCT00790842|450837290|FG002|Expansion Cohort|Withdrawal by Subject|3|||
125328856|NCT00790842|450837291|FG003|Expansion Cohort|Withdrawal by Subject|0|||
125328857|NCT00790842|450837292|FG004|Expansion Cohort|Withdrawal by Subject|0|||
125328858|NCT00790842|450837293|FG005|Expansion Cohort|Withdrawal by Subject|0|||
125328859|NCT00790842|450837294|FG006|Expansion Cohort|Withdrawal by Subject|0|||
125328860|NCT00790842|450837295|FG007|Expansion Cohort|Withdrawal by Subject|0|||
125328861|NCT00790842|450837296|FG008|Expansion Cohort|Withdrawal by Subject|0|||
125328862|NCT00790842|450837297|FG009|Expansion Cohort|Withdrawal by Subject|0|||
125328863|NCT00790842|450837298|FG010|Expansion Cohort|Withdrawal by Subject|0|||
125328864|NCT00790842|450837288|FG000|Expansion Cohort|Study Closure|0|||
125328865|NCT00790842|450837289|FG001|Expansion Cohort|Study Closure|0|||
125328866|NCT00790842|450837290|FG002|Expansion Cohort|Study Closure|1|||
125328867|NCT00790842|450837291|FG003|Expansion Cohort|Study Closure|0|||
125328868|NCT00790842|450837292|FG004|Expansion Cohort|Study Closure|0|||
125328869|NCT00790842|450837293|FG005|Expansion Cohort|Study Closure|0|||
125328870|NCT00790842|450837294|FG006|Expansion Cohort|Study Closure|0|||
125328871|NCT00790842|450837295|FG007|Expansion Cohort|Study Closure|0|||
125328872|NCT00790842|450837296|FG008|Expansion Cohort|Study Closure|0|||
125328873|NCT00790842|450837297|FG009|Expansion Cohort|Study Closure|0|||
125328874|NCT00790842|450837298|FG010|Expansion Cohort|Study Closure|0|||
125328875|NCT03809104|450837299|FG000|Overall Study|Withdrawal by Subject|3|||
125328876|NCT00885170|450837310|FG000|Overall Study|Adverse Event|12|||
125328877|NCT00885170|450837311|FG001|Overall Study|Adverse Event|4|||
125328878|NCT00885170|450837310|FG000|Overall Study|Excessive bone loss|6|||
125328879|NCT00885170|450837311|FG001|Overall Study|Excessive bone loss|3|||
125328880|NCT00885170|450837310|FG000|Overall Study|Lost to Follow-up|2|||
125328881|NCT00885170|450837311|FG001|Overall Study|Lost to Follow-up|1|||
125328882|NCT00885170|450837310|FG000|Overall Study|Physician Decision|2|||
125328883|NCT00885170|450837311|FG001|Overall Study|Physician Decision|1|||
125328884|NCT00885170|450837310|FG000|Overall Study|Protocol Violation|3|||
125328885|NCT00885170|450837311|FG001|Overall Study|Protocol Violation|1|||
125328886|NCT00885170|450837310|FG000|Overall Study|Withdrawal by Subject|13|||
124997231|NCT00792805|449617684|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125328887|NCT00885170|450837311|FG001|Overall Study|Withdrawal by Subject|13|||
125328888|NCT00561925|450837312|FG000|14 Day Lead-In Period|Adverse Event|38|||
125328889|NCT00561925|450837313|FG001|14 Day Lead-In Period|Adverse Event|0|||
125328890|NCT00561925|450837314|FG002|14 Day Lead-In Period|Adverse Event|0|||
125328891|NCT00561925|450837315|FG003|14 Day Lead-In Period|Adverse Event|0|||
125328892|NCT00561925|450837316|FG004|14 Day Lead-In Period|Adverse Event|0|||
125328893|NCT00561925|450837312|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
125328894|NCT00561925|450837313|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
125328895|NCT00561925|450837314|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
125328896|NCT00561925|450837315|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
125328897|NCT00561925|450837316|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
125328898|NCT00561925|450837312|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
125328899|NCT00561925|450837313|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
125328900|NCT00561925|450837314|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
125328901|NCT00561925|450837315|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
125328902|NCT00561925|450837316|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
124997232|NCT00792805|449617685|FG002|Overall Study|Abnormal laboratory value(s)|1|||
124997233|NCT00792805|449617683|FG000|Overall Study|Protocol deviation|0|||
124997234|NCT00792805|449617684|FG001|Overall Study|Protocol deviation|1|||
124997235|NCT00792805|449617685|FG002|Overall Study|Protocol deviation|1|||
124997236|NCT03224325|449617686|FG000|Overall Study|Adverse Event|1|||
124997237|NCT03224325|449617687|FG001|Overall Study|Adverse Event|0|||
124997238|NCT03224325|449617688|FG002|Overall Study|Adverse Event|0|||
124997239|NCT03224325|449617689|FG003|Overall Study|Adverse Event|0|||
124997240|NCT03224325|449617690|FG004|Overall Study|Adverse Event|0|||
124997241|NCT03224325|449617691|FG005|Overall Study|Adverse Event|0|||
124997242|NCT03224325|449617692|FG006|Overall Study|Adverse Event|1|||
124997243|NCT03224325|449617686|FG000|Overall Study|Withdrawal by Subject|0|||
124997244|NCT03224325|449617687|FG001|Overall Study|Withdrawal by Subject|0|||
124997245|NCT03224325|449617688|FG002|Overall Study|Withdrawal by Subject|0|||
124997246|NCT03224325|449617689|FG003|Overall Study|Withdrawal by Subject|1|||
124997247|NCT03224325|449617690|FG004|Overall Study|Withdrawal by Subject|0|||
124997248|NCT03224325|449617691|FG005|Overall Study|Withdrawal by Subject|0|||
124997249|NCT03224325|449617692|FG006|Overall Study|Withdrawal by Subject|0|||
124997250|NCT02952001|449617693|FG000|Overall Study|Adverse Event|3|||
124997251|NCT02952001|449617694|FG001|Overall Study|Adverse Event|0|||
124997252|NCT02952001|449617693|FG000|Overall Study|Prohibited therapy|10|||
124997253|NCT02952001|449617694|FG001|Overall Study|Prohibited therapy|3|||
124997254|NCT02952001|449617693|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
124997255|NCT02952001|449617694|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
124997256|NCT03278106|449617704|FG000|Overall Study|No protocol treatment|1|||
124997257|NCT02982187|449617705|FG000|Overall Study|Withdrawal by Subject|0|||
124997258|NCT02982187|449617706|FG001|Overall Study|Withdrawal by Subject|0|||
124997259|NCT02982187|449617707|FG002|Overall Study|Withdrawal by Subject|0|||
124997260|NCT02982187|449617708|FG003|Overall Study|Withdrawal by Subject|0|||
124997261|NCT02982187|449617709|FG004|Overall Study|Withdrawal by Subject|0|||
124997262|NCT02982187|449617710|FG005|Overall Study|Withdrawal by Subject|0|||
124997263|NCT02982187|449617711|FG006|Overall Study|Withdrawal by Subject|1|||
124997264|NCT02982187|449617712|FG007|Overall Study|Withdrawal by Subject|0|||
124997265|NCT02604433|449617713|FG000|Overall Study|Withdrawal by Subject|37|||
124997266|NCT02604433|449617714|FG001|Overall Study|Withdrawal by Subject|16|||
124997267|NCT02604433|449617713|FG000|Overall Study|Adverse Event|4|||
124997268|NCT02604433|449617714|FG001|Overall Study|Adverse Event|0|||
124997269|NCT02604433|449617713|FG000|Overall Study|Other reasons|3|||
124997270|NCT02604433|449617714|FG001|Overall Study|Other reasons|5|||
124997271|NCT02604433|449617713|FG000|Overall Study|Death|4|||
124997272|NCT02604433|449617714|FG001|Overall Study|Death|1|||
124997273|NCT02604433|449617713|FG000|Overall Study|Transition to Rollover Protocol|169|||
124997274|NCT02604433|449617714|FG001|Overall Study|Transition to Rollover Protocol|82|||
124997275|NCT02604433|449617713|FG000|Overall Study|Physician Decision|1|||
124997276|NCT02604433|449617714|FG001|Overall Study|Physician Decision|1|||
124997277|NCT02604433|449617713|FG000|Overall Study|Lack of Efficacy|0|||
125328903|NCT00561925|450837312|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
125328904|NCT00561925|450837313|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
124997278|NCT02604433|449617714|FG001|Overall Study|Lack of Efficacy|1|||
124997279|NCT03437278|449617715|FG000|Overall Study|Adverse Event|0|||
124997280|NCT03437278|449617716|FG001|Overall Study|Adverse Event|0|||
124997281|NCT03437278|449617717|FG002|Overall Study|Adverse Event|1|||
124997282|NCT03437278|449617715|FG000|Overall Study|Progressive disease|1|||
125328905|NCT00561925|450837314|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
125328906|NCT00561925|450837315|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
125328907|NCT00561925|450837316|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
125328908|NCT00561925|450837312|FG000|14 Day Lead-In Period|Other|5|||
125328909|NCT00561925|450837313|FG001|14 Day Lead-In Period|Other|0|||
125328910|NCT00561925|450837314|FG002|14 Day Lead-In Period|Other|0|||
125328911|NCT00561925|450837315|FG003|14 Day Lead-In Period|Other|0|||
125328912|NCT00561925|450837316|FG004|14 Day Lead-In Period|Other|0|||
125328913|NCT00561925|450837312|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
125328914|NCT00561925|450837313|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
125328915|NCT00561925|450837314|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
125328916|NCT00561925|450837315|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
125328917|NCT00561925|450837316|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
125328918|NCT00561925|450837312|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
124997283|NCT03437278|449617716|FG001|Overall Study|Progressive disease|0|||
124997284|NCT03437278|449617717|FG002|Overall Study|Progressive disease|0|||
124997285|NCT03437278|449617715|FG000|Overall Study|Physician Decision|1|||
124997286|NCT03437278|449617716|FG001|Overall Study|Physician Decision|0|||
124997287|NCT03437278|449617717|FG002|Overall Study|Physician Decision|1|||
124997288|NCT02202551|449617718|FG000|Overall Study|Adverse Event|8|||
124997289|NCT02202551|449617719|FG001|Overall Study|Adverse Event|19|||
124997290|NCT02202551|449617720|FG002|Overall Study|Adverse Event|5|||
124997291|NCT02202551|449617721|FG003|Overall Study|Adverse Event|9|||
125328919|NCT00561925|450837313|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
125328920|NCT00561925|450837314|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
125328921|NCT00561925|450837315|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
125328922|NCT00561925|450837316|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
125328923|NCT00561925|450837312|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
125328924|NCT00561925|450837313|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
125328925|NCT00561925|450837314|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
125328926|NCT00561925|450837315|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
125328927|NCT00561925|450837316|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
125328928|NCT00561925|450837312|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
125328929|NCT00561925|450837313|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
125328930|NCT00561925|450837314|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
125328931|NCT00561925|450837315|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
125328932|NCT00561925|450837316|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
125328933|NCT00561925|450837312|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
125328934|NCT00561925|450837313|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
125328935|NCT00561925|450837314|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
125328936|NCT00561925|450837315|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
125328937|NCT00561925|450837316|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
125328938|NCT00561925|450837312|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
125328939|NCT00561925|450837313|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
125328940|NCT00561925|450837314|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
125328941|NCT00561925|450837315|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
125328942|NCT00561925|450837316|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
125328943|NCT00561925|450837312|FG000|144-week Double-blind, Double-dummy|Death|0|||
125328944|NCT00561925|450837313|FG001|144-week Double-blind, Double-dummy|Death|6|||
125328945|NCT00561925|450837314|FG002|144-week Double-blind, Double-dummy|Death|3|||
125328946|NCT00561925|450837315|FG003|144-week Double-blind, Double-dummy|Death|0|||
125328947|NCT00561925|450837316|FG004|144-week Double-blind, Double-dummy|Death|0|||
125328948|NCT00561925|450837312|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
125328949|NCT00561925|450837313|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
125328950|NCT00561925|450837314|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
125328951|NCT00561925|450837315|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
125328952|NCT00561925|450837316|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
125328953|NCT00561925|450837312|FG000|144-week Double-blind, Double-dummy|Other|0|||
125328954|NCT00561925|450837313|FG001|144-week Double-blind, Double-dummy|Other|8|||
125328955|NCT00561925|450837314|FG002|144-week Double-blind, Double-dummy|Other|11|||
125328956|NCT00561925|450837315|FG003|144-week Double-blind, Double-dummy|Other|0|||
125328957|NCT00561925|450837316|FG004|144-week Double-blind, Double-dummy|Other|0|||
125328958|NCT00561925|450837312|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
125328959|NCT00561925|450837313|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
125328960|NCT00561925|450837314|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
125328961|NCT00561925|450837315|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
125328962|NCT00561925|450837316|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
125328963|NCT00724698|450837317|FG000|Overall Study|Adverse Event|9|||
125328964|NCT00724698|450837317|FG000|Overall Study|Failure of Therapy|4|||
125328965|NCT00724698|450837317|FG000|Overall Study|Poor Compliance|16|||
125328966|NCT00724698|450837317|FG000|Overall Study|Lost to Follow-up|36|||
125328967|NCT00724698|450837317|FG000|Overall Study|No Info|25|||
125328968|NCT05021978|450837318|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
125328969|NCT05021978|450837319|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
125328970|NCT05021978|450837320|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
125328971|NCT05021978|450837321|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
125328972|NCT05021978|450837318|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
125328973|NCT05021978|450837319|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
125328974|NCT05021978|450837320|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
125328975|NCT05021978|450837321|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
125328976|NCT02177032|450837324|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
125328977|NCT02177032|450837325|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
125328978|NCT02177032|450837326|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
125328979|NCT02177032|450837327|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
125328980|NCT02177032|450837324|FG000|Overall Study|Lost to Follow-up|0|||
125328981|NCT02177032|450837325|FG001|Overall Study|Lost to Follow-up|2|||
125328982|NCT02177032|450837326|FG002|Overall Study|Lost to Follow-up|0|||
125328983|NCT02177032|450837327|FG003|Overall Study|Lost to Follow-up|0|||
125328984|NCT02177032|450837324|FG000|Overall Study|OTHER|2|||
125328985|NCT02177032|450837325|FG001|Overall Study|OTHER|0|||
125328986|NCT02177032|450837326|FG002|Overall Study|OTHER|1|||
125328987|NCT02177032|450837327|FG003|Overall Study|OTHER|0|||
125328988|NCT02177032|450837324|FG000|Overall Study|Withdrawal by Subject|1|||
125328989|NCT02177032|450837325|FG001|Overall Study|Withdrawal by Subject|0|||
125328990|NCT02177032|450837326|FG002|Overall Study|Withdrawal by Subject|1|||
124997292|NCT02202551|449617718|FG000|Overall Study|Death|3|||
124997293|NCT02202551|449617719|FG001|Overall Study|Death|2|||
124997294|NCT02202551|449617720|FG002|Overall Study|Death|1|||
124997295|NCT02202551|449617721|FG003|Overall Study|Death|1|||
124997296|NCT02202551|449617718|FG000|Overall Study|Lost to Follow-up|0|||
124997297|NCT02202551|449617719|FG001|Overall Study|Lost to Follow-up|1|||
124997298|NCT02202551|449617720|FG002|Overall Study|Lost to Follow-up|0|||
124997299|NCT02202551|449617721|FG003|Overall Study|Lost to Follow-up|1|||
124997300|NCT02202551|449617718|FG000|Overall Study|Needed to take excluded medication|0|||
124997301|NCT02202551|449617719|FG001|Overall Study|Needed to take excluded medication|2|||
124997302|NCT02202551|449617720|FG002|Overall Study|Needed to take excluded medication|0|||
124997303|NCT02202551|449617721|FG003|Overall Study|Needed to take excluded medication|1|||
124997304|NCT02202551|449617718|FG000|Overall Study|Subject moved away|0|||
124997305|NCT02202551|449617719|FG001|Overall Study|Subject moved away|1|||
124997306|NCT02202551|449617720|FG002|Overall Study|Subject moved away|0|||
124997307|NCT02202551|449617721|FG003|Overall Study|Subject moved away|0|||
124997308|NCT02202551|449617718|FG000|Overall Study|DBS surgery|3|||
124997309|NCT02202551|449617719|FG001|Overall Study|DBS surgery|0|||
124997310|NCT02202551|449617720|FG002|Overall Study|DBS surgery|0|||
124997311|NCT02202551|449617721|FG003|Overall Study|DBS surgery|0|||
124997312|NCT02202551|449617718|FG000|Overall Study|Dyskinesia upon taper|1|||
124997313|NCT02202551|449617719|FG001|Overall Study|Dyskinesia upon taper|0|||
124997314|NCT02202551|449617720|FG002|Overall Study|Dyskinesia upon taper|0|||
124997315|NCT02202551|449617721|FG003|Overall Study|Dyskinesia upon taper|0|||
124997316|NCT02202551|449617718|FG000|Overall Study|Lack of Efficacy|0|||
124997317|NCT02202551|449617719|FG001|Overall Study|Lack of Efficacy|1|||
124997318|NCT02202551|449617720|FG002|Overall Study|Lack of Efficacy|0|||
124997319|NCT02202551|449617721|FG003|Overall Study|Lack of Efficacy|0|||
124997320|NCT02202551|449617718|FG000|Overall Study|Physician Decision|1|||
124997321|NCT02202551|449617719|FG001|Overall Study|Physician Decision|0|||
124997322|NCT02202551|449617720|FG002|Overall Study|Physician Decision|0|||
124997323|NCT02202551|449617721|FG003|Overall Study|Physician Decision|0|||
124997324|NCT02202551|449617718|FG000|Overall Study|Site closure|3|||
124997325|NCT02202551|449617719|FG001|Overall Study|Site closure|0|||
124997326|NCT02202551|449617720|FG002|Overall Study|Site closure|0|||
124997327|NCT02202551|449617721|FG003|Overall Study|Site closure|1|||
124997328|NCT02202551|449617718|FG000|Overall Study|Unable to complete visits per protocol|1|||
124997329|NCT02202551|449617719|FG001|Overall Study|Unable to complete visits per protocol|0|||
124997330|NCT02202551|449617720|FG002|Overall Study|Unable to complete visits per protocol|0|||
124997331|NCT02202551|449617721|FG003|Overall Study|Unable to complete visits per protocol|0|||
124997332|NCT02202551|449617718|FG000|Overall Study|Worsening Dyskinesia|0|||
124997333|NCT02202551|449617719|FG001|Overall Study|Worsening Dyskinesia|0|||
124997334|NCT02202551|449617720|FG002|Overall Study|Worsening Dyskinesia|0|||
124997335|NCT02202551|449617721|FG003|Overall Study|Worsening Dyskinesia|1|||
124997336|NCT02202551|449617718|FG000|Overall Study|Protocol Violation|0|||
124997337|NCT02202551|449617719|FG001|Overall Study|Protocol Violation|1|||
124997338|NCT02202551|449617720|FG002|Overall Study|Protocol Violation|0|||
124997339|NCT02202551|449617721|FG003|Overall Study|Protocol Violation|0|||
124997340|NCT02202551|449617718|FG000|Overall Study|Sponsor's decision|2|||
124997341|NCT02202551|449617719|FG001|Overall Study|Sponsor's decision|0|||
124997342|NCT02202551|449617720|FG002|Overall Study|Sponsor's decision|0|||
124997343|NCT02202551|449617721|FG003|Overall Study|Sponsor's decision|0|||
124997344|NCT02202551|449617718|FG000|Overall Study|Subject unwilling to proceed|1|||
124997345|NCT02202551|449617719|FG001|Overall Study|Subject unwilling to proceed|5|||
124997346|NCT02202551|449617720|FG002|Overall Study|Subject unwilling to proceed|3|||
124997347|NCT02202551|449617721|FG003|Overall Study|Subject unwilling to proceed|5|||
124997348|NCT02202551|449617718|FG000|Overall Study|Subject consent withdrawn|0|||
124997349|NCT02202551|449617719|FG001|Overall Study|Subject consent withdrawn|3|||
124997350|NCT02202551|449617720|FG002|Overall Study|Subject consent withdrawn|1|||
124997351|NCT02202551|449617721|FG003|Overall Study|Subject consent withdrawn|2|||
124997352|NCT02202551|449617718|FG000|Overall Study|eGFR<50mL/min/m2|2|||
124997353|NCT02202551|449617719|FG001|Overall Study|eGFR<50mL/min/m2|2|||
124997354|NCT02202551|449617720|FG002|Overall Study|eGFR<50mL/min/m2|0|||
124997355|NCT02202551|449617721|FG003|Overall Study|eGFR<50mL/min/m2|1|||
124997356|NCT02147353|449617722|FG000|Overall Study|Lost to Follow-up|2|||
124997357|NCT02147353|449617723|FG001|Overall Study|Lost to Follow-up|0|||
124997358|NCT02147353|449617722|FG000|Overall Study|unable to make visits|4|||
124997359|NCT02147353|449617723|FG001|Overall Study|unable to make visits|0|||
124997360|NCT02147353|449617722|FG000|Overall Study|medication noncompliance|3|||
124997361|NCT02147353|449617723|FG001|Overall Study|medication noncompliance|0|||
124997362|NCT01326533|449617734|FG000|Overall Study|Lost to Follow-up|2|||
124997363|NCT01326533|449617735|FG001|Overall Study|Lost to Follow-up|0|||
124997364|NCT01326533|449617734|FG000|Overall Study|Withdrawal by Subject|1|||
124997365|NCT01326533|449617735|FG001|Overall Study|Withdrawal by Subject|0|||
124997366|NCT01326533|449617734|FG000|Overall Study|Adverse Event|1|||
124997367|NCT01326533|449617735|FG001|Overall Study|Adverse Event|0|||
124997368|NCT00926211|449617736|FG000|Overall Study|Lost to Follow-up|1|||
124997369|NCT00894686|449617740|FG000|Overall Study|Withdrawal by Subject|50|||
125328991|NCT02177032|450837327|FG003|Overall Study|Withdrawal by Subject|0|||
125328992|NCT00665652|450837328|FG000|Overall Study|Adverse Event|4|||
125328993|NCT00665652|450837328|FG000|Overall Study|Death|1|||
125328994|NCT00665652|450837328|FG000|Overall Study|No longer met inclusion criteria.|1|||
125328995|NCT02556177|450837332|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
125328996|NCT02556177|450837333|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
125328997|NCT00734539|450837343|FG000|Main Study|Death|33|||
125328998|NCT00734539|450837344|FG001|Main Study|Death|32|||
125328999|NCT00734539|450837343|FG000|Main Study|Physician Decision|2|||
125329000|NCT00734539|450837344|FG001|Main Study|Physician Decision|0|||
125329001|NCT00734539|450837343|FG000|Main Study|Withdrawal by Subject|1|||
124997370|NCT00894686|449617740|FG000|Overall Study|Physician Decision|1|||
124997371|NCT00894686|449617740|FG000|Overall Study|Other|5|||
124997372|NCT00564018|449617743|FG000|Overall Study|Withdrawal by Subject|2|||
124997373|NCT00564018|449617744|FG001|Overall Study|Withdrawal by Subject|3|||
124997374|NCT00564018|449617745|FG002|Overall Study|Withdrawal by Subject|1|||
124997375|NCT03267940|449617746|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
124997376|NCT03267940|449617747|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
124997377|NCT03267940|449617748|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
124997378|NCT03267940|449617749|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
124997379|NCT03267940|449617750|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
124997380|NCT03267940|449617751|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
124997381|NCT03267940|449617746|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
124997382|NCT03267940|449617747|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
124997383|NCT03267940|449617748|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
124997384|NCT03267940|449617749|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
124997385|NCT03267940|449617750|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
124997386|NCT03267940|449617751|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
124997387|NCT03267940|449617746|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
124997388|NCT03267940|449617747|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
124997389|NCT03267940|449617748|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
124997390|NCT03267940|449617749|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
124997391|NCT03267940|449617750|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
124997392|NCT03267940|449617751|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
124997393|NCT03267940|449617746|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
124997394|NCT03267940|449617747|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
124997395|NCT03267940|449617748|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
124997396|NCT03267940|449617749|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
124997397|NCT03267940|449617750|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
124997398|NCT03267940|449617751|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
124997399|NCT03267940|449617746|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
124997400|NCT03267940|449617747|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
124997401|NCT03267940|449617748|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
124997402|NCT03267940|449617749|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
124997403|NCT03267940|449617750|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
124997404|NCT03267940|449617751|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
124997405|NCT03267940|449617746|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
124997406|NCT03267940|449617747|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
124997407|NCT03267940|449617748|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
124997408|NCT03267940|449617749|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
124997409|NCT03267940|449617750|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
124997410|NCT03267940|449617751|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
124997411|NCT03267940|449617746|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
124997412|NCT03267940|449617747|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
124997413|NCT03267940|449617748|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
124997414|NCT03267940|449617749|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
124997415|NCT03267940|449617750|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
124997416|NCT03267940|449617751|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
124997417|NCT03267940|449617746|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
124997418|NCT03267940|449617747|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
124997419|NCT03267940|449617748|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
124997420|NCT03267940|449617749|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
124997421|NCT03267940|449617750|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
125329002|NCT00734539|450837344|FG001|Main Study|Withdrawal by Subject|3|||
125329003|NCT00734539|450837343|FG000|Main Study|Enrolled in error; ineligible|1|||
125329004|NCT00734539|450837344|FG001|Main Study|Enrolled in error; ineligible|0|||
124997422|NCT03267940|449617751|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
124997423|NCT03267940|449617746|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
124997424|NCT03267940|449617747|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
124997425|NCT03267940|449617748|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
124997426|NCT03267940|449617749|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
124997427|NCT03267940|449617750|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
124997428|NCT03267940|449617751|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
124997429|NCT00388154|449617752|FG000|Overall Study|Withdrawal by Subject|1|||
124997430|NCT02240693|449617761|FG000|Overall Study|Adverse Event|0|||
124997431|NCT02240693|449617762|FG001|Overall Study|Adverse Event|0|||
124997432|NCT02240693|449617763|FG002|Overall Study|Adverse Event|0|||
124997433|NCT02240693|449617764|FG003|Overall Study|Adverse Event|0|||
124997434|NCT02240693|449617765|FG004|Overall Study|Adverse Event|1|||
124997435|NCT02240693|449617761|FG000|Overall Study|Withdrawal by Subject|0|||
124997436|NCT02240693|449617762|FG001|Overall Study|Withdrawal by Subject|0|||
124997437|NCT02240693|449617763|FG002|Overall Study|Withdrawal by Subject|2|||
124997438|NCT02240693|449617764|FG003|Overall Study|Withdrawal by Subject|1|||
124997439|NCT02240693|449617765|FG004|Overall Study|Withdrawal by Subject|0|||
124997440|NCT02240693|449617761|FG000|Overall Study|Other than specified|0|||
124997441|NCT02240693|449617762|FG001|Overall Study|Other than specified|0|||
124997442|NCT02240693|449617763|FG002|Overall Study|Other than specified|2|||
124997443|NCT02240693|449617764|FG003|Overall Study|Other than specified|0|||
124997444|NCT02240693|449617765|FG004|Overall Study|Other than specified|0|||
124997445|NCT01948908|449617766|FG000|Overall Study|Protocol Violation|1|||
124997446|NCT01948908|449617767|FG001|Overall Study|Protocol Violation|0|||
124997447|NCT01948908|449617768|FG002|Overall Study|Protocol Violation|2|||
124997448|NCT03291587|449617769|FG000|Overall Study|Lost to Follow-up|62|||
124997449|NCT03291587|449617770|FG001|Overall Study|Lost to Follow-up|43|||
124997450|NCT03291587|449617769|FG000|Overall Study|Refused to Answer|5|||
124997451|NCT03291587|449617770|FG001|Overall Study|Refused to Answer|2|||
124997452|NCT03291587|449617769|FG000|Overall Study|Death|2|||
124997453|NCT03291587|449617770|FG001|Overall Study|Death|4|||
124997454|NCT03291587|449617769|FG000|Overall Study|Not interested in participating|8|||
124997455|NCT03291587|449617770|FG001|Overall Study|Not interested in participating|6|||
124997456|NCT03291587|449617769|FG000|Overall Study|Too busy to participate|4|||
124997457|NCT03291587|449617770|FG001|Overall Study|Too busy to participate|2|||
124997458|NCT00796120|449617771|FG000|Overall Study|Death|3|||
124997459|NCT00796120|449617772|FG001|Overall Study|Death|0|||
124997460|NCT00796120|449617771|FG000|Overall Study|Adverse Event|11|||
124997461|NCT00796120|449617772|FG001|Overall Study|Adverse Event|6|||
124997462|NCT00796120|449617771|FG000|Overall Study|Progressive disease|22|||
124997463|NCT00796120|449617772|FG001|Overall Study|Progressive disease|13|||
124997464|NCT00796120|449617771|FG000|Overall Study|Participant refusal|3|||
124997465|NCT00796120|449617772|FG001|Overall Study|Participant refusal|4|||
124997466|NCT00796120|449617771|FG000|Overall Study|Other|6|||
124997467|NCT00796120|449617772|FG001|Overall Study|Other|17|||
124997468|NCT00796120|449617771|FG000|Overall Study|Physician Decision|16|||
124997469|NCT00796120|449617772|FG001|Overall Study|Physician Decision|17|||
124997470|NCT00796120|449617771|FG000|Overall Study|Randomized but not treated|0|||
124997471|NCT00796120|449617772|FG001|Overall Study|Randomized but not treated|3|||
124997472|NCT00413972|449617777|FG000|Overall Study|Adverse Event|2|||
124997473|NCT00413972|449617778|FG001|Overall Study|Adverse Event|1|||
124997474|NCT00413972|449617779|FG002|Overall Study|Adverse Event|0|||
124997475|NCT00413972|449617780|FG003|Overall Study|Adverse Event|0|||
124997476|NCT00413972|449617777|FG000|Overall Study|Lost to Follow-up|1|||
124997477|NCT00413972|449617778|FG001|Overall Study|Lost to Follow-up|2|||
124997478|NCT00413972|449617779|FG002|Overall Study|Lost to Follow-up|1|||
124997479|NCT00413972|449617780|FG003|Overall Study|Lost to Follow-up|0|||
124997480|NCT00413972|449617777|FG000|Overall Study|Withdrawal by Subject|4|||
124997481|NCT00413972|449617778|FG001|Overall Study|Withdrawal by Subject|5|||
124997482|NCT00413972|449617779|FG002|Overall Study|Withdrawal by Subject|7|||
124997483|NCT00413972|449617780|FG003|Overall Study|Withdrawal by Subject|2|||
124997484|NCT00413972|449617777|FG000|Overall Study|Protocol Violation|0|||
124997485|NCT00413972|449617778|FG001|Overall Study|Protocol Violation|0|||
124997486|NCT00413972|449617779|FG002|Overall Study|Protocol Violation|2|||
124997487|NCT00413972|449617780|FG003|Overall Study|Protocol Violation|0|||
124997488|NCT00413972|449617777|FG000|Overall Study|Other|0|||
124997489|NCT00413972|449617778|FG001|Overall Study|Other|0|||
124997490|NCT00413972|449617779|FG002|Overall Study|Other|0|||
124997491|NCT00413972|449617780|FG003|Overall Study|Other|1|||
124997492|NCT01898923|449617783|FG000|Overall Study|Lack of Efficacy|5|||
124997493|NCT01898923|449617784|FG001|Overall Study|Lack of Efficacy|6|||
124997494|NCT01898923|449617783|FG000|Overall Study|Adverse Event|3|||
124997495|NCT01898923|449617784|FG001|Overall Study|Adverse Event|1|||
124997496|NCT01898923|449617783|FG000|Overall Study|Lost to Follow-up|0|||
124997497|NCT01898923|449617784|FG001|Overall Study|Lost to Follow-up|1|||
124997498|NCT01898923|449617783|FG000|Overall Study|Withdrawal by Subject|4|||
124997499|NCT01898923|449617784|FG001|Overall Study|Withdrawal by Subject|7|||
124997500|NCT01898923|449617783|FG000|Overall Study|Physician Decision|3|||
124997501|NCT01898923|449617784|FG001|Overall Study|Physician Decision|4|||
124997502|NCT01898923|449617783|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
124997503|NCT01898923|449617784|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
124997504|NCT00381303|449617785|FG000|Overall Study|Lost to Follow-up|25|||
124997505|NCT00381303|449617786|FG001|Overall Study|Lost to Follow-up|9|||
124997506|NCT00381303|449617785|FG000|Overall Study|AE/HIV-related event|22|||
124997507|NCT00381303|449617786|FG001|Overall Study|AE/HIV-related event|6|||
124997508|NCT00381303|449617785|FG000|Overall Study|Non-Adherence|13|||
124997509|NCT00381303|449617786|FG001|Overall Study|Non-Adherence|6|||
124997510|NCT00381303|449617785|FG000|Overall Study|Withdrawal by Subject|13|||
124997511|NCT00381303|449617786|FG001|Overall Study|Withdrawal by Subject|6|||
124997512|NCT00381303|449617785|FG000|Overall Study|Virologic failure|6|||
124997513|NCT00381303|449617786|FG001|Overall Study|Virologic failure|4|||
124997514|NCT00381303|449617785|FG000|Overall Study|Ineligible to continue the trial|2|||
124997515|NCT00381303|449617786|FG001|Overall Study|Ineligible to continue the trial|1|||
124997516|NCT00381303|449617785|FG000|Overall Study|Pregnancy|2|||
124997517|NCT00381303|449617786|FG001|Overall Study|Pregnancy|0|||
124997518|NCT00381303|449617785|FG000|Overall Study|Physician Decision|1|||
124997519|NCT00381303|449617786|FG001|Overall Study|Physician Decision|0|||
124997520|NCT00381303|449617785|FG000|Overall Study|Physician's decision to close the site|3|||
124997521|NCT00381303|449617786|FG001|Overall Study|Physician's decision to close the site|1|||
124997522|NCT00381303|449617785|FG000|Overall Study|Subject moved out of state|2|||
124997523|NCT00381303|449617786|FG001|Overall Study|Subject moved out of state|0|||
124997524|NCT00381303|449617785|FG000|Overall Study|Subject taking too many different meds|1|||
124997525|NCT00381303|449617786|FG001|Overall Study|Subject taking too many different meds|0|||
124997526|NCT00381303|449617785|FG000|Overall Study|No virologic response by week 12|1|||
124997527|NCT00381303|449617786|FG001|Overall Study|No virologic response by week 12|0|||
124997528|NCT00381303|449617785|FG000|Overall Study|Subject was too busy for appointments|1|||
124997529|NCT00381303|449617786|FG001|Overall Study|Subject was too busy for appointments|0|||
124997530|NCT00381303|449617785|FG000|Overall Study|Subject did not continue visits|1|||
124997531|NCT00381303|449617786|FG001|Overall Study|Subject did not continue visits|0|||
124997532|NCT00381303|449617785|FG000|Overall Study|Subject primary physician's decision|1|||
124997533|NCT00381303|449617786|FG001|Overall Study|Subject primary physician's decision|0|||
124997534|NCT01966471|449617789|FG000|Overall Study|Death|44|||
124997535|NCT01966471|449617790|FG001|Overall Study|Death|56|||
124997536|NCT01966471|449617789|FG000|Overall Study|Lost to Follow-up|46|||
124997537|NCT01966471|449617790|FG001|Overall Study|Lost to Follow-up|39|||
124997538|NCT01966471|449617789|FG000|Overall Study|Various reasons|4|||
124997539|NCT01966471|449617790|FG001|Overall Study|Various reasons|4|||
124997540|NCT01966471|449617789|FG000|Overall Study|Physician Decision|7|||
124997541|NCT01966471|449617790|FG001|Overall Study|Physician Decision|5|||
124997542|NCT01966471|449617789|FG000|Overall Study|Study Terminated By Sponsor|758|||
124997543|NCT01966471|449617790|FG001|Overall Study|Study Terminated By Sponsor|773|||
124997544|NCT01966471|449617789|FG000|Overall Study|Withdrawal by Subject|59|||
124997545|NCT01966471|449617790|FG001|Overall Study|Withdrawal by Subject|51|||
124997546|NCT00494481|449617791|FG000|Overall Study|Condition under investigation worsened|11|||
124997547|NCT00494481|449617792|FG001|Overall Study|Condition under investigation worsened|13|||
124997548|NCT00494481|449617791|FG000|Overall Study|Adverse Event|15|||
124997549|NCT00494481|449617792|FG001|Overall Study|Adverse Event|11|||
124997550|NCT00494481|449617791|FG000|Overall Study|Other|1|||
124997551|NCT00494481|449617792|FG001|Overall Study|Other|0|||
124997552|NCT00494481|449617791|FG000|Overall Study|Never received IP|2|||
124997553|NCT00494481|449617792|FG001|Overall Study|Never received IP|0|||
124997554|NCT01030198|449617793|FG000|Overall Study|Could not measure efficacy accurately|0|||
124997555|NCT01030198|449617794|FG001|Overall Study|Could not measure efficacy accurately|7|||
124997556|NCT00332189|449617795|FG000|Overall Study|Adverse Event|3|||
124997557|NCT00332189|449617795|FG000|Overall Study|Uncooperative/Noncompliant|3|||
124997558|NCT00332189|449617795|FG000|Overall Study|Withdrawal by Subject|9|||
124997559|NCT00332189|449617795|FG000|Overall Study|Lack of Efficacy|4|||
124997560|NCT00332189|449617795|FG000|Overall Study|Moved out of country|2|||
124997561|NCT02370043|449617796|FG000|Overall Study|Withdrawal by Subject|0|||
124997562|NCT02370043|449617797|FG001|Overall Study|Withdrawal by Subject|0|||
124997563|NCT02370043|449617798|FG002|Overall Study|Withdrawal by Subject|0|||
124997564|NCT02370043|449617799|FG003|Overall Study|Withdrawal by Subject|0|||
124997565|NCT02370043|449617800|FG004|Overall Study|Withdrawal by Subject|1|||
124997566|NCT02370043|449617801|FG005|Overall Study|Withdrawal by Subject|1|||
124997567|NCT02279862|449617802|FG000|Overall Study|Study drug toxicity|3|||
124997568|NCT02279862|449617803|FG001|Overall Study|Study drug toxicity|6|||
124997569|NCT02279862|449617802|FG000|Overall Study|No longer meets criteria|0|||
124997570|NCT02279862|449617803|FG001|Overall Study|No longer meets criteria|1|||
124997571|NCT02279862|449617802|FG000|Overall Study|Administrative reason by sponsor|0|||
125210686|NCT02638259|450395634|FG000|Treatment Period 2|Withdrawal by Subject|1|||
124997572|NCT02279862|449617803|FG001|Overall Study|Administrative reason by sponsor|1|||
124997573|NCT02279862|449617802|FG000|Overall Study|Disease progression|5|||
124997574|NCT02279862|449617803|FG001|Overall Study|Disease progression|2|||
124997575|NCT02279862|449617802|FG000|Overall Study|Study closed by sponsor|16|||
124997576|NCT02279862|449617803|FG001|Overall Study|Study closed by sponsor|13|||
124997577|NCT02279862|449617802|FG000|Overall Study|Other|1|||
124997578|NCT02279862|449617803|FG001|Overall Study|Other|2|||
124997579|NCT02279862|449617802|FG000|Overall Study|Withdrawal by Subject|1|||
124997580|NCT02279862|449617803|FG001|Overall Study|Withdrawal by Subject|0|||
124997581|NCT01163721|449617804|FG000|Overall Study|Adverse Event|5|||
124997582|NCT01163721|449617805|FG001|Overall Study|Adverse Event|6|||
124997583|NCT01163721|449617804|FG000|Overall Study|Withdrawal by Subject|3|||
124997584|NCT01163721|449617805|FG001|Overall Study|Withdrawal by Subject|4|||
124997585|NCT01163721|449617804|FG000|Overall Study|Lost to Follow-up|0|||
124997586|NCT01163721|449617805|FG001|Overall Study|Lost to Follow-up|1|||
124997587|NCT01163721|449617804|FG000|Overall Study|Physician Decision|0|||
124997588|NCT01163721|449617805|FG001|Overall Study|Physician Decision|1|||
124997589|NCT00688181|449617806|FG000|Overall Study|Lost to Follow-up|17|||
124997590|NCT00688181|449617806|FG000|Overall Study|Unknown Reason|4|||
124997591|NCT00688181|449617806|FG000|Overall Study|Non-clinical Reason|2|||
124997592|NCT01050205|449617807|FG000|Overall Study|Lost to Follow-up|7|||
124997593|NCT01050205|449617808|FG001|Overall Study|Lost to Follow-up|1|||
124997594|NCT01050205|449617807|FG000|Overall Study|Withdrawal by Subject|1|||
124997595|NCT01050205|449617808|FG001|Overall Study|Withdrawal by Subject|1|||
124997596|NCT01050205|449617807|FG000|Overall Study|Relocated from area|1|||
124997597|NCT01050205|449617808|FG001|Overall Study|Relocated from area|2|||
124997598|NCT01050205|449617807|FG000|Overall Study|Discontinued Intervention|2|||
124997599|NCT01050205|449617808|FG001|Overall Study|Discontinued Intervention|0|||
124997600|NCT01119001|449617809|FG000|Overall Study|Withdrawal by Subject|2|||
124997601|NCT00810394|449617812|FG000|Overall Study|Withdrawal by Subject|3|||
124997602|NCT06515483|449617823|FG000|Overall Study|Subject withdraw due to family issues|1|||
124997603|NCT06515483|449617824|FG001|Overall Study|Subject withdraw due to family issues|0|||
124997604|NCT01103245|449619186|FG000|Overall Study|Withdrawal by Subject|1|||
124997605|NCT01103245|449619187|FG001|Overall Study|Withdrawal by Subject|0|||
124997606|NCT01103245|449619188|FG002|Overall Study|Withdrawal by Subject|3|||
124997607|NCT01103245|449619189|FG003|Overall Study|Withdrawal by Subject|0|||
124997608|NCT01103245|449619186|FG000|Overall Study|Inadequate IV access|1|||
124997609|NCT01103245|449619187|FG001|Overall Study|Inadequate IV access|0|||
124997610|NCT01103245|449619188|FG002|Overall Study|Inadequate IV access|0|||
124997611|NCT01103245|449619189|FG003|Overall Study|Inadequate IV access|0|||
124997612|NCT01103245|449619186|FG000|Overall Study|Adverse Event|0|||
124997613|NCT01103245|449619187|FG001|Overall Study|Adverse Event|2|||
124997614|NCT01103245|449619188|FG002|Overall Study|Adverse Event|1|||
124997615|NCT01103245|449619189|FG003|Overall Study|Adverse Event|0|||
124997616|NCT01103245|449619186|FG000|Overall Study|Physician Decision|1|||
124997617|NCT01103245|449619187|FG001|Overall Study|Physician Decision|0|||
124997618|NCT01103245|449619188|FG002|Overall Study|Physician Decision|0|||
124997619|NCT01103245|449619189|FG003|Overall Study|Physician Decision|0|||
124997620|NCT00720941|449619190|FG000|Overall Study|Protocol Violation|1|||
124997621|NCT00720941|449619191|FG001|Overall Study|Protocol Violation|2|||
124997622|NCT00720941|449619190|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
124997623|NCT00720941|449619191|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
124997624|NCT00720941|449619190|FG000|Overall Study|Lost to Follow-up|20|||
124997625|NCT00720941|449619191|FG001|Overall Study|Lost to Follow-up|15|||
124997626|NCT00720941|449619190|FG000|Overall Study|Physician Decision|14|||
124997627|NCT00720941|449619191|FG001|Overall Study|Physician Decision|12|||
124997628|NCT00720941|449619190|FG000|Overall Study|Withdrawal by Subject|29|||
124997629|NCT00720941|449619191|FG001|Overall Study|Withdrawal by Subject|36|||
124997630|NCT00355056|449619192|FG000|Randomization Period|Early Termination|4|||
124997631|NCT00355056|449619193|FG001|Randomization Period|Early Termination|6|||
124997632|NCT01072877|449619194|FG000|Overall Study|Lost to Follow-up|1|||
124997633|NCT01072877|449619195|FG001|Overall Study|Lost to Follow-up|1|||
124997634|NCT01072877|449619196|FG002|Overall Study|Lost to Follow-up|0|||
124997635|NCT01072877|449619197|FG003|Overall Study|Lost to Follow-up|2|||
124997636|NCT01072877|449619198|FG004|Overall Study|Lost to Follow-up|0|||
124997637|NCT02720536|449619199|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
124997638|NCT02720536|449619199|FG000|Overall Study|PR - pregnancy|2|||
124997639|NCT02720536|449619199|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
124997640|NCT02720536|449619199|FG000|Overall Study|PR - death|1|||
124997641|NCT02720536|449619199|FG000|Overall Study|PR - adverse event|1|||
124997642|NCT02720536|449619199|FG000|Overall Study|PR - abnormal lab value(s)|1|||
124997643|NCT02720536|449619199|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
124997644|NCT02120625|449619201|FG000|Overall Study|Physician Decision|2|||
124997645|NCT00820027|449619202|FG000|Overall Study|Adverse Event|15|||
124997646|NCT00820027|449619203|FG001|Overall Study|Adverse Event|8|||
124997647|NCT00820027|449619204|FG002|Overall Study|Adverse Event|10|||
124997648|NCT00820027|449619205|FG003|Overall Study|Adverse Event|5|||
124997649|NCT00820027|449619202|FG000|Overall Study|Lack of Efficacy|2|||
124997650|NCT00820027|449619203|FG001|Overall Study|Lack of Efficacy|1|||
125329005|NCT02504151|450837347|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
125329006|NCT02504151|450837348|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
125329007|NCT02504151|450837347|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
125329008|NCT02504151|450837348|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
124997651|NCT00820027|449619204|FG002|Overall Study|Lack of Efficacy|2|||
124997652|NCT00820027|449619205|FG003|Overall Study|Lack of Efficacy|2|||
124997653|NCT00820027|449619202|FG000|Overall Study|Physician Decision|0|||
124997654|NCT00820027|449619203|FG001|Overall Study|Physician Decision|1|||
124997655|NCT00820027|449619204|FG002|Overall Study|Physician Decision|1|||
124997656|NCT00820027|449619205|FG003|Overall Study|Physician Decision|0|||
124997657|NCT00820027|449619202|FG000|Overall Study|Protocol Violation|3|||
124997658|NCT00820027|449619203|FG001|Overall Study|Protocol Violation|0|||
124997659|NCT00820027|449619204|FG002|Overall Study|Protocol Violation|4|||
124997660|NCT00820027|449619205|FG003|Overall Study|Protocol Violation|0|||
124997661|NCT00820027|449619202|FG000|Overall Study|Withdrawal by Subject|6|||
124997662|NCT00820027|449619203|FG001|Overall Study|Withdrawal by Subject|4|||
124997663|NCT00820027|449619204|FG002|Overall Study|Withdrawal by Subject|4|||
124997664|NCT00820027|449619205|FG003|Overall Study|Withdrawal by Subject|6|||
124997665|NCT00908232|449619206|FG000|Cycle 1 to 4|Death|5|||
124997666|NCT00908232|449619207|FG001|Cycle 1 to 4|Death|0|||
124997667|NCT00908232|449619208|FG002|Cycle 1 to 4|Death|0|||
124997668|NCT00908232|449619209|FG003|Cycle 1 to 4|Death|0|||
124997669|NCT00908232|449619206|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
124997670|NCT00908232|449619207|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
124997671|NCT00908232|449619208|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
124997672|NCT00908232|449619209|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
124997673|NCT00908232|449619206|FG000|Cycle 1 to 4|Progressive Disease|6|||
124997674|NCT00908232|449619207|FG001|Cycle 1 to 4|Progressive Disease|0|||
124997675|NCT00908232|449619208|FG002|Cycle 1 to 4|Progressive Disease|0|||
124997676|NCT00908232|449619209|FG003|Cycle 1 to 4|Progressive Disease|0|||
124997677|NCT00908232|449619206|FG000|Cycle 1 to 4|Adverse Event|12|||
124997678|NCT00908232|449619207|FG001|Cycle 1 to 4|Adverse Event|0|||
124997679|NCT00908232|449619208|FG002|Cycle 1 to 4|Adverse Event|0|||
124997680|NCT00908232|449619209|FG003|Cycle 1 to 4|Adverse Event|0|||
124997681|NCT00908232|449619206|FG000|Cycle 1 to 4|Other|1|||
124997682|NCT00908232|449619207|FG001|Cycle 1 to 4|Other|0|||
124997683|NCT00908232|449619208|FG002|Cycle 1 to 4|Other|0|||
124997684|NCT00908232|449619209|FG003|Cycle 1 to 4|Other|0|||
124997685|NCT00908232|449619206|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
124997686|NCT00908232|449619207|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
124997687|NCT00908232|449619208|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
124997688|NCT00908232|449619209|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
124997689|NCT00908232|449619206|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
124997690|NCT00908232|449619207|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
124997691|NCT00908232|449619208|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
124997692|NCT00908232|449619209|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
124997693|NCT00908232|449619206|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
124997694|NCT00908232|449619207|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
124997695|NCT00908232|449619208|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
124997696|NCT00908232|449619209|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
124997697|NCT00908232|449619206|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
124997698|NCT00908232|449619207|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
124997699|NCT00908232|449619208|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
124997700|NCT00908232|449619209|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
124997701|NCT00908232|449619206|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
124997702|NCT00908232|449619207|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
124997703|NCT00908232|449619208|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
124997704|NCT00908232|449619209|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
124997705|NCT00908232|449619206|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
124997706|NCT00908232|449619207|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
124997707|NCT00908232|449619208|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
124997708|NCT00908232|449619209|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
124997709|NCT00908232|449619206|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
124997710|NCT00908232|449619207|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
124997711|NCT00908232|449619208|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
124997712|NCT00908232|449619209|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
124997713|NCT00908232|449619206|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
124997714|NCT00908232|449619207|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
124997715|NCT00908232|449619208|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
124997716|NCT00908232|449619209|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
124997717|NCT00954174|449619210|FG000|Overall Study|Adverse Event|28|||
124997718|NCT00954174|449619211|FG001|Overall Study|Adverse Event|23|||
124997719|NCT00954174|449619212|FG002|Overall Study|Adverse Event|4|||
124997720|NCT00954174|449619213|FG003|Overall Study|Adverse Event|9|||
124997721|NCT00954174|449619210|FG000|Overall Study|Death|4|||
124997722|NCT00954174|449619211|FG001|Overall Study|Death|2|||
124997723|NCT00954174|449619212|FG002|Overall Study|Death|0|||
124997724|NCT00954174|449619213|FG003|Overall Study|Death|0|||
124997725|NCT00954174|449619210|FG000|Overall Study|Lack of Efficacy|32|||
124997726|NCT00954174|449619211|FG001|Overall Study|Lack of Efficacy|22|||
124997727|NCT00954174|449619212|FG002|Overall Study|Lack of Efficacy|8|||
124997728|NCT00954174|449619213|FG003|Overall Study|Lack of Efficacy|6|||
124997729|NCT00954174|449619210|FG000|Overall Study|Withdrawal by Subject|14|||
124997730|NCT00954174|449619211|FG001|Overall Study|Withdrawal by Subject|10|||
124997731|NCT00954174|449619212|FG002|Overall Study|Withdrawal by Subject|4|||
124997732|NCT00954174|449619213|FG003|Overall Study|Withdrawal by Subject|3|||
124997733|NCT00954174|449619210|FG000|Overall Study|Medical Reason|4|||
124997734|NCT00954174|449619211|FG001|Overall Study|Medical Reason|2|||
124997735|NCT00954174|449619212|FG002|Overall Study|Medical Reason|1|||
124997736|NCT00954174|449619213|FG003|Overall Study|Medical Reason|0|||
124997737|NCT00954174|449619210|FG000|Overall Study|Ineligible|40|||
124997738|NCT00954174|449619211|FG001|Overall Study|Ineligible|47|||
124997739|NCT00954174|449619212|FG002|Overall Study|Ineligible|7|||
124997740|NCT00954174|449619213|FG003|Overall Study|Ineligible|4|||
124997741|NCT00954174|449619210|FG000|Overall Study|Never Treated|4|||
124997742|NCT00954174|449619211|FG001|Overall Study|Never Treated|17|||
124997743|NCT00954174|449619212|FG002|Overall Study|Never Treated|0|||
124997744|NCT00954174|449619213|FG003|Overall Study|Never Treated|3|||
124997745|NCT01776424|449619218|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
124997746|NCT01776424|449619219|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
124997747|NCT01776424|449619220|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
124997748|NCT01776424|449619218|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
124997749|NCT01776424|449619219|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
125329009|NCT02504151|450837347|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
124997750|NCT01776424|449619220|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
125329010|NCT02504151|450837348|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
125329011|NCT02504151|450837347|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
125329012|NCT02504151|450837348|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
125329013|NCT00389610|450837351|FG000|Overall Study|Disease Progression|0|||
125329014|NCT00389610|450837352|FG001|Overall Study|Disease Progression|19|||
125329015|NCT00389610|450837351|FG000|Overall Study|Death|0|||
125329016|NCT00389610|450837352|FG001|Overall Study|Death|1|||
125329017|NCT00389610|450837351|FG000|Overall Study|Physician Decision|0|||
124997751|NCT01776424|449619218|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
124997752|NCT01776424|449619219|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
124997753|NCT01776424|449619220|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
124997754|NCT01776424|449619218|FG000|LTOLE Part (Open Label)|Refused|5|||
124997755|NCT01776424|449619219|FG001|LTOLE Part (Open Label)|Refused|2|||
124997756|NCT01776424|449619220|FG002|LTOLE Part (Open Label)|Refused|11|||
124997757|NCT01776424|449619218|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
124997758|NCT01776424|449619219|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
124997759|NCT01776424|449619220|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
124997760|NCT00146757|449619221|FG000|Overall Study|Death|1|||
124997761|NCT00146757|449619222|FG001|Overall Study|Death|0|||
124997762|NCT00146757|449619221|FG000|Overall Study|Adverse Event|1|||
124997763|NCT00146757|449619222|FG001|Overall Study|Adverse Event|0|||
124997764|NCT03181451|449619230|FG000|Overall Study|Adverse Event|0|||
124997765|NCT03181451|449619231|FG001|Overall Study|Adverse Event|1|||
124997766|NCT03181451|449619232|FG002|Overall Study|Adverse Event|0|||
124997767|NCT03181451|449619230|FG000|Overall Study|Withdrawal by Subject|0|||
124997768|NCT03181451|449619231|FG001|Overall Study|Withdrawal by Subject|1|||
124997769|NCT03181451|449619232|FG002|Overall Study|Withdrawal by Subject|0|||
124997770|NCT04744285|449619240|FG000|Overall Study|Withdrawal by Subject|1|||
124997771|NCT04744285|449619241|FG001|Overall Study|Withdrawal by Subject|1|||
124997772|NCT04744285|449619242|FG002|Overall Study|Withdrawal by Subject|2|||
124997773|NCT04744285|449619243|FG003|Overall Study|Withdrawal by Subject|1|||
124997774|NCT00752622|449619251|FG000|Induction Phase|Adverse Event|3|||
124997775|NCT00752622|449619251|FG000|Induction Phase|Other|3|||
124997776|NCT00752622|449619251|FG000|Induction Phase|Non-responder|14|||
124997777|NCT00752622|449619251|FG000|Induction Phase|Withdrawal by Subject|1|||
124997778|NCT00752622|449619251|FG000|Induction Phase|Premature study termination|14|||
124997779|NCT00752622|449619251|FG000|Observational Phase|Premature Study Termination|36|||
125329018|NCT00389610|450837352|FG001|Overall Study|Physician Decision|1|||
124997780|NCT00752622|449619251|FG000|Observational Phase|Non-responder|2|||
125329019|NCT00389610|450837351|FG000|Overall Study|Withdrawal by Subject|0|||
125329020|NCT00389610|450837352|FG001|Overall Study|Withdrawal by Subject|1|||
124997781|NCT00752622|449619251|FG000|Observational Phase|Withdrawal by Subject|2|||
124997782|NCT00752622|449619251|FG000|Observational Phase|Adverse Event|1|||
124997783|NCT00752622|449619251|FG000|Observational Phase|Other|2|||
124997784|NCT00752622|449619251|FG000|Interventional Phase|Non-responder|2|||
124997785|NCT00752622|449619251|FG000|Interventional Phase|Physician Decision|1|||
124997786|NCT00752622|449619251|FG000|Interventional Phase|Premature Study Termination|5|||
124997787|NCT00576836|449619252|FG000|Overall Study|Death|0|||
124997788|NCT00576836|449619253|FG001|Overall Study|Death|1|||
124997789|NCT00576836|449619252|FG000|Overall Study|Physician Decision|0|||
124997790|NCT00576836|449619253|FG001|Overall Study|Physician Decision|1|||
124997791|NCT02520284|449619254|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
124997792|NCT02520284|449619255|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
124997793|NCT02520284|449619256|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
124997794|NCT02520284|449619254|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
124997795|NCT02520284|449619255|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
124997796|NCT02520284|449619256|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
124997797|NCT02520284|449619254|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
124997798|NCT02520284|449619255|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
124997799|NCT02520284|449619256|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
124997800|NCT02520284|449619254|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
124997801|NCT02520284|449619255|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
124997802|NCT02520284|449619256|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
124997803|NCT02520284|449619254|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
124997804|NCT02520284|449619255|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
124997805|NCT02520284|449619256|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
124997806|NCT02520284|449619254|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
124997807|NCT02520284|449619255|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
124997808|NCT02520284|449619256|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
124997809|NCT02520284|449619254|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
124997810|NCT02520284|449619255|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
124997811|NCT02520284|449619256|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
124997812|NCT02520284|449619254|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
124997813|NCT02520284|449619255|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
124997814|NCT02520284|449619256|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
124997815|NCT02520284|449619254|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
124997816|NCT02520284|449619255|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
124997817|NCT02520284|449619256|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
124997818|NCT02520284|449619254|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
124997819|NCT02520284|449619255|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
124997820|NCT02520284|449619256|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
124997821|NCT02520284|449619254|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
124997822|NCT02520284|449619255|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
124997823|NCT02520284|449619256|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
124997824|NCT01211522|449619259|FG000|Overall Study|Withdrawal by Subject|3|||
124997825|NCT01211522|449619260|FG001|Overall Study|Withdrawal by Subject|7|||
124997826|NCT01211522|449619261|FG002|Overall Study|Withdrawal by Subject|5|||
124997827|NCT01116882|449619268|FG000|30-day|Lost to Follow-up|50|||
124997828|NCT01116882|449619269|FG001|30-day|Lost to Follow-up|21|||
124997829|NCT01116882|449619268|FG000|30-day|Withdrawal by Subject|2|||
124997830|NCT01116882|449619269|FG001|30-day|Withdrawal by Subject|4|||
124997831|NCT01116882|449619268|FG000|30-day|Other Reasons|16|||
124997832|NCT01116882|449619269|FG001|30-day|Other Reasons|6|||
124997833|NCT01116882|449619268|FG000|12-month|Lost to Follow-up|111|||
125329021|NCT00538902|450837353|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
125329022|NCT00538902|450837354|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
125329023|NCT00538902|450837355|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
125329024|NCT00538902|450837353|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
125329025|NCT00538902|450837354|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
125329026|NCT00538902|450837355|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
125329027|NCT00538902|450837353|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
125329028|NCT00538902|450837354|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
125329029|NCT00538902|450837355|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
125329030|NCT00538902|450837353|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
125329031|NCT00538902|450837354|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
125329032|NCT00538902|450837355|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
125329033|NCT00538902|450837353|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
125329034|NCT00538902|450837354|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
125329035|NCT00538902|450837355|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
125329036|NCT00538902|450837353|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
125329037|NCT00538902|450837354|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
124997834|NCT01116882|449619269|FG001|12-month|Lost to Follow-up|42|||
125329038|NCT00538902|450837355|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
125329039|NCT00538902|450837353|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
125329040|NCT00538902|450837354|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
125329041|NCT00538902|450837355|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
125329042|NCT00538902|450837353|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
125329043|NCT00538902|450837354|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
125329044|NCT00538902|450837355|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
125329045|NCT02557139|450837359|FG000|Overall Study|Significant liver elevation|1|||
125329046|NCT02557139|450837360|FG001|Overall Study|Significant liver elevation|0|||
125329047|NCT02557139|450837361|FG002|Overall Study|Significant liver elevation|1|||
125329048|NCT02557139|450837359|FG000|Overall Study|Withdrawal by Subject|1|||
125329049|NCT02557139|450837360|FG001|Overall Study|Withdrawal by Subject|0|||
125329050|NCT02557139|450837361|FG002|Overall Study|Withdrawal by Subject|0|||
125329051|NCT02557139|450837359|FG000|Overall Study|Illness of prohibited medication|0|||
125329052|NCT02557139|450837360|FG001|Overall Study|Illness of prohibited medication|0|||
124997835|NCT01116882|449619268|FG000|12-month|Other Reasons|151|||
124997836|NCT01116882|449619269|FG001|12-month|Other Reasons|49|||
124997837|NCT01116882|449619268|FG000|12-month|Withdrawal by Subject|5|||
124997838|NCT01116882|449619269|FG001|12-month|Withdrawal by Subject|8|||
124997839|NCT00547365|449619270|FG000|Overall Study|Physician Decision|1|||
124997840|NCT00547365|449619270|FG000|Overall Study|Lost to Follow-up|1|||
124997841|NCT00547365|449619270|FG000|Overall Study|Protocol Violation|2|||
124997842|NCT00547365|449619270|FG000|Overall Study|death (not related to study)|4|||
124997843|NCT01139658|449619271|FG000|Overall Study|Adverse Event|10|||
124997844|NCT01139658|449619272|FG001|Overall Study|Adverse Event|27|||
124997845|NCT01139658|449619271|FG000|Overall Study|Lack of Efficacy|15|||
124997846|NCT01139658|449619272|FG001|Overall Study|Lack of Efficacy|7|||
124997847|NCT01139658|449619271|FG000|Overall Study|Withdrawal by Subject|2|||
124997848|NCT01139658|449619272|FG001|Overall Study|Withdrawal by Subject|4|||
124997849|NCT01139658|449619271|FG000|Overall Study|No documentation of treatment|1|||
124997850|NCT01139658|449619272|FG001|Overall Study|No documentation of treatment|0|||
124997851|NCT01139658|449619271|FG000|Overall Study|Other|28|||
124997852|NCT01139658|449619272|FG001|Overall Study|Other|75|||
124997853|NCT00504881|449619273|FG000|Overall Study|Lack of Efficacy|1|||
124997854|NCT00504881|449619274|FG001|Overall Study|Lack of Efficacy|5|||
124997855|NCT00504881|449619273|FG000|Overall Study|Lost to Follow-up|0|||
124997856|NCT00504881|449619274|FG001|Overall Study|Lost to Follow-up|2|||
124997857|NCT00504881|449619273|FG000|Overall Study|Withdrawal by Subject|1|||
124997858|NCT00504881|449619274|FG001|Overall Study|Withdrawal by Subject|4|||
124997859|NCT00504881|449619273|FG000|Overall Study|Non-Compliance|1|||
124997860|NCT00504881|449619274|FG001|Overall Study|Non-Compliance|0|||
124997861|NCT00504881|449619273|FG000|Overall Study|No Birth Control|0|||
124997862|NCT00504881|449619274|FG001|Overall Study|No Birth Control|1|||
124997863|NCT00504881|449619273|FG000|Overall Study|Safety Visit not performed|0|||
124997864|NCT00504881|449619274|FG001|Overall Study|Safety Visit not performed|1|||
124997865|NCT00504881|449619273|FG000|Overall Study|AE, serious fatal|0|||
124997866|NCT00504881|449619274|FG001|Overall Study|AE, serious fatal|1|||
124997867|NCT00504881|449619273|FG000|Overall Study|SAE, non-fatal|2|||
124997868|NCT00504881|449619274|FG001|Overall Study|SAE, non-fatal|6|||
124997869|NCT00504881|449619273|FG000|Overall Study|AE, non-serious non-fatal|4|||
124997870|NCT00504881|449619274|FG001|Overall Study|AE, non-serious non-fatal|14|||
124997871|NCT00504881|449619273|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
124997872|NCT00504881|449619274|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
124997873|NCT00504881|449619273|FG000|Overall Study|AE of unknown type|1|||
125329053|NCT02557139|450837361|FG002|Overall Study|Illness of prohibited medication|1|||
125329054|NCT01454102|450837362|FG000|Overall Study|Continuing in the treatment period|0|||
125329055|NCT01454102|450837363|FG001|Overall Study|Continuing in the treatment period|0|||
125329056|NCT01454102|450837364|FG002|Overall Study|Continuing in the treatment period|0|||
125329057|NCT01454102|450837365|FG003|Overall Study|Continuing in the treatment period|0|||
125329058|NCT01454102|450837366|FG004|Overall Study|Continuing in the treatment period|3|||
125329059|NCT01454102|450837367|FG005|Overall Study|Continuing in the treatment period|3|||
125329060|NCT01454102|450837368|FG006|Overall Study|Continuing in the treatment period|2|||
125329061|NCT01454102|450837369|FG007|Overall Study|Continuing in the treatment period|0|||
125329062|NCT01454102|450837370|FG008|Overall Study|Continuing in the treatment period|1|||
124997874|NCT00504881|449619274|FG001|Overall Study|AE of unknown type|0|||
124997875|NCT01777269|449619275|FG000|Overall Study|Adverse Event|24|||
124997876|NCT01777269|449619276|FG001|Overall Study|Adverse Event|33|||
124997877|NCT01777269|449619275|FG000|Overall Study|Lack of Efficacy|8|||
124997878|NCT01777269|449619276|FG001|Overall Study|Lack of Efficacy|10|||
124997879|NCT01777269|449619275|FG000|Overall Study|Protocol Violation|4|||
124997880|NCT01777269|449619276|FG001|Overall Study|Protocol Violation|4|||
124997881|NCT01777269|449619275|FG000|Overall Study|Participants reached stopping criteria|1|||
124997882|NCT01777269|449619276|FG001|Overall Study|Participants reached stopping criteria|1|||
124997883|NCT01777269|449619275|FG000|Overall Study|Lost to Follow-up|4|||
124997884|NCT01777269|449619276|FG001|Overall Study|Lost to Follow-up|0|||
124997885|NCT01777269|449619275|FG000|Overall Study|Physician Decision|5|||
124997886|NCT01777269|449619276|FG001|Overall Study|Physician Decision|2|||
124997887|NCT01777269|449619275|FG000|Overall Study|Withdrawal by Subject|9|||
124997888|NCT01777269|449619276|FG001|Overall Study|Withdrawal by Subject|9|||
124997889|NCT00803270|449619278|FG000|Overall Study|Lost to Follow-up|1|||
124997890|NCT00803270|449619279|FG001|Overall Study|Lost to Follow-up|2|||
124997891|NCT00593957|449619283|FG000|Overall Study|Physician Decision|0|||
124997892|NCT00593957|449619284|FG001|Overall Study|Physician Decision|1|||
124997893|NCT00593957|449619285|FG002|Overall Study|Physician Decision|2|||
124997894|NCT03707925|449619288|FG000|Overall Study|Inevaluable|1|||
124997895|NCT02511678|449619291|FG000|Overall Study|Withdrawal by Subject|2|||
124997896|NCT02511678|449619291|FG000|Overall Study|Lost to Follow-up|4|||
124997897|NCT02511678|449619291|FG000|Overall Study|Death|19|||
124997898|NCT02511678|449619291|FG000|Overall Study|Adverse Event|1|||
124997899|NCT02511678|449619291|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
124997900|NCT02511678|449619291|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
124997901|NCT02511678|449619291|FG000|Overall Study|Required Radiofrequency Ablation|1|||
124997902|NCT02511678|449619291|FG000|Overall Study|Biopsy was Negative|1|||
124997903|NCT02511678|449619291|FG000|Overall Study|Protocol Violation|1|||
124997904|NCT02511678|449619291|FG000|Overall Study|Received Radiation Treatment|1|||
124997905|NCT01295281|449619292|FG000|First Intervention (7 Days)|Death|0|||
124997906|NCT01295281|449619293|FG001|First Intervention (7 Days)|Death|1|||
124997907|NCT01411839|449619295|FG000|Overall Study|Lost to Follow-up|4|||
124997908|NCT01411839|449619296|FG001|Overall Study|Lost to Follow-up|3|||
124997909|NCT05461794|449619299|FG000|Overall Study|Withdrawal by Subject|1|||
124997910|NCT05461794|449619300|FG001|Overall Study|Withdrawal by Subject|1|||
124997911|NCT05461794|449619301|FG002|Overall Study|Withdrawal by Subject|3|||
124997912|NCT05461794|449619299|FG000|Overall Study|Study Terminated By Sponsor|18|||
124997913|NCT05461794|449619300|FG001|Overall Study|Study Terminated By Sponsor|13|||
124997914|NCT05461794|449619301|FG002|Overall Study|Study Terminated By Sponsor|16|||
124997915|NCT05461794|449619299|FG000|Overall Study|Death|20|||
124997916|NCT05461794|449619300|FG001|Overall Study|Death|5|||
124997917|NCT05461794|449619301|FG002|Overall Study|Death|19|||
124997918|NCT02684357|449619302|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
124997919|NCT02684357|449619303|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
124997920|NCT02684357|449619304|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
124997921|NCT02684357|449619305|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
124997922|NCT02684357|449619306|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
124997923|NCT02684357|449619307|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
124997924|NCT02684357|449619302|FG000|Part A|Lost to Follow-up|0|||
124997925|NCT02684357|449619303|FG001|Part A|Lost to Follow-up|2|||
124997926|NCT02684357|449619304|FG002|Part A|Lost to Follow-up|2|||
124997927|NCT02684357|449619305|FG003|Part A|Lost to Follow-up|0|||
124997928|NCT02684357|449619306|FG004|Part A|Lost to Follow-up|0|||
124997929|NCT02684357|449619307|FG005|Part A|Lost to Follow-up|0|||
124997930|NCT02684357|449619302|FG000|Part A|Withdrawal by Subject|3|||
124997931|NCT02684357|449619303|FG001|Part A|Withdrawal by Subject|0|||
124997932|NCT02684357|449619304|FG002|Part A|Withdrawal by Subject|0|||
124997933|NCT02684357|449619305|FG003|Part A|Withdrawal by Subject|0|||
124997934|NCT02684357|449619306|FG004|Part A|Withdrawal by Subject|0|||
124997935|NCT02684357|449619307|FG005|Part A|Withdrawal by Subject|0|||
124997936|NCT02684357|449619302|FG000|Part A|Other|0|||
124997937|NCT02684357|449619303|FG001|Part A|Other|1|||
124997938|NCT02684357|449619304|FG002|Part A|Other|0|||
124997939|NCT02684357|449619305|FG003|Part A|Other|0|||
124997940|NCT02684357|449619306|FG004|Part A|Other|0|||
124997941|NCT02684357|449619307|FG005|Part A|Other|0|||
124997942|NCT02684357|449619302|FG000|Part B|Adverse Event (Other)|0|||
124997943|NCT02684357|449619303|FG001|Part B|Adverse Event (Other)|0|||
124997944|NCT02684357|449619304|FG002|Part B|Adverse Event (Other)|0|||
124997945|NCT02684357|449619305|FG003|Part B|Adverse Event (Other)|1|||
125329063|NCT01454102|450837371|FG009|Overall Study|Continuing in the treatment period|0|||
125329064|NCT01454102|450837372|FG010|Overall Study|Continuing in the treatment period|0|||
125329065|NCT01454102|450837373|FG011|Overall Study|Continuing in the treatment period|4|||
124997946|NCT02684357|449619306|FG004|Part B|Adverse Event (Other)|1|||
125329066|NCT01454102|450837374|FG012|Overall Study|Continuing in the treatment period|7|||
124997947|NCT02684357|449619307|FG005|Part B|Adverse Event (Other)|1|||
124997948|NCT02684357|449619302|FG000|Part B|Lost to Follow-up|0|||
124997949|NCT02684357|449619303|FG001|Part B|Lost to Follow-up|0|||
124997950|NCT02684357|449619304|FG002|Part B|Lost to Follow-up|0|||
124997951|NCT02684357|449619305|FG003|Part B|Lost to Follow-up|1|||
124997952|NCT02684357|449619306|FG004|Part B|Lost to Follow-up|1|||
124997953|NCT02684357|449619307|FG005|Part B|Lost to Follow-up|7|||
124997954|NCT02684357|449619302|FG000|Part B|Withdrawal by Subject|0|||
124997955|NCT02684357|449619303|FG001|Part B|Withdrawal by Subject|0|||
124997956|NCT02684357|449619304|FG002|Part B|Withdrawal by Subject|0|||
124997957|NCT02684357|449619305|FG003|Part B|Withdrawal by Subject|0|||
124997958|NCT02684357|449619306|FG004|Part B|Withdrawal by Subject|2|||
124997959|NCT02684357|449619307|FG005|Part B|Withdrawal by Subject|4|||
124997960|NCT02684357|449619302|FG000|Part B|Other|0|||
124997961|NCT02684357|449619303|FG001|Part B|Other|0|||
125329067|NCT01454102|450837375|FG013|Overall Study|Continuing in the treatment period|4|||
125329068|NCT01454102|450837376|FG014|Overall Study|Continuing in the treatment period|3|||
125329069|NCT01454102|450837377|FG015|Overall Study|Continuing in the treatment period|1|||
125329070|NCT02592798|450837383|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
125329071|NCT02592798|450837384|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
125329072|NCT02592798|450837383|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
125329073|NCT02592798|450837384|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
125329074|NCT02592798|450837383|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
125329075|NCT02592798|450837384|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
125329076|NCT02592798|450837383|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
125329077|NCT02592798|450837384|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
125329078|NCT02592798|450837383|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
125329079|NCT02592798|450837384|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
125329080|NCT02592798|450837383|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
125329081|NCT02592798|450837384|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
125329082|NCT02592798|450837383|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
125329083|NCT02592798|450837384|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
125329084|NCT02592798|450837383|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
125329085|NCT02592798|450837384|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
125329086|NCT02592798|450837383|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
125329087|NCT02592798|450837384|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
125329088|NCT02592798|450837383|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
125329089|NCT02592798|450837384|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
125329090|NCT02592798|450837383|FG000|Transition From DB2 to OLE|Other reasons|1|||
125329091|NCT02592798|450837384|FG001|Transition From DB2 to OLE|Other reasons|0|||
125329092|NCT02592798|450837383|FG000|Open Label Period (OLE)|Other reasons|0|||
125329093|NCT02592798|450837384|FG001|Open Label Period (OLE)|Other reasons|2|||
125329094|NCT02592798|450837383|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
125329095|NCT02592798|450837384|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
125329096|NCT02592798|450837383|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
125329097|NCT02592798|450837384|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
125329098|NCT02592798|450837383|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
125329099|NCT02592798|450837384|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
125329100|NCT02592798|450837383|FG000|Open Label Period (OLE)|Adverse Event|0|||
125329101|NCT02592798|450837384|FG001|Open Label Period (OLE)|Adverse Event|1|||
125329102|NCT00705016|450837385|FG000|Overall Study|Adverse Event|6|||
125329103|NCT00705016|450837386|FG001|Overall Study|Adverse Event|11|||
125329104|NCT00705016|450837387|FG002|Overall Study|Adverse Event|10|||
125329105|NCT00705016|450837385|FG000|Overall Study|Death|5|||
125329106|NCT00705016|450837386|FG001|Overall Study|Death|7|||
125329107|NCT00705016|450837387|FG002|Overall Study|Death|5|||
125329108|NCT00705016|450837385|FG000|Overall Study|Protocol Violation|0|||
125329109|NCT00705016|450837386|FG001|Overall Study|Protocol Violation|1|||
125329110|NCT00705016|450837387|FG002|Overall Study|Protocol Violation|1|||
125329111|NCT00705016|450837385|FG000|Overall Study|Withdrawal by Subject|4|||
125329112|NCT00705016|450837386|FG001|Overall Study|Withdrawal by Subject|3|||
125329113|NCT00705016|450837387|FG002|Overall Study|Withdrawal by Subject|2|||
125329114|NCT00705016|450837385|FG000|Overall Study|Progressive Disease|33|||
125329115|NCT00705016|450837386|FG001|Overall Study|Progressive Disease|29|||
125329116|NCT00705016|450837387|FG002|Overall Study|Progressive Disease|33|||
125329117|NCT00705016|450837385|FG000|Overall Study|Symptomatic Deterioration|3|||
124997962|NCT02684357|449619304|FG002|Part B|Other|0|||
124997963|NCT02684357|449619305|FG003|Part B|Other|1|||
124997964|NCT02684357|449619306|FG004|Part B|Other|0|||
124997965|NCT02684357|449619307|FG005|Part B|Other|1|||
124997966|NCT01079130|449619308|FG000|Overall Study|Adverse Event|1|||
124997967|NCT01079130|449619309|FG001|Overall Study|Adverse Event|1|||
124997968|NCT01079130|449619310|FG002|Overall Study|Adverse Event|0|||
124997969|NCT01079130|449619311|FG003|Overall Study|Adverse Event|1|||
124997970|NCT01079130|449619312|FG004|Overall Study|Adverse Event|5|||
124997971|NCT01079130|449619313|FG005|Overall Study|Adverse Event|1|||
124997972|NCT01079130|449619308|FG000|Overall Study|Administrative problems|1|||
125329118|NCT00705016|450837386|FG001|Overall Study|Symptomatic Deterioration|1|||
125329119|NCT00705016|450837387|FG002|Overall Study|Symptomatic Deterioration|1|||
125329120|NCT00705016|450837385|FG000|Overall Study|Other|9|||
125329121|NCT00705016|450837386|FG001|Overall Study|Other|6|||
125329122|NCT00705016|450837387|FG002|Overall Study|Other|6|||
125329123|NCT01967940|450837394|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
125329124|NCT01967940|450837395|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
125329125|NCT01967940|450837396|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
125329126|NCT01967940|450837397|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
124997973|NCT01079130|449619309|FG001|Overall Study|Administrative problems|3|||
124997974|NCT01079130|449619310|FG002|Overall Study|Administrative problems|0|||
125329127|NCT01967940|450837394|FG000|Part 2|Adverse Event|0|||
125329128|NCT01967940|450837395|FG001|Part 2|Adverse Event|0|||
124997975|NCT01079130|449619311|FG003|Overall Study|Administrative problems|0|||
124997976|NCT01079130|449619312|FG004|Overall Study|Administrative problems|0|||
124997977|NCT01079130|449619313|FG005|Overall Study|Administrative problems|1|||
124997978|NCT01079130|449619308|FG000|Overall Study|Withdrawal by Subject|0|||
124997979|NCT01079130|449619309|FG001|Overall Study|Withdrawal by Subject|1|||
124997980|NCT01079130|449619310|FG002|Overall Study|Withdrawal by Subject|0|||
124997981|NCT01079130|449619311|FG003|Overall Study|Withdrawal by Subject|0|||
124997982|NCT01079130|449619312|FG004|Overall Study|Withdrawal by Subject|1|||
124997983|NCT01079130|449619313|FG005|Overall Study|Withdrawal by Subject|3|||
124997984|NCT01079130|449619308|FG000|Overall Study|Protocol deviation|0|||
124997985|NCT01079130|449619309|FG001|Overall Study|Protocol deviation|2|||
124997986|NCT01079130|449619310|FG002|Overall Study|Protocol deviation|1|||
124997987|NCT01079130|449619311|FG003|Overall Study|Protocol deviation|2|||
124997988|NCT01079130|449619312|FG004|Overall Study|Protocol deviation|0|||
124997989|NCT01079130|449619313|FG005|Overall Study|Protocol deviation|0|||
124997990|NCT01079130|449619308|FG000|Overall Study|Abnormal test procedure result(s)|0|||
124997991|NCT01079130|449619309|FG001|Overall Study|Abnormal test procedure result(s)|0|||
124997992|NCT01079130|449619310|FG002|Overall Study|Abnormal test procedure result(s)|0|||
124997993|NCT01079130|449619311|FG003|Overall Study|Abnormal test procedure result(s)|0|||
124997994|NCT01079130|449619312|FG004|Overall Study|Abnormal test procedure result(s)|1|||
124997995|NCT01079130|449619313|FG005|Overall Study|Abnormal test procedure result(s)|0|||
124997996|NCT01079130|449619308|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124997997|NCT01079130|449619309|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124997998|NCT01079130|449619310|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
124997999|NCT01079130|449619311|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
124998000|NCT01079130|449619312|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
124998001|NCT01079130|449619313|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
124998002|NCT01079130|449619308|FG000|Overall Study|Lost to Follow-up|0|||
124998003|NCT01079130|449619309|FG001|Overall Study|Lost to Follow-up|0|||
124998004|NCT01079130|449619310|FG002|Overall Study|Lost to Follow-up|0|||
124998005|NCT01079130|449619311|FG003|Overall Study|Lost to Follow-up|0|||
124998006|NCT01079130|449619312|FG004|Overall Study|Lost to Follow-up|1|||
124998007|NCT01079130|449619313|FG005|Overall Study|Lost to Follow-up|0|||
124998008|NCT04821869|449619319|FG000|Overall Study|Adverse Event|4|||
124998009|NCT04821869|449619319|FG000|Overall Study|Withdrawal by Subject|2|||
124998010|NCT04821869|449619319|FG000|Overall Study|Did not meet FEV1 criteria|1|||
124998011|NCT03444324|449619320|FG000|Overall Study|Withdrawal by Subject|0|||
124998012|NCT03444324|449619321|FG001|Overall Study|Withdrawal by Subject|1|||
124998013|NCT03444324|449619320|FG000|Overall Study|Lost to Follow-up|4|||
124998014|NCT03444324|449619321|FG001|Overall Study|Lost to Follow-up|2|||
124998015|NCT03444324|449619320|FG000|Overall Study|Protocol Violation|0|||
124998016|NCT03444324|449619321|FG001|Overall Study|Protocol Violation|1|||
124998017|NCT03444324|449619320|FG000|Overall Study|Lack of Trial Compliance|1|||
124998018|NCT03444324|449619321|FG001|Overall Study|Lack of Trial Compliance|1|||
124998019|NCT03444324|449619320|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
124998020|NCT03444324|449619321|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
124998021|NCT01390181|449620894|FG000|Overall Study|Lost to Follow-up|1|||
124998022|NCT01390181|449620894|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
124998023|NCT02805725|449620895|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
124998024|NCT02805725|449620896|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
124998025|NCT02805725|449620897|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
124998026|NCT02805725|449620898|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
124998027|NCT02805725|449620899|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
124998028|NCT02805725|449620895|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
124998029|NCT02805725|449620896|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
124998030|NCT02805725|449620897|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
124998031|NCT02805725|449620898|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
124998032|NCT02805725|449620899|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
124998033|NCT02805725|449620895|FG000|Phase II|Protocol Violation|0|||
124998034|NCT02805725|449620896|FG001|Phase II|Protocol Violation|0|||
124998035|NCT02805725|449620897|FG002|Phase II|Protocol Violation|0|||
124998036|NCT02805725|449620898|FG003|Phase II|Protocol Violation|0|||
124998037|NCT02805725|449620899|FG004|Phase II|Protocol Violation|6|||
124998038|NCT01195545|449620900|FG000|Overall Study|Protocol Violation|4|||
124998039|NCT02425644|449620901|FG000|Overall Study|Lost to Follow-up|2|||
124998040|NCT02425644|449620902|FG001|Overall Study|Lost to Follow-up|3|||
124998041|NCT02425644|449620901|FG000|Overall Study|Withdrawal by Subject|41|||
124998042|NCT02425644|449620902|FG001|Overall Study|Withdrawal by Subject|36|||
124998043|NCT02425644|449620901|FG000|Overall Study|Lack of Efficacy|3|||
124998044|NCT02425644|449620902|FG001|Overall Study|Lack of Efficacy|10|||
124998045|NCT02425644|449620901|FG000|Overall Study|Adverse Event|13|||
124998046|NCT02425644|449620902|FG001|Overall Study|Adverse Event|3|||
124998047|NCT02425644|449620901|FG000|Overall Study|Death|0|||
124998048|NCT02425644|449620902|FG001|Overall Study|Death|2|||
124998049|NCT02425644|449620901|FG000|Overall Study|Other|18|||
124998050|NCT02425644|449620902|FG001|Overall Study|Other|17|||
124998051|NCT00909792|449620903|FG000|Period 1|Did not meet inclusion criteria|0|||
124998052|NCT00909792|449620904|FG001|Period 1|Did not meet inclusion criteria|1|||
124998053|NCT00909792|449620903|FG000|Period 2|Biomicroscopy|1|||
124998054|NCT00909792|449620904|FG001|Period 2|Biomicroscopy|0|||
124998055|NCT00909792|449620903|FG000|Period 2|Lost to Follow-up|0|||
124998056|NCT00909792|449620904|FG001|Period 2|Lost to Follow-up|1|||
124998057|NCT01177787|449620905|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
124998058|NCT01177787|449620905|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
124998059|NCT01177787|449620905|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
124998060|NCT00402363|449620908|FG000|Overall Study|Adverse Event|9|||
124998061|NCT00402363|449620909|FG001|Overall Study|Adverse Event|14|||
124998062|NCT00402363|449620910|FG002|Overall Study|Adverse Event|2|||
124998063|NCT00402363|449620911|FG003|Overall Study|Adverse Event|2|||
124998064|NCT00402363|449620908|FG000|Overall Study|Withdrew Consent|10|||
124998065|NCT00402363|449620909|FG001|Overall Study|Withdrew Consent|5|||
124998066|NCT00402363|449620910|FG002|Overall Study|Withdrew Consent|2|||
124998067|NCT00402363|449620911|FG003|Overall Study|Withdrew Consent|1|||
124998068|NCT00402363|449620908|FG000|Overall Study|Protocol Violation|3|||
124998069|NCT00402363|449620909|FG001|Overall Study|Protocol Violation|5|||
124998070|NCT00402363|449620910|FG002|Overall Study|Protocol Violation|0|||
124998071|NCT00402363|449620911|FG003|Overall Study|Protocol Violation|3|||
124998072|NCT00402363|449620908|FG000|Overall Study|Lost to Follow-up|5|||
124998073|NCT00402363|449620909|FG001|Overall Study|Lost to Follow-up|4|||
124998074|NCT00402363|449620910|FG002|Overall Study|Lost to Follow-up|0|||
124998075|NCT00402363|449620911|FG003|Overall Study|Lost to Follow-up|2|||
124998076|NCT00402363|449620908|FG000|Overall Study|"Captured as Other"|6|||
124998077|NCT00402363|449620909|FG001|Overall Study|"Captured as Other"|2|||
124998078|NCT00402363|449620910|FG002|Overall Study|"Captured as Other"|2|||
124998079|NCT00402363|449620911|FG003|Overall Study|"Captured as Other"|2|||
124998080|NCT00293722|449620912|FG000|Overall Study|Other|427|||
124998081|NCT02634346|449620914|FG000|Overall Study|Withdrawal by Subject|8|||
124998082|NCT02634346|449620915|FG001|Overall Study|Withdrawal by Subject|9|||
124998083|NCT02634346|449620916|FG002|Overall Study|Withdrawal by Subject|8|||
124998084|NCT02634346|449620914|FG000|Overall Study|Adverse Event|2|||
124998085|NCT02634346|449620915|FG001|Overall Study|Adverse Event|2|||
124998086|NCT02634346|449620916|FG002|Overall Study|Adverse Event|7|||
124998087|NCT02634346|449620914|FG000|Overall Study|Lack of Efficacy|1|||
124998088|NCT02634346|449620915|FG001|Overall Study|Lack of Efficacy|2|||
124998089|NCT02634346|449620916|FG002|Overall Study|Lack of Efficacy|8|||
124998090|NCT02634346|449620914|FG000|Overall Study|Lost to Follow-up|1|||
124998091|NCT02634346|449620915|FG001|Overall Study|Lost to Follow-up|0|||
124998092|NCT02634346|449620916|FG002|Overall Study|Lost to Follow-up|0|||
124998093|NCT02634346|449620914|FG000|Overall Study|Protocol Violation|0|||
124998094|NCT02634346|449620915|FG001|Overall Study|Protocol Violation|1|||
124998095|NCT02634346|449620916|FG002|Overall Study|Protocol Violation|0|||
124998096|NCT02824263|449620918|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
124998097|NCT02824263|449620919|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
125329129|NCT01967940|450837396|FG002|Part 2|Adverse Event|0|||
125329130|NCT01967940|450837397|FG003|Part 2|Adverse Event|1|||
125329131|NCT01967940|450837394|FG000|Part 2|Unknown Reason|0|||
125329132|NCT01967940|450837395|FG001|Part 2|Unknown Reason|0|||
125329133|NCT01967940|450837396|FG002|Part 2|Unknown Reason|0|||
125329134|NCT01967940|450837397|FG003|Part 2|Unknown Reason|1|||
125329135|NCT00942604|450837399|FG000|Overall Study|Protocol Violation|1|||
125329136|NCT00942604|450837400|FG001|Overall Study|Protocol Violation|1|||
125329137|NCT00942604|450837399|FG000|Overall Study|Adverse Event|0|||
125329138|NCT00942604|450837400|FG001|Overall Study|Adverse Event|1|||
125329139|NCT00942604|450837399|FG000|Overall Study|Withdrawal by Subject|0|||
125329140|NCT00942604|450837400|FG001|Overall Study|Withdrawal by Subject|1|||
125329141|NCT00942604|450837399|FG000|Overall Study|Patient relocation|1|||
125329142|NCT00942604|450837400|FG001|Overall Study|Patient relocation|1|||
125329143|NCT01188343|450837401|FG000|Overall Study|Not vaccinated|0|||
125329144|NCT01188343|450837402|FG001|Overall Study|Not vaccinated|2|||
125329145|NCT01188343|450837403|FG002|Overall Study|Not vaccinated|1|||
125329146|NCT01188343|450837401|FG000|Overall Study|Withdrawal by Subject|1|||
125329147|NCT01188343|450837402|FG001|Overall Study|Withdrawal by Subject|24|||
125329148|NCT01188343|450837403|FG002|Overall Study|Withdrawal by Subject|0|||
124998098|NCT02824263|449620918|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
124998099|NCT02824263|449620919|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
124998100|NCT01008696|449620920|FG000|Overall Study|Participant's evasion of hospital visit|5|||
124998101|NCT01008696|449620921|FG001|Overall Study|Participant's evasion of hospital visit|4|||
124998102|NCT01008696|449620920|FG000|Overall Study|Withdrawal by Subject|2|||
124998103|NCT01008696|449620921|FG001|Overall Study|Withdrawal by Subject|4|||
124998104|NCT01008696|449620920|FG000|Overall Study|Physician Decision|5|||
124998105|NCT01008696|449620921|FG001|Overall Study|Physician Decision|1|||
125329149|NCT01143246|450837404|FG000|Overall Study|Adverse Event|24|||
125329150|NCT01143246|450837405|FG001|Overall Study|Adverse Event|28|||
125329151|NCT01143246|450837404|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
124998106|NCT01008696|449620920|FG000|Overall Study|Adverse Event|1|||
124998107|NCT01008696|449620921|FG001|Overall Study|Adverse Event|0|||
124998108|NCT01008696|449620920|FG000|Overall Study|Participants' non-cooperation|2|||
124998109|NCT01008696|449620921|FG001|Overall Study|Participants' non-cooperation|3|||
124998110|NCT01008696|449620920|FG000|Overall Study|Other|2|||
124998111|NCT01008696|449620921|FG001|Overall Study|Other|3|||
124998112|NCT01008696|449620920|FG000|Overall Study|Other|0|||
124998113|NCT01008696|449620921|FG001|Overall Study|Other|2|||
124998114|NCT00568321|449620922|FG000|Overall Study|Adverse Event|1|||
124998115|NCT00568321|449620923|FG001|Overall Study|Adverse Event|0|||
124998116|NCT00568321|449620924|FG002|Overall Study|Adverse Event|0|||
124998117|NCT00568321|449620922|FG000|Overall Study|Lack of Efficacy|8|||
124998118|NCT00568321|449620923|FG001|Overall Study|Lack of Efficacy|5|||
124998119|NCT00568321|449620924|FG002|Overall Study|Lack of Efficacy|6|||
124998120|NCT00568321|449620922|FG000|Overall Study|Lost to Follow-up|0|||
124998121|NCT00568321|449620923|FG001|Overall Study|Lost to Follow-up|0|||
124998122|NCT00568321|449620924|FG002|Overall Study|Lost to Follow-up|1|||
124998123|NCT00568321|449620922|FG000|Overall Study|Withdrawal by Subject|2|||
124998124|NCT00568321|449620923|FG001|Overall Study|Withdrawal by Subject|0|||
124998125|NCT00568321|449620924|FG002|Overall Study|Withdrawal by Subject|0|||
124998126|NCT00568321|449620922|FG000|Overall Study|Protocol Violation|0|||
124998127|NCT00568321|449620923|FG001|Overall Study|Protocol Violation|0|||
124998128|NCT00568321|449620924|FG002|Overall Study|Protocol Violation|1|||
124998129|NCT00568321|449620922|FG000|Overall Study|Randomized, not treated|2|||
124998130|NCT00568321|449620923|FG001|Overall Study|Randomized, not treated|0|||
124998131|NCT00568321|449620924|FG002|Overall Study|Randomized, not treated|1|||
124998132|NCT00937833|449620925|FG000|Overall Study|Protocol Violation|1|||
124998133|NCT00937833|449620926|FG001|Overall Study|Protocol Violation|2|||
124998134|NCT00937833|449620925|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
124998135|NCT00937833|449620926|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
124998136|NCT00937833|449620925|FG000|Overall Study|Lost to Follow-up|10|||
124998137|NCT00937833|449620926|FG001|Overall Study|Lost to Follow-up|8|||
124998138|NCT00937833|449620925|FG000|Overall Study|Withdrawal by Subject|4|||
124998139|NCT00937833|449620926|FG001|Overall Study|Withdrawal by Subject|6|||
124998140|NCT01676909|449620927|FG000|Overall Study|Withdrawal by Subject|3|||
124998141|NCT01676909|449620928|FG001|Overall Study|Withdrawal by Subject|5|||
125329152|NCT01143246|450837405|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
125329153|NCT01143246|450837404|FG000|Overall Study|Lost to Follow-up|0|||
125329154|NCT01143246|450837405|FG001|Overall Study|Lost to Follow-up|1|||
125329155|NCT01143246|450837404|FG000|Overall Study|Death|16|||
125329156|NCT01143246|450837405|FG001|Overall Study|Death|15|||
125329157|NCT01143246|450837404|FG000|Overall Study|Reason not Specified|3|||
125329158|NCT01143246|450837405|FG001|Overall Study|Reason not Specified|5|||
125329159|NCT01663103|450837406|FG000|Overall Study|Withdrawal by Subject|1|||
125329160|NCT01663103|450837407|FG001|Overall Study|Withdrawal by Subject|2|||
125329161|NCT01663103|450837406|FG000|Overall Study|Adverse Event|1|||
125329162|NCT01663103|450837407|FG001|Overall Study|Adverse Event|0|||
125329163|NCT01663103|450837406|FG000|Overall Study|dog bite|1|||
125329164|NCT01663103|450837407|FG001|Overall Study|dog bite|0|||
125329165|NCT05375760|450837408|FG000|Overall Study|Adverse Event|1|||
125329166|NCT05375760|450837409|FG001|Overall Study|Adverse Event|0|||
125329167|NCT05375760|450837408|FG000|Overall Study|Death|0|||
125329168|NCT05375760|450837409|FG001|Overall Study|Death|1|||
125329169|NCT05375760|450837408|FG000|Overall Study|Lost to Follow-up|6|||
125329170|NCT05375760|450837409|FG001|Overall Study|Lost to Follow-up|6|||
125329171|NCT05375760|450837408|FG000|Overall Study|Withdrawal by Subject|17|||
125329172|NCT05375760|450837409|FG001|Overall Study|Withdrawal by Subject|19|||
125329173|NCT05375760|450837408|FG000|Overall Study|Dosing halted by FDA|96|||
125329174|NCT05375760|450837409|FG001|Overall Study|Dosing halted by FDA|100|||
125329175|NCT05375760|450837408|FG000|Overall Study|Not compliant with study visit|2|||
125329176|NCT05375760|450837409|FG001|Overall Study|Not compliant with study visit|0|||
125329177|NCT05375760|450837408|FG000|Overall Study|Physician Decision|1|||
125329178|NCT05375760|450837409|FG001|Overall Study|Physician Decision|0|||
124998142|NCT01676909|449620927|FG000|Overall Study|Lost to Follow-up|15|||
124998143|NCT01676909|449620928|FG001|Overall Study|Lost to Follow-up|9|||
124998144|NCT00221195|449620933|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
124998145|NCT00221195|449620934|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
124998146|NCT00221195|449620933|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
124998147|NCT00221195|449620934|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
124998148|NCT00221195|449620933|FG000|Washout Period (Months 7-9)|Death|0|||
124998149|NCT00221195|449620934|FG001|Washout Period (Months 7-9)|Death|1|||
124998150|NCT00221195|449620933|FG000|Therapy 2 (Months 10-15)|Death|1|||
124998151|NCT00221195|449620934|FG001|Therapy 2 (Months 10-15)|Death|0|||
124998152|NCT00221195|449620933|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
125329179|NCT05375760|450837408|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
125329180|NCT05375760|450837409|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
125329181|NCT05375760|450837408|FG000|Overall Study|Participant moved|1|||
124998153|NCT00221195|449620934|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
124998154|NCT00162032|449620936|FG000|Overall Study|Lost to Follow-up|4|||
124998155|NCT00162032|449620937|FG001|Overall Study|Lost to Follow-up|2|||
124998156|NCT00162032|449620936|FG000|Overall Study|Reason not specified|1|||
124998157|NCT00162032|449620937|FG001|Overall Study|Reason not specified|0|||
124998158|NCT00833911|449620938|FG000|Titration|Adverse Event|18|||
124998159|NCT00833911|449620938|FG000|Titration|Withdrawal by Subject|3|||
124998160|NCT00833911|449620938|FG000|Maintenance Phase I|Adverse Event|73|||
124998161|NCT00833911|449620938|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
124998162|NCT00833911|449620938|FG000|Maintenance Phase I|Physician Decision|10|||
124998163|NCT00833911|449620938|FG000|Maintenance Phase I|Lack of Efficacy|4|||
124998164|NCT00833911|449620938|FG000|Maintenance Phase II|Adverse Event|6|||
124998165|NCT00833911|449620938|FG000|Maintenance Phase II|Physician Decision|2|||
124998166|NCT00833911|449620938|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
124998167|NCT00833911|449620938|FG000|Maintenance Phase II|Lack of Efficacy|1|||
124998168|NCT00718640|449620939|FG000|Overall Study|Adverse Event|4|||
124998169|NCT00718640|449620939|FG000|Overall Study|Death|1|||
124998170|NCT00718640|449620939|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
124998171|NCT00818389|449620942|FG000|Overall Study|Death|1|||
124998172|NCT00818389|449620943|FG001|Overall Study|Death|3|||
124998173|NCT00818389|449620942|FG000|Overall Study|ALS Disease Progression|1|||
124998174|NCT00818389|449620943|FG001|Overall Study|ALS Disease Progression|0|||
124998175|NCT00818389|449620942|FG000|Overall Study|Withdrawal by Subject|2|||
124998176|NCT00818389|449620943|FG001|Overall Study|Withdrawal by Subject|2|||
124998177|NCT00818389|449620942|FG000|Overall Study|Adverse Event|0|||
124998178|NCT00818389|449620943|FG001|Overall Study|Adverse Event|1|||
124998179|NCT01207596|449620944|FG000|Overall Study|Physician Decision|4|||
125329182|NCT05375760|450837409|FG001|Overall Study|Participant moved|0|||
125329183|NCT00363480|450837410|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
125329184|NCT00363480|450837410|FG000|Overall Study|Adverse Event|4|||
125329185|NCT00363480|450837410|FG000|Overall Study|Lost to Follow-up|5|||
125329186|NCT00363480|450837410|FG000|Overall Study|Withdrawal by Subject|5|||
125329187|NCT00363480|450837410|FG000|Overall Study|Non-compliance of subject|1|||
125329188|NCT00363480|450837410|FG000|Overall Study|Participant discontinued on its own|1|||
125329189|NCT05567783|450837413|FG000|Overall Study|Death|2|||
125329190|NCT05567783|450837414|FG001|Overall Study|Death|3|||
125329191|NCT05567783|450837415|FG002|Overall Study|Death|0|||
125329192|NCT05567783|450837413|FG000|Overall Study|Lost to Follow-up|25|||
124998180|NCT01207596|449620944|FG000|Overall Study|Lack of Efficacy|1|||
124998181|NCT01207596|449620944|FG000|Overall Study|Adverse Event|3|||
124998182|NCT01207596|449620944|FG000|Overall Study|Withdrawal by Subject|1|||
125329193|NCT05567783|450837414|FG001|Overall Study|Lost to Follow-up|19|||
124998183|NCT03548987|449620945|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
125329194|NCT05567783|450837415|FG002|Overall Study|Lost to Follow-up|17|||
125329195|NCT05567783|450837413|FG000|Overall Study|Physician Decision|10|||
125329196|NCT05567783|450837414|FG001|Overall Study|Physician Decision|7|||
125329197|NCT05567783|450837415|FG002|Overall Study|Physician Decision|9|||
125329198|NCT05567783|450837413|FG000|Overall Study|Study Terminated by Sponsor|924|||
125329199|NCT05567783|450837414|FG001|Overall Study|Study Terminated by Sponsor|937|||
125329200|NCT05567783|450837415|FG002|Overall Study|Study Terminated by Sponsor|941|||
125329201|NCT05567783|450837413|FG000|Overall Study|Withdrawal by Subject|23|||
125329202|NCT05567783|450837414|FG001|Overall Study|Withdrawal by Subject|27|||
125329203|NCT05567783|450837415|FG002|Overall Study|Withdrawal by Subject|24|||
125329204|NCT05567783|450837413|FG000|Overall Study|Incarcerated|1|||
125329205|NCT05567783|450837414|FG001|Overall Study|Incarcerated|0|||
125329206|NCT05567783|450837415|FG002|Overall Study|Incarcerated|0|||
125329207|NCT05567783|450837413|FG000|Overall Study|Participant randomized in error|4|||
125329208|NCT05567783|450837414|FG001|Overall Study|Participant randomized in error|2|||
125329209|NCT05567783|450837415|FG002|Overall Study|Participant randomized in error|2|||
125329210|NCT03113487|450837420|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
125329211|NCT03944577|450837426|FG000|Overall Study|Adverse Event|3|||
124998184|NCT03548987|449620946|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
124998185|NCT03548987|449620945|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
124998186|NCT03548987|449620946|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
125329212|NCT00949702|450837436|FG000|Overall Study|Death|40|||
125329213|NCT00949702|450837436|FG000|Overall Study|Disease progression|7|||
125329214|NCT00949702|450837436|FG000|Overall Study|Withdrawal of consent|1|||
125329215|NCT01654302|450837437|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
125329216|NCT01654302|450837438|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
125329217|NCT04119414|450837439|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
124998187|NCT03548987|449620945|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
124998188|NCT03548987|449620946|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
124998189|NCT03548987|449620945|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
124998190|NCT03548987|449620946|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
124998191|NCT03548987|449620945|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
125329218|NCT00630838|450837444|FG000|Overall Study|Death|0|||
125329219|NCT00630838|450837445|FG001|Overall Study|Death|1|||
124998192|NCT03548987|449620946|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
124998193|NCT03548987|449620945|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
124998194|NCT03548987|449620946|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
124998195|NCT03548987|449620945|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
124998196|NCT03548987|449620946|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
124998197|NCT03548987|449620945|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
124998198|NCT03548987|449620946|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
124998199|NCT03548987|449620945|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
124998200|NCT03548987|449620946|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
124998201|NCT03548987|449620945|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
124998202|NCT03548987|449620946|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
124998203|NCT03548987|449620945|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
124998204|NCT03548987|449620946|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
124998205|NCT03548987|449620945|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
124998206|NCT03548987|449620946|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
124998207|NCT03548987|449620945|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
124998208|NCT03548987|449620946|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
124998209|NCT03548987|449620945|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
124998210|NCT03548987|449620946|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
124998211|NCT01106014|449620949|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
124998212|NCT01106014|449620950|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
124998213|NCT01106014|449620949|FG000|Overall Study|Adverse Event|78|||
124998214|NCT01106014|449620950|FG001|Overall Study|Adverse Event|42|||
124998215|NCT01106014|449620949|FG000|Overall Study|Withdrawal by Subject|43|||
124998216|NCT01106014|449620950|FG001|Overall Study|Withdrawal by Subject|37|||
124998217|NCT01106014|449620949|FG000|Overall Study|Administrative reason|7|||
124998218|NCT01106014|449620950|FG001|Overall Study|Administrative reason|6|||
124998219|NCT01106014|449620949|FG000|Overall Study|Lost to Follow-up|2|||
124998220|NCT01106014|449620950|FG001|Overall Study|Lost to Follow-up|3|||
124998221|NCT00784693|449620951|FG000|Overall Study|Lost to Follow-up|0|||
124998222|NCT00784693|449620952|FG001|Overall Study|Lost to Follow-up|1|||
124998223|NCT00784693|449620951|FG000|Overall Study|Lack of Efficacy|1|||
124998224|NCT00784693|449620952|FG001|Overall Study|Lack of Efficacy|1|||
124998225|NCT00784693|449620951|FG000|Overall Study|Withdrawal by Subject|0|||
124998226|NCT00784693|449620952|FG001|Overall Study|Withdrawal by Subject|4|||
124998227|NCT00784693|449620951|FG000|Overall Study|Randomized but not Treated|1|||
124998228|NCT00784693|449620952|FG001|Overall Study|Randomized but not Treated|0|||
124998229|NCT00784693|449620951|FG000|Overall Study|Other|1|||
124998230|NCT00784693|449620952|FG001|Overall Study|Other|0|||
124998231|NCT00756470|449620955|FG000|Overall Study|Withdrawal by Subject|1|||
124998232|NCT00756470|449620955|FG000|Overall Study|Adverse Event|4|||
124998233|NCT02260882|449620956|FG000|Overall Study|Protocol Violation|0|||
124998234|NCT02260882|449620957|FG001|Overall Study|Protocol Violation|1|||
124998235|NCT02119325|449620958|FG000|Washout Period 1|Adverse Event|0|||
124998236|NCT02119325|449620959|FG001|Washout Period 1|Adverse Event|1|||
124998237|NCT03037619|449620965|FG000|Overall Study|Lost to Follow-up|0|||
125329220|NCT00630838|450837444|FG000|Overall Study|Lost to Follow-up|0|||
125329221|NCT00630838|450837445|FG001|Overall Study|Lost to Follow-up|1|||
125329222|NCT00670748|450837446|FG000|Overall Study|Death during treatment|1|||
125329223|NCT00670748|450837447|FG001|Overall Study|Death during treatment|1|||
125329224|NCT00670748|450837448|FG002|Overall Study|Death during treatment|1|||
125329225|NCT00670748|450837449|FG003|Overall Study|Death during treatment|0|||
125329226|NCT00670748|450837446|FG000|Overall Study|Not off study|2|||
125329227|NCT00670748|450837447|FG001|Overall Study|Not off study|1|||
125329228|NCT00670748|450837448|FG002|Overall Study|Not off study|1|||
125329229|NCT00670748|450837449|FG003|Overall Study|Not off study|1|||
125329230|NCT02807402|450837455|FG000|Overall Study|Failure to Return|1|||
125329231|NCT02807402|450837455|FG000|Overall Study|Death|3|||
125329232|NCT02807402|450837455|FG000|Overall Study|Other|2|||
125329233|NCT04922216|450837459|FG000|Overall Study|Withdrawal by Subject|0|||
125329234|NCT04922216|450837460|FG001|Overall Study|Withdrawal by Subject|1|||
124998238|NCT03037619|449620966|FG001|Overall Study|Lost to Follow-up|1|||
124998239|NCT03294109|449620967|FG000|Overall Study|Withdrawal by Subject|6|||
124998240|NCT03294109|449620968|FG001|Overall Study|Withdrawal by Subject|5|||
124998241|NCT01794923|449620973|FG000|Overall Study|Adverse Event|0|||
124998242|NCT01794923|449620974|FG001|Overall Study|Adverse Event|0|||
124998243|NCT01794923|449620975|FG002|Overall Study|Adverse Event|1|||
124998244|NCT02030405|449620984|FG000|Overall Study|Withdrawal by Subject|1|||
124998245|NCT02030405|449620984|FG000|Overall Study|Lost to Follow-up|1|||
124998246|NCT00986440|449620985|FG000|Overall Study|Progressive disease|27|||
124998247|NCT00986440|449620986|FG001|Overall Study|Progressive disease|37|||
124998248|NCT00986440|449620985|FG000|Overall Study|Serious adverse event or adverse event|9|||
125329235|NCT04922216|450837461|FG002|Overall Study|Withdrawal by Subject|0|||
125329236|NCT04922216|450837462|FG003|Overall Study|Withdrawal by Subject|0|||
124998249|NCT00986440|449620986|FG001|Overall Study|Serious adverse event or adverse event|2|||
124998250|NCT00986440|449620985|FG000|Overall Study|Withdrawal by Subject|1|||
124998251|NCT00986440|449620986|FG001|Overall Study|Withdrawal by Subject|2|||
124998252|NCT00986440|449620985|FG000|Overall Study|Screen failure (not dosed)|4|||
124998253|NCT00986440|449620986|FG001|Overall Study|Screen failure (not dosed)|2|||
124998254|NCT02973048|449620987|FG000|Overall Study|Epidural catheter insertion failure|1|||
124998255|NCT02973048|449620988|FG001|Overall Study|Epidural catheter insertion failure|0|||
124998256|NCT02973048|449620987|FG000|Overall Study|Withdrawal by Subject|0|||
124998257|NCT02973048|449620988|FG001|Overall Study|Withdrawal by Subject|3|||
124998258|NCT03431857|449620993|FG000|Overall Study|Death|6|||
124998259|NCT03431857|449620993|FG000|Overall Study|Lost to Follow-up|41|||
124998260|NCT03431857|449620993|FG000|Overall Study|Adverse Event|6|||
124998261|NCT03431857|449620993|FG000|Overall Study|Withdrawal by Subject|1|||
124998262|NCT01323621|449620996|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
124998263|NCT01323621|449620997|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
124998264|NCT01323621|449620998|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
124998265|NCT01323621|449620996|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
124998266|NCT01323621|449620997|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
124998267|NCT01323621|449620998|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
124998268|NCT01323621|449620996|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
124998269|NCT01323621|449620997|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
124998270|NCT01323621|449620998|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
124998271|NCT01323621|449620996|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
124998272|NCT01323621|449620997|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
124998273|NCT01323621|449620998|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
124998274|NCT01323621|449620996|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
124998275|NCT01323621|449620997|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
124998276|NCT01323621|449620998|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
124998277|NCT01323621|449620996|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
124998278|NCT01323621|449620997|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
124998279|NCT01323621|449620998|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
124998280|NCT01323621|449620996|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
124998281|NCT01323621|449620997|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
124998282|NCT01323621|449620998|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
124998283|NCT01323621|449620996|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
124998284|NCT01323621|449620997|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
124998285|NCT01323621|449620998|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
124998286|NCT01323621|449620996|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
124998287|NCT01323621|449620997|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
124998288|NCT01323621|449620998|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
124998289|NCT01323621|449620996|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
124998290|NCT01323621|449620997|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
124998291|NCT01323621|449620998|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
124998292|NCT01323621|449620996|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
124998293|NCT01323621|449620997|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
124998294|NCT01323621|449620998|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
124998295|NCT01323621|449620996|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
124998296|NCT01323621|449620997|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
124998297|NCT01323621|449620998|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
124998298|NCT00651157|449620999|FG000|Overall Study|Death|1|||
124998299|NCT00651157|449620999|FG000|Overall Study|Protocol Violation|1|||
124998300|NCT00364156|449621001|FG000|Overall Study|Withdrawal by Subject|73|||
124998301|NCT00364156|449621002|FG001|Overall Study|Withdrawal by Subject|80|||
124998302|NCT00364156|449621001|FG000|Overall Study|Protocol Violation|6|||
124998303|NCT00364156|449621002|FG001|Overall Study|Protocol Violation|1|||
124998304|NCT01472380|449621003|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
124998305|NCT01472380|449621003|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
124998306|NCT00292461|449621004|FG000|Overall Study|Adverse Event|4|||
124998307|NCT00292461|449621005|FG001|Overall Study|Adverse Event|2|||
124998308|NCT00292461|449621004|FG000|Overall Study|Lack of Efficacy|1|||
124998309|NCT00292461|449621005|FG001|Overall Study|Lack of Efficacy|0|||
124998310|NCT00292461|449621004|FG000|Overall Study|Withdrawal by Subject|0|||
124998311|NCT00292461|449621005|FG001|Overall Study|Withdrawal by Subject|1|||
124998312|NCT00292461|449621004|FG000|Overall Study|Protocol Violation|4|||
124998313|NCT00292461|449621005|FG001|Overall Study|Protocol Violation|3|||
124998314|NCT00292461|449621004|FG000|Overall Study|Lost to Follow-up|1|||
124998315|NCT00292461|449621005|FG001|Overall Study|Lost to Follow-up|0|||
124998316|NCT01891721|449621009|FG000|Overall Study|Lost to Follow-up|10|||
124998317|NCT01891721|449621010|FG001|Overall Study|Lost to Follow-up|5|||
124998318|NCT01891721|449621011|FG002|Overall Study|Lost to Follow-up|1|||
124998319|NCT04908189|449621034|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
125329237|NCT04922216|450837463|FG004|Overall Study|Withdrawal by Subject|0|||
124998320|NCT04908189|449621035|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
124998321|NCT04908189|449621036|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
124998322|NCT04908189|449621034|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
124998323|NCT04908189|449621035|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
124998324|NCT04908189|449621036|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
124998325|NCT04908189|449621034|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
124998326|NCT04908189|449621035|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
124998327|NCT04908189|449621036|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
124998328|NCT04908189|449621034|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
124998329|NCT04908189|449621035|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
124998330|NCT04908189|449621036|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
124998331|NCT04908189|449621034|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
124998332|NCT04908189|449621035|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
124998333|NCT04908189|449621036|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
124998334|NCT04908189|449621034|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
124998335|NCT04908189|449621035|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
124998336|NCT04908189|449621036|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
124998337|NCT04908189|449621034|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
125329238|NCT04922216|450837464|FG005|Overall Study|Withdrawal by Subject|0|||
125329239|NCT04922216|450837465|FG006|Overall Study|Withdrawal by Subject|0|||
125329240|NCT04922216|450837466|FG007|Overall Study|Withdrawal by Subject|2|||
124998338|NCT04908189|449621035|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
124998339|NCT04908189|449621036|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
124998340|NCT04908189|449621034|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
124998341|NCT04908189|449621035|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
124998342|NCT04908189|449621036|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
124998343|NCT04908189|449621034|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
124998344|NCT04908189|449621035|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
124998345|NCT04908189|449621036|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
124998346|NCT04908189|449621034|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
124998347|NCT04908189|449621035|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
124998348|NCT04908189|449621036|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
124998349|NCT04908189|449621034|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
124998350|NCT04908189|449621035|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
124998351|NCT04908189|449621036|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
124998352|NCT04908189|449621034|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
124998353|NCT04908189|449621035|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
124998354|NCT04908189|449621036|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
124998355|NCT04683731|449621037|FG000|Overall Study|Withdrawal by Subject|1|||
124998356|NCT04683731|449621038|FG001|Overall Study|Withdrawal by Subject|0|||
124998357|NCT04683731|449621039|FG002|Overall Study|Withdrawal by Subject|3|||
124998358|NCT04683731|449621040|FG003|Overall Study|Withdrawal by Subject|2|||
124998359|NCT04683731|449621037|FG000|Overall Study|Determined patient was not eligible|3|||
124998360|NCT04683731|449621038|FG001|Overall Study|Determined patient was not eligible|3|||
124998361|NCT04683731|449621039|FG002|Overall Study|Determined patient was not eligible|12|||
124998362|NCT04683731|449621040|FG003|Overall Study|Determined patient was not eligible|3|||
124998363|NCT02958267|449621043|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
124998364|NCT02958267|449621044|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
124998365|NCT02958267|449621043|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
124998366|NCT02958267|449621044|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
124998367|NCT02958267|449621043|FG000|Follow-up Visits|Additional treatment pursued|2|||
124998368|NCT02958267|449621044|FG001|Follow-up Visits|Additional treatment pursued|1|||
124998369|NCT01210118|449621045|FG000|Overall Study|Lost to Follow-up|1|||
124998370|NCT01210118|449621046|FG001|Overall Study|Lost to Follow-up|1|||
124998371|NCT01210118|449621045|FG000|Overall Study|Protocol Violation|1|||
124998372|NCT01210118|449621046|FG001|Overall Study|Protocol Violation|1|||
124998373|NCT01210118|449621045|FG000|Overall Study|Spontaneous abortion|1|||
124998374|NCT01210118|449621046|FG001|Overall Study|Spontaneous abortion|3|||
124998375|NCT01853982|449621047|FG000|Overall Study|Withdrawal by Subject|1|||
124998376|NCT01853982|449621048|FG001|Overall Study|Withdrawal by Subject|0|||
124998377|NCT01853982|449621047|FG000|Overall Study|Death|1|||
124998378|NCT01853982|449621048|FG001|Overall Study|Death|0|||
124998379|NCT01853982|449621047|FG000|Overall Study|Lost to Follow-up|0|||
125329241|NCT04922216|450837467|FG008|Overall Study|Withdrawal by Subject|0|||
125329242|NCT04922216|450837468|FG009|Overall Study|Withdrawal by Subject|0|||
125329243|NCT04922216|450837469|FG010|Overall Study|Withdrawal by Subject|0|||
125329244|NCT04922216|450837470|FG011|Overall Study|Withdrawal by Subject|0|||
125329245|NCT04922216|450837471|FG012|Overall Study|Withdrawal by Subject|1|||
125329246|NCT04922216|450837472|FG013|Overall Study|Withdrawal by Subject|1|||
125329247|NCT04922216|450837473|FG014|Overall Study|Withdrawal by Subject|1|||
125329248|NCT04922216|450837474|FG015|Overall Study|Withdrawal by Subject|0|||
125329249|NCT04922216|450837475|FG016|Overall Study|Withdrawal by Subject|0|||
125329250|NCT04922216|450837476|FG017|Overall Study|Withdrawal by Subject|1|||
125329251|NCT04922216|450837477|FG018|Overall Study|Withdrawal by Subject|1|||
125329252|NCT04922216|450837478|FG019|Overall Study|Withdrawal by Subject|1|||
125329253|NCT04922216|450837479|FG020|Overall Study|Withdrawal by Subject|1|||
125329254|NCT04922216|450837480|FG021|Overall Study|Withdrawal by Subject|0|||
125329255|NCT04922216|450837481|FG022|Overall Study|Withdrawal by Subject|0|||
125329256|NCT04922216|450837482|FG023|Overall Study|Withdrawal by Subject|2|||
125329257|NCT04922216|450837483|FG024|Overall Study|Withdrawal by Subject|0|||
125329258|NCT04922216|450837484|FG025|Overall Study|Withdrawal by Subject|0|||
125329259|NCT04922216|450837485|FG026|Overall Study|Withdrawal by Subject|1|||
125329260|NCT04922216|450837486|FG027|Overall Study|Withdrawal by Subject|0|||
125329261|NCT04922216|450837487|FG028|Overall Study|Withdrawal by Subject|0|||
125329262|NCT04922216|450837488|FG029|Overall Study|Withdrawal by Subject|0|||
125329263|NCT04922216|450837489|FG030|Overall Study|Withdrawal by Subject|1|||
125329264|NCT04922216|450837490|FG031|Overall Study|Withdrawal by Subject|0|||
125329265|NCT04922216|450837459|FG000|Overall Study|Lost to Follow-up|1|||
125329266|NCT04922216|450837460|FG001|Overall Study|Lost to Follow-up|0|||
125329267|NCT04922216|450837461|FG002|Overall Study|Lost to Follow-up|2|||
125329268|NCT04922216|450837462|FG003|Overall Study|Lost to Follow-up|0|||
125329269|NCT04922216|450837463|FG004|Overall Study|Lost to Follow-up|0|||
125329270|NCT04922216|450837464|FG005|Overall Study|Lost to Follow-up|2|||
125329271|NCT04922216|450837465|FG006|Overall Study|Lost to Follow-up|0|||
124998380|NCT01853982|449621048|FG001|Overall Study|Lost to Follow-up|1|||
124998381|NCT01839487|449621049|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
124998382|NCT01839487|449621050|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
124998383|NCT01839487|449621051|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
124998384|NCT01839487|449621052|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
124998385|NCT01839487|449621053|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
124998386|NCT01839487|449621054|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
124998387|NCT01839487|449621049|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
124998388|NCT01839487|449621050|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
124998389|NCT01839487|449621051|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
124998390|NCT01839487|449621052|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
124998391|NCT01839487|449621053|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
124998392|NCT01839487|449621054|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
124998393|NCT01839487|449621049|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
124998394|NCT01839487|449621050|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
124998395|NCT01839487|449621051|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
124998396|NCT01839487|449621052|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
124998397|NCT01839487|449621053|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
124998398|NCT01839487|449621054|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
124998399|NCT01839487|449621049|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
124998400|NCT01839487|449621050|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
124998401|NCT01839487|449621051|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
124998402|NCT01839487|449621052|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
124998403|NCT01839487|449621053|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
124998404|NCT01839487|449621054|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
124998405|NCT01839487|449621049|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
124998406|NCT01839487|449621050|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
124998407|NCT01839487|449621051|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
124998408|NCT01839487|449621052|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
124998409|NCT01839487|449621053|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
124998410|NCT01839487|449621054|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
124998411|NCT01839487|449621049|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
124998412|NCT01839487|449621050|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
125329272|NCT04922216|450837466|FG007|Overall Study|Lost to Follow-up|1|||
125329273|NCT04922216|450837467|FG008|Overall Study|Lost to Follow-up|1|||
125329274|NCT04922216|450837468|FG009|Overall Study|Lost to Follow-up|2|||
125329275|NCT04922216|450837469|FG010|Overall Study|Lost to Follow-up|2|||
125329276|NCT04922216|450837470|FG011|Overall Study|Lost to Follow-up|1|||
125329277|NCT04922216|450837471|FG012|Overall Study|Lost to Follow-up|1|||
125329278|NCT04922216|450837472|FG013|Overall Study|Lost to Follow-up|0|||
125329279|NCT04922216|450837473|FG014|Overall Study|Lost to Follow-up|1|||
125329280|NCT04922216|450837474|FG015|Overall Study|Lost to Follow-up|0|||
125329281|NCT04922216|450837475|FG016|Overall Study|Lost to Follow-up|0|||
125329282|NCT04922216|450837476|FG017|Overall Study|Lost to Follow-up|2|||
125329283|NCT04922216|450837477|FG018|Overall Study|Lost to Follow-up|1|||
125329284|NCT04922216|450837478|FG019|Overall Study|Lost to Follow-up|0|||
125329285|NCT04922216|450837479|FG020|Overall Study|Lost to Follow-up|1|||
125329286|NCT04922216|450837480|FG021|Overall Study|Lost to Follow-up|0|||
125329287|NCT04922216|450837481|FG022|Overall Study|Lost to Follow-up|2|||
125329288|NCT04922216|450837482|FG023|Overall Study|Lost to Follow-up|1|||
125329289|NCT04922216|450837483|FG024|Overall Study|Lost to Follow-up|0|||
124998413|NCT01839487|449621051|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
124998414|NCT01839487|449621052|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
124998415|NCT01839487|449621053|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
124998416|NCT01839487|449621054|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
124998417|NCT01839487|449621049|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
124998418|NCT01839487|449621050|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
125329290|NCT04922216|450837484|FG025|Overall Study|Lost to Follow-up|2|||
125329291|NCT04922216|450837485|FG026|Overall Study|Lost to Follow-up|0|||
125329292|NCT04922216|450837486|FG027|Overall Study|Lost to Follow-up|0|||
125329293|NCT04922216|450837487|FG028|Overall Study|Lost to Follow-up|1|||
125329294|NCT04922216|450837488|FG029|Overall Study|Lost to Follow-up|0|||
125329295|NCT04922216|450837489|FG030|Overall Study|Lost to Follow-up|2|||
125329296|NCT04922216|450837490|FG031|Overall Study|Lost to Follow-up|1|||
125329297|NCT04721977|450837491|FG000|Overall Study|Death|15|||
125329298|NCT04721977|450837491|FG000|Overall Study|Ongoing|51|||
125329299|NCT03278249|450837492|FG000|Overall Study|Withdrawal by Subject|2|||
125329300|NCT03278249|450837492|FG000|Overall Study|Lost to Follow-up|1|||
125329301|NCT00775190|450839064|FG000|Overall Study|Lost to Follow-up|2|||
125329302|NCT00775190|450839065|FG001|Overall Study|Lost to Follow-up|3|||
125329303|NCT00775190|450839064|FG000|Overall Study|Withdrawal by Subject|1|||
125329304|NCT00775190|450839065|FG001|Overall Study|Withdrawal by Subject|2|||
125329305|NCT00775190|450839064|FG000|Overall Study|Protocol Violation|1|||
125329306|NCT00775190|450839065|FG001|Overall Study|Protocol Violation|0|||
125329307|NCT00904033|450839070|FG000|Overall Study|Withdrawal by Subject|1|||
125329308|NCT00904033|450839071|FG001|Overall Study|Withdrawal by Subject|1|||
125329309|NCT00904033|450839072|FG002|Overall Study|Withdrawal by Subject|0|||
125329310|NCT00904033|450839073|FG003|Overall Study|Withdrawal by Subject|0|||
125329311|NCT00904033|450839070|FG000|Overall Study|Physician Decision|0|||
125329312|NCT00904033|450839071|FG001|Overall Study|Physician Decision|0|||
125329313|NCT00904033|450839072|FG002|Overall Study|Physician Decision|1|||
125329314|NCT00904033|450839073|FG003|Overall Study|Physician Decision|0|||
125329315|NCT00904033|450839070|FG000|Overall Study|Unable to obtain final blood draw|0|||
125329316|NCT00904033|450839071|FG001|Overall Study|Unable to obtain final blood draw|0|||
125329317|NCT00904033|450839072|FG002|Overall Study|Unable to obtain final blood draw|0|||
125329318|NCT00904033|450839073|FG003|Overall Study|Unable to obtain final blood draw|2|||
125329319|NCT01600716|450839076|FG000|Overall Study|Other Reasons|3|||
125329320|NCT01600716|450839077|FG001|Overall Study|Other Reasons|1|||
125329321|NCT01600716|450839076|FG000|Overall Study|Personal Reasons|0|||
125329322|NCT01600716|450839077|FG001|Overall Study|Personal Reasons|2|||
125329323|NCT01600716|450839076|FG000|Overall Study|Lost to Follow-up|0|||
125329324|NCT01600716|450839077|FG001|Overall Study|Lost to Follow-up|2|||
125329325|NCT01600716|450839076|FG000|Overall Study|Pregnancy|1|||
125329326|NCT01600716|450839077|FG001|Overall Study|Pregnancy|0|||
125329327|NCT01600716|450839076|FG000|Overall Study|Lack of Efficacy|2|||
125329328|NCT01600716|450839077|FG001|Overall Study|Lack of Efficacy|1|||
125329329|NCT01600716|450839076|FG000|Overall Study|Adverse Event|1|||
125329330|NCT01600716|450839077|FG001|Overall Study|Adverse Event|1|||
125329331|NCT03349034|450839080|FG000|Overall Study|catheters dislodged during transport|2|||
125329332|NCT03349034|450839081|FG001|Overall Study|catheters dislodged during transport|0|||
125329333|NCT03349034|450839080|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
125329334|NCT03349034|450839081|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
125329335|NCT03349034|450839080|FG000|Overall Study|soft tissue flap used|1|||
125329336|NCT03349034|450839081|FG001|Overall Study|soft tissue flap used|0|||
125329337|NCT03349034|450839080|FG000|Overall Study|Other|0|||
125329338|NCT03349034|450839081|FG001|Overall Study|Other|1|||
125329339|NCT01177397|450839082|FG000|Overall Study|Protocol Violation|0|||
125329340|NCT01177397|450839083|FG001|Overall Study|Protocol Violation|0|||
125329341|NCT01177397|450839084|FG002|Overall Study|Protocol Violation|0|||
125329342|NCT01177397|450839085|FG003|Overall Study|Protocol Violation|0|||
124998419|NCT01839487|449621051|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
125329343|NCT01177397|450839086|FG004|Overall Study|Protocol Violation|0|||
125329344|NCT01177397|450839087|FG005|Overall Study|Protocol Violation|1|||
125329345|NCT01177397|450839088|FG006|Overall Study|Protocol Violation|0|||
125329346|NCT01177397|450839089|FG007|Overall Study|Protocol Violation|0|||
125329347|NCT01177397|450839090|FG008|Overall Study|Protocol Violation|0|||
125329348|NCT01177397|450839091|FG009|Overall Study|Protocol Violation|0|||
125329349|NCT01177397|450839092|FG010|Overall Study|Protocol Violation|0|||
125329350|NCT01177397|450839093|FG011|Overall Study|Protocol Violation|0|||
124998420|NCT01839487|449621052|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
124998421|NCT01839487|449621053|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
124998422|NCT01839487|449621054|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
124998423|NCT01839487|449621049|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
124998424|NCT01839487|449621050|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
124998425|NCT01839487|449621051|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
124998426|NCT01839487|449621052|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
124998427|NCT01839487|449621053|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
124998428|NCT01839487|449621054|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
124998429|NCT01839487|449621049|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
124998430|NCT01839487|449621050|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
124998431|NCT01839487|449621051|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
124998432|NCT01839487|449621052|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
124998433|NCT01839487|449621053|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
124998434|NCT01839487|449621054|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
124998435|NCT05066724|449621055|FG000|Overall Study|Adverse Event|1|||
124998436|NCT05066724|449621055|FG000|Overall Study|Non-Compliance With Study Drug|5|||
124998437|NCT05066724|449621055|FG000|Overall Study|Withdrawal by Subject|6|||
125329351|NCT01177397|450839082|FG000|Overall Study|Lost to Follow-up|0|||
125329352|NCT01177397|450839083|FG001|Overall Study|Lost to Follow-up|0|||
125329353|NCT01177397|450839084|FG002|Overall Study|Lost to Follow-up|0|||
124998438|NCT05066724|449621055|FG000|Overall Study|Physician Decision|2|||
124998439|NCT00475033|449621056|FG000|Infant Series|Failed to return|3|||
124998440|NCT00475033|449621057|FG001|Infant Series|Failed to return|4|||
124998441|NCT00475033|449621056|FG000|Infant Series|Parent or legal guardian request|1|||
124998442|NCT00475033|449621057|FG001|Infant Series|Parent or legal guardian request|5|||
124998443|NCT00475033|449621056|FG000|Infant Series|Protocol Violation|1|||
124998444|NCT00475033|449621057|FG001|Infant Series|Protocol Violation|2|||
124998445|NCT00475033|449621056|FG000|Infant Series|Lost to Follow-up|2|||
124998446|NCT00475033|449621057|FG001|Infant Series|Lost to Follow-up|0|||
124998447|NCT00475033|449621056|FG000|Infant Series|Adverse Event|0|||
124998448|NCT00475033|449621057|FG001|Infant Series|Adverse Event|2|||
124998449|NCT00475033|449621056|FG000|After the Infant Series|Adverse Event|0|||
124998450|NCT00475033|449621057|FG001|After the Infant Series|Adverse Event|4|||
124998451|NCT00475033|449621056|FG000|After the Infant Series|Parent or legal guardian request|2|||
124998452|NCT00475033|449621057|FG001|After the Infant Series|Parent or legal guardian request|2|||
124998453|NCT00475033|449621056|FG000|After the Infant Series|Failed to return|2|||
124998454|NCT00475033|449621057|FG001|After the Infant Series|Failed to return|1|||
124998455|NCT00475033|449621056|FG000|After the Infant Series|Protocol Violation|1|||
124998456|NCT00475033|449621057|FG001|After the Infant Series|Protocol Violation|0|||
124998457|NCT00475033|449621056|FG000|After the Infant Series|Lost to Follow-up|1|||
124998458|NCT00475033|449621057|FG001|After the Infant Series|Lost to Follow-up|0|||
124998459|NCT00475033|449621056|FG000|After the Infant Series|Other|0|||
124998460|NCT00475033|449621057|FG001|After the Infant Series|Other|1|||
124998461|NCT00475033|449621056|FG000|Toddler Dose|Parent or legal guardian request|2|||
124998462|NCT00475033|449621057|FG001|Toddler Dose|Parent or legal guardian request|0|||
124998463|NCT00475033|449621056|FG000|Toddler Dose|Failed to return|1|||
124998464|NCT00475033|449621057|FG001|Toddler Dose|Failed to return|0|||
124998465|NCT00475033|449621056|FG000|Toddler Dose|Lost to Follow-up|1|||
124998466|NCT00475033|449621057|FG001|Toddler Dose|Lost to Follow-up|0|||
124998467|NCT04356183|449622081|FG000|Overall Study|Lost to Follow-up|1|||
124998468|NCT04356183|449622082|FG001|Overall Study|Lost to Follow-up|0|||
124998469|NCT04356183|449622081|FG000|Overall Study|Withdrawal by Subject|1|||
124998470|NCT04356183|449622082|FG001|Overall Study|Withdrawal by Subject|1|||
124998471|NCT02170389|449622085|FG000|Overall Study|Study terminated prior to start of treat|1|||
124998472|NCT00667355|449622086|FG000|Overall Study|Adverse Event|5|||
124998473|NCT00667355|449622086|FG000|Overall Study|Lost to Follow-up|1|||
124998474|NCT00667355|449622086|FG000|Overall Study|Other reason was not specified|5|||
124998475|NCT02960854|449622088|FG000|Overall Study|Not Disclosed|2|||
124998476|NCT02960854|449622089|FG001|Overall Study|Not Disclosed|2|||
124998477|NCT02960854|449622088|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
124998478|NCT02960854|449622089|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
124998479|NCT02960854|449622088|FG000|Overall Study|Subject Withdrew Consent|0|||
124998480|NCT02960854|449622089|FG001|Overall Study|Subject Withdrew Consent|1|||
124998481|NCT02960854|449622088|FG000|Overall Study|Death|4|||
125329354|NCT01177397|450839085|FG003|Overall Study|Lost to Follow-up|0|||
124998482|NCT02960854|449622089|FG001|Overall Study|Death|6|||
124998483|NCT00823901|449622090|FG000|Overall Study|Adverse Event|1|||
124998484|NCT00823901|449622091|FG001|Overall Study|Adverse Event|1|||
124998485|NCT00823901|449622090|FG000|Overall Study|Lack of Efficacy|1|||
124998486|NCT00823901|449622091|FG001|Overall Study|Lack of Efficacy|0|||
124998487|NCT00823901|449622090|FG000|Overall Study|Lost to Follow-up|2|||
125329355|NCT01177397|450839086|FG004|Overall Study|Lost to Follow-up|1|||
125329356|NCT01177397|450839087|FG005|Overall Study|Lost to Follow-up|0|||
125329357|NCT01177397|450839088|FG006|Overall Study|Lost to Follow-up|0|||
125329358|NCT01177397|450839089|FG007|Overall Study|Lost to Follow-up|2|||
125329359|NCT01177397|450839090|FG008|Overall Study|Lost to Follow-up|0|||
125329360|NCT01177397|450839091|FG009|Overall Study|Lost to Follow-up|0|||
125329361|NCT01177397|450839092|FG010|Overall Study|Lost to Follow-up|0|||
125329362|NCT01177397|450839093|FG011|Overall Study|Lost to Follow-up|0|||
125329363|NCT01177397|450839082|FG000|Overall Study|Death|0|||
125329364|NCT01177397|450839083|FG001|Overall Study|Death|0|||
124872819|NCT00500903|449155771|FG002|Overall Study|Reason Not Specified|2|||
124872820|NCT01648348|449155775|FG000|Overall Study|Cancel|1|||
124872821|NCT01648348|449155776|FG001|Overall Study|Cancel|0|||
124872822|NCT01648348|449155777|FG002|Overall Study|Cancel|0|||
124872823|NCT01648348|449155778|FG003|Overall Study|Cancel|0|||
124872824|NCT01648348|449155779|FG004|Overall Study|Cancel|3|||
124872825|NCT01648348|449155780|FG005|Overall Study|Cancel|6|||
124872826|NCT01648348|449155775|FG000|Overall Study|Replaced for MTD analysis|1|||
124872827|NCT01648348|449155776|FG001|Overall Study|Replaced for MTD analysis|0|||
124872828|NCT01648348|449155777|FG002|Overall Study|Replaced for MTD analysis|1|||
124872829|NCT01648348|449155778|FG003|Overall Study|Replaced for MTD analysis|0|||
124872830|NCT01648348|449155779|FG004|Overall Study|Replaced for MTD analysis|0|||
124872831|NCT01648348|449155780|FG005|Overall Study|Replaced for MTD analysis|0|||
124872832|NCT00696410|449155782|FG000|Overall Study|Lost to Follow-up|2|||
124872833|NCT00696410|449155783|FG001|Overall Study|Lost to Follow-up|0|||
124872834|NCT00696410|449155782|FG000|Overall Study|Withdrawal by Subject|8|||
124872835|NCT00696410|449155783|FG001|Overall Study|Withdrawal by Subject|0|||
124872836|NCT00696410|449155782|FG000|Overall Study|Physician Decision|3|||
124872837|NCT00696410|449155783|FG001|Overall Study|Physician Decision|0|||
124872838|NCT01951638|449155785|FG000|Treatment Period|Protocol Violation|0|||
124872839|NCT01951638|449155786|FG001|Treatment Period|Protocol Violation|0|||
124872840|NCT01951638|449155787|FG002|Treatment Period|Protocol Violation|0|||
124872841|NCT01951638|449155788|FG003|Treatment Period|Protocol Violation|2|||
124872842|NCT01951638|449155789|FG004|Treatment Period|Protocol Violation|0|||
124872843|NCT01951638|449155785|FG000|Treatment Period|Protocol-driven decision point|1|||
124872844|NCT01951638|449155786|FG001|Treatment Period|Protocol-driven decision point|3|||
124872845|NCT01951638|449155787|FG002|Treatment Period|Protocol-driven decision point|0|||
124872846|NCT01951638|449155788|FG003|Treatment Period|Protocol-driven decision point|0|||
124872847|NCT01951638|449155789|FG004|Treatment Period|Protocol-driven decision point|0|||
124872848|NCT01951638|449155785|FG000|Treatment Period|Logistical difficulties|0|||
124872849|NCT01951638|449155786|FG001|Treatment Period|Logistical difficulties|1|||
124872850|NCT01951638|449155787|FG002|Treatment Period|Logistical difficulties|1|||
124872851|NCT01951638|449155788|FG003|Treatment Period|Logistical difficulties|0|||
124872852|NCT01951638|449155789|FG004|Treatment Period|Logistical difficulties|0|||
124872853|NCT01951638|449155785|FG000|Treatment Period|Withdrawal by Subject|9|||
124872854|NCT01951638|449155786|FG001|Treatment Period|Withdrawal by Subject|6|||
124872855|NCT01951638|449155787|FG002|Treatment Period|Withdrawal by Subject|4|||
124872856|NCT01951638|449155788|FG003|Treatment Period|Withdrawal by Subject|5|||
124872857|NCT01951638|449155789|FG004|Treatment Period|Withdrawal by Subject|4|||
124872858|NCT01951638|449155785|FG000|Treatment Period|Death|0|||
124872859|NCT01951638|449155786|FG001|Treatment Period|Death|0|||
124872860|NCT01951638|449155787|FG002|Treatment Period|Death|0|||
124872861|NCT01951638|449155788|FG003|Treatment Period|Death|3|||
124872862|NCT01951638|449155789|FG004|Treatment Period|Death|1|||
124872863|NCT01951638|449155785|FG000|Treatment Period|Adverse Event|3|||
124872864|NCT01951638|449155786|FG001|Treatment Period|Adverse Event|4|||
124872865|NCT01951638|449155787|FG002|Treatment Period|Adverse Event|8|||
124872866|NCT01951638|449155788|FG003|Treatment Period|Adverse Event|6|||
124872867|NCT01951638|449155789|FG004|Treatment Period|Adverse Event|5|||
124872868|NCT01951638|449155785|FG000|Follow-up Period|Protocol Violation|0|||
124872869|NCT01951638|449155786|FG001|Follow-up Period|Protocol Violation|0|||
124872870|NCT01951638|449155787|FG002|Follow-up Period|Protocol Violation|0|||
124872871|NCT01951638|449155788|FG003|Follow-up Period|Protocol Violation|1|||
124872872|NCT01951638|449155789|FG004|Follow-up Period|Protocol Violation|0|||
124872873|NCT01951638|449155785|FG000|Follow-up Period|Logistical difficulties|0|||
124872874|NCT01951638|449155786|FG001|Follow-up Period|Logistical difficulties|2|||
124872875|NCT01951638|449155787|FG002|Follow-up Period|Logistical difficulties|0|||
124872876|NCT01951638|449155788|FG003|Follow-up Period|Logistical difficulties|0|||
124872877|NCT01951638|449155789|FG004|Follow-up Period|Logistical difficulties|1|||
125329365|NCT01177397|450839084|FG002|Overall Study|Death|1|||
125329366|NCT01177397|450839085|FG003|Overall Study|Death|1|||
125329367|NCT01177397|450839086|FG004|Overall Study|Death|0|||
124872878|NCT01951638|449155785|FG000|Follow-up Period|Withdrawal by Subject|1|||
124872879|NCT01951638|449155786|FG001|Follow-up Period|Withdrawal by Subject|5|||
124872880|NCT01951638|449155787|FG002|Follow-up Period|Withdrawal by Subject|2|||
124872881|NCT01951638|449155788|FG003|Follow-up Period|Withdrawal by Subject|1|||
124872882|NCT01951638|449155789|FG004|Follow-up Period|Withdrawal by Subject|2|||
124872883|NCT01951638|449155785|FG000|Follow-up Period|Lost to Follow-up|0|||
124872884|NCT01951638|449155786|FG001|Follow-up Period|Lost to Follow-up|1|||
124872885|NCT01951638|449155787|FG002|Follow-up Period|Lost to Follow-up|0|||
125329368|NCT01177397|450839087|FG005|Overall Study|Death|0|||
125329369|NCT01177397|450839088|FG006|Overall Study|Death|0|||
125329370|NCT01177397|450839089|FG007|Overall Study|Death|5|||
125329371|NCT01177397|450839090|FG008|Overall Study|Death|2|||
125329372|NCT01177397|450839091|FG009|Overall Study|Death|1|||
125329373|NCT01177397|450839092|FG010|Overall Study|Death|0|||
125329374|NCT01177397|450839093|FG011|Overall Study|Death|0|||
125329375|NCT01177397|450839082|FG000|Overall Study|Withdrawal by Subject|0|||
125329376|NCT01177397|450839083|FG001|Overall Study|Withdrawal by Subject|0|||
125329377|NCT01177397|450839084|FG002|Overall Study|Withdrawal by Subject|1|||
125329378|NCT01177397|450839085|FG003|Overall Study|Withdrawal by Subject|1|||
125329379|NCT01177397|450839086|FG004|Overall Study|Withdrawal by Subject|1|||
125329380|NCT01177397|450839087|FG005|Overall Study|Withdrawal by Subject|2|||
125329381|NCT01177397|450839088|FG006|Overall Study|Withdrawal by Subject|0|||
125329382|NCT01177397|450839089|FG007|Overall Study|Withdrawal by Subject|5|||
125329383|NCT01177397|450839090|FG008|Overall Study|Withdrawal by Subject|9|||
125329384|NCT01177397|450839091|FG009|Overall Study|Withdrawal by Subject|1|||
125329385|NCT01177397|450839092|FG010|Overall Study|Withdrawal by Subject|1|||
125329386|NCT01177397|450839093|FG011|Overall Study|Withdrawal by Subject|0|||
125329387|NCT01177397|450839082|FG000|Overall Study|Adverse Event|0|||
125329388|NCT01177397|450839083|FG001|Overall Study|Adverse Event|0|||
125329389|NCT01177397|450839084|FG002|Overall Study|Adverse Event|1|||
125329390|NCT01177397|450839085|FG003|Overall Study|Adverse Event|2|||
125329391|NCT01177397|450839086|FG004|Overall Study|Adverse Event|0|||
125329392|NCT01177397|450839087|FG005|Overall Study|Adverse Event|12|||
125329393|NCT01177397|450839088|FG006|Overall Study|Adverse Event|1|||
125329394|NCT01177397|450839089|FG007|Overall Study|Adverse Event|14|||
125329395|NCT01177397|450839090|FG008|Overall Study|Adverse Event|8|||
124998488|NCT00823901|449622091|FG001|Overall Study|Lost to Follow-up|1|||
124998489|NCT01369511|449622092|FG000|Overall Study|Adverse Event|1|||
124998490|NCT01369511|449622093|FG001|Overall Study|Adverse Event|1|||
124998491|NCT01369511|449622094|FG002|Overall Study|Adverse Event|5|||
124998492|NCT01369511|449622095|FG003|Overall Study|Adverse Event|0|||
124998493|NCT01369511|449622092|FG000|Overall Study|Entry criteria not met|2|||
124998494|NCT01369511|449622093|FG001|Overall Study|Entry criteria not met|0|||
124998495|NCT01369511|449622094|FG002|Overall Study|Entry criteria not met|0|||
124998496|NCT01369511|449622095|FG003|Overall Study|Entry criteria not met|1|||
124998497|NCT01369511|449622092|FG000|Overall Study|Lost to Follow-up|0|||
124998498|NCT01369511|449622093|FG001|Overall Study|Lost to Follow-up|1|||
124998499|NCT01369511|449622094|FG002|Overall Study|Lost to Follow-up|1|||
124998500|NCT01369511|449622095|FG003|Overall Study|Lost to Follow-up|2|||
124998501|NCT01369511|449622092|FG000|Overall Study|Protocol Violation|0|||
124998502|NCT01369511|449622093|FG001|Overall Study|Protocol Violation|1|||
124998503|NCT01369511|449622094|FG002|Overall Study|Protocol Violation|0|||
124998504|NCT01369511|449622095|FG003|Overall Study|Protocol Violation|2|||
124998505|NCT01369511|449622092|FG000|Overall Study|Physician Decision|3|||
124998506|NCT01369511|449622093|FG001|Overall Study|Physician Decision|4|||
124998507|NCT01369511|449622094|FG002|Overall Study|Physician Decision|0|||
124998508|NCT01369511|449622095|FG003|Overall Study|Physician Decision|0|||
124998509|NCT01369511|449622092|FG000|Overall Study|Sponsor decision|2|||
124998510|NCT01369511|449622093|FG001|Overall Study|Sponsor decision|0|||
124998511|NCT01369511|449622094|FG002|Overall Study|Sponsor decision|1|||
124998512|NCT01369511|449622095|FG003|Overall Study|Sponsor decision|0|||
124998513|NCT01369511|449622092|FG000|Overall Study|Withdrawal by Subject|5|||
124998514|NCT01369511|449622093|FG001|Overall Study|Withdrawal by Subject|6|||
124998515|NCT01369511|449622094|FG002|Overall Study|Withdrawal by Subject|4|||
124998516|NCT01369511|449622095|FG003|Overall Study|Withdrawal by Subject|6|||
124998517|NCT01376349|449622097|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
124998518|NCT01376349|449622098|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
124998519|NCT01376349|449622099|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
124998520|NCT01376349|449622097|FG000|Raondomized Treatment|Adverse Event|13|||
124998521|NCT01376349|449622098|FG001|Raondomized Treatment|Adverse Event|17|||
124998522|NCT01376349|449622099|FG002|Raondomized Treatment|Adverse Event|14|||
124998523|NCT01376349|449622097|FG000|Raondomized Treatment|Unkown|1|||
124998524|NCT01376349|449622098|FG001|Raondomized Treatment|Unkown|2|||
124998525|NCT01376349|449622099|FG002|Raondomized Treatment|Unkown|1|||
124998526|NCT01376349|449622097|FG000|Raondomized Treatment|Alternative Treatment|0|||
125329396|NCT01177397|450839091|FG009|Overall Study|Adverse Event|6|||
125329397|NCT01177397|450839092|FG010|Overall Study|Adverse Event|3|||
124998527|NCT01376349|449622098|FG001|Raondomized Treatment|Alternative Treatment|0|||
124998528|NCT01376349|449622099|FG002|Raondomized Treatment|Alternative Treatment|1|||
124998529|NCT01180998|449622100|FG000|Overall Study|Poor Vision|0|||
124998530|NCT01180998|449622101|FG001|Overall Study|Poor Vision|2|||
125329398|NCT01177397|450839093|FG011|Overall Study|Adverse Event|7|||
125329399|NCT01177397|450839082|FG000|Overall Study|Disease progression|1|||
125329400|NCT01177397|450839083|FG001|Overall Study|Disease progression|2|||
124998531|NCT01180998|449622102|FG002|Overall Study|Poor Vision|2|||
124998532|NCT01180998|449622100|FG000|Overall Study|Lost to Follow-up|0|||
124998533|NCT01180998|449622101|FG001|Overall Study|Lost to Follow-up|0|||
124998534|NCT01180998|449622102|FG002|Overall Study|Lost to Follow-up|1|||
124998535|NCT01180998|449622100|FG000|Overall Study|Protocol Violation|1|||
124998536|NCT01180998|449622101|FG001|Overall Study|Protocol Violation|2|||
124998537|NCT01180998|449622102|FG002|Overall Study|Protocol Violation|0|||
124998538|NCT01180998|449622100|FG000|Overall Study|Withdrawal by Subject|0|||
124998539|NCT01180998|449622101|FG001|Overall Study|Withdrawal by Subject|0|||
124998540|NCT01180998|449622102|FG002|Overall Study|Withdrawal by Subject|1|||
124998541|NCT01180998|449622100|FG000|Overall Study|Poor comfort|3|||
124998542|NCT01180998|449622101|FG001|Overall Study|Poor comfort|0|||
124998543|NCT01180998|449622102|FG002|Overall Study|Poor comfort|4|||
124998544|NCT01180998|449622100|FG000|Overall Study|Poor lens handling|0|||
124998545|NCT01180998|449622101|FG001|Overall Study|Poor lens handling|0|||
124998546|NCT01180998|449622102|FG002|Overall Study|Poor lens handling|2|||
124998547|NCT01176968|449622103|FG000|Overall Study|Adverse Event|10|||
124998548|NCT01176968|449622104|FG001|Overall Study|Adverse Event|11|||
124998549|NCT01176968|449622103|FG000|Overall Study|Death|2|||
124998550|NCT01176968|449622104|FG001|Overall Study|Death|3|||
124998551|NCT01176968|449622103|FG000|Overall Study|Lack of Efficacy|0|||
124998552|NCT01176968|449622104|FG001|Overall Study|Lack of Efficacy|1|||
124998553|NCT01176968|449622103|FG000|Overall Study|Lost to Follow-up|16|||
124998554|NCT01176968|449622104|FG001|Overall Study|Lost to Follow-up|14|||
124998555|NCT01176968|449622103|FG000|Overall Study|Withdrawal by Subject|48|||
124998556|NCT01176968|449622104|FG001|Overall Study|Withdrawal by Subject|48|||
124998557|NCT01176968|449622103|FG000|Overall Study|Protocol Violation|2|||
124998558|NCT01176968|449622104|FG001|Overall Study|Protocol Violation|1|||
124998559|NCT01176968|449622103|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
124998560|NCT01176968|449622104|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
124998561|NCT01176968|449622103|FG000|Overall Study|Study terminated by sponsor|0|||
124998562|NCT01176968|449622104|FG001|Overall Study|Study terminated by sponsor|1|||
124998563|NCT01176968|449622103|FG000|Overall Study|Reason not defined|5|||
124998564|NCT01176968|449622104|FG001|Overall Study|Reason not defined|3|||
124998565|NCT01137955|449622105|FG000|Overall Study|Withdrawal by Subject|5|||
124998566|NCT01137955|449622106|FG001|Overall Study|Withdrawal by Subject|4|||
124998567|NCT00068588|449622107|FG000|Overall Study|Adverse Event|0|||
124998568|NCT00068588|449622108|FG001|Overall Study|Adverse Event|0|||
124998569|NCT00068588|449622109|FG002|Overall Study|Adverse Event|2|||
124998570|NCT00068588|449622107|FG000|Overall Study|Withdrawal by Subject|0|||
124998571|NCT00068588|449622108|FG001|Overall Study|Withdrawal by Subject|0|||
124998572|NCT00068588|449622109|FG002|Overall Study|Withdrawal by Subject|1|||
124998573|NCT00068588|449622107|FG000|Overall Study|Poor KPS|0|||
124998574|NCT00068588|449622108|FG001|Overall Study|Poor KPS|0|||
124998575|NCT00068588|449622109|FG002|Overall Study|Poor KPS|1|||
124998576|NCT05193500|449622110|FG000|Overall Study|Withdrawal by Subject|7|||
124998577|NCT05193500|449622111|FG001|Overall Study|Withdrawal by Subject|4|||
124998578|NCT05193500|449622112|FG002|Overall Study|Withdrawal by Subject|3|||
124998579|NCT05193500|449622113|FG003|Overall Study|Withdrawal by Subject|5|||
124998580|NCT04098068|449622114|FG000|Overall Study|Disease Progression|7|||
124998581|NCT04098068|449622114|FG000|Overall Study|Withdrawal by Subject|2|||
124998582|NCT04098068|449622114|FG000|Overall Study|New Cancer Diagnosis|1|||
125329401|NCT01177397|450839084|FG002|Overall Study|Disease progression|5|||
125329402|NCT01177397|450839085|FG003|Overall Study|Disease progression|5|||
125329403|NCT01177397|450839086|FG004|Overall Study|Disease progression|4|||
125329404|NCT01177397|450839087|FG005|Overall Study|Disease progression|10|||
125329405|NCT01177397|450839088|FG006|Overall Study|Disease progression|10|||
124998583|NCT03871829|449622115|FG000|Overall Study|Lost to Follow-up|0|||
124998584|NCT03871829|449622116|FG001|Overall Study|Lost to Follow-up|1|||
124998585|NCT03871829|449622115|FG000|Overall Study|Withdrawal by Subject|1|||
124998586|NCT03871829|449622116|FG001|Overall Study|Withdrawal by Subject|1|||
124998587|NCT03871829|449622115|FG000|Overall Study|Death|12|||
124998588|NCT03871829|449622116|FG001|Overall Study|Death|8|||
124998589|NCT03871829|449622115|FG000|Overall Study|Study terminated by sponsor|31|||
124998590|NCT03871829|449622116|FG001|Overall Study|Study terminated by sponsor|34|||
124998591|NCT05458479|449622122|FG000|Overall Study|Lost to Follow-up|1|||
124998592|NCT01324323|449622123|FG000|Overall Study|Withdrawal by Subject|1|||
124998593|NCT00993915|449622130|FG000|Overall Study|Insufficient clinical response|3|||
124998594|NCT00993915|449622130|FG000|Overall Study|Withdrawal by Subject|2|||
124998595|NCT00993915|449622130|FG000|Overall Study|Other|1|||
124998596|NCT00993915|449622130|FG000|Overall Study|Ongoing|3|||
124998597|NCT01386658|449622131|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
125329406|NCT01177397|450839089|FG007|Overall Study|Disease progression|21|||
125329407|NCT01177397|450839090|FG008|Overall Study|Disease progression|18|||
124998598|NCT01386658|449622132|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
124998599|NCT01386658|449622131|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
125329408|NCT01177397|450839091|FG009|Overall Study|Disease progression|12|||
124998600|NCT01386658|449622132|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
124998601|NCT02465463|449622140|FG000|Overall Study|Lost to Follow-up|2|||
124998602|NCT02465463|449622141|FG001|Overall Study|Lost to Follow-up|1|||
124998603|NCT02465463|449622140|FG000|Overall Study|Death|1|||
124998604|NCT02465463|449622141|FG001|Overall Study|Death|0|||
124998605|NCT02465463|449622140|FG000|Overall Study|Protocol Violation|1|||
124998606|NCT02465463|449622141|FG001|Overall Study|Protocol Violation|0|||
124998607|NCT01498289|449622143|FG000|Overall Study|Adverse Event|16|||
124998608|NCT01498289|449622144|FG001|Overall Study|Adverse Event|18|||
124998609|NCT01498289|449622143|FG000|Overall Study|Death|6|||
124998610|NCT01498289|449622144|FG001|Overall Study|Death|8|||
124998611|NCT01498289|449622143|FG000|Overall Study|Withdrawal unrelated to AE|16|||
124998612|NCT01498289|449622144|FG001|Overall Study|Withdrawal unrelated to AE|16|||
124998613|NCT01498289|449622143|FG000|Overall Study|Progression/relapse|53|||
124998614|NCT01498289|449622144|FG001|Overall Study|Progression/relapse|59|||
124998615|NCT01498289|449622143|FG000|Overall Study|Not protocol specified|7|||
124998616|NCT01498289|449622144|FG001|Overall Study|Not protocol specified|2|||
124998617|NCT01498289|449622143|FG000|Overall Study|Reason under review|0|||
124998618|NCT01498289|449622144|FG001|Overall Study|Reason under review|1|||
124998619|NCT01774084|449622145|FG000|Overall Study|Personal reasons|1|||
124998620|NCT01774084|449622146|FG001|Overall Study|Personal reasons|0|||
124998621|NCT00821431|449622147|FG000|Overall Study|Adverse Event|6|||
124998622|NCT00821431|449622148|FG001|Overall Study|Adverse Event|3|||
124998623|NCT00821431|449622147|FG000|Overall Study|Withdrawal by Subject|5|||
124998624|NCT00821431|449622148|FG001|Overall Study|Withdrawal by Subject|0|||
124998625|NCT00821431|449622147|FG000|Overall Study|Lost to Follow-up|1|||
124998626|NCT00821431|449622148|FG001|Overall Study|Lost to Follow-up|0|||
124998627|NCT00821431|449622147|FG000|Overall Study|Protocol Violation|3|||
124998628|NCT00821431|449622148|FG001|Overall Study|Protocol Violation|1|||
124998629|NCT00821431|449622147|FG000|Overall Study|Physician Decision|0|||
124998630|NCT00821431|449622148|FG001|Overall Study|Physician Decision|1|||
124998631|NCT04526197|449622150|FG000|Period 1|Adverse Event|0|||
124998632|NCT04526197|449622151|FG001|Period 1|Adverse Event|1|||
124998633|NCT04526197|449622150|FG000|Period 1|Withdrawal by Subject|1|||
124998634|NCT04526197|449622151|FG001|Period 1|Withdrawal by Subject|0|||
124998635|NCT04526197|449622150|FG000|Period 2|Adverse Event|0|||
124998636|NCT04526197|449622151|FG001|Period 2|Adverse Event|1|||
124998637|NCT04526197|449622150|FG000|Period 2|Withdrawal by Subject|0|||
124998638|NCT04526197|449622151|FG001|Period 2|Withdrawal by Subject|1|||
124998639|NCT00372385|449622152|FG000|Overall Study|Adverse Event|6|||
124998640|NCT00372385|449622153|FG001|Overall Study|Adverse Event|11|||
124998641|NCT00372385|449622154|FG002|Overall Study|Adverse Event|9|||
124998642|NCT00372385|449622155|FG003|Overall Study|Adverse Event|7|||
124998643|NCT00372385|449622152|FG000|Overall Study|Noncompliance|0|||
124998644|NCT00372385|449622153|FG001|Overall Study|Noncompliance|1|||
124998645|NCT00372385|449622154|FG002|Overall Study|Noncompliance|1|||
124998646|NCT00372385|449622155|FG003|Overall Study|Noncompliance|1|||
124998647|NCT00372385|449622152|FG000|Overall Study|Physician Decision|1|||
124998648|NCT00372385|449622153|FG001|Overall Study|Physician Decision|0|||
124998649|NCT00372385|449622154|FG002|Overall Study|Physician Decision|0|||
124998650|NCT00372385|449622155|FG003|Overall Study|Physician Decision|0|||
124998651|NCT00372385|449622152|FG000|Overall Study|Lost to Follow-up|2|||
124998652|NCT00372385|449622153|FG001|Overall Study|Lost to Follow-up|0|||
124998653|NCT00372385|449622154|FG002|Overall Study|Lost to Follow-up|0|||
124998654|NCT00372385|449622155|FG003|Overall Study|Lost to Follow-up|0|||
124998655|NCT00372385|449622152|FG000|Overall Study|Withdrawal by Subject|2|||
124998656|NCT00372385|449622153|FG001|Overall Study|Withdrawal by Subject|1|||
124998657|NCT00372385|449622154|FG002|Overall Study|Withdrawal by Subject|0|||
124998658|NCT00372385|449622155|FG003|Overall Study|Withdrawal by Subject|0|||
124998659|NCT00372385|449622152|FG000|Overall Study|Refusal of Treatment|3|||
124998660|NCT00372385|449622153|FG001|Overall Study|Refusal of Treatment|6|||
125329409|NCT01177397|450839092|FG010|Overall Study|Disease progression|10|||
125329410|NCT01177397|450839093|FG011|Overall Study|Disease progression|8|||
125329411|NCT01177397|450839082|FG000|Overall Study|Other reasons|0|||
125329412|NCT01177397|450839083|FG001|Overall Study|Other reasons|0|||
125329413|NCT01177397|450839084|FG002|Overall Study|Other reasons|1|||
125329414|NCT01177397|450839085|FG003|Overall Study|Other reasons|0|||
125329415|NCT01177397|450839086|FG004|Overall Study|Other reasons|1|||
125329416|NCT01177397|450839087|FG005|Overall Study|Other reasons|1|||
124998661|NCT00372385|449622154|FG002|Overall Study|Refusal of Treatment|0|||
124998662|NCT00372385|449622155|FG003|Overall Study|Refusal of Treatment|0|||
124998663|NCT00372385|449622152|FG000|Overall Study|No Response|1|||
124998664|NCT00372385|449622153|FG001|Overall Study|No Response|1|||
125329417|NCT01177397|450839088|FG006|Overall Study|Other reasons|2|||
125329418|NCT01177397|450839089|FG007|Overall Study|Other reasons|6|||
125329419|NCT01177397|450839090|FG008|Overall Study|Other reasons|10|||
124998665|NCT00372385|449622154|FG002|Overall Study|No Response|0|||
124998666|NCT00372385|449622155|FG003|Overall Study|No Response|0|||
124998667|NCT00372385|449622152|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
124998668|NCT00372385|449622153|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
124998669|NCT00372385|449622154|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
125329420|NCT01177397|450839091|FG009|Overall Study|Other reasons|8|||
125329421|NCT01177397|450839092|FG010|Overall Study|Other reasons|0|||
124998670|NCT00372385|449622155|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
124998671|NCT00372385|449622152|FG000|Overall Study|Virologic Stopping Rule|17|||
124998672|NCT00372385|449622153|FG001|Overall Study|Virologic Stopping Rule|0|||
124998673|NCT00372385|449622154|FG002|Overall Study|Virologic Stopping Rule|0|||
124998674|NCT00372385|449622155|FG003|Overall Study|Virologic Stopping Rule|0|||
124998675|NCT01699789|449622156|FG000|Overall Study|Withdrawal by Subject|18|||
124998676|NCT01699789|449622157|FG001|Overall Study|Withdrawal by Subject|23|||
124998677|NCT01699789|449622156|FG000|Overall Study|Death|1|||
124998678|NCT01699789|449622157|FG001|Overall Study|Death|2|||
124998679|NCT01699789|449622156|FG000|Overall Study|Lost to Follow-up|83|||
124998680|NCT01699789|449622157|FG001|Overall Study|Lost to Follow-up|101|||
124998681|NCT02411578|449622160|FG000|Crossover Trial Phase|Pregnancy|0|||
124998682|NCT02411578|449622161|FG001|Crossover Trial Phase|Pregnancy|1|||
124998683|NCT01557348|449622162|FG000|Overall Study|Adverse Event|6|||
124998684|NCT01557348|449622163|FG001|Overall Study|Adverse Event|16|||
124998685|NCT01557348|449622162|FG000|Overall Study|Infusion reaction event|5|||
125329422|NCT01177397|450839093|FG011|Overall Study|Other reasons|2|||
125329423|NCT00865566|450839094|FG000|Overall Study|Death|1|||
125329424|NCT00865566|450839095|FG001|Overall Study|Death|11|||
124998686|NCT01557348|449622163|FG001|Overall Study|Infusion reaction event|5|||
124998687|NCT01557348|449622162|FG000|Overall Study|Death|7|||
124998688|NCT01557348|449622163|FG001|Overall Study|Death|4|||
124998689|NCT01557348|449622162|FG000|Overall Study|Insufficient Therapeutic Response|13|||
124998690|NCT01557348|449622163|FG001|Overall Study|Insufficient Therapeutic Response|28|||
124998691|NCT01557348|449622162|FG000|Overall Study|Withdrawal by Subject|5|||
124998692|NCT01557348|449622163|FG001|Overall Study|Withdrawal by Subject|4|||
124998693|NCT01557348|449622162|FG000|Overall Study|Lost to Follow-up|26|||
124998694|NCT01557348|449622163|FG001|Overall Study|Lost to Follow-up|22|||
124998695|NCT01557348|449622162|FG000|Overall Study|Administrative|18|||
124998696|NCT01557348|449622163|FG001|Overall Study|Administrative|11|||
124998697|NCT04343248|449622164|FG000|Overall Study|Withdrawal by Subject|5|||
125329425|NCT00865566|450839094|FG000|Overall Study|Lost to Follow-up|314|||
125329426|NCT00865566|450839095|FG001|Overall Study|Lost to Follow-up|315|||
125329427|NCT00865566|450839094|FG000|Overall Study|Withdrawal by Subject|45|||
125329428|NCT00865566|450839095|FG001|Overall Study|Withdrawal by Subject|65|||
125329429|NCT00865566|450839094|FG000|Overall Study|Physician Decision|0|||
125329430|NCT00865566|450839095|FG001|Overall Study|Physician Decision|1|||
125329431|NCT00865566|450839094|FG000|Overall Study|Participant relocated|78|||
125329432|NCT00865566|450839095|FG001|Overall Study|Participant relocated|107|||
125329433|NCT00865566|450839094|FG000|Overall Study|Participant unable to adhere|27|||
125329434|NCT00865566|450839095|FG001|Overall Study|Participant unable to adhere|42|||
125329435|NCT00865566|450839094|FG000|Overall Study|Other; N=245 due to early study closure|154|||
125329436|NCT00865566|450839095|FG001|Overall Study|Other; N=245 due to early study closure|139|||
125329437|NCT00865566|450839094|FG000|Overall Study|HIV infection|5|||
125329438|NCT00865566|450839095|FG001|Overall Study|HIV infection|7|||
125329439|NCT00719472|450839098|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
125329440|NCT00719472|450839098|FG000|Enrolled in Study|Subject decision to withdraw|8|||
125329441|NCT00719472|450839098|FG000|Enrolled in Study|Various Reasons|17|||
125329442|NCT00719472|450839098|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
125329443|NCT00719472|450839098|FG000|Received Cycle 1 Treatment|Death|5|||
125329444|NCT00719472|450839098|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
125329445|NCT00719472|450839098|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
125329446|NCT00719472|450839098|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
125329447|NCT00719472|450839098|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
125329448|NCT00719472|450839098|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
125329449|NCT00719472|450839098|FG000|Received Cycle 2 Treatment|Death|6|||
125329450|NCT00719472|450839098|FG000|Received Cycle 2 Treatment|Disease progression|3|||
124998698|NCT04343248|449622165|FG001|Overall Study|Withdrawal by Subject|6|||
124998699|NCT04343248|449622164|FG000|Overall Study|Death|1|||
124998700|NCT04343248|449622165|FG001|Overall Study|Death|2|||
124998701|NCT04343248|449622164|FG000|Overall Study|Lost to Follow-up|9|||
124998702|NCT04343248|449622165|FG001|Overall Study|Lost to Follow-up|6|||
124998703|NCT04343248|449622164|FG000|Overall Study|Physician Decision|0|||
124998704|NCT04343248|449622165|FG001|Overall Study|Physician Decision|1|||
124998705|NCT04343248|449622164|FG000|Overall Study|Adverse Event|1|||
124998706|NCT04343248|449622165|FG001|Overall Study|Adverse Event|0|||
125329451|NCT00719472|450839098|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
125329452|NCT00719472|450839098|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
125329453|NCT00719472|450839098|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
125329454|NCT00719472|450839098|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
125329455|NCT02395471|450839099|FG000|Overall Study|Lost to Follow-up|2|||
125329456|NCT02395471|450839100|FG001|Overall Study|Lost to Follow-up|0|||
125329457|NCT02395471|450839099|FG000|Overall Study|Withdrawal by Subject|2|||
124998707|NCT05125679|449622166|FG000|Overall Study|Study Terminated by Sponsor|2|||
124998708|NCT05125679|449622167|FG001|Overall Study|Study Terminated by Sponsor|5|||
124998709|NCT04484259|449622168|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
124998710|NCT04484259|449622169|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
124998711|NCT04484259|449622170|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
125329458|NCT02395471|450839100|FG001|Overall Study|Withdrawal by Subject|1|||
125329459|NCT02395471|450839099|FG000|Overall Study|Physician Decision|1|||
125329460|NCT02395471|450839100|FG001|Overall Study|Physician Decision|0|||
125329461|NCT02395471|450839099|FG000|Overall Study|Protocol Violation|0|||
125329462|NCT02395471|450839100|FG001|Overall Study|Protocol Violation|1|||
125329463|NCT02395471|450839099|FG000|Overall Study|Failure to swollow sponge twice|1|||
125329464|NCT02395471|450839100|FG001|Overall Study|Failure to swollow sponge twice|0|||
125329465|NCT02395471|450839099|FG000|Overall Study|Patient did not return for procedure|0|||
125329466|NCT02395471|450839100|FG001|Overall Study|Patient did not return for procedure|1|||
125329467|NCT02395471|450839099|FG000|Overall Study|Subject not eligible|1|||
125329468|NCT02395471|450839100|FG001|Overall Study|Subject not eligible|0|||
125329469|NCT01244893|450839101|FG000|Baseline|Protocol Violation|0|||
125329470|NCT01244893|450839102|FG001|Baseline|Protocol Violation|1|||
125329471|NCT01244893|450839101|FG000|1-Week Follow Up|Lost to Follow-up|1|||
125329472|NCT01244893|450839102|FG001|1-Week Follow Up|Lost to Follow-up|0|||
125329473|NCT00357552|450839103|FG000|Screening|Did not meet eligibility criteria|84|||
125329474|NCT00357552|450839103|FG000|Weeks 0 to 24|Death|1|||
125329475|NCT00357552|450839103|FG000|Weeks 24 to 104|Death|3|||
125329476|NCT00357552|450839103|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
125329477|NCT00711191|450839108|FG000|Overall Study|Adverse Event|1|||
125329478|NCT00711191|450839109|FG001|Overall Study|Adverse Event|1|||
124998712|NCT04484259|449622171|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
124998713|NCT04484259|449622172|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
124998714|NCT04484259|449622168|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
124998715|NCT04484259|449622169|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
124998716|NCT04484259|449622170|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
124998717|NCT04484259|449622171|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
124998718|NCT04484259|449622172|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
124998719|NCT04484259|449622168|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
124998720|NCT04484259|449622169|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
124998721|NCT04484259|449622170|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
124998722|NCT04484259|449622171|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
124998723|NCT04484259|449622172|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
124998724|NCT04484259|449622168|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
124998725|NCT04484259|449622169|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
124998726|NCT04484259|449622170|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
124998727|NCT04484259|449622171|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
124998728|NCT04484259|449622172|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
124998729|NCT04484259|449622168|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
124998730|NCT04484259|449622169|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
124998731|NCT04484259|449622170|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
124998732|NCT04484259|449622171|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
124998733|NCT04484259|449622172|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
124998734|NCT04484259|449622168|FG000|Randomized Treatment|Withdrawal by Subject|1|||
124998735|NCT04484259|449622169|FG001|Randomized Treatment|Withdrawal by Subject|0|||
124998736|NCT04484259|449622170|FG002|Randomized Treatment|Withdrawal by Subject|0|||
124998737|NCT04484259|449622171|FG003|Randomized Treatment|Withdrawal by Subject|0|||
124998738|NCT04484259|449622172|FG004|Randomized Treatment|Withdrawal by Subject|0|||
124998739|NCT01422850|449622181|FG000|Overall Study|Physician Decision|3|||
124998740|NCT04484831|449622182|FG000|Overall Study|Withdrawal by Subject|1|||
124998741|NCT04484831|449622183|FG001|Overall Study|Withdrawal by Subject|0|||
124998742|NCT02244996|449622184|FG000|Overall Study|Lack of Efficacy|2|||
124998743|NCT02244996|449622185|FG001|Overall Study|Lack of Efficacy|6|||
124998744|NCT01335009|449622186|FG000|Overall Study|Too ill to travel to study sites|1|||
124998745|NCT01335009|449622187|FG001|Overall Study|Too ill to travel to study sites|0|||
124998746|NCT01335009|449622186|FG000|Overall Study|Death|28|||
124998747|NCT01335009|449622187|FG001|Overall Study|Death|32|||
124998748|NCT01335009|449622186|FG000|Overall Study|Withdrawal by Subject|1|||
124998749|NCT01335009|449622187|FG001|Overall Study|Withdrawal by Subject|1|||
124998750|NCT01335009|449622186|FG000|Overall Study|Lost to Follow-up|1|||
124998751|NCT01335009|449622187|FG001|Overall Study|Lost to Follow-up|0|||
124998752|NCT04751656|449623750|FG000|Overall Study|Lost to Follow-up|1|||
124998753|NCT01128361|449623762|FG000|Overall Study|Lost to Follow-up|0|||
124998754|NCT01128361|449623763|FG001|Overall Study|Lost to Follow-up|1|||
124998755|NCT01128361|449623762|FG000|Overall Study|Withdrawal by Subject|5|||
124998756|NCT01128361|449623763|FG001|Overall Study|Withdrawal by Subject|2|||
124998757|NCT00146328|449623764|FG000|Overall Study|Adverse Event|39|||
124998758|NCT00146328|449623765|FG001|Overall Study|Adverse Event|48|||
124998759|NCT00146328|449623766|FG002|Overall Study|Adverse Event|79|||
124998760|NCT00146328|449623764|FG000|Overall Study|Protocol Violation|11|||
125329479|NCT00711191|450839110|FG002|Overall Study|Adverse Event|2|||
125329480|NCT00711191|450839108|FG000|Overall Study|Objective progression or relapse|2|||
124998761|NCT00146328|449623765|FG001|Overall Study|Protocol Violation|6|||
124998762|NCT00146328|449623766|FG002|Overall Study|Protocol Violation|12|||
124998763|NCT00146328|449623764|FG000|Overall Study|Lost to Follow-up|7|||
124998764|NCT00146328|449623765|FG001|Overall Study|Lost to Follow-up|4|||
124998765|NCT00146328|449623766|FG002|Overall Study|Lost to Follow-up|7|||
124998766|NCT00146328|449623764|FG000|Overall Study|Withdrawal by Subject|16|||
124998767|NCT00146328|449623765|FG001|Overall Study|Withdrawal by Subject|16|||
124998768|NCT00146328|449623766|FG002|Overall Study|Withdrawal by Subject|22|||
124998769|NCT00146328|449623764|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
124998770|NCT00146328|449623765|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
124998771|NCT00146328|449623766|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
124998772|NCT00146328|449623764|FG000|Overall Study|Trial ended/site closed|8|||
124998773|NCT00146328|449623765|FG001|Overall Study|Trial ended/site closed|2|||
124998774|NCT00146328|449623766|FG002|Overall Study|Trial ended/site closed|19|||
124998775|NCT00146328|449623764|FG000|Overall Study|Patient decision to end|0|||
124998776|NCT00146328|449623765|FG001|Overall Study|Patient decision to end|1|||
124998777|NCT00146328|449623766|FG002|Overall Study|Patient decision to end|6|||
124998778|NCT00146328|449623764|FG000|Overall Study|Enroll into other trial|2|||
124998779|NCT00146328|449623765|FG001|Overall Study|Enroll into other trial|4|||
124998780|NCT00146328|449623766|FG002|Overall Study|Enroll into other trial|2|||
124998781|NCT00146328|449623764|FG000|Overall Study|Death|0|||
124998782|NCT00146328|449623765|FG001|Overall Study|Death|1|||
124998783|NCT00146328|449623766|FG002|Overall Study|Death|1|||
124998784|NCT00146328|449623764|FG000|Overall Study|Moved|2|||
124998785|NCT00146328|449623765|FG001|Overall Study|Moved|0|||
124998786|NCT00146328|449623766|FG002|Overall Study|Moved|0|||
124998787|NCT00146328|449623764|FG000|Overall Study|Interaction with other medication|2|||
124998788|NCT00146328|449623765|FG001|Overall Study|Interaction with other medication|0|||
124998789|NCT00146328|449623766|FG002|Overall Study|Interaction with other medication|1|||
124998790|NCT01256658|449623767|FG000|Period 1|Lost to Follow-up|837|||
124998791|NCT01256658|449623768|FG001|Period 1|Lost to Follow-up|661|||
124998792|NCT01256658|449623767|FG000|Period 1|Withdrawal by Subject|35|||
124998793|NCT01256658|449623768|FG001|Period 1|Withdrawal by Subject|43|||
124998794|NCT01256658|449623767|FG000|Period 1|Death|48|||
124998795|NCT01256658|449623768|FG001|Period 1|Death|44|||
124998796|NCT00300781|449623769|FG000|Overall Study|Disease Progression|55|||
124998797|NCT00300781|449623770|FG001|Overall Study|Disease Progression|52|||
124998798|NCT00300781|449623769|FG000|Overall Study|Adverse Event|5|||
124998799|NCT00300781|449623770|FG001|Overall Study|Adverse Event|6|||
124998800|NCT00300781|449623769|FG000|Overall Study|Withdrawal by Subject|1|||
124998801|NCT00300781|449623770|FG001|Overall Study|Withdrawal by Subject|2|||
124998802|NCT00300781|449623769|FG000|Overall Study|Physician Decision|1|||
124998803|NCT00300781|449623770|FG001|Overall Study|Physician Decision|0|||
124998804|NCT00300781|449623769|FG000|Overall Study|Not Recorded|0|||
124998805|NCT00300781|449623770|FG001|Overall Study|Not Recorded|1|||
124998806|NCT00300781|449623769|FG000|Overall Study|Symptomatic Deterioration|1|||
124998807|NCT00300781|449623770|FG001|Overall Study|Symptomatic Deterioration|0|||
124998808|NCT00300781|449623769|FG000|Overall Study|Lost to Follow-up|0|||
124998809|NCT00300781|449623770|FG001|Overall Study|Lost to Follow-up|1|||
124998810|NCT02072434|449623774|FG000|Overall Study|Protocol Violation|10|||
124998811|NCT02072434|449623775|FG001|Overall Study|Protocol Violation|9|||
124998812|NCT02072434|449623774|FG000|Overall Study|Physician Decision|5|||
124998813|NCT02072434|449623775|FG001|Overall Study|Physician Decision|10|||
124998814|NCT02072434|449623774|FG000|Overall Study|Adverse event, serious fatal|1|||
124998815|NCT02072434|449623775|FG001|Overall Study|Adverse event, serious fatal|6|||
124998816|NCT02072434|449623774|FG000|Overall Study|Adverse Event|7|||
124998817|NCT02072434|449623775|FG001|Overall Study|Adverse Event|6|||
124998818|NCT02072434|449623774|FG000|Overall Study|Withdrawal by Subject|17|||
124998819|NCT02072434|449623775|FG001|Overall Study|Withdrawal by Subject|29|||
124998820|NCT02072434|449623774|FG000|Overall Study|Other|14|||
125329481|NCT00711191|450839109|FG001|Overall Study|Objective progression or relapse|3|||
125329482|NCT00711191|450839110|FG002|Overall Study|Objective progression or relapse|7|||
124998821|NCT02072434|449623775|FG001|Overall Study|Other|29|||
124998822|NCT02072434|449623774|FG000|Overall Study|Lost to Follow-up|0|||
124998823|NCT02072434|449623775|FG001|Overall Study|Lost to Follow-up|1|||
124998824|NCT02525861|449623778|FG000|Overall Study|Adverse Event|1|||
125329483|NCT00711191|450839108|FG000|Overall Study|Withdrawal by Subject|0|||
124998825|NCT02525861|449623779|FG001|Overall Study|Adverse Event|0|||
124998826|NCT02525861|449623778|FG000|Overall Study|Withdrawal by Subject|0|||
124998827|NCT02525861|449623779|FG001|Overall Study|Withdrawal by Subject|1|||
124998828|NCT02525861|449623778|FG000|Overall Study|Physician Decision|0|||
124998829|NCT02525861|449623779|FG001|Overall Study|Physician Decision|1|||
124998830|NCT01117454|449623782|FG000|Overall Study|Pregnancy|0|||
124998831|NCT01117454|449623783|FG001|Overall Study|Pregnancy|1|||
124998832|NCT00888433|449623784|FG000|Overall Study|Withdrawal by Subject|1|||
124998833|NCT00888433|449623785|FG001|Overall Study|Withdrawal by Subject|2|||
124998834|NCT00888433|449623784|FG000|Overall Study|Missed Visit|2|||
124998835|NCT00888433|449623785|FG001|Overall Study|Missed Visit|1|||
124998836|NCT01681628|449623786|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
124998837|NCT01681628|449623787|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
124998838|NCT01681628|449623786|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
125329484|NCT00711191|450839109|FG001|Overall Study|Withdrawal by Subject|1|||
124998839|NCT01681628|449623787|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
124998840|NCT01681628|449623786|FG000|19 Months Follow-up|Death|1|||
124998841|NCT01681628|449623787|FG001|19 Months Follow-up|Death|0|||
124998842|NCT01681628|449623786|FG000|19 Months Follow-up|Lost to Follow-up|61|||
124998843|NCT01681628|449623787|FG001|19 Months Follow-up|Lost to Follow-up|43|||
124998844|NCT01794520|449623788|FG000|Overall Study|Adverse events- related to progression|0|||
124998845|NCT01794520|449623789|FG001|Overall Study|Adverse events- related to progression|0|||
124998846|NCT01794520|449623790|FG002|Overall Study|Adverse events- related to progression|1|||
124998847|NCT01794520|449623791|FG003|Overall Study|Adverse events- related to progression|2|||
124998848|NCT01794520|449623792|FG004|Overall Study|Adverse events- related to progression|0|||
124998849|NCT01794520|449623793|FG005|Overall Study|Adverse events- related to progression|1|||
124998850|NCT01794520|449623794|FG006|Overall Study|Adverse events- related to progression|0|||
124998851|NCT01794520|449623788|FG000|Overall Study|Adverse event- not related to progression|1|||
124998852|NCT01794520|449623789|FG001|Overall Study|Adverse event- not related to progression|1|||
124998853|NCT01794520|449623790|FG002|Overall Study|Adverse event- not related to progression|0|||
124998854|NCT01794520|449623791|FG003|Overall Study|Adverse event- not related to progression|0|||
124998855|NCT01794520|449623792|FG004|Overall Study|Adverse event- not related to progression|2|||
124998856|NCT01794520|449623793|FG005|Overall Study|Adverse event- not related to progression|0|||
124998857|NCT01794520|449623794|FG006|Overall Study|Adverse event- not related to progression|0|||
124998858|NCT01794520|449623788|FG000|Overall Study|Progressive disease|5|||
124998859|NCT01794520|449623789|FG001|Overall Study|Progressive disease|6|||
124998860|NCT01794520|449623790|FG002|Overall Study|Progressive disease|2|||
124998861|NCT01794520|449623791|FG003|Overall Study|Progressive disease|5|||
124998862|NCT01794520|449623792|FG004|Overall Study|Progressive disease|27|||
124998863|NCT01794520|449623793|FG005|Overall Study|Progressive disease|18|||
124998864|NCT01794520|449623794|FG006|Overall Study|Progressive disease|0|||
124998865|NCT01794520|449623788|FG000|Overall Study|Withdrew consent|0|||
124998866|NCT01794520|449623789|FG001|Overall Study|Withdrew consent|0|||
124998867|NCT01794520|449623790|FG002|Overall Study|Withdrew consent|1|||
124998868|NCT01794520|449623791|FG003|Overall Study|Withdrew consent|1|||
124998869|NCT01794520|449623792|FG004|Overall Study|Withdrew consent|0|||
124998870|NCT01794520|449623793|FG005|Overall Study|Withdrew consent|0|||
124998871|NCT01794520|449623794|FG006|Overall Study|Withdrew consent|0|||
124998872|NCT01794520|449623788|FG000|Overall Study|Lost to Follow-up|0|||
124998873|NCT01794520|449623789|FG001|Overall Study|Lost to Follow-up|0|||
124998874|NCT01794520|449623790|FG002|Overall Study|Lost to Follow-up|0|||
124998875|NCT01794520|449623791|FG003|Overall Study|Lost to Follow-up|0|||
124998876|NCT01794520|449623792|FG004|Overall Study|Lost to Follow-up|1|||
124998877|NCT01794520|449623793|FG005|Overall Study|Lost to Follow-up|0|||
124998878|NCT01794520|449623794|FG006|Overall Study|Lost to Follow-up|0|||
124998879|NCT01794520|449623788|FG000|Overall Study|Toxicity|0|||
124998880|NCT01794520|449623789|FG001|Overall Study|Toxicity|2|||
124998881|NCT01794520|449623790|FG002|Overall Study|Toxicity|0|||
124998882|NCT01794520|449623791|FG003|Overall Study|Toxicity|0|||
124998883|NCT01794520|449623792|FG004|Overall Study|Toxicity|0|||
124998884|NCT01794520|449623793|FG005|Overall Study|Toxicity|0|||
124998885|NCT01794520|449623794|FG006|Overall Study|Toxicity|0|||
124998886|NCT01794520|449623788|FG000|Overall Study|Study terminated by sponsor|0|||
124998887|NCT01794520|449623789|FG001|Overall Study|Study terminated by sponsor|0|||
124998888|NCT01794520|449623790|FG002|Overall Study|Study terminated by sponsor|1|||
124998889|NCT01794520|449623791|FG003|Overall Study|Study terminated by sponsor|0|||
124998890|NCT01794520|449623792|FG004|Overall Study|Study terminated by sponsor|1|||
124998891|NCT01794520|449623793|FG005|Overall Study|Study terminated by sponsor|0|||
124998892|NCT01794520|449623794|FG006|Overall Study|Study terminated by sponsor|7|||
124998893|NCT01794520|449623788|FG000|Overall Study|Death|0|||
124998894|NCT01794520|449623789|FG001|Overall Study|Death|0|||
124998895|NCT01794520|449623790|FG002|Overall Study|Death|0|||
124998896|NCT01794520|449623791|FG003|Overall Study|Death|0|||
124998897|NCT01794520|449623792|FG004|Overall Study|Death|1|||
124998898|NCT01794520|449623793|FG005|Overall Study|Death|0|||
124998899|NCT01794520|449623794|FG006|Overall Study|Death|22|||
125329485|NCT00711191|450839110|FG002|Overall Study|Withdrawal by Subject|3|||
124998900|NCT01794520|449623788|FG000|Overall Study|Other, not specified|0|||
124998901|NCT01794520|449623789|FG001|Overall Study|Other, not specified|0|||
124998902|NCT01794520|449623790|FG002|Overall Study|Other, not specified|1|||
124998903|NCT01794520|449623791|FG003|Overall Study|Other, not specified|1|||
124998904|NCT01794520|449623792|FG004|Overall Study|Other, not specified|4|||
124998905|NCT01794520|449623793|FG005|Overall Study|Other, not specified|1|||
124998906|NCT01794520|449623794|FG006|Overall Study|Other, not specified|2|||
124998907|NCT04796896|449623796|FG000|Overall Study|Adverse Event|1|||
124998908|NCT04796896|449623797|FG001|Overall Study|Adverse Event|0|||
124998909|NCT04796896|449623798|FG002|Overall Study|Adverse Event|0|||
124998910|NCT04796896|449623799|FG003|Overall Study|Adverse Event|0|||
124998911|NCT04796896|449623800|FG004|Overall Study|Adverse Event|0|||
124998912|NCT04796896|449623801|FG005|Overall Study|Adverse Event|1|||
124998913|NCT04796896|449623802|FG006|Overall Study|Adverse Event|1|||
124998914|NCT04796896|449623803|FG007|Overall Study|Adverse Event|0|||
124998915|NCT04796896|449623804|FG008|Overall Study|Adverse Event|1|||
124998916|NCT04796896|449623805|FG009|Overall Study|Adverse Event|1|||
124998917|NCT04796896|449623806|FG010|Overall Study|Adverse Event|1|||
124998918|NCT04796896|449623807|FG011|Overall Study|Adverse Event|0|||
124998919|NCT04796896|449623796|FG000|Overall Study|Lost to Follow-up|24|||
124998920|NCT04796896|449623797|FG001|Overall Study|Lost to Follow-up|15|||
124998921|NCT04796896|449623798|FG002|Overall Study|Lost to Follow-up|6|||
124998922|NCT04796896|449623799|FG003|Overall Study|Lost to Follow-up|4|||
124998923|NCT04796896|449623800|FG004|Overall Study|Lost to Follow-up|21|||
124998924|NCT04796896|449623801|FG005|Overall Study|Lost to Follow-up|55|||
124998925|NCT04796896|449623802|FG006|Overall Study|Lost to Follow-up|237|||
124998926|NCT04796896|449623803|FG007|Overall Study|Lost to Follow-up|52|||
124998927|NCT04796896|449623804|FG008|Overall Study|Lost to Follow-up|221|||
124998928|NCT04796896|449623805|FG009|Overall Study|Lost to Follow-up|43|||
124998929|NCT04796896|449623806|FG010|Overall Study|Lost to Follow-up|142|||
124998930|NCT04796896|449623807|FG011|Overall Study|Lost to Follow-up|18|||
124998931|NCT04796896|449623796|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
124998932|NCT04796896|449623797|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
124998933|NCT04796896|449623798|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
124998934|NCT04796896|449623799|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
124998935|NCT04796896|449623800|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
124998936|NCT04796896|449623801|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
124998937|NCT04796896|449623802|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
124998938|NCT04796896|449623803|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
124998939|NCT04796896|449623804|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
124998940|NCT04796896|449623805|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
124998941|NCT04796896|449623806|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
124998942|NCT04796896|449623807|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
124998943|NCT04796896|449623796|FG000|Overall Study|Physician Decision|1|||
124998944|NCT04796896|449623797|FG001|Overall Study|Physician Decision|0|||
124998945|NCT04796896|449623798|FG002|Overall Study|Physician Decision|0|||
124998946|NCT04796896|449623799|FG003|Overall Study|Physician Decision|0|||
124998947|NCT04796896|449623800|FG004|Overall Study|Physician Decision|0|||
124998948|NCT04796896|449623801|FG005|Overall Study|Physician Decision|3|||
124998949|NCT04796896|449623802|FG006|Overall Study|Physician Decision|18|||
124998950|NCT04796896|449623803|FG007|Overall Study|Physician Decision|1|||
124998951|NCT04796896|449623804|FG008|Overall Study|Physician Decision|7|||
124998952|NCT04796896|449623805|FG009|Overall Study|Physician Decision|0|||
124998953|NCT04796896|449623806|FG010|Overall Study|Physician Decision|5|||
124998954|NCT04796896|449623807|FG011|Overall Study|Physician Decision|0|||
124998955|NCT04796896|449623796|FG000|Overall Study|Withdrawal by Subject|36|||
124998956|NCT04796896|449623797|FG001|Overall Study|Withdrawal by Subject|31|||
124998957|NCT04796896|449623798|FG002|Overall Study|Withdrawal by Subject|11|||
124998958|NCT04796896|449623799|FG003|Overall Study|Withdrawal by Subject|8|||
124998959|NCT04796896|449623800|FG004|Overall Study|Withdrawal by Subject|16|||
124998960|NCT04796896|449623801|FG005|Overall Study|Withdrawal by Subject|162|||
124998961|NCT04796896|449623802|FG006|Overall Study|Withdrawal by Subject|299|||
124998962|NCT04796896|449623803|FG007|Overall Study|Withdrawal by Subject|149|||
124998963|NCT04796896|449623804|FG008|Overall Study|Withdrawal by Subject|303|||
124998964|NCT04796896|449623805|FG009|Overall Study|Withdrawal by Subject|94|||
124998965|NCT04796896|449623806|FG010|Overall Study|Withdrawal by Subject|192|||
124998966|NCT04796896|449623807|FG011|Overall Study|Withdrawal by Subject|16|||
124998967|NCT04796896|449623796|FG000|Overall Study|Other Than Specified|6|||
124998968|NCT04796896|449623797|FG001|Overall Study|Other Than Specified|5|||
124998969|NCT04796896|449623798|FG002|Overall Study|Other Than Specified|3|||
124998970|NCT04796896|449623799|FG003|Overall Study|Other Than Specified|2|||
125329486|NCT03584789|450839111|FG000|Overall Study|refused EHR permission|19|||
125329487|NCT03584789|450839112|FG001|Overall Study|refused EHR permission|28|||
125329488|NCT03584789|450839113|FG002|Overall Study|refused EHR permission|23|||
124998971|NCT04796896|449623800|FG004|Overall Study|Other Than Specified|6|||
124998972|NCT04796896|449623801|FG005|Overall Study|Other Than Specified|31|||
124998973|NCT04796896|449623802|FG006|Overall Study|Other Than Specified|86|||
124998974|NCT04796896|449623803|FG007|Overall Study|Other Than Specified|66|||
124998975|NCT04796896|449623804|FG008|Overall Study|Other Than Specified|388|||
124998976|NCT04796896|449623805|FG009|Overall Study|Other Than Specified|48|||
124998977|NCT04796896|449623806|FG010|Overall Study|Other Than Specified|258|||
124998978|NCT04796896|449623807|FG011|Overall Study|Other Than Specified|4|||
124998979|NCT04796896|449623796|FG000|Overall Study|Protocol Deviation|0|||
124998980|NCT04796896|449623797|FG001|Overall Study|Protocol Deviation|0|||
125329489|NCT03584789|450839111|FG000|Overall Study|patients tied to a provider who retired|0|||
124998981|NCT04796896|449623798|FG002|Overall Study|Protocol Deviation|0|||
124998982|NCT04796896|449623799|FG003|Overall Study|Protocol Deviation|1|||
125329490|NCT03584789|450839112|FG001|Overall Study|patients tied to a provider who retired|0|||
125329491|NCT03584789|450839113|FG002|Overall Study|patients tied to a provider who retired|3|||
125329492|NCT02035267|450839114|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
125329493|NCT02035267|450839115|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
125329494|NCT02035267|450839116|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
125329495|NCT02035267|450839117|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
125329496|NCT02035267|450839114|FG000|Overall Study|Adverse Event|0|||
125329497|NCT02035267|450839115|FG001|Overall Study|Adverse Event|0|||
125329498|NCT02035267|450839116|FG002|Overall Study|Adverse Event|1|||
125329499|NCT02035267|450839117|FG003|Overall Study|Adverse Event|0|||
124998983|NCT04796896|449623800|FG004|Overall Study|Protocol Deviation|1|||
124998984|NCT04796896|449623801|FG005|Overall Study|Protocol Deviation|2|||
124998985|NCT04796896|449623802|FG006|Overall Study|Protocol Deviation|2|||
124998986|NCT04796896|449623803|FG007|Overall Study|Protocol Deviation|2|||
124998987|NCT04796896|449623804|FG008|Overall Study|Protocol Deviation|2|||
124998988|NCT04796896|449623805|FG009|Overall Study|Protocol Deviation|1|||
124998989|NCT04796896|449623806|FG010|Overall Study|Protocol Deviation|0|||
124998990|NCT04796896|449623807|FG011|Overall Study|Protocol Deviation|0|||
124998991|NCT04796896|449623796|FG000|Overall Study|Missing|0|||
124998992|NCT04796896|449623797|FG001|Overall Study|Missing|0|||
124998993|NCT04796896|449623798|FG002|Overall Study|Missing|0|||
124998994|NCT04796896|449623799|FG003|Overall Study|Missing|0|||
124998995|NCT04796896|449623800|FG004|Overall Study|Missing|0|||
124998996|NCT04796896|449623801|FG005|Overall Study|Missing|0|||
124998997|NCT04796896|449623802|FG006|Overall Study|Missing|2|||
124998998|NCT04796896|449623803|FG007|Overall Study|Missing|1|||
124998999|NCT04796896|449623804|FG008|Overall Study|Missing|2|||
124999000|NCT04796896|449623805|FG009|Overall Study|Missing|1|||
124999001|NCT04796896|449623806|FG010|Overall Study|Missing|1|||
124999002|NCT04796896|449623807|FG011|Overall Study|Missing|0|||
124999003|NCT04796896|449623796|FG000|Overall Study|Death|0|||
124999004|NCT04796896|449623797|FG001|Overall Study|Death|0|||
124999005|NCT04796896|449623798|FG002|Overall Study|Death|0|||
124999006|NCT04796896|449623799|FG003|Overall Study|Death|0|||
124999007|NCT04796896|449623800|FG004|Overall Study|Death|0|||
124999008|NCT04796896|449623801|FG005|Overall Study|Death|0|||
124999009|NCT04796896|449623802|FG006|Overall Study|Death|0|||
124999010|NCT04796896|449623803|FG007|Overall Study|Death|0|||
124999011|NCT04796896|449623804|FG008|Overall Study|Death|1|||
124999012|NCT04796896|449623805|FG009|Overall Study|Death|0|||
124999013|NCT04796896|449623806|FG010|Overall Study|Death|0|||
124999014|NCT04796896|449623807|FG011|Overall Study|Death|0|||
124999015|NCT02175004|449623812|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
124999016|NCT02175004|449623813|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
124999017|NCT02175004|449623812|FG000|Overall Study|Investigator Judgment|1|||
124999018|NCT02175004|449623813|FG001|Overall Study|Investigator Judgment|4|||
124999019|NCT02175004|449623812|FG000|Overall Study|Voluntary Withdrawal|6|||
124999020|NCT02175004|449623813|FG001|Overall Study|Voluntary Withdrawal|19|||
124999021|NCT02175004|449623812|FG000|Overall Study|Liver Transplant|1|||
124999022|NCT02175004|449623813|FG001|Overall Study|Liver Transplant|0|||
124999023|NCT02175004|449623812|FG000|Overall Study|Disease Progression|1|||
124999024|NCT02175004|449623813|FG001|Overall Study|Disease Progression|0|||
124999025|NCT02175004|449623812|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
124999026|NCT02175004|449623813|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
124999027|NCT01383161|449623814|FG000|Overall Study|Adverse Event|5|||
124999028|NCT01383161|449623815|FG001|Overall Study|Adverse Event|1|||
124999029|NCT01383161|449623814|FG000|Overall Study|Withdrawal by Subject|0|||
124999030|NCT01383161|449623815|FG001|Overall Study|Withdrawal by Subject|2|||
124999031|NCT01383161|449623814|FG000|Overall Study|Lack of Efficacy|0|||
124999032|NCT01383161|449623815|FG001|Overall Study|Lack of Efficacy|1|||
124999033|NCT03942406|449623822|FG000|Overall Study|Lost to Follow-up|4|||
124999034|NCT03942406|449623823|FG001|Overall Study|Lost to Follow-up|5|||
124999035|NCT03942406|449623824|FG002|Overall Study|Lost to Follow-up|3|||
124999036|NCT03942406|449623825|FG003|Overall Study|Lost to Follow-up|7|||
124999037|NCT03942406|449623826|FG004|Overall Study|Lost to Follow-up|1|||
124999038|NCT03942406|449623827|FG005|Overall Study|Lost to Follow-up|0|||
124999039|NCT03942406|449623828|FG006|Overall Study|Lost to Follow-up|0|||
124999040|NCT03942406|449623822|FG000|Overall Study|Withdrawal by Subject|3|||
124999041|NCT03942406|449623823|FG001|Overall Study|Withdrawal by Subject|1|||
125329500|NCT02035267|450839114|FG000|Overall Study|Lost to Follow-up|0|||
125329501|NCT02035267|450839115|FG001|Overall Study|Lost to Follow-up|0|||
124999042|NCT03942406|449623824|FG002|Overall Study|Withdrawal by Subject|1|||
124999043|NCT03942406|449623825|FG003|Overall Study|Withdrawal by Subject|3|||
124999044|NCT03942406|449623826|FG004|Overall Study|Withdrawal by Subject|0|||
124999045|NCT03942406|449623827|FG005|Overall Study|Withdrawal by Subject|0|||
124999046|NCT03942406|449623828|FG006|Overall Study|Withdrawal by Subject|0|||
124999047|NCT03942406|449623822|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
124999048|NCT03942406|449623823|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
124999049|NCT03942406|449623824|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
124999050|NCT03942406|449623825|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
124999051|NCT03942406|449623826|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
124999052|NCT03942406|449623827|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
124999053|NCT03942406|449623828|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
124999054|NCT00216203|449623831|FG000|Overall Study|Withdrawal by Subject|2|||
124999055|NCT04263909|449623832|FG000|Overall Study|Physician Decision|1|||
125329502|NCT02035267|450839116|FG002|Overall Study|Lost to Follow-up|0|||
125329503|NCT02035267|450839117|FG003|Overall Study|Lost to Follow-up|1|||
125329504|NCT02035267|450839114|FG000|Overall Study|Other unspecified|0|||
125329505|NCT02035267|450839115|FG001|Overall Study|Other unspecified|1|||
125329506|NCT02035267|450839116|FG002|Overall Study|Other unspecified|0|||
125329507|NCT02035267|450839117|FG003|Overall Study|Other unspecified|0|||
125329508|NCT02803580|450839119|FG000|Overall Study|Death|13|||
125329509|NCT02803580|450839119|FG000|Overall Study|Lost to Follow-up|19|||
125329510|NCT02803580|450839119|FG000|Overall Study|Withdrawal by Subject|3|||
125329511|NCT02803580|450839119|FG000|Overall Study|Inclusion in clinical trial|1|||
125329512|NCT00836693|450839125|FG000|Overall Study|Adverse Event|4|||
125329513|NCT00836693|450839126|FG001|Overall Study|Adverse Event|1|||
125329514|NCT00836693|450839125|FG000|Overall Study|Sponsor Decision|0|||
125329515|NCT00836693|450839126|FG001|Overall Study|Sponsor Decision|1|||
125329516|NCT00836693|450839125|FG000|Overall Study|Physician Decision|2|||
125329517|NCT00836693|450839126|FG001|Overall Study|Physician Decision|0|||
125329518|NCT00836693|450839125|FG000|Overall Study|Withdrawal by Subject|9|||
125329519|NCT00836693|450839126|FG001|Overall Study|Withdrawal by Subject|4|||
125329520|NCT00836693|450839125|FG000|Overall Study|Protocol Violation|1|||
125329521|NCT00836693|450839126|FG001|Overall Study|Protocol Violation|0|||
125329522|NCT00836693|450839125|FG000|Overall Study|Lost to Follow-up|1|||
125329523|NCT00836693|450839126|FG001|Overall Study|Lost to Follow-up|0|||
125329524|NCT02612779|450839127|FG000|Overall Study|Administrative reason by sponsor|4|||
125329525|NCT02612779|450839128|FG001|Overall Study|Administrative reason by sponsor|1|||
125329526|NCT02612779|450839127|FG000|Overall Study|No longer meet study criteria|0|||
125329527|NCT02612779|450839128|FG001|Overall Study|No longer meet study criteria|1|||
125329528|NCT02612779|450839127|FG000|Overall Study|Disease progression|29|||
125329529|NCT02612779|450839128|FG001|Overall Study|Disease progression|2|||
125329530|NCT02612779|450839127|FG000|Overall Study|Study drug toxicity|10|||
125329531|NCT02612779|450839128|FG001|Overall Study|Study drug toxicity|1|||
125329532|NCT02612779|450839127|FG000|Overall Study|Death|1|||
125329533|NCT02612779|450839128|FG001|Overall Study|Death|0|||
125329534|NCT02612779|450839127|FG000|Overall Study|Adverse event unrelated to study drug|5|||
125329535|NCT02612779|450839128|FG001|Overall Study|Adverse event unrelated to study drug|0|||
125329536|NCT02612779|450839127|FG000|Overall Study|Participant withdrew consent|4|||
125329537|NCT02612779|450839128|FG001|Overall Study|Participant withdrew consent|0|||
125329538|NCT02612779|450839127|FG000|Overall Study|Lost to Follow-up|1|||
125329539|NCT02612779|450839128|FG001|Overall Study|Lost to Follow-up|0|||
125329540|NCT02612779|450839127|FG000|Overall Study|Maximum clinical benefit|10|||
125329541|NCT02612779|450839128|FG001|Overall Study|Maximum clinical benefit|1|||
125329542|NCT02612779|450839127|FG000|Overall Study|Other reasons|4|||
125329543|NCT02612779|450839128|FG001|Overall Study|Other reasons|0|||
125329544|NCT02118961|450839129|FG000|Overall Study|Withdrawal by Subject|1|||
125329545|NCT02118961|450839130|FG001|Overall Study|Withdrawal by Subject|0|||
125329546|NCT01750229|450839131|FG000|Randomized Crossover Phase|Adverse Event|1|||
125329547|NCT01750229|450839131|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
125329548|NCT01750229|450839131|FG000|Long-term Follow-up Phase|Adverse Event|2|||
125329549|NCT01750229|450839131|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
125329550|NCT03722238|450839132|FG000|Overall Study|Protocol Violation|1|||
125329551|NCT03722238|450839133|FG001|Overall Study|Protocol Violation|0|||
125329552|NCT03722238|450839132|FG000|Overall Study|Physician Decision|1|||
125329553|NCT03722238|450839133|FG001|Overall Study|Physician Decision|0|||
125329554|NCT03722238|450839132|FG000|Overall Study|Death|1|||
125329555|NCT03722238|450839133|FG001|Overall Study|Death|0|||
125329556|NCT03722238|450839132|FG000|Overall Study|Lost to Follow-up|6|||
125329557|NCT03722238|450839133|FG001|Overall Study|Lost to Follow-up|0|||
125329558|NCT03722238|450839132|FG000|Overall Study|Partial missing data|44|||
125329559|NCT03722238|450839133|FG001|Overall Study|Partial missing data|1|||
125329560|NCT03722238|450839132|FG000|Overall Study|Withdrawal by Subject|2|||
125329561|NCT03722238|450839133|FG001|Overall Study|Withdrawal by Subject|0|||
125210687|NCT02638259|450395635|FG001|Treatment Period 2|Withdrawal by Subject|7|||
125329562|NCT03722238|450839132|FG000|Overall Study|Other|4|||
125329563|NCT03722238|450839133|FG001|Overall Study|Other|0|||
125329564|NCT03722238|450839132|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
125329565|NCT03722238|450839133|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
125329566|NCT03722238|450839132|FG000|Overall Study|Did not meet risk classification group criteria|90|||
125329567|NCT03722238|450839133|FG001|Overall Study|Did not meet risk classification group criteria|0|||
125329568|NCT03722238|450839132|FG000|Overall Study|Did not sign consent|17|||
125329569|NCT03722238|450839133|FG001|Overall Study|Did not sign consent|0|||
125329570|NCT03722238|450839132|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
125329571|NCT03722238|450839133|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
125329572|NCT03722238|450839132|FG000|Overall Study|Not willing to purchase study medication|142|||
125329573|NCT03722238|450839133|FG001|Overall Study|Not willing to purchase study medication|0|||
125329574|NCT03722238|450839132|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
125329575|NCT03722238|450839133|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
125329576|NCT03771664|450839134|FG000|Overall Study|Adverse Event|1|||
125329577|NCT03771664|450839135|FG001|Overall Study|Adverse Event|0|||
125329578|NCT03771664|450839134|FG000|Overall Study|Lost to Follow-up|1|||
125329579|NCT03771664|450839135|FG001|Overall Study|Lost to Follow-up|0|||
125329580|NCT03771664|450839134|FG000|Overall Study|Withdrawal by Participant|1|||
125329581|NCT03771664|450839135|FG001|Overall Study|Withdrawal by Participant|4|||
125329582|NCT03771664|450839134|FG000|Overall Study|Randomized but not Treated|0|||
125329583|NCT03771664|450839135|FG001|Overall Study|Randomized but not Treated|1|||
125329584|NCT00891904|450839136|FG000|Overall Study|Death|1|||
125329585|NCT00891904|450839136|FG000|Overall Study|Adverse Event|1|||
125329586|NCT03096288|450839138|FG000|Overall Study|Withdrawal by Subject|0|||
125329587|NCT03096288|450839139|FG001|Overall Study|Withdrawal by Subject|1|||
125329588|NCT03096288|450839140|FG002|Overall Study|Withdrawal by Subject|0|||
125329589|NCT03096288|450839141|FG003|Overall Study|Withdrawal by Subject|1|||
125329597|NCT01411891|450839148|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
125329598|NCT01411891|450839149|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
125329599|NCT02004093|450839150|FG000|Overall Study|Death|2|||
125329600|NCT02004093|450839151|FG001|Overall Study|Death|1|||
125329601|NCT02004093|450839150|FG000|Overall Study|Lack of Efficacy|66|||
125329602|NCT02004093|450839151|FG001|Overall Study|Lack of Efficacy|62|||
125329603|NCT02004093|450839150|FG000|Overall Study|Protocol Violation|0|||
125329604|NCT02004093|450839151|FG001|Overall Study|Protocol Violation|1|||
125329605|NCT02004093|450839150|FG000|Overall Study|Lost to Follow-up|0|||
125329606|NCT02004093|450839151|FG001|Overall Study|Lost to Follow-up|1|||
125329607|NCT02004093|450839150|FG000|Overall Study|Withdrawal by Subject|3|||
125329608|NCT02004093|450839151|FG001|Overall Study|Withdrawal by Subject|7|||
125329609|NCT02004093|450839150|FG000|Overall Study|Other|3|||
125329610|NCT02004093|450839151|FG001|Overall Study|Other|1|||
124999056|NCT04263909|449623833|FG001|Overall Study|Physician Decision|0|||
124999057|NCT04263909|449623834|FG002|Overall Study|Physician Decision|0|||
124999058|NCT04263909|449623832|FG000|Overall Study|Adverse Event|3|||
124999059|NCT04263909|449623833|FG001|Overall Study|Adverse Event|0|||
124999060|NCT04263909|449623834|FG002|Overall Study|Adverse Event|0|||
124999061|NCT04263909|449623832|FG000|Overall Study|Protocol Violation|5|||
124999062|NCT04263909|449623833|FG001|Overall Study|Protocol Violation|0|||
124999063|NCT04263909|449623834|FG002|Overall Study|Protocol Violation|0|||
124999064|NCT02310672|449623835|FG000|Overall Study|Death|1|||
124999065|NCT02310672|449623835|FG000|Overall Study|Lost to Follow-up|1|||
124999066|NCT02310672|449623835|FG000|Overall Study|Withdrawal by Subject|1|||
124999067|NCT02310672|449623835|FG000|Overall Study|Sponsor's decision|12|||
124999068|NCT04288778|449623836|FG000|Overall Study|Withdrawal by Subject|2|||
124999069|NCT04288778|449623836|FG000|Overall Study|Adverse Event|5|||
124999070|NCT04288778|449623836|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124999071|NCT04288778|449623836|FG000|Overall Study|Other|1|||
124999072|NCT04288778|449623836|FG000|Overall Study|Started but not treated|2|||
124999073|NCT03118674|449623841|FG000|Overall Study|Lost to Follow-up|2|||
124999074|NCT03118674|449623841|FG000|Overall Study|Screen Faliure|8|||
124999075|NCT03118674|449623841|FG000|Overall Study|Withdrawal by Subject|5|||
125329611|NCT04639258|450839152|FG000|Overall Study|Screen failure|5|||
125329612|NCT04639258|450839152|FG000|Overall Study|Physician Decision|2|||
125329613|NCT04639258|450839152|FG000|Overall Study|Early study termination|3|||
125329614|NCT04639258|450839152|FG000|Overall Study|Withdrawal by Subject|1|||
125329615|NCT00414596|450839153|FG000|Overall Study|Protocol Violation|2|||
125329616|NCT02558296|450839155|FG000|Completed the Study Through Week 24|Adverse Event|9|||
125329617|NCT02558296|450839156|FG001|Completed the Study Through Week 24|Adverse Event|3|||
124999076|NCT03153137|449623842|FG000|Overall Study|Lost to Follow-up|1|||
124999077|NCT03153137|449623843|FG001|Overall Study|Lost to Follow-up|0|||
124999078|NCT03153137|449623842|FG000|Overall Study|Withdrawal by Subject|2|||
125329618|NCT02558296|450839155|FG000|Completed the Study Through Week 24|Death|7|||
124999079|NCT03153137|449623843|FG001|Overall Study|Withdrawal by Subject|1|||
124999080|NCT03153137|449623842|FG000|Overall Study|Physician Decision|0|||
124999081|NCT03153137|449623843|FG001|Overall Study|Physician Decision|3|||
124999082|NCT04209621|449623844|FG000|Overall Study|Death|1|||
125329619|NCT02558296|450839156|FG001|Completed the Study Through Week 24|Death|7|||
125329620|NCT02558296|450839155|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
124872886|NCT01951638|449155788|FG003|Follow-up Period|Lost to Follow-up|1|||
124872887|NCT01951638|449155789|FG004|Follow-up Period|Lost to Follow-up|0|||
124872888|NCT01951638|449155785|FG000|Follow-up Period|Death|1|||
124872889|NCT01951638|449155786|FG001|Follow-up Period|Death|0|||
124872890|NCT01951638|449155787|FG002|Follow-up Period|Death|1|||
124872891|NCT01951638|449155788|FG003|Follow-up Period|Death|4|||
124872892|NCT01951638|449155789|FG004|Follow-up Period|Death|1|||
124872893|NCT01951638|449155785|FG000|Follow-up Period|Adverse Event|0|||
124872894|NCT01951638|449155786|FG001|Follow-up Period|Adverse Event|1|||
124872895|NCT01951638|449155787|FG002|Follow-up Period|Adverse Event|2|||
124872896|NCT01951638|449155788|FG003|Follow-up Period|Adverse Event|1|||
124872897|NCT01951638|449155789|FG004|Follow-up Period|Adverse Event|1|||
124872898|NCT00459342|449155792|FG000|Overall Study|Not eligible|1|||
124872899|NCT02686034|449155793|FG000|Run-In Period 1|Eligibility|12|||
124872900|NCT02686034|449155794|FG001|Run-In Period 1|Eligibility|10|||
124872901|NCT02686034|449155793|FG000|Run-In Period 1|Withdrawal by Subject|4|||
124872902|NCT02686034|449155794|FG001|Run-In Period 1|Withdrawal by Subject|3|||
124872903|NCT02686034|449155793|FG000|Run-In Period 1|Lost to Follow-up|4|||
124872904|NCT02686034|449155794|FG001|Run-In Period 1|Lost to Follow-up|4|||
124872905|NCT02686034|449155793|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
124872906|NCT02686034|449155794|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
124872907|NCT02686034|449155793|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
124872908|NCT02686034|449155794|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
124872909|NCT02686034|449155793|FG000|Randomized Controlled Period 2|Adverse Event|0|||
124872910|NCT02686034|449155794|FG001|Randomized Controlled Period 2|Adverse Event|2|||
124872911|NCT02686034|449155793|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
124872912|NCT02686034|449155794|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
124872913|NCT02686034|449155793|FG000|Open Label Period 3|Lost to Follow-up|0|||
124872914|NCT02686034|449155794|FG001|Open Label Period 3|Lost to Follow-up|1|||
124872915|NCT02243280|449157179|FG000|Treated|Adverse Event|1|||
124872916|NCT02243280|449157180|FG001|Treated|Adverse Event|0|||
124872917|NCT02243280|449157181|FG002|Treated|Adverse Event|0|||
124872918|NCT02243280|449157182|FG003|Treated|Adverse Event|0|||
124872919|NCT02243280|449157183|FG004|Treated|Adverse Event|0|||
124872920|NCT02243280|449157184|FG005|Treated|Adverse Event|0|||
124872921|NCT02243280|449157185|FG006|Treated|Adverse Event|0|||
124872922|NCT02243280|449157186|FG007|Treated|Adverse Event|0|||
124872923|NCT02243280|449157187|FG008|Treated|Adverse Event|0|||
124872924|NCT02243280|449157188|FG009|Treated|Adverse Event|0|||
124872925|NCT02243280|449157189|FG010|Treated|Adverse Event|1|||
124872926|NCT02243280|449157179|FG000|Treated|Lost to Follow-up|0|||
124872927|NCT02243280|449157180|FG001|Treated|Lost to Follow-up|0|||
124872928|NCT02243280|449157181|FG002|Treated|Lost to Follow-up|0|||
124872929|NCT02243280|449157182|FG003|Treated|Lost to Follow-up|0|||
124872930|NCT02243280|449157183|FG004|Treated|Lost to Follow-up|0|||
124872931|NCT02243280|449157184|FG005|Treated|Lost to Follow-up|0|||
124872932|NCT02243280|449157185|FG006|Treated|Lost to Follow-up|0|||
124872933|NCT02243280|449157186|FG007|Treated|Lost to Follow-up|0|||
124872934|NCT02243280|449157187|FG008|Treated|Lost to Follow-up|1|||
124872935|NCT02243280|449157188|FG009|Treated|Lost to Follow-up|0|||
124872936|NCT02243280|449157189|FG010|Treated|Lost to Follow-up|2|||
124872937|NCT00998400|449157194|FG000|Overall Study|Lack of interest/motivation|1|||
124872938|NCT00998400|449157195|FG001|Overall Study|Lack of interest/motivation|2|||
124872939|NCT00998400|449157194|FG000|Overall Study|Logistical problems|1|||
124872940|NCT00998400|449157195|FG001|Overall Study|Logistical problems|0|||
124872941|NCT01083641|449157196|FG000|Overall Study|Withdrawal by Subject|2|||
124872942|NCT03439189|449157197|FG000|Overall Study|Protocol Violation|19|||
124872943|NCT03439189|449157197|FG000|Overall Study|Lack of Efficacy|63|||
124872944|NCT01777321|449157198|FG000|Overall Study|Withdrawal by Subject|0|||
124872945|NCT01777321|449157199|FG001|Overall Study|Withdrawal by Subject|1|||
124872946|NCT01807156|449157200|FG000|Overall Study|Physician Decision|1|||
124872947|NCT03122119|449157203|FG000|Overall Study|Did not meet eligibility critria|1|||
124872948|NCT01493687|449157205|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
124872949|NCT01493687|449157206|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
124872950|NCT01493687|449157205|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
124872951|NCT01493687|449157206|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
124872952|NCT01493687|449157205|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
124872953|NCT01493687|449157206|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
124872954|NCT01493687|449157205|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
124872955|NCT01493687|449157206|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
124872956|NCT01493687|449157205|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
124872957|NCT01493687|449157206|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
124872958|NCT01493687|449157205|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
124872959|NCT01493687|449157206|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
124872960|NCT01493687|449157205|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
124999083|NCT04209621|449623844|FG000|Overall Study|Study Terminated Early|2|||
124999084|NCT02249767|449623845|FG000|Overall Study|Did not use medication|8|||
124999085|NCT02249767|449623846|FG001|Overall Study|Did not use medication|9|||
124999086|NCT02249767|449623847|FG002|Overall Study|Did not use medication|8|||
124999087|NCT01372410|449623848|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
124999088|NCT01372410|449623849|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
124999089|NCT01372410|449623850|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
124999090|NCT01372410|449623851|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
124999091|NCT01372410|449623852|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
124999092|NCT01372410|449623853|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
124999093|NCT01372410|449623854|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
124999094|NCT01372410|449623855|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
124999095|NCT01372410|449623848|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
124999096|NCT01372410|449623849|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
124999097|NCT01372410|449623850|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
124999098|NCT01372410|449623851|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
124999099|NCT01372410|449623852|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
124999100|NCT01372410|449623853|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
124999101|NCT01372410|449623854|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
124999102|NCT01372410|449623855|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
124999103|NCT01372410|449623848|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124999104|NCT01372410|449623849|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124999105|NCT01372410|449623850|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124999106|NCT01372410|449623851|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124999107|NCT01372410|449623852|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
124999108|NCT01372410|449623853|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124999109|NCT01372410|449623854|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124999110|NCT01372410|449623855|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124999111|NCT01372410|449623848|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
124999112|NCT01372410|449623849|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
124999113|NCT01372410|449623850|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
124999114|NCT01372410|449623851|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
124999115|NCT01372410|449623852|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
124999116|NCT01372410|449623853|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
124999117|NCT01372410|449623854|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
124999118|NCT01372410|449623855|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
124999119|NCT01372410|449623848|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
124999120|NCT01372410|449623849|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
124999121|NCT01372410|449623850|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
124999122|NCT01372410|449623851|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
124999123|NCT01372410|449623852|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
124999124|NCT01372410|449623853|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
124999125|NCT01372410|449623854|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
124999126|NCT01372410|449623855|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
124999127|NCT01372410|449623848|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
124999128|NCT01372410|449623849|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
124999129|NCT01372410|449623850|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
124999130|NCT01372410|449623851|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
124999131|NCT01372410|449623852|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
124999132|NCT01372410|449623853|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
124999133|NCT01372410|449623854|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
124999134|NCT01372410|449623855|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
124999135|NCT01372410|449623848|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
124999136|NCT01372410|449623849|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
124999137|NCT01372410|449623850|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
124999138|NCT01372410|449623851|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
124999139|NCT01372410|449623852|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
124999140|NCT01372410|449623853|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
124999141|NCT01372410|449623854|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
124999142|NCT01372410|449623855|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
124999143|NCT01372410|449623848|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
124999144|NCT01372410|449623849|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
124999145|NCT01372410|449623850|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
125329621|NCT02558296|450839156|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
124999146|NCT01372410|449623851|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
124999147|NCT01372410|449623852|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
125329622|NCT02558296|450839155|FG000|Completed the Study Through Week 24|Physician Decision|1|||
125329623|NCT02558296|450839156|FG001|Completed the Study Through Week 24|Physician Decision|0|||
124999148|NCT01372410|449623853|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
124999149|NCT01372410|449623854|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
124999150|NCT01372410|449623855|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
124999151|NCT01372410|449623848|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
124999152|NCT01372410|449623849|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
124999153|NCT01372410|449623850|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
124999154|NCT01372410|449623851|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
124999155|NCT01372410|449623852|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
124999156|NCT01372410|449623853|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
124999157|NCT01372410|449623854|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
124999158|NCT01372410|449623855|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
124999159|NCT01372410|449623848|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
124999160|NCT01372410|449623849|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
124999161|NCT01372410|449623850|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
124999162|NCT01372410|449623851|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
124999163|NCT01372410|449623852|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
124999164|NCT01372410|449623853|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
124999165|NCT01372410|449623854|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
124999166|NCT01372410|449623855|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
124999167|NCT04585646|449623856|FG000|First Intervention|Physician Decision|1|||
124999168|NCT04585646|449623857|FG001|First Intervention|Physician Decision|0|||
124999169|NCT04585646|449623856|FG000|First Intervention|Lost to Follow-up|0|||
124999170|NCT04585646|449623857|FG001|First Intervention|Lost to Follow-up|3|||
124999171|NCT04585646|449623856|FG000|First Intervention|Withdrawal by Subject|0|||
124999172|NCT04585646|449623857|FG001|First Intervention|Withdrawal by Subject|1|||
124999173|NCT01067326|449623864|FG000|Overall Study|Adverse Event|0|||
124999174|NCT01067326|449623865|FG001|Overall Study|Adverse Event|2|||
124999175|NCT01067326|449623864|FG000|Overall Study|Withdrawal by Subject|1|||
124999176|NCT01067326|449623865|FG001|Overall Study|Withdrawal by Subject|0|||
124999177|NCT01067326|449623864|FG000|Overall Study|Early Study Termination|1|||
124999178|NCT01067326|449623865|FG001|Overall Study|Early Study Termination|1|||
124999179|NCT01230788|449623872|FG000|Overall Study|Prescribed exclusion drug|1|||
124999180|NCT00769860|449623873|FG000|Overall Study|Withdrawal by Subject|2|||
124999181|NCT00769860|449623874|FG001|Overall Study|Withdrawal by Subject|0|||
124999182|NCT01603082|449623875|FG000|Overall Study|Adverse Event|0|||
124999183|NCT01603082|449623876|FG001|Overall Study|Adverse Event|1|||
124999184|NCT01603082|449623875|FG000|Overall Study|Withdrawal by Subject|1|||
124999185|NCT01603082|449623876|FG001|Overall Study|Withdrawal by Subject|0|||
124999186|NCT01603082|449623875|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
124999187|NCT01603082|449623876|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
124999188|NCT01019317|449623880|FG000|Overall Study|Not Eligible|4|||
124999189|NCT02000427|449623883|FG000|Overall Study|Death|22|||
124999190|NCT02708095|449623884|FG000|Overall Study|Adverse Event|4|||
124999191|NCT02708095|449623885|FG001|Overall Study|Adverse Event|10|||
124999192|NCT02708095|449623886|FG002|Overall Study|Adverse Event|11|||
124999193|NCT02708095|449623884|FG000|Overall Study|Lack of Efficacy|9|||
124999194|NCT02708095|449623885|FG001|Overall Study|Lack of Efficacy|3|||
124999195|NCT02708095|449623886|FG002|Overall Study|Lack of Efficacy|0|||
124999196|NCT02708095|449623884|FG000|Overall Study|Lost to Follow-up|2|||
124999197|NCT02708095|449623885|FG001|Overall Study|Lost to Follow-up|0|||
124999198|NCT02708095|449623886|FG002|Overall Study|Lost to Follow-up|0|||
124999199|NCT02708095|449623884|FG000|Overall Study|Physician Decision|2|||
124999200|NCT02708095|449623885|FG001|Overall Study|Physician Decision|3|||
124999201|NCT02708095|449623886|FG002|Overall Study|Physician Decision|2|||
125329624|NCT02558296|450839155|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
125329625|NCT02558296|450839156|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
125329626|NCT02558296|450839155|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
125329627|NCT02558296|450839156|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
125329628|NCT02558296|450839155|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
124999202|NCT02708095|449623884|FG000|Overall Study|Protocol Violation|0|||
124999203|NCT02708095|449623885|FG001|Overall Study|Protocol Violation|0|||
124999204|NCT02708095|449623886|FG002|Overall Study|Protocol Violation|1|||
124999205|NCT02708095|449623884|FG000|Overall Study|Withdrawal by Subject|5|||
124999206|NCT02708095|449623885|FG001|Overall Study|Withdrawal by Subject|3|||
124999207|NCT02708095|449623886|FG002|Overall Study|Withdrawal by Subject|4|||
124999208|NCT01313650|449623887|FG000|Overall Study|Adverse Event|9|||
124999209|NCT01313650|449623888|FG001|Overall Study|Adverse Event|34|||
124999210|NCT01313650|449623889|FG002|Overall Study|Adverse Event|24|||
124999211|NCT01313650|449623890|FG003|Overall Study|Adverse Event|23|||
124999212|NCT01313650|449623887|FG000|Overall Study|Lack of Efficacy|37|||
124999213|NCT01313650|449623888|FG001|Overall Study|Lack of Efficacy|20|||
124999214|NCT01313650|449623889|FG002|Overall Study|Lack of Efficacy|32|||
124999215|NCT01313650|449623890|FG003|Overall Study|Lack of Efficacy|20|||
124999216|NCT01313650|449623887|FG000|Overall Study|Lost to Follow-up|1|||
125329629|NCT02558296|450839156|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
125329630|NCT02558296|450839155|FG000|Completed the Study|Adverse Event|14|||
125329631|NCT02558296|450839156|FG001|Completed the Study|Adverse Event|5|||
125329632|NCT02558296|450839155|FG000|Completed the Study|Death|39|||
125329633|NCT02558296|450839156|FG001|Completed the Study|Death|25|||
125329634|NCT02558296|450839155|FG000|Completed the Study|Lost to Follow-up|31|||
125329635|NCT02558296|450839156|FG001|Completed the Study|Lost to Follow-up|23|||
125329636|NCT02558296|450839155|FG000|Completed the Study|Physician Decision|6|||
125329637|NCT02558296|450839156|FG001|Completed the Study|Physician Decision|0|||
125329638|NCT02558296|450839155|FG000|Completed the Study|Protocol Violation|2|||
125329639|NCT02558296|450839156|FG001|Completed the Study|Protocol Violation|1|||
125329640|NCT02558296|450839155|FG000|Completed the Study|Withdrawal by Subject|53|||
124999217|NCT01313650|449623888|FG001|Overall Study|Lost to Follow-up|0|||
124999218|NCT01313650|449623889|FG002|Overall Study|Lost to Follow-up|3|||
125329641|NCT02558296|450839156|FG001|Completed the Study|Withdrawal by Subject|31|||
125329642|NCT02558296|450839155|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
125329643|NCT02558296|450839156|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
125329644|NCT00297258|450839157|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
125329645|NCT00297258|450839157|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
125329646|NCT00297258|450839157|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
125329647|NCT00297258|450839157|FG000|Overall Study|Intercurrent Illness|3|||
125329648|NCT00297258|450839157|FG000|Overall Study|Intercurrent Death|2|||
125329649|NCT00297258|450839157|FG000|Overall Study|Deteriorization of General Condition|1|||
125329650|NCT00297258|450839157|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
125329651|NCT00297258|450839157|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
125329652|NCT00297258|450839157|FG000|Overall Study|Switch to Commercial Treatment|1|||
125329653|NCT00297258|450839157|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
125329654|NCT05038982|450839166|FG000|Overall Study|Withdrawal by Subject|0|||
125329655|NCT05038982|450839167|FG001|Overall Study|Withdrawal by Subject|2|||
125329656|NCT03133793|450839168|FG000|Overall Study|Withdrawal by Subject|0|||
125329657|NCT03133793|450839169|FG001|Overall Study|Withdrawal by Subject|4|||
125329658|NCT03133793|450839170|FG002|Overall Study|Withdrawal by Subject|2|||
125329659|NCT03133793|450839171|FG003|Overall Study|Withdrawal by Subject|4|||
125329660|NCT03133793|450839168|FG000|Overall Study|Lost to Follow-up|1|||
125329661|NCT03133793|450839169|FG001|Overall Study|Lost to Follow-up|0|||
125329662|NCT03133793|450839170|FG002|Overall Study|Lost to Follow-up|2|||
125329663|NCT03133793|450839171|FG003|Overall Study|Lost to Follow-up|0|||
125329664|NCT03133793|450839168|FG000|Overall Study|Death|0|||
125329665|NCT03133793|450839169|FG001|Overall Study|Death|0|||
125329666|NCT03133793|450839170|FG002|Overall Study|Death|0|||
125329667|NCT03133793|450839171|FG003|Overall Study|Death|1|||
125329668|NCT04476797|450839172|FG000|Overall Study|Withdrawal by Subject|1|||
125329669|NCT04476797|450839173|FG001|Overall Study|Withdrawal by Subject|0|||
125329670|NCT04476797|450839174|FG002|Overall Study|Withdrawal by Subject|0|||
125329671|NCT04476797|450839172|FG000|Overall Study|Death|0|||
125329672|NCT04476797|450839173|FG001|Overall Study|Death|1|||
125329673|NCT04476797|450839174|FG002|Overall Study|Death|2|||
125329674|NCT04476797|450839172|FG000|Overall Study|Sponsor Terminated Study|0|||
125329675|NCT04476797|450839173|FG001|Overall Study|Sponsor Terminated Study|18|||
125329676|NCT04476797|450839174|FG002|Overall Study|Sponsor Terminated Study|17|||
124999219|NCT01313650|449623890|FG003|Overall Study|Lost to Follow-up|2|||
124999220|NCT01313650|449623887|FG000|Overall Study|Withdrawal by Subject|16|||
124999221|NCT01313650|449623888|FG001|Overall Study|Withdrawal by Subject|20|||
124999222|NCT01313650|449623889|FG002|Overall Study|Withdrawal by Subject|15|||
124999223|NCT01313650|449623890|FG003|Overall Study|Withdrawal by Subject|15|||
124999224|NCT01313650|449623887|FG000|Overall Study|Protocol Violation|4|||
125329677|NCT03614156|450839175|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
125329678|NCT03614156|450839176|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
125329679|NCT03614156|450839177|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
125329680|NCT03614156|450839178|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
125329681|NCT03614156|450839175|FG000|Open-Label Treatment Period|Adverse Event|7|||
125329682|NCT03614156|450839176|FG001|Open-Label Treatment Period|Adverse Event|0|||
125329683|NCT03614156|450839177|FG002|Open-Label Treatment Period|Adverse Event|0|||
125329684|NCT03614156|450839178|FG003|Open-Label Treatment Period|Adverse Event|0|||
125329685|NCT03614156|450839175|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
125329686|NCT03614156|450839176|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
125329687|NCT03614156|450839177|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
125329688|NCT03614156|450839178|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
125329689|NCT03614156|450839175|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
125329690|NCT03614156|450839176|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
125329691|NCT03614156|450839177|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
124999225|NCT01313650|449623888|FG001|Overall Study|Protocol Violation|7|||
124999226|NCT01313650|449623889|FG002|Overall Study|Protocol Violation|5|||
124999227|NCT01313650|449623890|FG003|Overall Study|Protocol Violation|6|||
124999228|NCT01313650|449623887|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
124999229|NCT01313650|449623888|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
124999230|NCT01313650|449623889|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
124999231|NCT01313650|449623890|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
124999232|NCT05393037|449623891|FG000|Part A|Death|1|||
124999233|NCT05393037|449623892|FG001|Part A|Death|0|||
124999234|NCT05393037|449623891|FG000|Part A|Lost to Follow-up|1|||
124999235|NCT05393037|449623892|FG001|Part A|Lost to Follow-up|1|||
124999236|NCT05393037|449623891|FG000|Part A|Withdrawal by Subject|2|||
124999237|NCT05393037|449623892|FG001|Part A|Withdrawal by Subject|4|||
124999238|NCT05393037|449623891|FG000|Part B|Lost to Follow-up|1|||
124999239|NCT05393037|449623892|FG001|Part B|Lost to Follow-up|0|||
124999240|NCT01012739|449623893|FG000|Treatment Period 1|Adverse Event|0|||
124999241|NCT01012739|449623894|FG001|Treatment Period 1|Adverse Event|0|||
124999242|NCT01012739|449623895|FG002|Treatment Period 1|Adverse Event|0|||
124999243|NCT01012739|449623896|FG003|Treatment Period 1|Adverse Event|1|||
124999244|NCT01012739|449623893|FG000|Treatment Period 2|Abnormal test procedure results|0|||
124999245|NCT01012739|449623894|FG001|Treatment Period 2|Abnormal test procedure results|0|||
124999246|NCT01012739|449623895|FG002|Treatment Period 2|Abnormal test procedure results|0|||
124999247|NCT01012739|449623896|FG003|Treatment Period 2|Abnormal test procedure results|1|||
124999248|NCT04540133|449623897|FG000|Overall Study|Lost to Follow-up|1|||
124999249|NCT04540133|449623898|FG001|Overall Study|Lost to Follow-up|0|||
124999250|NCT00458341|449623899|FG000|Cycle 1|Adverse Event|1|||
124999251|NCT00458341|449623900|FG001|Cycle 1|Adverse Event|0|||
124999252|NCT00390910|449623901|FG000|Overall Study|Adverse Event|1|||
124999253|NCT00390910|449623902|FG001|Overall Study|Adverse Event|0|||
124999254|NCT00390910|449623903|FG002|Overall Study|Adverse Event|0|||
124999255|NCT00390910|449623901|FG000|Overall Study|Lost to Follow-up|0|||
124999256|NCT00390910|449623902|FG001|Overall Study|Lost to Follow-up|1|||
124999257|NCT00390910|449623903|FG002|Overall Study|Lost to Follow-up|5|||
124999258|NCT00390910|449623901|FG000|Overall Study|Withdrawal by Subject|1|||
124999259|NCT00390910|449623902|FG001|Overall Study|Withdrawal by Subject|3|||
124999260|NCT00390910|449623903|FG002|Overall Study|Withdrawal by Subject|2|||
124999261|NCT00390910|449623901|FG000|Overall Study|Migrated/moved from study area|0|||
124999262|NCT00390910|449623902|FG001|Overall Study|Migrated/moved from study area|0|||
124999263|NCT00390910|449623903|FG002|Overall Study|Migrated/moved from study area|3|||
124999264|NCT00174265|449623908|FG000|Overall Study|Adverse Event|7|||
124999265|NCT00174265|449623909|FG001|Overall Study|Adverse Event|4|||
124999266|NCT00174265|449623908|FG000|Overall Study|Lack of Efficacy|2|||
124999267|NCT00174265|449623909|FG001|Overall Study|Lack of Efficacy|2|||
124999268|NCT00174265|449623908|FG000|Overall Study|Withdrawal by Subject|3|||
124999269|NCT00174265|449623909|FG001|Overall Study|Withdrawal by Subject|5|||
124999270|NCT00174265|449623908|FG000|Overall Study|Lost to Follow-up|1|||
124999271|NCT00174265|449623909|FG001|Overall Study|Lost to Follow-up|0|||
124999272|NCT00174265|449623908|FG000|Overall Study|Other (Not specified)|16|||
124999273|NCT00174265|449623909|FG001|Overall Study|Other (Not specified)|10|||
124999274|NCT03471871|449623911|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
124999275|NCT03471871|449623912|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
124999276|NCT03471871|449623913|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
124999277|NCT03471871|449623914|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
124999278|NCT03471871|449623915|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
124999279|NCT03471871|449623911|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
124999280|NCT03471871|449623912|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
124999281|NCT03471871|449623913|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
124999282|NCT03471871|449623914|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
124999283|NCT03471871|449623915|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
124999284|NCT03471871|449623911|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
124999285|NCT03471871|449623912|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
124999286|NCT03471871|449623913|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
124999287|NCT03471871|449623914|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
124999288|NCT03471871|449623915|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
124999289|NCT03471871|449623911|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
124999290|NCT03471871|449623912|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
124999291|NCT03471871|449623913|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
124999292|NCT03471871|449623914|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
124999293|NCT03471871|449623915|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
124999294|NCT03471871|449623911|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
124999295|NCT03471871|449623912|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
124999296|NCT03471871|449623913|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
124999297|NCT03471871|449623914|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
124999298|NCT03471871|449623915|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
124999299|NCT04600336|449623917|FG000|Initial Treatment|Withdrawal by Subject|1|||
124999300|NCT04600336|449623918|FG001|Initial Treatment|Withdrawal by Subject|2|||
124999301|NCT04600336|449623919|FG002|Initial Treatment|Withdrawal by Subject|0|||
124999302|NCT04600336|449623920|FG003|Initial Treatment|Withdrawal by Subject|0|||
124999303|NCT04600336|449623917|FG000|Initial Treatment|Adverse Event|0|||
124999304|NCT04600336|449623918|FG001|Initial Treatment|Adverse Event|2|||
125329692|NCT03614156|450839178|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
125329693|NCT03614156|450839175|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
125329694|NCT03614156|450839176|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
125329695|NCT03614156|450839177|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
125329696|NCT03614156|450839178|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
125329697|NCT03614156|450839175|FG000|Open-Label Treatment Period|Protocol Violation|2|||
125329698|NCT03614156|450839176|FG001|Open-Label Treatment Period|Protocol Violation|0|||
125329699|NCT03614156|450839177|FG002|Open-Label Treatment Period|Protocol Violation|0|||
125329700|NCT03614156|450839178|FG003|Open-Label Treatment Period|Protocol Violation|0|||
125329701|NCT03614156|450839175|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
125329702|NCT03614156|450839176|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
125329703|NCT03614156|450839177|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
125329704|NCT03614156|450839178|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
125329705|NCT03614156|450839175|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
125329706|NCT03614156|450839176|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
125329707|NCT03614156|450839177|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
125329708|NCT03614156|450839178|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
125329709|NCT03614156|450839175|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
125329710|NCT03614156|450839176|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
125329711|NCT03614156|450839177|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
125329712|NCT03614156|450839178|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
125329713|NCT03614156|450839175|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
125329714|NCT03614156|450839176|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
125329715|NCT03614156|450839177|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
125329716|NCT03614156|450839178|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
125329717|NCT03614156|450839175|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125329718|NCT03614156|450839176|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125329719|NCT03614156|450839177|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
125329720|NCT03614156|450839178|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
125329721|NCT03614156|450839175|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
125329722|NCT03614156|450839176|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
125329723|NCT03614156|450839177|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
125329724|NCT03614156|450839178|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
125329725|NCT03614156|450839175|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
125329726|NCT03614156|450839176|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
125329727|NCT03614156|450839177|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
124999305|NCT04600336|449623919|FG002|Initial Treatment|Adverse Event|0|||
125329728|NCT03614156|450839178|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
125329729|NCT03614156|450839175|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
125329730|NCT03614156|450839176|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
125329731|NCT03614156|450839177|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
125329732|NCT03614156|450839178|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
125329733|NCT03614156|450839175|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
125329734|NCT03614156|450839176|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
125329735|NCT03614156|450839177|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
125329736|NCT03614156|450839178|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
125329737|NCT03614156|450839175|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
125329738|NCT03614156|450839176|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
125329739|NCT03614156|450839177|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
125329740|NCT03614156|450839178|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
125329741|NCT03614156|450839175|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
125329742|NCT03614156|450839176|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
125329743|NCT03614156|450839177|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
124999306|NCT04600336|449623920|FG003|Initial Treatment|Adverse Event|0|||
125329744|NCT03614156|450839178|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
125329745|NCT04287517|450839180|FG000|Overall Study|Withdrawal by Subject|1|||
125329746|NCT04287517|450839181|FG001|Overall Study|Withdrawal by Subject|1|||
125329747|NCT03070964|450839182|FG000|Overall Study|Progressive disease|8|||
125329748|NCT03070964|450839182|FG000|Overall Study|Treatment-unrelated adverse event|2|||
125329749|NCT03070964|450839182|FG000|Overall Study|Never treated|1|||
125329750|NCT03070964|450839182|FG000|Overall Study|Physician Decision|1|||
124999307|NCT04600336|449623917|FG000|Initial Treatment|Other complicating disease|0|||
125329751|NCT03070964|450839182|FG000|Overall Study|Withdrawal by Subject|1|||
125329752|NCT03070964|450839182|FG000|Overall Study|Adverse Event|1|||
125329753|NCT00834093|450839185|FG000|Overall Study|Progressive Disease|3|||
125329754|NCT00834093|450839185|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
125329755|NCT02425943|450839186|FG000|Overall Study|Adverse Event|3|||
125329756|NCT02425943|450839187|FG001|Overall Study|Adverse Event|1|||
125329757|NCT02425943|450839186|FG000|Overall Study|Lost to Follow-up|59|||
124999308|NCT04600336|449623918|FG001|Initial Treatment|Other complicating disease|0|||
124999309|NCT04600336|449623919|FG002|Initial Treatment|Other complicating disease|1|||
124999310|NCT04600336|449623920|FG003|Initial Treatment|Other complicating disease|0|||
124999311|NCT04600336|449623917|FG000|Crossover Treatment|Withdrawal by Subject|0|||
124999312|NCT04600336|449623918|FG001|Crossover Treatment|Withdrawal by Subject|0|||
124999313|NCT04600336|449623919|FG002|Crossover Treatment|Withdrawal by Subject|2|||
124999314|NCT04600336|449623920|FG003|Crossover Treatment|Withdrawal by Subject|1|||
124999315|NCT04600336|449623917|FG000|Crossover Treatment|Adverse Event|0|||
124999316|NCT04600336|449623918|FG001|Crossover Treatment|Adverse Event|0|||
124999317|NCT04600336|449623919|FG002|Crossover Treatment|Adverse Event|1|||
124999318|NCT04600336|449623920|FG003|Crossover Treatment|Adverse Event|1|||
124999319|NCT03769181|449626154|FG000|Overall Study|Adverse Event|1|||
124999320|NCT03769181|449626155|FG001|Overall Study|Adverse Event|0|||
124999321|NCT03769181|449626156|FG002|Overall Study|Adverse Event|2|||
124999322|NCT03769181|449626157|FG003|Overall Study|Adverse Event|4|||
124999323|NCT03769181|449626154|FG000|Overall Study|Withdrawal by Subject|1|||
124999324|NCT03769181|449626155|FG001|Overall Study|Withdrawal by Subject|0|||
124999325|NCT03769181|449626156|FG002|Overall Study|Withdrawal by Subject|2|||
124999326|NCT03769181|449626157|FG003|Overall Study|Withdrawal by Subject|1|||
124999327|NCT03769181|449626154|FG000|Overall Study|Progressive disease|9|||
124999328|NCT03769181|449626155|FG001|Overall Study|Progressive disease|7|||
124999329|NCT03769181|449626156|FG002|Overall Study|Progressive disease|13|||
124999330|NCT03769181|449626157|FG003|Overall Study|Progressive disease|6|||
124999331|NCT03769181|449626154|FG000|Overall Study|Other - Unspecified|2|||
124999332|NCT03769181|449626155|FG001|Overall Study|Other - Unspecified|1|||
124999333|NCT03769181|449626156|FG002|Overall Study|Other - Unspecified|0|||
124999334|NCT03769181|449626157|FG003|Overall Study|Other - Unspecified|0|||
124999335|NCT03971422|449626158|FG000|Overall Study|Lost to Follow-up|0|||
124999336|NCT03971422|449626159|FG001|Overall Study|Lost to Follow-up|1|||
124999337|NCT03971422|449626160|FG002|Overall Study|Lost to Follow-up|0|||
124999338|NCT03971422|449626158|FG000|Overall Study|Lack of Efficacy|5|||
124999339|NCT03971422|449626159|FG001|Overall Study|Lack of Efficacy|1|||
124999340|NCT03971422|449626160|FG002|Overall Study|Lack of Efficacy|1|||
124999341|NCT03971422|449626158|FG000|Overall Study|Adverse event, not fatal|2|||
124999342|NCT03971422|449626159|FG001|Overall Study|Adverse event, not fatal|2|||
124999343|NCT03971422|449626160|FG002|Overall Study|Adverse event, not fatal|5|||
124999344|NCT03971422|449626158|FG000|Overall Study|Worsening of MG Symptoms|1|||
124999345|NCT03971422|449626159|FG001|Overall Study|Worsening of MG Symptoms|4|||
124999346|NCT03971422|449626160|FG002|Overall Study|Worsening of MG Symptoms|2|||
124999347|NCT03971422|449626158|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
124999348|NCT03971422|449626159|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
124999349|NCT03971422|449626160|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
124999350|NCT03971422|449626158|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
124999351|NCT03971422|449626159|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
124999352|NCT03971422|449626160|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
124999353|NCT03971422|449626158|FG000|Overall Study|Due to COVID-19 pandemic|0|||
124999354|NCT03971422|449626159|FG001|Overall Study|Due to COVID-19 pandemic|1|||
124999355|NCT03971422|449626160|FG002|Overall Study|Due to COVID-19 pandemic|1|||
124999356|NCT03566810|449626161|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
124999357|NCT03566810|449626162|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
124999358|NCT03566810|449626163|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
124999359|NCT03566810|449626164|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
124999360|NCT03217266|449626165|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
124999361|NCT03217266|449626166|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
124999362|NCT03217266|449626167|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
124999363|NCT03217266|449626168|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
124999364|NCT03217266|449626165|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
124999365|NCT03217266|449626166|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
124999366|NCT03217266|449626167|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
124999367|NCT03217266|449626168|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
125329758|NCT02425943|450839187|FG001|Overall Study|Lost to Follow-up|37|||
124999368|NCT03217266|449626165|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
124999369|NCT03217266|449626166|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
124999370|NCT03217266|449626167|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
124999371|NCT03217266|449626168|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
125329759|NCT02425943|450839186|FG000|Overall Study|Protocol Violation|4|||
125329760|NCT02425943|450839187|FG001|Overall Study|Protocol Violation|1|||
124999372|NCT03078907|449626172|FG000|Overall Study|Adverse Event|2|||
124999373|NCT03078907|449626173|FG001|Overall Study|Adverse Event|0|||
124999374|NCT03078907|449626172|FG000|Overall Study|Other|1|||
124999375|NCT03078907|449626173|FG001|Overall Study|Other|0|||
124999376|NCT03078907|449626172|FG000|Overall Study|Protocol Violation|0|||
124999377|NCT03078907|449626173|FG001|Overall Study|Protocol Violation|1|||
124999378|NCT01955122|449626174|FG000|Overall Study|Physician Decision|5|||
124999379|NCT01955122|449626175|FG001|Overall Study|Physician Decision|5|||
124999380|NCT00826111|449626176|FG000|Overall Study|Lost to Follow-up|0|||
124999381|NCT00826111|449626177|FG001|Overall Study|Lost to Follow-up|1|||
124999382|NCT00826111|449626176|FG000|Overall Study|Protocol Violation|1|||
124999383|NCT00826111|449626177|FG001|Overall Study|Protocol Violation|0|||
124999384|NCT00826111|449626176|FG000|Overall Study|Withdrawal by Subject|5|||
124999385|NCT00826111|449626177|FG001|Overall Study|Withdrawal by Subject|0|||
124999386|NCT00826111|449626176|FG000|Overall Study|Physician Decision|1|||
124999387|NCT00826111|449626177|FG001|Overall Study|Physician Decision|1|||
124999388|NCT01672788|449626178|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
124999389|NCT01672788|449626179|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
124999390|NCT01672788|449626180|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
124999391|NCT01672788|449626181|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
124999392|NCT03511053|449626184|FG000|Overall Study|Withdrawal by Subject|1|||
124999393|NCT01929980|449626185|FG000|Overall Study|Physician Decision|1|||
124999394|NCT00985166|449626186|FG000|Overall Study|Lost to Follow-up|3|||
124999395|NCT00985166|449626187|FG001|Overall Study|Lost to Follow-up|2|||
124999396|NCT00985166|449626188|FG002|Overall Study|Lost to Follow-up|2|||
124999397|NCT00985166|449626186|FG000|Overall Study|Withdrawal by Subject|3|||
124999398|NCT00985166|449626187|FG001|Overall Study|Withdrawal by Subject|2|||
124999399|NCT00985166|449626188|FG002|Overall Study|Withdrawal by Subject|0|||
124999400|NCT00985166|449626186|FG000|Overall Study|Test not done|2|||
124999401|NCT00985166|449626187|FG001|Overall Study|Test not done|0|||
124999402|NCT00985166|449626188|FG002|Overall Study|Test not done|4|||
124999403|NCT00985166|449626186|FG000|Overall Study|Other|1|||
124999404|NCT00985166|449626187|FG001|Overall Study|Other|0|||
124999405|NCT00985166|449626188|FG002|Overall Study|Other|1|||
124999406|NCT01028222|449626189|FG000|Overall Study|Protocol deviation|1|||
124999407|NCT01028222|449626190|FG001|Overall Study|Protocol deviation|0|||
124999408|NCT01028222|449626189|FG000|Overall Study|Disease progression|33|||
124999409|NCT01028222|449626190|FG001|Overall Study|Disease progression|9|||
124999410|NCT01028222|449626189|FG000|Overall Study|Administrative problems|1|||
124999411|NCT01028222|449626190|FG001|Overall Study|Administrative problems|1|||
124999412|NCT01028222|449626189|FG000|Overall Study|Lost to Follow-up|0|||
124999413|NCT01028222|449626190|FG001|Overall Study|Lost to Follow-up|1|||
124999414|NCT01028222|449626189|FG000|Overall Study|Withdrawal by Subject|1|||
124999415|NCT01028222|449626190|FG001|Overall Study|Withdrawal by Subject|0|||
124999416|NCT01028222|449626189|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
124999417|NCT01028222|449626190|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
124999418|NCT01028222|449626189|FG000|Overall Study|Adverse Event|2|||
124999419|NCT01028222|449626190|FG001|Overall Study|Adverse Event|0|||
124999420|NCT03236246|449626193|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
124999421|NCT03236246|449626194|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
124999422|NCT03236246|449626193|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
124999423|NCT03236246|449626194|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
124999424|NCT03236246|449626193|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
124999425|NCT03236246|449626194|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
124999426|NCT03236246|449626193|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
124999427|NCT03236246|449626194|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
124999428|NCT03236246|449626193|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
124999429|NCT03236246|449626194|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
124999430|NCT03236246|449626193|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
124999431|NCT03236246|449626194|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
124999432|NCT03236246|449626193|FG000|24-Week Dose Titration Period|Death|3|||
124999433|NCT03236246|449626194|FG001|24-Week Dose Titration Period|Death|1|||
124999434|NCT03236246|449626193|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
124999435|NCT03236246|449626194|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
124999436|NCT03236246|449626193|FG000|24-Week Dose Titration Period|Adverse Event|7|||
124999437|NCT03236246|449626194|FG001|24-Week Dose Titration Period|Adverse Event|8|||
124999438|NCT03236246|449626193|FG000|24-Week Dose Titration Period|Captured as Other|1|||
124999439|NCT03236246|449626194|FG001|24-Week Dose Titration Period|Captured as Other|2|||
124999440|NCT03236246|449626193|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
124999441|NCT03236246|449626194|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
124999442|NCT03236246|449626193|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
124999443|NCT03236246|449626194|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
124999444|NCT03236246|449626193|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
124999445|NCT03236246|449626194|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
124999446|NCT03236246|449626193|FG000|24-Week Dose Maintenance Period|Death|0|||
125329761|NCT02425943|450839186|FG000|Overall Study|Withdrawal by Subject|64|||
125329762|NCT02425943|450839187|FG001|Overall Study|Withdrawal by Subject|31|||
125329763|NCT02425943|450839186|FG000|Overall Study|Other|6|||
125329764|NCT02425943|450839187|FG001|Overall Study|Other|0|||
125329765|NCT02379091|450839188|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
125329766|NCT02379091|450839189|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
125329767|NCT02379091|450839190|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
125329768|NCT02379091|450839191|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
125329769|NCT02379091|450839188|FG000|Overall Study|Principal Investigator Discretion|0|||
125329770|NCT02379091|450839189|FG001|Overall Study|Principal Investigator Discretion|1|||
125329771|NCT02379091|450839190|FG002|Overall Study|Principal Investigator Discretion|0|||
125329772|NCT02379091|450839191|FG003|Overall Study|Principal Investigator Discretion|0|||
125329773|NCT02379091|450839188|FG000|Overall Study|Lost to Follow-up|0|||
125329774|NCT02379091|450839189|FG001|Overall Study|Lost to Follow-up|0|||
125329775|NCT02379091|450839190|FG002|Overall Study|Lost to Follow-up|0|||
125329776|NCT02379091|450839191|FG003|Overall Study|Lost to Follow-up|1|||
125329777|NCT02379091|450839188|FG000|Overall Study|Voluntary Withdrawal|2|||
125329778|NCT02379091|450839189|FG001|Overall Study|Voluntary Withdrawal|5|||
125329779|NCT02379091|450839190|FG002|Overall Study|Voluntary Withdrawal|2|||
125329780|NCT02379091|450839191|FG003|Overall Study|Voluntary Withdrawal|4|||
125329781|NCT02379091|450839188|FG000|Overall Study|Study Termination|7|||
125329782|NCT02379091|450839189|FG001|Overall Study|Study Termination|2|||
125329783|NCT02379091|450839190|FG002|Overall Study|Study Termination|5|||
125329784|NCT02379091|450839191|FG003|Overall Study|Study Termination|8|||
125329785|NCT02379091|450839188|FG000|Overall Study|Lack of Efficacy|3|||
125329786|NCT02379091|450839189|FG001|Overall Study|Lack of Efficacy|0|||
125329787|NCT02379091|450839190|FG002|Overall Study|Lack of Efficacy|0|||
125329788|NCT02379091|450839191|FG003|Overall Study|Lack of Efficacy|0|||
125329789|NCT02129699|450839194|FG000|Overall Study|Did not start treatment|3|||
125329790|NCT02129699|450839195|FG001|Overall Study|Did not start treatment|2|||
125329791|NCT01076361|450839199|FG000|Overall Study|22 leads were excluded from analysis|21|||
125329792|NCT04801420|450839205|FG000|Overall Study|Other|1|||
125329793|NCT04801420|450839206|FG001|Overall Study|Other|2|||
125329794|NCT04801420|450839207|FG002|Overall Study|Other|1|||
125329795|NCT04801420|450839205|FG000|Overall Study|Lost to Follow-up|7|||
125329796|NCT04801420|450839206|FG001|Overall Study|Lost to Follow-up|9|||
125329797|NCT04801420|450839207|FG002|Overall Study|Lost to Follow-up|10|||
125329798|NCT04801420|450839205|FG000|Overall Study|Moved from study area|0|||
125329799|NCT04801420|450839206|FG001|Overall Study|Moved from study area|1|||
125329800|NCT04801420|450839207|FG002|Overall Study|Moved from study area|1|||
125329801|NCT04801420|450839205|FG000|Overall Study|Withdrawal by Subject|5|||
125329802|NCT04801420|450839206|FG001|Overall Study|Withdrawal by Subject|1|||
125329803|NCT04801420|450839207|FG002|Overall Study|Withdrawal by Subject|4|||
125329804|NCT04801420|450839205|FG000|Overall Study|Individual stopping criteria reached|0|||
125329805|NCT04801420|450839206|FG001|Overall Study|Individual stopping criteria reached|1|||
125329806|NCT04801420|450839207|FG002|Overall Study|Individual stopping criteria reached|0|||
125329807|NCT04801420|450839205|FG000|Overall Study|Ongoing in the study|195|||
125329808|NCT04801420|450839206|FG001|Overall Study|Ongoing in the study|195|||
125329809|NCT04801420|450839207|FG002|Overall Study|Ongoing in the study|192|||
125329810|NCT04774094|450839208|FG000|Overall Study|Other|2|||
125329811|NCT04774094|450839208|FG000|Overall Study|Withdrawal by Subject|9|||
125329812|NCT04774094|450839208|FG000|Overall Study|Lost to Follow-up|7|||
125329813|NCT04774094|450839208|FG000|Overall Study|Lack of Efficacy|5|||
125329814|NCT04774094|450839208|FG000|Overall Study|Death|17|||
125329815|NCT04774094|450839208|FG000|Overall Study|Adverse Event|4|||
125329816|NCT01357850|450841065|FG000|Overall Study|Lost to Follow-up|1|||
125329817|NCT01357850|450841066|FG001|Overall Study|Lost to Follow-up|0|||
125329818|NCT01357850|450841067|FG002|Overall Study|Lost to Follow-up|0|||
125329819|NCT01357850|450841068|FG003|Overall Study|Lost to Follow-up|0|||
125329820|NCT00815659|450841069|FG000|Overall Study|Adverse Event|9|||
125329821|NCT00815659|450841069|FG000|Overall Study|Withdrawal by Subject|9|||
125329822|NCT00815659|450841069|FG000|Overall Study|Lost to Follow-up|4|||
125329823|NCT00815659|450841069|FG000|Overall Study|Protocol Violation|1|||
125329824|NCT03847896|450841070|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
125329825|NCT03847896|450841071|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
125329826|NCT03847896|450841072|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
125329827|NCT03847896|450841073|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
125329828|NCT03847896|450841074|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
125329829|NCT03847896|450841070|FG000|Overall Study|Withdrawal by Subject|2|||
125329830|NCT03847896|450841071|FG001|Overall Study|Withdrawal by Subject|10|||
125210688|NCT04299048|450395637|FG000|Overall Study|Death|1|||
125329831|NCT03847896|450841072|FG002|Overall Study|Withdrawal by Subject|5|||
125329832|NCT03847896|450841073|FG003|Overall Study|Withdrawal by Subject|9|||
125329833|NCT03847896|450841074|FG004|Overall Study|Withdrawal by Subject|8|||
125329834|NCT03847896|450841070|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124999447|NCT03236246|449626194|FG001|24-Week Dose Maintenance Period|Death|1|||
124999448|NCT03236246|449626193|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
124999449|NCT03236246|449626194|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
124999450|NCT02598557|449626195|FG000|Overall Study|Withdrawal by Subject|1|||
124999451|NCT02598557|449626196|FG001|Overall Study|Withdrawal by Subject|0|||
124999452|NCT02598557|449626197|FG002|Overall Study|Withdrawal by Subject|1|||
124999453|NCT02598557|449626195|FG000|Overall Study|Participant did not start treatment|2|||
124999454|NCT02598557|449626196|FG001|Overall Study|Participant did not start treatment|1|||
124999455|NCT02598557|449626197|FG002|Overall Study|Participant did not start treatment|1|||
124999456|NCT02598557|449626195|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
124999457|NCT02598557|449626196|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
124999458|NCT02598557|449626197|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
124999459|NCT02598557|449626195|FG000|Overall Study|Adverse Event|1|||
124999460|NCT02598557|449626196|FG001|Overall Study|Adverse Event|1|||
124999461|NCT02598557|449626197|FG002|Overall Study|Adverse Event|0|||
124999462|NCT01637623|449626202|FG000|Overall Study|Lost to Follow-up|0|||
124999463|NCT01637623|449626203|FG001|Overall Study|Lost to Follow-up|0|||
124999464|NCT01637623|449626204|FG002|Overall Study|Lost to Follow-up|2|||
124999465|NCT01637623|449626202|FG000|Overall Study|Physician Decision|1|||
124999466|NCT01637623|449626203|FG001|Overall Study|Physician Decision|0|||
124999467|NCT01637623|449626204|FG002|Overall Study|Physician Decision|1|||
124999468|NCT04615247|449626205|FG000|Overall Study|Adverse Event|0|||
124999469|NCT04615247|449626206|FG001|Overall Study|Adverse Event|2|||
124999470|NCT04615247|449626205|FG000|Overall Study|Withdrawal by Subject|1|||
124999471|NCT04615247|449626206|FG001|Overall Study|Withdrawal by Subject|1|||
124999472|NCT02076113|449626211|FG000|Overall Study|Lost to Follow-up|4|||
124999473|NCT02076113|449626212|FG001|Overall Study|Lost to Follow-up|1|||
124999474|NCT02076113|449626211|FG000|Overall Study|Withdrawal by Subject|2|||
124999475|NCT02076113|449626212|FG001|Overall Study|Withdrawal by Subject|3|||
124999476|NCT02076113|449626211|FG000|Overall Study|Death|1|||
124999477|NCT02076113|449626212|FG001|Overall Study|Death|3|||
124999478|NCT02596620|449626217|FG000|Overall Study|Lost to Follow-up|1|||
124999479|NCT02596620|449626218|FG001|Overall Study|Lost to Follow-up|1|||
124999480|NCT01054144|449626219|FG000|Overall Study|Death|2|||
124999481|NCT05628285|449626220|FG000|Overall Study|Lost to Follow-up|1|||
124999482|NCT01284062|449626224|FG000|Overall Study|Adverse Event|4|||
124999483|NCT01284062|449626225|FG001|Overall Study|Adverse Event|5|||
124999484|NCT01284062|449626226|FG002|Overall Study|Adverse Event|0|||
124999485|NCT01284062|449626227|FG003|Overall Study|Adverse Event|5|||
124999486|NCT01284062|449626224|FG000|Overall Study|Lack of Efficacy|3|||
124999487|NCT01284062|449626225|FG001|Overall Study|Lack of Efficacy|2|||
124999488|NCT01284062|449626226|FG002|Overall Study|Lack of Efficacy|2|||
124999489|NCT01284062|449626227|FG003|Overall Study|Lack of Efficacy|1|||
124999490|NCT01284062|449626224|FG000|Overall Study|Medication error without adverse event|0|||
124999491|NCT01284062|449626225|FG001|Overall Study|Medication error without adverse event|0|||
124999492|NCT01284062|449626226|FG002|Overall Study|Medication error without adverse event|1|||
124999493|NCT01284062|449626227|FG003|Overall Study|Medication error without adverse event|0|||
124999494|NCT01284062|449626224|FG000|Overall Study|Protocol Violation|1|||
124999495|NCT01284062|449626225|FG001|Overall Study|Protocol Violation|0|||
124999496|NCT01284062|449626226|FG002|Overall Study|Protocol Violation|0|||
124999497|NCT01284062|449626227|FG003|Overall Study|Protocol Violation|2|||
124999498|NCT01284062|449626224|FG000|Overall Study|Withdrawal by Subject|3|||
124999499|NCT01284062|449626225|FG001|Overall Study|Withdrawal by Subject|1|||
124999500|NCT01284062|449626226|FG002|Overall Study|Withdrawal by Subject|2|||
124999501|NCT01284062|449626227|FG003|Overall Study|Withdrawal by Subject|5|||
124999502|NCT01284062|449626224|FG000|Overall Study|Other|0|||
124999503|NCT01284062|449626225|FG001|Overall Study|Other|0|||
124999504|NCT01284062|449626226|FG002|Overall Study|Other|0|||
124999505|NCT01284062|449626227|FG003|Overall Study|Other|1|||
124999506|NCT01284062|449626224|FG000|Overall Study|Site Closed|0|||
124999507|NCT01284062|449626225|FG001|Overall Study|Site Closed|0|||
124999508|NCT01284062|449626226|FG002|Overall Study|Site Closed|1|||
124999509|NCT01284062|449626227|FG003|Overall Study|Site Closed|0|||
124999510|NCT00559585|449626228|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
124999511|NCT00559585|449626229|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
124999512|NCT00559585|449626228|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
124999513|NCT00559585|449626229|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
124999514|NCT00559585|449626228|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
124999515|NCT00559585|449626229|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
124999516|NCT00559585|449626228|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
124999517|NCT00559585|449626229|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
124999518|NCT00559585|449626228|FG000|Double Blind ST Period Main Study|Death|1|||
124999519|NCT00559585|449626229|FG001|Double Blind ST Period Main Study|Death|1|||
125329835|NCT03847896|450841071|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125329836|NCT03847896|450841072|FG002|Overall Study|Withdrawal by parent/guardian|1|||
124872961|NCT01493687|449157206|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
125329837|NCT03847896|450841073|FG003|Overall Study|Withdrawal by parent/guardian|0|||
125329838|NCT03847896|450841074|FG004|Overall Study|Withdrawal by parent/guardian|0|||
125329839|NCT03847896|450841070|FG000|Overall Study|Adverse Event|2|||
125329840|NCT03847896|450841071|FG001|Overall Study|Adverse Event|1|||
125329841|NCT03847896|450841072|FG002|Overall Study|Adverse Event|3|||
125329842|NCT03847896|450841073|FG003|Overall Study|Adverse Event|2|||
125329843|NCT03847896|450841074|FG004|Overall Study|Adverse Event|4|||
125329844|NCT03847896|450841070|FG000|Overall Study|A severe exacerbation event|0|||
125329845|NCT03847896|450841071|FG001|Overall Study|A severe exacerbation event|0|||
125329846|NCT03847896|450841072|FG002|Overall Study|A severe exacerbation event|0|||
125329847|NCT03847896|450841073|FG003|Overall Study|A severe exacerbation event|0|||
125329848|NCT03847896|450841074|FG004|Overall Study|A severe exacerbation event|3|||
125329849|NCT03847896|450841070|FG000|Overall Study|Protocol Violation|0|||
125329850|NCT03847896|450841071|FG001|Overall Study|Protocol Violation|2|||
125329851|NCT03847896|450841072|FG002|Overall Study|Protocol Violation|1|||
125329852|NCT03847896|450841073|FG003|Overall Study|Protocol Violation|0|||
125329853|NCT03847896|450841074|FG004|Overall Study|Protocol Violation|2|||
125329854|NCT03847896|450841070|FG000|Overall Study|Lost to Follow-up|0|||
125329855|NCT03847896|450841071|FG001|Overall Study|Lost to Follow-up|0|||
125329856|NCT03847896|450841072|FG002|Overall Study|Lost to Follow-up|0|||
125329857|NCT03847896|450841073|FG003|Overall Study|Lost to Follow-up|1|||
125329858|NCT03847896|450841074|FG004|Overall Study|Lost to Follow-up|0|||
125329859|NCT03847896|450841070|FG000|Overall Study|Condition under investigation worsened|0|||
125329860|NCT03847896|450841071|FG001|Overall Study|Condition under investigation worsened|0|||
125329861|NCT03847896|450841072|FG002|Overall Study|Condition under investigation worsened|0|||
125329862|NCT03847896|450841073|FG003|Overall Study|Condition under investigation worsened|1|||
125329863|NCT03847896|450841074|FG004|Overall Study|Condition under investigation worsened|1|||
125329864|NCT03847896|450841070|FG000|Overall Study|Lack of Efficacy|0|||
125329865|NCT03847896|450841071|FG001|Overall Study|Lack of Efficacy|0|||
125329866|NCT03847896|450841072|FG002|Overall Study|Lack of Efficacy|0|||
125329867|NCT03847896|450841073|FG003|Overall Study|Lack of Efficacy|2|||
125329868|NCT03847896|450841074|FG004|Overall Study|Lack of Efficacy|2|||
125329869|NCT03847896|450841070|FG000|Overall Study|Other reasons|3|||
125329870|NCT03847896|450841071|FG001|Overall Study|Other reasons|3|||
125329871|NCT03847896|450841072|FG002|Overall Study|Other reasons|1|||
125329872|NCT03847896|450841073|FG003|Overall Study|Other reasons|2|||
125329873|NCT03847896|450841074|FG004|Overall Study|Other reasons|1|||
125329874|NCT00118417|450841075|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
125329875|NCT00118417|450841076|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
125329876|NCT00118417|450841075|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
125329877|NCT00118417|450841076|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
125329878|NCT00118417|450841075|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
125329879|NCT00118417|450841076|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
125329880|NCT00118417|450841075|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
125329881|NCT00118417|450841076|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
125329882|NCT00118417|450841075|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
125329883|NCT00118417|450841076|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
125329884|NCT02978781|450841077|FG000|Part A|Adverse Event|1|||
125329885|NCT02978781|450841078|FG001|Part A|Adverse Event|1|||
125329886|NCT02978781|450841079|FG002|Part A|Adverse Event|0|||
125329887|NCT02978781|450841080|FG003|Part A|Adverse Event|0|||
125329888|NCT02978781|450841081|FG004|Part A|Adverse Event|0|||
125329889|NCT02978781|450841077|FG000|Part A|Withdrawal by Subject|0|||
125329890|NCT02978781|450841078|FG001|Part A|Withdrawal by Subject|1|||
125329891|NCT02978781|450841079|FG002|Part A|Withdrawal by Subject|0|||
125329892|NCT02978781|450841080|FG003|Part A|Withdrawal by Subject|0|||
125329893|NCT02978781|450841081|FG004|Part A|Withdrawal by Subject|0|||
125329894|NCT02978781|450841077|FG000|Part B|Withdrawal by Subject|0|||
125329895|NCT02978781|450841078|FG001|Part B|Withdrawal by Subject|0|||
125329896|NCT02978781|450841079|FG002|Part B|Withdrawal by Subject|0|||
125329897|NCT02978781|450841080|FG003|Part B|Withdrawal by Subject|1|||
125329898|NCT02978781|450841081|FG004|Part B|Withdrawal by Subject|0|||
125329899|NCT02978781|450841077|FG000|Part C|Adverse Event|0|||
125329900|NCT02978781|450841078|FG001|Part C|Adverse Event|0|||
125329901|NCT02978781|450841079|FG002|Part C|Adverse Event|0|||
125329902|NCT02978781|450841080|FG003|Part C|Adverse Event|0|||
125329903|NCT02978781|450841081|FG004|Part C|Adverse Event|2|||
125329904|NCT02978781|450841077|FG000|Part C|Withdrawal by Subject|0|||
125329905|NCT02978781|450841078|FG001|Part C|Withdrawal by Subject|0|||
125329906|NCT02978781|450841079|FG002|Part C|Withdrawal by Subject|0|||
125329907|NCT02978781|450841080|FG003|Part C|Withdrawal by Subject|0|||
125329908|NCT02978781|450841081|FG004|Part C|Withdrawal by Subject|1|||
125329909|NCT02978781|450841077|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
125329910|NCT02978781|450841078|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
125329911|NCT02978781|450841079|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
125329912|NCT02978781|450841080|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
125329913|NCT02978781|450841081|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
124999520|NCT00559585|449626228|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
124999521|NCT00559585|449626229|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
124999522|NCT00559585|449626228|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
124999523|NCT00559585|449626229|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
124999524|NCT00559585|449626228|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
124999525|NCT00559585|449626229|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
124999526|NCT00559585|449626228|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
124999527|NCT00559585|449626229|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
124999528|NCT00559585|449626228|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
124999529|NCT00559585|449626229|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
124999530|NCT00559585|449626228|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
124999531|NCT00559585|449626229|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
124999532|NCT00559585|449626228|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
124999533|NCT00559585|449626229|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
124999534|NCT00559585|449626228|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
124999535|NCT00559585|449626229|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
124999536|NCT00559585|449626228|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
124999537|NCT00559585|449626229|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
124999538|NCT00559585|449626228|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
124999539|NCT00559585|449626229|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
124999540|NCT00559585|449626228|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
124999541|NCT00559585|449626229|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
124999542|NCT00559585|449626228|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
124999543|NCT00559585|449626229|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
124999544|NCT00559585|449626228|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
124999545|NCT00559585|449626229|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
124999546|NCT00559585|449626228|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
124999547|NCT00559585|449626229|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
124999548|NCT00559585|449626228|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
124999549|NCT00559585|449626229|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
124999550|NCT00559585|449626228|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
124999551|NCT00559585|449626229|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
124999552|NCT00559585|449626228|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
124999553|NCT00559585|449626229|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
124999554|NCT00559585|449626228|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
124999555|NCT00559585|449626229|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
124999556|NCT00559585|449626228|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
124999557|NCT00559585|449626229|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
124999558|NCT00559585|449626228|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
124999559|NCT00559585|449626229|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
124999560|NCT00559585|449626228|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
124999561|NCT00559585|449626229|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
124999562|NCT00559585|449626228|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
124999563|NCT00559585|449626229|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
124999564|NCT00559585|449626228|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
124999565|NCT00559585|449626229|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
124999566|NCT01717768|449626231|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
124999567|NCT01717768|449626232|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
124999568|NCT01717768|449626233|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
124999569|NCT01717768|449626234|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
125329914|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
125329915|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
124999570|NCT01717768|449626235|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
124999571|NCT01717768|449626236|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
124999572|NCT01717768|449626237|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
125329916|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Adverse Event|31|||
125329917|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Adverse Event|21|||
125329918|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
125329919|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
125329920|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
125329921|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
125329922|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
125329923|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
125329924|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
125329925|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
125329926|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Administrative problems|3|||
125329927|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Administrative problems|3|||
125329928|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Death|5|||
125329929|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Death|8|||
125329930|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Disease progression|139|||
125329931|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Disease progression|119|||
125329932|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
125329933|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
125329934|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
125329935|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
125329936|NCT00785785|450841082|FG000|Optional Extension Phase|Adverse Event|4|||
125329937|NCT00785785|450841083|FG001|Optional Extension Phase|Adverse Event|5|||
125329938|NCT00785785|450841082|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
125329939|NCT00785785|450841083|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
125329940|NCT00785785|450841082|FG000|Optional Extension Phase|Lost to Follow-up|1|||
124999573|NCT01717768|449626238|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
124999574|NCT01717768|449626239|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
124999575|NCT01717768|449626240|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
124999576|NCT01717768|449626241|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
124999577|NCT01717768|449626242|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
124999578|NCT01717768|449626231|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
124999579|NCT01717768|449626232|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
124999580|NCT01717768|449626233|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
124999581|NCT01717768|449626234|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
124999582|NCT01717768|449626235|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
125329941|NCT00785785|450841083|FG001|Optional Extension Phase|Lost to Follow-up|0|||
125329942|NCT00785785|450841082|FG000|Optional Extension Phase|Administrative problems|2|||
125329943|NCT00785785|450841083|FG001|Optional Extension Phase|Administrative problems|0|||
125329944|NCT00785785|450841082|FG000|Optional Extension Phase|Death|1|||
125329945|NCT00785785|450841083|FG001|Optional Extension Phase|Death|5|||
125329946|NCT00785785|450841082|FG000|Optional Extension Phase|Disease progression|22|||
125329947|NCT00785785|450841083|FG001|Optional Extension Phase|Disease progression|70|||
125329948|NCT00785785|450841082|FG000|Optional Extension Phase|Protocol deviation|0|||
125329949|NCT00785785|450841083|FG001|Optional Extension Phase|Protocol deviation|2|||
125329950|NCT00785785|450841082|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
125329951|NCT00785785|450841083|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
125329952|NCT02453321|450841084|FG000|Overall Study|Weakness|1|||
125329953|NCT02453321|450841085|FG001|Overall Study|Weakness|1|||
125329954|NCT02453321|450841086|FG002|Overall Study|Weakness|2|||
125329955|NCT02453321|450841084|FG000|Overall Study|Deep Venous Thrombosis|0|||
125329956|NCT02453321|450841085|FG001|Overall Study|Deep Venous Thrombosis|1|||
125329957|NCT02453321|450841086|FG002|Overall Study|Deep Venous Thrombosis|0|||
125329958|NCT00521404|450841087|FG000|Overall Study|Adverse Event|13|||
125329959|NCT00521404|450841087|FG000|Overall Study|Disease Progression|33|||
125329960|NCT00521404|450841087|FG000|Overall Study|Investigator decision|5|||
125329961|NCT00521404|450841087|FG000|Overall Study|Withdrawal of consent|3|||
125329962|NCT00521404|450841087|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
125329963|NCT00521404|450841087|FG000|Overall Study|Other|7|||
125329964|NCT02282605|450841089|FG000|Overall Study|negative SA result on Day -1|3|||
125329965|NCT02282605|450841090|FG001|Overall Study|negative SA result on Day -1|0|||
125329966|NCT02282605|450841091|FG002|Overall Study|negative SA result on Day -1|0|||
125329967|NCT04396639|450841096|FG000|Overall Study|Withdrawal by Subject|1|||
125329968|NCT04396639|450841096|FG000|Overall Study|Other|1|||
125329969|NCT01544335|450841097|FG000|Overall Study|Lost to Follow-up|27|||
125329970|NCT01544335|450841097|FG000|Overall Study|Death|4|||
125329971|NCT01544335|450841097|FG000|Overall Study|Disease progression|3|||
125329972|NCT01544335|450841097|FG000|Overall Study|Baseline Measurements not Available|19|||
125329973|NCT01532986|450841100|FG000|Overall Study|Death|9|||
125329974|NCT01532986|450841101|FG001|Overall Study|Death|9|||
125329975|NCT01532986|450841100|FG000|Overall Study|Withdrawal by Subject|7|||
125329976|NCT01532986|450841101|FG001|Overall Study|Withdrawal by Subject|10|||
125329977|NCT01532986|450841100|FG000|Overall Study|Physician Decision|7|||
125329978|NCT01532986|450841101|FG001|Overall Study|Physician Decision|5|||
125329979|NCT04614974|450841102|FG000|Overall Study|Lost to Follow-up|14|||
125329980|NCT04614974|450841103|FG001|Overall Study|Lost to Follow-up|11|||
125329981|NCT01635153|450841104|FG000|Overall Study|Lost to Follow-up|40|||
125329982|NCT01635153|450841105|FG001|Overall Study|Lost to Follow-up|43|||
125329983|NCT00658359|450841106|FG000|Overall Study|Death|3|||
125329984|NCT00658359|450841107|FG001|Overall Study|Death|1|||
125329985|NCT00658359|450841108|FG002|Overall Study|Death|2|||
125329986|NCT00658359|450841106|FG000|Overall Study|Adverse Event|13|||
125329987|NCT00658359|450841107|FG001|Overall Study|Adverse Event|6|||
125329988|NCT00658359|450841108|FG002|Overall Study|Adverse Event|9|||
125329989|NCT00658359|450841106|FG000|Overall Study|Protocol Violation|1|||
124999583|NCT01717768|449626236|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
124999584|NCT01717768|449626237|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
124999585|NCT01717768|449626238|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
124999586|NCT01717768|449626239|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
125329990|NCT00658359|450841107|FG001|Overall Study|Protocol Violation|0|||
124999587|NCT01717768|449626240|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
124999588|NCT01717768|449626241|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
124999589|NCT01717768|449626242|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
124999590|NCT01717768|449626231|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124999591|NCT01717768|449626232|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124999592|NCT01717768|449626233|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124999593|NCT01717768|449626234|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124999594|NCT01717768|449626235|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124999595|NCT01717768|449626236|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124999596|NCT01717768|449626237|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124999597|NCT01717768|449626238|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
124999598|NCT01717768|449626239|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124999599|NCT01717768|449626240|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124999600|NCT01717768|449626241|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124999601|NCT01717768|449626242|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124999602|NCT01717768|449626231|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124999603|NCT01717768|449626232|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124999604|NCT01717768|449626233|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124999605|NCT01717768|449626234|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124999606|NCT01717768|449626235|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124999607|NCT01717768|449626236|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124999608|NCT01717768|449626237|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124999609|NCT01717768|449626238|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124999610|NCT01717768|449626239|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124999611|NCT01717768|449626240|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
124999612|NCT01717768|449626241|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124999613|NCT01717768|449626242|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124999614|NCT04195581|449626245|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
124999615|NCT04195581|449626245|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
124999616|NCT04195581|449626245|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
124999617|NCT04195581|449626245|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
124999618|NCT04195581|449626245|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
124999619|NCT04195581|449626245|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
124999620|NCT01237340|449626250|FG000|Overall Study|Adverse Event|3|||
124999621|NCT01237340|449626250|FG000|Overall Study|Withdrawal by Subject|1|||
124999622|NCT01237340|449626250|FG000|Overall Study|Early termination of the trial|36|||
124999623|NCT01906346|449626251|FG000|Overall Study|AEs|1|||
124999624|NCT04226833|449626252|FG000|Overall Study|Death|0|||
124999625|NCT04226833|449626253|FG001|Overall Study|Death|0|||
124999626|NCT04226833|449626254|FG002|Overall Study|Death|1|||
124999627|NCT04226833|449626255|FG003|Overall Study|Death|0|||
124999628|NCT02876835|449626258|FG000|Treatment Period (51.1 Month)|Other|1|||
124999629|NCT02876835|449626259|FG001|Treatment Period (51.1 Month)|Other|0|||
124999630|NCT02876835|449626258|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
124999631|NCT02876835|449626259|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
124999632|NCT02876835|449626258|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
124999633|NCT02876835|449626259|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
124999634|NCT02876835|449626258|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
124999635|NCT02876835|449626259|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
124999636|NCT02540538|449626260|FG000|Overall Study|Pregnancy|0|||
124999637|NCT02540538|449626261|FG001|Overall Study|Pregnancy|1|||
124999638|NCT02540538|449626262|FG002|Overall Study|Pregnancy|0|||
124999639|NCT00403754|449626263|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
124999640|NCT00403754|449626264|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
124999641|NCT00403754|449626265|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
124999642|NCT00403754|449626266|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
124999643|NCT00403754|449626263|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
124999644|NCT00403754|449626264|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
125329991|NCT00658359|450841108|FG002|Overall Study|Protocol Violation|0|||
124999645|NCT00403754|449626265|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
124999646|NCT00403754|449626266|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
125329992|NCT00658359|450841106|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
125329993|NCT00658359|450841107|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
125329994|NCT00658359|450841108|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
125329995|NCT00658359|450841106|FG000|Overall Study|Withdrawal by Subject|7|||
125329996|NCT00658359|450841107|FG001|Overall Study|Withdrawal by Subject|4|||
125329997|NCT00658359|450841108|FG002|Overall Study|Withdrawal by Subject|2|||
125329998|NCT00658359|450841106|FG000|Overall Study|Lost to Follow-up|2|||
125329999|NCT00658359|450841107|FG001|Overall Study|Lost to Follow-up|2|||
125330000|NCT00658359|450841108|FG002|Overall Study|Lost to Follow-up|4|||
125330001|NCT00658359|450841106|FG000|Overall Study|Lack of Efficacy|0|||
125330002|NCT00658359|450841107|FG001|Overall Study|Lack of Efficacy|1|||
125330003|NCT00658359|450841108|FG002|Overall Study|Lack of Efficacy|0|||
125330004|NCT02754440|450841109|FG000|Overall Study|Protocol Violation|3|||
125330005|NCT02754440|450841110|FG001|Overall Study|Protocol Violation|2|||
125330006|NCT02754440|450841111|FG002|Overall Study|Protocol Violation|2|||
125330007|NCT02754440|450841112|FG003|Overall Study|Protocol Violation|6|||
125330008|NCT02754440|450841109|FG000|Overall Study|Adverse Event|3|||
125330009|NCT02754440|450841110|FG001|Overall Study|Adverse Event|1|||
125330010|NCT02754440|450841111|FG002|Overall Study|Adverse Event|0|||
125330011|NCT02754440|450841112|FG003|Overall Study|Adverse Event|9|||
124999647|NCT03049735|449626271|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
125330012|NCT02754440|450841109|FG000|Overall Study|Withdrawal by Subject|0|||
125330013|NCT02754440|450841110|FG001|Overall Study|Withdrawal by Subject|0|||
125330014|NCT02754440|450841111|FG002|Overall Study|Withdrawal by Subject|0|||
125330015|NCT02754440|450841112|FG003|Overall Study|Withdrawal by Subject|1|||
125330016|NCT02754440|450841109|FG000|Overall Study|Equipment failure|0|||
125330017|NCT02754440|450841110|FG001|Overall Study|Equipment failure|5|||
125330018|NCT02754440|450841111|FG002|Overall Study|Equipment failure|5|||
125330019|NCT02754440|450841112|FG003|Overall Study|Equipment failure|7|||
125330020|NCT02754440|450841109|FG000|Overall Study|Subject issues not resulting in AE|0|||
125330021|NCT02754440|450841110|FG001|Overall Study|Subject issues not resulting in AE|0|||
125330022|NCT02754440|450841111|FG002|Overall Study|Subject issues not resulting in AE|0|||
125330023|NCT02754440|450841112|FG003|Overall Study|Subject issues not resulting in AE|12|||
125330024|NCT02560558|450841113|FG000|Overall Study|Adverse Event|1|||
124999648|NCT03049735|449626272|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
124999649|NCT03049735|449626273|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
124999650|NCT03049735|449626271|FG000|Overall Study|Other|5|||
125330025|NCT02560558|450841114|FG001|Overall Study|Adverse Event|0|||
125330026|NCT02560558|450841113|FG000|Overall Study|Death|0|||
124999651|NCT03049735|449626272|FG001|Overall Study|Other|3|||
124999652|NCT03049735|449626273|FG002|Overall Study|Other|1|||
124999653|NCT03049735|449626271|FG000|Overall Study|Lack of Efficacy|4|||
124999654|NCT03049735|449626272|FG001|Overall Study|Lack of Efficacy|0|||
124999655|NCT03049735|449626273|FG002|Overall Study|Lack of Efficacy|3|||
124999656|NCT03049735|449626271|FG000|Overall Study|Protocol deviation|1|||
124999657|NCT03049735|449626272|FG001|Overall Study|Protocol deviation|0|||
124999658|NCT03049735|449626273|FG002|Overall Study|Protocol deviation|0|||
124999659|NCT03049735|449626271|FG000|Overall Study|Pregnancy|0|||
124999660|NCT03049735|449626272|FG001|Overall Study|Pregnancy|0|||
124999661|NCT03049735|449626273|FG002|Overall Study|Pregnancy|1|||
124999662|NCT03049735|449626271|FG000|Overall Study|Adverse Event|7|||
124999663|NCT03049735|449626272|FG001|Overall Study|Adverse Event|18|||
124999664|NCT03049735|449626273|FG002|Overall Study|Adverse Event|5|||
124999665|NCT03049735|449626271|FG000|Overall Study|Withdrawal by Subject|10|||
124999666|NCT03049735|449626272|FG001|Overall Study|Withdrawal by Subject|3|||
124999667|NCT03049735|449626273|FG002|Overall Study|Withdrawal by Subject|7|||
124999668|NCT03049735|449626271|FG000|Overall Study|Lost to Follow-up|1|||
124999669|NCT03049735|449626272|FG001|Overall Study|Lost to Follow-up|5|||
124999670|NCT03049735|449626273|FG002|Overall Study|Lost to Follow-up|5|||
124999671|NCT03153111|449626274|FG000|Overall Study|Death|2|||
124999672|NCT03153111|449626275|FG001|Overall Study|Death|5|||
124999673|NCT03153111|449626274|FG000|Overall Study|Lost to Follow-up|1|||
125330027|NCT02560558|450841114|FG001|Overall Study|Death|2|||
125330028|NCT02560558|450841113|FG000|Overall Study|Lost to Follow-up|0|||
124999674|NCT03153111|449626275|FG001|Overall Study|Lost to Follow-up|0|||
124999675|NCT03153111|449626274|FG000|Overall Study|Physician Decision|5|||
124999676|NCT03153111|449626275|FG001|Overall Study|Physician Decision|1|||
124999677|NCT03153111|449626274|FG000|Overall Study|Withdrawal by Subject|3|||
125330029|NCT02560558|450841114|FG001|Overall Study|Lost to Follow-up|4|||
125330030|NCT02560558|450841113|FG000|Overall Study|Protocol Violation|3|||
125330031|NCT02560558|450841114|FG001|Overall Study|Protocol Violation|0|||
125330032|NCT02560558|450841113|FG000|Overall Study|Withdrawal by Subject|3|||
125330033|NCT02560558|450841114|FG001|Overall Study|Withdrawal by Subject|0|||
125330034|NCT01263197|450841121|FG000|First Intervention (Period 1)|Adverse Event|0|||
125330035|NCT01263197|450841122|FG001|First Intervention (Period 1)|Adverse Event|0|||
125330036|NCT01263197|450841123|FG002|First Intervention (Period 1)|Adverse Event|0|||
125330037|NCT01263197|450841124|FG003|First Intervention (Period 1)|Adverse Event|0|||
125330038|NCT01263197|450841125|FG004|First Intervention (Period 1)|Adverse Event|0|||
124999678|NCT03153111|449626275|FG001|Overall Study|Withdrawal by Subject|3|||
124999679|NCT03891524|449626276|FG000|Overall Study|Death|0|||
124999680|NCT03891524|449626277|FG001|Overall Study|Death|0|||
124999681|NCT03891524|449626278|FG002|Overall Study|Death|0|||
124999682|NCT03891524|449626279|FG003|Overall Study|Death|0|||
124999683|NCT03891524|449626280|FG004|Overall Study|Death|0|||
124999684|NCT03891524|449626281|FG005|Overall Study|Death|0|||
124999685|NCT03891524|449626282|FG006|Overall Study|Death|0|||
124999686|NCT03891524|449626283|FG007|Overall Study|Death|1|||
124999687|NCT03891524|449626276|FG000|Overall Study|Withdrawal by Subject|0|||
124999688|NCT03891524|449626277|FG001|Overall Study|Withdrawal by Subject|1|||
124999689|NCT03891524|449626278|FG002|Overall Study|Withdrawal by Subject|2|||
124999690|NCT03891524|449626279|FG003|Overall Study|Withdrawal by Subject|1|||
124999691|NCT03891524|449626280|FG004|Overall Study|Withdrawal by Subject|2|||
124999692|NCT03891524|449626281|FG005|Overall Study|Withdrawal by Subject|2|||
124999693|NCT03891524|449626282|FG006|Overall Study|Withdrawal by Subject|2|||
124999694|NCT03891524|449626283|FG007|Overall Study|Withdrawal by Subject|1|||
124999695|NCT01572922|449626284|FG000|Overall Study|Adverse Event|1|||
124999696|NCT01572922|449626284|FG000|Overall Study|Protocol Violation|1|||
124999697|NCT01572922|449626284|FG000|Overall Study|Death|1|||
124999698|NCT03040622|449626285|FG000|Overall Study|unable to implant device|3|||
124999699|NCT00445068|449626286|FG000|Overall Study|Disease progression|26|||
124999700|NCT00445068|449626286|FG000|Overall Study|Adverse Event|5|||
124999701|NCT00445068|449626286|FG000|Overall Study|Abnormal laboratory value|2|||
124999702|NCT00445068|449626286|FG000|Overall Study|Withdrawal by Subject|2|||
124999703|NCT00445068|449626286|FG000|Overall Study|Death|1|||
124999704|NCT00447382|449626287|FG000|Overall Study|Adverse Event|1|||
124999705|NCT00447382|449626288|FG001|Overall Study|Adverse Event|1|||
124999706|NCT00447382|449626287|FG000|Overall Study|Lack of Efficacy|1|||
124999707|NCT00447382|449626288|FG001|Overall Study|Lack of Efficacy|0|||
124999708|NCT00447382|449626287|FG000|Overall Study|Protocol Violation|2|||
124999709|NCT00447382|449626288|FG001|Overall Study|Protocol Violation|0|||
124999710|NCT00447382|449626287|FG000|Overall Study|Unclassified|2|||
124999711|NCT00447382|449626288|FG001|Overall Study|Unclassified|5|||
124999712|NCT03144804|449626289|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
124999713|NCT04091451|449626290|FG000|Overall Study|Adverse Event|15|||
124999714|NCT04091451|449626291|FG001|Overall Study|Adverse Event|10|||
124999715|NCT04091451|449626290|FG000|Overall Study|Lost to Follow-up|8|||
124999716|NCT04091451|449626291|FG001|Overall Study|Lost to Follow-up|8|||
124999717|NCT04091451|449626290|FG000|Overall Study|Protocol Violation|5|||
124999718|NCT04091451|449626291|FG001|Overall Study|Protocol Violation|4|||
124999719|NCT04091451|449626290|FG000|Overall Study|Withdrawal by Subject|21|||
124999720|NCT04091451|449626291|FG001|Overall Study|Withdrawal by Subject|27|||
124999721|NCT04091451|449626290|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
124999722|NCT04091451|449626291|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
124999723|NCT04091451|449626290|FG000|Overall Study|Migrated/moved from the study area|3|||
124999724|NCT04091451|449626291|FG001|Overall Study|Migrated/moved from the study area|5|||
124999725|NCT04091451|449626290|FG000|Overall Study|Suspected HZ episode|1|||
124999726|NCT04091451|449626291|FG001|Overall Study|Suspected HZ episode|0|||
124999727|NCT04124614|449626292|FG000|Placebo Run-in Period|Not Randomized|34|||
124999728|NCT04124614|449626293|FG001|Placebo Run-in Period|Not Randomized|0|||
124999729|NCT04124614|449626294|FG002|Placebo Run-in Period|Not Randomized|0|||
124999730|NCT04124614|449626292|FG000|Double Blind Treatment Period|Adverse Event|0|||
124999731|NCT04124614|449626293|FG001|Double Blind Treatment Period|Adverse Event|7|||
124999732|NCT04124614|449626294|FG002|Double Blind Treatment Period|Adverse Event|22|||
124999733|NCT04124614|449626292|FG000|Double Blind Treatment Period|Death|0|||
124999734|NCT04124614|449626293|FG001|Double Blind Treatment Period|Death|0|||
124999735|NCT04124614|449626294|FG002|Double Blind Treatment Period|Death|1|||
124999736|NCT04124614|449626292|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
124999737|NCT04124614|449626293|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
124999738|NCT04124614|449626294|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
124999739|NCT04124614|449626292|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
124999740|NCT04124614|449626293|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
124999741|NCT04124614|449626294|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
124999742|NCT04124614|449626292|FG000|Double Blind Treatment Period|Physician Decision|0|||
124999743|NCT04124614|449626293|FG001|Double Blind Treatment Period|Physician Decision|0|||
124999744|NCT04124614|449626294|FG002|Double Blind Treatment Period|Physician Decision|3|||
124999745|NCT04124614|449626292|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
124999746|NCT04124614|449626293|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
124999747|NCT04124614|449626294|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
124999748|NCT04124614|449626292|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
124999749|NCT04124614|449626293|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
124999750|NCT04124614|449626294|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
124999751|NCT04124614|449626292|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
124999752|NCT04124614|449626293|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
124999753|NCT04124614|449626294|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
124999754|NCT01831544|449627522|FG000|Overall Study|Death|1|||
124999755|NCT01831544|449627522|FG000|Overall Study|Still on original MVAD device|2|||
125330039|NCT01263197|450841126|FG005|First Intervention (Period 1)|Adverse Event|1|||
124999756|NCT04175808|449627523|FG000|Part A|Miscellaneous|2|||
125330040|NCT01263197|450841121|FG000|Washout Period 1|Protocol Violation|0|||
125330041|NCT01263197|450841122|FG001|Washout Period 1|Protocol Violation|0|||
125330042|NCT01263197|450841123|FG002|Washout Period 1|Protocol Violation|0|||
125330043|NCT01263197|450841124|FG003|Washout Period 1|Protocol Violation|0|||
125330044|NCT01263197|450841125|FG004|Washout Period 1|Protocol Violation|1|||
124999757|NCT04175808|449627524|FG001|Part A|Miscellaneous|0|||
124999758|NCT04175808|449627525|FG002|Part A|Miscellaneous|0|||
124999759|NCT04175808|449627526|FG003|Part A|Miscellaneous|0|||
125330045|NCT01263197|450841126|FG005|Washout Period 1|Protocol Violation|0|||
125330046|NCT01263197|450841121|FG000|Washout Period 2|Physician Decision|0|||
125330047|NCT01263197|450841122|FG001|Washout Period 2|Physician Decision|0|||
125330048|NCT01263197|450841123|FG002|Washout Period 2|Physician Decision|0|||
124999760|NCT04175808|449627527|FG004|Part A|Miscellaneous|0|||
124999761|NCT04175808|449627528|FG005|Part A|Miscellaneous|0|||
124999762|NCT04175808|449627529|FG006|Part A|Miscellaneous|0|||
124999763|NCT03801902|449627530|FG000|Overall Study|Did not receive protocol treatment.|1|||
124999764|NCT03801902|449627531|FG001|Overall Study|Did not receive protocol treatment.|0|||
124999765|NCT03801902|449627532|FG002|Overall Study|Did not receive protocol treatment.|0|||
124999766|NCT03801902|449627533|FG003|Overall Study|Did not receive protocol treatment.|0|||
124999767|NCT00528866|449627537|FG000|Overall Study|Protocol Violation|6|||
124999768|NCT01601847|449627538|FG000|Overall Study|Death|1|||
124999769|NCT01601847|449627539|FG001|Overall Study|Death|0|||
124999770|NCT01601847|449627538|FG000|Overall Study|Withdrawal by Subject|11|||
124999771|NCT01601847|449627539|FG001|Overall Study|Withdrawal by Subject|7|||
124999772|NCT01601847|449627538|FG000|Overall Study|Lost to Follow-up|1|||
124999773|NCT01601847|449627539|FG001|Overall Study|Lost to Follow-up|3|||
124999774|NCT02234323|449627540|FG000|All Enrolled|Not Treated: Completed study in database|2|||
124999775|NCT02234323|449627540|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
124999776|NCT02234323|449627540|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
124999777|NCT02234323|449627540|FG000|All Treated|Death|1|||
124999778|NCT02234323|449627540|FG000|All Treated|Physician Decision|5|||
124999779|NCT02234323|449627540|FG000|All Treated|Lack of Efficacy|3|||
124999780|NCT02234323|449627540|FG000|All Treated|Exceeded lab value limit|2|||
124999781|NCT02234323|449627540|FG000|All Treated|Other|7|||
124999782|NCT02644941|449627541|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
124999783|NCT02644941|449627542|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
124999784|NCT04614662|449627543|FG000|Overall Study|Withdrawal by Subject|0|||
124999785|NCT04614662|449627544|FG001|Overall Study|Withdrawal by Subject|1|||
124999786|NCT01843218|449627547|FG000|Overall Study|Withdrawal by Subject|5|||
124999787|NCT01136811|449627548|FG000|Overall Study|Physician Decision|11|||
124999788|NCT01009554|449627549|FG000|Overall Study|Adverse Event|1|||
124999789|NCT01009554|449627550|FG001|Overall Study|Adverse Event|1|||
124999790|NCT01009554|449627549|FG000|Overall Study|Withdrawal by Subject|1|||
124999791|NCT01009554|449627550|FG001|Overall Study|Withdrawal by Subject|3|||
124999792|NCT01009554|449627549|FG000|Overall Study|Noncompliant with Study Product|0|||
124999793|NCT01009554|449627550|FG001|Overall Study|Noncompliant with Study Product|3|||
124999794|NCT01605253|449627551|FG000|Overall Study|Physician Decision|3|||
124999795|NCT01605253|449627552|FG001|Overall Study|Physician Decision|2|||
124999796|NCT01605253|449627551|FG000|Overall Study|Lost to Follow-up|3|||
124999797|NCT01605253|449627552|FG001|Overall Study|Lost to Follow-up|1|||
124999798|NCT03829319|449627563|FG000|Overall Study|Sponsor's Decision|4|||
124999799|NCT03829319|449627564|FG001|Overall Study|Sponsor's Decision|90|||
124999800|NCT03829319|449627565|FG002|Overall Study|Sponsor's Decision|102|||
124999801|NCT03829319|449627563|FG000|Overall Study|Withdrawal by Subject|1|||
124999802|NCT03829319|449627564|FG001|Overall Study|Withdrawal by Subject|5|||
124999803|NCT03829319|449627565|FG002|Overall Study|Withdrawal by Subject|4|||
124999804|NCT03829319|449627563|FG000|Overall Study|Physician Decision|0|||
124999805|NCT03829319|449627564|FG001|Overall Study|Physician Decision|3|||
124999806|NCT03829319|449627565|FG002|Overall Study|Physician Decision|0|||
124999807|NCT03829319|449627563|FG000|Overall Study|Lost to Follow-up|0|||
124999808|NCT03829319|449627564|FG001|Overall Study|Lost to Follow-up|0|||
124999809|NCT03829319|449627565|FG002|Overall Study|Lost to Follow-up|1|||
124999810|NCT03829319|449627563|FG000|Overall Study|Death|8|||
125330049|NCT01263197|450841124|FG003|Washout Period 2|Physician Decision|0|||
125330050|NCT01263197|450841125|FG004|Washout Period 2|Physician Decision|0|||
125330051|NCT01263197|450841126|FG005|Washout Period 2|Physician Decision|1|||
125330052|NCT01263197|450841121|FG000|Washout Period 2|Protocol Violation|0|||
124999811|NCT03829319|449627564|FG001|Overall Study|Death|277|||
124999812|NCT03829319|449627565|FG002|Overall Study|Death|266|||
124999813|NCT04498832|449627566|FG000|Overall Study|Adverse Event|1|||
124999814|NCT04498832|449627567|FG001|Overall Study|Adverse Event|3|||
124999815|NCT04498832|449627566|FG000|Overall Study|Withdrawal by Subject|0|||
124999816|NCT04498832|449627567|FG001|Overall Study|Withdrawal by Subject|1|||
124999817|NCT05579990|449627573|FG000|Overall Study|Lost to Follow-up|3|||
124999818|NCT03231943|449627577|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124999819|NCT03231943|449627578|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
124999820|NCT03231943|449627579|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
124999821|NCT03231943|449627580|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124999822|NCT03231943|449627581|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124999823|NCT03231943|449627582|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124999824|NCT03231943|449627583|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124999825|NCT03231943|449627584|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124999826|NCT03231943|449627585|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124999827|NCT03231943|449627586|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124999828|NCT03231943|449627587|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124999829|NCT03231943|449627588|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124999830|NCT03231943|449627589|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124999831|NCT03231943|449627577|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124999832|NCT03231943|449627578|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
124999833|NCT03231943|449627579|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124999834|NCT03231943|449627580|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124999835|NCT03231943|449627581|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124999836|NCT03231943|449627582|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124999837|NCT03231943|449627583|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124999838|NCT03231943|449627584|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124999839|NCT03231943|449627585|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124999840|NCT03231943|449627586|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124999841|NCT03231943|449627587|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124999842|NCT03231943|449627588|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124999843|NCT03231943|449627589|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124999844|NCT03231943|449627577|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
124999845|NCT03231943|449627578|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124999846|NCT03231943|449627579|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124999847|NCT03231943|449627580|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124999848|NCT03231943|449627581|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124999849|NCT03231943|449627582|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124999850|NCT03231943|449627583|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124999851|NCT03231943|449627584|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124999852|NCT03231943|449627585|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124999853|NCT03231943|449627586|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124999854|NCT03231943|449627587|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124999855|NCT03231943|449627588|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124999856|NCT03231943|449627589|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124999857|NCT03231943|449627577|FG000|Part 2|Adverse Event|0|||
124999858|NCT03231943|449627578|FG001|Part 2|Adverse Event|0|||
124999859|NCT03231943|449627579|FG002|Part 2|Adverse Event|0|||
124999860|NCT03231943|449627580|FG003|Part 2|Adverse Event|0|||
124999861|NCT03231943|449627581|FG004|Part 2|Adverse Event|0|||
124999862|NCT03231943|449627582|FG005|Part 2|Adverse Event|0|||
124999863|NCT03231943|449627583|FG006|Part 2|Adverse Event|0|||
124999864|NCT03231943|449627584|FG007|Part 2|Adverse Event|0|||
124999865|NCT03231943|449627585|FG008|Part 2|Adverse Event|0|||
124999866|NCT03231943|449627586|FG009|Part 2|Adverse Event|0|||
124999867|NCT03231943|449627587|FG010|Part 2|Adverse Event|1|||
124999868|NCT03231943|449627588|FG011|Part 2|Adverse Event|0|||
124999869|NCT03231943|449627589|FG012|Part 2|Adverse Event|0|||
124999870|NCT03231943|449627577|FG000|Part 2|Withdrawal by Subject|0|||
124999871|NCT03231943|449627578|FG001|Part 2|Withdrawal by Subject|0|||
124999872|NCT03231943|449627579|FG002|Part 2|Withdrawal by Subject|0|||
124999873|NCT03231943|449627580|FG003|Part 2|Withdrawal by Subject|0|||
124999874|NCT03231943|449627581|FG004|Part 2|Withdrawal by Subject|0|||
124999875|NCT03231943|449627582|FG005|Part 2|Withdrawal by Subject|0|||
124999876|NCT03231943|449627583|FG006|Part 2|Withdrawal by Subject|0|||
124999877|NCT03231943|449627584|FG007|Part 2|Withdrawal by Subject|0|||
124999878|NCT03231943|449627585|FG008|Part 2|Withdrawal by Subject|0|||
124999879|NCT03231943|449627586|FG009|Part 2|Withdrawal by Subject|0|||
124999880|NCT03231943|449627587|FG010|Part 2|Withdrawal by Subject|0|||
124999881|NCT03231943|449627588|FG011|Part 2|Withdrawal by Subject|1|||
124999882|NCT03231943|449627589|FG012|Part 2|Withdrawal by Subject|0|||
124999883|NCT04824521|449627592|FG000|Overall Study|Lost to Follow-up|1|||
124999884|NCT03338192|449628269|FG000|Year One to Year Two|High Blood Pressure|7|||
124999885|NCT03338192|449628270|FG001|Year One to Year Two|High Blood Pressure|1|||
124999886|NCT03338192|449628269|FG000|Year One to Year Two|HIV +|1|||
124999887|NCT03338192|449628270|FG001|Year One to Year Two|HIV +|0|||
124999888|NCT03338192|449628269|FG000|Year Two to Year Four|High Blood Pressure|1|||
124999889|NCT03338192|449628270|FG001|Year Two to Year Four|High Blood Pressure|0|||
124999890|NCT03338192|449628269|FG000|Year Two to Year Four|HIV +|2|||
124999891|NCT03338192|449628270|FG001|Year Two to Year Four|HIV +|0|||
124999892|NCT03338192|449628269|FG000|Year Four to Year Six|High Blood Pressure|2|||
124999893|NCT03338192|449628270|FG001|Year Four to Year Six|High Blood Pressure|1|||
124999894|NCT03808688|449628271|FG000|Overall Study|Adverse Event|13|||
124999895|NCT03808688|449628272|FG001|Overall Study|Adverse Event|17|||
124999896|NCT03808688|449628271|FG000|Overall Study|Lack of Efficacy|2|||
124999897|NCT03808688|449628272|FG001|Overall Study|Lack of Efficacy|0|||
125330053|NCT01263197|450841122|FG001|Washout Period 2|Protocol Violation|0|||
125330054|NCT01263197|450841123|FG002|Washout Period 2|Protocol Violation|0|||
125330055|NCT01263197|450841124|FG003|Washout Period 2|Protocol Violation|1|||
125330056|NCT01263197|450841125|FG004|Washout Period 2|Protocol Violation|0|||
125330057|NCT01263197|450841126|FG005|Washout Period 2|Protocol Violation|0|||
125330058|NCT01263197|450841121|FG000|Third Intervention (Period 3)|Adverse Event|0|||
125330059|NCT01263197|450841122|FG001|Third Intervention (Period 3)|Adverse Event|1|||
125330060|NCT01263197|450841123|FG002|Third Intervention (Period 3)|Adverse Event|0|||
125330061|NCT01263197|450841124|FG003|Third Intervention (Period 3)|Adverse Event|0|||
125330062|NCT01263197|450841125|FG004|Third Intervention (Period 3)|Adverse Event|0|||
125330063|NCT01263197|450841126|FG005|Third Intervention (Period 3)|Adverse Event|0|||
125330064|NCT01134055|450841127|FG000|Overall Study|Adverse Event|5|||
125330065|NCT01134055|450841128|FG001|Overall Study|Adverse Event|2|||
125330066|NCT01134055|450841129|FG002|Overall Study|Adverse Event|2|||
125330067|NCT01134055|450841130|FG003|Overall Study|Adverse Event|2|||
125330068|NCT01134055|450841131|FG004|Overall Study|Adverse Event|5|||
125330069|NCT01134055|450841132|FG005|Overall Study|Adverse Event|7|||
125330070|NCT01134055|450841133|FG006|Overall Study|Adverse Event|2|||
125330071|NCT01134055|450841127|FG000|Overall Study|Lost to Follow-up|0|||
125330072|NCT01134055|450841128|FG001|Overall Study|Lost to Follow-up|1|||
125330073|NCT01134055|450841129|FG002|Overall Study|Lost to Follow-up|0|||
125330074|NCT01134055|450841130|FG003|Overall Study|Lost to Follow-up|1|||
125330075|NCT01134055|450841131|FG004|Overall Study|Lost to Follow-up|0|||
125330076|NCT01134055|450841132|FG005|Overall Study|Lost to Follow-up|0|||
125330077|NCT01134055|450841133|FG006|Overall Study|Lost to Follow-up|0|||
125330078|NCT01134055|450841127|FG000|Overall Study|Withdrawal by Subject|3|||
125330079|NCT01134055|450841128|FG001|Overall Study|Withdrawal by Subject|3|||
125330080|NCT01134055|450841129|FG002|Overall Study|Withdrawal by Subject|1|||
125330081|NCT01134055|450841130|FG003|Overall Study|Withdrawal by Subject|2|||
125330082|NCT01134055|450841131|FG004|Overall Study|Withdrawal by Subject|0|||
125330083|NCT01134055|450841132|FG005|Overall Study|Withdrawal by Subject|0|||
125330084|NCT01134055|450841133|FG006|Overall Study|Withdrawal by Subject|8|||
125330085|NCT01134055|450841127|FG000|Overall Study|Protocol Violation|0|||
125330086|NCT01134055|450841128|FG001|Overall Study|Protocol Violation|0|||
125330087|NCT01134055|450841129|FG002|Overall Study|Protocol Violation|0|||
125330088|NCT01134055|450841130|FG003|Overall Study|Protocol Violation|1|||
125330089|NCT01134055|450841131|FG004|Overall Study|Protocol Violation|1|||
125330090|NCT01134055|450841132|FG005|Overall Study|Protocol Violation|0|||
125330091|NCT01134055|450841133|FG006|Overall Study|Protocol Violation|0|||
125330092|NCT01134055|450841127|FG000|Overall Study|Physician Decision|0|||
125330093|NCT01134055|450841128|FG001|Overall Study|Physician Decision|0|||
125330094|NCT01134055|450841129|FG002|Overall Study|Physician Decision|0|||
125330095|NCT01134055|450841130|FG003|Overall Study|Physician Decision|0|||
125330096|NCT01134055|450841131|FG004|Overall Study|Physician Decision|0|||
125330097|NCT01134055|450841132|FG005|Overall Study|Physician Decision|0|||
125330098|NCT01134055|450841133|FG006|Overall Study|Physician Decision|1|||
125330099|NCT03023397|450841138|FG000|Run-In|Failed screening allergen challenge|1|||
125330100|NCT03023397|450841139|FG001|Run-In|Failed screening allergen challenge|0|||
125330101|NCT03023397|450841140|FG002|Run-In|Failed screening allergen challenge|0|||
125330102|NCT03023397|450841138|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
125330103|NCT03023397|450841139|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
125330104|NCT03023397|450841140|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
125330105|NCT01146795|450841144|FG000|Overall Study|Withdrawal by Subject|4|||
125330106|NCT01146795|450841144|FG000|Overall Study|Adverse Event|6|||
125330107|NCT01146795|450841144|FG000|Overall Study|Still in treatment at study closure|10|||
125330108|NCT03853109|450841145|FG000|Overall Study|Withdrawal by Subject|0|||
125330109|NCT03853109|450841146|FG001|Overall Study|Withdrawal by Subject|0|||
125330110|NCT03853109|450841147|FG002|Overall Study|Withdrawal by Subject|1|||
125330111|NCT03853109|450841148|FG003|Overall Study|Withdrawal by Subject|2|||
124999898|NCT03808688|449628271|FG000|Overall Study|Lost to Follow-up|0|||
125330112|NCT03853109|450841149|FG004|Overall Study|Withdrawal by Subject|1|||
125330113|NCT03853109|450841150|FG005|Overall Study|Withdrawal by Subject|4|||
125330114|NCT03853109|450841151|FG006|Overall Study|Withdrawal by Subject|5|||
125330115|NCT03853109|450841152|FG007|Overall Study|Withdrawal by Subject|3|||
125330116|NCT03853109|450841145|FG000|Overall Study|Decision by Sponsor|0|||
125330117|NCT03853109|450841146|FG001|Overall Study|Decision by Sponsor|0|||
125330118|NCT03853109|450841147|FG002|Overall Study|Decision by Sponsor|1|||
125330119|NCT03853109|450841148|FG003|Overall Study|Decision by Sponsor|0|||
124999899|NCT03808688|449628272|FG001|Overall Study|Lost to Follow-up|2|||
125330120|NCT03853109|450841149|FG004|Overall Study|Decision by Sponsor|1|||
125330121|NCT03853109|450841150|FG005|Overall Study|Decision by Sponsor|1|||
125330122|NCT03853109|450841151|FG006|Overall Study|Decision by Sponsor|10|||
124999900|NCT03808688|449628271|FG000|Overall Study|Withdrawal by Subject|1|||
124999901|NCT03808688|449628272|FG001|Overall Study|Withdrawal by Subject|0|||
124999902|NCT03808688|449628271|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
124999903|NCT03808688|449628272|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
124999904|NCT03808688|449628271|FG000|Overall Study|IOP Too High|1|||
124999905|NCT03808688|449628272|FG001|Overall Study|IOP Too High|1|||
124999906|NCT03808688|449628271|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
124999907|NCT03808688|449628272|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
124999908|NCT03808688|449628271|FG000|Overall Study|Visit Out of Window|0|||
124999909|NCT03808688|449628272|FG001|Overall Study|Visit Out of Window|1|||
124999910|NCT03808688|449628271|FG000|Overall Study|Medication Non-Compliance|0|||
124999911|NCT03808688|449628272|FG001|Overall Study|Medication Non-Compliance|1|||
124999912|NCT03329196|449628273|FG000|Overall Study|Adverse Event|10|||
124999913|NCT03329196|449628274|FG001|Overall Study|Adverse Event|5|||
124999914|NCT03329196|449628273|FG000|Overall Study|Physician Decision|2|||
124999915|NCT03329196|449628274|FG001|Overall Study|Physician Decision|2|||
124999916|NCT03329196|449628273|FG000|Overall Study|Withdrawal by Subject|11|||
124999917|NCT03329196|449628274|FG001|Overall Study|Withdrawal by Subject|3|||
124999918|NCT03329196|449628273|FG000|Overall Study|Hepatic function abnormalities|0|||
124999919|NCT03329196|449628274|FG001|Overall Study|Hepatic function abnormalities|1|||
124999920|NCT03329196|449628273|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
124999921|NCT03329196|449628274|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
124999922|NCT03329196|449628273|FG000|Overall Study|Difficult to control Hb|2|||
124999923|NCT03329196|449628274|FG001|Overall Study|Difficult to control Hb|3|||
124999924|NCT03329196|449628273|FG000|Overall Study|Dialysis or renal transplant|13|||
124999925|NCT03329196|449628274|FG001|Overall Study|Dialysis or renal transplant|15|||
124999926|NCT02021292|449628278|FG000|Overall Study|Physician Decision|0|||
124999927|NCT02021292|449628279|FG001|Overall Study|Physician Decision|1|||
124999928|NCT02021292|449628278|FG000|Overall Study|Lost to Follow-up|0|||
124999929|NCT02021292|449628279|FG001|Overall Study|Lost to Follow-up|1|||
124999930|NCT02021292|449628278|FG000|Overall Study|Death|0|||
124999931|NCT02021292|449628279|FG001|Overall Study|Death|1|||
124999932|NCT04147234|449628280|FG000|Overall Study|Clinical deterioration|0|||
124999933|NCT04147234|449628281|FG001|Overall Study|Clinical deterioration|0|||
124999934|NCT04147234|449628282|FG002|Overall Study|Clinical deterioration|1|||
124999935|NCT04147234|449628283|FG003|Overall Study|Clinical deterioration|0|||
124999936|NCT04147234|449628284|FG004|Overall Study|Clinical deterioration|0|||
124999937|NCT04147234|449628285|FG005|Overall Study|Clinical deterioration|0|||
124999938|NCT04147234|449628286|FG006|Overall Study|Clinical deterioration|0|||
124999939|NCT04147234|449628280|FG000|Overall Study|Withdrawal by Subject|0|||
124999940|NCT04147234|449628281|FG001|Overall Study|Withdrawal by Subject|1|||
124999941|NCT04147234|449628282|FG002|Overall Study|Withdrawal by Subject|1|||
124999942|NCT04147234|449628283|FG003|Overall Study|Withdrawal by Subject|0|||
124999943|NCT04147234|449628284|FG004|Overall Study|Withdrawal by Subject|0|||
124999944|NCT04147234|449628285|FG005|Overall Study|Withdrawal by Subject|0|||
124999945|NCT04147234|449628286|FG006|Overall Study|Withdrawal by Subject|0|||
124999946|NCT04147234|449628280|FG000|Overall Study|Clinical disease progression|1|||
124999947|NCT04147234|449628281|FG001|Overall Study|Clinical disease progression|3|||
124999948|NCT04147234|449628282|FG002|Overall Study|Clinical disease progression|1|||
124999949|NCT04147234|449628283|FG003|Overall Study|Clinical disease progression|1|||
124999950|NCT04147234|449628284|FG004|Overall Study|Clinical disease progression|0|||
124999951|NCT04147234|449628285|FG005|Overall Study|Clinical disease progression|1|||
124999952|NCT04147234|449628286|FG006|Overall Study|Clinical disease progression|0|||
124999953|NCT04147234|449628280|FG000|Overall Study|Objective disease progression|6|||
124999954|NCT04147234|449628281|FG001|Overall Study|Objective disease progression|4|||
124999955|NCT04147234|449628282|FG002|Overall Study|Objective disease progression|3|||
124999956|NCT04147234|449628283|FG003|Overall Study|Objective disease progression|3|||
124999957|NCT04147234|449628284|FG004|Overall Study|Objective disease progression|5|||
124999958|NCT04147234|449628285|FG005|Overall Study|Objective disease progression|2|||
124999959|NCT04147234|449628286|FG006|Overall Study|Objective disease progression|3|||
124999960|NCT04147234|449628280|FG000|Overall Study|Adverse Event|0|||
124999961|NCT04147234|449628281|FG001|Overall Study|Adverse Event|0|||
124999962|NCT04147234|449628282|FG002|Overall Study|Adverse Event|0|||
124999963|NCT04147234|449628283|FG003|Overall Study|Adverse Event|0|||
124999964|NCT04147234|449628284|FG004|Overall Study|Adverse Event|1|||
124999965|NCT04147234|449628285|FG005|Overall Study|Adverse Event|0|||
124999966|NCT04147234|449628286|FG006|Overall Study|Adverse Event|0|||
124999967|NCT05972733|449628288|FG000|Overall Study|Lost to Follow-up|2|||
124999968|NCT05972733|449628288|FG000|Overall Study|Withdrawal by Subject|1|||
125330123|NCT03853109|450841152|FG007|Overall Study|Decision by Sponsor|2|||
125330124|NCT03853109|450841145|FG000|Overall Study|Lost to Follow-up|0|||
124999969|NCT04982588|449628291|FG000|Overall Study|Withdrawal by Subject|2|||
125330125|NCT03853109|450841146|FG001|Overall Study|Lost to Follow-up|0|||
125330126|NCT03853109|450841147|FG002|Overall Study|Lost to Follow-up|0|||
125330127|NCT03853109|450841148|FG003|Overall Study|Lost to Follow-up|0|||
125330128|NCT03853109|450841149|FG004|Overall Study|Lost to Follow-up|1|||
125330129|NCT03853109|450841150|FG005|Overall Study|Lost to Follow-up|3|||
124999970|NCT02366728|449628292|FG000|Overall Study|Death|0|||
124999971|NCT02366728|449628293|FG001|Overall Study|Death|0|||
124999972|NCT02366728|449628294|FG002|Overall Study|Death|1|||
124999973|NCT02366728|449628292|FG000|Overall Study|Adverse Event|1|||
124999974|NCT02366728|449628293|FG001|Overall Study|Adverse Event|0|||
124999975|NCT02366728|449628294|FG002|Overall Study|Adverse Event|0|||
124999976|NCT02366728|449628292|FG000|Overall Study|Screen Failure|2|||
124999977|NCT02366728|449628293|FG001|Overall Study|Screen Failure|1|||
124999978|NCT02366728|449628294|FG002|Overall Study|Screen Failure|0|||
124999979|NCT02366728|449628292|FG000|Overall Study|Only yielded 2 vaccines|1|||
124999980|NCT02366728|449628293|FG001|Overall Study|Only yielded 2 vaccines|0|||
124999981|NCT02366728|449628294|FG002|Overall Study|Only yielded 2 vaccines|0|||
124999982|NCT00992511|449628296|FG000|Overall Study|Migrated/moved from study area|1|||
124999983|NCT00992511|449628297|FG001|Overall Study|Migrated/moved from study area|0|||
124999984|NCT00992511|449628298|FG002|Overall Study|Migrated/moved from study area|1|||
124999985|NCT00992511|449628299|FG003|Overall Study|Migrated/moved from study area|2|||
124999986|NCT00992511|449628296|FG000|Overall Study|Lost to Follow-up|1|||
124999987|NCT00992511|449628297|FG001|Overall Study|Lost to Follow-up|0|||
124999988|NCT00992511|449628298|FG002|Overall Study|Lost to Follow-up|0|||
124999989|NCT00992511|449628299|FG003|Overall Study|Lost to Follow-up|2|||
124999990|NCT00992511|449628296|FG000|Overall Study|Withdrawal by Subject|0|||
124999991|NCT00992511|449628297|FG001|Overall Study|Withdrawal by Subject|0|||
124999992|NCT00992511|449628298|FG002|Overall Study|Withdrawal by Subject|1|||
124999993|NCT00992511|449628299|FG003|Overall Study|Withdrawal by Subject|1|||
124999994|NCT04498169|449628300|FG000|Study Completion|Adverse Event|1|||
124999995|NCT04498169|449628301|FG001|Study Completion|Adverse Event|1|||
124999996|NCT02993523|449628302|FG000|Overall Study|Withdrew Consent|0|||
124999997|NCT02993523|449628303|FG001|Overall Study|Withdrew Consent|0|||
124999998|NCT02993523|449628304|FG002|Overall Study|Withdrew Consent|2|||
124999999|NCT02993523|449628305|FG003|Overall Study|Withdrew Consent|9|||
125000000|NCT02993523|449628306|FG004|Overall Study|Withdrew Consent|0|||
125000001|NCT02993523|449628302|FG000|Overall Study|Lost to Follow-up|0|||
125000002|NCT02993523|449628303|FG001|Overall Study|Lost to Follow-up|0|||
125000003|NCT02993523|449628304|FG002|Overall Study|Lost to Follow-up|3|||
125000004|NCT02993523|449628305|FG003|Overall Study|Lost to Follow-up|6|||
125000005|NCT02993523|449628306|FG004|Overall Study|Lost to Follow-up|0|||
125000006|NCT02993523|449628302|FG000|Overall Study|Death|1|||
125000007|NCT02993523|449628303|FG001|Overall Study|Death|1|||
125000008|NCT02993523|449628304|FG002|Overall Study|Death|138|||
125000009|NCT02993523|449628305|FG003|Overall Study|Death|222|||
125000010|NCT02993523|449628306|FG004|Overall Study|Death|6|||
125000011|NCT02993523|449628302|FG000|Overall Study|Reason not Specified|0|||
125000012|NCT02993523|449628303|FG001|Overall Study|Reason not Specified|0|||
125000013|NCT02993523|449628304|FG002|Overall Study|Reason not Specified|1|||
125000014|NCT02993523|449628305|FG003|Overall Study|Reason not Specified|1|||
125000015|NCT02993523|449628306|FG004|Overall Study|Reason not Specified|0|||
125000016|NCT03694418|449628307|FG000|Overall Study|Lost to Follow-up|115|||
125000017|NCT03694418|449628308|FG001|Overall Study|Lost to Follow-up|23|||
125000018|NCT03694418|449628309|FG002|Overall Study|Lost to Follow-up|12|||
125000019|NCT03694418|449628310|FG003|Overall Study|Lost to Follow-up|12|||
125000020|NCT03694418|449628311|FG004|Overall Study|Lost to Follow-up|13|||
125000021|NCT05560763|449628315|FG000|Overall Study|Withdrawal by Subject|4|||
125000022|NCT02673619|449628316|FG000|Overall Study|Lost to Follow-up|1|||
125000023|NCT02673619|449628317|FG001|Overall Study|Lost to Follow-up|0|||
125000024|NCT02673619|449628318|FG002|Overall Study|Lost to Follow-up|0|||
125330130|NCT03853109|450841151|FG006|Overall Study|Lost to Follow-up|0|||
125330131|NCT03853109|450841152|FG007|Overall Study|Lost to Follow-up|0|||
125330132|NCT03853109|450841145|FG000|Overall Study|Death|2|||
125000025|NCT02673619|449628319|FG003|Overall Study|Lost to Follow-up|0|||
125000026|NCT02673619|449628316|FG000|Overall Study|Withdrawal by Subject|1|||
125000027|NCT02673619|449628317|FG001|Overall Study|Withdrawal by Subject|1|||
125000028|NCT02673619|449628318|FG002|Overall Study|Withdrawal by Subject|1|||
125330133|NCT03853109|450841146|FG001|Overall Study|Death|5|||
125000029|NCT02673619|449628319|FG003|Overall Study|Withdrawal by Subject|0|||
125000030|NCT02673619|449628316|FG000|Overall Study|Adverse Event|0|||
125000031|NCT02673619|449628317|FG001|Overall Study|Adverse Event|0|||
125000032|NCT02673619|449628318|FG002|Overall Study|Adverse Event|1|||
125000033|NCT02673619|449628319|FG003|Overall Study|Adverse Event|0|||
125000034|NCT02673619|449628316|FG000|Overall Study|Lack of Efficacy|0|||
125000035|NCT02673619|449628317|FG001|Overall Study|Lack of Efficacy|0|||
125000036|NCT02673619|449628318|FG002|Overall Study|Lack of Efficacy|1|||
125000037|NCT02673619|449628319|FG003|Overall Study|Lack of Efficacy|0|||
125000038|NCT04225806|449628320|FG000|Overall Study|Trial termination|15|||
125000039|NCT02408861|449628323|FG000|Overall Study|Death|0|||
125000040|NCT02408861|449628324|FG001|Overall Study|Death|3|||
125330134|NCT03853109|450841147|FG002|Overall Study|Death|8|||
125000041|NCT02408861|449628325|FG002|Overall Study|Death|1|||
125000042|NCT02408861|449628326|FG003|Overall Study|Death|2|||
125000043|NCT02408861|449628327|FG004|Overall Study|Death|4|||
125000044|NCT02408861|449628328|FG005|Overall Study|Death|1|||
125000045|NCT02408861|449628329|FG006|Overall Study|Death|0|||
125000046|NCT02408861|449628323|FG000|Overall Study|Lost to Follow-up|0|||
125000047|NCT02408861|449628324|FG001|Overall Study|Lost to Follow-up|0|||
125000048|NCT02408861|449628325|FG002|Overall Study|Lost to Follow-up|1|||
125000049|NCT02408861|449628326|FG003|Overall Study|Lost to Follow-up|1|||
125000050|NCT02408861|449628327|FG004|Overall Study|Lost to Follow-up|4|||
125000051|NCT02408861|449628328|FG005|Overall Study|Lost to Follow-up|2|||
125000052|NCT02408861|449628329|FG006|Overall Study|Lost to Follow-up|1|||
125000053|NCT02408861|449628323|FG000|Overall Study|Disease Progression|0|||
125000054|NCT02408861|449628324|FG001|Overall Study|Disease Progression|0|||
125000055|NCT02408861|449628325|FG002|Overall Study|Disease Progression|1|||
125000056|NCT02408861|449628326|FG003|Overall Study|Disease Progression|0|||
125000057|NCT02408861|449628327|FG004|Overall Study|Disease Progression|3|||
125000058|NCT02408861|449628328|FG005|Overall Study|Disease Progression|1|||
125000059|NCT02408861|449628329|FG006|Overall Study|Disease Progression|1|||
125330135|NCT03853109|450841148|FG003|Overall Study|Death|10|||
125000060|NCT02408861|449628323|FG000|Overall Study|Adverse Event|1|||
125000061|NCT02408861|449628324|FG001|Overall Study|Adverse Event|0|||
125000062|NCT02408861|449628325|FG002|Overall Study|Adverse Event|1|||
125000063|NCT02408861|449628326|FG003|Overall Study|Adverse Event|0|||
125000064|NCT02408861|449628327|FG004|Overall Study|Adverse Event|2|||
125000065|NCT02408861|449628328|FG005|Overall Study|Adverse Event|0|||
125000066|NCT02408861|449628329|FG006|Overall Study|Adverse Event|0|||
125000067|NCT02408861|449628323|FG000|Overall Study|Physician Decision|1|||
125000068|NCT02408861|449628324|FG001|Overall Study|Physician Decision|1|||
125000069|NCT02408861|449628325|FG002|Overall Study|Physician Decision|1|||
125000070|NCT02408861|449628326|FG003|Overall Study|Physician Decision|0|||
125000071|NCT02408861|449628327|FG004|Overall Study|Physician Decision|0|||
125000072|NCT02408861|449628328|FG005|Overall Study|Physician Decision|1|||
125000073|NCT02408861|449628329|FG006|Overall Study|Physician Decision|0|||
125000074|NCT02408861|449628323|FG000|Overall Study|Protocol Violation|1|||
125000075|NCT02408861|449628324|FG001|Overall Study|Protocol Violation|0|||
125000076|NCT02408861|449628325|FG002|Overall Study|Protocol Violation|0|||
125000077|NCT02408861|449628326|FG003|Overall Study|Protocol Violation|0|||
125000078|NCT02408861|449628327|FG004|Overall Study|Protocol Violation|0|||
125000079|NCT02408861|449628328|FG005|Overall Study|Protocol Violation|0|||
125000080|NCT02408861|449628329|FG006|Overall Study|Protocol Violation|0|||
125000081|NCT02408861|449628323|FG000|Overall Study|Withdrawal by Subject|0|||
125000082|NCT02408861|449628324|FG001|Overall Study|Withdrawal by Subject|0|||
125000083|NCT02408861|449628325|FG002|Overall Study|Withdrawal by Subject|0|||
125000084|NCT02408861|449628326|FG003|Overall Study|Withdrawal by Subject|0|||
125000085|NCT02408861|449628327|FG004|Overall Study|Withdrawal by Subject|1|||
125000086|NCT02408861|449628328|FG005|Overall Study|Withdrawal by Subject|1|||
125000087|NCT02408861|449628329|FG006|Overall Study|Withdrawal by Subject|0|||
125000088|NCT02408861|449628323|FG000|Overall Study|Other Treatment|0|||
125000089|NCT02408861|449628324|FG001|Overall Study|Other Treatment|0|||
125000090|NCT02408861|449628325|FG002|Overall Study|Other Treatment|0|||
125000091|NCT02408861|449628326|FG003|Overall Study|Other Treatment|0|||
125000092|NCT02408861|449628327|FG004|Overall Study|Other Treatment|0|||
125000093|NCT02408861|449628328|FG005|Overall Study|Other Treatment|1|||
125000094|NCT02408861|449628329|FG006|Overall Study|Other Treatment|1|||
125000095|NCT07052682|449628330|FG000|Overall Study|Withdrawal by Subject|4|||
125000096|NCT03756350|449630043|FG000|Overall Study|Lost to Follow-up|1|||
125330136|NCT03853109|450841149|FG004|Overall Study|Death|3|||
125330137|NCT03853109|450841150|FG005|Overall Study|Death|20|||
125330138|NCT03853109|450841151|FG006|Overall Study|Death|10|||
125330139|NCT03853109|450841152|FG007|Overall Study|Death|5|||
125330140|NCT01721044|450841155|FG000|Treatment Period|Adverse Event|7|||
125330141|NCT01721044|450841156|FG001|Treatment Period|Adverse Event|7|||
125000097|NCT01096342|449630045|FG000|Overall Study|Protocol Violation|1|||
125000098|NCT03434353|449630046|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
125000099|NCT03434353|449630047|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
125000100|NCT03434353|449630048|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
125000101|NCT03434353|449630049|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
125000102|NCT03434353|449630050|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
125000103|NCT03434353|449630046|FG000|Overall Study|Withdrew consent|1|||
125000104|NCT03434353|449630047|FG001|Overall Study|Withdrew consent|0|||
125000105|NCT03434353|449630048|FG002|Overall Study|Withdrew consent|3|||
125000106|NCT03434353|449630049|FG003|Overall Study|Withdrew consent|0|||
125000107|NCT03434353|449630050|FG004|Overall Study|Withdrew consent|0|||
125000108|NCT03434353|449630046|FG000|Overall Study|Adverse Event|1|||
125000109|NCT03434353|449630047|FG001|Overall Study|Adverse Event|0|||
125330142|NCT01721044|450841157|FG002|Treatment Period|Adverse Event|10|||
125330143|NCT01721044|450841155|FG000|Treatment Period|Death|0|||
125000110|NCT03434353|449630048|FG002|Overall Study|Adverse Event|0|||
125330144|NCT01721044|450841156|FG001|Treatment Period|Death|0|||
125330145|NCT01721044|450841157|FG002|Treatment Period|Death|1|||
125330146|NCT01721044|450841155|FG000|Treatment Period|Lack of Efficacy|16|||
125330147|NCT01721044|450841156|FG001|Treatment Period|Lack of Efficacy|4|||
125330148|NCT01721044|450841157|FG002|Treatment Period|Lack of Efficacy|4|||
125330149|NCT01721044|450841155|FG000|Treatment Period|Lost to Follow-up|0|||
125330150|NCT01721044|450841156|FG001|Treatment Period|Lost to Follow-up|0|||
125330151|NCT01721044|450841157|FG002|Treatment Period|Lost to Follow-up|1|||
125330152|NCT01721044|450841155|FG000|Treatment Period|Physician Decision|1|||
125330153|NCT01721044|450841156|FG001|Treatment Period|Physician Decision|0|||
125000111|NCT03434353|449630049|FG003|Overall Study|Adverse Event|0|||
125000112|NCT03434353|449630050|FG004|Overall Study|Adverse Event|1|||
125000113|NCT03434353|449630046|FG000|Overall Study|Lost to Follow-up|2|||
125000114|NCT03434353|449630047|FG001|Overall Study|Lost to Follow-up|0|||
125000115|NCT03434353|449630048|FG002|Overall Study|Lost to Follow-up|0|||
125000116|NCT03434353|449630049|FG003|Overall Study|Lost to Follow-up|0|||
125000117|NCT03434353|449630050|FG004|Overall Study|Lost to Follow-up|0|||
125000118|NCT04906616|449630051|FG000|Overall Study|Divorce|3|||
125000119|NCT04906616|449630052|FG001|Overall Study|Divorce|2|||
125000120|NCT02464228|449630053|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
125000121|NCT02464228|449630054|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
125000122|NCT02464228|449630055|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
125000123|NCT02464228|449630056|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
125000124|NCT02464228|449630053|FG000|Overall Study|Physician Decision|2|||
125000125|NCT02464228|449630054|FG001|Overall Study|Physician Decision|0|||
125000126|NCT02464228|449630055|FG002|Overall Study|Physician Decision|1|||
125000127|NCT02464228|449630056|FG003|Overall Study|Physician Decision|0|||
125000128|NCT02464228|449630053|FG000|Overall Study|Miscellaneous|1|||
125000129|NCT02464228|449630054|FG001|Overall Study|Miscellaneous|0|||
125000130|NCT02464228|449630055|FG002|Overall Study|Miscellaneous|1|||
125000131|NCT02464228|449630056|FG003|Overall Study|Miscellaneous|0|||
125000132|NCT02464228|449630053|FG000|Overall Study|Adverse Event|9|||
125000133|NCT02464228|449630054|FG001|Overall Study|Adverse Event|0|||
125000134|NCT02464228|449630055|FG002|Overall Study|Adverse Event|3|||
125000135|NCT02464228|449630056|FG003|Overall Study|Adverse Event|0|||
125000136|NCT02464228|449630053|FG000|Overall Study|Withdrawal by Subject|1|||
125000137|NCT02464228|449630054|FG001|Overall Study|Withdrawal by Subject|1|||
125000138|NCT02464228|449630055|FG002|Overall Study|Withdrawal by Subject|1|||
125000139|NCT02464228|449630056|FG003|Overall Study|Withdrawal by Subject|0|||
125000140|NCT02464228|449630053|FG000|Overall Study|Disease Progression|22|||
125000141|NCT02464228|449630054|FG001|Overall Study|Disease Progression|12|||
125000142|NCT02464228|449630055|FG002|Overall Study|Disease Progression|5|||
125000143|NCT02464228|449630056|FG003|Overall Study|Disease Progression|2|||
125000144|NCT01990534|449630057|FG000|Overall Study|Death|22|||
125000145|NCT01990534|449630057|FG000|Overall Study|Progressive disease|3|||
125000146|NCT01990534|449630057|FG000|Overall Study|Protocol Violation|1|||
125000147|NCT01990534|449630057|FG000|Overall Study|Withdrawal of Informed Consent|2|||
125000148|NCT01990534|449630057|FG000|Overall Study|Symptomatic Deterioration|1|||
125000149|NCT01990534|449630057|FG000|Overall Study|Withdrawal by Subject|3|||
125000150|NCT01990534|449630057|FG000|Overall Study|Reason not Specified|2|||
125000151|NCT01990534|449630057|FG000|Overall Study|Lost to Follow-up|1|||
125000152|NCT00234494|449630058|FG000|Overall Study|Protocol Violation|2|||
125000153|NCT01521897|449630065|FG000|Overall Study|Protocol Violation|18|||
125000154|NCT01521897|449630065|FG000|Overall Study|Lost to Follow-up|5|||
125000155|NCT03308942|449630072|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
125000156|NCT03308942|449630073|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
125000157|NCT03308942|449630074|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
125000158|NCT03308942|449630075|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
125000159|NCT03308942|449630076|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
125000160|NCT03308942|449630072|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
125000161|NCT03308942|449630073|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
125000162|NCT03308942|449630074|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
125000163|NCT03308942|449630075|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
125000164|NCT03308942|449630076|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
125000165|NCT03308942|449630072|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
125000166|NCT03308942|449630073|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
125000167|NCT03308942|449630074|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
125000168|NCT03308942|449630075|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
125000169|NCT03308942|449630076|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
125000170|NCT03308942|449630072|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
125000171|NCT03308942|449630073|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
125000172|NCT03308942|449630074|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
125000173|NCT03308942|449630075|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
125330154|NCT01721044|450841157|FG002|Treatment Period|Physician Decision|2|||
125000174|NCT03308942|449630076|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
125000175|NCT03308942|449630072|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
125000176|NCT03308942|449630073|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
125000177|NCT03308942|449630074|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
125000178|NCT03308942|449630075|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
125000179|NCT03308942|449630076|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
125000180|NCT03308942|449630072|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
125000181|NCT03308942|449630073|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
125000182|NCT03308942|449630074|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
125000183|NCT03308942|449630075|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
125000184|NCT03308942|449630076|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
125000185|NCT03308942|449630072|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
125000186|NCT03308942|449630073|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
125000187|NCT03308942|449630074|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
125000188|NCT03308942|449630075|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
125000189|NCT03308942|449630076|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
125000190|NCT02194062|449630077|FG000|Overall Study|Lost to Follow-up|2|||
125000191|NCT02194062|449630078|FG001|Overall Study|Lost to Follow-up|2|||
125000192|NCT02194062|449630079|FG002|Overall Study|Lost to Follow-up|5|||
125000193|NCT02276872|449630080|FG000|Overall Study|Adverse Event|1|||
125000194|NCT02276872|449630081|FG001|Overall Study|Adverse Event|0|||
125000195|NCT02276872|449630082|FG002|Overall Study|Adverse Event|0|||
125000196|NCT00867113|449630085|FG000|Treatment Period|Adverse Event|15|||
125000197|NCT00867113|449630085|FG000|Treatment Period|Death|2|||
125000198|NCT00867113|449630085|FG000|Treatment Period|Withdrawal by Subject|19|||
125000199|NCT00867113|449630085|FG000|Treatment Period|Lost to Follow-up|3|||
125000200|NCT00867113|449630085|FG000|Treatment Period|Administrative problems|1|||
125000201|NCT00867113|449630085|FG000|Treatment Period|Disease progression/relapse|1|||
125000202|NCT00867113|449630085|FG000|Treatment Period|Protocol Violation|4|||
125000203|NCT00867113|449630085|FG000|Post Treatment After Survival Follow-up|Death|1|||
125000204|NCT00867113|449630085|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
125000205|NCT00867113|449630085|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
125000206|NCT00867113|449630085|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
125000207|NCT01387230|449630086|FG000|Overall Study|Adverse Event|0|||
125330155|NCT01721044|450841155|FG000|Treatment Period|Protocol Violation|1|||
125330156|NCT01721044|450841156|FG001|Treatment Period|Protocol Violation|0|||
125330157|NCT01721044|450841157|FG002|Treatment Period|Protocol Violation|0|||
125330158|NCT01721044|450841155|FG000|Treatment Period|Withdrawal by Subject|7|||
125330159|NCT01721044|450841156|FG001|Treatment Period|Withdrawal by Subject|6|||
125330160|NCT01721044|450841157|FG002|Treatment Period|Withdrawal by Subject|1|||
125330161|NCT04032093|450841158|FG000|Overall Study|Lost to Follow-up|7|||
125330162|NCT04032093|450841159|FG001|Overall Study|Lost to Follow-up|7|||
125330163|NCT04032093|450841160|FG002|Overall Study|Lost to Follow-up|6|||
125330164|NCT04032093|450841161|FG003|Overall Study|Lost to Follow-up|10|||
125330165|NCT04032093|450841162|FG004|Overall Study|Lost to Follow-up|13|||
125330166|NCT04032093|450841163|FG005|Overall Study|Lost to Follow-up|7|||
125330167|NCT04032093|450841164|FG006|Overall Study|Lost to Follow-up|7|||
125330168|NCT04032093|450841165|FG007|Overall Study|Lost to Follow-up|5|||
125330169|NCT04032093|450841166|FG008|Overall Study|Lost to Follow-up|9|||
125330170|NCT04032093|450841167|FG009|Overall Study|Lost to Follow-up|12|||
125330171|NCT04032093|450841158|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
125330172|NCT04032093|450841159|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
125330173|NCT04032093|450841160|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
125330174|NCT04032093|450841161|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
125330175|NCT04032093|450841162|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
125330176|NCT04032093|450841163|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
125330177|NCT04032093|450841164|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
125330178|NCT04032093|450841165|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
125330179|NCT04032093|450841166|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
125330180|NCT04032093|450841167|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
125330181|NCT04032093|450841158|FG000|Overall Study|Other|1|||
125330182|NCT04032093|450841159|FG001|Overall Study|Other|0|||
125330183|NCT04032093|450841160|FG002|Overall Study|Other|0|||
125330184|NCT04032093|450841161|FG003|Overall Study|Other|1|||
125330185|NCT04032093|450841162|FG004|Overall Study|Other|1|||
125330186|NCT04032093|450841163|FG005|Overall Study|Other|0|||
125330187|NCT04032093|450841164|FG006|Overall Study|Other|0|||
125330188|NCT04032093|450841165|FG007|Overall Study|Other|0|||
125330189|NCT04032093|450841166|FG008|Overall Study|Other|0|||
125330190|NCT04032093|450841167|FG009|Overall Study|Other|1|||
125330191|NCT04032093|450841158|FG000|Overall Study|Withdrawal by Subject|1|||
125330192|NCT04032093|450841159|FG001|Overall Study|Withdrawal by Subject|3|||
125330193|NCT04032093|450841160|FG002|Overall Study|Withdrawal by Subject|2|||
125330194|NCT04032093|450841161|FG003|Overall Study|Withdrawal by Subject|2|||
125330195|NCT04032093|450841162|FG004|Overall Study|Withdrawal by Subject|3|||
125330196|NCT04032093|450841163|FG005|Overall Study|Withdrawal by Subject|0|||
125000208|NCT01387230|449630087|FG001|Overall Study|Adverse Event|1|||
125000209|NCT01387230|449630088|FG002|Overall Study|Adverse Event|3|||
125000210|NCT01387230|449630086|FG000|Overall Study|Lack of Efficacy|8|||
125000211|NCT01387230|449630087|FG001|Overall Study|Lack of Efficacy|5|||
125000212|NCT01387230|449630088|FG002|Overall Study|Lack of Efficacy|4|||
125000213|NCT01387230|449630086|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
125000214|NCT01387230|449630087|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
125000215|NCT01387230|449630088|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
125000216|NCT01387230|449630086|FG000|Overall Study|Lost to Follow-up|0|||
125000217|NCT01387230|449630087|FG001|Overall Study|Lost to Follow-up|0|||
125000218|NCT01387230|449630088|FG002|Overall Study|Lost to Follow-up|1|||
125000219|NCT01387230|449630086|FG000|Overall Study|Withdrawal by Subject|4|||
125000220|NCT01387230|449630087|FG001|Overall Study|Withdrawal by Subject|1|||
125000221|NCT01387230|449630088|FG002|Overall Study|Withdrawal by Subject|0|||
125000222|NCT02066051|449630089|FG000|Overall Study|Subject developed active GVHD|1|||
125000223|NCT03027557|449630095|FG000|Overall Study|Adverse Event|1|||
125000224|NCT03027557|449630096|FG001|Overall Study|Adverse Event|0|||
125000225|NCT03027557|449630097|FG002|Overall Study|Adverse Event|0|||
125000226|NCT01610687|449630098|FG000|Overall Study|Lack of Efficacy|26|||
125000227|NCT01610687|449630098|FG000|Overall Study|Adverse Event|18|||
125000228|NCT01610687|449630098|FG000|Overall Study|Moved out of area|6|||
125000229|NCT01610687|449630098|FG000|Overall Study|Withdrawal by Subject|7|||
125000230|NCT01610687|449630098|FG000|Overall Study|Lost to Follow-up|4|||
125000231|NCT01610687|449630098|FG000|Overall Study|Symptom control without study medication|2|||
125330197|NCT04032093|450841164|FG006|Overall Study|Withdrawal by Subject|0|||
125330198|NCT04032093|450841165|FG007|Overall Study|Withdrawal by Subject|0|||
125330199|NCT04032093|450841166|FG008|Overall Study|Withdrawal by Subject|0|||
125330200|NCT04032093|450841167|FG009|Overall Study|Withdrawal by Subject|0|||
125330201|NCT04032093|450841158|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125330202|NCT04032093|450841159|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125330203|NCT04032093|450841160|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
125330204|NCT04032093|450841161|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
125330205|NCT04032093|450841162|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
125330206|NCT04032093|450841163|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
125330207|NCT04032093|450841164|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
125330208|NCT04032093|450841165|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
125330209|NCT04032093|450841166|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
125330210|NCT04032093|450841167|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
125330211|NCT04032093|450841158|FG000|Overall Study|Adverse Event|0|||
125330212|NCT04032093|450841159|FG001|Overall Study|Adverse Event|0|||
125330213|NCT04032093|450841160|FG002|Overall Study|Adverse Event|0|||
125330214|NCT04032093|450841161|FG003|Overall Study|Adverse Event|0|||
125330215|NCT04032093|450841162|FG004|Overall Study|Adverse Event|0|||
125330216|NCT04032093|450841163|FG005|Overall Study|Adverse Event|0|||
125330217|NCT04032093|450841164|FG006|Overall Study|Adverse Event|0|||
125330218|NCT04032093|450841165|FG007|Overall Study|Adverse Event|0|||
125330219|NCT04032093|450841166|FG008|Overall Study|Adverse Event|0|||
125330220|NCT04032093|450841167|FG009|Overall Study|Adverse Event|1|||
125330221|NCT04032093|450841158|FG000|Overall Study|Physician Decision|0|||
125330222|NCT04032093|450841159|FG001|Overall Study|Physician Decision|0|||
125330223|NCT04032093|450841160|FG002|Overall Study|Physician Decision|0|||
125330224|NCT04032093|450841161|FG003|Overall Study|Physician Decision|0|||
125330225|NCT04032093|450841162|FG004|Overall Study|Physician Decision|0|||
125330226|NCT04032093|450841163|FG005|Overall Study|Physician Decision|1|||
125330227|NCT04032093|450841164|FG006|Overall Study|Physician Decision|0|||
125330228|NCT04032093|450841165|FG007|Overall Study|Physician Decision|0|||
125330229|NCT04032093|450841166|FG008|Overall Study|Physician Decision|0|||
125330230|NCT04032093|450841167|FG009|Overall Study|Physician Decision|0|||
125330231|NCT01457703|450841172|FG000|Overall Study|Screen Failure|5|||
125330232|NCT01457703|450841173|FG001|Overall Study|Screen Failure|7|||
125330233|NCT01457703|450841172|FG000|Overall Study|Withdrawal by Subject|1|||
125330234|NCT01457703|450841173|FG001|Overall Study|Withdrawal by Subject|4|||
125330235|NCT02952820|450841174|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
125330236|NCT02952820|450841175|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
125330237|NCT02952820|450841176|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
125330238|NCT02952820|450841174|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
125330239|NCT02952820|450841175|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
125000232|NCT01610687|449630098|FG000|Overall Study|Unable to make journey|1|||
125000233|NCT01610687|449630098|FG000|Overall Study|Death|1|||
125000234|NCT01610687|449630098|FG000|Overall Study|Cannabis affecting job|1|||
125330240|NCT02952820|450841176|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
125330241|NCT02952820|450841174|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
125000235|NCT01610687|449630098|FG000|Overall Study|Felt more alter without study medication|1|||
125330242|NCT02952820|450841175|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
125000236|NCT03836807|449630099|FG000|Overall Study|Physician Decision|1|||
125000237|NCT03836807|449630100|FG001|Overall Study|Physician Decision|0|||
125000238|NCT02430051|449630101|FG000|Overall Study|Withdrawal by Subject|6|||
125000239|NCT02430051|449630102|FG001|Overall Study|Withdrawal by Subject|3|||
125000240|NCT02430051|449630101|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
125000241|NCT02430051|449630102|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
125000242|NCT02430051|449630101|FG000|Overall Study|Protocol Violation|1|||
125000243|NCT02430051|449630102|FG001|Overall Study|Protocol Violation|0|||
125000244|NCT02019420|449630104|FG000|Overall Study|Did not receive study drug|2|||
125000245|NCT02019420|449630105|FG001|Overall Study|Did not receive study drug|2|||
125000246|NCT02019420|449630104|FG000|Overall Study|Withdrawal by Subject|1|||
125000247|NCT02019420|449630105|FG001|Overall Study|Withdrawal by Subject|3|||
125000248|NCT02019420|449630104|FG000|Overall Study|At request of sponsor or investigator|0|||
125000249|NCT02019420|449630105|FG001|Overall Study|At request of sponsor or investigator|1|||
125000250|NCT02019420|449630104|FG000|Overall Study|Death|104|||
125000251|NCT02019420|449630105|FG001|Overall Study|Death|99|||
125000252|NCT02019420|449630104|FG000|Overall Study|Transferred to other care facility|1|||
125000253|NCT02019420|449630105|FG001|Overall Study|Transferred to other care facility|1|||
125000254|NCT02554903|449630108|FG000|Overall Study|Death|1|||
125000255|NCT02554903|449630109|FG001|Overall Study|Death|1|||
125000256|NCT02554903|449630108|FG000|Overall Study|Physician Decision|2|||
125000257|NCT02554903|449630109|FG001|Overall Study|Physician Decision|2|||
125000258|NCT02554903|449630108|FG000|Overall Study|Heart Transplant|1|||
125000259|NCT02554903|449630109|FG001|Overall Study|Heart Transplant|2|||
125000260|NCT02742766|449630110|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125000261|NCT02742766|449630111|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125000262|NCT02742766|449630112|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125000263|NCT02742766|449630113|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125000264|NCT02742766|449630114|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125000265|NCT02742766|449630115|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125000266|NCT02742766|449630116|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125000267|NCT02742766|449630117|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125000268|NCT02742766|449630118|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125000269|NCT02742766|449630119|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125000270|NCT02742766|449630120|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125000271|NCT02742766|449630121|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125000272|NCT02742766|449630122|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125000273|NCT02742766|449630123|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
125000274|NCT02742766|449630124|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125000275|NCT02742766|449630125|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125000276|NCT02742766|449630126|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125000277|NCT02742766|449630127|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125000278|NCT02742766|449630128|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125000279|NCT02742766|449630110|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
125000280|NCT02742766|449630111|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
125000281|NCT02742766|449630112|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
125000282|NCT02742766|449630113|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
125000283|NCT02742766|449630114|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
125000284|NCT02742766|449630115|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
125000285|NCT02742766|449630116|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
125000286|NCT02742766|449630117|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
125000287|NCT02742766|449630118|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
125000288|NCT02742766|449630119|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
125000289|NCT02742766|449630120|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
125000290|NCT02742766|449630121|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
125000291|NCT02742766|449630122|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
125000292|NCT02742766|449630123|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
125000293|NCT02742766|449630124|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
125000294|NCT02742766|449630125|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
125000295|NCT02742766|449630126|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
125000296|NCT02742766|449630127|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
125000297|NCT02742766|449630128|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
125000298|NCT00999713|449630129|FG000|Overall Study|Physician Decision|2|||
125330243|NCT02952820|450841176|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
125330244|NCT02952820|450841174|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
125000299|NCT00999713|449630130|FG001|Overall Study|Physician Decision|0|||
125000300|NCT03739437|449630134|FG000|Overall Study|Lost to Follow-up|2|||
125000301|NCT03739437|449630135|FG001|Overall Study|Lost to Follow-up|5|||
125330245|NCT02952820|450841175|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
125000302|NCT01395316|449630138|FG000|Overall Study|Lost to Follow-up|2|||
125000303|NCT01395316|449630138|FG000|Overall Study|poor MRI quality|1|||
125000304|NCT03359590|449630140|FG000|First Intervention|Withdrawal by Subject|1|||
125000305|NCT03359590|449630141|FG001|First Intervention|Withdrawal by Subject|1|||
125000306|NCT03359590|449630140|FG000|First Intervention|Protocol Violation|0|||
125000307|NCT03359590|449630141|FG001|First Intervention|Protocol Violation|1|||
125000308|NCT02846532|449630142|FG000|Overall Study|Lost to Follow-up|0|||
125000309|NCT02846532|449630143|FG001|Overall Study|Lost to Follow-up|1|||
125000310|NCT02846532|449630144|FG002|Overall Study|Lost to Follow-up|1|||
125000311|NCT02846532|449630142|FG000|Overall Study|Withdrawal by Subject|1|||
125000312|NCT02846532|449630143|FG001|Overall Study|Withdrawal by Subject|2|||
125000313|NCT02846532|449630144|FG002|Overall Study|Withdrawal by Subject|0|||
125000314|NCT03951220|449630145|FG000|Overall Study|Withdrawal by Subject|9|||
125000315|NCT03951220|449630146|FG001|Overall Study|Withdrawal by Subject|2|||
125000316|NCT03951220|449630147|FG002|Overall Study|Withdrawal by Subject|0|||
125000317|NCT06132425|449630148|FG000|Overall Study|Withdrawal by Subject|3|||
125000318|NCT06132425|449630149|FG001|Overall Study|Withdrawal by Subject|0|||
125000319|NCT06132425|449630148|FG000|Overall Study|Did not follow study instructions|0|||
125000320|NCT06132425|449630149|FG001|Overall Study|Did not follow study instructions|2|||
125000321|NCT06132425|449630148|FG000|Overall Study|Lost to Follow-up|3|||
125000322|NCT06132425|449630149|FG001|Overall Study|Lost to Follow-up|5|||
125000323|NCT04598477|449630151|FG000|Overall Study|Adverse Event|2|||
125000324|NCT04598477|449630152|FG001|Overall Study|Adverse Event|0|||
125000325|NCT04598477|449630151|FG000|Overall Study|Death|0|||
125000326|NCT04598477|449630152|FG001|Overall Study|Death|1|||
125000327|NCT04598477|449630151|FG000|Overall Study|Lost to Follow-up|1|||
125000328|NCT04598477|449630152|FG001|Overall Study|Lost to Follow-up|0|||
125000329|NCT04598477|449630151|FG000|Overall Study|Physician Decision|7|||
125000330|NCT04598477|449630152|FG001|Overall Study|Physician Decision|2|||
125000331|NCT04598477|449630151|FG000|Overall Study|Pregnancy|0|||
125000332|NCT04598477|449630152|FG001|Overall Study|Pregnancy|1|||
125000333|NCT04598477|449630151|FG000|Overall Study|Requires Prohibited Medication|0|||
125000334|NCT04598477|449630152|FG001|Overall Study|Requires Prohibited Medication|1|||
125000335|NCT04598477|449630151|FG000|Overall Study|Study Terminated by Sponsor|18|||
125000336|NCT04598477|449630152|FG001|Overall Study|Study Terminated by Sponsor|12|||
125000337|NCT04598477|449630151|FG000|Overall Study|Withdrawal by Subject|16|||
125000338|NCT04598477|449630152|FG001|Overall Study|Withdrawal by Subject|12|||
125000339|NCT04598477|449630151|FG000|Overall Study|Other|15|||
125000340|NCT04598477|449630152|FG001|Overall Study|Other|8|||
125000341|NCT01298518|449630156|FG000|Overall Study|Withdrawal by Subject|0|||
125000342|NCT01298518|449630157|FG001|Overall Study|Withdrawal by Subject|0|||
125000343|NCT01298518|449630158|FG002|Overall Study|Withdrawal by Subject|1|||
125000344|NCT01019980|449630159|FG000|Overall Study|Drug not available.|2|||
125000345|NCT01019980|449630160|FG001|Overall Study|Drug not available.|0|||
125000346|NCT02038920|449630174|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
125000347|NCT02038920|449630175|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
125000348|NCT02038920|449630176|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
125000349|NCT02038920|449630177|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
125000350|NCT02038920|449630178|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
125000351|NCT02038920|449630179|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
125000352|NCT02038920|449630174|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
125000353|NCT02038920|449630175|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
125000354|NCT02038920|449630176|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
125000355|NCT02038920|449630177|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
125000356|NCT02038920|449630178|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
125000357|NCT02038920|449630179|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
125000358|NCT02038920|449630174|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
125000359|NCT02038920|449630175|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
125000360|NCT02038920|449630176|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
125000361|NCT02038920|449630177|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
125330246|NCT02952820|450841176|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
125330247|NCT02952820|450841174|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
125330248|NCT02952820|450841175|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
125000362|NCT02038920|449630178|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
125000363|NCT02038920|449630179|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
125000364|NCT02038920|449630174|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
125000365|NCT02038920|449630175|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
125000366|NCT02038920|449630176|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
125000367|NCT02038920|449630177|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
125000368|NCT02038920|449630178|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
125000369|NCT02038920|449630179|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
125000370|NCT02038920|449630174|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
125000371|NCT02038920|449630175|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
125000372|NCT02038920|449630176|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
125000373|NCT02038920|449630177|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
125000374|NCT02038920|449630178|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
125000375|NCT02038920|449630179|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
125000376|NCT02038920|449630174|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
125000377|NCT02038920|449630175|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
125000378|NCT02038920|449630176|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
125000379|NCT02038920|449630177|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
125000380|NCT02038920|449630178|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
125000381|NCT02038920|449630179|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
125000382|NCT02038920|449630174|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
125000383|NCT02038920|449630175|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
125000384|NCT02038920|449630176|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
125000385|NCT02038920|449630177|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
125000386|NCT02038920|449630178|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
125000387|NCT02038920|449630179|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
125000388|NCT02038920|449630174|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
125330249|NCT02952820|450841176|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
125330250|NCT02952820|450841174|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
125330251|NCT02952820|450841175|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
125330252|NCT02952820|450841176|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
125330253|NCT02952820|450841174|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
125330254|NCT02952820|450841175|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
125330255|NCT02952820|450841176|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
125330256|NCT02952820|450841174|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
125330257|NCT02952820|450841175|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
125330258|NCT02952820|450841176|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
125330259|NCT02952820|450841174|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
125330260|NCT02952820|450841175|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
125330261|NCT02952820|450841176|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
125330262|NCT02952820|450841174|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
125330263|NCT02952820|450841175|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
125330264|NCT02952820|450841176|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
125330265|NCT02952820|450841174|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
125000389|NCT02038920|449630175|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
125330266|NCT02952820|450841175|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
125330267|NCT02952820|450841176|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
125330268|NCT02952820|450841174|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
125330269|NCT02952820|450841175|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
125330270|NCT02952820|450841176|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
125330271|NCT02952820|450841174|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
125330272|NCT02952820|450841175|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
125330273|NCT02952820|450841176|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
125330274|NCT02952820|450841174|FG000|Active Treatment Period (6 Months)|Not treated|0|||
125330275|NCT02952820|450841175|FG001|Active Treatment Period (6 Months)|Not treated|0|||
125330276|NCT02952820|450841176|FG002|Active Treatment Period (6 Months)|Not treated|1|||
125330277|NCT04139018|450841177|FG000|Overall Study|Screen fail|1|||
125330278|NCT04139018|450841178|FG001|Overall Study|Screen fail|0|||
125000390|NCT02038920|449630176|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
125000391|NCT02038920|449630177|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
125000392|NCT02038920|449630178|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
125000393|NCT02038920|449630179|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
125000394|NCT02038920|449630174|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
125000395|NCT02038920|449630175|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
125000396|NCT02038920|449630176|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
125000397|NCT02038920|449630177|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
125000398|NCT02038920|449630178|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
125000399|NCT02038920|449630179|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
125000400|NCT02038920|449630174|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
125000401|NCT02038920|449630175|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
125000402|NCT02038920|449630176|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
125000403|NCT02038920|449630177|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
125000404|NCT02038920|449630178|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
125330279|NCT04139018|450841177|FG000|Overall Study|Withdrawal by Subject|2|||
125330280|NCT04139018|450841178|FG001|Overall Study|Withdrawal by Subject|0|||
125000405|NCT02038920|449630179|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
125000406|NCT02038920|449630174|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
125330281|NCT04139018|450841177|FG000|Overall Study|Lost to Follow-up|0|||
125330282|NCT04139018|450841178|FG001|Overall Study|Lost to Follow-up|1|||
125330283|NCT03486834|450841179|FG000|Overall Study|Withdrawal by Subject|46|||
125330284|NCT03486834|450841180|FG001|Overall Study|Withdrawal by Subject|46|||
125330285|NCT03486834|450841181|FG002|Overall Study|Withdrawal by Subject|52|||
125330286|NCT03486834|450841179|FG000|Overall Study|Adverse Event|8|||
125330287|NCT03486834|450841180|FG001|Overall Study|Adverse Event|7|||
125330288|NCT03486834|450841181|FG002|Overall Study|Adverse Event|0|||
125330289|NCT03486834|450841179|FG000|Overall Study|Lost to Follow-up|41|||
125330290|NCT03486834|450841180|FG001|Overall Study|Lost to Follow-up|24|||
125330291|NCT03486834|450841181|FG002|Overall Study|Lost to Follow-up|39|||
125330292|NCT03486834|450841179|FG000|Overall Study|Non-compliance with Study Drug|2|||
125330293|NCT03486834|450841180|FG001|Overall Study|Non-compliance with Study Drug|2|||
125330294|NCT03486834|450841181|FG002|Overall Study|Non-compliance with Study Drug|0|||
125330295|NCT03486834|450841179|FG000|Overall Study|Physician Decision|5|||
125330296|NCT03486834|450841180|FG001|Overall Study|Physician Decision|2|||
125330297|NCT03486834|450841181|FG002|Overall Study|Physician Decision|3|||
125330298|NCT03486834|450841179|FG000|Overall Study|Pregnancy|10|||
125330299|NCT03486834|450841180|FG001|Overall Study|Pregnancy|12|||
125330300|NCT03486834|450841181|FG002|Overall Study|Pregnancy|12|||
125330301|NCT03486834|450841179|FG000|Overall Study|Protocol Deviation|2|||
125330302|NCT03486834|450841180|FG001|Overall Study|Protocol Deviation|3|||
125330303|NCT03486834|450841181|FG002|Overall Study|Protocol Deviation|3|||
125330304|NCT03486834|450841179|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
125330305|NCT03486834|450841180|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
125330306|NCT03486834|450841181|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
125330307|NCT03486834|450841179|FG000|Overall Study|Randomized but not treated|4|||
125330308|NCT03486834|450841180|FG001|Overall Study|Randomized but not treated|4|||
125330309|NCT03486834|450841181|FG002|Overall Study|Randomized but not treated|1|||
125330310|NCT02745119|450841200|FG000|Overall Study|Adverse Event|1|||
125330311|NCT02745119|450841201|FG001|Overall Study|Adverse Event|0|||
125330312|NCT02745119|450841202|FG002|Overall Study|Adverse Event|1|||
125330313|NCT02745119|450841203|FG003|Overall Study|Adverse Event|3|||
125330314|NCT02745119|450841200|FG000|Overall Study|Death|3|||
125330315|NCT02745119|450841201|FG001|Overall Study|Death|3|||
125330316|NCT02745119|450841202|FG002|Overall Study|Death|0|||
125330317|NCT02745119|450841203|FG003|Overall Study|Death|4|||
125330318|NCT02745119|450841200|FG000|Overall Study|Lost to Follow-up|0|||
125330319|NCT02745119|450841201|FG001|Overall Study|Lost to Follow-up|0|||
125330320|NCT02745119|450841202|FG002|Overall Study|Lost to Follow-up|0|||
125330321|NCT02745119|450841203|FG003|Overall Study|Lost to Follow-up|1|||
125330322|NCT02745119|450841200|FG000|Overall Study|Protocol Deviation|0|||
125330323|NCT02745119|450841201|FG001|Overall Study|Protocol Deviation|0|||
125330324|NCT02745119|450841202|FG002|Overall Study|Protocol Deviation|0|||
125330325|NCT02745119|450841203|FG003|Overall Study|Protocol Deviation|1|||
125330326|NCT02745119|450841200|FG000|Overall Study|Withdrawal by Subject|7|||
125330327|NCT02745119|450841201|FG001|Overall Study|Withdrawal by Subject|15|||
125330328|NCT02745119|450841202|FG002|Overall Study|Withdrawal by Subject|8|||
125330329|NCT02745119|450841203|FG003|Overall Study|Withdrawal by Subject|14|||
125330330|NCT02745119|450841200|FG000|Overall Study|Study Terminated by Sponsor|134|||
125330331|NCT02745119|450841201|FG001|Overall Study|Study Terminated by Sponsor|252|||
125330332|NCT02745119|450841202|FG002|Overall Study|Study Terminated by Sponsor|135|||
125330333|NCT02745119|450841203|FG003|Overall Study|Study Terminated by Sponsor|251|||
125330334|NCT02745119|450841200|FG000|Overall Study|Physician Decision|0|||
125330335|NCT02745119|450841201|FG001|Overall Study|Physician Decision|2|||
125330336|NCT02745119|450841202|FG002|Overall Study|Physician Decision|2|||
125000407|NCT02038920|449630175|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
125000408|NCT02038920|449630176|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
125000409|NCT02038920|449630177|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
125000410|NCT02038920|449630178|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
125000411|NCT02038920|449630179|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
125000412|NCT02038920|449630174|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
125000413|NCT02038920|449630175|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
125000414|NCT02038920|449630176|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
125000415|NCT02038920|449630177|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
125000416|NCT02038920|449630178|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
125330337|NCT02745119|450841203|FG003|Overall Study|Physician Decision|2|||
125000417|NCT02038920|449630179|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
125330338|NCT02745119|450841200|FG000|Overall Study|Reason Not Specified|0|||
125330339|NCT02745119|450841201|FG001|Overall Study|Reason Not Specified|2|||
125330340|NCT02745119|450841202|FG002|Overall Study|Reason Not Specified|0|||
125330341|NCT02745119|450841203|FG003|Overall Study|Reason Not Specified|1|||
125330342|NCT01587924|450841204|FG000|Overall Study|Adverse Event|0|||
125330343|NCT01587924|450841205|FG001|Overall Study|Adverse Event|2|||
125330344|NCT01587924|450841206|FG002|Overall Study|Adverse Event|0|||
125330345|NCT01587924|450841207|FG003|Overall Study|Adverse Event|0|||
125330346|NCT01587924|450841204|FG000|Overall Study|Protocol Violation|2|||
125330347|NCT01587924|450841205|FG001|Overall Study|Protocol Violation|1|||
125330348|NCT01587924|450841206|FG002|Overall Study|Protocol Violation|2|||
125330349|NCT01587924|450841207|FG003|Overall Study|Protocol Violation|1|||
125330350|NCT01587924|450841204|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
125330351|NCT01587924|450841205|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
125330352|NCT01587924|450841206|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
125330353|NCT01587924|450841207|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
125330354|NCT01587924|450841204|FG000|Overall Study|Withdrawal by Subject|0|||
125330355|NCT01587924|450841205|FG001|Overall Study|Withdrawal by Subject|1|||
125330356|NCT01587924|450841206|FG002|Overall Study|Withdrawal by Subject|1|||
125330357|NCT01587924|450841207|FG003|Overall Study|Withdrawal by Subject|0|||
125330358|NCT00432172|450841208|FG000|Overall Study|Physician Decision|0|||
125330359|NCT00432172|450841209|FG001|Overall Study|Physician Decision|0|||
125330360|NCT00432172|450841210|FG002|Overall Study|Physician Decision|2|||
125330361|NCT00432172|450841211|FG003|Overall Study|Physician Decision|0|||
125330362|NCT00432172|450841208|FG000|Overall Study|Adverse Event|4|||
125330363|NCT00432172|450841209|FG001|Overall Study|Adverse Event|2|||
125330364|NCT00432172|450841210|FG002|Overall Study|Adverse Event|4|||
125330365|NCT00432172|450841211|FG003|Overall Study|Adverse Event|3|||
125330366|NCT00432172|450841208|FG000|Overall Study|Disease progression|0|||
125330367|NCT00432172|450841209|FG001|Overall Study|Disease progression|2|||
125000418|NCT02383589|449630181|FG000|Treatment Period|Adverse Event|1|||
125000419|NCT02383589|449630182|FG001|Treatment Period|Adverse Event|3|||
125000420|NCT02383589|449630181|FG000|Treatment Period|Lost to Follow-up|0|||
125000421|NCT02383589|449630182|FG001|Treatment Period|Lost to Follow-up|1|||
125000422|NCT02383589|449630181|FG000|Treatment Period|Withdrawal by Subject|0|||
125000423|NCT02383589|449630182|FG001|Treatment Period|Withdrawal by Subject|5|||
125000424|NCT02383589|449630181|FG000|Treatment Period|Non-compliance with study drug|0|||
125000425|NCT02383589|449630182|FG001|Treatment Period|Non-compliance with study drug|1|||
125000426|NCT02383589|449630181|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
125000427|NCT02383589|449630182|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
125000428|NCT02383589|449630181|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
125000429|NCT02383589|449630182|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
125000430|NCT02383589|449630181|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
125000431|NCT02383589|449630182|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
125000432|NCT00047320|449630183|FG000|Overall Study|Lack of Efficacy|8|||
125000433|NCT00047320|449630183|FG000|Overall Study|Lost to Follow-up|1|||
125000434|NCT00047320|449630183|FG000|Overall Study|Physician Decision|8|||
125000435|NCT00047320|449630183|FG000|Overall Study|Withdrawal by Subject|9|||
125000436|NCT00047320|449630183|FG000|Overall Study|Ineligible|2|||
125000437|NCT00866697|449630184|FG000|Overall Study|Study closed/terminated|156|||
125000438|NCT00866697|449630185|FG001|Overall Study|Study closed/terminated|138|||
125000439|NCT00866697|449630184|FG000|Overall Study|Lost to Follow-up|22|||
125000440|NCT00866697|449630185|FG001|Overall Study|Lost to Follow-up|28|||
125000441|NCT00866697|449630184|FG000|Overall Study|Physician Decision|3|||
125000442|NCT00866697|449630185|FG001|Overall Study|Physician Decision|5|||
125000443|NCT00866697|449630184|FG000|Overall Study|Withdrawal by Subject|33|||
125000444|NCT00866697|449630185|FG001|Overall Study|Withdrawal by Subject|57|||
125000445|NCT04376060|449630186|FG000|Overall Study|Physician Decision|1|||
125000446|NCT04275297|449630187|FG000|Overall Study|Lost to Follow-up|1|||
125000447|NCT04275297|449630188|FG001|Overall Study|Lost to Follow-up|1|||
125000448|NCT02818920|449630189|FG000|Overall Study|Unresectable|4|||
125000449|NCT02818920|449630189|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
125000450|NCT02818920|449630189|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
125000451|NCT02818920|449630189|FG000|Overall Study|Adverse Event|3|||
125000452|NCT02818920|449630189|FG000|Overall Study|Developed Other Disease|1|||
125000453|NCT02818920|449630189|FG000|Overall Study|Refused Further Treatment|1|||
125000454|NCT05460273|449630190|FG000|Overall Study|Death|43|||
125000455|NCT05460273|449630191|FG001|Overall Study|Death|9|||
125000456|NCT05460273|449630190|FG000|Overall Study|Lost to Follow-up|7|||
125000457|NCT05460273|449630191|FG001|Overall Study|Lost to Follow-up|0|||
125000458|NCT05460273|449630190|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
125000459|NCT05460273|449630191|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
125000460|NCT04890054|449631705|FG000|Overall Study|Lost to Follow-up|202|||
125000461|NCT04890054|449631706|FG001|Overall Study|Lost to Follow-up|219|||
125000462|NCT01940354|449631707|FG000|Overall Study|Withdrawal by Subject|4|||
125000463|NCT01940354|449631708|FG001|Overall Study|Withdrawal by Subject|2|||
125000464|NCT03872453|449631709|FG000|Overall Study|Adverse Event|1|||
125000465|NCT03872453|449631710|FG001|Overall Study|Adverse Event|1|||
125000466|NCT03872453|449631711|FG002|Overall Study|Adverse Event|0|||
125000467|NCT03872453|449631712|FG003|Overall Study|Adverse Event|0|||
125000468|NCT03872453|449631709|FG000|Overall Study|Lost to Follow-up|8|||
125000469|NCT03872453|449631710|FG001|Overall Study|Lost to Follow-up|7|||
125000470|NCT03872453|449631711|FG002|Overall Study|Lost to Follow-up|4|||
125330368|NCT00432172|450841210|FG002|Overall Study|Disease progression|5|||
125330369|NCT00432172|450841211|FG003|Overall Study|Disease progression|1|||
125330370|NCT00432172|450841208|FG000|Overall Study|Withdrawal by Subject|0|||
125330371|NCT00432172|450841209|FG001|Overall Study|Withdrawal by Subject|1|||
125000471|NCT03872453|449631712|FG003|Overall Study|Lost to Follow-up|4|||
125330372|NCT00432172|450841210|FG002|Overall Study|Withdrawal by Subject|0|||
125330373|NCT00432172|450841211|FG003|Overall Study|Withdrawal by Subject|2|||
125330374|NCT00432172|450841208|FG000|Overall Study|No treatment received|2|||
125330375|NCT00432172|450841209|FG001|Overall Study|No treatment received|2|||
125330376|NCT00432172|450841210|FG002|Overall Study|No treatment received|0|||
125330377|NCT00432172|450841211|FG003|Overall Study|No treatment received|1|||
125330378|NCT01106248|450841213|FG000|Overall Study|Adverse Event|1|||
125330379|NCT01106248|450841213|FG000|Overall Study|Administrative|2|||
125000472|NCT03872453|449631709|FG000|Overall Study|Never Treated Migraine|19|||
125000473|NCT03872453|449631710|FG001|Overall Study|Never Treated Migraine|17|||
125000474|NCT03872453|449631711|FG002|Overall Study|Never Treated Migraine|13|||
125000475|NCT03872453|449631712|FG003|Overall Study|Never Treated Migraine|12|||
125000476|NCT03872453|449631709|FG000|Overall Study|Pregnancy|1|||
125000477|NCT03872453|449631710|FG001|Overall Study|Pregnancy|0|||
125000478|NCT03872453|449631711|FG002|Overall Study|Pregnancy|0|||
125000479|NCT03872453|449631712|FG003|Overall Study|Pregnancy|0|||
125000480|NCT03872453|449631709|FG000|Overall Study|Protocol Deviation|2|||
125000481|NCT03872453|449631710|FG001|Overall Study|Protocol Deviation|0|||
125000482|NCT03872453|449631711|FG002|Overall Study|Protocol Deviation|0|||
125000483|NCT03872453|449631712|FG003|Overall Study|Protocol Deviation|2|||
125000484|NCT03872453|449631709|FG000|Overall Study|Withdrawal by Subject|0|||
125000485|NCT03872453|449631710|FG001|Overall Study|Withdrawal by Subject|1|||
125000486|NCT03872453|449631711|FG002|Overall Study|Withdrawal by Subject|2|||
125000487|NCT03872453|449631712|FG003|Overall Study|Withdrawal by Subject|0|||
125000488|NCT03872453|449631709|FG000|Overall Study|Other Than Specified|1|||
125000489|NCT03872453|449631710|FG001|Overall Study|Other Than Specified|0|||
125000490|NCT03872453|449631711|FG002|Overall Study|Other Than Specified|0|||
125000491|NCT03872453|449631712|FG003|Overall Study|Other Than Specified|0|||
125000492|NCT00352885|449631713|FG000|Overall Study|Withdrawal by Subject|0|||
125000493|NCT00352885|449631714|FG001|Overall Study|Withdrawal by Subject|3|||
125000494|NCT00352885|449631713|FG000|Overall Study|Development of major depression|0|||
125000495|NCT00352885|449631714|FG001|Overall Study|Development of major depression|1|||
125000496|NCT00352885|449631713|FG000|Overall Study|Progression of metastatic melanoma|5|||
125000497|NCT00352885|449631714|FG001|Overall Study|Progression of metastatic melanoma|3|||
125000498|NCT00352885|449631713|FG000|Overall Study|Side effects of IL-2 administration|1|||
125000499|NCT00352885|449631714|FG001|Overall Study|Side effects of IL-2 administration|0|||
125000500|NCT03873493|449631715|FG000|Overall Study|Withdrawal by Subject|1|||
125000501|NCT03873493|449631715|FG000|Overall Study|Death|9|||
125000502|NCT03873493|449631715|FG000|Overall Study|Lost to Follow-up|1|||
125000503|NCT03873493|449631715|FG000|Overall Study|Study Terminated by Sponsor|1|||
125000504|NCT03873493|449631715|FG000|Overall Study|Other|2|||
125000505|NCT00440700|449631719|FG000|Overall Study|Withdrawal by Subject|8|||
125000506|NCT00440700|449631720|FG001|Overall Study|Withdrawal by Subject|8|||
125000507|NCT00440700|449631721|FG002|Overall Study|Withdrawal by Subject|4|||
125000508|NCT01423812|449631722|FG000|Overall Study|Lost to Follow-up|2|||
125000509|NCT01423812|449631723|FG001|Overall Study|Lost to Follow-up|2|||
125000510|NCT01423812|449631722|FG000|Overall Study|Withdrawal by Subject|1|||
125000511|NCT01423812|449631723|FG001|Overall Study|Withdrawal by Subject|2|||
125000512|NCT01179672|449631724|FG000|Overall Study|Adverse Event|17|||
125000513|NCT01179672|449631725|FG001|Overall Study|Adverse Event|8|||
125000514|NCT01179672|449631724|FG000|Overall Study|Withdrawal by Subject|10|||
125000515|NCT01179672|449631725|FG001|Overall Study|Withdrawal by Subject|12|||
125000516|NCT01179672|449631724|FG000|Overall Study|Entry Criteria Not Met|0|||
125000517|NCT01179672|449631725|FG001|Overall Study|Entry Criteria Not Met|2|||
125000518|NCT01179672|449631724|FG000|Overall Study|Lost to Follow-up|0|||
125000519|NCT01179672|449631725|FG001|Overall Study|Lost to Follow-up|1|||
125000520|NCT01179672|449631724|FG000|Overall Study|Protocol Violation|2|||
125000521|NCT01179672|449631725|FG001|Overall Study|Protocol Violation|2|||
125330380|NCT00357903|450841214|FG000|Overall Study|Adverse Event|87|||
125330381|NCT00357903|450841215|FG001|Overall Study|Adverse Event|4|||
125000522|NCT01179672|449631724|FG000|Overall Study|Physician Decision|1|||
125000523|NCT01179672|449631725|FG001|Overall Study|Physician Decision|1|||
125000524|NCT02748018|449631728|FG000|Study Period|Adverse Event|1|||
125000525|NCT02748018|449631729|FG001|Study Period|Adverse Event|3|||
125000526|NCT02748018|449631730|FG002|Study Period|Adverse Event|4|||
125000527|NCT02748018|449631731|FG003|Study Period|Adverse Event|0|||
125000528|NCT02748018|449631732|FG004|Study Period|Adverse Event|3|||
125000529|NCT02748018|449631733|FG005|Study Period|Adverse Event|3|||
125000530|NCT02748018|449631728|FG000|Study Period|Withdrawal by Subject|7|||
125000531|NCT02748018|449631729|FG001|Study Period|Withdrawal by Subject|4|||
125000532|NCT02748018|449631730|FG002|Study Period|Withdrawal by Subject|4|||
125000533|NCT02748018|449631731|FG003|Study Period|Withdrawal by Subject|11|||
125000534|NCT02748018|449631732|FG004|Study Period|Withdrawal by Subject|12|||
125330382|NCT00357903|450841214|FG000|Overall Study|Death|33|||
125330383|NCT00357903|450841215|FG001|Overall Study|Death|0|||
125330384|NCT00357903|450841214|FG000|Overall Study|Lost to Follow-up|23|||
125000535|NCT02748018|449631733|FG005|Study Period|Withdrawal by Subject|10|||
125000536|NCT02748018|449631728|FG000|Study Period|Pregnancy|0|||
125000537|NCT02748018|449631729|FG001|Study Period|Pregnancy|1|||
125000538|NCT02748018|449631730|FG002|Study Period|Pregnancy|0|||
125000539|NCT02748018|449631731|FG003|Study Period|Pregnancy|0|||
125000540|NCT02748018|449631732|FG004|Study Period|Pregnancy|1|||
125000541|NCT02748018|449631733|FG005|Study Period|Pregnancy|0|||
125000542|NCT02748018|449631728|FG000|Study Period|Physician Decision|2|||
125000543|NCT02748018|449631729|FG001|Study Period|Physician Decision|2|||
125330385|NCT00357903|450841215|FG001|Overall Study|Lost to Follow-up|4|||
125330386|NCT00357903|450841214|FG000|Overall Study|Physician Decision|39|||
125330387|NCT00357903|450841215|FG001|Overall Study|Physician Decision|5|||
125330388|NCT00357903|450841214|FG000|Overall Study|Withdrawal by Subject|57|||
125330389|NCT00357903|450841215|FG001|Overall Study|Withdrawal by Subject|7|||
125330390|NCT00357903|450841214|FG000|Overall Study|Completed month 12 only|0|||
125330391|NCT00357903|450841215|FG001|Overall Study|Completed month 12 only|1|||
125330392|NCT00357903|450841214|FG000|Overall Study|Protocol issues|14|||
125330393|NCT00357903|450841215|FG001|Overall Study|Protocol issues|3|||
125330394|NCT00357903|450841214|FG000|Overall Study|Response status|61|||
125330395|NCT00357903|450841215|FG001|Overall Study|Response status|9|||
125330396|NCT00357903|450841214|FG000|Overall Study|Other|49|||
125330397|NCT00357903|450841215|FG001|Overall Study|Other|10|||
125330398|NCT00606593|450841216|FG000|Overall Study|Adverse Event|0|||
125330399|NCT00606593|450841217|FG001|Overall Study|Adverse Event|0|||
125330400|NCT00606593|450841218|FG002|Overall Study|Adverse Event|0|||
125330401|NCT00606593|450841219|FG003|Overall Study|Adverse Event|1|||
125330402|NCT00606593|450841220|FG004|Overall Study|Adverse Event|1|||
125330403|NCT00606593|450841221|FG005|Overall Study|Adverse Event|0|||
125330404|NCT00606593|450841222|FG006|Overall Study|Adverse Event|1|||
125330405|NCT00606593|450841223|FG007|Overall Study|Adverse Event|2|||
125330406|NCT00606593|450841224|FG008|Overall Study|Adverse Event|1|||
125330407|NCT00606593|450841225|FG009|Overall Study|Adverse Event|0|||
125330408|NCT00606593|450841216|FG000|Overall Study|Withdrawal of consent|1|||
125330409|NCT00606593|450841217|FG001|Overall Study|Withdrawal of consent|0|||
125330410|NCT00606593|450841218|FG002|Overall Study|Withdrawal of consent|1|||
125330411|NCT00606593|450841219|FG003|Overall Study|Withdrawal of consent|0|||
125330412|NCT00606593|450841220|FG004|Overall Study|Withdrawal of consent|0|||
125330413|NCT00606593|450841221|FG005|Overall Study|Withdrawal of consent|0|||
125330414|NCT00606593|450841222|FG006|Overall Study|Withdrawal of consent|0|||
125330415|NCT00606593|450841223|FG007|Overall Study|Withdrawal of consent|0|||
125330416|NCT00606593|450841224|FG008|Overall Study|Withdrawal of consent|0|||
125330417|NCT00606593|450841225|FG009|Overall Study|Withdrawal of consent|0|||
125330418|NCT00606593|450841216|FG000|Overall Study|Administrative/Other|0|||
125330419|NCT00606593|450841217|FG001|Overall Study|Administrative/Other|0|||
125330420|NCT00606593|450841218|FG002|Overall Study|Administrative/Other|1|||
125330421|NCT00606593|450841219|FG003|Overall Study|Administrative/Other|0|||
125330422|NCT00606593|450841220|FG004|Overall Study|Administrative/Other|0|||
125330423|NCT00606593|450841221|FG005|Overall Study|Administrative/Other|0|||
125330424|NCT00606593|450841222|FG006|Overall Study|Administrative/Other|0|||
125330425|NCT00606593|450841223|FG007|Overall Study|Administrative/Other|0|||
125330426|NCT00606593|450841224|FG008|Overall Study|Administrative/Other|0|||
125330427|NCT00606593|450841225|FG009|Overall Study|Administrative/Other|0|||
125330428|NCT03181529|450841228|FG000|Overall Study|Withdrawal by Subject|1|||
125330429|NCT03181529|450841229|FG001|Overall Study|Withdrawal by Subject|1|||
125330430|NCT03181529|450841228|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
125330431|NCT03181529|450841229|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
125330432|NCT06042855|450841236|FG000|Overall Study|No Receipt of Study Drug|48|||
125330433|NCT06042855|450841237|FG001|Overall Study|No Receipt of Study Drug|57|||
125330434|NCT06042855|450841236|FG000|Overall Study|Administratively Withdrawn|59|||
125000544|NCT02748018|449631730|FG002|Study Period|Physician Decision|1|||
125000545|NCT02748018|449631731|FG003|Study Period|Physician Decision|0|||
125000546|NCT02748018|449631732|FG004|Study Period|Physician Decision|2|||
125000547|NCT02748018|449631733|FG005|Study Period|Physician Decision|0|||
125000548|NCT02748018|449631728|FG000|Study Period|Lost to Follow-up|0|||
125000549|NCT02748018|449631729|FG001|Study Period|Lost to Follow-up|0|||
125000550|NCT02748018|449631730|FG002|Study Period|Lost to Follow-up|0|||
125000551|NCT02748018|449631731|FG003|Study Period|Lost to Follow-up|2|||
125000552|NCT02748018|449631732|FG004|Study Period|Lost to Follow-up|0|||
125000553|NCT02748018|449631733|FG005|Study Period|Lost to Follow-up|1|||
125000554|NCT02748018|449631728|FG000|Continuation Period|Adverse Event|2|||
125330435|NCT06042855|450841237|FG001|Overall Study|Administratively Withdrawn|59|||
125330436|NCT03313037|450841238|FG000|Overall Study|Protocol Violation|4|||
125000555|NCT02748018|449631729|FG001|Continuation Period|Adverse Event|0|||
125330437|NCT03313037|450841239|FG001|Overall Study|Protocol Violation|1|||
125000556|NCT02748018|449631730|FG002|Continuation Period|Adverse Event|1|||
125000557|NCT02748018|449631731|FG003|Continuation Period|Adverse Event|1|||
125000558|NCT02748018|449631732|FG004|Continuation Period|Adverse Event|1|||
125000559|NCT02748018|449631733|FG005|Continuation Period|Adverse Event|4|||
125000560|NCT02748018|449631728|FG000|Continuation Period|Withdrawal by Subject|3|||
125330438|NCT03313037|450841238|FG000|Overall Study|Other|1|||
125330439|NCT03313037|450841239|FG001|Overall Study|Other|1|||
125330440|NCT03313037|450841238|FG000|Overall Study|Withdrawal by Subject|4|||
125330441|NCT03313037|450841239|FG001|Overall Study|Withdrawal by Subject|3|||
125330442|NCT03313037|450841238|FG000|Overall Study|No longer meets eligibility criteria|1|||
125330443|NCT03313037|450841239|FG001|Overall Study|No longer meets eligibility criteria|7|||
125330444|NCT03313037|450841238|FG000|Overall Study|Lost to Follow-up|9|||
125330445|NCT03313037|450841239|FG001|Overall Study|Lost to Follow-up|8|||
125330446|NCT03313037|450841238|FG000|Overall Study|Randomized but not treated|1|||
125330447|NCT03313037|450841239|FG001|Overall Study|Randomized but not treated|0|||
125330448|NCT00525161|450841246|FG000|Overall Study|Adverse Event|1|||
125330449|NCT02447003|450841247|FG000|Overall Study|Other|0|||
125330450|NCT02447003|450841248|FG001|Overall Study|Other|4|||
125330451|NCT02447003|450841247|FG000|Overall Study|Site discontinued|0|||
125330452|NCT02447003|450841248|FG001|Overall Study|Site discontinued|2|||
125330453|NCT02447003|450841247|FG000|Overall Study|Physician Decision|0|||
125330454|NCT02447003|450841248|FG001|Overall Study|Physician Decision|1|||
125330455|NCT02447003|450841247|FG000|Overall Study|Withdrawal by Subject|4|||
125330456|NCT02447003|450841248|FG001|Overall Study|Withdrawal by Subject|3|||
125330457|NCT02447003|450841247|FG000|Overall Study|Sponsor Decision|6|||
125330458|NCT02447003|450841248|FG001|Overall Study|Sponsor Decision|11|||
125330459|NCT02447003|450841247|FG000|Overall Study|Progressive Disease|1|||
125330460|NCT02447003|450841248|FG001|Overall Study|Progressive Disease|0|||
125330461|NCT02447003|450841247|FG000|Overall Study|Lost to Follow-up|5|||
125330462|NCT02447003|450841248|FG001|Overall Study|Lost to Follow-up|0|||
125330463|NCT02447003|450841247|FG000|Overall Study|Death|154|||
125330464|NCT02447003|450841248|FG001|Overall Study|Death|63|||
125330465|NCT03848728|450841249|FG000|Overall Study|Death|16|||
125330466|NCT03848728|450841250|FG001|Overall Study|Death|13|||
125330467|NCT03848728|450841249|FG000|Overall Study|Outmigrated to non-study community|98|||
125330468|NCT03848728|450841250|FG001|Overall Study|Outmigrated to non-study community|106|||
125330469|NCT03848728|450841249|FG000|Overall Study|Transfered to non-study clinic|32|||
125330470|NCT03848728|450841250|FG001|Overall Study|Transfered to non-study clinic|48|||
125330471|NCT03848728|450841249|FG000|Overall Study|Withdrawal by Subject|1|||
125330472|NCT03848728|450841250|FG001|Overall Study|Withdrawal by Subject|0|||
125330473|NCT04161157|450841251|FG000|Overall Study|Lost to Follow-up|4|||
125330474|NCT04161157|450841251|FG000|Overall Study|Death|3|||
125330475|NCT04161157|450841251|FG000|Overall Study|Ineligible|2|||
125330476|NCT04161157|450841251|FG000|Overall Study|Withdrawal by Subject|4|||
125330477|NCT01108185|450841252|FG000|Overall Study|Non-compliance|15|||
125330478|NCT01108185|450841252|FG000|Overall Study|Lost to Follow-up|12|||
125330479|NCT02581410|450841253|FG000|Vaccination Phase|Adverse Event|2|||
125330480|NCT02581410|450841254|FG001|Vaccination Phase|Adverse Event|1|||
125330481|NCT02581410|450841253|FG000|Vaccination Phase|Withdrawal by Subject|0|||
125330482|NCT02581410|450841254|FG001|Vaccination Phase|Withdrawal by Subject|1|||
125330483|NCT02581410|450841253|FG000|Vaccination Phase|Migrated/moved from study area|0|||
125330484|NCT02581410|450841254|FG001|Vaccination Phase|Migrated/moved from study area|1|||
125330485|NCT02581410|450841253|FG000|End of Study Phase|Adverse Event|4|||
125330486|NCT02581410|450841254|FG001|End of Study Phase|Adverse Event|3|||
125330487|NCT02581410|450841253|FG000|End of Study Phase|Withdrawal by Subject|1|||
125330488|NCT02581410|450841254|FG001|End of Study Phase|Withdrawal by Subject|2|||
125330489|NCT02581410|450841253|FG000|End of Study Phase|Migrated/moved from study area|0|||
125330490|NCT02581410|450841254|FG001|End of Study Phase|Migrated/moved from study area|3|||
125330491|NCT02581410|450841253|FG000|End of Study Phase|Lost to Follow-up|0|||
125330492|NCT02581410|450841254|FG001|End of Study Phase|Lost to Follow-up|2|||
125330493|NCT02581410|450841253|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
125330494|NCT02581410|450841254|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
125330495|NCT06083506|450841260|FG000|Overall Study|Physician Decision|2|||
125330496|NCT06083506|450841260|FG000|Overall Study|Lack of Efficacy|1|||
125330497|NCT02000115|450841261|FG000|Overall Study|Death|56|||
125330498|NCT02000115|450841262|FG001|Overall Study|Death|45|||
125330499|NCT02000115|450841263|FG002|Overall Study|Death|0|||
125330500|NCT02000115|450841264|FG003|Overall Study|Death|0|||
125330501|NCT02000115|450841261|FG000|Overall Study|Missed Visit|6|||
125330502|NCT02000115|450841262|FG001|Overall Study|Missed Visit|8|||
125330503|NCT02000115|450841263|FG002|Overall Study|Missed Visit|1|||
125330504|NCT02000115|450841264|FG003|Overall Study|Missed Visit|0|||
125330505|NCT02000115|450841261|FG000|Overall Study|Protocol Violation|2|||
125330506|NCT02000115|450841262|FG001|Overall Study|Protocol Violation|1|||
125330507|NCT02000115|450841263|FG002|Overall Study|Protocol Violation|0|||
125330508|NCT02000115|450841264|FG003|Overall Study|Protocol Violation|0|||
125330509|NCT02000115|450841261|FG000|Overall Study|Physician Decision|2|||
125330510|NCT02000115|450841262|FG001|Overall Study|Physician Decision|0|||
125330511|NCT02000115|450841263|FG002|Overall Study|Physician Decision|0|||
125330512|NCT02000115|450841264|FG003|Overall Study|Physician Decision|0|||
125330513|NCT02000115|450841261|FG000|Overall Study|Withdrawal by Subject|11|||
125330514|NCT02000115|450841262|FG001|Overall Study|Withdrawal by Subject|11|||
125330515|NCT02000115|450841263|FG002|Overall Study|Withdrawal by Subject|0|||
125000561|NCT02748018|449631729|FG001|Continuation Period|Withdrawal by Subject|5|||
125000562|NCT02748018|449631730|FG002|Continuation Period|Withdrawal by Subject|3|||
125000563|NCT02748018|449631731|FG003|Continuation Period|Withdrawal by Subject|9|||
125000564|NCT02748018|449631732|FG004|Continuation Period|Withdrawal by Subject|11|||
125000565|NCT02748018|449631733|FG005|Continuation Period|Withdrawal by Subject|1|||
125000566|NCT02748018|449631728|FG000|Continuation Period|Lost to Follow-up|0|||
125000567|NCT02748018|449631729|FG001|Continuation Period|Lost to Follow-up|2|||
125000568|NCT02748018|449631730|FG002|Continuation Period|Lost to Follow-up|1|||
125000569|NCT02748018|449631731|FG003|Continuation Period|Lost to Follow-up|0|||
125000570|NCT02748018|449631732|FG004|Continuation Period|Lost to Follow-up|1|||
125000571|NCT02748018|449631733|FG005|Continuation Period|Lost to Follow-up|0|||
125000572|NCT02748018|449631728|FG000|Continuation Period|Pregnancy|1|||
125000573|NCT02748018|449631729|FG001|Continuation Period|Pregnancy|2|||
125000574|NCT02748018|449631730|FG002|Continuation Period|Pregnancy|0|||
125000575|NCT02748018|449631731|FG003|Continuation Period|Pregnancy|0|||
125000576|NCT02748018|449631732|FG004|Continuation Period|Pregnancy|0|||
125000577|NCT02748018|449631733|FG005|Continuation Period|Pregnancy|0|||
125000578|NCT02748018|449631728|FG000|Continuation Period|Physician Decision|0|||
125000579|NCT02748018|449631729|FG001|Continuation Period|Physician Decision|1|||
125000580|NCT02748018|449631730|FG002|Continuation Period|Physician Decision|2|||
125000581|NCT02748018|449631731|FG003|Continuation Period|Physician Decision|0|||
125000582|NCT02748018|449631732|FG004|Continuation Period|Physician Decision|2|||
125000583|NCT02748018|449631733|FG005|Continuation Period|Physician Decision|1|||
125000584|NCT02748018|449631728|FG000|Continuation Period|Protocol Violation|0|||
125000585|NCT02748018|449631729|FG001|Continuation Period|Protocol Violation|1|||
125000586|NCT02748018|449631730|FG002|Continuation Period|Protocol Violation|0|||
125000587|NCT02748018|449631731|FG003|Continuation Period|Protocol Violation|0|||
125000588|NCT02748018|449631732|FG004|Continuation Period|Protocol Violation|0|||
125000589|NCT02748018|449631733|FG005|Continuation Period|Protocol Violation|0|||
125000590|NCT02315898|449631734|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
125000591|NCT02315898|449631735|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
125000592|NCT02315898|449631736|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
125000593|NCT02315898|449631737|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
125000594|NCT00578786|449631747|FG000|Overall Study|Adverse Event|27|||
125000595|NCT00578786|449631748|FG001|Overall Study|Adverse Event|37|||
125000596|NCT00578786|449631749|FG002|Overall Study|Adverse Event|17|||
125000597|NCT00578786|449631747|FG000|Overall Study|Lack of Efficacy|2|||
125000598|NCT00578786|449631748|FG001|Overall Study|Lack of Efficacy|5|||
125000599|NCT00578786|449631749|FG002|Overall Study|Lack of Efficacy|2|||
125000600|NCT00578786|449631747|FG000|Overall Study|Early Escape from Prior Study|2|||
125000601|NCT00578786|449631748|FG001|Overall Study|Early Escape from Prior Study|1|||
125000602|NCT00578786|449631749|FG002|Overall Study|Early Escape from Prior Study|2|||
125000603|NCT00578786|449631747|FG000|Overall Study|Withdrawal by Subject|7|||
125000604|NCT00578786|449631748|FG001|Overall Study|Withdrawal by Subject|8|||
125000605|NCT00578786|449631749|FG002|Overall Study|Withdrawal by Subject|5|||
125000606|NCT00578786|449631747|FG000|Overall Study|Protocol Violation|0|||
125000607|NCT00578786|449631748|FG001|Overall Study|Protocol Violation|3|||
125000608|NCT00578786|449631749|FG002|Overall Study|Protocol Violation|1|||
125000609|NCT00578786|449631747|FG000|Overall Study|Physician Decision|1|||
125000610|NCT00578786|449631748|FG001|Overall Study|Physician Decision|0|||
125000611|NCT00578786|449631749|FG002|Overall Study|Physician Decision|1|||
125000612|NCT00578786|449631747|FG000|Overall Study|Sponsor Decision|0|||
125000613|NCT00578786|449631748|FG001|Overall Study|Sponsor Decision|0|||
125000614|NCT00578786|449631749|FG002|Overall Study|Sponsor Decision|1|||
125000615|NCT00578786|449631747|FG000|Overall Study|Lost to Follow-up|0|||
125000616|NCT00578786|449631748|FG001|Overall Study|Lost to Follow-up|4|||
125000617|NCT00578786|449631749|FG002|Overall Study|Lost to Follow-up|0|||
125000618|NCT00578786|449631747|FG000|Overall Study|Pregnancy|0|||
125000619|NCT00578786|449631748|FG001|Overall Study|Pregnancy|1|||
125000620|NCT00578786|449631749|FG002|Overall Study|Pregnancy|0|||
125000621|NCT00578786|449631747|FG000|Overall Study|Not Otherwise Specified|0|||
125330516|NCT02000115|450841264|FG003|Overall Study|Withdrawal by Subject|0|||
125330517|NCT02000115|450841261|FG000|Overall Study|Lost to Follow-up|0|||
125000622|NCT00578786|449631748|FG001|Overall Study|Not Otherwise Specified|4|||
125000623|NCT00578786|449631749|FG002|Overall Study|Not Otherwise Specified|1|||
125000624|NCT00578786|449631747|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
125000625|NCT00578786|449631748|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
125000626|NCT00578786|449631749|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
125000627|NCT05105789|449631750|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
125000628|NCT00323297|449631753|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
125000629|NCT00323297|449631754|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
125000630|NCT00323297|449631753|FG000|Part A (Double Blind Randomized)|Death|0|||
125000631|NCT00323297|449631754|FG001|Part A (Double Blind Randomized)|Death|1|||
125330518|NCT02000115|450841262|FG001|Overall Study|Lost to Follow-up|1|||
125000632|NCT00323297|449631753|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
125000633|NCT00323297|449631754|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
125000634|NCT00323297|449631753|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
125000635|NCT00323297|449631754|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
125000636|NCT00323297|449631753|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
125000637|NCT00323297|449631754|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
125000638|NCT00323297|449631753|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
125000639|NCT00323297|449631754|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
125000640|NCT00323297|449631753|FG000|Part B (Open-label)|Death|0|||
125000641|NCT00323297|449631754|FG001|Part B (Open-label)|Death|1|||
125000642|NCT00323297|449631753|FG000|Part B (Open-label)|Reason unspecified|0|||
125000643|NCT00323297|449631754|FG001|Part B (Open-label)|Reason unspecified|1|||
125000644|NCT00323297|449631753|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
125000645|NCT00323297|449631754|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
125000646|NCT00323297|449631753|FG000|Part B (Open-label)|Lack of Efficacy|3|||
125000647|NCT00323297|449631754|FG001|Part B (Open-label)|Lack of Efficacy|1|||
125000648|NCT00323297|449631753|FG000|Part B (Open-label)|Adverse Event|5|||
125000649|NCT00323297|449631754|FG001|Part B (Open-label)|Adverse Event|5|||
125000650|NCT00323297|449631753|FG000|Part B (Open-label)|Protocol Violation|0|||
125000651|NCT00323297|449631754|FG001|Part B (Open-label)|Protocol Violation|1|||
125000652|NCT01003990|449631755|FG000|Overall Study|Adverse Event|8|||
125000653|NCT01003990|449631756|FG001|Overall Study|Adverse Event|5|||
125000654|NCT01003990|449631757|FG002|Overall Study|Adverse Event|11|||
125000655|NCT01003990|449631755|FG000|Overall Study|Death|0|||
125000656|NCT01003990|449631756|FG001|Overall Study|Death|8|||
125000657|NCT01003990|449631757|FG002|Overall Study|Death|1|||
125000658|NCT01003990|449631755|FG000|Overall Study|Lack of Efficacy|10|||
125000659|NCT01003990|449631756|FG001|Overall Study|Lack of Efficacy|2|||
125000660|NCT01003990|449631757|FG002|Overall Study|Lack of Efficacy|3|||
125000661|NCT01003990|449631755|FG000|Overall Study|Lost to Follow-up|30|||
125000662|NCT01003990|449631756|FG001|Overall Study|Lost to Follow-up|12|||
125000663|NCT01003990|449631757|FG002|Overall Study|Lost to Follow-up|7|||
125000664|NCT01003990|449631755|FG000|Overall Study|Reasons Not Identified|14|||
125000665|NCT01003990|449631756|FG001|Overall Study|Reasons Not Identified|13|||
125000666|NCT01003990|449631757|FG002|Overall Study|Reasons Not Identified|8|||
125000667|NCT01003990|449631755|FG000|Overall Study|Poor/Non-compliance|4|||
125000668|NCT01003990|449631756|FG001|Overall Study|Poor/Non-compliance|3|||
125000669|NCT01003990|449631757|FG002|Overall Study|Poor/Non-compliance|2|||
125000670|NCT01003990|449631755|FG000|Overall Study|Pregnancy|10|||
125000671|NCT01003990|449631756|FG001|Overall Study|Pregnancy|2|||
125000672|NCT01003990|449631757|FG002|Overall Study|Pregnancy|4|||
125000673|NCT01003990|449631755|FG000|Overall Study|No Longer Met Study Criteria|4|||
125000674|NCT01003990|449631756|FG001|Overall Study|No Longer Met Study Criteria|1|||
125000675|NCT01003990|449631757|FG002|Overall Study|No Longer Met Study Criteria|0|||
125000676|NCT01003990|449631755|FG000|Overall Study|Subject Withdrew Consent|12|||
125000677|NCT01003990|449631756|FG001|Overall Study|Subject Withdrew Consent|5|||
125000678|NCT01003990|449631757|FG002|Overall Study|Subject Withdrew Consent|7|||
125000679|NCT00634010|449631762|FG000|Overall Study|Adverse Event|2|||
125000680|NCT00634010|449631763|FG001|Overall Study|Adverse Event|5|||
125000681|NCT00634010|449631762|FG000|Overall Study|Withdrawal by Subject|5|||
125000682|NCT00634010|449631763|FG001|Overall Study|Withdrawal by Subject|6|||
125000683|NCT00634010|449631762|FG000|Overall Study|Physician Decision|1|||
125000684|NCT00634010|449631763|FG001|Overall Study|Physician Decision|1|||
125000685|NCT00634010|449631762|FG000|Overall Study|Disease Progression|1|||
125000686|NCT00634010|449631763|FG001|Overall Study|Disease Progression|1|||
125000687|NCT00634010|449631762|FG000|Overall Study|Non-Compliant|1|||
125000688|NCT00634010|449631763|FG001|Overall Study|Non-Compliant|1|||
125000689|NCT00448435|449631769|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
125000690|NCT00448435|449631770|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
125000691|NCT01822522|449631771|FG000|Overall Study|Adverse Event|1|||
125000692|NCT01822522|449631772|FG001|Overall Study|Adverse Event|1|||
125000693|NCT01822522|449631773|FG002|Overall Study|Adverse Event|1|||
125000694|NCT01822522|449631774|FG003|Overall Study|Adverse Event|0|||
125330519|NCT02000115|450841263|FG002|Overall Study|Lost to Follow-up|0|||
125000695|NCT01822522|449631775|FG004|Overall Study|Adverse Event|0|||
125000696|NCT01822522|449631776|FG005|Overall Study|Adverse Event|1|||
125000697|NCT01822522|449631771|FG000|Overall Study|Death|3|||
125000698|NCT01822522|449631772|FG001|Overall Study|Death|0|||
125000699|NCT01822522|449631773|FG002|Overall Study|Death|2|||
125000700|NCT01822522|449631774|FG003|Overall Study|Death|0|||
125000701|NCT01822522|449631775|FG004|Overall Study|Death|0|||
125000702|NCT01822522|449631776|FG005|Overall Study|Death|0|||
125000703|NCT01822522|449631771|FG000|Overall Study|Lost to Follow-up|0|||
125000704|NCT01822522|449631772|FG001|Overall Study|Lost to Follow-up|0|||
125000705|NCT01822522|449631773|FG002|Overall Study|Lost to Follow-up|1|||
125000706|NCT01822522|449631774|FG003|Overall Study|Lost to Follow-up|1|||
125000707|NCT01822522|449631775|FG004|Overall Study|Lost to Follow-up|0|||
125000708|NCT01822522|449631776|FG005|Overall Study|Lost to Follow-up|1|||
125330520|NCT02000115|450841264|FG003|Overall Study|Lost to Follow-up|0|||
125330521|NCT02000115|450841261|FG000|Overall Study|Non-compliance|2|||
125330522|NCT02000115|450841262|FG001|Overall Study|Non-compliance|1|||
125330523|NCT02000115|450841263|FG002|Overall Study|Non-compliance|0|||
125330524|NCT02000115|450841264|FG003|Overall Study|Non-compliance|0|||
125330525|NCT02000115|450841261|FG000|Overall Study|Withdrawn on day of randomization|0|||
125330526|NCT02000115|450841262|FG001|Overall Study|Withdrawn on day of randomization|1|||
125330527|NCT02000115|450841263|FG002|Overall Study|Withdrawn on day of randomization|0|||
125330528|NCT02000115|450841264|FG003|Overall Study|Withdrawn on day of randomization|0|||
125330529|NCT02000115|450841261|FG000|Overall Study|Still on Study|0|||
125330530|NCT02000115|450841262|FG001|Overall Study|Still on Study|0|||
125330531|NCT02000115|450841263|FG002|Overall Study|Still on Study|0|||
125330532|NCT02000115|450841264|FG003|Overall Study|Still on Study|53|||
125330533|NCT03493464|450841269|FG000|Overall Study|Surgery not performed|1|||
125330534|NCT02374450|450841270|FG000|Overall Study|Protocol Violation|0|||
125330535|NCT02374450|450841271|FG001|Overall Study|Protocol Violation|1|||
125000709|NCT01822522|449631771|FG000|Overall Study|Withdrawal by Subject|0|||
125000710|NCT01822522|449631772|FG001|Overall Study|Withdrawal by Subject|0|||
125000711|NCT01822522|449631773|FG002|Overall Study|Withdrawal by Subject|0|||
125000712|NCT01822522|449631774|FG003|Overall Study|Withdrawal by Subject|1|||
125000713|NCT01822522|449631775|FG004|Overall Study|Withdrawal by Subject|0|||
125000714|NCT01822522|449631776|FG005|Overall Study|Withdrawal by Subject|0|||
125000715|NCT01822522|449631771|FG000|Overall Study|Lack of Efficacy|0|||
125330536|NCT02374450|450841272|FG002|Overall Study|Protocol Violation|0|||
125330537|NCT02374450|450841270|FG000|Overall Study|Withdrawal by Subject|91|||
125330538|NCT02374450|450841271|FG001|Overall Study|Withdrawal by Subject|110|||
125000716|NCT01822522|449631772|FG001|Overall Study|Lack of Efficacy|0|||
125000717|NCT01822522|449631773|FG002|Overall Study|Lack of Efficacy|0|||
125000718|NCT01822522|449631774|FG003|Overall Study|Lack of Efficacy|0|||
125000719|NCT01822522|449631775|FG004|Overall Study|Lack of Efficacy|0|||
125000720|NCT01822522|449631776|FG005|Overall Study|Lack of Efficacy|2|||
125000721|NCT00890929|449631777|FG000|Overall Study|Death before treatment|2|||
125000722|NCT00890929|449631777|FG000|Overall Study|Withdrawal by Subject|3|||
125000723|NCT00890929|449631777|FG000|Overall Study|Physician Decision|1|||
125000724|NCT01006265|449631780|FG000|Overall Study|Lost to Follow-up|1|||
125000725|NCT01006265|449631781|FG001|Overall Study|Lost to Follow-up|0|||
125000726|NCT01006265|449631782|FG002|Overall Study|Lost to Follow-up|1|||
125000727|NCT01006265|449631783|FG003|Overall Study|Lost to Follow-up|0|||
125000728|NCT01006265|449631780|FG000|Overall Study|Withdrawal by Subject|4|||
125000729|NCT01006265|449631781|FG001|Overall Study|Withdrawal by Subject|7|||
125000730|NCT01006265|449631782|FG002|Overall Study|Withdrawal by Subject|5|||
125000731|NCT01006265|449631783|FG003|Overall Study|Withdrawal by Subject|5|||
125000732|NCT01006265|449631780|FG000|Overall Study|Administrative reason|1|||
125000733|NCT01006265|449631781|FG001|Overall Study|Administrative reason|2|||
125000734|NCT01006265|449631782|FG002|Overall Study|Administrative reason|3|||
125000735|NCT01006265|449631783|FG003|Overall Study|Administrative reason|0|||
125000736|NCT01272947|449631784|FG000|Overall Study|Abnormal Laboratory Value|2|||
125000737|NCT01272947|449631785|FG001|Overall Study|Abnormal Laboratory Value|2|||
125000738|NCT02510560|449631788|FG000|Overall Study|Discontinued from Treatment|27|||
125000739|NCT02510560|449631789|FG001|Overall Study|Discontinued from Treatment|18|||
125000740|NCT02510560|449631790|FG002|Overall Study|Discontinued from Treatment|19|||
125000741|NCT02510560|449631788|FG000|Overall Study|Other|4|||
125000742|NCT02510560|449631789|FG001|Overall Study|Other|4|||
125000743|NCT02510560|449631790|FG002|Overall Study|Other|3|||
125000744|NCT00132496|449631791|FG000|Overall Study|Withdrawal by Subject|1|||
125000745|NCT00132496|449631792|FG001|Overall Study|Withdrawal by Subject|2|||
125000746|NCT00132496|449631791|FG000|Overall Study|Physician Decision|1|||
125000747|NCT00132496|449631792|FG001|Overall Study|Physician Decision|0|||
125000748|NCT01093625|449631797|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
125000749|NCT01093625|449631798|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
125000750|NCT01093625|449631797|FG000|2-Week Visit|Withdrawal by Subject|1|||
125000751|NCT01093625|449631798|FG001|2-Week Visit|Withdrawal by Subject|0|||
125000752|NCT01093625|449631797|FG000|1-Month Visit|Lost to Follow-up|2|||
125000753|NCT01093625|449631798|FG001|1-Month Visit|Lost to Follow-up|0|||
125000754|NCT01093625|449631797|FG000|3-Month Visit|Lost to Follow-up|2|||
125000755|NCT01093625|449631798|FG001|3-Month Visit|Lost to Follow-up|0|||
125330539|NCT02374450|450841272|FG002|Overall Study|Withdrawal by Subject|4|||
125330540|NCT02374450|450841270|FG000|Overall Study|Lost to Follow-up|168|||
125330541|NCT02374450|450841271|FG001|Overall Study|Lost to Follow-up|194|||
125330542|NCT02374450|450841272|FG002|Overall Study|Lost to Follow-up|138|||
125000756|NCT01093625|449631797|FG000|6-Month Visit|Withdrawal by Subject|6|||
125000757|NCT01093625|449631798|FG001|6-Month Visit|Withdrawal by Subject|7|||
125000758|NCT01093625|449631797|FG000|6-Month Visit|Lost to Follow-up|2|||
125000759|NCT01093625|449631798|FG001|6-Month Visit|Lost to Follow-up|2|||
125000760|NCT01093625|449631797|FG000|1-Year Visit|Lost to Follow-up|5|||
125000761|NCT01093625|449631798|FG001|1-Year Visit|Lost to Follow-up|3|||
125000762|NCT02014740|449631799|FG000|Overall Study|Lost to Follow-up|4|||
125000763|NCT02014740|449631800|FG001|Overall Study|Lost to Follow-up|4|||
125000764|NCT02014740|449631799|FG000|Overall Study|Withdrawal by Subject|2|||
125000765|NCT02014740|449631800|FG001|Overall Study|Withdrawal by Subject|1|||
125000766|NCT01431534|449631801|FG000|Treatment Phase|Adverse Event|0|||
125000767|NCT01431534|449631802|FG001|Treatment Phase|Adverse Event|0|||
125000768|NCT01431534|449631803|FG002|Treatment Phase|Adverse Event|1|||
125000769|NCT01431534|449631801|FG000|Treatment Phase|Progressive Disease|4|||
125000770|NCT01431534|449631802|FG001|Treatment Phase|Progressive Disease|3|||
125000771|NCT01431534|449631803|FG002|Treatment Phase|Progressive Disease|10|||
125000772|NCT04427501|449631806|FG000|Overall Study|Death|0|||
125000773|NCT04427501|449631807|FG001|Overall Study|Death|0|||
125000774|NCT04427501|449631808|FG002|Overall Study|Death|0|||
125000775|NCT04427501|449631809|FG003|Overall Study|Death|0|||
125000776|NCT04427501|449631810|FG004|Overall Study|Death|0|||
125000777|NCT04427501|449631811|FG005|Overall Study|Death|15|||
125000778|NCT04427501|449631812|FG006|Overall Study|Death|0|||
125000779|NCT04427501|449631813|FG007|Overall Study|Death|0|||
125000780|NCT04427501|449631814|FG008|Overall Study|Death|0|||
125000781|NCT04427501|449631815|FG009|Overall Study|Death|0|||
125000782|NCT04427501|449631816|FG010|Overall Study|Death|0|||
125000783|NCT04427501|449631817|FG011|Overall Study|Death|0|||
125330543|NCT02374450|450841270|FG000|Overall Study|Death|173|||
125330544|NCT02374450|450841271|FG001|Overall Study|Death|185|||
125330545|NCT02374450|450841272|FG002|Overall Study|Death|81|||
125330546|NCT02374450|450841270|FG000|Overall Study|Migrated from the study area|538|||
125330547|NCT02374450|450841271|FG001|Overall Study|Migrated from the study area|648|||
125330548|NCT02374450|450841272|FG002|Overall Study|Migrated from the study area|181|||
125330549|NCT02374450|450841270|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
125330550|NCT02374450|450841271|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
125330551|NCT02374450|450841272|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
125330552|NCT02374450|450841270|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
125330553|NCT02374450|450841271|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
125330554|NCT02374450|450841272|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
125330555|NCT02374450|450841270|FG000|Overall Study|Other|0|||
125330556|NCT02374450|450841271|FG001|Overall Study|Other|21|||
125330557|NCT02374450|450841272|FG002|Overall Study|Other|79|||
125330558|NCT04145349|450842568|FG000|Overall Study|Withdrawal by Subject|3|||
125330559|NCT04145349|450842569|FG001|Overall Study|Withdrawal by Subject|0|||
125330560|NCT04145349|450842568|FG000|Overall Study|Lost to Follow-up|0|||
125330561|NCT04145349|450842569|FG001|Overall Study|Lost to Follow-up|1|||
125330562|NCT04145349|450842568|FG000|Overall Study|On study treatment (Ongoing)|0|||
125330563|NCT04145349|450842569|FG001|Overall Study|On study treatment (Ongoing)|1|||
125330564|NCT01148979|450842570|FG000|Overall Study|Lost to Follow-up|0|||
125330565|NCT01148979|450842571|FG001|Overall Study|Lost to Follow-up|1|||
125330566|NCT01376804|450842572|FG000|Treatment Period|Withdrawal by Subject|1|||
125330567|NCT01376804|450842572|FG000|Treatment Period|Adverse Event|6|||
125330568|NCT01376804|450842572|FG000|Treatment Period|Patient did not receive study drug|1|||
125330569|NCT00882557|450842573|FG000|Overall Study|Withdrawal by Subject|1|||
125330570|NCT00882557|450842574|FG001|Overall Study|Withdrawal by Subject|0|||
125330571|NCT00882557|450842573|FG000|Overall Study|Trouble with Vein Access|1|||
125330572|NCT00882557|450842574|FG001|Overall Study|Trouble with Vein Access|0|||
125330573|NCT00882557|450842573|FG000|Overall Study|Randomized Not Treated|0|||
125330574|NCT00882557|450842574|FG001|Overall Study|Randomized Not Treated|1|||
125330575|NCT01383356|450842579|FG000|Period 1|Adverse Event|5|||
125330576|NCT01383356|450842580|FG001|Period 1|Adverse Event|3|||
125330577|NCT01383356|450842579|FG000|Period 1|Non-compliance|3|||
125330578|NCT01383356|450842580|FG001|Period 1|Non-compliance|0|||
125330579|NCT01383356|450842579|FG000|Period 1|Out of Range Mid-study-Test|0|||
125330580|NCT01383356|450842580|FG001|Period 1|Out of Range Mid-study-Test|1|||
125330581|NCT01383356|450842579|FG000|Period 1|Personal|0|||
125330582|NCT01383356|450842580|FG001|Period 1|Personal|2|||
125330583|NCT00602472|450842586|FG000|Overall Study|Adverse Event|5|||
125000784|NCT04427501|449631806|FG000|Overall Study|Lost to Follow-up|5|||
125000785|NCT04427501|449631807|FG001|Overall Study|Lost to Follow-up|1|||
125000786|NCT04427501|449631808|FG002|Overall Study|Lost to Follow-up|2|||
125330584|NCT00602472|450842587|FG001|Overall Study|Adverse Event|23|||
125330585|NCT00602472|450842586|FG000|Overall Study|Protocol Violation|4|||
125330586|NCT00602472|450842587|FG001|Overall Study|Protocol Violation|19|||
125330587|NCT00602472|450842586|FG000|Overall Study|Withdrawal by Subject|8|||
125330588|NCT00602472|450842587|FG001|Overall Study|Withdrawal by Subject|14|||
125330589|NCT00602472|450842586|FG000|Overall Study|Other incl. lack of efficacy|4|||
125330590|NCT00602472|450842587|FG001|Overall Study|Other incl. lack of efficacy|2|||
125330591|NCT03038880|450842588|FG000|Overall Study|Death|1|||
125000787|NCT04427501|449631809|FG003|Overall Study|Lost to Follow-up|0|||
125000788|NCT04427501|449631810|FG004|Overall Study|Lost to Follow-up|2|||
125000789|NCT04427501|449631811|FG005|Overall Study|Lost to Follow-up|11|||
125000790|NCT04427501|449631812|FG006|Overall Study|Lost to Follow-up|10|||
125000791|NCT04427501|449631813|FG007|Overall Study|Lost to Follow-up|10|||
125000792|NCT04427501|449631814|FG008|Overall Study|Lost to Follow-up|2|||
125000793|NCT04427501|449631815|FG009|Overall Study|Lost to Follow-up|5|||
125000794|NCT04427501|449631816|FG010|Overall Study|Lost to Follow-up|2|||
125000795|NCT04427501|449631817|FG011|Overall Study|Lost to Follow-up|0|||
125000796|NCT04427501|449631806|FG000|Overall Study|Physician Decision|0|||
125000797|NCT04427501|449631807|FG001|Overall Study|Physician Decision|3|||
125000798|NCT04427501|449631808|FG002|Overall Study|Physician Decision|0|||
125000799|NCT04427501|449631809|FG003|Overall Study|Physician Decision|0|||
125000800|NCT04427501|449631810|FG004|Overall Study|Physician Decision|0|||
125000801|NCT04427501|449631811|FG005|Overall Study|Physician Decision|0|||
125000802|NCT04427501|449631812|FG006|Overall Study|Physician Decision|2|||
125000803|NCT04427501|449631813|FG007|Overall Study|Physician Decision|0|||
125000804|NCT04427501|449631814|FG008|Overall Study|Physician Decision|0|||
125000805|NCT04427501|449631815|FG009|Overall Study|Physician Decision|0|||
125000806|NCT04427501|449631816|FG010|Overall Study|Physician Decision|0|||
125000807|NCT04427501|449631817|FG011|Overall Study|Physician Decision|0|||
125000808|NCT04427501|449631806|FG000|Overall Study|Withdrawal by Subject|9|||
125000809|NCT04427501|449631807|FG001|Overall Study|Withdrawal by Subject|2|||
125000810|NCT04427501|449631808|FG002|Overall Study|Withdrawal by Subject|2|||
125000811|NCT04427501|449631809|FG003|Overall Study|Withdrawal by Subject|3|||
125000812|NCT04427501|449631810|FG004|Overall Study|Withdrawal by Subject|7|||
125000813|NCT04427501|449631811|FG005|Overall Study|Withdrawal by Subject|25|||
125000814|NCT04427501|449631812|FG006|Overall Study|Withdrawal by Subject|15|||
125000815|NCT04427501|449631813|FG007|Overall Study|Withdrawal by Subject|7|||
125000816|NCT04427501|449631814|FG008|Overall Study|Withdrawal by Subject|4|||
125000817|NCT04427501|449631815|FG009|Overall Study|Withdrawal by Subject|1|||
125000818|NCT04427501|449631816|FG010|Overall Study|Withdrawal by Subject|4|||
125000819|NCT04427501|449631817|FG011|Overall Study|Withdrawal by Subject|0|||
125000820|NCT04427501|449631806|FG000|Overall Study|Other - as reported by the investigator|1|||
125000821|NCT04427501|449631807|FG001|Overall Study|Other - as reported by the investigator|0|||
125000822|NCT04427501|449631808|FG002|Overall Study|Other - as reported by the investigator|0|||
125000823|NCT04427501|449631809|FG003|Overall Study|Other - as reported by the investigator|0|||
125000824|NCT04427501|449631810|FG004|Overall Study|Other - as reported by the investigator|0|||
125000825|NCT04427501|449631811|FG005|Overall Study|Other - as reported by the investigator|6|||
125000826|NCT04427501|449631812|FG006|Overall Study|Other - as reported by the investigator|6|||
125000827|NCT04427501|449631813|FG007|Overall Study|Other - as reported by the investigator|0|||
125000828|NCT04427501|449631814|FG008|Overall Study|Other - as reported by the investigator|0|||
125000829|NCT04427501|449631815|FG009|Overall Study|Other - as reported by the investigator|0|||
125000830|NCT04427501|449631816|FG010|Overall Study|Other - as reported by the investigator|0|||
125000831|NCT04427501|449631817|FG011|Overall Study|Other - as reported by the investigator|0|||
125000832|NCT04427501|449631806|FG000|Overall Study|Other|0|||
125000833|NCT04427501|449631807|FG001|Overall Study|Other|0|||
125000834|NCT04427501|449631808|FG002|Overall Study|Other|0|||
125000835|NCT04427501|449631809|FG003|Overall Study|Other|0|||
125000836|NCT04427501|449631810|FG004|Overall Study|Other|0|||
125000837|NCT04427501|449631811|FG005|Overall Study|Other|0|||
125000838|NCT04427501|449631812|FG006|Overall Study|Other|0|||
125000839|NCT04427501|449631813|FG007|Overall Study|Other|0|||
125000840|NCT04427501|449631814|FG008|Overall Study|Other|0|||
125330592|NCT03038880|450842589|FG001|Overall Study|Death|2|||
125330593|NCT03038880|450842590|FG002|Overall Study|Death|0|||
125330594|NCT03038880|450842588|FG000|Overall Study|Physician Decision|2|||
125330595|NCT03038880|450842589|FG001|Overall Study|Physician Decision|1|||
125330596|NCT03038880|450842590|FG002|Overall Study|Physician Decision|0|||
125330597|NCT02054104|450842597|FG000|Overall Study|Did not want to continue due to college classes|1|||
125330598|NCT02054104|450842598|FG001|Overall Study|Did not want to continue due to college classes|0|||
125330599|NCT02054104|450842597|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
125330600|NCT02054104|450842598|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
125330601|NCT02054104|450842597|FG000|Overall Study|No evidence of immunologic response|2|||
125330602|NCT02054104|450842598|FG001|Overall Study|No evidence of immunologic response|2|||
125330603|NCT02054104|450842597|FG000|Overall Study|Disease Progression On Study|4|||
125330604|NCT02054104|450842598|FG001|Overall Study|Disease Progression On Study|5|||
125330605|NCT02054104|450842597|FG000|Overall Study|Diagnosis of lymphoma|0|||
125330606|NCT02054104|450842598|FG001|Overall Study|Diagnosis of lymphoma|1|||
125330607|NCT02054104|450842597|FG000|Overall Study|Inconclusive response|0|||
125330608|NCT02054104|450842598|FG001|Overall Study|Inconclusive response|1|||
125330609|NCT00823615|450842599|FG000|Period 2|Lost to Follow-up|2|||
125000841|NCT04427501|449631815|FG009|Overall Study|Other|0|||
125000842|NCT04427501|449631816|FG010|Overall Study|Other|0|||
125000843|NCT04427501|449631817|FG011|Overall Study|Other|1|||
125000844|NCT04936841|449631818|FG000|Overall Study|Death|1|||
125330610|NCT00823615|450842600|FG001|Period 2|Lost to Follow-up|0|||
125000845|NCT00639223|449631819|FG000|Overall Study|Lost to Follow-up|0|||
125330611|NCT00823615|450842599|FG000|Period 2|Time/Job Conflict|1|||
125000846|NCT00639223|449631820|FG001|Overall Study|Lost to Follow-up|2|||
125000847|NCT02499770|449631828|FG000|Overall Study|Death|17|||
125000848|NCT02499770|449631829|FG001|Overall Study|Death|56|||
125000849|NCT02499770|449631828|FG000|Overall Study|Study completion|1|||
125000850|NCT02499770|449631829|FG001|Overall Study|Study completion|10|||
125000851|NCT02499770|449631828|FG000|Overall Study|Withdrawal by Subject|0|||
125000852|NCT02499770|449631829|FG001|Overall Study|Withdrawal by Subject|7|||
125000853|NCT02499770|449631828|FG000|Overall Study|Lost to Follow-up|0|||
125000854|NCT02499770|449631829|FG001|Overall Study|Lost to Follow-up|2|||
125000855|NCT02499770|449631828|FG000|Overall Study|Subject declined further treatment|1|||
125000856|NCT02499770|449631829|FG001|Overall Study|Subject declined further treatment|0|||
125000857|NCT02499770|449631828|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
125000858|NCT02499770|449631829|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
125000859|NCT02499770|449631828|FG000|Overall Study|Randomized but not enrolled|0|||
125000860|NCT02499770|449631829|FG001|Overall Study|Randomized but not enrolled|1|||
125000861|NCT02273726|449631830|FG000|Overall Study|Death|70|||
125000862|NCT02273726|449631831|FG001|Overall Study|Death|62|||
125000863|NCT02273726|449631830|FG000|Overall Study|Withdrawal by Subject|41|||
125000864|NCT02273726|449631831|FG001|Overall Study|Withdrawal by Subject|29|||
125000865|NCT02273726|449631830|FG000|Overall Study|Kidney transplant|31|||
125000866|NCT02273726|449631831|FG001|Overall Study|Kidney transplant|39|||
125000867|NCT02273726|449631830|FG000|Overall Study|Physician Decision|30|||
125000868|NCT02273726|449631831|FG001|Overall Study|Physician Decision|15|||
125000869|NCT02273726|449631830|FG000|Overall Study|Adverse Event|27|||
125330612|NCT00823615|450842600|FG001|Period 2|Time/Job Conflict|2|||
125330613|NCT03926611|450842601|FG000|Overall Study|Adverse Event|0|||
125330614|NCT03926611|450842602|FG001|Overall Study|Adverse Event|0|||
125330615|NCT03926611|450842603|FG002|Overall Study|Adverse Event|0|||
125330616|NCT03926611|450842604|FG003|Overall Study|Adverse Event|3|||
125330617|NCT03926611|450842605|FG004|Overall Study|Adverse Event|1|||
125330618|NCT03926611|450842606|FG005|Overall Study|Adverse Event|3|||
125330619|NCT03926611|450842607|FG006|Overall Study|Adverse Event|0|||
125330620|NCT03926611|450842601|FG000|Overall Study|Lack of Efficacy|1|||
125330621|NCT03926611|450842602|FG001|Overall Study|Lack of Efficacy|2|||
125330622|NCT03926611|450842603|FG002|Overall Study|Lack of Efficacy|0|||
125330623|NCT03926611|450842604|FG003|Overall Study|Lack of Efficacy|0|||
125330624|NCT03926611|450842605|FG004|Overall Study|Lack of Efficacy|1|||
125330625|NCT03926611|450842606|FG005|Overall Study|Lack of Efficacy|0|||
125330626|NCT03926611|450842607|FG006|Overall Study|Lack of Efficacy|1|||
125330627|NCT03926611|450842601|FG000|Overall Study|Physician Decision|0|||
125330628|NCT03926611|450842602|FG001|Overall Study|Physician Decision|0|||
125000870|NCT02273726|449631831|FG001|Overall Study|Adverse Event|9|||
125000871|NCT02273726|449631830|FG000|Overall Study|Lost to Follow-up|6|||
125000872|NCT02273726|449631831|FG001|Overall Study|Lost to Follow-up|3|||
125000873|NCT02273726|449631830|FG000|Overall Study|Lack of Efficacy|6|||
125000874|NCT02273726|449631831|FG001|Overall Study|Lack of Efficacy|1|||
125000875|NCT02273726|449631830|FG000|Overall Study|Protocol Violation|4|||
125000876|NCT02273726|449631831|FG001|Overall Study|Protocol Violation|0|||
125000877|NCT02273726|449631830|FG000|Overall Study|Other than specified|28|||
125000878|NCT02273726|449631831|FG001|Overall Study|Other than specified|30|||
125000879|NCT02129205|449631832|FG000|Overall Study|Withdrawal by Subject|0|||
125000880|NCT02129205|449631833|FG001|Overall Study|Withdrawal by Subject|0|||
125000881|NCT02129205|449631834|FG002|Overall Study|Withdrawal by Subject|0|||
125000882|NCT02129205|449631835|FG003|Overall Study|Withdrawal by Subject|0|||
125000883|NCT02129205|449631836|FG004|Overall Study|Withdrawal by Subject|1|||
125000884|NCT02129205|449631837|FG005|Overall Study|Withdrawal by Subject|1|||
125000885|NCT02129205|449631838|FG006|Overall Study|Withdrawal by Subject|1|||
125000886|NCT02129205|449631839|FG007|Overall Study|Withdrawal by Subject|0|||
125000887|NCT02129205|449631840|FG008|Overall Study|Withdrawal by Subject|1|||
125000888|NCT02129205|449631841|FG009|Overall Study|Withdrawal by Subject|0|||
125000889|NCT02129205|449631832|FG000|Overall Study|Other|1|||
125000890|NCT02129205|449631833|FG001|Overall Study|Other|0|||
125000891|NCT02129205|449631834|FG002|Overall Study|Other|0|||
125000892|NCT02129205|449631835|FG003|Overall Study|Other|0|||
125000893|NCT02129205|449631836|FG004|Overall Study|Other|2|||
125000894|NCT02129205|449631837|FG005|Overall Study|Other|3|||
125000895|NCT02129205|449631838|FG006|Overall Study|Other|3|||
125000896|NCT02129205|449631839|FG007|Overall Study|Other|2|||
125330629|NCT03926611|450842603|FG002|Overall Study|Physician Decision|0|||
125330630|NCT03926611|450842604|FG003|Overall Study|Physician Decision|0|||
125000897|NCT02129205|449631840|FG008|Overall Study|Other|1|||
125000898|NCT02129205|449631841|FG009|Overall Study|Other|0|||
125000899|NCT02877927|449631844|FG000|Overall Study|Adverse Event|1|||
125000900|NCT02877927|449631845|FG001|Overall Study|Adverse Event|0|||
125000901|NCT02877927|449631844|FG000|Overall Study|Lost to Follow-up|37|||
125000902|NCT02877927|449631845|FG001|Overall Study|Lost to Follow-up|38|||
125000903|NCT02877927|449631844|FG000|Overall Study|Withdrawal by Subject|11|||
125000904|NCT02877927|449631845|FG001|Overall Study|Withdrawal by Subject|12|||
125000905|NCT02877927|449631844|FG000|Overall Study|Physician Decision|0|||
125000906|NCT02877927|449631845|FG001|Overall Study|Physician Decision|1|||
125000907|NCT02877927|449631844|FG000|Overall Study|Missed EOT/PTE Visit|5|||
125330631|NCT03926611|450842605|FG004|Overall Study|Physician Decision|0|||
125330632|NCT03926611|450842606|FG005|Overall Study|Physician Decision|1|||
125330633|NCT03926611|450842607|FG006|Overall Study|Physician Decision|0|||
125000908|NCT02877927|449631845|FG001|Overall Study|Missed EOT/PTE Visit|6|||
125000909|NCT00708175|449631846|FG000|Overall Study|Adverse Event|4|||
125000910|NCT00708175|449631847|FG001|Overall Study|Adverse Event|5|||
125000911|NCT00708175|449631846|FG000|Overall Study|Protocol Violation|2|||
125000912|NCT00708175|449631847|FG001|Overall Study|Protocol Violation|3|||
125000913|NCT00708175|449631846|FG000|Overall Study|Lost to Follow-up|5|||
125000914|NCT00708175|449631847|FG001|Overall Study|Lost to Follow-up|3|||
125000915|NCT00708175|449631846|FG000|Overall Study|Withdrawal by Subject|5|||
125000916|NCT00708175|449631847|FG001|Overall Study|Withdrawal by Subject|7|||
125000917|NCT00708175|449631846|FG000|Overall Study|BMD loss >7%|2|||
125000918|NCT00708175|449631847|FG001|Overall Study|BMD loss >7%|3|||
125000919|NCT02906787|449631851|FG000|Overall Study|Withdrawal by Subject|12|||
125000920|NCT02906787|449631852|FG001|Overall Study|Withdrawal by Subject|10|||
125000921|NCT02906787|449631851|FG000|Overall Study|Missed|24|||
125000922|NCT02906787|449631852|FG001|Overall Study|Missed|22|||
125000923|NCT04435782|449631855|FG000|Overall Study|Study terminated by sponsor|4|||
125000924|NCT03672461|449631856|FG000|Overall Study|COVID Related|4|||
125000925|NCT03672461|449631857|FG001|Overall Study|COVID Related|2|||
125000926|NCT03672461|449631856|FG000|Overall Study|Adverse Event|2|||
125000927|NCT03672461|449631857|FG001|Overall Study|Adverse Event|0|||
125000928|NCT03672461|449631856|FG000|Overall Study|Serious Adverse Event|0|||
125000929|NCT03672461|449631857|FG001|Overall Study|Serious Adverse Event|1|||
125000930|NCT03672461|449631856|FG000|Overall Study|Too Busy|3|||
125000931|NCT03672461|449631857|FG001|Overall Study|Too Busy|1|||
125000932|NCT03672461|449631856|FG000|Overall Study|Lost to Follow-up|1|||
125000933|NCT03672461|449631857|FG001|Overall Study|Lost to Follow-up|2|||
125000934|NCT03672461|449631856|FG000|Overall Study|Family|2|||
125000935|NCT03672461|449631857|FG001|Overall Study|Family|2|||
125000936|NCT03672461|449631856|FG000|Overall Study|No remote technology access|0|||
125000937|NCT03672461|449631857|FG001|Overall Study|No remote technology access|1|||
125000938|NCT03672461|449631856|FG000|Overall Study|Withdrawal by Subject|1|||
125000939|NCT03672461|449631857|FG001|Overall Study|Withdrawal by Subject|0|||
125000940|NCT03672461|449631856|FG000|Overall Study|Cannot tolerate intervention|1|||
125000941|NCT03672461|449631857|FG001|Overall Study|Cannot tolerate intervention|0|||
125000942|NCT03672461|449631856|FG000|Overall Study|Incomplete outcome data|6|||
125000943|NCT03672461|449631857|FG001|Overall Study|Incomplete outcome data|1|||
125000944|NCT01310803|449633964|FG000|Overall Study|Subject terminated by Sponsor|1|||
125000945|NCT01310803|449633965|FG001|Overall Study|Subject terminated by Sponsor|0|||
125000946|NCT01306890|449633966|FG000|Overall Study|Adverse Event|2|||
125000947|NCT01306890|449633966|FG000|Overall Study|Death|1223|||
125000948|NCT01306890|449633966|FG000|Overall Study|Lost to Follow-up|58|||
125000949|NCT01306890|449633966|FG000|Overall Study|Withdrawal by Subject|88|||
125330634|NCT03926611|450842601|FG000|Overall Study|Protocol Violation|1|||
125330635|NCT03926611|450842602|FG001|Overall Study|Protocol Violation|0|||
125330636|NCT03926611|450842603|FG002|Overall Study|Protocol Violation|0|||
125330637|NCT03926611|450842604|FG003|Overall Study|Protocol Violation|1|||
125330638|NCT03926611|450842605|FG004|Overall Study|Protocol Violation|1|||
125330639|NCT03926611|450842606|FG005|Overall Study|Protocol Violation|1|||
125330640|NCT03926611|450842607|FG006|Overall Study|Protocol Violation|1|||
125330641|NCT03926611|450842601|FG000|Overall Study|Technical problems|0|||
125330642|NCT03926611|450842602|FG001|Overall Study|Technical problems|0|||
125330643|NCT03926611|450842603|FG002|Overall Study|Technical problems|0|||
125330644|NCT03926611|450842604|FG003|Overall Study|Technical problems|0|||
125330645|NCT03926611|450842605|FG004|Overall Study|Technical problems|0|||
125330646|NCT03926611|450842606|FG005|Overall Study|Technical problems|1|||
125330647|NCT03926611|450842607|FG006|Overall Study|Technical problems|0|||
125330648|NCT03926611|450842601|FG000|Overall Study|Withdrawal by Subject|1|||
125330649|NCT03926611|450842602|FG001|Overall Study|Withdrawal by Subject|1|||
125330650|NCT03926611|450842603|FG002|Overall Study|Withdrawal by Subject|1|||
125330651|NCT03926611|450842604|FG003|Overall Study|Withdrawal by Subject|0|||
125330652|NCT03926611|450842605|FG004|Overall Study|Withdrawal by Subject|0|||
125330653|NCT03926611|450842606|FG005|Overall Study|Withdrawal by Subject|1|||
125330654|NCT03926611|450842607|FG006|Overall Study|Withdrawal by Subject|3|||
125330655|NCT03926611|450842601|FG000|Overall Study|Covid-19 pandemic|0|||
125000950|NCT01306890|449633966|FG000|Overall Study|Unspecified reasons|104|||
125330656|NCT03926611|450842602|FG001|Overall Study|Covid-19 pandemic|0|||
125330657|NCT03926611|450842603|FG002|Overall Study|Covid-19 pandemic|1|||
125000951|NCT01306890|449633966|FG000|Overall Study|Study Termination|3|||
125000952|NCT01306890|449633966|FG000|Overall Study|No discontinuation documentation|41|||
125000953|NCT03739762|449633971|FG000|Overall Study|Lost to Follow-up|1|||
125000954|NCT03739762|449633972|FG001|Overall Study|Lost to Follow-up|1|||
125000955|NCT03739762|449633971|FG000|Overall Study|Withdrawal by Subject|2|||
125000956|NCT03739762|449633972|FG001|Overall Study|Withdrawal by Subject|6|||
125000957|NCT01131351|449633974|FG000|Overall Study|Adverse Event|0|||
125330658|NCT03926611|450842604|FG003|Overall Study|Covid-19 pandemic|0|||
125330659|NCT03926611|450842605|FG004|Overall Study|Covid-19 pandemic|1|||
125000958|NCT01131351|449633975|FG001|Overall Study|Adverse Event|2|||
125000959|NCT01131351|449633974|FG000|Overall Study|Protocol Deviation|0|||
125000960|NCT01131351|449633975|FG001|Overall Study|Protocol Deviation|1|||
125330660|NCT03926611|450842606|FG005|Overall Study|Covid-19 pandemic|2|||
125330661|NCT03926611|450842607|FG006|Overall Study|Covid-19 pandemic|0|||
125330662|NCT00084136|450842608|FG000|PI Comparison|Death|10|||
125000961|NCT02294682|449633976|FG000|Overall Study|Could not swallow pills|1|||
125000962|NCT02294682|449633977|FG001|Overall Study|Could not swallow pills|0|||
125000963|NCT03422172|449633980|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
125000964|NCT03422172|449633980|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
125000965|NCT03422172|449633980|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
125000966|NCT00059839|449633983|FG000|Overall Study|Death|1|||
125000967|NCT00059839|449633984|FG001|Overall Study|Death|1|||
125000968|NCT00059839|449633983|FG000|Overall Study|Lack of Efficacy|6|||
125000969|NCT00059839|449633984|FG001|Overall Study|Lack of Efficacy|5|||
125000970|NCT00059839|449633983|FG000|Overall Study|Lost to Follow-up|2|||
125000971|NCT00059839|449633984|FG001|Overall Study|Lost to Follow-up|0|||
125000972|NCT00059839|449633983|FG000|Overall Study|Physician Decision|1|||
125000973|NCT00059839|449633984|FG001|Overall Study|Physician Decision|2|||
125000974|NCT00059839|449633983|FG000|Overall Study|Withdrawal by Subject|1|||
125000975|NCT00059839|449633984|FG001|Overall Study|Withdrawal by Subject|6|||
125000976|NCT00059839|449633983|FG000|Overall Study|Ineligible|1|||
125000977|NCT00059839|449633984|FG001|Overall Study|Ineligible|3|||
125000978|NCT00129623|449633985|FG000|Overall Study|Adverse Event|3|||
125000979|NCT00129623|449633986|FG001|Overall Study|Adverse Event|7|||
125000980|NCT00129623|449633985|FG000|Overall Study|Refused Treatment|5|||
125000981|NCT00129623|449633986|FG001|Overall Study|Refused Treatment|3|||
125330663|NCT00084136|450842609|FG001|PI Comparison|Death|9|||
125330664|NCT00084136|450842610|FG002|PI Comparison|Death|0|||
125330665|NCT00084136|450842608|FG000|PI Comparison|Lost to Follow-up|11|||
125330666|NCT00084136|450842609|FG001|PI Comparison|Lost to Follow-up|8|||
125330667|NCT00084136|450842610|FG002|PI Comparison|Lost to Follow-up|0|||
125330668|NCT00084136|450842608|FG000|PI Comparison|Withdrawal by Subject|33|||
125330669|NCT00084136|450842609|FG001|PI Comparison|Withdrawal by Subject|30|||
125330670|NCT00084136|450842610|FG002|PI Comparison|Withdrawal by Subject|0|||
125330671|NCT00084136|450842608|FG000|PI Comparison|Clinic site closed|1|||
125330672|NCT00084136|450842609|FG001|PI Comparison|Clinic site closed|0|||
125330673|NCT00084136|450842610|FG002|PI Comparison|Clinic site closed|0|||
125330674|NCT00084136|450842608|FG000|NRTI Comparison|Death|20|||
125330675|NCT00084136|450842609|FG001|NRTI Comparison|Death|0|||
125330676|NCT00084136|450842610|FG002|NRTI Comparison|Death|18|||
125330677|NCT00084136|450842608|FG000|NRTI Comparison|Lost to Follow-up|14|||
125330678|NCT00084136|450842609|FG001|NRTI Comparison|Lost to Follow-up|0|||
125330679|NCT00084136|450842610|FG002|NRTI Comparison|Lost to Follow-up|12|||
125330680|NCT00084136|450842608|FG000|NRTI Comparison|Withdrawal by Subject|54|||
125330681|NCT00084136|450842609|FG001|NRTI Comparison|Withdrawal by Subject|0|||
125330682|NCT00084136|450842610|FG002|NRTI Comparison|Withdrawal by Subject|38|||
125330683|NCT00084136|450842608|FG000|NRTI Comparison|Clinic site closed|12|||
125330684|NCT00084136|450842609|FG001|NRTI Comparison|Clinic site closed|0|||
125330685|NCT00084136|450842610|FG002|NRTI Comparison|Clinic site closed|14|||
125330686|NCT00084136|450842608|FG000|NRTI Comparison|Not reason above|1|||
125330687|NCT00084136|450842609|FG001|NRTI Comparison|Not reason above|0|||
125330688|NCT00084136|450842610|FG002|NRTI Comparison|Not reason above|0|||
125330689|NCT02230670|450842611|FG000|Overall Study|Adverse Event|1|||
125330690|NCT02230670|450842612|FG001|Overall Study|Adverse Event|2|||
125330691|NCT02230670|450842611|FG000|Overall Study|Withdrawal by Subject|2|||
125330692|NCT02230670|450842612|FG001|Overall Study|Withdrawal by Subject|2|||
125330693|NCT02230670|450842611|FG000|Overall Study|Physician Decision|0|||
125330694|NCT02230670|450842612|FG001|Overall Study|Physician Decision|1|||
125330695|NCT02230670|450842611|FG000|Overall Study|Protocol Violation|0|||
125330696|NCT02230670|450842612|FG001|Overall Study|Protocol Violation|1|||
125330697|NCT02230670|450842611|FG000|Overall Study|Progression to Child-Pugh C|1|||
125330698|NCT02230670|450842612|FG001|Overall Study|Progression to Child-Pugh C|2|||
125330699|NCT00892099|450842614|FG000|Overall Study|Death|1|||
125330700|NCT00892099|450842615|FG001|Overall Study|Death|0|||
125330701|NCT00892099|450842616|FG002|Overall Study|Death|1|||
125330702|NCT00892099|450842614|FG000|Overall Study|Adverse Event|1|||
125330703|NCT00892099|450842615|FG001|Overall Study|Adverse Event|0|||
125330704|NCT00892099|450842616|FG002|Overall Study|Adverse Event|0|||
125330705|NCT00892099|450842614|FG000|Overall Study|replocated|1|||
125330706|NCT00892099|450842615|FG001|Overall Study|replocated|0|||
125330707|NCT00892099|450842616|FG002|Overall Study|replocated|2|||
125330708|NCT00892099|450842614|FG000|Overall Study|Prolonged hospitalization|1|||
125330709|NCT00892099|450842615|FG001|Overall Study|Prolonged hospitalization|0|||
125330710|NCT00892099|450842616|FG002|Overall Study|Prolonged hospitalization|1|||
125000982|NCT00129623|449633985|FG000|Overall Study|Failure to Return|1|||
125000983|NCT00129623|449633986|FG001|Overall Study|Failure to Return|1|||
125000984|NCT00129623|449633985|FG000|Overall Study|Relocated job out of state|1|||
125000985|NCT00129623|449633986|FG001|Overall Study|Relocated job out of state|0|||
125000986|NCT00129623|449633985|FG000|Overall Study|Uncertainty to return|0|||
125000987|NCT00129623|449633986|FG001|Overall Study|Uncertainty to return|1|||
125000988|NCT03155373|449633987|FG000|Overall Study|No longer required surgery|1|||
125330711|NCT00892099|450842614|FG000|Overall Study|no further details|1|||
125330712|NCT00892099|450842615|FG001|Overall Study|no further details|0|||
125330713|NCT00892099|450842616|FG002|Overall Study|no further details|1|||
125330714|NCT00892099|450842614|FG000|Overall Study|kidney function recovered|0|||
125330715|NCT00892099|450842615|FG001|Overall Study|kidney function recovered|1|||
125330716|NCT00892099|450842616|FG002|Overall Study|kidney function recovered|0|||
125330717|NCT00892099|450842614|FG000|Overall Study|investigator decision|0|||
125330718|NCT00892099|450842615|FG001|Overall Study|investigator decision|0|||
125330719|NCT00892099|450842616|FG002|Overall Study|investigator decision|1|||
125330720|NCT00892099|450842614|FG000|Overall Study|Lost to Follow-up|0|||
125330721|NCT00892099|450842615|FG001|Overall Study|Lost to Follow-up|0|||
125330722|NCT00892099|450842616|FG002|Overall Study|Lost to Follow-up|1|||
125330723|NCT01657019|450842617|FG000|Overall Study|Withdrawal by Subject|65|||
125330724|NCT01657019|450842617|FG000|Overall Study|Adverse Event|55|||
125330725|NCT01657019|450842617|FG000|Overall Study|Lost to Follow-up|48|||
125330726|NCT01657019|450842617|FG000|Overall Study|Protocol Violation|6|||
125330727|NCT01657019|450842617|FG000|Overall Study|Lack of Efficacy|3|||
125330728|NCT01657019|450842617|FG000|Overall Study|Other|58|||
125330729|NCT00998296|450842618|FG000|Overall Study|Progressive disease|0|||
125330730|NCT00998296|450842619|FG001|Overall Study|Progressive disease|1|||
125000989|NCT03155373|449633987|FG000|Overall Study|Protocol Violation|1|||
125000990|NCT03155373|449633987|FG000|Overall Study|Death|2|||
125000991|NCT03155373|449633987|FG000|Overall Study|Withdrawal by Subject|3|||
125000992|NCT05352048|449633992|FG000|Overall Study|Lost to Follow-up|1|||
125000993|NCT05352048|449633992|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
125000994|NCT01214187|449633993|FG000|Overall Study|Adverse Event|6|||
125000995|NCT01214187|449633994|FG001|Overall Study|Adverse Event|2|||
125000996|NCT01214187|449633993|FG000|Overall Study|Death|1|||
125000997|NCT01214187|449633994|FG001|Overall Study|Death|1|||
125000998|NCT01214187|449633993|FG000|Overall Study|Withdrawal by Subject|0|||
125000999|NCT01214187|449633994|FG001|Overall Study|Withdrawal by Subject|3|||
125001000|NCT01233869|449634002|FG000|Initial Treatment Period (24 Months)|Death|1|||
125001001|NCT01233869|449634003|FG001|Initial Treatment Period (24 Months)|Death|0|||
125001002|NCT01233869|449634004|FG002|Initial Treatment Period (24 Months)|Death|0|||
125001003|NCT01233869|449634005|FG003|Initial Treatment Period (24 Months)|Death|0|||
125001004|NCT01233869|449634002|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
125001005|NCT01233869|449634003|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
125001006|NCT01233869|449634004|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
125001007|NCT01233869|449634005|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
125001008|NCT01233869|449634002|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
125001009|NCT01233869|449634003|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
125001010|NCT01233869|449634004|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
125001011|NCT01233869|449634005|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
125001012|NCT01233869|449634002|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
125001013|NCT01233869|449634003|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
125001014|NCT01233869|449634004|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
125001015|NCT01233869|449634005|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
125001016|NCT01233869|449634002|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
125001017|NCT01233869|449634003|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
125001018|NCT01233869|449634004|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
125001019|NCT01233869|449634005|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
125001020|NCT01233869|449634002|FG000|Extended Treatment Period (46 Months)|Other|3|||
125001021|NCT01233869|449634003|FG001|Extended Treatment Period (46 Months)|Other|0|||
125001022|NCT01233869|449634004|FG002|Extended Treatment Period (46 Months)|Other|0|||
125001023|NCT01233869|449634005|FG003|Extended Treatment Period (46 Months)|Other|3|||
125001024|NCT01233869|449634002|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
125001025|NCT01233869|449634003|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
125001026|NCT01233869|449634004|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
125001027|NCT01233869|449634005|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
125001028|NCT03678103|449634006|FG000|Overall Study|Withdrawn prior to completion|4|||
125001029|NCT00537485|449634007|FG000|Overall Study|Adverse Event|10|||
125001030|NCT00537485|449634008|FG001|Overall Study|Adverse Event|5|||
125001031|NCT00537485|449634007|FG000|Overall Study|Withdrawal by Subject|3|||
125001032|NCT00537485|449634008|FG001|Overall Study|Withdrawal by Subject|2|||
125001033|NCT00537485|449634007|FG000|Overall Study|Withdrawal by Subject|1|||
125001034|NCT00537485|449634008|FG001|Overall Study|Withdrawal by Subject|3|||
125001035|NCT00537485|449634007|FG000|Overall Study|Physician Decision|1|||
125001036|NCT00537485|449634008|FG001|Overall Study|Physician Decision|0|||
125001037|NCT01241552|449634014|FG000|Overall Study|Lack of Efficacy|1|||
125001038|NCT01241552|449634015|FG001|Overall Study|Lack of Efficacy|0|||
125330731|NCT00998296|450842620|FG002|Overall Study|Progressive disease|0|||
125330732|NCT00998296|450842621|FG003|Overall Study|Progressive disease|0|||
125330733|NCT00998296|450842622|FG004|Overall Study|Progressive disease|0|||
125330734|NCT00998296|450842623|FG005|Overall Study|Progressive disease|0|||
125001039|NCT01241552|449634016|FG002|Overall Study|Lack of Efficacy|0|||
125001040|NCT01241552|449634017|FG003|Overall Study|Lack of Efficacy|0|||
125001041|NCT01241552|449634014|FG000|Overall Study|Death|26|||
125001042|NCT01241552|449634015|FG001|Overall Study|Death|30|||
125001043|NCT01241552|449634016|FG002|Overall Study|Death|20|||
125001044|NCT01241552|449634017|FG003|Overall Study|Death|25|||
125001045|NCT01241552|449634014|FG000|Overall Study|Adverse Event|1|||
125001046|NCT01241552|449634015|FG001|Overall Study|Adverse Event|1|||
125001047|NCT01241552|449634016|FG002|Overall Study|Adverse Event|0|||
125001048|NCT01241552|449634017|FG003|Overall Study|Adverse Event|0|||
125001049|NCT01241552|449634014|FG000|Overall Study|Technical Problems|2|||
125001050|NCT01241552|449634015|FG001|Overall Study|Technical Problems|0|||
125001051|NCT01241552|449634016|FG002|Overall Study|Technical Problems|2|||
125001052|NCT01241552|449634017|FG003|Overall Study|Technical Problems|2|||
125001053|NCT01241552|449634014|FG000|Overall Study|Progressive Disease|0|||
125001054|NCT01241552|449634015|FG001|Overall Study|Progressive Disease|0|||
125001055|NCT01241552|449634016|FG002|Overall Study|Progressive Disease|1|||
125001056|NCT01241552|449634017|FG003|Overall Study|Progressive Disease|2|||
125001057|NCT01241552|449634014|FG000|Overall Study|Protocol Violation|0|||
125001058|NCT01241552|449634015|FG001|Overall Study|Protocol Violation|2|||
125001059|NCT01241552|449634016|FG002|Overall Study|Protocol Violation|6|||
125001060|NCT01241552|449634017|FG003|Overall Study|Protocol Violation|1|||
125001061|NCT01241552|449634014|FG000|Overall Study|Withdrawal by Subject|7|||
125001062|NCT01241552|449634015|FG001|Overall Study|Withdrawal by Subject|15|||
125001063|NCT01241552|449634016|FG002|Overall Study|Withdrawal by Subject|14|||
125001064|NCT01241552|449634017|FG003|Overall Study|Withdrawal by Subject|15|||
125330735|NCT00998296|450842624|FG006|Overall Study|Progressive disease|1|||
125330736|NCT00998296|450842625|FG007|Overall Study|Progressive disease|0|||
125330737|NCT00998296|450842626|FG008|Overall Study|Progressive disease|0|||
125330738|NCT00998296|450842627|FG009|Overall Study|Progressive disease|14|||
125330739|NCT00998296|450842628|FG010|Overall Study|Progressive disease|5|||
125330740|NCT00998296|450842618|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
125330741|NCT00998296|450842619|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
125330742|NCT00998296|450842620|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
125330743|NCT00998296|450842621|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
125330744|NCT00998296|450842622|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
125330745|NCT00998296|450842623|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
125330746|NCT00998296|450842624|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
125330747|NCT00998296|450842625|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
125330748|NCT00998296|450842626|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
125330749|NCT00998296|450842627|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
125330750|NCT00998296|450842628|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
125330751|NCT00998296|450842618|FG000|Overall Study|Other adverse event|0|||
125330752|NCT00998296|450842619|FG001|Overall Study|Other adverse event|0|||
125330753|NCT00998296|450842620|FG002|Overall Study|Other adverse event|0|||
125330754|NCT00998296|450842621|FG003|Overall Study|Other adverse event|0|||
125330755|NCT00998296|450842622|FG004|Overall Study|Other adverse event|1|||
125330756|NCT00998296|450842623|FG005|Overall Study|Other adverse event|0|||
125330757|NCT00998296|450842624|FG006|Overall Study|Other adverse event|0|||
125330758|NCT00998296|450842625|FG007|Overall Study|Other adverse event|0|||
125330759|NCT00998296|450842626|FG008|Overall Study|Other adverse event|0|||
125330760|NCT00998296|450842627|FG009|Overall Study|Other adverse event|1|||
125330761|NCT00998296|450842628|FG010|Overall Study|Other adverse event|2|||
125330762|NCT00998296|450842618|FG000|Overall Study|Refused to continue taking trial med.|0|||
125330763|NCT00998296|450842619|FG001|Overall Study|Refused to continue taking trial med.|0|||
125330764|NCT00998296|450842620|FG002|Overall Study|Refused to continue taking trial med.|0|||
125330765|NCT00998296|450842621|FG003|Overall Study|Refused to continue taking trial med.|0|||
125330766|NCT00998296|450842622|FG004|Overall Study|Refused to continue taking trial med.|0|||
125330767|NCT00998296|450842623|FG005|Overall Study|Refused to continue taking trial med.|0|||
125330768|NCT00998296|450842624|FG006|Overall Study|Refused to continue taking trial med.|0|||
125330769|NCT00998296|450842625|FG007|Overall Study|Refused to continue taking trial med.|0|||
125330770|NCT00998296|450842626|FG008|Overall Study|Refused to continue taking trial med.|0|||
125330771|NCT00998296|450842627|FG009|Overall Study|Refused to continue taking trial med.|2|||
125330772|NCT00998296|450842628|FG010|Overall Study|Refused to continue taking trial med.|0|||
125330773|NCT00998296|450842618|FG000|Overall Study|Reason other than those specified above|0|||
125001065|NCT01241552|449634014|FG000|Overall Study|Physician Decision|2|||
125001066|NCT01241552|449634015|FG001|Overall Study|Physician Decision|4|||
125001067|NCT01241552|449634016|FG002|Overall Study|Physician Decision|2|||
125001068|NCT01241552|449634017|FG003|Overall Study|Physician Decision|3|||
125001069|NCT01241552|449634014|FG000|Overall Study|Lost to Follow-up|2|||
125001070|NCT01241552|449634015|FG001|Overall Study|Lost to Follow-up|11|||
125001071|NCT01241552|449634016|FG002|Overall Study|Lost to Follow-up|15|||
125330774|NCT00998296|450842619|FG001|Overall Study|Reason other than those specified above|0|||
125330775|NCT00998296|450842620|FG002|Overall Study|Reason other than those specified above|0|||
125330776|NCT00998296|450842621|FG003|Overall Study|Reason other than those specified above|0|||
125001072|NCT01241552|449634017|FG003|Overall Study|Lost to Follow-up|16|||
125001073|NCT01296035|449634019|FG000|Overall Study|Withdrawal by Subject|1|||
125001074|NCT05696236|449634024|FG000|Overall Study|Lost to Follow-up|1|||
125001075|NCT05696236|449634025|FG001|Overall Study|Lost to Follow-up|0|||
125001076|NCT05696236|449634024|FG000|Overall Study|Later determined to not be eligible for participation|0|||
125001077|NCT05696236|449634025|FG001|Overall Study|Later determined to not be eligible for participation|1|||
125001078|NCT05696236|449634024|FG000|Overall Study|Withdrawal by Subject|2|||
125001079|NCT05696236|449634025|FG001|Overall Study|Withdrawal by Subject|2|||
125001080|NCT01829360|449634028|FG000|Overall Study|Protocol Violation|0|||
125001081|NCT01829360|449634029|FG001|Overall Study|Protocol Violation|0|||
125001082|NCT01829360|449634030|FG002|Overall Study|Protocol Violation|1|||
125001083|NCT01829360|449634031|FG003|Overall Study|Protocol Violation|0|||
125001084|NCT01145495|449634034|FG000|Overall Study|Adverse Event|6|||
125001085|NCT01145495|449634034|FG000|Overall Study|Withdrawal by Subject|6|||
125001086|NCT01145495|449634034|FG000|Overall Study|Disease progression after respone|2|||
125001087|NCT01886313|449634037|FG000|Overall Study|Adverse Event|1|||
125001088|NCT01886313|449634038|FG001|Overall Study|Adverse Event|1|||
125001089|NCT03838198|449634039|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
125001090|NCT03838198|449634040|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
125001091|NCT03838198|449634041|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
125001092|NCT03838198|449634042|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
125001093|NCT03838198|449634039|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
125001094|NCT03838198|449634040|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
125001095|NCT03838198|449634041|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
125001096|NCT03838198|449634042|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
125001097|NCT02378220|449634043|FG000|Overall Study|Death|6|||
125001098|NCT02378220|449634044|FG001|Overall Study|Death|1|||
125001099|NCT00312221|449634045|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
125001100|NCT00312221|449634046|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
125001101|NCT00312221|449634047|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
125001102|NCT00312221|449634048|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
125001103|NCT00312221|449634045|FG000|Open-label Run-in Period|Adverse Event|74|||
125001104|NCT00312221|449634046|FG001|Open-label Run-in Period|Adverse Event|0|||
125001105|NCT00312221|449634047|FG002|Open-label Run-in Period|Adverse Event|0|||
125001106|NCT00312221|449634048|FG003|Open-label Run-in Period|Adverse Event|0|||
125001107|NCT00312221|449634045|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
125001108|NCT00312221|449634046|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
125001109|NCT00312221|449634047|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
125001110|NCT00312221|449634048|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
125001111|NCT00312221|449634045|FG000|Open-label Run-in Period|Administrative|42|||
125001112|NCT00312221|449634046|FG001|Open-label Run-in Period|Administrative|0|||
125001113|NCT00312221|449634047|FG002|Open-label Run-in Period|Administrative|0|||
125001114|NCT00312221|449634048|FG003|Open-label Run-in Period|Administrative|0|||
125001115|NCT00312221|449634045|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
125001116|NCT00312221|449634046|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
125001117|NCT00312221|449634047|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
125001118|NCT00312221|449634048|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
125001119|NCT00312221|449634045|FG000|Open-label Run-in Period|Did not qualify|5|||
125001120|NCT00312221|449634046|FG001|Open-label Run-in Period|Did not qualify|0|||
125001121|NCT00312221|449634047|FG002|Open-label Run-in Period|Did not qualify|0|||
125001122|NCT00312221|449634048|FG003|Open-label Run-in Period|Did not qualify|0|||
125001123|NCT00312221|449634045|FG000|Double-blind Phase|Withdrawal by Subject|0|||
125001124|NCT00312221|449634046|FG001|Double-blind Phase|Withdrawal by Subject|6|||
125001125|NCT00312221|449634047|FG002|Double-blind Phase|Withdrawal by Subject|8|||
125001126|NCT00312221|449634048|FG003|Double-blind Phase|Withdrawal by Subject|7|||
125001127|NCT00312221|449634045|FG000|Double-blind Phase|Adverse Event|0|||
125001128|NCT00312221|449634046|FG001|Double-blind Phase|Adverse Event|10|||
125001129|NCT00312221|449634047|FG002|Double-blind Phase|Adverse Event|19|||
125001130|NCT00312221|449634048|FG003|Double-blind Phase|Adverse Event|18|||
125001131|NCT00312221|449634045|FG000|Double-blind Phase|Lost to Follow-up|0|||
125001132|NCT00312221|449634046|FG001|Double-blind Phase|Lost to Follow-up|0|||
125001133|NCT00312221|449634047|FG002|Double-blind Phase|Lost to Follow-up|2|||
125001134|NCT00312221|449634048|FG003|Double-blind Phase|Lost to Follow-up|2|||
125001135|NCT00312221|449634045|FG000|Double-blind Phase|Administrative|0|||
125001136|NCT00312221|449634046|FG001|Double-blind Phase|Administrative|26|||
125001137|NCT00312221|449634047|FG002|Double-blind Phase|Administrative|37|||
125001138|NCT00312221|449634048|FG003|Double-blind Phase|Administrative|33|||
125001139|NCT00312221|449634045|FG000|Double-blind Phase|Lack of Efficacy|0|||
125001140|NCT00312221|449634046|FG001|Double-blind Phase|Lack of Efficacy|17|||
125001141|NCT00312221|449634047|FG002|Double-blind Phase|Lack of Efficacy|6|||
125001142|NCT00312221|449634048|FG003|Double-blind Phase|Lack of Efficacy|10|||
125001143|NCT02060721|449634049|FG000|Overall Study|Lost to Follow-up|1|||
125001144|NCT02060721|449634049|FG000|Overall Study|Physician Decision|2|||
125001145|NCT02060721|449634049|FG000|Overall Study|Death|14|||
125001146|NCT02060721|449634049|FG000|Overall Study|Withdrawal by Subject|2|||
125001147|NCT02060721|449634049|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
125001148|NCT00117507|449634050|FG000|Overall Study|Adverse Event|4|||
125001149|NCT00117507|449634050|FG000|Overall Study|Abnormal laboratory values|3|||
125001150|NCT00117507|449634050|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125001151|NCT00117507|449634050|FG000|Overall Study|Patient withdrew consent|4|||
125001152|NCT00117507|449634050|FG000|Overall Study|Death|3|||
125001153|NCT00866723|449634051|FG000|Overall Study|Withdrawal by Subject|1|||
125001154|NCT00866723|449634051|FG000|Overall Study|Disease Progression|4|||
125001155|NCT01271803|449634052|FG000|Overall Study|Progressive disease|0|||
125001156|NCT01271803|449634053|FG001|Overall Study|Progressive disease|0|||
125001157|NCT01271803|449634054|FG002|Overall Study|Progressive disease|2|||
125330777|NCT00998296|450842622|FG004|Overall Study|Reason other than those specified above|0|||
125330778|NCT00998296|450842623|FG005|Overall Study|Reason other than those specified above|0|||
125001158|NCT01271803|449634052|FG000|Overall Study|Death|53|||
125001159|NCT01271803|449634053|FG001|Overall Study|Death|34|||
125001160|NCT01271803|449634054|FG002|Overall Study|Death|0|||
125001161|NCT01271803|449634052|FG000|Overall Study|Withdrawal by Subject|1|||
125001162|NCT01271803|449634053|FG001|Overall Study|Withdrawal by Subject|5|||
125001163|NCT01271803|449634054|FG002|Overall Study|Withdrawal by Subject|0|||
125001164|NCT01271803|449634052|FG000|Overall Study|Lost to Follow-up|1|||
125001165|NCT01271803|449634053|FG001|Overall Study|Lost to Follow-up|0|||
125001166|NCT01271803|449634054|FG002|Overall Study|Lost to Follow-up|0|||
125001167|NCT01862640|449634058|FG000|Overall Study|Adverse Event|4|||
125001168|NCT01862640|449634059|FG001|Overall Study|Adverse Event|10|||
125001169|NCT01862640|449634060|FG002|Overall Study|Adverse Event|6|||
125001170|NCT01862640|449634061|FG003|Overall Study|Adverse Event|8|||
125001171|NCT01862640|449634058|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
125001172|NCT01862640|449634059|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
125001173|NCT01862640|449634060|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
125001174|NCT01862640|449634061|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
125001175|NCT01862640|449634058|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
125001176|NCT01862640|449634059|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
125001177|NCT01862640|449634060|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
125001178|NCT01862640|449634061|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
125001179|NCT01862640|449634058|FG000|Overall Study|Withdrawal by Subject|2|||
125001180|NCT01862640|449634059|FG001|Overall Study|Withdrawal by Subject|4|||
125001181|NCT01862640|449634060|FG002|Overall Study|Withdrawal by Subject|8|||
125330779|NCT00998296|450842624|FG006|Overall Study|Reason other than those specified above|0|||
125330780|NCT00998296|450842625|FG007|Overall Study|Reason other than those specified above|0|||
125330781|NCT00998296|450842626|FG008|Overall Study|Reason other than those specified above|0|||
125330782|NCT00998296|450842627|FG009|Overall Study|Reason other than those specified above|1|||
125330783|NCT00998296|450842628|FG010|Overall Study|Reason other than those specified above|0|||
125330784|NCT02346721|450842629|FG000|Overall Study|Withdrew Consent|3|||
125330785|NCT02346721|450842629|FG000|Overall Study|Lack of Efficacy|1|||
125330786|NCT03219528|450842635|FG000|Overall Study|Lost to Follow-up|5|||
125330787|NCT03219528|450842636|FG001|Overall Study|Lost to Follow-up|4|||
125330788|NCT03219528|450842635|FG000|Overall Study|Withdrawal by Subject|4|||
125330789|NCT03219528|450842636|FG001|Overall Study|Withdrawal by Subject|4|||
125330790|NCT02120898|450842637|FG000|Overall Study|Withdrawal by Subject|4|||
125330791|NCT02120898|450842638|FG001|Overall Study|Withdrawal by Subject|2|||
125330792|NCT02120898|450842639|FG002|Overall Study|Withdrawal by Subject|2|||
125330793|NCT02120898|450842637|FG000|Overall Study|Non-compliance with study drug|3|||
125330794|NCT02120898|450842638|FG001|Overall Study|Non-compliance with study drug|0|||
125330795|NCT02120898|450842639|FG002|Overall Study|Non-compliance with study drug|0|||
125330796|NCT02120898|450842637|FG000|Overall Study|Adverse Event|1|||
125330797|NCT02120898|450842638|FG001|Overall Study|Adverse Event|2|||
125330798|NCT02120898|450842639|FG002|Overall Study|Adverse Event|1|||
125330799|NCT02120898|450842637|FG000|Overall Study|Protocol Violation|1|||
125330800|NCT02120898|450842638|FG001|Overall Study|Protocol Violation|2|||
125330801|NCT02120898|450842639|FG002|Overall Study|Protocol Violation|0|||
125001182|NCT01862640|449634061|FG003|Overall Study|Withdrawal by Subject|5|||
125001183|NCT01862640|449634058|FG000|Overall Study|Protocol Deviation|0|||
125001184|NCT01862640|449634059|FG001|Overall Study|Protocol Deviation|0|||
125001185|NCT01862640|449634060|FG002|Overall Study|Protocol Deviation|1|||
125001186|NCT01862640|449634061|FG003|Overall Study|Protocol Deviation|0|||
125001187|NCT05211739|449634062|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
125001188|NCT05211739|449634063|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
125001189|NCT05211739|449634062|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
125001190|NCT05211739|449634063|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
125330802|NCT02120898|450842637|FG000|Overall Study|Lost to Follow-up|0|||
125330803|NCT02120898|450842638|FG001|Overall Study|Lost to Follow-up|0|||
125001191|NCT05211739|449634062|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
125001192|NCT05211739|449634063|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
125001193|NCT05211739|449634062|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
125001194|NCT05211739|449634063|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
125001195|NCT02178553|449634066|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
125001196|NCT02178553|449634067|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
125001197|NCT02178553|449634066|FG000|Overall Study|Physician Decision|0|||
125001198|NCT02178553|449634067|FG001|Overall Study|Physician Decision|4|||
125001199|NCT02178553|449634066|FG000|Overall Study|Technical problem with injection|1|||
125001200|NCT02178553|449634067|FG001|Overall Study|Technical problem with injection|3|||
125001201|NCT01975428|449634068|FG000|Overall Study|Lost to Follow-up|17|||
125001202|NCT01975428|449634069|FG001|Overall Study|Lost to Follow-up|4|||
125001203|NCT01975428|449634068|FG000|Overall Study|Withdrawal by Subject|3|||
125001204|NCT01975428|449634069|FG001|Overall Study|Withdrawal by Subject|10|||
125001205|NCT02187809|449634070|FG000|Overall Study|The study was terminated|3|||
125001206|NCT05085665|449634071|FG000|Overall Study|Physician Decision|2|||
125001207|NCT01641809|449634072|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
125001208|NCT01641809|449634073|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
125001209|NCT01641809|449634074|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
125001210|NCT01641809|449634075|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
125001211|NCT01641809|449634072|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
125001212|NCT01641809|449634073|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
125001213|NCT01641809|449634074|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
125001214|NCT01641809|449634075|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
125001215|NCT01641809|449634072|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
125001216|NCT01641809|449634073|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
125001217|NCT01641809|449634074|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
125001218|NCT01641809|449634075|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
125001219|NCT01641809|449634072|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
125001220|NCT01641809|449634073|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
125001221|NCT01641809|449634074|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
125001222|NCT01641809|449634075|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
125001223|NCT01641809|449634072|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
125001224|NCT01641809|449634073|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
125001225|NCT01641809|449634074|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
125001226|NCT01641809|449634075|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
125001227|NCT01641809|449634072|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
125001228|NCT01641809|449634073|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
125001229|NCT01641809|449634074|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
125001230|NCT01641809|449634075|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
125001231|NCT01641809|449634072|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
125001232|NCT01641809|449634073|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
125001233|NCT01641809|449634074|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
125001234|NCT01641809|449634075|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
125001235|NCT01641809|449634072|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
125001236|NCT01641809|449634073|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
125001237|NCT01641809|449634074|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
125001238|NCT01641809|449634075|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
125001239|NCT01641809|449634072|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
125001240|NCT01641809|449634073|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
125001241|NCT01641809|449634074|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
125001242|NCT01641809|449634075|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
125001243|NCT01641809|449634072|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
125001244|NCT01641809|449634073|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
125001245|NCT01641809|449634074|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
125001246|NCT01641809|449634075|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
125001247|NCT01641809|449634072|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
125001248|NCT01641809|449634073|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
125001249|NCT01641809|449634074|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
125001250|NCT01641809|449634075|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
125001251|NCT01641809|449634072|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
125001252|NCT01641809|449634073|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
125001253|NCT01641809|449634074|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
125001254|NCT01641809|449634075|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
125001255|NCT01641809|449634072|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
125001256|NCT01641809|449634073|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
125001257|NCT01641809|449634074|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
125001258|NCT01641809|449634075|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
125001259|NCT01641809|449634072|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
125001260|NCT01641809|449634073|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
125001261|NCT01641809|449634074|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
125001262|NCT01641809|449634075|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
125001263|NCT01641809|449634072|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
125001264|NCT01641809|449634073|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
125001265|NCT01641809|449634074|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
125001266|NCT01641809|449634075|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
125001267|NCT01641809|449634072|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
125001268|NCT01641809|449634073|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
125001269|NCT01641809|449634074|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
125001270|NCT01641809|449634075|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
125001271|NCT01641809|449634072|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
125001272|NCT01641809|449634073|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
125001273|NCT01641809|449634074|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
125001274|NCT01641809|449634075|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
125001275|NCT01641809|449634072|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
125001276|NCT01641809|449634073|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
125001277|NCT01641809|449634074|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
125330804|NCT02120898|450842639|FG002|Overall Study|Lost to Follow-up|1|||
125330805|NCT00831181|450842640|FG000|Overall Study|Adverse Event|12|||
125001278|NCT01641809|449634075|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
125001279|NCT03690141|449634076|FG000|Overall Study|Adverse Event|5|||
125001280|NCT03690141|449634076|FG000|Overall Study|Withdrawal by Subject|3|||
125001281|NCT03690141|449634076|FG000|Overall Study|Physician Decision|4|||
125001282|NCT03690141|449634076|FG000|Overall Study|Disease progression|4|||
125001283|NCT00778622|449634077|FG000|Overall Study|Adverse Event|5|||
125001284|NCT00778622|449634078|FG001|Overall Study|Adverse Event|4|||
125001285|NCT00778622|449634079|FG002|Overall Study|Adverse Event|7|||
125001286|NCT00778622|449634077|FG000|Overall Study|Withdrawal by Subject|4|||
125001287|NCT00778622|449634078|FG001|Overall Study|Withdrawal by Subject|5|||
125001288|NCT00778622|449634079|FG002|Overall Study|Withdrawal by Subject|5|||
125001289|NCT00778622|449634077|FG000|Overall Study|Lost to Follow-up|3|||
125001290|NCT00778622|449634078|FG001|Overall Study|Lost to Follow-up|3|||
125001291|NCT00778622|449634079|FG002|Overall Study|Lost to Follow-up|2|||
125001292|NCT00778622|449634077|FG000|Overall Study|Protocol Violation|0|||
125001293|NCT00778622|449634078|FG001|Overall Study|Protocol Violation|3|||
125001294|NCT00778622|449634079|FG002|Overall Study|Protocol Violation|0|||
125330806|NCT00196313|450842643|FG000|Overall Study|Protocol Violation|2|||
125330807|NCT00196313|450842644|FG001|Overall Study|Protocol Violation|3|||
125330808|NCT00196313|450842643|FG000|Overall Study|Withdrawal by Subject|3|||
125330809|NCT00196313|450842644|FG001|Overall Study|Withdrawal by Subject|1|||
125330810|NCT00196313|450842643|FG000|Overall Study|Adverse Event|3|||
125330811|NCT00196313|450842644|FG001|Overall Study|Adverse Event|1|||
125330812|NCT00196313|450842643|FG000|Overall Study|Subject Pregnant|1|||
125330813|NCT00196313|450842644|FG001|Overall Study|Subject Pregnant|1|||
125330814|NCT00196313|450842643|FG000|Overall Study|Lost to Follow-up|2|||
125330815|NCT00196313|450842644|FG001|Overall Study|Lost to Follow-up|2|||
125330816|NCT00043979|450842645|FG000|Period 1|recipient with progressive disease|7|||
125330817|NCT00043979|450842646|FG001|Period 1|recipient with progressive disease|4|||
125330818|NCT00043979|450842647|FG002|Period 1|recipient with progressive disease|3|||
125330819|NCT04085289|450842648|FG000|Overall Study|Withdrawal by Subject|0|||
125330820|NCT04085289|450842649|FG001|Overall Study|Withdrawal by Subject|0|||
125330821|NCT04085289|450842650|FG002|Overall Study|Withdrawal by Subject|1|||
125001295|NCT00778622|449634077|FG000|Overall Study|Lack of Efficacy|2|||
125001296|NCT00778622|449634078|FG001|Overall Study|Lack of Efficacy|0|||
125001297|NCT00778622|449634079|FG002|Overall Study|Lack of Efficacy|0|||
125001298|NCT00778622|449634077|FG000|Overall Study|immigration|1|||
125001299|NCT00778622|449634078|FG001|Overall Study|immigration|0|||
125001300|NCT00778622|449634079|FG002|Overall Study|immigration|0|||
125001301|NCT00778622|449634077|FG000|Overall Study|Other|1|||
125001302|NCT00778622|449634078|FG001|Overall Study|Other|0|||
125001303|NCT00778622|449634079|FG002|Overall Study|Other|1|||
125001304|NCT01505010|449634080|FG000|Overall Study|Protocol Violation|0|||
125001305|NCT01505010|449634081|FG001|Overall Study|Protocol Violation|1|||
125001306|NCT01505010|449634080|FG000|Overall Study|Lost to Follow-up|0|||
125001307|NCT01505010|449634081|FG001|Overall Study|Lost to Follow-up|1|||
125001308|NCT02558231|449634085|FG000|Overall Study|Death|4|||
125001309|NCT02558231|449634086|FG001|Overall Study|Death|12|||
125001310|NCT02558231|449634085|FG000|Overall Study|Lost to Follow-up|7|||
125330822|NCT02919995|450842654|FG000|Overall Study|Adverse Event|0|||
125330823|NCT02919995|450842655|FG001|Overall Study|Adverse Event|0|||
125330824|NCT02919995|450842656|FG002|Overall Study|Adverse Event|0|||
125330825|NCT02919995|450842657|FG003|Overall Study|Adverse Event|0|||
125330826|NCT02919995|450842658|FG004|Overall Study|Adverse Event|0|||
125330827|NCT02919995|450842659|FG005|Overall Study|Adverse Event|1|||
125330828|NCT03196349|450842660|FG000|Overall Study|Did not receive study drug|0|||
125330829|NCT03196349|450842661|FG001|Overall Study|Did not receive study drug|1|||
125330830|NCT03196349|450842662|FG002|Overall Study|Did not receive study drug|2|||
125330831|NCT03196349|450842660|FG000|Overall Study|No data entered|2|||
125330832|NCT03196349|450842661|FG001|Overall Study|No data entered|4|||
125330833|NCT03196349|450842662|FG002|Overall Study|No data entered|0|||
125330834|NCT03196349|450842660|FG000|Overall Study|Study Terminated early|15|||
125330835|NCT03196349|450842661|FG001|Overall Study|Study Terminated early|9|||
125330836|NCT03196349|450842662|FG002|Overall Study|Study Terminated early|11|||
125330837|NCT02892448|450842672|FG000|Overall Study|Screening failure|2|||
125330838|NCT02892448|450842673|FG001|Overall Study|Screening failure|2|||
125330839|NCT02892448|450842674|FG002|Overall Study|Screening failure|1|||
125330840|NCT01012440|450842675|FG000|Overall Study|Withdrawal by Subject|2|||
125330841|NCT00594815|450842676|FG000|Overall Study|Never Treated|3|||
125330842|NCT00594815|450842676|FG000|Overall Study|Withdrawal by Subject|2|||
125330843|NCT00594815|450842676|FG000|Overall Study|Toxicity|4|||
125330844|NCT02691507|450842677|FG000|Overall Study|Missed Visit 3|0|||
125330845|NCT02691507|450842678|FG001|Overall Study|Missed Visit 3|1|||
125330846|NCT01812252|450842679|FG000|Overall Study|Persistent Disease|1|||
125330847|NCT01812252|450842680|FG001|Overall Study|Persistent Disease|0|||
125330848|NCT01812252|450842679|FG000|Overall Study|Not transplanted|11|||
125330849|NCT01812252|450842680|FG001|Overall Study|Not transplanted|11|||
125330850|NCT01812252|450842679|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
125330851|NCT01812252|450842680|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
125330852|NCT01812252|450842679|FG000|Overall Study|Withdrawal by Subject|1|||
125330853|NCT01812252|450842680|FG001|Overall Study|Withdrawal by Subject|1|||
125330854|NCT01812252|450842679|FG000|Overall Study|Screen Failure|1|||
125330855|NCT01812252|450842680|FG001|Overall Study|Screen Failure|0|||
125330856|NCT04634253|450842682|FG000|Overall Study|Adverse Event|1|||
125330857|NCT04634253|450842683|FG001|Overall Study|Adverse Event|1|||
125330858|NCT04634253|450842684|FG002|Overall Study|Adverse Event|0|||
125330859|NCT04634253|450842682|FG000|Overall Study|Physician Decision|0|||
125330860|NCT04634253|450842683|FG001|Overall Study|Physician Decision|1|||
125330861|NCT04634253|450842684|FG002|Overall Study|Physician Decision|0|||
125330862|NCT04634253|450842682|FG000|Overall Study|Withdrawal by Subject|1|||
125330863|NCT04634253|450842683|FG001|Overall Study|Withdrawal by Subject|0|||
125330864|NCT04634253|450842684|FG002|Overall Study|Withdrawal by Subject|3|||
125330865|NCT03155841|450842685|FG000|Overall Study|Protocol Violation|3|||
125001311|NCT02558231|449634086|FG001|Overall Study|Lost to Follow-up|4|||
125001312|NCT02558231|449634085|FG000|Overall Study|Withdrawal by Subject|7|||
125001313|NCT02558231|449634086|FG001|Overall Study|Withdrawal by Subject|4|||
125001314|NCT02558231|449634085|FG000|Overall Study|Physician Decision|7|||
125001315|NCT02558231|449634086|FG001|Overall Study|Physician Decision|5|||
125001316|NCT02558231|449634085|FG000|Overall Study|Sponsor Decision|0|||
125001317|NCT02558231|449634086|FG001|Overall Study|Sponsor Decision|1|||
125001318|NCT02536755|449634088|FG000|Overall Study|Adverse Event|4|||
125001319|NCT02301936|449634089|FG000|Overall Study|Lost to Follow-up|1|||
125001320|NCT02301936|449634090|FG001|Overall Study|Lost to Follow-up|0|||
125001321|NCT03065023|449634092|FG000|Overall Study|Progressive Disease|0|||
125001322|NCT03065023|449634093|FG001|Overall Study|Progressive Disease|1|||
125001323|NCT03065023|449634094|FG002|Overall Study|Progressive Disease|0|||
125001324|NCT03065023|449634095|FG003|Overall Study|Progressive Disease|0|||
125001325|NCT03065023|449634096|FG004|Overall Study|Progressive Disease|0|||
125001326|NCT03065023|449634092|FG000|Overall Study|Death|2|||
125001327|NCT03065023|449634093|FG001|Overall Study|Death|0|||
125001328|NCT03065023|449634094|FG002|Overall Study|Death|1|||
125001329|NCT03065023|449634095|FG003|Overall Study|Death|1|||
125001330|NCT03065023|449634096|FG004|Overall Study|Death|0|||
125001331|NCT03065023|449634092|FG000|Overall Study|Lost to Follow-up|0|||
125001332|NCT03065023|449634093|FG001|Overall Study|Lost to Follow-up|1|||
125001333|NCT03065023|449634094|FG002|Overall Study|Lost to Follow-up|0|||
125001334|NCT03065023|449634095|FG003|Overall Study|Lost to Follow-up|0|||
125001335|NCT03065023|449634096|FG004|Overall Study|Lost to Follow-up|0|||
125001336|NCT03065023|449634092|FG000|Overall Study|Participant Decision|0|||
125001337|NCT03065023|449634093|FG001|Overall Study|Participant Decision|0|||
125001338|NCT03065023|449634094|FG002|Overall Study|Participant Decision|0|||
125330866|NCT03155841|450842686|FG001|Overall Study|Protocol Violation|4|||
125330867|NCT03529422|450842691|FG000|Overall Study|Withdrawal by Subject|1|||
125330868|NCT03529422|450842691|FG000|Overall Study|Protocol Violation|1|||
125001339|NCT03065023|449634095|FG003|Overall Study|Participant Decision|1|||
125001340|NCT03065023|449634096|FG004|Overall Study|Participant Decision|0|||
125001341|NCT03065023|449634092|FG000|Overall Study|Withdrawal by Subject|0|||
125001342|NCT03065023|449634093|FG001|Overall Study|Withdrawal by Subject|0|||
125001343|NCT03065023|449634094|FG002|Overall Study|Withdrawal by Subject|0|||
125330869|NCT03529422|450842691|FG000|Overall Study|Disease progression|2|||
125330870|NCT05006573|450842692|FG000|Double-blind Treatment Period|Physician Decision|2|||
125330871|NCT05006573|450842693|FG001|Double-blind Treatment Period|Physician Decision|0|||
125330872|NCT05006573|450842692|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
125001344|NCT03065023|449634095|FG003|Overall Study|Withdrawal by Subject|1|||
125001345|NCT03065023|449634096|FG004|Overall Study|Withdrawal by Subject|0|||
125001346|NCT04029961|449634097|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
125001347|NCT04029961|449634098|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
125001348|NCT04029961|449634097|FG000|Overall Study|Change in Treatment Course|0|||
125001349|NCT04029961|449634098|FG001|Overall Study|Change in Treatment Course|1|||
125001350|NCT03427125|449634099|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
125001351|NCT03427125|449634100|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
125001352|NCT03427125|449634101|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
125001353|NCT05975840|449634104|FG000|Overall Study|Other|1|||
125001354|NCT05975840|449634105|FG001|Overall Study|Other|0|||
125330873|NCT05006573|450842693|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
125330874|NCT05006573|450842692|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
125330875|NCT05006573|450842693|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
125330876|NCT05006573|450842692|FG000|Double-blind Treatment Period|Protocol Violation|2|||
125330877|NCT05006573|450842693|FG001|Double-blind Treatment Period|Protocol Violation|0|||
125001355|NCT05975840|449634106|FG002|Overall Study|Other|0|||
125001356|NCT05975840|449634107|FG003|Overall Study|Other|0|||
125001357|NCT05975840|449634108|FG004|Overall Study|Other|1|||
125001358|NCT05975840|449634109|FG005|Overall Study|Other|0|||
125001359|NCT05975840|449634110|FG006|Overall Study|Other|0|||
125001360|NCT05975840|449634111|FG007|Overall Study|Other|0|||
125001361|NCT05975840|449634104|FG000|Overall Study|Lost to Follow-up|3|||
125001362|NCT05975840|449634105|FG001|Overall Study|Lost to Follow-up|6|||
125001363|NCT05975840|449634106|FG002|Overall Study|Lost to Follow-up|3|||
125001364|NCT05975840|449634107|FG003|Overall Study|Lost to Follow-up|1|||
125001365|NCT05975840|449634108|FG004|Overall Study|Lost to Follow-up|4|||
125001366|NCT05975840|449634109|FG005|Overall Study|Lost to Follow-up|1|||
125001367|NCT05975840|449634110|FG006|Overall Study|Lost to Follow-up|2|||
125001368|NCT05975840|449634111|FG007|Overall Study|Lost to Follow-up|4|||
125001369|NCT05975840|449634104|FG000|Overall Study|Migrated/moved from the study area|1|||
125001370|NCT05975840|449634105|FG001|Overall Study|Migrated/moved from the study area|0|||
125001371|NCT05975840|449634106|FG002|Overall Study|Migrated/moved from the study area|0|||
125001372|NCT05975840|449634107|FG003|Overall Study|Migrated/moved from the study area|0|||
125330878|NCT05006573|450842692|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
125330879|NCT05006573|450842693|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
125330880|NCT05006573|450842692|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
125330881|NCT05006573|450842693|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
125330882|NCT01967238|450842694|FG000|Overall Study|Adverse Event|1|||
125330883|NCT01967238|450842695|FG001|Overall Study|Adverse Event|1|||
125330884|NCT01967238|450842696|FG002|Overall Study|Adverse Event|0|||
125330885|NCT01967238|450842694|FG000|Overall Study|Lost to Follow-up|1|||
125330886|NCT01967238|450842695|FG001|Overall Study|Lost to Follow-up|0|||
125330887|NCT01967238|450842696|FG002|Overall Study|Lost to Follow-up|1|||
125330888|NCT01967238|450842694|FG000|Overall Study|Withdrawal by Subject|0|||
125330889|NCT01967238|450842695|FG001|Overall Study|Withdrawal by Subject|0|||
125330890|NCT01967238|450842696|FG002|Overall Study|Withdrawal by Subject|1|||
125330891|NCT05232682|450842697|FG000|Overall Study|Lost to Follow-up|2|||
125330892|NCT03387085|450842698|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
125330893|NCT01442103|450843983|FG000|Overall Study|Lost to Follow-up|2|||
125330894|NCT02202759|450843984|FG000|Overall Study|Study Terminated by Sponsor|3|||
125330895|NCT02202759|450843985|FG001|Overall Study|Study Terminated by Sponsor|3|||
125330896|NCT02202759|450843986|FG002|Overall Study|Study Terminated by Sponsor|3|||
125330897|NCT02202759|450843984|FG000|Overall Study|Withdrawal by Subject|2|||
125330898|NCT02202759|450843985|FG001|Overall Study|Withdrawal by Subject|1|||
125001373|NCT05975840|449634108|FG004|Overall Study|Migrated/moved from the study area|0|||
125001374|NCT05975840|449634109|FG005|Overall Study|Migrated/moved from the study area|0|||
125001375|NCT05975840|449634110|FG006|Overall Study|Migrated/moved from the study area|0|||
125001376|NCT05975840|449634111|FG007|Overall Study|Migrated/moved from the study area|0|||
125001377|NCT05975840|449634104|FG000|Overall Study|Withdrawal by Subject|0|||
125001378|NCT05975840|449634105|FG001|Overall Study|Withdrawal by Subject|5|||
125001379|NCT05975840|449634106|FG002|Overall Study|Withdrawal by Subject|2|||
125001380|NCT05975840|449634107|FG003|Overall Study|Withdrawal by Subject|2|||
125330899|NCT02202759|450843986|FG002|Overall Study|Withdrawal by Subject|1|||
125330900|NCT02202759|450843984|FG000|Overall Study|Reason not Specified|4|||
125330901|NCT02202759|450843985|FG001|Overall Study|Reason not Specified|11|||
125001381|NCT05975840|449634108|FG004|Overall Study|Withdrawal by Subject|0|||
125001382|NCT05975840|449634109|FG005|Overall Study|Withdrawal by Subject|2|||
125330902|NCT02202759|450843986|FG002|Overall Study|Reason not Specified|10|||
125001383|NCT05975840|449634110|FG006|Overall Study|Withdrawal by Subject|2|||
125001384|NCT05975840|449634111|FG007|Overall Study|Withdrawal by Subject|1|||
125001385|NCT05975840|449634104|FG000|Overall Study|Protocol Violation|0|||
125001386|NCT05975840|449634105|FG001|Overall Study|Protocol Violation|1|||
125001387|NCT05975840|449634106|FG002|Overall Study|Protocol Violation|0|||
125001388|NCT05975840|449634107|FG003|Overall Study|Protocol Violation|0|||
125001389|NCT05975840|449634108|FG004|Overall Study|Protocol Violation|0|||
125001390|NCT05975840|449634109|FG005|Overall Study|Protocol Violation|0|||
125001391|NCT05975840|449634110|FG006|Overall Study|Protocol Violation|0|||
125001392|NCT05975840|449634111|FG007|Overall Study|Protocol Violation|0|||
125001393|NCT05975840|449634104|FG000|Overall Study|Adverse Event|0|||
125001394|NCT05975840|449634105|FG001|Overall Study|Adverse Event|0|||
125001395|NCT05975840|449634106|FG002|Overall Study|Adverse Event|0|||
125001396|NCT05975840|449634107|FG003|Overall Study|Adverse Event|1|||
125001397|NCT05975840|449634108|FG004|Overall Study|Adverse Event|0|||
125001398|NCT05975840|449634109|FG005|Overall Study|Adverse Event|0|||
125001399|NCT05975840|449634110|FG006|Overall Study|Adverse Event|0|||
125001400|NCT05975840|449634111|FG007|Overall Study|Adverse Event|0|||
125001401|NCT05975840|449634104|FG000|Overall Study|Death|0|||
125001402|NCT05975840|449634105|FG001|Overall Study|Death|1|||
125001403|NCT05975840|449634106|FG002|Overall Study|Death|0|||
125001404|NCT05975840|449634107|FG003|Overall Study|Death|0|||
125001405|NCT05975840|449634108|FG004|Overall Study|Death|0|||
125001406|NCT05975840|449634109|FG005|Overall Study|Death|0|||
125001407|NCT05975840|449634110|FG006|Overall Study|Death|0|||
125001408|NCT05975840|449634111|FG007|Overall Study|Death|1|||
125001409|NCT04014361|449634114|FG000|Period 2|Physician Decision|0|||
125001410|NCT04014361|449634115|FG001|Period 2|Physician Decision|0|||
125001411|NCT04014361|449634116|FG002|Period 2|Physician Decision|0|||
125001412|NCT04014361|449634117|FG003|Period 2|Physician Decision|1|||
125001413|NCT04014361|449634118|FG004|Period 2|Physician Decision|0|||
125001414|NCT04014361|449634119|FG005|Period 2|Physician Decision|0|||
125001415|NCT04014361|449634120|FG006|Period 2|Physician Decision|0|||
125001416|NCT04014361|449634121|FG007|Period 2|Physician Decision|0|||
125001417|NCT01130051|449634123|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
125001418|NCT01130051|449634124|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
125001419|NCT01130051|449634123|FG000|Washout Period of 14 Days|Protocol Violation|1|||
125001420|NCT01130051|449634124|FG001|Washout Period of 14 Days|Protocol Violation|1|||
125001421|NCT04252287|449634127|FG000|Overall Study|Death|5|||
125001422|NCT04252287|449634128|FG001|Overall Study|Death|3|||
125001423|NCT04252287|449634127|FG000|Overall Study|Lost to Follow-up|4|||
125001424|NCT04252287|449634128|FG001|Overall Study|Lost to Follow-up|6|||
125001425|NCT04252287|449634127|FG000|Overall Study|Withdrawal by Subject|19|||
125001426|NCT04252287|449634128|FG001|Overall Study|Withdrawal by Subject|16|||
125001427|NCT04252287|449634127|FG000|Overall Study|Protocol Violation|3|||
125001428|NCT04252287|449634128|FG001|Overall Study|Protocol Violation|4|||
125001429|NCT03610165|449634131|FG000|Overall Study|Device didn't work|0|||
125001430|NCT03610165|449634132|FG001|Overall Study|Device didn't work|1|||
125001431|NCT04667247|449634134|FG000|Overall Study|Withdrawal by Subject|0|||
125001432|NCT04667247|449634135|FG001|Overall Study|Withdrawal by Subject|1|||
125001433|NCT06950879|449634136|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
125001434|NCT01444651|449635575|FG000|Overall Study|Adverse Event|3|||
125001435|NCT01444651|449635576|FG001|Overall Study|Adverse Event|2|||
125001436|NCT01444651|449635575|FG000|Overall Study|Lost to Follow-up|5|||
125001437|NCT01444651|449635576|FG001|Overall Study|Lost to Follow-up|5|||
125001438|NCT01444651|449635575|FG000|Overall Study|Non-fasting|2|||
125001439|NCT01444651|449635576|FG001|Overall Study|Non-fasting|1|||
125001440|NCT01444651|449635575|FG000|Overall Study|Missing data|1|||
125001441|NCT01444651|449635576|FG001|Overall Study|Missing data|1|||
125001442|NCT03383289|449635579|FG000|Overall Study|Death|83|||
125330903|NCT01987453|450843987|FG000|Overall Study|Death|0|||
125330904|NCT01987453|450843988|FG001|Overall Study|Death|0|||
125330905|NCT01987453|450843989|FG002|Overall Study|Death|1|||
125330906|NCT01987453|450843987|FG000|Overall Study|Lack of Efficacy|1|||
125330907|NCT01987453|450843988|FG001|Overall Study|Lack of Efficacy|12|||
125330908|NCT01987453|450843989|FG002|Overall Study|Lack of Efficacy|0|||
125330909|NCT01590888|450843991|FG000|Overall Study|Adverse Event|3|||
125330910|NCT01590888|450843992|FG001|Overall Study|Adverse Event|0|||
125330911|NCT01590888|450843993|FG002|Overall Study|Adverse Event|1|||
125330912|NCT01590888|450843991|FG000|Overall Study|Lost to Follow-up|1|||
125330913|NCT01590888|450843992|FG001|Overall Study|Lost to Follow-up|0|||
125330914|NCT01590888|450843993|FG002|Overall Study|Lost to Follow-up|0|||
125330915|NCT01646125|450843994|FG000|Overall Study|Untreated|2|||
125330916|NCT01646125|450843995|FG001|Overall Study|Untreated|5|||
125330917|NCT01646125|450843994|FG000|Overall Study|Adverse Event|2|||
125001443|NCT03383289|449635580|FG001|Overall Study|Death|78|||
125001444|NCT03383289|449635579|FG000|Overall Study|discharge from facility|84|||
125001445|NCT03383289|449635580|FG001|Overall Study|discharge from facility|84|||
125001446|NCT03383289|449635579|FG000|Overall Study|Withdrawal by Subject|4|||
125001447|NCT03383289|449635580|FG001|Overall Study|Withdrawal by Subject|1|||
125001448|NCT00832117|449635581|FG000|Overall Study|Death|1|||
125001449|NCT00832117|449635581|FG000|Overall Study|Disease Progression|11|||
125001450|NCT00404066|449635582|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
125001451|NCT00404066|449635582|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
125330918|NCT01646125|450843995|FG001|Overall Study|Adverse Event|1|||
125330919|NCT01646125|450843994|FG000|Overall Study|Death|1|||
125330920|NCT01646125|450843995|FG001|Overall Study|Death|1|||
125330921|NCT01646125|450843994|FG000|Overall Study|Physician Decision|1|||
125330922|NCT01646125|450843995|FG001|Overall Study|Physician Decision|3|||
125330923|NCT01646125|450843994|FG000|Overall Study|Progressive disease|22|||
125330924|NCT01646125|450843995|FG001|Overall Study|Progressive disease|16|||
125330925|NCT01646125|450843994|FG000|Overall Study|Study terminated by sponsor|2|||
125330926|NCT01646125|450843995|FG001|Overall Study|Study terminated by sponsor|1|||
125330927|NCT01646125|450843994|FG000|Overall Study|Subject/Guardian decision|1|||
125330928|NCT01646125|450843995|FG001|Overall Study|Subject/Guardian decision|1|||
125330929|NCT05462756|450843998|FG000|Treatment Period|Adverse Event|3|||
125330930|NCT05462756|450843999|FG001|Treatment Period|Adverse Event|0|||
125330931|NCT05462756|450843998|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
125330932|NCT05462756|450843999|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
125330933|NCT05462756|450843998|FG000|Treatment Period|Death|0|||
125330934|NCT05462756|450843999|FG001|Treatment Period|Death|1|||
125330935|NCT05462756|450843998|FG000|Treatment Period|Lost to Follow-up|2|||
125330936|NCT05462756|450843999|FG001|Treatment Period|Lost to Follow-up|1|||
125330937|NCT05462756|450843998|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
125330938|NCT05462756|450843999|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
125330939|NCT05462756|450843998|FG000|Treatment Period|Physician Decision|2|||
125001452|NCT01524133|449635585|FG000|Treatment Phase|Withdrawal by Subject|13|||
125001453|NCT01524133|449635586|FG001|Treatment Phase|Withdrawal by Subject|28|||
125001454|NCT01524133|449635587|FG002|Treatment Phase|Withdrawal by Subject|31|||
125001455|NCT01524133|449635585|FG000|Treatment Phase|Physician Decision|6|||
125001456|NCT01524133|449635586|FG001|Treatment Phase|Physician Decision|3|||
125001457|NCT01524133|449635587|FG002|Treatment Phase|Physician Decision|3|||
125001458|NCT01524133|449635585|FG000|Treatment Phase|Lost to Follow-up|0|||
125001459|NCT01524133|449635586|FG001|Treatment Phase|Lost to Follow-up|1|||
125001460|NCT01524133|449635587|FG002|Treatment Phase|Lost to Follow-up|2|||
125001461|NCT01524133|449635585|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
125001462|NCT01524133|449635586|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
125001463|NCT01524133|449635587|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
125001464|NCT01524133|449635585|FG000|Overall Study 52 Weeks|Physician Decision|1|||
125001465|NCT01524133|449635586|FG001|Overall Study 52 Weeks|Physician Decision|0|||
125001466|NCT01524133|449635587|FG002|Overall Study 52 Weeks|Physician Decision|2|||
125001467|NCT01524133|449635585|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
125001468|NCT01524133|449635586|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
125001469|NCT01524133|449635587|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
125001470|NCT03842163|449635592|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
125001471|NCT03842163|449635592|FG000|Overall Study|Scintigraphy was not performed|44|||
125001472|NCT03829241|449635593|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
125001473|NCT03829241|449635594|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
125001474|NCT03829241|449635593|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
125001475|NCT03829241|449635594|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
125001476|NCT03829241|449635593|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
125001477|NCT03829241|449635594|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
125001478|NCT03829241|449635593|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
125001479|NCT03829241|449635594|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
125001480|NCT03829241|449635593|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
125001481|NCT03829241|449635594|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
125001482|NCT03829241|449635593|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
125001483|NCT03829241|449635594|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
125001484|NCT03829241|449635593|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
125001485|NCT03829241|449635594|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
125001486|NCT03829241|449635593|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
125001487|NCT03829241|449635594|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
125001488|NCT03829241|449635593|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
125001489|NCT03829241|449635594|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
125001490|NCT03829241|449635593|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
125001491|NCT03829241|449635594|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
125001492|NCT03829241|449635593|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
125001493|NCT03829241|449635594|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
125330940|NCT05462756|450843999|FG001|Treatment Period|Physician Decision|0|||
125330941|NCT05462756|450843998|FG000|Treatment Period|Protocol Violation|0|||
125330942|NCT05462756|450843999|FG001|Treatment Period|Protocol Violation|1|||
125330943|NCT05462756|450843998|FG000|Treatment Period|Withdrawal by Subject|5|||
125330944|NCT05462756|450843999|FG001|Treatment Period|Withdrawal by Subject|12|||
125330945|NCT05462756|450843998|FG000|Follow-Up Period|Adverse Event|1|||
125001494|NCT03829241|449635593|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
125001495|NCT03829241|449635594|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
125330946|NCT05462756|450843999|FG001|Follow-Up Period|Adverse Event|0|||
125001496|NCT03829241|449635593|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
125001497|NCT03829241|449635594|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
125001498|NCT03829241|449635593|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
125001499|NCT03829241|449635594|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
125001500|NCT00698451|449635595|FG000|Overall Study|Adverse Event|22|||
125001501|NCT00698451|449635595|FG000|Overall Study|Physician Decision|2|||
125001502|NCT00698451|449635595|FG000|Overall Study|Protocol Violation|6|||
125001503|NCT00698451|449635595|FG000|Overall Study|Withdrawal by Subject|6|||
125001504|NCT00698451|449635595|FG000|Overall Study|Disease progression|3|||
125001505|NCT02224599|449635596|FG000|Overall Study|Physician Decision|1|||
125001506|NCT02224599|449635596|FG000|Overall Study|Progression of Disease|1|||
125001507|NCT00733304|449635597|FG000|Overall Study|Adverse Event|3|||
125001508|NCT00733304|449635598|FG001|Overall Study|Adverse Event|0|||
125001509|NCT00733304|449635599|FG002|Overall Study|Adverse Event|0|||
125001510|NCT00733304|449635597|FG000|Overall Study|Lack of Efficacy|0|||
125001511|NCT00733304|449635598|FG001|Overall Study|Lack of Efficacy|0|||
125001512|NCT00733304|449635599|FG002|Overall Study|Lack of Efficacy|2|||
125001513|NCT00733304|449635597|FG000|Overall Study|Lost to Follow-up|0|||
125001514|NCT00733304|449635598|FG001|Overall Study|Lost to Follow-up|1|||
125001515|NCT00733304|449635599|FG002|Overall Study|Lost to Follow-up|0|||
125001516|NCT00733304|449635597|FG000|Overall Study|Physician Decision|3|||
125001517|NCT00733304|449635598|FG001|Overall Study|Physician Decision|1|||
125001518|NCT00733304|449635599|FG002|Overall Study|Physician Decision|3|||
125001519|NCT00733304|449635597|FG000|Overall Study|Withdrawal by Subject|1|||
125001520|NCT00733304|449635598|FG001|Overall Study|Withdrawal by Subject|1|||
125001521|NCT00733304|449635599|FG002|Overall Study|Withdrawal by Subject|0|||
125001522|NCT01187550|449635600|FG000|Overall Study|Protocol Violation|3|||
125001523|NCT01187550|449635601|FG001|Overall Study|Protocol Violation|1|||
125001524|NCT01187550|449635600|FG000|Overall Study|Other|3|||
125001525|NCT01187550|449635601|FG001|Overall Study|Other|0|||
125001526|NCT01187550|449635600|FG000|Overall Study|Randomized but not treated|8|||
125001527|NCT01187550|449635601|FG001|Overall Study|Randomized but not treated|0|||
125001528|NCT02616614|449635611|FG000|Overall Study|Withdrawal by Subject|10|||
125001529|NCT02616614|449635612|FG001|Overall Study|Withdrawal by Subject|5|||
125001530|NCT02616614|449635613|FG002|Overall Study|Withdrawal by Subject|6|||
125001531|NCT02616614|449635611|FG000|Overall Study|Physician Decision|2|||
125001532|NCT02616614|449635612|FG001|Overall Study|Physician Decision|1|||
125001533|NCT02616614|449635613|FG002|Overall Study|Physician Decision|0|||
125001534|NCT02616614|449635611|FG000|Overall Study|Adverse Event|1|||
125001535|NCT02616614|449635612|FG001|Overall Study|Adverse Event|4|||
125001536|NCT02616614|449635613|FG002|Overall Study|Adverse Event|1|||
125001537|NCT02616614|449635611|FG000|Overall Study|Protocol Violation|0|||
125001538|NCT02616614|449635612|FG001|Overall Study|Protocol Violation|3|||
125001539|NCT02616614|449635613|FG002|Overall Study|Protocol Violation|1|||
125001540|NCT02616614|449635611|FG000|Overall Study|Prohibited Medication|12|||
125001541|NCT02616614|449635612|FG001|Overall Study|Prohibited Medication|9|||
125001542|NCT02616614|449635613|FG002|Overall Study|Prohibited Medication|5|||
125001543|NCT02616614|449635611|FG000|Overall Study|More than 3 applications missed|6|||
125001544|NCT02616614|449635612|FG001|Overall Study|More than 3 applications missed|8|||
125001545|NCT02616614|449635613|FG002|Overall Study|More than 3 applications missed|1|||
125001546|NCT02616614|449635611|FG000|Overall Study|Lost to Follow-up|31|||
125001547|NCT02616614|449635612|FG001|Overall Study|Lost to Follow-up|28|||
125001548|NCT02616614|449635613|FG002|Overall Study|Lost to Follow-up|13|||
125001549|NCT02616614|449635611|FG000|Overall Study|Pregnancy|2|||
125001550|NCT02616614|449635612|FG001|Overall Study|Pregnancy|0|||
125001551|NCT02616614|449635613|FG002|Overall Study|Pregnancy|1|||
125001552|NCT02616614|449635611|FG000|Overall Study|Other|1|||
125001553|NCT02616614|449635612|FG001|Overall Study|Other|2|||
125001554|NCT02616614|449635613|FG002|Overall Study|Other|1|||
125001555|NCT00596934|449635614|FG000|Overall Study|Protocol Violation|1|||
125001556|NCT00596934|449635614|FG000|Overall Study|Withdrawal by Subject|1|||
125001557|NCT02445755|449635615|FG000|Overall Study|Withdrawal by Subject|2|||
125001558|NCT02445755|449635615|FG000|Overall Study|Protocol Violation|6|||
125001559|NCT02445755|449635615|FG000|Overall Study|Screen Failure|5|||
125001560|NCT03239483|449635616|FG000|Overall Study|Lost to Follow-up|1|||
125001561|NCT03239483|449635617|FG001|Overall Study|Lost to Follow-up|0|||
125001562|NCT03239483|449635616|FG000|Overall Study|Withdrawal by Subject|1|||
125001563|NCT03239483|449635617|FG001|Overall Study|Withdrawal by Subject|0|||
125001564|NCT00728481|449635618|FG000|Overall Study|Withdrawal by Subject|0|||
125001565|NCT00728481|449635619|FG001|Overall Study|Withdrawal by Subject|1|||
125001566|NCT00728481|449635618|FG000|Overall Study|Adverse Event|0|||
125001567|NCT00728481|449635619|FG001|Overall Study|Adverse Event|1|||
125001568|NCT00728481|449635618|FG000|Overall Study|Study medication non-compliance|0|||
125001569|NCT00728481|449635619|FG001|Overall Study|Study medication non-compliance|2|||
125001570|NCT00728481|449635618|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
125001571|NCT00728481|449635619|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
125001572|NCT01251120|449635623|FG000|Overall Study|Lack of Efficacy|0|||
125001573|NCT01251120|449635624|FG001|Overall Study|Lack of Efficacy|1|||
125330947|NCT05462756|450843998|FG000|Follow-Up Period|Death|1|||
125330948|NCT05462756|450843999|FG001|Follow-Up Period|Death|0|||
125330949|NCT05462756|450843998|FG000|Follow-Up Period|Lost to Follow-up|3|||
125330950|NCT05462756|450843999|FG001|Follow-Up Period|Lost to Follow-up|1|||
125330951|NCT05462756|450843998|FG000|Follow-Up Period|Withdrawal by Subject|0|||
125330952|NCT05462756|450843999|FG001|Follow-Up Period|Withdrawal by Subject|4|||
125001574|NCT01807923|449635629|FG000|Overall Study|Adverse Event|2|||
125001575|NCT01807923|449635630|FG001|Overall Study|Adverse Event|1|||
125001576|NCT01807923|449635631|FG002|Overall Study|Adverse Event|2|||
125001577|NCT01807923|449635629|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
125001578|NCT01807923|449635630|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
125001579|NCT01807923|449635631|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
125001580|NCT01807923|449635629|FG000|Overall Study|Physician Decision|0|||
125001581|NCT01807923|449635630|FG001|Overall Study|Physician Decision|0|||
125001582|NCT01807923|449635631|FG002|Overall Study|Physician Decision|1|||
125001583|NCT01807923|449635629|FG000|Overall Study|Not Eligible (Genotype)|0|||
125001584|NCT01807923|449635630|FG001|Overall Study|Not Eligible (Genotype)|0|||
125001585|NCT01807923|449635631|FG002|Overall Study|Not Eligible (Genotype)|1|||
125001586|NCT01807923|449635629|FG000|Overall Study|Randomized But Not Treated|3|||
125001587|NCT01807923|449635630|FG001|Overall Study|Randomized But Not Treated|2|||
125001588|NCT01807923|449635631|FG002|Overall Study|Randomized But Not Treated|5|||
125001589|NCT00108069|449635632|FG000|Overall Study|Never rec'd study drug|0|||
125001590|NCT00108069|449635633|FG001|Overall Study|Never rec'd study drug|1|||
125001591|NCT00108069|449635632|FG000|Overall Study|Adverse Event|1|||
125001592|NCT00108069|449635633|FG001|Overall Study|Adverse Event|1|||
125001593|NCT00108069|449635632|FG000|Overall Study|Withdrawal by Subject|1|||
125001594|NCT00108069|449635633|FG001|Overall Study|Withdrawal by Subject|0|||
125001595|NCT00108069|449635632|FG000|Overall Study|Death|1|||
125001596|NCT00108069|449635633|FG001|Overall Study|Death|0|||
125001597|NCT00108069|449635632|FG000|Overall Study|Progessive disease|27|||
125001598|NCT00108069|449635633|FG001|Overall Study|Progessive disease|11|||
125001599|NCT00995007|449635634|FG000|Overall Study|Withdrew consent|1|||
125001600|NCT00995007|449635635|FG001|Overall Study|Withdrew consent|0|||
125001601|NCT00995007|449635634|FG000|Overall Study|Refused further treatment|8|||
125001602|NCT00995007|449635635|FG001|Overall Study|Refused further treatment|2|||
125001603|NCT00995007|449635634|FG000|Overall Study|Toxicity|8|||
125001604|NCT00995007|449635635|FG001|Overall Study|Toxicity|0|||
125001605|NCT01910116|449635636|FG000|Overall Study|Adverse Event|0|||
125001606|NCT01910116|449635637|FG001|Overall Study|Adverse Event|3|||
125001607|NCT01910116|449635636|FG000|Overall Study|Lack of Efficacy|3|||
125001608|NCT01910116|449635637|FG001|Overall Study|Lack of Efficacy|4|||
125001609|NCT01910116|449635636|FG000|Overall Study|Lost to Follow-up|1|||
125001610|NCT01910116|449635637|FG001|Overall Study|Lost to Follow-up|0|||
125001611|NCT01910116|449635636|FG000|Overall Study|Protocol Violation|1|||
125001612|NCT01910116|449635637|FG001|Overall Study|Protocol Violation|2|||
125001613|NCT01910116|449635636|FG000|Overall Study|Withdrawal by Subject|8|||
125001614|NCT01910116|449635637|FG001|Overall Study|Withdrawal by Subject|3|||
125001615|NCT01910116|449635636|FG000|Overall Study|uncertain allocation|1|||
125001616|NCT01910116|449635637|FG001|Overall Study|uncertain allocation|3|||
125001617|NCT01910116|449635636|FG000|Overall Study|incomplete data|0|||
125001618|NCT01910116|449635637|FG001|Overall Study|incomplete data|1|||
125001619|NCT03606980|449635638|FG000|Overall Study|Lost to Follow-up|3|||
125001620|NCT03606980|449635639|FG001|Overall Study|Lost to Follow-up|2|||
125001621|NCT03606980|449635640|FG002|Overall Study|Lost to Follow-up|3|||
125001622|NCT03606980|449635638|FG000|Overall Study|Withdrawal by Subject|1|||
125001623|NCT03606980|449635639|FG001|Overall Study|Withdrawal by Subject|0|||
125001624|NCT03606980|449635640|FG002|Overall Study|Withdrawal by Subject|4|||
125001625|NCT02469896|449635643|FG000|Overall Study|Withdrawal by Subject|2|||
125001626|NCT02469896|449635644|FG001|Overall Study|Withdrawal by Subject|0|||
125001627|NCT01294150|449635645|FG000|Overall Study|Physician Decision|2|||
125001628|NCT01294150|449635646|FG001|Overall Study|Physician Decision|2|||
125001629|NCT03675776|449635647|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
125001630|NCT03675776|449635648|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
125001631|NCT03675776|449635649|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
125001632|NCT03675776|449635647|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
125001633|NCT03675776|449635648|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
125001634|NCT03675776|449635649|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
125001635|NCT04233164|449635652|FG000|Overall Study|Unable to obtain specimen|0|||
125001636|NCT04233164|449635653|FG001|Overall Study|Unable to obtain specimen|1|||
125001637|NCT01840605|449635654|FG000|Overall Study|Adverse Event|0|||
125001638|NCT01840605|449635655|FG001|Overall Study|Adverse Event|1|||
125001639|NCT01840605|449635654|FG000|Overall Study|Physician Decision|2|||
125001640|NCT01840605|449635655|FG001|Overall Study|Physician Decision|1|||
125001641|NCT01351623|449635656|FG000|Overall Study|Protocol Violation|2|||
125001642|NCT01351623|449635656|FG000|Overall Study|Adverse Event|4|||
125001643|NCT01351623|449635656|FG000|Overall Study|Withdrawal by Subject|1|||
125001644|NCT01351623|449635656|FG000|Overall Study|Death|2|||
125330953|NCT04040933|450844001|FG000|Overall Study|Protocol Violation|1|||
125001645|NCT01130974|449635658|FG000|Overall Study|Protocol Violation|10|||
125001646|NCT01130974|449635659|FG001|Overall Study|Protocol Violation|10|||
125001647|NCT01130974|449635658|FG000|Overall Study|Withdrawal by Subject|0|||
125001648|NCT01130974|449635659|FG001|Overall Study|Withdrawal by Subject|1|||
125001649|NCT01130974|449635658|FG000|Overall Study|Ineligibility criteria|5|||
125001650|NCT01130974|449635659|FG001|Overall Study|Ineligibility criteria|2|||
125001651|NCT00387764|449635660|FG000|Overall Study|Adverse Event|12|||
125001652|NCT00387764|449635660|FG000|Overall Study|Withdrawal by Subject|8|||
125001653|NCT00387764|449635660|FG000|Overall Study|Sponsor Terminated Study|1|||
125001654|NCT00387764|449635660|FG000|Overall Study|Physician Decision|1|||
125001655|NCT00387764|449635660|FG000|Overall Study|Other|2|||
125001656|NCT00387764|449635660|FG000|Overall Study|Death|7|||
125001657|NCT04399122|449635661|FG000|Overall Study|Lost to Follow-up|2|||
125001658|NCT04399122|449635662|FG001|Overall Study|Lost to Follow-up|0|||
125001659|NCT04399122|449635661|FG000|Overall Study|Withdrawal by Subject|1|||
125001660|NCT04399122|449635662|FG001|Overall Study|Withdrawal by Subject|0|||
125001661|NCT01102803|449635665|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
125001662|NCT01102803|449635666|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
125001663|NCT01102803|449635665|FG000|Post to Follow-Up|Lost to Follow-up|1|||
125001664|NCT01102803|449635666|FG001|Post to Follow-Up|Lost to Follow-up|3|||
125001665|NCT02684279|449635667|FG000|Overall Study|Adverse Event|87|||
125001666|NCT02684279|449635667|FG000|Overall Study|Lack of Efficacy|4|||
125001667|NCT02684279|449635667|FG000|Overall Study|Lost to Follow-up|61|||
125001668|NCT02684279|449635667|FG000|Overall Study|Protocol Violation|6|||
125001669|NCT02684279|449635667|FG000|Overall Study|Pregnancy|8|||
125001670|NCT02684279|449635667|FG000|Overall Study|Withdrawal by Subject|92|||
125001671|NCT02684279|449635667|FG000|Overall Study|non-compliance with study drug|9|||
125001672|NCT02684279|449635667|FG000|Overall Study|non compliance with study visits|2|||
125001673|NCT02684279|449635667|FG000|Overall Study|subject to have surgery|1|||
125001674|NCT02684279|449635667|FG000|Overall Study|family emergency|1|||
125001675|NCT02684279|449635667|FG000|Overall Study|Site closures|7|||
125001676|NCT02684279|449635667|FG000|Overall Study|Physician Decision|1|||
125001677|NCT02733185|449635668|FG000|Overall Study|Withdrawal by Subject|12|||
125001678|NCT02733185|449635669|FG001|Overall Study|Withdrawal by Subject|10|||
125001679|NCT02733185|449635670|FG002|Overall Study|Withdrawal by Subject|17|||
125001680|NCT02733185|449635671|FG003|Overall Study|Withdrawal by Subject|21|||
125001681|NCT02733185|449635668|FG000|Overall Study|Death|46|||
125001682|NCT02733185|449635669|FG001|Overall Study|Death|34|||
125001683|NCT02733185|449635670|FG002|Overall Study|Death|35|||
125001684|NCT02733185|449635671|FG003|Overall Study|Death|43|||
125001685|NCT02733185|449635668|FG000|Overall Study|Lost to Follow-up|17|||
125001686|NCT02733185|449635669|FG001|Overall Study|Lost to Follow-up|18|||
125001687|NCT02733185|449635670|FG002|Overall Study|Lost to Follow-up|16|||
125001688|NCT02733185|449635671|FG003|Overall Study|Lost to Follow-up|11|||
125001689|NCT00671554|449635675|FG000|Overall Study|Disease progression|3|||
125001690|NCT00601250|449635676|FG000|Overall Study|Adverse Event|3|||
125001691|NCT00601250|449635677|FG001|Overall Study|Adverse Event|9|||
125001692|NCT00601250|449635676|FG000|Overall Study|Protocol Violation|3|||
125001693|NCT00601250|449635677|FG001|Overall Study|Protocol Violation|2|||
125001694|NCT00601250|449635676|FG000|Overall Study|Lost to Follow-up|2|||
125001695|NCT00601250|449635677|FG001|Overall Study|Lost to Follow-up|6|||
125330954|NCT04040933|450844001|FG000|Overall Study|Withdrawal by Subject|2|||
125330955|NCT01705509|450844006|FG000|Inclusion CPET|Screen Failure|5|||
125001696|NCT00601250|449635676|FG000|Overall Study|Withdrawal by Subject|4|||
125001697|NCT00601250|449635677|FG001|Overall Study|Withdrawal by Subject|13|||
125001698|NCT00601250|449635676|FG000|Overall Study|Other incl. lack of efficacy|2|||
125330956|NCT01705509|450844006|FG000|Inclusion CPET|Withdrawal by Subject|2|||
125330957|NCT01705509|450844006|FG000|CPET w/ Ranexa|Screen Failure|2|||
125330958|NCT01528969|450844009|FG000|Overall Study|absent from the school at baseline|2|||
125330959|NCT01528969|450844010|FG001|Overall Study|absent from the school at baseline|0|||
125330960|NCT01662102|450844011|FG000|Overall Study|Sponsor's decision|1|||
125001699|NCT00601250|449635677|FG001|Overall Study|Other incl. lack of efficacy|9|||
125001700|NCT01810016|449635678|FG000|Overall Study|Progressive disease|1|||
125330961|NCT01662102|450844012|FG001|Overall Study|Sponsor's decision|0|||
125001701|NCT01810016|449635679|FG001|Overall Study|Progressive disease|1|||
125001702|NCT01810016|449635680|FG002|Overall Study|Progressive disease|0|||
125001703|NCT01810016|449635678|FG000|Overall Study|Death|0|||
125001704|NCT01810016|449635679|FG001|Overall Study|Death|0|||
125001705|NCT01810016|449635680|FG002|Overall Study|Death|1|||
125001706|NCT03828292|449635683|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
125001707|NCT03828292|449635684|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
125001708|NCT03828292|449635685|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
125001709|NCT03828292|449635686|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
125001710|NCT03828292|449635687|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
125001711|NCT03828292|449635688|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
125001712|NCT03828292|449635683|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
125001713|NCT03828292|449635684|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
125001714|NCT03828292|449635685|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
125001715|NCT03828292|449635686|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
125001716|NCT03828292|449635687|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
125001717|NCT03828292|449635688|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
125001718|NCT03828292|449635683|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
125001719|NCT03828292|449635684|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
125001720|NCT03828292|449635685|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
125001721|NCT03828292|449635686|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
125001722|NCT03828292|449635687|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
125001723|NCT03828292|449635688|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
125001724|NCT03828292|449635683|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
125001725|NCT03828292|449635684|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
125001726|NCT03828292|449635685|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
125001727|NCT03828292|449635686|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
125001728|NCT03828292|449635687|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
125001729|NCT03828292|449635688|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
125001730|NCT03828292|449635683|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
125001731|NCT03828292|449635684|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
125001732|NCT03828292|449635685|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
125001733|NCT03828292|449635686|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
125001734|NCT03828292|449635687|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
125001735|NCT03828292|449635688|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
125001736|NCT01436071|449637416|FG000|Overall Study|Adverse Event|1|||
125001737|NCT01436071|449637417|FG001|Overall Study|Adverse Event|0|||
125001738|NCT01436071|449637416|FG000|Overall Study|Lack of Efficacy|16|||
125001739|NCT01436071|449637417|FG001|Overall Study|Lack of Efficacy|7|||
125001740|NCT01436071|449637416|FG000|Overall Study|Protocol Violation|0|||
125001741|NCT01436071|449637417|FG001|Overall Study|Protocol Violation|1|||
125001742|NCT01436071|449637416|FG000|Overall Study|Lost to Follow-up|3|||
125001743|NCT01436071|449637417|FG001|Overall Study|Lost to Follow-up|1|||
125001744|NCT01436071|449637416|FG000|Overall Study|Physician Decision|1|||
125001745|NCT01436071|449637417|FG001|Overall Study|Physician Decision|0|||
125001746|NCT01436071|449637416|FG000|Overall Study|Withdrawal by Subject|2|||
125001747|NCT01436071|449637417|FG001|Overall Study|Withdrawal by Subject|2|||
125001748|NCT01436071|449637416|FG000|Overall Study|Did Not Receive Trial Medication|3|||
125001749|NCT01436071|449637417|FG001|Overall Study|Did Not Receive Trial Medication|3|||
125001750|NCT03047551|449637421|FG000|Overall Study|Did not receive TAS|1|||
125001751|NCT03047551|449637422|FG001|Overall Study|Did not receive TAS|0|||
125001752|NCT03047551|449637421|FG000|Overall Study|Physician Decision|1|||
125001753|NCT03047551|449637422|FG001|Overall Study|Physician Decision|0|||
125001754|NCT03047551|449637421|FG000|Overall Study|Withdrawal by Subject|0|||
125001755|NCT03047551|449637422|FG001|Overall Study|Withdrawal by Subject|1|||
125001756|NCT03047551|449637421|FG000|Overall Study|Probe malfunction|0|||
125001757|NCT03047551|449637422|FG001|Overall Study|Probe malfunction|1|||
125001758|NCT03047551|449637421|FG000|Overall Study|Ineligible|0|||
125001759|NCT03047551|449637422|FG001|Overall Study|Ineligible|1|||
125001760|NCT00726622|449637423|FG000|Overall Study|Withdrawal by Subject|16|||
125001761|NCT00726622|449637424|FG001|Overall Study|Withdrawal by Subject|2|||
125001762|NCT00726622|449637423|FG000|Overall Study|Physician Decision|0|||
125001763|NCT00726622|449637424|FG001|Overall Study|Physician Decision|1|||
125001764|NCT00726622|449637423|FG000|Overall Study|Metastasis|2|||
125001765|NCT00726622|449637424|FG001|Overall Study|Metastasis|0|||
125001766|NCT02462928|449637425|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
125001767|NCT02462928|449637426|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
125001768|NCT02462928|449637427|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
125001769|NCT02462928|449637425|FG000|Overall Study|Adverse Event|47|||
125001770|NCT02462928|449637426|FG001|Overall Study|Adverse Event|51|||
125001771|NCT02462928|449637427|FG002|Overall Study|Adverse Event|25|||
125001772|NCT02462928|449637425|FG000|Overall Study|Lack of Efficacy|3|||
125001773|NCT02462928|449637426|FG001|Overall Study|Lack of Efficacy|8|||
125001774|NCT02462928|449637427|FG002|Overall Study|Lack of Efficacy|3|||
125001775|NCT02462928|449637425|FG000|Overall Study|Lost to Follow-up|4|||
125001776|NCT02462928|449637426|FG001|Overall Study|Lost to Follow-up|4|||
125001777|NCT02462928|449637427|FG002|Overall Study|Lost to Follow-up|1|||
125001778|NCT02462928|449637425|FG000|Overall Study|Withdrawal by Patient|31|||
125001779|NCT02462928|449637426|FG001|Overall Study|Withdrawal by Patient|21|||
125001780|NCT02462928|449637427|FG002|Overall Study|Withdrawal by Patient|21|||
125001781|NCT02462928|449637425|FG000|Overall Study|Protocol Violation|0|||
125001782|NCT02462928|449637426|FG001|Overall Study|Protocol Violation|1|||
125001783|NCT02462928|449637427|FG002|Overall Study|Protocol Violation|0|||
125001784|NCT02462928|449637425|FG000|Overall Study|Reason not Specified|4|||
125001785|NCT02462928|449637426|FG001|Overall Study|Reason not Specified|6|||
125001786|NCT02462928|449637427|FG002|Overall Study|Reason not Specified|5|||
125033620|NCT00408005|449743818|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
125330962|NCT00275509|450844015|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
125330963|NCT00275509|450844016|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
125330964|NCT03388164|450844017|FG000|Overall Study|Withdrawal by Subject|3|||
125330965|NCT03388164|450844018|FG001|Overall Study|Withdrawal by Subject|1|||
125330966|NCT03967444|450844019|FG000|Overall Study|Lost to Follow-up|1|||
125330967|NCT03967444|450844020|FG001|Overall Study|Lost to Follow-up|2|||
125330968|NCT01821118|450844022|FG000|Overall Study|Death|0|||
125330969|NCT01821118|450844023|FG001|Overall Study|Death|1|||
125330970|NCT01605799|450844024|FG000|Overall Study|Withdrawal by Subject|2|||
125330971|NCT01605799|450844025|FG001|Overall Study|Withdrawal by Subject|1|||
125330972|NCT00345358|450844026|FG000|Primary Vaccination Phase|Other|0|||
125330973|NCT00345358|450844027|FG001|Primary Vaccination Phase|Other|1|||
125330974|NCT00345358|450844028|FG002|Primary Vaccination Phase|Other|1|||
125330975|NCT00345358|450844029|FG003|Primary Vaccination Phase|Other|0|||
125330976|NCT00345358|450844026|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
125330977|NCT00345358|450844027|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
125330978|NCT00345358|450844028|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
125330979|NCT00345358|450844029|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
125330980|NCT00345358|450844026|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
125001787|NCT01493557|449637428|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
125001788|NCT01493557|449637429|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
125001789|NCT01493557|449637430|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
125001790|NCT01493557|449637428|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
125001791|NCT01493557|449637429|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
125001792|NCT01493557|449637430|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
125001793|NCT01493557|449637428|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
125001794|NCT01493557|449637429|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
125001795|NCT01493557|449637430|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
125001796|NCT01493557|449637428|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
125001797|NCT01493557|449637429|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
125001798|NCT01493557|449637430|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
125001799|NCT01493557|449637428|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
125001800|NCT01493557|449637429|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
125001801|NCT01493557|449637430|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
125001802|NCT01493557|449637428|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
125001803|NCT01493557|449637429|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
125001804|NCT01493557|449637430|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
125001805|NCT01493557|449637428|FG000|Not Randomized to Management Strategies|Early termination|0|||
125001806|NCT01493557|449637429|FG001|Not Randomized to Management Strategies|Early termination|0|||
125001807|NCT01493557|449637430|FG002|Not Randomized to Management Strategies|Early termination|34|||
125001808|NCT01493557|449637428|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
125001809|NCT01493557|449637429|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
125001810|NCT01493557|449637430|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
125001811|NCT01493557|449637428|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
125001812|NCT01493557|449637429|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
125001813|NCT01493557|449637430|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
125001814|NCT01493557|449637428|FG000|Randomized to Management Strategies|Other adverse event|8|||
125001815|NCT01493557|449637429|FG001|Randomized to Management Strategies|Other adverse event|5|||
125001816|NCT01493557|449637430|FG002|Randomized to Management Strategies|Other adverse event|0|||
125001817|NCT01493557|449637428|FG000|Randomized to Management Strategies|Protocol Violation|3|||
125001818|NCT01493557|449637429|FG001|Randomized to Management Strategies|Protocol Violation|0|||
125001819|NCT01493557|449637430|FG002|Randomized to Management Strategies|Protocol Violation|0|||
125001820|NCT01493557|449637428|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
125001821|NCT01493557|449637429|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
125001822|NCT01493557|449637430|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
125001823|NCT01493557|449637428|FG000|Randomized to Management Strategies|Other than stated above|1|||
125001824|NCT01493557|449637429|FG001|Randomized to Management Strategies|Other than stated above|3|||
125001825|NCT01493557|449637430|FG002|Randomized to Management Strategies|Other than stated above|0|||
125001826|NCT01493557|449637428|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
125001827|NCT01493557|449637429|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
125001828|NCT01493557|449637430|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
125001829|NCT01493557|449637428|FG000|Adding the Second Strategy|Other adverse event|1|||
125001830|NCT01493557|449637429|FG001|Adding the Second Strategy|Other adverse event|2|||
125330981|NCT00345358|450844027|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
125330982|NCT00345358|450844028|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
125001831|NCT01493557|449637430|FG002|Adding the Second Strategy|Other adverse event|0|||
125001832|NCT01493557|449637428|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
125001833|NCT01493557|449637429|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
125001834|NCT01493557|449637430|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
125001835|NCT01890148|449637445|FG000|Overall Study|Adverse Event|1|||
125001836|NCT01215175|449637446|FG000|Overall Study|Lost to Follow-up|0|||
125001837|NCT01215175|449637447|FG001|Overall Study|Lost to Follow-up|1|||
125001838|NCT01215175|449637448|FG002|Overall Study|Lost to Follow-up|0|||
125001839|NCT01215175|449637449|FG003|Overall Study|Lost to Follow-up|1|||
125001840|NCT01215175|449637450|FG004|Overall Study|Lost to Follow-up|0|||
125001841|NCT01678209|449637451|FG000|Overall Study|could not scan twice|1|||
125001842|NCT01678209|449637452|FG001|Overall Study|could not scan twice|1|||
125001843|NCT01678209|449637453|FG002|Overall Study|could not scan twice|1|||
125001844|NCT01678209|449637451|FG000|Overall Study|scheduling conflicts|0|||
125001845|NCT01678209|449637452|FG001|Overall Study|scheduling conflicts|0|||
125001846|NCT01678209|449637453|FG002|Overall Study|scheduling conflicts|1|||
125001847|NCT01678209|449637451|FG000|Overall Study|screen fail|16|||
125001848|NCT01678209|449637452|FG001|Overall Study|screen fail|17|||
125001849|NCT01678209|449637453|FG002|Overall Study|screen fail|16|||
125001850|NCT00702845|449637454|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
125001851|NCT00702845|449637455|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
125001852|NCT00702845|449637454|FG000|Overall Study|Too high ovarian response|5|||
125001853|NCT00702845|449637455|FG001|Overall Study|Too high ovarian response|1|||
125001854|NCT00702845|449637454|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
125001855|NCT00702845|449637455|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
125001856|NCT00702845|449637454|FG000|Overall Study|Insufficient ovarian response|1|||
125001857|NCT00702845|449637455|FG001|Overall Study|Insufficient ovarian response|0|||
125001858|NCT00702845|449637454|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
125001859|NCT00702845|449637455|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
125001860|NCT00702845|449637454|FG000|Overall Study|No or abnormal fertilization|4|||
125001861|NCT00702845|449637455|FG001|Overall Study|No or abnormal fertilization|2|||
125001862|NCT00702845|449637454|FG000|Overall Study|Patient's decision|2|||
125001863|NCT00702845|449637455|FG001|Overall Study|Patient's decision|1|||
125001864|NCT00702845|449637454|FG000|Overall Study|Not randomized|0|||
125001865|NCT00702845|449637455|FG001|Overall Study|Not randomized|1|||
125001866|NCT02973425|449637459|FG000|Overall Study|Lost to Follow-up|49|||
125001867|NCT02973425|449637460|FG001|Overall Study|Lost to Follow-up|53|||
125001868|NCT03876171|449637461|FG000|Overall Study|Withdrawal by Subject|3|||
125001869|NCT03876171|449637462|FG001|Overall Study|Withdrawal by Subject|3|||
125001870|NCT03876171|449637461|FG000|Overall Study|Re-arrest|0|||
125001871|NCT03876171|449637462|FG001|Overall Study|Re-arrest|4|||
125001872|NCT03503513|449637463|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
125001873|NCT03503513|449637463|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
125330983|NCT00345358|450844029|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
125330984|NCT00345358|450844026|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
125330985|NCT00345358|450844027|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
125330986|NCT00345358|450844028|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
125330987|NCT00345358|450844029|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
125330988|NCT00345358|450844026|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
125330989|NCT00345358|450844027|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
125330990|NCT00345358|450844028|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
125330991|NCT00345358|450844029|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
125330992|NCT00345358|450844026|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
125330993|NCT00345358|450844027|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
125330994|NCT00345358|450844028|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
125330995|NCT00345358|450844029|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
125330996|NCT00499083|450844030|FG000|Overall Study|Not evaluable|3|||
125330997|NCT00686686|450844031|FG000|Overall Study|Non-compliance|1|||
125330998|NCT00686686|450844031|FG000|Overall Study|Adverse Event|2|||
125330999|NCT00686686|450844031|FG000|Overall Study|Lost to Follow-up|3|||
125331000|NCT00131248|450844035|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
125331001|NCT00131248|450844036|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
125331002|NCT00477386|450844037|FG000|Overall Study|Adverse Event|4|||
125331003|NCT00477386|450844038|FG001|Overall Study|Adverse Event|8|||
125331004|NCT00477386|450844037|FG000|Overall Study|Disease progression, relapse|3|||
125001874|NCT03503513|449637463|FG000|Overall Study|Physician Decision|3|||
125001875|NCT03503513|449637463|FG000|Overall Study|Withdrawal by Subject|2|||
125001876|NCT03503513|449637463|FG000|Overall Study|Lost to Follow-up|1|||
125001877|NCT00929656|449637468|FG000|Overall Study|Lost to Follow-up|0|||
125001878|NCT00929656|449637469|FG001|Overall Study|Lost to Follow-up|1|||
125331005|NCT00477386|450844038|FG001|Overall Study|Disease progression, relapse|4|||
125331006|NCT00477386|450844037|FG000|Overall Study|Disease progression, refractory|1|||
125001879|NCT00607880|449637470|FG000|Overall Study|Unable to place port due to occlusion|1|||
125001880|NCT00607880|449637471|FG001|Overall Study|Unable to place port due to occlusion|0|||
125001881|NCT01170039|449637474|FG000|Overall Study|Withdrawal by Subject|5|||
125001882|NCT01170039|449637475|FG001|Overall Study|Withdrawal by Subject|3|||
125001883|NCT01170039|449637474|FG000|Overall Study|Lack of funding, drug not available|3|||
125001884|NCT01170039|449637475|FG001|Overall Study|Lack of funding, drug not available|3|||
125001885|NCT00908583|449637476|FG000|Phase 1|Withdrawal by Subject|1|||
125001886|NCT00908583|449637476|FG000|Phase 1|Adverse Event|4|||
125001887|NCT00908583|449637476|FG000|Phase 2|Physician Decision|1|||
125001888|NCT00908583|449637476|FG000|Phase 2|Adverse Event|1|||
125001889|NCT00908583|449637476|FG000|Phase 3|Adverse Event|2|||
125001890|NCT00908583|449637476|FG000|Phase 4|Adverse Event|1|||
125001891|NCT00908583|449637476|FG000|Phase 4|Physician Decision|1|||
125001892|NCT00908583|449637476|FG000|Phase 5|Adverse Event|3|||
125001893|NCT00993954|449637477|FG000|Overall Study|Protocol Violation|21|||
125001894|NCT00993954|449637478|FG001|Overall Study|Protocol Violation|2|||
125001895|NCT00860951|449637479|FG000|Overall Study|Withdrawal by Subject|2|||
125001896|NCT00860951|449637479|FG000|Overall Study|Lost to Follow-up|5|||
125001897|NCT00727649|449637480|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
125001898|NCT00727649|449637481|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
125001899|NCT00727649|449637480|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
125001900|NCT00727649|449637481|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
125001901|NCT00727649|449637480|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
125001902|NCT00727649|449637481|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
125001903|NCT00727649|449637480|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
125001904|NCT00727649|449637481|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
125001905|NCT00727649|449637480|FG000|Second Intervention (4-weeks)|Death|1|||
125001906|NCT00727649|449637481|FG001|Second Intervention (4-weeks)|Death|0|||
125001907|NCT00727649|449637480|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
125001908|NCT00727649|449637481|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
125001909|NCT00727649|449637480|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
125001910|NCT00727649|449637481|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
125001911|NCT03627767|449637482|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
125001912|NCT03627767|449637483|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
125001913|NCT03627767|449637484|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
125001914|NCT03627767|449637485|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
125001915|NCT03627767|449637486|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
125001916|NCT03627767|449637482|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
125001917|NCT03627767|449637483|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
125001918|NCT03627767|449637484|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
125001919|NCT03627767|449637485|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
125001920|NCT03627767|449637486|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
125001921|NCT03627767|449637482|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
125001922|NCT03627767|449637483|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
125001923|NCT03627767|449637484|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
125001924|NCT03627767|449637485|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
125001925|NCT03627767|449637486|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
125001926|NCT03627767|449637482|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
125001927|NCT03627767|449637483|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
125001928|NCT03627767|449637484|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
125001929|NCT03627767|449637485|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
125001930|NCT03627767|449637486|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
125001931|NCT03627767|449637482|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
125001932|NCT03627767|449637483|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
125001933|NCT03627767|449637484|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
125001934|NCT03627767|449637485|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
125001935|NCT03627767|449637486|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
125001936|NCT03627767|449637482|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
125001937|NCT03627767|449637483|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
125001938|NCT03627767|449637484|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
125001939|NCT03627767|449637485|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
125001940|NCT03627767|449637486|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
125001941|NCT03627767|449637482|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
125001942|NCT03627767|449637483|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
125001943|NCT03627767|449637484|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
125001944|NCT03627767|449637485|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
125001945|NCT03627767|449637486|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
125001946|NCT03627767|449637482|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
125331007|NCT00477386|450844038|FG001|Overall Study|Disease progression, refractory|3|||
125331008|NCT00477386|450844037|FG000|Overall Study|Other|1|||
125331009|NCT00477386|450844038|FG001|Overall Study|Other|2|||
125331010|NCT00477386|450844037|FG000|Overall Study|Physician Decision|1|||
125331011|NCT00477386|450844038|FG001|Overall Study|Physician Decision|0|||
125331012|NCT00477386|450844037|FG000|Overall Study|Withdrawal by Subject|1|||
125331013|NCT00477386|450844038|FG001|Overall Study|Withdrawal by Subject|0|||
125331014|NCT01254422|450844039|FG000|Overall Study|Protocol Violation|1|||
125331015|NCT01254422|450844040|FG001|Overall Study|Protocol Violation|0|||
125331016|NCT01254422|450844039|FG000|Overall Study|Adverse Event|1|||
125331017|NCT01254422|450844040|FG001|Overall Study|Adverse Event|0|||
125331018|NCT01254422|450844039|FG000|Overall Study|Serious adverse event|0|||
125331019|NCT01254422|450844040|FG001|Overall Study|Serious adverse event|1|||
125331020|NCT01254422|450844039|FG000|Overall Study|Lost to Follow-up|1|||
125331021|NCT01254422|450844040|FG001|Overall Study|Lost to Follow-up|0|||
125331022|NCT02207088|450844041|FG000|Overall Study|Adverse Event|2|||
125331023|NCT00643162|450844042|FG000|Overall Study|Withdrawal by Subject|1|||
125331024|NCT00643162|450844043|FG001|Overall Study|Withdrawal by Subject|1|||
125331025|NCT02284243|450844044|FG000|Overall Study|Lack of Efficacy|3|||
125331026|NCT02284243|450844045|FG001|Overall Study|Lack of Efficacy|3|||
125331027|NCT02284243|450844044|FG000|Overall Study|Adverse Event|1|||
125331028|NCT02284243|450844045|FG001|Overall Study|Adverse Event|0|||
125331029|NCT02699749|450844050|FG000|Overall Study|Other|0|||
125001947|NCT03627767|449637483|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
125001948|NCT03627767|449637484|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
125001949|NCT03627767|449637485|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
125001950|NCT03627767|449637486|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
125001951|NCT03627767|449637482|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
125001952|NCT03627767|449637483|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
125001953|NCT03627767|449637484|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
125001954|NCT03627767|449637485|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
125001955|NCT03627767|449637486|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
125001956|NCT03627767|449637482|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
125001957|NCT03627767|449637483|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
125001958|NCT03627767|449637484|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
125001959|NCT03627767|449637485|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
125001960|NCT03627767|449637486|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
125001961|NCT03627767|449637482|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
125001962|NCT03627767|449637483|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
125331030|NCT02699749|450844051|FG001|Overall Study|Other|0|||
125331031|NCT02699749|450844052|FG002|Overall Study|Other|2|||
125331032|NCT02699749|450844053|FG003|Overall Study|Other|0|||
125331033|NCT02699749|450844054|FG004|Overall Study|Other|0|||
125331034|NCT02699749|450844055|FG005|Overall Study|Other|1|||
125331035|NCT02699749|450844056|FG006|Overall Study|Other|1|||
125331036|NCT02699749|450844057|FG007|Overall Study|Other|0|||
125331037|NCT02699749|450844058|FG008|Overall Study|Other|0|||
125331038|NCT02699749|450844059|FG009|Overall Study|Other|0|||
125331039|NCT02699749|450844060|FG010|Overall Study|Other|1|||
125331040|NCT02699749|450844061|FG011|Overall Study|Other|0|||
125331041|NCT02699749|450844062|FG012|Overall Study|Other|0|||
125331042|NCT02699749|450844063|FG013|Overall Study|Other|0|||
125331043|NCT02699749|450844050|FG000|Overall Study|Progressive Disease|3|||
125331044|NCT02699749|450844051|FG001|Overall Study|Progressive Disease|3|||
125331045|NCT02699749|450844052|FG002|Overall Study|Progressive Disease|14|||
125331046|NCT02699749|450844053|FG003|Overall Study|Progressive Disease|3|||
125331047|NCT02699749|450844054|FG004|Overall Study|Progressive Disease|3|||
125331048|NCT02699749|450844055|FG005|Overall Study|Progressive Disease|7|||
125331049|NCT02699749|450844056|FG006|Overall Study|Progressive Disease|5|||
125331050|NCT02699749|450844057|FG007|Overall Study|Progressive Disease|5|||
125001963|NCT03627767|449637484|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
125001964|NCT03627767|449637485|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
125331051|NCT02699749|450844058|FG008|Overall Study|Progressive Disease|6|||
125331052|NCT02699749|450844059|FG009|Overall Study|Progressive Disease|6|||
125331053|NCT02699749|450844060|FG010|Overall Study|Progressive Disease|5|||
125331054|NCT02699749|450844061|FG011|Overall Study|Progressive Disease|4|||
125331055|NCT02699749|450844062|FG012|Overall Study|Progressive Disease|3|||
125331056|NCT02699749|450844063|FG013|Overall Study|Progressive Disease|5|||
125331057|NCT02699749|450844050|FG000|Overall Study|Death|0|||
125331058|NCT02699749|450844051|FG001|Overall Study|Death|0|||
125331059|NCT02699749|450844052|FG002|Overall Study|Death|0|||
125331060|NCT02699749|450844053|FG003|Overall Study|Death|0|||
125331061|NCT02699749|450844054|FG004|Overall Study|Death|0|||
125331062|NCT02699749|450844055|FG005|Overall Study|Death|0|||
125331063|NCT02699749|450844056|FG006|Overall Study|Death|0|||
125331064|NCT02699749|450844057|FG007|Overall Study|Death|0|||
125331065|NCT02699749|450844058|FG008|Overall Study|Death|0|||
125331066|NCT02699749|450844059|FG009|Overall Study|Death|0|||
125331067|NCT02699749|450844060|FG010|Overall Study|Death|0|||
125331068|NCT02699749|450844061|FG011|Overall Study|Death|0|||
125331069|NCT02699749|450844062|FG012|Overall Study|Death|0|||
125331070|NCT02699749|450844063|FG013|Overall Study|Death|1|||
125331071|NCT02699749|450844050|FG000|Overall Study|Lost to Follow-up|0|||
125331072|NCT02699749|450844051|FG001|Overall Study|Lost to Follow-up|0|||
125331073|NCT02699749|450844052|FG002|Overall Study|Lost to Follow-up|0|||
125331074|NCT02699749|450844053|FG003|Overall Study|Lost to Follow-up|0|||
125331075|NCT02699749|450844054|FG004|Overall Study|Lost to Follow-up|0|||
125331076|NCT02699749|450844055|FG005|Overall Study|Lost to Follow-up|1|||
125331077|NCT02699749|450844056|FG006|Overall Study|Lost to Follow-up|0|||
125331078|NCT02699749|450844057|FG007|Overall Study|Lost to Follow-up|1|||
125331079|NCT02699749|450844058|FG008|Overall Study|Lost to Follow-up|0|||
125331080|NCT02699749|450844059|FG009|Overall Study|Lost to Follow-up|0|||
125331081|NCT02699749|450844060|FG010|Overall Study|Lost to Follow-up|0|||
125331082|NCT02699749|450844061|FG011|Overall Study|Lost to Follow-up|0|||
125331083|NCT02699749|450844062|FG012|Overall Study|Lost to Follow-up|0|||
125331084|NCT02699749|450844063|FG013|Overall Study|Lost to Follow-up|0|||
125331085|NCT02721966|450844065|FG000|Overall Study|Protocol Violation|1|||
125331086|NCT02721966|450844066|FG001|Overall Study|Protocol Violation|0|||
125331087|NCT02721966|450844067|FG002|Overall Study|Protocol Violation|0|||
125331088|NCT02721966|450844068|FG003|Overall Study|Protocol Violation|0|||
125331089|NCT02721966|450844069|FG004|Overall Study|Protocol Violation|0|||
125331090|NCT02721966|450844065|FG000|Overall Study|Withdrawal by Subject|9|||
125331091|NCT02721966|450844066|FG001|Overall Study|Withdrawal by Subject|2|||
125331092|NCT02721966|450844067|FG002|Overall Study|Withdrawal by Subject|3|||
125331093|NCT02721966|450844068|FG003|Overall Study|Withdrawal by Subject|7|||
125331094|NCT02721966|450844069|FG004|Overall Study|Withdrawal by Subject|0|||
125331095|NCT02721966|450844065|FG000|Overall Study|Adverse Event|4|||
125331096|NCT02721966|450844066|FG001|Overall Study|Adverse Event|4|||
125331097|NCT02721966|450844067|FG002|Overall Study|Adverse Event|3|||
125331098|NCT02721966|450844068|FG003|Overall Study|Adverse Event|0|||
125331099|NCT02721966|450844069|FG004|Overall Study|Adverse Event|0|||
125331100|NCT02721966|450844065|FG000|Overall Study|Death|1|||
125331101|NCT02721966|450844066|FG001|Overall Study|Death|0|||
125331102|NCT02721966|450844067|FG002|Overall Study|Death|0|||
125331103|NCT02721966|450844068|FG003|Overall Study|Death|0|||
125331104|NCT02721966|450844069|FG004|Overall Study|Death|0|||
125331105|NCT02721966|450844065|FG000|Overall Study|Lack of Efficacy|7|||
125331106|NCT02721966|450844066|FG001|Overall Study|Lack of Efficacy|4|||
125331107|NCT02721966|450844067|FG002|Overall Study|Lack of Efficacy|0|||
125331108|NCT02721966|450844068|FG003|Overall Study|Lack of Efficacy|0|||
125331109|NCT02721966|450844069|FG004|Overall Study|Lack of Efficacy|0|||
125331110|NCT02721966|450844065|FG000|Overall Study|Lost to Follow-up|0|||
125331111|NCT02721966|450844066|FG001|Overall Study|Lost to Follow-up|0|||
125331112|NCT02721966|450844067|FG002|Overall Study|Lost to Follow-up|3|||
125331113|NCT02721966|450844068|FG003|Overall Study|Lost to Follow-up|0|||
125331114|NCT02721966|450844069|FG004|Overall Study|Lost to Follow-up|0|||
125331115|NCT02721966|450844065|FG000|Overall Study|Physician Decision|1|||
125331116|NCT02721966|450844066|FG001|Overall Study|Physician Decision|1|||
125331117|NCT02721966|450844067|FG002|Overall Study|Physician Decision|0|||
125331118|NCT02721966|450844068|FG003|Overall Study|Physician Decision|0|||
125331119|NCT02721966|450844069|FG004|Overall Study|Physician Decision|0|||
125331120|NCT02721966|450844065|FG000|Overall Study|Pregnancy|1|||
125331121|NCT02721966|450844066|FG001|Overall Study|Pregnancy|0|||
125331122|NCT02721966|450844067|FG002|Overall Study|Pregnancy|0|||
125331123|NCT02721966|450844068|FG003|Overall Study|Pregnancy|0|||
125331124|NCT02721966|450844069|FG004|Overall Study|Pregnancy|0|||
125331125|NCT02721966|450844065|FG000|Overall Study|Did not continue to period 2|5|||
125331126|NCT02721966|450844066|FG001|Overall Study|Did not continue to period 2|12|||
125331127|NCT02721966|450844067|FG002|Overall Study|Did not continue to period 2|0|||
125331128|NCT02721966|450844068|FG003|Overall Study|Did not continue to period 2|0|||
125331129|NCT02721966|450844069|FG004|Overall Study|Did not continue to period 2|5|||
125331130|NCT03857867|450844070|FG000|Overall Study|Physician Decision|1|||
125331131|NCT02157883|450844071|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
125331132|NCT02157883|450844071|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
125331133|NCT02157883|450844071|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
125331134|NCT02157883|450844071|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
125331135|NCT02157883|450844071|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
125331136|NCT00888940|450844072|FG000|Overall Study|Adverse Event|12|||
125331137|NCT00888940|450844073|FG001|Overall Study|Adverse Event|3|||
125331138|NCT00888940|450844072|FG000|Overall Study|Lost to Follow-up|5|||
125331139|NCT00888940|450844073|FG001|Overall Study|Lost to Follow-up|5|||
125331140|NCT00888940|450844072|FG000|Overall Study|Randomized Not Treated|11|||
125331141|NCT00888940|450844073|FG001|Overall Study|Randomized Not Treated|13|||
125331142|NCT00607373|450844074|FG000|Treatment Period|Adverse Event|0|||
125331143|NCT00607373|450844075|FG001|Treatment Period|Adverse Event|4|||
125331144|NCT00607373|450844074|FG000|Treatment Period|Physician Decision|0|||
125331145|NCT00607373|450844075|FG001|Treatment Period|Physician Decision|1|||
125331146|NCT00607373|450844074|FG000|Treatment Period|Withdrawal by Subject|0|||
125331147|NCT00607373|450844075|FG001|Treatment Period|Withdrawal by Subject|1|||
125331148|NCT00607373|450844074|FG000|Follow-up Period|Other|0|||
125331149|NCT00607373|450844075|FG001|Follow-up Period|Other|1|||
125331150|NCT00607373|450844074|FG000|Follow-up Period|Protocol Violation|0|||
125331151|NCT00607373|450844075|FG001|Follow-up Period|Protocol Violation|1|||
125331152|NCT00607373|450844074|FG000|Follow-up Period|Withdrawal by Subject|1|||
125331153|NCT00607373|450844075|FG001|Follow-up Period|Withdrawal by Subject|3|||
125331154|NCT01918306|450844076|FG000|Overall Study|progresive disease|4|||
125331155|NCT01918306|450844077|FG001|Overall Study|progresive disease|0|||
125331156|NCT01918306|450844078|FG002|Overall Study|progresive disease|1|||
125331157|NCT01918306|450844079|FG003|Overall Study|progresive disease|1|||
125331158|NCT01918306|450844076|FG000|Overall Study|Withdrawal by Subject|0|||
125331159|NCT01918306|450844077|FG001|Overall Study|Withdrawal by Subject|0|||
125331160|NCT01918306|450844078|FG002|Overall Study|Withdrawal by Subject|0|||
125331161|NCT01918306|450844079|FG003|Overall Study|Withdrawal by Subject|2|||
125331162|NCT01918306|450844076|FG000|Overall Study|neutropenia|1|||
125331163|NCT01918306|450844077|FG001|Overall Study|neutropenia|0|||
125331164|NCT01918306|450844078|FG002|Overall Study|neutropenia|0|||
125331165|NCT01918306|450844079|FG003|Overall Study|neutropenia|0|||
125331166|NCT01918306|450844076|FG000|Overall Study|Lack of Efficacy|1|||
125331167|NCT01918306|450844077|FG001|Overall Study|Lack of Efficacy|0|||
125331168|NCT01918306|450844078|FG002|Overall Study|Lack of Efficacy|0|||
125331169|NCT01918306|450844079|FG003|Overall Study|Lack of Efficacy|0|||
125331170|NCT01918306|450844076|FG000|Overall Study|progress disease, crossover|0|||
125331171|NCT01918306|450844077|FG001|Overall Study|progress disease, crossover|0|||
125331172|NCT01918306|450844078|FG002|Overall Study|progress disease, crossover|1|||
125331173|NCT01918306|450844079|FG003|Overall Study|progress disease, crossover|0|||
125331174|NCT02170077|450844080|FG000|Overall Study|Withdrawal by Subject|3|||
125331175|NCT02170077|450844081|FG001|Overall Study|Withdrawal by Subject|4|||
125331176|NCT02170077|450844082|FG002|Overall Study|Withdrawal by Subject|2|||
125331177|NCT02170077|450844080|FG000|Overall Study|Adverse Event|4|||
125331178|NCT02170077|450844081|FG001|Overall Study|Adverse Event|4|||
125331179|NCT02170077|450844082|FG002|Overall Study|Adverse Event|4|||
125331180|NCT02170077|450844080|FG000|Overall Study|Lost to Follow-up|0|||
125331181|NCT02170077|450844081|FG001|Overall Study|Lost to Follow-up|1|||
125331182|NCT02170077|450844082|FG002|Overall Study|Lost to Follow-up|0|||
125331183|NCT02170077|450844080|FG000|Overall Study|Exclusion criteria|2|||
125331184|NCT02170077|450844081|FG001|Overall Study|Exclusion criteria|2|||
125331185|NCT02170077|450844082|FG002|Overall Study|Exclusion criteria|5|||
125331186|NCT02170077|450844080|FG000|Overall Study|Exacerbation of seizures|0|||
125331187|NCT02170077|450844081|FG001|Overall Study|Exacerbation of seizures|2|||
125331188|NCT02170077|450844082|FG002|Overall Study|Exacerbation of seizures|1|||
125331189|NCT01780974|450844083|FG000|Overall Study|Death|1|||
125331190|NCT01780974|450844084|FG001|Overall Study|Death|0|||
125331191|NCT01780974|450844083|FG000|Overall Study|Adverse Event|1|||
125331192|NCT01780974|450844084|FG001|Overall Study|Adverse Event|3|||
125331193|NCT01724346|450844085|FG000|Overall Study|Death|42|||
125331194|NCT01724346|450844086|FG001|Overall Study|Death|42|||
125331195|NCT01724346|450844085|FG000|Overall Study|Lost to Follow-up|5|||
125331196|NCT01724346|450844086|FG001|Overall Study|Lost to Follow-up|1|||
125331197|NCT01724346|450844085|FG000|Overall Study|Withdrawal by Subject|27|||
125331198|NCT01724346|450844086|FG001|Overall Study|Withdrawal by Subject|19|||
125331199|NCT01724346|450844085|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
125331200|NCT01724346|450844086|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
125331201|NCT02876601|450844087|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
125331202|NCT02876601|450844088|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
125331203|NCT02876601|450844089|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
125001965|NCT03627767|449637486|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
125001966|NCT03627767|449637482|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
125001967|NCT03627767|449637483|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
125331204|NCT02876601|450844090|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
125331205|NCT00256997|450844091|FG000|Overall Study|Protocol Violation|1|||
125331206|NCT00256997|450844092|FG001|Overall Study|Protocol Violation|4|||
125331207|NCT00256997|450844091|FG000|Overall Study|Lack of Efficacy|1|||
125331208|NCT00256997|450844092|FG001|Overall Study|Lack of Efficacy|4|||
125331209|NCT00256997|450844091|FG000|Overall Study|Death|2|||
125331210|NCT00256997|450844092|FG001|Overall Study|Death|0|||
125331211|NCT00256997|450844091|FG000|Overall Study|Adverse Event|4|||
125331212|NCT00256997|450844092|FG001|Overall Study|Adverse Event|0|||
125331213|NCT00256997|450844091|FG000|Overall Study|Lost to Follow-up|3|||
125331214|NCT00256997|450844092|FG001|Overall Study|Lost to Follow-up|5|||
125331215|NCT00256997|450844091|FG000|Overall Study|Withdrawal by Subject|13|||
125331216|NCT00256997|450844092|FG001|Overall Study|Withdrawal by Subject|3|||
125331217|NCT00256997|450844091|FG000|Overall Study|Started but not treated|2|||
125331218|NCT00256997|450844092|FG001|Overall Study|Started but not treated|0|||
125331219|NCT00256997|450844091|FG000|Overall Study|Other|5|||
125331220|NCT00256997|450844092|FG001|Overall Study|Other|8|||
125331221|NCT00256997|450844091|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
125331222|NCT00256997|450844092|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
125331223|NCT00256997|450844091|FG000|Overall Study|Participant Non-compliant|3|||
125331224|NCT00256997|450844092|FG001|Overall Study|Participant Non-compliant|6|||
125331225|NCT00256997|450844091|FG000|Overall Study|Investigator Withdrew Participant|2|||
125331226|NCT00256997|450844092|FG001|Overall Study|Investigator Withdrew Participant|1|||
125331227|NCT00354432|450844093|FG000|Overall Study|Adverse Event|3|||
125001968|NCT03627767|449637484|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
125001969|NCT03627767|449637485|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
125001970|NCT03627767|449637486|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
125001971|NCT03627767|449637482|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
125001972|NCT03627767|449637483|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
125001973|NCT03627767|449637484|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
125001974|NCT03627767|449637485|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
125331228|NCT00354432|450844094|FG001|Overall Study|Adverse Event|1|||
125331229|NCT00354432|450844095|FG002|Overall Study|Adverse Event|5|||
125331230|NCT00354432|450844096|FG003|Overall Study|Adverse Event|5|||
125331231|NCT00354432|450844093|FG000|Overall Study|Off/Toxicity|3|||
125331232|NCT00354432|450844094|FG001|Overall Study|Off/Toxicity|7|||
125331233|NCT00354432|450844095|FG002|Overall Study|Off/Toxicity|5|||
125331234|NCT00354432|450844096|FG003|Overall Study|Off/Toxicity|5|||
125331235|NCT02736578|450844097|FG000|Overall Study|Adverse Event|1|||
125331236|NCT02736578|450844098|FG001|Overall Study|Adverse Event|0|||
125331237|NCT02827877|450844099|FG000|Overall Study|Withdrawal by Subject|1|||
125331238|NCT04953728|450845626|FG000|Overall Study|Withdrawal by Subject|3|||
125331239|NCT04953728|450845626|FG000|Overall Study|Physician Decision|1|||
125331240|NCT02105662|450845629|FG000|Overall Study|Lost to Follow-up|5|||
125331241|NCT02105662|450845629|FG000|Overall Study|Withdrawal by Subject|1|||
125331242|NCT02331277|450845630|FG000|Overall Study|Withdrawal by Subject|1|||
125331243|NCT02331277|450845631|FG001|Overall Study|Withdrawal by Subject|0|||
125331244|NCT03978117|450845632|FG000|Overall Study|Non-Compliance|26|||
125331245|NCT03978117|450845633|FG001|Overall Study|Non-Compliance|26|||
125331246|NCT03978117|450845632|FG000|Overall Study|Lost to Follow-up|4|||
125331247|NCT03978117|450845633|FG001|Overall Study|Lost to Follow-up|4|||
125331248|NCT00990704|450845635|FG000|Overall Study|Adverse Event|1|||
125331249|NCT00990704|450845636|FG001|Overall Study|Adverse Event|1|||
125331250|NCT00990704|450845635|FG000|Overall Study|Physician Decision|0|||
125331251|NCT00990704|450845636|FG001|Overall Study|Physician Decision|1|||
125331252|NCT01354899|450845640|FG000|Overall Study|discharge from the hospital|2|||
125331253|NCT01354899|450845640|FG000|Overall Study|Protocol Violation|1|||
125331254|NCT00641667|450845641|FG000|Overall Study|Withdrawal by Subject|1|||
125331255|NCT00641667|450845641|FG000|Overall Study|Adverse Event|1|||
125331256|NCT00641667|450845641|FG000|Overall Study|Physician Decision|1|||
125331257|NCT00641667|450845641|FG000|Overall Study|Worsening of underlying disease|3|||
125331258|NCT01235741|450845642|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
125331259|NCT01235741|450845643|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
125331260|NCT01235741|450845644|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
125331261|NCT01235741|450845642|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
125001975|NCT03627767|449637486|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
125001976|NCT03627767|449637482|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
125001977|NCT03627767|449637483|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
125001978|NCT03627767|449637484|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
125001979|NCT03627767|449637485|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
125001980|NCT03627767|449637486|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
125001981|NCT03627767|449637482|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
125001982|NCT03627767|449637483|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
125001983|NCT03627767|449637484|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
125089877|NCT00545740|449947042|FG002|Overall Study|Accepted only monthly telephone calls|0|||
125331262|NCT01235741|450845643|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
125331263|NCT01235741|450845644|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
125331264|NCT01235741|450845642|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
125331265|NCT01235741|450845643|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
125331266|NCT01235741|450845644|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
125331267|NCT01235741|450845642|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
125331268|NCT01235741|450845643|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
125331269|NCT01235741|450845644|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
125331270|NCT01235741|450845642|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
125331271|NCT01235741|450845643|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
125331272|NCT01235741|450845644|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
125331273|NCT01235741|450845642|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
125331274|NCT01235741|450845643|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
125331275|NCT01235741|450845644|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
125331276|NCT01235741|450845642|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
125001984|NCT03627767|449637485|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
125001985|NCT03627767|449637486|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
125331277|NCT01235741|450845643|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
125331278|NCT01235741|450845644|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
125331279|NCT01235741|450845642|FG000|Randomized to Treatment|Adverse Event|0|||
125331280|NCT01235741|450845643|FG001|Randomized to Treatment|Adverse Event|1|||
125001986|NCT03627767|449637482|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
125001987|NCT03627767|449637483|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
125001988|NCT03627767|449637484|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
125331281|NCT01235741|450845644|FG002|Randomized to Treatment|Adverse Event|1|||
125331282|NCT01235741|450845642|FG000|Randomized to Treatment|Sponsor terminated study|0|||
125331283|NCT01235741|450845643|FG001|Randomized to Treatment|Sponsor terminated study|35|||
125331284|NCT01235741|450845644|FG002|Randomized to Treatment|Sponsor terminated study|34|||
125331285|NCT01235741|450845642|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
125331286|NCT01235741|450845643|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
125331287|NCT01235741|450845644|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
125331288|NCT01235741|450845642|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
125331289|NCT01235741|450845643|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
125331290|NCT01235741|450845644|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
125331291|NCT01235741|450845642|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
125331292|NCT01235741|450845643|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
125331293|NCT01235741|450845644|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
125331294|NCT01106690|450845645|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
125331295|NCT01106690|450845646|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
125331296|NCT01106690|450845647|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
125331297|NCT01106690|450845645|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
125331298|NCT01106690|450845646|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
125331299|NCT01106690|450845647|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
125331300|NCT01106690|450845645|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
125331301|NCT01106690|450845646|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
125331302|NCT01106690|450845647|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
125331303|NCT01106690|450845645|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
125331304|NCT01106690|450845646|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
125331305|NCT01106690|450845647|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
125331306|NCT01106690|450845645|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
125331307|NCT01106690|450845646|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
125331308|NCT01106690|450845647|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
125331309|NCT01106690|450845645|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
125331310|NCT01106690|450845646|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
125331311|NCT01106690|450845647|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
125331312|NCT01106690|450845645|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
125331313|NCT01106690|450845646|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
125331314|NCT01106690|450845647|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
125331315|NCT01106690|450845645|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
125331316|NCT01106690|450845646|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
125331317|NCT01106690|450845647|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
125331318|NCT01106690|450845645|FG000|Core Period: Baseline to Week 26|Other|10|||
125331319|NCT01106690|450845646|FG001|Core Period: Baseline to Week 26|Other|2|||
125331320|NCT01106690|450845647|FG002|Core Period: Baseline to Week 26|Other|6|||
125331321|NCT01106690|450845645|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
125331322|NCT01106690|450845646|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
125331323|NCT01106690|450845647|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
125331324|NCT01106690|450845645|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
125331325|NCT01106690|450845646|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
125331326|NCT01106690|450845647|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
125331327|NCT01106690|450845645|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
125331328|NCT01106690|450845646|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
125331329|NCT01106690|450845647|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
125331330|NCT01106690|450845645|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
125001989|NCT03627767|449637485|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
125331331|NCT01106690|450845646|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
125331332|NCT01106690|450845647|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
125331333|NCT01106690|450845645|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
125331334|NCT01106690|450845646|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
125331335|NCT01106690|450845647|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
125331336|NCT01106690|450845645|FG000|Extension Period: Week 26 to Week 52|Other|8|||
125331337|NCT01106690|450845646|FG001|Extension Period: Week 26 to Week 52|Other|3|||
125331338|NCT01106690|450845647|FG002|Extension Period: Week 26 to Week 52|Other|4|||
125331339|NCT01106690|450845645|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
125331340|NCT01106690|450845646|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
125331341|NCT01106690|450845647|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
125331342|NCT02863419|450845648|FG000|Overall Study|Lost to Follow-up|0|||
125331343|NCT02863419|450845649|FG001|Overall Study|Lost to Follow-up|1|||
125331344|NCT02863419|450845650|FG002|Overall Study|Lost to Follow-up|4|||
125331345|NCT02863419|450845648|FG000|Overall Study|Withdrawal by Subject|5|||
125331346|NCT02863419|450845649|FG001|Overall Study|Withdrawal by Subject|5|||
125331347|NCT02863419|450845650|FG002|Overall Study|Withdrawal by Subject|3|||
125331348|NCT02863419|450845648|FG000|Overall Study|Died|3|||
125331349|NCT02863419|450845649|FG001|Overall Study|Died|4|||
125331350|NCT02863419|450845650|FG002|Overall Study|Died|1|||
125331351|NCT02454517|450845664|FG000|Overall Study|Withdrawal by Subject|3|||
125331352|NCT02454517|450845665|FG001|Overall Study|Withdrawal by Subject|0|||
125331353|NCT02454517|450845664|FG000|Overall Study|Lost to Follow-up|4|||
125331354|NCT02454517|450845665|FG001|Overall Study|Lost to Follow-up|7|||
125331355|NCT02454517|450845664|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
125331356|NCT02454517|450845665|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
125331357|NCT00473382|450845666|FG000|Core Study|Adverse Event|3|||
125331358|NCT00473382|450845667|FG001|Core Study|Adverse Event|1|||
125331359|NCT00473382|450845668|FG002|Core Study|Adverse Event|1|||
125331360|NCT00473382|450845666|FG000|Core Study|Death|3|||
125331361|NCT00473382|450845667|FG001|Core Study|Death|5|||
125331362|NCT00473382|450845668|FG002|Core Study|Death|10|||
125331363|NCT00473382|450845666|FG000|Core Study|Lost to Follow-up|3|||
125331364|NCT00473382|450845667|FG001|Core Study|Lost to Follow-up|3|||
125331365|NCT00473382|450845668|FG002|Core Study|Lost to Follow-up|3|||
125331366|NCT00473382|450845666|FG000|Core Study|Physician Decision|1|||
125331367|NCT00473382|450845667|FG001|Core Study|Physician Decision|2|||
125331368|NCT00473382|450845668|FG002|Core Study|Physician Decision|2|||
125331369|NCT00473382|450845666|FG000|Core Study|Subject non-compliance|5|||
125331370|NCT00473382|450845667|FG001|Core Study|Subject non-compliance|2|||
125331371|NCT00473382|450845668|FG002|Core Study|Subject non-compliance|1|||
125331372|NCT00473382|450845666|FG000|Core Study|Subject needed other treatment|1|||
125331373|NCT00473382|450845667|FG001|Core Study|Subject needed other treatment|3|||
125331374|NCT00473382|450845668|FG002|Core Study|Subject needed other treatment|2|||
125331375|NCT00473382|450845666|FG000|Core Study|Subject's decision|12|||
125331376|NCT00473382|450845667|FG001|Core Study|Subject's decision|11|||
125331377|NCT00473382|450845668|FG002|Core Study|Subject's decision|10|||
125331378|NCT00473382|450845666|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
125331379|NCT00473382|450845667|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
125331380|NCT00473382|450845668|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
125331381|NCT00473382|450845666|FG000|Open-label Extension Through Month 48|Death|1|||
125331382|NCT00473382|450845667|FG001|Open-label Extension Through Month 48|Death|3|||
125331383|NCT00473382|450845668|FG002|Open-label Extension Through Month 48|Death|3|||
125331384|NCT00473382|450845666|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
125331385|NCT00473382|450845667|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
125331386|NCT00473382|450845668|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
125331387|NCT00473382|450845666|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
125331388|NCT00473382|450845667|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
125331389|NCT00473382|450845668|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
125331390|NCT00473382|450845666|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
125331391|NCT00473382|450845667|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
125331392|NCT00473382|450845668|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
125331393|NCT00473382|450845666|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
125331394|NCT00473382|450845667|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
125331395|NCT00473382|450845668|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
125001990|NCT03627767|449637486|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
125331396|NCT00473382|450845666|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
125331397|NCT00473382|450845667|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
125331398|NCT00473382|450845668|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
125331399|NCT00473382|450845666|FG000|Open-label Extension Through Month 60|Death|1|||
125331400|NCT00473382|450845667|FG001|Open-label Extension Through Month 60|Death|7|||
125331401|NCT00473382|450845668|FG002|Open-label Extension Through Month 60|Death|4|||
125331402|NCT00473382|450845666|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
125331403|NCT00473382|450845667|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
125331404|NCT00473382|450845668|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
125331405|NCT00473382|450845666|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
125331406|NCT00473382|450845667|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
125331407|NCT00473382|450845668|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
125331408|NCT00473382|450845666|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
125331409|NCT00473382|450845667|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
125331410|NCT00473382|450845668|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
125331411|NCT00473382|450845666|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
125331412|NCT00473382|450845667|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
125331413|NCT00473382|450845668|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
125331414|NCT01189032|450845669|FG000|Overall Study|Adverse Event|1|||
125331415|NCT01189032|450845670|FG001|Overall Study|Adverse Event|3|||
125331416|NCT01189032|450845671|FG002|Overall Study|Adverse Event|4|||
125331417|NCT01189032|450845669|FG000|Overall Study|Lack of Efficacy|2|||
125331418|NCT01189032|450845670|FG001|Overall Study|Lack of Efficacy|3|||
125331419|NCT01189032|450845671|FG002|Overall Study|Lack of Efficacy|0|||
125331420|NCT01189032|450845669|FG000|Overall Study|Withdrawal by Subject|1|||
125331421|NCT01189032|450845670|FG001|Overall Study|Withdrawal by Subject|0|||
125331422|NCT01189032|450845671|FG002|Overall Study|Withdrawal by Subject|1|||
125331423|NCT01189032|450845669|FG000|Overall Study|Protocol Violation|1|||
125331424|NCT01189032|450845670|FG001|Overall Study|Protocol Violation|1|||
125331425|NCT01189032|450845671|FG002|Overall Study|Protocol Violation|1|||
125331426|NCT01470326|450845672|FG000|Overall Study|Protocol Violation|32|||
125331427|NCT01470326|450845672|FG000|Overall Study|No Drug Administration Information|2|||
125331428|NCT01470326|450845672|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
125331429|NCT01166282|450845673|FG000|Open-label Period|Adverse Event|0|||
125331430|NCT01166282|450845674|FG001|Open-label Period|Adverse Event|0|||
125331431|NCT01166282|450845675|FG002|Open-label Period|Adverse Event|6|||
125331432|NCT01166282|450845673|FG000|Open-label Period|Withdrawal by Subject|0|||
125331433|NCT01166282|450845674|FG001|Open-label Period|Withdrawal by Subject|0|||
125331434|NCT01166282|450845675|FG002|Open-label Period|Withdrawal by Subject|4|||
125331435|NCT01166282|450845673|FG000|Open-label Period|Lack of Efficacy|0|||
125331436|NCT01166282|450845674|FG001|Open-label Period|Lack of Efficacy|0|||
125331437|NCT01166282|450845675|FG002|Open-label Period|Lack of Efficacy|2|||
125331438|NCT01166282|450845673|FG000|Open-label Period|Remission|0|||
125331439|NCT01166282|450845674|FG001|Open-label Period|Remission|0|||
125331440|NCT01166282|450845675|FG002|Open-label Period|Remission|4|||
125001991|NCT03627767|449637482|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
125001992|NCT03627767|449637483|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
125001993|NCT03627767|449637484|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
125001994|NCT03627767|449637485|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
125001995|NCT03627767|449637486|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
125001996|NCT03627767|449637482|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
125001997|NCT03627767|449637483|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
125001998|NCT03627767|449637484|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
125001999|NCT03627767|449637485|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
125002000|NCT03627767|449637486|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
125002001|NCT03627767|449637482|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
125002002|NCT03627767|449637483|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
125002003|NCT03627767|449637484|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
125002004|NCT03627767|449637485|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
125002005|NCT03627767|449637486|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
125002006|NCT03627767|449637482|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
125002007|NCT03627767|449637483|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
125002008|NCT03627767|449637484|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
125002009|NCT03627767|449637485|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
125002010|NCT03627767|449637486|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
125002011|NCT01873417|449637487|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
125002012|NCT01873417|449637487|FG000|Overall Study|Adverse Event|24|||
125331441|NCT01166282|450845673|FG000|Open-label Period|Irregular Compliance|0|||
125331442|NCT01166282|450845674|FG001|Open-label Period|Irregular Compliance|0|||
125002013|NCT01873417|449637487|FG000|Overall Study|Lost to Follow-up|2|||
125331443|NCT01166282|450845675|FG002|Open-label Period|Irregular Compliance|1|||
125331444|NCT02577718|450845676|FG000|Overall Study|Death|6|||
125331445|NCT02577718|450845676|FG000|Overall Study|Withdrawal by Subject|2|||
125331446|NCT01995838|450845677|FG000|Overall Study|Lost to Follow-up|0|||
125331447|NCT01995838|450845678|FG001|Overall Study|Lost to Follow-up|1|||
125331448|NCT01995838|450845679|FG002|Overall Study|Lost to Follow-up|0|||
125331449|NCT01995838|450845680|FG003|Overall Study|Lost to Follow-up|0|||
125331450|NCT01995838|450845681|FG004|Overall Study|Lost to Follow-up|0|||
125331451|NCT01995838|450845682|FG005|Overall Study|Lost to Follow-up|0|||
125331452|NCT01995838|450845683|FG006|Overall Study|Lost to Follow-up|1|||
125331453|NCT01995838|450845677|FG000|Overall Study|Participant choice|2|||
125331454|NCT01995838|450845678|FG001|Overall Study|Participant choice|0|||
125331455|NCT01995838|450845679|FG002|Overall Study|Participant choice|0|||
125331456|NCT01995838|450845680|FG003|Overall Study|Participant choice|0|||
125331457|NCT01995838|450845681|FG004|Overall Study|Participant choice|0|||
125331458|NCT01995838|450845682|FG005|Overall Study|Participant choice|1|||
125002014|NCT01873417|449637487|FG000|Overall Study|Withdrawal by Subject|2|||
125002015|NCT01873417|449637487|FG000|Overall Study|Physician Decision|3|||
125331459|NCT01995838|450845683|FG006|Overall Study|Participant choice|1|||
125331460|NCT01995838|450845677|FG000|Overall Study|Adverse Event|0|||
125331461|NCT01995838|450845678|FG001|Overall Study|Adverse Event|0|||
125331462|NCT01995838|450845679|FG002|Overall Study|Adverse Event|0|||
125331463|NCT01995838|450845680|FG003|Overall Study|Adverse Event|0|||
125331464|NCT01995838|450845681|FG004|Overall Study|Adverse Event|0|||
125331465|NCT01995838|450845682|FG005|Overall Study|Adverse Event|0|||
125331466|NCT01995838|450845683|FG006|Overall Study|Adverse Event|1|||
125331467|NCT01995838|450845677|FG000|Overall Study|Withdrawal by Subject|0|||
125331468|NCT01995838|450845678|FG001|Overall Study|Withdrawal by Subject|0|||
125331469|NCT01995838|450845679|FG002|Overall Study|Withdrawal by Subject|0|||
125331470|NCT01995838|450845680|FG003|Overall Study|Withdrawal by Subject|0|||
125331471|NCT01995838|450845681|FG004|Overall Study|Withdrawal by Subject|1|||
125331472|NCT01995838|450845682|FG005|Overall Study|Withdrawal by Subject|0|||
125331473|NCT01995838|450845683|FG006|Overall Study|Withdrawal by Subject|0|||
125331474|NCT01995838|450845677|FG000|Overall Study|Other|3|||
125331475|NCT01995838|450845678|FG001|Overall Study|Other|1|||
125331476|NCT01995838|450845679|FG002|Overall Study|Other|0|||
125331477|NCT01995838|450845680|FG003|Overall Study|Other|2|||
125331478|NCT01995838|450845681|FG004|Overall Study|Other|1|||
125002016|NCT00785044|449637488|FG000|Overall Study|Dosed at non-participating sites|152|||
125002017|NCT00785044|449637488|FG000|Overall Study|Death|77|||
125002018|NCT00785044|449637488|FG000|Overall Study|Lost to Follow-up|266|||
125002019|NCT00785044|449637488|FG000|Overall Study|Withdrawal by Subject|1|||
125002020|NCT00385203|449637489|FG000|Overall Study|Adverse Event|5|||
125002021|NCT00385203|449637490|FG001|Overall Study|Adverse Event|4|||
125002022|NCT00385203|449637489|FG000|Overall Study|Death|1|||
125002023|NCT00385203|449637490|FG001|Overall Study|Death|0|||
125002024|NCT00385203|449637489|FG000|Overall Study|Condition under investigation worsened|18|||
125002025|NCT00385203|449637490|FG001|Overall Study|Condition under investigation worsened|3|||
125002026|NCT00385203|449637489|FG000|Overall Study|Incorrect enrollment|2|||
125002027|NCT00385203|449637490|FG001|Overall Study|Incorrect enrollment|0|||
125002028|NCT01798992|449637491|FG000|Overall Study|Administrative withdrawal|0|||
125002029|NCT01798992|449637492|FG001|Overall Study|Administrative withdrawal|1|||
125002030|NCT01798992|449637493|FG002|Overall Study|Administrative withdrawal|0|||
125002031|NCT01798992|449637494|FG003|Overall Study|Administrative withdrawal|1|||
125002032|NCT01798992|449637491|FG000|Overall Study|Lost to Follow-up|0|||
125002033|NCT01798992|449637492|FG001|Overall Study|Lost to Follow-up|1|||
125002034|NCT01798992|449637493|FG002|Overall Study|Lost to Follow-up|1|||
125002035|NCT01798992|449637494|FG003|Overall Study|Lost to Follow-up|0|||
125002036|NCT01798992|449637491|FG000|Overall Study|Insufficient biopsy tissue|0|||
125002037|NCT01798992|449637492|FG001|Overall Study|Insufficient biopsy tissue|0|||
125002038|NCT01798992|449637493|FG002|Overall Study|Insufficient biopsy tissue|1|||
125002039|NCT01798992|449637494|FG003|Overall Study|Insufficient biopsy tissue|0|||
125002040|NCT03823404|449637495|FG000|Overall Study|Lost to Follow-up|1|||
125002041|NCT03823404|449637496|FG001|Overall Study|Lost to Follow-up|2|||
125002042|NCT03823404|449637497|FG002|Overall Study|Lost to Follow-up|3|||
125002043|NCT03823404|449637495|FG000|Overall Study|Protocol Violation|2|||
125002044|NCT03823404|449637496|FG001|Overall Study|Protocol Violation|0|||
125002045|NCT03823404|449637497|FG002|Overall Study|Protocol Violation|2|||
125002046|NCT03823404|449637495|FG000|Overall Study|Adverse Event|35|||
125002047|NCT03823404|449637496|FG001|Overall Study|Adverse Event|38|||
125002048|NCT03823404|449637497|FG002|Overall Study|Adverse Event|8|||
125002049|NCT03823404|449637495|FG000|Overall Study|Withdrawal by Subject|38|||
125002050|NCT03823404|449637496|FG001|Overall Study|Withdrawal by Subject|40|||
125002051|NCT03823404|449637497|FG002|Overall Study|Withdrawal by Subject|35|||
125002052|NCT03823404|449637495|FG000|Overall Study|Death|4|||
125002053|NCT03823404|449637496|FG001|Overall Study|Death|0|||
125002054|NCT03823404|449637497|FG002|Overall Study|Death|0|||
125002055|NCT03823404|449637495|FG000|Overall Study|Other: Various reasons provided|5|||
125331479|NCT01995838|450845682|FG005|Overall Study|Other|1|||
125331480|NCT01995838|450845683|FG006|Overall Study|Other|2|||
125331481|NCT01967576|450845684|FG000|Overall Study|Withdrawal by Subject|3|||
125331482|NCT01967576|450845684|FG000|Overall Study|Progressed/Removed from treatment|1|||
125331483|NCT01967576|450845684|FG000|Overall Study|Study closing at site|1|||
125331484|NCT01967576|450845684|FG000|Overall Study|Adverse Event|1|||
125331485|NCT01967576|450845684|FG000|Overall Study|Refused further treatment|1|||
125331486|NCT00380367|450845687|FG000|Overall Study|Lost to Follow-up|1|||
125002056|NCT03823404|449637496|FG001|Overall Study|Other: Various reasons provided|5|||
125002057|NCT03823404|449637497|FG002|Overall Study|Other: Various reasons provided|6|||
125002058|NCT02308007|449637498|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
125002059|NCT02308007|449637499|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
125002060|NCT02308007|449637500|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
125002061|NCT02308007|449637498|FG000|Overall Study|Positive for STD at Baseline|7|||
125002062|NCT02308007|449637499|FG001|Overall Study|Positive for STD at Baseline|11|||
125002063|NCT02308007|449637500|FG002|Overall Study|Positive for STD at Baseline|7|||
125002064|NCT02308007|449637498|FG000|Overall Study|Lost to Follow-up|3|||
125002065|NCT02308007|449637499|FG001|Overall Study|Lost to Follow-up|0|||
125002066|NCT02308007|449637500|FG002|Overall Study|Lost to Follow-up|1|||
125002067|NCT00528567|449637505|FG000|Overall Study|Death|4|||
125002068|NCT00528567|449637506|FG001|Overall Study|Death|5|||
125002069|NCT00528567|449637505|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
125002070|NCT00528567|449637506|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
125002071|NCT00528567|449637505|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
125002072|NCT00528567|449637506|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
125002073|NCT00528567|449637505|FG000|Overall Study|Violation Criteria at Entry|3|||
125002074|NCT00528567|449637506|FG001|Overall Study|Violation Criteria at Entry|17|||
125331487|NCT00380367|450845687|FG000|Overall Study|Withdrawal by Subject|1|||
125002075|NCT00528567|449637505|FG000|Overall Study|Withdrew Consent|59|||
125002076|NCT00528567|449637506|FG001|Overall Study|Withdrew Consent|55|||
125002077|NCT00528567|449637505|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
125002078|NCT00528567|449637506|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
125002079|NCT00528567|449637505|FG000|Overall Study|Failure to Return|1|||
125002080|NCT00528567|449637506|FG001|Overall Study|Failure to Return|4|||
125002081|NCT00528567|449637505|FG000|Overall Study|Other Protocol Violation|5|||
125002082|NCT00528567|449637506|FG001|Overall Study|Other Protocol Violation|21|||
125002083|NCT00528567|449637505|FG000|Overall Study|Administrative/Other|22|||
125002084|NCT00528567|449637506|FG001|Overall Study|Administrative/Other|75|||
125002085|NCT03085758|449637509|FG000|Overall Study|Death|26|||
125002086|NCT03085758|449637510|FG001|Overall Study|Death|24|||
125002087|NCT03085758|449637511|FG002|Overall Study|Death|53|||
125002088|NCT03085758|449637509|FG000|Overall Study|Lost to Follow-up|1|||
125002089|NCT03085758|449637510|FG001|Overall Study|Lost to Follow-up|1|||
125002090|NCT03085758|449637511|FG002|Overall Study|Lost to Follow-up|1|||
125002091|NCT03085758|449637509|FG000|Overall Study|Withdrawal by Subject|2|||
125002092|NCT03085758|449637510|FG001|Overall Study|Withdrawal by Subject|2|||
125002093|NCT03085758|449637511|FG002|Overall Study|Withdrawal by Subject|1|||
125002094|NCT03085758|449637509|FG000|Overall Study|Refusal to recall it up to day 90|0|||
125002095|NCT03085758|449637510|FG001|Overall Study|Refusal to recall it up to day 90|0|||
125002096|NCT03085758|449637511|FG002|Overall Study|Refusal to recall it up to day 90|1|||
125002097|NCT03085758|449637509|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
125002098|NCT03085758|449637510|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
125002099|NCT03085758|449637511|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
125002100|NCT04004429|449637512|FG000|Overall Study|Protocol Violation|1|||
125002101|NCT04004429|449637513|FG001|Overall Study|Protocol Violation|0|||
125002102|NCT04004429|449637514|FG002|Overall Study|Protocol Violation|0|||
125002103|NCT04004429|449637512|FG000|Overall Study|Physician Decision|0|||
125002104|NCT04004429|449637513|FG001|Overall Study|Physician Decision|1|||
125002105|NCT04004429|449637514|FG002|Overall Study|Physician Decision|1|||
125002106|NCT04004429|449637512|FG000|Overall Study|Withdrawal by Subject|1|||
125002107|NCT04004429|449637513|FG001|Overall Study|Withdrawal by Subject|1|||
125331488|NCT00392769|450845691|FG000|Overall Study|Clinical Deterioration|9|||
125331489|NCT00392769|450845691|FG000|Overall Study|Adverse Event|1|||
125331490|NCT00060840|450845700|FG000|Overall Study|Change in surgical plan|2|||
125331491|NCT00060840|450845701|FG001|Overall Study|Change in surgical plan|6|||
125331492|NCT00060840|450845700|FG000|Overall Study|Death|0|||
125331493|NCT00060840|450845701|FG001|Overall Study|Death|1|||
125331494|NCT00060840|450845700|FG000|Overall Study|Withdrawal by Subject|0|||
125331495|NCT00060840|450845701|FG001|Overall Study|Withdrawal by Subject|1|||
125331496|NCT00060840|450845700|FG000|Overall Study|Subinvestigator unavailable|0|||
125331497|NCT00060840|450845701|FG001|Overall Study|Subinvestigator unavailable|1|||
125002108|NCT04004429|449637514|FG002|Overall Study|Withdrawal by Subject|1|||
125002109|NCT00631189|449637517|FG000|Initial Phase|Protocol Violation|347|||
125002110|NCT00631189|449637518|FG001|Initial Phase|Protocol Violation|0|||
125002111|NCT00631189|449637519|FG002|Initial Phase|Protocol Violation|0|||
125002112|NCT00631189|449637520|FG003|Initial Phase|Protocol Violation|0|||
125002113|NCT00631189|449637517|FG000|Initial Phase|Withdrawal by Subject|4|||
125002114|NCT00631189|449637518|FG001|Initial Phase|Withdrawal by Subject|0|||
125002115|NCT00631189|449637519|FG002|Initial Phase|Withdrawal by Subject|0|||
125002116|NCT00631189|449637520|FG003|Initial Phase|Withdrawal by Subject|0|||
125002117|NCT00631189|449637517|FG000|Treatment Phase|Withdrawal by Subject|0|||
125331498|NCT00060840|450845700|FG000|Overall Study|Physician Decision|1|||
125331499|NCT00060840|450845701|FG001|Overall Study|Physician Decision|0|||
125331500|NCT00060840|450845700|FG000|Overall Study|Other|1|||
125331501|NCT00060840|450845701|FG001|Overall Study|Other|0|||
125331502|NCT03710161|450845703|FG000|Overall Study|Study halted due to COVID pandemic|3|||
125331503|NCT03710161|450845704|FG001|Overall Study|Study halted due to COVID pandemic|2|||
125331504|NCT00541385|450845706|FG000|Overall Study|Adverse Event|6|||
125331505|NCT00541385|450845707|FG001|Overall Study|Adverse Event|3|||
125331506|NCT00541385|450845706|FG000|Overall Study|Withdrawal by Subject|2|||
125002118|NCT00631189|449637518|FG001|Treatment Phase|Withdrawal by Subject|2|||
125002119|NCT00631189|449637519|FG002|Treatment Phase|Withdrawal by Subject|1|||
125002120|NCT00631189|449637520|FG003|Treatment Phase|Withdrawal by Subject|1|||
125002121|NCT00631189|449637517|FG000|Treatment Phase|Protocol Violation|0|||
125002122|NCT00631189|449637518|FG001|Treatment Phase|Protocol Violation|1|||
125002123|NCT00631189|449637519|FG002|Treatment Phase|Protocol Violation|6|||
125002124|NCT00631189|449637520|FG003|Treatment Phase|Protocol Violation|2|||
125002125|NCT00631189|449637517|FG000|Treatment Phase|Adverse Event|0|||
125002126|NCT00631189|449637518|FG001|Treatment Phase|Adverse Event|3|||
125002127|NCT00631189|449637519|FG002|Treatment Phase|Adverse Event|2|||
125002128|NCT00631189|449637520|FG003|Treatment Phase|Adverse Event|4|||
125002129|NCT00631189|449637517|FG000|Treatment Phase|Lost to Follow-up|0|||
125002130|NCT00631189|449637518|FG001|Treatment Phase|Lost to Follow-up|1|||
125002131|NCT00631189|449637519|FG002|Treatment Phase|Lost to Follow-up|0|||
125002132|NCT00631189|449637520|FG003|Treatment Phase|Lost to Follow-up|0|||
125002133|NCT00631189|449637517|FG000|Treatment Phase|Pregnancy|0|||
125002134|NCT00631189|449637518|FG001|Treatment Phase|Pregnancy|0|||
125002135|NCT00631189|449637519|FG002|Treatment Phase|Pregnancy|1|||
125002136|NCT00631189|449637520|FG003|Treatment Phase|Pregnancy|0|||
125002137|NCT00631189|449637517|FG000|Treatment Phase|patient did not take pravastatin|0|||
125002138|NCT00631189|449637518|FG001|Treatment Phase|patient did not take pravastatin|0|||
125002139|NCT00631189|449637519|FG002|Treatment Phase|patient did not take pravastatin|1|||
125002140|NCT00631189|449637520|FG003|Treatment Phase|patient did not take pravastatin|0|||
125002141|NCT04464265|449637521|FG000|Overall Study|Physician Decision|2|||
125002142|NCT00974090|449637526|FG000|Period 1: Double Blind Period|Adverse Event|2|||
125002143|NCT00974090|449637527|FG001|Period 1: Double Blind Period|Adverse Event|1|||
125002144|NCT00974090|449637526|FG000|Period 1: Double Blind Period|Physician Decision|1|||
125002145|NCT00974090|449637527|FG001|Period 1: Double Blind Period|Physician Decision|0|||
125002146|NCT00974090|449637526|FG000|Period 2: Open-label Period|Adverse Event|4|||
125002147|NCT00974090|449637527|FG001|Period 2: Open-label Period|Adverse Event|6|||
125002148|NCT00974090|449637526|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
125002149|NCT00974090|449637527|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
125002150|NCT00974090|449637526|FG000|Period 2: Open-label Period|Physician Decision|0|||
125002151|NCT00974090|449637527|FG001|Period 2: Open-label Period|Physician Decision|3|||
125002152|NCT00974090|449637526|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
125002153|NCT00974090|449637527|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
125002154|NCT03189862|449637528|FG000|Overall Study|Withdrawal by Subject|1|||
125002155|NCT03189862|449637529|FG001|Overall Study|Withdrawal by Subject|0|||
125002156|NCT03189862|449637528|FG000|Overall Study|Lost to Follow-up|54|||
125002157|NCT03189862|449637529|FG001|Overall Study|Lost to Follow-up|62|||
125002158|NCT00056862|449637530|FG000|Overall Study|Protocol Violation|1|||
125002159|NCT00056862|449637531|FG001|Overall Study|Protocol Violation|0|||
125002160|NCT01122576|449637532|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
125002161|NCT01122576|449637533|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
125002162|NCT01122576|449637534|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
125002163|NCT01122576|449637532|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
125002164|NCT01122576|449637533|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
125002165|NCT01122576|449637534|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
125002166|NCT01122576|449637532|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
125002167|NCT01122576|449637533|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
125002168|NCT01122576|449637534|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
125002169|NCT00381563|449637539|FG000|Overall Study|Withdrawal by Subject|5|||
125002170|NCT00381563|449637540|FG001|Overall Study|Withdrawal by Subject|5|||
125002171|NCT00381563|449637539|FG000|Overall Study|Lost to Follow-up|2|||
125331507|NCT00541385|450845707|FG001|Overall Study|Withdrawal by Subject|2|||
125331508|NCT00541385|450845706|FG000|Overall Study|Lost to Follow-up|6|||
125331509|NCT00541385|450845707|FG001|Overall Study|Lost to Follow-up|1|||
125002172|NCT00381563|449637540|FG001|Overall Study|Lost to Follow-up|0|||
125002173|NCT00381563|449637539|FG000|Overall Study|Protocol Violation|0|||
125002174|NCT00381563|449637540|FG001|Overall Study|Protocol Violation|1|||
125002175|NCT00931944|449637542|FG000|Overall Study|Adverse Event|4|||
125002176|NCT00931944|449637542|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
125002177|NCT00931944|449637542|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
125002178|NCT00931944|449637542|FG000|Overall Study|Death|28|||
125002179|NCT00931944|449637542|FG000|Overall Study|Other|2|||
125002180|NCT01132612|449637543|FG000|Overall Study|Death|0|||
125002181|NCT01132612|449637544|FG001|Overall Study|Death|0|||
125002182|NCT01132612|449637545|FG002|Overall Study|Death|1|||
125331510|NCT00541385|450845706|FG000|Overall Study|Parasite reappearance/malaria|67|||
125331511|NCT00541385|450845707|FG001|Overall Study|Parasite reappearance/malaria|32|||
125331512|NCT01499355|450845710|FG000|Run-In Period|Study Termination|15|||
125331513|NCT01499355|450845711|FG001|Run-In Period|Study Termination|0|||
125331514|NCT01499355|450845712|FG002|Run-In Period|Study Termination|0|||
125331515|NCT01499355|450845713|FG003|Run-In Period|Study Termination|0|||
125331516|NCT01499355|450845710|FG000|Run-In Period|Other|3|||
125331517|NCT01499355|450845711|FG001|Run-In Period|Other|0|||
125331518|NCT01499355|450845712|FG002|Run-In Period|Other|0|||
125331519|NCT01499355|450845713|FG003|Run-In Period|Other|0|||
125331520|NCT01499355|450845710|FG000|Run-In Period|Death|2|||
125331521|NCT01499355|450845711|FG001|Run-In Period|Death|0|||
125331522|NCT01499355|450845712|FG002|Run-In Period|Death|0|||
125331523|NCT01499355|450845713|FG003|Run-In Period|Death|0|||
125331524|NCT01499355|450845710|FG000|Run-In Period|Investigator Decision|2|||
125331525|NCT01499355|450845711|FG001|Run-In Period|Investigator Decision|0|||
125331526|NCT01499355|450845712|FG002|Run-In Period|Investigator Decision|0|||
125331527|NCT01499355|450845713|FG003|Run-In Period|Investigator Decision|0|||
125331528|NCT01499355|450845710|FG000|Run-In Period|Consent Withdrawn|1|||
125331529|NCT01499355|450845711|FG001|Run-In Period|Consent Withdrawn|0|||
125331530|NCT01499355|450845712|FG002|Run-In Period|Consent Withdrawn|0|||
125331531|NCT01499355|450845713|FG003|Run-In Period|Consent Withdrawn|0|||
125331532|NCT01499355|450845710|FG000|Run-In Period|Adverse Event|8|||
125331533|NCT01499355|450845711|FG001|Run-In Period|Adverse Event|0|||
125331534|NCT01499355|450845712|FG002|Run-In Period|Adverse Event|0|||
125331535|NCT01499355|450845713|FG003|Run-In Period|Adverse Event|0|||
125331536|NCT01499355|450845710|FG000|Double-Blind Period|Adverse Event|0|||
125331537|NCT01499355|450845711|FG001|Double-Blind Period|Adverse Event|2|||
125331538|NCT01499355|450845712|FG002|Double-Blind Period|Adverse Event|3|||
125331539|NCT01499355|450845713|FG003|Double-Blind Period|Adverse Event|2|||
125002183|NCT01132612|449637543|FG000|Overall Study|Protocol deviation|0|||
125002184|NCT01132612|449637544|FG001|Overall Study|Protocol deviation|0|||
125002185|NCT01132612|449637545|FG002|Overall Study|Protocol deviation|3|||
125002186|NCT01132612|449637543|FG000|Overall Study|Lost to Follow-up|2|||
125002187|NCT01132612|449637544|FG001|Overall Study|Lost to Follow-up|2|||
125002188|NCT01132612|449637545|FG002|Overall Study|Lost to Follow-up|7|||
125002189|NCT01132612|449637543|FG000|Overall Study|Adverse Event|5|||
125002190|NCT01132612|449637544|FG001|Overall Study|Adverse Event|2|||
125002191|NCT01132612|449637545|FG002|Overall Study|Adverse Event|15|||
125002192|NCT01132612|449637543|FG000|Overall Study|Withdrawal by Subject|5|||
125002193|NCT01132612|449637544|FG001|Overall Study|Withdrawal by Subject|8|||
125002194|NCT01132612|449637545|FG002|Overall Study|Withdrawal by Subject|19|||
125002195|NCT01132612|449637543|FG000|Overall Study|Administrative problems|5|||
125002196|NCT01132612|449637544|FG001|Overall Study|Administrative problems|1|||
125002197|NCT01132612|449637545|FG002|Overall Study|Administrative problems|52|||
125002198|NCT01132612|449637543|FG000|Overall Study|Lack of Efficacy|23|||
125002199|NCT01132612|449637544|FG001|Overall Study|Lack of Efficacy|22|||
125002200|NCT01132612|449637545|FG002|Overall Study|Lack of Efficacy|73|||
125002201|NCT02252536|449637546|FG000|Overall Study|Lost to Follow-up|5|||
125002202|NCT02252536|449637547|FG001|Overall Study|Lost to Follow-up|3|||
125002203|NCT01438151|449637550|FG000|Overall Study|study terminated|8|||
125002204|NCT00006392|449637557|FG000|Overall Study|Ineligible|11|||
125002205|NCT00006392|449637558|FG001|Overall Study|Ineligible|3|||
125002206|NCT00006392|449637559|FG002|Overall Study|Ineligible|5|||
125002207|NCT00006392|449637560|FG003|Overall Study|Ineligible|5|||
125002208|NCT00006392|449637557|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
125002209|NCT00006392|449637558|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
125002210|NCT00006392|449637559|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
125002211|NCT00006392|449637560|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
125002212|NCT02545322|449637562|FG000|Overall Study|Withdrawal by Subject|3|||
125002213|NCT02401412|449637563|FG000|Overall Study|Lost to Follow-up|1|||
125002214|NCT02401412|449637564|FG001|Overall Study|Lost to Follow-up|0|||
125002215|NCT02401412|449637563|FG000|Overall Study|Discontinued Intervention|15|||
125002216|NCT02401412|449637564|FG001|Overall Study|Discontinued Intervention|21|||
125002217|NCT02401412|449637563|FG000|Overall Study|Withdrawal by Subject|4|||
125002218|NCT02401412|449637564|FG001|Overall Study|Withdrawal by Subject|4|||
125002219|NCT02401412|449637563|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
125002220|NCT02401412|449637564|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
125002221|NCT02401412|449637563|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
125002222|NCT02401412|449637564|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
125331540|NCT01499355|450845710|FG000|Double-Blind Period|Study Termination|0|||
125331541|NCT01499355|450845711|FG001|Double-Blind Period|Study Termination|18|||
125331542|NCT01499355|450845712|FG002|Double-Blind Period|Study Termination|16|||
125331543|NCT01499355|450845713|FG003|Double-Blind Period|Study Termination|14|||
125331544|NCT01499355|450845710|FG000|Double-Blind Period|Other|0|||
125331545|NCT01499355|450845711|FG001|Double-Blind Period|Other|1|||
125331546|NCT01499355|450845712|FG002|Double-Blind Period|Other|2|||
125331547|NCT01499355|450845713|FG003|Double-Blind Period|Other|2|||
125331548|NCT01499355|450845710|FG000|Double-Blind Period|Death|0|||
125331549|NCT01499355|450845711|FG001|Double-Blind Period|Death|1|||
125331550|NCT01499355|450845712|FG002|Double-Blind Period|Death|0|||
125002223|NCT01184053|449637565|FG000|Overall Study|progression while on treatment|3|||
125002224|NCT01174238|449637566|FG000|Overall Study|Lost to Follow-up|2|||
125002225|NCT02593786|449637567|FG000|Overall Study|Disease progression|12|||
125002226|NCT02593786|449637568|FG001|Overall Study|Disease progression|16|||
125002227|NCT02593786|449637569|FG002|Overall Study|Disease progression|10|||
125002228|NCT02593786|449637570|FG003|Overall Study|Disease progression|7|||
125002229|NCT02593786|449637567|FG000|Overall Study|Study drug toxicity|1|||
125002230|NCT02593786|449637568|FG001|Overall Study|Study drug toxicity|0|||
125002231|NCT02593786|449637569|FG002|Overall Study|Study drug toxicity|0|||
125331551|NCT01499355|450845713|FG003|Double-Blind Period|Death|0|||
125331552|NCT01499355|450845710|FG000|Double-Blind Period|Investigator Decision|0|||
125331553|NCT01499355|450845711|FG001|Double-Blind Period|Investigator Decision|0|||
125331554|NCT01499355|450845712|FG002|Double-Blind Period|Investigator Decision|3|||
125331555|NCT01499355|450845713|FG003|Double-Blind Period|Investigator Decision|3|||
125331556|NCT01499355|450845710|FG000|Double-Blind Period|Consent Withdrawn|0|||
125331557|NCT01499355|450845711|FG001|Double-Blind Period|Consent Withdrawn|0|||
125331558|NCT01499355|450845712|FG002|Double-Blind Period|Consent Withdrawn|1|||
125331559|NCT01499355|450845713|FG003|Double-Blind Period|Consent Withdrawn|2|||
125331560|NCT01499355|450845710|FG000|Double-Blind Period|Lost to Follow-up|0|||
125331561|NCT01499355|450845711|FG001|Double-Blind Period|Lost to Follow-up|1|||
125331562|NCT01499355|450845712|FG002|Double-Blind Period|Lost to Follow-up|0|||
125331563|NCT01499355|450845713|FG003|Double-Blind Period|Lost to Follow-up|0|||
125331564|NCT01526733|450845714|FG000|Phase 1|Protocol Violation|1|||
125331565|NCT01526733|450845715|FG001|Phase 1|Protocol Violation|0|||
125331566|NCT01526733|450845714|FG000|Phase 1|Withdrawal by Subject|1|||
125331567|NCT01526733|450845715|FG001|Phase 1|Withdrawal by Subject|1|||
125331568|NCT01599637|450845716|FG000|Overall Study|administrative problems|0|||
124872962|NCT01493687|449157205|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
124872963|NCT01493687|449157206|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
124872964|NCT01493687|449157205|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
124872965|NCT01493687|449157206|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
124872966|NCT01493687|449157205|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
124872967|NCT01493687|449157206|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
124872968|NCT01493687|449157205|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
124872969|NCT01493687|449157206|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
124872970|NCT01493687|449157205|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
124872971|NCT01493687|449157206|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
124872972|NCT01493687|449157205|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
124872973|NCT01493687|449157206|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
124872974|NCT01493687|449157205|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
124872975|NCT01493687|449157206|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
124872976|NCT01493687|449157205|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
124872977|NCT01493687|449157206|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
124872978|NCT02364180|449157209|FG000|Overall Study|Screen Fail|1|||
125002232|NCT02593786|449637570|FG003|Overall Study|Study drug toxicity|0|||
125002233|NCT02593786|449637567|FG000|Overall Study|Adverse event unrelated to study drug|1|||
125331569|NCT01599637|450845717|FG001|Overall Study|administrative problems|2|||
125331570|NCT01599637|450845718|FG002|Overall Study|administrative problems|0|||
125331571|NCT01599637|450845716|FG000|Overall Study|Adverse Event|1|||
125331572|NCT01599637|450845717|FG001|Overall Study|Adverse Event|0|||
125331573|NCT01599637|450845718|FG002|Overall Study|Adverse Event|0|||
125331574|NCT02565108|450845719|FG000|Overall Study|Adverse Event|1|||
125331575|NCT02565108|450845720|FG001|Overall Study|Adverse Event|0|||
125331576|NCT02565108|450845719|FG000|Overall Study|Withdrew Consent|1|||
125331577|NCT02565108|450845720|FG001|Overall Study|Withdrew Consent|0|||
125331578|NCT01310075|450845721|FG000|Overall Study|Lost to Follow-up|1|||
125331579|NCT01310075|450845722|FG001|Overall Study|Lost to Follow-up|0|||
125331580|NCT01310075|450845721|FG000|Overall Study|Physician Decision|10|||
125331581|NCT01310075|450845722|FG001|Overall Study|Physician Decision|7|||
125331582|NCT01310075|450845721|FG000|Overall Study|Protocol Violation|2|||
125331583|NCT01310075|450845722|FG001|Overall Study|Protocol Violation|2|||
125331584|NCT01310075|450845721|FG000|Overall Study|Withdrawal by Subject|1|||
125331585|NCT01310075|450845722|FG001|Overall Study|Withdrawal by Subject|1|||
125331586|NCT02395081|450845723|FG000|Overall Study|Withdrawal by Subject|1|||
125331587|NCT02395081|450845724|FG001|Overall Study|Withdrawal by Subject|1|||
125331588|NCT02395081|450845725|FG002|Overall Study|Withdrawal by Subject|0|||
125331589|NCT02395081|450845723|FG000|Overall Study|Moved where blood couldn't be collected|4|||
125331590|NCT02395081|450845724|FG001|Overall Study|Moved where blood couldn't be collected|1|||
125002234|NCT02593786|449637568|FG001|Overall Study|Adverse event unrelated to study drug|1|||
125331591|NCT02395081|450845725|FG002|Overall Study|Moved where blood couldn't be collected|3|||
125331592|NCT02395081|450845723|FG000|Overall Study|Fetal Loss|2|||
125331593|NCT02395081|450845724|FG001|Overall Study|Fetal Loss|3|||
125331594|NCT02395081|450845725|FG002|Overall Study|Fetal Loss|1|||
125331595|NCT02991040|450845726|FG000|Overall Study|Withdrawal by Subject|2|||
125002235|NCT02593786|449637569|FG002|Overall Study|Adverse event unrelated to study drug|1|||
125002236|NCT02593786|449637570|FG003|Overall Study|Adverse event unrelated to study drug|0|||
125002237|NCT02593786|449637567|FG000|Overall Study|Participant request to discontinue study therapy|0|||
125002238|NCT02593786|449637568|FG001|Overall Study|Participant request to discontinue study therapy|2|||
125002239|NCT02593786|449637569|FG002|Overall Study|Participant request to discontinue study therapy|0|||
125002240|NCT02593786|449637570|FG003|Overall Study|Participant request to discontinue study therapy|0|||
125002241|NCT02593786|449637567|FG000|Overall Study|Other reasons|1|||
125002242|NCT02593786|449637568|FG001|Overall Study|Other reasons|1|||
125002243|NCT02593786|449637569|FG002|Overall Study|Other reasons|0|||
125002244|NCT02593786|449637570|FG003|Overall Study|Other reasons|5|||
125002245|NCT01479829|449637571|FG000|Overall Study|Withdrawal by Subject|8|||
125002246|NCT01479829|449637572|FG001|Overall Study|Withdrawal by Subject|10|||
125002247|NCT01791803|449637574|FG000|Overall Study|Withdrawal by Subject|0|||
125002248|NCT01791803|449637575|FG001|Overall Study|Withdrawal by Subject|0|||
125002249|NCT01791803|449637576|FG002|Overall Study|Withdrawal by Subject|0|||
125002250|NCT01791803|449637577|FG003|Overall Study|Withdrawal by Subject|2|||
125002251|NCT01791803|449637574|FG000|Overall Study|Physician Decision|0|||
125002252|NCT01791803|449637575|FG001|Overall Study|Physician Decision|2|||
125002253|NCT01791803|449637576|FG002|Overall Study|Physician Decision|0|||
125002254|NCT01791803|449637577|FG003|Overall Study|Physician Decision|1|||
125002255|NCT01791803|449637574|FG000|Overall Study|Death|0|||
125002256|NCT01791803|449637575|FG001|Overall Study|Death|0|||
125002257|NCT01791803|449637576|FG002|Overall Study|Death|2|||
125002258|NCT01791803|449637577|FG003|Overall Study|Death|2|||
125002259|NCT01093326|449637581|FG000|Overall Study|Death|0|||
125002260|NCT01093326|449637582|FG001|Overall Study|Death|1|||
125002261|NCT01093326|449637583|FG002|Overall Study|Death|0|||
125002262|NCT01093326|449637581|FG000|Overall Study|Lack of Efficacy|7|||
125002263|NCT01093326|449637582|FG001|Overall Study|Lack of Efficacy|6|||
125002264|NCT01093326|449637583|FG002|Overall Study|Lack of Efficacy|3|||
125002265|NCT01093326|449637581|FG000|Overall Study|Lost to Follow-up|2|||
125002266|NCT01093326|449637582|FG001|Overall Study|Lost to Follow-up|5|||
125331596|NCT02991040|450845726|FG000|Overall Study|Lost to Follow-up|2|||
125331597|NCT01286480|450845727|FG000|Overall Study|Withdrawal by Subject|5|||
125331598|NCT01286480|450845728|FG001|Overall Study|Withdrawal by Subject|3|||
125002267|NCT01093326|449637583|FG002|Overall Study|Lost to Follow-up|4|||
125002268|NCT01093326|449637581|FG000|Overall Study|Physician Decision|3|||
125331599|NCT02536963|450845729|FG000|Overall Study|Withdrawal by Subject|18|||
125331600|NCT02668393|450845731|FG000|Overall Study|Progressive disease|6|||
125331601|NCT02668393|450845732|FG001|Overall Study|Progressive disease|3|||
125331602|NCT02668393|450845731|FG000|Overall Study|Adverse Event|0|||
125331603|NCT02668393|450845732|FG001|Overall Study|Adverse Event|2|||
125331604|NCT02668393|450845731|FG000|Overall Study|Withdrawal from the trial|0|||
125331605|NCT02668393|450845732|FG001|Overall Study|Withdrawal from the trial|1|||
125331606|NCT02668393|450845731|FG000|Overall Study|Lack of benefit and side effects|1|||
125331607|NCT02668393|450845732|FG001|Overall Study|Lack of benefit and side effects|0|||
125331608|NCT02141204|450845733|FG000|Overall Study|Lost to Follow-up|2|||
125331609|NCT02141204|450845734|FG001|Overall Study|Lost to Follow-up|1|||
125331610|NCT02141204|450845733|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
125331611|NCT02141204|450845734|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
125331612|NCT02141204|450845733|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
125331613|NCT02141204|450845734|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
125331614|NCT02141204|450845733|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
125331615|NCT02141204|450845734|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
125331616|NCT02963506|450845736|FG000|Double-Blind Period|Adverse Event|0|||
125331617|NCT02963506|450845737|FG001|Double-Blind Period|Adverse Event|0|||
125331618|NCT02963506|450845738|FG002|Double-Blind Period|Adverse Event|1|||
125331619|NCT02963506|450845739|FG003|Double-Blind Period|Adverse Event|0|||
125331620|NCT02963506|450845740|FG004|Double-Blind Period|Adverse Event|0|||
125331621|NCT02963506|450845741|FG005|Double-Blind Period|Adverse Event|0|||
125331622|NCT02963506|450845742|FG006|Double-Blind Period|Adverse Event|0|||
125331623|NCT02963506|450845743|FG007|Double-Blind Period|Adverse Event|0|||
125331624|NCT02963506|450845744|FG008|Double-Blind Period|Adverse Event|0|||
125331625|NCT02963506|450845745|FG009|Double-Blind Period|Adverse Event|0|||
125331626|NCT02963506|450845746|FG010|Double-Blind Period|Adverse Event|0|||
125331627|NCT02963506|450845747|FG011|Double-Blind Period|Adverse Event|0|||
125331628|NCT02963506|450845748|FG012|Double-Blind Period|Adverse Event|0|||
125002269|NCT01093326|449637582|FG001|Overall Study|Physician Decision|1|||
125002270|NCT01093326|449637583|FG002|Overall Study|Physician Decision|3|||
125002271|NCT01093326|449637581|FG000|Overall Study|Withdrawal by Subject|30|||
125002272|NCT01093326|449637582|FG001|Overall Study|Withdrawal by Subject|27|||
125002273|NCT01093326|449637583|FG002|Overall Study|Withdrawal by Subject|26|||
125002274|NCT01093326|449637581|FG000|Overall Study|Adverse Event|2|||
125002275|NCT01093326|449637582|FG001|Overall Study|Adverse Event|1|||
125331629|NCT02963506|450845736|FG000|Double-Blind Period|Death|0|||
125002276|NCT01093326|449637583|FG002|Overall Study|Adverse Event|4|||
125002277|NCT01093326|449637581|FG000|Overall Study|Other|0|||
125331630|NCT02963506|450845737|FG001|Double-Blind Period|Death|0|||
125331631|NCT02963506|450845738|FG002|Double-Blind Period|Death|0|||
125331632|NCT02963506|450845739|FG003|Double-Blind Period|Death|1|||
125331633|NCT02963506|450845740|FG004|Double-Blind Period|Death|0|||
125331634|NCT02963506|450845741|FG005|Double-Blind Period|Death|0|||
125331635|NCT02963506|450845742|FG006|Double-Blind Period|Death|0|||
125331636|NCT02963506|450845743|FG007|Double-Blind Period|Death|0|||
125002278|NCT01093326|449637582|FG001|Overall Study|Other|0|||
125002279|NCT01093326|449637583|FG002|Overall Study|Other|1|||
125002280|NCT01444456|449637584|FG000|Overall Study|Withdrawal by Subject|21|||
125002281|NCT01444456|449637584|FG000|Overall Study|Physician Decision|9|||
125002282|NCT01444456|449637584|FG000|Overall Study|Lost to Follow-up|37|||
125002283|NCT01444456|449637584|FG000|Overall Study|Death|73|||
125002284|NCT01444456|449637584|FG000|Overall Study|Ineligibility determined|23|||
125002285|NCT01444456|449637584|FG000|Overall Study|Other|18|||
125002286|NCT01444456|449637584|FG000|Overall Study|Not treated|104|||
125002287|NCT04263896|449637585|FG000|Overall Study|Withdrawal by Subject|2|||
125002288|NCT04263896|449637586|FG001|Overall Study|Withdrawal by Subject|4|||
125002289|NCT04263896|449637585|FG000|Overall Study|converted to open procedure|0|||
125002290|NCT04263896|449637586|FG001|Overall Study|converted to open procedure|1|||
125002291|NCT04263896|449637585|FG000|Overall Study|Lost to Follow-up|9|||
125002292|NCT04263896|449637586|FG001|Overall Study|Lost to Follow-up|11|||
125002293|NCT04263896|449637585|FG000|Overall Study|surveys lost in mail|5|||
125002294|NCT04263896|449637586|FG001|Overall Study|surveys lost in mail|3|||
125002295|NCT04263896|449637585|FG000|Overall Study|excluded from analysis|1|||
125002296|NCT04263896|449637586|FG001|Overall Study|excluded from analysis|0|||
125002297|NCT04752475|449639058|FG000|Overall Study|Withdrawal by Subject|1|||
125002298|NCT04752475|449639059|FG001|Overall Study|Withdrawal by Subject|1|||
125002299|NCT00594516|449639064|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
125002300|NCT00594516|449639065|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
125002301|NCT00594516|449639066|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
125002302|NCT00594516|449639064|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
125002303|NCT00594516|449639065|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
125002304|NCT00594516|449639066|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
125002305|NCT00594516|449639064|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
125002306|NCT00594516|449639065|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
125002307|NCT00594516|449639066|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
125002308|NCT00594516|449639064|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
125002309|NCT00594516|449639065|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
125002310|NCT00594516|449639066|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
125002311|NCT00594516|449639064|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
125002312|NCT00594516|449639065|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
125002313|NCT00594516|449639066|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
125002314|NCT00594516|449639064|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
125002315|NCT00594516|449639065|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
125002316|NCT00594516|449639066|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
125002317|NCT00594516|449639064|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
125002318|NCT00594516|449639065|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
125002319|NCT00594516|449639066|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
125002320|NCT00594516|449639064|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
125002321|NCT00594516|449639065|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
125002322|NCT00594516|449639066|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
125002323|NCT00594516|449639064|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
125002324|NCT00594516|449639065|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
125002325|NCT00594516|449639066|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
125002326|NCT00088907|449639067|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
125002327|NCT00088907|449639068|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
125002328|NCT00088907|449639067|FG000|Randomized Study (Step 1)|Adverse Event|14|||
125002329|NCT00088907|449639068|FG001|Randomized Study (Step 1)|Adverse Event|19|||
125002330|NCT00088907|449639067|FG000|Randomized Study (Step 1)|Death|11|||
125002331|NCT00088907|449639068|FG001|Randomized Study (Step 1)|Death|12|||
125002332|NCT00088907|449639067|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
125002333|NCT00088907|449639068|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
125002334|NCT00088907|449639067|FG000|Randomized Study (Step 1)|complicating disease|3|||
125002335|NCT00088907|449639068|FG001|Randomized Study (Step 1)|complicating disease|1|||
125002336|NCT00088907|449639067|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
125331637|NCT02963506|450845744|FG008|Double-Blind Period|Death|0|||
125331638|NCT02963506|450845745|FG009|Double-Blind Period|Death|0|||
125002337|NCT00088907|449639068|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
125002338|NCT00088907|449639067|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
125002339|NCT00088907|449639068|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
125002340|NCT00088907|449639067|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
125331639|NCT02963506|450845746|FG010|Double-Blind Period|Death|0|||
125331640|NCT02963506|450845747|FG011|Double-Blind Period|Death|0|||
125331641|NCT02963506|450845748|FG012|Double-Blind Period|Death|0|||
125331642|NCT02963506|450845736|FG000|Double-Blind Period|Lost to Follow-up|0|||
125002341|NCT00088907|449639068|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
125331643|NCT02963506|450845737|FG001|Double-Blind Period|Lost to Follow-up|1|||
125331644|NCT02963506|450845738|FG002|Double-Blind Period|Lost to Follow-up|0|||
125331645|NCT02963506|450845739|FG003|Double-Blind Period|Lost to Follow-up|0|||
125331646|NCT02963506|450845740|FG004|Double-Blind Period|Lost to Follow-up|0|||
125331647|NCT02963506|450845741|FG005|Double-Blind Period|Lost to Follow-up|0|||
125331648|NCT02963506|450845742|FG006|Double-Blind Period|Lost to Follow-up|0|||
125331649|NCT02963506|450845743|FG007|Double-Blind Period|Lost to Follow-up|0|||
125331650|NCT02963506|450845744|FG008|Double-Blind Period|Lost to Follow-up|0|||
125331651|NCT02963506|450845745|FG009|Double-Blind Period|Lost to Follow-up|0|||
125331652|NCT02963506|450845746|FG010|Double-Blind Period|Lost to Follow-up|0|||
125331653|NCT02963506|450845747|FG011|Double-Blind Period|Lost to Follow-up|0|||
125331654|NCT02963506|450845748|FG012|Double-Blind Period|Lost to Follow-up|0|||
125331655|NCT02963506|450845736|FG000|Double-Blind Period|Withdrawal by Subject|0|||
125331656|NCT02963506|450845737|FG001|Double-Blind Period|Withdrawal by Subject|0|||
125331657|NCT02963506|450845738|FG002|Double-Blind Period|Withdrawal by Subject|1|||
125331658|NCT02963506|450845739|FG003|Double-Blind Period|Withdrawal by Subject|1|||
125331659|NCT02963506|450845740|FG004|Double-Blind Period|Withdrawal by Subject|0|||
125331660|NCT02963506|450845741|FG005|Double-Blind Period|Withdrawal by Subject|0|||
125331661|NCT02963506|450845742|FG006|Double-Blind Period|Withdrawal by Subject|0|||
125331662|NCT02963506|450845743|FG007|Double-Blind Period|Withdrawal by Subject|0|||
125331663|NCT02963506|450845744|FG008|Double-Blind Period|Withdrawal by Subject|0|||
125331664|NCT02963506|450845745|FG009|Double-Blind Period|Withdrawal by Subject|0|||
125331665|NCT02963506|450845746|FG010|Double-Blind Period|Withdrawal by Subject|0|||
125331666|NCT02963506|450845747|FG011|Double-Blind Period|Withdrawal by Subject|0|||
125331667|NCT02963506|450845748|FG012|Double-Blind Period|Withdrawal by Subject|0|||
125331668|NCT02963506|450845736|FG000|Double-Blind Period|No compliance|0|||
125331669|NCT02963506|450845737|FG001|Double-Blind Period|No compliance|1|||
125331670|NCT02963506|450845738|FG002|Double-Blind Period|No compliance|0|||
125331671|NCT02963506|450845739|FG003|Double-Blind Period|No compliance|0|||
125331672|NCT02963506|450845740|FG004|Double-Blind Period|No compliance|0|||
125331673|NCT02963506|450845741|FG005|Double-Blind Period|No compliance|0|||
125331674|NCT02963506|450845742|FG006|Double-Blind Period|No compliance|0|||
125331675|NCT02963506|450845743|FG007|Double-Blind Period|No compliance|0|||
125331676|NCT02963506|450845744|FG008|Double-Blind Period|No compliance|0|||
125331677|NCT02963506|450845745|FG009|Double-Blind Period|No compliance|0|||
125331678|NCT02963506|450845746|FG010|Double-Blind Period|No compliance|0|||
125331679|NCT02963506|450845747|FG011|Double-Blind Period|No compliance|0|||
125331680|NCT02963506|450845748|FG012|Double-Blind Period|No compliance|0|||
125331681|NCT02963506|450845736|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331682|NCT02963506|450845737|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
125331683|NCT02963506|450845738|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331684|NCT02963506|450845739|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331685|NCT02963506|450845740|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331686|NCT02963506|450845741|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331687|NCT02963506|450845742|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331688|NCT02963506|450845743|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331689|NCT02963506|450845744|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331690|NCT02963506|450845745|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331691|NCT02963506|450845746|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331692|NCT02963506|450845747|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331693|NCT02963506|450845748|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125002342|NCT00088907|449639067|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
125002343|NCT00088907|449639068|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
125002344|NCT00088907|449639067|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
125002345|NCT00088907|449639068|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
125002346|NCT00088907|449639067|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
125002347|NCT00088907|449639068|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
125331694|NCT02963506|450845736|FG000|Dose-Blind Period|Adverse Event|0|||
125331695|NCT02963506|450845737|FG001|Dose-Blind Period|Adverse Event|0|||
125331696|NCT02963506|450845738|FG002|Dose-Blind Period|Adverse Event|0|||
125331697|NCT02963506|450845739|FG003|Dose-Blind Period|Adverse Event|0|||
125331698|NCT02963506|450845740|FG004|Dose-Blind Period|Adverse Event|0|||
125331699|NCT02963506|450845741|FG005|Dose-Blind Period|Adverse Event|1|||
125331700|NCT02963506|450845742|FG006|Dose-Blind Period|Adverse Event|3|||
125331701|NCT02963506|450845743|FG007|Dose-Blind Period|Adverse Event|2|||
125331702|NCT02963506|450845744|FG008|Dose-Blind Period|Adverse Event|2|||
125331703|NCT02963506|450845745|FG009|Dose-Blind Period|Adverse Event|2|||
125331704|NCT02963506|450845746|FG010|Dose-Blind Period|Adverse Event|1|||
125002348|NCT03426787|449639073|FG000|Overall Study|Withdrawal by Subject|6|||
125002349|NCT03426787|449639073|FG000|Overall Study|Lost to Follow-up|7|||
125331705|NCT02963506|450845747|FG011|Dose-Blind Period|Adverse Event|1|||
125331706|NCT02963506|450845748|FG012|Dose-Blind Period|Adverse Event|6|||
125331707|NCT02963506|450845736|FG000|Dose-Blind Period|Lack of Efficacy|0|||
125331708|NCT02963506|450845737|FG001|Dose-Blind Period|Lack of Efficacy|0|||
125331709|NCT02963506|450845738|FG002|Dose-Blind Period|Lack of Efficacy|0|||
125331710|NCT02963506|450845739|FG003|Dose-Blind Period|Lack of Efficacy|0|||
125331711|NCT02963506|450845740|FG004|Dose-Blind Period|Lack of Efficacy|0|||
125331712|NCT02963506|450845741|FG005|Dose-Blind Period|Lack of Efficacy|0|||
125331713|NCT02963506|450845742|FG006|Dose-Blind Period|Lack of Efficacy|0|||
125331714|NCT02963506|450845743|FG007|Dose-Blind Period|Lack of Efficacy|1|||
125331715|NCT02963506|450845744|FG008|Dose-Blind Period|Lack of Efficacy|0|||
125331716|NCT02963506|450845745|FG009|Dose-Blind Period|Lack of Efficacy|1|||
125331717|NCT02963506|450845746|FG010|Dose-Blind Period|Lack of Efficacy|0|||
125331718|NCT02963506|450845747|FG011|Dose-Blind Period|Lack of Efficacy|0|||
125331719|NCT02963506|450845748|FG012|Dose-Blind Period|Lack of Efficacy|0|||
125331720|NCT02963506|450845736|FG000|Dose-Blind Period|Lost to Follow-up|0|||
125331721|NCT02963506|450845737|FG001|Dose-Blind Period|Lost to Follow-up|0|||
125331722|NCT02963506|450845738|FG002|Dose-Blind Period|Lost to Follow-up|0|||
125331723|NCT02963506|450845739|FG003|Dose-Blind Period|Lost to Follow-up|0|||
125331724|NCT02963506|450845740|FG004|Dose-Blind Period|Lost to Follow-up|0|||
125331725|NCT02963506|450845741|FG005|Dose-Blind Period|Lost to Follow-up|1|||
125331726|NCT02963506|450845742|FG006|Dose-Blind Period|Lost to Follow-up|0|||
125331727|NCT02963506|450845743|FG007|Dose-Blind Period|Lost to Follow-up|0|||
125331728|NCT02963506|450845744|FG008|Dose-Blind Period|Lost to Follow-up|1|||
125331729|NCT02963506|450845745|FG009|Dose-Blind Period|Lost to Follow-up|0|||
125331730|NCT02963506|450845746|FG010|Dose-Blind Period|Lost to Follow-up|0|||
125331731|NCT02963506|450845747|FG011|Dose-Blind Period|Lost to Follow-up|1|||
125331732|NCT02963506|450845748|FG012|Dose-Blind Period|Lost to Follow-up|0|||
125331733|NCT02963506|450845736|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
125002350|NCT03426787|449639073|FG000|Overall Study|Unrelated to intervention death|1|||
125002351|NCT02217436|449639074|FG000|Overall Study|Protocol Violation|1|||
125331734|NCT02963506|450845737|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
125331735|NCT02963506|450845738|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
125331736|NCT02963506|450845739|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
125331737|NCT02963506|450845740|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
125331738|NCT02963506|450845741|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
125331739|NCT02963506|450845742|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
125331740|NCT02963506|450845743|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
125331741|NCT02963506|450845744|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
125331742|NCT02963506|450845745|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
125331743|NCT02963506|450845746|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
125331744|NCT02963506|450845747|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
125331745|NCT02963506|450845748|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
125331746|NCT02963506|450845736|FG000|Dose-Blind Period|Sponsor decision|0|||
125331747|NCT02963506|450845737|FG001|Dose-Blind Period|Sponsor decision|0|||
125331748|NCT02963506|450845738|FG002|Dose-Blind Period|Sponsor decision|0|||
125331749|NCT02963506|450845739|FG003|Dose-Blind Period|Sponsor decision|0|||
125331750|NCT02963506|450845740|FG004|Dose-Blind Period|Sponsor decision|0|||
125331751|NCT02963506|450845741|FG005|Dose-Blind Period|Sponsor decision|1|||
125331752|NCT02963506|450845742|FG006|Dose-Blind Period|Sponsor decision|0|||
125331753|NCT02963506|450845743|FG007|Dose-Blind Period|Sponsor decision|0|||
125331754|NCT02963506|450845744|FG008|Dose-Blind Period|Sponsor decision|0|||
125331755|NCT02963506|450845745|FG009|Dose-Blind Period|Sponsor decision|0|||
125331756|NCT02963506|450845746|FG010|Dose-Blind Period|Sponsor decision|0|||
125331757|NCT02963506|450845747|FG011|Dose-Blind Period|Sponsor decision|0|||
125331758|NCT02963506|450845748|FG012|Dose-Blind Period|Sponsor decision|0|||
125331759|NCT02963506|450845736|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125331760|NCT02963506|450845737|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125331761|NCT02963506|450845738|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125331762|NCT02963506|450845739|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125331763|NCT02963506|450845740|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125331764|NCT02963506|450845741|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125002352|NCT02217436|449639075|FG001|Overall Study|Protocol Violation|1|||
125002353|NCT02217436|449639074|FG000|Overall Study|Incomplete data|0|||
125002354|NCT02217436|449639075|FG001|Overall Study|Incomplete data|1|||
125331765|NCT02963506|450845742|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125331766|NCT02963506|450845743|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125331767|NCT02963506|450845744|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125331768|NCT02963506|450845745|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125331769|NCT02963506|450845746|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125331770|NCT02963506|450845747|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125002355|NCT04641299|449639076|FG000|Overall Study|Adverse Event|0|||
125331771|NCT02963506|450845748|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
125002356|NCT04641299|449639077|FG001|Overall Study|Adverse Event|0|||
125331772|NCT00750438|450845749|FG000|Overall Study|Protocol Violation|4|||
125002357|NCT04641299|449639078|FG002|Overall Study|Adverse Event|2|||
125002358|NCT04641299|449639079|FG003|Overall Study|Adverse Event|0|||
125002359|NCT04641299|449639076|FG000|Overall Study|Lost to Follow-up|0|||
125002360|NCT04641299|449639077|FG001|Overall Study|Lost to Follow-up|1|||
125002361|NCT04641299|449639078|FG002|Overall Study|Lost to Follow-up|0|||
125002362|NCT04641299|449639079|FG003|Overall Study|Lost to Follow-up|0|||
125002363|NCT04641299|449639076|FG000|Overall Study|Withdrawal by Subject|1|||
125002364|NCT04641299|449639077|FG001|Overall Study|Withdrawal by Subject|0|||
125002365|NCT04641299|449639078|FG002|Overall Study|Withdrawal by Subject|0|||
125002366|NCT04641299|449639079|FG003|Overall Study|Withdrawal by Subject|0|||
125002367|NCT04641299|449639076|FG000|Overall Study|Reason not given|1|||
125002368|NCT04641299|449639077|FG001|Overall Study|Reason not given|0|||
125002369|NCT04641299|449639078|FG002|Overall Study|Reason not given|0|||
125002370|NCT04641299|449639079|FG003|Overall Study|Reason not given|0|||
125002371|NCT01016964|449639082|FG000|Overall Study|Lost to Follow-up|3|||
125002372|NCT01016964|449639083|FG001|Overall Study|Lost to Follow-up|3|||
125002373|NCT01650285|449639084|FG000|Overall Study|Adverse Event|1|||
125002374|NCT00659529|449639085|FG000|Overall Study|Withdrawal by Subject|4|||
125331773|NCT00750438|450845750|FG001|Overall Study|Protocol Violation|1|||
125331774|NCT00750438|450845749|FG000|Overall Study|Physician Decision|2|||
125331775|NCT00750438|450845750|FG001|Overall Study|Physician Decision|2|||
125331776|NCT00750438|450845749|FG000|Overall Study|Withdrawal by Subject|1|||
125002375|NCT00659529|449639085|FG000|Overall Study|Protocol Violation|3|||
125002376|NCT00659529|449639085|FG000|Overall Study|Screen failure|9|||
125002377|NCT00907257|449639088|FG000|Overall Study|Adverse Event|0|||
125002378|NCT00907257|449639089|FG001|Overall Study|Adverse Event|4|||
125002379|NCT00907257|449639088|FG000|Overall Study|Protocol Violation|1|||
125002380|NCT00907257|449639089|FG001|Overall Study|Protocol Violation|2|||
125002381|NCT00907257|449639088|FG000|Overall Study|Lost to Follow-up|3|||
125002382|NCT00907257|449639089|FG001|Overall Study|Lost to Follow-up|3|||
125002383|NCT00907257|449639088|FG000|Overall Study|Withdrawal by Subject|1|||
125002384|NCT00907257|449639089|FG001|Overall Study|Withdrawal by Subject|2|||
125002385|NCT00907257|449639088|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
125002386|NCT00907257|449639089|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
125002387|NCT00907257|449639088|FG000|Overall Study|Moved|1|||
125002388|NCT00907257|449639089|FG001|Overall Study|Moved|0|||
125002389|NCT00907257|449639088|FG000|Overall Study|Personal Reasons|6|||
125002390|NCT00907257|449639089|FG001|Overall Study|Personal Reasons|1|||
125002391|NCT00283049|449639090|FG000|Overall Study|Adverse Event|6|||
125002392|NCT00283049|449639091|FG001|Overall Study|Adverse Event|1|||
125002393|NCT00283049|449639092|FG002|Overall Study|Adverse Event|4|||
125002394|NCT00283049|449639090|FG000|Overall Study|Protocol Violation|3|||
125002395|NCT00283049|449639091|FG001|Overall Study|Protocol Violation|0|||
125002396|NCT00283049|449639092|FG002|Overall Study|Protocol Violation|3|||
125002397|NCT00283049|449639090|FG000|Overall Study|Death|1|||
125002398|NCT00283049|449639091|FG001|Overall Study|Death|1|||
125002399|NCT00283049|449639092|FG002|Overall Study|Death|1|||
125002400|NCT00283049|449639090|FG000|Overall Study|Lack of Efficacy|0|||
125331777|NCT00750438|450845750|FG001|Overall Study|Withdrawal by Subject|1|||
125331778|NCT00928408|450845755|FG000|Overall Study|Other|2|||
125331779|NCT00928408|450845755|FG000|Overall Study|Withdrawal by Subject|4|||
125331780|NCT00928408|450845755|FG000|Overall Study|Death|5|||
125331781|NCT00928408|450845755|FG000|Overall Study|Lost to Follow-up|12|||
125331782|NCT00536744|450845756|FG000|Overall Study|Adverse Event|13|||
125331783|NCT00536744|450845757|FG001|Overall Study|Adverse Event|10|||
125331784|NCT00536744|450845756|FG000|Overall Study|Death|2|||
125331785|NCT00536744|450845757|FG001|Overall Study|Death|1|||
125331786|NCT00536744|450845756|FG000|Overall Study|Physician Decision|3|||
125331787|NCT00536744|450845757|FG001|Overall Study|Physician Decision|1|||
125331788|NCT00536744|450845756|FG000|Overall Study|Lost to Follow-up|3|||
125331789|NCT00536744|450845757|FG001|Overall Study|Lost to Follow-up|5|||
125331790|NCT00536744|450845756|FG000|Overall Study|Withdrawal by Subject|7|||
125331791|NCT00536744|450845757|FG001|Overall Study|Withdrawal by Subject|8|||
125331792|NCT00536744|450845756|FG000|Overall Study|PI tried alternative treatment|1|||
125331793|NCT00536744|450845757|FG001|Overall Study|PI tried alternative treatment|3|||
125331794|NCT00787644|450845758|FG000|Overall Study|Lost to Follow-up|1|||
125331795|NCT00787644|450845759|FG001|Overall Study|Lost to Follow-up|1|||
125331796|NCT00787644|450845758|FG000|Overall Study|Withdrawal by Subject|1|||
125002401|NCT00283049|449639091|FG001|Overall Study|Lack of Efficacy|1|||
125002402|NCT00283049|449639092|FG002|Overall Study|Lack of Efficacy|1|||
125002403|NCT00283049|449639090|FG000|Overall Study|Lost to Follow-up|4|||
125331797|NCT00787644|450845759|FG001|Overall Study|Withdrawal by Subject|1|||
125002404|NCT00283049|449639091|FG001|Overall Study|Lost to Follow-up|2|||
125002405|NCT00283049|449639092|FG002|Overall Study|Lost to Follow-up|5|||
125002406|NCT00283049|449639090|FG000|Overall Study|Withdrawal by Subject|26|||
125002407|NCT00283049|449639091|FG001|Overall Study|Withdrawal by Subject|24|||
125002408|NCT00283049|449639092|FG002|Overall Study|Withdrawal by Subject|19|||
125002409|NCT00283049|449639090|FG000|Overall Study|Discontinuation of Study|18|||
125002410|NCT00283049|449639091|FG001|Overall Study|Discontinuation of Study|16|||
125331798|NCT02908672|450845760|FG000|Run-in Period|Death|12|||
125331799|NCT02908672|450845761|FG001|Run-in Period|Death|10|||
125331800|NCT02908672|450845762|FG002|Run-in Period|Death|0|||
125331801|NCT02908672|450845763|FG003|Run-in Period|Death|0|||
125331802|NCT02908672|450845760|FG000|Run-in Period|Lost to Follow-up|1|||
125331803|NCT02908672|450845761|FG001|Run-in Period|Lost to Follow-up|1|||
125331804|NCT02908672|450845762|FG002|Run-in Period|Lost to Follow-up|0|||
125331805|NCT02908672|450845763|FG003|Run-in Period|Lost to Follow-up|0|||
125331806|NCT02908672|450845760|FG000|Run-in Period|Reason Not Specified|2|||
125331807|NCT02908672|450845761|FG001|Run-in Period|Reason Not Specified|0|||
125331808|NCT02908672|450845762|FG002|Run-in Period|Reason Not Specified|0|||
125331809|NCT02908672|450845763|FG003|Run-in Period|Reason Not Specified|0|||
125331810|NCT02908672|450845760|FG000|Run-in Period|Protocol Violation|1|||
125331811|NCT02908672|450845761|FG001|Run-in Period|Protocol Violation|1|||
125331812|NCT02908672|450845762|FG002|Run-in Period|Protocol Violation|0|||
125331813|NCT02908672|450845763|FG003|Run-in Period|Protocol Violation|0|||
125331814|NCT02908672|450845760|FG000|Run-in Period|Study Ended by Sponsor|5|||
125331815|NCT02908672|450845761|FG001|Run-in Period|Study Ended by Sponsor|1|||
125331816|NCT02908672|450845762|FG002|Run-in Period|Study Ended by Sponsor|0|||
125331817|NCT02908672|450845763|FG003|Run-in Period|Study Ended by Sponsor|0|||
125331818|NCT02908672|450845760|FG000|Run-in Period|Withdrawal by Subject|3|||
125331819|NCT02908672|450845761|FG001|Run-in Period|Withdrawal by Subject|9|||
125331820|NCT02908672|450845762|FG002|Run-in Period|Withdrawal by Subject|0|||
125331821|NCT02908672|450845763|FG003|Run-in Period|Withdrawal by Subject|0|||
125331822|NCT02908672|450845760|FG000|Triple Combination Period|Death|0|||
125002411|NCT00283049|449639092|FG002|Overall Study|Discontinuation of Study|20|||
125002412|NCT00283049|449639090|FG000|Overall Study|No longer requires study treatment|0|||
125002413|NCT00283049|449639091|FG001|Overall Study|No longer requires study treatment|0|||
125002414|NCT00283049|449639092|FG002|Overall Study|No longer requires study treatment|1|||
125002415|NCT00295633|449639093|FG000|Overall Study|Lack of Efficacy|19|||
125002416|NCT00295633|449639094|FG001|Overall Study|Lack of Efficacy|7|||
125002417|NCT00295633|449639095|FG002|Overall Study|Lack of Efficacy|16|||
125002418|NCT00295633|449639093|FG000|Overall Study|Withdrawal of consent by subject|16|||
125002419|NCT00295633|449639094|FG001|Overall Study|Withdrawal of consent by subject|16|||
125002420|NCT00295633|449639095|FG002|Overall Study|Withdrawal of consent by subject|26|||
125002421|NCT00295633|449639093|FG000|Overall Study|Adverse Event|9|||
125002422|NCT00295633|449639094|FG001|Overall Study|Adverse Event|17|||
125002423|NCT00295633|449639095|FG002|Overall Study|Adverse Event|9|||
125002424|NCT00295633|449639093|FG000|Overall Study|Lost to Follow-up|6|||
125002425|NCT00295633|449639094|FG001|Overall Study|Lost to Follow-up|11|||
125002426|NCT00295633|449639095|FG002|Overall Study|Lost to Follow-up|7|||
125002427|NCT00295633|449639093|FG000|Overall Study|Physician Decision|9|||
125002428|NCT00295633|449639094|FG001|Overall Study|Physician Decision|10|||
125002429|NCT00295633|449639095|FG002|Overall Study|Physician Decision|8|||
125002430|NCT00295633|449639093|FG000|Overall Study|Poor/Noncompliance|2|||
125002431|NCT00295633|449639094|FG001|Overall Study|Poor/Noncompliance|2|||
125002432|NCT00295633|449639095|FG002|Overall Study|Poor/Noncompliance|6|||
125002433|NCT00295633|449639093|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
125002434|NCT00295633|449639094|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
125002435|NCT00295633|449639095|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
125002436|NCT00295633|449639093|FG000|Overall Study|Death|1|||
125002437|NCT00295633|449639094|FG001|Overall Study|Death|1|||
125002438|NCT00295633|449639095|FG002|Overall Study|Death|0|||
125002439|NCT00295633|449639093|FG000|Overall Study|Administrative reason by sponsor|0|||
125002440|NCT00295633|449639094|FG001|Overall Study|Administrative reason by sponsor|0|||
125002441|NCT00295633|449639095|FG002|Overall Study|Administrative reason by sponsor|1|||
125002442|NCT00763971|449639096|FG000|Overall Study|Adverse Event|5|||
125002443|NCT00763971|449639097|FG001|Overall Study|Adverse Event|2|||
125002444|NCT00763971|449639098|FG002|Overall Study|Adverse Event|4|||
125002445|NCT00763971|449639096|FG000|Overall Study|Protocol Violation|3|||
125002446|NCT00763971|449639097|FG001|Overall Study|Protocol Violation|3|||
125331823|NCT02908672|450845761|FG001|Triple Combination Period|Death|0|||
125331824|NCT02908672|450845762|FG002|Triple Combination Period|Death|150|||
125331825|NCT02908672|450845763|FG003|Triple Combination Period|Death|127|||
125331826|NCT02908672|450845760|FG000|Triple Combination Period|Lost to Follow-up|0|||
125002447|NCT00763971|449639098|FG002|Overall Study|Protocol Violation|2|||
125002448|NCT00763971|449639096|FG000|Overall Study|Withdrawal by Subject|4|||
125002449|NCT00763971|449639097|FG001|Overall Study|Withdrawal by Subject|5|||
125002450|NCT00763971|449639098|FG002|Overall Study|Withdrawal by Subject|5|||
125002451|NCT00763971|449639096|FG000|Overall Study|Lost to Follow-up|0|||
125002452|NCT00763971|449639097|FG001|Overall Study|Lost to Follow-up|1|||
125002453|NCT00763971|449639098|FG002|Overall Study|Lost to Follow-up|0|||
125002454|NCT00763971|449639096|FG000|Overall Study|Lack of Efficacy|11|||
125002455|NCT00763971|449639097|FG001|Overall Study|Lack of Efficacy|22|||
125002456|NCT00763971|449639098|FG002|Overall Study|Lack of Efficacy|54|||
125331827|NCT02908672|450845761|FG001|Triple Combination Period|Lost to Follow-up|0|||
125002457|NCT00763971|449639096|FG000|Overall Study|Unable to swallow capsule|2|||
125331828|NCT02908672|450845762|FG002|Triple Combination Period|Lost to Follow-up|6|||
125331829|NCT02908672|450845763|FG003|Triple Combination Period|Lost to Follow-up|8|||
125331830|NCT02908672|450845760|FG000|Triple Combination Period|Reason Not Specified|0|||
125331831|NCT02908672|450845761|FG001|Triple Combination Period|Reason Not Specified|0|||
125331832|NCT02908672|450845762|FG002|Triple Combination Period|Reason Not Specified|0|||
125331833|NCT02908672|450845763|FG003|Triple Combination Period|Reason Not Specified|1|||
125331834|NCT02908672|450845760|FG000|Triple Combination Period|Physician Decision|0|||
125331835|NCT02908672|450845761|FG001|Triple Combination Period|Physician Decision|0|||
125331836|NCT02908672|450845762|FG002|Triple Combination Period|Physician Decision|1|||
125331837|NCT02908672|450845763|FG003|Triple Combination Period|Physician Decision|1|||
125331838|NCT02908672|450845760|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
125331839|NCT02908672|450845761|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
125331840|NCT02908672|450845762|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
125331841|NCT02908672|450845763|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
125331842|NCT02908672|450845760|FG000|Triple Combination Period|Withdrawal by Subject|0|||
125331843|NCT02908672|450845761|FG001|Triple Combination Period|Withdrawal by Subject|0|||
125331844|NCT02908672|450845762|FG002|Triple Combination Period|Withdrawal by Subject|13|||
125331845|NCT02908672|450845763|FG003|Triple Combination Period|Withdrawal by Subject|16|||
125331846|NCT04163016|450845764|FG000|Enrollment|Adverse Event|1|||
125331847|NCT04163016|450845765|FG001|Enrollment|Adverse Event|0|||
125331848|NCT04163016|450845766|FG002|Enrollment|Adverse Event|0|||
125331849|NCT04163016|450845767|FG003|Enrollment|Adverse Event|0|||
125331850|NCT04163016|450845764|FG000|Treatment|Adverse Event|0|||
125331851|NCT04163016|450845765|FG001|Treatment|Adverse Event|1|||
125331852|NCT04163016|450845766|FG002|Treatment|Adverse Event|0|||
125331853|NCT04163016|450845767|FG003|Treatment|Adverse Event|0|||
125331854|NCT04163016|450845764|FG000|Treatment|Withdrawal by Subject|0|||
125331855|NCT04163016|450845765|FG001|Treatment|Withdrawal by Subject|2|||
125331856|NCT04163016|450845766|FG002|Treatment|Withdrawal by Subject|0|||
125331857|NCT04163016|450845767|FG003|Treatment|Withdrawal by Subject|0|||
125331858|NCT04163016|450845764|FG000|Treatment|Indeterminate TB-test|0|||
125331859|NCT04163016|450845765|FG001|Treatment|Indeterminate TB-test|0|||
125331860|NCT04163016|450845766|FG002|Treatment|Indeterminate TB-test|0|||
125331861|NCT04163016|450845767|FG003|Treatment|Indeterminate TB-test|1|||
125331862|NCT04163016|450845764|FG000|Treatment|Participant did not want to continue in study|0|||
125331863|NCT04163016|450845765|FG001|Treatment|Participant did not want to continue in study|0|||
125331864|NCT04163016|450845766|FG002|Treatment|Participant did not want to continue in study|0|||
125331865|NCT04163016|450845767|FG003|Treatment|Participant did not want to continue in study|1|||
125331866|NCT01071798|450846978|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
125331867|NCT01071798|450846978|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
125331868|NCT01071798|450846978|FG000|Participants Who Received One Cycle|Patient requirement|20|||
125331869|NCT01071798|450846978|FG000|Participants Who Received One Cycle|Death|5|||
125331870|NCT01071798|450846978|FG000|Participants Who Received One Cycle|Change of therapy|6|||
125331871|NCT01071798|450846978|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
125331872|NCT01071798|450846978|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
125331873|NCT01071798|450846978|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
125331874|NCT01071798|450846978|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
125331875|NCT01071798|450846978|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
125331876|NCT00145158|450846981|FG000|Overall Study|premature withdrawal|2|||
125331877|NCT00145158|450846982|FG001|Overall Study|premature withdrawal|3|||
125331878|NCT01227018|450846986|FG000|Overall Study|Disease progression|9|||
125331879|NCT01227018|450846986|FG000|Overall Study|Toxicity|2|||
125331880|NCT01227018|450846986|FG000|Overall Study|Withdrew after beginning treatment|4|||
125331881|NCT00753649|450846987|FG000|Overall Study|Migrated/moved from study area|1|||
125331882|NCT00753649|450846988|FG001|Overall Study|Migrated/moved from study area|0|||
125331883|NCT00753649|450846987|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
125331884|NCT00753649|450846988|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
125331885|NCT00753649|450846987|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
125331886|NCT00753649|450846988|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
125331887|NCT00753649|450846987|FG000|Overall Study|Protocol Violation|2|||
125331888|NCT00753649|450846988|FG001|Overall Study|Protocol Violation|0|||
125331889|NCT00499616|450846989|FG000|Overall Study|Death|1|||
125331890|NCT00499616|450846990|FG001|Overall Study|Death|5|||
125331891|NCT00499616|450846991|FG002|Overall Study|Death|3|||
125331892|NCT00499616|450846992|FG003|Overall Study|Death|1|||
125331893|NCT00499616|450846989|FG000|Overall Study|Lack of Efficacy|5|||
125331894|NCT00499616|450846990|FG001|Overall Study|Lack of Efficacy|0|||
125331895|NCT00499616|450846991|FG002|Overall Study|Lack of Efficacy|19|||
125331896|NCT00499616|450846992|FG003|Overall Study|Lack of Efficacy|0|||
125331897|NCT00499616|450846989|FG000|Overall Study|Lost to Follow-up|0|||
125331898|NCT00499616|450846990|FG001|Overall Study|Lost to Follow-up|0|||
125331899|NCT00499616|450846991|FG002|Overall Study|Lost to Follow-up|1|||
125331900|NCT00499616|450846992|FG003|Overall Study|Lost to Follow-up|0|||
125331901|NCT00499616|450846989|FG000|Overall Study|Physician Decision|6|||
125331902|NCT00499616|450846990|FG001|Overall Study|Physician Decision|16|||
125331903|NCT00499616|450846991|FG002|Overall Study|Physician Decision|9|||
125331904|NCT00499616|450846992|FG003|Overall Study|Physician Decision|0|||
125331905|NCT00499616|450846989|FG000|Overall Study|Withdrawal by Subject|1|||
125331906|NCT00499616|450846990|FG001|Overall Study|Withdrawal by Subject|0|||
125331907|NCT00499616|450846991|FG002|Overall Study|Withdrawal by Subject|1|||
125331908|NCT00499616|450846992|FG003|Overall Study|Withdrawal by Subject|0|||
125331909|NCT00499616|450846989|FG000|Overall Study|Ineligible|1|||
125331910|NCT00499616|450846990|FG001|Overall Study|Ineligible|2|||
125331911|NCT00499616|450846991|FG002|Overall Study|Ineligible|0|||
125331912|NCT00499616|450846992|FG003|Overall Study|Ineligible|15|||
125331913|NCT00499616|450846989|FG000|Overall Study|Not evaluable|0|||
125331914|NCT00499616|450846990|FG001|Overall Study|Not evaluable|0|||
125331915|NCT00499616|450846991|FG002|Overall Study|Not evaluable|0|||
125331916|NCT00499616|450846992|FG003|Overall Study|Not evaluable|41|||
125331917|NCT00499616|450846989|FG000|Overall Study|Patient/Parent Refusal|1|||
125331918|NCT00499616|450846990|FG001|Overall Study|Patient/Parent Refusal|5|||
125331919|NCT00499616|450846991|FG002|Overall Study|Patient/Parent Refusal|3|||
125331920|NCT00499616|450846992|FG003|Overall Study|Patient/Parent Refusal|0|||
125331921|NCT01938716|450847000|FG000|Overall Study|Physician Decision|2|||
125331922|NCT01938716|450847000|FG000|Overall Study|Withdrawal by Subject|2|||
125331923|NCT00098813|450847001|FG000|Overall Study|Death|8|||
125331924|NCT00098813|450847001|FG000|Overall Study|Protocol Violation|1|||
125331925|NCT00098813|450847001|FG000|Overall Study|Withdrawal by Subject|7|||
125331926|NCT00098813|450847001|FG000|Overall Study|Progression of Disease|1|||
125331927|NCT00098813|450847001|FG000|Overall Study|Other complicating disease|1|||
125331928|NCT00098813|450847001|FG000|Overall Study|Reversal of RAI resistance|1|||
125331929|NCT00433004|450847004|FG000|Overall Study|Lost to Follow-up|5|||
125331930|NCT00433004|450847005|FG001|Overall Study|Lost to Follow-up|7|||
125331931|NCT00220636|450847006|FG000|Overall Study|Withdrawal by Subject|4|||
125331932|NCT00330967|450847007|FG000|Overall Study|Withdrawal by Subject|0|||
125331933|NCT00330967|450847008|FG001|Overall Study|Withdrawal by Subject|5|||
125331934|NCT00330967|450847007|FG000|Overall Study|Physician Decision|0|||
125331935|NCT00330967|450847008|FG001|Overall Study|Physician Decision|9|||
125331936|NCT00790088|450847011|FG000|Overall Study|Protocol Violation|11|||
125331937|NCT00790088|450847011|FG000|Overall Study|Withdrawal by Subject|17|||
125331938|NCT00790088|450847011|FG000|Overall Study|Lost to Follow-up|7|||
125331939|NCT00790088|450847011|FG000|Overall Study|Physician Decision|4|||
125331940|NCT04329806|450847012|FG000|Overall Study|Physician Decision|3|||
125331941|NCT04329806|450847013|FG001|Overall Study|Physician Decision|4|||
125331942|NCT02636595|450847016|FG000|Overall Study|Lost to Follow-up|1|||
125331943|NCT02636595|450847016|FG000|Overall Study|Other|1|||
125331944|NCT02578706|450847020|FG000|Overall Study|Withdrawal by Subject|1|||
125331945|NCT02578706|450847021|FG001|Overall Study|Withdrawal by Subject|0|||
125331946|NCT02578706|450847022|FG002|Overall Study|Withdrawal by Subject|0|||
125331947|NCT02578706|450847020|FG000|Overall Study|Lost to Follow-up|0|||
125331948|NCT02578706|450847021|FG001|Overall Study|Lost to Follow-up|4|||
125331949|NCT02578706|450847022|FG002|Overall Study|Lost to Follow-up|0|||
125331950|NCT02578706|450847020|FG000|Overall Study|Physician Decision|0|||
125331951|NCT02578706|450847021|FG001|Overall Study|Physician Decision|1|||
125331952|NCT02578706|450847022|FG002|Overall Study|Physician Decision|0|||
125331953|NCT02015637|450847026|FG000|Overall Study|Lost to Follow-up|3|||
125331954|NCT02015637|450847027|FG001|Overall Study|Lost to Follow-up|5|||
125331955|NCT02015637|450847026|FG000|Overall Study|Adverse Event|3|||
125331956|NCT02015637|450847027|FG001|Overall Study|Adverse Event|0|||
125331957|NCT02015637|450847026|FG000|Overall Study|Did not take study drug|2|||
125331958|NCT02015637|450847027|FG001|Overall Study|Did not take study drug|0|||
125331959|NCT04455815|450847032|FG000|Randomisation Phase|Adverse Event|1|||
125331960|NCT04455815|450847033|FG001|Randomisation Phase|Adverse Event|0|||
125331961|NCT04455815|450847032|FG000|Treatment Phase|Adverse Event|0|||
125331962|NCT04455815|450847033|FG001|Treatment Phase|Adverse Event|1|||
125331963|NCT04455815|450847032|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
125331964|NCT04455815|450847033|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
125331965|NCT04455815|450847032|FG000|Treatment Phase|Withdrawal by Subject|1|||
125331966|NCT04455815|450847033|FG001|Treatment Phase|Withdrawal by Subject|1|||
125331967|NCT02106390|450847034|FG000|Overall Study|Withdrawal by Subject|15|||
125331968|NCT02106390|450847035|FG001|Overall Study|Withdrawal by Subject|16|||
125002458|NCT00763971|449639097|FG001|Overall Study|Unable to swallow capsule|1|||
125331969|NCT02106390|450847036|FG002|Overall Study|Withdrawal by Subject|15|||
125331970|NCT02106390|450847034|FG000|Overall Study|Lost to Follow-up|25|||
125331971|NCT02106390|450847035|FG001|Overall Study|Lost to Follow-up|20|||
125331972|NCT02106390|450847036|FG002|Overall Study|Lost to Follow-up|13|||
125331973|NCT02106390|450847034|FG000|Overall Study|Other: Administrative Reason|8|||
125331974|NCT02106390|450847035|FG001|Overall Study|Other: Administrative Reason|5|||
125331975|NCT02106390|450847036|FG002|Overall Study|Other: Administrative Reason|12|||
125331976|NCT02106390|450847034|FG000|Overall Study|Other: Unspecified|1|||
125331977|NCT02106390|450847035|FG001|Overall Study|Other: Unspecified|4|||
125331978|NCT02106390|450847036|FG002|Overall Study|Other: Unspecified|2|||
125331979|NCT02106390|450847034|FG000|Overall Study|Adverse Event|0|||
125002459|NCT00763971|449639098|FG002|Overall Study|Unable to swallow capsule|1|||
125331980|NCT02106390|450847035|FG001|Overall Study|Adverse Event|2|||
125331981|NCT02106390|450847036|FG002|Overall Study|Adverse Event|1|||
125331982|NCT02106390|450847034|FG000|Overall Study|Protocol Violation|0|||
125331983|NCT02106390|450847035|FG001|Overall Study|Protocol Violation|1|||
125331984|NCT02106390|450847036|FG002|Overall Study|Protocol Violation|0|||
125331985|NCT03198507|450847037|FG000|Overall Study|Withdrawal by Subject|1|||
125331986|NCT03198507|450847038|FG001|Overall Study|Withdrawal by Subject|0|||
125331987|NCT00241839|450847043|FG000|Overall Study|Withdrawal by Subject|18|||
125331988|NCT00241839|450847044|FG001|Overall Study|Withdrawal by Subject|17|||
125331989|NCT00241839|450847043|FG000|Overall Study|Adverse Event|1|||
125331990|NCT00241839|450847044|FG001|Overall Study|Adverse Event|1|||
125331991|NCT00439517|450847045|FG000|Overall Study|Subject on treatment|1|||
125331992|NCT00439517|450847046|FG001|Overall Study|Subject on treatment|0|||
125331993|NCT00439517|450847045|FG000|Overall Study|Subject in survival follow-up|1|||
125331994|NCT00439517|450847046|FG001|Overall Study|Subject in survival follow-up|0|||
125331995|NCT02304367|450847047|FG000|Overall Study|Lack of Response to Bruosumab|1|||
125331996|NCT02304367|450847047|FG000|Overall Study|Sponsor Decision|3|||
125331997|NCT02304367|450847047|FG000|Overall Study|Death|2|||
125331998|NCT02304367|450847047|FG000|Overall Study|Physician Decision|1|||
125331999|NCT02304367|450847047|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
125332000|NCT00526071|450847048|FG000|Overall Study|Adverse Event|1|||
125332001|NCT00526071|450847048|FG000|Overall Study|Withdrawal by Subject|1|||
125332002|NCT00526071|450847048|FG000|Overall Study|Lack of Response to Study Drug|4|||
125332003|NCT00467753|450847049|FG000|Overall Study|Lost to Follow-up|1|||
125332004|NCT00467753|450847050|FG001|Overall Study|Lost to Follow-up|2|||
125332005|NCT00467753|450847049|FG000|Overall Study|Adverse Event|2|||
125332006|NCT00467753|450847050|FG001|Overall Study|Adverse Event|0|||
125332007|NCT01869764|450847051|FG000|Overall Study|Withdrawal by Subject|0|||
125332008|NCT01869764|450847052|FG001|Overall Study|Withdrawal by Subject|2|||
125332009|NCT01626872|450847053|FG000|Overall Study|Physician Decision|13|||
125332010|NCT01626872|450847054|FG001|Overall Study|Physician Decision|9|||
125332011|NCT01626872|450847055|FG002|Overall Study|Physician Decision|6|||
125332012|NCT01626872|450847053|FG000|Overall Study|Withdrawal by Subject|19|||
125332013|NCT01626872|450847054|FG001|Overall Study|Withdrawal by Subject|27|||
125332014|NCT01626872|450847055|FG002|Overall Study|Withdrawal by Subject|8|||
125332015|NCT01626872|450847053|FG000|Overall Study|Adverse Event (including Death)|20|||
125332016|NCT01626872|450847054|FG001|Overall Study|Adverse Event (including Death)|28|||
125332017|NCT01626872|450847055|FG002|Overall Study|Adverse Event (including Death)|8|||
125332018|NCT01626872|450847053|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
125332019|NCT01626872|450847054|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
125332020|NCT01626872|450847055|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
125332021|NCT00960999|450847056|FG000|Overall Study|Withdrawal by Subject|1|||
125332022|NCT00960999|450847057|FG001|Overall Study|Withdrawal by Subject|0|||
125332023|NCT00960999|450847056|FG000|Overall Study|Protocol Violation|5|||
125002460|NCT00763971|449639096|FG000|Overall Study|Personal reason|3|||
125002461|NCT00763971|449639097|FG001|Overall Study|Personal reason|0|||
125002462|NCT00763971|449639098|FG002|Overall Study|Personal reason|0|||
125002463|NCT00763971|449639096|FG000|Overall Study|Exclusion criteria met|1|||
125002464|NCT00763971|449639097|FG001|Overall Study|Exclusion criteria met|0|||
125002465|NCT00763971|449639098|FG002|Overall Study|Exclusion criteria met|0|||
125002466|NCT00763971|449639096|FG000|Overall Study|Sponsor decision|1|||
125002467|NCT00763971|449639097|FG001|Overall Study|Sponsor decision|0|||
125002468|NCT00763971|449639098|FG002|Overall Study|Sponsor decision|0|||
125002469|NCT00763971|449639096|FG000|Overall Study|Due to holiday season|2|||
125002470|NCT00763971|449639097|FG001|Overall Study|Due to holiday season|0|||
125002471|NCT00763971|449639098|FG002|Overall Study|Due to holiday season|1|||
125002472|NCT00763971|449639096|FG000|Overall Study|Randomization error|0|||
125002473|NCT00763971|449639097|FG001|Overall Study|Randomization error|0|||
125002474|NCT00763971|449639098|FG002|Overall Study|Randomization error|1|||
125002475|NCT00763971|449639096|FG000|Overall Study|Medical monitor decision|0|||
125002476|NCT00763971|449639097|FG001|Overall Study|Medical monitor decision|0|||
125002477|NCT00763971|449639098|FG002|Overall Study|Medical monitor decision|1|||
125002478|NCT00763971|449639096|FG000|Overall Study|Moved to another country|0|||
125002479|NCT00763971|449639097|FG001|Overall Study|Moved to another country|1|||
125002480|NCT00763971|449639098|FG002|Overall Study|Moved to another country|0|||
125332024|NCT00960999|450847057|FG001|Overall Study|Protocol Violation|2|||
125332025|NCT00960999|450847056|FG000|Overall Study|RT dose constraints not met|2|||
125332026|NCT00960999|450847057|FG001|Overall Study|RT dose constraints not met|0|||
125332027|NCT01696188|450847058|FG000|Overall Study|Protocol Violation|1|||
125332028|NCT01696188|450847059|FG001|Overall Study|Protocol Violation|1|||
125332029|NCT01578486|450847060|FG000|Overall Study|Physician Decision|3|||
125002481|NCT00763971|449639096|FG000|Overall Study|Subject wanted dose reduction|0|||
125002482|NCT00763971|449639097|FG001|Overall Study|Subject wanted dose reduction|1|||
125002483|NCT00763971|449639098|FG002|Overall Study|Subject wanted dose reduction|0|||
125002484|NCT00763971|449639096|FG000|Overall Study|Lack of availability|0|||
125002485|NCT00763971|449639097|FG001|Overall Study|Lack of availability|1|||
125002486|NCT00763971|449639098|FG002|Overall Study|Lack of availability|0|||
125332030|NCT01578486|450847060|FG000|Overall Study|Withdrawal by Subject|2|||
125332031|NCT01958164|450847061|FG000|Overall Study|Adverse Event|0|||
125332032|NCT01958164|450847062|FG001|Overall Study|Adverse Event|2|||
125332033|NCT01958164|450847061|FG000|Overall Study|Lost to Follow-up|2|||
125332034|NCT01958164|450847062|FG001|Overall Study|Lost to Follow-up|3|||
125332035|NCT00828204|450847065|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
125332036|NCT00828204|450847066|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
125332037|NCT00828204|450847065|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
125332038|NCT00828204|450847066|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
125332039|NCT00828204|450847065|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
125332040|NCT00828204|450847066|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
125332041|NCT00828204|450847065|FG000|Main Study: After Study Restart|Adverse Event|0|||
125332042|NCT00828204|450847066|FG001|Main Study: After Study Restart|Adverse Event|2|||
125332043|NCT00828204|450847065|FG000|Main Study: After Study Restart|Noncompliance|0|||
125332044|NCT00828204|450847066|FG001|Main Study: After Study Restart|Noncompliance|1|||
125332045|NCT00828204|450847065|FG000|Extension Study|Lost to Follow-up|0|||
125332046|NCT00828204|450847066|FG001|Extension Study|Lost to Follow-up|1|||
125332047|NCT00828204|450847065|FG000|Extension Study|Physician Decision|0|||
125332048|NCT00828204|450847066|FG001|Extension Study|Physician Decision|2|||
125332049|NCT02302339|450847069|FG000|Overall Study|Lost to Follow-up|1|||
125332050|NCT02302339|450847070|FG001|Overall Study|Lost to Follow-up|0|||
125332051|NCT02302339|450847071|FG002|Overall Study|Lost to Follow-up|0|||
125332052|NCT02302339|450847072|FG003|Overall Study|Lost to Follow-up|0|||
125332053|NCT02302339|450847069|FG000|Overall Study|Withdrawal by Subject|0|||
125332054|NCT02302339|450847070|FG001|Overall Study|Withdrawal by Subject|2|||
125332055|NCT02302339|450847071|FG002|Overall Study|Withdrawal by Subject|1|||
125332056|NCT02302339|450847072|FG003|Overall Study|Withdrawal by Subject|0|||
125332057|NCT01642589|450847076|FG000|Overall Study|Withdrawal by Subject|1|||
125332058|NCT01642589|450847077|FG001|Overall Study|Withdrawal by Subject|1|||
125332059|NCT01185080|450847082|FG000|Overall Study|Adverse Event|1|||
125332060|NCT01185080|450847083|FG001|Overall Study|Adverse Event|1|||
125332061|NCT01185080|450847084|FG002|Overall Study|Adverse Event|0|||
125332062|NCT01185080|450847082|FG000|Overall Study|Personal reasons|0|||
125332063|NCT01185080|450847083|FG001|Overall Study|Personal reasons|0|||
125332064|NCT01185080|450847084|FG002|Overall Study|Personal reasons|1|||
125332065|NCT01104311|450847089|FG000|Overall Study|Withdrawal by Subject|6|||
125332066|NCT01104311|450847090|FG001|Overall Study|Withdrawal by Subject|6|||
125332067|NCT01104311|450847089|FG000|Overall Study|Protocol Violation|0|||
125332068|NCT01104311|450847090|FG001|Overall Study|Protocol Violation|1|||
125332069|NCT01104311|450847089|FG000|Overall Study|Physician Decision|2|||
125332070|NCT01104311|450847090|FG001|Overall Study|Physician Decision|2|||
125332071|NCT01104311|450847089|FG000|Overall Study|low compliance|1|||
125332072|NCT01104311|450847090|FG001|Overall Study|low compliance|1|||
125332073|NCT01104311|450847089|FG000|Overall Study|Adverse Event|1|||
125332074|NCT01104311|450847090|FG001|Overall Study|Adverse Event|2|||
125332075|NCT01255436|450848948|FG000|Overall Study|Lost to Follow-up|178|||
125332076|NCT01255436|450848949|FG001|Overall Study|Lost to Follow-up|191|||
125332077|NCT01255436|450848948|FG000|Overall Study|Death, stroke, or MI|4|||
125332078|NCT01255436|450848949|FG001|Overall Study|Death, stroke, or MI|3|||
125002487|NCT00763971|449639096|FG000|Overall Study|Performed final visit on phone|0|||
125002488|NCT00763971|449639097|FG001|Overall Study|Performed final visit on phone|1|||
125002489|NCT00763971|449639098|FG002|Overall Study|Performed final visit on phone|0|||
125002490|NCT00763971|449639096|FG000|Overall Study|Participation in 489-326 required|1|||
125002491|NCT00763971|449639097|FG001|Overall Study|Participation in 489-326 required|0|||
125002492|NCT00763971|449639098|FG002|Overall Study|Participation in 489-326 required|0|||
125002493|NCT04439071|449639100|FG000|Overall Study|Lost to Follow-up|0|||
125002494|NCT04439071|449639101|FG001|Overall Study|Lost to Follow-up|3|||
125002495|NCT04439071|449639100|FG000|Overall Study|Withdrawal by Subject|3|||
125002496|NCT04439071|449639101|FG001|Overall Study|Withdrawal by Subject|8|||
125002497|NCT04439071|449639100|FG000|Overall Study|Death|6|||
125002498|NCT04439071|449639101|FG001|Overall Study|Death|4|||
125002499|NCT04439071|449639100|FG000|Overall Study|Other than specified|3|||
125002500|NCT04439071|449639101|FG001|Overall Study|Other than specified|3|||
125002501|NCT04439071|449639100|FG000|Overall Study|Randomized but not treated|2|||
125002502|NCT04439071|449639101|FG001|Overall Study|Randomized but not treated|0|||
125002503|NCT00024167|449639104|FG000|Overall Study|Death|53|||
125332079|NCT00372593|450848950|FG000|Overall Study|Adverse Event|43|||
125332080|NCT00372593|450848951|FG001|Overall Study|Adverse Event|45|||
125332081|NCT00372593|450848952|FG002|Overall Study|Adverse Event|0|||
125332082|NCT00372593|450848950|FG000|Overall Study|Death|16|||
125332083|NCT00372593|450848951|FG001|Overall Study|Death|20|||
125332084|NCT00372593|450848952|FG002|Overall Study|Death|1|||
125002504|NCT00024167|449639105|FG001|Overall Study|Death|47|||
125002505|NCT01186796|449639119|FG000|Overall Study|Adverse Event|3|||
125002506|NCT01186796|449639120|FG001|Overall Study|Adverse Event|0|||
125002507|NCT01186796|449639119|FG000|Overall Study|Withdrawal by Subject|1|||
125002508|NCT01186796|449639120|FG001|Overall Study|Withdrawal by Subject|1|||
125002509|NCT01186796|449639119|FG000|Overall Study|Protocol Violation|0|||
125002510|NCT01186796|449639120|FG001|Overall Study|Protocol Violation|1|||
125002511|NCT02459769|449639121|FG000|Overall Study|Withdrawal by Subject|7|||
125002512|NCT02459769|449639122|FG001|Overall Study|Withdrawal by Subject|4|||
125002513|NCT02459769|449639123|FG002|Overall Study|Withdrawal by Subject|8|||
125002514|NCT02459769|449639124|FG003|Overall Study|Withdrawal by Subject|5|||
125002515|NCT02459769|449639121|FG000|Overall Study|Lost to Follow-up|1|||
125002516|NCT02459769|449639122|FG001|Overall Study|Lost to Follow-up|0|||
125002517|NCT02459769|449639123|FG002|Overall Study|Lost to Follow-up|1|||
125002518|NCT02459769|449639124|FG003|Overall Study|Lost to Follow-up|0|||
125002519|NCT01287364|449639125|FG000|Overall Study|Adverse Event|0|||
125002520|NCT01287364|449639126|FG001|Overall Study|Adverse Event|3|||
125002521|NCT01287364|449639125|FG000|Overall Study|Protocol Violation|5|||
125002522|NCT01287364|449639126|FG001|Overall Study|Protocol Violation|5|||
125002523|NCT01287364|449639125|FG000|Overall Study|Other Reason|4|||
125002524|NCT01287364|449639126|FG001|Overall Study|Other Reason|2|||
125002525|NCT01379573|449639128|FG000|Overall Study|Lost to Follow-up|1|||
125002526|NCT01379573|449639128|FG000|Overall Study|Screen Failure|10|||
125002527|NCT00962390|449639132|FG000|Overall Study|Adverse Event|0|||
125002528|NCT00962390|449639133|FG001|Overall Study|Adverse Event|0|||
125002529|NCT00962390|449639134|FG002|Overall Study|Adverse Event|3|||
125002530|NCT00962390|449639135|FG003|Overall Study|Adverse Event|1|||
125002531|NCT00962390|449639132|FG000|Overall Study|Lost to Follow-up|2|||
125002532|NCT00962390|449639133|FG001|Overall Study|Lost to Follow-up|2|||
125002533|NCT00962390|449639134|FG002|Overall Study|Lost to Follow-up|0|||
125002534|NCT00962390|449639135|FG003|Overall Study|Lost to Follow-up|0|||
125002535|NCT00962390|449639132|FG000|Overall Study|Protocol Violation|1|||
125002536|NCT00962390|449639133|FG001|Overall Study|Protocol Violation|0|||
125002537|NCT00962390|449639134|FG002|Overall Study|Protocol Violation|0|||
125002538|NCT00962390|449639135|FG003|Overall Study|Protocol Violation|0|||
125332085|NCT00372593|450848950|FG000|Overall Study|Lack of Efficacy|82|||
125332086|NCT00372593|450848951|FG001|Overall Study|Lack of Efficacy|71|||
125332087|NCT00372593|450848952|FG002|Overall Study|Lack of Efficacy|2|||
125332088|NCT00372593|450848950|FG000|Overall Study|Lost to Follow-up|1|||
125332089|NCT00372593|450848951|FG001|Overall Study|Lost to Follow-up|0|||
125332090|NCT00372593|450848952|FG002|Overall Study|Lost to Follow-up|0|||
125332091|NCT00372593|450848950|FG000|Overall Study|Physician Decision|42|||
125332092|NCT00372593|450848951|FG001|Overall Study|Physician Decision|41|||
125332093|NCT00372593|450848952|FG002|Overall Study|Physician Decision|0|||
125332094|NCT00372593|450848950|FG000|Overall Study|Ineligible|20|||
125332095|NCT00372593|450848951|FG001|Overall Study|Ineligible|21|||
125332096|NCT00372593|450848952|FG002|Overall Study|Ineligible|1|||
125332097|NCT03534180|450848953|FG000|Overall Study|Withdrawal by Subject|1|||
125332098|NCT04439136|450848954|FG000|Overall Study|Ineligible|1|||
125332099|NCT04439136|450848954|FG000|Overall Study|Never Started Treatment|2|||
125332100|NCT04439136|450848954|FG000|Overall Study|Adverse Event|4|||
125002539|NCT00962390|449639132|FG000|Overall Study|Withdrawal by Subject|1|||
125002540|NCT00962390|449639133|FG001|Overall Study|Withdrawal by Subject|1|||
125002541|NCT00962390|449639134|FG002|Overall Study|Withdrawal by Subject|1|||
125002542|NCT00962390|449639135|FG003|Overall Study|Withdrawal by Subject|0|||
125002543|NCT03740997|449639144|FG000|Overall Study|Withdrawal by Subject|1|||
125002544|NCT03740997|449639145|FG001|Overall Study|Withdrawal by Subject|0|||
125002545|NCT03740997|449639144|FG000|Overall Study|Participant was unable to complete study procedures|1|||
125002546|NCT03740997|449639145|FG001|Overall Study|Participant was unable to complete study procedures|0|||
125002547|NCT01026142|449639146|FG000|Overall Study|Death|136|||
125002548|NCT01026142|449639147|FG001|Overall Study|Death|134|||
125002549|NCT01026142|449639146|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
125002550|NCT01026142|449639147|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
125002551|NCT01829425|449639148|FG000|Overall Study|Withdrawal by Subject|4|||
125002552|NCT01829425|449639149|FG001|Overall Study|Withdrawal by Subject|3|||
125002553|NCT01829425|449639148|FG000|Overall Study|Lost to Follow-up|2|||
125089878|NCT00545740|449947043|FG003|Overall Study|Accepted only monthly telephone calls|0|||
125332101|NCT04439136|450848954|FG000|Overall Study|Death|3|||
125332102|NCT04439136|450848954|FG000|Overall Study|Disease Progression|27|||
125332103|NCT04439136|450848954|FG000|Overall Study|Alternative Therapy|1|||
125332104|NCT04439136|450848954|FG000|Overall Study|Increased Tumor Burden|1|||
125332105|NCT04439136|450848954|FG000|Overall Study|Symptomatic Detrioration|1|||
125002554|NCT01829425|449639149|FG001|Overall Study|Lost to Follow-up|1|||
125002555|NCT04178967|449639150|FG000|Induction Period|Adverse Event|4|||
125002556|NCT04178967|449639151|FG001|Induction Period|Adverse Event|6|||
125002557|NCT04178967|449639152|FG002|Induction Period|Adverse Event|0|||
125002558|NCT04178967|449639153|FG003|Induction Period|Adverse Event|0|||
125002559|NCT04178967|449639154|FG004|Induction Period|Adverse Event|0|||
125002560|NCT04178967|449639155|FG005|Induction Period|Adverse Event|0|||
125002561|NCT04178967|449639156|FG006|Induction Period|Adverse Event|0|||
125002562|NCT04178967|449639157|FG007|Induction Period|Adverse Event|0|||
125002563|NCT04178967|449639158|FG008|Induction Period|Adverse Event|0|||
125002564|NCT04178967|449639159|FG009|Induction Period|Adverse Event|0|||
125332106|NCT02223858|450848955|FG000|Overall Study|Death|1|||
125332107|NCT02223858|450848956|FG001|Overall Study|Death|1|||
125332108|NCT02223858|450848955|FG000|Overall Study|Lost to Follow-up|6|||
125332109|NCT02223858|450848956|FG001|Overall Study|Lost to Follow-up|11|||
125332110|NCT02223858|450848955|FG000|Overall Study|Withdrawal by Subject|8|||
125332111|NCT02223858|450848956|FG001|Overall Study|Withdrawal by Subject|5|||
125332112|NCT02223858|450848955|FG000|Overall Study|Refused|9|||
125332113|NCT02223858|450848956|FG001|Overall Study|Refused|9|||
125332114|NCT03682770|450848959|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
125332115|NCT03682770|450848960|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
125332116|NCT03682770|450848961|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
125332117|NCT03682770|450848962|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
125332118|NCT03682770|450848963|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
125332119|NCT03682770|450848964|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
125332120|NCT03682770|450848965|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
125332121|NCT03682770|450848959|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
125332122|NCT03682770|450848960|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
125332123|NCT03682770|450848961|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
125002565|NCT04178967|449639160|FG010|Induction Period|Adverse Event|0|||
125002566|NCT04178967|449639150|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
125002567|NCT04178967|449639151|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
125002568|NCT04178967|449639152|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
125002569|NCT04178967|449639153|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
125002570|NCT04178967|449639154|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
125002571|NCT04178967|449639155|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
125002572|NCT04178967|449639156|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
125002573|NCT04178967|449639157|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
125002574|NCT04178967|449639158|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
125002575|NCT04178967|449639159|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
125002576|NCT04178967|449639160|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
125002577|NCT04178967|449639150|FG000|Induction Period|Lack of Efficacy|4|||
125002578|NCT04178967|449639151|FG001|Induction Period|Lack of Efficacy|1|||
125002579|NCT04178967|449639152|FG002|Induction Period|Lack of Efficacy|0|||
125002580|NCT04178967|449639153|FG003|Induction Period|Lack of Efficacy|0|||
125002581|NCT04178967|449639154|FG004|Induction Period|Lack of Efficacy|0|||
125002582|NCT04178967|449639155|FG005|Induction Period|Lack of Efficacy|0|||
125002583|NCT04178967|449639156|FG006|Induction Period|Lack of Efficacy|0|||
125002584|NCT04178967|449639157|FG007|Induction Period|Lack of Efficacy|0|||
125002585|NCT04178967|449639158|FG008|Induction Period|Lack of Efficacy|0|||
125002586|NCT04178967|449639159|FG009|Induction Period|Lack of Efficacy|0|||
125002587|NCT04178967|449639160|FG010|Induction Period|Lack of Efficacy|0|||
125002588|NCT04178967|449639150|FG000|Induction Period|Protocol Violation|0|||
125002589|NCT04178967|449639151|FG001|Induction Period|Protocol Violation|6|||
125002590|NCT04178967|449639152|FG002|Induction Period|Protocol Violation|0|||
125002591|NCT04178967|449639153|FG003|Induction Period|Protocol Violation|0|||
125002592|NCT04178967|449639154|FG004|Induction Period|Protocol Violation|0|||
125002593|NCT04178967|449639155|FG005|Induction Period|Protocol Violation|0|||
125002594|NCT04178967|449639156|FG006|Induction Period|Protocol Violation|0|||
125002595|NCT04178967|449639157|FG007|Induction Period|Protocol Violation|0|||
125002596|NCT04178967|449639158|FG008|Induction Period|Protocol Violation|0|||
125002597|NCT04178967|449639159|FG009|Induction Period|Protocol Violation|0|||
125002598|NCT04178967|449639160|FG010|Induction Period|Protocol Violation|0|||
125002599|NCT04178967|449639150|FG000|Induction Period|Withdrawal by Subject|6|||
125002600|NCT04178967|449639151|FG001|Induction Period|Withdrawal by Subject|4|||
125002601|NCT04178967|449639152|FG002|Induction Period|Withdrawal by Subject|0|||
125002602|NCT04178967|449639153|FG003|Induction Period|Withdrawal by Subject|0|||
125002603|NCT04178967|449639154|FG004|Induction Period|Withdrawal by Subject|0|||
125002604|NCT04178967|449639155|FG005|Induction Period|Withdrawal by Subject|0|||
125002605|NCT04178967|449639156|FG006|Induction Period|Withdrawal by Subject|0|||
125002606|NCT04178967|449639157|FG007|Induction Period|Withdrawal by Subject|0|||
125002607|NCT04178967|449639158|FG008|Induction Period|Withdrawal by Subject|0|||
125002608|NCT04178967|449639159|FG009|Induction Period|Withdrawal by Subject|0|||
125002609|NCT04178967|449639160|FG010|Induction Period|Withdrawal by Subject|0|||
125002610|NCT04178967|449639150|FG000|Induction Period|Lost to Follow-up|2|||
125002611|NCT04178967|449639151|FG001|Induction Period|Lost to Follow-up|0|||
125002612|NCT04178967|449639152|FG002|Induction Period|Lost to Follow-up|0|||
125002613|NCT04178967|449639153|FG003|Induction Period|Lost to Follow-up|0|||
125002614|NCT04178967|449639154|FG004|Induction Period|Lost to Follow-up|0|||
125002615|NCT04178967|449639155|FG005|Induction Period|Lost to Follow-up|0|||
125332124|NCT03682770|450848962|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
125002616|NCT04178967|449639156|FG006|Induction Period|Lost to Follow-up|0|||
125002617|NCT04178967|449639157|FG007|Induction Period|Lost to Follow-up|0|||
125002618|NCT04178967|449639158|FG008|Induction Period|Lost to Follow-up|0|||
125002619|NCT04178967|449639159|FG009|Induction Period|Lost to Follow-up|0|||
125002620|NCT04178967|449639160|FG010|Induction Period|Lost to Follow-up|0|||
125002621|NCT04178967|449639150|FG000|Induction Period|Participant Missed Study Visits|0|||
125332125|NCT03682770|450848963|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
125332126|NCT03682770|450848964|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
125332127|NCT03682770|450848965|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
125332128|NCT03682770|450848959|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
125332129|NCT03682770|450848960|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
125332130|NCT03682770|450848961|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
125332131|NCT03682770|450848962|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
125002622|NCT04178967|449639151|FG001|Induction Period|Participant Missed Study Visits|1|||
125002623|NCT04178967|449639152|FG002|Induction Period|Participant Missed Study Visits|0|||
125002624|NCT04178967|449639153|FG003|Induction Period|Participant Missed Study Visits|0|||
125332132|NCT03682770|450848963|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
125332133|NCT03682770|450848964|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
125332134|NCT03682770|450848965|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
125332135|NCT03682770|450848959|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
125332136|NCT03682770|450848960|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
125332137|NCT03682770|450848961|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
125332138|NCT03682770|450848962|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
125332139|NCT03682770|450848963|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
125332140|NCT03682770|450848964|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
125332141|NCT03682770|450848965|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
125332142|NCT03682770|450848959|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
125332143|NCT03682770|450848960|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
125332144|NCT03682770|450848961|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
125332145|NCT03682770|450848962|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
125332146|NCT03682770|450848963|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
125332147|NCT03682770|450848964|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
125332148|NCT03682770|450848965|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
125332149|NCT03682770|450848959|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
125332150|NCT03682770|450848960|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
125332151|NCT03682770|450848961|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
125332152|NCT03682770|450848962|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
125332153|NCT03682770|450848963|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
125332154|NCT03682770|450848964|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
125332155|NCT03682770|450848965|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
125332156|NCT03682770|450848959|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
125332157|NCT03682770|450848960|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
125332158|NCT03682770|450848961|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
125332159|NCT03682770|450848962|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
125332160|NCT03682770|450848963|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
125332161|NCT03682770|450848964|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
125332162|NCT03682770|450848965|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
125332163|NCT03682770|450848959|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
125332164|NCT03682770|450848960|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
125332165|NCT03682770|450848961|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
125332166|NCT03682770|450848962|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
125332167|NCT03682770|450848963|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
125332168|NCT03682770|450848964|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
125332169|NCT03682770|450848965|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
125332170|NCT03682770|450848959|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
125332171|NCT03682770|450848960|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
125332172|NCT03682770|450848961|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
125332173|NCT03682770|450848962|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
125332174|NCT03682770|450848963|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
125332175|NCT03682770|450848964|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
125332176|NCT03682770|450848965|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
125332177|NCT03682770|450848959|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
125332178|NCT03682770|450848960|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
125332179|NCT03682770|450848961|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
125332180|NCT03682770|450848962|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
125002625|NCT04178967|449639154|FG004|Induction Period|Participant Missed Study Visits|0|||
125002626|NCT04178967|449639155|FG005|Induction Period|Participant Missed Study Visits|0|||
125002627|NCT04178967|449639156|FG006|Induction Period|Participant Missed Study Visits|0|||
125002628|NCT04178967|449639157|FG007|Induction Period|Participant Missed Study Visits|0|||
125332181|NCT03682770|450848963|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
125332182|NCT03682770|450848964|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
125332183|NCT03682770|450848965|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
125332184|NCT03682770|450848959|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
125332185|NCT03682770|450848960|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
125332186|NCT03682770|450848961|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
125332187|NCT03682770|450848962|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
125332188|NCT03682770|450848963|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
125332189|NCT03682770|450848964|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
125332190|NCT03682770|450848965|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
125332191|NCT03682770|450848959|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
125332192|NCT03682770|450848960|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
125332193|NCT03682770|450848961|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
125332194|NCT03682770|450848962|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
125332195|NCT03682770|450848963|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
125332196|NCT03682770|450848964|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
125332197|NCT03682770|450848965|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
125332198|NCT02362282|450848966|FG000|Overall Study|Withdrawal by Subject|1|||
125332199|NCT02362282|450848967|FG001|Overall Study|Withdrawal by Subject|0|||
125332200|NCT03599089|450848974|FG000|Overall Study|Lost to Follow-up|1|||
125332201|NCT03599089|450848975|FG001|Overall Study|Lost to Follow-up|0|||
125332202|NCT03599089|450848976|FG002|Overall Study|Lost to Follow-up|0|||
125332203|NCT03599089|450848977|FG003|Overall Study|Lost to Follow-up|0|||
125332204|NCT03599089|450848974|FG000|Overall Study|Withdrawal by Subject|2|||
125332205|NCT03599089|450848975|FG001|Overall Study|Withdrawal by Subject|1|||
125332206|NCT03599089|450848976|FG002|Overall Study|Withdrawal by Subject|0|||
125332207|NCT03599089|450848977|FG003|Overall Study|Withdrawal by Subject|0|||
125332208|NCT03599089|450848974|FG000|Overall Study|Lack of Efficacy|0|||
125332209|NCT03599089|450848975|FG001|Overall Study|Lack of Efficacy|0|||
125332210|NCT03599089|450848976|FG002|Overall Study|Lack of Efficacy|1|||
125332211|NCT03599089|450848977|FG003|Overall Study|Lack of Efficacy|2|||
125332212|NCT03214666|450848978|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
125332213|NCT03214666|450848979|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
125332214|NCT03214666|450848980|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
125332215|NCT03214666|450848981|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
125332216|NCT03214666|450848982|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
125332217|NCT03214666|450848983|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
125332218|NCT00470275|450848984|FG000|Overall Study|Death|1|||
125332219|NCT00470275|450848984|FG000|Overall Study|Lack of Efficacy|7|||
125332220|NCT00470275|450848984|FG000|Overall Study|Withdrawal by Subject|2|||
125332221|NCT00318643|450848990|FG000|Overall Study|Adverse Event|0|||
125332222|NCT00318643|450848991|FG001|Overall Study|Adverse Event|0|||
125332223|NCT00318643|450848992|FG002|Overall Study|Adverse Event|0|||
125332224|NCT00318643|450848993|FG003|Overall Study|Adverse Event|0|||
125332225|NCT00318643|450848994|FG004|Overall Study|Adverse Event|1|||
125332226|NCT00318643|450848990|FG000|Overall Study|Participant's Decision|0|||
125332227|NCT00318643|450848991|FG001|Overall Study|Participant's Decision|0|||
125332228|NCT00318643|450848992|FG002|Overall Study|Participant's Decision|0|||
125332229|NCT00318643|450848993|FG003|Overall Study|Participant's Decision|0|||
125332230|NCT00318643|450848994|FG004|Overall Study|Participant's Decision|1|||
125332231|NCT00318643|450848990|FG000|Overall Study|Investigator's Decision|0|||
125332232|NCT00318643|450848991|FG001|Overall Study|Investigator's Decision|0|||
125332233|NCT00318643|450848992|FG002|Overall Study|Investigator's Decision|0|||
125332234|NCT00318643|450848993|FG003|Overall Study|Investigator's Decision|0|||
125332235|NCT00318643|450848994|FG004|Overall Study|Investigator's Decision|1|||
125332236|NCT01519921|450848997|FG000|Overall Study|Adverse Event|10|||
125332237|NCT01519921|450848998|FG001|Overall Study|Adverse Event|9|||
125332238|NCT01519921|450848997|FG000|Overall Study|Lack of Efficacy|4|||
125332239|NCT01519921|450848998|FG001|Overall Study|Lack of Efficacy|3|||
125332240|NCT01519921|450848997|FG000|Overall Study|Withdrawal by Subject|3|||
125332241|NCT01519921|450848998|FG001|Overall Study|Withdrawal by Subject|0|||
125332242|NCT01519921|450848997|FG000|Overall Study|Lost to Follow-up|2|||
125332243|NCT01519921|450848998|FG001|Overall Study|Lost to Follow-up|1|||
125332244|NCT01519921|450848997|FG000|Overall Study|Treatment refusal|2|||
125002629|NCT04178967|449639158|FG008|Induction Period|Participant Missed Study Visits|0|||
125002630|NCT04178967|449639159|FG009|Induction Period|Participant Missed Study Visits|0|||
125002631|NCT04178967|449639160|FG010|Induction Period|Participant Missed Study Visits|0|||
125002632|NCT04178967|449639150|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
125002633|NCT04178967|449639151|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
125332245|NCT01519921|450848998|FG001|Overall Study|Treatment refusal|1|||
125332246|NCT01519921|450848997|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
125332247|NCT01519921|450848998|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
125332248|NCT02500797|450848999|FG000|Overall Study|Cancel (rapid disease progression)|0|||
125332249|NCT02500797|450849000|FG001|Overall Study|Cancel (rapid disease progression)|0|||
125332250|NCT02500797|450849001|FG002|Overall Study|Cancel (rapid disease progression)|0|||
125332251|NCT02500797|450849002|FG003|Overall Study|Cancel (rapid disease progression)|0|||
125332252|NCT02500797|450849003|FG004|Overall Study|Cancel (rapid disease progression)|1|||
125332253|NCT02500797|450849004|FG005|Overall Study|Cancel (rapid disease progression)|1|||
125332254|NCT02500797|450849005|FG006|Overall Study|Cancel (rapid disease progression)|0|||
125332255|NCT02500797|450849006|FG007|Overall Study|Cancel (rapid disease progression)|0|||
125332256|NCT02500797|450848999|FG000|Overall Study|Withdrawal by Subject|1|||
125332257|NCT02500797|450849000|FG001|Overall Study|Withdrawal by Subject|0|||
125332258|NCT02500797|450849001|FG002|Overall Study|Withdrawal by Subject|0|||
125332259|NCT02500797|450849002|FG003|Overall Study|Withdrawal by Subject|0|||
125332260|NCT02500797|450849003|FG004|Overall Study|Withdrawal by Subject|0|||
125332261|NCT02500797|450849004|FG005|Overall Study|Withdrawal by Subject|0|||
125332262|NCT02500797|450849005|FG006|Overall Study|Withdrawal by Subject|0|||
125002634|NCT04178967|449639152|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
125332263|NCT02500797|450849006|FG007|Overall Study|Withdrawal by Subject|0|||
125332264|NCT01415882|450849009|FG000|Overall Study|Ineligible|1|||
125332265|NCT01415882|450849010|FG001|Overall Study|Ineligible|0|||
125332266|NCT01415882|450849011|FG002|Overall Study|Ineligible|0|||
125332267|NCT01415882|450849012|FG003|Overall Study|Ineligible|3|||
125332268|NCT01415882|450849013|FG004|Overall Study|Ineligible|0|||
125332269|NCT01415882|450849009|FG000|Overall Study|Withdrawal by Subject|0|||
125332270|NCT01415882|450849010|FG001|Overall Study|Withdrawal by Subject|1|||
125332271|NCT01415882|450849011|FG002|Overall Study|Withdrawal by Subject|0|||
125332272|NCT01415882|450849012|FG003|Overall Study|Withdrawal by Subject|1|||
125332273|NCT01415882|450849013|FG004|Overall Study|Withdrawal by Subject|0|||
125332274|NCT00357006|450849018|FG000|Overall Study|Lost to Follow-up|1|||
125332275|NCT00357006|450849019|FG001|Overall Study|Lost to Follow-up|2|||
125332276|NCT00357006|450849020|FG002|Overall Study|Lost to Follow-up|1|||
125332277|NCT00357006|450849018|FG000|Overall Study|Withdrawal by Subject|1|||
125332278|NCT00357006|450849019|FG001|Overall Study|Withdrawal by Subject|3|||
125332279|NCT00357006|450849020|FG002|Overall Study|Withdrawal by Subject|2|||
125332280|NCT00976560|450849021|FG000|Overall Study|Adverse Event|5|||
125332281|NCT00976560|450849022|FG001|Overall Study|Adverse Event|5|||
125332282|NCT00976560|450849021|FG000|Overall Study|Lack of Efficacy|3|||
125332283|NCT00976560|450849022|FG001|Overall Study|Lack of Efficacy|5|||
125332284|NCT00976560|450849021|FG000|Overall Study|Protocol Violation|1|||
125332285|NCT00976560|450849022|FG001|Overall Study|Protocol Violation|0|||
125332286|NCT00976560|450849021|FG000|Overall Study|Lost to Follow-up|1|||
125332287|NCT00976560|450849022|FG001|Overall Study|Lost to Follow-up|0|||
125332288|NCT00976560|450849021|FG000|Overall Study|Physician Decision|2|||
125332289|NCT00976560|450849022|FG001|Overall Study|Physician Decision|0|||
125332290|NCT00976560|450849021|FG000|Overall Study|Withdrawal by Subject|2|||
125332291|NCT00976560|450849022|FG001|Overall Study|Withdrawal by Subject|3|||
125332292|NCT01216189|450849023|FG000|Overall Study|Lost to Follow-up|21|||
125332293|NCT01216189|450849024|FG001|Overall Study|Lost to Follow-up|3|||
125332294|NCT01216189|450849023|FG000|Overall Study|Death|4|||
125332295|NCT01216189|450849024|FG001|Overall Study|Death|2|||
125332296|NCT00125164|450849027|FG000|Overall Study|Adverse Event|0|||
125332297|NCT00125164|450849028|FG001|Overall Study|Adverse Event|0|||
125332298|NCT00125164|450849029|FG002|Overall Study|Adverse Event|2|||
125002635|NCT04178967|449639153|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
125332299|NCT00125164|450849030|FG003|Overall Study|Adverse Event|4|||
125332300|NCT00125164|450849027|FG000|Overall Study|Lost to Follow-up|0|||
125332301|NCT00125164|450849028|FG001|Overall Study|Lost to Follow-up|0|||
125332302|NCT00125164|450849029|FG002|Overall Study|Lost to Follow-up|1|||
125332303|NCT00125164|450849030|FG003|Overall Study|Lost to Follow-up|1|||
125332304|NCT00125164|450849027|FG000|Overall Study|Withdrawal by Subject|2|||
125332305|NCT00125164|450849028|FG001|Overall Study|Withdrawal by Subject|0|||
125332306|NCT00125164|450849029|FG002|Overall Study|Withdrawal by Subject|1|||
125332307|NCT00125164|450849030|FG003|Overall Study|Withdrawal by Subject|1|||
125332308|NCT01339052|450849031|FG000|Overall Study|Disease progression|13|||
125002636|NCT04178967|449639154|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
125002637|NCT04178967|449639155|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
125332309|NCT01339052|450849032|FG001|Overall Study|Disease progression|46|||
125332310|NCT01339052|450849031|FG000|Overall Study|Adverse Event|1|||
125332311|NCT01339052|450849032|FG001|Overall Study|Adverse Event|1|||
125332312|NCT01339052|450849031|FG000|Overall Study|Withdrawal by Subject|0|||
125332313|NCT01339052|450849032|FG001|Overall Study|Withdrawal by Subject|3|||
125332314|NCT01339052|450849031|FG000|Overall Study|Physician Decision|1|||
125332315|NCT01339052|450849032|FG001|Overall Study|Physician Decision|0|||
125332316|NCT02637037|450849033|FG000|Overall Study|Positive drug screen at admission|1|||
125332317|NCT02637037|450849034|FG001|Overall Study|Positive drug screen at admission|0|||
125332318|NCT02637037|450849033|FG000|Overall Study|Withdrawal by Subject|2|||
125332319|NCT02637037|450849034|FG001|Overall Study|Withdrawal by Subject|1|||
125332320|NCT02637037|450849033|FG000|Overall Study|Adverse Event|1|||
125332321|NCT02637037|450849034|FG001|Overall Study|Adverse Event|0|||
125332322|NCT03339219|450849035|FG000|Overall Study|Death|12|||
125332323|NCT03339219|450849035|FG000|Overall Study|Site Terminated by Sponsor|22|||
125332324|NCT03339219|450849035|FG000|Overall Study|Withdrawal by Subject|1|||
125332325|NCT01469377|450849037|FG000|Overall Study|Protocol Deviation|7|||
125332326|NCT01469377|450849038|FG001|Overall Study|Protocol Deviation|10|||
125332327|NCT01469377|450849039|FG002|Overall Study|Protocol Deviation|10|||
125332328|NCT01469377|450849037|FG000|Overall Study|Lost to Follow-up|3|||
125332329|NCT01469377|450849038|FG001|Overall Study|Lost to Follow-up|2|||
125332330|NCT01469377|450849039|FG002|Overall Study|Lost to Follow-up|5|||
125332331|NCT01469377|450849037|FG000|Overall Study|Withdrawal of Consent|12|||
125332332|NCT01469377|450849038|FG001|Overall Study|Withdrawal of Consent|14|||
125332333|NCT01469377|450849039|FG002|Overall Study|Withdrawal of Consent|15|||
125332334|NCT01469377|450849037|FG000|Overall Study|Adverse Event|8|||
125332335|NCT01469377|450849038|FG001|Overall Study|Adverse Event|18|||
125332336|NCT01469377|450849039|FG002|Overall Study|Adverse Event|36|||
125332337|NCT01469377|450849037|FG000|Overall Study|Insufficient Therapeutic Response|3|||
125332338|NCT01469377|450849038|FG001|Overall Study|Insufficient Therapeutic Response|4|||
125332339|NCT01469377|450849039|FG002|Overall Study|Insufficient Therapeutic Response|0|||
125332340|NCT01469377|450849037|FG000|Overall Study|Other Miscellaneous Reasons|2|||
125332341|NCT01469377|450849038|FG001|Overall Study|Other Miscellaneous Reasons|0|||
125332342|NCT01469377|450849039|FG002|Overall Study|Other Miscellaneous Reasons|0|||
125332343|NCT01733680|450849040|FG000|Overall Study|Withdrawal by Subject|0|||
125332344|NCT01733680|450849041|FG001|Overall Study|Withdrawal by Subject|1|||
125332345|NCT04139798|450849046|FG000|Overall Study|Withdrawal by Subject|6|||
125332346|NCT04139798|450849047|FG001|Overall Study|Withdrawal by Subject|5|||
125332347|NCT04139798|450849046|FG000|Overall Study|Lost to Follow-up|2|||
125332348|NCT04139798|450849047|FG001|Overall Study|Lost to Follow-up|5|||
125332349|NCT04139798|450849046|FG000|Overall Study|Discontinued|4|||
125332350|NCT04139798|450849047|FG001|Overall Study|Discontinued|2|||
125332351|NCT04139798|450849046|FG000|Overall Study|Adverse Event|1|||
125332352|NCT04139798|450849047|FG001|Overall Study|Adverse Event|3|||
125332353|NCT04139798|450849046|FG000|Overall Study|Protocol Violation|1|||
125332354|NCT04139798|450849047|FG001|Overall Study|Protocol Violation|0|||
125332355|NCT04269889|450849048|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
125332356|NCT04308291|450849051|FG000|Run-In Phase|Withdrawal by Subject|4|||
125332357|NCT04308291|450849051|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
125332358|NCT04308291|450849051|FG000|Study Phase 6-M|Physician Decision|2|||
125332359|NCT04308291|450849051|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
125332360|NCT04308291|450849051|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
125332361|NCT04308291|450849051|FG000|Study Phase 12-M|Physician Decision|2|||
125332362|NCT04308291|450849051|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
125332363|NCT03610269|450849053|FG000|Overall Study|Physician Decision|10|||
125332364|NCT03610269|450849053|FG000|Overall Study|Protocol Violation|1|||
125332365|NCT03610269|450849053|FG000|Overall Study|Unable to draw blood|1|||
125332366|NCT03610269|450849053|FG000|Overall Study|Screen fail|4|||
125332367|NCT04411667|450849056|FG000|Overall Study|Physician Decision|1|||
125332368|NCT04411667|450849057|FG001|Overall Study|Physician Decision|0|||
125332369|NCT00067002|450849058|FG000|Overall Study|Early Death|1|||
125332370|NCT00067002|450849059|FG001|Overall Study|Early Death|2|||
125332371|NCT00067002|450849058|FG000|Overall Study|Delayed|1|||
125332372|NCT00067002|450849059|FG001|Overall Study|Delayed|1|||
125332373|NCT00067002|450849058|FG000|Overall Study|Graft Failure|5|||
125332374|NCT00067002|450849059|FG001|Overall Study|Graft Failure|6|||
125332375|NCT01354314|450849064|FG000|Overall Study|Lost to Follow-up|1|||
125332376|NCT01354314|450849065|FG001|Overall Study|Lost to Follow-up|0|||
125332377|NCT01354314|450849066|FG002|Overall Study|Lost to Follow-up|1|||
125332378|NCT01354314|450849067|FG003|Overall Study|Lost to Follow-up|1|||
125332379|NCT01354314|450849064|FG000|Overall Study|Withdrawal by Subject|0|||
125332380|NCT01354314|450849065|FG001|Overall Study|Withdrawal by Subject|0|||
125332381|NCT01354314|450849066|FG002|Overall Study|Withdrawal by Subject|1|||
125332382|NCT01354314|450849067|FG003|Overall Study|Withdrawal by Subject|0|||
125332383|NCT01354314|450849064|FG000|Overall Study|Adverse Event|0|||
125332384|NCT01354314|450849065|FG001|Overall Study|Adverse Event|0|||
125332385|NCT01354314|450849066|FG002|Overall Study|Adverse Event|0|||
125332386|NCT01354314|450849067|FG003|Overall Study|Adverse Event|1|||
125332387|NCT01354314|450849064|FG000|Overall Study|Protocol Violation|1|||
125332388|NCT01354314|450849065|FG001|Overall Study|Protocol Violation|1|||
125332389|NCT01354314|450849066|FG002|Overall Study|Protocol Violation|0|||
125332390|NCT01354314|450849067|FG003|Overall Study|Protocol Violation|0|||
125332391|NCT01354314|450849064|FG000|Overall Study|Less than 90% Adherence|4|||
125332392|NCT01354314|450849065|FG001|Overall Study|Less than 90% Adherence|2|||
125332393|NCT01354314|450849066|FG002|Overall Study|Less than 90% Adherence|6|||
125332394|NCT01354314|450849067|FG003|Overall Study|Less than 90% Adherence|4|||
125332395|NCT00478023|450849069|FG000|Overall Study|Adverse Event|11|||
125332396|NCT00478023|450849070|FG001|Overall Study|Adverse Event|7|||
125332397|NCT00478023|450849071|FG002|Overall Study|Adverse Event|8|||
125332398|NCT00478023|450849072|FG003|Overall Study|Adverse Event|14|||
125332399|NCT00478023|450849073|FG004|Overall Study|Adverse Event|6|||
125332400|NCT00478023|450849069|FG000|Overall Study|Death|1|||
125002638|NCT04178967|449639156|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
125002639|NCT04178967|449639157|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
125002640|NCT04178967|449639158|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
125002641|NCT04178967|449639159|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
125002642|NCT04178967|449639160|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
125002643|NCT04178967|449639150|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125002644|NCT04178967|449639151|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125002645|NCT04178967|449639152|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125002646|NCT04178967|449639153|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125002647|NCT04178967|449639154|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125002648|NCT04178967|449639155|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
125332401|NCT00478023|450849070|FG001|Overall Study|Death|0|||
125332402|NCT00478023|450849071|FG002|Overall Study|Death|0|||
125332403|NCT00478023|450849072|FG003|Overall Study|Death|0|||
125332404|NCT00478023|450849073|FG004|Overall Study|Death|0|||
125332405|NCT00478023|450849069|FG000|Overall Study|Lack of Efficacy|11|||
125332406|NCT00478023|450849070|FG001|Overall Study|Lack of Efficacy|10|||
125332407|NCT00478023|450849071|FG002|Overall Study|Lack of Efficacy|4|||
125332408|NCT00478023|450849072|FG003|Overall Study|Lack of Efficacy|5|||
125332409|NCT00478023|450849073|FG004|Overall Study|Lack of Efficacy|41|||
125332410|NCT00478023|450849069|FG000|Overall Study|Lost to Follow-up|3|||
125332411|NCT00478023|450849070|FG001|Overall Study|Lost to Follow-up|1|||
125332412|NCT00478023|450849071|FG002|Overall Study|Lost to Follow-up|1|||
125332413|NCT00478023|450849072|FG003|Overall Study|Lost to Follow-up|1|||
125332414|NCT00478023|450849073|FG004|Overall Study|Lost to Follow-up|0|||
125332415|NCT00478023|450849069|FG000|Overall Study|Withdrawal by Subject|2|||
125332416|NCT00478023|450849070|FG001|Overall Study|Withdrawal by Subject|3|||
125332417|NCT00478023|450849071|FG002|Overall Study|Withdrawal by Subject|2|||
125332418|NCT00478023|450849072|FG003|Overall Study|Withdrawal by Subject|4|||
125332419|NCT00478023|450849073|FG004|Overall Study|Withdrawal by Subject|5|||
125332420|NCT00478023|450849069|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
125332421|NCT00478023|450849070|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
125332422|NCT00478023|450849071|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
125332423|NCT00478023|450849072|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
125332424|NCT00478023|450849073|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
125332425|NCT00714870|450849075|FG000|Overall Study|Lost to Follow-up|22|||
125332426|NCT00714870|450849076|FG001|Overall Study|Lost to Follow-up|5|||
125332427|NCT00714870|450849075|FG000|Overall Study|patient unable to come b/c back pain|1|||
125332428|NCT00714870|450849076|FG001|Overall Study|patient unable to come b/c back pain|0|||
125002649|NCT04178967|449639156|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125002650|NCT04178967|449639157|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125002651|NCT04178967|449639158|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125332429|NCT00714870|450849075|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
125332430|NCT00714870|450849076|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
125332431|NCT02357368|450849077|FG000|Overall Study|Lost to Follow-up|0|||
125332432|NCT02357368|450849078|FG001|Overall Study|Lost to Follow-up|0|||
125332433|NCT02357368|450849079|FG002|Overall Study|Lost to Follow-up|0|||
125332434|NCT02357368|450849080|FG003|Overall Study|Lost to Follow-up|1|||
125332435|NCT02357368|450849077|FG000|Overall Study|Pregnancy|3|||
125332436|NCT02357368|450849078|FG001|Overall Study|Pregnancy|2|||
125332437|NCT02357368|450849079|FG002|Overall Study|Pregnancy|0|||
125332438|NCT02357368|450849080|FG003|Overall Study|Pregnancy|0|||
125332439|NCT02357368|450849077|FG000|Overall Study|Withdrawal by Subject|3|||
125332440|NCT02357368|450849078|FG001|Overall Study|Withdrawal by Subject|1|||
125002652|NCT04178967|449639159|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125002653|NCT04178967|449639160|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125002654|NCT04178967|449639150|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125332441|NCT02357368|450849079|FG002|Overall Study|Withdrawal by Subject|1|||
125332442|NCT02357368|450849080|FG003|Overall Study|Withdrawal by Subject|2|||
125332443|NCT02377817|450849081|FG000|Overall Study|Transportation/childcare barriers.|2|||
125332444|NCT02377817|450849082|FG001|Overall Study|Transportation/childcare barriers.|0|||
125332445|NCT02377817|450849081|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
125002655|NCT04178967|449639151|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125332446|NCT02377817|450849082|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
125332447|NCT03895840|450849083|FG000|Overall Study|Withdrawal by Subject|21|||
125332448|NCT01147874|450849086|FG000|Overall Study|Adverse Event|5|||
124872979|NCT00089141|449157210|FG000|Overall Study|Termination of trial|18|||
125332449|NCT01147874|450849086|FG000|Overall Study|Investigator's Request|1|||
125332450|NCT01147874|450849086|FG000|Overall Study|Lost to Follow-up|25|||
125332451|NCT01147874|450849086|FG000|Overall Study|Other|5|||
125002656|NCT04178967|449639152|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125332452|NCT01147874|450849086|FG000|Overall Study|Protocol Violation|5|||
125332453|NCT01147874|450849086|FG000|Overall Study|Sponsor's Decision|2|||
125332454|NCT01147874|450849086|FG000|Overall Study|Withdrawal by Subject|24|||
125332455|NCT02175030|450849088|FG000|Overall Study|Failed screen after consent|7|||
125332456|NCT02175030|450849089|FG001|Overall Study|Failed screen after consent|6|||
125332457|NCT02175030|450849088|FG000|Overall Study|Failed IUD Insertion|20|||
125332458|NCT02175030|450849089|FG001|Overall Study|Failed IUD Insertion|21|||
125332459|NCT02175030|450849088|FG000|Overall Study|Physician Decision|1|||
125332460|NCT02175030|450849089|FG001|Overall Study|Physician Decision|1|||
125332461|NCT02175030|450849088|FG000|Overall Study|Lost to Follow-up|6|||
125332462|NCT02175030|450849089|FG001|Overall Study|Lost to Follow-up|6|||
125332463|NCT02175030|450849088|FG000|Overall Study|Withdrawal by Subject|1|||
125332464|NCT02175030|450849089|FG001|Overall Study|Withdrawal by Subject|4|||
125332465|NCT02817464|450849090|FG000|Overall Study|Lost to Follow-up|1|||
125332466|NCT02817464|450849091|FG001|Overall Study|Lost to Follow-up|0|||
125332467|NCT02817464|450849090|FG000|Overall Study|Discontinued early due to personal decision|1|||
125332468|NCT02817464|450849091|FG001|Overall Study|Discontinued early due to personal decision|1|||
125332469|NCT00885534|450849092|FG000|Overall Study|Patient deemed ineligible|1|||
125332470|NCT02453711|450849093|FG000|Overall Study|Withdrawal by Subject|5|||
125332471|NCT02453711|450849094|FG001|Overall Study|Withdrawal by Subject|4|||
125332472|NCT02453711|450849095|FG002|Overall Study|Withdrawal by Subject|6|||
125332473|NCT02453711|450849096|FG003|Overall Study|Withdrawal by Subject|4|||
125332474|NCT02453711|450849097|FG004|Overall Study|Withdrawal by Subject|1|||
125332475|NCT02453711|450849098|FG005|Overall Study|Withdrawal by Subject|1|||
125332476|NCT02453711|450849099|FG006|Overall Study|Withdrawal by Subject|0|||
125332477|NCT02453711|450849100|FG007|Overall Study|Withdrawal by Subject|1|||
125332478|NCT02453711|450849101|FG008|Overall Study|Withdrawal by Subject|7|||
125332479|NCT02453711|450849093|FG000|Overall Study|Lost to Follow-up|5|||
125332480|NCT02453711|450849094|FG001|Overall Study|Lost to Follow-up|3|||
125332481|NCT02453711|450849095|FG002|Overall Study|Lost to Follow-up|2|||
125332482|NCT02453711|450849096|FG003|Overall Study|Lost to Follow-up|3|||
125332483|NCT02453711|450849097|FG004|Overall Study|Lost to Follow-up|1|||
125332484|NCT02453711|450849098|FG005|Overall Study|Lost to Follow-up|5|||
125332485|NCT02453711|450849099|FG006|Overall Study|Lost to Follow-up|2|||
125332486|NCT02453711|450849100|FG007|Overall Study|Lost to Follow-up|6|||
125332487|NCT02453711|450849101|FG008|Overall Study|Lost to Follow-up|6|||
125332488|NCT02453711|450849093|FG000|Overall Study|Death|0|||
125332489|NCT02453711|450849094|FG001|Overall Study|Death|0|||
125332490|NCT02453711|450849095|FG002|Overall Study|Death|0|||
125332491|NCT02453711|450849096|FG003|Overall Study|Death|0|||
125332492|NCT02453711|450849097|FG004|Overall Study|Death|0|||
125332493|NCT02453711|450849098|FG005|Overall Study|Death|0|||
125332494|NCT02453711|450849099|FG006|Overall Study|Death|1|||
125332495|NCT02453711|450849100|FG007|Overall Study|Death|0|||
125332496|NCT02453711|450849101|FG008|Overall Study|Death|0|||
125332497|NCT02453711|450849093|FG000|Overall Study|Unclassified|1|||
125332498|NCT02453711|450849094|FG001|Overall Study|Unclassified|0|||
125332499|NCT02453711|450849095|FG002|Overall Study|Unclassified|1|||
125332500|NCT02453711|450849096|FG003|Overall Study|Unclassified|0|||
125332501|NCT02453711|450849097|FG004|Overall Study|Unclassified|0|||
125332502|NCT02453711|450849098|FG005|Overall Study|Unclassified|0|||
125332503|NCT02453711|450849099|FG006|Overall Study|Unclassified|0|||
125332504|NCT02453711|450849100|FG007|Overall Study|Unclassified|0|||
125332505|NCT02453711|450849101|FG008|Overall Study|Unclassified|0|||
125332506|NCT01273519|450849104|FG000|Overall Study|Adverse Event|3|||
125332507|NCT01273519|450849105|FG001|Overall Study|Adverse Event|0|||
125332508|NCT01273519|450849106|FG002|Overall Study|Adverse Event|0|||
125332509|NCT01273519|450849104|FG000|Overall Study|Lost to Follow-up|2|||
125332510|NCT01273519|450849105|FG001|Overall Study|Lost to Follow-up|1|||
125332511|NCT01273519|450849106|FG002|Overall Study|Lost to Follow-up|3|||
125332512|NCT01273519|450849104|FG000|Overall Study|Lack of Efficacy|8|||
125332513|NCT01273519|450849105|FG001|Overall Study|Lack of Efficacy|3|||
125332514|NCT01273519|450849106|FG002|Overall Study|Lack of Efficacy|4|||
125332515|NCT01273519|450849104|FG000|Overall Study|Other|6|||
125332516|NCT01273519|450849105|FG001|Overall Study|Other|1|||
125332517|NCT01273519|450849106|FG002|Overall Study|Other|1|||
125332518|NCT04292899|450849107|FG000|Overall Study|Death|21|||
125332519|NCT04292899|450849108|FG001|Overall Study|Death|28|||
125332520|NCT04292899|450849109|FG002|Overall Study|Death|188|||
125332521|NCT04292899|450849110|FG003|Overall Study|Death|371|||
125002657|NCT04178967|449639153|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
125332522|NCT04292899|450849107|FG000|Overall Study|Lost to Follow-up|8|||
125332523|NCT04292899|450849108|FG001|Overall Study|Lost to Follow-up|4|||
125332524|NCT04292899|450849109|FG002|Overall Study|Lost to Follow-up|22|||
125332525|NCT04292899|450849110|FG003|Overall Study|Lost to Follow-up|235|||
125332526|NCT04292899|450849107|FG000|Overall Study|Withdrew consent|1|||
125332527|NCT04292899|450849108|FG001|Overall Study|Withdrew consent|0|||
125332528|NCT04292899|450849109|FG002|Overall Study|Withdrew consent|11|||
125332529|NCT04292899|450849110|FG003|Overall Study|Withdrew consent|32|||
125332530|NCT04292899|450849107|FG000|Overall Study|Adverse Event|2|||
125332531|NCT04292899|450849108|FG001|Overall Study|Adverse Event|1|||
125332532|NCT04292899|450849109|FG002|Overall Study|Adverse Event|2|||
125332533|NCT04292899|450849110|FG003|Overall Study|Adverse Event|2|||
125332534|NCT04292899|450849107|FG000|Overall Study|Investigator's Discretion|0|||
125332535|NCT04292899|450849108|FG001|Overall Study|Investigator's Discretion|0|||
125332536|NCT04292899|450849109|FG002|Overall Study|Investigator's Discretion|0|||
125332537|NCT04292899|450849110|FG003|Overall Study|Investigator's Discretion|3|||
125332538|NCT04292899|450849107|FG000|Overall Study|Non-compliance With Study Drug|0|||
125332539|NCT04292899|450849108|FG001|Overall Study|Non-compliance With Study Drug|0|||
125332540|NCT04292899|450849109|FG002|Overall Study|Non-compliance With Study Drug|0|||
125332541|NCT04292899|450849110|FG003|Overall Study|Non-compliance With Study Drug|1|||
125332542|NCT04292899|450849107|FG000|Overall Study|Protocol Violation|0|||
125332543|NCT04292899|450849108|FG001|Overall Study|Protocol Violation|0|||
125332544|NCT04292899|450849109|FG002|Overall Study|Protocol Violation|0|||
125332545|NCT04292899|450849110|FG003|Overall Study|Protocol Violation|1|||
125332546|NCT03695367|450849111|FG000|Overall Study|Missed the Day 28 visit.|1|||
125332547|NCT03695367|450849112|FG001|Overall Study|Missed the Day 28 visit.|0|||
125332548|NCT03695367|450849111|FG000|Overall Study|Lost to Follow-up|0|||
125332549|NCT03695367|450849112|FG001|Overall Study|Lost to Follow-up|1|||
125332550|NCT03695367|450849111|FG000|Overall Study|Withdrawal by Subject|0|||
125332551|NCT03695367|450849112|FG001|Overall Study|Withdrawal by Subject|1|||
125332552|NCT03695367|450849111|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
125332553|NCT03695367|450849112|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
125332554|NCT01209325|450849116|FG000|Overall Study|Lost to Follow-up|24|||
125332555|NCT01209325|450849116|FG000|Overall Study|Adverse Event|1|||
125332556|NCT01209325|450849116|FG000|Overall Study|Relocated|3|||
125332557|NCT01209325|450849116|FG000|Overall Study|Refusal after starting therapy|8|||
125332558|NCT01209325|450849116|FG000|Overall Study|Protocol Violation|4|||
125332559|NCT01209325|450849116|FG000|Overall Study|Refusal prior to therapy|1|||
125332560|NCT01209325|450849116|FG000|Overall Study|Incarceration|2|||
125332561|NCT00396253|450849117|FG000|Overall Study|Protocol Violation|1|||
125332562|NCT00396253|450849117|FG000|Overall Study|Withdrawal by Subject|7|||
125332563|NCT00396253|450849117|FG000|Overall Study|Death|3|||
125332564|NCT00396253|450849117|FG000|Overall Study|Physician Decision|1|||
125332565|NCT00396253|450849117|FG000|Overall Study|Change in eligibility status|1|||
125332566|NCT05340478|450849119|FG000|Overall Study|Scheduling Issues|10|||
125332567|NCT05340478|450849120|FG001|Overall Study|Scheduling Issues|4|||
125332568|NCT05340478|450849119|FG000|Overall Study|Neither member of dyad started treatment|2|||
125332569|NCT05340478|450849120|FG001|Overall Study|Neither member of dyad started treatment|2|||
125332570|NCT05340478|450849119|FG000|Overall Study|Withdrawn from study|2|||
125332571|NCT05340478|450849120|FG001|Overall Study|Withdrawn from study|2|||
125332572|NCT05340478|450849119|FG000|Overall Study|Lost to Follow-up|1|||
125332573|NCT05340478|450849120|FG001|Overall Study|Lost to Follow-up|4|||
125332574|NCT00092443|450849123|FG000|Overall Study|Adverse Event|9|||
125332575|NCT00092443|450849124|FG001|Overall Study|Adverse Event|13|||
125332576|NCT00092443|450849123|FG000|Overall Study|Lost to Follow-up|7|||
125332577|NCT00092443|450849124|FG001|Overall Study|Lost to Follow-up|3|||
125332578|NCT00092443|450849123|FG000|Overall Study|Protocol Violation|11|||
125332579|NCT00092443|450849124|FG001|Overall Study|Protocol Violation|9|||
125002658|NCT04178967|449639154|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125002659|NCT04178967|449639155|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125002660|NCT04178967|449639156|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125002661|NCT04178967|449639157|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125002662|NCT04178967|449639158|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125002663|NCT04178967|449639159|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125002664|NCT04178967|449639160|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125002665|NCT04178967|449639150|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
125002666|NCT04178967|449639151|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
125002667|NCT04178967|449639152|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
125002668|NCT04178967|449639153|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
125002669|NCT04178967|449639154|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
125002670|NCT04178967|449639155|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
125002671|NCT04178967|449639156|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
125002672|NCT04178967|449639157|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
125002673|NCT04178967|449639158|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
125002674|NCT04178967|449639159|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
125002675|NCT04178967|449639160|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
125002676|NCT04178967|449639150|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125002677|NCT04178967|449639151|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125089879|NCT00545740|449947040|FG000|Overall Study|Sponsor decision|0|||
125332580|NCT00092443|450849123|FG000|Overall Study|Withdrawal by Subject|9|||
125332581|NCT00092443|450849124|FG001|Overall Study|Withdrawal by Subject|11|||
125332582|NCT00092443|450849123|FG000|Overall Study|Moved|5|||
125332583|NCT00092443|450849124|FG001|Overall Study|Moved|5|||
125332584|NCT00092443|450849123|FG000|Overall Study|Other|17|||
125002678|NCT04178967|449639152|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125002679|NCT04178967|449639153|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125002680|NCT04178967|449639154|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
125002681|NCT04178967|449639155|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
125002682|NCT04178967|449639156|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125002683|NCT04178967|449639157|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
125002684|NCT04178967|449639158|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125002685|NCT04178967|449639159|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125002686|NCT04178967|449639160|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125002687|NCT04178967|449639150|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
125002688|NCT04178967|449639151|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
125002689|NCT04178967|449639152|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
125002690|NCT04178967|449639153|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
125002691|NCT04178967|449639154|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
125002692|NCT04178967|449639155|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
125002693|NCT04178967|449639156|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
125002694|NCT04178967|449639157|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
125002695|NCT04178967|449639158|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
125002696|NCT04178967|449639159|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
125332585|NCT00092443|450849124|FG001|Overall Study|Other|13|||
125332586|NCT03207763|450850505|FG000|Overall Study|Lost to Follow-up|1|||
125332587|NCT03207763|450850506|FG001|Overall Study|Lost to Follow-up|0|||
125332588|NCT02605122|450850507|FG000|Overall Study|Withdrawal by Subject|4|||
125332589|NCT02605122|450850508|FG001|Overall Study|Withdrawal by Subject|1|||
125332590|NCT02605122|450850507|FG000|Overall Study|Lost to Follow-up|1|||
125332591|NCT02605122|450850508|FG001|Overall Study|Lost to Follow-up|1|||
125332592|NCT00807001|450850510|FG000|Overall Study|Non-compliance|0|||
125332593|NCT00807001|450850511|FG001|Overall Study|Non-compliance|1|||
125332594|NCT00807001|450850512|FG002|Overall Study|Non-compliance|0|||
125332595|NCT00807001|450850513|FG003|Overall Study|Non-compliance|0|||
125332596|NCT00807001|450850514|FG004|Overall Study|Non-compliance|0|||
125332597|NCT00854113|450850515|FG000|Overall Study|Adverse Event|0|||
125332598|NCT00854113|450850516|FG001|Overall Study|Adverse Event|0|||
125332599|NCT00854113|450850517|FG002|Overall Study|Adverse Event|0|||
125332600|NCT00854113|450850518|FG003|Overall Study|Adverse Event|0|||
125332601|NCT00854113|450850519|FG004|Overall Study|Adverse Event|0|||
125332602|NCT00854113|450850520|FG005|Overall Study|Adverse Event|0|||
125332603|NCT00854113|450850521|FG006|Overall Study|Adverse Event|0|||
125332604|NCT00854113|450850522|FG007|Overall Study|Adverse Event|2|||
125332605|NCT00854113|450850523|FG008|Overall Study|Adverse Event|0|||
125332606|NCT00854113|450850524|FG009|Overall Study|Adverse Event|0|||
125332607|NCT00854113|450850525|FG010|Overall Study|Adverse Event|0|||
125332608|NCT00854113|450850515|FG000|Overall Study|Withdrawal by Subject|0|||
125332609|NCT00854113|450850516|FG001|Overall Study|Withdrawal by Subject|0|||
125332610|NCT00854113|450850517|FG002|Overall Study|Withdrawal by Subject|0|||
125332611|NCT00854113|450850518|FG003|Overall Study|Withdrawal by Subject|0|||
125332612|NCT00854113|450850519|FG004|Overall Study|Withdrawal by Subject|0|||
125332613|NCT00854113|450850520|FG005|Overall Study|Withdrawal by Subject|0|||
125332614|NCT00854113|450850521|FG006|Overall Study|Withdrawal by Subject|0|||
125332615|NCT00854113|450850522|FG007|Overall Study|Withdrawal by Subject|1|||
125332616|NCT00854113|450850523|FG008|Overall Study|Withdrawal by Subject|1|||
125332617|NCT00854113|450850524|FG009|Overall Study|Withdrawal by Subject|0|||
125332618|NCT00854113|450850525|FG010|Overall Study|Withdrawal by Subject|0|||
125332619|NCT02273596|450850529|FG000|24-Week Treatment Period|Adverse Event|3|||
125332620|NCT02273596|450850529|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
125332621|NCT02273596|450850529|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
125332622|NCT02273596|450850529|FG000|24-Week Treatment Period|Physician Decision|1|||
125332623|NCT02273596|450850529|FG000|24-Week Treatment Period|Protocol Deviation|1|||
125332624|NCT02273596|450850529|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
125332625|NCT02273596|450850529|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
125332626|NCT02273596|450850529|FG000|Extension Period|Lost to Follow-up|1|||
125332627|NCT02273596|450850529|FG000|Extension Period|Protocol Deviation|1|||
125332628|NCT02604160|450850530|FG000|Overall Study|Protocol Violation|0|||
125332629|NCT02604160|450850531|FG001|Overall Study|Protocol Violation|1|||
125332630|NCT02604160|450850530|FG000|Overall Study|Physician Decision|0|||
125332631|NCT02604160|450850531|FG001|Overall Study|Physician Decision|1|||
125332632|NCT01596062|450850532|FG000|Overall Study|Adverse Event|1|||
125332633|NCT01596062|450850533|FG001|Overall Study|Adverse Event|0|||
125332634|NCT01596062|450850534|FG002|Overall Study|Adverse Event|2|||
125332635|NCT01596062|450850532|FG000|Overall Study|Lack of Efficacy|0|||
125332636|NCT01596062|450850533|FG001|Overall Study|Lack of Efficacy|0|||
125332637|NCT01596062|450850534|FG002|Overall Study|Lack of Efficacy|1|||
125332638|NCT02139592|450850535|FG000|Overall Study|Case Report Forms Uncollected|8|||
125332639|NCT03180840|450850536|FG000|Overall Study|Withdrawal by Subject|1|||
125332640|NCT01413204|450850546|FG000|Overall Study|Adverse Event|1|||
125332641|NCT01413204|450850547|FG001|Overall Study|Adverse Event|2|||
125332642|NCT01413204|450850548|FG002|Overall Study|Adverse Event|2|||
125332643|NCT01413204|450850546|FG000|Overall Study|Physician Decision|3|||
125332644|NCT01413204|450850547|FG001|Overall Study|Physician Decision|0|||
125332645|NCT01413204|450850548|FG002|Overall Study|Physician Decision|2|||
125332646|NCT01413204|450850546|FG000|Overall Study|Withdrawal by Subject|1|||
125332647|NCT01413204|450850547|FG001|Overall Study|Withdrawal by Subject|4|||
125332648|NCT01413204|450850548|FG002|Overall Study|Withdrawal by Subject|4|||
125332649|NCT01413204|450850546|FG000|Overall Study|Clearly not eligible for the study|0|||
125332650|NCT01413204|450850547|FG001|Overall Study|Clearly not eligible for the study|0|||
125332651|NCT01413204|450850548|FG002|Overall Study|Clearly not eligible for the study|1|||
125332652|NCT01413204|450850546|FG000|Overall Study|Fasting plasma glucose level increased|1|||
125332653|NCT01413204|450850547|FG001|Overall Study|Fasting plasma glucose level increased|0|||
125332654|NCT01413204|450850548|FG002|Overall Study|Fasting plasma glucose level increased|10|||
125332655|NCT00123422|450850549|FG000|Overall Study|Physician Decision|2|||
125332656|NCT00123422|450850550|FG001|Overall Study|Physician Decision|2|||
125332657|NCT00123422|450850551|FG002|Overall Study|Physician Decision|6|||
125332658|NCT00123422|450850549|FG000|Overall Study|Withdrawal by Subject|1|||
125332659|NCT00123422|450850550|FG001|Overall Study|Withdrawal by Subject|2|||
125332660|NCT00123422|450850551|FG002|Overall Study|Withdrawal by Subject|2|||
125332661|NCT00123422|450850549|FG000|Overall Study|Lost to Follow-up|1|||
125332662|NCT00123422|450850550|FG001|Overall Study|Lost to Follow-up|2|||
125332663|NCT00123422|450850551|FG002|Overall Study|Lost to Follow-up|2|||
125332664|NCT04555616|450850552|FG000|Overall Study|Death|1|||
125332665|NCT04555616|450850553|FG001|Overall Study|Death|0|||
125332666|NCT04555616|450850554|FG002|Overall Study|Death|1|||
125332667|NCT04555616|450850552|FG000|Overall Study|Withdrawal by Subject|2|||
125332668|NCT04555616|450850553|FG001|Overall Study|Withdrawal by Subject|1|||
125332669|NCT04555616|450850554|FG002|Overall Study|Withdrawal by Subject|0|||
125332670|NCT04816669|450850557|FG000|Part 1|Adverse Event|1|||
125332671|NCT04816669|450850558|FG001|Part 1|Adverse Event|1|||
125332672|NCT04816669|450850559|FG002|Part 1|Adverse Event|0|||
125332673|NCT04816669|450850560|FG003|Part 1|Adverse Event|0|||
125332674|NCT04816669|450850557|FG000|Part 1|Lost to Follow-up|2|||
125332675|NCT04816669|450850558|FG001|Part 1|Lost to Follow-up|2|||
125332676|NCT04816669|450850559|FG002|Part 1|Lost to Follow-up|0|||
125332677|NCT04816669|450850560|FG003|Part 1|Lost to Follow-up|0|||
125332678|NCT04816669|450850557|FG000|Part 1|Protocol Violation|0|||
125332679|NCT04816669|450850558|FG001|Part 1|Protocol Violation|1|||
125332680|NCT04816669|450850559|FG002|Part 1|Protocol Violation|0|||
125332681|NCT04816669|450850560|FG003|Part 1|Protocol Violation|0|||
125332682|NCT04816669|450850557|FG000|Part 1|Withdrawal by Subject|1|||
125332683|NCT04816669|450850558|FG001|Part 1|Withdrawal by Subject|2|||
125332684|NCT04816669|450850559|FG002|Part 1|Withdrawal by Subject|0|||
125332685|NCT04816669|450850560|FG003|Part 1|Withdrawal by Subject|0|||
125332686|NCT04816669|450850557|FG000|Part 2|Other|0|||
125332687|NCT04816669|450850558|FG001|Part 2|Other|0|||
125332688|NCT04816669|450850559|FG002|Part 2|Other|1|||
125332689|NCT04816669|450850560|FG003|Part 2|Other|0|||
125332690|NCT04816669|450850557|FG000|Part 2|Withdrawal by Subject|0|||
125332691|NCT04816669|450850558|FG001|Part 2|Withdrawal by Subject|0|||
125332692|NCT04816669|450850559|FG002|Part 2|Withdrawal by Subject|0|||
125332693|NCT04816669|450850560|FG003|Part 2|Withdrawal by Subject|1|||
125332694|NCT04816669|450850557|FG000|Part 2|Lost to Follow-up|0|||
125332695|NCT04816669|450850558|FG001|Part 2|Lost to Follow-up|0|||
125332696|NCT04816669|450850559|FG002|Part 2|Lost to Follow-up|1|||
125332697|NCT04816669|450850560|FG003|Part 2|Lost to Follow-up|0|||
125332698|NCT01229267|450850561|FG000|Overall Study|Adverse Event|4|||
125002697|NCT04178967|449639160|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
125002698|NCT04178967|449639150|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125002699|NCT04178967|449639151|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125002700|NCT04178967|449639152|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125002701|NCT04178967|449639153|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
125002702|NCT04178967|449639154|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125332699|NCT01229267|450850562|FG001|Overall Study|Adverse Event|6|||
125332700|NCT01229267|450850563|FG002|Overall Study|Adverse Event|3|||
125332701|NCT01229267|450850564|FG003|Overall Study|Adverse Event|2|||
125332702|NCT01229267|450850565|FG004|Overall Study|Adverse Event|10|||
125332703|NCT01229267|450850561|FG000|Overall Study|Death|40|||
125332704|NCT01229267|450850562|FG001|Overall Study|Death|37|||
125332705|NCT01229267|450850563|FG002|Overall Study|Death|35|||
125332706|NCT01229267|450850564|FG003|Overall Study|Death|13|||
125332707|NCT01229267|450850565|FG004|Overall Study|Death|103|||
125332708|NCT01229267|450850561|FG000|Overall Study|Withdrawal by Subject|23|||
125332709|NCT01229267|450850562|FG001|Overall Study|Withdrawal by Subject|22|||
125332710|NCT01229267|450850563|FG002|Overall Study|Withdrawal by Subject|32|||
125332711|NCT01229267|450850564|FG003|Overall Study|Withdrawal by Subject|14|||
125332712|NCT01229267|450850565|FG004|Overall Study|Withdrawal by Subject|59|||
125332713|NCT01229267|450850561|FG000|Overall Study|Protocol Violation|0|||
125332714|NCT01229267|450850562|FG001|Overall Study|Protocol Violation|1|||
125332715|NCT01229267|450850563|FG002|Overall Study|Protocol Violation|0|||
125332716|NCT01229267|450850564|FG003|Overall Study|Protocol Violation|0|||
125332717|NCT01229267|450850565|FG004|Overall Study|Protocol Violation|0|||
125332718|NCT01229267|450850561|FG000|Overall Study|Progressive disease|0|||
125332719|NCT01229267|450850562|FG001|Overall Study|Progressive disease|0|||
125332720|NCT01229267|450850563|FG002|Overall Study|Progressive disease|0|||
125332721|NCT01229267|450850564|FG003|Overall Study|Progressive disease|0|||
125332722|NCT01229267|450850565|FG004|Overall Study|Progressive disease|1|||
125332723|NCT01229267|450850561|FG000|Overall Study|Physician Decision|8|||
125332724|NCT01229267|450850562|FG001|Overall Study|Physician Decision|11|||
125332725|NCT01229267|450850563|FG002|Overall Study|Physician Decision|8|||
125332726|NCT01229267|450850564|FG003|Overall Study|Physician Decision|3|||
125332727|NCT01229267|450850565|FG004|Overall Study|Physician Decision|25|||
125332728|NCT01229267|450850561|FG000|Overall Study|Lost to Follow-up|6|||
125332729|NCT01229267|450850562|FG001|Overall Study|Lost to Follow-up|5|||
125332730|NCT01229267|450850563|FG002|Overall Study|Lost to Follow-up|8|||
125332731|NCT01229267|450850564|FG003|Overall Study|Lost to Follow-up|3|||
125332732|NCT01229267|450850565|FG004|Overall Study|Lost to Follow-up|22|||
125332733|NCT01358721|450850568|FG000|Overall Study|Withdrawal by Subject|0|||
125332734|NCT01358721|450850569|FG001|Overall Study|Withdrawal by Subject|0|||
125332735|NCT01358721|450850570|FG002|Overall Study|Withdrawal by Subject|0|||
125332736|NCT01358721|450850571|FG003|Overall Study|Withdrawal by Subject|1|||
125332737|NCT01358721|450850568|FG000|Overall Study|Death|0|||
125332738|NCT01358721|450850569|FG001|Overall Study|Death|2|||
125332739|NCT01358721|450850570|FG002|Overall Study|Death|0|||
125332740|NCT01358721|450850571|FG003|Overall Study|Death|0|||
125332741|NCT01358721|450850568|FG000|Overall Study|Study Drug Toxicity|1|||
125332742|NCT01358721|450850569|FG001|Overall Study|Study Drug Toxicity|3|||
125332743|NCT01358721|450850570|FG002|Overall Study|Study Drug Toxicity|4|||
125332744|NCT01358721|450850571|FG003|Overall Study|Study Drug Toxicity|5|||
125332745|NCT01358721|450850568|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
125332746|NCT01358721|450850569|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
125332747|NCT01358721|450850570|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
125332748|NCT01358721|450850571|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
125332749|NCT01358721|450850568|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
125332750|NCT01358721|450850569|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
125332751|NCT01358721|450850570|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
125332752|NCT01358721|450850571|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
125332753|NCT01358721|450850568|FG000|Overall Study|Adverse Event related to study drug|1|||
125332754|NCT01358721|450850569|FG001|Overall Study|Adverse Event related to study drug|0|||
125332755|NCT01358721|450850570|FG002|Overall Study|Adverse Event related to study drug|0|||
125332756|NCT01358721|450850571|FG003|Overall Study|Adverse Event related to study drug|1|||
125332757|NCT01358721|450850568|FG000|Overall Study|Disease Progression|19|||
125332758|NCT01358721|450850569|FG001|Overall Study|Disease Progression|15|||
125332759|NCT01358721|450850570|FG002|Overall Study|Disease Progression|17|||
125332760|NCT01358721|450850571|FG003|Overall Study|Disease Progression|15|||
125332761|NCT01358721|450850568|FG000|Overall Study|Out of State/Unmet Criteria|0|||
125332762|NCT01358721|450850569|FG001|Overall Study|Out of State/Unmet Criteria|0|||
125332763|NCT01358721|450850570|FG002|Overall Study|Out of State/Unmet Criteria|1|||
125332764|NCT01358721|450850571|FG003|Overall Study|Out of State/Unmet Criteria|0|||
125332765|NCT01908803|450850572|FG000|Overall Study|Adverse Event|1|||
125332766|NCT01908803|450850573|FG001|Overall Study|Adverse Event|0|||
125332767|NCT01908803|450850572|FG000|Overall Study|Physician Decision|0|||
125332768|NCT01908803|450850573|FG001|Overall Study|Physician Decision|1|||
125332769|NCT01908803|450850572|FG000|Overall Study|Withdrawal by Subject|1|||
125332770|NCT01908803|450850573|FG001|Overall Study|Withdrawal by Subject|0|||
125332771|NCT01908803|450850572|FG000|Overall Study|Randomization Error|1|||
125332772|NCT01908803|450850573|FG001|Overall Study|Randomization Error|0|||
125332773|NCT01908803|450850572|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
125332774|NCT01908803|450850573|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
125332775|NCT00867815|450850574|FG000|Overall Study|Lost to Follow-up|1|||
125332776|NCT01864603|450850575|FG000|Stage 2|DSMB design modification|86056|||
125332777|NCT01864603|450850576|FG001|Stage 2|DSMB design modification|92558|||
125332778|NCT02446899|450850577|FG000|Overall Study|Adverse Event|4|||
125332779|NCT02446899|450850578|FG001|Overall Study|Adverse Event|7|||
125332780|NCT02446899|450850577|FG000|Overall Study|Condition Under Investigation Worsened|1|||
125332781|NCT02446899|450850578|FG001|Overall Study|Condition Under Investigation Worsened|4|||
125332782|NCT02446899|450850577|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
125332783|NCT02446899|450850578|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
125332784|NCT02446899|450850577|FG000|Overall Study|Lack of Efficacy|2|||
125332785|NCT02446899|450850578|FG001|Overall Study|Lack of Efficacy|8|||
125332786|NCT02446899|450850577|FG000|Overall Study|Lost to Follow-up|1|||
125332787|NCT02446899|450850578|FG001|Overall Study|Lost to Follow-up|3|||
125332788|NCT02446899|450850577|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
125332789|NCT02446899|450850578|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
125332790|NCT02446899|450850577|FG000|Overall Study|Withdrawal by Subject|11|||
125332791|NCT02446899|450850578|FG001|Overall Study|Withdrawal by Subject|19|||
125332792|NCT02446899|450850577|FG000|Overall Study|Miscellaneous|5|||
125332793|NCT02446899|450850578|FG001|Overall Study|Miscellaneous|4|||
125332794|NCT02446899|450850577|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
125332795|NCT02446899|450850578|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
125332796|NCT04050202|450850579|FG000|Overall Study|Lost to Follow-up|2|||
125332797|NCT00001213|450850580|FG000|Overall Study|Death|18|||
125332798|NCT01554241|450850582|FG000|Overall Study|Death|3|||
125332799|NCT01554241|450850583|FG001|Overall Study|Death|1|||
125332800|NCT01554241|450850584|FG002|Overall Study|Death|1|||
125002703|NCT04178967|449639155|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
125002704|NCT04178967|449639156|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
125002705|NCT04178967|449639157|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
125002706|NCT04178967|449639158|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125002707|NCT04178967|449639159|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125002708|NCT04178967|449639160|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125332801|NCT01554241|450850585|FG003|Overall Study|Death|0|||
125332802|NCT01554241|450850582|FG000|Overall Study|protocol specified renal stone|0|||
125332803|NCT01554241|450850583|FG001|Overall Study|protocol specified renal stone|0|||
125332804|NCT01554241|450850584|FG002|Overall Study|protocol specified renal stone|0|||
125332805|NCT01554241|450850585|FG003|Overall Study|protocol specified renal stone|1|||
125332806|NCT01554241|450850582|FG000|Overall Study|protocol specified change in eGFR|0|||
125332807|NCT01554241|450850583|FG001|Overall Study|protocol specified change in eGFR|0|||
125332808|NCT01554241|450850584|FG002|Overall Study|protocol specified change in eGFR|1|||
125332809|NCT01554241|450850585|FG003|Overall Study|protocol specified change in eGFR|0|||
125332810|NCT01554241|450850582|FG000|Overall Study|Withdrawal by Subject|0|||
125332811|NCT01554241|450850583|FG001|Overall Study|Withdrawal by Subject|0|||
125332812|NCT01554241|450850584|FG002|Overall Study|Withdrawal by Subject|2|||
125332813|NCT01554241|450850585|FG003|Overall Study|Withdrawal by Subject|0|||
125332814|NCT02974543|450850590|FG000|Overall Study|Withdrawal by Subject|1|||
125332815|NCT02974543|450850591|FG001|Overall Study|Withdrawal by Subject|0|||
125332816|NCT00742235|450850592|FG000|Overall Study|Lost to Follow-up|0|||
125332817|NCT00742235|450850593|FG001|Overall Study|Lost to Follow-up|31|||
125332818|NCT01237899|450850594|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
125332819|NCT01237899|450850595|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
125332820|NCT01237899|450850596|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
125332821|NCT01237899|450850597|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
125332822|NCT01237899|450850598|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
125332823|NCT01237899|450850599|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
125332824|NCT01237899|450850600|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
125332825|NCT01237899|450850601|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
125332826|NCT01237899|450850602|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
125002709|NCT04178967|449639150|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
125002710|NCT04178967|449639151|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
125002711|NCT04178967|449639152|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
125002712|NCT04178967|449639153|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
125002713|NCT04178967|449639154|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
125002714|NCT04178967|449639155|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
125002715|NCT04178967|449639156|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
125002716|NCT04178967|449639157|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
125002717|NCT04178967|449639158|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
125002718|NCT04178967|449639159|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
125002719|NCT04178967|449639160|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
125002720|NCT04178967|449639150|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125002721|NCT04178967|449639151|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125002722|NCT04178967|449639152|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125002723|NCT04178967|449639153|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125002724|NCT04178967|449639154|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125002725|NCT04178967|449639155|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125002726|NCT04178967|449639156|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125002727|NCT04178967|449639157|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125002728|NCT04178967|449639158|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
125002729|NCT04178967|449639159|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
125002730|NCT04178967|449639160|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
125002731|NCT04178967|449639150|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125002732|NCT04178967|449639151|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125002733|NCT04178967|449639152|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125332827|NCT01237899|450850603|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
125332828|NCT01237899|450850604|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
125089880|NCT00545740|449947041|FG001|Overall Study|Sponsor decision|1|||
125332829|NCT02141438|450850606|FG000|Overall Study|Death|1308|||
125332830|NCT02141438|450850606|FG000|Overall Study|Lost to Follow-up|84|||
125332831|NCT02141438|450850606|FG000|Overall Study|Withdrawal by Subject|52|||
125332832|NCT02141438|450850606|FG000|Overall Study|Physician Decision|1|||
125332833|NCT02141438|450850606|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
125332834|NCT05661409|450850607|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
125332835|NCT05661409|450850608|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
125332836|NCT05661409|450850609|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
125332837|NCT05661409|450850610|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
125332838|NCT05661409|450850611|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
125332839|NCT05661409|450850612|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
125332840|NCT05661409|450850607|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
125332841|NCT05661409|450850608|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
125332842|NCT05661409|450850609|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
125332843|NCT05661409|450850610|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
125332844|NCT05661409|450850611|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
125332845|NCT05661409|450850612|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
125332846|NCT05661409|450850607|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
125332847|NCT05661409|450850608|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
125332848|NCT05661409|450850609|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
125332849|NCT05661409|450850610|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
125332850|NCT05661409|450850611|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
125332851|NCT05661409|450850612|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
125332852|NCT05661409|450850607|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
125332853|NCT05661409|450850608|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
125332854|NCT05661409|450850609|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
125332855|NCT05661409|450850610|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
125332856|NCT05661409|450850611|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
125332857|NCT05661409|450850612|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
125332858|NCT05661409|450850607|FG000|Overall Study|Miscommu-nication about administration|0|||
125332859|NCT05661409|450850608|FG001|Overall Study|Miscommu-nication about administration|0|||
125332860|NCT05661409|450850609|FG002|Overall Study|Miscommu-nication about administration|0|||
125332861|NCT05661409|450850610|FG003|Overall Study|Miscommu-nication about administration|0|||
125332862|NCT05661409|450850611|FG004|Overall Study|Miscommu-nication about administration|0|||
125332863|NCT05661409|450850612|FG005|Overall Study|Miscommu-nication about administration|1|||
125332864|NCT05782179|450850613|FG000|Overall Study|Adverse Event|0|||
125332865|NCT05782179|450850614|FG001|Overall Study|Adverse Event|0|||
125332866|NCT05782179|450850615|FG002|Overall Study|Adverse Event|2|||
125332867|NCT05782179|450850616|FG003|Overall Study|Adverse Event|0|||
125332868|NCT05782179|450850617|FG004|Overall Study|Adverse Event|0|||
125332869|NCT05782179|450850618|FG005|Overall Study|Adverse Event|0|||
125332870|NCT03675321|450850619|FG000|Overall Study|Lack of Efficacy|2|||
125332871|NCT03675321|450850620|FG001|Overall Study|Lack of Efficacy|2|||
125332872|NCT03675321|450850619|FG000|Overall Study|Withdrawal by Subject|1|||
125332873|NCT03675321|450850620|FG001|Overall Study|Withdrawal by Subject|3|||
125332874|NCT02999672|450850626|FG000|Overall Study|Death|0|||
125332875|NCT02999672|450850627|FG001|Overall Study|Death|1|||
125332876|NCT02999672|450850626|FG000|Overall Study|Study Terminated by Sponsor|0|||
125332877|NCT02999672|450850627|FG001|Overall Study|Study Terminated by Sponsor|1|||
125332878|NCT02999672|450850626|FG000|Overall Study|Progressive Disease|9|||
125332879|NCT02999672|450850627|FG001|Overall Study|Progressive Disease|5|||
125002734|NCT04178967|449639153|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125002735|NCT04178967|449639154|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125002736|NCT04178967|449639155|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125002737|NCT04178967|449639156|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125002738|NCT04178967|449639157|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125002739|NCT04178967|449639158|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125002740|NCT04178967|449639159|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
125002741|NCT04178967|449639160|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125002742|NCT04178967|449639150|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125002743|NCT04178967|449639151|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125002744|NCT04178967|449639152|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125002745|NCT04178967|449639153|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125332880|NCT02999672|450850626|FG000|Overall Study|Adverse Event|4|||
125332881|NCT02999672|450850627|FG001|Overall Study|Adverse Event|0|||
125332882|NCT03565497|450850628|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
125332883|NCT03565497|450850629|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
125332884|NCT03565497|450850630|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
125332885|NCT03565497|450850628|FG000|Overall Study|Lost to Follow-up|1|||
125332886|NCT03565497|450850629|FG001|Overall Study|Lost to Follow-up|1|||
125332887|NCT03565497|450850630|FG002|Overall Study|Lost to Follow-up|2|||
125332888|NCT03565497|450850628|FG000|Overall Study|Withdrawal by Subject|1|||
125332889|NCT03565497|450850629|FG001|Overall Study|Withdrawal by Subject|1|||
125332890|NCT03565497|450850630|FG002|Overall Study|Withdrawal by Subject|1|||
125332891|NCT02194985|450850633|FG000|Overall Study|Adverse Event|1|||
125332892|NCT02194985|450850633|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
125332893|NCT02194985|450850633|FG000|Overall Study|Physician Decision|4|||
125332894|NCT02194985|450850633|FG000|Overall Study|Lost to Follow-up|1|||
125332895|NCT02194985|450850633|FG000|Overall Study|Withdrawal by Subject|2|||
125332896|NCT02561832|450850634|FG000|Overall Study|Withdrawal by Subject|1|||
125332897|NCT02561832|450850635|FG001|Overall Study|Withdrawal by Subject|1|||
125332898|NCT02561832|450850634|FG000|Overall Study|Adverse Event|3|||
125002746|NCT04178967|449639154|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125002747|NCT04178967|449639155|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125002748|NCT04178967|449639156|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125002749|NCT04178967|449639157|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125002750|NCT04178967|449639158|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
125002751|NCT04178967|449639159|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
125002752|NCT04178967|449639160|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
125002753|NCT04178967|449639150|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
125002754|NCT04178967|449639151|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
125002755|NCT04178967|449639152|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
125002756|NCT04178967|449639153|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
125089881|NCT00545740|449947042|FG002|Overall Study|Sponsor decision|0|||
125002757|NCT04178967|449639154|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
125332899|NCT02561832|450850635|FG001|Overall Study|Adverse Event|0|||
125332900|NCT02561832|450850634|FG000|Overall Study|Disease progression|3|||
125332901|NCT02561832|450850635|FG001|Overall Study|Disease progression|3|||
125332902|NCT03048578|450850637|FG000|Overall Study|Withdrawal by Subject|5|||
125332903|NCT03048578|450850638|FG001|Overall Study|Withdrawal by Subject|6|||
125332904|NCT03048578|450850637|FG000|Overall Study|Lost to Follow-up|22|||
125332905|NCT03048578|450850638|FG001|Overall Study|Lost to Follow-up|10|||
125332906|NCT03048578|450850637|FG000|Overall Study|Adverse Event|1|||
125332907|NCT03048578|450850638|FG001|Overall Study|Adverse Event|2|||
125332908|NCT03048578|450850637|FG000|Overall Study|Terminated|3|||
125332909|NCT03048578|450850638|FG001|Overall Study|Terminated|2|||
125332910|NCT00996333|450850643|FG000|Overall Study|Screen failure|1|||
125332911|NCT00996333|450850643|FG000|Overall Study|Withdrawal by Subject|1|||
125332912|NCT00996333|450850643|FG000|Overall Study|Death|4|||
125332913|NCT00996333|450850643|FG000|Overall Study|Adverse Event|1|||
125332914|NCT00996333|450850643|FG000|Overall Study|Physician Decision|1|||
125332915|NCT00996333|450850643|FG000|Overall Study|Other|5|||
125332916|NCT01301027|450850645|FG000|Overall Study|Physician Decision|2|||
125332917|NCT01301027|450850646|FG001|Overall Study|Physician Decision|0|||
125332918|NCT01301027|450850645|FG000|Overall Study|Withdrawal by Subject|2|||
125332919|NCT01301027|450850646|FG001|Overall Study|Withdrawal by Subject|3|||
125332920|NCT01301027|450850645|FG000|Overall Study|Adverse Event|0|||
125332921|NCT01301027|450850646|FG001|Overall Study|Adverse Event|2|||
125332922|NCT01301027|450850645|FG000|Overall Study|Fracture|1|||
125332923|NCT01301027|450850646|FG001|Overall Study|Fracture|3|||
125332924|NCT01301027|450850645|FG000|Overall Study|Transplant|0|||
125332925|NCT01301027|450850646|FG001|Overall Study|Transplant|2|||
125332926|NCT01301027|450850645|FG000|Overall Study|Volume Overload|3|||
125332927|NCT01301027|450850646|FG001|Overall Study|Volume Overload|0|||
125332928|NCT00074490|450850647|FG000|Overall Study|Progressive malignancy|0|||
125332929|NCT00074490|450850648|FG001|Overall Study|Progressive malignancy|7|||
125332930|NCT00074490|450850649|FG002|Overall Study|Progressive malignancy|0|||
125332931|NCT00074490|450850650|FG003|Overall Study|Progressive malignancy|0|||
125332932|NCT00074490|450850651|FG004|Overall Study|Progressive malignancy|3|||
125332933|NCT00074490|450850652|FG005|Overall Study|Progressive malignancy|0|||
125002758|NCT04178967|449639155|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
125002759|NCT04178967|449639156|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
125002760|NCT04178967|449639157|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
125332934|NCT02722499|450850653|FG000|Overall Study|Lost to Follow-up|2|||
125332935|NCT02722499|450850654|FG001|Overall Study|Lost to Follow-up|0|||
125332936|NCT02722499|450850655|FG002|Overall Study|Lost to Follow-up|1|||
125332937|NCT03566485|450850657|FG000|Overall Study|Disease progression|5|||
125332938|NCT03566485|450850658|FG001|Overall Study|Disease progression|4|||
125332939|NCT03566485|450850657|FG000|Overall Study|Clinical progression|0|||
125332940|NCT03566485|450850658|FG001|Overall Study|Clinical progression|1|||
125332941|NCT03566485|450850657|FG000|Overall Study|Toxicity|0|||
125332942|NCT03566485|450850658|FG001|Overall Study|Toxicity|2|||
125332943|NCT04999852|450850659|FG000|Overall Study|Withdrawal by Subject|11|||
125332944|NCT04999852|450850660|FG001|Overall Study|Withdrawal by Subject|1|||
125332945|NCT04999852|450850659|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
125332946|NCT04999852|450850660|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
125002761|NCT04178967|449639158|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
125002762|NCT04178967|449639159|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
125002763|NCT04178967|449639160|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
125332947|NCT02506244|450850661|FG000|Overall Study|Did not undergo active monitoring|458|||
125332948|NCT02506244|450850662|FG001|Overall Study|Did not undergo active monitoring|459|||
125332949|NCT02506244|450850663|FG002|Overall Study|Did not undergo active monitoring|0|||
125332950|NCT02840461|450850672|FG000|Overall Study|Adverse Event|1|||
125332951|NCT02840461|450850673|FG001|Overall Study|Adverse Event|5|||
125332952|NCT02840461|450850674|FG002|Overall Study|Adverse Event|3|||
125332953|NCT02840461|450850672|FG000|Overall Study|Lost to Follow-up|10|||
125332954|NCT02840461|450850673|FG001|Overall Study|Lost to Follow-up|7|||
125332955|NCT02840461|450850674|FG002|Overall Study|Lost to Follow-up|6|||
125332956|NCT02840461|450850672|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
125332957|NCT02840461|450850673|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
125332958|NCT02840461|450850674|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
125332959|NCT02840461|450850672|FG000|Overall Study|Protocol Violation|2|||
125332960|NCT02840461|450850673|FG001|Overall Study|Protocol Violation|3|||
125332961|NCT02840461|450850674|FG002|Overall Study|Protocol Violation|1|||
125332962|NCT02840461|450850672|FG000|Overall Study|Withdrawal by Subject|10|||
125332963|NCT02840461|450850673|FG001|Overall Study|Withdrawal by Subject|6|||
125332964|NCT02840461|450850674|FG002|Overall Study|Withdrawal by Subject|2|||
125332965|NCT02840461|450850672|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
125332966|NCT02840461|450850673|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
125332967|NCT02840461|450850674|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
125332968|NCT01737502|450850675|FG000|Phase I|Disease progression|2|||
125332969|NCT01737502|450850676|FG001|Phase I|Disease progression|3|||
125332970|NCT01737502|450850675|FG000|Phase I|Complicating disease|1|||
125332971|NCT01737502|450850676|FG001|Phase I|Complicating disease|0|||
125332972|NCT01737502|450850675|FG000|Phase II|Adverse Event|0|||
125332973|NCT01737502|450850676|FG001|Phase II|Adverse Event|3|||
125332974|NCT01737502|450850675|FG000|Phase II|Disease progression|0|||
125332975|NCT01737502|450850676|FG001|Phase II|Disease progression|18|||
125332976|NCT01737502|450850675|FG000|Phase II|Death|0|||
125332977|NCT01737502|450850676|FG001|Phase II|Death|1|||
125332978|NCT01737502|450850675|FG000|Phase II|Transition to hospice care|0|||
125332979|NCT01737502|450850676|FG001|Phase II|Transition to hospice care|1|||
125332980|NCT04672655|450850680|FG000|Overall Study|Lost to Follow-up|12|||
125332981|NCT04672655|450850681|FG001|Overall Study|Lost to Follow-up|17|||
125332982|NCT04672655|450850680|FG000|Overall Study|Withdrawal by Subject|1|||
125332983|NCT04672655|450850681|FG001|Overall Study|Withdrawal by Subject|0|||
125332984|NCT04672655|450850680|FG000|Overall Study|Withdrawal by Study|1|||
125332985|NCT04672655|450850681|FG001|Overall Study|Withdrawal by Study|0|||
125332986|NCT00494676|450850682|FG000|Allocation|Withdrawal by Subject|2|||
125332987|NCT00494676|450850683|FG001|Allocation|Withdrawal by Subject|4|||
125332988|NCT00494676|450850682|FG000|First Intervention|Withdrawal by Subject|1|||
125332989|NCT00494676|450850683|FG001|First Intervention|Withdrawal by Subject|3|||
125332990|NCT00494676|450850682|FG000|Second Intervention|Withdrawal by Subject|1|||
125332991|NCT00494676|450850683|FG001|Second Intervention|Withdrawal by Subject|1|||
125332992|NCT01932437|450852101|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
125332993|NCT01932437|450852102|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
125332994|NCT01932437|450852103|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
125332995|NCT01932437|450852104|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
125332996|NCT01932437|450852105|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
125332997|NCT01932437|450852106|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
125332998|NCT04638660|450852116|FG000|Overall Study|Withdrawal by Subject|2|||
125332999|NCT04638660|450852117|FG001|Overall Study|Withdrawal by Subject|0|||
125333000|NCT04638660|450852116|FG000|Overall Study|Lost to Follow-up|1|||
125333001|NCT04638660|450852117|FG001|Overall Study|Lost to Follow-up|0|||
125333002|NCT04939415|450852118|FG000|Overall Study|Withdrawal by Subject|1|||
125333003|NCT04939415|450852119|FG001|Overall Study|Withdrawal by Subject|3|||
125333004|NCT04939415|450852118|FG000|Overall Study|Lost to Follow-up|0|||
125333005|NCT04939415|450852119|FG001|Overall Study|Lost to Follow-up|2|||
125333006|NCT03399552|450852121|FG000|Overall Study|No evidence of disease|1|||
125333007|NCT03399552|450852121|FG000|Overall Study|Unevaluable|1|||
125333008|NCT01931566|450852122|FG000|Overall Study|Randomized But Not Treated|6|||
125333009|NCT01931566|450852123|FG001|Overall Study|Randomized But Not Treated|9|||
125333010|NCT01931566|450852124|FG002|Overall Study|Randomized But Not Treated|14|||
125333011|NCT01931566|450852122|FG000|Overall Study|Adverse Event|37|||
125333012|NCT01931566|450852123|FG001|Overall Study|Adverse Event|167|||
125002764|NCT04178967|449639150|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
125333013|NCT01931566|450852124|FG002|Overall Study|Adverse Event|132|||
125333014|NCT01931566|450852122|FG000|Overall Study|Major Protocol Deviation|5|||
125333015|NCT01931566|450852123|FG001|Overall Study|Major Protocol Deviation|14|||
125333016|NCT01931566|450852124|FG002|Overall Study|Major Protocol Deviation|21|||
125333017|NCT01931566|450852122|FG000|Overall Study|Lost to Follow-up|3|||
125333018|NCT01931566|450852123|FG001|Overall Study|Lost to Follow-up|26|||
125333019|NCT01931566|450852124|FG002|Overall Study|Lost to Follow-up|23|||
125333020|NCT01931566|450852122|FG000|Overall Study|Voluntary Withdrawal|78|||
125333021|NCT01931566|450852123|FG001|Overall Study|Voluntary Withdrawal|245|||
125333022|NCT01931566|450852124|FG002|Overall Study|Voluntary Withdrawal|225|||
125333023|NCT01931566|450852122|FG000|Overall Study|Study Termination|289|||
125333024|NCT01931566|450852123|FG001|Overall Study|Study Termination|968|||
125333025|NCT01931566|450852124|FG002|Overall Study|Study Termination|1037|||
125333026|NCT01931566|450852122|FG000|Overall Study|Reason Not Specified|11|||
125333027|NCT01931566|450852123|FG001|Overall Study|Reason Not Specified|47|||
125333028|NCT01931566|450852124|FG002|Overall Study|Reason Not Specified|53|||
125333029|NCT01931566|450852122|FG000|Overall Study|Missing|0|||
125333030|NCT01931566|450852123|FG001|Overall Study|Missing|0|||
125333031|NCT01931566|450852124|FG002|Overall Study|Missing|1|||
125333032|NCT00611026|450852128|FG000|Randomized to Double-blind Treatment|Not treated|2|||
125333033|NCT00611026|450852129|FG001|Randomized to Double-blind Treatment|Not treated|1|||
125333034|NCT00611026|450852130|FG002|Randomized to Double-blind Treatment|Not treated|3|||
125333035|NCT00611026|450852128|FG000|Double-blind Treatment Period|Death|1|||
125333036|NCT00611026|450852129|FG001|Double-blind Treatment Period|Death|0|||
125333037|NCT00611026|450852130|FG002|Double-blind Treatment Period|Death|0|||
125333038|NCT00611026|450852128|FG000|Double-blind Treatment Period|Adverse Event|9|||
125333039|NCT00611026|450852129|FG001|Double-blind Treatment Period|Adverse Event|28|||
125333040|NCT00611026|450852130|FG002|Double-blind Treatment Period|Adverse Event|46|||
125333041|NCT00611026|450852128|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
125333042|NCT00611026|450852129|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
125333043|NCT00611026|450852130|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
125333044|NCT00611026|450852128|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
125333045|NCT00611026|450852129|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
125333046|NCT00611026|450852130|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
125333047|NCT00611026|450852128|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
125333048|NCT00611026|450852129|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
125333049|NCT00611026|450852130|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
125333050|NCT00611026|450852128|FG000|Double-blind Treatment Period|Other|13|||
125333051|NCT00611026|450852129|FG001|Double-blind Treatment Period|Other|20|||
125333052|NCT00611026|450852130|FG002|Double-blind Treatment Period|Other|18|||
125333053|NCT05019521|450852131|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
125333054|NCT05019521|450852132|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
125333055|NCT05019521|450852133|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
125333056|NCT05019521|450852134|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
125333057|NCT05019521|450852135|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
125333058|NCT05019521|450852136|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
125333059|NCT05019521|450852137|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
125333060|NCT05019521|450852131|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
125333061|NCT05019521|450852132|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
125333062|NCT05019521|450852133|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
125333063|NCT05019521|450852134|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
125333064|NCT05019521|450852135|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
125333065|NCT05019521|450852136|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
125333066|NCT05019521|450852137|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
125333067|NCT05019521|450852131|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
125333068|NCT05019521|450852132|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
125333069|NCT05019521|450852133|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
125333070|NCT05019521|450852134|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
125333071|NCT05019521|450852135|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
125333072|NCT05019521|450852136|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
125333073|NCT05019521|450852137|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
125333074|NCT05019521|450852131|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
125333075|NCT05019521|450852132|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
125333076|NCT05019521|450852133|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
125333077|NCT05019521|450852134|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
125333078|NCT05019521|450852135|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
125333079|NCT05019521|450852136|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
125333080|NCT05019521|450852137|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
125333081|NCT05019521|450852131|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
125333082|NCT05019521|450852132|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
125002765|NCT04178967|449639151|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
125002766|NCT04178967|449639152|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
125002767|NCT04178967|449639153|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
125333083|NCT05019521|450852133|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
125333084|NCT05019521|450852134|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
125333085|NCT05019521|450852135|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
125333086|NCT05019521|450852136|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
125333087|NCT05019521|450852137|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
125333088|NCT05019521|450852131|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
125333089|NCT05019521|450852132|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333090|NCT05019521|450852133|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333091|NCT05019521|450852134|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333092|NCT05019521|450852135|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333093|NCT05019521|450852136|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333094|NCT05019521|450852137|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333095|NCT05019521|450852131|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
125333096|NCT05019521|450852132|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
125333097|NCT05019521|450852133|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
125333098|NCT05019521|450852134|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
125333099|NCT05019521|450852135|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
125333100|NCT05019521|450852136|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
125333101|NCT05019521|450852137|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
125333102|NCT05019521|450852131|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
125333103|NCT05019521|450852132|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
125333104|NCT05019521|450852133|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
125333105|NCT05019521|450852134|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
125333106|NCT05019521|450852135|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
125333107|NCT05019521|450852136|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
125333108|NCT05019521|450852137|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
125333109|NCT05019521|450852131|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
125333110|NCT05019521|450852132|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
125333111|NCT05019521|450852133|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
125333112|NCT05019521|450852134|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
125333113|NCT05019521|450852135|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
125333114|NCT05019521|450852136|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
125333115|NCT05019521|450852137|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
125333116|NCT05019521|450852131|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
125333117|NCT05019521|450852132|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
125333118|NCT05019521|450852133|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
125333119|NCT05019521|450852134|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
125333120|NCT05019521|450852135|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
125333121|NCT05019521|450852136|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
125333122|NCT05019521|450852137|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
125333123|NCT05019521|450852131|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
125333124|NCT05019521|450852132|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
125333125|NCT05019521|450852133|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
125333126|NCT05019521|450852134|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
125333127|NCT05019521|450852135|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
125333128|NCT05019521|450852136|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
125333129|NCT05019521|450852137|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
125333130|NCT05019521|450852131|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
125333131|NCT05019521|450852132|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
125333132|NCT05019521|450852133|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
125333133|NCT05019521|450852134|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
125333134|NCT05019521|450852135|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
125333135|NCT05019521|450852136|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
125333136|NCT05019521|450852137|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
125333137|NCT05019521|450852131|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333138|NCT05019521|450852132|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333139|NCT05019521|450852133|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333140|NCT05019521|450852134|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333141|NCT05019521|450852135|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333142|NCT05019521|450852136|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
125333143|NCT05019521|450852137|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125002768|NCT04178967|449639154|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
125333144|NCT05019521|450852131|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
125333145|NCT05019521|450852132|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
125333146|NCT05019521|450852133|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
125333147|NCT05019521|450852134|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
125333148|NCT05019521|450852135|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
125333149|NCT05019521|450852136|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
125333150|NCT05019521|450852137|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
125333151|NCT05019521|450852131|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
125333152|NCT05019521|450852132|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
125333153|NCT05019521|450852133|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
125333154|NCT05019521|450852134|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
125333155|NCT05019521|450852135|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
125333156|NCT05019521|450852136|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
125333157|NCT05019521|450852137|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
125333158|NCT00760617|450852138|FG000|Overall Study|Adverse Event|5|||
125333159|NCT00760617|450852139|FG001|Overall Study|Adverse Event|2|||
125333160|NCT00760617|450852140|FG002|Overall Study|Adverse Event|0|||
125333161|NCT00760617|450852138|FG000|Overall Study|Lost to Follow-up|0|||
125333162|NCT00760617|450852139|FG001|Overall Study|Lost to Follow-up|0|||
125333163|NCT00760617|450852140|FG002|Overall Study|Lost to Follow-up|5|||
125333164|NCT04625101|450852141|FG000|Overall Study|Withdrawal by Subject|0|||
125333165|NCT04625101|450852142|FG001|Overall Study|Withdrawal by Subject|1|||
125333166|NCT04625101|450852141|FG000|Overall Study|Protocol Deviation|1|||
125333167|NCT04625101|450852142|FG001|Overall Study|Protocol Deviation|0|||
125333168|NCT02533453|450852150|FG000|Overall Study|Adverse Event|6|||
125333169|NCT02533453|450852150|FG000|Overall Study|Protocol Violation|1|||
125333170|NCT02533453|450852150|FG000|Overall Study|Withdrawal by Subject|2|||
125333171|NCT02039843|450852160|FG000|Randomization and Observation Period|Adverse Event|2|||
125333172|NCT02039843|450852161|FG001|Randomization and Observation Period|Adverse Event|0|||
125333173|NCT02039843|450852160|FG000|Randomization and Observation Period|Death|1|||
125333174|NCT02039843|450852161|FG001|Randomization and Observation Period|Death|0|||
125333175|NCT02039843|450852160|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
125333176|NCT02039843|450852161|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
125333177|NCT02039843|450852160|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
125333178|NCT02039843|450852161|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
125333179|NCT02039843|450852160|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
125333180|NCT02039843|450852161|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
125333181|NCT02039843|450852160|FG000|Pairing With a Study Dog|Death|1|||
125333182|NCT02039843|450852161|FG001|Pairing With a Study Dog|Death|0|||
125333183|NCT02039843|450852160|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
125333184|NCT02039843|450852161|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
125333185|NCT02039843|450852160|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
125333186|NCT02039843|450852161|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
125333187|NCT02039843|450852160|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
125333188|NCT02039843|450852161|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
125333189|NCT00806819|450852166|FG000|Overall Study|progressive disease (modified RECIST )|217|||
125333190|NCT00806819|450852167|FG001|Overall Study|progressive disease (modified RECIST )|216|||
125333191|NCT00806819|450852166|FG000|Overall Study|Worsening or AE of underlying disease|18|||
125333192|NCT00806819|450852167|FG001|Overall Study|Worsening or AE of underlying disease|25|||
125333193|NCT00806819|450852166|FG000|Overall Study|Other AE|38|||
125333194|NCT00806819|450852167|FG001|Overall Study|Other AE|40|||
125333195|NCT00806819|450852166|FG000|Overall Study|Protocol Violation|9|||
125333196|NCT00806819|450852167|FG001|Overall Study|Protocol Violation|4|||
125333197|NCT00806819|450852166|FG000|Overall Study|Lost to Follow-up|1|||
125333198|NCT00806819|450852167|FG001|Overall Study|Lost to Follow-up|0|||
125333199|NCT00806819|450852166|FG000|Overall Study|Withdrawal by Subject|32|||
125333200|NCT00806819|450852167|FG001|Overall Study|Withdrawal by Subject|29|||
125333201|NCT00806819|450852166|FG000|Overall Study|Not treated|6|||
125333202|NCT00806819|450852167|FG001|Overall Study|Not treated|3|||
125333203|NCT00806819|450852166|FG000|Overall Study|Reasons other than stated above|25|||
125333204|NCT00806819|450852167|FG001|Overall Study|Reasons other than stated above|41|||
125333205|NCT02752165|450852173|FG000|Overall Study|Withdrawal by Subject|6|||
125333206|NCT02752165|450852174|FG001|Overall Study|Withdrawal by Subject|6|||
125333207|NCT02752165|450852173|FG000|Overall Study|Protocol Violation|6|||
125333208|NCT02752165|450852174|FG001|Overall Study|Protocol Violation|5|||
125333209|NCT02752165|450852173|FG000|Overall Study|Lost to Follow-up|33|||
125002769|NCT04178967|449639155|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
125002770|NCT04178967|449639156|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
125089882|NCT00545740|449947043|FG003|Overall Study|Sponsor decision|0|||
125333210|NCT02752165|450852174|FG001|Overall Study|Lost to Follow-up|38|||
125333211|NCT01704599|450852175|FG000|Overall Study|Adverse Event|1|||
125333212|NCT03843541|450852183|FG000|Overall Study|Adverse Event|4|||
125333213|NCT03843541|450852184|FG001|Overall Study|Adverse Event|2|||
125333214|NCT03843541|450852185|FG002|Overall Study|Adverse Event|3|||
125333215|NCT03843541|450852183|FG000|Overall Study|Death|1|||
125333216|NCT03843541|450852184|FG001|Overall Study|Death|0|||
125333217|NCT03843541|450852185|FG002|Overall Study|Death|0|||
125333218|NCT03843541|450852183|FG000|Overall Study|Lack of adherence to study medication|0|||
125333219|NCT03843541|450852184|FG001|Overall Study|Lack of adherence to study medication|0|||
125333220|NCT03843541|450852185|FG002|Overall Study|Lack of adherence to study medication|1|||
125333221|NCT03843541|450852183|FG000|Overall Study|Physician Decision|1|||
125333222|NCT03843541|450852184|FG001|Overall Study|Physician Decision|2|||
125333223|NCT03843541|450852185|FG002|Overall Study|Physician Decision|2|||
125333224|NCT03843541|450852183|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
125333225|NCT03843541|450852184|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
125002771|NCT04178967|449639157|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
125002772|NCT04178967|449639158|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
125002773|NCT04178967|449639159|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
125002774|NCT04178967|449639160|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
125333226|NCT03843541|450852185|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
125333227|NCT03843541|450852183|FG000|Overall Study|Withdrawal by Subject|6|||
125333228|NCT03843541|450852184|FG001|Overall Study|Withdrawal by Subject|9|||
125333229|NCT03843541|450852185|FG002|Overall Study|Withdrawal by Subject|7|||
125333230|NCT03843541|450852183|FG000|Overall Study|Administration of rescue mucolytic|0|||
125333231|NCT03843541|450852184|FG001|Overall Study|Administration of rescue mucolytic|0|||
125333232|NCT03843541|450852185|FG002|Overall Study|Administration of rescue mucolytic|1|||
125333233|NCT03843541|450852183|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
125333234|NCT03843541|450852184|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
125333235|NCT03843541|450852185|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
125333236|NCT05767749|450852194|FG000|Overall Study|Withdrawal by Subject|0|||
125333237|NCT05767749|450852195|FG001|Overall Study|Withdrawal by Subject|0|||
125333238|NCT05767749|450852196|FG002|Overall Study|Withdrawal by Subject|2|||
125333239|NCT05767749|450852197|FG003|Overall Study|Withdrawal by Subject|2|||
125333240|NCT05767749|450852198|FG004|Overall Study|Withdrawal by Subject|2|||
125333241|NCT05767749|450852199|FG005|Overall Study|Withdrawal by Subject|2|||
125333242|NCT01077050|450854007|FG000|Overall Study|Subjects signed ICF could not be located|1|||
125333243|NCT01077050|450854007|FG000|Overall Study|Screen failure|8|||
125333244|NCT03894813|450854008|FG000|Overall Study|Adverse Event|1|||
125333245|NCT03894813|450854009|FG001|Overall Study|Adverse Event|1|||
125333246|NCT03894813|450854008|FG000|Overall Study|Lack of Efficacy|3|||
125333247|NCT03894813|450854009|FG001|Overall Study|Lack of Efficacy|3|||
125333248|NCT03894813|450854008|FG000|Overall Study|Lost to Follow-up|1|||
125333249|NCT03894813|450854009|FG001|Overall Study|Lost to Follow-up|0|||
125333250|NCT03894813|450854008|FG000|Overall Study|Pregnancy|2|||
125333251|NCT03894813|450854009|FG001|Overall Study|Pregnancy|1|||
125333252|NCT03894813|450854008|FG000|Overall Study|Protocol Violation|3|||
125333253|NCT03894813|450854009|FG001|Overall Study|Protocol Violation|7|||
125333254|NCT03894813|450854008|FG000|Overall Study|Withdrawal by Subject|1|||
125333255|NCT03894813|450854009|FG001|Overall Study|Withdrawal by Subject|3|||
125333256|NCT03894813|450854008|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
125333257|NCT03894813|450854009|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
125333258|NCT03083873|450854011|FG000|Overall Study|Death|6|||
125333259|NCT03083873|450854012|FG001|Overall Study|Death|15|||
125333260|NCT03083873|450854013|FG002|Overall Study|Death|13|||
125333261|NCT03083873|450854014|FG003|Overall Study|Death|9|||
125333262|NCT03083873|450854015|FG004|Overall Study|Death|0|||
125333263|NCT03083873|450854011|FG000|Overall Study|Sponsor Terminated Study|0|||
125002775|NCT00628251|449639161|FG000|Randomised Part|Withdrawal by Subject|0|||
125002776|NCT00628251|449639162|FG001|Randomised Part|Withdrawal by Subject|0|||
125002777|NCT00628251|449639163|FG002|Randomised Part|Withdrawal by Subject|1|||
125002778|NCT00628251|449639161|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
125002779|NCT00628251|449639162|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
125002780|NCT00628251|449639163|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
125002781|NCT00628251|449639161|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
125002782|NCT00628251|449639162|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
125333264|NCT03083873|450854012|FG001|Overall Study|Sponsor Terminated Study|1|||
125333265|NCT03083873|450854013|FG002|Overall Study|Sponsor Terminated Study|2|||
125333266|NCT03083873|450854014|FG003|Overall Study|Sponsor Terminated Study|3|||
125333267|NCT03083873|450854015|FG004|Overall Study|Sponsor Terminated Study|0|||
125333268|NCT03083873|450854011|FG000|Overall Study|Lost to Follow-up|0|||
125333269|NCT03083873|450854012|FG001|Overall Study|Lost to Follow-up|1|||
125333270|NCT03083873|450854013|FG002|Overall Study|Lost to Follow-up|1|||
125333271|NCT03083873|450854014|FG003|Overall Study|Lost to Follow-up|0|||
125333272|NCT03083873|450854015|FG004|Overall Study|Lost to Follow-up|0|||
125333273|NCT03083873|450854011|FG000|Overall Study|Withdrawal by Subject|2|||
125333274|NCT03083873|450854012|FG001|Overall Study|Withdrawal by Subject|0|||
125333275|NCT03083873|450854013|FG002|Overall Study|Withdrawal by Subject|0|||
125333276|NCT03083873|450854014|FG003|Overall Study|Withdrawal by Subject|0|||
125333277|NCT03083873|450854015|FG004|Overall Study|Withdrawal by Subject|0|||
125333278|NCT03083873|450854011|FG000|Overall Study|Did Not Receive TIL|2|||
125333279|NCT03083873|450854012|FG001|Overall Study|Did Not Receive TIL|5|||
125333280|NCT03083873|450854013|FG002|Overall Study|Did Not Receive TIL|3|||
125333281|NCT03083873|450854014|FG003|Overall Study|Did Not Receive TIL|1|||
125333282|NCT03083873|450854015|FG004|Overall Study|Did Not Receive TIL|0|||
125333283|NCT01677377|450854016|FG000|Overall Study|Protocol Violation|1|||
125333284|NCT01677377|450854017|FG001|Overall Study|Protocol Violation|0|||
125333285|NCT01677377|450854018|FG002|Overall Study|Protocol Violation|0|||
125333286|NCT01677377|450854016|FG000|Overall Study|Lost to Follow-up|0|||
125333287|NCT01677377|450854017|FG001|Overall Study|Lost to Follow-up|1|||
125333288|NCT01677377|450854018|FG002|Overall Study|Lost to Follow-up|1|||
125333289|NCT01677377|450854016|FG000|Overall Study|Withdrawal by Subject|0|||
125333290|NCT01677377|450854017|FG001|Overall Study|Withdrawal by Subject|0|||
125333291|NCT01677377|450854018|FG002|Overall Study|Withdrawal by Subject|3|||
125333292|NCT01677377|450854016|FG000|Overall Study|Lack of Efficacy|0|||
125333293|NCT01677377|450854017|FG001|Overall Study|Lack of Efficacy|0|||
125333294|NCT01677377|450854018|FG002|Overall Study|Lack of Efficacy|1|||
125333295|NCT01677377|450854016|FG000|Overall Study|Pregnancy|0|||
125333296|NCT01677377|450854017|FG001|Overall Study|Pregnancy|0|||
125333297|NCT01677377|450854018|FG002|Overall Study|Pregnancy|1|||
125333298|NCT02656693|450854032|FG000|Overall Study|Pregnancy|1|||
125333299|NCT02656693|450854033|FG001|Overall Study|Pregnancy|1|||
125333300|NCT02656693|450854034|FG002|Overall Study|Pregnancy|1|||
125333301|NCT02656693|450854032|FG000|Overall Study|Bariatric surgery|0|||
125333302|NCT02656693|450854033|FG001|Overall Study|Bariatric surgery|1|||
125333303|NCT02656693|450854034|FG002|Overall Study|Bariatric surgery|2|||
125333304|NCT02269267|450854036|FG000|Overall Study|Death|5|||
125333305|NCT03773796|450854037|FG000|Overall Study|Adverse Event|1|||
125333306|NCT03773796|450854037|FG000|Overall Study|Withdrawal by Subject|1|||
125333307|NCT03773796|450854037|FG000|Overall Study|Lack of Efficacy|1|||
125333308|NCT03805659|450854039|FG000|Overall Study|Withdrawal by Subject|0|||
125333309|NCT03805659|450854040|FG001|Overall Study|Withdrawal by Subject|1|||
125333310|NCT00796419|450854041|FG000|Overall Study|Death|0|||
125333311|NCT00796419|450854042|FG001|Overall Study|Death|1|||
125333312|NCT01250145|450854043|FG000|Overall Study|Adverse Event|2|||
125333313|NCT01250145|450854044|FG001|Overall Study|Adverse Event|1|||
125333314|NCT01250145|450854043|FG000|Overall Study|Withdrawal by Subject|0|||
125333315|NCT01250145|450854044|FG001|Overall Study|Withdrawal by Subject|4|||
125333316|NCT01069900|450854046|FG000|Overall Study|Technical problems|0|||
125333317|NCT01069900|450854047|FG001|Overall Study|Technical problems|1|||
125333318|NCT01069900|450854046|FG000|Overall Study|Lost to Follow-up|7|||
125333319|NCT01069900|450854047|FG001|Overall Study|Lost to Follow-up|1|||
125333320|NCT01069900|450854046|FG000|Overall Study|Withdrawal by Subject|6|||
125333321|NCT01069900|450854047|FG001|Overall Study|Withdrawal by Subject|1|||
125333322|NCT01069900|450854046|FG000|Overall Study|Protocol Violation|4|||
125333323|NCT01069900|450854047|FG001|Overall Study|Protocol Violation|1|||
125333324|NCT01069900|450854046|FG000|Overall Study|Insufficient Therapeutic effect|1|||
125333325|NCT01069900|450854047|FG001|Overall Study|Insufficient Therapeutic effect|0|||
125333326|NCT02687191|450854049|FG000|Overall Study|Death|0|||
125333327|NCT02687191|450854050|FG001|Overall Study|Death|1|||
125333328|NCT02687191|450854051|FG002|Overall Study|Death|1|||
125333329|NCT02687191|450854052|FG003|Overall Study|Death|0|||
125333330|NCT02687191|450854053|FG004|Overall Study|Death|1|||
125333331|NCT02687191|450854054|FG005|Overall Study|Death|1|||
125333332|NCT02687191|450854049|FG000|Overall Study|Withdrawal by Subject|0|||
125333333|NCT02687191|450854050|FG001|Overall Study|Withdrawal by Subject|0|||
125002783|NCT00628251|449639163|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
125002784|NCT00628251|449639161|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
125002785|NCT00628251|449639162|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
125333334|NCT02687191|450854051|FG002|Overall Study|Withdrawal by Subject|0|||
125333335|NCT02687191|450854052|FG003|Overall Study|Withdrawal by Subject|1|||
125333336|NCT02687191|450854053|FG004|Overall Study|Withdrawal by Subject|0|||
125333337|NCT02687191|450854054|FG005|Overall Study|Withdrawal by Subject|0|||
125333338|NCT01788358|450854060|FG000|Overall Study|Other|11|||
125333339|NCT01788358|450854060|FG000|Overall Study|Logistical difficulties|1|||
125333340|NCT01788358|450854060|FG000|Overall Study|Lost to Follow-up|5|||
125333341|NCT01788358|450854060|FG000|Overall Study|Protocol Violation|3|||
125333342|NCT01788358|450854060|FG000|Overall Study|Withdrawal by Subject|26|||
125333343|NCT01788358|450854060|FG000|Overall Study|Lack of Efficacy|1|||
125333344|NCT01788358|450854060|FG000|Overall Study|Adverse Event|51|||
125333345|NCT01168219|450854061|FG000|Overall Study|off study before starting treatment|2|||
125333346|NCT01168219|450854061|FG000|Overall Study|withdrew before transplant|1|||
125333347|NCT01168219|450854061|FG000|Overall Study|ineligible due to CML|2|||
125333348|NCT02736890|450854064|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
125333349|NCT02736890|450854065|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
125333350|NCT02736890|450854064|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
125333351|NCT02736890|450854065|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
125333352|NCT02873702|450854066|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
125333353|NCT02873702|450854067|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
125333354|NCT02873702|450854068|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
125333355|NCT02873702|450854069|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
125333356|NCT02873702|450854066|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
125333357|NCT02873702|450854067|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
125333358|NCT02873702|450854068|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
125333359|NCT02873702|450854069|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
125333360|NCT02873702|450854066|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
125333361|NCT02873702|450854067|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
125333362|NCT02873702|450854068|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
125333363|NCT02873702|450854069|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
125333364|NCT02873702|450854066|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
125333365|NCT02873702|450854067|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
125333366|NCT02873702|450854068|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
125333367|NCT02873702|450854069|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
125333368|NCT02873702|450854066|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
125333369|NCT02873702|450854067|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
125333370|NCT02873702|450854068|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
125333371|NCT02873702|450854069|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
125333372|NCT01039376|450854072|FG000|Overall Study|Lost to Follow-up|5|||
125333373|NCT01039376|450854073|FG001|Overall Study|Lost to Follow-up|12|||
125333374|NCT01039376|450854072|FG000|Overall Study|Physician Decision|15|||
125333375|NCT01039376|450854073|FG001|Overall Study|Physician Decision|10|||
125333376|NCT01039376|450854072|FG000|Overall Study|Withdrawal by Subject|20|||
125333377|NCT01039376|450854073|FG001|Overall Study|Withdrawal by Subject|32|||
125333378|NCT01039376|450854072|FG000|Overall Study|Study terminated by Sponsor|90|||
125333379|NCT01039376|450854073|FG001|Overall Study|Study terminated by Sponsor|72|||
125333380|NCT03252925|450854074|FG000|Overall Study|Withdrawal by Subject|1|||
125333381|NCT03252925|450854075|FG001|Overall Study|Withdrawal by Subject|0|||
125333382|NCT03252925|450854074|FG000|Overall Study|Protocol Violation|6|||
125333383|NCT03252925|450854075|FG001|Overall Study|Protocol Violation|0|||
125333384|NCT03252925|450854074|FG000|Overall Study|Adverse Event|1|||
125333385|NCT03252925|450854075|FG001|Overall Study|Adverse Event|0|||
125333386|NCT03252925|450854074|FG000|Overall Study|Lost to Follow-up|6|||
125333387|NCT03252925|450854075|FG001|Overall Study|Lost to Follow-up|6|||
125333388|NCT03830892|450854083|FG000|Overall Study|Physician Decision|2|||
125333389|NCT03830892|450854084|FG001|Overall Study|Physician Decision|3|||
125333390|NCT03830892|450854083|FG000|Overall Study|Study terminated due to COVID|4|||
125333391|NCT03830892|450854084|FG001|Overall Study|Study terminated due to COVID|0|||
125333392|NCT03830892|450854083|FG000|Overall Study|Protocol Violation|0|||
125333393|NCT03830892|450854084|FG001|Overall Study|Protocol Violation|1|||
125333394|NCT03830892|450854083|FG000|Overall Study|Withdrawal by Subject|0|||
125333395|NCT03830892|450854084|FG001|Overall Study|Withdrawal by Subject|2|||
125333396|NCT01499277|450854085|FG000|Overall Study|Adverse Event|3|||
125333397|NCT01499277|450854086|FG001|Overall Study|Adverse Event|6|||
125333398|NCT01499277|450854085|FG000|Overall Study|Death|3|||
125333399|NCT01499277|450854086|FG001|Overall Study|Death|2|||
125333400|NCT01499277|450854085|FG000|Overall Study|Lost to Follow-up|15|||
125333401|NCT01499277|450854086|FG001|Overall Study|Lost to Follow-up|8|||
125333402|NCT01499277|450854085|FG000|Overall Study|Protocol Violation|2|||
125333403|NCT01499277|450854086|FG001|Overall Study|Protocol Violation|3|||
125333404|NCT01499277|450854085|FG000|Overall Study|Withdrawal by Subject|16|||
125333405|NCT01499277|450854086|FG001|Overall Study|Withdrawal by Subject|6|||
125333406|NCT01499277|450854085|FG000|Overall Study|Lack of therapeutic response and other|8|||
125333407|NCT01499277|450854086|FG001|Overall Study|Lack of therapeutic response and other|7|||
125333408|NCT04661579|450854087|FG000|Overall Study|Lost to Follow-up|19|||
125333409|NCT04661579|450854088|FG001|Overall Study|Lost to Follow-up|10|||
125333410|NCT04661579|450854089|FG002|Overall Study|Lost to Follow-up|2|||
125002786|NCT00628251|449639163|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
125002787|NCT00628251|449639161|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
125002788|NCT00628251|449639162|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
125333411|NCT04661579|450854090|FG003|Overall Study|Lost to Follow-up|7|||
125002789|NCT00628251|449639163|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
125002790|NCT00628251|449639161|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
125333412|NCT04661579|450854091|FG004|Overall Study|Lost to Follow-up|11|||
125333413|NCT04661579|450854087|FG000|Overall Study|Physician Decision|2|||
125333414|NCT04661579|450854088|FG001|Overall Study|Physician Decision|0|||
125333415|NCT04661579|450854089|FG002|Overall Study|Physician Decision|0|||
125333416|NCT04661579|450854090|FG003|Overall Study|Physician Decision|1|||
125333417|NCT04661579|450854091|FG004|Overall Study|Physician Decision|0|||
125333418|NCT04661579|450854087|FG000|Overall Study|Withdrawal by Subject|1|||
125333419|NCT04661579|450854088|FG001|Overall Study|Withdrawal by Subject|4|||
125333420|NCT04661579|450854089|FG002|Overall Study|Withdrawal by Subject|0|||
125333421|NCT04661579|450854090|FG003|Overall Study|Withdrawal by Subject|2|||
125333422|NCT04661579|450854091|FG004|Overall Study|Withdrawal by Subject|0|||
125333423|NCT04661579|450854087|FG000|Overall Study|Death|1|||
125333424|NCT04661579|450854088|FG001|Overall Study|Death|0|||
125333425|NCT04661579|450854089|FG002|Overall Study|Death|0|||
125333426|NCT04661579|450854090|FG003|Overall Study|Death|0|||
125333427|NCT04661579|450854091|FG004|Overall Study|Death|0|||
125333428|NCT04661579|450854087|FG000|Overall Study|Other|1|||
125333429|NCT04661579|450854088|FG001|Overall Study|Other|2|||
125333430|NCT04661579|450854089|FG002|Overall Study|Other|1|||
125333431|NCT04661579|450854090|FG003|Overall Study|Other|1|||
125333432|NCT04661579|450854091|FG004|Overall Study|Other|1|||
125333433|NCT04661579|450854087|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
125333434|NCT04661579|450854088|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
125333435|NCT04661579|450854089|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
125333436|NCT04661579|450854090|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
125333437|NCT04661579|450854091|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
125333438|NCT04730271|450854093|FG000|Overall Study|Adverse Event|0|||
125333439|NCT04730271|450854094|FG001|Overall Study|Adverse Event|2|||
125333440|NCT04730271|450854093|FG000|Overall Study|Withdrawal by Subject|1|||
125333441|NCT04730271|450854094|FG001|Overall Study|Withdrawal by Subject|1|||
125333442|NCT04730271|450854093|FG000|Overall Study|Protocol Violation|7|||
125333443|NCT04730271|450854094|FG001|Overall Study|Protocol Violation|13|||
125333444|NCT04730271|450854093|FG000|Overall Study|Lost to Follow-up|3|||
125333445|NCT04730271|450854094|FG001|Overall Study|Lost to Follow-up|3|||
125333446|NCT04730271|450854093|FG000|Overall Study|Death|1|||
125333447|NCT04730271|450854094|FG001|Overall Study|Death|0|||
125333448|NCT02023697|450854099|FG000|Treatment Period|Radiological progression|13|||
125333449|NCT02023697|450854100|FG001|Treatment Period|Radiological progression|17|||
125002791|NCT00628251|449639162|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
125333450|NCT02023697|450854101|FG002|Treatment Period|Radiological progression|26|||
125333451|NCT02023697|450854099|FG000|Treatment Period|Never Treated|5|||
125333452|NCT02023697|450854100|FG001|Treatment Period|Never Treated|6|||
125333453|NCT02023697|450854101|FG002|Treatment Period|Never Treated|10|||
125333454|NCT02023697|450854099|FG000|Treatment Period|Adverse Event|13|||
125333455|NCT02023697|450854100|FG001|Treatment Period|Adverse Event|25|||
125333456|NCT02023697|450854101|FG002|Treatment Period|Adverse Event|23|||
125333457|NCT02023697|450854099|FG000|Treatment Period|Logistical difficulties|1|||
125333458|NCT02023697|450854100|FG001|Treatment Period|Logistical difficulties|1|||
125333459|NCT02023697|450854101|FG002|Treatment Period|Logistical difficulties|1|||
125333460|NCT02023697|450854099|FG000|Treatment Period|Clinical progression|10|||
125333461|NCT02023697|450854100|FG001|Treatment Period|Clinical progression|8|||
125333462|NCT02023697|450854101|FG002|Treatment Period|Clinical progression|28|||
125002792|NCT00628251|449639163|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
125002793|NCT00041067|449639164|FG000|Overall Study|Adverse Event|20|||
125002794|NCT00041067|449639164|FG000|Overall Study|Progression|19|||
125002795|NCT00041067|449639164|FG000|Overall Study|Patient refusal|12|||
125002796|NCT00041067|449639164|FG000|Overall Study|Other reasons|23|||
125002797|NCT00041067|449639164|FG000|Overall Study|Ineligible|2|||
125002798|NCT01968070|449639166|FG000|Period 1|Withdrawal by Subject|0|||
125002799|NCT01968070|449639167|FG001|Period 1|Withdrawal by Subject|1|||
125002800|NCT01968070|449639168|FG002|Period 1|Withdrawal by Subject|0|||
125002801|NCT01968070|449639169|FG003|Period 1|Withdrawal by Subject|0|||
125002802|NCT01968070|449639170|FG004|Period 1|Withdrawal by Subject|0|||
125002803|NCT01968070|449639171|FG005|Period 1|Withdrawal by Subject|0|||
125002804|NCT01968070|449639172|FG006|Period 1|Withdrawal by Subject|1|||
125002805|NCT01968070|449639173|FG007|Period 1|Withdrawal by Subject|0|||
125002806|NCT01968070|449639174|FG008|Period 1|Withdrawal by Subject|0|||
125002807|NCT01968070|449639175|FG009|Period 1|Withdrawal by Subject|0|||
125002808|NCT01968070|449639176|FG010|Period 1|Withdrawal by Subject|0|||
125333463|NCT02023697|450854099|FG000|Treatment Period|Withdrawal by Subject|4|||
125333464|NCT02023697|450854100|FG001|Treatment Period|Withdrawal by Subject|5|||
125333465|NCT02023697|450854101|FG002|Treatment Period|Withdrawal by Subject|13|||
125333466|NCT02023697|450854099|FG000|Treatment Period|Safety outcome reached|0|||
125333467|NCT02023697|450854100|FG001|Treatment Period|Safety outcome reached|1|||
125333468|NCT02023697|450854101|FG002|Treatment Period|Safety outcome reached|0|||
125333469|NCT02023697|450854099|FG000|Treatment Period|Physician Decision|0|||
125333470|NCT02023697|450854100|FG001|Treatment Period|Physician Decision|0|||
125333471|NCT02023697|450854101|FG002|Treatment Period|Physician Decision|1|||
125002809|NCT01968070|449639177|FG011|Period 1|Withdrawal by Subject|0|||
125002810|NCT01968070|449639178|FG012|Period 1|Withdrawal by Subject|0|||
125002811|NCT01968070|449639179|FG013|Period 1|Withdrawal by Subject|0|||
125002812|NCT01968070|449639180|FG014|Period 1|Withdrawal by Subject|0|||
125333472|NCT02023697|450854099|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
125333473|NCT02023697|450854100|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
125333474|NCT02023697|450854101|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
125333475|NCT02023697|450854099|FG000|Active Follow-up Period|Lost to Follow-up|1|||
125333476|NCT02023697|450854100|FG001|Active Follow-up Period|Lost to Follow-up|1|||
125333477|NCT02023697|450854101|FG002|Active Follow-up Period|Lost to Follow-up|1|||
125333478|NCT02023697|450854099|FG000|Active Follow-up Period|Deterioration of general condition|1|||
125333479|NCT02023697|450854100|FG001|Active Follow-up Period|Deterioration of general condition|1|||
125333480|NCT02023697|450854101|FG002|Active Follow-up Period|Deterioration of general condition|1|||
125333481|NCT02023697|450854099|FG000|Active Follow-up Period|Other unspecified|2|||
125333482|NCT02023697|450854100|FG001|Active Follow-up Period|Other unspecified|0|||
125333483|NCT02023697|450854101|FG002|Active Follow-up Period|Other unspecified|1|||
125333484|NCT02023697|450854099|FG000|Active Follow-up Period|Clinical progression|0|||
125002813|NCT01968070|449639181|FG015|Period 1|Withdrawal by Subject|1|||
125002814|NCT01968070|449639182|FG016|Period 1|Withdrawal by Subject|0|||
125002815|NCT01968070|449639183|FG017|Period 1|Withdrawal by Subject|0|||
125002816|NCT01968070|449639166|FG000|Period 1|Protocol Violation|0|||
125002817|NCT01968070|449639167|FG001|Period 1|Protocol Violation|0|||
125002818|NCT01968070|449639168|FG002|Period 1|Protocol Violation|0|||
125002819|NCT01968070|449639169|FG003|Period 1|Protocol Violation|1|||
125002820|NCT01968070|449639170|FG004|Period 1|Protocol Violation|1|||
125002821|NCT01968070|449639171|FG005|Period 1|Protocol Violation|0|||
125002822|NCT01968070|449639172|FG006|Period 1|Protocol Violation|0|||
125002823|NCT01968070|449639173|FG007|Period 1|Protocol Violation|0|||
125002824|NCT01968070|449639174|FG008|Period 1|Protocol Violation|0|||
125002825|NCT01968070|449639175|FG009|Period 1|Protocol Violation|0|||
125002826|NCT01968070|449639176|FG010|Period 1|Protocol Violation|0|||
125002827|NCT01968070|449639177|FG011|Period 1|Protocol Violation|0|||
125002828|NCT01968070|449639178|FG012|Period 1|Protocol Violation|0|||
125002829|NCT01968070|449639179|FG013|Period 1|Protocol Violation|0|||
125002830|NCT01968070|449639180|FG014|Period 1|Protocol Violation|0|||
125002831|NCT01968070|449639181|FG015|Period 1|Protocol Violation|0|||
125002832|NCT01968070|449639182|FG016|Period 1|Protocol Violation|0|||
125002833|NCT01968070|449639183|FG017|Period 1|Protocol Violation|0|||
125002834|NCT01968070|449639166|FG000|Period 1|Lost to Follow-up|0|||
125002835|NCT01968070|449639167|FG001|Period 1|Lost to Follow-up|0|||
125002836|NCT01968070|449639168|FG002|Period 1|Lost to Follow-up|0|||
125002837|NCT01968070|449639169|FG003|Period 1|Lost to Follow-up|1|||
125002838|NCT01968070|449639170|FG004|Period 1|Lost to Follow-up|0|||
125002839|NCT01968070|449639171|FG005|Period 1|Lost to Follow-up|0|||
125002840|NCT01968070|449639172|FG006|Period 1|Lost to Follow-up|0|||
125002841|NCT01968070|449639173|FG007|Period 1|Lost to Follow-up|0|||
125002842|NCT01968070|449639174|FG008|Period 1|Lost to Follow-up|0|||
125002843|NCT01968070|449639175|FG009|Period 1|Lost to Follow-up|0|||
125002844|NCT01968070|449639176|FG010|Period 1|Lost to Follow-up|0|||
125002845|NCT01968070|449639177|FG011|Period 1|Lost to Follow-up|0|||
125002846|NCT01968070|449639178|FG012|Period 1|Lost to Follow-up|0|||
125002847|NCT01968070|449639179|FG013|Period 1|Lost to Follow-up|0|||
125002848|NCT01968070|449639180|FG014|Period 1|Lost to Follow-up|0|||
125002849|NCT01968070|449639181|FG015|Period 1|Lost to Follow-up|0|||
125002850|NCT01968070|449639182|FG016|Period 1|Lost to Follow-up|0|||
125002851|NCT01968070|449639183|FG017|Period 1|Lost to Follow-up|0|||
125002852|NCT01968070|449639166|FG000|Period 1|Adverse Event|0|||
125002853|NCT01968070|449639167|FG001|Period 1|Adverse Event|0|||
125002854|NCT01968070|449639168|FG002|Period 1|Adverse Event|0|||
125002855|NCT01968070|449639169|FG003|Period 1|Adverse Event|0|||
125002856|NCT01968070|449639170|FG004|Period 1|Adverse Event|0|||
125002857|NCT01968070|449639171|FG005|Period 1|Adverse Event|0|||
125002858|NCT01968070|449639172|FG006|Period 1|Adverse Event|1|||
125002859|NCT01968070|449639173|FG007|Period 1|Adverse Event|0|||
125002860|NCT01968070|449639174|FG008|Period 1|Adverse Event|0|||
125002861|NCT01968070|449639175|FG009|Period 1|Adverse Event|0|||
125002862|NCT01968070|449639176|FG010|Period 1|Adverse Event|0|||
125002863|NCT01968070|449639177|FG011|Period 1|Adverse Event|0|||
125002864|NCT01968070|449639178|FG012|Period 1|Adverse Event|0|||
125002865|NCT01968070|449639179|FG013|Period 1|Adverse Event|0|||
125002866|NCT01968070|449639180|FG014|Period 1|Adverse Event|0|||
125002867|NCT01968070|449639181|FG015|Period 1|Adverse Event|0|||
125002868|NCT01968070|449639182|FG016|Period 1|Adverse Event|0|||
125002869|NCT01968070|449639183|FG017|Period 1|Adverse Event|0|||
125002870|NCT01968070|449639166|FG000|Period 1|Physician Decision|0|||
125002871|NCT01968070|449639167|FG001|Period 1|Physician Decision|0|||
125002872|NCT01968070|449639168|FG002|Period 1|Physician Decision|0|||
125002873|NCT01968070|449639169|FG003|Period 1|Physician Decision|0|||
125002874|NCT01968070|449639170|FG004|Period 1|Physician Decision|0|||
125002875|NCT01968070|449639171|FG005|Period 1|Physician Decision|0|||
125002876|NCT01968070|449639172|FG006|Period 1|Physician Decision|0|||
125002877|NCT01968070|449639173|FG007|Period 1|Physician Decision|0|||
125002878|NCT01968070|449639174|FG008|Period 1|Physician Decision|0|||
125002879|NCT01968070|449639175|FG009|Period 1|Physician Decision|0|||
125333485|NCT02023697|450854100|FG001|Active Follow-up Period|Clinical progression|2|||
125333486|NCT02023697|450854101|FG002|Active Follow-up Period|Clinical progression|1|||
125333487|NCT02023697|450854099|FG000|Active Follow-up Period|Radiological progression|0|||
125333488|NCT02023697|450854100|FG001|Active Follow-up Period|Radiological progression|0|||
125333489|NCT02023697|450854101|FG002|Active Follow-up Period|Radiological progression|1|||
125333490|NCT02023697|450854099|FG000|Active Follow-up Period|Death|83|||
125333491|NCT02023697|450854100|FG001|Active Follow-up Period|Death|82|||
125333492|NCT02023697|450854101|FG002|Active Follow-up Period|Death|87|||
125333493|NCT02023697|450854099|FG000|Long-term Follow-up Period|Death|9|||
125333494|NCT02023697|450854100|FG001|Long-term Follow-up Period|Death|6|||
125333495|NCT02023697|450854101|FG002|Long-term Follow-up Period|Death|4|||
125333496|NCT02023697|450854099|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
125333497|NCT02023697|450854100|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
125333498|NCT02023697|450854101|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
125333499|NCT02023697|450854099|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
125333500|NCT02023697|450854100|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
125333501|NCT02023697|450854101|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
125333502|NCT02023697|450854099|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
125333503|NCT02023697|450854100|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
125333504|NCT02023697|450854101|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
125002880|NCT01968070|449639176|FG010|Period 1|Physician Decision|0|||
125002881|NCT01968070|449639177|FG011|Period 1|Physician Decision|1|||
125002882|NCT01968070|449639178|FG012|Period 1|Physician Decision|0|||
125002883|NCT01968070|449639179|FG013|Period 1|Physician Decision|0|||
125002884|NCT01968070|449639180|FG014|Period 1|Physician Decision|0|||
125333505|NCT02023697|450854099|FG000|Long-term Follow-up Period|Technical problems|0|||
125333506|NCT02023697|450854100|FG001|Long-term Follow-up Period|Technical problems|0|||
125333507|NCT02023697|450854101|FG002|Long-term Follow-up Period|Technical problems|1|||
125333508|NCT02023697|450854099|FG000|Long-term Follow-up Period|Other unspecified|6|||
125333509|NCT02023697|450854100|FG001|Long-term Follow-up Period|Other unspecified|3|||
125333510|NCT02023697|450854101|FG002|Long-term Follow-up Period|Other unspecified|5|||
125333511|NCT00845897|450854102|FG000|Overall Study|Lost to Follow-up|1|||
125333512|NCT00845897|450854103|FG001|Overall Study|Lost to Follow-up|1|||
125333513|NCT00845897|450854104|FG002|Overall Study|Lost to Follow-up|0|||
125333514|NCT00845897|450854102|FG000|Overall Study|Withdrawal by Subject|0|||
125333515|NCT00845897|450854103|FG001|Overall Study|Withdrawal by Subject|3|||
125333516|NCT00845897|450854104|FG002|Overall Study|Withdrawal by Subject|2|||
125333517|NCT00845897|450854102|FG000|Overall Study|Ulcer did not heal|1|||
125333518|NCT00845897|450854103|FG001|Overall Study|Ulcer did not heal|0|||
125333519|NCT00845897|450854104|FG002|Overall Study|Ulcer did not heal|1|||
125333520|NCT00845897|450854102|FG000|Overall Study|Too ill to participate|0|||
125333521|NCT00845897|450854103|FG001|Overall Study|Too ill to participate|1|||
125333522|NCT00845897|450854104|FG002|Overall Study|Too ill to participate|0|||
125333523|NCT03904693|450854105|FG000|Overall Study|Death|0|||
125333524|NCT03904693|450854106|FG001|Overall Study|Death|0|||
125002885|NCT01968070|449639181|FG015|Period 1|Physician Decision|0|||
125002886|NCT01968070|449639182|FG016|Period 1|Physician Decision|0|||
125002887|NCT01968070|449639183|FG017|Period 1|Physician Decision|0|||
125333525|NCT03904693|450854107|FG002|Overall Study|Death|3|||
125333526|NCT03904693|450854105|FG000|Overall Study|Physician Decision|0|||
125002888|NCT01968070|449639166|FG000|Period 2|Withdrawal by Subject|0|||
125002889|NCT01968070|449639167|FG001|Period 2|Withdrawal by Subject|0|||
125002890|NCT01968070|449639168|FG002|Period 2|Withdrawal by Subject|0|||
125002891|NCT01968070|449639169|FG003|Period 2|Withdrawal by Subject|0|||
125002892|NCT01968070|449639170|FG004|Period 2|Withdrawal by Subject|1|||
125089883|NCT00545740|449947040|FG000|Overall Study|Lack of time|0|||
125089884|NCT00545740|449947041|FG001|Overall Study|Lack of time|1|||
125089885|NCT00545740|449947042|FG002|Overall Study|Lack of time|0|||
125089886|NCT00545740|449947043|FG003|Overall Study|Lack of time|0|||
125089887|NCT00545740|449947040|FG000|Overall Study|Non-adherence to visits|0|||
125089888|NCT00545740|449947041|FG001|Overall Study|Non-adherence to visits|1|||
125089889|NCT00545740|449947042|FG002|Overall Study|Non-adherence to visits|0|||
125089890|NCT00545740|449947043|FG003|Overall Study|Non-adherence to visits|0|||
125089891|NCT00545740|449947040|FG000|Overall Study|Patient difficulties|0|||
125089892|NCT00545740|449947041|FG001|Overall Study|Patient difficulties|1|||
125333527|NCT03904693|450854106|FG001|Overall Study|Physician Decision|0|||
125333528|NCT03904693|450854107|FG002|Overall Study|Physician Decision|2|||
125333529|NCT03904693|450854105|FG000|Overall Study|Withdrawal by Subject|0|||
125002893|NCT01968070|449639171|FG005|Period 2|Withdrawal by Subject|0|||
125333530|NCT03904693|450854106|FG001|Overall Study|Withdrawal by Subject|1|||
125333531|NCT03904693|450854107|FG002|Overall Study|Withdrawal by Subject|4|||
125333532|NCT00068419|450854108|FG000|Overall Study|Adverse Event|3|||
125333533|NCT00068419|450854108|FG000|Overall Study|Lack of Efficacy|24|||
125333534|NCT00068419|450854108|FG000|Overall Study|Lost to Follow-up|1|||
125002894|NCT01968070|449639172|FG006|Period 2|Withdrawal by Subject|0|||
125089893|NCT00545740|449947042|FG002|Overall Study|Patient difficulties|0|||
125333535|NCT00068419|450854108|FG000|Overall Study|Physician Decision|7|||
125333536|NCT00068419|450854108|FG000|Overall Study|Withdrawal by Subject|14|||
125333537|NCT00068419|450854108|FG000|Overall Study|Ineligible|11|||
125333538|NCT01160822|450854115|FG000|Overall Study|Adverse Event|0|||
125333539|NCT01160822|450854116|FG001|Overall Study|Adverse Event|0|||
125333540|NCT01160822|450854117|FG002|Overall Study|Adverse Event|0|||
125333541|NCT01160822|450854118|FG003|Overall Study|Adverse Event|0|||
125333542|NCT01160822|450854119|FG004|Overall Study|Adverse Event|1|||
125333543|NCT01160822|450854120|FG005|Overall Study|Adverse Event|2|||
125333544|NCT01160822|450854121|FG006|Overall Study|Adverse Event|5|||
125333545|NCT01160822|450854115|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125333546|NCT01160822|450854116|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125333547|NCT01160822|450854117|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
125333548|NCT01160822|450854118|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
125333549|NCT01160822|450854119|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
125333550|NCT01160822|450854120|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
125333551|NCT01160822|450854121|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
125333552|NCT01160822|450854115|FG000|Overall Study|Withdrawal by Subject|0|||
125333553|NCT01160822|450854116|FG001|Overall Study|Withdrawal by Subject|0|||
125333554|NCT01160822|450854117|FG002|Overall Study|Withdrawal by Subject|0|||
125333555|NCT01160822|450854118|FG003|Overall Study|Withdrawal by Subject|0|||
125333556|NCT01160822|450854119|FG004|Overall Study|Withdrawal by Subject|0|||
125333557|NCT01160822|450854120|FG005|Overall Study|Withdrawal by Subject|0|||
125333558|NCT01160822|450854121|FG006|Overall Study|Withdrawal by Subject|1|||
125333559|NCT01160822|450854115|FG000|Overall Study|Lost to Follow-up|0|||
125333560|NCT01160822|450854116|FG001|Overall Study|Lost to Follow-up|0|||
125333561|NCT01160822|450854117|FG002|Overall Study|Lost to Follow-up|0|||
125333562|NCT01160822|450854118|FG003|Overall Study|Lost to Follow-up|0|||
125333563|NCT01160822|450854119|FG004|Overall Study|Lost to Follow-up|1|||
125333564|NCT01160822|450854120|FG005|Overall Study|Lost to Follow-up|0|||
125333565|NCT01160822|450854121|FG006|Overall Study|Lost to Follow-up|0|||
125333566|NCT01160822|450854115|FG000|Overall Study|Administrative problems|0|||
125333567|NCT01160822|450854116|FG001|Overall Study|Administrative problems|0|||
125333568|NCT01160822|450854117|FG002|Overall Study|Administrative problems|0|||
125333569|NCT01160822|450854118|FG003|Overall Study|Administrative problems|0|||
125333570|NCT01160822|450854119|FG004|Overall Study|Administrative problems|1|||
125333571|NCT01160822|450854120|FG005|Overall Study|Administrative problems|0|||
125333572|NCT01160822|450854121|FG006|Overall Study|Administrative problems|0|||
125333573|NCT01160822|450854115|FG000|Overall Study|Protocol deviation|0|||
125333574|NCT01160822|450854116|FG001|Overall Study|Protocol deviation|0|||
125333575|NCT01160822|450854117|FG002|Overall Study|Protocol deviation|0|||
125333576|NCT01160822|450854118|FG003|Overall Study|Protocol deviation|0|||
125333577|NCT01160822|450854119|FG004|Overall Study|Protocol deviation|2|||
125333578|NCT01160822|450854120|FG005|Overall Study|Protocol deviation|0|||
125333579|NCT01160822|450854121|FG006|Overall Study|Protocol deviation|0|||
125333580|NCT00314795|450854124|FG000|Overall Study|Adverse Event|8|||
125333581|NCT00314795|450854124|FG000|Overall Study|Death|4|||
125333582|NCT00314795|450854124|FG000|Overall Study|Reason not Specified|3|||
125333583|NCT00314795|450854124|FG000|Overall Study|Renal Transplant|3|||
125333584|NCT00314795|450854124|FG000|Overall Study|Participants Withdrew Consent|2|||
125333585|NCT04717336|450854126|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
125333586|NCT04717336|450854127|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
125333587|NCT04717336|450854126|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
125333588|NCT04717336|450854127|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
125333589|NCT01500720|450854128|FG000|Overall Study|Randomized But Not Treated|1|||
125333590|NCT01500720|450854129|FG001|Overall Study|Randomized But Not Treated|1|||
125333591|NCT01500720|450854128|FG000|Overall Study|Other|4|||
125333592|NCT01500720|450854129|FG001|Overall Study|Other|8|||
125333593|NCT02624986|450854130|FG000|Overall Study|Death|0|||
125333594|NCT02624986|450854131|FG001|Overall Study|Death|1|||
125333595|NCT02624986|450854132|FG002|Overall Study|Death|2|||
125333596|NCT02624986|450854133|FG003|Overall Study|Death|2|||
125333597|NCT02624986|450854134|FG004|Overall Study|Death|2|||
125333598|NCT02624986|450854135|FG005|Overall Study|Death|0|||
125333599|NCT02624986|450854136|FG006|Overall Study|Death|0|||
125333600|NCT02624986|450854137|FG007|Overall Study|Death|1|||
125333601|NCT02624986|450854130|FG000|Overall Study|Study Terminated by Sponsor|1|||
125333602|NCT02624986|450854131|FG001|Overall Study|Study Terminated by Sponsor|1|||
125333603|NCT02624986|450854132|FG002|Overall Study|Study Terminated by Sponsor|0|||
125333604|NCT02624986|450854133|FG003|Overall Study|Study Terminated by Sponsor|1|||
125333605|NCT02624986|450854134|FG004|Overall Study|Study Terminated by Sponsor|2|||
125333606|NCT02624986|450854135|FG005|Overall Study|Study Terminated by Sponsor|2|||
125333607|NCT02624986|450854136|FG006|Overall Study|Study Terminated by Sponsor|4|||
125333608|NCT02624986|450854137|FG007|Overall Study|Study Terminated by Sponsor|3|||
125333609|NCT02624986|450854130|FG000|Overall Study|Progressive Disease|0|||
125333610|NCT02624986|450854131|FG001|Overall Study|Progressive Disease|1|||
125333611|NCT02624986|450854132|FG002|Overall Study|Progressive Disease|0|||
125333612|NCT02624986|450854133|FG003|Overall Study|Progressive Disease|0|||
125333613|NCT02624986|450854134|FG004|Overall Study|Progressive Disease|0|||
125333614|NCT02624986|450854135|FG005|Overall Study|Progressive Disease|0|||
125333615|NCT02624986|450854136|FG006|Overall Study|Progressive Disease|0|||
125333616|NCT02624986|450854137|FG007|Overall Study|Progressive Disease|0|||
125333617|NCT02624986|450854130|FG000|Overall Study|Protocol Violation|1|||
125333618|NCT02624986|450854131|FG001|Overall Study|Protocol Violation|0|||
125333619|NCT02624986|450854132|FG002|Overall Study|Protocol Violation|0|||
125333620|NCT02624986|450854133|FG003|Overall Study|Protocol Violation|0|||
125333621|NCT02624986|450854134|FG004|Overall Study|Protocol Violation|0|||
125333622|NCT02624986|450854135|FG005|Overall Study|Protocol Violation|0|||
125333623|NCT02624986|450854136|FG006|Overall Study|Protocol Violation|0|||
125333624|NCT02624986|450854137|FG007|Overall Study|Protocol Violation|0|||
125333625|NCT02624986|450854130|FG000|Overall Study|Withdrawal by Subject|0|||
125333626|NCT02624986|450854131|FG001|Overall Study|Withdrawal by Subject|0|||
125333627|NCT02624986|450854132|FG002|Overall Study|Withdrawal by Subject|0|||
125333628|NCT02624986|450854133|FG003|Overall Study|Withdrawal by Subject|0|||
125333629|NCT02624986|450854134|FG004|Overall Study|Withdrawal by Subject|0|||
125333630|NCT02624986|450854135|FG005|Overall Study|Withdrawal by Subject|0|||
125002895|NCT01968070|449639173|FG007|Period 2|Withdrawal by Subject|0|||
125002896|NCT01968070|449639174|FG008|Period 2|Withdrawal by Subject|0|||
125002897|NCT01968070|449639175|FG009|Period 2|Withdrawal by Subject|0|||
125333631|NCT02624986|450854136|FG006|Overall Study|Withdrawal by Subject|0|||
125333632|NCT02624986|450854137|FG007|Overall Study|Withdrawal by Subject|1|||
125333633|NCT02527421|450854138|FG000|Overall Study|Withdrawal by Subject|1|||
125333634|NCT02527421|450854139|FG001|Overall Study|Withdrawal by Subject|0|||
125333635|NCT02116205|450854140|FG000|Overall Study|Withdrawal by Subject|2|||
125333636|NCT02116205|450854141|FG001|Overall Study|Withdrawal by Subject|4|||
125333637|NCT02116205|450854142|FG002|Overall Study|Withdrawal by Subject|1|||
125333638|NCT02116205|450854143|FG003|Overall Study|Withdrawal by Subject|3|||
125333639|NCT02116205|450854140|FG000|Overall Study|Lost to Follow-up|0|||
125333640|NCT02116205|450854141|FG001|Overall Study|Lost to Follow-up|2|||
125333641|NCT02116205|450854142|FG002|Overall Study|Lost to Follow-up|1|||
125333642|NCT02116205|450854143|FG003|Overall Study|Lost to Follow-up|2|||
125333643|NCT02116205|450854140|FG000|Overall Study|Physician Decision|0|||
125333644|NCT02116205|450854141|FG001|Overall Study|Physician Decision|1|||
125333645|NCT02116205|450854142|FG002|Overall Study|Physician Decision|1|||
125333646|NCT02116205|450854143|FG003|Overall Study|Physician Decision|1|||
125333647|NCT02116205|450854140|FG000|Overall Study|Exclusion criteria|0|||
125333648|NCT02116205|450854141|FG001|Overall Study|Exclusion criteria|0|||
125333649|NCT02116205|450854142|FG002|Overall Study|Exclusion criteria|1|||
125333650|NCT02116205|450854143|FG003|Overall Study|Exclusion criteria|0|||
125333651|NCT02541604|450854144|FG000|Overall Study|Death|6|||
125333652|NCT02541604|450854145|FG001|Overall Study|Death|5|||
125333653|NCT02541604|450854146|FG002|Overall Study|Death|7|||
125333654|NCT02541604|450854147|FG003|Overall Study|Death|2|||
125333655|NCT02541604|450854148|FG004|Overall Study|Death|9|||
125333656|NCT02541604|450854149|FG005|Overall Study|Death|8|||
125333657|NCT02541604|450854150|FG006|Overall Study|Death|9|||
125333658|NCT02541604|450854151|FG007|Overall Study|Death|9|||
125333659|NCT02541604|450854152|FG008|Overall Study|Death|3|||
125333660|NCT02541604|450854153|FG009|Overall Study|Death|4|||
125333661|NCT02541604|450854154|FG010|Overall Study|Death|2|||
125333662|NCT02541604|450854155|FG011|Overall Study|Death|3|||
125333663|NCT02541604|450854144|FG000|Overall Study|Lost to Follow-up|2|||
125333664|NCT02541604|450854145|FG001|Overall Study|Lost to Follow-up|0|||
125333665|NCT02541604|450854146|FG002|Overall Study|Lost to Follow-up|1|||
125333666|NCT02541604|450854147|FG003|Overall Study|Lost to Follow-up|0|||
125333667|NCT02541604|450854148|FG004|Overall Study|Lost to Follow-up|0|||
125333668|NCT02541604|450854149|FG005|Overall Study|Lost to Follow-up|1|||
125333669|NCT02541604|450854150|FG006|Overall Study|Lost to Follow-up|1|||
125333670|NCT02541604|450854151|FG007|Overall Study|Lost to Follow-up|0|||
125333671|NCT02541604|450854152|FG008|Overall Study|Lost to Follow-up|0|||
125333672|NCT02541604|450854153|FG009|Overall Study|Lost to Follow-up|0|||
125333673|NCT02541604|450854154|FG010|Overall Study|Lost to Follow-up|0|||
125333674|NCT02541604|450854155|FG011|Overall Study|Lost to Follow-up|0|||
125333675|NCT02541604|450854144|FG000|Overall Study|Withdrawal by Subject|2|||
125333676|NCT02541604|450854145|FG001|Overall Study|Withdrawal by Subject|0|||
125333677|NCT02541604|450854146|FG002|Overall Study|Withdrawal by Subject|1|||
125002898|NCT01968070|449639176|FG010|Period 2|Withdrawal by Subject|0|||
125002899|NCT01968070|449639177|FG011|Period 2|Withdrawal by Subject|0|||
125333678|NCT02541604|450854147|FG003|Overall Study|Withdrawal by Subject|0|||
125333679|NCT02541604|450854148|FG004|Overall Study|Withdrawal by Subject|1|||
125333680|NCT02541604|450854149|FG005|Overall Study|Withdrawal by Subject|1|||
125333681|NCT02541604|450854150|FG006|Overall Study|Withdrawal by Subject|0|||
125333682|NCT02541604|450854151|FG007|Overall Study|Withdrawal by Subject|0|||
125002900|NCT01968070|449639178|FG012|Period 2|Withdrawal by Subject|0|||
125333683|NCT02541604|450854152|FG008|Overall Study|Withdrawal by Subject|1|||
125333684|NCT02541604|450854153|FG009|Overall Study|Withdrawal by Subject|0|||
125333685|NCT02541604|450854154|FG010|Overall Study|Withdrawal by Subject|0|||
125333686|NCT02541604|450854155|FG011|Overall Study|Withdrawal by Subject|0|||
125089894|NCT00545740|449947043|FG003|Overall Study|Patient difficulties|0|||
125002901|NCT01968070|449639179|FG013|Period 2|Withdrawal by Subject|0|||
125002902|NCT01968070|449639180|FG014|Period 2|Withdrawal by Subject|0|||
125002903|NCT01968070|449639181|FG015|Period 2|Withdrawal by Subject|0|||
125002904|NCT01968070|449639182|FG016|Period 2|Withdrawal by Subject|0|||
125002905|NCT01968070|449639183|FG017|Period 2|Withdrawal by Subject|0|||
125002906|NCT00882310|449639187|FG000|Overall Study|Screen Failure|10|||
125002907|NCT00882310|449639187|FG000|Overall Study|Never received treatment|1|||
125002908|NCT00882310|449639187|FG000|Overall Study|Death|6|||
125002909|NCT00882310|449639187|FG000|Overall Study|Progression of disease|4|||
125002910|NCT00882310|449639187|FG000|Overall Study|Adverse Event|1|||
125002911|NCT04246801|449639190|FG000|Overall Study|Adverse Event|1|||
125002912|NCT04246801|449639191|FG001|Overall Study|Adverse Event|1|||
125089895|NCT00545740|449947040|FG000|Overall Study|Husband against study|0|||
125089896|NCT00545740|449947041|FG001|Overall Study|Husband against study|0|||
125089897|NCT00545740|449947042|FG002|Overall Study|Husband against study|1|||
125089898|NCT00545740|449947043|FG003|Overall Study|Husband against study|0|||
125089899|NCT00082628|449947046|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
125333687|NCT02541604|450854144|FG000|Overall Study|Study Terminated by Sponsor|1|||
125333688|NCT02541604|450854145|FG001|Overall Study|Study Terminated by Sponsor|4|||
125333689|NCT02541604|450854146|FG002|Overall Study|Study Terminated by Sponsor|2|||
125333690|NCT02541604|450854147|FG003|Overall Study|Study Terminated by Sponsor|1|||
125333691|NCT02541604|450854148|FG004|Overall Study|Study Terminated by Sponsor|0|||
125333692|NCT02541604|450854149|FG005|Overall Study|Study Terminated by Sponsor|0|||
125333693|NCT02541604|450854150|FG006|Overall Study|Study Terminated by Sponsor|0|||
125333694|NCT02541604|450854151|FG007|Overall Study|Study Terminated by Sponsor|0|||
125333695|NCT02541604|450854152|FG008|Overall Study|Study Terminated by Sponsor|0|||
125333696|NCT02541604|450854153|FG009|Overall Study|Study Terminated by Sponsor|0|||
125333697|NCT02541604|450854154|FG010|Overall Study|Study Terminated by Sponsor|0|||
125333698|NCT02541604|450854155|FG011|Overall Study|Study Terminated by Sponsor|0|||
125333699|NCT02541604|450854144|FG000|Overall Study|Medical condition may jeopardize safety|0|||
125333700|NCT02541604|450854145|FG001|Overall Study|Medical condition may jeopardize safety|0|||
125333701|NCT02541604|450854146|FG002|Overall Study|Medical condition may jeopardize safety|0|||
125333702|NCT02541604|450854147|FG003|Overall Study|Medical condition may jeopardize safety|0|||
125333703|NCT02541604|450854148|FG004|Overall Study|Medical condition may jeopardize safety|0|||
125333704|NCT02541604|450854149|FG005|Overall Study|Medical condition may jeopardize safety|0|||
125333705|NCT02541604|450854150|FG006|Overall Study|Medical condition may jeopardize safety|0|||
125333706|NCT02541604|450854151|FG007|Overall Study|Medical condition may jeopardize safety|1|||
125333707|NCT02541604|450854152|FG008|Overall Study|Medical condition may jeopardize safety|0|||
125333708|NCT02541604|450854153|FG009|Overall Study|Medical condition may jeopardize safety|0|||
125333709|NCT02541604|450854154|FG010|Overall Study|Medical condition may jeopardize safety|0|||
125333710|NCT02541604|450854155|FG011|Overall Study|Medical condition may jeopardize safety|0|||
125333711|NCT00560352|450854159|FG000|Overall Study|Adverse event unrelated to study drug|2|||
125333712|NCT00560352|450854160|FG001|Overall Study|Adverse event unrelated to study drug|1|||
125333713|NCT00560352|450854161|FG002|Overall Study|Adverse event unrelated to study drug|1|||
125333714|NCT00560352|450854159|FG000|Overall Study|Study drug toxicity|3|||
125333715|NCT00560352|450854160|FG001|Overall Study|Study drug toxicity|0|||
125333716|NCT00560352|450854161|FG002|Overall Study|Study drug toxicity|1|||
125333717|NCT00560352|450854159|FG000|Overall Study|Disease progression|0|||
125333718|NCT00560352|450854160|FG001|Overall Study|Disease progression|1|||
125333719|NCT00560352|450854161|FG002|Overall Study|Disease progression|1|||
125333720|NCT00560352|450854159|FG000|Overall Study|Withdrawal by Subject|1|||
125333721|NCT00560352|450854160|FG001|Overall Study|Withdrawal by Subject|1|||
125333722|NCT00560352|450854161|FG002|Overall Study|Withdrawal by Subject|1|||
125333723|NCT00560352|450854159|FG000|Overall Study|Maximum clinical benefit|1|||
125333724|NCT00560352|450854160|FG001|Overall Study|Maximum clinical benefit|0|||
125333725|NCT00560352|450854161|FG002|Overall Study|Maximum clinical benefit|0|||
125333726|NCT04434937|450854162|FG000|Overall Study|Death|4|||
125333727|NCT04434937|450854162|FG000|Overall Study|Withdrawal by Subject|1|||
125333728|NCT04434937|450854162|FG000|Overall Study|Transitioned to Rollover Study|19|||
125333729|NCT04434937|450854162|FG000|Overall Study|Progressive Disease|18|||
125333730|NCT00924027|450854163|FG000|Overall Study|Lost to Further Follow-Up|4|||
125333731|NCT00924027|450854164|FG001|Overall Study|Lost to Further Follow-Up|0|||
125333732|NCT00924027|450854165|FG002|Overall Study|Lost to Further Follow-Up|0|||
125002913|NCT04246801|449639190|FG000|Overall Study|Protocol Violation|1|||
125002914|NCT04246801|449639191|FG001|Overall Study|Protocol Violation|1|||
125002915|NCT04246801|449639190|FG000|Overall Study|Lack of Efficacy|0|||
125333733|NCT00924027|450854166|FG003|Overall Study|Lost to Further Follow-Up|0|||
125333734|NCT00924027|450854163|FG000|Overall Study|Physician Decision|1|||
125333735|NCT00924027|450854164|FG001|Overall Study|Physician Decision|0|||
125333736|NCT00924027|450854165|FG002|Overall Study|Physician Decision|0|||
125333737|NCT00924027|450854166|FG003|Overall Study|Physician Decision|1|||
125333738|NCT00924027|450854163|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
125333739|NCT00924027|450854164|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
125333740|NCT00924027|450854165|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
125333741|NCT00924027|450854166|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
125333742|NCT00924027|450854163|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
125333743|NCT00924027|450854164|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
125333744|NCT00924027|450854165|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
125333745|NCT00924027|450854166|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
125333746|NCT00924027|450854163|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
125333747|NCT00924027|450854164|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
125333748|NCT00924027|450854165|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
125333749|NCT00924027|450854166|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
125333750|NCT04695977|450854167|FG000|Overall Study|Sponsor Decision|9|||
125333751|NCT04695977|450854168|FG001|Overall Study|Sponsor Decision|4|||
125333752|NCT04695977|450854167|FG000|Overall Study|Death|2|||
125333753|NCT04695977|450854168|FG001|Overall Study|Death|5|||
125333754|NCT03474965|450854169|FG000|Overall Study|Pregnancy|1|||
125333755|NCT03474965|450854170|FG001|Overall Study|Pregnancy|0|||
125333756|NCT03474965|450854171|FG002|Overall Study|Pregnancy|0|||
125333757|NCT03474965|450854172|FG003|Overall Study|Pregnancy|0|||
125333758|NCT03474965|450854169|FG000|Overall Study|Lost to Follow-up|0|||
125333759|NCT03474965|450854170|FG001|Overall Study|Lost to Follow-up|0|||
125333760|NCT03474965|450854171|FG002|Overall Study|Lost to Follow-up|1|||
125333761|NCT03474965|450854172|FG003|Overall Study|Lost to Follow-up|0|||
125333762|NCT03474965|450854169|FG000|Overall Study|Death|1|||
125333763|NCT03474965|450854170|FG001|Overall Study|Death|0|||
125333764|NCT03474965|450854171|FG002|Overall Study|Death|0|||
125333765|NCT03474965|450854172|FG003|Overall Study|Death|0|||
125333766|NCT03474965|450854169|FG000|Overall Study|Adverse Event|1|||
125333767|NCT03474965|450854170|FG001|Overall Study|Adverse Event|0|||
125333768|NCT03474965|450854171|FG002|Overall Study|Adverse Event|0|||
125333769|NCT03474965|450854172|FG003|Overall Study|Adverse Event|1|||
125333770|NCT03474965|450854169|FG000|Overall Study|Physician Decision|3|||
125333771|NCT03474965|450854170|FG001|Overall Study|Physician Decision|1|||
125333772|NCT03474965|450854171|FG002|Overall Study|Physician Decision|2|||
125333773|NCT03474965|450854172|FG003|Overall Study|Physician Decision|0|||
125333774|NCT03474965|450854169|FG000|Overall Study|Participant Decision|7|||
125333775|NCT03474965|450854170|FG001|Overall Study|Participant Decision|0|||
125333776|NCT03474965|450854171|FG002|Overall Study|Participant Decision|1|||
125333777|NCT03474965|450854172|FG003|Overall Study|Participant Decision|0|||
125333778|NCT03474965|450854169|FG000|Overall Study|Guardian Decision|4|||
125333779|NCT03474965|450854170|FG001|Overall Study|Guardian Decision|2|||
125333780|NCT03474965|450854171|FG002|Overall Study|Guardian Decision|7|||
125333781|NCT03474965|450854172|FG003|Overall Study|Guardian Decision|2|||
125333782|NCT00684060|450856034|FG000|Overall Study|Lost to Follow-up|1|||
125333783|NCT00684060|450856035|FG001|Overall Study|Lost to Follow-up|0|||
125333784|NCT00684060|450856034|FG000|Overall Study|New stenosis identified|1|||
125333785|NCT00684060|450856035|FG001|Overall Study|New stenosis identified|0|||
125333786|NCT00684060|450856034|FG000|Overall Study|Unable to collect MRI|1|||
125333787|NCT00684060|450856035|FG001|Overall Study|Unable to collect MRI|2|||
125333788|NCT00684060|450856034|FG000|Overall Study|Death|0|||
125333789|NCT00684060|450856035|FG001|Overall Study|Death|1|||
125333790|NCT03751657|450856036|FG000|Overall Study|Physician Decision|0|||
125333791|NCT03751657|450856037|FG001|Overall Study|Physician Decision|1|||
125333792|NCT03751657|450856036|FG000|Overall Study|Withdrawal by Subject|1|||
125333793|NCT03751657|450856037|FG001|Overall Study|Withdrawal by Subject|1|||
125333794|NCT03751657|450856036|FG000|Overall Study|Lost to Follow-up|2|||
125333795|NCT03751657|450856037|FG001|Overall Study|Lost to Follow-up|1|||
125333796|NCT02600819|450856038|FG000|GEN Phase|Adverse Event|2|||
125333797|NCT02600819|450856039|FG001|GEN Phase|Adverse Event|0|||
125333798|NCT02600819|450856038|FG000|GEN Phase|Death|2|||
125333799|NCT02600819|450856039|FG001|GEN Phase|Death|0|||
125333800|NCT02600819|450856038|FG000|GEN Phase|Investigator's Discretion|4|||
125333801|NCT02600819|450856039|FG001|GEN Phase|Investigator's Discretion|0|||
125333802|NCT02600819|450856038|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
125333803|NCT02600819|450856039|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
125333804|NCT02600819|450856038|FG000|GEN Phase|Withdrew Consent|5|||
125333805|NCT02600819|450856039|FG001|GEN Phase|Withdrew Consent|0|||
125333806|NCT02600819|450856038|FG000|GEN Phase|Lost to Follow-up|2|||
125333807|NCT02600819|450856039|FG001|GEN Phase|Lost to Follow-up|0|||
125333808|NCT01027273|450856040|FG000|Overall Study|Lost to Follow-up|57|||
125333809|NCT01027273|450856041|FG001|Overall Study|Lost to Follow-up|31|||
125333810|NCT01027273|450856040|FG000|Overall Study|Death|2|||
125333811|NCT01027273|450856041|FG001|Overall Study|Death|2|||
125333812|NCT02904954|450856043|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
125333813|NCT02904954|450856044|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
125333814|NCT02904954|450856043|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
125333815|NCT02904954|450856044|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
125333816|NCT02904954|450856043|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
125333817|NCT02904954|450856044|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
125333818|NCT02904954|450856043|FG000|Adjuvant Durvalumab|Recurrence|2|||
125333819|NCT02904954|450856044|FG001|Adjuvant Durvalumab|Recurrence|0|||
125333820|NCT02904954|450856043|FG000|Adjuvant Durvalumab|Adverse Event|2|||
125333821|NCT02904954|450856044|FG001|Adjuvant Durvalumab|Adverse Event|6|||
125333822|NCT02904954|450856043|FG000|Adjuvant Durvalumab|Participant wishes|12|||
125333823|NCT02904954|450856044|FG001|Adjuvant Durvalumab|Participant wishes|7|||
125333824|NCT02904954|450856043|FG000|Adjuvant Durvalumab|Physician Decision|2|||
125333825|NCT02904954|450856044|FG001|Adjuvant Durvalumab|Physician Decision|1|||
125333826|NCT02904954|450856043|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
125333827|NCT02904954|450856044|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
125333828|NCT02904954|450856043|FG000|Adjuvant Durvalumab|Death|0|||
125333829|NCT02904954|450856044|FG001|Adjuvant Durvalumab|Death|1|||
125333830|NCT02904954|450856043|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
125333831|NCT02904954|450856044|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
125333832|NCT05097963|450856045|FG000|Overall Study|Protocol Violation|13|||
125333833|NCT05097963|450856045|FG000|Overall Study|Withdrawal by Subject|21|||
125333834|NCT00859456|450856046|FG000|Overall Study|Adverse Event|3|||
125333835|NCT00859456|450856046|FG000|Overall Study|Progressive disease|2|||
125333836|NCT00859456|450856046|FG000|Overall Study|Non-compliance|3|||
125333837|NCT00337675|450856047|FG000|Overall Study|Adverse Event|10|||
125333838|NCT00337675|450856048|FG001|Overall Study|Adverse Event|9|||
125333839|NCT00337675|450856049|FG002|Overall Study|Adverse Event|19|||
125333840|NCT00337675|450856047|FG000|Overall Study|Lack of Efficacy|10|||
125333841|NCT00337675|450856048|FG001|Overall Study|Lack of Efficacy|7|||
125333842|NCT00337675|450856049|FG002|Overall Study|Lack of Efficacy|9|||
125333843|NCT00337675|450856047|FG000|Overall Study|Lost to Follow-up|22|||
125333844|NCT00337675|450856048|FG001|Overall Study|Lost to Follow-up|19|||
125333845|NCT00337675|450856049|FG002|Overall Study|Lost to Follow-up|17|||
125333846|NCT00337675|450856047|FG000|Overall Study|Physician Decision|9|||
125333847|NCT00337675|450856048|FG001|Overall Study|Physician Decision|17|||
125333848|NCT00337675|450856049|FG002|Overall Study|Physician Decision|14|||
125333849|NCT00337675|450856047|FG000|Overall Study|Protocol Violation|21|||
125333850|NCT00337675|450856048|FG001|Overall Study|Protocol Violation|24|||
125333851|NCT00337675|450856049|FG002|Overall Study|Protocol Violation|19|||
125333852|NCT00337675|450856047|FG000|Overall Study|Withdrawal by Subject|25|||
125333853|NCT00337675|450856048|FG001|Overall Study|Withdrawal by Subject|25|||
125333854|NCT00337675|450856049|FG002|Overall Study|Withdrawal by Subject|19|||
125333855|NCT00337675|450856047|FG000|Overall Study|Progressive Disease|0|||
125333856|NCT00337675|450856048|FG001|Overall Study|Progressive Disease|2|||
125333857|NCT00337675|450856049|FG002|Overall Study|Progressive Disease|0|||
125333858|NCT00337675|450856047|FG000|Overall Study|Trial Terminated|0|||
125333859|NCT00337675|450856048|FG001|Overall Study|Trial Terminated|0|||
125333860|NCT00337675|450856049|FG002|Overall Study|Trial Terminated|2|||
125333861|NCT01491607|450856054|FG000|Overall Study|Lost to Follow-up|7|||
125333862|NCT01491607|450856054|FG000|Overall Study|Withdrawal by Subject|3|||
125333863|NCT01317277|450856055|FG000|Overall Study|Lost to Follow-up|3|||
125333864|NCT01317277|450856056|FG001|Overall Study|Lost to Follow-up|1|||
125333865|NCT01317277|450856055|FG000|Overall Study|Lost MEMS|1|||
125333866|NCT01317277|450856056|FG001|Overall Study|Lost MEMS|1|||
125333867|NCT01317277|450856055|FG000|Overall Study|Unable to comply with intervention|1|||
125333868|NCT01317277|450856056|FG001|Overall Study|Unable to comply with intervention|0|||
125333869|NCT01317277|450856055|FG000|Overall Study|Withdrawal by Subject|1|||
125333870|NCT01317277|450856056|FG001|Overall Study|Withdrawal by Subject|0|||
125333871|NCT01317277|450856055|FG000|Overall Study|Adverse Event|1|||
125333872|NCT01317277|450856056|FG001|Overall Study|Adverse Event|0|||
125333873|NCT00774566|450856057|FG000|Overall Study|Protocol Violation|18|||
125333874|NCT00774566|450856058|FG001|Overall Study|Protocol Violation|15|||
125333875|NCT01075685|450856061|FG000|Overall Study|Protocol Violation|9|||
125333876|NCT01075685|450856062|FG001|Overall Study|Protocol Violation|1|||
125333877|NCT01075685|450856061|FG000|Overall Study|Withdrawal by Subject|20|||
125333878|NCT01075685|450856062|FG001|Overall Study|Withdrawal by Subject|5|||
125333879|NCT01075685|450856061|FG000|Overall Study|Lost to Follow-up|563|||
125333880|NCT01075685|450856062|FG001|Overall Study|Lost to Follow-up|220|||
125333881|NCT02858362|450856063|FG000|Overall Study|Protocol Violation|0|||
125333882|NCT02858362|450856064|FG001|Overall Study|Protocol Violation|1|||
125333883|NCT02858362|450856065|FG002|Overall Study|Protocol Violation|0|||
125333884|NCT02858362|450856063|FG000|Overall Study|Withdrawal by Subject|1|||
125333885|NCT02858362|450856064|FG001|Overall Study|Withdrawal by Subject|0|||
125333886|NCT02858362|450856065|FG002|Overall Study|Withdrawal by Subject|0|||
125333887|NCT02858362|450856063|FG000|Overall Study|Early Study Termination|0|||
125333888|NCT02858362|450856064|FG001|Overall Study|Early Study Termination|0|||
125333889|NCT02858362|450856065|FG002|Overall Study|Early Study Termination|3|||
125333890|NCT02858362|450856063|FG000|Overall Study|Lost to Follow-up|1|||
125333891|NCT02858362|450856064|FG001|Overall Study|Lost to Follow-up|0|||
125333892|NCT02858362|450856065|FG002|Overall Study|Lost to Follow-up|0|||
125333893|NCT01262989|450856066|FG000|Period 1|Lost to Follow-up|1|||
125333894|NCT01262989|450856067|FG001|Period 1|Lost to Follow-up|1|||
125333895|NCT01262989|450856066|FG000|Period 1|Intercurrent disease|0|||
125333896|NCT01262989|450856067|FG001|Period 1|Intercurrent disease|1|||
125333897|NCT01262989|450856066|FG000|Period 1|Positive answer for exclusion criteria|0|||
125333898|NCT01262989|450856067|FG001|Period 1|Positive answer for exclusion criteria|1|||
125333899|NCT01262989|450856066|FG000|Period 2|Intercurrent disease|0|||
125333900|NCT01262989|450856067|FG001|Period 2|Intercurrent disease|1|||
125333901|NCT02813577|450856068|FG000|Overall Study|Study terminated|4|||
125333902|NCT00775593|450856074|FG000|Overall Study|Unmet eligibility criteria|6|||
125333903|NCT00775593|450856074|FG000|Overall Study|Death|1|||
125333904|NCT02067676|450856075|FG000|Overall Study|Withdrawal by Subject|1|||
125333905|NCT02067676|450856076|FG001|Overall Study|Withdrawal by Subject|0|||
125333906|NCT02067676|450856077|FG002|Overall Study|Withdrawal by Subject|0|||
125333907|NCT02067676|450856078|FG003|Overall Study|Withdrawal by Subject|0|||
125333908|NCT02067676|450856079|FG004|Overall Study|Withdrawal by Subject|0|||
125333909|NCT02067676|450856080|FG005|Overall Study|Withdrawal by Subject|0|||
125333910|NCT02164461|450856088|FG000|Overall Study|Adverse Event|0|||
125333911|NCT02164461|450856089|FG001|Overall Study|Adverse Event|0|||
125333912|NCT02164461|450856090|FG002|Overall Study|Adverse Event|1|||
125333913|NCT02164461|450856088|FG000|Overall Study|Disease Progression|1|||
125333914|NCT02164461|450856089|FG001|Overall Study|Disease Progression|3|||
125333915|NCT02164461|450856090|FG002|Overall Study|Disease Progression|4|||
125333916|NCT02164461|450856088|FG000|Overall Study|Withdrawal by Subject|0|||
125333917|NCT02164461|450856089|FG001|Overall Study|Withdrawal by Subject|3|||
125333918|NCT02164461|450856090|FG002|Overall Study|Withdrawal by Subject|0|||
125333919|NCT02100696|450856092|FG000|Induction Phase|Adverse Event|0|||
125333920|NCT02100696|450856093|FG001|Induction Phase|Adverse Event|0|||
125333921|NCT02100696|450856094|FG002|Induction Phase|Adverse Event|1|||
125333922|NCT02100696|450856095|FG003|Induction Phase|Adverse Event|0|||
125333923|NCT02100696|450856096|FG004|Induction Phase|Adverse Event|0|||
125333924|NCT02100696|450856097|FG005|Induction Phase|Adverse Event|0|||
125333925|NCT02100696|450856092|FG000|Induction Phase|Lost to Follow-up|1|||
125333926|NCT02100696|450856093|FG001|Induction Phase|Lost to Follow-up|0|||
125333927|NCT02100696|450856094|FG002|Induction Phase|Lost to Follow-up|1|||
125333928|NCT02100696|450856095|FG003|Induction Phase|Lost to Follow-up|0|||
125333929|NCT02100696|450856096|FG004|Induction Phase|Lost to Follow-up|0|||
125333930|NCT02100696|450856097|FG005|Induction Phase|Lost to Follow-up|0|||
125333931|NCT02100696|450856092|FG000|Induction Phase|Protocol Violation|0|||
125333932|NCT02100696|450856093|FG001|Induction Phase|Protocol Violation|1|||
125333933|NCT02100696|450856094|FG002|Induction Phase|Protocol Violation|1|||
125333934|NCT02100696|450856095|FG003|Induction Phase|Protocol Violation|0|||
125333935|NCT02100696|450856096|FG004|Induction Phase|Protocol Violation|0|||
125333936|NCT02100696|450856097|FG005|Induction Phase|Protocol Violation|0|||
125333937|NCT02100696|450856092|FG000|Induction Phase|Withdrawal by Subject|8|||
125333938|NCT02100696|450856093|FG001|Induction Phase|Withdrawal by Subject|2|||
125333939|NCT02100696|450856094|FG002|Induction Phase|Withdrawal by Subject|13|||
125333940|NCT02100696|450856095|FG003|Induction Phase|Withdrawal by Subject|0|||
125333941|NCT02100696|450856096|FG004|Induction Phase|Withdrawal by Subject|0|||
125333942|NCT02100696|450856097|FG005|Induction Phase|Withdrawal by Subject|0|||
125333943|NCT02100696|450856092|FG000|Induction Phase|Physician Decision|1|||
125333944|NCT02100696|450856093|FG001|Induction Phase|Physician Decision|0|||
125333945|NCT02100696|450856094|FG002|Induction Phase|Physician Decision|2|||
125333946|NCT02100696|450856095|FG003|Induction Phase|Physician Decision|0|||
125333947|NCT02100696|450856096|FG004|Induction Phase|Physician Decision|0|||
125333948|NCT02100696|450856097|FG005|Induction Phase|Physician Decision|0|||
125333949|NCT02100696|450856092|FG000|Induction Phase|Multiple Reasons|5|||
125333950|NCT02100696|450856093|FG001|Induction Phase|Multiple Reasons|2|||
125333951|NCT02100696|450856094|FG002|Induction Phase|Multiple Reasons|8|||
125333952|NCT02100696|450856095|FG003|Induction Phase|Multiple Reasons|0|||
125333953|NCT02100696|450856096|FG004|Induction Phase|Multiple Reasons|0|||
125333954|NCT02100696|450856097|FG005|Induction Phase|Multiple Reasons|0|||
125333955|NCT02100696|450856092|FG000|Maintenance Phase|Adverse Event|0|||
125333956|NCT02100696|450856093|FG001|Maintenance Phase|Adverse Event|0|||
125333957|NCT02100696|450856094|FG002|Maintenance Phase|Adverse Event|0|||
125333958|NCT02100696|450856095|FG003|Maintenance Phase|Adverse Event|0|||
125333959|NCT02100696|450856096|FG004|Maintenance Phase|Adverse Event|0|||
125333960|NCT02100696|450856097|FG005|Maintenance Phase|Adverse Event|2|||
125333961|NCT02100696|450856092|FG000|Maintenance Phase|Lost to Follow-up|0|||
125333962|NCT02100696|450856093|FG001|Maintenance Phase|Lost to Follow-up|0|||
125333963|NCT02100696|450856094|FG002|Maintenance Phase|Lost to Follow-up|0|||
125333964|NCT02100696|450856095|FG003|Maintenance Phase|Lost to Follow-up|0|||
125333965|NCT02100696|450856096|FG004|Maintenance Phase|Lost to Follow-up|1|||
125333966|NCT02100696|450856097|FG005|Maintenance Phase|Lost to Follow-up|0|||
125333967|NCT02100696|450856092|FG000|Maintenance Phase|Protocol Violation|0|||
125333968|NCT02100696|450856093|FG001|Maintenance Phase|Protocol Violation|0|||
125333969|NCT02100696|450856094|FG002|Maintenance Phase|Protocol Violation|0|||
125333970|NCT02100696|450856095|FG003|Maintenance Phase|Protocol Violation|0|||
125333971|NCT02100696|450856096|FG004|Maintenance Phase|Protocol Violation|1|||
125333972|NCT02100696|450856097|FG005|Maintenance Phase|Protocol Violation|0|||
125333973|NCT02100696|450856092|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125333974|NCT02100696|450856093|FG001|Maintenance Phase|Withdrawal by Subject|0|||
125333975|NCT02100696|450856094|FG002|Maintenance Phase|Withdrawal by Subject|0|||
125333976|NCT02100696|450856095|FG003|Maintenance Phase|Withdrawal by Subject|1|||
125333977|NCT02100696|450856096|FG004|Maintenance Phase|Withdrawal by Subject|4|||
125333978|NCT02100696|450856097|FG005|Maintenance Phase|Withdrawal by Subject|2|||
125333979|NCT02100696|450856092|FG000|Maintenance Phase|Physician Decision|0|||
125333980|NCT02100696|450856093|FG001|Maintenance Phase|Physician Decision|0|||
125333981|NCT02100696|450856094|FG002|Maintenance Phase|Physician Decision|0|||
125333982|NCT02100696|450856095|FG003|Maintenance Phase|Physician Decision|0|||
125333983|NCT02100696|450856096|FG004|Maintenance Phase|Physician Decision|1|||
125333984|NCT02100696|450856097|FG005|Maintenance Phase|Physician Decision|0|||
125333985|NCT02100696|450856092|FG000|Maintenance Phase|Multiple Reasons|0|||
125333986|NCT02100696|450856093|FG001|Maintenance Phase|Multiple Reasons|0|||
125333987|NCT02100696|450856094|FG002|Maintenance Phase|Multiple Reasons|0|||
125333988|NCT02100696|450856095|FG003|Maintenance Phase|Multiple Reasons|0|||
125333989|NCT02100696|450856096|FG004|Maintenance Phase|Multiple Reasons|2|||
125333990|NCT02100696|450856097|FG005|Maintenance Phase|Multiple Reasons|1|||
125333991|NCT03865381|450856100|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
125333992|NCT03865381|450856100|FG000|Overall Study|Withdrawal by Subject|2|||
125333993|NCT05626322|450856101|FG000|Overall Study|Death|2|||
125333994|NCT05626322|450856102|FG001|Overall Study|Death|0|||
125333995|NCT05626322|450856103|FG002|Overall Study|Death|0|||
125333996|NCT05626322|450856101|FG000|Overall Study|Physician Decision|1|||
125333997|NCT05626322|450856102|FG001|Overall Study|Physician Decision|0|||
125333998|NCT05626322|450856103|FG002|Overall Study|Physician Decision|0|||
125333999|NCT05626322|450856101|FG000|Overall Study|Progressive Disease|0|||
125334000|NCT05626322|450856102|FG001|Overall Study|Progressive Disease|1|||
125334001|NCT05626322|450856103|FG002|Overall Study|Progressive Disease|1|||
125334002|NCT05626322|450856101|FG000|Overall Study|Study terminated by sponsor|0|||
125334003|NCT05626322|450856102|FG001|Overall Study|Study terminated by sponsor|1|||
125334004|NCT05626322|450856103|FG002|Overall Study|Study terminated by sponsor|0|||
125334005|NCT00369265|450856104|FG000|Overall Study|Study terminated|4|||
125334006|NCT00369265|450856105|FG001|Overall Study|Study terminated|7|||
125334007|NCT00048074|450856108|FG000|Overall Study|Adverse Event|46|||
125334008|NCT00048074|450856109|FG001|Overall Study|Adverse Event|41|||
125334009|NCT00048074|450856110|FG002|Overall Study|Adverse Event|53|||
125334010|NCT00048074|450856108|FG000|Overall Study|Death|3|||
125334011|NCT00048074|450856109|FG001|Overall Study|Death|3|||
125334012|NCT00048074|450856110|FG002|Overall Study|Death|2|||
125334013|NCT00048074|450856108|FG000|Overall Study|Lost to Follow-up|2|||
125334014|NCT00048074|450856109|FG001|Overall Study|Lost to Follow-up|6|||
125334015|NCT00048074|450856110|FG002|Overall Study|Lost to Follow-up|6|||
125334016|NCT00048074|450856108|FG000|Overall Study|Withdrawal by Subject|28|||
125334017|NCT00048074|450856109|FG001|Overall Study|Withdrawal by Subject|30|||
125334018|NCT00048074|450856110|FG002|Overall Study|Withdrawal by Subject|35|||
125334019|NCT00048074|450856108|FG000|Overall Study|Protocol Violation|1|||
125334020|NCT00048074|450856109|FG001|Overall Study|Protocol Violation|3|||
125334021|NCT00048074|450856110|FG002|Overall Study|Protocol Violation|0|||
125334022|NCT00048074|450856108|FG000|Overall Study|Study participation was terminated|0|||
125334023|NCT00048074|450856109|FG001|Overall Study|Study participation was terminated|1|||
125334024|NCT00048074|450856110|FG002|Overall Study|Study participation was terminated|0|||
125334025|NCT00048074|450856108|FG000|Overall Study|Husband ill|0|||
125334026|NCT00048074|450856109|FG001|Overall Study|Husband ill|1|||
125334027|NCT00048074|450856110|FG002|Overall Study|Husband ill|0|||
125334028|NCT00048074|450856108|FG000|Overall Study|Poor compliance|0|||
125334029|NCT00048074|450856109|FG001|Overall Study|Poor compliance|1|||
125334030|NCT00048074|450856110|FG002|Overall Study|Poor compliance|0|||
125334031|NCT00048074|450856108|FG000|Overall Study|Out of station|0|||
125334032|NCT00048074|450856109|FG001|Overall Study|Out of station|1|||
125334033|NCT00048074|450856110|FG002|Overall Study|Out of station|1|||
125334034|NCT00048074|450856108|FG000|Overall Study|Social reasons|1|||
125334035|NCT00048074|450856109|FG001|Overall Study|Social reasons|0|||
125334036|NCT00048074|450856110|FG002|Overall Study|Social reasons|0|||
125334037|NCT02873377|450856111|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
125334038|NCT02873377|450856112|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
125334039|NCT02873377|450856111|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
125334040|NCT02873377|450856112|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
125334041|NCT00740857|450856121|FG000|Overall Study|Withdrawal by Subject|1|||
125334042|NCT00740857|450856122|FG001|Overall Study|Withdrawal by Subject|0|||
125334043|NCT00740857|450856123|FG002|Overall Study|Withdrawal by Subject|0|||
125334044|NCT03532451|450856127|FG000|Overall Study|Withdrawal by Subject|0|||
125334045|NCT03532451|450856128|FG001|Overall Study|Withdrawal by Subject|1|||
125334046|NCT03532451|450856127|FG000|Overall Study|Did not undergo surgery|1|||
125334047|NCT03532451|450856128|FG001|Overall Study|Did not undergo surgery|1|||
125334048|NCT01519167|450856129|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
125334049|NCT01519167|450856130|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
125334050|NCT01519167|450856129|FG000|Overall Study|Adverse Event|0|||
125334051|NCT01519167|450856130|FG001|Overall Study|Adverse Event|1|||
125334052|NCT01519167|450856129|FG000|Overall Study|Lack of Efficacy|0|||
125334053|NCT01519167|450856130|FG001|Overall Study|Lack of Efficacy|1|||
125334054|NCT01519167|450856129|FG000|Overall Study|Medical condition changes&deep sedation|0|||
125334055|NCT01519167|450856130|FG001|Overall Study|Medical condition changes&deep sedation|2|||
125334056|NCT01519167|450856129|FG000|Overall Study|Physician Decision|0|||
125334057|NCT01519167|450856130|FG001|Overall Study|Physician Decision|1|||
125334058|NCT04200352|450856141|FG000|Overall Study|Death|1|||
125334059|NCT04200352|450856141|FG000|Overall Study|Adverse Event|6|||
125334060|NCT04200352|450856141|FG000|Overall Study|Withdrawal by parent/guardian|6|||
125334061|NCT04200352|450856141|FG000|Overall Study|Lack of Efficacy|1|||
125334062|NCT04200352|450856141|FG000|Overall Study|Other than specified|6|||
125334063|NCT00233064|450856142|FG000|Overall Study|Lost to Follow-up|7|||
125334064|NCT00233064|450856143|FG001|Overall Study|Lost to Follow-up|7|||
125334065|NCT00233064|450856142|FG000|Overall Study|Withdrawal by Subject|5|||
125334066|NCT00233064|450856143|FG001|Overall Study|Withdrawal by Subject|3|||
125334067|NCT00233064|450856142|FG000|Overall Study|Death|0|||
125334068|NCT00233064|450856143|FG001|Overall Study|Death|1|||
125334069|NCT00233064|450856142|FG000|Overall Study|Relocation|0|||
125334070|NCT00233064|450856143|FG001|Overall Study|Relocation|1|||
125334071|NCT00233064|450856142|FG000|Overall Study|Protocol Violation|1|||
125334072|NCT00233064|450856143|FG001|Overall Study|Protocol Violation|0|||
125334073|NCT00233064|450856142|FG000|Overall Study|Moved to Dom. Republic|1|||
125334074|NCT00233064|450856143|FG001|Overall Study|Moved to Dom. Republic|0|||
125334075|NCT01120964|450856150|FG000|Overall Study|Did not receive full treatment|1|||
125334076|NCT01120964|450856151|FG001|Overall Study|Did not receive full treatment|0|||
125334077|NCT04237116|450856155|FG000|Overall Study|Adverse Event|0|||
125334078|NCT04237116|450856156|FG001|Overall Study|Adverse Event|1|||
125334079|NCT04237116|450856155|FG000|Overall Study|Study terminated by Sponsor|4|||
125334080|NCT04237116|450856156|FG001|Overall Study|Study terminated by Sponsor|1|||
125334081|NCT00829504|450856157|FG000|First Intervention|Adverse Event|1|||
125334082|NCT00829504|450856158|FG001|First Intervention|Adverse Event|0|||
125334083|NCT00829504|450856157|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
125334084|NCT00829504|450856158|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
125334085|NCT00829504|450856157|FG000|Second Intervention|Physician Decision|1|||
125334086|NCT00829504|450856158|FG001|Second Intervention|Physician Decision|0|||
125334087|NCT03212144|450856159|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
125334088|NCT03212144|450856160|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
125334089|NCT03212144|450856159|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
125334090|NCT03212144|450856160|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
125334091|NCT00599339|450856161|FG000|Overall Study|Adverse Event|79|||
125334092|NCT00599339|450856161|FG000|Overall Study|Withdrawal by Subject|137|||
125334093|NCT00599339|450856161|FG000|Overall Study|Other Reason|179|||
125334094|NCT00599339|450856161|FG000|Overall Study|Lost to Follow-up|221|||
125334095|NCT00599339|450856161|FG000|Overall Study|No valid data consent|36|||
125334096|NCT00599339|450856161|FG000|Overall Study|Study Termination Status Unknown|12|||
125334097|NCT05307692|450856163|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
125334098|NCT05307692|450856164|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
125334099|NCT05307692|450856165|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
125334100|NCT05307692|450856166|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
125334101|NCT05307692|450856163|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
125334102|NCT05307692|450856164|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
125334103|NCT05307692|450856165|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
125334104|NCT05307692|450856166|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
125334105|NCT05307692|450856163|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
125334106|NCT05307692|450856164|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
125334107|NCT05307692|450856165|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
125334108|NCT05307692|450856166|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
125334109|NCT05307692|450856163|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
125334110|NCT05307692|450856164|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
125334111|NCT05307692|450856165|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
125334112|NCT05307692|450856166|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
125334113|NCT05307692|450856163|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
125334114|NCT05307692|450856164|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
125334115|NCT05307692|450856165|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
125334116|NCT05307692|450856166|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
125334117|NCT05307692|450856163|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
125334118|NCT05307692|450856164|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
125334119|NCT05307692|450856165|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
125334120|NCT05307692|450856166|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
125334121|NCT05307692|450856163|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
125334122|NCT05307692|450856164|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
125334123|NCT05307692|450856165|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
125334124|NCT05307692|450856166|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
125334125|NCT05307692|450856163|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
125334126|NCT05307692|450856164|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
125334127|NCT05307692|450856165|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
125334128|NCT05307692|450856166|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
125334129|NCT02003924|450856173|FG000|Double-blind Phase|Lost to Follow-up|2|||
125334130|NCT02003924|450856174|FG001|Double-blind Phase|Lost to Follow-up|1|||
125334131|NCT02003924|450856175|FG002|Double-blind Phase|Lost to Follow-up|0|||
125334132|NCT02003924|450856173|FG000|Double-blind Phase|Protocol Violation|1|||
125334133|NCT02003924|450856174|FG001|Double-blind Phase|Protocol Violation|2|||
125334134|NCT02003924|450856175|FG002|Double-blind Phase|Protocol Violation|0|||
125334135|NCT02003924|450856173|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
125334136|NCT02003924|450856174|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
125334137|NCT02003924|450856175|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
125334138|NCT02003924|450856173|FG000|Double-blind Phase|Disease Progression|229|||
125334139|NCT02003924|450856174|FG001|Double-blind Phase|Disease Progression|247|||
125334140|NCT02003924|450856175|FG002|Double-blind Phase|Disease Progression|0|||
125334141|NCT02003924|450856173|FG000|Double-blind Phase|Adverse Event|120|||
125334142|NCT02003924|450856174|FG001|Double-blind Phase|Adverse Event|31|||
125334143|NCT02003924|450856175|FG002|Double-blind Phase|Adverse Event|0|||
125334144|NCT02003924|450856173|FG000|Double-blind Phase|Randomized But not Treated|3|||
125334145|NCT02003924|450856174|FG001|Double-blind Phase|Randomized But not Treated|3|||
125334146|NCT02003924|450856175|FG002|Double-blind Phase|Randomized But not Treated|0|||
125334147|NCT02003924|450856173|FG000|Double-blind Phase|Other|29|||
125334148|NCT02003924|450856174|FG001|Double-blind Phase|Other|50|||
125334149|NCT02003924|450856175|FG002|Double-blind Phase|Other|0|||
125334150|NCT02003924|450856173|FG000|Open-label Phase|Lost to Follow-up|0|||
125334151|NCT02003924|450856174|FG001|Open-label Phase|Lost to Follow-up|0|||
125334152|NCT02003924|450856175|FG002|Open-label Phase|Lost to Follow-up|1|||
125334153|NCT02003924|450856173|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
125334154|NCT02003924|450856174|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
125334155|NCT02003924|450856175|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
125334156|NCT02003924|450856173|FG000|Open-label Phase|Disease Progression|59|||
125334157|NCT02003924|450856174|FG001|Open-label Phase|Disease Progression|0|||
125334158|NCT02003924|450856175|FG002|Open-label Phase|Disease Progression|5|||
125334159|NCT02003924|450856173|FG000|Open-label Phase|Adverse Event|25|||
125334160|NCT02003924|450856174|FG001|Open-label Phase|Adverse Event|0|||
125334161|NCT02003924|450856175|FG002|Open-label Phase|Adverse Event|10|||
125334162|NCT02003924|450856173|FG000|Open-label Phase|Other|7|||
125334163|NCT02003924|450856174|FG001|Open-label Phase|Other|0|||
125334164|NCT02003924|450856175|FG002|Open-label Phase|Other|0|||
125334165|NCT02003924|450856173|FG000|Long-term Follow-up Phase|Death|288|||
125334166|NCT02003924|450856174|FG001|Long-term Follow-up Phase|Death|174|||
125334167|NCT02003924|450856175|FG002|Long-term Follow-up Phase|Death|4|||
125334168|NCT02003924|450856173|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
125334169|NCT02003924|450856174|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
125334170|NCT02003924|450856175|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
125334171|NCT02003924|450856173|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
125334172|NCT02003924|450856174|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
125334173|NCT02003924|450856175|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
125334174|NCT02003924|450856173|FG000|Long-term Follow-up Phase|Other|5|||
125334175|NCT02003924|450856174|FG001|Long-term Follow-up Phase|Other|2|||
125334176|NCT02003924|450856175|FG002|Long-term Follow-up Phase|Other|1|||
125334177|NCT00114517|450856182|FG000|Overall Study|Adverse Event|6|||
125334178|NCT00114517|450856183|FG001|Overall Study|Adverse Event|1|||
125334179|NCT00114517|450856184|FG002|Overall Study|Adverse Event|6|||
125334180|NCT00114517|450856185|FG003|Overall Study|Adverse Event|3|||
125334181|NCT00114517|450856182|FG000|Overall Study|Lost to Follow-up|2|||
125334182|NCT00114517|450856183|FG001|Overall Study|Lost to Follow-up|2|||
125002916|NCT04246801|449639191|FG001|Overall Study|Lack of Efficacy|2|||
125002917|NCT04246801|449639190|FG000|Overall Study|Lost to Follow-up|1|||
125334183|NCT00114517|450856184|FG002|Overall Study|Lost to Follow-up|2|||
125002918|NCT04246801|449639191|FG001|Overall Study|Lost to Follow-up|1|||
125334184|NCT00114517|450856185|FG003|Overall Study|Lost to Follow-up|1|||
125334185|NCT00114517|450856182|FG000|Overall Study|Too busy|3|||
125334186|NCT00114517|450856183|FG001|Overall Study|Too busy|1|||
125334187|NCT00114517|450856184|FG002|Overall Study|Too busy|1|||
125334188|NCT00114517|450856185|FG003|Overall Study|Too busy|2|||
125334189|NCT00114517|450856182|FG000|Overall Study|Moved from area|0|||
125334190|NCT00114517|450856183|FG001|Overall Study|Moved from area|3|||
125334191|NCT00114517|450856184|FG002|Overall Study|Moved from area|2|||
125334192|NCT00114517|450856185|FG003|Overall Study|Moved from area|1|||
125334193|NCT00114517|450856182|FG000|Overall Study|Did not want estradiol|1|||
125002919|NCT04246801|449639190|FG000|Overall Study|Withdrawal by Subject|2|||
125334194|NCT00114517|450856183|FG001|Overall Study|Did not want estradiol|1|||
125334195|NCT00114517|450856184|FG002|Overall Study|Did not want estradiol|0|||
125334196|NCT00114517|450856185|FG003|Overall Study|Did not want estradiol|0|||
125334197|NCT00114517|450856182|FG000|Overall Study|Armed-services duty|0|||
125334198|NCT00114517|450856183|FG001|Overall Study|Armed-services duty|1|||
125334199|NCT00114517|450856184|FG002|Overall Study|Armed-services duty|0|||
125334200|NCT00114517|450856185|FG003|Overall Study|Armed-services duty|1|||
125334201|NCT00114517|450856182|FG000|Overall Study|Competing family issue|0|||
125334202|NCT00114517|450856183|FG001|Overall Study|Competing family issue|1|||
125334203|NCT00114517|450856184|FG002|Overall Study|Competing family issue|0|||
125334204|NCT00114517|450856185|FG003|Overall Study|Competing family issue|1|||
125334205|NCT00114517|450856182|FG000|Overall Study|Physician Decision|0|||
125334206|NCT00114517|450856183|FG001|Overall Study|Physician Decision|1|||
125334207|NCT00114517|450856184|FG002|Overall Study|Physician Decision|0|||
125334208|NCT00114517|450856185|FG003|Overall Study|Physician Decision|0|||
125334209|NCT00114517|450856182|FG000|Overall Study|Lost interest|0|||
125334210|NCT00114517|450856183|FG001|Overall Study|Lost interest|0|||
125334211|NCT00114517|450856184|FG002|Overall Study|Lost interest|1|||
125334212|NCT00114517|450856185|FG003|Overall Study|Lost interest|0|||
125334213|NCT00114517|450856182|FG000|Overall Study|Weight increase|0|||
125334214|NCT00114517|450856183|FG001|Overall Study|Weight increase|0|||
125334215|NCT00114517|450856184|FG002|Overall Study|Weight increase|1|||
125334216|NCT00114517|450856185|FG003|Overall Study|Weight increase|0|||
125334217|NCT00114517|450856182|FG000|Overall Study|Concern about blood clots|0|||
125334218|NCT00114517|450856183|FG001|Overall Study|Concern about blood clots|0|||
125334219|NCT00114517|450856184|FG002|Overall Study|Concern about blood clots|1|||
125334220|NCT00114517|450856185|FG003|Overall Study|Concern about blood clots|0|||
125334221|NCT00114517|450856182|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
125334222|NCT00114517|450856183|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
125334223|NCT00114517|450856184|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
125334224|NCT00114517|450856185|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
125334225|NCT00702715|450857988|FG000|Overall Study|Lost to Follow-up|1|||
125334226|NCT00702715|450857989|FG001|Overall Study|Lost to Follow-up|0|||
125334227|NCT02840799|450857992|FG000|Phase 1|Physician Decision|1|||
125334228|NCT02840799|450857993|FG001|Phase 1|Physician Decision|3|||
125334229|NCT02840799|450857992|FG000|Phase 1|Withdrawal by Subject|4|||
125334230|NCT02840799|450857993|FG001|Phase 1|Withdrawal by Subject|0|||
125334231|NCT02840799|450857992|FG000|Phase 2 (Crossover)|Adverse Event|0|||
125334232|NCT02840799|450857993|FG001|Phase 2 (Crossover)|Adverse Event|1|||
125334233|NCT02840799|450857992|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
125334234|NCT02840799|450857993|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
125334235|NCT01193257|450857999|FG000|Overall Study|Death|202|||
125334236|NCT01193257|450858000|FG001|Overall Study|Death|391|||
125334237|NCT01193257|450857999|FG000|Overall Study|Study termination by sponsor|0|||
125002920|NCT04246801|449639191|FG001|Overall Study|Withdrawal by Subject|1|||
125002921|NCT03684642|449639192|FG000|Overall Study|Adverse Event|6|||
125002922|NCT03684642|449639193|FG001|Overall Study|Adverse Event|15|||
125002923|NCT03684642|449639194|FG002|Overall Study|Adverse Event|11|||
125002924|NCT03684642|449639192|FG000|Overall Study|Withdrawal by Subject|35|||
125002925|NCT03684642|449639193|FG001|Overall Study|Withdrawal by Subject|53|||
125002926|NCT03684642|449639194|FG002|Overall Study|Withdrawal by Subject|23|||
125002927|NCT03684642|449639192|FG000|Overall Study|Lack of Efficacy|0|||
125002928|NCT03684642|449639193|FG001|Overall Study|Lack of Efficacy|0|||
125002929|NCT03684642|449639194|FG002|Overall Study|Lack of Efficacy|1|||
125002930|NCT03684642|449639192|FG000|Overall Study|Poor compliance to protocol|0|||
125002931|NCT03684642|449639193|FG001|Overall Study|Poor compliance to protocol|4|||
125002932|NCT03684642|449639194|FG002|Overall Study|Poor compliance to protocol|1|||
125002933|NCT03684642|449639192|FG000|Overall Study|Other than specified|62|||
125002934|NCT03684642|449639193|FG001|Overall Study|Other than specified|60|||
125002935|NCT03684642|449639194|FG002|Overall Study|Other than specified|67|||
125002936|NCT03684642|449639192|FG000|Overall Study|Randomized and not treated|0|||
125002937|NCT03684642|449639193|FG001|Overall Study|Randomized and not treated|0|||
125334238|NCT01193257|450858000|FG001|Overall Study|Study termination by sponsor|3|||
125334239|NCT01193257|450857999|FG000|Overall Study|Withdrawal by Subject|26|||
125334240|NCT01193257|450858000|FG001|Overall Study|Withdrawal by Subject|86|||
125334241|NCT01193257|450857999|FG000|Overall Study|Lost to Follow-up|2|||
125334242|NCT01193257|450858000|FG001|Overall Study|Lost to Follow-up|3|||
125334243|NCT01193257|450857999|FG000|Overall Study|Unblinded due to futility|135|||
125334244|NCT01193257|450858000|FG001|Overall Study|Unblinded due to futility|251|||
125334245|NCT01621802|450858004|FG000|Overall Study|Protocol Violation|0|||
125334246|NCT01621802|450858005|FG001|Overall Study|Protocol Violation|0|||
125334247|NCT01621802|450858006|FG002|Overall Study|Protocol Violation|0|||
125334248|NCT01621802|450858007|FG003|Overall Study|Protocol Violation|0|||
125334249|NCT01621802|450858008|FG004|Overall Study|Protocol Violation|0|||
125334250|NCT01621802|450858009|FG005|Overall Study|Protocol Violation|1|||
125334251|NCT01621802|450858004|FG000|Overall Study|Withdrawal by Subject|8|||
125334252|NCT01621802|450858005|FG001|Overall Study|Withdrawal by Subject|4|||
125334253|NCT01621802|450858006|FG002|Overall Study|Withdrawal by Subject|4|||
125334254|NCT01621802|450858007|FG003|Overall Study|Withdrawal by Subject|2|||
125334255|NCT01621802|450858008|FG004|Overall Study|Withdrawal by Subject|2|||
125334256|NCT01621802|450858009|FG005|Overall Study|Withdrawal by Subject|0|||
125334257|NCT01621802|450858004|FG000|Overall Study|Migrated/moved from study area|0|||
125334258|NCT01621802|450858005|FG001|Overall Study|Migrated/moved from study area|0|||
125334259|NCT01621802|450858006|FG002|Overall Study|Migrated/moved from study area|2|||
125334260|NCT01621802|450858007|FG003|Overall Study|Migrated/moved from study area|0|||
125334261|NCT01621802|450858008|FG004|Overall Study|Migrated/moved from study area|1|||
125334262|NCT01621802|450858009|FG005|Overall Study|Migrated/moved from study area|0|||
125334263|NCT01621802|450858004|FG000|Overall Study|Others|3|||
125334264|NCT01621802|450858005|FG001|Overall Study|Others|3|||
125334265|NCT01621802|450858006|FG002|Overall Study|Others|3|||
125334266|NCT01621802|450858007|FG003|Overall Study|Others|2|||
125334267|NCT01621802|450858008|FG004|Overall Study|Others|1|||
125334268|NCT01621802|450858009|FG005|Overall Study|Others|0|||
125334269|NCT01621802|450858004|FG000|Overall Study|Lost to Follow-up|36|||
125334270|NCT01621802|450858005|FG001|Overall Study|Lost to Follow-up|16|||
125334271|NCT01621802|450858006|FG002|Overall Study|Lost to Follow-up|24|||
125334272|NCT01621802|450858007|FG003|Overall Study|Lost to Follow-up|7|||
125334273|NCT01621802|450858008|FG004|Overall Study|Lost to Follow-up|31|||
125334274|NCT01621802|450858009|FG005|Overall Study|Lost to Follow-up|11|||
125334275|NCT02948634|450858010|FG000|Overall Study|Lack of efficacy and study suspended|10|||
125334276|NCT02948634|450858011|FG001|Overall Study|Lack of efficacy and study suspended|2|||
125334277|NCT03052400|450858014|FG000|Overall Study|Lost to Follow-up|1|||
125334278|NCT03052400|450858015|FG001|Overall Study|Lost to Follow-up|0|||
125334279|NCT03052400|450858014|FG000|Overall Study|Withdrawal by Subject|0|||
125334280|NCT03052400|450858015|FG001|Overall Study|Withdrawal by Subject|1|||
125334281|NCT00555061|450858016|FG000|Overall Study|Adverse Event|3|||
125334282|NCT00555061|450858016|FG000|Overall Study|Protocol Violation|1|||
125334283|NCT00555061|450858016|FG000|Overall Study|Lost to Follow-up|2|||
125334284|NCT00555061|450858016|FG000|Overall Study|Withdrawal by Subject|2|||
125334285|NCT00555061|450858016|FG000|Overall Study|Participant enrolled, but never treated|1|||
125334286|NCT00485134|450858018|FG000|Overall Study|Lost to Follow-up|1|||
125334287|NCT00485134|450858019|FG001|Overall Study|Lost to Follow-up|0|||
125334288|NCT00485134|450858020|FG002|Overall Study|Lost to Follow-up|0|||
125334289|NCT00485134|450858021|FG003|Overall Study|Lost to Follow-up|0|||
125334290|NCT00485134|450858022|FG004|Overall Study|Lost to Follow-up|0|||
125334291|NCT00485134|450858023|FG005|Overall Study|Lost to Follow-up|0|||
125334292|NCT00485134|450858024|FG006|Overall Study|Lost to Follow-up|0|||
125334293|NCT00485134|450858025|FG007|Overall Study|Lost to Follow-up|0|||
125334294|NCT00485134|450858018|FG000|Overall Study|Withdrawal by Subject|0|||
125334295|NCT00485134|450858019|FG001|Overall Study|Withdrawal by Subject|1|||
125334296|NCT00485134|450858020|FG002|Overall Study|Withdrawal by Subject|0|||
125334297|NCT00485134|450858021|FG003|Overall Study|Withdrawal by Subject|0|||
125334298|NCT00485134|450858022|FG004|Overall Study|Withdrawal by Subject|0|||
125334299|NCT00485134|450858023|FG005|Overall Study|Withdrawal by Subject|0|||
125334300|NCT00485134|450858024|FG006|Overall Study|Withdrawal by Subject|0|||
125334301|NCT00485134|450858025|FG007|Overall Study|Withdrawal by Subject|0|||
125334302|NCT00485134|450858018|FG000|Overall Study|Change in health status|0|||
125334303|NCT00485134|450858019|FG001|Overall Study|Change in health status|1|||
125334304|NCT00485134|450858020|FG002|Overall Study|Change in health status|2|||
125334305|NCT00485134|450858021|FG003|Overall Study|Change in health status|1|||
125334306|NCT00485134|450858022|FG004|Overall Study|Change in health status|0|||
125334307|NCT00485134|450858023|FG005|Overall Study|Change in health status|1|||
125334308|NCT00485134|450858024|FG006|Overall Study|Change in health status|0|||
125334309|NCT00485134|450858025|FG007|Overall Study|Change in health status|0|||
125334310|NCT00485134|450858018|FG000|Overall Study|Withdrew for adverse event|0|||
125334311|NCT00485134|450858019|FG001|Overall Study|Withdrew for adverse event|0|||
125334312|NCT00485134|450858020|FG002|Overall Study|Withdrew for adverse event|1|||
125334313|NCT00485134|450858021|FG003|Overall Study|Withdrew for adverse event|0|||
125334314|NCT00485134|450858022|FG004|Overall Study|Withdrew for adverse event|0|||
125334315|NCT00485134|450858023|FG005|Overall Study|Withdrew for adverse event|0|||
125334316|NCT00485134|450858024|FG006|Overall Study|Withdrew for adverse event|0|||
125334317|NCT00485134|450858025|FG007|Overall Study|Withdrew for adverse event|0|||
125334318|NCT00485134|450858018|FG000|Overall Study|Positive drug test|0|||
125334319|NCT00485134|450858019|FG001|Overall Study|Positive drug test|0|||
125334320|NCT00485134|450858020|FG002|Overall Study|Positive drug test|0|||
125334321|NCT00485134|450858021|FG003|Overall Study|Positive drug test|0|||
125334322|NCT00485134|450858022|FG004|Overall Study|Positive drug test|2|||
125334323|NCT00485134|450858023|FG005|Overall Study|Positive drug test|1|||
125334324|NCT00485134|450858024|FG006|Overall Study|Positive drug test|0|||
125334325|NCT00485134|450858025|FG007|Overall Study|Positive drug test|0|||
125334326|NCT00485134|450858018|FG000|Overall Study|Non-compliance|0|||
125334327|NCT00485134|450858019|FG001|Overall Study|Non-compliance|0|||
125334328|NCT00485134|450858020|FG002|Overall Study|Non-compliance|0|||
125334329|NCT00485134|450858021|FG003|Overall Study|Non-compliance|0|||
125334330|NCT00485134|450858022|FG004|Overall Study|Non-compliance|1|||
125334331|NCT00485134|450858023|FG005|Overall Study|Non-compliance|2|||
125334332|NCT00485134|450858024|FG006|Overall Study|Non-compliance|2|||
125334333|NCT00485134|450858025|FG007|Overall Study|Non-compliance|0|||
125334334|NCT00485134|450858018|FG000|Overall Study|Unable to comply with study schedule|0|||
125334335|NCT00485134|450858019|FG001|Overall Study|Unable to comply with study schedule|0|||
125334336|NCT00485134|450858020|FG002|Overall Study|Unable to comply with study schedule|0|||
125334337|NCT00485134|450858021|FG003|Overall Study|Unable to comply with study schedule|0|||
125334338|NCT00485134|450858022|FG004|Overall Study|Unable to comply with study schedule|0|||
125334339|NCT00485134|450858023|FG005|Overall Study|Unable to comply with study schedule|0|||
125334340|NCT00485134|450858024|FG006|Overall Study|Unable to comply with study schedule|0|||
125334341|NCT00485134|450858025|FG007|Overall Study|Unable to comply with study schedule|1|||
125334342|NCT00485134|450858018|FG000|Overall Study|Pregnancy|0|||
125334343|NCT00485134|450858019|FG001|Overall Study|Pregnancy|0|||
125334344|NCT00485134|450858020|FG002|Overall Study|Pregnancy|0|||
125334345|NCT00485134|450858021|FG003|Overall Study|Pregnancy|0|||
125334346|NCT00485134|450858022|FG004|Overall Study|Pregnancy|0|||
125334347|NCT00485134|450858023|FG005|Overall Study|Pregnancy|0|||
125334348|NCT00485134|450858024|FG006|Overall Study|Pregnancy|1|||
125334349|NCT00485134|450858025|FG007|Overall Study|Pregnancy|0|||
125334350|NCT00970684|450858026|FG000|Overall Study|Lack of Efficacy|5|||
125334351|NCT00970684|450858026|FG000|Overall Study|Adverse Event|4|||
125334352|NCT00970684|450858026|FG000|Overall Study|Withdrawal by Subject|1|||
125334353|NCT00481091|450858027|FG000|Overall Study|Withdrawal by Subject|0|||
125334354|NCT00481091|450858028|FG001|Overall Study|Withdrawal by Subject|1|||
125334355|NCT00481091|450858029|FG002|Overall Study|Withdrawal by Subject|1|||
125334356|NCT00481091|450858030|FG003|Overall Study|Withdrawal by Subject|0|||
125334357|NCT00481091|450858031|FG004|Overall Study|Withdrawal by Subject|0|||
125334358|NCT00481091|450858032|FG005|Overall Study|Withdrawal by Subject|0|||
125334359|NCT00481091|450858033|FG006|Overall Study|Withdrawal by Subject|0|||
125334360|NCT00481091|450858034|FG007|Overall Study|Withdrawal by Subject|0|||
125334361|NCT00481091|450858035|FG008|Overall Study|Withdrawal by Subject|1|||
125334362|NCT00481091|450858036|FG009|Overall Study|Withdrawal by Subject|6|||
125334363|NCT00481091|450858027|FG000|Overall Study|Other, Not Specified|0|||
125334364|NCT00481091|450858028|FG001|Overall Study|Other, Not Specified|1|||
125334365|NCT00481091|450858029|FG002|Overall Study|Other, Not Specified|1|||
125002938|NCT03684642|449639194|FG002|Overall Study|Randomized and not treated|1|||
125002939|NCT03684642|449639192|FG000|Overall Study|Missing completion status but alive at last contact|0|||
125002940|NCT03684642|449639193|FG001|Overall Study|Missing completion status but alive at last contact|1|||
125002941|NCT03684642|449639194|FG002|Overall Study|Missing completion status but alive at last contact|2|||
125002942|NCT04201821|449639203|FG000|Overall Study|Withdrawal by Subject|2|||
125002943|NCT01326728|449639204|FG000|Overall Study|Death|13|||
125002944|NCT01326728|449639205|FG001|Overall Study|Death|0|||
125002945|NCT01326728|449639204|FG000|Overall Study|Early closure of study|34|||
125334366|NCT00481091|450858030|FG003|Overall Study|Other, Not Specified|0|||
125334367|NCT00481091|450858031|FG004|Overall Study|Other, Not Specified|0|||
125334368|NCT00481091|450858032|FG005|Overall Study|Other, Not Specified|1|||
125334369|NCT00481091|450858033|FG006|Overall Study|Other, Not Specified|0|||
125334370|NCT00481091|450858034|FG007|Overall Study|Other, Not Specified|0|||
125334371|NCT00481091|450858035|FG008|Overall Study|Other, Not Specified|0|||
125334372|NCT00481091|450858036|FG009|Overall Study|Other, Not Specified|4|||
125334373|NCT00481091|450858027|FG000|Overall Study|Adverse Event|1|||
125334374|NCT00481091|450858028|FG001|Overall Study|Adverse Event|2|||
125334375|NCT00481091|450858029|FG002|Overall Study|Adverse Event|0|||
125334376|NCT00481091|450858030|FG003|Overall Study|Adverse Event|1|||
125334377|NCT00481091|450858031|FG004|Overall Study|Adverse Event|1|||
125334378|NCT00481091|450858032|FG005|Overall Study|Adverse Event|1|||
125334379|NCT00481091|450858033|FG006|Overall Study|Adverse Event|2|||
125334380|NCT00481091|450858034|FG007|Overall Study|Adverse Event|1|||
125334381|NCT00481091|450858035|FG008|Overall Study|Adverse Event|1|||
125334382|NCT00481091|450858036|FG009|Overall Study|Adverse Event|6|||
125334383|NCT00481091|450858027|FG000|Overall Study|Progressive disease clinical|0|||
125334384|NCT00481091|450858028|FG001|Overall Study|Progressive disease clinical|0|||
125334385|NCT00481091|450858029|FG002|Overall Study|Progressive disease clinical|0|||
125334386|NCT00481091|450858030|FG003|Overall Study|Progressive disease clinical|0|||
125334387|NCT00481091|450858031|FG004|Overall Study|Progressive disease clinical|0|||
125002946|NCT01326728|449639205|FG001|Overall Study|Early closure of study|9|||
125002947|NCT03785678|449639206|FG000|Overall Study|Death|44|||
125334388|NCT00481091|450858032|FG005|Overall Study|Progressive disease clinical|0|||
125334389|NCT00481091|450858033|FG006|Overall Study|Progressive disease clinical|0|||
125334390|NCT00481091|450858034|FG007|Overall Study|Progressive disease clinical|0|||
125334391|NCT00481091|450858035|FG008|Overall Study|Progressive disease clinical|1|||
125334392|NCT00481091|450858036|FG009|Overall Study|Progressive disease clinical|7|||
125334393|NCT00481091|450858027|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
125334394|NCT00481091|450858028|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
125334395|NCT00481091|450858029|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
125334396|NCT00481091|450858030|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
125334397|NCT00481091|450858031|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
125334398|NCT00481091|450858032|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
125334399|NCT00481091|450858033|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
125334400|NCT00481091|450858034|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
125334401|NCT00481091|450858035|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
125334402|NCT00481091|450858036|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
125334403|NCT00481091|450858027|FG000|Overall Study|Progressive disease other|1|||
125334404|NCT00481091|450858028|FG001|Overall Study|Progressive disease other|1|||
125334405|NCT00481091|450858029|FG002|Overall Study|Progressive disease other|0|||
125334406|NCT00481091|450858030|FG003|Overall Study|Progressive disease other|1|||
125334407|NCT00481091|450858031|FG004|Overall Study|Progressive disease other|1|||
125334408|NCT00481091|450858032|FG005|Overall Study|Progressive disease other|1|||
125334409|NCT00481091|450858033|FG006|Overall Study|Progressive disease other|0|||
125334410|NCT00481091|450858034|FG007|Overall Study|Progressive disease other|2|||
125334411|NCT00481091|450858035|FG008|Overall Study|Progressive disease other|0|||
125334412|NCT00481091|450858036|FG009|Overall Study|Progressive disease other|0|||
125334413|NCT00481091|450858027|FG000|Overall Study|No reason given|0|||
125334414|NCT00481091|450858028|FG001|Overall Study|No reason given|0|||
125334415|NCT00481091|450858029|FG002|Overall Study|No reason given|1|||
125334416|NCT00481091|450858030|FG003|Overall Study|No reason given|1|||
125334417|NCT00481091|450858031|FG004|Overall Study|No reason given|1|||
125334418|NCT00481091|450858032|FG005|Overall Study|No reason given|0|||
125334419|NCT00481091|450858033|FG006|Overall Study|No reason given|1|||
125334420|NCT00481091|450858034|FG007|Overall Study|No reason given|1|||
125334421|NCT00481091|450858035|FG008|Overall Study|No reason given|1|||
125334422|NCT00481091|450858036|FG009|Overall Study|No reason given|4|||
125334423|NCT04294680|450858037|FG000|Overall Study|Withdrawal by Subject|2|||
125334424|NCT04294680|450858038|FG001|Overall Study|Withdrawal by Subject|1|||
125334425|NCT04294680|450858037|FG000|Overall Study|Follow-up visits completed outside of window|1|||
125334426|NCT04294680|450858038|FG001|Overall Study|Follow-up visits completed outside of window|0|||
125334427|NCT01296672|450858039|FG000|Overall Study|Lost to Follow-up|73|||
125334428|NCT01296672|450858040|FG001|Overall Study|Lost to Follow-up|18|||
125334429|NCT04027608|450858041|FG000|Overall Study|Withdrawal by Subject|13|||
125334430|NCT04027608|450858042|FG001|Overall Study|Withdrawal by Subject|2|||
125334431|NCT04027608|450858041|FG000|Overall Study|Protocol Violation|2|||
125334432|NCT04027608|450858042|FG001|Overall Study|Protocol Violation|1|||
125334433|NCT04027608|450858041|FG000|Overall Study|Physician Decision|1|||
125334434|NCT04027608|450858042|FG001|Overall Study|Physician Decision|0|||
125334435|NCT04027608|450858041|FG000|Overall Study|Lost to Follow-up|20|||
125334436|NCT04027608|450858042|FG001|Overall Study|Lost to Follow-up|4|||
125334437|NCT01386970|450858044|FG000|Overall Study|Withdrawal by Subject|0|||
125334438|NCT01386970|450858045|FG001|Overall Study|Withdrawal by Subject|1|||
125334439|NCT01386970|450858044|FG000|Overall Study|Adverse Event|4|||
125334440|NCT01386970|450858045|FG001|Overall Study|Adverse Event|1|||
125334441|NCT04881942|450858046|FG000|Overall Study|Adverse Event|0|||
125334442|NCT04881942|450858047|FG001|Overall Study|Adverse Event|0|||
125334443|NCT04881942|450858048|FG002|Overall Study|Adverse Event|0|||
125334444|NCT04881942|450858049|FG003|Overall Study|Adverse Event|0|||
125334445|NCT04881942|450858050|FG004|Overall Study|Adverse Event|1|||
125334446|NCT04881942|450858046|FG000|Overall Study|Alternates|0|||
125334447|NCT04881942|450858047|FG001|Overall Study|Alternates|0|||
125334448|NCT04881942|450858048|FG002|Overall Study|Alternates|0|||
125334449|NCT04881942|450858049|FG003|Overall Study|Alternates|0|||
125334450|NCT04881942|450858050|FG004|Overall Study|Alternates|2|||
125334451|NCT01349959|450858051|FG000|Overall Study|Adverse Event|7|||
125334452|NCT02675634|450858052|FG000|Test Period 1|Adverse Event|0|||
125334453|NCT02675634|450858053|FG001|Test Period 1|Adverse Event|1|||
125334454|NCT02675634|450858054|FG002|Test Period 1|Adverse Event|0|||
125334455|NCT02675634|450858055|FG003|Test Period 1|Adverse Event|1|||
125334456|NCT02675634|450858056|FG004|Test Period 1|Adverse Event|0|||
125334457|NCT02675634|450858057|FG005|Test Period 1|Adverse Event|0|||
125334458|NCT02675634|450858052|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
125334459|NCT02675634|450858053|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
125334460|NCT02675634|450858054|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
125334461|NCT02675634|450858055|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
125334462|NCT02675634|450858056|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
125334463|NCT02675634|450858057|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
125334464|NCT02675634|450858052|FG000|Test Period 2|Lack of Efficacy|1|||
125334465|NCT02675634|450858053|FG001|Test Period 2|Lack of Efficacy|0|||
125334466|NCT02675634|450858054|FG002|Test Period 2|Lack of Efficacy|0|||
125334467|NCT02675634|450858055|FG003|Test Period 2|Lack of Efficacy|0|||
125334468|NCT02675634|450858056|FG004|Test Period 2|Lack of Efficacy|0|||
125334469|NCT02675634|450858057|FG005|Test Period 2|Lack of Efficacy|0|||
125334470|NCT02675634|450858052|FG000|Test Period 2|Adverse Event|0|||
125334471|NCT02675634|450858053|FG001|Test Period 2|Adverse Event|0|||
125002948|NCT03785678|449639207|FG001|Overall Study|Death|42|||
125002949|NCT03785678|449639206|FG000|Overall Study|Lost to Follow-up|4|||
125334472|NCT02675634|450858054|FG002|Test Period 2|Adverse Event|0|||
125334473|NCT02675634|450858055|FG003|Test Period 2|Adverse Event|0|||
125334474|NCT02675634|450858056|FG004|Test Period 2|Adverse Event|0|||
125334475|NCT02675634|450858057|FG005|Test Period 2|Adverse Event|1|||
125334476|NCT01652534|450858058|FG000|Overall Study|Lack of Efficacy|1|||
125334477|NCT01652534|450858059|FG001|Overall Study|Lack of Efficacy|0|||
125334478|NCT03860259|450858060|FG000|Overall Study|Lost to Follow-up|5|||
125334479|NCT03860259|450858061|FG001|Overall Study|Lost to Follow-up|5|||
125334480|NCT03860259|450858060|FG000|Overall Study|Protocol Violation|1|||
125334481|NCT03860259|450858061|FG001|Overall Study|Protocol Violation|0|||
125334482|NCT00811018|450858062|FG000|Overall Study|Additional Chronic Treatment|31|||
125334483|NCT00811018|450858062|FG000|Overall Study|Adverse Event|79|||
125334484|NCT00811018|450858062|FG000|Overall Study|Death|147|||
125334485|NCT00811018|450858062|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
125334486|NCT00811018|450858062|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
125334487|NCT00811018|450858062|FG000|Overall Study|Investigator Decision|57|||
125334488|NCT00811018|450858062|FG000|Overall Study|Lost to Follow-up|19|||
125334489|NCT00811018|450858062|FG000|Overall Study|Pregnancy|6|||
125334490|NCT00811018|450858062|FG000|Overall Study|Sponsor Decision|450|||
125334491|NCT00811018|450858062|FG000|Overall Study|Withdrawal by Subject|70|||
125334492|NCT00811018|450858062|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
125334493|NCT00811018|450858062|FG000|Overall Study|Other|26|||
125334494|NCT00934362|450858066|FG000|Overall Study|Adverse Event|1|||
125334495|NCT00934362|450858067|FG001|Overall Study|Adverse Event|0|||
125334496|NCT03527732|450858068|FG000|Overall Study|Lost to Follow-up|21|||
125334497|NCT03527732|450858069|FG001|Overall Study|Lost to Follow-up|23|||
125334498|NCT03527732|450858070|FG002|Overall Study|Lost to Follow-up|80|||
125334499|NCT03527732|450858071|FG003|Overall Study|Lost to Follow-up|62|||
125334500|NCT03527732|450858072|FG004|Overall Study|Lost to Follow-up|12|||
125334501|NCT03527732|450858073|FG005|Overall Study|Lost to Follow-up|20|||
125334502|NCT02280408|450858074|FG000|Overall Study|Lost to Follow-up|0|||
125334503|NCT02280408|450858075|FG001|Overall Study|Lost to Follow-up|2|||
125334504|NCT02280408|450858076|FG002|Overall Study|Lost to Follow-up|0|||
125334505|NCT02280408|450858077|FG003|Overall Study|Lost to Follow-up|0|||
125334506|NCT01092117|450858078|FG000|Index Procedure to 1 Month|Death|1|||
125334507|NCT01092117|450858078|FG000|1 Month|Death|1|||
125334508|NCT01092117|450858078|FG000|1 Month|Withdrawal by Subject|1|||
125334509|NCT01092117|450858078|FG000|1 Month|Lost to Follow-up|1|||
125334510|NCT01092117|450858078|FG000|6 Months|Death|2|||
125334511|NCT01092117|450858078|FG000|6 Months|Withdrawal by Subject|3|||
125334512|NCT01092117|450858078|FG000|12 Month|Death|11|||
125334513|NCT01092117|450858078|FG000|12 Month|Withdrawal by Subject|2|||
125334514|NCT01092117|450858078|FG000|12 Month|Lost to Follow-up|1|||
125334515|NCT01092117|450858078|FG000|Year 2|Death|5|||
125334516|NCT01092117|450858078|FG000|Year 2|Withdrawal by Subject|4|||
125334517|NCT01092117|450858078|FG000|Year 2|Lost to Follow-up|1|||
125334518|NCT01092117|450858078|FG000|Year 3|Death|7|||
125334519|NCT01092117|450858078|FG000|Year 3|Withdrawal by Subject|9|||
125334520|NCT01092117|450858078|FG000|Year 3|Lost to Follow-up|3|||
125334521|NCT01092117|450858078|FG000|Year 4|Death|8|||
125334522|NCT01092117|450858078|FG000|Year 4|Withdrawal by Subject|4|||
125334523|NCT01092117|450858078|FG000|Year 4|Lost to Follow-up|4|||
125334524|NCT03710083|450858079|FG000|Overall Study|Withdrawal by Subject|2|||
125334525|NCT03710083|450858079|FG000|Overall Study|Unsuccessful Procedure|1|||
125334526|NCT05300763|450858080|FG000|Overall Study|Adverse Event|0|||
125334527|NCT05300763|450858081|FG001|Overall Study|Adverse Event|1|||
125334528|NCT05300763|450858080|FG000|Overall Study|Major Protocol Deviation|1|||
125002950|NCT03785678|449639207|FG001|Overall Study|Lost to Follow-up|2|||
125334529|NCT05300763|450858081|FG001|Overall Study|Major Protocol Deviation|0|||
125334530|NCT05300763|450858080|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
125334531|NCT05300763|450858081|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
125334532|NCT00441064|450858086|FG000|Overall Study|Adverse Event|1|||
125002951|NCT03785678|449639206|FG000|Overall Study|Physician Decision|0|||
125002952|NCT03785678|449639207|FG001|Overall Study|Physician Decision|2|||
125002953|NCT03785678|449639206|FG000|Overall Study|Withdrawal by Subject|5|||
125334533|NCT00441064|450858087|FG001|Overall Study|Adverse Event|0|||
125334534|NCT00441064|450858086|FG000|Overall Study|Abnormal laboratory values|0|||
125334535|NCT00441064|450858087|FG001|Overall Study|Abnormal laboratory values|2|||
125334536|NCT00441064|450858086|FG000|Overall Study|Abnormal test procedure results|0|||
125334537|NCT00441064|450858087|FG001|Overall Study|Abnormal test procedure results|1|||
125334538|NCT00441064|450858086|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125334539|NCT00441064|450858087|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125334540|NCT00441064|450858086|FG000|Overall Study|Protocol Deviation|3|||
125334541|NCT00441064|450858087|FG001|Overall Study|Protocol Deviation|2|||
125334542|NCT00441064|450858086|FG000|Overall Study|Patient withdrew consent|5|||
125334543|NCT00441064|450858087|FG001|Overall Study|Patient withdrew consent|2|||
125334544|NCT00953056|450858088|FG000|Overall Study|Withdrew Consent|0|||
125002954|NCT03785678|449639207|FG001|Overall Study|Withdrawal by Subject|3|||
125002955|NCT02374021|449639211|FG000|Overall Study|Adverse Event|1|||
125334545|NCT00953056|450858089|FG001|Overall Study|Withdrew Consent|0|||
125334546|NCT00953056|450858090|FG002|Overall Study|Withdrew Consent|0|||
125002956|NCT02374021|449639212|FG001|Overall Study|Adverse Event|0|||
125002957|NCT02374021|449639211|FG000|Overall Study|Lost to Follow-up|3|||
125002958|NCT02374021|449639212|FG001|Overall Study|Lost to Follow-up|2|||
125002959|NCT02374021|449639211|FG000|Overall Study|Physician Decision|0|||
125002960|NCT02374021|449639212|FG001|Overall Study|Physician Decision|3|||
125002961|NCT02374021|449639211|FG000|Overall Study|Withdrawal by Subject|6|||
125002962|NCT02374021|449639212|FG001|Overall Study|Withdrawal by Subject|5|||
125002963|NCT02374021|449639211|FG000|Overall Study|Poor Adherence|0|||
125002964|NCT02374021|449639212|FG001|Overall Study|Poor Adherence|1|||
125002965|NCT02374021|449639211|FG000|Overall Study|Scan protocol not followed|0|||
125002966|NCT02374021|449639212|FG001|Overall Study|Scan protocol not followed|1|||
125002967|NCT02374021|449639211|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
125002968|NCT02374021|449639212|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
125002969|NCT01667107|449639213|FG000|Overall Study|Adverse Event|4|||
125002970|NCT01667107|449639214|FG001|Overall Study|Adverse Event|3|||
125002971|NCT01667107|449639213|FG000|Overall Study|Tolerability issues|0|||
125002972|NCT01667107|449639214|FG001|Overall Study|Tolerability issues|2|||
125334547|NCT00953056|450858091|FG003|Overall Study|Withdrew Consent|0|||
125334548|NCT00953056|450858092|FG004|Overall Study|Withdrew Consent|2|||
125334549|NCT00953056|450858093|FG005|Overall Study|Withdrew Consent|3|||
125334550|NCT00953056|450858088|FG000|Overall Study|Serious Adverse Event|0|||
125334551|NCT00953056|450858089|FG001|Overall Study|Serious Adverse Event|0|||
125334552|NCT00953056|450858090|FG002|Overall Study|Serious Adverse Event|0|||
125334553|NCT00953056|450858091|FG003|Overall Study|Serious Adverse Event|0|||
125334554|NCT00953056|450858092|FG004|Overall Study|Serious Adverse Event|0|||
125334555|NCT00953056|450858093|FG005|Overall Study|Serious Adverse Event|1|||
125334556|NCT03962504|450858094|FG000|Overall Study|Other|11|||
125334557|NCT03962504|450858095|FG001|Overall Study|Other|32|||
125334558|NCT01077076|450858096|FG000|First Intervention|Withdrawal by Subject|1|||
125334559|NCT01077076|450858097|FG001|First Intervention|Withdrawal by Subject|0|||
125334560|NCT01077076|450858098|FG002|First Intervention|Withdrawal by Subject|0|||
125334561|NCT01077076|450858099|FG003|First Intervention|Withdrawal by Subject|0|||
125334562|NCT01077076|450858100|FG004|First Intervention|Withdrawal by Subject|0|||
125334563|NCT01077076|450858101|FG005|First Intervention|Withdrawal by Subject|0|||
125334564|NCT01077076|450858096|FG000|Third Intervention|Death in the participant's family|0|||
125334565|NCT01077076|450858097|FG001|Third Intervention|Death in the participant's family|0|||
125334566|NCT01077076|450858098|FG002|Third Intervention|Death in the participant's family|0|||
125334567|NCT01077076|450858099|FG003|Third Intervention|Death in the participant's family|0|||
125334568|NCT01077076|450858100|FG004|Third Intervention|Death in the participant's family|0|||
125334569|NCT01077076|450858101|FG005|Third Intervention|Death in the participant's family|1|||
125334570|NCT01976741|450858102|FG000|Overall Study|Withdrawal by Subject|1|||
125334571|NCT01976741|450858103|FG001|Overall Study|Withdrawal by Subject|0|||
125334572|NCT01976741|450858104|FG002|Overall Study|Withdrawal by Subject|1|||
125334573|NCT01976741|450858105|FG003|Overall Study|Withdrawal by Subject|1|||
125334574|NCT01976741|450858106|FG004|Overall Study|Withdrawal by Subject|0|||
125334575|NCT01976741|450858107|FG005|Overall Study|Withdrawal by Subject|0|||
125334576|NCT01976741|450858108|FG006|Overall Study|Withdrawal by Subject|1|||
125334577|NCT01976741|450858109|FG007|Overall Study|Withdrawal by Subject|4|||
125334578|NCT01976741|450858110|FG008|Overall Study|Withdrawal by Subject|0|||
125334579|NCT01976741|450858111|FG009|Overall Study|Withdrawal by Subject|0|||
125334580|NCT01976741|450858102|FG000|Overall Study|Adverse Event|0|||
125334581|NCT01976741|450858103|FG001|Overall Study|Adverse Event|0|||
125334582|NCT01976741|450858104|FG002|Overall Study|Adverse Event|2|||
125334583|NCT01976741|450858105|FG003|Overall Study|Adverse Event|0|||
125334584|NCT01976741|450858106|FG004|Overall Study|Adverse Event|0|||
125334585|NCT01976741|450858107|FG005|Overall Study|Adverse Event|0|||
125334586|NCT01976741|450858108|FG006|Overall Study|Adverse Event|3|||
125334587|NCT01976741|450858109|FG007|Overall Study|Adverse Event|8|||
125002973|NCT01667107|449639213|FG000|Overall Study|Protocol Violation|0|||
125002974|NCT01667107|449639214|FG001|Overall Study|Protocol Violation|1|||
125334588|NCT01976741|450858110|FG008|Overall Study|Adverse Event|1|||
125334589|NCT01976741|450858111|FG009|Overall Study|Adverse Event|4|||
125334590|NCT00889720|450858112|FG000|Overall Study|Withdrawal by Subject|4|||
125002975|NCT01667107|449639213|FG000|Overall Study|Lack of Efficacy|0|||
125002976|NCT01667107|449639214|FG001|Overall Study|Lack of Efficacy|1|||
125334591|NCT00889720|450858112|FG000|Overall Study|Other|4|||
125334592|NCT00670306|450858113|FG000|Overall Study|Adverse Event|8|||
125334593|NCT00670306|450858113|FG000|Overall Study|Lack of Efficacy|10|||
125334594|NCT00670306|450858113|FG000|Overall Study|Withdrawal by Subject|9|||
125334595|NCT00670306|450858113|FG000|Overall Study|Physician Decision|1|||
125334596|NCT00670306|450858113|FG000|Overall Study|Lost to Follow-up|8|||
125334597|NCT00670306|450858113|FG000|Overall Study|incl/excl criterias did not meet|19|||
125002977|NCT01162239|449639215|FG000|Treatment Phase|Withdrawal by Subject|1|||
125002978|NCT01162239|449639216|FG001|Treatment Phase|Withdrawal by Subject|3|||
125002979|NCT01162239|449639217|FG002|Treatment Phase|Withdrawal by Subject|2|||
125002980|NCT01162239|449639218|FG003|Treatment Phase|Withdrawal by Subject|3|||
125002981|NCT01162239|449639215|FG000|Treatment Phase|Death|0|||
125002982|NCT01162239|449639216|FG001|Treatment Phase|Death|0|||
125002983|NCT01162239|449639217|FG002|Treatment Phase|Death|0|||
125002984|NCT01162239|449639218|FG003|Treatment Phase|Death|1|||
125002985|NCT01162239|449639215|FG000|Treatment Phase|Lost to Follow-up|5|||
125002986|NCT01162239|449639216|FG001|Treatment Phase|Lost to Follow-up|4|||
125002987|NCT01162239|449639217|FG002|Treatment Phase|Lost to Follow-up|2|||
125002988|NCT01162239|449639218|FG003|Treatment Phase|Lost to Follow-up|1|||
125002989|NCT01162239|449639215|FG000|Extended Follow-up|Lost to Follow-up|8|||
125089900|NCT00082628|449947047|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
125089901|NCT00082628|449947048|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
125089902|NCT00082628|449947049|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
125089903|NCT00082628|449947050|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
125089904|NCT00082628|449947046|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
125089905|NCT00082628|449947047|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
125089906|NCT00082628|449947048|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
125089907|NCT00082628|449947049|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
125089908|NCT00082628|449947050|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
125089909|NCT00082628|449947046|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
125089910|NCT00082628|449947047|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
125089911|NCT00082628|449947048|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
125089912|NCT00082628|449947049|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
125089913|NCT00082628|449947050|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
125089914|NCT00082628|449947046|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
125089915|NCT00082628|449947047|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
125089916|NCT00082628|449947048|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
125334598|NCT01327482|450858114|FG000|Overall Study|Adverse Event|1|||
125334599|NCT00476229|450858115|FG000|Overall Study|Progressive shortness of breath|1|||
125334600|NCT01032889|450858116|FG000|Overall Study|Adverse Event|2|||
125334601|NCT01032889|450858117|FG001|Overall Study|Adverse Event|2|||
125334602|NCT01032889|450858118|FG002|Overall Study|Adverse Event|0|||
125334603|NCT01032889|450858116|FG000|Overall Study|Withdrawal of Consent|1|||
125334604|NCT01032889|450858117|FG001|Overall Study|Withdrawal of Consent|2|||
125334605|NCT01032889|450858118|FG002|Overall Study|Withdrawal of Consent|1|||
125334606|NCT01032889|450858116|FG000|Overall Study|Patient Request|0|||
125334607|NCT01032889|450858117|FG001|Overall Study|Patient Request|1|||
125334608|NCT01032889|450858118|FG002|Overall Study|Patient Request|0|||
125334609|NCT01032889|450858116|FG000|Overall Study|Lost to Follow-up|1|||
125334610|NCT01032889|450858117|FG001|Overall Study|Lost to Follow-up|1|||
125334611|NCT01032889|450858118|FG002|Overall Study|Lost to Follow-up|0|||
125334612|NCT01032889|450858116|FG000|Overall Study|Lack of Submental Fat|2|||
125334613|NCT01032889|450858117|FG001|Overall Study|Lack of Submental Fat|8|||
125334614|NCT01032889|450858118|FG002|Overall Study|Lack of Submental Fat|1|||
125334615|NCT01032889|450858116|FG000|Overall Study|Miscellaneous Reasons|2|||
125334616|NCT01032889|450858117|FG001|Overall Study|Miscellaneous Reasons|1|||
125334617|NCT01032889|450858118|FG002|Overall Study|Miscellaneous Reasons|1|||
125334618|NCT00993148|450858120|FG000|Overall Study|Lost to Follow-up|2|||
125334619|NCT00993148|450858120|FG000|Overall Study|never initiated treatment|1|||
125334620|NCT00472030|450858121|FG000|Overall Study|Physician Decision|1|||
125334621|NCT00472030|450858122|FG001|Overall Study|Physician Decision|0|||
125334622|NCT00912197|450858125|FG000|Overall Study|Withdrawal by Subject|3|||
125334623|NCT00912197|450858126|FG001|Overall Study|Withdrawal by Subject|3|||
125334624|NCT01615029|450858132|FG000|Overall Study|Adverse Event|0|||
125334625|NCT01615029|450858133|FG001|Overall Study|Adverse Event|0|||
125334626|NCT01615029|450858134|FG002|Overall Study|Adverse Event|0|||
125334627|NCT01615029|450858135|FG003|Overall Study|Adverse Event|0|||
125334628|NCT01615029|450858136|FG004|Overall Study|Adverse Event|1|||
125334629|NCT01615029|450858132|FG000|Overall Study|Death|0|||
125334630|NCT01615029|450858133|FG001|Overall Study|Death|0|||
125334631|NCT01615029|450858134|FG002|Overall Study|Death|0|||
125334632|NCT01615029|450858135|FG003|Overall Study|Death|0|||
125334633|NCT01615029|450858136|FG004|Overall Study|Death|1|||
125334634|NCT01615029|450858132|FG000|Overall Study|Lost to Follow-up|0|||
125002990|NCT01162239|449639216|FG001|Extended Follow-up|Lost to Follow-up|13|||
125334635|NCT01615029|450858133|FG001|Overall Study|Lost to Follow-up|0|||
125334636|NCT01615029|450858134|FG002|Overall Study|Lost to Follow-up|0|||
125334637|NCT01615029|450858135|FG003|Overall Study|Lost to Follow-up|0|||
125334638|NCT01615029|450858136|FG004|Overall Study|Lost to Follow-up|1|||
125334639|NCT01615029|450858132|FG000|Overall Study|Progressive disease|2|||
125089917|NCT00082628|449947049|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
125089918|NCT00082628|449947050|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
125089919|NCT00082628|449947046|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
125089920|NCT00082628|449947047|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
125089921|NCT00082628|449947048|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
125089922|NCT00082628|449947049|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
125089923|NCT00082628|449947050|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
125089924|NCT00082628|449947046|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
125089925|NCT00082628|449947047|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
125089926|NCT00082628|449947048|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
125089927|NCT00082628|449947049|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
125089928|NCT00082628|449947050|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
125089929|NCT00082628|449947046|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
125089930|NCT00082628|449947047|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
125089931|NCT00082628|449947048|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
125089932|NCT00082628|449947049|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
125089933|NCT00082628|449947050|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
125089934|NCT02177942|449947055|FG000|Overall Study|Adverse Event|1|||
125089935|NCT02177942|449947056|FG001|Overall Study|Adverse Event|0|||
125089936|NCT02177942|449947055|FG000|Overall Study|Lost to Follow-up|1|||
125089937|NCT02177942|449947056|FG001|Overall Study|Lost to Follow-up|1|||
125089938|NCT02177942|449947055|FG000|Overall Study|Protocol Violation|4|||
125089939|NCT02177942|449947056|FG001|Overall Study|Protocol Violation|6|||
125089940|NCT02177942|449947055|FG000|Overall Study|Withdrawal by Subject|71|||
125089941|NCT02177942|449947056|FG001|Overall Study|Withdrawal by Subject|81|||
125089942|NCT01351415|449947057|FG000|Overall Study|Withdrawal by Subject|15|||
125089943|NCT01351415|449947058|FG001|Overall Study|Withdrawal by Subject|17|||
125089944|NCT01351415|449947057|FG000|Overall Study|Trial termination by the Sponsor|28|||
125089945|NCT01351415|449947058|FG001|Overall Study|Trial termination by the Sponsor|19|||
125089946|NCT01351415|449947057|FG000|Overall Study|Lost to Follow-up|5|||
125089947|NCT01351415|449947058|FG001|Overall Study|Lost to Follow-up|7|||
125089948|NCT01351415|449947057|FG000|Overall Study|Death|190|||
125089949|NCT01351415|449947058|FG001|Overall Study|Death|187|||
125089950|NCT01351415|449947057|FG000|Overall Study|Physician Decision|2|||
125089951|NCT01351415|449947058|FG001|Overall Study|Physician Decision|3|||
125089952|NCT01351415|449947057|FG000|Overall Study|Reason unknown|0|||
125089953|NCT01351415|449947058|FG001|Overall Study|Reason unknown|2|||
125089954|NCT01351415|449947057|FG000|Overall Study|Never Started|5|||
125089955|NCT01351415|449947058|FG001|Overall Study|Never Started|5|||
125089956|NCT01234337|449947059|FG000|Overall Study|Adverse Event|58|||
125089957|NCT01234337|449947060|FG001|Overall Study|Adverse Event|21|||
125089958|NCT01234337|449947059|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
125089959|NCT01234337|449947060|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
125089960|NCT01234337|449947059|FG000|Overall Study|Investi. decision not protocol driven|5|||
125089961|NCT01234337|449947060|FG001|Overall Study|Investi. decision not protocol driven|6|||
125089962|NCT01234337|449947059|FG000|Overall Study|Non-compliant with study medication|3|||
125089963|NCT01234337|449947060|FG001|Overall Study|Non-compliant with study medication|2|||
125089964|NCT01234337|449947059|FG000|Overall Study|Randomized but not treated|6|||
125089965|NCT01234337|449947060|FG001|Overall Study|Randomized but not treated|4|||
125334640|NCT01615029|450858133|FG001|Overall Study|Progressive disease|1|||
125334641|NCT01615029|450858134|FG002|Overall Study|Progressive disease|1|||
125334642|NCT01615029|450858135|FG003|Overall Study|Progressive disease|1|||
125334643|NCT01615029|450858136|FG004|Overall Study|Progressive disease|5|||
125334644|NCT01615029|450858132|FG000|Overall Study|Physician Decision|0|||
125334645|NCT01615029|450858133|FG001|Overall Study|Physician Decision|0|||
125334646|NCT01615029|450858134|FG002|Overall Study|Physician Decision|0|||
125334647|NCT01615029|450858135|FG003|Overall Study|Physician Decision|0|||
125334648|NCT01615029|450858136|FG004|Overall Study|Physician Decision|1|||
125334649|NCT01615029|450858132|FG000|Overall Study|Ongoing|1|||
125334650|NCT01615029|450858133|FG001|Overall Study|Ongoing|2|||
125334651|NCT01615029|450858134|FG002|Overall Study|Ongoing|3|||
125334652|NCT01615029|450858135|FG003|Overall Study|Ongoing|2|||
125334653|NCT01615029|450858136|FG004|Overall Study|Ongoing|23|||
125334654|NCT01326104|450858137|FG000|Overall Study|progressed prior to vaccine|0|||
125334655|NCT01326104|450858138|FG001|Overall Study|progressed prior to vaccine|2|||
125334656|NCT01326104|450858137|FG000|Overall Study|unable to make vaccine|0|||
125334657|NCT01326104|450858138|FG001|Overall Study|unable to make vaccine|2|||
125334658|NCT01287741|450858139|FG000|Overall Study|Withdrawal by Subject|35|||
125089966|NCT01234337|449947059|FG000|Overall Study|Lost to Follow-up|0|||
125334659|NCT01287741|450858140|FG001|Overall Study|Withdrawal by Subject|38|||
125334660|NCT01287741|450858139|FG000|Overall Study|Protocol Violation|2|||
125334661|NCT01287741|450858140|FG001|Overall Study|Protocol Violation|0|||
125334662|NCT01287741|450858139|FG000|Overall Study|Physician Decision|15|||
125334663|NCT01287741|450858140|FG001|Overall Study|Physician Decision|23|||
125334664|NCT01287741|450858139|FG000|Overall Study|Non-compliance|8|||
125334665|NCT01287741|450858140|FG001|Overall Study|Non-compliance|6|||
125334666|NCT01287741|450858139|FG000|Overall Study|Lost to Follow-up|10|||
125089967|NCT01234337|449947060|FG001|Overall Study|Lost to Follow-up|1|||
125089968|NCT01234337|449947059|FG000|Overall Study|Protocol Violation|2|||
125089969|NCT01234337|449947060|FG001|Overall Study|Protocol Violation|3|||
125089970|NCT01234337|449947059|FG000|Overall Study|Withdrawal by Subject|11|||
125089971|NCT01234337|449947060|FG001|Overall Study|Withdrawal by Subject|9|||
125089972|NCT01234337|449947059|FG000|Overall Study|Death|0|||
125089973|NCT01234337|449947060|FG001|Overall Study|Death|1|||
125089974|NCT01234337|449947059|FG000|Overall Study|Switch to commercial drug|0|||
125089975|NCT01234337|449947060|FG001|Overall Study|Switch to commercial drug|1|||
125089976|NCT04118127|449947065|FG000|Overall Study|Trial terminated by sponsor|0|||
125089977|NCT04118127|449947066|FG001|Overall Study|Trial terminated by sponsor|12|||
125089978|NCT04118127|449947065|FG000|Overall Study|Adverse Event|1|||
125089979|NCT04118127|449947066|FG001|Overall Study|Adverse Event|2|||
125089980|NCT04118127|449947065|FG000|Overall Study|Physician Decision|0|||
125089981|NCT04118127|449947066|FG001|Overall Study|Physician Decision|1|||
125089982|NCT04118127|449947065|FG000|Overall Study|Withdrawal by Subject|2|||
125089983|NCT04118127|449947066|FG001|Overall Study|Withdrawal by Subject|1|||
125334667|NCT01287741|450858140|FG001|Overall Study|Lost to Follow-up|8|||
125334668|NCT01287741|450858139|FG000|Overall Study|Death|32|||
125334669|NCT01287741|450858140|FG001|Overall Study|Death|44|||
125334670|NCT01287741|450858139|FG000|Overall Study|Adverse Event|4|||
125334671|NCT01287741|450858140|FG001|Overall Study|Adverse Event|6|||
125334672|NCT01287741|450858139|FG000|Overall Study|Study terminated by Sponsor|307|||
125334673|NCT01287741|450858140|FG001|Overall Study|Study terminated by Sponsor|315|||
125334674|NCT01287741|450858139|FG000|Overall Study|Progressive disease|190|||
125334675|NCT01287741|450858140|FG001|Overall Study|Progressive disease|166|||
125334676|NCT01287741|450858139|FG000|Overall Study|Reason not specified|23|||
125334677|NCT01287741|450858140|FG001|Overall Study|Reason not specified|9|||
125089984|NCT03480360|449947067|FG000|Overall Study|Death|2|||
125089985|NCT01646255|449947072|FG000|Overall Study|Adverse Event|7|||
125089986|NCT01646255|449947073|FG001|Overall Study|Adverse Event|8|||
125089987|NCT01646255|449947072|FG000|Overall Study|Lack of Efficacy|2|||
125089988|NCT01646255|449947073|FG001|Overall Study|Lack of Efficacy|0|||
125089989|NCT01646255|449947072|FG000|Overall Study|Withdrawal by Subject|10|||
125089990|NCT01646255|449947073|FG001|Overall Study|Withdrawal by Subject|6|||
125089991|NCT01646255|449947072|FG000|Overall Study|Compliance is not well|1|||
125089992|NCT01646255|449947073|FG001|Overall Study|Compliance is not well|0|||
125089993|NCT01646255|449947072|FG000|Overall Study|Inclusion Criteria Deviation|1|||
125089994|NCT01646255|449947073|FG001|Overall Study|Inclusion Criteria Deviation|0|||
125089995|NCT03480841|449947074|FG000|Overall Study|Lost to Follow-up|2|||
125089996|NCT02380703|449947075|FG000|Overall Study|Withdrawal by Subject|12|||
125089997|NCT02380703|449947076|FG001|Overall Study|Withdrawal by Subject|9|||
125089998|NCT02380703|449947075|FG000|Overall Study|Lost to Follow-up|12|||
125089999|NCT02380703|449947076|FG001|Overall Study|Lost to Follow-up|12|||
125090000|NCT02380703|449947075|FG000|Overall Study|Caregiver death|1|||
125090001|NCT02380703|449947076|FG001|Overall Study|Caregiver death|0|||
125090002|NCT02380703|449947075|FG000|Overall Study|Person with dementia (PWD) death|7|||
125090003|NCT02380703|449947076|FG001|Overall Study|Person with dementia (PWD) death|8|||
125090004|NCT02380703|449947075|FG000|Overall Study|Entered Long-term Care|4|||
125090005|NCT02380703|449947076|FG001|Overall Study|Entered Long-term Care|7|||
125090006|NCT01362049|449947077|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
125090007|NCT01362049|449947078|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
125090008|NCT01362049|449947079|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
125090009|NCT01362049|449947080|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
125090010|NCT01362049|449947077|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
125090011|NCT01362049|449947078|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
125090012|NCT01362049|449947079|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
125090013|NCT01362049|449947080|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
125090014|NCT01524900|449948644|FG000|Overall Study|Lost to Follow-up|3|||
125090015|NCT01524900|449948645|FG001|Overall Study|Lost to Follow-up|12|||
125090016|NCT01524900|449948646|FG002|Overall Study|Lost to Follow-up|1|||
125090017|NCT01524900|449948647|FG003|Overall Study|Lost to Follow-up|0|||
125090018|NCT01524900|449948648|FG004|Overall Study|Lost to Follow-up|0|||
125090019|NCT01524900|449948644|FG000|Overall Study|Other reason than stated above|1|||
125090020|NCT01524900|449948645|FG001|Overall Study|Other reason than stated above|1|||
125090021|NCT01524900|449948646|FG002|Overall Study|Other reason than stated above|0|||
125090022|NCT01524900|449948647|FG003|Overall Study|Other reason than stated above|0|||
125090023|NCT01524900|449948648|FG004|Overall Study|Other reason than stated above|0|||
125090024|NCT01524900|449948644|FG000|Overall Study|No reason documented|2|||
125334678|NCT04421027|450858141|FG000|Treatment Period|Adverse Event|5|||
125090025|NCT01524900|449948645|FG001|Overall Study|No reason documented|1|||
125090026|NCT01524900|449948646|FG002|Overall Study|No reason documented|0|||
125334679|NCT04421027|450858142|FG001|Treatment Period|Adverse Event|3|||
125334680|NCT04421027|450858143|FG002|Treatment Period|Adverse Event|0|||
125334681|NCT04421027|450858144|FG003|Treatment Period|Adverse Event|0|||
125334682|NCT04421027|450858141|FG000|Treatment Period|Death|98|||
125334683|NCT04421027|450858142|FG001|Treatment Period|Death|61|||
125334684|NCT04421027|450858143|FG002|Treatment Period|Death|0|||
125334685|NCT04421027|450858144|FG003|Treatment Period|Death|0|||
125334686|NCT04421027|450858141|FG000|Treatment Period|Lost to Follow-up|22|||
125334687|NCT04421027|450858142|FG001|Treatment Period|Lost to Follow-up|20|||
125334688|NCT04421027|450858143|FG002|Treatment Period|Lost to Follow-up|0|||
125334689|NCT04421027|450858144|FG003|Treatment Period|Lost to Follow-up|0|||
125334690|NCT04421027|450858141|FG000|Treatment Period|Other-Unknown|15|||
125334691|NCT04421027|450858142|FG001|Treatment Period|Other-Unknown|9|||
125334692|NCT04421027|450858143|FG002|Treatment Period|Other-Unknown|0|||
125334693|NCT04421027|450858144|FG003|Treatment Period|Other-Unknown|0|||
125334694|NCT04421027|450858141|FG000|Treatment Period|Physician Decision|1|||
125334695|NCT04421027|450858142|FG001|Treatment Period|Physician Decision|1|||
125334696|NCT04421027|450858143|FG002|Treatment Period|Physician Decision|0|||
125334697|NCT04421027|450858144|FG003|Treatment Period|Physician Decision|0|||
125334698|NCT04421027|450858141|FG000|Treatment Period|Withdrawal by Subject|7|||
125334699|NCT04421027|450858142|FG001|Treatment Period|Withdrawal by Subject|12|||
125334700|NCT04421027|450858143|FG002|Treatment Period|Withdrawal by Subject|0|||
125334701|NCT04421027|450858144|FG003|Treatment Period|Withdrawal by Subject|0|||
125334702|NCT04421027|450858141|FG000|Treatment Period|Randomized Not Dosed|9|||
125334703|NCT04421027|450858142|FG001|Treatment Period|Randomized Not Dosed|14|||
125334704|NCT04421027|450858143|FG002|Treatment Period|Randomized Not Dosed|0|||
125334705|NCT04421027|450858144|FG003|Treatment Period|Randomized Not Dosed|0|||
125334706|NCT04421027|450858141|FG000|Follow-Up Period|Adverse Event|0|||
125334707|NCT04421027|450858142|FG001|Follow-Up Period|Adverse Event|0|||
125334708|NCT04421027|450858143|FG002|Follow-Up Period|Adverse Event|0|||
125334709|NCT04421027|450858144|FG003|Follow-Up Period|Adverse Event|3|||
125334710|NCT04421027|450858141|FG000|Follow-Up Period|Death|0|||
125334711|NCT04421027|450858142|FG001|Follow-Up Period|Death|0|||
125334712|NCT04421027|450858143|FG002|Follow-Up Period|Death|16|||
125334713|NCT04421027|450858144|FG003|Follow-Up Period|Death|17|||
125334714|NCT04421027|450858141|FG000|Follow-Up Period|Lost to Follow-up|0|||
125334715|NCT04421027|450858142|FG001|Follow-Up Period|Lost to Follow-up|0|||
125334716|NCT04421027|450858143|FG002|Follow-Up Period|Lost to Follow-up|7|||
125334717|NCT04421027|450858144|FG003|Follow-Up Period|Lost to Follow-up|7|||
125334718|NCT04421027|450858141|FG000|Follow-Up Period|Protocol Deviation|0|||
125334719|NCT04421027|450858142|FG001|Follow-Up Period|Protocol Deviation|0|||
125334720|NCT04421027|450858143|FG002|Follow-Up Period|Protocol Deviation|1|||
125334721|NCT04421027|450858144|FG003|Follow-Up Period|Protocol Deviation|0|||
125334722|NCT04421027|450858141|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
125334723|NCT04421027|450858142|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
125334724|NCT04421027|450858143|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
125334725|NCT04421027|450858144|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
125334726|NCT04421027|450858141|FG000|Follow-Up Period|Left message, participant did not call back|0|||
125334727|NCT04421027|450858142|FG001|Follow-Up Period|Left message, participant did not call back|0|||
125334728|NCT04421027|450858143|FG002|Follow-Up Period|Left message, participant did not call back|0|||
125334729|NCT04421027|450858144|FG003|Follow-Up Period|Left message, participant did not call back|1|||
125334730|NCT04421027|450858141|FG000|Follow-Up Period|Participant died|0|||
125334731|NCT04421027|450858142|FG001|Follow-Up Period|Participant died|0|||
125334732|NCT04421027|450858143|FG002|Follow-Up Period|Participant died|0|||
125334733|NCT04421027|450858144|FG003|Follow-Up Period|Participant died|1|||
125334734|NCT04421027|450858141|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
125090027|NCT01524900|449948647|FG003|Overall Study|No reason documented|1|||
125090028|NCT01524900|449948648|FG004|Overall Study|No reason documented|0|||
125090029|NCT03824704|449948649|FG000|Overall Study|Study Terminated by Sponsor|1|||
125090030|NCT00298766|449948650|FG000|Overall Study|Adverse Event|18|||
125090031|NCT00298766|449948650|FG000|Overall Study|Death|2|||
125090032|NCT00298766|449948650|FG000|Overall Study|Withdrawal by Subject|9|||
125090033|NCT00298766|449948650|FG000|Overall Study|Treatment ongoing|4|||
125090034|NCT00298766|449948650|FG000|Overall Study|Progression of amyloid markers|4|||
125090035|NCT00298766|449948650|FG000|Overall Study|Deterioration in KPS and organ function|1|||
125090036|NCT00298766|449948650|FG000|Overall Study|Subjects overall condition deterioration|4|||
125090037|NCT00298766|449948650|FG000|Overall Study|Other|4|||
125334735|NCT04421027|450858142|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
125334736|NCT04421027|450858143|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
125334737|NCT04421027|450858144|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
125334738|NCT00802945|450858145|FG000|Overall Study|Death|27|||
125334739|NCT00802945|450858146|FG001|Overall Study|Death|23|||
125334740|NCT00802945|450858145|FG000|Overall Study|Terminated by sponsor|8|||
125334741|NCT00802945|450858146|FG001|Overall Study|Terminated by sponsor|12|||
125334742|NCT02930018|450858148|FG000|Overall Study|Lost to Follow-up|1|||
125334743|NCT02930018|450858149|FG001|Overall Study|Lost to Follow-up|1|||
125334744|NCT02930018|450858148|FG000|Overall Study|Withdrawal by Subject|5|||
125334745|NCT02930018|450858149|FG001|Overall Study|Withdrawal by Subject|2|||
125334746|NCT04193189|450858151|FG000|Overall Study|Lost to Follow-up|9|||
125334747|NCT04193189|450858152|FG001|Overall Study|Lost to Follow-up|7|||
125334748|NCT04193189|450858153|FG002|Overall Study|Lost to Follow-up|9|||
125334749|NCT04193189|450858154|FG003|Overall Study|Lost to Follow-up|0|||
125334750|NCT04193189|450858151|FG000|Overall Study|Withdrawal by Subject|1|||
125334751|NCT04193189|450858152|FG001|Overall Study|Withdrawal by Subject|2|||
125334752|NCT04193189|450858153|FG002|Overall Study|Withdrawal by Subject|2|||
125334753|NCT04193189|450858154|FG003|Overall Study|Withdrawal by Subject|0|||
125334754|NCT04193189|450858151|FG000|Overall Study|Death|1|||
125334755|NCT04193189|450858152|FG001|Overall Study|Death|1|||
125334756|NCT04193189|450858153|FG002|Overall Study|Death|0|||
125334757|NCT04193189|450858154|FG003|Overall Study|Death|0|||
125334758|NCT04193189|450858151|FG000|Overall Study|Protocol Violation|0|||
125334759|NCT04193189|450858152|FG001|Overall Study|Protocol Violation|0|||
125334760|NCT04193189|450858153|FG002|Overall Study|Protocol Violation|0|||
125334761|NCT04193189|450858154|FG003|Overall Study|Protocol Violation|1|||
125334762|NCT00539864|450859706|FG000|Overall Study|Lost to Follow-up|0|||
125334763|NCT00539864|450859707|FG001|Overall Study|Lost to Follow-up|1|||
125334764|NCT00539864|450859706|FG000|Overall Study|Withdrawal by Subject|1|||
125334765|NCT00539864|450859707|FG001|Overall Study|Withdrawal by Subject|1|||
125334766|NCT02565784|450859708|FG000|First Treatment|Adverse Event|1|||
125334767|NCT02565784|450859708|FG000|First Treatment|Withdrawal by Subject|1|||
125334768|NCT02565784|450859708|FG000|Second Treatment|Withdrawal by Subject|2|||
125334769|NCT00943072|450859714|FG000|Overall Study|Adverse Event|0|||
125334770|NCT00943072|450859715|FG001|Overall Study|Adverse Event|3|||
125334771|NCT00943072|450859714|FG000|Overall Study|Death|0|||
125334772|NCT00943072|450859715|FG001|Overall Study|Death|2|||
125334773|NCT00943072|450859714|FG000|Overall Study|Withdrawal by Subject|3|||
125334774|NCT00943072|450859715|FG001|Overall Study|Withdrawal by Subject|1|||
125334775|NCT00943072|450859714|FG000|Overall Study|Protocol Violation|0|||
125334776|NCT00943072|450859715|FG001|Overall Study|Protocol Violation|1|||
125334777|NCT00943072|450859714|FG000|Overall Study|Lost to Follow-up|1|||
125334778|NCT00943072|450859715|FG001|Overall Study|Lost to Follow-up|2|||
125334779|NCT00943072|450859714|FG000|Overall Study|Lack of Efficacy|0|||
125334780|NCT00943072|450859715|FG001|Overall Study|Lack of Efficacy|4|||
125334781|NCT00943072|450859714|FG000|Overall Study|Other|1|||
125334782|NCT00943072|450859715|FG001|Overall Study|Other|1|||
125334783|NCT00552188|450859716|FG000|Overall Study|Adverse Event|0|||
125334784|NCT00552188|450859717|FG001|Overall Study|Adverse Event|2|||
125334785|NCT00552188|450859716|FG000|Overall Study|Lost to Follow-up|2|||
125334786|NCT00552188|450859717|FG001|Overall Study|Lost to Follow-up|1|||
125334787|NCT00552188|450859716|FG000|Overall Study|Withdrawal of consent|0|||
125334788|NCT00552188|450859717|FG001|Overall Study|Withdrawal of consent|1|||
125334789|NCT00552188|450859716|FG000|Overall Study|Subject returned to home country|0|||
125334790|NCT00552188|450859717|FG001|Overall Study|Subject returned to home country|1|||
125334791|NCT03887702|450859718|FG000|Overall Study|Study terminated|0|||
125334792|NCT03887702|450859719|FG001|Overall Study|Study terminated|0|||
125334793|NCT03887702|450859720|FG002|Overall Study|Study terminated|2|||
125334794|NCT03887702|450859721|FG003|Overall Study|Study terminated|2|||
125334795|NCT01675544|450859724|FG000|Overall Study|Withdrawal by Subject|2|||
125334796|NCT00476008|450859729|FG000|Overall Study|Adverse Event|4|||
125334797|NCT00476008|450859730|FG001|Overall Study|Adverse Event|4|||
125334798|NCT00476008|450859729|FG000|Overall Study|Placebo concerns|2|||
125090038|NCT02988115|449948652|FG000|Overall Study|Adverse Event|6|||
125334799|NCT00476008|450859730|FG001|Overall Study|Placebo concerns|2|||
125334800|NCT00476008|450859729|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
125334801|NCT00476008|450859730|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
125334802|NCT00476008|450859729|FG000|Overall Study|Withdrawal by Subject|0|||
125334803|NCT00476008|450859730|FG001|Overall Study|Withdrawal by Subject|1|||
125334804|NCT00476008|450859729|FG000|Overall Study|Death|1|||
125090039|NCT02988115|449948653|FG001|Overall Study|Adverse Event|1|||
125090040|NCT02988115|449948652|FG000|Overall Study|Sponsor Decision|5|||
125090041|NCT02988115|449948653|FG001|Overall Study|Sponsor Decision|2|||
125090042|NCT02988115|449948652|FG000|Overall Study|Withdrawal by Subject|1|||
125334805|NCT00476008|450859730|FG001|Overall Study|Death|0|||
125334806|NCT00792571|450859736|FG000|Overall Study|Death|1|||
125334807|NCT00792571|450859736|FG000|Overall Study|Adverse Event|4|||
125334808|NCT00792571|450859736|FG000|Overall Study|Withdrawal by Subject|1|||
125334809|NCT00792571|450859736|FG000|Overall Study|Other|4|||
125334810|NCT03790696|450859738|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
125334811|NCT03790696|450859739|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
125334812|NCT01149148|450859740|FG000|Overall Study|Lost to Follow-up|1|||
125334813|NCT01149148|450859741|FG001|Overall Study|Lost to Follow-up|2|||
125334814|NCT01149148|450859740|FG000|Overall Study|Death|1|||
125334815|NCT01149148|450859741|FG001|Overall Study|Death|0|||
125334816|NCT03436082|450859742|FG000|Overall Study|Did not undergo procedure|1|||
125334817|NCT03436082|450859743|FG001|Overall Study|Did not undergo procedure|0|||
125334818|NCT00950859|450859746|FG000|Overall Study|Adverse Event|3|||
125090043|NCT02988115|449948653|FG001|Overall Study|Withdrawal by Subject|1|||
125090044|NCT02988115|449948652|FG000|Overall Study|Withdrawn by Mistake|1|||
125090045|NCT02988115|449948653|FG001|Overall Study|Withdrawn by Mistake|0|||
125090046|NCT02988115|449948652|FG000|Overall Study|Lost to Follow-up|1|||
125090047|NCT02988115|449948653|FG001|Overall Study|Lost to Follow-up|0|||
125090048|NCT01731951|449948654|FG000|Overall Study|Documented Disease Progression|1|||
125090049|NCT01731951|449948655|FG001|Overall Study|Documented Disease Progression|0|||
125090050|NCT01731951|449948656|FG002|Overall Study|Documented Disease Progression|0|||
125090051|NCT01731951|449948657|FG003|Overall Study|Documented Disease Progression|0|||
125090052|NCT01731951|449948658|FG004|Overall Study|Documented Disease Progression|0|||
125090053|NCT01731951|449948659|FG005|Overall Study|Documented Disease Progression|0|||
125090054|NCT01731951|449948654|FG000|Overall Study|Lost to Follow-up|2|||
125334819|NCT00950859|450859747|FG001|Overall Study|Adverse Event|3|||
125334820|NCT00950859|450859746|FG000|Overall Study|Insufficient Viral Load Response|12|||
125334821|NCT00950859|450859747|FG001|Overall Study|Insufficient Viral Load Response|3|||
125334822|NCT00950859|450859746|FG000|Overall Study|Protocol Violation|1|||
125334823|NCT00950859|450859747|FG001|Overall Study|Protocol Violation|1|||
125334824|NCT00950859|450859746|FG000|Overall Study|Lost to Follow-up|0|||
125334825|NCT00950859|450859747|FG001|Overall Study|Lost to Follow-up|3|||
125334826|NCT04896086|450859748|FG000|Overall Study|Lost to Follow-up|0|||
125334827|NCT04896086|450859749|FG001|Overall Study|Lost to Follow-up|2|||
125334828|NCT04896086|450859750|FG002|Overall Study|Lost to Follow-up|1|||
125334829|NCT04896086|450859751|FG003|Overall Study|Lost to Follow-up|0|||
125334830|NCT04896086|450859752|FG004|Overall Study|Lost to Follow-up|0|||
125334831|NCT04896086|450859748|FG000|Overall Study|Physician Decision|0|||
125334832|NCT04896086|450859749|FG001|Overall Study|Physician Decision|1|||
125334833|NCT04896086|450859750|FG002|Overall Study|Physician Decision|0|||
125334834|NCT04896086|450859751|FG003|Overall Study|Physician Decision|0|||
125334835|NCT04896086|450859752|FG004|Overall Study|Physician Decision|0|||
125334836|NCT04896086|450859748|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
125334837|NCT04896086|450859749|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
125334838|NCT04896086|450859750|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
125334839|NCT04896086|450859751|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
125334840|NCT04896086|450859752|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
125334841|NCT04896086|450859748|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
125334842|NCT04896086|450859749|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
125334843|NCT04896086|450859750|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
125334844|NCT04896086|450859751|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
125334845|NCT04896086|450859752|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
125334846|NCT02249832|450859755|FG000|Overall Study|Withdrawal by Subject|3|||
125334847|NCT02249832|450859755|FG000|Overall Study|Lost to Follow-up|10|||
125334848|NCT02563067|450859762|FG000|Overall Study|Subject/guardian decision|14|||
125334849|NCT02563067|450859763|FG001|Overall Study|Subject/guardian decision|20|||
125334850|NCT02563067|450859764|FG002|Overall Study|Subject/guardian decision|16|||
125334851|NCT02563067|450859762|FG000|Overall Study|Physician Decision|0|||
125334852|NCT02563067|450859763|FG001|Overall Study|Physician Decision|1|||
125334853|NCT02563067|450859764|FG002|Overall Study|Physician Decision|3|||
125334854|NCT02563067|450859762|FG000|Overall Study|Lost to Follow-up|1|||
125334855|NCT02563067|450859763|FG001|Overall Study|Lost to Follow-up|2|||
125334856|NCT02563067|450859764|FG002|Overall Study|Lost to Follow-up|0|||
125334857|NCT02563067|450859762|FG000|Overall Study|Technical problems|0|||
125334858|NCT02563067|450859763|FG001|Overall Study|Technical problems|1|||
125334859|NCT02563067|450859764|FG002|Overall Study|Technical problems|0|||
125334860|NCT02563067|450859762|FG000|Overall Study|Lack of Efficacy|1|||
125334861|NCT02563067|450859763|FG001|Overall Study|Lack of Efficacy|0|||
125334862|NCT02563067|450859764|FG002|Overall Study|Lack of Efficacy|0|||
125334863|NCT02563067|450859762|FG000|Overall Study|Death|0|||
125334864|NCT02563067|450859763|FG001|Overall Study|Death|1|||
125334865|NCT02563067|450859764|FG002|Overall Study|Death|1|||
125334866|NCT02563067|450859762|FG000|Overall Study|Adverse Event|2|||
125090055|NCT01731951|449948655|FG001|Overall Study|Lost to Follow-up|0|||
125334867|NCT02563067|450859763|FG001|Overall Study|Adverse Event|1|||
125334868|NCT02563067|450859764|FG002|Overall Study|Adverse Event|0|||
125334869|NCT02563067|450859762|FG000|Overall Study|Death post Treatment/safety period|1|||
125334870|NCT02563067|450859763|FG001|Overall Study|Death post Treatment/safety period|0|||
125334871|NCT02563067|450859764|FG002|Overall Study|Death post Treatment/safety period|0|||
125334872|NCT03544333|450859774|FG000|Overall Study|Withdrawal by Subject|1|||
125090056|NCT01731951|449948656|FG002|Overall Study|Lost to Follow-up|0|||
125334873|NCT03544333|450859775|FG001|Overall Study|Withdrawal by Subject|0|||
125334874|NCT01039519|450859779|FG000|Treatment|Progressive disease|20|||
125334875|NCT01039519|450859779|FG000|Treatment|Treatment failure|2|||
125334876|NCT01039519|450859779|FG000|Treatment|Adverse Event|3|||
125334877|NCT01039519|450859779|FG000|Treatment|Physician Decision|2|||
125334878|NCT01039519|450859779|FG000|Survival Follow-up|Death|23|||
125334879|NCT01039519|450859779|FG000|Survival Follow-up|Sponsor decision|4|||
125334880|NCT00808080|450859780|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
125334881|NCT00423917|450859783|FG000|Overall Study|Cancel|2|||
125334882|NCT00423917|450859783|FG000|Overall Study|Ineligible|1|||
125334883|NCT01396447|450859786|FG000|Overall Study|Did Not Receive Treatment|3|||
125334884|NCT01396447|450859787|FG001|Overall Study|Did Not Receive Treatment|2|||
125334885|NCT01396447|450859788|FG002|Overall Study|Did Not Receive Treatment|1|||
125334886|NCT01396447|450859789|FG003|Overall Study|Did Not Receive Treatment|0|||
125334887|NCT01396447|450859786|FG000|Overall Study|Adverse Event|15|||
125334888|NCT01396447|450859787|FG001|Overall Study|Adverse Event|12|||
125334889|NCT01396447|450859788|FG002|Overall Study|Adverse Event|12|||
125334890|NCT01396447|450859789|FG003|Overall Study|Adverse Event|17|||
125334891|NCT01396447|450859786|FG000|Overall Study|Insufficient Therapeutic Response|5|||
125334892|NCT01396447|450859787|FG001|Overall Study|Insufficient Therapeutic Response|5|||
125334893|NCT01396447|450859788|FG002|Overall Study|Insufficient Therapeutic Response|2|||
125334894|NCT01396447|450859789|FG003|Overall Study|Insufficient Therapeutic Response|4|||
125334895|NCT01396447|450859786|FG000|Overall Study|Protocol Violation|5|||
125334896|NCT01396447|450859787|FG001|Overall Study|Protocol Violation|2|||
125334897|NCT01396447|450859788|FG002|Overall Study|Protocol Violation|3|||
125334898|NCT01396447|450859789|FG003|Overall Study|Protocol Violation|7|||
125334899|NCT01396447|450859786|FG000|Overall Study|Withdrawal of Consent|11|||
125334900|NCT01396447|450859787|FG001|Overall Study|Withdrawal of Consent|9|||
125334901|NCT01396447|450859788|FG002|Overall Study|Withdrawal of Consent|4|||
125334902|NCT01396447|450859789|FG003|Overall Study|Withdrawal of Consent|15|||
125334903|NCT01396447|450859786|FG000|Overall Study|Lost to Follow-up|4|||
125090057|NCT01731951|449948657|FG003|Overall Study|Lost to Follow-up|1|||
125090058|NCT01731951|449948658|FG004|Overall Study|Lost to Follow-up|3|||
125090059|NCT01731951|449948659|FG005|Overall Study|Lost to Follow-up|1|||
125090060|NCT01731951|449948654|FG000|Overall Study|Withdrawal of Consent|1|||
125090061|NCT01731951|449948655|FG001|Overall Study|Withdrawal of Consent|0|||
125090062|NCT01731951|449948656|FG002|Overall Study|Withdrawal of Consent|0|||
125090063|NCT01731951|449948657|FG003|Overall Study|Withdrawal of Consent|0|||
125090064|NCT01731951|449948658|FG004|Overall Study|Withdrawal of Consent|0|||
125090065|NCT01731951|449948659|FG005|Overall Study|Withdrawal of Consent|2|||
125090066|NCT01731951|449948654|FG000|Overall Study|Death|13|||
125090067|NCT01731951|449948655|FG001|Overall Study|Death|15|||
125090068|NCT01731951|449948656|FG002|Overall Study|Death|9|||
125090069|NCT01731951|449948657|FG003|Overall Study|Death|8|||
125090070|NCT01731951|449948658|FG004|Overall Study|Death|9|||
125090071|NCT01731951|449948659|FG005|Overall Study|Death|6|||
125090072|NCT03287089|449948660|FG000|Overall Study|Lost to Follow-up|0|||
125090073|NCT03287089|449948661|FG001|Overall Study|Lost to Follow-up|2|||
125090074|NCT03287089|449948660|FG000|Overall Study|Physician Decision|0|||
125090075|NCT03287089|449948661|FG001|Overall Study|Physician Decision|2|||
125090076|NCT03287089|449948660|FG000|Overall Study|Withdrawal by Subject|0|||
125090077|NCT03287089|449948661|FG001|Overall Study|Withdrawal by Subject|2|||
125090078|NCT00661362|449948662|FG000|Overall Study|Adverse Event|5|||
125090079|NCT00661362|449948663|FG001|Overall Study|Adverse Event|4|||
125090080|NCT00661362|449948662|FG000|Overall Study|Incorrect enrollment|2|||
125090081|NCT00661362|449948663|FG001|Overall Study|Incorrect enrollment|0|||
125090082|NCT00661362|449948662|FG000|Overall Study|Study specific discontinuation criteria|4|||
125090083|NCT00661362|449948663|FG001|Overall Study|Study specific discontinuation criteria|11|||
125090084|NCT00661362|449948662|FG000|Overall Study|Withdrawal by Subject|13|||
125090085|NCT00661362|449948663|FG001|Overall Study|Withdrawal by Subject|23|||
125090086|NCT00661362|449948662|FG000|Overall Study|Lost to Follow-up|3|||
125090087|NCT00661362|449948663|FG001|Overall Study|Lost to Follow-up|1|||
125090088|NCT00661362|449948662|FG000|Overall Study|Severe non-compliance to protocol|0|||
125090089|NCT00661362|449948663|FG001|Overall Study|Severe non-compliance to protocol|1|||
125090090|NCT00661362|449948662|FG000|Overall Study|Safety reasons|1|||
125090091|NCT00661362|449948663|FG001|Overall Study|Safety reasons|0|||
125090092|NCT00661362|449948662|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
125090093|NCT00661362|449948663|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
125334904|NCT01396447|450859787|FG001|Overall Study|Lost to Follow-up|8|||
125334905|NCT01396447|450859788|FG002|Overall Study|Lost to Follow-up|7|||
125334906|NCT01396447|450859789|FG003|Overall Study|Lost to Follow-up|9|||
125090094|NCT00775138|449948664|FG000|Overall Study|Withdrawal by Subject|0|||
125334907|NCT01396447|450859786|FG000|Overall Study|Other Miscellaneous Reasons|0|||
125090095|NCT00775138|449948665|FG001|Overall Study|Withdrawal by Subject|0|||
125090096|NCT00775138|449948666|FG002|Overall Study|Withdrawal by Subject|2|||
125090097|NCT00775138|449948667|FG003|Overall Study|Withdrawal by Subject|2|||
125090098|NCT00775138|449948664|FG000|Overall Study|Adverse Event|0|||
125090099|NCT00775138|449948665|FG001|Overall Study|Adverse Event|0|||
125334908|NCT01396447|450859787|FG001|Overall Study|Other Miscellaneous Reasons|2|||
125334909|NCT01396447|450859788|FG002|Overall Study|Other Miscellaneous Reasons|1|||
125334910|NCT01396447|450859789|FG003|Overall Study|Other Miscellaneous Reasons|0|||
125334911|NCT00578292|450859790|FG000|Overall Study|Death|1|||
125334912|NCT00578292|450859790|FG000|Overall Study|Graft failure|2|||
125334913|NCT00856518|450859794|FG000|Overall Study|Lost to Follow-up|4|||
125334914|NCT00856518|450859795|FG001|Overall Study|Lost to Follow-up|2|||
125334915|NCT04849559|450859796|FG000|Overall Study|Withdrawal by Subject|2|||
125334916|NCT04849559|450859797|FG001|Overall Study|Withdrawal by Subject|1|||
125334917|NCT00947193|450859798|FG000|Overall Study|Lost to Follow-up|1|||
125334918|NCT00947193|450859799|FG001|Overall Study|Lost to Follow-up|0|||
125334919|NCT00947193|450859798|FG000|Overall Study|Withdrawal by Subject|1|||
125334920|NCT00947193|450859799|FG001|Overall Study|Withdrawal by Subject|0|||
125334921|NCT00947193|450859798|FG000|Overall Study|Factor VIII >1%|1|||
125334922|NCT00947193|450859799|FG001|Overall Study|Factor VIII >1%|0|||
125334923|NCT02105961|450859800|FG000|Overall Study|Adverse Event|18|||
125334924|NCT02105961|450859801|FG001|Overall Study|Adverse Event|7|||
125334925|NCT02105961|450859802|FG002|Overall Study|Adverse Event|13|||
125334926|NCT02105961|450859800|FG000|Overall Study|Lack of Efficacy|3|||
125334927|NCT02105961|450859801|FG001|Overall Study|Lack of Efficacy|0|||
125334928|NCT02105961|450859802|FG002|Overall Study|Lack of Efficacy|3|||
125334929|NCT02105961|450859800|FG000|Overall Study|Lost to Follow-up|2|||
125334930|NCT02105961|450859801|FG001|Overall Study|Lost to Follow-up|0|||
125334931|NCT02105961|450859802|FG002|Overall Study|Lost to Follow-up|1|||
125334932|NCT02105961|450859800|FG000|Overall Study|Physician Decision|3|||
125334933|NCT02105961|450859801|FG001|Overall Study|Physician Decision|3|||
125334934|NCT02105961|450859802|FG002|Overall Study|Physician Decision|2|||
125334935|NCT02105961|450859800|FG000|Overall Study|Withdrawal by Subject|15|||
125334936|NCT02105961|450859801|FG001|Overall Study|Withdrawal by Subject|7|||
125334937|NCT02105961|450859802|FG002|Overall Study|Withdrawal by Subject|11|||
125334938|NCT00459186|450859803|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
125334939|NCT00459186|450859803|FG000|PET Imaging and Assessment|Adverse Event|3|||
125334940|NCT01485172|450859804|FG000|Overall Study|Adverse Event|2|||
125334941|NCT01485172|450859805|FG001|Overall Study|Adverse Event|1|||
125334942|NCT01485172|450859806|FG002|Overall Study|Adverse Event|2|||
125334943|NCT01485172|450859807|FG003|Overall Study|Adverse Event|2|||
125334944|NCT01485172|450859808|FG004|Overall Study|Adverse Event|1|||
125334945|NCT01485172|450859809|FG005|Overall Study|Adverse Event|2|||
125334946|NCT01485172|450859804|FG000|Overall Study|Lack of Efficacy|2|||
125334947|NCT01485172|450859805|FG001|Overall Study|Lack of Efficacy|0|||
125334948|NCT01485172|450859806|FG002|Overall Study|Lack of Efficacy|0|||
125334949|NCT01485172|450859807|FG003|Overall Study|Lack of Efficacy|0|||
125334950|NCT01485172|450859808|FG004|Overall Study|Lack of Efficacy|0|||
125090100|NCT00775138|449948666|FG002|Overall Study|Adverse Event|1|||
125090101|NCT00775138|449948667|FG003|Overall Study|Adverse Event|0|||
125090102|NCT04880642|449948668|FG000|Randomization|Withdrawal by Subject|2|||
125090103|NCT04880642|449948669|FG001|Randomization|Withdrawal by Subject|3|||
125090104|NCT04880642|449948668|FG000|Treatment Period|Adverse Event|0|||
125090105|NCT04880642|449948669|FG001|Treatment Period|Adverse Event|1|||
125334951|NCT01485172|450859809|FG005|Overall Study|Lack of Efficacy|0|||
125334952|NCT01485172|450859804|FG000|Overall Study|Protocol Violation|0|||
125334953|NCT01485172|450859805|FG001|Overall Study|Protocol Violation|0|||
125334954|NCT01485172|450859806|FG002|Overall Study|Protocol Violation|4|||
125334955|NCT01485172|450859807|FG003|Overall Study|Protocol Violation|5|||
125334956|NCT01485172|450859808|FG004|Overall Study|Protocol Violation|1|||
125334957|NCT01485172|450859809|FG005|Overall Study|Protocol Violation|0|||
125334958|NCT01485172|450859804|FG000|Overall Study|Protocol defined stopping criteria|1|||
125334959|NCT01485172|450859805|FG001|Overall Study|Protocol defined stopping criteria|0|||
125334960|NCT01485172|450859806|FG002|Overall Study|Protocol defined stopping criteria|0|||
125334961|NCT01485172|450859807|FG003|Overall Study|Protocol defined stopping criteria|0|||
125334962|NCT01485172|450859808|FG004|Overall Study|Protocol defined stopping criteria|1|||
125334963|NCT01485172|450859809|FG005|Overall Study|Protocol defined stopping criteria|0|||
125334964|NCT01485172|450859804|FG000|Overall Study|Lost to Follow-up|0|||
125090106|NCT04880642|449948668|FG000|Treatment Period|Death|6|||
125090107|NCT04880642|449948669|FG001|Treatment Period|Death|6|||
125090108|NCT04880642|449948668|FG000|Treatment Period|Lost to Follow-up|1|||
125090109|NCT04880642|449948669|FG001|Treatment Period|Lost to Follow-up|0|||
125334965|NCT01485172|450859805|FG001|Overall Study|Lost to Follow-up|0|||
125334966|NCT01485172|450859806|FG002|Overall Study|Lost to Follow-up|1|||
125334967|NCT01485172|450859807|FG003|Overall Study|Lost to Follow-up|0|||
125334968|NCT01485172|450859808|FG004|Overall Study|Lost to Follow-up|0|||
125334969|NCT01485172|450859809|FG005|Overall Study|Lost to Follow-up|1|||
125334970|NCT01485172|450859804|FG000|Overall Study|Physician Decision|0|||
125334971|NCT01485172|450859805|FG001|Overall Study|Physician Decision|0|||
125334972|NCT01485172|450859806|FG002|Overall Study|Physician Decision|0|||
125334973|NCT01485172|450859807|FG003|Overall Study|Physician Decision|0|||
125334974|NCT01485172|450859808|FG004|Overall Study|Physician Decision|1|||
125334975|NCT01485172|450859809|FG005|Overall Study|Physician Decision|0|||
125334976|NCT01485172|450859804|FG000|Overall Study|Withdrawal by Subject|2|||
125334977|NCT01485172|450859805|FG001|Overall Study|Withdrawal by Subject|0|||
125334978|NCT01485172|450859806|FG002|Overall Study|Withdrawal by Subject|0|||
125334979|NCT01485172|450859807|FG003|Overall Study|Withdrawal by Subject|1|||
125334980|NCT01485172|450859808|FG004|Overall Study|Withdrawal by Subject|1|||
125334981|NCT01485172|450859809|FG005|Overall Study|Withdrawal by Subject|1|||
125090110|NCT04880642|449948668|FG000|Treatment Period|Protocol Violation|0|||
125090111|NCT04880642|449948669|FG001|Treatment Period|Protocol Violation|1|||
125090112|NCT04880642|449948668|FG000|Treatment Period|Withdrawal by Subject|5|||
125334982|NCT02920242|450859813|FG000|Overall Study|Withdrawal by Subject|1|||
125334983|NCT02920242|450859814|FG001|Overall Study|Withdrawal by Subject|0|||
125334984|NCT02920242|450859815|FG002|Overall Study|Withdrawal by Subject|1|||
125334985|NCT02920242|450859813|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
125334986|NCT02920242|450859814|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
125334987|NCT02920242|450859815|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
125334988|NCT01587014|450859816|FG000|Overall Study|Death|2|||
125334989|NCT02948088|450859817|FG000|Overall Study|Lost to Follow-up|8|||
125334990|NCT02948088|450859817|FG000|Overall Study|Death|1|||
125334991|NCT02948088|450859817|FG000|Overall Study|Withdrawal by Subject|4|||
125334992|NCT02948088|450859817|FG000|Overall Study|Other|2|||
125334993|NCT01409811|450859818|FG000|Overall Study|Insurance denial|1|||
125334994|NCT01942733|450859819|FG000|Overall Study|Lost to Follow-up|1|||
125334995|NCT01942733|450859819|FG000|Overall Study|Non-compliance with IMP|1|||
125334996|NCT01942733|450859819|FG000|Overall Study|Administrative|1|||
125334997|NCT00634101|450859820|FG000|Overall Study|Study Terminated|3|||
125334998|NCT00634101|450859821|FG001|Overall Study|Study Terminated|3|||
125334999|NCT00634101|450859820|FG000|Overall Study|Lost to Follow-up|2|||
125335000|NCT00634101|450859821|FG001|Overall Study|Lost to Follow-up|0|||
125335001|NCT00838513|450859823|FG000|Screening Period|Screen Failure|3|||
125335002|NCT00838513|450859823|FG000|Extension Treatment Period|Death|1|||
125335003|NCT00838513|450859823|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
125335004|NCT00139477|450859827|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
125335005|NCT00139477|450859828|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
125335006|NCT00139477|450859827|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
125335007|NCT00139477|450859828|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
125335008|NCT00139477|450859827|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
125335009|NCT00139477|450859828|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
125335010|NCT00139477|450859827|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
125335011|NCT00139477|450859828|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
125335012|NCT00139477|450859827|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
125335013|NCT00139477|450859828|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
125335014|NCT00139477|450859827|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
125335015|NCT00139477|450859828|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
125335016|NCT00139477|450859827|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
125335017|NCT00139477|450859828|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
125335018|NCT00573144|450859831|FG000|Overall Study|Withdrawal by Subject|2|||
125335019|NCT00573144|450859832|FG001|Overall Study|Withdrawal by Subject|3|||
125335020|NCT02625909|450859833|FG000|Overall Study|Death|2|||
125335021|NCT02625909|450859834|FG001|Overall Study|Death|0|||
125335022|NCT02625909|450859833|FG000|Overall Study|Lost to Follow-up|3|||
125335023|NCT02625909|450859834|FG001|Overall Study|Lost to Follow-up|5|||
125335024|NCT02625909|450859833|FG000|Overall Study|Lack of Efficacy|9|||
125335025|NCT02625909|450859834|FG001|Overall Study|Lack of Efficacy|2|||
125335026|NCT02625909|450859833|FG000|Overall Study|Reinfection|3|||
125335027|NCT02625909|450859834|FG001|Overall Study|Reinfection|2|||
125335028|NCT02367833|450859835|FG000|Overall Study|Withdrawal by Subject|1|||
125335029|NCT02367833|450859836|FG001|Overall Study|Withdrawal by Subject|1|||
125335030|NCT02367833|450859837|FG002|Overall Study|Withdrawal by Subject|0|||
125335031|NCT00035932|450859840|FG000|Overall Study|Adverse Event|10|||
125335032|NCT00035932|450859841|FG001|Overall Study|Adverse Event|9|||
125335033|NCT00035932|450859842|FG002|Overall Study|Adverse Event|9|||
125335034|NCT00035932|450859840|FG000|Overall Study|Death|0|||
125335035|NCT00035932|450859841|FG001|Overall Study|Death|0|||
125335036|NCT00035932|450859842|FG002|Overall Study|Death|1|||
125335037|NCT00035932|450859840|FG000|Overall Study|Disease Progression / Relapse|1|||
125335038|NCT00035932|450859841|FG001|Overall Study|Disease Progression / Relapse|1|||
125335039|NCT00035932|450859842|FG002|Overall Study|Disease Progression / Relapse|0|||
125335040|NCT00035932|450859840|FG000|Overall Study|Lost to Follow-up|4|||
125335041|NCT00035932|450859841|FG001|Overall Study|Lost to Follow-up|4|||
125335042|NCT00035932|450859842|FG002|Overall Study|Lost to Follow-up|3|||
125335043|NCT00035932|450859840|FG000|Overall Study|Noncompliance|6|||
125335044|NCT00035932|450859841|FG001|Overall Study|Noncompliance|7|||
125335045|NCT00035932|450859842|FG002|Overall Study|Noncompliance|6|||
125335046|NCT00035932|450859840|FG000|Overall Study|Protocol Violation While on Study|0|||
125335047|NCT00035932|450859841|FG001|Overall Study|Protocol Violation While on Study|1|||
125335048|NCT00035932|450859842|FG002|Overall Study|Protocol Violation While on Study|2|||
125335049|NCT00035932|450859840|FG000|Overall Study|Withdrawal by Subject|1|||
125335050|NCT00035932|450859841|FG001|Overall Study|Withdrawal by Subject|5|||
125335051|NCT00035932|450859842|FG002|Overall Study|Withdrawal by Subject|0|||
125090113|NCT04880642|449948669|FG001|Treatment Period|Withdrawal by Subject|3|||
125335052|NCT00035932|450859840|FG000|Overall Study|Study Termination by Sponsor|1|||
125335053|NCT00035932|450859841|FG001|Overall Study|Study Termination by Sponsor|0|||
125335054|NCT00035932|450859842|FG002|Overall Study|Study Termination by Sponsor|0|||
125335055|NCT00035932|450859840|FG000|Overall Study|Lack of Efficacy|33|||
125335056|NCT00035932|450859841|FG001|Overall Study|Lack of Efficacy|33|||
125335057|NCT00035932|450859842|FG002|Overall Study|Lack of Efficacy|28|||
125335058|NCT01459497|450859843|FG000|Overall Study|Inability to meet trial constraints.|1|||
125335059|NCT01459497|450859844|FG001|Overall Study|Inability to meet trial constraints.|0|||
125335060|NCT01459497|450859843|FG000|Overall Study|Physician Decision|1|||
125335061|NCT01459497|450859844|FG001|Overall Study|Physician Decision|1|||
125335062|NCT01459497|450859843|FG000|Overall Study|Hospitalization.|0|||
125335063|NCT01459497|450859844|FG001|Overall Study|Hospitalization.|3|||
125335064|NCT01459497|450859843|FG000|Overall Study|Disease progression.|0|||
125335065|NCT01459497|450859844|FG001|Overall Study|Disease progression.|1|||
125335066|NCT01192191|450859845|FG000|Overall Study|Adverse Event|7|||
125335067|NCT01192191|450859846|FG001|Overall Study|Adverse Event|12|||
125335068|NCT01192191|450859845|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
125335069|NCT01192191|450859846|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
125335070|NCT01192191|450859845|FG000|Overall Study|Lost to Follow-up|0|||
125335071|NCT01192191|450859846|FG001|Overall Study|Lost to Follow-up|1|||
125335072|NCT01192191|450859845|FG000|Overall Study|Withdrawal by Subject|1|||
125335073|NCT01192191|450859846|FG001|Overall Study|Withdrawal by Subject|6|||
125335074|NCT03179319|450859847|FG000|Overall Study|Lost to Follow-up|6|||
125335075|NCT03179319|450859848|FG001|Overall Study|Lost to Follow-up|0|||
125335076|NCT04393454|450859851|FG000|Overall Study|Death|1|||
125335077|NCT04393454|450859851|FG000|Overall Study|Lost to Follow-up|1|||
125335078|NCT02260180|450861756|FG000|Overall Study|Adverse Event|2|||
125335079|NCT02260180|450861757|FG001|Overall Study|Adverse Event|0|||
125335080|NCT02260180|450861758|FG002|Overall Study|Adverse Event|1|||
125335081|NCT03860818|450861769|FG000|Overall Study|Death|144|||
125335082|NCT03860818|450861770|FG001|Overall Study|Death|195|||
125335083|NCT03860818|450861769|FG000|Overall Study|Graft Loss|32|||
125335084|NCT03860818|450861770|FG001|Overall Study|Graft Loss|45|||
125335085|NCT03126344|450861771|FG000|Overall Study|Lost to Follow-up|0|||
125335086|NCT03126344|450861772|FG001|Overall Study|Lost to Follow-up|0|||
125335087|NCT03126344|450861773|FG002|Overall Study|Lost to Follow-up|5|||
125335088|NCT05367492|450861774|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
125335089|NCT05367492|450861775|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
125335090|NCT05367492|450861776|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
125335091|NCT05367492|450861774|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
125335092|NCT05367492|450861775|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
125335093|NCT05367492|450861776|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
125335094|NCT05367492|450861774|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
125335095|NCT05367492|450861775|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
125335096|NCT05367492|450861776|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
125335097|NCT05367492|450861774|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
125335098|NCT05367492|450861775|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
125335099|NCT05367492|450861776|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
125335100|NCT01088048|450861777|FG000|Overall Study|Adverse Event|7|||
125335101|NCT01088048|450861778|FG001|Overall Study|Adverse Event|9|||
125335102|NCT01088048|450861779|FG002|Overall Study|Adverse Event|7|||
125335103|NCT01088048|450861780|FG003|Overall Study|Adverse Event|5|||
125335104|NCT01088048|450861781|FG004|Overall Study|Adverse Event|6|||
125335105|NCT01088048|450861782|FG005|Overall Study|Adverse Event|3|||
125335106|NCT01088048|450861783|FG006|Overall Study|Adverse Event|3|||
125335107|NCT01088048|450861784|FG007|Overall Study|Adverse Event|0|||
125335108|NCT01088048|450861785|FG008|Overall Study|Adverse Event|2|||
125335109|NCT01088048|450861786|FG009|Overall Study|Adverse Event|2|||
125335110|NCT01088048|450861777|FG000|Overall Study|Withdrew Consent|1|||
125335111|NCT01088048|450861778|FG001|Overall Study|Withdrew Consent|1|||
125335112|NCT01088048|450861779|FG002|Overall Study|Withdrew Consent|1|||
125335113|NCT01088048|450861780|FG003|Overall Study|Withdrew Consent|1|||
125335114|NCT01088048|450861781|FG004|Overall Study|Withdrew Consent|2|||
125335115|NCT01088048|450861782|FG005|Overall Study|Withdrew Consent|1|||
125335116|NCT01088048|450861783|FG006|Overall Study|Withdrew Consent|0|||
125335117|NCT01088048|450861784|FG007|Overall Study|Withdrew Consent|2|||
125335118|NCT01088048|450861785|FG008|Overall Study|Withdrew Consent|2|||
125335119|NCT01088048|450861786|FG009|Overall Study|Withdrew Consent|1|||
125335120|NCT01088048|450861777|FG000|Overall Study|Concomitant Medication Prohibited|1|||
125335121|NCT01088048|450861778|FG001|Overall Study|Concomitant Medication Prohibited|0|||
125335122|NCT01088048|450861779|FG002|Overall Study|Concomitant Medication Prohibited|0|||
125335123|NCT01088048|450861780|FG003|Overall Study|Concomitant Medication Prohibited|0|||
125335124|NCT01088048|450861781|FG004|Overall Study|Concomitant Medication Prohibited|0|||
125335125|NCT01088048|450861782|FG005|Overall Study|Concomitant Medication Prohibited|0|||
125335126|NCT01088048|450861783|FG006|Overall Study|Concomitant Medication Prohibited|0|||
125335127|NCT01088048|450861784|FG007|Overall Study|Concomitant Medication Prohibited|0|||
125335128|NCT01088048|450861785|FG008|Overall Study|Concomitant Medication Prohibited|0|||
125335129|NCT01088048|450861786|FG009|Overall Study|Concomitant Medication Prohibited|0|||
125335130|NCT01088048|450861777|FG000|Overall Study|Investigator Request|2|||
125335131|NCT01088048|450861778|FG001|Overall Study|Investigator Request|2|||
125335132|NCT01088048|450861779|FG002|Overall Study|Investigator Request|0|||
125335133|NCT01088048|450861780|FG003|Overall Study|Investigator Request|0|||
125335134|NCT01088048|450861781|FG004|Overall Study|Investigator Request|3|||
125335135|NCT01088048|450861782|FG005|Overall Study|Investigator Request|1|||
125335136|NCT01088048|450861783|FG006|Overall Study|Investigator Request|1|||
125335137|NCT01088048|450861784|FG007|Overall Study|Investigator Request|0|||
125335138|NCT01088048|450861785|FG008|Overall Study|Investigator Request|0|||
125335139|NCT01088048|450861786|FG009|Overall Study|Investigator Request|0|||
125335140|NCT01088048|450861777|FG000|Overall Study|Patient Non-compliance|0|||
125335141|NCT01088048|450861778|FG001|Overall Study|Patient Non-compliance|1|||
125335142|NCT01088048|450861779|FG002|Overall Study|Patient Non-compliance|0|||
125335143|NCT01088048|450861780|FG003|Overall Study|Patient Non-compliance|0|||
125335144|NCT01088048|450861781|FG004|Overall Study|Patient Non-compliance|0|||
125335145|NCT01088048|450861782|FG005|Overall Study|Patient Non-compliance|0|||
125335146|NCT01088048|450861783|FG006|Overall Study|Patient Non-compliance|0|||
125335147|NCT01088048|450861784|FG007|Overall Study|Patient Non-compliance|0|||
125335148|NCT01088048|450861785|FG008|Overall Study|Patient Non-compliance|0|||
125335149|NCT01088048|450861786|FG009|Overall Study|Patient Non-compliance|0|||
125335150|NCT01088048|450861777|FG000|Overall Study|Disease Progression|7|||
125335151|NCT01088048|450861778|FG001|Overall Study|Disease Progression|4|||
125335152|NCT01088048|450861779|FG002|Overall Study|Disease Progression|3|||
125335153|NCT01088048|450861780|FG003|Overall Study|Disease Progression|5|||
125335154|NCT01088048|450861781|FG004|Overall Study|Disease Progression|3|||
125335155|NCT01088048|450861782|FG005|Overall Study|Disease Progression|3|||
125335156|NCT01088048|450861783|FG006|Overall Study|Disease Progression|2|||
125335157|NCT01088048|450861784|FG007|Overall Study|Disease Progression|1|||
125335158|NCT01088048|450861785|FG008|Overall Study|Disease Progression|0|||
125335159|NCT01088048|450861786|FG009|Overall Study|Disease Progression|0|||
125335160|NCT01088048|450861777|FG000|Overall Study|Death|1|||
125335161|NCT01088048|450861778|FG001|Overall Study|Death|5|||
125335162|NCT01088048|450861779|FG002|Overall Study|Death|3|||
125335163|NCT01088048|450861780|FG003|Overall Study|Death|3|||
125335164|NCT01088048|450861781|FG004|Overall Study|Death|1|||
125335165|NCT01088048|450861782|FG005|Overall Study|Death|3|||
125335166|NCT01088048|450861783|FG006|Overall Study|Death|0|||
125335167|NCT01088048|450861784|FG007|Overall Study|Death|0|||
125335168|NCT01088048|450861785|FG008|Overall Study|Death|3|||
125335169|NCT01088048|450861786|FG009|Overall Study|Death|1|||
125335170|NCT01088048|450861777|FG000|Overall Study|Other|3|||
125335171|NCT01088048|450861778|FG001|Overall Study|Other|5|||
125335172|NCT01088048|450861779|FG002|Overall Study|Other|0|||
125335173|NCT01088048|450861780|FG003|Overall Study|Other|0|||
125335174|NCT01088048|450861781|FG004|Overall Study|Other|2|||
125335175|NCT01088048|450861782|FG005|Overall Study|Other|0|||
125335176|NCT01088048|450861783|FG006|Overall Study|Other|0|||
125335177|NCT01088048|450861784|FG007|Overall Study|Other|2|||
125335178|NCT01088048|450861785|FG008|Overall Study|Other|0|||
125335179|NCT01088048|450861786|FG009|Overall Study|Other|0|||
125335180|NCT01330108|450861790|FG000|Overall Study|Withdrawal by Subject|4|||
125002991|NCT01162239|449639217|FG002|Extended Follow-up|Lost to Follow-up|8|||
125335181|NCT00243269|450861791|FG000|Overall Study|Protocol Violation|2|||
125335182|NCT00243269|450861792|FG001|Overall Study|Protocol Violation|1|||
125335183|NCT00243269|450861793|FG002|Overall Study|Protocol Violation|0|||
125335184|NCT00243269|450861794|FG003|Overall Study|Protocol Violation|1|||
125335185|NCT00243269|450861791|FG000|Overall Study|Lost to Follow-up|1|||
125335186|NCT00243269|450861792|FG001|Overall Study|Lost to Follow-up|0|||
125335187|NCT00243269|450861793|FG002|Overall Study|Lost to Follow-up|1|||
125335188|NCT00243269|450861794|FG003|Overall Study|Lost to Follow-up|3|||
125335189|NCT03085797|450861796|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
125335190|NCT03085797|450861797|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
125002992|NCT01162239|449639218|FG003|Extended Follow-up|Lost to Follow-up|6|||
125002993|NCT00228566|449639219|FG000|Overall Study|Adverse Event|31|||
125002994|NCT00228566|449639219|FG000|Overall Study|Lack of Efficacy|14|||
125335191|NCT03085797|450861796|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
125335192|NCT03085797|450861797|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
125335193|NCT03085797|450861796|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
125335194|NCT03085797|450861797|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
125335195|NCT00545272|450861798|FG000|Overall Study|Protocol deviation|0|||
125335196|NCT00545272|450861799|FG001|Overall Study|Protocol deviation|1|||
125335197|NCT00545272|450861800|FG002|Overall Study|Protocol deviation|0|||
125335198|NCT00545272|450861801|FG003|Overall Study|Protocol deviation|1|||
125335199|NCT00545272|450861802|FG004|Overall Study|Protocol deviation|0|||
125335200|NCT00545272|450861803|FG005|Overall Study|Protocol deviation|1|||
125335201|NCT00545272|450861798|FG000|Overall Study|Adverse Event|0|||
125335202|NCT00545272|450861799|FG001|Overall Study|Adverse Event|0|||
125335203|NCT00545272|450861800|FG002|Overall Study|Adverse Event|1|||
125335204|NCT00545272|450861801|FG003|Overall Study|Adverse Event|0|||
125335205|NCT00545272|450861802|FG004|Overall Study|Adverse Event|0|||
125335206|NCT00545272|450861803|FG005|Overall Study|Adverse Event|1|||
125335207|NCT00545272|450861798|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125335208|NCT00545272|450861799|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125335209|NCT00545272|450861800|FG002|Overall Study|Abnormal laboratory value(s)|0|||
125335210|NCT00545272|450861801|FG003|Overall Study|Abnormal laboratory value(s)|0|||
125335211|NCT00545272|450861802|FG004|Overall Study|Abnormal laboratory value(s)|0|||
125335212|NCT00545272|450861803|FG005|Overall Study|Abnormal laboratory value(s)|1|||
125335213|NCT00545272|450861798|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125335214|NCT00545272|450861799|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125335215|NCT00545272|450861800|FG002|Overall Study|Abnormal test procedure result(s)|0|||
125335216|NCT00545272|450861801|FG003|Overall Study|Abnormal test procedure result(s)|0|||
125335217|NCT00545272|450861802|FG004|Overall Study|Abnormal test procedure result(s)|1|||
125335218|NCT00545272|450861803|FG005|Overall Study|Abnormal test procedure result(s)|0|||
125335219|NCT00545272|450861798|FG000|Overall Study|Lost to Follow-up|0|||
125335220|NCT00545272|450861799|FG001|Overall Study|Lost to Follow-up|0|||
125335221|NCT00545272|450861800|FG002|Overall Study|Lost to Follow-up|0|||
125335222|NCT00545272|450861801|FG003|Overall Study|Lost to Follow-up|0|||
125335223|NCT00545272|450861802|FG004|Overall Study|Lost to Follow-up|1|||
125335224|NCT00545272|450861803|FG005|Overall Study|Lost to Follow-up|0|||
125335225|NCT01837823|450861804|FG000|Overall Study|Lost to Follow-up|6|||
125335226|NCT00436345|450861809|FG000|Overall Study|ICU resident beyond follow-up period|3|||
125335227|NCT00436345|450861810|FG001|Overall Study|ICU resident beyond follow-up period|0|||
125335228|NCT01175083|450861811|FG000|Primary Epoch|Withdrawal by Subject|0|||
125335229|NCT01175083|450861812|FG001|Primary Epoch|Withdrawal by Subject|0|||
125335230|NCT01175083|450861813|FG002|Primary Epoch|Withdrawal by Subject|0|||
125335231|NCT01175083|450861814|FG003|Primary Epoch|Withdrawal by Subject|0|||
125335232|NCT01175083|450861815|FG004|Primary Epoch|Withdrawal by Subject|0|||
125335233|NCT01175083|450861816|FG005|Primary Epoch|Withdrawal by Subject|2|||
125335234|NCT01175083|450861811|FG000|Primary Epoch|Lost to Follow-up|0|||
125335235|NCT01175083|450861812|FG001|Primary Epoch|Lost to Follow-up|0|||
125335236|NCT01175083|450861813|FG002|Primary Epoch|Lost to Follow-up|0|||
125335237|NCT01175083|450861814|FG003|Primary Epoch|Lost to Follow-up|0|||
125335238|NCT01175083|450861815|FG004|Primary Epoch|Lost to Follow-up|0|||
125335239|NCT01175083|450861816|FG005|Primary Epoch|Lost to Follow-up|1|||
125335240|NCT01175083|450861811|FG000|Booster Epoch|Death|0|||
125335241|NCT01175083|450861812|FG001|Booster Epoch|Death|0|||
125335242|NCT01175083|450861813|FG002|Booster Epoch|Death|1|||
125335243|NCT01175083|450861814|FG003|Booster Epoch|Death|0|||
125335244|NCT01175083|450861815|FG004|Booster Epoch|Death|0|||
125335245|NCT01175083|450861816|FG005|Booster Epoch|Death|0|||
125335246|NCT01175083|450861811|FG000|Booster Epoch|Withdrawal by Subject|0|||
125335247|NCT01175083|450861812|FG001|Booster Epoch|Withdrawal by Subject|0|||
125335248|NCT01175083|450861813|FG002|Booster Epoch|Withdrawal by Subject|0|||
125335249|NCT01175083|450861814|FG003|Booster Epoch|Withdrawal by Subject|1|||
125335250|NCT01175083|450861815|FG004|Booster Epoch|Withdrawal by Subject|0|||
125335251|NCT01175083|450861816|FG005|Booster Epoch|Withdrawal by Subject|0|||
125335252|NCT00475306|450861817|FG000|Overall Study|Protocol Violation|1|||
125335253|NCT00475306|450861818|FG001|Overall Study|Protocol Violation|1|||
125335254|NCT00475306|450861819|FG002|Overall Study|Protocol Violation|0|||
125335255|NCT00475306|450861820|FG003|Overall Study|Protocol Violation|1|||
125090114|NCT04880642|449948668|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
125090115|NCT04880642|449948669|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
125090116|NCT04880642|449948668|FG000|Follow-up|Death|4|||
125335256|NCT01716052|450861821|FG000|Overall Study|Withdrawal of funding|1|||
125335257|NCT01716052|450861822|FG001|Overall Study|Withdrawal of funding|1|||
125090117|NCT04880642|449948669|FG001|Follow-up|Death|3|||
125090118|NCT04880642|449948668|FG000|Follow-up|Withdrawal by Subject|1|||
125335258|NCT02405442|450861823|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
125335259|NCT02405442|450861824|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
125335260|NCT02405442|450861825|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
125335261|NCT02405442|450861826|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
125335262|NCT02405442|450861823|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
125335263|NCT02405442|450861824|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
125335264|NCT02405442|450861825|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
125090119|NCT04880642|449948669|FG001|Follow-up|Withdrawal by Subject|0|||
125090120|NCT02906644|449948670|FG000|First 2 Weeks|Withdrawal by Subject|0|||
125090121|NCT02906644|449948671|FG001|First 2 Weeks|Withdrawal by Subject|2|||
125090122|NCT02906644|449948670|FG000|First 2 Weeks|Physician Decision|1|||
125335265|NCT02405442|450861826|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
125335266|NCT02405442|450861823|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
125335267|NCT02405442|450861824|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
125335268|NCT02405442|450861825|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
125090123|NCT02906644|449948671|FG001|First 2 Weeks|Physician Decision|1|||
125335269|NCT02405442|450861826|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
125335270|NCT02405442|450861823|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
125335271|NCT02405442|450861824|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
125335272|NCT02405442|450861825|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
125335273|NCT02405442|450861826|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
125335274|NCT02405442|450861823|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
125335275|NCT02405442|450861824|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
125335276|NCT02405442|450861825|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
125335277|NCT02405442|450861826|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
125335278|NCT02405442|450861823|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
125335279|NCT02405442|450861824|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
125335280|NCT02405442|450861825|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
125335281|NCT02405442|450861826|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
125335282|NCT02405442|450861823|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
125335283|NCT02405442|450861824|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
125335284|NCT02405442|450861825|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
125335285|NCT02405442|450861826|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
125335286|NCT02405442|450861823|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
125335287|NCT02405442|450861824|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
125335288|NCT02405442|450861825|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
125335289|NCT02405442|450861826|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
125335290|NCT02405442|450861823|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
125335291|NCT02405442|450861824|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
125335292|NCT02405442|450861825|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
125335293|NCT02405442|450861826|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
125335294|NCT02405442|450861823|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
125335295|NCT02405442|450861824|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
125335296|NCT02405442|450861825|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
125335297|NCT02405442|450861826|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
125335298|NCT02405442|450861823|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
125335299|NCT02405442|450861824|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
125335300|NCT02405442|450861825|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
125335301|NCT02405442|450861826|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
125335302|NCT02405442|450861823|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
125335303|NCT02405442|450861824|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
125335304|NCT02405442|450861825|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
125335305|NCT02405442|450861826|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
125335306|NCT02405442|450861823|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
125335307|NCT02405442|450861824|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
125335308|NCT02405442|450861825|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
125335309|NCT02405442|450861826|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
125335310|NCT02405442|450861823|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
125335311|NCT02405442|450861824|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
125335312|NCT02405442|450861825|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
125335313|NCT02405442|450861826|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
125335314|NCT03275350|450861828|FG000|Overall Study|Lost to Follow-up|4|||
125335315|NCT03275350|450861829|FG001|Overall Study|Lost to Follow-up|6|||
125335316|NCT03275350|450861828|FG000|Overall Study|Death|2|||
125335317|NCT03275350|450861829|FG001|Overall Study|Death|1|||
125335318|NCT03275350|450861828|FG000|Overall Study|Physician Decision|1|||
125335319|NCT03275350|450861829|FG001|Overall Study|Physician Decision|0|||
125335320|NCT03275350|450861828|FG000|Overall Study|Incarcerated|1|||
125335321|NCT03275350|450861829|FG001|Overall Study|Incarcerated|1|||
125335322|NCT00926029|450861830|FG000|Overall Study|Lost to Follow-up|2|||
125335323|NCT00926029|450861831|FG001|Overall Study|Lost to Follow-up|1|||
125335324|NCT00926029|450861832|FG002|Overall Study|Lost to Follow-up|1|||
125090124|NCT02906644|449948670|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
125090125|NCT02906644|449948671|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
125335325|NCT04154189|450861835|FG000|Overall Study|Withdrawal by Subject|4|||
125335326|NCT04154189|450861836|FG001|Overall Study|Withdrawal by Subject|6|||
125335327|NCT04154189|450861835|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
125090126|NCT02906644|449948670|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
125090127|NCT02906644|449948671|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
125090128|NCT02452034|449948672|FG000|Overall Study|Adverse Event|0|||
125090129|NCT02452034|449948673|FG001|Overall Study|Adverse Event|0|||
125335328|NCT04154189|450861836|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
125090130|NCT02452034|449948674|FG002|Overall Study|Adverse Event|0|||
125335329|NCT04154189|450861835|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
125335330|NCT04154189|450861836|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
125335331|NCT04154189|450861835|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
125335332|NCT04154189|450861836|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
125335333|NCT04154189|450861835|FG000|Overall Study|Death|25|||
125335334|NCT04154189|450861836|FG001|Overall Study|Death|25|||
125335335|NCT02147561|450861839|FG000|Overall Study|Lost to Follow-up|3|||
125335336|NCT02147561|450861839|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
125335337|NCT01191762|450861840|FG000|Overall Study|Adverse Event|1|||
125335338|NCT01191762|450861841|FG001|Overall Study|Adverse Event|0|||
125335339|NCT02283762|450861844|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
125335340|NCT02283762|450861845|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
125335341|NCT02283762|450861844|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
125335342|NCT02283762|450861845|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
125335343|NCT02283762|450861844|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
125335344|NCT02283762|450861845|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
125335345|NCT02283762|450861844|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
125335346|NCT02283762|450861845|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
125335347|NCT02283762|450861844|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
125335348|NCT02283762|450861845|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
125335349|NCT02283762|450861844|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
125335350|NCT02283762|450861845|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
125335351|NCT02283762|450861844|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
125335352|NCT02283762|450861845|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
125335353|NCT02283762|450861844|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
125335354|NCT02283762|450861845|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
125335355|NCT02283762|450861844|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
125335356|NCT02283762|450861845|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
125335357|NCT02283762|450861844|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
125335358|NCT02283762|450861845|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
125335359|NCT02283762|450861844|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
125335360|NCT02283762|450861845|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
125335361|NCT02283762|450861844|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
125335362|NCT02283762|450861845|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
125335363|NCT00202878|450861846|FG000|Overall Study|Death|964|||
125335364|NCT00202878|450861847|FG001|Overall Study|Death|968|||
125335365|NCT00202878|450861846|FG000|Overall Study|Only Vital Status Known|357|||
125335366|NCT00202878|450861847|FG001|Overall Study|Only Vital Status Known|356|||
125335367|NCT00202878|450861846|FG000|Overall Study|Lost to Follow-up|44|||
125335368|NCT00202878|450861847|FG001|Overall Study|Lost to Follow-up|49|||
125335369|NCT00202878|450861846|FG000|Overall Study|Site Closure|39|||
125335370|NCT00202878|450861847|FG001|Overall Study|Site Closure|36|||
125335371|NCT00202878|450861846|FG000|Overall Study|Withdrawal by Subject|795|||
125335372|NCT00202878|450861847|FG001|Overall Study|Withdrawal by Subject|808|||
125335373|NCT03801031|450861852|FG000|Overall Study|Lost to Follow-up|1|||
125335374|NCT03801031|450861853|FG001|Overall Study|Lost to Follow-up|0|||
125335375|NCT03801031|450861852|FG000|Overall Study|Unable to comply|1|||
125335376|NCT03801031|450861853|FG001|Overall Study|Unable to comply|0|||
125335377|NCT03801031|450861852|FG000|Overall Study|Withdrawal by Subject|0|||
125335378|NCT03801031|450861853|FG001|Overall Study|Withdrawal by Subject|1|||
125335379|NCT00486291|450861854|FG000|Overall Study|Adverse Event|3|||
125335380|NCT00486291|450861855|FG001|Overall Study|Adverse Event|4|||
125335381|NCT00486291|450861854|FG000|Overall Study|Lost to Follow-up|3|||
125335382|NCT00486291|450861855|FG001|Overall Study|Lost to Follow-up|7|||
125335383|NCT00486291|450861854|FG000|Overall Study|protocol non-compliance|10|||
125335384|NCT00486291|450861855|FG001|Overall Study|protocol non-compliance|15|||
125335385|NCT00486291|450861854|FG000|Overall Study|requirement for restricted medication|0|||
125335386|NCT00486291|450861855|FG001|Overall Study|requirement for restricted medication|3|||
125335387|NCT00126490|450861861|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
125335388|NCT00975780|450861862|FG000|Follow Up|Death|88|||
125335389|NCT00975780|450861863|FG001|Follow Up|Death|122|||
125335390|NCT00975780|450861862|FG000|Follow Up|Facility Withdrawal|7|||
125335391|NCT00975780|450861863|FG001|Follow Up|Facility Withdrawal|23|||
125335392|NCT00975780|450861862|FG000|Follow Up|Discharged from Facility|7|||
125335393|NCT00975780|450861863|FG001|Follow Up|Discharged from Facility|12|||
125335394|NCT03051178|450861866|FG000|Overall Study|Withdrawal by Subject|5|||
125335395|NCT01598506|450861867|FG000|Overall Study|Withdrawal by Subject|2|||
125335396|NCT04080167|450861872|FG000|Overall Study|Lost to Follow-up-Patients|7|||
125335397|NCT04080167|450861873|FG001|Overall Study|Lost to Follow-up-Patients|14|||
125335398|NCT04080167|450861874|FG002|Overall Study|Lost to Follow-up-Patients|0|||
125335399|NCT04080167|450861872|FG000|Overall Study|Lost to Follow-up-Providers|2|||
125335400|NCT04080167|450861873|FG001|Overall Study|Lost to Follow-up-Providers|2|||
125335401|NCT04080167|450861874|FG002|Overall Study|Lost to Follow-up-Providers|0|||
125335402|NCT04080167|450861872|FG000|Overall Study|Withdrawal by Subject|1|||
125335403|NCT04080167|450861873|FG001|Overall Study|Withdrawal by Subject|2|||
125335404|NCT04080167|450861874|FG002|Overall Study|Withdrawal by Subject|0|||
125335405|NCT04080167|450861872|FG000|Overall Study|Withdrawal by Provider|0|||
125335406|NCT04080167|450861873|FG001|Overall Study|Withdrawal by Provider|0|||
125335407|NCT04080167|450861874|FG002|Overall Study|Withdrawal by Provider|4|||
125335408|NCT04080167|450861872|FG000|Overall Study|Death-Patient|2|||
125335409|NCT04080167|450861873|FG001|Overall Study|Death-Patient|1|||
125335410|NCT04080167|450861874|FG002|Overall Study|Death-Patient|0|||
125335411|NCT04080167|450861872|FG000|Overall Study|Hydroxyurea New Starts|0|||
125335412|NCT04080167|450861873|FG001|Overall Study|Hydroxyurea New Starts|0|||
125335413|NCT04080167|450861874|FG002|Overall Study|Hydroxyurea New Starts|1|||
125335414|NCT04080167|450861872|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
125335415|NCT04080167|450861873|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
125335416|NCT04080167|450861874|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
125335417|NCT03530124|450861877|FG000|Overall Study|Withdrawal by Subject|0|||
125335418|NCT03530124|450861878|FG001|Overall Study|Withdrawal by Subject|1|||
125335419|NCT03530124|450861877|FG000|Overall Study|Protocol Violation|1|||
125335420|NCT03530124|450861878|FG001|Overall Study|Protocol Violation|0|||
125335421|NCT03530124|450861877|FG000|Overall Study|Discharged prior to study completion|1|||
125335422|NCT03530124|450861878|FG001|Overall Study|Discharged prior to study completion|0|||
125335423|NCT01047553|450861879|FG000|Overall Study|Adverse Event|10|||
125335424|NCT01047553|450861880|FG001|Overall Study|Adverse Event|5|||
125335425|NCT01047553|450861879|FG000|Overall Study|Withdrawal by Subject|4|||
125335426|NCT01047553|450861880|FG001|Overall Study|Withdrawal by Subject|2|||
125335427|NCT01047553|450861879|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
125335428|NCT01047553|450861880|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
125335429|NCT01047553|450861879|FG000|Overall Study|Lost to Follow-up|1|||
125335430|NCT01047553|450861880|FG001|Overall Study|Lost to Follow-up|0|||
125335431|NCT01047553|450861879|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
125335432|NCT01047553|450861880|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
125335433|NCT01047553|450861879|FG000|Overall Study|PI's decision|0|||
125335434|NCT01047553|450861880|FG001|Overall Study|PI's decision|1|||
125335435|NCT01583296|450861881|FG000|Overall Study|Withdrawal by Subject|11|||
125335436|NCT01583296|450861882|FG001|Overall Study|Withdrawal by Subject|10|||
125335437|NCT01063283|450861883|FG000|Cycle 1|Adverse Event|2|||
125335438|NCT01063283|450861884|FG001|Cycle 1|Adverse Event|0|||
125335439|NCT01063283|450861885|FG002|Cycle 1|Adverse Event|0|||
125335440|NCT01063283|450861883|FG000|Cycle 1|Technical failure in data collection|1|||
125335441|NCT01063283|450861884|FG001|Cycle 1|Technical failure in data collection|0|||
125335442|NCT01063283|450861885|FG002|Cycle 1|Technical failure in data collection|0|||
125335443|NCT05343624|450861886|FG000|Overall Study|Chart review not completed|1|||
125335444|NCT01120717|450861887|FG000|Overall Study|Withdrawal by Subject|11|||
125335445|NCT01120717|450861888|FG001|Overall Study|Withdrawal by Subject|6|||
125335446|NCT01120717|450861887|FG000|Overall Study|Adverse Event|10|||
125335447|NCT01120717|450861888|FG001|Overall Study|Adverse Event|6|||
125335448|NCT01120717|450861887|FG000|Overall Study|Protocol Deviation|2|||
125335449|NCT01120717|450861888|FG001|Overall Study|Protocol Deviation|5|||
125335450|NCT01120717|450861887|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
125335451|NCT01120717|450861888|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
125335452|NCT01120717|450861887|FG000|Overall Study|Lost to Follow-up|2|||
125335453|NCT01120717|450861888|FG001|Overall Study|Lost to Follow-up|3|||
125335454|NCT01120717|450861887|FG000|Overall Study|Death|3|||
125335455|NCT01120717|450861888|FG001|Overall Study|Death|1|||
125335456|NCT01120717|450861887|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
125335457|NCT01120717|450861888|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
125335458|NCT02504216|450861893|FG000|Overall Study|Lost to Follow-up|3|||
125335459|NCT02504216|450861894|FG001|Overall Study|Lost to Follow-up|3|||
125335460|NCT02504216|450861893|FG000|Overall Study|Withdrawal by Subject|8|||
125335461|NCT02504216|450861894|FG001|Overall Study|Withdrawal by Subject|12|||
125335462|NCT00862082|450861895|FG000|Overall Study|Sponsor decision to terminate the study|5|||
125335463|NCT00862082|450861896|FG001|Overall Study|Sponsor decision to terminate the study|0|||
125335464|NCT00862082|450861895|FG000|Overall Study|Withdrawal by Subject|0|||
125335465|NCT00862082|450861896|FG001|Overall Study|Withdrawal by Subject|1|||
125335466|NCT02598583|450861897|FG000|Extension Period|Withdrawal by Subject|1|||
125335467|NCT02598583|450861898|FG001|Extension Period|Withdrawal by Subject|0|||
125335468|NCT05334212|450861907|FG000|Overall Study|Study terminated prematurely|7|||
125335469|NCT02152956|450861908|FG000|Overall Study|Adverse Event|0|||
125335470|NCT02152956|450861909|FG001|Overall Study|Adverse Event|0|||
125335471|NCT02152956|450861910|FG002|Overall Study|Adverse Event|0|||
125335472|NCT02152956|450861911|FG003|Overall Study|Adverse Event|0|||
125335473|NCT02152956|450861912|FG004|Overall Study|Adverse Event|0|||
125335474|NCT02152956|450861913|FG005|Overall Study|Adverse Event|0|||
125335475|NCT02152956|450861914|FG006|Overall Study|Adverse Event|0|||
125335476|NCT02152956|450861915|FG007|Overall Study|Adverse Event|0|||
125335477|NCT02152956|450861916|FG008|Overall Study|Adverse Event|0|||
125335478|NCT02152956|450861917|FG009|Overall Study|Adverse Event|0|||
125335479|NCT02152956|450861918|FG010|Overall Study|Adverse Event|0|||
125335480|NCT02152956|450861919|FG011|Overall Study|Adverse Event|4|||
125335481|NCT02152956|450861920|FG012|Overall Study|Adverse Event|0|||
125335482|NCT02152956|450861908|FG000|Overall Study|Death|0|||
125335483|NCT02152956|450861909|FG001|Overall Study|Death|3|||
125335484|NCT02152956|450861910|FG002|Overall Study|Death|3|||
125090131|NCT02452034|449948675|FG003|Overall Study|Adverse Event|0|||
125090132|NCT02452034|449948676|FG004|Overall Study|Adverse Event|0|||
125090133|NCT02452034|449948677|FG005|Overall Study|Adverse Event|1|||
125090134|NCT02452034|449948672|FG000|Overall Study|Death|0|||
125090135|NCT02452034|449948673|FG001|Overall Study|Death|0|||
125090136|NCT02452034|449948674|FG002|Overall Study|Death|0|||
125335485|NCT02152956|450861911|FG003|Overall Study|Death|4|||
125335486|NCT02152956|450861912|FG004|Overall Study|Death|1|||
125335487|NCT02152956|450861913|FG005|Overall Study|Death|2|||
125335488|NCT02152956|450861914|FG006|Overall Study|Death|6|||
125335489|NCT02152956|450861915|FG007|Overall Study|Death|6|||
125335490|NCT02152956|450861916|FG008|Overall Study|Death|4|||
125335491|NCT02152956|450861917|FG009|Overall Study|Death|5|||
125335492|NCT02152956|450861918|FG010|Overall Study|Death|3|||
125335493|NCT02152956|450861919|FG011|Overall Study|Death|143|||
125335494|NCT02152956|450861920|FG012|Overall Study|Death|12|||
125335495|NCT02152956|450861908|FG000|Overall Study|Lost to Follow-up|0|||
125335496|NCT02152956|450861909|FG001|Overall Study|Lost to Follow-up|1|||
125335497|NCT02152956|450861910|FG002|Overall Study|Lost to Follow-up|0|||
125335498|NCT02152956|450861911|FG003|Overall Study|Lost to Follow-up|0|||
125335499|NCT02152956|450861912|FG004|Overall Study|Lost to Follow-up|0|||
125335500|NCT02152956|450861913|FG005|Overall Study|Lost to Follow-up|0|||
125335501|NCT02152956|450861914|FG006|Overall Study|Lost to Follow-up|0|||
125335502|NCT02152956|450861915|FG007|Overall Study|Lost to Follow-up|0|||
125335503|NCT02152956|450861916|FG008|Overall Study|Lost to Follow-up|0|||
125335504|NCT02152956|450861917|FG009|Overall Study|Lost to Follow-up|0|||
125335505|NCT02152956|450861918|FG010|Overall Study|Lost to Follow-up|0|||
125335506|NCT02152956|450861919|FG011|Overall Study|Lost to Follow-up|3|||
125335507|NCT02152956|450861920|FG012|Overall Study|Lost to Follow-up|0|||
125335508|NCT02152956|450861908|FG000|Overall Study|Withdrawal by Subject|1|||
125335509|NCT02152956|450861909|FG001|Overall Study|Withdrawal by Subject|0|||
125335510|NCT02152956|450861910|FG002|Overall Study|Withdrawal by Subject|1|||
125335511|NCT02152956|450861911|FG003|Overall Study|Withdrawal by Subject|0|||
125335512|NCT02152956|450861912|FG004|Overall Study|Withdrawal by Subject|2|||
125335513|NCT02152956|450861913|FG005|Overall Study|Withdrawal by Subject|2|||
125335514|NCT02152956|450861914|FG006|Overall Study|Withdrawal by Subject|0|||
125335515|NCT02152956|450861915|FG007|Overall Study|Withdrawal by Subject|0|||
125335516|NCT02152956|450861916|FG008|Overall Study|Withdrawal by Subject|1|||
125335517|NCT02152956|450861917|FG009|Overall Study|Withdrawal by Subject|0|||
125335518|NCT02152956|450861918|FG010|Overall Study|Withdrawal by Subject|0|||
125335519|NCT02152956|450861919|FG011|Overall Study|Withdrawal by Subject|4|||
125335520|NCT02152956|450861920|FG012|Overall Study|Withdrawal by Subject|0|||
125335521|NCT02152956|450861908|FG000|Overall Study|Physician Decision|0|||
125335522|NCT02152956|450861909|FG001|Overall Study|Physician Decision|0|||
125335523|NCT02152956|450861910|FG002|Overall Study|Physician Decision|0|||
125335524|NCT02152956|450861911|FG003|Overall Study|Physician Decision|0|||
125335525|NCT02152956|450861912|FG004|Overall Study|Physician Decision|0|||
125335526|NCT02152956|450861913|FG005|Overall Study|Physician Decision|0|||
125335527|NCT02152956|450861914|FG006|Overall Study|Physician Decision|0|||
125335528|NCT02152956|450861915|FG007|Overall Study|Physician Decision|0|||
125335529|NCT02152956|450861916|FG008|Overall Study|Physician Decision|0|||
125335530|NCT02152956|450861917|FG009|Overall Study|Physician Decision|0|||
125335531|NCT02152956|450861918|FG010|Overall Study|Physician Decision|0|||
125090137|NCT02452034|449948675|FG003|Overall Study|Death|0|||
125090138|NCT02452034|449948676|FG004|Overall Study|Death|1|||
125335532|NCT02152956|450861919|FG011|Overall Study|Physician Decision|1|||
125335533|NCT02152956|450861920|FG012|Overall Study|Physician Decision|0|||
125335534|NCT02152956|450861908|FG000|Overall Study|Study terminated by sponsor|0|||
125335535|NCT02152956|450861909|FG001|Overall Study|Study terminated by sponsor|0|||
125335536|NCT02152956|450861910|FG002|Overall Study|Study terminated by sponsor|0|||
125335537|NCT02152956|450861911|FG003|Overall Study|Study terminated by sponsor|0|||
125335538|NCT02152956|450861912|FG004|Overall Study|Study terminated by sponsor|0|||
125335539|NCT02152956|450861913|FG005|Overall Study|Study terminated by sponsor|0|||
125335540|NCT02152956|450861914|FG006|Overall Study|Study terminated by sponsor|0|||
125335541|NCT02152956|450861915|FG007|Overall Study|Study terminated by sponsor|0|||
125335542|NCT02152956|450861916|FG008|Overall Study|Study terminated by sponsor|0|||
125335543|NCT02152956|450861917|FG009|Overall Study|Study terminated by sponsor|0|||
125335544|NCT02152956|450861918|FG010|Overall Study|Study terminated by sponsor|0|||
125090139|NCT02452034|449948677|FG005|Overall Study|Death|1|||
125335545|NCT02152956|450861919|FG011|Overall Study|Study terminated by sponsor|29|||
125335546|NCT02152956|450861920|FG012|Overall Study|Study terminated by sponsor|0|||
125335547|NCT02152956|450861908|FG000|Overall Study|progressive disease|0|||
125335548|NCT02152956|450861909|FG001|Overall Study|progressive disease|0|||
125335549|NCT02152956|450861910|FG002|Overall Study|progressive disease|0|||
125335550|NCT02152956|450861911|FG003|Overall Study|progressive disease|0|||
125335551|NCT02152956|450861912|FG004|Overall Study|progressive disease|0|||
125335552|NCT02152956|450861913|FG005|Overall Study|progressive disease|0|||
125335553|NCT02152956|450861914|FG006|Overall Study|progressive disease|0|||
125335554|NCT02152956|450861915|FG007|Overall Study|progressive disease|0|||
125335555|NCT02152956|450861916|FG008|Overall Study|progressive disease|1|||
125335556|NCT02152956|450861917|FG009|Overall Study|progressive disease|0|||
125335557|NCT02152956|450861918|FG010|Overall Study|progressive disease|0|||
125335558|NCT02152956|450861919|FG011|Overall Study|progressive disease|1|||
125335559|NCT02152956|450861920|FG012|Overall Study|progressive disease|0|||
125335560|NCT02445794|450861921|FG000|Overall Study|Adverse Event|0|||
125335561|NCT02445794|450861922|FG001|Overall Study|Adverse Event|0|||
125335562|NCT02445794|450861923|FG002|Overall Study|Adverse Event|2|||
125335563|NCT02445794|450861924|FG003|Overall Study|Adverse Event|0|||
125335564|NCT01668589|450861925|FG000|Overall Study|Lost to Follow-up|29|||
125335565|NCT01668589|450861926|FG001|Overall Study|Lost to Follow-up|37|||
125335566|NCT01668589|450861927|FG002|Overall Study|Lost to Follow-up|15|||
125335567|NCT01668589|450861928|FG003|Overall Study|Lost to Follow-up|5|||
125335568|NCT01668589|450861925|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
125335569|NCT01668589|450861926|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
125335570|NCT01668589|450861927|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
125335571|NCT01668589|450861928|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
125335572|NCT01668589|450861925|FG000|Overall Study|Death|12|||
125335573|NCT01668589|450861926|FG001|Overall Study|Death|3|||
125335574|NCT01668589|450861927|FG002|Overall Study|Death|2|||
125335575|NCT01668589|450861928|FG003|Overall Study|Death|11|||
125335576|NCT01668589|450861925|FG000|Overall Study|Other|44|||
125335577|NCT01668589|450861926|FG001|Overall Study|Other|10|||
125335578|NCT01668589|450861927|FG002|Overall Study|Other|7|||
125335579|NCT01668589|450861928|FG003|Overall Study|Other|15|||
125335580|NCT00661427|450861931|FG000|Overall Study|Adverse Event|5|||
125335581|NCT00661427|450861932|FG001|Overall Study|Adverse Event|5|||
125335582|NCT00661427|450861931|FG000|Overall Study|Patient not treated|0|||
125335583|NCT00661427|450861932|FG001|Overall Study|Patient not treated|2|||
125335584|NCT00488683|450861933|FG000|Overall Study|Withdrawal by Subject|1|||
125335585|NCT00488683|450861934|FG001|Overall Study|Withdrawal by Subject|2|||
125335586|NCT00488683|450861935|FG002|Overall Study|Withdrawal by Subject|2|||
125335587|NCT00488683|450861933|FG000|Overall Study|Lost to Follow-up|5|||
125335588|NCT00488683|450861934|FG001|Overall Study|Lost to Follow-up|3|||
125335589|NCT00488683|450861935|FG002|Overall Study|Lost to Follow-up|0|||
125002995|NCT00228566|449639219|FG000|Overall Study|Lost to Follow-up|16|||
125002996|NCT00228566|449639219|FG000|Overall Study|Physician Decision|5|||
125002997|NCT00228566|449639219|FG000|Overall Study|Withdrawal by Subject|4|||
125002998|NCT00228566|449639219|FG000|Overall Study|Miscellaneous|1|||
125002999|NCT04448756|449639220|FG000|Overall Study|Adverse Event|0|||
125003000|NCT04448756|449639221|FG001|Overall Study|Adverse Event|1|||
125003001|NCT04448756|449639222|FG002|Overall Study|Adverse Event|0|||
125003002|NCT04448756|449639220|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
125003003|NCT04448756|449639221|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
125003004|NCT04448756|449639222|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
125003005|NCT04448756|449639220|FG000|Overall Study|Withdrawal by Subject|0|||
125003006|NCT04448756|449639221|FG001|Overall Study|Withdrawal by Subject|3|||
125003007|NCT04448756|449639222|FG002|Overall Study|Withdrawal by Subject|1|||
125003008|NCT04448756|449639220|FG000|Overall Study|Death|2|||
125003009|NCT04448756|449639221|FG001|Overall Study|Death|1|||
125003010|NCT04448756|449639222|FG002|Overall Study|Death|0|||
125003011|NCT00835120|449639223|FG000|Overall Study|Lack of Efficacy|1|||
125003012|NCT00835120|449639223|FG000|Overall Study|Lost to Follow-up|3|||
125003013|NCT00835120|449639223|FG000|Overall Study|Adverse Event|2|||
125003014|NCT00835120|449639223|FG000|Overall Study|Withdrawal by Subject|2|||
125003015|NCT01624259|449639224|FG000|Overall Study|Adverse Event|18|||
125003016|NCT01624259|449639225|FG001|Overall Study|Adverse Event|18|||
125003017|NCT01624259|449639224|FG000|Overall Study|Protocol Violation|1|||
125003018|NCT01624259|449639225|FG001|Overall Study|Protocol Violation|2|||
125003019|NCT01624259|449639224|FG000|Overall Study|Withdrawal by Subject|5|||
125003020|NCT01624259|449639225|FG001|Overall Study|Withdrawal by Subject|7|||
125003021|NCT01624259|449639224|FG000|Overall Study|Physician Decision|1|||
125003022|NCT01624259|449639225|FG001|Overall Study|Physician Decision|1|||
125003023|NCT01624259|449639224|FG000|Overall Study|Lost to Follow-up|2|||
125335590|NCT00488683|450861933|FG000|Overall Study|Protocol Violation|5|||
125335591|NCT00488683|450861934|FG001|Overall Study|Protocol Violation|1|||
125003024|NCT01624259|449639225|FG001|Overall Study|Lost to Follow-up|3|||
125335592|NCT00488683|450861935|FG002|Overall Study|Protocol Violation|0|||
125335593|NCT00488683|450861933|FG000|Overall Study|Unable to Classify|1|||
125335594|NCT00488683|450861934|FG001|Overall Study|Unable to Classify|0|||
125335595|NCT00488683|450861935|FG002|Overall Study|Unable to Classify|0|||
125335596|NCT02079740|450863597|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
125335597|NCT02079740|450863598|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
125335598|NCT02079740|450863599|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
125335599|NCT02079740|450863600|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
125335600|NCT02079740|450863601|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
125335601|NCT02079740|450863602|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
125335602|NCT02079740|450863603|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
125335603|NCT02079740|450863604|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
125335604|NCT02079740|450863605|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
125335605|NCT02079740|450863606|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
125335606|NCT02079740|450863607|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
125335607|NCT02079740|450863608|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
125335608|NCT02079740|450863609|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
125335609|NCT02079740|450863597|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
125335610|NCT02079740|450863598|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
125335611|NCT02079740|450863599|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
125335612|NCT02079740|450863600|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
125335613|NCT02079740|450863601|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
125335614|NCT02079740|450863602|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
125335615|NCT02079740|450863603|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
125335616|NCT02079740|450863604|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
125335617|NCT02079740|450863605|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
125335618|NCT02079740|450863606|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
125335619|NCT02079740|450863607|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
125335620|NCT02079740|450863608|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
125335621|NCT02079740|450863609|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
125335622|NCT02079740|450863597|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
125335623|NCT02079740|450863598|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
125335624|NCT02079740|450863599|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
125335625|NCT02079740|450863600|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
125335626|NCT02079740|450863601|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
125335627|NCT02079740|450863602|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
125335628|NCT02079740|450863603|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
125335629|NCT02079740|450863604|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
125335630|NCT02079740|450863605|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
125335631|NCT02079740|450863606|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
125335632|NCT02079740|450863607|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
125335633|NCT02079740|450863608|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
125335634|NCT02079740|450863609|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
125335635|NCT02079740|450863597|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125335636|NCT02079740|450863598|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125335637|NCT02079740|450863599|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125335638|NCT02079740|450863600|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125335639|NCT02079740|450863601|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125335640|NCT02079740|450863602|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125335641|NCT02079740|450863603|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125335642|NCT02079740|450863604|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
125335643|NCT02079740|450863605|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125335644|NCT02079740|450863606|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125335645|NCT02079740|450863607|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125335646|NCT02079740|450863608|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125335647|NCT02079740|450863609|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125335648|NCT02079740|450863597|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
125335649|NCT02079740|450863598|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
125335650|NCT02079740|450863599|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
125335651|NCT02079740|450863600|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
125335652|NCT02079740|450863601|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
125335653|NCT02079740|450863602|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
125335654|NCT02079740|450863603|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
125335655|NCT02079740|450863604|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
125335656|NCT02079740|450863605|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
125335657|NCT02079740|450863606|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
125335658|NCT02079740|450863607|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
125335659|NCT02079740|450863608|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
125335660|NCT02079740|450863609|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
125335661|NCT02328014|450863610|FG000|Overall Study|Adverse Event|1|||
125335662|NCT02328014|450863611|FG001|Overall Study|Adverse Event|0|||
125335663|NCT02328014|450863612|FG002|Overall Study|Adverse Event|0|||
125335664|NCT02328014|450863613|FG003|Overall Study|Adverse Event|1|||
125335665|NCT02328014|450863610|FG000|Overall Study|Death|0|||
125335666|NCT02328014|450863611|FG001|Overall Study|Death|0|||
125335667|NCT02328014|450863612|FG002|Overall Study|Death|0|||
125335668|NCT02328014|450863613|FG003|Overall Study|Death|4|||
125335669|NCT02328014|450863610|FG000|Overall Study|Physician Decision|0|||
125090140|NCT02452034|449948672|FG000|Overall Study|Physician Decision|0|||
125090141|NCT02452034|449948673|FG001|Overall Study|Physician Decision|1|||
125090142|NCT02452034|449948674|FG002|Overall Study|Physician Decision|1|||
125090143|NCT02452034|449948675|FG003|Overall Study|Physician Decision|0|||
125090144|NCT02452034|449948676|FG004|Overall Study|Physician Decision|0|||
125090145|NCT02452034|449948677|FG005|Overall Study|Physician Decision|0|||
125090146|NCT02452034|449948672|FG000|Overall Study|Protocol Violation|0|||
125090147|NCT02452034|449948673|FG001|Overall Study|Protocol Violation|0|||
125090148|NCT02452034|449948674|FG002|Overall Study|Protocol Violation|0|||
125090149|NCT02452034|449948675|FG003|Overall Study|Protocol Violation|0|||
125090150|NCT02452034|449948676|FG004|Overall Study|Protocol Violation|0|||
125090151|NCT02452034|449948677|FG005|Overall Study|Protocol Violation|1|||
125090152|NCT02452034|449948672|FG000|Overall Study|Screen Failure|1|||
125090153|NCT02452034|449948673|FG001|Overall Study|Screen Failure|0|||
125335670|NCT02328014|450863611|FG001|Overall Study|Physician Decision|0|||
125335671|NCT02328014|450863612|FG002|Overall Study|Physician Decision|0|||
125335672|NCT02328014|450863613|FG003|Overall Study|Physician Decision|1|||
125335673|NCT02328014|450863610|FG000|Overall Study|Disease Progression|1|||
125003025|NCT01624259|449639224|FG000|Overall Study|Abnormal laboratory measure|3|||
125003026|NCT01624259|449639225|FG001|Overall Study|Abnormal laboratory measure|0|||
125003027|NCT00232141|449639226|FG000|Overall Study|Adverse Event|9|||
125003028|NCT00232141|449639227|FG001|Overall Study|Adverse Event|4|||
125003029|NCT00232141|449639226|FG000|Overall Study|Lack of Efficacy|0|||
125003030|NCT00232141|449639227|FG001|Overall Study|Lack of Efficacy|3|||
125003031|NCT00232141|449639226|FG000|Overall Study|Lost to Follow-up|9|||
125003032|NCT00232141|449639227|FG001|Overall Study|Lost to Follow-up|6|||
125003033|NCT00232141|449639226|FG000|Overall Study|Other|8|||
125003034|NCT00232141|449639227|FG001|Overall Study|Other|10|||
125003035|NCT00232141|449639226|FG000|Overall Study|Withdrawal by Subject|5|||
125003036|NCT00232141|449639227|FG001|Overall Study|Withdrawal by Subject|3|||
125003037|NCT04572854|449639228|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
125003038|NCT04572854|449639229|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
125003039|NCT04572854|449639230|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
125003040|NCT04572854|449639231|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
125003041|NCT04572854|449639228|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
125003042|NCT04572854|449639229|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
125003043|NCT04572854|449639230|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
125003044|NCT04572854|449639231|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
125003045|NCT04313153|449640617|FG000|Overall Study|Adverse Event (includes Death)|14|||
125003046|NCT04313153|449640618|FG001|Overall Study|Adverse Event (includes Death)|19|||
125003047|NCT04313153|449640619|FG002|Overall Study|Adverse Event (includes Death)|10|||
125003048|NCT04313153|449640617|FG000|Overall Study|Physician Decision|4|||
125003049|NCT04313153|449640618|FG001|Overall Study|Physician Decision|2|||
125003050|NCT04313153|449640619|FG002|Overall Study|Physician Decision|1|||
125003051|NCT04313153|449640617|FG000|Overall Study|Withdrawal by Subject|7|||
125003052|NCT04313153|449640618|FG001|Overall Study|Withdrawal by Subject|6|||
125003053|NCT04313153|449640619|FG002|Overall Study|Withdrawal by Subject|2|||
125003054|NCT04313153|449640617|FG000|Overall Study|Lack of Efficacy|3|||
125003055|NCT04313153|449640618|FG001|Overall Study|Lack of Efficacy|3|||
125003056|NCT04313153|449640619|FG002|Overall Study|Lack of Efficacy|0|||
125003057|NCT04313153|449640617|FG000|Overall Study|Lost to Follow-up|1|||
125003058|NCT04313153|449640618|FG001|Overall Study|Lost to Follow-up|0|||
125003059|NCT04313153|449640619|FG002|Overall Study|Lost to Follow-up|2|||
125003060|NCT04313153|449640617|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
125003061|NCT04313153|449640618|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
125003062|NCT04313153|449640619|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
125003063|NCT04313153|449640617|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
125003064|NCT04313153|449640618|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
125003065|NCT04313153|449640619|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
125003066|NCT04313153|449640617|FG000|Overall Study|Change in Dialysis Modality|0|||
125003067|NCT04313153|449640618|FG001|Overall Study|Change in Dialysis Modality|1|||
125003068|NCT04313153|449640619|FG002|Overall Study|Change in Dialysis Modality|2|||
125003069|NCT04313153|449640617|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
125003070|NCT04313153|449640618|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
125003071|NCT04313153|449640619|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
125003072|NCT04313153|449640617|FG000|Overall Study|Other|5|||
125003073|NCT04313153|449640618|FG001|Overall Study|Other|3|||
125003074|NCT04313153|449640619|FG002|Overall Study|Other|2|||
125003075|NCT05586269|449640620|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
125003076|NCT05586269|449640621|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
125003077|NCT05586269|449640622|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
125003078|NCT05586269|449640623|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
125335674|NCT02328014|450863611|FG001|Overall Study|Disease Progression|0|||
125335675|NCT02328014|450863612|FG002|Overall Study|Disease Progression|1|||
125335676|NCT02328014|450863613|FG003|Overall Study|Disease Progression|3|||
125335677|NCT02328014|450863610|FG000|Overall Study|Study Terminated by Sponsor|4|||
125335678|NCT02328014|450863611|FG001|Overall Study|Study Terminated by Sponsor|1|||
125335679|NCT02328014|450863612|FG002|Overall Study|Study Terminated by Sponsor|1|||
125335680|NCT02328014|450863613|FG003|Overall Study|Study Terminated by Sponsor|0|||
125335681|NCT02328014|450863610|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
125335682|NCT02328014|450863611|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
125335683|NCT02328014|450863612|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
125335684|NCT02328014|450863613|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
125335685|NCT02328014|450863610|FG000|Overall Study|Withdrawal by Subject|0|||
125335686|NCT02328014|450863611|FG001|Overall Study|Withdrawal by Subject|0|||
125335687|NCT02328014|450863612|FG002|Overall Study|Withdrawal by Subject|0|||
125335688|NCT02328014|450863613|FG003|Overall Study|Withdrawal by Subject|1|||
125335689|NCT01274338|450863614|FG000|Overall Study|Lack of Efficacy|72|||
125335690|NCT01274338|450863615|FG001|Overall Study|Lack of Efficacy|108|||
125335691|NCT01274338|450863616|FG002|Overall Study|Lack of Efficacy|116|||
125335692|NCT01274338|450863617|FG003|Overall Study|Lack of Efficacy|0|||
125335693|NCT01274338|450863618|FG004|Overall Study|Lack of Efficacy|0|||
125335694|NCT01274338|450863619|FG005|Overall Study|Lack of Efficacy|0|||
125335695|NCT01274338|450863614|FG000|Overall Study|Adverse Event|272|||
125335696|NCT01274338|450863615|FG001|Overall Study|Adverse Event|105|||
125335697|NCT01274338|450863616|FG002|Overall Study|Adverse Event|180|||
125335698|NCT01274338|450863617|FG003|Overall Study|Adverse Event|1|||
125335699|NCT01274338|450863618|FG004|Overall Study|Adverse Event|0|||
125335700|NCT01274338|450863619|FG005|Overall Study|Adverse Event|0|||
125335701|NCT01274338|450863614|FG000|Overall Study|Death|8|||
125335702|NCT01274338|450863615|FG001|Overall Study|Death|1|||
125335703|NCT01274338|450863616|FG002|Overall Study|Death|0|||
125335704|NCT01274338|450863617|FG003|Overall Study|Death|0|||
125335705|NCT01274338|450863618|FG004|Overall Study|Death|0|||
125335706|NCT01274338|450863619|FG005|Overall Study|Death|0|||
125335707|NCT01274338|450863614|FG000|Overall Study|Withdrawal by Subject|27|||
125335708|NCT01274338|450863615|FG001|Overall Study|Withdrawal by Subject|99|||
125335709|NCT01274338|450863616|FG002|Overall Study|Withdrawal by Subject|17|||
125335710|NCT01274338|450863617|FG003|Overall Study|Withdrawal by Subject|0|||
125335711|NCT01274338|450863618|FG004|Overall Study|Withdrawal by Subject|0|||
125335712|NCT01274338|450863619|FG005|Overall Study|Withdrawal by Subject|0|||
125335713|NCT01274338|450863614|FG000|Overall Study|Did not start treatment|8|||
125335714|NCT01274338|450863615|FG001|Overall Study|Did not start treatment|116|||
125335715|NCT01274338|450863616|FG002|Overall Study|Did not start treatment|7|||
125335716|NCT01274338|450863617|FG003|Overall Study|Did not start treatment|0|||
125335717|NCT01274338|450863618|FG004|Overall Study|Did not start treatment|0|||
125335718|NCT01274338|450863619|FG005|Overall Study|Did not start treatment|0|||
125335719|NCT01274338|450863614|FG000|Overall Study|Alternative therapy|0|||
125335720|NCT01274338|450863615|FG001|Overall Study|Alternative therapy|1|||
125335721|NCT01274338|450863616|FG002|Overall Study|Alternative therapy|0|||
125335722|NCT01274338|450863617|FG003|Overall Study|Alternative therapy|0|||
125335723|NCT01274338|450863618|FG004|Overall Study|Alternative therapy|0|||
125335724|NCT01274338|450863619|FG005|Overall Study|Alternative therapy|0|||
125335725|NCT01274338|450863614|FG000|Overall Study|Other complicating diseases|0|||
125335726|NCT01274338|450863615|FG001|Overall Study|Other complicating diseases|3|||
125335727|NCT01274338|450863616|FG002|Overall Study|Other complicating diseases|1|||
125335728|NCT01274338|450863617|FG003|Overall Study|Other complicating diseases|0|||
125335729|NCT01274338|450863618|FG004|Overall Study|Other complicating diseases|0|||
125335730|NCT01274338|450863619|FG005|Overall Study|Other complicating diseases|0|||
125335731|NCT01274338|450863614|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
125335732|NCT01274338|450863615|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
125335733|NCT01274338|450863616|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
125335734|NCT01274338|450863617|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
125335735|NCT01274338|450863618|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
125335736|NCT01274338|450863619|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
125335737|NCT01274338|450863614|FG000|Overall Study|Pregnancy|0|||
125003079|NCT05586269|449640620|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
125335738|NCT01274338|450863615|FG001|Overall Study|Pregnancy|0|||
125335739|NCT01274338|450863616|FG002|Overall Study|Pregnancy|1|||
125335740|NCT01274338|450863617|FG003|Overall Study|Pregnancy|0|||
125335741|NCT01274338|450863618|FG004|Overall Study|Pregnancy|0|||
125335742|NCT01274338|450863619|FG005|Overall Study|Pregnancy|0|||
125335743|NCT01274338|450863614|FG000|Overall Study|Reason not reported|12|||
125335744|NCT01274338|450863615|FG001|Overall Study|Reason not reported|21|||
125335745|NCT01274338|450863616|FG002|Overall Study|Reason not reported|3|||
125335746|NCT01274338|450863617|FG003|Overall Study|Reason not reported|0|||
125335747|NCT01274338|450863618|FG004|Overall Study|Reason not reported|1|||
125335748|NCT01274338|450863619|FG005|Overall Study|Reason not reported|0|||
125335749|NCT03493945|450863620|FG000|Phase I Dose Escalation|Ineligible|0|||
125335750|NCT03493945|450863621|FG001|Phase I Dose Escalation|Ineligible|0|||
125335751|NCT03493945|450863622|FG002|Phase I Dose Escalation|Ineligible|1|||
125335752|NCT03493945|450863623|FG003|Phase I Dose Escalation|Ineligible|0|||
125335753|NCT03493945|450863624|FG004|Phase I Dose Escalation|Ineligible|0|||
125335754|NCT03493945|450863625|FG005|Phase I Dose Escalation|Ineligible|0|||
125335755|NCT03493945|450863626|FG006|Phase I Dose Escalation|Ineligible|0|||
125335756|NCT03493945|450863620|FG000|Phase I Dose Escalation|New therapy|0|||
125335757|NCT03493945|450863621|FG001|Phase I Dose Escalation|New therapy|1|||
125335758|NCT03493945|450863622|FG002|Phase I Dose Escalation|New therapy|0|||
125335759|NCT03493945|450863623|FG003|Phase I Dose Escalation|New therapy|0|||
125335760|NCT03493945|450863624|FG004|Phase I Dose Escalation|New therapy|0|||
125335761|NCT03493945|450863625|FG005|Phase I Dose Escalation|New therapy|0|||
125335762|NCT03493945|450863626|FG006|Phase I Dose Escalation|New therapy|0|||
125335763|NCT03493945|450863620|FG000|Phase II Dose Expansion|Refused further treatment|0|||
125335764|NCT03493945|450863621|FG001|Phase II Dose Expansion|Refused further treatment|0|||
125335765|NCT03493945|450863622|FG002|Phase II Dose Expansion|Refused further treatment|0|||
125335766|NCT03493945|450863623|FG003|Phase II Dose Expansion|Refused further treatment|0|||
125335767|NCT03493945|450863624|FG004|Phase II Dose Expansion|Refused further treatment|1|||
125335768|NCT03493945|450863625|FG005|Phase II Dose Expansion|Refused further treatment|1|||
125335769|NCT03493945|450863626|FG006|Phase II Dose Expansion|Refused further treatment|0|||
125335770|NCT03493945|450863620|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
125335771|NCT03493945|450863621|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
125335772|NCT03493945|450863622|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
125335773|NCT03493945|450863623|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
125335774|NCT03493945|450863624|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
125335775|NCT03493945|450863625|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
125335776|NCT03493945|450863626|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
125335777|NCT05422339|450863631|FG000|Overall Study|Withdrawal by Subject|17|||
125335778|NCT05422339|450863632|FG001|Overall Study|Withdrawal by Subject|15|||
125335779|NCT04319198|450863633|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
125335780|NCT04319198|450863634|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
125335781|NCT04319198|450863635|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
125335782|NCT04319198|450863633|FG000|Overall Study|Death|0|||
125335783|NCT04319198|450863634|FG001|Overall Study|Death|3|||
125335784|NCT04319198|450863635|FG002|Overall Study|Death|3|||
125335785|NCT04319198|450863633|FG000|Overall Study|Reason Not Specified|0|||
125335786|NCT04319198|450863634|FG001|Overall Study|Reason Not Specified|2|||
125335787|NCT04319198|450863635|FG002|Overall Study|Reason Not Specified|4|||
125335788|NCT04319198|450863633|FG000|Overall Study|Withdrawal of Consent|0|||
125335789|NCT04319198|450863634|FG001|Overall Study|Withdrawal of Consent|0|||
125335790|NCT04319198|450863635|FG002|Overall Study|Withdrawal of Consent|5|||
125335791|NCT04319198|450863633|FG000|Overall Study|Site Terminated by Sponsor|0|||
125335792|NCT04319198|450863634|FG001|Overall Study|Site Terminated by Sponsor|1|||
125335793|NCT04319198|450863635|FG002|Overall Study|Site Terminated by Sponsor|0|||
125335794|NCT05472038|450863636|FG000|Overall Study|Adverse Event|0|||
125335795|NCT05472038|450863637|FG001|Overall Study|Adverse Event|0|||
125335796|NCT05472038|450863638|FG002|Overall Study|Adverse Event|1|||
125335797|NCT05472038|450863639|FG003|Overall Study|Adverse Event|0|||
125335798|NCT05472038|450863640|FG004|Overall Study|Adverse Event|0|||
125335799|NCT05472038|450863641|FG005|Overall Study|Adverse Event|0|||
125335800|NCT05472038|450863642|FG006|Overall Study|Adverse Event|0|||
125335801|NCT05472038|450863643|FG007|Overall Study|Adverse Event|0|||
125335802|NCT05472038|450863644|FG008|Overall Study|Adverse Event|0|||
125335803|NCT05472038|450863645|FG009|Overall Study|Adverse Event|0|||
125335804|NCT05472038|450863646|FG010|Overall Study|Adverse Event|0|||
125335805|NCT05472038|450863647|FG011|Overall Study|Adverse Event|0|||
125335806|NCT05472038|450863636|FG000|Overall Study|Death|0|||
125335807|NCT05472038|450863637|FG001|Overall Study|Death|0|||
125335808|NCT05472038|450863638|FG002|Overall Study|Death|0|||
125335809|NCT05472038|450863639|FG003|Overall Study|Death|0|||
125003080|NCT05586269|449640621|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
125003081|NCT05586269|449640622|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
125003082|NCT05586269|449640623|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
125003083|NCT01920594|449640626|FG000|Overall Study|Adverse Event|4|||
125003084|NCT01920594|449640627|FG001|Overall Study|Adverse Event|2|||
125335810|NCT05472038|450863640|FG004|Overall Study|Death|0|||
125335811|NCT05472038|450863641|FG005|Overall Study|Death|1|||
125335812|NCT05472038|450863642|FG006|Overall Study|Death|0|||
125335813|NCT05472038|450863643|FG007|Overall Study|Death|0|||
125335814|NCT05472038|450863644|FG008|Overall Study|Death|0|||
125335815|NCT05472038|450863645|FG009|Overall Study|Death|0|||
125335816|NCT05472038|450863646|FG010|Overall Study|Death|0|||
125335817|NCT05472038|450863647|FG011|Overall Study|Death|0|||
125335818|NCT05472038|450863636|FG000|Overall Study|Lost to Follow-up|1|||
125335819|NCT05472038|450863637|FG001|Overall Study|Lost to Follow-up|3|||
125335820|NCT05472038|450863638|FG002|Overall Study|Lost to Follow-up|3|||
125335821|NCT05472038|450863639|FG003|Overall Study|Lost to Follow-up|9|||
125335822|NCT05472038|450863640|FG004|Overall Study|Lost to Follow-up|2|||
125335823|NCT05472038|450863641|FG005|Overall Study|Lost to Follow-up|2|||
125335824|NCT05472038|450863642|FG006|Overall Study|Lost to Follow-up|1|||
125335825|NCT05472038|450863643|FG007|Overall Study|Lost to Follow-up|0|||
125335826|NCT05472038|450863644|FG008|Overall Study|Lost to Follow-up|1|||
125335827|NCT05472038|450863645|FG009|Overall Study|Lost to Follow-up|0|||
125335828|NCT05472038|450863646|FG010|Overall Study|Lost to Follow-up|2|||
125335829|NCT05472038|450863647|FG011|Overall Study|Lost to Follow-up|1|||
125335830|NCT05472038|450863636|FG000|Overall Study|Physician Decision|0|||
125335831|NCT05472038|450863637|FG001|Overall Study|Physician Decision|0|||
125335832|NCT05472038|450863638|FG002|Overall Study|Physician Decision|0|||
125335833|NCT05472038|450863639|FG003|Overall Study|Physician Decision|0|||
125335834|NCT05472038|450863640|FG004|Overall Study|Physician Decision|1|||
125335835|NCT05472038|450863641|FG005|Overall Study|Physician Decision|0|||
125335836|NCT05472038|450863642|FG006|Overall Study|Physician Decision|0|||
125335837|NCT05472038|450863643|FG007|Overall Study|Physician Decision|0|||
125335838|NCT05472038|450863644|FG008|Overall Study|Physician Decision|0|||
125335839|NCT05472038|450863645|FG009|Overall Study|Physician Decision|0|||
125335840|NCT05472038|450863646|FG010|Overall Study|Physician Decision|0|||
125335841|NCT05472038|450863647|FG011|Overall Study|Physician Decision|0|||
125335842|NCT05472038|450863636|FG000|Overall Study|Withdrawal by Subject|1|||
125335843|NCT05472038|450863637|FG001|Overall Study|Withdrawal by Subject|3|||
125335844|NCT05472038|450863638|FG002|Overall Study|Withdrawal by Subject|1|||
125335845|NCT05472038|450863639|FG003|Overall Study|Withdrawal by Subject|6|||
125335846|NCT05472038|450863640|FG004|Overall Study|Withdrawal by Subject|1|||
125335847|NCT05472038|450863641|FG005|Overall Study|Withdrawal by Subject|3|||
125335848|NCT05472038|450863642|FG006|Overall Study|Withdrawal by Subject|0|||
125335849|NCT05472038|450863643|FG007|Overall Study|Withdrawal by Subject|2|||
125335850|NCT05472038|450863644|FG008|Overall Study|Withdrawal by Subject|3|||
125335851|NCT05472038|450863645|FG009|Overall Study|Withdrawal by Subject|1|||
125335852|NCT05472038|450863646|FG010|Overall Study|Withdrawal by Subject|2|||
125335853|NCT05472038|450863647|FG011|Overall Study|Withdrawal by Subject|2|||
125335854|NCT05472038|450863636|FG000|Overall Study|Protocol Violation|0|||
125335855|NCT05472038|450863637|FG001|Overall Study|Protocol Violation|0|||
125335856|NCT05472038|450863638|FG002|Overall Study|Protocol Violation|0|||
125335857|NCT05472038|450863639|FG003|Overall Study|Protocol Violation|0|||
125335858|NCT05472038|450863640|FG004|Overall Study|Protocol Violation|0|||
125335859|NCT05472038|450863641|FG005|Overall Study|Protocol Violation|0|||
125335860|NCT05472038|450863642|FG006|Overall Study|Protocol Violation|0|||
125335861|NCT05472038|450863643|FG007|Overall Study|Protocol Violation|1|||
125335862|NCT05472038|450863644|FG008|Overall Study|Protocol Violation|1|||
125335863|NCT05472038|450863645|FG009|Overall Study|Protocol Violation|1|||
125335864|NCT05472038|450863646|FG010|Overall Study|Protocol Violation|1|||
125335865|NCT05472038|450863647|FG011|Overall Study|Protocol Violation|1|||
125335866|NCT05472038|450863636|FG000|Overall Study|Not vaccinated|0|||
125335867|NCT05472038|450863637|FG001|Overall Study|Not vaccinated|0|||
125335868|NCT05472038|450863638|FG002|Overall Study|Not vaccinated|0|||
125003085|NCT01920594|449640626|FG000|Overall Study|Lost to Follow-up|1|||
125003086|NCT01920594|449640627|FG001|Overall Study|Lost to Follow-up|0|||
125003087|NCT01920594|449640626|FG000|Overall Study|Recovery|2|||
125003088|NCT01920594|449640627|FG001|Overall Study|Recovery|0|||
125003089|NCT01920594|449640626|FG000|Overall Study|Investigator discretion|0|||
125003090|NCT01920594|449640627|FG001|Overall Study|Investigator discretion|1|||
125003091|NCT00928564|449640628|FG000|Overall Study|Lost to Follow-up|6|||
125003092|NCT00928564|449640629|FG001|Overall Study|Lost to Follow-up|0|||
125003093|NCT02460497|449640633|FG000|Overall Study|Participant Requested Withdrawal|4|||
125003094|NCT02460497|449640633|FG000|Overall Study|Non-Compliance|1|||
125003095|NCT02460497|449640633|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
125003096|NCT02460497|449640633|FG000|Overall Study|Lost to Follow-up|2|||
125003097|NCT02460497|449640633|FG000|Overall Study|Investigator Decision|1|||
125003098|NCT02012296|449640638|FG000|Overall Study|Lack of Efficacy|0|||
125003099|NCT02012296|449640639|FG001|Overall Study|Lack of Efficacy|0|||
125003100|NCT02012296|449640640|FG002|Overall Study|Lack of Efficacy|15|||
125003101|NCT02012296|449640638|FG000|Overall Study|Adverse Event|0|||
125003102|NCT02012296|449640639|FG001|Overall Study|Adverse Event|0|||
125003103|NCT02012296|449640640|FG002|Overall Study|Adverse Event|2|||
125003104|NCT02012296|449640638|FG000|Overall Study|Early study closure|0|||
125335869|NCT05472038|450863639|FG003|Overall Study|Not vaccinated|1|||
125335870|NCT05472038|450863640|FG004|Overall Study|Not vaccinated|0|||
125335871|NCT05472038|450863641|FG005|Overall Study|Not vaccinated|0|||
125335872|NCT05472038|450863642|FG006|Overall Study|Not vaccinated|0|||
125335873|NCT05472038|450863643|FG007|Overall Study|Not vaccinated|0|||
125335874|NCT05472038|450863644|FG008|Overall Study|Not vaccinated|0|||
125335875|NCT05472038|450863645|FG009|Overall Study|Not vaccinated|0|||
125335876|NCT05472038|450863646|FG010|Overall Study|Not vaccinated|0|||
125335877|NCT05472038|450863647|FG011|Overall Study|Not vaccinated|0|||
125335878|NCT05369208|450863650|FG000|Core Phase|Prohibited Medication Required|2|||
125335879|NCT05369208|450863650|FG000|Core Phase|Adverse Event|1|||
125335880|NCT05369208|450863650|FG000|Core Phase|Lack of Efficacy|1|||
125335881|NCT06056310|450863651|FG000|Overall Study|Other Reasons|2|||
125335882|NCT06056310|450863651|FG000|Overall Study|Sponsor Request|16|||
125335883|NCT02674152|450863654|FG000|Overall Study|Personal Reasons|1|||
125335884|NCT02674152|450863655|FG001|Overall Study|Personal Reasons|0|||
125335885|NCT02674152|450863656|FG002|Overall Study|Personal Reasons|0|||
125335886|NCT02674152|450863657|FG003|Overall Study|Personal Reasons|1|||
125335887|NCT02674152|450863658|FG004|Overall Study|Personal Reasons|1|||
125335888|NCT02674152|450863654|FG000|Overall Study|Other adverse event or clinical progression|0|||
125335889|NCT02674152|450863655|FG001|Overall Study|Other adverse event or clinical progression|1|||
125335890|NCT02674152|450863656|FG002|Overall Study|Other adverse event or clinical progression|0|||
125335891|NCT02674152|450863657|FG003|Overall Study|Other adverse event or clinical progression|3|||
125335892|NCT02674152|450863658|FG004|Overall Study|Other adverse event or clinical progression|0|||
125335893|NCT02674152|450863654|FG000|Overall Study|Dose-limiting toxicity|0|||
125335894|NCT02674152|450863655|FG001|Overall Study|Dose-limiting toxicity|0|||
125335895|NCT02674152|450863656|FG002|Overall Study|Dose-limiting toxicity|0|||
125335896|NCT02674152|450863657|FG003|Overall Study|Dose-limiting toxicity|0|||
125335897|NCT02674152|450863658|FG004|Overall Study|Dose-limiting toxicity|1|||
125335898|NCT02674152|450863654|FG000|Overall Study|Progressive Disease|2|||
125335899|NCT02674152|450863655|FG001|Overall Study|Progressive Disease|1|||
125335900|NCT02674152|450863656|FG002|Overall Study|Progressive Disease|1|||
125335901|NCT02674152|450863657|FG003|Overall Study|Progressive Disease|13|||
125335902|NCT02674152|450863658|FG004|Overall Study|Progressive Disease|2|||
125335903|NCT02674152|450863654|FG000|Overall Study|Adverse Event|0|||
125335904|NCT02674152|450863655|FG001|Overall Study|Adverse Event|0|||
125335905|NCT02674152|450863656|FG002|Overall Study|Adverse Event|1|||
125335906|NCT02674152|450863657|FG003|Overall Study|Adverse Event|0|||
125335907|NCT02674152|450863658|FG004|Overall Study|Adverse Event|1|||
125335908|NCT04934722|450863659|FG000|Overall Study|Death|4|||
125335909|NCT04934722|450863660|FG001|Overall Study|Death|3|||
125335910|NCT04934722|450863659|FG000|Overall Study|Participants Ongoing|88|||
125335911|NCT04934722|450863660|FG001|Overall Study|Participants Ongoing|91|||
125335912|NCT05265624|450863669|FG000|Overall Study|Lost to Follow-up|3|||
125335913|NCT05265624|450863670|FG001|Overall Study|Lost to Follow-up|0|||
125335914|NCT05265624|450863669|FG000|Overall Study|Withdrawal by Subject|1|||
125335915|NCT05265624|450863670|FG001|Overall Study|Withdrawal by Subject|0|||
125335916|NCT06039579|450863671|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
125335917|NCT06039579|450863672|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
125335918|NCT06039579|450863673|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
125335919|NCT06039579|450863674|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
125335920|NCT06039579|450863675|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
125335921|NCT06039579|450863676|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
125335922|NCT06039579|450863677|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
125003105|NCT02012296|449640639|FG001|Overall Study|Early study closure|0|||
125003106|NCT02012296|449640640|FG002|Overall Study|Early study closure|5|||
125003107|NCT02012296|449640638|FG000|Overall Study|Protocol Violation|0|||
125003108|NCT02012296|449640639|FG001|Overall Study|Protocol Violation|1|||
125003109|NCT02012296|449640640|FG002|Overall Study|Protocol Violation|0|||
125003110|NCT01448213|449640641|FG000|Overall Study|Lost to Follow-up|12|||
125003111|NCT01448213|449640642|FG001|Overall Study|Lost to Follow-up|10|||
125003112|NCT01448213|449640641|FG000|Overall Study|Adverse Event|4|||
125003113|NCT01448213|449640642|FG001|Overall Study|Adverse Event|10|||
125003114|NCT01448213|449640641|FG000|Overall Study|Protocol Violation|1|||
125003115|NCT01448213|449640642|FG001|Overall Study|Protocol Violation|2|||
125003116|NCT01330914|449640643|FG000|Overall Study|Withdrawal by Subject|4|||
125003117|NCT01330914|449640643|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
125003118|NCT02615470|449640644|FG000|Overall Study|Lost to Follow-up|21|||
125003119|NCT02615470|449640645|FG001|Overall Study|Lost to Follow-up|32|||
125003120|NCT04163900|449640652|FG000|Overall Study|Radiological disease progression|112|||
125003121|NCT04163900|449640653|FG001|Overall Study|Radiological disease progression|127|||
125003122|NCT04163900|449640652|FG000|Overall Study|Study closure|98|||
125003123|NCT04163900|449640653|FG001|Overall Study|Study closure|133|||
125003124|NCT04163900|449640652|FG000|Overall Study|Adverse Event|78|||
125003125|NCT04163900|449640653|FG001|Overall Study|Adverse Event|32|||
125003126|NCT04163900|449640652|FG000|Overall Study|Withdrawal by Subject|37|||
125003127|NCT04163900|449640653|FG001|Overall Study|Withdrawal by Subject|34|||
125003128|NCT04163900|449640652|FG000|Overall Study|Death|29|||
125003129|NCT04163900|449640653|FG001|Overall Study|Death|16|||
125003130|NCT04163900|449640652|FG000|Overall Study|Physician Decision|17|||
125003131|NCT04163900|449640653|FG001|Overall Study|Physician Decision|25|||
125003132|NCT04163900|449640652|FG000|Overall Study|Clinical disease progression|14|||
125003133|NCT04163900|449640653|FG001|Overall Study|Clinical disease progression|13|||
125335923|NCT06039579|450863678|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
125335924|NCT02356159|450863687|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
125335925|NCT02356159|450863688|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
125335926|NCT02356159|450863689|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
125335927|NCT02356159|450863690|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
125335928|NCT02356159|450863691|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
125003134|NCT04163900|449640652|FG000|Overall Study|Protocol Violation|3|||
125003135|NCT04163900|449640653|FG001|Overall Study|Protocol Violation|4|||
125003136|NCT04163900|449640652|FG000|Overall Study|Lost to Follow-up|0|||
125335929|NCT02356159|450863692|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
125335930|NCT00861705|450863693|FG000|Overall Study|Never Began Treatment|7|||
125335931|NCT00861705|450863694|FG001|Overall Study|Never Began Treatment|3|||
125335932|NCT00861705|450863695|FG002|Overall Study|Never Began Treatment|0|||
125335933|NCT00861705|450863696|FG003|Overall Study|Never Began Treatment|1|||
125335934|NCT06418152|450863698|FG000|Overall Study|Frequent DBS setting changes|1|||
125335935|NCT06418152|450863698|FG000|Overall Study|Withdrawal by Subject|2|||
125335936|NCT03653507|450863699|FG000|Overall Study|Miscellaneous|28|||
125335937|NCT03653507|450863700|FG001|Overall Study|Miscellaneous|19|||
125335938|NCT03653507|450863699|FG000|Overall Study|Withdrawal by Subject|37|||
125335939|NCT03653507|450863700|FG001|Overall Study|Withdrawal by Subject|22|||
125335940|NCT03653507|450863699|FG000|Overall Study|Protocol Deviation|2|||
125335941|NCT03653507|450863700|FG001|Overall Study|Protocol Deviation|1|||
125335942|NCT03653507|450863699|FG000|Overall Study|Progressive disease|117|||
125335943|NCT03653507|450863700|FG001|Overall Study|Progressive disease|168|||
125335944|NCT03653507|450863699|FG000|Overall Study|Lost to Follow-up|1|||
125335945|NCT03653507|450863700|FG001|Overall Study|Lost to Follow-up|1|||
125335946|NCT03653507|450863699|FG000|Overall Study|Death|25|||
125335947|NCT03653507|450863700|FG001|Overall Study|Death|22|||
125335948|NCT03653507|450863699|FG000|Overall Study|Adverse Event|35|||
125335949|NCT03653507|450863700|FG001|Overall Study|Adverse Event|14|||
125335950|NCT05250115|450863701|FG000|Overall Study|Premature study end|40|||
125335951|NCT05250115|450863701|FG000|Overall Study|Adverse Event|8|||
125335952|NCT05250115|450863701|FG000|Overall Study|Lost to Follow-up|7|||
125335953|NCT05250115|450863701|FG000|Overall Study|Withdrawal by Subject|6|||
125335954|NCT05250115|450863701|FG000|Overall Study|Withdrawal of informed consent|1|||
125335955|NCT05250115|450863701|FG000|Overall Study|Other|7|||
125335956|NCT04401267|450863702|FG000|Overall Study|Death|0|||
125335957|NCT04401267|450863703|FG001|Overall Study|Death|1|||
125335958|NCT04401267|450863702|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
125335959|NCT04401267|450863703|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
125335960|NCT04401267|450863702|FG000|Overall Study|Found to be Ineligible|1|||
125335961|NCT04401267|450863703|FG001|Overall Study|Found to be Ineligible|0|||
125335962|NCT03360682|450863704|FG000|Overall Study|Adverse Event|3|||
125335963|NCT05815342|450863707|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
125335964|NCT05815342|450863707|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
125335965|NCT05815342|450863707|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
125335966|NCT05815342|450863707|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
125335967|NCT05815342|450863707|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
125335968|NCT01701674|450863708|FG000|Overall Study|Unable to safely complete treatment|1|||
125335969|NCT05604170|450863709|FG000|Overall Study|Lack of Efficacy|5|||
125335970|NCT05604170|450863709|FG000|Overall Study|Adverse Event|6|||
125335971|NCT05604170|450863709|FG000|Overall Study|Physician Decision|6|||
125335972|NCT05604170|450863709|FG000|Overall Study|Lost to Follow-up|6|||
125335973|NCT05604170|450863709|FG000|Overall Study|Withdrawal by Subject|11|||
125335974|NCT05604170|450863709|FG000|Overall Study|Early study termination by sponsor|77|||
125335975|NCT05604170|450863709|FG000|Overall Study|Other|6|||
125335976|NCT05767021|450863710|FG000|Overall Study|Adverse Event|2|||
125335977|NCT05767021|450863710|FG000|Overall Study|Protocol Deviation|1|||
125335978|NCT05767021|450863710|FG000|Overall Study|Withdrawal by Subject|1|||
125335979|NCT05767021|450863710|FG000|Overall Study|Physician Decision|1|||
125335980|NCT05767021|450863710|FG000|Overall Study|Lack of Efficacy|11|||
125335981|NCT05767021|450863710|FG000|Overall Study|Assigned Treatment by Mistake|1|||
125335982|NCT03032172|450863711|FG000|Treatment Period|Adverse Event|0|||
125335983|NCT03032172|450863712|FG001|Treatment Period|Adverse Event|1|||
125335984|NCT03032172|450863713|FG002|Treatment Period|Adverse Event|0|||
125335985|NCT03032172|450863714|FG003|Treatment Period|Adverse Event|0|||
125335986|NCT03032172|450863715|FG004|Treatment Period|Adverse Event|0|||
125003137|NCT04163900|449640653|FG001|Overall Study|Lost to Follow-up|1|||
125003138|NCT01830855|449640654|FG000|Overall Study|Other|7|||
125003139|NCT01830855|449640655|FG001|Overall Study|Other|1|||
125003140|NCT01830855|449640656|FG002|Overall Study|Other|4|||
125335987|NCT03032172|450863716|FG005|Treatment Period|Adverse Event|0|||
125335988|NCT03032172|450863717|FG006|Treatment Period|Adverse Event|0|||
125335989|NCT03032172|450863718|FG007|Treatment Period|Adverse Event|0|||
125335990|NCT03032172|450863711|FG000|Treatment Period|Lack of Efficacy|0|||
125335991|NCT03032172|450863712|FG001|Treatment Period|Lack of Efficacy|1|||
125335992|NCT03032172|450863713|FG002|Treatment Period|Lack of Efficacy|0|||
125335993|NCT03032172|450863714|FG003|Treatment Period|Lack of Efficacy|0|||
125335994|NCT03032172|450863715|FG004|Treatment Period|Lack of Efficacy|0|||
125335995|NCT03032172|450863716|FG005|Treatment Period|Lack of Efficacy|0|||
125335996|NCT03032172|450863717|FG006|Treatment Period|Lack of Efficacy|0|||
125335997|NCT03032172|450863718|FG007|Treatment Period|Lack of Efficacy|0|||
125335998|NCT03032172|450863711|FG000|Treatment Period|Non-compliance With Study Drug|0|||
125335999|NCT03032172|450863712|FG001|Treatment Period|Non-compliance With Study Drug|1|||
125336000|NCT03032172|450863713|FG002|Treatment Period|Non-compliance With Study Drug|0|||
125336001|NCT03032172|450863714|FG003|Treatment Period|Non-compliance With Study Drug|0|||
125336002|NCT03032172|450863715|FG004|Treatment Period|Non-compliance With Study Drug|0|||
125336003|NCT03032172|450863716|FG005|Treatment Period|Non-compliance With Study Drug|0|||
125336004|NCT03032172|450863717|FG006|Treatment Period|Non-compliance With Study Drug|0|||
125336005|NCT03032172|450863718|FG007|Treatment Period|Non-compliance With Study Drug|0|||
125336006|NCT03032172|450863711|FG000|Treatment Period|Reason Not Specified|0|||
125336007|NCT03032172|450863712|FG001|Treatment Period|Reason Not Specified|4|||
125336008|NCT03032172|450863713|FG002|Treatment Period|Reason Not Specified|1|||
125336009|NCT03032172|450863714|FG003|Treatment Period|Reason Not Specified|0|||
125003141|NCT01830855|449640657|FG003|Overall Study|Other|4|||
125003142|NCT01830855|449640654|FG000|Overall Study|Medication error without associated AE|1|||
125003143|NCT01830855|449640655|FG001|Overall Study|Medication error without associated AE|0|||
125336010|NCT03032172|450863715|FG004|Treatment Period|Reason Not Specified|0|||
125336011|NCT03032172|450863716|FG005|Treatment Period|Reason Not Specified|0|||
125336012|NCT03032172|450863717|FG006|Treatment Period|Reason Not Specified|0|||
125336013|NCT03032172|450863718|FG007|Treatment Period|Reason Not Specified|0|||
125336014|NCT03032172|450863711|FG000|Treatment Period|Physician Decision|0|||
125336015|NCT03032172|450863712|FG001|Treatment Period|Physician Decision|2|||
125336016|NCT03032172|450863713|FG002|Treatment Period|Physician Decision|1|||
125336017|NCT03032172|450863714|FG003|Treatment Period|Physician Decision|0|||
125336018|NCT03032172|450863715|FG004|Treatment Period|Physician Decision|0|||
125336019|NCT03032172|450863716|FG005|Treatment Period|Physician Decision|0|||
125336020|NCT03032172|450863717|FG006|Treatment Period|Physician Decision|0|||
125336021|NCT03032172|450863718|FG007|Treatment Period|Physician Decision|0|||
125336022|NCT03032172|450863711|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
125336023|NCT03032172|450863712|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
125336024|NCT03032172|450863713|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
125336025|NCT03032172|450863714|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
125336026|NCT03032172|450863715|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
125336027|NCT03032172|450863716|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
125336028|NCT03032172|450863717|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
125336029|NCT03032172|450863718|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
125336030|NCT03032172|450863711|FG000|Treatment Period|Withdrawal by Subject|2|||
125336031|NCT03032172|450863712|FG001|Treatment Period|Withdrawal by Subject|0|||
125336032|NCT03032172|450863713|FG002|Treatment Period|Withdrawal by Subject|3|||
125336033|NCT03032172|450863714|FG003|Treatment Period|Withdrawal by Subject|0|||
125336034|NCT03032172|450863715|FG004|Treatment Period|Withdrawal by Subject|0|||
125336035|NCT03032172|450863716|FG005|Treatment Period|Withdrawal by Subject|0|||
125336036|NCT03032172|450863717|FG006|Treatment Period|Withdrawal by Subject|0|||
125336037|NCT03032172|450863718|FG007|Treatment Period|Withdrawal by Subject|0|||
125336038|NCT03032172|450863711|FG000|Open-label Extension Period|Death|0|||
125336039|NCT03032172|450863712|FG001|Open-label Extension Period|Death|0|||
125336040|NCT03032172|450863713|FG002|Open-label Extension Period|Death|0|||
125336041|NCT03032172|450863714|FG003|Open-label Extension Period|Death|0|||
125336042|NCT03032172|450863715|FG004|Open-label Extension Period|Death|0|||
125336043|NCT03032172|450863716|FG005|Open-label Extension Period|Death|0|||
125336044|NCT03032172|450863717|FG006|Open-label Extension Period|Death|0|||
125336045|NCT03032172|450863718|FG007|Open-label Extension Period|Death|2|||
125336046|NCT03032172|450863711|FG000|Open-label Extension Period|Reason Not Specified|0|||
125336047|NCT03032172|450863712|FG001|Open-label Extension Period|Reason Not Specified|0|||
125336048|NCT03032172|450863713|FG002|Open-label Extension Period|Reason Not Specified|0|||
125336049|NCT03032172|450863714|FG003|Open-label Extension Period|Reason Not Specified|0|||
125336050|NCT03032172|450863715|FG004|Open-label Extension Period|Reason Not Specified|0|||
125336051|NCT03032172|450863716|FG005|Open-label Extension Period|Reason Not Specified|5|||
125336052|NCT03032172|450863717|FG006|Open-label Extension Period|Reason Not Specified|3|||
125336053|NCT03032172|450863718|FG007|Open-label Extension Period|Reason Not Specified|0|||
125336054|NCT03032172|450863711|FG000|Open-label Extension Period|Pregnancy|0|||
125336055|NCT03032172|450863712|FG001|Open-label Extension Period|Pregnancy|0|||
125336056|NCT03032172|450863713|FG002|Open-label Extension Period|Pregnancy|0|||
125336057|NCT03032172|450863714|FG003|Open-label Extension Period|Pregnancy|0|||
125336058|NCT03032172|450863715|FG004|Open-label Extension Period|Pregnancy|0|||
125336059|NCT03032172|450863716|FG005|Open-label Extension Period|Pregnancy|0|||
125336060|NCT03032172|450863717|FG006|Open-label Extension Period|Pregnancy|1|||
125336061|NCT03032172|450863718|FG007|Open-label Extension Period|Pregnancy|0|||
125336062|NCT03032172|450863711|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
125336063|NCT03032172|450863712|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
125003144|NCT01830855|449640656|FG002|Overall Study|Medication error without associated AE|0|||
125003145|NCT01830855|449640657|FG003|Overall Study|Medication error without associated AE|1|||
125003146|NCT01830855|449640654|FG000|Overall Study|Pregnancy|3|||
125336064|NCT03032172|450863713|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
125336065|NCT03032172|450863714|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
125336066|NCT03032172|450863715|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
125336067|NCT03032172|450863716|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
125336068|NCT03032172|450863717|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
125336069|NCT03032172|450863718|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
125336070|NCT04885998|450863720|FG000|Overall Study|Withdrawal by Subject|0|||
125336071|NCT04885998|450863721|FG001|Overall Study|Withdrawal by Subject|2|||
125336072|NCT04885998|450863722|FG002|Overall Study|Withdrawal by Subject|0|||
125336073|NCT04885998|450863723|FG003|Overall Study|Withdrawal by Subject|3|||
125336074|NCT04885998|450863720|FG000|Overall Study|Lost to Follow-up|1|||
125336075|NCT04885998|450863721|FG001|Overall Study|Lost to Follow-up|1|||
125336076|NCT04885998|450863722|FG002|Overall Study|Lost to Follow-up|0|||
125336077|NCT04885998|450863723|FG003|Overall Study|Lost to Follow-up|0|||
125336078|NCT04885998|450863720|FG000|Overall Study|Death|2|||
125336079|NCT04885998|450863721|FG001|Overall Study|Death|1|||
125336080|NCT04885998|450863722|FG002|Overall Study|Death|2|||
125336081|NCT04885998|450863723|FG003|Overall Study|Death|2|||
125336082|NCT04885998|450863720|FG000|Overall Study|Decision by sponsor|1|||
125336083|NCT04885998|450863721|FG001|Overall Study|Decision by sponsor|1|||
125336084|NCT04885998|450863722|FG002|Overall Study|Decision by sponsor|0|||
125336085|NCT04885998|450863723|FG003|Overall Study|Decision by sponsor|0|||
125336086|NCT04154943|450863731|FG000|Overall Study|Study Ongoing|68|||
125336087|NCT04154943|450863731|FG000|Overall Study|Lost to Follow-up|1|||
125336088|NCT04154943|450863731|FG000|Overall Study|Decision by the Investigator|1|||
125336089|NCT04154943|450863731|FG000|Overall Study|Death|5|||
125336090|NCT04154943|450863731|FG000|Overall Study|Withdrawal by Subject|4|||
125336091|NCT02869867|450863732|FG000|Overall Study|Protocol Violation|1|||
125336092|NCT02869867|450863733|FG001|Overall Study|Protocol Violation|0|||
125336093|NCT02869867|450863732|FG000|Overall Study|Lost to Follow-up|5|||
125336094|NCT02869867|450863733|FG001|Overall Study|Lost to Follow-up|5|||
125336095|NCT06284525|450863736|FG000|Overall Study|Withdrawal by Subject|1|||
125336096|NCT02362035|450863737|FG000|Overall Study|Death|67|||
125003147|NCT01830855|449640655|FG001|Overall Study|Pregnancy|1|||
125003148|NCT01830855|449640656|FG002|Overall Study|Pregnancy|2|||
125003149|NCT01830855|449640657|FG003|Overall Study|Pregnancy|1|||
125003150|NCT01830855|449640654|FG000|Overall Study|No longer meets eligibility criteria|11|||
125003151|NCT01830855|449640655|FG001|Overall Study|No longer meets eligibility criteria|2|||
125003152|NCT01830855|449640656|FG002|Overall Study|No longer meets eligibility criteria|3|||
125003153|NCT01830855|449640657|FG003|Overall Study|No longer meets eligibility criteria|5|||
125003154|NCT01830855|449640654|FG000|Overall Study|Adverse Event|11|||
125003155|NCT01830855|449640655|FG001|Overall Study|Adverse Event|5|||
125003156|NCT01830855|449640656|FG002|Overall Study|Adverse Event|6|||
125003157|NCT01830855|449640657|FG003|Overall Study|Adverse Event|3|||
125003158|NCT01830855|449640654|FG000|Overall Study|Protocol deviation|10|||
125003159|NCT01830855|449640655|FG001|Overall Study|Protocol deviation|5|||
125003160|NCT01830855|449640656|FG002|Overall Study|Protocol deviation|6|||
125003161|NCT01830855|449640657|FG003|Overall Study|Protocol deviation|6|||
125003162|NCT01830855|449640654|FG000|Overall Study|Withdrawal by Subject|33|||
125003163|NCT01830855|449640655|FG001|Overall Study|Withdrawal by Subject|14|||
125003164|NCT01830855|449640656|FG002|Overall Study|Withdrawal by Subject|10|||
125003165|NCT01830855|449640657|FG003|Overall Study|Withdrawal by Subject|12|||
125003166|NCT01830855|449640654|FG000|Overall Study|No longer willing to participate|32|||
125003167|NCT01830855|449640655|FG001|Overall Study|No longer willing to participate|13|||
125003168|NCT01830855|449640656|FG002|Overall Study|No longer willing to participate|12|||
125003169|NCT01830855|449640657|FG003|Overall Study|No longer willing to participate|17|||
125003170|NCT01830855|449640654|FG000|Overall Study|Lost to Follow-up|47|||
125003171|NCT01830855|449640655|FG001|Overall Study|Lost to Follow-up|20|||
125003172|NCT01830855|449640656|FG002|Overall Study|Lost to Follow-up|23|||
125003173|NCT01830855|449640657|FG003|Overall Study|Lost to Follow-up|33|||
125003174|NCT01667081|449640658|FG000|Overall Study|Death|43|||
125003175|NCT01667081|449640659|FG001|Overall Study|Death|3|||
125003176|NCT01667081|449640658|FG000|Overall Study|Lost to Follow-up|99|||
125003177|NCT01667081|449640659|FG001|Overall Study|Lost to Follow-up|48|||
125003178|NCT01667081|449640658|FG000|Overall Study|Physician Decision|16|||
125003179|NCT01667081|449640659|FG001|Overall Study|Physician Decision|2|||
125003180|NCT01667081|449640658|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
125003181|NCT01667081|449640659|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
125003182|NCT01667081|449640658|FG000|Overall Study|Withdrawal by Subject|90|||
125003183|NCT01667081|449640659|FG001|Overall Study|Withdrawal by Subject|35|||
125003184|NCT00930722|449640660|FG000|Overall Study|Lost to Follow-up|16|||
125003185|NCT00930722|449640660|FG000|Overall Study|No longer willing to participate|9|||
125336097|NCT02362035|450863737|FG000|Overall Study|Lost to Follow-up|3|||
125336098|NCT02362035|450863737|FG000|Overall Study|Adverse Event|1|||
125336099|NCT02362035|450863737|FG000|Overall Study|Physician Decision|1|||
125336100|NCT02362035|450863737|FG000|Overall Study|Subject started another cancer therapy|10|||
125336101|NCT02362035|450863737|FG000|Overall Study|Study terminated by sponsor|45|||
125336102|NCT02362035|450863737|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
125336103|NCT02362035|450863737|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
125336104|NCT02362035|450863737|FG000|Overall Study|Disease progression|11|||
125336105|NCT02362035|450863737|FG000|Overall Study|Withdrawal by Subject|20|||
125336106|NCT04250194|450863740|FG000|Overall Study|Declined to schedule biopsy|6|||
125336107|NCT04250194|450863741|FG001|Overall Study|Declined to schedule biopsy|10|||
125336108|NCT04250194|450863740|FG000|Overall Study|Medically Unfit for Biopsy|2|||
125336109|NCT04250194|450863741|FG001|Overall Study|Medically Unfit for Biopsy|1|||
125336110|NCT04250194|450863740|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
125336111|NCT04250194|450863741|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
125336112|NCT04250194|450863740|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
125336113|NCT04250194|450863741|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
125336114|NCT04250194|450863740|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
125336115|NCT04250194|450863741|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
125336116|NCT04516967|450863742|FG000|Core Phase|Adverse Event|2|||
125336117|NCT04516967|450863743|FG001|Core Phase|Adverse Event|1|||
125336118|NCT04516967|450863744|FG002|Core Phase|Adverse Event|0|||
125336119|NCT04516967|450863742|FG000|Core Phase|Physician Decision|1|||
125336120|NCT04516967|450863743|FG001|Core Phase|Physician Decision|1|||
125336121|NCT04516967|450863744|FG002|Core Phase|Physician Decision|0|||
125336122|NCT04516967|450863742|FG000|Core Phase|Lack of Efficacy|7|||
125336123|NCT04516967|450863743|FG001|Core Phase|Lack of Efficacy|18|||
125336124|NCT04516967|450863744|FG002|Core Phase|Lack of Efficacy|0|||
125336125|NCT03570749|450863745|FG000|Overall Study|Ongoing|26|||
125336126|NCT03570749|450863746|FG001|Overall Study|Ongoing|25|||
125336127|NCT03570749|450863747|FG002|Overall Study|Ongoing|25|||
125336128|NCT03570749|450863748|FG003|Overall Study|Ongoing|26|||
125336129|NCT03570749|450863749|FG004|Overall Study|Ongoing|140|||
125336130|NCT03570749|450863750|FG005|Overall Study|Ongoing|142|||
125336131|NCT03570749|450863751|FG006|Overall Study|Ongoing|220|||
125336132|NCT03570749|450863745|FG000|Overall Study|Adverse Event|0|||
125336133|NCT03570749|450863746|FG001|Overall Study|Adverse Event|0|||
125090154|NCT02452034|449948674|FG002|Overall Study|Screen Failure|0|||
125090155|NCT02452034|449948675|FG003|Overall Study|Screen Failure|1|||
125090156|NCT02452034|449948676|FG004|Overall Study|Screen Failure|0|||
125090157|NCT02452034|449948677|FG005|Overall Study|Screen Failure|0|||
125090158|NCT02452034|449948672|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
125090159|NCT02452034|449948673|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
125090160|NCT02452034|449948674|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
125090161|NCT02452034|449948675|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
125090162|NCT02452034|449948676|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
125090163|NCT02452034|449948677|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
125090164|NCT00561795|449948678|FG000|Overall Study|Adverse Event|3|||
125090165|NCT00561795|449948679|FG001|Overall Study|Adverse Event|3|||
125090166|NCT00561795|449948680|FG002|Overall Study|Adverse Event|0|||
125090167|NCT00561795|449948681|FG003|Overall Study|Adverse Event|0|||
125336134|NCT03570749|450863747|FG002|Overall Study|Adverse Event|0|||
125336135|NCT03570749|450863748|FG003|Overall Study|Adverse Event|0|||
125003186|NCT00930722|449640660|FG000|Overall Study|Study terminated by sponsor|2|||
125003187|NCT03034460|449640661|FG000|Overall Study|Adverse Event|0|||
125003188|NCT03034460|449640662|FG001|Overall Study|Adverse Event|1|||
125003189|NCT03034460|449640661|FG000|Overall Study|Withdrawal by Subject|2|||
125003190|NCT03034460|449640662|FG001|Overall Study|Withdrawal by Subject|2|||
125003191|NCT03034460|449640661|FG000|Overall Study|Personal Reasons|1|||
125003192|NCT03034460|449640662|FG001|Overall Study|Personal Reasons|0|||
125003193|NCT00419120|449640663|FG000|Long Term Follow up Period|study ongoing|10|||
125003194|NCT03631667|449640672|FG000|Overall Study|Withdrawal by Subject|3|||
125003195|NCT01446016|449640673|FG000|Overall Study|Lost to Follow-up|3|||
125003196|NCT01446016|449640673|FG000|Overall Study|Withdrawal by Subject|1|||
125003197|NCT01446016|449640673|FG000|Overall Study|Toxicity|3|||
125090168|NCT00561795|449948678|FG000|Overall Study|Study Closed/Terminated|0|||
125090169|NCT00561795|449948679|FG001|Overall Study|Study Closed/Terminated|3|||
125336136|NCT03570749|450863749|FG004|Overall Study|Adverse Event|2|||
125336137|NCT03570749|450863750|FG005|Overall Study|Adverse Event|3|||
125336138|NCT03570749|450863751|FG006|Overall Study|Adverse Event|6|||
125336139|NCT03570749|450863745|FG000|Overall Study|Lack of Efficacy|0|||
125336140|NCT03570749|450863746|FG001|Overall Study|Lack of Efficacy|0|||
125336141|NCT03570749|450863747|FG002|Overall Study|Lack of Efficacy|0|||
125336142|NCT03570749|450863748|FG003|Overall Study|Lack of Efficacy|0|||
125336143|NCT03570749|450863749|FG004|Overall Study|Lack of Efficacy|8|||
125003198|NCT01087957|449640683|FG000|Overall Study|Death|2|||
125090170|NCT00561795|449948680|FG002|Overall Study|Study Closed/Terminated|0|||
125003199|NCT01087957|449640684|FG001|Overall Study|Death|2|||
125003200|NCT01087957|449640683|FG000|Overall Study|Lost to Follow-up|3|||
125003201|NCT01087957|449640684|FG001|Overall Study|Lost to Follow-up|4|||
125003202|NCT01087957|449640683|FG000|Overall Study|Protocol Violation|13|||
125003203|NCT01087957|449640684|FG001|Overall Study|Protocol Violation|25|||
125003204|NCT01087957|449640683|FG000|Overall Study|Withdrawal by Subject|18|||
125003205|NCT01087957|449640684|FG001|Overall Study|Withdrawal by Subject|15|||
125003206|NCT01087957|449640683|FG000|Overall Study|Physician Decision|5|||
125003207|NCT01087957|449640684|FG001|Overall Study|Physician Decision|9|||
125003208|NCT01186939|449640685|FG000|Overall Study|Death|7|||
125003209|NCT01186939|449640685|FG000|Overall Study|Withdrawal by Subject|2|||
125003210|NCT01186939|449640685|FG000|Overall Study|No longer receiving clinical benefit|17|||
125003211|NCT01186939|449640685|FG000|Overall Study|Program closed|5|||
125003212|NCT01186939|449640685|FG000|Overall Study|Sponsor decision|4|||
125003213|NCT01186939|449640685|FG000|Overall Study|Started additional treatment|1|||
125003214|NCT01186939|449640685|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
125003215|NCT01186939|449640685|FG000|Overall Study|Myocardial infarction|1|||
125003216|NCT01186939|449640685|FG000|Overall Study|Bone marrow transplant|1|||
125003217|NCT01186939|449640685|FG000|Overall Study|Transformation to AML|1|||
125003218|NCT01754857|449640686|FG000|Overall Study|Adverse Event|7|||
125003219|NCT01754857|449640686|FG000|Overall Study|Disease progression|3|||
125003220|NCT01754857|449640686|FG000|Overall Study|Physician Decision|2|||
125003221|NCT01754857|449640686|FG000|Overall Study|Withdrawal by Subject|3|||
125003222|NCT01754857|449640686|FG000|Overall Study|other complicating disease|1|||
125003223|NCT01754857|449640686|FG000|Overall Study|ineligible to continue onto maintenance|1|||
125003224|NCT01754857|449640686|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
125003225|NCT01754857|449640686|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
125003226|NCT01509079|449640687|FG000|Overall Study|Lack of Efficacy|0|||
125003227|NCT01509079|449640688|FG001|Overall Study|Lack of Efficacy|2|||
125003228|NCT01509079|449640687|FG000|Overall Study|started an excluded medication|0|||
125003229|NCT01509079|449640688|FG001|Overall Study|started an excluded medication|1|||
125003230|NCT01399190|449640691|FG000|Overall Study|Not Eligible for Final Analysis|5|||
125003231|NCT01399190|449640691|FG000|Overall Study|Adverse Event|8|||
125003232|NCT01399190|449640691|FG000|Overall Study|Participant's Request|5|||
125003233|NCT01399190|449640691|FG000|Overall Study|Physician Decision|2|||
125003234|NCT00436618|449640695|FG000|Overall Study|Withdrawal by Subject|5|||
125003235|NCT00436618|449640696|FG001|Overall Study|Withdrawal by Subject|8|||
125003236|NCT00436618|449640697|FG002|Overall Study|Withdrawal by Subject|11|||
125003237|NCT00436618|449640695|FG000|Overall Study|Adverse Event|8|||
125003238|NCT00436618|449640696|FG001|Overall Study|Adverse Event|8|||
125003239|NCT00436618|449640697|FG002|Overall Study|Adverse Event|9|||
125003240|NCT00436618|449640695|FG000|Overall Study|Alternate Treatment|3|||
125003241|NCT00436618|449640696|FG001|Overall Study|Alternate Treatment|4|||
125003242|NCT00436618|449640697|FG002|Overall Study|Alternate Treatment|12|||
125003243|NCT00436618|449640695|FG000|Overall Study|Other Medical Problems|3|||
125090171|NCT00561795|449948681|FG003|Overall Study|Study Closed/Terminated|0|||
125090172|NCT00561795|449948678|FG000|Overall Study|Physician Decision|1|||
125336144|NCT03570749|450863750|FG005|Overall Study|Lack of Efficacy|2|||
125336145|NCT03570749|450863751|FG006|Overall Study|Lack of Efficacy|7|||
125336146|NCT03570749|450863745|FG000|Overall Study|Lost to Follow-up|0|||
125336147|NCT03570749|450863746|FG001|Overall Study|Lost to Follow-up|0|||
125336148|NCT03570749|450863747|FG002|Overall Study|Lost to Follow-up|0|||
125336149|NCT03570749|450863748|FG003|Overall Study|Lost to Follow-up|0|||
125336150|NCT03570749|450863749|FG004|Overall Study|Lost to Follow-up|5|||
125336151|NCT03570749|450863750|FG005|Overall Study|Lost to Follow-up|10|||
125336152|NCT03570749|450863751|FG006|Overall Study|Lost to Follow-up|10|||
125336153|NCT03570749|450863745|FG000|Overall Study|Pregnancy|0|||
125336154|NCT03570749|450863746|FG001|Overall Study|Pregnancy|0|||
125336155|NCT03570749|450863747|FG002|Overall Study|Pregnancy|0|||
125336156|NCT03570749|450863748|FG003|Overall Study|Pregnancy|0|||
125336157|NCT03570749|450863749|FG004|Overall Study|Pregnancy|0|||
125336158|NCT03570749|450863750|FG005|Overall Study|Pregnancy|1|||
125336159|NCT03570749|450863751|FG006|Overall Study|Pregnancy|1|||
125336160|NCT03570749|450863745|FG000|Overall Study|Screen Fail|0|||
125336161|NCT03570749|450863746|FG001|Overall Study|Screen Fail|0|||
125336162|NCT03570749|450863747|FG002|Overall Study|Screen Fail|0|||
125336163|NCT03570749|450863748|FG003|Overall Study|Screen Fail|0|||
125336164|NCT03570749|450863749|FG004|Overall Study|Screen Fail|0|||
125336165|NCT03570749|450863750|FG005|Overall Study|Screen Fail|0|||
125336166|NCT03570749|450863751|FG006|Overall Study|Screen Fail|1|||
125336167|NCT03570749|450863745|FG000|Overall Study|Withdrawal by Subject|2|||
125336168|NCT03570749|450863746|FG001|Overall Study|Withdrawal by Subject|3|||
125003244|NCT00436618|449640696|FG001|Overall Study|Other Medical Problems|1|||
125003245|NCT00436618|449640697|FG002|Overall Study|Other Medical Problems|7|||
125003246|NCT00436618|449640695|FG000|Overall Study|Death|4|||
125003247|NCT00436618|449640696|FG001|Overall Study|Death|2|||
125003248|NCT00436618|449640697|FG002|Overall Study|Death|3|||
125003249|NCT00436618|449640695|FG000|Overall Study|New Primary or Other Reasons|6|||
125336169|NCT03570749|450863747|FG002|Overall Study|Withdrawal by Subject|2|||
125336170|NCT03570749|450863748|FG003|Overall Study|Withdrawal by Subject|1|||
125336171|NCT03570749|450863749|FG004|Overall Study|Withdrawal by Subject|17|||
125090173|NCT00561795|449948679|FG001|Overall Study|Physician Decision|0|||
125090174|NCT00561795|449948680|FG002|Overall Study|Physician Decision|0|||
125090175|NCT00561795|449948681|FG003|Overall Study|Physician Decision|0|||
125090176|NCT04235959|449948683|FG000|Overall Study|Protocol Violation|0|||
125090177|NCT04235959|449948684|FG001|Overall Study|Protocol Violation|1|||
125090178|NCT04235959|449948685|FG002|Overall Study|Protocol Violation|0|||
125090179|NCT04235959|449948683|FG000|Overall Study|Adverse Event|1|||
125090180|NCT04235959|449948684|FG001|Overall Study|Adverse Event|0|||
125090181|NCT04235959|449948685|FG002|Overall Study|Adverse Event|0|||
125090182|NCT02135848|449948688|FG000|Overall Study|Adverse Event|2|||
125090183|NCT02135848|449948689|FG001|Overall Study|Adverse Event|0|||
125090184|NCT02135848|449948688|FG000|Overall Study|Withdrawal by Subject|1|||
125090185|NCT02135848|449948689|FG001|Overall Study|Withdrawal by Subject|1|||
125090186|NCT04212221|449948693|FG000|Overall Study|Remained on Treatment|0|||
125090187|NCT04212221|449948694|FG001|Overall Study|Remained on Treatment|0|||
125090188|NCT04212221|449948695|FG002|Overall Study|Remained on Treatment|0|||
125090189|NCT04212221|449948696|FG003|Overall Study|Remained on Treatment|1|||
125090190|NCT04212221|449948697|FG004|Overall Study|Remained on Treatment|0|||
125090191|NCT04212221|449948698|FG005|Overall Study|Remained on Treatment|0|||
125090192|NCT04212221|449948699|FG006|Overall Study|Remained on Treatment|3|||
125090193|NCT04212221|449948700|FG007|Overall Study|Remained on Treatment|9|||
125090194|NCT04212221|449948693|FG000|Overall Study|Adverse Event|0|||
125090195|NCT04212221|449948694|FG001|Overall Study|Adverse Event|0|||
125090196|NCT04212221|449948695|FG002|Overall Study|Adverse Event|0|||
125090197|NCT04212221|449948696|FG003|Overall Study|Adverse Event|0|||
125090198|NCT04212221|449948697|FG004|Overall Study|Adverse Event|0|||
125090199|NCT04212221|449948698|FG005|Overall Study|Adverse Event|0|||
125090200|NCT04212221|449948699|FG006|Overall Study|Adverse Event|2|||
125090201|NCT04212221|449948700|FG007|Overall Study|Adverse Event|3|||
125090202|NCT04212221|449948693|FG000|Overall Study|Death|0|||
125336172|NCT03570749|450863750|FG005|Overall Study|Withdrawal by Subject|12|||
125336173|NCT03570749|450863751|FG006|Overall Study|Withdrawal by Subject|15|||
125336174|NCT03570749|450863745|FG000|Overall Study|Other|0|||
125336175|NCT03570749|450863746|FG001|Overall Study|Other|0|||
125336176|NCT03570749|450863747|FG002|Overall Study|Other|0|||
125336177|NCT03570749|450863748|FG003|Overall Study|Other|0|||
125336178|NCT03570749|450863749|FG004|Overall Study|Other|17|||
125336179|NCT03570749|450863750|FG005|Overall Study|Other|14|||
125336180|NCT03570749|450863751|FG006|Overall Study|Other|21|||
125336181|NCT01239381|450863752|FG000|Overall Study|Protocol Violation|1|||
125336182|NCT01239381|450863752|FG000|Overall Study|Withdrawal by Subject|1|||
125336183|NCT06237049|450863753|FG000|Overall Study|Death|0|||
125336184|NCT06237049|450863754|FG001|Overall Study|Death|0|||
125336185|NCT06237049|450863755|FG002|Overall Study|Death|0|||
125336186|NCT06237049|450863756|FG003|Overall Study|Death|1|||
125336187|NCT06237049|450863753|FG000|Overall Study|Lost to Follow-up|11|||
125336188|NCT06237049|450863754|FG001|Overall Study|Lost to Follow-up|5|||
125336189|NCT06237049|450863755|FG002|Overall Study|Lost to Follow-up|8|||
125336190|NCT06237049|450863756|FG003|Overall Study|Lost to Follow-up|8|||
125336191|NCT06237049|450863753|FG000|Overall Study|Protocol Violation|0|||
125336192|NCT06237049|450863754|FG001|Overall Study|Protocol Violation|1|||
125336193|NCT06237049|450863755|FG002|Overall Study|Protocol Violation|0|||
125336194|NCT06237049|450863756|FG003|Overall Study|Protocol Violation|1|||
125336195|NCT06237049|450863753|FG000|Overall Study|Withdrawal by Subject|4|||
125336196|NCT06237049|450863754|FG001|Overall Study|Withdrawal by Subject|2|||
125336197|NCT06237049|450863755|FG002|Overall Study|Withdrawal by Subject|1|||
125336198|NCT06237049|450863756|FG003|Overall Study|Withdrawal by Subject|0|||
125336199|NCT05014412|450863758|FG000|Overall Study|Death|11|||
125336200|NCT05014412|450863759|FG001|Overall Study|Death|7|||
125336201|NCT05014412|450863760|FG002|Overall Study|Death|4|||
125336202|NCT05014412|450863761|FG003|Overall Study|Death|7|||
125336203|NCT05014412|450863758|FG000|Overall Study|Withdrawal by Subject|1|||
125336204|NCT05014412|450863759|FG001|Overall Study|Withdrawal by Subject|1|||
125336205|NCT05014412|450863760|FG002|Overall Study|Withdrawal by Subject|1|||
125090203|NCT04212221|449948694|FG001|Overall Study|Death|0|||
125090204|NCT04212221|449948695|FG002|Overall Study|Death|0|||
125090205|NCT04212221|449948696|FG003|Overall Study|Death|0|||
125090206|NCT04212221|449948697|FG004|Overall Study|Death|0|||
125336206|NCT05014412|450863761|FG003|Overall Study|Withdrawal by Subject|2|||
125336207|NCT05014412|450863758|FG000|Overall Study|Ongoing|21|||
125336208|NCT05014412|450863759|FG001|Overall Study|Ongoing|4|||
125090207|NCT04212221|449948698|FG005|Overall Study|Death|0|||
125090208|NCT04212221|449948699|FG006|Overall Study|Death|0|||
125090209|NCT04212221|449948700|FG007|Overall Study|Death|2|||
125336209|NCT05014412|450863760|FG002|Overall Study|Ongoing|6|||
125336210|NCT05014412|450863761|FG003|Overall Study|Ongoing|20|||
125336211|NCT02101775|450863762|FG000|Overall Study|Adverse Event|4|||
125336212|NCT02101775|450863763|FG001|Overall Study|Adverse Event|0|||
125336213|NCT02101775|450863764|FG002|Overall Study|Adverse Event|0|||
125336214|NCT02101775|450863762|FG000|Overall Study|Admission to Hospital|0|||
125336215|NCT02101775|450863763|FG001|Overall Study|Admission to Hospital|1|||
125336216|NCT02101775|450863764|FG002|Overall Study|Admission to Hospital|0|||
125336217|NCT01886872|450863767|FG000|Overall Study|Ineligible|7|||
125336218|NCT01886872|450863768|FG001|Overall Study|Ineligible|4|||
125336219|NCT01886872|450863769|FG002|Overall Study|Ineligible|12|||
125336220|NCT04908397|450863770|FG000|Overall Study|Withdrawal by Subject|2|||
125336221|NCT04264442|450863771|FG000|Overall Study|Lack of Efficacy|6|||
125336222|NCT04264442|450863771|FG000|Overall Study|Lost to Follow-up|2|||
125336223|NCT04264442|450863771|FG000|Overall Study|Sponsor Decision|23|||
125336224|NCT04264442|450863771|FG000|Overall Study|Withdrawal by Subject|11|||
125336225|NCT04264442|450863771|FG000|Overall Study|Study Termination|5|||
125336226|NCT04941482|450863772|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
125336227|NCT04941482|450863773|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
125336228|NCT04604275|450863774|FG000|Washout-1 Week|Withdrawal by Subject|1|||
125090210|NCT04212221|449948693|FG000|Overall Study|Disease progression according to irRECIST|1|||
125090211|NCT04212221|449948694|FG001|Overall Study|Disease progression according to irRECIST|2|||
125090212|NCT04212221|449948695|FG002|Overall Study|Disease progression according to irRECIST|3|||
125090213|NCT04212221|449948696|FG003|Overall Study|Disease progression according to irRECIST|3|||
125090214|NCT04212221|449948697|FG004|Overall Study|Disease progression according to irRECIST|2|||
125090215|NCT04212221|449948698|FG005|Overall Study|Disease progression according to irRECIST|2|||
125090216|NCT04212221|449948699|FG006|Overall Study|Disease progression according to irRECIST|21|||
125090217|NCT04212221|449948700|FG007|Overall Study|Disease progression according to irRECIST|17|||
125090218|NCT04212221|449948693|FG000|Overall Study|Global Deterioration of Health Status|0|||
125090219|NCT04212221|449948694|FG001|Overall Study|Global Deterioration of Health Status|0|||
125090220|NCT04212221|449948695|FG002|Overall Study|Global Deterioration of Health Status|0|||
125090221|NCT04212221|449948696|FG003|Overall Study|Global Deterioration of Health Status|0|||
125090222|NCT04212221|449948697|FG004|Overall Study|Global Deterioration of Health Status|0|||
125336229|NCT04604275|450863775|FG001|Washout-1 Week|Withdrawal by Subject|0|||
125336230|NCT05615935|450864954|FG000|Overall Study|Lost to Follow-up|1|||
125336231|NCT05615935|450864955|FG001|Overall Study|Lost to Follow-up|1|||
125336232|NCT02838420|450864959|FG000|Overall Study|Ongoing in Study|113|||
125336233|NCT02838420|450864960|FG001|Overall Study|Ongoing in Study|45|||
125336234|NCT02838420|450864959|FG000|Overall Study|Lost to Follow-up|1|||
125336235|NCT02838420|450864960|FG001|Overall Study|Lost to Follow-up|0|||
125336236|NCT02838420|450864959|FG000|Overall Study|Withdrawal by Subject|3|||
125336237|NCT02838420|450864960|FG001|Overall Study|Withdrawal by Subject|4|||
125336238|NCT02838420|450864959|FG000|Overall Study|Death|8|||
125336239|NCT02838420|450864960|FG001|Overall Study|Death|13|||
125336240|NCT03745313|450864961|FG000|At 30 Days Follow-up|Death|2|||
125336241|NCT03745313|450864961|FG000|At 6 Months Follow-up|Death|1|||
125336242|NCT03745313|450864961|FG000|At 6 Months Follow-up|Missed Visit|1|||
125336243|NCT03745313|450864961|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
125336244|NCT03745313|450864961|FG000|At 1 Year Follow-up|Death|2|||
125336245|NCT03745313|450864961|FG000|At 1 Year Follow-up|Missed Visit|2|||
125336246|NCT03745313|450864961|FG000|At 2 Year Follow-up|Missed Visit|1|||
125336247|NCT04879628|450864962|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
125336248|NCT04879628|450864963|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
125336249|NCT04879628|450864964|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
125336250|NCT04879628|450864965|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
125336251|NCT04879628|450864962|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
125336252|NCT04879628|450864963|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
125336253|NCT04879628|450864964|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
125336254|NCT04879628|450864965|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
125336255|NCT04879628|450864962|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
125336256|NCT04879628|450864963|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
125336257|NCT04879628|450864964|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
125336258|NCT04879628|450864965|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
125336259|NCT04879628|450864962|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
125336260|NCT04879628|450864963|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
125336261|NCT04879628|450864964|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
125336262|NCT04879628|450864965|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
125336263|NCT05446870|450864966|FG000|Overall Study|Death|6|||
125336264|NCT05446870|450864967|FG001|Overall Study|Death|5|||
125336265|NCT05446870|450864966|FG000|Overall Study|Lost to Follow-up|0|||
125336266|NCT05446870|450864967|FG001|Overall Study|Lost to Follow-up|1|||
125336267|NCT05446870|450864966|FG000|Overall Study|Physician Decision|52|||
125336268|NCT05446870|450864967|FG001|Overall Study|Physician Decision|53|||
125336269|NCT05446870|450864966|FG000|Overall Study|Withdrawal by Subject|3|||
125336270|NCT05446870|450864967|FG001|Overall Study|Withdrawal by Subject|3|||
125336271|NCT03516812|450864968|FG000|Overall Study|Adverse Event|4|||
125336272|NCT03516812|450864968|FG000|Overall Study|Lack of Efficacy|2|||
125336273|NCT02689505|450864971|FG000|Overall Study|Progressive disease|2|||
125336274|NCT02689505|450864972|FG001|Overall Study|Progressive disease|2|||
125336275|NCT02689505|450864973|FG002|Overall Study|Progressive disease|3|||
125336276|NCT02689505|450864974|FG003|Overall Study|Progressive disease|9|||
125336277|NCT02689505|450864975|FG004|Overall Study|Progressive disease|1|||
125336278|NCT02689505|450864971|FG000|Overall Study|Dose Limiting Toxicity|0|||
125336279|NCT02689505|450864972|FG001|Overall Study|Dose Limiting Toxicity|1|||
125336280|NCT02689505|450864973|FG002|Overall Study|Dose Limiting Toxicity|0|||
125336281|NCT02689505|450864974|FG003|Overall Study|Dose Limiting Toxicity|0|||
125336282|NCT02689505|450864975|FG004|Overall Study|Dose Limiting Toxicity|2|||
125336283|NCT02689505|450864971|FG000|Overall Study|Other AE or clinical progression|0|||
125336284|NCT02689505|450864972|FG001|Overall Study|Other AE or clinical progression|2|||
125336285|NCT02689505|450864973|FG002|Overall Study|Other AE or clinical progression|0|||
125336286|NCT02689505|450864974|FG003|Overall Study|Other AE or clinical progression|2|||
125336287|NCT02689505|450864975|FG004|Overall Study|Other AE or clinical progression|0|||
125336288|NCT04875195|450864976|FG000|Overall Study|Death|9|||
125336289|NCT04875195|450864977|FG001|Overall Study|Death|3|||
125336290|NCT04875195|450864976|FG000|Overall Study|Withdrawal by Subject|2|||
125336291|NCT04875195|450864977|FG001|Overall Study|Withdrawal by Subject|1|||
125336292|NCT04875195|450864976|FG000|Overall Study|Ongoing in study|49|||
125336293|NCT04875195|450864977|FG001|Overall Study|Ongoing in study|2|||
125336294|NCT03389802|450864978|FG000|Overall Study|Lack of Efficacy|3|||
125336295|NCT03389802|450864979|FG001|Overall Study|Lack of Efficacy|3|||
125336296|NCT03389802|450864980|FG002|Overall Study|Lack of Efficacy|13|||
125336297|NCT03389802|450864981|FG003|Overall Study|Lack of Efficacy|6|||
125336298|NCT03389802|450864982|FG004|Overall Study|Lack of Efficacy|1|||
125336299|NCT03389802|450864978|FG000|Overall Study|Adverse Event|0|||
125336300|NCT03389802|450864979|FG001|Overall Study|Adverse Event|0|||
125336301|NCT03389802|450864980|FG002|Overall Study|Adverse Event|1|||
125336302|NCT03389802|450864981|FG003|Overall Study|Adverse Event|0|||
125336303|NCT03389802|450864982|FG004|Overall Study|Adverse Event|4|||
125336304|NCT03389802|450864978|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
125336305|NCT03389802|450864979|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
125336306|NCT03389802|450864980|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
125336307|NCT03389802|450864981|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
125336308|NCT03389802|450864982|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
125336309|NCT05190120|450864983|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
125336310|NCT05190120|450864984|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
125336311|NCT05190120|450864985|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
125336312|NCT05190120|450864986|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
125090223|NCT04212221|449948698|FG005|Overall Study|Global Deterioration of Health Status|0|||
125090224|NCT04212221|449948699|FG006|Overall Study|Global Deterioration of Health Status|0|||
125090225|NCT04212221|449948700|FG007|Overall Study|Global Deterioration of Health Status|2|||
125090226|NCT04212221|449948693|FG000|Overall Study|Investigator's Decision|0|||
125090227|NCT04212221|449948694|FG001|Overall Study|Investigator's Decision|0|||
125090228|NCT04212221|449948695|FG002|Overall Study|Investigator's Decision|0|||
125090229|NCT04212221|449948696|FG003|Overall Study|Investigator's Decision|1|||
125090230|NCT04212221|449948697|FG004|Overall Study|Investigator's Decision|0|||
125090231|NCT04212221|449948698|FG005|Overall Study|Investigator's Decision|0|||
125090232|NCT04212221|449948699|FG006|Overall Study|Investigator's Decision|3|||
125090233|NCT04212221|449948700|FG007|Overall Study|Investigator's Decision|0|||
125090234|NCT04212221|449948693|FG000|Overall Study|Participant refused to continue treatment|0|||
125090235|NCT04212221|449948694|FG001|Overall Study|Participant refused to continue treatment|1|||
125090236|NCT04212221|449948695|FG002|Overall Study|Participant refused to continue treatment|0|||
125090237|NCT04212221|449948696|FG003|Overall Study|Participant refused to continue treatment|1|||
125090238|NCT04212221|449948697|FG004|Overall Study|Participant refused to continue treatment|1|||
125090239|NCT04212221|449948698|FG005|Overall Study|Participant refused to continue treatment|2|||
125090240|NCT04212221|449948699|FG006|Overall Study|Participant refused to continue treatment|4|||
125090241|NCT04212221|449948700|FG007|Overall Study|Participant refused to continue treatment|2|||
125336313|NCT05190120|450864983|FG000|Overall Study|Lost to Follow-up|5|||
125336314|NCT05190120|450864984|FG001|Overall Study|Lost to Follow-up|0|||
125336315|NCT05190120|450864985|FG002|Overall Study|Lost to Follow-up|2|||
125336316|NCT05190120|450864986|FG003|Overall Study|Lost to Follow-up|3|||
125336317|NCT02446600|450864987|FG000|Overall Study|Never treated|20|||
125336318|NCT02446600|450864988|FG001|Overall Study|Never treated|2|||
125336319|NCT02446600|450864989|FG002|Overall Study|Never treated|6|||
125090242|NCT04212221|449948693|FG000|Overall Study|Protocol Violation|0|||
125090243|NCT04212221|449948694|FG001|Overall Study|Protocol Violation|0|||
125336320|NCT02446600|450864990|FG003|Overall Study|Never treated|0|||
125336321|NCT02446600|450864987|FG000|Overall Study|Withdrawal by Subject|19|||
125336322|NCT02446600|450864988|FG001|Overall Study|Withdrawal by Subject|5|||
125336323|NCT02446600|450864989|FG002|Overall Study|Withdrawal by Subject|17|||
125336324|NCT02446600|450864990|FG003|Overall Study|Withdrawal by Subject|0|||
125336325|NCT02446600|450864987|FG000|Overall Study|Ineligible|1|||
125336326|NCT02446600|450864988|FG001|Overall Study|Ineligible|4|||
125336327|NCT02446600|450864989|FG002|Overall Study|Ineligible|4|||
125336328|NCT02446600|450864990|FG003|Overall Study|Ineligible|1|||
125336329|NCT02446600|450864987|FG000|Overall Study|Duplicate Enrollment|0|||
125336330|NCT02446600|450864988|FG001|Overall Study|Duplicate Enrollment|1|||
125336331|NCT02446600|450864989|FG002|Overall Study|Duplicate Enrollment|0|||
125336332|NCT02446600|450864990|FG003|Overall Study|Duplicate Enrollment|0|||
125336333|NCT04108858|450864991|FG000|Overall Study|Adverse Event|1|||
125336334|NCT01005745|450864992|FG000|Overall Study|No TIL growth|1|||
125336335|NCT01005745|450864992|FG000|Overall Study|Disease progressed during TIL growth|3|||
125336336|NCT01005745|450864992|FG000|Overall Study|Death prior to treatment|1|||
125336337|NCT01005745|450864992|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
125336338|NCT03069352|450864993|FG000|Overall Study|Ongoing|12|||
125336339|NCT03069352|450864994|FG001|Overall Study|Ongoing|40|||
125336340|NCT02621424|450864995|FG000|Overall Study|Withdrawal by Subject|1|||
125336341|NCT02621424|450864996|FG001|Overall Study|Withdrawal by Subject|2|||
125336342|NCT05646251|450865003|FG000|Overall Study|Physician Decision|1|||
125336343|NCT05646251|450865004|FG001|Overall Study|Physician Decision|0|||
125336344|NCT05646251|450865005|FG002|Overall Study|Physician Decision|2|||
125336345|NCT05148234|450865006|FG000|Phase I|Ineligible|0|||
125336346|NCT05148234|450865007|FG001|Phase I|Ineligible|0|||
125336347|NCT05148234|450865008|FG002|Phase I|Ineligible|0|||
125336348|NCT05148234|450865009|FG003|Phase I|Ineligible|0|||
125336349|NCT05148234|450865010|FG004|Phase I|Ineligible|0|||
125336350|NCT05148234|450865011|FG005|Phase I|Ineligible|0|||
125336351|NCT05148234|450865012|FG006|Phase I|Ineligible|0|||
125336352|NCT05148234|450865013|FG007|Phase I|Ineligible|1|||
125336353|NCT05148234|450865006|FG000|Phase I|Company closed the trial.|0|||
125336354|NCT05148234|450865007|FG001|Phase I|Company closed the trial.|1|||
125336355|NCT05148234|450865008|FG002|Phase I|Company closed the trial.|0|||
125336356|NCT05148234|450865009|FG003|Phase I|Company closed the trial.|0|||
125336357|NCT05148234|450865010|FG004|Phase I|Company closed the trial.|0|||
125336358|NCT05148234|450865011|FG005|Phase I|Company closed the trial.|0|||
125336359|NCT05148234|450865012|FG006|Phase I|Company closed the trial.|0|||
125336360|NCT05148234|450865013|FG007|Phase I|Company closed the trial.|0|||
125336361|NCT03061201|450865015|FG000|Overall Study|Participants Terminated at Month 36|0|||
125336362|NCT03061201|450865016|FG001|Overall Study|Participants Terminated at Month 36|1|||
125336363|NCT03061201|450865017|FG002|Overall Study|Participants Terminated at Month 36|0|||
125336364|NCT03061201|450865018|FG003|Overall Study|Participants Terminated at Month 36|1|||
125336365|NCT03061201|450865015|FG000|Overall Study|Lost to Follow-up|1|||
125336366|NCT03061201|450865016|FG001|Overall Study|Lost to Follow-up|0|||
125336367|NCT03061201|450865017|FG002|Overall Study|Lost to Follow-up|0|||
125336368|NCT03061201|450865018|FG003|Overall Study|Lost to Follow-up|0|||
125336369|NCT03062358|450865019|FG000|Overall Study|Death|269|||
125336370|NCT03062358|450865020|FG001|Overall Study|Death|145|||
125336371|NCT03062358|450865019|FG000|Overall Study|Withdrawal by Subject|2|||
125336372|NCT03062358|450865020|FG001|Overall Study|Withdrawal by Subject|1|||
125336373|NCT03062358|450865019|FG000|Overall Study|Sponsor Decision|29|||
125336374|NCT03062358|450865020|FG001|Overall Study|Sponsor Decision|7|||
125336375|NCT04745676|450865021|FG000|Overall Study|Death|1|||
125336376|NCT04745676|450865022|FG001|Overall Study|Death|0|||
125336377|NCT04745676|450865023|FG002|Overall Study|Death|0|||
125336378|NCT03861273|450865024|FG000|Screening Phase (3 Weeks)|Other|1|||
125336379|NCT03861273|450865024|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
125336380|NCT03861273|450865024|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
125336381|NCT03861273|450865024|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
125336382|NCT03861273|450865024|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
125336383|NCT04659603|450865025|FG000|Overall Study|Study terminated by sponsor|0|||
125336384|NCT04659603|450865026|FG001|Overall Study|Study terminated by sponsor|0|||
125336385|NCT04659603|450865027|FG002|Overall Study|Study terminated by sponsor|2|||
125336386|NCT04659603|450865025|FG000|Overall Study|Withdrawal by Subject|0|||
125336387|NCT04659603|450865026|FG001|Overall Study|Withdrawal by Subject|5|||
125336388|NCT04659603|450865027|FG002|Overall Study|Withdrawal by Subject|0|||
125336389|NCT04659603|450865025|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
125336390|NCT04659603|450865026|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
125336391|NCT04659603|450865027|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
125336392|NCT03799341|450865028|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
125336393|NCT03799341|450865029|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
125336394|NCT03799341|450865030|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
125336395|NCT03799341|450865028|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
125336396|NCT03799341|450865029|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
125336397|NCT03799341|450865030|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
125336398|NCT03799341|450865028|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
125336399|NCT03799341|450865029|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
125090244|NCT04212221|449948695|FG002|Overall Study|Protocol Violation|0|||
125336400|NCT03799341|450865030|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
125090245|NCT04212221|449948696|FG003|Overall Study|Protocol Violation|0|||
125090246|NCT04212221|449948697|FG004|Overall Study|Protocol Violation|0|||
125090247|NCT04212221|449948698|FG005|Overall Study|Protocol Violation|0|||
125090248|NCT04212221|449948699|FG006|Overall Study|Protocol Violation|0|||
125090249|NCT04212221|449948700|FG007|Overall Study|Protocol Violation|1|||
125090250|NCT00636506|449948705|FG000|Overall Study|Lost to Follow-up|8|||
125090251|NCT00636506|449948705|FG000|Overall Study|Explanted|1|||
125090252|NCT00636506|449948705|FG000|Overall Study|Withdrawal by Subject|6|||
125090253|NCT00636506|449948705|FG000|Overall Study|Procedure aborted|1|||
125090254|NCT03742271|449948706|FG000|Overall Study|Unsatisfactory Visual Response|1|||
125090255|NCT03742271|449948706|FG000|Overall Study|Withdrawal by Subject|3|||
125090256|NCT03742271|449948706|FG000|Overall Study|Lost to Follow-up|4|||
125090257|NCT03742271|449948706|FG000|Overall Study|Failed Insertion & removal|3|||
125090258|NCT03742271|449948706|FG000|Overall Study|Protocol Violation|1|||
125090259|NCT01624974|449948708|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
125090260|NCT01624974|449948709|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
125090261|NCT01624974|449948708|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
125090262|NCT01624974|449948709|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
125090263|NCT01624974|449948708|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
125336401|NCT03799341|450865028|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
125336402|NCT03799341|450865029|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
125336403|NCT03799341|450865030|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
125336404|NCT03799341|450865028|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
125336405|NCT03799341|450865029|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
125336406|NCT03799341|450865030|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
125336407|NCT03799341|450865028|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
125336408|NCT03799341|450865029|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
125336409|NCT03799341|450865030|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
125336410|NCT01231906|450865033|FG000|Overall Study|Lack of Efficacy|75|||
125336411|NCT01231906|450865034|FG001|Overall Study|Lack of Efficacy|68|||
125336412|NCT01231906|450865033|FG000|Overall Study|Lost to Follow-up|1|||
125336413|NCT01231906|450865034|FG001|Overall Study|Lost to Follow-up|0|||
125336414|NCT01231906|450865033|FG000|Overall Study|Physician Decision|34|||
125336415|NCT01231906|450865034|FG001|Overall Study|Physician Decision|24|||
125336416|NCT01231906|450865033|FG000|Overall Study|Withdrawal by Subject|0|||
125336417|NCT01231906|450865034|FG001|Overall Study|Withdrawal by Subject|4|||
125336418|NCT01231906|450865033|FG000|Overall Study|Ineligible|10|||
125336419|NCT01231906|450865034|FG001|Overall Study|Ineligible|3|||
125336420|NCT01231906|450865033|FG000|Overall Study|No treatment|1|||
125336421|NCT01231906|450865034|FG001|Overall Study|No treatment|2|||
125336422|NCT01116648|450865035|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
125336423|NCT01116648|450865036|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
125336424|NCT01116648|450865037|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
125336425|NCT01116648|450865038|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
125336426|NCT01116648|450865039|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
125336427|NCT01116648|450865040|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
125336428|NCT01116648|450865041|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
125336429|NCT01116648|450865042|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
125336430|NCT01116648|450865043|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
125336431|NCT01116648|450865044|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
125336432|NCT01116648|450865045|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
125336433|NCT01116648|450865046|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
125336434|NCT01116648|450865047|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
125336435|NCT01116648|450865048|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
125336436|NCT01116648|450865049|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
125336437|NCT04539938|450865050|FG000|Overall Study|Death|30|||
125336438|NCT04539938|450865050|FG000|Overall Study|Withdrawal by Subject|4|||
125336439|NCT03100149|450865056|FG000|Overall Study|Adverse Event|0|||
125090264|NCT01624974|449948709|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
125090265|NCT01624974|449948708|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
125336440|NCT03100149|450865057|FG001|Overall Study|Adverse Event|1|||
125336441|NCT03100149|450865058|FG002|Overall Study|Adverse Event|0|||
125336442|NCT03100149|450865056|FG000|Overall Study|Participant Moved out of Country|0|||
125336443|NCT03100149|450865057|FG001|Overall Study|Participant Moved out of Country|0|||
125336444|NCT03100149|450865058|FG002|Overall Study|Participant Moved out of Country|1|||
125336445|NCT03100149|450865056|FG000|Overall Study|Withdrawal by Subject|0|||
125336446|NCT03100149|450865057|FG001|Overall Study|Withdrawal by Subject|3|||
125336447|NCT03100149|450865058|FG002|Overall Study|Withdrawal by Subject|1|||
125336448|NCT04827732|450865064|FG000|Overall Study|Did not start treatment|0|||
125336449|NCT04827732|450865065|FG001|Overall Study|Did not start treatment|1|||
125336450|NCT04827732|450865066|FG002|Overall Study|Did not start treatment|0|||
125336451|NCT04827732|450865067|FG003|Overall Study|Did not start treatment|1|||
125336452|NCT01754597|450865070|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
125336453|NCT01754597|450865071|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
125336454|NCT01588236|450865072|FG000|Overall Study|Adverse Event|5|||
125336455|NCT01588236|450865073|FG001|Overall Study|Adverse Event|4|||
125336456|NCT01588236|450865074|FG002|Overall Study|Adverse Event|1|||
125336457|NCT01588236|450865072|FG000|Overall Study|Lost to Follow-up|8|||
125336458|NCT01588236|450865073|FG001|Overall Study|Lost to Follow-up|13|||
125336459|NCT01588236|450865074|FG002|Overall Study|Lost to Follow-up|6|||
125336460|NCT01588236|450865072|FG000|Overall Study|Physician Decision|1|||
125336461|NCT01588236|450865073|FG001|Overall Study|Physician Decision|2|||
125336462|NCT01588236|450865074|FG002|Overall Study|Physician Decision|0|||
125336463|NCT01588236|450865072|FG000|Overall Study|Protocol Violation|0|||
125336464|NCT01588236|450865073|FG001|Overall Study|Protocol Violation|1|||
125336465|NCT01588236|450865074|FG002|Overall Study|Protocol Violation|1|||
125336466|NCT01588236|450865072|FG000|Overall Study|Withdrawal by Subject|14|||
125336467|NCT01588236|450865073|FG001|Overall Study|Withdrawal by Subject|16|||
125336468|NCT01588236|450865074|FG002|Overall Study|Withdrawal by Subject|18|||
125336469|NCT01588236|450865072|FG000|Overall Study|Exclusion Criteria met during study|2|||
125336470|NCT01588236|450865073|FG001|Overall Study|Exclusion Criteria met during study|1|||
125336471|NCT01588236|450865074|FG002|Overall Study|Exclusion Criteria met during study|0|||
125336472|NCT01588236|450865072|FG000|Overall Study|sponsor decision|1|||
125336473|NCT01588236|450865073|FG001|Overall Study|sponsor decision|6|||
125336474|NCT01588236|450865074|FG002|Overall Study|sponsor decision|2|||
125336475|NCT04544410|450865077|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
125336476|NCT04544410|450865078|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
125336477|NCT04544410|450865077|FG000|Double-blind Treatment Period|Adverse Event|1|||
125336478|NCT04544410|450865078|FG001|Double-blind Treatment Period|Adverse Event|0|||
125336479|NCT04544410|450865077|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
125336480|NCT04544410|450865078|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
125336481|NCT04544410|450865077|FG000|Double-blind Treatment Period|Protocol Violation|1|||
125336482|NCT04544410|450865078|FG001|Double-blind Treatment Period|Protocol Violation|0|||
125336483|NCT04544410|450865077|FG000|Open-Label Treatment Period|Study Terminated|15|||
125336484|NCT04544410|450865078|FG001|Open-Label Treatment Period|Study Terminated|19|||
125336485|NCT04544410|450865077|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
125336486|NCT04544410|450865078|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
125336487|NCT04544410|450865077|FG000|Open-Label Treatment Period|Adverse Event|0|||
125336488|NCT04544410|450865078|FG001|Open-Label Treatment Period|Adverse Event|1|||
125336489|NCT04544410|450865077|FG000|Open-Label Treatment Period|Physician Decision|1|||
125336490|NCT04544410|450865078|FG001|Open-Label Treatment Period|Physician Decision|0|||
125336491|NCT04544410|450865077|FG000|Open-Label Treatment Period|Other|0|||
125336492|NCT04544410|450865078|FG001|Open-Label Treatment Period|Other|1|||
125336493|NCT03414684|450865455|FG000|First-course Treatment|Complete response|0|||
125336494|NCT03414684|450865456|FG001|First-course Treatment|Complete response|1|||
125336495|NCT03414684|450865455|FG000|First-course Treatment|Intercurrent illness|1|||
125336496|NCT03414684|450865456|FG001|First-course Treatment|Intercurrent illness|0|||
125336497|NCT03414684|450865455|FG000|First-course Treatment|Progressive Disease|31|||
125336498|NCT03414684|450865456|FG001|First-course Treatment|Progressive Disease|32|||
125336499|NCT03414684|450865455|FG000|First-course Treatment|Adverse Event|1|||
125336500|NCT03414684|450865456|FG001|First-course Treatment|Adverse Event|2|||
125336501|NCT03414684|450865455|FG000|First-course Treatment|Physician Decision|0|||
125336502|NCT03414684|450865456|FG001|First-course Treatment|Physician Decision|1|||
125336503|NCT03414684|450865455|FG000|First-course Treatment|Withdrawal by Subject|0|||
125336504|NCT03414684|450865456|FG001|First-course Treatment|Withdrawal by Subject|1|||
125336505|NCT03414684|450865455|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
125336506|NCT03414684|450865456|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
125336507|NCT03414684|450865455|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
125336508|NCT03414684|450865456|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
125336509|NCT03414684|450865455|FG000|First-course Treatment|Still on treatment|3|||
125336510|NCT03414684|450865456|FG001|First-course Treatment|Still on treatment|0|||
125336511|NCT03414684|450865455|FG000|First-course Treatment|Never started protocol therapy|2|||
125336512|NCT03414684|450865456|FG001|First-course Treatment|Never started protocol therapy|1|||
125336513|NCT03414684|450865455|FG000|Crossover Treatment|Progressive disease|0|||
125336514|NCT03414684|450865456|FG001|Crossover Treatment|Progressive disease|12|||
125336515|NCT03414684|450865455|FG000|Crossover Treatment|Adverse Event|0|||
125336516|NCT03414684|450865456|FG001|Crossover Treatment|Adverse Event|3|||
125336517|NCT03414684|450865455|FG000|Crossover Treatment|Physician Decision|0|||
125336518|NCT03414684|450865456|FG001|Crossover Treatment|Physician Decision|1|||
125336519|NCT03414684|450865455|FG000|Crossover Treatment|Still on treatment|0|||
125336520|NCT03414684|450865456|FG001|Crossover Treatment|Still on treatment|2|||
125336521|NCT04038580|450865457|FG000|Washout 1|Death|0|||
125336522|NCT04038580|450865458|FG001|Washout 1|Death|0|||
125336523|NCT04038580|450865459|FG002|Washout 1|Death|0|||
125336524|NCT04038580|450865460|FG003|Washout 1|Death|1|||
125336525|NCT04038580|450865461|FG004|Washout 1|Death|0|||
125336526|NCT04038580|450865462|FG005|Washout 1|Death|0|||
125003250|NCT00436618|449640696|FG001|Overall Study|New Primary or Other Reasons|2|||
125336527|NCT04038580|450865457|FG000|Washout 1|Withdrawal by Subject|0|||
125336528|NCT04038580|450865458|FG001|Washout 1|Withdrawal by Subject|0|||
125336529|NCT04038580|450865459|FG002|Washout 1|Withdrawal by Subject|0|||
125336530|NCT04038580|450865460|FG003|Washout 1|Withdrawal by Subject|0|||
125336531|NCT04038580|450865461|FG004|Washout 1|Withdrawal by Subject|1|||
125336532|NCT04038580|450865462|FG005|Washout 1|Withdrawal by Subject|0|||
125336533|NCT04038580|450865457|FG000|Wash-out 2|Withdrawal by Subject|1|||
125336534|NCT04038580|450865458|FG001|Wash-out 2|Withdrawal by Subject|0|||
125336535|NCT04038580|450865459|FG002|Wash-out 2|Withdrawal by Subject|0|||
125336536|NCT04038580|450865460|FG003|Wash-out 2|Withdrawal by Subject|2|||
125336537|NCT04038580|450865461|FG004|Wash-out 2|Withdrawal by Subject|0|||
125336538|NCT04038580|450865462|FG005|Wash-out 2|Withdrawal by Subject|1|||
125336539|NCT04038580|450865457|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
125336540|NCT04038580|450865458|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
125336541|NCT04038580|450865459|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
125336542|NCT04038580|450865460|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
125336543|NCT04038580|450865461|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
125336544|NCT04038580|450865462|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
125336545|NCT04038580|450865457|FG000|Wash-out 3|Withdrawal by Subject|1|||
125336546|NCT04038580|450865458|FG001|Wash-out 3|Withdrawal by Subject|0|||
125336547|NCT04038580|450865459|FG002|Wash-out 3|Withdrawal by Subject|2|||
125336548|NCT04038580|450865460|FG003|Wash-out 3|Withdrawal by Subject|0|||
125336549|NCT04038580|450865461|FG004|Wash-out 3|Withdrawal by Subject|0|||
125336550|NCT04038580|450865462|FG005|Wash-out 3|Withdrawal by Subject|0|||
125336551|NCT04972162|450865469|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
125336552|NCT04972162|450865470|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
125336553|NCT03761173|450865471|FG000|Overall Study|Lost to Follow-up|93|||
125336554|NCT03761173|450865471|FG000|Overall Study|Withdrawal by Subject|74|||
125336555|NCT03761173|450865471|FG000|Overall Study|Death|45|||
125336556|NCT03761173|450865471|FG000|Overall Study|Withdrawal for Other Reasons|29|||
125336557|NCT03761173|450865471|FG000|Overall Study|Protocol Violation|1|||
125336558|NCT00336024|450865472|FG000|Overall Study|Death|2|||
125336559|NCT00336024|450865473|FG001|Overall Study|Death|1|||
125336560|NCT00336024|450865472|FG000|Overall Study|Physician Decision|4|||
125336561|NCT00336024|450865473|FG001|Overall Study|Physician Decision|1|||
125336562|NCT00336024|450865472|FG000|Overall Study|Protocol Violation|1|||
125336563|NCT00336024|450865473|FG001|Overall Study|Protocol Violation|0|||
125336564|NCT00336024|450865472|FG000|Overall Study|Withdrawal by Subject|1|||
125336565|NCT00336024|450865473|FG001|Overall Study|Withdrawal by Subject|2|||
125336566|NCT00336024|450865472|FG000|Overall Study|Failure to fulfill consolidation|1|||
125336567|NCT00336024|450865473|FG001|Overall Study|Failure to fulfill consolidation|1|||
125336568|NCT00336024|450865472|FG000|Overall Study|Progressive Disease|4|||
125336569|NCT00336024|450865473|FG001|Overall Study|Progressive Disease|7|||
125336570|NCT00336024|450865472|FG000|Overall Study|Ineligible|7|||
125336571|NCT00336024|450865473|FG001|Overall Study|Ineligible|7|||
125336572|NCT03147287|450865479|FG000|Overall Study|Randomized Not Treated|2|||
125336573|NCT03147287|450865480|FG001|Overall Study|Randomized Not Treated|1|||
125336574|NCT03147287|450865481|FG002|Overall Study|Randomized Not Treated|1|||
125336575|NCT03147287|450865479|FG000|Overall Study|Progressive Disease RECIST|31|||
125336576|NCT03147287|450865480|FG001|Overall Study|Progressive Disease RECIST|72|||
125336577|NCT03147287|450865481|FG002|Overall Study|Progressive Disease RECIST|32|||
125336578|NCT03147287|450865479|FG000|Overall Study|Progressive Disease not RECIST|13|||
125336579|NCT03147287|450865480|FG001|Overall Study|Progressive Disease not RECIST|21|||
125336580|NCT03147287|450865481|FG002|Overall Study|Progressive Disease not RECIST|13|||
125336581|NCT03147287|450865479|FG000|Overall Study|Physician Decision|1|||
125336582|NCT03147287|450865480|FG001|Overall Study|Physician Decision|2|||
125336583|NCT03147287|450865481|FG002|Overall Study|Physician Decision|1|||
125336584|NCT03147287|450865479|FG000|Overall Study|Intercurrent illness|0|||
125336585|NCT03147287|450865480|FG001|Overall Study|Intercurrent illness|1|||
125336586|NCT03147287|450865481|FG002|Overall Study|Intercurrent illness|0|||
125336587|NCT03147287|450865479|FG000|Overall Study|Withdrawal by Subject|2|||
125336588|NCT03147287|450865480|FG001|Overall Study|Withdrawal by Subject|3|||
125336589|NCT03147287|450865481|FG002|Overall Study|Withdrawal by Subject|2|||
125003251|NCT00436618|449640697|FG002|Overall Study|New Primary or Other Reasons|12|||
125003252|NCT00436618|449640695|FG000|Overall Study|Still on treatment|1|||
125003253|NCT00436618|449640696|FG001|Overall Study|Still on treatment|2|||
125003254|NCT00436618|449640697|FG002|Overall Study|Still on treatment|7|||
125003255|NCT00698204|449640698|FG000|Overall Study|Withdrawal by Subject|1|||
125003256|NCT00698204|449640699|FG001|Overall Study|Withdrawal by Subject|0|||
125336590|NCT03147287|450865479|FG000|Overall Study|Patient Non-Compliance|0|||
125336591|NCT03147287|450865480|FG001|Overall Study|Patient Non-Compliance|2|||
125336592|NCT03147287|450865481|FG002|Overall Study|Patient Non-Compliance|0|||
125336593|NCT03147287|450865479|FG000|Overall Study|Patient moved|0|||
125336594|NCT03147287|450865480|FG001|Overall Study|Patient moved|1|||
125336595|NCT03147287|450865481|FG002|Overall Study|Patient moved|0|||
125003257|NCT01949155|449640700|FG000|Overall Study|Lost to Follow-up|1|||
125003258|NCT01949155|449640701|FG001|Overall Study|Lost to Follow-up|0|||
125003259|NCT01949155|449640700|FG000|Overall Study|Protocol Violation|1|||
125003260|NCT01949155|449640701|FG001|Overall Study|Protocol Violation|0|||
125003261|NCT00314249|449640702|FG000|Overall Study|Adverse Event|73|||
125003262|NCT00314249|449640703|FG001|Overall Study|Adverse Event|94|||
125003263|NCT00314249|449640702|FG000|Overall Study|Lack of Efficacy|33|||
125003264|NCT00314249|449640703|FG001|Overall Study|Lack of Efficacy|24|||
125003265|NCT00314249|449640702|FG000|Overall Study|Withdrawal by Subject|21|||
125003266|NCT00314249|449640703|FG001|Overall Study|Withdrawal by Subject|28|||
125003267|NCT00314249|449640702|FG000|Overall Study|Lost to Follow-up|15|||
125003268|NCT00314249|449640703|FG001|Overall Study|Lost to Follow-up|9|||
125003269|NCT00314249|449640702|FG000|Overall Study|Physician Decision|1|||
125003270|NCT00314249|449640703|FG001|Overall Study|Physician Decision|1|||
125003271|NCT00314249|449640702|FG000|Overall Study|Withdrawn for other reasons|4|||
125003272|NCT00314249|449640703|FG001|Overall Study|Withdrawn for other reasons|1|||
125003273|NCT00314249|449640702|FG000|Overall Study|Non-Compliant|5|||
125003274|NCT00314249|449640703|FG001|Overall Study|Non-Compliant|6|||
125003275|NCT00210184|449640704|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
125003276|NCT01118325|449640707|FG000|Overall Study|Adverse Event|1|||
125003277|NCT01118325|449640708|FG001|Overall Study|Adverse Event|0|||
125003278|NCT01118325|449640709|FG002|Overall Study|Adverse Event|1|||
125003279|NCT03334409|449640710|FG000|Overall Study|Did not meet inclusion criteria|1|||
125003280|NCT03334409|449640711|FG001|Overall Study|Did not meet inclusion criteria|0|||
125003281|NCT00975715|449640712|FG000|Titration Period|Adverse Event|6|||
125003282|NCT00975715|449640713|FG001|Titration Period|Adverse Event|0|||
125336596|NCT03147287|450865479|FG000|Overall Study|Arm A crossover without PD|1|||
125336597|NCT03147287|450865480|FG001|Overall Study|Arm A crossover without PD|0|||
125336598|NCT03147287|450865481|FG002|Overall Study|Arm A crossover without PD|0|||
125336599|NCT03147287|450865479|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
125336600|NCT03147287|450865480|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
125336601|NCT03147287|450865481|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
125003283|NCT00975715|449640712|FG000|Titration Period|Protocol Violation|1|||
125003284|NCT00975715|449640713|FG001|Titration Period|Protocol Violation|0|||
125003285|NCT00975715|449640712|FG000|Maintenance Period|Adverse Event|2|||
125003286|NCT00975715|449640713|FG001|Maintenance Period|Adverse Event|1|||
125003287|NCT01674712|449640718|FG000|Overall Study|Adverse Event|5|||
125003288|NCT01674712|449640719|FG001|Overall Study|Adverse Event|6|||
125003289|NCT01674712|449640720|FG002|Overall Study|Adverse Event|3|||
125003290|NCT01674712|449640721|FG003|Overall Study|Adverse Event|4|||
125003291|NCT01674712|449640722|FG004|Overall Study|Adverse Event|6|||
125003292|NCT01674712|449640718|FG000|Overall Study|Lost to Follow-up|1|||
125003293|NCT01674712|449640719|FG001|Overall Study|Lost to Follow-up|0|||
125003294|NCT01674712|449640720|FG002|Overall Study|Lost to Follow-up|0|||
125003295|NCT01674712|449640721|FG003|Overall Study|Lost to Follow-up|0|||
125003296|NCT01674712|449640722|FG004|Overall Study|Lost to Follow-up|0|||
125003297|NCT01674712|449640718|FG000|Overall Study|Protocol Violation|2|||
125003298|NCT01674712|449640719|FG001|Overall Study|Protocol Violation|0|||
125003299|NCT01674712|449640720|FG002|Overall Study|Protocol Violation|0|||
125003300|NCT01674712|449640721|FG003|Overall Study|Protocol Violation|0|||
125003301|NCT01674712|449640722|FG004|Overall Study|Protocol Violation|0|||
125003302|NCT01674712|449640718|FG000|Overall Study|Withdrawal by Subject|2|||
125003303|NCT01674712|449640719|FG001|Overall Study|Withdrawal by Subject|2|||
125003304|NCT01674712|449640720|FG002|Overall Study|Withdrawal by Subject|5|||
125003305|NCT01674712|449640721|FG003|Overall Study|Withdrawal by Subject|4|||
125003306|NCT01674712|449640722|FG004|Overall Study|Withdrawal by Subject|3|||
125003307|NCT01674712|449640718|FG000|Overall Study|Administrative|0|||
125003308|NCT01674712|449640719|FG001|Overall Study|Administrative|1|||
125003309|NCT01674712|449640720|FG002|Overall Study|Administrative|0|||
125003310|NCT01674712|449640721|FG003|Overall Study|Administrative|0|||
125003311|NCT01674712|449640722|FG004|Overall Study|Administrative|1|||
125003312|NCT01674712|449640718|FG000|Overall Study|Lack of Efficacy|0|||
125003313|NCT01674712|449640719|FG001|Overall Study|Lack of Efficacy|0|||
125003314|NCT01674712|449640720|FG002|Overall Study|Lack of Efficacy|1|||
125003315|NCT01674712|449640721|FG003|Overall Study|Lack of Efficacy|0|||
125003316|NCT01674712|449640722|FG004|Overall Study|Lack of Efficacy|1|||
125090266|NCT01624974|449948709|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
125090267|NCT01624974|449948708|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
125090268|NCT01624974|449948709|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
125090269|NCT01624974|449948708|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
125090270|NCT01624974|449948709|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
125090271|NCT01624974|449948708|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
125090272|NCT01624974|449948709|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
125090273|NCT01624974|449948708|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
125090274|NCT01624974|449948709|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
125090275|NCT01624974|449948708|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
125090276|NCT01624974|449948709|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
125090277|NCT01624974|449948708|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
125090278|NCT01624974|449948709|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
125090279|NCT01624974|449948708|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
125090280|NCT01624974|449948709|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
125090281|NCT01624974|449948708|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
125090282|NCT01624974|449948709|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
125090283|NCT01376908|449948710|FG000|Overall Study|Protocol Violation|1|||
125090284|NCT01376908|449948711|FG001|Overall Study|Protocol Violation|1|||
125090285|NCT01376908|449948710|FG000|Overall Study|Withdrawal by Subject|1|||
125003317|NCT00874770|449640723|FG000|Overall Study|Lack of Efficacy|2|||
125003318|NCT00874770|449640724|FG001|Overall Study|Lack of Efficacy|0|||
125003319|NCT00874770|449640725|FG002|Overall Study|Lack of Efficacy|0|||
125003320|NCT00874770|449640726|FG003|Overall Study|Lack of Efficacy|2|||
125003321|NCT00874770|449640723|FG000|Overall Study|Adverse Event|1|||
125003322|NCT00874770|449640724|FG001|Overall Study|Adverse Event|1|||
125003323|NCT00874770|449640725|FG002|Overall Study|Adverse Event|4|||
125003324|NCT00874770|449640726|FG003|Overall Study|Adverse Event|2|||
125003325|NCT00874770|449640723|FG000|Overall Study|Lost to Follow-up|1|||
125003326|NCT00874770|449640724|FG001|Overall Study|Lost to Follow-up|0|||
125003327|NCT00874770|449640725|FG002|Overall Study|Lost to Follow-up|0|||
125003328|NCT00874770|449640726|FG003|Overall Study|Lost to Follow-up|1|||
125003329|NCT00874770|449640723|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
125003330|NCT00874770|449640724|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
125003331|NCT00874770|449640725|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
125003332|NCT00874770|449640726|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
125003333|NCT05395104|449640727|FG000|Overall Study|Met Liver Stopping Criteria|1|||
125003334|NCT05395104|449640727|FG000|Overall Study|Withdrawal by Subject|1|||
125003335|NCT03974334|449640728|FG000|Overall Study|Lost to Follow-up|1|||
125003336|NCT01109173|449640729|FG000|Overall Study|Adverse Event|15|||
125003337|NCT01109173|449640730|FG001|Overall Study|Adverse Event|17|||
125003338|NCT01109173|449640731|FG002|Overall Study|Adverse Event|9|||
125003339|NCT01109173|449640732|FG003|Overall Study|Adverse Event|6|||
125003340|NCT01109173|449640729|FG000|Overall Study|Lost to Follow-up|0|||
125003341|NCT01109173|449640730|FG001|Overall Study|Lost to Follow-up|1|||
125003342|NCT01109173|449640731|FG002|Overall Study|Lost to Follow-up|0|||
125003343|NCT01109173|449640732|FG003|Overall Study|Lost to Follow-up|0|||
125003344|NCT01109173|449640729|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
125003345|NCT01109173|449640730|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
125003346|NCT01109173|449640731|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
125003347|NCT01109173|449640732|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
125003348|NCT01109173|449640729|FG000|Overall Study|Noncompliance|0|||
125003349|NCT01109173|449640730|FG001|Overall Study|Noncompliance|1|||
125003350|NCT01109173|449640731|FG002|Overall Study|Noncompliance|0|||
125003351|NCT01109173|449640732|FG003|Overall Study|Noncompliance|0|||
125003352|NCT01109173|449640729|FG000|Overall Study|Treatment Failure|25|||
125003353|NCT01109173|449640730|FG001|Overall Study|Treatment Failure|32|||
125003354|NCT01109173|449640731|FG002|Overall Study|Treatment Failure|69|||
125003355|NCT01109173|449640732|FG003|Overall Study|Treatment Failure|64|||
125003356|NCT01109173|449640729|FG000|Overall Study|Protocol Violation|4|||
125003357|NCT01109173|449640730|FG001|Overall Study|Protocol Violation|5|||
125003358|NCT01109173|449640731|FG002|Overall Study|Protocol Violation|1|||
125003359|NCT01109173|449640732|FG003|Overall Study|Protocol Violation|2|||
125003360|NCT01109173|449640729|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
125003361|NCT01109173|449640730|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
125003362|NCT01109173|449640731|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
125003363|NCT01109173|449640732|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
125003364|NCT01109173|449640729|FG000|Overall Study|Not Specifiied|5|||
125003365|NCT01109173|449640730|FG001|Overall Study|Not Specifiied|4|||
125003366|NCT01109173|449640731|FG002|Overall Study|Not Specifiied|9|||
125003367|NCT01109173|449640732|FG003|Overall Study|Not Specifiied|14|||
125003368|NCT00770770|449640735|FG000|Overall Study|Lost to Follow-up|1|||
125003369|NCT00770770|449640736|FG001|Overall Study|Lost to Follow-up|0|||
125003370|NCT00770770|449640735|FG000|Overall Study|Withdrawal by Subject|1|||
125003371|NCT00770770|449640736|FG001|Overall Study|Withdrawal by Subject|0|||
125003372|NCT00770770|449640735|FG000|Overall Study|Death|0|||
125003373|NCT00770770|449640736|FG001|Overall Study|Death|1|||
125003374|NCT00770770|449640735|FG000|Overall Study|Study Terminated|8|||
125003375|NCT00770770|449640736|FG001|Overall Study|Study Terminated|0|||
125003376|NCT05372653|449640741|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
125003377|NCT05372653|449640742|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
125003378|NCT05372653|449640741|FG000|Overall Study|Adverse Event|0|||
125003379|NCT05372653|449640742|FG001|Overall Study|Adverse Event|1|||
125090286|NCT01376908|449948711|FG001|Overall Study|Withdrawal by Subject|2|||
125003380|NCT00711529|449640749|FG000|Overall Study|Protocol Violation|2|||
125003381|NCT00711529|449640750|FG001|Overall Study|Protocol Violation|0|||
125003382|NCT00711529|449640749|FG000|Overall Study|Withdrawal by Subject|2|||
125090287|NCT01468844|449948714|FG000|Overall Study|Adverse Event|1|||
125090288|NCT01468844|449948715|FG001|Overall Study|Adverse Event|0|||
125090289|NCT01468844|449948714|FG000|Overall Study|Withdrawal by Subject|1|||
125090290|NCT01468844|449948715|FG001|Overall Study|Withdrawal by Subject|0|||
125090291|NCT00266695|449948718|FG000|Overall Study|Adverse Event|1|||
125090292|NCT00266695|449948718|FG000|Overall Study|Death|9|||
125090293|NCT00266695|449948718|FG000|Overall Study|Physician Decision|1|||
125090294|NCT00266695|449948718|FG000|Overall Study|Lost to Follow-up|3|||
125090295|NCT00266695|449948718|FG000|Overall Study|Withdrawal by Subject|15|||
125090296|NCT03607994|449948719|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
125003383|NCT00711529|449640750|FG001|Overall Study|Withdrawal by Subject|6|||
125003384|NCT03681951|449640755|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
125003385|NCT03681951|449640756|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
125003386|NCT03681951|449640757|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
125003387|NCT03681951|449640758|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
125003388|NCT03681951|449640759|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
125003389|NCT03681951|449640760|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
125003390|NCT03681951|449640761|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
125003391|NCT03681951|449640762|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
125003392|NCT03681951|449640755|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
125003393|NCT03681951|449640756|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
125003394|NCT03681951|449640757|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
125003395|NCT03681951|449640758|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
125003396|NCT03681951|449640759|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
125003397|NCT03681951|449640760|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
125003398|NCT03681951|449640761|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
125003399|NCT03681951|449640762|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
125003400|NCT03681951|449640755|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
125003401|NCT03681951|449640756|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
125003402|NCT03681951|449640757|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
125003403|NCT03681951|449640758|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
125003404|NCT03681951|449640759|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
125003405|NCT03681951|449640760|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
125003406|NCT03681951|449640761|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
125003407|NCT03681951|449640762|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
125003408|NCT01020448|449640763|FG000|Pre-assignment|Adverse Event|6|||
125003409|NCT01020448|449640763|FG000|Pre-assignment|Withdrawal by Subject|5|||
125003410|NCT01020448|449640763|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
125003411|NCT01020448|449640763|FG000|Treatment|Adverse Event|11|||
125003412|NCT01020448|449640763|FG000|Treatment|Consent Withdrawn|3|||
125003413|NCT01020448|449640763|FG000|Treatment|Disease Progression|2|||
125003414|NCT01020448|449640763|FG000|Treatment|Lack of Efficacy|8|||
125003415|NCT01020448|449640763|FG000|Treatment|Lost to Follow-up|2|||
125003416|NCT01230554|449640764|FG000|Overall Study|Lost to Follow-up|2|||
125003417|NCT01230554|449640764|FG000|Overall Study|Inability to maintain visit schedule|1|||
125003418|NCT00685685|449640765|FG000|Washout Period of 7 Days|Adverse Event|2|||
125003419|NCT00685685|449640766|FG001|Washout Period of 7 Days|Adverse Event|0|||
125003420|NCT00685685|449640765|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
125003421|NCT00685685|449640766|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
125003422|NCT01660451|449640769|FG000|Overall Study|Protocol Violation|0|||
125003423|NCT01660451|449640770|FG001|Overall Study|Protocol Violation|1|||
125003424|NCT01660451|449640771|FG002|Overall Study|Protocol Violation|1|||
125003425|NCT01660451|449640769|FG000|Overall Study|AE not associated with clinical disease progression|13|||
125003426|NCT01660451|449640770|FG001|Overall Study|AE not associated with clinical disease progression|10|||
125003427|NCT01660451|449640771|FG002|Overall Study|AE not associated with clinical disease progression|40|||
125003428|NCT01660451|449640769|FG000|Overall Study|AE associated with clinical disease progression|1|||
125003429|NCT01660451|449640770|FG001|Overall Study|AE associated with clinical disease progression|3|||
125003430|NCT01660451|449640771|FG002|Overall Study|AE associated with clinical disease progression|11|||
125003431|NCT01660451|449640769|FG000|Overall Study|Sponsor Decision|0|||
125003432|NCT01660451|449640770|FG001|Overall Study|Sponsor Decision|0|||
125003433|NCT01660451|449640771|FG002|Overall Study|Sponsor Decision|1|||
125003434|NCT01660451|449640769|FG000|Overall Study|Protocol Deviation|0|||
125003435|NCT01660451|449640770|FG001|Overall Study|Protocol Deviation|0|||
125003436|NCT01660451|449640771|FG002|Overall Study|Protocol Deviation|1|||
125003437|NCT01660451|449640769|FG000|Overall Study|Physician Decision|1|||
125090297|NCT03607994|449948720|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
125090298|NCT02417935|449948721|FG000|Treatment Period|Adverse Event|12|||
125090299|NCT02417935|449948722|FG001|Treatment Period|Adverse Event|10|||
125090300|NCT02417935|449948721|FG000|Treatment Period|Lost to Follow-up|1|||
125090301|NCT02417935|449948722|FG001|Treatment Period|Lost to Follow-up|0|||
125090302|NCT02417935|449948721|FG000|Treatment Period|Entry Criteria not met|0|||
125090303|NCT02417935|449948722|FG001|Treatment Period|Entry Criteria not met|1|||
125090304|NCT02417935|449948721|FG000|Treatment Period|Protocol Violation|2|||
125090305|NCT02417935|449948722|FG001|Treatment Period|Protocol Violation|1|||
125090306|NCT02417935|449948721|FG000|Treatment Period|Withdrawal by Subject|3|||
125090307|NCT02417935|449948722|FG001|Treatment Period|Withdrawal by Subject|3|||
125090308|NCT02417935|449948721|FG000|Treatment Period|Physician Decision|3|||
125090309|NCT02417935|449948722|FG001|Treatment Period|Physician Decision|1|||
125090310|NCT02850276|449948723|FG000|Overall Study|screen failure|43|||
125090311|NCT02850276|449948723|FG000|Overall Study|Withdrawal by Subject|14|||
125090312|NCT02850276|449948723|FG000|Overall Study|Physician Decision|2|||
125090313|NCT02850276|449948723|FG000|Overall Study|Lost to Follow-up|2|||
125090314|NCT01899729|449948724|FG000|Overall Study|Adverse Event|1|||
125090315|NCT01899729|449948725|FG001|Overall Study|Adverse Event|0|||
125090316|NCT01899729|449948726|FG002|Overall Study|Adverse Event|0|||
125003438|NCT01660451|449640770|FG001|Overall Study|Physician Decision|2|||
125003439|NCT01660451|449640771|FG002|Overall Study|Physician Decision|5|||
125003440|NCT01660451|449640769|FG000|Overall Study|Withdrawal by Subject|1|||
125003441|NCT01660451|449640770|FG001|Overall Study|Withdrawal by Subject|1|||
125003442|NCT01660451|449640771|FG002|Overall Study|Withdrawal by Subject|20|||
125003443|NCT01660451|449640769|FG000|Overall Study|Trial closure.|0|||
125090317|NCT01899729|449948727|FG003|Overall Study|Adverse Event|0|||
125090318|NCT01899729|449948728|FG004|Overall Study|Adverse Event|1|||
125090319|NCT01899729|449948724|FG000|Overall Study|Withdrawal by Subject|1|||
125090320|NCT01899729|449948725|FG001|Overall Study|Withdrawal by Subject|2|||
125090321|NCT01899729|449948726|FG002|Overall Study|Withdrawal by Subject|0|||
125090322|NCT01899729|449948727|FG003|Overall Study|Withdrawal by Subject|0|||
125090323|NCT01899729|449948728|FG004|Overall Study|Withdrawal by Subject|0|||
125090324|NCT01899729|449948724|FG000|Overall Study|Lack of Efficacy|0|||
125090325|NCT01899729|449948725|FG001|Overall Study|Lack of Efficacy|0|||
125090326|NCT01899729|449948726|FG002|Overall Study|Lack of Efficacy|2|||
125090327|NCT01899729|449948727|FG003|Overall Study|Lack of Efficacy|0|||
125090328|NCT01899729|449948728|FG004|Overall Study|Lack of Efficacy|1|||
125090329|NCT01454531|449948729|FG000|Overall Study|Adverse Event|14|||
125003444|NCT01660451|449640770|FG001|Overall Study|Trial closure.|0|||
125003445|NCT01660451|449640771|FG002|Overall Study|Trial closure.|1|||
125003446|NCT01660451|449640769|FG000|Overall Study|Switching to other therapy|0|||
125003447|NCT01660451|449640770|FG001|Overall Study|Switching to other therapy|1|||
125003448|NCT01660451|449640771|FG002|Overall Study|Switching to other therapy|1|||
125003449|NCT01660451|449640769|FG000|Overall Study|Progressive disease - clinical progression|4|||
125003450|NCT01660451|449640770|FG001|Overall Study|Progressive disease - clinical progression|10|||
125003451|NCT01660451|449640771|FG002|Overall Study|Progressive disease - clinical progression|9|||
125003452|NCT01660451|449640769|FG000|Overall Study|Progressive disease - radiological progression|12|||
125003453|NCT01660451|449640770|FG001|Overall Study|Progressive disease - radiological progression|23|||
125003454|NCT01660451|449640771|FG002|Overall Study|Progressive disease - radiological progression|50|||
125003455|NCT01660451|449640769|FG000|Overall Study|Death|1|||
125003456|NCT01660451|449640770|FG001|Overall Study|Death|0|||
125003457|NCT01660451|449640771|FG002|Overall Study|Death|1|||
125003458|NCT01660451|449640769|FG000|Overall Study|Other|0|||
125003459|NCT01660451|449640770|FG001|Overall Study|Other|0|||
125003460|NCT01660451|449640771|FG002|Overall Study|Other|1|||
125003461|NCT00523718|449641831|FG000|Overall Study|Withdrawal by Subject|1|||
125003462|NCT00523718|449641832|FG001|Overall Study|Withdrawal by Subject|0|||
125003463|NCT00523718|449641831|FG000|Overall Study|Protocol Violation|2|||
125003464|NCT00523718|449641832|FG001|Overall Study|Protocol Violation|0|||
125003465|NCT02113579|449641833|FG000|Overall Study|Adverse Event|1|||
125003466|NCT02113579|449641834|FG001|Overall Study|Adverse Event|0|||
125003467|NCT02113579|449641833|FG000|Overall Study|Withdrawal by Subject|3|||
125003468|NCT02113579|449641834|FG001|Overall Study|Withdrawal by Subject|2|||
125003469|NCT02113579|449641833|FG000|Overall Study|Lost to Follow-up|6|||
125003470|NCT02113579|449641834|FG001|Overall Study|Lost to Follow-up|2|||
125003471|NCT02060383|449641835|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
125003472|NCT02060383|449641836|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
125003473|NCT02060383|449641837|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
125003474|NCT02060383|449641838|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
125003475|NCT02060383|449641839|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
125003476|NCT02060383|449641835|FG000|Core Phase|Adverse Event|2|||
125003477|NCT02060383|449641836|FG001|Core Phase|Adverse Event|0|||
125003478|NCT02060383|449641837|FG002|Core Phase|Adverse Event|0|||
125003479|NCT02060383|449641838|FG003|Core Phase|Adverse Event|2|||
125003480|NCT02060383|449641839|FG004|Core Phase|Adverse Event|6|||
125003481|NCT02060383|449641835|FG000|Core Phase|Administrative problems|0|||
125003482|NCT02060383|449641836|FG001|Core Phase|Administrative problems|1|||
125003483|NCT02060383|449641837|FG002|Core Phase|Administrative problems|0|||
125003484|NCT02060383|449641838|FG003|Core Phase|Administrative problems|0|||
125003485|NCT02060383|449641839|FG004|Core Phase|Administrative problems|0|||
125003486|NCT02060383|449641835|FG000|Core Phase|Protocol Violation|0|||
125003487|NCT02060383|449641836|FG001|Core Phase|Protocol Violation|0|||
125003488|NCT02060383|449641837|FG002|Core Phase|Protocol Violation|0|||
125003489|NCT02060383|449641838|FG003|Core Phase|Protocol Violation|1|||
125003490|NCT02060383|449641839|FG004|Core Phase|Protocol Violation|0|||
125003491|NCT02060383|449641835|FG000|Core Phase|Withdrawal by Subject|0|||
125003492|NCT02060383|449641836|FG001|Core Phase|Withdrawal by Subject|0|||
125003493|NCT02060383|449641837|FG002|Core Phase|Withdrawal by Subject|0|||
125003494|NCT02060383|449641838|FG003|Core Phase|Withdrawal by Subject|4|||
125003495|NCT02060383|449641839|FG004|Core Phase|Withdrawal by Subject|2|||
125003496|NCT02060383|449641835|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
125003497|NCT02060383|449641836|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
125003498|NCT02060383|449641837|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
125003499|NCT02060383|449641838|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
125003500|NCT02060383|449641839|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
125003501|NCT02060383|449641835|FG000|Extension Phase|Adverse Event|1|||
125003502|NCT02060383|449641836|FG001|Extension Phase|Adverse Event|1|||
125003503|NCT02060383|449641837|FG002|Extension Phase|Adverse Event|2|||
125003504|NCT02060383|449641838|FG003|Extension Phase|Adverse Event|0|||
125003505|NCT02060383|449641839|FG004|Extension Phase|Adverse Event|1|||
125003506|NCT02060383|449641835|FG000|Extension Phase|Withdrawal by Subject|0|||
125003507|NCT02060383|449641836|FG001|Extension Phase|Withdrawal by Subject|1|||
125003508|NCT02060383|449641837|FG002|Extension Phase|Withdrawal by Subject|0|||
125003509|NCT02060383|449641838|FG003|Extension Phase|Withdrawal by Subject|0|||
125003510|NCT02060383|449641839|FG004|Extension Phase|Withdrawal by Subject|2|||
125003511|NCT02060383|449641835|FG000|Extension Phase|Administrative problems|1|||
125003512|NCT02060383|449641836|FG001|Extension Phase|Administrative problems|0|||
125003513|NCT02060383|449641837|FG002|Extension Phase|Administrative problems|0|||
125003514|NCT02060383|449641838|FG003|Extension Phase|Administrative problems|0|||
125003515|NCT02060383|449641839|FG004|Extension Phase|Administrative problems|0|||
125003516|NCT02060383|449641835|FG000|Extension Phase|Death|0|||
125003517|NCT02060383|449641836|FG001|Extension Phase|Death|0|||
125003518|NCT02060383|449641837|FG002|Extension Phase|Death|1|||
125003519|NCT02060383|449641838|FG003|Extension Phase|Death|0|||
125003520|NCT02060383|449641839|FG004|Extension Phase|Death|1|||
125003521|NCT02060383|449641835|FG000|Extension Phase|Protocol Violation|0|||
125003522|NCT02060383|449641836|FG001|Extension Phase|Protocol Violation|0|||
125003523|NCT02060383|449641837|FG002|Extension Phase|Protocol Violation|0|||
125003524|NCT02060383|449641838|FG003|Extension Phase|Protocol Violation|0|||
125003525|NCT02060383|449641839|FG004|Extension Phase|Protocol Violation|1|||
125003526|NCT00332839|449641840|FG000|Core (Months 0 - 12)|Administrative problems|1|||
125003527|NCT00332839|449641841|FG001|Core (Months 0 - 12)|Administrative problems|1|||
125003528|NCT00332839|449641840|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
125003529|NCT00332839|449641841|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
125003530|NCT00332839|449641840|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
125003531|NCT00332839|449641841|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
125003532|NCT00332839|449641840|FG000|Core (Months 0 - 12)|Adverse Event|5|||
125003533|NCT00332839|449641841|FG001|Core (Months 0 - 12)|Adverse Event|15|||
125003534|NCT00332839|449641840|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
125003535|NCT00332839|449641841|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
125003536|NCT00332839|449641840|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
125003537|NCT00332839|449641841|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
125003538|NCT00332839|449641840|FG000|Follow-up (Months 12 - 60)|Death|1|||
125003539|NCT00332839|449641841|FG001|Follow-up (Months 12 - 60)|Death|1|||
125003540|NCT02020863|449641843|FG000|Overall Study|Discovery of Metastatic disease|4|||
125003541|NCT02020863|449641843|FG000|Overall Study|Team chose not to place an a line|1|||
125003542|NCT03523728|449641848|FG000|Stage 1 (24 Months)|Adverse Event|2|||
125003543|NCT03523728|449641849|FG001|Stage 1 (24 Months)|Adverse Event|2|||
125003544|NCT03523728|449641850|FG002|Stage 1 (24 Months)|Adverse Event|4|||
125003545|NCT03523728|449641851|FG003|Stage 1 (24 Months)|Adverse Event|0|||
125003546|NCT03523728|449641852|FG004|Stage 1 (24 Months)|Adverse Event|0|||
125003547|NCT03523728|449641848|FG000|Stage 1 (24 Months)|Progressive disease|0|||
125003548|NCT03523728|449641849|FG001|Stage 1 (24 Months)|Progressive disease|0|||
125003549|NCT03523728|449641850|FG002|Stage 1 (24 Months)|Progressive disease|1|||
125003550|NCT03523728|449641851|FG003|Stage 1 (24 Months)|Progressive disease|0|||
125003551|NCT03523728|449641852|FG004|Stage 1 (24 Months)|Progressive disease|0|||
125003552|NCT03523728|449641848|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
125003553|NCT03523728|449641849|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
125003554|NCT03523728|449641850|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
125003555|NCT03523728|449641851|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
125003556|NCT03523728|449641852|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
125003557|NCT03523728|449641848|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
125003558|NCT03523728|449641849|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
125003559|NCT03523728|449641850|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
125003560|NCT03523728|449641851|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
125003561|NCT03523728|449641852|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
125003562|NCT03523728|449641848|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
125003563|NCT03523728|449641849|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
125003564|NCT03523728|449641850|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
125003565|NCT03523728|449641851|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
125003566|NCT03523728|449641852|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
125003567|NCT03523728|449641848|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
125003568|NCT03523728|449641849|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
125003569|NCT03523728|449641850|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
125003570|NCT03523728|449641851|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
125003571|NCT03523728|449641852|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
125003572|NCT03523728|449641848|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
125003573|NCT03523728|449641849|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
125003574|NCT03523728|449641850|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
125003575|NCT03523728|449641851|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
125003576|NCT03523728|449641852|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
125003577|NCT03523728|449641848|FG000|Stage 2 (24 Months)|Adverse Event|0|||
125090330|NCT01454531|449948729|FG000|Overall Study|Withdrawal by Subject|5|||
125090331|NCT01454531|449948729|FG000|Overall Study|Lost to Follow-up|1|||
125090332|NCT01454531|449948729|FG000|Overall Study|Physician Decision|1|||
125090333|NCT01454531|449948729|FG000|Overall Study|Delay in IMP administration|1|||
125090334|NCT01454531|449948729|FG000|Overall Study|Other|1|||
125090335|NCT00252499|449948740|FG000|Overall Study|Lost to Follow-up|1|||
125090336|NCT00252499|449948741|FG001|Overall Study|Lost to Follow-up|0|||
125090337|NCT00252499|449948742|FG002|Overall Study|Lost to Follow-up|0|||
125090338|NCT04490499|449948743|FG000|Overall Study|Withdrawal by Subject|2|||
125090339|NCT02646332|449948744|FG000|Overall Study|Lost to Follow-up|0|||
125090340|NCT02646332|449948745|FG001|Overall Study|Lost to Follow-up|3|||
125090341|NCT01882439|449948748|FG000|Overall Study|Adverse event related to study drug|3|||
125090342|NCT01882439|449948749|FG001|Overall Study|Adverse event related to study drug|8|||
125090343|NCT01882439|449948750|FG002|Overall Study|Adverse event related to study drug|1|||
125090344|NCT01882439|449948751|FG003|Overall Study|Adverse event related to study drug|2|||
125090345|NCT01882439|449948748|FG000|Overall Study|Pregnancy|0|||
125090346|NCT01882439|449948749|FG001|Overall Study|Pregnancy|1|||
125090347|NCT01882439|449948750|FG002|Overall Study|Pregnancy|0|||
125090348|NCT01882439|449948751|FG003|Overall Study|Pregnancy|0|||
125090349|NCT01882439|449948748|FG000|Overall Study|Protocol Violation|2|||
125090350|NCT01882439|449948749|FG001|Overall Study|Protocol Violation|2|||
125090351|NCT01882439|449948750|FG002|Overall Study|Protocol Violation|0|||
125090352|NCT01882439|449948751|FG003|Overall Study|Protocol Violation|1|||
125090353|NCT01882439|449948748|FG000|Overall Study|No longer willing to participate|1|||
125090354|NCT01882439|449948749|FG001|Overall Study|No longer willing to participate|4|||
125090355|NCT01882439|449948750|FG002|Overall Study|No longer willing to participate|2|||
125090356|NCT01882439|449948751|FG003|Overall Study|No longer willing to participate|3|||
125090357|NCT01882439|449948748|FG000|Overall Study|Medication error with no associated AE|0|||
125090358|NCT01882439|449948749|FG001|Overall Study|Medication error with no associated AE|0|||
125090359|NCT01882439|449948750|FG002|Overall Study|Medication error with no associated AE|2|||
125090360|NCT01882439|449948751|FG003|Overall Study|Medication error with no associated AE|0|||
125090361|NCT01882439|449948748|FG000|Overall Study|Insufficient clinical response|1|||
125090362|NCT01882439|449948749|FG001|Overall Study|Insufficient clinical response|4|||
125090363|NCT01882439|449948750|FG002|Overall Study|Insufficient clinical response|4|||
125090364|NCT01882439|449948751|FG003|Overall Study|Insufficient clinical response|2|||
125090365|NCT01882439|449948748|FG000|Overall Study|Adverse event unrelated to study drug|2|||
125090366|NCT01882439|449948749|FG001|Overall Study|Adverse event unrelated to study drug|2|||
125090367|NCT01882439|449948750|FG002|Overall Study|Adverse event unrelated to study drug|1|||
125090368|NCT01882439|449948751|FG003|Overall Study|Adverse event unrelated to study drug|1|||
125090369|NCT03125902|449948754|FG000|Overall Study|Adverse Event|0|||
125090370|NCT03125902|449948755|FG001|Overall Study|Adverse Event|1|||
125090371|NCT03125902|449948754|FG000|Overall Study|Death|119|||
125090372|NCT03125902|449948755|FG001|Overall Study|Death|229|||
125090373|NCT03125902|449948754|FG000|Overall Study|Lost to Follow-up|4|||
125090374|NCT03125902|449948755|FG001|Overall Study|Lost to Follow-up|13|||
125090375|NCT03125902|449948754|FG000|Overall Study|Other|0|||
125090376|NCT03125902|449948755|FG001|Overall Study|Other|4|||
125090377|NCT03125902|449948754|FG000|Overall Study|Physician Decision|2|||
125090378|NCT03125902|449948755|FG001|Overall Study|Physician Decision|1|||
125090379|NCT03125902|449948754|FG000|Overall Study|Progressive Disease|0|||
125090380|NCT03125902|449948755|FG001|Overall Study|Progressive Disease|3|||
125090381|NCT03125902|449948754|FG000|Overall Study|Study Terminated By Sponsor|74|||
125090382|NCT03125902|449948755|FG001|Overall Study|Study Terminated By Sponsor|143|||
125090383|NCT03125902|449948754|FG000|Overall Study|Withdrawal by Subject|21|||
125090384|NCT03125902|449948755|FG001|Overall Study|Withdrawal by Subject|37|||
125090385|NCT02269709|449948756|FG000|Time of Enrollment|Withdrawal by Subject|3|||
125090386|NCT02269709|449948756|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
125090387|NCT02269709|449948756|FG000|Six Month Follow-up|Lost to Follow-up|12|||
125003578|NCT03523728|449641849|FG001|Stage 2 (24 Months)|Adverse Event|0|||
125003579|NCT03523728|449641850|FG002|Stage 2 (24 Months)|Adverse Event|0|||
125003580|NCT03523728|449641851|FG003|Stage 2 (24 Months)|Adverse Event|1|||
125003581|NCT03523728|449641852|FG004|Stage 2 (24 Months)|Adverse Event|2|||
125003582|NCT03523728|449641848|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
125003583|NCT03523728|449641849|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
125003584|NCT03523728|449641850|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
125003585|NCT03523728|449641851|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
125003586|NCT03523728|449641852|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
125003587|NCT03523728|449641848|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
125003588|NCT03523728|449641849|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
125003589|NCT03523728|449641850|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
125003590|NCT03523728|449641851|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
125003591|NCT03523728|449641852|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
125003592|NCT03523728|449641848|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
125003593|NCT03523728|449641849|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
125003594|NCT03523728|449641850|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
125003595|NCT03523728|449641851|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
125003596|NCT03523728|449641852|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
125003597|NCT03523728|449641848|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
125003598|NCT03523728|449641849|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
125003599|NCT03523728|449641850|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
125003600|NCT03523728|449641851|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
125003601|NCT03523728|449641852|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
125003602|NCT00621751|449641853|FG000|Overall Study|Adverse Event|0|||
125003603|NCT00621751|449641854|FG001|Overall Study|Adverse Event|1|||
125003604|NCT01950247|449641856|FG000|Overall Study|Withdrawal by Subject|28|||
125003605|NCT01950247|449641857|FG001|Overall Study|Withdrawal by Subject|13|||
125003606|NCT01950247|449641856|FG000|Overall Study|Lost to Follow-up|18|||
125003607|NCT01950247|449641857|FG001|Overall Study|Lost to Follow-up|16|||
125003608|NCT01950247|449641856|FG000|Overall Study|Physician Decision|3|||
125003609|NCT01950247|449641857|FG001|Overall Study|Physician Decision|4|||
125003610|NCT01950247|449641856|FG000|Overall Study|Adverse Event|3|||
125003611|NCT01950247|449641857|FG001|Overall Study|Adverse Event|2|||
125003612|NCT01950247|449641856|FG000|Overall Study|Death|1|||
125003613|NCT01950247|449641857|FG001|Overall Study|Death|1|||
125003614|NCT01950247|449641856|FG000|Overall Study|Not Defined|4|||
125003615|NCT01950247|449641857|FG001|Overall Study|Not Defined|10|||
125003616|NCT00710879|449641860|FG000|Overall Study|Lost to Follow-up|2|||
125003617|NCT00710879|449641861|FG001|Overall Study|Lost to Follow-up|1|||
125003618|NCT00710879|449641860|FG000|Overall Study|Protocol Violation|0|||
125003619|NCT00710879|449641861|FG001|Overall Study|Protocol Violation|3|||
125003620|NCT01809132|449641862|FG000|Overall Study|Withdrawal by Subject|0|||
125003621|NCT01809132|449641863|FG001|Overall Study|Withdrawal by Subject|0|||
125003622|NCT01809132|449641864|FG002|Overall Study|Withdrawal by Subject|1|||
125003623|NCT00434421|449641865|FG000|Overall Study|Withdrawal by Subject|1|||
125003624|NCT00434421|449641865|FG000|Overall Study|Non-compliance with study treatment|1|||
125003625|NCT01688466|449641866|FG000|Overall Study|Withdrawal by Subject|2|||
125003626|NCT01688466|449641867|FG001|Overall Study|Withdrawal by Subject|1|||
125003627|NCT01688466|449641866|FG000|Overall Study|Death|0|||
125003628|NCT01688466|449641867|FG001|Overall Study|Death|1|||
125003629|NCT01688466|449641866|FG000|Overall Study|Adverse Event|0|||
125003630|NCT01688466|449641867|FG001|Overall Study|Adverse Event|4|||
125003631|NCT01688466|449641866|FG000|Overall Study|Not evaluable|0|||
125003632|NCT01688466|449641867|FG001|Overall Study|Not evaluable|1|||
125003633|NCT01205438|449641868|FG000|Overall Study|Adverse Event|19|||
125003634|NCT01205438|449641869|FG001|Overall Study|Adverse Event|17|||
125003635|NCT01205438|449641870|FG002|Overall Study|Adverse Event|24|||
125003636|NCT01205438|449641868|FG000|Overall Study|Death|1|||
125003637|NCT01205438|449641869|FG001|Overall Study|Death|1|||
125003638|NCT01205438|449641870|FG002|Overall Study|Death|3|||
125003639|NCT01205438|449641868|FG000|Overall Study|Entry Criteria Not Met|16|||
125003640|NCT01205438|449641869|FG001|Overall Study|Entry Criteria Not Met|15|||
125003641|NCT01205438|449641870|FG002|Overall Study|Entry Criteria Not Met|13|||
125003642|NCT01205438|449641868|FG000|Overall Study|Lack of Efficacy|14|||
125003643|NCT01205438|449641869|FG001|Overall Study|Lack of Efficacy|11|||
125003644|NCT01205438|449641870|FG002|Overall Study|Lack of Efficacy|14|||
125003645|NCT01205438|449641868|FG000|Overall Study|Lost to Follow-up|6|||
125003646|NCT01205438|449641869|FG001|Overall Study|Lost to Follow-up|7|||
125003647|NCT01205438|449641870|FG002|Overall Study|Lost to Follow-up|8|||
125003648|NCT01205438|449641868|FG000|Overall Study|Withdrawal by Subject|19|||
125003649|NCT01205438|449641869|FG001|Overall Study|Withdrawal by Subject|25|||
125003650|NCT01205438|449641870|FG002|Overall Study|Withdrawal by Subject|19|||
125003651|NCT01205438|449641868|FG000|Overall Study|Physician Decision|0|||
125003652|NCT01205438|449641869|FG001|Overall Study|Physician Decision|3|||
125003653|NCT01205438|449641870|FG002|Overall Study|Physician Decision|2|||
125003654|NCT01205438|449641868|FG000|Overall Study|Protocol Violation|2|||
125003655|NCT01205438|449641869|FG001|Overall Study|Protocol Violation|7|||
125003656|NCT01205438|449641870|FG002|Overall Study|Protocol Violation|4|||
125003657|NCT01205438|449641868|FG000|Overall Study|Sponsor Decision|0|||
125003658|NCT01205438|449641869|FG001|Overall Study|Sponsor Decision|1|||
125003659|NCT01205438|449641870|FG002|Overall Study|Sponsor Decision|1|||
125003660|NCT04029116|449641875|FG000|Overall Study|Adverse Event|0|||
125003661|NCT04029116|449641876|FG001|Overall Study|Adverse Event|2|||
125003662|NCT04029116|449641875|FG000|Overall Study|Lost to Follow-up|3|||
125003663|NCT04029116|449641876|FG001|Overall Study|Lost to Follow-up|5|||
125003664|NCT04029116|449641875|FG000|Overall Study|Physician Decision|2|||
125003665|NCT04029116|449641876|FG001|Overall Study|Physician Decision|0|||
125003666|NCT04029116|449641875|FG000|Overall Study|Pregnancy|1|||
125003667|NCT04029116|449641876|FG001|Overall Study|Pregnancy|2|||
125003668|NCT04029116|449641875|FG000|Overall Study|Withdrawal by Subject|4|||
125003669|NCT04029116|449641876|FG001|Overall Study|Withdrawal by Subject|6|||
125003670|NCT04029116|449641875|FG000|Overall Study|Other|2|||
125003671|NCT04029116|449641876|FG001|Overall Study|Other|1|||
125003672|NCT01514136|449641880|FG000|Test Period 1; Test A|Protocol Violation|1|||
125003673|NCT01514136|449641881|FG001|Test Period 1; Test A|Protocol Violation|0|||
125003674|NCT01514136|449641882|FG002|Test Period 1; Test A|Protocol Violation|0|||
125003675|NCT01514136|449641883|FG003|Test Period 1; Test A|Protocol Violation|0|||
125003676|NCT01514136|449641884|FG004|Test Period 1; Test A|Protocol Violation|0|||
125003677|NCT01514136|449641885|FG005|Test Period 1; Test A|Protocol Violation|0|||
125003678|NCT01514136|449641886|FG006|Test Period 1; Test A|Protocol Violation|0|||
125003679|NCT01514136|449641887|FG007|Test Period 1; Test A|Protocol Violation|0|||
125003680|NCT01514136|449641880|FG000|Test Period 1; Test A|Break from study holiday|2|||
125003681|NCT01514136|449641881|FG001|Test Period 1; Test A|Break from study holiday|0|||
125003682|NCT01514136|449641882|FG002|Test Period 1; Test A|Break from study holiday|0|||
125003683|NCT01514136|449641883|FG003|Test Period 1; Test A|Break from study holiday|0|||
125003684|NCT01514136|449641884|FG004|Test Period 1; Test A|Break from study holiday|0|||
125003685|NCT01514136|449641885|FG005|Test Period 1; Test A|Break from study holiday|0|||
125003686|NCT01514136|449641886|FG006|Test Period 1; Test A|Break from study holiday|0|||
125003687|NCT01514136|449641887|FG007|Test Period 1; Test A|Break from study holiday|0|||
125003688|NCT01514136|449641880|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
125003689|NCT01514136|449641881|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
125003690|NCT01514136|449641882|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
125003691|NCT01514136|449641883|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
125003692|NCT01514136|449641884|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
125003693|NCT01514136|449641885|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
125003694|NCT01514136|449641886|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
125003695|NCT01514136|449641887|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
125003696|NCT01514136|449641880|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
125003697|NCT01514136|449641881|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
125003698|NCT01514136|449641882|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
125003699|NCT01514136|449641883|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
125003700|NCT01514136|449641884|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
125003701|NCT01514136|449641885|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
125003702|NCT01514136|449641886|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
125003703|NCT01514136|449641887|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
125003704|NCT01514136|449641880|FG000|Test Period 2; Test A*|Adverse Event|0|||
125003705|NCT01514136|449641881|FG001|Test Period 2; Test A*|Adverse Event|0|||
125003706|NCT01514136|449641882|FG002|Test Period 2; Test A*|Adverse Event|0|||
125003707|NCT01514136|449641883|FG003|Test Period 2; Test A*|Adverse Event|0|||
125003708|NCT01514136|449641884|FG004|Test Period 2; Test A*|Adverse Event|1|||
125003709|NCT01514136|449641885|FG005|Test Period 2; Test A*|Adverse Event|0|||
125003710|NCT01514136|449641886|FG006|Test Period 2; Test A*|Adverse Event|0|||
125003711|NCT01514136|449641887|FG007|Test Period 2; Test A*|Adverse Event|0|||
125003712|NCT01514136|449641880|FG000|Test Period 2; Test A*|Holiday|0|||
125003713|NCT01514136|449641881|FG001|Test Period 2; Test A*|Holiday|0|||
125003714|NCT01514136|449641882|FG002|Test Period 2; Test A*|Holiday|0|||
125003715|NCT01514136|449641883|FG003|Test Period 2; Test A*|Holiday|0|||
125090388|NCT02504424|449948757|FG000|Overall Study|Withdrawal by Subject|2|||
125003716|NCT01514136|449641884|FG004|Test Period 2; Test A*|Holiday|1|||
125003717|NCT01514136|449641885|FG005|Test Period 2; Test A*|Holiday|0|||
125003718|NCT01514136|449641886|FG006|Test Period 2; Test A*|Holiday|0|||
125003719|NCT01514136|449641887|FG007|Test Period 2; Test A*|Holiday|0|||
125003720|NCT01514136|449641880|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
125003721|NCT01514136|449641881|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
125003722|NCT01514136|449641882|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
125003723|NCT01514136|449641883|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
125003724|NCT01514136|449641884|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
125003725|NCT01514136|449641885|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
125003726|NCT01514136|449641886|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
125003727|NCT01514136|449641887|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
125003728|NCT01514136|449641880|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
125003729|NCT01514136|449641881|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
125003730|NCT01514136|449641882|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
125003731|NCT01514136|449641883|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
125003732|NCT01514136|449641884|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
125003733|NCT01514136|449641885|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
125003734|NCT01514136|449641886|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
125003735|NCT01514136|449641887|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
125003736|NCT01514136|449641880|FG000|Test Period 2; Test C*|holiday|0|||
125003737|NCT01514136|449641881|FG001|Test Period 2; Test C*|holiday|0|||
125003738|NCT01514136|449641882|FG002|Test Period 2; Test C*|holiday|0|||
125003739|NCT01514136|449641883|FG003|Test Period 2; Test C*|holiday|0|||
125003740|NCT01514136|449641884|FG004|Test Period 2; Test C*|holiday|0|||
125003741|NCT01514136|449641885|FG005|Test Period 2; Test C*|holiday|0|||
125003742|NCT01514136|449641886|FG006|Test Period 2; Test C*|holiday|1|||
125003743|NCT01514136|449641887|FG007|Test Period 2; Test C*|holiday|0|||
125003744|NCT01514136|449641880|FG000|Test Period 2; Test C*|Protocol Violation|0|||
125003745|NCT01514136|449641881|FG001|Test Period 2; Test C*|Protocol Violation|0|||
125003746|NCT01514136|449641882|FG002|Test Period 2; Test C*|Protocol Violation|0|||
125003747|NCT01514136|449641883|FG003|Test Period 2; Test C*|Protocol Violation|0|||
125003748|NCT01514136|449641884|FG004|Test Period 2; Test C*|Protocol Violation|0|||
125003749|NCT01514136|449641885|FG005|Test Period 2; Test C*|Protocol Violation|0|||
125003750|NCT01514136|449641886|FG006|Test Period 2; Test C*|Protocol Violation|1|||
125003751|NCT01514136|449641887|FG007|Test Period 2; Test C*|Protocol Violation|0|||
125003752|NCT02941926|449641888|FG000|Core Phase|Progressive disease|1109|||
125003753|NCT02941926|449641888|FG000|Core Phase|Adverse Event|504|||
125003754|NCT02941926|449641888|FG000|Core Phase|Subject/guardian decision|127|||
125003755|NCT02941926|449641888|FG000|Core Phase|Physician Decision|112|||
125003756|NCT02941926|449641888|FG000|Core Phase|Death|46|||
125003757|NCT02941926|449641888|FG000|Core Phase|Protocol deviation|34|||
125003758|NCT02941926|449641888|FG000|Core Phase|Lost to Follow-up|8|||
125003759|NCT02941926|449641888|FG000|Core Phase|Technical problems|5|||
125003760|NCT02941926|449641888|FG000|Extension Phase|Physician Decision|155|||
125003761|NCT02941926|449641888|FG000|Extension Phase|Progressive disease|115|||
125003762|NCT02941926|449641888|FG000|Extension Phase|Adverse Event|13|||
125003763|NCT02941926|449641888|FG000|Extension Phase|Subject/Guardian decision|12|||
125003764|NCT02941926|449641888|FG000|Extension Phase|Death|6|||
125003765|NCT02729740|449641889|FG000|Overall Study|Early Termination|130|||
125003766|NCT02729740|449641889|FG000|Overall Study|Other|1|||
125003767|NCT00307333|449641890|FG000|Overall Study|Lost to Follow-up|11|||
125003768|NCT00307333|449641891|FG001|Overall Study|Lost to Follow-up|3|||
125003769|NCT00601705|449641895|FG000|Overall Study|Withdrawal by Subject|1|||
125003770|NCT04513665|449641896|FG000|Overall Study|Adverse Event|2|||
125003771|NCT04513665|449641897|FG001|Overall Study|Adverse Event|0|||
125003772|NCT04513665|449641896|FG000|Overall Study|Lack of Efficacy|14|||
125090389|NCT00440232|449948760|FG000|Overall Study|Lost to Follow-up|1|||
125090390|NCT00440232|449948761|FG001|Overall Study|Lost to Follow-up|1|||
125090391|NCT00440232|449948760|FG000|Overall Study|Unable to treat within allowed time|0|||
125090392|NCT00440232|449948761|FG001|Overall Study|Unable to treat within allowed time|1|||
125090393|NCT00440232|449948760|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
125090394|NCT00440232|449948761|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
125090395|NCT00362297|449948762|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
125090396|NCT00362297|449948763|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
125090397|NCT00426842|449948764|FG000|Overall Study|Lost to Follow-up|1|||
125090398|NCT01070381|449948765|FG000|Period 2, 1 Week of Wear|Handling|0|||
125090399|NCT01070381|449948766|FG001|Period 2, 1 Week of Wear|Handling|1|||
125090400|NCT01070381|449948765|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
125090401|NCT01070381|449948766|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
125090402|NCT03512028|449948768|FG000|Overall Study|Withdrawal by Subject|2|||
125090403|NCT03512028|449948769|FG001|Overall Study|Withdrawal by Subject|0|||
125090404|NCT03512028|449948768|FG000|Overall Study|Protocol Violation|2|||
125090405|NCT03512028|449948769|FG001|Overall Study|Protocol Violation|0|||
125090406|NCT01259388|449948772|FG000|Overall Study|Adverse Event|3|||
125090407|NCT01259388|449948773|FG001|Overall Study|Adverse Event|0|||
125090408|NCT01259388|449948772|FG000|Overall Study|Withdrawal by Subject|1|||
125090409|NCT01259388|449948773|FG001|Overall Study|Withdrawal by Subject|1|||
125090410|NCT01259388|449948772|FG000|Overall Study|Physician Decision|1|||
125090411|NCT01259388|449948773|FG001|Overall Study|Physician Decision|0|||
125090412|NCT02743494|449948774|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
125090413|NCT02743494|449948775|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
125090414|NCT02743494|449948774|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
125090415|NCT02743494|449948775|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
125090416|NCT02743494|449948774|FG000|Treatment Period|Completed treatment|229|||
125090417|NCT02743494|449948775|FG001|Treatment Period|Completed treatment|99|||
125090418|NCT02743494|449948774|FG000|Treatment Period|Disease recurrence|149|||
125003773|NCT04513665|449641897|FG001|Overall Study|Lack of Efficacy|0|||
125003774|NCT02608879|449641914|FG000|Overall Study|Lost to Follow-up|1|||
125003775|NCT02608879|449641915|FG001|Overall Study|Lost to Follow-up|0|||
125003776|NCT02608879|449641916|FG002|Overall Study|Lost to Follow-up|0|||
125003777|NCT02608879|449641914|FG000|Overall Study|Did not meet continuation criteria|0|||
125003778|NCT02608879|449641915|FG001|Overall Study|Did not meet continuation criteria|0|||
125003779|NCT02608879|449641916|FG002|Overall Study|Did not meet continuation criteria|3|||
125003780|NCT00760669|449641917|FG000|Overall Study|Not assessed for overall improvement|18|||
125003781|NCT00760669|449641917|FG000|Overall Study|Participants missing efficacy assessment|6|||
125003782|NCT00760669|449641917|FG000|Overall Study|Participants with overlapping cases|1|||
125003783|NCT00760669|449641917|FG000|Overall Study|Took drug before entering in contract|5|||
125003784|NCT01572675|449641918|FG000|Overall Study|End of prescribed treatment|140|||
125003785|NCT01572675|449641919|FG001|Overall Study|End of prescribed treatment|118|||
125003786|NCT01572675|449641918|FG000|Overall Study|Recovery|16|||
125003787|NCT01572675|449641919|FG001|Overall Study|Recovery|23|||
125003788|NCT01572675|449641918|FG000|Overall Study|Lack of Efficacy|31|||
125003789|NCT01572675|449641919|FG001|Overall Study|Lack of Efficacy|31|||
125003790|NCT01572675|449641918|FG000|Overall Study|Intolerance|6|||
125003791|NCT01572675|449641919|FG001|Overall Study|Intolerance|5|||
125090419|NCT02743494|449948775|FG001|Treatment Period|Disease recurrence|113|||
125090420|NCT02743494|449948774|FG000|Treatment Period|Study drug toxicity|57|||
125090421|NCT02743494|449948775|FG001|Treatment Period|Study drug toxicity|8|||
125003792|NCT01572675|449641918|FG000|Overall Study|Improved symptoms|8|||
125003793|NCT01572675|449641919|FG001|Overall Study|Improved symptoms|2|||
125003794|NCT01572675|449641918|FG000|Overall Study|Surgical intervention|3|||
125003795|NCT01572675|449641919|FG001|Overall Study|Surgical intervention|6|||
125090422|NCT02743494|449948774|FG000|Treatment Period|Death|1|||
125090423|NCT02743494|449948775|FG001|Treatment Period|Death|0|||
125003796|NCT01572675|449641918|FG000|Overall Study|Withdrawal by Subject|5|||
125003797|NCT01572675|449641919|FG001|Overall Study|Withdrawal by Subject|1|||
125003798|NCT01572675|449641918|FG000|Overall Study|Physician Decision|2|||
125003799|NCT01572675|449641919|FG001|Overall Study|Physician Decision|2|||
125003800|NCT01572675|449641918|FG000|Overall Study|Death unrelated to coxibs|1|||
125003801|NCT01572675|449641919|FG001|Overall Study|Death unrelated to coxibs|1|||
125003802|NCT01572675|449641918|FG000|Overall Study|Other disease detected|1|||
125003803|NCT01572675|449641919|FG001|Overall Study|Other disease detected|1|||
125003804|NCT01572675|449641918|FG000|Overall Study|Unknown reason|1|||
125003805|NCT01572675|449641919|FG001|Overall Study|Unknown reason|1|||
125003806|NCT01572675|449641918|FG000|Overall Study|Rheumatologist new evaluation|0|||
125003807|NCT01572675|449641919|FG001|Overall Study|Rheumatologist new evaluation|1|||
125003808|NCT01572675|449641918|FG000|Overall Study|Missing data|1|||
125003809|NCT01572675|449641919|FG001|Overall Study|Missing data|4|||
125003810|NCT01572675|449641918|FG000|Overall Study|Lost to Follow-up|22|||
125003811|NCT01572675|449641919|FG001|Overall Study|Lost to Follow-up|27|||
125003812|NCT03346057|449641923|FG000|Overall Study|Death|1|||
125003813|NCT03346057|449641924|FG001|Overall Study|Death|2|||
125003814|NCT03346057|449641925|FG002|Overall Study|Death|0|||
125003815|NCT03346057|449641926|FG003|Overall Study|Death|0|||
125003816|NCT03346057|449641923|FG000|Overall Study|Lost to Follow-up|0|||
125003817|NCT03346057|449641924|FG001|Overall Study|Lost to Follow-up|2|||
125003818|NCT03346057|449641925|FG002|Overall Study|Lost to Follow-up|1|||
125003819|NCT03346057|449641926|FG003|Overall Study|Lost to Follow-up|0|||
125003820|NCT03346057|449641923|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
125003821|NCT03346057|449641924|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
125003822|NCT03346057|449641925|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
125003823|NCT03346057|449641926|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
125003824|NCT03346057|449641923|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
125003825|NCT03346057|449641924|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
125003826|NCT03346057|449641925|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
125003827|NCT03346057|449641926|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
125003828|NCT03346057|449641923|FG000|Overall Study|Physician Decision|3|||
125003829|NCT03346057|449641924|FG001|Overall Study|Physician Decision|2|||
125003830|NCT03346057|449641925|FG002|Overall Study|Physician Decision|0|||
125003831|NCT03346057|449641926|FG003|Overall Study|Physician Decision|2|||
125003832|NCT03346057|449641923|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
125003833|NCT03346057|449641924|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
125003834|NCT03346057|449641925|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
125003835|NCT03346057|449641926|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
125003836|NCT03346057|449641923|FG000|Overall Study|Withdrawal by Subject|1|||
125003837|NCT03346057|449641924|FG001|Overall Study|Withdrawal by Subject|0|||
125003838|NCT03346057|449641925|FG002|Overall Study|Withdrawal by Subject|0|||
125003839|NCT03346057|449641926|FG003|Overall Study|Withdrawal by Subject|0|||
125003840|NCT02966223|449641927|FG000|Overall Study|Physician Decision|3|||
125003841|NCT02966223|449641927|FG000|Overall Study|Withdrawal by Subject|11|||
125003842|NCT02966223|449641927|FG000|Overall Study|Lost to Follow-up|1|||
125003843|NCT02003014|449641928|FG000|Overall Study|Case report forms uncollected|9|||
125003844|NCT02003014|449641928|FG000|Overall Study|Treatment started after contract period|1|||
125003845|NCT02003014|449641928|FG000|Overall Study|Patient did not visit the study site|5|||
125003846|NCT02003014|449641928|FG000|Overall Study|Investigator's transfer|4|||
125003847|NCT01159912|449641929|FG000|Overall Study|Adverse Event|2|||
125003848|NCT01159912|449641930|FG001|Overall Study|Adverse Event|2|||
125003849|NCT01159912|449641931|FG002|Overall Study|Adverse Event|3|||
125003850|NCT01159912|449641929|FG000|Overall Study|Lack of Efficacy|23|||
125003851|NCT01159912|449641930|FG001|Overall Study|Lack of Efficacy|15|||
125003852|NCT01159912|449641931|FG002|Overall Study|Lack of Efficacy|14|||
125003853|NCT01159912|449641929|FG000|Overall Study|Protocol Violation|1|||
125003854|NCT01159912|449641930|FG001|Overall Study|Protocol Violation|2|||
125003855|NCT01159912|449641931|FG002|Overall Study|Protocol Violation|3|||
125003856|NCT01159912|449641929|FG000|Overall Study|Lost to Follow-up|4|||
125003857|NCT01159912|449641930|FG001|Overall Study|Lost to Follow-up|0|||
125003858|NCT01159912|449641931|FG002|Overall Study|Lost to Follow-up|0|||
125003859|NCT01159912|449641929|FG000|Overall Study|Physician Decision|0|||
125003860|NCT01159912|449641930|FG001|Overall Study|Physician Decision|0|||
125003861|NCT01159912|449641931|FG002|Overall Study|Physician Decision|3|||
125003862|NCT01159912|449641929|FG000|Overall Study|Withdrawal by Subject|10|||
125003863|NCT01159912|449641930|FG001|Overall Study|Withdrawal by Subject|3|||
125003864|NCT01159912|449641931|FG002|Overall Study|Withdrawal by Subject|3|||
125003865|NCT02456662|449641933|FG000|Overall Study|Lost to Follow-up|2|||
125003866|NCT02456662|449641934|FG001|Overall Study|Lost to Follow-up|1|||
125003867|NCT00805025|449641936|FG000|Overall Study|Screened but not enrolled/treated|42|||
125003868|NCT00805025|449641936|FG000|Overall Study|Adverse Event|4|||
125003869|NCT00805025|449641936|FG000|Overall Study|Withdrawal by Subject|2|||
125003870|NCT00805025|449641936|FG000|Overall Study|Physician Decision|1|||
125003871|NCT00375219|449641939|FG000|Overall Study|Failure to achieve a response|16|||
125003872|NCT00375219|449641940|FG001|Overall Study|Failure to achieve a response|2|||
125003873|NCT00375219|449641941|FG002|Overall Study|Failure to achieve a response|0|||
125003874|NCT00375219|449641939|FG000|Overall Study|Adverse Event|8|||
125003875|NCT00375219|449641940|FG001|Overall Study|Adverse Event|2|||
125003876|NCT00375219|449641941|FG002|Overall Study|Adverse Event|1|||
125003877|NCT00375219|449641939|FG000|Overall Study|Protocol Violation|1|||
125003878|NCT00375219|449641940|FG001|Overall Study|Protocol Violation|0|||
125003879|NCT00375219|449641941|FG002|Overall Study|Protocol Violation|1|||
125003880|NCT00375219|449641939|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
125003881|NCT00375219|449641940|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
125003882|NCT00375219|449641941|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
125003883|NCT00375219|449641939|FG000|Overall Study|Lost to Follow-up|1|||
125003884|NCT00375219|449641940|FG001|Overall Study|Lost to Follow-up|1|||
125003885|NCT00375219|449641941|FG002|Overall Study|Lost to Follow-up|0|||
125003886|NCT00375219|449641939|FG000|Overall Study|Disease progression|18|||
125003887|NCT00375219|449641940|FG001|Overall Study|Disease progression|9|||
125003888|NCT00375219|449641941|FG002|Overall Study|Disease progression|12|||
125003889|NCT00375219|449641939|FG000|Overall Study|Death|4|||
125003890|NCT00375219|449641940|FG001|Overall Study|Death|3|||
125003891|NCT00375219|449641941|FG002|Overall Study|Death|7|||
125003892|NCT00375219|449641939|FG000|Overall Study|Hematologic resistance|1|||
125003893|NCT00375219|449641940|FG001|Overall Study|Hematologic resistance|0|||
125003894|NCT00375219|449641941|FG002|Overall Study|Hematologic resistance|0|||
125003895|NCT00375219|449641939|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
125003896|NCT00375219|449641940|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
125003897|NCT00375219|449641941|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
125003898|NCT00375219|449641939|FG000|Overall Study|Allograft|2|||
125003899|NCT00375219|449641940|FG001|Overall Study|Allograft|0|||
125003900|NCT00375219|449641941|FG002|Overall Study|Allograft|0|||
125003901|NCT00375219|449641939|FG000|Overall Study|Cord blood transplantation|1|||
125003902|NCT00375219|449641940|FG001|Overall Study|Cord blood transplantation|0|||
125003903|NCT00375219|449641941|FG002|Overall Study|Cord blood transplantation|0|||
125003904|NCT00375219|449641939|FG000|Overall Study|Withdrawal by Subject|1|||
125003905|NCT00375219|449641940|FG001|Overall Study|Withdrawal by Subject|0|||
125003906|NCT00375219|449641941|FG002|Overall Study|Withdrawal by Subject|0|||
125003907|NCT02281357|449641942|FG000|Overall Study|Adverse Event|2|||
125003908|NCT02281357|449641943|FG001|Overall Study|Adverse Event|1|||
125003909|NCT02281357|449641942|FG000|Overall Study|Lost to Follow-up|1|||
125003910|NCT02281357|449641943|FG001|Overall Study|Lost to Follow-up|0|||
125003911|NCT02281357|449641942|FG000|Overall Study|Withdrawal by Subject|4|||
125003912|NCT02281357|449641943|FG001|Overall Study|Withdrawal by Subject|3|||
125003913|NCT03007979|449641946|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
125003914|NCT00482703|449641947|FG000|Overall Study|Poor compliance|1|||
125003915|NCT00482703|449641948|FG001|Overall Study|Poor compliance|0|||
125003916|NCT01428661|449641955|FG000|Double-Masked Phase|Protocol Violation|9|||
125003917|NCT01428661|449641956|FG001|Double-Masked Phase|Protocol Violation|4|||
125003918|NCT01428661|449641957|FG002|Double-Masked Phase|Protocol Violation|0|||
125003919|NCT01428661|449641955|FG000|Double-Masked Phase|Adverse Event|13|||
125003920|NCT01428661|449641956|FG001|Double-Masked Phase|Adverse Event|4|||
125003921|NCT01428661|449641957|FG002|Double-Masked Phase|Adverse Event|0|||
125003922|NCT01428661|449641955|FG000|Double-Masked Phase|Lost to Follow-up|14|||
125003923|NCT01428661|449641956|FG001|Double-Masked Phase|Lost to Follow-up|14|||
125003924|NCT01428661|449641957|FG002|Double-Masked Phase|Lost to Follow-up|0|||
125003925|NCT01428661|449641955|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
125003926|NCT01428661|449641956|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
125003927|NCT01428661|449641957|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
125003928|NCT01428661|449641955|FG000|Double-Masked Phase|Lack of Efficacy|2|||
125090424|NCT02743494|449948774|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
125090425|NCT02743494|449948775|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
125090426|NCT02743494|449948774|FG000|Treatment Period|Participant request to discontinue treatment|30|||
125090427|NCT02743494|449948775|FG001|Treatment Period|Participant request to discontinue treatment|5|||
125090428|NCT02743494|449948774|FG000|Treatment Period|Participant withdrew consent|12|||
125090429|NCT02743494|449948775|FG001|Treatment Period|Participant withdrew consent|4|||
125090430|NCT02743494|449948774|FG000|Treatment Period|Lost to Follow-up|0|||
125090431|NCT02743494|449948775|FG001|Treatment Period|Lost to Follow-up|1|||
125090432|NCT02743494|449948774|FG000|Treatment Period|Poor/Non-compliance|1|||
125090433|NCT02743494|449948775|FG001|Treatment Period|Poor/Non-compliance|0|||
125090434|NCT02743494|449948774|FG000|Treatment Period|Other reasons|7|||
125090435|NCT02743494|449948775|FG001|Treatment Period|Other reasons|2|||
125090436|NCT03529162|449948776|FG000|Overall Study|Lost to Follow-up|2|||
125090437|NCT03529162|449948777|FG001|Overall Study|Lost to Follow-up|2|||
125090438|NCT00983827|449948778|FG000|Overall Study|Withdrawal by Subject|1|||
125003929|NCT01428661|449641956|FG001|Double-Masked Phase|Lack of Efficacy|1|||
125003930|NCT01428661|449641957|FG002|Double-Masked Phase|Lack of Efficacy|0|||
125003931|NCT01428661|449641955|FG000|Double-Masked Phase|*Various|1|||
125003932|NCT01428661|449641956|FG001|Double-Masked Phase|*Various|6|||
125003933|NCT01428661|449641957|FG002|Double-Masked Phase|*Various|0|||
125003934|NCT01428661|449641955|FG000|Open Label Extension|Protocol Violation|0|||
125090439|NCT01521494|449948779|FG000|Overall Study|Adverse Event|1|||
125090440|NCT01521494|449948780|FG001|Overall Study|Adverse Event|2|||
125090441|NCT01521494|449948781|FG002|Overall Study|Adverse Event|9|||
125090442|NCT01521494|449948782|FG003|Overall Study|Adverse Event|6|||
125090443|NCT01521494|449948783|FG004|Overall Study|Adverse Event|2|||
125090444|NCT01521494|449948779|FG000|Overall Study|Lack of Efficacy|0|||
125090445|NCT01521494|449948780|FG001|Overall Study|Lack of Efficacy|0|||
125090446|NCT01521494|449948781|FG002|Overall Study|Lack of Efficacy|0|||
125090447|NCT01521494|449948782|FG003|Overall Study|Lack of Efficacy|0|||
125090448|NCT01521494|449948783|FG004|Overall Study|Lack of Efficacy|2|||
125090449|NCT01521494|449948779|FG000|Overall Study|Withdrawal by Subject|1|||
125090450|NCT01521494|449948780|FG001|Overall Study|Withdrawal by Subject|1|||
125090451|NCT01521494|449948781|FG002|Overall Study|Withdrawal by Subject|0|||
125090452|NCT01521494|449948782|FG003|Overall Study|Withdrawal by Subject|2|||
125090453|NCT01521494|449948783|FG004|Overall Study|Withdrawal by Subject|0|||
125090454|NCT01521494|449948779|FG000|Overall Study|Decrease in serum phosphate|0|||
125090455|NCT01521494|449948780|FG001|Overall Study|Decrease in serum phosphate|2|||
125090456|NCT01521494|449948781|FG002|Overall Study|Decrease in serum phosphate|3|||
125090457|NCT01521494|449948782|FG003|Overall Study|Decrease in serum phosphate|12|||
125090458|NCT01521494|449948783|FG004|Overall Study|Decrease in serum phosphate|0|||
125090459|NCT01521494|449948779|FG000|Overall Study|Decrease in serum calcium|0|||
125090460|NCT01521494|449948780|FG001|Overall Study|Decrease in serum calcium|0|||
125090461|NCT01521494|449948781|FG002|Overall Study|Decrease in serum calcium|0|||
125090462|NCT01521494|449948782|FG003|Overall Study|Decrease in serum calcium|1|||
125090463|NCT01521494|449948783|FG004|Overall Study|Decrease in serum calcium|1|||
125090464|NCT01521494|449948779|FG000|Overall Study|Physician Decision|0|||
125090465|NCT01521494|449948780|FG001|Overall Study|Physician Decision|0|||
125090466|NCT01521494|449948781|FG002|Overall Study|Physician Decision|0|||
125090467|NCT01521494|449948782|FG003|Overall Study|Physician Decision|0|||
125090468|NCT01521494|449948783|FG004|Overall Study|Physician Decision|2|||
125090469|NCT02728804|449948791|FG000|Overall Study|Ineligible|3|||
125090470|NCT02728804|449948791|FG000|Overall Study|Did not complete baseline questionnaire|9|||
125090471|NCT02728804|449948791|FG000|Overall Study|Death|99|||
125090472|NCT01854918|449948792|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
125090473|NCT01854918|449948793|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
125090474|NCT01854918|449948792|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
125090475|NCT01854918|449948793|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
125090476|NCT01854918|449948792|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
125090477|NCT01854918|449948793|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
125090478|NCT01854918|449948792|FG000|SOC-controlled Period (Year 1)|Death|5|||
125090479|NCT01854918|449948793|FG001|SOC-controlled Period (Year 1)|Death|5|||
125090480|NCT01854918|449948792|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
125090481|NCT01854918|449948793|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
125090482|NCT01854918|449948792|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
125090483|NCT01854918|449948793|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
125090484|NCT01854918|449948792|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
125090485|NCT01854918|449948793|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
125090486|NCT01854918|449948792|FG000|All-IP Period (Years 2 and 3)|Death|5|||
125090487|NCT01854918|449948793|FG001|All-IP Period (Years 2 and 3)|Death|16|||
125090488|NCT02146352|449948798|FG000|Overall Study|Death|1|||
125090489|NCT02146352|449948798|FG000|Overall Study|Patient entered hospice care|1|||
125090490|NCT02918006|449948799|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
125090491|NCT02918006|449948800|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
125090492|NCT02918006|449948801|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
125090493|NCT02918006|449948799|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
125090494|NCT02918006|449948800|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
125003935|NCT01428661|449641956|FG001|Open Label Extension|Protocol Violation|0|||
125003936|NCT01428661|449641957|FG002|Open Label Extension|Protocol Violation|9|||
125003937|NCT01428661|449641955|FG000|Open Label Extension|Adverse Event|0|||
125003938|NCT01428661|449641956|FG001|Open Label Extension|Adverse Event|0|||
125003939|NCT01428661|449641957|FG002|Open Label Extension|Adverse Event|15|||
125003940|NCT01428661|449641955|FG000|Open Label Extension|Lost to Follow-up|0|||
125003941|NCT01428661|449641956|FG001|Open Label Extension|Lost to Follow-up|0|||
125003942|NCT01428661|449641957|FG002|Open Label Extension|Lost to Follow-up|38|||
125003943|NCT01428661|449641955|FG000|Open Label Extension|Withdrawal by Subject|0|||
125003944|NCT01428661|449641956|FG001|Open Label Extension|Withdrawal by Subject|0|||
125003945|NCT01428661|449641957|FG002|Open Label Extension|Withdrawal by Subject|49|||
125003946|NCT01428661|449641955|FG000|Open Label Extension|Lack of Efficacy|0|||
125003947|NCT01428661|449641956|FG001|Open Label Extension|Lack of Efficacy|0|||
125003948|NCT01428661|449641957|FG002|Open Label Extension|Lack of Efficacy|24|||
125003949|NCT01428661|449641955|FG000|Open Label Extension|**Various|0|||
125003950|NCT01428661|449641956|FG001|Open Label Extension|**Various|0|||
125003951|NCT01428661|449641957|FG002|Open Label Extension|**Various|185|||
125003952|NCT00972777|449641958|FG000|Overall Study|Adverse Event|3|||
125003953|NCT00972777|449641959|FG001|Overall Study|Adverse Event|2|||
125003954|NCT00972777|449641958|FG000|Overall Study|Lost to Follow-up|0|||
125003955|NCT00972777|449641959|FG001|Overall Study|Lost to Follow-up|4|||
125003956|NCT00972777|449641958|FG000|Overall Study|Withdrawal by Subject|4|||
125003957|NCT00972777|449641959|FG001|Overall Study|Withdrawal by Subject|5|||
125003958|NCT00972777|449641958|FG000|Overall Study|Physician Decision|4|||
125003959|NCT00972777|449641959|FG001|Overall Study|Physician Decision|0|||
125003960|NCT00972777|449641958|FG000|Overall Study|Protocol Violation|0|||
125003961|NCT00972777|449641959|FG001|Overall Study|Protocol Violation|2|||
125003962|NCT00972777|449641958|FG000|Overall Study|Screening Failure|2|||
125003963|NCT00972777|449641959|FG001|Overall Study|Screening Failure|1|||
125003964|NCT00972777|449641958|FG000|Overall Study|Missed visit|1|||
125003965|NCT00972777|449641959|FG001|Overall Study|Missed visit|0|||
125003966|NCT00729378|449643545|FG000|Baseline|Did not complete study measurements|72|||
125003967|NCT00729378|449643546|FG001|Baseline|Did not complete study measurements|33|||
125003968|NCT00729378|449643545|FG000|Baseline|Withdrawal by Subject|66|||
125003969|NCT00729378|449643546|FG001|Baseline|Withdrawal by Subject|59|||
125003970|NCT00729378|449643545|FG000|12-months|Lost to Follow-up|100|||
125003971|NCT00729378|449643546|FG001|12-months|Lost to Follow-up|65|||
125003972|NCT00729378|449643545|FG000|24-months|Lost to Follow-up|72|||
125003973|NCT00729378|449643546|FG001|24-months|Lost to Follow-up|51|||
125003974|NCT00729378|449643545|FG000|36-months|Lost to Follow-up|15|||
125003975|NCT00729378|449643546|FG001|36-months|Lost to Follow-up|6|||
125003976|NCT02246582|449643549|FG000|Overall Study|Withdrawal by Subject|3|||
125003977|NCT02246582|449643550|FG001|Overall Study|Withdrawal by Subject|4|||
125003978|NCT03441334|449643552|FG000|Overall Study|Withdrawal by Subject|1|||
125003979|NCT03441334|449643553|FG001|Overall Study|Withdrawal by Subject|0|||
125003980|NCT02592551|449643556|FG000|Overall Study|Not evaluable|1|||
125003981|NCT02592551|449643557|FG001|Overall Study|Not evaluable|3|||
125090495|NCT02918006|449948801|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
125003982|NCT02592551|449643558|FG002|Overall Study|Not evaluable|0|||
125003983|NCT01876251|449643559|FG000|Overall Study|Clinical progression|1|||
125003984|NCT01876251|449643560|FG001|Overall Study|Clinical progression|0|||
125003985|NCT01876251|449643561|FG002|Overall Study|Clinical progression|0|||
125003986|NCT01876251|449643559|FG000|Overall Study|Death|2|||
125003987|NCT01876251|449643560|FG001|Overall Study|Death|0|||
125003988|NCT01876251|449643561|FG002|Overall Study|Death|1|||
125003989|NCT01876251|449643559|FG000|Overall Study|Participant started new treatment|1|||
125003990|NCT01876251|449643560|FG001|Overall Study|Participant started new treatment|0|||
125003991|NCT01876251|449643561|FG002|Overall Study|Participant started new treatment|1|||
125003992|NCT01876251|449643559|FG000|Overall Study|Participant refused further follow-up|0|||
125003993|NCT01876251|449643560|FG001|Overall Study|Participant refused further follow-up|0|||
125003994|NCT01876251|449643561|FG002|Overall Study|Participant refused further follow-up|1|||
125003995|NCT01876251|449643559|FG000|Overall Study|Study terminated|1|||
125003996|NCT01876251|449643560|FG001|Overall Study|Study terminated|0|||
125003997|NCT01876251|449643561|FG002|Overall Study|Study terminated|0|||
125003998|NCT01876251|449643559|FG000|Overall Study|Objective progression or relapse|10|||
125003999|NCT01876251|449643560|FG001|Overall Study|Objective progression or relapse|3|||
125004000|NCT01876251|449643561|FG002|Overall Study|Objective progression or relapse|8|||
125004001|NCT00268437|449643562|FG000|Overall Study|Ineligible|1|||
125004002|NCT01628107|449643566|FG000|Overall Study|Withdrawal by Subject|17|||
125004003|NCT01628107|449643566|FG000|Overall Study|Lost to Follow-up|4|||
125004004|NCT01628107|449643566|FG000|Overall Study|Adverse Event|33|||
125004005|NCT01628107|449643566|FG000|Overall Study|Physician Decision|2|||
125004006|NCT01628107|449643566|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
125004007|NCT01628107|449643566|FG000|Overall Study|Non-compliant with Study Procedures|10|||
125004008|NCT01628107|449643566|FG000|Overall Study|Not Treated|8|||
125004009|NCT01628107|449643566|FG000|Overall Study|Sponsor Decision|11|||
125004010|NCT01628107|449643566|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
125004011|NCT01628107|449643566|FG000|Overall Study|Relocated|8|||
125004012|NCT01628107|449643566|FG000|Overall Study|Kidney Transplant|9|||
125004013|NCT01628107|449643566|FG000|Overall Study|Use of Standard of Care|9|||
125004014|NCT01086410|449643567|FG000|Overall Study|Adverse Event|1|||
125004015|NCT01086410|449643568|FG001|Overall Study|Adverse Event|0|||
125004016|NCT01086410|449643569|FG002|Overall Study|Adverse Event|0|||
125004017|NCT01086410|449643570|FG003|Overall Study|Adverse Event|2|||
125004018|NCT01086410|449643567|FG000|Overall Study|Lack of Efficacy|1|||
125004019|NCT01086410|449643568|FG001|Overall Study|Lack of Efficacy|1|||
125004020|NCT01086410|449643569|FG002|Overall Study|Lack of Efficacy|0|||
125004021|NCT01086410|449643570|FG003|Overall Study|Lack of Efficacy|0|||
125004022|NCT01086410|449643567|FG000|Overall Study|Protocol Violation|1|||
125004023|NCT01086410|449643568|FG001|Overall Study|Protocol Violation|1|||
125004024|NCT01086410|449643569|FG002|Overall Study|Protocol Violation|0|||
125004025|NCT01086410|449643570|FG003|Overall Study|Protocol Violation|0|||
125004026|NCT01086410|449643567|FG000|Overall Study|Lost to Follow-up|0|||
125004027|NCT01086410|449643568|FG001|Overall Study|Lost to Follow-up|0|||
125004028|NCT01086410|449643569|FG002|Overall Study|Lost to Follow-up|1|||
125004029|NCT01086410|449643570|FG003|Overall Study|Lost to Follow-up|0|||
125004030|NCT02953639|449643571|FG000|Overall Study|Adverse Event|2|||
125004031|NCT02953639|449643572|FG001|Overall Study|Adverse Event|0|||
125004032|NCT02953639|449643573|FG002|Overall Study|Adverse Event|1|||
125004033|NCT02953639|449643571|FG000|Overall Study|Lost to Follow-up|8|||
125004034|NCT02953639|449643572|FG001|Overall Study|Lost to Follow-up|4|||
125004035|NCT02953639|449643573|FG002|Overall Study|Lost to Follow-up|3|||
125004036|NCT02953639|449643571|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125004037|NCT02953639|449643572|FG001|Overall Study|Non-Compliance With Study Drug|2|||
125004038|NCT02953639|449643573|FG002|Overall Study|Non-Compliance With Study Drug|1|||
125004039|NCT02953639|449643571|FG000|Overall Study|Multiple Reasons|1|||
125004040|NCT02953639|449643572|FG001|Overall Study|Multiple Reasons|0|||
125004041|NCT02953639|449643573|FG002|Overall Study|Multiple Reasons|1|||
125004042|NCT02953639|449643571|FG000|Overall Study|Physician Decision|1|||
125004043|NCT02953639|449643572|FG001|Overall Study|Physician Decision|0|||
125004044|NCT02953639|449643573|FG002|Overall Study|Physician Decision|0|||
125004045|NCT02953639|449643571|FG000|Overall Study|Withdrawal by Subject|7|||
125004046|NCT02953639|449643572|FG001|Overall Study|Withdrawal by Subject|8|||
125004047|NCT02953639|449643573|FG002|Overall Study|Withdrawal by Subject|10|||
125004048|NCT02953639|449643571|FG000|Overall Study|Completed or Discontinued information is missing|1|||
125004049|NCT02953639|449643572|FG001|Overall Study|Completed or Discontinued information is missing|0|||
125004050|NCT02953639|449643573|FG002|Overall Study|Completed or Discontinued information is missing|0|||
125004051|NCT04196803|449643574|FG000|Overall Study|Withdrawal by Subject|1|||
125004052|NCT04196803|449643575|FG001|Overall Study|Withdrawal by Subject|3|||
125004053|NCT04196803|449643574|FG000|Overall Study|Adverse Event|4|||
125004054|NCT04196803|449643575|FG001|Overall Study|Adverse Event|2|||
125004055|NCT04196803|449643574|FG000|Overall Study|Lost to Follow-up|0|||
125004056|NCT04196803|449643575|FG001|Overall Study|Lost to Follow-up|1|||
125004057|NCT01022996|449643576|FG000|Overall Study|Adverse Event|14|||
125090496|NCT02918006|449948799|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
125090497|NCT02918006|449948800|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
125090498|NCT02918006|449948801|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
125090499|NCT02918006|449948799|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
125090500|NCT02918006|449948800|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
125090501|NCT02918006|449948801|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
125090502|NCT02918006|449948799|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
125090503|NCT02918006|449948800|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
125090504|NCT02918006|449948801|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
125090505|NCT02918006|449948799|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
125090506|NCT02918006|449948800|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
125090507|NCT02918006|449948801|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
125090508|NCT02918006|449948799|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
125090509|NCT02918006|449948800|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
125090510|NCT02918006|449948801|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
125090511|NCT02918006|449948799|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
125090512|NCT02918006|449948800|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
125090513|NCT02918006|449948801|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
125004058|NCT01022996|449643576|FG000|Overall Study|Withdrawal by Subject|3|||
125004059|NCT01022996|449643576|FG000|Overall Study|Lost to Follow-up|1|||
125004060|NCT01022996|449643576|FG000|Overall Study|Administrative problems|6|||
125004061|NCT01022996|449643576|FG000|Overall Study|Disease Progression|32|||
125004062|NCT01022996|449643576|FG000|Overall Study|Protocol Violation|1|||
125004063|NCT03349775|449643577|FG000|Overall Study|Side Effects|1|||
125004064|NCT03349775|449643578|FG001|Overall Study|Side Effects|2|||
125004065|NCT03349775|449643577|FG000|Overall Study|Withdrawal by Subject|1|||
125004066|NCT03349775|449643578|FG001|Overall Study|Withdrawal by Subject|1|||
125004067|NCT03349775|449643577|FG000|Overall Study|No primary outcome measurements|0|||
125004068|NCT03349775|449643578|FG001|Overall Study|No primary outcome measurements|1|||
125004069|NCT01516970|449643579|FG000|Overall Study|Lost to Follow-up|7|||
125004070|NCT01516970|449643580|FG001|Overall Study|Lost to Follow-up|8|||
125004071|NCT01516970|449643579|FG000|Overall Study|Adverse Event|1|||
125004072|NCT01516970|449643580|FG001|Overall Study|Adverse Event|5|||
125004073|NCT01516970|449643579|FG000|Overall Study|Withdrawal by Subject|1|||
125004074|NCT01516970|449643580|FG001|Overall Study|Withdrawal by Subject|1|||
125004075|NCT01516970|449643579|FG000|Overall Study|Other|9|||
125004076|NCT01516970|449643580|FG001|Overall Study|Other|7|||
125004077|NCT01756040|449643581|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
125004078|NCT01756040|449643581|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
125004079|NCT01756040|449643581|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
125004080|NCT00884325|449643582|FG000|Overall Study|Lost to Follow-up|1|||
125004081|NCT00884325|449643583|FG001|Overall Study|Lost to Follow-up|2|||
125004082|NCT00884325|449643582|FG000|Overall Study|Lack of Efficacy|0|||
125004083|NCT00884325|449643583|FG001|Overall Study|Lack of Efficacy|1|||
125004084|NCT00884325|449643582|FG000|Overall Study|Withdrawal by Subject|1|||
125004085|NCT00884325|449643583|FG001|Overall Study|Withdrawal by Subject|1|||
125004086|NCT00884325|449643582|FG000|Overall Study|Not provided|1|||
125004087|NCT00884325|449643583|FG001|Overall Study|Not provided|0|||
125004088|NCT00892177|449643600|FG000|Phase II|Ineligible|0|||
125004089|NCT00892177|449643601|FG001|Phase II|Ineligible|0|||
125004090|NCT00892177|449643602|FG002|Phase II|Ineligible|0|||
125004091|NCT00892177|449643603|FG003|Phase II|Ineligible|0|||
125004092|NCT00892177|449643604|FG004|Phase II|Ineligible|1|||
125004093|NCT00892177|449643605|FG005|Phase II|Ineligible|1|||
125004094|NCT00892177|449643600|FG000|Phase II|Withdrawal by Subject|0|||
125004095|NCT00892177|449643601|FG001|Phase II|Withdrawal by Subject|0|||
125004096|NCT00892177|449643602|FG002|Phase II|Withdrawal by Subject|0|||
125004097|NCT00892177|449643603|FG003|Phase II|Withdrawal by Subject|0|||
125004098|NCT00892177|449643604|FG004|Phase II|Withdrawal by Subject|4|||
125004099|NCT00892177|449643605|FG005|Phase II|Withdrawal by Subject|1|||
125004100|NCT00616434|449643609|FG000|Overall Study|Adverse Event|5|||
125090514|NCT02918006|449948799|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
125004101|NCT00616434|449643610|FG001|Overall Study|Adverse Event|2|||
125004102|NCT00616434|449643609|FG000|Overall Study|Physician Decision|0|||
125004103|NCT00616434|449643610|FG001|Overall Study|Physician Decision|4|||
125004104|NCT00616434|449643609|FG000|Overall Study|Withdrawal by Subject|1|||
125090515|NCT02918006|449948800|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
125004105|NCT00616434|449643610|FG001|Overall Study|Withdrawal by Subject|1|||
125004106|NCT00616434|449643609|FG000|Overall Study|Protocol deviation|0|||
125004107|NCT00616434|449643610|FG001|Overall Study|Protocol deviation|1|||
125004108|NCT03945591|449643611|FG000|Overall Study|Participant not transplanted|1|||
125004109|NCT03945591|449643611|FG000|Overall Study|Change in treatment plan|3|||
125090516|NCT02918006|449948801|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
125090517|NCT01156012|449948803|FG000|Overall Study|Adverse Event|3|||
125090518|NCT01156012|449948804|FG001|Overall Study|Adverse Event|1|||
125090519|NCT01156012|449948803|FG000|Overall Study|Lost to Follow-up|1|||
125090520|NCT01156012|449948804|FG001|Overall Study|Lost to Follow-up|0|||
125090521|NCT01156012|449948803|FG000|Overall Study|Withdrawal by Subject|1|||
125090522|NCT01156012|449948804|FG001|Overall Study|Withdrawal by Subject|0|||
125090523|NCT01156012|449948803|FG000|Overall Study|use of commercial drug instead of study|0|||
125090524|NCT01156012|449948804|FG001|Overall Study|use of commercial drug instead of study|1|||
125090525|NCT01156012|449948803|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
125090526|NCT01156012|449948804|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
125090527|NCT02475564|449948805|FG000|Overall Study|Withdrawal by Subject|1|||
125090528|NCT02475564|449948806|FG001|Overall Study|Withdrawal by Subject|0|||
125090529|NCT02475564|449948805|FG000|Overall Study|Lost to Follow-up|2|||
125090530|NCT02475564|449948806|FG001|Overall Study|Lost to Follow-up|1|||
125090531|NCT02475564|449948805|FG000|Overall Study|Intense Menstrual bleeding|1|||
125090532|NCT02475564|449948806|FG001|Overall Study|Intense Menstrual bleeding|0|||
125090533|NCT00939094|449948808|FG000|Overall Study|Adverse Event|9|||
125090534|NCT00939094|449948809|FG001|Overall Study|Adverse Event|0|||
125090535|NCT00939094|449948808|FG000|Overall Study|Withdrawal by Subject|1|||
125090536|NCT00939094|449948809|FG001|Overall Study|Withdrawal by Subject|6|||
125090537|NCT00939094|449948808|FG000|Overall Study|Lost to Follow-up|1|||
125090538|NCT00939094|449948809|FG001|Overall Study|Lost to Follow-up|1|||
125090539|NCT00939094|449948808|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
125090540|NCT00939094|449948809|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125090541|NCT00939094|449948808|FG000|Overall Study|Severe non-compliance to protocol|0|||
125090542|NCT00939094|449948809|FG001|Overall Study|Severe non-compliance to protocol|1|||
125090543|NCT00939094|449948808|FG000|Overall Study|Study stopped by sponsor|0|||
125090544|NCT00939094|449948809|FG001|Overall Study|Study stopped by sponsor|2|||
125090545|NCT00939094|449948808|FG000|Overall Study|Abnormal ECG findings|1|||
125090546|NCT00939094|449948809|FG001|Overall Study|Abnormal ECG findings|0|||
125090547|NCT01906489|449948810|FG000|Overall Study|Adverse Event|10|||
125090548|NCT01906489|449948811|FG001|Overall Study|Adverse Event|3|||
125090549|NCT01906489|449948810|FG000|Overall Study|Worsening of CKD|6|||
125090550|NCT01906489|449948811|FG001|Overall Study|Worsening of CKD|4|||
125090551|NCT01906489|449948810|FG000|Overall Study|Withdrawal by Subject|5|||
125090552|NCT01906489|449948811|FG001|Overall Study|Withdrawal by Subject|0|||
125090553|NCT01906489|449948810|FG000|Overall Study|Worsening of Anemia|1|||
125090554|NCT01906489|449948811|FG001|Overall Study|Worsening of Anemia|0|||
125090555|NCT01906489|449948810|FG000|Overall Study|Protocol Violation|0|||
125090556|NCT01906489|449948811|FG001|Overall Study|Protocol Violation|1|||
125090557|NCT01906489|449948810|FG000|Overall Study|Non- Compliance|1|||
125090558|NCT01906489|449948811|FG001|Overall Study|Non- Compliance|0|||
125090559|NCT01906489|449948810|FG000|Overall Study|Sponsor Decision|1|||
125090560|NCT01906489|449948811|FG001|Overall Study|Sponsor Decision|0|||
125090561|NCT01906489|449948810|FG000|Overall Study|Lost to Follow-up|1|||
125090562|NCT01906489|449948811|FG001|Overall Study|Lost to Follow-up|1|||
125090563|NCT01906489|449948810|FG000|Overall Study|Other|1|||
125090564|NCT01906489|449948811|FG001|Overall Study|Other|0|||
125090565|NCT01503229|449950831|FG000|Overall Study|Withdrew consent|1|||
125090566|NCT00240331|449950832|FG000|Overall Study|Withdrawal by Subject|125|||
125090567|NCT00240331|449950833|FG001|Overall Study|Withdrawal by Subject|132|||
125090568|NCT00240331|449950832|FG000|Overall Study|Option selected by investigator|1|||
125090569|NCT00240331|449950833|FG001|Overall Study|Option selected by investigator|2|||
125090570|NCT02551874|449950834|FG000|Overall Study|Lost to Follow-up|0|||
125090571|NCT02551874|449950835|FG001|Overall Study|Lost to Follow-up|2|||
125090572|NCT02551874|449950834|FG000|Overall Study|Pregnancy|0|||
125090573|NCT02551874|449950835|FG001|Overall Study|Pregnancy|1|||
125090574|NCT02551874|449950834|FG000|Overall Study|Reason not reported|10|||
125090575|NCT02551874|449950835|FG001|Overall Study|Reason not reported|4|||
125090576|NCT02551874|449950834|FG000|Overall Study|Did not receive randomized treatment|0|||
125090577|NCT02551874|449950835|FG001|Overall Study|Did not receive randomized treatment|7|||
125090578|NCT02551874|449950834|FG000|Overall Study|Did not enter long-term study|18|||
125090579|NCT02551874|449950835|FG001|Overall Study|Did not enter long-term study|25|||
125090580|NCT02491463|449950836|FG000|Overall Study|Withdrawal by Subject|1|||
125090581|NCT02491463|449950837|FG001|Overall Study|Withdrawal by Subject|2|||
125090582|NCT02491463|449950838|FG002|Overall Study|Withdrawal by Subject|0|||
125090583|NCT02491463|449950839|FG003|Overall Study|Withdrawal by Subject|0|||
125090584|NCT02491463|449950836|FG000|Overall Study|Migrated/moved from study area|1|||
125090585|NCT02491463|449950837|FG001|Overall Study|Migrated/moved from study area|5|||
125090586|NCT02491463|449950838|FG002|Overall Study|Migrated/moved from study area|1|||
125090587|NCT02491463|449950839|FG003|Overall Study|Migrated/moved from study area|1|||
125090588|NCT02491463|449950836|FG000|Overall Study|Lost to Follow-up|0|||
125090589|NCT02491463|449950837|FG001|Overall Study|Lost to Follow-up|3|||
125004110|NCT03945591|449643611|FG000|Overall Study|Adverse Event|1|||
125004111|NCT03083847|449643612|FG000|Main|Physician Decision|0|||
125004112|NCT03083847|449643613|FG001|Main|Physician Decision|0|||
125004113|NCT03083847|449643614|FG002|Main|Physician Decision|0|||
125004114|NCT03083847|449643615|FG003|Main|Physician Decision|0|||
125004115|NCT03083847|449643616|FG004|Main|Physician Decision|0|||
125004116|NCT03083847|449643617|FG005|Main|Physician Decision|1|||
125004117|NCT03083847|449643618|FG006|Main|Physician Decision|0|||
125004118|NCT03083847|449643619|FG007|Main|Physician Decision|0|||
125004119|NCT03083847|449643620|FG008|Main|Physician Decision|0|||
125004120|NCT03083847|449643621|FG009|Main|Physician Decision|0|||
125004121|NCT03083847|449643612|FG000|Main|Pregnancy|0|||
125004122|NCT03083847|449643613|FG001|Main|Pregnancy|0|||
125004123|NCT03083847|449643614|FG002|Main|Pregnancy|0|||
125004124|NCT03083847|449643615|FG003|Main|Pregnancy|0|||
125004125|NCT03083847|449643616|FG004|Main|Pregnancy|0|||
125004126|NCT03083847|449643617|FG005|Main|Pregnancy|0|||
125004127|NCT03083847|449643618|FG006|Main|Pregnancy|0|||
125004128|NCT03083847|449643619|FG007|Main|Pregnancy|1|||
125004129|NCT03083847|449643620|FG008|Main|Pregnancy|0|||
125004130|NCT03083847|449643621|FG009|Main|Pregnancy|0|||
125004131|NCT03083847|449643612|FG000|Main|Adverse Event|0|||
125004132|NCT03083847|449643613|FG001|Main|Adverse Event|0|||
125004133|NCT03083847|449643614|FG002|Main|Adverse Event|0|||
125004134|NCT03083847|449643615|FG003|Main|Adverse Event|0|||
125004135|NCT03083847|449643616|FG004|Main|Adverse Event|0|||
125004136|NCT03083847|449643617|FG005|Main|Adverse Event|0|||
125004137|NCT03083847|449643618|FG006|Main|Adverse Event|0|||
125004138|NCT03083847|449643619|FG007|Main|Adverse Event|2|||
125004139|NCT03083847|449643620|FG008|Main|Adverse Event|0|||
125004140|NCT03083847|449643621|FG009|Main|Adverse Event|0|||
125004141|NCT03083847|449643612|FG000|Main|Withdrawal by Subject|0|||
125004142|NCT03083847|449643613|FG001|Main|Withdrawal by Subject|0|||
125004143|NCT03083847|449643614|FG002|Main|Withdrawal by Subject|0|||
125004144|NCT03083847|449643615|FG003|Main|Withdrawal by Subject|0|||
125004145|NCT03083847|449643616|FG004|Main|Withdrawal by Subject|0|||
125004146|NCT03083847|449643617|FG005|Main|Withdrawal by Subject|0|||
125004147|NCT03083847|449643618|FG006|Main|Withdrawal by Subject|1|||
125004148|NCT03083847|449643619|FG007|Main|Withdrawal by Subject|1|||
125004149|NCT03083847|449643620|FG008|Main|Withdrawal by Subject|0|||
125004150|NCT03083847|449643621|FG009|Main|Withdrawal by Subject|0|||
125004151|NCT00058552|449643623|FG000|Overall Study|Died prior to receiving treatment|4|||
125004152|NCT00058552|449643624|FG001|Overall Study|Died prior to receiving treatment|2|||
125004153|NCT00058552|449643623|FG000|Overall Study|Disease progression|52|||
125004154|NCT00058552|449643624|FG001|Overall Study|Disease progression|44|||
125004155|NCT00058552|449643623|FG000|Overall Study|Adverse Event|4|||
125004156|NCT00058552|449643624|FG001|Overall Study|Adverse Event|2|||
125004157|NCT00058552|449643623|FG000|Overall Study|Withdrawal by Subject|3|||
125004158|NCT00058552|449643624|FG001|Overall Study|Withdrawal by Subject|5|||
125004159|NCT00058552|449643623|FG000|Overall Study|Physician Decision|2|||
125004160|NCT00058552|449643624|FG001|Overall Study|Physician Decision|5|||
125004161|NCT00058552|449643623|FG000|Overall Study|Clinical disease progression|0|||
125004162|NCT00058552|449643624|FG001|Overall Study|Clinical disease progression|4|||
125004163|NCT02319668|449643625|FG000|Overall Study|Other (Not specified)|0|||
125004164|NCT02319668|449643626|FG001|Overall Study|Other (Not specified)|2|||
125004165|NCT02316340|449643629|FG000|First Progression|Clinical progression|2|||
125004166|NCT02316340|449643630|FG001|First Progression|Clinical progression|1|||
125004167|NCT02316340|449643629|FG000|First Progression|Withdrawal by Subject|1|||
125004168|NCT02316340|449643630|FG001|First Progression|Withdrawal by Subject|0|||
125004169|NCT01986920|449643631|FG000|A- 101 25%|Withdrawal by Subject|1|||
125004170|NCT01986920|449643632|FG001|A- 101 25%|Withdrawal by Subject|0|||
125004171|NCT01986920|449643633|FG002|A- 101 25%|Withdrawal by Subject|0|||
125004172|NCT01986920|449643634|FG003|A- 101 25%|Withdrawal by Subject|0|||
125004173|NCT01986920|449643631|FG000|A-101 32.5%|Withdrawal by Subject|0|||
125004174|NCT01986920|449643632|FG001|A-101 32.5%|Withdrawal by Subject|1|||
125004175|NCT01986920|449643633|FG002|A-101 32.5%|Withdrawal by Subject|0|||
125004176|NCT01986920|449643634|FG003|A-101 32.5%|Withdrawal by Subject|0|||
125004177|NCT01986920|449643631|FG000|A-101 40%|Withdrawal by Subject|0|||
125004178|NCT01986920|449643632|FG001|A-101 40%|Withdrawal by Subject|0|||
125004179|NCT01986920|449643633|FG002|A-101 40%|Withdrawal by Subject|1|||
125004180|NCT01986920|449643634|FG003|A-101 40%|Withdrawal by Subject|0|||
125004181|NCT01986920|449643631|FG000|Placebo|Withdrawal by Subject|0|||
125004182|NCT01986920|449643632|FG001|Placebo|Withdrawal by Subject|0|||
125004183|NCT01986920|449643633|FG002|Placebo|Withdrawal by Subject|0|||
125004184|NCT01986920|449643634|FG003|Placebo|Withdrawal by Subject|1|||
125004185|NCT03781323|449643635|FG000|Overall Study|Withdrawal by Subject|1|||
125004186|NCT01338415|449643636|FG000|Core + Extension|Adverse Event|8|||
125004187|NCT01338415|449643637|FG001|Core + Extension|Adverse Event|6|||
125004188|NCT01338415|449643638|FG002|Core + Extension|Adverse Event|0|||
125004189|NCT01338415|449643636|FG000|Core + Extension|Withdrawal by Subject|1|||
125004190|NCT01338415|449643637|FG001|Core + Extension|Withdrawal by Subject|1|||
125090590|NCT02491463|449950838|FG002|Overall Study|Lost to Follow-up|3|||
125090591|NCT02491463|449950839|FG003|Overall Study|Lost to Follow-up|0|||
125090592|NCT01491802|449950840|FG000|Overall Study|Adverse Event|1|||
125090593|NCT01491802|449950841|FG001|Overall Study|Adverse Event|1|||
125004191|NCT01338415|449643638|FG002|Core + Extension|Withdrawal by Subject|0|||
125004192|NCT01338415|449643636|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
125004193|NCT01338415|449643637|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
125004194|NCT01338415|449643638|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
125004195|NCT01338415|449643636|FG000|Core + Extension|Other (administrative reason)|1|||
125004196|NCT01338415|449643637|FG001|Core + Extension|Other (administrative reason)|0|||
125004197|NCT01338415|449643638|FG002|Core + Extension|Other (administrative reason)|0|||
125004198|NCT01338415|449643636|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
125004199|NCT01338415|449643637|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
125004200|NCT01338415|449643638|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
125004201|NCT01338415|449643636|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
125004202|NCT01338415|449643637|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
125004203|NCT01338415|449643638|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
125004204|NCT01338415|449643636|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
125004205|NCT01338415|449643637|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
125004206|NCT01338415|449643638|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
125004207|NCT01338415|449643636|FG000|Exceptional Use Treatment Period|Death|0|||
125004208|NCT01338415|449643637|FG001|Exceptional Use Treatment Period|Death|0|||
125004209|NCT01338415|449643638|FG002|Exceptional Use Treatment Period|Death|1|||
125004210|NCT04880447|449643644|FG000|Overall Study|No vaccination information|1|||
125004211|NCT04880447|449643644|FG000|Overall Study|No adverse event information (missing information)|1|||
125004212|NCT04880447|449643644|FG000|Overall Study|Disease not covered in this study|35|||
125004213|NCT01970488|449643645|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
125004214|NCT01970488|449643646|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
125004215|NCT01970488|449643647|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
125004216|NCT01970488|449643648|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
125004217|NCT01970488|449643649|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
125004218|NCT01970488|449643645|FG000|Part 1: Through Week 16|Protocol Violation|1|||
125004219|NCT01970488|449643646|FG001|Part 1: Through Week 16|Protocol Violation|2|||
125004220|NCT01970488|449643647|FG002|Part 1: Through Week 16|Protocol Violation|0|||
125004221|NCT01970488|449643648|FG003|Part 1: Through Week 16|Protocol Violation|0|||
125004222|NCT01970488|449643649|FG004|Part 1: Through Week 16|Protocol Violation|0|||
125004223|NCT01970488|449643645|FG000|Part 1: Through Week 16|Adverse Event|6|||
125004224|NCT01970488|449643646|FG001|Part 1: Through Week 16|Adverse Event|5|||
125004225|NCT01970488|449643647|FG002|Part 1: Through Week 16|Adverse Event|0|||
125004226|NCT01970488|449643648|FG003|Part 1: Through Week 16|Adverse Event|0|||
125004227|NCT01970488|449643649|FG004|Part 1: Through Week 16|Adverse Event|0|||
125004228|NCT01970488|449643645|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
125004229|NCT01970488|449643646|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
125004230|NCT01970488|449643647|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
125004231|NCT01970488|449643648|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
125004232|NCT01970488|449643649|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
125004233|NCT01970488|449643645|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
125004234|NCT01970488|449643646|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
125004235|NCT01970488|449643647|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
125004236|NCT01970488|449643648|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
125004237|NCT01970488|449643649|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
125004238|NCT01970488|449643645|FG000|Part 2: Post Week 16|Physician Decision|0|||
125004239|NCT01970488|449643646|FG001|Part 2: Post Week 16|Physician Decision|0|||
125004240|NCT01970488|449643647|FG002|Part 2: Post Week 16|Physician Decision|0|||
125090594|NCT01491802|449950840|FG000|Overall Study|Withdrawal by Subject|0|||
125004241|NCT01970488|449643648|FG003|Part 2: Post Week 16|Physician Decision|0|||
125004242|NCT01970488|449643649|FG004|Part 2: Post Week 16|Physician Decision|1|||
125090595|NCT01491802|449950841|FG001|Overall Study|Withdrawal by Subject|1|||
125090596|NCT00386152|449950846|FG000|Overall Study|Adverse Event|6|||
125090597|NCT00386152|449950847|FG001|Overall Study|Adverse Event|5|||
125090598|NCT00386152|449950848|FG002|Overall Study|Adverse Event|4|||
125090599|NCT00386152|449950846|FG000|Overall Study|Chang from original chemo stratification|4|||
125090600|NCT00386152|449950847|FG001|Overall Study|Chang from original chemo stratification|5|||
125090601|NCT00386152|449950848|FG002|Overall Study|Chang from original chemo stratification|6|||
125090602|NCT00386152|449950846|FG000|Overall Study|Death|3|||
125090603|NCT00386152|449950847|FG001|Overall Study|Death|0|||
125090604|NCT00386152|449950848|FG002|Overall Study|Death|1|||
125090605|NCT00386152|449950846|FG000|Overall Study|Disease progression|7|||
125090606|NCT00386152|449950847|FG001|Overall Study|Disease progression|4|||
125090607|NCT00386152|449950848|FG002|Overall Study|Disease progression|5|||
125090608|NCT00386152|449950846|FG000|Overall Study|Physician Decision|13|||
125090609|NCT00386152|449950847|FG001|Overall Study|Physician Decision|10|||
125090610|NCT00386152|449950848|FG002|Overall Study|Physician Decision|4|||
125090611|NCT00386152|449950846|FG000|Overall Study|Lost to Follow-up|1|||
125090612|NCT00386152|449950847|FG001|Overall Study|Lost to Follow-up|0|||
125090613|NCT00386152|449950848|FG002|Overall Study|Lost to Follow-up|0|||
125090614|NCT00386152|449950846|FG000|Overall Study|Completed chemotherapy|4|||
125090615|NCT00386152|449950847|FG001|Overall Study|Completed chemotherapy|5|||
125090616|NCT00386152|449950848|FG002|Overall Study|Completed chemotherapy|1|||
125090617|NCT00386152|449950846|FG000|Overall Study|Protocol Violation|3|||
125090618|NCT00386152|449950847|FG001|Overall Study|Protocol Violation|5|||
125090619|NCT00386152|449950848|FG002|Overall Study|Protocol Violation|2|||
125090620|NCT00386152|449950846|FG000|Overall Study|Withdrawal by Subject|3|||
125090621|NCT00386152|449950847|FG001|Overall Study|Withdrawal by Subject|6|||
125090622|NCT00386152|449950848|FG002|Overall Study|Withdrawal by Subject|10|||
125090623|NCT00508872|449950852|FG000|Overall Study|Lost to Follow-up|1|||
125090624|NCT00508872|449950852|FG000|Overall Study|Physician Decision|1|||
125090625|NCT03007472|449950853|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
125090626|NCT03007472|449950853|FG000|Overall Study|Death|2|||
125090627|NCT03007472|449950853|FG000|Overall Study|Loss to Follow Up|1|||
125090628|NCT00253747|449950856|FG000|Overall Study|Lost to Follow-up|13|||
125090629|NCT00253747|449950857|FG001|Overall Study|Lost to Follow-up|14|||
125090630|NCT00253747|449950856|FG000|Overall Study|Withdrawal by Subject|10|||
125090631|NCT00253747|449950857|FG001|Overall Study|Withdrawal by Subject|11|||
125090632|NCT00253747|449950856|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
125090633|NCT00253747|449950857|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
125090634|NCT01977651|449950858|FG000|4 Month Treatment Period|Adverse Event|34|||
125090635|NCT01977651|449950858|FG000|4 Month Treatment Period|Death|3|||
125090636|NCT01977651|449950858|FG000|4 Month Treatment Period|Progressive Disease|43|||
125090637|NCT01977651|449950858|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
125090638|NCT01977651|449950858|FG000|4 Month Treatment Period|Physician Decision|4|||
125090639|NCT01977651|449950858|FG000|1 Year Extension Period|Adverse Event|14|||
125090640|NCT01977651|449950858|FG000|1 Year Extension Period|Death|10|||
125090641|NCT01977651|449950858|FG000|1 Year Extension Period|Lost to Follow-up|2|||
125090642|NCT01977651|449950858|FG000|1 Year Extension Period|Progressive Disease|86|||
125090643|NCT01977651|449950858|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
125090644|NCT01977651|449950858|FG000|1 Year Extension Period|Physician Decision|6|||
125090645|NCT01977651|449950858|FG000|1 Year Extension Period|Miscellaneous|1|||
125090646|NCT01977651|449950858|FG000|Post 1 Year Extension Period|Adverse Event|5|||
125090647|NCT01977651|449950858|FG000|Post 1 Year Extension Period|Death|13|||
125090648|NCT01977651|449950858|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
125090649|NCT01977651|449950858|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
125090650|NCT01977651|449950858|FG000|Post 1 Year Extension Period|Physician Decision|4|||
125090651|NCT01977651|449950858|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
125090652|NCT00104299|449950859|FG000|Overall Study|Adverse Event|3|||
125090653|NCT00104299|449950860|FG001|Overall Study|Adverse Event|1|||
125090654|NCT00104299|449950859|FG000|Overall Study|Death|2|||
125090655|NCT00104299|449950860|FG001|Overall Study|Death|2|||
125090656|NCT00104299|449950859|FG000|Overall Study|Withdrawal by Subject|2|||
125090657|NCT00104299|449950860|FG001|Overall Study|Withdrawal by Subject|6|||
125090658|NCT00104299|449950859|FG000|Overall Study|Physician Decision|1|||
125090659|NCT00104299|449950860|FG001|Overall Study|Physician Decision|1|||
125090660|NCT00104299|449950859|FG000|Overall Study|To have renal transplant|1|||
125090661|NCT00104299|449950860|FG001|Overall Study|To have renal transplant|0|||
125090662|NCT03672006|449950862|FG000|Overall Study|exclusion criteria met|0|||
125090663|NCT03672006|449950863|FG001|Overall Study|exclusion criteria met|1|||
124872980|NCT00089141|449157211|FG001|Overall Study|Termination of trial|24|||
124872981|NCT00508261|449157212|FG000|Overall Study|Other|0|||
124872982|NCT00508261|449157213|FG001|Overall Study|Other|1|||
124872983|NCT00508261|449157214|FG002|Overall Study|Other|1|||
125090664|NCT00608426|449950864|FG000|Overall Study|Death|32|||
125090665|NCT00608426|449950865|FG001|Overall Study|Death|36|||
125090666|NCT00608426|449950864|FG000|Overall Study|Lost to Follow-up|485|||
125090667|NCT00608426|449950865|FG001|Overall Study|Lost to Follow-up|521|||
124872984|NCT00508261|449157215|FG003|Overall Study|Other|0|||
124872985|NCT00508261|449157212|FG000|Overall Study|Serious Adverse Event|0|||
124872986|NCT00508261|449157213|FG001|Overall Study|Serious Adverse Event|1|||
124872987|NCT00508261|449157214|FG002|Overall Study|Serious Adverse Event|0|||
125004243|NCT01970488|449643645|FG000|Part 2: Post Week 16|Non-compliance|0|||
125090668|NCT00608426|449950864|FG000|Overall Study|refused, health issues, wrong address|319|||
125090669|NCT00608426|449950865|FG001|Overall Study|refused, health issues, wrong address|348|||
125090670|NCT02630459|449950869|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
125090671|NCT02630459|449950870|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
125090672|NCT02630459|449950871|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
125090673|NCT02630459|449950872|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
125090674|NCT02630459|449950873|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
125090675|NCT02630459|449950874|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
125090676|NCT02630459|449950875|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
125090677|NCT02630459|449950876|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
125090678|NCT02630459|449950869|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
125090679|NCT02630459|449950870|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
125090680|NCT02630459|449950871|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
125090681|NCT02630459|449950872|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
125090682|NCT02630459|449950873|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
125090683|NCT02630459|449950874|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
125090684|NCT02630459|449950875|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
125090685|NCT02630459|449950876|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
125090686|NCT02630459|449950869|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
125090687|NCT02630459|449950870|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
125090688|NCT02630459|449950871|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
125090689|NCT02630459|449950872|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
125090690|NCT02630459|449950873|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
125090691|NCT02630459|449950874|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
125090692|NCT02630459|449950875|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
125090693|NCT02630459|449950876|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
125090694|NCT02630459|449950869|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
125090695|NCT02630459|449950870|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
125090696|NCT02630459|449950871|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
125090697|NCT02630459|449950872|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
125090698|NCT02630459|449950873|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
125090699|NCT02630459|449950874|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
125090700|NCT02630459|449950875|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
125090701|NCT02630459|449950876|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
125090702|NCT02630459|449950869|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
125090703|NCT02630459|449950870|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
125090704|NCT02630459|449950871|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
125090705|NCT02630459|449950872|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
125090706|NCT02630459|449950873|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
125090707|NCT02630459|449950874|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
125090708|NCT02630459|449950875|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
125090709|NCT02630459|449950876|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
125090710|NCT02630459|449950869|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
125090711|NCT02630459|449950870|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
125090712|NCT02630459|449950871|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
125090713|NCT02630459|449950872|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
125090714|NCT02630459|449950873|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
125090715|NCT02630459|449950874|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
125090716|NCT02630459|449950875|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
125090717|NCT02630459|449950876|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
125090718|NCT02630459|449950869|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
125004244|NCT01970488|449643646|FG001|Part 2: Post Week 16|Non-compliance|0|||
125004245|NCT01970488|449643647|FG002|Part 2: Post Week 16|Non-compliance|1|||
125004246|NCT01970488|449643648|FG003|Part 2: Post Week 16|Non-compliance|0|||
125004247|NCT01970488|449643649|FG004|Part 2: Post Week 16|Non-compliance|0|||
125004248|NCT01970488|449643645|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
125004249|NCT01970488|449643646|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
125004250|NCT01970488|449643647|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
125004251|NCT01970488|449643648|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
125004252|NCT01970488|449643649|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
125004253|NCT01970488|449643645|FG000|Part 2: Post Week 16|Adverse Event|0|||
125090719|NCT02630459|449950870|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
125090720|NCT02630459|449950871|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
125090721|NCT02630459|449950872|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
125090722|NCT02630459|449950873|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
125090723|NCT02630459|449950874|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
125090724|NCT02630459|449950875|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
125090725|NCT02630459|449950876|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
125090726|NCT01453439|449950877|FG000|Treatment Phase|Withdrawal by Subject|13|||
125090727|NCT01453439|449950878|FG001|Treatment Phase|Withdrawal by Subject|10|||
125090728|NCT01453439|449950877|FG000|Treatment Phase|Suicidal Ideation|2|||
125090729|NCT01453439|449950878|FG001|Treatment Phase|Suicidal Ideation|0|||
125090730|NCT01453439|449950877|FG000|Treatment Phase|Need for higher level of care|1|||
125090731|NCT01453439|449950878|FG001|Treatment Phase|Need for higher level of care|1|||
125090732|NCT01453439|449950877|FG000|Treatment Phase|Therapist conflict of interest|1|||
125090733|NCT01453439|449950878|FG001|Treatment Phase|Therapist conflict of interest|0|||
125090734|NCT01453439|449950877|FG000|Follow-up|Withdrawal by Subject|0|||
125090735|NCT01453439|449950878|FG001|Follow-up|Withdrawal by Subject|1|||
125090736|NCT01453439|449950877|FG000|Follow-up|Lost to Follow-up|5|||
125090737|NCT01453439|449950878|FG001|Follow-up|Lost to Follow-up|10|||
125090738|NCT01014442|449950879|FG000|Overall Study|Adverse Event|0|||
125090739|NCT01014442|449950880|FG001|Overall Study|Adverse Event|8|||
125090740|NCT01014442|449950879|FG000|Overall Study|Withdrawal by Subject|4|||
125090741|NCT01014442|449950880|FG001|Overall Study|Withdrawal by Subject|4|||
125090742|NCT01014442|449950879|FG000|Overall Study|Protocol Violation|2|||
125090743|NCT01014442|449950880|FG001|Overall Study|Protocol Violation|5|||
125090744|NCT01014442|449950879|FG000|Overall Study|Lack of Compliance|0|||
125090745|NCT01014442|449950880|FG001|Overall Study|Lack of Compliance|1|||
125090746|NCT01014442|449950879|FG000|Overall Study|Unspecified Reason|1|||
125090747|NCT01014442|449950880|FG001|Overall Study|Unspecified Reason|1|||
125090748|NCT01220024|449950891|FG000|Overall Study|Lost to Follow-up|1|||
125090749|NCT01220024|449950892|FG001|Overall Study|Lost to Follow-up|1|||
125090750|NCT00174460|449950895|FG000|Overall Study|Withdrawal by Subject|0|||
125090751|NCT00174460|449950896|FG001|Overall Study|Withdrawal by Subject|1|||
125090752|NCT00490815|449950897|FG000|Overall Study|Adverse Event|2|||
125090753|NCT00490815|449950898|FG001|Overall Study|Adverse Event|3|||
125090754|NCT00490815|449950897|FG000|Overall Study|Withdrawal by Subject|4|||
125090755|NCT00490815|449950898|FG001|Overall Study|Withdrawal by Subject|0|||
125090756|NCT00490815|449950897|FG000|Overall Study|Lost to Follow-up|1|||
125090757|NCT00490815|449950898|FG001|Overall Study|Lost to Follow-up|3|||
125090758|NCT00490815|449950897|FG000|Overall Study|Death|1|||
125090759|NCT00490815|449950898|FG001|Overall Study|Death|3|||
125090760|NCT00579059|449950900|FG000|Overall Study|Study Canceled at 1 Year|21|||
125090761|NCT00579059|449950901|FG001|Overall Study|Study Canceled at 1 Year|10|||
125090762|NCT04047472|449950902|FG000|Overall Study|Adverse Event|3|||
125090763|NCT04047472|449950903|FG001|Overall Study|Adverse Event|3|||
125090764|NCT04047472|449950902|FG000|Overall Study|Death|0|||
125090765|NCT04047472|449950903|FG001|Overall Study|Death|1|||
125090766|NCT04047472|449950902|FG000|Overall Study|Lost to Follow-up|1|||
125090767|NCT04047472|449950903|FG001|Overall Study|Lost to Follow-up|0|||
125090768|NCT04047472|449950902|FG000|Overall Study|Physician Decision|1|||
125090769|NCT04047472|449950903|FG001|Overall Study|Physician Decision|2|||
125090770|NCT04047472|449950902|FG000|Overall Study|Protocol Violation|1|||
125090771|NCT04047472|449950903|FG001|Overall Study|Protocol Violation|0|||
125090772|NCT04047472|449950902|FG000|Overall Study|Withdrawal by Subject|10|||
125090773|NCT04047472|449950903|FG001|Overall Study|Withdrawal by Subject|10|||
125090774|NCT02030067|449950904|FG000|Overall Study|Disease Progression|1|||
125090775|NCT02030067|449950905|FG001|Overall Study|Disease Progression|1|||
125090776|NCT02030067|449950906|FG002|Overall Study|Disease Progression|2|||
125090777|NCT02030067|449950907|FG003|Overall Study|Disease Progression|2|||
125090778|NCT02030067|449950908|FG004|Overall Study|Disease Progression|3|||
125090779|NCT02030067|449950909|FG005|Overall Study|Disease Progression|2|||
125090780|NCT02030067|449950910|FG006|Overall Study|Disease Progression|3|||
125090781|NCT02030067|449950911|FG007|Overall Study|Disease Progression|3|||
125090782|NCT02030067|449950912|FG008|Overall Study|Disease Progression|4|||
125090783|NCT02030067|449950913|FG009|Overall Study|Disease Progression|3|||
125090784|NCT02030067|449950914|FG010|Overall Study|Disease Progression|7|||
125090785|NCT02030067|449950915|FG011|Overall Study|Disease Progression|2|||
125090786|NCT02030067|449950916|FG012|Overall Study|Disease Progression|59|||
125090787|NCT02030067|449950904|FG000|Overall Study|Withdrawal by Subject|0|||
125090788|NCT02030067|449950905|FG001|Overall Study|Withdrawal by Subject|0|||
125090789|NCT02030067|449950906|FG002|Overall Study|Withdrawal by Subject|0|||
125090790|NCT02030067|449950907|FG003|Overall Study|Withdrawal by Subject|1|||
125090791|NCT02030067|449950908|FG004|Overall Study|Withdrawal by Subject|0|||
125090792|NCT02030067|449950909|FG005|Overall Study|Withdrawal by Subject|0|||
125090793|NCT02030067|449950910|FG006|Overall Study|Withdrawal by Subject|0|||
125090794|NCT02030067|449950911|FG007|Overall Study|Withdrawal by Subject|1|||
125090795|NCT02030067|449950912|FG008|Overall Study|Withdrawal by Subject|0|||
125090796|NCT02030067|449950913|FG009|Overall Study|Withdrawal by Subject|0|||
125090797|NCT02030067|449950914|FG010|Overall Study|Withdrawal by Subject|3|||
125090798|NCT02030067|449950915|FG011|Overall Study|Withdrawal by Subject|0|||
125090799|NCT02030067|449950916|FG012|Overall Study|Withdrawal by Subject|6|||
125090800|NCT02030067|449950904|FG000|Overall Study|Physician Decision|0|||
125090801|NCT02030067|449950905|FG001|Overall Study|Physician Decision|0|||
125090802|NCT02030067|449950906|FG002|Overall Study|Physician Decision|0|||
125090803|NCT02030067|449950907|FG003|Overall Study|Physician Decision|0|||
125090804|NCT02030067|449950908|FG004|Overall Study|Physician Decision|0|||
125090805|NCT02030067|449950909|FG005|Overall Study|Physician Decision|0|||
125090806|NCT02030067|449950910|FG006|Overall Study|Physician Decision|0|||
125090807|NCT02030067|449950911|FG007|Overall Study|Physician Decision|0|||
125090808|NCT02030067|449950912|FG008|Overall Study|Physician Decision|0|||
125090809|NCT02030067|449950913|FG009|Overall Study|Physician Decision|0|||
125090810|NCT02030067|449950914|FG010|Overall Study|Physician Decision|1|||
125090811|NCT02030067|449950915|FG011|Overall Study|Physician Decision|0|||
125090812|NCT02030067|449950916|FG012|Overall Study|Physician Decision|3|||
125090813|NCT02030067|449950904|FG000|Overall Study|other reasons|0|||
125090814|NCT02030067|449950905|FG001|Overall Study|other reasons|0|||
125090815|NCT02030067|449950906|FG002|Overall Study|other reasons|0|||
125090816|NCT02030067|449950907|FG003|Overall Study|other reasons|0|||
125090817|NCT02030067|449950908|FG004|Overall Study|other reasons|0|||
125090818|NCT02030067|449950909|FG005|Overall Study|other reasons|1|||
125090819|NCT02030067|449950910|FG006|Overall Study|other reasons|0|||
125090820|NCT02030067|449950911|FG007|Overall Study|other reasons|0|||
125090821|NCT02030067|449950912|FG008|Overall Study|other reasons|2|||
125090822|NCT02030067|449950913|FG009|Overall Study|other reasons|0|||
125090823|NCT02030067|449950914|FG010|Overall Study|other reasons|0|||
125090824|NCT02030067|449950915|FG011|Overall Study|other reasons|0|||
125090825|NCT02030067|449950916|FG012|Overall Study|other reasons|4|||
125090826|NCT02030067|449950904|FG000|Overall Study|Adverse Event|0|||
125090827|NCT02030067|449950905|FG001|Overall Study|Adverse Event|0|||
125090828|NCT02030067|449950906|FG002|Overall Study|Adverse Event|0|||
125090829|NCT02030067|449950907|FG003|Overall Study|Adverse Event|0|||
125090830|NCT02030067|449950908|FG004|Overall Study|Adverse Event|0|||
125090831|NCT02030067|449950909|FG005|Overall Study|Adverse Event|0|||
125090832|NCT02030067|449950910|FG006|Overall Study|Adverse Event|0|||
125090833|NCT02030067|449950911|FG007|Overall Study|Adverse Event|0|||
125090834|NCT02030067|449950912|FG008|Overall Study|Adverse Event|0|||
125090835|NCT02030067|449950913|FG009|Overall Study|Adverse Event|0|||
125090836|NCT02030067|449950914|FG010|Overall Study|Adverse Event|0|||
125090837|NCT02030067|449950915|FG011|Overall Study|Adverse Event|1|||
125090838|NCT02030067|449950916|FG012|Overall Study|Adverse Event|8|||
125090839|NCT01756846|449950917|FG000|Overall Study|Lost to Follow-up|5|||
125090840|NCT01756846|449950918|FG001|Overall Study|Lost to Follow-up|10|||
125090841|NCT01756846|449950917|FG000|Overall Study|Withdrawal by Subject|1|||
125090842|NCT01756846|449950918|FG001|Overall Study|Withdrawal by Subject|2|||
125090843|NCT01284127|449950919|FG000|Overall Study|Adverse Event|2|||
125090844|NCT01284127|449950919|FG000|Overall Study|Withdrawal by Subject|4|||
125090845|NCT01284127|449950919|FG000|Overall Study|Physician Decision|1|||
125090846|NCT00699582|449950922|FG000|Overall Study|Adverse Event|4|||
125090847|NCT00699582|449950923|FG001|Overall Study|Adverse Event|11|||
125090848|NCT00699582|449950924|FG002|Overall Study|Adverse Event|23|||
125090849|NCT00699582|449950922|FG000|Overall Study|Withdrawal by Subject|6|||
125090850|NCT00699582|449950923|FG001|Overall Study|Withdrawal by Subject|7|||
125090851|NCT00699582|449950924|FG002|Overall Study|Withdrawal by Subject|4|||
125090852|NCT00699582|449950922|FG000|Overall Study|Lack of Efficacy|1|||
125090853|NCT00699582|449950923|FG001|Overall Study|Lack of Efficacy|0|||
125090854|NCT00699582|449950924|FG002|Overall Study|Lack of Efficacy|1|||
125090855|NCT00699582|449950922|FG000|Overall Study|Progressive Disease|1|||
125090856|NCT00699582|449950923|FG001|Overall Study|Progressive Disease|0|||
125090857|NCT00699582|449950924|FG002|Overall Study|Progressive Disease|0|||
125090858|NCT00699582|449950922|FG000|Overall Study|Administrative/Other|4|||
125004254|NCT01970488|449643646|FG001|Part 2: Post Week 16|Adverse Event|0|||
125004255|NCT01970488|449643647|FG002|Part 2: Post Week 16|Adverse Event|5|||
125004256|NCT01970488|449643648|FG003|Part 2: Post Week 16|Adverse Event|1|||
125004257|NCT01970488|449643649|FG004|Part 2: Post Week 16|Adverse Event|1|||
125004258|NCT01970488|449643645|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
125004259|NCT01970488|449643646|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
125004260|NCT01970488|449643647|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
125004261|NCT01970488|449643648|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
125004262|NCT01970488|449643649|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
125004263|NCT01970488|449643645|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
125004264|NCT01970488|449643646|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
125004265|NCT01970488|449643647|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
125004266|NCT01970488|449643648|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
125004267|NCT01970488|449643649|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
125004268|NCT04060563|449643650|FG000|Overall Study|Lost to Follow-up|1|||
125004269|NCT04060563|449643651|FG001|Overall Study|Lost to Follow-up|1|||
125004270|NCT04060563|449643650|FG000|Overall Study|Physician Decision|0|||
125004271|NCT04060563|449643651|FG001|Overall Study|Physician Decision|1|||
125004272|NCT02613884|449643660|FG000|Overall Study|Death|1|||
125004273|NCT02613884|449643660|FG000|Overall Study|Lost to Follow-up|1|||
125004274|NCT00433914|449643664|FG000|Overall Study|Withdrawal by Subject|0|||
125004275|NCT00433914|449643665|FG001|Overall Study|Withdrawal by Subject|2|||
125004276|NCT00433914|449643664|FG000|Overall Study|Lost to Follow-up|0|||
125004277|NCT00433914|449643665|FG001|Overall Study|Lost to Follow-up|1|||
125004278|NCT02486653|449643666|FG000|Overall Study|Withdrawal by Subject|1|||
125004279|NCT02486653|449643667|FG001|Overall Study|Withdrawal by Subject|3|||
125004280|NCT02486653|449643666|FG000|Overall Study|Protocol Violation|1|||
125004281|NCT02486653|449643667|FG001|Overall Study|Protocol Violation|0|||
125004282|NCT02486653|449643666|FG000|Overall Study|surgery cancelled|4|||
125004283|NCT02486653|449643667|FG001|Overall Study|surgery cancelled|1|||
125004284|NCT01848353|449643678|FG000|Phase 1|Withdrawal by Subject|3|||
125004285|NCT01848353|449643679|FG001|Phase 1|Withdrawal by Subject|1|||
125004286|NCT01848353|449643680|FG002|Phase 1|Withdrawal by Subject|0|||
125004287|NCT01848353|449643681|FG003|Phase 1|Withdrawal by Subject|0|||
125004288|NCT01848353|449643678|FG000|Phase 2|Withdrawal by Subject|3|||
125004289|NCT01848353|449643679|FG001|Phase 2|Withdrawal by Subject|2|||
125004290|NCT01848353|449643680|FG002|Phase 2|Withdrawal by Subject|0|||
125004291|NCT01848353|449643681|FG003|Phase 2|Withdrawal by Subject|0|||
125004292|NCT01848353|449643678|FG000|Phase 3|Withdrawal by Subject|1|||
125004293|NCT01848353|449643679|FG001|Phase 3|Withdrawal by Subject|1|||
125004294|NCT01848353|449643680|FG002|Phase 3|Withdrawal by Subject|0|||
125004295|NCT01848353|449643681|FG003|Phase 3|Withdrawal by Subject|0|||
125004296|NCT03933397|449643682|FG000|Overall Study|No emergency department visit|65|||
125004297|NCT03933397|449643683|FG001|Overall Study|No emergency department visit|71|||
125004298|NCT03933397|449643682|FG000|Overall Study|Missed emergency department visit|25|||
125004299|NCT03933397|449643683|FG001|Overall Study|Missed emergency department visit|30|||
125004300|NCT03933397|449643682|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
125004301|NCT03933397|449643683|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
125004302|NCT03933397|449643682|FG000|Overall Study|Withdrawal by Subject|1|||
125004303|NCT03933397|449643683|FG001|Overall Study|Withdrawal by Subject|0|||
125004304|NCT03933397|449643682|FG000|Overall Study|Physician Decision|1|||
125004305|NCT03933397|449643683|FG001|Overall Study|Physician Decision|1|||
125004306|NCT03933397|449643682|FG000|Overall Study|missing pain score|1|||
125004307|NCT03933397|449643683|FG001|Overall Study|missing pain score|1|||
125004308|NCT03933397|449643682|FG000|Overall Study|Confirmed COVID-19|1|||
125004309|NCT03933397|449643683|FG001|Overall Study|Confirmed COVID-19|2|||
125004310|NCT00935272|449643686|FG000|Overall Study|Lost to Follow-up|10|||
125004311|NCT00935272|449643687|FG001|Overall Study|Lost to Follow-up|3|||
125004312|NCT00935272|449643686|FG000|Overall Study|Withdrawal by Subject|8|||
125004313|NCT00935272|449643687|FG001|Overall Study|Withdrawal by Subject|2|||
125004314|NCT00935272|449643686|FG000|Overall Study|Physician Decision|1|||
125004315|NCT00935272|449643687|FG001|Overall Study|Physician Decision|0|||
125004316|NCT00935272|449643686|FG000|Overall Study|Protocol Violation|0|||
125004317|NCT00935272|449643687|FG001|Overall Study|Protocol Violation|1|||
125004318|NCT01478360|449643688|FG000|Overall Study|Lost to Follow-up|1|||
125004319|NCT01478360|449643689|FG001|Overall Study|Lost to Follow-up|0|||
125004320|NCT01478360|449643688|FG000|Overall Study|Adverse Event|0|||
125090859|NCT00699582|449950923|FG001|Overall Study|Administrative/Other|3|||
125090860|NCT00699582|449950924|FG002|Overall Study|Administrative/Other|0|||
125004321|NCT01478360|449643689|FG001|Overall Study|Adverse Event|1|||
125004322|NCT01478360|449643688|FG000|Overall Study|Administrative problems|1|||
125004323|NCT01478360|449643689|FG001|Overall Study|Administrative problems|2|||
125004324|NCT04223791|449643690|FG000|Overall Study|Lost to Follow-up|0|||
125004325|NCT04223791|449643691|FG001|Overall Study|Lost to Follow-up|4|||
125090861|NCT00699582|449950922|FG000|Overall Study|Randomized, Not Treated|2|||
125090862|NCT00699582|449950923|FG001|Overall Study|Randomized, Not Treated|1|||
125090863|NCT00699582|449950924|FG002|Overall Study|Randomized, Not Treated|0|||
125090864|NCT02909504|449950930|FG000|Overall Study|Adverse Event|2|||
125090865|NCT02909504|449950930|FG000|Overall Study|Lack of Efficacy|3|||
125090866|NCT02909504|449950930|FG000|Overall Study|Withdrawal by Subject|4|||
125090867|NCT02909504|449950930|FG000|Overall Study|Pregnancy|1|||
125090868|NCT02909504|449950930|FG000|Overall Study|Subject moved|1|||
125090869|NCT02909504|449950930|FG000|Overall Study|Lost to Follow-up|1|||
125090870|NCT01843933|449950931|FG000|Overall Study|Data lost|6|||
125090871|NCT01843933|449950932|FG001|Overall Study|Data lost|4|||
125090872|NCT04411472|449950934|FG000|Overall Study|Adverse Event|5|||
125090873|NCT04411472|449950935|FG001|Overall Study|Adverse Event|10|||
125090874|NCT04411472|449950936|FG002|Overall Study|Adverse Event|1|||
125090875|NCT04411472|449950937|FG003|Overall Study|Adverse Event|0|||
125090876|NCT04411472|449950938|FG004|Overall Study|Adverse Event|0|||
125090877|NCT04411472|449950939|FG005|Overall Study|Adverse Event|0|||
125090878|NCT04411472|449950934|FG000|Overall Study|Protocol Violation|1|||
125090879|NCT04411472|449950935|FG001|Overall Study|Protocol Violation|0|||
125090880|NCT04411472|449950936|FG002|Overall Study|Protocol Violation|0|||
125090881|NCT04411472|449950937|FG003|Overall Study|Protocol Violation|0|||
125090882|NCT04411472|449950938|FG004|Overall Study|Protocol Violation|0|||
125090883|NCT04411472|449950939|FG005|Overall Study|Protocol Violation|0|||
125090884|NCT04411472|449950934|FG000|Overall Study|Withdrawal by Subject|0|||
125090885|NCT04411472|449950935|FG001|Overall Study|Withdrawal by Subject|1|||
125090886|NCT04411472|449950936|FG002|Overall Study|Withdrawal by Subject|0|||
125090887|NCT04411472|449950937|FG003|Overall Study|Withdrawal by Subject|1|||
125090888|NCT04411472|449950938|FG004|Overall Study|Withdrawal by Subject|0|||
125090889|NCT04411472|449950939|FG005|Overall Study|Withdrawal by Subject|0|||
125090890|NCT04411472|449950934|FG000|Overall Study|Physician Decision|1|||
125090891|NCT04411472|449950935|FG001|Overall Study|Physician Decision|0|||
125090892|NCT04411472|449950936|FG002|Overall Study|Physician Decision|0|||
125090893|NCT04411472|449950937|FG003|Overall Study|Physician Decision|0|||
125090894|NCT04411472|449950938|FG004|Overall Study|Physician Decision|0|||
125090895|NCT04411472|449950939|FG005|Overall Study|Physician Decision|0|||
125090896|NCT04411472|449950934|FG000|Overall Study|Study terminated by sponsor|17|||
125090897|NCT04411472|449950935|FG001|Overall Study|Study terminated by sponsor|20|||
125090898|NCT04411472|449950936|FG002|Overall Study|Study terminated by sponsor|3|||
125090899|NCT04411472|449950937|FG003|Overall Study|Study terminated by sponsor|0|||
125090900|NCT04411472|449950938|FG004|Overall Study|Study terminated by sponsor|0|||
125090901|NCT04411472|449950939|FG005|Overall Study|Study terminated by sponsor|0|||
125090902|NCT01747655|449950940|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
125090903|NCT01747655|449950941|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
125090904|NCT01747655|449950940|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
125090905|NCT01747655|449950941|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
125090906|NCT01747655|449950940|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
125090907|NCT01747655|449950941|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
125090908|NCT00982111|449950942|FG000|Overall Study|Adverse Event|1|||
125090909|NCT00982111|449950943|FG001|Overall Study|Adverse Event|1|||
125090910|NCT00982111|449950942|FG000|Overall Study|Progressive Disease|46|||
125090911|NCT00982111|449950943|FG001|Overall Study|Progressive Disease|39|||
125090912|NCT00982111|449950942|FG000|Overall Study|Lost to Follow-up|9|||
125090913|NCT00982111|449950943|FG001|Overall Study|Lost to Follow-up|6|||
125090914|NCT00982111|449950942|FG000|Overall Study|New Anti-Cancer Therapy|5|||
125090915|NCT00982111|449950943|FG001|Overall Study|New Anti-Cancer Therapy|5|||
125090916|NCT00982111|449950942|FG000|Overall Study|Medical Decision|1|||
125090917|NCT00982111|449950943|FG001|Overall Study|Medical Decision|0|||
125090918|NCT00982111|449950942|FG000|Overall Study|Withdrawal by Subject|17|||
125090919|NCT00982111|449950943|FG001|Overall Study|Withdrawal by Subject|19|||
125090920|NCT00982111|449950942|FG000|Overall Study|Global Study End|0|||
125090921|NCT00982111|449950943|FG001|Overall Study|Global Study End|1|||
125090922|NCT00982111|449950942|FG000|Overall Study|Sponsor's Decision|0|||
125090923|NCT00982111|449950943|FG001|Overall Study|Sponsor's Decision|1|||
125090924|NCT03769753|449950944|FG000|Overall Study|Not Treated|6|||
125090925|NCT03769753|449950944|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
125090926|NCT01482598|449950945|FG000|Overall Study|Death|7|||
125090927|NCT01482598|449950946|FG001|Overall Study|Death|10|||
125090928|NCT01482598|449950945|FG000|Overall Study|Physician Decision|0|||
125090929|NCT01482598|449950946|FG001|Overall Study|Physician Decision|3|||
125090930|NCT01482598|449950945|FG000|Overall Study|Withdrawal by Subject|4|||
125090931|NCT01482598|449950946|FG001|Overall Study|Withdrawal by Subject|5|||
125090932|NCT01482598|449950945|FG000|Overall Study|Lost to Follow-up|5|||
125090933|NCT01482598|449950946|FG001|Overall Study|Lost to Follow-up|4|||
125090934|NCT01373294|449950947|FG000|Overall Study|Adverse Event|1|||
125090935|NCT01373294|449950948|FG001|Overall Study|Adverse Event|0|||
125090936|NCT01920061|449950950|FG000|Overall Study|Death|1|||
125090937|NCT01920061|449950951|FG001|Overall Study|Death|1|||
125004326|NCT04223791|449643690|FG000|Overall Study|Physician Decision|5|||
125004327|NCT04223791|449643691|FG001|Overall Study|Physician Decision|1|||
125004328|NCT04223791|449643690|FG000|Overall Study|Protocol Violation|1|||
125004329|NCT04223791|449643691|FG001|Overall Study|Protocol Violation|1|||
125004330|NCT04223791|449643690|FG000|Overall Study|Withdrawal by Subject|10|||
125004331|NCT04223791|449643691|FG001|Overall Study|Withdrawal by Subject|12|||
125004332|NCT04223791|449643690|FG000|Overall Study|Pregnancy|1|||
125004333|NCT04223791|449643691|FG001|Overall Study|Pregnancy|1|||
125004334|NCT04223791|449643690|FG000|Overall Study|Ongoing in Study|305|||
125004335|NCT04223791|449643691|FG001|Overall Study|Ongoing in Study|302|||
125004336|NCT00395863|449646023|FG000|Overall Study|Patients did not complete both exams|2|||
125004337|NCT00395863|449646024|FG001|Overall Study|Patients did not complete both exams|3|||
125004338|NCT01069120|449646025|FG000|Overall Study|Study prematurely terminated|27|||
125004339|NCT05097716|449646026|FG000|Period 1|Adverse Event|1|||
125004340|NCT05097716|449646026|FG000|Period 1|Close contact with highly-transmissible infection|1|||
125004341|NCT02678416|449646040|FG000|Part 1|Withdrawal by Subject|1|||
125004342|NCT02678416|449646040|FG000|Part 2|Adverse Event|2|||
125004343|NCT02678416|449646040|FG000|Part 2|Withdrawal by Subject|1|||
125004344|NCT04556136|449646041|FG000|Overall Study|Lost to Follow-up|6|||
125004345|NCT04556136|449646042|FG001|Overall Study|Lost to Follow-up|6|||
125004346|NCT04556136|449646041|FG000|Overall Study|Physician Decision|2|||
125004347|NCT04556136|449646042|FG001|Overall Study|Physician Decision|1|||
125004348|NCT04556136|449646041|FG000|Overall Study|Withdrawal by Subject|2|||
125004349|NCT04556136|449646042|FG001|Overall Study|Withdrawal by Subject|1|||
125004350|NCT02289352|449646052|FG000|Overall Study|Withdrawal by Subject|1|||
125004351|NCT02289352|449646053|FG001|Overall Study|Withdrawal by Subject|1|||
125004352|NCT02289352|449646054|FG002|Overall Study|Withdrawal by Subject|0|||
125004353|NCT04340557|449646055|FG000|Overall Study|Transferred to ICU and/or death|1|||
125004354|NCT04340557|449646056|FG001|Overall Study|Transferred to ICU and/or death|2|||
125004355|NCT01177384|449646057|FG000|Overall Study|Adverse Event|6|||
125004356|NCT01177384|449646058|FG001|Overall Study|Adverse Event|4|||
125004357|NCT01177384|449646057|FG000|Overall Study|Lack of Efficacy|0|||
125004358|NCT01177384|449646058|FG001|Overall Study|Lack of Efficacy|1|||
125004359|NCT01177384|449646057|FG000|Overall Study|Lost to Follow-up|3|||
125004360|NCT01177384|449646058|FG001|Overall Study|Lost to Follow-up|4|||
125004361|NCT01177384|449646057|FG000|Overall Study|Physician Decision|0|||
125004362|NCT01177384|449646058|FG001|Overall Study|Physician Decision|3|||
125004363|NCT01177384|449646057|FG000|Overall Study|Protocol Violation|0|||
125004364|NCT01177384|449646058|FG001|Overall Study|Protocol Violation|2|||
125004365|NCT01177384|449646057|FG000|Overall Study|Withdrawal by Subject|5|||
125004366|NCT01177384|449646058|FG001|Overall Study|Withdrawal by Subject|12|||
125004367|NCT01849497|449646059|FG000|Overall Study|Withdrawal by Subject|1|||
125004368|NCT01849497|449646060|FG001|Overall Study|Withdrawal by Subject|2|||
125004369|NCT01849497|449646059|FG000|Overall Study|Sponsor Decision|0|||
125004370|NCT01849497|449646060|FG001|Overall Study|Sponsor Decision|1|||
125004371|NCT01849497|449646059|FG000|Overall Study|Lost to Follow-up|0|||
125004372|NCT01849497|449646060|FG001|Overall Study|Lost to Follow-up|1|||
125004373|NCT00911625|449646086|FG000|Overall Study|Lost to Follow-up|7|||
125004374|NCT00911625|449646087|FG001|Overall Study|Lost to Follow-up|0|||
125004375|NCT00529451|449646088|FG000|Overall Study|Subject withdrew consent|16|||
125004376|NCT00529451|449646089|FG001|Overall Study|Subject withdrew consent|21|||
125090938|NCT01920061|449950952|FG002|Overall Study|Death|0|||
125090939|NCT01920061|449950953|FG003|Overall Study|Death|1|||
125004377|NCT00529451|449646090|FG002|Overall Study|Subject withdrew consent|13|||
125004378|NCT00529451|449646091|FG003|Overall Study|Subject withdrew consent|12|||
125004379|NCT00529451|449646088|FG000|Overall Study|Adverse Event|9|||
125004380|NCT00529451|449646089|FG001|Overall Study|Adverse Event|16|||
125004381|NCT00529451|449646090|FG002|Overall Study|Adverse Event|14|||
125004382|NCT00529451|449646091|FG003|Overall Study|Adverse Event|8|||
125004383|NCT00529451|449646088|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
125004384|NCT00529451|449646089|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
125090940|NCT01920061|449950954|FG004|Overall Study|Death|1|||
125090941|NCT01920061|449950955|FG005|Overall Study|Death|0|||
125090942|NCT01920061|449950956|FG006|Overall Study|Death|0|||
125090943|NCT01920061|449950957|FG007|Overall Study|Death|1|||
125090944|NCT01920061|449950958|FG008|Overall Study|Death|0|||
125090945|NCT01920061|449950959|FG009|Overall Study|Death|1|||
125090946|NCT01920061|449950960|FG010|Overall Study|Death|0|||
125090947|NCT01920061|449950961|FG011|Overall Study|Death|1|||
125090948|NCT01920061|449950962|FG012|Overall Study|Death|0|||
125090949|NCT01920061|449950963|FG013|Overall Study|Death|2|||
125090950|NCT01920061|449950964|FG014|Overall Study|Death|0|||
125090951|NCT01920061|449950965|FG015|Overall Study|Death|0|||
125090952|NCT01920061|449950966|FG016|Overall Study|Death|0|||
125090953|NCT01920061|449950967|FG017|Overall Study|Death|0|||
125090954|NCT01920061|449950968|FG018|Overall Study|Death|1|||
125090955|NCT01920061|449950969|FG019|Overall Study|Death|0|||
125090956|NCT01920061|449950950|FG000|Overall Study|Lost to Follow-up|0|||
125090957|NCT01920061|449950951|FG001|Overall Study|Lost to Follow-up|2|||
125090958|NCT01920061|449950952|FG002|Overall Study|Lost to Follow-up|0|||
125090959|NCT01920061|449950953|FG003|Overall Study|Lost to Follow-up|0|||
125090960|NCT01920061|449950954|FG004|Overall Study|Lost to Follow-up|0|||
125090961|NCT01920061|449950955|FG005|Overall Study|Lost to Follow-up|0|||
125090962|NCT01920061|449950956|FG006|Overall Study|Lost to Follow-up|1|||
125090963|NCT01920061|449950957|FG007|Overall Study|Lost to Follow-up|0|||
125090964|NCT01920061|449950958|FG008|Overall Study|Lost to Follow-up|0|||
125090965|NCT01920061|449950959|FG009|Overall Study|Lost to Follow-up|0|||
125090966|NCT01920061|449950960|FG010|Overall Study|Lost to Follow-up|3|||
125090967|NCT01920061|449950961|FG011|Overall Study|Lost to Follow-up|0|||
125090968|NCT01920061|449950962|FG012|Overall Study|Lost to Follow-up|0|||
125090969|NCT01920061|449950963|FG013|Overall Study|Lost to Follow-up|0|||
125090970|NCT01920061|449950964|FG014|Overall Study|Lost to Follow-up|0|||
125090971|NCT01920061|449950965|FG015|Overall Study|Lost to Follow-up|0|||
125090972|NCT01920061|449950966|FG016|Overall Study|Lost to Follow-up|0|||
125090973|NCT01920061|449950967|FG017|Overall Study|Lost to Follow-up|1|||
125090974|NCT01920061|449950968|FG018|Overall Study|Lost to Follow-up|4|||
125090975|NCT01920061|449950969|FG019|Overall Study|Lost to Follow-up|3|||
125090976|NCT01920061|449950950|FG000|Overall Study|Other|1|||
125090977|NCT01920061|449950951|FG001|Overall Study|Other|1|||
125090978|NCT01920061|449950952|FG002|Overall Study|Other|2|||
125090979|NCT01920061|449950953|FG003|Overall Study|Other|1|||
125090980|NCT01920061|449950954|FG004|Overall Study|Other|0|||
125090981|NCT01920061|449950955|FG005|Overall Study|Other|1|||
125090982|NCT01920061|449950956|FG006|Overall Study|Other|0|||
125090983|NCT01920061|449950957|FG007|Overall Study|Other|0|||
125090984|NCT01920061|449950958|FG008|Overall Study|Other|0|||
125090985|NCT01920061|449950959|FG009|Overall Study|Other|1|||
125090986|NCT01920061|449950960|FG010|Overall Study|Other|1|||
125090987|NCT01920061|449950961|FG011|Overall Study|Other|2|||
125090988|NCT01920061|449950962|FG012|Overall Study|Other|1|||
125090989|NCT01920061|449950963|FG013|Overall Study|Other|4|||
125090990|NCT01920061|449950964|FG014|Overall Study|Other|0|||
125090991|NCT01920061|449950965|FG015|Overall Study|Other|1|||
125090992|NCT01920061|449950966|FG016|Overall Study|Other|1|||
125090993|NCT01920061|449950967|FG017|Overall Study|Other|0|||
125090994|NCT01920061|449950968|FG018|Overall Study|Other|1|||
125090995|NCT01920061|449950969|FG019|Overall Study|Other|1|||
125090996|NCT01920061|449950950|FG000|Overall Study|Participant refused further follow-up|0|||
125090997|NCT01920061|449950951|FG001|Overall Study|Participant refused further follow-up|0|||
125090998|NCT01920061|449950952|FG002|Overall Study|Participant refused further follow-up|0|||
125090999|NCT01920061|449950953|FG003|Overall Study|Participant refused further follow-up|0|||
125091000|NCT01920061|449950954|FG004|Overall Study|Participant refused further follow-up|1|||
125091001|NCT01920061|449950955|FG005|Overall Study|Participant refused further follow-up|1|||
125091002|NCT01920061|449950956|FG006|Overall Study|Participant refused further follow-up|0|||
125091003|NCT01920061|449950957|FG007|Overall Study|Participant refused further follow-up|0|||
125091004|NCT01920061|449950958|FG008|Overall Study|Participant refused further follow-up|1|||
125091005|NCT01920061|449950959|FG009|Overall Study|Participant refused further follow-up|0|||
125091006|NCT01920061|449950960|FG010|Overall Study|Participant refused further follow-up|1|||
125091007|NCT01920061|449950961|FG011|Overall Study|Participant refused further follow-up|0|||
125091008|NCT01920061|449950962|FG012|Overall Study|Participant refused further follow-up|1|||
125091009|NCT01920061|449950963|FG013|Overall Study|Participant refused further follow-up|0|||
125091010|NCT01920061|449950964|FG014|Overall Study|Participant refused further follow-up|1|||
125091011|NCT01920061|449950965|FG015|Overall Study|Participant refused further follow-up|2|||
125091012|NCT01920061|449950966|FG016|Overall Study|Participant refused further follow-up|1|||
125091013|NCT01920061|449950967|FG017|Overall Study|Participant refused further follow-up|1|||
125091014|NCT01920061|449950968|FG018|Overall Study|Participant refused further follow-up|0|||
125091015|NCT01920061|449950969|FG019|Overall Study|Participant refused further follow-up|0|||
125091016|NCT00517634|449950970|FG000|Second Treatment Period|Withdrawal by Subject|0|||
125091017|NCT00517634|449950971|FG001|Second Treatment Period|Withdrawal by Subject|0|||
125004385|NCT00529451|449646090|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
125004386|NCT00529451|449646091|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
125004387|NCT00529451|449646088|FG000|Overall Study|Lost to Follow-up|4|||
125004388|NCT00529451|449646089|FG001|Overall Study|Lost to Follow-up|7|||
125004389|NCT00529451|449646090|FG002|Overall Study|Lost to Follow-up|4|||
125004390|NCT00529451|449646091|FG003|Overall Study|Lost to Follow-up|4|||
125004391|NCT00529451|449646088|FG000|Overall Study|Protocol deviation|1|||
125004392|NCT00529451|449646089|FG001|Overall Study|Protocol deviation|1|||
125004393|NCT00529451|449646090|FG002|Overall Study|Protocol deviation|4|||
125004394|NCT00529451|449646091|FG003|Overall Study|Protocol deviation|1|||
125004395|NCT00529451|449646088|FG000|Overall Study|Administrative problems|1|||
125004396|NCT00529451|449646089|FG001|Overall Study|Administrative problems|1|||
125004397|NCT00529451|449646090|FG002|Overall Study|Administrative problems|0|||
125004398|NCT00529451|449646091|FG003|Overall Study|Administrative problems|2|||
125004399|NCT01289821|449646094|FG000|Treatment Period|Withdrawal by Subject|1|||
125004400|NCT01289821|449646094|FG000|Treatment Period|Physician Decision|3|||
125004401|NCT01289821|449646094|FG000|Treatment Period|Adverse Event|4|||
125004402|NCT01289821|449646094|FG000|Treatment Period|Radiological Progression|43|||
125004403|NCT01289821|449646094|FG000|Treatment Period|Clinical Progression|2|||
125004404|NCT01289821|449646094|FG000|Treatment Period|Therapeutic procedure required|1|||
125004405|NCT01289821|449646094|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
125004406|NCT01289821|449646094|FG000|Safety Follow-up Period|Protocol Violation|3|||
125004407|NCT01289821|449646094|FG000|Safety Follow-up Period|Unspecified reason|1|||
125004408|NCT01289821|449646094|FG000|Survival Follow-up Period|Protocol Violation|1|||
125004409|NCT01289821|449646094|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
125004410|NCT01289821|449646094|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
125004411|NCT00773136|449646100|FG000|Overall Study|Physician Decision|2|||
125004412|NCT01010633|449646103|FG000|Overall Study|Adverse Event|1|||
125004413|NCT01010633|449646104|FG001|Overall Study|Adverse Event|1|||
125004414|NCT01010633|449646103|FG000|Overall Study|Protocol Violation|1|||
125004415|NCT01010633|449646104|FG001|Overall Study|Protocol Violation|2|||
125004416|NCT01010633|449646103|FG000|Overall Study|Withdrawal by Subject|2|||
125004417|NCT01010633|449646104|FG001|Overall Study|Withdrawal by Subject|1|||
125004418|NCT01010633|449646103|FG000|Overall Study|Investigator decision|0|||
125004419|NCT01010633|449646104|FG001|Overall Study|Investigator decision|1|||
125004420|NCT00097773|449646106|FG000|Overall Study|Lost to Follow-up|2|||
125004421|NCT00097773|449646107|FG001|Overall Study|Lost to Follow-up|2|||
125004422|NCT00097773|449646108|FG002|Overall Study|Lost to Follow-up|0|||
125004423|NCT00097773|449646109|FG003|Overall Study|Lost to Follow-up|1|||
125004424|NCT00097773|449646106|FG000|Overall Study|Physician Decision|2|||
125004425|NCT00097773|449646107|FG001|Overall Study|Physician Decision|2|||
125004426|NCT00097773|449646108|FG002|Overall Study|Physician Decision|3|||
125004427|NCT00097773|449646109|FG003|Overall Study|Physician Decision|1|||
125004428|NCT00097773|449646106|FG000|Overall Study|Withdrawal by Subject|3|||
125004429|NCT00097773|449646107|FG001|Overall Study|Withdrawal by Subject|3|||
125004430|NCT00097773|449646108|FG002|Overall Study|Withdrawal by Subject|3|||
125004431|NCT00097773|449646109|FG003|Overall Study|Withdrawal by Subject|1|||
125004432|NCT00097773|449646106|FG000|Overall Study|Adverse Event|0|||
125004433|NCT00097773|449646107|FG001|Overall Study|Adverse Event|1|||
125004434|NCT00097773|449646108|FG002|Overall Study|Adverse Event|0|||
125004435|NCT00097773|449646109|FG003|Overall Study|Adverse Event|0|||
125004436|NCT00097773|449646106|FG000|Overall Study|Other|1|||
125004437|NCT00097773|449646107|FG001|Overall Study|Other|0|||
125004438|NCT00097773|449646108|FG002|Overall Study|Other|2|||
125004439|NCT00097773|449646109|FG003|Overall Study|Other|0|||
125004440|NCT00003702|449646110|FG000|Overall Study|Ineligible cell types|2|||
125004441|NCT00003702|449646111|FG001|Overall Study|Ineligible cell types|2|||
125004442|NCT00003702|449646110|FG000|Overall Study|Did not meet criteria for persistence|8|||
125091018|NCT00517634|449950972|FG002|Second Treatment Period|Withdrawal by Subject|0|||
125091019|NCT00517634|449950973|FG003|Second Treatment Period|Withdrawal by Subject|0|||
125091020|NCT00517634|449950974|FG004|Second Treatment Period|Withdrawal by Subject|1|||
125091021|NCT00517634|449950975|FG005|Second Treatment Period|Withdrawal by Subject|0|||
125091022|NCT03091920|449950976|FG000|Overall Study|Adverse Event|0|||
125091023|NCT03091920|449950977|FG001|Overall Study|Adverse Event|1|||
125091024|NCT03091920|449950978|FG002|Overall Study|Adverse Event|0|||
125091025|NCT03143855|449950979|FG000|Overall Study|Withdrawal by Subject|4|||
125091026|NCT03143855|449950980|FG001|Overall Study|Withdrawal by Subject|3|||
125091027|NCT03143855|449950979|FG000|Overall Study|Protocol Violation|1|||
125091028|NCT03143855|449950980|FG001|Overall Study|Protocol Violation|0|||
125091029|NCT03143855|449950979|FG000|Overall Study|Participant experienced withdrawal|0|||
125091030|NCT03143855|449950980|FG001|Overall Study|Participant experienced withdrawal|1|||
125091031|NCT00453349|449950981|FG000|Randomized|Adverse Event|12|||
125091032|NCT00453349|449950982|FG001|Randomized|Adverse Event|11|||
125091033|NCT00453349|449950981|FG000|Randomized|Lack of Efficacy|2|||
125091034|NCT00453349|449950982|FG001|Randomized|Lack of Efficacy|1|||
125091035|NCT00453349|449950981|FG000|Randomized|Lost to Follow-up|7|||
125091036|NCT00453349|449950982|FG001|Randomized|Lost to Follow-up|5|||
125091037|NCT00453349|449950981|FG000|Randomized|Protocol Violation|1|||
125091038|NCT00453349|449950982|FG001|Randomized|Protocol Violation|1|||
125091039|NCT00453349|449950981|FG000|Randomized|Withdrawal by Subject|3|||
125091040|NCT00453349|449950982|FG001|Randomized|Withdrawal by Subject|5|||
125091041|NCT00453349|449950981|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
125091042|NCT00453349|449950982|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
125091043|NCT00453349|449950981|FG000|Completed Study|Adverse Event|12|||
125091044|NCT00453349|449950982|FG001|Completed Study|Adverse Event|11|||
125091045|NCT00453349|449950981|FG000|Completed Study|Lack of Efficacy|2|||
125091046|NCT00453349|449950982|FG001|Completed Study|Lack of Efficacy|1|||
125091047|NCT00453349|449950981|FG000|Completed Study|Lost to Follow-up|7|||
125091048|NCT00453349|449950982|FG001|Completed Study|Lost to Follow-up|5|||
125091049|NCT00453349|449950981|FG000|Completed Study|Protocol Violation|1|||
125091050|NCT00453349|449950982|FG001|Completed Study|Protocol Violation|1|||
125091051|NCT00453349|449950981|FG000|Completed Study|Withdrawal by Subject|3|||
125091052|NCT00453349|449950982|FG001|Completed Study|Withdrawal by Subject|5|||
125091053|NCT00453349|449950981|FG000|Completed Study|Lost to follow up after study treatment|2|||
125091054|NCT00453349|449950982|FG001|Completed Study|Lost to follow up after study treatment|11|||
125091055|NCT04369742|449950984|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
125091056|NCT04369742|449950985|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
125091057|NCT04369742|449950984|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
125091058|NCT04369742|449950985|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
125091059|NCT02098733|449950990|FG000|Overall Study|Data Not Available|5|||
125091060|NCT02098733|449950990|FG000|Overall Study|Lost to Follow-up|5|||
125091061|NCT00695318|449950991|FG000|Overall Study|Lost to Follow-up|1|||
125004443|NCT00003702|449646111|FG001|Overall Study|Did not meet criteria for persistence|5|||
125004444|NCT00003702|449646110|FG000|Overall Study|WHO score > 6|2|||
125004445|NCT00003702|449646111|FG001|Overall Study|WHO score > 6|1|||
125004446|NCT00003702|449646110|FG000|Overall Study|Inadequate documentation of disease|1|||
125004447|NCT00003702|449646111|FG001|Overall Study|Inadequate documentation of disease|3|||
125004448|NCT01009034|449646112|FG000|Overall Study|Lost to Follow-up|2|||
125004449|NCT01009034|449646112|FG000|Overall Study|Withdrawal by Subject|2|||
125004450|NCT01494350|449646113|FG000|Overall Study|Worsening of lesion|1|||
125004451|NCT00698932|449646114|FG000|Overall Study|Adverse Event|0|||
125004452|NCT00698932|449646115|FG001|Overall Study|Adverse Event|2|||
125004453|NCT00698932|449646114|FG000|Overall Study|Incorrect enrollment|0|||
125004454|NCT00698932|449646115|FG001|Overall Study|Incorrect enrollment|2|||
125004455|NCT00698932|449646114|FG000|Overall Study|Study specific discontinuation criteria|3|||
125004456|NCT00698932|449646115|FG001|Overall Study|Study specific discontinuation criteria|4|||
125004457|NCT00698932|449646114|FG000|Overall Study|Withdrawal by Subject|11|||
125004458|NCT00698932|449646115|FG001|Overall Study|Withdrawal by Subject|23|||
125004459|NCT00698932|449646114|FG000|Overall Study|Lost to Follow-up|6|||
125004460|NCT00698932|449646115|FG001|Overall Study|Lost to Follow-up|1|||
125004461|NCT00698932|449646114|FG000|Overall Study|Severe non-compliance to protocol|1|||
125004462|NCT00698932|449646115|FG001|Overall Study|Severe non-compliance to protocol|2|||
125004463|NCT00698932|449646114|FG000|Overall Study|Safety reasons|0|||
125004464|NCT00698932|449646115|FG001|Overall Study|Safety reasons|2|||
125004465|NCT00698932|449646114|FG000|Overall Study|Death|1|||
125004466|NCT00698932|449646115|FG001|Overall Study|Death|0|||
125004467|NCT01245387|449646116|FG000|Overall Study|Lost to Follow-up|106|||
125004468|NCT01245387|449646116|FG000|Overall Study|Lack of Efficacy|195|||
125004469|NCT01245387|449646116|FG000|Overall Study|Adverse Event|9|||
125004470|NCT01245387|449646116|FG000|Overall Study|Death|3|||
125004471|NCT01245387|449646116|FG000|Overall Study|Other|131|||
125004472|NCT01245387|449646116|FG000|Overall Study|Missing discontinuation status|369|||
125004473|NCT00757003|449646117|FG000|Overall Study|Death|33|||
125004474|NCT00757003|449646117|FG000|Overall Study|Lost to Follow-up|9|||
125004475|NCT00757003|449646117|FG000|Overall Study|Withdrawal by Subject|4|||
125004476|NCT00757003|449646117|FG000|Overall Study|Surgically explanted|2|||
125004477|NCT00757003|449646117|FG000|Overall Study|Not implanted|1|||
125004478|NCT02146599|449646120|FG000|Overall Study|Failed to meet inclusion criteria|5|||
125004479|NCT03061175|449646126|FG000|Baseline|Participant was deemed ineligible|1|||
125004480|NCT03061175|449646127|FG001|Baseline|Participant was deemed ineligible|0|||
125004481|NCT03061175|449646126|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
125004482|NCT03061175|449646127|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
125004483|NCT03061175|449646126|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
125004484|NCT03061175|449646127|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
125004485|NCT03061175|449646126|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
125004486|NCT03061175|449646127|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
125004487|NCT02243865|449646128|FG000|Overall Study|Protocol Violation|1|||
125004488|NCT02243865|449646129|FG001|Overall Study|Protocol Violation|3|||
125004489|NCT02243865|449646128|FG000|Overall Study|Lost to Follow-up|1|||
125004490|NCT02243865|449646129|FG001|Overall Study|Lost to Follow-up|1|||
125004491|NCT02243865|449646128|FG000|Overall Study|Withdrawal by Subject|1|||
125004492|NCT02243865|449646129|FG001|Overall Study|Withdrawal by Subject|0|||
125004493|NCT02243865|449646128|FG000|Overall Study|Adverse Event|1|||
125004494|NCT02243865|449646129|FG001|Overall Study|Adverse Event|1|||
125004495|NCT03044249|449646132|FG000|Overall Study|Adverse Event|4|||
125004496|NCT03044249|449646133|FG001|Overall Study|Adverse Event|9|||
125004497|NCT03044249|449646132|FG000|Overall Study|Lost to Follow-up|1|||
125004498|NCT03044249|449646133|FG001|Overall Study|Lost to Follow-up|0|||
125004499|NCT03044249|449646132|FG000|Overall Study|Non-compliance with Study Drug|1|||
125004500|NCT03044249|449646133|FG001|Overall Study|Non-compliance with Study Drug|0|||
125004501|NCT03044249|449646132|FG000|Overall Study|Study Terminated by Sponsor|2|||
125004502|NCT03044249|449646133|FG001|Overall Study|Study Terminated by Sponsor|0|||
125004503|NCT03044249|449646132|FG000|Overall Study|Withdrawal by Subject|2|||
125004504|NCT03044249|449646133|FG001|Overall Study|Withdrawal by Subject|5|||
125091062|NCT00695318|449950992|FG001|Overall Study|Lost to Follow-up|0|||
125091063|NCT00695318|449950991|FG000|Overall Study|Withdrawal by Subject|2|||
125091064|NCT00695318|449950992|FG001|Overall Study|Withdrawal by Subject|0|||
125091065|NCT00695318|449950991|FG000|Overall Study|Death|1|||
125091066|NCT00695318|449950992|FG001|Overall Study|Death|1|||
125091067|NCT00695318|449950991|FG000|Overall Study|Study Terminated|1|||
125091068|NCT00695318|449950992|FG001|Overall Study|Study Terminated|0|||
125091069|NCT00434876|449950993|FG000|Overall Study|Lost to Follow-up|1|||
125091070|NCT00434876|449950994|FG001|Overall Study|Lost to Follow-up|1|||
125091071|NCT01078389|449952896|FG000|Overall Study|Adverse Event|10|||
125091072|NCT01078389|449952897|FG001|Overall Study|Adverse Event|6|||
125091073|NCT01078389|449952896|FG000|Overall Study|Major Protocol Deviation|2|||
125091074|NCT01078389|449952897|FG001|Overall Study|Major Protocol Deviation|0|||
125091075|NCT01078389|449952896|FG000|Overall Study|Lost to Follow-up|23|||
125091076|NCT01078389|449952897|FG001|Overall Study|Lost to Follow-up|23|||
125091077|NCT01078389|449952896|FG000|Overall Study|Voluntary Withdrawal|20|||
125091078|NCT01078389|449952897|FG001|Overall Study|Voluntary Withdrawal|36|||
125091079|NCT01078389|449952896|FG000|Overall Study|Other|9|||
125091080|NCT01078389|449952897|FG001|Overall Study|Other|2|||
125091081|NCT01002573|449952898|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
125091082|NCT01002573|449952899|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
125091083|NCT02028182|449952900|FG000|Overall Study|Protocol Violation|2|||
125091084|NCT02198040|449952903|FG000|Overall Study|Work reasons|0|||
125091085|NCT02198040|449952904|FG001|Overall Study|Work reasons|1|||
125091086|NCT02198040|449952905|FG002|Overall Study|Work reasons|0|||
125091087|NCT02198040|449952903|FG000|Overall Study|Withdrawal by Subject|0|||
125091088|NCT02198040|449952904|FG001|Overall Study|Withdrawal by Subject|0|||
125091089|NCT02198040|449952905|FG002|Overall Study|Withdrawal by Subject|1|||
125091090|NCT04524663|449952906|FG000|Overall Study|Withdrawal by Subject|0|||
125091091|NCT04524663|449952907|FG001|Overall Study|Withdrawal by Subject|2|||
125091092|NCT00337935|449952908|FG000|Overall Study|Adverse Event|2|||
125091093|NCT00337935|449952909|FG001|Overall Study|Adverse Event|5|||
125091094|NCT00337935|449952908|FG000|Overall Study|Death|2|||
125091095|NCT00337935|449952909|FG001|Overall Study|Death|8|||
125091096|NCT00337935|449952908|FG000|Overall Study|Physician Decision|1|||
125091097|NCT00337935|449952909|FG001|Overall Study|Physician Decision|1|||
124872988|NCT00508261|449157215|FG003|Overall Study|Serious Adverse Event|0|||
124872989|NCT00508261|449157212|FG000|Overall Study|Withdrawal by Subject|3|||
125091098|NCT00337935|449952908|FG000|Overall Study|Lost to Follow-up|0|||
125091099|NCT00337935|449952909|FG001|Overall Study|Lost to Follow-up|1|||
125091100|NCT00337935|449952908|FG000|Overall Study|Protocol Violation|4|||
125091101|NCT00337935|449952909|FG001|Overall Study|Protocol Violation|3|||
125091102|NCT00337935|449952908|FG000|Overall Study|Withdrawal by Subject|1|||
125091103|NCT00337935|449952909|FG001|Overall Study|Withdrawal by Subject|7|||
125091104|NCT00337935|449952908|FG000|Overall Study|Other|0|||
125091105|NCT00337935|449952909|FG001|Overall Study|Other|1|||
125091106|NCT00337935|449952908|FG000|Overall Study|Lack of Efficacy|0|||
125091107|NCT00337935|449952909|FG001|Overall Study|Lack of Efficacy|1|||
125091108|NCT01884675|449952910|FG000|Overall Study|Study closed/terminated|3|||
125091109|NCT01884675|449952911|FG001|Overall Study|Study closed/terminated|2|||
125091110|NCT02361307|449952912|FG000|Overall Study|Unstable medical condition.|0|||
125091111|NCT02361307|449952913|FG001|Overall Study|Unstable medical condition.|1|||
125091112|NCT00711009|449952914|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
125091113|NCT00711009|449952915|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
125091114|NCT00711009|449952914|FG000|Overall Study|Withdrawal by Subject|4|||
125091115|NCT00711009|449952915|FG001|Overall Study|Withdrawal by Subject|2|||
125091116|NCT00711009|449952914|FG000|Overall Study|Lost to Follow-up|3|||
125091117|NCT00711009|449952915|FG001|Overall Study|Lost to Follow-up|9|||
125091118|NCT00711009|449952914|FG000|Overall Study|Participant Noncompliant|0|||
125091119|NCT00711009|449952915|FG001|Overall Study|Participant Noncompliant|1|||
125091120|NCT00711009|449952914|FG000|Overall Study|Virologic Failure|2|||
125091121|NCT00711009|449952915|FG001|Overall Study|Virologic Failure|1|||
125091122|NCT00711009|449952914|FG000|Overall Study|Pregnancy|1|||
125091123|NCT00711009|449952915|FG001|Overall Study|Pregnancy|0|||
125091124|NCT00711009|449952914|FG000|Overall Study|Site closing|0|||
125091125|NCT00711009|449952915|FG001|Overall Study|Site closing|1|||
125091126|NCT00711009|449952914|FG000|Overall Study|Dose adjustment|1|||
125091127|NCT00711009|449952915|FG001|Overall Study|Dose adjustment|0|||
125091128|NCT03359811|449952916|FG000|Overall Study|Protocol Violation|2|||
125091129|NCT03359811|449952917|FG001|Overall Study|Protocol Violation|0|||
125091130|NCT01682876|449952918|FG000|Overall Study|Administrative reason|4|||
125091131|NCT01682876|449952919|FG001|Overall Study|Administrative reason|4|||
125091132|NCT01682876|449952920|FG002|Overall Study|Administrative reason|0|||
125091133|NCT01682876|449952921|FG003|Overall Study|Administrative reason|3|||
125091134|NCT01682876|449952918|FG000|Overall Study|Adverse Event|0|||
125091135|NCT01682876|449952919|FG001|Overall Study|Adverse Event|0|||
125091136|NCT01682876|449952920|FG002|Overall Study|Adverse Event|0|||
125091137|NCT01682876|449952921|FG003|Overall Study|Adverse Event|1|||
125091138|NCT01682876|449952918|FG000|Overall Study|Lost to Follow-up|11|||
125091139|NCT01682876|449952919|FG001|Overall Study|Lost to Follow-up|15|||
125091140|NCT01682876|449952920|FG002|Overall Study|Lost to Follow-up|9|||
125091141|NCT01682876|449952921|FG003|Overall Study|Lost to Follow-up|11|||
125091142|NCT01682876|449952918|FG000|Overall Study|Protocol Violation|1|||
125091143|NCT01682876|449952919|FG001|Overall Study|Protocol Violation|1|||
125091144|NCT01682876|449952920|FG002|Overall Study|Protocol Violation|1|||
125091145|NCT01682876|449952921|FG003|Overall Study|Protocol Violation|1|||
125091146|NCT01682876|449952918|FG000|Overall Study|Withdrawal by Subject|4|||
125091147|NCT01682876|449952919|FG001|Overall Study|Withdrawal by Subject|0|||
125091148|NCT01682876|449952920|FG002|Overall Study|Withdrawal by Subject|0|||
125091149|NCT01682876|449952921|FG003|Overall Study|Withdrawal by Subject|2|||
125091150|NCT01682876|449952918|FG000|Overall Study|Other|1|||
125091151|NCT01682876|449952919|FG001|Overall Study|Other|0|||
125091152|NCT01682876|449952920|FG002|Overall Study|Other|1|||
125091153|NCT01682876|449952921|FG003|Overall Study|Other|1|||
125091154|NCT02534324|449952923|FG000|Overall Study|Protocol Violation|4|||
125091155|NCT02534324|449952924|FG001|Overall Study|Protocol Violation|1|||
125091156|NCT02534324|449952923|FG000|Overall Study|Lost to Follow-up|20|||
125091157|NCT02534324|449952924|FG001|Overall Study|Lost to Follow-up|7|||
125091158|NCT02534324|449952923|FG000|Overall Study|Adverse Event|1|||
125091159|NCT02534324|449952924|FG001|Overall Study|Adverse Event|0|||
125091160|NCT01459016|449952927|FG000|Overall Study|Withdrawal by Subject|11|||
125091161|NCT01459016|449952927|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
125091162|NCT00303602|449952931|FG000|Overall Study|Adverse Event|2|||
125091163|NCT00303602|449952932|FG001|Overall Study|Adverse Event|2|||
125091164|NCT00303602|449952931|FG000|Overall Study|Withdrawal by Subject|5|||
125091165|NCT00303602|449952932|FG001|Overall Study|Withdrawal by Subject|6|||
125091166|NCT00303602|449952931|FG000|Overall Study|Lost to Follow-up|5|||
125091167|NCT00303602|449952932|FG001|Overall Study|Lost to Follow-up|2|||
125091168|NCT00303602|449952931|FG000|Overall Study|Protocol entry criteria not met|2|||
125091169|NCT00303602|449952932|FG001|Overall Study|Protocol entry criteria not met|2|||
125091170|NCT00303602|449952931|FG000|Overall Study|Physician Decision|2|||
125091171|NCT00303602|449952932|FG001|Overall Study|Physician Decision|1|||
125091172|NCT00303602|449952931|FG000|Overall Study|Noncompliance|2|||
125091173|NCT00303602|449952932|FG001|Overall Study|Noncompliance|2|||
125091174|NCT00303602|449952931|FG000|Overall Study|Protocol Violation|1|||
125091175|NCT00303602|449952932|FG001|Overall Study|Protocol Violation|0|||
125091176|NCT00663208|449952937|FG000|Treatment Period|Lost to Follow-up|0|||
125091177|NCT00663208|449952938|FG001|Treatment Period|Lost to Follow-up|1|||
125091178|NCT00663208|449952939|FG002|Treatment Period|Lost to Follow-up|0|||
125091179|NCT00663208|449952940|FG003|Treatment Period|Lost to Follow-up|0|||
125091180|NCT00663208|449952941|FG004|Treatment Period|Lost to Follow-up|0|||
125091181|NCT00663208|449952942|FG005|Treatment Period|Lost to Follow-up|0|||
125091182|NCT00663208|449952943|FG006|Treatment Period|Lost to Follow-up|0|||
125091183|NCT00663208|449952937|FG000|Follow-up Period|Lost to Follow-up|2|||
125091184|NCT00663208|449952938|FG001|Follow-up Period|Lost to Follow-up|0|||
125091185|NCT00663208|449952939|FG002|Follow-up Period|Lost to Follow-up|3|||
125091186|NCT00663208|449952940|FG003|Follow-up Period|Lost to Follow-up|2|||
125091187|NCT00663208|449952941|FG004|Follow-up Period|Lost to Follow-up|0|||
125091188|NCT00663208|449952942|FG005|Follow-up Period|Lost to Follow-up|0|||
125091189|NCT00663208|449952943|FG006|Follow-up Period|Lost to Follow-up|0|||
125091190|NCT00663208|449952937|FG000|Follow-up Period|Other reason|1|||
125091191|NCT00663208|449952938|FG001|Follow-up Period|Other reason|0|||
125091192|NCT00663208|449952939|FG002|Follow-up Period|Other reason|0|||
125091193|NCT00663208|449952940|FG003|Follow-up Period|Other reason|0|||
125091194|NCT00663208|449952941|FG004|Follow-up Period|Other reason|0|||
125091195|NCT00663208|449952942|FG005|Follow-up Period|Other reason|0|||
125091196|NCT00663208|449952943|FG006|Follow-up Period|Other reason|1|||
125091197|NCT04563845|449952945|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125091198|NCT04563845|449952946|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125091199|NCT04563845|449952947|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125091200|NCT04563845|449952948|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125091201|NCT04563845|449952949|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125091202|NCT04563845|449952950|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125091203|NCT04563845|449952951|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125091204|NCT04563845|449952952|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
125091205|NCT04563845|449952953|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125091206|NCT04563845|449952954|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125091207|NCT04563845|449952955|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125091208|NCT04563845|449952956|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125091209|NCT04563845|449952957|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125091210|NCT04563845|449952958|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125091211|NCT04563845|449952945|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125091212|NCT04563845|449952946|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125091213|NCT04563845|449952947|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125091214|NCT04563845|449952948|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125091215|NCT04563845|449952949|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
125091216|NCT04563845|449952950|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125091217|NCT04563845|449952951|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125091218|NCT04563845|449952952|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125091219|NCT04563845|449952953|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125091220|NCT04563845|449952954|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125091221|NCT04563845|449952955|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125091222|NCT04563845|449952956|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125091223|NCT04563845|449952957|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125091224|NCT04563845|449952958|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125091225|NCT02146274|449952959|FG000|Overall Study|Protocol Violation|73|||
125091226|NCT01539720|449952960|FG000|Overall Study|Screen Fail|15|||
125091227|NCT01539720|449952961|FG001|Overall Study|Screen Fail|3|||
125091228|NCT01539720|449952960|FG000|Overall Study|Lost to Follow-up|14|||
125091229|NCT01539720|449952961|FG001|Overall Study|Lost to Follow-up|7|||
125091230|NCT03938857|449952965|FG000|Overall Study|Physician Decision|1|||
125091231|NCT03938857|449952966|FG001|Overall Study|Physician Decision|0|||
125091232|NCT03938857|449952967|FG002|Overall Study|Physician Decision|0|||
125091233|NCT03938857|449952968|FG003|Overall Study|Physician Decision|0|||
125091234|NCT02516605|449952969|FG000|Overall Study|Protocol Violation|0|||
125091235|NCT02516605|449952970|FG001|Overall Study|Protocol Violation|0|||
125091236|NCT02516605|449952971|FG002|Overall Study|Protocol Violation|0|||
125091237|NCT02516605|449952972|FG003|Overall Study|Protocol Violation|0|||
125091238|NCT02516605|449952973|FG004|Overall Study|Protocol Violation|1|||
125091239|NCT02516605|449952969|FG000|Overall Study|Withdrawal by Subject|0|||
125091240|NCT02516605|449952970|FG001|Overall Study|Withdrawal by Subject|0|||
125091241|NCT02516605|449952971|FG002|Overall Study|Withdrawal by Subject|0|||
125091242|NCT02516605|449952972|FG003|Overall Study|Withdrawal by Subject|1|||
125091243|NCT02516605|449952973|FG004|Overall Study|Withdrawal by Subject|0|||
125091244|NCT02577107|449952974|FG000|Overall Study|Protocol deviation|0|||
125091245|NCT02577107|449952975|FG001|Overall Study|Protocol deviation|1|||
125091246|NCT00577382|449952976|FG000|Overall Study|Adverse Event|0|||
125091247|NCT00577382|449952977|FG001|Overall Study|Adverse Event|6|||
125091248|NCT00577382|449952976|FG000|Overall Study|Withdrawal by Subject|0|||
125091249|NCT00577382|449952977|FG001|Overall Study|Withdrawal by Subject|1|||
125091250|NCT00577382|449952976|FG000|Overall Study|Progressive Disease|17|||
125091251|NCT00577382|449952977|FG001|Overall Study|Progressive Disease|19|||
124872990|NCT00508261|449157213|FG001|Overall Study|Withdrawal by Subject|4|||
125091252|NCT00577382|449952976|FG000|Overall Study|Intercurrent Illness|1|||
125091253|NCT00577382|449952977|FG001|Overall Study|Intercurrent Illness|2|||
125091254|NCT00577382|449952976|FG000|Overall Study|Death|1|||
125091255|NCT00577382|449952977|FG001|Overall Study|Death|1|||
125004505|NCT02101021|449646134|FG000|Overall Study|Death|4|||
125004506|NCT02101021|449646135|FG001|Overall Study|Death|3|||
125004507|NCT02101021|449646136|FG002|Overall Study|Death|6|||
125004508|NCT02101021|449646137|FG003|Overall Study|Death|0|||
125004509|NCT02101021|449646138|FG004|Overall Study|Death|3|||
125004510|NCT02101021|449646134|FG000|Overall Study|Withdrew Consent from study|1|||
125004511|NCT02101021|449646135|FG001|Overall Study|Withdrew Consent from study|1|||
125004512|NCT02101021|449646136|FG002|Overall Study|Withdrew Consent from study|0|||
125004513|NCT02101021|449646137|FG003|Overall Study|Withdrew Consent from study|2|||
125004514|NCT02101021|449646138|FG004|Overall Study|Withdrew Consent from study|0|||
125004515|NCT02101021|449646134|FG000|Overall Study|Lost to Follow-up|1|||
125004516|NCT02101021|449646135|FG001|Overall Study|Lost to Follow-up|0|||
125004517|NCT02101021|449646136|FG002|Overall Study|Lost to Follow-up|0|||
125004518|NCT02101021|449646137|FG003|Overall Study|Lost to Follow-up|0|||
125004519|NCT02101021|449646138|FG004|Overall Study|Lost to Follow-up|0|||
125004520|NCT02101021|449646134|FG000|Overall Study|Study Terminated by Sponsor|1|||
125004521|NCT02101021|449646135|FG001|Overall Study|Study Terminated by Sponsor|0|||
125004522|NCT02101021|449646136|FG002|Overall Study|Study Terminated by Sponsor|1|||
125004523|NCT02101021|449646137|FG003|Overall Study|Study Terminated by Sponsor|1|||
125004524|NCT02101021|449646138|FG004|Overall Study|Study Terminated by Sponsor|1|||
125004525|NCT01368042|449646139|FG000|Overall Study|Death|14|||
125004526|NCT01368042|449646139|FG000|Overall Study|Protocol Violation|11|||
125004527|NCT01368042|449646139|FG000|Overall Study|Lost to Follow-up|4|||
125004528|NCT01368042|449646139|FG000|Overall Study|Transplanted|1|||
125004529|NCT01621542|449646140|FG000|Overall Study|Adverse Event|0|||
125004530|NCT01621542|449646141|FG001|Overall Study|Adverse Event|0|||
125004531|NCT01621542|449646142|FG002|Overall Study|Adverse Event|1|||
125004532|NCT01621542|449646143|FG003|Overall Study|Adverse Event|3|||
125004533|NCT01621542|449646144|FG004|Overall Study|Adverse Event|0|||
125004534|NCT01621542|449646145|FG005|Overall Study|Adverse Event|0|||
125004535|NCT01621542|449646140|FG000|Overall Study|Death|0|||
125004536|NCT01621542|449646141|FG001|Overall Study|Death|1|||
125004537|NCT01621542|449646142|FG002|Overall Study|Death|0|||
125004538|NCT01621542|449646143|FG003|Overall Study|Death|0|||
125004539|NCT01621542|449646144|FG004|Overall Study|Death|0|||
125004540|NCT01621542|449646145|FG005|Overall Study|Death|0|||
125004541|NCT01621542|449646140|FG000|Overall Study|Physician Decision|1|||
125004542|NCT01621542|449646141|FG001|Overall Study|Physician Decision|0|||
125004543|NCT01621542|449646142|FG002|Overall Study|Physician Decision|1|||
125004544|NCT01621542|449646143|FG003|Overall Study|Physician Decision|13|||
125004545|NCT01621542|449646144|FG004|Overall Study|Physician Decision|3|||
125004546|NCT01621542|449646145|FG005|Overall Study|Physician Decision|1|||
125004547|NCT01621542|449646140|FG000|Overall Study|Withdrawal by Subject|2|||
125004548|NCT01621542|449646141|FG001|Overall Study|Withdrawal by Subject|0|||
125004549|NCT01621542|449646142|FG002|Overall Study|Withdrawal by Subject|1|||
125004550|NCT01621542|449646143|FG003|Overall Study|Withdrawal by Subject|3|||
125004551|NCT01621542|449646144|FG004|Overall Study|Withdrawal by Subject|3|||
125004552|NCT01621542|449646145|FG005|Overall Study|Withdrawal by Subject|3|||
125004553|NCT01621542|449646140|FG000|Overall Study|progression/treatment failure|2|||
125004554|NCT01621542|449646141|FG001|Overall Study|progression/treatment failure|4|||
125004555|NCT01621542|449646142|FG002|Overall Study|progression/treatment failure|3|||
125004556|NCT01621542|449646143|FG003|Overall Study|progression/treatment failure|7|||
125004557|NCT01621542|449646144|FG004|Overall Study|progression/treatment failure|3|||
125004558|NCT01621542|449646145|FG005|Overall Study|progression/treatment failure|5|||
125004559|NCT01621542|449646140|FG000|Overall Study|Protocol Violation|0|||
125004560|NCT01621542|449646141|FG001|Overall Study|Protocol Violation|0|||
125004561|NCT01621542|449646142|FG002|Overall Study|Protocol Violation|0|||
125004562|NCT01621542|449646143|FG003|Overall Study|Protocol Violation|1|||
125004563|NCT01621542|449646144|FG004|Overall Study|Protocol Violation|0|||
125004564|NCT01621542|449646145|FG005|Overall Study|Protocol Violation|0|||
125004565|NCT01621542|449646140|FG000|Overall Study|study stopped by sponsor|0|||
125004566|NCT01621542|449646141|FG001|Overall Study|study stopped by sponsor|0|||
125004567|NCT01621542|449646142|FG002|Overall Study|study stopped by sponsor|0|||
125004568|NCT01621542|449646143|FG003|Overall Study|study stopped by sponsor|1|||
125004569|NCT01621542|449646144|FG004|Overall Study|study stopped by sponsor|0|||
125004570|NCT01621542|449646145|FG005|Overall Study|study stopped by sponsor|0|||
125004571|NCT00955279|449646146|FG000|Overall Study|Other|0|||
125004572|NCT00955279|449646147|FG001|Overall Study|Other|0|||
125091256|NCT00577382|449952976|FG000|Overall Study|Lost to Follow-up|2|||
125004573|NCT00955279|449646148|FG002|Overall Study|Other|3|||
125004574|NCT00955279|449646146|FG000|Overall Study|Death|1|||
125004575|NCT00955279|449646147|FG001|Overall Study|Death|1|||
125004576|NCT00955279|449646148|FG002|Overall Study|Death|1|||
125004577|NCT00955279|449646146|FG000|Overall Study|Lost to Follow-up|0|||
125004578|NCT00955279|449646147|FG001|Overall Study|Lost to Follow-up|3|||
125004579|NCT00955279|449646148|FG002|Overall Study|Lost to Follow-up|1|||
125091257|NCT00577382|449952977|FG001|Overall Study|Lost to Follow-up|2|||
125091258|NCT02839330|449952978|FG000|Overall Study|Adverse Event|0|||
125091259|NCT02839330|449952979|FG001|Overall Study|Adverse Event|1|||
125091260|NCT02839330|449952980|FG002|Overall Study|Adverse Event|2|||
125091261|NCT02839330|449952981|FG003|Overall Study|Adverse Event|2|||
125091262|NCT02839330|449952978|FG000|Overall Study|Death|4|||
125091263|NCT02839330|449952979|FG001|Overall Study|Death|6|||
125091264|NCT02839330|449952980|FG002|Overall Study|Death|1|||
125091265|NCT02839330|449952981|FG003|Overall Study|Death|1|||
125091266|NCT02839330|449952978|FG000|Overall Study|Withdrawal by Subject|27|||
125091267|NCT02839330|449952979|FG001|Overall Study|Withdrawal by Subject|19|||
125091268|NCT02839330|449952980|FG002|Overall Study|Withdrawal by Subject|11|||
125091269|NCT02839330|449952981|FG003|Overall Study|Withdrawal by Subject|13|||
125091270|NCT02839330|449952978|FG000|Overall Study|Lost to Follow-up|22|||
125091271|NCT02839330|449952979|FG001|Overall Study|Lost to Follow-up|27|||
125091272|NCT02839330|449952980|FG002|Overall Study|Lost to Follow-up|29|||
125091273|NCT02839330|449952981|FG003|Overall Study|Lost to Follow-up|25|||
125091274|NCT02839330|449952978|FG000|Overall Study|Administrative Reason|0|||
125091275|NCT02839330|449952979|FG001|Overall Study|Administrative Reason|0|||
125091276|NCT02839330|449952980|FG002|Overall Study|Administrative Reason|0|||
125091277|NCT02839330|449952981|FG003|Overall Study|Administrative Reason|1|||
125091278|NCT02839330|449952978|FG000|Overall Study|Protocol Violation|1|||
125091279|NCT02839330|449952979|FG001|Overall Study|Protocol Violation|2|||
125091280|NCT02839330|449952980|FG002|Overall Study|Protocol Violation|2|||
125091281|NCT02839330|449952981|FG003|Overall Study|Protocol Violation|3|||
125091282|NCT02839330|449952978|FG000|Overall Study|Other reason, not specified|4|||
125091283|NCT02839330|449952979|FG001|Overall Study|Other reason, not specified|3|||
125091284|NCT02839330|449952980|FG002|Overall Study|Other reason, not specified|3|||
125091285|NCT02839330|449952981|FG003|Overall Study|Other reason, not specified|6|||
125091286|NCT03802331|449952983|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
125091287|NCT03802331|449952984|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
125091288|NCT02074059|449952985|FG000|Overall Study|Death|0|||
125091289|NCT02074059|449952986|FG001|Overall Study|Death|0|||
125091290|NCT02074059|449952987|FG002|Overall Study|Death|0|||
125091291|NCT02074059|449952988|FG003|Overall Study|Death|0|||
125091292|NCT02074059|449952989|FG004|Overall Study|Death|1|||
125091293|NCT02074059|449952990|FG005|Overall Study|Death|1|||
125091294|NCT00779506|449952992|FG000|Overall Study|Screening Failed|2|||
125091295|NCT00779506|449952992|FG000|Overall Study|Adverse Event|4|||
125091296|NCT00779506|449952992|FG000|Overall Study|Lack of Efficacy|11|||
125091297|NCT00779506|449952992|FG000|Overall Study|Protocol Violation|5|||
125091298|NCT00779506|449952992|FG000|Overall Study|Withdrawal by Subject|6|||
125091299|NCT00779506|449952992|FG000|Overall Study|Lost to Follow-up|1|||
125091300|NCT01632345|449952995|FG000|Treatment: Part I|Adverse Event|1|||
125091301|NCT01632345|449952996|FG001|Treatment: Part I|Adverse Event|4|||
125091302|NCT01632345|449952997|FG002|Treatment: Part I|Adverse Event|2|||
125091303|NCT01632345|449952998|FG003|Treatment: Part I|Adverse Event|1|||
125091304|NCT01632345|449952999|FG004|Treatment: Part I|Adverse Event|3|||
125091305|NCT01632345|449953000|FG005|Treatment: Part I|Adverse Event|0|||
125091306|NCT01632345|449953001|FG006|Treatment: Part I|Adverse Event|0|||
125091307|NCT01632345|449952995|FG000|Treatment: Part I|Lack of Efficacy|0|||
125091308|NCT01632345|449952996|FG001|Treatment: Part I|Lack of Efficacy|1|||
125091309|NCT01632345|449952997|FG002|Treatment: Part I|Lack of Efficacy|0|||
125091310|NCT01632345|449952998|FG003|Treatment: Part I|Lack of Efficacy|1|||
125091311|NCT01632345|449952999|FG004|Treatment: Part I|Lack of Efficacy|1|||
125091312|NCT01632345|449953000|FG005|Treatment: Part I|Lack of Efficacy|0|||
125091313|NCT01632345|449953001|FG006|Treatment: Part I|Lack of Efficacy|0|||
125091314|NCT01632345|449952995|FG000|Treatment: Part I|Lost to Follow-up|3|||
125091315|NCT01632345|449952996|FG001|Treatment: Part I|Lost to Follow-up|2|||
125091316|NCT01632345|449952997|FG002|Treatment: Part I|Lost to Follow-up|1|||
125091317|NCT01632345|449952998|FG003|Treatment: Part I|Lost to Follow-up|3|||
125091318|NCT01632345|449952999|FG004|Treatment: Part I|Lost to Follow-up|4|||
125091319|NCT01632345|449953000|FG005|Treatment: Part I|Lost to Follow-up|0|||
125091320|NCT01632345|449953001|FG006|Treatment: Part I|Lost to Follow-up|0|||
125091321|NCT01632345|449952995|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
125091322|NCT01632345|449952996|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
125004580|NCT00955279|449646146|FG000|Overall Study|Withdrawal by Subject|2|||
125004581|NCT00955279|449646147|FG001|Overall Study|Withdrawal by Subject|0|||
125004582|NCT00955279|449646148|FG002|Overall Study|Withdrawal by Subject|3|||
125004583|NCT02632721|449646150|FG000|Overall Study|Adverse Event|0|||
125004584|NCT02632721|449646151|FG001|Overall Study|Adverse Event|0|||
125004585|NCT02632721|449646152|FG002|Overall Study|Adverse Event|2|||
125004586|NCT02632721|449646153|FG003|Overall Study|Adverse Event|5|||
125004587|NCT02632721|449646154|FG004|Overall Study|Adverse Event|3|||
125004588|NCT02632721|449646150|FG000|Overall Study|Dose limiting toxicity|0|||
125004589|NCT02632721|449646151|FG001|Overall Study|Dose limiting toxicity|0|||
125004590|NCT02632721|449646152|FG002|Overall Study|Dose limiting toxicity|0|||
125004591|NCT02632721|449646153|FG003|Overall Study|Dose limiting toxicity|1|||
125004592|NCT02632721|449646154|FG004|Overall Study|Dose limiting toxicity|0|||
125004593|NCT02632721|449646150|FG000|Overall Study|Progressive disease|3|||
125004594|NCT02632721|449646151|FG001|Overall Study|Progressive disease|0|||
125004595|NCT02632721|449646152|FG002|Overall Study|Progressive disease|4|||
125004596|NCT02632721|449646153|FG003|Overall Study|Progressive disease|6|||
125004597|NCT02632721|449646154|FG004|Overall Study|Progressive disease|5|||
125004598|NCT02632721|449646150|FG000|Overall Study|Refused to continue taking trial medication|0|||
125004599|NCT02632721|449646151|FG001|Overall Study|Refused to continue taking trial medication|1|||
125004600|NCT02632721|449646152|FG002|Overall Study|Refused to continue taking trial medication|1|||
125004601|NCT02632721|449646153|FG003|Overall Study|Refused to continue taking trial medication|1|||
125004602|NCT02632721|449646154|FG004|Overall Study|Refused to continue taking trial medication|2|||
125004603|NCT02632721|449646150|FG000|Overall Study|Inadequate clinical condition|0|||
125004604|NCT02632721|449646151|FG001|Overall Study|Inadequate clinical condition|0|||
125004605|NCT02632721|449646152|FG002|Overall Study|Inadequate clinical condition|0|||
125004606|NCT02632721|449646153|FG003|Overall Study|Inadequate clinical condition|0|||
125004607|NCT02632721|449646154|FG004|Overall Study|Inadequate clinical condition|1|||
125004608|NCT02632721|449646150|FG000|Overall Study|No meet eligibility|0|||
125004609|NCT02632721|449646151|FG001|Overall Study|No meet eligibility|0|||
125004610|NCT02632721|449646152|FG002|Overall Study|No meet eligibility|0|||
125004611|NCT02632721|449646153|FG003|Overall Study|No meet eligibility|0|||
125004612|NCT02632721|449646154|FG004|Overall Study|No meet eligibility|1|||
125004613|NCT02632721|449646150|FG000|Overall Study|Allergic reaction|0|||
125004614|NCT02632721|449646151|FG001|Overall Study|Allergic reaction|0|||
125004615|NCT02632721|449646152|FG002|Overall Study|Allergic reaction|0|||
125004616|NCT02632721|449646153|FG003|Overall Study|Allergic reaction|1|||
125004617|NCT02632721|449646154|FG004|Overall Study|Allergic reaction|0|||
125004618|NCT02632721|449646150|FG000|Overall Study|Receiving Decitabine locally|0|||
125004619|NCT02632721|449646151|FG001|Overall Study|Receiving Decitabine locally|0|||
125004620|NCT02632721|449646152|FG002|Overall Study|Receiving Decitabine locally|1|||
125004621|NCT02632721|449646153|FG003|Overall Study|Receiving Decitabine locally|0|||
125004622|NCT02632721|449646154|FG004|Overall Study|Receiving Decitabine locally|0|||
125004623|NCT02632721|449646150|FG000|Overall Study|No benefit from study treatment|1|||
125004624|NCT02632721|449646151|FG001|Overall Study|No benefit from study treatment|1|||
125004625|NCT02632721|449646152|FG002|Overall Study|No benefit from study treatment|0|||
125004626|NCT02632721|449646153|FG003|Overall Study|No benefit from study treatment|0|||
125004627|NCT02632721|449646154|FG004|Overall Study|No benefit from study treatment|1|||
125004628|NCT02632721|449646150|FG000|Overall Study|Patient wish for other treatment|0|||
125004629|NCT02632721|449646151|FG001|Overall Study|Patient wish for other treatment|1|||
125004630|NCT02632721|449646152|FG002|Overall Study|Patient wish for other treatment|0|||
125004631|NCT02632721|449646153|FG003|Overall Study|Patient wish for other treatment|0|||
125004632|NCT02632721|449646154|FG004|Overall Study|Patient wish for other treatment|0|||
125004633|NCT02632721|449646150|FG000|Overall Study|Relapsed Pneumonia|0|||
125004634|NCT02632721|449646151|FG001|Overall Study|Relapsed Pneumonia|0|||
125004635|NCT02632721|449646152|FG002|Overall Study|Relapsed Pneumonia|0|||
125004636|NCT02632721|449646153|FG003|Overall Study|Relapsed Pneumonia|0|||
125004637|NCT02632721|449646154|FG004|Overall Study|Relapsed Pneumonia|1|||
125004638|NCT02632721|449646150|FG000|Overall Study|Therapy refractory AML|0|||
125004639|NCT02632721|449646151|FG001|Overall Study|Therapy refractory AML|0|||
125004640|NCT02632721|449646152|FG002|Overall Study|Therapy refractory AML|0|||
125004641|NCT02632721|449646153|FG003|Overall Study|Therapy refractory AML|0|||
125004642|NCT02632721|449646154|FG004|Overall Study|Therapy refractory AML|1|||
125004643|NCT02632721|449646150|FG000|Overall Study|Increase of white blood cell count|0|||
125004644|NCT02632721|449646151|FG001|Overall Study|Increase of white blood cell count|0|||
125004645|NCT02632721|449646152|FG002|Overall Study|Increase of white blood cell count|0|||
125004646|NCT02632721|449646153|FG003|Overall Study|Increase of white blood cell count|0|||
125004647|NCT02632721|449646154|FG004|Overall Study|Increase of white blood cell count|1|||
125091323|NCT01632345|449952997|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
125091324|NCT01632345|449952998|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
125091325|NCT01632345|449952999|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
125091326|NCT01632345|449953000|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
125091327|NCT01632345|449953001|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
125091328|NCT01632345|449952995|FG000|Treatment: Part I|Physician Decision|2|||
125091329|NCT01632345|449952996|FG001|Treatment: Part I|Physician Decision|1|||
125091330|NCT01632345|449952997|FG002|Treatment: Part I|Physician Decision|0|||
125091331|NCT01632345|449952998|FG003|Treatment: Part I|Physician Decision|0|||
125091332|NCT01632345|449952999|FG004|Treatment: Part I|Physician Decision|1|||
125091333|NCT01632345|449953000|FG005|Treatment: Part I|Physician Decision|0|||
125091334|NCT01632345|449953001|FG006|Treatment: Part I|Physician Decision|0|||
125091335|NCT01632345|449952995|FG000|Treatment: Part I|Pregnancy|0|||
125091336|NCT01632345|449952996|FG001|Treatment: Part I|Pregnancy|1|||
125091337|NCT01632345|449952997|FG002|Treatment: Part I|Pregnancy|0|||
125091338|NCT01632345|449952998|FG003|Treatment: Part I|Pregnancy|0|||
125091339|NCT01632345|449952999|FG004|Treatment: Part I|Pregnancy|0|||
125091340|NCT01632345|449953000|FG005|Treatment: Part I|Pregnancy|0|||
125091341|NCT01632345|449953001|FG006|Treatment: Part I|Pregnancy|0|||
125091342|NCT01632345|449952995|FG000|Treatment: Part I|Protocol Deviation|0|||
125091343|NCT01632345|449952996|FG001|Treatment: Part I|Protocol Deviation|0|||
125091344|NCT01632345|449952997|FG002|Treatment: Part I|Protocol Deviation|1|||
125091345|NCT01632345|449952998|FG003|Treatment: Part I|Protocol Deviation|1|||
125091346|NCT01632345|449952999|FG004|Treatment: Part I|Protocol Deviation|0|||
125091347|NCT01632345|449953000|FG005|Treatment: Part I|Protocol Deviation|0|||
125091348|NCT01632345|449953001|FG006|Treatment: Part I|Protocol Deviation|0|||
125091349|NCT01632345|449952995|FG000|Treatment: Part I|Withdrawal by Subject|3|||
125091350|NCT01632345|449952996|FG001|Treatment: Part I|Withdrawal by Subject|4|||
125091351|NCT01632345|449952997|FG002|Treatment: Part I|Withdrawal by Subject|4|||
125091352|NCT01632345|449952998|FG003|Treatment: Part I|Withdrawal by Subject|1|||
125091353|NCT01632345|449952999|FG004|Treatment: Part I|Withdrawal by Subject|4|||
125091354|NCT01632345|449953000|FG005|Treatment: Part I|Withdrawal by Subject|0|||
125091355|NCT01632345|449953001|FG006|Treatment: Part I|Withdrawal by Subject|0|||
125091356|NCT01632345|449952995|FG000|Treatment: Part II|Adverse Event|0|||
125091357|NCT01632345|449952996|FG001|Treatment: Part II|Adverse Event|0|||
125091358|NCT01632345|449952997|FG002|Treatment: Part II|Adverse Event|0|||
125091359|NCT01632345|449952998|FG003|Treatment: Part II|Adverse Event|0|||
125091360|NCT01632345|449952999|FG004|Treatment: Part II|Adverse Event|0|||
125091361|NCT01632345|449953000|FG005|Treatment: Part II|Adverse Event|3|||
125091362|NCT01632345|449953001|FG006|Treatment: Part II|Adverse Event|8|||
125091363|NCT01632345|449952995|FG000|Treatment: Part II|Lost to Follow-up|0|||
125091364|NCT01632345|449952996|FG001|Treatment: Part II|Lost to Follow-up|0|||
125091365|NCT01632345|449952997|FG002|Treatment: Part II|Lost to Follow-up|0|||
125091366|NCT01632345|449952998|FG003|Treatment: Part II|Lost to Follow-up|0|||
125091367|NCT01632345|449952999|FG004|Treatment: Part II|Lost to Follow-up|0|||
125091368|NCT01632345|449953000|FG005|Treatment: Part II|Lost to Follow-up|3|||
125091369|NCT01632345|449953001|FG006|Treatment: Part II|Lost to Follow-up|1|||
125091370|NCT01632345|449952995|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
125091371|NCT01632345|449952996|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
125091372|NCT01632345|449952997|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
125091373|NCT01632345|449952998|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
125091374|NCT01632345|449952999|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
125091375|NCT01632345|449953000|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
125091376|NCT01632345|449953001|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
125091377|NCT01632345|449952995|FG000|Treatment: Part II|Withdrawal by Subject|0|||
125091378|NCT01632345|449952996|FG001|Treatment: Part II|Withdrawal by Subject|0|||
125091379|NCT01632345|449952997|FG002|Treatment: Part II|Withdrawal by Subject|0|||
125091380|NCT01632345|449952998|FG003|Treatment: Part II|Withdrawal by Subject|0|||
125091381|NCT01632345|449952999|FG004|Treatment: Part II|Withdrawal by Subject|0|||
125091382|NCT01632345|449953000|FG005|Treatment: Part II|Withdrawal by Subject|2|||
125091383|NCT01632345|449953001|FG006|Treatment: Part II|Withdrawal by Subject|2|||
125091384|NCT02853318|449953005|FG000|Overall Study|Withdrawal by Subject|1|||
125091385|NCT01997333|449953006|FG000|Randomization and Treatment|Disease Progression|70|||
125091386|NCT01997333|449953007|FG001|Randomization and Treatment|Disease Progression|159|||
125091387|NCT01997333|449953006|FG000|Randomization and Treatment|Adverse Event|10|||
125091388|NCT01997333|449953007|FG001|Randomization and Treatment|Adverse Event|32|||
125091389|NCT01997333|449953006|FG000|Randomization and Treatment|Physician Decision|0|||
125091390|NCT01997333|449953007|FG001|Randomization and Treatment|Physician Decision|4|||
125091391|NCT01997333|449953006|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
125091392|NCT01997333|449953007|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
125091393|NCT01997333|449953006|FG000|Randomization and Treatment|Did not receive treatment|17|||
125091394|NCT01997333|449953007|FG001|Randomization and Treatment|Did not receive treatment|5|||
125091395|NCT01997333|449953006|FG000|Survival Follow up|Withdrawal by Subject|15|||
125004648|NCT02632721|449646150|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
125004649|NCT02632721|449646151|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
125004650|NCT02632721|449646152|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
125004651|NCT02632721|449646153|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
125004652|NCT02632721|449646154|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
125004653|NCT00544648|449646160|FG000|Overall Study|Withdrawal by Subject|1|||
125004654|NCT00544648|449646161|FG001|Overall Study|Withdrawal by Subject|0|||
125004655|NCT00544648|449646160|FG000|Overall Study|Adverse Event|1|||
125004656|NCT00544648|449646161|FG001|Overall Study|Adverse Event|1|||
125004657|NCT00544648|449646160|FG000|Overall Study|progression of disease|1|||
125004658|NCT00544648|449646161|FG001|Overall Study|progression of disease|0|||
125004659|NCT02663271|449646162|FG000|Overall Study|Withdrawal by Subject|5|||
125004660|NCT02663271|449646162|FG000|Overall Study|Lack of Efficacy|1|||
125004661|NCT01235793|449646163|FG000|Overall Study|Death|6|||
125004662|NCT04166383|449646169|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
125004663|NCT04166383|449646169|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
125004664|NCT04166383|449646169|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
125004665|NCT03044886|449646171|FG000|Overall Study|Lost to Follow-up|15|||
125004666|NCT03044886|449646172|FG001|Overall Study|Lost to Follow-up|10|||
125004667|NCT03044886|449646173|FG002|Overall Study|Lost to Follow-up|12|||
125004668|NCT02921269|449646174|FG000|Overall Study|Did not complete DLT period|1|||
125004669|NCT02054325|449646185|FG000|Overall Study|Lost to Follow-up|8|||
125004670|NCT02054325|449646186|FG001|Overall Study|Lost to Follow-up|5|||
125004671|NCT00504153|449646193|FG000|Overall Study|Withdrawal by Subject|1|||
125004672|NCT00504153|449646193|FG000|Overall Study|Adverse Event|4|||
125004673|NCT00504153|449646193|FG000|Overall Study|Death|1|||
125004674|NCT00074581|449646195|FG000|Overall Study|Death|15|||
125004675|NCT00074581|449646196|FG001|Overall Study|Death|16|||
125004676|NCT00074581|449646195|FG000|Overall Study|Withdrawal by Subject|50|||
125004677|NCT00074581|449646196|FG001|Overall Study|Withdrawal by Subject|49|||
125004678|NCT00074581|449646195|FG000|Overall Study|Unable to adhere to visit schedule|13|||
125004679|NCT00074581|449646196|FG001|Overall Study|Unable to adhere to visit schedule|14|||
125004680|NCT00074581|449646195|FG000|Overall Study|Relocated|14|||
125004681|NCT00074581|449646196|FG001|Overall Study|Relocated|9|||
125004682|NCT00074581|449646195|FG000|Overall Study|Were withdrawn by investigator|5|||
125004683|NCT00074581|449646196|FG001|Overall Study|Were withdrawn by investigator|2|||
125004684|NCT00074581|449646195|FG000|Overall Study|Lost to Follow-up|16|||
125004685|NCT00074581|449646196|FG001|Overall Study|Lost to Follow-up|11|||
125004686|NCT00074581|449646195|FG000|Overall Study|Ended relationship w. index participant|117|||
125004687|NCT00074581|449646196|FG001|Overall Study|Ended relationship w. index participant|106|||
125004688|NCT00074581|449646195|FG000|Overall Study|Other|14|||
125004689|NCT00074581|449646196|FG001|Overall Study|Other|19|||
125004690|NCT02322229|449646199|FG000|Overall Study|Physician Decision|2|||
125004691|NCT00617604|449646201|FG000|Overall Study|Death|2|||
125004692|NCT00617604|449646202|FG001|Overall Study|Death|1|||
125004693|NCT00617604|449646201|FG000|Overall Study|Lost to Follow-up|1|||
125004694|NCT00617604|449646202|FG001|Overall Study|Lost to Follow-up|0|||
125004695|NCT00617604|449646201|FG000|Overall Study|Miscellaneous Reasons|8|||
125004696|NCT00617604|449646202|FG001|Overall Study|Miscellaneous Reasons|10|||
125004697|NCT00617604|449646201|FG000|Overall Study|Withdrawal by Subject|4|||
125004698|NCT00617604|449646202|FG001|Overall Study|Withdrawal by Subject|6|||
125004699|NCT00617604|449646201|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
125004700|NCT00617604|449646202|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
125004701|NCT03250832|449646203|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
125004702|NCT03250832|449646204|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
125004703|NCT03250832|449646205|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
125004704|NCT03250832|449646206|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
125004705|NCT03250832|449646207|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
125004706|NCT03250832|449646208|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
125004707|NCT03250832|449646209|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
125004708|NCT03250832|449646210|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
125004709|NCT03250832|449646211|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
125004710|NCT03250832|449646212|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
125004711|NCT03250832|449646213|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
125004712|NCT03250832|449646214|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
125004713|NCT03250832|449646203|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
125004714|NCT03250832|449646204|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
125004715|NCT03250832|449646205|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
125091396|NCT01997333|449953007|FG001|Survival Follow up|Withdrawal by Subject|6|||
125091397|NCT01997333|449953006|FG000|Survival Follow up|Lost to Follow-up|0|||
125091398|NCT01997333|449953007|FG001|Survival Follow up|Lost to Follow-up|6|||
125091399|NCT01997333|449953006|FG000|Survival Follow up|Various|1|||
125091400|NCT01997333|449953007|FG001|Survival Follow up|Various|2|||
125091401|NCT01535638|449953008|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
125091402|NCT01535638|449953009|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
125091403|NCT01535638|449953010|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
125091404|NCT01535638|449953011|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
125091405|NCT01535638|449953012|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
125091406|NCT01535638|449953013|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
125091407|NCT01535638|449953008|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
125091408|NCT01535638|449953009|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
125091409|NCT01535638|449953010|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
125091410|NCT01535638|449953011|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
125091411|NCT01535638|449953012|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
125091412|NCT01535638|449953013|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
125091413|NCT05060003|449953014|FG000|Overall Study|ctDNA negative|7|||
125091414|NCT00819052|449953015|FG000|Overall Study|Adverse Event|0|||
125091415|NCT00819052|449953016|FG001|Overall Study|Adverse Event|5|||
125091416|NCT00819052|449953015|FG000|Overall Study|Protocol Violation|1|||
125091417|NCT00819052|449953016|FG001|Overall Study|Protocol Violation|2|||
125091418|NCT00819052|449953015|FG000|Overall Study|Lost to Follow-up|1|||
125091419|NCT00819052|449953016|FG001|Overall Study|Lost to Follow-up|2|||
125091420|NCT00819052|449953015|FG000|Overall Study|Withdrawal by Subject|1|||
125004716|NCT03250832|449646206|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
125004717|NCT03250832|449646207|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
125004718|NCT03250832|449646208|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
125004719|NCT03250832|449646209|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
125004720|NCT03250832|449646210|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
125004721|NCT03250832|449646211|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
125004722|NCT03250832|449646212|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
125004723|NCT03250832|449646213|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
125004724|NCT03250832|449646214|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
125004725|NCT03250832|449646203|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125004726|NCT03250832|449646204|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125004727|NCT03250832|449646205|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
125004728|NCT03250832|449646206|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125004729|NCT03250832|449646207|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125004730|NCT03250832|449646208|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125004731|NCT03250832|449646209|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125004732|NCT03250832|449646210|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125004733|NCT03250832|449646211|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125004734|NCT03250832|449646212|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125004735|NCT03250832|449646213|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125004736|NCT03250832|449646214|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125004737|NCT03250832|449646203|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
125004738|NCT03250832|449646204|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
125004739|NCT03250832|449646205|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
125004740|NCT03250832|449646206|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
125004741|NCT03250832|449646207|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
125004742|NCT03250832|449646208|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
125004743|NCT03250832|449646209|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
125004744|NCT03250832|449646210|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
125004745|NCT03250832|449646211|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
125004746|NCT03250832|449646212|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
125004747|NCT03250832|449646213|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
125004748|NCT03250832|449646214|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
125004749|NCT03250832|449646203|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125004750|NCT03250832|449646204|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125004751|NCT03250832|449646205|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125091421|NCT00819052|449953016|FG001|Overall Study|Withdrawal by Subject|2|||
125091422|NCT00819052|449953015|FG000|Overall Study|Lack of Efficacy|1|||
125091423|NCT00819052|449953016|FG001|Overall Study|Lack of Efficacy|1|||
125091424|NCT00819052|449953015|FG000|Overall Study|Pregnancy|1|||
125091425|NCT00819052|449953016|FG001|Overall Study|Pregnancy|2|||
125091426|NCT00819052|449953015|FG000|Overall Study|Death or events leading to death|1|||
125091427|NCT00819052|449953016|FG001|Overall Study|Death or events leading to death|0|||
125091428|NCT01277666|449953021|FG000|Overall Study|Adverse Event|26|||
125091429|NCT01277666|449953022|FG001|Overall Study|Adverse Event|25|||
125091430|NCT01277666|449953023|FG002|Overall Study|Adverse Event|20|||
125091431|NCT01277666|449953021|FG000|Overall Study|Lack of Efficacy|8|||
125091432|NCT01277666|449953022|FG001|Overall Study|Lack of Efficacy|20|||
125091433|NCT01277666|449953023|FG002|Overall Study|Lack of Efficacy|12|||
125091434|NCT01277666|449953021|FG000|Overall Study|Protocol Violation|2|||
125091435|NCT01277666|449953022|FG001|Overall Study|Protocol Violation|3|||
125091436|NCT01277666|449953023|FG002|Overall Study|Protocol Violation|2|||
125091437|NCT01277666|449953021|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
125091438|NCT01277666|449953022|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
125004752|NCT03250832|449646206|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125004753|NCT03250832|449646207|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125004754|NCT03250832|449646208|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125004755|NCT03250832|449646209|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125004756|NCT03250832|449646210|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
125004757|NCT03250832|449646211|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125004758|NCT03250832|449646212|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125004759|NCT03250832|449646213|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125004760|NCT03250832|449646214|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125004761|NCT03250832|449646203|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125004762|NCT03250832|449646204|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125004763|NCT03250832|449646205|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125004764|NCT03250832|449646206|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125004765|NCT03250832|449646207|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125004766|NCT03250832|449646208|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125004767|NCT03250832|449646209|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125004768|NCT03250832|449646210|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
125004769|NCT03250832|449646211|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125004770|NCT03250832|449646212|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125004771|NCT03250832|449646213|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125004772|NCT03250832|449646214|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125004773|NCT03250832|449646203|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125004774|NCT03250832|449646204|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125004775|NCT03250832|449646205|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125004776|NCT03250832|449646206|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125004777|NCT03250832|449646207|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125004778|NCT03250832|449646208|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125004779|NCT03250832|449646209|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125004780|NCT03250832|449646210|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
125004781|NCT03250832|449646211|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125004782|NCT03250832|449646212|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125004783|NCT03250832|449646213|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125004784|NCT03250832|449646214|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125004785|NCT03250832|449646203|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
125004786|NCT03250832|449646204|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
125004787|NCT03250832|449646205|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
125004788|NCT03250832|449646206|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
125004789|NCT03250832|449646207|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
125004790|NCT03250832|449646208|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
125004791|NCT03250832|449646209|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
125004792|NCT03250832|449646210|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
125004793|NCT03250832|449646211|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
125004794|NCT03250832|449646212|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
125091439|NCT01277666|449953023|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
125091440|NCT01277666|449953021|FG000|Overall Study|Lost to Follow-up|1|||
125091441|NCT01277666|449953022|FG001|Overall Study|Lost to Follow-up|1|||
125091442|NCT01277666|449953023|FG002|Overall Study|Lost to Follow-up|2|||
125091443|NCT01277666|449953021|FG000|Overall Study|Withdrawal by Subject|7|||
125091444|NCT01277666|449953022|FG001|Overall Study|Withdrawal by Subject|8|||
125091445|NCT01277666|449953023|FG002|Overall Study|Withdrawal by Subject|6|||
125091446|NCT01277666|449953021|FG000|Overall Study|Death|0|||
125091447|NCT01277666|449953022|FG001|Overall Study|Death|0|||
125091448|NCT01277666|449953023|FG002|Overall Study|Death|1|||
125091449|NCT03702166|449953024|FG000|Overall Study|Lost to Follow-up|1|||
125091450|NCT03702166|449953024|FG000|Overall Study|Withdrawal by Subject|1|||
125091451|NCT01657903|449953025|FG000|Overall Study|Lost to Follow-up|1|||
125091452|NCT01657903|449953025|FG000|Overall Study|Withdrawal by Subject|1|||
125091453|NCT00620815|449953028|FG000|Overall Study|Adverse Event|1|||
125091454|NCT00620815|449953029|FG001|Overall Study|Adverse Event|1|||
125091455|NCT00620815|449953030|FG002|Overall Study|Adverse Event|2|||
125091456|NCT00620815|449953028|FG000|Overall Study|Withdrawal by Subject|1|||
125091457|NCT00620815|449953029|FG001|Overall Study|Withdrawal by Subject|2|||
125091458|NCT00620815|449953030|FG002|Overall Study|Withdrawal by Subject|0|||
125091459|NCT00620815|449953028|FG000|Overall Study|Lost to Follow-up|1|||
125091460|NCT00620815|449953029|FG001|Overall Study|Lost to Follow-up|6|||
125091461|NCT00620815|449953030|FG002|Overall Study|Lost to Follow-up|3|||
125091462|NCT00620815|449953028|FG000|Overall Study|Inappropriate enrolment|0|||
125091463|NCT00620815|449953029|FG001|Overall Study|Inappropriate enrolment|0|||
125091464|NCT00620815|449953030|FG002|Overall Study|Inappropriate enrolment|1|||
125091465|NCT00620815|449953028|FG000|Overall Study|Protocol Violation|1|||
125091466|NCT00620815|449953029|FG001|Overall Study|Protocol Violation|2|||
125091467|NCT00620815|449953030|FG002|Overall Study|Protocol Violation|1|||
125091468|NCT01888367|449953033|FG000|Overall Study|Physician Decision|3|||
125091469|NCT01888367|449953034|FG001|Overall Study|Physician Decision|4|||
125091470|NCT01888367|449953035|FG002|Overall Study|Physician Decision|2|||
125091471|NCT01888367|449953033|FG000|Overall Study|Death|2|||
125091472|NCT01888367|449953034|FG001|Overall Study|Death|0|||
125091473|NCT01888367|449953035|FG002|Overall Study|Death|1|||
125091474|NCT01888367|449953033|FG000|Overall Study|Withdrawal by Subject|1|||
125091475|NCT01888367|449953034|FG001|Overall Study|Withdrawal by Subject|0|||
125091476|NCT01888367|449953035|FG002|Overall Study|Withdrawal by Subject|1|||
125091477|NCT01888367|449953033|FG000|Overall Study|Lost to Follow-up|1|||
125091478|NCT01888367|449953034|FG001|Overall Study|Lost to Follow-up|1|||
125091479|NCT01888367|449953035|FG002|Overall Study|Lost to Follow-up|0|||
125091480|NCT01888367|449953033|FG000|Overall Study|Protocol Violation|0|||
125091481|NCT01888367|449953034|FG001|Overall Study|Protocol Violation|0|||
125091482|NCT01888367|449953035|FG002|Overall Study|Protocol Violation|1|||
125091483|NCT01888367|449953033|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
125091484|NCT01888367|449953034|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
125091485|NCT01888367|449953035|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
125091486|NCT00842829|449953037|FG000|Dose Titration Period|Adverse Event|11|||
125091487|NCT00842829|449953038|FG001|Dose Titration Period|Adverse Event|10|||
125091488|NCT00842829|449953039|FG002|Dose Titration Period|Adverse Event|0|||
125091489|NCT00842829|449953037|FG000|Dose Titration Period|Lack of Efficacy|4|||
125091490|NCT00842829|449953038|FG001|Dose Titration Period|Lack of Efficacy|1|||
125091491|NCT00842829|449953039|FG002|Dose Titration Period|Lack of Efficacy|0|||
125091492|NCT00842829|449953037|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
125091493|NCT00842829|449953038|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
125091494|NCT00842829|449953039|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
125091495|NCT00842829|449953037|FG000|Dose Titration Period|Withdrawal by Subject|2|||
125091496|NCT00842829|449953038|FG001|Dose Titration Period|Withdrawal by Subject|6|||
125091497|NCT00842829|449953039|FG002|Dose Titration Period|Withdrawal by Subject|0|||
125091498|NCT00842829|449953037|FG000|Dose Titration Period|Other|5|||
125091499|NCT00842829|449953038|FG001|Dose Titration Period|Other|4|||
125091500|NCT00842829|449953039|FG002|Dose Titration Period|Other|0|||
125091501|NCT00842829|449953037|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
125091502|NCT00842829|449953038|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
125091503|NCT00842829|449953039|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
125091504|NCT00842829|449953037|FG000|Dose Titration Period|Non-compliance to study drug|2|||
125091505|NCT00842829|449953038|FG001|Dose Titration Period|Non-compliance to study drug|1|||
125091506|NCT00842829|449953039|FG002|Dose Titration Period|Non-compliance to study drug|0|||
125091507|NCT00842829|449953037|FG000|Treatment Period|Adverse Event|0|||
125091508|NCT00842829|449953038|FG001|Treatment Period|Adverse Event|0|||
125091509|NCT00842829|449953039|FG002|Treatment Period|Adverse Event|15|||
125091510|NCT00842829|449953037|FG000|Treatment Period|Lack of Efficacy|0|||
125091511|NCT00842829|449953038|FG001|Treatment Period|Lack of Efficacy|0|||
125091512|NCT00842829|449953039|FG002|Treatment Period|Lack of Efficacy|6|||
125091513|NCT00842829|449953037|FG000|Treatment Period|Unstable persistent cancer pain|0|||
125091514|NCT00842829|449953038|FG001|Treatment Period|Unstable persistent cancer pain|0|||
125091515|NCT00842829|449953039|FG002|Treatment Period|Unstable persistent cancer pain|5|||
125091516|NCT00842829|449953037|FG000|Treatment Period|Withdrawal by Subject|0|||
125091517|NCT00842829|449953038|FG001|Treatment Period|Withdrawal by Subject|0|||
125091518|NCT00842829|449953039|FG002|Treatment Period|Withdrawal by Subject|11|||
125091519|NCT00842829|449953037|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
125091520|NCT00842829|449953038|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
125091521|NCT00842829|449953039|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
125091522|NCT00842829|449953037|FG000|Treatment Period|Protocol Violation|0|||
125091523|NCT00842829|449953038|FG001|Treatment Period|Protocol Violation|0|||
125091524|NCT00842829|449953039|FG002|Treatment Period|Protocol Violation|2|||
125091525|NCT00842829|449953037|FG000|Treatment Period|Other|0|||
125091526|NCT00842829|449953038|FG001|Treatment Period|Other|0|||
125091527|NCT00842829|449953039|FG002|Treatment Period|Other|18|||
125091528|NCT00842829|449953037|FG000|Treatment Period|Non-compliance to study procedures|0|||
125091529|NCT00842829|449953038|FG001|Treatment Period|Non-compliance to study procedures|0|||
125091530|NCT00842829|449953039|FG002|Treatment Period|Non-compliance to study procedures|4|||
125091531|NCT00842829|449953037|FG000|Treatment Period|Unclear completion status|0|||
125091532|NCT00842829|449953038|FG001|Treatment Period|Unclear completion status|0|||
125091533|NCT00842829|449953039|FG002|Treatment Period|Unclear completion status|1|||
125091534|NCT00842829|449953037|FG000|Continuation Period|Adverse Event|0|||
125091535|NCT00842829|449953038|FG001|Continuation Period|Adverse Event|0|||
125091536|NCT00842829|449953039|FG002|Continuation Period|Adverse Event|32|||
125091537|NCT00842829|449953037|FG000|Continuation Period|Lack of Efficacy|0|||
125091538|NCT00842829|449953038|FG001|Continuation Period|Lack of Efficacy|0|||
125091539|NCT00842829|449953039|FG002|Continuation Period|Lack of Efficacy|6|||
125091540|NCT00842829|449953037|FG000|Continuation Period|Unstable persistent cancer pain|0|||
125091541|NCT00842829|449953038|FG001|Continuation Period|Unstable persistent cancer pain|0|||
125091542|NCT00842829|449953039|FG002|Continuation Period|Unstable persistent cancer pain|3|||
125091543|NCT00842829|449953037|FG000|Continuation Period|Withdrawal by Subject|0|||
125091544|NCT00842829|449953038|FG001|Continuation Period|Withdrawal by Subject|0|||
125091545|NCT00842829|449953039|FG002|Continuation Period|Withdrawal by Subject|10|||
125091546|NCT00842829|449953037|FG000|Continuation Period|Other|0|||
125091547|NCT00842829|449953038|FG001|Continuation Period|Other|0|||
125091548|NCT00842829|449953039|FG002|Continuation Period|Other|7|||
125091549|NCT00842829|449953037|FG000|Continuation Period|Non-compliance to study procedures|0|||
125091550|NCT00842829|449953038|FG001|Continuation Period|Non-compliance to study procedures|0|||
125091551|NCT00842829|449953039|FG002|Continuation Period|Non-compliance to study procedures|2|||
125091552|NCT00842829|449953037|FG000|Continuation Period|Non-compliance to study drug|0|||
125091553|NCT00842829|449953038|FG001|Continuation Period|Non-compliance to study drug|0|||
125091554|NCT00842829|449953039|FG002|Continuation Period|Non-compliance to study drug|1|||
125091555|NCT03969589|449953042|FG000|Overall Study|Lost to Follow-up|3|||
125091556|NCT03969589|449953043|FG001|Overall Study|Lost to Follow-up|2|||
125091557|NCT03969589|449953042|FG000|Overall Study|Declined Follow-Up|0|||
125091558|NCT03969589|449953043|FG001|Overall Study|Declined Follow-Up|1|||
125091559|NCT03417999|449953046|FG000|Overall Study|Withdrawal by Subject|1|||
125091560|NCT03417999|449953047|FG001|Overall Study|Withdrawal by Subject|0|||
125091561|NCT03417999|449953048|FG002|Overall Study|Withdrawal by Subject|0|||
125091562|NCT03417999|449953046|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
125091563|NCT03417999|449953047|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
125091564|NCT03417999|449953048|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
125091565|NCT03417999|449953046|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
125091566|NCT03417999|449953047|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
125091567|NCT03417999|449953048|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
125091568|NCT03417999|449953046|FG000|Overall Study|Inadequate study staff available to process samples|0|||
125091569|NCT03417999|449953047|FG001|Overall Study|Inadequate study staff available to process samples|0|||
125091570|NCT03417999|449953048|FG002|Overall Study|Inadequate study staff available to process samples|1|||
125091571|NCT00039377|449954722|FG000|Initial Registration|Adverse Event|2|||
125091572|NCT00039377|449954723|FG001|Initial Registration|Adverse Event|0|||
125091573|NCT00039377|449954724|FG002|Initial Registration|Adverse Event|0|||
125091574|NCT00039377|449954725|FG003|Initial Registration|Adverse Event|0|||
125091575|NCT00039377|449954722|FG000|Initial Registration|Relapsed|6|||
125091576|NCT00039377|449954723|FG001|Initial Registration|Relapsed|0|||
125091577|NCT00039377|449954724|FG002|Initial Registration|Relapsed|0|||
125091578|NCT00039377|449954725|FG003|Initial Registration|Relapsed|0|||
125091579|NCT00039377|449954722|FG000|Initial Registration|Received non-protocol therapy|11|||
125091580|NCT00039377|449954723|FG001|Initial Registration|Received non-protocol therapy|0|||
125091581|NCT00039377|449954724|FG002|Initial Registration|Received non-protocol therapy|0|||
125091582|NCT00039377|449954725|FG003|Initial Registration|Received non-protocol therapy|0|||
125091583|NCT00039377|449954722|FG000|Initial Registration|Withdrawal by Subject|3|||
125091584|NCT00039377|449954723|FG001|Initial Registration|Withdrawal by Subject|0|||
125091585|NCT00039377|449954724|FG002|Initial Registration|Withdrawal by Subject|0|||
125091586|NCT00039377|449954725|FG003|Initial Registration|Withdrawal by Subject|0|||
125091587|NCT04067310|449954729|FG000|Overall Study|Physician Decision|2|||
125091588|NCT04067310|449954730|FG001|Overall Study|Physician Decision|6|||
125091589|NCT04067310|449954729|FG000|Overall Study|Lost to Follow-up|0|||
125091590|NCT04067310|449954730|FG001|Overall Study|Lost to Follow-up|1|||
125091591|NCT04067310|449954729|FG000|Overall Study|Withdrawal by Subject|3|||
125091592|NCT04067310|449954730|FG001|Overall Study|Withdrawal by Subject|0|||
125091593|NCT01249404|449954731|FG000|Overall Study|Study treatment not received|0|||
125091594|NCT01249404|449954732|FG001|Overall Study|Study treatment not received|1|||
125091595|NCT01249404|449954733|FG002|Overall Study|Study treatment not received|2|||
125091596|NCT01249404|449954731|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
125091597|NCT01249404|449954732|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
125091598|NCT01249404|449954733|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
125091599|NCT01249404|449954731|FG000|Overall Study|Adverse Event|2|||
125091600|NCT01249404|449954732|FG001|Overall Study|Adverse Event|2|||
125091601|NCT01249404|449954733|FG002|Overall Study|Adverse Event|2|||
125091602|NCT01249404|449954731|FG000|Overall Study|Withdrawal by Subject|2|||
125091603|NCT01249404|449954732|FG001|Overall Study|Withdrawal by Subject|2|||
125091604|NCT01249404|449954733|FG002|Overall Study|Withdrawal by Subject|0|||
125091605|NCT01249404|449954731|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
125091606|NCT01249404|449954732|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
125091607|NCT01249404|449954733|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
125091608|NCT01249404|449954731|FG000|Overall Study|Non compliance to visit schedule|0|||
125091609|NCT01249404|449954732|FG001|Overall Study|Non compliance to visit schedule|1|||
125091610|NCT01249404|449954733|FG002|Overall Study|Non compliance to visit schedule|0|||
125091611|NCT01020812|449954734|FG000|Overall Study|Physician Decision|1|||
125091612|NCT01020812|449954734|FG000|Overall Study|Withdrawal by Subject|1|||
125091613|NCT01020812|449954734|FG000|Overall Study|Protocol Violation|1|||
125091614|NCT02927990|449954735|FG000|Overall Study|Protocol Violation|4|||
125091615|NCT02927990|449954735|FG000|Overall Study|Physician Decision|9|||
125091616|NCT02927990|449954735|FG000|Overall Study|Room switched and therefore no study device available|15|||
125091617|NCT02927990|449954735|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
125091618|NCT00960323|449954736|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
125091619|NCT02719028|449954742|FG000|Overall Study|Adverse Event|2|||
125091620|NCT02719028|449954743|FG001|Overall Study|Adverse Event|1|||
125091621|NCT02719028|449954744|FG002|Overall Study|Adverse Event|4|||
125091622|NCT02719028|449954745|FG003|Overall Study|Adverse Event|8|||
125091623|NCT02719028|449954742|FG000|Overall Study|Physician Decision|0|||
125091624|NCT02719028|449954743|FG001|Overall Study|Physician Decision|1|||
125091625|NCT02719028|449954744|FG002|Overall Study|Physician Decision|1|||
125091626|NCT02719028|449954745|FG003|Overall Study|Physician Decision|1|||
125004795|NCT03250832|449646213|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
125004796|NCT03250832|449646214|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
125004797|NCT03250832|449646203|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
125004798|NCT03250832|449646204|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
125004799|NCT03250832|449646205|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
125004800|NCT03250832|449646206|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
125004801|NCT03250832|449646207|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
125004802|NCT03250832|449646208|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
125004803|NCT03250832|449646209|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
125004804|NCT03250832|449646210|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
125004805|NCT03250832|449646211|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
125004806|NCT03250832|449646212|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
125004807|NCT03250832|449646213|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
125004808|NCT03250832|449646214|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
125004809|NCT03250832|449646203|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125004810|NCT03250832|449646204|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125004811|NCT03250832|449646205|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125004812|NCT03250832|449646206|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125004813|NCT03250832|449646207|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125004814|NCT03250832|449646208|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125004815|NCT03250832|449646209|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125004816|NCT03250832|449646210|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125004817|NCT03250832|449646211|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
125004818|NCT03250832|449646212|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
125004819|NCT03250832|449646213|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125004820|NCT03250832|449646214|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125004821|NCT03250832|449646203|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
125004822|NCT03250832|449646204|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
125004823|NCT03250832|449646205|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
125004824|NCT03250832|449646206|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
125004825|NCT03250832|449646207|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
125004826|NCT03250832|449646208|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
125004827|NCT03250832|449646209|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
125004828|NCT03250832|449646210|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
125004829|NCT03250832|449646211|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
125004830|NCT03250832|449646212|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
125004831|NCT03250832|449646213|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
125004832|NCT03250832|449646214|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
125004833|NCT03250832|449646203|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125004834|NCT03250832|449646204|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125004835|NCT03250832|449646205|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125004836|NCT03250832|449646206|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125004837|NCT03250832|449646207|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125004838|NCT03250832|449646208|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125004839|NCT03250832|449646209|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125004840|NCT03250832|449646210|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125004841|NCT03250832|449646211|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125004842|NCT03250832|449646212|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125004843|NCT03250832|449646213|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125004844|NCT03250832|449646214|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
125004845|NCT02303704|449646215|FG000|Overall Study|Protocol Violation|5|||
125004846|NCT02303704|449646216|FG001|Overall Study|Protocol Violation|9|||
125004847|NCT00705432|449646219|FG000|Treatment Period|Adverse Event|45|||
125004848|NCT00705432|449646220|FG001|Treatment Period|Adverse Event|37|||
125004849|NCT00705432|449646221|FG002|Treatment Period|Adverse Event|51|||
125004850|NCT00705432|449646222|FG003|Treatment Period|Adverse Event|12|||
125004851|NCT00705432|449646223|FG004|Treatment Period|Adverse Event|8|||
125004852|NCT00705432|449646224|FG005|Treatment Period|Adverse Event|9|||
125004853|NCT00705432|449646219|FG000|Treatment Period|Treatment failure|92|||
125004854|NCT00705432|449646220|FG001|Treatment Period|Treatment failure|42|||
125004855|NCT00705432|449646221|FG002|Treatment Period|Treatment failure|33|||
125004856|NCT00705432|449646222|FG003|Treatment Period|Treatment failure|25|||
125004857|NCT00705432|449646223|FG004|Treatment Period|Treatment failure|13|||
125004858|NCT00705432|449646224|FG005|Treatment Period|Treatment failure|14|||
125004859|NCT00705432|449646219|FG000|Treatment Period|Non medical reason|26|||
125004860|NCT00705432|449646220|FG001|Treatment Period|Non medical reason|32|||
125004861|NCT00705432|449646221|FG002|Treatment Period|Non medical reason|37|||
125004862|NCT00705432|449646222|FG003|Treatment Period|Non medical reason|4|||
125004863|NCT00705432|449646223|FG004|Treatment Period|Non medical reason|7|||
125004864|NCT00705432|449646224|FG005|Treatment Period|Non medical reason|7|||
125004865|NCT00705432|449646219|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
125004866|NCT00705432|449646220|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
125004867|NCT00705432|449646221|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
125004868|NCT00705432|449646222|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
125004869|NCT00705432|449646223|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
125004870|NCT00705432|449646224|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
125004871|NCT00705432|449646219|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
125004872|NCT00705432|449646220|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
125004873|NCT00705432|449646221|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
125004874|NCT00705432|449646222|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
125004875|NCT00705432|449646223|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
125004876|NCT00705432|449646224|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
125004877|NCT04411628|449646225|FG000|Overall Study|Withdrawal by Subject|1|||
125004878|NCT04411628|449646226|FG001|Overall Study|Withdrawal by Subject|1|||
125004879|NCT04411628|449646227|FG002|Overall Study|Withdrawal by Subject|2|||
125004880|NCT04411628|449646228|FG003|Overall Study|Withdrawal by Subject|0|||
125004881|NCT04411628|449646225|FG000|Overall Study|Lost to Follow-up|0|||
125004882|NCT04411628|449646226|FG001|Overall Study|Lost to Follow-up|1|||
125004883|NCT04411628|449646227|FG002|Overall Study|Lost to Follow-up|0|||
125004884|NCT04411628|449646228|FG003|Overall Study|Lost to Follow-up|0|||
125004885|NCT00521053|449646229|FG000|Observation Phase|Disease Progression|55|||
125004886|NCT00521053|449646229|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
125004887|NCT00521053|449646229|FG000|Observation Phase|Death|2|||
125004888|NCT00521053|449646229|FG000|Observation Phase|Adverse Event|1|||
125004889|NCT00521053|449646229|FG000|Observation Phase|Other non-study melanoma treatment|1|||
125004890|NCT00521053|449646229|FG000|Observation Phase|Physician Decision|1|||
125004891|NCT00732251|449646230|FG000|Overall Study|Lost to Follow-up|3|||
125004892|NCT00732251|449646230|FG000|Overall Study|Withdrawal by Subject|3|||
125004893|NCT00732251|449646230|FG000|Overall Study|Early Term due to Site Closure|1|||
125004894|NCT01034540|449646231|FG000|Overall Study|Adverse Event|0|||
125004895|NCT01034540|449646232|FG001|Overall Study|Adverse Event|1|||
125004896|NCT03519867|449646235|FG000|Overall Study|Adverse Event|1|||
125004897|NCT03519867|449646236|FG001|Overall Study|Adverse Event|1|||
125004898|NCT03519867|449646237|FG002|Overall Study|Adverse Event|0|||
125004899|NCT03519867|449646238|FG003|Overall Study|Adverse Event|0|||
125004900|NCT03519867|449646239|FG004|Overall Study|Adverse Event|0|||
125004901|NCT03519867|449646240|FG005|Overall Study|Adverse Event|0|||
125004902|NCT03519867|449646241|FG006|Overall Study|Adverse Event|0|||
125004903|NCT03519867|449646242|FG007|Overall Study|Adverse Event|0|||
125004904|NCT03519867|449646243|FG008|Overall Study|Adverse Event|0|||
125004905|NCT03519867|449646244|FG009|Overall Study|Adverse Event|0|||
125004906|NCT03519867|449646235|FG000|Overall Study|Protocol Violation|0|||
125091627|NCT02719028|449954742|FG000|Overall Study|Use of prohibited medication|0|||
125091628|NCT02719028|449954743|FG001|Overall Study|Use of prohibited medication|0|||
125091629|NCT02719028|449954744|FG002|Overall Study|Use of prohibited medication|1|||
125091630|NCT02719028|449954745|FG003|Overall Study|Use of prohibited medication|0|||
125091631|NCT02719028|449954742|FG000|Overall Study|Protocol Violation|0|||
125091632|NCT02719028|449954743|FG001|Overall Study|Protocol Violation|0|||
125091633|NCT02719028|449954744|FG002|Overall Study|Protocol Violation|0|||
125091634|NCT02719028|449954745|FG003|Overall Study|Protocol Violation|1|||
125091635|NCT03287960|449954747|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
125091636|NCT03287960|449954747|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
125091637|NCT03730987|449954748|FG000|Overall Study|Lost to Follow-up|2|||
125091638|NCT03730987|449954749|FG001|Overall Study|Lost to Follow-up|0|||
125091639|NCT03730987|449954750|FG002|Overall Study|Lost to Follow-up|2|||
125091640|NCT03730987|449954751|FG003|Overall Study|Lost to Follow-up|0|||
125091641|NCT01667731|449954757|FG000|Overall Study|Enrolled but not treated|0|||
125091642|NCT01667731|449954758|FG001|Overall Study|Enrolled but not treated|0|||
125091643|NCT01667731|449954759|FG002|Overall Study|Enrolled but not treated|0|||
125091644|NCT01667731|449954760|FG003|Overall Study|Enrolled but not treated|0|||
125091645|NCT01667731|449954761|FG004|Overall Study|Enrolled but not treated|1|||
125091646|NCT01667731|449954757|FG000|Overall Study|Efficacy Failure|1|||
125091647|NCT01667731|449954758|FG001|Overall Study|Efficacy Failure|12|||
125091648|NCT01667731|449954759|FG002|Overall Study|Efficacy Failure|0|||
125091649|NCT01667731|449954760|FG003|Overall Study|Efficacy Failure|1|||
125091650|NCT01667731|449954761|FG004|Overall Study|Efficacy Failure|24|||
125091651|NCT01667731|449954757|FG000|Overall Study|Lost to Follow-up|2|||
125091652|NCT01667731|449954758|FG001|Overall Study|Lost to Follow-up|3|||
125091653|NCT01667731|449954759|FG002|Overall Study|Lost to Follow-up|1|||
125091654|NCT01667731|449954760|FG003|Overall Study|Lost to Follow-up|1|||
125091655|NCT01667731|449954761|FG004|Overall Study|Lost to Follow-up|2|||
125091656|NCT01667731|449954757|FG000|Overall Study|Subject Withdrew Consent|2|||
125091657|NCT01667731|449954758|FG001|Overall Study|Subject Withdrew Consent|0|||
125091658|NCT01667731|449954759|FG002|Overall Study|Subject Withdrew Consent|1|||
125091659|NCT01667731|449954760|FG003|Overall Study|Subject Withdrew Consent|0|||
125091660|NCT01667731|449954761|FG004|Overall Study|Subject Withdrew Consent|1|||
125091661|NCT01667731|449954757|FG000|Overall Study|Death|0|||
125091662|NCT01667731|449954758|FG001|Overall Study|Death|1|||
125091663|NCT01667731|449954759|FG002|Overall Study|Death|0|||
125091664|NCT01667731|449954760|FG003|Overall Study|Death|0|||
125091665|NCT01667731|449954761|FG004|Overall Study|Death|0|||
125091666|NCT01425268|449954762|FG000|Overall Study|Withdrawal by Subject|2|||
125091667|NCT01425268|449954763|FG001|Overall Study|Withdrawal by Subject|0|||
125091668|NCT01425268|449954762|FG000|Overall Study|Sponsor Decision|5|||
125091669|NCT01425268|449954763|FG001|Overall Study|Sponsor Decision|0|||
125091670|NCT01425268|449954762|FG000|Overall Study|Physician Decision|1|||
125091671|NCT01425268|449954763|FG001|Overall Study|Physician Decision|0|||
125091672|NCT03633461|449954764|FG000|Overall Study|Lost to Follow-up|0|||
125091673|NCT03633461|449954765|FG001|Overall Study|Lost to Follow-up|1|||
125091674|NCT01345162|449954770|FG000|Overall Study|Protocol Violation|2|||
125091675|NCT01345162|449954771|FG001|Overall Study|Protocol Violation|4|||
125091676|NCT01871870|449954772|FG000|Overall Study|Hardware issues|7|||
125091677|NCT01871870|449954772|FG000|Overall Study|hyperglycemia|2|||
125091678|NCT01716585|449954788|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
125091679|NCT01716585|449954789|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
125091680|NCT01716585|449954788|FG000|Double-blind Treatment|Adverse Event|2|||
125091681|NCT01716585|449954789|FG001|Double-blind Treatment|Adverse Event|1|||
125091682|NCT01716585|449954788|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
125091683|NCT01716585|449954789|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
125091684|NCT01716585|449954788|FG000|Double-blind Treatment|Lost to Follow-up|2|||
125091685|NCT01716585|449954789|FG001|Double-blind Treatment|Lost to Follow-up|0|||
125091686|NCT01716585|449954788|FG000|Double-blind Treatment|Subject Noncompliant|1|||
125091687|NCT01716585|449954789|FG001|Double-blind Treatment|Subject Noncompliant|0|||
125091688|NCT01716585|449954788|FG000|Double-blind Treatment|Other|1|||
125091689|NCT01716585|449954789|FG001|Double-blind Treatment|Other|0|||
125091690|NCT01716585|449954788|FG000|Open-label Treatment|Adverse Event|0|||
125091691|NCT01716585|449954789|FG001|Open-label Treatment|Adverse Event|2|||
125091692|NCT01716585|449954788|FG000|Open-label Treatment|Virologic Failure|0|||
125091693|NCT01716585|449954789|FG001|Open-label Treatment|Virologic Failure|2|||
125091694|NCT01716585|449954788|FG000|Open-label Treatment|Withdrawal by Subject|0|||
125091695|NCT01716585|449954789|FG001|Open-label Treatment|Withdrawal by Subject|3|||
125091696|NCT00504595|449954790|FG000|Overall Study|Lack of Efficacy|1|||
125091697|NCT00504595|449954791|FG001|Overall Study|Lack of Efficacy|0|||
125091698|NCT00504595|449954792|FG002|Overall Study|Lack of Efficacy|0|||
125091699|NCT00504595|449954793|FG003|Overall Study|Lack of Efficacy|0|||
125091700|NCT00504595|449954790|FG000|Overall Study|Other|0|||
125091701|NCT00504595|449954791|FG001|Overall Study|Other|0|||
125091702|NCT00504595|449954792|FG002|Overall Study|Other|2|||
125091703|NCT00504595|449954793|FG003|Overall Study|Other|0|||
125091704|NCT02764229|449954794|FG000|Overall Study|Withdrawal by Subject|15|||
125091705|NCT02764229|449954794|FG000|Overall Study|Adverse Event|9|||
125091706|NCT02764229|449954794|FG000|Overall Study|Physician Decision|5|||
125091707|NCT02764229|449954794|FG000|Overall Study|Lost to Follow-up|3|||
125091708|NCT02764229|449954794|FG000|Overall Study|Lack of Efficacy|1|||
125091709|NCT02764229|449954794|FG000|Overall Study|Study Stopped by Sponsor|69|||
125091710|NCT00851721|449954798|FG000|Overall Study|planned surgery|1|||
125091711|NCT00851721|449954799|FG001|Overall Study|planned surgery|0|||
125091712|NCT00851721|449954798|FG000|Overall Study|Death|1|||
125091713|NCT00851721|449954799|FG001|Overall Study|Death|0|||
125091714|NCT00851721|449954798|FG000|Overall Study|Adverse Event|0|||
125091715|NCT00851721|449954799|FG001|Overall Study|Adverse Event|1|||
125091716|NCT03451630|449954802|FG000|Overall Study|Death|15|||
125091717|NCT03451630|449954803|FG001|Overall Study|Death|16|||
125091718|NCT03451630|449954804|FG002|Overall Study|Death|11|||
125091719|NCT03451630|449954802|FG000|Overall Study|Lost to Follow-up|9|||
125091720|NCT03451630|449954803|FG001|Overall Study|Lost to Follow-up|0|||
125091721|NCT03451630|449954804|FG002|Overall Study|Lost to Follow-up|4|||
125091722|NCT03451630|449954802|FG000|Overall Study|Withdrawal by Subject|0|||
125091723|NCT03451630|449954803|FG001|Overall Study|Withdrawal by Subject|3|||
125091724|NCT03451630|449954804|FG002|Overall Study|Withdrawal by Subject|0|||
125091725|NCT03451630|449954802|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
125091726|NCT03451630|449954803|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
125091727|NCT03451630|449954804|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
125091728|NCT03370133|449954809|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
125091729|NCT03370133|449954810|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
125091730|NCT03370133|449954811|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
125091731|NCT03370133|449954812|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
125091732|NCT03370133|449954813|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
125091733|NCT03370133|449954814|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
125091734|NCT03370133|449954809|FG000|Initial Treatment Period (WK 16)|Death|1|||
125091735|NCT03370133|449954810|FG001|Initial Treatment Period (WK 16)|Death|1|||
125091736|NCT03370133|449954811|FG002|Initial Treatment Period (WK 16)|Death|1|||
125091737|NCT03370133|449954812|FG003|Initial Treatment Period (WK 16)|Death|0|||
125091738|NCT03370133|449954813|FG004|Initial Treatment Period (WK 16)|Death|0|||
125091739|NCT03370133|449954814|FG005|Initial Treatment Period (WK 16)|Death|0|||
125091740|NCT03370133|449954809|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
125091741|NCT03370133|449954810|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
125091742|NCT03370133|449954811|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
125091743|NCT03370133|449954812|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
125091744|NCT03370133|449954813|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
125091745|NCT03370133|449954814|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
125091746|NCT03370133|449954809|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
125091747|NCT03370133|449954810|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
125091748|NCT03370133|449954811|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
125091749|NCT03370133|449954812|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
125091750|NCT03370133|449954813|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
125091751|NCT03370133|449954814|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
125091752|NCT03370133|449954809|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
125091753|NCT03370133|449954810|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
125091754|NCT03370133|449954811|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
125091755|NCT03370133|449954812|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
125091756|NCT03370133|449954813|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
125091757|NCT03370133|449954814|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
125091758|NCT03370133|449954809|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
125091759|NCT03370133|449954810|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
125091760|NCT03370133|449954811|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
125091761|NCT03370133|449954812|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
125091762|NCT03370133|449954813|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
125091763|NCT03370133|449954814|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
125091764|NCT03370133|449954809|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
125091765|NCT03370133|449954810|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
125091766|NCT03370133|449954811|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
125091767|NCT03370133|449954812|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
125091768|NCT03370133|449954813|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
125091769|NCT03370133|449954814|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
125091770|NCT03370133|449954809|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
125091771|NCT03370133|449954810|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
125091772|NCT03370133|449954811|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
125091773|NCT03370133|449954812|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
125091774|NCT03370133|449954813|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
125091775|NCT03370133|449954814|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
125091776|NCT03370133|449954809|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
125091777|NCT03370133|449954810|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
125091778|NCT03370133|449954811|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
125091779|NCT03370133|449954812|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
125091780|NCT03370133|449954813|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
125091781|NCT03370133|449954814|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
125091782|NCT03370133|449954809|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
125091783|NCT03370133|449954810|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
125091784|NCT03370133|449954811|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
125091785|NCT03370133|449954812|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
125091786|NCT03370133|449954813|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
125091787|NCT03370133|449954814|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
125091788|NCT03370133|449954809|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
125091789|NCT03370133|449954810|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
125091790|NCT03370133|449954811|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
125091791|NCT03370133|449954812|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
125091792|NCT03370133|449954813|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
125091793|NCT03370133|449954814|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
125091794|NCT03370133|449954809|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
125091795|NCT03370133|449954810|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
125091796|NCT03370133|449954811|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
125091797|NCT03370133|449954812|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
125091798|NCT03370133|449954813|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
125091799|NCT03370133|449954814|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
125091800|NCT03370133|449954809|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
125091801|NCT03370133|449954810|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
125091802|NCT03370133|449954811|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
125091803|NCT03370133|449954812|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
125091804|NCT03370133|449954813|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
125091805|NCT03370133|449954814|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
125091806|NCT03370133|449954809|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
125091807|NCT03370133|449954810|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
125091808|NCT03370133|449954811|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
125091809|NCT03370133|449954812|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
125091810|NCT03370133|449954813|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
125091811|NCT03370133|449954814|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
125091812|NCT03370133|449954809|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
125091813|NCT03370133|449954810|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
125091814|NCT03370133|449954811|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
125091815|NCT03370133|449954812|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
125091816|NCT03370133|449954813|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
125091817|NCT03370133|449954814|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
124872991|NCT00508261|449157214|FG002|Overall Study|Withdrawal by Subject|4|||
125004907|NCT03519867|449646236|FG001|Overall Study|Protocol Violation|0|||
125004908|NCT03519867|449646237|FG002|Overall Study|Protocol Violation|0|||
125004909|NCT03519867|449646238|FG003|Overall Study|Protocol Violation|0|||
125004910|NCT03519867|449646239|FG004|Overall Study|Protocol Violation|0|||
125004911|NCT03519867|449646240|FG005|Overall Study|Protocol Violation|1|||
125004912|NCT03519867|449646241|FG006|Overall Study|Protocol Violation|0|||
125004913|NCT03519867|449646242|FG007|Overall Study|Protocol Violation|0|||
125004914|NCT03519867|449646243|FG008|Overall Study|Protocol Violation|0|||
125004915|NCT03519867|449646244|FG009|Overall Study|Protocol Violation|0|||
125004916|NCT03519867|449646235|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
125004917|NCT03519867|449646236|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
125004918|NCT03519867|449646237|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
125004919|NCT03519867|449646238|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
125004920|NCT03519867|449646239|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
125004921|NCT03519867|449646240|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
125004922|NCT03519867|449646241|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
125004923|NCT03519867|449646242|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
125004924|NCT03519867|449646243|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
125004925|NCT03519867|449646244|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
125004926|NCT03519867|449646235|FG000|Overall Study|Admin. of other reversal agent|1|||
125004927|NCT03519867|449646236|FG001|Overall Study|Admin. of other reversal agent|1|||
125004928|NCT03519867|449646237|FG002|Overall Study|Admin. of other reversal agent|0|||
125004929|NCT03519867|449646238|FG003|Overall Study|Admin. of other reversal agent|0|||
125004930|NCT03519867|449646239|FG004|Overall Study|Admin. of other reversal agent|0|||
125004931|NCT03519867|449646240|FG005|Overall Study|Admin. of other reversal agent|1|||
125004932|NCT03519867|449646241|FG006|Overall Study|Admin. of other reversal agent|0|||
125004933|NCT03519867|449646242|FG007|Overall Study|Admin. of other reversal agent|0|||
125004934|NCT03519867|449646243|FG008|Overall Study|Admin. of other reversal agent|0|||
125004935|NCT03519867|449646244|FG009|Overall Study|Admin. of other reversal agent|0|||
125004936|NCT03519867|449646235|FG000|Overall Study|Reason not provided|1|||
125004937|NCT03519867|449646236|FG001|Overall Study|Reason not provided|1|||
125004938|NCT03519867|449646237|FG002|Overall Study|Reason not provided|1|||
125004939|NCT03519867|449646238|FG003|Overall Study|Reason not provided|1|||
125004940|NCT03519867|449646239|FG004|Overall Study|Reason not provided|0|||
125004941|NCT03519867|449646240|FG005|Overall Study|Reason not provided|1|||
125004942|NCT03519867|449646241|FG006|Overall Study|Reason not provided|0|||
125004943|NCT03519867|449646242|FG007|Overall Study|Reason not provided|1|||
125004944|NCT03519867|449646243|FG008|Overall Study|Reason not provided|1|||
125004945|NCT03519867|449646244|FG009|Overall Study|Reason not provided|0|||
125004946|NCT01252810|449646245|FG000|Overall Study|Withdrawal by Subject|4|||
125004947|NCT01252810|449646246|FG001|Overall Study|Withdrawal by Subject|1|||
125004948|NCT01252810|449646245|FG000|Overall Study|Lost to Follow-up|0|||
125004949|NCT01252810|449646246|FG001|Overall Study|Lost to Follow-up|1|||
125004950|NCT01252810|449646245|FG000|Overall Study|Physician Decision|2|||
125004951|NCT01252810|449646246|FG001|Overall Study|Physician Decision|1|||
125004952|NCT01252810|449646245|FG000|Overall Study|Various reasons|8|||
125004953|NCT01252810|449646246|FG001|Overall Study|Various reasons|0|||
125004954|NCT00667823|449646248|FG000|Overall Study|Lost to Follow-up|5|||
125004955|NCT00667823|449646248|FG000|Overall Study|Adverse Event|7|||
125004956|NCT00667823|449646248|FG000|Overall Study|Death|182|||
125004957|NCT00667823|449646248|FG000|Overall Study|Withdrawal by Subject|12|||
125004958|NCT00667823|449646248|FG000|Overall Study|Other|8|||
125004959|NCT00667823|449646248|FG000|Overall Study|Missing (completion page missing)|2|||
125004960|NCT04376827|449646249|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
125004961|NCT04376827|449646250|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
125004962|NCT04376827|449646249|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
125004963|NCT04376827|449646250|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
125004964|NCT04376827|449646249|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
125004965|NCT04376827|449646250|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
125004966|NCT04376827|449646249|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
125004967|NCT04376827|449646250|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
125091818|NCT01365468|449954815|FG000|Overall Study|Physician Decision|1|||
125091819|NCT01365468|449954816|FG001|Overall Study|Physician Decision|0|||
125091820|NCT01365468|449954815|FG000|Overall Study|Disease progression|1|||
125091821|NCT01365468|449954816|FG001|Overall Study|Disease progression|0|||
125091822|NCT01365468|449954815|FG000|Overall Study|Lost to Follow-up|2|||
125091823|NCT01365468|449954816|FG001|Overall Study|Lost to Follow-up|0|||
125091824|NCT03524664|449954817|FG000|Overall Study|Withdrawal by Subject|1|||
125091825|NCT03524664|449954818|FG001|Overall Study|Withdrawal by Subject|2|||
125091826|NCT03524664|449954817|FG000|Overall Study|Lost to Follow-up|4|||
125091827|NCT03524664|449954818|FG001|Overall Study|Lost to Follow-up|13|||
125091828|NCT02694562|449954819|FG000|Overall Study|Death|8|||
125091829|NCT02694562|449954819|FG000|Overall Study|Protocol Violation|4|||
125091830|NCT02694562|449954819|FG000|Overall Study|Lost to Follow-up|3|||
125091831|NCT02694562|449954819|FG000|Overall Study|Screen Failure|2|||
125091832|NCT02694562|449954819|FG000|Overall Study|Physician Decision|1|||
125091833|NCT00423267|449954820|FG000|Period A|Withdrawal by Subject|0|||
125091834|NCT00423267|449954821|FG001|Period A|Withdrawal by Subject|1|||
125091835|NCT00423267|449954820|FG000|Period A|Non-compliance with protocol|1|||
125091836|NCT00423267|449954821|FG001|Period A|Non-compliance with protocol|0|||
125091837|NCT00423267|449954820|FG000|Period A|Administrative|1|||
125091838|NCT00423267|449954821|FG001|Period A|Administrative|0|||
125091839|NCT01333865|449954822|FG000|Overall Study|Adverse Event|2|||
125091840|NCT00684073|449954823|FG000|Selection|Selection/non-selection criteria|3|||
125091841|NCT00684073|449954823|FG000|Selection|Death|1|||
125091842|NCT00684073|449954823|FG000|Selection|noncompliance|1|||
125091843|NCT00684073|449954823|FG000|Selection|Lost to Follow-up|1|||
125091844|NCT00684073|449954823|FG000|Selection|request of the sponsor|1|||
125091845|NCT00684073|449954823|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
125091846|NCT00591786|449954826|FG000|Overall Study|Withdrawal of Informed Consent|0|||
125091847|NCT00591786|449954827|FG001|Overall Study|Withdrawal of Informed Consent|0|||
125091848|NCT00591786|449954828|FG002|Overall Study|Withdrawal of Informed Consent|1|||
125091849|NCT00591786|449954829|FG003|Overall Study|Withdrawal of Informed Consent|0|||
125091850|NCT00591786|449954830|FG004|Overall Study|Withdrawal of Informed Consent|0|||
125091851|NCT00591786|449954831|FG005|Overall Study|Withdrawal of Informed Consent|0|||
125091852|NCT00591786|449954832|FG006|Overall Study|Withdrawal of Informed Consent|0|||
125091853|NCT00591786|449954833|FG007|Overall Study|Withdrawal of Informed Consent|0|||
125091854|NCT00591786|449954834|FG008|Overall Study|Withdrawal of Informed Consent|0|||
125091855|NCT00591786|449954835|FG009|Overall Study|Withdrawal of Informed Consent|0|||
125091856|NCT00554229|449954836|FG000|Overall Study|Lost to Follow-up|3|||
125091857|NCT00554229|449954837|FG001|Overall Study|Lost to Follow-up|6|||
125091858|NCT00554229|449954836|FG000|Overall Study|Withdrawal by Subject|29|||
125091859|NCT00554229|449954837|FG001|Overall Study|Withdrawal by Subject|37|||
125091860|NCT00554229|449954836|FG000|Overall Study|Adverse Event|71|||
125091861|NCT00554229|449954837|FG001|Overall Study|Adverse Event|39|||
125091862|NCT00554229|449954836|FG000|Overall Study|Protocol Violation|3|||
125091863|NCT00554229|449954837|FG001|Overall Study|Protocol Violation|3|||
125091864|NCT00554229|449954836|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
125091865|NCT00554229|449954837|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
125091866|NCT00554229|449954836|FG000|Overall Study|Randomised but no treatment received|1|||
125091867|NCT00554229|449954837|FG001|Overall Study|Randomised but no treatment received|0|||
125091868|NCT01140646|449954838|FG000|Overall Study|Adverse Event|4|||
125091869|NCT01140646|449954838|FG000|Overall Study|Refused Further Treatment|5|||
125091870|NCT00689728|449954840|FG000|Double-Blind Treatment|Adverse Event|1|||
125091871|NCT00689728|449954841|FG001|Double-Blind Treatment|Adverse Event|0|||
125091872|NCT00689728|449954842|FG002|Double-Blind Treatment|Adverse Event|0|||
125091873|NCT00689728|449954840|FG000|Double-Blind Treatment|Protocol Violation|0|||
125091874|NCT00689728|449954841|FG001|Double-Blind Treatment|Protocol Violation|0|||
125091875|NCT00689728|449954842|FG002|Double-Blind Treatment|Protocol Violation|1|||
125091876|NCT00689728|449954840|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
125091877|NCT00689728|449954841|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
125091878|NCT00689728|449954842|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
125091879|NCT00689728|449954840|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
125091880|NCT00689728|449954841|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
125091881|NCT00689728|449954842|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
125091882|NCT00689728|449954840|FG000|Rescue|Adverse Event|0|||
125091883|NCT00689728|449954841|FG001|Rescue|Adverse Event|1|||
125091884|NCT00689728|449954842|FG002|Rescue|Adverse Event|0|||
125091885|NCT00689728|449954840|FG000|Rescue|Withdrawal by Subject|1|||
125091886|NCT00689728|449954841|FG001|Rescue|Withdrawal by Subject|1|||
125091887|NCT00689728|449954842|FG002|Rescue|Withdrawal by Subject|1|||
125091888|NCT00689728|449954840|FG000|Optional Follow-Up|Adverse Event|1|||
125091889|NCT00689728|449954841|FG001|Optional Follow-Up|Adverse Event|0|||
125091890|NCT00689728|449954842|FG002|Optional Follow-Up|Adverse Event|0|||
125091891|NCT00689728|449954840|FG000|Optional Follow-Up|Lack of Efficacy|0|||
125091892|NCT00689728|449954841|FG001|Optional Follow-Up|Lack of Efficacy|1|||
125091893|NCT00689728|449954842|FG002|Optional Follow-Up|Lack of Efficacy|1|||
125091894|NCT00689728|449954840|FG000|Optional Follow-Up|Lost to Follow-up|0|||
125091895|NCT00689728|449954841|FG001|Optional Follow-Up|Lost to Follow-up|1|||
125091896|NCT00689728|449954842|FG002|Optional Follow-Up|Lost to Follow-up|1|||
125091897|NCT00689728|449954840|FG000|Optional Follow-Up|Protocol Violation|0|||
125091898|NCT00689728|449954841|FG001|Optional Follow-Up|Protocol Violation|0|||
125091899|NCT00689728|449954842|FG002|Optional Follow-Up|Protocol Violation|1|||
125091900|NCT00689728|449954840|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
125091901|NCT00689728|449954841|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
125091902|NCT00689728|449954842|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
125091903|NCT00784836|449954847|FG000|Overall Study|Early Study Termination|3|||
125091904|NCT00660829|449954849|FG000|Overall Study|Adverse Event|3|||
125091905|NCT00660829|449954850|FG001|Overall Study|Adverse Event|4|||
125091906|NCT00660829|449954849|FG000|Overall Study|Lack of Efficacy|2|||
125091907|NCT00660829|449954850|FG001|Overall Study|Lack of Efficacy|3|||
125091908|NCT00660829|449954849|FG000|Overall Study|Non-Compliance|0|||
125091909|NCT00660829|449954850|FG001|Overall Study|Non-Compliance|4|||
125091910|NCT00660829|449954849|FG000|Overall Study|Withdrawal by Subject|1|||
125091911|NCT00660829|449954850|FG001|Overall Study|Withdrawal by Subject|2|||
125091912|NCT00660829|449954849|FG000|Overall Study|Lost to Follow-up|3|||
125091913|NCT00660829|449954850|FG001|Overall Study|Lost to Follow-up|2|||
125091914|NCT00660829|449954849|FG000|Overall Study|Other|9|||
125091915|NCT00660829|449954850|FG001|Overall Study|Other|4|||
125091916|NCT03590613|449954851|FG000|Period 2, 4 Days|Physician Decision|0|||
125091917|NCT03590613|449954852|FG001|Period 2, 4 Days|Physician Decision|0|||
125091918|NCT03590613|449954853|FG002|Period 2, 4 Days|Physician Decision|0|||
125091919|NCT03590613|449954854|FG003|Period 2, 4 Days|Physician Decision|1|||
125091920|NCT00280059|449954855|FG000|Efficacy Assessment Phase|Death|2|||
125091921|NCT00280059|449954856|FG001|Efficacy Assessment Phase|Death|0|||
125091922|NCT00280059|449954855|FG000|Efficacy Assessment Phase|Adverse Event|33|||
125091923|NCT00280059|449954856|FG001|Efficacy Assessment Phase|Adverse Event|31|||
125091924|NCT00280059|449954855|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
125091925|NCT00280059|449954856|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
125091926|NCT00280059|449954855|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
125091927|NCT00280059|449954856|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
125091928|NCT00280059|449954855|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
125091929|NCT00280059|449954856|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
125091930|NCT00280059|449954855|FG000|Efficacy Assessment Phase|Other|7|||
125091931|NCT00280059|449954856|FG001|Efficacy Assessment Phase|Other|8|||
125091932|NCT00280059|449954855|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
125091933|NCT00280059|449954856|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
125091934|NCT01130831|449954859|FG000|Overall Study|Withdrawal by Subject|7|||
125091935|NCT01130831|449954859|FG000|Overall Study|Death|4|||
125091936|NCT01130831|449954859|FG000|Overall Study|Information was missing|3|||
125091937|NCT00951912|449954860|FG000|Overall Study|Lack of Efficacy|1|||
125091938|NCT00951912|449954861|FG001|Overall Study|Lack of Efficacy|0|||
125091939|NCT00951912|449954862|FG002|Overall Study|Lack of Efficacy|0|||
125091940|NCT00951912|449954860|FG000|Overall Study|Adverse Event|0|||
125091941|NCT00951912|449954861|FG001|Overall Study|Adverse Event|1|||
125091942|NCT00951912|449954862|FG002|Overall Study|Adverse Event|1|||
125091943|NCT00951912|449954860|FG000|Overall Study|Lost to Follow-up|2|||
125091944|NCT00951912|449954861|FG001|Overall Study|Lost to Follow-up|2|||
125091945|NCT00951912|449954862|FG002|Overall Study|Lost to Follow-up|0|||
125091946|NCT00951912|449954860|FG000|Overall Study|Physician Decision|1|||
125091947|NCT00951912|449954861|FG001|Overall Study|Physician Decision|0|||
125091948|NCT00951912|449954862|FG002|Overall Study|Physician Decision|1|||
125091949|NCT00951912|449954860|FG000|Overall Study|Withdrawal by Subject|1|||
125091950|NCT00951912|449954861|FG001|Overall Study|Withdrawal by Subject|1|||
125091951|NCT00951912|449954862|FG002|Overall Study|Withdrawal by Subject|0|||
125091952|NCT00951912|449954860|FG000|Overall Study|Other:Depression|1|||
125091953|NCT00951912|449954861|FG001|Overall Study|Other:Depression|0|||
125091954|NCT00951912|449954862|FG002|Overall Study|Other:Depression|0|||
125091955|NCT00951912|449954860|FG000|Overall Study|Other: Colon cancer|1|||
125091956|NCT00951912|449954861|FG001|Overall Study|Other: Colon cancer|0|||
125091957|NCT00951912|449954862|FG002|Overall Study|Other: Colon cancer|0|||
125091958|NCT00951912|449954860|FG000|Overall Study|Other: Stroke|0|||
125091959|NCT00951912|449954861|FG001|Overall Study|Other: Stroke|1|||
125091960|NCT00951912|449954862|FG002|Overall Study|Other: Stroke|0|||
125091961|NCT01513460|449954866|FG000|Overall Study|Death|0|||
125091962|NCT01513460|449954867|FG001|Overall Study|Death|0|||
125091963|NCT01513460|449954868|FG002|Overall Study|Death|1|||
125091964|NCT01513460|449954866|FG000|Overall Study|Lost to Follow-up|0|||
125091965|NCT01513460|449954867|FG001|Overall Study|Lost to Follow-up|0|||
125091966|NCT01513460|449954868|FG002|Overall Study|Lost to Follow-up|2|||
125091967|NCT01513460|449954866|FG000|Overall Study|Abnormal laboratory value|1|||
125091968|NCT01513460|449954867|FG001|Overall Study|Abnormal laboratory value|0|||
125091969|NCT01513460|449954868|FG002|Overall Study|Abnormal laboratory value|1|||
125091970|NCT01513460|449954866|FG000|Overall Study|Lack of Efficacy|1|||
125091971|NCT01513460|449954867|FG001|Overall Study|Lack of Efficacy|2|||
125091972|NCT01513460|449954868|FG002|Overall Study|Lack of Efficacy|5|||
125091973|NCT01513460|449954866|FG000|Overall Study|Protocol deviations|3|||
125091974|NCT01513460|449954867|FG001|Overall Study|Protocol deviations|4|||
125091975|NCT01513460|449954868|FG002|Overall Study|Protocol deviations|3|||
125091976|NCT01513460|449954866|FG000|Overall Study|Withdrawal by Subject|7|||
125091977|NCT01513460|449954867|FG001|Overall Study|Withdrawal by Subject|8|||
125091978|NCT01513460|449954868|FG002|Overall Study|Withdrawal by Subject|21|||
125091979|NCT01513460|449954866|FG000|Overall Study|Adverse Event|16|||
125091980|NCT01513460|449954867|FG001|Overall Study|Adverse Event|18|||
125091981|NCT01513460|449954868|FG002|Overall Study|Adverse Event|23|||
125091982|NCT01513460|449954866|FG000|Overall Study|Abnormal test procedure|1|||
125091983|NCT01513460|449954867|FG001|Overall Study|Abnormal test procedure|0|||
125091984|NCT01513460|449954868|FG002|Overall Study|Abnormal test procedure|0|||
125091985|NCT00489216|449954869|FG000|Overall Study|Adverse Event|1|||
125091986|NCT02612194|449954874|FG000|Overall Study|Death|5|||
125091987|NCT02612194|449954875|FG001|Overall Study|Death|0|||
125091988|NCT02612194|449954876|FG002|Overall Study|Death|2|||
125091989|NCT02612194|449954874|FG000|Overall Study|Early Study Termination|1|||
125091990|NCT02612194|449954875|FG001|Overall Study|Early Study Termination|0|||
125091991|NCT02612194|449954876|FG002|Overall Study|Early Study Termination|0|||
125091992|NCT02539160|449954877|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
125091993|NCT02539160|449954878|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
125091994|NCT02539160|449954879|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
125091995|NCT02539160|449954880|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
125091996|NCT02539160|449954877|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
125091997|NCT02539160|449954878|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
125091998|NCT02539160|449954879|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
125091999|NCT02539160|449954880|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
125092000|NCT02539160|449954877|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
125092001|NCT02539160|449954878|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
125092002|NCT02539160|449954879|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
125092003|NCT02539160|449954880|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
125092004|NCT01681004|449954881|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
125092005|NCT01681004|449954882|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
125092006|NCT01681004|449954881|FG000|Study Completion|Lost to Follow-up|8|||
125092007|NCT01681004|449954882|FG001|Study Completion|Lost to Follow-up|3|||
125092008|NCT01681004|449954881|FG000|Study Completion|Physician Decision|1|||
125092009|NCT01681004|449954882|FG001|Study Completion|Physician Decision|3|||
125092010|NCT01681004|449954881|FG000|Study Completion|Site Termination|2|||
125092011|NCT01681004|449954882|FG001|Study Completion|Site Termination|1|||
125092012|NCT01681004|449954881|FG000|Study Completion|Death|1|||
125092013|NCT01681004|449954882|FG001|Study Completion|Death|1|||
125092014|NCT00372905|449954883|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
125092015|NCT00372905|449954884|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
125092016|NCT00372905|449954885|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
125092017|NCT00372905|449954886|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
125092018|NCT00372905|449954883|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
125092019|NCT00372905|449954884|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
125092020|NCT00372905|449954885|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
125004968|NCT04376827|449646249|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
125004969|NCT04376827|449646250|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
125033621|NCT01701258|449743820|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
125033622|NCT01701258|449743821|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
125033623|NCT01701258|449743822|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
125092021|NCT00372905|449954886|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
125092022|NCT00372905|449954883|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
125092023|NCT00372905|449954884|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
125092024|NCT00372905|449954885|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
125092025|NCT00372905|449954886|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
125092026|NCT00372905|449954883|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
125092027|NCT00372905|449954884|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
125092028|NCT00372905|449954885|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
125092029|NCT00372905|449954886|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
125092030|NCT00372905|449954883|FG000|Follow up Until Relapse or Progression|Study closed|0|||
125092031|NCT00372905|449954884|FG001|Follow up Until Relapse or Progression|Study closed|0|||
125092032|NCT00372905|449954885|FG002|Follow up Until Relapse or Progression|Study closed|0|||
125092033|NCT00372905|449954886|FG003|Follow up Until Relapse or Progression|Study closed|3|||
125092034|NCT00372905|449954883|FG000|Follow up Until Relapse or Progression|Other|0|||
125092035|NCT00372905|449954884|FG001|Follow up Until Relapse or Progression|Other|1|||
125092036|NCT00372905|449954885|FG002|Follow up Until Relapse or Progression|Other|0|||
125092037|NCT00372905|449954886|FG003|Follow up Until Relapse or Progression|Other|0|||
125092038|NCT02312934|449954887|FG000|Overall Study|Lost to Follow-up|1|||
125092039|NCT02312934|449954888|FG001|Overall Study|Lost to Follow-up|0|||
125092040|NCT02312934|449954887|FG000|Overall Study|Physician Decision|1|||
125092041|NCT02312934|449954888|FG001|Overall Study|Physician Decision|0|||
125092042|NCT00701064|449954890|FG000|Overall Study|Protocol Violation|1|||
125092043|NCT00701064|449954891|FG001|Overall Study|Protocol Violation|1|||
125092044|NCT00701064|449954890|FG000|Overall Study|Withdrawal by Subject|1|||
125092045|NCT00701064|449954891|FG001|Overall Study|Withdrawal by Subject|1|||
125092046|NCT00701064|449954890|FG000|Overall Study|initiated other PTSD treatment|2|||
125092047|NCT00701064|449954891|FG001|Overall Study|initiated other PTSD treatment|2|||
125092048|NCT00689299|449954892|FG000|Overall Study|Adverse Event|2|||
125092049|NCT00689299|449954893|FG001|Overall Study|Adverse Event|1|||
125092050|NCT00689299|449954894|FG002|Overall Study|Adverse Event|1|||
125092051|NCT00689299|449954892|FG000|Overall Study|Lost to Follow-up|0|||
125092052|NCT00689299|449954893|FG001|Overall Study|Lost to Follow-up|1|||
125092053|NCT00689299|449954894|FG002|Overall Study|Lost to Follow-up|1|||
125092054|NCT00689299|449954892|FG000|Overall Study|Withdrawal by Subject|4|||
125092055|NCT00689299|449954893|FG001|Overall Study|Withdrawal by Subject|1|||
125092056|NCT00689299|449954894|FG002|Overall Study|Withdrawal by Subject|3|||
125092057|NCT00689299|449954892|FG000|Overall Study|Protocol Violation|1|||
125092058|NCT00689299|449954893|FG001|Overall Study|Protocol Violation|0|||
125092059|NCT00689299|449954894|FG002|Overall Study|Protocol Violation|0|||
125092060|NCT02613910|449954897|FG000|Overall Study|Termination of study|1|||
125092061|NCT03395704|449954898|FG000|Overall Study|Adverse Event|2|||
125092062|NCT03395704|449954899|FG001|Overall Study|Adverse Event|1|||
125092063|NCT03395704|449954898|FG000|Overall Study|Withdrawal by Subject|2|||
125092064|NCT03395704|449954899|FG001|Overall Study|Withdrawal by Subject|1|||
125092065|NCT03395704|449954898|FG000|Overall Study|Physician Decision|0|||
125092066|NCT03395704|449954899|FG001|Overall Study|Physician Decision|1|||
125092067|NCT00758394|449954900|FG000|2nd Intervention Order|Lost to Follow-up|0|||
125092068|NCT00758394|449954901|FG001|2nd Intervention Order|Lost to Follow-up|1|||
125092069|NCT00758394|449954902|FG002|2nd Intervention Order|Lost to Follow-up|0|||
125092070|NCT00758394|449954903|FG003|2nd Intervention Order|Lost to Follow-up|0|||
125092071|NCT00758394|449954900|FG000|3rd Intervention|Lost to Follow-up|1|||
125092072|NCT00758394|449954901|FG001|3rd Intervention|Lost to Follow-up|0|||
125092073|NCT00758394|449954902|FG002|3rd Intervention|Lost to Follow-up|0|||
125092074|NCT00758394|449954903|FG003|3rd Intervention|Lost to Follow-up|1|||
125092075|NCT04823494|449956709|FG000|Overall Study|Programming software malfunction.|1|||
125092076|NCT04823494|449956710|FG001|Overall Study|Programming software malfunction.|0|||
125092077|NCT04823494|449956709|FG000|Overall Study|Withdrawal by Subject|1|||
125092078|NCT04823494|449956710|FG001|Overall Study|Withdrawal by Subject|0|||
125092079|NCT04823494|449956709|FG000|Overall Study|Devices lost|0|||
125092080|NCT04823494|449956710|FG001|Overall Study|Devices lost|1|||
125092081|NCT03726320|449956711|FG000|Overall Study|Lost to Follow-up|2|||
125092082|NCT03726320|449956712|FG001|Overall Study|Lost to Follow-up|4|||
125092083|NCT03726320|449956713|FG002|Overall Study|Lost to Follow-up|0|||
125092084|NCT03726320|449956711|FG000|Overall Study|Time Constraints|4|||
125092085|NCT03726320|449956712|FG001|Overall Study|Time Constraints|1|||
125092086|NCT03726320|449956713|FG002|Overall Study|Time Constraints|0|||
125092087|NCT03726320|449956711|FG000|Overall Study|Ineligible after enrollment|3|||
125092088|NCT03726320|449956712|FG001|Overall Study|Ineligible after enrollment|3|||
125092089|NCT03726320|449956713|FG002|Overall Study|Ineligible after enrollment|0|||
125092090|NCT03726320|449956711|FG000|Overall Study|Clinic / insurance issue|2|||
125092091|NCT03726320|449956712|FG001|Overall Study|Clinic / insurance issue|0|||
125092092|NCT03726320|449956713|FG002|Overall Study|Clinic / insurance issue|0|||
125092093|NCT03726320|449956711|FG000|Overall Study|Language barrier|1|||
125092094|NCT03726320|449956712|FG001|Overall Study|Language barrier|0|||
125092095|NCT03726320|449956713|FG002|Overall Study|Language barrier|0|||
125092096|NCT03726320|449956711|FG000|Overall Study|Provider left the clinic|0|||
125092097|NCT03726320|449956712|FG001|Overall Study|Provider left the clinic|0|||
125092098|NCT03726320|449956713|FG002|Overall Study|Provider left the clinic|1|||
125092099|NCT01684930|449956716|FG000|Overall Study|Withdrawal by Subject|3|||
125092100|NCT01684930|449956717|FG001|Overall Study|Withdrawal by Subject|1|||
125092101|NCT00313716|449956727|FG000|Overall Study|Death|3|||
125092102|NCT00313716|449956728|FG001|Overall Study|Death|2|||
125092103|NCT00313716|449956729|FG002|Overall Study|Death|9|||
125092104|NCT00313716|449956730|FG003|Overall Study|Death|3|||
125092105|NCT00313716|449956731|FG004|Overall Study|Death|5|||
125092106|NCT00313716|449956732|FG005|Overall Study|Death|9|||
125092107|NCT00313716|449956727|FG000|Overall Study|Lost to Follow-up|2|||
125092108|NCT00313716|449956728|FG001|Overall Study|Lost to Follow-up|5|||
125092109|NCT00313716|449956729|FG002|Overall Study|Lost to Follow-up|2|||
125092110|NCT00313716|449956730|FG003|Overall Study|Lost to Follow-up|1|||
125092111|NCT00313716|449956731|FG004|Overall Study|Lost to Follow-up|0|||
125092112|NCT00313716|449956732|FG005|Overall Study|Lost to Follow-up|4|||
125092113|NCT00313716|449956727|FG000|Overall Study|Withdrawal by Subject|0|||
125092114|NCT00313716|449956728|FG001|Overall Study|Withdrawal by Subject|1|||
125092115|NCT00313716|449956729|FG002|Overall Study|Withdrawal by Subject|1|||
125092116|NCT00313716|449956730|FG003|Overall Study|Withdrawal by Subject|0|||
125092117|NCT00313716|449956731|FG004|Overall Study|Withdrawal by Subject|1|||
125092118|NCT00313716|449956732|FG005|Overall Study|Withdrawal by Subject|0|||
125092119|NCT01041027|449956734|FG000|Overall Study|Withdrawal by Subject|2|||
125092120|NCT01041027|449956734|FG000|Overall Study|Protocol Violation|1|||
125092121|NCT01041027|449956734|FG000|Overall Study|Delayed Radiation Therapy|1|||
125092122|NCT01041027|449956734|FG000|Overall Study|Adverse Event|4|||
125092123|NCT01347931|449956735|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
125092124|NCT02493712|449956736|FG000|Overall Study|Withdrawal by Subject|1|||
125092125|NCT02493712|449956737|FG001|Overall Study|Withdrawal by Subject|0|||
125092126|NCT02493712|449956738|FG002|Overall Study|Withdrawal by Subject|2|||
125092127|NCT02493712|449956736|FG000|Overall Study|Protocol Violation|0|||
125092128|NCT02493712|449956737|FG001|Overall Study|Protocol Violation|0|||
125092129|NCT02493712|449956738|FG002|Overall Study|Protocol Violation|1|||
125092130|NCT02493712|449956736|FG000|Overall Study|Lost to Follow-up|1|||
125092131|NCT02493712|449956737|FG001|Overall Study|Lost to Follow-up|0|||
125092132|NCT02493712|449956738|FG002|Overall Study|Lost to Follow-up|0|||
125092133|NCT02493712|449956736|FG000|Overall Study|Physician Decision|0|||
125092134|NCT02493712|449956737|FG001|Overall Study|Physician Decision|1|||
125092135|NCT02493712|449956738|FG002|Overall Study|Physician Decision|0|||
125092136|NCT02493712|449956736|FG000|Overall Study|Lack of Efficacy|0|||
125092137|NCT02493712|449956737|FG001|Overall Study|Lack of Efficacy|5|||
125092138|NCT02493712|449956738|FG002|Overall Study|Lack of Efficacy|3|||
125092139|NCT02528643|449956739|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
125092140|NCT02528643|449956740|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
125092141|NCT02528643|449956739|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
125092142|NCT02528643|449956740|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
125092143|NCT02528643|449956739|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
125092144|NCT02528643|449956740|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
125092145|NCT02528643|449956739|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
125092146|NCT02528643|449956740|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
125092147|NCT02528643|449956739|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
125092148|NCT02528643|449956740|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
125092149|NCT02528643|449956739|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
125092150|NCT02528643|449956740|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
125092151|NCT02528643|449956739|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
125092152|NCT02528643|449956740|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
125092153|NCT04120116|449956741|FG000|Overall Study|Lost to Follow-up|0|||
125092154|NCT04120116|449956742|FG001|Overall Study|Lost to Follow-up|1|||
125092155|NCT04120116|449956743|FG002|Overall Study|Lost to Follow-up|0|||
125092156|NCT04120116|449956744|FG003|Overall Study|Lost to Follow-up|2|||
125092157|NCT04120116|449956741|FG000|Overall Study|Withdrawal by Subject|1|||
125092158|NCT04120116|449956742|FG001|Overall Study|Withdrawal by Subject|0|||
125092159|NCT04120116|449956743|FG002|Overall Study|Withdrawal by Subject|1|||
125092160|NCT04120116|449956744|FG003|Overall Study|Withdrawal by Subject|1|||
125092161|NCT04120116|449956741|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
125092162|NCT04120116|449956742|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
125092163|NCT04120116|449956743|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
125092164|NCT04120116|449956744|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
125092165|NCT02087085|449956745|FG000|Overall Study|Adverse Event|10|||
125092166|NCT02087085|449956746|FG001|Overall Study|Adverse Event|14|||
125092167|NCT02087085|449956745|FG000|Overall Study|Lack of Efficacy|4|||
125004970|NCT05162027|449648087|FG000|Overall Study|Adverse Event|1|||
125004971|NCT05162027|449648088|FG001|Overall Study|Adverse Event|0|||
125004972|NCT02767323|449648092|FG000|Overall Study|Withdrawal by Subject|17|||
125004973|NCT02767323|449648093|FG001|Overall Study|Withdrawal by Subject|5|||
125004974|NCT02767323|449648094|FG002|Overall Study|Withdrawal by Subject|13|||
125004975|NCT02767323|449648095|FG003|Overall Study|Withdrawal by Subject|0|||
125004976|NCT02767323|449648092|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
125004977|NCT02767323|449648093|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
125004978|NCT02767323|449648094|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
125004979|NCT02767323|449648095|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
125004980|NCT00388505|449648097|FG000|Overall Study|Adverse Event or Death|43|||
125004981|NCT00388505|449648098|FG001|Overall Study|Adverse Event or Death|17|||
125004982|NCT00388505|449648097|FG000|Overall Study|Withdrawal by Subject|24|||
125004983|NCT00388505|449648098|FG001|Overall Study|Withdrawal by Subject|9|||
125004984|NCT00388505|449648097|FG000|Overall Study|Lost to Follow-up|5|||
125004985|NCT00388505|449648098|FG001|Overall Study|Lost to Follow-up|3|||
125004986|NCT00388505|449648097|FG000|Overall Study|Inappropriate Enrollment|0|||
125004987|NCT00388505|449648098|FG001|Overall Study|Inappropriate Enrollment|1|||
125004988|NCT00388505|449648097|FG000|Overall Study|Administrative Reason|1|||
125004989|NCT00388505|449648098|FG001|Overall Study|Administrative Reason|0|||
125004990|NCT00388505|449648097|FG000|Overall Study|Protocol Violation|6|||
125004991|NCT00388505|449648098|FG001|Overall Study|Protocol Violation|5|||
125004992|NCT00388505|449648097|FG000|Overall Study|Unable to classify|4|||
125004993|NCT00388505|449648098|FG001|Overall Study|Unable to classify|3|||
125004994|NCT01480284|449648101|FG000|Overall Study|Withdrawal by Subject|2|||
125004995|NCT01480284|449648102|FG001|Overall Study|Withdrawal by Subject|0|||
125004996|NCT01480284|449648101|FG000|Overall Study|Adverse Event|1|||
125004997|NCT01480284|449648102|FG001|Overall Study|Adverse Event|0|||
125004998|NCT01480284|449648101|FG000|Overall Study|Study closed/terminated|3|||
125004999|NCT01480284|449648102|FG001|Overall Study|Study closed/terminated|0|||
125005000|NCT01480284|449648101|FG000|Overall Study|Lost to Follow-up|1|||
125005001|NCT01480284|449648102|FG001|Overall Study|Lost to Follow-up|0|||
125005002|NCT01480284|449648101|FG000|Overall Study|Physician Decision|1|||
125005003|NCT01480284|449648102|FG001|Overall Study|Physician Decision|0|||
125005004|NCT01641237|449648103|FG000|Period II|Withdrawal by Subject|1|||
125005005|NCT01641237|449648104|FG001|Period II|Withdrawal by Subject|0|||
125005006|NCT01641237|449648105|FG002|Period II|Withdrawal by Subject|0|||
125005007|NCT01641237|449648106|FG003|Period II|Withdrawal by Subject|0|||
125005008|NCT01641237|449648103|FG000|Period III|Lost to Follow-up|1|||
125005009|NCT01641237|449648104|FG001|Period III|Lost to Follow-up|0|||
125005010|NCT01641237|449648105|FG002|Period III|Lost to Follow-up|0|||
125005011|NCT01641237|449648106|FG003|Period III|Lost to Follow-up|0|||
125005012|NCT00709111|449648107|FG000|Overall Study|Withdrawal by Subject|1|||
125005013|NCT00709111|449648107|FG000|Overall Study|Unable to attend clinic visits|1|||
125005014|NCT02716675|449648108|FG000|Overall Study|Death|2|||
125005015|NCT02716675|449648109|FG001|Overall Study|Death|3|||
125005016|NCT02716675|449648110|FG002|Overall Study|Death|0|||
125005017|NCT02716675|449648108|FG000|Overall Study|Physician Decision|2|||
125005018|NCT02716675|449648109|FG001|Overall Study|Physician Decision|1|||
125005019|NCT02716675|449648110|FG002|Overall Study|Physician Decision|1|||
125005020|NCT02716675|449648108|FG000|Overall Study|Lost to Follow-up|100|||
125005021|NCT02716675|449648109|FG001|Overall Study|Lost to Follow-up|87|||
125005022|NCT02716675|449648110|FG002|Overall Study|Lost to Follow-up|99|||
125005023|NCT02716675|449648108|FG000|Overall Study|Withdrawal by Subject|22|||
125005024|NCT02716675|449648109|FG001|Overall Study|Withdrawal by Subject|25|||
125005025|NCT02716675|449648110|FG002|Overall Study|Withdrawal by Subject|20|||
125005026|NCT02716675|449648108|FG000|Overall Study|Protocol Violation|0|||
125005027|NCT02716675|449648109|FG001|Overall Study|Protocol Violation|3|||
125005028|NCT02716675|449648110|FG002|Overall Study|Protocol Violation|1|||
125005029|NCT02716675|449648108|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
125005030|NCT02716675|449648109|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
125005031|NCT02716675|449648110|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
125005032|NCT02716675|449648108|FG000|Overall Study|Other|38|||
125005033|NCT02716675|449648109|FG001|Overall Study|Other|47|||
125005034|NCT02716675|449648110|FG002|Overall Study|Other|48|||
125005035|NCT01301456|449648111|FG000|Stage 1|Withdrawal by Subject|0|||
125005036|NCT01301456|449648112|FG001|Stage 1|Withdrawal by Subject|0|||
125005037|NCT01301456|449648113|FG002|Stage 1|Withdrawal by Subject|1|||
125092168|NCT02087085|449956746|FG001|Overall Study|Lack of Efficacy|3|||
125005038|NCT01301456|449648114|FG003|Stage 1|Withdrawal by Subject|0|||
125005039|NCT01301456|449648115|FG004|Stage 1|Withdrawal by Subject|1|||
125005040|NCT01301456|449648116|FG005|Stage 1|Withdrawal by Subject|0|||
125005041|NCT01301456|449648117|FG006|Stage 1|Withdrawal by Subject|0|||
125005042|NCT01301456|449648118|FG007|Stage 1|Withdrawal by Subject|0|||
125005043|NCT01301456|449648119|FG008|Stage 1|Withdrawal by Subject|0|||
125005044|NCT01301456|449648120|FG009|Stage 1|Withdrawal by Subject|0|||
124872992|NCT00508261|449157215|FG003|Overall Study|Withdrawal by Subject|0|||
125092169|NCT02087085|449956745|FG000|Overall Study|Lost to Follow-up|6|||
125092170|NCT02087085|449956746|FG001|Overall Study|Lost to Follow-up|4|||
125092171|NCT02087085|449956745|FG000|Overall Study|Withdrawal by Subject|9|||
125092172|NCT02087085|449956746|FG001|Overall Study|Withdrawal by Subject|11|||
125092173|NCT02087085|449956745|FG000|Overall Study|Protocol Violation|1|||
125092174|NCT02087085|449956746|FG001|Overall Study|Protocol Violation|0|||
125092175|NCT02087085|449956745|FG000|Overall Study|Study Terminated by Sponsor|87|||
125092176|NCT02087085|449956746|FG001|Overall Study|Study Terminated by Sponsor|80|||
125092177|NCT02087085|449956745|FG000|Overall Study|Other Miscellaneous Reasons|3|||
125092178|NCT02087085|449956746|FG001|Overall Study|Other Miscellaneous Reasons|4|||
125092179|NCT01191190|449956747|FG000|Overall Study|Withdrawal by Subject|1|||
125092180|NCT00883896|449956755|FG000|Overall Study|Lost to Follow-up|0|||
125092181|NCT00883896|449956756|FG001|Overall Study|Lost to Follow-up|0|||
125092182|NCT00883896|449956757|FG002|Overall Study|Lost to Follow-up|0|||
125092183|NCT00883896|449956758|FG003|Overall Study|Lost to Follow-up|2|||
125092184|NCT00883896|449956755|FG000|Overall Study|Withdrawal by Subject|5|||
125092185|NCT00883896|449956756|FG001|Overall Study|Withdrawal by Subject|0|||
125092186|NCT00883896|449956757|FG002|Overall Study|Withdrawal by Subject|1|||
125092187|NCT00883896|449956758|FG003|Overall Study|Withdrawal by Subject|3|||
125092188|NCT00883896|449956755|FG000|Overall Study|Lack of Efficacy|0|||
125092189|NCT00883896|449956756|FG001|Overall Study|Lack of Efficacy|0|||
125092190|NCT00883896|449956757|FG002|Overall Study|Lack of Efficacy|0|||
125092191|NCT00883896|449956758|FG003|Overall Study|Lack of Efficacy|2|||
125092192|NCT00883896|449956755|FG000|Overall Study|Other|1|||
125092193|NCT00883896|449956756|FG001|Overall Study|Other|0|||
125092194|NCT00883896|449956757|FG002|Overall Study|Other|0|||
125092195|NCT00883896|449956758|FG003|Overall Study|Other|0|||
125092196|NCT01856920|449956759|FG000|Overall Study|Disease Progression On Study|3|||
125092197|NCT01856920|449956760|FG001|Overall Study|Disease Progression On Study|4|||
125092198|NCT01856920|449956759|FG000|Overall Study|Disease Progression before Treatment|1|||
125092199|NCT01856920|449956760|FG001|Overall Study|Disease Progression before Treatment|0|||
125092200|NCT01856920|449956759|FG000|Overall Study|Ineligible|0|||
125092201|NCT01856920|449956760|FG001|Overall Study|Ineligible|1|||
125092202|NCT01856920|449956759|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
125092203|NCT01856920|449956760|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
125092204|NCT01856920|449956759|FG000|Overall Study|Refused further Treatment|5|||
125092205|NCT01856920|449956760|FG001|Overall Study|Refused further Treatment|1|||
125092206|NCT01856920|449956759|FG000|Overall Study|Other Reasons|0|||
125092207|NCT01856920|449956760|FG001|Overall Study|Other Reasons|1|||
125092208|NCT01856920|449956759|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
125092209|NCT01856920|449956760|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
125092210|NCT02545270|449956761|FG000|Overall Study|technical difficulties|0|||
125092211|NCT02545270|449956762|FG001|Overall Study|technical difficulties|1|||
125092212|NCT02545270|449956763|FG002|Overall Study|technical difficulties|0|||
125092213|NCT02545270|449956761|FG000|Overall Study|Videos being too similar to other|0|||
125092214|NCT02545270|449956762|FG001|Overall Study|Videos being too similar to other|0|||
125092215|NCT02545270|449956763|FG002|Overall Study|Videos being too similar to other|2|||
125092216|NCT00761891|449956764|FG000|Overall Study|Withdrawal by Subject|10|||
125092217|NCT01707667|449956765|FG000|Period 1|expulsion of colonic sensor catheter|1|||
125092218|NCT01707667|449956766|FG001|Period 1|expulsion of colonic sensor catheter|0|||
125092219|NCT04382066|449956774|FG000|Overall Study|Adverse Event|1|||
125092220|NCT04382066|449956775|FG001|Overall Study|Adverse Event|0|||
125092221|NCT04382066|449956776|FG002|Overall Study|Adverse Event|0|||
125092222|NCT04382066|449956774|FG000|Overall Study|Death|1|||
125092223|NCT04382066|449956775|FG001|Overall Study|Death|0|||
125092224|NCT04382066|449956776|FG002|Overall Study|Death|1|||
125092225|NCT03326323|449956779|FG000|Overall Study|Unable to receive ANH protocol|3|||
125092226|NCT04225026|449956781|FG000|Overall Study|Withdrawal by Subject|4|||
125092227|NCT04225026|449956781|FG000|Overall Study|Adverse Event|1|||
125092228|NCT04225026|449956781|FG000|Overall Study|Other|1|||
125092229|NCT04225026|449956781|FG000|Overall Study|Death|11|||
125092230|NCT04225026|449956781|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
125092231|NCT00779142|449956782|FG000|Overall Study|Screen Failures|3|||
125092232|NCT00672490|449956783|FG000|Overall Study|Withdrawal by Subject|8|||
125092233|NCT00672490|449956784|FG001|Overall Study|Withdrawal by Subject|8|||
125092234|NCT00672490|449956783|FG000|Overall Study|Lack of Compliance|2|||
125092235|NCT00672490|449956784|FG001|Overall Study|Lack of Compliance|7|||
125092236|NCT00672490|449956783|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
125092237|NCT00672490|449956784|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
125092238|NCT00672490|449956783|FG000|Overall Study|Adverse Event|5|||
125092239|NCT00672490|449956784|FG001|Overall Study|Adverse Event|8|||
125092240|NCT00672490|449956783|FG000|Overall Study|Violation of Concomitant Medicine|1|||
125092241|NCT00672490|449956784|FG001|Overall Study|Violation of Concomitant Medicine|0|||
125092242|NCT00672490|449956783|FG000|Overall Study|Intolerance|0|||
125092243|NCT00672490|449956784|FG001|Overall Study|Intolerance|2|||
125092244|NCT00672490|449956783|FG000|Overall Study|Lost to Follow-up|1|||
125092245|NCT00672490|449956784|FG001|Overall Study|Lost to Follow-up|5|||
125092246|NCT00672490|449956783|FG000|Overall Study|No reason was provided|6|||
125092247|NCT00672490|449956784|FG001|Overall Study|No reason was provided|2|||
125092248|NCT04533204|449956787|FG000|Overall Study|Unable to understand training instructions|1|||
125092249|NCT04533204|449956788|FG001|Overall Study|Unable to understand training instructions|1|||
125092250|NCT03982069|449956789|FG000|Overall Study|Lost to Follow-up|5|||
125092251|NCT03982069|449956790|FG001|Overall Study|Lost to Follow-up|5|||
125092252|NCT03982069|449956791|FG002|Overall Study|Lost to Follow-up|3|||
125092253|NCT03982069|449956792|FG003|Overall Study|Lost to Follow-up|5|||
125092254|NCT03982069|449956789|FG000|Overall Study|Physician Decision|0|||
125092255|NCT03982069|449956790|FG001|Overall Study|Physician Decision|1|||
125092256|NCT03982069|449956791|FG002|Overall Study|Physician Decision|0|||
125092257|NCT03982069|449956792|FG003|Overall Study|Physician Decision|0|||
125092258|NCT03982069|449956789|FG000|Overall Study|Withdrawal by Subject|2|||
125092259|NCT03982069|449956790|FG001|Overall Study|Withdrawal by Subject|1|||
125092260|NCT03982069|449956791|FG002|Overall Study|Withdrawal by Subject|5|||
125092261|NCT03982069|449956792|FG003|Overall Study|Withdrawal by Subject|2|||
125092262|NCT03982069|449956789|FG000|Overall Study|Specimen loss|3|||
125092263|NCT03982069|449956790|FG001|Overall Study|Specimen loss|3|||
125092264|NCT03982069|449956791|FG002|Overall Study|Specimen loss|1|||
125092265|NCT03982069|449956792|FG003|Overall Study|Specimen loss|1|||
125092266|NCT01218477|449956793|FG000|Overall Study|Disease progression|2|||
125092267|NCT01218477|449956794|FG001|Overall Study|Disease progression|3|||
125092268|NCT01218477|449956795|FG002|Overall Study|Disease progression|6|||
125092269|NCT01218477|449956796|FG003|Overall Study|Disease progression|2|||
125092270|NCT01218477|449956793|FG000|Overall Study|Study drug toxicity|0|||
125092271|NCT01218477|449956794|FG001|Overall Study|Study drug toxicity|2|||
125092272|NCT01218477|449956795|FG002|Overall Study|Study drug toxicity|5|||
125092273|NCT01218477|449956796|FG003|Overall Study|Study drug toxicity|0|||
125092274|NCT01218477|449956793|FG000|Overall Study|No longer meets study criteria|1|||
125092275|NCT01218477|449956794|FG001|Overall Study|No longer meets study criteria|0|||
125092276|NCT01218477|449956795|FG002|Overall Study|No longer meets study criteria|0|||
125092277|NCT01218477|449956796|FG003|Overall Study|No longer meets study criteria|0|||
125092278|NCT01218477|449956793|FG000|Overall Study|Withdrawal by Subject|0|||
125092279|NCT01218477|449956794|FG001|Overall Study|Withdrawal by Subject|0|||
125092280|NCT01218477|449956795|FG002|Overall Study|Withdrawal by Subject|1|||
125092281|NCT01218477|449956796|FG003|Overall Study|Withdrawal by Subject|0|||
125092282|NCT01218477|449956793|FG000|Overall Study|Prepared for cell transplantation|0|||
125092283|NCT01218477|449956794|FG001|Overall Study|Prepared for cell transplantation|1|||
125092284|NCT01218477|449956795|FG002|Overall Study|Prepared for cell transplantation|1|||
125092285|NCT01218477|449956796|FG003|Overall Study|Prepared for cell transplantation|0|||
125092286|NCT01218477|449956793|FG000|Overall Study|Administrative reason by sponsor|0|||
125092287|NCT01218477|449956794|FG001|Overall Study|Administrative reason by sponsor|0|||
125092288|NCT01218477|449956795|FG002|Overall Study|Administrative reason by sponsor|1|||
125092289|NCT01218477|449956796|FG003|Overall Study|Administrative reason by sponsor|0|||
125092290|NCT01218477|449956793|FG000|Overall Study|Maximum clinical benefit|0|||
125092291|NCT01218477|449956794|FG001|Overall Study|Maximum clinical benefit|2|||
125092292|NCT01218477|449956795|FG002|Overall Study|Maximum clinical benefit|0|||
125092293|NCT01218477|449956796|FG003|Overall Study|Maximum clinical benefit|0|||
125092294|NCT03137433|449956797|FG000|Overall Study|Withdrawal by Subject|11|||
125092295|NCT03137433|449956798|FG001|Overall Study|Withdrawal by Subject|11|||
125092296|NCT03137433|449956797|FG000|Overall Study|Lost to Follow-up|5|||
125092297|NCT03137433|449956798|FG001|Overall Study|Lost to Follow-up|6|||
125092298|NCT03137433|449956797|FG000|Overall Study|Physician Decision|2|||
125092299|NCT03137433|449956798|FG001|Overall Study|Physician Decision|0|||
125092300|NCT03137433|449956797|FG000|Overall Study|Moved out of study area|1|||
125092301|NCT03137433|449956798|FG001|Overall Study|Moved out of study area|0|||
125092302|NCT03137433|449956797|FG000|Overall Study|Too far out of window due to COVID|0|||
125092303|NCT03137433|449956798|FG001|Overall Study|Too far out of window due to COVID|1|||
125092304|NCT00265382|449956799|FG000|Overall Study|Adverse Event|21|||
125092305|NCT00265382|449956799|FG000|Overall Study|Laboratory Abnormality|1|||
125092306|NCT00265382|449956799|FG000|Overall Study|Lost to Follow-up|3|||
125092307|NCT00265382|449956799|FG000|Overall Study|Lack of Efficacy|6|||
125092308|NCT00265382|449956799|FG000|Overall Study|Miscellaneous|6|||
125092309|NCT00265382|449956799|FG000|Overall Study|Withdrawal by Subject|13|||
125092310|NCT00265382|449956799|FG000|Overall Study|Study terminated by sponsor|94|||
125092311|NCT00265382|449956799|FG000|Overall Study|Death|1|||
125092312|NCT00760994|449956800|FG000|Overall Study|Lost to Follow-up|4|||
125092313|NCT00760994|449956801|FG001|Overall Study|Lost to Follow-up|4|||
125092314|NCT00760994|449956802|FG002|Overall Study|Lost to Follow-up|3|||
125092315|NCT01853397|449956803|FG000|Overall Study|Withdrawal by Subject|0|||
125092316|NCT01853397|449956804|FG001|Overall Study|Withdrawal by Subject|0|||
125092317|NCT01853397|449956805|FG002|Overall Study|Withdrawal by Subject|0|||
125092318|NCT01853397|449956806|FG003|Overall Study|Withdrawal by Subject|1|||
125092319|NCT01853397|449956803|FG000|Overall Study|Subject Noncompliance|0|||
125092320|NCT01853397|449956804|FG001|Overall Study|Subject Noncompliance|0|||
125092321|NCT01853397|449956805|FG002|Overall Study|Subject Noncompliance|0|||
125092322|NCT01853397|449956806|FG003|Overall Study|Subject Noncompliance|1|||
125092323|NCT02132312|449956807|FG000|Overall Study|Adverse Event|2|||
125092324|NCT02132312|449956808|FG001|Overall Study|Adverse Event|0|||
125092325|NCT02132312|449956807|FG000|Overall Study|Physician Decision|1|||
125092326|NCT02132312|449956808|FG001|Overall Study|Physician Decision|1|||
125092327|NCT02132312|449956807|FG000|Overall Study|Protocol Violation|0|||
125092328|NCT02132312|449956808|FG001|Overall Study|Protocol Violation|1|||
125092329|NCT02132312|449956807|FG000|Overall Study|Withdrawal by Subject|1|||
125092330|NCT02132312|449956808|FG001|Overall Study|Withdrawal by Subject|0|||
125092331|NCT02132312|449956807|FG000|Overall Study|Lost to Follow-up|2|||
125092332|NCT02132312|449956808|FG001|Overall Study|Lost to Follow-up|1|||
125092333|NCT01724021|449956811|FG000|Overall Study|Adverse Event|11|||
125092334|NCT01724021|449956812|FG001|Overall Study|Adverse Event|6|||
125092335|NCT01724021|449956811|FG000|Overall Study|Death|46|||
125092336|NCT01724021|449956812|FG001|Overall Study|Death|58|||
125092337|NCT01724021|449956811|FG000|Overall Study|Participant request/ Withdrew consent|18|||
125092338|NCT01724021|449956812|FG001|Overall Study|Participant request/ Withdrew consent|14|||
125092339|NCT01724021|449956811|FG000|Overall Study|Lost to Follow-up|15|||
125092340|NCT01724021|449956812|FG001|Overall Study|Lost to Follow-up|15|||
125092341|NCT01724021|449956811|FG000|Overall Study|Reason Not Specified|36|||
125092342|NCT01724021|449956812|FG001|Overall Study|Reason Not Specified|39|||
125092343|NCT01724021|449956811|FG000|Overall Study|Missing|1|||
125092344|NCT01724021|449956812|FG001|Overall Study|Missing|1|||
125092345|NCT00486720|449956815|FG000|Overall Study|Adverse Event|1|||
125092346|NCT00486720|449956816|FG001|Overall Study|Adverse Event|2|||
125092347|NCT00486720|449956815|FG000|Overall Study|Lack of Efficacy|4|||
125092348|NCT00486720|449956816|FG001|Overall Study|Lack of Efficacy|6|||
125092349|NCT00486720|449956815|FG000|Overall Study|Physician Decision|1|||
125092350|NCT00486720|449956816|FG001|Overall Study|Physician Decision|2|||
125092351|NCT00486720|449956815|FG000|Overall Study|Protocol Violation|1|||
125092352|NCT00486720|449956816|FG001|Overall Study|Protocol Violation|0|||
125092353|NCT00486720|449956815|FG000|Overall Study|Withdrawal by Subject|3|||
125092354|NCT00486720|449956816|FG001|Overall Study|Withdrawal by Subject|1|||
125092355|NCT00486720|449956815|FG000|Overall Study|Progressive Disease|0|||
125092356|NCT00486720|449956816|FG001|Overall Study|Progressive Disease|1|||
125092357|NCT02452892|449956817|FG000|Week 1 Initial Randommization|Adverse Event|1|||
125092358|NCT02452892|449956818|FG001|Week 1 Initial Randommization|Adverse Event|0|||
125092359|NCT02452892|449956819|FG002|Week 1 Initial Randommization|Adverse Event|0|||
125092360|NCT02452892|449956820|FG003|Week 1 Initial Randommization|Adverse Event|0|||
125092361|NCT02452892|449956817|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
125092362|NCT02452892|449956818|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
125092363|NCT02452892|449956819|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
125092364|NCT02452892|449956820|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
125092365|NCT02452892|449956817|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
125092366|NCT02452892|449956818|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
125092367|NCT02452892|449956819|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
125092368|NCT02452892|449956820|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
125092369|NCT02452892|449956817|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
125092370|NCT02452892|449956818|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
125092371|NCT02452892|449956819|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
125092372|NCT02452892|449956820|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
125092373|NCT02452892|449956817|FG000|Follow-up|Withdrawal by Subject|0|||
125092374|NCT02452892|449956818|FG001|Follow-up|Withdrawal by Subject|0|||
125092375|NCT02452892|449956819|FG002|Follow-up|Withdrawal by Subject|0|||
125092376|NCT02452892|449956820|FG003|Follow-up|Withdrawal by Subject|1|||
125092377|NCT02452892|449956817|FG000|Follow-up|Subject left town on Day 42|1|||
125092378|NCT02452892|449956818|FG001|Follow-up|Subject left town on Day 42|0|||
125092379|NCT02452892|449956819|FG002|Follow-up|Subject left town on Day 42|0|||
125092380|NCT02452892|449956820|FG003|Follow-up|Subject left town on Day 42|0|||
125092381|NCT00955682|449956821|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
125092382|NCT00955682|449956822|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
125092383|NCT02041533|449956824|FG000|Pre-Treatment Period|Disease Progression|1|||
125092384|NCT02041533|449956825|FG001|Pre-Treatment Period|Disease Progression|1|||
125092385|NCT02041533|449956824|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
125092386|NCT02041533|449956825|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
125092387|NCT02041533|449956824|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
125092388|NCT02041533|449956825|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
125092389|NCT02041533|449956824|FG000|Treatment Period|Disease progression|189|||
125092390|NCT02041533|449956825|FG001|Treatment Period|Disease progression|146|||
125092391|NCT02041533|449956824|FG000|Treatment Period|Study drug toxicity|30|||
125092392|NCT02041533|449956825|FG001|Treatment Period|Study drug toxicity|34|||
125092393|NCT02041533|449956824|FG000|Treatment Period|Death|1|||
125092394|NCT02041533|449956825|FG001|Treatment Period|Death|0|||
125092395|NCT02041533|449956824|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
125092396|NCT02041533|449956825|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
125092397|NCT02041533|449956824|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
125092398|NCT02041533|449956825|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
125092399|NCT02041533|449956824|FG000|Treatment Period|Participant withdrew consent|2|||
125092400|NCT02041533|449956825|FG001|Treatment Period|Participant withdrew consent|2|||
125092401|NCT02041533|449956824|FG000|Treatment Period|Maximum clinical benefit|0|||
125092402|NCT02041533|449956825|FG001|Treatment Period|Maximum clinical benefit|18|||
125092403|NCT02041533|449956824|FG000|Treatment Period|Poor/Non-compliance|1|||
125092404|NCT02041533|449956825|FG001|Treatment Period|Poor/Non-compliance|0|||
125092405|NCT02041533|449956824|FG000|Treatment Period|Administrative reason by sponsor|1|||
125092406|NCT02041533|449956825|FG001|Treatment Period|Administrative reason by sponsor|0|||
125092407|NCT02041533|449956824|FG000|Treatment Period|Other reasons|9|||
125092408|NCT02041533|449956825|FG001|Treatment Period|Other reasons|2|||
125092409|NCT02041533|449956824|FG000|Treatment Period|Not Reported|0|||
125092410|NCT02041533|449956825|FG001|Treatment Period|Not Reported|1|||
125092411|NCT02117024|449956826|FG000|Overall Study|Progressive Disease|26|||
125092412|NCT02117024|449956827|FG001|Overall Study|Progressive Disease|9|||
125092413|NCT02117024|449956826|FG000|Overall Study|Significant Clinical Progression|7|||
125092414|NCT02117024|449956827|FG001|Overall Study|Significant Clinical Progression|4|||
125092415|NCT02117024|449956826|FG000|Overall Study|Death|5|||
125092416|NCT02117024|449956827|FG001|Overall Study|Death|0|||
125092417|NCT02117024|449956826|FG000|Overall Study|Withdrawal by Subject|3|||
125092418|NCT02117024|449956827|FG001|Overall Study|Withdrawal by Subject|1|||
125092419|NCT02117024|449956826|FG000|Overall Study|Protocol Violation|1|||
125092420|NCT02117024|449956827|FG001|Overall Study|Protocol Violation|0|||
125092421|NCT02117024|449956826|FG000|Overall Study|Adverse Event|1|||
125092422|NCT02117024|449956827|FG001|Overall Study|Adverse Event|2|||
125092423|NCT02117024|449956826|FG000|Overall Study|Randomized in Error|1|||
125092424|NCT02117024|449956827|FG001|Overall Study|Randomized in Error|0|||
125092425|NCT02117024|449956826|FG000|Overall Study|Patient returned to primary oncologist|0|||
125092426|NCT02117024|449956827|FG001|Overall Study|Patient returned to primary oncologist|1|||
125092427|NCT02117024|449956826|FG000|Overall Study|Patient took treatment break|0|||
125092428|NCT02117024|449956827|FG001|Overall Study|Patient took treatment break|1|||
125092429|NCT02117024|449956826|FG000|Overall Study|Physician Decision|0|||
125092430|NCT02117024|449956827|FG001|Overall Study|Physician Decision|2|||
125092431|NCT00565721|449956830|FG000|Overall Study|Screen Failure|2|||
125092432|NCT00565721|449956830|FG000|Overall Study|Lost to Follow-up|6|||
125092433|NCT00565721|449956830|FG000|Overall Study|Technical Problems|1|||
125092434|NCT00565721|449956830|FG000|Overall Study|Physician Decision|2|||
125092435|NCT00565721|449956830|FG000|Overall Study|Other reasons|6|||
124872993|NCT00508261|449157212|FG000|Overall Study|Migrated/ moved from study area|0|||
125092436|NCT02813681|449956833|FG000|Overall Study|Physician Decision|5|||
125092437|NCT02813681|449956834|FG001|Overall Study|Physician Decision|5|||
125092438|NCT02813681|449956835|FG002|Overall Study|Physician Decision|0|||
125092439|NCT02813681|449956833|FG000|Overall Study|Lost to Follow-up|0|||
125092440|NCT02813681|449956834|FG001|Overall Study|Lost to Follow-up|1|||
125092441|NCT02813681|449956835|FG002|Overall Study|Lost to Follow-up|0|||
125092442|NCT02500706|449956836|FG000|Overall Study|Adverse Event|0|||
125092443|NCT02500706|449956837|FG001|Overall Study|Adverse Event|0|||
125092444|NCT02500706|449956838|FG002|Overall Study|Adverse Event|1|||
125092445|NCT02500706|449956836|FG000|Overall Study|Lost to Follow-up|0|||
125092446|NCT02500706|449956837|FG001|Overall Study|Lost to Follow-up|1|||
125092447|NCT02500706|449956838|FG002|Overall Study|Lost to Follow-up|1|||
125092448|NCT02500706|449956836|FG000|Overall Study|Withdrawal by Subject|4|||
125092449|NCT02500706|449956837|FG001|Overall Study|Withdrawal by Subject|6|||
125092450|NCT02500706|449956838|FG002|Overall Study|Withdrawal by Subject|4|||
125092451|NCT02500706|449956836|FG000|Overall Study|Unclassified|0|||
125092452|NCT02500706|449956837|FG001|Overall Study|Unclassified|0|||
125092453|NCT02500706|449956838|FG002|Overall Study|Unclassified|1|||
125092454|NCT00529152|449956839|FG000|Overall Study|Adverse Event|2|||
125092455|NCT00529152|449956839|FG000|Overall Study|Withdrawal by Subject|2|||
125092456|NCT00529152|449956839|FG000|Overall Study|Lost to Follow-up|1|||
125092457|NCT01497899|449956844|FG000|Double-Blind Phase|Randomized but not Treated|1|||
125092458|NCT01497899|449956845|FG001|Double-Blind Phase|Randomized but not Treated|0|||
125092459|NCT01497899|449956846|FG002|Double-Blind Phase|Randomized but not Treated|0|||
125092460|NCT01497899|449956847|FG003|Double-Blind Phase|Randomized but not Treated|0|||
125092461|NCT01497899|449956844|FG000|Double-Blind Phase|Adverse Event|1|||
125092462|NCT01497899|449956845|FG001|Double-Blind Phase|Adverse Event|0|||
125092463|NCT01497899|449956846|FG002|Double-Blind Phase|Adverse Event|0|||
125005045|NCT01301456|449648121|FG010|Stage 1|Withdrawal by Subject|0|||
125005046|NCT01301456|449648122|FG011|Stage 1|Withdrawal by Subject|0|||
125005047|NCT01301456|449648111|FG000|Stage 1|Randomized but not treated|0|||
125005048|NCT01301456|449648112|FG001|Stage 1|Randomized but not treated|0|||
125005049|NCT01301456|449648113|FG002|Stage 1|Randomized but not treated|0|||
125005050|NCT01301456|449648114|FG003|Stage 1|Randomized but not treated|0|||
125005051|NCT01301456|449648115|FG004|Stage 1|Randomized but not treated|0|||
125005052|NCT01301456|449648116|FG005|Stage 1|Randomized but not treated|0|||
125005053|NCT01301456|449648117|FG006|Stage 1|Randomized but not treated|1|||
125005054|NCT01301456|449648118|FG007|Stage 1|Randomized but not treated|0|||
125005055|NCT01301456|449648119|FG008|Stage 1|Randomized but not treated|0|||
125005056|NCT01301456|449648120|FG009|Stage 1|Randomized but not treated|0|||
125005057|NCT01301456|449648121|FG010|Stage 1|Randomized but not treated|0|||
125005058|NCT01301456|449648122|FG011|Stage 1|Randomized but not treated|0|||
125005059|NCT01301456|449648111|FG000|Stage 2|Adverse Event|0|||
125005060|NCT01301456|449648112|FG001|Stage 2|Adverse Event|0|||
125005061|NCT01301456|449648113|FG002|Stage 2|Adverse Event|0|||
125005062|NCT01301456|449648114|FG003|Stage 2|Adverse Event|0|||
125005063|NCT01301456|449648115|FG004|Stage 2|Adverse Event|0|||
125005064|NCT01301456|449648116|FG005|Stage 2|Adverse Event|0|||
125005065|NCT01301456|449648117|FG006|Stage 2|Adverse Event|0|||
125005066|NCT01301456|449648118|FG007|Stage 2|Adverse Event|0|||
125005067|NCT01301456|449648119|FG008|Stage 2|Adverse Event|0|||
125005068|NCT01301456|449648120|FG009|Stage 2|Adverse Event|0|||
125005069|NCT01301456|449648121|FG010|Stage 2|Adverse Event|1|||
125005070|NCT01301456|449648122|FG011|Stage 2|Adverse Event|0|||
125005071|NCT00915772|449648123|FG000|Overall Study|Adverse Event|12|||
125005072|NCT00915772|449648124|FG001|Overall Study|Adverse Event|13|||
125005073|NCT00915772|449648125|FG002|Overall Study|Adverse Event|11|||
125005074|NCT00915772|449648123|FG000|Overall Study|Protocol Violation|4|||
125005075|NCT00915772|449648124|FG001|Overall Study|Protocol Violation|1|||
125005076|NCT00915772|449648125|FG002|Overall Study|Protocol Violation|2|||
125005077|NCT00915772|449648123|FG000|Overall Study|Lost to Follow-up|1|||
125005078|NCT00915772|449648124|FG001|Overall Study|Lost to Follow-up|2|||
125005079|NCT00915772|449648125|FG002|Overall Study|Lost to Follow-up|2|||
125005080|NCT00915772|449648123|FG000|Overall Study|Lack of Efficacy|9|||
125005081|NCT00915772|449648124|FG001|Overall Study|Lack of Efficacy|15|||
125005082|NCT00915772|449648125|FG002|Overall Study|Lack of Efficacy|3|||
125005083|NCT00915772|449648123|FG000|Overall Study|Refused to continue trial medication|6|||
125005084|NCT00915772|449648124|FG001|Overall Study|Refused to continue trial medication|8|||
125005085|NCT00915772|449648125|FG002|Overall Study|Refused to continue trial medication|4|||
125005086|NCT00915772|449648123|FG000|Overall Study|Any other reason|4|||
125005087|NCT00915772|449648124|FG001|Overall Study|Any other reason|7|||
125005088|NCT00915772|449648125|FG002|Overall Study|Any other reason|7|||
125005089|NCT03583450|449648126|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
125005090|NCT03583450|449648127|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
125005091|NCT03374995|449648128|FG000|Overall Study|Withdrawal by Subject|0|||
125005092|NCT03374995|449648129|FG001|Overall Study|Withdrawal by Subject|1|||
125005093|NCT01383096|449648130|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
125005094|NCT01383096|449648131|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
125092464|NCT01497899|449956847|FG003|Double-Blind Phase|Adverse Event|0|||
125092465|NCT01497899|449956844|FG000|Double-Blind Phase|Lack of Efficacy|0|||
125005095|NCT01383096|449648132|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
125092466|NCT01497899|449956845|FG001|Double-Blind Phase|Lack of Efficacy|1|||
125005096|NCT01383096|449648130|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
125005097|NCT01383096|449648131|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
125005098|NCT01383096|449648132|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
125005099|NCT01383096|449648130|FG000|Third Intervention (8 Days)|Elevated AST|0|||
125005100|NCT01383096|449648131|FG001|Third Intervention (8 Days)|Elevated AST|1|||
125005101|NCT01383096|449648132|FG002|Third Intervention (8 Days)|Elevated AST|0|||
125005102|NCT01383096|449648130|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
125005103|NCT01383096|449648131|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
125092467|NCT01497899|449956846|FG002|Double-Blind Phase|Lack of Efficacy|0|||
125092468|NCT01497899|449956847|FG003|Double-Blind Phase|Lack of Efficacy|0|||
125092469|NCT01497899|449956844|FG000|Double-Blind Phase|Investigator's Discretion|1|||
125092470|NCT01497899|449956845|FG001|Double-Blind Phase|Investigator's Discretion|0|||
125092471|NCT01497899|449956846|FG002|Double-Blind Phase|Investigator's Discretion|0|||
125092472|NCT01497899|449956847|FG003|Double-Blind Phase|Investigator's Discretion|0|||
125092473|NCT01497899|449956844|FG000|Double-Blind Phase|Withdrew Consent|0|||
125092474|NCT01497899|449956845|FG001|Double-Blind Phase|Withdrew Consent|1|||
125092475|NCT01497899|449956846|FG002|Double-Blind Phase|Withdrew Consent|0|||
125092476|NCT01497899|449956847|FG003|Double-Blind Phase|Withdrew Consent|0|||
125092477|NCT01497899|449956844|FG000|Double-Blind Phase|Lost to Follow-up|3|||
125092478|NCT01497899|449956845|FG001|Double-Blind Phase|Lost to Follow-up|2|||
125092479|NCT01497899|449956846|FG002|Double-Blind Phase|Lost to Follow-up|0|||
125092480|NCT01497899|449956847|FG003|Double-Blind Phase|Lost to Follow-up|0|||
125092481|NCT01497899|449956844|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
125092482|NCT01497899|449956845|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
125092483|NCT01497899|449956846|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
125092484|NCT01497899|449956847|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
125092485|NCT01497899|449956844|FG000|Open-Label Extension Phase|Adverse Event|1|||
125092486|NCT01497899|449956845|FG001|Open-Label Extension Phase|Adverse Event|0|||
125092487|NCT01497899|449956846|FG002|Open-Label Extension Phase|Adverse Event|0|||
125092488|NCT01497899|449956847|FG003|Open-Label Extension Phase|Adverse Event|0|||
125092489|NCT01497899|449956844|FG000|Open-Label Extension Phase|Death|1|||
125092490|NCT01497899|449956845|FG001|Open-Label Extension Phase|Death|0|||
125092491|NCT01497899|449956846|FG002|Open-Label Extension Phase|Death|0|||
125092492|NCT01497899|449956847|FG003|Open-Label Extension Phase|Death|0|||
125092493|NCT01497899|449956844|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
125092494|NCT01497899|449956845|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
125092495|NCT01497899|449956846|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
125092496|NCT01497899|449956847|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
125092497|NCT01497899|449956844|FG000|Open-Label Extension Phase|Pregnancy|0|||
125092498|NCT01497899|449956845|FG001|Open-Label Extension Phase|Pregnancy|1|||
125092499|NCT01497899|449956846|FG002|Open-Label Extension Phase|Pregnancy|1|||
125092500|NCT01497899|449956847|FG003|Open-Label Extension Phase|Pregnancy|0|||
125092501|NCT01497899|449956844|FG000|Open-Label Extension Phase|Protocol Violation|0|||
125092502|NCT01497899|449956845|FG001|Open-Label Extension Phase|Protocol Violation|0|||
125092503|NCT01497899|449956846|FG002|Open-Label Extension Phase|Protocol Violation|1|||
125092504|NCT01497899|449956847|FG003|Open-Label Extension Phase|Protocol Violation|0|||
125092505|NCT01497899|449956844|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
125092506|NCT01497899|449956845|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
125092507|NCT01497899|449956846|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
125092508|NCT01497899|449956847|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
125092509|NCT05047601|449956849|FG000|Overall Study|Lost to Follow-up|9|||
125092510|NCT05047601|449956850|FG001|Overall Study|Lost to Follow-up|11|||
125092511|NCT05047601|449956851|FG002|Overall Study|Lost to Follow-up|7|||
125092512|NCT05047601|449956849|FG000|Overall Study|Withdrawal by Subject|25|||
125092513|NCT05047601|449956850|FG001|Overall Study|Withdrawal by Subject|36|||
125092514|NCT05047601|449956851|FG002|Overall Study|Withdrawal by Subject|23|||
125092515|NCT05047601|449956849|FG000|Overall Study|Other|10|||
125092516|NCT05047601|449956850|FG001|Overall Study|Other|6|||
125092517|NCT05047601|449956851|FG002|Overall Study|Other|5|||
125092518|NCT00286234|449956852|FG000|Overall Study|Protocol Violation|1|||
125092519|NCT00286234|449956853|FG001|Overall Study|Protocol Violation|2|||
125092520|NCT00286234|449956854|FG002|Overall Study|Protocol Violation|0|||
125092521|NCT00286234|449956855|FG003|Overall Study|Protocol Violation|1|||
125092522|NCT00286234|449956852|FG000|Overall Study|Physician Decision|1|||
125092523|NCT00286234|449956853|FG001|Overall Study|Physician Decision|0|||
125092524|NCT00286234|449956854|FG002|Overall Study|Physician Decision|0|||
125092525|NCT00286234|449956855|FG003|Overall Study|Physician Decision|1|||
125092526|NCT00286234|449956852|FG000|Overall Study|Adverse Event|0|||
125092527|NCT00286234|449956853|FG001|Overall Study|Adverse Event|0|||
125092528|NCT00286234|449956854|FG002|Overall Study|Adverse Event|0|||
125092529|NCT00286234|449956855|FG003|Overall Study|Adverse Event|1|||
125092530|NCT00286234|449956852|FG000|Overall Study|Adverse Event|0|||
125092531|NCT00286234|449956853|FG001|Overall Study|Adverse Event|0|||
125092532|NCT00286234|449956854|FG002|Overall Study|Adverse Event|0|||
125092533|NCT00286234|449956855|FG003|Overall Study|Adverse Event|1|||
125092534|NCT01874288|449956863|FG000|Overall Study|Withdrawal by Subject|1|||
125092535|NCT01874288|449956864|FG001|Overall Study|Withdrawal by Subject|0|||
125092536|NCT01874288|449956865|FG002|Overall Study|Withdrawal by Subject|2|||
125092537|NCT01874288|449956866|FG003|Overall Study|Withdrawal by Subject|1|||
125092538|NCT01874288|449956867|FG004|Overall Study|Withdrawal by Subject|1|||
125092539|NCT01874288|449956863|FG000|Overall Study|Physician Decision|0|||
125092540|NCT01874288|449956864|FG001|Overall Study|Physician Decision|0|||
125092541|NCT01874288|449956865|FG002|Overall Study|Physician Decision|0|||
125092542|NCT01874288|449956866|FG003|Overall Study|Physician Decision|1|||
125092543|NCT01874288|449956867|FG004|Overall Study|Physician Decision|0|||
125092544|NCT01874288|449956863|FG000|Overall Study|Progressive disease|2|||
125092545|NCT01874288|449956864|FG001|Overall Study|Progressive disease|0|||
125092546|NCT01874288|449956865|FG002|Overall Study|Progressive disease|3|||
125092547|NCT01874288|449956866|FG003|Overall Study|Progressive disease|5|||
125092548|NCT01874288|449956867|FG004|Overall Study|Progressive disease|1|||
125092549|NCT00283062|449956868|FG000|Overall Study|Did not receive any study medication|5|||
125092550|NCT00283062|449956869|FG001|Overall Study|Did not receive any study medication|4|||
125092551|NCT00283062|449956870|FG002|Overall Study|Did not receive any study medication|36|||
125092552|NCT00283062|449956871|FG003|Overall Study|Did not receive any study medication|45|||
125092553|NCT00283062|449956868|FG000|Overall Study|Adverse Event|2|||
125092554|NCT00283062|449956869|FG001|Overall Study|Adverse Event|0|||
125092555|NCT00283062|449956870|FG002|Overall Study|Adverse Event|1|||
125092556|NCT00283062|449956871|FG003|Overall Study|Adverse Event|0|||
125092557|NCT00283062|449956868|FG000|Overall Study|Lost to Follow-up|1|||
125092558|NCT00283062|449956869|FG001|Overall Study|Lost to Follow-up|0|||
125092559|NCT00283062|449956870|FG002|Overall Study|Lost to Follow-up|1|||
125092560|NCT00283062|449956871|FG003|Overall Study|Lost to Follow-up|0|||
125092561|NCT00283062|449956868|FG000|Overall Study|Progressive disease|0|||
125092562|NCT00283062|449956869|FG001|Overall Study|Progressive disease|0|||
125092563|NCT00283062|449956870|FG002|Overall Study|Progressive disease|1|||
125092564|NCT00283062|449956871|FG003|Overall Study|Progressive disease|0|||
125092565|NCT00283062|449956868|FG000|Overall Study|Participant did not wish to continue|3|||
125005104|NCT01383096|449648132|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
125005105|NCT01383096|449648130|FG000|Third Intervention (8 Days)|Adverse Event|1|||
125005106|NCT01383096|449648131|FG001|Third Intervention (8 Days)|Adverse Event|0|||
125005107|NCT01383096|449648132|FG002|Third Intervention (8 Days)|Adverse Event|0|||
125005108|NCT01383096|449648130|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
125005109|NCT01383096|449648131|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
125005110|NCT01383096|449648132|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
125005111|NCT01383096|449648130|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
125005112|NCT01383096|449648131|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
125005113|NCT01383096|449648132|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
125005114|NCT01383096|449648130|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
125005115|NCT01383096|449648131|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
125005116|NCT01383096|449648132|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
125005117|NCT01383096|449648130|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
125005118|NCT01383096|449648131|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
125005119|NCT01383096|449648132|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
125005120|NCT01383096|449648130|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
125005121|NCT01383096|449648131|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
125005122|NCT01383096|449648132|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
125005123|NCT01383096|449648130|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
125005124|NCT01383096|449648131|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
125005125|NCT01383096|449648132|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
125005126|NCT01211535|449648133|FG000|Overall Study|Adverse Event|0|||
125005127|NCT01211535|449648134|FG001|Overall Study|Adverse Event|1|||
125005128|NCT03593850|449648139|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
125005129|NCT03593850|449648140|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
125005130|NCT01735279|449648141|FG000|Overall Study|Lost to Follow-up|11|||
125005131|NCT01735279|449648142|FG001|Overall Study|Lost to Follow-up|8|||
125005132|NCT00922480|449648154|FG000|Main Study|Protocol Violation|3|||
125005133|NCT00922480|449648155|FG001|Main Study|Protocol Violation|6|||
125092566|NCT00283062|449956869|FG001|Overall Study|Participant did not wish to continue|2|||
125092567|NCT00283062|449956870|FG002|Overall Study|Participant did not wish to continue|1|||
125092568|NCT00283062|449956871|FG003|Overall Study|Participant did not wish to continue|0|||
125092569|NCT00283062|449956868|FG000|Overall Study|Undefined|0|||
125005134|NCT00922480|449648154|FG000|Main Study|Adverse Event|6|||
125005135|NCT00922480|449648155|FG001|Main Study|Adverse Event|7|||
125092570|NCT00283062|449956869|FG001|Overall Study|Undefined|1|||
125092571|NCT00283062|449956870|FG002|Overall Study|Undefined|1|||
125092572|NCT00283062|449956871|FG003|Overall Study|Undefined|4|||
125005136|NCT00922480|449648154|FG000|Main Study|Lack of Efficacy|3|||
125005137|NCT00922480|449648155|FG001|Main Study|Lack of Efficacy|0|||
125005138|NCT00922480|449648154|FG000|Main Study|Withdrawal by Subject|20|||
125005139|NCT00922480|449648155|FG001|Main Study|Withdrawal by Subject|15|||
125005140|NCT00922480|449648154|FG000|Main Study|Lost to Follow-up|5|||
125005141|NCT00922480|449648155|FG001|Main Study|Lost to Follow-up|0|||
125005142|NCT00922480|449648154|FG000|Main Study|Physician Decision|0|||
125005143|NCT00922480|449648155|FG001|Main Study|Physician Decision|1|||
125005144|NCT00922480|449648154|FG000|Extension Study|Protocol Violation|3|||
125005145|NCT00922480|449648155|FG001|Extension Study|Protocol Violation|0|||
125005146|NCT00922480|449648154|FG000|Extension Study|Adverse Event|1|||
125005147|NCT00922480|449648155|FG001|Extension Study|Adverse Event|1|||
125005148|NCT00922480|449648154|FG000|Extension Study|Withdrawal by Subject|1|||
125005149|NCT00922480|449648155|FG001|Extension Study|Withdrawal by Subject|1|||
125005150|NCT00922480|449648154|FG000|Extension Study|Others|0|||
125005151|NCT00922480|449648155|FG001|Extension Study|Others|1|||
125005152|NCT01011439|449648156|FG000|Overall Study|Death|37|||
125005153|NCT01011439|449648156|FG000|Overall Study|Lost to Follow-up|4|||
125005154|NCT01011439|449648156|FG000|Overall Study|Withdrawal by Subject|1|||
125005155|NCT01011439|449648156|FG000|Overall Study|Sponsor's decision|15|||
125005156|NCT01372150|449648157|FG000|Overall Study|Lack of Efficacy|3|||
125005157|NCT01372150|449648158|FG001|Overall Study|Lack of Efficacy|0|||
125005158|NCT01372150|449648159|FG002|Overall Study|Lack of Efficacy|1|||
125005159|NCT01372150|449648157|FG000|Overall Study|Lost to Follow-up|4|||
125005160|NCT01372150|449648158|FG001|Overall Study|Lost to Follow-up|5|||
125005161|NCT01372150|449648159|FG002|Overall Study|Lost to Follow-up|6|||
125005162|NCT01372150|449648157|FG000|Overall Study|Protocol Violation|1|||
125005163|NCT01372150|449648158|FG001|Overall Study|Protocol Violation|0|||
125005164|NCT01372150|449648159|FG002|Overall Study|Protocol Violation|3|||
125005165|NCT01372150|449648157|FG000|Overall Study|Withdrawal by Subject|2|||
125005166|NCT01372150|449648158|FG001|Overall Study|Withdrawal by Subject|7|||
125005167|NCT01372150|449648159|FG002|Overall Study|Withdrawal by Subject|2|||
125005168|NCT01372150|449648157|FG000|Overall Study|Other|1|||
125005169|NCT01372150|449648158|FG001|Overall Study|Other|0|||
125005170|NCT01372150|449648159|FG002|Overall Study|Other|2|||
125005171|NCT01372150|449648157|FG000|Overall Study|Adverse Event|2|||
125005172|NCT01372150|449648158|FG001|Overall Study|Adverse Event|1|||
125005173|NCT01372150|449648159|FG002|Overall Study|Adverse Event|2|||
125005174|NCT01372150|449648157|FG000|Overall Study|Randomized but not treated|0|||
125092573|NCT00283062|449956868|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
125092574|NCT00283062|449956869|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
125092575|NCT00283062|449956870|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
125092576|NCT00283062|449956871|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
125092577|NCT00827112|449956874|FG000|Overall Study|Adverse Event|2|||
125092578|NCT00827112|449956875|FG001|Overall Study|Adverse Event|0|||
125092579|NCT00827112|449956874|FG000|Overall Study|Lack of Efficacy|2|||
125092580|NCT00827112|449956875|FG001|Overall Study|Lack of Efficacy|0|||
125092581|NCT00827112|449956874|FG000|Overall Study|Lost to Follow-up|3|||
125092582|NCT00827112|449956875|FG001|Overall Study|Lost to Follow-up|2|||
125092583|NCT00827112|449956874|FG000|Overall Study|Pregnancy|0|||
125092584|NCT00827112|449956875|FG001|Overall Study|Pregnancy|1|||
125092585|NCT00827112|449956874|FG000|Overall Study|Protocol Violation|0|||
125092586|NCT00827112|449956875|FG001|Overall Study|Protocol Violation|2|||
125092587|NCT00827112|449956874|FG000|Overall Study|Withdrawal by Subject|2|||
125092588|NCT00827112|449956875|FG001|Overall Study|Withdrawal by Subject|1|||
125092589|NCT00827112|449956874|FG000|Overall Study|Randomized but not treated|5|||
125092590|NCT00827112|449956875|FG001|Overall Study|Randomized but not treated|3|||
125092591|NCT00827112|449956874|FG000|Overall Study|Other|1|||
125092592|NCT00827112|449956875|FG001|Overall Study|Other|3|||
125092593|NCT01475214|449956876|FG000|Overall Study|Lost to Follow-up|1|||
125092594|NCT01475214|449956877|FG001|Overall Study|Lost to Follow-up|0|||
125092595|NCT01475214|449956878|FG002|Overall Study|Lost to Follow-up|1|||
125092596|NCT01475214|449956876|FG000|Overall Study|Physician Decision|2|||
125092597|NCT01475214|449956877|FG001|Overall Study|Physician Decision|0|||
125092598|NCT01475214|449956878|FG002|Overall Study|Physician Decision|0|||
125092599|NCT01475214|449956876|FG000|Overall Study|Withdrawal by Subject|2|||
125092600|NCT01475214|449956877|FG001|Overall Study|Withdrawal by Subject|4|||
125092601|NCT01475214|449956878|FG002|Overall Study|Withdrawal by Subject|1|||
125092602|NCT00877929|449956881|FG000|Overall Study|Adverse Event|11|||
125092603|NCT00877929|449956882|FG001|Overall Study|Adverse Event|20|||
125092604|NCT00877929|449956881|FG000|Overall Study|Protocol Violation|3|||
125092605|NCT00877929|449956882|FG001|Overall Study|Protocol Violation|3|||
125092606|NCT00877929|449956881|FG000|Overall Study|Lost to Follow-up|0|||
125092607|NCT00877929|449956882|FG001|Overall Study|Lost to Follow-up|1|||
125092608|NCT00877929|449956881|FG000|Overall Study|Withdrawal by Subject|4|||
125092609|NCT00877929|449956882|FG001|Overall Study|Withdrawal by Subject|4|||
125092610|NCT00877929|449956881|FG000|Overall Study|Lack of Efficacy|0|||
125092611|NCT00877929|449956882|FG001|Overall Study|Lack of Efficacy|1|||
125092612|NCT00877929|449956881|FG000|Overall Study|Other reason (not specified)|2|||
125092613|NCT00877929|449956882|FG001|Overall Study|Other reason (not specified)|6|||
125092614|NCT02127931|449956885|FG000|Overall Study|Glitch in Game|1|||
125092615|NCT00422942|449956886|FG000|Overall Study|Study terminated by Sponsor|3|||
125005175|NCT01372150|449648158|FG001|Overall Study|Randomized but not treated|1|||
125005176|NCT01372150|449648159|FG002|Overall Study|Randomized but not treated|0|||
125005177|NCT00536809|449648160|FG000|Phase II|Adverse Event|1|||
125005178|NCT00536809|449648160|FG000|Phase II|Referred for surgical resection|1|||
125005179|NCT01526551|449648161|FG000|Overall Study|Lack of returned parental consent form|424|||
125005180|NCT05215262|449648162|FG000|Overall Study|Lost to Follow-up|12|||
125005181|NCT05215262|449648163|FG001|Overall Study|Lost to Follow-up|0|||
125005182|NCT00718549|449648168|FG000|Induction Phase|Disease Progression|1|||
125005183|NCT00718549|449648169|FG001|Induction Phase|Disease Progression|0|||
125005184|NCT00718549|449648170|FG002|Induction Phase|Disease Progression|0|||
125005185|NCT00718549|449648168|FG000|Induction Phase|Eligibility Criteria Violation|2|||
125005186|NCT00718549|449648169|FG001|Induction Phase|Eligibility Criteria Violation|0|||
125005187|NCT00718549|449648170|FG002|Induction Phase|Eligibility Criteria Violation|0|||
125005188|NCT00718549|449648168|FG000|Induction Phase|Early Termination - No Additional Info|59|||
125005189|NCT00718549|449648169|FG001|Induction Phase|Early Termination - No Additional Info|0|||
125005190|NCT00718549|449648170|FG002|Induction Phase|Early Termination - No Additional Info|0|||
125005191|NCT00718549|449648168|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
125005192|NCT00718549|449648169|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
125005193|NCT00718549|449648170|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
125005194|NCT00718549|449648168|FG000|Maintenance/ Observation Phase|Death|0|||
125005195|NCT00718549|449648169|FG001|Maintenance/ Observation Phase|Death|1|||
125005196|NCT00718549|449648170|FG002|Maintenance/ Observation Phase|Death|2|||
125005197|NCT00718549|449648168|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
125005198|NCT00718549|449648169|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
125005199|NCT00718549|449648170|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
125005200|NCT00718549|449648168|FG000|Maintenance/ Observation Phase|Progression|0|||
125005201|NCT00718549|449648169|FG001|Maintenance/ Observation Phase|Progression|5|||
125005202|NCT00718549|449648170|FG002|Maintenance/ Observation Phase|Progression|14|||
125005203|NCT00718549|449648168|FG000|Maintenance/ Observation Phase|Relapse|0|||
125005204|NCT00718549|449648169|FG001|Maintenance/ Observation Phase|Relapse|3|||
125005205|NCT00718549|449648170|FG002|Maintenance/ Observation Phase|Relapse|2|||
125005206|NCT01353508|449648171|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
125005207|NCT01353508|449648172|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
125005208|NCT01353508|449648173|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
125005209|NCT01353508|449648174|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
125005210|NCT01353508|449648171|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
125005211|NCT01353508|449648172|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
125005212|NCT01353508|449648173|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
125005213|NCT01353508|449648174|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
125005214|NCT02606461|449648175|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
125005215|NCT02606461|449648176|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
125005216|NCT02606461|449648177|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
125005217|NCT02606461|449648178|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
125005218|NCT02606461|449648179|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
125005219|NCT02606461|449648180|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
125005220|NCT02092350|449648185|FG000|Overall Study|Adverse Event|0|||
125005221|NCT02092350|449648186|FG001|Overall Study|Adverse Event|3|||
125005222|NCT02092350|449648185|FG000|Overall Study|Death|2|||
125005223|NCT02092350|449648186|FG001|Overall Study|Death|5|||
125005224|NCT02092350|449648185|FG000|Overall Study|Lost to Follow-up|3|||
125005225|NCT02092350|449648186|FG001|Overall Study|Lost to Follow-up|1|||
125005226|NCT02092350|449648185|FG000|Overall Study|Protocol Violation|1|||
125005227|NCT02092350|449648186|FG001|Overall Study|Protocol Violation|0|||
125005228|NCT02092350|449648185|FG000|Overall Study|Physician Decision|1|||
125005229|NCT02092350|449648186|FG001|Overall Study|Physician Decision|1|||
125005230|NCT02092350|449648185|FG000|Overall Study|Screen Failure|1|||
125005231|NCT02092350|449648186|FG001|Overall Study|Screen Failure|0|||
125005232|NCT02092350|449648185|FG000|Overall Study|Withdrawal by Subject|2|||
125005233|NCT02092350|449648186|FG001|Overall Study|Withdrawal by Subject|2|||
125005234|NCT00239226|449648187|FG000|Overall Study|permAF during stabilization period|0|||
125005235|NCT00239226|449648188|FG001|Overall Study|permAF during stabilization period|0|||
125005236|NCT00239226|449648189|FG002|Overall Study|permAF during stabilization period|0|||
124872994|NCT00508261|449157213|FG001|Overall Study|Migrated/ moved from study area|1|||
125005237|NCT00239226|449648190|FG003|Overall Study|permAF during stabilization period|3|||
125005238|NCT00239226|449648187|FG000|Overall Study|Lost to Follow-up|1|||
125005239|NCT00239226|449648188|FG001|Overall Study|Lost to Follow-up|0|||
125092616|NCT02828982|449956887|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
125092617|NCT02828982|449956888|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
125092618|NCT03691831|449958139|FG000|Overall Study|Lost to Follow-up|16|||
125092619|NCT03691831|449958140|FG001|Overall Study|Lost to Follow-up|12|||
125092620|NCT03691831|449958139|FG000|Overall Study|Withdrawal by Subject|9|||
125092621|NCT03691831|449958140|FG001|Overall Study|Withdrawal by Subject|17|||
125092622|NCT03691831|449958139|FG000|Overall Study|Investigator Decision|2|||
125092623|NCT03691831|449958140|FG001|Overall Study|Investigator Decision|2|||
125092624|NCT03922945|449958141|FG000|Overall Study|Adverse Event|1|||
125092625|NCT03922945|449958142|FG001|Overall Study|Adverse Event|1|||
125092626|NCT03922945|449958143|FG002|Overall Study|Adverse Event|2|||
125092627|NCT03922945|449958141|FG000|Overall Study|Lost to Follow-up|13|||
125092628|NCT03922945|449958142|FG001|Overall Study|Lost to Follow-up|9|||
125092629|NCT03922945|449958143|FG002|Overall Study|Lost to Follow-up|20|||
125092630|NCT03922945|449958141|FG000|Overall Study|Lack of Efficacy|2|||
125092631|NCT03922945|449958142|FG001|Overall Study|Lack of Efficacy|0|||
125092632|NCT03922945|449958143|FG002|Overall Study|Lack of Efficacy|1|||
125092633|NCT03922945|449958141|FG000|Overall Study|Protocol Non-Compliance|0|||
125092634|NCT03922945|449958142|FG001|Overall Study|Protocol Non-Compliance|0|||
125092635|NCT03922945|449958143|FG002|Overall Study|Protocol Non-Compliance|1|||
125092636|NCT03922945|449958141|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
125092637|NCT03922945|449958142|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
125092638|NCT03922945|449958143|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
125092639|NCT03922945|449958141|FG000|Overall Study|All Other Personal Reasons|1|||
125092640|NCT03922945|449958142|FG001|Overall Study|All Other Personal Reasons|1|||
125092641|NCT03922945|449958143|FG002|Overall Study|All Other Personal Reasons|2|||
125092642|NCT02079077|449958149|FG000|Overall Study|Lost to Follow-up|5|||
125092643|NCT02079077|449958150|FG001|Overall Study|Lost to Follow-up|7|||
125092644|NCT02079077|449958149|FG000|Overall Study|Became STIs Positive|1|||
125092645|NCT02079077|449958150|FG001|Overall Study|Became STIs Positive|2|||
125092646|NCT00772031|449958151|FG000|Overall Study|Early termination of trial|12|||
125092647|NCT00772031|449958152|FG001|Overall Study|Early termination of trial|10|||
125092648|NCT00772031|449958151|FG000|Overall Study|Lost to Follow-up|20|||
125092649|NCT00772031|449958152|FG001|Overall Study|Lost to Follow-up|33|||
125092650|NCT02681094|449958153|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
125092651|NCT02681094|449958154|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
125092652|NCT02681094|449958155|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
125092653|NCT02681094|449958153|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
125092654|NCT02681094|449958154|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
125092655|NCT02681094|449958155|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
125092656|NCT02681094|449958153|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
125092657|NCT02681094|449958154|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
125092658|NCT02681094|449958155|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
125092659|NCT02681094|449958153|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
125092660|NCT02681094|449958154|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
125092661|NCT02681094|449958155|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
125092662|NCT02681094|449958153|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
125092663|NCT02681094|449958154|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
125092664|NCT02681094|449958155|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
125092665|NCT02681094|449958153|FG000|1 -Modified Enrolled Participants Set|Other|6|||
125092666|NCT02681094|449958154|FG001|1 -Modified Enrolled Participants Set|Other|6|||
125092667|NCT02681094|449958155|FG002|1 -Modified Enrolled Participants Set|Other|7|||
125092668|NCT02681094|449958153|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
125092669|NCT02681094|449958154|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
125092670|NCT02681094|449958155|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
125092671|NCT02681094|449958153|FG000|2 - Enrolled Participants Set|Participant decision|7|||
125092672|NCT02681094|449958154|FG001|2 - Enrolled Participants Set|Participant decision|10|||
125092673|NCT02681094|449958155|FG002|2 - Enrolled Participants Set|Participant decision|9|||
125092674|NCT02681094|449958153|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
125092675|NCT02681094|449958154|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
125092676|NCT02681094|449958155|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
125092677|NCT02681094|449958153|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
125092678|NCT02681094|449958154|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
125092679|NCT02681094|449958155|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
125092680|NCT02681094|449958153|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
125092681|NCT02681094|449958154|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
125092682|NCT02681094|449958155|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
125092683|NCT02681094|449958153|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
125092684|NCT02681094|449958154|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
125092685|NCT02681094|449958155|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
125092686|NCT02681094|449958153|FG000|2 - Enrolled Participants Set|Other|6|||
125092687|NCT02681094|449958154|FG001|2 - Enrolled Participants Set|Other|6|||
125092688|NCT02681094|449958155|FG002|2 - Enrolled Participants Set|Other|7|||
125092689|NCT02681094|449958153|FG000|2 - Enrolled Participants Set|No treatment given|0|||
125092690|NCT02681094|449958154|FG001|2 - Enrolled Participants Set|No treatment given|1|||
125092691|NCT02681094|449958155|FG002|2 - Enrolled Participants Set|No treatment given|1|||
125092692|NCT00310440|449958156|FG000|Overall Study|Lost to Follow-up|17|||
125092693|NCT00310440|449958157|FG001|Overall Study|Lost to Follow-up|8|||
125092694|NCT00310440|449958156|FG000|Overall Study|Withdrawal by Subject|2|||
125092695|NCT00310440|449958157|FG001|Overall Study|Withdrawal by Subject|1|||
125092696|NCT00310440|449958156|FG000|Overall Study|Missed 12 Month Visit|7|||
125092697|NCT00310440|449958157|FG001|Overall Study|Missed 12 Month Visit|4|||
125092698|NCT01098266|449958158|FG000|Overall Study|Physician Decision|1|||
125092699|NCT01098266|449958159|FG001|Overall Study|Physician Decision|0|||
125092700|NCT01098266|449958158|FG000|Overall Study|Death|3|||
125092701|NCT01098266|449958159|FG001|Overall Study|Death|2|||
125092702|NCT01098266|449958158|FG000|Overall Study|Withdrawal by Subject|3|||
125092703|NCT01098266|449958159|FG001|Overall Study|Withdrawal by Subject|5|||
125092704|NCT00525499|449958160|FG000|Overall Study|Lost to Follow-up|2|||
125092705|NCT00525499|449958161|FG001|Overall Study|Lost to Follow-up|4|||
125092706|NCT00525499|449958162|FG002|Overall Study|Lost to Follow-up|1|||
125092707|NCT00525499|449958163|FG003|Overall Study|Lost to Follow-up|4|||
125092708|NCT00525499|449958160|FG000|Overall Study|Adverse Event|0|||
125092709|NCT00525499|449958161|FG001|Overall Study|Adverse Event|1|||
125092710|NCT00525499|449958162|FG002|Overall Study|Adverse Event|0|||
125092711|NCT00525499|449958163|FG003|Overall Study|Adverse Event|1|||
125092712|NCT00525499|449958160|FG000|Overall Study|Withdrawal by Subject|5|||
125092713|NCT00525499|449958161|FG001|Overall Study|Withdrawal by Subject|1|||
125092714|NCT00525499|449958162|FG002|Overall Study|Withdrawal by Subject|5|||
125092715|NCT00525499|449958163|FG003|Overall Study|Withdrawal by Subject|2|||
125092716|NCT00525499|449958160|FG000|Overall Study|Protocol Violation|0|||
125092717|NCT00525499|449958161|FG001|Overall Study|Protocol Violation|1|||
125092718|NCT00525499|449958162|FG002|Overall Study|Protocol Violation|1|||
125092719|NCT00525499|449958163|FG003|Overall Study|Protocol Violation|0|||
125092720|NCT03339999|449958164|FG000|Overall Study|Adverse Event|1|||
125092721|NCT03339999|449958165|FG001|Overall Study|Adverse Event|2|||
125092722|NCT03339999|449958166|FG002|Overall Study|Adverse Event|2|||
125092723|NCT03339999|449958167|FG003|Overall Study|Adverse Event|1|||
125092724|NCT03339999|449958164|FG000|Overall Study|Lack of Efficacy|0|||
125092725|NCT03339999|449958165|FG001|Overall Study|Lack of Efficacy|1|||
125092726|NCT03339999|449958166|FG002|Overall Study|Lack of Efficacy|0|||
125092727|NCT03339999|449958167|FG003|Overall Study|Lack of Efficacy|0|||
125092728|NCT03339999|449958164|FG000|Overall Study|Lost to Follow-up|0|||
125092729|NCT03339999|449958165|FG001|Overall Study|Lost to Follow-up|0|||
125092730|NCT03339999|449958166|FG002|Overall Study|Lost to Follow-up|0|||
125092731|NCT03339999|449958167|FG003|Overall Study|Lost to Follow-up|1|||
125092732|NCT03339999|449958164|FG000|Overall Study|Study Terminated by Sponsor|6|||
125092733|NCT03339999|449958165|FG001|Overall Study|Study Terminated by Sponsor|3|||
125092734|NCT03339999|449958166|FG002|Overall Study|Study Terminated by Sponsor|4|||
125092735|NCT03339999|449958167|FG003|Overall Study|Study Terminated by Sponsor|3|||
125092736|NCT01733758|449958170|FG000|Overall Study|Adverse Event|5|||
125092737|NCT01733758|449958171|FG001|Overall Study|Adverse Event|7|||
125092738|NCT01733758|449958172|FG002|Overall Study|Adverse Event|8|||
125092739|NCT01733758|449958173|FG003|Overall Study|Adverse Event|1|||
125092740|NCT01733758|449958170|FG000|Overall Study|Withdrawal by Subject|1|||
125092741|NCT01733758|449958171|FG001|Overall Study|Withdrawal by Subject|1|||
125092742|NCT01733758|449958172|FG002|Overall Study|Withdrawal by Subject|5|||
125092743|NCT01733758|449958173|FG003|Overall Study|Withdrawal by Subject|3|||
125092744|NCT01733758|449958170|FG000|Overall Study|Persistent Hyperglycemia|3|||
125092745|NCT01733758|449958171|FG001|Overall Study|Persistent Hyperglycemia|2|||
125092746|NCT01733758|449958172|FG002|Overall Study|Persistent Hyperglycemia|0|||
125092747|NCT01733758|449958173|FG003|Overall Study|Persistent Hyperglycemia|0|||
125092748|NCT01733758|449958170|FG000|Overall Study|Protocol Violation|0|||
125092749|NCT01733758|449958171|FG001|Overall Study|Protocol Violation|1|||
125005240|NCT00239226|449648189|FG002|Overall Study|Lost to Follow-up|1|||
125005241|NCT00239226|449648190|FG003|Overall Study|Lost to Follow-up|0|||
125005242|NCT00646906|449648192|FG000|Crossover Period 1|Withdrawal by Subject|1|||
125005243|NCT00646906|449648193|FG001|Crossover Period 1|Withdrawal by Subject|0|||
125005244|NCT00646906|449648194|FG002|Crossover Period 1|Withdrawal by Subject|0|||
125005245|NCT00646906|449648195|FG003|Crossover Period 1|Withdrawal by Subject|0|||
125005246|NCT00646906|449648196|FG004|Crossover Period 1|Withdrawal by Subject|0|||
125005247|NCT00646906|449648197|FG005|Crossover Period 1|Withdrawal by Subject|1|||
125005248|NCT00646906|449648198|FG006|Crossover Period 1|Withdrawal by Subject|0|||
125005249|NCT00646906|449648192|FG000|Crossover Period 2|Withdrawal by Subject|0|||
125005250|NCT00646906|449648193|FG001|Crossover Period 2|Withdrawal by Subject|1|||
125005251|NCT00646906|449648194|FG002|Crossover Period 2|Withdrawal by Subject|2|||
125005252|NCT00646906|449648195|FG003|Crossover Period 2|Withdrawal by Subject|1|||
125005253|NCT00646906|449648196|FG004|Crossover Period 2|Withdrawal by Subject|0|||
125005254|NCT00646906|449648197|FG005|Crossover Period 2|Withdrawal by Subject|0|||
125005255|NCT00646906|449648198|FG006|Crossover Period 2|Withdrawal by Subject|0|||
125005256|NCT00646906|449648192|FG000|Crossover Period 2|Physician Decision|0|||
125005257|NCT00646906|449648193|FG001|Crossover Period 2|Physician Decision|0|||
125005258|NCT00646906|449648194|FG002|Crossover Period 2|Physician Decision|0|||
125005259|NCT00646906|449648195|FG003|Crossover Period 2|Physician Decision|0|||
125005260|NCT00646906|449648196|FG004|Crossover Period 2|Physician Decision|0|||
125005261|NCT00646906|449648197|FG005|Crossover Period 2|Physician Decision|0|||
125005262|NCT00646906|449648198|FG006|Crossover Period 2|Physician Decision|1|||
125005263|NCT01303965|449648199|FG000|Overall Study|Adverse Event|1|||
125005264|NCT01303965|449648200|FG001|Overall Study|Adverse Event|1|||
125005265|NCT01303965|449648199|FG000|Overall Study|Death|0|||
125005266|NCT01303965|449648200|FG001|Overall Study|Death|3|||
125005267|NCT01303965|449648199|FG000|Overall Study|Withdrawal by Subject|1|||
125005268|NCT01303965|449648200|FG001|Overall Study|Withdrawal by Subject|0|||
125005269|NCT01303965|449648199|FG000|Overall Study|Disease Progression|1|||
125005270|NCT01303965|449648200|FG001|Overall Study|Disease Progression|6|||
125005271|NCT02448225|449648204|FG000|Overall Study|Withdrawal by Subject|1|||
125005272|NCT02448225|449648204|FG000|Overall Study|Did not get FSPG scan|18|||
125005273|NCT02448225|449648204|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
125005274|NCT00851682|449648205|FG000|Overall Study|screen failure|5|||
125005275|NCT00851682|449648206|FG001|Overall Study|screen failure|0|||
125005276|NCT02844920|449648209|FG000|Overall Study|Lost to Follow-up|2|||
125005277|NCT00800436|449648214|FG000|Overall Study|Withdrawal by Subject|0|||
125005278|NCT00800436|449648215|FG001|Overall Study|Withdrawal by Subject|0|||
125092750|NCT01733758|449958172|FG002|Overall Study|Protocol Violation|2|||
125092751|NCT01733758|449958173|FG003|Overall Study|Protocol Violation|2|||
125092752|NCT01733758|449958170|FG000|Overall Study|Non-compliance|1|||
125092753|NCT01733758|449958171|FG001|Overall Study|Non-compliance|0|||
125092754|NCT01733758|449958172|FG002|Overall Study|Non-compliance|0|||
125092755|NCT01733758|449958173|FG003|Overall Study|Non-compliance|0|||
125092756|NCT01733758|449958170|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
125092757|NCT01733758|449958171|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
125092758|NCT01733758|449958172|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
125092759|NCT01733758|449958173|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
125092760|NCT01733758|449958170|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
125092761|NCT01733758|449958171|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
125005279|NCT00800436|449648216|FG002|Overall Study|Withdrawal by Subject|1|||
125005280|NCT00800436|449648217|FG003|Overall Study|Withdrawal by Subject|1|||
125005281|NCT00800436|449648218|FG004|Overall Study|Withdrawal by Subject|0|||
125005282|NCT00800436|449648219|FG005|Overall Study|Withdrawal by Subject|0|||
125005283|NCT00800436|449648220|FG006|Overall Study|Withdrawal by Subject|0|||
125005284|NCT00766090|449648221|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125005285|NCT00766090|449648222|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125005286|NCT00766090|449648223|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125005287|NCT00766090|449648224|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125005288|NCT00766090|449648225|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125005289|NCT00766090|449648226|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125005290|NCT00766090|449648227|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125005291|NCT00766090|449648228|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125005292|NCT00766090|449648229|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
125005293|NCT00766090|449648230|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125005294|NCT00766090|449648231|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125005295|NCT00766090|449648232|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125005296|NCT00766090|449648221|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
125005297|NCT00766090|449648222|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125005298|NCT00766090|449648223|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125005299|NCT00766090|449648224|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125005300|NCT00766090|449648225|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125005301|NCT00766090|449648226|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125092762|NCT01733758|449958172|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
125092763|NCT01733758|449958173|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
125092764|NCT03380091|449958176|FG000|Overall Study|Withdrawal by Subject|2|||
125092765|NCT03380091|449958177|FG001|Overall Study|Withdrawal by Subject|1|||
125092766|NCT05602818|449958178|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
125092767|NCT05602818|449958179|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
125092768|NCT05602818|449958180|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
125092769|NCT05602818|449958181|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
125092770|NCT05602818|449958182|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
125092771|NCT05602818|449958183|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
125092772|NCT05602818|449958184|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
125092773|NCT05602818|449958185|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
125092774|NCT05602818|449958186|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
125092775|NCT05602818|449958187|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
125092776|NCT05602818|449958188|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
125092777|NCT05602818|449958189|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
125092778|NCT05602818|449958178|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
125092779|NCT05602818|449958179|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
125092780|NCT05602818|449958180|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
125092781|NCT05602818|449958181|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
125092782|NCT05602818|449958182|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
125092783|NCT05602818|449958183|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
125092784|NCT05602818|449958184|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
125092785|NCT05602818|449958185|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
125092786|NCT05602818|449958186|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
125092787|NCT05602818|449958187|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
125092788|NCT05602818|449958188|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
125092789|NCT05602818|449958189|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
125092790|NCT05602818|449958178|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
125092791|NCT05602818|449958179|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125092792|NCT05602818|449958180|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125092793|NCT05602818|449958181|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125092794|NCT05602818|449958182|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125092795|NCT05602818|449958183|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125092796|NCT05602818|449958184|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125092797|NCT05602818|449958185|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125092798|NCT05602818|449958186|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125092799|NCT05602818|449958187|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125092800|NCT05602818|449958188|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125092801|NCT05602818|449958189|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125092802|NCT05602818|449958178|FG000|Qualification Phase (3 Days)|Other|1|||
125092803|NCT05602818|449958179|FG001|Qualification Phase (3 Days)|Other|0|||
125092804|NCT05602818|449958180|FG002|Qualification Phase (3 Days)|Other|0|||
125092805|NCT05602818|449958181|FG003|Qualification Phase (3 Days)|Other|0|||
125092806|NCT05602818|449958182|FG004|Qualification Phase (3 Days)|Other|0|||
125092807|NCT05602818|449958183|FG005|Qualification Phase (3 Days)|Other|0|||
125092808|NCT05602818|449958184|FG006|Qualification Phase (3 Days)|Other|0|||
125092809|NCT05602818|449958185|FG007|Qualification Phase (3 Days)|Other|0|||
125092810|NCT05602818|449958186|FG008|Qualification Phase (3 Days)|Other|0|||
125092811|NCT05602818|449958187|FG009|Qualification Phase (3 Days)|Other|0|||
125092812|NCT05602818|449958188|FG010|Qualification Phase (3 Days)|Other|0|||
125092813|NCT05602818|449958189|FG011|Qualification Phase (3 Days)|Other|0|||
125092814|NCT05602818|449958178|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125092815|NCT05602818|449958179|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
125092816|NCT05602818|449958180|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125092817|NCT05602818|449958181|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125092818|NCT05602818|449958182|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125092819|NCT05602818|449958183|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125092820|NCT05602818|449958184|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125092821|NCT05602818|449958185|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125092822|NCT05602818|449958186|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125092823|NCT05602818|449958187|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125092824|NCT05602818|449958188|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125092825|NCT05602818|449958189|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125092826|NCT05602818|449958178|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
125092827|NCT05602818|449958179|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
125005302|NCT00766090|449648227|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125005303|NCT00766090|449648228|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125005304|NCT00766090|449648229|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125005305|NCT00766090|449648230|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125005306|NCT00766090|449648231|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125005307|NCT00766090|449648232|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125005308|NCT00766090|449648221|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
125005309|NCT00766090|449648222|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125005310|NCT00766090|449648223|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125005311|NCT00766090|449648224|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
125005312|NCT00766090|449648225|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125005313|NCT00766090|449648226|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125005314|NCT00766090|449648227|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125005315|NCT00766090|449648228|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125005316|NCT00766090|449648229|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125005317|NCT00766090|449648230|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125005318|NCT00766090|449648231|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125005319|NCT00766090|449648232|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125005320|NCT00766090|449648221|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
125005321|NCT00766090|449648222|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
125005322|NCT00766090|449648223|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
125005323|NCT00766090|449648224|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
125005324|NCT00766090|449648225|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
125005325|NCT00766090|449648226|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
125005326|NCT00766090|449648227|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
125005327|NCT00766090|449648228|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
125005328|NCT00766090|449648229|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
125005329|NCT00766090|449648230|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
125005330|NCT00766090|449648231|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
125005331|NCT00766090|449648232|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
125005332|NCT00766090|449648221|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125005333|NCT00766090|449648222|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125005334|NCT00766090|449648223|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125005335|NCT00766090|449648224|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125005336|NCT00766090|449648225|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
125005337|NCT00766090|449648226|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125005338|NCT00766090|449648227|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125005339|NCT00766090|449648228|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125005340|NCT00766090|449648229|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125005341|NCT00766090|449648230|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125005342|NCT00766090|449648231|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125005343|NCT00766090|449648232|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125005344|NCT00766090|449648221|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125005345|NCT00766090|449648222|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125005346|NCT00766090|449648223|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
125005347|NCT00766090|449648224|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125005348|NCT00766090|449648225|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125005349|NCT00766090|449648226|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125005350|NCT00766090|449648227|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125005351|NCT00766090|449648228|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125005352|NCT00766090|449648229|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125005353|NCT00766090|449648230|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125005354|NCT00766090|449648231|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125005355|NCT00766090|449648232|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125005356|NCT00766090|449648221|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
125005357|NCT00766090|449648222|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
125005358|NCT00766090|449648223|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
125005359|NCT00766090|449648224|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
125005360|NCT00766090|449648225|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
125005361|NCT00766090|449648226|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
125005362|NCT00766090|449648227|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
125005363|NCT00766090|449648228|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
125005364|NCT00766090|449648229|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
125005365|NCT00766090|449648230|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
125005366|NCT00766090|449648231|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
125005367|NCT00766090|449648232|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
125005368|NCT00766090|449648221|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125005369|NCT00766090|449648222|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125005370|NCT00766090|449648223|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125005371|NCT00766090|449648224|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125005372|NCT00766090|449648225|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125005373|NCT00766090|449648226|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
125005374|NCT00766090|449648227|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125005375|NCT00766090|449648228|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125005376|NCT00766090|449648229|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125005377|NCT00766090|449648230|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125005378|NCT00766090|449648231|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125005379|NCT00766090|449648232|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125005380|NCT00766090|449648221|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
125005381|NCT00766090|449648222|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
125005382|NCT00766090|449648223|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
125005383|NCT00766090|449648224|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
125005384|NCT00766090|449648225|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
125005385|NCT00766090|449648226|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
125005386|NCT00766090|449648227|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
125005387|NCT00766090|449648228|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
125005388|NCT00766090|449648229|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
125005389|NCT00766090|449648230|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
125005390|NCT00766090|449648231|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
125005391|NCT00766090|449648232|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
125005392|NCT00766090|449648221|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125005393|NCT00766090|449648222|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125005394|NCT00766090|449648223|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125005395|NCT00766090|449648224|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125005396|NCT00766090|449648225|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
125005397|NCT00766090|449648226|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125005398|NCT00766090|449648227|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125005399|NCT00766090|449648228|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125005400|NCT00766090|449648229|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125005401|NCT00766090|449648230|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125005402|NCT00766090|449648231|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125005403|NCT00766090|449648232|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125005404|NCT01106027|449648240|FG000|Overall Study|Lost graft early, discontinued|1|||
125005405|NCT02871778|449648241|FG000|Part A: Treatment Period 1|Adverse Event|1|||
125005406|NCT02871778|449648242|FG001|Part A: Treatment Period 1|Adverse Event|1|||
125005407|NCT02871778|449648243|FG002|Part A: Treatment Period 1|Adverse Event|1|||
125005408|NCT02871778|449648244|FG003|Part A: Treatment Period 1|Adverse Event|0|||
125005409|NCT02871778|449648245|FG004|Part A: Treatment Period 1|Adverse Event|0|||
125005410|NCT02871778|449648246|FG005|Part A: Treatment Period 1|Adverse Event|0|||
125005411|NCT02871778|449648247|FG006|Part A: Treatment Period 1|Adverse Event|0|||
125005412|NCT02871778|449648248|FG007|Part A: Treatment Period 1|Adverse Event|0|||
125005413|NCT02871778|449648241|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
125005414|NCT02871778|449648242|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
125005415|NCT02871778|449648243|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
125005416|NCT02871778|449648244|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
125005417|NCT02871778|449648245|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
125005418|NCT02871778|449648246|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
125005419|NCT02871778|449648247|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
125005420|NCT02871778|449648248|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
125005421|NCT02871778|449648241|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
125005422|NCT02871778|449648242|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
125005423|NCT02871778|449648243|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
125005424|NCT02871778|449648244|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
125005425|NCT02871778|449648245|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
125005426|NCT02871778|449648246|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
125005427|NCT02871778|449648247|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
125005428|NCT02871778|449648248|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
125005429|NCT02871778|449648241|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
125005430|NCT02871778|449648242|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
125005431|NCT02871778|449648243|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
125005432|NCT02871778|449648244|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
125005433|NCT02871778|449648245|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
125005434|NCT02871778|449648246|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
125005435|NCT02871778|449648247|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
125005436|NCT02871778|449648248|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
125005437|NCT02871778|449648241|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
125005438|NCT02871778|449648242|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
125005439|NCT02871778|449648243|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
125005440|NCT02871778|449648244|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
125005441|NCT02871778|449648245|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
125005442|NCT02871778|449648246|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
125005443|NCT02871778|449648247|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
125005444|NCT02871778|449648248|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
125005445|NCT02871778|449648241|FG000|Part A: Treatment Period 2|Adverse Event|2|||
125005446|NCT02871778|449648242|FG001|Part A: Treatment Period 2|Adverse Event|2|||
125005447|NCT02871778|449648243|FG002|Part A: Treatment Period 2|Adverse Event|0|||
125005448|NCT02871778|449648244|FG003|Part A: Treatment Period 2|Adverse Event|0|||
125005449|NCT02871778|449648245|FG004|Part A: Treatment Period 2|Adverse Event|0|||
125005450|NCT02871778|449648246|FG005|Part A: Treatment Period 2|Adverse Event|0|||
125005451|NCT02871778|449648247|FG006|Part A: Treatment Period 2|Adverse Event|0|||
125005452|NCT02871778|449648248|FG007|Part A: Treatment Period 2|Adverse Event|0|||
125005453|NCT02871778|449648241|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
125005454|NCT02871778|449648242|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
125005455|NCT02871778|449648243|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
125005456|NCT02871778|449648244|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
125005457|NCT02871778|449648245|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
125005458|NCT02871778|449648246|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
125005459|NCT02871778|449648247|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
125005460|NCT02871778|449648248|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
125005461|NCT02871778|449648241|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
125005462|NCT02871778|449648242|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
125005463|NCT02871778|449648243|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
125005464|NCT02871778|449648244|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
125005465|NCT02871778|449648245|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
125005466|NCT02871778|449648246|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
125005467|NCT02871778|449648247|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
125005468|NCT02871778|449648248|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
125005469|NCT02871778|449648241|FG000|Part B: Treatment Period 3|Adverse Event|0|||
125005470|NCT02871778|449648242|FG001|Part B: Treatment Period 3|Adverse Event|0|||
125005471|NCT02871778|449648243|FG002|Part B: Treatment Period 3|Adverse Event|0|||
125005472|NCT02871778|449648244|FG003|Part B: Treatment Period 3|Adverse Event|0|||
125005473|NCT02871778|449648245|FG004|Part B: Treatment Period 3|Adverse Event|1|||
125005474|NCT02871778|449648246|FG005|Part B: Treatment Period 3|Adverse Event|1|||
125005475|NCT02871778|449648247|FG006|Part B: Treatment Period 3|Adverse Event|1|||
125005476|NCT02871778|449648248|FG007|Part B: Treatment Period 3|Adverse Event|0|||
125005477|NCT02653300|449648249|FG000|Overall Study|Withdrawal by Subject|2|||
125005478|NCT02170779|449648250|FG000|Overall Study|Withdrawal by Subject|1|||
125005479|NCT02170779|449648251|FG001|Overall Study|Withdrawal by Subject|0|||
125005480|NCT02170779|449648250|FG000|Overall Study|Lost to Follow-up|0|||
125005481|NCT02170779|449648251|FG001|Overall Study|Lost to Follow-up|1|||
125005482|NCT00369785|449648252|FG000|Overall Study|Physician Decision|3|||
125005483|NCT00369785|449648253|FG001|Overall Study|Physician Decision|2|||
125005484|NCT00369785|449648252|FG000|Overall Study|Death|1|||
125005485|NCT00369785|449648253|FG001|Overall Study|Death|2|||
125005486|NCT00369785|449648252|FG000|Overall Study|Withdrawal by Subject|7|||
125005487|NCT00369785|449648253|FG001|Overall Study|Withdrawal by Subject|6|||
125005488|NCT00369785|449648252|FG000|Overall Study|Toxicity|6|||
125005489|NCT00369785|449648253|FG001|Overall Study|Toxicity|4|||
125005490|NCT00369785|449648252|FG000|Overall Study|Never started|0|||
125005491|NCT00369785|449648253|FG001|Overall Study|Never started|2|||
125005492|NCT00369785|449648252|FG000|Overall Study|Progression|4|||
125005493|NCT00369785|449648253|FG001|Overall Study|Progression|4|||
125005494|NCT00369785|449648252|FG000|Overall Study|Multiple reasons|6|||
125005495|NCT00369785|449648253|FG001|Overall Study|Multiple reasons|5|||
125005496|NCT00800683|449648254|FG000|Overall Study|Adverse Event|11|||
125005497|NCT00800683|449648255|FG001|Overall Study|Adverse Event|8|||
125005498|NCT00800683|449648254|FG000|Overall Study|Lost to Follow-up|3|||
125005499|NCT00800683|449648255|FG001|Overall Study|Lost to Follow-up|1|||
125005500|NCT00800683|449648254|FG000|Overall Study|Withdrawal by Subject|1|||
125005501|NCT00800683|449648255|FG001|Overall Study|Withdrawal by Subject|7|||
125005502|NCT00800683|449648254|FG000|Overall Study|Lack of Efficacy|1|||
125005503|NCT00800683|449648255|FG001|Overall Study|Lack of Efficacy|1|||
125005504|NCT00800683|449648254|FG000|Overall Study|Other|1|||
125005505|NCT00800683|449648255|FG001|Overall Study|Other|2|||
125005506|NCT03492554|449648258|FG000|Overall Study|Protocol Violation|0|||
125005507|NCT03492554|449648259|FG001|Overall Study|Protocol Violation|14|||
125005508|NCT02463071|449648263|FG000|Overall Study|Adverse Event|3|||
125005509|NCT02463071|449648264|FG001|Overall Study|Adverse Event|5|||
125005510|NCT02463071|449648265|FG002|Overall Study|Adverse Event|1|||
125005511|NCT02463071|449648263|FG000|Overall Study|Death|1|||
125005512|NCT02463071|449648264|FG001|Overall Study|Death|0|||
125005513|NCT02463071|449648265|FG002|Overall Study|Death|0|||
125005514|NCT02463071|449648263|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
125092828|NCT05602818|449958180|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
125092829|NCT05602818|449958181|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
125092830|NCT05602818|449958182|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
125005515|NCT02463071|449648264|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125005516|NCT02463071|449648265|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
125005517|NCT02463071|449648263|FG000|Overall Study|Reason not specified|7|||
125005518|NCT02463071|449648264|FG001|Overall Study|Reason not specified|9|||
125005519|NCT02463071|449648265|FG002|Overall Study|Reason not specified|4|||
125005520|NCT02463071|449648263|FG000|Overall Study|Protocol Violation|0|||
125005521|NCT02463071|449648264|FG001|Overall Study|Protocol Violation|2|||
125005522|NCT02463071|449648265|FG002|Overall Study|Protocol Violation|0|||
125005523|NCT02463071|449648263|FG000|Overall Study|Lost to Follow-up|0|||
125005524|NCT02463071|449648264|FG001|Overall Study|Lost to Follow-up|0|||
125005525|NCT02463071|449648265|FG002|Overall Study|Lost to Follow-up|1|||
125005526|NCT00888381|449648268|FG000|Overall Study|Lost to Follow-up|0|||
125005527|NCT00888381|449648269|FG001|Overall Study|Lost to Follow-up|1|||
125005528|NCT03986866|449648270|FG000|Overall Study|Withdrawal by Subject|0|||
125005529|NCT03986866|449648271|FG001|Overall Study|Withdrawal by Subject|3|||
125005530|NCT03986866|449648270|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
125005531|NCT03986866|449648271|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
125005532|NCT05093322|449648274|FG000|Overall Study|Death|6|||
125005533|NCT05093322|449648275|FG001|Overall Study|Death|2|||
125005534|NCT05093322|449648274|FG000|Overall Study|Other|4|||
125005535|NCT05093322|449648275|FG001|Overall Study|Other|1|||
125005536|NCT00574145|449649803|FG000|Overall Study|Withdrawal by Subject|2|||
125005537|NCT00574145|449649804|FG001|Overall Study|Withdrawal by Subject|1|||
125005538|NCT02737852|449649805|FG000|Overall Study|Withdrawal by Subject|2|||
125005539|NCT00761306|449649806|FG000|Overall Study|Adverse Event|5|||
125005540|NCT00761306|449649806|FG000|Overall Study|Lack of Efficacy|4|||
125005541|NCT00761306|449649806|FG000|Overall Study|Protocol Violation|2|||
125005542|NCT00761306|449649806|FG000|Overall Study|Withdrawal of Consent|3|||
125005543|NCT00761306|449649806|FG000|Overall Study|Lost to Follow-up|1|||
125005544|NCT00761306|449649806|FG000|Overall Study|Administrative or Other Reasons|5|||
125005545|NCT04042740|449649807|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
125005546|NCT04042740|449649807|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
125005547|NCT00880555|449649808|FG000|Overall Study|Physician Decision|0|||
125005548|NCT00880555|449649809|FG001|Overall Study|Physician Decision|8|||
125005549|NCT00880555|449649810|FG002|Overall Study|Physician Decision|0|||
125005550|NCT00880555|449649811|FG003|Overall Study|Physician Decision|2|||
125005551|NCT00880555|449649812|FG004|Overall Study|Physician Decision|1|||
125005552|NCT00880555|449649813|FG005|Overall Study|Physician Decision|0|||
125005553|NCT00880555|449649808|FG000|Overall Study|Withdrawal by Subject|1|||
125005554|NCT00880555|449649809|FG001|Overall Study|Withdrawal by Subject|1|||
125005555|NCT00880555|449649810|FG002|Overall Study|Withdrawal by Subject|0|||
125005556|NCT00880555|449649811|FG003|Overall Study|Withdrawal by Subject|0|||
125005557|NCT00880555|449649812|FG004|Overall Study|Withdrawal by Subject|0|||
125005558|NCT00880555|449649813|FG005|Overall Study|Withdrawal by Subject|0|||
125005559|NCT00880555|449649808|FG000|Overall Study|Lack of resources (hired rater)|9|||
125092831|NCT05602818|449958183|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
125005560|NCT00880555|449649809|FG001|Overall Study|Lack of resources (hired rater)|7|||
125092832|NCT05602818|449958184|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
125005561|NCT00880555|449649810|FG002|Overall Study|Lack of resources (hired rater)|5|||
125005562|NCT00880555|449649811|FG003|Overall Study|Lack of resources (hired rater)|0|||
125005563|NCT00880555|449649812|FG004|Overall Study|Lack of resources (hired rater)|0|||
125005564|NCT00880555|449649813|FG005|Overall Study|Lack of resources (hired rater)|0|||
125092833|NCT05602818|449958185|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
125092834|NCT05602818|449958186|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
125092835|NCT05602818|449958187|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
125092836|NCT05602818|449958188|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
125092837|NCT05602818|449958189|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
125092838|NCT05602818|449958178|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
125092839|NCT05602818|449958179|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
125092840|NCT05602818|449958180|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
125092841|NCT05602818|449958181|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
125092842|NCT05602818|449958182|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
125092843|NCT05602818|449958183|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
125092844|NCT05602818|449958184|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
125092845|NCT05602818|449958185|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
125092846|NCT05602818|449958186|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
125092847|NCT05602818|449958187|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
125092848|NCT05602818|449958188|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
125092849|NCT05602818|449958189|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
125092850|NCT05602818|449958178|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
125092851|NCT05602818|449958179|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
125092852|NCT05602818|449958180|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
125092853|NCT05602818|449958181|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
125092854|NCT05602818|449958182|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
125092855|NCT05602818|449958183|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
125092856|NCT05602818|449958184|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
125092857|NCT05602818|449958185|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
125092858|NCT05602818|449958186|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
125092859|NCT05602818|449958187|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
125092860|NCT05602818|449958188|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
125092861|NCT05602818|449958189|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
125092862|NCT04594213|449958190|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
125092863|NCT04594213|449958191|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
125092864|NCT04594213|449958192|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
124872995|NCT00508261|449157214|FG002|Overall Study|Migrated/ moved from study area|0|||
125005565|NCT00880555|449649808|FG000|Overall Study|Death|0|||
125005566|NCT00880555|449649809|FG001|Overall Study|Death|0|||
125005567|NCT00880555|449649810|FG002|Overall Study|Death|0|||
125005568|NCT00880555|449649811|FG003|Overall Study|Death|0|||
125005569|NCT00880555|449649812|FG004|Overall Study|Death|0|||
125005570|NCT00880555|449649813|FG005|Overall Study|Death|1|||
125005571|NCT00880555|449649808|FG000|Overall Study|Lost to Follow-up|0|||
125005572|NCT00880555|449649809|FG001|Overall Study|Lost to Follow-up|1|||
125005573|NCT00880555|449649810|FG002|Overall Study|Lost to Follow-up|0|||
125005574|NCT00880555|449649811|FG003|Overall Study|Lost to Follow-up|0|||
125005575|NCT00880555|449649812|FG004|Overall Study|Lost to Follow-up|0|||
125005576|NCT00880555|449649813|FG005|Overall Study|Lost to Follow-up|0|||
125005577|NCT02982590|449649815|FG000|Overall Study|Lost to Follow-up|0|||
125005578|NCT02982590|449649816|FG001|Overall Study|Lost to Follow-up|1|||
125005579|NCT02982590|449649815|FG000|Overall Study|Death|4|||
125005580|NCT02982590|449649816|FG001|Overall Study|Death|0|||
125005581|NCT01168973|449649817|FG000|Overall Study|Progressive Disease|341|||
125005582|NCT01168973|449649818|FG001|Overall Study|Progressive Disease|429|||
125005583|NCT01168973|449649817|FG000|Overall Study|Adverse Event|94|||
125005584|NCT01168973|449649818|FG001|Overall Study|Adverse Event|55|||
125005585|NCT01168973|449649817|FG000|Overall Study|Withdrawal by Subject|90|||
125005586|NCT01168973|449649818|FG001|Overall Study|Withdrawal by Subject|53|||
125005587|NCT01168973|449649817|FG000|Overall Study|Death|42|||
125005588|NCT01168973|449649818|FG001|Overall Study|Death|45|||
125005589|NCT01168973|449649817|FG000|Overall Study|Physician Decision|37|||
125005590|NCT01168973|449649818|FG001|Overall Study|Physician Decision|19|||
125005591|NCT01168973|449649817|FG000|Overall Study|Sponsor Decision|2|||
125005592|NCT01168973|449649818|FG001|Overall Study|Sponsor Decision|1|||
125005593|NCT01168973|449649817|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
125005594|NCT01168973|449649818|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
125005595|NCT04479436|449649824|FG000|Overall Study|Progressive disease|26|||
125005596|NCT04479436|449649825|FG001|Overall Study|Progressive disease|1|||
125005597|NCT04479436|449649824|FG000|Overall Study|Adverse Event|6|||
125005598|NCT04479436|449649825|FG001|Overall Study|Adverse Event|0|||
125005599|NCT04479436|449649824|FG000|Overall Study|Withdrawal by Subject|5|||
125005600|NCT04479436|449649825|FG001|Overall Study|Withdrawal by Subject|0|||
125005601|NCT04479436|449649824|FG000|Overall Study|Clinical progression|1|||
125005602|NCT04479436|449649825|FG001|Overall Study|Clinical progression|0|||
125005603|NCT04479436|449649824|FG000|Overall Study|Physician Decision|1|||
125005604|NCT04479436|449649825|FG001|Overall Study|Physician Decision|0|||
125005605|NCT02357134|449649826|FG000|Overall Study|Lost to Follow-up|1|||
125005606|NCT02357134|449649827|FG001|Overall Study|Lost to Follow-up|0|||
125005607|NCT02357134|449649828|FG002|Overall Study|Lost to Follow-up|0|||
125005608|NCT02357134|449649829|FG003|Overall Study|Lost to Follow-up|0|||
125005609|NCT01380730|449649830|FG000|Overall Study|Death|0|||
125005610|NCT01380730|449649831|FG001|Overall Study|Death|0|||
125005611|NCT01380730|449649832|FG002|Overall Study|Death|0|||
125005612|NCT01380730|449649833|FG003|Overall Study|Death|0|||
125005613|NCT01380730|449649834|FG004|Overall Study|Death|1|||
125005614|NCT01380730|449649835|FG005|Overall Study|Death|0|||
125005615|NCT01380730|449649836|FG006|Overall Study|Death|0|||
125005616|NCT01380730|449649837|FG007|Overall Study|Death|0|||
125005617|NCT00467779|449649838|FG000|Stage 1|Adverse Event|1|||
125005618|NCT00467779|449649839|FG001|Stage 1|Adverse Event|0|||
125005619|NCT00467779|449649840|FG002|Stage 1|Adverse Event|0|||
125005620|NCT00467779|449649841|FG003|Stage 1|Adverse Event|0|||
125005621|NCT00467779|449649842|FG004|Stage 1|Adverse Event|0|||
125005622|NCT00467779|449649843|FG005|Stage 1|Adverse Event|1|||
125005623|NCT00467779|449649844|FG006|Stage 1|Adverse Event|2|||
125005624|NCT00467779|449649845|FG007|Stage 1|Adverse Event|1|||
125005625|NCT00467779|449649846|FG008|Stage 1|Adverse Event|0|||
125005626|NCT00467779|449649847|FG009|Stage 1|Adverse Event|0|||
125005627|NCT00467779|449649848|FG010|Stage 1|Adverse Event|0|||
125005628|NCT00467779|449649849|FG011|Stage 1|Adverse Event|0|||
125005629|NCT00467779|449649850|FG012|Stage 1|Adverse Event|0|||
125005630|NCT00467779|449649851|FG013|Stage 1|Adverse Event|0|||
125005631|NCT00467779|449649852|FG014|Stage 1|Adverse Event|0|||
125005632|NCT00467779|449649838|FG000|Stage 1|Disease Progression|2|||
125005633|NCT00467779|449649839|FG001|Stage 1|Disease Progression|2|||
125005634|NCT00467779|449649840|FG002|Stage 1|Disease Progression|2|||
125005635|NCT00467779|449649841|FG003|Stage 1|Disease Progression|3|||
125005636|NCT00467779|449649842|FG004|Stage 1|Disease Progression|2|||
125005637|NCT00467779|449649843|FG005|Stage 1|Disease Progression|2|||
125005638|NCT00467779|449649844|FG006|Stage 1|Disease Progression|4|||
125005639|NCT00467779|449649845|FG007|Stage 1|Disease Progression|5|||
125005640|NCT00467779|449649846|FG008|Stage 1|Disease Progression|0|||
125005641|NCT00467779|449649847|FG009|Stage 1|Disease Progression|0|||
125005642|NCT00467779|449649848|FG010|Stage 1|Disease Progression|0|||
125005643|NCT00467779|449649849|FG011|Stage 1|Disease Progression|0|||
125005644|NCT00467779|449649850|FG012|Stage 1|Disease Progression|0|||
125005645|NCT00467779|449649851|FG013|Stage 1|Disease Progression|0|||
125005646|NCT00467779|449649852|FG014|Stage 1|Disease Progression|0|||
125005647|NCT00467779|449649838|FG000|Stage 1|Unspecified Reason|1|||
125005648|NCT00467779|449649839|FG001|Stage 1|Unspecified Reason|0|||
125005649|NCT00467779|449649840|FG002|Stage 1|Unspecified Reason|1|||
125005650|NCT00467779|449649841|FG003|Stage 1|Unspecified Reason|0|||
125005651|NCT00467779|449649842|FG004|Stage 1|Unspecified Reason|1|||
125005652|NCT00467779|449649843|FG005|Stage 1|Unspecified Reason|2|||
125005653|NCT00467779|449649844|FG006|Stage 1|Unspecified Reason|0|||
125005654|NCT00467779|449649845|FG007|Stage 1|Unspecified Reason|0|||
125005655|NCT00467779|449649846|FG008|Stage 1|Unspecified Reason|0|||
125005656|NCT00467779|449649847|FG009|Stage 1|Unspecified Reason|0|||
125005657|NCT00467779|449649848|FG010|Stage 1|Unspecified Reason|0|||
125092865|NCT04594213|449958193|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
125092866|NCT04594213|449958194|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
125092867|NCT04594213|449958195|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
125092868|NCT04594213|449958190|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
125092869|NCT04594213|449958191|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
125092870|NCT04594213|449958192|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
125092871|NCT04594213|449958193|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
125092872|NCT04594213|449958194|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
125092873|NCT04594213|449958195|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
125092874|NCT04594213|449958190|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
125092875|NCT04594213|449958191|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
125092876|NCT04594213|449958192|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
125092877|NCT04594213|449958193|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
125092878|NCT04594213|449958194|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
125092879|NCT04594213|449958195|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
125092880|NCT04594213|449958190|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
125092881|NCT04594213|449958191|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
125092882|NCT04594213|449958192|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
125092883|NCT04594213|449958193|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
125092884|NCT04594213|449958194|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
125092885|NCT04594213|449958195|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
125092886|NCT04594213|449958190|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
125092887|NCT04594213|449958191|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
125092888|NCT04594213|449958192|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
125092889|NCT04594213|449958193|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
125092890|NCT04594213|449958194|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
125092891|NCT04594213|449958195|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
125092892|NCT04594213|449958190|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
125092893|NCT04594213|449958191|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
125092894|NCT04594213|449958192|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
125092895|NCT04594213|449958193|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
125092896|NCT04594213|449958194|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
125092897|NCT04594213|449958195|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
125092898|NCT04594213|449958190|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
125092899|NCT04594213|449958191|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
125092900|NCT04594213|449958192|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
125092901|NCT04594213|449958193|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
125092902|NCT04594213|449958194|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
125092903|NCT04594213|449958195|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
125092904|NCT04594213|449958190|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
125092905|NCT04594213|449958191|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
125092906|NCT04594213|449958192|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
125092907|NCT04594213|449958193|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
125092908|NCT04594213|449958194|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
125092909|NCT04594213|449958195|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
125092910|NCT04594213|449958190|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
125092911|NCT04594213|449958191|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
125092912|NCT04594213|449958192|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
125092913|NCT04594213|449958193|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
125092914|NCT04594213|449958194|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
125092915|NCT04594213|449958195|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
125092916|NCT04594213|449958190|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
125092917|NCT04594213|449958191|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
125092918|NCT04594213|449958192|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
125092919|NCT04594213|449958193|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
125092920|NCT04594213|449958194|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
125092921|NCT04594213|449958195|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
125092922|NCT04594213|449958190|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
125092923|NCT04594213|449958191|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
125092924|NCT04594213|449958192|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
125092925|NCT04594213|449958193|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
125092926|NCT04594213|449958194|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
125092927|NCT04594213|449958195|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
125092928|NCT03814499|449958201|FG000|Overall Study|Lost to Follow-up|3|||
125092929|NCT01589185|449958202|FG000|Overall Study|Death|1|||
125092930|NCT01589185|449958203|FG001|Overall Study|Death|2|||
125092931|NCT01589185|449958204|FG002|Overall Study|Death|2|||
125092932|NCT01589185|449958205|FG003|Overall Study|Death|0|||
125092933|NCT01589185|449958206|FG004|Overall Study|Death|1|||
125092934|NCT01589185|449958202|FG000|Overall Study|Lost to Follow-up|1|||
125092935|NCT01589185|449958203|FG001|Overall Study|Lost to Follow-up|0|||
125092936|NCT01589185|449958204|FG002|Overall Study|Lost to Follow-up|2|||
125092937|NCT01589185|449958205|FG003|Overall Study|Lost to Follow-up|3|||
125092938|NCT01589185|449958206|FG004|Overall Study|Lost to Follow-up|0|||
125092939|NCT02046993|449958207|FG000|Overall Study|Withdrawal by Subject|2|||
125092940|NCT02046993|449958208|FG001|Overall Study|Withdrawal by Subject|10|||
125092941|NCT02046993|449958207|FG000|Overall Study|Lost to Follow-up|1|||
125092942|NCT02046993|449958208|FG001|Overall Study|Lost to Follow-up|1|||
125092943|NCT00598442|449958211|FG000|Overall Study|Adverse Event|3|||
125092944|NCT00598442|449958212|FG001|Overall Study|Adverse Event|0|||
125092945|NCT00598442|449958213|FG002|Overall Study|Adverse Event|0|||
125092946|NCT00598442|449958211|FG000|Overall Study|Death|19|||
125092947|NCT00598442|449958212|FG001|Overall Study|Death|11|||
125092948|NCT00598442|449958213|FG002|Overall Study|Death|11|||
125092949|NCT00598442|449958211|FG000|Overall Study|Lost to Follow-up|4|||
125092950|NCT00598442|449958212|FG001|Overall Study|Lost to Follow-up|3|||
125092951|NCT00598442|449958213|FG002|Overall Study|Lost to Follow-up|3|||
125092952|NCT00598442|449958211|FG000|Overall Study|Physician Decision|2|||
125092953|NCT00598442|449958212|FG001|Overall Study|Physician Decision|1|||
125092954|NCT00598442|449958213|FG002|Overall Study|Physician Decision|1|||
125092955|NCT00598442|449958211|FG000|Overall Study|Withdrawal by Subject|8|||
125092956|NCT00598442|449958212|FG001|Overall Study|Withdrawal by Subject|16|||
125092957|NCT00598442|449958213|FG002|Overall Study|Withdrawal by Subject|6|||
125092958|NCT00598442|449958211|FG000|Overall Study|Noncompliance|0|||
125092959|NCT00598442|449958212|FG001|Overall Study|Noncompliance|2|||
125092960|NCT00598442|449958213|FG002|Overall Study|Noncompliance|1|||
125092961|NCT00598442|449958211|FG000|Overall Study|Relocation|1|||
125092962|NCT00598442|449958212|FG001|Overall Study|Relocation|4|||
125092963|NCT00598442|449958213|FG002|Overall Study|Relocation|0|||
125092964|NCT00598442|449958211|FG000|Overall Study|Renal transplant|0|||
125092965|NCT00598442|449958212|FG001|Overall Study|Renal transplant|0|||
125092966|NCT00598442|449958213|FG002|Overall Study|Renal transplant|1|||
125092967|NCT00598442|449958211|FG000|Overall Study|Site closed by sponsor|5|||
125092968|NCT00598442|449958212|FG001|Overall Study|Site closed by sponsor|2|||
125092969|NCT00598442|449958213|FG002|Overall Study|Site closed by sponsor|1|||
125092970|NCT00598442|449958211|FG000|Overall Study|Started dialysis|1|||
125092971|NCT00598442|449958212|FG001|Overall Study|Started dialysis|0|||
125092972|NCT00598442|449958213|FG002|Overall Study|Started dialysis|0|||
125092973|NCT01729559|449958219|FG000|Overall Study|Protocol Violation|31|||
125092974|NCT01729559|449958220|FG001|Overall Study|Protocol Violation|28|||
125092975|NCT03764813|449958225|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
125092976|NCT03764813|449958226|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
125092977|NCT03764813|449958227|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
125092978|NCT03764813|449958228|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
125092979|NCT01654666|449958233|FG000|Overall Study|Protocol Violation|7|||
125092980|NCT01654666|449958234|FG001|Overall Study|Protocol Violation|4|||
125092981|NCT01654666|449958235|FG002|Overall Study|Protocol Violation|8|||
125092982|NCT01654666|449958233|FG000|Overall Study|Lost to Follow-up|4|||
125092983|NCT01654666|449958234|FG001|Overall Study|Lost to Follow-up|5|||
125092984|NCT01654666|449958235|FG002|Overall Study|Lost to Follow-up|5|||
125092985|NCT01654666|449958233|FG000|Overall Study|Withdrawal by Subject|4|||
125092986|NCT01654666|449958234|FG001|Overall Study|Withdrawal by Subject|4|||
125092987|NCT01654666|449958235|FG002|Overall Study|Withdrawal by Subject|1|||
125092988|NCT00535262|449958236|FG000|Overall Study|No funding|3|||
125092989|NCT02898662|449958237|FG000|Overall Study|Adverse Event|1|||
125092990|NCT02898662|449958238|FG001|Overall Study|Adverse Event|0|||
125092991|NCT02898662|449958237|FG000|Overall Study|Loss of asthma control|23|||
125092992|NCT02898662|449958238|FG001|Overall Study|Loss of asthma control|24|||
125092993|NCT02898662|449958237|FG000|Overall Study|Withdrawal by Subject|4|||
125092994|NCT02898662|449958238|FG001|Overall Study|Withdrawal by Subject|1|||
125092995|NCT02898662|449958237|FG000|Overall Study|Technical issue|0|||
125092996|NCT02898662|449958238|FG001|Overall Study|Technical issue|1|||
125092997|NCT02898662|449958237|FG000|Overall Study|Randomized in error|0|||
125092998|NCT02898662|449958238|FG001|Overall Study|Randomized in error|1|||
125092999|NCT02898662|449958237|FG000|Overall Study|Subject decision|1|||
125093000|NCT02898662|449958238|FG001|Overall Study|Subject decision|0|||
125093001|NCT02898662|449958237|FG000|Overall Study|Other|0|||
125093002|NCT02898662|449958238|FG001|Overall Study|Other|1|||
125005658|NCT00467779|449649849|FG011|Stage 1|Unspecified Reason|0|||
125005659|NCT00467779|449649850|FG012|Stage 1|Unspecified Reason|0|||
125005660|NCT00467779|449649851|FG013|Stage 1|Unspecified Reason|0|||
125005661|NCT00467779|449649852|FG014|Stage 1|Unspecified Reason|0|||
125005662|NCT00467779|449649838|FG000|Stage 1|Physician Decision|0|||
125005663|NCT00467779|449649839|FG001|Stage 1|Physician Decision|1|||
125005664|NCT00467779|449649840|FG002|Stage 1|Physician Decision|0|||
125005665|NCT00467779|449649841|FG003|Stage 1|Physician Decision|0|||
125005666|NCT00467779|449649842|FG004|Stage 1|Physician Decision|0|||
125005667|NCT00467779|449649843|FG005|Stage 1|Physician Decision|0|||
125005668|NCT00467779|449649844|FG006|Stage 1|Physician Decision|0|||
125005669|NCT00467779|449649845|FG007|Stage 1|Physician Decision|0|||
125005670|NCT00467779|449649846|FG008|Stage 1|Physician Decision|0|||
125005671|NCT00467779|449649847|FG009|Stage 1|Physician Decision|0|||
125005672|NCT00467779|449649848|FG010|Stage 1|Physician Decision|0|||
125005673|NCT00467779|449649849|FG011|Stage 1|Physician Decision|0|||
125005674|NCT00467779|449649850|FG012|Stage 1|Physician Decision|0|||
125005675|NCT00467779|449649851|FG013|Stage 1|Physician Decision|0|||
125005676|NCT00467779|449649852|FG014|Stage 1|Physician Decision|0|||
125005677|NCT00467779|449649838|FG000|Stage 1|Withdrawal by Subject|0|||
125005678|NCT00467779|449649839|FG001|Stage 1|Withdrawal by Subject|0|||
125005679|NCT00467779|449649840|FG002|Stage 1|Withdrawal by Subject|0|||
125005680|NCT00467779|449649841|FG003|Stage 1|Withdrawal by Subject|0|||
125005681|NCT00467779|449649842|FG004|Stage 1|Withdrawal by Subject|0|||
125005682|NCT00467779|449649843|FG005|Stage 1|Withdrawal by Subject|0|||
125005683|NCT00467779|449649844|FG006|Stage 1|Withdrawal by Subject|1|||
125005684|NCT00467779|449649845|FG007|Stage 1|Withdrawal by Subject|1|||
125005685|NCT00467779|449649846|FG008|Stage 1|Withdrawal by Subject|0|||
125005686|NCT00467779|449649847|FG009|Stage 1|Withdrawal by Subject|0|||
125005687|NCT00467779|449649848|FG010|Stage 1|Withdrawal by Subject|0|||
125005688|NCT00467779|449649849|FG011|Stage 1|Withdrawal by Subject|0|||
125005689|NCT00467779|449649850|FG012|Stage 1|Withdrawal by Subject|0|||
125005690|NCT00467779|449649851|FG013|Stage 1|Withdrawal by Subject|0|||
125005691|NCT00467779|449649852|FG014|Stage 1|Withdrawal by Subject|0|||
125005692|NCT00467779|449649838|FG000|Stage 1A|Adverse Event|0|||
125005693|NCT00467779|449649839|FG001|Stage 1A|Adverse Event|0|||
125005694|NCT00467779|449649840|FG002|Stage 1A|Adverse Event|0|||
125005695|NCT00467779|449649841|FG003|Stage 1A|Adverse Event|0|||
125005696|NCT00467779|449649842|FG004|Stage 1A|Adverse Event|0|||
125005697|NCT00467779|449649843|FG005|Stage 1A|Adverse Event|0|||
125005698|NCT00467779|449649844|FG006|Stage 1A|Adverse Event|0|||
125005699|NCT00467779|449649845|FG007|Stage 1A|Adverse Event|0|||
125005700|NCT00467779|449649846|FG008|Stage 1A|Adverse Event|0|||
125005701|NCT00467779|449649847|FG009|Stage 1A|Adverse Event|0|||
125005702|NCT00467779|449649848|FG010|Stage 1A|Adverse Event|0|||
125005703|NCT00467779|449649849|FG011|Stage 1A|Adverse Event|0|||
125005704|NCT00467779|449649850|FG012|Stage 1A|Adverse Event|1|||
125005705|NCT00467779|449649851|FG013|Stage 1A|Adverse Event|0|||
125005706|NCT00467779|449649852|FG014|Stage 1A|Adverse Event|0|||
125005707|NCT00467779|449649838|FG000|Stage 1A|Death|0|||
125005708|NCT00467779|449649839|FG001|Stage 1A|Death|0|||
125005709|NCT00467779|449649840|FG002|Stage 1A|Death|0|||
125005710|NCT00467779|449649841|FG003|Stage 1A|Death|0|||
125005711|NCT00467779|449649842|FG004|Stage 1A|Death|0|||
125005712|NCT00467779|449649843|FG005|Stage 1A|Death|0|||
125005713|NCT00467779|449649844|FG006|Stage 1A|Death|0|||
125093003|NCT00917553|449958239|FG000|Overall Study|Lost to Follow-up|2|||
125093004|NCT00917553|449958240|FG001|Overall Study|Lost to Follow-up|1|||
125005714|NCT00467779|449649845|FG007|Stage 1A|Death|0|||
125005715|NCT00467779|449649846|FG008|Stage 1A|Death|0|||
125005716|NCT00467779|449649847|FG009|Stage 1A|Death|0|||
125005717|NCT00467779|449649848|FG010|Stage 1A|Death|0|||
125005718|NCT00467779|449649849|FG011|Stage 1A|Death|1|||
125005719|NCT00467779|449649850|FG012|Stage 1A|Death|1|||
125005720|NCT00467779|449649851|FG013|Stage 1A|Death|0|||
125005721|NCT00467779|449649852|FG014|Stage 1A|Death|0|||
125005722|NCT00467779|449649838|FG000|Stage 1A|Disease Progression|0|||
125005723|NCT00467779|449649839|FG001|Stage 1A|Disease Progression|0|||
125005724|NCT00467779|449649840|FG002|Stage 1A|Disease Progression|0|||
125005725|NCT00467779|449649841|FG003|Stage 1A|Disease Progression|0|||
125005726|NCT00467779|449649842|FG004|Stage 1A|Disease Progression|0|||
125005727|NCT00467779|449649843|FG005|Stage 1A|Disease Progression|0|||
125005728|NCT00467779|449649844|FG006|Stage 1A|Disease Progression|0|||
125005729|NCT00467779|449649845|FG007|Stage 1A|Disease Progression|0|||
125005730|NCT00467779|449649846|FG008|Stage 1A|Disease Progression|0|||
125005731|NCT00467779|449649847|FG009|Stage 1A|Disease Progression|2|||
125005732|NCT00467779|449649848|FG010|Stage 1A|Disease Progression|2|||
125005733|NCT00467779|449649849|FG011|Stage 1A|Disease Progression|5|||
125005734|NCT00467779|449649850|FG012|Stage 1A|Disease Progression|2|||
125005735|NCT00467779|449649851|FG013|Stage 1A|Disease Progression|0|||
125005736|NCT00467779|449649852|FG014|Stage 1A|Disease Progression|0|||
125093005|NCT01616173|449958241|FG000|Overall Study|Lost to Follow-up|0|||
125093006|NCT01616173|449958242|FG001|Overall Study|Lost to Follow-up|2|||
125093007|NCT01616173|449958243|FG002|Overall Study|Lost to Follow-up|0|||
125093008|NCT03432819|449958246|FG000|Overall Study|Lost to Follow-up|2|||
125093009|NCT03432819|449958247|FG001|Overall Study|Lost to Follow-up|2|||
125093010|NCT03432819|449958246|FG000|Overall Study|Withdrawal by Subject|5|||
125093011|NCT03432819|449958247|FG001|Overall Study|Withdrawal by Subject|3|||
125093012|NCT04738123|449958250|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
125093013|NCT04738123|449958251|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
125093014|NCT04738123|449958250|FG000|Overall Study|Progressive Disease|0|||
125093015|NCT04738123|449958251|FG001|Overall Study|Progressive Disease|4|||
125093016|NCT04738123|449958250|FG000|Overall Study|Adverse Event|8|||
125093017|NCT04738123|449958251|FG001|Overall Study|Adverse Event|7|||
125093018|NCT04738123|449958250|FG000|Overall Study|Other Reasons|0|||
125093019|NCT04738123|449958251|FG001|Overall Study|Other Reasons|1|||
125093020|NCT04738123|449958250|FG000|Overall Study|Suicidal or assaultive behavior|0|||
125093021|NCT04738123|449958251|FG001|Overall Study|Suicidal or assaultive behavior|2|||
125093022|NCT04738123|449958250|FG000|Overall Study|Protocol Violation|2|||
125093023|NCT04738123|449958251|FG001|Overall Study|Protocol Violation|2|||
125093024|NCT04738123|449958250|FG000|Overall Study|Consent Withdrawn|35|||
125093025|NCT04738123|449958251|FG001|Overall Study|Consent Withdrawn|22|||
125093026|NCT03604159|449958252|FG000|Overall Study|Lost to Follow-up|6|||
125093027|NCT03604159|449958253|FG001|Overall Study|Lost to Follow-up|7|||
125093028|NCT00787527|449958256|FG000|Overall Study|Toxicity|3|||
125093029|NCT00083616|449958259|FG000|Overall Study|Disease Progression|16|||
125093030|NCT00083616|449958259|FG000|Overall Study|Lost to Follow-up|1|||
125093031|NCT00083616|449958259|FG000|Overall Study|Physician Decision|2|||
125093032|NCT00083616|449958259|FG000|Overall Study|Withdrawal by Subject|3|||
125093033|NCT00083616|449958259|FG000|Overall Study|Ineligibility determined|2|||
125093034|NCT00083616|449958259|FG000|Overall Study|Non-compliance|1|||
125093035|NCT00083616|449958259|FG000|Overall Study|Other|6|||
125093036|NCT01474993|449958262|FG000|Overall Study|Lost to Follow-up|1|||
125093037|NCT01474993|449958263|FG001|Overall Study|Lost to Follow-up|2|||
125093038|NCT01474993|449958262|FG000|Overall Study|Adverse Event|0|||
125093039|NCT01474993|449958263|FG001|Overall Study|Adverse Event|1|||
125093040|NCT03258710|449958264|FG000|Overall Study|Adverse Event|1|||
125093041|NCT03258710|449958264|FG000|Overall Study|Protocol-defined stopping criteria|1|||
125093042|NCT03258710|449958264|FG000|Overall Study|Physician Decision|1|||
125093043|NCT03137173|449958265|FG000|Overall Study|Withdrawal by Subject|8|||
125093044|NCT03137173|449958266|FG001|Overall Study|Withdrawal by Subject|13|||
125093045|NCT03137173|449958265|FG000|Overall Study|Death|1|||
125093046|NCT03137173|449958266|FG001|Overall Study|Death|3|||
125093047|NCT03137173|449958265|FG000|Overall Study|Physician Decision|1|||
125093048|NCT03137173|449958266|FG001|Overall Study|Physician Decision|0|||
125093049|NCT03137173|449958265|FG000|Overall Study|Lost to Follow-up|13|||
125093050|NCT03137173|449958266|FG001|Overall Study|Lost to Follow-up|18|||
125093051|NCT03137173|449958265|FG000|Overall Study|Other reasons|3|||
125093052|NCT03137173|449958266|FG001|Overall Study|Other reasons|2|||
125093053|NCT03044730|449958277|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
125093054|NCT03044730|449958277|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
125093055|NCT03044730|449958277|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
125093056|NCT03044730|449958277|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
125093057|NCT03044730|449958277|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
125093058|NCT03044730|449958277|FG000|Cycles 4 and Beyond|Adverse Event|1|||
125093059|NCT03044730|449958277|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
125093060|NCT03044730|449958277|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
125093061|NCT03044730|449958277|FG000|On Follow-up for 2 Years|Death|17|||
125093062|NCT00690612|449960076|FG000|Overall Study|Adverse Event|1|||
125005737|NCT00467779|449649838|FG000|Stage 1A|Physician Decision|0|||
125005738|NCT00467779|449649839|FG001|Stage 1A|Physician Decision|0|||
125005739|NCT00467779|449649840|FG002|Stage 1A|Physician Decision|0|||
125005740|NCT00467779|449649841|FG003|Stage 1A|Physician Decision|0|||
125005741|NCT00467779|449649842|FG004|Stage 1A|Physician Decision|0|||
125005742|NCT00467779|449649843|FG005|Stage 1A|Physician Decision|0|||
125005743|NCT00467779|449649844|FG006|Stage 1A|Physician Decision|0|||
125005744|NCT00467779|449649845|FG007|Stage 1A|Physician Decision|0|||
125005745|NCT00467779|449649846|FG008|Stage 1A|Physician Decision|0|||
125005746|NCT00467779|449649847|FG009|Stage 1A|Physician Decision|1|||
125005747|NCT00467779|449649848|FG010|Stage 1A|Physician Decision|0|||
125005748|NCT00467779|449649849|FG011|Stage 1A|Physician Decision|0|||
125005749|NCT00467779|449649850|FG012|Stage 1A|Physician Decision|0|||
125005750|NCT00467779|449649851|FG013|Stage 1A|Physician Decision|0|||
125005751|NCT00467779|449649852|FG014|Stage 1A|Physician Decision|0|||
125005752|NCT00467779|449649838|FG000|Stage 1A|Withdrawal by Subject|0|||
125005753|NCT00467779|449649839|FG001|Stage 1A|Withdrawal by Subject|0|||
125005754|NCT00467779|449649840|FG002|Stage 1A|Withdrawal by Subject|0|||
125005755|NCT00467779|449649841|FG003|Stage 1A|Withdrawal by Subject|0|||
125005756|NCT00467779|449649842|FG004|Stage 1A|Withdrawal by Subject|0|||
125005757|NCT00467779|449649843|FG005|Stage 1A|Withdrawal by Subject|0|||
125005758|NCT00467779|449649844|FG006|Stage 1A|Withdrawal by Subject|0|||
125005759|NCT00467779|449649845|FG007|Stage 1A|Withdrawal by Subject|0|||
125005760|NCT00467779|449649846|FG008|Stage 1A|Withdrawal by Subject|0|||
125005761|NCT00467779|449649847|FG009|Stage 1A|Withdrawal by Subject|0|||
125005762|NCT00467779|449649848|FG010|Stage 1A|Withdrawal by Subject|1|||
125005763|NCT00467779|449649849|FG011|Stage 1A|Withdrawal by Subject|1|||
125005764|NCT00467779|449649850|FG012|Stage 1A|Withdrawal by Subject|1|||
125005765|NCT00467779|449649851|FG013|Stage 1A|Withdrawal by Subject|0|||
125005766|NCT00467779|449649852|FG014|Stage 1A|Withdrawal by Subject|0|||
125005767|NCT00467779|449649838|FG000|Stage 1A|Unspecified Reason|0|||
125005768|NCT00467779|449649839|FG001|Stage 1A|Unspecified Reason|0|||
125005769|NCT00467779|449649840|FG002|Stage 1A|Unspecified Reason|0|||
125005770|NCT00467779|449649841|FG003|Stage 1A|Unspecified Reason|0|||
125005771|NCT00467779|449649842|FG004|Stage 1A|Unspecified Reason|0|||
125005772|NCT00467779|449649843|FG005|Stage 1A|Unspecified Reason|0|||
125005773|NCT00467779|449649844|FG006|Stage 1A|Unspecified Reason|0|||
125005774|NCT00467779|449649845|FG007|Stage 1A|Unspecified Reason|0|||
125005775|NCT00467779|449649846|FG008|Stage 1A|Unspecified Reason|0|||
125005776|NCT00467779|449649847|FG009|Stage 1A|Unspecified Reason|0|||
125005777|NCT00467779|449649848|FG010|Stage 1A|Unspecified Reason|0|||
125005778|NCT00467779|449649849|FG011|Stage 1A|Unspecified Reason|1|||
125005779|NCT00467779|449649850|FG012|Stage 1A|Unspecified Reason|1|||
125005780|NCT00467779|449649851|FG013|Stage 1A|Unspecified Reason|0|||
125005781|NCT00467779|449649852|FG014|Stage 1A|Unspecified Reason|0|||
125005782|NCT00467779|449649838|FG000|Stage 2|Adverse Event|0|||
125005783|NCT00467779|449649839|FG001|Stage 2|Adverse Event|0|||
125005784|NCT00467779|449649840|FG002|Stage 2|Adverse Event|0|||
125005785|NCT00467779|449649841|FG003|Stage 2|Adverse Event|0|||
125005786|NCT00467779|449649842|FG004|Stage 2|Adverse Event|0|||
125005787|NCT00467779|449649843|FG005|Stage 2|Adverse Event|0|||
125005788|NCT00467779|449649844|FG006|Stage 2|Adverse Event|0|||
125005789|NCT00467779|449649845|FG007|Stage 2|Adverse Event|0|||
125005790|NCT00467779|449649846|FG008|Stage 2|Adverse Event|1|||
125005791|NCT00467779|449649847|FG009|Stage 2|Adverse Event|0|||
125005792|NCT00467779|449649848|FG010|Stage 2|Adverse Event|0|||
125005793|NCT00467779|449649849|FG011|Stage 2|Adverse Event|0|||
125005794|NCT00467779|449649850|FG012|Stage 2|Adverse Event|0|||
125005795|NCT00467779|449649851|FG013|Stage 2|Adverse Event|0|||
125005796|NCT00467779|449649852|FG014|Stage 2|Adverse Event|0|||
125005797|NCT00467779|449649838|FG000|Stage 2|Death|0|||
125005798|NCT00467779|449649839|FG001|Stage 2|Death|0|||
125005799|NCT00467779|449649840|FG002|Stage 2|Death|0|||
125005800|NCT00467779|449649841|FG003|Stage 2|Death|0|||
125005801|NCT00467779|449649842|FG004|Stage 2|Death|0|||
125005802|NCT00467779|449649843|FG005|Stage 2|Death|0|||
125005803|NCT00467779|449649844|FG006|Stage 2|Death|0|||
125005804|NCT00467779|449649845|FG007|Stage 2|Death|0|||
125005805|NCT00467779|449649846|FG008|Stage 2|Death|1|||
125005806|NCT00467779|449649847|FG009|Stage 2|Death|0|||
125005807|NCT00467779|449649848|FG010|Stage 2|Death|0|||
125005808|NCT00467779|449649849|FG011|Stage 2|Death|0|||
125005809|NCT00467779|449649850|FG012|Stage 2|Death|0|||
125005810|NCT00467779|449649851|FG013|Stage 2|Death|0|||
125005811|NCT00467779|449649852|FG014|Stage 2|Death|0|||
125005812|NCT00467779|449649838|FG000|Stage 2|Disease Progression|0|||
125005813|NCT00467779|449649839|FG001|Stage 2|Disease Progression|0|||
125005814|NCT00467779|449649840|FG002|Stage 2|Disease Progression|0|||
125005815|NCT00467779|449649841|FG003|Stage 2|Disease Progression|0|||
125005816|NCT00467779|449649842|FG004|Stage 2|Disease Progression|0|||
125005817|NCT00467779|449649843|FG005|Stage 2|Disease Progression|0|||
125005818|NCT00467779|449649844|FG006|Stage 2|Disease Progression|0|||
125005819|NCT00467779|449649845|FG007|Stage 2|Disease Progression|0|||
125005820|NCT00467779|449649846|FG008|Stage 2|Disease Progression|16|||
125005821|NCT00467779|449649847|FG009|Stage 2|Disease Progression|0|||
125093063|NCT00690612|449960076|FG000|Overall Study|Withdrawal by Subject|2|||
125093064|NCT00911508|449960077|FG000|Overall Study|Lost to Follow-up|27|||
125093065|NCT00911508|449960078|FG001|Overall Study|Lost to Follow-up|18|||
125093066|NCT00911508|449960077|FG000|Overall Study|Withdrawal by Subject|79|||
125093067|NCT00911508|449960078|FG001|Overall Study|Withdrawal by Subject|112|||
125093068|NCT01409382|449960079|FG000|Overall Study|Lost to Follow-up|1|||
125093069|NCT01409382|449960080|FG001|Overall Study|Lost to Follow-up|1|||
125093070|NCT01409382|449960079|FG000|Overall Study|Protocol Violation|0|||
125093071|NCT01409382|449960080|FG001|Overall Study|Protocol Violation|3|||
125093072|NCT01409382|449960079|FG000|Overall Study|Multiple pregnancy|2|||
125093073|NCT01409382|449960080|FG001|Overall Study|Multiple pregnancy|4|||
125093074|NCT01409382|449960079|FG000|Overall Study|Still pregnant when study ended|13|||
125093075|NCT01409382|449960080|FG001|Overall Study|Still pregnant when study ended|2|||
125093076|NCT01409382|449960079|FG000|Overall Study|Did not manage to get pregnant|64|||
125093077|NCT01409382|449960080|FG001|Overall Study|Did not manage to get pregnant|70|||
125005822|NCT00467779|449649848|FG010|Stage 2|Disease Progression|0|||
125005823|NCT00467779|449649849|FG011|Stage 2|Disease Progression|0|||
125005824|NCT00467779|449649850|FG012|Stage 2|Disease Progression|0|||
125005825|NCT00467779|449649851|FG013|Stage 2|Disease Progression|0|||
125005826|NCT00467779|449649852|FG014|Stage 2|Disease Progression|0|||
125005827|NCT00467779|449649838|FG000|Stage 2|Unspecified Reason|0|||
125005828|NCT00467779|449649839|FG001|Stage 2|Unspecified Reason|0|||
125005829|NCT00467779|449649840|FG002|Stage 2|Unspecified Reason|0|||
125005830|NCT00467779|449649841|FG003|Stage 2|Unspecified Reason|0|||
125005831|NCT00467779|449649842|FG004|Stage 2|Unspecified Reason|0|||
125005832|NCT00467779|449649843|FG005|Stage 2|Unspecified Reason|0|||
125005833|NCT00467779|449649844|FG006|Stage 2|Unspecified Reason|0|||
125005834|NCT00467779|449649845|FG007|Stage 2|Unspecified Reason|0|||
125005835|NCT00467779|449649846|FG008|Stage 2|Unspecified Reason|3|||
125005836|NCT00467779|449649847|FG009|Stage 2|Unspecified Reason|0|||
125005837|NCT00467779|449649848|FG010|Stage 2|Unspecified Reason|0|||
125005838|NCT00467779|449649849|FG011|Stage 2|Unspecified Reason|0|||
125005839|NCT00467779|449649850|FG012|Stage 2|Unspecified Reason|0|||
125005840|NCT00467779|449649851|FG013|Stage 2|Unspecified Reason|0|||
125005841|NCT00467779|449649852|FG014|Stage 2|Unspecified Reason|0|||
125005842|NCT00467779|449649838|FG000|Stage 2A|Adverse Event|0|||
125005843|NCT00467779|449649839|FG001|Stage 2A|Adverse Event|0|||
125005844|NCT00467779|449649840|FG002|Stage 2A|Adverse Event|0|||
125005845|NCT00467779|449649841|FG003|Stage 2A|Adverse Event|0|||
125005846|NCT00467779|449649842|FG004|Stage 2A|Adverse Event|0|||
125005847|NCT00467779|449649843|FG005|Stage 2A|Adverse Event|0|||
125005848|NCT00467779|449649844|FG006|Stage 2A|Adverse Event|0|||
125005849|NCT00467779|449649845|FG007|Stage 2A|Adverse Event|0|||
125005850|NCT00467779|449649846|FG008|Stage 2A|Adverse Event|0|||
125005851|NCT00467779|449649847|FG009|Stage 2A|Adverse Event|0|||
125005852|NCT00467779|449649848|FG010|Stage 2A|Adverse Event|0|||
125005853|NCT00467779|449649849|FG011|Stage 2A|Adverse Event|0|||
125005854|NCT00467779|449649850|FG012|Stage 2A|Adverse Event|0|||
125005855|NCT00467779|449649851|FG013|Stage 2A|Adverse Event|2|||
125005856|NCT00467779|449649852|FG014|Stage 2A|Adverse Event|0|||
125005857|NCT00467779|449649838|FG000|Stage 2A|Death|0|||
125005858|NCT00467779|449649839|FG001|Stage 2A|Death|0|||
125005859|NCT00467779|449649840|FG002|Stage 2A|Death|0|||
125005860|NCT00467779|449649841|FG003|Stage 2A|Death|0|||
125005861|NCT00467779|449649842|FG004|Stage 2A|Death|0|||
125005862|NCT00467779|449649843|FG005|Stage 2A|Death|0|||
125005863|NCT00467779|449649844|FG006|Stage 2A|Death|0|||
125005864|NCT00467779|449649845|FG007|Stage 2A|Death|0|||
125005865|NCT00467779|449649846|FG008|Stage 2A|Death|0|||
125005866|NCT00467779|449649847|FG009|Stage 2A|Death|0|||
125005867|NCT00467779|449649848|FG010|Stage 2A|Death|0|||
125005868|NCT00467779|449649849|FG011|Stage 2A|Death|0|||
125005869|NCT00467779|449649850|FG012|Stage 2A|Death|0|||
125005870|NCT00467779|449649851|FG013|Stage 2A|Death|1|||
125005871|NCT00467779|449649852|FG014|Stage 2A|Death|0|||
125005872|NCT00467779|449649838|FG000|Stage 2A|Disease Progression|0|||
125005873|NCT00467779|449649839|FG001|Stage 2A|Disease Progression|0|||
125005874|NCT00467779|449649840|FG002|Stage 2A|Disease Progression|0|||
125005875|NCT00467779|449649841|FG003|Stage 2A|Disease Progression|0|||
125005876|NCT00467779|449649842|FG004|Stage 2A|Disease Progression|0|||
125005877|NCT00467779|449649843|FG005|Stage 2A|Disease Progression|0|||
125005878|NCT00467779|449649844|FG006|Stage 2A|Disease Progression|0|||
125005879|NCT00467779|449649845|FG007|Stage 2A|Disease Progression|0|||
125005880|NCT00467779|449649846|FG008|Stage 2A|Disease Progression|0|||
125005881|NCT00467779|449649847|FG009|Stage 2A|Disease Progression|0|||
125005882|NCT00467779|449649848|FG010|Stage 2A|Disease Progression|0|||
125005883|NCT00467779|449649849|FG011|Stage 2A|Disease Progression|0|||
125005884|NCT00467779|449649850|FG012|Stage 2A|Disease Progression|0|||
125005885|NCT00467779|449649851|FG013|Stage 2A|Disease Progression|10|||
125005886|NCT00467779|449649852|FG014|Stage 2A|Disease Progression|0|||
125005887|NCT00467779|449649838|FG000|Stage 2A|Unspecified Reason|0|||
125005888|NCT00467779|449649839|FG001|Stage 2A|Unspecified Reason|0|||
125005889|NCT00467779|449649840|FG002|Stage 2A|Unspecified Reason|0|||
125005890|NCT00467779|449649841|FG003|Stage 2A|Unspecified Reason|0|||
125005891|NCT00467779|449649842|FG004|Stage 2A|Unspecified Reason|0|||
125005892|NCT00467779|449649843|FG005|Stage 2A|Unspecified Reason|0|||
125005893|NCT00467779|449649844|FG006|Stage 2A|Unspecified Reason|0|||
125005894|NCT00467779|449649845|FG007|Stage 2A|Unspecified Reason|0|||
125005895|NCT00467779|449649846|FG008|Stage 2A|Unspecified Reason|0|||
125005896|NCT00467779|449649847|FG009|Stage 2A|Unspecified Reason|0|||
125005897|NCT00467779|449649848|FG010|Stage 2A|Unspecified Reason|0|||
125005898|NCT00467779|449649849|FG011|Stage 2A|Unspecified Reason|0|||
125005899|NCT00467779|449649850|FG012|Stage 2A|Unspecified Reason|0|||
125005900|NCT00467779|449649851|FG013|Stage 2A|Unspecified Reason|7|||
125005901|NCT00467779|449649852|FG014|Stage 2A|Unspecified Reason|0|||
125005902|NCT00467779|449649838|FG000|Stage 2A|Withdrawal by Subject|0|||
125005903|NCT00467779|449649839|FG001|Stage 2A|Withdrawal by Subject|0|||
125005904|NCT00467779|449649840|FG002|Stage 2A|Withdrawal by Subject|0|||
125005905|NCT00467779|449649841|FG003|Stage 2A|Withdrawal by Subject|0|||
125005906|NCT00467779|449649842|FG004|Stage 2A|Withdrawal by Subject|0|||
125005907|NCT00467779|449649843|FG005|Stage 2A|Withdrawal by Subject|0|||
125005908|NCT00467779|449649844|FG006|Stage 2A|Withdrawal by Subject|0|||
125005909|NCT00467779|449649845|FG007|Stage 2A|Withdrawal by Subject|0|||
125005910|NCT00467779|449649846|FG008|Stage 2A|Withdrawal by Subject|0|||
125005911|NCT00467779|449649847|FG009|Stage 2A|Withdrawal by Subject|0|||
125005912|NCT00467779|449649848|FG010|Stage 2A|Withdrawal by Subject|0|||
125005913|NCT00467779|449649849|FG011|Stage 2A|Withdrawal by Subject|0|||
125005914|NCT00467779|449649850|FG012|Stage 2A|Withdrawal by Subject|0|||
125005915|NCT00467779|449649851|FG013|Stage 2A|Withdrawal by Subject|1|||
125005916|NCT00467779|449649852|FG014|Stage 2A|Withdrawal by Subject|0|||
125005917|NCT00467779|449649838|FG000|Stage 3|Adverse Event|0|||
125005918|NCT00467779|449649839|FG001|Stage 3|Adverse Event|0|||
125005919|NCT00467779|449649840|FG002|Stage 3|Adverse Event|0|||
125005920|NCT00467779|449649841|FG003|Stage 3|Adverse Event|0|||
125005921|NCT00467779|449649842|FG004|Stage 3|Adverse Event|0|||
125005922|NCT00467779|449649843|FG005|Stage 3|Adverse Event|0|||
125005923|NCT00467779|449649844|FG006|Stage 3|Adverse Event|0|||
125005924|NCT00467779|449649845|FG007|Stage 3|Adverse Event|0|||
125005925|NCT00467779|449649846|FG008|Stage 3|Adverse Event|0|||
125005926|NCT00467779|449649847|FG009|Stage 3|Adverse Event|0|||
125005927|NCT00467779|449649848|FG010|Stage 3|Adverse Event|0|||
125005928|NCT00467779|449649849|FG011|Stage 3|Adverse Event|0|||
125005929|NCT00467779|449649850|FG012|Stage 3|Adverse Event|0|||
125005930|NCT00467779|449649851|FG013|Stage 3|Adverse Event|0|||
125005931|NCT00467779|449649852|FG014|Stage 3|Adverse Event|2|||
125005932|NCT00467779|449649838|FG000|Stage 3|Death|0|||
125005933|NCT00467779|449649839|FG001|Stage 3|Death|0|||
125005934|NCT00467779|449649840|FG002|Stage 3|Death|0|||
125005935|NCT00467779|449649841|FG003|Stage 3|Death|0|||
125005936|NCT00467779|449649842|FG004|Stage 3|Death|0|||
125005937|NCT00467779|449649843|FG005|Stage 3|Death|0|||
125005938|NCT00467779|449649844|FG006|Stage 3|Death|0|||
125005939|NCT00467779|449649845|FG007|Stage 3|Death|0|||
125005940|NCT00467779|449649846|FG008|Stage 3|Death|0|||
125005941|NCT00467779|449649847|FG009|Stage 3|Death|0|||
125005942|NCT00467779|449649848|FG010|Stage 3|Death|0|||
125005943|NCT00467779|449649849|FG011|Stage 3|Death|0|||
125005944|NCT00467779|449649850|FG012|Stage 3|Death|0|||
125005945|NCT00467779|449649851|FG013|Stage 3|Death|0|||
125005946|NCT00467779|449649852|FG014|Stage 3|Death|1|||
125005947|NCT00467779|449649838|FG000|Stage 3|Disease Progression|0|||
125005948|NCT00467779|449649839|FG001|Stage 3|Disease Progression|0|||
125005949|NCT00467779|449649840|FG002|Stage 3|Disease Progression|0|||
125005950|NCT00467779|449649841|FG003|Stage 3|Disease Progression|0|||
125005951|NCT00467779|449649842|FG004|Stage 3|Disease Progression|0|||
125005952|NCT00467779|449649843|FG005|Stage 3|Disease Progression|0|||
125005953|NCT00467779|449649844|FG006|Stage 3|Disease Progression|0|||
125005954|NCT00467779|449649845|FG007|Stage 3|Disease Progression|0|||
125005955|NCT00467779|449649846|FG008|Stage 3|Disease Progression|0|||
125005956|NCT00467779|449649847|FG009|Stage 3|Disease Progression|0|||
125005957|NCT00467779|449649848|FG010|Stage 3|Disease Progression|0|||
125005958|NCT00467779|449649849|FG011|Stage 3|Disease Progression|0|||
125005959|NCT00467779|449649850|FG012|Stage 3|Disease Progression|0|||
125005960|NCT00467779|449649851|FG013|Stage 3|Disease Progression|0|||
125005961|NCT00467779|449649852|FG014|Stage 3|Disease Progression|9|||
125005962|NCT00467779|449649838|FG000|Stage 3|Unspecified Reason|0|||
125005963|NCT00467779|449649839|FG001|Stage 3|Unspecified Reason|0|||
125005964|NCT00467779|449649840|FG002|Stage 3|Unspecified Reason|0|||
125005965|NCT00467779|449649841|FG003|Stage 3|Unspecified Reason|0|||
125005966|NCT00467779|449649842|FG004|Stage 3|Unspecified Reason|0|||
125005967|NCT00467779|449649843|FG005|Stage 3|Unspecified Reason|0|||
125005968|NCT00467779|449649844|FG006|Stage 3|Unspecified Reason|0|||
125005969|NCT00467779|449649845|FG007|Stage 3|Unspecified Reason|0|||
125005970|NCT00467779|449649846|FG008|Stage 3|Unspecified Reason|0|||
125005971|NCT00467779|449649847|FG009|Stage 3|Unspecified Reason|0|||
125005972|NCT00467779|449649848|FG010|Stage 3|Unspecified Reason|0|||
125005973|NCT00467779|449649849|FG011|Stage 3|Unspecified Reason|0|||
125005974|NCT00467779|449649850|FG012|Stage 3|Unspecified Reason|0|||
125005975|NCT00467779|449649851|FG013|Stage 3|Unspecified Reason|0|||
125005976|NCT00467779|449649852|FG014|Stage 3|Unspecified Reason|5|||
125005977|NCT01195090|449649853|FG000|Overall Study|Adverse Event|1|||
125005978|NCT01195090|449649854|FG001|Overall Study|Adverse Event|2|||
125005979|NCT01195090|449649853|FG000|Overall Study|Lost to Follow-up|2|||
125005980|NCT01195090|449649854|FG001|Overall Study|Lost to Follow-up|2|||
125005981|NCT01195090|449649853|FG000|Overall Study|Protocol Violation|3|||
125005982|NCT01195090|449649854|FG001|Overall Study|Protocol Violation|4|||
125005983|NCT05111041|449649857|FG000|Overall Study|Lost to Follow-up|6|||
125005984|NCT05111041|449649858|FG001|Overall Study|Lost to Follow-up|7|||
125005985|NCT05111041|449649857|FG000|Overall Study|Withdrawal by Subject|1|||
125005986|NCT05111041|449649858|FG001|Overall Study|Withdrawal by Subject|0|||
125005987|NCT01205230|449649859|FG000|Overall Study|Adverse Event|4|||
125005988|NCT01205230|449649860|FG001|Overall Study|Adverse Event|0|||
125005989|NCT01205230|449649859|FG000|Overall Study|Physician Decision|1|||
125005990|NCT01205230|449649860|FG001|Overall Study|Physician Decision|0|||
125005992|NCT00791258|449649862|FG000|Overall Study|Adverse Event|87|||
125005993|NCT00791258|449649862|FG000|Overall Study|Lost to Follow-up|18|||
125005994|NCT00791258|449649862|FG000|Overall Study|Protocol Violation|109|||
125005995|NCT00791258|449649862|FG000|Overall Study|Withdrawal by Subject|40|||
125005996|NCT00791258|449649862|FG000|Overall Study|Did not take medication for >3 days|1|||
125005997|NCT00791258|449649862|FG000|Overall Study|subject left area|2|||
125005998|NCT00791258|449649862|FG000|Overall Study|non-compliance|3|||
125005999|NCT00791258|449649862|FG000|Overall Study|Subject incarcerated|1|||
125006000|NCT00791258|449649862|FG000|Overall Study|Subject required restricted medication|1|||
125006001|NCT00791258|449649862|FG000|Overall Study|Lack of Efficacy|1|||
125006002|NCT00041080|449649863|FG000|Overall Study|Adverse Event|21|||
125006003|NCT00041080|449649864|FG001|Overall Study|Adverse Event|1|||
125006004|NCT00041080|449649863|FG000|Overall Study|Withdrawal by Subject|6|||
125006005|NCT00041080|449649864|FG001|Overall Study|Withdrawal by Subject|6|||
125006006|NCT00041080|449649863|FG000|Overall Study|Concommitant Illness/Other|1|||
125006007|NCT00041080|449649864|FG001|Overall Study|Concommitant Illness/Other|2|||
125006008|NCT00041080|449649863|FG000|Overall Study|Did not start therapy|1|||
125006009|NCT00041080|449649864|FG001|Overall Study|Did not start therapy|1|||
125006010|NCT00041080|449649863|FG000|Overall Study|Ineligible|1|||
125006011|NCT00041080|449649864|FG001|Overall Study|Ineligible|0|||
125006012|NCT04784897|449649865|FG000|Overall Study|Death|4|||
125006013|NCT04784897|449649866|FG001|Overall Study|Death|2|||
125006014|NCT04784897|449649867|FG002|Overall Study|Death|1|||
125006015|NCT04784897|449649865|FG000|Overall Study|Withdrawal by Subject|0|||
125006016|NCT04784897|449649866|FG001|Overall Study|Withdrawal by Subject|0|||
125006017|NCT04784897|449649867|FG002|Overall Study|Withdrawal by Subject|1|||
125006018|NCT04667377|449649868|FG000|Dose Escalation Period|Other not specified below|3|||
125006019|NCT04667377|449649869|FG001|Dose Escalation Period|Other not specified below|3|||
125006020|NCT04667377|449649870|FG002|Dose Escalation Period|Other not specified below|2|||
125006021|NCT04667377|449649871|FG003|Dose Escalation Period|Other not specified below|1|||
125006022|NCT04667377|449649872|FG004|Dose Escalation Period|Other not specified below|3|||
125006023|NCT04667377|449649868|FG000|Dose Escalation Period|Protocol Violation|2|||
125006024|NCT04667377|449649869|FG001|Dose Escalation Period|Protocol Violation|2|||
125006025|NCT04667377|449649870|FG002|Dose Escalation Period|Protocol Violation|0|||
125006026|NCT04667377|449649871|FG003|Dose Escalation Period|Protocol Violation|2|||
125006027|NCT04667377|449649872|FG004|Dose Escalation Period|Protocol Violation|1|||
125006028|NCT04667377|449649868|FG000|Dose Escalation Period|Burden of study procedures|2|||
125006029|NCT04667377|449649869|FG001|Dose Escalation Period|Burden of study procedures|1|||
125006030|NCT04667377|449649870|FG002|Dose Escalation Period|Burden of study procedures|1|||
125006031|NCT04667377|449649871|FG003|Dose Escalation Period|Burden of study procedures|1|||
125006032|NCT04667377|449649872|FG004|Dose Escalation Period|Burden of study procedures|5|||
125006033|NCT04667377|449649868|FG000|Dose Escalation Period|Change of residence|0|||
125093078|NCT01409382|449960079|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
125093079|NCT01409382|449960080|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
125093080|NCT01233076|449960081|FG000|Period 2, One Week|Lost to Follow-up|1|||
125093081|NCT01233076|449960082|FG001|Period 2, One Week|Lost to Follow-up|0|||
125093082|NCT01786707|449960084|FG000|Overall Study|Lost to Follow-up|1|||
125093083|NCT01786707|449960085|FG001|Overall Study|Lost to Follow-up|1|||
125006034|NCT04667377|449649869|FG001|Dose Escalation Period|Change of residence|0|||
125006035|NCT04667377|449649870|FG002|Dose Escalation Period|Change of residence|1|||
125006036|NCT04667377|449649871|FG003|Dose Escalation Period|Change of residence|0|||
125006037|NCT04667377|449649872|FG004|Dose Escalation Period|Change of residence|0|||
125006038|NCT04667377|449649868|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
125006039|NCT04667377|449649869|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
125006040|NCT04667377|449649870|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
125006041|NCT04667377|449649871|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
125006042|NCT04667377|449649872|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
125006043|NCT04667377|449649868|FG000|Dose Escalation Period|Adverse Event|9|||
125006044|NCT04667377|449649869|FG001|Dose Escalation Period|Adverse Event|10|||
125006045|NCT04667377|449649870|FG002|Dose Escalation Period|Adverse Event|12|||
125006046|NCT04667377|449649871|FG003|Dose Escalation Period|Adverse Event|17|||
125006047|NCT04667377|449649872|FG004|Dose Escalation Period|Adverse Event|3|||
125006048|NCT04667377|449649868|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
125006049|NCT04667377|449649869|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
125006050|NCT04667377|449649870|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
125006051|NCT04667377|449649871|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
125006052|NCT04667377|449649872|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
125006053|NCT04667377|449649868|FG000|Dose Escalation Period|Not treated|1|||
125006054|NCT04667377|449649869|FG001|Dose Escalation Period|Not treated|0|||
125006055|NCT04667377|449649870|FG002|Dose Escalation Period|Not treated|0|||
125006056|NCT04667377|449649871|FG003|Dose Escalation Period|Not treated|0|||
125006057|NCT04667377|449649872|FG004|Dose Escalation Period|Not treated|0|||
125006058|NCT04667377|449649868|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
125006059|NCT04667377|449649869|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
125006060|NCT04667377|449649870|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
125093084|NCT02058940|449960087|FG000|Overall Study|Discharged from Critical Care Unit|1|||
125093085|NCT01519700|449960088|FG000|Overall Study|Death|1|||
125006061|NCT04667377|449649871|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
125006062|NCT04667377|449649872|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
125093086|NCT01519700|449960089|FG001|Overall Study|Death|0|||
125093087|NCT01519700|449960090|FG002|Overall Study|Death|0|||
125093088|NCT01519700|449960091|FG003|Overall Study|Death|0|||
125093089|NCT01519700|449960088|FG000|Overall Study|Lost to Follow-up|0|||
125093090|NCT01519700|449960089|FG001|Overall Study|Lost to Follow-up|0|||
125093091|NCT01519700|449960090|FG002|Overall Study|Lost to Follow-up|1|||
125093092|NCT01519700|449960091|FG003|Overall Study|Lost to Follow-up|1|||
125093093|NCT01519700|449960088|FG000|Overall Study|Physician Decision|1|||
125093094|NCT01519700|449960089|FG001|Overall Study|Physician Decision|1|||
125093095|NCT01519700|449960090|FG002|Overall Study|Physician Decision|3|||
125093096|NCT01519700|449960091|FG003|Overall Study|Physician Decision|0|||
125093097|NCT01519700|449960088|FG000|Overall Study|Withdrawal by Subject|5|||
125093098|NCT01519700|449960089|FG001|Overall Study|Withdrawal by Subject|3|||
125093099|NCT01519700|449960090|FG002|Overall Study|Withdrawal by Subject|3|||
125093100|NCT01519700|449960091|FG003|Overall Study|Withdrawal by Subject|2|||
125093101|NCT01519700|449960088|FG000|Overall Study|Other Reason|2|||
125093102|NCT01519700|449960089|FG001|Overall Study|Other Reason|2|||
125093103|NCT01519700|449960090|FG002|Overall Study|Other Reason|0|||
125093104|NCT01519700|449960091|FG003|Overall Study|Other Reason|4|||
125093105|NCT01789476|449960097|FG000|Overall Study|Lack of Efficacy|6|||
125093106|NCT01789476|449960098|FG001|Overall Study|Lack of Efficacy|2|||
125093107|NCT01789476|449960097|FG000|Overall Study|Adverse Event|1|||
125093108|NCT01789476|449960098|FG001|Overall Study|Adverse Event|0|||
125093109|NCT01789476|449960097|FG000|Overall Study|Unable to get IV access|1|||
125093110|NCT01789476|449960098|FG001|Overall Study|Unable to get IV access|0|||
125093111|NCT00965458|449960099|FG000|Overall Study|Adverse Event|1|||
125093112|NCT00965458|449960100|FG001|Overall Study|Adverse Event|0|||
125093113|NCT00965458|449960099|FG000|Overall Study|Lost to Follow-up|1|||
125093114|NCT00965458|449960100|FG001|Overall Study|Lost to Follow-up|3|||
125093115|NCT00965458|449960099|FG000|Overall Study|Withdrawal by Subject|0|||
125093116|NCT00965458|449960100|FG001|Overall Study|Withdrawal by Subject|1|||
125093117|NCT04177862|449960107|FG000|Overall Study|Protocol Violation|2|||
125093118|NCT04177862|449960108|FG001|Overall Study|Protocol Violation|7|||
125093119|NCT00379639|449960109|FG000|Overall Study|Disease Progression|3|||
125093120|NCT00379639|449960110|FG001|Overall Study|Disease Progression|3|||
125093121|NCT00379639|449960111|FG002|Overall Study|Disease Progression|3|||
125093122|NCT00379639|449960112|FG003|Overall Study|Disease Progression|4|||
125093123|NCT00379639|449960113|FG004|Overall Study|Disease Progression|4|||
125093124|NCT00379639|449960109|FG000|Overall Study|Physician Decision|0|||
125093125|NCT00379639|449960110|FG001|Overall Study|Physician Decision|2|||
125093126|NCT00379639|449960111|FG002|Overall Study|Physician Decision|1|||
125093127|NCT00379639|449960112|FG003|Overall Study|Physician Decision|1|||
125093128|NCT00379639|449960113|FG004|Overall Study|Physician Decision|0|||
125093129|NCT00379639|449960109|FG000|Overall Study|Symptomatic Deterioration|0|||
125093130|NCT00379639|449960110|FG001|Overall Study|Symptomatic Deterioration|0|||
125093131|NCT00379639|449960111|FG002|Overall Study|Symptomatic Deterioration|1|||
125093132|NCT00379639|449960112|FG003|Overall Study|Symptomatic Deterioration|0|||
125093133|NCT00379639|449960113|FG004|Overall Study|Symptomatic Deterioration|1|||
125093134|NCT00379639|449960109|FG000|Overall Study|Adverse Event|0|||
125093135|NCT00379639|449960110|FG001|Overall Study|Adverse Event|0|||
125093136|NCT00379639|449960111|FG002|Overall Study|Adverse Event|1|||
125093137|NCT00379639|449960112|FG003|Overall Study|Adverse Event|0|||
125093138|NCT00379639|449960113|FG004|Overall Study|Adverse Event|1|||
125006063|NCT04667377|449649868|FG000|Dose Escalation Period|Lost to Follow-up|0|||
125006064|NCT04667377|449649869|FG001|Dose Escalation Period|Lost to Follow-up|1|||
125006065|NCT04667377|449649870|FG002|Dose Escalation Period|Lost to Follow-up|0|||
125006066|NCT04667377|449649871|FG003|Dose Escalation Period|Lost to Follow-up|0|||
125006067|NCT04667377|449649872|FG004|Dose Escalation Period|Lost to Follow-up|0|||
125006068|NCT04667377|449649868|FG000|Maintenance Period|Perceived lack of efficacy|0|||
125006069|NCT04667377|449649869|FG001|Maintenance Period|Perceived lack of efficacy|2|||
125006070|NCT04667377|449649870|FG002|Maintenance Period|Perceived lack of efficacy|1|||
125006071|NCT04667377|449649871|FG003|Maintenance Period|Perceived lack of efficacy|0|||
125006072|NCT04667377|449649872|FG004|Maintenance Period|Perceived lack of efficacy|1|||
125006073|NCT04667377|449649868|FG000|Maintenance Period|Adverse Event|2|||
125006074|NCT04667377|449649869|FG001|Maintenance Period|Adverse Event|8|||
125006075|NCT04667377|449649870|FG002|Maintenance Period|Adverse Event|5|||
125006076|NCT04667377|449649871|FG003|Maintenance Period|Adverse Event|4|||
125006077|NCT04667377|449649872|FG004|Maintenance Period|Adverse Event|1|||
125006078|NCT04667377|449649868|FG000|Maintenance Period|Adverse event: COVID infection|0|||
125006079|NCT04667377|449649869|FG001|Maintenance Period|Adverse event: COVID infection|1|||
125006080|NCT04667377|449649870|FG002|Maintenance Period|Adverse event: COVID infection|0|||
125006081|NCT04667377|449649871|FG003|Maintenance Period|Adverse event: COVID infection|0|||
125006082|NCT04667377|449649872|FG004|Maintenance Period|Adverse event: COVID infection|0|||
125006083|NCT04667377|449649868|FG000|Maintenance Period|COVID-related|0|||
125006084|NCT04667377|449649869|FG001|Maintenance Period|COVID-related|0|||
125006085|NCT04667377|449649870|FG002|Maintenance Period|COVID-related|1|||
125006086|NCT04667377|449649871|FG003|Maintenance Period|COVID-related|1|||
125006087|NCT04667377|449649872|FG004|Maintenance Period|COVID-related|0|||
125006088|NCT04667377|449649868|FG000|Maintenance Period|Protocol Violation|1|||
125006089|NCT04667377|449649869|FG001|Maintenance Period|Protocol Violation|0|||
125006090|NCT04667377|449649870|FG002|Maintenance Period|Protocol Violation|0|||
125006091|NCT04667377|449649871|FG003|Maintenance Period|Protocol Violation|0|||
125006092|NCT04667377|449649872|FG004|Maintenance Period|Protocol Violation|1|||
125006093|NCT04667377|449649868|FG000|Maintenance Period|Burden of study procedures|1|||
125006094|NCT04667377|449649869|FG001|Maintenance Period|Burden of study procedures|2|||
125006095|NCT04667377|449649870|FG002|Maintenance Period|Burden of study procedures|0|||
125006096|NCT04667377|449649871|FG003|Maintenance Period|Burden of study procedures|1|||
125006097|NCT04667377|449649872|FG004|Maintenance Period|Burden of study procedures|0|||
125006098|NCT04667377|449649868|FG000|Maintenance Period|Change of residence|0|||
125006099|NCT04667377|449649869|FG001|Maintenance Period|Change of residence|1|||
125006100|NCT04667377|449649870|FG002|Maintenance Period|Change of residence|0|||
125006101|NCT04667377|449649871|FG003|Maintenance Period|Change of residence|0|||
125006102|NCT04667377|449649872|FG004|Maintenance Period|Change of residence|1|||
125006103|NCT04667377|449649868|FG000|Maintenance Period|Missing|1|||
125006104|NCT04667377|449649869|FG001|Maintenance Period|Missing|0|||
125006105|NCT04667377|449649870|FG002|Maintenance Period|Missing|0|||
125006106|NCT04667377|449649871|FG003|Maintenance Period|Missing|0|||
125006107|NCT04667377|449649872|FG004|Maintenance Period|Missing|0|||
125006108|NCT04667377|449649868|FG000|Maintenance Period|Other than listed above|2|||
125006109|NCT04667377|449649869|FG001|Maintenance Period|Other than listed above|0|||
125006110|NCT04667377|449649870|FG002|Maintenance Period|Other than listed above|3|||
125006111|NCT04667377|449649871|FG003|Maintenance Period|Other than listed above|2|||
125006112|NCT04667377|449649872|FG004|Maintenance Period|Other than listed above|6|||
125093139|NCT00379639|449960109|FG000|Overall Study|Lost to Follow-up|0|||
125093140|NCT00379639|449960110|FG001|Overall Study|Lost to Follow-up|0|||
125093141|NCT00379639|449960111|FG002|Overall Study|Lost to Follow-up|0|||
125093142|NCT00379639|449960112|FG003|Overall Study|Lost to Follow-up|1|||
125093143|NCT00379639|449960113|FG004|Overall Study|Lost to Follow-up|0|||
125093144|NCT00379639|449960109|FG000|Overall Study|Other|0|||
125093145|NCT00379639|449960110|FG001|Overall Study|Other|0|||
125093146|NCT00379639|449960111|FG002|Overall Study|Other|3|||
125093147|NCT00379639|449960112|FG003|Overall Study|Other|0|||
125093148|NCT00379639|449960113|FG004|Overall Study|Other|0|||
125093149|NCT00594958|449960114|FG000|Overall Study|Withdrawal by Subject|1|||
125093150|NCT00594958|449960115|FG001|Overall Study|Withdrawal by Subject|0|||
125093151|NCT00594958|449960116|FG002|Overall Study|Withdrawal by Subject|1|||
125093152|NCT00594958|449960114|FG000|Overall Study|Adverse Event|4|||
125093153|NCT00594958|449960115|FG001|Overall Study|Adverse Event|1|||
125093154|NCT00594958|449960116|FG002|Overall Study|Adverse Event|2|||
125093155|NCT00594958|449960114|FG000|Overall Study|Pregnancy|0|||
125093156|NCT00594958|449960115|FG001|Overall Study|Pregnancy|2|||
125093157|NCT00594958|449960116|FG002|Overall Study|Pregnancy|0|||
125006113|NCT04667377|449649868|FG000|Maintenance Period|Withdrawal by Subject|0|||
125006114|NCT04667377|449649869|FG001|Maintenance Period|Withdrawal by Subject|1|||
125006115|NCT04667377|449649870|FG002|Maintenance Period|Withdrawal by Subject|0|||
125006116|NCT04667377|449649871|FG003|Maintenance Period|Withdrawal by Subject|0|||
125006117|NCT04667377|449649872|FG004|Maintenance Period|Withdrawal by Subject|0|||
125006118|NCT04667377|449649868|FG000|Maintenance Period|Lost to Follow-up|1|||
125006119|NCT04667377|449649869|FG001|Maintenance Period|Lost to Follow-up|0|||
125006120|NCT04667377|449649870|FG002|Maintenance Period|Lost to Follow-up|1|||
125006121|NCT04667377|449649871|FG003|Maintenance Period|Lost to Follow-up|0|||
125006122|NCT04667377|449649872|FG004|Maintenance Period|Lost to Follow-up|1|||
125006123|NCT02428855|449649873|FG000|Overall Study|Withdrawal by Subject|2|||
125006124|NCT02066311|449649874|FG000|Overall Study|Adverse Event|4|||
125006125|NCT02066311|449649874|FG000|Overall Study|Withdrawal by Subject|1|||
125006126|NCT03198520|449649881|FG000|Overall Study|Physician Decision|2|||
125006127|NCT03198520|449649881|FG000|Overall Study|Protocol Violation|2|||
125006128|NCT03198520|449649881|FG000|Overall Study|Withdrawal by Subject|1|||
125006129|NCT03198520|449649881|FG000|Overall Study|Study Ended|1|||
125006130|NCT01670539|449649882|FG000|Overall Study|Death|3|||
125006131|NCT01670539|449649883|FG001|Overall Study|Death|5|||
125006132|NCT01670539|449649882|FG000|Overall Study|Withdrawal by Subject|3|||
125006133|NCT01670539|449649883|FG001|Overall Study|Withdrawal by Subject|0|||
125006134|NCT04353596|449649884|FG000|Overall Study|Protocol Violation|4|||
125006135|NCT04353596|449649885|FG001|Overall Study|Protocol Violation|4|||
125006136|NCT04353596|449649884|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
125006137|NCT04353596|449649885|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
125006138|NCT05418673|449649886|FG000|Overall Study|Study Terminated by Sponsor|2|||
125006139|NCT05418673|449649887|FG001|Overall Study|Study Terminated by Sponsor|4|||
125006140|NCT05418673|449649886|FG000|Overall Study|Lost to Follow-up|1|||
125006141|NCT05418673|449649887|FG001|Overall Study|Lost to Follow-up|0|||
125006142|NCT02665052|449649888|FG000|Overall Study|Lost to Follow-up|1|||
125006143|NCT02665052|449649889|FG001|Overall Study|Lost to Follow-up|0|||
125006144|NCT02665052|449649890|FG002|Overall Study|Lost to Follow-up|0|||
125006145|NCT02665052|449649891|FG003|Overall Study|Lost to Follow-up|0|||
125006146|NCT02665052|449649888|FG000|Overall Study|Withdrawal by Subject|1|||
125006147|NCT02665052|449649889|FG001|Overall Study|Withdrawal by Subject|1|||
125006148|NCT02665052|449649890|FG002|Overall Study|Withdrawal by Subject|0|||
125006149|NCT02665052|449649891|FG003|Overall Study|Withdrawal by Subject|5|||
125006150|NCT02665052|449649888|FG000|Overall Study|Adverse Event|1|||
125006151|NCT02665052|449649889|FG001|Overall Study|Adverse Event|1|||
125006152|NCT02665052|449649890|FG002|Overall Study|Adverse Event|0|||
125006153|NCT02665052|449649891|FG003|Overall Study|Adverse Event|0|||
125006154|NCT00823823|449649892|FG000|Overall Study|Lost to Follow-up|3|||
125006155|NCT00823823|449649893|FG001|Overall Study|Lost to Follow-up|1|||
125006156|NCT00823823|449649892|FG000|Overall Study|Protocol Violation|5|||
125006157|NCT00823823|449649893|FG001|Overall Study|Protocol Violation|5|||
125006158|NCT04422990|449649898|FG000|Overall Study|Withdrawal by Subject|0|||
125006159|NCT04422990|449649899|FG001|Overall Study|Withdrawal by Subject|1|||
125006160|NCT04422990|449649898|FG000|Overall Study|Travel|3|||
125093158|NCT00594958|449960114|FG000|Overall Study|Protocol Violation|1|||
125006161|NCT04422990|449649899|FG001|Overall Study|Travel|0|||
125006162|NCT01490814|449649900|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
125006163|NCT01490814|449649901|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
125006164|NCT01490814|449649900|FG000|Overall Study|Physician Decision|1|||
125093159|NCT00594958|449960115|FG001|Overall Study|Protocol Violation|0|||
125093160|NCT00594958|449960116|FG002|Overall Study|Protocol Violation|2|||
125093161|NCT00594958|449960114|FG000|Overall Study|Lost to Follow-up|5|||
125093162|NCT00594958|449960115|FG001|Overall Study|Lost to Follow-up|0|||
125093163|NCT00594958|449960116|FG002|Overall Study|Lost to Follow-up|3|||
125006165|NCT01490814|449649901|FG001|Overall Study|Physician Decision|0|||
125093164|NCT00594958|449960114|FG000|Overall Study|administrative|3|||
125093165|NCT00594958|449960115|FG001|Overall Study|administrative|0|||
125093166|NCT00594958|449960116|FG002|Overall Study|administrative|2|||
125093167|NCT05637515|449960117|FG000|Overall Study|Withdrawal by Subject|17|||
125093168|NCT05637515|449960118|FG001|Overall Study|Withdrawal by Subject|17|||
125093169|NCT03233009|449960119|FG000|Overall Study|Lost to Follow-up|1|||
125093170|NCT00278473|449960121|FG000|Overall Study|drop out|4|||
125093171|NCT00278473|449960122|FG001|Overall Study|drop out|3|||
125093172|NCT03039686|449960123|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
125093173|NCT03039686|449960124|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
125093174|NCT03039686|449960125|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
125093175|NCT03039686|449960123|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
125093176|NCT03039686|449960124|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
125093177|NCT03039686|449960125|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
125093178|NCT03039686|449960123|FG000|Double-blind Period|Withdrawal by Subject|2|||
125093179|NCT03039686|449960124|FG001|Double-blind Period|Withdrawal by Subject|2|||
125093180|NCT03039686|449960125|FG002|Double-blind Period|Withdrawal by Subject|1|||
125093181|NCT03039686|449960123|FG000|Double-blind Period|Death|0|||
125093182|NCT03039686|449960124|FG001|Double-blind Period|Death|0|||
125093183|NCT03039686|449960125|FG002|Double-blind Period|Death|1|||
125093184|NCT03039686|449960123|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
125093185|NCT03039686|449960124|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
125093186|NCT03039686|449960125|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
125093187|NCT03039686|449960123|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
125093188|NCT03039686|449960124|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
125093189|NCT03039686|449960125|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
125093190|NCT03039686|449960123|FG000|Open Label Period|Withdrawal by Subject|0|||
125093191|NCT03039686|449960124|FG001|Open Label Period|Withdrawal by Subject|3|||
125093192|NCT03039686|449960125|FG002|Open Label Period|Withdrawal by Subject|1|||
125093193|NCT02158949|449960126|FG000|Overall Study|Withdrawal by Subject|1|||
125093194|NCT02158949|449960127|FG001|Overall Study|Withdrawal by Subject|0|||
125093195|NCT02158949|449960126|FG000|Overall Study|Lost to Follow-up|5|||
125093196|NCT02158949|449960127|FG001|Overall Study|Lost to Follow-up|11|||
125093197|NCT02322866|449960128|FG000|Overall Study|Adverse Event|6|||
125093198|NCT02322866|449960129|FG001|Overall Study|Adverse Event|11|||
125093199|NCT02322866|449960128|FG000|Overall Study|Withdrawal of Consent|16|||
125093200|NCT02322866|449960129|FG001|Overall Study|Withdrawal of Consent|25|||
125093201|NCT02322866|449960128|FG000|Overall Study|Lost to Follow-up|36|||
125093202|NCT02322866|449960129|FG001|Overall Study|Lost to Follow-up|39|||
125093203|NCT02322866|449960128|FG000|Overall Study|Protocol Violation|1|||
125093204|NCT02322866|449960129|FG001|Overall Study|Protocol Violation|0|||
125093205|NCT02322866|449960128|FG000|Overall Study|Noncompliance with Treatment|3|||
125093206|NCT02322866|449960129|FG001|Overall Study|Noncompliance with Treatment|4|||
125093207|NCT02322866|449960128|FG000|Overall Study|Lack of Efficacy|3|||
125093208|NCT02322866|449960129|FG001|Overall Study|Lack of Efficacy|1|||
125093209|NCT02322866|449960128|FG000|Overall Study|Other Miscellaneous Reasons|6|||
125093210|NCT02322866|449960129|FG001|Overall Study|Other Miscellaneous Reasons|6|||
125093211|NCT00656136|449960136|FG000|Overall Study|Progressive disease|177|||
125093212|NCT00656136|449960137|FG001|Overall Study|Progressive disease|322|||
125093213|NCT00656136|449960136|FG000|Overall Study|Other Adverse Event|5|||
125093214|NCT00656136|449960137|FG001|Overall Study|Other Adverse Event|51|||
125093215|NCT00656136|449960136|FG000|Overall Study|Protocol Violation|2|||
125093216|NCT00656136|449960137|FG001|Overall Study|Protocol Violation|3|||
125093217|NCT00656136|449960136|FG000|Overall Study|Patient refused to take study medication|7|||
125093218|NCT00656136|449960137|FG001|Overall Study|Patient refused to take study medication|10|||
125093219|NCT00656136|449960136|FG000|Overall Study|Unknown and others|4|||
125093220|NCT00656136|449960137|FG001|Overall Study|Unknown and others|4|||
125093221|NCT02505945|449960138|FG000|Overall Study|Withdrawal by Subject|13|||
125093222|NCT02505945|449960139|FG001|Overall Study|Withdrawal by Subject|2|||
125093223|NCT02505945|449960138|FG000|Overall Study|Adverse Event|1|||
125093224|NCT02505945|449960139|FG001|Overall Study|Adverse Event|0|||
125093225|NCT02505945|449960138|FG000|Overall Study|Physician Decision|2|||
125093226|NCT02505945|449960139|FG001|Overall Study|Physician Decision|1|||
125093227|NCT02505945|449960138|FG000|Overall Study|Lost to Follow-up|6|||
125093228|NCT02505945|449960139|FG001|Overall Study|Lost to Follow-up|1|||
125093229|NCT00635804|449960140|FG000|Overall Study|Adverse Event|0|||
125093230|NCT00635804|449960141|FG001|Overall Study|Adverse Event|0|||
125093231|NCT00635804|449960142|FG002|Overall Study|Adverse Event|0|||
125093232|NCT00635804|449960143|FG003|Overall Study|Adverse Event|0|||
125093233|NCT00635804|449960144|FG004|Overall Study|Adverse Event|0|||
125006166|NCT01490814|449649900|FG000|Overall Study|Withdrawal by Subject|0|||
125006167|NCT01490814|449649901|FG001|Overall Study|Withdrawal by Subject|5|||
125006168|NCT03024970|449649908|FG000|First Intervention|Adverse Event|1|||
125006169|NCT03024970|449649909|FG001|First Intervention|Adverse Event|0|||
125006170|NCT03024970|449649908|FG000|Second Intervention|Lost to Follow-up|1|||
125006171|NCT03024970|449649909|FG001|Second Intervention|Lost to Follow-up|0|||
125006172|NCT01221727|449649913|FG000|Overall Study|Physician Decision|2|||
125006173|NCT01221727|449649914|FG001|Overall Study|Physician Decision|0|||
125006174|NCT01221727|449649913|FG000|Overall Study|Withdrawal by Subject|1|||
125006175|NCT01221727|449649914|FG001|Overall Study|Withdrawal by Subject|1|||
125006176|NCT02790138|449649915|FG000|Overall Study|Adverse Event|5|||
125006177|NCT02790138|449649916|FG001|Overall Study|Adverse Event|2|||
125006178|NCT02790138|449649915|FG000|Overall Study|Significant Protocol Deviation|0|||
125006179|NCT02790138|449649916|FG001|Overall Study|Significant Protocol Deviation|1|||
125006180|NCT02790138|449649915|FG000|Overall Study|Lost to Follow-up|1|||
125006181|NCT02790138|449649916|FG001|Overall Study|Lost to Follow-up|0|||
125006182|NCT02790138|449649915|FG000|Overall Study|Voluntary Withdrawal|8|||
125006183|NCT02790138|449649916|FG001|Overall Study|Voluntary Withdrawal|9|||
125006184|NCT02790138|449649915|FG000|Overall Study|Lack of Efficacy|6|||
125006185|NCT02790138|449649916|FG001|Overall Study|Lack of Efficacy|7|||
125006186|NCT02790138|449649915|FG000|Overall Study|Reason not Specified|1|||
125006187|NCT02790138|449649916|FG001|Overall Study|Reason not Specified|0|||
125006188|NCT01786603|449649917|FG000|Overall Study|Death|5|||
125006189|NCT01786603|449649918|FG001|Overall Study|Death|1|||
125006190|NCT01786603|449649917|FG000|Overall Study|Adverse Event|6|||
125006191|NCT01786603|449649918|FG001|Overall Study|Adverse Event|2|||
125006192|NCT01786603|449649917|FG000|Overall Study|Physician decision to withdraw|6|||
125006193|NCT01786603|449649918|FG001|Overall Study|Physician decision to withdraw|7|||
125006194|NCT01786603|449649917|FG000|Overall Study|Lost to Follow-up|1|||
125006195|NCT01786603|449649918|FG001|Overall Study|Lost to Follow-up|2|||
125006196|NCT01226459|449649919|FG000|Overall Study|Adverse Event|2|||
125006197|NCT01226459|449649920|FG001|Overall Study|Adverse Event|8|||
125006198|NCT01226459|449649919|FG000|Overall Study|Protocol Violation|4|||
125006199|NCT01226459|449649920|FG001|Overall Study|Protocol Violation|3|||
125006200|NCT01226459|449649919|FG000|Overall Study|Withdrawal by Subject|10|||
125006201|NCT01226459|449649920|FG001|Overall Study|Withdrawal by Subject|13|||
125006202|NCT01226459|449649919|FG000|Overall Study|Lost to Follow-up|4|||
125006203|NCT01226459|449649920|FG001|Overall Study|Lost to Follow-up|8|||
125006204|NCT01226459|449649919|FG000|Overall Study|Pregnancy|1|||
125006205|NCT01226459|449649920|FG001|Overall Study|Pregnancy|0|||
125006206|NCT00474708|449649921|FG000|Overall Study|Lack of Efficacy|11|||
125006207|NCT00474708|449649922|FG001|Overall Study|Lack of Efficacy|5|||
125006208|NCT00474708|449649921|FG000|Overall Study|Suicide ideation/behavior|0|||
125006209|NCT00474708|449649922|FG001|Overall Study|Suicide ideation/behavior|1|||
125006210|NCT00474708|449649921|FG000|Overall Study|Withdrawal by Subject|7|||
125006211|NCT00474708|449649922|FG001|Overall Study|Withdrawal by Subject|0|||
125006212|NCT00474708|449649921|FG000|Overall Study|Lack of compliance|12|||
125006213|NCT00474708|449649922|FG001|Overall Study|Lack of compliance|4|||
125006214|NCT00474708|449649921|FG000|Overall Study|Lost to Follow-up|18|||
125006215|NCT00474708|449649922|FG001|Overall Study|Lost to Follow-up|9|||
125006216|NCT00474708|449649921|FG000|Overall Study|Physician Decision|9|||
125006217|NCT00474708|449649922|FG001|Overall Study|Physician Decision|6|||
125006218|NCT03700320|449649926|FG000|Overall Study|Adverse Event|5|||
125006219|NCT03700320|449649927|FG001|Overall Study|Adverse Event|31|||
125006220|NCT03700320|449649926|FG000|Overall Study|Lack of Efficacy|2|||
125006221|NCT03700320|449649927|FG001|Overall Study|Lack of Efficacy|5|||
125006222|NCT03700320|449649926|FG000|Overall Study|Withdrawal by Subject|29|||
125006223|NCT03700320|449649927|FG001|Overall Study|Withdrawal by Subject|75|||
125006224|NCT03700320|449649926|FG000|Overall Study|Lost to Follow-up|16|||
125006225|NCT03700320|449649927|FG001|Overall Study|Lost to Follow-up|23|||
125006226|NCT03700320|449649926|FG000|Overall Study|Pregnancy|2|||
125006227|NCT03700320|449649927|FG001|Overall Study|Pregnancy|4|||
125006228|NCT03700320|449649926|FG000|Overall Study|Protocol Deviation|7|||
125006229|NCT03700320|449649927|FG001|Overall Study|Protocol Deviation|31|||
125006230|NCT03700320|449649926|FG000|Overall Study|Non-compliance with Study Drug|1|||
125006231|NCT03700320|449649927|FG001|Overall Study|Non-compliance with Study Drug|3|||
125006232|NCT03700320|449649926|FG000|Overall Study|Reason not Specified|0|||
125006233|NCT03700320|449649927|FG001|Overall Study|Reason not Specified|1|||
125006234|NCT00175877|449649928|FG000|Overall Study|Adverse Event|136|||
125006235|NCT00175877|449649928|FG000|Overall Study|Withdrawal by Subject|141|||
125006236|NCT00175877|449649928|FG000|Overall Study|Lost to Follow-up|9|||
125006237|NCT00175877|449649928|FG000|Overall Study|Lack of Efficacy|26|||
125006238|NCT00175877|449649928|FG000|Overall Study|Protocol Violation|15|||
125006239|NCT00175877|449649928|FG000|Overall Study|Other Reason|20|||
125006240|NCT00175877|449649928|FG000|Overall Study|AE & Other|1|||
125006241|NCT00175877|449649928|FG000|Overall Study|Withdrawal by subject & Other|1|||
125006242|NCT01092143|449649931|FG000|Overall Study|Adverse Event|10|||
125006243|NCT01092143|449649932|FG001|Overall Study|Adverse Event|5|||
125006244|NCT01092143|449649933|FG002|Overall Study|Adverse Event|1|||
125006245|NCT01092143|449649934|FG003|Overall Study|Adverse Event|4|||
125006246|NCT01092143|449649935|FG004|Overall Study|Adverse Event|3|||
125006247|NCT01092143|449649931|FG000|Overall Study|Lost to Follow-up|1|||
125006248|NCT01092143|449649932|FG001|Overall Study|Lost to Follow-up|0|||
125006249|NCT01092143|449649933|FG002|Overall Study|Lost to Follow-up|1|||
125006250|NCT01092143|449649934|FG003|Overall Study|Lost to Follow-up|0|||
125006251|NCT01092143|449649935|FG004|Overall Study|Lost to Follow-up|0|||
125006252|NCT01092143|449649931|FG000|Overall Study|Consent withdrawn|2|||
125006253|NCT01092143|449649932|FG001|Overall Study|Consent withdrawn|1|||
125006254|NCT01092143|449649933|FG002|Overall Study|Consent withdrawn|0|||
125006255|NCT01092143|449649934|FG003|Overall Study|Consent withdrawn|1|||
125006256|NCT01092143|449649935|FG004|Overall Study|Consent withdrawn|3|||
125093234|NCT00635804|449960145|FG005|Overall Study|Adverse Event|1|||
125093235|NCT00635804|449960146|FG006|Overall Study|Adverse Event|0|||
125093236|NCT00635804|449960147|FG007|Overall Study|Adverse Event|0|||
125093237|NCT00635804|449960140|FG000|Overall Study|Withdrawal by Subject|1|||
125093238|NCT00635804|449960141|FG001|Overall Study|Withdrawal by Subject|0|||
125093239|NCT00635804|449960142|FG002|Overall Study|Withdrawal by Subject|0|||
125093240|NCT00635804|449960143|FG003|Overall Study|Withdrawal by Subject|0|||
125093241|NCT00635804|449960144|FG004|Overall Study|Withdrawal by Subject|0|||
125093242|NCT00635804|449960145|FG005|Overall Study|Withdrawal by Subject|0|||
125093243|NCT00635804|449960146|FG006|Overall Study|Withdrawal by Subject|0|||
125093244|NCT00635804|449960147|FG007|Overall Study|Withdrawal by Subject|0|||
125093245|NCT01097057|449960148|FG000|Overall Study|Physician Decision|3|||
125093246|NCT01101321|449960149|FG000|Period 1|Withdrawal by Subject|1|||
125093247|NCT01101321|449960150|FG001|Period 1|Withdrawal by Subject|1|||
125093248|NCT01101321|449960149|FG000|Period 1|Adverse Event|3|||
125093249|NCT01101321|449960150|FG001|Period 1|Adverse Event|3|||
125093250|NCT01270139|449960151|FG000|Overall Study|Adverse Event|8|||
125093251|NCT01270139|449960152|FG001|Overall Study|Adverse Event|17|||
125093252|NCT01270139|449960153|FG002|Overall Study|Adverse Event|18|||
125093253|NCT01270139|449960151|FG000|Overall Study|Lost to Follow-up|10|||
125093254|NCT01270139|449960152|FG001|Overall Study|Lost to Follow-up|9|||
125093255|NCT01270139|449960153|FG002|Overall Study|Lost to Follow-up|2|||
125093256|NCT02452320|449960154|FG000|Overall Study|Adverse Event|0|||
125093257|NCT02452320|449960155|FG001|Overall Study|Adverse Event|1|||
125093258|NCT03198559|449960156|FG000|Overall Study|Adverse Event|2|||
125093259|NCT01072175|449960157|FG000|Part A (Drug-Drug Interaction)|Death|1|||
125093260|NCT01072175|449960158|FG001|Part A (Drug-Drug Interaction)|Death|0|||
125093261|NCT01072175|449960159|FG002|Part A (Drug-Drug Interaction)|Death|0|||
125093262|NCT01072175|449960160|FG003|Part A (Drug-Drug Interaction)|Death|0|||
125093263|NCT01072175|449960161|FG004|Part A (Drug-Drug Interaction)|Death|0|||
125093264|NCT01072175|449960162|FG005|Part A (Drug-Drug Interaction)|Death|0|||
125093265|NCT01072175|449960163|FG006|Part A (Drug-Drug Interaction)|Death|0|||
125093266|NCT01072175|449960164|FG007|Part A (Drug-Drug Interaction)|Death|0|||
125093267|NCT01072175|449960165|FG008|Part A (Drug-Drug Interaction)|Death|0|||
125093268|NCT01072175|449960166|FG009|Part A (Drug-Drug Interaction)|Death|0|||
125093269|NCT01072175|449960167|FG010|Part A (Drug-Drug Interaction)|Death|0|||
125093270|NCT01072175|449960168|FG011|Part A (Drug-Drug Interaction)|Death|0|||
125093271|NCT01072175|449960169|FG012|Part A (Drug-Drug Interaction)|Death|0|||
125093272|NCT01072175|449960157|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
125093273|NCT01072175|449960158|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125093274|NCT01072175|449960159|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125093275|NCT01072175|449960160|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125093276|NCT01072175|449960161|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125006257|NCT01092143|449649931|FG000|Overall Study|Not treated|0|||
125006258|NCT01092143|449649932|FG001|Overall Study|Not treated|0|||
125006259|NCT01092143|449649933|FG002|Overall Study|Not treated|1|||
125006260|NCT01092143|449649934|FG003|Overall Study|Not treated|0|||
125006261|NCT01092143|449649935|FG004|Overall Study|Not treated|0|||
125006262|NCT01092143|449649931|FG000|Overall Study|did not reversibility criteria|0|||
125006263|NCT01092143|449649932|FG001|Overall Study|did not reversibility criteria|0|||
125006264|NCT01092143|449649933|FG002|Overall Study|did not reversibility criteria|1|||
125006265|NCT01092143|449649934|FG003|Overall Study|did not reversibility criteria|0|||
125006266|NCT01092143|449649935|FG004|Overall Study|did not reversibility criteria|0|||
125006267|NCT01092143|449649931|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
125006268|NCT01092143|449649932|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
125006269|NCT01092143|449649933|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
125006270|NCT01092143|449649934|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
125006271|NCT01092143|449649935|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
125006272|NCT01092143|449649931|FG000|Overall Study|Ineligible patient|1|||
125006273|NCT01092143|449649932|FG001|Overall Study|Ineligible patient|0|||
125006274|NCT01092143|449649933|FG002|Overall Study|Ineligible patient|0|||
125006275|NCT01092143|449649934|FG003|Overall Study|Ineligible patient|0|||
125006276|NCT01092143|449649935|FG004|Overall Study|Ineligible patient|0|||
125006277|NCT01092143|449649931|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
125006278|NCT01092143|449649932|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
125006279|NCT01092143|449649933|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
125006280|NCT01092143|449649934|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
125006281|NCT01092143|449649935|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
125006282|NCT01092143|449649931|FG000|Overall Study|Patient travel|0|||
125006283|NCT01092143|449649932|FG001|Overall Study|Patient travel|0|||
125006284|NCT01092143|449649933|FG002|Overall Study|Patient travel|0|||
125006285|NCT01092143|449649934|FG003|Overall Study|Patient travel|0|||
125006286|NCT01092143|449649935|FG004|Overall Study|Patient travel|1|||
125006287|NCT01092143|449649931|FG000|Overall Study|Non compliance with study medication|0|||
125006288|NCT01092143|449649932|FG001|Overall Study|Non compliance with study medication|0|||
125093277|NCT01072175|449960162|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125006289|NCT01092143|449649933|FG002|Overall Study|Non compliance with study medication|0|||
125006290|NCT01092143|449649934|FG003|Overall Study|Non compliance with study medication|0|||
125093278|NCT01072175|449960163|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125093279|NCT01072175|449960164|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125093280|NCT01072175|449960165|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125093281|NCT01072175|449960166|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125093282|NCT01072175|449960167|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125093283|NCT01072175|449960168|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125093284|NCT01072175|449960169|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125093285|NCT01072175|449960157|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
125093286|NCT01072175|449960158|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125093287|NCT01072175|449960159|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125093288|NCT01072175|449960160|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125093289|NCT01072175|449960161|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125006291|NCT01092143|449649935|FG004|Overall Study|Non compliance with study medication|1|||
125006292|NCT01092143|449649931|FG000|Overall Study|Randomized by mistake|0|||
125006293|NCT01092143|449649932|FG001|Overall Study|Randomized by mistake|0|||
125006294|NCT01092143|449649933|FG002|Overall Study|Randomized by mistake|0|||
125006295|NCT01092143|449649934|FG003|Overall Study|Randomized by mistake|1|||
125006296|NCT01092143|449649935|FG004|Overall Study|Randomized by mistake|0|||
125006297|NCT01092143|449649931|FG000|Overall Study|Pregnancy|0|||
125006298|NCT01092143|449649932|FG001|Overall Study|Pregnancy|0|||
125006299|NCT01092143|449649933|FG002|Overall Study|Pregnancy|0|||
125006300|NCT01092143|449649934|FG003|Overall Study|Pregnancy|1|||
125093290|NCT01072175|449960162|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125093291|NCT01072175|449960163|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125093292|NCT01072175|449960164|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125093293|NCT01072175|449960165|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125093294|NCT01072175|449960166|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125093295|NCT01072175|449960167|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125093296|NCT01072175|449960168|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125093297|NCT01072175|449960169|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125093298|NCT01072175|449960157|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
125093299|NCT01072175|449960158|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
125093300|NCT01072175|449960159|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
125093301|NCT01072175|449960160|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
125093302|NCT01072175|449960161|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
125093303|NCT01072175|449960162|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
125093304|NCT01072175|449960163|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
125093305|NCT01072175|449960164|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
125093306|NCT01072175|449960165|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
125093307|NCT01072175|449960166|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
125006301|NCT01092143|449649935|FG004|Overall Study|Pregnancy|0|||
125006302|NCT00932425|449649938|FG000|Overall Study|Lost to Follow-up|0|||
125006303|NCT00932425|449649939|FG001|Overall Study|Lost to Follow-up|1|||
125006304|NCT00932425|449649938|FG000|Overall Study|Withdrawal by Subject|0|||
125006305|NCT00932425|449649939|FG001|Overall Study|Withdrawal by Subject|1|||
125006306|NCT00397033|449649943|FG000|Overall Study|Adverse Event|7|||
125006307|NCT00397033|449649944|FG001|Overall Study|Adverse Event|10|||
125006308|NCT00397033|449649945|FG002|Overall Study|Adverse Event|4|||
125006309|NCT00397033|449649943|FG000|Overall Study|Lack of Efficacy|22|||
125006310|NCT00397033|449649944|FG001|Overall Study|Lack of Efficacy|12|||
125006311|NCT00397033|449649945|FG002|Overall Study|Lack of Efficacy|9|||
125006312|NCT00397033|449649943|FG000|Overall Study|Lost to Follow-up|3|||
125006313|NCT00397033|449649944|FG001|Overall Study|Lost to Follow-up|3|||
125006314|NCT00397033|449649945|FG002|Overall Study|Lost to Follow-up|3|||
125006315|NCT00397033|449649943|FG000|Overall Study|Withdrawal by Subject|12|||
125006316|NCT00397033|449649944|FG001|Overall Study|Withdrawal by Subject|7|||
125006317|NCT00397033|449649945|FG002|Overall Study|Withdrawal by Subject|5|||
125006318|NCT00397033|449649943|FG000|Overall Study|Other|0|||
125093308|NCT01072175|449960167|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
125006319|NCT00397033|449649944|FG001|Overall Study|Other|5|||
125006320|NCT00397033|449649945|FG002|Overall Study|Other|2|||
125006321|NCT01984164|449649946|FG000|Overall Study|Withdrawal by Subject|4|||
125006322|NCT01984164|449649947|FG001|Overall Study|Withdrawal by Subject|3|||
125006323|NCT01984164|449649946|FG000|Overall Study|Adverse Event|5|||
125006324|NCT01984164|449649947|FG001|Overall Study|Adverse Event|19|||
125006325|NCT01984164|449649946|FG000|Overall Study|Lost to Follow-up|1|||
125006326|NCT01984164|449649947|FG001|Overall Study|Lost to Follow-up|3|||
125006327|NCT05293743|449649948|FG000|Overall Study|Withdrawal by Subject|1|||
125006328|NCT05293743|449649949|FG001|Overall Study|Withdrawal by Subject|0|||
125006329|NCT02546765|449649950|FG000|Overall Study|Withdrawal by Subject|0|||
125006330|NCT02546765|449649951|FG001|Overall Study|Withdrawal by Subject|1|||
125006331|NCT02546765|449649952|FG002|Overall Study|Withdrawal by Subject|0|||
125006332|NCT02546765|449649953|FG003|Overall Study|Withdrawal by Subject|0|||
125006333|NCT02064920|449649954|FG000|Overall Study|Adverse Event|0|||
125006334|NCT02064920|449649955|FG001|Overall Study|Adverse Event|4|||
125006335|NCT02064920|449649954|FG000|Overall Study|Physician Decision|0|||
125006336|NCT02064920|449649955|FG001|Overall Study|Physician Decision|1|||
125006337|NCT02064920|449649954|FG000|Overall Study|Technical Problems|0|||
125006338|NCT02064920|449649955|FG001|Overall Study|Technical Problems|1|||
125006339|NCT02064920|449649954|FG000|Overall Study|Withdrawal by Subject|1|||
125006340|NCT02064920|449649955|FG001|Overall Study|Withdrawal by Subject|3|||
125006341|NCT01129921|449649958|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
125006342|NCT01129921|449649959|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
125006343|NCT01129921|449649958|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
125006344|NCT01129921|449649959|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
125006345|NCT01129921|449649958|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
125006346|NCT01129921|449649959|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
125006347|NCT01129921|449649958|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
125006348|NCT01129921|449649959|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
124872996|NCT00508261|449157215|FG003|Overall Study|Migrated/ moved from study area|0|||
125093309|NCT01072175|449960168|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
125093310|NCT01072175|449960169|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
125093311|NCT01072175|449960157|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125093312|NCT01072175|449960158|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125093313|NCT01072175|449960159|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
125093314|NCT01072175|449960160|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125093315|NCT01072175|449960161|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
125093316|NCT01072175|449960162|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125093317|NCT01072175|449960163|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125093318|NCT01072175|449960164|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125093319|NCT01072175|449960165|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125093320|NCT01072175|449960166|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125093321|NCT01072175|449960167|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125093322|NCT01072175|449960168|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125093323|NCT01072175|449960169|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125093324|NCT01072175|449960157|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
125093325|NCT01072175|449960158|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
125093326|NCT01072175|449960159|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
125093327|NCT01072175|449960160|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
125093328|NCT01072175|449960161|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
125093329|NCT01072175|449960162|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
125093330|NCT01072175|449960163|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
125093331|NCT01072175|449960164|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
125093332|NCT01072175|449960165|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
125093333|NCT01072175|449960166|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
125093334|NCT01072175|449960167|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
125093335|NCT01072175|449960168|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
125093336|NCT01072175|449960169|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
125093337|NCT01072175|449960157|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
125093338|NCT01072175|449960158|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
125093339|NCT01072175|449960159|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
125093340|NCT01072175|449960160|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
125093341|NCT01072175|449960161|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
125093342|NCT01072175|449960162|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
125093343|NCT01072175|449960163|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
125093344|NCT01072175|449960164|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
125093345|NCT01072175|449960165|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
125093346|NCT01072175|449960166|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
125093347|NCT01072175|449960167|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
125093348|NCT01072175|449960168|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
125093349|NCT01072175|449960169|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
125093350|NCT01072175|449960157|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
125093351|NCT01072175|449960158|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
125093352|NCT01072175|449960159|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
125093353|NCT01072175|449960160|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
125093354|NCT01072175|449960161|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
124872997|NCT00508261|449157212|FG000|Overall Study|Lost to Follow-up|0|||
125006349|NCT00583024|449649960|FG000|Overall Study|Lost to Follow-up|4|||
125006350|NCT02229539|449651769|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
125006351|NCT02229539|449651770|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
125006352|NCT02229539|449651771|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
125006353|NCT02229539|449651769|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
125006354|NCT02229539|449651770|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
125006355|NCT02229539|449651771|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
125006356|NCT02229539|449651769|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
125006357|NCT02229539|449651770|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
125006358|NCT02229539|449651771|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
125006359|NCT02229539|449651769|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
125006360|NCT02229539|449651770|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
125006361|NCT02229539|449651771|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
125006362|NCT02229539|449651769|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
125006363|NCT02229539|449651770|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
125006364|NCT02229539|449651771|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
125006365|NCT02229539|449651769|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
125006366|NCT02229539|449651770|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
125006367|NCT02229539|449651771|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
125006368|NCT03227471|449651775|FG000|Overall Study|Withdrawal by Subject|0|||
125006369|NCT03227471|449651776|FG001|Overall Study|Withdrawal by Subject|0|||
125006370|NCT03227471|449651777|FG002|Overall Study|Withdrawal by Subject|0|||
125006371|NCT03227471|449651778|FG003|Overall Study|Withdrawal by Subject|0|||
125006372|NCT03227471|449651779|FG004|Overall Study|Withdrawal by Subject|1|||
125006373|NCT03227471|449651780|FG005|Overall Study|Withdrawal by Subject|0|||
125006374|NCT03227471|449651781|FG006|Overall Study|Withdrawal by Subject|0|||
125006375|NCT03227471|449651782|FG007|Overall Study|Withdrawal by Subject|0|||
125006376|NCT03227471|449651783|FG008|Overall Study|Withdrawal by Subject|0|||
125006377|NCT03227471|449651784|FG009|Overall Study|Withdrawal by Subject|0|||
125006378|NCT03227471|449651785|FG010|Overall Study|Withdrawal by Subject|0|||
125006379|NCT03227471|449651786|FG011|Overall Study|Withdrawal by Subject|0|||
125006380|NCT03227471|449651787|FG012|Overall Study|Withdrawal by Subject|1|||
125006381|NCT03227471|449651788|FG013|Overall Study|Withdrawal by Subject|0|||
125006382|NCT03227471|449651789|FG014|Overall Study|Withdrawal by Subject|0|||
125006383|NCT03227471|449651775|FG000|Overall Study|Randomized, Never Dosed|0|||
125006384|NCT03227471|449651776|FG001|Overall Study|Randomized, Never Dosed|0|||
125006385|NCT03227471|449651777|FG002|Overall Study|Randomized, Never Dosed|0|||
125006386|NCT03227471|449651778|FG003|Overall Study|Randomized, Never Dosed|0|||
125006387|NCT03227471|449651779|FG004|Overall Study|Randomized, Never Dosed|0|||
125006388|NCT03227471|449651780|FG005|Overall Study|Randomized, Never Dosed|0|||
125006389|NCT03227471|449651781|FG006|Overall Study|Randomized, Never Dosed|0|||
125006390|NCT03227471|449651782|FG007|Overall Study|Randomized, Never Dosed|0|||
125006391|NCT03227471|449651783|FG008|Overall Study|Randomized, Never Dosed|0|||
125006392|NCT03227471|449651784|FG009|Overall Study|Randomized, Never Dosed|0|||
125006393|NCT03227471|449651785|FG010|Overall Study|Randomized, Never Dosed|0|||
125006394|NCT03227471|449651786|FG011|Overall Study|Randomized, Never Dosed|0|||
125006395|NCT03227471|449651787|FG012|Overall Study|Randomized, Never Dosed|0|||
125006396|NCT03227471|449651788|FG013|Overall Study|Randomized, Never Dosed|0|||
125006397|NCT03227471|449651789|FG014|Overall Study|Randomized, Never Dosed|1|||
125006398|NCT00382720|449651790|FG000|Overall Study|Adverse Event|21|||
125006399|NCT00382720|449651791|FG001|Overall Study|Adverse Event|23|||
125006400|NCT00382720|449651792|FG002|Overall Study|Adverse Event|15|||
125006401|NCT00382720|449651790|FG000|Overall Study|Protocol Violation|2|||
125006402|NCT00382720|449651791|FG001|Overall Study|Protocol Violation|5|||
125006403|NCT00382720|449651792|FG002|Overall Study|Protocol Violation|1|||
125006404|NCT00382720|449651790|FG000|Overall Study|Death|0|||
125006405|NCT00382720|449651791|FG001|Overall Study|Death|1|||
125006406|NCT00382720|449651792|FG002|Overall Study|Death|2|||
125006407|NCT00382720|449651790|FG000|Overall Study|Progressive disease|37|||
125093355|NCT01072175|449960162|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
125093356|NCT01072175|449960163|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
125093357|NCT01072175|449960164|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
125093358|NCT01072175|449960165|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
125093359|NCT01072175|449960166|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
125093360|NCT01072175|449960167|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
125093361|NCT01072175|449960168|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
125093362|NCT01072175|449960169|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
125093363|NCT01072175|449960157|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
125093364|NCT01072175|449960158|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
125093365|NCT01072175|449960159|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
125093366|NCT01072175|449960160|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
125093367|NCT01072175|449960161|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
125093368|NCT01072175|449960162|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
125093369|NCT01072175|449960163|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
125093370|NCT01072175|449960164|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
125093371|NCT01072175|449960165|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
125093372|NCT01072175|449960166|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
125093373|NCT01072175|449960167|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
125093374|NCT01072175|449960168|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
125093375|NCT01072175|449960169|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
125093376|NCT01072175|449960157|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
125093377|NCT01072175|449960158|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
125093378|NCT01072175|449960159|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
125093379|NCT01072175|449960160|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
125093380|NCT01072175|449960161|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
125093381|NCT01072175|449960162|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
125093382|NCT01072175|449960163|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
125093383|NCT01072175|449960164|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
125093384|NCT01072175|449960165|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
125093385|NCT01072175|449960166|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
125093386|NCT01072175|449960167|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
125093387|NCT01072175|449960168|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
125093388|NCT01072175|449960169|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
125093389|NCT01072175|449960157|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125093390|NCT01072175|449960158|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125093391|NCT01072175|449960159|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125093392|NCT01072175|449960160|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125093393|NCT01072175|449960161|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125093394|NCT01072175|449960162|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125093395|NCT01072175|449960163|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
125093396|NCT01072175|449960164|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
125093397|NCT01072175|449960165|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125093398|NCT01072175|449960166|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125093399|NCT01072175|449960167|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125093400|NCT01072175|449960168|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125093401|NCT01072175|449960169|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125093402|NCT01072175|449960157|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
125093403|NCT01072175|449960158|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
125093404|NCT01072175|449960159|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
125093405|NCT01072175|449960160|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
125093406|NCT01072175|449960161|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
125093407|NCT01072175|449960162|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
125093408|NCT01072175|449960163|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
125093409|NCT01072175|449960164|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
125093410|NCT01072175|449960165|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
125093411|NCT01072175|449960166|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
125093412|NCT01072175|449960167|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
125093413|NCT01072175|449960168|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
125093414|NCT01072175|449960169|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
125093415|NCT01072175|449960157|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125093416|NCT01072175|449960158|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125093417|NCT01072175|449960159|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125093418|NCT01072175|449960160|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125093419|NCT01072175|449960161|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125093420|NCT01072175|449960162|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
125093421|NCT01072175|449960163|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
125093422|NCT01072175|449960164|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125093423|NCT01072175|449960165|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125093424|NCT01072175|449960166|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125093425|NCT01072175|449960167|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125093426|NCT01072175|449960168|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125093427|NCT01072175|449960169|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125093428|NCT01072175|449960157|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125093429|NCT01072175|449960158|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125093430|NCT01072175|449960159|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125093431|NCT01072175|449960160|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125093432|NCT01072175|449960161|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125093433|NCT01072175|449960162|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125093434|NCT01072175|449960163|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125093435|NCT01072175|449960164|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125093436|NCT01072175|449960165|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
125093437|NCT01072175|449960166|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125093438|NCT01072175|449960167|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125093439|NCT01072175|449960168|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125093440|NCT01072175|449960169|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125093441|NCT01072175|449960157|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125093442|NCT01072175|449960158|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125093443|NCT01072175|449960159|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125093444|NCT01072175|449960160|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125093445|NCT01072175|449960161|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125093446|NCT01072175|449960162|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
124872998|NCT00508261|449157213|FG001|Overall Study|Lost to Follow-up|1|||
125093447|NCT01072175|449960163|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125093448|NCT01072175|449960164|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125093449|NCT01072175|449960165|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
125093450|NCT01072175|449960166|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125093451|NCT01072175|449960167|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125093452|NCT01072175|449960168|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125093453|NCT01072175|449960169|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125093454|NCT01072175|449960157|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125093455|NCT01072175|449960158|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125093456|NCT01072175|449960159|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125093457|NCT01072175|449960160|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125093458|NCT01072175|449960161|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125093459|NCT01072175|449960162|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125093460|NCT01072175|449960163|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125093461|NCT01072175|449960164|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125093462|NCT01072175|449960165|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
125093463|NCT01072175|449960166|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125093464|NCT01072175|449960167|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125093465|NCT01072175|449960168|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125093466|NCT01072175|449960169|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125093467|NCT01072175|449960157|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125093468|NCT01072175|449960158|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125093469|NCT01072175|449960159|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125093470|NCT01072175|449960160|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125093471|NCT01072175|449960161|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125093472|NCT01072175|449960162|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125093473|NCT01072175|449960163|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125093474|NCT01072175|449960164|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125093475|NCT01072175|449960165|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
125093476|NCT01072175|449960166|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125093477|NCT01072175|449960167|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125093478|NCT01072175|449960168|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125093479|NCT01072175|449960169|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125093480|NCT01072175|449960157|FG000|Part D (HPMC Capsules)|Death|0|||
125093481|NCT01072175|449960158|FG001|Part D (HPMC Capsules)|Death|0|||
125093482|NCT01072175|449960159|FG002|Part D (HPMC Capsules)|Death|0|||
125093483|NCT01072175|449960160|FG003|Part D (HPMC Capsules)|Death|0|||
125093484|NCT01072175|449960161|FG004|Part D (HPMC Capsules)|Death|0|||
125093485|NCT01072175|449960162|FG005|Part D (HPMC Capsules)|Death|0|||
125093486|NCT01072175|449960163|FG006|Part D (HPMC Capsules)|Death|0|||
125093487|NCT01072175|449960164|FG007|Part D (HPMC Capsules)|Death|0|||
125093488|NCT01072175|449960165|FG008|Part D (HPMC Capsules)|Death|0|||
125093489|NCT01072175|449960166|FG009|Part D (HPMC Capsules)|Death|10|||
125093490|NCT01072175|449960167|FG010|Part D (HPMC Capsules)|Death|12|||
125093491|NCT01072175|449960168|FG011|Part D (HPMC Capsules)|Death|28|||
125093492|NCT01072175|449960169|FG012|Part D (HPMC Capsules)|Death|26|||
125093493|NCT01072175|449960157|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
125093494|NCT01072175|449960158|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
125093495|NCT01072175|449960159|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
125093496|NCT01072175|449960160|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
125093497|NCT01072175|449960161|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
125093498|NCT01072175|449960162|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
125093499|NCT01072175|449960163|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
125093500|NCT01072175|449960164|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
125093501|NCT01072175|449960165|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
125093502|NCT01072175|449960166|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
125093503|NCT01072175|449960167|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
125093504|NCT01072175|449960168|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
125093505|NCT01072175|449960169|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
125093506|NCT01072175|449960157|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
125093507|NCT01072175|449960158|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
125093508|NCT01072175|449960159|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
125093509|NCT01072175|449960160|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
125093510|NCT01072175|449960161|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
125006408|NCT00382720|449651791|FG001|Overall Study|Progressive disease|28|||
125006409|NCT00382720|449651792|FG002|Overall Study|Progressive disease|38|||
125006410|NCT00382720|449651790|FG000|Overall Study|Withdrew consent|1|||
125006411|NCT00382720|449651791|FG001|Overall Study|Withdrew consent|1|||
125006412|NCT00382720|449651792|FG002|Overall Study|Withdrew consent|2|||
125006413|NCT00382720|449651790|FG000|Overall Study|Withdrawal by Subject|11|||
125006414|NCT00382720|449651791|FG001|Overall Study|Withdrawal by Subject|20|||
125006415|NCT00382720|449651792|FG002|Overall Study|Withdrawal by Subject|12|||
125006416|NCT00382720|449651790|FG000|Overall Study|Surgery|1|||
125006417|NCT00382720|449651791|FG001|Overall Study|Surgery|1|||
125006418|NCT00382720|449651792|FG002|Overall Study|Surgery|4|||
125006419|NCT00382720|449651790|FG000|Overall Study|Patient did not receive study medication|1|||
125006420|NCT00382720|449651791|FG001|Overall Study|Patient did not receive study medication|1|||
125006421|NCT00382720|449651792|FG002|Overall Study|Patient did not receive study medication|4|||
125006422|NCT00382720|449651790|FG000|Overall Study|Clinically progressive disease|0|||
125006423|NCT00382720|449651791|FG001|Overall Study|Clinically progressive disease|1|||
125006424|NCT00382720|449651792|FG002|Overall Study|Clinically progressive disease|0|||
125006425|NCT00382720|449651790|FG000|Overall Study|Good prognosis|0|||
125006426|NCT00382720|449651791|FG001|Overall Study|Good prognosis|1|||
125006427|NCT00382720|449651792|FG002|Overall Study|Good prognosis|0|||
125006428|NCT00382720|449651790|FG000|Overall Study|Investigator/Clinical decision|5|||
125006429|NCT00382720|449651791|FG001|Overall Study|Investigator/Clinical decision|6|||
125006430|NCT00382720|449651792|FG002|Overall Study|Investigator/Clinical decision|6|||
125006431|NCT00382720|449651790|FG000|Overall Study|Discontinued at end of study|0|||
125006432|NCT00382720|449651791|FG001|Overall Study|Discontinued at end of study|1|||
125006433|NCT00382720|449651792|FG002|Overall Study|Discontinued at end of study|2|||
125006434|NCT00682448|449651793|FG000|Overall Study|Adverse Event|1|||
125006435|NCT00682448|449651794|FG001|Overall Study|Adverse Event|2|||
125006436|NCT00682448|449651793|FG000|Overall Study|Lack of Efficacy|1|||
125006437|NCT00682448|449651794|FG001|Overall Study|Lack of Efficacy|0|||
125006438|NCT00682448|449651793|FG000|Overall Study|Lost to Follow-up|1|||
125006439|NCT00682448|449651794|FG001|Overall Study|Lost to Follow-up|3|||
125006440|NCT00682448|449651793|FG000|Overall Study|Pregnancy|0|||
125006441|NCT00682448|449651794|FG001|Overall Study|Pregnancy|1|||
125006442|NCT00682448|449651793|FG000|Overall Study|Withdrawal by Subject|2|||
125006443|NCT00682448|449651794|FG001|Overall Study|Withdrawal by Subject|0|||
125006444|NCT00257166|449651798|FG000|Overall Study|Adverse Event|18|||
125006445|NCT00257166|449651799|FG001|Overall Study|Adverse Event|13|||
125006446|NCT00257166|449651798|FG000|Overall Study|Laboratory abnormality|1|||
125006447|NCT00257166|449651799|FG001|Overall Study|Laboratory abnormality|0|||
125006448|NCT00257166|449651798|FG000|Overall Study|Lost to Follow-up|8|||
125006449|NCT00257166|449651799|FG001|Overall Study|Lost to Follow-up|1|||
125006450|NCT00257166|449651798|FG000|Overall Study|Withdrawal by Subject|9|||
125006451|NCT00257166|449651799|FG001|Overall Study|Withdrawal by Subject|2|||
125006452|NCT00257166|449651798|FG000|Overall Study|Other|16|||
125006453|NCT00257166|449651799|FG001|Overall Study|Other|21|||
125006454|NCT00257166|449651798|FG000|Overall Study|Randomized, but not treated|1|||
125006455|NCT00257166|449651799|FG001|Overall Study|Randomized, but not treated|0|||
125006456|NCT04050670|449651804|FG000|Period 3|Physician Decision|0|||
125006457|NCT04050670|449651805|FG001|Period 3|Physician Decision|1|||
125006458|NCT04050670|449651806|FG002|Period 3|Physician Decision|0|||
125006459|NCT03335163|449651813|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
125006460|NCT03335163|449651813|FG000|Overall Study|Withdrawal by Subject|18|||
125006461|NCT00525044|449651814|FG000|Overall Study|Lost to Follow-up|0|||
125006462|NCT00525044|449651815|FG001|Overall Study|Lost to Follow-up|1|||
125006463|NCT02553265|449651817|FG000|Enrollment|Death|0|||
125006464|NCT02553265|449651818|FG001|Enrollment|Death|0|||
125006465|NCT02553265|449651819|FG002|Enrollment|Death|1|||
125006466|NCT02553265|449651817|FG000|First Intervention (28 Days)|Adverse Event|1|||
125093511|NCT01072175|449960162|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
125093512|NCT01072175|449960163|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
125093513|NCT01072175|449960164|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
125093514|NCT01072175|449960165|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
125093515|NCT01072175|449960166|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
125093516|NCT01072175|449960167|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
125093517|NCT01072175|449960168|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
125093518|NCT01072175|449960169|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
125093519|NCT01072175|449960157|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
125093520|NCT01072175|449960158|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
125093521|NCT01072175|449960159|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
125093522|NCT01072175|449960160|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
125093523|NCT01072175|449960161|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
125093524|NCT01072175|449960162|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
125093525|NCT01072175|449960163|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
125093526|NCT01072175|449960164|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
125093527|NCT01072175|449960165|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
125093528|NCT01072175|449960166|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
125093529|NCT01072175|449960167|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
125093530|NCT01072175|449960168|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
125093531|NCT01072175|449960169|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
125006467|NCT02553265|449651818|FG001|First Intervention (28 Days)|Adverse Event|0|||
125006468|NCT02553265|449651819|FG002|First Intervention (28 Days)|Adverse Event|0|||
125006469|NCT02553265|449651817|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
125006470|NCT02553265|449651818|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
125093532|NCT01072175|449960157|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125093533|NCT01072175|449960158|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125093534|NCT01072175|449960159|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125093535|NCT01072175|449960160|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125093536|NCT01072175|449960161|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125093537|NCT01072175|449960162|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125093538|NCT01072175|449960163|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125093539|NCT01072175|449960164|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125093540|NCT01072175|449960165|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125093541|NCT01072175|449960166|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125093542|NCT01072175|449960167|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
125093543|NCT01072175|449960168|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
125093544|NCT01072175|449960169|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125093545|NCT02477215|449960172|FG000|Dose Escalation Phase|Physician Decision|1|||
125093546|NCT02477215|449960173|FG001|Dose Escalation Phase|Physician Decision|2|||
125093547|NCT02477215|449960174|FG002|Dose Escalation Phase|Physician Decision|0|||
125093548|NCT02477215|449960172|FG000|Fixed Dose Phase|Physician Decision|0|||
125093549|NCT02477215|449960173|FG001|Fixed Dose Phase|Physician Decision|7|||
125093550|NCT02477215|449960174|FG002|Fixed Dose Phase|Physician Decision|0|||
125093551|NCT02210559|449960175|FG000|Overall Study|Progressive Disease|3|||
125093552|NCT02210559|449960176|FG001|Overall Study|Progressive Disease|2|||
125093553|NCT02210559|449960175|FG000|Overall Study|Adverse Event|2|||
125093554|NCT02210559|449960176|FG001|Overall Study|Adverse Event|2|||
125093555|NCT02210559|449960175|FG000|Overall Study|Physician Decision|1|||
125093556|NCT02210559|449960176|FG001|Overall Study|Physician Decision|0|||
125093557|NCT02210559|449960175|FG000|Overall Study|Withdrawal by Subject|0|||
125093558|NCT02210559|449960176|FG001|Overall Study|Withdrawal by Subject|1|||
125093559|NCT02210559|449960175|FG000|Overall Study|Other than specified|0|||
125093560|NCT02210559|449960176|FG001|Overall Study|Other than specified|1|||
125093561|NCT01474291|449960177|FG000|Overall Study|Not Evaluable for Efficacy|26|||
125093562|NCT01474291|449960177|FG000|Overall Study|Lack of Treatment Efficacy|88|||
125093563|NCT01474291|449960177|FG000|Overall Study|Adverse Event|53|||
125093564|NCT01474291|449960177|FG000|Overall Study|Lost to Follow-up|29|||
125093565|NCT01474291|449960177|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
125093566|NCT01474291|449960177|FG000|Overall Study|No Reason Reported|10|||
125093567|NCT01474291|449960177|FG000|Overall Study|Death|2|||
125093568|NCT00438815|449960181|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
125093569|NCT00438815|449960181|FG000|Overall Study|3-month follow-up no longer required|12|||
125093570|NCT00438815|449960181|FG000|Overall Study|Noncompliance with protocol requirements|9|||
125093571|NCT00438815|449960181|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
125093572|NCT00438815|449960181|FG000|Overall Study|Lost to Follow-up|6|||
125093573|NCT00438815|449960181|FG000|Overall Study|Withdrawal by Subject|6|||
125093574|NCT00438815|449960181|FG000|Overall Study|Death|1|||
125093575|NCT00679354|449960186|FG000|Overall Study|Death|3|||
125093576|NCT00679354|449960186|FG000|Overall Study|Lack of Efficacy|22|||
125093577|NCT00679354|449960186|FG000|Overall Study|Physician Decision|4|||
125093578|NCT00679354|449960186|FG000|Overall Study|Ineligible|1|||
125093579|NCT00665002|449960193|FG000|Overall Study|Progression/relapse during treatment|11|||
125093580|NCT00665002|449960193|FG000|Overall Study|Cytogenetic resistance|1|||
125093581|NCT00697255|449960194|FG000|Stage 1a|Insufficient ovarian response|1|||
125093582|NCT00697255|449960195|FG001|Stage 1a|Insufficient ovarian response|0|||
125093583|NCT00697255|449960194|FG000|Stage 1a|Multifollicular growth|1|||
125093584|NCT00697255|449960195|FG001|Stage 1a|Multifollicular growth|0|||
125093585|NCT00697255|449960194|FG000|Stage 1a|Not growing of dominant follicle|1|||
125093586|NCT00697255|449960195|FG001|Stage 1a|Not growing of dominant follicle|0|||
125093587|NCT00697255|449960194|FG000|Stage 1b|Not growing of dominant follicle|0|||
125093588|NCT00697255|449960195|FG001|Stage 1b|Not growing of dominant follicle|1|||
125093589|NCT00697255|449960194|FG000|Stage 1b|Insufficient ovarian response|0|||
125093590|NCT00697255|449960195|FG001|Stage 1b|Insufficient ovarian response|1|||
125093591|NCT01303159|449960203|FG000|Overall Study|Death|16|||
125093592|NCT01303159|449960203|FG000|Overall Study|Study Termination|7|||
125093593|NCT02243306|449960204|FG000|Overall Study|Adverse Event|0|||
125093594|NCT02243306|449960205|FG001|Overall Study|Adverse Event|1|||
125093595|NCT02243306|449960204|FG000|Overall Study|Other: Reached stopping criteria|0|||
125093596|NCT02243306|449960205|FG001|Overall Study|Other: Reached stopping criteria|1|||
125093597|NCT02243306|449960204|FG000|Overall Study|Physician Decision|0|||
125093598|NCT02243306|449960205|FG001|Overall Study|Physician Decision|1|||
125093599|NCT00496782|449960209|FG000|Overall Study|Protocol Violation|1|||
125093600|NCT00496782|449960210|FG001|Overall Study|Protocol Violation|2|||
125093601|NCT02242305|449960215|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
125093602|NCT02242305|449960216|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
125093603|NCT02242305|449960215|FG000|Overall Study|Adverse Event|1|||
125093604|NCT02242305|449960216|FG001|Overall Study|Adverse Event|0|||
125093605|NCT02242305|449960215|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
125093606|NCT02242305|449960216|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
125093607|NCT02242305|449960215|FG000|Overall Study|Subject withdraws inform consent|0|||
125093608|NCT02242305|449960216|FG001|Overall Study|Subject withdraws inform consent|4|||
125093609|NCT02242305|449960215|FG000|Overall Study|Lost to Follow-up|2|||
125093610|NCT02242305|449960216|FG001|Overall Study|Lost to Follow-up|0|||
125093611|NCT01005875|449960224|FG000|Overall Study|Death|3|||
125093612|NCT00242658|449960227|FG000|Overall Study|Lost to Follow-up|22|||
125093613|NCT00242658|449960228|FG001|Overall Study|Lost to Follow-up|19|||
125093614|NCT01815099|449960229|FG000|Overall Study|Lack of Efficacy|1|||
125093615|NCT01815099|449960229|FG000|Overall Study|unable to attend study visits|1|||
125093616|NCT00643851|449960230|FG000|Overall Study|Death|0|||
125093617|NCT00643851|449960231|FG001|Overall Study|Death|1|||
125093618|NCT00643851|449960232|FG002|Overall Study|Death|0|||
125093619|NCT00643851|449960230|FG000|Overall Study|Lack of Efficacy|0|||
125093620|NCT00643851|449960231|FG001|Overall Study|Lack of Efficacy|1|||
125093621|NCT00643851|449960232|FG002|Overall Study|Lack of Efficacy|0|||
125093622|NCT00643851|449960230|FG000|Overall Study|Adverse Event|2|||
125093623|NCT00643851|449960231|FG001|Overall Study|Adverse Event|6|||
125093624|NCT00643851|449960232|FG002|Overall Study|Adverse Event|6|||
125093625|NCT00643851|449960230|FG000|Overall Study|Lost to Follow-up|4|||
125093626|NCT00643851|449960231|FG001|Overall Study|Lost to Follow-up|6|||
125093627|NCT00643851|449960232|FG002|Overall Study|Lost to Follow-up|9|||
125093628|NCT00643851|449960230|FG000|Overall Study|Withdrawal by Subject|8|||
125093629|NCT00643851|449960231|FG001|Overall Study|Withdrawal by Subject|15|||
125093630|NCT00643851|449960232|FG002|Overall Study|Withdrawal by Subject|9|||
125093631|NCT00643851|449960230|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
125093632|NCT00643851|449960231|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
125093633|NCT00643851|449960232|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
125093634|NCT04557189|449960235|FG000|Overall Study|Adverse Event|0|||
125093635|NCT04557189|449960236|FG001|Overall Study|Adverse Event|1|||
125093636|NCT04557189|449960235|FG000|Overall Study|Lost to Follow-up|1|||
125093637|NCT04557189|449960236|FG001|Overall Study|Lost to Follow-up|1|||
125093638|NCT04557189|449960235|FG000|Overall Study|Withdrawal by Subject|2|||
125093639|NCT04557189|449960236|FG001|Overall Study|Withdrawal by Subject|1|||
125093640|NCT04557189|449960235|FG000|Overall Study|Reason not Specified|3|||
125093641|NCT04557189|449960236|FG001|Overall Study|Reason not Specified|6|||
125093642|NCT01728454|449960237|FG000|Stage 1 and 2|Pregnancy|1|||
125093643|NCT01728454|449960238|FG001|Stage 1 and 2|Pregnancy|0|||
125093644|NCT01728454|449960239|FG002|Stage 1 and 2|Pregnancy|0|||
125093645|NCT01728454|449960237|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
125093646|NCT01728454|449960238|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
125093647|NCT01728454|449960239|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
125093648|NCT01728454|449960237|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
125093649|NCT01728454|449960238|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
125093650|NCT01728454|449960239|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
125093651|NCT01728454|449960237|FG000|Stage 1 and 2|Lost to Follow-up|1|||
125093652|NCT01728454|449960238|FG001|Stage 1 and 2|Lost to Follow-up|1|||
125093653|NCT01728454|449960239|FG002|Stage 1 and 2|Lost to Follow-up|0|||
125093654|NCT01728454|449960237|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
125093655|NCT01728454|449960238|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
125093656|NCT01728454|449960239|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
125093657|NCT01728454|449960237|FG000|Stage 3|Reason Missing|0|||
125093658|NCT01728454|449960238|FG001|Stage 3|Reason Missing|0|||
125093659|NCT01728454|449960239|FG002|Stage 3|Reason Missing|1|||
125093660|NCT01728454|449960237|FG000|Stage 3|Subject Required Other Treatment|0|||
125093661|NCT01728454|449960238|FG001|Stage 3|Subject Required Other Treatment|1|||
125093662|NCT01728454|449960239|FG002|Stage 3|Subject Required Other Treatment|0|||
125093663|NCT01728454|449960237|FG000|Stage 3|Pregnancy|1|||
125093664|NCT01728454|449960238|FG001|Stage 3|Pregnancy|0|||
125093665|NCT01728454|449960239|FG002|Stage 3|Pregnancy|0|||
125093666|NCT01728454|449960237|FG000|Stage 3|Withdrew Consent|1|||
125093667|NCT01728454|449960238|FG001|Stage 3|Withdrew Consent|0|||
125093668|NCT01728454|449960239|FG002|Stage 3|Withdrew Consent|1|||
125093669|NCT01728454|449960237|FG000|Stage 3|Non-compliance with Protocol|0|||
125093670|NCT01728454|449960238|FG001|Stage 3|Non-compliance with Protocol|0|||
125093671|NCT01728454|449960239|FG002|Stage 3|Non-compliance with Protocol|1|||
125093672|NCT01728454|449960237|FG000|Stage 3|Lost to Follow-up|0|||
125093673|NCT01728454|449960238|FG001|Stage 3|Lost to Follow-up|3|||
125093674|NCT01728454|449960239|FG002|Stage 3|Lost to Follow-up|1|||
125093675|NCT01728454|449960237|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
125093676|NCT01728454|449960238|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
125093677|NCT01728454|449960239|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
125093678|NCT01190839|449960240|FG000|Overall Study|Adverse Event|32|||
125093679|NCT01190839|449960241|FG001|Overall Study|Adverse Event|41|||
125093680|NCT01190839|449960240|FG000|Overall Study|Protocol Violation|2|||
125093681|NCT01190839|449960241|FG001|Overall Study|Protocol Violation|2|||
125093682|NCT01190839|449960240|FG000|Overall Study|Lost to Follow-up|7|||
125093683|NCT01190839|449960241|FG001|Overall Study|Lost to Follow-up|1|||
125093684|NCT01190839|449960240|FG000|Overall Study|Death|1|||
125093685|NCT01190839|449960241|FG001|Overall Study|Death|0|||
125093686|NCT01190839|449960240|FG000|Overall Study|Trial stopped by Sponsor|71|||
125093687|NCT01190839|449960241|FG001|Overall Study|Trial stopped by Sponsor|68|||
125093688|NCT01190839|449960240|FG000|Overall Study|Undefined|35|||
125006471|NCT02553265|449651819|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
125006472|NCT02553265|449651817|FG000|Second Intervention (28 Days)|Adverse Event|1|||
125006473|NCT02553265|449651818|FG001|Second Intervention (28 Days)|Adverse Event|0|||
125006474|NCT02553265|449651819|FG002|Second Intervention (28 Days)|Adverse Event|0|||
125006475|NCT02553265|449651817|FG000|Third Intervention (28 Days)|Adverse Event|1|||
125006476|NCT02553265|449651818|FG001|Third Intervention (28 Days)|Adverse Event|0|||
125006477|NCT02553265|449651819|FG002|Third Intervention (28 Days)|Adverse Event|0|||
125006478|NCT02553265|449651817|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
125006479|NCT02553265|449651818|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
125006480|NCT02553265|449651819|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
125006481|NCT03713034|449651822|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
125093689|NCT01190839|449960241|FG001|Overall Study|Undefined|31|||
125093690|NCT01190839|449960240|FG000|Overall Study|Randomized but not treated|2|||
125093691|NCT01190839|449960241|FG001|Overall Study|Randomized but not treated|4|||
125093692|NCT03077646|449960245|FG000|Overall Study|Lost to Follow-up|29|||
125093693|NCT03077646|449960246|FG001|Overall Study|Lost to Follow-up|30|||
125093694|NCT03077646|449960247|FG002|Overall Study|Lost to Follow-up|31|||
125093695|NCT02058966|449960248|FG000|Open-Label Methamphetamine|Adverse Event|1|||
125093696|NCT02058966|449960248|FG000|First Intervention|Withdrawal by Subject|1|||
125093697|NCT02545504|449960250|FG000|Overall Study|Death|174|||
125093698|NCT02545504|449960251|FG001|Overall Study|Death|168|||
125093699|NCT02545504|449960250|FG000|Overall Study|Unknown reason|30|||
125093700|NCT02545504|449960251|FG001|Overall Study|Unknown reason|32|||
125093701|NCT02545504|449960250|FG000|Overall Study|Withdrew consent|9|||
125093702|NCT02545504|449960251|FG001|Overall Study|Withdrew consent|11|||
125093703|NCT02545504|449960250|FG000|Overall Study|Investigator's discretion|3|||
125093704|NCT02545504|449960251|FG001|Overall Study|Investigator's discretion|1|||
125093705|NCT02545504|449960250|FG000|Overall Study|Lost to Follow-up|2|||
125093706|NCT02545504|449960251|FG001|Overall Study|Lost to Follow-up|2|||
125093707|NCT01336647|449962348|FG000|Overall Study|Lost to Follow-up|4|||
125093708|NCT01336647|449962349|FG001|Overall Study|Lost to Follow-up|1|||
125093709|NCT01336647|449962350|FG002|Overall Study|Lost to Follow-up|3|||
125093710|NCT05056311|449962351|FG000|Overall Study|Lost to Follow-up|14|||
125093711|NCT05056311|449962351|FG000|Overall Study|Withdrawal by Subject|1|||
125093712|NCT05056311|449962351|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
125093713|NCT05111548|449962352|FG000|Overall Study|Withdrawal by Subject|2|||
125093714|NCT05111548|449962353|FG001|Overall Study|Withdrawal by Subject|1|||
125093715|NCT05111548|449962352|FG000|Overall Study|Adverse Event|1|||
125006482|NCT03713034|449651823|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
125006483|NCT02982239|449651826|FG000|Overall Study|Lost to Follow-up|3|||
125006484|NCT02982239|449651827|FG001|Overall Study|Lost to Follow-up|2|||
125006485|NCT02023242|449651836|FG000|Overall Study|Lost to Follow-up|3|||
125006486|NCT02023242|449651837|FG001|Overall Study|Lost to Follow-up|1|||
125006487|NCT02023242|449651836|FG000|Overall Study|Death|0|||
125006488|NCT02023242|449651837|FG001|Overall Study|Death|1|||
125006489|NCT04854434|449651845|FG000|Overall Study|Death|1|||
125006490|NCT04854434|449651846|FG001|Overall Study|Death|3|||
125006491|NCT04854434|449651847|FG002|Overall Study|Death|4|||
125006492|NCT04854434|449651845|FG000|Overall Study|Study Terminated by Sponsor|2|||
125006493|NCT04854434|449651846|FG001|Overall Study|Study Terminated by Sponsor|0|||
125006494|NCT04854434|449651847|FG002|Overall Study|Study Terminated by Sponsor|0|||
125006495|NCT04854434|449651845|FG000|Overall Study|Other|1|||
125006496|NCT04854434|449651846|FG001|Overall Study|Other|1|||
125006497|NCT04854434|449651847|FG002|Overall Study|Other|0|||
125006498|NCT00514514|449651849|FG000|Pre-phase|Death|10|||
125006499|NCT00514514|449651850|FG001|Pre-phase|Death|0|||
125006500|NCT00514514|449651851|FG002|Pre-phase|Death|0|||
125006501|NCT00514514|449651849|FG000|Pre-phase|administrative problems|2|||
125006502|NCT00514514|449651850|FG001|Pre-phase|administrative problems|0|||
125006503|NCT00514514|449651851|FG002|Pre-phase|administrative problems|0|||
125006504|NCT00514514|449651849|FG000|Pre-phase|Protocol Violation|6|||
125006505|NCT00514514|449651850|FG001|Pre-phase|Protocol Violation|0|||
125006506|NCT00514514|449651851|FG002|Pre-phase|Protocol Violation|0|||
125006507|NCT00514514|449651849|FG000|Pre-phase|condition no longer requires study drug|7|||
125006508|NCT00514514|449651850|FG001|Pre-phase|condition no longer requires study drug|0|||
125006509|NCT00514514|449651851|FG002|Pre-phase|condition no longer requires study drug|0|||
125006510|NCT00514514|449651849|FG000|Pre-phase|abnormal test procedure results|15|||
125006511|NCT00514514|449651850|FG001|Pre-phase|abnormal test procedure results|0|||
125006512|NCT00514514|449651851|FG002|Pre-phase|abnormal test procedure results|0|||
125006513|NCT00514514|449651849|FG000|Pre-phase|Lost to Follow-up|2|||
125006514|NCT00514514|449651850|FG001|Pre-phase|Lost to Follow-up|0|||
125006515|NCT00514514|449651851|FG002|Pre-phase|Lost to Follow-up|0|||
125006516|NCT00514514|449651849|FG000|Pre-phase|abnormal lab values|23|||
125006517|NCT00514514|449651850|FG001|Pre-phase|abnormal lab values|0|||
125006518|NCT00514514|449651851|FG002|Pre-phase|abnormal lab values|0|||
125006519|NCT00514514|449651849|FG000|Pre-phase|Lack of Efficacy|35|||
125006520|NCT00514514|449651850|FG001|Pre-phase|Lack of Efficacy|0|||
125006521|NCT00514514|449651851|FG002|Pre-phase|Lack of Efficacy|0|||
125006522|NCT00514514|449651849|FG000|Pre-phase|Adverse Event|137|||
125006523|NCT00514514|449651850|FG001|Pre-phase|Adverse Event|0|||
125006524|NCT00514514|449651851|FG002|Pre-phase|Adverse Event|0|||
125006525|NCT00514514|449651849|FG000|Pre-phase|Withdrawal by Subject|66|||
125006526|NCT00514514|449651850|FG001|Pre-phase|Withdrawal by Subject|0|||
125006527|NCT00514514|449651851|FG002|Pre-phase|Withdrawal by Subject|0|||
125093716|NCT05111548|449962353|FG001|Overall Study|Adverse Event|0|||
125093717|NCT00151775|449962364|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
125093718|NCT00151775|449962365|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
125006528|NCT00514514|449651849|FG000|Randomized - 9 Month|Death|3|||
125006529|NCT00514514|449651850|FG001|Randomized - 9 Month|Death|2|||
125006530|NCT00514514|449651851|FG002|Randomized - 9 Month|Death|2|||
125006531|NCT00514514|449651849|FG000|Randomized - 9 Month|Administrative problems|1|||
125006532|NCT00514514|449651850|FG001|Randomized - 9 Month|Administrative problems|1|||
125006533|NCT00514514|449651851|FG002|Randomized - 9 Month|Administrative problems|2|||
125006534|NCT00514514|449651849|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
125006535|NCT00514514|449651850|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
125006536|NCT00514514|449651851|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
125006537|NCT00514514|449651849|FG000|Randomized - 9 Month|Protocol Violation|1|||
125006538|NCT00514514|449651850|FG001|Randomized - 9 Month|Protocol Violation|1|||
125006539|NCT00514514|449651851|FG002|Randomized - 9 Month|Protocol Violation|0|||
125006540|NCT00514514|449651849|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
125006541|NCT00514514|449651850|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
125006542|NCT00514514|449651851|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
125006543|NCT00514514|449651849|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
125006544|NCT00514514|449651850|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
125006545|NCT00514514|449651851|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
125006546|NCT00514514|449651849|FG000|Randomized - 9 Month|Adverse Event|25|||
125006547|NCT00514514|449651850|FG001|Randomized - 9 Month|Adverse Event|44|||
125006548|NCT00514514|449651851|FG002|Randomized - 9 Month|Adverse Event|27|||
125006549|NCT00514514|449651849|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
125006550|NCT00514514|449651850|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
125006551|NCT00514514|449651851|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
125006552|NCT00514514|449651849|FG000|Extension - 4 Years|Lost to Follow-up|12|||
125006553|NCT00514514|449651850|FG001|Extension - 4 Years|Lost to Follow-up|10|||
125006554|NCT00514514|449651851|FG002|Extension - 4 Years|Lost to Follow-up|9|||
125006555|NCT00514514|449651849|FG000|Extension - 4 Years|Administrative problems|3|||
125006556|NCT00514514|449651850|FG001|Extension - 4 Years|Administrative problems|1|||
125006557|NCT00514514|449651851|FG002|Extension - 4 Years|Administrative problems|1|||
125006558|NCT00514514|449651849|FG000|Extension - 4 Years|Death|8|||
125006559|NCT00514514|449651850|FG001|Extension - 4 Years|Death|3|||
125006560|NCT00514514|449651851|FG002|Extension - 4 Years|Death|6|||
125006561|NCT00514514|449651849|FG000|Extension - 4 Years|Adverse Event|9|||
125006562|NCT00514514|449651850|FG001|Extension - 4 Years|Adverse Event|6|||
125006563|NCT00514514|449651851|FG002|Extension - 4 Years|Adverse Event|3|||
125006564|NCT02667275|449651852|FG000|Overall Study|Protocol Violation|11|||
125006565|NCT02667275|449651853|FG001|Overall Study|Protocol Violation|7|||
125006566|NCT02667275|449651852|FG000|Overall Study|Lost to Follow-up|0|||
125006567|NCT02667275|449651853|FG001|Overall Study|Lost to Follow-up|2|||
125006568|NCT02667275|449651852|FG000|Overall Study|Withdrawal by Subject|0|||
125006569|NCT02667275|449651853|FG001|Overall Study|Withdrawal by Subject|5|||
125006570|NCT02667275|449651852|FG000|Overall Study|Discontinued early without completing|0|||
125006571|NCT02667275|449651853|FG001|Overall Study|Discontinued early without completing|1|||
125006572|NCT01274715|449651854|FG000|Overall Study|Lost to Follow-up|1|||
125006573|NCT01274715|449651854|FG000|Overall Study|After consent, met exclusion criteria.|1|||
125006574|NCT01274715|449651854|FG000|Overall Study|After consent, met exclusion criteria.|1|||
125006575|NCT01274715|449651854|FG000|Overall Study|After consent, met exclusion criteria.|1|||
125006576|NCT02285920|449651857|FG000|Overall Study|Kidney transplantation|2|||
125006577|NCT02285920|449651858|FG001|Overall Study|Kidney transplantation|2|||
125006578|NCT02285920|449651859|FG002|Overall Study|Kidney transplantation|2|||
125006579|NCT02285920|449651860|FG003|Overall Study|Kidney transplantation|0|||
125006580|NCT02285920|449651857|FG000|Overall Study|Change to peritoneal dialysis|0|||
125006581|NCT02285920|449651858|FG001|Overall Study|Change to peritoneal dialysis|0|||
125006582|NCT02285920|449651859|FG002|Overall Study|Change to peritoneal dialysis|1|||
125006583|NCT02285920|449651860|FG003|Overall Study|Change to peritoneal dialysis|0|||
125006584|NCT02285920|449651857|FG000|Overall Study|Transfer to non-participating unit|0|||
125006585|NCT02285920|449651858|FG001|Overall Study|Transfer to non-participating unit|1|||
125006586|NCT02285920|449651859|FG002|Overall Study|Transfer to non-participating unit|0|||
125006587|NCT02285920|449651860|FG003|Overall Study|Transfer to non-participating unit|0|||
125006588|NCT02285920|449651857|FG000|Overall Study|Dialysis discontinuation|0|||
125006589|NCT02285920|449651858|FG001|Overall Study|Dialysis discontinuation|1|||
125006590|NCT02285920|449651859|FG002|Overall Study|Dialysis discontinuation|0|||
125006591|NCT02285920|449651860|FG003|Overall Study|Dialysis discontinuation|0|||
125006592|NCT02285920|449651857|FG000|Overall Study|Death|2|||
125006593|NCT02285920|449651858|FG001|Overall Study|Death|0|||
125006594|NCT02285920|449651859|FG002|Overall Study|Death|2|||
125006595|NCT02285920|449651860|FG003|Overall Study|Death|1|||
125006596|NCT01101438|449651861|FG000|Overall Study|Withdrawal by Subject|8|||
125006597|NCT01101438|449651862|FG001|Overall Study|Withdrawal by Subject|9|||
125006598|NCT02713542|449651863|FG000|Overall Study|Use of prohibited medication|14|||
125006599|NCT02713542|449651864|FG001|Overall Study|Use of prohibited medication|5|||
125006600|NCT02713542|449651863|FG000|Overall Study|Withdrawal by Subject|4|||
125006601|NCT02713542|449651864|FG001|Overall Study|Withdrawal by Subject|1|||
125006602|NCT00590044|449651874|FG000|Overall Study|Withdrawal by Subject|2|||
125006603|NCT00590044|449651875|FG001|Overall Study|Withdrawal by Subject|2|||
125006604|NCT00590044|449651874|FG000|Overall Study|wrong insulin arm assigned|1|||
125006605|NCT00590044|449651875|FG001|Overall Study|wrong insulin arm assigned|0|||
125006606|NCT00590044|449651874|FG000|Overall Study|Protocol Violation|1|||
125006607|NCT00590044|449651875|FG001|Overall Study|Protocol Violation|0|||
125006608|NCT03199040|449651876|FG000|Overall Study|Lack of Efficacy|2|||
125006609|NCT03199040|449651877|FG001|Overall Study|Lack of Efficacy|0|||
125006610|NCT03199040|449651876|FG000|Overall Study|Withdrawal by Subject|2|||
125006611|NCT03199040|449651877|FG001|Overall Study|Withdrawal by Subject|0|||
125006612|NCT03199040|449651876|FG000|Overall Study|Adverse Event|0|||
125006613|NCT03199040|449651877|FG001|Overall Study|Adverse Event|1|||
125006614|NCT03199040|449651876|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
125006615|NCT03199040|449651877|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
125006616|NCT00199836|449651880|FG000|Overall Study|Progressive Disease|5|||
125006617|NCT00199836|449651880|FG000|Overall Study|Death|1|||
125006618|NCT01708291|449651881|FG000|Overall Study|fighting|2|||
125006619|NCT01708291|449651882|FG001|Overall Study|fighting|1|||
125006620|NCT01843972|449651883|FG000|Overall Study|Withdrawal by Subject|0|||
125006621|NCT01843972|449651884|FG001|Overall Study|Withdrawal by Subject|0|||
125006622|NCT01843972|449651885|FG002|Overall Study|Withdrawal by Subject|0|||
125006623|NCT01843972|449651886|FG003|Overall Study|Withdrawal by Subject|0|||
125006624|NCT01843972|449651887|FG004|Overall Study|Withdrawal by Subject|1|||
125006625|NCT01843972|449651888|FG005|Overall Study|Withdrawal by Subject|0|||
125006626|NCT01843972|449651889|FG006|Overall Study|Withdrawal by Subject|0|||
125006627|NCT01843972|449651890|FG007|Overall Study|Withdrawal by Subject|0|||
125006628|NCT01843972|449651891|FG008|Overall Study|Withdrawal by Subject|0|||
125006629|NCT01843972|449651892|FG009|Overall Study|Withdrawal by Subject|0|||
125006630|NCT01854645|449651898|FG000|Overall Study|Protocol-Specified Criteria|13|||
125006631|NCT01854645|449651899|FG001|Overall Study|Protocol-Specified Criteria|10|||
125006632|NCT01854645|449651900|FG002|Overall Study|Protocol-Specified Criteria|8|||
125006633|NCT01854645|449651901|FG003|Overall Study|Protocol-Specified Criteria|5|||
125006634|NCT01854645|449651902|FG004|Overall Study|Protocol-Specified Criteria|7|||
125006635|NCT01854645|449651898|FG000|Overall Study|Administrative Reasons / Missing|0|||
125006636|NCT01854645|449651899|FG001|Overall Study|Administrative Reasons / Missing|0|||
125006637|NCT01854645|449651900|FG002|Overall Study|Administrative Reasons / Missing|0|||
125006638|NCT01854645|449651901|FG003|Overall Study|Administrative Reasons / Missing|1|||
125093719|NCT00151775|449962366|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
125093720|NCT00151775|449962367|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
125093721|NCT00151775|449962368|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
125093722|NCT00151775|449962369|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
125093723|NCT00151775|449962370|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
125093724|NCT00151775|449962371|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
125093725|NCT00151775|449962372|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
125093726|NCT00151775|449962373|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
125093727|NCT00151775|449962374|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
125093728|NCT00151775|449962375|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
125093729|NCT00151775|449962364|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
125093730|NCT00151775|449962365|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
125093731|NCT00151775|449962366|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
125093732|NCT00151775|449962367|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
125093733|NCT00151775|449962368|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
125093734|NCT00151775|449962369|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
125093735|NCT00151775|449962370|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
125093736|NCT00151775|449962371|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
125093737|NCT00151775|449962372|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
125093738|NCT00151775|449962373|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
125093739|NCT00151775|449962374|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
125093740|NCT00151775|449962375|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
125093741|NCT00151775|449962364|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125093742|NCT00151775|449962365|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
125093743|NCT00151775|449962366|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125093744|NCT00151775|449962367|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125093745|NCT00151775|449962368|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125093746|NCT00151775|449962369|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125093747|NCT00151775|449962370|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125093748|NCT00151775|449962371|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125093749|NCT00151775|449962372|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125093750|NCT00151775|449962373|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125093751|NCT00151775|449962374|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125093752|NCT00151775|449962375|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125093753|NCT00151775|449962364|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
125093754|NCT00151775|449962365|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
125093755|NCT00151775|449962366|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
125093756|NCT00151775|449962367|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
125093757|NCT00151775|449962368|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
125093758|NCT00151775|449962369|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
125093759|NCT00151775|449962370|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
125093760|NCT00151775|449962371|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
125093761|NCT00151775|449962372|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
125093762|NCT00151775|449962373|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
125093763|NCT00151775|449962374|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
125093764|NCT00151775|449962375|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
125093765|NCT00151775|449962364|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125093766|NCT00151775|449962365|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125093767|NCT00151775|449962366|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125093768|NCT00151775|449962367|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125093769|NCT00151775|449962368|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125093770|NCT00151775|449962369|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
125093771|NCT00151775|449962370|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125093772|NCT00151775|449962371|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125093773|NCT00151775|449962372|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125093774|NCT00151775|449962373|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125093775|NCT00151775|449962374|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125093776|NCT00151775|449962375|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125093777|NCT00151775|449962364|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125093778|NCT00151775|449962365|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125093779|NCT00151775|449962366|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125093780|NCT00151775|449962367|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125093781|NCT00151775|449962368|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125093782|NCT00151775|449962369|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
125093783|NCT00151775|449962370|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125093784|NCT00151775|449962371|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125093785|NCT00151775|449962372|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125093786|NCT00151775|449962373|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125093787|NCT00151775|449962374|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125093788|NCT00151775|449962375|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125093789|NCT00151775|449962364|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125093790|NCT00151775|449962365|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125093791|NCT00151775|449962366|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125093792|NCT00151775|449962367|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125093793|NCT00151775|449962368|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125093794|NCT00151775|449962369|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125093795|NCT00151775|449962370|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
125093796|NCT00151775|449962371|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125093797|NCT00151775|449962372|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125093798|NCT00151775|449962373|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125093799|NCT00151775|449962374|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125093800|NCT00151775|449962375|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125093801|NCT00151775|449962364|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125093802|NCT00151775|449962365|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125093803|NCT00151775|449962366|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125093804|NCT00151775|449962367|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125093805|NCT00151775|449962368|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125093806|NCT00151775|449962369|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
125093807|NCT00151775|449962370|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125093808|NCT00151775|449962371|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125093809|NCT00151775|449962372|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125093810|NCT00151775|449962373|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125093811|NCT00151775|449962374|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125093812|NCT00151775|449962375|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125093813|NCT00151775|449962364|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
125093814|NCT00151775|449962365|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
125093815|NCT00151775|449962366|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
125093816|NCT00151775|449962367|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
125093817|NCT00151775|449962368|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
125093818|NCT00151775|449962369|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
125093819|NCT00151775|449962370|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
125093820|NCT00151775|449962371|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
125093821|NCT00151775|449962372|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
125093822|NCT00151775|449962373|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
125093823|NCT00151775|449962374|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
125093824|NCT00151775|449962375|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
125093825|NCT00151775|449962364|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125093826|NCT00151775|449962365|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125093827|NCT00151775|449962366|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125093828|NCT00151775|449962367|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125093829|NCT00151775|449962368|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125093830|NCT00151775|449962369|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125093831|NCT00151775|449962370|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
125093832|NCT00151775|449962371|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125093833|NCT00151775|449962372|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125093834|NCT00151775|449962373|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125093835|NCT00151775|449962374|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125093836|NCT00151775|449962375|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125093837|NCT00151775|449962364|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125093838|NCT00151775|449962365|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125093839|NCT00151775|449962366|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
125093840|NCT00151775|449962367|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125093841|NCT00151775|449962368|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125093842|NCT00151775|449962369|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125093843|NCT00151775|449962370|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125093844|NCT00151775|449962371|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125093845|NCT00151775|449962372|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125093846|NCT00151775|449962373|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125093847|NCT00151775|449962374|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125093848|NCT00151775|449962375|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125093849|NCT00151775|449962364|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125093850|NCT00151775|449962365|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125093851|NCT00151775|449962366|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
125093852|NCT00151775|449962367|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125093853|NCT00151775|449962368|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125093854|NCT00151775|449962369|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125093855|NCT00151775|449962370|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125093856|NCT00151775|449962371|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125093857|NCT00151775|449962372|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125093858|NCT00151775|449962373|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125093859|NCT00151775|449962374|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125093860|NCT00151775|449962375|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125093861|NCT00151775|449962364|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125093862|NCT00151775|449962365|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125093863|NCT00151775|449962366|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125093864|NCT00151775|449962367|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125093865|NCT00151775|449962368|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125093866|NCT00151775|449962369|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125093867|NCT00151775|449962370|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125093868|NCT00151775|449962371|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125093869|NCT00151775|449962372|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125093870|NCT00151775|449962373|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125093871|NCT00151775|449962374|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125093872|NCT00151775|449962375|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
125093873|NCT00151775|449962364|FG000|Period 4: Open Label|Increased blood pressure|0|||
125093874|NCT00151775|449962365|FG001|Period 4: Open Label|Increased blood pressure|0|||
125093875|NCT00151775|449962366|FG002|Period 4: Open Label|Increased blood pressure|0|||
125093876|NCT00151775|449962367|FG003|Period 4: Open Label|Increased blood pressure|0|||
125093877|NCT00151775|449962368|FG004|Period 4: Open Label|Increased blood pressure|1|||
125093878|NCT00151775|449962369|FG005|Period 4: Open Label|Increased blood pressure|0|||
125093879|NCT00151775|449962370|FG006|Period 4: Open Label|Increased blood pressure|0|||
125093880|NCT00151775|449962371|FG007|Period 4: Open Label|Increased blood pressure|0|||
125093881|NCT00151775|449962372|FG008|Period 4: Open Label|Increased blood pressure|0|||
125093882|NCT00151775|449962373|FG009|Period 4: Open Label|Increased blood pressure|1|||
125093883|NCT00151775|449962374|FG010|Period 4: Open Label|Increased blood pressure|0|||
125093884|NCT00151775|449962375|FG011|Period 4: Open Label|Increased blood pressure|0|||
125093885|NCT00151775|449962364|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
125093886|NCT00151775|449962365|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
125093887|NCT00151775|449962366|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
125093888|NCT00151775|449962367|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
125093889|NCT00151775|449962368|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
125093890|NCT00151775|449962369|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
125093891|NCT00151775|449962370|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
125093892|NCT00151775|449962371|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
125093893|NCT00151775|449962372|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
125006639|NCT01854645|449651902|FG004|Overall Study|Administrative Reasons / Missing|1|||
125006640|NCT01854645|449651898|FG000|Overall Study|Protocol Violation|3|||
125006641|NCT01854645|449651899|FG001|Overall Study|Protocol Violation|0|||
125006642|NCT01854645|449651900|FG002|Overall Study|Protocol Violation|5|||
125006643|NCT01854645|449651901|FG003|Overall Study|Protocol Violation|4|||
125006644|NCT01854645|449651902|FG004|Overall Study|Protocol Violation|1|||
125006645|NCT01854645|449651898|FG000|Overall Study|Lost to Follow-up|10|||
125006646|NCT01854645|449651899|FG001|Overall Study|Lost to Follow-up|7|||
125006647|NCT01854645|449651900|FG002|Overall Study|Lost to Follow-up|8|||
125006648|NCT01854645|449651901|FG003|Overall Study|Lost to Follow-up|5|||
125006649|NCT01854645|449651902|FG004|Overall Study|Lost to Follow-up|0|||
125006650|NCT01854645|449651898|FG000|Overall Study|Physician Decision|1|||
125006651|NCT01854645|449651899|FG001|Overall Study|Physician Decision|5|||
125006652|NCT01854645|449651900|FG002|Overall Study|Physician Decision|3|||
125006653|NCT01854645|449651901|FG003|Overall Study|Physician Decision|3|||
125006654|NCT01854645|449651902|FG004|Overall Study|Physician Decision|7|||
125006655|NCT01854645|449651898|FG000|Overall Study|Withdrawal by Subject|31|||
125006656|NCT01854645|449651899|FG001|Overall Study|Withdrawal by Subject|41|||
125006657|NCT01854645|449651900|FG002|Overall Study|Withdrawal by Subject|30|||
125006658|NCT01854645|449651901|FG003|Overall Study|Withdrawal by Subject|21|||
125006659|NCT01854645|449651902|FG004|Overall Study|Withdrawal by Subject|24|||
125006660|NCT01854645|449651898|FG000|Overall Study|Lack of Efficacy|7|||
125006661|NCT01854645|449651899|FG001|Overall Study|Lack of Efficacy|12|||
125006662|NCT01854645|449651900|FG002|Overall Study|Lack of Efficacy|9|||
125006663|NCT01854645|449651901|FG003|Overall Study|Lack of Efficacy|3|||
125006664|NCT01854645|449651902|FG004|Overall Study|Lack of Efficacy|9|||
125006665|NCT01854645|449651898|FG000|Overall Study|Adverse Event|33|||
125006666|NCT01854645|449651899|FG001|Overall Study|Adverse Event|31|||
125006667|NCT01854645|449651900|FG002|Overall Study|Adverse Event|19|||
125006668|NCT01854645|449651901|FG003|Overall Study|Adverse Event|20|||
125006669|NCT01854645|449651902|FG004|Overall Study|Adverse Event|11|||
125006670|NCT01202279|449651905|FG000|Overall Study|Adverse Event|8|||
125006671|NCT01202279|449651906|FG001|Overall Study|Adverse Event|6|||
125006672|NCT01202279|449651905|FG000|Overall Study|Withdrawal by Subject|13|||
125006673|NCT01202279|449651906|FG001|Overall Study|Withdrawal by Subject|10|||
125006674|NCT01202279|449651905|FG000|Overall Study|Physician Decision|0|||
125006675|NCT01202279|449651906|FG001|Overall Study|Physician Decision|1|||
125006676|NCT01202279|449651905|FG000|Overall Study|Lost to Follow-up|10|||
125006677|NCT01202279|449651906|FG001|Overall Study|Lost to Follow-up|7|||
125006678|NCT01202279|449651905|FG000|Overall Study|Protocol Violation|1|||
125006679|NCT01202279|449651906|FG001|Overall Study|Protocol Violation|1|||
125006680|NCT01202279|449651905|FG000|Overall Study|study compliance|5|||
125006681|NCT01202279|449651906|FG001|Overall Study|study compliance|2|||
125006682|NCT00475722|449651909|FG000|Overall Study|Withdrawal by Subject|12|||
125006683|NCT00475722|449651910|FG001|Overall Study|Withdrawal by Subject|12|||
125006684|NCT00475722|449651909|FG000|Overall Study|Protocol Violation|3|||
125006685|NCT00475722|449651910|FG001|Overall Study|Protocol Violation|0|||
125006686|NCT00916279|449651911|FG000|Overall Study|Death|2|||
125006687|NCT00916279|449651911|FG000|Overall Study|Lost to Follow-up|2|||
125006688|NCT00310804|449651912|FG000|Overall Study|Lost to Follow-up|2|||
125006689|NCT00310804|449651913|FG001|Overall Study|Lost to Follow-up|0|||
125006690|NCT00310804|449651912|FG000|Overall Study|Withdrawal by Subject|3|||
125006691|NCT00310804|449651913|FG001|Overall Study|Withdrawal by Subject|0|||
125006692|NCT02109562|449651914|FG000|Overall Study|Insufficient clinical response|2|||
125006693|NCT02109562|449651915|FG001|Overall Study|Insufficient clinical response|0|||
125006694|NCT02109562|449651916|FG002|Overall Study|Insufficient clinical response|4|||
125006695|NCT02109562|449651914|FG000|Overall Study|Adverse Event|0|||
125006696|NCT02109562|449651915|FG001|Overall Study|Adverse Event|2|||
125006697|NCT02109562|449651916|FG002|Overall Study|Adverse Event|3|||
125006698|NCT02109562|449651914|FG000|Overall Study|Lost to Follow-up|1|||
125006699|NCT02109562|449651915|FG001|Overall Study|Lost to Follow-up|0|||
125006700|NCT02109562|449651916|FG002|Overall Study|Lost to Follow-up|1|||
125006701|NCT02109562|449651914|FG000|Overall Study|Protocol Violation|0|||
125006702|NCT02109562|449651915|FG001|Overall Study|Protocol Violation|3|||
125006703|NCT02109562|449651916|FG002|Overall Study|Protocol Violation|1|||
125006704|NCT02109562|449651914|FG000|Overall Study|Withdrawal by Subject|20|||
125006705|NCT02109562|449651915|FG001|Overall Study|Withdrawal by Subject|25|||
125006706|NCT02109562|449651916|FG002|Overall Study|Withdrawal by Subject|21|||
125006707|NCT02109562|449651914|FG000|Overall Study|Physician Decision|3|||
125006708|NCT02109562|449651915|FG001|Overall Study|Physician Decision|4|||
125006709|NCT02109562|449651916|FG002|Overall Study|Physician Decision|5|||
125006710|NCT00688155|449651921|FG000|Overall Study|Withdrawal by Subject|2|||
125093894|NCT00151775|449962373|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
125006711|NCT00688155|449651922|FG001|Overall Study|Withdrawal by Subject|2|||
125006712|NCT00688155|449651923|FG002|Overall Study|Withdrawal by Subject|1|||
125006713|NCT00688155|449651924|FG003|Overall Study|Withdrawal by Subject|1|||
125006714|NCT03318978|449651931|FG000|Overall Study|Withdrawal by Subject|1|||
125006715|NCT01200238|449651933|FG000|Overall Study|Adverse Event|2|||
125006716|NCT01200238|449651934|FG001|Overall Study|Adverse Event|1|||
125093895|NCT00151775|449962374|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
125093896|NCT00151775|449962375|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
125093897|NCT00151775|449962364|FG000|Period 4: Open Label|Adverse Event|0|||
125093898|NCT00151775|449962365|FG001|Period 4: Open Label|Adverse Event|0|||
125093899|NCT00151775|449962366|FG002|Period 4: Open Label|Adverse Event|0|||
125093900|NCT00151775|449962367|FG003|Period 4: Open Label|Adverse Event|0|||
125093901|NCT00151775|449962368|FG004|Period 4: Open Label|Adverse Event|1|||
125093902|NCT00151775|449962369|FG005|Period 4: Open Label|Adverse Event|0|||
125093903|NCT00151775|449962370|FG006|Period 4: Open Label|Adverse Event|0|||
125093904|NCT00151775|449962371|FG007|Period 4: Open Label|Adverse Event|0|||
125093905|NCT00151775|449962372|FG008|Period 4: Open Label|Adverse Event|0|||
125006717|NCT01200238|449651933|FG000|Overall Study|Progressive Disease|5|||
125006718|NCT01200238|449651934|FG001|Overall Study|Progressive Disease|8|||
125006719|NCT01200238|449651933|FG000|Overall Study|Withdrawal by Subject|0|||
125006720|NCT01200238|449651934|FG001|Overall Study|Withdrawal by Subject|1|||
125006725|NCT05050318|449653280|FG000|Overall Study|Protocol Deviation|1|||
125006726|NCT05050318|449653281|FG001|Overall Study|Protocol Deviation|0|||
125006727|NCT05050318|449653282|FG002|Overall Study|Protocol Deviation|0|||
125006728|NCT02142738|449653287|FG000|Overall Study|Adverse Event|13|||
125006729|NCT02142738|449653288|FG001|Overall Study|Adverse Event|9|||
125006730|NCT02142738|449653287|FG000|Overall Study|Death|92|||
125006731|NCT02142738|449653288|FG001|Overall Study|Death|112|||
125006732|NCT02142738|449653287|FG000|Overall Study|Lost to Follow-up|0|||
125093906|NCT00151775|449962373|FG009|Period 4: Open Label|Adverse Event|2|||
125006733|NCT02142738|449653288|FG001|Overall Study|Lost to Follow-up|3|||
125006734|NCT02142738|449653287|FG000|Overall Study|Withdrawal by Subject|6|||
125006735|NCT02142738|449653288|FG001|Overall Study|Withdrawal by Subject|7|||
125006736|NCT02142738|449653287|FG000|Overall Study|Follow up ended by sponsor|43|||
125006737|NCT02142738|449653288|FG001|Overall Study|Follow up ended by sponsor|20|||
125006738|NCT03688880|449653289|FG000|Overall Study|Withdrawal by Subject|0|||
125006739|NCT03688880|449653290|FG001|Overall Study|Withdrawal by Subject|2|||
125006740|NCT03688880|449653289|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
125006741|NCT03688880|449653290|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
125006742|NCT03688880|449653289|FG000|Overall Study|Lost to Follow-up|4|||
125006743|NCT03688880|449653290|FG001|Overall Study|Lost to Follow-up|7|||
125006744|NCT03688880|449653289|FG000|Overall Study|Adverse Event|0|||
125006745|NCT03688880|449653290|FG001|Overall Study|Adverse Event|2|||
125006746|NCT03688880|449653289|FG000|Overall Study|Device deficiencies|0|||
125006747|NCT03688880|449653290|FG001|Overall Study|Device deficiencies|2|||
125006748|NCT03688880|449653289|FG000|Overall Study|Other|10|||
125006749|NCT03688880|449653290|FG001|Overall Study|Other|16|||
125006750|NCT01858532|449653291|FG000|Overall Study|Adverse Event|58|||
125006751|NCT01858532|449653292|FG001|Overall Study|Adverse Event|50|||
125006752|NCT01858532|449653293|FG002|Overall Study|Adverse Event|23|||
125006753|NCT01858532|449653294|FG003|Overall Study|Adverse Event|28|||
125006754|NCT01858532|449653291|FG000|Overall Study|Withdrew consent|71|||
125006755|NCT01858532|449653292|FG001|Overall Study|Withdrew consent|93|||
125006756|NCT01858532|449653293|FG002|Overall Study|Withdrew consent|46|||
125006757|NCT01858532|449653294|FG003|Overall Study|Withdrew consent|27|||
125006758|NCT01858532|449653291|FG000|Overall Study|Lost to Follow-up|17|||
125006759|NCT01858532|449653292|FG001|Overall Study|Lost to Follow-up|26|||
125006760|NCT01858532|449653293|FG002|Overall Study|Lost to Follow-up|11|||
125006761|NCT01858532|449653294|FG003|Overall Study|Lost to Follow-up|14|||
125006762|NCT01858532|449653291|FG000|Overall Study|Deterioration of medical status|3|||
125006763|NCT01858532|449653292|FG001|Overall Study|Deterioration of medical status|4|||
125006764|NCT01858532|449653293|FG002|Overall Study|Deterioration of medical status|3|||
125006765|NCT01858532|449653294|FG003|Overall Study|Deterioration of medical status|7|||
125006766|NCT01858532|449653291|FG000|Overall Study|Investigator request|3|||
125006767|NCT01858532|449653292|FG001|Overall Study|Investigator request|4|||
125006768|NCT01858532|449653293|FG002|Overall Study|Investigator request|2|||
125006769|NCT01858532|449653294|FG003|Overall Study|Investigator request|6|||
125006770|NCT01858532|449653291|FG000|Overall Study|Other, not specified|29|||
125006771|NCT01858532|449653292|FG001|Overall Study|Other, not specified|15|||
125006772|NCT01858532|449653293|FG002|Overall Study|Other, not specified|13|||
125006773|NCT01858532|449653294|FG003|Overall Study|Other, not specified|11|||
125006774|NCT00066742|449653295|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
125006775|NCT00066742|449653295|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
125006776|NCT00066742|449653295|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
125006777|NCT00066742|449653295|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
125006778|NCT00066742|449653295|FG000|Induction Chemoradiotherapy|Ineligible|3|||
125006779|NCT00066742|449653295|FG000|Consolidation Chemotherapy|not protocol specified|1|||
125006780|NCT00066742|449653295|FG000|Consolidation Chemotherapy|Ineligible|2|||
125006781|NCT03794583|449653297|FG000|Overall Study|Death|8|||
125006782|NCT03794583|449653297|FG000|Overall Study|Study Terminated by Sponsor|24|||
125006783|NCT03794583|449653297|FG000|Overall Study|Withdrawal by Subject|9|||
125006784|NCT01994382|449653306|FG000|Overall Study|Informed consent withdrawn|0|||
125006785|NCT01994382|449653307|FG001|Overall Study|Informed consent withdrawn|0|||
125006786|NCT01994382|449653308|FG002|Overall Study|Informed consent withdrawn|0|||
125006787|NCT01994382|449653309|FG003|Overall Study|Informed consent withdrawn|0|||
125006788|NCT01994382|449653310|FG004|Overall Study|Informed consent withdrawn|0|||
125006789|NCT01994382|449653311|FG005|Overall Study|Informed consent withdrawn|0|||
125006790|NCT01994382|449653312|FG006|Overall Study|Informed consent withdrawn|1|||
125006791|NCT01994382|449653313|FG007|Overall Study|Informed consent withdrawn|0|||
125006792|NCT01994382|449653314|FG008|Overall Study|Informed consent withdrawn|0|||
124872999|NCT00508261|449157214|FG002|Overall Study|Lost to Follow-up|1|||
125093907|NCT00151775|449962374|FG010|Period 4: Open Label|Adverse Event|0|||
125093908|NCT00151775|449962375|FG011|Period 4: Open Label|Adverse Event|0|||
125093909|NCT00151775|449962364|FG000|Period 4: Open Label|Lost to Follow-up|0|||
125093910|NCT00151775|449962365|FG001|Period 4: Open Label|Lost to Follow-up|0|||
125093911|NCT00151775|449962366|FG002|Period 4: Open Label|Lost to Follow-up|0|||
125093912|NCT00151775|449962367|FG003|Period 4: Open Label|Lost to Follow-up|0|||
125093913|NCT00151775|449962368|FG004|Period 4: Open Label|Lost to Follow-up|17|||
125093914|NCT00151775|449962369|FG005|Period 4: Open Label|Lost to Follow-up|0|||
125093915|NCT00151775|449962370|FG006|Period 4: Open Label|Lost to Follow-up|0|||
125093916|NCT00151775|449962371|FG007|Period 4: Open Label|Lost to Follow-up|0|||
125093917|NCT00151775|449962372|FG008|Period 4: Open Label|Lost to Follow-up|0|||
125093918|NCT00151775|449962373|FG009|Period 4: Open Label|Lost to Follow-up|7|||
125093919|NCT00151775|449962374|FG010|Period 4: Open Label|Lost to Follow-up|0|||
125093920|NCT00151775|449962375|FG011|Period 4: Open Label|Lost to Follow-up|0|||
125093921|NCT00151775|449962364|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
125093922|NCT00151775|449962365|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
125093923|NCT00151775|449962366|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
125093924|NCT00151775|449962367|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
125093925|NCT00151775|449962368|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
125093926|NCT00151775|449962369|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
125093927|NCT00151775|449962370|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
125093928|NCT00151775|449962371|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
125093929|NCT00151775|449962372|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
125093930|NCT00151775|449962373|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
125093931|NCT00151775|449962374|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
125093932|NCT00151775|449962375|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
125093933|NCT00151775|449962364|FG000|Period 4: Open Label|Other|0|||
125093934|NCT00151775|449962365|FG001|Period 4: Open Label|Other|0|||
125093935|NCT00151775|449962366|FG002|Period 4: Open Label|Other|0|||
125093936|NCT00151775|449962367|FG003|Period 4: Open Label|Other|0|||
125093937|NCT00151775|449962368|FG004|Period 4: Open Label|Other|1|||
125093938|NCT00151775|449962369|FG005|Period 4: Open Label|Other|0|||
125093939|NCT00151775|449962370|FG006|Period 4: Open Label|Other|0|||
125093940|NCT00151775|449962371|FG007|Period 4: Open Label|Other|0|||
125093941|NCT00151775|449962372|FG008|Period 4: Open Label|Other|0|||
125093942|NCT00151775|449962373|FG009|Period 4: Open Label|Other|3|||
125093943|NCT00151775|449962374|FG010|Period 4: Open Label|Other|0|||
125093944|NCT00151775|449962375|FG011|Period 4: Open Label|Other|0|||
125093945|NCT00151775|449962364|FG000|Period 4: Open Label|Physician Decision|0|||
125093946|NCT00151775|449962365|FG001|Period 4: Open Label|Physician Decision|0|||
125093947|NCT00151775|449962366|FG002|Period 4: Open Label|Physician Decision|0|||
125093948|NCT00151775|449962367|FG003|Period 4: Open Label|Physician Decision|0|||
125093949|NCT00151775|449962368|FG004|Period 4: Open Label|Physician Decision|0|||
125093950|NCT00151775|449962369|FG005|Period 4: Open Label|Physician Decision|0|||
125093951|NCT00151775|449962370|FG006|Period 4: Open Label|Physician Decision|0|||
125093952|NCT00151775|449962371|FG007|Period 4: Open Label|Physician Decision|0|||
125093953|NCT00151775|449962372|FG008|Period 4: Open Label|Physician Decision|0|||
125093954|NCT00151775|449962373|FG009|Period 4: Open Label|Physician Decision|2|||
125093955|NCT00151775|449962374|FG010|Period 4: Open Label|Physician Decision|0|||
125093956|NCT00151775|449962375|FG011|Period 4: Open Label|Physician Decision|0|||
125093957|NCT00151775|449962364|FG000|Period 4: Open Label|Protocol Violation|0|||
125093958|NCT00151775|449962365|FG001|Period 4: Open Label|Protocol Violation|0|||
125093959|NCT00151775|449962366|FG002|Period 4: Open Label|Protocol Violation|0|||
125093960|NCT00151775|449962367|FG003|Period 4: Open Label|Protocol Violation|0|||
125093961|NCT00151775|449962368|FG004|Period 4: Open Label|Protocol Violation|1|||
125093962|NCT00151775|449962369|FG005|Period 4: Open Label|Protocol Violation|0|||
125093963|NCT00151775|449962370|FG006|Period 4: Open Label|Protocol Violation|0|||
125093964|NCT00151775|449962371|FG007|Period 4: Open Label|Protocol Violation|0|||
125093965|NCT00151775|449962372|FG008|Period 4: Open Label|Protocol Violation|0|||
125093966|NCT00151775|449962373|FG009|Period 4: Open Label|Protocol Violation|0|||
125093967|NCT00151775|449962374|FG010|Period 4: Open Label|Protocol Violation|0|||
125093968|NCT00151775|449962375|FG011|Period 4: Open Label|Protocol Violation|0|||
125093969|NCT00474994|449962384|FG000|Overall Study|Patient Not treated|1|||
125093970|NCT00474994|449962384|FG000|Overall Study|Patient evaluable for toxicity only|3|||
125093971|NCT00474994|449962384|FG000|Overall Study|Patient found to be ineligible|1|||
125093972|NCT04516291|449962385|FG000|Treatment Period (24 Weeks)|Other|1|||
125093973|NCT04516291|449962386|FG001|Treatment Period (24 Weeks)|Other|0|||
125093974|NCT04516291|449962387|FG002|Treatment Period (24 Weeks)|Other|0|||
125093975|NCT04516291|449962388|FG003|Treatment Period (24 Weeks)|Other|2|||
125093976|NCT04516291|449962389|FG004|Treatment Period (24 Weeks)|Other|2|||
125093977|NCT04516291|449962390|FG005|Treatment Period (24 Weeks)|Other|4|||
125093978|NCT04516291|449962391|FG006|Treatment Period (24 Weeks)|Other|2|||
125093979|NCT04516291|449962392|FG007|Treatment Period (24 Weeks)|Other|0|||
125093980|NCT04516291|449962385|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125093981|NCT04516291|449962386|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
125093982|NCT04516291|449962387|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
125093983|NCT04516291|449962388|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125093984|NCT04516291|449962389|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
125093985|NCT04516291|449962390|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125093986|NCT04516291|449962391|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125093987|NCT04516291|449962392|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125093988|NCT04516291|449962385|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
125093989|NCT04516291|449962386|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
125093990|NCT04516291|449962387|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
125093991|NCT04516291|449962388|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
125093992|NCT04516291|449962389|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
125093993|NCT04516291|449962390|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
125093994|NCT04516291|449962391|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
125093995|NCT04516291|449962392|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
125093996|NCT04516291|449962385|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125093997|NCT04516291|449962386|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
125093998|NCT04516291|449962387|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125093999|NCT04516291|449962388|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125094000|NCT04516291|449962389|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125094001|NCT04516291|449962390|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125094002|NCT04516291|449962391|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125094003|NCT04516291|449962392|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125094004|NCT04516291|449962385|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
125094005|NCT04516291|449962386|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
125094006|NCT04516291|449962387|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
125094007|NCT04516291|449962388|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
125094008|NCT04516291|449962389|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
125094009|NCT04516291|449962390|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
125094010|NCT04516291|449962391|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
125094011|NCT04516291|449962392|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
125094012|NCT04516291|449962385|FG000|Follow-up Period (12 Weeks)|Other|0|||
125094013|NCT04516291|449962386|FG001|Follow-up Period (12 Weeks)|Other|1|||
125094014|NCT04516291|449962387|FG002|Follow-up Period (12 Weeks)|Other|0|||
125094015|NCT04516291|449962388|FG003|Follow-up Period (12 Weeks)|Other|2|||
125094016|NCT04516291|449962389|FG004|Follow-up Period (12 Weeks)|Other|0|||
125094017|NCT04516291|449962390|FG005|Follow-up Period (12 Weeks)|Other|0|||
125094018|NCT04516291|449962391|FG006|Follow-up Period (12 Weeks)|Other|0|||
125094019|NCT04516291|449962392|FG007|Follow-up Period (12 Weeks)|Other|0|||
125094020|NCT04516291|449962385|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
125094021|NCT04516291|449962386|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
125094022|NCT04516291|449962387|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
125094023|NCT04516291|449962388|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
125094024|NCT04516291|449962389|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
125094025|NCT04516291|449962390|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
125094026|NCT04516291|449962391|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
125094027|NCT04516291|449962392|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
125094028|NCT04516291|449962385|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
125094029|NCT04516291|449962386|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
125094030|NCT04516291|449962387|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
125094031|NCT04516291|449962388|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
125094032|NCT04516291|449962389|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
125094033|NCT04516291|449962390|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
125094034|NCT04516291|449962391|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
125094035|NCT04516291|449962392|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
125094036|NCT02181634|449962396|FG000|Overall Study|Lack of Efficacy|33|||
125094037|NCT02181634|449962396|FG000|Overall Study|Adverse Event|17|||
125094038|NCT02181634|449962396|FG000|Overall Study|Physician Decision|8|||
125094039|NCT02181634|449962396|FG000|Overall Study|Withdrawal by Subject|5|||
125094040|NCT02181634|449962396|FG000|Overall Study|Death|2|||
125094041|NCT02181634|449962396|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
125094042|NCT02181634|449962396|FG000|Overall Study|Ineligible|1|||
125094043|NCT02181634|449962396|FG000|Overall Study|Max number of dose reduction|1|||
125094044|NCT02181634|449962396|FG000|Overall Study|Symptomatic progression|1|||
125094045|NCT02181634|449962396|FG000|Overall Study|Patient opted to proceed to surgery|1|||
125094046|NCT01928758|449962406|FG000|Overall Study|Lost to Follow-up|14|||
125094047|NCT01928758|449962407|FG001|Overall Study|Lost to Follow-up|9|||
125094048|NCT01928758|449962406|FG000|Overall Study|Withdrawal by Subject|5|||
125094049|NCT01928758|449962407|FG001|Overall Study|Withdrawal by Subject|2|||
125094050|NCT01928758|449962406|FG000|Overall Study|Adverse Event|3|||
125094051|NCT01928758|449962407|FG001|Overall Study|Adverse Event|5|||
125094052|NCT01928758|449962406|FG000|Overall Study|Protocol Violation|3|||
125094053|NCT01928758|449962407|FG001|Overall Study|Protocol Violation|4|||
125094054|NCT02718131|449962408|FG000|Overall Study|Withdrawal by Subject|1|||
125094055|NCT02718131|449962409|FG001|Overall Study|Withdrawal by Subject|0|||
125094056|NCT02718131|449962408|FG000|Overall Study|Adverse Event|1|||
125094057|NCT02718131|449962409|FG001|Overall Study|Adverse Event|0|||
125094058|NCT02718131|449962408|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
125094059|NCT02718131|449962409|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
125094060|NCT00719706|449962410|FG000|Overall Study|Adverse Event|5|||
125094061|NCT00719706|449962411|FG001|Overall Study|Adverse Event|4|||
125094062|NCT00719706|449962410|FG000|Overall Study|Withdrawal by Subject|1|||
125094063|NCT00719706|449962411|FG001|Overall Study|Withdrawal by Subject|2|||
125094064|NCT00719706|449962410|FG000|Overall Study|Protocol Violation|3|||
125094065|NCT00719706|449962411|FG001|Overall Study|Protocol Violation|0|||
125094066|NCT00134563|449962414|FG000|Overall Study|Not treated due to protocol violation|0|||
125094067|NCT00134563|449962415|FG001|Overall Study|Not treated due to protocol violation|1|||
125094068|NCT00134563|449962416|FG002|Overall Study|Not treated due to protocol violation|1|||
125094069|NCT00134563|449962414|FG000|Overall Study|Adverse Event|29|||
125094070|NCT00134563|449962415|FG001|Overall Study|Adverse Event|37|||
125094071|NCT00134563|449962416|FG002|Overall Study|Adverse Event|38|||
125094072|NCT00134563|449962414|FG000|Overall Study|Lack of Efficacy|24|||
125094073|NCT00134563|449962415|FG001|Overall Study|Lack of Efficacy|14|||
125094074|NCT00134563|449962416|FG002|Overall Study|Lack of Efficacy|17|||
125094075|NCT00134563|449962414|FG000|Overall Study|Protocol Violation|3|||
125094076|NCT00134563|449962415|FG001|Overall Study|Protocol Violation|2|||
125094077|NCT00134563|449962416|FG002|Overall Study|Protocol Violation|5|||
125094078|NCT00134563|449962414|FG000|Overall Study|Lost to Follow-up|4|||
125094079|NCT00134563|449962415|FG001|Overall Study|Lost to Follow-up|0|||
125094080|NCT00134563|449962416|FG002|Overall Study|Lost to Follow-up|2|||
125094081|NCT00134563|449962414|FG000|Overall Study|progressive disease|11|||
125094082|NCT00134563|449962415|FG001|Overall Study|progressive disease|4|||
125094083|NCT00134563|449962416|FG002|Overall Study|progressive disease|2|||
125094084|NCT00134563|449962414|FG000|Overall Study|did not wish to continue|33|||
125094085|NCT00134563|449962415|FG001|Overall Study|did not wish to continue|32|||
125094086|NCT00134563|449962416|FG002|Overall Study|did not wish to continue|26|||
125094087|NCT00134563|449962414|FG000|Overall Study|Reason other than above|0|||
125094088|NCT00134563|449962415|FG001|Overall Study|Reason other than above|2|||
125094089|NCT00134563|449962416|FG002|Overall Study|Reason other than above|5|||
125094090|NCT03382639|449962420|FG000|Overall Study|Adverse Event|2|||
125094091|NCT03382639|449962421|FG001|Overall Study|Adverse Event|0|||
125094092|NCT03382639|449962422|FG002|Overall Study|Adverse Event|1|||
125094093|NCT03382639|449962423|FG003|Overall Study|Adverse Event|1|||
125094094|NCT03382639|449962420|FG000|Overall Study|Lost to Follow-up|1|||
125094095|NCT03382639|449962421|FG001|Overall Study|Lost to Follow-up|0|||
125094096|NCT03382639|449962422|FG002|Overall Study|Lost to Follow-up|0|||
125094097|NCT03382639|449962423|FG003|Overall Study|Lost to Follow-up|0|||
125094098|NCT03382639|449962420|FG000|Overall Study|Withdrawal by Subject|4|||
125094099|NCT03382639|449962421|FG001|Overall Study|Withdrawal by Subject|3|||
125094100|NCT03382639|449962422|FG002|Overall Study|Withdrawal by Subject|2|||
125094101|NCT03382639|449962423|FG003|Overall Study|Withdrawal by Subject|3|||
125094102|NCT03382639|449962420|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
125094103|NCT03382639|449962421|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
125094104|NCT03382639|449962422|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
125094105|NCT03382639|449962423|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
125094106|NCT03382639|449962420|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
125094107|NCT03382639|449962421|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
125094108|NCT03382639|449962422|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
125094109|NCT03382639|449962423|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
125094110|NCT03382639|449962420|FG000|Overall Study|Other|2|||
125094111|NCT03382639|449962421|FG001|Overall Study|Other|0|||
125094112|NCT03382639|449962422|FG002|Overall Study|Other|0|||
125094113|NCT03382639|449962423|FG003|Overall Study|Other|3|||
125094114|NCT02406586|449962424|FG000|Overall Study|Lost to Follow-up|0|||
125094115|NCT02406586|449962425|FG001|Overall Study|Lost to Follow-up|4|||
125094116|NCT02406586|449962426|FG002|Overall Study|Lost to Follow-up|2|||
125094117|NCT02406586|449962424|FG000|Overall Study|Withdrawal by Subject|1|||
125094118|NCT02406586|449962425|FG001|Overall Study|Withdrawal by Subject|0|||
125094119|NCT02406586|449962426|FG002|Overall Study|Withdrawal by Subject|0|||
125094120|NCT00682539|449962429|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
125094121|NCT00682539|449962430|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
125094122|NCT00682539|449962431|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
125094123|NCT00682539|449962429|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
125094124|NCT00682539|449962430|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
125094125|NCT00682539|449962431|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
125094126|NCT01911546|449962434|FG000|Overall Study|Lost to Follow-up|1|||
125094127|NCT01911546|449962434|FG000|Overall Study|Everolimus was discontinued|5|||
125094128|NCT02546193|449962435|FG000|Overall Study|Withdrawal by Subject|2|||
125094129|NCT02546193|449962436|FG001|Overall Study|Withdrawal by Subject|0|||
125094130|NCT02546193|449962437|FG002|Overall Study|Withdrawal by Subject|1|||
125094131|NCT02546193|449962438|FG003|Overall Study|Withdrawal by Subject|0|||
125094132|NCT02546193|449962435|FG000|Overall Study|Not eligible at time of induction|4|||
125094133|NCT02546193|449962436|FG001|Overall Study|Not eligible at time of induction|6|||
125094134|NCT02546193|449962437|FG002|Overall Study|Not eligible at time of induction|1|||
125094135|NCT02546193|449962438|FG003|Overall Study|Not eligible at time of induction|0|||
125094136|NCT01287403|449962439|FG000|1st Intervention (1 Day)|Adverse Event|1|||
125094137|NCT00148109|449962440|FG000|Overall Study|Lack of Efficacy|10|||
125094138|NCT00148109|449962441|FG001|Overall Study|Lack of Efficacy|18|||
125094139|NCT00148109|449962440|FG000|Overall Study|Adverse Event|0|||
125094140|NCT00148109|449962441|FG001|Overall Study|Adverse Event|2|||
125094141|NCT00148109|449962440|FG000|Overall Study|Withdrawal by Subject|2|||
125094142|NCT00148109|449962441|FG001|Overall Study|Withdrawal by Subject|0|||
125094143|NCT00649220|449962442|FG000|Overall Study|Adverse Event|2|||
125094144|NCT00649220|449962442|FG000|Overall Study|Withdrawal by Subject|1|||
125094145|NCT01399619|449962443|FG000|Overall Study|Adverse Event|10|||
125094146|NCT01399619|449962444|FG001|Overall Study|Adverse Event|0|||
125094147|NCT01399619|449962445|FG002|Overall Study|Adverse Event|4|||
125094148|NCT01399619|449962446|FG003|Overall Study|Adverse Event|10|||
125094149|NCT01399619|449962443|FG000|Overall Study|Lack of Efficacy|9|||
125094150|NCT01399619|449962444|FG001|Overall Study|Lack of Efficacy|0|||
125094151|NCT01399619|449962445|FG002|Overall Study|Lack of Efficacy|5|||
125094152|NCT01399619|449962446|FG003|Overall Study|Lack of Efficacy|0|||
125094153|NCT01399619|449962443|FG000|Overall Study|Withdrawal by Subject|6|||
125094154|NCT01399619|449962444|FG001|Overall Study|Withdrawal by Subject|0|||
125094155|NCT01399619|449962445|FG002|Overall Study|Withdrawal by Subject|3|||
125094156|NCT01399619|449962446|FG003|Overall Study|Withdrawal by Subject|4|||
125094157|NCT01399619|449962443|FG000|Overall Study|Protocol Violation|0|||
125094158|NCT01399619|449962444|FG001|Overall Study|Protocol Violation|0|||
125094159|NCT01399619|449962445|FG002|Overall Study|Protocol Violation|0|||
125094160|NCT01399619|449962446|FG003|Overall Study|Protocol Violation|1|||
125094161|NCT01399619|449962443|FG000|Overall Study|Not treated|0|||
125094162|NCT01399619|449962444|FG001|Overall Study|Not treated|0|||
125094163|NCT01399619|449962445|FG002|Overall Study|Not treated|0|||
125094164|NCT01399619|449962446|FG003|Overall Study|Not treated|2|||
125094165|NCT02557308|449962447|FG000|Overall Study|Withdrawal by Subject|11|||
125094166|NCT02557308|449962448|FG001|Overall Study|Withdrawal by Subject|3|||
125094167|NCT02557308|449962449|FG002|Overall Study|Withdrawal by Subject|2|||
125094168|NCT02557308|449962450|FG003|Overall Study|Withdrawal by Subject|0|||
125094169|NCT02557308|449962451|FG004|Overall Study|Withdrawal by Subject|1|||
125094170|NCT02557308|449962452|FG005|Overall Study|Withdrawal by Subject|0|||
125094171|NCT02557308|449962453|FG006|Overall Study|Withdrawal by Subject|10|||
125094172|NCT02557308|449962454|FG007|Overall Study|Withdrawal by Subject|1|||
125094173|NCT02557308|449962447|FG000|Overall Study|Disease Progression|0|||
125094174|NCT02557308|449962448|FG001|Overall Study|Disease Progression|1|||
125094175|NCT02557308|449962449|FG002|Overall Study|Disease Progression|0|||
125094176|NCT02557308|449962450|FG003|Overall Study|Disease Progression|0|||
125094177|NCT02557308|449962451|FG004|Overall Study|Disease Progression|0|||
125094178|NCT02557308|449962452|FG005|Overall Study|Disease Progression|0|||
125094179|NCT02557308|449962453|FG006|Overall Study|Disease Progression|0|||
125094180|NCT02557308|449962454|FG007|Overall Study|Disease Progression|0|||
125094181|NCT02557308|449962447|FG000|Overall Study|Lack of Efficacy|3|||
125094182|NCT02557308|449962448|FG001|Overall Study|Lack of Efficacy|0|||
125094183|NCT02557308|449962449|FG002|Overall Study|Lack of Efficacy|0|||
125094184|NCT02557308|449962450|FG003|Overall Study|Lack of Efficacy|0|||
125094185|NCT02557308|449962451|FG004|Overall Study|Lack of Efficacy|0|||
125094186|NCT02557308|449962452|FG005|Overall Study|Lack of Efficacy|0|||
125094187|NCT02557308|449962453|FG006|Overall Study|Lack of Efficacy|1|||
125094188|NCT02557308|449962454|FG007|Overall Study|Lack of Efficacy|0|||
125094189|NCT02557308|449962447|FG000|Overall Study|Adverse Event|4|||
125094190|NCT02557308|449962448|FG001|Overall Study|Adverse Event|1|||
125094191|NCT02557308|449962449|FG002|Overall Study|Adverse Event|2|||
125094192|NCT02557308|449962450|FG003|Overall Study|Adverse Event|0|||
125094193|NCT02557308|449962451|FG004|Overall Study|Adverse Event|0|||
125094194|NCT02557308|449962452|FG005|Overall Study|Adverse Event|0|||
125094195|NCT02557308|449962453|FG006|Overall Study|Adverse Event|4|||
125094196|NCT02557308|449962454|FG007|Overall Study|Adverse Event|1|||
125094197|NCT02557308|449962447|FG000|Overall Study|Lost to Follow-up|2|||
125094198|NCT02557308|449962448|FG001|Overall Study|Lost to Follow-up|0|||
125094199|NCT02557308|449962449|FG002|Overall Study|Lost to Follow-up|1|||
125094200|NCT02557308|449962450|FG003|Overall Study|Lost to Follow-up|0|||
125094201|NCT02557308|449962451|FG004|Overall Study|Lost to Follow-up|0|||
125094202|NCT02557308|449962452|FG005|Overall Study|Lost to Follow-up|0|||
125094203|NCT02557308|449962453|FG006|Overall Study|Lost to Follow-up|2|||
125094204|NCT02557308|449962454|FG007|Overall Study|Lost to Follow-up|0|||
125094205|NCT02557308|449962447|FG000|Overall Study|Death|1|||
125094206|NCT02557308|449962448|FG001|Overall Study|Death|0|||
124873000|NCT00508261|449157215|FG003|Overall Study|Lost to Follow-up|1|||
125094207|NCT02557308|449962449|FG002|Overall Study|Death|0|||
125094208|NCT02557308|449962450|FG003|Overall Study|Death|0|||
125094209|NCT02557308|449962451|FG004|Overall Study|Death|0|||
125094210|NCT02557308|449962452|FG005|Overall Study|Death|0|||
125094211|NCT02557308|449962453|FG006|Overall Study|Death|0|||
125094212|NCT02557308|449962454|FG007|Overall Study|Death|0|||
125094213|NCT02557308|449962447|FG000|Overall Study|Study Close|98|||
125094214|NCT02557308|449962448|FG001|Overall Study|Study Close|18|||
125094215|NCT02557308|449962449|FG002|Overall Study|Study Close|5|||
125094216|NCT02557308|449962450|FG003|Overall Study|Study Close|3|||
125094217|NCT02557308|449962451|FG004|Overall Study|Study Close|1|||
125094218|NCT02557308|449962452|FG005|Overall Study|Study Close|0|||
125094219|NCT02557308|449962453|FG006|Overall Study|Study Close|123|||
125094220|NCT02557308|449962454|FG007|Overall Study|Study Close|5|||
125094221|NCT02557308|449962447|FG000|Overall Study|Except for study close|5|||
125094222|NCT02557308|449962448|FG001|Overall Study|Except for study close|0|||
125094223|NCT02557308|449962449|FG002|Overall Study|Except for study close|0|||
125094224|NCT02557308|449962450|FG003|Overall Study|Except for study close|0|||
125094225|NCT02557308|449962451|FG004|Overall Study|Except for study close|3|||
125094226|NCT02557308|449962452|FG005|Overall Study|Except for study close|0|||
125094227|NCT02557308|449962453|FG006|Overall Study|Except for study close|6|||
125094228|NCT02557308|449962454|FG007|Overall Study|Except for study close|10|||
125094229|NCT00351611|449962457|FG000|Overall Study|Adverse Event|11|||
125094230|NCT00351611|449962458|FG001|Overall Study|Adverse Event|3|||
125094231|NCT00351611|449962457|FG000|Overall Study|Death|1|||
125094232|NCT00351611|449962458|FG001|Overall Study|Death|0|||
125094233|NCT00351611|449962457|FG000|Overall Study|Lost to Follow-up|1|||
125094234|NCT00351611|449962458|FG001|Overall Study|Lost to Follow-up|0|||
125094235|NCT00351611|449962457|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
125094236|NCT00351611|449962458|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
125094237|NCT00351611|449962457|FG000|Overall Study|Other|1|||
125094238|NCT00351611|449962458|FG001|Overall Study|Other|0|||
125094239|NCT00351611|449962457|FG000|Overall Study|Protocol Violation|0|||
125094240|NCT00351611|449962458|FG001|Overall Study|Protocol Violation|2|||
125094241|NCT00267202|449962459|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
125094242|NCT00267202|449962460|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
125094243|NCT00267202|449962459|FG000|Overall Study|Withdrawal by Subject|12|||
125094244|NCT00267202|449962460|FG001|Overall Study|Withdrawal by Subject|15|||
125094245|NCT00267202|449962459|FG000|Overall Study|Adverse Event|13|||
125094246|NCT00267202|449962460|FG001|Overall Study|Adverse Event|7|||
125094247|NCT00267202|449962459|FG000|Overall Study|Protocol Violation|2|||
125094248|NCT00267202|449962460|FG001|Overall Study|Protocol Violation|3|||
125094249|NCT00267202|449962459|FG000|Overall Study|Administrative problems|2|||
125094250|NCT00267202|449962460|FG001|Overall Study|Administrative problems|1|||
125094251|NCT00267202|449962459|FG000|Overall Study|Lost to Follow-up|3|||
125094252|NCT00267202|449962460|FG001|Overall Study|Lost to Follow-up|0|||
125094253|NCT00368069|449962461|FG000|Overall Study|Adverse Event|5|||
125094254|NCT00368069|449962462|FG001|Overall Study|Adverse Event|2|||
125094255|NCT00368069|449962461|FG000|Overall Study|Lack of Efficacy|0|||
125094256|NCT00368069|449962462|FG001|Overall Study|Lack of Efficacy|1|||
125094257|NCT00368069|449962461|FG000|Overall Study|Lost to Follow-up|1|||
125094258|NCT00368069|449962462|FG001|Overall Study|Lost to Follow-up|0|||
125094259|NCT00368069|449962461|FG000|Overall Study|Protocol Violation|0|||
125094260|NCT00368069|449962462|FG001|Overall Study|Protocol Violation|2|||
125094261|NCT00368069|449962461|FG000|Overall Study|Withdrawal of Consent|2|||
125094262|NCT00368069|449962462|FG001|Overall Study|Withdrawal of Consent|1|||
125094263|NCT00368069|449962461|FG000|Overall Study|no blood sampling possible|0|||
125094264|NCT00368069|449962462|FG001|Overall Study|no blood sampling possible|1|||
125094265|NCT03907072|449962466|FG000|Overall Study|Study Terminated by Sponsor|2|||
125094266|NCT03907072|449962467|FG001|Overall Study|Study Terminated by Sponsor|2|||
125094267|NCT03907072|449962468|FG002|Overall Study|Study Terminated by Sponsor|2|||
125094268|NCT01430559|449962472|FG000|Overall Study|Adverse Event|7|||
125094269|NCT01430559|449962473|FG001|Overall Study|Adverse Event|3|||
125094270|NCT01430559|449962472|FG000|Overall Study|Entry criteria not met|1|||
125094271|NCT01430559|449962473|FG001|Overall Study|Entry criteria not met|1|||
125094272|NCT01430559|449962472|FG000|Overall Study|Lost to Follow-up|1|||
125094273|NCT01430559|449962473|FG001|Overall Study|Lost to Follow-up|0|||
125094274|NCT01430559|449962472|FG000|Overall Study|Medication error|1|||
125094275|NCT01430559|449962473|FG001|Overall Study|Medication error|0|||
125094276|NCT01430559|449962472|FG000|Overall Study|Withdrawal by Subject|3|||
125094277|NCT01430559|449962473|FG001|Overall Study|Withdrawal by Subject|2|||
125094278|NCT01430559|449962472|FG000|Overall Study|Protocol Violation|1|||
125094279|NCT01430559|449962473|FG001|Overall Study|Protocol Violation|0|||
125094280|NCT01430559|449962472|FG000|Overall Study|Other|3|||
125094281|NCT01430559|449962473|FG001|Overall Study|Other|3|||
125094282|NCT01430559|449962472|FG000|Overall Study|Randomized, Not Treated|3|||
125094283|NCT01430559|449962473|FG001|Overall Study|Randomized, Not Treated|3|||
125094284|NCT01177943|449962474|FG000|First Intervention|Withdrawal by Subject|2|||
125094285|NCT01177943|449962475|FG001|First Intervention|Withdrawal by Subject|0|||
125094286|NCT00808665|449962476|FG000|Overall Study|Withdrawal by Subject|1|||
125094287|NCT00808665|449962477|FG001|Overall Study|Withdrawal by Subject|0|||
125094288|NCT00808665|449962476|FG000|Overall Study|only required minimally invasive surgery|1|||
125094289|NCT00808665|449962477|FG001|Overall Study|only required minimally invasive surgery|0|||
125094290|NCT00808665|449962476|FG000|Overall Study|surgery cancelled|1|||
125094291|NCT00808665|449962477|FG001|Overall Study|surgery cancelled|0|||
125094292|NCT00808665|449962476|FG000|Overall Study|required an additional procedure|0|||
125094293|NCT00808665|449962477|FG001|Overall Study|required an additional procedure|1|||
125094294|NCT00808665|449962476|FG000|Overall Study|Physician Decision|3|||
125094295|NCT00808665|449962477|FG001|Overall Study|Physician Decision|1|||
125094296|NCT00808665|449962476|FG000|Overall Study|Medication stopped by resident|0|||
125094297|NCT00808665|449962477|FG001|Overall Study|Medication stopped by resident|1|||
125094298|NCT03319160|449962478|FG000|Overall Study|Data not available.|7|||
125094299|NCT02431559|449962479|FG000|Overall Study|Adverse Event|0|||
125094300|NCT02431559|449962480|FG001|Overall Study|Adverse Event|1|||
125094301|NCT02431559|449962481|FG002|Overall Study|Adverse Event|0|||
125094302|NCT02431559|449962482|FG003|Overall Study|Adverse Event|4|||
125094303|NCT02431559|449962479|FG000|Overall Study|Progressive disease|2|||
125094304|NCT02431559|449962480|FG001|Overall Study|Progressive disease|1|||
125094305|NCT02431559|449962481|FG002|Overall Study|Progressive disease|4|||
125094306|NCT02431559|449962482|FG003|Overall Study|Progressive disease|22|||
125094307|NCT02431559|449962479|FG000|Overall Study|Withdrawal by Subject|0|||
125094308|NCT02431559|449962480|FG001|Overall Study|Withdrawal by Subject|1|||
125094309|NCT02431559|449962481|FG002|Overall Study|Withdrawal by Subject|0|||
125094310|NCT02431559|449962482|FG003|Overall Study|Withdrawal by Subject|4|||
125094311|NCT02431559|449962479|FG000|Overall Study|Physician Decision|0|||
125094312|NCT02431559|449962480|FG001|Overall Study|Physician Decision|0|||
125094313|NCT02431559|449962481|FG002|Overall Study|Physician Decision|0|||
125094314|NCT02431559|449962482|FG003|Overall Study|Physician Decision|1|||
125094315|NCT02543918|449962483|FG000|Overall Study|Never treated|0|||
125094316|NCT02543918|449962484|FG001|Overall Study|Never treated|1|||
125094317|NCT02543918|449962483|FG000|Overall Study|Lost to Follow-up|1|||
125094318|NCT02543918|449962484|FG001|Overall Study|Lost to Follow-up|1|||
125094319|NCT02543918|449962483|FG000|Overall Study|Withdrawal by Subject|1|||
125094320|NCT02543918|449962484|FG001|Overall Study|Withdrawal by Subject|1|||
125094321|NCT02543918|449962483|FG000|Overall Study|Adverse Event|1|||
125094322|NCT02543918|449962484|FG001|Overall Study|Adverse Event|1|||
125094323|NCT01411917|449962486|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
125094324|NCT01411917|449962487|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
125094325|NCT04806334|449962494|FG000|Overall Study|Withdrawal by Subject|1|||
125094326|NCT01731600|449962497|FG000|Overall Study|Adverse Event|2|||
125094327|NCT01731600|449962498|FG001|Overall Study|Adverse Event|0|||
125094328|NCT01731600|449962497|FG000|Overall Study|Withdrawal criteria|1|||
125094329|NCT01731600|449962498|FG001|Overall Study|Withdrawal criteria|0|||
125094330|NCT01731600|449962497|FG000|Overall Study|Other reasons|3|||
125094331|NCT01731600|449962498|FG001|Overall Study|Other reasons|0|||
125094332|NCT00465894|449962499|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
125094333|NCT00465894|449962500|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
125094334|NCT00465894|449962499|FG000|Treatment For 12 Weeks|Family Issues|1|||
125094335|NCT00465894|449962500|FG001|Treatment For 12 Weeks|Family Issues|1|||
124873001|NCT00180479|449157216|FG000|Overall Study|Death|4|||
125094336|NCT00465894|449962499|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
125094337|NCT00465894|449962500|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
125094338|NCT01636076|449962501|FG000|Overall Study|Terminated by sponsor|1|||
125094339|NCT01636076|449962502|FG001|Overall Study|Terminated by sponsor|1|||
125094340|NCT01636076|449962501|FG000|Overall Study|Lack of Efficacy|0|||
125094341|NCT01636076|449962502|FG001|Overall Study|Lack of Efficacy|1|||
125094342|NCT01636076|449962501|FG000|Overall Study|Lost to Follow-up|1|||
125094343|NCT01636076|449962502|FG001|Overall Study|Lost to Follow-up|0|||
125094344|NCT01636076|449962501|FG000|Overall Study|Physician Decision|1|||
125094345|NCT01636076|449962502|FG001|Overall Study|Physician Decision|1|||
125094346|NCT01636076|449962501|FG000|Overall Study|Non-compliance with study treatment|1|||
125094347|NCT01636076|449962502|FG001|Overall Study|Non-compliance with study treatment|1|||
125094348|NCT01636076|449962501|FG000|Overall Study|Adverse Event|6|||
125094349|NCT01636076|449962502|FG001|Overall Study|Adverse Event|11|||
125094350|NCT01636076|449962501|FG000|Overall Study|Withdrawal by Subject|7|||
125094351|NCT01636076|449962502|FG001|Overall Study|Withdrawal by Subject|10|||
125094352|NCT00540228|449962503|FG000|Overall Study|Adverse Event|2|||
125094353|NCT00540228|449962504|FG001|Overall Study|Adverse Event|0|||
125094354|NCT00540228|449962505|FG002|Overall Study|Adverse Event|0|||
125094355|NCT00540228|449962506|FG003|Overall Study|Adverse Event|0|||
125094356|NCT00540228|449962507|FG004|Overall Study|Adverse Event|0|||
125094357|NCT00540228|449962503|FG000|Overall Study|Lost to Follow-up|1|||
125094358|NCT00540228|449962504|FG001|Overall Study|Lost to Follow-up|1|||
125094359|NCT00540228|449962505|FG002|Overall Study|Lost to Follow-up|0|||
125094360|NCT00540228|449962506|FG003|Overall Study|Lost to Follow-up|0|||
125094361|NCT00540228|449962507|FG004|Overall Study|Lost to Follow-up|0|||
125094362|NCT02173158|449962509|FG000|Efficacy Phase|Adverse Event|1|||
125094363|NCT00765726|449962521|FG000|Overall Study|Withdrawal by Subject|1|||
125094364|NCT00765726|449962521|FG000|Overall Study|Discontinuation of study by sponsor|8|||
125094365|NCT01265511|449962522|FG000|Overall Study|Lack of Efficacy|2|||
125094366|NCT01265511|449962523|FG001|Overall Study|Lack of Efficacy|1|||
125094367|NCT01265511|449962522|FG000|Overall Study|Met stopping rules|0|||
125094368|NCT01265511|449962523|FG001|Overall Study|Met stopping rules|2|||
125094369|NCT00323479|449962524|FG000|Overall Study|Adverse Event|2|||
125094370|NCT00323479|449962524|FG000|Overall Study|Withdrawal by Subject|2|||
125094371|NCT00323479|449962524|FG000|Overall Study|Protocol Violation|3|||
125094372|NCT00323479|449962524|FG000|Overall Study|house moving|1|||
125094373|NCT01362062|449962525|FG000|Overall Study|Adverse Event|1|||
125094374|NCT01362062|449962526|FG001|Overall Study|Adverse Event|0|||
125094375|NCT01362062|449962525|FG000|Overall Study|Lost to Follow-up|11|||
125094376|NCT01362062|449962526|FG001|Overall Study|Lost to Follow-up|0|||
125094377|NCT01362062|449962525|FG000|Overall Study|Withdrawal by Subject|2|||
125094378|NCT01362062|449962526|FG001|Overall Study|Withdrawal by Subject|0|||
125094379|NCT01362062|449962525|FG000|Overall Study|Non-compliant participant|2|||
125094380|NCT01362062|449962526|FG001|Overall Study|Non-compliant participant|0|||
125094381|NCT01362062|449962525|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
125094382|NCT01362062|449962526|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
125094383|NCT01362062|449962525|FG000|Overall Study|Had significant improvement|9|||
125094384|NCT01362062|449962526|FG001|Overall Study|Had significant improvement|0|||
125094385|NCT00967343|449962528|FG000|Overall Study|Study termination by sponsor|12|||
125094386|NCT00967343|449962528|FG000|Overall Study|Death|24|||
125094387|NCT00967343|449962528|FG000|Overall Study|Relapse|1|||
125094388|NCT00967343|449962528|FG000|Overall Study|Lost to Follow-up|1|||
125094389|NCT00950755|449962529|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
125094390|NCT00950755|449962529|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
125094391|NCT00950755|449962529|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
125094392|NCT00950755|449962529|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
125094393|NCT00950755|449962529|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
125094394|NCT00950755|449962529|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
125094395|NCT00950755|449962529|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
125094396|NCT00950755|449962529|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
125094397|NCT00950755|449962529|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
125094398|NCT00950755|449962529|FG000|Long-Term Follow-Up|Death|8|||
125094399|NCT00508820|449962530|FG000|Overall Study|Adverse Event|6|||
125094400|NCT00508820|449962531|FG001|Overall Study|Adverse Event|10|||
125094401|NCT00508820|449962530|FG000|Overall Study|Death|6|||
125094402|NCT00508820|449962531|FG001|Overall Study|Death|8|||
125094403|NCT00508820|449962530|FG000|Overall Study|Lost to Follow-up|1|||
125094404|NCT00508820|449962531|FG001|Overall Study|Lost to Follow-up|1|||
125094405|NCT00508820|449962530|FG000|Overall Study|Physician Decision|8|||
125094406|NCT00508820|449962531|FG001|Overall Study|Physician Decision|2|||
125094407|NCT00508820|449962530|FG000|Overall Study|Pregnancy|0|||
124873002|NCT00180479|449157217|FG001|Overall Study|Death|2|||
125094408|NCT00508820|449962531|FG001|Overall Study|Pregnancy|2|||
125094409|NCT00508820|449962530|FG000|Overall Study|Protocol Violation|2|||
125094410|NCT00508820|449962531|FG001|Overall Study|Protocol Violation|0|||
125094411|NCT00508820|449962530|FG000|Overall Study|Withdrawal by Subject|10|||
125094412|NCT00508820|449962531|FG001|Overall Study|Withdrawal by Subject|12|||
125094413|NCT00508820|449962530|FG000|Overall Study|Other|11|||
125094414|NCT00508820|449962531|FG001|Overall Study|Other|2|||
125094415|NCT00508820|449962530|FG000|Overall Study|Noncompliance|1|||
125094416|NCT00508820|449962531|FG001|Overall Study|Noncompliance|0|||
125094417|NCT00508820|449962530|FG000|Overall Study|Requirement for alternative therapy|7|||
125094418|NCT00508820|449962531|FG001|Overall Study|Requirement for alternative therapy|15|||
125094419|NCT00508820|449962530|FG000|Overall Study|Protocol-specified Criteria|3|||
125094420|NCT00508820|449962531|FG001|Overall Study|Protocol-specified Criteria|12|||
125094421|NCT02926833|449964034|FG000|Overall Study|Death|1|||
125094422|NCT02926833|449964035|FG001|Overall Study|Death|1|||
125094423|NCT02926833|449964036|FG002|Overall Study|Death|2|||
125094424|NCT02926833|449964037|FG003|Overall Study|Death|13|||
125094425|NCT02926833|449964034|FG000|Overall Study|Lost to Follow-up|1|||
125094426|NCT02926833|449964035|FG001|Overall Study|Lost to Follow-up|2|||
125094427|NCT02926833|449964036|FG002|Overall Study|Lost to Follow-up|0|||
125094428|NCT02926833|449964037|FG003|Overall Study|Lost to Follow-up|3|||
125094429|NCT02926833|449964034|FG000|Overall Study|Full Consent Withdrawal|0|||
125094430|NCT02926833|449964035|FG001|Overall Study|Full Consent Withdrawal|0|||
125094431|NCT02926833|449964036|FG002|Overall Study|Full Consent Withdrawal|0|||
125094432|NCT02926833|449964037|FG003|Overall Study|Full Consent Withdrawal|2|||
125094433|NCT02926833|449964034|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
125094434|NCT02926833|449964035|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
125094435|NCT02926833|449964036|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
125094436|NCT02926833|449964037|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
125094437|NCT02926833|449964034|FG000|Overall Study|Investigator Decision|0|||
125094438|NCT02926833|449964035|FG001|Overall Study|Investigator Decision|1|||
125094439|NCT02926833|449964036|FG002|Overall Study|Investigator Decision|0|||
125094440|NCT02926833|449964037|FG003|Overall Study|Investigator Decision|0|||
125094441|NCT02926833|449964034|FG000|Overall Study|Adverse Event|0|||
125094442|NCT02926833|449964035|FG001|Overall Study|Adverse Event|0|||
125094443|NCT02926833|449964036|FG002|Overall Study|Adverse Event|1|||
125094444|NCT02926833|449964037|FG003|Overall Study|Adverse Event|0|||
125094445|NCT02926833|449964034|FG000|Overall Study|Partial Withdrawal of Consent|0|||
125094446|NCT02926833|449964035|FG001|Overall Study|Partial Withdrawal of Consent|0|||
125094447|NCT02926833|449964036|FG002|Overall Study|Partial Withdrawal of Consent|0|||
125094448|NCT02926833|449964037|FG003|Overall Study|Partial Withdrawal of Consent|1|||
125094449|NCT01277757|449964040|FG000|Overall Study|Disease Progression|1|||
125094450|NCT01277757|449964040|FG000|Overall Study|Withdrawal by Subject|1|||
125094451|NCT04308668|449964041|FG000|Overall Study|Lost to Follow-up|32|||
125094452|NCT04308668|449964042|FG001|Overall Study|Lost to Follow-up|38|||
125094453|NCT04308668|449964041|FG000|Overall Study|Withdrawal by Subject|4|||
125094454|NCT04308668|449964042|FG001|Overall Study|Withdrawal by Subject|4|||
125094455|NCT01945866|449964043|FG000|Overall Study|Eyes did not complete or were dropped|2|||
125006793|NCT01994382|449653315|FG009|Overall Study|Informed consent withdrawn|0|||
125006794|NCT01994382|449653316|FG010|Overall Study|Informed consent withdrawn|0|||
125006795|NCT01994382|449653317|FG011|Overall Study|Informed consent withdrawn|0|||
125006796|NCT01994382|449653318|FG012|Overall Study|Informed consent withdrawn|0|||
125006797|NCT01994382|449653319|FG013|Overall Study|Informed consent withdrawn|0|||
125006798|NCT01994382|449653320|FG014|Overall Study|Informed consent withdrawn|0|||
125006799|NCT01994382|449653321|FG015|Overall Study|Informed consent withdrawn|0|||
125006800|NCT01994382|449653322|FG016|Overall Study|Informed consent withdrawn|0|||
125006801|NCT01994382|449653306|FG000|Overall Study|Progressive disease|3|||
125006802|NCT01994382|449653307|FG001|Overall Study|Progressive disease|4|||
125094456|NCT01945866|449964044|FG001|Overall Study|Eyes did not complete or were dropped|0|||
125094457|NCT03808298|449964045|FG000|Overall Study|Adverse Event|3|||
125094458|NCT03808298|449964045|FG000|Overall Study|Physician Decision|1|||
125094459|NCT03808298|449964045|FG000|Overall Study|Withdrawal by Subject|1|||
125094460|NCT03808298|449964045|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
125094461|NCT01004822|449964046|FG000|Overall Study|Objective progression or relapse|3|||
125094462|NCT01004822|449964047|FG001|Overall Study|Objective progression or relapse|3|||
125094463|NCT01004822|449964048|FG002|Overall Study|Objective progression or relapse|0|||
125094464|NCT01004822|449964049|FG003|Overall Study|Objective progression or relapse|1|||
125094465|NCT01004822|449964050|FG004|Overall Study|Objective progression or relapse|2|||
125094466|NCT01004822|449964051|FG005|Overall Study|Objective progression or relapse|2|||
125094467|NCT01004822|449964052|FG006|Overall Study|Objective progression or relapse|1|||
125094468|NCT01004822|449964053|FG007|Overall Study|Objective progression or relapse|4|||
125094469|NCT01004822|449964046|FG000|Overall Study|Global deterioration of health status|0|||
125094470|NCT01004822|449964047|FG001|Overall Study|Global deterioration of health status|0|||
125094471|NCT01004822|449964048|FG002|Overall Study|Global deterioration of health status|0|||
125094472|NCT01004822|449964049|FG003|Overall Study|Global deterioration of health status|1|||
125094473|NCT01004822|449964050|FG004|Overall Study|Global deterioration of health status|0|||
125094474|NCT01004822|449964051|FG005|Overall Study|Global deterioration of health status|0|||
125094475|NCT01004822|449964052|FG006|Overall Study|Global deterioration of health status|1|||
125094476|NCT01004822|449964053|FG007|Overall Study|Global deterioration of health status|0|||
125094477|NCT01004822|449964046|FG000|Overall Study|No longer willing to continue|0|||
125094478|NCT01004822|449964047|FG001|Overall Study|No longer willing to continue|0|||
125094479|NCT01004822|449964048|FG002|Overall Study|No longer willing to continue|0|||
125094480|NCT01004822|449964049|FG003|Overall Study|No longer willing to continue|1|||
125094481|NCT01004822|449964050|FG004|Overall Study|No longer willing to continue|2|||
125094482|NCT01004822|449964051|FG005|Overall Study|No longer willing to continue|1|||
125094483|NCT01004822|449964052|FG006|Overall Study|No longer willing to continue|1|||
125094484|NCT01004822|449964053|FG007|Overall Study|No longer willing to continue|0|||
125094485|NCT01004822|449964046|FG000|Overall Study|Adverse Event|0|||
125094486|NCT01004822|449964047|FG001|Overall Study|Adverse Event|0|||
125094487|NCT01004822|449964048|FG002|Overall Study|Adverse Event|0|||
125094488|NCT01004822|449964049|FG003|Overall Study|Adverse Event|0|||
125094489|NCT01004822|449964050|FG004|Overall Study|Adverse Event|0|||
125094490|NCT01004822|449964051|FG005|Overall Study|Adverse Event|0|||
125094491|NCT01004822|449964052|FG006|Overall Study|Adverse Event|1|||
125094492|NCT01004822|449964053|FG007|Overall Study|Adverse Event|1|||
125094493|NCT01004822|449964046|FG000|Overall Study|Other|0|||
125094494|NCT01004822|449964047|FG001|Overall Study|Other|0|||
125094495|NCT01004822|449964048|FG002|Overall Study|Other|4|||
125094496|NCT01004822|449964049|FG003|Overall Study|Other|1|||
125094497|NCT01004822|449964050|FG004|Overall Study|Other|0|||
125094498|NCT01004822|449964051|FG005|Overall Study|Other|1|||
125094499|NCT01004822|449964052|FG006|Overall Study|Other|0|||
125094500|NCT01004822|449964053|FG007|Overall Study|Other|0|||
125094501|NCT01858701|449964054|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
125094502|NCT01858701|449964055|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
125094503|NCT01858701|449964054|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
125094504|NCT01858701|449964055|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
125094505|NCT01858701|449964054|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
125094506|NCT01858701|449964055|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
125094507|NCT01858701|449964054|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
125094508|NCT01858701|449964055|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
125094509|NCT01674010|449964056|FG000|Open Treatment Phase 1|Adverse Event|10|||
125094510|NCT01674010|449964057|FG001|Open Treatment Phase 1|Adverse Event|0|||
125094511|NCT01674010|449964058|FG002|Open Treatment Phase 1|Adverse Event|0|||
125094512|NCT01674010|449964056|FG000|Open Treatment Phase 1|Death|1|||
125094513|NCT01674010|449964057|FG001|Open Treatment Phase 1|Death|0|||
125094514|NCT01674010|449964058|FG002|Open Treatment Phase 1|Death|0|||
125094515|NCT01674010|449964056|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
125094516|NCT01674010|449964057|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
125094517|NCT01674010|449964058|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
125094518|NCT01674010|449964056|FG000|Open Treatment Phase 1|Physician Decision|9|||
125094519|NCT01674010|449964057|FG001|Open Treatment Phase 1|Physician Decision|0|||
125094520|NCT01674010|449964058|FG002|Open Treatment Phase 1|Physician Decision|0|||
125094521|NCT01674010|449964056|FG000|Open Treatment Phase 1|Protocol Violation|7|||
125094522|NCT01674010|449964057|FG001|Open Treatment Phase 1|Protocol Violation|0|||
125094523|NCT01674010|449964058|FG002|Open Treatment Phase 1|Protocol Violation|0|||
125094524|NCT01674010|449964056|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
125094525|NCT01674010|449964057|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
125094526|NCT01674010|449964058|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
125094527|NCT01674010|449964056|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
125094528|NCT01674010|449964057|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
125094529|NCT01674010|449964058|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
125094530|NCT01674010|449964056|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
125094531|NCT01674010|449964057|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
125094532|NCT01674010|449964058|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
125094533|NCT01674010|449964056|FG000|Randomization Phase 2|Adverse Event|0|||
125094534|NCT01674010|449964057|FG001|Randomization Phase 2|Adverse Event|1|||
125094535|NCT01674010|449964058|FG002|Randomization Phase 2|Adverse Event|1|||
125094536|NCT01674010|449964056|FG000|Randomization Phase 2|Lost to Follow-up|0|||
125094537|NCT01674010|449964057|FG001|Randomization Phase 2|Lost to Follow-up|1|||
125094538|NCT01674010|449964058|FG002|Randomization Phase 2|Lost to Follow-up|2|||
125094539|NCT01674010|449964056|FG000|Randomization Phase 2|Mood episode recurrence|0|||
125094540|NCT01674010|449964057|FG001|Randomization Phase 2|Mood episode recurrence|8|||
125094541|NCT01674010|449964058|FG002|Randomization Phase 2|Mood episode recurrence|2|||
125094542|NCT01674010|449964056|FG000|Randomization Phase 2|Physician Decision|0|||
125094543|NCT01674010|449964057|FG001|Randomization Phase 2|Physician Decision|0|||
125094544|NCT01674010|449964058|FG002|Randomization Phase 2|Physician Decision|2|||
125094545|NCT01674010|449964056|FG000|Randomization Phase 2|Pregnancy|0|||
125094546|NCT01674010|449964057|FG001|Randomization Phase 2|Pregnancy|1|||
125094547|NCT01674010|449964058|FG002|Randomization Phase 2|Pregnancy|1|||
125094548|NCT01674010|449964056|FG000|Randomization Phase 2|Protocol Violation|0|||
125094549|NCT01674010|449964057|FG001|Randomization Phase 2|Protocol Violation|1|||
125094550|NCT01674010|449964058|FG002|Randomization Phase 2|Protocol Violation|1|||
125094551|NCT01674010|449964056|FG000|Randomization Phase 2|Sponsor Decision|0|||
125094552|NCT01674010|449964057|FG001|Randomization Phase 2|Sponsor Decision|42|||
125094553|NCT01674010|449964058|FG002|Randomization Phase 2|Sponsor Decision|45|||
125094554|NCT01674010|449964056|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
125094555|NCT01674010|449964057|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
125094556|NCT01674010|449964058|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
125094557|NCT01801475|449964063|FG000|Overall Study|Withdrawal by Subject|0|||
125094558|NCT01801475|449964064|FG001|Overall Study|Withdrawal by Subject|0|||
125094559|NCT01801475|449964065|FG002|Overall Study|Withdrawal by Subject|0|||
125094560|NCT01801475|449964066|FG003|Overall Study|Withdrawal by Subject|0|||
125094561|NCT01801475|449964067|FG004|Overall Study|Withdrawal by Subject|1|||
125094562|NCT00421928|449964070|FG000|Overall Study|Adverse Event|61|||
125094563|NCT00421928|449964071|FG001|Overall Study|Adverse Event|140|||
125094564|NCT00421928|449964072|FG002|Overall Study|Adverse Event|22|||
125094565|NCT00421928|449964070|FG000|Overall Study|Lost to Follow-up|5|||
125094566|NCT00421928|449964071|FG001|Overall Study|Lost to Follow-up|0|||
125094567|NCT00421928|449964072|FG002|Overall Study|Lost to Follow-up|3|||
125094568|NCT00421928|449964070|FG000|Overall Study|Withdrawal by Subject|50|||
125094569|NCT00421928|449964071|FG001|Overall Study|Withdrawal by Subject|48|||
125094570|NCT00421928|449964072|FG002|Overall Study|Withdrawal by Subject|43|||
125094571|NCT00421928|449964070|FG000|Overall Study|Lack of Efficacy|15|||
125094572|NCT00421928|449964071|FG001|Overall Study|Lack of Efficacy|7|||
125094573|NCT00421928|449964072|FG002|Overall Study|Lack of Efficacy|35|||
125094574|NCT00421928|449964070|FG000|Overall Study|Study drug non-compliant|6|||
125094575|NCT00421928|449964071|FG001|Overall Study|Study drug non-compliant|7|||
125094576|NCT00421928|449964072|FG002|Overall Study|Study drug non-compliant|4|||
125094577|NCT00421928|449964070|FG000|Overall Study|All other|26|||
125094578|NCT00421928|449964071|FG001|Overall Study|All other|21|||
125094579|NCT00421928|449964072|FG002|Overall Study|All other|27|||
125094580|NCT00421928|449964070|FG000|Overall Study|Death|0|||
125094581|NCT00421928|449964071|FG001|Overall Study|Death|1|||
125094582|NCT00421928|449964072|FG002|Overall Study|Death|0|||
125094583|NCT02713490|449964081|FG000|Overall Study|Withdrawal by Subject|2|||
125094584|NCT02713490|449964082|FG001|Overall Study|Withdrawal by Subject|1|||
125094585|NCT02713490|449964081|FG000|Overall Study|Did not receive study drug|1|||
125094586|NCT02713490|449964082|FG001|Overall Study|Did not receive study drug|0|||
125094587|NCT02713490|449964081|FG000|Overall Study|Met exclusion criteria|0|||
125094588|NCT02713490|449964082|FG001|Overall Study|Met exclusion criteria|1|||
125094589|NCT00346775|449964083|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
125094590|NCT00346775|449964084|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
125094591|NCT00346775|449964083|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
125094592|NCT00346775|449964084|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
125094593|NCT00346775|449964083|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
125094594|NCT00346775|449964084|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
125094595|NCT03799198|449964085|FG000|Overall Study|Lost to Follow-up|4|||
125094596|NCT03799198|449964086|FG001|Overall Study|Lost to Follow-up|8|||
125094597|NCT03799198|449964085|FG000|Overall Study|Death|0|||
125094598|NCT03799198|449964086|FG001|Overall Study|Death|1|||
125094599|NCT00960869|449964087|FG000|Overall Study|Adverse Event|17|||
125094600|NCT00960869|449964088|FG001|Overall Study|Adverse Event|26|||
125094601|NCT00960869|449964087|FG000|Overall Study|Withdrawal by Subject|16|||
125094602|NCT00960869|449964088|FG001|Overall Study|Withdrawal by Subject|14|||
125094603|NCT00960869|449964087|FG000|Overall Study|Lost to Follow-up|1|||
125094604|NCT00960869|449964088|FG001|Overall Study|Lost to Follow-up|4|||
125094605|NCT00960869|449964087|FG000|Overall Study|Misc|19|||
125094606|NCT00960869|449964088|FG001|Overall Study|Misc|18|||
125094607|NCT01714726|449964089|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
125094608|NCT01714726|449964090|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
125094609|NCT01714726|449964091|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
125094610|NCT01714726|449964092|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
125094611|NCT01714726|449964089|FG000|Double-Blinded Induction Period|Adverse Event|0|||
125094612|NCT01714726|449964090|FG001|Double-Blinded Induction Period|Adverse Event|1|||
125094613|NCT01714726|449964091|FG002|Double-Blinded Induction Period|Adverse Event|0|||
125094614|NCT01714726|449964092|FG003|Double-Blinded Induction Period|Adverse Event|0|||
125094615|NCT01714726|449964089|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
125094616|NCT01714726|449964090|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
125094617|NCT01714726|449964091|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
125094618|NCT01714726|449964092|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
125094619|NCT01714726|449964089|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
125094620|NCT01714726|449964090|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
125094621|NCT01714726|449964091|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
125094622|NCT01714726|449964092|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
125094623|NCT01714726|449964089|FG000|Open-Label Period|Other|0|||
125094624|NCT01714726|449964090|FG001|Open-Label Period|Other|0|||
125094625|NCT01714726|449964091|FG002|Open-Label Period|Other|1|||
125094626|NCT01714726|449964092|FG003|Open-Label Period|Other|3|||
125094627|NCT01714726|449964089|FG000|Open-Label Period|Adverse Event|0|||
125094628|NCT01714726|449964090|FG001|Open-Label Period|Adverse Event|0|||
125094629|NCT01714726|449964091|FG002|Open-Label Period|Adverse Event|1|||
125094630|NCT01714726|449964092|FG003|Open-Label Period|Adverse Event|0|||
125094631|NCT01714726|449964089|FG000|Open-Label Period|Withdrawal by Subject|0|||
125094632|NCT01714726|449964090|FG001|Open-Label Period|Withdrawal by Subject|0|||
125094633|NCT01714726|449964091|FG002|Open-Label Period|Withdrawal by Subject|9|||
125094634|NCT01714726|449964092|FG003|Open-Label Period|Withdrawal by Subject|19|||
125094635|NCT01714726|449964089|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
125094636|NCT01714726|449964090|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
125094637|NCT01714726|449964091|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
125094638|NCT01714726|449964092|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
125094639|NCT01714726|449964089|FG000|Open-Label Period|Lost to Follow-up|0|||
125094640|NCT01714726|449964090|FG001|Open-Label Period|Lost to Follow-up|0|||
125094641|NCT01714726|449964091|FG002|Open-Label Period|Lost to Follow-up|3|||
125094642|NCT01714726|449964092|FG003|Open-Label Period|Lost to Follow-up|4|||
125094643|NCT00548340|449964095|FG000|Overall Study|Protocol Violation|2|||
125094644|NCT00548340|449964096|FG001|Overall Study|Protocol Violation|3|||
125094645|NCT00548340|449964097|FG002|Overall Study|Protocol Violation|3|||
125094646|NCT00548340|449964095|FG000|Overall Study|Adverse Event|2|||
125094647|NCT00548340|449964096|FG001|Overall Study|Adverse Event|2|||
125094648|NCT00548340|449964097|FG002|Overall Study|Adverse Event|2|||
125006803|NCT01994382|449653308|FG002|Overall Study|Progressive disease|4|||
125006804|NCT01994382|449653309|FG003|Overall Study|Progressive disease|3|||
125006805|NCT01994382|449653310|FG004|Overall Study|Progressive disease|2|||
125006806|NCT01994382|449653311|FG005|Overall Study|Progressive disease|3|||
125006807|NCT01994382|449653312|FG006|Overall Study|Progressive disease|3|||
125006808|NCT01994382|449653313|FG007|Overall Study|Progressive disease|6|||
125006809|NCT01994382|449653314|FG008|Overall Study|Progressive disease|2|||
125006810|NCT01994382|449653315|FG009|Overall Study|Progressive disease|2|||
125094649|NCT00548340|449964095|FG000|Overall Study|Lost to Follow-up|1|||
125006811|NCT01994382|449653316|FG010|Overall Study|Progressive disease|13|||
125094650|NCT00548340|449964096|FG001|Overall Study|Lost to Follow-up|1|||
125094651|NCT00548340|449964097|FG002|Overall Study|Lost to Follow-up|0|||
125094652|NCT00548340|449964095|FG000|Overall Study|Withdrawal by Subject|2|||
125094653|NCT00548340|449964096|FG001|Overall Study|Withdrawal by Subject|4|||
125094654|NCT00548340|449964097|FG002|Overall Study|Withdrawal by Subject|3|||
125094655|NCT00548340|449964095|FG000|Overall Study|Other|1|||
125094656|NCT00548340|449964096|FG001|Overall Study|Other|1|||
125094657|NCT00548340|449964097|FG002|Overall Study|Other|1|||
125094658|NCT01096017|449964098|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
125094659|NCT01096017|449964099|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
124873003|NCT00180479|449157216|FG000|Overall Study|Lost to Follow-up|9|||
125094660|NCT02600559|449964103|FG000|Overall Study|Withdrawal by Subject|3|||
125094661|NCT02600559|449964103|FG000|Overall Study|Lost to Follow-up|20|||
125094662|NCT00501969|449964104|FG000|Overall Study|Major Protocol Violation|4|||
125094663|NCT00501969|449964104|FG000|Overall Study|Lack of Efficacy|29|||
125094664|NCT00501969|449964104|FG000|Overall Study|Adverse Event|76|||
125094665|NCT00501969|449964104|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
125094666|NCT00501969|449964104|FG000|Overall Study|Subject withdrew consent|51|||
125094667|NCT00501969|449964104|FG000|Overall Study|Lost to Follow-up|4|||
125094668|NCT00501969|449964104|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
125094669|NCT00501969|449964104|FG000|Overall Study|Other: Sponsors Request|10|||
125094670|NCT00501969|449964104|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
125094671|NCT00501969|449964104|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
125094672|NCT00501969|449964104|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
125094673|NCT00501969|449964104|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
125094674|NCT00501969|449964104|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
125094675|NCT00501969|449964104|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
125094676|NCT00501969|449964104|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
125094677|NCT00501969|449964104|FG000|Overall Study|Other: As Required by Local EC|2|||
125094678|NCT00501969|449964104|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
125094679|NCT00501969|449964104|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
125094680|NCT00665366|449964105|FG000|Overall Study|Lack of Efficacy|11|||
125094681|NCT00665366|449964106|FG001|Overall Study|Lack of Efficacy|10|||
125094682|NCT00665366|449964105|FG000|Overall Study|Adverse Event|25|||
125094683|NCT00665366|449964106|FG001|Overall Study|Adverse Event|23|||
125094684|NCT00665366|449964105|FG000|Overall Study|Withdrawal by Subject|11|||
125094685|NCT00665366|449964106|FG001|Overall Study|Withdrawal by Subject|14|||
125094686|NCT00665366|449964105|FG000|Overall Study|Lost to Follow-up|3|||
125094687|NCT00665366|449964106|FG001|Overall Study|Lost to Follow-up|5|||
125094688|NCT00665366|449964105|FG000|Overall Study|Poor compliance/noncompliance|3|||
125094689|NCT00665366|449964106|FG001|Overall Study|Poor compliance/noncompliance|5|||
125094690|NCT00665366|449964105|FG000|Overall Study|Pregnancy|1|||
125094691|NCT00665366|449964106|FG001|Overall Study|Pregnancy|0|||
125094692|NCT00665366|449964105|FG000|Overall Study|No longer meets study criteria|0|||
125094693|NCT00665366|449964106|FG001|Overall Study|No longer meets study criteria|1|||
125094694|NCT00665366|449964105|FG000|Overall Study|Other reasons|4|||
125094695|NCT00665366|449964106|FG001|Overall Study|Other reasons|1|||
125094696|NCT01545375|449964107|FG000|Overall Study|Adverse Event|2|||
125094697|NCT01545375|449964108|FG001|Overall Study|Adverse Event|1|||
125094698|NCT01545375|449964107|FG000|Overall Study|Lost to Follow-up|34|||
125094699|NCT01545375|449964108|FG001|Overall Study|Lost to Follow-up|31|||
125094700|NCT01545375|449964107|FG000|Overall Study|Protocol Violation|3|||
125094701|NCT01545375|449964108|FG001|Overall Study|Protocol Violation|3|||
125094702|NCT01545375|449964107|FG000|Overall Study|Withdrawal by Subject|58|||
125094703|NCT01545375|449964108|FG001|Overall Study|Withdrawal by Subject|55|||
125094704|NCT01846039|449964109|FG000|Overall Study|Protocol Violation|1|||
125094705|NCT01846039|449964109|FG000|Overall Study|Subject Withdrew Consent|1|||
125094706|NCT04854421|449964112|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
125094707|NCT04854421|449964113|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
125094708|NCT01980056|449964114|FG000|Overall Study|Death|1|||
125094709|NCT01980056|449964115|FG001|Overall Study|Death|1|||
125094710|NCT01980056|449964116|FG002|Overall Study|Death|0|||
125094711|NCT00408408|449964117|FG000|Overall Study|No follow up data|2|||
125094712|NCT00408408|449964118|FG001|Overall Study|No follow up data|3|||
125094713|NCT00408408|449964119|FG002|Overall Study|No follow up data|0|||
125094714|NCT00408408|449964120|FG003|Overall Study|No follow up data|7|||
125094715|NCT00408408|449964121|FG004|Overall Study|No follow up data|5|||
124873004|NCT00180479|449157217|FG001|Overall Study|Lost to Follow-up|7|||
125094716|NCT00408408|449964122|FG005|Overall Study|No follow up data|3|||
125094717|NCT00399542|449964127|FG000|Overall Study|Adverse Event|18|||
125094718|NCT00399542|449964128|FG001|Overall Study|Adverse Event|15|||
125094719|NCT00399542|449964127|FG000|Overall Study|Protocol Violation|13|||
125094720|NCT00399542|449964128|FG001|Overall Study|Protocol Violation|3|||
125094721|NCT00399542|449964127|FG000|Overall Study|Withdrawal by Subject|28|||
125094722|NCT00399542|449964128|FG001|Overall Study|Withdrawal by Subject|10|||
125094723|NCT00399542|449964127|FG000|Overall Study|Lack of Efficacy|18|||
125094724|NCT00399542|449964128|FG001|Overall Study|Lack of Efficacy|8|||
125094725|NCT00399542|449964127|FG000|Overall Study|Lost to Follow-up|6|||
125094726|NCT00399542|449964128|FG001|Overall Study|Lost to Follow-up|6|||
125094727|NCT00399542|449964127|FG000|Overall Study|Other|1|||
125094728|NCT00399542|449964128|FG001|Overall Study|Other|0|||
125094729|NCT00399542|449964127|FG000|Overall Study|Physician Decision|0|||
125094730|NCT00399542|449964128|FG001|Overall Study|Physician Decision|1|||
125094731|NCT03172026|449964129|FG000|Overall Study|Withdrawal by Subject|1|||
125094732|NCT03172026|449964130|FG001|Overall Study|Withdrawal by Subject|0|||
125094733|NCT03172026|449964129|FG000|Overall Study|COVID restrictions|1|||
125094734|NCT03172026|449964130|FG001|Overall Study|COVID restrictions|0|||
125094735|NCT00265109|449964131|FG000|Overall Study|Withdrawal by Subject|5|||
125094736|NCT00265109|449964131|FG000|Overall Study|Adverse Event|1|||
125094737|NCT02463097|449964132|FG000|Overall Study|Withdrawal by Subject|1|||
125094738|NCT01757821|449964133|FG000|Overall Study|Adverse Event|1|||
125094739|NCT00334893|449964134|FG000|Overall Study|Not Treated|1|||
125094740|NCT00334893|449964135|FG001|Overall Study|Not Treated|0|||
125094741|NCT01552408|449964139|FG000|Overall Study|Lost to Follow-up|2|||
125094742|NCT01552408|449964140|FG001|Overall Study|Lost to Follow-up|0|||
125094743|NCT01552408|449964139|FG000|Overall Study|Relocation|0|||
125094744|NCT01552408|449964140|FG001|Overall Study|Relocation|1|||
125094745|NCT01552408|449964139|FG000|Overall Study|Withdrawal by Subject|2|||
125094746|NCT01552408|449964140|FG001|Overall Study|Withdrawal by Subject|1|||
125094747|NCT03457701|449964147|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
125094748|NCT03457701|449964148|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
125094749|NCT03457701|449964147|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
125094750|NCT03457701|449964148|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
125094751|NCT01288911|449964149|FG000|Double-blind Period|Death|11|||
125094752|NCT01288911|449964150|FG001|Double-blind Period|Death|7|||
125094753|NCT01288911|449964149|FG000|Double-blind Period|Lost to Follow-up|0|||
125094754|NCT01288911|449964150|FG001|Double-blind Period|Lost to Follow-up|2|||
125094755|NCT01288911|449964149|FG000|Double-blind Period|Progressive Disease|75|||
125094756|NCT01288911|449964150|FG001|Double-blind Period|Progressive Disease|103|||
125094757|NCT01288911|449964149|FG000|Double-blind Period|Protocol Violation|1|||
125094758|NCT01288911|449964150|FG001|Double-blind Period|Protocol Violation|0|||
125094759|NCT01288911|449964149|FG000|Double-blind Period|Withdrawal by Subject|25|||
125094760|NCT01288911|449964150|FG001|Double-blind Period|Withdrawal by Subject|26|||
125094761|NCT01288911|449964149|FG000|Double-blind Period|Miscellaneous Reason|29|||
125094762|NCT01288911|449964150|FG001|Double-blind Period|Miscellaneous Reason|42|||
125094763|NCT01288911|449964149|FG000|Double-blind Period|Randomized but never received study drug|1|||
125094764|NCT01288911|449964150|FG001|Double-blind Period|Randomized but never received study drug|2|||
125094765|NCT01288911|449964149|FG000|Open-label Period (All Enzalutamide)|Death|0|||
125094766|NCT01288911|449964150|FG001|Open-label Period (All Enzalutamide)|Death|1|||
125094767|NCT01288911|449964149|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
125094768|NCT01288911|449964150|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
125094769|NCT01288911|449964149|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
125094770|NCT01288911|449964150|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
125094771|NCT01288911|449964149|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
125094772|NCT01288911|449964150|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
125094773|NCT01288911|449964149|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
125094774|NCT01288911|449964150|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
125094775|NCT01288911|449964149|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
125094776|NCT01288911|449964150|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
125094777|NCT02451137|449964157|FG000|Overall Study|Randomized but not treated|19|||
125094778|NCT02451137|449964158|FG001|Overall Study|Randomized but not treated|27|||
125094779|NCT02451137|449964157|FG000|Overall Study|Adverse Event|43|||
125094780|NCT02451137|449964158|FG001|Overall Study|Adverse Event|42|||
125094781|NCT02451137|449964157|FG000|Overall Study|Lack of Efficacy|4|||
125094782|NCT02451137|449964158|FG001|Overall Study|Lack of Efficacy|9|||
125094783|NCT02451137|449964157|FG000|Overall Study|Participant decision:discontinue insulin|41|||
125094784|NCT02451137|449964158|FG001|Overall Study|Participant decision:discontinue insulin|43|||
125094785|NCT02451137|449964157|FG000|Overall Study|Hypoglycemia|2|||
125094786|NCT02451137|449964158|FG001|Overall Study|Hypoglycemia|1|||
125094787|NCT02451137|449964157|FG000|Overall Study|Investigator's decision|23|||
125094788|NCT02451137|449964158|FG001|Overall Study|Investigator's decision|19|||
125094789|NCT02451137|449964157|FG000|Overall Study|Lost to Follow-up|53|||
125094790|NCT02451137|449964158|FG001|Overall Study|Lost to Follow-up|61|||
125094791|NCT02451137|449964157|FG000|Overall Study|Physician Decision|6|||
125094792|NCT02451137|449964158|FG001|Overall Study|Physician Decision|5|||
125094793|NCT02451137|449964157|FG000|Overall Study|Sponsor decision|13|||
125094794|NCT02451137|449964158|FG001|Overall Study|Sponsor decision|25|||
125094795|NCT02451137|449964157|FG000|Overall Study|Withdrawal by Subject|40|||
125094796|NCT02451137|449964158|FG001|Overall Study|Withdrawal by Subject|63|||
125094797|NCT02451137|449964157|FG000|Overall Study|Other than specified above|2|||
125094798|NCT02451137|449964158|FG001|Overall Study|Other than specified above|3|||
125094799|NCT01977573|449964161|FG000|Overall Study|Adverse Event|7|||
125094800|NCT01977573|449964162|FG001|Overall Study|Adverse Event|0|||
125094801|NCT01977573|449964163|FG002|Overall Study|Adverse Event|2|||
125094802|NCT01977573|449964164|FG003|Overall Study|Adverse Event|1|||
125094803|NCT01977573|449964161|FG000|Overall Study|Lost to Follow-up|1|||
125094804|NCT01977573|449964162|FG001|Overall Study|Lost to Follow-up|0|||
125094805|NCT01977573|449964163|FG002|Overall Study|Lost to Follow-up|0|||
125094806|NCT01977573|449964164|FG003|Overall Study|Lost to Follow-up|1|||
125094807|NCT01977573|449964161|FG000|Overall Study|Physician Decision|1|||
125094808|NCT01977573|449964162|FG001|Overall Study|Physician Decision|0|||
125094809|NCT01977573|449964163|FG002|Overall Study|Physician Decision|0|||
125094810|NCT01977573|449964164|FG003|Overall Study|Physician Decision|0|||
125094811|NCT01977573|449964161|FG000|Overall Study|Protocol Violation|3|||
125094812|NCT01977573|449964162|FG001|Overall Study|Protocol Violation|1|||
125094813|NCT01977573|449964163|FG002|Overall Study|Protocol Violation|0|||
125094814|NCT01977573|449964164|FG003|Overall Study|Protocol Violation|0|||
125094815|NCT01977573|449964161|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
125094816|NCT01977573|449964162|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
125094817|NCT01977573|449964163|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
125094818|NCT01977573|449964164|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
125094819|NCT01977573|449964161|FG000|Overall Study|Withdrawal by Subject|6|||
125094820|NCT01977573|449964162|FG001|Overall Study|Withdrawal by Subject|1|||
125094821|NCT01977573|449964163|FG002|Overall Study|Withdrawal by Subject|1|||
125094822|NCT01977573|449964164|FG003|Overall Study|Withdrawal by Subject|1|||
125094823|NCT02993731|449964165|FG000|Overall Study|Study Termination|101|||
125094824|NCT02993731|449964166|FG001|Overall Study|Study Termination|105|||
125094825|NCT01189201|449966304|FG000|Overall Study|Adverse Event|1|||
125094826|NCT01266967|449966305|FG000|Overall Study|Death|69|||
125094827|NCT01266967|449966306|FG001|Overall Study|Death|61|||
125094828|NCT01266967|449966305|FG000|Overall Study|Study Closed/Terminated|15|||
125094829|NCT01266967|449966306|FG001|Overall Study|Study Closed/Terminated|17|||
125094830|NCT01266967|449966305|FG000|Overall Study|Lost to Follow-up|2|||
125094831|NCT01266967|449966306|FG001|Overall Study|Lost to Follow-up|1|||
125094832|NCT01266967|449966305|FG000|Overall Study|Physician Decision|0|||
125094833|NCT01266967|449966306|FG001|Overall Study|Physician Decision|1|||
125094834|NCT01266967|449966305|FG000|Overall Study|Withdrawal by Subject|3|||
125094835|NCT01266967|449966306|FG001|Overall Study|Withdrawal by Subject|3|||
125094836|NCT04398030|449966307|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
125094837|NCT04398030|449966308|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
125094838|NCT04398030|449966307|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
125094839|NCT04398030|449966308|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
125094840|NCT03159455|449966311|FG000|Overall Study|Adverse Event|0|||
125094841|NCT03159455|449966312|FG001|Overall Study|Adverse Event|0|||
125094842|NCT03159455|449966313|FG002|Overall Study|Adverse Event|0|||
125094843|NCT03159455|449966314|FG003|Overall Study|Adverse Event|0|||
125094844|NCT03159455|449966315|FG004|Overall Study|Adverse Event|0|||
125094845|NCT03159455|449966316|FG005|Overall Study|Adverse Event|1|||
125094846|NCT02946515|449966320|FG000|Overall Study|Lost to Follow-up|2|||
125094847|NCT02946515|449966321|FG001|Overall Study|Lost to Follow-up|1|||
125094848|NCT02501642|449966322|FG000|Overall Study|Lost to Follow-up|7|||
125094849|NCT02501642|449966323|FG001|Overall Study|Lost to Follow-up|11|||
125094850|NCT01153971|449966334|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
125094851|NCT01153971|449966334|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
125094852|NCT01153971|449966334|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
125094853|NCT01153971|449966334|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
125094854|NCT01153971|449966334|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
125094855|NCT01153971|449966334|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
125094856|NCT01153971|449966334|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
125094857|NCT03410693|449966335|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
125094858|NCT03410693|449966336|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
125094859|NCT03410693|449966335|FG000|Overall Study|Disc trt: Lost to follow up|0|||
125094860|NCT03410693|449966336|FG001|Overall Study|Disc trt: Lost to follow up|1|||
125094861|NCT03410693|449966335|FG000|Overall Study|Disc trt: radiological progression|58|||
125094862|NCT03410693|449966336|FG001|Overall Study|Disc trt: radiological progression|50|||
125094863|NCT03410693|449966335|FG000|Overall Study|Disc trt: Other|1|||
125094864|NCT03410693|449966336|FG001|Overall Study|Disc trt: Other|0|||
125094865|NCT03410693|449966335|FG000|Overall Study|Study drug never administered|1|||
125094866|NCT03410693|449966336|FG001|Overall Study|Study drug never administered|6|||
125094867|NCT03410693|449966335|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
125094868|NCT03410693|449966336|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
125094869|NCT03410693|449966335|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
125094870|NCT03410693|449966336|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
125094871|NCT03410693|449966335|FG000|Overall Study|Disc trt: Physician decision|0|||
125094872|NCT03410693|449966336|FG001|Overall Study|Disc trt: Physician decision|5|||
125094873|NCT03410693|449966335|FG000|Overall Study|Disc trt: clinical progression|1|||
125094874|NCT03410693|449966336|FG001|Overall Study|Disc trt: clinical progression|5|||
125094875|NCT03410693|449966335|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
125094876|NCT03410693|449966336|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
125094877|NCT00953576|449966337|FG000|Overall Study|Adverse Event|0|||
125094878|NCT00953576|449966338|FG001|Overall Study|Adverse Event|1|||
125094879|NCT00953576|449966337|FG000|Overall Study|Ineligible after Consent|2|||
125094880|NCT00953576|449966338|FG001|Overall Study|Ineligible after Consent|0|||
125094881|NCT03628781|449966345|FG000|Overall Study|Lost to Follow-up|16|||
125094882|NCT03628781|449966346|FG001|Overall Study|Lost to Follow-up|8|||
125094883|NCT03628781|449966345|FG000|Overall Study|Withdrawal by Subject|16|||
125094884|NCT03628781|449966346|FG001|Overall Study|Withdrawal by Subject|1|||
125094885|NCT00656669|449966347|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
125006812|NCT01994382|449653317|FG011|Overall Study|Progressive disease|8|||
125006813|NCT01994382|449653318|FG012|Overall Study|Progressive disease|7|||
125006814|NCT01994382|449653319|FG013|Overall Study|Progressive disease|3|||
125006815|NCT01994382|449653320|FG014|Overall Study|Progressive disease|6|||
125006816|NCT01994382|449653321|FG015|Overall Study|Progressive disease|44|||
125006817|NCT01994382|449653322|FG016|Overall Study|Progressive disease|28|||
125006818|NCT01994382|449653306|FG000|Overall Study|Physician Decision|0|||
125006819|NCT01994382|449653307|FG001|Overall Study|Physician Decision|1|||
125006820|NCT01994382|449653308|FG002|Overall Study|Physician Decision|0|||
125006821|NCT01994382|449653309|FG003|Overall Study|Physician Decision|0|||
125006822|NCT01994382|449653310|FG004|Overall Study|Physician Decision|0|||
125006823|NCT01994382|449653311|FG005|Overall Study|Physician Decision|0|||
125006824|NCT01994382|449653312|FG006|Overall Study|Physician Decision|0|||
125006825|NCT01994382|449653313|FG007|Overall Study|Physician Decision|0|||
125006826|NCT01994382|449653314|FG008|Overall Study|Physician Decision|0|||
125006827|NCT01994382|449653315|FG009|Overall Study|Physician Decision|0|||
125006828|NCT01994382|449653316|FG010|Overall Study|Physician Decision|3|||
125006829|NCT01994382|449653317|FG011|Overall Study|Physician Decision|1|||
125006830|NCT01994382|449653318|FG012|Overall Study|Physician Decision|1|||
125006831|NCT01994382|449653319|FG013|Overall Study|Physician Decision|0|||
125006832|NCT01994382|449653320|FG014|Overall Study|Physician Decision|1|||
125006833|NCT01994382|449653321|FG015|Overall Study|Physician Decision|4|||
125006834|NCT01994382|449653322|FG016|Overall Study|Physician Decision|2|||
125006835|NCT01994382|449653306|FG000|Overall Study|Death|0|||
125006836|NCT01994382|449653307|FG001|Overall Study|Death|0|||
125006837|NCT01994382|449653308|FG002|Overall Study|Death|0|||
125006838|NCT01994382|449653309|FG003|Overall Study|Death|0|||
125006839|NCT01994382|449653310|FG004|Overall Study|Death|1|||
125006840|NCT01994382|449653311|FG005|Overall Study|Death|0|||
125006841|NCT01994382|449653312|FG006|Overall Study|Death|0|||
125006842|NCT01994382|449653313|FG007|Overall Study|Death|0|||
125006843|NCT01994382|449653314|FG008|Overall Study|Death|1|||
125006844|NCT01994382|449653315|FG009|Overall Study|Death|1|||
125006845|NCT01994382|449653316|FG010|Overall Study|Death|0|||
125006846|NCT01994382|449653317|FG011|Overall Study|Death|0|||
125006847|NCT01994382|449653318|FG012|Overall Study|Death|0|||
125006848|NCT01994382|449653319|FG013|Overall Study|Death|0|||
125006849|NCT01994382|449653320|FG014|Overall Study|Death|0|||
125006850|NCT01994382|449653321|FG015|Overall Study|Death|1|||
125006851|NCT01994382|449653322|FG016|Overall Study|Death|0|||
125006852|NCT01994382|449653306|FG000|Overall Study|Adverse Event|0|||
125006853|NCT01994382|449653307|FG001|Overall Study|Adverse Event|1|||
125006854|NCT01994382|449653308|FG002|Overall Study|Adverse Event|2|||
125006855|NCT01994382|449653309|FG003|Overall Study|Adverse Event|0|||
125094886|NCT00656669|449966347|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
125094887|NCT00656669|449966347|FG000|AC (Cycles 6-9)|Adverse Event|1|||
125006856|NCT01994382|449653310|FG004|Overall Study|Adverse Event|0|||
125006857|NCT01994382|449653311|FG005|Overall Study|Adverse Event|0|||
125006858|NCT01994382|449653312|FG006|Overall Study|Adverse Event|0|||
125006859|NCT01994382|449653313|FG007|Overall Study|Adverse Event|0|||
125006860|NCT01994382|449653314|FG008|Overall Study|Adverse Event|0|||
125006861|NCT01994382|449653315|FG009|Overall Study|Adverse Event|0|||
125006862|NCT01994382|449653316|FG010|Overall Study|Adverse Event|15|||
125006863|NCT01994382|449653317|FG011|Overall Study|Adverse Event|2|||
125006864|NCT01994382|449653318|FG012|Overall Study|Adverse Event|7|||
125006865|NCT01994382|449653319|FG013|Overall Study|Adverse Event|3|||
125006866|NCT01994382|449653320|FG014|Overall Study|Adverse Event|17|||
125006867|NCT01994382|449653321|FG015|Overall Study|Adverse Event|6|||
125006868|NCT01994382|449653322|FG016|Overall Study|Adverse Event|3|||
125006869|NCT01994382|449653306|FG000|Overall Study|Other than specified|0|||
125006870|NCT01994382|449653307|FG001|Overall Study|Other than specified|0|||
125006871|NCT01994382|449653308|FG002|Overall Study|Other than specified|0|||
125006872|NCT01994382|449653309|FG003|Overall Study|Other than specified|0|||
125006873|NCT01994382|449653310|FG004|Overall Study|Other than specified|0|||
125006874|NCT01994382|449653311|FG005|Overall Study|Other than specified|0|||
125006875|NCT01994382|449653312|FG006|Overall Study|Other than specified|0|||
125006876|NCT01994382|449653313|FG007|Overall Study|Other than specified|0|||
125006877|NCT01994382|449653314|FG008|Overall Study|Other than specified|0|||
125006878|NCT01994382|449653315|FG009|Overall Study|Other than specified|0|||
125006879|NCT01994382|449653316|FG010|Overall Study|Other than specified|2|||
125006880|NCT01994382|449653317|FG011|Overall Study|Other than specified|0|||
125006881|NCT01994382|449653318|FG012|Overall Study|Other than specified|2|||
125006882|NCT01994382|449653319|FG013|Overall Study|Other than specified|0|||
125006883|NCT01994382|449653320|FG014|Overall Study|Other than specified|0|||
125006884|NCT01994382|449653321|FG015|Overall Study|Other than specified|4|||
125006885|NCT01994382|449653322|FG016|Overall Study|Other than specified|4|||
125006886|NCT01994382|449653306|FG000|Overall Study|Withdrawal by Subject|0|||
125006887|NCT01994382|449653307|FG001|Overall Study|Withdrawal by Subject|0|||
125006888|NCT01994382|449653308|FG002|Overall Study|Withdrawal by Subject|0|||
125006889|NCT01994382|449653309|FG003|Overall Study|Withdrawal by Subject|0|||
125006890|NCT01994382|449653310|FG004|Overall Study|Withdrawal by Subject|0|||
125094888|NCT00656669|449966347|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
125094889|NCT03778021|449966348|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
125094890|NCT03778021|449966349|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
125094891|NCT00679042|449966352|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
125094892|NCT00679042|449966352|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
125094893|NCT00679042|449966352|FG000|5-Year Follow Up|Death|1|||
125094894|NCT00679042|449966352|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
125094895|NCT00679042|449966352|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
125094896|NCT02687815|449966353|FG000|Overall Study|Lost to Follow-up|2|||
125094897|NCT02687815|449966354|FG001|Overall Study|Lost to Follow-up|4|||
125094898|NCT02687815|449966353|FG000|Overall Study|Withdrawal by Subject|2|||
125094899|NCT02687815|449966354|FG001|Overall Study|Withdrawal by Subject|4|||
125094900|NCT03472586|449966362|FG000|Overall Study|Physician Decision|6|||
125094901|NCT03472586|449966362|FG000|Overall Study|Death|6|||
125094902|NCT03472586|449966362|FG000|Overall Study|Adverse Event|1|||
125094903|NCT02528331|449966363|FG000|Overall Study|Withdrawal by Subject|2|||
125094904|NCT06045026|449966366|FG000|Overall Study|Lost to Follow-up|60|||
125094905|NCT06045026|449966366|FG000|Overall Study|Adverse Event|12|||
125094906|NCT06045026|449966366|FG000|Overall Study|Withdrawal by Subject|3|||
125094907|NCT06045026|449966366|FG000|Overall Study|Enrollment closed|1|||
125094908|NCT00920582|449966367|FG000|Overall Study|Lost to Follow-up|5|||
125094909|NCT00920582|449966368|FG001|Overall Study|Lost to Follow-up|1|||
125094910|NCT00920582|449966369|FG002|Overall Study|Lost to Follow-up|2|||
125094911|NCT00920582|449966370|FG003|Overall Study|Lost to Follow-up|0|||
125094912|NCT00920582|449966367|FG000|Overall Study|Withdrawal by Subject|5|||
125094913|NCT00920582|449966368|FG001|Overall Study|Withdrawal by Subject|4|||
125094914|NCT00920582|449966369|FG002|Overall Study|Withdrawal by Subject|6|||
125094915|NCT00920582|449966370|FG003|Overall Study|Withdrawal by Subject|3|||
125094916|NCT00920582|449966367|FG000|Overall Study|Protocol Violation|1|||
125094917|NCT00920582|449966368|FG001|Overall Study|Protocol Violation|0|||
125094918|NCT00920582|449966369|FG002|Overall Study|Protocol Violation|0|||
125094919|NCT00920582|449966370|FG003|Overall Study|Protocol Violation|0|||
125094920|NCT00920582|449966367|FG000|Overall Study|Other|2|||
125094921|NCT00920582|449966368|FG001|Overall Study|Other|1|||
125094922|NCT00920582|449966369|FG002|Overall Study|Other|3|||
125094923|NCT00920582|449966370|FG003|Overall Study|Other|2|||
125094924|NCT00383292|449966376|FG000|Overall Study|Adverse Event|4|||
125094925|NCT00383292|449966377|FG001|Overall Study|Adverse Event|1|||
125094926|NCT00383292|449966378|FG002|Overall Study|Adverse Event|2|||
125094927|NCT00383292|449966376|FG000|Overall Study|Death|3|||
125094928|NCT00383292|449966377|FG001|Overall Study|Death|3|||
125094929|NCT00383292|449966378|FG002|Overall Study|Death|3|||
125094930|NCT00383292|449966376|FG000|Overall Study|Physician Decision|4|||
125094931|NCT00383292|449966377|FG001|Overall Study|Physician Decision|0|||
125094932|NCT00383292|449966378|FG002|Overall Study|Physician Decision|1|||
125094933|NCT00383292|449966376|FG000|Overall Study|Withdrawal by Subject|3|||
125094934|NCT00383292|449966377|FG001|Overall Study|Withdrawal by Subject|2|||
125094935|NCT00383292|449966378|FG002|Overall Study|Withdrawal by Subject|2|||
125094936|NCT00383292|449966376|FG000|Overall Study|Other|1|||
125094937|NCT00383292|449966377|FG001|Overall Study|Other|0|||
125094938|NCT00383292|449966378|FG002|Overall Study|Other|0|||
125094939|NCT03329404|449966379|FG000|Overall Study|The study was suspended.|1|||
125094940|NCT03329404|449966380|FG001|Overall Study|The study was suspended.|4|||
125094941|NCT01016912|449966381|FG000|End of Treatment Period|Lack of Efficacy|0|||
125094942|NCT01016912|449966382|FG001|End of Treatment Period|Lack of Efficacy|1|||
125094943|NCT01016912|449966383|FG002|End of Treatment Period|Lack of Efficacy|0|||
125094944|NCT01016912|449966384|FG003|End of Treatment Period|Lack of Efficacy|4|||
125094945|NCT01016912|449966385|FG004|End of Treatment Period|Lack of Efficacy|4|||
125094946|NCT01016912|449966381|FG000|End of Treatment Period|Adverse Event|0|||
125094947|NCT01016912|449966382|FG001|End of Treatment Period|Adverse Event|1|||
125094948|NCT01016912|449966383|FG002|End of Treatment Period|Adverse Event|1|||
125094949|NCT01016912|449966384|FG003|End of Treatment Period|Adverse Event|0|||
125094950|NCT01016912|449966385|FG004|End of Treatment Period|Adverse Event|0|||
125094951|NCT01016912|449966381|FG000|End of Treatment Period|Completed double-blind period only|0|||
125094952|NCT01016912|449966382|FG001|End of Treatment Period|Completed double-blind period only|1|||
125094953|NCT01016912|449966383|FG002|End of Treatment Period|Completed double-blind period only|0|||
125094954|NCT01016912|449966384|FG003|End of Treatment Period|Completed double-blind period only|0|||
125094955|NCT01016912|449966385|FG004|End of Treatment Period|Completed double-blind period only|0|||
125094956|NCT01016912|449966381|FG000|Follow-up Period|Other reason|0|||
125094957|NCT01016912|449966382|FG001|Follow-up Period|Other reason|0|||
125094958|NCT01016912|449966383|FG002|Follow-up Period|Other reason|1|||
125094959|NCT01016912|449966384|FG003|Follow-up Period|Other reason|1|||
125094960|NCT01016912|449966385|FG004|Follow-up Period|Other reason|0|||
125094961|NCT02221882|449966386|FG000|Overall Study|Withdrawal by Subject|0|||
125094962|NCT02221882|449966387|FG001|Overall Study|Withdrawal by Subject|0|||
125094963|NCT02221882|449966388|FG002|Overall Study|Withdrawal by Subject|4|||
125094964|NCT02221882|449966389|FG003|Overall Study|Withdrawal by Subject|2|||
125094965|NCT02221882|449966390|FG004|Overall Study|Withdrawal by Subject|2|||
125094966|NCT02221882|449966391|FG005|Overall Study|Withdrawal by Subject|2|||
125094967|NCT02221882|449966386|FG000|Overall Study|Death|0|||
125094968|NCT02221882|449966387|FG001|Overall Study|Death|1|||
125094969|NCT02221882|449966388|FG002|Overall Study|Death|0|||
125094970|NCT02221882|449966389|FG003|Overall Study|Death|0|||
125094971|NCT02221882|449966390|FG004|Overall Study|Death|0|||
125094972|NCT02221882|449966391|FG005|Overall Study|Death|0|||
125094973|NCT00796367|449966392|FG000|Overall Study|Adverse Event|6|||
125094974|NCT00796367|449966393|FG001|Overall Study|Adverse Event|4|||
125094975|NCT00796367|449966394|FG002|Overall Study|Adverse Event|7|||
125094976|NCT00796367|449966392|FG000|Overall Study|Lost to Follow-up|5|||
125094977|NCT00796367|449966393|FG001|Overall Study|Lost to Follow-up|4|||
125094978|NCT00796367|449966394|FG002|Overall Study|Lost to Follow-up|21|||
125094979|NCT00796367|449966392|FG000|Overall Study|Withdrawal by Subject|9|||
125094980|NCT00796367|449966393|FG001|Overall Study|Withdrawal by Subject|11|||
125094981|NCT00796367|449966394|FG002|Overall Study|Withdrawal by Subject|12|||
125094982|NCT00796367|449966392|FG000|Overall Study|Lack of Efficacy|2|||
125094983|NCT00796367|449966393|FG001|Overall Study|Lack of Efficacy|1|||
125094984|NCT00796367|449966394|FG002|Overall Study|Lack of Efficacy|0|||
125094985|NCT00796367|449966392|FG000|Overall Study|non compliance|3|||
125094986|NCT00796367|449966393|FG001|Overall Study|non compliance|1|||
125094987|NCT00796367|449966394|FG002|Overall Study|non compliance|1|||
125094988|NCT00796367|449966392|FG000|Overall Study|Pregnancy|1|||
125094989|NCT00796367|449966393|FG001|Overall Study|Pregnancy|0|||
125094990|NCT00796367|449966394|FG002|Overall Study|Pregnancy|1|||
125094991|NCT00796367|449966392|FG000|Overall Study|Requirement for restricted medication|2|||
125094992|NCT00796367|449966393|FG001|Overall Study|Requirement for restricted medication|0|||
125094993|NCT00796367|449966394|FG002|Overall Study|Requirement for restricted medication|2|||
125094994|NCT00796367|449966392|FG000|Overall Study|other|2|||
125094995|NCT00796367|449966393|FG001|Overall Study|other|4|||
125094996|NCT00796367|449966394|FG002|Overall Study|other|3|||
125094997|NCT05664672|449966395|FG000|Overall Study|Adverse Event|0|||
125094998|NCT05664672|449966396|FG001|Overall Study|Adverse Event|0|||
125094999|NCT05664672|449966397|FG002|Overall Study|Adverse Event|0|||
125095000|NCT05664672|449966398|FG003|Overall Study|Adverse Event|0|||
125095001|NCT05664672|449966399|FG004|Overall Study|Adverse Event|0|||
125095002|NCT05664672|449966400|FG005|Overall Study|Adverse Event|1|||
125095003|NCT05664672|449966395|FG000|Overall Study|Withdrawal by Subject|0|||
125095004|NCT05664672|449966396|FG001|Overall Study|Withdrawal by Subject|1|||
125095005|NCT05664672|449966397|FG002|Overall Study|Withdrawal by Subject|3|||
125095006|NCT05664672|449966398|FG003|Overall Study|Withdrawal by Subject|0|||
125095007|NCT05664672|449966399|FG004|Overall Study|Withdrawal by Subject|5|||
125095008|NCT05664672|449966400|FG005|Overall Study|Withdrawal by Subject|6|||
125095009|NCT05664672|449966395|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
125095010|NCT05664672|449966396|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
125095011|NCT05664672|449966397|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
125095012|NCT05664672|449966398|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
125095013|NCT05664672|449966399|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
125095014|NCT05664672|449966400|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
125095015|NCT05664672|449966395|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
125095016|NCT05664672|449966396|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
125095017|NCT05664672|449966397|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
125095018|NCT05664672|449966398|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
125095019|NCT05664672|449966399|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
125095020|NCT05664672|449966400|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
125095021|NCT04236986|449966409|FG000|Overall Study|Withdrawal by Subject|3|||
125095022|NCT04236986|449966410|FG001|Overall Study|Withdrawal by Subject|1|||
125095023|NCT04034225|449966411|FG000|Overall Study|Death|3|||
125095024|NCT04034225|449966411|FG000|Overall Study|Withdrawal by Subject|2|||
125095025|NCT04034225|449966411|FG000|Overall Study|Study termination by Sponsor|18|||
125095026|NCT04034225|449966411|FG000|Overall Study|Physician Decision|1|||
125095027|NCT04034225|449966411|FG000|Overall Study|Lack of Efficacy|1|||
125095028|NCT01326481|449966417|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
125006891|NCT01994382|449653311|FG005|Overall Study|Withdrawal by Subject|0|||
125006892|NCT01994382|449653312|FG006|Overall Study|Withdrawal by Subject|0|||
125006893|NCT01994382|449653313|FG007|Overall Study|Withdrawal by Subject|0|||
125006894|NCT01994382|449653314|FG008|Overall Study|Withdrawal by Subject|0|||
125006895|NCT01994382|449653315|FG009|Overall Study|Withdrawal by Subject|0|||
125006896|NCT01994382|449653316|FG010|Overall Study|Withdrawal by Subject|6|||
125006897|NCT01994382|449653317|FG011|Overall Study|Withdrawal by Subject|0|||
125006898|NCT01994382|449653318|FG012|Overall Study|Withdrawal by Subject|2|||
125006899|NCT01994382|449653319|FG013|Overall Study|Withdrawal by Subject|0|||
125006900|NCT01994382|449653320|FG014|Overall Study|Withdrawal by Subject|4|||
125006901|NCT01994382|449653321|FG015|Overall Study|Withdrawal by Subject|3|||
125006902|NCT01994382|449653322|FG016|Overall Study|Withdrawal by Subject|0|||
125006903|NCT01994382|449653306|FG000|Overall Study|Lost to Follow-up|0|||
125006904|NCT01994382|449653307|FG001|Overall Study|Lost to Follow-up|0|||
125006905|NCT01994382|449653308|FG002|Overall Study|Lost to Follow-up|0|||
125006906|NCT01994382|449653309|FG003|Overall Study|Lost to Follow-up|0|||
125006907|NCT01994382|449653310|FG004|Overall Study|Lost to Follow-up|0|||
125006908|NCT01994382|449653311|FG005|Overall Study|Lost to Follow-up|0|||
125006909|NCT01994382|449653312|FG006|Overall Study|Lost to Follow-up|0|||
125006910|NCT01994382|449653313|FG007|Overall Study|Lost to Follow-up|0|||
125006911|NCT01994382|449653314|FG008|Overall Study|Lost to Follow-up|0|||
125006912|NCT01994382|449653315|FG009|Overall Study|Lost to Follow-up|0|||
125006913|NCT01994382|449653316|FG010|Overall Study|Lost to Follow-up|1|||
125006914|NCT01994382|449653317|FG011|Overall Study|Lost to Follow-up|0|||
125006915|NCT01994382|449653318|FG012|Overall Study|Lost to Follow-up|0|||
125006916|NCT01994382|449653319|FG013|Overall Study|Lost to Follow-up|0|||
125006917|NCT01994382|449653320|FG014|Overall Study|Lost to Follow-up|0|||
125006918|NCT01994382|449653321|FG015|Overall Study|Lost to Follow-up|0|||
125006919|NCT01994382|449653322|FG016|Overall Study|Lost to Follow-up|0|||
125006920|NCT01994382|449653306|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125033624|NCT01701258|449743823|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
125095029|NCT00307736|449966418|FG000|Overall Study|Adverse Event|0|||
125095030|NCT00307736|449966419|FG001|Overall Study|Adverse Event|0|||
125095031|NCT00307736|449966420|FG002|Overall Study|Adverse Event|1|||
125095032|NCT00307736|449966421|FG003|Overall Study|Adverse Event|3|||
125095033|NCT00307736|449966418|FG000|Overall Study|Withdrawal by Subject|0|||
125095034|NCT00307736|449966419|FG001|Overall Study|Withdrawal by Subject|0|||
125095035|NCT00307736|449966420|FG002|Overall Study|Withdrawal by Subject|2|||
125095036|NCT00307736|449966421|FG003|Overall Study|Withdrawal by Subject|0|||
125095037|NCT02260791|449966424|FG000|Overall Study|Lost to Follow-up|4|||
125095038|NCT02260791|449966425|FG001|Overall Study|Lost to Follow-up|4|||
125095039|NCT02260791|449966424|FG000|Overall Study|Lack of Efficacy|2|||
125095040|NCT02260791|449966425|FG001|Overall Study|Lack of Efficacy|1|||
125095041|NCT02260791|449966424|FG000|Overall Study|Adverse Event|13|||
125095042|NCT02260791|449966425|FG001|Overall Study|Adverse Event|9|||
125095043|NCT02260791|449966424|FG000|Overall Study|Death|1|||
125095044|NCT02260791|449966425|FG001|Overall Study|Death|0|||
125095045|NCT02260791|449966424|FG000|Overall Study|Withdrawal by Subject|11|||
125095046|NCT02260791|449966425|FG001|Overall Study|Withdrawal by Subject|16|||
125095047|NCT02260791|449966424|FG000|Overall Study|Screen failure|0|||
125095048|NCT02260791|449966425|FG001|Overall Study|Screen failure|1|||
125095049|NCT02260791|449966424|FG000|Overall Study|Protocol deviation|2|||
125095050|NCT02260791|449966425|FG001|Overall Study|Protocol deviation|3|||
125095051|NCT00606931|449966426|FG000|Overall Study|Withdrawal by Subject|3|||
125095052|NCT02924129|449966440|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
125095053|NCT02924129|449966441|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
125095054|NCT02924129|449966440|FG000|Overall Study|Withdrawal by Subject|2|||
125095055|NCT02924129|449966441|FG001|Overall Study|Withdrawal by Subject|2|||
125095056|NCT02924129|449966440|FG000|Overall Study|Physician Decision|1|||
125095057|NCT02924129|449966441|FG001|Overall Study|Physician Decision|0|||
125095058|NCT02924129|449966440|FG000|Overall Study|Missed Visit|0|||
125095059|NCT02924129|449966441|FG001|Overall Study|Missed Visit|1|||
125095060|NCT01348828|449966443|FG000|Overall Study|Death|20|||
125095061|NCT01348828|449966443|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
125095062|NCT01348828|449966443|FG000|Overall Study|Conversion|2|||
125095063|NCT01348828|449966443|FG000|Overall Study|missed visit|1|||
125095064|NCT00302731|449966444|FG000|Overall Study|Lost to Follow-up|1|||
125095065|NCT00302731|449966445|FG001|Overall Study|Lost to Follow-up|2|||
125095066|NCT00302731|449966446|FG002|Overall Study|Lost to Follow-up|0|||
125095067|NCT00302731|449966447|FG003|Overall Study|Lost to Follow-up|0|||
125095068|NCT00302731|449966444|FG000|Overall Study|Adverse Event|0|||
125095069|NCT00302731|449966445|FG001|Overall Study|Adverse Event|2|||
125095070|NCT00302731|449966446|FG002|Overall Study|Adverse Event|2|||
125095071|NCT00302731|449966447|FG003|Overall Study|Adverse Event|0|||
125095072|NCT00302731|449966444|FG000|Overall Study|Withdrawal by Subject|1|||
125095073|NCT00302731|449966445|FG001|Overall Study|Withdrawal by Subject|1|||
125095074|NCT00302731|449966446|FG002|Overall Study|Withdrawal by Subject|0|||
125095075|NCT00302731|449966447|FG003|Overall Study|Withdrawal by Subject|0|||
125095076|NCT00302731|449966444|FG000|Overall Study|Protocol Violation|1|||
125095077|NCT00302731|449966445|FG001|Overall Study|Protocol Violation|0|||
125095078|NCT00302731|449966446|FG002|Overall Study|Protocol Violation|0|||
125095079|NCT00302731|449966447|FG003|Overall Study|Protocol Violation|0|||
125095080|NCT00302731|449966444|FG000|Overall Study|cancer unrelated to study discovered|1|||
125095081|NCT00302731|449966445|FG001|Overall Study|cancer unrelated to study discovered|0|||
125095082|NCT00302731|449966446|FG002|Overall Study|cancer unrelated to study discovered|1|||
125095083|NCT00302731|449966447|FG003|Overall Study|cancer unrelated to study discovered|0|||
125095084|NCT01000311|449966448|FG000|Overall Study|Adverse Event|2|||
125095085|NCT01000311|449966449|FG001|Overall Study|Adverse Event|5|||
125095086|NCT01000311|449966448|FG000|Overall Study|Withdrawal by Subject|16|||
125095087|NCT01000311|449966449|FG001|Overall Study|Withdrawal by Subject|24|||
125095088|NCT01000311|449966448|FG000|Overall Study|Lost to Follow-up|15|||
125095089|NCT01000311|449966449|FG001|Overall Study|Lost to Follow-up|24|||
125095090|NCT01000311|449966448|FG000|Overall Study|Protocol Violation|1|||
125095091|NCT01000311|449966449|FG001|Overall Study|Protocol Violation|2|||
125095092|NCT01000311|449966448|FG000|Overall Study|Inappropriate enrollment|2|||
125095093|NCT01000311|449966449|FG001|Overall Study|Inappropriate enrollment|0|||
125095094|NCT01000311|449966448|FG000|Overall Study|Administrative reason|9|||
125095095|NCT01000311|449966449|FG001|Overall Study|Administrative reason|15|||
125095096|NCT01610752|449966452|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
125095097|NCT01610752|449966453|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
125095098|NCT01610752|449966454|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
125095099|NCT02815670|449966455|FG000|Overall Study|Prematurely discontinued of the trial|1|||
125095100|NCT02354599|449966459|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
125095101|NCT02354599|449966460|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
125095102|NCT02354599|449966461|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
125095103|NCT02354599|449966462|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
125095104|NCT02354599|449966463|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
125095105|NCT02354599|449966464|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
125095106|NCT02354599|449966459|FG000|Overall Study|Withdrawal by Subject|1|||
125095107|NCT02354599|449966460|FG001|Overall Study|Withdrawal by Subject|1|||
125095108|NCT02354599|449966461|FG002|Overall Study|Withdrawal by Subject|0|||
125095109|NCT02354599|449966462|FG003|Overall Study|Withdrawal by Subject|0|||
125095110|NCT02354599|449966463|FG004|Overall Study|Withdrawal by Subject|0|||
125095111|NCT02354599|449966464|FG005|Overall Study|Withdrawal by Subject|0|||
125095112|NCT01087944|449966480|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
125095113|NCT01087944|449966481|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
125095114|NCT01087944|449966480|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
125095115|NCT01087944|449966481|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
125095116|NCT01159665|449966482|FG000|Overall Study|Withdrawal by Subject|0|||
125095117|NCT01159665|449966483|FG001|Overall Study|Withdrawal by Subject|1|||
125095118|NCT01159665|449966484|FG002|Overall Study|Withdrawal by Subject|0|||
125095119|NCT01159665|449966485|FG003|Overall Study|Withdrawal by Subject|0|||
125095120|NCT01159665|449966486|FG004|Overall Study|Withdrawal by Subject|0|||
125095121|NCT01159665|449966487|FG005|Overall Study|Withdrawal by Subject|0|||
125095122|NCT01377194|449966489|FG000|Overall Study|Adverse Event|3|||
125095123|NCT01377194|449966490|FG001|Overall Study|Adverse Event|12|||
125095124|NCT01377194|449966491|FG002|Overall Study|Adverse Event|19|||
125095125|NCT01377194|449966489|FG000|Overall Study|Lack of Efficacy|3|||
125095126|NCT01377194|449966490|FG001|Overall Study|Lack of Efficacy|3|||
125095127|NCT01377194|449966491|FG002|Overall Study|Lack of Efficacy|3|||
125095128|NCT01377194|449966489|FG000|Overall Study|Protocol Violation|4|||
125095129|NCT01377194|449966490|FG001|Overall Study|Protocol Violation|10|||
125095130|NCT01377194|449966491|FG002|Overall Study|Protocol Violation|6|||
125095131|NCT01377194|449966489|FG000|Overall Study|Withdrawal by Subject|8|||
125095132|NCT01377194|449966490|FG001|Overall Study|Withdrawal by Subject|10|||
125095133|NCT01377194|449966491|FG002|Overall Study|Withdrawal by Subject|7|||
125095134|NCT01377194|449966489|FG000|Overall Study|Lost to Follow-up|14|||
125095135|NCT01377194|449966490|FG001|Overall Study|Lost to Follow-up|8|||
125095136|NCT01377194|449966491|FG002|Overall Study|Lost to Follow-up|11|||
125095137|NCT01230489|449966492|FG000|Overall Study|Death|2|||
125095138|NCT01230489|449966492|FG000|Overall Study|Adverse Event|2|||
125095139|NCT01230489|449966492|FG000|Overall Study|Treatment modality changed|1|||
125006921|NCT01994382|449653307|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125006922|NCT01994382|449653308|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125006923|NCT01994382|449653309|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125006924|NCT01994382|449653310|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125006925|NCT01994382|449653311|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125006926|NCT01994382|449653312|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125006927|NCT01994382|449653313|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125095140|NCT01791543|449966493|FG000|Overall Study|Lost to Follow-up|1|||
125095141|NCT01791543|449966493|FG000|Overall Study|Adverse Event|1|||
125095142|NCT01846442|449967614|FG000|Overall Study|Adverse Event|2|||
125095143|NCT01846442|449967615|FG001|Overall Study|Adverse Event|4|||
125095144|NCT01846442|449967616|FG002|Overall Study|Adverse Event|2|||
125095145|NCT01846442|449967617|FG003|Overall Study|Adverse Event|1|||
125095146|NCT01846442|449967614|FG000|Overall Study|Lost to Follow-up|0|||
125095147|NCT01846442|449967615|FG001|Overall Study|Lost to Follow-up|0|||
125095148|NCT01846442|449967616|FG002|Overall Study|Lost to Follow-up|1|||
125095149|NCT01846442|449967617|FG003|Overall Study|Lost to Follow-up|0|||
125095150|NCT01846442|449967614|FG000|Overall Study|Withdrawal by Subject|3|||
125095151|NCT01846442|449967615|FG001|Overall Study|Withdrawal by Subject|2|||
125095152|NCT01846442|449967616|FG002|Overall Study|Withdrawal by Subject|0|||
125095153|NCT01846442|449967617|FG003|Overall Study|Withdrawal by Subject|1|||
125095154|NCT01846442|449967614|FG000|Overall Study|Left the city/Lost medication|1|||
125095155|NCT01846442|449967615|FG001|Overall Study|Left the city/Lost medication|0|||
125095156|NCT01846442|449967616|FG002|Overall Study|Left the city/Lost medication|1|||
125095157|NCT01846442|449967617|FG003|Overall Study|Left the city/Lost medication|1|||
125095158|NCT01224171|449967623|FG000|Overall Study|Adverse Event|8|||
125095159|NCT01224171|449967624|FG001|Overall Study|Adverse Event|4|||
125095160|NCT01224171|449967623|FG000|Overall Study|Protocol Violation|0|||
125095161|NCT01224171|449967624|FG001|Overall Study|Protocol Violation|1|||
125095162|NCT01224171|449967623|FG000|Overall Study|Lack of Efficacy|5|||
125095163|NCT01224171|449967624|FG001|Overall Study|Lack of Efficacy|1|||
125095164|NCT01224171|449967623|FG000|Overall Study|Withdrawal of Consent|2|||
125095165|NCT01224171|449967624|FG001|Overall Study|Withdrawal of Consent|4|||
125095166|NCT01224171|449967623|FG000|Overall Study|Lost to Follow-up|0|||
125095167|NCT01224171|449967624|FG001|Overall Study|Lost to Follow-up|3|||
125095168|NCT03737812|449967625|FG000|Overall Study|Withdrawal by Subject|1|||
125095169|NCT03737812|449967626|FG001|Overall Study|Withdrawal by Subject|2|||
125095170|NCT03737812|449967627|FG002|Overall Study|Withdrawal by Subject|1|||
125095171|NCT03737812|449967625|FG000|Overall Study|Sponsor Discontinued the Study|4|||
125095172|NCT03737812|449967626|FG001|Overall Study|Sponsor Discontinued the Study|3|||
125095173|NCT03737812|449967627|FG002|Overall Study|Sponsor Discontinued the Study|2|||
125095174|NCT03737812|449967625|FG000|Overall Study|Adverse Event|0|||
125095175|NCT03737812|449967626|FG001|Overall Study|Adverse Event|1|||
125095176|NCT03737812|449967627|FG002|Overall Study|Adverse Event|0|||
125095177|NCT03737812|449967625|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
125095178|NCT03737812|449967626|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
125095179|NCT03737812|449967627|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
125095180|NCT02624713|449967628|FG000|Overall Study|Lost to Follow-up|14|||
125095181|NCT02624713|449967629|FG001|Overall Study|Lost to Follow-up|0|||
125095182|NCT00285857|449967633|FG000|Overall Study|Withdrawal by Subject|2|||
125095183|NCT00285857|449967633|FG000|Overall Study|Inadequate initial breast cytology|1|||
125095184|NCT00285857|449967633|FG000|Overall Study|Adverse Event|1|||
125095185|NCT01161173|449967639|FG000|Overall Study|Protocol Violation|13|||
125095186|NCT01161173|449967639|FG000|Overall Study|Lost to Follow-up|7|||
125095187|NCT01161173|449967639|FG000|Overall Study|Progressive Disease|82|||
125095188|NCT01161173|449967639|FG000|Overall Study|Withdrawal of Consent|5|||
125095189|NCT01161173|449967639|FG000|Overall Study|Unacceptable Toxicity|21|||
125095190|NCT01161173|449967639|FG000|Overall Study|Death|194|||
125095191|NCT01161173|449967639|FG000|Overall Study|End of Study|2|||
125095192|NCT01161173|449967639|FG000|Overall Study|Reasons Not Specified|23|||
125095193|NCT00792467|449967642|FG000|Overall Study|progression of disease|17|||
125095194|NCT00792467|449967642|FG000|Overall Study|Adverse Event|1|||
125095195|NCT00792467|449967642|FG000|Overall Study|patient request|1|||
125095196|NCT00792467|449967642|FG000|Overall Study|Lost to Follow-up|1|||
125095197|NCT00792467|449967642|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
125095198|NCT00792467|449967642|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
125095199|NCT03911401|449967643|FG000|Overall Study|Adverse Event|1|||
125095200|NCT03911401|449967644|FG001|Overall Study|Adverse Event|2|||
125095201|NCT03911401|449967645|FG002|Overall Study|Adverse Event|5|||
125095202|NCT03911401|449967643|FG000|Overall Study|Lack of Efficacy|1|||
125095203|NCT03911401|449967644|FG001|Overall Study|Lack of Efficacy|1|||
125095204|NCT03911401|449967645|FG002|Overall Study|Lack of Efficacy|8|||
125095205|NCT03911401|449967643|FG000|Overall Study|Physician Decision|0|||
125095206|NCT03911401|449967644|FG001|Overall Study|Physician Decision|0|||
125095207|NCT03911401|449967645|FG002|Overall Study|Physician Decision|1|||
125095208|NCT03911401|449967643|FG000|Overall Study|Withdrawal by Subject|1|||
125095209|NCT03911401|449967644|FG001|Overall Study|Withdrawal by Subject|2|||
125095210|NCT03911401|449967645|FG002|Overall Study|Withdrawal by Subject|0|||
125095211|NCT03911401|449967643|FG000|Overall Study|Withdrawal by parent/guardian|4|||
125095212|NCT03911401|449967644|FG001|Overall Study|Withdrawal by parent/guardian|4|||
125095213|NCT03911401|449967645|FG002|Overall Study|Withdrawal by parent/guardian|11|||
125095214|NCT00462501|449967646|FG000|Overall Study|Not treated|3|||
125095215|NCT00462501|449967646|FG000|Overall Study|Adverse Event|2|||
125095216|NCT00933543|449967649|FG000|Overall Study|Adverse Event|2|||
125006928|NCT01994382|449653314|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125006929|NCT01994382|449653315|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125006930|NCT01994382|449653316|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
125006931|NCT01994382|449653317|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125006932|NCT01994382|449653318|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
125006933|NCT01994382|449653319|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125006934|NCT01994382|449653320|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125006935|NCT01994382|449653321|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
125006936|NCT01994382|449653322|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
125006937|NCT01994382|449653306|FG000|Overall Study|Protocol violation/noncompliance|0|||
125006938|NCT01994382|449653307|FG001|Overall Study|Protocol violation/noncompliance|0|||
125006939|NCT01994382|449653308|FG002|Overall Study|Protocol violation/noncompliance|0|||
125006940|NCT01994382|449653309|FG003|Overall Study|Protocol violation/noncompliance|0|||
125006941|NCT01994382|449653310|FG004|Overall Study|Protocol violation/noncompliance|0|||
125006942|NCT01994382|449653311|FG005|Overall Study|Protocol violation/noncompliance|0|||
125006943|NCT01994382|449653312|FG006|Overall Study|Protocol violation/noncompliance|0|||
125006944|NCT01994382|449653313|FG007|Overall Study|Protocol violation/noncompliance|0|||
125006945|NCT01994382|449653314|FG008|Overall Study|Protocol violation/noncompliance|0|||
125006946|NCT01994382|449653315|FG009|Overall Study|Protocol violation/noncompliance|0|||
125006947|NCT01994382|449653316|FG010|Overall Study|Protocol violation/noncompliance|0|||
125006948|NCT01994382|449653317|FG011|Overall Study|Protocol violation/noncompliance|1|||
125006949|NCT01994382|449653318|FG012|Overall Study|Protocol violation/noncompliance|0|||
125006950|NCT01994382|449653319|FG013|Overall Study|Protocol violation/noncompliance|0|||
125006951|NCT01994382|449653320|FG014|Overall Study|Protocol violation/noncompliance|0|||
125006952|NCT01994382|449653321|FG015|Overall Study|Protocol violation/noncompliance|0|||
125006953|NCT01994382|449653322|FG016|Overall Study|Protocol violation/noncompliance|2|||
125006954|NCT01994382|449653306|FG000|Overall Study|Rolled over to Phase 2a|0|||
125006955|NCT01994382|449653307|FG001|Overall Study|Rolled over to Phase 2a|0|||
125006956|NCT01994382|449653308|FG002|Overall Study|Rolled over to Phase 2a|1|||
125006957|NCT01994382|449653309|FG003|Overall Study|Rolled over to Phase 2a|0|||
125006958|NCT01994382|449653310|FG004|Overall Study|Rolled over to Phase 2a|0|||
125006959|NCT01994382|449653311|FG005|Overall Study|Rolled over to Phase 2a|0|||
125006960|NCT01994382|449653312|FG006|Overall Study|Rolled over to Phase 2a|0|||
125006961|NCT01994382|449653313|FG007|Overall Study|Rolled over to Phase 2a|0|||
125006962|NCT01994382|449653314|FG008|Overall Study|Rolled over to Phase 2a|0|||
125006963|NCT01994382|449653315|FG009|Overall Study|Rolled over to Phase 2a|2|||
125006964|NCT01994382|449653316|FG010|Overall Study|Rolled over to Phase 2a|0|||
125006965|NCT01994382|449653317|FG011|Overall Study|Rolled over to Phase 2a|0|||
125006966|NCT01994382|449653318|FG012|Overall Study|Rolled over to Phase 2a|0|||
125006967|NCT01994382|449653319|FG013|Overall Study|Rolled over to Phase 2a|0|||
125006968|NCT01994382|449653320|FG014|Overall Study|Rolled over to Phase 2a|0|||
125006969|NCT01994382|449653321|FG015|Overall Study|Rolled over to Phase 2a|0|||
125006970|NCT01994382|449653322|FG016|Overall Study|Rolled over to Phase 2a|0|||
125006971|NCT02234284|449653323|FG000|Overall Study|Death|4|||
125006972|NCT02234284|449653324|FG001|Overall Study|Death|2|||
125006973|NCT02234284|449653323|FG000|Overall Study|Withdrawal by Subject|1|||
125006974|NCT02234284|449653324|FG001|Overall Study|Withdrawal by Subject|0|||
125006975|NCT02234284|449653323|FG000|Overall Study|Lost to Follow-up|20|||
125006976|NCT02234284|449653324|FG001|Overall Study|Lost to Follow-up|7|||
125006977|NCT00233363|449653325|FG000|Overall Study|Adverse Event|1|||
125006978|NCT00233363|449653326|FG001|Overall Study|Adverse Event|2|||
125006979|NCT00233363|449653325|FG000|Overall Study|Lack of Efficacy|0|||
125006980|NCT00233363|449653326|FG001|Overall Study|Lack of Efficacy|2|||
125006981|NCT00233363|449653325|FG000|Overall Study|Withdrawal by Subject|1|||
125006982|NCT00233363|449653326|FG001|Overall Study|Withdrawal by Subject|1|||
125006983|NCT00233363|449653325|FG000|Overall Study|Aggravation of complication|1|||
125006984|NCT00233363|449653326|FG001|Overall Study|Aggravation of complication|0|||
125006985|NCT00873366|449653332|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
125006986|NCT00873366|449653332|FG000|Overall Study|Off tamoxifen due to side effects|2|||
125006987|NCT00873366|449653332|FG000|Overall Study|Refused to continue DM-BT testing|3|||
125006988|NCT01576172|449653333|FG000|Overall Study|Ineligible|2|||
125006989|NCT01576172|449653334|FG001|Overall Study|Ineligible|1|||
125006990|NCT01576172|449653333|FG000|Overall Study|Withdrawal by Subject|2|||
125006991|NCT01576172|449653334|FG001|Overall Study|Withdrawal by Subject|0|||
125006992|NCT01576172|449653333|FG000|Overall Study|Insurance issue|1|||
125006993|NCT01576172|449653334|FG001|Overall Study|Insurance issue|0|||
125006994|NCT01537198|449653341|FG000|Overall Study|RSV infection|2|||
125095217|NCT00933543|449967650|FG001|Overall Study|Adverse Event|1|||
125095218|NCT00933543|449967649|FG000|Overall Study|Lost to Follow-up|0|||
125095219|NCT00933543|449967650|FG001|Overall Study|Lost to Follow-up|1|||
125095220|NCT00933543|449967649|FG000|Overall Study|Withdrawal by Subject|0|||
125095221|NCT00933543|449967650|FG001|Overall Study|Withdrawal by Subject|1|||
125095222|NCT00933543|449967649|FG000|Overall Study|Lack of Efficacy|0|||
125095223|NCT00933543|449967650|FG001|Overall Study|Lack of Efficacy|3|||
125095224|NCT00933543|449967649|FG000|Overall Study|Other|1|||
125095225|NCT00933543|449967650|FG001|Overall Study|Other|1|||
125095226|NCT04837807|449967651|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
125095227|NCT04837807|449967652|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
125095228|NCT00612456|449967657|FG000|Overall Study|Adverse Event|1|||
125095229|NCT00612456|449967658|FG001|Overall Study|Adverse Event|0|||
125095230|NCT00612456|449967659|FG002|Overall Study|Adverse Event|0|||
125095231|NCT00612456|449967657|FG000|Overall Study|Lack of Efficacy|1|||
125095232|NCT00612456|449967658|FG001|Overall Study|Lack of Efficacy|1|||
125095233|NCT00612456|449967659|FG002|Overall Study|Lack of Efficacy|0|||
125095234|NCT00612456|449967657|FG000|Overall Study|Withdrawal by Subject|0|||
125095235|NCT00612456|449967658|FG001|Overall Study|Withdrawal by Subject|1|||
125095236|NCT00612456|449967659|FG002|Overall Study|Withdrawal by Subject|0|||
125095237|NCT01258803|449967660|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
125095238|NCT01258803|449967661|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
125095239|NCT01258803|449967662|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
125095240|NCT01258803|449967663|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
125095241|NCT01258803|449967664|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
125095242|NCT01258803|449967665|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
125095243|NCT01258803|449967660|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
125095244|NCT01258803|449967661|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
125095245|NCT01258803|449967662|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
125095246|NCT01258803|449967663|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
125095247|NCT01258803|449967664|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
125095248|NCT01258803|449967665|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
125095249|NCT01258803|449967660|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
125095250|NCT01258803|449967661|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
125095251|NCT01258803|449967662|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
125095252|NCT01258803|449967663|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
125095253|NCT01258803|449967664|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
125095254|NCT01258803|449967665|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
125095255|NCT04652245|449967667|FG000|Wash-Out Period|Adverse Event|0|||
125095256|NCT04652245|449967668|FG001|Wash-Out Period|Adverse Event|2|||
125095257|NCT04652245|449967667|FG000|Wash-Out Period|Withdrawal by Subject|0|||
125095258|NCT04652245|449967668|FG001|Wash-Out Period|Withdrawal by Subject|2|||
125095259|NCT04419558|449967671|FG000|DB Period (48 Weeks)|Adverse Event|6|||
125095260|NCT04419558|449967672|FG001|DB Period (48 Weeks)|Adverse Event|6|||
125095261|NCT04419558|449967671|FG000|DB Period (48 Weeks)|Death|14|||
125095262|NCT04419558|449967672|FG001|DB Period (48 Weeks)|Death|11|||
125095263|NCT04419558|449967671|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
125095264|NCT04419558|449967672|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
125095265|NCT04419558|449967671|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
125095266|NCT04419558|449967672|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
125095267|NCT04419558|449967671|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
125095268|NCT04419558|449967672|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
125095269|NCT04419558|449967671|FG000|DB Period (48 Weeks)|Disease Progression|1|||
125095270|NCT04419558|449967672|FG001|DB Period (48 Weeks)|Disease Progression|0|||
125095271|NCT04419558|449967671|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
125095272|NCT04419558|449967672|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
125095273|NCT04419558|449967671|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
125095274|NCT04419558|449967672|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
125095275|NCT04419558|449967671|FG000|DB Period (48 Weeks)|Participant Decision|4|||
125095276|NCT04419558|449967672|FG001|DB Period (48 Weeks)|Participant Decision|3|||
125095277|NCT04419558|449967671|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
125095278|NCT04419558|449967672|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
125095279|NCT04419558|449967671|FG000|OLE Period (48 Weeks)|Death|4|||
125095280|NCT04419558|449967672|FG001|OLE Period (48 Weeks)|Death|6|||
125095281|NCT04419558|449967671|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
125095282|NCT04419558|449967672|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
125095283|NCT04419558|449967671|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
125095284|NCT04419558|449967672|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
125095285|NCT00903357|449967673|FG000|First Intervention|Withdrawal by Subject|5|||
125095286|NCT00903357|449967674|FG001|First Intervention|Withdrawal by Subject|3|||
125095287|NCT00903357|449967673|FG000|First Intervention|Flu|0|||
125095288|NCT00903357|449967674|FG001|First Intervention|Flu|1|||
125095289|NCT00903357|449967673|FG000|Wash Out Period of 2 Weeks|Flu|0|||
125095290|NCT00903357|449967674|FG001|Wash Out Period of 2 Weeks|Flu|1|||
125095291|NCT00903357|449967673|FG000|Second Intervention|Lost to Follow-up|1|||
125095292|NCT00903357|449967674|FG001|Second Intervention|Lost to Follow-up|0|||
125095293|NCT05146999|449967675|FG000|Overall Study|Withdrew consent|6|||
125095294|NCT05146999|449967676|FG001|Overall Study|Withdrew consent|1|||
125095295|NCT05146999|449967675|FG000|Overall Study|Lost to Follow-up|3|||
125095296|NCT05146999|449967676|FG001|Overall Study|Lost to Follow-up|2|||
125095297|NCT05146999|449967675|FG000|Overall Study|Other|1|||
125095298|NCT05146999|449967676|FG001|Overall Study|Other|3|||
125095299|NCT04668157|449967677|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
125095300|NCT04668157|449967678|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
125095301|NCT04668157|449967677|FG000|Treatment Period (52 Weeks)|Other|0|||
125095302|NCT04668157|449967678|FG001|Treatment Period (52 Weeks)|Other|2|||
125095303|NCT04246996|449967682|FG000|Overall Study|Physician Decision|1|||
125095304|NCT04246996|449967683|FG001|Overall Study|Physician Decision|1|||
125095305|NCT04246996|449967682|FG000|Overall Study|Did not meet eligibility criteria|1|||
125095306|NCT04246996|449967683|FG001|Overall Study|Did not meet eligibility criteria|4|||
125095307|NCT02442284|449967685|FG000|Overall Study|Adverse Event|1|||
125095308|NCT02442284|449967685|FG000|Overall Study|Withdrew Consent|2|||
125095309|NCT02442284|449967685|FG000|Overall Study|Lost to Follow-up|3|||
125095310|NCT02442284|449967685|FG000|Overall Study|Other|1|||
125095311|NCT01365182|449967686|FG000|Overall Study|Withdrawal by Subject|10|||
125095312|NCT01365182|449967687|FG001|Overall Study|Withdrawal by Subject|13|||
125095313|NCT01365182|449967688|FG002|Overall Study|Withdrawal by Subject|12|||
125095314|NCT02309372|449967691|FG000|Overall Study|Lost to Follow-up|3|||
125095315|NCT02309372|449967692|FG001|Overall Study|Lost to Follow-up|2|||
125095316|NCT02129192|449967693|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
125095317|NCT02129192|449967694|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
125095318|NCT01231620|449967696|FG000|Overall Study|Physician Decision|3|||
125095319|NCT01231620|449967697|FG001|Overall Study|Physician Decision|5|||
125095320|NCT01231620|449967698|FG002|Overall Study|Physician Decision|10|||
125095321|NCT01231620|449967696|FG000|Overall Study|Death|12|||
125095322|NCT01231620|449967697|FG001|Overall Study|Death|14|||
125095323|NCT01231620|449967698|FG002|Overall Study|Death|11|||
125095324|NCT01231620|449967696|FG000|Overall Study|Adverse Event|2|||
125095325|NCT01231620|449967697|FG001|Overall Study|Adverse Event|2|||
125095326|NCT01231620|449967698|FG002|Overall Study|Adverse Event|1|||
125095327|NCT01231620|449967696|FG000|Overall Study|Withdrawal by Subject|6|||
125095328|NCT01231620|449967697|FG001|Overall Study|Withdrawal by Subject|6|||
125095329|NCT01231620|449967698|FG002|Overall Study|Withdrawal by Subject|8|||
125095330|NCT01231620|449967696|FG000|Overall Study|Lost to Follow-up|3|||
125095331|NCT01231620|449967697|FG001|Overall Study|Lost to Follow-up|4|||
125095332|NCT01231620|449967698|FG002|Overall Study|Lost to Follow-up|9|||
125095333|NCT02400281|449967699|FG000|Overall Study|Adverse Event|0|||
125095334|NCT02400281|449967700|FG001|Overall Study|Adverse Event|0|||
125095335|NCT02400281|449967701|FG002|Overall Study|Adverse Event|1|||
125095336|NCT02400281|449967702|FG003|Overall Study|Adverse Event|0|||
125095337|NCT02400281|449967703|FG004|Overall Study|Adverse Event|1|||
125095338|NCT02400281|449967704|FG005|Overall Study|Adverse Event|0|||
125095339|NCT02400281|449967699|FG000|Overall Study|Physician Decision|0|||
125006995|NCT01537198|449653341|FG000|Overall Study|Adverse Event|4|||
125006996|NCT01537198|449653341|FG000|Overall Study|No Further Visits to the Clinic|37|||
125006997|NCT01537198|449653341|FG000|Overall Study|Other|111|||
125006998|NCT01231659|449653342|FG000|Overall Study|Adverse Event|9|||
125006999|NCT01231659|449653342|FG000|Overall Study|Disease Progression|48|||
125007000|NCT01231659|449653342|FG000|Overall Study|Death|2|||
125007001|NCT01231659|449653342|FG000|Overall Study|Patient refused to complete study visit|1|||
125007002|NCT01231659|449653342|FG000|Overall Study|Other protocol defined criteria|12|||
125007003|NCT01022502|449653343|FG000|Overall Study|Adverse Event|1|||
125007004|NCT01022502|449653343|FG000|Overall Study|employment related reasons|1|||
125007005|NCT01022502|449653343|FG000|Overall Study|Withdrawal by Subject|1|||
125007006|NCT01390272|449653344|FG000|Overall Study|Death|3|||
125007007|NCT01390272|449653345|FG001|Overall Study|Death|2|||
125007008|NCT01390272|449653344|FG000|Overall Study|Withdrawal by Subject|9|||
125007009|NCT01390272|449653345|FG001|Overall Study|Withdrawal by Subject|5|||
125007010|NCT01390272|449653344|FG000|Overall Study|Patient moved, no longer eligible|5|||
125007011|NCT01390272|449653345|FG001|Overall Study|Patient moved, no longer eligible|8|||
125007012|NCT01536951|449653349|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
125007013|NCT01536951|449653350|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
125007014|NCT01536951|449653351|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
125007015|NCT01536951|449653352|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
125007016|NCT01536951|449653353|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
125007017|NCT01536951|449653354|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
125007018|NCT01536951|449653355|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
125007019|NCT01536951|449653356|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
125007020|NCT01536951|449653357|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
125007021|NCT01536951|449653349|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
125007022|NCT01536951|449653350|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
125007023|NCT01536951|449653351|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
125007024|NCT01536951|449653352|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
125007025|NCT01536951|449653353|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
125007026|NCT01536951|449653354|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
125007027|NCT01536951|449653355|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
125007028|NCT01536951|449653356|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
125007029|NCT01536951|449653357|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
125007030|NCT00430482|449653358|FG000|Completed Treatment|Insufficient Treatment|7|||
125007031|NCT00430482|449653359|FG001|Completed Treatment|Insufficient Treatment|11|||
125007032|NCT00545402|449653360|FG000|Overall Study|Discontinuation of treatment|17|||
125007033|NCT00545402|449653361|FG001|Overall Study|Discontinuation of treatment|9|||
125007034|NCT00545402|449653360|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
125007035|NCT00545402|449653361|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
125007036|NCT00545402|449653360|FG000|Overall Study|Death|5|||
125007037|NCT00545402|449653361|FG001|Overall Study|Death|7|||
125007038|NCT00545402|449653360|FG000|Overall Study|Graft loss|2|||
125007039|NCT00545402|449653361|FG001|Overall Study|Graft loss|4|||
125007040|NCT00545402|449653360|FG000|Overall Study|Withdrawal by Subject|0|||
125007041|NCT00545402|449653361|FG001|Overall Study|Withdrawal by Subject|1|||
125007042|NCT00545402|449653360|FG000|Overall Study|Protocol Violation|1|||
125007043|NCT00545402|449653361|FG001|Overall Study|Protocol Violation|0|||
125007044|NCT00545402|449653360|FG000|Overall Study|Reason not specified|1|||
125007045|NCT00545402|449653361|FG001|Overall Study|Reason not specified|1|||
125007046|NCT00555477|449653362|FG000|Overall Study|Adverse Event|0|||
125007047|NCT00555477|449653363|FG001|Overall Study|Adverse Event|9|||
125007048|NCT00555477|449653362|FG000|Overall Study|Withdrawal by Subject|1|||
125007049|NCT00555477|449653363|FG001|Overall Study|Withdrawal by Subject|2|||
125007050|NCT00555477|449653362|FG000|Overall Study|Physician Decision|1|||
125007051|NCT00555477|449653363|FG001|Overall Study|Physician Decision|2|||
125007052|NCT01721876|449653364|FG000|Overall Study|Not treated|1|||
125007053|NCT01721876|449653365|FG001|Overall Study|Not treated|4|||
125007054|NCT01721876|449653364|FG000|Overall Study|Disease progression / relapse|123|||
125007055|NCT01721876|449653365|FG001|Overall Study|Disease progression / relapse|156|||
125007056|NCT01721876|449653364|FG000|Overall Study|Death|6|||
125007057|NCT01721876|449653365|FG001|Overall Study|Death|13|||
125007058|NCT01721876|449653364|FG000|Overall Study|Adverse Event|41|||
125007059|NCT01721876|449653365|FG001|Overall Study|Adverse Event|165|||
125007060|NCT01721876|449653364|FG000|Overall Study|Protocol Violation|2|||
125007061|NCT01721876|449653365|FG001|Overall Study|Protocol Violation|1|||
125007062|NCT01721876|449653364|FG000|Overall Study|Withdrawal by Subject|15|||
125007063|NCT01721876|449653365|FG001|Overall Study|Withdrawal by Subject|38|||
125007064|NCT01721876|449653364|FG000|Overall Study|Reason not listed|34|||
125007065|NCT01721876|449653365|FG001|Overall Study|Reason not listed|63|||
125007066|NCT01721876|449653364|FG000|Overall Study|Sponsor terminated trial|0|||
125007067|NCT01721876|449653365|FG001|Overall Study|Sponsor terminated trial|4|||
125007068|NCT01721057|449653366|FG000|Treatment Period|Withdrawal by Subject|11|||
125095340|NCT02400281|449967700|FG001|Overall Study|Physician Decision|0|||
125095341|NCT02400281|449967701|FG002|Overall Study|Physician Decision|1|||
125095342|NCT02400281|449967702|FG003|Overall Study|Physician Decision|0|||
125095343|NCT02400281|449967703|FG004|Overall Study|Physician Decision|0|||
125095344|NCT02400281|449967704|FG005|Overall Study|Physician Decision|0|||
125095345|NCT00412360|449967705|FG000|Overall Study|Lost to Follow-up|0|||
125095346|NCT00412360|449967706|FG001|Overall Study|Lost to Follow-up|1|||
125095347|NCT00412360|449967705|FG000|Overall Study|Not Transplanted|1|||
125095348|NCT00412360|449967706|FG001|Overall Study|Not Transplanted|2|||
125095349|NCT02576652|449967708|FG000|Overall Study|Withdrawal by Subject|2|||
125095350|NCT00553319|449967719|FG000|Overall Study|Lost to Follow-up|10|||
125095351|NCT00553319|449967720|FG001|Overall Study|Lost to Follow-up|9|||
125095352|NCT00553319|449967721|FG002|Overall Study|Lost to Follow-up|5|||
125095353|NCT00553319|449967719|FG000|Overall Study|wanted treatment elsewhere|2|||
125095354|NCT00553319|449967720|FG001|Overall Study|wanted treatment elsewhere|1|||
125095355|NCT00553319|449967721|FG002|Overall Study|wanted treatment elsewhere|1|||
125095356|NCT00553319|449967719|FG000|Overall Study|non-compliance|0|||
125095357|NCT00553319|449967720|FG001|Overall Study|non-compliance|0|||
125095358|NCT00553319|449967721|FG002|Overall Study|non-compliance|2|||
125095359|NCT00553319|449967719|FG000|Overall Study|incarceration|1|||
125095360|NCT00553319|449967720|FG001|Overall Study|incarceration|0|||
125095361|NCT00553319|449967721|FG002|Overall Study|incarceration|0|||
125095362|NCT00553319|449967719|FG000|Overall Study|moved|1|||
125095363|NCT00553319|449967720|FG001|Overall Study|moved|0|||
125095364|NCT00553319|449967721|FG002|Overall Study|moved|1|||
125095365|NCT01078974|449967722|FG000|Overall Study|Adverse Event|3|||
125095366|NCT00495794|449967727|FG000|Overall Study|Pharmacist did not activate patient|522|||
125095367|NCT00495794|449967728|FG001|Overall Study|Pharmacist did not activate patient|0|||
125095368|NCT03039699|449967729|FG000|Overall Study|Incorrect inclusion|5|||
125095369|NCT03039699|449967730|FG001|Overall Study|Incorrect inclusion|4|||
125095370|NCT03039699|449967729|FG000|Overall Study|Lack of data to assess study endpoint|5|||
125095371|NCT03039699|449967730|FG001|Overall Study|Lack of data to assess study endpoint|3|||
125095372|NCT03039699|449967729|FG000|Overall Study|Bacterial infection|12|||
125095373|NCT03039699|449967730|FG001|Overall Study|Bacterial infection|28|||
125095374|NCT02985541|449969316|FG000|Overall Study|Withdrawal by Subject|33|||
125095375|NCT02985541|449969316|FG000|Overall Study|Lost to Follow-up|26|||
125095376|NCT02985541|449969316|FG000|Overall Study|Adverse Event|27|||
125095377|NCT02985541|449969316|FG000|Overall Study|Physician Decision|2|||
125095378|NCT02985541|449969316|FG000|Overall Study|Pregnancy|2|||
125095379|NCT02985541|449969316|FG000|Overall Study|Wish for pregnancy|44|||
125095380|NCT02985541|449969316|FG000|Overall Study|Other reason|5|||
125095381|NCT02985541|449969316|FG000|Overall Study|Not valid for analysis|2|||
125095382|NCT00761761|449969322|FG000|Overall Study|Lost to Follow-up|3|||
125095383|NCT00761761|449969323|FG001|Overall Study|Lost to Follow-up|1|||
125095384|NCT00761761|449969322|FG000|Overall Study|Withdrawal by Subject|3|||
125095385|NCT00761761|449969323|FG001|Overall Study|Withdrawal by Subject|0|||
125095386|NCT04511533|449969325|FG000|Treatment|Other|2|||
125095387|NCT04511533|449969325|FG000|Treatment|Withdrawal by Subject|11|||
125095388|NCT04511533|449969325|FG000|Treatment|Death|5|||
125095389|NCT04511533|449969325|FG000|Treatment|Physician Decision|1|||
125095390|NCT04511533|449969325|FG000|Treatment|Progressive Disease|61|||
125095391|NCT04511533|449969325|FG000|Follow-Up|Other|7|||
125095392|NCT04511533|449969325|FG000|Follow-Up|Withdrawal by Subject|5|||
125095393|NCT04511533|449969325|FG000|Follow-Up|Lost to Follow-up|2|||
125095394|NCT04511533|449969325|FG000|Follow-Up|Death|4|||
125095395|NCT01982942|449969326|FG000|Overall Study|Adverse Event|10|||
125095396|NCT01982942|449969327|FG001|Overall Study|Adverse Event|5|||
125095397|NCT01982942|449969326|FG000|Overall Study|Lost to Follow-up|4|||
125095398|NCT01982942|449969327|FG001|Overall Study|Lost to Follow-up|3|||
125095399|NCT01982942|449969326|FG000|Overall Study|Multiple sclerosis progression|3|||
125095400|NCT01982942|449969327|FG001|Overall Study|Multiple sclerosis progression|2|||
125095401|NCT01982942|449969326|FG000|Overall Study|Wanted to try therapy not permitted|1|||
125095402|NCT01982942|449969327|FG001|Overall Study|Wanted to try therapy not permitted|0|||
125095403|NCT01982942|449969326|FG000|Overall Study|Subject declined future visits|0|||
125095404|NCT01982942|449969327|FG001|Overall Study|Subject declined future visits|1|||
125095405|NCT01982942|449969326|FG000|Overall Study|Left geographical area|2|||
125095406|NCT01982942|449969327|FG001|Overall Study|Left geographical area|0|||
125095407|NCT01982942|449969326|FG000|Overall Study|Too many pills|1|||
125095408|NCT01982942|449969327|FG001|Overall Study|Too many pills|0|||
125095409|NCT01982942|449969326|FG000|Overall Study|MS Relapse|0|||
125095410|NCT01982942|449969327|FG001|Overall Study|MS Relapse|1|||
125095411|NCT01982942|449969326|FG000|Overall Study|Chose to join a stem cell trial|0|||
125007069|NCT01721057|449653367|FG001|Treatment Period|Withdrawal by Subject|5|||
125007070|NCT01721057|449653368|FG002|Treatment Period|Withdrawal by Subject|8|||
125007071|NCT01721057|449653369|FG003|Treatment Period|Withdrawal by Subject|0|||
125007072|NCT01721057|449653370|FG004|Treatment Period|Withdrawal by Subject|0|||
125007073|NCT01721057|449653371|FG005|Treatment Period|Withdrawal by Subject|0|||
125007074|NCT01721057|449653372|FG006|Treatment Period|Withdrawal by Subject|0|||
125007075|NCT01721057|449653366|FG000|Treatment Period|Adverse Event|7|||
125007076|NCT01721057|449653367|FG001|Treatment Period|Adverse Event|10|||
125007077|NCT01721057|449653368|FG002|Treatment Period|Adverse Event|12|||
125007078|NCT01721057|449653369|FG003|Treatment Period|Adverse Event|0|||
125007079|NCT01721057|449653370|FG004|Treatment Period|Adverse Event|0|||
125007080|NCT01721057|449653371|FG005|Treatment Period|Adverse Event|0|||
125007081|NCT01721057|449653372|FG006|Treatment Period|Adverse Event|0|||
125007082|NCT01721057|449653366|FG000|Treatment Period|Lack of Efficacy|7|||
125007083|NCT01721057|449653367|FG001|Treatment Period|Lack of Efficacy|3|||
125007084|NCT01721057|449653368|FG002|Treatment Period|Lack of Efficacy|0|||
125007085|NCT01721057|449653369|FG003|Treatment Period|Lack of Efficacy|0|||
125007086|NCT01721057|449653370|FG004|Treatment Period|Lack of Efficacy|0|||
125007087|NCT01721057|449653371|FG005|Treatment Period|Lack of Efficacy|0|||
125007088|NCT01721057|449653372|FG006|Treatment Period|Lack of Efficacy|0|||
125007089|NCT01721057|449653366|FG000|Treatment Period|Lost to Follow-up|1|||
125007090|NCT01721057|449653367|FG001|Treatment Period|Lost to Follow-up|0|||
125007091|NCT01721057|449653368|FG002|Treatment Period|Lost to Follow-up|0|||
125007092|NCT01721057|449653369|FG003|Treatment Period|Lost to Follow-up|0|||
125007093|NCT01721057|449653370|FG004|Treatment Period|Lost to Follow-up|0|||
125007094|NCT01721057|449653371|FG005|Treatment Period|Lost to Follow-up|0|||
125007095|NCT01721057|449653372|FG006|Treatment Period|Lost to Follow-up|0|||
125007096|NCT01721057|449653366|FG000|Treatment Period|Physician Decision|0|||
125007097|NCT01721057|449653367|FG001|Treatment Period|Physician Decision|1|||
125007098|NCT01721057|449653368|FG002|Treatment Period|Physician Decision|3|||
125007099|NCT01721057|449653369|FG003|Treatment Period|Physician Decision|0|||
125007100|NCT01721057|449653370|FG004|Treatment Period|Physician Decision|0|||
125007101|NCT01721057|449653371|FG005|Treatment Period|Physician Decision|0|||
125007102|NCT01721057|449653372|FG006|Treatment Period|Physician Decision|0|||
125007103|NCT01721057|449653366|FG000|Treatment Period|Death|2|||
125007104|NCT01721057|449653367|FG001|Treatment Period|Death|0|||
125007105|NCT01721057|449653368|FG002|Treatment Period|Death|0|||
125007106|NCT01721057|449653369|FG003|Treatment Period|Death|0|||
125007107|NCT01721057|449653370|FG004|Treatment Period|Death|0|||
125007108|NCT01721057|449653371|FG005|Treatment Period|Death|0|||
125007109|NCT01721057|449653372|FG006|Treatment Period|Death|0|||
125007110|NCT01721057|449653366|FG000|Rescue Period|Adverse Event|0|||
125007111|NCT01721057|449653367|FG001|Rescue Period|Adverse Event|0|||
125007112|NCT01721057|449653368|FG002|Rescue Period|Adverse Event|0|||
125007113|NCT01721057|449653369|FG003|Rescue Period|Adverse Event|1|||
125007114|NCT01721057|449653370|FG004|Rescue Period|Adverse Event|0|||
125007115|NCT01721057|449653371|FG005|Rescue Period|Adverse Event|0|||
125007116|NCT01721057|449653372|FG006|Rescue Period|Adverse Event|0|||
125007117|NCT01721057|449653366|FG000|Rescue Period|Lack of Efficacy|0|||
125007118|NCT01721057|449653367|FG001|Rescue Period|Lack of Efficacy|0|||
125007119|NCT01721057|449653368|FG002|Rescue Period|Lack of Efficacy|0|||
125007120|NCT01721057|449653369|FG003|Rescue Period|Lack of Efficacy|2|||
125007121|NCT01721057|449653370|FG004|Rescue Period|Lack of Efficacy|0|||
125007122|NCT01721057|449653371|FG005|Rescue Period|Lack of Efficacy|0|||
125007123|NCT01721057|449653372|FG006|Rescue Period|Lack of Efficacy|0|||
125007124|NCT03805750|449653373|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
125007125|NCT03805750|449653374|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
125007126|NCT01177683|449653375|FG000|Study Treatment|Disease Progressions during treatment|2|||
125007127|NCT01177683|449653376|FG001|Study Treatment|Disease Progressions during treatment|0|||
125007128|NCT01177683|449653377|FG002|Study Treatment|Disease Progressions during treatment|3|||
125007129|NCT01177683|449653375|FG000|Study Treatment|Adverse Event|0|||
125007130|NCT01177683|449653376|FG001|Study Treatment|Adverse Event|1|||
125007131|NCT01177683|449653377|FG002|Study Treatment|Adverse Event|12|||
125007132|NCT01177683|449653375|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
125095412|NCT01982942|449969327|FG001|Overall Study|Chose to join a stem cell trial|1|||
125095413|NCT01982942|449969326|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
125095414|NCT01982942|449969327|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
125095415|NCT02918968|449969330|FG000|1st Line AAT|Progressive disease|9|||
125095416|NCT02918968|449969331|FG001|1st Line AAT|Progressive disease|4|||
125095417|NCT02918968|449969330|FG000|1st Line AAT|Adverse Event|12|||
125095418|NCT02918968|449969331|FG001|1st Line AAT|Adverse Event|3|||
125095419|NCT02918968|449969330|FG000|1st Line AAT|Physician Decision|4|||
125095420|NCT02918968|449969331|FG001|1st Line AAT|Physician Decision|2|||
125095421|NCT02918968|449969330|FG000|1st Line AAT|Withdrawal by Subject|2|||
125095422|NCT02918968|449969331|FG001|1st Line AAT|Withdrawal by Subject|1|||
125095423|NCT02918968|449969330|FG000|1st Line AAT|Lost to Follow-up|0|||
125095424|NCT02918968|449969331|FG001|1st Line AAT|Lost to Follow-up|1|||
125095425|NCT02918968|449969330|FG000|1st Line AAT|Death|1|||
125095426|NCT02918968|449969331|FG001|1st Line AAT|Death|0|||
125095427|NCT02918968|449969330|FG000|1st Line AAT|Miscellaneous|1|||
125095428|NCT02918968|449969331|FG001|1st Line AAT|Miscellaneous|0|||
125095429|NCT02918968|449969330|FG000|2nd Line AAT|Progressive disease|21|||
125095430|NCT02918968|449969331|FG001|2nd Line AAT|Progressive disease|3|||
125095431|NCT02918968|449969330|FG000|2nd Line AAT|Adverse Event|2|||
125095432|NCT02918968|449969331|FG001|2nd Line AAT|Adverse Event|5|||
125095433|NCT02918968|449969330|FG000|2nd Line AAT|Physician Decision|0|||
125095434|NCT02918968|449969331|FG001|2nd Line AAT|Physician Decision|1|||
125095435|NCT02918968|449969330|FG000|2nd Line AAT|Withdrawal by Subject|2|||
125095436|NCT02918968|449969331|FG001|2nd Line AAT|Withdrawal by Subject|2|||
125095437|NCT02918968|449969330|FG000|2nd Line AAT|Death|0|||
125095438|NCT02918968|449969331|FG001|2nd Line AAT|Death|1|||
125095439|NCT00727246|449969332|FG000|Overall Study|could not complete MRI|0|||
125095440|NCT00727246|449969333|FG001|Overall Study|could not complete MRI|1|||
125095441|NCT00727246|449969334|FG002|Overall Study|could not complete MRI|0|||
125095442|NCT00727246|449969335|FG003|Overall Study|could not complete MRI|1|||
125095443|NCT00727246|449969332|FG000|Overall Study|incidental finding|0|||
125095444|NCT00727246|449969333|FG001|Overall Study|incidental finding|0|||
125095445|NCT00727246|449969334|FG002|Overall Study|incidental finding|0|||
125095446|NCT00727246|449969335|FG003|Overall Study|incidental finding|1|||
125095447|NCT00727246|449969332|FG000|Overall Study|withdrawn|0|||
125095448|NCT00727246|449969333|FG001|Overall Study|withdrawn|0|||
125095449|NCT00727246|449969334|FG002|Overall Study|withdrawn|1|||
125095450|NCT00727246|449969335|FG003|Overall Study|withdrawn|0|||
125095451|NCT02696382|449969340|FG000|Overall Study|Death|7|||
125095452|NCT02696382|449969341|FG001|Overall Study|Death|2|||
125095453|NCT02696382|449969340|FG000|Overall Study|Withdrawal by Subject|5|||
125095454|NCT02696382|449969341|FG001|Overall Study|Withdrawal by Subject|12|||
125095455|NCT02696382|449969340|FG000|Overall Study|Lost to Follow-up|4|||
125095456|NCT02696382|449969341|FG001|Overall Study|Lost to Follow-up|7|||
125095457|NCT00483574|449969343|FG000|Overall Study|Adverse Event|6|||
125095458|NCT00483574|449969344|FG001|Overall Study|Adverse Event|0|||
125095459|NCT00483574|449969343|FG000|Overall Study|Protocol Violation|28|||
125095460|NCT00483574|449969344|FG001|Overall Study|Protocol Violation|9|||
125095461|NCT00483574|449969343|FG000|Overall Study|Lost to Follow-up|16|||
125095462|NCT00483574|449969344|FG001|Overall Study|Lost to Follow-up|4|||
125095463|NCT00483574|449969343|FG000|Overall Study|Withdrawal by Subject|52|||
125095464|NCT00483574|449969344|FG001|Overall Study|Withdrawal by Subject|0|||
125095465|NCT00998166|449969345|FG000|Overall Study|Early Study Termination|8|||
125095466|NCT04988035|449969358|FG000|Overall Study|Death|19|||
125095467|NCT04988035|449969359|FG001|Overall Study|Death|13|||
125095468|NCT04988035|449969358|FG000|Overall Study|Lost to Follow-up|12|||
125095469|NCT04988035|449969359|FG001|Overall Study|Lost to Follow-up|6|||
125095470|NCT04988035|449969358|FG000|Overall Study|Protocol Violation|0|||
125095471|NCT04988035|449969359|FG001|Overall Study|Protocol Violation|1|||
125095472|NCT04988035|449969358|FG000|Overall Study|Withdrawal by Subject|2|||
125095473|NCT04988035|449969359|FG001|Overall Study|Withdrawal by Subject|4|||
125095474|NCT04988035|449969358|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
125095475|NCT04988035|449969359|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
125095476|NCT03602976|449969360|FG000|Overall Study|Withdrawal by Subject|1|||
125095477|NCT04626947|449969361|FG000|Overall Study|Study terminated|14|||
125095478|NCT01428882|449969362|FG000|Overall Study|Lack of Efficacy|2|||
125095479|NCT01428882|449969363|FG001|Overall Study|Lack of Efficacy|7|||
125095480|NCT01428882|449969362|FG000|Overall Study|Protocol Violation|4|||
125095481|NCT01428882|449969363|FG001|Overall Study|Protocol Violation|3|||
125095482|NCT00429026|449969366|FG000|Overall Study|Inevaluable for response.|40|||
125095483|NCT03831282|449969369|FG000|Overall Study|Could not place sensor|1|||
125095484|NCT03556202|449969372|FG000|Extension Treatment Period|Adverse Event|18|||
125095485|NCT03556202|449969373|FG001|Extension Treatment Period|Adverse Event|14|||
125095486|NCT03556202|449969374|FG002|Extension Treatment Period|Adverse Event|9|||
125095487|NCT03556202|449969372|FG000|Extension Treatment Period|Death|2|||
125095488|NCT03556202|449969373|FG001|Extension Treatment Period|Death|6|||
125095489|NCT03556202|449969374|FG002|Extension Treatment Period|Death|0|||
125095490|NCT03556202|449969372|FG000|Extension Treatment Period|Lack of Efficacy|5|||
125095491|NCT03556202|449969373|FG001|Extension Treatment Period|Lack of Efficacy|12|||
125095492|NCT03556202|449969374|FG002|Extension Treatment Period|Lack of Efficacy|18|||
125095493|NCT03556202|449969372|FG000|Extension Treatment Period|Lost to Follow-up|9|||
125095494|NCT03556202|449969373|FG001|Extension Treatment Period|Lost to Follow-up|20|||
125095495|NCT03556202|449969374|FG002|Extension Treatment Period|Lost to Follow-up|2|||
125095496|NCT03556202|449969372|FG000|Extension Treatment Period|Pregnancy|2|||
125095497|NCT03556202|449969373|FG001|Extension Treatment Period|Pregnancy|4|||
125095498|NCT03556202|449969374|FG002|Extension Treatment Period|Pregnancy|3|||
125095499|NCT03556202|449969372|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
125095500|NCT03556202|449969373|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
125095501|NCT03556202|449969374|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
125095502|NCT03556202|449969372|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
125095503|NCT03556202|449969373|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
125095504|NCT03556202|449969374|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
125095505|NCT03556202|449969372|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
125095506|NCT03556202|449969373|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
125095507|NCT03556202|449969374|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
125095508|NCT03556202|449969372|FG000|Extension Treatment Period|Physician Decision|0|||
125095509|NCT03556202|449969373|FG001|Extension Treatment Period|Physician Decision|8|||
125095510|NCT03556202|449969374|FG002|Extension Treatment Period|Physician Decision|2|||
125095511|NCT03556202|449969372|FG000|Extension Treatment Period|Protocol Violation|0|||
125095512|NCT03556202|449969373|FG001|Extension Treatment Period|Protocol Violation|1|||
125095513|NCT03556202|449969374|FG002|Extension Treatment Period|Protocol Violation|1|||
125095514|NCT03556202|449969372|FG000|Extension Treatment Period|Sponsor Decision|0|||
125095515|NCT03556202|449969373|FG001|Extension Treatment Period|Sponsor Decision|1|||
125095516|NCT03556202|449969374|FG002|Extension Treatment Period|Sponsor Decision|0|||
125095517|NCT03556202|449969372|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
125095518|NCT03556202|449969373|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
125095519|NCT03556202|449969374|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
125095520|NCT03556202|449969372|FG000|Follow-Up Period (12 Weeks)|Death|1|||
125095521|NCT03556202|449969373|FG001|Follow-Up Period (12 Weeks)|Death|0|||
125095522|NCT03556202|449969374|FG002|Follow-Up Period (12 Weeks)|Death|0|||
125095523|NCT03556202|449969372|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
125095524|NCT03556202|449969373|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
125095525|NCT03556202|449969374|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
125095526|NCT03556202|449969372|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
125095527|NCT03556202|449969373|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
125095528|NCT03556202|449969374|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
125095529|NCT03556202|449969372|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
125095530|NCT03556202|449969373|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
125095531|NCT03556202|449969374|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
125095532|NCT03556202|449969372|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
125095533|NCT03556202|449969373|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
125095534|NCT03556202|449969374|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
125095535|NCT03556202|449969372|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
125095536|NCT03556202|449969373|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
125095537|NCT03556202|449969374|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
125095538|NCT03556202|449969372|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
125095539|NCT03556202|449969373|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
125095540|NCT03556202|449969374|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
125095541|NCT03556202|449969372|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
125095542|NCT03556202|449969373|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
125095543|NCT03556202|449969374|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
125095544|NCT03556202|449969372|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
125095545|NCT03556202|449969373|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
125095546|NCT03556202|449969374|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
125095547|NCT03556202|449969372|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
125095548|NCT03556202|449969373|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
125095549|NCT03556202|449969374|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
125095550|NCT03556202|449969372|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
125095551|NCT03556202|449969373|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
125095552|NCT03556202|449969374|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
125095553|NCT03556202|449969372|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
125095554|NCT03556202|449969373|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
125095555|NCT03556202|449969374|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
125095556|NCT03556202|449969372|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
125095557|NCT03556202|449969373|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
125095558|NCT03556202|449969374|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
125095559|NCT01539512|449969375|FG000|Overall Study|Adverse Event|9|||
125095560|NCT01539512|449969376|FG001|Overall Study|Adverse Event|7|||
125095561|NCT01539512|449969375|FG000|Overall Study|Physician Decision|1|||
125095562|NCT01539512|449969376|FG001|Overall Study|Physician Decision|1|||
125095563|NCT01539512|449969375|FG000|Overall Study|Withdrawal by Subject|12|||
125095564|NCT01539512|449969376|FG001|Overall Study|Withdrawal by Subject|5|||
125095565|NCT01539512|449969375|FG000|Overall Study|Richter's Transformation|1|||
125095566|NCT01539512|449969376|FG001|Overall Study|Richter's Transformation|0|||
125095567|NCT04479358|449969383|FG000|Overall Study|Withdrawal by Subject|0|||
125095568|NCT04479358|449969384|FG001|Overall Study|Withdrawal by Subject|0|||
125095569|NCT04479358|449969385|FG002|Overall Study|Withdrawal by Subject|1|||
125095570|NCT04479358|449969386|FG003|Overall Study|Withdrawal by Subject|0|||
125007133|NCT01177683|449653376|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
125007134|NCT01177683|449653377|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
125007135|NCT01177683|449653375|FG000|Study Treatment|Alternative therapy|0|||
125007136|NCT01177683|449653376|FG001|Study Treatment|Alternative therapy|0|||
125007137|NCT01177683|449653377|FG002|Study Treatment|Alternative therapy|4|||
125007138|NCT01177683|449653375|FG000|Study Treatment|Physician Decision|1|||
125007139|NCT01177683|449653376|FG001|Study Treatment|Physician Decision|0|||
125007140|NCT01177683|449653377|FG002|Study Treatment|Physician Decision|1|||
125007141|NCT01177683|449653375|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
125007142|NCT01177683|449653376|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
125007143|NCT01177683|449653377|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
125007144|NCT01177683|449653375|FG000|Study Treatment|Symptomatic Deterioration|0|||
125007145|NCT01177683|449653376|FG001|Study Treatment|Symptomatic Deterioration|0|||
125007146|NCT01177683|449653377|FG002|Study Treatment|Symptomatic Deterioration|1|||
125007147|NCT01177683|449653375|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
125007148|NCT01177683|449653376|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
125007149|NCT01177683|449653377|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
125007150|NCT01177683|449653375|FG000|Follow up|Patient lost to follow up|0|||
125007151|NCT01177683|449653376|FG001|Follow up|Patient lost to follow up|0|||
125007152|NCT01177683|449653377|FG002|Follow up|Patient lost to follow up|2|||
125007153|NCT01177683|449653375|FG000|Follow up|Death|2|||
125007154|NCT01177683|449653376|FG001|Follow up|Death|1|||
125007155|NCT01177683|449653377|FG002|Follow up|Death|7|||
125007156|NCT01177683|449653375|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
125007157|NCT01177683|449653376|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
125007158|NCT01177683|449653377|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
125007159|NCT00789880|449653378|FG000|Overall Study|Adverse Event|0|||
125007160|NCT00789880|449653379|FG001|Overall Study|Adverse Event|0|||
125007161|NCT00789880|449653380|FG002|Overall Study|Adverse Event|0|||
125007162|NCT00789880|449653381|FG003|Overall Study|Adverse Event|0|||
125007163|NCT00789880|449653382|FG004|Overall Study|Adverse Event|1|||
125007164|NCT00789880|449653383|FG005|Overall Study|Adverse Event|0|||
125007165|NCT00789880|449653378|FG000|Overall Study|Protocol Violation|0|||
125007166|NCT00789880|449653379|FG001|Overall Study|Protocol Violation|1|||
125007167|NCT00789880|449653380|FG002|Overall Study|Protocol Violation|0|||
125007168|NCT00789880|449653381|FG003|Overall Study|Protocol Violation|1|||
125007169|NCT00789880|449653382|FG004|Overall Study|Protocol Violation|0|||
125007170|NCT00789880|449653383|FG005|Overall Study|Protocol Violation|0|||
125007171|NCT00789880|449653378|FG000|Overall Study|Withdrawal by Subject|1|||
125007172|NCT00789880|449653379|FG001|Overall Study|Withdrawal by Subject|0|||
125007173|NCT00789880|449653380|FG002|Overall Study|Withdrawal by Subject|0|||
125007174|NCT00789880|449653381|FG003|Overall Study|Withdrawal by Subject|0|||
125007175|NCT00789880|449653382|FG004|Overall Study|Withdrawal by Subject|2|||
125007176|NCT00789880|449653383|FG005|Overall Study|Withdrawal by Subject|0|||
125007177|NCT01977820|449653388|FG000|Overall Study|Sponsor terminated the study|1|||
125007178|NCT01977820|449653389|FG001|Overall Study|Sponsor terminated the study|1|||
125007179|NCT02568475|449653390|FG000|Overall Study|Lost to Follow-up|40|||
125007180|NCT02568475|449653391|FG001|Overall Study|Lost to Follow-up|39|||
125007181|NCT02568475|449653390|FG000|Overall Study|Withdrawal by Subject|2|||
125007182|NCT02568475|449653391|FG001|Overall Study|Withdrawal by Subject|0|||
125007183|NCT02568475|449653390|FG000|Overall Study|Discharged home|4|||
125007184|NCT02568475|449653391|FG001|Overall Study|Discharged home|4|||
125007185|NCT02568475|449653390|FG000|Overall Study|Short-term: Discharge location unknown|4|||
125007186|NCT02568475|449653391|FG001|Overall Study|Short-term: Discharge location unknown|0|||
125007187|NCT02568475|449653390|FG000|Overall Study|Transferred to another facility|1|||
125095571|NCT04479358|449969387|FG004|Overall Study|Withdrawal by Subject|0|||
125095572|NCT04479358|449969388|FG005|Overall Study|Withdrawal by Subject|1|||
125095573|NCT00764465|449969389|FG000|Overall Study|Adverse Event|2|||
125095574|NCT00764465|449969390|FG001|Overall Study|Adverse Event|0|||
125095575|NCT00764465|449969391|FG002|Overall Study|Adverse Event|0|||
125095576|NCT00764465|449969392|FG003|Overall Study|Adverse Event|1|||
125095577|NCT00764465|449969393|FG004|Overall Study|Adverse Event|1|||
125095578|NCT00764465|449969394|FG005|Overall Study|Adverse Event|1|||
125095579|NCT00764465|449969389|FG000|Overall Study|Withdrawal by Subject|0|||
125095580|NCT00764465|449969390|FG001|Overall Study|Withdrawal by Subject|1|||
125095581|NCT00764465|449969391|FG002|Overall Study|Withdrawal by Subject|1|||
125095582|NCT00764465|449969392|FG003|Overall Study|Withdrawal by Subject|0|||
125095583|NCT00764465|449969393|FG004|Overall Study|Withdrawal by Subject|0|||
125095584|NCT00764465|449969394|FG005|Overall Study|Withdrawal by Subject|0|||
125095585|NCT01333501|449969395|FG000|Overall Study|Adverse Event|3|||
125095586|NCT01333501|449969396|FG001|Overall Study|Adverse Event|1|||
125095587|NCT01333501|449969395|FG000|Overall Study|Abnormal laboratory value|2|||
125095588|NCT01333501|449969396|FG001|Overall Study|Abnormal laboratory value|1|||
125095589|NCT01333501|449969395|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125095590|NCT01333501|449969396|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
125095591|NCT01333501|449969395|FG000|Overall Study|Withdrawn consent|3|||
125095592|NCT01333501|449969396|FG001|Overall Study|Withdrawn consent|12|||
125095593|NCT00674440|449969397|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
125095594|NCT00674440|449969397|FG000|Overall Study|did not have surgery, so unevaluable|7|||
125095595|NCT00674440|449969397|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
125095596|NCT00914940|449969398|FG000|D0 to D100 Post-transplant|Death|2|||
125095597|NCT00914940|449969398|FG000|D101 to 2 Years Post-transplant|Death|8|||
125095598|NCT00914940|449969398|FG000|2 Years to 5 Years Post-transplant|Death|3|||
125095599|NCT04095039|449969400|FG000|Overall Study|Withdrawal by Subject|2|||
125095600|NCT04095039|449969401|FG001|Overall Study|Withdrawal by Subject|16|||
125095601|NCT04095039|449969400|FG000|Overall Study|Transplanted|21|||
125007188|NCT02568475|449653391|FG001|Overall Study|Transferred to another facility|0|||
125007189|NCT01889238|449653394|FG000|Overall Study|Death|1|||
125007190|NCT01889238|449653394|FG000|Overall Study|Withdrawal by Subject|1|||
125007191|NCT01889238|449653394|FG000|Overall Study|Adverse Event|6|||
125007192|NCT01889238|449653394|FG000|Overall Study|Disease Progression|104|||
125007193|NCT01889238|449653394|FG000|Overall Study|Other|6|||
125007194|NCT04136184|449653395|FG000|Overall Study|Lost to Follow-up|0|||
125007195|NCT04136184|449653396|FG001|Overall Study|Lost to Follow-up|3|||
125007196|NCT04136184|449653395|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
125007197|NCT04136184|449653396|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
125007198|NCT02844816|449653397|FG000|Overall Study|No protocol treatment received|5|||
125007199|NCT02844816|449653398|FG001|Overall Study|No protocol treatment received|1|||
125007200|NCT02844816|449653397|FG000|Overall Study|Ineligible|22|||
125007201|NCT02844816|449653398|FG001|Overall Study|Ineligible|15|||
125007202|NCT02844816|449653397|FG000|Overall Study|Participant refusal|5|||
125007203|NCT02844816|449653398|FG001|Overall Study|Participant refusal|5|||
125007204|NCT02844816|449653397|FG000|Overall Study|Adverse Event|5|||
125007205|NCT02844816|449653398|FG001|Overall Study|Adverse Event|4|||
125007206|NCT02844816|449653397|FG000|Overall Study|Death|0|||
125007207|NCT02844816|449653398|FG001|Overall Study|Death|1|||
125007208|NCT02844816|449653397|FG000|Overall Study|Disease progression/recurrence|50|||
125007209|NCT02844816|449653398|FG001|Overall Study|Disease progression/recurrence|24|||
125007210|NCT02844816|449653397|FG000|Overall Study|Physician Decision|1|||
125007211|NCT02844816|449653398|FG001|Overall Study|Physician Decision|1|||
125007212|NCT02717754|449653401|FG000|Overall Study|Incorrect Infusion Duration|0|||
125007213|NCT02717754|449653402|FG001|Overall Study|Incorrect Infusion Duration|0|||
125007214|NCT02717754|449653403|FG002|Overall Study|Incorrect Infusion Duration|0|||
125007215|NCT02717754|449653404|FG003|Overall Study|Incorrect Infusion Duration|10|||
125007216|NCT02717754|449653405|FG004|Overall Study|Incorrect Infusion Duration|20|||
125007217|NCT02717754|449653406|FG005|Overall Study|Incorrect Infusion Duration|20|||
125007218|NCT03520959|449653407|FG000|Overall Study|Study terminated by Sponsor|0|||
125007219|NCT03520959|449653408|FG001|Overall Study|Study terminated by Sponsor|1|||
125007220|NCT03734016|449653409|FG000|Overall Study|Sponsor Ended Study|225|||
125007221|NCT03734016|449653410|FG001|Overall Study|Sponsor Ended Study|200|||
125007222|NCT03734016|449653409|FG000|Overall Study|Death|69|||
125007223|NCT03734016|449653410|FG001|Overall Study|Death|83|||
125007224|NCT03734016|449653409|FG000|Overall Study|Withdrawal by Subject|21|||
125007225|NCT03734016|449653410|FG001|Overall Study|Withdrawal by Subject|27|||
125007226|NCT03734016|449653409|FG000|Overall Study|Physician Decision|1|||
125007227|NCT03734016|449653410|FG001|Overall Study|Physician Decision|12|||
125007228|NCT03734016|449653409|FG000|Overall Study|Lost to Follow-up|6|||
125007229|NCT03734016|449653410|FG001|Overall Study|Lost to Follow-up|2|||
125007230|NCT03734016|449653409|FG000|Overall Study|Miscellaneous|5|||
125007231|NCT03734016|449653410|FG001|Overall Study|Miscellaneous|1|||
125007232|NCT01979835|449653411|FG000|Primary Outcome SA Measurment|failed insertion|18|||
125007233|NCT01979835|449653411|FG000|Follow-up|Lost to Follow-up|32|||
125007234|NCT02592018|449653414|FG000|Overall Study|Adverse Event|1|||
125007235|NCT02592018|449653414|FG000|Overall Study|Lost to Follow-up|1|||
125007236|NCT02710136|449653417|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
125007237|NCT02710136|449653418|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
125007238|NCT00418665|449653419|FG000|Treatment Period|Ineligibility determined|1|||
125007239|NCT00418665|449653420|FG001|Treatment Period|Ineligibility determined|1|||
125007240|NCT00418665|449653421|FG002|Treatment Period|Ineligibility determined|0|||
125007241|NCT00418665|449653419|FG000|Treatment Period|Adverse Event|2|||
125095602|NCT04095039|449969401|FG001|Overall Study|Transplanted|24|||
125007242|NCT00418665|449653420|FG001|Treatment Period|Adverse Event|2|||
125007243|NCT00418665|449653421|FG002|Treatment Period|Adverse Event|0|||
125007244|NCT00418665|449653419|FG000|Treatment Period|Withdrawal by Subject|0|||
125095603|NCT04095039|449969400|FG000|Overall Study|Transferred to Non-study Facility|47|||
125095604|NCT04095039|449969401|FG001|Overall Study|Transferred to Non-study Facility|44|||
125095605|NCT04095039|449969400|FG000|Overall Study|Withdrawal from internvention target|0|||
125095606|NCT04095039|449969401|FG001|Overall Study|Withdrawal from internvention target|2|||
125095607|NCT04095039|449969400|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
125095608|NCT04095039|449969401|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
125095609|NCT04095039|449969400|FG000|Overall Study|Cacliphylaxis|0|||
125095610|NCT04095039|449969401|FG001|Overall Study|Cacliphylaxis|1|||
125095611|NCT04095039|449969400|FG000|Overall Study|Pregnancy|1|||
125095612|NCT04095039|449969401|FG001|Overall Study|Pregnancy|0|||
125095613|NCT02370173|449969402|FG000|Overall Study|Protocol Violation|1|||
125095614|NCT02370173|449969403|FG001|Overall Study|Protocol Violation|1|||
125095615|NCT02370173|449969402|FG000|Overall Study|Withdrawal by Subject|2|||
125095616|NCT02370173|449969403|FG001|Overall Study|Withdrawal by Subject|2|||
125095617|NCT03205605|449969404|FG000|Overall Study|Withdrawal by Subject|1|||
125095618|NCT00945815|449969407|FG000|Overall Study|Death|3|||
125095619|NCT00945815|449969407|FG000|Overall Study|Not protocol specified|1|||
125095620|NCT00945815|449969407|FG000|Overall Study|Ineligible|3|||
125095621|NCT00945815|449969407|FG000|Overall Study|Did not begin protocol therapy|1|||
125095622|NCT01990339|449969410|FG000|Overall Study|Data Not Available|49|||
125095623|NCT01990339|449969410|FG000|Overall Study|Voluntary Withdrawal|1402|||
125095624|NCT01990339|449969410|FG000|Overall Study|Lost to Follow-up|861|||
125095625|NCT01038609|449969411|FG000|Overall Study|Adverse Event|0|||
125095626|NCT01038609|449969412|FG001|Overall Study|Adverse Event|0|||
125095627|NCT01038609|449969413|FG002|Overall Study|Adverse Event|1|||
125095628|NCT01038609|449969414|FG003|Overall Study|Adverse Event|0|||
125095629|NCT01038609|449969415|FG004|Overall Study|Adverse Event|0|||
125095630|NCT01038609|449969411|FG000|Overall Study|Dosing Error|0|||
125095631|NCT01038609|449969412|FG001|Overall Study|Dosing Error|0|||
125095632|NCT01038609|449969413|FG002|Overall Study|Dosing Error|0|||
125095633|NCT01038609|449969414|FG003|Overall Study|Dosing Error|1|||
125095634|NCT01038609|449969415|FG004|Overall Study|Dosing Error|1|||
125095635|NCT01038609|449969411|FG000|Overall Study|Death in the Family|1|||
125095636|NCT01038609|449969412|FG001|Overall Study|Death in the Family|0|||
125095637|NCT01038609|449969413|FG002|Overall Study|Death in the Family|0|||
125095638|NCT01038609|449969414|FG003|Overall Study|Death in the Family|0|||
125095639|NCT01038609|449969415|FG004|Overall Study|Death in the Family|0|||
125095640|NCT01038609|449969411|FG000|Overall Study|Refusal of Blood Draws|0|||
125095641|NCT01038609|449969412|FG001|Overall Study|Refusal of Blood Draws|1|||
125095642|NCT01038609|449969413|FG002|Overall Study|Refusal of Blood Draws|0|||
125095643|NCT01038609|449969414|FG003|Overall Study|Refusal of Blood Draws|0|||
125095644|NCT01038609|449969415|FG004|Overall Study|Refusal of Blood Draws|0|||
125095645|NCT01728194|449969416|FG000|Overall Study|Lost to Follow-up|4|||
125095646|NCT01728194|449969417|FG001|Overall Study|Lost to Follow-up|3|||
125095647|NCT01728194|449969416|FG000|Overall Study|Physician Decision|4|||
125095648|NCT01728194|449969417|FG001|Overall Study|Physician Decision|0|||
125095649|NCT01728194|449969416|FG000|Overall Study|Withdrawal by Subject|7|||
125095650|NCT01728194|449969417|FG001|Overall Study|Withdrawal by Subject|3|||
125095651|NCT01728194|449969416|FG000|Overall Study|Perceived Medication Side Effects|4|||
125095652|NCT01728194|449969417|FG001|Overall Study|Perceived Medication Side Effects|0|||
125095653|NCT01728194|449969416|FG000|Overall Study|Family Member Request|1|||
125095654|NCT01728194|449969417|FG001|Overall Study|Family Member Request|0|||
125095655|NCT01590810|449969420|FG000|Overall Study|Physician Decision|0|||
125095656|NCT01590810|449969421|FG001|Overall Study|Physician Decision|1|||
125095657|NCT01590810|449969422|FG002|Overall Study|Physician Decision|1|||
125095658|NCT01590810|449969423|FG003|Overall Study|Physician Decision|0|||
125095659|NCT01590810|449969424|FG004|Overall Study|Physician Decision|0|||
125095660|NCT04604015|449969425|FG000|Overall Study|Incomplete Data Collection|33|||
125095661|NCT03655951|449969427|FG000|Overall Study|Lost to Follow-up|39|||
125095662|NCT03655951|449969428|FG001|Overall Study|Lost to Follow-up|20|||
125095663|NCT03655951|449969427|FG000|Overall Study|Withdrawal by Subject|0|||
125095664|NCT03655951|449969428|FG001|Overall Study|Withdrawal by Subject|1|||
125095665|NCT03575975|449969430|FG000|Overall Study|Lost to Follow-up|1|||
125095666|NCT03575975|449969431|FG001|Overall Study|Lost to Follow-up|0|||
125095667|NCT03575975|449969432|FG002|Overall Study|Lost to Follow-up|0|||
125095668|NCT00129220|449969434|FG000|Study Period II|Adverse Event|9|||
125095669|NCT00129220|449969435|FG001|Study Period II|Adverse Event|5|||
125095670|NCT00129220|449969436|FG002|Study Period II|Adverse Event|7|||
125095671|NCT00129220|449969434|FG000|Study Period II|Lack of Efficacy|15|||
125007245|NCT00418665|449653420|FG001|Treatment Period|Withdrawal by Subject|3|||
125007246|NCT00418665|449653421|FG002|Treatment Period|Withdrawal by Subject|1|||
125007247|NCT00418665|449653419|FG000|Treatment Period|Requirement for alternative therapy|1|||
125007248|NCT00418665|449653420|FG001|Treatment Period|Requirement for alternative therapy|0|||
125007249|NCT00418665|449653421|FG002|Treatment Period|Requirement for alternative therapy|0|||
125007250|NCT00418665|449653419|FG000|Treatment Period|Physician Decision|1|||
125007251|NCT00418665|449653420|FG001|Treatment Period|Physician Decision|0|||
125007252|NCT00418665|449653421|FG002|Treatment Period|Physician Decision|3|||
125007253|NCT00418665|449653419|FG000|Treatment Extension|Adverse Event|1|||
125007254|NCT00418665|449653420|FG001|Treatment Extension|Adverse Event|0|||
125007255|NCT00418665|449653421|FG002|Treatment Extension|Adverse Event|0|||
125007256|NCT00418665|449653419|FG000|Treatment Extension|Withdrawal by Subject|1|||
125007257|NCT00418665|449653420|FG001|Treatment Extension|Withdrawal by Subject|0|||
125007258|NCT00418665|449653421|FG002|Treatment Extension|Withdrawal by Subject|0|||
125007259|NCT00418665|449653419|FG000|Treatment Extension|Requirement for alternative therapy|2|||
125007260|NCT00418665|449653420|FG001|Treatment Extension|Requirement for alternative therapy|2|||
125007261|NCT00418665|449653421|FG002|Treatment Extension|Requirement for alternative therapy|0|||
125007262|NCT00418665|449653419|FG000|Treatment Extension|Physician Decision|2|||
125007263|NCT00418665|449653420|FG001|Treatment Extension|Physician Decision|2|||
125007264|NCT00418665|449653421|FG002|Treatment Extension|Physician Decision|1|||
125007265|NCT00418665|449653419|FG000|Treatment Extension|Death|0|||
125007266|NCT00418665|449653420|FG001|Treatment Extension|Death|0|||
125007267|NCT00418665|449653421|FG002|Treatment Extension|Death|1|||
125007268|NCT01133379|449653424|FG000|Overall Study|Withdrawal by Subject|0|||
125007269|NCT01133379|449653425|FG001|Overall Study|Withdrawal by Subject|1|||
125007270|NCT01133379|449653426|FG002|Overall Study|Withdrawal by Subject|1|||
125007271|NCT01133379|449653424|FG000|Overall Study|Lost to Follow-up|1|||
125007272|NCT01133379|449653425|FG001|Overall Study|Lost to Follow-up|1|||
125007273|NCT01133379|449653426|FG002|Overall Study|Lost to Follow-up|1|||
125007274|NCT00591214|449653427|FG000|Overall Study|Physician Decision|7|||
125007275|NCT00591214|449653427|FG000|Overall Study|Withdrawal by Subject|1|||
125007276|NCT01704287|449655013|FG000|Initial Treatment Period|Death|139|||
125007277|NCT01704287|449655014|FG001|Initial Treatment Period|Death|129|||
125007278|NCT01704287|449655015|FG002|Initial Treatment Period|Death|71|||
125007279|NCT01704287|449655016|FG003|Initial Treatment Period|Death|0|||
125007280|NCT01704287|449655017|FG004|Initial Treatment Period|Death|0|||
125007281|NCT01704287|449655013|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
125007282|NCT01704287|449655014|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
125007283|NCT01704287|449655015|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
125007284|NCT01704287|449655016|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
125007285|NCT01704287|449655017|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
125007286|NCT01704287|449655013|FG000|Initial Treatment Period|Lost to Follow-up|5|||
125007287|NCT01704287|449655014|FG001|Initial Treatment Period|Lost to Follow-up|3|||
125007288|NCT01704287|449655015|FG002|Initial Treatment Period|Lost to Follow-up|0|||
125007289|NCT01704287|449655016|FG003|Initial Treatment Period|Lost to Follow-up|0|||
125007290|NCT01704287|449655017|FG004|Initial Treatment Period|Lost to Follow-up|0|||
125007291|NCT01704287|449655013|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
125007292|NCT01704287|449655014|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
125007293|NCT01704287|449655015|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
125007294|NCT01704287|449655016|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
125007295|NCT01704287|449655017|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
125007296|NCT01704287|449655013|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
125007297|NCT01704287|449655014|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
125007298|NCT01704287|449655015|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
125007299|NCT01704287|449655016|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
125007300|NCT01704287|449655017|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
125007301|NCT01704287|449655013|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
125007302|NCT01704287|449655014|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
125007303|NCT01704287|449655015|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
125007304|NCT01704287|449655016|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
125007305|NCT01704287|449655017|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
125007306|NCT01704287|449655013|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
125007307|NCT01704287|449655014|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
125007308|NCT01704287|449655015|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
125007309|NCT01704287|449655016|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
125007310|NCT01704287|449655017|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
125007311|NCT04490395|449655018|FG000|Overall Study|Lost to Follow-up|0|||
125095672|NCT00129220|449969435|FG001|Study Period II|Lack of Efficacy|1|||
125095673|NCT00129220|449969436|FG002|Study Period II|Lack of Efficacy|28|||
125095674|NCT00129220|449969434|FG000|Study Period II|Entry Criteria Not Met|2|||
125095675|NCT00129220|449969435|FG001|Study Period II|Entry Criteria Not Met|0|||
125095676|NCT00129220|449969436|FG002|Study Period II|Entry Criteria Not Met|2|||
125095677|NCT00129220|449969434|FG000|Study Period II|Protocol Violation|4|||
125095678|NCT00129220|449969435|FG001|Study Period II|Protocol Violation|2|||
125095679|NCT00129220|449969436|FG002|Study Period II|Protocol Violation|1|||
125095680|NCT00129220|449969434|FG000|Study Period II|Physician Decision|0|||
125095681|NCT00129220|449969435|FG001|Study Period II|Physician Decision|1|||
125095682|NCT00129220|449969436|FG002|Study Period II|Physician Decision|0|||
125095683|NCT00129220|449969434|FG000|Study Period II|Withdrawal by Subject|1|||
125095684|NCT00129220|449969435|FG001|Study Period II|Withdrawal by Subject|3|||
125095685|NCT00129220|449969436|FG002|Study Period II|Withdrawal by Subject|4|||
125095686|NCT00129220|449969434|FG000|Study Period II|Reason Not Specified|2|||
125095687|NCT00129220|449969435|FG001|Study Period II|Reason Not Specified|0|||
125095688|NCT00129220|449969436|FG002|Study Period II|Reason Not Specified|5|||
125095689|NCT00129220|449969434|FG000|Study Period III|Adverse Event|1|||
125095690|NCT00129220|449969435|FG001|Study Period III|Adverse Event|0|||
125095691|NCT00129220|449969436|FG002|Study Period III|Adverse Event|3|||
125095692|NCT00129220|449969434|FG000|Study Period III|Protocol Violation|1|||
125095693|NCT00129220|449969435|FG001|Study Period III|Protocol Violation|1|||
125095694|NCT00129220|449969436|FG002|Study Period III|Protocol Violation|2|||
125095695|NCT00129220|449969434|FG000|Study Period III|Withdrawal by Subject|1|||
125095696|NCT00129220|449969435|FG001|Study Period III|Withdrawal by Subject|0|||
125095697|NCT00129220|449969436|FG002|Study Period III|Withdrawal by Subject|3|||
125095698|NCT00129220|449969434|FG000|Study Period III|Sponsor Decision|1|||
125095699|NCT00129220|449969435|FG001|Study Period III|Sponsor Decision|0|||
125095700|NCT00129220|449969436|FG002|Study Period III|Sponsor Decision|0|||
125095701|NCT00129220|449969434|FG000|Study Period III|Reason Not Specified|9|||
125095702|NCT00129220|449969435|FG001|Study Period III|Reason Not Specified|0|||
125095703|NCT00129220|449969436|FG002|Study Period III|Reason Not Specified|2|||
125095704|NCT01883362|449969437|FG000|Treatment|Adverse Event|1|||
125095705|NCT01883362|449969438|FG001|Treatment|Adverse Event|8|||
125095706|NCT01883362|449969437|FG000|Treatment|Withdrawal by Subject|6|||
125095707|NCT01883362|449969438|FG001|Treatment|Withdrawal by Subject|2|||
125095708|NCT01883362|449969437|FG000|Treatment|Administrative problems|4|||
125095709|NCT01883362|449969438|FG001|Treatment|Administrative problems|1|||
125095710|NCT01883362|449969437|FG000|Treatment|Relapse|4|||
125095711|NCT01883362|449969438|FG001|Treatment|Relapse|2|||
125095712|NCT01883362|449969437|FG000|Treatment|Randomized, not treated|1|||
125095713|NCT01883362|449969438|FG001|Treatment|Randomized, not treated|1|||
125095714|NCT01883362|449969437|FG000|Post Treatment Follow-up|Protocol Violation|0|||
125095715|NCT01883362|449969438|FG001|Post Treatment Follow-up|Protocol Violation|1|||
125095716|NCT01883362|449969437|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
125095717|NCT01883362|449969438|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
125095718|NCT01883362|449969437|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
125095719|NCT01883362|449969438|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
125095720|NCT01883362|449969437|FG000|Post Treatment Follow-up|Administrative problems|2|||
125095721|NCT01883362|449969438|FG001|Post Treatment Follow-up|Administrative problems|0|||
125095722|NCT01883362|449969437|FG000|Post Treatment Follow-up|Death|8|||
125095723|NCT01883362|449969438|FG001|Post Treatment Follow-up|Death|4|||
125095724|NCT01883362|449969437|FG000|Post Treatment Follow-up|Relapse|1|||
125095725|NCT01883362|449969438|FG001|Post Treatment Follow-up|Relapse|2|||
125095726|NCT01349816|449969441|FG000|Overall Study|Withdrawal by Subject|4|||
125095727|NCT01349816|449969441|FG000|Overall Study|Physician Decision|1|||
125095728|NCT01349816|449969441|FG000|Overall Study|Adverse Event|14|||
125095729|NCT01349816|449969441|FG000|Overall Study|Lost to Follow-up|2|||
125095730|NCT01349816|449969441|FG000|Overall Study|Protocol Violation|1|||
125095731|NCT01349816|449969441|FG000|Overall Study|Protocol-specified criteria|8|||
125095732|NCT01383317|449969442|FG000|Overall Study|Lost to Follow-up|2|||
125095733|NCT01383317|449969443|FG001|Overall Study|Lost to Follow-up|1|||
125095734|NCT01383317|449969442|FG000|Overall Study|Death|1|||
125095735|NCT01383317|449969443|FG001|Overall Study|Death|0|||
125095736|NCT01383317|449969442|FG000|Overall Study|Adverse Event|0|||
125095737|NCT01383317|449969443|FG001|Overall Study|Adverse Event|1|||
125095738|NCT02569996|449969444|FG000|Overall Study|Adverse Event|6|||
125095739|NCT02569996|449969444|FG000|Overall Study|Physician Decision|3|||
125095740|NCT02569996|449969444|FG000|Overall Study|Progression of the disease|18|||
125095741|NCT02569996|449969444|FG000|Overall Study|New anti-lymphoma treatment|1|||
125095742|NCT02569996|449969444|FG000|Overall Study|Non-compliance|9|||
125095743|NCT02569996|449969444|FG000|Overall Study|Withdrawal by Subject|5|||
125095744|NCT02569996|449969444|FG000|Overall Study|Lost to Follow-up|5|||
125095745|NCT02569996|449969444|FG000|Overall Study|Complete remission|7|||
125095746|NCT02569996|449969444|FG000|Overall Study|Unknown reason|1|||
125095747|NCT02911285|449969447|FG000|Overall Study|Lost to Follow-up|8|||
125095748|NCT02911285|449969448|FG001|Overall Study|Lost to Follow-up|5|||
125095749|NCT02911285|449969447|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
125095750|NCT02911285|449969448|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
125095751|NCT01397409|449969449|FG000|Stage 2|Adverse Event|0|||
125095752|NCT01397409|449969450|FG001|Stage 2|Adverse Event|0|||
125095753|NCT01397409|449969451|FG002|Stage 2|Adverse Event|0|||
125095754|NCT01397409|449969452|FG003|Stage 2|Adverse Event|0|||
125095755|NCT01397409|449969453|FG004|Stage 2|Adverse Event|6|||
125095756|NCT01397409|449969454|FG005|Stage 2|Adverse Event|3|||
125095757|NCT01397409|449969455|FG006|Stage 2|Adverse Event|0|||
125095758|NCT01397409|449969456|FG007|Stage 2|Adverse Event|0|||
125095759|NCT01397409|449969457|FG008|Stage 2|Adverse Event|0|||
125095760|NCT01397409|449969458|FG009|Stage 2|Adverse Event|0|||
125095761|NCT01397409|449969449|FG000|Stage 2|Personal Reasons|0|||
125095762|NCT01397409|449969450|FG001|Stage 2|Personal Reasons|0|||
125095763|NCT01397409|449969451|FG002|Stage 2|Personal Reasons|0|||
125095764|NCT01397409|449969452|FG003|Stage 2|Personal Reasons|0|||
125095765|NCT01397409|449969453|FG004|Stage 2|Personal Reasons|1|||
125095766|NCT01397409|449969454|FG005|Stage 2|Personal Reasons|0|||
125095767|NCT01397409|449969455|FG006|Stage 2|Personal Reasons|0|||
125095768|NCT01397409|449969456|FG007|Stage 2|Personal Reasons|0|||
125095769|NCT01397409|449969457|FG008|Stage 2|Personal Reasons|0|||
125095770|NCT01397409|449969458|FG009|Stage 2|Personal Reasons|0|||
125095771|NCT01397409|449969449|FG000|Stage 2|Other Miscellaneous Reasons|0|||
125095772|NCT01397409|449969450|FG001|Stage 2|Other Miscellaneous Reasons|0|||
125095773|NCT01397409|449969451|FG002|Stage 2|Other Miscellaneous Reasons|0|||
125095774|NCT01397409|449969452|FG003|Stage 2|Other Miscellaneous Reasons|0|||
125095775|NCT01397409|449969453|FG004|Stage 2|Other Miscellaneous Reasons|1|||
125095776|NCT01397409|449969454|FG005|Stage 2|Other Miscellaneous Reasons|1|||
125095777|NCT01397409|449969455|FG006|Stage 2|Other Miscellaneous Reasons|0|||
125095778|NCT01397409|449969456|FG007|Stage 2|Other Miscellaneous Reasons|0|||
125095779|NCT01397409|449969457|FG008|Stage 2|Other Miscellaneous Reasons|0|||
125095780|NCT01397409|449969458|FG009|Stage 2|Other Miscellaneous Reasons|0|||
125095781|NCT01397409|449969449|FG000|Stage 3|Adverse Event|0|||
125095782|NCT01397409|449969450|FG001|Stage 3|Adverse Event|0|||
125095783|NCT01397409|449969451|FG002|Stage 3|Adverse Event|0|||
125095784|NCT01397409|449969452|FG003|Stage 3|Adverse Event|0|||
125095785|NCT01397409|449969453|FG004|Stage 3|Adverse Event|0|||
125095786|NCT01397409|449969454|FG005|Stage 3|Adverse Event|0|||
125095787|NCT01397409|449969455|FG006|Stage 3|Adverse Event|0|||
125095788|NCT01397409|449969456|FG007|Stage 3|Adverse Event|1|||
125095789|NCT01397409|449969457|FG008|Stage 3|Adverse Event|0|||
125095790|NCT01397409|449969458|FG009|Stage 3|Adverse Event|0|||
125095791|NCT01397409|449969449|FG000|Stage 3|Other Miscellaneous Reasons|0|||
125095792|NCT01397409|449969450|FG001|Stage 3|Other Miscellaneous Reasons|0|||
125095793|NCT01397409|449969451|FG002|Stage 3|Other Miscellaneous Reasons|0|||
125095794|NCT01397409|449969452|FG003|Stage 3|Other Miscellaneous Reasons|0|||
125095795|NCT01397409|449969453|FG004|Stage 3|Other Miscellaneous Reasons|0|||
125095796|NCT01397409|449969454|FG005|Stage 3|Other Miscellaneous Reasons|0|||
125095797|NCT01397409|449969455|FG006|Stage 3|Other Miscellaneous Reasons|0|||
125095798|NCT01397409|449969456|FG007|Stage 3|Other Miscellaneous Reasons|1|||
125095799|NCT01397409|449969457|FG008|Stage 3|Other Miscellaneous Reasons|0|||
125095800|NCT01397409|449969458|FG009|Stage 3|Other Miscellaneous Reasons|0|||
125095801|NCT01207427|449969459|FG000|Double-blind Treatment Period|Adverse Event|0|||
125095802|NCT01207427|449969460|FG001|Double-blind Treatment Period|Adverse Event|1|||
125095803|NCT01207427|449969461|FG002|Double-blind Treatment Period|Adverse Event|0|||
125095804|NCT01207427|449969459|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
125095805|NCT01207427|449969460|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
125095806|NCT01207427|449969461|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
125095807|NCT01207427|449969459|FG000|Double-blind Treatment Period|Protocol Violation|2|||
125095808|NCT01207427|449969460|FG001|Double-blind Treatment Period|Protocol Violation|1|||
125095809|NCT01207427|449969461|FG002|Double-blind Treatment Period|Protocol Violation|1|||
125095810|NCT01207427|449969459|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
125095811|NCT01207427|449969460|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
125095812|NCT01207427|449969461|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
125095813|NCT01790633|449969462|FG000|Overall Study|Protocol Violation|1|||
125095814|NCT01790633|449969463|FG001|Overall Study|Protocol Violation|2|||
125095815|NCT01790633|449969462|FG000|Overall Study|Did not have serology performed|47|||
125095816|NCT01790633|449969463|FG001|Overall Study|Did not have serology performed|0|||
125095817|NCT01790633|449969462|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
125095818|NCT01790633|449969463|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
125095819|NCT02930889|449971165|FG000|Overall Study|Lost to Follow-up|2|||
125095820|NCT02930889|449971165|FG000|Overall Study|Withdrawal by Subject|6|||
125007312|NCT04490395|449655019|FG001|Overall Study|Lost to Follow-up|1|||
125007313|NCT02230254|449655020|FG000|Overall Study|Lost to Follow-up|3|||
125007314|NCT01462435|449655022|FG000|Overall Study|Lack of Efficacy|1|||
125007315|NCT01462435|449655023|FG001|Overall Study|Lack of Efficacy|0|||
125007316|NCT01462435|449655024|FG002|Overall Study|Lack of Efficacy|0|||
125007317|NCT01462435|449655025|FG003|Overall Study|Lack of Efficacy|3|||
125007318|NCT01462435|449655022|FG000|Overall Study|Physician Decision|0|||
125007319|NCT01462435|449655023|FG001|Overall Study|Physician Decision|0|||
125007320|NCT01462435|449655024|FG002|Overall Study|Physician Decision|1|||
125007321|NCT01462435|449655025|FG003|Overall Study|Physician Decision|0|||
125007322|NCT01462435|449655022|FG000|Overall Study|Withdrawal by Subject|0|||
125007323|NCT01462435|449655023|FG001|Overall Study|Withdrawal by Subject|0|||
125007324|NCT01462435|449655024|FG002|Overall Study|Withdrawal by Subject|0|||
125007325|NCT01462435|449655025|FG003|Overall Study|Withdrawal by Subject|1|||
125007326|NCT01462435|449655022|FG000|Overall Study|Lost to Follow-up|0|||
125007327|NCT01462435|449655023|FG001|Overall Study|Lost to Follow-up|0|||
125007328|NCT01462435|449655024|FG002|Overall Study|Lost to Follow-up|0|||
125007329|NCT01462435|449655025|FG003|Overall Study|Lost to Follow-up|1|||
125007330|NCT01942148|449655026|FG000|Overall Study|Adverse Event|4|||
125007331|NCT01942148|449655026|FG000|Overall Study|Lack of Efficacy|2|||
125007332|NCT01942148|449655026|FG000|Overall Study|Physician Decision|11|||
125007333|NCT01942148|449655026|FG000|Overall Study|Protocol Violation|1|||
125007334|NCT01942148|449655026|FG000|Overall Study|Withdrawal by Subject|8|||
125007335|NCT01942148|449655026|FG000|Overall Study|Use of the prohibition medicine|1|||
125007336|NCT02573870|449655028|FG000|Overall Study|Adverse Event|0|||
125007337|NCT02573870|449655029|FG001|Overall Study|Adverse Event|2|||
125007338|NCT02573870|449655028|FG000|Overall Study|Lack of Efficacy|0|||
125007339|NCT02573870|449655029|FG001|Overall Study|Lack of Efficacy|1|||
125007340|NCT02573870|449655028|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
125007341|NCT02573870|449655029|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
125007342|NCT02573870|449655028|FG000|Overall Study|Lost to Follow-up|0|||
125007343|NCT02573870|449655029|FG001|Overall Study|Lost to Follow-up|1|||
125007344|NCT02573870|449655028|FG000|Overall Study|Other: Fail to Meet Visit|0|||
125007345|NCT02573870|449655029|FG001|Overall Study|Other: Fail to Meet Visit|2|||
125007346|NCT00257725|449655030|FG000|Overall Study|Adverse Event|3|||
125007347|NCT03785925|449655032|FG000|Overall Study|Withdrawal by Subject|15|||
125007348|NCT03785925|449655032|FG000|Overall Study|Lost to Follow-up|1|||
125007349|NCT00806195|449655034|FG000|Overall Study|Death|6|||
125007350|NCT00806195|449655035|FG001|Overall Study|Death|0|||
125007351|NCT00806195|449655036|FG002|Overall Study|Death|1|||
125007352|NCT00806195|449655037|FG003|Overall Study|Death|0|||
125007353|NCT00806195|449655034|FG000|Overall Study|Adverse Event|25|||
125007354|NCT00806195|449655035|FG001|Overall Study|Adverse Event|5|||
125007355|NCT00806195|449655036|FG002|Overall Study|Adverse Event|11|||
125007356|NCT00806195|449655037|FG003|Overall Study|Adverse Event|2|||
125007357|NCT00806195|449655034|FG000|Overall Study|Withdrawal by Subject|119|||
125007358|NCT00806195|449655035|FG001|Overall Study|Withdrawal by Subject|31|||
125007359|NCT00806195|449655036|FG002|Overall Study|Withdrawal by Subject|76|||
125007360|NCT00806195|449655037|FG003|Overall Study|Withdrawal by Subject|35|||
125007361|NCT00806195|449655034|FG000|Overall Study|Lost to Follow-up|217|||
125007362|NCT00806195|449655035|FG001|Overall Study|Lost to Follow-up|66|||
125095821|NCT02930889|449971165|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
125007363|NCT00806195|449655036|FG002|Overall Study|Lost to Follow-up|90|||
125007364|NCT00806195|449655037|FG003|Overall Study|Lost to Follow-up|34|||
125007365|NCT00806195|449655034|FG000|Overall Study|Inappropriate Enrollment|0|||
125007366|NCT00806195|449655035|FG001|Overall Study|Inappropriate Enrollment|1|||
125007367|NCT00806195|449655036|FG002|Overall Study|Inappropriate Enrollment|0|||
125007368|NCT00806195|449655037|FG003|Overall Study|Inappropriate Enrollment|0|||
125007369|NCT00806195|449655034|FG000|Overall Study|Administrative Reason|113|||
125007370|NCT00806195|449655035|FG001|Overall Study|Administrative Reason|35|||
125007371|NCT00806195|449655036|FG002|Overall Study|Administrative Reason|66|||
125007372|NCT00806195|449655037|FG003|Overall Study|Administrative Reason|26|||
125007373|NCT00806195|449655034|FG000|Overall Study|Protocol Violation|34|||
125007374|NCT00806195|449655035|FG001|Overall Study|Protocol Violation|24|||
125095822|NCT00198107|449971169|FG000|Double-Blind Period|Adverse Event|1|||
125095823|NCT00198107|449971170|FG001|Double-Blind Period|Adverse Event|1|||
125095824|NCT00198107|449971171|FG002|Double-Blind Period|Adverse Event|0|||
125095825|NCT00198107|449971169|FG000|Double-Blind Period|Lack of Efficacy|2|||
125095826|NCT00198107|449971170|FG001|Double-Blind Period|Lack of Efficacy|0|||
125095827|NCT00198107|449971171|FG002|Double-Blind Period|Lack of Efficacy|0|||
125095828|NCT00198107|449971169|FG000|Double-Blind Period|Lost to Follow-up|2|||
125095829|NCT00198107|449971170|FG001|Double-Blind Period|Lost to Follow-up|1|||
125095830|NCT00198107|449971171|FG002|Double-Blind Period|Lost to Follow-up|0|||
125095831|NCT00198107|449971169|FG000|Double-Blind Period|Physician Decision|1|||
125095832|NCT00198107|449971170|FG001|Double-Blind Period|Physician Decision|0|||
125095833|NCT00198107|449971171|FG002|Double-Blind Period|Physician Decision|0|||
125095834|NCT00198107|449971169|FG000|Double-Blind Period|Withdrawal by Subject|0|||
125095835|NCT00198107|449971170|FG001|Double-Blind Period|Withdrawal by Subject|1|||
125095836|NCT00198107|449971171|FG002|Double-Blind Period|Withdrawal by Subject|0|||
125095837|NCT00198107|449971169|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
125095838|NCT00198107|449971170|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
125095839|NCT00198107|449971171|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
125095840|NCT03996694|449971180|FG000|First Washout (7 Days)|positive urine drug screen|0|||
125095841|NCT03996694|449971181|FG001|First Washout (7 Days)|positive urine drug screen|0|||
125095842|NCT03996694|449971182|FG002|First Washout (7 Days)|positive urine drug screen|1|||
125095843|NCT03996694|449971183|FG003|First Washout (7 Days)|positive urine drug screen|0|||
125095844|NCT03996694|449971184|FG004|First Washout (7 Days)|positive urine drug screen|0|||
125095845|NCT03996694|449971185|FG005|First Washout (7 Days)|positive urine drug screen|0|||
125095846|NCT03996694|449971180|FG000|First Washout (7 Days)|Adverse Event|0|||
125095847|NCT03996694|449971181|FG001|First Washout (7 Days)|Adverse Event|1|||
125095848|NCT03996694|449971182|FG002|First Washout (7 Days)|Adverse Event|0|||
125095849|NCT03996694|449971183|FG003|First Washout (7 Days)|Adverse Event|0|||
125095850|NCT03996694|449971184|FG004|First Washout (7 Days)|Adverse Event|0|||
125095851|NCT03996694|449971185|FG005|First Washout (7 Days)|Adverse Event|0|||
125095852|NCT03996694|449971180|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
125095853|NCT03996694|449971181|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
125095854|NCT03996694|449971182|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
125095855|NCT03996694|449971183|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
125095856|NCT03996694|449971184|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
125095857|NCT03996694|449971185|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
125095858|NCT03996694|449971180|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
125095859|NCT03996694|449971181|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
125095860|NCT03996694|449971182|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
125095861|NCT03996694|449971183|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
125095862|NCT03996694|449971184|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
125095863|NCT03996694|449971185|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
125095864|NCT00451191|449971190|FG000|Overall Study|withdrawal or received alternate tx|15|||
125095865|NCT00451191|449971191|FG001|Overall Study|withdrawal or received alternate tx|11|||
125095866|NCT01269346|449971193|FG000|Treatment Phase|Disease progression|3|||
125095867|NCT01269346|449971193|FG000|Treatment Phase|Adverse Event|3|||
125095868|NCT01269346|449971193|FG000|Treatment Phase|Withdrawal by Subject|1|||
125095869|NCT01269346|449971193|FG000|Treatment Phase|Other|2|||
125095870|NCT01269346|449971193|FG000|Extension Phase|Adverse Event|6|||
125095871|NCT01269346|449971193|FG000|Extension Phase|Withdrawal by Subject|4|||
125095872|NCT01269346|449971193|FG000|Extension Phase|Disease progression|22|||
125095873|NCT01269346|449971193|FG000|Extension Phase|Physician decision or participant choice|9|||
125095874|NCT01269346|449971193|FG000|Extension Phase|Clinical progression|1|||
125095875|NCT01269346|449971193|FG000|Extension Phase|Started a prohibited con med|1|||
125095876|NCT00247416|449971194|FG000|Overall Study|3 patients were found to be ineligible|1|||
125095877|NCT00247416|449971195|FG001|Overall Study|3 patients were found to be ineligible|2|||
125095878|NCT00798161|449971196|FG000|Overall Study|Adverse Event|3|||
125095879|NCT00798161|449971197|FG001|Overall Study|Adverse Event|4|||
125095880|NCT00798161|449971198|FG002|Overall Study|Adverse Event|6|||
125095881|NCT00798161|449971199|FG003|Overall Study|Adverse Event|6|||
125095882|NCT00798161|449971200|FG004|Overall Study|Adverse Event|5|||
125095883|NCT00798161|449971201|FG005|Overall Study|Adverse Event|2|||
125007375|NCT00806195|449655036|FG002|Overall Study|Protocol Violation|26|||
125007376|NCT00806195|449655037|FG003|Overall Study|Protocol Violation|9|||
125007377|NCT02490475|449655038|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
125007378|NCT02490475|449655039|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
125007379|NCT02490475|449655040|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
125007380|NCT02490475|449655041|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
125007381|NCT02490475|449655038|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
125007382|NCT02490475|449655039|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
125007383|NCT02490475|449655040|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
125007384|NCT02490475|449655041|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
125007385|NCT02490475|449655038|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
125007386|NCT02490475|449655039|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
125007387|NCT02490475|449655040|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
125007388|NCT02490475|449655041|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
125007389|NCT02490475|449655038|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
125007390|NCT02490475|449655039|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
125007391|NCT02490475|449655040|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
125007392|NCT02490475|449655041|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
125007393|NCT02490475|449655038|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
125007394|NCT02490475|449655039|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
125007395|NCT02490475|449655040|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
125007396|NCT02490475|449655041|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
125007397|NCT02490475|449655038|FG000|Period 2: Extension Phase|Refused Treatment|0|||
125007398|NCT02490475|449655039|FG001|Period 2: Extension Phase|Refused Treatment|0|||
125095884|NCT00798161|449971202|FG006|Overall Study|Adverse Event|4|||
125095885|NCT00798161|449971196|FG000|Overall Study|Protocol Violation|2|||
125095886|NCT00798161|449971197|FG001|Overall Study|Protocol Violation|1|||
125095887|NCT00798161|449971198|FG002|Overall Study|Protocol Violation|3|||
125095888|NCT00798161|449971199|FG003|Overall Study|Protocol Violation|3|||
125095889|NCT00798161|449971200|FG004|Overall Study|Protocol Violation|3|||
125095890|NCT00798161|449971201|FG005|Overall Study|Protocol Violation|2|||
125095891|NCT00798161|449971202|FG006|Overall Study|Protocol Violation|0|||
125095892|NCT00798161|449971196|FG000|Overall Study|Lost to Follow-up|1|||
125095893|NCT00798161|449971197|FG001|Overall Study|Lost to Follow-up|3|||
125095894|NCT00798161|449971198|FG002|Overall Study|Lost to Follow-up|4|||
125095895|NCT00798161|449971199|FG003|Overall Study|Lost to Follow-up|3|||
125095896|NCT00798161|449971200|FG004|Overall Study|Lost to Follow-up|4|||
125095897|NCT00798161|449971201|FG005|Overall Study|Lost to Follow-up|0|||
125095898|NCT00798161|449971202|FG006|Overall Study|Lost to Follow-up|0|||
125095899|NCT00798161|449971196|FG000|Overall Study|Withdrawal by Subject|5|||
125095900|NCT00798161|449971197|FG001|Overall Study|Withdrawal by Subject|4|||
125095901|NCT00798161|449971198|FG002|Overall Study|Withdrawal by Subject|5|||
125095902|NCT00798161|449971199|FG003|Overall Study|Withdrawal by Subject|4|||
125095903|NCT00798161|449971200|FG004|Overall Study|Withdrawal by Subject|2|||
125095904|NCT00798161|449971201|FG005|Overall Study|Withdrawal by Subject|3|||
125095905|NCT00798161|449971202|FG006|Overall Study|Withdrawal by Subject|1|||
125095906|NCT00798161|449971196|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
125095907|NCT00798161|449971197|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
125095908|NCT00798161|449971198|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
125095909|NCT00798161|449971199|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
125095910|NCT00798161|449971200|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
125095911|NCT00798161|449971201|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
125095912|NCT00798161|449971202|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
125095913|NCT02706327|449971203|FG000|Overall Study|Lost to Follow-up|1|||
125095914|NCT02706327|449971204|FG001|Overall Study|Lost to Follow-up|1|||
125095915|NCT02706327|449971205|FG002|Overall Study|Lost to Follow-up|2|||
125095916|NCT02213666|449971208|FG000|Overall Study|Withdrawal by Subject|1|||
125095917|NCT01319422|449971209|FG000|Overall Study|Withdrawal by Subject|1|||
125095918|NCT01319422|449971210|FG001|Overall Study|Withdrawal by Subject|0|||
125095919|NCT03417245|449971212|FG000|Overall Study|Adverse Event|1|||
125095920|NCT03417245|449971213|FG001|Overall Study|Adverse Event|0|||
125095921|NCT03417245|449971212|FG000|Overall Study|Protocol Violation|1|||
125095922|NCT03417245|449971213|FG001|Overall Study|Protocol Violation|0|||
125095923|NCT03417245|449971212|FG000|Overall Study|Withdrawal by Subject|1|||
125095924|NCT03417245|449971213|FG001|Overall Study|Withdrawal by Subject|1|||
125095925|NCT02708524|449971221|FG000|Overall Study|Adverse Event|0|||
125095926|NCT02708524|449971222|FG001|Overall Study|Adverse Event|1|||
125095927|NCT02708524|449971223|FG002|Overall Study|Adverse Event|0|||
125095928|NCT02708524|449971224|FG003|Overall Study|Adverse Event|0|||
125095929|NCT02708524|449971221|FG000|Overall Study|Lens Discomfort|1|||
125095930|NCT02708524|449971222|FG001|Overall Study|Lens Discomfort|0|||
125095931|NCT02708524|449971223|FG002|Overall Study|Lens Discomfort|1|||
125095932|NCT02708524|449971224|FG003|Overall Study|Lens Discomfort|0|||
125095933|NCT02708524|449971221|FG000|Overall Study|Lost to Follow-up|1|||
125095934|NCT02708524|449971222|FG001|Overall Study|Lost to Follow-up|1|||
125095935|NCT02708524|449971223|FG002|Overall Study|Lost to Follow-up|1|||
125095936|NCT02708524|449971224|FG003|Overall Study|Lost to Follow-up|0|||
125095937|NCT02708524|449971221|FG000|Overall Study|Protocol Violation|0|||
125095938|NCT02708524|449971222|FG001|Overall Study|Protocol Violation|1|||
125095939|NCT02708524|449971223|FG002|Overall Study|Protocol Violation|0|||
125095940|NCT02708524|449971224|FG003|Overall Study|Protocol Violation|0|||
125095941|NCT02708524|449971221|FG000|Overall Study|Withdrawal by Subject|1|||
125095942|NCT02708524|449971222|FG001|Overall Study|Withdrawal by Subject|1|||
125095943|NCT02708524|449971223|FG002|Overall Study|Withdrawal by Subject|0|||
125007399|NCT02490475|449655040|FG002|Period 2: Extension Phase|Refused Treatment|0|||
125007400|NCT02490475|449655041|FG003|Period 2: Extension Phase|Refused Treatment|1|||
125007401|NCT02490475|449655038|FG000|Period 2: Extension Phase|Adverse Event|0|||
125007402|NCT02490475|449655039|FG001|Period 2: Extension Phase|Adverse Event|0|||
125007403|NCT02490475|449655040|FG002|Period 2: Extension Phase|Adverse Event|1|||
125007404|NCT02490475|449655041|FG003|Period 2: Extension Phase|Adverse Event|0|||
125007405|NCT00139776|449655042|FG000|Period I|Did not enter Period II|575|||
125007406|NCT00139776|449655043|FG001|Period I|Did not enter Period II|0|||
125007407|NCT00139776|449655044|FG002|Period I|Did not enter Period II|0|||
125007408|NCT00139776|449655045|FG003|Period I|Did not enter Period II|0|||
125007409|NCT00139776|449655042|FG000|Period II|Not Randomized into Period III|0|||
125007410|NCT00139776|449655043|FG001|Period II|Not Randomized into Period III|322|||
125007411|NCT00139776|449655044|FG002|Period II|Not Randomized into Period III|0|||
125007412|NCT00139776|449655045|FG003|Period II|Not Randomized into Period III|0|||
125007413|NCT00139776|449655042|FG000|Period III|Adverse Event|0|||
125007414|NCT00139776|449655043|FG001|Period III|Adverse Event|0|||
125007415|NCT00139776|449655044|FG002|Period III|Adverse Event|22|||
125007416|NCT00139776|449655045|FG003|Period III|Adverse Event|23|||
125007417|NCT00139776|449655042|FG000|Period III|Other|0|||
125007418|NCT00139776|449655043|FG001|Period III|Other|0|||
125007419|NCT00139776|449655044|FG002|Period III|Other|23|||
125007420|NCT00139776|449655045|FG003|Period III|Other|34|||
125007421|NCT00139776|449655042|FG000|Period III|Lack of Efficacy|0|||
125007422|NCT00139776|449655043|FG001|Period III|Lack of Efficacy|0|||
125007423|NCT00139776|449655044|FG002|Period III|Lack of Efficacy|10|||
125007424|NCT00139776|449655045|FG003|Period III|Lack of Efficacy|24|||
125007425|NCT00139776|449655042|FG000|Period III|Lost to Follow-up|0|||
125007426|NCT00139776|449655043|FG001|Period III|Lost to Follow-up|0|||
125007427|NCT00139776|449655044|FG002|Period III|Lost to Follow-up|5|||
125007428|NCT00139776|449655045|FG003|Period III|Lost to Follow-up|4|||
125007429|NCT00139776|449655042|FG000|Period III|Withdrawal by Subject|0|||
125007430|NCT00139776|449655043|FG001|Period III|Withdrawal by Subject|0|||
125007431|NCT00139776|449655044|FG002|Period III|Withdrawal by Subject|16|||
125007432|NCT00139776|449655045|FG003|Period III|Withdrawal by Subject|21|||
125007433|NCT01519934|449655050|FG000|Overall Study|Lost to Follow-up|3|||
125007434|NCT01368536|449655053|FG000|Overall Study|Adverse Event|5|||
125007435|NCT01368536|449655054|FG001|Overall Study|Adverse Event|6|||
125007436|NCT01368536|449655055|FG002|Overall Study|Adverse Event|8|||
125007437|NCT01368536|449655053|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125007438|NCT01368536|449655054|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125007439|NCT01368536|449655055|FG002|Overall Study|Abnormal laboratory value(s)|2|||
125007440|NCT01368536|449655053|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125007441|NCT01368536|449655054|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125007442|NCT01368536|449655055|FG002|Overall Study|Abnormal test procedure result(s)|1|||
125007443|NCT01368536|449655053|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
125007444|NCT01368536|449655054|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125007445|NCT01368536|449655055|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
125007446|NCT01368536|449655053|FG000|Overall Study|No longer required study medication|0|||
125007447|NCT01368536|449655054|FG001|Overall Study|No longer required study medication|0|||
125007448|NCT01368536|449655055|FG002|Overall Study|No longer required study medication|1|||
125007449|NCT01368536|449655053|FG000|Overall Study|Withdrawal by Subject|2|||
125007450|NCT01368536|449655054|FG001|Overall Study|Withdrawal by Subject|5|||
125007451|NCT01368536|449655055|FG002|Overall Study|Withdrawal by Subject|4|||
125007452|NCT01368536|449655053|FG000|Overall Study|Lost to Follow-up|3|||
125007453|NCT01368536|449655054|FG001|Overall Study|Lost to Follow-up|3|||
125007454|NCT01368536|449655055|FG002|Overall Study|Lost to Follow-up|5|||
125007455|NCT01368536|449655053|FG000|Overall Study|Administrative problems|34|||
125007456|NCT01368536|449655054|FG001|Overall Study|Administrative problems|39|||
125007457|NCT01368536|449655055|FG002|Overall Study|Administrative problems|35|||
125007458|NCT01368536|449655053|FG000|Overall Study|Protocol deviation|0|||
125007459|NCT01368536|449655054|FG001|Overall Study|Protocol deviation|3|||
125007460|NCT01368536|449655055|FG002|Overall Study|Protocol deviation|1|||
125007461|NCT03861936|449655056|FG000|Overall Study|Withdrawal by Subject|4|||
125007462|NCT03861936|449655057|FG001|Overall Study|Withdrawal by Subject|1|||
125007463|NCT03861936|449655058|FG002|Overall Study|Withdrawal by Subject|3|||
125007464|NCT03861936|449655056|FG000|Overall Study|Lost to Follow-up|5|||
125007465|NCT03861936|449655057|FG001|Overall Study|Lost to Follow-up|3|||
125007466|NCT03861936|449655058|FG002|Overall Study|Lost to Follow-up|3|||
125007467|NCT03861936|449655056|FG000|Overall Study|Physician Decision|0|||
125007468|NCT03861936|449655057|FG001|Overall Study|Physician Decision|1|||
125007469|NCT03861936|449655058|FG002|Overall Study|Physician Decision|0|||
125007470|NCT03861936|449655056|FG000|Overall Study|Protocol Deviation|0|||
125007471|NCT03861936|449655057|FG001|Overall Study|Protocol Deviation|0|||
125007472|NCT03861936|449655058|FG002|Overall Study|Protocol Deviation|1|||
125007473|NCT03861936|449655056|FG000|Overall Study|Reason not Specified|5|||
125007474|NCT03861936|449655057|FG001|Overall Study|Reason not Specified|5|||
125007475|NCT03861936|449655058|FG002|Overall Study|Reason not Specified|3|||
125007476|NCT00359021|449655059|FG000|Overall Study|Adverse Event|26|||
125007477|NCT00359021|449655060|FG001|Overall Study|Adverse Event|8|||
125007478|NCT00359021|449655059|FG000|Overall Study|Subject Non-Compliant|1|||
125007479|NCT00359021|449655060|FG001|Overall Study|Subject Non-Compliant|2|||
125007480|NCT00359021|449655059|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
125007481|NCT00359021|449655060|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
125007482|NCT00359021|449655059|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
125007483|NCT00359021|449655060|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
125007484|NCT00359021|449655059|FG000|Overall Study|Withdrawal by Subject|2|||
125095944|NCT02708524|449971224|FG003|Overall Study|Withdrawal by Subject|0|||
125095945|NCT02708524|449971221|FG000|Overall Study|Dispensed incorrect study lens|0|||
125095946|NCT02708524|449971222|FG001|Overall Study|Dispensed incorrect study lens|1|||
125095947|NCT02708524|449971223|FG002|Overall Study|Dispensed incorrect study lens|1|||
125095948|NCT02708524|449971224|FG003|Overall Study|Dispensed incorrect study lens|0|||
125095949|NCT02708524|449971221|FG000|Overall Study|Did not wear lens at final visit|0|||
125095950|NCT02708524|449971222|FG001|Overall Study|Did not wear lens at final visit|1|||
125095951|NCT02708524|449971223|FG002|Overall Study|Did not wear lens at final visit|0|||
125095952|NCT02708524|449971224|FG003|Overall Study|Did not wear lens at final visit|0|||
125095953|NCT02708524|449971221|FG000|Overall Study|Subject lost study lens|1|||
125095954|NCT02708524|449971222|FG001|Overall Study|Subject lost study lens|0|||
125095955|NCT02708524|449971223|FG002|Overall Study|Subject lost study lens|0|||
125007485|NCT00359021|449655060|FG001|Overall Study|Withdrawal by Subject|9|||
125007486|NCT00359021|449655059|FG000|Overall Study|Lost to Follow-up|1|||
125007487|NCT00359021|449655060|FG001|Overall Study|Lost to Follow-up|0|||
125007488|NCT00359021|449655059|FG000|Overall Study|Other|4|||
125007489|NCT00359021|449655060|FG001|Overall Study|Other|1|||
125007490|NCT00359021|449655059|FG000|Overall Study|Pregnancy|1|||
125007491|NCT00359021|449655060|FG001|Overall Study|Pregnancy|0|||
125007492|NCT01835015|449655064|FG000|Overall Study|Adverse Event|0|||
125007493|NCT01835015|449655065|FG001|Overall Study|Adverse Event|0|||
125007494|NCT01835015|449655066|FG002|Overall Study|Adverse Event|1|||
125007495|NCT01835015|449655067|FG003|Overall Study|Adverse Event|0|||
125007496|NCT01835015|449655068|FG004|Overall Study|Adverse Event|0|||
125007497|NCT04569032|449655069|FG000|Overall Study|Death|10|||
125007498|NCT04569032|449655070|FG001|Overall Study|Death|13|||
125007499|NCT04569032|449655069|FG000|Overall Study|Withdrawal by Subject|2|||
125007500|NCT04569032|449655070|FG001|Overall Study|Withdrawal by Subject|0|||
125007501|NCT04569032|449655069|FG000|Overall Study|Lost to Follow-up|0|||
125007502|NCT04569032|449655070|FG001|Overall Study|Lost to Follow-up|1|||
125007503|NCT04569032|449655069|FG000|Overall Study|In long term follow up|22|||
125007504|NCT04569032|449655070|FG001|Overall Study|In long term follow up|34|||
125007505|NCT00701090|449655072|FG000|Overall Study|Adverse Event|11|||
125007506|NCT00701090|449655073|FG001|Overall Study|Adverse Event|2|||
125007507|NCT00701090|449655072|FG000|Overall Study|Death|0|||
125007508|NCT00701090|449655073|FG001|Overall Study|Death|1|||
125007509|NCT00701090|449655072|FG000|Overall Study|Lack of Efficacy|5|||
125007510|NCT00701090|449655073|FG001|Overall Study|Lack of Efficacy|4|||
125007511|NCT00701090|449655072|FG000|Overall Study|Lost to Follow-up|9|||
125007512|NCT00701090|449655073|FG001|Overall Study|Lost to Follow-up|9|||
125007513|NCT00701090|449655072|FG000|Overall Study|Physician Decision|3|||
125007514|NCT00701090|449655073|FG001|Overall Study|Physician Decision|4|||
125007515|NCT00701090|449655072|FG000|Overall Study|Protocol Violation|2|||
125007516|NCT00701090|449655073|FG001|Overall Study|Protocol Violation|3|||
125007517|NCT00701090|449655072|FG000|Overall Study|Withdrawal by Subject|11|||
125007518|NCT00701090|449655073|FG001|Overall Study|Withdrawal by Subject|16|||
125007519|NCT00701090|449655072|FG000|Overall Study|Other|7|||
125007520|NCT00701090|449655073|FG001|Overall Study|Other|12|||
125007521|NCT04534491|449655078|FG000|Overall Study|Not completed end-of-study interview|24|||
125007522|NCT04534491|449655078|FG000|Overall Study|Non-users|70|||
125007523|NCT04534491|449655078|FG000|Overall Study|Non-verifiable users|58|||
125007524|NCT00113074|449655080|FG000|Overall Study|Lost to Follow-up|10|||
125007525|NCT00113074|449655081|FG001|Overall Study|Lost to Follow-up|10|||
125007526|NCT00113074|449655082|FG002|Overall Study|Lost to Follow-up|14|||
125007527|NCT02114268|449655083|FG000|Overall Study|Lost to Follow-up|4|||
125007528|NCT02114268|449655084|FG001|Overall Study|Lost to Follow-up|1|||
125007529|NCT02114268|449655085|FG002|Overall Study|Lost to Follow-up|1|||
125007530|NCT02114268|449655086|FG003|Overall Study|Lost to Follow-up|0|||
125095956|NCT02708524|449971224|FG003|Overall Study|Subject lost study lens|0|||
125095957|NCT03781167|449971230|FG000|Overall Study|Adverse Event|23|||
125007531|NCT02114268|449655087|FG004|Overall Study|Lost to Follow-up|0|||
125007532|NCT02114268|449655088|FG005|Overall Study|Lost to Follow-up|2|||
125007533|NCT02114268|449655083|FG000|Overall Study|Withdrawal by Subject|1|||
125007534|NCT02114268|449655084|FG001|Overall Study|Withdrawal by Subject|0|||
125007535|NCT02114268|449655085|FG002|Overall Study|Withdrawal by Subject|0|||
125007536|NCT02114268|449655086|FG003|Overall Study|Withdrawal by Subject|0|||
125007537|NCT02114268|449655087|FG004|Overall Study|Withdrawal by Subject|0|||
125007538|NCT02114268|449655088|FG005|Overall Study|Withdrawal by Subject|1|||
125095958|NCT03781167|449971231|FG001|Overall Study|Adverse Event|25|||
125095959|NCT03781167|449971230|FG000|Overall Study|Withdrew consent|16|||
125095960|NCT03781167|449971231|FG001|Overall Study|Withdrew consent|12|||
125095961|NCT03781167|449971230|FG000|Overall Study|Lost to Follow-up|0|||
125095962|NCT03781167|449971231|FG001|Overall Study|Lost to Follow-up|1|||
125095963|NCT03781167|449971230|FG000|Overall Study|Lack of Efficacy|4|||
125095964|NCT03781167|449971231|FG001|Overall Study|Lack of Efficacy|5|||
125095965|NCT03781167|449971230|FG000|Overall Study|Difficulty with drug delivery system|2|||
125095966|NCT03781167|449971231|FG001|Overall Study|Difficulty with drug delivery system|3|||
125095967|NCT03781167|449971230|FG000|Overall Study|Other, not specified|2|||
125095968|NCT03781167|449971231|FG001|Overall Study|Other, not specified|2|||
125095969|NCT01590628|449971239|FG000|Overall Study|Death|2|||
125095970|NCT01590628|449971240|FG001|Overall Study|Death|0|||
125095971|NCT00475657|449971241|FG000|Overall Study|Death|1|||
125095972|NCT00475657|449971241|FG000|Overall Study|Sponsor's Decision|3|||
125095973|NCT02992743|449971242|FG000|Overall Study|Withdrawal by Subject|1|||
125095974|NCT02992743|449971243|FG001|Overall Study|Withdrawal by Subject|1|||
125095975|NCT02992743|449971242|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
125095976|NCT02992743|449971243|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
125095977|NCT02992743|449971242|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
125095978|NCT02992743|449971243|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
125095979|NCT02992743|449971242|FG000|Overall Study|No measurable disease|1|||
125095980|NCT02992743|449971243|FG001|Overall Study|No measurable disease|0|||
125095981|NCT02992743|449971242|FG000|Overall Study|Lost to Follow-up|0|||
125095982|NCT02992743|449971243|FG001|Overall Study|Lost to Follow-up|1|||
125095983|NCT00761735|449971244|FG000|Overall Study|Lost to Follow-up|6|||
125095984|NCT00761735|449971244|FG000|Overall Study|Withdrawal by Subject|6|||
125095985|NCT00761735|449971244|FG000|Overall Study|Non-compliance with protocol|1|||
125095986|NCT00761735|449971244|FG000|Overall Study|Administrative|1|||
125095987|NCT03290131|449971245|FG000|Overall Study|Adverse Event|22|||
125095988|NCT03290131|449971246|FG001|Overall Study|Adverse Event|57|||
125095989|NCT03290131|449971247|FG002|Overall Study|Adverse Event|11|||
125095990|NCT03290131|449971245|FG000|Overall Study|Withdrawal by Subject|18|||
125095991|NCT03290131|449971246|FG001|Overall Study|Withdrawal by Subject|13|||
125095992|NCT03290131|449971247|FG002|Overall Study|Withdrawal by Subject|8|||
125095993|NCT03290131|449971245|FG000|Overall Study|MS Relapse|2|||
125095994|NCT03290131|449971246|FG001|Overall Study|MS Relapse|1|||
125095995|NCT03290131|449971247|FG002|Overall Study|MS Relapse|0|||
125095996|NCT03290131|449971245|FG000|Overall Study|Unknown reason|0|||
125095997|NCT03290131|449971246|FG001|Overall Study|Unknown reason|1|||
125095998|NCT03290131|449971247|FG002|Overall Study|Unknown reason|0|||
125095999|NCT00381680|449971248|FG000|Overall Study|Adverse Event|9|||
125096000|NCT00381680|449971249|FG001|Overall Study|Adverse Event|3|||
125096001|NCT00381680|449971248|FG000|Overall Study|Death|10|||
125096002|NCT00381680|449971249|FG001|Overall Study|Death|7|||
125096003|NCT00381680|449971248|FG000|Overall Study|Lost to Follow-up|3|||
125096004|NCT00381680|449971249|FG001|Overall Study|Lost to Follow-up|2|||
125096005|NCT00381680|449971248|FG000|Overall Study|Physician Decision|25|||
125096006|NCT00381680|449971249|FG001|Overall Study|Physician Decision|6|||
125096007|NCT00381680|449971248|FG000|Overall Study|Withdrawal by Subject|3|||
125096008|NCT00381680|449971249|FG001|Overall Study|Withdrawal by Subject|1|||
125096009|NCT00381680|449971248|FG000|Overall Study|Entry onto another COG Trial|1|||
125096010|NCT00381680|449971249|FG001|Overall Study|Entry onto another COG Trial|2|||
125096011|NCT00381680|449971248|FG000|Overall Study|Alternative Therapy|11|||
125096012|NCT00381680|449971249|FG001|Overall Study|Alternative Therapy|5|||
125096013|NCT00381680|449971248|FG000|Overall Study|Secondary Malignancy|3|||
125096014|NCT00381680|449971249|FG001|Overall Study|Secondary Malignancy|0|||
125096015|NCT00381680|449971248|FG000|Overall Study|Delay initiation|1|||
125096016|NCT00381680|449971249|FG001|Overall Study|Delay initiation|0|||
125096017|NCT00381680|449971248|FG000|Overall Study|Stem Cell Transplant|26|||
125096018|NCT00381680|449971249|FG001|Overall Study|Stem Cell Transplant|10|||
125096019|NCT00381680|449971248|FG000|Overall Study|Relapse|18|||
125096020|NCT00381680|449971249|FG001|Overall Study|Relapse|9|||
125096021|NCT00381680|449971248|FG000|Overall Study|Induction Failure|4|||
125096022|NCT00381680|449971249|FG001|Overall Study|Induction Failure|1|||
125096023|NCT00381680|449971248|FG000|Overall Study|Progression|1|||
125096024|NCT00381680|449971249|FG001|Overall Study|Progression|1|||
125096025|NCT00381680|449971248|FG000|Overall Study|Other not otherwise specified|7|||
125096026|NCT00381680|449971249|FG001|Overall Study|Other not otherwise specified|2|||
125096027|NCT00381680|449971248|FG000|Overall Study|Ineligible|3|||
125096028|NCT00381680|449971249|FG001|Overall Study|Ineligible|1|||
125096029|NCT03099096|449971254|FG000|Overall Study|Adverse Event|1|||
125096030|NCT03099096|449971254|FG000|Overall Study|Physician Decision|1|||
125007539|NCT02114268|449655083|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
125007540|NCT02114268|449655084|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
125007541|NCT02114268|449655085|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
125007542|NCT02114268|449655086|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
125007543|NCT02114268|449655087|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
125007544|NCT02114268|449655088|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
125007545|NCT03962738|449655089|FG000|Overall Study|Protocol Deviation|3|||
125007546|NCT03962738|449655090|FG001|Overall Study|Protocol Deviation|0|||
125007547|NCT03962738|449655091|FG002|Overall Study|Protocol Deviation|1|||
125007548|NCT03962738|449655092|FG003|Overall Study|Protocol Deviation|1|||
125007549|NCT03962738|449655089|FG000|Overall Study|Withdrawal by Subject|4|||
125007550|NCT03962738|449655090|FG001|Overall Study|Withdrawal by Subject|0|||
125007551|NCT03962738|449655091|FG002|Overall Study|Withdrawal by Subject|0|||
125007552|NCT03962738|449655092|FG003|Overall Study|Withdrawal by Subject|0|||
125007553|NCT03962738|449655089|FG000|Overall Study|Lost to Follow-up|0|||
125007554|NCT03962738|449655090|FG001|Overall Study|Lost to Follow-up|0|||
125007555|NCT03962738|449655091|FG002|Overall Study|Lost to Follow-up|1|||
125007556|NCT03962738|449655092|FG003|Overall Study|Lost to Follow-up|0|||
125007557|NCT00509067|449655093|FG000|Overall Study|Lost to Follow-up|1|||
125007558|NCT00509067|449655094|FG001|Overall Study|Lost to Follow-up|1|||
125007559|NCT00509067|449655093|FG000|Overall Study|Adverse Event|3|||
125007560|NCT00509067|449655094|FG001|Overall Study|Adverse Event|1|||
125007561|NCT00509067|449655093|FG000|Overall Study|Protocol Violation|0|||
125007562|NCT00509067|449655094|FG001|Overall Study|Protocol Violation|3|||
125007563|NCT00131469|449655095|FG000|Overall Study|Withdrawal by Subject|3|||
125007564|NCT00131469|449655096|FG001|Overall Study|Withdrawal by Subject|4|||
125007565|NCT00131469|449655095|FG000|Overall Study|Protocol Violation|3|||
125007566|NCT00131469|449655096|FG001|Overall Study|Protocol Violation|1|||
125007567|NCT00131469|449655095|FG000|Overall Study|Death|0|||
125007568|NCT00131469|449655096|FG001|Overall Study|Death|1|||
125007569|NCT00131469|449655095|FG000|Overall Study|Lost to Follow-up|0|||
125007570|NCT00131469|449655096|FG001|Overall Study|Lost to Follow-up|1|||
125007571|NCT00131469|449655095|FG000|Overall Study|scan not analyzable|3|||
125007572|NCT00131469|449655096|FG001|Overall Study|scan not analyzable|6|||
125007573|NCT00574288|449655097|FG000|Overall Study|Adverse Event|2|||
125007574|NCT00574288|449655098|FG001|Overall Study|Adverse Event|0|||
125007575|NCT00574288|449655099|FG002|Overall Study|Adverse Event|0|||
125007576|NCT00574288|449655100|FG003|Overall Study|Adverse Event|0|||
125007577|NCT00574288|449655101|FG004|Overall Study|Adverse Event|1|||
125007578|NCT00574288|449655102|FG005|Overall Study|Adverse Event|0|||
125007579|NCT00574288|449655103|FG006|Overall Study|Adverse Event|0|||
125007580|NCT00574288|449655097|FG000|Overall Study|Death|0|||
125007581|NCT00574288|449655098|FG001|Overall Study|Death|0|||
125007582|NCT00574288|449655099|FG002|Overall Study|Death|0|||
125007583|NCT00574288|449655100|FG003|Overall Study|Death|0|||
125007584|NCT00574288|449655101|FG004|Overall Study|Death|0|||
125007585|NCT00574288|449655102|FG005|Overall Study|Death|25|||
125007586|NCT00574288|449655103|FG006|Overall Study|Death|21|||
125007587|NCT00574288|449655097|FG000|Overall Study|Lost to Follow-up|0|||
125007588|NCT00574288|449655098|FG001|Overall Study|Lost to Follow-up|0|||
125007589|NCT00574288|449655099|FG002|Overall Study|Lost to Follow-up|0|||
125007590|NCT00574288|449655100|FG003|Overall Study|Lost to Follow-up|0|||
125007591|NCT00574288|449655101|FG004|Overall Study|Lost to Follow-up|0|||
125007592|NCT00574288|449655102|FG005|Overall Study|Lost to Follow-up|1|||
125007593|NCT00574288|449655103|FG006|Overall Study|Lost to Follow-up|2|||
125007594|NCT00574288|449655097|FG000|Overall Study|Study Terminated By Sponsor|0|||
125007595|NCT00574288|449655098|FG001|Overall Study|Study Terminated By Sponsor|0|||
125007596|NCT00574288|449655099|FG002|Overall Study|Study Terminated By Sponsor|0|||
125007597|NCT00574288|449655100|FG003|Overall Study|Study Terminated By Sponsor|0|||
125007598|NCT00574288|449655101|FG004|Overall Study|Study Terminated By Sponsor|0|||
125007599|NCT00574288|449655102|FG005|Overall Study|Study Terminated By Sponsor|0|||
125007600|NCT00574288|449655103|FG006|Overall Study|Study Terminated By Sponsor|5|||
125007601|NCT00574288|449655097|FG000|Overall Study|Progressive Disease|17|||
125007602|NCT00574288|449655098|FG001|Overall Study|Progressive Disease|2|||
125007603|NCT00574288|449655099|FG002|Overall Study|Progressive Disease|3|||
125007604|NCT00574288|449655100|FG003|Overall Study|Progressive Disease|2|||
125007605|NCT00574288|449655101|FG004|Overall Study|Progressive Disease|1|||
125007606|NCT00574288|449655102|FG005|Overall Study|Progressive Disease|0|||
125007607|NCT00574288|449655103|FG006|Overall Study|Progressive Disease|0|||
125007608|NCT00574288|449655097|FG000|Overall Study|Other|1|||
125007609|NCT00574288|449655098|FG001|Overall Study|Other|1|||
125007610|NCT00574288|449655099|FG002|Overall Study|Other|0|||
125007611|NCT00574288|449655100|FG003|Overall Study|Other|0|||
125007612|NCT00574288|449655101|FG004|Overall Study|Other|0|||
125007613|NCT00574288|449655102|FG005|Overall Study|Other|0|||
125007614|NCT00574288|449655103|FG006|Overall Study|Other|0|||
125007615|NCT02247960|449655104|FG000|Patient Consent and Randomization|Physician Decision|2|||
125007616|NCT02247960|449655105|FG001|Patient Consent and Randomization|Physician Decision|2|||
125007617|NCT02247960|449655104|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
125096031|NCT04629534|449971261|FG000|Overall Study|Physician Decision|1|||
125096032|NCT04629534|449971262|FG001|Overall Study|Physician Decision|0|||
125096033|NCT04629534|449971261|FG000|Overall Study|Protocol Violation|0|||
125096034|NCT04629534|449971262|FG001|Overall Study|Protocol Violation|2|||
125096035|NCT02190604|449971263|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125096036|NCT02190604|449971264|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125096037|NCT02190604|449971265|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125096038|NCT02190604|449971266|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125096039|NCT02190604|449971267|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125096040|NCT02190604|449971268|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125096041|NCT02190604|449971269|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125096042|NCT02190604|449971270|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125096043|NCT02190604|449971271|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125096044|NCT02190604|449971272|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125096045|NCT02190604|449971273|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125096046|NCT02190604|449971274|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125096047|NCT02190604|449971275|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125096048|NCT02190604|449971276|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125096049|NCT02190604|449971277|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
125096050|NCT02190604|449971278|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125096051|NCT02190604|449971279|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125096052|NCT02190604|449971280|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125096053|NCT02190604|449971281|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125096054|NCT02190604|449971263|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125096055|NCT02190604|449971264|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125096056|NCT02190604|449971265|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125096057|NCT02190604|449971266|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125096058|NCT02190604|449971267|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125096059|NCT02190604|449971268|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125096060|NCT02190604|449971269|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125096061|NCT02190604|449971270|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125096062|NCT02190604|449971271|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125096063|NCT02190604|449971272|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125096064|NCT02190604|449971273|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125096065|NCT02190604|449971274|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125096066|NCT02190604|449971275|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125096067|NCT02190604|449971276|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
125096068|NCT02190604|449971277|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125096069|NCT02190604|449971278|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125096070|NCT02190604|449971279|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125096071|NCT02190604|449971280|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125096072|NCT02190604|449971281|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125096073|NCT02797951|449971282|FG000|Overall Study|Adverse Event|4|||
125096074|NCT02797951|449971282|FG000|Overall Study|Death|1|||
125096075|NCT02797951|449971282|FG000|Overall Study|Lack of Efficacy|19|||
125096076|NCT02797951|449971282|FG000|Overall Study|Lost to Follow-up|4|||
125096077|NCT02797951|449971282|FG000|Overall Study|Physician Decision|6|||
125096078|NCT02797951|449971282|FG000|Overall Study|Withdrawal by Subject|15|||
125096079|NCT02369874|449971286|FG000|Overall Study|Lost to Follow-up|2|||
125096080|NCT02369874|449971287|FG001|Overall Study|Lost to Follow-up|2|||
125096081|NCT02369874|449971288|FG002|Overall Study|Lost to Follow-up|2|||
125096082|NCT02369874|449971286|FG000|Overall Study|Withdrawal by Subject|7|||
125096083|NCT02369874|449971287|FG001|Overall Study|Withdrawal by Subject|9|||
125096084|NCT02369874|449971288|FG002|Overall Study|Withdrawal by Subject|27|||
125096085|NCT02369874|449971286|FG000|Overall Study|Miscellaneous|1|||
125096086|NCT02369874|449971287|FG001|Overall Study|Miscellaneous|1|||
125096087|NCT02369874|449971288|FG002|Overall Study|Miscellaneous|0|||
125096088|NCT02369874|449971286|FG000|Overall Study|On Treatment/Off Study|34|||
125096089|NCT02369874|449971287|FG001|Overall Study|On Treatment/Off Study|45|||
125096090|NCT02369874|449971288|FG002|Overall Study|On Treatment/Off Study|32|||
125096091|NCT01012765|449971289|FG000|Treatment Period 1|Adverse Event|1|||
125096092|NCT01012765|449971290|FG001|Treatment Period 1|Adverse Event|0|||
125096093|NCT01012765|449971291|FG002|Treatment Period 1|Adverse Event|1|||
125096094|NCT01012765|449971292|FG003|Treatment Period 1|Adverse Event|0|||
125096095|NCT01012765|449971293|FG004|Treatment Period 1|Adverse Event|0|||
125096096|NCT01012765|449971294|FG005|Treatment Period 1|Adverse Event|0|||
125096097|NCT01012765|449971289|FG000|Treatment Period 1|Withdrawal by Subject|2|||
125096098|NCT01012765|449971290|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125096099|NCT01012765|449971291|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125096100|NCT01012765|449971292|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125096101|NCT01012765|449971293|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125096102|NCT01012765|449971294|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125096103|NCT01012765|449971289|FG000|Treatment Period 1|Administrative problems|0|||
125096104|NCT01012765|449971290|FG001|Treatment Period 1|Administrative problems|0|||
125096105|NCT01012765|449971291|FG002|Treatment Period 1|Administrative problems|1|||
125096106|NCT01012765|449971292|FG003|Treatment Period 1|Administrative problems|1|||
125096107|NCT01012765|449971293|FG004|Treatment Period 1|Administrative problems|1|||
125096108|NCT01012765|449971294|FG005|Treatment Period 1|Administrative problems|0|||
125096109|NCT01012765|449971289|FG000|Treatment Period 1|Protocol Violation|0|||
125096110|NCT01012765|449971290|FG001|Treatment Period 1|Protocol Violation|0|||
125096111|NCT01012765|449971291|FG002|Treatment Period 1|Protocol Violation|0|||
125096112|NCT01012765|449971292|FG003|Treatment Period 1|Protocol Violation|2|||
125096113|NCT01012765|449971293|FG004|Treatment Period 1|Protocol Violation|1|||
125096114|NCT01012765|449971294|FG005|Treatment Period 1|Protocol Violation|0|||
125096115|NCT01012765|449971289|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
125096116|NCT01012765|449971290|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
125096117|NCT01012765|449971291|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
125096118|NCT01012765|449971292|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
125096119|NCT01012765|449971293|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
125096120|NCT01012765|449971294|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
125096121|NCT01012765|449971289|FG000|Treatment Period 2|Withdrawal by Subject|1|||
125096122|NCT01012765|449971290|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125096123|NCT01012765|449971291|FG002|Treatment Period 2|Withdrawal by Subject|1|||
125096124|NCT01012765|449971292|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125096125|NCT01012765|449971293|FG004|Treatment Period 2|Withdrawal by Subject|1|||
125096126|NCT01012765|449971294|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125096127|NCT01012765|449971289|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
125096128|NCT01012765|449971290|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
125096129|NCT01012765|449971291|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
125096130|NCT01012765|449971292|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
125096131|NCT01012765|449971293|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
125096132|NCT01012765|449971294|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
125096133|NCT01012765|449971289|FG000|Treatment Period 2|Adverse Event|0|||
125096134|NCT01012765|449971290|FG001|Treatment Period 2|Adverse Event|1|||
125096135|NCT01012765|449971291|FG002|Treatment Period 2|Adverse Event|1|||
125096136|NCT01012765|449971292|FG003|Treatment Period 2|Adverse Event|0|||
125096137|NCT01012765|449971293|FG004|Treatment Period 2|Adverse Event|0|||
125096138|NCT01012765|449971294|FG005|Treatment Period 2|Adverse Event|0|||
125096139|NCT01012765|449971289|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
125096140|NCT01012765|449971290|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
125096141|NCT01012765|449971291|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
125096142|NCT01012765|449971292|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
125096143|NCT01012765|449971293|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
125096144|NCT01012765|449971294|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
125096145|NCT01326312|449971295|FG000|Overall Study|Adverse Event|11|||
125096146|NCT01326312|449971296|FG001|Overall Study|Adverse Event|11|||
125096147|NCT01326312|449971297|FG002|Overall Study|Adverse Event|1|||
125096148|NCT01326312|449971295|FG000|Overall Study|Withdrawal by Subject|1|||
125096149|NCT01326312|449971296|FG001|Overall Study|Withdrawal by Subject|2|||
125096150|NCT01326312|449971297|FG002|Overall Study|Withdrawal by Subject|1|||
125096151|NCT01326312|449971295|FG000|Overall Study|Protocol Violation|0|||
125096152|NCT01326312|449971296|FG001|Overall Study|Protocol Violation|1|||
125096153|NCT01326312|449971297|FG002|Overall Study|Protocol Violation|0|||
125096154|NCT01326312|449971295|FG000|Overall Study|Lack of Efficacy|13|||
125096155|NCT01326312|449971296|FG001|Overall Study|Lack of Efficacy|7|||
125096156|NCT01326312|449971297|FG002|Overall Study|Lack of Efficacy|1|||
125096157|NCT01326312|449971295|FG000|Overall Study|Death|1|||
125096158|NCT01326312|449971296|FG001|Overall Study|Death|0|||
125096159|NCT01326312|449971297|FG002|Overall Study|Death|1|||
125096160|NCT01326312|449971295|FG000|Overall Study|progressive disease|0|||
125096161|NCT01326312|449971296|FG001|Overall Study|progressive disease|1|||
125096162|NCT01326312|449971297|FG002|Overall Study|progressive disease|1|||
125096163|NCT01326312|449971295|FG000|Overall Study|Study terminated by Sponsor|8|||
125096164|NCT01326312|449971296|FG001|Overall Study|Study terminated by Sponsor|32|||
125096165|NCT01326312|449971297|FG002|Overall Study|Study terminated by Sponsor|46|||
125096166|NCT01326312|449971295|FG000|Overall Study|Treatment arm terminated|19|||
125096167|NCT01326312|449971296|FG001|Overall Study|Treatment arm terminated|0|||
125096168|NCT01326312|449971297|FG002|Overall Study|Treatment arm terminated|0|||
125007618|NCT02247960|449655105|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
125007619|NCT02247960|449655104|FG000|Catheter Removed|Lost to Follow-up|7|||
125007620|NCT02247960|449655105|FG001|Catheter Removed|Lost to Follow-up|10|||
125007621|NCT00356889|449655106|FG000|Overall Study|Protocol Violation|2|||
125007622|NCT00356889|449655106|FG000|Overall Study|Adverse Event|1|||
125007623|NCT00702325|449655107|FG000|Overall Study|Adverse Event|1|||
125007624|NCT00702325|449655108|FG001|Overall Study|Adverse Event|0|||
125007625|NCT00702325|449655107|FG000|Overall Study|Withdrawal by Subject|7|||
125007626|NCT00702325|449655108|FG001|Overall Study|Withdrawal by Subject|7|||
125007627|NCT00702325|449655107|FG000|Overall Study|Lost to Follow-up|3|||
125007628|NCT00702325|449655108|FG001|Overall Study|Lost to Follow-up|4|||
125007629|NCT00702325|449655107|FG000|Overall Study|Incorrect enrollment|5|||
125007630|NCT00702325|449655108|FG001|Overall Study|Incorrect enrollment|7|||
125007631|NCT00702325|449655107|FG000|Overall Study|Developed study discontinuation criteria|18|||
125007632|NCT00702325|449655108|FG001|Overall Study|Developed study discontinuation criteria|28|||
125007633|NCT00702325|449655107|FG000|Overall Study|Severe noncompliance to protocol|3|||
125007634|NCT00702325|449655108|FG001|Overall Study|Severe noncompliance to protocol|3|||
125007635|NCT00702325|449655107|FG000|Overall Study|Termination due to lab results|1|||
125007636|NCT00702325|449655108|FG001|Overall Study|Termination due to lab results|0|||
125007637|NCT00702325|449655107|FG000|Overall Study|Didn't follow study medication dosage|0|||
125007638|NCT00702325|449655108|FG001|Overall Study|Didn't follow study medication dosage|2|||
125007639|NCT00702325|449655107|FG000|Overall Study|Withdrew consent|0|||
125007640|NCT00702325|449655108|FG001|Overall Study|Withdrew consent|1|||
125007641|NCT00702325|449655107|FG000|Overall Study|Incorrectly Discontinued|0|||
125007642|NCT00702325|449655108|FG001|Overall Study|Incorrectly Discontinued|1|||
125007643|NCT00736034|449655109|FG000|Overall Study|Adverse Event|2|||
125007644|NCT03716050|449655113|FG000|Overall Study|Lost to Follow-up|0|||
125007645|NCT03716050|449655114|FG001|Overall Study|Lost to Follow-up|0|||
125007646|NCT03716050|449655115|FG002|Overall Study|Lost to Follow-up|1|||
125007647|NCT03716050|449655116|FG003|Overall Study|Lost to Follow-up|0|||
125007648|NCT03716050|449655117|FG004|Overall Study|Lost to Follow-up|0|||
125007649|NCT03716050|449655118|FG005|Overall Study|Lost to Follow-up|0|||
125007650|NCT03716050|449655119|FG006|Overall Study|Lost to Follow-up|0|||
125007651|NCT03716050|449655120|FG007|Overall Study|Lost to Follow-up|0|||
125007652|NCT03716050|449655113|FG000|Overall Study|Physician Decision|0|||
125007653|NCT03716050|449655114|FG001|Overall Study|Physician Decision|0|||
125007654|NCT03716050|449655115|FG002|Overall Study|Physician Decision|0|||
125007655|NCT03716050|449655116|FG003|Overall Study|Physician Decision|1|||
125007656|NCT03716050|449655117|FG004|Overall Study|Physician Decision|0|||
125007657|NCT03716050|449655118|FG005|Overall Study|Physician Decision|0|||
125007658|NCT03716050|449655119|FG006|Overall Study|Physician Decision|0|||
125007659|NCT03716050|449655120|FG007|Overall Study|Physician Decision|0|||
125007660|NCT03716050|449655113|FG000|Overall Study|Protocol Violation|0|||
125007661|NCT03716050|449655114|FG001|Overall Study|Protocol Violation|0|||
125007662|NCT03716050|449655115|FG002|Overall Study|Protocol Violation|0|||
125007663|NCT03716050|449655116|FG003|Overall Study|Protocol Violation|1|||
125007664|NCT03716050|449655117|FG004|Overall Study|Protocol Violation|0|||
125007665|NCT03716050|449655118|FG005|Overall Study|Protocol Violation|0|||
125007666|NCT03716050|449655119|FG006|Overall Study|Protocol Violation|0|||
125007667|NCT03716050|449655120|FG007|Overall Study|Protocol Violation|2|||
125007668|NCT03123250|449655121|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
125007669|NCT02361944|449655122|FG000|Overall Study|surgery cancellation|0|||
125007670|NCT02361944|449655123|FG001|Overall Study|surgery cancellation|1|||
125007671|NCT02566577|449655124|FG000|Overall Study|Withdrawal by Subject|1|||
125007672|NCT02566577|449655125|FG001|Overall Study|Withdrawal by Subject|1|||
125007673|NCT02566577|449655124|FG000|Overall Study|Equipment failure|1|||
125007674|NCT02566577|449655125|FG001|Overall Study|Equipment failure|1|||
125007675|NCT02566577|449655124|FG000|Overall Study|Physical limitation|1|||
125007676|NCT02566577|449655125|FG001|Overall Study|Physical limitation|0|||
125007677|NCT00073528|449655133|FG000|Overall Study|Death|488|||
125007678|NCT00073528|449655134|FG001|Overall Study|Death|473|||
125007679|NCT00073528|449655133|FG000|Overall Study|Lost to Follow-up|52|||
125007680|NCT00073528|449655134|FG001|Overall Study|Lost to Follow-up|45|||
125007681|NCT00073528|449655133|FG000|Overall Study|Withdrawal by Subject|50|||
125007682|NCT00073528|449655134|FG001|Overall Study|Withdrawal by Subject|45|||
125007683|NCT00073528|449655133|FG000|Overall Study|Study terminated by Sponsor|10|||
125007684|NCT00073528|449655134|FG001|Overall Study|Study terminated by Sponsor|29|||
125096169|NCT01326312|449971295|FG000|Overall Study|QTc > 500|0|||
125096170|NCT01326312|449971296|FG001|Overall Study|QTc > 500|1|||
125096171|NCT01326312|449971297|FG002|Overall Study|QTc > 500|0|||
125096172|NCT02219477|449971298|FG000|Overall Study|Adverse Event|0|||
125096173|NCT02219477|449971299|FG001|Overall Study|Adverse Event|1|||
125096174|NCT02219477|449971300|FG002|Overall Study|Adverse Event|1|||
125096175|NCT02219477|449971298|FG000|Overall Study|Withdrawal by Subject|0|||
125096176|NCT02219477|449971299|FG001|Overall Study|Withdrawal by Subject|1|||
125096177|NCT02219477|449971300|FG002|Overall Study|Withdrawal by Subject|0|||
125096178|NCT00499694|449971305|FG000|Overall Study|Patient never received treatment.|1|||
125096179|NCT04338685|449971306|FG000|Overall Study|Death|3|||
125096180|NCT04338685|449971307|FG001|Overall Study|Death|4|||
125096181|NCT04338685|449971308|FG002|Overall Study|Death|2|||
125096182|NCT04338685|449971309|FG003|Overall Study|Death|4|||
125096183|NCT04338685|449971310|FG004|Overall Study|Death|4|||
125096184|NCT04338685|449971311|FG005|Overall Study|Death|8|||
125096185|NCT04338685|449971312|FG006|Overall Study|Death|1|||
125096186|NCT04338685|449971313|FG007|Overall Study|Death|0|||
125096187|NCT04338685|449971314|FG008|Overall Study|Death|0|||
125096188|NCT04338685|449971306|FG000|Overall Study|Study terminated by Sponsor|0|||
125096189|NCT04338685|449971307|FG001|Overall Study|Study terminated by Sponsor|0|||
125096190|NCT04338685|449971308|FG002|Overall Study|Study terminated by Sponsor|1|||
125096191|NCT04338685|449971309|FG003|Overall Study|Study terminated by Sponsor|4|||
125096192|NCT04338685|449971310|FG004|Overall Study|Study terminated by Sponsor|0|||
125096193|NCT04338685|449971311|FG005|Overall Study|Study terminated by Sponsor|5|||
125096194|NCT04338685|449971312|FG006|Overall Study|Study terminated by Sponsor|2|||
125096195|NCT04338685|449971313|FG007|Overall Study|Study terminated by Sponsor|4|||
125096196|NCT04338685|449971314|FG008|Overall Study|Study terminated by Sponsor|1|||
125096197|NCT04338685|449971306|FG000|Overall Study|Withdrawal by Subject|1|||
125096198|NCT04338685|449971307|FG001|Overall Study|Withdrawal by Subject|2|||
125096199|NCT04338685|449971308|FG002|Overall Study|Withdrawal by Subject|0|||
125096200|NCT04338685|449971309|FG003|Overall Study|Withdrawal by Subject|2|||
125096201|NCT04338685|449971310|FG004|Overall Study|Withdrawal by Subject|0|||
125096202|NCT04338685|449971311|FG005|Overall Study|Withdrawal by Subject|5|||
125096203|NCT04338685|449971312|FG006|Overall Study|Withdrawal by Subject|1|||
125096204|NCT04338685|449971313|FG007|Overall Study|Withdrawal by Subject|1|||
125096205|NCT04338685|449971314|FG008|Overall Study|Withdrawal by Subject|0|||
125096206|NCT00234533|449971315|FG000|Overall Study|Withdrawal by Subject|6|||
125096207|NCT00234533|449971315|FG000|Overall Study|Adverse Event|2|||
125096208|NCT00234533|449971315|FG000|Overall Study|Enrolled but not treated|3|||
125096209|NCT01484691|449971317|FG000|Overall Study|Withdrawal by Subject|1|||
125096210|NCT01484691|449971318|FG001|Overall Study|Withdrawal by Subject|1|||
125096211|NCT01484691|449971319|FG002|Overall Study|Withdrawal by Subject|1|||
125096212|NCT01484691|449971317|FG000|Overall Study|Physician Decision|0|||
125096213|NCT01484691|449971318|FG001|Overall Study|Physician Decision|2|||
125096214|NCT01484691|449971319|FG002|Overall Study|Physician Decision|1|||
125096215|NCT01314261|449971324|FG000|Overall Study|Adverse Event|1|||
125096216|NCT01314261|449971325|FG001|Overall Study|Adverse Event|0|||
125096217|NCT01314261|449971326|FG002|Overall Study|Adverse Event|0|||
125096218|NCT01314261|449971327|FG003|Overall Study|Adverse Event|0|||
125096219|NCT01314261|449971324|FG000|Overall Study|Withdrawal by Subject|0|||
125096220|NCT01314261|449971325|FG001|Overall Study|Withdrawal by Subject|3|||
125096221|NCT01314261|449971326|FG002|Overall Study|Withdrawal by Subject|1|||
125096222|NCT01314261|449971327|FG003|Overall Study|Withdrawal by Subject|0|||
125096223|NCT01314261|449971324|FG000|Overall Study|Lost to Follow-up|1|||
125096224|NCT01314261|449971325|FG001|Overall Study|Lost to Follow-up|0|||
125096225|NCT01314261|449971326|FG002|Overall Study|Lost to Follow-up|2|||
125096226|NCT01314261|449971327|FG003|Overall Study|Lost to Follow-up|2|||
125096227|NCT01314261|449971324|FG000|Overall Study|Virologic Failure|0|||
125096228|NCT01314261|449971325|FG001|Overall Study|Virologic Failure|1|||
125096229|NCT01314261|449971326|FG002|Overall Study|Virologic Failure|0|||
125096230|NCT01314261|449971327|FG003|Overall Study|Virologic Failure|1|||
125096231|NCT04524507|449971328|FG000|Overall Study|Lost to Follow-up|2|||
125096232|NCT04524507|449971329|FG001|Overall Study|Lost to Follow-up|4|||
125096233|NCT04524507|449971328|FG000|Overall Study|Withdrawal by Subject|2|||
125096234|NCT04524507|449971329|FG001|Overall Study|Withdrawal by Subject|9|||
125096235|NCT04524507|449971328|FG000|Overall Study|Death|2|||
125096236|NCT04524507|449971329|FG001|Overall Study|Death|10|||
125096237|NCT02711306|449971330|FG000|Overall Study|Withdrawal by Subject|2|||
125096238|NCT02711306|449971331|FG001|Overall Study|Withdrawal by Subject|2|||
125096239|NCT02811640|449971332|FG000|Overall Study|Technology malfunction|2|||
125096240|NCT02441517|449971333|FG000|Overall Study|Lost to Follow-up|1|||
125096241|NCT02441517|449971333|FG000|Overall Study|Withdrawal by Subject|2|||
125096242|NCT02441517|449971333|FG000|Overall Study|Study Terminated by Sponsor|1|||
125096243|NCT01393444|449971334|FG000|Overall Study|Withdrawal by Subject|1|||
125096244|NCT01393444|449971334|FG000|Overall Study|Determined ineligible during screening.|2|||
125096245|NCT03575806|449972763|FG000|Overall Study|Withdrawal by Subject|0|||
125096246|NCT03575806|449972764|FG001|Overall Study|Withdrawal by Subject|2|||
125096247|NCT03575806|449972763|FG000|Overall Study|Protocol Violation|0|||
125096248|NCT03575806|449972764|FG001|Overall Study|Protocol Violation|2|||
125096249|NCT01458535|449972765|FG000|Overall Study|Other|0|||
125096250|NCT01458535|449972766|FG001|Overall Study|Other|0|||
125007685|NCT00073528|449655133|FG000|Overall Study|Other|18|||
125007686|NCT00073528|449655134|FG001|Overall Study|Other|19|||
125007687|NCT00073528|449655133|FG000|Overall Study|Other|9|||
125007688|NCT00073528|449655134|FG001|Overall Study|Other|12|||
125007689|NCT00073528|449655133|FG000|Overall Study|Protocol Violation|3|||
125007690|NCT00073528|449655134|FG001|Overall Study|Protocol Violation|5|||
125007691|NCT03086057|449655135|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
125007692|NCT03086057|449655136|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
125007693|NCT03086057|449655137|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
125007694|NCT03086057|449655138|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
125007695|NCT03086057|449655135|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
125007696|NCT03086057|449655136|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
125007697|NCT03086057|449655137|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
125007698|NCT03086057|449655138|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
125007699|NCT03086057|449655135|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
125007700|NCT03086057|449655136|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
125007701|NCT03086057|449655137|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
125007702|NCT03086057|449655138|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
125007703|NCT03086057|449655135|FG000|Stage 1: PrEP Uptake|Death|1|||
125007704|NCT03086057|449655136|FG001|Stage 1: PrEP Uptake|Death|0|||
125007705|NCT03086057|449655137|FG002|Stage 1: PrEP Uptake|Death|0|||
125007706|NCT03086057|449655138|FG003|Stage 1: PrEP Uptake|Death|0|||
125007707|NCT03086057|449655135|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
125007708|NCT03086057|449655136|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
125007709|NCT03086057|449655137|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
125007710|NCT03086057|449655138|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
125007711|NCT03086057|449655135|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
125007712|NCT03086057|449655136|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
125007713|NCT03086057|449655137|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
125007714|NCT03086057|449655138|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
125007715|NCT03086057|449655135|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
125007716|NCT03086057|449655136|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
125007717|NCT03086057|449655137|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
125007718|NCT03086057|449655138|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
125007719|NCT04305275|449655139|FG000|Overall Study|Adverse Event|4|||
125007720|NCT04305275|449655140|FG001|Overall Study|Adverse Event|0|||
125007721|NCT04305275|449655139|FG000|Overall Study|Lost to Follow-up|1|||
125007722|NCT04305275|449655140|FG001|Overall Study|Lost to Follow-up|1|||
125007723|NCT04305275|449655139|FG000|Overall Study|Withdrawal by Participant|8|||
125007724|NCT04305275|449655140|FG001|Overall Study|Withdrawal by Participant|1|||
125007725|NCT00117598|449655144|FG000|Prior to Treatment Cross Over|Death|40|||
125007726|NCT00117598|449655145|FG001|Prior to Treatment Cross Over|Death|41|||
125007727|NCT00117598|449655146|FG002|Prior to Treatment Cross Over|Death|37|||
125007728|NCT00117598|449655147|FG003|Prior to Treatment Cross Over|Death|0|||
125007729|NCT00117598|449655148|FG004|Prior to Treatment Cross Over|Death|0|||
125007730|NCT00117598|449655144|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
125007731|NCT00117598|449655145|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
125007732|NCT00117598|449655146|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
125007733|NCT00117598|449655147|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
125007734|NCT00117598|449655148|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
125007735|NCT00117598|449655144|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
125007736|NCT00117598|449655145|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
125007737|NCT00117598|449655146|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
125007738|NCT00117598|449655147|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
125007739|NCT00117598|449655148|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
125007740|NCT00117598|449655144|FG000|Prior to Treatment Cross Over|Other|15|||
125007741|NCT00117598|449655145|FG001|Prior to Treatment Cross Over|Other|9|||
125007742|NCT00117598|449655146|FG002|Prior to Treatment Cross Over|Other|9|||
125007743|NCT00117598|449655147|FG003|Prior to Treatment Cross Over|Other|0|||
125007744|NCT00117598|449655148|FG004|Prior to Treatment Cross Over|Other|0|||
125007745|NCT00117598|449655144|FG000|After Treament Cross Over|Death|0|||
125007746|NCT00117598|449655145|FG001|After Treament Cross Over|Death|0|||
125007747|NCT00117598|449655146|FG002|After Treament Cross Over|Death|0|||
125007748|NCT00117598|449655147|FG003|After Treament Cross Over|Death|1|||
125007749|NCT00117598|449655148|FG004|After Treament Cross Over|Death|2|||
125007750|NCT00117598|449655144|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
125007751|NCT00117598|449655145|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
125007752|NCT00117598|449655146|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
125007753|NCT00117598|449655147|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
125007754|NCT00117598|449655148|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
125096251|NCT01458535|449972767|FG002|Overall Study|Other|0|||
125096252|NCT01458535|449972768|FG003|Overall Study|Other|0|||
125096253|NCT01458535|449972769|FG004|Overall Study|Other|1|||
125096254|NCT01458535|449972770|FG005|Overall Study|Other|1|||
125096255|NCT01458535|449972765|FG000|Overall Study|Withdrawal by Subject|0|||
125096256|NCT01458535|449972766|FG001|Overall Study|Withdrawal by Subject|0|||
125096257|NCT01458535|449972767|FG002|Overall Study|Withdrawal by Subject|2|||
125096258|NCT01458535|449972768|FG003|Overall Study|Withdrawal by Subject|0|||
125096259|NCT01458535|449972769|FG004|Overall Study|Withdrawal by Subject|1|||
125096260|NCT01458535|449972770|FG005|Overall Study|Withdrawal by Subject|1|||
125096261|NCT01458535|449972765|FG000|Overall Study|Lost to Follow-up|0|||
125007755|NCT00117598|449655144|FG000|After Treament Cross Over|Other|0|||
125007756|NCT00117598|449655145|FG001|After Treament Cross Over|Other|0|||
125007757|NCT00117598|449655146|FG002|After Treament Cross Over|Other|0|||
125007758|NCT00117598|449655147|FG003|After Treament Cross Over|Other|1|||
125007759|NCT00117598|449655148|FG004|After Treament Cross Over|Other|2|||
125007760|NCT04688775|449655156|FG000|Placebo-controlled Period|Randomized, not treated|1|||
125007761|NCT04688775|449655157|FG001|Placebo-controlled Period|Randomized, not treated|1|||
125007762|NCT04688775|449655158|FG002|Placebo-controlled Period|Randomized, not treated|0|||
125007763|NCT04688775|449655159|FG003|Placebo-controlled Period|Randomized, not treated|0|||
125007764|NCT04688775|449655156|FG000|Placebo-controlled Period|Adverse Event|2|||
125007765|NCT04688775|449655157|FG001|Placebo-controlled Period|Adverse Event|0|||
125007766|NCT04688775|449655158|FG002|Placebo-controlled Period|Adverse Event|0|||
125007767|NCT04688775|449655159|FG003|Placebo-controlled Period|Adverse Event|0|||
125007768|NCT04688775|449655156|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
125007769|NCT04688775|449655157|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
125007770|NCT04688775|449655158|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
125007771|NCT04688775|449655159|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
125007772|NCT04688775|449655156|FG000|Placebo-controlled Period|Protocol Violation|0|||
125007773|NCT04688775|449655157|FG001|Placebo-controlled Period|Protocol Violation|1|||
125007774|NCT04688775|449655158|FG002|Placebo-controlled Period|Protocol Violation|0|||
125007775|NCT04688775|449655159|FG003|Placebo-controlled Period|Protocol Violation|0|||
125007776|NCT04688775|449655156|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
125007777|NCT04688775|449655157|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
125007778|NCT04688775|449655158|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
125007779|NCT04688775|449655159|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
125007780|NCT04688775|449655156|FG000|Placebo-controlled Period|Other reasons|0|||
125007781|NCT04688775|449655157|FG001|Placebo-controlled Period|Other reasons|1|||
125007782|NCT04688775|449655158|FG002|Placebo-controlled Period|Other reasons|0|||
125007783|NCT04688775|449655159|FG003|Placebo-controlled Period|Other reasons|0|||
125007784|NCT04688775|449655156|FG000|Delayed Start Period|Adverse Event|0|||
125007785|NCT04688775|449655157|FG001|Delayed Start Period|Adverse Event|0|||
125007786|NCT04688775|449655158|FG002|Delayed Start Period|Adverse Event|1|||
125007787|NCT04688775|449655159|FG003|Delayed Start Period|Adverse Event|0|||
125007788|NCT04688775|449655156|FG000|Delayed Start Period|Lack of Efficacy|0|||
125007789|NCT04688775|449655157|FG001|Delayed Start Period|Lack of Efficacy|0|||
125007790|NCT04688775|449655158|FG002|Delayed Start Period|Lack of Efficacy|0|||
125007791|NCT04688775|449655159|FG003|Delayed Start Period|Lack of Efficacy|3|||
125007792|NCT04688775|449655156|FG000|Delayed Start Period|Withdrawal by Subject|0|||
125007793|NCT04688775|449655157|FG001|Delayed Start Period|Withdrawal by Subject|0|||
125007794|NCT04688775|449655158|FG002|Delayed Start Period|Withdrawal by Subject|2|||
125007795|NCT04688775|449655159|FG003|Delayed Start Period|Withdrawal by Subject|4|||
125007796|NCT04688775|449655156|FG000|Delayed Start Period|Lost to Follow-up|0|||
125007797|NCT04688775|449655157|FG001|Delayed Start Period|Lost to Follow-up|0|||
125007798|NCT04688775|449655158|FG002|Delayed Start Period|Lost to Follow-up|2|||
125007799|NCT04688775|449655159|FG003|Delayed Start Period|Lost to Follow-up|1|||
125007800|NCT04688775|449655156|FG000|Delayed Start Period|other reasons|0|||
125007801|NCT04688775|449655157|FG001|Delayed Start Period|other reasons|0|||
125007802|NCT04688775|449655158|FG002|Delayed Start Period|other reasons|1|||
125007803|NCT04688775|449655159|FG003|Delayed Start Period|other reasons|0|||
125096262|NCT01458535|449972766|FG001|Overall Study|Lost to Follow-up|2|||
125007804|NCT01770912|449655160|FG000|Overall Study|Lost to Follow-up|2|||
125007805|NCT01770912|449655161|FG001|Overall Study|Lost to Follow-up|0|||
125007806|NCT01817751|449655166|FG000|Overall Study|Physician Decision|1|||
125007807|NCT00382018|449655167|FG000|Overall Study|Progression|0|||
125096263|NCT01458535|449972767|FG002|Overall Study|Lost to Follow-up|0|||
125096264|NCT01458535|449972768|FG003|Overall Study|Lost to Follow-up|3|||
125007808|NCT00382018|449655168|FG001|Overall Study|Progression|136|||
125007809|NCT00382018|449655169|FG002|Overall Study|Progression|51|||
125007810|NCT00382018|449655170|FG003|Overall Study|Progression|43|||
125007811|NCT00382018|449655167|FG000|Overall Study|Death|0|||
125007812|NCT00382018|449655168|FG001|Overall Study|Death|9|||
125007813|NCT00382018|449655169|FG002|Overall Study|Death|7|||
125007814|NCT00382018|449655170|FG003|Overall Study|Death|11|||
125007815|NCT00382018|449655167|FG000|Overall Study|Withdrawal by Subject|0|||
125007816|NCT00382018|449655168|FG001|Overall Study|Withdrawal by Subject|4|||
125007817|NCT00382018|449655169|FG002|Overall Study|Withdrawal by Subject|3|||
125007818|NCT00382018|449655170|FG003|Overall Study|Withdrawal by Subject|4|||
125007819|NCT00382018|449655167|FG000|Overall Study|Other, not protocol specified|0|||
125007820|NCT00382018|449655168|FG001|Overall Study|Other, not protocol specified|16|||
125007821|NCT00382018|449655169|FG002|Overall Study|Other, not protocol specified|3|||
125007822|NCT00382018|449655170|FG003|Overall Study|Other, not protocol specified|1|||
125007823|NCT00493220|449655171|FG000|Third Intervention|Withdrawal by Subject|1|||
125007824|NCT00493220|449655172|FG001|Third Intervention|Withdrawal by Subject|0|||
125007825|NCT00493220|449655173|FG002|Third Intervention|Withdrawal by Subject|0|||
125007826|NCT00493220|449655174|FG003|Third Intervention|Withdrawal by Subject|0|||
125007827|NCT00493220|449655175|FG004|Third Intervention|Withdrawal by Subject|0|||
125007828|NCT00493220|449655176|FG005|Third Intervention|Withdrawal by Subject|0|||
125007829|NCT02625233|449655177|FG000|Overall Study|Adverse Event|2|||
125007830|NCT02625233|449655178|FG001|Overall Study|Adverse Event|0|||
125007831|NCT01449461|449655181|FG000|Overall Study|Adverse Event|0|||
125007832|NCT01449461|449655182|FG001|Overall Study|Adverse Event|3|||
125007833|NCT01449461|449655183|FG002|Overall Study|Adverse Event|2|||
125007834|NCT01449461|449655184|FG003|Overall Study|Adverse Event|3|||
125007835|NCT01449461|449655185|FG004|Overall Study|Adverse Event|4|||
125007836|NCT01449461|449655186|FG005|Overall Study|Adverse Event|4|||
125007837|NCT01449461|449655181|FG000|Overall Study|Death|0|||
125007838|NCT01449461|449655182|FG001|Overall Study|Death|2|||
125007839|NCT01449461|449655183|FG002|Overall Study|Death|0|||
125007840|NCT01449461|449655184|FG003|Overall Study|Death|0|||
125007841|NCT01449461|449655185|FG004|Overall Study|Death|7|||
125007842|NCT01449461|449655186|FG005|Overall Study|Death|1|||
125007843|NCT01449461|449655181|FG000|Overall Study|Physician Decision|0|||
125007844|NCT01449461|449655182|FG001|Overall Study|Physician Decision|1|||
125007845|NCT01449461|449655183|FG002|Overall Study|Physician Decision|0|||
125007846|NCT01449461|449655184|FG003|Overall Study|Physician Decision|4|||
125007847|NCT01449461|449655185|FG004|Overall Study|Physician Decision|1|||
125007848|NCT01449461|449655186|FG005|Overall Study|Physician Decision|0|||
125007849|NCT01449461|449655181|FG000|Overall Study|Documented Progressive Disease|4|||
125007850|NCT01449461|449655182|FG001|Overall Study|Documented Progressive Disease|7|||
125007851|NCT01449461|449655183|FG002|Overall Study|Documented Progressive Disease|14|||
125007852|NCT01449461|449655184|FG003|Overall Study|Documented Progressive Disease|15|||
125007853|NCT01449461|449655185|FG004|Overall Study|Documented Progressive Disease|24|||
125007854|NCT01449461|449655186|FG005|Overall Study|Documented Progressive Disease|5|||
125007855|NCT01449461|449655181|FG000|Overall Study|Clinical Progressive Disease|2|||
125007856|NCT01449461|449655182|FG001|Overall Study|Clinical Progressive Disease|2|||
125007857|NCT01449461|449655183|FG002|Overall Study|Clinical Progressive Disease|0|||
125007858|NCT01449461|449655184|FG003|Overall Study|Clinical Progressive Disease|3|||
125007859|NCT01449461|449655185|FG004|Overall Study|Clinical Progressive Disease|4|||
125007860|NCT01449461|449655186|FG005|Overall Study|Clinical Progressive Disease|2|||
125007861|NCT01449461|449655181|FG000|Overall Study|Protocol Violation|0|||
125007862|NCT01449461|449655182|FG001|Overall Study|Protocol Violation|0|||
125007863|NCT01449461|449655183|FG002|Overall Study|Protocol Violation|0|||
125007864|NCT01449461|449655184|FG003|Overall Study|Protocol Violation|1|||
125007865|NCT01449461|449655185|FG004|Overall Study|Protocol Violation|0|||
125007866|NCT01449461|449655186|FG005|Overall Study|Protocol Violation|0|||
125007867|NCT01449461|449655181|FG000|Overall Study|Site Terminated by Sponsor|0|||
125007868|NCT01449461|449655182|FG001|Overall Study|Site Terminated by Sponsor|1|||
125007869|NCT01449461|449655183|FG002|Overall Study|Site Terminated by Sponsor|2|||
125007870|NCT01449461|449655184|FG003|Overall Study|Site Terminated by Sponsor|3|||
125007871|NCT01449461|449655185|FG004|Overall Study|Site Terminated by Sponsor|4|||
125007872|NCT01449461|449655186|FG005|Overall Study|Site Terminated by Sponsor|1|||
125007873|NCT01449461|449655181|FG000|Overall Study|Withdrawal by Subject|0|||
125007874|NCT01449461|449655182|FG001|Overall Study|Withdrawal by Subject|1|||
125007875|NCT01449461|449655183|FG002|Overall Study|Withdrawal by Subject|0|||
125007876|NCT01449461|449655184|FG003|Overall Study|Withdrawal by Subject|0|||
125007877|NCT01449461|449655185|FG004|Overall Study|Withdrawal by Subject|2|||
125007878|NCT01449461|449655186|FG005|Overall Study|Withdrawal by Subject|1|||
125007879|NCT01449461|449655181|FG000|Overall Study|Reason not Specified|0|||
125007880|NCT01449461|449655182|FG001|Overall Study|Reason not Specified|1|||
125007881|NCT01449461|449655183|FG002|Overall Study|Reason not Specified|0|||
125007882|NCT01449461|449655184|FG003|Overall Study|Reason not Specified|3|||
125007883|NCT01449461|449655185|FG004|Overall Study|Reason not Specified|2|||
125007884|NCT01449461|449655186|FG005|Overall Study|Reason not Specified|1|||
125007885|NCT01357577|449655187|FG000|Overall Study|Lost to Follow-up|20|||
125007886|NCT01357577|449655188|FG001|Overall Study|Lost to Follow-up|16|||
125007887|NCT01357577|449655187|FG000|Overall Study|Withdrawal by Subject|16|||
125007888|NCT01357577|449655188|FG001|Overall Study|Withdrawal by Subject|8|||
125007889|NCT01357577|449655187|FG000|Overall Study|look at data in database?|1|||
125007890|NCT01357577|449655188|FG001|Overall Study|look at data in database?|2|||
125007891|NCT00938717|449656419|FG000|Overall Study|Adverse Event|10|||
125007892|NCT00938717|449656420|FG001|Overall Study|Adverse Event|41|||
125007893|NCT00938717|449656419|FG000|Overall Study|Protocol Violation|11|||
125007894|NCT00938717|449656420|FG001|Overall Study|Protocol Violation|8|||
125007895|NCT00938717|449656419|FG000|Overall Study|Withdrawal by Subject|26|||
125007896|NCT00938717|449656420|FG001|Overall Study|Withdrawal by Subject|24|||
125007897|NCT00938717|449656419|FG000|Overall Study|Lost to Follow-up|13|||
125007898|NCT00938717|449656420|FG001|Overall Study|Lost to Follow-up|18|||
125007899|NCT00938717|449656419|FG000|Overall Study|Lack of Efficacy|33|||
125007900|NCT00938717|449656420|FG001|Overall Study|Lack of Efficacy|15|||
125007901|NCT00938717|449656419|FG000|Overall Study|Other reason|5|||
125007902|NCT00938717|449656420|FG001|Overall Study|Other reason|2|||
125007903|NCT05092919|449656422|FG000|Overall Study|Lost to Follow-up|7|||
125007904|NCT05092919|449656422|FG000|Overall Study|Withdrawal by Subject|2|||
125007905|NCT02248259|449656424|FG000|Treatment Period 1|Adverse Event|0|||
125007906|NCT02248259|449656425|FG001|Treatment Period 1|Adverse Event|0|||
125007907|NCT02248259|449656426|FG002|Treatment Period 1|Adverse Event|1|||
125007908|NCT02248259|449656427|FG003|Treatment Period 1|Adverse Event|0|||
125007909|NCT01848288|449656431|FG000|Overall Study|Death|1|||
125007910|NCT01848288|449656431|FG000|Overall Study|Protocol Violation|1|||
125007911|NCT01848288|449656431|FG000|Overall Study|Withdrawal by Subject|1|||
125007912|NCT00677820|449656433|FG000|Overall Study|Lost to Follow-up|1|||
125007913|NCT00677820|449656434|FG001|Overall Study|Lost to Follow-up|0|||
125007914|NCT02865018|449656458|FG000|Overall Study|Withdrawal by Subject|1|||
125007915|NCT00290290|449656461|FG000|Overall Study|Death|3|||
125007916|NCT00290290|449656462|FG001|Overall Study|Death|4|||
125007917|NCT00290290|449656461|FG000|Overall Study|Withdrawal by Subject|2|||
125007918|NCT00290290|449656462|FG001|Overall Study|Withdrawal by Subject|2|||
125007919|NCT00290290|449656461|FG000|Overall Study|Underwent clean surgical procedure|13|||
125007920|NCT00290290|449656462|FG001|Overall Study|Underwent clean surgical procedure|12|||
125007921|NCT00549939|449656468|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
125007922|NCT00549939|449656469|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
125007923|NCT00549939|449656470|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
125007924|NCT00549939|449656468|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
125007925|NCT00549939|449656469|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
125007926|NCT00549939|449656470|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
125007927|NCT00549939|449656468|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
125007928|NCT00549939|449656469|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
125007929|NCT00549939|449656470|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
125007930|NCT00549939|449656468|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
125007931|NCT00549939|449656469|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
125007932|NCT00549939|449656470|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
125007933|NCT00549939|449656468|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
125007934|NCT00549939|449656469|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
125007935|NCT00549939|449656470|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
125007936|NCT00549939|449656468|FG000|40-week Open Label Treatment Period|Other|0|||
125007937|NCT00549939|449656469|FG001|40-week Open Label Treatment Period|Other|1|||
125007938|NCT00549939|449656470|FG002|40-week Open Label Treatment Period|Other|4|||
125007939|NCT03677596|449656471|FG000|Overall Study|Adverse Event|0|||
125007940|NCT03677596|449656472|FG001|Overall Study|Adverse Event|1|||
125007941|NCT03677596|449656471|FG000|Overall Study|Death|10|||
125007942|NCT03677596|449656472|FG001|Overall Study|Death|6|||
125007943|NCT03677596|449656471|FG000|Overall Study|Lost to Follow-up|0|||
125007944|NCT03677596|449656472|FG001|Overall Study|Lost to Follow-up|1|||
125007945|NCT03677596|449656471|FG000|Overall Study|Progressive Disease|8|||
125007946|NCT03677596|449656472|FG001|Overall Study|Progressive Disease|8|||
125007947|NCT03677596|449656471|FG000|Overall Study|Withdrawal by Subject|3|||
125007948|NCT03677596|449656472|FG001|Overall Study|Withdrawal by Subject|0|||
125007949|NCT03677596|449656471|FG000|Overall Study|Disease Relapse|2|||
125007950|NCT03677596|449656472|FG001|Overall Study|Disease Relapse|2|||
125096265|NCT01458535|449972769|FG004|Overall Study|Lost to Follow-up|2|||
125096266|NCT01458535|449972770|FG005|Overall Study|Lost to Follow-up|2|||
125096267|NCT01458535|449972765|FG000|Overall Study|Adverse Event|0|||
125096268|NCT01458535|449972766|FG001|Overall Study|Adverse Event|0|||
125096269|NCT01458535|449972767|FG002|Overall Study|Adverse Event|0|||
125096270|NCT01458535|449972768|FG003|Overall Study|Adverse Event|1|||
125096271|NCT01458535|449972769|FG004|Overall Study|Adverse Event|0|||
125096272|NCT01458535|449972770|FG005|Overall Study|Adverse Event|0|||
125096273|NCT01238861|449972771|FG000|Overall Study|Lost to Follow-up|4|||
125096274|NCT01238861|449972772|FG001|Overall Study|Lost to Follow-up|2|||
125096275|NCT01238861|449972773|FG002|Overall Study|Lost to Follow-up|3|||
125007951|NCT03677596|449656471|FG000|Overall Study|Other|0|||
125007952|NCT03677596|449656472|FG001|Overall Study|Other|1|||
125007953|NCT00003895|449656473|FG000|Overall Study|Adverse Event|4|||
125007954|NCT00003895|449656474|FG001|Overall Study|Adverse Event|0|||
125007955|NCT00003895|449656473|FG000|Overall Study|Lack of Efficacy|1|||
125096276|NCT01238861|449972774|FG003|Overall Study|Lost to Follow-up|1|||
125096277|NCT01238861|449972775|FG004|Overall Study|Lost to Follow-up|1|||
125096278|NCT01238861|449972776|FG005|Overall Study|Lost to Follow-up|2|||
125096279|NCT01238861|449972771|FG000|Overall Study|Unplanned surgery|1|||
125096280|NCT01238861|449972772|FG001|Overall Study|Unplanned surgery|0|||
125096281|NCT01238861|449972773|FG002|Overall Study|Unplanned surgery|0|||
125096282|NCT01238861|449972774|FG003|Overall Study|Unplanned surgery|0|||
125096283|NCT01238861|449972775|FG004|Overall Study|Unplanned surgery|0|||
125096284|NCT01238861|449972776|FG005|Overall Study|Unplanned surgery|0|||
125096285|NCT01238861|449972771|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
125096286|NCT01238861|449972772|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
125096287|NCT01238861|449972773|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
125096288|NCT01238861|449972774|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
125096289|NCT01238861|449972775|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
125096290|NCT01238861|449972776|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
125096291|NCT01238861|449972771|FG000|Overall Study|Incorrect enrollment/randomization|0|||
125096292|NCT01238861|449972772|FG001|Overall Study|Incorrect enrollment/randomization|0|||
125096293|NCT01238861|449972773|FG002|Overall Study|Incorrect enrollment/randomization|1|||
125096294|NCT01238861|449972774|FG003|Overall Study|Incorrect enrollment/randomization|0|||
125096295|NCT01238861|449972775|FG004|Overall Study|Incorrect enrollment/randomization|1|||
125096296|NCT01238861|449972776|FG005|Overall Study|Incorrect enrollment/randomization|0|||
125096297|NCT01238861|449972771|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
125096298|NCT01238861|449972772|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
125096299|NCT01238861|449972773|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
125096300|NCT01238861|449972774|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
125096301|NCT01238861|449972775|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
125096302|NCT01238861|449972776|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
125096303|NCT01238861|449972771|FG000|Overall Study|Subject moved out of state/area|0|||
125096304|NCT01238861|449972772|FG001|Overall Study|Subject moved out of state/area|0|||
125096305|NCT01238861|449972773|FG002|Overall Study|Subject moved out of state/area|1|||
125007956|NCT00003895|449656474|FG001|Overall Study|Lack of Efficacy|1|||
125007957|NCT00003895|449656473|FG000|Overall Study|Patient Vacation|2|||
125007958|NCT00003895|449656474|FG001|Overall Study|Patient Vacation|0|||
125007959|NCT00003895|449656473|FG000|Overall Study|Withdrawal by Subject|0|||
125007960|NCT00003895|449656474|FG001|Overall Study|Withdrawal by Subject|3|||
125007961|NCT04912245|449656477|FG000|Overall Study|Withdrawal by Subject|21|||
125007962|NCT04912245|449656478|FG001|Overall Study|Withdrawal by Subject|4|||
125007963|NCT04912245|449656477|FG000|Overall Study|Lost to Follow-up|5|||
125007964|NCT04912245|449656478|FG001|Overall Study|Lost to Follow-up|11|||
125007965|NCT01134614|449656479|FG000|Overall Study|Still on treatment as of March 2013|21|||
125007966|NCT01134614|449656480|FG001|Overall Study|Still on treatment as of March 2013|13|||
125007967|NCT01134614|449656479|FG000|Overall Study|Progressive disease|60|||
125007968|NCT01134614|449656480|FG001|Overall Study|Progressive disease|54|||
125007969|NCT01134614|449656479|FG000|Overall Study|Adverse Event|26|||
125007970|NCT01134614|449656480|FG001|Overall Study|Adverse Event|39|||
125007971|NCT01134614|449656479|FG000|Overall Study|Death|5|||
125007972|NCT01134614|449656480|FG001|Overall Study|Death|8|||
125007973|NCT01134614|449656479|FG000|Overall Study|Withdrawal by Subject|3|||
125096306|NCT01238861|449972774|FG003|Overall Study|Subject moved out of state/area|1|||
125096307|NCT01238861|449972775|FG004|Overall Study|Subject moved out of state/area|0|||
125096308|NCT01238861|449972776|FG005|Overall Study|Subject moved out of state/area|0|||
125096309|NCT01238861|449972771|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
125096310|NCT01238861|449972772|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
125007974|NCT01134614|449656480|FG001|Overall Study|Withdrawal by Subject|2|||
125007975|NCT01134614|449656479|FG000|Overall Study|Alternative therapy|2|||
125007976|NCT01134614|449656480|FG001|Overall Study|Alternative therapy|0|||
125007977|NCT01134614|449656479|FG000|Overall Study|Complicating disease|2|||
125007978|NCT01134614|449656480|FG001|Overall Study|Complicating disease|1|||
125007979|NCT01134614|449656479|FG000|Overall Study|Physician's decision|0|||
125007980|NCT01134614|449656480|FG001|Overall Study|Physician's decision|1|||
125007981|NCT01134614|449656479|FG000|Overall Study|Never started treatment|4|||
125007982|NCT01134614|449656480|FG001|Overall Study|Never started treatment|1|||
125007983|NCT01134614|449656479|FG000|Overall Study|Pt received tx not allowed on study|0|||
125007984|NCT01134614|449656480|FG001|Overall Study|Pt received tx not allowed on study|1|||
125007985|NCT01134614|449656479|FG000|Overall Study|Symptomatic deterioration|0|||
125007986|NCT01134614|449656480|FG001|Overall Study|Symptomatic deterioration|1|||
125007987|NCT01134614|449656479|FG000|Overall Study|Patient in hospice care|0|||
125007988|NCT01134614|449656480|FG001|Overall Study|Patient in hospice care|1|||
125007989|NCT02752035|449656481|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
125007990|NCT02752035|449656482|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
125007991|NCT02752035|449656483|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
125007992|NCT02752035|449656484|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
125007993|NCT02752035|449656481|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
125007994|NCT02752035|449656482|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
125007995|NCT02752035|449656483|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
125007996|NCT02752035|449656484|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
125007997|NCT02752035|449656481|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
125007998|NCT02752035|449656482|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
125007999|NCT02752035|449656483|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
125008000|NCT02752035|449656484|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
125008001|NCT02752035|449656481|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
125008002|NCT02752035|449656482|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
125008003|NCT02752035|449656483|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
125008004|NCT02752035|449656484|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
125008005|NCT02752035|449656481|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
125008006|NCT02752035|449656482|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
125008007|NCT02752035|449656483|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
125008008|NCT02752035|449656484|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
125008009|NCT02752035|449656481|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
125008010|NCT02752035|449656482|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
125008011|NCT02752035|449656483|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
125008012|NCT02752035|449656484|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
125008013|NCT02752035|449656481|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
125008014|NCT02752035|449656482|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
125008015|NCT02752035|449656483|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
125008016|NCT02752035|449656484|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
125008017|NCT02752035|449656481|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
125008018|NCT02752035|449656482|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
125008019|NCT02752035|449656483|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
125008020|NCT02752035|449656484|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
125008021|NCT02752035|449656481|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
125008022|NCT02752035|449656482|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
125008023|NCT02752035|449656483|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
125008024|NCT02752035|449656484|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
125008025|NCT02752035|449656481|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
125008026|NCT02752035|449656482|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
125008027|NCT02752035|449656483|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
125008028|NCT02752035|449656484|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
125008029|NCT02752035|449656481|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
125008030|NCT02752035|449656482|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
125008031|NCT02752035|449656483|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
125008032|NCT02752035|449656484|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
125008033|NCT02752035|449656481|FG000|Randomization: Approximately 3 Years|Death|0|||
125008034|NCT02752035|449656482|FG001|Randomization: Approximately 3 Years|Death|25|||
125008035|NCT02752035|449656483|FG002|Randomization: Approximately 3 Years|Death|13|||
125008036|NCT02752035|449656484|FG003|Randomization: Approximately 3 Years|Death|4|||
125008037|NCT02752035|449656481|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
125008038|NCT02752035|449656482|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
125008039|NCT02752035|449656483|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
125008040|NCT02752035|449656484|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
125008041|NCT02752035|449656481|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
125008042|NCT02752035|449656482|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
125008043|NCT02752035|449656483|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
125008044|NCT02752035|449656484|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
125008045|NCT02752035|449656481|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
125008046|NCT02752035|449656482|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
125008047|NCT02752035|449656483|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
125008048|NCT02752035|449656484|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
125008049|NCT02752035|449656481|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
125008050|NCT02752035|449656482|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
125008051|NCT02752035|449656483|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
125008052|NCT02752035|449656484|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
125008053|NCT02752035|449656481|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
125008054|NCT02752035|449656482|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
125008055|NCT02752035|449656483|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
125008056|NCT02752035|449656484|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
125008057|NCT01161043|449656487|FG000|Overall Study|Withdrawal by Subject|3|||
125008058|NCT01236573|449656488|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
125008059|NCT01236573|449656489|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
125008060|NCT01236573|449656490|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
125008061|NCT01236573|449656491|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
125008062|NCT01236573|449656492|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
125008063|NCT01236573|449656493|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
125008064|NCT01236573|449656494|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
125008065|NCT01236573|449656495|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
125008066|NCT01236573|449656496|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
125008067|NCT01236573|449656497|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
125008068|NCT01236573|449656498|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
125008069|NCT01236573|449656488|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
125008070|NCT01236573|449656489|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
125008071|NCT01236573|449656490|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
125008072|NCT01236573|449656491|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
125008073|NCT01236573|449656492|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
125008074|NCT01236573|449656493|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
125008075|NCT01236573|449656494|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
125008076|NCT01236573|449656495|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
125008077|NCT01236573|449656496|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
125008078|NCT01236573|449656497|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
125008079|NCT01236573|449656498|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
125008080|NCT01236573|449656488|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
125008081|NCT01236573|449656489|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
125008082|NCT01236573|449656490|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
125008083|NCT01236573|449656491|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
125008084|NCT01236573|449656492|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
125008085|NCT01236573|449656493|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
125008086|NCT01236573|449656494|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
125008087|NCT01236573|449656495|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
125008088|NCT01236573|449656496|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
125008089|NCT01236573|449656497|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
125008090|NCT01236573|449656498|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
125008091|NCT02164929|449656501|FG000|Overall Study|Converted to open procedure|1|||
125008092|NCT02164929|449656502|FG001|Overall Study|Converted to open procedure|0|||
125008093|NCT02164929|449656503|FG002|Overall Study|Converted to open procedure|0|||
125008094|NCT02164929|449656504|FG003|Overall Study|Converted to open procedure|2|||
125008095|NCT02164929|449656501|FG000|Overall Study|Failed regional block|0|||
125008096|NCT02164929|449656502|FG001|Overall Study|Failed regional block|0|||
125008097|NCT02164929|449656503|FG002|Overall Study|Failed regional block|1|||
125008098|NCT02164929|449656504|FG003|Overall Study|Failed regional block|0|||
125008099|NCT00971178|449656505|FG000|Overall Study|Lost to Follow-up|2|||
125008100|NCT00971178|449656506|FG001|Overall Study|Lost to Follow-up|2|||
125008101|NCT00971178|449656507|FG002|Overall Study|Lost to Follow-up|2|||
125008102|NCT02161575|449656509|FG000|Overall Study|Protocol Violation|8|||
125008103|NCT02161575|449656509|FG000|Overall Study|Lack of Efficacy|1|||
125008104|NCT02161575|449656509|FG000|Overall Study|Adverse Event|2|||
125008105|NCT00424749|449656511|FG000|Overall Study|Withdrawal by Subject|1|||
125008106|NCT04109222|449656516|FG000|Overall Study|Adverse Event|1|||
125008107|NCT04109222|449656517|FG001|Overall Study|Adverse Event|0|||
125008108|NCT04109222|449656518|FG002|Overall Study|Adverse Event|0|||
125008109|NCT03023059|449656519|FG000|Overall Study|Withdrawal by Subject|5|||
125008110|NCT02138617|449656520|FG000|Overall Study|Death|1|||
125008111|NCT02138617|449656521|FG001|Overall Study|Death|2|||
125008112|NCT02138617|449656522|FG002|Overall Study|Death|2|||
125008113|NCT02138617|449656520|FG000|Overall Study|Adverse Event|8|||
125008114|NCT02138617|449656521|FG001|Overall Study|Adverse Event|5|||
125008115|NCT02138617|449656522|FG002|Overall Study|Adverse Event|2|||
125008116|NCT02138617|449656520|FG000|Overall Study|Disease Progression|20|||
125008117|NCT02138617|449656521|FG001|Overall Study|Disease Progression|13|||
125008118|NCT02138617|449656522|FG002|Overall Study|Disease Progression|4|||
125008119|NCT02138617|449656520|FG000|Overall Study|Withdrawal by Subject|7|||
125008120|NCT02138617|449656521|FG001|Overall Study|Withdrawal by Subject|10|||
125008121|NCT02138617|449656522|FG002|Overall Study|Withdrawal by Subject|2|||
125008122|NCT02138617|449656520|FG000|Overall Study|other complicating disease|0|||
125008123|NCT02138617|449656521|FG001|Overall Study|other complicating disease|2|||
125008124|NCT02138617|449656522|FG002|Overall Study|other complicating disease|0|||
125008125|NCT02138617|449656520|FG000|Overall Study|Protocol Violation|1|||
125008126|NCT02138617|449656521|FG001|Overall Study|Protocol Violation|0|||
125008127|NCT02138617|449656522|FG002|Overall Study|Protocol Violation|0|||
125008128|NCT02138617|449656520|FG000|Overall Study|Physician Decision|7|||
125096311|NCT01238861|449972773|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
125008129|NCT02138617|449656521|FG001|Overall Study|Physician Decision|6|||
125008130|NCT02138617|449656522|FG002|Overall Study|Physician Decision|0|||
125008131|NCT02138617|449656520|FG000|Overall Study|financial reason|0|||
125008132|NCT02138617|449656521|FG001|Overall Study|financial reason|1|||
125008133|NCT02138617|449656522|FG002|Overall Study|financial reason|0|||
125008134|NCT02138617|449656520|FG000|Overall Study|other therapy|3|||
125008135|NCT02138617|449656521|FG001|Overall Study|other therapy|4|||
125096312|NCT01238861|449972774|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
125096313|NCT01238861|449972775|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
125096314|NCT01238861|449972776|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
125096315|NCT01238861|449972771|FG000|Overall Study|Personal problems|0|||
125096316|NCT01238861|449972772|FG001|Overall Study|Personal problems|0|||
125096317|NCT01238861|449972773|FG002|Overall Study|Personal problems|0|||
125008136|NCT02138617|449656522|FG002|Overall Study|other therapy|0|||
125008137|NCT00596947|449656527|FG000|Overall Study|study halted due to low enrollment|5|||
125008138|NCT00596947|449656528|FG001|Overall Study|study halted due to low enrollment|3|||
125008139|NCT00596947|449656527|FG000|Overall Study|Lost to Follow-up|1|||
125008140|NCT00596947|449656528|FG001|Overall Study|Lost to Follow-up|0|||
125008141|NCT00496730|449656529|FG000|Overall Study|Lost to Follow-up|4|||
125008142|NCT00496730|449656530|FG001|Overall Study|Lost to Follow-up|3|||
125008143|NCT00496730|449656529|FG000|Overall Study|Withdrawal by Subject|2|||
125008144|NCT00496730|449656530|FG001|Overall Study|Withdrawal by Subject|2|||
125008145|NCT03654976|449656534|FG000|Overall Study|Withdrawal by Subject|12|||
125008146|NCT03654976|449656535|FG001|Overall Study|Withdrawal by Subject|11|||
125008147|NCT03654976|449656534|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
125008148|NCT03654976|449656535|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
125008149|NCT03654976|449656534|FG000|Overall Study|Adverse Event|5|||
125008150|NCT03654976|449656535|FG001|Overall Study|Adverse Event|0|||
125008151|NCT03654976|449656534|FG000|Overall Study|Lost to Follow-up|2|||
125008152|NCT03654976|449656535|FG001|Overall Study|Lost to Follow-up|0|||
125008153|NCT03654976|449656534|FG000|Overall Study|Lack of Efficacy|0|||
125008154|NCT03654976|449656535|FG001|Overall Study|Lack of Efficacy|1|||
125008155|NCT03098836|449656536|FG000|Overall Study|Adverse Event|1|||
125008156|NCT03098836|449656537|FG001|Overall Study|Adverse Event|3|||
125008157|NCT03098836|449656536|FG000|Overall Study|Lack of Efficacy|30|||
125008158|NCT03098836|449656537|FG001|Overall Study|Lack of Efficacy|15|||
125008159|NCT03098836|449656536|FG000|Overall Study|Physician Decision|2|||
125008160|NCT03098836|449656537|FG001|Overall Study|Physician Decision|1|||
125008161|NCT03098836|449656536|FG000|Overall Study|Withdrawal by Subject|3|||
125008162|NCT03098836|449656537|FG001|Overall Study|Withdrawal by Subject|2|||
125008163|NCT00898443|449656538|FG000|Overall Study|Withdrawal by Subject|1|||
125008164|NCT00898443|449656539|FG001|Overall Study|Withdrawal by Subject|0|||
125008165|NCT04695392|449656540|FG000|Overall Study|Withdrawn by parent/guardian|0|||
125008166|NCT04695392|449656541|FG001|Overall Study|Withdrawn by parent/guardian|1|||
125008167|NCT04695392|449656540|FG000|Overall Study|Withdrawn by physician|0|||
125008168|NCT04695392|449656541|FG001|Overall Study|Withdrawn by physician|1|||
125008169|NCT00427349|449656542|FG000|Overall Study|Lack of Efficacy|23|||
125008170|NCT00427349|449656542|FG000|Overall Study|Adverse Event|14|||
125008171|NCT00427349|449656542|FG000|Overall Study|Death|1|||
125008172|NCT00427349|449656542|FG000|Overall Study|Withdrawal by Subject|3|||
125008173|NCT00427349|449656542|FG000|Overall Study|Alternative therapy|1|||
125008174|NCT00427349|449656542|FG000|Overall Study|Other|2|||
125008175|NCT00427349|449656542|FG000|Overall Study|Ineligible|1|||
125008176|NCT00427349|449656542|FG000|Overall Study|Never started therapy|1|||
125008177|NCT00698997|449656545|FG000|Overall Study|Lost to Follow-up|3|||
125008178|NCT00698997|449656546|FG001|Overall Study|Lost to Follow-up|0|||
125096318|NCT01238861|449972774|FG003|Overall Study|Personal problems|1|||
125096319|NCT01238861|449972775|FG004|Overall Study|Personal problems|0|||
125096320|NCT01238861|449972776|FG005|Overall Study|Personal problems|0|||
125008179|NCT00698997|449656545|FG000|Overall Study|Withdrawal by Subject|7|||
125008180|NCT00698997|449656546|FG001|Overall Study|Withdrawal by Subject|27|||
125096321|NCT01238861|449972771|FG000|Overall Study|Unable to continue visits|0|||
125096322|NCT01238861|449972772|FG001|Overall Study|Unable to continue visits|0|||
125096323|NCT01238861|449972773|FG002|Overall Study|Unable to continue visits|0|||
125096324|NCT01238861|449972774|FG003|Overall Study|Unable to continue visits|1|||
125096325|NCT01238861|449972775|FG004|Overall Study|Unable to continue visits|0|||
125096326|NCT01238861|449972776|FG005|Overall Study|Unable to continue visits|1|||
125096327|NCT01238861|449972771|FG000|Overall Study|Serious adverse event|0|||
125096328|NCT01238861|449972772|FG001|Overall Study|Serious adverse event|0|||
125096329|NCT01238861|449972773|FG002|Overall Study|Serious adverse event|0|||
125096330|NCT01238861|449972774|FG003|Overall Study|Serious adverse event|0|||
125096331|NCT01238861|449972775|FG004|Overall Study|Serious adverse event|0|||
125096332|NCT01238861|449972776|FG005|Overall Study|Serious adverse event|1|||
125096333|NCT01238861|449972771|FG000|Overall Study|Lack of compliance|0|||
125096334|NCT01238861|449972772|FG001|Overall Study|Lack of compliance|0|||
125096335|NCT01238861|449972773|FG002|Overall Study|Lack of compliance|0|||
125096336|NCT01238861|449972774|FG003|Overall Study|Lack of compliance|0|||
125096337|NCT01238861|449972775|FG004|Overall Study|Lack of compliance|0|||
125096338|NCT01238861|449972776|FG005|Overall Study|Lack of compliance|1|||
125096339|NCT01238861|449972771|FG000|Overall Study|Adverse Event|0|||
125096340|NCT01238861|449972772|FG001|Overall Study|Adverse Event|1|||
125096341|NCT01238861|449972773|FG002|Overall Study|Adverse Event|0|||
125096342|NCT01238861|449972774|FG003|Overall Study|Adverse Event|0|||
125008181|NCT05082376|449656549|FG000|Overall Study|Lost to Follow-up|2|||
125008182|NCT01877915|449656550|FG000|Overall Study|Lost to Follow-up|10|||
125008183|NCT01877915|449656551|FG001|Overall Study|Lost to Follow-up|9|||
125008184|NCT01877915|449656550|FG000|Overall Study|Withdrawal by Subject|42|||
125008185|NCT01877915|449656551|FG001|Overall Study|Withdrawal by Subject|55|||
125008186|NCT01877915|449656550|FG000|Overall Study|Other|2|||
125008187|NCT01877915|449656551|FG001|Overall Study|Other|4|||
125008188|NCT00943579|449656552|FG000|Overall Study|Adverse Event|4|||
125008189|NCT00943579|449656553|FG001|Overall Study|Adverse Event|3|||
125008190|NCT00943579|449656552|FG000|Overall Study|Lack of Efficacy|2|||
125008191|NCT00943579|449656553|FG001|Overall Study|Lack of Efficacy|2|||
125008192|NCT01502709|449657587|FG000|Overall Study|Lost to Follow-up|4|||
125008193|NCT01502709|449657588|FG001|Overall Study|Lost to Follow-up|0|||
125008194|NCT00937937|449657590|FG000|Overall Study|Adverse Event|6|||
125008195|NCT00937937|449657590|FG000|Overall Study|Withdrawal by Subject|2|||
125008196|NCT00937937|449657590|FG000|Overall Study|Progression/relapse|61|||
125008197|NCT00937937|449657590|FG000|Overall Study|Death|1|||
125008198|NCT00937937|449657590|FG000|Overall Study|Other|2|||
125008199|NCT04024228|449657592|FG000|Overall Study|Adverse Event|1|||
125008200|NCT04024228|449657593|FG001|Overall Study|Adverse Event|0|||
125008201|NCT04024228|449657592|FG000|Overall Study|Protocol Deviation|0|||
125008202|NCT04024228|449657593|FG001|Overall Study|Protocol Deviation|2|||
125008203|NCT04024228|449657592|FG000|Overall Study|Withdrawal by Subject|3|||
125008204|NCT04024228|449657593|FG001|Overall Study|Withdrawal by Subject|4|||
125008205|NCT02932410|449657594|FG000|Overall Study|Death|7|||
125008206|NCT02932410|449657595|FG001|Overall Study|Death|6|||
125008207|NCT02932410|449657596|FG002|Overall Study|Death|0|||
125008208|NCT02932410|449657597|FG003|Overall Study|Death|0|||
125008209|NCT02932410|449657594|FG000|Overall Study|Lost to Follow-up|1|||
125008210|NCT02932410|449657595|FG001|Overall Study|Lost to Follow-up|2|||
125008211|NCT02932410|449657596|FG002|Overall Study|Lost to Follow-up|0|||
125008212|NCT02932410|449657597|FG003|Overall Study|Lost to Follow-up|0|||
125008213|NCT02932410|449657594|FG000|Overall Study|Parent/Subjects decision|6|||
125008214|NCT02932410|449657595|FG001|Overall Study|Parent/Subjects decision|6|||
125008215|NCT02932410|449657596|FG002|Overall Study|Parent/Subjects decision|1|||
125008216|NCT02932410|449657597|FG003|Overall Study|Parent/Subjects decision|0|||
125008217|NCT02932410|449657594|FG000|Overall Study|Physician Decision|0|||
125008218|NCT02932410|449657595|FG001|Overall Study|Physician Decision|1|||
125008219|NCT02932410|449657596|FG002|Overall Study|Physician Decision|0|||
125008220|NCT02932410|449657597|FG003|Overall Study|Physician Decision|0|||
125008221|NCT01007032|449657603|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
125008222|NCT01007032|449657604|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
125008223|NCT01007032|449657605|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
125008224|NCT01007032|449657606|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
125008225|NCT01007032|449657603|FG000|Overall Study|Withdrawal by Subject|0|||
125008226|NCT01007032|449657604|FG001|Overall Study|Withdrawal by Subject|0|||
125008227|NCT01007032|449657605|FG002|Overall Study|Withdrawal by Subject|0|||
125008228|NCT01007032|449657606|FG003|Overall Study|Withdrawal by Subject|1|||
125008229|NCT01841749|449657607|FG000|Overall Study|Protocol Violation|1|||
125008230|NCT05197049|449657613|FG000|Overall Study|Death|0|||
125008231|NCT05197049|449657614|FG001|Overall Study|Death|1|||
125008232|NCT05197049|449657615|FG002|Overall Study|Death|0|||
125008233|NCT05197049|449657613|FG000|Overall Study|Lost to Follow-up|3|||
125008234|NCT05197049|449657614|FG001|Overall Study|Lost to Follow-up|1|||
125096343|NCT01238861|449972775|FG004|Overall Study|Adverse Event|0|||
125096344|NCT01238861|449972776|FG005|Overall Study|Adverse Event|0|||
125096345|NCT01238861|449972771|FG000|Overall Study|Withdrawal by Subject|6|||
125096346|NCT01238861|449972772|FG001|Overall Study|Withdrawal by Subject|5|||
125096347|NCT01238861|449972773|FG002|Overall Study|Withdrawal by Subject|4|||
125096348|NCT01238861|449972774|FG003|Overall Study|Withdrawal by Subject|8|||
125096349|NCT01238861|449972775|FG004|Overall Study|Withdrawal by Subject|10|||
125096350|NCT01238861|449972776|FG005|Overall Study|Withdrawal by Subject|9|||
125096351|NCT01855607|449972777|FG000|Overall Study|Withdrawal by Subject|1|||
125096352|NCT01855607|449972777|FG000|Overall Study|Study was terminated|11|||
125096353|NCT04001790|449972782|FG000|Overall Study|Withdrawal by Subject|1|||
125096354|NCT04001790|449972783|FG001|Overall Study|Withdrawal by Subject|2|||
125096355|NCT04963231|449972788|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
125096356|NCT04963231|449972789|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
125096357|NCT04963231|449972790|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
125096358|NCT04963231|449972788|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
125096359|NCT04963231|449972789|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
125096360|NCT04963231|449972790|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
125096361|NCT04963231|449972788|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
125096362|NCT04963231|449972789|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
125096363|NCT04963231|449972790|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
125096364|NCT04963231|449972788|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
125096365|NCT04963231|449972789|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
125096366|NCT04963231|449972790|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
125096367|NCT04963231|449972788|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
125096368|NCT04963231|449972789|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
125096369|NCT04963231|449972790|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
125096370|NCT04963231|449972788|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
125096371|NCT04963231|449972789|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
125096372|NCT04963231|449972790|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
125096373|NCT04963231|449972788|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
125096374|NCT04963231|449972789|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
125008235|NCT05197049|449657615|FG002|Overall Study|Lost to Follow-up|0|||
125008236|NCT05197049|449657613|FG000|Overall Study|Withdrawal by Subject|15|||
125008237|NCT05197049|449657614|FG001|Overall Study|Withdrawal by Subject|3|||
125008238|NCT05197049|449657615|FG002|Overall Study|Withdrawal by Subject|1|||
125008239|NCT05197049|449657613|FG000|Overall Study|GCP non-compliance|1|||
125008240|NCT05197049|449657614|FG001|Overall Study|GCP non-compliance|2|||
125008241|NCT05197049|449657615|FG002|Overall Study|GCP non-compliance|0|||
125008242|NCT02577406|449657622|FG000|Randomized Period|Death|1|||
125008243|NCT02577406|449657623|FG001|Randomized Period|Death|0|||
125008244|NCT02577406|449657622|FG000|Randomized Period|Other reasons|0|||
125008245|NCT02577406|449657623|FG001|Randomized Period|Other reasons|20|||
125008246|NCT02577406|449657622|FG000|Treatment Period|Death|38|||
125008247|NCT02577406|449657623|FG001|Treatment Period|Death|23|||
125008248|NCT02577406|449657622|FG000|Treatment Period|Adverse Event|17|||
125096375|NCT04963231|449972790|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
125096376|NCT04576702|449972791|FG000|Overall Study|Death|1|||
125096377|NCT04576702|449972792|FG001|Overall Study|Death|0|||
125096378|NCT04576702|449972793|FG002|Overall Study|Death|0|||
125096379|NCT04576702|449972794|FG003|Overall Study|Death|0|||
125096380|NCT04576702|449972791|FG000|Overall Study|Withdrawal by Subject|0|||
125096381|NCT04576702|449972792|FG001|Overall Study|Withdrawal by Subject|2|||
125096382|NCT04576702|449972793|FG002|Overall Study|Withdrawal by Subject|1|||
125096383|NCT04576702|449972794|FG003|Overall Study|Withdrawal by Subject|0|||
125096384|NCT04576702|449972791|FG000|Overall Study|Lost to Follow-up|3|||
125096385|NCT04576702|449972792|FG001|Overall Study|Lost to Follow-up|3|||
125096386|NCT04576702|449972793|FG002|Overall Study|Lost to Follow-up|3|||
125096387|NCT04576702|449972794|FG003|Overall Study|Lost to Follow-up|4|||
125096388|NCT00229931|449972799|FG000|Overall Study|Death|1|||
125096389|NCT00229931|449972800|FG001|Overall Study|Death|0|||
125096390|NCT00229931|449972799|FG000|Overall Study|Lost to Follow-up|3|||
125096391|NCT00229931|449972800|FG001|Overall Study|Lost to Follow-up|2|||
125096392|NCT00465101|449972801|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
125096393|NCT00465101|449972801|FG000|Overall Study|Change in health precluded follow up|4|||
125096394|NCT00465101|449972801|FG000|Overall Study|Did not meet study criteria|4|||
125096395|NCT00465101|449972801|FG000|Overall Study|Lost to Follow-up|5|||
125096396|NCT00465101|449972801|FG000|Overall Study|Other|6|||
125096397|NCT00465101|449972801|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
125096398|NCT00465101|449972801|FG000|Overall Study|Patient postponed procedure|1|||
125096399|NCT00465101|449972801|FG000|Overall Study|Site closed due to IRB expiration|1|||
125096400|NCT00465101|449972801|FG000|Overall Study|Unable to obtain IRB approval|1|||
125096401|NCT00465101|449972801|FG000|Overall Study|Death|3|||
125096402|NCT00465101|449972801|FG000|Overall Study|Withdrawal by Subject|25|||
125096403|NCT00465101|449972801|FG000|Overall Study|Physician Decision|1|||
125096404|NCT00465101|449972801|FG000|Overall Study|Withdrew consent prior to procedure|3|||
125096405|NCT00361504|449972802|FG000|Overall Study|Withdrawal by Subject|94|||
125096406|NCT00361504|449972803|FG001|Overall Study|Withdrawal by Subject|31|||
125096407|NCT00361504|449972802|FG000|Overall Study|Lost to Follow-up|40|||
125096408|NCT00361504|449972803|FG001|Overall Study|Lost to Follow-up|7|||
125096409|NCT00361504|449972802|FG000|Overall Study|Adverse Event|203|||
125096410|NCT00361504|449972803|FG001|Overall Study|Adverse Event|82|||
125096411|NCT00361504|449972802|FG000|Overall Study|Lack of Efficacy|72|||
125096412|NCT00361504|449972803|FG001|Overall Study|Lack of Efficacy|7|||
125096413|NCT00361504|449972802|FG000|Overall Study|Resolution of Pain|2|||
125096414|NCT00361504|449972803|FG001|Overall Study|Resolution of Pain|0|||
125008249|NCT02577406|449657623|FG001|Treatment Period|Adverse Event|12|||
125008250|NCT02577406|449657622|FG000|Treatment Period|Progressive Disease|53|||
125008251|NCT02577406|449657623|FG001|Treatment Period|Progressive Disease|37|||
125008252|NCT02577406|449657622|FG000|Treatment Period|Withdrawal by Subject|10|||
125008253|NCT02577406|449657623|FG001|Treatment Period|Withdrawal by Subject|24|||
125008254|NCT02577406|449657622|FG000|Treatment Period|Lost to Follow-up|0|||
125008255|NCT02577406|449657623|FG001|Treatment Period|Lost to Follow-up|1|||
125008256|NCT02577406|449657622|FG000|Treatment Period|Transition to commercially available treatment|1|||
125008257|NCT02577406|449657623|FG001|Treatment Period|Transition to commercially available treatment|1|||
125008258|NCT02577406|449657622|FG000|Treatment Period|Physician Decision|1|||
125008259|NCT02577406|449657623|FG001|Treatment Period|Physician Decision|0|||
125008260|NCT02577406|449657622|FG000|Treatment Period|Disease Relapse|28|||
125008261|NCT02577406|449657623|FG001|Treatment Period|Disease Relapse|1|||
125008262|NCT02577406|449657622|FG000|Treatment Period|Protocol Violation|0|||
125008263|NCT02577406|449657623|FG001|Treatment Period|Protocol Violation|1|||
125008264|NCT02577406|449657622|FG000|Treatment Period|Other Reasons|3|||
125008265|NCT02577406|449657623|FG001|Treatment Period|Other Reasons|39|||
125096415|NCT00361504|449972802|FG000|Overall Study|Study medication non compliant|42|||
125096416|NCT00361504|449972803|FG001|Overall Study|Study medication non compliant|15|||
125096417|NCT00361504|449972802|FG000|Overall Study|All other|28|||
125096418|NCT00361504|449972803|FG001|Overall Study|All other|3|||
125096419|NCT01374516|449972806|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
125096420|NCT01374516|449972807|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
125096421|NCT01374516|449972806|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
125096422|NCT01374516|449972807|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
125008266|NCT02577406|449657622|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
125008267|NCT02577406|449657623|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
125008268|NCT04033445|449657624|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
125008269|NCT04033445|449657625|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
125008270|NCT04033445|449657626|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
125008271|NCT04033445|449657627|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
125008272|NCT04033445|449657628|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
125008273|NCT04033445|449657629|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
125008274|NCT04033445|449657630|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
125008275|NCT04033445|449657631|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
125008276|NCT04033445|449657632|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
125008277|NCT04033445|449657633|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
125008278|NCT04033445|449657634|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
125096423|NCT01374516|449972806|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
125008279|NCT04033445|449657635|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
125096424|NCT01374516|449972807|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
125096425|NCT01374516|449972806|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
125096426|NCT01374516|449972807|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
125096427|NCT01374516|449972806|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
125096428|NCT01374516|449972807|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
125096429|NCT01374516|449972806|FG000|Surveillance Expansion Period|Protocol Violation|386|||
125096430|NCT01374516|449972807|FG001|Surveillance Expansion Period|Protocol Violation|217|||
125096431|NCT01374516|449972806|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
125096432|NCT01374516|449972807|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
125096433|NCT01374516|449972806|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
125096434|NCT01374516|449972807|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
125096435|NCT01374516|449972806|FG000|Surveillance Expansion Period|Serious adverse event|20|||
125096436|NCT01374516|449972807|FG001|Surveillance Expansion Period|Serious adverse event|5|||
125096437|NCT03219372|449972808|FG000|Overall Study|Withdrawal by Subject|1|||
125096438|NCT03219372|449972809|FG001|Overall Study|Withdrawal by Subject|0|||
125096439|NCT00450814|449972810|FG000|Overall Study|Failed to complete the initial therapy|0|||
125096440|NCT00450814|449972811|FG001|Overall Study|Failed to complete the initial therapy|0|||
125096441|NCT00450814|449972812|FG002|Overall Study|Failed to complete the initial therapy|0|||
125096442|NCT00450814|449972813|FG003|Overall Study|Failed to complete the initial therapy|1|||
125096443|NCT00450814|449972814|FG004|Overall Study|Failed to complete the initial therapy|1|||
125096444|NCT00450814|449972815|FG005|Overall Study|Failed to complete the initial therapy|1|||
125096445|NCT00450814|449972816|FG006|Overall Study|Failed to complete the initial therapy|0|||
125096446|NCT00450814|449972817|FG007|Overall Study|Failed to complete the initial therapy|0|||
125096447|NCT00450814|449972818|FG008|Overall Study|Failed to complete the initial therapy|0|||
125096448|NCT00450814|449972819|FG009|Overall Study|Failed to complete the initial therapy|0|||
125096449|NCT00450814|449972820|FG010|Overall Study|Failed to complete the initial therapy|0|||
125096450|NCT00450814|449972810|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
125096451|NCT00450814|449972811|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
125096452|NCT00450814|449972812|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
125096453|NCT00450814|449972813|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
125096454|NCT00450814|449972814|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
125096455|NCT00450814|449972815|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
125096456|NCT00450814|449972816|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
125096457|NCT00450814|449972817|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
125096458|NCT00450814|449972818|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
125096459|NCT00450814|449972819|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
125096460|NCT00450814|449972820|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
125096461|NCT00401726|449972821|FG000|Overall Study|Adverse Event|34|||
125096462|NCT00401726|449972822|FG001|Overall Study|Adverse Event|45|||
125096463|NCT00401726|449972821|FG000|Overall Study|Death|0|||
125096464|NCT00401726|449972822|FG001|Overall Study|Death|3|||
125096465|NCT00401726|449972821|FG000|Overall Study|Sponsor Request|0|||
125096466|NCT00401726|449972822|FG001|Overall Study|Sponsor Request|1|||
125096467|NCT00401726|449972821|FG000|Overall Study|Physician Decision|3|||
125096468|NCT00401726|449972822|FG001|Overall Study|Physician Decision|6|||
125096469|NCT00401726|449972821|FG000|Overall Study|Lost to Follow-up|23|||
125096470|NCT00401726|449972822|FG001|Overall Study|Lost to Follow-up|20|||
125096471|NCT00401726|449972821|FG000|Overall Study|Protocol Violation|6|||
125096472|NCT00401726|449972822|FG001|Overall Study|Protocol Violation|3|||
125096473|NCT00401726|449972821|FG000|Overall Study|Withdrawal by Subject|18|||
125096474|NCT00401726|449972822|FG001|Overall Study|Withdrawal by Subject|24|||
125096475|NCT00401726|449972821|FG000|Overall Study|Lack of Efficacy|4|||
125096476|NCT00401726|449972822|FG001|Overall Study|Lack of Efficacy|6|||
125096477|NCT00401726|449972821|FG000|Overall Study|Protocol Deviation|9|||
125096478|NCT00401726|449972822|FG001|Overall Study|Protocol Deviation|4|||
125096479|NCT02067728|449972823|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
125096480|NCT02067728|449972824|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
125096481|NCT02067728|449972823|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
125096482|NCT02067728|449972824|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
125096483|NCT02067728|449972823|FG000|6 Month Measurements|Unable to attend|114|||
125096484|NCT02067728|449972824|FG001|6 Month Measurements|Unable to attend|97|||
125096485|NCT03732534|449972828|FG000|Overall Study|Study terminated by Sponsor|6|||
125008280|NCT04033445|449657636|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
125008281|NCT04033445|449657637|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
125008282|NCT04033445|449657624|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125008283|NCT04033445|449657625|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125008284|NCT04033445|449657626|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125008285|NCT04033445|449657627|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125008286|NCT04033445|449657628|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125008287|NCT04033445|449657629|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
125008288|NCT04033445|449657630|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
125008289|NCT04033445|449657631|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125008290|NCT04033445|449657632|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125096486|NCT00814502|449972829|FG000|Overall Study|Adverse Event|1|||
125096487|NCT00814502|449972830|FG001|Overall Study|Adverse Event|0|||
125096488|NCT00814502|449972829|FG000|Overall Study|Withdrawal by Subject|0|||
125096489|NCT00814502|449972830|FG001|Overall Study|Withdrawal by Subject|2|||
125096490|NCT03735849|449972835|FG000|Overall Study|Lost to Follow-up|1|||
125096491|NCT03735849|449972836|FG001|Overall Study|Lost to Follow-up|0|||
125096492|NCT03735849|449972837|FG002|Overall Study|Lost to Follow-up|0|||
125096493|NCT03735849|449972835|FG000|Overall Study|Participant unable to adhere to visit|1|||
125096494|NCT03735849|449972836|FG001|Overall Study|Participant unable to adhere to visit|0|||
125096495|NCT03735849|449972837|FG002|Overall Study|Participant unable to adhere to visit|0|||
125096496|NCT03735849|449972835|FG000|Overall Study|Not Randomized|0|||
125096497|NCT03735849|449972836|FG001|Overall Study|Not Randomized|0|||
125096498|NCT03735849|449972837|FG002|Overall Study|Not Randomized|4|||
125096499|NCT01050998|449972839|FG000|Overall Study|Adverse Event|1|||
125096500|NCT01050998|449972840|FG001|Overall Study|Adverse Event|0|||
125096501|NCT01050998|449972841|FG002|Overall Study|Adverse Event|1|||
125096502|NCT01050998|449972842|FG003|Overall Study|Adverse Event|0|||
125096503|NCT01050998|449972843|FG004|Overall Study|Adverse Event|2|||
125096504|NCT01050998|449972839|FG000|Overall Study|Withdrawal by Subject|0|||
125096505|NCT01050998|449972840|FG001|Overall Study|Withdrawal by Subject|0|||
125096506|NCT01050998|449972841|FG002|Overall Study|Withdrawal by Subject|0|||
125096507|NCT01050998|449972842|FG003|Overall Study|Withdrawal by Subject|1|||
125096508|NCT01050998|449972843|FG004|Overall Study|Withdrawal by Subject|3|||
125096509|NCT01050998|449972839|FG000|Overall Study|Other|3|||
125096510|NCT01050998|449972840|FG001|Overall Study|Other|2|||
125096511|NCT01050998|449972841|FG002|Overall Study|Other|1|||
125096512|NCT01050998|449972842|FG003|Overall Study|Other|1|||
125096513|NCT01050998|449972843|FG004|Overall Study|Other|5|||
125096514|NCT01050998|449972839|FG000|Overall Study|Data integrity issues|0|||
125096515|NCT01050998|449972840|FG001|Overall Study|Data integrity issues|0|||
125096516|NCT01050998|449972841|FG002|Overall Study|Data integrity issues|1|||
125096517|NCT01050998|449972842|FG003|Overall Study|Data integrity issues|1|||
125096518|NCT01050998|449972843|FG004|Overall Study|Data integrity issues|4|||
125096519|NCT02304484|449972851|FG000|Overall Study|Death|9|||
125096520|NCT02304484|449972851|FG000|Overall Study|Withdrawal by Subject|14|||
125096521|NCT02304484|449972851|FG000|Overall Study|Lost to Follow-up|2|||
125096522|NCT02967055|449972852|FG000|Overall Study|Excluded|40|||
125096523|NCT02967055|449972852|FG000|Overall Study|Screen fail|3|||
125096524|NCT02967055|449972852|FG000|Overall Study|Lost to Follow-up|2|||
125096525|NCT02967055|449972852|FG000|Overall Study|Stopped due to side effects|3|||
125096526|NCT02967055|449972852|FG000|Overall Study|Stopped due to drug cost|1|||
125096527|NCT00145795|449972853|FG000|Overall Study|Adverse Event|1|||
125096528|NCT00145795|449972854|FG001|Overall Study|Adverse Event|0|||
125096529|NCT00976989|449972855|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
125096530|NCT00976989|449972856|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
125096531|NCT00976989|449972857|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
125096532|NCT00976989|449972855|FG000|Overall Study|Death|5|||
125096533|NCT00976989|449972856|FG001|Overall Study|Death|7|||
125096534|NCT00976989|449972857|FG002|Overall Study|Death|10|||
125096535|NCT00976989|449972855|FG000|Overall Study|Refused Treatment|4|||
125096536|NCT00976989|449972856|FG001|Overall Study|Refused Treatment|3|||
125096537|NCT00976989|449972857|FG002|Overall Study|Refused Treatment|5|||
125096538|NCT00976989|449972855|FG000|Overall Study|Failure to Return|2|||
125096539|NCT00976989|449972856|FG001|Overall Study|Failure to Return|1|||
125096540|NCT00976989|449972857|FG002|Overall Study|Failure to Return|0|||
125008291|NCT04033445|449657633|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125008292|NCT04033445|449657634|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125008293|NCT04033445|449657635|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125008294|NCT04033445|449657636|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125008295|NCT04033445|449657637|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125008296|NCT04033445|449657624|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
125008297|NCT04033445|449657625|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125008298|NCT04033445|449657626|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125008299|NCT04033445|449657627|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125008300|NCT04033445|449657628|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125008301|NCT04033445|449657629|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125008302|NCT04033445|449657630|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
125008303|NCT04033445|449657631|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125008304|NCT04033445|449657632|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125008305|NCT04033445|449657633|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125096541|NCT00976989|449972855|FG000|Overall Study|Recurrence of Disease|0|||
125096542|NCT00976989|449972856|FG001|Overall Study|Recurrence of Disease|1|||
125096543|NCT00976989|449972857|FG002|Overall Study|Recurrence of Disease|0|||
125096544|NCT00976989|449972855|FG000|Overall Study|Other|1|||
125096545|NCT00976989|449972856|FG001|Overall Study|Other|0|||
125096546|NCT00976989|449972857|FG002|Overall Study|Other|1|||
125096547|NCT00570492|449972858|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
125096548|NCT00570492|449972859|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
125096549|NCT00570492|449972860|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
125096550|NCT00570492|449972858|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
125096551|NCT00570492|449972859|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
125096552|NCT00570492|449972860|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
125096553|NCT00570492|449972858|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
125096554|NCT00570492|449972859|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
125096555|NCT00570492|449972860|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
125096556|NCT00570492|449972858|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
125096557|NCT00570492|449972859|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
125096558|NCT00570492|449972860|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
125096559|NCT00570492|449972858|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
125096560|NCT00570492|449972859|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
125096561|NCT00570492|449972860|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
125096562|NCT00570492|449972858|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
125096563|NCT00570492|449972859|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
125096564|NCT00570492|449972860|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
125096565|NCT00570492|449972858|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
125096566|NCT00570492|449972859|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
125096567|NCT00570492|449972860|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
125096568|NCT00570492|449972858|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
125096569|NCT00570492|449972859|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
125096570|NCT00570492|449972860|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
125096571|NCT00570492|449972858|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
125096572|NCT00570492|449972859|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
125096573|NCT00570492|449972860|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
125096574|NCT00570492|449972858|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
125096575|NCT00570492|449972859|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
125096576|NCT00570492|449972860|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
125096577|NCT00570492|449972858|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
125096578|NCT00570492|449972859|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
125096579|NCT00570492|449972860|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
125096580|NCT00570492|449972858|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
125096581|NCT00570492|449972859|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
125096582|NCT00570492|449972860|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
125096583|NCT00570492|449972858|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
125096584|NCT00570492|449972859|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
125096585|NCT00570492|449972860|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
125096586|NCT00570492|449972858|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
125096587|NCT00570492|449972859|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
125096588|NCT00570492|449972860|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
125096589|NCT03958045|449972861|FG000|Overall Study|Withdrawal by Subject|1|||
125096590|NCT02283411|449972862|FG000|Overall Study|Withdrawal by Subject|3|||
125096591|NCT02283411|449972862|FG000|Overall Study|Screen Failed|28|||
125096592|NCT02500732|449972864|FG000|Overall Study|Physician Decision|0|||
125096593|NCT02500732|449972865|FG001|Overall Study|Physician Decision|1|||
125096594|NCT04409262|449972866|FG000|Overall Study|Adverse Event|0|||
125096595|NCT04409262|449972867|FG001|Overall Study|Adverse Event|2|||
125096596|NCT04409262|449972866|FG000|Overall Study|Death|55|||
125096597|NCT04409262|449972867|FG001|Overall Study|Death|97|||
125096598|NCT04409262|449972866|FG000|Overall Study|Lost to Follow-up|12|||
125096599|NCT04409262|449972867|FG001|Overall Study|Lost to Follow-up|23|||
125096600|NCT04409262|449972866|FG000|Overall Study|Lack of Staff|0|||
125096601|NCT04409262|449972867|FG001|Overall Study|Lack of Staff|1|||
125096602|NCT04409262|449972866|FG000|Overall Study|Protocol Violation|3|||
125096603|NCT04409262|449972867|FG001|Overall Study|Protocol Violation|1|||
125096604|NCT04409262|449972866|FG000|Overall Study|Withdrawal by Subject|5|||
125096605|NCT04409262|449972867|FG001|Overall Study|Withdrawal by Subject|10|||
125096606|NCT03328325|449972868|FG000|Overall Study|Lost to Follow-up|4|||
125096607|NCT03328325|449972868|FG000|Overall Study|Physician Decision|1|||
125096608|NCT03328325|449972868|FG000|Overall Study|Withdrawal by Subject|3|||
125096609|NCT03328325|449972868|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
125096610|NCT03759340|449972870|FG000|Overall Study|Adverse Event|2|||
125096611|NCT03759340|449972870|FG000|Overall Study|Lost to Follow-up|1|||
125096612|NCT03759340|449972870|FG000|Overall Study|Withdrawal by Subject|15|||
125008306|NCT04033445|449657634|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125008307|NCT04033445|449657635|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125008308|NCT04033445|449657636|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125008309|NCT04033445|449657637|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125008310|NCT04033445|449657624|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125008311|NCT04033445|449657625|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125008312|NCT04033445|449657626|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125008313|NCT04033445|449657627|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125008314|NCT04033445|449657628|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125008315|NCT04033445|449657629|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
125008316|NCT04033445|449657630|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
125008317|NCT04033445|449657631|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125008318|NCT04033445|449657632|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125008319|NCT04033445|449657633|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125008320|NCT04033445|449657634|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125008321|NCT04033445|449657635|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125008322|NCT04033445|449657636|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125008323|NCT04033445|449657637|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125008324|NCT04033445|449657624|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125008325|NCT04033445|449657625|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125008326|NCT04033445|449657626|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125008327|NCT04033445|449657627|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125008328|NCT04033445|449657628|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125008329|NCT04033445|449657629|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125008330|NCT04033445|449657630|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
125008331|NCT04033445|449657631|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125008332|NCT04033445|449657632|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125008333|NCT04033445|449657633|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125008334|NCT04033445|449657634|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125008335|NCT04033445|449657635|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125008336|NCT04033445|449657636|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125008337|NCT04033445|449657637|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125008338|NCT04033445|449657624|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
125008339|NCT04033445|449657625|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
125008340|NCT04033445|449657626|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
125008341|NCT04033445|449657627|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
125008342|NCT04033445|449657628|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
125008343|NCT04033445|449657629|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
125008344|NCT04033445|449657630|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
125008345|NCT04033445|449657631|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
125008346|NCT04033445|449657632|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
125008347|NCT04033445|449657633|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
125008348|NCT04033445|449657634|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
125008349|NCT04033445|449657635|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
125008350|NCT04033445|449657636|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
125008351|NCT04033445|449657637|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
125008352|NCT04033445|449657624|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125008353|NCT04033445|449657625|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
125008354|NCT04033445|449657626|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125008355|NCT04033445|449657627|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125008356|NCT04033445|449657628|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125008357|NCT04033445|449657629|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
125096613|NCT03759340|449972870|FG000|Overall Study|Study Terminated by Sponsor|38|||
125096614|NCT00736840|449972871|FG000|Overall Study|Lost to Follow-up|13|||
125096615|NCT03289676|449972874|FG000|Overall Study|Withdrawal by Subject|2|||
125096616|NCT03289676|449972875|FG001|Overall Study|Withdrawal by Subject|0|||
125096617|NCT03289676|449972874|FG000|Overall Study|Protocol Violation|2|||
125096618|NCT03289676|449972875|FG001|Overall Study|Protocol Violation|0|||
125096619|NCT03289676|449972874|FG000|Overall Study|Lost to Follow-up|0|||
125096620|NCT03289676|449972875|FG001|Overall Study|Lost to Follow-up|1|||
125096621|NCT00422227|449972876|FG000|Overall Study|Adverse Event|3|||
125096622|NCT00422227|449972877|FG001|Overall Study|Adverse Event|8|||
125096623|NCT00422227|449972876|FG000|Overall Study|Lost to Follow-up|1|||
125096624|NCT00422227|449972877|FG001|Overall Study|Lost to Follow-up|3|||
125096625|NCT00422227|449972876|FG000|Overall Study|Withdrawal by Subject|0|||
125096626|NCT00422227|449972877|FG001|Overall Study|Withdrawal by Subject|4|||
125096627|NCT01396434|449972878|FG000|Overall Study|Lost to Follow-up|1|||
125096628|NCT01396434|449972879|FG001|Overall Study|Lost to Follow-up|0|||
125096629|NCT01396434|449972880|FG002|Overall Study|Lost to Follow-up|0|||
125096630|NCT01396434|449972878|FG000|Overall Study|Other|10|||
125096631|NCT01396434|449972879|FG001|Overall Study|Other|0|||
125096632|NCT01396434|449972880|FG002|Overall Study|Other|0|||
125096633|NCT00157157|449972881|FG000|Overall Study|Withdrawal by Subject|6|||
125096634|NCT00157157|449972881|FG000|Overall Study|Physician Decision|1|||
125096635|NCT00157157|449972881|FG000|Overall Study|Lost to Follow-up|1|||
125096636|NCT00157157|449972881|FG000|Overall Study|Enrolled in another study|1|||
125096637|NCT00157157|449972881|FG000|Overall Study|Met exclusion criteria|1|||
125096638|NCT00157157|449972881|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
125096639|NCT01018680|449974486|FG000|Overall Study|Adverse Event|23|||
125096640|NCT01018680|449974487|FG001|Overall Study|Adverse Event|40|||
125096641|NCT01018680|449974486|FG000|Overall Study|Withdrawal by Subject|10|||
125096642|NCT01018680|449974487|FG001|Overall Study|Withdrawal by Subject|10|||
125096643|NCT01018680|449974486|FG000|Overall Study|Protocol Violation|5|||
125096644|NCT01018680|449974487|FG001|Overall Study|Protocol Violation|8|||
125096645|NCT01018680|449974486|FG000|Overall Study|Sponsor Decision|6|||
125096646|NCT01018680|449974487|FG001|Overall Study|Sponsor Decision|7|||
125096647|NCT01018680|449974486|FG000|Overall Study|Lack of Efficacy|8|||
125096648|NCT01018680|449974487|FG001|Overall Study|Lack of Efficacy|2|||
125096649|NCT01018680|449974486|FG000|Overall Study|Lost to Follow-up|5|||
125096650|NCT01018680|449974487|FG001|Overall Study|Lost to Follow-up|3|||
125096651|NCT01018680|449974486|FG000|Overall Study|Entry Criteria Not Met|1|||
125096652|NCT01018680|449974487|FG001|Overall Study|Entry Criteria Not Met|4|||
125096653|NCT01018680|449974486|FG000|Overall Study|Physician Decision|3|||
125096654|NCT01018680|449974487|FG001|Overall Study|Physician Decision|1|||
125096655|NCT02383966|449974491|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
125096656|NCT02383966|449974492|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
125096657|NCT02383966|449974491|FG000|Overall Study|Randomized, but not treated|1|||
125096658|NCT02383966|449974492|FG001|Overall Study|Randomized, but not treated|3|||
125096659|NCT02163759|449974493|FG000|Overall Study|Withdrawal by Subject|1|||
125096660|NCT02163759|449974494|FG001|Overall Study|Withdrawal by Subject|5|||
125096661|NCT02163759|449974495|FG002|Overall Study|Withdrawal by Subject|1|||
125096662|NCT02163759|449974493|FG000|Overall Study|Adverse Event|0|||
125096663|NCT02163759|449974494|FG001|Overall Study|Adverse Event|0|||
125096664|NCT02163759|449974495|FG002|Overall Study|Adverse Event|1|||
125096665|NCT02163759|449974493|FG000|Overall Study|Death|0|||
125096666|NCT02163759|449974494|FG001|Overall Study|Death|0|||
125096667|NCT02163759|449974495|FG002|Overall Study|Death|1|||
125096668|NCT00219349|449974507|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
125096669|NCT00219349|449974507|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
125096670|NCT00219349|449974507|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
125096671|NCT00219349|449974507|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
125096672|NCT02777554|449974509|FG000|Overall Study|Adverse Event|4|||
125096673|NCT02777554|449974510|FG001|Overall Study|Adverse Event|4|||
125096674|NCT02777554|449974511|FG002|Overall Study|Adverse Event|0|||
125096675|NCT02777554|449974512|FG003|Overall Study|Adverse Event|1|||
125096676|NCT02777554|449974513|FG004|Overall Study|Adverse Event|0|||
125096677|NCT02777554|449974514|FG005|Overall Study|Adverse Event|0|||
125096678|NCT02777554|449974509|FG000|Overall Study|Withdrawal by Subject|3|||
125096679|NCT02777554|449974510|FG001|Overall Study|Withdrawal by Subject|1|||
125096680|NCT02777554|449974511|FG002|Overall Study|Withdrawal by Subject|1|||
125096681|NCT02777554|449974512|FG003|Overall Study|Withdrawal by Subject|0|||
125096682|NCT02777554|449974513|FG004|Overall Study|Withdrawal by Subject|0|||
125096683|NCT02777554|449974514|FG005|Overall Study|Withdrawal by Subject|0|||
125096684|NCT02777554|449974509|FG000|Overall Study|Discharged early due to hurricane|22|||
125096685|NCT02777554|449974510|FG001|Overall Study|Discharged early due to hurricane|20|||
125096686|NCT02777554|449974511|FG002|Overall Study|Discharged early due to hurricane|0|||
125096687|NCT02777554|449974512|FG003|Overall Study|Discharged early due to hurricane|0|||
125096688|NCT02777554|449974513|FG004|Overall Study|Discharged early due to hurricane|0|||
125008358|NCT04033445|449657630|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125008359|NCT04033445|449657631|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125008360|NCT04033445|449657632|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125008361|NCT04033445|449657633|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125008362|NCT04033445|449657634|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125008363|NCT04033445|449657635|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125008364|NCT04033445|449657636|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125008365|NCT04033445|449657637|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125008366|NCT04033445|449657624|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
125008367|NCT04033445|449657625|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125008368|NCT04033445|449657626|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125008369|NCT04033445|449657627|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125008370|NCT04033445|449657628|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125008371|NCT04033445|449657629|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
125008372|NCT04033445|449657630|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125008373|NCT04033445|449657631|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125008374|NCT04033445|449657632|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125008375|NCT04033445|449657633|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125096689|NCT02777554|449974514|FG005|Overall Study|Discharged early due to hurricane|0|||
125096690|NCT02777554|449974509|FG000|Overall Study|Other - Miscellaneous|1|||
125008376|NCT04033445|449657634|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125008377|NCT04033445|449657635|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125008378|NCT04033445|449657636|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125008379|NCT04033445|449657637|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125008380|NCT04033445|449657624|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
125008381|NCT04033445|449657625|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
125008382|NCT04033445|449657626|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
125008383|NCT04033445|449657627|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
125008384|NCT04033445|449657628|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
125008385|NCT04033445|449657629|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
125008386|NCT04033445|449657630|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
125008387|NCT04033445|449657631|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
125008388|NCT04033445|449657632|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
125008389|NCT04033445|449657633|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
125008390|NCT04033445|449657634|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
125008391|NCT04033445|449657635|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
125008392|NCT04033445|449657636|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
125008393|NCT04033445|449657637|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
125008394|NCT04033445|449657624|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125008395|NCT04033445|449657625|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125008396|NCT04033445|449657626|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125008397|NCT04033445|449657627|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125008398|NCT04033445|449657628|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125008399|NCT04033445|449657629|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125008400|NCT04033445|449657630|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125008401|NCT04033445|449657631|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
125008402|NCT04033445|449657632|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
125008403|NCT04033445|449657633|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125008404|NCT04033445|449657634|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125008405|NCT04033445|449657635|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125008406|NCT04033445|449657636|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125008407|NCT04033445|449657637|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125008408|NCT04033445|449657624|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125008409|NCT04033445|449657625|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125008410|NCT04033445|449657626|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125008411|NCT04033445|449657627|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125008412|NCT04033445|449657628|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125008413|NCT04033445|449657629|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125008414|NCT04033445|449657630|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125008415|NCT04033445|449657631|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125008416|NCT04033445|449657632|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
125008417|NCT04033445|449657633|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125008418|NCT04033445|449657634|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125008419|NCT04033445|449657635|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125008420|NCT04033445|449657636|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125008421|NCT04033445|449657637|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125008422|NCT04033445|449657624|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125008423|NCT04033445|449657625|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125008424|NCT04033445|449657626|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125008425|NCT04033445|449657627|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
125008426|NCT04033445|449657628|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125096691|NCT02777554|449974510|FG001|Overall Study|Other - Miscellaneous|0|||
125008427|NCT04033445|449657629|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125096692|NCT02777554|449974511|FG002|Overall Study|Other - Miscellaneous|0|||
125096693|NCT02777554|449974512|FG003|Overall Study|Other - Miscellaneous|0|||
125096694|NCT02777554|449974513|FG004|Overall Study|Other - Miscellaneous|0|||
125096695|NCT02777554|449974514|FG005|Overall Study|Other - Miscellaneous|0|||
125096696|NCT00270205|449974515|FG000|Overall Study|Lost to Follow-up|1|||
125096697|NCT00270205|449974516|FG001|Overall Study|Lost to Follow-up|0|||
125096698|NCT00270205|449974517|FG002|Overall Study|Lost to Follow-up|0|||
125096699|NCT00270205|449974518|FG003|Overall Study|Lost to Follow-up|1|||
125096700|NCT00869362|449974519|FG000|Overall Study|Death|0|||
125096701|NCT00869362|449974520|FG001|Overall Study|Death|2|||
125096702|NCT00869362|449974519|FG000|Overall Study|Lost to Follow-up|1|||
125096703|NCT00869362|449974520|FG001|Overall Study|Lost to Follow-up|3|||
125096704|NCT01945034|449974521|FG000|Overall Study|Medication Error|0|||
125096705|NCT01945034|449974522|FG001|Overall Study|Medication Error|1|||
125096706|NCT01945034|449974523|FG002|Overall Study|Medication Error|0|||
125096707|NCT01945034|449974521|FG000|Overall Study|Withdrawal by Subject|0|||
125096708|NCT01945034|449974522|FG001|Overall Study|Withdrawal by Subject|3|||
125096709|NCT01945034|449974523|FG002|Overall Study|Withdrawal by Subject|1|||
125096710|NCT01945034|449974521|FG000|Overall Study|Other|0|||
125008428|NCT04033445|449657630|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125008429|NCT04033445|449657631|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125008430|NCT04033445|449657632|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125008431|NCT04033445|449657633|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125008432|NCT04033445|449657634|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125008433|NCT04033445|449657635|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125008434|NCT04033445|449657636|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125008435|NCT04033445|449657637|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125008436|NCT04033445|449657624|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125008437|NCT04033445|449657625|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125008438|NCT04033445|449657626|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125008439|NCT04033445|449657627|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125008440|NCT04033445|449657628|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125008441|NCT04033445|449657629|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125008442|NCT04033445|449657630|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125008443|NCT04033445|449657631|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
125008444|NCT04033445|449657632|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
125008445|NCT04033445|449657633|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125008446|NCT04033445|449657634|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125096711|NCT01945034|449974522|FG001|Overall Study|Other|1|||
125096712|NCT01945034|449974523|FG002|Overall Study|Other|3|||
125096713|NCT01945034|449974521|FG000|Overall Study|Lost to Follow-up|0|||
125096714|NCT01945034|449974522|FG001|Overall Study|Lost to Follow-up|0|||
125096715|NCT01945034|449974523|FG002|Overall Study|Lost to Follow-up|2|||
125096716|NCT01945034|449974521|FG000|Overall Study|Protocol Violation|1|||
125096717|NCT01945034|449974522|FG001|Overall Study|Protocol Violation|0|||
125096718|NCT01945034|449974523|FG002|Overall Study|Protocol Violation|1|||
125096719|NCT03053102|449974524|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
125096720|NCT03053102|449974524|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
125096721|NCT03323034|449974526|FG000|Overall Study|Lack of Efficacy|5|||
125096722|NCT03323034|449974527|FG001|Overall Study|Lack of Efficacy|5|||
125096723|NCT03323034|449974528|FG002|Overall Study|Lack of Efficacy|6|||
125096724|NCT03323034|449974529|FG003|Overall Study|Lack of Efficacy|5|||
125096725|NCT03323034|449974530|FG004|Overall Study|Lack of Efficacy|5|||
125096726|NCT03323034|449974526|FG000|Overall Study|Physician Decision|0|||
125096727|NCT03323034|449974527|FG001|Overall Study|Physician Decision|0|||
125096728|NCT03323034|449974528|FG002|Overall Study|Physician Decision|0|||
125096729|NCT03323034|449974529|FG003|Overall Study|Physician Decision|0|||
125096730|NCT03323034|449974530|FG004|Overall Study|Physician Decision|1|||
125096731|NCT03323034|449974526|FG000|Overall Study|Withdrawal by Subject|1|||
125096732|NCT03323034|449974527|FG001|Overall Study|Withdrawal by Subject|1|||
125096733|NCT03323034|449974528|FG002|Overall Study|Withdrawal by Subject|0|||
125096734|NCT03323034|449974529|FG003|Overall Study|Withdrawal by Subject|1|||
125096735|NCT03323034|449974530|FG004|Overall Study|Withdrawal by Subject|0|||
125096736|NCT02660489|449974531|FG000|Overall Study|Lost to Follow-up|1|||
125096737|NCT02660489|449974532|FG001|Overall Study|Lost to Follow-up|1|||
125096738|NCT02660489|449974531|FG000|Overall Study|Adverse Event|1|||
125096739|NCT02660489|449974532|FG001|Overall Study|Adverse Event|3|||
125096740|NCT02660489|449974531|FG000|Overall Study|no rhinovirus infection|4|||
125096741|NCT02660489|449974532|FG001|Overall Study|no rhinovirus infection|4|||
125096742|NCT04887922|449974533|FG000|1st Randomization|Decided not to have surgery|0|||
125096743|NCT04887922|449974534|FG001|1st Randomization|Decided not to have surgery|1|||
125096744|NCT04887922|449974535|FG002|1st Randomization|Decided not to have surgery|0|||
125096745|NCT04887922|449974536|FG003|1st Randomization|Decided not to have surgery|0|||
125096746|NCT04887922|449974537|FG004|1st Randomization|Decided not to have surgery|0|||
125096747|NCT00718809|449974538|FG000|Overall Study|Disease progression|9|||
125096748|NCT00718809|449974539|FG001|Overall Study|Disease progression|7|||
125096749|NCT00718809|449974538|FG000|Overall Study|Adverse Event|1|||
125096750|NCT00718809|449974539|FG001|Overall Study|Adverse Event|1|||
125096751|NCT00718809|449974538|FG000|Overall Study|Withdrawal by Subject|0|||
125096752|NCT00718809|449974539|FG001|Overall Study|Withdrawal by Subject|1|||
125096753|NCT00718809|449974538|FG000|Overall Study|Lost to Follow-up|1|||
125096754|NCT00718809|449974539|FG001|Overall Study|Lost to Follow-up|0|||
125096755|NCT00718809|449974538|FG000|Overall Study|Noncompliance|1|||
125096756|NCT00718809|449974539|FG001|Overall Study|Noncompliance|0|||
125008447|NCT04033445|449657635|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125096757|NCT00463385|449974540|FG000|Overall Study|Other|4|||
125096758|NCT00463385|449974541|FG001|Overall Study|Other|3|||
125096759|NCT00463385|449974542|FG002|Overall Study|Other|6|||
125096760|NCT00463385|449974543|FG003|Overall Study|Other|4|||
125096761|NCT00463385|449974540|FG000|Overall Study|Adverse Event|5|||
125096762|NCT00463385|449974541|FG001|Overall Study|Adverse Event|8|||
125096763|NCT00463385|449974542|FG002|Overall Study|Adverse Event|4|||
125096764|NCT00463385|449974543|FG003|Overall Study|Adverse Event|2|||
125096765|NCT00463385|449974540|FG000|Overall Study|Lack of Efficacy|6|||
125008448|NCT04033445|449657636|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125008449|NCT04033445|449657637|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125008450|NCT04033445|449657624|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125008451|NCT04033445|449657625|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125008452|NCT04033445|449657626|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125008453|NCT04033445|449657627|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125008454|NCT04033445|449657628|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125008455|NCT04033445|449657629|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125008456|NCT04033445|449657630|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125008457|NCT04033445|449657631|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
125008458|NCT04033445|449657632|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125008459|NCT04033445|449657633|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125008460|NCT04033445|449657634|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125008461|NCT04033445|449657635|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125008462|NCT04033445|449657636|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125008463|NCT04033445|449657637|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125008464|NCT04033445|449657624|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125008465|NCT04033445|449657625|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125008466|NCT04033445|449657626|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125008467|NCT04033445|449657627|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125008468|NCT04033445|449657628|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125008469|NCT04033445|449657629|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125008470|NCT04033445|449657630|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125008471|NCT04033445|449657631|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
125008472|NCT04033445|449657632|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125008473|NCT04033445|449657633|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125008474|NCT04033445|449657634|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125008475|NCT04033445|449657635|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125008476|NCT04033445|449657636|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125008477|NCT04033445|449657637|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125008478|NCT04033445|449657624|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
125008479|NCT04033445|449657625|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
125008480|NCT04033445|449657626|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
125008481|NCT04033445|449657627|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
125008482|NCT04033445|449657628|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
125008483|NCT04033445|449657629|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
125008484|NCT04033445|449657630|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
125008485|NCT04033445|449657631|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
125008486|NCT04033445|449657632|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
125008487|NCT04033445|449657633|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
125008488|NCT04033445|449657634|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
125096766|NCT00463385|449974541|FG001|Overall Study|Lack of Efficacy|6|||
125096767|NCT00463385|449974542|FG002|Overall Study|Lack of Efficacy|7|||
125096768|NCT00463385|449974543|FG003|Overall Study|Lack of Efficacy|9|||
125096769|NCT00463385|449974540|FG000|Overall Study|Withdrawal by Subject|3|||
125008489|NCT04033445|449657635|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
125008490|NCT04033445|449657636|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
125008491|NCT04033445|449657637|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
125008492|NCT04033445|449657624|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
125008493|NCT04033445|449657625|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
125008494|NCT04033445|449657626|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
125008495|NCT04033445|449657627|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
125008496|NCT04033445|449657628|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
125008497|NCT04033445|449657629|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
125008498|NCT04033445|449657630|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
125008499|NCT04033445|449657631|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
125008500|NCT04033445|449657632|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
125008501|NCT04033445|449657633|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
125008502|NCT04033445|449657634|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
125008503|NCT04033445|449657635|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
125008504|NCT04033445|449657636|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
125008505|NCT04033445|449657637|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
125008506|NCT04033445|449657624|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125008507|NCT04033445|449657625|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125008508|NCT04033445|449657626|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125008509|NCT04033445|449657627|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125008510|NCT04033445|449657628|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125008511|NCT04033445|449657629|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125008512|NCT04033445|449657630|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125008513|NCT04033445|449657631|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125008514|NCT04033445|449657632|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125008515|NCT04033445|449657633|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125008516|NCT04033445|449657634|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
125008517|NCT04033445|449657635|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
125008518|NCT04033445|449657636|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125008519|NCT04033445|449657637|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
125008520|NCT04033445|449657624|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
125008521|NCT04033445|449657625|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
125008522|NCT04033445|449657626|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
125008523|NCT04033445|449657627|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
125008524|NCT04033445|449657628|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
125008525|NCT04033445|449657629|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
125008526|NCT04033445|449657630|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
125008527|NCT04033445|449657631|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
125008528|NCT04033445|449657632|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
125008529|NCT04033445|449657633|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
125008530|NCT04033445|449657634|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
125008531|NCT04033445|449657635|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
125008532|NCT04033445|449657636|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
125008533|NCT04033445|449657637|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
125008534|NCT04033445|449657624|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
125008535|NCT04033445|449657625|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
125008536|NCT04033445|449657626|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
125008537|NCT04033445|449657627|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
125008538|NCT04033445|449657628|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
125008539|NCT04033445|449657629|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
125008540|NCT04033445|449657630|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
125008541|NCT04033445|449657631|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
125008542|NCT04033445|449657632|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
125008543|NCT04033445|449657633|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
125008544|NCT04033445|449657634|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
125008545|NCT04033445|449657635|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
125008546|NCT04033445|449657636|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
125008547|NCT04033445|449657637|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
125008548|NCT04033445|449657624|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125008549|NCT04033445|449657625|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125008550|NCT04033445|449657626|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125096770|NCT00463385|449974541|FG001|Overall Study|Withdrawal by Subject|3|||
125008551|NCT04033445|449657627|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125008552|NCT04033445|449657628|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125008553|NCT04033445|449657629|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125008554|NCT04033445|449657630|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125008555|NCT04033445|449657631|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125008556|NCT04033445|449657632|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125008557|NCT04033445|449657633|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125008558|NCT04033445|449657634|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125008559|NCT04033445|449657635|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125008560|NCT04033445|449657636|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125008561|NCT04033445|449657637|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
125008562|NCT04033445|449657624|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
125008563|NCT04033445|449657625|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
125008564|NCT04033445|449657626|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
125008565|NCT04033445|449657627|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
125008566|NCT04033445|449657628|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
125008567|NCT04033445|449657629|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
125008568|NCT04033445|449657630|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
125008569|NCT04033445|449657631|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
125008570|NCT04033445|449657632|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
125008571|NCT04033445|449657633|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
125008572|NCT04033445|449657634|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
125008573|NCT04033445|449657635|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
125008574|NCT04033445|449657636|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
125008575|NCT04033445|449657637|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
125008576|NCT04033445|449657624|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125008577|NCT04033445|449657625|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125008578|NCT04033445|449657626|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125008579|NCT04033445|449657627|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125008580|NCT04033445|449657628|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125008581|NCT04033445|449657629|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125008582|NCT04033445|449657630|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125008583|NCT04033445|449657631|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125008584|NCT04033445|449657632|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125008585|NCT04033445|449657633|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
125008586|NCT04033445|449657634|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125008587|NCT04033445|449657635|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
125008588|NCT04033445|449657636|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
125008589|NCT04033445|449657637|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125008590|NCT05500274|449657641|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
125008591|NCT05500274|449657642|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
125008592|NCT05500274|449657641|FG000|Overall Study|Lost to Follow-up|76|||
125008593|NCT05500274|449657642|FG001|Overall Study|Lost to Follow-up|51|||
125008594|NCT05807464|449657645|FG000|Overall Study|Adverse Event|1|||
125008595|NCT04754802|449657646|FG000|Overall Study|Lost to Follow-up|0|||
125008596|NCT04754802|449657647|FG001|Overall Study|Lost to Follow-up|2|||
125008597|NCT04754802|449657646|FG000|Overall Study|Withdrawal by Subject|2|||
125008598|NCT04754802|449657647|FG001|Overall Study|Withdrawal by Subject|0|||
125008599|NCT04451161|449657648|FG000|Overall Study|Lost to Follow-up|28|||
125008600|NCT04451161|449657649|FG001|Overall Study|Lost to Follow-up|37|||
125008601|NCT04451161|449657650|FG002|Overall Study|Lost to Follow-up|22|||
125008602|NCT04451161|449657651|FG003|Overall Study|Lost to Follow-up|13|||
125008603|NCT04451161|449657652|FG004|Overall Study|Lost to Follow-up|11|||
125008604|NCT04451161|449657653|FG005|Overall Study|Lost to Follow-up|14|||
125008605|NCT04451161|449657648|FG000|Overall Study|Withdrawal by Subject|3|||
125008606|NCT04451161|449657649|FG001|Overall Study|Withdrawal by Subject|0|||
125008607|NCT04451161|449657650|FG002|Overall Study|Withdrawal by Subject|0|||
125008608|NCT04451161|449657651|FG003|Overall Study|Withdrawal by Subject|0|||
125008609|NCT04451161|449657652|FG004|Overall Study|Withdrawal by Subject|2|||
125008610|NCT04451161|449657653|FG005|Overall Study|Withdrawal by Subject|4|||
125008611|NCT01555151|449657654|FG000|Overall Study|Withdrawal by Subject|6|||
125008612|NCT01555151|449657655|FG001|Overall Study|Withdrawal by Subject|2|||
125008613|NCT01555151|449657656|FG002|Overall Study|Withdrawal by Subject|0|||
125008614|NCT01555151|449657657|FG003|Overall Study|Withdrawal by Subject|2|||
125008615|NCT01555151|449657654|FG000|Overall Study|Administrative|3|||
125008616|NCT01555151|449657655|FG001|Overall Study|Administrative|1|||
125008617|NCT01555151|449657656|FG002|Overall Study|Administrative|2|||
125008618|NCT01555151|449657657|FG003|Overall Study|Administrative|0|||
125008619|NCT01555151|449657654|FG000|Overall Study|Protocol Violation|3|||
125008620|NCT01555151|449657655|FG001|Overall Study|Protocol Violation|3|||
125008621|NCT01555151|449657656|FG002|Overall Study|Protocol Violation|3|||
125008622|NCT01555151|449657657|FG003|Overall Study|Protocol Violation|5|||
125008623|NCT01555151|449657654|FG000|Overall Study|Adverse Event|1|||
125008624|NCT01555151|449657655|FG001|Overall Study|Adverse Event|2|||
125008625|NCT01555151|449657656|FG002|Overall Study|Adverse Event|1|||
125008626|NCT01555151|449657657|FG003|Overall Study|Adverse Event|2|||
125008627|NCT01555151|449657654|FG000|Overall Study|Lost to Follow-up|0|||
125008628|NCT01555151|449657655|FG001|Overall Study|Lost to Follow-up|0|||
125008629|NCT01555151|449657656|FG002|Overall Study|Lost to Follow-up|0|||
125008630|NCT01555151|449657657|FG003|Overall Study|Lost to Follow-up|1|||
125008631|NCT03596866|449657658|FG000|Overall Study|Site terminated by Sponsor|64|||
125008632|NCT03596866|449657659|FG001|Overall Study|Site terminated by Sponsor|65|||
125008633|NCT03596866|449657658|FG000|Overall Study|Death|37|||
125008634|NCT03596866|449657659|FG001|Overall Study|Death|24|||
125008635|NCT03596866|449657658|FG000|Overall Study|Withdrawal by Subject|4|||
125008636|NCT03596866|449657659|FG001|Overall Study|Withdrawal by Subject|6|||
125008637|NCT03596866|449657658|FG000|Overall Study|Missing|0|||
125008638|NCT03596866|449657659|FG001|Overall Study|Missing|6|||
125008639|NCT03596866|449657658|FG000|Overall Study|Lost to Follow-up|2|||
125008640|NCT03596866|449657659|FG001|Overall Study|Lost to Follow-up|3|||
125008641|NCT03596866|449657658|FG000|Overall Study|Protocol Violation|1|||
125008642|NCT03596866|449657659|FG001|Overall Study|Protocol Violation|0|||
125008643|NCT03596866|449657658|FG000|Overall Study|Reason Not Specified|14|||
125008644|NCT03596866|449657659|FG001|Overall Study|Reason Not Specified|13|||
125008645|NCT05525689|449657660|FG000|Overall Study|Lost to Follow-up|1|||
125008646|NCT05525689|449657661|FG001|Overall Study|Lost to Follow-up|0|||
125008647|NCT01671111|449657662|FG000|Overall Study|Adverse Event|2|||
125008648|NCT01671111|449657662|FG000|Overall Study|Lack of Efficacy|1|||
125008649|NCT01671111|449657662|FG000|Overall Study|Withdrawal by Subject|2|||
125008650|NCT01671111|449657662|FG000|Overall Study|Physician Decision|1|||
125008651|NCT01671111|449657662|FG000|Overall Study|Other|24|||
125008652|NCT03680911|449657663|FG000|At Home Treatment|Study Termination|3|||
125008653|NCT03680911|449657664|FG001|At Home Treatment|Study Termination|0|||
125008654|NCT03680911|449657663|FG000|At Home Treatment|Lost to Follow-up|0|||
125008655|NCT03680911|449657664|FG001|At Home Treatment|Lost to Follow-up|1|||
125008656|NCT03680911|449657663|FG000|At Home Treatment|Withdrawal by Subject|0|||
125008657|NCT03680911|449657664|FG001|At Home Treatment|Withdrawal by Subject|2|||
125008658|NCT03680911|449657663|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
125008659|NCT03680911|449657664|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
125008660|NCT04702737|449657673|FG000|Overall Study|Decision by Sponsor|1|||
125008661|NCT04702737|449657673|FG000|Overall Study|Withdrawal of Consent from Study|3|||
125008662|NCT04702737|449657673|FG000|Overall Study|Lost to Follow-up|1|||
125008663|NCT04702737|449657673|FG000|Overall Study|Death|35|||
125008664|NCT02811549|449657674|FG000|Overall Study|Lost to Follow-up|1|||
125008665|NCT02811549|449657674|FG000|Overall Study|Withdrawal by Subject|3|||
125008666|NCT02811549|449657674|FG000|Overall Study|Subject screen failed|4|||
125008667|NCT02811549|449657674|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
125008668|NCT03472924|449657676|FG000|Overall Study|Adverse Event|1|||
125008669|NCT03472924|449657677|FG001|Overall Study|Adverse Event|0|||
125008670|NCT01436084|449657678|FG000|Overall Study|Disease Progression|2|||
125008671|NCT01436084|449657678|FG000|Overall Study|Withdrawal by Subject|1|||
125008672|NCT01436084|449657678|FG000|Overall Study|Early Closure of Study|1|||
125008673|NCT04425720|449657684|FG000|Overall Study|Withdrawal by Subject|0|||
125008674|NCT04425720|449657685|FG001|Overall Study|Withdrawal by Subject|20|||
125008675|NCT00290186|449657686|FG000|Overall Study|Adverse Event|1|||
125008676|NCT00290186|449657687|FG001|Overall Study|Adverse Event|1|||
125008677|NCT00290186|449657686|FG000|Overall Study|Lost to Follow-up|3|||
125008678|NCT00290186|449657687|FG001|Overall Study|Lost to Follow-up|2|||
125008679|NCT00290186|449657686|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
125008680|NCT00290186|449657687|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
125008681|NCT00290186|449657686|FG000|Overall Study|Withdrawal by Subject|0|||
125008682|NCT00290186|449657687|FG001|Overall Study|Withdrawal by Subject|1|||
125008683|NCT00445224|449657688|FG000|Specific Exercises|Withdrawal by Subject|3|||
125008684|NCT00445224|449657689|FG001|Specific Exercises|Withdrawal by Subject|3|||
125008685|NCT00445224|449657688|FG000|Specific Exercises|Withdrawal by Subject|1|||
125008686|NCT00445224|449657689|FG001|Specific Exercises|Withdrawal by Subject|0|||
125008687|NCT03159091|449657699|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
125008688|NCT03159091|449657700|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
125008689|NCT03159091|449657699|FG000|Overall Study|Patient has taken no dose of study drug|0|||
125008690|NCT03159091|449657700|FG001|Overall Study|Patient has taken no dose of study drug|1|||
125008691|NCT00262522|449657701|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
125008692|NCT00262522|449657702|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
125008693|NCT00262522|449657703|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
125008694|NCT00262522|449657704|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
125008695|NCT00262522|449657701|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
125008696|NCT00262522|449657702|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
125008697|NCT00262522|449657703|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
125008698|NCT00262522|449657704|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
125008699|NCT00262522|449657701|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
125008700|NCT00262522|449657702|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
125008701|NCT00262522|449657703|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
125008702|NCT00262522|449657704|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
125008703|NCT00262522|449657701|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
125008704|NCT00262522|449657702|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
125008705|NCT00262522|449657703|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
125008706|NCT00262522|449657704|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
125008707|NCT00262522|449657701|FG000|Study Start Through 8 Weeks|Death|1|||
125008708|NCT00262522|449657702|FG001|Study Start Through 8 Weeks|Death|0|||
125008709|NCT00262522|449657703|FG002|Study Start Through 8 Weeks|Death|0|||
125096771|NCT00463385|449974542|FG002|Overall Study|Withdrawal by Subject|3|||
125096772|NCT00463385|449974543|FG003|Overall Study|Withdrawal by Subject|4|||
125096773|NCT00463385|449974540|FG000|Overall Study|Lost to Follow-up|0|||
125096774|NCT00463385|449974541|FG001|Overall Study|Lost to Follow-up|0|||
125096775|NCT00463385|449974542|FG002|Overall Study|Lost to Follow-up|0|||
125096776|NCT00463385|449974543|FG003|Overall Study|Lost to Follow-up|1|||
125096777|NCT00463385|449974540|FG000|Overall Study|Death|2|||
125096778|NCT00463385|449974541|FG001|Overall Study|Death|1|||
125096779|NCT00463385|449974542|FG002|Overall Study|Death|2|||
125096780|NCT00463385|449974543|FG003|Overall Study|Death|0|||
125096781|NCT00463385|449974540|FG000|Overall Study|Missing|2|||
125096782|NCT00463385|449974541|FG001|Overall Study|Missing|0|||
125096783|NCT00463385|449974542|FG002|Overall Study|Missing|0|||
125096784|NCT00463385|449974543|FG003|Overall Study|Missing|2|||
125096785|NCT00463385|449974540|FG000|Overall Study|1 participant received commercial drug|0|||
125096786|NCT00463385|449974541|FG001|Overall Study|1 participant received commercial drug|1|||
125096787|NCT00463385|449974542|FG002|Overall Study|1 participant received commercial drug|0|||
125096788|NCT00463385|449974543|FG003|Overall Study|1 participant received commercial drug|0|||
125096789|NCT00536991|449974546|FG000|Overall Study|Withdrawal by Subject|10|||
125096790|NCT00536991|449974546|FG000|Overall Study|Physician Decision|1|||
125096791|NCT00536991|449974546|FG000|Overall Study|patient ineligible|2|||
125096792|NCT01600755|449974547|FG000|Overall Study|Withdrawal by Subject|6|||
125096793|NCT00447265|449974552|FG000|Overall Study|Physician Decision|1|||
125096794|NCT00447265|449974553|FG001|Overall Study|Physician Decision|0|||
125096795|NCT02204449|449974554|FG000|Overall Study|Lost to Follow-up|7|||
125096796|NCT02204449|449974555|FG001|Overall Study|Lost to Follow-up|9|||
125096797|NCT02204449|449974554|FG000|Overall Study|Death|0|||
125096798|NCT02204449|449974555|FG001|Overall Study|Death|1|||
125096799|NCT02204449|449974554|FG000|Overall Study|Withdrawal by Subject|0|||
125096800|NCT02204449|449974555|FG001|Overall Study|Withdrawal by Subject|1|||
125096801|NCT00503035|449974556|FG000|Overall Study|Lost to Follow-up|2|||
125096802|NCT00503035|449974556|FG000|Overall Study|Physician Decision|3|||
125096803|NCT00503035|449974556|FG000|Overall Study|Ineligible|15|||
125096804|NCT03868410|449974557|FG000|Overall Study|Physician Decision|0|||
125096805|NCT03868410|449974558|FG001|Overall Study|Physician Decision|1|||
125096806|NCT01059175|449974559|FG000|Overall Study|Death|17|||
125096807|NCT01059175|449974560|FG001|Overall Study|Death|17|||
125096808|NCT01059175|449974559|FG000|Overall Study|Adverse Event|4|||
125096809|NCT01059175|449974560|FG001|Overall Study|Adverse Event|2|||
125096810|NCT01059175|449974559|FG000|Overall Study|Lost to Follow-up|0|||
125096811|NCT01059175|449974560|FG001|Overall Study|Lost to Follow-up|1|||
125096812|NCT00643006|449974562|FG000|Overall Study|Lost to Follow-up|5|||
125008710|NCT00262522|449657704|FG003|Study Start Through 8 Weeks|Death|0|||
125008711|NCT00262522|449657701|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
125008712|NCT00262522|449657702|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
125008713|NCT00262522|449657703|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
125008714|NCT00262522|449657704|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
125008715|NCT00262522|449657701|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
125008716|NCT00262522|449657702|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
125008717|NCT00262522|449657703|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
125008718|NCT00262522|449657704|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
125008719|NCT00262522|449657701|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
125008720|NCT00262522|449657702|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
125008721|NCT00262522|449657703|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
125008722|NCT00262522|449657704|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
125008723|NCT00262522|449657701|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
125008724|NCT00262522|449657702|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
125008725|NCT00262522|449657703|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
125008726|NCT00262522|449657704|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
125008727|NCT00262522|449657701|FG000|Study Start Through 48 Weeks|Death|2|||
125008728|NCT00262522|449657702|FG001|Study Start Through 48 Weeks|Death|0|||
125008729|NCT00262522|449657703|FG002|Study Start Through 48 Weeks|Death|1|||
125008730|NCT00262522|449657704|FG003|Study Start Through 48 Weeks|Death|0|||
125008731|NCT00262522|449657701|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
125008732|NCT00262522|449657702|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
125008733|NCT00262522|449657703|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
125008734|NCT00262522|449657704|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
125008735|NCT00262522|449657701|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
125008736|NCT00262522|449657702|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
125008737|NCT00262522|449657703|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
125008738|NCT00262522|449657704|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
125008739|NCT00262522|449657701|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
125008740|NCT00262522|449657702|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
125008741|NCT00262522|449657703|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
125008742|NCT00262522|449657704|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
125008743|NCT00262522|449657701|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
125008744|NCT00262522|449657702|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
125008745|NCT00262522|449657703|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
125008746|NCT00262522|449657704|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
125008747|NCT00262522|449657701|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
125008748|NCT00262522|449657702|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
125008749|NCT00262522|449657703|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
125008750|NCT00262522|449657704|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
125008751|NCT00262522|449657701|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
125008752|NCT00262522|449657702|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
125008753|NCT00262522|449657703|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
125008754|NCT00262522|449657704|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
125008755|NCT00262522|449657701|FG000|Study Start Through 96 Weeks|Death|2|||
125008756|NCT00262522|449657702|FG001|Study Start Through 96 Weeks|Death|0|||
125096813|NCT00643006|449974563|FG001|Overall Study|Lost to Follow-up|4|||
125008757|NCT00262522|449657703|FG002|Study Start Through 96 Weeks|Death|2|||
125008758|NCT00262522|449657704|FG003|Study Start Through 96 Weeks|Death|0|||
125008759|NCT00262522|449657701|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
125008760|NCT00262522|449657702|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
125008761|NCT00262522|449657703|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
125008762|NCT00262522|449657704|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
125008763|NCT00262522|449657701|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
125008764|NCT00262522|449657702|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
125008765|NCT00262522|449657703|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
125008766|NCT00262522|449657704|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
125008767|NCT04814823|449657705|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
125008768|NCT04085523|449657706|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
125008769|NCT04085523|449657707|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
125008770|NCT04085523|449657708|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
125008771|NCT04085523|449657709|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
125008772|NCT04085523|449657710|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
125008773|NCT04085523|449657711|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
125008774|NCT03977974|449657716|FG000|Period 2|Adverse Event|0|||
125008775|NCT03977974|449657717|FG001|Period 2|Adverse Event|0|||
125008776|NCT03977974|449657718|FG002|Period 2|Adverse Event|0|||
125008777|NCT03977974|449657719|FG003|Period 2|Adverse Event|0|||
125008778|NCT03977974|449657720|FG004|Period 2|Adverse Event|1|||
125008779|NCT03977974|449657721|FG005|Period 2|Adverse Event|0|||
125008780|NCT03977974|449657722|FG006|Period 2|Adverse Event|0|||
125008781|NCT03977974|449657723|FG007|Period 2|Adverse Event|0|||
125008782|NCT03977974|449657724|FG008|Period 2|Adverse Event|0|||
125008783|NCT03977974|449657725|FG009|Period 2|Adverse Event|0|||
125008784|NCT03977974|449657726|FG010|Period 2|Adverse Event|0|||
125008785|NCT03977974|449657727|FG011|Period 2|Adverse Event|0|||
125008786|NCT03977974|449657728|FG012|Period 2|Adverse Event|0|||
125008787|NCT03697720|449658434|FG000|Overall Study|Lost to Follow-up|7|||
125008788|NCT03281668|449658439|FG000|Overall Study|Physician Decision|1|||
125008789|NCT03281668|449658439|FG000|Overall Study|scheduling conflict, family circumstance|2|||
125008790|NCT03281668|449658439|FG000|Overall Study|Withdrawal by Subject|4|||
125008791|NCT03281668|449658439|FG000|Overall Study|Lost to Follow-up|1|||
125008792|NCT01940471|449658447|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
125008793|NCT01940471|449658448|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
125008794|NCT01940471|449658449|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
125008795|NCT01940471|449658450|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
125008796|NCT01940471|449658447|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
125008797|NCT01940471|449658448|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
125008798|NCT01940471|449658449|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
125008799|NCT01940471|449658450|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
125008800|NCT01940471|449658447|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
125008801|NCT01940471|449658448|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
125008802|NCT01940471|449658449|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
125008803|NCT01940471|449658450|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
125008804|NCT01940471|449658447|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
125008805|NCT01940471|449658448|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
125008806|NCT01940471|449658449|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
125008807|NCT01940471|449658450|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
125008808|NCT01940471|449658447|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
125008809|NCT01940471|449658448|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
125008810|NCT01940471|449658449|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
125008811|NCT01940471|449658450|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
125008812|NCT01940471|449658447|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
125008813|NCT01940471|449658448|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
125008814|NCT01940471|449658449|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
125008815|NCT01940471|449658450|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
125008816|NCT01940471|449658447|FG000|Period 1: Double-blind Phase|Death|2|||
125008817|NCT01940471|449658448|FG001|Period 1: Double-blind Phase|Death|1|||
125008818|NCT01940471|449658449|FG002|Period 1: Double-blind Phase|Death|0|||
125008819|NCT01940471|449658450|FG003|Period 1: Double-blind Phase|Death|0|||
125008820|NCT01940471|449658447|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
125008821|NCT01940471|449658448|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
125008822|NCT01940471|449658449|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
125008823|NCT01940471|449658450|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
125008824|NCT01940471|449658447|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
125008825|NCT01940471|449658448|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
125008826|NCT01940471|449658449|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
125008827|NCT01940471|449658450|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
125008828|NCT01940471|449658447|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
125008829|NCT01940471|449658448|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
125008830|NCT01940471|449658449|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
125008831|NCT01940471|449658450|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
125008832|NCT01940471|449658447|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
125008833|NCT01940471|449658448|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
125008834|NCT01940471|449658449|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
125008835|NCT01940471|449658450|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
125008836|NCT01940471|449658447|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
125008837|NCT01940471|449658448|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
125008838|NCT01940471|449658449|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
125008839|NCT01940471|449658450|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
125008840|NCT01940471|449658447|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
125008841|NCT01940471|449658448|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
125008842|NCT01940471|449658449|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
125008843|NCT01940471|449658450|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
125008844|NCT01940471|449658447|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
125008845|NCT01940471|449658448|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
125008846|NCT01940471|449658449|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
125008847|NCT01940471|449658450|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
125008848|NCT01940471|449658447|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
125008849|NCT01940471|449658448|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
125008850|NCT01940471|449658449|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
125008851|NCT01940471|449658450|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
125008852|NCT01940471|449658447|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
125008853|NCT01940471|449658448|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
125008854|NCT01940471|449658449|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
125008855|NCT01940471|449658450|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
125008856|NCT01940471|449658447|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
125008857|NCT01940471|449658448|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
125008858|NCT01940471|449658449|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
125008859|NCT01940471|449658450|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
125008860|NCT01940471|449658447|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
125008861|NCT01940471|449658448|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
125008862|NCT01940471|449658449|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
125008863|NCT01940471|449658450|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
125008864|NCT01940471|449658447|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
125008865|NCT01940471|449658448|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
125008866|NCT01940471|449658449|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
125008867|NCT01940471|449658450|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
125008868|NCT01940471|449658447|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
125008869|NCT01940471|449658448|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
125008870|NCT01940471|449658449|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
125008871|NCT01940471|449658450|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
125008872|NCT01940471|449658447|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
125008873|NCT01940471|449658448|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
125008874|NCT01940471|449658449|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
125008875|NCT01940471|449658450|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
125008876|NCT03462719|449658451|FG000|Overall Study|Withdrawal by Subject|4|||
125008877|NCT03462719|449658452|FG001|Overall Study|Withdrawal by Subject|3|||
125008878|NCT03462719|449658451|FG000|Overall Study|Ongoing|87|||
125008879|NCT03462719|449658452|FG001|Overall Study|Ongoing|72|||
125008880|NCT03740165|449658453|FG000|Overall Study|Death|232|||
125008881|NCT03740165|449658454|FG001|Overall Study|Death|242|||
125008882|NCT03740165|449658455|FG002|Overall Study|Death|229|||
125008883|NCT03740165|449658453|FG000|Overall Study|Lost to Follow-up|0|||
125096814|NCT03471507|449974564|FG000|Overall Study|Lost to Follow-up|1|||
125096815|NCT03471507|449974565|FG001|Overall Study|Lost to Follow-up|3|||
125096816|NCT03471507|449974564|FG000|Overall Study|Physician Decision|0|||
125096817|NCT03471507|449974565|FG001|Overall Study|Physician Decision|1|||
125008884|NCT03740165|449658454|FG001|Overall Study|Lost to Follow-up|0|||
125008885|NCT03740165|449658455|FG002|Overall Study|Lost to Follow-up|1|||
125008886|NCT03740165|449658453|FG000|Overall Study|Withdrawal by Subject|7|||
125008887|NCT03740165|449658454|FG001|Overall Study|Withdrawal by Subject|4|||
125008888|NCT03740165|449658455|FG002|Overall Study|Withdrawal by Subject|3|||
125008889|NCT03740165|449658453|FG000|Overall Study|Ongoing in Study|216|||
125008890|NCT03740165|449658454|FG001|Overall Study|Ongoing in Study|212|||
125008891|NCT03740165|449658455|FG002|Overall Study|Ongoing in Study|221|||
125008892|NCT02044133|449658456|FG000|Overall Study|Lost to Follow-up|1|||
125008893|NCT02044133|449658457|FG001|Overall Study|Lost to Follow-up|1|||
125008894|NCT02044133|449658456|FG000|Overall Study|Death|1|||
125008895|NCT02044133|449658457|FG001|Overall Study|Death|0|||
125008896|NCT02044133|449658456|FG000|Overall Study|Release|3|||
125008897|NCT02044133|449658457|FG001|Overall Study|Release|4|||
125008898|NCT02044133|449658456|FG000|Overall Study|Transfer|1|||
125008899|NCT02044133|449658457|FG001|Overall Study|Transfer|0|||
125008900|NCT02044133|449658456|FG000|Overall Study|refusal of blood sampling|0|||
125008901|NCT02044133|449658457|FG001|Overall Study|refusal of blood sampling|1|||
125008902|NCT05318937|449658458|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125008903|NCT05318937|449658459|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125008904|NCT05318937|449658458|FG000|Overall Study|Lost to Follow-up|0|||
125008905|NCT05318937|449658459|FG001|Overall Study|Lost to Follow-up|1|||
125008906|NCT05318937|449658458|FG000|Overall Study|Withdrawal by Subject|0|||
125008907|NCT05318937|449658459|FG001|Overall Study|Withdrawal by Subject|2|||
125008908|NCT05318937|449658458|FG000|Overall Study|Protocol Violation|0|||
125008909|NCT05318937|449658459|FG001|Overall Study|Protocol Violation|1|||
125008910|NCT05678257|449658467|FG000|Overall Study|Withdrawal by Subject|2|||
125008911|NCT05678257|449658468|FG001|Overall Study|Withdrawal by Subject|0|||
125008912|NCT05678257|449658469|FG002|Overall Study|Withdrawal by Subject|5|||
125008913|NCT05678257|449658467|FG000|Overall Study|Physician Decision|1|||
125008914|NCT05678257|449658468|FG001|Overall Study|Physician Decision|0|||
125008915|NCT05678257|449658469|FG002|Overall Study|Physician Decision|1|||
125008916|NCT05678257|449658467|FG000|Overall Study|Adverse Event|1|||
125008917|NCT05678257|449658468|FG001|Overall Study|Adverse Event|3|||
125008918|NCT05678257|449658469|FG002|Overall Study|Adverse Event|1|||
125008919|NCT05678257|449658467|FG000|Overall Study|Progressive disease|11|||
125008920|NCT05678257|449658468|FG001|Overall Study|Progressive disease|18|||
125096818|NCT03471507|449974564|FG000|Overall Study|Withdrawal by Subject|2|||
125096819|NCT03471507|449974565|FG001|Overall Study|Withdrawal by Subject|1|||
125096820|NCT01151085|449974566|FG000|Overall Study|Lost to Follow-up|31|||
125096821|NCT01151085|449974566|FG000|Overall Study|Protocol Violation|25|||
125096822|NCT01308476|449974568|FG000|Overall Study|Lost to Follow-up|2|||
125096823|NCT01308476|449974569|FG001|Overall Study|Lost to Follow-up|2|||
125096824|NCT01308476|449974568|FG000|Overall Study|Other|1|||
125096825|NCT01308476|449974569|FG001|Overall Study|Other|0|||
125096826|NCT06104423|449974572|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
125096827|NCT06104423|449974573|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
125096828|NCT06104423|449974574|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
125096829|NCT06104423|449974572|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
125096830|NCT06104423|449974573|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
125096831|NCT06104423|449974574|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
125096832|NCT00750061|449974575|FG000|Overall Study|Adverse Event|2|||
125096833|NCT00750061|449974576|FG001|Overall Study|Adverse Event|0|||
125096834|NCT00750061|449974575|FG000|Overall Study|Withdrawal by Subject|0|||
125096835|NCT00750061|449974576|FG001|Overall Study|Withdrawal by Subject|1|||
125096836|NCT00750061|449974575|FG000|Overall Study|Physician Decision|0|||
125096837|NCT00750061|449974576|FG001|Overall Study|Physician Decision|1|||
125096838|NCT00812968|449974577|FG000|Overall Study|Relapse after erythroid response|6|||
125008921|NCT05678257|449658469|FG002|Overall Study|Progressive disease|7|||
125008922|NCT05678257|449658467|FG000|Overall Study|No longer clinically benefitting|2|||
125008923|NCT05678257|449658468|FG001|Overall Study|No longer clinically benefitting|1|||
125096839|NCT00812968|449974577|FG000|Overall Study|Disease progression|1|||
125096840|NCT00812968|449974577|FG000|Overall Study|No further treatment required|1|||
125096841|NCT00812968|449974577|FG000|Overall Study|Study closed due to marketing approval|3|||
125096842|NCT03246152|449974579|FG000|Overall Study|Lost to Follow-up|2|||
125096843|NCT03246152|449974579|FG000|Overall Study|Protocol Violation|1|||
125096844|NCT01243762|449974584|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
125096845|NCT01243762|449974585|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
125096846|NCT01243762|449974586|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
125096847|NCT01243762|449974587|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
125096848|NCT01243762|449974588|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
125096849|NCT01243762|449974589|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
125096850|NCT01243762|449974590|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
125096851|NCT01243762|449974584|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
125096852|NCT01243762|449974585|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
125096853|NCT01243762|449974586|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
125096854|NCT01243762|449974587|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
125096855|NCT01243762|449974588|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
125096856|NCT01243762|449974589|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
125096857|NCT01243762|449974590|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
125096858|NCT01243762|449974584|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
125096859|NCT01243762|449974585|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
125096860|NCT01243762|449974586|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
125096861|NCT01243762|449974587|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
125096862|NCT01243762|449974588|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
125096863|NCT01243762|449974589|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
125096864|NCT01243762|449974590|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
125096865|NCT01243762|449974584|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
125096866|NCT01243762|449974585|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
125096867|NCT01243762|449974586|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
125096868|NCT01243762|449974587|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
125096869|NCT01243762|449974588|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
125096870|NCT01243762|449974589|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
125096871|NCT01243762|449974590|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
125096872|NCT01243762|449974584|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
125096873|NCT01243762|449974585|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
125096874|NCT01243762|449974586|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
125096875|NCT01243762|449974587|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
125096876|NCT01243762|449974588|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
125096877|NCT01243762|449974589|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
125096878|NCT01243762|449974590|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
125096879|NCT01243762|449974584|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
125096880|NCT01243762|449974585|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
125096881|NCT01243762|449974586|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
125096882|NCT01243762|449974587|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
125096883|NCT01243762|449974588|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
125096884|NCT01243762|449974589|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
125096885|NCT01243762|449974590|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
125096886|NCT01243762|449974584|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
125096887|NCT01243762|449974585|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
125096888|NCT01243762|449974586|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
125096889|NCT01243762|449974587|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
125096890|NCT01243762|449974588|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
125096891|NCT01243762|449974589|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
125096892|NCT01243762|449974590|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
125096893|NCT01243762|449974584|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
125096894|NCT01243762|449974585|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
125096895|NCT01243762|449974586|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
125096896|NCT01243762|449974587|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
125096897|NCT01243762|449974588|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
125096898|NCT01243762|449974589|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
125096899|NCT01243762|449974590|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
125096900|NCT02059265|449974591|FG000|Overall Study|Ineligible|4|||
125096901|NCT04753606|449974596|FG000|Overall Study|Adverse Event|1|||
125096902|NCT04753606|449974597|FG001|Overall Study|Adverse Event|0|||
125096903|NCT04753606|449974598|FG002|Overall Study|Adverse Event|0|||
125096904|NCT04145531|449974604|FG000|Part A|Adverse Event|2|||
125096905|NCT04145531|449974605|FG001|Part A|Adverse Event|12|||
125096906|NCT04145531|449974606|FG002|Part A|Adverse Event|6|||
125096907|NCT04145531|449974607|FG003|Part A|Adverse Event|0|||
125096908|NCT04145531|449974604|FG000|Part A|Death|1|||
125096909|NCT04145531|449974605|FG001|Part A|Death|2|||
125096910|NCT04145531|449974606|FG002|Part A|Death|0|||
125096911|NCT04145531|449974607|FG003|Part A|Death|0|||
125096912|NCT04145531|449974604|FG000|Part A|Physician Decision|2|||
125096913|NCT04145531|449974605|FG001|Part A|Physician Decision|5|||
125096914|NCT04145531|449974606|FG002|Part A|Physician Decision|2|||
125096915|NCT04145531|449974607|FG003|Part A|Physician Decision|0|||
125096916|NCT04145531|449974604|FG000|Part A|Progressive disease|0|||
125096917|NCT04145531|449974605|FG001|Part A|Progressive disease|2|||
125096918|NCT04145531|449974606|FG002|Part A|Progressive disease|1|||
125096919|NCT04145531|449974607|FG003|Part A|Progressive disease|0|||
125096920|NCT04145531|449974604|FG000|Part A|Protocol deviation|0|||
125096921|NCT04145531|449974605|FG001|Part A|Protocol deviation|0|||
125096922|NCT04145531|449974606|FG002|Part A|Protocol deviation|1|||
125096923|NCT04145531|449974607|FG003|Part A|Protocol deviation|0|||
125096924|NCT04145531|449974604|FG000|Part A|Withdrawal by parent or guardian|1|||
125096925|NCT04145531|449974605|FG001|Part A|Withdrawal by parent or guardian|0|||
125096926|NCT04145531|449974606|FG002|Part A|Withdrawal by parent or guardian|0|||
125096927|NCT04145531|449974607|FG003|Part A|Withdrawal by parent or guardian|0|||
125096928|NCT04145531|449974604|FG000|Part A|Withdrawal by participant|0|||
125096929|NCT04145531|449974605|FG001|Part A|Withdrawal by participant|0|||
125008924|NCT05678257|449658469|FG002|Overall Study|No longer clinically benefitting|0|||
125008925|NCT05678257|449658467|FG000|Overall Study|Sponsor decision|5|||
125008926|NCT05678257|449658468|FG001|Overall Study|Sponsor decision|9|||
125008927|NCT05678257|449658469|FG002|Overall Study|Sponsor decision|8|||
125008928|NCT05678257|449658467|FG000|Overall Study|Protocol Violation|0|||
125008929|NCT05678257|449658468|FG001|Overall Study|Protocol Violation|0|||
125008930|NCT05678257|449658469|FG002|Overall Study|Protocol Violation|1|||
125008931|NCT05678257|449658467|FG000|Overall Study|Patient non-compliance|0|||
125008932|NCT05678257|449658468|FG001|Overall Study|Patient non-compliance|0|||
125008933|NCT05678257|449658469|FG002|Overall Study|Patient non-compliance|3|||
125008934|NCT05314517|449658470|FG000|Double-blind Period|Adverse Event|4|||
125008935|NCT05314517|449658471|FG001|Double-blind Period|Adverse Event|0|||
125008936|NCT05314517|449658472|FG002|Double-blind Period|Adverse Event|0|||
125008937|NCT05314517|449658473|FG003|Double-blind Period|Adverse Event|0|||
125008938|NCT05314517|449658470|FG000|Double-blind Period|Noncompliance|0|||
125008939|NCT05314517|449658471|FG001|Double-blind Period|Noncompliance|1|||
125008940|NCT05314517|449658472|FG002|Double-blind Period|Noncompliance|0|||
125008941|NCT05314517|449658473|FG003|Double-blind Period|Noncompliance|0|||
125008942|NCT05314517|449658470|FG000|Double-blind Period|Randomized, not treated|1|||
125008943|NCT05314517|449658471|FG001|Double-blind Period|Randomized, not treated|0|||
125008944|NCT05314517|449658472|FG002|Double-blind Period|Randomized, not treated|0|||
125008945|NCT05314517|449658473|FG003|Double-blind Period|Randomized, not treated|0|||
125008946|NCT05314517|449658470|FG000|Open-label Extension|Adverse Event|0|||
125008947|NCT05314517|449658471|FG001|Open-label Extension|Adverse Event|0|||
125008948|NCT05314517|449658472|FG002|Open-label Extension|Adverse Event|1|||
125008949|NCT05314517|449658473|FG003|Open-label Extension|Adverse Event|2|||
125008950|NCT05314517|449658470|FG000|Open-label Extension|Investigator decision|0|||
125096930|NCT04145531|449974606|FG002|Part A|Withdrawal by participant|1|||
125096931|NCT04145531|449974607|FG003|Part A|Withdrawal by participant|0|||
125096932|NCT04145531|449974604|FG000|Part A|Other|0|||
125096933|NCT04145531|449974605|FG001|Part A|Other|0|||
125096934|NCT04145531|449974606|FG002|Part A|Other|1|||
125096935|NCT04145531|449974607|FG003|Part A|Other|0|||
125096936|NCT04145531|449974604|FG000|Part B|Adverse Event|0|||
125096937|NCT04145531|449974605|FG001|Part B|Adverse Event|0|||
125096938|NCT04145531|449974606|FG002|Part B|Adverse Event|0|||
125096939|NCT04145531|449974607|FG003|Part B|Adverse Event|21|||
125096940|NCT04145531|449974604|FG000|Part B|Physician Decision|0|||
125096941|NCT04145531|449974605|FG001|Part B|Physician Decision|0|||
125096942|NCT04145531|449974606|FG002|Part B|Physician Decision|0|||
125096943|NCT04145531|449974607|FG003|Part B|Physician Decision|7|||
125096944|NCT04145531|449974604|FG000|Part B|Progressive disease|0|||
125096945|NCT04145531|449974605|FG001|Part B|Progressive disease|0|||
125096946|NCT04145531|449974606|FG002|Part B|Progressive disease|0|||
125096947|NCT04145531|449974607|FG003|Part B|Progressive disease|1|||
125096948|NCT04145531|449974604|FG000|Part B|Recurrent disease|0|||
125096949|NCT04145531|449974605|FG001|Part B|Recurrent disease|0|||
125096950|NCT04145531|449974606|FG002|Part B|Recurrent disease|0|||
125096951|NCT04145531|449974607|FG003|Part B|Recurrent disease|1|||
125096952|NCT04145531|449974604|FG000|Part B|Withdrawal by parent or guardian|0|||
125096953|NCT04145531|449974605|FG001|Part B|Withdrawal by parent or guardian|0|||
125096954|NCT04145531|449974606|FG002|Part B|Withdrawal by parent or guardian|0|||
125096955|NCT04145531|449974607|FG003|Part B|Withdrawal by parent or guardian|3|||
125096956|NCT04145531|449974604|FG000|Part B|Withdrawal by participant|0|||
125096957|NCT04145531|449974605|FG001|Part B|Withdrawal by participant|0|||
125096958|NCT04145531|449974606|FG002|Part B|Withdrawal by participant|0|||
125096959|NCT04145531|449974607|FG003|Part B|Withdrawal by participant|1|||
125096960|NCT04145531|449974604|FG000|Part B|Other|0|||
125096961|NCT04145531|449974605|FG001|Part B|Other|0|||
125096962|NCT04145531|449974606|FG002|Part B|Other|0|||
125096963|NCT04145531|449974607|FG003|Part B|Other|1|||
125096964|NCT02985996|449974608|FG000|Overall Study|Withdrawal by Subject|0|||
125096965|NCT02985996|449974609|FG001|Overall Study|Withdrawal by Subject|0|||
125096966|NCT02985996|449974610|FG002|Overall Study|Withdrawal by Subject|1|||
125096967|NCT02985996|449974611|FG003|Overall Study|Withdrawal by Subject|0|||
125096968|NCT02985996|449974612|FG004|Overall Study|Withdrawal by Subject|0|||
125096969|NCT02985996|449974608|FG000|Overall Study|Protocol Violation|0|||
125096970|NCT02985996|449974609|FG001|Overall Study|Protocol Violation|1|||
125096971|NCT02985996|449974610|FG002|Overall Study|Protocol Violation|0|||
125096972|NCT02985996|449974611|FG003|Overall Study|Protocol Violation|0|||
125096973|NCT02985996|449974612|FG004|Overall Study|Protocol Violation|0|||
125096974|NCT00442572|449974613|FG000|Overall Study|Relapse|8|||
125096975|NCT00442572|449974614|FG001|Overall Study|Relapse|1|||
125096976|NCT00442572|449974613|FG000|Overall Study|Lost to Follow-up|0|||
125096977|NCT00442572|449974614|FG001|Overall Study|Lost to Follow-up|1|||
125096978|NCT00442572|449974613|FG000|Overall Study|Withdrawal by Subject|0|||
125096979|NCT00442572|449974614|FG001|Overall Study|Withdrawal by Subject|1|||
125096980|NCT04246593|449974618|FG000|Overall Study|Withdrawal by Subject|14|||
125008951|NCT05314517|449658471|FG001|Open-label Extension|Investigator decision|0|||
125008952|NCT05314517|449658472|FG002|Open-label Extension|Investigator decision|1|||
125008953|NCT05314517|449658473|FG003|Open-label Extension|Investigator decision|0|||
125008954|NCT05314517|449658470|FG000|Open-label Extension|Lost to Follow-up|0|||
125008955|NCT05314517|449658471|FG001|Open-label Extension|Lost to Follow-up|0|||
125008956|NCT05314517|449658472|FG002|Open-label Extension|Lost to Follow-up|0|||
125008957|NCT05314517|449658473|FG003|Open-label Extension|Lost to Follow-up|1|||
125008958|NCT05314517|449658470|FG000|Open-label Extension|Withdrawal by Subject|0|||
125008959|NCT05314517|449658471|FG001|Open-label Extension|Withdrawal by Subject|0|||
125008960|NCT05314517|449658472|FG002|Open-label Extension|Withdrawal by Subject|1|||
125008961|NCT05314517|449658473|FG003|Open-label Extension|Withdrawal by Subject|2|||
125008962|NCT05314517|449658470|FG000|Open-label Extension|Use of prohibited medication|0|||
125096981|NCT04246593|449974619|FG001|Overall Study|Withdrawal by Subject|13|||
125096982|NCT04246593|449974618|FG000|Overall Study|Lost to Follow-up|124|||
125008963|NCT05314517|449658471|FG001|Open-label Extension|Use of prohibited medication|0|||
125008964|NCT05314517|449658472|FG002|Open-label Extension|Use of prohibited medication|1|||
125008965|NCT05314517|449658473|FG003|Open-label Extension|Use of prohibited medication|0|||
125008966|NCT05314517|449658470|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
125008967|NCT05314517|449658471|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
125008968|NCT05314517|449658472|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
125008969|NCT05314517|449658473|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
125008970|NCT04969276|449658474|FG000|Overall Study|Protocol Deviation|0|||
125008971|NCT04969276|449658475|FG001|Overall Study|Protocol Deviation|1|||
125008972|NCT04969276|449658476|FG002|Overall Study|Protocol Deviation|0|||
125008973|NCT04969276|449658474|FG000|Overall Study|Withdrawal by Subject|1|||
125008974|NCT04969276|449658475|FG001|Overall Study|Withdrawal by Subject|10|||
125008975|NCT04969276|449658476|FG002|Overall Study|Withdrawal by Subject|0|||
125008976|NCT04969276|449658474|FG000|Overall Study|Lost to Follow-up|0|||
125008977|NCT04969276|449658475|FG001|Overall Study|Lost to Follow-up|1|||
125008978|NCT04969276|449658476|FG002|Overall Study|Lost to Follow-up|0|||
125008979|NCT04655144|449658480|FG000|Overall Study|Consumed THC|1|||
125008980|NCT04655144|449658481|FG001|Overall Study|Consumed THC|0|||
125008981|NCT04655144|449658480|FG000|Overall Study|Unilateral embolization|0|||
125008982|NCT04655144|449658481|FG001|Overall Study|Unilateral embolization|1|||
125008983|NCT04490018|449658482|FG000|Overall Study|Protocol Violation|0|||
125008984|NCT04490018|449658483|FG001|Overall Study|Protocol Violation|2|||
125008985|NCT04490018|449658484|FG002|Overall Study|Protocol Violation|1|||
125008986|NCT04490018|449658482|FG000|Overall Study|Lost to Follow-up|2|||
125008987|NCT04490018|449658483|FG001|Overall Study|Lost to Follow-up|2|||
125008988|NCT04490018|449658484|FG002|Overall Study|Lost to Follow-up|0|||
125008989|NCT04490018|449658482|FG000|Overall Study|Withdrawal by Subject|2|||
125008990|NCT04490018|449658483|FG001|Overall Study|Withdrawal by Subject|1|||
125008991|NCT04490018|449658484|FG002|Overall Study|Withdrawal by Subject|0|||
125008992|NCT04490018|449658482|FG000|Overall Study|Withdrawal by parent/guardian|2|||
125008993|NCT04490018|449658483|FG001|Overall Study|Withdrawal by parent/guardian|3|||
125008994|NCT04490018|449658484|FG002|Overall Study|Withdrawal by parent/guardian|0|||
125008995|NCT00282295|449658486|FG000|Overall Study|Adverse Event|0|||
125008996|NCT00282295|449658487|FG001|Overall Study|Adverse Event|1|||
125008997|NCT00282295|449658488|FG002|Overall Study|Adverse Event|0|||
125008998|NCT00282295|449658486|FG000|Overall Study|Serious Adverse Events|0|||
125008999|NCT00282295|449658487|FG001|Overall Study|Serious Adverse Events|0|||
125009000|NCT00282295|449658488|FG002|Overall Study|Serious Adverse Events|1|||
125009001|NCT00282295|449658486|FG000|Overall Study|Protocol Violation|0|||
125009002|NCT00282295|449658487|FG001|Overall Study|Protocol Violation|2|||
125009003|NCT00282295|449658488|FG002|Overall Study|Protocol Violation|1|||
125009004|NCT00282295|449658486|FG000|Overall Study|Withdrawal by Subject|2|||
125009005|NCT00282295|449658487|FG001|Overall Study|Withdrawal by Subject|6|||
125009006|NCT00282295|449658488|FG002|Overall Study|Withdrawal by Subject|4|||
125009007|NCT00282295|449658486|FG000|Overall Study|Lost to Follow-up|1|||
125009008|NCT00282295|449658487|FG001|Overall Study|Lost to Follow-up|7|||
125009009|NCT00282295|449658488|FG002|Overall Study|Lost to Follow-up|2|||
125009010|NCT00282295|449658486|FG000|Overall Study|Other|0|||
125009011|NCT00282295|449658487|FG001|Overall Study|Other|1|||
125009012|NCT00282295|449658488|FG002|Overall Study|Other|0|||
125009013|NCT03337542|449658489|FG000|Overall Study|Withdrew Consent|17|||
125009014|NCT03337542|449658489|FG000|Overall Study|Allergic Adverse Event|1|||
125009015|NCT03337542|449658489|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
125009016|NCT03337542|449658489|FG000|Overall Study|Lost to Follow-up|1|||
125009017|NCT03337542|449658489|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
125009018|NCT01401842|449658490|FG000|Overall Study|Withdrawal by Subject|3|||
125009019|NCT01401842|449658491|FG001|Overall Study|Withdrawal by Subject|2|||
125009020|NCT01401842|449658490|FG000|Overall Study|academic reason|4|||
125009021|NCT01401842|449658491|FG001|Overall Study|academic reason|1|||
125009022|NCT01401842|449658490|FG000|Overall Study|changed companies|20|||
125096983|NCT04246593|449974619|FG001|Overall Study|Lost to Follow-up|71|||
125009023|NCT01401842|449658491|FG001|Overall Study|changed companies|34|||
125096984|NCT04246593|449974618|FG000|Overall Study|Moved out of area/became ineligible|3|||
125096985|NCT04246593|449974619|FG001|Overall Study|Moved out of area/became ineligible|1|||
125096986|NCT04246593|449974618|FG000|Overall Study|Reason unknown|4|||
125096987|NCT04246593|449974619|FG001|Overall Study|Reason unknown|2|||
125096988|NCT02058849|449974622|FG000|Overall Study|Hospitalization|1|||
125096989|NCT02058849|449974623|FG001|Overall Study|Hospitalization|1|||
125096990|NCT02058849|449974622|FG000|Overall Study|Death|1|||
125096991|NCT02058849|449974623|FG001|Overall Study|Death|0|||
125096992|NCT02058849|449974622|FG000|Overall Study|Lost to Follow-up|1|||
125096993|NCT02058849|449974623|FG001|Overall Study|Lost to Follow-up|0|||
125096994|NCT02058849|449974622|FG000|Overall Study|Withdrawal by Subject|4|||
125096995|NCT02058849|449974623|FG001|Overall Study|Withdrawal by Subject|0|||
125096996|NCT02260804|449974630|FG000|Induction Study Period|Protocol Violation|2|||
125096997|NCT02260804|449974631|FG001|Induction Study Period|Protocol Violation|0|||
125096998|NCT02260804|449974630|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
125096999|NCT02260804|449974631|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
125097000|NCT02260804|449974630|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
125097001|NCT02260804|449974631|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
125097002|NCT02260804|449974630|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
125097003|NCT02260804|449974631|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
125097004|NCT02260804|449974630|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
125097005|NCT02260804|449974631|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
125097006|NCT02260804|449974630|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
125097007|NCT02260804|449974631|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
125097008|NCT02260804|449974630|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
125097009|NCT02260804|449974631|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
125097010|NCT02260804|449974630|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
125097011|NCT02260804|449974631|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
125097012|NCT02260804|449974630|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
125097013|NCT02260804|449974631|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
125097014|NCT02260804|449974630|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
125097015|NCT02260804|449974631|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
125097016|NCT02260804|449974630|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
125097017|NCT02260804|449974631|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
125097018|NCT02207413|449974632|FG000|Overall Study|Withdrawal by Subject|1|||
125097019|NCT02207413|449974633|FG001|Overall Study|Withdrawal by Subject|0|||
125097020|NCT02207413|449974634|FG002|Overall Study|Withdrawal by Subject|0|||
125097021|NCT02207413|449974635|FG003|Overall Study|Withdrawal by Subject|0|||
125097022|NCT02207413|449974636|FG004|Overall Study|Withdrawal by Subject|3|||
125097023|NCT02207413|449974637|FG005|Overall Study|Withdrawal by Subject|7|||
125097024|NCT02207413|449974632|FG000|Overall Study|Lost to Follow-up|0|||
125097025|NCT02207413|449974633|FG001|Overall Study|Lost to Follow-up|0|||
125097026|NCT02207413|449974634|FG002|Overall Study|Lost to Follow-up|0|||
125097027|NCT02207413|449974635|FG003|Overall Study|Lost to Follow-up|1|||
125097028|NCT02207413|449974636|FG004|Overall Study|Lost to Follow-up|1|||
125097029|NCT02207413|449974637|FG005|Overall Study|Lost to Follow-up|5|||
125097030|NCT02207413|449974632|FG000|Overall Study|Adverse Event|0|||
125097031|NCT02207413|449974633|FG001|Overall Study|Adverse Event|0|||
125097032|NCT02207413|449974634|FG002|Overall Study|Adverse Event|0|||
125097033|NCT02207413|449974635|FG003|Overall Study|Adverse Event|0|||
125097034|NCT02207413|449974636|FG004|Overall Study|Adverse Event|2|||
125097035|NCT02207413|449974637|FG005|Overall Study|Adverse Event|1|||
125097036|NCT02207413|449974632|FG000|Overall Study|Migrated/moved from study area|0|||
125097037|NCT02207413|449974633|FG001|Overall Study|Migrated/moved from study area|0|||
125097038|NCT02207413|449974634|FG002|Overall Study|Migrated/moved from study area|0|||
125097039|NCT02207413|449974635|FG003|Overall Study|Migrated/moved from study area|0|||
125097040|NCT02207413|449974636|FG004|Overall Study|Migrated/moved from study area|1|||
125097041|NCT02207413|449974637|FG005|Overall Study|Migrated/moved from study area|0|||
125097042|NCT00066573|449976365|FG000|Overall Study|Did not received protocol treatment|28|||
125097043|NCT00066573|449976366|FG001|Overall Study|Did not received protocol treatment|28|||
125097044|NCT01241591|449976367|FG000|Overall Study|Lack of Efficacy|5|||
125097045|NCT01241591|449976368|FG001|Overall Study|Lack of Efficacy|2|||
125097046|NCT01241591|449976369|FG002|Overall Study|Lack of Efficacy|2|||
125097047|NCT01241591|449976370|FG003|Overall Study|Lack of Efficacy|3|||
125097048|NCT01241591|449976367|FG000|Overall Study|Protocol Violation|5|||
125097049|NCT01241591|449976368|FG001|Overall Study|Protocol Violation|2|||
125097050|NCT01241591|449976369|FG002|Overall Study|Protocol Violation|3|||
125097051|NCT01241591|449976370|FG003|Overall Study|Protocol Violation|0|||
125097052|NCT01241591|449976367|FG000|Overall Study|Lost to Follow-up|1|||
125097053|NCT01241591|449976368|FG001|Overall Study|Lost to Follow-up|2|||
125097054|NCT01241591|449976369|FG002|Overall Study|Lost to Follow-up|2|||
125009024|NCT01401842|449658490|FG000|Overall Study|discharged from US Army|3|||
125009025|NCT01401842|449658491|FG001|Overall Study|discharged from US Army|4|||
125009026|NCT01401842|449658490|FG000|Overall Study|invalid follow-up strength data|1|||
125009027|NCT01401842|449658491|FG001|Overall Study|invalid follow-up strength data|4|||
125009028|NCT01401842|449658490|FG000|Overall Study|on profile|9|||
125009029|NCT01401842|449658491|FG001|Overall Study|on profile|5|||
125009030|NCT01401842|449658490|FG000|Overall Study|other/unknown|28|||
125009031|NCT01401842|449658491|FG001|Overall Study|other/unknown|17|||
125009032|NCT00121108|449658494|FG000|Overall Study|Lost to Follow-up|10|||
125009033|NCT00121108|449658495|FG001|Overall Study|Lost to Follow-up|22|||
125009034|NCT00121108|449658494|FG000|Overall Study|Withdrawal by Subject|106|||
125009035|NCT00121108|449658495|FG001|Overall Study|Withdrawal by Subject|195|||
125009036|NCT00121108|449658494|FG000|Overall Study|Death|5|||
125009037|NCT00121108|449658495|FG001|Overall Study|Death|8|||
125009038|NCT01380379|449658496|FG000|Overall Study|Pregnancy|1|||
125009039|NCT03496012|449660275|FG000|Overall Study|Withdrawal by Subject|2|||
125009040|NCT03496012|449660276|FG001|Overall Study|Withdrawal by Subject|0|||
125009041|NCT03496012|449660277|FG002|Overall Study|Withdrawal by Subject|2|||
125009042|NCT03496012|449660275|FG000|Overall Study|Adverse Event|0|||
125009043|NCT03496012|449660276|FG001|Overall Study|Adverse Event|0|||
125009044|NCT03496012|449660277|FG002|Overall Study|Adverse Event|1|||
125009045|NCT03496012|449660275|FG000|Overall Study|Reason Not Specified|2|||
125009046|NCT03496012|449660276|FG001|Overall Study|Reason Not Specified|0|||
125009047|NCT03496012|449660277|FG002|Overall Study|Reason Not Specified|1|||
125009048|NCT02322125|449660278|FG000|Overall Study|Withdrawal by Subject|2|||
125009049|NCT00766038|449660284|FG000|Overall Study|Lost to Follow-up|15|||
125009050|NCT00766038|449660285|FG001|Overall Study|Lost to Follow-up|14|||
125009051|NCT00449670|449660287|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
125009052|NCT00449670|449660288|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
125009053|NCT00449670|449660287|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
125009054|NCT00449670|449660288|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
125009055|NCT00449670|449660287|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
125009056|NCT00449670|449660288|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
125009057|NCT00449670|449660287|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
125009058|NCT00449670|449660288|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
125009059|NCT00449670|449660287|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
125009060|NCT00449670|449660288|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
125009061|NCT00449670|449660287|FG000|Booster Phase (Study no.109873)|Other|0|||
125009062|NCT00449670|449660288|FG001|Booster Phase (Study no.109873)|Other|2|||
125009063|NCT04183790|449660292|FG000|Overall Study|Participants did not rollover to Part B|12|||
125009064|NCT04183790|449660293|FG001|Overall Study|Participants did not rollover to Part B|0|||
125009065|NCT04183790|449660292|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
125009066|NCT04183790|449660293|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
125009067|NCT04183790|449660292|FG000|Overall Study|Commercial drug is available for participant|6|||
125009068|NCT04183790|449660293|FG001|Overall Study|Commercial drug is available for participant|0|||
125009069|NCT04183790|449660292|FG000|Overall Study|Adverse Event|1|||
125009070|NCT04183790|449660293|FG001|Overall Study|Adverse Event|0|||
125009071|NCT04183790|449660292|FG000|Overall Study|Not enrolled in 107 study|0|||
125009072|NCT04183790|449660293|FG001|Overall Study|Not enrolled in 107 study|2|||
125009073|NCT01251653|449660294|FG000|Overall Study|Progressive Disease|1|||
125009074|NCT01251653|449660295|FG001|Overall Study|Progressive Disease|7|||
125009075|NCT01251653|449660296|FG002|Overall Study|Progressive Disease|16|||
125009076|NCT01251653|449660297|FG003|Overall Study|Progressive Disease|4|||
125009077|NCT01251653|449660298|FG004|Overall Study|Progressive Disease|0|||
125009078|NCT01251653|449660299|FG005|Overall Study|Progressive Disease|17|||
125009079|NCT01251653|449660300|FG006|Overall Study|Progressive Disease|14|||
125009080|NCT01251653|449660301|FG007|Overall Study|Progressive Disease|7|||
125009081|NCT01251653|449660302|FG008|Overall Study|Progressive Disease|5|||
125009082|NCT01251653|449660294|FG000|Overall Study|Dose-limiting toxicity|0|||
125009083|NCT01251653|449660295|FG001|Overall Study|Dose-limiting toxicity|1|||
125009084|NCT01251653|449660296|FG002|Overall Study|Dose-limiting toxicity|1|||
125009085|NCT01251653|449660297|FG003|Overall Study|Dose-limiting toxicity|1|||
125009086|NCT01251653|449660298|FG004|Overall Study|Dose-limiting toxicity|0|||
125009087|NCT01251653|449660299|FG005|Overall Study|Dose-limiting toxicity|0|||
125009088|NCT01251653|449660300|FG006|Overall Study|Dose-limiting toxicity|2|||
125009089|NCT01251653|449660301|FG007|Overall Study|Dose-limiting toxicity|0|||
125009090|NCT01251653|449660302|FG008|Overall Study|Dose-limiting toxicity|0|||
125009091|NCT01251653|449660294|FG000|Overall Study|Adverse Event|1|||
125009092|NCT01251653|449660295|FG001|Overall Study|Adverse Event|0|||
125009093|NCT01251653|449660296|FG002|Overall Study|Adverse Event|2|||
125009094|NCT01251653|449660297|FG003|Overall Study|Adverse Event|1|||
125009095|NCT01251653|449660298|FG004|Overall Study|Adverse Event|1|||
125009096|NCT01251653|449660299|FG005|Overall Study|Adverse Event|0|||
125009097|NCT01251653|449660300|FG006|Overall Study|Adverse Event|2|||
125009098|NCT01251653|449660301|FG007|Overall Study|Adverse Event|2|||
125097055|NCT01241591|449976370|FG003|Overall Study|Lost to Follow-up|2|||
125097056|NCT01241591|449976367|FG000|Overall Study|Screen Failure|3|||
125097057|NCT01241591|449976368|FG001|Overall Study|Screen Failure|2|||
125097058|NCT01241591|449976369|FG002|Overall Study|Screen Failure|1|||
125097059|NCT01241591|449976370|FG003|Overall Study|Screen Failure|0|||
125097060|NCT01241591|449976367|FG000|Overall Study|Withdrawal by Subject|6|||
125097061|NCT01241591|449976368|FG001|Overall Study|Withdrawal by Subject|4|||
125097062|NCT01241591|449976369|FG002|Overall Study|Withdrawal by Subject|2|||
125097063|NCT01241591|449976370|FG003|Overall Study|Withdrawal by Subject|2|||
125097064|NCT01241591|449976367|FG000|Overall Study|Other|0|||
125097065|NCT01241591|449976368|FG001|Overall Study|Other|1|||
125097066|NCT01241591|449976369|FG002|Overall Study|Other|0|||
125097067|NCT01241591|449976370|FG003|Overall Study|Other|1|||
125097068|NCT01241591|449976367|FG000|Overall Study|Adverse Event|3|||
125097069|NCT01241591|449976368|FG001|Overall Study|Adverse Event|11|||
125097070|NCT01241591|449976369|FG002|Overall Study|Adverse Event|12|||
125097071|NCT01241591|449976370|FG003|Overall Study|Adverse Event|4|||
125097072|NCT02147132|449976371|FG000|Overall Study|Lost to Follow-up|1|||
125097073|NCT02147132|449976372|FG001|Overall Study|Lost to Follow-up|0|||
125097074|NCT02147132|449976373|FG002|Overall Study|Lost to Follow-up|0|||
125097075|NCT02147132|449976374|FG003|Overall Study|Lost to Follow-up|0|||
125097076|NCT01798056|449976375|FG000|Overall Study|Serious Adverse Event|13|||
125097077|NCT01798056|449976376|FG001|Overall Study|Serious Adverse Event|12|||
125097078|NCT01798056|449976375|FG000|Overall Study|Withdrawal by Subject|12|||
125097079|NCT01798056|449976376|FG001|Overall Study|Withdrawal by Subject|9|||
125097080|NCT01798056|449976375|FG000|Overall Study|Migrated/moved from study area|1|||
125097081|NCT01798056|449976376|FG001|Overall Study|Migrated/moved from study area|1|||
125097082|NCT01798056|449976375|FG000|Overall Study|Lost to Follow-up|1|||
125097083|NCT01798056|449976376|FG001|Overall Study|Lost to Follow-up|1|||
125097084|NCT01798056|449976375|FG000|Overall Study|Other|0|||
125097085|NCT01798056|449976376|FG001|Overall Study|Other|2|||
125097086|NCT02842736|449976379|FG000|Overall Study|Lost to Follow-up|13|||
125097087|NCT02842736|449976379|FG000|Overall Study|Intervention for menstrual bleeding|17|||
125097088|NCT02842736|449976379|FG000|Overall Study|Withdrawal by Subject|4|||
125097089|NCT02842736|449976379|FG000|Overall Study|Pregnancy|3|||
125097090|NCT02842736|449976379|FG000|Overall Study|Hysterectomy for fibroids|2|||
125097091|NCT02842736|449976379|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
125097092|NCT02842736|449976379|FG000|Overall Study|IUD: Mirena|1|||
125097093|NCT02646566|449976380|FG000|Overall Study|Lost to Follow-up|5|||
125097094|NCT02646566|449976381|FG001|Overall Study|Lost to Follow-up|4|||
125097095|NCT02646566|449976382|FG002|Overall Study|Lost to Follow-up|5|||
125097096|NCT02646566|449976380|FG000|Overall Study|Treatment failure|1|||
125097097|NCT02646566|449976381|FG001|Overall Study|Treatment failure|0|||
125097098|NCT02646566|449976382|FG002|Overall Study|Treatment failure|0|||
125097099|NCT02815540|449976385|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
125097100|NCT02222246|449976386|FG000|Overall Study|No Emergency Department Visits|27|||
125097101|NCT02222246|449976387|FG001|Overall Study|No Emergency Department Visits|26|||
125097102|NCT02222246|449976386|FG000|Overall Study|Physician Decision|0|||
125097103|NCT02222246|449976387|FG001|Overall Study|Physician Decision|1|||
125097104|NCT02064231|449976388|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
125097105|NCT02064231|449976389|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
125097106|NCT02064231|449976390|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
125097107|NCT02064231|449976391|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
125097108|NCT02064231|449976388|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
125097109|NCT02064231|449976389|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
125097110|NCT02064231|449976390|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
125097111|NCT02064231|449976391|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
125097112|NCT02064231|449976388|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
125097113|NCT02064231|449976389|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
125097114|NCT02064231|449976390|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
125097115|NCT02064231|449976391|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
125097116|NCT02064231|449976388|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
125097117|NCT02064231|449976389|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
125097118|NCT02064231|449976390|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
125097119|NCT02064231|449976391|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
125097120|NCT04621227|449976392|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
125097121|NCT04621227|449976392|FG000|Period 3 (29 Days)|Adverse Event|1|||
125097122|NCT04621227|449976392|FG000|Period 8 (2 Days)|Adverse Event|1|||
125097123|NCT01548573|449976393|FG000|Overall Study|Death|3|||
125097124|NCT01548573|449976393|FG000|Overall Study|Withdrawal by Subject|2|||
125097125|NCT01366846|449976396|FG000|Overall Study|Withdrawal by Subject|2|||
125097126|NCT01366846|449976397|FG001|Overall Study|Withdrawal by Subject|0|||
125097127|NCT01366846|449976398|FG002|Overall Study|Withdrawal by Subject|0|||
125097128|NCT01366846|449976399|FG003|Overall Study|Withdrawal by Subject|0|||
125097129|NCT01366846|449976396|FG000|Overall Study|Communication Difficulties|1|||
125097130|NCT01366846|449976397|FG001|Overall Study|Communication Difficulties|4|||
125097131|NCT01366846|449976398|FG002|Overall Study|Communication Difficulties|0|||
125097132|NCT01366846|449976399|FG003|Overall Study|Communication Difficulties|1|||
125097133|NCT01366846|449976396|FG000|Overall Study|Scheduling Conflicts|0|||
125097134|NCT01366846|449976397|FG001|Overall Study|Scheduling Conflicts|0|||
125097135|NCT01366846|449976398|FG002|Overall Study|Scheduling Conflicts|1|||
125097136|NCT01366846|449976399|FG003|Overall Study|Scheduling Conflicts|0|||
125097137|NCT00558831|449976400|FG000|Overall Study|Lost to Follow-up|1|||
125097138|NCT01342445|449976401|FG000|Overall Study|Experienced side effects|0|||
125097139|NCT01342445|449976402|FG001|Overall Study|Experienced side effects|2|||
125097140|NCT05299359|449976403|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
125097141|NCT05299359|449976404|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
125097142|NCT05299359|449976403|FG000|Main Part: Day 1 up to Day 366|Other|2|||
125097143|NCT05299359|449976404|FG001|Main Part: Day 1 up to Day 366|Other|0|||
125097144|NCT05299359|449976403|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
125097145|NCT05299359|449976404|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
125097146|NCT05299359|449976403|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
125097147|NCT05299359|449976404|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
125097148|NCT05299359|449976403|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
125009099|NCT01251653|449660302|FG008|Overall Study|Adverse Event|1|||
125009100|NCT01251653|449660294|FG000|Overall Study|Withdrawal by Subject|1|||
125009101|NCT01251653|449660295|FG001|Overall Study|Withdrawal by Subject|0|||
125009102|NCT01251653|449660296|FG002|Overall Study|Withdrawal by Subject|1|||
125009103|NCT01251653|449660297|FG003|Overall Study|Withdrawal by Subject|0|||
125009104|NCT01251653|449660298|FG004|Overall Study|Withdrawal by Subject|1|||
125009105|NCT01251653|449660299|FG005|Overall Study|Withdrawal by Subject|1|||
125009106|NCT01251653|449660300|FG006|Overall Study|Withdrawal by Subject|0|||
125009107|NCT01251653|449660301|FG007|Overall Study|Withdrawal by Subject|1|||
125009108|NCT01251653|449660302|FG008|Overall Study|Withdrawal by Subject|0|||
125009109|NCT01251653|449660294|FG000|Overall Study|Other reason not mentioned above|0|||
125009110|NCT01251653|449660295|FG001|Overall Study|Other reason not mentioned above|0|||
125009111|NCT01251653|449660296|FG002|Overall Study|Other reason not mentioned above|0|||
125009112|NCT01251653|449660297|FG003|Overall Study|Other reason not mentioned above|0|||
125009113|NCT01251653|449660298|FG004|Overall Study|Other reason not mentioned above|0|||
125009114|NCT01251653|449660299|FG005|Overall Study|Other reason not mentioned above|0|||
125009115|NCT01251653|449660300|FG006|Overall Study|Other reason not mentioned above|0|||
125009116|NCT01251653|449660301|FG007|Overall Study|Other reason not mentioned above|2|||
125009117|NCT01251653|449660302|FG008|Overall Study|Other reason not mentioned above|0|||
125009118|NCT00847145|449660303|FG000|Overall Study|AE or Death|0|||
125009119|NCT00847145|449660304|FG001|Overall Study|AE or Death|1|||
125009120|NCT00847145|449660305|FG002|Overall Study|AE or Death|1|||
125009121|NCT00847145|449660306|FG003|Overall Study|AE or Death|0|||
125009122|NCT00847145|449660307|FG004|Overall Study|AE or Death|0|||
125009123|NCT00847145|449660308|FG005|Overall Study|AE or Death|0|||
125009124|NCT00847145|449660309|FG006|Overall Study|AE or Death|0|||
125009125|NCT00847145|449660310|FG007|Overall Study|AE or Death|0|||
125009126|NCT00847145|449660303|FG000|Overall Study|Withdrawal by Subject|3|||
125009127|NCT00847145|449660304|FG001|Overall Study|Withdrawal by Subject|4|||
125009128|NCT00847145|449660305|FG002|Overall Study|Withdrawal by Subject|6|||
125009129|NCT00847145|449660306|FG003|Overall Study|Withdrawal by Subject|1|||
125009130|NCT00847145|449660307|FG004|Overall Study|Withdrawal by Subject|0|||
125009131|NCT00847145|449660308|FG005|Overall Study|Withdrawal by Subject|0|||
125009132|NCT00847145|449660309|FG006|Overall Study|Withdrawal by Subject|1|||
125009133|NCT00847145|449660310|FG007|Overall Study|Withdrawal by Subject|1|||
125009134|NCT00847145|449660303|FG000|Overall Study|Lost to Follow-up|3|||
125009135|NCT00847145|449660304|FG001|Overall Study|Lost to Follow-up|1|||
125009136|NCT00847145|449660305|FG002|Overall Study|Lost to Follow-up|1|||
125009137|NCT00847145|449660306|FG003|Overall Study|Lost to Follow-up|0|||
125009138|NCT00847145|449660307|FG004|Overall Study|Lost to Follow-up|4|||
125009139|NCT00847145|449660308|FG005|Overall Study|Lost to Follow-up|4|||
125009140|NCT00847145|449660309|FG006|Overall Study|Lost to Follow-up|8|||
125009141|NCT00847145|449660310|FG007|Overall Study|Lost to Follow-up|2|||
125009142|NCT00847145|449660303|FG000|Overall Study|Inappropriate enrollment|0|||
125009143|NCT00847145|449660304|FG001|Overall Study|Inappropriate enrollment|0|||
125009144|NCT00847145|449660305|FG002|Overall Study|Inappropriate enrollment|0|||
125009145|NCT00847145|449660306|FG003|Overall Study|Inappropriate enrollment|0|||
125009146|NCT00847145|449660307|FG004|Overall Study|Inappropriate enrollment|1|||
125009147|NCT00847145|449660308|FG005|Overall Study|Inappropriate enrollment|0|||
125009148|NCT00847145|449660309|FG006|Overall Study|Inappropriate enrollment|0|||
125009149|NCT00847145|449660310|FG007|Overall Study|Inappropriate enrollment|0|||
125009150|NCT00847145|449660303|FG000|Overall Study|Protocol Violation|0|||
125009151|NCT00847145|449660304|FG001|Overall Study|Protocol Violation|0|||
125009152|NCT00847145|449660305|FG002|Overall Study|Protocol Violation|3|||
125009153|NCT00847145|449660306|FG003|Overall Study|Protocol Violation|0|||
125009154|NCT00847145|449660307|FG004|Overall Study|Protocol Violation|1|||
125009155|NCT00847145|449660308|FG005|Overall Study|Protocol Violation|0|||
125009156|NCT00847145|449660309|FG006|Overall Study|Protocol Violation|0|||
125009157|NCT00847145|449660310|FG007|Overall Study|Protocol Violation|1|||
125009158|NCT02833974|449660312|FG000|Overall Study|Lost to Follow-up|1|||
125009159|NCT02833974|449660313|FG001|Overall Study|Lost to Follow-up|0|||
125009160|NCT02833974|449660312|FG000|Overall Study|Adverse Event|0|||
125009161|NCT02833974|449660313|FG001|Overall Study|Adverse Event|3|||
125009162|NCT04419610|449660314|FG000|Overall Study|Withdrawal by Subject|3|||
125009163|NCT04419610|449660315|FG001|Overall Study|Withdrawal by Subject|1|||
125009164|NCT04419610|449660314|FG000|Overall Study|Adverse Event|1|||
125009165|NCT04419610|449660315|FG001|Overall Study|Adverse Event|0|||
125009166|NCT04419610|449660314|FG000|Overall Study|discharged early|1|||
125009167|NCT04419610|449660315|FG001|Overall Study|discharged early|1|||
125009168|NCT01439282|449660316|FG000|Overall Study|Adverse Event|5|||
125009169|NCT01439282|449660317|FG001|Overall Study|Adverse Event|0|||
125009170|NCT01439282|449660316|FG000|Overall Study|Withdrawal by Subject|2|||
125009171|NCT01439282|449660317|FG001|Overall Study|Withdrawal by Subject|0|||
125009172|NCT01439282|449660316|FG000|Overall Study|Other|1|||
125009173|NCT01439282|449660317|FG001|Overall Study|Other|1|||
125009174|NCT01524198|449660318|FG000|Overall Study|Protocol Violation|8|||
125009175|NCT01524198|449660319|FG001|Overall Study|Protocol Violation|6|||
125009176|NCT01524198|449660318|FG000|Overall Study|Withdrawal by Subject|15|||
125097149|NCT05299359|449976404|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
125097150|NCT05299359|449976403|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
125097151|NCT05299359|449976404|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
125097152|NCT05299359|449976403|FG000|Extension Part: Day 1 to Day 366|Other|0|||
125097153|NCT05299359|449976404|FG001|Extension Part: Day 1 to Day 366|Other|1|||
125097154|NCT02392078|449976405|FG000|Overall Study|Did not have procedure|32|||
125097155|NCT02392078|449976406|FG001|Overall Study|Did not have procedure|43|||
125097156|NCT02392078|449976407|FG002|Overall Study|Did not have procedure|20|||
125097157|NCT02392078|449976408|FG003|Overall Study|Did not have procedure|1|||
125097158|NCT02652793|449976411|FG000|Overall Study|Adverse Event|1|||
125097159|NCT02652793|449976411|FG000|Overall Study|Lost to Follow-up|2|||
125097160|NCT02652793|449976411|FG000|Overall Study|Withdrawal by Subject|1|||
125097161|NCT02957149|449976412|FG000|Overall Study|Withdrawal by Subject|5|||
125097162|NCT04579666|449976413|FG000|RTP (Up to Week 52)|Adverse Event|4|||
125097163|NCT04579666|449976414|FG001|RTP (Up to Week 52)|Adverse Event|3|||
125097164|NCT04579666|449976415|FG002|RTP (Up to Week 52)|Adverse Event|0|||
125097165|NCT04579666|449976416|FG003|RTP (Up to Week 52)|Adverse Event|0|||
125097166|NCT04579666|449976413|FG000|RTP (Up to Week 52)|Death|24|||
125097167|NCT04579666|449976414|FG001|RTP (Up to Week 52)|Death|9|||
125097168|NCT04579666|449976415|FG002|RTP (Up to Week 52)|Death|0|||
125097169|NCT04579666|449976416|FG003|RTP (Up to Week 52)|Death|0|||
125097170|NCT04579666|449976413|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
125097171|NCT04579666|449976414|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
125097172|NCT04579666|449976415|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
125097173|NCT04579666|449976416|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
125097174|NCT04579666|449976413|FG000|RTP (Up to Week 52)|Physician Decision|4|||
125097175|NCT04579666|449976414|FG001|RTP (Up to Week 52)|Physician Decision|1|||
125097176|NCT04579666|449976415|FG002|RTP (Up to Week 52)|Physician Decision|0|||
125097177|NCT04579666|449976416|FG003|RTP (Up to Week 52)|Physician Decision|0|||
125097178|NCT04579666|449976413|FG000|RTP (Up to Week 52)|Progressive disease|1|||
125097179|NCT04579666|449976414|FG001|RTP (Up to Week 52)|Progressive disease|0|||
125097180|NCT04579666|449976415|FG002|RTP (Up to Week 52)|Progressive disease|0|||
125097181|NCT04579666|449976416|FG003|RTP (Up to Week 52)|Progressive disease|0|||
125097182|NCT04579666|449976413|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
125097183|NCT04579666|449976414|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
125097184|NCT04579666|449976415|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
125097185|NCT04579666|449976416|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
125097186|NCT04579666|449976413|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
125097187|NCT04579666|449976414|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
125097188|NCT04579666|449976415|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
125097189|NCT04579666|449976416|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
125097190|NCT04579666|449976413|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
125097191|NCT04579666|449976414|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
125097192|NCT04579666|449976415|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
125097193|NCT04579666|449976416|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
125097194|NCT04579666|449976413|FG000|RTP (Up to Week 52)|Other|2|||
125097195|NCT04579666|449976414|FG001|RTP (Up to Week 52)|Other|0|||
125097196|NCT04579666|449976415|FG002|RTP (Up to Week 52)|Other|0|||
125097197|NCT04579666|449976416|FG003|RTP (Up to Week 52)|Other|0|||
125097198|NCT04579666|449976413|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
125097199|NCT04579666|449976414|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
125097200|NCT04579666|449976415|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
125097201|NCT04579666|449976416|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
125097202|NCT04579666|449976413|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
125097203|NCT04579666|449976414|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
125097204|NCT04579666|449976415|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
125097205|NCT04579666|449976416|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
125097206|NCT04579666|449976413|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
125097207|NCT04579666|449976414|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
125097208|NCT04579666|449976415|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
125097209|NCT04579666|449976416|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
125097210|NCT04579666|449976413|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
125097211|NCT04579666|449976414|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
125097212|NCT04579666|449976415|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
125097213|NCT04579666|449976416|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
125097214|NCT04579666|449976413|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
125097215|NCT04579666|449976414|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
125097216|NCT04579666|449976415|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
125097217|NCT04579666|449976416|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
125097218|NCT05450198|449976417|FG000|Overall Study|Withdrawal by Subject|1|||
125097219|NCT05450198|449976418|FG001|Overall Study|Withdrawal by Subject|1|||
125097220|NCT05450198|449976419|FG002|Overall Study|Withdrawal by Subject|2|||
125097221|NCT05450198|449976420|FG003|Overall Study|Withdrawal by Subject|0|||
125097222|NCT05450198|449976417|FG000|Overall Study|Lost to Follow-up|1|||
125097223|NCT05450198|449976418|FG001|Overall Study|Lost to Follow-up|0|||
125097224|NCT05450198|449976419|FG002|Overall Study|Lost to Follow-up|2|||
125097225|NCT05450198|449976420|FG003|Overall Study|Lost to Follow-up|1|||
125097226|NCT04359758|449976424|FG000|Overall Study|Protocol Violation|3|||
125097227|NCT04359758|449976425|FG001|Overall Study|Protocol Violation|2|||
125097228|NCT01748162|449976426|FG000|Overall Study|no additional croup episodes to evaluate|2|||
125097229|NCT01748162|449976427|FG001|Overall Study|no additional croup episodes to evaluate|2|||
125097230|NCT01748162|449976426|FG000|Overall Study|participant consented but did not begin|0|||
125097231|NCT01748162|449976427|FG001|Overall Study|participant consented but did not begin|1|||
125097232|NCT01748162|449976426|FG000|Overall Study|reasons not available|3|||
125097233|NCT01748162|449976427|FG001|Overall Study|reasons not available|2|||
125097234|NCT00505765|449976428|FG000|Overall Study|Withdrawal by Subject|1|||
125097235|NCT00505765|449976429|FG001|Overall Study|Withdrawal by Subject|0|||
125097236|NCT00505765|449976430|FG002|Overall Study|Withdrawal by Subject|0|||
125097237|NCT00505765|449976428|FG000|Overall Study|Adverse Event|1|||
125097238|NCT00505765|449976429|FG001|Overall Study|Adverse Event|2|||
125097239|NCT00505765|449976430|FG002|Overall Study|Adverse Event|0|||
125097240|NCT00505765|449976428|FG000|Overall Study|Noncompliance|0|||
125097241|NCT00505765|449976429|FG001|Overall Study|Noncompliance|1|||
125097242|NCT00505765|449976430|FG002|Overall Study|Noncompliance|3|||
125097243|NCT03841331|449976431|FG000|Overall Study|Withdrawal by Subject|4|||
125097244|NCT03841331|449976432|FG001|Overall Study|Withdrawal by Subject|9|||
125097245|NCT03841331|449976431|FG000|Overall Study|Lost to Follow-up|5|||
125097246|NCT03841331|449976432|FG001|Overall Study|Lost to Follow-up|1|||
125097247|NCT02743117|449976433|FG000|Overall Study|Lost to Follow-up|0|||
125009177|NCT01524198|449660319|FG001|Overall Study|Withdrawal by Subject|10|||
125009178|NCT02232802|449660320|FG000|Period 1|Sponsor request|1|||
125009179|NCT02232802|449660321|FG001|Period 1|Sponsor request|0|||
125009180|NCT02232802|449660320|FG000|Period 1|Adverse Event|1|||
125009181|NCT02232802|449660321|FG001|Period 1|Adverse Event|1|||
125009182|NCT00885703|449660326|FG000|Overall Study|Death|9|||
125009183|NCT00885703|449660327|FG001|Overall Study|Death|7|||
125009184|NCT00885703|449660328|FG002|Overall Study|Death|8|||
125009185|NCT00885703|449660329|FG003|Overall Study|Death|7|||
125009186|NCT00885703|449660330|FG004|Overall Study|Death|7|||
125009187|NCT00885703|449660331|FG005|Overall Study|Death|8|||
125009188|NCT00885703|449660332|FG006|Overall Study|Death|4|||
125009189|NCT00885703|449660326|FG000|Overall Study|Lost to Follow-up|0|||
125009190|NCT00885703|449660327|FG001|Overall Study|Lost to Follow-up|0|||
125009191|NCT00885703|449660328|FG002|Overall Study|Lost to Follow-up|1|||
125009192|NCT00885703|449660329|FG003|Overall Study|Lost to Follow-up|0|||
125009193|NCT00885703|449660330|FG004|Overall Study|Lost to Follow-up|0|||
125009194|NCT00885703|449660331|FG005|Overall Study|Lost to Follow-up|1|||
125009195|NCT00885703|449660332|FG006|Overall Study|Lost to Follow-up|0|||
125009196|NCT00885703|449660326|FG000|Overall Study|Withdrawal by Subject|0|||
125009197|NCT00885703|449660327|FG001|Overall Study|Withdrawal by Subject|0|||
125009198|NCT00885703|449660328|FG002|Overall Study|Withdrawal by Subject|0|||
125009199|NCT00885703|449660329|FG003|Overall Study|Withdrawal by Subject|1|||
125009200|NCT00885703|449660330|FG004|Overall Study|Withdrawal by Subject|3|||
125009201|NCT00885703|449660331|FG005|Overall Study|Withdrawal by Subject|1|||
125009202|NCT00885703|449660332|FG006|Overall Study|Withdrawal by Subject|1|||
125009203|NCT00885703|449660326|FG000|Overall Study|Ineligible (no CM)|1|||
125009204|NCT00885703|449660327|FG001|Overall Study|Ineligible (no CM)|3|||
125009205|NCT00885703|449660328|FG002|Overall Study|Ineligible (no CM)|2|||
125009206|NCT00885703|449660329|FG003|Overall Study|Ineligible (no CM)|1|||
125009207|NCT00885703|449660330|FG004|Overall Study|Ineligible (no CM)|2|||
125097248|NCT02743117|449976434|FG001|Overall Study|Lost to Follow-up|1|||
125097249|NCT02743117|449976433|FG000|Overall Study|Other|1|||
125009208|NCT00885703|449660331|FG005|Overall Study|Ineligible (no CM)|3|||
125097250|NCT02743117|449976434|FG001|Overall Study|Other|0|||
125009209|NCT00885703|449660332|FG006|Overall Study|Ineligible (no CM)|1|||
125009210|NCT01183143|449660334|FG000|Overall Study|Protocol Violation|115|||
125097251|NCT01207219|449976435|FG000|Overall Study|changed diagnosis during study period|5|||
125097252|NCT01207219|449976436|FG001|Overall Study|changed diagnosis during study period|3|||
125097253|NCT01207219|449976437|FG002|Overall Study|changed diagnosis during study period|1|||
125097254|NCT01207219|449976435|FG000|Overall Study|Lost to Follow-up|6|||
125097255|NCT01207219|449976436|FG001|Overall Study|Lost to Follow-up|8|||
125097256|NCT01207219|449976437|FG002|Overall Study|Lost to Follow-up|6|||
125097257|NCT03532048|449976439|FG000|Overall Study|Lost to Follow-up|12|||
125097258|NCT03532048|449976440|FG001|Overall Study|Lost to Follow-up|17|||
125097259|NCT03532048|449976439|FG000|Overall Study|Withdrawal by Subject|7|||
125097260|NCT03532048|449976440|FG001|Overall Study|Withdrawal by Subject|0|||
125097261|NCT01901393|449976443|FG000|Overall Study|Adverse Event|1|||
125097262|NCT01901393|449976444|FG001|Overall Study|Adverse Event|0|||
125097263|NCT04585906|449976445|FG000|Overall Study|Lost to Follow-up|8|||
125097264|NCT04585906|449976446|FG001|Overall Study|Lost to Follow-up|5|||
125009211|NCT01183143|449660334|FG000|Overall Study|Withdrawal by Subject|19|||
125097265|NCT00634933|449976451|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
125097266|NCT00634933|449976452|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
125097267|NCT00634933|449976453|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
125097268|NCT00634933|449976454|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
125097269|NCT00634933|449976455|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
125097270|NCT00634933|449976451|FG000|Part A: Baseline to Week 24|Death|1|||
125097271|NCT00634933|449976452|FG001|Part A: Baseline to Week 24|Death|0|||
125097272|NCT00634933|449976453|FG002|Part A: Baseline to Week 24|Death|0|||
125097273|NCT00634933|449976454|FG003|Part A: Baseline to Week 24|Death|0|||
125097274|NCT00634933|449976455|FG004|Part A: Baseline to Week 24|Death|0|||
125097275|NCT00634933|449976451|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
125097276|NCT00634933|449976452|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
125097277|NCT00634933|449976453|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
125097278|NCT00634933|449976454|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
125097279|NCT00634933|449976455|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
125097280|NCT00634933|449976451|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
125097281|NCT00634933|449976452|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
125097282|NCT00634933|449976453|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
125097283|NCT00634933|449976454|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
125097284|NCT00634933|449976455|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
125097285|NCT00634933|449976451|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
125097286|NCT00634933|449976452|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
125097287|NCT00634933|449976453|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
125097288|NCT00634933|449976454|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
125097289|NCT00634933|449976455|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
125097290|NCT00634933|449976451|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
125097291|NCT00634933|449976452|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
125097292|NCT00634933|449976453|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
125097293|NCT00634933|449976454|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
125097294|NCT00634933|449976455|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
125097295|NCT00634933|449976451|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
125097296|NCT00634933|449976452|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
125009212|NCT01183143|449660334|FG000|Overall Study|Subject Questionnaires not returned|5|||
125009213|NCT01183143|449660334|FG000|Overall Study|Subjects enrolled, but not treated|11|||
125009214|NCT04096274|449660336|FG000|Phase I|Lost to Follow-up|5|||
125009215|NCT04096274|449660337|FG001|Phase I|Lost to Follow-up|5|||
125009216|NCT04096274|449660336|FG000|Phase II|Lost to Follow-up|11|||
125009217|NCT04096274|449660337|FG001|Phase II|Lost to Follow-up|11|||
125009218|NCT03197493|449660340|FG000|Overall Study|Withdrawal by Subject|5|||
125009219|NCT00516048|449660343|FG000|Overall Study|Death|0|||
125009220|NCT00516048|449660344|FG001|Overall Study|Death|0|||
125009221|NCT00516048|449660345|FG002|Overall Study|Death|1|||
125097297|NCT00634933|449976453|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
125097298|NCT00634933|449976454|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
125009222|NCT00516048|449660343|FG000|Overall Study|Subject Decision|0|||
125009223|NCT00516048|449660344|FG001|Overall Study|Subject Decision|2|||
125009224|NCT00516048|449660345|FG002|Overall Study|Subject Decision|0|||
125009225|NCT02807480|449660348|FG000|Overall Study|Withdrawal by Subject|14|||
125097299|NCT00634933|449976455|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
125097300|NCT00634933|449976451|FG000|Part A: Baseline to Week 24|Other|1|||
125097301|NCT00634933|449976452|FG001|Part A: Baseline to Week 24|Other|8|||
125097302|NCT00634933|449976453|FG002|Part A: Baseline to Week 24|Other|5|||
125097303|NCT00634933|449976454|FG003|Part A: Baseline to Week 24|Other|0|||
125097304|NCT00634933|449976455|FG004|Part A: Baseline to Week 24|Other|0|||
125097305|NCT00634933|449976451|FG000|Between Part A and Part B|Physician Decision|0|||
125097306|NCT00634933|449976452|FG001|Between Part A and Part B|Physician Decision|1|||
125097307|NCT00634933|449976453|FG002|Between Part A and Part B|Physician Decision|0|||
125097308|NCT00634933|449976454|FG003|Between Part A and Part B|Physician Decision|0|||
125097309|NCT00634933|449976455|FG004|Between Part A and Part B|Physician Decision|0|||
125097310|NCT00634933|449976451|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
125097311|NCT00634933|449976452|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
125097312|NCT00634933|449976453|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
125097313|NCT00634933|449976454|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
125097314|NCT00634933|449976455|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
125097315|NCT00634933|449976451|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
125097316|NCT00634933|449976452|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
125097317|NCT00634933|449976453|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
125097318|NCT00634933|449976454|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
125009226|NCT02807480|449660349|FG001|Overall Study|Withdrawal by Subject|10|||
125009227|NCT00054704|449660350|FG000|Overall Study|Lack of Efficacy|2|||
125009228|NCT00054704|449660351|FG001|Overall Study|Lack of Efficacy|3|||
125009229|NCT00054704|449660350|FG000|Overall Study|Adverse Event|3|||
125009230|NCT00054704|449660351|FG001|Overall Study|Adverse Event|1|||
125009231|NCT00054704|449660350|FG000|Overall Study|Lost to Follow-up|0|||
125009232|NCT00054704|449660351|FG001|Overall Study|Lost to Follow-up|1|||
125009233|NCT02163187|449660352|FG000|Overall Study|Device removed|1|||
125009234|NCT02163187|449660353|FG001|Overall Study|Device removed|0|||
125009235|NCT02163187|449660352|FG000|Overall Study|Progressive disease|1|||
125009236|NCT02163187|449660353|FG001|Overall Study|Progressive disease|0|||
125009237|NCT00362414|449660354|FG000|Overall Study|Death|2|||
125009238|NCT00362414|449660354|FG000|Overall Study|Adverse Event|1|||
125009239|NCT02369848|449660355|FG000|Overall Study|Death|1|||
125009240|NCT02369848|449660355|FG000|Overall Study|Withdrawal by Subject|2|||
125009241|NCT02369848|449660355|FG000|Overall Study|Lost to Follow-up|1|||
125009242|NCT01543152|449660356|FG000|Overall Study|Withdrawal by Subject|0|||
125009243|NCT01543152|449660357|FG001|Overall Study|Withdrawal by Subject|2|||
125009244|NCT01543152|449660358|FG002|Overall Study|Withdrawal by Subject|0|||
125009245|NCT01543152|449660359|FG003|Overall Study|Withdrawal by Subject|0|||
125009246|NCT01543152|449660360|FG004|Overall Study|Withdrawal by Subject|0|||
125009247|NCT02053168|449660361|FG000|Overall Study|Withdrawal by Subject|1|||
125009248|NCT02053168|449660361|FG000|Overall Study|Physician Decision|1|||
125009249|NCT02053168|449660361|FG000|Overall Study|Lost to Follow-up|1|||
125009250|NCT00636675|449660362|FG000|Overall Study|Lost to Follow-up|121|||
125009251|NCT00636675|449660363|FG001|Overall Study|Lost to Follow-up|31|||
125009252|NCT00636675|449660362|FG000|Overall Study|Withdrawal by Subject|19|||
125009253|NCT00636675|449660363|FG001|Overall Study|Withdrawal by Subject|10|||
125009254|NCT00096785|449660364|FG000|Overall Study|Lost to Follow-up|1|||
125009255|NCT00096785|449660365|FG001|Overall Study|Lost to Follow-up|0|||
125009256|NCT00096785|449660364|FG000|Overall Study|Withdrawal by Subject|0|||
125009257|NCT00096785|449660365|FG001|Overall Study|Withdrawal by Subject|1|||
125009258|NCT00096785|449660364|FG000|Overall Study|Relocated|1|||
125009259|NCT00096785|449660365|FG001|Overall Study|Relocated|0|||
125097319|NCT00634933|449976455|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
125097320|NCT00634933|449976451|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
125097321|NCT00634933|449976452|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
125009260|NCT04053868|449660366|FG000|Overall Study|Withdrawal by Subject|1|||
125009261|NCT04053868|449660367|FG001|Overall Study|Withdrawal by Subject|0|||
125009262|NCT00833053|449660371|FG000|Overall Study|Adverse Event|4|||
125009263|NCT00833053|449660372|FG001|Overall Study|Adverse Event|0|||
125009264|NCT00833053|449660371|FG000|Overall Study|Treatment Failure|3|||
125009265|NCT00833053|449660372|FG001|Overall Study|Treatment Failure|1|||
125097322|NCT00634933|449976453|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
125097323|NCT00634933|449976454|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
125097324|NCT00634933|449976455|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
125009266|NCT00833053|449660371|FG000|Overall Study|Withdrawal by Subject|0|||
125009267|NCT00833053|449660372|FG001|Overall Study|Withdrawal by Subject|1|||
125009268|NCT00833053|449660371|FG000|Overall Study|Protocol Violation|2|||
125009269|NCT00833053|449660372|FG001|Overall Study|Protocol Violation|1|||
125009270|NCT02187471|449660374|FG000|Overall Study|Protocol Violation|4|||
125009271|NCT02187471|449660375|FG001|Overall Study|Protocol Violation|5|||
125009272|NCT02187471|449660376|FG002|Overall Study|Protocol Violation|4|||
125009273|NCT02187471|449660377|FG003|Overall Study|Protocol Violation|4|||
125009274|NCT02187471|449660374|FG000|Overall Study|Missing|0|||
125009275|NCT02187471|449660375|FG001|Overall Study|Missing|0|||
125009276|NCT02187471|449660376|FG002|Overall Study|Missing|0|||
125009277|NCT02187471|449660377|FG003|Overall Study|Missing|1|||
125009278|NCT02187471|449660374|FG000|Overall Study|Lack of Efficacy|18|||
125009279|NCT02187471|449660375|FG001|Overall Study|Lack of Efficacy|9|||
125009280|NCT02187471|449660376|FG002|Overall Study|Lack of Efficacy|13|||
125009281|NCT02187471|449660377|FG003|Overall Study|Lack of Efficacy|11|||
125009282|NCT02187471|449660374|FG000|Overall Study|Adverse Event|24|||
125009283|NCT02187471|449660375|FG001|Overall Study|Adverse Event|34|||
125009284|NCT02187471|449660376|FG002|Overall Study|Adverse Event|44|||
125009285|NCT02187471|449660377|FG003|Overall Study|Adverse Event|36|||
125009286|NCT02187471|449660374|FG000|Overall Study|Withdrawal by Subject|23|||
125009287|NCT02187471|449660375|FG001|Overall Study|Withdrawal by Subject|29|||
125009288|NCT02187471|449660376|FG002|Overall Study|Withdrawal by Subject|22|||
125009289|NCT02187471|449660377|FG003|Overall Study|Withdrawal by Subject|24|||
125009290|NCT02187471|449660374|FG000|Overall Study|Other|7|||
125009291|NCT02187471|449660375|FG001|Overall Study|Other|5|||
125009292|NCT02187471|449660376|FG002|Overall Study|Other|3|||
125009293|NCT02187471|449660377|FG003|Overall Study|Other|4|||
125009294|NCT02236520|449660378|FG000|Overall Study|Physician Decision|0|||
125009295|NCT02236520|449660379|FG001|Overall Study|Physician Decision|5|||
125009296|NCT02236520|449660380|FG002|Overall Study|Physician Decision|0|||
125009297|NCT02236520|449660381|FG003|Overall Study|Physician Decision|0|||
125009298|NCT02236520|449660378|FG000|Overall Study|Withdrawal by Subject|1|||
125009299|NCT02236520|449660379|FG001|Overall Study|Withdrawal by Subject|0|||
125009300|NCT02236520|449660380|FG002|Overall Study|Withdrawal by Subject|0|||
125009301|NCT02236520|449660381|FG003|Overall Study|Withdrawal by Subject|1|||
125009302|NCT02236520|449660378|FG000|Overall Study|Pregnancy|1|||
125009303|NCT02236520|449660379|FG001|Overall Study|Pregnancy|0|||
125009304|NCT02236520|449660380|FG002|Overall Study|Pregnancy|0|||
125009305|NCT02236520|449660381|FG003|Overall Study|Pregnancy|0|||
125009306|NCT01785160|449660382|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
125009307|NCT01785160|449660382|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
125009308|NCT00957528|449660383|FG000|Overall Study|Protocol Violation|0|||
125009309|NCT00957528|449660384|FG001|Overall Study|Protocol Violation|1|||
125009310|NCT00957528|449660385|FG002|Overall Study|Protocol Violation|0|||
125009311|NCT00957528|449660383|FG000|Overall Study|Withdrawal by Subject|0|||
125009312|NCT00957528|449660384|FG001|Overall Study|Withdrawal by Subject|0|||
125009313|NCT00957528|449660385|FG002|Overall Study|Withdrawal by Subject|1|||
125009314|NCT02081534|449660390|FG000|Overall Study|Adverse Event|5|||
125009315|NCT02081534|449660391|FG001|Overall Study|Adverse Event|4|||
125009316|NCT02081534|449660392|FG002|Overall Study|Adverse Event|3|||
125009317|NCT02081534|449660393|FG003|Overall Study|Adverse Event|10|||
125009318|NCT02081534|449660394|FG004|Overall Study|Adverse Event|2|||
125009319|NCT02081534|449660395|FG005|Overall Study|Adverse Event|8|||
125009320|NCT02081534|449660396|FG006|Overall Study|Adverse Event|2|||
125009321|NCT02081534|449660390|FG000|Overall Study|Withdrawal by Subject|0|||
125009322|NCT02081534|449660391|FG001|Overall Study|Withdrawal by Subject|1|||
125009323|NCT02081534|449660392|FG002|Overall Study|Withdrawal by Subject|1|||
125009324|NCT02081534|449660393|FG003|Overall Study|Withdrawal by Subject|1|||
125009325|NCT02081534|449660394|FG004|Overall Study|Withdrawal by Subject|1|||
125009326|NCT02081534|449660395|FG005|Overall Study|Withdrawal by Subject|0|||
125009327|NCT02081534|449660396|FG006|Overall Study|Withdrawal by Subject|1|||
125009328|NCT02081534|449660390|FG000|Overall Study|Protocol Violation|0|||
125009329|NCT02081534|449660391|FG001|Overall Study|Protocol Violation|3|||
125097325|NCT00634933|449976451|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
125097326|NCT00634933|449976452|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
125097327|NCT00634933|449976453|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
125097328|NCT00634933|449976454|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
125009330|NCT02081534|449660392|FG002|Overall Study|Protocol Violation|0|||
125009331|NCT02081534|449660393|FG003|Overall Study|Protocol Violation|0|||
125009332|NCT02081534|449660394|FG004|Overall Study|Protocol Violation|0|||
125009333|NCT02081534|449660395|FG005|Overall Study|Protocol Violation|0|||
125009334|NCT02081534|449660396|FG006|Overall Study|Protocol Violation|1|||
125009335|NCT02081534|449660390|FG000|Overall Study|Lost to Follow-up|0|||
125009336|NCT02081534|449660391|FG001|Overall Study|Lost to Follow-up|0|||
125009337|NCT02081534|449660392|FG002|Overall Study|Lost to Follow-up|0|||
125097329|NCT00634933|449976455|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
125097330|NCT00634933|449976451|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
125097331|NCT00634933|449976452|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
125097332|NCT00634933|449976453|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
125097333|NCT00634933|449976454|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
125097334|NCT00634933|449976455|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
125097335|NCT00634933|449976451|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
125097336|NCT00634933|449976452|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
125097337|NCT00634933|449976453|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
125097338|NCT00634933|449976454|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
125097339|NCT00634933|449976455|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
125097340|NCT00634933|449976451|FG000|Part B: Week 24 to Week 52|Other|0|||
125097341|NCT00634933|449976452|FG001|Part B: Week 24 to Week 52|Other|0|||
125097342|NCT00634933|449976453|FG002|Part B: Week 24 to Week 52|Other|5|||
125097343|NCT00634933|449976454|FG003|Part B: Week 24 to Week 52|Other|0|||
125097344|NCT00634933|449976455|FG004|Part B: Week 24 to Week 52|Other|1|||
125097345|NCT01049360|449976456|FG000|Period 1|Adverse Event|0|||
125097346|NCT01049360|449976457|FG001|Period 1|Adverse Event|1|||
125097347|NCT01049360|449976458|FG002|Period 1|Adverse Event|0|||
125097348|NCT01049360|449976459|FG003|Period 1|Adverse Event|1|||
125097349|NCT01049360|449976460|FG004|Period 1|Adverse Event|0|||
125097350|NCT01049360|449976461|FG005|Period 1|Adverse Event|0|||
125097351|NCT01049360|449976462|FG006|Period 1|Adverse Event|0|||
125097352|NCT01049360|449976463|FG007|Period 1|Adverse Event|1|||
125097353|NCT01049360|449976464|FG008|Period 1|Adverse Event|0|||
125097354|NCT01049360|449976465|FG009|Period 1|Adverse Event|0|||
125097355|NCT01049360|449976466|FG010|Period 1|Adverse Event|0|||
125097356|NCT01049360|449976467|FG011|Period 1|Adverse Event|0|||
125097357|NCT01049360|449976468|FG012|Period 1|Adverse Event|1|||
125097358|NCT01049360|449976469|FG013|Period 1|Adverse Event|1|||
125097359|NCT01049360|449976470|FG014|Period 1|Adverse Event|0|||
125097360|NCT01049360|449976471|FG015|Period 1|Adverse Event|0|||
125097361|NCT01049360|449976472|FG016|Period 1|Adverse Event|1|||
125097362|NCT01049360|449976473|FG017|Period 1|Adverse Event|0|||
125097363|NCT01049360|449976474|FG018|Period 1|Adverse Event|1|||
125097364|NCT01049360|449976475|FG019|Period 1|Adverse Event|0|||
125097365|NCT01049360|449976456|FG000|Period 1|Did not meet inc/exc criteria|0|||
125097366|NCT01049360|449976457|FG001|Period 1|Did not meet inc/exc criteria|0|||
125097367|NCT01049360|449976458|FG002|Period 1|Did not meet inc/exc criteria|0|||
125097368|NCT01049360|449976459|FG003|Period 1|Did not meet inc/exc criteria|0|||
125097369|NCT01049360|449976460|FG004|Period 1|Did not meet inc/exc criteria|0|||
125097370|NCT01049360|449976461|FG005|Period 1|Did not meet inc/exc criteria|0|||
125097371|NCT01049360|449976462|FG006|Period 1|Did not meet inc/exc criteria|0|||
125097372|NCT01049360|449976463|FG007|Period 1|Did not meet inc/exc criteria|1|||
125097373|NCT01049360|449976464|FG008|Period 1|Did not meet inc/exc criteria|1|||
125097374|NCT01049360|449976465|FG009|Period 1|Did not meet inc/exc criteria|0|||
125097375|NCT01049360|449976466|FG010|Period 1|Did not meet inc/exc criteria|0|||
125097376|NCT01049360|449976467|FG011|Period 1|Did not meet inc/exc criteria|0|||
125097377|NCT01049360|449976468|FG012|Period 1|Did not meet inc/exc criteria|0|||
125097378|NCT01049360|449976469|FG013|Period 1|Did not meet inc/exc criteria|0|||
125097379|NCT01049360|449976470|FG014|Period 1|Did not meet inc/exc criteria|0|||
125009338|NCT02081534|449660393|FG003|Overall Study|Lost to Follow-up|2|||
125009339|NCT02081534|449660394|FG004|Overall Study|Lost to Follow-up|1|||
125009340|NCT02081534|449660395|FG005|Overall Study|Lost to Follow-up|1|||
125009341|NCT02081534|449660396|FG006|Overall Study|Lost to Follow-up|0|||
125009342|NCT00762892|449660397|FG000|Overall Study|Lost to Follow-up|2|||
125009343|NCT00762892|449660398|FG001|Overall Study|Lost to Follow-up|5|||
125009344|NCT00762892|449660397|FG000|Overall Study|Withdrawal by Subject|0|||
125009345|NCT00762892|449660398|FG001|Overall Study|Withdrawal by Subject|1|||
125009346|NCT00762892|449660397|FG000|Overall Study|Death|1|||
125009347|NCT00762892|449660398|FG001|Overall Study|Death|0|||
125009348|NCT00762892|449660397|FG000|Overall Study|Pregnancy|1|||
125009349|NCT00762892|449660398|FG001|Overall Study|Pregnancy|0|||
125097380|NCT01049360|449976471|FG015|Period 1|Did not meet inc/exc criteria|0|||
125097381|NCT01049360|449976472|FG016|Period 1|Did not meet inc/exc criteria|0|||
125097382|NCT01049360|449976473|FG017|Period 1|Did not meet inc/exc criteria|0|||
125097383|NCT01049360|449976474|FG018|Period 1|Did not meet inc/exc criteria|0|||
125097384|NCT01049360|449976475|FG019|Period 1|Did not meet inc/exc criteria|0|||
125097385|NCT01049360|449976456|FG000|Period 1|Withdrawal by Subject|0|||
125097386|NCT01049360|449976457|FG001|Period 1|Withdrawal by Subject|0|||
125097387|NCT01049360|449976458|FG002|Period 1|Withdrawal by Subject|0|||
125097388|NCT01049360|449976459|FG003|Period 1|Withdrawal by Subject|0|||
125097389|NCT01049360|449976460|FG004|Period 1|Withdrawal by Subject|0|||
125097390|NCT01049360|449976461|FG005|Period 1|Withdrawal by Subject|0|||
125097391|NCT01049360|449976462|FG006|Period 1|Withdrawal by Subject|0|||
125009350|NCT00762892|449660397|FG000|Overall Study|Incarceration|1|||
125009351|NCT00762892|449660398|FG001|Overall Study|Incarceration|0|||
125009352|NCT02234479|449660399|FG000|Overall Study|Withdrawal by Subject|1|||
125009353|NCT02234479|449660400|FG001|Overall Study|Withdrawal by Subject|3|||
125009354|NCT02318667|449660401|FG000|Overall Study|Adverse Event|1|||
125009355|NCT02318667|449660401|FG000|Overall Study|Lack of Efficacy|6|||
125009356|NCT02318667|449660401|FG000|Overall Study|Protocol Violation|2|||
125009357|NCT02289742|449660402|FG000|First Wear Period|Adverse event prior to treatment|0|||
125009358|NCT02289742|449660403|FG001|First Wear Period|Adverse event prior to treatment|1|||
125009359|NCT02289742|449660404|FG002|First Wear Period|Adverse event prior to treatment|0|||
125009360|NCT02289742|449660405|FG003|First Wear Period|Adverse event prior to treatment|0|||
125009361|NCT02289742|449660402|FG000|First Wear Period|Adverse Event|0|||
125009362|NCT02289742|449660403|FG001|First Wear Period|Adverse Event|0|||
125009363|NCT02289742|449660404|FG002|First Wear Period|Adverse Event|1|||
125009364|NCT02289742|449660405|FG003|First Wear Period|Adverse Event|0|||
125009365|NCT02289742|449660402|FG000|First Wear Period|Other prior to treatment|0|||
125009366|NCT02289742|449660403|FG001|First Wear Period|Other prior to treatment|0|||
125009367|NCT02289742|449660404|FG002|First Wear Period|Other prior to treatment|0|||
125009368|NCT02289742|449660405|FG003|First Wear Period|Other prior to treatment|1|||
125009369|NCT02289742|449660402|FG000|Third Wear Period|Adverse Event|0|||
125009370|NCT02289742|449660403|FG001|Third Wear Period|Adverse Event|1|||
125009371|NCT02289742|449660404|FG002|Third Wear Period|Adverse Event|0|||
125009372|NCT02289742|449660405|FG003|Third Wear Period|Adverse Event|0|||
125009373|NCT02289742|449660402|FG000|Third Wear Period|Reason not given|0|||
125009374|NCT02289742|449660403|FG001|Third Wear Period|Reason not given|0|||
125009375|NCT02289742|449660404|FG002|Third Wear Period|Reason not given|0|||
125009376|NCT02289742|449660405|FG003|Third Wear Period|Reason not given|1|||
125009377|NCT01365039|449660406|FG000|Overall Study|Study related symptoms and complaints|1|||
125009378|NCT01365039|449660407|FG001|Overall Study|Study related symptoms and complaints|0|||
125009379|NCT00383084|449660414|FG000|Overall Study|Withdrawal by Subject|12|||
125009380|NCT00383084|449660415|FG001|Overall Study|Withdrawal by Subject|10|||
125009381|NCT02159729|449660416|FG000|Overall Study|Adverse Event|0|||
125009382|NCT02159729|449660417|FG001|Overall Study|Adverse Event|1|||
125009383|NCT02159729|449660416|FG000|Overall Study|Subject's Request|13|||
125009384|NCT02159729|449660417|FG001|Overall Study|Subject's Request|10|||
125009385|NCT02159729|449660416|FG000|Overall Study|Lost to Follow-up|24|||
125009386|NCT02159729|449660417|FG001|Overall Study|Lost to Follow-up|9|||
125009387|NCT02159729|449660416|FG000|Overall Study|Non compliance|2|||
125009388|NCT02159729|449660417|FG001|Overall Study|Non compliance|0|||
125009389|NCT02159729|449660416|FG000|Overall Study|Other Unspecified|3|||
125009390|NCT02159729|449660417|FG001|Overall Study|Other Unspecified|1|||
125009391|NCT02636582|449660418|FG000|Overall Study|Surgical Pathology|1|||
125009392|NCT02636582|449660419|FG001|Overall Study|Surgical Pathology|0|||
125097392|NCT01049360|449976463|FG007|Period 1|Withdrawal by Subject|0|||
125097393|NCT01049360|449976464|FG008|Period 1|Withdrawal by Subject|1|||
125097394|NCT01049360|449976465|FG009|Period 1|Withdrawal by Subject|0|||
125097395|NCT01049360|449976466|FG010|Period 1|Withdrawal by Subject|1|||
125097396|NCT01049360|449976467|FG011|Period 1|Withdrawal by Subject|0|||
125097397|NCT01049360|449976468|FG012|Period 1|Withdrawal by Subject|1|||
125097398|NCT01049360|449976469|FG013|Period 1|Withdrawal by Subject|0|||
125097399|NCT01049360|449976470|FG014|Period 1|Withdrawal by Subject|0|||
125097400|NCT01049360|449976471|FG015|Period 1|Withdrawal by Subject|0|||
125097401|NCT01049360|449976472|FG016|Period 1|Withdrawal by Subject|0|||
125097402|NCT01049360|449976473|FG017|Period 1|Withdrawal by Subject|0|||
125097403|NCT01049360|449976474|FG018|Period 1|Withdrawal by Subject|0|||
125097404|NCT01049360|449976475|FG019|Period 1|Withdrawal by Subject|0|||
125097405|NCT01049360|449976456|FG000|Period 2|Protocol Violation|0|||
125097406|NCT01049360|449976457|FG001|Period 2|Protocol Violation|0|||
125097407|NCT01049360|449976458|FG002|Period 2|Protocol Violation|0|||
125097408|NCT01049360|449976459|FG003|Period 2|Protocol Violation|1|||
125097409|NCT01049360|449976460|FG004|Period 2|Protocol Violation|0|||
125097410|NCT01049360|449976461|FG005|Period 2|Protocol Violation|0|||
125097411|NCT01049360|449976462|FG006|Period 2|Protocol Violation|0|||
125097412|NCT01049360|449976463|FG007|Period 2|Protocol Violation|0|||
125097413|NCT01049360|449976464|FG008|Period 2|Protocol Violation|0|||
125097414|NCT01049360|449976465|FG009|Period 2|Protocol Violation|0|||
125097415|NCT01049360|449976466|FG010|Period 2|Protocol Violation|0|||
125097416|NCT01049360|449976467|FG011|Period 2|Protocol Violation|0|||
125097417|NCT01049360|449976468|FG012|Period 2|Protocol Violation|0|||
125097418|NCT01049360|449976469|FG013|Period 2|Protocol Violation|0|||
125097419|NCT01049360|449976470|FG014|Period 2|Protocol Violation|1|||
125097420|NCT01049360|449976471|FG015|Period 2|Protocol Violation|1|||
125097421|NCT01049360|449976472|FG016|Period 2|Protocol Violation|0|||
125097422|NCT01049360|449976473|FG017|Period 2|Protocol Violation|0|||
125097423|NCT01049360|449976474|FG018|Period 2|Protocol Violation|0|||
125097424|NCT01049360|449976475|FG019|Period 2|Protocol Violation|0|||
125097425|NCT01049360|449976456|FG000|Period 2|Adverse Event|0|||
125009393|NCT01263483|449660420|FG000|Overall Study|Adverse Event|4|||
125009394|NCT01263483|449660421|FG001|Overall Study|Adverse Event|0|||
125009395|NCT01263483|449660422|FG002|Overall Study|Adverse Event|3|||
125009396|NCT01263483|449660420|FG000|Overall Study|Withdrawal by Subject|1|||
125009397|NCT01263483|449660421|FG001|Overall Study|Withdrawal by Subject|0|||
125009398|NCT01263483|449660422|FG002|Overall Study|Withdrawal by Subject|0|||
125009399|NCT01263483|449660420|FG000|Overall Study|Lack of Efficacy|2|||
125009400|NCT01263483|449660421|FG001|Overall Study|Lack of Efficacy|0|||
125009401|NCT01263483|449660422|FG002|Overall Study|Lack of Efficacy|0|||
125009402|NCT01263483|449660420|FG000|Overall Study|Protocol Violation|0|||
125009403|NCT01263483|449660421|FG001|Overall Study|Protocol Violation|1|||
125009404|NCT01263483|449660422|FG002|Overall Study|Protocol Violation|1|||
125009405|NCT01263483|449660420|FG000|Overall Study|Participant Unavailability|0|||
125009406|NCT01263483|449660421|FG001|Overall Study|Participant Unavailability|1|||
125009407|NCT01263483|449660422|FG002|Overall Study|Participant Unavailability|1|||
125009408|NCT00326209|449660423|FG000|Overall Study|Adverse Event|28|||
125009409|NCT00326209|449660423|FG000|Overall Study|Withdrawal by Subject|22|||
125009410|NCT00326209|449660423|FG000|Overall Study|Lack of Efficacy|31|||
125009411|NCT00326209|449660423|FG000|Overall Study|Lost to Follow-up|18|||
125009412|NCT00326209|449660423|FG000|Overall Study|Participant non-compliant|6|||
125009413|NCT00326209|449660423|FG000|Overall Study|Sponsor closed study|173|||
125009414|NCT00326209|449660423|FG000|Overall Study|Prohibited medication use|1|||
125009415|NCT00326209|449660423|FG000|Overall Study|Violation of entry criteria|1|||
125009416|NCT00326209|449660423|FG000|Overall Study|Withdrawn in error|1|||
125009417|NCT00326209|449660423|FG000|Overall Study|Pregnancy|1|||
125009418|NCT00714285|449660424|FG000|Overall Study|Lost to Follow-up|0|||
125009419|NCT00714285|449660425|FG001|Overall Study|Lost to Follow-up|2|||
125009420|NCT00714285|449660426|FG002|Overall Study|Lost to Follow-up|0|||
125009421|NCT00714285|449660427|FG003|Overall Study|Lost to Follow-up|1|||
125009422|NCT00714285|449660424|FG000|Overall Study|Migrated/moved from study area|0|||
125009423|NCT00714285|449660425|FG001|Overall Study|Migrated/moved from study area|1|||
125009424|NCT00714285|449660426|FG002|Overall Study|Migrated/moved from study area|0|||
125009425|NCT00714285|449660427|FG003|Overall Study|Migrated/moved from study area|0|||
125097426|NCT01049360|449976457|FG001|Period 2|Adverse Event|1|||
125009426|NCT01372384|449660428|FG000|Overall Study|Progression of disease|3|||
125097427|NCT01049360|449976458|FG002|Period 2|Adverse Event|0|||
125097428|NCT01049360|449976459|FG003|Period 2|Adverse Event|0|||
125097429|NCT01049360|449976460|FG004|Period 2|Adverse Event|0|||
125097430|NCT01049360|449976461|FG005|Period 2|Adverse Event|0|||
125097431|NCT01049360|449976462|FG006|Period 2|Adverse Event|0|||
125097432|NCT01049360|449976463|FG007|Period 2|Adverse Event|0|||
125097433|NCT01049360|449976464|FG008|Period 2|Adverse Event|1|||
125097434|NCT01049360|449976465|FG009|Period 2|Adverse Event|0|||
125009427|NCT01131676|449660433|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
125009428|NCT01131676|449660434|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
125009429|NCT01131676|449660435|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
125009430|NCT01131676|449660433|FG000|Discontinuation From Treatment|Not treated|4|||
125009431|NCT01131676|449660434|FG001|Discontinuation From Treatment|Not treated|2|||
125009432|NCT01131676|449660435|FG002|Discontinuation From Treatment|Not treated|2|||
125097435|NCT01049360|449976466|FG010|Period 2|Adverse Event|0|||
125097436|NCT01049360|449976467|FG011|Period 2|Adverse Event|0|||
125097437|NCT01049360|449976468|FG012|Period 2|Adverse Event|0|||
125097438|NCT01049360|449976469|FG013|Period 2|Adverse Event|0|||
125097439|NCT01049360|449976470|FG014|Period 2|Adverse Event|0|||
125097440|NCT01049360|449976471|FG015|Period 2|Adverse Event|0|||
125097441|NCT01049360|449976472|FG016|Period 2|Adverse Event|0|||
125097442|NCT01049360|449976473|FG017|Period 2|Adverse Event|0|||
125097443|NCT01049360|449976474|FG018|Period 2|Adverse Event|0|||
125097444|NCT01049360|449976475|FG019|Period 2|Adverse Event|1|||
125097445|NCT01049360|449976456|FG000|Period 2|Withdrawal by Subject|0|||
125097446|NCT01049360|449976457|FG001|Period 2|Withdrawal by Subject|0|||
125097447|NCT01049360|449976458|FG002|Period 2|Withdrawal by Subject|0|||
125097448|NCT01049360|449976459|FG003|Period 2|Withdrawal by Subject|1|||
125097449|NCT01049360|449976460|FG004|Period 2|Withdrawal by Subject|0|||
125097450|NCT01049360|449976461|FG005|Period 2|Withdrawal by Subject|0|||
125097451|NCT01049360|449976462|FG006|Period 2|Withdrawal by Subject|0|||
125097452|NCT01049360|449976463|FG007|Period 2|Withdrawal by Subject|0|||
125097453|NCT01049360|449976464|FG008|Period 2|Withdrawal by Subject|0|||
125097454|NCT01049360|449976465|FG009|Period 2|Withdrawal by Subject|0|||
125097455|NCT01049360|449976466|FG010|Period 2|Withdrawal by Subject|0|||
125097456|NCT01049360|449976467|FG011|Period 2|Withdrawal by Subject|0|||
125097457|NCT01049360|449976468|FG012|Period 2|Withdrawal by Subject|0|||
125097458|NCT01049360|449976469|FG013|Period 2|Withdrawal by Subject|0|||
125097459|NCT01049360|449976470|FG014|Period 2|Withdrawal by Subject|1|||
125097460|NCT01049360|449976471|FG015|Period 2|Withdrawal by Subject|0|||
125097461|NCT01049360|449976472|FG016|Period 2|Withdrawal by Subject|0|||
125097462|NCT01049360|449976473|FG017|Period 2|Withdrawal by Subject|0|||
125097463|NCT01049360|449976474|FG018|Period 2|Withdrawal by Subject|0|||
125009433|NCT01131676|449660433|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
125009434|NCT01131676|449660434|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
125009435|NCT01131676|449660435|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
125009436|NCT01131676|449660433|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
125097464|NCT01049360|449976475|FG019|Period 2|Withdrawal by Subject|1|||
125097465|NCT01049360|449976456|FG000|Period 2|Lack of Efficacy|0|||
125097466|NCT01049360|449976457|FG001|Period 2|Lack of Efficacy|0|||
125097467|NCT01049360|449976458|FG002|Period 2|Lack of Efficacy|0|||
125097468|NCT01049360|449976459|FG003|Period 2|Lack of Efficacy|0|||
125097469|NCT01049360|449976460|FG004|Period 2|Lack of Efficacy|0|||
125009437|NCT01131676|449660434|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
125097470|NCT01049360|449976461|FG005|Period 2|Lack of Efficacy|1|||
125097471|NCT01049360|449976462|FG006|Period 2|Lack of Efficacy|0|||
125097472|NCT01049360|449976463|FG007|Period 2|Lack of Efficacy|0|||
125097473|NCT01049360|449976464|FG008|Period 2|Lack of Efficacy|0|||
125097474|NCT01049360|449976465|FG009|Period 2|Lack of Efficacy|0|||
125097475|NCT01049360|449976466|FG010|Period 2|Lack of Efficacy|0|||
125097476|NCT01049360|449976467|FG011|Period 2|Lack of Efficacy|0|||
125097477|NCT01049360|449976468|FG012|Period 2|Lack of Efficacy|0|||
125097478|NCT01049360|449976469|FG013|Period 2|Lack of Efficacy|0|||
125097479|NCT01049360|449976470|FG014|Period 2|Lack of Efficacy|0|||
125097480|NCT01049360|449976471|FG015|Period 2|Lack of Efficacy|0|||
125097481|NCT01049360|449976472|FG016|Period 2|Lack of Efficacy|0|||
125097482|NCT01049360|449976473|FG017|Period 2|Lack of Efficacy|0|||
125097483|NCT01049360|449976474|FG018|Period 2|Lack of Efficacy|0|||
125097484|NCT01049360|449976475|FG019|Period 2|Lack of Efficacy|0|||
125097485|NCT01049360|449976456|FG000|Period 4|Protocol Violation|0|||
125097486|NCT01049360|449976457|FG001|Period 4|Protocol Violation|0|||
125097487|NCT01049360|449976458|FG002|Period 4|Protocol Violation|0|||
125097488|NCT01049360|449976459|FG003|Period 4|Protocol Violation|0|||
125097489|NCT01049360|449976460|FG004|Period 4|Protocol Violation|0|||
125097490|NCT01049360|449976461|FG005|Period 4|Protocol Violation|0|||
125097491|NCT01049360|449976462|FG006|Period 4|Protocol Violation|0|||
125097492|NCT01049360|449976463|FG007|Period 4|Protocol Violation|0|||
125097493|NCT01049360|449976464|FG008|Period 4|Protocol Violation|0|||
125097494|NCT01049360|449976465|FG009|Period 4|Protocol Violation|0|||
125097495|NCT01049360|449976466|FG010|Period 4|Protocol Violation|0|||
125097496|NCT01049360|449976467|FG011|Period 4|Protocol Violation|0|||
125097497|NCT01049360|449976468|FG012|Period 4|Protocol Violation|0|||
125097498|NCT01049360|449976469|FG013|Period 4|Protocol Violation|0|||
125097499|NCT01049360|449976470|FG014|Period 4|Protocol Violation|0|||
125097500|NCT01049360|449976471|FG015|Period 4|Protocol Violation|0|||
125097501|NCT01049360|449976472|FG016|Period 4|Protocol Violation|0|||
125097502|NCT01049360|449976473|FG017|Period 4|Protocol Violation|1|||
125097503|NCT01049360|449976474|FG018|Period 4|Protocol Violation|0|||
125097504|NCT01049360|449976475|FG019|Period 4|Protocol Violation|0|||
125097505|NCT01049360|449976456|FG000|Period 4|Withdrawal by Subject|0|||
125097506|NCT01049360|449976457|FG001|Period 4|Withdrawal by Subject|0|||
125097507|NCT01049360|449976458|FG002|Period 4|Withdrawal by Subject|0|||
125097508|NCT01049360|449976459|FG003|Period 4|Withdrawal by Subject|1|||
125097509|NCT01049360|449976460|FG004|Period 4|Withdrawal by Subject|0|||
125097510|NCT01049360|449976461|FG005|Period 4|Withdrawal by Subject|0|||
125097511|NCT01049360|449976462|FG006|Period 4|Withdrawal by Subject|0|||
125097512|NCT01049360|449976463|FG007|Period 4|Withdrawal by Subject|0|||
125097513|NCT01049360|449976464|FG008|Period 4|Withdrawal by Subject|0|||
125097514|NCT01049360|449976465|FG009|Period 4|Withdrawal by Subject|0|||
125097515|NCT01049360|449976466|FG010|Period 4|Withdrawal by Subject|0|||
125097516|NCT01049360|449976467|FG011|Period 4|Withdrawal by Subject|0|||
125097517|NCT01049360|449976468|FG012|Period 4|Withdrawal by Subject|0|||
125097518|NCT01049360|449976469|FG013|Period 4|Withdrawal by Subject|0|||
125097519|NCT01049360|449976470|FG014|Period 4|Withdrawal by Subject|0|||
125097520|NCT01049360|449976471|FG015|Period 4|Withdrawal by Subject|0|||
125097521|NCT01049360|449976472|FG016|Period 4|Withdrawal by Subject|0|||
125097522|NCT01049360|449976473|FG017|Period 4|Withdrawal by Subject|0|||
125097523|NCT01049360|449976474|FG018|Period 4|Withdrawal by Subject|0|||
125097524|NCT01049360|449976475|FG019|Period 4|Withdrawal by Subject|0|||
125097525|NCT01694849|449976476|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
125097526|NCT01694849|449976477|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
125097527|NCT01694849|449976478|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
125097528|NCT01694849|449976476|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
125097529|NCT01694849|449976477|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
125097530|NCT01694849|449976478|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
125097531|NCT01694849|449976476|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
125097532|NCT01694849|449976477|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
125097533|NCT01694849|449976478|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
125097534|NCT01694849|449976476|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
125097535|NCT01694849|449976477|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
125097536|NCT01694849|449976478|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
125097537|NCT01694849|449976476|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
125097538|NCT01694849|449976477|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
125097539|NCT01694849|449976478|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
125097540|NCT01694849|449976476|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
125097541|NCT01694849|449976477|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
125097542|NCT01694849|449976478|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
125097543|NCT01694849|449976476|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
125097544|NCT01694849|449976477|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
125097545|NCT01694849|449976478|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
125097546|NCT01694849|449976476|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
125097547|NCT01694849|449976477|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
125097548|NCT01694849|449976478|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
125097549|NCT00596466|449976481|FG000|Overall Study|Lack of Efficacy|5|||
125097550|NCT00596466|449976481|FG000|Overall Study|Adverse Event|4|||
125097551|NCT00596466|449976481|FG000|Overall Study|Withdrawal by Subject|2|||
125097552|NCT00596466|449976481|FG000|Overall Study|Protocol Violation|2|||
125097553|NCT00596466|449976481|FG000|Overall Study|Unpecified|2|||
125097554|NCT00596466|449976481|FG000|Overall Study|Enrolled, not treated|2|||
125097555|NCT00908375|449976482|FG000|Overall Study|Withdrawal by Subject|2|||
125097556|NCT00908375|449976483|FG001|Overall Study|Withdrawal by Subject|4|||
125097557|NCT00908375|449976482|FG000|Overall Study|Lost to Follow-up|8|||
125097558|NCT00908375|449976483|FG001|Overall Study|Lost to Follow-up|6|||
125097559|NCT00752206|449976484|FG000|Overall Study|Disease progression|8|||
125097560|NCT00752206|449976485|FG001|Overall Study|Disease progression|11|||
125097561|NCT00752206|449976484|FG000|Overall Study|Pregnancy|1|||
125097562|NCT00752206|449976485|FG001|Overall Study|Pregnancy|0|||
125097563|NCT00678652|449976486|FG000|Overall Study|Protocol Violation|2|||
125097564|NCT00678652|449976487|FG001|Overall Study|Protocol Violation|0|||
125097565|NCT00678652|449976488|FG002|Overall Study|Protocol Violation|0|||
125097566|NCT00678652|449976489|FG003|Overall Study|Protocol Violation|0|||
125097567|NCT00678652|449976486|FG000|Overall Study|Pregnancy|0|||
125097568|NCT00678652|449976487|FG001|Overall Study|Pregnancy|0|||
125097569|NCT00678652|449976488|FG002|Overall Study|Pregnancy|1|||
125097570|NCT00678652|449976489|FG003|Overall Study|Pregnancy|0|||
125097571|NCT00678652|449976486|FG000|Overall Study|Relocation|1|||
125097572|NCT00678652|449976487|FG001|Overall Study|Relocation|0|||
125097573|NCT00678652|449976488|FG002|Overall Study|Relocation|0|||
125097574|NCT00678652|449976489|FG003|Overall Study|Relocation|0|||
125097575|NCT05770401|449976492|FG000|Overall Study|Lost to Follow-up|5|||
125097576|NCT05770401|449976493|FG001|Overall Study|Lost to Follow-up|4|||
125097577|NCT00402298|449976494|FG000|Overall Study|Withdrawal by Subject|1|||
125097578|NCT00402298|449976495|FG001|Overall Study|Withdrawal by Subject|0|||
125097579|NCT00480077|449976496|FG000|Overall Study|Death|19|||
125097580|NCT00480077|449976497|FG001|Overall Study|Death|15|||
125097581|NCT00480077|449976496|FG000|Overall Study|early exit|12|||
125097582|NCT00480077|449976497|FG001|Overall Study|early exit|11|||
125097583|NCT04784455|449976498|FG000|Overall Study|Death|4|||
125097584|NCT04298229|449976503|FG000|Overall Study|Physician Decision|1|||
125097585|NCT04298229|449976504|FG001|Overall Study|Physician Decision|1|||
125097586|NCT04298229|449976503|FG000|Overall Study|Withdrawal by Subject|1|||
125097587|NCT04298229|449976504|FG001|Overall Study|Withdrawal by Subject|1|||
125097588|NCT04298229|449976503|FG000|Overall Study|Did not receive IV loop diuretics|2|||
125097589|NCT04298229|449976504|FG001|Overall Study|Did not receive IV loop diuretics|0|||
125097590|NCT00262119|449976506|FG000|Overall Study|Lost to Follow-up|38|||
125097591|NCT00262119|449976507|FG001|Overall Study|Lost to Follow-up|51|||
125097592|NCT00262119|449976508|FG002|Overall Study|Lost to Follow-up|42|||
125097593|NCT00262119|449976506|FG000|Overall Study|Death|20|||
125097594|NCT00262119|449976507|FG001|Overall Study|Death|19|||
125097595|NCT00262119|449976508|FG002|Overall Study|Death|16|||
125097596|NCT01683565|449976509|FG000|Overall Study|Lost to Follow-up|2|||
125097597|NCT01683565|449976510|FG001|Overall Study|Lost to Follow-up|0|||
125097598|NCT01683565|449976509|FG000|Overall Study|Discontinued Intervention|1|||
125097599|NCT01683565|449976510|FG001|Overall Study|Discontinued Intervention|1|||
125097600|NCT00071006|449976511|FG000|Overall Study|Lack of Efficacy|7|||
125097601|NCT00071006|449976511|FG000|Overall Study|Adverse Event|1|||
125097602|NCT00071006|449976511|FG000|Overall Study|Withdrawal by Subject|1|||
125097603|NCT00071006|449976511|FG000|Overall Study|Other|3|||
125097604|NCT00859313|449976512|FG000|Overall Study|Lack of Efficacy|2|||
125097605|NCT00859313|449976512|FG000|Overall Study|Adverse Event|1|||
125097606|NCT00859313|449976512|FG000|Overall Study|staff error|1|||
125097607|NCT05261126|449976513|FG000|Overall Study|Death|0|||
125097608|NCT05261126|449976514|FG001|Overall Study|Death|0|||
125097609|NCT05261126|449976515|FG002|Overall Study|Death|1|||
125097610|NCT05261126|449976516|FG003|Overall Study|Death|0|||
125097611|NCT05261126|449976517|FG004|Overall Study|Death|0|||
125097612|NCT05261126|449976513|FG000|Overall Study|Lost to Follow-up|0|||
125097613|NCT05261126|449976514|FG001|Overall Study|Lost to Follow-up|0|||
125097614|NCT05261126|449976515|FG002|Overall Study|Lost to Follow-up|0|||
125097615|NCT05261126|449976516|FG003|Overall Study|Lost to Follow-up|0|||
125097616|NCT05261126|449976517|FG004|Overall Study|Lost to Follow-up|1|||
125097617|NCT05261126|449976513|FG000|Overall Study|Physician Decision|1|||
125097618|NCT05261126|449976514|FG001|Overall Study|Physician Decision|0|||
125097619|NCT05261126|449976515|FG002|Overall Study|Physician Decision|0|||
125097620|NCT05261126|449976516|FG003|Overall Study|Physician Decision|0|||
125097621|NCT05261126|449976517|FG004|Overall Study|Physician Decision|0|||
125097622|NCT05261126|449976513|FG000|Overall Study|Screen Failure|0|||
125097623|NCT05261126|449976514|FG001|Overall Study|Screen Failure|0|||
125097624|NCT05261126|449976515|FG002|Overall Study|Screen Failure|0|||
125097625|NCT05261126|449976516|FG003|Overall Study|Screen Failure|0|||
125097626|NCT05261126|449976517|FG004|Overall Study|Screen Failure|1|||
125097627|NCT05261126|449976513|FG000|Overall Study|Withdrawal by Subject|1|||
125097628|NCT05261126|449976514|FG001|Overall Study|Withdrawal by Subject|0|||
125097629|NCT05261126|449976515|FG002|Overall Study|Withdrawal by Subject|1|||
125097630|NCT05261126|449976516|FG003|Overall Study|Withdrawal by Subject|1|||
125097631|NCT05261126|449976517|FG004|Overall Study|Withdrawal by Subject|0|||
125097632|NCT05261126|449976513|FG000|Overall Study|Not Recorded|0|||
125097633|NCT05261126|449976514|FG001|Overall Study|Not Recorded|0|||
125097634|NCT05261126|449976515|FG002|Overall Study|Not Recorded|0|||
125097635|NCT05261126|449976516|FG003|Overall Study|Not Recorded|1|||
125097636|NCT05261126|449976517|FG004|Overall Study|Not Recorded|0|||
125097637|NCT03901274|449976518|FG000|Overall Study|Lost to Follow-up|120|||
125097638|NCT03901274|449976519|FG001|Overall Study|Lost to Follow-up|124|||
125097639|NCT03901274|449976518|FG000|Overall Study|Withdrawal by Subject|0|||
125097640|NCT03901274|449976519|FG001|Overall Study|Withdrawal by Subject|6|||
125097641|NCT05570604|449976520|FG000|Overall Study|Lost to Follow-up|1|||
125097642|NCT05570604|449976521|FG001|Overall Study|Lost to Follow-up|5|||
125097643|NCT05570604|449976520|FG000|Overall Study|Illness|2|||
125097644|NCT05570604|449976521|FG001|Overall Study|Illness|2|||
125097645|NCT00145119|449976524|FG000|Overall Study|Death|45|||
125097646|NCT04527380|449976525|FG000|Overall Study|Lack of Efficacy|0|||
125097647|NCT04527380|449976526|FG001|Overall Study|Lack of Efficacy|1|||
125097648|NCT04527380|449976525|FG000|Overall Study|Withdrawal by Subject|1|||
125097649|NCT04527380|449976526|FG001|Overall Study|Withdrawal by Subject|0|||
125097650|NCT05437211|449976533|FG000|Overall Study|Patient's decision|1|||
125097651|NCT05437211|449976534|FG001|Overall Study|Patient's decision|1|||
125097652|NCT00931515|449976544|FG000|Overall Study|Lost to Follow-up|2|||
125097653|NCT00931515|449976545|FG001|Overall Study|Lost to Follow-up|5|||
125097654|NCT00686894|449976546|FG000|Overall Study|Relapse|2|||
125097655|NCT00686894|449976546|FG000|Overall Study|Protocol Violation|4|||
125097656|NCT01013207|449978436|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
125097657|NCT04196023|449978443|FG000|Overall Study|Withdrawal by Subject|0|||
125097658|NCT04196023|449978444|FG001|Overall Study|Withdrawal by Subject|1|||
125097659|NCT04196023|449978443|FG000|Overall Study|Adverse Event|3|||
125097660|NCT04196023|449978444|FG001|Overall Study|Adverse Event|1|||
125097661|NCT04196023|449978443|FG000|Overall Study|Lost to Follow-up|0|||
125097662|NCT04196023|449978444|FG001|Overall Study|Lost to Follow-up|1|||
125097663|NCT03358407|449978445|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
125097664|NCT03358407|449978446|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
125097665|NCT03358407|449978447|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
125097666|NCT03358407|449978448|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
125097667|NCT03358407|449978449|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
125097668|NCT03358407|449978450|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
125097669|NCT03358407|449978451|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
125097670|NCT03358407|449978452|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
125097671|NCT03358407|449978453|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
125097672|NCT03358407|449978454|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
125009438|NCT01131676|449660435|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
125009439|NCT01131676|449660433|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
125009440|NCT01131676|449660434|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
125009441|NCT01131676|449660435|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
125009442|NCT01131676|449660433|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
125009443|NCT01131676|449660434|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
125009444|NCT01131676|449660435|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
125009445|NCT01131676|449660433|FG000|Discontinuation From Treatment|Other than those specified|162|||
125009446|NCT01131676|449660434|FG001|Discontinuation From Treatment|Other than those specified|142|||
125009447|NCT01131676|449660435|FG002|Discontinuation From Treatment|Other than those specified|125|||
125009448|NCT01131676|449660433|FG000|Discontinuation From Treatment|Adverse Event|303|||
125009449|NCT01131676|449660434|FG001|Discontinuation From Treatment|Adverse Event|267|||
125009450|NCT01131676|449660435|FG002|Discontinuation From Treatment|Adverse Event|273|||
125009451|NCT01131676|449660433|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
125009452|NCT01131676|449660434|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
125009453|NCT01131676|449660435|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
125009454|NCT01131676|449660433|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
125009455|NCT01131676|449660434|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
125009456|NCT01131676|449660435|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
125009457|NCT01131676|449660433|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
125009458|NCT01131676|449660434|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
125009459|NCT01131676|449660435|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
125009460|NCT01131676|449660433|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
125009461|NCT01131676|449660434|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
125009462|NCT01131676|449660435|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
125009463|NCT01131676|449660433|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
125009464|NCT01131676|449660434|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
125009465|NCT01131676|449660435|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
125009466|NCT01131676|449660433|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
125009467|NCT01131676|449660434|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
125009468|NCT01131676|449660435|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
125009469|NCT01961349|449660436|FG000|Overall Study|Withdrawal by Subject|1|||
125009470|NCT01961349|449660437|FG001|Overall Study|Withdrawal by Subject|4|||
125009471|NCT01961349|449660438|FG002|Overall Study|Withdrawal by Subject|0|||
125009472|NCT01961349|449660436|FG000|Overall Study|Adverse Event|0|||
125009473|NCT01961349|449660437|FG001|Overall Study|Adverse Event|0|||
125009474|NCT01961349|449660438|FG002|Overall Study|Adverse Event|1|||
125009475|NCT01961349|449660436|FG000|Overall Study|registration error, personal reason etc|2|||
125009476|NCT01961349|449660437|FG001|Overall Study|registration error, personal reason etc|2|||
125009477|NCT01961349|449660438|FG002|Overall Study|registration error, personal reason etc|1|||
125009478|NCT00829179|449660441|FG000|Overall Study|Withdrawal by Subject|1|||
125009479|NCT03000179|449660442|FG000|Overall Study|Lost to Follow-up|2|||
125009480|NCT01075412|449660444|FG000|Overall Study|Withdrawal by Subject|0|||
125009481|NCT01075412|449660445|FG001|Overall Study|Withdrawal by Subject|1|||
125009482|NCT00865904|449660448|FG000|Overall Study|Randomized but not Treated|2|||
125009483|NCT00865904|449660449|FG001|Overall Study|Randomized but not Treated|0|||
125009484|NCT00865904|449660450|FG002|Overall Study|Randomized but not Treated|0|||
125009485|NCT00865904|449660451|FG003|Overall Study|Randomized but not Treated|1|||
125009486|NCT00865904|449660452|FG004|Overall Study|Randomized but not Treated|1|||
125009487|NCT03625687|449660453|FG000|Overall Study|Death|1|||
125009488|NCT01431274|449660454|FG000|Overall Study|Adverse Event|51|||
125009489|NCT01431274|449660455|FG001|Overall Study|Adverse Event|37|||
125009490|NCT01431274|449660456|FG002|Overall Study|Adverse Event|43|||
125009491|NCT01431274|449660457|FG003|Overall Study|Adverse Event|30|||
125009492|NCT01431274|449660458|FG004|Overall Study|Adverse Event|37|||
125009493|NCT01431274|449660454|FG000|Overall Study|Consent withdrawn not due to AE|29|||
125009494|NCT01431274|449660455|FG001|Overall Study|Consent withdrawn not due to AE|20|||
125009495|NCT01431274|449660456|FG002|Overall Study|Consent withdrawn not due to AE|17|||
125009496|NCT01431274|449660457|FG003|Overall Study|Consent withdrawn not due to AE|20|||
125009497|NCT01431274|449660458|FG004|Overall Study|Consent withdrawn not due to AE|11|||
125009498|NCT01431274|449660454|FG000|Overall Study|Non compliant with protocol|5|||
125009499|NCT01431274|449660455|FG001|Overall Study|Non compliant with protocol|8|||
125009500|NCT01431274|449660456|FG002|Overall Study|Non compliant with protocol|4|||
125009501|NCT01431274|449660457|FG003|Overall Study|Non compliant with protocol|4|||
125009502|NCT01431274|449660458|FG004|Overall Study|Non compliant with protocol|4|||
125009503|NCT01431274|449660454|FG000|Overall Study|Lost to Follow-up|6|||
125009504|NCT01431274|449660455|FG001|Overall Study|Lost to Follow-up|7|||
125009505|NCT01431274|449660456|FG002|Overall Study|Lost to Follow-up|1|||
125009506|NCT01431274|449660457|FG003|Overall Study|Lost to Follow-up|4|||
125097673|NCT03358407|449978445|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125009507|NCT01431274|449660458|FG004|Overall Study|Lost to Follow-up|0|||
125009508|NCT01431274|449660454|FG000|Overall Study|Other reason not stated above|6|||
125097674|NCT03358407|449978446|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125009509|NCT01431274|449660455|FG001|Overall Study|Other reason not stated above|5|||
125009510|NCT01431274|449660456|FG002|Overall Study|Other reason not stated above|7|||
125009511|NCT01431274|449660457|FG003|Overall Study|Other reason not stated above|2|||
125009512|NCT01431274|449660458|FG004|Overall Study|Other reason not stated above|4|||
125009513|NCT00711425|449660463|FG000|Overall Study|Protocol Violation|1|||
125009514|NCT00711425|449660463|FG000|Overall Study|Death|2|||
125009515|NCT00711425|449660463|FG000|Overall Study|Lost to Follow-up|1|||
125009516|NCT00916149|449660464|FG000|Overall Study|Lost to Follow-up|3|||
125009517|NCT00916149|449660465|FG001|Overall Study|Lost to Follow-up|2|||
125009518|NCT00916149|449660466|FG002|Overall Study|Lost to Follow-up|0|||
125009519|NCT00916149|449660464|FG000|Overall Study|Unable to place scalp EEG leads|1|||
125009520|NCT00916149|449660465|FG001|Overall Study|Unable to place scalp EEG leads|0|||
125009521|NCT00916149|449660466|FG002|Overall Study|Unable to place scalp EEG leads|0|||
125009522|NCT00589420|449660467|FG000|Overall Study|screen failure|1|||
125009523|NCT01846624|449660468|FG000|Overall Study|Died during induction, no midostaurin|1|||
125009524|NCT03574753|449660469|FG000|Overall Study|Adverse Event|3|||
125009525|NCT03574753|449660469|FG000|Overall Study|Progression/relapse|19|||
125009526|NCT03574753|449660469|FG000|Overall Study|Death|1|||
125009527|NCT00307151|449661626|FG000|Overall Study|Death|4|||
125009528|NCT00307151|449661627|FG001|Overall Study|Death|3|||
125009529|NCT00307151|449661628|FG002|Overall Study|Death|10|||
125009530|NCT00307151|449661629|FG003|Overall Study|Death|3|||
125009531|NCT00307151|449661626|FG000|Overall Study|Severe debilitation, unable to continue|1|||
125009532|NCT00307151|449661627|FG001|Overall Study|Severe debilitation, unable to continue|0|||
125009533|NCT00307151|449661628|FG002|Overall Study|Severe debilitation, unable to continue|0|||
125009534|NCT00307151|449661629|FG003|Overall Study|Severe debilitation, unable to continue|0|||
125009535|NCT00307151|449661626|FG000|Overall Study|Subject unable to get to clinic|1|||
125009536|NCT00307151|449661627|FG001|Overall Study|Subject unable to get to clinic|0|||
125009537|NCT00307151|449661628|FG002|Overall Study|Subject unable to get to clinic|6|||
125009538|NCT00307151|449661629|FG003|Overall Study|Subject unable to get to clinic|2|||
125009539|NCT00307151|449661626|FG000|Overall Study|Withdrew consent|0|||
125009540|NCT00307151|449661627|FG001|Overall Study|Withdrew consent|1|||
125009541|NCT00307151|449661628|FG002|Overall Study|Withdrew consent|1|||
125009542|NCT00307151|449661629|FG003|Overall Study|Withdrew consent|3|||
125009543|NCT00307151|449661626|FG000|Overall Study|Not willing to adhere to study reqs|2|||
125009544|NCT00307151|449661627|FG001|Overall Study|Not willing to adhere to study reqs|0|||
125009545|NCT00307151|449661628|FG002|Overall Study|Not willing to adhere to study reqs|2|||
125009546|NCT00307151|449661629|FG003|Overall Study|Not willing to adhere to study reqs|2|||
125009547|NCT00307151|449661626|FG000|Overall Study|Clinic unable to contact subject|3|||
125009548|NCT00307151|449661627|FG001|Overall Study|Clinic unable to contact subject|3|||
125009549|NCT00307151|449661628|FG002|Overall Study|Clinic unable to contact subject|1|||
125009550|NCT00307151|449661629|FG003|Overall Study|Clinic unable to contact subject|1|||
125009551|NCT01490450|449661630|FG000|Period 1|Lack of Efficacy|2|||
125009552|NCT01490450|449661631|FG001|Period 1|Lack of Efficacy|0|||
125009553|NCT01490450|449661632|FG002|Period 1|Lack of Efficacy|3|||
125009554|NCT01490450|449661633|FG003|Period 1|Lack of Efficacy|0|||
125009555|NCT01490450|449661630|FG000|Period 1|Adverse Event|0|||
125009556|NCT01490450|449661631|FG001|Period 1|Adverse Event|0|||
125009557|NCT01490450|449661632|FG002|Period 1|Adverse Event|0|||
125009558|NCT01490450|449661633|FG003|Period 1|Adverse Event|5|||
125009559|NCT01490450|449661630|FG000|Period 1|Request to discontinue treatment|1|||
125009560|NCT01490450|449661631|FG001|Period 1|Request to discontinue treatment|0|||
125009561|NCT01490450|449661632|FG002|Period 1|Request to discontinue treatment|0|||
125009562|NCT01490450|449661633|FG003|Period 1|Request to discontinue treatment|0|||
125009563|NCT01490450|449661630|FG000|Period 1|Withdrawal by Subject|0|||
125009564|NCT01490450|449661631|FG001|Period 1|Withdrawal by Subject|0|||
125009565|NCT01490450|449661632|FG002|Period 1|Withdrawal by Subject|0|||
125009566|NCT01490450|449661633|FG003|Period 1|Withdrawal by Subject|3|||
125009567|NCT01490450|449661630|FG000|Period 1|No longer met study criteria|0|||
125009568|NCT01490450|449661631|FG001|Period 1|No longer met study criteria|1|||
125009569|NCT01490450|449661632|FG002|Period 1|No longer met study criteria|1|||
125009570|NCT01490450|449661633|FG003|Period 1|No longer met study criteria|0|||
125009571|NCT01490450|449661630|FG000|Period 2|Lack of Efficacy|0|||
125009572|NCT01490450|449661631|FG001|Period 2|Lack of Efficacy|0|||
125009573|NCT01490450|449661632|FG002|Period 2|Lack of Efficacy|0|||
125009574|NCT01490450|449661633|FG003|Period 2|Lack of Efficacy|1|||
125009575|NCT01490450|449661630|FG000|Period 2|Adverse Event|1|||
125009576|NCT01490450|449661631|FG001|Period 2|Adverse Event|1|||
125009577|NCT01490450|449661632|FG002|Period 2|Adverse Event|0|||
125009578|NCT01490450|449661633|FG003|Period 2|Adverse Event|1|||
125009579|NCT01490450|449661630|FG000|Period 2|Withdrawal by Subject|1|||
125009580|NCT01490450|449661631|FG001|Period 2|Withdrawal by Subject|0|||
125009581|NCT01490450|449661632|FG002|Period 2|Withdrawal by Subject|0|||
125097675|NCT03358407|449978447|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125097676|NCT03358407|449978448|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125097677|NCT03358407|449978449|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
125097678|NCT03358407|449978450|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125097679|NCT03358407|449978451|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125097680|NCT03358407|449978452|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125097681|NCT03358407|449978453|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125097682|NCT03358407|449978454|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125097683|NCT03358407|449978445|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
125097684|NCT03358407|449978446|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
125097685|NCT03358407|449978447|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
125097686|NCT03358407|449978448|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
125097687|NCT03358407|449978449|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
125097688|NCT03358407|449978450|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
125097689|NCT03358407|449978451|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
125097690|NCT03358407|449978452|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
125097691|NCT03358407|449978453|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
125097692|NCT03358407|449978454|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
125097693|NCT03358407|449978445|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
125097694|NCT03358407|449978446|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
125097695|NCT03358407|449978447|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
125097696|NCT03358407|449978448|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
125097697|NCT03358407|449978449|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
125097698|NCT03358407|449978450|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
125097699|NCT03358407|449978451|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
125097700|NCT03358407|449978452|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
125097701|NCT03358407|449978453|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
125097702|NCT03358407|449978454|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
125097703|NCT03358407|449978445|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125097704|NCT03358407|449978446|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125097705|NCT03358407|449978447|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125097706|NCT03358407|449978448|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125097707|NCT03358407|449978449|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125097708|NCT03358407|449978450|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
125097709|NCT03358407|449978451|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
125009582|NCT01490450|449661633|FG003|Period 2|Withdrawal by Subject|0|||
125009583|NCT01490450|449661630|FG000|Period 2|Lost to Follow-up|0|||
125009584|NCT01490450|449661631|FG001|Period 2|Lost to Follow-up|0|||
125009585|NCT01490450|449661632|FG002|Period 2|Lost to Follow-up|0|||
125009586|NCT01490450|449661633|FG003|Period 2|Lost to Follow-up|2|||
125009587|NCT00253643|449661636|FG000|Overall Study|Withdrawal by Subject|0|||
125009588|NCT00253643|449661637|FG001|Overall Study|Withdrawal by Subject|0|||
125009589|NCT00253643|449661638|FG002|Overall Study|Withdrawal by Subject|1|||
125009590|NCT00253643|449661639|FG003|Overall Study|Withdrawal by Subject|1|||
125009591|NCT00253643|449661636|FG000|Overall Study|Non-Compliance|0|||
125009592|NCT00253643|449661637|FG001|Overall Study|Non-Compliance|0|||
125009593|NCT00253643|449661638|FG002|Overall Study|Non-Compliance|0|||
125009594|NCT00253643|449661639|FG003|Overall Study|Non-Compliance|2|||
125009595|NCT01111851|449661640|FG000|Overall Study|All planned PET scans were not obtained.|2|||
125009596|NCT01111851|449661641|FG001|Overall Study|All planned PET scans were not obtained.|0|||
125009597|NCT01471015|449661642|FG000|Overall Study|Death|0|||
125009598|NCT01471015|449661643|FG001|Overall Study|Death|1|||
125009599|NCT01471015|449661644|FG002|Overall Study|Death|1|||
125009600|NCT01299376|449661646|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
125009601|NCT01299376|449661647|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
125009602|NCT01299376|449661646|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
125009603|NCT01299376|449661647|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
125009604|NCT01299376|449661646|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
125009605|NCT01299376|449661647|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
125009606|NCT01299376|449661646|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
125009607|NCT01299376|449661647|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
125009608|NCT01299376|449661646|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
125009609|NCT01299376|449661647|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
125009610|NCT01299376|449661646|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
125009611|NCT01299376|449661647|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
125009612|NCT01299376|449661646|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
125009613|NCT01299376|449661647|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
125009614|NCT01299376|449661646|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
125009615|NCT01299376|449661647|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
125009616|NCT01299376|449661646|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
125009617|NCT01299376|449661647|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
125097710|NCT03358407|449978452|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125097711|NCT03358407|449978453|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125097712|NCT03358407|449978454|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125097713|NCT03358407|449978445|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
125009618|NCT01299376|449661646|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
125009619|NCT01299376|449661647|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
125009620|NCT01299376|449661646|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
125009621|NCT01299376|449661647|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
125009622|NCT04315181|449661651|FG000|Overall Study|Non-responsive to drug conditions.|1|||
125009623|NCT05879107|449661652|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
125009624|NCT05879107|449661653|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
125009625|NCT05879107|449661652|FG000|Overall Study|Migrated / moved from the study area|1|||
125009626|NCT05879107|449661653|FG001|Overall Study|Migrated / moved from the study area|1|||
125009627|NCT05879107|449661652|FG000|Overall Study|Lost to Follow-up|8|||
125009628|NCT05879107|449661653|FG001|Overall Study|Lost to Follow-up|13|||
125009629|NCT05879107|449661652|FG000|Overall Study|Death|0|||
125009630|NCT05879107|449661653|FG001|Overall Study|Death|2|||
125009631|NCT05879107|449661652|FG000|Overall Study|Other|0|||
125009632|NCT05879107|449661653|FG001|Overall Study|Other|3|||
125009633|NCT04607148|449661656|FG000|Overall Study|Withdrawal by Subject|0|||
125009634|NCT04607148|449661657|FG001|Overall Study|Withdrawal by Subject|4|||
125009635|NCT04607148|449661658|FG002|Overall Study|Withdrawal by Subject|2|||
125009636|NCT04607148|449661659|FG003|Overall Study|Withdrawal by Subject|8|||
125009637|NCT04607148|449661656|FG000|Overall Study|Study Terminated by Sponsor|14|||
125009638|NCT04607148|449661657|FG001|Overall Study|Study Terminated by Sponsor|59|||
125009639|NCT04607148|449661658|FG002|Overall Study|Study Terminated by Sponsor|9|||
125009640|NCT04607148|449661659|FG003|Overall Study|Study Terminated by Sponsor|39|||
125009641|NCT04607148|449661656|FG000|Overall Study|Sponsor Decision|0|||
125009642|NCT04607148|449661657|FG001|Overall Study|Sponsor Decision|0|||
125009643|NCT04607148|449661658|FG002|Overall Study|Sponsor Decision|1|||
125009644|NCT04607148|449661659|FG003|Overall Study|Sponsor Decision|0|||
125009645|NCT04607148|449661656|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125009646|NCT04607148|449661657|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125009647|NCT04607148|449661658|FG002|Overall Study|Non-Compliance With Study Drug|0|||
125009648|NCT04607148|449661659|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125009649|NCT04607148|449661656|FG000|Overall Study|Lost to Follow-up|0|||
125009650|NCT04607148|449661657|FG001|Overall Study|Lost to Follow-up|2|||
125009651|NCT04607148|449661658|FG002|Overall Study|Lost to Follow-up|0|||
125009652|NCT04607148|449661659|FG003|Overall Study|Lost to Follow-up|0|||
125009653|NCT04607148|449661656|FG000|Overall Study|Death|0|||
125009654|NCT04607148|449661657|FG001|Overall Study|Death|3|||
125009655|NCT04607148|449661658|FG002|Overall Study|Death|0|||
125009656|NCT04607148|449661659|FG003|Overall Study|Death|1|||
125009657|NCT04607148|449661656|FG000|Overall Study|Adverse Event|0|||
125009658|NCT04607148|449661657|FG001|Overall Study|Adverse Event|1|||
125009659|NCT04607148|449661658|FG002|Overall Study|Adverse Event|0|||
125009660|NCT04607148|449661659|FG003|Overall Study|Adverse Event|0|||
125009661|NCT00912028|449661662|FG000|Overall Study|Lost to Follow-up|2|||
125009662|NCT00912028|449661663|FG001|Overall Study|Lost to Follow-up|3|||
125009663|NCT00912028|449661664|FG002|Overall Study|Lost to Follow-up|0|||
125009664|NCT00912028|449661665|FG003|Overall Study|Lost to Follow-up|1|||
125009665|NCT00912028|449661666|FG004|Overall Study|Lost to Follow-up|3|||
125009666|NCT00912028|449661662|FG000|Overall Study|Withdrawal by Subject|3|||
125009667|NCT00912028|449661663|FG001|Overall Study|Withdrawal by Subject|0|||
125009668|NCT00912028|449661664|FG002|Overall Study|Withdrawal by Subject|0|||
125009669|NCT00912028|449661665|FG003|Overall Study|Withdrawal by Subject|0|||
125009670|NCT00912028|449661666|FG004|Overall Study|Withdrawal by Subject|0|||
125009671|NCT02973087|449661669|FG000|Overall Study|Withdrawal by Subject|2|||
125009672|NCT02973087|449661670|FG001|Overall Study|Withdrawal by Subject|1|||
125009673|NCT02973087|449661669|FG000|Overall Study|Adverse Event|1|||
125009674|NCT02973087|449661670|FG001|Overall Study|Adverse Event|0|||
125009675|NCT02973087|449661669|FG000|Overall Study|other|1|||
125009676|NCT02973087|449661670|FG001|Overall Study|other|1|||
125009677|NCT00932360|449661673|FG000|Washout (One Week)|Withdrawal by Subject|0|||
125009678|NCT00932360|449661674|FG001|Washout (One Week)|Withdrawal by Subject|0|||
125009679|NCT00932360|449661675|FG002|Washout (One Week)|Withdrawal by Subject|0|||
125009680|NCT00932360|449661676|FG003|Washout (One Week)|Withdrawal by Subject|0|||
125009681|NCT00932360|449661677|FG004|Washout (One Week)|Withdrawal by Subject|2|||
125009682|NCT00932360|449661678|FG005|Washout (One Week)|Withdrawal by Subject|0|||
125009683|NCT01924182|449661679|FG000|Overall Study|Withdrawal by Subject|1|||
125009684|NCT01924182|449661680|FG001|Overall Study|Withdrawal by Subject|0|||
125009685|NCT04143009|449661681|FG000|Pilot Trial|Lost to Follow-up|0|||
125009686|NCT04143009|449661682|FG001|Pilot Trial|Lost to Follow-up|1|||
125009687|NCT04143009|449661683|FG002|Pilot Trial|Lost to Follow-up|1|||
125009688|NCT00993265|449661684|FG000|Overall Study|Adverse Event|1|||
125009689|NCT00993265|449661685|FG001|Overall Study|Adverse Event|0|||
125009690|NCT00993265|449661684|FG000|Overall Study|Changed dose of concomitant drug|2|||
125009691|NCT00993265|449661685|FG001|Overall Study|Changed dose of concomitant drug|0|||
125009692|NCT00993265|449661684|FG000|Overall Study|Non-compliant with study medication|1|||
125009693|NCT00993265|449661685|FG001|Overall Study|Non-compliant with study medication|0|||
125009694|NCT01744665|449661686|FG000|Monitoring Phase|Adverse Event|4|||
125009695|NCT01744665|449661686|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
125009696|NCT01744665|449661686|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
125097714|NCT03358407|449978446|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
125097715|NCT03358407|449978447|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
125097716|NCT03358407|449978448|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
125097717|NCT03358407|449978449|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
125097718|NCT03358407|449978450|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
125097719|NCT03358407|449978451|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
125097720|NCT03358407|449978452|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
125097721|NCT03358407|449978453|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
125097722|NCT03358407|449978454|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
125097723|NCT03605758|449978455|FG000|Overall Study|Lost to Follow-up|2|||
125097724|NCT03605758|449978456|FG001|Overall Study|Lost to Follow-up|1|||
125097725|NCT03605758|449978455|FG000|Overall Study|Illness|0|||
125097726|NCT03605758|449978456|FG001|Overall Study|Illness|1|||
125097727|NCT03605758|449978455|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
125097728|NCT03605758|449978456|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
125097729|NCT00489411|449978457|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
125097730|NCT00489411|449978458|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
125097731|NCT00489411|449978457|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
125097732|NCT00489411|449978458|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
125097733|NCT00489411|449978457|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
125097734|NCT00489411|449978458|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
125097735|NCT00489411|449978457|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
125097736|NCT00489411|449978458|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
125097737|NCT00489411|449978457|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
125097738|NCT00489411|449978458|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
125097739|NCT01283009|449978459|FG000|Overall Study|Death|83|||
125097740|NCT01283009|449978460|FG001|Overall Study|Death|78|||
125097741|NCT01283009|449978459|FG000|Overall Study|Study ended early|23|||
125097742|NCT01283009|449978460|FG001|Overall Study|Study ended early|26|||
125097743|NCT01283009|449978459|FG000|Overall Study|Withdrawal by Subject|10|||
125097744|NCT01283009|449978460|FG001|Overall Study|Withdrawal by Subject|8|||
125097745|NCT01283009|449978459|FG000|Overall Study|Physician Decision|1|||
125097746|NCT01283009|449978460|FG001|Overall Study|Physician Decision|1|||
125097747|NCT01283009|449978459|FG000|Overall Study|Lost to Follow-up|1|||
125097748|NCT01283009|449978460|FG001|Overall Study|Lost to Follow-up|0|||
125097749|NCT01283009|449978459|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
125097750|NCT01283009|449978460|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
125097751|NCT04640168|449978464|FG000|Overall Study|Withdrawal by Subject|8|||
125097752|NCT04640168|449978465|FG001|Overall Study|Withdrawal by Subject|7|||
125097753|NCT04640168|449978464|FG000|Overall Study|Lost to Follow-up|1|||
125097754|NCT04640168|449978465|FG001|Overall Study|Lost to Follow-up|0|||
125097755|NCT04640168|449978464|FG000|Overall Study|Enrolled but not treated|12|||
125097756|NCT04640168|449978465|FG001|Overall Study|Enrolled but not treated|12|||
125097757|NCT04366258|449978469|FG000|Baseline Assessments|Screen Failure|21|||
125097758|NCT04366258|449978469|FG000|Baseline Assessments|Early Termination|3|||
125097759|NCT00308555|449978470|FG000|Overall Study|Withdrawal by Subject|1|||
125097760|NCT00308555|449978471|FG001|Overall Study|Withdrawal by Subject|0|||
125097761|NCT00308555|449978470|FG000|Overall Study|Physician Decision|2|||
125097762|NCT00308555|449978471|FG001|Overall Study|Physician Decision|0|||
125097763|NCT00276458|449978472|FG000|Overall Study|Adverse Event|0|||
125097764|NCT00276458|449978473|FG001|Overall Study|Adverse Event|2|||
125097765|NCT00276458|449978472|FG000|Overall Study|Lost to Follow-up|2|||
125097766|NCT00276458|449978473|FG001|Overall Study|Lost to Follow-up|2|||
125097767|NCT00276458|449978472|FG000|Overall Study|Protocol Violation|4|||
125097768|NCT00276458|449978473|FG001|Overall Study|Protocol Violation|3|||
125097769|NCT02940392|449978476|FG000|Overall Study|Lost to Follow-up|3|||
125097770|NCT02940392|449978476|FG000|Overall Study|Retreatment|3|||
125097771|NCT02940392|449978476|FG000|Overall Study|Death|2|||
125097772|NCT00910000|449978480|FG000|Overall Study|Adverse Event|0|||
125097773|NCT00910000|449978481|FG001|Overall Study|Adverse Event|3|||
125097774|NCT00910000|449978482|FG002|Overall Study|Adverse Event|2|||
125097775|NCT00910000|449978483|FG003|Overall Study|Adverse Event|2|||
125097776|NCT00910000|449978484|FG004|Overall Study|Adverse Event|0|||
125097777|NCT00910000|449978485|FG005|Overall Study|Adverse Event|1|||
125097778|NCT00910000|449978480|FG000|Overall Study|Withdrawal by Subject|0|||
125097779|NCT00910000|449978481|FG001|Overall Study|Withdrawal by Subject|0|||
125097780|NCT00910000|449978482|FG002|Overall Study|Withdrawal by Subject|1|||
125097781|NCT00910000|449978483|FG003|Overall Study|Withdrawal by Subject|0|||
125097782|NCT00910000|449978484|FG004|Overall Study|Withdrawal by Subject|1|||
125097783|NCT00910000|449978485|FG005|Overall Study|Withdrawal by Subject|0|||
125097784|NCT03125382|449978486|FG000|Randomization|screening failure|1|||
125097785|NCT03125382|449978487|FG001|Randomization|screening failure|4|||
125097786|NCT03125382|449978488|FG002|Randomization|screening failure|2|||
125097787|NCT03125382|449978489|FG003|Randomization|screening failure|0|||
125097788|NCT03125382|449978486|FG000|Follow-up|Death|1|||
125097789|NCT03125382|449978487|FG001|Follow-up|Death|2|||
125097790|NCT03125382|449978488|FG002|Follow-up|Death|1|||
125097791|NCT03125382|449978489|FG003|Follow-up|Death|2|||
125097792|NCT03125382|449978486|FG000|Follow-up|Lost to Follow-up|1|||
125097793|NCT03125382|449978487|FG001|Follow-up|Lost to Follow-up|4|||
125097794|NCT03125382|449978488|FG002|Follow-up|Lost to Follow-up|3|||
125097795|NCT03125382|449978489|FG003|Follow-up|Lost to Follow-up|1|||
125097796|NCT02686749|449978490|FG000|Overall Study|terminated for poor enrollment|2|||
125097797|NCT02686749|449978491|FG001|Overall Study|terminated for poor enrollment|2|||
125097798|NCT05147311|449978494|FG000|Overall Study|Did not complete survey|2|||
125097799|NCT05147311|449978495|FG001|Overall Study|Did not complete survey|1|||
125097800|NCT05147311|449978494|FG000|Overall Study|Patient too sick|1|||
125097801|NCT05147311|449978495|FG001|Overall Study|Patient too sick|2|||
125097802|NCT05147311|449978494|FG000|Overall Study|Death|0|||
125097803|NCT05147311|449978495|FG001|Overall Study|Death|1|||
125097804|NCT05147311|449978494|FG000|Overall Study|Declined survey|1|||
125097805|NCT05147311|449978495|FG001|Overall Study|Declined survey|0|||
125097806|NCT04505592|449978497|FG000|Overall Study|Death|2|||
125097807|NCT04505592|449978498|FG001|Overall Study|Death|1|||
125097808|NCT01015118|449978503|FG000|Overall Study|Protocol Violation|5|||
125097809|NCT01015118|449978504|FG001|Overall Study|Protocol Violation|6|||
125097810|NCT01015118|449978503|FG000|Overall Study|Withdrawal by Subject|103|||
125097811|NCT01015118|449978504|FG001|Overall Study|Withdrawal by Subject|27|||
125097812|NCT01015118|449978503|FG000|Overall Study|Other Adverse Event (AE)|141|||
125097813|NCT01015118|449978504|FG001|Overall Study|Other Adverse Event (AE)|33|||
125097814|NCT01015118|449978503|FG000|Overall Study|Worsening or AE of underlying disease|5|||
125097815|NCT01015118|449978504|FG001|Overall Study|Worsening or AE of underlying disease|4|||
125097816|NCT01015118|449978503|FG000|Overall Study|Progressive disease|364|||
125097817|NCT01015118|449978504|FG001|Overall Study|Progressive disease|229|||
125097818|NCT01015118|449978503|FG000|Overall Study|Not treated|9|||
125097819|NCT01015118|449978504|FG001|Overall Study|Not treated|5|||
125097820|NCT01015118|449978503|FG000|Overall Study|Other than stated above|42|||
125097821|NCT01015118|449978504|FG001|Overall Study|Other than stated above|23|||
125097822|NCT03522506|449978505|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125097823|NCT03522506|449978506|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125097824|NCT03522506|449978507|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125097825|NCT03522506|449978508|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
125097826|NCT03522506|449978505|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
125097827|NCT03522506|449978506|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
125097828|NCT03522506|449978507|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
125097829|NCT03522506|449978508|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
125097830|NCT03480243|449978509|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
125097831|NCT03480243|449978509|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
125097832|NCT02388906|449978511|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
125097833|NCT02388906|449978512|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
125097834|NCT02388906|449978511|FG000|Treatment Period|Disease progression|121|||
125097835|NCT02388906|449978512|FG001|Treatment Period|Disease progression|100|||
125097836|NCT02388906|449978511|FG000|Treatment Period|Study drug toxicity|41|||
125097837|NCT02388906|449978512|FG001|Treatment Period|Study drug toxicity|208|||
125097838|NCT02388906|449978511|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
125097839|NCT02388906|449978512|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
125097840|NCT02388906|449978511|FG000|Treatment Period|Participant request to stop treatment|5|||
125097841|NCT02388906|449978512|FG001|Treatment Period|Participant request to stop treatment|9|||
125097842|NCT02388906|449978511|FG000|Treatment Period|Participant withdrew consent|2|||
125097843|NCT02388906|449978512|FG001|Treatment Period|Participant withdrew consent|3|||
125097844|NCT02388906|449978511|FG000|Treatment Period|Poor/non-compliance|0|||
125097845|NCT02388906|449978512|FG001|Treatment Period|Poor/non-compliance|1|||
125097846|NCT02388906|449978511|FG000|Treatment Period|Participant no longer meets study criteria|0|||
125097847|NCT02388906|449978512|FG001|Treatment Period|Participant no longer meets study criteria|1|||
125097848|NCT02388906|449978511|FG000|Treatment Period|Other reasons|3|||
125097849|NCT02388906|449978512|FG001|Treatment Period|Other reasons|3|||
125097850|NCT04365387|449978521|FG000|Overall Study|Adverse Event|4|||
125097851|NCT04365387|449978522|FG001|Overall Study|Adverse Event|2|||
125097852|NCT04365387|449978521|FG000|Overall Study|Participants request|14|||
125097853|NCT04365387|449978522|FG001|Overall Study|Participants request|14|||
125097854|NCT04365387|449978521|FG000|Overall Study|Lost to Follow-up|8|||
125097855|NCT04365387|449978522|FG001|Overall Study|Lost to Follow-up|5|||
125097856|NCT04365387|449978521|FG000|Overall Study|Protocol deviation|3|||
125097857|NCT04365387|449978522|FG001|Overall Study|Protocol deviation|4|||
125097858|NCT04365387|449978521|FG000|Overall Study|Participant compliance with visit schedule|1|||
125097859|NCT04365387|449978522|FG001|Overall Study|Participant compliance with visit schedule|0|||
125097860|NCT04365387|449978521|FG000|Overall Study|Participant incarcerated|1|||
125097861|NCT04365387|449978522|FG001|Overall Study|Participant incarcerated|0|||
125097862|NCT04365387|449978521|FG000|Overall Study|Participant moved out of town (relocated)|0|||
125097863|NCT04365387|449978522|FG001|Overall Study|Participant moved out of town (relocated)|1|||
125097864|NCT04365387|449978521|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
125097865|NCT04365387|449978522|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
125097866|NCT04365387|449978521|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
125097867|NCT04365387|449978522|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
125097868|NCT04410991|449978523|FG000|Overall Study|Poor compliance to protocol|5|||
125097869|NCT04410991|449978524|FG001|Overall Study|Poor compliance to protocol|4|||
125097870|NCT04410991|449978523|FG000|Overall Study|Withdrawal by Subject|59|||
125097871|NCT04410991|449978524|FG001|Overall Study|Withdrawal by Subject|55|||
125097872|NCT04410991|449978523|FG000|Overall Study|Other|10|||
125097873|NCT04410991|449978524|FG001|Overall Study|Other|4|||
125097874|NCT03282123|449978525|FG000|Overall Study|Withdrawal by Subject|5|||
125097875|NCT00938366|449978526|FG000|Overall Study|Withdrawal by Subject|1|||
125097876|NCT00938366|449978527|FG001|Overall Study|Withdrawal by Subject|0|||
125097877|NCT01463631|449978534|FG000|Overall Study|Withdrawal by Subject|0|||
125097878|NCT01463631|449978535|FG001|Overall Study|Withdrawal by Subject|0|||
125097879|NCT01463631|449978536|FG002|Overall Study|Withdrawal by Subject|0|||
125097880|NCT01463631|449978537|FG003|Overall Study|Withdrawal by Subject|1|||
125097881|NCT01463631|449978534|FG000|Overall Study|Death|0|||
125097882|NCT01463631|449978535|FG001|Overall Study|Death|0|||
125097883|NCT01463631|449978536|FG002|Overall Study|Death|1|||
125097884|NCT01463631|449978537|FG003|Overall Study|Death|0|||
125097885|NCT01463631|449978534|FG000|Overall Study|Progressive Disease|0|||
125097886|NCT01463631|449978535|FG001|Overall Study|Progressive Disease|0|||
125097887|NCT01463631|449978536|FG002|Overall Study|Progressive Disease|0|||
125097888|NCT01463631|449978537|FG003|Overall Study|Progressive Disease|5|||
125097889|NCT05966129|449978540|FG000|Overall Study|Death|1|||
125097890|NCT05966129|449978541|FG001|Overall Study|Death|2|||
125097891|NCT05966129|449978540|FG000|Overall Study|Lost to Follow-up|63|||
125009697|NCT01744665|449661686|FG000|Monitoring Phase|Withdrawal by Subject|5|||
125009698|NCT01744665|449661686|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
125009699|NCT01744665|449661686|FG000|Consolidation Phase|Adverse Event|2|||
125009700|NCT01744665|449661686|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
125009701|NCT01744665|449661686|FG000|Consolidation Phase|Withdrawal by Subject|4|||
125009702|NCT01744665|449661686|FG000|Consolidation Phase|Administrative problems|9|||
125009703|NCT01744665|449661686|FG000|Re-initiation Phase|Administrative problems|10|||
125009704|NCT01744665|449661686|FG000|Re-initiation Phase|Adverse Event|1|||
125009705|NCT01744665|449661686|FG000|Re-initiation Phase|No longer required treatment|1|||
125009706|NCT01744665|449661686|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
125009707|NCT01357655|449661687|FG000|Overall Study|Administrative Reason by Sponsor|45|||
125009708|NCT01357655|449661688|FG001|Overall Study|Administrative Reason by Sponsor|0|||
125009709|NCT01357655|449661687|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
125009710|NCT01357655|449661688|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
125009711|NCT01357655|449661687|FG000|Overall Study|Disease Progression|1|||
125009712|NCT01357655|449661688|FG001|Overall Study|Disease Progression|0|||
125009713|NCT01357655|449661687|FG000|Overall Study|Lost to Follow-up|2|||
125009714|NCT01357655|449661688|FG001|Overall Study|Lost to Follow-up|0|||
125009715|NCT01357655|449661687|FG000|Overall Study|Maximum Clinical Benefit|2|||
125009716|NCT01357655|449661688|FG001|Overall Study|Maximum Clinical Benefit|0|||
125009717|NCT01357655|449661687|FG000|Overall Study|Reason Unspecified|1|||
125009718|NCT01357655|449661688|FG001|Overall Study|Reason Unspecified|0|||
125009719|NCT01357655|449661687|FG000|Overall Study|Study Drug Toxicity|11|||
125009720|NCT01357655|449661688|FG001|Overall Study|Study Drug Toxicity|0|||
125009721|NCT01357655|449661687|FG000|Overall Study|Subject Withdrew Consent|1|||
125009722|NCT01357655|449661688|FG001|Overall Study|Subject Withdrew Consent|0|||
125009723|NCT05003622|449661689|FG000|Overall Study|Progressive disease|2|||
125009724|NCT05003622|449661689|FG000|Overall Study|Withdrawal by Subject|1|||
125009725|NCT00609986|449661690|FG000|Overall Study|Did not receive transplant or treatment|8|||
125009726|NCT00609986|449661691|FG001|Overall Study|Did not receive transplant or treatment|3|||
125009727|NCT03184077|449661694|FG000|Overall Study|Lost to Follow-up|21|||
125009728|NCT03184077|449661695|FG001|Overall Study|Lost to Follow-up|21|||
125009729|NCT02046096|449661703|FG000|Overall Study|Death|28|||
125009730|NCT02046096|449661704|FG001|Overall Study|Death|45|||
125009731|NCT02046096|449661703|FG000|Overall Study|Lost to Follow-up|9|||
125009732|NCT02046096|449661704|FG001|Overall Study|Lost to Follow-up|20|||
125009733|NCT02046096|449661703|FG000|Overall Study|Withdrawal by Subject|5|||
125009734|NCT02046096|449661704|FG001|Overall Study|Withdrawal by Subject|17|||
125009735|NCT02046096|449661703|FG000|Overall Study|Other endpoint|2|||
125009736|NCT02046096|449661704|FG001|Overall Study|Other endpoint|19|||
125009737|NCT01045798|449661705|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
125009738|NCT01045798|449661706|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
125009739|NCT01045798|449661705|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
125009740|NCT01045798|449661706|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
125009741|NCT01045798|449661705|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
125009742|NCT01045798|449661706|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
125009743|NCT01045798|449661705|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
125009744|NCT01045798|449661706|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
125009745|NCT02090413|449661707|FG000|Overall Study|Adverse Event|11|||
125009746|NCT02090413|449661708|FG001|Overall Study|Adverse Event|15|||
125009747|NCT02090413|449661709|FG002|Overall Study|Adverse Event|20|||
125009748|NCT02090413|449661707|FG000|Overall Study|Flushing event|2|||
125009749|NCT02090413|449661708|FG001|Overall Study|Flushing event|0|||
125009750|NCT02090413|449661709|FG002|Overall Study|Flushing event|1|||
125009751|NCT02090413|449661707|FG000|Overall Study|Withdrawal by Subject|2|||
125009752|NCT02090413|449661708|FG001|Overall Study|Withdrawal by Subject|2|||
125009753|NCT02090413|449661709|FG002|Overall Study|Withdrawal by Subject|2|||
125009754|NCT02090413|449661707|FG000|Overall Study|Investigator Decision|1|||
125009755|NCT02090413|449661708|FG001|Overall Study|Investigator Decision|1|||
125009756|NCT02090413|449661709|FG002|Overall Study|Investigator Decision|0|||
125009757|NCT02090413|449661707|FG000|Overall Study|Other|2|||
125009758|NCT02090413|449661708|FG001|Overall Study|Other|1|||
125009759|NCT02090413|449661709|FG002|Overall Study|Other|0|||
125009760|NCT02090413|449661707|FG000|Overall Study|Lost to Follow-up|1|||
125009761|NCT02090413|449661708|FG001|Overall Study|Lost to Follow-up|1|||
125009762|NCT02090413|449661709|FG002|Overall Study|Lost to Follow-up|0|||
125009763|NCT05321069|449661714|FG000|Overall Study|Adverse Event|52|||
125009764|NCT05321069|449661715|FG001|Overall Study|Adverse Event|52|||
125009765|NCT05321069|449661716|FG002|Overall Study|Adverse Event|64|||
125009766|NCT05321069|449661714|FG000|Overall Study|Protocol Violation|1|||
125009767|NCT05321069|449661715|FG001|Overall Study|Protocol Violation|1|||
125009768|NCT05321069|449661716|FG002|Overall Study|Protocol Violation|0|||
125009769|NCT05321069|449661714|FG000|Overall Study|Withdrawal by Subject|23|||
125009770|NCT05321069|449661715|FG001|Overall Study|Withdrawal by Subject|18|||
125009771|NCT05321069|449661716|FG002|Overall Study|Withdrawal by Subject|12|||
125009772|NCT05321069|449661714|FG000|Overall Study|Lost to Follow-up|1|||
125009773|NCT05321069|449661715|FG001|Overall Study|Lost to Follow-up|0|||
125009774|NCT05321069|449661716|FG002|Overall Study|Lost to Follow-up|1|||
125009775|NCT05321069|449661714|FG000|Overall Study|No reason stated by the participants|23|||
125009776|NCT05321069|449661715|FG001|Overall Study|No reason stated by the participants|22|||
125009777|NCT05321069|449661716|FG002|Overall Study|No reason stated by the participants|16|||
125009778|NCT05321069|449661714|FG000|Overall Study|Lack of Efficacy|1|||
125009779|NCT05321069|449661715|FG001|Overall Study|Lack of Efficacy|1|||
125009780|NCT05321069|449661716|FG002|Overall Study|Lack of Efficacy|0|||
125009781|NCT06156215|449661719|FG000|Overall Study|Withdrawal by Subject|2|||
125009782|NCT06156215|449661720|FG001|Overall Study|Withdrawal by Subject|4|||
125009783|NCT06156215|449661721|FG002|Overall Study|Withdrawal by Subject|4|||
125009784|NCT06156215|449661722|FG003|Overall Study|Withdrawal by Subject|0|||
125009785|NCT06156215|449661723|FG004|Overall Study|Withdrawal by Subject|2|||
125009786|NCT06156215|449661724|FG005|Overall Study|Withdrawal by Subject|2|||
125009787|NCT06156215|449661719|FG000|Overall Study|Left ED without completing study|9|||
125009788|NCT06156215|449661720|FG001|Overall Study|Left ED without completing study|3|||
125009789|NCT06156215|449661721|FG002|Overall Study|Left ED without completing study|9|||
125009790|NCT06156215|449661722|FG003|Overall Study|Left ED without completing study|0|||
125009791|NCT06156215|449661723|FG004|Overall Study|Left ED without completing study|8|||
125009792|NCT06156215|449661724|FG005|Overall Study|Left ED without completing study|16|||
125009793|NCT06156215|449661719|FG000|Overall Study|Physician Decision|1|||
125009794|NCT06156215|449661720|FG001|Overall Study|Physician Decision|0|||
125009795|NCT06156215|449661721|FG002|Overall Study|Physician Decision|0|||
125009796|NCT06156215|449661722|FG003|Overall Study|Physician Decision|0|||
125009797|NCT06156215|449661723|FG004|Overall Study|Physician Decision|0|||
125009798|NCT06156215|449661724|FG005|Overall Study|Physician Decision|0|||
125009799|NCT06156215|449661719|FG000|Overall Study|Became or found ineligible|2|||
125009800|NCT06156215|449661720|FG001|Overall Study|Became or found ineligible|0|||
125009801|NCT06156215|449661721|FG002|Overall Study|Became or found ineligible|2|||
125009802|NCT06156215|449661722|FG003|Overall Study|Became or found ineligible|0|||
125097892|NCT05966129|449978541|FG001|Overall Study|Lost to Follow-up|66|||
125097893|NCT05966129|449978540|FG000|Overall Study|Protocol Violation|1|||
125097894|NCT05966129|449978541|FG001|Overall Study|Protocol Violation|0|||
125097895|NCT05966129|449978540|FG000|Overall Study|Withdrawal by Subject|26|||
125097896|NCT05966129|449978541|FG001|Overall Study|Withdrawal by Subject|25|||
125097897|NCT05966129|449978540|FG000|Overall Study|Surgery not completed|63|||
125097898|NCT05966129|449978541|FG001|Overall Study|Surgery not completed|69|||
125097899|NCT05966129|449978540|FG000|Overall Study|Surgery logistics issue|2|||
125097900|NCT05966129|449978541|FG001|Overall Study|Surgery logistics issue|1|||
125097901|NCT01298323|449978542|FG000|Overall Study|Adverse Event|2|||
125097902|NCT01298323|449978543|FG001|Overall Study|Adverse Event|4|||
125097903|NCT01298323|449978542|FG000|Overall Study|Death|11|||
125097904|NCT01298323|449978543|FG001|Overall Study|Death|16|||
125097905|NCT01298323|449978542|FG000|Overall Study|Lost to Follow-up|1|||
125097906|NCT01298323|449978543|FG001|Overall Study|Lost to Follow-up|0|||
125097907|NCT01298323|449978542|FG000|Overall Study|Withdrawal by Subject|6|||
125097908|NCT01298323|449978543|FG001|Overall Study|Withdrawal by Subject|3|||
125097909|NCT01298323|449978542|FG000|Overall Study|Protocol Violation|1|||
125097910|NCT01298323|449978543|FG001|Overall Study|Protocol Violation|0|||
125097911|NCT01298323|449978542|FG000|Overall Study|Other|10|||
125097912|NCT01298323|449978543|FG001|Overall Study|Other|9|||
125097913|NCT01298323|449978542|FG000|Overall Study|Ongoing|55|||
125097914|NCT01298323|449978543|FG001|Overall Study|Ongoing|55|||
125097915|NCT01298323|449978542|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125097916|NCT01298323|449978543|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
125097917|NCT04089566|449978544|FG000|Overall Study|Death|0|||
125097918|NCT04089566|449978545|FG001|Overall Study|Death|6|||
125097919|NCT04089566|449978546|FG002|Overall Study|Death|10|||
125097920|NCT04089566|449978547|FG003|Overall Study|Death|0|||
125097921|NCT04089566|449978548|FG004|Overall Study|Death|0|||
125097922|NCT04089566|449978549|FG005|Overall Study|Death|0|||
125097923|NCT04089566|449978544|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
125097924|NCT04089566|449978545|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
125097925|NCT04089566|449978546|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
125097926|NCT04089566|449978547|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
125097927|NCT04089566|449978548|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
125097928|NCT04089566|449978549|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
125097929|NCT04089566|449978544|FG000|Overall Study|Reason not Specified|0|||
125097930|NCT04089566|449978545|FG001|Overall Study|Reason not Specified|4|||
125097931|NCT04089566|449978546|FG002|Overall Study|Reason not Specified|4|||
125097932|NCT04089566|449978547|FG003|Overall Study|Reason not Specified|1|||
125097933|NCT04089566|449978548|FG004|Overall Study|Reason not Specified|0|||
125097934|NCT04089566|449978549|FG005|Overall Study|Reason not Specified|0|||
125097935|NCT04794491|449978558|FG000|Overall Study|Adverse Event|1|||
125097936|NCT04794491|449978558|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
125097937|NCT04794491|449978558|FG000|Overall Study|Noncompliance With Study Intervention|1|||
125097938|NCT04794491|449978558|FG000|Overall Study|Withdrawal by Subject|2|||
125097939|NCT02950831|449978559|FG000|Overall Study|Lost to Follow-up|1|||
125097940|NCT02950831|449978559|FG000|Overall Study|Withdrawal by Subject|3|||
125097941|NCT02950831|449978559|FG000|Overall Study|stimulation trail failure|5|||
125097942|NCT01965600|449978560|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
125097943|NCT01965600|449978561|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
125097944|NCT01965600|449978562|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
125097945|NCT01965600|449978563|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
125097946|NCT01965600|449978560|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
125097947|NCT01965600|449978561|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
125097948|NCT01965600|449978562|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
125097949|NCT01965600|449978563|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
125097950|NCT01965600|449978560|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
125097951|NCT01965600|449978561|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
125097952|NCT01965600|449978562|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
125097953|NCT01965600|449978563|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
125097954|NCT01965600|449978560|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
125097955|NCT01965600|449978561|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
125097956|NCT01965600|449978562|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
125097957|NCT01965600|449978563|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
125097958|NCT01965600|449978560|FG000|Second Intervention|Study terminated by Sponsor|0|||
125097959|NCT01965600|449978561|FG001|Second Intervention|Study terminated by Sponsor|0|||
125097960|NCT01965600|449978562|FG002|Second Intervention|Study terminated by Sponsor|2|||
125097961|NCT01965600|449978563|FG003|Second Intervention|Study terminated by Sponsor|2|||
125097962|NCT01875731|449978569|FG000|Overall Study|Fail to obtain lab sample|1|||
125097963|NCT01875731|449978570|FG001|Overall Study|Fail to obtain lab sample|0|||
125097964|NCT03418727|449978573|FG000|Overall Study|Adverse Event|1|||
125097965|NCT03418727|449978574|FG001|Overall Study|Adverse Event|2|||
125097966|NCT03418727|449978575|FG002|Overall Study|Adverse Event|0|||
125097967|NCT03418727|449978573|FG000|Overall Study|Withdrawal by Subject|0|||
125097968|NCT03418727|449978574|FG001|Overall Study|Withdrawal by Subject|0|||
125097969|NCT03418727|449978575|FG002|Overall Study|Withdrawal by Subject|2|||
125097970|NCT03145207|449978580|FG000|Overall Study|volunteer started taking allergy shots|1|||
125097971|NCT03145207|449978580|FG000|Overall Study|baseline blood pressure high|1|||
125097972|NCT04678557|449978583|FG000|Overall Study|Withdrawal by Subject|1|||
125097973|NCT04678557|449978584|FG001|Overall Study|Withdrawal by Subject|0|||
125097974|NCT04678557|449978583|FG000|Overall Study|Lack of Efficacy|0|||
125097975|NCT04678557|449978584|FG001|Overall Study|Lack of Efficacy|13|||
125097976|NCT04678557|449978583|FG000|Overall Study|Safety Evaluation|0|||
125097977|NCT04678557|449978584|FG001|Overall Study|Safety Evaluation|1|||
125097978|NCT00223990|449978585|FG000|Overall Study|Moved from area|2|||
125097979|NCT00223990|449978586|FG001|Overall Study|Moved from area|1|||
125097980|NCT00223990|449978585|FG000|Overall Study|Withdrawal by Subject|4|||
125097981|NCT00223990|449978586|FG001|Overall Study|Withdrawal by Subject|8|||
125097982|NCT00223990|449978585|FG000|Overall Study|Lost to Follow-up|1|||
125097983|NCT00223990|449978586|FG001|Overall Study|Lost to Follow-up|0|||
125097984|NCT02513732|449980108|FG000|Overall Study|Lost to Follow-up|11|||
125097985|NCT02513732|449980108|FG000|Overall Study|Death|9|||
125097986|NCT02513732|449980108|FG000|Overall Study|Changing hospital|2|||
125097987|NCT01740297|449980110|FG000|Overall Study|Withdrawal by Subject|4|||
125097988|NCT01740297|449980111|FG001|Overall Study|Withdrawal by Subject|16|||
125097989|NCT01740297|449980112|FG002|Overall Study|Withdrawal by Subject|17|||
125097990|NCT01740297|449980110|FG000|Overall Study|Death|8|||
125097991|NCT01740297|449980111|FG001|Overall Study|Death|46|||
125097992|NCT01740297|449980112|FG002|Overall Study|Death|40|||
125097993|NCT01740297|449980110|FG000|Overall Study|Lost to Follow-up|1|||
125097994|NCT01740297|449980111|FG001|Overall Study|Lost to Follow-up|2|||
125097995|NCT01740297|449980112|FG002|Overall Study|Lost to Follow-up|4|||
125097996|NCT00761462|449980116|FG000|Treatment|Subjects never received study medication|23|||
125097997|NCT00761462|449980117|FG001|Treatment|Subjects never received study medication|12|||
125097998|NCT00761462|449980116|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
125097999|NCT00761462|449980117|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
125098000|NCT00761462|449980116|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
125098001|NCT00761462|449980117|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
125009803|NCT06156215|449661723|FG004|Overall Study|Became or found ineligible|1|||
125009804|NCT06156215|449661724|FG005|Overall Study|Became or found ineligible|2|||
125009805|NCT00597753|449661729|FG000|Overall Study|Adverse Event|6|||
125009806|NCT00597753|449661730|FG001|Overall Study|Adverse Event|2|||
125009807|NCT00597753|449661729|FG000|Overall Study|Death|55|||
125009808|NCT00597753|449661730|FG001|Overall Study|Death|29|||
125009809|NCT00597753|449661729|FG000|Overall Study|Lack of Efficacy|2|||
125009810|NCT00597753|449661730|FG001|Overall Study|Lack of Efficacy|0|||
125009811|NCT00597753|449661729|FG000|Overall Study|Lost to Follow-up|10|||
125009812|NCT00597753|449661730|FG001|Overall Study|Lost to Follow-up|3|||
125009813|NCT00597753|449661729|FG000|Overall Study|Physician Decision|5|||
125009814|NCT00597753|449661730|FG001|Overall Study|Physician Decision|1|||
125009815|NCT00597753|449661729|FG000|Overall Study|Pregnancy|1|||
125009816|NCT00597753|449661730|FG001|Overall Study|Pregnancy|0|||
125009817|NCT00597753|449661729|FG000|Overall Study|Withdrawal by Subject|35|||
125009818|NCT00597753|449661730|FG001|Overall Study|Withdrawal by Subject|12|||
125009819|NCT00597753|449661729|FG000|Overall Study|Discontinued Dialysis|0|||
125009820|NCT00597753|449661730|FG001|Overall Study|Discontinued Dialysis|1|||
125009821|NCT00597753|449661729|FG000|Overall Study|Never dosed|2|||
125009822|NCT00597753|449661730|FG001|Overall Study|Never dosed|0|||
125009823|NCT00597753|449661729|FG000|Overall Study|Noncompliance|2|||
125009824|NCT00597753|449661730|FG001|Overall Study|Noncompliance|1|||
125009825|NCT00597753|449661729|FG000|Overall Study|Relocation|17|||
125009826|NCT00597753|449661730|FG001|Overall Study|Relocation|6|||
125009827|NCT00597753|449661729|FG000|Overall Study|Renal transplant|10|||
125009828|NCT00597753|449661730|FG001|Overall Study|Renal transplant|3|||
125009829|NCT00597753|449661729|FG000|Overall Study|Site closed by sponsor|19|||
125009830|NCT00597753|449661730|FG001|Overall Study|Site closed by sponsor|7|||
125009831|NCT00597753|449661729|FG000|Overall Study|Site elected to close|2|||
125009832|NCT00597753|449661730|FG001|Overall Study|Site elected to close|4|||
125009833|NCT03451851|449661731|FG000|PCP: Week 0 -16|Adverse Event|1|||
125009834|NCT03451851|449661732|FG001|PCP: Week 0 -16|Adverse Event|0|||
125009835|NCT03451851|449661733|FG002|PCP: Week 0 -16|Adverse Event|0|||
125009836|NCT03451851|449661734|FG003|PCP: Week 0 -16|Adverse Event|0|||
125009837|NCT03451851|449661735|FG004|PCP: Week 0 -16|Adverse Event|0|||
125009838|NCT03451851|449661736|FG005|PCP: Week 0 -16|Adverse Event|0|||
125009839|NCT03451851|449661737|FG006|PCP: Week 0 -16|Adverse Event|1|||
125009840|NCT03451851|449661738|FG007|PCP: Week 0 -16|Adverse Event|0|||
125009841|NCT03451851|449661731|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
125009842|NCT03451851|449661732|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
125009843|NCT03451851|449661733|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
125009844|NCT03451851|449661734|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
125009845|NCT03451851|449661735|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
125009846|NCT03451851|449661736|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
125009847|NCT03451851|449661737|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
125009848|NCT03451851|449661738|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
125009849|NCT03451851|449661731|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
125009850|NCT03451851|449661732|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
125009851|NCT03451851|449661733|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
125009852|NCT03451851|449661734|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
125009853|NCT03451851|449661735|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
125009854|NCT03451851|449661736|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
125098002|NCT00761462|449980116|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
125009855|NCT03451851|449661737|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
125009856|NCT03451851|449661738|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
125009857|NCT03451851|449661731|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
125009858|NCT03451851|449661732|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
125009859|NCT03451851|449661733|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
125009860|NCT03451851|449661734|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
125009861|NCT03451851|449661735|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
125009862|NCT03451851|449661736|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
125009863|NCT03451851|449661737|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
125009864|NCT03451851|449661738|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
125009865|NCT03451851|449661731|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
125009866|NCT03451851|449661732|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
125009867|NCT03451851|449661733|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
125009868|NCT03451851|449661734|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
125009869|NCT03451851|449661735|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
125009870|NCT03451851|449661736|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
125098003|NCT00761462|449980117|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
125098004|NCT01479777|449980118|FG000|Overall Study|Physician Decision|2|||
125098005|NCT01541644|449980122|FG000|Overall Study|Withdrawal by Subject|3|||
125098006|NCT02389621|449980125|FG000|Treatment Period|Withdrawal by Subject|1|||
125098007|NCT02389621|449980126|FG001|Treatment Period|Withdrawal by Subject|1|||
125098008|NCT02389621|449980125|FG000|Posttreatment Period|Adverse Event|3|||
125098009|NCT02389621|449980126|FG001|Posttreatment Period|Adverse Event|1|||
125098010|NCT02389621|449980125|FG000|Posttreatment Period|Withdrawal by Subject|3|||
125098011|NCT02389621|449980126|FG001|Posttreatment Period|Withdrawal by Subject|2|||
125098012|NCT02389621|449980125|FG000|Posttreatment Period|Lost to Follow-up|1|||
125098013|NCT02389621|449980126|FG001|Posttreatment Period|Lost to Follow-up|1|||
125098014|NCT02389621|449980125|FG000|Posttreatment Period|Other - Miscellaneous|2|||
125098015|NCT02389621|449980126|FG001|Posttreatment Period|Other - Miscellaneous|0|||
125098016|NCT00953017|449980145|FG000|Overall Study|DId not show up for colonoscopy|4|||
125098017|NCT00953017|449980146|FG001|Overall Study|DId not show up for colonoscopy|4|||
125098018|NCT00953017|449980147|FG002|Overall Study|DId not show up for colonoscopy|5|||
125098019|NCT00953017|449980148|FG003|Overall Study|DId not show up for colonoscopy|4|||
125098020|NCT00953017|449980145|FG000|Overall Study|Incomplete data|1|||
125098021|NCT00953017|449980146|FG001|Overall Study|Incomplete data|1|||
125098022|NCT00953017|449980147|FG002|Overall Study|Incomplete data|0|||
125098023|NCT00953017|449980148|FG003|Overall Study|Incomplete data|0|||
125098024|NCT00953017|449980145|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
125098025|NCT00953017|449980146|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
125098026|NCT00953017|449980147|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
125098027|NCT00953017|449980148|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
125098028|NCT00953017|449980145|FG000|Overall Study|Brown stool prior to procedure|0|||
125098029|NCT00953017|449980146|FG001|Overall Study|Brown stool prior to procedure|0|||
125098030|NCT00953017|449980147|FG002|Overall Study|Brown stool prior to procedure|1|||
125098031|NCT00953017|449980148|FG003|Overall Study|Brown stool prior to procedure|0|||
125098032|NCT01473602|449980150|FG000|Overall Study|Adverse Event|1|||
125098033|NCT01473602|449980151|FG001|Overall Study|Adverse Event|2|||
125098034|NCT01473602|449980150|FG000|Overall Study|Death|0|||
125098035|NCT01473602|449980151|FG001|Overall Study|Death|1|||
125009871|NCT03451851|449661737|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
125009872|NCT03451851|449661738|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
125009873|NCT03451851|449661731|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
125009874|NCT03451851|449661732|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
125009875|NCT03451851|449661733|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
125009876|NCT03451851|449661734|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
125009877|NCT03451851|449661735|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
125009878|NCT03451851|449661736|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
125009879|NCT03451851|449661737|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
125009880|NCT03451851|449661738|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
125009881|NCT05885737|449661739|FG000|DB Period|Adverse Event|4|||
125009882|NCT05885737|449661740|FG001|DB Period|Adverse Event|4|||
125009883|NCT05885737|449661739|FG000|DB Period|Lost to Follow-up|0|||
125009884|NCT05885737|449661740|FG001|DB Period|Lost to Follow-up|1|||
125009885|NCT05885737|449661739|FG000|DB Period|Physician Decision|2|||
125009886|NCT05885737|449661740|FG001|DB Period|Physician Decision|0|||
125009887|NCT05885737|449661739|FG000|DB Period|Withdrawal by Subject|12|||
125009888|NCT05885737|449661740|FG001|DB Period|Withdrawal by Subject|6|||
125009889|NCT05885737|449661739|FG000|DB Period|Other: Unspecified|2|||
125009890|NCT05885737|449661740|FG001|DB Period|Other: Unspecified|2|||
125009891|NCT05885737|449661739|FG000|OLE Period|Adverse Event|3|||
125009892|NCT05885737|449661740|FG001|OLE Period|Adverse Event|2|||
125009893|NCT05885737|449661739|FG000|OLE Period|Physician Decision|1|||
125009894|NCT05885737|449661740|FG001|OLE Period|Physician Decision|0|||
125009895|NCT05885737|449661739|FG000|OLE Period|Withdrawal by Subject|5|||
125009896|NCT05885737|449661740|FG001|OLE Period|Withdrawal by Subject|5|||
125009897|NCT05885737|449661739|FG000|OLE Period|Other: Unspecified|2|||
125009898|NCT05885737|449661740|FG001|OLE Period|Other: Unspecified|1|||
125009899|NCT02966509|449663580|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
125009900|NCT02966509|449663581|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
125009901|NCT02966509|449663580|FG000|Baseline Satisfaction Survey|Death|0|||
125009902|NCT02966509|449663581|FG001|Baseline Satisfaction Survey|Death|1|||
125009903|NCT02966509|449663580|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
125009904|NCT02966509|449663581|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
125009905|NCT02966509|449663580|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
125009906|NCT02966509|449663581|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
125009907|NCT02966509|449663580|FG000|6 Month Satisfaction Decision Survey|Death|22|||
125009908|NCT02966509|449663581|FG001|6 Month Satisfaction Decision Survey|Death|25|||
125009909|NCT02966509|449663580|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
125009910|NCT02966509|449663581|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
125009911|NCT02966509|449663580|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
125009912|NCT02966509|449663581|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
125009913|NCT02966509|449663580|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
125009914|NCT02966509|449663581|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
125009915|NCT02966509|449663580|FG000|6 Month Satisfaction Survey|Death|36|||
125009916|NCT02966509|449663581|FG001|6 Month Satisfaction Survey|Death|33|||
125009917|NCT02966509|449663580|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
125009918|NCT02966509|449663581|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
125009919|NCT02966509|449663580|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
125009920|NCT02966509|449663581|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
125009921|NCT02966509|449663580|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
125009922|NCT02966509|449663581|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
125009923|NCT02966509|449663580|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
125009924|NCT02966509|449663581|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
125009925|NCT02966509|449663580|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
125009926|NCT02966509|449663581|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
125009927|NCT01717287|449663582|FG000|Overall Study|Lost to Follow-up|0|||
125009928|NCT01717287|449663583|FG001|Overall Study|Lost to Follow-up|2|||
125009929|NCT01717287|449663582|FG000|Overall Study|Protocol Violation|0|||
125009930|NCT01717287|449663583|FG001|Overall Study|Protocol Violation|1|||
125009931|NCT00404820|449663584|FG000|Overall Study|Adverse Event|4|||
125009932|NCT00404820|449663585|FG001|Overall Study|Adverse Event|16|||
125009933|NCT00404820|449663584|FG000|Overall Study|Withdrawal by Subject|5|||
125009934|NCT00404820|449663585|FG001|Overall Study|Withdrawal by Subject|3|||
125009935|NCT00404820|449663584|FG000|Overall Study|Lost to Follow-up|7|||
125009936|NCT00404820|449663585|FG001|Overall Study|Lost to Follow-up|3|||
125009937|NCT00404820|449663584|FG000|Overall Study|Administrative problems|2|||
125009938|NCT00404820|449663585|FG001|Overall Study|Administrative problems|0|||
125009939|NCT00404820|449663584|FG000|Overall Study|Death|1|||
125009940|NCT00404820|449663585|FG001|Overall Study|Death|0|||
125009941|NCT00404820|449663584|FG000|Overall Study|Other|0|||
125009942|NCT00404820|449663585|FG001|Overall Study|Other|2|||
125009943|NCT01469182|449663588|FG000|Overall Study|Adverse Event|21|||
125009944|NCT01469182|449663589|FG001|Overall Study|Adverse Event|3|||
125009945|NCT01469182|449663588|FG000|Overall Study|Lost to Follow-up|3|||
125009946|NCT01469182|449663589|FG001|Overall Study|Lost to Follow-up|0|||
125009947|NCT01469182|449663588|FG000|Overall Study|Withdrawal by Subject|4|||
125009948|NCT01469182|449663589|FG001|Overall Study|Withdrawal by Subject|1|||
125009949|NCT01469182|449663588|FG000|Overall Study|Protocol Violation|4|||
125009950|NCT01469182|449663589|FG001|Overall Study|Protocol Violation|2|||
125009951|NCT01469182|449663588|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
125009952|NCT01469182|449663589|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
125009953|NCT02687542|449663592|FG000|Overall Study|Medication error without associated AEs|0|||
125009954|NCT02687542|449663593|FG001|Overall Study|Medication error without associated AEs|0|||
125009955|NCT02687542|449663594|FG002|Overall Study|Medication error without associated AEs|0|||
125009956|NCT02687542|449663595|FG003|Overall Study|Medication error without associated AEs|0|||
125009957|NCT02687542|449663596|FG004|Overall Study|Medication error without associated AEs|1|||
125009958|NCT02687542|449663592|FG000|Overall Study|Lost to Follow-up|0|||
125009959|NCT02687542|449663593|FG001|Overall Study|Lost to Follow-up|0|||
125098036|NCT01473602|449980150|FG000|Overall Study|Lost to Follow-up|1|||
125098037|NCT01473602|449980151|FG001|Overall Study|Lost to Follow-up|1|||
125098038|NCT01473602|449980150|FG000|Overall Study|Withdrawal by Subject|5|||
125098039|NCT01473602|449980151|FG001|Overall Study|Withdrawal by Subject|4|||
125098040|NCT01473602|449980150|FG000|Overall Study|Physician Decision|1|||
125009960|NCT02687542|449663594|FG002|Overall Study|Lost to Follow-up|0|||
125009961|NCT02687542|449663595|FG003|Overall Study|Lost to Follow-up|0|||
125009962|NCT02687542|449663596|FG004|Overall Study|Lost to Follow-up|1|||
125009963|NCT02687542|449663592|FG000|Overall Study|Protocol Violation|0|||
125009964|NCT02687542|449663593|FG001|Overall Study|Protocol Violation|1|||
124873005|NCT00180479|449157216|FG000|Overall Study|Withdrawal by Subject|3|||
124873006|NCT00180479|449157217|FG001|Overall Study|Withdrawal by Subject|3|||
124873007|NCT00180479|449157216|FG000|Overall Study|Informed consent not signed|0|||
124873008|NCT00180479|449157217|FG001|Overall Study|Informed consent not signed|1|||
124873009|NCT00526630|449157226|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
124873010|NCT00526630|449157227|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
124873011|NCT00526630|449157226|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
124873012|NCT00526630|449157227|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
124873013|NCT03518125|449157229|FG000|Overall Study|Lost to Follow-up|0|||
124873014|NCT03518125|449157230|FG001|Overall Study|Lost to Follow-up|2|||
124873015|NCT03518125|449157231|FG002|Overall Study|Lost to Follow-up|0|||
124873016|NCT03518125|449157232|FG003|Overall Study|Lost to Follow-up|0|||
124873017|NCT03518125|449157233|FG004|Overall Study|Lost to Follow-up|3|||
124873018|NCT03518125|449157234|FG005|Overall Study|Lost to Follow-up|5|||
124873019|NCT03518125|449157229|FG000|Overall Study|Physician Decision|0|||
124873020|NCT03518125|449157230|FG001|Overall Study|Physician Decision|1|||
124873021|NCT03518125|449157231|FG002|Overall Study|Physician Decision|0|||
124873022|NCT03518125|449157232|FG003|Overall Study|Physician Decision|0|||
124873023|NCT03518125|449157233|FG004|Overall Study|Physician Decision|0|||
124873024|NCT03518125|449157234|FG005|Overall Study|Physician Decision|0|||
125098041|NCT01473602|449980151|FG001|Overall Study|Physician Decision|0|||
125098042|NCT00449761|449980153|FG000|Overall Study|Disease progression|12|||
125098043|NCT00449761|449980153|FG000|Overall Study|Death|5|||
125098044|NCT00449761|449980153|FG000|Overall Study|New cancer therapy|1|||
125098045|NCT00344968|449980156|FG000|Overall Study|Adverse Event|5|||
125098046|NCT00344968|449980157|FG001|Overall Study|Adverse Event|4|||
125098047|NCT00344968|449980158|FG002|Overall Study|Adverse Event|15|||
125098048|NCT00344968|449980156|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
125098049|NCT00344968|449980157|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
125098050|NCT00344968|449980158|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
125098051|NCT00344968|449980156|FG000|Overall Study|Protocol Violation|2|||
125098052|NCT00344968|449980157|FG001|Overall Study|Protocol Violation|2|||
125098053|NCT00344968|449980158|FG002|Overall Study|Protocol Violation|5|||
125098054|NCT00344968|449980156|FG000|Overall Study|Withdrawal by Subject|14|||
125098055|NCT00344968|449980157|FG001|Overall Study|Withdrawal by Subject|31|||
125098056|NCT00344968|449980158|FG002|Overall Study|Withdrawal by Subject|27|||
125098057|NCT00344968|449980156|FG000|Overall Study|Lost to Follow-up|24|||
125098058|NCT00344968|449980157|FG001|Overall Study|Lost to Follow-up|37|||
125098059|NCT00344968|449980158|FG002|Overall Study|Lost to Follow-up|37|||
125098060|NCT00344968|449980156|FG000|Overall Study|Death|11|||
125098061|NCT00344968|449980157|FG001|Overall Study|Death|27|||
125098062|NCT00344968|449980158|FG002|Overall Study|Death|31|||
125098063|NCT00344968|449980156|FG000|Overall Study|Other|0|||
125098064|NCT00344968|449980157|FG001|Overall Study|Other|1|||
125098065|NCT00344968|449980158|FG002|Overall Study|Other|0|||
125098066|NCT03735680|449980159|FG000|Overall Study|Withdrawal by Subject|0|||
125098067|NCT03735680|449980160|FG001|Overall Study|Withdrawal by Subject|1|||
125098068|NCT03735680|449980161|FG002|Overall Study|Withdrawal by Subject|0|||
125098069|NCT03735680|449980162|FG003|Overall Study|Withdrawal by Subject|0|||
125098070|NCT03735680|449980163|FG004|Overall Study|Withdrawal by Subject|0|||
125098071|NCT03735680|449980164|FG005|Overall Study|Withdrawal by Subject|1|||
125098072|NCT03735680|449980159|FG000|Overall Study|Patient unable or unwilling to continue|0|||
125098073|NCT03735680|449980160|FG001|Overall Study|Patient unable or unwilling to continue|0|||
125098074|NCT03735680|449980161|FG002|Overall Study|Patient unable or unwilling to continue|1|||
125098075|NCT03735680|449980162|FG003|Overall Study|Patient unable or unwilling to continue|0|||
125098076|NCT03735680|449980163|FG004|Overall Study|Patient unable or unwilling to continue|0|||
125098077|NCT03735680|449980164|FG005|Overall Study|Patient unable or unwilling to continue|0|||
125098078|NCT01422876|449980166|FG000|Week 24|Lost to Follow-up|1|||
125098079|NCT01422876|449980167|FG001|Week 24|Lost to Follow-up|1|||
125098080|NCT01422876|449980168|FG002|Week 24|Lost to Follow-up|2|||
125098081|NCT01422876|449980169|FG003|Week 24|Lost to Follow-up|4|||
125098082|NCT01422876|449980170|FG004|Week 24|Lost to Follow-up|2|||
125098083|NCT01422876|449980171|FG005|Week 24|Lost to Follow-up|0|||
125098084|NCT01422876|449980172|FG006|Week 24|Lost to Follow-up|1|||
124873025|NCT03518125|449157229|FG000|Overall Study|Withdrawal by Subject|1|||
125098085|NCT01422876|449980173|FG007|Week 24|Lost to Follow-up|3|||
125098086|NCT01422876|449980174|FG008|Week 24|Lost to Follow-up|3|||
125098087|NCT01422876|449980175|FG009|Week 24|Lost to Follow-up|4|||
124873026|NCT03518125|449157230|FG001|Overall Study|Withdrawal by Subject|1|||
124873027|NCT03518125|449157231|FG002|Overall Study|Withdrawal by Subject|0|||
124873028|NCT03518125|449157232|FG003|Overall Study|Withdrawal by Subject|1|||
125098088|NCT01422876|449980166|FG000|Week 24|Consent withdrawn|5|||
125098089|NCT01422876|449980167|FG001|Week 24|Consent withdrawn|1|||
125098090|NCT01422876|449980168|FG002|Week 24|Consent withdrawn|3|||
125098091|NCT01422876|449980169|FG003|Week 24|Consent withdrawn|4|||
125098092|NCT01422876|449980170|FG004|Week 24|Consent withdrawn|5|||
125098093|NCT01422876|449980171|FG005|Week 24|Consent withdrawn|6|||
125098094|NCT01422876|449980172|FG006|Week 24|Consent withdrawn|5|||
125098095|NCT01422876|449980173|FG007|Week 24|Consent withdrawn|4|||
124873029|NCT03518125|449157233|FG004|Overall Study|Withdrawal by Subject|1|||
124873030|NCT03518125|449157234|FG005|Overall Study|Withdrawal by Subject|3|||
124873031|NCT03518125|449157229|FG000|Overall Study|Missed Day 394 Visit|1|||
124873032|NCT03518125|449157230|FG001|Overall Study|Missed Day 394 Visit|0|||
125009965|NCT02687542|449663594|FG002|Overall Study|Protocol Violation|0|||
125009966|NCT02687542|449663595|FG003|Overall Study|Protocol Violation|0|||
125009967|NCT02687542|449663596|FG004|Overall Study|Protocol Violation|0|||
125009968|NCT02687542|449663592|FG000|Overall Study|Other|5|||
125009969|NCT02687542|449663593|FG001|Overall Study|Other|9|||
125009970|NCT02687542|449663594|FG002|Overall Study|Other|10|||
125009971|NCT02687542|449663595|FG003|Overall Study|Other|6|||
125009972|NCT02687542|449663596|FG004|Overall Study|Other|5|||
125009973|NCT02687542|449663592|FG000|Overall Study|Adverse Event|3|||
125009974|NCT02687542|449663593|FG001|Overall Study|Adverse Event|1|||
125009975|NCT02687542|449663594|FG002|Overall Study|Adverse Event|3|||
125009976|NCT02687542|449663595|FG003|Overall Study|Adverse Event|2|||
125009977|NCT02687542|449663596|FG004|Overall Study|Adverse Event|9|||
125009978|NCT02687542|449663592|FG000|Overall Study|Withdrawal by Subject|0|||
125009979|NCT02687542|449663593|FG001|Overall Study|Withdrawal by Subject|1|||
125009980|NCT02687542|449663594|FG002|Overall Study|Withdrawal by Subject|1|||
125009981|NCT02687542|449663595|FG003|Overall Study|Withdrawal by Subject|2|||
125009982|NCT02687542|449663596|FG004|Overall Study|Withdrawal by Subject|4|||
125009983|NCT01838616|449663597|FG000|Titration Period|Adverse Event|18|||
125009984|NCT01838616|449663598|FG001|Titration Period|Adverse Event|48|||
125009985|NCT01838616|449663597|FG000|Titration Period|Lack of Efficacy|5|||
125009986|NCT01838616|449663598|FG001|Titration Period|Lack of Efficacy|12|||
125009987|NCT01838616|449663597|FG000|Titration Period|Withdrawal by Subject|5|||
125009988|NCT01838616|449663598|FG001|Titration Period|Withdrawal by Subject|5|||
125009989|NCT01838616|449663597|FG000|Titration Period|Technical problems|1|||
125009990|NCT01838616|449663598|FG001|Titration Period|Technical problems|0|||
125009991|NCT01838616|449663597|FG000|Titration Period|Other|1|||
125009992|NCT01838616|449663598|FG001|Titration Period|Other|0|||
125009993|NCT01838616|449663597|FG000|Titration Period|Protocol Violation|0|||
125009994|NCT01838616|449663598|FG001|Titration Period|Protocol Violation|1|||
125009995|NCT01838616|449663597|FG000|Continuation Period|Lack of Efficacy|3|||
125009996|NCT01838616|449663598|FG001|Continuation Period|Lack of Efficacy|5|||
125009997|NCT01838616|449663597|FG000|Continuation Period|Adverse Event|8|||
125009998|NCT01838616|449663598|FG001|Continuation Period|Adverse Event|4|||
125009999|NCT01838616|449663597|FG000|Continuation Period|Protocol Violation|2|||
125010000|NCT01838616|449663598|FG001|Continuation Period|Protocol Violation|0|||
125010001|NCT01838616|449663597|FG000|Continuation Period|Lost to Follow-up|1|||
125010002|NCT01838616|449663598|FG001|Continuation Period|Lost to Follow-up|0|||
125010003|NCT01838616|449663597|FG000|Continuation Period|Withdrawal by Subject|0|||
125010004|NCT01838616|449663598|FG001|Continuation Period|Withdrawal by Subject|4|||
125010005|NCT01838616|449663597|FG000|Continuation Period|Technical problems|0|||
125010006|NCT01838616|449663598|FG001|Continuation Period|Technical problems|1|||
125010007|NCT01838616|449663597|FG000|Pick-up Arm|Lack of Efficacy|4|||
125010008|NCT01838616|449663598|FG001|Pick-up Arm|Lack of Efficacy|0|||
125010009|NCT01838616|449663597|FG000|Pick-up Arm|Adverse Event|9|||
125010010|NCT01838616|449663598|FG001|Pick-up Arm|Adverse Event|0|||
125010011|NCT01838616|449663597|FG000|Pick-up Arm|Withdrawal by Subject|1|||
125010012|NCT01838616|449663598|FG001|Pick-up Arm|Withdrawal by Subject|0|||
125010013|NCT01838616|449663597|FG000|Pick-up Arm|Technical problems|1|||
125010014|NCT01838616|449663598|FG001|Pick-up Arm|Technical problems|0|||
125010015|NCT00003535|449663599|FG000|Overall Study|Not evaluable|5|||
125010016|NCT02181816|449663600|FG000|Overall Study|Case Report Forms Uncollected|38|||
125010017|NCT02181816|449663600|FG000|Overall Study|Protocol Deviation|21|||
125010018|NCT03807349|449663603|FG000|Overall Study|Early Study Termination|9|||
125010019|NCT00294060|449663604|FG000|Overall Study|Death|225|||
125010020|NCT00294060|449663604|FG000|Overall Study|Other|59|||
125010021|NCT00294060|449663604|FG000|Overall Study|Lost to Follow-up|55|||
125010022|NCT00294060|449663604|FG000|Overall Study|Withdrawal by Subject|11|||
125010023|NCT00294060|449663604|FG000|Overall Study|Physician Decision|797|||
125010024|NCT00294060|449663604|FG000|Overall Study|Medical condition|3|||
125010025|NCT00294060|449663604|FG000|Overall Study|Device explanted/not replaced|23|||
125010026|NCT01360554|449663605|FG000|Overall Study|Death|359|||
125010027|NCT01360554|449663606|FG001|Overall Study|Death|371|||
125010028|NCT01360554|449663605|FG000|Overall Study|Lost to Follow-up|4|||
125010029|NCT01360554|449663606|FG001|Overall Study|Lost to Follow-up|4|||
125010030|NCT01360554|449663605|FG000|Overall Study|Withdrawal by Subject|23|||
125010031|NCT01360554|449663606|FG001|Overall Study|Withdrawal by Subject|24|||
125010032|NCT01360554|449663605|FG000|Overall Study|Study terminated by sponsor|49|||
125010033|NCT01360554|449663606|FG001|Overall Study|Study terminated by sponsor|37|||
125010034|NCT01360554|449663605|FG000|Overall Study|Other, not specified|1|||
125010035|NCT01360554|449663606|FG001|Overall Study|Other, not specified|0|||
125010036|NCT01360554|449663605|FG000|Overall Study|Randomized but not treated.|3|||
125010037|NCT01360554|449663606|FG001|Overall Study|Randomized but not treated.|3|||
124873033|NCT03518125|449157231|FG002|Overall Study|Missed Day 394 Visit|0|||
125010038|NCT00187096|449663608|FG000|Overall Study|unacceptable toxicity|0|||
125010039|NCT00187096|449663609|FG001|Overall Study|unacceptable toxicity|0|||
125010040|NCT00187096|449663610|FG002|Overall Study|unacceptable toxicity|1|||
125010041|NCT00111800|449663611|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
125010042|NCT00111800|449663612|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
125010043|NCT00111800|449663613|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
125010044|NCT00111800|449663614|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
125010045|NCT00111800|449663615|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
125010046|NCT00111800|449663616|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
125010047|NCT00111800|449663611|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
125010048|NCT00111800|449663612|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
125010049|NCT00111800|449663613|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
125010050|NCT00111800|449663614|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
125010051|NCT00111800|449663615|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
125010052|NCT00111800|449663616|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
125010053|NCT00111800|449663611|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
125010054|NCT00111800|449663612|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
125010055|NCT00111800|449663613|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
125010056|NCT00111800|449663614|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
125010057|NCT00111800|449663615|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
125010058|NCT00111800|449663616|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
125010059|NCT00111800|449663611|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
125010060|NCT00111800|449663612|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
125010061|NCT00111800|449663613|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
125010062|NCT00111800|449663614|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
125010063|NCT00111800|449663615|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
125098096|NCT01422876|449980174|FG008|Week 24|Consent withdrawn|3|||
125098097|NCT01422876|449980175|FG009|Week 24|Consent withdrawn|6|||
125098098|NCT01422876|449980166|FG000|Week 24|Death|0|||
125098099|NCT01422876|449980167|FG001|Week 24|Death|1|||
125098100|NCT01422876|449980168|FG002|Week 24|Death|0|||
125098101|NCT01422876|449980169|FG003|Week 24|Death|0|||
125098102|NCT01422876|449980170|FG004|Week 24|Death|0|||
125098103|NCT01422876|449980171|FG005|Week 24|Death|0|||
125098104|NCT01422876|449980172|FG006|Week 24|Death|0|||
125098105|NCT01422876|449980173|FG007|Week 24|Death|0|||
125098106|NCT01422876|449980174|FG008|Week 24|Death|0|||
125098107|NCT01422876|449980175|FG009|Week 24|Death|0|||
125098108|NCT01422876|449980166|FG000|Week 52|Lost to Follow-up|3|||
125098109|NCT01422876|449980167|FG001|Week 52|Lost to Follow-up|5|||
125098110|NCT01422876|449980168|FG002|Week 52|Lost to Follow-up|7|||
125098111|NCT01422876|449980169|FG003|Week 52|Lost to Follow-up|5|||
125098112|NCT01422876|449980170|FG004|Week 52|Lost to Follow-up|8|||
125098113|NCT01422876|449980171|FG005|Week 52|Lost to Follow-up|5|||
125098114|NCT01422876|449980172|FG006|Week 52|Lost to Follow-up|5|||
125098115|NCT01422876|449980173|FG007|Week 52|Lost to Follow-up|8|||
125098116|NCT01422876|449980174|FG008|Week 52|Lost to Follow-up|7|||
125098117|NCT01422876|449980175|FG009|Week 52|Lost to Follow-up|8|||
125098118|NCT01422876|449980166|FG000|Week 52|Consent withdrawn|9|||
125098119|NCT01422876|449980167|FG001|Week 52|Consent withdrawn|4|||
125098120|NCT01422876|449980168|FG002|Week 52|Consent withdrawn|6|||
125098121|NCT01422876|449980169|FG003|Week 52|Consent withdrawn|12|||
125098122|NCT01422876|449980170|FG004|Week 52|Consent withdrawn|7|||
125098123|NCT01422876|449980171|FG005|Week 52|Consent withdrawn|12|||
125098124|NCT01422876|449980172|FG006|Week 52|Consent withdrawn|10|||
125098125|NCT01422876|449980173|FG007|Week 52|Consent withdrawn|12|||
125098126|NCT01422876|449980174|FG008|Week 52|Consent withdrawn|13|||
125098127|NCT01422876|449980175|FG009|Week 52|Consent withdrawn|9|||
125098128|NCT01422876|449980166|FG000|Week 52|Death|0|||
125098129|NCT01422876|449980167|FG001|Week 52|Death|1|||
125098130|NCT01422876|449980168|FG002|Week 52|Death|0|||
125098131|NCT01422876|449980169|FG003|Week 52|Death|1|||
125098132|NCT01422876|449980170|FG004|Week 52|Death|0|||
125098133|NCT01422876|449980171|FG005|Week 52|Death|0|||
125098134|NCT01422876|449980172|FG006|Week 52|Death|1|||
125098135|NCT01422876|449980173|FG007|Week 52|Death|3|||
125098136|NCT01422876|449980174|FG008|Week 52|Death|1|||
125098137|NCT01422876|449980175|FG009|Week 52|Death|0|||
125098138|NCT00054639|449980185|FG000|Overall Study|Lack of Efficacy|1|||
125098139|NCT00054639|449980185|FG000|Overall Study|Physician Decision|1|||
125098140|NCT05028816|449980197|FG000|Overall Study|Lost to Follow-up|5|||
125098141|NCT05028816|449980198|FG001|Overall Study|Lost to Follow-up|3|||
125098142|NCT05028816|449980197|FG000|Overall Study|Withdrawal by Subject|4|||
125098143|NCT05028816|449980198|FG001|Overall Study|Withdrawal by Subject|1|||
125098144|NCT05028816|449980197|FG000|Overall Study|Physician Decision|1|||
125098145|NCT05028816|449980198|FG001|Overall Study|Physician Decision|0|||
125098146|NCT05064436|449980199|FG000|Overall Study|Other Reasons|1|||
125098147|NCT05064436|449980200|FG001|Overall Study|Other Reasons|0|||
125098148|NCT01711736|449980202|FG000|Overall Study|Lost to Follow-up|4|||
125098149|NCT01711736|449980203|FG001|Overall Study|Lost to Follow-up|1|||
125098150|NCT01711736|449980202|FG000|Overall Study|Withdrawal by Subject|6|||
125098151|NCT01711736|449980203|FG001|Overall Study|Withdrawal by Subject|6|||
125098152|NCT01711736|449980202|FG000|Overall Study|Migrated/moved from study area|2|||
125098153|NCT01711736|449980203|FG001|Overall Study|Migrated/moved from study area|1|||
125098154|NCT02506101|449980204|FG000|Overall Study|Transportation issues|1|||
124873034|NCT03518125|449157232|FG003|Overall Study|Missed Day 394 Visit|0|||
124873035|NCT03518125|449157233|FG004|Overall Study|Missed Day 394 Visit|0|||
124873036|NCT03518125|449157234|FG005|Overall Study|Missed Day 394 Visit|0|||
124873037|NCT00106184|449157237|FG000|Overall Study|Withdrawal by Subject|3|||
124873038|NCT00106184|449157238|FG001|Overall Study|Withdrawal by Subject|2|||
124873039|NCT00409682|449157247|FG000|Open-label Induction Period|Adverse Event|1|||
124873040|NCT00409682|449157248|FG001|Open-label Induction Period|Adverse Event|0|||
124873041|NCT00409682|449157249|FG002|Open-label Induction Period|Adverse Event|0|||
124873042|NCT00409682|449157247|FG000|Open-label Induction Period|Lack of Efficacy|1|||
124873043|NCT00409682|449157248|FG001|Open-label Induction Period|Lack of Efficacy|0|||
124873044|NCT00409682|449157249|FG002|Open-label Induction Period|Lack of Efficacy|0|||
124873045|NCT00409682|449157247|FG000|Open-label Induction Period|Protocol Violation|1|||
124873046|NCT00409682|449157248|FG001|Open-label Induction Period|Protocol Violation|0|||
124873047|NCT00409682|449157249|FG002|Open-label Induction Period|Protocol Violation|0|||
124873048|NCT00409682|449157247|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
124873049|NCT00409682|449157248|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
124873050|NCT00409682|449157249|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
124873051|NCT00409682|449157247|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
124873052|NCT00409682|449157248|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
124873053|NCT00409682|449157249|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
124873054|NCT00409682|449157247|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
124873055|NCT00409682|449157248|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
124873056|NCT00409682|449157249|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
124873057|NCT00409682|449157247|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
124873058|NCT00409682|449157248|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
124873059|NCT00409682|449157249|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
124873060|NCT00409682|449157247|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
124873061|NCT00409682|449157248|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
124873062|NCT00409682|449157249|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
124873063|NCT00409682|449157247|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
124873064|NCT00409682|449157248|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
124873065|NCT00409682|449157249|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
124873066|NCT00409682|449157247|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
124873067|NCT00409682|449157248|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
124873068|NCT00409682|449157249|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
124873069|NCT01896869|449157250|FG000|Overall Study|Withdrawal by Subject|0|||
124873070|NCT01896869|449157251|FG001|Overall Study|Withdrawal by Subject|6|||
124873071|NCT01896869|449157250|FG000|Overall Study|Lost to Follow-up|1|||
124873072|NCT01896869|449157251|FG001|Overall Study|Lost to Follow-up|0|||
124873073|NCT01089374|449157259|FG000|Overall Study|Lost to Follow-up|3|||
124873074|NCT01089374|449157260|FG001|Overall Study|Lost to Follow-up|0|||
124873075|NCT01089374|449157259|FG000|Overall Study|Withdrawal by Subject|1|||
124873076|NCT01089374|449157260|FG001|Overall Study|Withdrawal by Subject|0|||
124873077|NCT01089374|449157259|FG000|Overall Study|Study closed early - low accrual|6|||
124873078|NCT01089374|449157260|FG001|Overall Study|Study closed early - low accrual|0|||
125010064|NCT00111800|449663616|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
125010065|NCT00111800|449663611|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
125010066|NCT00111800|449663612|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
125010067|NCT00111800|449663613|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
124873079|NCT02856113|449157261|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
124873080|NCT02856113|449157262|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
124873081|NCT02856113|449157261|FG000|Overall Study|Significant Protocol Deviation|1|||
124873082|NCT02856113|449157262|FG001|Overall Study|Significant Protocol Deviation|0|||
124873083|NCT02856113|449157261|FG000|Overall Study|Lost to Follow-up|3|||
124873084|NCT02856113|449157262|FG001|Overall Study|Lost to Follow-up|5|||
124873085|NCT02856113|449157261|FG000|Overall Study|Voluntary Withdrawal|3|||
124873086|NCT02856113|449157262|FG001|Overall Study|Voluntary Withdrawal|5|||
124873087|NCT02856113|449157261|FG000|Overall Study|Pregnancy|0|||
124873088|NCT02856113|449157262|FG001|Overall Study|Pregnancy|1|||
124873089|NCT02856113|449157261|FG000|Overall Study|Principal Investigator Discretion|2|||
124873090|NCT02856113|449157262|FG001|Overall Study|Principal Investigator Discretion|1|||
124873091|NCT02856113|449157261|FG000|Overall Study|Randomized but not Treated|1|||
124873092|NCT02856113|449157262|FG001|Overall Study|Randomized but not Treated|0|||
124873093|NCT02856113|449157261|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
124873094|NCT02856113|449157262|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
124873095|NCT03494166|449157263|FG000|Overall Study|Death|0|||
124873096|NCT03494166|449157264|FG001|Overall Study|Death|0|||
124873097|NCT03494166|449157265|FG002|Overall Study|Death|0|||
124873098|NCT03494166|449157266|FG003|Overall Study|Death|1|||
124873099|NCT03494166|449157267|FG004|Overall Study|Death|3|||
124873100|NCT03494166|449157268|FG005|Overall Study|Death|0|||
124873101|NCT03494166|449157263|FG000|Overall Study|Lost to Follow-up|2|||
124873102|NCT03494166|449157264|FG001|Overall Study|Lost to Follow-up|2|||
124873103|NCT03494166|449157265|FG002|Overall Study|Lost to Follow-up|2|||
124873104|NCT03494166|449157266|FG003|Overall Study|Lost to Follow-up|2|||
124873105|NCT03494166|449157267|FG004|Overall Study|Lost to Follow-up|14|||
124873106|NCT03494166|449157268|FG005|Overall Study|Lost to Follow-up|0|||
124873107|NCT03494166|449157263|FG000|Overall Study|Withdrawal by Subject|10|||
124873108|NCT03494166|449157264|FG001|Overall Study|Withdrawal by Subject|7|||
124873109|NCT03494166|449157265|FG002|Overall Study|Withdrawal by Subject|0|||
124873110|NCT03494166|449157266|FG003|Overall Study|Withdrawal by Subject|5|||
124873111|NCT03494166|449157267|FG004|Overall Study|Withdrawal by Subject|3|||
124873112|NCT03494166|449157268|FG005|Overall Study|Withdrawal by Subject|17|||
124873113|NCT03494166|449157263|FG000|Overall Study|Screen failure|1|||
124873114|NCT03494166|449157264|FG001|Overall Study|Screen failure|0|||
124873115|NCT03494166|449157265|FG002|Overall Study|Screen failure|0|||
124873116|NCT03494166|449157266|FG003|Overall Study|Screen failure|0|||
124873117|NCT03494166|449157267|FG004|Overall Study|Screen failure|1|||
124873118|NCT03494166|449157268|FG005|Overall Study|Screen failure|0|||
124873119|NCT02857426|449157269|FG000|Overall Study|Disease progression|34|||
124873120|NCT02857426|449157270|FG001|Overall Study|Disease progression|13|||
124873121|NCT02857426|449157269|FG000|Overall Study|Study drug toxicity|4|||
124873122|NCT02857426|449157270|FG001|Overall Study|Study drug toxicity|1|||
124873123|NCT02857426|449157269|FG000|Overall Study|Death|1|||
124873124|NCT02857426|449157270|FG001|Overall Study|Death|0|||
124873125|NCT02857426|449157269|FG000|Overall Study|Adverse event unrelated to study drug|6|||
124873126|NCT02857426|449157270|FG001|Overall Study|Adverse event unrelated to study drug|2|||
124873127|NCT02857426|449157269|FG000|Overall Study|Participant withdrew consent|1|||
124873128|NCT02857426|449157270|FG001|Overall Study|Participant withdrew consent|1|||
124873129|NCT02857426|449157269|FG000|Overall Study|Maximum clinical benefit|1|||
124873130|NCT02857426|449157270|FG001|Overall Study|Maximum clinical benefit|0|||
124873131|NCT02857426|449157269|FG000|Overall Study|Completed treatment|0|||
125010068|NCT00111800|449663614|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
125010069|NCT00111800|449663615|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
125010070|NCT00111800|449663616|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
125010071|NCT00111800|449663611|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
125010072|NCT00111800|449663612|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
125010073|NCT00111800|449663613|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
125010074|NCT00111800|449663614|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
125010075|NCT00111800|449663615|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
125010076|NCT00111800|449663616|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
125010077|NCT00111800|449663611|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
125010078|NCT00111800|449663612|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
125010079|NCT00111800|449663613|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
125010080|NCT00111800|449663614|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
125010081|NCT00111800|449663615|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
125010082|NCT00111800|449663616|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
125010083|NCT00111800|449663611|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
125010084|NCT00111800|449663612|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
125010085|NCT00111800|449663613|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
125010086|NCT00111800|449663614|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
125010087|NCT00111800|449663615|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
125010088|NCT00111800|449663616|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
125010089|NCT00111800|449663611|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
125010090|NCT00111800|449663612|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
125010091|NCT00111800|449663613|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
125098155|NCT02506101|449980205|FG001|Overall Study|Transportation issues|0|||
125098156|NCT02506101|449980204|FG000|Overall Study|No enrollment and staff unavailability|1|||
125098157|NCT02506101|449980205|FG001|Overall Study|No enrollment and staff unavailability|0|||
125098158|NCT00003526|449980206|FG000|Overall Study|Not evaluable|6|||
125098159|NCT00779857|449980207|FG000|Overall Study|Death|1|||
125098160|NCT00779857|449980207|FG000|Overall Study|Withdrawal by Subject|3|||
125098161|NCT00779857|449980207|FG000|Overall Study|Missed Visit|2|||
125098162|NCT00620776|449980212|FG000|Overall Study|Did not receive treatment|3|||
125098163|NCT00620776|449980213|FG001|Overall Study|Did not receive treatment|5|||
125098164|NCT00620776|449980212|FG000|Overall Study|Adverse Event|2|||
125098165|NCT00620776|449980213|FG001|Overall Study|Adverse Event|3|||
125098166|NCT00620776|449980212|FG000|Overall Study|Lack of Efficacy|2|||
125098167|NCT00620776|449980213|FG001|Overall Study|Lack of Efficacy|1|||
125098168|NCT00620776|449980212|FG000|Overall Study|Lost to Follow-up|2|||
125098169|NCT00620776|449980213|FG001|Overall Study|Lost to Follow-up|5|||
125098170|NCT00620776|449980212|FG000|Overall Study|Withdrawal by Subject|3|||
125098171|NCT00620776|449980213|FG001|Overall Study|Withdrawal by Subject|2|||
125098172|NCT01725217|449980214|FG000|Overall Study|Withdrawal by Subject|1|||
125098173|NCT01725217|449980215|FG001|Overall Study|Withdrawal by Subject|0|||
125098174|NCT01725217|449980216|FG002|Overall Study|Withdrawal by Subject|0|||
125098175|NCT03992456|449980217|FG000|Overall Study|Withdrawal by Subject|1|||
125098176|NCT03992456|449980218|FG001|Overall Study|Withdrawal by Subject|0|||
125098177|NCT03992456|449980217|FG000|Overall Study|Disease progression|4|||
125098178|NCT03992456|449980218|FG001|Overall Study|Disease progression|5|||
125098179|NCT03992456|449980217|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
125098180|NCT03992456|449980218|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
125098181|NCT01977625|449980219|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
125098182|NCT01977625|449980220|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
125098183|NCT01977625|449980219|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
125098184|NCT01977625|449980220|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
125098185|NCT04113746|449980221|FG000|Overall Study|Lost to Follow-up|4|||
125098186|NCT04113746|449980222|FG001|Overall Study|Lost to Follow-up|4|||
125098187|NCT02594384|449980223|FG000|Overall Study|Disease Progression|3|||
125098188|NCT02594384|449980224|FG001|Overall Study|Disease Progression|7|||
125098189|NCT02594384|449980225|FG002|Overall Study|Disease Progression|0|||
125098190|NCT02594384|449980226|FG003|Overall Study|Disease Progression|2|||
125098191|NCT02594384|449980227|FG004|Overall Study|Disease Progression|2|||
125098192|NCT02594384|449980228|FG005|Overall Study|Disease Progression|12|||
125098193|NCT02594384|449980229|FG006|Overall Study|Disease Progression|5|||
125098194|NCT02594384|449980230|FG007|Overall Study|Disease Progression|5|||
125098195|NCT02594384|449980223|FG000|Overall Study|Adverse Event|0|||
125098196|NCT02594384|449980224|FG001|Overall Study|Adverse Event|1|||
125098197|NCT02594384|449980225|FG002|Overall Study|Adverse Event|4|||
125098198|NCT02594384|449980226|FG003|Overall Study|Adverse Event|1|||
125098199|NCT02594384|449980227|FG004|Overall Study|Adverse Event|0|||
125098200|NCT02594384|449980228|FG005|Overall Study|Adverse Event|6|||
124873132|NCT02857426|449157270|FG001|Overall Study|Completed treatment|2|||
124873133|NCT02110901|449157274|FG000|Overall Study|Death|6|||
124873134|NCT02110901|449157275|FG001|Overall Study|Death|3|||
124873135|NCT02110901|449157274|FG000|Overall Study|Lost to Follow-up|12|||
124873136|NCT02110901|449157275|FG001|Overall Study|Lost to Follow-up|8|||
124873137|NCT02110901|449157274|FG000|Overall Study|Withdrawal by Subject|7|||
124873138|NCT02110901|449157275|FG001|Overall Study|Withdrawal by Subject|3|||
124873139|NCT02110901|449157274|FG000|Overall Study|received a kidney transplant|5|||
124873140|NCT02110901|449157275|FG001|Overall Study|received a kidney transplant|0|||
125098201|NCT02594384|449980229|FG006|Overall Study|Adverse Event|1|||
125098202|NCT02594384|449980230|FG007|Overall Study|Adverse Event|1|||
125098203|NCT02594384|449980223|FG000|Overall Study|Withdrawal by Subject|0|||
125098204|NCT02594384|449980224|FG001|Overall Study|Withdrawal by Subject|0|||
125098205|NCT02594384|449980225|FG002|Overall Study|Withdrawal by Subject|0|||
125098206|NCT02594384|449980226|FG003|Overall Study|Withdrawal by Subject|1|||
125098207|NCT02594384|449980227|FG004|Overall Study|Withdrawal by Subject|0|||
125098208|NCT02594384|449980228|FG005|Overall Study|Withdrawal by Subject|0|||
125098209|NCT02594384|449980229|FG006|Overall Study|Withdrawal by Subject|0|||
124873141|NCT00758459|449157276|FG000|Overall Study|Adverse Event|3|||
124873142|NCT00758459|449157277|FG001|Overall Study|Adverse Event|2|||
124873143|NCT00758459|449157276|FG000|Overall Study|Protocol Violation|0|||
125098210|NCT02594384|449980230|FG007|Overall Study|Withdrawal by Subject|1|||
125098211|NCT02594384|449980223|FG000|Overall Study|Physician Decision|0|||
124873144|NCT00758459|449157277|FG001|Overall Study|Protocol Violation|1|||
124873145|NCT00758459|449157276|FG000|Overall Study|Withdrawal by Subject|0|||
124873146|NCT00758459|449157277|FG001|Overall Study|Withdrawal by Subject|1|||
124873147|NCT01780935|449157279|FG000|Overall Study|Admin problems due to early termination|321|||
124873148|NCT01780935|449157280|FG001|Overall Study|Admin problems due to early termination|309|||
124873149|NCT01780935|449157279|FG000|Overall Study|Adverse Event|2|||
125010092|NCT00111800|449663614|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
125010093|NCT00111800|449663615|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
125010094|NCT00111800|449663616|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
125010095|NCT00111800|449663611|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
125010096|NCT00111800|449663612|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
125010097|NCT00111800|449663613|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
125010098|NCT00111800|449663614|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
125010099|NCT00111800|449663615|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
125010100|NCT00111800|449663616|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
125010101|NCT00111800|449663611|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
125010102|NCT00111800|449663612|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
125010103|NCT00111800|449663613|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
125010104|NCT00111800|449663614|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
125010105|NCT00111800|449663615|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
125010106|NCT00111800|449663616|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
125010107|NCT00111800|449663611|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
125010108|NCT00111800|449663612|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
125010109|NCT00111800|449663613|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
125010110|NCT00111800|449663614|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
125010111|NCT00111800|449663615|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
125010112|NCT00111800|449663616|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
125010113|NCT00111800|449663611|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
125010114|NCT00111800|449663612|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
125010115|NCT00111800|449663613|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
125010116|NCT00111800|449663614|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
125010117|NCT00111800|449663615|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
125010118|NCT00111800|449663616|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
125010119|NCT00111800|449663611|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
125010120|NCT00111800|449663612|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
125010121|NCT00111800|449663613|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
125010122|NCT00111800|449663614|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
125010123|NCT00111800|449663615|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
125010124|NCT00111800|449663616|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
125010125|NCT00111800|449663611|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
125010126|NCT00111800|449663612|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
125010127|NCT00111800|449663613|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
125010128|NCT00111800|449663614|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
125010129|NCT00111800|449663615|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
125010130|NCT00111800|449663616|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
125010131|NCT00111800|449663611|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
125010132|NCT00111800|449663612|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
125010133|NCT00111800|449663613|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
125010134|NCT00111800|449663614|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
125010135|NCT00111800|449663615|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
125010136|NCT00111800|449663616|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
125010137|NCT00111800|449663611|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
125010138|NCT00111800|449663612|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
125010139|NCT00111800|449663613|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
125010140|NCT00111800|449663614|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
125010141|NCT00111800|449663615|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
125010142|NCT00111800|449663616|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
125010143|NCT00111800|449663611|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
125010144|NCT00111800|449663612|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
125010145|NCT00111800|449663613|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
124873150|NCT01780935|449157280|FG001|Overall Study|Adverse Event|4|||
124873151|NCT01780935|449157279|FG000|Overall Study|Death|1|||
124873152|NCT01780935|449157280|FG001|Overall Study|Death|6|||
124873153|NCT01780935|449157279|FG000|Overall Study|Lost to Follow-up|2|||
124873154|NCT01780935|449157280|FG001|Overall Study|Lost to Follow-up|6|||
124873155|NCT01780935|449157279|FG000|Overall Study|Physician Decision|1|||
124873156|NCT01780935|449157280|FG001|Overall Study|Physician Decision|1|||
124873157|NCT01780935|449157279|FG000|Overall Study|Protocol deviation|0|||
124873158|NCT01780935|449157280|FG001|Overall Study|Protocol deviation|1|||
124873159|NCT01780935|449157279|FG000|Overall Study|Patient withdrew consent|8|||
124873160|NCT01780935|449157280|FG001|Overall Study|Patient withdrew consent|9|||
124873161|NCT00855595|449157281|FG000|Overall Study|Withdrawal by Subject|1|||
124873162|NCT00855595|449157282|FG001|Overall Study|Withdrawal by Subject|2|||
124873163|NCT00855595|449157281|FG000|Overall Study|Lost to Follow-up|3|||
124873164|NCT00855595|449157282|FG001|Overall Study|Lost to Follow-up|3|||
124873165|NCT00855595|449157281|FG000|Overall Study|Adverse Event|1|||
124873166|NCT00855595|449157282|FG001|Overall Study|Adverse Event|1|||
124873167|NCT00855595|449157281|FG000|Overall Study|patient moved out of state|1|||
124873168|NCT00855595|449157282|FG001|Overall Study|patient moved out of state|0|||
124873169|NCT00855595|449157281|FG000|Overall Study|patient left country|0|||
124873170|NCT00855595|449157282|FG001|Overall Study|patient left country|1|||
124873171|NCT00166296|449157283|FG000|Overall Study|Withdrawal by Subject|1|||
124873172|NCT00166296|449157284|FG001|Overall Study|Withdrawal by Subject|3|||
124873173|NCT00166296|449157283|FG000|Overall Study|Adverse Event|2|||
124873174|NCT00166296|449157284|FG001|Overall Study|Adverse Event|4|||
124873175|NCT00166296|449157283|FG000|Overall Study|Lost to Follow-up|4|||
124873176|NCT00166296|449157284|FG001|Overall Study|Lost to Follow-up|2|||
124873177|NCT04035200|449157285|FG000|Overall Study|Lost to Follow-up|0|||
124873178|NCT04035200|449157286|FG001|Overall Study|Lost to Follow-up|1|||
124873179|NCT04035200|449157287|FG002|Overall Study|Lost to Follow-up|0|||
124873180|NCT04035200|449157285|FG000|Overall Study|Withdrawal by Subject|1|||
124873181|NCT04035200|449157286|FG001|Overall Study|Withdrawal by Subject|4|||
124873182|NCT04035200|449157287|FG002|Overall Study|Withdrawal by Subject|4|||
124873183|NCT04035200|449157285|FG000|Overall Study|COVID-19|1|||
124873184|NCT04035200|449157286|FG001|Overall Study|COVID-19|0|||
124873185|NCT04035200|449157287|FG002|Overall Study|COVID-19|0|||
124873186|NCT04035200|449157285|FG000|Overall Study|Early Termination|0|||
124873187|NCT04035200|449157286|FG001|Overall Study|Early Termination|1|||
124873188|NCT04035200|449157287|FG002|Overall Study|Early Termination|0|||
125010146|NCT00111800|449663614|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
125010147|NCT00111800|449663615|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
125010148|NCT00111800|449663616|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
125010149|NCT00111800|449663611|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
125010150|NCT00111800|449663612|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
124873189|NCT04035200|449157285|FG000|Overall Study|Non-compliance|0|||
124873190|NCT04035200|449157286|FG001|Overall Study|Non-compliance|1|||
124873191|NCT04035200|449157287|FG002|Overall Study|Non-compliance|0|||
125010151|NCT00111800|449663613|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
124873192|NCT00946296|449157288|FG000|Overall Study|Physician Decision|3|||
125010152|NCT00111800|449663614|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
124873193|NCT00946296|449157289|FG001|Overall Study|Physician Decision|0|||
124873194|NCT01422408|449157294|FG000|Overall Study|Adverse Event|1|||
125098212|NCT02594384|449980224|FG001|Overall Study|Physician Decision|0|||
125098213|NCT02594384|449980225|FG002|Overall Study|Physician Decision|0|||
125098214|NCT02594384|449980226|FG003|Overall Study|Physician Decision|0|||
125098215|NCT02594384|449980227|FG004|Overall Study|Physician Decision|0|||
125098216|NCT02594384|449980228|FG005|Overall Study|Physician Decision|1|||
125098217|NCT02594384|449980229|FG006|Overall Study|Physician Decision|2|||
125098218|NCT02594384|449980230|FG007|Overall Study|Physician Decision|0|||
125098219|NCT02594384|449980223|FG000|Overall Study|Progressive Leukocytosis|0|||
125098220|NCT02594384|449980224|FG001|Overall Study|Progressive Leukocytosis|0|||
125098221|NCT02594384|449980225|FG002|Overall Study|Progressive Leukocytosis|1|||
125098222|NCT02594384|449980226|FG003|Overall Study|Progressive Leukocytosis|0|||
125098223|NCT02594384|449980227|FG004|Overall Study|Progressive Leukocytosis|0|||
125098224|NCT02594384|449980228|FG005|Overall Study|Progressive Leukocytosis|0|||
125098225|NCT02594384|449980229|FG006|Overall Study|Progressive Leukocytosis|0|||
125098226|NCT02594384|449980230|FG007|Overall Study|Progressive Leukocytosis|0|||
125098227|NCT02594384|449980223|FG000|Overall Study|Lack of Efficacy|0|||
125098228|NCT02594384|449980224|FG001|Overall Study|Lack of Efficacy|0|||
125098229|NCT02594384|449980225|FG002|Overall Study|Lack of Efficacy|0|||
125098230|NCT02594384|449980226|FG003|Overall Study|Lack of Efficacy|0|||
125098231|NCT02594384|449980227|FG004|Overall Study|Lack of Efficacy|1|||
125098232|NCT02594384|449980228|FG005|Overall Study|Lack of Efficacy|0|||
125098233|NCT02594384|449980229|FG006|Overall Study|Lack of Efficacy|0|||
125098234|NCT02594384|449980230|FG007|Overall Study|Lack of Efficacy|0|||
125098235|NCT02594384|449980223|FG000|Overall Study|Substantial noncompliance|0|||
125098236|NCT02594384|449980224|FG001|Overall Study|Substantial noncompliance|0|||
125098237|NCT02594384|449980225|FG002|Overall Study|Substantial noncompliance|0|||
125098238|NCT02594384|449980226|FG003|Overall Study|Substantial noncompliance|0|||
124873195|NCT01422408|449157294|FG000|Overall Study|Withdrawal by Subject|3|||
124873196|NCT03185481|449157295|FG000|Overall Study|Adverse Event|1|||
124873197|NCT03185481|449157295|FG000|Overall Study|Study Terminated by Sponsor|4|||
124873198|NCT00701038|449157296|FG000|Overall Study|study amended pilot group of patients|4|||
124873199|NCT00701038|449157297|FG001|Overall Study|study amended pilot group of patients|4|||
124873200|NCT00386022|449157299|FG000|Plus Estrogen|Lost to Follow-up|2|||
124873201|NCT00386022|449157300|FG001|Plus Estrogen|Lost to Follow-up|0|||
124873202|NCT00386022|449157299|FG000|Plus Estrogen|Adverse Event|0|||
124873203|NCT00386022|449157300|FG001|Plus Estrogen|Adverse Event|1|||
124873204|NCT01064297|449157304|FG000|Overall Study|Lost to Follow-up|791|||
124873205|NCT01064297|449157305|FG001|Overall Study|Lost to Follow-up|48|||
124873206|NCT01064297|449157306|FG002|Overall Study|Lost to Follow-up|133|||
124873207|NCT00168038|449157312|FG000|Overall Study|Adverse Event|1|||
124873208|NCT00168038|449157312|FG000|Overall Study|Therapy failure|1|||
124873209|NCT01345630|449158835|FG000|Overall Study|Adverse Event|22|||
124873210|NCT01345630|449158836|FG001|Overall Study|Adverse Event|23|||
124873211|NCT01345630|449158835|FG000|Overall Study|Lost to Follow-up|17|||
124873212|NCT01345630|449158836|FG001|Overall Study|Lost to Follow-up|16|||
124873213|NCT01345630|449158835|FG000|Overall Study|Protocol Violation|4|||
124873214|NCT01345630|449158836|FG001|Overall Study|Protocol Violation|1|||
124873215|NCT01345630|449158835|FG000|Overall Study|Medication error without associated AE|0|||
124873216|NCT01345630|449158836|FG001|Overall Study|Medication error without associated AE|1|||
124873217|NCT01345630|449158835|FG000|Overall Study|Study terminated by sponsor|254|||
124873218|NCT01345630|449158836|FG001|Overall Study|Study terminated by sponsor|285|||
124873219|NCT01345630|449158835|FG000|Overall Study|Other reasons|6|||
124873220|NCT01345630|449158836|FG001|Overall Study|Other reasons|8|||
124873221|NCT01345630|449158835|FG000|Overall Study|Withdrawn due to pregnancy|1|||
124873222|NCT01345630|449158836|FG001|Overall Study|Withdrawn due to pregnancy|2|||
124873223|NCT01345630|449158835|FG000|Overall Study|No longer willing to participate|9|||
124873224|NCT01345630|449158836|FG001|Overall Study|No longer willing to participate|12|||
124873225|NCT01345630|449158835|FG000|Overall Study|Insufficient clinical response|48|||
124873226|NCT01345630|449158836|FG001|Overall Study|Insufficient clinical response|11|||
124873227|NCT04233372|449158837|FG000|Overall Study|Lost to Follow-up|104|||
124873228|NCT04233372|449158837|FG000|Overall Study|Adverse Event|8|||
124873229|NCT04233372|449158837|FG000|Overall Study|Withdrawal by Subject|2|||
124873230|NCT01090310|449158838|FG000|Core Study|Adverse Event|2|||
124873231|NCT01090310|449158839|FG001|Core Study|Adverse Event|2|||
124873232|NCT01090310|449158840|FG002|Core Study|Adverse Event|1|||
124873233|NCT01090310|449158841|FG003|Core Study|Adverse Event|1|||
124873234|NCT01090310|449158838|FG000|Core Study|Subject withdrew consent|0|||
124873235|NCT01090310|449158839|FG001|Core Study|Subject withdrew consent|3|||
124873236|NCT01090310|449158840|FG002|Core Study|Subject withdrew consent|1|||
124873237|NCT01090310|449158841|FG003|Core Study|Subject withdrew consent|1|||
124873238|NCT01090310|449158838|FG000|Core Study|Abnormal test procedure result|0|||
124873239|NCT01090310|449158839|FG001|Core Study|Abnormal test procedure result|0|||
124873240|NCT01090310|449158840|FG002|Core Study|Abnormal test procedure result|1|||
124873241|NCT01090310|449158841|FG003|Core Study|Abnormal test procedure result|0|||
124873242|NCT01090310|449158838|FG000|Core Study|Administrative reasons|5|||
124873243|NCT01090310|449158839|FG001|Core Study|Administrative reasons|6|||
124873244|NCT01090310|449158840|FG002|Core Study|Administrative reasons|4|||
124873245|NCT01090310|449158841|FG003|Core Study|Administrative reasons|4|||
124873246|NCT01090310|449158838|FG000|Core Study|Protocol deviation|1|||
124873247|NCT01090310|449158839|FG001|Core Study|Protocol deviation|0|||
124873248|NCT01090310|449158840|FG002|Core Study|Protocol deviation|0|||
124873249|NCT01090310|449158841|FG003|Core Study|Protocol deviation|1|||
124873250|NCT01090310|449158838|FG000|Extension Study|Aministrative problems|13|||
124873251|NCT01090310|449158839|FG001|Extension Study|Aministrative problems|15|||
125098239|NCT02594384|449980227|FG004|Overall Study|Substantial noncompliance|0|||
125098240|NCT02594384|449980228|FG005|Overall Study|Substantial noncompliance|0|||
124873252|NCT01090310|449158840|FG002|Extension Study|Aministrative problems|14|||
124873253|NCT01090310|449158841|FG003|Extension Study|Aministrative problems|18|||
124873254|NCT01090310|449158838|FG000|Extension Study|Adverse Event|0|||
125098241|NCT02594384|449980229|FG006|Overall Study|Substantial noncompliance|1|||
125098242|NCT02594384|449980230|FG007|Overall Study|Substantial noncompliance|0|||
124873255|NCT01090310|449158839|FG001|Extension Study|Adverse Event|0|||
124873256|NCT01090310|449158840|FG002|Extension Study|Adverse Event|0|||
124873257|NCT01090310|449158841|FG003|Extension Study|Adverse Event|1|||
124873258|NCT01090310|449158838|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
124873259|NCT01090310|449158839|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
124873260|NCT01090310|449158840|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
124873261|NCT01090310|449158841|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
124873262|NCT01090310|449158838|FG000|Extension Study|Subject withdrew consent|0|||
124873263|NCT01090310|449158839|FG001|Extension Study|Subject withdrew consent|1|||
124873264|NCT01090310|449158840|FG002|Extension Study|Subject withdrew consent|0|||
124873265|NCT01090310|449158841|FG003|Extension Study|Subject withdrew consent|0|||
125098243|NCT04964960|449980233|FG000|Overall Study|Withdrawal by Subject|1|||
124873266|NCT00695786|449158842|FG000|Overall Study|Adverse Event|0|||
124873267|NCT00695786|449158843|FG001|Overall Study|Adverse Event|3|||
124873268|NCT00695786|449158844|FG002|Overall Study|Adverse Event|4|||
124873269|NCT00695786|449158845|FG003|Overall Study|Adverse Event|2|||
124873270|NCT00695786|449158842|FG000|Overall Study|Lost to Follow-up|0|||
124873271|NCT00695786|449158843|FG001|Overall Study|Lost to Follow-up|5|||
124873272|NCT00695786|449158844|FG002|Overall Study|Lost to Follow-up|1|||
124873273|NCT00695786|449158845|FG003|Overall Study|Lost to Follow-up|1|||
124873274|NCT00695786|449158842|FG000|Overall Study|Withdrawal by Subject|0|||
124873275|NCT00695786|449158843|FG001|Overall Study|Withdrawal by Subject|4|||
124873276|NCT00695786|449158844|FG002|Overall Study|Withdrawal by Subject|3|||
124873277|NCT00695786|449158845|FG003|Overall Study|Withdrawal by Subject|1|||
124873278|NCT00695786|449158842|FG000|Overall Study|Deemed Ineligible|1|||
124873279|NCT00695786|449158843|FG001|Overall Study|Deemed Ineligible|0|||
124873280|NCT00695786|449158844|FG002|Overall Study|Deemed Ineligible|0|||
124873281|NCT00695786|449158845|FG003|Overall Study|Deemed Ineligible|0|||
124873282|NCT00695786|449158842|FG000|Overall Study|Lack of Efficacy|0|||
124873283|NCT00695786|449158843|FG001|Overall Study|Lack of Efficacy|0|||
124873284|NCT00695786|449158844|FG002|Overall Study|Lack of Efficacy|0|||
124873285|NCT00695786|449158845|FG003|Overall Study|Lack of Efficacy|4|||
124873286|NCT01364922|449158846|FG000|Open-label (OL) Period|Adverse Event|7|||
124873287|NCT01364922|449158847|FG001|Open-label (OL) Period|Adverse Event|0|||
124873288|NCT01364922|449158848|FG002|Open-label (OL) Period|Adverse Event|0|||
124873289|NCT01364922|449158846|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
124873290|NCT01364922|449158847|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
124873291|NCT01364922|449158848|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
124873292|NCT01364922|449158846|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
124873293|NCT01364922|449158847|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
124873294|NCT01364922|449158848|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
124873295|NCT01364922|449158846|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
124873296|NCT01364922|449158847|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
124873297|NCT01364922|449158848|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
124873298|NCT01364922|449158846|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
124873299|NCT01364922|449158847|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
124873300|NCT01364922|449158848|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
124873301|NCT01364922|449158846|FG000|Open-label (OL) Period|Other, Unspecified|1|||
124873302|NCT01364922|449158847|FG001|Open-label (OL) Period|Other, Unspecified|0|||
124873303|NCT01364922|449158848|FG002|Open-label (OL) Period|Other, Unspecified|0|||
124873304|NCT01364922|449158846|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
124873305|NCT01364922|449158847|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
124873306|NCT01364922|449158848|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
124873307|NCT01364922|449158846|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
124873308|NCT01364922|449158847|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
124873309|NCT01364922|449158848|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
124873310|NCT01364922|449158846|FG000|Double-Blind (DB) Period|Adverse Event|0|||
124873311|NCT01364922|449158847|FG001|Double-Blind (DB) Period|Adverse Event|0|||
124873312|NCT01364922|449158848|FG002|Double-Blind (DB) Period|Adverse Event|1|||
124873313|NCT01364922|449158846|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
124873314|NCT01364922|449158847|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
124873315|NCT01364922|449158848|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
124873316|NCT01787097|449158852|FG000|Overall Study|Withdrawal by Subject|1|||
124873317|NCT01787097|449158853|FG001|Overall Study|Withdrawal by Subject|0|||
124873318|NCT01787097|449158854|FG002|Overall Study|Withdrawal by Subject|0|||
124873319|NCT01787097|449158855|FG003|Overall Study|Withdrawal by Subject|0|||
124873320|NCT00949884|449158856|FG000|Overall Study|Adverse Event|14|||
124873321|NCT00949884|449158857|FG001|Overall Study|Adverse Event|3|||
125098244|NCT00483119|449980234|FG000|Overall Study|Adverse Event|0|||
125098245|NCT00483119|449980235|FG001|Overall Study|Adverse Event|1|||
125098246|NCT00483119|449980234|FG000|Overall Study|Physician Decision|1|||
125098247|NCT00483119|449980235|FG001|Overall Study|Physician Decision|0|||
125098248|NCT04668066|449980236|FG000|Part 1: Treatment Phase|Adverse Event|0|||
125098249|NCT04668066|449980237|FG001|Part 1: Treatment Phase|Adverse Event|0|||
125098250|NCT04668066|449980238|FG002|Part 1: Treatment Phase|Adverse Event|0|||
124873322|NCT00949884|449158858|FG002|Overall Study|Adverse Event|12|||
124873323|NCT00949884|449158856|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
124873324|NCT00949884|449158857|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
124873325|NCT00949884|449158858|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
124873326|NCT00949884|449158856|FG000|Overall Study|Lost to Follow-up|7|||
124873327|NCT00949884|449158857|FG001|Overall Study|Lost to Follow-up|5|||
124873328|NCT00949884|449158858|FG002|Overall Study|Lost to Follow-up|5|||
124873329|NCT00949884|449158856|FG000|Overall Study|Physician Decision|5|||
124873330|NCT00949884|449158857|FG001|Overall Study|Physician Decision|0|||
124873331|NCT00949884|449158858|FG002|Overall Study|Physician Decision|6|||
124873332|NCT00949884|449158856|FG000|Overall Study|Treatment non-compliance|5|||
124873333|NCT00949884|449158857|FG001|Overall Study|Treatment non-compliance|0|||
125098251|NCT04668066|449980239|FG003|Part 1: Treatment Phase|Adverse Event|0|||
125098252|NCT04668066|449980240|FG004|Part 1: Treatment Phase|Adverse Event|0|||
124873334|NCT00949884|449158858|FG002|Overall Study|Treatment non-compliance|8|||
124873335|NCT00949884|449158856|FG000|Overall Study|Withdrawal by Subject|13|||
124873336|NCT00949884|449158857|FG001|Overall Study|Withdrawal by Subject|4|||
124873337|NCT00949884|449158858|FG002|Overall Study|Withdrawal by Subject|16|||
124873338|NCT00949884|449158856|FG000|Overall Study|Lack of Efficacy|4|||
124873339|NCT00949884|449158857|FG001|Overall Study|Lack of Efficacy|2|||
124873340|NCT00949884|449158858|FG002|Overall Study|Lack of Efficacy|7|||
124873341|NCT00949884|449158856|FG000|Overall Study|Study terminated by sponsor|0|||
124873342|NCT00949884|449158857|FG001|Overall Study|Study terminated by sponsor|0|||
124873343|NCT00949884|449158858|FG002|Overall Study|Study terminated by sponsor|1|||
124873344|NCT00944658|449158859|FG000|Treatment 12 Weeks|Adverse Event|0|||
124873345|NCT00944658|449158860|FG001|Treatment 12 Weeks|Adverse Event|2|||
124873346|NCT02832622|449158866|FG000|Overall Study|MPP not programmed|1259|||
124873347|NCT02832622|449158866|FG000|Overall Study|Withdrawal by Subject|123|||
124873348|NCT02832622|449158866|FG000|Overall Study|Death|119|||
124873349|NCT02832622|449158866|FG000|Overall Study|Unsuccessful CRT implant|93|||
124873350|NCT02832622|449158866|FG000|Overall Study|Lost to Follow-up|45|||
124873351|NCT02832622|449158866|FG000|Overall Study|Patient non-compliance|42|||
124873352|NCT02832622|449158866|FG000|Overall Study|Withdrawal by other reasons|25|||
124873353|NCT02832622|449158866|FG000|Overall Study|System explant|24|||
124873354|NCT02832622|449158866|FG000|Overall Study|Physician Decision|6|||
124873355|NCT02472652|449158867|FG000|Overall Study|Lost to Follow-up|1|||
124873356|NCT03704584|449158868|FG000|Overall Study|Withdrawal by Subject|1|||
124873357|NCT03704584|449158869|FG001|Overall Study|Withdrawal by Subject|0|||
124873358|NCT03185832|449158870|FG000|Overall Study|Death|9|||
124873359|NCT03185832|449158871|FG001|Overall Study|Death|14|||
124873360|NCT03185832|449158872|FG002|Overall Study|Death|9|||
124873361|NCT03185832|449158873|FG003|Overall Study|Death|7|||
124873362|NCT03185832|449158870|FG000|Overall Study|Withdrawn - vital status available|0|||
124873363|NCT03185832|449158871|FG001|Overall Study|Withdrawn - vital status available|1|||
124873364|NCT03185832|449158872|FG002|Overall Study|Withdrawn - vital status available|1|||
124873365|NCT03185832|449158873|FG003|Overall Study|Withdrawn - vital status available|4|||
124873366|NCT02323646|449158875|FG000|Treatment Course 1|Adverse Event|1|||
124873367|NCT02323646|449158876|FG001|Treatment Course 1|Adverse Event|0|||
124873368|NCT02323646|449158877|FG002|Treatment Course 1|Adverse Event|1|||
124873369|NCT02323646|449158875|FG000|Treatment Course 1|Heavy Bleeding|1|||
124873370|NCT02323646|449158876|FG001|Treatment Course 1|Heavy Bleeding|1|||
124873371|NCT02323646|449158877|FG002|Treatment Course 1|Heavy Bleeding|0|||
124873372|NCT02323646|449158875|FG000|Treatment Course 1|Lost to Follow-up|1|||
124873373|NCT02323646|449158876|FG001|Treatment Course 1|Lost to Follow-up|0|||
124873374|NCT02323646|449158877|FG002|Treatment Course 1|Lost to Follow-up|2|||
124873375|NCT02323646|449158875|FG000|Treatment Course 1|Withdrawal by Subject|0|||
124873376|NCT02323646|449158876|FG001|Treatment Course 1|Withdrawal by Subject|2|||
124873377|NCT02323646|449158877|FG002|Treatment Course 1|Withdrawal by Subject|0|||
124873378|NCT02323646|449158875|FG000|Treatment Course 2|Adverse Event|1|||
124873379|NCT02323646|449158876|FG001|Treatment Course 2|Adverse Event|0|||
124873380|NCT02323646|449158877|FG002|Treatment Course 2|Adverse Event|1|||
124873381|NCT02323646|449158875|FG000|Treatment Course 2|Lost to Follow-up|0|||
124873382|NCT02323646|449158876|FG001|Treatment Course 2|Lost to Follow-up|0|||
124873383|NCT02323646|449158877|FG002|Treatment Course 2|Lost to Follow-up|1|||
124873384|NCT02323646|449158875|FG000|Treatment Course 2|Non-compliance|0|||
124873385|NCT02323646|449158876|FG001|Treatment Course 2|Non-compliance|1|||
124873386|NCT02323646|449158877|FG002|Treatment Course 2|Non-compliance|1|||
124873387|NCT00521144|449158878|FG000|Overall Study|Not Treated|0|||
125098253|NCT04668066|449980241|FG005|Part 1: Treatment Phase|Adverse Event|0|||
125098254|NCT04668066|449980242|FG006|Part 1: Treatment Phase|Adverse Event|0|||
125098255|NCT04668066|449980243|FG007|Part 1: Treatment Phase|Adverse Event|0|||
125098256|NCT04668066|449980244|FG008|Part 1: Treatment Phase|Adverse Event|0|||
125098257|NCT04668066|449980245|FG009|Part 1: Treatment Phase|Adverse Event|0|||
125098258|NCT04668066|449980246|FG010|Part 1: Treatment Phase|Adverse Event|0|||
125098259|NCT04668066|449980247|FG011|Part 1: Treatment Phase|Adverse Event|1|||
125098260|NCT04668066|449980248|FG012|Part 1: Treatment Phase|Adverse Event|1|||
124873388|NCT00521144|449158879|FG001|Overall Study|Not Treated|0|||
124873389|NCT00521144|449158880|FG002|Overall Study|Not Treated|0|||
124873390|NCT00521144|449158881|FG003|Overall Study|Not Treated|1|||
124873391|NCT00521144|449158882|FG004|Overall Study|Not Treated|0|||
124873392|NCT00521144|449158878|FG000|Overall Study|Adverse Event|0|||
124873393|NCT00521144|449158879|FG001|Overall Study|Adverse Event|1|||
124873394|NCT00521144|449158880|FG002|Overall Study|Adverse Event|0|||
124873395|NCT00521144|449158881|FG003|Overall Study|Adverse Event|0|||
124873396|NCT00521144|449158882|FG004|Overall Study|Adverse Event|1|||
124873397|NCT00521144|449158878|FG000|Overall Study|Progressive Disease|4|||
124873398|NCT00521144|449158879|FG001|Overall Study|Progressive Disease|2|||
124873399|NCT00521144|449158880|FG002|Overall Study|Progressive Disease|2|||
124873400|NCT00521144|449158881|FG003|Overall Study|Progressive Disease|0|||
124873401|NCT00521144|449158882|FG004|Overall Study|Progressive Disease|6|||
124873402|NCT01370525|449158883|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
125098261|NCT04668066|449980249|FG013|Part 1: Treatment Phase|Adverse Event|0|||
124873403|NCT01370525|449158884|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
124873404|NCT01370525|449158883|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
124873405|NCT01370525|449158884|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
124873406|NCT01370525|449158883|FG000|Overall Study|Adverse Event|0|||
124873407|NCT01370525|449158884|FG001|Overall Study|Adverse Event|1|||
124873408|NCT01370525|449158883|FG000|Overall Study|Protocol Violation|2|||
124873409|NCT01370525|449158884|FG001|Overall Study|Protocol Violation|1|||
124873410|NCT01370525|449158883|FG000|Overall Study|Lost to follow up|2|||
124873411|NCT01370525|449158884|FG001|Overall Study|Lost to follow up|6|||
124873412|NCT05131165|449158891|FG000|Overall Study|Death|1|||
124873413|NCT05131165|449158892|FG001|Overall Study|Death|1|||
124873414|NCT05131165|449158893|FG002|Overall Study|Death|0|||
124873415|NCT05131165|449158891|FG000|Overall Study|Lost to Follow-up|2|||
124873416|NCT05131165|449158892|FG001|Overall Study|Lost to Follow-up|2|||
124873417|NCT05131165|449158893|FG002|Overall Study|Lost to Follow-up|5|||
124873418|NCT05131165|449158891|FG000|Overall Study|Transferred out of clinic|1|||
124873419|NCT05131165|449158892|FG001|Overall Study|Transferred out of clinic|0|||
124873420|NCT05131165|449158893|FG002|Overall Study|Transferred out of clinic|3|||
124873421|NCT05131165|449158891|FG000|Overall Study|Dropped out|1|||
124873422|NCT05131165|449158892|FG001|Overall Study|Dropped out|2|||
124873423|NCT05131165|449158893|FG002|Overall Study|Dropped out|0|||
124873424|NCT02459262|449158899|FG000|Overall Study|Withdrawal by Subject|0|||
124873425|NCT02459262|449158900|FG001|Overall Study|Withdrawal by Subject|0|||
124873426|NCT02459262|449158901|FG002|Overall Study|Withdrawal by Subject|0|||
124873427|NCT02459262|449158902|FG003|Overall Study|Withdrawal by Subject|0|||
124873428|NCT02459262|449158903|FG004|Overall Study|Withdrawal by Subject|0|||
124873429|NCT02459262|449158904|FG005|Overall Study|Withdrawal by Subject|0|||
124873430|NCT02459262|449158905|FG006|Overall Study|Withdrawal by Subject|0|||
124873431|NCT02459262|449158906|FG007|Overall Study|Withdrawal by Subject|0|||
124873432|NCT02459262|449158907|FG008|Overall Study|Withdrawal by Subject|0|||
124873433|NCT02459262|449158908|FG009|Overall Study|Withdrawal by Subject|1|||
124873434|NCT02459262|449158909|FG010|Overall Study|Withdrawal by Subject|0|||
124873435|NCT05168579|449158910|FG000|Overall Study|Lack of Consent|1|||
124873436|NCT05168579|449158911|FG001|Overall Study|Lack of Consent|0|||
124873437|NCT05168579|449158910|FG000|Overall Study|Conflicts with time|2|||
124873438|NCT05168579|449158911|FG001|Overall Study|Conflicts with time|0|||
124873439|NCT05168579|449158910|FG000|Overall Study|Time slots were full|3|||
124873440|NCT05168579|449158911|FG001|Overall Study|Time slots were full|0|||
124873441|NCT05168579|449158910|FG000|Overall Study|Lost to Follow-up|0|||
124873442|NCT05168579|449158911|FG001|Overall Study|Lost to Follow-up|15|||
124873443|NCT01242748|449158912|FG000|Overall Study|Adverse Event|10|||
124873444|NCT01242748|449158913|FG001|Overall Study|Adverse Event|5|||
124873445|NCT01242748|449158912|FG000|Overall Study|Lost to Follow-up|6|||
124873446|NCT01242748|449158913|FG001|Overall Study|Lost to Follow-up|2|||
124873447|NCT01242748|449158912|FG000|Overall Study|Physician Decision|3|||
124873448|NCT01242748|449158913|FG001|Overall Study|Physician Decision|2|||
124873449|NCT01242748|449158912|FG000|Overall Study|Protocol Violation|1|||
124873450|NCT01242748|449158913|FG001|Overall Study|Protocol Violation|0|||
124873451|NCT01242748|449158912|FG000|Overall Study|Withdrawal by Subject|10|||
124873452|NCT01242748|449158913|FG001|Overall Study|Withdrawal by Subject|2|||
124873453|NCT01242748|449158912|FG000|Overall Study|Miscellaneous reasons|8|||
124873454|NCT01242748|449158913|FG001|Overall Study|Miscellaneous reasons|3|||
124873455|NCT00840801|449158914|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
124873456|NCT00840801|449158915|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
124873457|NCT00840801|449158916|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
124873458|NCT00840801|449158914|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
124873459|NCT00840801|449158915|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
125010153|NCT00111800|449663615|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
125010154|NCT00111800|449663616|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
125010155|NCT00111800|449663611|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
125010156|NCT00111800|449663612|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
125010157|NCT00111800|449663613|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
125010158|NCT00111800|449663614|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
124873460|NCT00840801|449158916|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
124873461|NCT00840801|449158914|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
124873462|NCT00840801|449158915|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
124873463|NCT00840801|449158916|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
124873464|NCT00840801|449158914|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
124873465|NCT00840801|449158915|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
124873466|NCT00840801|449158916|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
124873467|NCT00508404|449158925|FG000|Overall Study|Ongoing at Data Cut-off|12|||
124873468|NCT00508404|449158925|FG000|Overall Study|Adverse Event|2|||
124873469|NCT00508404|449158925|FG000|Overall Study|Death|16|||
124873470|NCT00508404|449158925|FG000|Overall Study|Physician Decision|2|||
124873471|NCT00508404|449158925|FG000|Overall Study|Withdrawal by Subject|3|||
124873472|NCT00508404|449158925|FG000|Overall Study|Protocol-specified Criteria|2|||
124873473|NCT00508404|449158925|FG000|Overall Study|Lost to Follow-up|2|||
124873474|NCT00508404|449158925|FG000|Overall Study|Other - Not Specified|3|||
124873475|NCT01591382|449158926|FG000|Overall Study|Discharged Prior to Study Completion|2|||
124873476|NCT01591382|449158927|FG001|Overall Study|Discharged Prior to Study Completion|1|||
124873477|NCT01591382|449158926|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
124873478|NCT01591382|449158927|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
124873479|NCT03170375|449158928|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
124873480|NCT03170375|449158929|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
124873481|NCT03170375|449158930|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
124873482|NCT03170375|449158928|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
124873483|NCT03170375|449158929|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
124873484|NCT03170375|449158930|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
124873485|NCT00855062|449158931|FG000|Step1|Early Study Closure|5|||
124873486|NCT00855062|449158932|FG001|Step1|Early Study Closure|7|||
124873487|NCT00855062|449158931|FG000|Step1|Adverse Event|1|||
124873488|NCT00855062|449158932|FG001|Step1|Adverse Event|1|||
124873489|NCT00855062|449158931|FG000|Step1|Protocol Violation|1|||
124873490|NCT00855062|449158932|FG001|Step1|Protocol Violation|0|||
124873491|NCT00855062|449158931|FG000|Step1|Pregnancy|1|||
124873492|NCT00855062|449158932|FG001|Step1|Pregnancy|0|||
124873493|NCT00855062|449158931|FG000|Step1|Withdrawal by Subject|2|||
124873494|NCT00855062|449158932|FG001|Step1|Withdrawal by Subject|3|||
124873495|NCT00855062|449158931|FG000|Step2|Early Study Closure|6|||
124873496|NCT00855062|449158932|FG001|Step2|Early Study Closure|2|||
124873497|NCT00855062|449158931|FG000|Step2|Adverse Event|0|||
124873498|NCT00855062|449158932|FG001|Step2|Adverse Event|3|||
124873499|NCT00855062|449158931|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
124873500|NCT00855062|449158932|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
124873501|NCT01376323|449158934|FG000|Overall Study|Adverse Event|1|||
124873502|NCT01376323|449158935|FG001|Overall Study|Adverse Event|0|||
124873503|NCT01376323|449158936|FG002|Overall Study|Adverse Event|0|||
124873504|NCT01376323|449158937|FG003|Overall Study|Adverse Event|2|||
124873505|NCT01376323|449158938|FG004|Overall Study|Adverse Event|0|||
124873506|NCT01376323|449158934|FG000|Overall Study|Lost to Follow-up|0|||
124873507|NCT01376323|449158935|FG001|Overall Study|Lost to Follow-up|0|||
124873508|NCT01376323|449158936|FG002|Overall Study|Lost to Follow-up|0|||
124873509|NCT01376323|449158937|FG003|Overall Study|Lost to Follow-up|2|||
124873510|NCT01376323|449158938|FG004|Overall Study|Lost to Follow-up|0|||
124873511|NCT01376323|449158934|FG000|Overall Study|Physician Decision|1|||
124873512|NCT01376323|449158935|FG001|Overall Study|Physician Decision|0|||
124873513|NCT01376323|449158936|FG002|Overall Study|Physician Decision|2|||
124873514|NCT01376323|449158937|FG003|Overall Study|Physician Decision|1|||
124873515|NCT01376323|449158938|FG004|Overall Study|Physician Decision|1|||
124873516|NCT01376323|449158934|FG000|Overall Study|Withdrawal by Subject|0|||
124873517|NCT01376323|449158935|FG001|Overall Study|Withdrawal by Subject|1|||
124873518|NCT01376323|449158936|FG002|Overall Study|Withdrawal by Subject|1|||
124873519|NCT01376323|449158937|FG003|Overall Study|Withdrawal by Subject|0|||
125010159|NCT00111800|449663615|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
125010160|NCT00111800|449663616|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
125010161|NCT00111800|449663611|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
125010162|NCT00111800|449663612|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
125010163|NCT00111800|449663613|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
125010164|NCT00111800|449663614|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
124873520|NCT01376323|449158938|FG004|Overall Study|Withdrawal by Subject|0|||
124873521|NCT01960725|449158939|FG000|Overall Study|Lost to Follow-up|4|||
124873522|NCT01960725|449158940|FG001|Overall Study|Lost to Follow-up|3|||
124873523|NCT01960725|449158939|FG000|Overall Study|Withdrawal by Subject|1|||
124873524|NCT01960725|449158940|FG001|Overall Study|Withdrawal by Subject|0|||
124873525|NCT01960725|449158939|FG000|Overall Study|unable to obtain blood sample|1|||
124873526|NCT01960725|449158940|FG001|Overall Study|unable to obtain blood sample|2|||
124873527|NCT02634788|449158941|FG000|Overall Study|Adverse Event|0|||
124873528|NCT02634788|449158942|FG001|Overall Study|Adverse Event|8|||
124873529|NCT02634788|449158943|FG002|Overall Study|Adverse Event|3|||
124873530|NCT02634788|449158944|FG003|Overall Study|Adverse Event|1|||
124873531|NCT02634788|449158941|FG000|Overall Study|Lack of Efficacy|4|||
124873532|NCT02634788|449158942|FG001|Overall Study|Lack of Efficacy|0|||
124873533|NCT02634788|449158943|FG002|Overall Study|Lack of Efficacy|1|||
124873534|NCT02634788|449158944|FG003|Overall Study|Lack of Efficacy|4|||
124873535|NCT02634788|449158941|FG000|Overall Study|Lost to Follow-up|0|||
124873536|NCT02634788|449158942|FG001|Overall Study|Lost to Follow-up|1|||
124873537|NCT02634788|449158943|FG002|Overall Study|Lost to Follow-up|0|||
124873538|NCT02634788|449158944|FG003|Overall Study|Lost to Follow-up|0|||
124873539|NCT02634788|449158941|FG000|Overall Study|Withdrawal by Subject|0|||
124873540|NCT02634788|449158942|FG001|Overall Study|Withdrawal by Subject|1|||
124873541|NCT02634788|449158943|FG002|Overall Study|Withdrawal by Subject|1|||
124873542|NCT02634788|449158944|FG003|Overall Study|Withdrawal by Subject|0|||
124873543|NCT02831257|449158945|FG000|Overall Study|Lack of Efficacy|3|||
124873544|NCT02831257|449158945|FG000|Overall Study|Adverse Event|2|||
124873545|NCT02831257|449158945|FG000|Overall Study|Physician Decision|1|||
124873546|NCT02831257|449158945|FG000|Overall Study|Withdrawal by Subject|6|||
124873547|NCT01281202|449158946|FG000|Overall Study|Adverse Event|2|||
124873548|NCT01281202|449158947|FG001|Overall Study|Adverse Event|0|||
124873549|NCT01281202|449158946|FG000|Overall Study|Withdrawal by Subject|2|||
124873550|NCT01281202|449158947|FG001|Overall Study|Withdrawal by Subject|2|||
124873551|NCT01281202|449158946|FG000|Overall Study|Protocol Violation|11|||
124873552|NCT01281202|449158947|FG001|Overall Study|Protocol Violation|10|||
124873553|NCT01281202|449158946|FG000|Overall Study|Administrative|2|||
124873554|NCT01281202|449158947|FG001|Overall Study|Administrative|8|||
124873555|NCT01281202|449158946|FG000|Overall Study|Lost to Follow-up|11|||
124873556|NCT01281202|449158947|FG001|Overall Study|Lost to Follow-up|13|||
124873557|NCT01281202|449158946|FG000|Overall Study|Incarceration|0|||
124873558|NCT01281202|449158947|FG001|Overall Study|Incarceration|3|||
124873559|NCT03138733|449158948|FG000|Overall Study|Death|17|||
124873560|NCT03138733|449158949|FG001|Overall Study|Death|18|||
124873561|NCT03138733|449158948|FG000|Overall Study|Withdrawal by Subject|11|||
124873562|NCT03138733|449158949|FG001|Overall Study|Withdrawal by Subject|6|||
124873563|NCT03138733|449158948|FG000|Overall Study|Lost to Follow-up|3|||
124873564|NCT03138733|449158949|FG001|Overall Study|Lost to Follow-up|2|||
124873565|NCT03138733|449158948|FG000|Overall Study|Adverse Event|1|||
124873566|NCT03138733|449158949|FG001|Overall Study|Adverse Event|0|||
124873567|NCT03138733|449158948|FG000|Overall Study|Protocol Violation|1|||
124873568|NCT03138733|449158949|FG001|Overall Study|Protocol Violation|3|||
124873569|NCT03138733|449158948|FG000|Overall Study|Administrative or logistical reason|1|||
124873570|NCT03138733|449158949|FG001|Overall Study|Administrative or logistical reason|0|||
124873571|NCT03138733|449158948|FG000|Overall Study|The patient was transferred to another hospital|1|||
124873572|NCT03138733|449158949|FG001|Overall Study|The patient was transferred to another hospital|0|||
124873573|NCT02612064|449158960|FG000|Overall Study|Withdrawal by Subject|1|||
124873574|NCT02612064|449158961|FG001|Overall Study|Withdrawal by Subject|1|||
124873575|NCT02612064|449158960|FG000|Overall Study|Other|0|||
124873576|NCT02612064|449158961|FG001|Overall Study|Other|2|||
124873577|NCT01669798|449158962|FG000|Overall Study|Physician Decision|5|||
124873578|NCT00717860|449158964|FG000|Overall Study|Clinical adverse experience|5|||
125010165|NCT00111800|449663615|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
125010166|NCT00111800|449663616|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
125010167|NCT00111800|449663611|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
125010168|NCT00111800|449663612|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
125010169|NCT00111800|449663613|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
125010170|NCT00111800|449663614|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
125010171|NCT00111800|449663615|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
125010172|NCT00111800|449663616|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
125010173|NCT00111800|449663611|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
125010174|NCT00111800|449663612|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
125010175|NCT00111800|449663613|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
125010176|NCT00111800|449663614|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
125010177|NCT00111800|449663615|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
125010178|NCT00111800|449663616|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
124873579|NCT00717860|449158965|FG001|Overall Study|Clinical adverse experience|9|||
124873580|NCT00717860|449158964|FG000|Overall Study|Laboratory adverse experience|2|||
124873581|NCT00717860|449158965|FG001|Overall Study|Laboratory adverse experience|2|||
124873582|NCT00717860|449158964|FG000|Overall Study|Lack of Efficacy|7|||
124873583|NCT00717860|449158965|FG001|Overall Study|Lack of Efficacy|13|||
124873584|NCT00717860|449158964|FG000|Overall Study|Discontinued for other reason|6|||
124873585|NCT00717860|449158965|FG001|Overall Study|Discontinued for other reason|1|||
124873586|NCT00717860|449158964|FG000|Overall Study|Withdrew consent|7|||
125010179|NCT00111800|449663611|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
125010180|NCT00111800|449663612|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
125010181|NCT00111800|449663613|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
124873587|NCT00717860|449158965|FG001|Overall Study|Withdrew consent|3|||
124873588|NCT00698646|449158969|FG000|Overall Study|Adverse Event|8|||
124873589|NCT00698646|449158970|FG001|Overall Study|Adverse Event|7|||
124873590|NCT00698646|449158971|FG002|Overall Study|Adverse Event|8|||
124873591|NCT00698646|449158969|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
124873592|NCT00698646|449158970|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
124873593|NCT00698646|449158971|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
124873594|NCT00698646|449158969|FG000|Overall Study|Protocol Deviation|6|||
124873595|NCT00698646|449158970|FG001|Overall Study|Protocol Deviation|2|||
124873596|NCT00698646|449158971|FG002|Overall Study|Protocol Deviation|3|||
124873597|NCT00698646|449158969|FG000|Overall Study|Withdrawal by Subject|10|||
124873598|NCT00698646|449158970|FG001|Overall Study|Withdrawal by Subject|11|||
124873599|NCT00698646|449158971|FG002|Overall Study|Withdrawal by Subject|8|||
124873600|NCT00698646|449158969|FG000|Overall Study|Lost to Follow-up|0|||
124873601|NCT00698646|449158970|FG001|Overall Study|Lost to Follow-up|0|||
124873602|NCT00698646|449158971|FG002|Overall Study|Lost to Follow-up|2|||
124873603|NCT00698646|449158969|FG000|Overall Study|Administrative problems|1|||
124873604|NCT00698646|449158970|FG001|Overall Study|Administrative problems|0|||
124873605|NCT00698646|449158971|FG002|Overall Study|Administrative problems|1|||
124873606|NCT00279201|449158972|FG000|Initiation|Death|1|||
124873607|NCT00279201|449158973|FG001|Initiation|Death|5|||
124873608|NCT00279201|449158974|FG002|Initiation|Death|0|||
124873609|NCT00279201|449158975|FG003|Initiation|Death|0|||
124873610|NCT00279201|449158976|FG004|Initiation|Death|0|||
124873611|NCT00279201|449158977|FG005|Initiation|Death|0|||
124873612|NCT00279201|449158972|FG000|Initiation|Adverse Event|6|||
124873613|NCT00279201|449158973|FG001|Initiation|Adverse Event|15|||
124873614|NCT00279201|449158974|FG002|Initiation|Adverse Event|0|||
124873615|NCT00279201|449158975|FG003|Initiation|Adverse Event|0|||
124873616|NCT00279201|449158976|FG004|Initiation|Adverse Event|0|||
124873617|NCT00279201|449158977|FG005|Initiation|Adverse Event|0|||
124873618|NCT00279201|449158972|FG000|Initiation|Lost to Follow-up|42|||
124873619|NCT00279201|449158973|FG001|Initiation|Lost to Follow-up|41|||
124873620|NCT00279201|449158974|FG002|Initiation|Lost to Follow-up|0|||
124873621|NCT00279201|449158975|FG003|Initiation|Lost to Follow-up|0|||
124873622|NCT00279201|449158976|FG004|Initiation|Lost to Follow-up|0|||
124873623|NCT00279201|449158977|FG005|Initiation|Lost to Follow-up|0|||
124873624|NCT00279201|449158972|FG000|Initiation|Entry Criteria Exclusion|7|||
124873625|NCT00279201|449158973|FG001|Initiation|Entry Criteria Exclusion|9|||
124873626|NCT00279201|449158974|FG002|Initiation|Entry Criteria Exclusion|0|||
124873627|NCT00279201|449158975|FG003|Initiation|Entry Criteria Exclusion|0|||
124873628|NCT00279201|449158976|FG004|Initiation|Entry Criteria Exclusion|0|||
124873629|NCT00279201|449158977|FG005|Initiation|Entry Criteria Exclusion|0|||
124873630|NCT00279201|449158972|FG000|Initiation|Protocol Violation|9|||
124873631|NCT00279201|449158973|FG001|Initiation|Protocol Violation|10|||
124873632|NCT00279201|449158974|FG002|Initiation|Protocol Violation|0|||
124873633|NCT00279201|449158975|FG003|Initiation|Protocol Violation|0|||
124873634|NCT00279201|449158976|FG004|Initiation|Protocol Violation|0|||
124873635|NCT00279201|449158977|FG005|Initiation|Protocol Violation|0|||
124873636|NCT00279201|449158972|FG000|Initiation|Withdrawal by Subject|35|||
124873637|NCT00279201|449158973|FG001|Initiation|Withdrawal by Subject|41|||
124873638|NCT00279201|449158974|FG002|Initiation|Withdrawal by Subject|0|||
124873639|NCT00279201|449158975|FG003|Initiation|Withdrawal by Subject|0|||
124873640|NCT00279201|449158976|FG004|Initiation|Withdrawal by Subject|0|||
124873641|NCT00279201|449158977|FG005|Initiation|Withdrawal by Subject|0|||
124873642|NCT00279201|449158972|FG000|Initiation|Physician Decision|15|||
124873643|NCT00279201|449158973|FG001|Initiation|Physician Decision|18|||
124873644|NCT00279201|449158974|FG002|Initiation|Physician Decision|0|||
124873645|NCT00279201|449158975|FG003|Initiation|Physician Decision|0|||
124873646|NCT00279201|449158976|FG004|Initiation|Physician Decision|0|||
124873647|NCT00279201|449158977|FG005|Initiation|Physician Decision|0|||
124873648|NCT00279201|449158972|FG000|Initiation|Sponsor Decision|13|||
125010182|NCT00111800|449663614|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
125010183|NCT00111800|449663615|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
125010184|NCT00111800|449663616|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
125010185|NCT00111800|449663611|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
125010186|NCT00111800|449663612|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
125010187|NCT00111800|449663613|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
125010188|NCT00111800|449663614|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
125010189|NCT00111800|449663615|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
124873649|NCT00279201|449158973|FG001|Initiation|Sponsor Decision|5|||
124873650|NCT00279201|449158974|FG002|Initiation|Sponsor Decision|0|||
124873651|NCT00279201|449158975|FG003|Initiation|Sponsor Decision|0|||
124873652|NCT00279201|449158976|FG004|Initiation|Sponsor Decision|0|||
124873653|NCT00279201|449158977|FG005|Initiation|Sponsor Decision|0|||
124873654|NCT00279201|449158972|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
124873655|NCT00279201|449158973|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
124873656|NCT00279201|449158974|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
124873657|NCT00279201|449158975|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
124873658|NCT00279201|449158976|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
124873659|NCT00279201|449158977|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
124873660|NCT00279201|449158972|FG000|Maintenance|Lack of Efficacy|32|||
124873661|NCT00279201|449158973|FG001|Maintenance|Lack of Efficacy|30|||
124873662|NCT00279201|449158974|FG002|Maintenance|Lack of Efficacy|0|||
124873663|NCT00279201|449158975|FG003|Maintenance|Lack of Efficacy|0|||
124873664|NCT00279201|449158976|FG004|Maintenance|Lack of Efficacy|0|||
124873665|NCT00279201|449158977|FG005|Maintenance|Lack of Efficacy|0|||
124873666|NCT00279201|449158972|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
124873667|NCT00279201|449158973|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
124873668|NCT00279201|449158974|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
124873669|NCT00279201|449158975|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
124873670|NCT00279201|449158976|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
124873671|NCT00279201|449158977|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
124873672|NCT00279201|449158972|FG000|Maintenance|Adverse Event|4|||
124873673|NCT00279201|449158973|FG001|Maintenance|Adverse Event|4|||
124873674|NCT00279201|449158974|FG002|Maintenance|Adverse Event|0|||
124873675|NCT00279201|449158975|FG003|Maintenance|Adverse Event|0|||
124873676|NCT00279201|449158976|FG004|Maintenance|Adverse Event|0|||
124873677|NCT00279201|449158977|FG005|Maintenance|Adverse Event|0|||
124873678|NCT00279201|449158972|FG000|Maintenance|Death|4|||
124873679|NCT00279201|449158973|FG001|Maintenance|Death|4|||
124873680|NCT00279201|449158974|FG002|Maintenance|Death|0|||
124873681|NCT00279201|449158975|FG003|Maintenance|Death|0|||
124873682|NCT00279201|449158976|FG004|Maintenance|Death|0|||
124873683|NCT00279201|449158977|FG005|Maintenance|Death|0|||
124873684|NCT00279201|449158972|FG000|Maintenance|Lost to Follow-up|17|||
124873685|NCT00279201|449158973|FG001|Maintenance|Lost to Follow-up|13|||
124873686|NCT00279201|449158974|FG002|Maintenance|Lost to Follow-up|0|||
124873687|NCT00279201|449158975|FG003|Maintenance|Lost to Follow-up|0|||
124873688|NCT00279201|449158976|FG004|Maintenance|Lost to Follow-up|0|||
124873689|NCT00279201|449158977|FG005|Maintenance|Lost to Follow-up|0|||
124873690|NCT00279201|449158972|FG000|Maintenance|Entry Criteria Exclusion|1|||
124873691|NCT00279201|449158973|FG001|Maintenance|Entry Criteria Exclusion|4|||
124873692|NCT00279201|449158974|FG002|Maintenance|Entry Criteria Exclusion|0|||
124873693|NCT00279201|449158975|FG003|Maintenance|Entry Criteria Exclusion|0|||
124873694|NCT00279201|449158976|FG004|Maintenance|Entry Criteria Exclusion|0|||
124873695|NCT00279201|449158977|FG005|Maintenance|Entry Criteria Exclusion|0|||
124873696|NCT00279201|449158972|FG000|Maintenance|Protocol Violation|16|||
124873697|NCT00279201|449158973|FG001|Maintenance|Protocol Violation|24|||
124873698|NCT00279201|449158974|FG002|Maintenance|Protocol Violation|0|||
124873699|NCT00279201|449158975|FG003|Maintenance|Protocol Violation|0|||
124873700|NCT00279201|449158976|FG004|Maintenance|Protocol Violation|0|||
124873701|NCT00279201|449158977|FG005|Maintenance|Protocol Violation|0|||
124873702|NCT00279201|449158972|FG000|Maintenance|Withdrawal by Subject|18|||
124873703|NCT00279201|449158973|FG001|Maintenance|Withdrawal by Subject|18|||
124873704|NCT00279201|449158974|FG002|Maintenance|Withdrawal by Subject|0|||
124873705|NCT00279201|449158975|FG003|Maintenance|Withdrawal by Subject|0|||
124873706|NCT00279201|449158976|FG004|Maintenance|Withdrawal by Subject|0|||
124873707|NCT00279201|449158977|FG005|Maintenance|Withdrawal by Subject|0|||
124873708|NCT00279201|449158972|FG000|Maintenance|Physician Decision|9|||
124873709|NCT00279201|449158973|FG001|Maintenance|Physician Decision|9|||
124873710|NCT00279201|449158974|FG002|Maintenance|Physician Decision|0|||
125010190|NCT00111800|449663616|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
125010191|NCT00111800|449663611|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
125010192|NCT00111800|449663612|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
125010193|NCT00111800|449663613|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
125010194|NCT00111800|449663614|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
125010195|NCT00111800|449663615|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
125010196|NCT00111800|449663616|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
125010197|NCT01549275|449663617|FG000|Overall Study|Lost to Follow-up|1|||
125010198|NCT01549275|449663618|FG001|Overall Study|Lost to Follow-up|0|||
125010199|NCT02113436|449663621|FG000|Period 1: 8 Weeks|Adverse Event|1|||
125010200|NCT02113436|449663622|FG001|Period 1: 8 Weeks|Adverse Event|0|||
125010201|NCT02113436|449663623|FG002|Period 1: 8 Weeks|Adverse Event|0|||
125010202|NCT02113436|449663624|FG003|Period 1: 8 Weeks|Adverse Event|0|||
125010203|NCT02113436|449663621|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
124873711|NCT00279201|449158975|FG003|Maintenance|Physician Decision|0|||
124873712|NCT00279201|449158976|FG004|Maintenance|Physician Decision|0|||
124873713|NCT00279201|449158977|FG005|Maintenance|Physician Decision|0|||
124873714|NCT00279201|449158972|FG000|Maintenance|Sponsor Decision|4|||
124873715|NCT00279201|449158973|FG001|Maintenance|Sponsor Decision|0|||
124873716|NCT00279201|449158974|FG002|Maintenance|Sponsor Decision|0|||
124873717|NCT00279201|449158975|FG003|Maintenance|Sponsor Decision|0|||
124873718|NCT00279201|449158976|FG004|Maintenance|Sponsor Decision|0|||
124873719|NCT00279201|449158977|FG005|Maintenance|Sponsor Decision|0|||
124873720|NCT00279201|449158972|FG000|Maintenance|HbA1c>7.5%|123|||
124873721|NCT00279201|449158973|FG001|Maintenance|HbA1c>7.5%|126|||
124873722|NCT00279201|449158974|FG002|Maintenance|HbA1c>7.5%|0|||
125010204|NCT02113436|449663622|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
125010205|NCT02113436|449663623|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
124873723|NCT00279201|449158975|FG003|Maintenance|HbA1c>7.5%|0|||
124873724|NCT00279201|449158976|FG004|Maintenance|HbA1c>7.5%|0|||
124873725|NCT00279201|449158977|FG005|Maintenance|HbA1c>7.5%|0|||
124873726|NCT00279201|449158972|FG000|Intensification Addendum|Withdrawal by Subject|0|||
124873727|NCT00279201|449158973|FG001|Intensification Addendum|Withdrawal by Subject|0|||
124873728|NCT00279201|449158974|FG002|Intensification Addendum|Withdrawal by Subject|12|||
124873729|NCT00279201|449158975|FG003|Intensification Addendum|Withdrawal by Subject|14|||
124873730|NCT00279201|449158976|FG004|Intensification Addendum|Withdrawal by Subject|9|||
124873731|NCT00279201|449158977|FG005|Intensification Addendum|Withdrawal by Subject|18|||
124873732|NCT00279201|449158972|FG000|Intensification Addendum|Lost to Follow-up|0|||
124873733|NCT00279201|449158973|FG001|Intensification Addendum|Lost to Follow-up|0|||
124873734|NCT00279201|449158974|FG002|Intensification Addendum|Lost to Follow-up|4|||
124873735|NCT00279201|449158975|FG003|Intensification Addendum|Lost to Follow-up|6|||
124873736|NCT00279201|449158976|FG004|Intensification Addendum|Lost to Follow-up|7|||
124873737|NCT00279201|449158977|FG005|Intensification Addendum|Lost to Follow-up|7|||
124873738|NCT00279201|449158972|FG000|Intensification Addendum|Protocol Violation|0|||
124873739|NCT00279201|449158973|FG001|Intensification Addendum|Protocol Violation|0|||
124873740|NCT00279201|449158974|FG002|Intensification Addendum|Protocol Violation|2|||
124873741|NCT00279201|449158975|FG003|Intensification Addendum|Protocol Violation|2|||
124873742|NCT00279201|449158976|FG004|Intensification Addendum|Protocol Violation|6|||
124873743|NCT00279201|449158977|FG005|Intensification Addendum|Protocol Violation|6|||
124873744|NCT00279201|449158972|FG000|Intensification Addendum|Adverse Event|0|||
124873745|NCT00279201|449158973|FG001|Intensification Addendum|Adverse Event|0|||
124873746|NCT00279201|449158974|FG002|Intensification Addendum|Adverse Event|0|||
124873747|NCT00279201|449158975|FG003|Intensification Addendum|Adverse Event|4|||
124873748|NCT00279201|449158976|FG004|Intensification Addendum|Adverse Event|1|||
124873749|NCT00279201|449158977|FG005|Intensification Addendum|Adverse Event|3|||
124873750|NCT00279201|449158972|FG000|Intensification Addendum|Physician Decision|0|||
124873751|NCT00279201|449158973|FG001|Intensification Addendum|Physician Decision|0|||
124873752|NCT00279201|449158974|FG002|Intensification Addendum|Physician Decision|4|||
124873753|NCT00279201|449158975|FG003|Intensification Addendum|Physician Decision|1|||
124873754|NCT00279201|449158976|FG004|Intensification Addendum|Physician Decision|3|||
124873755|NCT00279201|449158977|FG005|Intensification Addendum|Physician Decision|2|||
124873756|NCT00279201|449158972|FG000|Intensification Addendum|Sponsor Decision|0|||
124873757|NCT00279201|449158973|FG001|Intensification Addendum|Sponsor Decision|0|||
124873758|NCT00279201|449158974|FG002|Intensification Addendum|Sponsor Decision|0|||
124873759|NCT00279201|449158975|FG003|Intensification Addendum|Sponsor Decision|0|||
124873760|NCT00279201|449158976|FG004|Intensification Addendum|Sponsor Decision|1|||
124873761|NCT00279201|449158977|FG005|Intensification Addendum|Sponsor Decision|1|||
124873762|NCT00279201|449158972|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
124873763|NCT00279201|449158973|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
124873764|NCT00279201|449158974|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
124873765|NCT00279201|449158975|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
124873766|NCT00279201|449158976|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
124873767|NCT00279201|449158977|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
124873768|NCT00279201|449158972|FG000|Intensification Addendum|Lack of Efficacy|0|||
124873769|NCT00279201|449158973|FG001|Intensification Addendum|Lack of Efficacy|0|||
124873770|NCT00279201|449158974|FG002|Intensification Addendum|Lack of Efficacy|0|||
124873771|NCT00279201|449158975|FG003|Intensification Addendum|Lack of Efficacy|1|||
124873772|NCT00279201|449158976|FG004|Intensification Addendum|Lack of Efficacy|1|||
124873773|NCT00279201|449158977|FG005|Intensification Addendum|Lack of Efficacy|0|||
124873774|NCT00279201|449158972|FG000|Intensification Addendum|Death|0|||
124873775|NCT00279201|449158973|FG001|Intensification Addendum|Death|0|||
124873776|NCT00279201|449158974|FG002|Intensification Addendum|Death|0|||
124873777|NCT00279201|449158975|FG003|Intensification Addendum|Death|0|||
124873778|NCT00279201|449158976|FG004|Intensification Addendum|Death|1|||
124873779|NCT00279201|449158977|FG005|Intensification Addendum|Death|0|||
124873780|NCT00316173|449158978|FG000|Run-in Phase|Adverse Event|1|||
124873781|NCT00316173|449158979|FG001|Run-in Phase|Adverse Event|0|||
124873782|NCT00316173|449158978|FG000|Run-in Phase|Protocol Violation|1|||
124873783|NCT00316173|449158979|FG001|Run-in Phase|Protocol Violation|0|||
124873784|NCT00316173|449158978|FG000|Run-in Phase|Study Follow-up Stopped|5|||
124873785|NCT00316173|449158979|FG001|Run-in Phase|Study Follow-up Stopped|0|||
124873786|NCT00316173|449158978|FG000|Treatment Phase|Adverse Event|0|||
124873787|NCT00316173|449158979|FG001|Treatment Phase|Adverse Event|1|||
124873788|NCT00316173|449158978|FG000|Treatment Phase|Lack of Efficacy|0|||
124873789|NCT00316173|449158979|FG001|Treatment Phase|Lack of Efficacy|3|||
124873790|NCT00316173|449158978|FG000|Treatment Phase|Lost to Follow-up|0|||
124873791|NCT00316173|449158979|FG001|Treatment Phase|Lost to Follow-up|3|||
124873792|NCT00316173|449158978|FG000|Treatment Phase|Withdrawal by Subject|0|||
124873793|NCT00316173|449158979|FG001|Treatment Phase|Withdrawal by Subject|1|||
124873794|NCT00316173|449158978|FG000|Treatment Phase|Study Follow-up Stopped|0|||
124873795|NCT00316173|449158979|FG001|Treatment Phase|Study Follow-up Stopped|34|||
124873796|NCT02390531|449158980|FG000|Overall Study|Death|0|||
124873797|NCT02390531|449158981|FG001|Overall Study|Death|2|||
124873798|NCT02390531|449158982|FG002|Overall Study|Death|0|||
124873799|NCT02390531|449158983|FG003|Overall Study|Death|1|||
124873800|NCT02390531|449158984|FG004|Overall Study|Death|0|||
124873801|NCT02390531|449158985|FG005|Overall Study|Death|0|||
124873802|NCT02390531|449158986|FG006|Overall Study|Death|0|||
124873803|NCT02390531|449158987|FG007|Overall Study|Death|1|||
124873804|NCT02390531|449158980|FG000|Overall Study|Protocol Violation|0|||
124873805|NCT02390531|449158981|FG001|Overall Study|Protocol Violation|0|||
124873806|NCT02390531|449158982|FG002|Overall Study|Protocol Violation|0|||
124873807|NCT02390531|449158983|FG003|Overall Study|Protocol Violation|0|||
125010206|NCT02113436|449663624|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
125010207|NCT02113436|449663621|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
125010208|NCT02113436|449663622|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
125010209|NCT02113436|449663623|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
125010210|NCT02113436|449663624|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
125010211|NCT02113436|449663621|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
125010212|NCT02113436|449663622|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
125010213|NCT02113436|449663623|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
125010214|NCT02113436|449663624|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
125010215|NCT02113436|449663621|FG000|Period 2: 16 Weeks|Adverse Event|0|||
125010216|NCT02113436|449663622|FG001|Period 2: 16 Weeks|Adverse Event|0|||
125010217|NCT02113436|449663623|FG002|Period 2: 16 Weeks|Adverse Event|4|||
125010218|NCT02113436|449663624|FG003|Period 2: 16 Weeks|Adverse Event|5|||
125010219|NCT02113436|449663621|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
125010220|NCT02113436|449663622|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
125010221|NCT02113436|449663623|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
125010222|NCT02113436|449663624|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
125010223|NCT02113436|449663621|FG000|Period 2: 16 Weeks|Physician Decision|0|||
125010224|NCT02113436|449663622|FG001|Period 2: 16 Weeks|Physician Decision|0|||
125010225|NCT02113436|449663623|FG002|Period 2: 16 Weeks|Physician Decision|2|||
125010226|NCT02113436|449663624|FG003|Period 2: 16 Weeks|Physician Decision|0|||
125010227|NCT02113436|449663621|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
125010228|NCT02113436|449663622|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
125010229|NCT02113436|449663623|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
125010230|NCT02113436|449663624|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
125010231|NCT02969187|449663627|FG000|Overall Study|Physician Decision|12|||
125010232|NCT02969187|449663628|FG001|Overall Study|Physician Decision|13|||
125010233|NCT01486927|449663629|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
125010234|NCT01486927|449663629|FG000|Overall Study|Physician Decision|1|||
125010235|NCT01486927|449663629|FG000|Overall Study|50 Exposure days not reached|2|||
125010236|NCT01486927|449663629|FG000|Overall Study|Withdrawal by Subject|8|||
125010237|NCT01486927|449663629|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
125010238|NCT00365456|449663630|FG000|Trial Period I (12 Months)|Adverse Event|84|||
125010239|NCT00365456|449663631|FG001|Trial Period I (12 Months)|Adverse Event|0|||
125010240|NCT00365456|449663630|FG000|Trial Period I (12 Months)|Non-compliance|3|||
125010241|NCT00365456|449663631|FG001|Trial Period I (12 Months)|Non-compliance|0|||
125010242|NCT00365456|449663630|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
125010243|NCT00365456|449663631|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
125010244|NCT00365456|449663630|FG000|Trial Period I (12 Months)|Other|11|||
125010245|NCT00365456|449663631|FG001|Trial Period I (12 Months)|Other|0|||
125010246|NCT00365456|449663630|FG000|Trial Period II (12 Months)|Adverse Event|0|||
125010247|NCT00365456|449663631|FG001|Trial Period II (12 Months)|Adverse Event|6|||
125010248|NCT00365456|449663630|FG000|Trial Period II (12 Months)|Non-compliance|0|||
125010249|NCT00365456|449663631|FG001|Trial Period II (12 Months)|Non-compliance|2|||
125010250|NCT00365456|449663630|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
125010251|NCT00365456|449663631|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
125010252|NCT00365456|449663630|FG000|Trial Period II (12 Months)|Other|0|||
125010253|NCT00365456|449663631|FG001|Trial Period II (12 Months)|Other|1|||
125010254|NCT00365456|449663630|FG000|Trial Period III (12 Months)|Adverse Event|13|||
125010255|NCT00365456|449663631|FG001|Trial Period III (12 Months)|Adverse Event|3|||
125010256|NCT00365456|449663630|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
125010257|NCT00365456|449663631|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
124873808|NCT02390531|449158984|FG004|Overall Study|Protocol Violation|1|||
124873809|NCT02390531|449158985|FG005|Overall Study|Protocol Violation|0|||
124873810|NCT02390531|449158986|FG006|Overall Study|Protocol Violation|2|||
124873811|NCT02390531|449158987|FG007|Overall Study|Protocol Violation|0|||
125010258|NCT00365456|449663630|FG000|Trial Period III (12 Months)|Other|1|||
125010259|NCT00365456|449663631|FG001|Trial Period III (12 Months)|Other|1|||
125010260|NCT03668600|449663632|FG000|Overall Study|Study Terminated by the Sponsor|157|||
125010261|NCT03668600|449663632|FG000|Overall Study|Protocol Violation|1|||
125010262|NCT03668600|449663632|FG000|Overall Study|Pregnancy|1|||
125010263|NCT03668600|449663632|FG000|Overall Study|Lost to Follow-up|7|||
125010264|NCT03668600|449663632|FG000|Overall Study|Withdrawal by Subject|56|||
125010265|NCT03668600|449663632|FG000|Overall Study|Lack of Efficacy|7|||
125010266|NCT03668600|449663632|FG000|Overall Study|Adverse Event|1|||
124873812|NCT00511875|449158988|FG000|Overall Study|Lost to Follow-up|4|||
125010267|NCT01476475|449663634|FG000|Overall Study|Adverse Event|6|||
125098262|NCT04668066|449980250|FG014|Part 1: Treatment Phase|Adverse Event|0|||
125098263|NCT04668066|449980251|FG015|Part 1: Treatment Phase|Adverse Event|0|||
125098264|NCT04668066|449980252|FG016|Part 1: Treatment Phase|Adverse Event|0|||
125098265|NCT04668066|449980253|FG017|Part 1: Treatment Phase|Adverse Event|0|||
125098266|NCT04668066|449980254|FG018|Part 1: Treatment Phase|Adverse Event|0|||
125098267|NCT04668066|449980236|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
125098268|NCT04668066|449980237|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
125098269|NCT04668066|449980238|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
125098270|NCT04668066|449980239|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
125098271|NCT04668066|449980240|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
125098272|NCT04668066|449980241|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
125098273|NCT04668066|449980242|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
125098274|NCT04668066|449980243|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
125098275|NCT04668066|449980244|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
125098276|NCT04668066|449980245|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
125098277|NCT04668066|449980246|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
125098278|NCT04668066|449980247|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
125098279|NCT04668066|449980248|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
125098280|NCT04668066|449980249|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
125098281|NCT04668066|449980250|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
125098282|NCT04668066|449980251|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
125098283|NCT04668066|449980252|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
125098284|NCT04668066|449980253|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
125098285|NCT04668066|449980254|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
125098286|NCT04668066|449980236|FG000|Part 1: Treatment Phase|Other|0|||
125098287|NCT04668066|449980237|FG001|Part 1: Treatment Phase|Other|0|||
125098288|NCT04668066|449980238|FG002|Part 1: Treatment Phase|Other|0|||
125098289|NCT04668066|449980239|FG003|Part 1: Treatment Phase|Other|0|||
125098290|NCT04668066|449980240|FG004|Part 1: Treatment Phase|Other|0|||
125098291|NCT04668066|449980241|FG005|Part 1: Treatment Phase|Other|0|||
125098292|NCT04668066|449980242|FG006|Part 1: Treatment Phase|Other|0|||
125098293|NCT04668066|449980243|FG007|Part 1: Treatment Phase|Other|0|||
125098294|NCT04668066|449980244|FG008|Part 1: Treatment Phase|Other|0|||
125098295|NCT04668066|449980245|FG009|Part 1: Treatment Phase|Other|0|||
125098296|NCT04668066|449980246|FG010|Part 1: Treatment Phase|Other|0|||
125098297|NCT04668066|449980247|FG011|Part 1: Treatment Phase|Other|1|||
125098298|NCT04668066|449980248|FG012|Part 1: Treatment Phase|Other|0|||
125098299|NCT04668066|449980249|FG013|Part 1: Treatment Phase|Other|0|||
125098300|NCT04668066|449980250|FG014|Part 1: Treatment Phase|Other|0|||
125098301|NCT04668066|449980251|FG015|Part 1: Treatment Phase|Other|0|||
125098302|NCT04668066|449980252|FG016|Part 1: Treatment Phase|Other|0|||
125098303|NCT04668066|449980253|FG017|Part 1: Treatment Phase|Other|0|||
125098304|NCT04668066|449980254|FG018|Part 1: Treatment Phase|Other|0|||
125098305|NCT04668066|449980236|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125010268|NCT01476475|449663635|FG001|Overall Study|Adverse Event|0|||
125010269|NCT01476475|449663634|FG000|Overall Study|Poor compliance to protocol|1|||
125010270|NCT01476475|449663635|FG001|Overall Study|Poor compliance to protocol|1|||
125010271|NCT01476475|449663634|FG000|Overall Study|Other reasons|4|||
125010272|NCT01476475|449663635|FG001|Overall Study|Other reasons|2|||
125010273|NCT01278745|449663636|FG000|Overall Study|Death|2|||
125010274|NCT01278745|449663637|FG001|Overall Study|Death|5|||
125010275|NCT01278745|449663638|FG002|Overall Study|Death|7|||
125010276|NCT01278745|449663639|FG003|Overall Study|Death|0|||
125010277|NCT01278745|449663636|FG000|Overall Study|Physician Decision|1|||
125010278|NCT01278745|449663637|FG001|Overall Study|Physician Decision|0|||
125010279|NCT01278745|449663638|FG002|Overall Study|Physician Decision|0|||
125010280|NCT01278745|449663639|FG003|Overall Study|Physician Decision|9|||
125010281|NCT01278745|449663636|FG000|Overall Study|Withdrawal by Subject|1|||
125010282|NCT01278745|449663637|FG001|Overall Study|Withdrawal by Subject|1|||
125010283|NCT01278745|449663638|FG002|Overall Study|Withdrawal by Subject|5|||
125010284|NCT01278745|449663639|FG003|Overall Study|Withdrawal by Subject|1|||
125010285|NCT01278745|449663636|FG000|Overall Study|Sponsor Decision|1|||
125010286|NCT01278745|449663637|FG001|Overall Study|Sponsor Decision|0|||
125010287|NCT01278745|449663638|FG002|Overall Study|Sponsor Decision|62|||
125010288|NCT01278745|449663639|FG003|Overall Study|Sponsor Decision|6|||
125098306|NCT04668066|449980237|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125098307|NCT04668066|449980238|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125098308|NCT04668066|449980239|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125098309|NCT04668066|449980240|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125098310|NCT04668066|449980241|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
124873813|NCT00511875|449158989|FG001|Overall Study|Lost to Follow-up|0|||
124873814|NCT00511875|449158988|FG000|Overall Study|Missing variables|1|||
124873815|NCT00511875|449158989|FG001|Overall Study|Missing variables|0|||
124873816|NCT02618616|449158990|FG000|Overall Study|Lack of Efficacy|4|||
124873817|NCT02618616|449158991|FG001|Overall Study|Lack of Efficacy|0|||
124873818|NCT02618616|449158990|FG000|Overall Study|Pregnancy|0|||
124873819|NCT02618616|449158991|FG001|Overall Study|Pregnancy|1|||
124873820|NCT02618616|449158990|FG000|Overall Study|Adverse Event|8|||
124873821|NCT02618616|449158991|FG001|Overall Study|Adverse Event|0|||
124873822|NCT02618616|449158990|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
124873823|NCT02618616|449158991|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
125010289|NCT01278745|449663636|FG000|Overall Study|Ineligible|0|||
125010290|NCT01278745|449663637|FG001|Overall Study|Ineligible|0|||
125010291|NCT01278745|449663638|FG002|Overall Study|Ineligible|42|||
125010292|NCT01278745|449663639|FG003|Overall Study|Ineligible|61|||
125010293|NCT01278745|449663636|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
125010294|NCT01278745|449663637|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
125010295|NCT01278745|449663638|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
125010296|NCT01278745|449663639|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
125010297|NCT01816061|449663642|FG000|Overall Study|Lost to Follow-up|13|||
125010298|NCT01816061|449663643|FG001|Overall Study|Lost to Follow-up|24|||
125010299|NCT01265615|449663644|FG000|Overall Study|Protocol Violation|2|||
125010300|NCT01265615|449663645|FG001|Overall Study|Protocol Violation|2|||
125010301|NCT01265615|449663646|FG002|Overall Study|Protocol Violation|4|||
125010302|NCT01265615|449663647|FG003|Overall Study|Protocol Violation|3|||
125010303|NCT02576444|449663649|FG000|Overall Study|Death|1|||
125010304|NCT02576444|449663650|FG001|Overall Study|Death|1|||
125010305|NCT02576444|449663651|FG002|Overall Study|Death|0|||
125010306|NCT02576444|449663652|FG003|Overall Study|Death|0|||
125010307|NCT02576444|449663649|FG000|Overall Study|Withdrawal by Subject|0|||
125010308|NCT02576444|449663650|FG001|Overall Study|Withdrawal by Subject|0|||
125098311|NCT04668066|449980242|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
124873824|NCT02618616|449158990|FG000|Overall Study|Consent withdrawn by subject|8|||
125010309|NCT02576444|449663651|FG002|Overall Study|Withdrawal by Subject|2|||
125010310|NCT02576444|449663652|FG003|Overall Study|Withdrawal by Subject|0|||
125010311|NCT02576444|449663649|FG000|Overall Study|Adverse Event|0|||
125010312|NCT02576444|449663650|FG001|Overall Study|Adverse Event|0|||
124873825|NCT02618616|449158991|FG001|Overall Study|Consent withdrawn by subject|5|||
124873826|NCT02618616|449158990|FG000|Overall Study|Lost to Follow-up|0|||
124873827|NCT02618616|449158991|FG001|Overall Study|Lost to Follow-up|1|||
124873828|NCT04225988|449158992|FG000|Overall Study|Withdrawal by Subject|2|||
124873829|NCT04225988|449158993|FG001|Overall Study|Withdrawal by Subject|0|||
124873830|NCT00766675|449160102|FG000|Overall Study|Adverse Event|16|||
124873831|NCT00766675|449160102|FG000|Overall Study|Lost to Follow-up|2|||
124873832|NCT00766675|449160102|FG000|Overall Study|Withdrawal by Subject|11|||
124873833|NCT00766675|449160102|FG000|Overall Study|Protocol Violation|8|||
124873834|NCT00766675|449160102|FG000|Overall Study|Participant took prohibited medication|1|||
124873835|NCT00766675|449160102|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
124873836|NCT00766675|449160102|FG000|Overall Study|Insufficient therapy|1|||
125098312|NCT04668066|449980243|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125098313|NCT04668066|449980244|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125098314|NCT04668066|449980245|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125098315|NCT04668066|449980246|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125098316|NCT04668066|449980247|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125098317|NCT04668066|449980248|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
125098318|NCT04668066|449980249|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125098319|NCT04668066|449980250|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125098320|NCT04668066|449980251|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
125098321|NCT04668066|449980252|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125098322|NCT04668066|449980253|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125098323|NCT04668066|449980254|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125098324|NCT04668066|449980236|FG000|Part 1: Follow-Up|Adverse Event|0|||
125098325|NCT04668066|449980237|FG001|Part 1: Follow-Up|Adverse Event|0|||
125098326|NCT04668066|449980238|FG002|Part 1: Follow-Up|Adverse Event|0|||
125098327|NCT04668066|449980239|FG003|Part 1: Follow-Up|Adverse Event|0|||
125098328|NCT04668066|449980240|FG004|Part 1: Follow-Up|Adverse Event|0|||
125098329|NCT04668066|449980241|FG005|Part 1: Follow-Up|Adverse Event|0|||
125098330|NCT04668066|449980242|FG006|Part 1: Follow-Up|Adverse Event|0|||
125098331|NCT04668066|449980243|FG007|Part 1: Follow-Up|Adverse Event|0|||
125098332|NCT04668066|449980244|FG008|Part 1: Follow-Up|Adverse Event|0|||
125098333|NCT04668066|449980245|FG009|Part 1: Follow-Up|Adverse Event|0|||
125098334|NCT04668066|449980246|FG010|Part 1: Follow-Up|Adverse Event|0|||
125098335|NCT04668066|449980247|FG011|Part 1: Follow-Up|Adverse Event|1|||
125098336|NCT04668066|449980248|FG012|Part 1: Follow-Up|Adverse Event|0|||
125098337|NCT04668066|449980249|FG013|Part 1: Follow-Up|Adverse Event|0|||
125098338|NCT04668066|449980250|FG014|Part 1: Follow-Up|Adverse Event|0|||
125098339|NCT04668066|449980251|FG015|Part 1: Follow-Up|Adverse Event|0|||
125098340|NCT04668066|449980252|FG016|Part 1: Follow-Up|Adverse Event|0|||
125098341|NCT04668066|449980253|FG017|Part 1: Follow-Up|Adverse Event|0|||
125098342|NCT04668066|449980254|FG018|Part 1: Follow-Up|Adverse Event|0|||
125098343|NCT04668066|449980236|FG000|Part 1: Follow-Up|Other|0|||
125098344|NCT04668066|449980237|FG001|Part 1: Follow-Up|Other|0|||
125098345|NCT04668066|449980238|FG002|Part 1: Follow-Up|Other|0|||
125098346|NCT04668066|449980239|FG003|Part 1: Follow-Up|Other|0|||
125098347|NCT04668066|449980240|FG004|Part 1: Follow-Up|Other|0|||
125098348|NCT04668066|449980241|FG005|Part 1: Follow-Up|Other|0|||
125098349|NCT04668066|449980242|FG006|Part 1: Follow-Up|Other|0|||
125098350|NCT04668066|449980243|FG007|Part 1: Follow-Up|Other|0|||
125098351|NCT04668066|449980244|FG008|Part 1: Follow-Up|Other|0|||
125098352|NCT04668066|449980245|FG009|Part 1: Follow-Up|Other|0|||
125098353|NCT04668066|449980246|FG010|Part 1: Follow-Up|Other|0|||
125098354|NCT04668066|449980247|FG011|Part 1: Follow-Up|Other|1|||
125098355|NCT04668066|449980248|FG012|Part 1: Follow-Up|Other|1|||
125098356|NCT04668066|449980249|FG013|Part 1: Follow-Up|Other|0|||
125098357|NCT04668066|449980250|FG014|Part 1: Follow-Up|Other|0|||
125098358|NCT04668066|449980251|FG015|Part 1: Follow-Up|Other|0|||
125098359|NCT04668066|449980252|FG016|Part 1: Follow-Up|Other|0|||
125098360|NCT04668066|449980253|FG017|Part 1: Follow-Up|Other|0|||
125098361|NCT04668066|449980254|FG018|Part 1: Follow-Up|Other|0|||
125098362|NCT04668066|449980236|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
125098363|NCT04668066|449980237|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
125098364|NCT04668066|449980238|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
125098365|NCT04668066|449980239|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
125098366|NCT04668066|449980240|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
124873837|NCT02240108|449160103|FG000|Overall Study|Other than specified|8|||
124873838|NCT02240108|449160104|FG001|Overall Study|Other than specified|6|||
124873839|NCT02240108|449160103|FG000|Overall Study|Adverse Event|1|||
124873840|NCT02240108|449160104|FG001|Overall Study|Adverse Event|9|||
124873841|NCT02240108|449160103|FG000|Overall Study|Pregnancy|1|||
125098367|NCT04668066|449980241|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
125098368|NCT04668066|449980242|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
125098369|NCT04668066|449980243|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
125098370|NCT04668066|449980244|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
125098371|NCT04668066|449980245|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
124873842|NCT02240108|449160104|FG001|Overall Study|Pregnancy|0|||
124873843|NCT02240108|449160103|FG000|Overall Study|Withdrawal by Subject|4|||
124873844|NCT02240108|449160104|FG001|Overall Study|Withdrawal by Subject|9|||
124873845|NCT02240108|449160103|FG000|Overall Study|StudyTerminated by Sponsor|0|||
124873846|NCT02240108|449160104|FG001|Overall Study|StudyTerminated by Sponsor|1|||
124873847|NCT03938454|449160105|FG000|Overall Study|Protocol Violation|1|||
124873848|NCT03938454|449160105|FG000|Overall Study|Withdrawal by Subject|2|||
124873849|NCT03938454|449160105|FG000|Overall Study|Lost to Follow-up|3|||
124873850|NCT01142388|449160106|FG000|Overall Study|Lack of Efficacy|21|||
124873851|NCT01142388|449160107|FG001|Overall Study|Lack of Efficacy|31|||
124873852|NCT01142388|449160106|FG000|Overall Study|Adverse Event|9|||
124873853|NCT01142388|449160107|FG001|Overall Study|Adverse Event|5|||
124873854|NCT01142388|449160106|FG000|Overall Study|Death|3|||
124873855|NCT01142388|449160107|FG001|Overall Study|Death|2|||
124873856|NCT01142388|449160106|FG000|Overall Study|Withdrawal by Subject|5|||
124873857|NCT01142388|449160107|FG001|Overall Study|Withdrawal by Subject|3|||
124873858|NCT01142388|449160106|FG000|Overall Study|Alternative therapy|1|||
124873859|NCT01142388|449160107|FG001|Overall Study|Alternative therapy|0|||
124873860|NCT01142388|449160106|FG000|Overall Study|Other complications|0|||
124873861|NCT01142388|449160107|FG001|Overall Study|Other complications|2|||
124873862|NCT01142388|449160106|FG000|Overall Study|Other|1|||
124873863|NCT01142388|449160107|FG001|Overall Study|Other|1|||
124873864|NCT01142388|449160106|FG000|Overall Study|Never started therapy|7|||
124873865|NCT01142388|449160107|FG001|Overall Study|Never started therapy|3|||
124873866|NCT04244396|449160112|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
124873867|NCT04244396|449160112|FG000|Overall Study|Withdrawal by Subject|2|||
124873868|NCT04244396|449160112|FG000|Overall Study|Study termination|37|||
124873869|NCT00335452|449160115|FG000|Overall Study|Death|156|||
124873870|NCT00335452|449160116|FG001|Overall Study|Death|144|||
124873871|NCT00335452|449160117|FG002|Overall Study|Death|158|||
124873872|NCT00335452|449160118|FG003|Overall Study|Death|129|||
124873873|NCT00335452|449160115|FG000|Overall Study|Lost to Follow-up|2|||
124873874|NCT00335452|449160116|FG001|Overall Study|Lost to Follow-up|3|||
125010313|NCT02576444|449663651|FG002|Overall Study|Adverse Event|1|||
125010314|NCT02576444|449663652|FG003|Overall Study|Adverse Event|0|||
125010315|NCT02576444|449663649|FG000|Overall Study|Physician Decision|0|||
125010316|NCT02576444|449663650|FG001|Overall Study|Physician Decision|0|||
125010317|NCT02576444|449663651|FG002|Overall Study|Physician Decision|1|||
125010318|NCT02576444|449663652|FG003|Overall Study|Physician Decision|0|||
125010319|NCT01843842|449663657|FG000|Overall Study|Do not meet inclusion criteria|1|||
125010320|NCT01843842|449663658|FG001|Overall Study|Do not meet inclusion criteria|1|||
125010321|NCT02953340|449663659|FG000|Overall Study|Death|0|||
125010322|NCT02953340|449663660|FG001|Overall Study|Death|1|||
125010323|NCT02953340|449663659|FG000|Overall Study|Investigator Decision|3|||
125010324|NCT02953340|449663660|FG001|Overall Study|Investigator Decision|3|||
125010325|NCT02953340|449663659|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
125010326|NCT02953340|449663660|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
125010327|NCT02953340|449663659|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
125010328|NCT02953340|449663660|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
125010329|NCT02953340|449663659|FG000|Overall Study|Withdrawal by Subject|9|||
125010330|NCT02953340|449663660|FG001|Overall Study|Withdrawal by Subject|9|||
125010331|NCT02953340|449663659|FG000|Overall Study|Sponsor decision|0|||
125010332|NCT02953340|449663660|FG001|Overall Study|Sponsor decision|2|||
125010333|NCT02953340|449663659|FG000|Overall Study|Lost to Follow-up|3|||
125010334|NCT02953340|449663660|FG001|Overall Study|Lost to Follow-up|2|||
125010335|NCT02953340|449663659|FG000|Overall Study|Reason not specified|2|||
125010336|NCT02953340|449663660|FG001|Overall Study|Reason not specified|2|||
125010337|NCT01376778|449663661|FG000|Overall Study|Lost to Follow-up|3|||
125010338|NCT01376778|449663662|FG001|Overall Study|Lost to Follow-up|2|||
125010339|NCT00928889|449663663|FG000|Overall Study|Lost to Follow-up|3|||
125010340|NCT00928889|449663664|FG001|Overall Study|Lost to Follow-up|1|||
125098372|NCT04668066|449980246|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
125098373|NCT04668066|449980247|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
125098374|NCT04668066|449980248|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
124873875|NCT00335452|449160117|FG002|Overall Study|Lost to Follow-up|1|||
124873876|NCT00335452|449160118|FG003|Overall Study|Lost to Follow-up|2|||
124873877|NCT01750879|449160132|FG000|Overall Study|Adverse Event|8|||
124873878|NCT01750879|449160133|FG001|Overall Study|Adverse Event|0|||
124873879|NCT01750879|449160132|FG000|Overall Study|Lack of Efficacy|1|||
125010341|NCT00928889|449663663|FG000|Overall Study|Protocol Violation|0|||
125010342|NCT00928889|449663664|FG001|Overall Study|Protocol Violation|1|||
125010343|NCT00928889|449663663|FG000|Overall Study|Adverse Event|1|||
125010344|NCT00928889|449663664|FG001|Overall Study|Adverse Event|0|||
125010345|NCT00928889|449663663|FG000|Overall Study|Other|1|||
125010346|NCT00928889|449663664|FG001|Overall Study|Other|0|||
125010347|NCT02343159|449663670|FG000|Overall Study|Early Study Termination|16|||
124873880|NCT01750879|449160133|FG001|Overall Study|Lack of Efficacy|0|||
124873881|NCT01750879|449160132|FG000|Overall Study|Withdrawal by Subject|1|||
124873882|NCT01750879|449160133|FG001|Overall Study|Withdrawal by Subject|0|||
124873883|NCT01750879|449160132|FG000|Overall Study|Did not complete per protocol|0|||
124873884|NCT01750879|449160133|FG001|Overall Study|Did not complete per protocol|3|||
124873885|NCT02421666|449160134|FG000|6-month Follow-up|Lost to Follow-up|8|||
124873886|NCT02421666|449160135|FG001|6-month Follow-up|Lost to Follow-up|7|||
124873887|NCT02421666|449160134|FG000|6-month Follow-up|Withdrawal by Subject|5|||
124873888|NCT02421666|449160135|FG001|6-month Follow-up|Withdrawal by Subject|6|||
124873889|NCT02421666|449160134|FG000|12-month Follow-up|Lost to Follow-up|5|||
124873890|NCT02421666|449160135|FG001|12-month Follow-up|Lost to Follow-up|5|||
124873891|NCT02421666|449160134|FG000|12-month Follow-up|Withdrawal by Subject|6|||
124873892|NCT02421666|449160135|FG001|12-month Follow-up|Withdrawal by Subject|11|||
124873893|NCT02093663|449160140|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
124873894|NCT02093663|449160141|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
124873895|NCT02093663|449160142|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
124873896|NCT02093663|449160143|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
124873897|NCT02093663|449160144|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
124873898|NCT02093663|449160140|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
124873899|NCT02093663|449160141|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
124873900|NCT02093663|449160142|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
124873901|NCT02093663|449160143|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
124873902|NCT02093663|449160144|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
124873903|NCT02093663|449160140|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
124873904|NCT02093663|449160141|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
124873905|NCT02093663|449160142|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
124873906|NCT02093663|449160143|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
124873907|NCT02093663|449160144|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
124873908|NCT02093663|449160140|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
124873909|NCT02093663|449160141|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
124873910|NCT02093663|449160142|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
124873911|NCT02093663|449160143|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
124873912|NCT02093663|449160144|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
124873913|NCT02093663|449160140|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
124873914|NCT02093663|449160141|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
124873915|NCT02093663|449160142|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
124873916|NCT02093663|449160143|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
124873917|NCT02093663|449160144|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
124873918|NCT02093663|449160140|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
124873919|NCT02093663|449160141|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
124873920|NCT02093663|449160142|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
124873921|NCT02093663|449160143|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
124873922|NCT02093663|449160144|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
124873923|NCT02093663|449160140|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
124873924|NCT02093663|449160141|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
124873925|NCT02093663|449160142|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
124873926|NCT02093663|449160143|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
124873927|NCT02093663|449160144|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
124873928|NCT02093663|449160140|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
124873929|NCT02093663|449160141|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
124873930|NCT02093663|449160142|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
124873931|NCT02093663|449160143|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
124873932|NCT02093663|449160144|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
124873933|NCT02093663|449160140|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
124873934|NCT02093663|449160141|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
124873935|NCT02093663|449160142|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
124873936|NCT02093663|449160143|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
124873937|NCT02093663|449160144|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
124873938|NCT02277990|449160169|FG000|Overall Study|Death|170|||
124873939|NCT02277990|449160170|FG001|Overall Study|Death|188|||
125010348|NCT02343159|449663671|FG001|Overall Study|Early Study Termination|19|||
125010349|NCT02343159|449663672|FG002|Overall Study|Early Study Termination|23|||
125010350|NCT02343159|449663670|FG000|Overall Study|Physician Decision|2|||
125010351|NCT02343159|449663671|FG001|Overall Study|Physician Decision|0|||
125010352|NCT02343159|449663672|FG002|Overall Study|Physician Decision|1|||
125010353|NCT02343159|449663670|FG000|Overall Study|Withdrawal by Subject|3|||
125010354|NCT02343159|449663671|FG001|Overall Study|Withdrawal by Subject|0|||
124873940|NCT02277990|449160169|FG000|Overall Study|Withdrawal by Subject|64|||
124873941|NCT02277990|449160170|FG001|Overall Study|Withdrawal by Subject|53|||
125010355|NCT02343159|449663672|FG002|Overall Study|Withdrawal by Subject|2|||
125010356|NCT02343159|449663670|FG000|Overall Study|Lost to Follow-up|0|||
125010357|NCT02343159|449663671|FG001|Overall Study|Lost to Follow-up|2|||
124873942|NCT02277990|449160169|FG000|Overall Study|Physician Decision|40|||
124873943|NCT02277990|449160170|FG001|Overall Study|Physician Decision|34|||
124873944|NCT02277990|449160169|FG000|Overall Study|Lost to Follow-up|66|||
124873945|NCT02277990|449160170|FG001|Overall Study|Lost to Follow-up|69|||
124873946|NCT02277990|449160169|FG000|Overall Study|Had other reason|26|||
124873947|NCT02277990|449160170|FG001|Overall Study|Had other reason|32|||
124873948|NCT04711603|449160171|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
124873949|NCT04711603|449160172|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
124873950|NCT04711603|449160173|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
124873951|NCT04711603|449160174|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
124873952|NCT04711603|449160171|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
124873953|NCT04711603|449160172|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
124873954|NCT04711603|449160173|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
124873955|NCT04711603|449160174|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
124873956|NCT04711603|449160171|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
124873957|NCT04711603|449160172|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
124873958|NCT04711603|449160173|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
124873959|NCT04711603|449160174|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
124873960|NCT04711603|449160171|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
124873961|NCT04711603|449160172|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
124873962|NCT04711603|449160173|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
124873963|NCT04711603|449160174|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
124873964|NCT04711603|449160171|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
124873965|NCT04711603|449160172|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
124873966|NCT04711603|449160173|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
124873967|NCT04711603|449160174|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
124873968|NCT04711603|449160171|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
124873969|NCT04711603|449160172|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
124873970|NCT04711603|449160173|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
124873971|NCT04711603|449160174|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
124873972|NCT04711603|449160171|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
124873973|NCT04711603|449160172|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
124873974|NCT04711603|449160173|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
124873975|NCT04711603|449160174|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
124873976|NCT04711603|449160171|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
124873977|NCT04711603|449160172|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
124873978|NCT04711603|449160173|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
124873979|NCT04711603|449160174|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
124873980|NCT04711603|449160171|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
124873981|NCT04711603|449160172|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
124873982|NCT04711603|449160173|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
124873983|NCT04711603|449160174|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
124873984|NCT04711603|449160171|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
124873985|NCT04711603|449160172|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
124969471|NCT00334542|449517400|FG000|Overall Study|New cancer diagnosis|1|||
124969472|NCT00013611|449517401|FG000|Overall Study|Lost to Follow-up|91|||
124969473|NCT00013611|449517402|FG001|Overall Study|Lost to Follow-up|100|||
124969474|NCT02094898|449517408|FG000|Overall Study|Clinical Worsening|2|||
124969475|NCT02094898|449517408|FG000|Overall Study|Adverse Event|2|||
124969476|NCT02094898|449517408|FG000|Overall Study|Lack of Efficacy|1|||
124969477|NCT03520075|449517409|FG000|Phase 1 (Dose Escalation)|Death|2|||
124969478|NCT03520075|449517410|FG001|Phase 1 (Dose Escalation)|Death|2|||
124969479|NCT03520075|449517411|FG002|Phase 1 (Dose Escalation)|Death|3|||
124969480|NCT03520075|449517412|FG003|Phase 1 (Dose Escalation)|Death|2|||
124969481|NCT03520075|449517413|FG004|Phase 1 (Dose Escalation)|Death|6|||
124969482|NCT03520075|449517414|FG005|Phase 1 (Dose Escalation)|Death|5|||
124969483|NCT03520075|449517415|FG006|Phase 1 (Dose Escalation)|Death|3|||
124969484|NCT03520075|449517416|FG007|Phase 1 (Dose Escalation)|Death|2|||
124969485|NCT03520075|449517417|FG008|Phase 1 (Dose Escalation)|Death|3|||
124969486|NCT03520075|449517418|FG009|Phase 1 (Dose Escalation)|Death|1|||
124969487|NCT03520075|449517419|FG010|Phase 1 (Dose Escalation)|Death|5|||
124969488|NCT03520075|449517420|FG011|Phase 1 (Dose Escalation)|Death|7|||
124969489|NCT03520075|449517421|FG012|Phase 1 (Dose Escalation)|Death|11|||
124969490|NCT03520075|449517422|FG013|Phase 1 (Dose Escalation)|Death|0|||
124969491|NCT03520075|449517423|FG014|Phase 1 (Dose Escalation)|Death|0|||
124969492|NCT03520075|449517424|FG015|Phase 1 (Dose Escalation)|Death|0|||
124969493|NCT03520075|449517425|FG016|Phase 1 (Dose Escalation)|Death|0|||
124969494|NCT03520075|449517426|FG017|Phase 1 (Dose Escalation)|Death|0|||
124969495|NCT03520075|449517427|FG018|Phase 1 (Dose Escalation)|Death|0|||
124969496|NCT03520075|449517409|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
124873986|NCT04711603|449160173|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
124873987|NCT04711603|449160174|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
124873988|NCT04711603|449160171|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
124873989|NCT04711603|449160172|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
124873990|NCT04711603|449160173|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
124873991|NCT04711603|449160174|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
124873992|NCT04711603|449160171|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
124873993|NCT04711603|449160172|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
124873994|NCT04711603|449160173|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
124873995|NCT04711603|449160174|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
124873996|NCT04252742|449160178|FG000|Overall Study|Decision by sponsor|0|||
124873997|NCT04252742|449160179|FG001|Overall Study|Decision by sponsor|2|||
124873998|NCT04252742|449160178|FG000|Overall Study|Withdrawal by Subject|15|||
124873999|NCT04252742|449160179|FG001|Overall Study|Withdrawal by Subject|9|||
124874000|NCT04252742|449160178|FG000|Overall Study|Lost to Follow-up|0|||
124874001|NCT04252742|449160179|FG001|Overall Study|Lost to Follow-up|1|||
124874002|NCT04270747|449160181|FG000|Through Week 16|Adverse Event|1|||
124874003|NCT04270747|449160182|FG001|Through Week 16|Adverse Event|2|||
124874004|NCT04270747|449160183|FG002|Through Week 16|Adverse Event|0|||
124874005|NCT04270747|449160181|FG000|Through Week 16|Death|0|||
124874006|NCT04270747|449160182|FG001|Through Week 16|Death|2|||
124874007|NCT04270747|449160183|FG002|Through Week 16|Death|0|||
124874008|NCT04270747|449160181|FG000|Through Week 16|Consent Withdrawn|3|||
124874009|NCT04270747|449160182|FG001|Through Week 16|Consent Withdrawn|3|||
124874010|NCT04270747|449160183|FG002|Through Week 16|Consent Withdrawn|0|||
124874011|NCT04270747|449160181|FG000|Through Week 16|Physician Decision|1|||
124874012|NCT04270747|449160182|FG001|Through Week 16|Physician Decision|1|||
124874013|NCT04270747|449160183|FG002|Through Week 16|Physician Decision|0|||
125010358|NCT02343159|449663672|FG002|Overall Study|Lost to Follow-up|2|||
125010359|NCT02343159|449663670|FG000|Overall Study|Adverse Event|4|||
125010360|NCT02343159|449663671|FG001|Overall Study|Adverse Event|4|||
125010361|NCT02343159|449663672|FG002|Overall Study|Adverse Event|2|||
125010362|NCT02343159|449663670|FG000|Overall Study|Sponsor Decision|0|||
125010363|NCT02343159|449663671|FG001|Overall Study|Sponsor Decision|1|||
125010364|NCT02343159|449663672|FG002|Overall Study|Sponsor Decision|0|||
125010365|NCT02343159|449663670|FG000|Overall Study|Enrollment Error|1|||
125010366|NCT02343159|449663671|FG001|Overall Study|Enrollment Error|0|||
125010367|NCT02343159|449663672|FG002|Overall Study|Enrollment Error|0|||
125010368|NCT02375724|449663675|FG000|Overall Study|Lack of Efficacy|1|||
125010369|NCT02375724|449663676|FG001|Overall Study|Lack of Efficacy|1|||
125010370|NCT02375724|449663675|FG000|Overall Study|Withdrawal by Subject|1|||
125010371|NCT02375724|449663676|FG001|Overall Study|Withdrawal by Subject|1|||
125010372|NCT02375724|449663675|FG000|Overall Study|Lost to Follow-up|1|||
125010373|NCT02375724|449663676|FG001|Overall Study|Lost to Follow-up|0|||
125010374|NCT02375724|449663675|FG000|Overall Study|Protocol Violation|1|||
125010375|NCT02375724|449663676|FG001|Overall Study|Protocol Violation|0|||
125010376|NCT02375724|449663675|FG000|Overall Study|Adverse Event|2|||
125010377|NCT02375724|449663676|FG001|Overall Study|Adverse Event|4|||
125010378|NCT04712110|449663677|FG000|Overall Study|Lost to Follow-up|0|||
125010379|NCT04712110|449663678|FG001|Overall Study|Lost to Follow-up|1|||
125010380|NCT04712110|449663677|FG000|Overall Study|Withdrawal by Subject|0|||
125010381|NCT04712110|449663678|FG001|Overall Study|Withdrawal by Subject|4|||
125010382|NCT04712110|449663677|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
125010383|NCT04712110|449663678|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
125010384|NCT01517893|449663679|FG000|Overall Study|Withdrawal by Subject|3|||
125010385|NCT01517893|449663680|FG001|Overall Study|Withdrawal by Subject|0|||
124874014|NCT04270747|449160181|FG000|Through Week 16|Lost to Follow-up|2|||
124874015|NCT04270747|449160182|FG001|Through Week 16|Lost to Follow-up|0|||
124874016|NCT04270747|449160183|FG002|Through Week 16|Lost to Follow-up|0|||
124874017|NCT04270747|449160181|FG000|Through Week 16|Protocol Violation|1|||
125010386|NCT01309659|449663681|FG000|Overall Study|Protocol Violation|0|||
125010387|NCT01309659|449663682|FG001|Overall Study|Protocol Violation|1|||
125010388|NCT03462576|449663683|FG000|Overall Study|Protocol Violation|5|||
125010389|NCT03462576|449663684|FG001|Overall Study|Protocol Violation|11|||
125010390|NCT03462576|449663685|FG002|Overall Study|Protocol Violation|7|||
125010391|NCT03462576|449663683|FG000|Overall Study|Device Malfunction|0|||
125010392|NCT03462576|449663684|FG001|Overall Study|Device Malfunction|0|||
125010393|NCT03462576|449663685|FG002|Overall Study|Device Malfunction|1|||
125010394|NCT02285777|449663689|FG000|Overall Study|Withdrawal by Subject|1|||
125010395|NCT02285777|449663690|FG001|Overall Study|Withdrawal by Subject|1|||
125098375|NCT04668066|449980249|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
124874018|NCT04270747|449160182|FG001|Through Week 16|Protocol Violation|2|||
125010396|NCT02285777|449663689|FG000|Overall Study|Lost to Follow-up|4|||
125010397|NCT02285777|449663690|FG001|Overall Study|Lost to Follow-up|2|||
125010398|NCT03962101|449663693|FG000|Overall Study|Adverse Event|1|||
124874019|NCT04270747|449160183|FG002|Through Week 16|Protocol Violation|0|||
124874020|NCT04270747|449160181|FG000|Through Week 16|Protocol Specified Criteria|6|||
124874021|NCT04270747|449160182|FG001|Through Week 16|Protocol Specified Criteria|7|||
124874022|NCT04270747|449160183|FG002|Through Week 16|Protocol Specified Criteria|0|||
124874023|NCT04270747|449160181|FG000|Through Week 16|Miscellaneous|1|||
124874024|NCT04270747|449160182|FG001|Through Week 16|Miscellaneous|1|||
124874025|NCT04270747|449160183|FG002|Through Week 16|Miscellaneous|0|||
124874026|NCT04270747|449160181|FG000|Post Week 16|Adverse Event|7|||
124874027|NCT04270747|449160182|FG001|Post Week 16|Adverse Event|5|||
124874028|NCT04270747|449160183|FG002|Post Week 16|Adverse Event|1|||
124874029|NCT04270747|449160181|FG000|Post Week 16|Death|2|||
124874030|NCT04270747|449160182|FG001|Post Week 16|Death|0|||
124874031|NCT04270747|449160183|FG002|Post Week 16|Death|2|||
124874032|NCT04270747|449160181|FG000|Post Week 16|Consent Withdrawn|4|||
124874033|NCT04270747|449160182|FG001|Post Week 16|Consent Withdrawn|3|||
124874034|NCT04270747|449160183|FG002|Post Week 16|Consent Withdrawn|6|||
124874035|NCT04270747|449160181|FG000|Post Week 16|Physician Decision|3|||
124874036|NCT04270747|449160182|FG001|Post Week 16|Physician Decision|1|||
124874037|NCT04270747|449160183|FG002|Post Week 16|Physician Decision|1|||
124874038|NCT04270747|449160181|FG000|Post Week 16|Lost to Follow-up|2|||
124874039|NCT04270747|449160182|FG001|Post Week 16|Lost to Follow-up|1|||
124874040|NCT04270747|449160183|FG002|Post Week 16|Lost to Follow-up|0|||
124874041|NCT04270747|449160181|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
124874042|NCT04270747|449160182|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
124874043|NCT04270747|449160183|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
124874044|NCT04270747|449160181|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
124874045|NCT04270747|449160182|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
124874046|NCT04270747|449160183|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
124874047|NCT04270747|449160181|FG000|Post Week 16|Miscellaneous|1|||
124874048|NCT04270747|449160182|FG001|Post Week 16|Miscellaneous|0|||
124874049|NCT04270747|449160183|FG002|Post Week 16|Miscellaneous|1|||
124874050|NCT01784068|449160186|FG000|NTCS Phase|Adverse Event|5|||
124874051|NCT01784068|449160187|FG001|NTCS Phase|Adverse Event|0|||
124874052|NCT01784068|449160186|FG000|NTCS Phase|Physician Decision|2|||
124874053|NCT01784068|449160187|FG001|NTCS Phase|Physician Decision|0|||
124874054|NCT01784068|449160186|FG000|NTCS Phase|Patient/guardian decision|3|||
124874055|NCT01784068|449160187|FG001|NTCS Phase|Patient/guardian decision|0|||
124874056|NCT01784068|449160186|FG000|NTCS Phase|Death|2|||
124874057|NCT01784068|449160187|FG001|NTCS Phase|Death|0|||
124874058|NCT01784068|449160186|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
124874059|NCT01784068|449160187|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
124874060|NCT01784068|449160186|FG000|TFR Phase|Physician Decision|0|||
124874061|NCT01784068|449160187|FG001|TFR Phase|Physician Decision|1|||
124874062|NCT01784068|449160186|FG000|TFR Phase|Patient/guardian decision|0|||
124874063|NCT01784068|449160187|FG001|TFR Phase|Patient/guardian decision|3|||
124874064|NCT01784068|449160186|FG000|TFR Phase|Death|0|||
124874065|NCT01784068|449160187|FG001|TFR Phase|Death|1|||
124874066|NCT01784068|449160186|FG000|TFR Phase|Lack of Efficacy|0|||
124874067|NCT01784068|449160187|FG001|TFR Phase|Lack of Efficacy|88|||
124874068|NCT05614089|449160188|FG000|Overall Study|Pregnancy|5|||
124874069|NCT05614089|449160189|FG001|Overall Study|Pregnancy|2|||
124874070|NCT05614089|449160188|FG000|Overall Study|Lost to Follow-up|5|||
124874071|NCT05614089|449160189|FG001|Overall Study|Lost to Follow-up|1|||
124874072|NCT05614089|449160188|FG000|Overall Study|Death|0|||
124874073|NCT05614089|449160189|FG001|Overall Study|Death|1|||
124874074|NCT05614089|449160188|FG000|Overall Study|Adverse Event|1|||
124874075|NCT05614089|449160189|FG001|Overall Study|Adverse Event|0|||
125010399|NCT03962101|449663693|FG000|Overall Study|Physician Decision|2|||
125010400|NCT03962101|449663693|FG000|Overall Study|Not related to medical events|1|||
125010401|NCT00271596|449663700|FG000|Overall Study|Protocol Violation|1|||
125010402|NCT00271596|449663701|FG001|Overall Study|Protocol Violation|0|||
125010403|NCT00271596|449663700|FG000|Overall Study|Withdrawal by Subject|0|||
125010404|NCT00271596|449663701|FG001|Overall Study|Withdrawal by Subject|1|||
125010405|NCT01069172|449663706|FG000|Overall Study|Withdrawal by Subject|1|||
125010406|NCT01069172|449663707|FG001|Overall Study|Withdrawal by Subject|0|||
125010407|NCT04206605|449663708|FG000|Overall Study|Adverse Event|0|||
125010408|NCT04206605|449663709|FG001|Overall Study|Adverse Event|1|||
124874076|NCT05701995|449160195|FG000|Pre-Treatment|Randomization Error|1|||
124874077|NCT05701995|449160196|FG001|Pre-Treatment|Randomization Error|1|||
124874078|NCT05701995|449160195|FG000|Treatment|Withdrawal by Subject|8|||
124874079|NCT05701995|449160196|FG001|Treatment|Withdrawal by Subject|4|||
124874080|NCT05701995|449160195|FG000|Treatment|Lost to Follow-up|2|||
124874081|NCT05701995|449160196|FG001|Treatment|Lost to Follow-up|3|||
124874082|NCT05701995|449160195|FG000|Treatment|Adverse Event|3|||
124874083|NCT05701995|449160196|FG001|Treatment|Adverse Event|1|||
124874084|NCT05701995|449160195|FG000|Treatment|Other Reason|1|||
124874085|NCT05701995|449160196|FG001|Treatment|Other Reason|1|||
124874086|NCT05701995|449160195|FG000|Treatment|Death|1|||
125010409|NCT04206605|449663708|FG000|Overall Study|Withdrawal by Subject|1|||
124874087|NCT05701995|449160196|FG001|Treatment|Death|0|||
124874088|NCT05701995|449160195|FG000|Treatment|Physician Decision|0|||
124874089|NCT05701995|449160196|FG001|Treatment|Physician Decision|1|||
124874090|NCT04987762|449160200|FG000|Overall Study|Study was Terminated by Sponsor|103|||
124874091|NCT00504426|449160206|FG000|Overall Study|Adverse Event|0|||
124874092|NCT00504426|449160207|FG001|Overall Study|Adverse Event|0|||
124874093|NCT00504426|449160208|FG002|Overall Study|Adverse Event|2|||
124874094|NCT00504426|449160209|FG003|Overall Study|Adverse Event|0|||
124874095|NCT00504426|449160206|FG000|Overall Study|Protocol Violation|1|||
124874096|NCT00504426|449160207|FG001|Overall Study|Protocol Violation|1|||
124874097|NCT00504426|449160208|FG002|Overall Study|Protocol Violation|2|||
124874098|NCT00504426|449160209|FG003|Overall Study|Protocol Violation|0|||
124874099|NCT00504426|449160206|FG000|Overall Study|Withdrawal by Subject|2|||
124874100|NCT00504426|449160207|FG001|Overall Study|Withdrawal by Subject|0|||
124874101|NCT00504426|449160208|FG002|Overall Study|Withdrawal by Subject|0|||
124874102|NCT00504426|449160209|FG003|Overall Study|Withdrawal by Subject|0|||
124874103|NCT03988166|449160210|FG000|Overall Study|Lost to Follow-up|2|||
124874104|NCT03988166|449160210|FG000|Overall Study|Death|1|||
124874105|NCT03248375|449160211|FG000|Overall Study|Lost to Follow-up|5|||
124874106|NCT04992546|449160212|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
124874107|NCT04992546|449160212|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
124874108|NCT04992546|449160212|FG000|Open-Label Treatment Period|Adverse Event|3|||
124874109|NCT04992546|449160212|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
124874110|NCT00633464|449160214|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
124874111|NCT00633464|449160215|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
124874112|NCT00633464|449160214|FG000|Overall Study|Never Treated (Randomized in error)|0|||
124874113|NCT00633464|449160215|FG001|Overall Study|Never Treated (Randomized in error)|1|||
124874114|NCT04058353|449160216|FG000|Overall Study|Adverse Event|2|||
124874115|NCT04058353|449160217|FG001|Overall Study|Adverse Event|1|||
124874116|NCT04058353|449160216|FG000|Overall Study|Physician Decision|1|||
124874117|NCT04058353|449160217|FG001|Overall Study|Physician Decision|0|||
124874118|NCT04058353|449160216|FG000|Overall Study|Other|1|||
124874119|NCT04058353|449160217|FG001|Overall Study|Other|0|||
124874120|NCT00542880|449160219|FG000|Period 1|Eligibility criteria not fulfilled|2|||
124874121|NCT00542880|449160220|FG001|Period 1|Eligibility criteria not fulfilled|6|||
124874122|NCT00542880|449160219|FG000|Period 1|Adverse Event|2|||
124874123|NCT00542880|449160220|FG001|Period 1|Adverse Event|2|||
124874124|NCT00542880|449160219|FG000|Period 1|Development of study-specific criteria|1|||
125010410|NCT04206605|449663709|FG001|Overall Study|Withdrawal by Subject|0|||
124874125|NCT00542880|449160220|FG001|Period 1|Development of study-specific criteria|2|||
125010411|NCT03901079|449663712|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
125010412|NCT00843518|449663713|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
125010413|NCT00843518|449663714|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
125010414|NCT00843518|449663713|FG000|Period 2 (Double-blind Treatment)|Death|0|||
125010415|NCT00843518|449663714|FG001|Period 2 (Double-blind Treatment)|Death|1|||
125010416|NCT00843518|449663713|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
125010417|NCT00843518|449663714|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
125010418|NCT00843518|449663713|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
125010419|NCT00843518|449663714|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
125010420|NCT00843518|449663713|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
125010421|NCT00843518|449663714|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
125010422|NCT00843518|449663713|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
125010423|NCT00843518|449663714|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
125010424|NCT00843518|449663713|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
125010425|NCT00843518|449663714|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
125010426|NCT00827606|449663715|FG000|Overall Study|Protocol Violation|4|||
125010427|NCT00827606|449663716|FG001|Overall Study|Protocol Violation|3|||
125010428|NCT00827606|449663715|FG000|Overall Study|Lost to Follow-up|3|||
125010429|NCT00827606|449663716|FG001|Overall Study|Lost to Follow-up|1|||
125010430|NCT00827606|449663715|FG000|Overall Study|Withdrawal by Subject|7|||
125010431|NCT00827606|449663716|FG001|Overall Study|Withdrawal by Subject|6|||
124874126|NCT00542880|449160219|FG000|Period 1|Withdrawal by Subject|1|||
124874127|NCT00542880|449160220|FG001|Period 1|Withdrawal by Subject|1|||
124874128|NCT00542880|449160219|FG000|Period 1|Protocol Violation|0|||
124874129|NCT00542880|449160220|FG001|Period 1|Protocol Violation|1|||
125010432|NCT00827606|449663715|FG000|Overall Study|Pregnancy|0|||
125010433|NCT00827606|449663716|FG001|Overall Study|Pregnancy|1|||
125010434|NCT00827606|449663715|FG000|Overall Study|Other|5|||
125098376|NCT04668066|449980250|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
124874130|NCT00542880|449160219|FG000|Period 2|Adverse Event|5|||
124874131|NCT00542880|449160220|FG001|Period 2|Adverse Event|7|||
124874132|NCT00542880|449160219|FG000|Period 2|Eligibility not fulfilled|0|||
124874133|NCT00542880|449160220|FG001|Period 2|Eligibility not fulfilled|1|||
125010435|NCT00827606|449663716|FG001|Overall Study|Other|13|||
125010436|NCT00827606|449663715|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
125098377|NCT04668066|449980251|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
125098378|NCT04668066|449980252|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
125098379|NCT04668066|449980253|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
125098380|NCT04668066|449980254|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
125098381|NCT04668066|449980236|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125098382|NCT04668066|449980237|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125098383|NCT04668066|449980238|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125098384|NCT04668066|449980239|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125098385|NCT04668066|449980240|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125098386|NCT04668066|449980241|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125098387|NCT04668066|449980242|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125098388|NCT04668066|449980243|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125098389|NCT04668066|449980244|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125098390|NCT04668066|449980245|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125098391|NCT04668066|449980246|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125098392|NCT04668066|449980247|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125098393|NCT04668066|449980248|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125098394|NCT04668066|449980249|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125098395|NCT04668066|449980250|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125098396|NCT04668066|449980251|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125098397|NCT04668066|449980252|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125098398|NCT04668066|449980253|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125098399|NCT04668066|449980254|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
125098400|NCT04668066|449980236|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
125098401|NCT04668066|449980237|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
125098402|NCT04668066|449980238|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
125098403|NCT04668066|449980239|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
125098404|NCT04668066|449980240|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
125098405|NCT04668066|449980241|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
125098406|NCT04668066|449980242|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
125098407|NCT04668066|449980243|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
125098408|NCT04668066|449980244|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
125098409|NCT04668066|449980245|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
125098410|NCT04668066|449980246|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
125098411|NCT04668066|449980247|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
125098412|NCT04668066|449980248|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
125098413|NCT04668066|449980249|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
125098414|NCT04668066|449980250|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
125098415|NCT04668066|449980251|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
125098416|NCT04668066|449980252|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
125098417|NCT04668066|449980253|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
125098418|NCT04668066|449980254|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
125098419|NCT04668066|449980236|FG000|Part 2: Treatment Phase|Other|0|||
125098420|NCT04668066|449980237|FG001|Part 2: Treatment Phase|Other|0|||
125098421|NCT04668066|449980238|FG002|Part 2: Treatment Phase|Other|0|||
125098422|NCT04668066|449980239|FG003|Part 2: Treatment Phase|Other|0|||
125098423|NCT04668066|449980240|FG004|Part 2: Treatment Phase|Other|0|||
125098424|NCT04668066|449980241|FG005|Part 2: Treatment Phase|Other|0|||
125098425|NCT04668066|449980242|FG006|Part 2: Treatment Phase|Other|0|||
125098426|NCT04668066|449980243|FG007|Part 2: Treatment Phase|Other|0|||
125098427|NCT04668066|449980244|FG008|Part 2: Treatment Phase|Other|0|||
125098428|NCT04668066|449980245|FG009|Part 2: Treatment Phase|Other|0|||
125098429|NCT04668066|449980246|FG010|Part 2: Treatment Phase|Other|0|||
125098430|NCT04668066|449980247|FG011|Part 2: Treatment Phase|Other|0|||
125098431|NCT04668066|449980248|FG012|Part 2: Treatment Phase|Other|0|||
125098432|NCT04668066|449980249|FG013|Part 2: Treatment Phase|Other|0|||
125098433|NCT04668066|449980250|FG014|Part 2: Treatment Phase|Other|0|||
125098434|NCT04668066|449980251|FG015|Part 2: Treatment Phase|Other|0|||
125098435|NCT04668066|449980252|FG016|Part 2: Treatment Phase|Other|0|||
125098436|NCT04668066|449980253|FG017|Part 2: Treatment Phase|Other|0|||
125098437|NCT04668066|449980254|FG018|Part 2: Treatment Phase|Other|1|||
125098438|NCT04668066|449980236|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
125098439|NCT04668066|449980237|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
125098440|NCT04668066|449980238|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
125098441|NCT04668066|449980239|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
125098442|NCT04668066|449980240|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
125098443|NCT04668066|449980241|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
124874134|NCT00542880|449160219|FG000|Period 2|Discontinuation criteria|2|||
124874135|NCT00542880|449160220|FG001|Period 2|Discontinuation criteria|0|||
124874136|NCT00542880|449160219|FG000|Period 2|Severe non-compliance|0|||
124874137|NCT00542880|449160220|FG001|Period 2|Severe non-compliance|1|||
124874138|NCT00542880|449160219|FG000|Period 2|Other|0|||
124874139|NCT00542880|449160220|FG001|Period 2|Other|1|||
124874140|NCT00542880|449160219|FG000|Period 3|Adverse Event|0|||
124874141|NCT00542880|449160220|FG001|Period 3|Adverse Event|2|||
124874142|NCT00696384|449160221|FG000|Open Label Phase|Adverse Event|27|||
124874143|NCT00696384|449160222|FG001|Open Label Phase|Adverse Event|0|||
124874144|NCT00696384|449160223|FG002|Open Label Phase|Adverse Event|0|||
124874145|NCT00696384|449160221|FG000|Open Label Phase|Protocol Violation|18|||
124874146|NCT00696384|449160222|FG001|Open Label Phase|Protocol Violation|0|||
124874147|NCT00696384|449160223|FG002|Open Label Phase|Protocol Violation|0|||
124874148|NCT00696384|449160221|FG000|Open Label Phase|Lost to Follow-up|24|||
124874149|NCT00696384|449160222|FG001|Open Label Phase|Lost to Follow-up|0|||
124874150|NCT00696384|449160223|FG002|Open Label Phase|Lost to Follow-up|0|||
124874151|NCT00696384|449160221|FG000|Open Label Phase|Withdrawal by Subject|37|||
124874152|NCT00696384|449160222|FG001|Open Label Phase|Withdrawal by Subject|0|||
124874153|NCT00696384|449160223|FG002|Open Label Phase|Withdrawal by Subject|0|||
124874154|NCT00696384|449160221|FG000|Open Label Phase|Other|6|||
124874155|NCT00696384|449160222|FG001|Open Label Phase|Other|0|||
124874156|NCT00696384|449160223|FG002|Open Label Phase|Other|0|||
124874157|NCT00696384|449160221|FG000|Open Label Phase|Lack of Efficacy|3|||
124874158|NCT00696384|449160222|FG001|Open Label Phase|Lack of Efficacy|0|||
124874159|NCT00696384|449160223|FG002|Open Label Phase|Lack of Efficacy|0|||
124874160|NCT00696384|449160221|FG000|Open Label Phase|Physician Decision|4|||
124874161|NCT00696384|449160222|FG001|Open Label Phase|Physician Decision|0|||
124874162|NCT00696384|449160223|FG002|Open Label Phase|Physician Decision|0|||
124874163|NCT00696384|449160221|FG000|Double Blind Phase|Adverse Event|0|||
124874164|NCT00696384|449160222|FG001|Double Blind Phase|Adverse Event|2|||
124874165|NCT00696384|449160223|FG002|Double Blind Phase|Adverse Event|2|||
124874166|NCT00696384|449160221|FG000|Double Blind Phase|Lost to Follow-up|0|||
124874167|NCT00696384|449160222|FG001|Double Blind Phase|Lost to Follow-up|2|||
124874168|NCT00696384|449160223|FG002|Double Blind Phase|Lost to Follow-up|1|||
124874169|NCT00696384|449160221|FG000|Double Blind Phase|Withdrawal by Subject|0|||
124874170|NCT00696384|449160222|FG001|Double Blind Phase|Withdrawal by Subject|4|||
124874171|NCT00696384|449160223|FG002|Double Blind Phase|Withdrawal by Subject|3|||
124874172|NCT00696384|449160221|FG000|Double Blind Phase|Lack of Efficacy|0|||
124874173|NCT00696384|449160222|FG001|Double Blind Phase|Lack of Efficacy|1|||
124874174|NCT00696384|449160223|FG002|Double Blind Phase|Lack of Efficacy|0|||
124874175|NCT00696384|449160221|FG000|Double Blind Phase|Physician Decision|0|||
124874176|NCT00696384|449160222|FG001|Double Blind Phase|Physician Decision|2|||
124874177|NCT00696384|449160223|FG002|Double Blind Phase|Physician Decision|0|||
124874178|NCT02027402|449160225|FG000|Overall Study|Withdrawal by Subject|4|||
124874179|NCT02027402|449160226|FG001|Overall Study|Withdrawal by Subject|1|||
124874180|NCT04179721|449160232|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
124874181|NCT04179721|449160233|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
125098444|NCT04668066|449980242|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
125098445|NCT04668066|449980243|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
124874182|NCT04179721|449160232|FG000|Overall Study|Lost to Follow-up|0|||
124874183|NCT04179721|449160233|FG001|Overall Study|Lost to Follow-up|1|||
124874184|NCT01984697|449161986|FG000|Overall Study|Adverse Event|0|||
124874185|NCT01984697|449161987|FG001|Overall Study|Adverse Event|0|||
124874186|NCT01984697|449161988|FG002|Overall Study|Adverse Event|2|||
124874187|NCT01984697|449161989|FG003|Overall Study|Adverse Event|0|||
124874188|NCT01984697|449161990|FG004|Overall Study|Adverse Event|0|||
124874189|NCT01984697|449161986|FG000|Overall Study|Lost to Follow-up|14|||
124874190|NCT01984697|449161987|FG001|Overall Study|Lost to Follow-up|5|||
124874191|NCT01984697|449161988|FG002|Overall Study|Lost to Follow-up|10|||
124874192|NCT01984697|449161989|FG003|Overall Study|Lost to Follow-up|6|||
124874193|NCT01984697|449161990|FG004|Overall Study|Lost to Follow-up|21|||
124874194|NCT01984697|449161986|FG000|Overall Study|Physician Decision|3|||
124874195|NCT01984697|449161987|FG001|Overall Study|Physician Decision|0|||
124874196|NCT01984697|449161988|FG002|Overall Study|Physician Decision|0|||
124874197|NCT01984697|449161989|FG003|Overall Study|Physician Decision|1|||
124874198|NCT01984697|449161990|FG004|Overall Study|Physician Decision|0|||
124874199|NCT01984697|449161986|FG000|Overall Study|Protocol Violation|8|||
124874200|NCT01984697|449161987|FG001|Overall Study|Protocol Violation|5|||
124874201|NCT01984697|449161988|FG002|Overall Study|Protocol Violation|3|||
124874202|NCT01984697|449161989|FG003|Overall Study|Protocol Violation|2|||
124874203|NCT01984697|449161990|FG004|Overall Study|Protocol Violation|0|||
124874204|NCT01984697|449161986|FG000|Overall Study|Withdrawal by Subject|15|||
124874205|NCT01984697|449161987|FG001|Overall Study|Withdrawal by Subject|21|||
124874206|NCT01984697|449161988|FG002|Overall Study|Withdrawal by Subject|13|||
124874207|NCT01984697|449161989|FG003|Overall Study|Withdrawal by Subject|11|||
124874208|NCT01984697|449161990|FG004|Overall Study|Withdrawal by Subject|13|||
124874209|NCT01984697|449161986|FG000|Overall Study|Missed last follow-up visit|1|||
124874210|NCT01984697|449161987|FG001|Overall Study|Missed last follow-up visit|0|||
124874211|NCT01984697|449161988|FG002|Overall Study|Missed last follow-up visit|0|||
125098446|NCT04668066|449980244|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
124874212|NCT01984697|449161989|FG003|Overall Study|Missed last follow-up visit|0|||
124874213|NCT01984697|449161990|FG004|Overall Study|Missed last follow-up visit|0|||
124874214|NCT01984697|449161986|FG000|Overall Study|Death|0|||
124874215|NCT01984697|449161987|FG001|Overall Study|Death|0|||
124874216|NCT01984697|449161988|FG002|Overall Study|Death|0|||
124874217|NCT01984697|449161989|FG003|Overall Study|Death|1|||
124874218|NCT01984697|449161990|FG004|Overall Study|Death|0|||
124874219|NCT01984697|449161986|FG000|Overall Study|Pregnancy|2|||
124874220|NCT01984697|449161987|FG001|Overall Study|Pregnancy|0|||
124874221|NCT01984697|449161988|FG002|Overall Study|Pregnancy|1|||
124874222|NCT01984697|449161989|FG003|Overall Study|Pregnancy|0|||
124874223|NCT01984697|449161990|FG004|Overall Study|Pregnancy|1|||
124874224|NCT03308825|449161991|FG000|Overall Study|Lost to Follow-up|2|||
124874225|NCT03308825|449161992|FG001|Overall Study|Lost to Follow-up|2|||
124874226|NCT03308825|449161993|FG002|Overall Study|Lost to Follow-up|1|||
124874227|NCT03308825|449161994|FG003|Overall Study|Lost to Follow-up|0|||
124874228|NCT03308825|449161991|FG000|Overall Study|Protocol Violation|0|||
124874229|NCT03308825|449161992|FG001|Overall Study|Protocol Violation|2|||
124874230|NCT03308825|449161993|FG002|Overall Study|Protocol Violation|0|||
124874231|NCT03308825|449161994|FG003|Overall Study|Protocol Violation|0|||
124874232|NCT04737109|449161995|FG000|Study Treatment|Disease Progression|5|||
124874233|NCT04737109|449161996|FG001|Study Treatment|Disease Progression|0|||
124874234|NCT04737109|449161997|FG002|Study Treatment|Disease Progression|0|||
124874235|NCT04737109|449161998|FG003|Study Treatment|Disease Progression|0|||
124874236|NCT04737109|449161995|FG000|Study Treatment|Death on study|1|||
124874237|NCT04737109|449161996|FG001|Study Treatment|Death on study|0|||
124874238|NCT04737109|449161997|FG002|Study Treatment|Death on study|0|||
124874239|NCT04737109|449161998|FG003|Study Treatment|Death on study|0|||
124874240|NCT02259517|449161999|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
124874241|NCT02259517|449162000|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
124874242|NCT02259517|449162001|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
124874243|NCT02259517|449161999|FG000|Overall Study|Withdrawal by Subject|0|||
125098447|NCT04668066|449980245|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
125098448|NCT04668066|449980246|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
125098449|NCT04668066|449980247|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
125098450|NCT04668066|449980248|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
125098451|NCT04668066|449980249|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
125098452|NCT04668066|449980250|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
125098453|NCT04668066|449980251|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
125098454|NCT04668066|449980252|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
125098455|NCT04668066|449980253|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
125098456|NCT04668066|449980254|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
125098457|NCT01195662|449980259|FG000|Double Blind Treatment Period|Adverse Event|4|||
125098458|NCT01195662|449980260|FG001|Double Blind Treatment Period|Adverse Event|1|||
125098459|NCT01195662|449980261|FG002|Double Blind Treatment Period|Adverse Event|2|||
125098460|NCT01195662|449980259|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
125098461|NCT01195662|449980260|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
125098462|NCT01195662|449980261|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
125098463|NCT01195662|449980259|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
125098464|NCT01195662|449980260|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
125098465|NCT01195662|449980261|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
124874244|NCT02259517|449162000|FG001|Overall Study|Withdrawal by Subject|0|||
124874245|NCT02259517|449162001|FG002|Overall Study|Withdrawal by Subject|3|||
124874246|NCT01289418|449162002|FG000|Day 8 Survey|email address invalid|283|||
124874247|NCT01289418|449162002|FG000|Day 8 Survey|participants did not complete the survey|1935|||
124874248|NCT01289418|449162002|FG000|Day 29 Survey|email address invalid|283|||
124874249|NCT01289418|449162002|FG000|Day 29 Survey|participants did not complete the survey|2185|||
124874250|NCT03928028|449162011|FG000|Overall Study|Physician Decision|9|||
124874251|NCT03928028|449162012|FG001|Overall Study|Physician Decision|6|||
124874252|NCT03928028|449162013|FG002|Overall Study|Physician Decision|3|||
124874253|NCT03928028|449162011|FG000|Overall Study|Withdrawal by Subject|12|||
124874254|NCT03928028|449162012|FG001|Overall Study|Withdrawal by Subject|3|||
124874255|NCT03928028|449162013|FG002|Overall Study|Withdrawal by Subject|3|||
124874256|NCT04669600|449162017|FG000|Overall Study|Withdrawal by Subject|1|||
124874257|NCT04669600|449162017|FG000|Overall Study|Other|6|||
124874258|NCT00710606|449162020|FG000|Overall Study|Adverse Event|0|||
124874259|NCT00710606|449162021|FG001|Overall Study|Adverse Event|2|||
124874260|NCT00514683|449162026|FG000|Overall Study|Not treated|2|||
124874261|NCT00514683|449162027|FG001|Overall Study|Not treated|1|||
124874262|NCT00514683|449162028|FG002|Overall Study|Not treated|0|||
125098466|NCT01195662|449980259|FG000|Double Blind Treatment Period|Administrative reason|2|||
125010437|NCT00827606|449663716|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
125010438|NCT00827606|449663715|FG000|Overall Study|Adverse Event|4|||
125010439|NCT00827606|449663716|FG001|Overall Study|Adverse Event|2|||
125010440|NCT04037748|449663719|FG000|Treatment Period 1|Withdrawal by Subject|3|||
125010441|NCT04037748|449663720|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125010442|NCT04037748|449663719|FG000|Treatment Period 1|Adverse Event|1|||
125010443|NCT04037748|449663720|FG001|Treatment Period 1|Adverse Event|1|||
125010444|NCT04037748|449663719|FG000|Treatment Period 1|Protocol Violation|4|||
125010445|NCT04037748|449663720|FG001|Treatment Period 1|Protocol Violation|5|||
125010446|NCT04037748|449663719|FG000|Treatment Period 2|Adverse Event|0|||
125010447|NCT04037748|449663720|FG001|Treatment Period 2|Adverse Event|1|||
125010448|NCT04037748|449663719|FG000|Treatment Period 2|Protocol Violation|2|||
125010449|NCT04037748|449663720|FG001|Treatment Period 2|Protocol Violation|0|||
125010450|NCT04544475|449663725|FG000|Overall Study|Withdrawal by Subject|1|||
125010451|NCT04544475|449663726|FG001|Overall Study|Withdrawal by Subject|3|||
125010452|NCT01378858|449663727|FG000|Overall Study|Withdrawal by Subject|4|||
125010453|NCT01378858|449663728|FG001|Overall Study|Withdrawal by Subject|4|||
125010454|NCT00942175|449663729|FG000|Overall Study|Adverse Event|2|||
125010455|NCT00942175|449663730|FG001|Overall Study|Adverse Event|1|||
125010456|NCT00942175|449663731|FG002|Overall Study|Adverse Event|0|||
125010457|NCT00942175|449663732|FG003|Overall Study|Adverse Event|0|||
125010458|NCT00942175|449663729|FG000|Overall Study|Protocol Violation|0|||
125010459|NCT00942175|449663730|FG001|Overall Study|Protocol Violation|1|||
125010460|NCT00942175|449663731|FG002|Overall Study|Protocol Violation|2|||
125010461|NCT00942175|449663732|FG003|Overall Study|Protocol Violation|0|||
125010462|NCT00942175|449663729|FG000|Overall Study|Pregnancy|0|||
125010463|NCT00942175|449663730|FG001|Overall Study|Pregnancy|0|||
125010464|NCT00942175|449663731|FG002|Overall Study|Pregnancy|0|||
125010465|NCT00942175|449663732|FG003|Overall Study|Pregnancy|1|||
125010466|NCT00942175|449663729|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
125010467|NCT00942175|449663730|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
125010468|NCT00942175|449663731|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
125010469|NCT00942175|449663732|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
125010470|NCT00942175|449663729|FG000|Overall Study|Low Platelet Count|0|||
125010471|NCT00942175|449663730|FG001|Overall Study|Low Platelet Count|2|||
125010472|NCT00942175|449663731|FG002|Overall Study|Low Platelet Count|0|||
125010473|NCT00942175|449663732|FG003|Overall Study|Low Platelet Count|0|||
125010474|NCT02664272|449663733|FG000|Overall Study|Fluoroscopic images not made available|2|||
125010475|NCT03073980|449663734|FG000|Overall Study|Lost to Follow-up|10|||
125010476|NCT03073980|449663735|FG001|Overall Study|Lost to Follow-up|2|||
125010477|NCT03073980|449663736|FG002|Overall Study|Lost to Follow-up|9|||
125010478|NCT03073980|449663734|FG000|Overall Study|No post-procedure data|0|||
125010479|NCT03073980|449663735|FG001|Overall Study|No post-procedure data|0|||
125010480|NCT03073980|449663736|FG002|Overall Study|No post-procedure data|2|||
125010481|NCT00501007|449663737|FG000|Overall Study|Inclusion criteria not met.|29|||
125010482|NCT00501007|449663738|FG001|Overall Study|Inclusion criteria not met.|25|||
125010483|NCT00545064|449663739|FG000|Overall Study|Lost to Follow-up|3|||
125010484|NCT00545064|449663739|FG000|Overall Study|Withdrawal by Subject|2|||
125010485|NCT00545064|449663739|FG000|Overall Study|did not complete course of treatment|1|||
125010486|NCT00545064|449663739|FG000|Overall Study|cancel all appointments, no rebooking|1|||
125010487|NCT00545064|449663739|FG000|Overall Study|inclement weather|1|||
125010488|NCT01358760|449663744|FG000|Overall Study|Adverse Event|3|||
125010489|NCT01358760|449663745|FG001|Overall Study|Adverse Event|4|||
125010490|NCT01358760|449663746|FG002|Overall Study|Adverse Event|3|||
125010491|NCT01358760|449663744|FG000|Overall Study|Lost to Follow-up|1|||
125010492|NCT01358760|449663745|FG001|Overall Study|Lost to Follow-up|1|||
125010493|NCT01358760|449663746|FG002|Overall Study|Lost to Follow-up|3|||
125010494|NCT01358760|449663744|FG000|Overall Study|Withdrawal by Subject|5|||
125010495|NCT01358760|449663745|FG001|Overall Study|Withdrawal by Subject|3|||
125010496|NCT01358760|449663746|FG002|Overall Study|Withdrawal by Subject|2|||
125010497|NCT01358760|449663744|FG000|Overall Study|Physician Decision|1|||
125010498|NCT01358760|449663745|FG001|Overall Study|Physician Decision|0|||
125010499|NCT01358760|449663746|FG002|Overall Study|Physician Decision|1|||
125010500|NCT01358760|449663744|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
125010501|NCT01358760|449663745|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
125010502|NCT01358760|449663746|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
125010503|NCT01506960|449663747|FG000|Overall Study|Did not meet angiographic criteria|47|||
125010504|NCT02321930|449663752|FG000|Overall Study|Lost to Follow-up|1|||
125010505|NCT01293968|449663753|FG000|Overall Study|non-cooperation|3|||
125010506|NCT01293968|449663754|FG001|Overall Study|non-cooperation|3|||
125010507|NCT00853749|449663755|FG000|Overall Study|Lost to Follow-up|0|||
125010508|NCT00853749|449663756|FG001|Overall Study|Lost to Follow-up|1|||
125010509|NCT01392677|449663757|FG000|Overall Study|Adverse Event|3|||
125010510|NCT01392677|449663758|FG001|Overall Study|Adverse Event|1|||
125010511|NCT01392677|449663757|FG000|Overall Study|Withdrawal by Subject|0|||
125010512|NCT01392677|449663758|FG001|Overall Study|Withdrawal by Subject|2|||
124874263|NCT00514683|449162029|FG003|Overall Study|Not treated|0|||
124874264|NCT00514683|449162030|FG004|Overall Study|Not treated|1|||
124874265|NCT00514683|449162026|FG000|Overall Study|Adverse Event|21|||
124874266|NCT00514683|449162027|FG001|Overall Study|Adverse Event|20|||
124874267|NCT00514683|449162028|FG002|Overall Study|Adverse Event|15|||
124874268|NCT00514683|449162029|FG003|Overall Study|Adverse Event|13|||
124874269|NCT00514683|449162030|FG004|Overall Study|Adverse Event|27|||
124874270|NCT00514683|449162026|FG000|Overall Study|Protocol Violation|1|||
125010513|NCT01392677|449663757|FG000|Overall Study|Incorrect enrollment|2|||
125010514|NCT01392677|449663758|FG001|Overall Study|Incorrect enrollment|3|||
125010515|NCT01392677|449663757|FG000|Overall Study|Other reason|3|||
125010516|NCT01392677|449663758|FG001|Overall Study|Other reason|2|||
125010517|NCT00736255|449665059|FG000|Overall Study|Adverse Event|1|||
125010518|NCT00736255|449665060|FG001|Overall Study|Adverse Event|0|||
125010519|NCT00736255|449665059|FG000|Overall Study|Physician Decision|1|||
125010520|NCT00736255|449665060|FG001|Overall Study|Physician Decision|0|||
125010521|NCT00736255|449665059|FG000|Overall Study|Non-compliance|1|||
125010522|NCT00736255|449665060|FG001|Overall Study|Non-compliance|1|||
125010523|NCT00840086|449665065|FG000|Overall Study|Adverse Event|1|||
125010524|NCT00840086|449665065|FG000|Overall Study|Protocol Violation|2|||
125010525|NCT00840086|449665065|FG000|Overall Study|Lost to Follow-up|1|||
125010526|NCT03332498|449665066|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
125010527|NCT03332498|449665067|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
125010528|NCT03332498|449665068|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
125010529|NCT01566773|449665069|FG000|Overall Study|Protocol specified criteria|4|||
125010530|NCT01566773|449665069|FG000|Overall Study|Protocol Violation|4|||
125010531|NCT01566773|449665069|FG000|Overall Study|Withdrawal by Subject|9|||
125010532|NCT01566773|449665069|FG000|Overall Study|Administrative reason|1|||
125010533|NCT01566773|449665069|FG000|Overall Study|Adverse Event|10|||
125010534|NCT01566773|449665069|FG000|Overall Study|Physician Decision|2|||
125010535|NCT04036708|449665070|FG000|Overall Study|Lost to Follow-up|14|||
125010536|NCT04036708|449665071|FG001|Overall Study|Lost to Follow-up|4|||
125010537|NCT04036708|449665072|FG002|Overall Study|Lost to Follow-up|14|||
125010538|NCT04036708|449665073|FG003|Overall Study|Lost to Follow-up|4|||
125010539|NCT01033734|449665074|FG000|Overall Study|Withdrawal by Subject|1|||
125010540|NCT01444742|449665077|FG000|Overall Study|Death|1|||
125010541|NCT02535715|449665078|FG000|Overall Study|Withdrawal by Subject|0|||
125010542|NCT02535715|449665079|FG001|Overall Study|Withdrawal by Subject|0|||
125010543|NCT02535715|449665080|FG002|Overall Study|Withdrawal by Subject|1|||
125010544|NCT00909181|449665081|FG000|Overall Study|Lost to Follow-up|39|||
125010545|NCT00909181|449665082|FG001|Overall Study|Lost to Follow-up|18|||
125010546|NCT00909181|449665083|FG002|Overall Study|Lost to Follow-up|33|||
125010547|NCT02349048|449665085|FG000|Overall Study|Withdrawal by Subject|4|||
125010548|NCT02349048|449665086|FG001|Overall Study|Withdrawal by Subject|0|||
125010549|NCT02349048|449665085|FG000|Overall Study|Lost to Follow-up|1|||
125010550|NCT02349048|449665086|FG001|Overall Study|Lost to Follow-up|0|||
125010551|NCT00094770|449665089|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
125010552|NCT00094770|449665090|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
125010553|NCT00094770|449665089|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
125010554|NCT00094770|449665090|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
125010555|NCT00094770|449665089|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
125010556|NCT00094770|449665090|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
125010557|NCT00094770|449665089|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
125010558|NCT00094770|449665090|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
125010559|NCT00094770|449665089|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
125010560|NCT00094770|449665090|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
125010561|NCT00094770|449665089|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
125010562|NCT00094770|449665090|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
125010563|NCT00094770|449665089|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
125010564|NCT00094770|449665090|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
125010565|NCT00094770|449665089|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
125010566|NCT00094770|449665090|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
125010567|NCT00094770|449665089|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
125010568|NCT00094770|449665090|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
125010569|NCT00094770|449665089|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
125010570|NCT00094770|449665090|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
125010571|NCT00094770|449665089|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
125010572|NCT00094770|449665090|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
125010573|NCT00094770|449665089|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
125010574|NCT00094770|449665090|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
124874271|NCT00514683|449162027|FG001|Overall Study|Protocol Violation|1|||
124874272|NCT00514683|449162028|FG002|Overall Study|Protocol Violation|0|||
124874273|NCT00514683|449162029|FG003|Overall Study|Protocol Violation|1|||
124874274|NCT00514683|449162030|FG004|Overall Study|Protocol Violation|0|||
125010575|NCT00094770|449665089|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
125010576|NCT00094770|449665090|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
124874275|NCT00514683|449162026|FG000|Overall Study|Withdrawal by Subject|2|||
124874276|NCT00514683|449162027|FG001|Overall Study|Withdrawal by Subject|2|||
124874277|NCT00514683|449162028|FG002|Overall Study|Withdrawal by Subject|1|||
124874278|NCT00514683|449162029|FG003|Overall Study|Withdrawal by Subject|0|||
124874279|NCT00514683|449162030|FG004|Overall Study|Withdrawal by Subject|4|||
124874280|NCT00514683|449162026|FG000|Overall Study|Reason other than listed above|0|||
124874281|NCT00514683|449162027|FG001|Overall Study|Reason other than listed above|1|||
124874282|NCT00514683|449162028|FG002|Overall Study|Reason other than listed above|2|||
124874283|NCT00514683|449162029|FG003|Overall Study|Reason other than listed above|0|||
124874284|NCT00514683|449162030|FG004|Overall Study|Reason other than listed above|1|||
124874285|NCT02736825|449162031|FG000|Overall Study|Lost to Follow-up|10|||
124874286|NCT02736825|449162032|FG001|Overall Study|Lost to Follow-up|11|||
124874287|NCT02736825|449162031|FG000|Overall Study|Early Termination|0|||
124874288|NCT02736825|449162032|FG001|Overall Study|Early Termination|1|||
124874289|NCT00790452|449162034|FG000|Overall Study|Drug supply issue|1|||
124874290|NCT00790452|449162035|FG001|Overall Study|Drug supply issue|0|||
124874291|NCT01564368|449162036|FG000|Overall Study|Ineligible|18|||
124874292|NCT01564368|449162036|FG000|Overall Study|Not Randomized in Parent study|116|||
124874293|NCT01564368|449162036|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
124874294|NCT01564368|449162036|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
124874295|NCT01373931|449162039|FG000|Lead-in Period|Adverse Event|2|||
124874296|NCT01373931|449162040|FG001|Lead-in Period|Adverse Event|0|||
124874297|NCT01373931|449162039|FG000|Period 1|Adverse Event|2|||
124874298|NCT01373931|449162040|FG001|Period 1|Adverse Event|0|||
124874299|NCT01373931|449162039|FG000|Period 1|Withdrawal by Subject|0|||
124874300|NCT01373931|449162040|FG001|Period 1|Withdrawal by Subject|2|||
124874301|NCT04857034|449162041|FG000|Placebo-Controlled Period|Request to discontinue|2|||
124874302|NCT04857034|449162042|FG001|Placebo-Controlled Period|Request to discontinue|2|||
124874303|NCT04857034|449162043|FG002|Placebo-Controlled Period|Request to discontinue|0|||
124874304|NCT04857034|449162044|FG003|Placebo-Controlled Period|Request to discontinue|0|||
124874305|NCT04857034|449162045|FG004|Placebo-Controlled Period|Request to discontinue|0|||
124874306|NCT04857034|449162041|FG000|Placebo-Controlled Period|withdrew consent|1|||
124874307|NCT04857034|449162042|FG001|Placebo-Controlled Period|withdrew consent|1|||
124874308|NCT04857034|449162043|FG002|Placebo-Controlled Period|withdrew consent|2|||
124874309|NCT04857034|449162044|FG003|Placebo-Controlled Period|withdrew consent|0|||
124874310|NCT04857034|449162045|FG004|Placebo-Controlled Period|withdrew consent|0|||
124874311|NCT04857034|449162041|FG000|Placebo-Controlled Period|Pregnancy|1|||
124874312|NCT04857034|449162042|FG001|Placebo-Controlled Period|Pregnancy|1|||
124874313|NCT04857034|449162043|FG002|Placebo-Controlled Period|Pregnancy|0|||
124874314|NCT04857034|449162044|FG003|Placebo-Controlled Period|Pregnancy|0|||
124874315|NCT04857034|449162045|FG004|Placebo-Controlled Period|Pregnancy|0|||
124874316|NCT04857034|449162041|FG000|Placebo-Controlled Period|Ongoing study period|0|||
124874317|NCT04857034|449162042|FG001|Placebo-Controlled Period|Ongoing study period|1|||
124874318|NCT04857034|449162043|FG002|Placebo-Controlled Period|Ongoing study period|0|||
124874319|NCT04857034|449162044|FG003|Placebo-Controlled Period|Ongoing study period|0|||
124874320|NCT04857034|449162045|FG004|Placebo-Controlled Period|Ongoing study period|0|||
124874321|NCT04857034|449162041|FG000|Active Treatment Period|Lack of Efficacy|1|||
124874322|NCT04857034|449162042|FG001|Active Treatment Period|Lack of Efficacy|0|||
124874323|NCT04857034|449162043|FG002|Active Treatment Period|Lack of Efficacy|0|||
124874324|NCT04857034|449162044|FG003|Active Treatment Period|Lack of Efficacy|0|||
124874325|NCT04857034|449162045|FG004|Active Treatment Period|Lack of Efficacy|0|||
124874326|NCT04857034|449162041|FG000|Active Treatment Period|request to discontinue|0|||
124874327|NCT04857034|449162042|FG001|Active Treatment Period|request to discontinue|1|||
124874328|NCT04857034|449162043|FG002|Active Treatment Period|request to discontinue|0|||
124874329|NCT04857034|449162044|FG003|Active Treatment Period|request to discontinue|1|||
124874330|NCT04857034|449162045|FG004|Active Treatment Period|request to discontinue|0|||
124874331|NCT04857034|449162041|FG000|Active Treatment Period|administrative reason by sponsor|1|||
124874332|NCT04857034|449162042|FG001|Active Treatment Period|administrative reason by sponsor|5|||
125010577|NCT00094770|449665089|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
125010578|NCT00094770|449665090|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
124874333|NCT04857034|449162043|FG002|Active Treatment Period|administrative reason by sponsor|0|||
124874334|NCT04857034|449162044|FG003|Active Treatment Period|administrative reason by sponsor|2|||
124874335|NCT04857034|449162045|FG004|Active Treatment Period|administrative reason by sponsor|2|||
124874336|NCT04857034|449162041|FG000|Active Treatment Period|other reasons|1|||
124874337|NCT04857034|449162042|FG001|Active Treatment Period|other reasons|1|||
124874338|NCT04857034|449162043|FG002|Active Treatment Period|other reasons|0|||
124874339|NCT04857034|449162044|FG003|Active Treatment Period|other reasons|0|||
124874340|NCT04857034|449162045|FG004|Active Treatment Period|other reasons|1|||
124874341|NCT04857034|449162041|FG000|Active Treatment Period|Ongoing Study Period|2|||
124874342|NCT04857034|449162042|FG001|Active Treatment Period|Ongoing Study Period|4|||
124874343|NCT04857034|449162043|FG002|Active Treatment Period|Ongoing Study Period|0|||
124874344|NCT04857034|449162044|FG003|Active Treatment Period|Ongoing Study Period|1|||
124874345|NCT04857034|449162045|FG004|Active Treatment Period|Ongoing Study Period|0|||
124874346|NCT02940574|449162046|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
124874347|NCT02940574|449162047|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
124874348|NCT02940574|449162046|FG000|1-year Follow-up|Lost to Follow-up|3|||
124874349|NCT02940574|449162047|FG001|1-year Follow-up|Lost to Follow-up|4|||
124874350|NCT00387894|449162048|FG000|Overall Study|Withdrawal by Subject|1|||
124874351|NCT00659490|449162049|FG000|Overall Study|Lost to Follow-up|2|||
124874352|NCT00659490|449162050|FG001|Overall Study|Lost to Follow-up|0|||
124874353|NCT00659490|449162051|FG002|Overall Study|Lost to Follow-up|1|||
124874354|NCT00827541|449162056|FG000|Overall Study|Exitus|1|||
124874355|NCT00827541|449162057|FG001|Overall Study|Exitus|8|||
124874356|NCT00827541|449162056|FG000|Overall Study|Other|1|||
124874357|NCT00827541|449162057|FG001|Overall Study|Other|3|||
124874358|NCT00827541|449162056|FG000|Overall Study|Pathogen not susceptible|1|||
124874359|NCT00827541|449162057|FG001|Overall Study|Pathogen not susceptible|0|||
124874360|NCT00827541|449162056|FG000|Overall Study|Lack of effectiveness|1|||
124874361|NCT00827541|449162057|FG001|Overall Study|Lack of effectiveness|0|||
124874362|NCT00520975|449162058|FG000|Overall Study|Disease progression|31|||
124874363|NCT00520975|449162059|FG001|Overall Study|Disease progression|23|||
124874364|NCT00520975|449162058|FG000|Overall Study|Adverse Event|7|||
124874365|NCT00520975|449162059|FG001|Overall Study|Adverse Event|10|||
124874366|NCT00520975|449162058|FG000|Overall Study|Death|0|||
124874367|NCT00520975|449162059|FG001|Overall Study|Death|2|||
124874368|NCT00520975|449162058|FG000|Overall Study|Withdrawal by Subject|3|||
124874369|NCT00520975|449162059|FG001|Overall Study|Withdrawal by Subject|5|||
124874370|NCT00520975|449162058|FG000|Overall Study|Other therapy|2|||
124874371|NCT00520975|449162059|FG001|Overall Study|Other therapy|4|||
124874372|NCT00520975|449162058|FG000|Overall Study|Other reasons|4|||
125098467|NCT01195662|449980260|FG001|Double Blind Treatment Period|Administrative reason|1|||
125098468|NCT01195662|449980261|FG002|Double Blind Treatment Period|Administrative reason|1|||
125098469|NCT01195662|449980259|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
125098470|NCT01195662|449980260|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
125098471|NCT01195662|449980261|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
125098472|NCT01195662|449980259|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
125098473|NCT01195662|449980260|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
125098474|NCT01195662|449980261|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
125098475|NCT01195662|449980259|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
125098476|NCT01195662|449980260|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
125098477|NCT01195662|449980261|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
125010579|NCT00094770|449665089|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
125010580|NCT00094770|449665090|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
125010581|NCT00094770|449665089|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
125010582|NCT00094770|449665090|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
125010583|NCT00094770|449665089|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
125010584|NCT00094770|449665090|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
125010585|NCT00094770|449665089|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
125010586|NCT00094770|449665090|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
125010587|NCT00914927|449665091|FG000|Overall Study|Adverse Event|0|||
125010588|NCT00914927|449665092|FG001|Overall Study|Adverse Event|0|||
125010589|NCT00914927|449665093|FG002|Overall Study|Adverse Event|0|||
125010590|NCT00914927|449665094|FG003|Overall Study|Adverse Event|0|||
125010591|NCT00914927|449665095|FG004|Overall Study|Adverse Event|1|||
125010592|NCT00914927|449665096|FG005|Overall Study|Adverse Event|0|||
125010593|NCT00914927|449665097|FG006|Overall Study|Adverse Event|0|||
125010594|NCT00914927|449665091|FG000|Overall Study|Withdrawal by Subject|0|||
125010595|NCT00914927|449665092|FG001|Overall Study|Withdrawal by Subject|1|||
125010596|NCT00914927|449665093|FG002|Overall Study|Withdrawal by Subject|0|||
125010597|NCT00914927|449665094|FG003|Overall Study|Withdrawal by Subject|1|||
125010598|NCT00914927|449665095|FG004|Overall Study|Withdrawal by Subject|0|||
125010599|NCT00914927|449665096|FG005|Overall Study|Withdrawal by Subject|0|||
125010600|NCT00914927|449665097|FG006|Overall Study|Withdrawal by Subject|0|||
125010601|NCT00914927|449665091|FG000|Overall Study|Lost to Follow-up|0|||
125010602|NCT00914927|449665092|FG001|Overall Study|Lost to Follow-up|0|||
125010603|NCT00914927|449665093|FG002|Overall Study|Lost to Follow-up|0|||
125010604|NCT00914927|449665094|FG003|Overall Study|Lost to Follow-up|1|||
125098478|NCT01195662|449980259|FG000|Double Blind Treatment Period|Non-specified|3|||
124874373|NCT00520975|449162059|FG001|Overall Study|Other reasons|2|||
124874374|NCT00520975|449162058|FG000|Overall Study|Not start protocol therapy|1|||
124874375|NCT00520975|449162059|FG001|Overall Study|Not start protocol therapy|2|||
124874376|NCT04810221|449162060|FG000|Overall Study|Physician Decision|3|||
124874377|NCT03642938|449162061|FG000|Overall Study|Withdrawal by Subject|0|||
124874378|NCT03642938|449162062|FG001|Overall Study|Withdrawal by Subject|0|||
125010605|NCT00914927|449665095|FG004|Overall Study|Lost to Follow-up|0|||
125010606|NCT00914927|449665096|FG005|Overall Study|Lost to Follow-up|0|||
125010607|NCT00914927|449665097|FG006|Overall Study|Lost to Follow-up|0|||
124874379|NCT03642938|449162063|FG002|Overall Study|Withdrawal by Subject|0|||
124874380|NCT03642938|449162064|FG003|Overall Study|Withdrawal by Subject|1|||
124874381|NCT00105235|449162065|FG000|Overall Study|Death|4|||
124874382|NCT00105235|449162065|FG000|Overall Study|Physician Decision|1|||
124874383|NCT00105235|449162065|FG000|Overall Study|Withdrawal by Subject|2|||
124874384|NCT01964326|449162066|FG000|Overall Study|Adverse Event|48|||
124874385|NCT01964326|449162066|FG000|Overall Study|Death|2|||
124874386|NCT01964326|449162066|FG000|Overall Study|Protocol Violation|4|||
124874387|NCT01964326|449162066|FG000|Overall Study|Lost to Follow-up|88|||
124874388|NCT01964326|449162066|FG000|Overall Study|Withdrawal by Subject|87|||
124874389|NCT01964326|449162066|FG000|Overall Study|Pregnancy|1|||
124874390|NCT01964326|449162066|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
124874391|NCT01964326|449162066|FG000|Overall Study|Physician Decision|55|||
124874392|NCT01964326|449162066|FG000|Overall Study|Investigator Discretion|1|||
124874393|NCT01964326|449162066|FG000|Overall Study|Other|9|||
124874394|NCT01964326|449162066|FG000|Overall Study|Did not meet eligibility criteria|1|||
124874395|NCT01995539|449162067|FG000|Overall Study|Screening Failure|1|||
124874396|NCT01995539|449162067|FG000|Overall Study|Withdrawal by Investigator|15|||
124874397|NCT01995539|449162067|FG000|Overall Study|Withdrawal by Subject|11|||
124874398|NCT01995539|449162067|FG000|Overall Study|Lost to Follow-up|5|||
124874399|NCT01995539|449162067|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
124874400|NCT00261495|449162068|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
124874401|NCT00261495|449162069|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
124874402|NCT00261495|449162068|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
124874403|NCT00261495|449162069|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
124874404|NCT00261495|449162068|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
124874405|NCT00261495|449162069|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
124874406|NCT00261495|449162068|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
124874407|NCT00261495|449162069|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
124874408|NCT00261495|449162068|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
124874409|NCT00261495|449162069|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
124874410|NCT00261495|449162068|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
124874411|NCT00261495|449162069|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
124874412|NCT00261495|449162068|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
124874413|NCT00261495|449162069|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
124874414|NCT00261495|449162068|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
124874415|NCT00261495|449162069|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
124874416|NCT00261495|449162068|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
124874417|NCT00261495|449162069|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
124874418|NCT00261495|449162068|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
124874419|NCT00261495|449162069|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
124874420|NCT00261495|449162068|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
124874421|NCT00261495|449162069|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
124874422|NCT00261495|449162068|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
124874423|NCT00261495|449162069|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
124874424|NCT00261495|449162068|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
124874425|NCT00261495|449162069|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
124874426|NCT00261495|449162068|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
124874427|NCT00261495|449162069|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
124874428|NCT00261495|449162068|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
124874429|NCT00261495|449162069|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
124874430|NCT00261495|449162068|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
124874431|NCT00261495|449162069|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
124874432|NCT00261495|449162068|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
124874433|NCT00261495|449162069|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
124874434|NCT00261495|449162068|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
124874435|NCT00261495|449162069|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
124874436|NCT00261495|449162068|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
124874437|NCT00261495|449162069|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
124874438|NCT00261495|449162068|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
124874439|NCT00261495|449162069|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
124874440|NCT00261495|449162068|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
124874441|NCT00261495|449162069|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
124874442|NCT03953898|449162072|FG000|Overall Study|Lack of Efficacy|8|||
125010608|NCT00914927|449665091|FG000|Overall Study|Administrative/Other|2|||
125010609|NCT00914927|449665092|FG001|Overall Study|Administrative/Other|1|||
125010610|NCT00914927|449665093|FG002|Overall Study|Administrative/Other|0|||
124874443|NCT03953898|449162072|FG000|Overall Study|Death|3|||
125010611|NCT00914927|449665094|FG003|Overall Study|Administrative/Other|0|||
124874444|NCT03953898|449162072|FG000|Overall Study|Withdrawal by Subject|2|||
124874445|NCT03953898|449162072|FG000|Overall Study|Adverse Event|1|||
124874446|NCT01932697|449162073|FG000|Overall Study|Received a different amount of tx|1|||
124874447|NCT01932697|449162074|FG001|Overall Study|Received a different amount of tx|0|||
124874448|NCT01932697|449162073|FG000|Overall Study|Ineligible|1|||
124874449|NCT01932697|449162074|FG001|Overall Study|Ineligible|0|||
124874450|NCT01119768|449162075|FG000|Treatment Period|Lack of Efficacy|18|||
124874451|NCT01119768|449162076|FG001|Treatment Period|Lack of Efficacy|25|||
124874452|NCT01059643|449162077|FG000|Overall Study|Adverse Event|3|||
124874453|NCT01059643|449162077|FG000|Overall Study|Withdrawal by Subject|2|||
124874454|NCT01059643|449162077|FG000|Overall Study|Physician Decision|1|||
124874455|NCT00643123|449162084|FG000|Overall Study|Lost to Follow-up|4|||
124874456|NCT00643123|449162085|FG001|Overall Study|Lost to Follow-up|0|||
124874457|NCT00643123|449162084|FG000|Overall Study|Withdrawal by Subject|1|||
124874458|NCT00643123|449162085|FG001|Overall Study|Withdrawal by Subject|1|||
124874459|NCT02923739|449162086|FG000|Overall Study|Withdrawal by Subject|2|||
124874460|NCT02923739|449162087|FG001|Overall Study|Withdrawal by Subject|0|||
124874461|NCT02923739|449162088|FG002|Overall Study|Withdrawal by Subject|0|||
124874462|NCT02923739|449162089|FG003|Overall Study|Withdrawal by Subject|0|||
124874463|NCT02923739|449162086|FG000|Overall Study|Failed Screening|3|||
124874464|NCT02923739|449162087|FG001|Overall Study|Failed Screening|0|||
124874465|NCT02923739|449162088|FG002|Overall Study|Failed Screening|0|||
124874466|NCT02923739|449162089|FG003|Overall Study|Failed Screening|0|||
124874467|NCT01059630|449162094|FG000|Overall Study|Death|100|||
124874468|NCT01059630|449162095|FG001|Overall Study|Death|84|||
124874469|NCT01059630|449162094|FG000|Overall Study|Lost to Follow-up|4|||
124874470|NCT01059630|449162095|FG001|Overall Study|Lost to Follow-up|1|||
124874471|NCT01059630|449162094|FG000|Overall Study|Physician Decision|2|||
124874472|NCT01059630|449162095|FG001|Overall Study|Physician Decision|4|||
124874473|NCT01059630|449162094|FG000|Overall Study|Withdrawal by Subject|21|||
124874474|NCT01059630|449162095|FG001|Overall Study|Withdrawal by Subject|14|||
124874475|NCT00763958|449162098|FG000|Overall Study|did not meet final criteria|4|||
124874476|NCT00763958|449162099|FG001|Overall Study|did not meet final criteria|4|||
124874477|NCT00763958|449162098|FG000|Overall Study|Lost to Follow-up|10|||
124874478|NCT00763958|449162099|FG001|Overall Study|Lost to Follow-up|2|||
124874479|NCT00763958|449162098|FG000|Overall Study|Believed they were receiving placebo|0|||
124874480|NCT00763958|449162099|FG001|Overall Study|Believed they were receiving placebo|5|||
124874481|NCT04681729|449162100|FG000|Overall Study|Lack of Efficacy|2|||
124874482|NCT04681729|449162101|FG001|Overall Study|Lack of Efficacy|2|||
124874483|NCT04681729|449162100|FG000|Overall Study|Withdrawal by Subject|8|||
124874484|NCT04681729|449162101|FG001|Overall Study|Withdrawal by Subject|9|||
124874485|NCT02535364|449162103|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
124874486|NCT02535364|449162103|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
124874487|NCT02535364|449162103|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
124874488|NCT02535364|449162103|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
124874489|NCT02535364|449162103|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
124874490|NCT02535364|449162103|FG000|Part B Screening|Death|2|||
124874491|NCT02535364|449162103|FG000|Part B Screening|Physician Decision|1|||
124874492|NCT02535364|449162103|FG000|Part B Screening|Withdrawal by Subject|1|||
124874493|NCT02535364|449162103|FG000|Part B Screening|Adverse Event|1|||
124874494|NCT02535364|449162103|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
124874495|NCT02535364|449162103|FG000|Study Treatment|Death|1|||
124874496|NCT02535364|449162103|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
124874497|NCT02535364|449162103|FG000|12-Month Follow-up Period|Disease progression|22|||
124874498|NCT02535364|449162103|FG000|12-Month Follow-up Period|Death|5|||
124874499|NCT02535364|449162103|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
124874500|NCT02535364|449162103|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
124874501|NCT02535364|449162103|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
124874502|NCT04766086|449162106|FG000|Overall Study|Lost to Follow-up|3|||
124874503|NCT04766086|449162107|FG001|Overall Study|Lost to Follow-up|5|||
124874504|NCT04766086|449162108|FG002|Overall Study|Lost to Follow-up|3|||
124874505|NCT04766086|449162106|FG000|Overall Study|Withdrawal by Subject|1|||
124874506|NCT04766086|449162107|FG001|Overall Study|Withdrawal by Subject|1|||
124874507|NCT04766086|449162108|FG002|Overall Study|Withdrawal by Subject|2|||
124874508|NCT04766086|449162106|FG000|Overall Study|Other|0|||
124874509|NCT04766086|449162107|FG001|Overall Study|Other|0|||
125010612|NCT00914927|449665095|FG004|Overall Study|Administrative/Other|1|||
124874510|NCT04766086|449162108|FG002|Overall Study|Other|1|||
125010613|NCT00914927|449665096|FG005|Overall Study|Administrative/Other|0|||
124874511|NCT02496767|449162120|FG000|Open-label Lead-in Phase|Adverse Event|176|||
124874512|NCT02496767|449162121|FG001|Open-label Lead-in Phase|Adverse Event|0|||
124874513|NCT02496767|449162122|FG002|Open-label Lead-in Phase|Adverse Event|0|||
124874514|NCT02496767|449162123|FG003|Open-label Lead-in Phase|Adverse Event|0|||
124874515|NCT02496767|449162124|FG004|Open-label Lead-in Phase|Adverse Event|0|||
124874516|NCT02496767|449162125|FG005|Open-label Lead-in Phase|Adverse Event|0|||
124874517|NCT02496767|449162126|FG006|Open-label Lead-in Phase|Adverse Event|0|||
124874518|NCT02496767|449162127|FG007|Open-label Lead-in Phase|Adverse Event|0|||
124874519|NCT02496767|449162120|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
124874520|NCT02496767|449162121|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
124874521|NCT02496767|449162122|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
124874522|NCT02496767|449162123|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
124874523|NCT02496767|449162124|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
124874524|NCT02496767|449162125|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
124874525|NCT02496767|449162126|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
124874526|NCT02496767|449162127|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
124874527|NCT02496767|449162120|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
124874528|NCT02496767|449162121|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
124874529|NCT02496767|449162122|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
124874530|NCT02496767|449162123|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
124874531|NCT02496767|449162124|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
124874532|NCT02496767|449162125|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
124874533|NCT02496767|449162126|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
124874534|NCT02496767|449162127|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
124874535|NCT02496767|449162120|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
124874536|NCT02496767|449162121|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
124874537|NCT02496767|449162122|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
124874538|NCT02496767|449162123|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
124874539|NCT02496767|449162124|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
124874540|NCT02496767|449162125|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
124874541|NCT02496767|449162126|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
124874542|NCT02496767|449162127|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
124874543|NCT02496767|449162120|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
124874544|NCT02496767|449162121|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
124874545|NCT02496767|449162122|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
124874546|NCT02496767|449162123|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
124874547|NCT02496767|449162124|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
124874548|NCT02496767|449162125|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
124874549|NCT02496767|449162126|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
124874550|NCT02496767|449162127|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
124874551|NCT02496767|449162120|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
124874552|NCT02496767|449162121|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
124874553|NCT02496767|449162122|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
124874554|NCT02496767|449162123|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
124874555|NCT02496767|449162124|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
124874556|NCT02496767|449162125|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
124874557|NCT02496767|449162126|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
124874558|NCT02496767|449162127|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
124874559|NCT02496767|449162120|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
124874560|NCT02496767|449162121|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
124874561|NCT02496767|449162122|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
124874562|NCT02496767|449162123|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
124874563|NCT02496767|449162124|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
124874564|NCT02496767|449162125|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
124874565|NCT02496767|449162126|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
124874566|NCT02496767|449162127|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
124874567|NCT02496767|449162120|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
124874568|NCT02496767|449162121|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
124874569|NCT02496767|449162122|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
124874570|NCT02496767|449162123|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
124874571|NCT02496767|449162124|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
124874572|NCT02496767|449162125|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
124874573|NCT02496767|449162126|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
124874574|NCT02496767|449162127|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
124874575|NCT02496767|449162120|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
125010614|NCT00914927|449665097|FG006|Overall Study|Administrative/Other|0|||
125010615|NCT01648790|449665098|FG000|Treatment 3|Withdrawal by Subject|0|||
125010616|NCT01648790|449665099|FG001|Treatment 3|Withdrawal by Subject|0|||
125010617|NCT01648790|449665100|FG002|Treatment 3|Withdrawal by Subject|0|||
125010618|NCT01648790|449665101|FG003|Treatment 3|Withdrawal by Subject|1|||
125010619|NCT01648790|449665102|FG004|Treatment 3|Withdrawal by Subject|0|||
125010620|NCT03370120|449665105|FG000|Overall Study|Adverse event, non-fatal|24|||
124874576|NCT02496767|449162121|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
124874577|NCT02496767|449162122|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
124874578|NCT02496767|449162123|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
124874579|NCT02496767|449162124|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
124874580|NCT02496767|449162125|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
124874581|NCT02496767|449162126|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
124874582|NCT02496767|449162127|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
124874583|NCT02496767|449162120|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
124874584|NCT02496767|449162121|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
124874585|NCT02496767|449162122|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
124874586|NCT02496767|449162123|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
124874587|NCT02496767|449162124|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
124874588|NCT02496767|449162125|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
124874589|NCT02496767|449162126|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
124874590|NCT02496767|449162127|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
124874591|NCT02496767|449162120|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
124874592|NCT02496767|449162121|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
124874593|NCT02496767|449162122|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
124874594|NCT02496767|449162123|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
124874595|NCT02496767|449162124|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
124874596|NCT02496767|449162125|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
124874597|NCT02496767|449162126|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
124874598|NCT02496767|449162127|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
124874599|NCT02496767|449162120|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
124874600|NCT02496767|449162121|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
124874601|NCT02496767|449162122|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
124874602|NCT02496767|449162123|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
124874603|NCT02496767|449162124|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
124874604|NCT02496767|449162125|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
124874605|NCT02496767|449162126|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
124874606|NCT02496767|449162127|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
124874607|NCT02496767|449162120|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
124874608|NCT02496767|449162121|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
124874609|NCT02496767|449162122|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
124874610|NCT02496767|449162123|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
124874611|NCT02496767|449162124|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
124874612|NCT02496767|449162125|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
124874613|NCT02496767|449162126|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
124874614|NCT02496767|449162127|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
124874615|NCT02496767|449162120|FG000|Double-blind, Withdrawal Phase|Death|0|||
124874616|NCT02496767|449162121|FG001|Double-blind, Withdrawal Phase|Death|0|||
124874617|NCT02496767|449162122|FG002|Double-blind, Withdrawal Phase|Death|0|||
124874618|NCT02496767|449162123|FG003|Double-blind, Withdrawal Phase|Death|0|||
124874619|NCT02496767|449162124|FG004|Double-blind, Withdrawal Phase|Death|0|||
124874620|NCT02496767|449162125|FG005|Double-blind, Withdrawal Phase|Death|0|||
124874621|NCT02496767|449162126|FG006|Double-blind, Withdrawal Phase|Death|1|||
124874622|NCT02496767|449162127|FG007|Double-blind, Withdrawal Phase|Death|2|||
124874623|NCT02496767|449162120|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
124874624|NCT02496767|449162121|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
124874625|NCT02496767|449162122|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
124874626|NCT02496767|449162123|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
124874627|NCT02496767|449162124|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
124874628|NCT02496767|449162125|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
124874629|NCT02496767|449162126|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
124874630|NCT02496767|449162127|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
125010621|NCT03370120|449665105|FG000|Overall Study|Withdrawal by Subject|6|||
125010622|NCT03370120|449665105|FG000|Overall Study|Lost to Follow-up|1|||
125010623|NCT03370120|449665105|FG000|Overall Study|Lack of Efficacy|37|||
125010624|NCT03370120|449665105|FG000|Overall Study|Per sponsor's instructions|1|||
125010625|NCT03370120|449665105|FG000|Overall Study|Study was terminated by parent company UCB|2|||
125010626|NCT03370120|449665105|FG000|Overall Study|The study was ended by the promoter|3|||
125010627|NCT03370120|449665105|FG000|Overall Study|Discontinuation of drug development|3|||
125010628|NCT03370120|449665105|FG000|Overall Study|End of project|2|||
125010629|NCT03370120|449665105|FG000|Overall Study|Premature study closure|2|||
125010630|NCT03370120|449665105|FG000|Overall Study|Premature program termination|1|||
125010631|NCT03370120|449665105|FG000|Overall Study|Premature study termination|7|||
125010632|NCT03370120|449665105|FG000|Overall Study|Trial terminated by sponsor|2|||
125010633|NCT03370120|449665105|FG000|Overall Study|Trial discontinued by sponsor|2|||
125010634|NCT03370120|449665105|FG000|Overall Study|Study ended|15|||
124874631|NCT02889133|449162128|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
124874632|NCT02889133|449162129|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
124874633|NCT02889133|449162128|FG000|Completed Primary Outcome|Manufacturing error|3|||
124874634|NCT02889133|449162129|FG001|Completed Primary Outcome|Manufacturing error|8|||
124874635|NCT02889133|449162128|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
124874636|NCT02889133|449162129|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
124874637|NCT02889133|449162128|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
124874638|NCT02889133|449162129|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
124874639|NCT02889133|449162128|FG000|Completed Primary Outcome|Protocol Violation|1|||
124874640|NCT02889133|449162129|FG001|Completed Primary Outcome|Protocol Violation|0|||
124874641|NCT02889133|449162128|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
124874642|NCT02889133|449162129|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
124874643|NCT02889133|449162128|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
124874644|NCT02889133|449162129|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
124874645|NCT02889133|449162128|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
124874646|NCT02889133|449162129|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
124874647|NCT02889133|449162128|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
124874648|NCT02889133|449162129|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
124874649|NCT02889133|449162128|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
124874650|NCT02889133|449162129|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
124874651|NCT05687032|449162130|FG000|Treatment Phase|Adverse Event|13|||
124874652|NCT05687032|449162130|FG000|Treatment Phase|Death|1|||
124874653|NCT05687032|449162130|FG000|Treatment Phase|Physician Decision|3|||
124874654|NCT05687032|449162130|FG000|Treatment Phase|Progressive disease|9|||
124874655|NCT05687032|449162130|FG000|Treatment Phase|Withdrawal by Subject|5|||
124874656|NCT05687032|449162130|FG000|Follow-Up Phase|Death|16|||
124874657|NCT05687032|449162130|FG000|Follow-Up Phase|Ongoing|26|||
124874658|NCT05479604|449162133|FG000|Overall Study|Lost to Follow-up|1|||
124874659|NCT05479604|449162134|FG001|Overall Study|Lost to Follow-up|5|||
124874660|NCT01678131|449162139|FG000|Overall Study|Adverse Event|0|||
124874661|NCT01678131|449162140|FG001|Overall Study|Adverse Event|1|||
124874662|NCT01678131|449162141|FG002|Overall Study|Adverse Event|0|||
124874663|NCT01678131|449162139|FG000|Overall Study|Withdrawal by Subject|0|||
124874664|NCT01678131|449162140|FG001|Overall Study|Withdrawal by Subject|0|||
124874665|NCT01678131|449162141|FG002|Overall Study|Withdrawal by Subject|2|||
124874666|NCT00112580|449162142|FG000|Overall Study|Adverse Event|1|||
124874667|NCT00112580|449162143|FG001|Overall Study|Adverse Event|2|||
124874668|NCT00112580|449162142|FG000|Overall Study|Disease progression|5|||
124874669|NCT00112580|449162143|FG001|Overall Study|Disease progression|16|||
124874670|NCT00112580|449162142|FG000|Overall Study|Participant withdrew consent|2|||
124874671|NCT00112580|449162143|FG001|Overall Study|Participant withdrew consent|1|||
124874672|NCT05619003|449162145|FG000|Overall Study|Adverse Event|1|||
124874673|NCT03444376|449162146|FG000|Part A|Disease relapse or Progression|1|||
124874674|NCT03444376|449162146|FG000|Part A|Withdrawal by Subject|2|||
124874675|NCT03444376|449162146|FG000|Part A|Adverse Event|1|||
124874676|NCT03444376|449162146|FG000|Part B|Disease relapse or Progression|18|||
124874677|NCT03444376|449162146|FG000|Part B|Withdrawal by Subject|2|||
124874678|NCT03444376|449162146|FG000|Part B|Adverse Event|2|||
124874679|NCT03444376|449162146|FG000|Part B|Physician Decision|1|||
124874680|NCT03444376|449162146|FG000|Part C|Disease relapse or Progression|43|||
124874681|NCT03444376|449162146|FG000|Part C|Withdrawal by Subject|5|||
124874682|NCT03444376|449162146|FG000|Part C|Adverse Event|2|||
124874683|NCT03444376|449162146|FG000|Part C|Physician Decision|2|||
124874684|NCT03444376|449162146|FG000|Part C|Death|1|||
124874685|NCT00685945|449163503|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
124874686|NCT03183388|449163504|FG000|Overall Study|Lost to Follow-up|3|||
124874687|NCT03183388|449163505|FG001|Overall Study|Lost to Follow-up|5|||
124874688|NCT03183388|449163504|FG000|Overall Study|Physician Decision|1|||
124874689|NCT03183388|449163505|FG001|Overall Study|Physician Decision|4|||
124874690|NCT03183388|449163504|FG000|Overall Study|Withdrawal by Subject|4|||
124874691|NCT03183388|449163505|FG001|Overall Study|Withdrawal by Subject|1|||
124874692|NCT03183388|449163504|FG000|Overall Study|Moved|1|||
124874693|NCT03183388|449163505|FG001|Overall Study|Moved|0|||
124874694|NCT03183388|449163504|FG000|Overall Study|Met Exclusion Criteria|2|||
124874695|NCT03183388|449163505|FG001|Overall Study|Met Exclusion Criteria|2|||
124874696|NCT03183388|449163504|FG000|Overall Study|COVID Pandemic Related|2|||
124874697|NCT03183388|449163505|FG001|Overall Study|COVID Pandemic Related|4|||
124874698|NCT00847405|449163506|FG000|First Intervention|Adverse Event|0|||
124874699|NCT00847405|449163507|FG001|First Intervention|Adverse Event|1|||
124874700|NCT00847405|449163506|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
124874701|NCT00847405|449163507|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
124874702|NCT01728792|449163508|FG000|Overall Study|Withdrawal of Consent|1|||
124874703|NCT01728792|449163509|FG001|Overall Study|Withdrawal of Consent|1|||
124874704|NCT01728792|449163510|FG002|Overall Study|Withdrawal of Consent|0|||
124874705|NCT01728792|449163511|FG003|Overall Study|Withdrawal of Consent|1|||
124874706|NCT01728792|449163512|FG004|Overall Study|Withdrawal of Consent|0|||
125098479|NCT01195662|449980260|FG001|Double Blind Treatment Period|Non-specified|0|||
125010635|NCT03370120|449665105|FG000|Overall Study|Clinical trial has been cancelled|1|||
125010636|NCT03370120|449665105|FG000|Overall Study|End of study per sponsor decision|2|||
125098480|NCT01195662|449980261|FG002|Double Blind Treatment Period|Non-specified|0|||
125098481|NCT01195662|449980259|FG000|Double Blind Treatment Period|Missing disposition information|0|||
125098482|NCT01195662|449980260|FG001|Double Blind Treatment Period|Missing disposition information|1|||
125098483|NCT01195662|449980261|FG002|Double Blind Treatment Period|Missing disposition information|1|||
125098484|NCT01195662|449980259|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
125098485|NCT01195662|449980260|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
125098486|NCT01195662|449980261|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
125098487|NCT01195662|449980259|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
125098488|NCT01195662|449980260|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
125098489|NCT01195662|449980261|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
125098490|NCT01215968|449980262|FG000|Overall Study|Adverse Event|0|||
125098491|NCT01215968|449980263|FG001|Overall Study|Adverse Event|2|||
125098492|NCT01215968|449980262|FG000|Overall Study|Protocol Violation|2|||
125098493|NCT01215968|449980263|FG001|Overall Study|Protocol Violation|4|||
125098494|NCT01215968|449980262|FG000|Overall Study|Not received study drug|0|||
125098495|NCT01215968|449980263|FG001|Overall Study|Not received study drug|1|||
125098496|NCT05643573|449980267|FG000|Overall Study|Adverse Event|117|||
125098497|NCT05643573|449980268|FG001|Overall Study|Adverse Event|90|||
125098498|NCT05643573|449980267|FG000|Overall Study|Death|53|||
125098499|NCT05643573|449980268|FG001|Overall Study|Death|57|||
125098500|NCT05643573|449980267|FG000|Overall Study|Lost to Follow-up|6|||
125098501|NCT05643573|449980268|FG001|Overall Study|Lost to Follow-up|3|||
125098502|NCT05643573|449980267|FG000|Overall Study|Other|18|||
125098503|NCT05643573|449980268|FG001|Overall Study|Other|15|||
125098504|NCT05643573|449980267|FG000|Overall Study|Outcome event|64|||
125098505|NCT05643573|449980268|FG001|Overall Study|Outcome event|36|||
125098506|NCT05643573|449980267|FG000|Overall Study|Physician Decision|33|||
125098507|NCT05643573|449980268|FG001|Overall Study|Physician Decision|19|||
125098508|NCT05643573|449980267|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
125098509|NCT05643573|449980268|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
125098510|NCT05643573|449980267|FG000|Overall Study|Site terminated by sponsor|10|||
125098511|NCT05643573|449980268|FG001|Overall Study|Site terminated by sponsor|10|||
125098512|NCT05643573|449980267|FG000|Overall Study|Study terminated by sponsor|1|||
125098513|NCT05643573|449980268|FG001|Overall Study|Study terminated by sponsor|0|||
125098514|NCT05643573|449980267|FG000|Overall Study|Withdrawal by Subject|178|||
125098515|NCT05643573|449980268|FG001|Overall Study|Withdrawal by Subject|130|||
125098516|NCT04768881|449980271|FG000|Overall Study|Completed Study Follow-up|0|||
125098517|NCT04768881|449980272|FG001|Overall Study|Completed Study Follow-up|2|||
125098518|NCT04768881|449980271|FG000|Overall Study|Death|3|||
125098519|NCT04768881|449980272|FG001|Overall Study|Death|2|||
125098520|NCT04768881|449980271|FG000|Overall Study|Study Terminated by Sponsor|2|||
125010637|NCT03370120|449665105|FG000|Overall Study|Promoter's decision|2|||
125010638|NCT03370120|449665105|FG000|Overall Study|The trial has been suspended|3|||
125010639|NCT03370120|449665105|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
125010640|NCT03370120|449665105|FG000|Overall Study|Early termination by order of sponsor|2|||
125010641|NCT03370120|449665105|FG000|Overall Study|Discontinuation of the study|5|||
125010642|NCT03370120|449665105|FG000|Overall Study|End of clinical trial discontinuation|1|||
125010643|NCT03370120|449665105|FG000|Overall Study|Because the clinical trial ended halfway|4|||
125010644|NCT03370120|449665105|FG000|Overall Study|Development discontinued|5|||
125010645|NCT03370120|449665105|FG000|Overall Study|Padsenovil program closed|3|||
125010646|NCT03370120|449665105|FG000|Overall Study|End of project|2|||
125010647|NCT03370120|449665105|FG000|Overall Study|Termination of project|1|||
125010648|NCT03370120|449665105|FG000|Overall Study|The study was interrupted by sponsor|4|||
125010649|NCT03370120|449665105|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
125010650|NCT03370120|449665105|FG000|Overall Study|End of sponsor decision|1|||
125010651|NCT03370120|449665105|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
125010652|NCT03370120|449665105|FG000|Overall Study|Early termination of studies|5|||
125010653|NCT03370120|449665105|FG000|Overall Study|This study is ended early|1|||
125098521|NCT04768881|449980272|FG001|Overall Study|Study Terminated by Sponsor|2|||
125098522|NCT04768881|449980271|FG000|Overall Study|Withdrawal by Subject|2|||
125098523|NCT04768881|449980272|FG001|Overall Study|Withdrawal by Subject|0|||
125098524|NCT04768881|449980271|FG000|Overall Study|Other|2|||
125098525|NCT04768881|449980272|FG001|Overall Study|Other|0|||
125098526|NCT01083121|449980274|FG000|Overall Study|Use of Humira outside the approved label|81|||
125098527|NCT01958619|449980279|FG000|Overall Study|Protocol Violation|2|||
125098528|NCT01958619|449980280|FG001|Overall Study|Protocol Violation|0|||
125098529|NCT01958619|449980281|FG002|Overall Study|Protocol Violation|1|||
125098530|NCT01958619|449980282|FG003|Overall Study|Protocol Violation|0|||
125010654|NCT03370120|449665105|FG000|Overall Study|End of padsevonil program|2|||
125010655|NCT03370120|449665105|FG000|Overall Study|Decision of sponsor|6|||
125098531|NCT02396849|449980284|FG000|Overall Study|Lost to Follow-up|1|||
125010656|NCT03370120|449665105|FG000|Overall Study|Asked by the sponsor|3|||
125010657|NCT03370120|449665105|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
125010658|NCT03370120|449665105|FG000|Overall Study|PI decision poor compliance from participant|1|||
125010659|NCT03370120|449665105|FG000|Overall Study|Promoter ended the study|3|||
125010660|NCT03370120|449665105|FG000|Overall Study|Premature study close by sponsor's decision|4|||
125010661|NCT03370120|449665105|FG000|Overall Study|Study terminated by sponsor|33|||
125010662|NCT03370120|449665105|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
125010663|NCT03370120|449665105|FG000|Overall Study|Sponsor decision to terminate study|63|||
125010664|NCT03370120|449665105|FG000|Overall Study|Program closure|3|||
125010665|NCT03370120|449665105|FG000|Overall Study|Study ended prematurely|1|||
125010666|NCT03370120|449665105|FG000|Overall Study|Study stopped by sponsor|2|||
125010667|NCT03370120|449665105|FG000|Overall Study|Program termination|55|||
125010668|NCT03370120|449665105|FG000|Overall Study|Sponsor decision|62|||
125010669|NCT03370120|449665105|FG000|Overall Study|Sponsor study closure|10|||
125010670|NCT00454857|449665106|FG000|Overall Study|Withdrawal by Subject|15|||
125010671|NCT00454857|449665106|FG000|Overall Study|Lost to Follow-up|16|||
125010672|NCT00454857|449665106|FG000|Overall Study|Noncompliance|6|||
125010673|NCT00454857|449665106|FG000|Overall Study|Death|5|||
125010674|NCT00454857|449665106|FG000|Overall Study|Other|11|||
125010675|NCT00454857|449665106|FG000|Overall Study|Reason unknown|1|||
125010676|NCT04206020|449665110|FG000|Overall Study|Adverse Event|1|||
125010677|NCT04206020|449665111|FG001|Overall Study|Adverse Event|4|||
125010678|NCT04206020|449665110|FG000|Overall Study|Protocol Violation|2|||
125010679|NCT04206020|449665111|FG001|Overall Study|Protocol Violation|0|||
125010680|NCT04206020|449665110|FG000|Overall Study|Withdrawal by Subject|2|||
125010681|NCT04206020|449665111|FG001|Overall Study|Withdrawal by Subject|0|||
125010682|NCT04206020|449665110|FG000|Overall Study|Lost to Follow-up|2|||
125010683|NCT04206020|449665111|FG001|Overall Study|Lost to Follow-up|0|||
125010684|NCT04206020|449665110|FG000|Overall Study|Pregnancy|0|||
125010685|NCT04206020|449665111|FG001|Overall Study|Pregnancy|1|||
125010686|NCT04206020|449665110|FG000|Overall Study|Unable to attend visits|1|||
125010687|NCT04206020|449665111|FG001|Overall Study|Unable to attend visits|2|||
125010688|NCT01197521|449665116|FG000|Overall Study|Not reported|24|||
125010689|NCT01197521|449665117|FG001|Overall Study|Not reported|25|||
125010690|NCT01197521|449665118|FG002|Overall Study|Not reported|21|||
125010691|NCT01197521|449665116|FG000|Overall Study|Enrolment in long term extension|42|||
125010692|NCT01197521|449665117|FG001|Overall Study|Enrolment in long term extension|36|||
125010693|NCT01197521|449665118|FG002|Overall Study|Enrolment in long term extension|87|||
125010694|NCT01197521|449665116|FG000|Overall Study|Severe non-compliance to protocol|1|||
125010695|NCT01197521|449665117|FG001|Overall Study|Severe non-compliance to protocol|3|||
125010696|NCT01197521|449665118|FG002|Overall Study|Severe non-compliance to protocol|3|||
125010697|NCT01197521|449665116|FG000|Overall Study|Lack of therapeutic response|2|||
125010698|NCT01197521|449665117|FG001|Overall Study|Lack of therapeutic response|3|||
125010699|NCT01197521|449665118|FG002|Overall Study|Lack of therapeutic response|4|||
125010700|NCT01197521|449665116|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
125010701|NCT01197521|449665117|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
125010702|NCT01197521|449665118|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
125010703|NCT01197521|449665116|FG000|Overall Study|Lost to Follow-up|3|||
125010704|NCT01197521|449665117|FG001|Overall Study|Lost to Follow-up|2|||
125010705|NCT01197521|449665118|FG002|Overall Study|Lost to Follow-up|2|||
125010706|NCT01197521|449665116|FG000|Overall Study|Adverse Event|25|||
125010707|NCT01197521|449665117|FG001|Overall Study|Adverse Event|28|||
125010708|NCT01197521|449665118|FG002|Overall Study|Adverse Event|24|||
125010709|NCT00258674|449665123|FG000|Overall Study|Death|32|||
125010710|NCT00258674|449665124|FG001|Overall Study|Death|53|||
125010711|NCT00258674|449665125|FG002|Overall Study|Death|34|||
125010712|NCT03715153|449665126|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
125010713|NCT03715153|449665127|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
125010714|NCT03715153|449665126|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
125010715|NCT03715153|449665127|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
125010716|NCT03715153|449665126|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
125010717|NCT03715153|449665127|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
125010718|NCT03715153|449665126|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
125010719|NCT03715153|449665127|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
125010720|NCT03715153|449665126|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
125010721|NCT03715153|449665127|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
125010722|NCT03715153|449665126|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
125010723|NCT03715153|449665127|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
125010724|NCT00450723|449665131|FG000|Overall Study|Physician Decision|5|||
125010725|NCT00078325|449665132|FG000|Overall Study|Adverse Event|15|||
125010726|NCT00078325|449665133|FG001|Overall Study|Adverse Event|10|||
125010727|NCT00078325|449665134|FG002|Overall Study|Adverse Event|5|||
125010728|NCT00078325|449665132|FG000|Overall Study|Protocol Violation|2|||
125010729|NCT00078325|449665133|FG001|Overall Study|Protocol Violation|2|||
125010730|NCT00078325|449665134|FG002|Overall Study|Protocol Violation|0|||
124874707|NCT01728792|449163508|FG000|Overall Study|Lost to Follow-up|2|||
124874708|NCT01728792|449163509|FG001|Overall Study|Lost to Follow-up|1|||
124874709|NCT01728792|449163510|FG002|Overall Study|Lost to Follow-up|4|||
124874710|NCT01728792|449163511|FG003|Overall Study|Lost to Follow-up|2|||
124874711|NCT01728792|449163512|FG004|Overall Study|Lost to Follow-up|0|||
124874712|NCT04277455|449163515|FG000|Overall Study|Lost to Follow-up|1|||
124874713|NCT00949715|449163516|FG000|Overall Study|Physician Decision|1|||
124874714|NCT00949715|449163517|FG001|Overall Study|Physician Decision|0|||
124874715|NCT00949715|449163516|FG000|Overall Study|Lost to Follow-up|1|||
124874716|NCT00949715|449163517|FG001|Overall Study|Lost to Follow-up|0|||
124874717|NCT00949715|449163516|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
124874718|NCT00949715|449163517|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
124874719|NCT01352585|449163522|FG000|Overall Study|Adverse Event|2|||
124874720|NCT01352585|449163523|FG001|Overall Study|Adverse Event|1|||
124874721|NCT01352585|449163522|FG000|Overall Study|Lost to Follow-up|1|||
124874722|NCT01352585|449163523|FG001|Overall Study|Lost to Follow-up|0|||
124874723|NCT01352585|449163522|FG000|Overall Study|Other|5|||
124874724|NCT01352585|449163523|FG001|Overall Study|Other|2|||
124874725|NCT02276066|449163526|FG000|Overall Study|Lost to Follow-up|21|||
124874726|NCT02276066|449163527|FG001|Overall Study|Lost to Follow-up|11|||
124874727|NCT05050578|449163528|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
124874728|NCT05050578|449163529|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
124874729|NCT05050578|449163528|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
124874730|NCT05050578|449163529|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
124874731|NCT05050578|449163528|FG000|Period 2, 30 Days|Protocol Violation|0|||
124874732|NCT05050578|449163529|FG001|Period 2, 30 Days|Protocol Violation|1|||
124874733|NCT03386032|449163530|FG000|Overall Study|Lack of Efficacy|6|||
124874734|NCT03386032|449163531|FG001|Overall Study|Lack of Efficacy|2|||
124874735|NCT03386032|449163532|FG002|Overall Study|Lack of Efficacy|0|||
124874736|NCT03386032|449163530|FG000|Overall Study|Adverse Event|2|||
124874737|NCT03386032|449163531|FG001|Overall Study|Adverse Event|2|||
124874738|NCT03386032|449163532|FG002|Overall Study|Adverse Event|0|||
124874739|NCT03386032|449163530|FG000|Overall Study|Withdrawal by Subject|1|||
124874740|NCT03386032|449163531|FG001|Overall Study|Withdrawal by Subject|0|||
124874741|NCT03386032|449163532|FG002|Overall Study|Withdrawal by Subject|0|||
124874742|NCT03386032|449163530|FG000|Overall Study|Lost to Follow-up|9|||
124874743|NCT03386032|449163531|FG001|Overall Study|Lost to Follow-up|3|||
124874744|NCT03386032|449163532|FG002|Overall Study|Lost to Follow-up|0|||
124874745|NCT02710292|449163538|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
124874746|NCT02710292|449163539|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
124874747|NCT02710292|449163538|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
124874748|NCT02710292|449163539|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
124874749|NCT04525547|449163540|FG000|Overall Study|Not treated with Ofev|2|||
124874750|NCT04525547|449163540|FG000|Overall Study|Off-label use|2|||
124874751|NCT04525547|449163540|FG000|Overall Study|Lost to Follow-up|1|||
124874752|NCT00800202|449163541|FG000|Overall Study|Adverse Event|7|||
124874753|NCT00800202|449163542|FG001|Overall Study|Adverse Event|6|||
124874754|NCT00800202|449163541|FG000|Overall Study|Death|1|||
124874755|NCT00800202|449163542|FG001|Overall Study|Death|0|||
124874756|NCT00800202|449163541|FG000|Overall Study|Other|5|||
124874757|NCT00800202|449163542|FG001|Overall Study|Other|0|||
124874758|NCT00800202|449163541|FG000|Overall Study|Disease Progression|54|||
124874759|NCT00800202|449163542|FG001|Overall Study|Disease Progression|18|||
124874760|NCT04425902|449163543|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
124874761|NCT02901626|449163552|FG000|Overall Study|Lost to Follow-up|1|||
124874762|NCT02901626|449163553|FG001|Overall Study|Lost to Follow-up|1|||
124874763|NCT00331344|449163554|FG000|Phase I|Adverse Event|0|||
124874764|NCT00331344|449163555|FG001|Phase I|Adverse Event|0|||
124874765|NCT00331344|449163556|FG002|Phase I|Adverse Event|0|||
124874766|NCT00331344|449163557|FG003|Phase I|Adverse Event|1|||
124874767|NCT00331344|449163558|FG004|Phase I|Adverse Event|2|||
125010731|NCT00078325|449665132|FG000|Overall Study|Withdrawal by Subject|1|||
125010732|NCT00078325|449665133|FG001|Overall Study|Withdrawal by Subject|5|||
125010733|NCT00078325|449665134|FG002|Overall Study|Withdrawal by Subject|3|||
125010734|NCT00078325|449665132|FG000|Overall Study|Lost to Follow-up|0|||
124874768|NCT00331344|449163559|FG005|Phase I|Adverse Event|2|||
124874769|NCT00331344|449163560|FG006|Phase I|Adverse Event|0|||
124874770|NCT00331344|449163561|FG007|Phase I|Adverse Event|1|||
124874771|NCT00331344|449163562|FG008|Phase I|Adverse Event|0|||
124874772|NCT00331344|449163554|FG000|Phase II|Death|0|||
124874773|NCT00331344|449163555|FG001|Phase II|Death|0|||
124874774|NCT00331344|449163556|FG002|Phase II|Death|0|||
124874775|NCT00331344|449163557|FG003|Phase II|Death|0|||
124874776|NCT00331344|449163558|FG004|Phase II|Death|0|||
124874777|NCT00331344|449163559|FG005|Phase II|Death|0|||
124874778|NCT00331344|449163560|FG006|Phase II|Death|0|||
124874779|NCT00331344|449163561|FG007|Phase II|Death|0|||
124874780|NCT00331344|449163562|FG008|Phase II|Death|4|||
124874781|NCT05674890|449163563|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
124874782|NCT05674890|449163564|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
125010735|NCT00078325|449665133|FG001|Overall Study|Lost to Follow-up|1|||
124874783|NCT05674890|449163563|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
124874784|NCT05674890|449163564|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
124874785|NCT05674890|449163563|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
124874786|NCT05674890|449163564|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
124874787|NCT02228967|449163565|FG000|Overall Study|Lost to Follow-up|146|||
124874788|NCT02228967|449163566|FG001|Overall Study|Lost to Follow-up|142|||
124874789|NCT02228967|449163565|FG000|Overall Study|Withdrawal by Subject|13|||
124874790|NCT02228967|449163566|FG001|Overall Study|Withdrawal by Subject|18|||
124874791|NCT00642902|449163567|FG000|Overall Study|Adverse Event|0|||
124874792|NCT00642902|449163568|FG001|Overall Study|Adverse Event|1|||
124874793|NCT00642902|449163569|FG002|Overall Study|Adverse Event|3|||
124874794|NCT00642902|449163570|FG003|Overall Study|Adverse Event|1|||
124874795|NCT00642902|449163567|FG000|Overall Study|Lost to Follow-up|1|||
124874796|NCT00642902|449163568|FG001|Overall Study|Lost to Follow-up|1|||
124874797|NCT00642902|449163569|FG002|Overall Study|Lost to Follow-up|0|||
124874798|NCT00642902|449163570|FG003|Overall Study|Lost to Follow-up|0|||
124874799|NCT00642902|449163567|FG000|Overall Study|Lack of Efficacy|0|||
124874800|NCT00642902|449163568|FG001|Overall Study|Lack of Efficacy|3|||
124874801|NCT00642902|449163569|FG002|Overall Study|Lack of Efficacy|3|||
124874802|NCT00642902|449163570|FG003|Overall Study|Lack of Efficacy|0|||
124874803|NCT00642902|449163567|FG000|Overall Study|Death|1|||
124874804|NCT00642902|449163568|FG001|Overall Study|Death|0|||
124874805|NCT00642902|449163569|FG002|Overall Study|Death|0|||
124874806|NCT00642902|449163570|FG003|Overall Study|Death|0|||
124874807|NCT00642902|449163567|FG000|Overall Study|Premature termination of clinical trial|37|||
124874808|NCT00642902|449163568|FG001|Overall Study|Premature termination of clinical trial|32|||
124874809|NCT00642902|449163569|FG002|Overall Study|Premature termination of clinical trial|35|||
124874810|NCT00642902|449163570|FG003|Overall Study|Premature termination of clinical trial|35|||
124874811|NCT00642902|449163567|FG000|Overall Study|Randomized, but not treated|0|||
124874812|NCT00642902|449163568|FG001|Overall Study|Randomized, but not treated|0|||
124874813|NCT00642902|449163569|FG002|Overall Study|Randomized, but not treated|1|||
124874814|NCT00642902|449163570|FG003|Overall Study|Randomized, but not treated|0|||
124874815|NCT00642902|449163567|FG000|Overall Study|Other|1|||
124874816|NCT00642902|449163568|FG001|Overall Study|Other|5|||
124874817|NCT00642902|449163569|FG002|Overall Study|Other|1|||
124874818|NCT00642902|449163570|FG003|Overall Study|Other|4|||
125010736|NCT00078325|449665134|FG002|Overall Study|Lost to Follow-up|1|||
125010737|NCT00078325|449665132|FG000|Overall Study|Physician Decision|2|||
125010738|NCT00078325|449665133|FG001|Overall Study|Physician Decision|0|||
125010739|NCT00078325|449665134|FG002|Overall Study|Physician Decision|1|||
125010740|NCT00078325|449665132|FG000|Overall Study|Miscellaneous|1|||
125010741|NCT00078325|449665133|FG001|Overall Study|Miscellaneous|1|||
125010742|NCT00078325|449665134|FG002|Overall Study|Miscellaneous|1|||
125010743|NCT00578136|449665135|FG000|Overall Study|Not given intervention|1|||
125010744|NCT00578136|449665136|FG001|Overall Study|Not given intervention|1|||
125010745|NCT02047253|449665137|FG000|Overall Study|Lost to Follow-up|8|||
125010746|NCT03710486|449665139|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
125010747|NCT03710486|449665140|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
125010748|NCT03710486|449665139|FG000|Overall Study|Missing|0|||
125010749|NCT03710486|449665140|FG001|Overall Study|Missing|2|||
125010750|NCT01987960|449665141|FG000|Period 1|Adverse Event|24|||
125010751|NCT01987960|449665142|FG001|Period 1|Adverse Event|0|||
125010752|NCT01987960|449665143|FG002|Period 1|Adverse Event|0|||
125010753|NCT01987960|449665144|FG003|Period 1|Adverse Event|0|||
125010754|NCT01987960|449665141|FG000|Period 1|Lack of Efficacy|4|||
125010755|NCT01987960|449665142|FG001|Period 1|Lack of Efficacy|0|||
125010756|NCT01987960|449665143|FG002|Period 1|Lack of Efficacy|0|||
125010757|NCT01987960|449665144|FG003|Period 1|Lack of Efficacy|0|||
125010758|NCT01987960|449665141|FG000|Period 1|Non-compliance with IMP|6|||
125010759|NCT01987960|449665142|FG001|Period 1|Non-compliance with IMP|0|||
124874819|NCT01538472|449163571|FG000|Overall Study|Disease Progression|3|||
124874820|NCT01538472|449163571|FG000|Overall Study|Death|1|||
124874821|NCT02309112|449163572|FG000|Overall Study|Withdrawal by Subject|1|||
124874822|NCT02309112|449163573|FG001|Overall Study|Withdrawal by Subject|0|||
124874823|NCT02309112|449163574|FG002|Overall Study|Withdrawal by Subject|1|||
124874824|NCT02309112|449163572|FG000|Overall Study|Lost to Follow-up|0|||
124874825|NCT02309112|449163573|FG001|Overall Study|Lost to Follow-up|1|||
125010760|NCT01987960|449665143|FG002|Period 1|Non-compliance with IMP|0|||
125010761|NCT01987960|449665144|FG003|Period 1|Non-compliance with IMP|0|||
125010762|NCT01987960|449665141|FG000|Period 1|Protocol Violation|12|||
125010763|NCT01987960|449665142|FG001|Period 1|Protocol Violation|0|||
125010764|NCT01987960|449665143|FG002|Period 1|Protocol Violation|0|||
125010765|NCT01987960|449665144|FG003|Period 1|Protocol Violation|0|||
124874826|NCT02309112|449163574|FG002|Overall Study|Lost to Follow-up|0|||
124874827|NCT03815019|449163575|FG000|Overall Study|Withdrawal by Subject|6|||
124874828|NCT03815019|449163576|FG001|Overall Study|Withdrawal by Subject|8|||
125010766|NCT01987960|449665141|FG000|Period 1|Withdrawal by Subject|21|||
125010767|NCT01987960|449665142|FG001|Period 1|Withdrawal by Subject|0|||
124874829|NCT03759834|449163577|FG000|Overall Study|Withdrawal by Subject|1|||
124874830|NCT03937219|449163578|FG000|Overall Study|Death|223|||
124874831|NCT03937219|449163579|FG001|Overall Study|Death|211|||
124874832|NCT03937219|449163578|FG000|Overall Study|Withdrawal by Subject|17|||
124874833|NCT03937219|449163579|FG001|Overall Study|Withdrawal by Subject|25|||
124874834|NCT03937219|449163578|FG000|Overall Study|Lost to Follow-up|3|||
124874835|NCT03937219|449163579|FG001|Overall Study|Lost to Follow-up|4|||
124874836|NCT04803214|449163580|FG000|Overall Study|Adverse Event|1|||
124874837|NCT04803214|449163581|FG001|Overall Study|Adverse Event|0|||
124874838|NCT04803214|449163580|FG000|Overall Study|Withdrawal by Subject|1|||
124874839|NCT04803214|449163581|FG001|Overall Study|Withdrawal by Subject|2|||
124874840|NCT04803214|449163580|FG000|Overall Study|Lost to Follow-up|2|||
124874841|NCT04803214|449163581|FG001|Overall Study|Lost to Follow-up|4|||
124874842|NCT04803214|449163580|FG000|Overall Study|Physician Decision|1|||
124874843|NCT04803214|449163581|FG001|Overall Study|Physician Decision|1|||
124874844|NCT04803214|449163580|FG000|Overall Study|Missed 12 month visit|0|||
124874845|NCT04803214|449163581|FG001|Overall Study|Missed 12 month visit|3|||
124874846|NCT03764072|449163584|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
124874847|NCT03764072|449163585|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
124874848|NCT03764072|449163586|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
124874849|NCT03764072|449163587|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
124874850|NCT03764072|449163588|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
124874851|NCT03764072|449163589|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
124874852|NCT03764072|449163584|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
124874853|NCT03764072|449163585|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
124874854|NCT03764072|449163586|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
124874855|NCT03764072|449163587|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
124874856|NCT03764072|449163588|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
124874857|NCT03764072|449163589|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
124874858|NCT03764072|449163584|FG000|Overall Study|Lost to Follow-up|0|||
124874859|NCT03764072|449163585|FG001|Overall Study|Lost to Follow-up|0|||
124874860|NCT03764072|449163586|FG002|Overall Study|Lost to Follow-up|0|||
124874861|NCT03764072|449163587|FG003|Overall Study|Lost to Follow-up|0|||
124874862|NCT03764072|449163588|FG004|Overall Study|Lost to Follow-up|1|||
124874863|NCT03764072|449163589|FG005|Overall Study|Lost to Follow-up|0|||
124874864|NCT00558064|449163592|FG000|Overall Study|Adverse Event|3|||
124874865|NCT00558064|449163593|FG001|Overall Study|Adverse Event|2|||
124874866|NCT00558064|449163592|FG000|Overall Study|Lack of Efficacy|0|||
124874867|NCT00558064|449163593|FG001|Overall Study|Lack of Efficacy|1|||
124874868|NCT00558064|449163592|FG000|Overall Study|Protocol Violation|1|||
124874869|NCT00558064|449163593|FG001|Overall Study|Protocol Violation|0|||
124874870|NCT00558064|449163592|FG000|Overall Study|Lost to Follow-up|0|||
124874871|NCT00558064|449163593|FG001|Overall Study|Lost to Follow-up|1|||
124874872|NCT00558064|449163592|FG000|Overall Study|Withdrawal by Subject|0|||
124874873|NCT00558064|449163593|FG001|Overall Study|Withdrawal by Subject|1|||
124874874|NCT00558064|449163592|FG000|Overall Study|No visit within allowance period|1|||
124874875|NCT00558064|449163593|FG001|Overall Study|No visit within allowance period|0|||
124874876|NCT00982930|449163599|FG000|Overall Study|Adverse Event|1|||
124874877|NCT00982930|449163599|FG000|Overall Study|Withdrawal by Subject|1|||
124874878|NCT00982930|449163599|FG000|Overall Study|Administrative Problems|2|||
124874879|NCT00941798|449163600|FG000|Overall Study|Withdrawal by Subject|72|||
124874880|NCT00941798|449163601|FG001|Overall Study|Withdrawal by Subject|74|||
124874881|NCT00941798|449163600|FG000|Overall Study|Adverse Event|43|||
124874882|NCT00941798|449163601|FG001|Overall Study|Adverse Event|23|||
124874883|NCT00941798|449163600|FG000|Overall Study|Lost to Follow-up|29|||
124874884|NCT00941798|449163601|FG001|Overall Study|Lost to Follow-up|23|||
124874885|NCT00941798|449163600|FG000|Overall Study|Protocol Violation|17|||
124874886|NCT00941798|449163601|FG001|Overall Study|Protocol Violation|20|||
124874887|NCT00941798|449163600|FG000|Overall Study|Administrative problems|13|||
124874888|NCT00941798|449163601|FG001|Overall Study|Administrative problems|23|||
124874889|NCT00941798|449163600|FG000|Overall Study|Lack of Efficacy|10|||
124874890|NCT00941798|449163601|FG001|Overall Study|Lack of Efficacy|17|||
125010768|NCT01987960|449665143|FG002|Period 1|Withdrawal by Subject|0|||
125010769|NCT01987960|449665144|FG003|Period 1|Withdrawal by Subject|0|||
125010770|NCT01987960|449665141|FG000|Period 1|Lost to Follow-up|40|||
125010771|NCT01987960|449665142|FG001|Period 1|Lost to Follow-up|0|||
125010772|NCT01987960|449665143|FG002|Period 1|Lost to Follow-up|0|||
125010773|NCT01987960|449665144|FG003|Period 1|Lost to Follow-up|0|||
124874891|NCT00941798|449163600|FG000|Overall Study|Patient's inability to use device|6|||
124874892|NCT00941798|449163601|FG001|Overall Study|Patient's inability to use device|1|||
124874893|NCT00941798|449163600|FG000|Overall Study|Abnormal test procedure results|3|||
124874894|NCT00941798|449163601|FG001|Overall Study|Abnormal test procedure results|1|||
124874895|NCT00941798|449163600|FG000|Overall Study|Abnormal laboratory values|1|||
124874896|NCT00941798|449163601|FG001|Overall Study|Abnormal laboratory values|2|||
125010774|NCT01987960|449665141|FG000|Period 1|administrative or other reason|75|||
125010775|NCT01987960|449665142|FG001|Period 1|administrative or other reason|0|||
124874897|NCT00941798|449163600|FG000|Overall Study|Death|0|||
124874898|NCT00941798|449163601|FG001|Overall Study|Death|1|||
124874899|NCT01489189|449163602|FG000|Overall Study|Withdrawal by Subject|20|||
124874900|NCT01489189|449163603|FG001|Overall Study|Withdrawal by Subject|23|||
124874901|NCT01489189|449163602|FG000|Overall Study|Death|10|||
124874902|NCT01489189|449163603|FG001|Overall Study|Death|8|||
124874903|NCT01489189|449163602|FG000|Overall Study|Missed Visit|1|||
124874904|NCT01489189|449163603|FG001|Overall Study|Missed Visit|4|||
124874905|NCT05597722|449163604|FG000|Overall Study|Study was terminated|6|||
124874906|NCT05597722|449163605|FG001|Overall Study|Study was terminated|1|||
124874907|NCT04108000|449163606|FG000|Overall Study|Death of patient|1|||
124874908|NCT04108000|449163607|FG001|Overall Study|Death of patient|0|||
124874909|NCT04108000|449163608|FG002|Overall Study|Death of patient|1|||
124874910|NCT04108000|449163609|FG003|Overall Study|Death of patient|0|||
124874911|NCT04108000|449163606|FG000|Overall Study|Withdrawal by Subject|2|||
124874912|NCT04108000|449163607|FG001|Overall Study|Withdrawal by Subject|2|||
124874913|NCT04108000|449163608|FG002|Overall Study|Withdrawal by Subject|0|||
124874914|NCT04108000|449163609|FG003|Overall Study|Withdrawal by Subject|0|||
124874915|NCT04108000|449163606|FG000|Overall Study|Death of surrogate partner|0|||
124874916|NCT04108000|449163607|FG001|Overall Study|Death of surrogate partner|1|||
124874917|NCT04108000|449163608|FG002|Overall Study|Death of surrogate partner|0|||
124874918|NCT04108000|449163609|FG003|Overall Study|Death of surrogate partner|1|||
124874919|NCT03750006|449163612|FG000|Overall Study|Withdrawal by Subject|8|||
124874920|NCT03750006|449163612|FG000|Overall Study|COVID PANDEMIC|11|||
124874921|NCT03881696|449163622|FG000|Overall Study|Adverse Event|2|||
124874922|NCT03881696|449163623|FG001|Overall Study|Adverse Event|0|||
124874923|NCT03881696|449163622|FG000|Overall Study|Withdrawal by Subject|2|||
124874924|NCT03881696|449163623|FG001|Overall Study|Withdrawal by Subject|0|||
124874925|NCT03881696|449163622|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
124874926|NCT03881696|449163623|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
124874927|NCT03881696|449163622|FG000|Overall Study|Failure to meet continuation criteria|1|||
124874928|NCT03881696|449163623|FG001|Overall Study|Failure to meet continuation criteria|0|||
124874929|NCT04082884|449164597|FG000|Overall Study|Withdrawal by Subject|1|||
124874930|NCT01649232|449164598|FG000|Overall Study|Physician Decision|2|||
124874931|NCT01649232|449164599|FG001|Overall Study|Physician Decision|0|||
124874932|NCT02347657|449164600|FG000|Overall Study|Physician Decision|0|||
124874933|NCT02347657|449164601|FG001|Overall Study|Physician Decision|1|||
124874934|NCT02347657|449164600|FG000|Overall Study|Adverse Event|8|||
124874935|NCT02347657|449164601|FG001|Overall Study|Adverse Event|4|||
124874936|NCT02347657|449164600|FG000|Overall Study|Withdrawal by Subject|6|||
124874937|NCT02347657|449164601|FG001|Overall Study|Withdrawal by Subject|7|||
124874938|NCT02347657|449164600|FG000|Overall Study|Randomized but not treated|1|||
124874939|NCT02347657|449164601|FG001|Overall Study|Randomized but not treated|0|||
124874940|NCT02347657|449164600|FG000|Overall Study|Other|3|||
124874941|NCT02347657|449164601|FG001|Overall Study|Other|3|||
124874942|NCT00621543|449164602|FG000|Overall Study|Lost to Follow-up|23|||
124874943|NCT02709005|449164605|FG000|Overall Study|Lost to Follow-up|1|||
124874944|NCT02709005|449164606|FG001|Overall Study|Lost to Follow-up|1|||
124874945|NCT02709005|449164605|FG000|Overall Study|Withdrawal by Subject|3|||
124874946|NCT02709005|449164606|FG001|Overall Study|Withdrawal by Subject|0|||
124874947|NCT00499863|449164611|FG000|Overall Study|Lack of Efficacy|21|||
124874948|NCT00499863|449164612|FG001|Overall Study|Lack of Efficacy|27|||
124874949|NCT00499863|449164611|FG000|Overall Study|Protocol Violation|12|||
124874950|NCT00499863|449164612|FG001|Overall Study|Protocol Violation|7|||
125010776|NCT01987960|449665143|FG002|Period 1|administrative or other reason|0|||
125010777|NCT01987960|449665144|FG003|Period 1|administrative or other reason|0|||
125010778|NCT01987960|449665141|FG000|Period 1|Withdrawal of consent before treatment|4|||
125010779|NCT01987960|449665142|FG001|Period 1|Withdrawal of consent before treatment|0|||
124874951|NCT00499863|449164611|FG000|Overall Study|Withdrawal by Subject|6|||
124874952|NCT00499863|449164612|FG001|Overall Study|Withdrawal by Subject|4|||
124874953|NCT00499863|449164611|FG000|Overall Study|Adverse Event|8|||
124874954|NCT00499863|449164612|FG001|Overall Study|Adverse Event|2|||
124874955|NCT00499863|449164611|FG000|Overall Study|Sponsor decision|2|||
124874956|NCT00499863|449164612|FG001|Overall Study|Sponsor decision|2|||
125010780|NCT01987960|449665143|FG002|Period 1|Withdrawal of consent before treatment|0|||
125010781|NCT01987960|449665144|FG003|Period 1|Withdrawal of consent before treatment|0|||
125010782|NCT01987960|449665141|FG000|Period 2|Adverse Event|0|||
125010783|NCT01987960|449665142|FG001|Period 2|Adverse Event|0|||
125010784|NCT01987960|449665143|FG002|Period 2|Adverse Event|1|||
124874957|NCT00499863|449164611|FG000|Overall Study|Lost to Follow-up|1|||
124874958|NCT00499863|449164612|FG001|Overall Study|Lost to Follow-up|1|||
124874959|NCT00571701|449164613|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
124874960|NCT00571701|449164614|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
124874961|NCT00571701|449164613|FG000|First Intervention 12 Months|Death|1|||
124874962|NCT00571701|449164614|FG001|First Intervention 12 Months|Death|0|||
124874963|NCT00571701|449164613|FG000|Second Intervention 12 Months|Adverse Event|0|||
124874964|NCT00571701|449164614|FG001|Second Intervention 12 Months|Adverse Event|1|||
124874965|NCT00571701|449164613|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
124874966|NCT00571701|449164614|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
124874967|NCT03351738|449164619|FG000|Overall Study|Withdrawal by Subject|0|||
124874968|NCT03351738|449164620|FG001|Overall Study|Withdrawal by Subject|1|||
124874969|NCT03351738|449164621|FG002|Overall Study|Withdrawal by Subject|0|||
124874970|NCT03351738|449164622|FG003|Overall Study|Withdrawal by Subject|1|||
124874971|NCT03351738|449164623|FG004|Overall Study|Withdrawal by Subject|0|||
124874972|NCT03351738|449164624|FG005|Overall Study|Withdrawal by Subject|0|||
124874973|NCT01375205|449164627|FG000|Overall Study|Lost to Follow-up|15|||
124874974|NCT01375205|449164628|FG001|Overall Study|Lost to Follow-up|12|||
124874975|NCT01375205|449164627|FG000|Overall Study|Withdrawal by Subject|6|||
124874976|NCT01375205|449164628|FG001|Overall Study|Withdrawal by Subject|1|||
124874977|NCT03056534|449164630|FG000|Overall Study|Participant withdrew consent|8|||
124874978|NCT03056534|449164630|FG000|Overall Study|Participant not able to return|6|||
124874979|NCT03056534|449164630|FG000|Overall Study|Lost to Follow-up|37|||
124874980|NCT03056534|449164630|FG000|Overall Study|Investigator judgment|1|||
124874981|NCT03056534|449164630|FG000|Overall Study|Death|4|||
124874982|NCT03056534|449164630|FG000|Overall Study|Adverse Event|1|||
124874983|NCT03056534|449164630|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
124874984|NCT02063828|449164631|FG000|Overall Study|Withdrawal by Subject|4|||
124874985|NCT02063828|449164632|FG001|Overall Study|Withdrawal by Subject|6|||
124874986|NCT02063828|449164633|FG002|Overall Study|Withdrawal by Subject|3|||
124874987|NCT02063828|449164631|FG000|Overall Study|Death|0|||
124874988|NCT02063828|449164632|FG001|Overall Study|Death|0|||
124874989|NCT02063828|449164633|FG002|Overall Study|Death|1|||
124874990|NCT00532155|449164634|FG000|Overall Study|Adverse Event|66|||
124874991|NCT00532155|449164635|FG001|Overall Study|Adverse Event|123|||
124874992|NCT00532155|449164634|FG000|Overall Study|Lack of Efficacy|332|||
124874993|NCT00532155|449164635|FG001|Overall Study|Lack of Efficacy|255|||
124874994|NCT00532155|449164634|FG000|Overall Study|Protocol Violation|1|||
124874995|NCT00532155|449164635|FG001|Overall Study|Protocol Violation|3|||
124874996|NCT00532155|449164634|FG000|Overall Study|Lost to Follow-up|2|||
124874997|NCT00532155|449164635|FG001|Overall Study|Lost to Follow-up|0|||
124874998|NCT00532155|449164634|FG000|Overall Study|Physician Decision|16|||
124874999|NCT00532155|449164635|FG001|Overall Study|Physician Decision|15|||
124875000|NCT00532155|449164634|FG000|Overall Study|Withdrawal by Subject|23|||
124875001|NCT00532155|449164635|FG001|Overall Study|Withdrawal by Subject|44|||
124875002|NCT00532155|449164634|FG000|Overall Study|Consent withdrawn|5|||
124875003|NCT00532155|449164635|FG001|Overall Study|Consent withdrawn|7|||
124875004|NCT00532155|449164634|FG000|Overall Study|Moved|1|||
124875005|NCT00532155|449164635|FG001|Overall Study|Moved|0|||
124875006|NCT00532155|449164634|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
124875007|NCT00532155|449164635|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
124875008|NCT00532155|449164634|FG000|Overall Study|Occurence of a second cancer|0|||
124875009|NCT00532155|449164635|FG001|Overall Study|Occurence of a second cancer|1|||
124875010|NCT00532155|449164634|FG000|Overall Study|Occurence of a secondary cancer|0|||
124875011|NCT00532155|449164635|FG001|Overall Study|Occurence of a secondary cancer|1|||
124875012|NCT00532155|449164634|FG000|Overall Study|Promotor ended study|1|||
124875013|NCT00532155|449164635|FG001|Overall Study|Promotor ended study|0|||
124875014|NCT00532155|449164634|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
124875015|NCT00532155|449164635|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
125010785|NCT01987960|449665144|FG003|Period 2|Adverse Event|0|||
125010786|NCT01987960|449665141|FG000|Period 2|Withdrawal by Subject|0|||
125010787|NCT01987960|449665142|FG001|Period 2|Withdrawal by Subject|0|||
125010788|NCT01987960|449665143|FG002|Period 2|Withdrawal by Subject|1|||
125010789|NCT01987960|449665144|FG003|Period 2|Withdrawal by Subject|0|||
124875016|NCT00532155|449164634|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
124875017|NCT00532155|449164635|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
124875018|NCT00532155|449164634|FG000|Overall Study|Study stopped|1|||
124875019|NCT00532155|449164635|FG001|Overall Study|Study stopped|0|||
125010790|NCT01987960|449665141|FG000|Period 2|Administrative or other reason|0|||
125010791|NCT01987960|449665142|FG001|Period 2|Administrative or other reason|5|||
125010792|NCT01987960|449665143|FG002|Period 2|Administrative or other reason|7|||
125010793|NCT01987960|449665144|FG003|Period 2|Administrative or other reason|0|||
125010794|NCT01987960|449665141|FG000|Period 3|Adverse Event|0|||
125010795|NCT01987960|449665142|FG001|Period 3|Adverse Event|0|||
125010796|NCT01987960|449665143|FG002|Period 3|Adverse Event|0|||
125098532|NCT02396849|449980285|FG001|Overall Study|Lost to Follow-up|1|||
124875020|NCT00532155|449164634|FG000|Overall Study|Study terminated by sponsor|1|||
125010797|NCT01987960|449665144|FG003|Period 3|Adverse Event|7|||
124875021|NCT00532155|449164635|FG001|Overall Study|Study terminated by sponsor|0|||
124875022|NCT00532155|449164634|FG000|Overall Study|Study termination stop further treatment|4|||
124875023|NCT00532155|449164635|FG001|Overall Study|Study termination stop further treatment|0|||
125010798|NCT01987960|449665141|FG000|Period 3|Non-compliance with IMP|0|||
125010799|NCT01987960|449665142|FG001|Period 3|Non-compliance with IMP|0|||
125010800|NCT01987960|449665143|FG002|Period 3|Non-compliance with IMP|0|||
124875024|NCT00532155|449164634|FG000|Overall Study|Did not receive study medication|2|||
124875025|NCT00532155|449164635|FG001|Overall Study|Did not receive study medication|6|||
124875026|NCT03483038|449164636|FG000|Overall Study|Subjects still in follow-up|18|||
124875027|NCT02134925|449164637|FG000|Overall Study|Withdrawal by Subject|1|||
124875028|NCT02134925|449164638|FG001|Overall Study|Withdrawal by Subject|0|||
124875029|NCT02134925|449164637|FG000|Overall Study|Cancel|1|||
124875030|NCT02134925|449164638|FG001|Overall Study|Cancel|6|||
124875031|NCT02158884|449164643|FG000|Baseline Assessment|Missed performance assessment|3|||
124875032|NCT02158884|449164643|FG000|Baseline Assessment|Missed SMFA|1|||
124875033|NCT02158884|449164643|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
124875034|NCT02158884|449164643|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
124875035|NCT02158884|449164643|FG000|6 Month Assessment|Missed SMFA|20|||
124875036|NCT02158884|449164643|FG000|12 Month Assessment|Missed SMFA|17|||
124875037|NCT01313286|449164650|FG000|Period 1|Withdrawal by Subject|2|||
124875038|NCT01313286|449164651|FG001|Period 1|Withdrawal by Subject|0|||
124875039|NCT02034708|449164652|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
124875040|NCT02034708|449164653|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
124875041|NCT02034708|449164652|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
124875042|NCT02034708|449164653|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
124875043|NCT02034708|449164652|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
124875044|NCT02034708|449164653|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
124875045|NCT02034708|449164652|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
124875046|NCT02034708|449164653|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
124875047|NCT00654901|449164654|FG000|Overall Study|Lost to Follow-up|1|||
124875048|NCT00654901|449164655|FG001|Overall Study|Lost to Follow-up|0|||
124875049|NCT00654901|449164656|FG002|Overall Study|Lost to Follow-up|1|||
124875050|NCT00654901|449164657|FG003|Overall Study|Lost to Follow-up|0|||
124875051|NCT00654901|449164654|FG000|Overall Study|Withdrawal by Subject|3|||
124875052|NCT00654901|449164655|FG001|Overall Study|Withdrawal by Subject|0|||
124875053|NCT00654901|449164656|FG002|Overall Study|Withdrawal by Subject|1|||
124875054|NCT00654901|449164657|FG003|Overall Study|Withdrawal by Subject|0|||
124875055|NCT04241094|449164666|FG000|Overall Study|Dropped out of treatment|4|||
124875056|NCT04241094|449164666|FG000|Overall Study|Ineligible after clinical assessment|2|||
124875057|NCT04241094|449164666|FG000|Overall Study|Lost to Follow-up|2|||
124875058|NCT02332590|449164669|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
124875059|NCT02332590|449164670|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
124875060|NCT02332590|449164669|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
124875061|NCT02332590|449164670|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
124875062|NCT02332590|449164669|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
124875063|NCT02332590|449164670|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
124875064|NCT02332590|449164669|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
124875065|NCT02332590|449164670|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
124875066|NCT02332590|449164669|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
124875067|NCT02332590|449164670|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
124875068|NCT02332590|449164669|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
124875069|NCT02332590|449164670|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
124875070|NCT02332590|449164669|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
124875071|NCT02332590|449164670|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
124875072|NCT02332590|449164669|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
124875073|NCT02332590|449164670|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
124875074|NCT02332590|449164669|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
124875075|NCT02332590|449164670|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
124875076|NCT04739761|449164675|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
124875077|NCT04739761|449164676|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
124875078|NCT04739761|449164675|FG000|Overall Study|By complete response from the participant|1|||
124875079|NCT04739761|449164676|FG001|Overall Study|By complete response from the participant|0|||
124875080|NCT04739761|449164675|FG000|Overall Study|Lost to Follow-up|3|||
124875081|NCT04739761|449164676|FG001|Overall Study|Lost to Follow-up|3|||
124875082|NCT04739761|449164675|FG000|Overall Study|Death|13|||
124875083|NCT04739761|449164676|FG001|Overall Study|Death|13|||
124875084|NCT04739761|449164675|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
124875085|NCT04739761|449164676|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
124875086|NCT04739761|449164675|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
124875087|NCT04739761|449164676|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
124875088|NCT04739761|449164675|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
124875089|NCT04739761|449164676|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
124875090|NCT04739761|449164675|FG000|Overall Study|Adverse Event|0|||
124875091|NCT04739761|449164676|FG001|Overall Study|Adverse Event|3|||
125098533|NCT02396849|449980284|FG000|Overall Study|Did not tolerate intervention|1|||
124875092|NCT04739761|449164675|FG000|Overall Study|Participant decision|1|||
124875093|NCT04739761|449164676|FG001|Overall Study|Participant decision|0|||
124875094|NCT04739761|449164675|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
124875095|NCT04739761|449164676|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
124875096|NCT04739761|449164675|FG000|Overall Study|Participant immediately started next line of treatment|1|||
124875097|NCT04739761|449164676|FG001|Overall Study|Participant immediately started next line of treatment|0|||
124875098|NCT04739761|449164675|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
124875099|NCT04739761|449164676|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
124875100|NCT04739761|449164675|FG000|Overall Study|Lack of clinical benefit|1|||
124875101|NCT04739761|449164676|FG001|Overall Study|Lack of clinical benefit|0|||
124875102|NCT04739761|449164675|FG000|Overall Study|Disease progression|5|||
124875103|NCT04739761|449164676|FG001|Overall Study|Disease progression|5|||
124875104|NCT04739761|449164675|FG000|Overall Study|Withdrawal by Subject|14|||
124875105|NCT04739761|449164676|FG001|Overall Study|Withdrawal by Subject|13|||
124875106|NCT04739761|449164675|FG000|Overall Study|Protocol Violation|1|||
124875107|NCT04739761|449164676|FG001|Overall Study|Protocol Violation|0|||
124875108|NCT04739761|449164675|FG000|Overall Study|Physician Decision|2|||
124875109|NCT04739761|449164676|FG001|Overall Study|Physician Decision|0|||
124875110|NCT01582789|449165835|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
124875111|NCT01582789|449165836|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
124875112|NCT01191840|449165844|FG000|Overall Study|withdrew consent|2|||
124875113|NCT01191840|449165845|FG001|Overall Study|withdrew consent|1|||
124875114|NCT01191840|449165844|FG000|Overall Study|Subject discontinued treatment|1|||
124875115|NCT01191840|449165845|FG001|Overall Study|Subject discontinued treatment|2|||
124875116|NCT01191840|449165844|FG000|Overall Study|Lost to Follow-up|4|||
124875117|NCT01191840|449165845|FG001|Overall Study|Lost to Follow-up|6|||
124875118|NCT01191840|449165844|FG000|Overall Study|Non Staph Infection|4|||
124875119|NCT01191840|449165845|FG001|Overall Study|Non Staph Infection|3|||
124875120|NCT01191840|449165844|FG000|Overall Study|ineligible at enrollment|1|||
124875121|NCT01191840|449165845|FG001|Overall Study|ineligible at enrollment|0|||
124875122|NCT01191840|449165844|FG000|Overall Study|IRB approval lapse|0|||
124875123|NCT01191840|449165845|FG001|Overall Study|IRB approval lapse|2|||
124875124|NCT01191840|449165844|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
124875125|NCT01191840|449165845|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
124875126|NCT01191840|449165844|FG000|Overall Study|Withdrawal by Subject|2|||
124875127|NCT01191840|449165845|FG001|Overall Study|Withdrawal by Subject|0|||
124875128|NCT01392300|449165846|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
124875129|NCT01392300|449165847|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
124875130|NCT01392300|449165848|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
124875131|NCT01392300|449165846|FG000|Main Period (MP)|Withdrawal by Subject|5|||
125010801|NCT01987960|449665144|FG003|Period 3|Non-compliance with IMP|1|||
125010802|NCT01987960|449665141|FG000|Period 3|Protocol Violation|0|||
125010803|NCT01987960|449665142|FG001|Period 3|Protocol Violation|0|||
125010804|NCT01987960|449665143|FG002|Period 3|Protocol Violation|0|||
125010805|NCT01987960|449665144|FG003|Period 3|Protocol Violation|6|||
125010806|NCT01987960|449665141|FG000|Period 3|Withdrawal by Subject|0|||
125010807|NCT01987960|449665142|FG001|Period 3|Withdrawal by Subject|0|||
125010808|NCT01987960|449665143|FG002|Period 3|Withdrawal by Subject|0|||
125010809|NCT01987960|449665144|FG003|Period 3|Withdrawal by Subject|9|||
125010810|NCT01987960|449665141|FG000|Period 3|Lost to Follow-up|0|||
125010811|NCT01987960|449665142|FG001|Period 3|Lost to Follow-up|0|||
125010812|NCT01987960|449665143|FG002|Period 3|Lost to Follow-up|0|||
125010813|NCT01987960|449665144|FG003|Period 3|Lost to Follow-up|5|||
125010814|NCT01987960|449665141|FG000|Period 3|Administrative or other reason|0|||
125010815|NCT01987960|449665142|FG001|Period 3|Administrative or other reason|0|||
125010816|NCT01987960|449665143|FG002|Period 3|Administrative or other reason|0|||
125010817|NCT01987960|449665144|FG003|Period 3|Administrative or other reason|43|||
125010818|NCT01892163|449665151|FG000|Overall Study|Death|1|||
125010819|NCT01892163|449665152|FG001|Overall Study|Death|1|||
125010820|NCT01892163|449665151|FG000|Overall Study|Lost to Follow-up|1|||
125010821|NCT01892163|449665152|FG001|Overall Study|Lost to Follow-up|0|||
125010822|NCT03302975|449665154|FG000|Overall Study|Lost to Follow-up|4|||
125010823|NCT00219284|449665157|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
125010824|NCT00219284|449665158|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
125010825|NCT00219284|449665157|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
125010826|NCT00219284|449665158|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
125010827|NCT00219284|449665157|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
125010828|NCT00219284|449665158|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
125098534|NCT02396849|449980285|FG001|Overall Study|Did not tolerate intervention|1|||
124875132|NCT01392300|449165847|FG001|Main Period (MP)|Withdrawal by Subject|1|||
124875133|NCT01392300|449165848|FG002|Main Period (MP)|Withdrawal by Subject|0|||
124875134|NCT01392300|449165846|FG000|Main Period (MP)|Lost to Follow-up|3|||
125010829|NCT00219284|449665157|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
124875135|NCT01392300|449165847|FG001|Main Period (MP)|Lost to Follow-up|3|||
124875136|NCT01392300|449165848|FG002|Main Period (MP)|Lost to Follow-up|0|||
124875137|NCT01392300|449165846|FG000|Main Period (MP)|Non-compliance|1|||
124875138|NCT01392300|449165847|FG001|Main Period (MP)|Non-compliance|0|||
124875139|NCT01392300|449165848|FG002|Main Period (MP)|Non-compliance|0|||
124875140|NCT01392300|449165846|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
124875141|NCT01392300|449165847|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
124875142|NCT01392300|449165848|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
124875143|NCT01392300|449165846|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
124875144|NCT01392300|449165847|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
124875145|NCT01392300|449165848|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
124875146|NCT01392300|449165846|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
124875147|NCT01392300|449165847|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
124875148|NCT01392300|449165848|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
124875149|NCT01392300|449165846|FG000|Open Label Extension (OLEX) Period|Death|0|||
124875150|NCT01392300|449165847|FG001|Open Label Extension (OLEX) Period|Death|0|||
124875151|NCT01392300|449165848|FG002|Open Label Extension (OLEX) Period|Death|4|||
124875152|NCT01392300|449165846|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
124875153|NCT01392300|449165847|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
124875154|NCT01392300|449165848|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
124875155|NCT01392300|449165846|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
124875156|NCT01392300|449165847|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
124875157|NCT01392300|449165848|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
124875158|NCT01392300|449165846|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
124875159|NCT01392300|449165847|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
124875160|NCT01392300|449165848|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
124875161|NCT01802437|449165853|FG000|Overall Study|Lost to Follow-up|1|||
124875162|NCT01802437|449165854|FG001|Overall Study|Lost to Follow-up|0|||
124875163|NCT01802437|449165853|FG000|Overall Study|Withdrawal by Subject|3|||
124875164|NCT01802437|449165854|FG001|Overall Study|Withdrawal by Subject|4|||
124875165|NCT01682213|449165862|FG000|Overall Study|Withdrawal by Subject|2|||
124875166|NCT00742079|449165863|FG000|Overall Study|Lost to Follow-up|0|||
124875167|NCT00742079|449165864|FG001|Overall Study|Lost to Follow-up|1|||
124875168|NCT01181726|449165865|FG000|First Intervention|Adverse Event|1|||
124875169|NCT01181726|449165866|FG001|First Intervention|Adverse Event|0|||
124875170|NCT01264380|449165867|FG000|Period C|Disease Progression|0|||
124875171|NCT01264380|449165868|FG001|Period C|Disease Progression|0|||
124875172|NCT01264380|449165869|FG002|Period C|Disease Progression|4|||
124875173|NCT01264380|449165867|FG000|Period C|Death|0|||
124875174|NCT01264380|449165868|FG001|Period C|Death|0|||
124875175|NCT01264380|449165869|FG002|Period C|Death|2|||
124875176|NCT01264380|449165867|FG000|Period C|Follow-up for survival status|0|||
124875177|NCT01264380|449165868|FG001|Period C|Follow-up for survival status|0|||
124875178|NCT01264380|449165869|FG002|Period C|Follow-up for survival status|6|||
124875179|NCT01264380|449165867|FG000|Period C|Withdrawal by Subject|0|||
124875180|NCT01264380|449165868|FG001|Period C|Withdrawal by Subject|0|||
124875181|NCT01264380|449165869|FG002|Period C|Withdrawal by Subject|1|||
124875182|NCT01264380|449165867|FG000|Period C|Adverse Event|0|||
124875183|NCT01264380|449165868|FG001|Period C|Adverse Event|0|||
124875184|NCT01264380|449165869|FG002|Period C|Adverse Event|1|||
124875185|NCT01147822|449165870|FG000|Overall Study|Lost to Follow-up|14|||
124875186|NCT01147822|449165871|FG001|Overall Study|Lost to Follow-up|6|||
124875187|NCT01147822|449165870|FG000|Overall Study|Withdrawal by Subject|10|||
124875188|NCT01147822|449165871|FG001|Overall Study|Withdrawal by Subject|16|||
124875189|NCT01147822|449165870|FG000|Overall Study|Physician Decision|9|||
124875190|NCT01147822|449165871|FG001|Overall Study|Physician Decision|8|||
124875191|NCT01147822|449165870|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
124875192|NCT01147822|449165871|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
124875193|NCT01147822|449165870|FG000|Overall Study|Protocol Violation|1|||
124875194|NCT01147822|449165871|FG001|Overall Study|Protocol Violation|1|||
124875195|NCT04382924|449165873|FG000|Overall Study|Death|2|||
124875196|NCT04382924|449165874|FG001|Overall Study|Death|5|||
125010830|NCT00219284|449665158|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
125010831|NCT00219284|449665157|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
125010832|NCT00219284|449665158|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
125010833|NCT00219284|449665157|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
124875197|NCT04382924|449165875|FG002|Overall Study|Death|4|||
124875198|NCT04382924|449165873|FG000|Overall Study|Protocol Violation|0|||
124875199|NCT04382924|449165874|FG001|Overall Study|Protocol Violation|1|||
124875200|NCT04382924|449165875|FG002|Overall Study|Protocol Violation|1|||
124875201|NCT04382924|449165873|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
124875202|NCT04382924|449165874|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
124875203|NCT04382924|449165875|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
124875204|NCT04382924|449165873|FG000|Overall Study|Withdrawal by Subject|6|||
124875205|NCT04382924|449165874|FG001|Overall Study|Withdrawal by Subject|3|||
124875206|NCT04382924|449165875|FG002|Overall Study|Withdrawal by Subject|6|||
124875207|NCT02013388|449165878|FG000|Overall Study|work emergency|1|||
124875208|NCT02013388|449165879|FG001|Overall Study|work emergency|0|||
124875209|NCT02013388|449165880|FG002|Overall Study|work emergency|0|||
124875210|NCT02013388|449165881|FG003|Overall Study|work emergency|0|||
124875211|NCT02013388|449165882|FG004|Overall Study|work emergency|1|||
124875212|NCT02013388|449165883|FG005|Overall Study|work emergency|0|||
124875213|NCT02013388|449165884|FG006|Overall Study|work emergency|0|||
124875214|NCT02013388|449165885|FG007|Overall Study|work emergency|0|||
124875215|NCT00429663|449165886|FG000|Overall Study|Lost to Follow-up|24|||
124875216|NCT00429663|449165887|FG001|Overall Study|Lost to Follow-up|31|||
124875217|NCT00429663|449165886|FG000|Overall Study|Physician Decision|6|||
124875218|NCT00429663|449165887|FG001|Overall Study|Physician Decision|3|||
124875219|NCT00429663|449165886|FG000|Overall Study|Withdrawal by Subject|2|||
124875220|NCT00429663|449165887|FG001|Overall Study|Withdrawal by Subject|5|||
124875221|NCT00429663|449165886|FG000|Overall Study|Death|4|||
125010834|NCT00219284|449665158|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
125010835|NCT00219284|449665157|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
125010836|NCT00219284|449665158|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
125010837|NCT00219284|449665157|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
125010838|NCT00219284|449665158|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
125010839|NCT00219284|449665157|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
125010840|NCT00219284|449665158|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
125010841|NCT04722042|449665159|FG000|Overall Study|Withdrawal by Subject|2|||
125010842|NCT04722042|449665160|FG001|Overall Study|Withdrawal by Subject|1|||
125010843|NCT04722042|449665161|FG002|Overall Study|Withdrawal by Subject|0|||
125010844|NCT02269787|449665169|FG000|Overall Study|Lost to Follow-up|20|||
125010845|NCT02269787|449665170|FG001|Overall Study|Lost to Follow-up|6|||
125010846|NCT02269787|449665169|FG000|Overall Study|Death|2|||
125010847|NCT02269787|449665170|FG001|Overall Study|Death|3|||
125010848|NCT02269787|449665169|FG000|Overall Study|Incapacitated|0|||
125010849|NCT02269787|449665170|FG001|Overall Study|Incapacitated|1|||
125010850|NCT00687440|449665171|FG000|Overall Study|Adverse Event|3|||
125010851|NCT00687440|449665171|FG000|Overall Study|Lost to Follow-up|3|||
125010852|NCT00687440|449665171|FG000|Overall Study|Lack of Efficacy|2|||
125010853|NCT00687440|449665171|FG000|Overall Study|Death|2|||
125010854|NCT00687440|449665171|FG000|Overall Study|Other|1|||
125010855|NCT00687440|449665171|FG000|Overall Study|Missing|1|||
125010856|NCT02228720|449665172|FG000|Open Label - Day 30|Lost to Follow-up|1|||
125010857|NCT03996876|449665177|FG000|Overall Study|Incomplete Data|2|||
125010858|NCT03996876|449665178|FG001|Overall Study|Incomplete Data|4|||
125010859|NCT05264740|449665183|FG000|Baseline|Withdrawal by Subject|0|||
125010860|NCT05264740|449665184|FG001|Baseline|Withdrawal by Subject|1|||
125010861|NCT05264740|449665183|FG000|Follow Up 1|Lost to Follow-up|1|||
125010862|NCT05264740|449665184|FG001|Follow Up 1|Lost to Follow-up|1|||
125010863|NCT05264740|449665183|FG000|Follow Up 1|Withdrawal by Subject|0|||
125010864|NCT05264740|449665184|FG001|Follow Up 1|Withdrawal by Subject|1|||
125010865|NCT05264740|449665183|FG000|Follow Up 2|Lost to Follow-up|1|||
125010866|NCT05264740|449665184|FG001|Follow Up 2|Lost to Follow-up|4|||
125010867|NCT05264740|449665183|FG000|Follow Up 3|Lost to Follow-up|7|||
125010868|NCT05264740|449665184|FG001|Follow Up 3|Lost to Follow-up|4|||
125010869|NCT01538628|449665185|FG000|Overall Study|Withdrawal by Subject|1|||
125010870|NCT01538628|449665186|FG001|Overall Study|Withdrawal by Subject|1|||
125010871|NCT01538628|449665185|FG000|Overall Study|Lost to Follow-up|0|||
125010872|NCT01538628|449665186|FG001|Overall Study|Lost to Follow-up|1|||
125010873|NCT04360551|449666499|FG000|Overall Study|Withdrawal by Subject|1|||
125010874|NCT04360551|449666500|FG001|Overall Study|Withdrawal by Subject|0|||
125010875|NCT00388973|449666505|FG000|Overall Study|Adverse Event|16|||
125010876|NCT00388973|449666506|FG001|Overall Study|Adverse Event|6|||
125010877|NCT00388973|449666505|FG000|Overall Study|Lack of Efficacy|1|||
125010878|NCT00388973|449666506|FG001|Overall Study|Lack of Efficacy|12|||
125010879|NCT00388973|449666505|FG000|Overall Study|Protocol Violation|3|||
125010880|NCT00388973|449666506|FG001|Overall Study|Protocol Violation|0|||
124875222|NCT00429663|449165887|FG001|Overall Study|Death|0|||
124875223|NCT04207840|449165888|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
124875224|NCT04207840|449165889|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
124875225|NCT04207840|449165890|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
124875226|NCT04207840|449165888|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
124875227|NCT04207840|449165889|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
124875228|NCT04207840|449165890|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
124875229|NCT03243422|449165891|FG000|Overall Study|Death|20|||
125010881|NCT00388973|449666505|FG000|Overall Study|Withdrawal by Subject|14|||
125010882|NCT00388973|449666506|FG001|Overall Study|Withdrawal by Subject|17|||
125010883|NCT00388973|449666505|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
125010884|NCT00388973|449666506|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
125098535|NCT00985114|449980286|FG000|Overall Study|Adverse Event|1|||
124875230|NCT03243422|449165892|FG001|Overall Study|Death|21|||
124875231|NCT03243422|449165891|FG000|Overall Study|Lost to Follow-up|9|||
124875232|NCT03243422|449165892|FG001|Overall Study|Lost to Follow-up|21|||
124875233|NCT03243422|449165891|FG000|Overall Study|Withdrawal by Subject|22|||
124875234|NCT03243422|449165892|FG001|Overall Study|Withdrawal by Subject|8|||
124875235|NCT03261271|449165896|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
124875236|NCT03261271|449165897|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
124875237|NCT02173054|449165898|FG000|Overall Study|lack of compliance|1|||
124875238|NCT02173054|449165899|FG001|Overall Study|lack of compliance|0|||
124875239|NCT02173054|449165900|FG002|Overall Study|lack of compliance|0|||
124875240|NCT02173054|449165898|FG000|Overall Study|Withdrawal by Subject|0|||
124875241|NCT02173054|449165899|FG001|Overall Study|Withdrawal by Subject|0|||
124875242|NCT02173054|449165900|FG002|Overall Study|Withdrawal by Subject|1|||
124875243|NCT01559454|449165903|FG000|Overall Study|Lost to Follow-up|3|||
124875244|NCT01559454|449165904|FG001|Overall Study|Lost to Follow-up|2|||
124875245|NCT01559454|449165903|FG000|Overall Study|Withdrawal by Subject|0|||
124875246|NCT01559454|449165904|FG001|Overall Study|Withdrawal by Subject|1|||
124875247|NCT01559454|449165903|FG000|Overall Study|Physician Decision|0|||
124875248|NCT01559454|449165904|FG001|Overall Study|Physician Decision|1|||
124875249|NCT01559454|449165903|FG000|Overall Study|Protocol Violation|0|||
124875250|NCT01559454|449165904|FG001|Overall Study|Protocol Violation|1|||
124875251|NCT01559454|449165903|FG000|Overall Study|Lack of Efficacy|0|||
124875252|NCT01559454|449165904|FG001|Overall Study|Lack of Efficacy|1|||
124875253|NCT01114204|449165905|FG000|Overall Study|Adverse Event|3|||
124875254|NCT01114204|449165906|FG001|Overall Study|Adverse Event|2|||
124875255|NCT01114204|449165905|FG000|Overall Study|Lost to Follow-up|1|||
124875256|NCT01114204|449165906|FG001|Overall Study|Lost to Follow-up|0|||
124875257|NCT01114204|449165905|FG000|Overall Study|Withdrawal by Subject|10|||
124875258|NCT01114204|449165906|FG001|Overall Study|Withdrawal by Subject|6|||
124875259|NCT01114204|449165905|FG000|Overall Study|Death|1|||
124875260|NCT01114204|449165906|FG001|Overall Study|Death|0|||
124875261|NCT01114204|449165905|FG000|Overall Study|Other-Personal reasons|2|||
124875262|NCT01114204|449165906|FG001|Overall Study|Other-Personal reasons|0|||
124875263|NCT01114204|449165905|FG000|Overall Study|Other-Medical monitor request|1|||
124875264|NCT01114204|449165906|FG001|Overall Study|Other-Medical monitor request|0|||
124875265|NCT01114204|449165905|FG000|Overall Study|Other-Participant request|2|||
124875266|NCT01114204|449165906|FG001|Overall Study|Other-Participant request|0|||
124875267|NCT01114204|449165905|FG000|Overall Study|Other-Protocol Violation|1|||
124875268|NCT01114204|449165906|FG001|Overall Study|Other-Protocol Violation|0|||
124875269|NCT03420781|449165914|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
124875270|NCT03420781|449165915|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
124875271|NCT03420781|449165916|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
124875272|NCT03420781|449165917|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
125010885|NCT00388973|449666505|FG000|Overall Study|Did not complete 61 days of treatment|5|||
125010886|NCT00388973|449666506|FG001|Overall Study|Did not complete 61 days of treatment|4|||
125010887|NCT00388973|449666505|FG000|Overall Study|Left region|0|||
125010888|NCT00388973|449666506|FG001|Overall Study|Left region|1|||
125010889|NCT00388973|449666505|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
125010890|NCT00388973|449666506|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
125010891|NCT04773106|449666522|FG000|Overall Study|Withdrawal by Subject|3|||
125010892|NCT04773106|449666522|FG000|Overall Study|Death|1|||
125010893|NCT02700412|449666523|FG000|Overall Study|Adverse Event|6|||
125010894|NCT02700412|449666523|FG000|Overall Study|Death|1|||
125010895|NCT02700412|449666523|FG000|Overall Study|Lack of Efficacy|19|||
125010896|NCT02700412|449666523|FG000|Overall Study|Protocol Violation|5|||
125010897|NCT02700412|449666523|FG000|Overall Study|Withdrawal by Subject|2|||
125010898|NCT04416555|449666524|FG000|Overall Study|Withdrawal by Subject|0|||
125010899|NCT04416555|449666525|FG001|Overall Study|Withdrawal by Subject|3|||
125010900|NCT03374189|449666534|FG000|Overall Study|Lost to Follow-up|1|||
125010901|NCT03374189|449666535|FG001|Overall Study|Lost to Follow-up|0|||
125010902|NCT00552175|449666536|FG000|Overall Study|Lack of Efficacy|2|||
125010903|NCT00552175|449666537|FG001|Overall Study|Lack of Efficacy|0|||
125010904|NCT00552175|449666538|FG002|Overall Study|Lack of Efficacy|1|||
125098536|NCT00985114|449980287|FG001|Overall Study|Adverse Event|0|||
125098537|NCT00985114|449980286|FG000|Overall Study|Withdrawal by Subject|0|||
124875273|NCT03420781|449165918|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
124875274|NCT03420781|449165914|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
124875275|NCT03420781|449165915|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
124875276|NCT03420781|449165916|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
124875277|NCT03420781|449165917|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
124875278|NCT03420781|449165918|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
124875279|NCT03420781|449165914|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
124875280|NCT03420781|449165915|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
125010905|NCT00552175|449666536|FG000|Overall Study|Adverse Event|9|||
125010906|NCT00552175|449666537|FG001|Overall Study|Adverse Event|9|||
125010907|NCT00552175|449666538|FG002|Overall Study|Adverse Event|10|||
125010908|NCT00552175|449666536|FG000|Overall Study|Withdrawal by Subject|2|||
124875281|NCT03420781|449165916|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
124875282|NCT03420781|449165917|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
124875283|NCT03420781|449165918|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
124875284|NCT03420781|449165914|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
124875285|NCT03420781|449165915|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
124875286|NCT03420781|449165916|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
124875287|NCT03420781|449165917|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
124875288|NCT03420781|449165918|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
124875289|NCT03420781|449165914|FG000|Treatment Period (40 Weeks)|Death|2|||
124875290|NCT03420781|449165915|FG001|Treatment Period (40 Weeks)|Death|2|||
124875291|NCT03420781|449165916|FG002|Treatment Period (40 Weeks)|Death|0|||
124875292|NCT03420781|449165917|FG003|Treatment Period (40 Weeks)|Death|0|||
124875293|NCT03420781|449165918|FG004|Treatment Period (40 Weeks)|Death|0|||
124875294|NCT03420781|449165914|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
124875295|NCT03420781|449165915|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
124875296|NCT03420781|449165916|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
124875297|NCT03420781|449165917|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
124875298|NCT03420781|449165918|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
124875299|NCT03420781|449165914|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
124875300|NCT03420781|449165915|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
124875301|NCT03420781|449165916|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
124875302|NCT03420781|449165917|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
124875303|NCT03420781|449165918|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
124875304|NCT03420781|449165914|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
124875305|NCT03420781|449165915|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
124875306|NCT03420781|449165916|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
124875307|NCT03420781|449165917|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
124875308|NCT03420781|449165918|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
124875309|NCT03420781|449165914|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
124875310|NCT03420781|449165915|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
124875311|NCT03420781|449165916|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
124875312|NCT03420781|449165917|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
124875313|NCT03420781|449165918|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
124875314|NCT03420781|449165914|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
124875315|NCT03420781|449165915|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
124875316|NCT03420781|449165916|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
124875317|NCT03420781|449165917|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
124875318|NCT03420781|449165918|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
124875319|NCT03420781|449165914|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
124875320|NCT03420781|449165915|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
124875321|NCT03420781|449165916|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
124875322|NCT03420781|449165917|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
124875323|NCT03420781|449165918|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
125098538|NCT00985114|449980287|FG001|Overall Study|Withdrawal by Subject|2|||
125098539|NCT01119118|449980288|FG000|Overall Study|Adverse Event|1|||
125098540|NCT01593761|449980291|FG000|Overall Study|Lost to Follow-up|1|||
125098541|NCT01593761|449980291|FG000|Overall Study|culture negative for MRSA at baseline|5|||
125098542|NCT01593761|449980291|FG000|Overall Study|positive for hepatitis C virus|1|||
125098543|NCT01593761|449980291|FG000|Overall Study|secondary cellulitis|1|||
125098544|NCT01302366|449981834|FG000|Overall Study|patient choice or noncompliance|5|||
125098545|NCT00509223|449981837|FG000|Overall Study|Lost to Follow-up|1|||
125098546|NCT00509223|449981838|FG001|Overall Study|Lost to Follow-up|1|||
125098547|NCT00509223|449981837|FG000|Overall Study|Adverse Event|1|||
125098548|NCT00509223|449981838|FG001|Overall Study|Adverse Event|1|||
125098549|NCT00509223|449981837|FG000|Overall Study|Withdrawal by Subject|25|||
125098550|NCT00509223|449981838|FG001|Overall Study|Withdrawal by Subject|6|||
125098551|NCT00509223|449981837|FG000|Overall Study|Including: subject change of address|5|||
125098552|NCT00509223|449981838|FG001|Overall Study|Including: subject change of address|2|||
125098553|NCT00509223|449981837|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
125098554|NCT00509223|449981838|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
125098555|NCT00934661|449981839|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
124875324|NCT03420781|449165914|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
124875325|NCT03420781|449165915|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
124875326|NCT03420781|449165916|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
125098556|NCT00934661|449981840|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
124875327|NCT03420781|449165917|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
125098557|NCT00467051|449981841|FG000|Overall Study|Adverse Event|2|||
125098558|NCT00437294|449981845|FG000|Overall Study|Adverse Event|5|||
125098559|NCT00437294|449981846|FG001|Overall Study|Adverse Event|4|||
125010909|NCT00552175|449666537|FG001|Overall Study|Withdrawal by Subject|2|||
125010910|NCT00552175|449666538|FG002|Overall Study|Withdrawal by Subject|1|||
125010911|NCT00552175|449666536|FG000|Overall Study|Lost to Follow-up|0|||
125010912|NCT00552175|449666537|FG001|Overall Study|Lost to Follow-up|0|||
125010913|NCT00552175|449666538|FG002|Overall Study|Lost to Follow-up|1|||
125010914|NCT00552175|449666536|FG000|Overall Study|Entry Criteria Not Met|1|||
125010915|NCT00552175|449666537|FG001|Overall Study|Entry Criteria Not Met|1|||
125010916|NCT00552175|449666538|FG002|Overall Study|Entry Criteria Not Met|0|||
125010917|NCT00552175|449666536|FG000|Overall Study|Reason Not Specified|3|||
125010918|NCT00552175|449666537|FG001|Overall Study|Reason Not Specified|1|||
125010919|NCT00552175|449666538|FG002|Overall Study|Reason Not Specified|1|||
125010920|NCT03975920|449666539|FG000|Overall Study|Lost to Follow-up|1|||
125010921|NCT03975920|449666540|FG001|Overall Study|Lost to Follow-up|2|||
125010922|NCT03975920|449666539|FG000|Overall Study|Protocol Violation|1|||
125010923|NCT03975920|449666540|FG001|Overall Study|Protocol Violation|1|||
125010924|NCT03975920|449666539|FG000|Overall Study|Did not complete survey|2|||
125010925|NCT03975920|449666540|FG001|Overall Study|Did not complete survey|1|||
125010926|NCT00884273|449666541|FG000|Overall Study|Adverse Event|0|||
125010927|NCT00884273|449666542|FG001|Overall Study|Adverse Event|2|||
125010928|NCT00884273|449666541|FG000|Overall Study|Protocol Violation|1|||
125010929|NCT00884273|449666542|FG001|Overall Study|Protocol Violation|3|||
125010930|NCT00884273|449666541|FG000|Overall Study|Practical reasons|1|||
125010931|NCT00884273|449666542|FG001|Overall Study|Practical reasons|0|||
125010932|NCT01147744|449666548|FG000|Overall Study|Protocol Violation|1|||
125010933|NCT01147744|449666549|FG001|Overall Study|Protocol Violation|0|||
125010934|NCT01147744|449666550|FG002|Overall Study|Protocol Violation|1|||
125010935|NCT01147744|449666551|FG003|Overall Study|Protocol Violation|0|||
125010936|NCT01147744|449666552|FG004|Overall Study|Protocol Violation|1|||
125010937|NCT01147744|449666553|FG005|Overall Study|Protocol Violation|3|||
125010938|NCT01147744|449666554|FG006|Overall Study|Protocol Violation|1|||
125010939|NCT01147744|449666548|FG000|Overall Study|Physician Decision|0|||
125010940|NCT01147744|449666549|FG001|Overall Study|Physician Decision|1|||
125010941|NCT01147744|449666550|FG002|Overall Study|Physician Decision|1|||
125010942|NCT01147744|449666551|FG003|Overall Study|Physician Decision|0|||
125010943|NCT01147744|449666552|FG004|Overall Study|Physician Decision|0|||
125010944|NCT01147744|449666553|FG005|Overall Study|Physician Decision|0|||
125010945|NCT01147744|449666554|FG006|Overall Study|Physician Decision|1|||
125010946|NCT01147744|449666548|FG000|Overall Study|Lack of Efficacy|11|||
125010947|NCT01147744|449666549|FG001|Overall Study|Lack of Efficacy|11|||
125010948|NCT01147744|449666550|FG002|Overall Study|Lack of Efficacy|9|||
125010949|NCT01147744|449666551|FG003|Overall Study|Lack of Efficacy|11|||
125010950|NCT01147744|449666552|FG004|Overall Study|Lack of Efficacy|13|||
125010951|NCT01147744|449666553|FG005|Overall Study|Lack of Efficacy|8|||
125010952|NCT01147744|449666554|FG006|Overall Study|Lack of Efficacy|7|||
125010953|NCT01147744|449666548|FG000|Overall Study|Adverse Event|1|||
125010954|NCT01147744|449666549|FG001|Overall Study|Adverse Event|2|||
125010955|NCT01147744|449666550|FG002|Overall Study|Adverse Event|3|||
125010956|NCT01147744|449666551|FG003|Overall Study|Adverse Event|0|||
125010957|NCT01147744|449666552|FG004|Overall Study|Adverse Event|2|||
125010958|NCT01147744|449666553|FG005|Overall Study|Adverse Event|1|||
125010959|NCT01147744|449666554|FG006|Overall Study|Adverse Event|2|||
125010960|NCT01147744|449666548|FG000|Overall Study|Withdrawal by Subject|8|||
125010961|NCT01147744|449666549|FG001|Overall Study|Withdrawal by Subject|4|||
125010962|NCT01147744|449666550|FG002|Overall Study|Withdrawal by Subject|2|||
125010963|NCT01147744|449666551|FG003|Overall Study|Withdrawal by Subject|2|||
125010964|NCT01147744|449666552|FG004|Overall Study|Withdrawal by Subject|2|||
125010965|NCT01147744|449666553|FG005|Overall Study|Withdrawal by Subject|5|||
125010966|NCT01147744|449666554|FG006|Overall Study|Withdrawal by Subject|2|||
125010967|NCT01147744|449666548|FG000|Overall Study|Lost to Follow-up|0|||
125010968|NCT01147744|449666549|FG001|Overall Study|Lost to Follow-up|1|||
125010969|NCT01147744|449666550|FG002|Overall Study|Lost to Follow-up|0|||
125010970|NCT01147744|449666551|FG003|Overall Study|Lost to Follow-up|0|||
125010971|NCT01147744|449666552|FG004|Overall Study|Lost to Follow-up|0|||
125010972|NCT01147744|449666553|FG005|Overall Study|Lost to Follow-up|0|||
125010973|NCT01147744|449666554|FG006|Overall Study|Lost to Follow-up|0|||
125010974|NCT01147744|449666548|FG000|Overall Study|Sponsor decision to amend protocol|7|||
125010975|NCT01147744|449666549|FG001|Overall Study|Sponsor decision to amend protocol|4|||
125010976|NCT01147744|449666550|FG002|Overall Study|Sponsor decision to amend protocol|2|||
125010977|NCT01147744|449666551|FG003|Overall Study|Sponsor decision to amend protocol|5|||
125010978|NCT01147744|449666552|FG004|Overall Study|Sponsor decision to amend protocol|7|||
125010979|NCT01147744|449666553|FG005|Overall Study|Sponsor decision to amend protocol|2|||
125010980|NCT01147744|449666554|FG006|Overall Study|Sponsor decision to amend protocol|6|||
125010981|NCT01147744|449666548|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
125010982|NCT01147744|449666549|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
125010983|NCT01147744|449666550|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
125010984|NCT01147744|449666551|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
125098560|NCT00437294|449981845|FG000|Overall Study|Death|5|||
125098561|NCT00437294|449981846|FG001|Overall Study|Death|2|||
125098562|NCT00437294|449981845|FG000|Overall Study|Physician Decision|0|||
125098563|NCT00437294|449981846|FG001|Overall Study|Physician Decision|3|||
125098564|NCT00437294|449981845|FG000|Overall Study|Withdrawal by Subject|5|||
125098565|NCT00437294|449981846|FG001|Overall Study|Withdrawal by Subject|0|||
125098566|NCT00437294|449981845|FG000|Overall Study|Progressive Disease|19|||
125098567|NCT00437294|449981846|FG001|Overall Study|Progressive Disease|23|||
125098568|NCT00437294|449981845|FG000|Overall Study|Sponsor Decision|8|||
125098569|NCT00437294|449981846|FG001|Overall Study|Sponsor Decision|9|||
125098570|NCT00437294|449981845|FG000|Overall Study|Protocol Violation|0|||
125098571|NCT00437294|449981846|FG001|Overall Study|Protocol Violation|1|||
125098572|NCT00437294|449981845|FG000|Overall Study|Entry criteria not met|1|||
125098573|NCT00437294|449981846|FG001|Overall Study|Entry criteria not met|1|||
125098574|NCT03113760|449981850|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
125098575|NCT03113760|449981851|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
125098576|NCT03113760|449981852|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
125098577|NCT03113760|449981853|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
125098578|NCT03113760|449981850|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
125098579|NCT03113760|449981851|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
125098580|NCT03113760|449981852|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
125098581|NCT03113760|449981853|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
125098582|NCT03113760|449981850|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
125098583|NCT03113760|449981851|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
125098584|NCT03113760|449981852|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
125098585|NCT03113760|449981853|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
125098586|NCT01012609|449981854|FG000|Overall Study|Withdrawal by Subject|1|||
125098587|NCT01012609|449981855|FG001|Overall Study|Withdrawal by Subject|1|||
125098588|NCT01453296|449981856|FG000|Treatment Period 1|Adverse Event|0|||
125098589|NCT01453296|449981857|FG001|Treatment Period 1|Adverse Event|1|||
125098590|NCT01453296|449981856|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
125098591|NCT01453296|449981857|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
125098592|NCT01453296|449981856|FG000|Treatment Period 2|Adverse Event|1|||
125098593|NCT01453296|449981857|FG001|Treatment Period 2|Adverse Event|0|||
125098594|NCT01453296|449981856|FG000|Treatment Period 2|Withdrawal by Subject|1|||
125098595|NCT01453296|449981857|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125098596|NCT03557775|449981858|FG000|Overall Study|Withdrawal by Subject|1|||
125098597|NCT03557775|449981859|FG001|Overall Study|Withdrawal by Subject|2|||
125098598|NCT03557775|449981860|FG002|Overall Study|Withdrawal by Subject|4|||
125098599|NCT03557775|449981858|FG000|Overall Study|Physician Decision|0|||
125098600|NCT03557775|449981859|FG001|Overall Study|Physician Decision|1|||
125098601|NCT03557775|449981860|FG002|Overall Study|Physician Decision|0|||
125098602|NCT03205046|449981868|FG000|Overall Study|Death|10|||
125098603|NCT03205046|449981869|FG001|Overall Study|Death|6|||
125098604|NCT03205046|449981868|FG000|Overall Study|Withdrawal by Subject|1|||
125098605|NCT03205046|449981869|FG001|Overall Study|Withdrawal by Subject|2|||
125098606|NCT03205046|449981868|FG000|Overall Study|Lost to Follow-up|0|||
125098607|NCT03205046|449981869|FG001|Overall Study|Lost to Follow-up|1|||
125098608|NCT03205046|449981868|FG000|Overall Study|Study terminated by sponsor|2|||
125098609|NCT03205046|449981869|FG001|Overall Study|Study terminated by sponsor|1|||
125098610|NCT01023815|449981870|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
125098611|NCT01023815|449981871|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
125098612|NCT01023815|449981872|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
125098613|NCT01023815|449981873|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
125098614|NCT01023815|449981870|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
125098615|NCT01023815|449981871|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
125098616|NCT01023815|449981872|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
125098617|NCT01023815|449981873|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
125098618|NCT01023815|449981870|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
125098619|NCT01023815|449981871|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
125098620|NCT01023815|449981872|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
125098621|NCT01023815|449981873|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
125098622|NCT01023815|449981870|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
125098623|NCT01023815|449981871|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
125098624|NCT01023815|449981872|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
125098625|NCT01023815|449981873|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
125098626|NCT01023815|449981870|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
125098627|NCT01023815|449981871|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
125098628|NCT01023815|449981872|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
125010985|NCT01147744|449666552|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
125010986|NCT01147744|449666553|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
125010987|NCT01147744|449666554|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
125010988|NCT02536313|449666555|FG000|Overall Study|Lack of Efficacy|0|||
125010989|NCT02536313|449666556|FG001|Overall Study|Lack of Efficacy|1|||
125010990|NCT02437864|449666566|FG000|Overall Study|Protocol Violation|4|||
125010991|NCT02437864|449666567|FG001|Overall Study|Protocol Violation|0|||
125010992|NCT00807742|449666569|FG000|Overall Study|Death|9|||
125010993|NCT00807742|449666570|FG001|Overall Study|Death|2|||
125010994|NCT00807742|449666569|FG000|Overall Study|Withdrawal by Subject|2|||
125010995|NCT00807742|449666570|FG001|Overall Study|Withdrawal by Subject|1|||
125010996|NCT00807742|449666569|FG000|Overall Study|Lost to Follow-up|35|||
125010997|NCT00807742|449666570|FG001|Overall Study|Lost to Follow-up|51|||
125010998|NCT00492752|449666571|FG000|Double Blind Treatment|Death|13|||
125010999|NCT00492752|449666572|FG001|Double Blind Treatment|Death|0|||
125011000|NCT00492752|449666573|FG002|Double Blind Treatment|Death|2|||
125011001|NCT00492752|449666574|FG003|Double Blind Treatment|Death|0|||
125011002|NCT00492752|449666571|FG000|Double Blind Treatment|Adverse Event|1|||
125011003|NCT00492752|449666572|FG001|Double Blind Treatment|Adverse Event|0|||
125011004|NCT00492752|449666573|FG002|Double Blind Treatment|Adverse Event|0|||
125011005|NCT00492752|449666574|FG003|Double Blind Treatment|Adverse Event|0|||
125011006|NCT00492752|449666571|FG000|Double Blind Treatment|Protocol Violation|0|||
125011007|NCT00492752|449666572|FG001|Double Blind Treatment|Protocol Violation|0|||
125011008|NCT00492752|449666573|FG002|Double Blind Treatment|Protocol Violation|1|||
125011009|NCT00492752|449666574|FG003|Double Blind Treatment|Protocol Violation|0|||
125011010|NCT00492752|449666571|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
125011011|NCT00492752|449666572|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
125011012|NCT00492752|449666573|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
125011013|NCT00492752|449666574|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
125011014|NCT00492752|449666571|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
125011015|NCT00492752|449666572|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
125011016|NCT00492752|449666573|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
125011017|NCT00492752|449666574|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
125011018|NCT00492752|449666571|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
125011019|NCT00492752|449666572|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
125011020|NCT00492752|449666573|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
125011021|NCT00492752|449666574|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
125011022|NCT00492752|449666571|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
125011023|NCT00492752|449666572|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
125011024|NCT00492752|449666573|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
125011025|NCT00492752|449666574|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
125011026|NCT00492752|449666571|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
125011027|NCT00492752|449666572|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
125011028|NCT00492752|449666573|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
125011029|NCT00492752|449666574|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
125011030|NCT00492752|449666571|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
125011031|NCT00492752|449666572|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
125011032|NCT00492752|449666573|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
125011033|NCT00492752|449666574|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
125011034|NCT00492752|449666571|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
125011035|NCT00492752|449666572|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
125011036|NCT00492752|449666573|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
125011037|NCT00492752|449666574|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
125011038|NCT00492752|449666571|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
125011039|NCT00492752|449666572|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
125011040|NCT00492752|449666573|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
125011041|NCT00492752|449666574|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
125011042|NCT02258451|449666575|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
125011043|NCT02258451|449666576|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
125011044|NCT02258451|449666575|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
125011045|NCT02258451|449666576|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
125011046|NCT02258451|449666575|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
125011047|NCT02258451|449666576|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
125011048|NCT02258451|449666575|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
125098629|NCT01023815|449981873|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
125098630|NCT03253809|449981876|FG000|Overall Study|Unable to obtain study related data|14|||
125098631|NCT03919669|449981877|FG000|Overall Study|Withdrawal by Subject|1|||
125098632|NCT03919669|449981878|FG001|Overall Study|Withdrawal by Subject|0|||
125098633|NCT03919669|449981879|FG002|Overall Study|Withdrawal by Subject|0|||
125098634|NCT02319642|449981880|FG000|Overall Study|Adverse Event|2|||
125098635|NCT02319642|449981881|FG001|Overall Study|Adverse Event|4|||
125098636|NCT02319642|449981880|FG000|Overall Study|Lack of Efficacy|1|||
125098637|NCT02319642|449981881|FG001|Overall Study|Lack of Efficacy|1|||
125098638|NCT02319642|449981880|FG000|Overall Study|Withdrawal by Subject|1|||
125098639|NCT02319642|449981881|FG001|Overall Study|Withdrawal by Subject|1|||
125098640|NCT05048875|449981887|FG000|Overall Study|Withdrawal by Subject|1|||
125098641|NCT05048875|449981888|FG001|Overall Study|Withdrawal by Subject|0|||
125098642|NCT05048875|449981889|FG002|Overall Study|Withdrawal by Subject|0|||
125098643|NCT05048875|449981890|FG003|Overall Study|Withdrawal by Subject|0|||
125098644|NCT05048875|449981891|FG004|Overall Study|Withdrawal by Subject|0|||
125098645|NCT05048875|449981892|FG005|Overall Study|Withdrawal by Subject|0|||
125098646|NCT05048875|449981893|FG006|Overall Study|Withdrawal by Subject|0|||
125098647|NCT05048875|449981894|FG007|Overall Study|Withdrawal by Subject|0|||
125098648|NCT05048875|449981887|FG000|Overall Study|Adverse Event|0|||
125098649|NCT05048875|449981888|FG001|Overall Study|Adverse Event|0|||
125098650|NCT05048875|449981889|FG002|Overall Study|Adverse Event|0|||
125098651|NCT05048875|449981890|FG003|Overall Study|Adverse Event|1|||
125098652|NCT05048875|449981891|FG004|Overall Study|Adverse Event|0|||
125098653|NCT05048875|449981892|FG005|Overall Study|Adverse Event|0|||
125098654|NCT05048875|449981893|FG006|Overall Study|Adverse Event|0|||
125098655|NCT05048875|449981894|FG007|Overall Study|Adverse Event|0|||
125098656|NCT02255422|449981899|FG000|Overall Study|Withdrawal by Subject|0|||
125098657|NCT02255422|449981900|FG001|Overall Study|Withdrawal by Subject|0|||
125098658|NCT02255422|449981901|FG002|Overall Study|Withdrawal by Subject|0|||
125098659|NCT02255422|449981902|FG003|Overall Study|Withdrawal by Subject|0|||
125098660|NCT02255422|449981903|FG004|Overall Study|Withdrawal by Subject|0|||
125098661|NCT02255422|449981904|FG005|Overall Study|Withdrawal by Subject|0|||
125098662|NCT02255422|449981905|FG006|Overall Study|Withdrawal by Subject|2|||
125098663|NCT02255422|449981899|FG000|Overall Study|Lost to Follow-up|0|||
125098664|NCT02255422|449981900|FG001|Overall Study|Lost to Follow-up|0|||
125098665|NCT02255422|449981901|FG002|Overall Study|Lost to Follow-up|1|||
125098666|NCT02255422|449981902|FG003|Overall Study|Lost to Follow-up|0|||
125098667|NCT02255422|449981903|FG004|Overall Study|Lost to Follow-up|0|||
125098668|NCT02255422|449981904|FG005|Overall Study|Lost to Follow-up|0|||
125098669|NCT02255422|449981905|FG006|Overall Study|Lost to Follow-up|0|||
125098670|NCT04411641|449981906|FG000|DB Period|Other|7|||
125098671|NCT04411641|449981907|FG001|DB Period|Other|27|||
125098672|NCT04411641|449981908|FG002|DB Period|Other|0|||
125098673|NCT04411641|449981909|FG003|DB Period|Other|0|||
125098674|NCT04411641|449981906|FG000|DB Period|Withdrawal by Subject|67|||
125098675|NCT04411641|449981907|FG001|DB Period|Withdrawal by Subject|122|||
125098676|NCT04411641|449981908|FG002|DB Period|Withdrawal by Subject|0|||
125098677|NCT04411641|449981909|FG003|DB Period|Withdrawal by Subject|0|||
125098678|NCT04411641|449981906|FG000|DB Period|Progressive disease|76|||
125098679|NCT04411641|449981907|FG001|DB Period|Progressive disease|116|||
125098680|NCT04411641|449981908|FG002|DB Period|Progressive disease|0|||
125098681|NCT04411641|449981909|FG003|DB Period|Progressive disease|0|||
125098682|NCT04411641|449981906|FG000|DB Period|Poor compliance to protocol|1|||
125098683|NCT04411641|449981907|FG001|DB Period|Poor compliance to protocol|5|||
125098684|NCT04411641|449981908|FG002|DB Period|Poor compliance to protocol|0|||
125098685|NCT04411641|449981909|FG003|DB Period|Poor compliance to protocol|0|||
125098686|NCT04411641|449981906|FG000|DB Period|Lack of Efficacy|19|||
125098687|NCT04411641|449981907|FG001|DB Period|Lack of Efficacy|19|||
125098688|NCT04411641|449981908|FG002|DB Period|Lack of Efficacy|0|||
125098689|NCT04411641|449981909|FG003|DB Period|Lack of Efficacy|0|||
125098690|NCT04411641|449981906|FG000|DB Period|Adverse Event|13|||
125098691|NCT04411641|449981907|FG001|DB Period|Adverse Event|29|||
125098692|NCT04411641|449981908|FG002|DB Period|Adverse Event|0|||
125098693|NCT04411641|449981909|FG003|DB Period|Adverse Event|0|||
125098694|NCT04411641|449981906|FG000|DB Period|Randomized and not treated|2|||
125098695|NCT04411641|449981907|FG001|DB Period|Randomized and not treated|2|||
125098696|NCT04411641|449981908|FG002|DB Period|Randomized and not treated|0|||
125098697|NCT04411641|449981909|FG003|DB Period|Randomized and not treated|0|||
125098698|NCT04411641|449981906|FG000|OL|Withdrawal by Subject|0|||
125098699|NCT04411641|449981907|FG001|OL|Withdrawal by Subject|0|||
125098700|NCT04411641|449981908|FG002|OL|Withdrawal by Subject|6|||
125098701|NCT04411641|449981909|FG003|OL|Withdrawal by Subject|17|||
125098702|NCT04411641|449981906|FG000|OL|Progressive disease|0|||
125098703|NCT04411641|449981907|FG001|OL|Progressive disease|0|||
125098704|NCT04411641|449981908|FG002|OL|Progressive disease|1|||
125098705|NCT04411641|449981909|FG003|OL|Progressive disease|2|||
125098706|NCT04411641|449981906|FG000|OL|Poor compliance to protocol|0|||
125098707|NCT04411641|449981907|FG001|OL|Poor compliance to protocol|0|||
125098708|NCT04411641|449981908|FG002|OL|Poor compliance to protocol|1|||
125098709|NCT04411641|449981909|FG003|OL|Poor compliance to protocol|0|||
125098710|NCT04411641|449981906|FG000|OL|Adverse Event|0|||
125098711|NCT04411641|449981907|FG001|OL|Adverse Event|0|||
125098712|NCT04411641|449981908|FG002|OL|Adverse Event|1|||
125098713|NCT04411641|449981909|FG003|OL|Adverse Event|0|||
125098714|NCT04411641|449981906|FG000|OL|Other|0|||
125098715|NCT04411641|449981907|FG001|OL|Other|0|||
125098716|NCT04411641|449981908|FG002|OL|Other|0|||
125098717|NCT04411641|449981909|FG003|OL|Other|6|||
125098718|NCT01250418|449981917|FG000|Overall Study|monitor data failure|1|||
125011049|NCT02258451|449666576|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
125011050|NCT02258451|449666575|FG000|Overall Study|Discontinuation all treatment due to death|4|||
125011051|NCT02258451|449666576|FG001|Overall Study|Discontinuation all treatment due to death|3|||
125011052|NCT02258451|449666575|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
125011053|NCT02258451|449666576|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
125011054|NCT02258451|449666575|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
125011055|NCT02258451|449666576|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
125011056|NCT02258451|449666575|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
125011057|NCT02258451|449666576|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
125011058|NCT02258451|449666575|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
125011059|NCT02258451|449666576|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
125011060|NCT02258451|449666575|FG000|Overall Study|Other reason|1|||
125011061|NCT02258451|449666576|FG001|Overall Study|Other reason|1|||
125011062|NCT02258451|449666575|FG000|Overall Study|Never treated|2|||
125011063|NCT02258451|449666576|FG001|Overall Study|Never treated|3|||
125011064|NCT05419128|449666577|FG000|Overall Study|Withdrawal by Subject|1|||
125011065|NCT05419128|449666578|FG001|Overall Study|Withdrawal by Subject|1|||
125011066|NCT05419128|449666579|FG002|Overall Study|Withdrawal by Subject|0|||
125011067|NCT05419128|449666580|FG003|Overall Study|Withdrawal by Subject|1|||
125011068|NCT05419128|449666581|FG004|Overall Study|Withdrawal by Subject|1|||
125011069|NCT05419128|449666582|FG005|Overall Study|Withdrawal by Subject|0|||
125011070|NCT05419128|449666577|FG000|Overall Study|Lost to Follow-up|0|||
125011071|NCT05419128|449666578|FG001|Overall Study|Lost to Follow-up|0|||
125011072|NCT05419128|449666579|FG002|Overall Study|Lost to Follow-up|1|||
125011073|NCT05419128|449666580|FG003|Overall Study|Lost to Follow-up|0|||
125011074|NCT05419128|449666581|FG004|Overall Study|Lost to Follow-up|0|||
125011075|NCT05419128|449666582|FG005|Overall Study|Lost to Follow-up|1|||
125011076|NCT03834519|449666583|FG000|Overall Study|Lost to Follow-up|2|||
125011077|NCT03834519|449666584|FG001|Overall Study|Lost to Follow-up|1|||
125011078|NCT03834519|449666583|FG000|Overall Study|Withdrawal by Subject|5|||
125011079|NCT03834519|449666584|FG001|Overall Study|Withdrawal by Subject|8|||
125011080|NCT03834519|449666583|FG000|Overall Study|Death|368|||
125011081|NCT03834519|449666584|FG001|Overall Study|Death|174|||
125011082|NCT03834519|449666583|FG000|Overall Study|Physician Decision|5|||
125011083|NCT03834519|449666584|FG001|Overall Study|Physician Decision|1|||
125011084|NCT03834519|449666583|FG000|Overall Study|Sponsor decision|149|||
125011085|NCT03834519|449666584|FG001|Overall Study|Sponsor decision|80|||
125011086|NCT04066491|449666585|FG000|Overall Study|Randomized, not treated|0|||
125011087|NCT04066491|449666586|FG001|Overall Study|Randomized, not treated|0|||
125011088|NCT04066491|449666587|FG002|Overall Study|Randomized, not treated|2|||
125011089|NCT04506086|449666588|FG000|Overall Study|Withdrawal by Subject|2|||
125011090|NCT00517751|449666589|FG000|Overall Study|Death|3|||
125011091|NCT00517751|449666589|FG000|Overall Study|Withdrawal by Subject|37|||
125011092|NCT00517751|449666589|FG000|Overall Study|Lost to Follow-up|4|||
125011093|NCT00517751|449666589|FG000|Overall Study|patient not over due|6|||
125011094|NCT00517751|449666589|FG000|Overall Study|Patient not due for visit|76|||
125011095|NCT00517751|449666589|FG000|Overall Study|Missing|3|||
125011096|NCT01484977|449666594|FG000|Overall Study|Adverse Event|8|||
125011097|NCT01484977|449666594|FG000|Overall Study|Lack of Efficacy|4|||
125011098|NCT01484977|449666594|FG000|Overall Study|Protocol Violation|6|||
125011099|NCT01484977|449666594|FG000|Overall Study|Lost to Follow-up|1|||
125011100|NCT01484977|449666594|FG000|Overall Study|Withdrawal by Subject|4|||
125011101|NCT01484977|449666594|FG000|Overall Study|Subject Protocol Non-compliant|1|||
125011102|NCT01484977|449666594|FG000|Overall Study|Moving Overseas|1|||
125098719|NCT01250418|449981918|FG001|Overall Study|monitor data failure|1|||
125011103|NCT01484977|449666594|FG000|Overall Study|Low White Blood Cell Count|1|||
125011104|NCT01484977|449666594|FG000|Overall Study|Lack of Compliance|1|||
125011105|NCT00495820|449666595|FG000|Overall Study|Adverse Event|1|||
125098720|NCT01761565|449981919|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
125098721|NCT05182840|449981921|FG000|Run-in Period|Not treated|0|||
125098722|NCT05182840|449981922|FG001|Run-in Period|Not treated|1|||
125011106|NCT00495820|449666596|FG001|Overall Study|Adverse Event|1|||
125098723|NCT05182840|449981923|FG002|Run-in Period|Not treated|0|||
125098724|NCT05182840|449981924|FG003|Run-in Period|Not treated|0|||
125098725|NCT05182840|449981925|FG004|Run-in Period|Not treated|0|||
125098726|NCT05182840|449981926|FG005|Run-in Period|Not treated|0|||
125098727|NCT05182840|449981927|FG006|Run-in Period|Not treated|0|||
125098728|NCT05182840|449981928|FG007|Run-in Period|Not treated|0|||
125098729|NCT05182840|449981929|FG008|Run-in Period|Not treated|0|||
125098730|NCT05182840|449981930|FG009|Run-in Period|Not treated|0|||
125098731|NCT05182840|449981921|FG000|Run-in Period|Other reason but not sponsor termination|14|||
125098732|NCT05182840|449981922|FG001|Run-in Period|Other reason but not sponsor termination|18|||
125098733|NCT05182840|449981923|FG002|Run-in Period|Other reason but not sponsor termination|0|||
125098734|NCT05182840|449981924|FG003|Run-in Period|Other reason but not sponsor termination|0|||
125098735|NCT05182840|449981925|FG004|Run-in Period|Other reason but not sponsor termination|0|||
125098736|NCT05182840|449981926|FG005|Run-in Period|Other reason but not sponsor termination|0|||
125098737|NCT05182840|449981927|FG006|Run-in Period|Other reason but not sponsor termination|0|||
125098738|NCT05182840|449981928|FG007|Run-in Period|Other reason but not sponsor termination|0|||
125098739|NCT05182840|449981929|FG008|Run-in Period|Other reason but not sponsor termination|0|||
125098740|NCT05182840|449981930|FG009|Run-in Period|Other reason but not sponsor termination|0|||
125098741|NCT05182840|449981921|FG000|Run-in Period|No reason available|2|||
125098742|NCT05182840|449981922|FG001|Run-in Period|No reason available|2|||
125098743|NCT05182840|449981923|FG002|Run-in Period|No reason available|0|||
125098744|NCT05182840|449981924|FG003|Run-in Period|No reason available|0|||
125098745|NCT05182840|449981925|FG004|Run-in Period|No reason available|0|||
125098746|NCT05182840|449981926|FG005|Run-in Period|No reason available|0|||
125098747|NCT05182840|449981927|FG006|Run-in Period|No reason available|0|||
125098748|NCT05182840|449981928|FG007|Run-in Period|No reason available|0|||
125098749|NCT05182840|449981929|FG008|Run-in Period|No reason available|0|||
125098750|NCT05182840|449981930|FG009|Run-in Period|No reason available|0|||
125098751|NCT05182840|449981921|FG000|Run-in Period|Burden of study procedures|2|||
125098752|NCT05182840|449981922|FG001|Run-in Period|Burden of study procedures|2|||
125098753|NCT05182840|449981923|FG002|Run-in Period|Burden of study procedures|0|||
125098754|NCT05182840|449981924|FG003|Run-in Period|Burden of study procedures|0|||
125098755|NCT05182840|449981925|FG004|Run-in Period|Burden of study procedures|0|||
125098756|NCT05182840|449981926|FG005|Run-in Period|Burden of study procedures|0|||
125098757|NCT05182840|449981927|FG006|Run-in Period|Burden of study procedures|0|||
125098758|NCT05182840|449981928|FG007|Run-in Period|Burden of study procedures|0|||
125098759|NCT05182840|449981929|FG008|Run-in Period|Burden of study procedures|0|||
125098760|NCT05182840|449981930|FG009|Run-in Period|Burden of study procedures|0|||
125098761|NCT05182840|449981921|FG000|Run-in Period|Change of residence|1|||
125098762|NCT05182840|449981922|FG001|Run-in Period|Change of residence|0|||
125098763|NCT05182840|449981923|FG002|Run-in Period|Change of residence|0|||
125098764|NCT05182840|449981924|FG003|Run-in Period|Change of residence|0|||
125098765|NCT05182840|449981925|FG004|Run-in Period|Change of residence|0|||
125098766|NCT05182840|449981926|FG005|Run-in Period|Change of residence|0|||
125098767|NCT05182840|449981927|FG006|Run-in Period|Change of residence|0|||
125098768|NCT05182840|449981928|FG007|Run-in Period|Change of residence|0|||
125098769|NCT05182840|449981929|FG008|Run-in Period|Change of residence|0|||
125098770|NCT05182840|449981930|FG009|Run-in Period|Change of residence|0|||
125098771|NCT05182840|449981921|FG000|Run-in Period|Adverse Event|5|||
125098772|NCT05182840|449981922|FG001|Run-in Period|Adverse Event|5|||
125098773|NCT05182840|449981923|FG002|Run-in Period|Adverse Event|0|||
125098774|NCT05182840|449981924|FG003|Run-in Period|Adverse Event|0|||
125098775|NCT05182840|449981925|FG004|Run-in Period|Adverse Event|0|||
125098776|NCT05182840|449981926|FG005|Run-in Period|Adverse Event|0|||
125098777|NCT05182840|449981927|FG006|Run-in Period|Adverse Event|0|||
125098778|NCT05182840|449981928|FG007|Run-in Period|Adverse Event|0|||
125098779|NCT05182840|449981929|FG008|Run-in Period|Adverse Event|0|||
125098780|NCT05182840|449981930|FG009|Run-in Period|Adverse Event|0|||
125098781|NCT05182840|449981921|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
125098782|NCT05182840|449981922|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
125098783|NCT05182840|449981923|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
125098784|NCT05182840|449981924|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
125098785|NCT05182840|449981925|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
125098786|NCT05182840|449981926|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
125098787|NCT05182840|449981927|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
125098788|NCT05182840|449981928|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
125098789|NCT05182840|449981929|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
125098790|NCT05182840|449981930|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
125098791|NCT05182840|449981921|FG000|Treatment Period|Reason missing|0|||
125098792|NCT05182840|449981922|FG001|Treatment Period|Reason missing|0|||
125098793|NCT05182840|449981923|FG002|Treatment Period|Reason missing|1|||
125098794|NCT05182840|449981924|FG003|Treatment Period|Reason missing|0|||
125098795|NCT05182840|449981925|FG004|Treatment Period|Reason missing|0|||
125098796|NCT05182840|449981926|FG005|Treatment Period|Reason missing|0|||
124875328|NCT03420781|449165918|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
125011107|NCT04857996|449666597|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
125011108|NCT04857996|449666598|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
125011109|NCT04857996|449666597|FG000|Overall Study|Lost to Follow-up|1|||
125011110|NCT04857996|449666598|FG001|Overall Study|Lost to Follow-up|3|||
125011111|NCT04857996|449666597|FG000|Overall Study|Site Closure|1|||
125011112|NCT04857996|449666598|FG001|Overall Study|Site Closure|0|||
125011113|NCT04857996|449666597|FG000|Overall Study|Withdrawal by Subject|1|||
125011114|NCT04857996|449666598|FG001|Overall Study|Withdrawal by Subject|0|||
125011115|NCT00820950|449666599|FG000|Overall Study|Scheduling Conflict|0|||
125011116|NCT00820950|449666600|FG001|Overall Study|Scheduling Conflict|0|||
125011117|NCT00820950|449666601|FG002|Overall Study|Scheduling Conflict|0|||
125011118|NCT00820950|449666602|FG003|Overall Study|Scheduling Conflict|0|||
125011119|NCT00820950|449666603|FG004|Overall Study|Scheduling Conflict|0|||
125011120|NCT00820950|449666604|FG005|Overall Study|Scheduling Conflict|0|||
125011121|NCT00820950|449666605|FG006|Overall Study|Scheduling Conflict|1|||
125011122|NCT00820950|449666606|FG007|Overall Study|Scheduling Conflict|1|||
125011123|NCT00820950|449666607|FG008|Overall Study|Scheduling Conflict|0|||
125011124|NCT00820950|449666608|FG009|Overall Study|Scheduling Conflict|0|||
125011125|NCT00820950|449666599|FG000|Overall Study|Protocol Violation|1|||
125011126|NCT00820950|449666600|FG001|Overall Study|Protocol Violation|1|||
125011127|NCT00820950|449666601|FG002|Overall Study|Protocol Violation|0|||
125011128|NCT00820950|449666602|FG003|Overall Study|Protocol Violation|0|||
125011129|NCT00820950|449666603|FG004|Overall Study|Protocol Violation|0|||
125011130|NCT00820950|449666604|FG005|Overall Study|Protocol Violation|0|||
125011131|NCT00820950|449666605|FG006|Overall Study|Protocol Violation|0|||
125011132|NCT00820950|449666606|FG007|Overall Study|Protocol Violation|0|||
125011133|NCT00820950|449666607|FG008|Overall Study|Protocol Violation|0|||
125011134|NCT00820950|449666608|FG009|Overall Study|Protocol Violation|0|||
125011135|NCT00798135|449666609|FG000|Overall Study|Disease progression, relapse|11|||
125011136|NCT00798135|449666609|FG000|Overall Study|Disease progression, refractory|1|||
125011137|NCT00798135|449666609|FG000|Overall Study|Physician Decision|1|||
125011138|NCT01423851|449666613|FG000|Whole Study|Disease progression|2|||
125011139|NCT01423851|449666614|FG001|Whole Study|Disease progression|1|||
125011140|NCT01423851|449666615|FG002|Whole Study|Disease progression|1|||
125011141|NCT01423851|449666616|FG003|Whole Study|Disease progression|4|||
125011142|NCT01423851|449666617|FG004|Whole Study|Disease progression|1|||
125011143|NCT01423851|449666618|FG005|Whole Study|Disease progression|3|||
125011144|NCT01423851|449666619|FG006|Whole Study|Disease progression|1|||
125011145|NCT01423851|449666620|FG007|Whole Study|Disease progression|4|||
125011146|NCT01423851|449666621|FG008|Whole Study|Disease progression|0|||
125011147|NCT01423851|449666622|FG009|Whole Study|Disease progression|2|||
125011148|NCT01423851|449666623|FG010|Whole Study|Disease progression|10|||
125011149|NCT01423851|449666613|FG000|Whole Study|Physician Decision|0|||
125011150|NCT01423851|449666614|FG001|Whole Study|Physician Decision|1|||
125011151|NCT01423851|449666615|FG002|Whole Study|Physician Decision|2|||
125011152|NCT01423851|449666616|FG003|Whole Study|Physician Decision|0|||
125011153|NCT01423851|449666617|FG004|Whole Study|Physician Decision|2|||
125011154|NCT01423851|449666618|FG005|Whole Study|Physician Decision|0|||
125011155|NCT01423851|449666619|FG006|Whole Study|Physician Decision|2|||
125011156|NCT01423851|449666620|FG007|Whole Study|Physician Decision|1|||
125011157|NCT01423851|449666621|FG008|Whole Study|Physician Decision|3|||
125011158|NCT01423851|449666622|FG009|Whole Study|Physician Decision|4|||
125011159|NCT01423851|449666623|FG010|Whole Study|Physician Decision|12|||
125011160|NCT01423851|449666613|FG000|Whole Study|Withdrawal by Subject|1|||
125011161|NCT01423851|449666614|FG001|Whole Study|Withdrawal by Subject|1|||
125011162|NCT01423851|449666615|FG002|Whole Study|Withdrawal by Subject|0|||
125011163|NCT01423851|449666616|FG003|Whole Study|Withdrawal by Subject|0|||
125011164|NCT01423851|449666617|FG004|Whole Study|Withdrawal by Subject|0|||
125011165|NCT01423851|449666618|FG005|Whole Study|Withdrawal by Subject|0|||
125011166|NCT01423851|449666619|FG006|Whole Study|Withdrawal by Subject|0|||
125011167|NCT01423851|449666620|FG007|Whole Study|Withdrawal by Subject|0|||
125011168|NCT01423851|449666621|FG008|Whole Study|Withdrawal by Subject|2|||
125011169|NCT01423851|449666622|FG009|Whole Study|Withdrawal by Subject|0|||
125011170|NCT01423851|449666623|FG010|Whole Study|Withdrawal by Subject|4|||
125011171|NCT01423851|449666613|FG000|Whole Study|Adverse Event|0|||
125011172|NCT01423851|449666614|FG001|Whole Study|Adverse Event|0|||
125011173|NCT01423851|449666615|FG002|Whole Study|Adverse Event|0|||
125011174|NCT01423851|449666616|FG003|Whole Study|Adverse Event|2|||
125011175|NCT01423851|449666617|FG004|Whole Study|Adverse Event|0|||
125011176|NCT01423851|449666618|FG005|Whole Study|Adverse Event|0|||
125011177|NCT01423851|449666619|FG006|Whole Study|Adverse Event|0|||
125011178|NCT01423851|449666620|FG007|Whole Study|Adverse Event|3|||
125011179|NCT01423851|449666621|FG008|Whole Study|Adverse Event|3|||
125011180|NCT01423851|449666622|FG009|Whole Study|Adverse Event|2|||
125098797|NCT05182840|449981927|FG006|Treatment Period|Reason missing|0|||
125011181|NCT01423851|449666623|FG010|Whole Study|Adverse Event|3|||
125011182|NCT03080883|449666624|FG000|Overall Study|Withdrawal by Subject|11|||
125011183|NCT03080883|449666625|FG001|Overall Study|Withdrawal by Subject|15|||
125011184|NCT03080883|449666624|FG000|Overall Study|Adverse Event|22|||
125011185|NCT03080883|449666625|FG001|Overall Study|Adverse Event|22|||
125098798|NCT05182840|449981928|FG007|Treatment Period|Reason missing|0|||
125098799|NCT05182840|449981929|FG008|Treatment Period|Reason missing|0|||
125098800|NCT05182840|449981930|FG009|Treatment Period|Reason missing|0|||
125098801|NCT05182840|449981921|FG000|Treatment Period|Other but not sponsor termination|0|||
125098802|NCT05182840|449981922|FG001|Treatment Period|Other but not sponsor termination|0|||
125098803|NCT05182840|449981923|FG002|Treatment Period|Other but not sponsor termination|8|||
125098804|NCT05182840|449981924|FG003|Treatment Period|Other but not sponsor termination|6|||
125098805|NCT05182840|449981925|FG004|Treatment Period|Other but not sponsor termination|6|||
125098806|NCT05182840|449981926|FG005|Treatment Period|Other but not sponsor termination|7|||
125098807|NCT05182840|449981927|FG006|Treatment Period|Other but not sponsor termination|5|||
125098808|NCT05182840|449981928|FG007|Treatment Period|Other but not sponsor termination|8|||
125098809|NCT05182840|449981929|FG008|Treatment Period|Other but not sponsor termination|7|||
125098810|NCT05182840|449981930|FG009|Treatment Period|Other but not sponsor termination|2|||
125098811|NCT05182840|449981921|FG000|Treatment Period|Protocol deviation|0|||
125098812|NCT05182840|449981922|FG001|Treatment Period|Protocol deviation|0|||
125098813|NCT05182840|449981923|FG002|Treatment Period|Protocol deviation|0|||
125098814|NCT05182840|449981924|FG003|Treatment Period|Protocol deviation|0|||
125098815|NCT05182840|449981925|FG004|Treatment Period|Protocol deviation|0|||
125098816|NCT05182840|449981926|FG005|Treatment Period|Protocol deviation|0|||
125098817|NCT05182840|449981927|FG006|Treatment Period|Protocol deviation|0|||
125098818|NCT05182840|449981928|FG007|Treatment Period|Protocol deviation|0|||
125098819|NCT05182840|449981929|FG008|Treatment Period|Protocol deviation|1|||
125098820|NCT05182840|449981930|FG009|Treatment Period|Protocol deviation|0|||
125098821|NCT05182840|449981921|FG000|Treatment Period|No reason available|0|||
125098822|NCT05182840|449981922|FG001|Treatment Period|No reason available|0|||
125098823|NCT05182840|449981923|FG002|Treatment Period|No reason available|0|||
125098824|NCT05182840|449981924|FG003|Treatment Period|No reason available|1|||
125098825|NCT05182840|449981925|FG004|Treatment Period|No reason available|0|||
125098826|NCT05182840|449981926|FG005|Treatment Period|No reason available|2|||
125098827|NCT05182840|449981927|FG006|Treatment Period|No reason available|0|||
125098828|NCT05182840|449981928|FG007|Treatment Period|No reason available|1|||
125098829|NCT05182840|449981929|FG008|Treatment Period|No reason available|0|||
125098830|NCT05182840|449981930|FG009|Treatment Period|No reason available|0|||
125098831|NCT05182840|449981921|FG000|Treatment Period|Burden of study procedures|0|||
125098832|NCT05182840|449981922|FG001|Treatment Period|Burden of study procedures|0|||
125098833|NCT05182840|449981923|FG002|Treatment Period|Burden of study procedures|0|||
125098834|NCT05182840|449981924|FG003|Treatment Period|Burden of study procedures|0|||
125098835|NCT05182840|449981925|FG004|Treatment Period|Burden of study procedures|1|||
125098836|NCT05182840|449981926|FG005|Treatment Period|Burden of study procedures|0|||
125098837|NCT05182840|449981927|FG006|Treatment Period|Burden of study procedures|0|||
125098838|NCT05182840|449981928|FG007|Treatment Period|Burden of study procedures|0|||
125098839|NCT05182840|449981929|FG008|Treatment Period|Burden of study procedures|0|||
125098840|NCT05182840|449981930|FG009|Treatment Period|Burden of study procedures|0|||
125098841|NCT05182840|449981921|FG000|Treatment Period|Change of residence|0|||
125098842|NCT05182840|449981922|FG001|Treatment Period|Change of residence|0|||
125098843|NCT05182840|449981923|FG002|Treatment Period|Change of residence|0|||
125098844|NCT05182840|449981924|FG003|Treatment Period|Change of residence|0|||
125098845|NCT05182840|449981925|FG004|Treatment Period|Change of residence|0|||
125098846|NCT05182840|449981926|FG005|Treatment Period|Change of residence|1|||
125098847|NCT05182840|449981927|FG006|Treatment Period|Change of residence|0|||
125098848|NCT05182840|449981928|FG007|Treatment Period|Change of residence|0|||
125098849|NCT05182840|449981929|FG008|Treatment Period|Change of residence|0|||
125098850|NCT05182840|449981930|FG009|Treatment Period|Change of residence|0|||
125098851|NCT05182840|449981921|FG000|Treatment Period|Adverse Event|0|||
125098852|NCT05182840|449981922|FG001|Treatment Period|Adverse Event|0|||
125098853|NCT05182840|449981923|FG002|Treatment Period|Adverse Event|4|||
125098854|NCT05182840|449981924|FG003|Treatment Period|Adverse Event|16|||
125098855|NCT05182840|449981925|FG004|Treatment Period|Adverse Event|12|||
125098856|NCT05182840|449981926|FG005|Treatment Period|Adverse Event|6|||
125098857|NCT05182840|449981927|FG006|Treatment Period|Adverse Event|4|||
125098858|NCT05182840|449981928|FG007|Treatment Period|Adverse Event|8|||
125098859|NCT05182840|449981929|FG008|Treatment Period|Adverse Event|16|||
125098860|NCT05182840|449981930|FG009|Treatment Period|Adverse Event|5|||
125098861|NCT05182840|449981921|FG000|Treatment Period|Not treated with study drug|0|||
125098862|NCT05182840|449981922|FG001|Treatment Period|Not treated with study drug|0|||
125098863|NCT05182840|449981923|FG002|Treatment Period|Not treated with study drug|0|||
125098864|NCT05182840|449981924|FG003|Treatment Period|Not treated with study drug|1|||
125098865|NCT05182840|449981925|FG004|Treatment Period|Not treated with study drug|0|||
125098866|NCT05182840|449981926|FG005|Treatment Period|Not treated with study drug|0|||
125098867|NCT05182840|449981927|FG006|Treatment Period|Not treated with study drug|1|||
125098868|NCT05182840|449981928|FG007|Treatment Period|Not treated with study drug|1|||
124969497|NCT03520075|449517410|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
125098869|NCT05182840|449981929|FG008|Treatment Period|Not treated with study drug|0|||
125098870|NCT05182840|449981930|FG009|Treatment Period|Not treated with study drug|0|||
125098871|NCT02161380|449981931|FG000|Overall Study|Lost to Follow-up|0|||
125098872|NCT02161380|449981932|FG001|Overall Study|Lost to Follow-up|1|||
125098873|NCT02161380|449981933|FG002|Overall Study|Lost to Follow-up|0|||
125098874|NCT02161380|449981934|FG003|Overall Study|Lost to Follow-up|0|||
125098875|NCT02268214|449981941|FG000|Overall Study|Subject no longer meets study criteria|0|||
125098876|NCT02268214|449981942|FG001|Overall Study|Subject no longer meets study criteria|2|||
125098877|NCT02268214|449981943|FG002|Overall Study|Subject no longer meets study criteria|0|||
125098878|NCT02268214|449981941|FG000|Overall Study|Pregnancy|2|||
125098879|NCT02268214|449981942|FG001|Overall Study|Pregnancy|2|||
125098880|NCT02268214|449981943|FG002|Overall Study|Pregnancy|1|||
125098881|NCT02268214|449981941|FG000|Overall Study|Lost to Follow-up|3|||
125098882|NCT02268214|449981942|FG001|Overall Study|Lost to Follow-up|3|||
125098883|NCT02268214|449981943|FG002|Overall Study|Lost to Follow-up|4|||
125098884|NCT02268214|449981941|FG000|Overall Study|Lack of Efficacy|1|||
125098885|NCT02268214|449981942|FG001|Overall Study|Lack of Efficacy|0|||
125098886|NCT02268214|449981943|FG002|Overall Study|Lack of Efficacy|2|||
125098887|NCT02268214|449981941|FG000|Overall Study|Adverse Event|11|||
125098888|NCT02268214|449981942|FG001|Overall Study|Adverse Event|14|||
125098889|NCT02268214|449981943|FG002|Overall Study|Adverse Event|9|||
125098890|NCT02268214|449981941|FG000|Overall Study|Withdrawal by Subject|4|||
125098891|NCT02268214|449981942|FG001|Overall Study|Withdrawal by Subject|5|||
125098892|NCT02268214|449981943|FG002|Overall Study|Withdrawal by Subject|10|||
125098893|NCT02268214|449981941|FG000|Overall Study|Subject request to discontinue treatment|10|||
125098894|NCT02268214|449981942|FG001|Overall Study|Subject request to discontinue treatment|8|||
125098895|NCT02268214|449981943|FG002|Overall Study|Subject request to discontinue treatment|6|||
125098896|NCT02268214|449981941|FG000|Overall Study|Poor/non-compliance|2|||
125098897|NCT02268214|449981942|FG001|Overall Study|Poor/non-compliance|1|||
125098898|NCT02268214|449981943|FG002|Overall Study|Poor/non-compliance|2|||
125098899|NCT02268214|449981941|FG000|Overall Study|Other reasons|7|||
125098900|NCT02268214|449981942|FG001|Overall Study|Other reasons|3|||
125098901|NCT02268214|449981943|FG002|Overall Study|Other reasons|3|||
125098902|NCT02268214|449981941|FG000|Overall Study|Not entering long-term period|2|||
125098903|NCT02268214|449981942|FG001|Overall Study|Not entering long-term period|3|||
125098904|NCT02268214|449981943|FG002|Overall Study|Not entering long-term period|5|||
125098905|NCT04342390|449981944|FG000|Overall Study|Lost to Follow-up|3|||
125098906|NCT04342390|449981945|FG001|Overall Study|Lost to Follow-up|0|||
125098907|NCT00948896|449981955|FG000|Randomization to 24 Months of Age|Death|1|||
125098908|NCT00948896|449981956|FG001|Randomization to 24 Months of Age|Death|0|||
125098909|NCT00948896|449981957|FG002|Randomization to 24 Months of Age|Death|0|||
125098910|NCT00948896|449981958|FG003|Randomization to 24 Months of Age|Death|0|||
125098911|NCT00948896|449981959|FG004|Randomization to 24 Months of Age|Death|2|||
125098912|NCT00948896|449981960|FG005|Randomization to 24 Months of Age|Death|1|||
125098913|NCT00948896|449981961|FG006|Randomization to 24 Months of Age|Death|2|||
125098914|NCT00948896|449981962|FG007|Randomization to 24 Months of Age|Death|1|||
125098915|NCT00948896|449981955|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
125098916|NCT00948896|449981956|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
125098917|NCT00948896|449981957|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
125098918|NCT00948896|449981958|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
125098919|NCT00948896|449981959|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
125098920|NCT00948896|449981960|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
125098921|NCT00948896|449981961|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
125098922|NCT00948896|449981962|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
125098923|NCT00948896|449981955|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
125098924|NCT00948896|449981956|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
125098925|NCT00948896|449981957|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
125098926|NCT00948896|449981958|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
125098927|NCT00948896|449981959|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
125098928|NCT00948896|449981960|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
125098929|NCT00948896|449981961|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
125098930|NCT00948896|449981962|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
125098931|NCT00948896|449981955|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
125098932|NCT00948896|449981956|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
125098933|NCT00948896|449981957|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
125098934|NCT00948896|449981958|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
125098935|NCT00948896|449981959|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
125098936|NCT00948896|449981960|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
125098937|NCT00948896|449981961|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
125098938|NCT00948896|449981962|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
125098939|NCT00948896|449981955|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
125098940|NCT00948896|449981956|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
124875329|NCT03420781|449165914|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
124875330|NCT03420781|449165915|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
125011186|NCT03080883|449666624|FG000|Overall Study|Alternative Therapy|0|||
125011187|NCT03080883|449666625|FG001|Overall Study|Alternative Therapy|3|||
125011188|NCT03080883|449666624|FG000|Overall Study|Other Complicating Disease|9|||
125011189|NCT03080883|449666625|FG001|Overall Study|Other Complicating Disease|5|||
125011190|NCT03080883|449666624|FG000|Overall Study|Death|21|||
125011191|NCT03080883|449666625|FG001|Overall Study|Death|16|||
125011192|NCT03080883|449666624|FG000|Overall Study|Physician Decision|2|||
125011193|NCT03080883|449666625|FG001|Overall Study|Physician Decision|2|||
125011194|NCT03080883|449666624|FG000|Overall Study|Disease Progression|2|||
125011195|NCT03080883|449666625|FG001|Overall Study|Disease Progression|8|||
125011196|NCT03080883|449666624|FG000|Overall Study|Lost to Follow-up|1|||
125011197|NCT03080883|449666625|FG001|Overall Study|Lost to Follow-up|1|||
125011198|NCT00346073|449668292|FG000|Overall Study|Serious Adverse Event|2|||
125011199|NCT00346073|449668293|FG001|Overall Study|Serious Adverse Event|0|||
125011200|NCT00346073|449668292|FG000|Overall Study|Lost to Follow-up|39|||
125011201|NCT00346073|449668293|FG001|Overall Study|Lost to Follow-up|24|||
125011202|NCT00075023|449668296|FG000|Pilot Study|Physician Decision|1|||
125011203|NCT00075023|449668297|FG001|Pilot Study|Physician Decision|2|||
125011204|NCT00075023|449668296|FG000|Pilot Study|Withdrawal by Subject|1|||
125011205|NCT00075023|449668297|FG001|Pilot Study|Withdrawal by Subject|0|||
125011206|NCT04342871|449668298|FG000|Overall Study|Death|4|||
125011207|NCT04342871|449668298|FG000|Overall Study|Clinical deterioration/illness progression|2|||
125011208|NCT04342871|449668298|FG000|Overall Study|Did not complete baseline assessments|5|||
125011209|NCT04342871|449668298|FG000|Overall Study|Lost to Follow-up|13|||
125011210|NCT03670953|449668299|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
125011211|NCT03670953|449668300|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
125011212|NCT03670953|449668301|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
125011213|NCT03670953|449668302|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
125011214|NCT03670953|449668299|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
125011215|NCT03670953|449668300|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
125011216|NCT03670953|449668301|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
125011217|NCT03670953|449668302|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
125011218|NCT03670953|449668299|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
125011219|NCT03670953|449668300|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
125011220|NCT03670953|449668301|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
125011221|NCT03670953|449668302|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
125011222|NCT03670953|449668299|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
125011223|NCT03670953|449668300|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
125011224|NCT03670953|449668301|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
125011225|NCT03670953|449668302|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
125011226|NCT03670953|449668299|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
125011227|NCT03670953|449668300|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
125011228|NCT03670953|449668301|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
125011229|NCT03670953|449668302|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
125011230|NCT03670953|449668299|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
125011231|NCT03670953|449668300|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
125011232|NCT03670953|449668301|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
125011233|NCT03670953|449668302|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
125011234|NCT03670953|449668299|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
125011235|NCT03670953|449668300|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
125011236|NCT03670953|449668301|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
125011237|NCT03670953|449668302|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
125011238|NCT03670953|449668299|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
125011239|NCT03670953|449668300|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
125011240|NCT03670953|449668301|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
125011241|NCT03670953|449668302|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
125011242|NCT03670953|449668299|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
125011243|NCT03670953|449668300|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
125011244|NCT03670953|449668301|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
125011245|NCT03670953|449668302|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
125011246|NCT03670953|449668299|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
125011247|NCT03670953|449668300|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
125011248|NCT03670953|449668301|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
125011249|NCT03670953|449668302|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
125011250|NCT03670953|449668299|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
125011251|NCT03670953|449668300|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
125011252|NCT03670953|449668301|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
125098941|NCT00948896|449981957|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
125098942|NCT00948896|449981958|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
125098943|NCT00948896|449981959|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
125098944|NCT00948896|449981960|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
125098945|NCT00948896|449981961|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
125098946|NCT00948896|449981962|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
125098947|NCT00948896|449981955|FG000|24 Months of Age to 36 Months of Age|Death|0|||
125098948|NCT00948896|449981956|FG001|24 Months of Age to 36 Months of Age|Death|2|||
125098949|NCT00948896|449981957|FG002|24 Months of Age to 36 Months of Age|Death|2|||
125098950|NCT00948896|449981958|FG003|24 Months of Age to 36 Months of Age|Death|0|||
125098951|NCT00948896|449981959|FG004|24 Months of Age to 36 Months of Age|Death|0|||
125098952|NCT00948896|449981960|FG005|24 Months of Age to 36 Months of Age|Death|1|||
125098953|NCT00948896|449981961|FG006|24 Months of Age to 36 Months of Age|Death|0|||
125098954|NCT00948896|449981962|FG007|24 Months of Age to 36 Months of Age|Death|0|||
125098955|NCT00948896|449981955|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
125098956|NCT00948896|449981956|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
125098957|NCT00948896|449981957|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
125098958|NCT00948896|449981958|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
125098959|NCT00948896|449981959|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
125098960|NCT00948896|449981960|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
125098961|NCT00948896|449981961|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
125098962|NCT00948896|449981962|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
125098963|NCT00948896|449981955|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
125098964|NCT00948896|449981956|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
125098965|NCT00948896|449981957|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
125098966|NCT00948896|449981958|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
125098967|NCT00948896|449981959|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
125098968|NCT00948896|449981960|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
125098969|NCT00948896|449981961|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
125098970|NCT00948896|449981962|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
125098971|NCT00948896|449981955|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
125098972|NCT00948896|449981956|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
125098973|NCT00948896|449981957|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
125098974|NCT00948896|449981958|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
125098975|NCT00948896|449981959|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
125098976|NCT00948896|449981960|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
125098977|NCT00948896|449981961|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
125098978|NCT00948896|449981962|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
125098979|NCT00948896|449981955|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
125098980|NCT00948896|449981956|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
125098981|NCT00948896|449981957|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
125098982|NCT00948896|449981958|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
125098983|NCT00948896|449981959|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
125098984|NCT00948896|449981960|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
125098985|NCT00948896|449981961|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
125098986|NCT00948896|449981962|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
125098987|NCT03795233|449981963|FG000|Overall Study|Withdrawal by Subject|2|||
125098988|NCT03795233|449981964|FG001|Overall Study|Withdrawal by Subject|1|||
125098989|NCT03795233|449981963|FG000|Overall Study|Lost to Follow-up|1|||
125098990|NCT03795233|449981964|FG001|Overall Study|Lost to Follow-up|0|||
125098991|NCT03795233|449981963|FG000|Overall Study|Death|1|||
125098992|NCT03795233|449981964|FG001|Overall Study|Death|0|||
125098993|NCT05403502|449981965|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
125098994|NCT05403502|449981965|FG000|Humalog Lead-In Period|Physician Decision|2|||
125098995|NCT05403502|449981965|FG000|Humalog Lead-In Period|Protocol Violation|1|||
125098996|NCT05403502|449981965|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
125098997|NCT05403502|449981965|FG000|Lyumjev Treatment Period|Physician Decision|2|||
125098998|NCT01054443|449981966|FG000|Overall Study|Withdrawal by Subject|0|||
125098999|NCT01054443|449981967|FG001|Overall Study|Withdrawal by Subject|0|||
125099000|NCT01054443|449981968|FG002|Overall Study|Withdrawal by Subject|0|||
125099001|NCT01054443|449981969|FG003|Overall Study|Withdrawal by Subject|1|||
125099002|NCT01003691|449981973|FG000|Overall Study|Adverse Event|0|||
125099003|NCT01003691|449981974|FG001|Overall Study|Adverse Event|0|||
125099004|NCT01003691|449981975|FG002|Overall Study|Adverse Event|0|||
125099005|NCT01003691|449981976|FG003|Overall Study|Adverse Event|1|||
125099006|NCT00167414|449981977|FG000|Overall Study|Death|10|||
125099007|NCT01869959|449981978|FG000|Randomization Period|Physician Decision|0|||
125099008|NCT01869959|449981979|FG001|Randomization Period|Physician Decision|0|||
125099009|NCT01869959|449981980|FG002|Randomization Period|Physician Decision|0|||
125099010|NCT01869959|449981981|FG003|Randomization Period|Physician Decision|0|||
125099011|NCT01869959|449981982|FG004|Randomization Period|Physician Decision|1|||
125099012|NCT01869959|449981978|FG000|Treatment Period|Adverse Event|1|||
125099013|NCT01869959|449981979|FG001|Treatment Period|Adverse Event|0|||
125099014|NCT01869959|449981980|FG002|Treatment Period|Adverse Event|3|||
125099015|NCT01869959|449981981|FG003|Treatment Period|Adverse Event|1|||
125099016|NCT01869959|449981982|FG004|Treatment Period|Adverse Event|0|||
125099017|NCT01869959|449981978|FG000|Treatment Period|Sponsor decision|0|||
125099018|NCT01869959|449981979|FG001|Treatment Period|Sponsor decision|1|||
125099019|NCT01869959|449981980|FG002|Treatment Period|Sponsor decision|0|||
125099020|NCT01869959|449981981|FG003|Treatment Period|Sponsor decision|1|||
125099021|NCT01869959|449981982|FG004|Treatment Period|Sponsor decision|0|||
125099022|NCT01869959|449981978|FG000|Treatment Period|Withdrawal by Subject|0|||
125099023|NCT01869959|449981979|FG001|Treatment Period|Withdrawal by Subject|1|||
125099024|NCT01869959|449981980|FG002|Treatment Period|Withdrawal by Subject|0|||
125099025|NCT01869959|449981981|FG003|Treatment Period|Withdrawal by Subject|0|||
125099026|NCT01869959|449981982|FG004|Treatment Period|Withdrawal by Subject|0|||
125099027|NCT02576951|449981986|FG000|Overall Study|Lost to Follow-up|0|||
125099028|NCT02576951|449981987|FG001|Overall Study|Lost to Follow-up|0|||
125099029|NCT02576951|449981988|FG002|Overall Study|Lost to Follow-up|2|||
125099030|NCT02576951|449981989|FG003|Overall Study|Lost to Follow-up|2|||
125099031|NCT02576951|449981986|FG000|Overall Study|Withdrawal by Subject|1|||
125099032|NCT02576951|449981987|FG001|Overall Study|Withdrawal by Subject|0|||
125099033|NCT02576951|449981988|FG002|Overall Study|Withdrawal by Subject|0|||
125099034|NCT02576951|449981989|FG003|Overall Study|Withdrawal by Subject|2|||
125099035|NCT02576951|449981986|FG000|Overall Study|Protocol Violation|0|||
125099036|NCT02576951|449981987|FG001|Overall Study|Protocol Violation|0|||
125099037|NCT02576951|449981988|FG002|Overall Study|Protocol Violation|0|||
125099038|NCT02576951|449981989|FG003|Overall Study|Protocol Violation|1|||
125099039|NCT00822237|449984363|FG000|Dose 1 Vaccination|Not vaccinated|3|||
125099040|NCT00822237|449984364|FG001|Dose 1 Vaccination|Not vaccinated|0|||
125099041|NCT00822237|449984363|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
125099042|NCT00822237|449984364|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
125099043|NCT00822237|449984363|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
125099044|NCT00822237|449984364|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
125099045|NCT00822237|449984363|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
125099046|NCT00822237|449984364|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
125099047|NCT00822237|449984363|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
125099048|NCT00822237|449984364|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
125099049|NCT00968539|449984369|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
125099050|NCT00968539|449984370|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
125099051|NCT00457249|449984371|FG000|Overall Study|Lost to Follow-up|3|||
125099052|NCT00457249|449984372|FG001|Overall Study|Lost to Follow-up|0|||
125099053|NCT00457249|449984371|FG000|Overall Study|Protocol Violation|4|||
125099054|NCT00457249|449984372|FG001|Overall Study|Protocol Violation|1|||
125099055|NCT00457249|449984371|FG000|Overall Study|Withdrawal by Subject|3|||
125099056|NCT00457249|449984372|FG001|Overall Study|Withdrawal by Subject|1|||
125099057|NCT00457249|449984371|FG000|Overall Study|Serious Adverse Events|2|||
125099058|NCT00457249|449984372|FG001|Overall Study|Serious Adverse Events|0|||
125099059|NCT00326118|449984373|FG000|Active Phase|Withdrawal by Subject|4|||
125099060|NCT00326118|449984374|FG001|Active Phase|Withdrawal by Subject|1|||
125099061|NCT02916056|449984375|FG000|Overall Study|Adverse Event|6|||
125099062|NCT02916056|449984375|FG000|Overall Study|Lost to Follow-up|1|||
125099063|NCT02916056|449984375|FG000|Overall Study|Other|12|||
125099064|NCT02916056|449984375|FG000|Overall Study|Protocol Violation|1|||
125099065|NCT02916056|449984375|FG000|Overall Study|Withdrawal by Subject|8|||
125099066|NCT02916056|449984375|FG000|Overall Study|Study Terminated by Sponsor|269|||
125099067|NCT00290511|449984376|FG000|Overall Study|Adverse Event|1|||
125099068|NCT00290511|449984376|FG000|Overall Study|Death|1|||
125099069|NCT00290511|449984376|FG000|Overall Study|Physician Decision|1|||
125099070|NCT00290511|449984376|FG000|Overall Study|Withdrawal by Subject|1|||
125099071|NCT00122954|449984377|FG000|Overall Study|Withdrawal by Subject|2|||
125099072|NCT00122954|449984378|FG001|Overall Study|Withdrawal by Subject|2|||
125099073|NCT00122954|449984377|FG000|Overall Study|Protocol Violation|0|||
125099074|NCT00122954|449984378|FG001|Overall Study|Protocol Violation|1|||
125099075|NCT00526162|449984384|FG000|Overall Study|Device not implanted|3|||
125099076|NCT05279807|449984385|FG000|Overall Study|Withdrawal by Subject|1|||
125099077|NCT05279807|449984386|FG001|Overall Study|Withdrawal by Subject|0|||
125099078|NCT05279807|449984385|FG000|Overall Study|Adverse Event|0|||
125099079|NCT05279807|449984386|FG001|Overall Study|Adverse Event|1|||
125099080|NCT05279807|449984385|FG000|Overall Study|Laboratory Abnormal Results|1|||
125099081|NCT05279807|449984386|FG001|Overall Study|Laboratory Abnormal Results|0|||
125099082|NCT05993299|449984387|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
125099083|NCT05993299|449984387|FG000|Overall Study|Ongoing|4|||
125099084|NCT03110107|449984388|FG000|Treatment Period|Disease Progression|3|||
125099085|NCT03110107|449984389|FG001|Treatment Period|Disease Progression|9|||
125099086|NCT03110107|449984390|FG002|Treatment Period|Disease Progression|8|||
125099087|NCT03110107|449984391|FG003|Treatment Period|Disease Progression|11|||
125099088|NCT03110107|449984392|FG004|Treatment Period|Disease Progression|8|||
125099089|NCT03110107|449984393|FG005|Treatment Period|Disease Progression|4|||
125099090|NCT03110107|449984394|FG006|Treatment Period|Disease Progression|6|||
125099091|NCT03110107|449984395|FG007|Treatment Period|Disease Progression|7|||
125099092|NCT03110107|449984396|FG008|Treatment Period|Disease Progression|2|||
125099093|NCT03110107|449984397|FG009|Treatment Period|Disease Progression|10|||
125099094|NCT03110107|449984398|FG010|Treatment Period|Disease Progression|5|||
125099095|NCT03110107|449984399|FG011|Treatment Period|Disease Progression|2|||
125099096|NCT03110107|449984400|FG012|Treatment Period|Disease Progression|0|||
125099097|NCT03110107|449984401|FG013|Treatment Period|Disease Progression|5|||
125099098|NCT03110107|449984402|FG014|Treatment Period|Disease Progression|14|||
125099099|NCT03110107|449984403|FG015|Treatment Period|Disease Progression|14|||
125099100|NCT03110107|449984404|FG016|Treatment Period|Disease Progression|4|||
125099101|NCT03110107|449984405|FG017|Treatment Period|Disease Progression|3|||
125099102|NCT03110107|449984406|FG018|Treatment Period|Disease Progression|16|||
125099103|NCT03110107|449984407|FG019|Treatment Period|Disease Progression|14|||
125099104|NCT03110107|449984408|FG020|Treatment Period|Disease Progression|12|||
125099105|NCT03110107|449984409|FG021|Treatment Period|Disease Progression|16|||
125099106|NCT03110107|449984410|FG022|Treatment Period|Disease Progression|18|||
125099107|NCT03110107|449984411|FG023|Treatment Period|Disease Progression|13|||
125099108|NCT03110107|449984412|FG024|Treatment Period|Disease Progression|16|||
125099109|NCT03110107|449984413|FG025|Treatment Period|Disease Progression|31|||
125099110|NCT03110107|449984388|FG000|Treatment Period|Study drug toxicity|1|||
125099111|NCT03110107|449984389|FG001|Treatment Period|Study drug toxicity|0|||
125099112|NCT03110107|449984390|FG002|Treatment Period|Study drug toxicity|1|||
125099113|NCT03110107|449984391|FG003|Treatment Period|Study drug toxicity|2|||
125099114|NCT03110107|449984392|FG004|Treatment Period|Study drug toxicity|0|||
125099115|NCT03110107|449984393|FG005|Treatment Period|Study drug toxicity|3|||
125099116|NCT03110107|449984394|FG006|Treatment Period|Study drug toxicity|1|||
125099117|NCT03110107|449984395|FG007|Treatment Period|Study drug toxicity|1|||
125099118|NCT03110107|449984396|FG008|Treatment Period|Study drug toxicity|3|||
125099119|NCT03110107|449984397|FG009|Treatment Period|Study drug toxicity|2|||
125099120|NCT03110107|449984398|FG010|Treatment Period|Study drug toxicity|0|||
125099121|NCT03110107|449984399|FG011|Treatment Period|Study drug toxicity|2|||
125099122|NCT03110107|449984400|FG012|Treatment Period|Study drug toxicity|0|||
125099123|NCT03110107|449984401|FG013|Treatment Period|Study drug toxicity|0|||
125099124|NCT03110107|449984402|FG014|Treatment Period|Study drug toxicity|2|||
125099125|NCT03110107|449984403|FG015|Treatment Period|Study drug toxicity|3|||
125099126|NCT03110107|449984404|FG016|Treatment Period|Study drug toxicity|3|||
125099127|NCT03110107|449984405|FG017|Treatment Period|Study drug toxicity|3|||
125099128|NCT03110107|449984406|FG018|Treatment Period|Study drug toxicity|1|||
125099129|NCT03110107|449984407|FG019|Treatment Period|Study drug toxicity|2|||
125099130|NCT03110107|449984408|FG020|Treatment Period|Study drug toxicity|2|||
125099131|NCT03110107|449984409|FG021|Treatment Period|Study drug toxicity|0|||
125099132|NCT03110107|449984410|FG022|Treatment Period|Study drug toxicity|2|||
125099133|NCT03110107|449984411|FG023|Treatment Period|Study drug toxicity|6|||
125099134|NCT03110107|449984412|FG024|Treatment Period|Study drug toxicity|7|||
125099135|NCT03110107|449984413|FG025|Treatment Period|Study drug toxicity|6|||
125099136|NCT03110107|449984388|FG000|Treatment Period|Death|0|||
125099137|NCT03110107|449984389|FG001|Treatment Period|Death|0|||
125099138|NCT03110107|449984390|FG002|Treatment Period|Death|0|||
125099139|NCT03110107|449984391|FG003|Treatment Period|Death|0|||
125099140|NCT03110107|449984392|FG004|Treatment Period|Death|0|||
125099141|NCT03110107|449984393|FG005|Treatment Period|Death|0|||
125099142|NCT03110107|449984394|FG006|Treatment Period|Death|0|||
125099143|NCT03110107|449984395|FG007|Treatment Period|Death|0|||
125099144|NCT03110107|449984396|FG008|Treatment Period|Death|0|||
125099145|NCT03110107|449984397|FG009|Treatment Period|Death|0|||
125099146|NCT03110107|449984398|FG010|Treatment Period|Death|0|||
125099147|NCT03110107|449984399|FG011|Treatment Period|Death|0|||
125099148|NCT03110107|449984400|FG012|Treatment Period|Death|1|||
125099149|NCT03110107|449984401|FG013|Treatment Period|Death|0|||
125099150|NCT03110107|449984402|FG014|Treatment Period|Death|0|||
125099151|NCT03110107|449984403|FG015|Treatment Period|Death|0|||
125099152|NCT03110107|449984404|FG016|Treatment Period|Death|0|||
125099153|NCT03110107|449984405|FG017|Treatment Period|Death|0|||
125099154|NCT03110107|449984406|FG018|Treatment Period|Death|0|||
125099155|NCT03110107|449984407|FG019|Treatment Period|Death|0|||
125099156|NCT03110107|449984408|FG020|Treatment Period|Death|0|||
125099157|NCT03110107|449984409|FG021|Treatment Period|Death|0|||
125099158|NCT03110107|449984410|FG022|Treatment Period|Death|0|||
125099159|NCT03110107|449984411|FG023|Treatment Period|Death|0|||
125099160|NCT03110107|449984412|FG024|Treatment Period|Death|0|||
125099161|NCT03110107|449984413|FG025|Treatment Period|Death|0|||
125099162|NCT03110107|449984388|FG000|Treatment Period|Adverse Event|0|||
125099163|NCT03110107|449984389|FG001|Treatment Period|Adverse Event|0|||
124875331|NCT03420781|449165916|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
125011253|NCT03670953|449668302|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
125011254|NCT03670953|449668299|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
125011255|NCT03670953|449668300|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
125011256|NCT03670953|449668301|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
125011257|NCT03670953|449668302|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
125011258|NCT03670953|449668299|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
125011259|NCT03670953|449668300|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
125011260|NCT03670953|449668301|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
125011261|NCT03670953|449668302|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
125011262|NCT03670953|449668299|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
125011263|NCT03670953|449668300|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
125011264|NCT03670953|449668301|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
125011265|NCT03670953|449668302|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
125011266|NCT03670953|449668299|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
125011267|NCT03670953|449668300|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
125011268|NCT03670953|449668301|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
125011269|NCT03670953|449668302|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
125011270|NCT03670953|449668299|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
125011271|NCT03670953|449668300|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
125011272|NCT03670953|449668301|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
125011273|NCT03670953|449668302|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
125011274|NCT03670953|449668299|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
125011275|NCT03670953|449668300|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
125011276|NCT03670953|449668301|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
125011277|NCT03670953|449668302|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
125011278|NCT03670953|449668299|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
125011279|NCT03670953|449668300|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
125011280|NCT03670953|449668301|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
125011281|NCT03670953|449668302|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
125011282|NCT04179734|449668303|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
125011283|NCT04179734|449668304|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
125011284|NCT04179734|449668303|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
125011285|NCT04179734|449668304|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
125011286|NCT01429584|449668306|FG000|Overall Study|Withdrawal by Subject|1|||
125011287|NCT01429584|449668307|FG001|Overall Study|Withdrawal by Subject|0|||
125011288|NCT01429584|449668306|FG000|Overall Study|Protocol Violation|0|||
125011289|NCT01429584|449668307|FG001|Overall Study|Protocol Violation|1|||
125011290|NCT02263079|449668308|FG000|Overall Study|Physician Decision|1|||
125011291|NCT02263079|449668309|FG001|Overall Study|Physician Decision|0|||
125011292|NCT02263079|449668310|FG002|Overall Study|Physician Decision|0|||
125011293|NCT02263079|449668308|FG000|Overall Study|Withdrawal by Subject|2|||
125011294|NCT02263079|449668309|FG001|Overall Study|Withdrawal by Subject|8|||
125011295|NCT02263079|449668310|FG002|Overall Study|Withdrawal by Subject|0|||
125011296|NCT02603120|449668311|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
125099164|NCT03110107|449984390|FG002|Treatment Period|Adverse Event|1|||
125099165|NCT03110107|449984391|FG003|Treatment Period|Adverse Event|0|||
125099166|NCT03110107|449984392|FG004|Treatment Period|Adverse Event|0|||
125099167|NCT03110107|449984393|FG005|Treatment Period|Adverse Event|2|||
125099168|NCT03110107|449984394|FG006|Treatment Period|Adverse Event|0|||
125099169|NCT03110107|449984395|FG007|Treatment Period|Adverse Event|2|||
125099170|NCT03110107|449984396|FG008|Treatment Period|Adverse Event|0|||
125099171|NCT03110107|449984397|FG009|Treatment Period|Adverse Event|1|||
125099172|NCT03110107|449984398|FG010|Treatment Period|Adverse Event|0|||
125099173|NCT03110107|449984399|FG011|Treatment Period|Adverse Event|0|||
125099174|NCT03110107|449984400|FG012|Treatment Period|Adverse Event|0|||
125099175|NCT03110107|449984401|FG013|Treatment Period|Adverse Event|0|||
125099176|NCT03110107|449984402|FG014|Treatment Period|Adverse Event|0|||
125099177|NCT03110107|449984403|FG015|Treatment Period|Adverse Event|2|||
125099178|NCT03110107|449984404|FG016|Treatment Period|Adverse Event|0|||
125099179|NCT03110107|449984405|FG017|Treatment Period|Adverse Event|1|||
125099180|NCT03110107|449984406|FG018|Treatment Period|Adverse Event|2|||
125099181|NCT03110107|449984407|FG019|Treatment Period|Adverse Event|1|||
125099182|NCT03110107|449984408|FG020|Treatment Period|Adverse Event|4|||
125099183|NCT03110107|449984409|FG021|Treatment Period|Adverse Event|2|||
125099184|NCT03110107|449984410|FG022|Treatment Period|Adverse Event|2|||
125099185|NCT03110107|449984411|FG023|Treatment Period|Adverse Event|2|||
125099186|NCT03110107|449984412|FG024|Treatment Period|Adverse Event|2|||
125099187|NCT03110107|449984413|FG025|Treatment Period|Adverse Event|4|||
125099188|NCT03110107|449984388|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
125099189|NCT03110107|449984389|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
125099190|NCT03110107|449984390|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
125099191|NCT03110107|449984391|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
125099192|NCT03110107|449984392|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
125099193|NCT03110107|449984393|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
125099194|NCT03110107|449984394|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
125099195|NCT03110107|449984395|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
125099196|NCT03110107|449984396|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
125099197|NCT03110107|449984397|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
125099198|NCT03110107|449984398|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
125099199|NCT03110107|449984399|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
125099200|NCT03110107|449984400|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
125099201|NCT03110107|449984401|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
125099202|NCT03110107|449984402|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
125099203|NCT03110107|449984403|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
125099204|NCT03110107|449984404|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
125099205|NCT03110107|449984405|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
125099206|NCT03110107|449984406|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
125099207|NCT03110107|449984407|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
125099208|NCT03110107|449984408|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
124875332|NCT03420781|449165917|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
125099209|NCT03110107|449984409|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
125099210|NCT03110107|449984410|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
125099211|NCT03110107|449984411|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
125099212|NCT03110107|449984412|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
125099213|NCT03110107|449984413|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
125099214|NCT03110107|449984388|FG000|Treatment Period|Participant withdrew consent|0|||
125099215|NCT03110107|449984389|FG001|Treatment Period|Participant withdrew consent|0|||
125099216|NCT03110107|449984390|FG002|Treatment Period|Participant withdrew consent|1|||
125099217|NCT03110107|449984391|FG003|Treatment Period|Participant withdrew consent|0|||
125099218|NCT03110107|449984392|FG004|Treatment Period|Participant withdrew consent|4|||
125099219|NCT03110107|449984393|FG005|Treatment Period|Participant withdrew consent|3|||
125099220|NCT03110107|449984394|FG006|Treatment Period|Participant withdrew consent|0|||
125099221|NCT03110107|449984395|FG007|Treatment Period|Participant withdrew consent|0|||
125099222|NCT03110107|449984396|FG008|Treatment Period|Participant withdrew consent|0|||
124875333|NCT03420781|449165918|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
124875334|NCT00215540|449165929|FG000|Overall Study|Withdrew from study medication|1|||
125099223|NCT03110107|449984397|FG009|Treatment Period|Participant withdrew consent|1|||
125099224|NCT03110107|449984398|FG010|Treatment Period|Participant withdrew consent|0|||
125099225|NCT03110107|449984399|FG011|Treatment Period|Participant withdrew consent|0|||
124875335|NCT00215540|449165930|FG001|Overall Study|Withdrew from study medication|0|||
125011297|NCT02603120|449668312|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
125011298|NCT02603120|449668311|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
125011299|NCT02603120|449668312|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
125011300|NCT02603120|449668311|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
125011301|NCT02603120|449668312|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
125011302|NCT02603120|449668311|FG000|Double-Blind Treatment Phase|Death|2|||
125011303|NCT02603120|449668312|FG001|Double-Blind Treatment Phase|Death|0|||
125011304|NCT02603120|449668311|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
125011305|NCT02603120|449668312|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
125011306|NCT02603120|449668311|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
125011307|NCT02603120|449668312|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
125011308|NCT02603120|449668311|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
125011309|NCT02603120|449668312|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
125011310|NCT02603120|449668311|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
125011311|NCT02603120|449668312|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
125011312|NCT02603120|449668311|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
125011313|NCT02603120|449668312|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
125011314|NCT02603120|449668311|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
125011315|NCT02603120|449668312|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
125011316|NCT02603120|449668311|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
125011317|NCT02603120|449668312|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
125011318|NCT02603120|449668311|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
125011319|NCT02603120|449668312|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
125011320|NCT02603120|449668311|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
125011321|NCT02603120|449668312|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
125011322|NCT02603120|449668311|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
125011323|NCT02603120|449668312|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
125011324|NCT01199042|449668315|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
125011325|NCT01199042|449668315|FG000|At Home (3 Months)|Lost to Follow-up|1|||
125011326|NCT00176605|449668318|FG000|Overall Study|Withdrawal by Subject|2|||
125011327|NCT01321710|449668319|FG000|Overall Study|Lost to Follow-up|4|||
125011328|NCT01321710|449668320|FG001|Overall Study|Lost to Follow-up|5|||
125011329|NCT01321710|449668321|FG002|Overall Study|Lost to Follow-up|0|||
125011330|NCT01227187|449668324|FG000|Overall Study|Physician Decision|0|||
125011331|NCT01227187|449668325|FG001|Overall Study|Physician Decision|0|||
125011332|NCT01227187|449668326|FG002|Overall Study|Physician Decision|0|||
125011333|NCT01227187|449668327|FG003|Overall Study|Physician Decision|1|||
125011334|NCT01761292|449668328|FG000|Part 1|Adverse Event|1|||
125011335|NCT01761292|449668328|FG000|Part 1|not receiving treatment in Part 1|1|||
125011336|NCT01761292|449668328|FG000|Extension 1|Withdrawal by Subject|1|||
125011337|NCT02554019|449668329|FG000|Overall Study|Withdrawal by Subject|1|||
125011338|NCT02554019|449668330|FG001|Overall Study|Withdrawal by Subject|0|||
125011339|NCT02554019|449668331|FG002|Overall Study|Withdrawal by Subject|2|||
125011340|NCT02554019|449668329|FG000|Overall Study|Adverse Event|1|||
125011341|NCT02554019|449668330|FG001|Overall Study|Adverse Event|0|||
125011342|NCT02554019|449668331|FG002|Overall Study|Adverse Event|0|||
125011343|NCT02463409|449668332|FG000|Overall Study|Withdrawal by Subject|1|||
125011344|NCT02463409|449668332|FG000|Overall Study|Screen failure|1|||
125011345|NCT00772954|449668333|FG000|Overall Study|Adverse Event|0|||
125011346|NCT00772954|449668334|FG001|Overall Study|Adverse Event|0|||
125011347|NCT00772954|449668335|FG002|Overall Study|Adverse Event|1|||
125011348|NCT02495844|449668336|FG000|Overall Study|Lack of Efficacy|1|||
125011349|NCT02495844|449668337|FG001|Overall Study|Lack of Efficacy|2|||
125011350|NCT02495844|449668336|FG000|Overall Study|AE, non-fatal|0|||
125011351|NCT02495844|449668337|FG001|Overall Study|AE, non-fatal|1|||
125011352|NCT02495844|449668336|FG000|Overall Study|Hepatitis Positivity|0|||
125011353|NCT02495844|449668337|FG001|Overall Study|Hepatitis Positivity|1|||
125011354|NCT02325219|449668338|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
125011355|NCT02325219|449668339|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
125011356|NCT02325219|449668340|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
125011357|NCT02325219|449668341|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
125011358|NCT02325219|449668342|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
125011359|NCT02325219|449668338|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
125011360|NCT02325219|449668339|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
125011361|NCT02325219|449668340|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
125011362|NCT02325219|449668341|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
125011363|NCT02325219|449668342|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
125011364|NCT02325219|449668338|FG000|Controlled Period (Week 0 - 16)|Other|0|||
125011365|NCT02325219|449668339|FG001|Controlled Period (Week 0 - 16)|Other|0|||
125011366|NCT02325219|449668340|FG002|Controlled Period (Week 0 - 16)|Other|1|||
125011367|NCT02325219|449668341|FG003|Controlled Period (Week 0 - 16)|Other|0|||
125011368|NCT02325219|449668342|FG004|Controlled Period (Week 0 - 16)|Other|0|||
125011369|NCT02325219|449668338|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
125011370|NCT02325219|449668339|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
125011371|NCT02325219|449668340|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
125011372|NCT02325219|449668341|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
125011373|NCT02325219|449668342|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
125011374|NCT02325219|449668338|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
125011375|NCT02325219|449668339|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
125011376|NCT02325219|449668340|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
125011377|NCT02325219|449668341|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
125011378|NCT02325219|449668342|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
125011379|NCT02325219|449668338|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
125011380|NCT02325219|449668339|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
125011381|NCT02325219|449668340|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
125011382|NCT02325219|449668341|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
125011383|NCT02325219|449668342|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
125011384|NCT00880399|449668344|FG000|Overall Study|Adverse Event|4|||
125011385|NCT00880399|449668345|FG001|Overall Study|Adverse Event|6|||
125011386|NCT00880399|449668346|FG002|Overall Study|Adverse Event|5|||
125011387|NCT00880399|449668344|FG000|Overall Study|Lack of Efficacy|1|||
125011388|NCT00880399|449668345|FG001|Overall Study|Lack of Efficacy|4|||
125011389|NCT00880399|449668346|FG002|Overall Study|Lack of Efficacy|2|||
125011390|NCT00880399|449668344|FG000|Overall Study|Protocol Violation|4|||
125011391|NCT00880399|449668345|FG001|Overall Study|Protocol Violation|4|||
125011392|NCT00880399|449668346|FG002|Overall Study|Protocol Violation|6|||
125011393|NCT00880399|449668344|FG000|Overall Study|Study closed/terminated|3|||
125011394|NCT00880399|449668345|FG001|Overall Study|Study closed/terminated|7|||
125011395|NCT00880399|449668346|FG002|Overall Study|Study closed/terminated|4|||
125011396|NCT00880399|449668344|FG000|Overall Study|Lost to Follow-up|8|||
125011397|NCT00880399|449668345|FG001|Overall Study|Lost to Follow-up|5|||
125011398|NCT00880399|449668346|FG002|Overall Study|Lost to Follow-up|3|||
125011399|NCT00880399|449668344|FG000|Overall Study|Physician Decision|5|||
125011400|NCT00880399|449668345|FG001|Overall Study|Physician Decision|0|||
125011401|NCT00880399|449668346|FG002|Overall Study|Physician Decision|3|||
125011402|NCT00880399|449668344|FG000|Overall Study|Withdrawal by Subject|6|||
125011403|NCT00880399|449668345|FG001|Overall Study|Withdrawal by Subject|3|||
125011404|NCT00880399|449668346|FG002|Overall Study|Withdrawal by Subject|3|||
125011405|NCT04353284|449668347|FG000|Overall Study|Adverse Event|1|||
125011406|NCT04353284|449668348|FG001|Overall Study|Adverse Event|1|||
125011407|NCT04353284|449668347|FG000|Overall Study|Lost to Follow-up|1|||
125011408|NCT04353284|449668348|FG001|Overall Study|Lost to Follow-up|0|||
125011409|NCT01911442|449668349|FG000|Overall Study|Adverse Event|2|||
125011410|NCT01911442|449668350|FG001|Overall Study|Adverse Event|2|||
125011411|NCT01911442|449668351|FG002|Overall Study|Adverse Event|4|||
125011412|NCT01911442|449668349|FG000|Overall Study|Lack of Efficacy|1|||
125011413|NCT01911442|449668350|FG001|Overall Study|Lack of Efficacy|1|||
125011414|NCT01911442|449668351|FG002|Overall Study|Lack of Efficacy|1|||
125011415|NCT01911442|449668349|FG000|Overall Study|Lost to Follow-up|2|||
125011416|NCT01911442|449668350|FG001|Overall Study|Lost to Follow-up|0|||
125011417|NCT01911442|449668351|FG002|Overall Study|Lost to Follow-up|1|||
125011418|NCT01911442|449668349|FG000|Overall Study|Withdrawal by Subject|1|||
125011419|NCT01911442|449668350|FG001|Overall Study|Withdrawal by Subject|0|||
125011420|NCT01911442|449668351|FG002|Overall Study|Withdrawal by Subject|6|||
125011421|NCT01911442|449668349|FG000|Overall Study|Mother's Work Schedule|0|||
125011422|NCT01911442|449668350|FG001|Overall Study|Mother's Work Schedule|1|||
125011423|NCT01911442|449668351|FG002|Overall Study|Mother's Work Schedule|0|||
125011424|NCT00122681|449668357|FG000|Overall Study|Adverse Event|20|||
125011425|NCT00122681|449668358|FG001|Overall Study|Adverse Event|16|||
125011426|NCT00122681|449668357|FG000|Overall Study|Lost to Follow-up|1080|||
125011427|NCT00122681|449668358|FG001|Overall Study|Lost to Follow-up|1097|||
125011428|NCT00122681|449668357|FG000|Overall Study|Protocol Violation|7|||
125011429|NCT00122681|449668358|FG001|Overall Study|Protocol Violation|10|||
125011430|NCT00122681|449668357|FG000|Overall Study|Withdrawal by Subject|257|||
125011431|NCT00122681|449668358|FG001|Overall Study|Withdrawal by Subject|251|||
125011432|NCT00122681|449668357|FG000|Overall Study|Personal reasons|150|||
125011433|NCT00122681|449668358|FG001|Overall Study|Personal reasons|147|||
125011434|NCT02819635|449668360|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
125011435|NCT02819635|449668361|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
125011436|NCT02819635|449668362|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
125011437|NCT02819635|449668363|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
125011438|NCT02819635|449668364|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
125011439|NCT02819635|449668365|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
125011440|NCT02819635|449668366|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
125011441|NCT02819635|449668367|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
125011442|NCT02819635|449668368|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
125011443|NCT02819635|449668369|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
125011444|NCT02819635|449668370|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
125011445|NCT02819635|449668371|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
125011446|NCT02819635|449668360|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
125011447|NCT02819635|449668361|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
125011448|NCT02819635|449668362|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
125011449|NCT02819635|449668363|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
125011450|NCT02819635|449668364|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
125011451|NCT02819635|449668365|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
125011452|NCT02819635|449668366|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
125011453|NCT02819635|449668367|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
125011454|NCT02819635|449668368|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
125011455|NCT02819635|449668369|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
125011456|NCT02819635|449668370|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
125011457|NCT02819635|449668371|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
125011458|NCT02819635|449668360|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
125011459|NCT02819635|449668361|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
125011460|NCT02819635|449668362|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
125011461|NCT02819635|449668363|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
125011462|NCT02819635|449668364|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
125011463|NCT02819635|449668365|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
125011464|NCT02819635|449668366|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
125011465|NCT02819635|449668367|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
125011466|NCT02819635|449668368|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
125011467|NCT02819635|449668369|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
125011468|NCT02819635|449668370|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
125011469|NCT02819635|449668371|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
125011470|NCT02819635|449668360|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125011471|NCT02819635|449668361|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125011472|NCT02819635|449668362|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125011473|NCT02819635|449668363|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125011474|NCT02819635|449668364|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125011475|NCT02819635|449668365|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125011476|NCT02819635|449668366|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
125011477|NCT02819635|449668367|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125011478|NCT02819635|449668368|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125011479|NCT02819635|449668369|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125011480|NCT02819635|449668370|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125011481|NCT02819635|449668371|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125011482|NCT02819635|449668360|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
125011483|NCT02819635|449668361|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
125011484|NCT02819635|449668362|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
125011485|NCT02819635|449668363|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
125011486|NCT02819635|449668364|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
125011487|NCT02819635|449668365|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
125011488|NCT02819635|449668366|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
125011489|NCT02819635|449668367|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
125011490|NCT02819635|449668368|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
125011491|NCT02819635|449668369|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
125011492|NCT02819635|449668370|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
125011493|NCT02819635|449668371|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
125011494|NCT02819635|449668360|FG000|Substudy 2, Part 2|Adverse Event|0|||
125011495|NCT02819635|449668361|FG001|Substudy 2, Part 2|Adverse Event|0|||
125011496|NCT02819635|449668362|FG002|Substudy 2, Part 2|Adverse Event|0|||
125011497|NCT02819635|449668363|FG003|Substudy 2, Part 2|Adverse Event|0|||
125011498|NCT02819635|449668364|FG004|Substudy 2, Part 2|Adverse Event|0|||
125011499|NCT02819635|449668365|FG005|Substudy 2, Part 2|Adverse Event|4|||
125011500|NCT02819635|449668366|FG006|Substudy 2, Part 2|Adverse Event|0|||
125011501|NCT02819635|449668367|FG007|Substudy 2, Part 2|Adverse Event|0|||
125011502|NCT02819635|449668368|FG008|Substudy 2, Part 2|Adverse Event|0|||
125011503|NCT02819635|449668369|FG009|Substudy 2, Part 2|Adverse Event|0|||
125011504|NCT02819635|449668370|FG010|Substudy 2, Part 2|Adverse Event|0|||
125011505|NCT02819635|449668371|FG011|Substudy 2, Part 2|Adverse Event|0|||
125011506|NCT02819635|449668360|FG000|Substudy 2, Part 2|Withdrew consent|0|||
125011507|NCT02819635|449668361|FG001|Substudy 2, Part 2|Withdrew consent|0|||
125011508|NCT02819635|449668362|FG002|Substudy 2, Part 2|Withdrew consent|0|||
125011509|NCT02819635|449668363|FG003|Substudy 2, Part 2|Withdrew consent|0|||
125011510|NCT02819635|449668364|FG004|Substudy 2, Part 2|Withdrew consent|0|||
125011511|NCT02819635|449668365|FG005|Substudy 2, Part 2|Withdrew consent|3|||
125011512|NCT02819635|449668366|FG006|Substudy 2, Part 2|Withdrew consent|1|||
125011513|NCT02819635|449668367|FG007|Substudy 2, Part 2|Withdrew consent|0|||
125011514|NCT02819635|449668368|FG008|Substudy 2, Part 2|Withdrew consent|0|||
125011515|NCT02819635|449668369|FG009|Substudy 2, Part 2|Withdrew consent|0|||
125011516|NCT02819635|449668370|FG010|Substudy 2, Part 2|Withdrew consent|0|||
125011517|NCT02819635|449668371|FG011|Substudy 2, Part 2|Withdrew consent|0|||
125011518|NCT02819635|449668360|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
125011519|NCT02819635|449668361|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
125011520|NCT02819635|449668362|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
125011521|NCT02819635|449668363|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
125011522|NCT02819635|449668364|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
125011523|NCT02819635|449668365|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
125011524|NCT02819635|449668366|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
125011525|NCT02819635|449668367|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
125011526|NCT02819635|449668368|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
125011527|NCT02819635|449668369|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
125011528|NCT02819635|449668370|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
125011529|NCT02819635|449668371|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
125011530|NCT02819635|449668360|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125011531|NCT02819635|449668361|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125011532|NCT02819635|449668362|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125011533|NCT02819635|449668363|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125011534|NCT02819635|449668364|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125011535|NCT02819635|449668365|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125011536|NCT02819635|449668366|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
125011537|NCT02819635|449668367|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125011538|NCT02819635|449668368|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125011539|NCT02819635|449668369|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125011540|NCT02819635|449668370|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125011541|NCT02819635|449668371|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125011542|NCT02819635|449668360|FG000|Substudy 2, Part 2|Other, not specified|0|||
125011543|NCT02819635|449668361|FG001|Substudy 2, Part 2|Other, not specified|0|||
125011544|NCT02819635|449668362|FG002|Substudy 2, Part 2|Other, not specified|0|||
125011545|NCT02819635|449668363|FG003|Substudy 2, Part 2|Other, not specified|0|||
125011546|NCT02819635|449668364|FG004|Substudy 2, Part 2|Other, not specified|0|||
125011547|NCT02819635|449668365|FG005|Substudy 2, Part 2|Other, not specified|4|||
125011548|NCT02819635|449668366|FG006|Substudy 2, Part 2|Other, not specified|8|||
125011549|NCT02819635|449668367|FG007|Substudy 2, Part 2|Other, not specified|0|||
125011550|NCT02819635|449668368|FG008|Substudy 2, Part 2|Other, not specified|0|||
125011551|NCT02819635|449668369|FG009|Substudy 2, Part 2|Other, not specified|0|||
125011552|NCT02819635|449668370|FG010|Substudy 2, Part 2|Other, not specified|0|||
125099226|NCT03110107|449984400|FG012|Treatment Period|Participant withdrew consent|0|||
125011553|NCT02819635|449668371|FG011|Substudy 2, Part 2|Other, not specified|0|||
125099227|NCT03110107|449984401|FG013|Treatment Period|Participant withdrew consent|0|||
125099228|NCT03110107|449984402|FG014|Treatment Period|Participant withdrew consent|0|||
125099229|NCT03110107|449984403|FG015|Treatment Period|Participant withdrew consent|0|||
125099230|NCT03110107|449984404|FG016|Treatment Period|Participant withdrew consent|0|||
125099231|NCT03110107|449984405|FG017|Treatment Period|Participant withdrew consent|0|||
125099232|NCT03110107|449984406|FG018|Treatment Period|Participant withdrew consent|0|||
125099233|NCT03110107|449984407|FG019|Treatment Period|Participant withdrew consent|1|||
125099234|NCT03110107|449984408|FG020|Treatment Period|Participant withdrew consent|0|||
125099235|NCT03110107|449984409|FG021|Treatment Period|Participant withdrew consent|2|||
125099236|NCT03110107|449984410|FG022|Treatment Period|Participant withdrew consent|0|||
125099237|NCT03110107|449984411|FG023|Treatment Period|Participant withdrew consent|0|||
125099238|NCT03110107|449984412|FG024|Treatment Period|Participant withdrew consent|0|||
125099239|NCT03110107|449984413|FG025|Treatment Period|Participant withdrew consent|2|||
125099240|NCT03110107|449984388|FG000|Treatment Period|Participants no longer meets study criteria|0|||
125011554|NCT02819635|449668360|FG000|Substudy 3|Adverse Event|0|||
125011555|NCT02819635|449668361|FG001|Substudy 3|Adverse Event|0|||
125011556|NCT02819635|449668362|FG002|Substudy 3|Adverse Event|0|||
125011557|NCT02819635|449668363|FG003|Substudy 3|Adverse Event|0|||
125011558|NCT02819635|449668364|FG004|Substudy 3|Adverse Event|0|||
125011559|NCT02819635|449668365|FG005|Substudy 3|Adverse Event|0|||
125011560|NCT02819635|449668366|FG006|Substudy 3|Adverse Event|0|||
125011561|NCT02819635|449668367|FG007|Substudy 3|Adverse Event|0|||
125011562|NCT02819635|449668368|FG008|Substudy 3|Adverse Event|32|||
125011563|NCT02819635|449668369|FG009|Substudy 3|Adverse Event|3|||
125011564|NCT02819635|449668370|FG010|Substudy 3|Adverse Event|12|||
125011565|NCT02819635|449668371|FG011|Substudy 3|Adverse Event|18|||
125011566|NCT02819635|449668360|FG000|Substudy 3|Withdrew consent|0|||
125011567|NCT02819635|449668361|FG001|Substudy 3|Withdrew consent|0|||
125011568|NCT02819635|449668362|FG002|Substudy 3|Withdrew consent|0|||
125011569|NCT02819635|449668363|FG003|Substudy 3|Withdrew consent|0|||
125011570|NCT02819635|449668364|FG004|Substudy 3|Withdrew consent|0|||
125011571|NCT02819635|449668365|FG005|Substudy 3|Withdrew consent|0|||
125011572|NCT02819635|449668366|FG006|Substudy 3|Withdrew consent|0|||
125011573|NCT02819635|449668367|FG007|Substudy 3|Withdrew consent|0|||
125011574|NCT02819635|449668368|FG008|Substudy 3|Withdrew consent|11|||
125011575|NCT02819635|449668369|FG009|Substudy 3|Withdrew consent|1|||
125011576|NCT02819635|449668370|FG010|Substudy 3|Withdrew consent|4|||
125011577|NCT02819635|449668371|FG011|Substudy 3|Withdrew consent|9|||
125011578|NCT02819635|449668360|FG000|Substudy 3|Lost to Follow-up|0|||
125011579|NCT02819635|449668361|FG001|Substudy 3|Lost to Follow-up|0|||
125011580|NCT02819635|449668362|FG002|Substudy 3|Lost to Follow-up|0|||
125011581|NCT02819635|449668363|FG003|Substudy 3|Lost to Follow-up|0|||
125011582|NCT02819635|449668364|FG004|Substudy 3|Lost to Follow-up|0|||
125011583|NCT02819635|449668365|FG005|Substudy 3|Lost to Follow-up|0|||
125011584|NCT02819635|449668366|FG006|Substudy 3|Lost to Follow-up|0|||
125011585|NCT02819635|449668367|FG007|Substudy 3|Lost to Follow-up|0|||
125011586|NCT02819635|449668368|FG008|Substudy 3|Lost to Follow-up|1|||
125011587|NCT02819635|449668369|FG009|Substudy 3|Lost to Follow-up|0|||
125011588|NCT02819635|449668370|FG010|Substudy 3|Lost to Follow-up|1|||
125011589|NCT02819635|449668371|FG011|Substudy 3|Lost to Follow-up|1|||
125011590|NCT02819635|449668360|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
125011591|NCT02819635|449668361|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
125011592|NCT02819635|449668362|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
125011593|NCT02819635|449668363|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
125011594|NCT02819635|449668364|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
125011595|NCT02819635|449668365|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
125011596|NCT02819635|449668366|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
125011597|NCT02819635|449668367|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
125011598|NCT02819635|449668368|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
125011599|NCT02819635|449668369|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
125011600|NCT02819635|449668370|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
125011601|NCT02819635|449668371|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
125011602|NCT02819635|449668360|FG000|Substudy 3|Other, not specified|0|||
125011603|NCT02819635|449668361|FG001|Substudy 3|Other, not specified|0|||
125011604|NCT02819635|449668362|FG002|Substudy 3|Other, not specified|0|||
125011605|NCT02819635|449668363|FG003|Substudy 3|Other, not specified|0|||
125011606|NCT02819635|449668364|FG004|Substudy 3|Other, not specified|0|||
125011607|NCT02819635|449668365|FG005|Substudy 3|Other, not specified|0|||
125011608|NCT02819635|449668366|FG006|Substudy 3|Other, not specified|0|||
125099241|NCT03110107|449984389|FG001|Treatment Period|Participants no longer meets study criteria|0|||
125099242|NCT03110107|449984390|FG002|Treatment Period|Participants no longer meets study criteria|0|||
125011609|NCT02819635|449668367|FG007|Substudy 3|Other, not specified|0|||
125011610|NCT02819635|449668368|FG008|Substudy 3|Other, not specified|202|||
125011611|NCT02819635|449668369|FG009|Substudy 3|Other, not specified|5|||
125011612|NCT02819635|449668370|FG010|Substudy 3|Other, not specified|89|||
125011613|NCT02819635|449668371|FG011|Substudy 3|Other, not specified|39|||
125099243|NCT03110107|449984391|FG003|Treatment Period|Participants no longer meets study criteria|0|||
125099244|NCT03110107|449984392|FG004|Treatment Period|Participants no longer meets study criteria|0|||
125099245|NCT03110107|449984393|FG005|Treatment Period|Participants no longer meets study criteria|0|||
125099246|NCT03110107|449984394|FG006|Treatment Period|Participants no longer meets study criteria|0|||
125099247|NCT03110107|449984395|FG007|Treatment Period|Participants no longer meets study criteria|0|||
125099248|NCT03110107|449984396|FG008|Treatment Period|Participants no longer meets study criteria|0|||
125099249|NCT03110107|449984397|FG009|Treatment Period|Participants no longer meets study criteria|0|||
125099250|NCT03110107|449984398|FG010|Treatment Period|Participants no longer meets study criteria|0|||
125099251|NCT03110107|449984399|FG011|Treatment Period|Participants no longer meets study criteria|0|||
125099252|NCT03110107|449984400|FG012|Treatment Period|Participants no longer meets study criteria|0|||
125099253|NCT03110107|449984401|FG013|Treatment Period|Participants no longer meets study criteria|0|||
125099254|NCT03110107|449984402|FG014|Treatment Period|Participants no longer meets study criteria|0|||
125099255|NCT03110107|449984403|FG015|Treatment Period|Participants no longer meets study criteria|0|||
125099256|NCT03110107|449984404|FG016|Treatment Period|Participants no longer meets study criteria|0|||
125099257|NCT03110107|449984405|FG017|Treatment Period|Participants no longer meets study criteria|0|||
125099258|NCT03110107|449984406|FG018|Treatment Period|Participants no longer meets study criteria|0|||
125099259|NCT03110107|449984407|FG019|Treatment Period|Participants no longer meets study criteria|0|||
125099260|NCT03110107|449984408|FG020|Treatment Period|Participants no longer meets study criteria|0|||
125099261|NCT03110107|449984409|FG021|Treatment Period|Participants no longer meets study criteria|0|||
125099262|NCT03110107|449984410|FG022|Treatment Period|Participants no longer meets study criteria|0|||
125099263|NCT03110107|449984411|FG023|Treatment Period|Participants no longer meets study criteria|1|||
125099264|NCT03110107|449984412|FG024|Treatment Period|Participants no longer meets study criteria|0|||
125099265|NCT03110107|449984413|FG025|Treatment Period|Participants no longer meets study criteria|0|||
125099266|NCT03110107|449984388|FG000|Treatment Period|Other Reasons|0|||
125099267|NCT03110107|449984389|FG001|Treatment Period|Other Reasons|0|||
125099268|NCT03110107|449984390|FG002|Treatment Period|Other Reasons|1|||
125099269|NCT03110107|449984391|FG003|Treatment Period|Other Reasons|1|||
125099270|NCT03110107|449984392|FG004|Treatment Period|Other Reasons|0|||
125099271|NCT03110107|449984393|FG005|Treatment Period|Other Reasons|1|||
125099272|NCT03110107|449984394|FG006|Treatment Period|Other Reasons|0|||
125099273|NCT03110107|449984395|FG007|Treatment Period|Other Reasons|0|||
125099274|NCT03110107|449984396|FG008|Treatment Period|Other Reasons|0|||
125099275|NCT03110107|449984397|FG009|Treatment Period|Other Reasons|0|||
125099276|NCT03110107|449984398|FG010|Treatment Period|Other Reasons|0|||
125099277|NCT03110107|449984399|FG011|Treatment Period|Other Reasons|0|||
125099278|NCT03110107|449984400|FG012|Treatment Period|Other Reasons|0|||
125099279|NCT03110107|449984401|FG013|Treatment Period|Other Reasons|0|||
125099280|NCT03110107|449984402|FG014|Treatment Period|Other Reasons|0|||
125099281|NCT03110107|449984403|FG015|Treatment Period|Other Reasons|0|||
125099282|NCT03110107|449984404|FG016|Treatment Period|Other Reasons|0|||
125099283|NCT03110107|449984405|FG017|Treatment Period|Other Reasons|0|||
125099284|NCT03110107|449984406|FG018|Treatment Period|Other Reasons|0|||
125099285|NCT03110107|449984407|FG019|Treatment Period|Other Reasons|0|||
125099286|NCT03110107|449984408|FG020|Treatment Period|Other Reasons|0|||
125099287|NCT03110107|449984409|FG021|Treatment Period|Other Reasons|0|||
125099288|NCT03110107|449984410|FG022|Treatment Period|Other Reasons|0|||
125099289|NCT03110107|449984411|FG023|Treatment Period|Other Reasons|0|||
125099290|NCT03110107|449984412|FG024|Treatment Period|Other Reasons|1|||
125099291|NCT03110107|449984413|FG025|Treatment Period|Other Reasons|0|||
125099292|NCT03985982|449984414|FG000|Double-Blind Phase|Lost to Follow-up|4|||
125099293|NCT03985982|449984415|FG001|Double-Blind Phase|Lost to Follow-up|3|||
125099294|NCT03985982|449984416|FG002|Double-Blind Phase|Lost to Follow-up|0|||
125099295|NCT03985982|449984414|FG000|Double-Blind Phase|Physician Decision|1|||
125099296|NCT03985982|449984415|FG001|Double-Blind Phase|Physician Decision|0|||
125099297|NCT03985982|449984416|FG002|Double-Blind Phase|Physician Decision|0|||
125099298|NCT03985982|449984414|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
125099299|NCT03985982|449984415|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
125099300|NCT03985982|449984416|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
125099301|NCT03985982|449984414|FG000|Double-Blind Phase|COVID-19|1|||
125099302|NCT03985982|449984415|FG001|Double-Blind Phase|COVID-19|0|||
125099303|NCT03985982|449984416|FG002|Double-Blind Phase|COVID-19|0|||
125099304|NCT03985982|449984414|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
124875336|NCT00215540|449165931|FG002|Overall Study|Withdrew from study medication|0|||
124875337|NCT02799472|449165938|FG000|Overall Study|Withdrawal by Subject|2|||
125099305|NCT03985982|449984415|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
125099306|NCT03985982|449984416|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
125099307|NCT03985982|449984414|FG000|Open-Label Phase|Lost to Follow-up|0|||
124875338|NCT02799472|449165939|FG001|Overall Study|Withdrawal by Subject|4|||
125099308|NCT03985982|449984415|FG001|Open-Label Phase|Lost to Follow-up|0|||
125099309|NCT03985982|449984416|FG002|Open-Label Phase|Lost to Follow-up|13|||
125099310|NCT03985982|449984414|FG000|Open-Label Phase|Physician Decision|0|||
125099311|NCT03985982|449984415|FG001|Open-Label Phase|Physician Decision|0|||
125099312|NCT03985982|449984416|FG002|Open-Label Phase|Physician Decision|2|||
125099313|NCT03985982|449984414|FG000|Open-Label Phase|Withdrawal by Subject|0|||
125099314|NCT03985982|449984415|FG001|Open-Label Phase|Withdrawal by Subject|0|||
125099315|NCT03985982|449984416|FG002|Open-Label Phase|Withdrawal by Subject|11|||
125099316|NCT03526549|449984418|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
125099317|NCT03526549|449984419|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
125099318|NCT03526549|449984418|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
125099319|NCT03526549|449984419|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
125099320|NCT03526549|449984418|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
125099321|NCT03526549|449984419|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
125099322|NCT03526549|449984418|FG000|Open-label Phase|Adverse Event|4|||
125099323|NCT03526549|449984419|FG001|Open-label Phase|Adverse Event|0|||
125099324|NCT03526549|449984418|FG000|Open-label Phase|Withdrawal by Subject|54|||
125099325|NCT03526549|449984419|FG001|Open-label Phase|Withdrawal by Subject|0|||
125099326|NCT03526549|449984418|FG000|Open-label Phase|Lost to Follow-up|35|||
125099327|NCT03526549|449984419|FG001|Open-label Phase|Lost to Follow-up|0|||
125099328|NCT03526549|449984418|FG000|Open-label Phase|Other than Specified|5|||
125099329|NCT03526549|449984419|FG001|Open-label Phase|Other than Specified|0|||
125099330|NCT05981365|449984426|FG000|Period 1|Adverse Event|1|||
125099331|NCT05981365|449984427|FG001|Period 1|Adverse Event|0|||
125099332|NCT04780776|449984428|FG000|Titration Week 1-5|Lost to Follow-up|2|||
125099333|NCT04780776|449984429|FG001|Titration Week 1-5|Lost to Follow-up|8|||
125099334|NCT04780776|449984428|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
125099335|NCT04780776|449984429|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
125099336|NCT04780776|449984428|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
125099337|NCT04780776|449984429|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
125099338|NCT03927989|449984430|FG000|Overall Study|Withdrawal by Subject|0|||
125099339|NCT03927989|449984431|FG001|Overall Study|Withdrawal by Subject|1|||
125099340|NCT03772574|449984432|FG000|Overall Study|Protocol Violation|2|||
125099341|NCT03772574|449984433|FG001|Overall Study|Protocol Violation|0|||
125099342|NCT03772574|449984434|FG002|Overall Study|Protocol Violation|0|||
125099343|NCT03772574|449984432|FG000|Overall Study|Discomfort|0|||
125099344|NCT03772574|449984433|FG001|Overall Study|Discomfort|5|||
125099345|NCT03772574|449984434|FG002|Overall Study|Discomfort|4|||
125099346|NCT03193996|449984438|FG000|Overall Study|Withdrawal by Subject|4|||
125099347|NCT03193996|449984438|FG000|Overall Study|Lost to Follow-up|4|||
125099348|NCT03193996|449984438|FG000|Overall Study|Physician Decision|2|||
125099349|NCT03193996|449984438|FG000|Overall Study|Pregnancy|1|||
125099350|NCT03193996|449984438|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
125099351|NCT03193996|449984438|FG000|Overall Study|Complicating disease|1|||
125099352|NCT00348348|449984442|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
125099353|NCT00348348|449984443|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
125099354|NCT00348348|449984442|FG000|Overall Study|Lack of Efficacy|1|||
125099355|NCT00348348|449984443|FG001|Overall Study|Lack of Efficacy|1|||
125099356|NCT00348348|449984442|FG000|Overall Study|Lost to Follow-up|8|||
125099357|NCT00348348|449984443|FG001|Overall Study|Lost to Follow-up|10|||
125099358|NCT00348348|449984442|FG000|Overall Study|Withdrawal by Subject|4|||
125099359|NCT00348348|449984443|FG001|Overall Study|Withdrawal by Subject|1|||
125099360|NCT00348348|449984442|FG000|Overall Study|Other|7|||
125099361|NCT00348348|449984443|FG001|Overall Study|Other|4|||
125099362|NCT00348348|449984442|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
125099363|NCT00348348|449984443|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
125099364|NCT00348348|449984442|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
125099365|NCT00348348|449984443|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
125099366|NCT00348348|449984442|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
125099367|NCT00348348|449984443|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
125099368|NCT00348348|449984442|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
125099369|NCT00348348|449984443|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
125099370|NCT00348348|449984442|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
125099371|NCT00348348|449984443|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
125099372|NCT00348348|449984442|FG000|Overall Study|Adverse event probably related to study|1|||
125099373|NCT00348348|449984443|FG001|Overall Study|Adverse event probably related to study|0|||
125099374|NCT01471197|449984444|FG000|Overall Study|Disease Progression|4|||
125099375|NCT01471197|449984445|FG001|Overall Study|Disease Progression|2|||
125099376|NCT01471197|449984444|FG000|Overall Study|Death|1|||
125099377|NCT01471197|449984445|FG001|Overall Study|Death|0|||
125099378|NCT01471197|449984444|FG000|Overall Study|Study Drug Toxicity|1|||
125099379|NCT01471197|449984445|FG001|Overall Study|Study Drug Toxicity|0|||
125099380|NCT00924313|449984446|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
125099381|NCT00491322|449984449|FG000|Overall Study|Protocol Violation|1|||
125099382|NCT00491322|449984450|FG001|Overall Study|Protocol Violation|0|||
125099383|NCT00491322|449984449|FG000|Overall Study|Pregnancy|0|||
125099384|NCT00491322|449984450|FG001|Overall Study|Pregnancy|1|||
125099385|NCT02331680|449984452|FG000|Overall Study|Adverse Event|3|||
125099386|NCT02331680|449984453|FG001|Overall Study|Adverse Event|0|||
125099387|NCT02331680|449984454|FG002|Overall Study|Adverse Event|2|||
125099388|NCT02331680|449984452|FG000|Overall Study|Physician Decision|1|||
125099389|NCT02331680|449984453|FG001|Overall Study|Physician Decision|1|||
125099390|NCT02331680|449984454|FG002|Overall Study|Physician Decision|2|||
125099391|NCT02331680|449984452|FG000|Overall Study|Withdrawal by Subject|0|||
125099392|NCT02331680|449984453|FG001|Overall Study|Withdrawal by Subject|1|||
125099393|NCT02331680|449984454|FG002|Overall Study|Withdrawal by Subject|2|||
125099394|NCT02331680|449984452|FG000|Overall Study|Met withdrawal criteria|2|||
125099395|NCT02331680|449984453|FG001|Overall Study|Met withdrawal criteria|2|||
125099396|NCT02331680|449984454|FG002|Overall Study|Met withdrawal criteria|5|||
125099397|NCT02331680|449984452|FG000|Overall Study|Non-compliance with study drug|0|||
125099398|NCT02331680|449984453|FG001|Overall Study|Non-compliance with study drug|0|||
125099399|NCT02331680|449984454|FG002|Overall Study|Non-compliance with study drug|1|||
125099400|NCT02331680|449984452|FG000|Overall Study|Protocol Violation|0|||
125099401|NCT02331680|449984453|FG001|Overall Study|Protocol Violation|0|||
125099402|NCT02331680|449984454|FG002|Overall Study|Protocol Violation|3|||
125099403|NCT03426995|449984455|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125099404|NCT03426995|449984456|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125099405|NCT03426995|449984457|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
125099406|NCT03426995|449984458|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125099407|NCT03426995|449984459|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125099408|NCT03426995|449984460|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125099409|NCT03426995|449984461|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125099410|NCT03426995|449984462|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125099411|NCT03426995|449984463|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125099412|NCT03426995|449984464|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125099413|NCT03426995|449984465|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125099414|NCT03426995|449984466|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125099415|NCT03426995|449984467|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125099416|NCT03426995|449984468|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125099417|NCT03426995|449984469|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125099418|NCT03426995|449984470|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125099419|NCT03426995|449984471|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125099420|NCT03426995|449984472|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125099421|NCT03426995|449984473|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125099422|NCT03426995|449984455|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125099423|NCT03426995|449984456|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125099424|NCT03426995|449984457|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125099425|NCT03426995|449984458|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125099426|NCT03426995|449984459|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125099427|NCT03426995|449984460|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
125099428|NCT03426995|449984461|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125099429|NCT03426995|449984462|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125099430|NCT03426995|449984463|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125099431|NCT03426995|449984464|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125099432|NCT03426995|449984465|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125099433|NCT03426995|449984466|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125099434|NCT03426995|449984467|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125099435|NCT03426995|449984468|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125099436|NCT03426995|449984469|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125099437|NCT03426995|449984470|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125099438|NCT03426995|449984471|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125099439|NCT03426995|449984472|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125099440|NCT03426995|449984473|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125099441|NCT03426995|449984455|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125099442|NCT03426995|449984456|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125099443|NCT03426995|449984457|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125099444|NCT03426995|449984458|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125099445|NCT03426995|449984459|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
125099446|NCT03426995|449984460|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
125099447|NCT03426995|449984461|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125099448|NCT03426995|449984462|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
124875339|NCT02799472|449165938|FG000|Overall Study|Lack of Efficacy|2|||
124875340|NCT02799472|449165939|FG001|Overall Study|Lack of Efficacy|0|||
125099449|NCT03426995|449984463|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125099450|NCT03426995|449984464|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125099451|NCT03426995|449984465|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125099452|NCT03426995|449984466|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125099453|NCT03426995|449984467|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125099454|NCT03426995|449984468|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125099455|NCT03426995|449984469|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125099456|NCT03426995|449984470|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125099457|NCT03426995|449984471|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125099458|NCT03426995|449984472|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125099459|NCT03426995|449984473|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125099460|NCT03426995|449984455|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125099461|NCT03426995|449984456|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125099462|NCT03426995|449984457|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125099463|NCT03426995|449984458|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125099464|NCT03426995|449984459|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125099465|NCT03426995|449984460|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125099466|NCT03426995|449984461|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125099467|NCT03426995|449984462|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125099468|NCT03426995|449984463|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125099469|NCT03426995|449984464|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125099470|NCT03426995|449984465|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
125099471|NCT03426995|449984466|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125099472|NCT03426995|449984467|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125099473|NCT03426995|449984468|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125099474|NCT03426995|449984469|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125099475|NCT03426995|449984470|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125099476|NCT03426995|449984471|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125099477|NCT03426995|449984472|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125099478|NCT03426995|449984473|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125099479|NCT03426995|449984455|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125099480|NCT03426995|449984456|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125099481|NCT03426995|449984457|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125099482|NCT03426995|449984458|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125099483|NCT03426995|449984459|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125099484|NCT03426995|449984460|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125099485|NCT03426995|449984461|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125099486|NCT03426995|449984462|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
125099487|NCT03426995|449984463|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125099488|NCT03426995|449984464|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125099489|NCT03426995|449984465|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125099490|NCT03426995|449984466|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125099491|NCT03426995|449984467|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125099492|NCT03426995|449984468|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125099493|NCT03426995|449984469|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125099494|NCT03426995|449984470|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125099495|NCT03426995|449984471|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125099496|NCT03426995|449984472|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125099497|NCT03426995|449984473|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125099498|NCT03426995|449984455|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125099499|NCT03426995|449984456|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125099500|NCT03426995|449984457|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125099501|NCT03426995|449984458|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125099502|NCT03426995|449984459|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125099503|NCT03426995|449984460|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125099504|NCT03426995|449984461|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125099505|NCT03426995|449984462|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125099506|NCT03426995|449984463|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125099507|NCT03426995|449984464|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125099508|NCT03426995|449984465|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125099509|NCT03426995|449984466|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125099510|NCT03426995|449984467|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125099511|NCT03426995|449984468|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125099512|NCT03426995|449984469|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
125099513|NCT03426995|449984470|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
125099514|NCT03426995|449984471|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125011614|NCT03179891|449668374|FG000|First Intervention|Withdrawal by Subject|1|||
125011615|NCT03179891|449668375|FG001|First Intervention|Withdrawal by Subject|1|||
125011616|NCT03179891|449668374|FG000|First Intervention|Unspecified reason|1|||
125011617|NCT03179891|449668375|FG001|First Intervention|Unspecified reason|0|||
125011618|NCT03179891|449668374|FG000|First Intervention|Protocol Violation|0|||
125011619|NCT03179891|449668375|FG001|First Intervention|Protocol Violation|1|||
125011620|NCT01349465|449668377|FG000|Overall Study|Adverse Event|1|||
125011621|NCT01349465|449668378|FG001|Overall Study|Adverse Event|0|||
125011622|NCT01349465|449668377|FG000|Overall Study|Death|3|||
125011623|NCT01349465|449668378|FG001|Overall Study|Death|0|||
125011624|NCT01349465|449668377|FG000|Overall Study|Lost to Follow-up|10|||
125011625|NCT01349465|449668378|FG001|Overall Study|Lost to Follow-up|1|||
125011626|NCT01349465|449668377|FG000|Overall Study|Withdrawal by Subject|4|||
125011627|NCT01349465|449668378|FG001|Overall Study|Withdrawal by Subject|2|||
125011628|NCT01349465|449668377|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
125011629|NCT01349465|449668378|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
125011630|NCT00632099|449668379|FG000|Overall Study|Lost to Follow-up|3|||
125011631|NCT00632099|449668380|FG001|Overall Study|Lost to Follow-up|3|||
125011632|NCT02004262|449668383|FG000|Overall Study|Death|67|||
125011633|NCT02004262|449668384|FG001|Overall Study|Death|64|||
125011634|NCT02004262|449668385|FG002|Overall Study|Death|66|||
125011635|NCT02004262|449668386|FG003|Overall Study|Death|28|||
125011636|NCT02004262|449668387|FG004|Overall Study|Death|29|||
125011637|NCT02004262|449668388|FG005|Overall Study|Death|22|||
125011638|NCT02004262|449668383|FG000|Overall Study|Withdrawal by Subject|1|||
125011639|NCT02004262|449668384|FG001|Overall Study|Withdrawal by Subject|0|||
125011640|NCT02004262|449668385|FG002|Overall Study|Withdrawal by Subject|4|||
125011641|NCT02004262|449668386|FG003|Overall Study|Withdrawal by Subject|0|||
125011642|NCT02004262|449668387|FG004|Overall Study|Withdrawal by Subject|1|||
125011643|NCT02004262|449668388|FG005|Overall Study|Withdrawal by Subject|3|||
125011644|NCT02004262|449668383|FG000|Overall Study|Lost to Follow-up|1|||
125011645|NCT02004262|449668384|FG001|Overall Study|Lost to Follow-up|1|||
125011646|NCT02004262|449668385|FG002|Overall Study|Lost to Follow-up|0|||
125011647|NCT02004262|449668386|FG003|Overall Study|Lost to Follow-up|0|||
125011648|NCT02004262|449668387|FG004|Overall Study|Lost to Follow-up|0|||
125011649|NCT02004262|449668388|FG005|Overall Study|Lost to Follow-up|0|||
125011650|NCT02004262|449668383|FG000|Overall Study|Study Terminated by Sponsor|4|||
125011651|NCT02004262|449668384|FG001|Overall Study|Study Terminated by Sponsor|3|||
125011652|NCT02004262|449668385|FG002|Overall Study|Study Terminated by Sponsor|2|||
125011653|NCT02004262|449668386|FG003|Overall Study|Study Terminated by Sponsor|1|||
125011654|NCT02004262|449668387|FG004|Overall Study|Study Terminated by Sponsor|1|||
125011655|NCT02004262|449668388|FG005|Overall Study|Study Terminated by Sponsor|5|||
125011656|NCT01923285|449668389|FG000|Overall Study|Withdrawal by Subject|7|||
125011657|NCT01923285|449668390|FG001|Overall Study|Withdrawal by Subject|6|||
125011658|NCT03200366|449668395|FG000|Patient Navigation Intervention Given|Death|0|||
125011659|NCT03200366|449668396|FG001|Patient Navigation Intervention Given|Death|2|||
125011660|NCT03200366|449668397|FG002|Patient Navigation Intervention Given|Death|0|||
125011661|NCT03200366|449668395|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
125011662|NCT03200366|449668396|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
125011663|NCT03200366|449668397|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
125011664|NCT03200366|449668395|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
125011665|NCT03200366|449668396|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
125011666|NCT03200366|449668397|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
125011667|NCT03200366|449668395|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
125011668|NCT03200366|449668396|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
125011669|NCT03200366|449668397|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
125011670|NCT03200366|449668395|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
125011671|NCT03200366|449668396|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
125011672|NCT03200366|449668397|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
125011673|NCT03200366|449668395|FG000|6 Month Post-Baseline Interview|Death|1|||
125011674|NCT03200366|449668396|FG001|6 Month Post-Baseline Interview|Death|1|||
125011675|NCT03200366|449668397|FG002|6 Month Post-Baseline Interview|Death|1|||
125011676|NCT03200366|449668395|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
125011677|NCT03200366|449668396|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
125011678|NCT03200366|449668397|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
125011679|NCT03200366|449668395|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
125011680|NCT03200366|449668396|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
125011681|NCT03200366|449668397|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
125011682|NCT03200366|449668395|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
125011683|NCT03200366|449668396|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
125011684|NCT03200366|449668397|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
125099515|NCT03426995|449984472|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125099516|NCT03426995|449984473|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125099517|NCT03426995|449984455|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125099518|NCT03426995|449984456|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125099519|NCT03426995|449984457|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125099520|NCT03426995|449984458|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125099521|NCT03426995|449984459|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125099522|NCT03426995|449984460|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125099523|NCT03426995|449984461|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125099524|NCT03426995|449984462|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125099525|NCT03426995|449984463|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125099526|NCT03426995|449984464|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125099527|NCT03426995|449984465|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125099528|NCT03426995|449984466|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125099529|NCT03426995|449984467|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125099530|NCT03426995|449984468|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125099531|NCT03426995|449984469|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
125099532|NCT03426995|449984470|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
125099533|NCT03426995|449984471|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125099534|NCT03426995|449984472|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125099535|NCT03426995|449984473|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125099536|NCT05939388|449984474|FG000|Overall Study|Lost to Follow-up|1|||
125099537|NCT00602667|449984475|FG000|Overall Study|Still on Therapy|0|||
125099538|NCT00602667|449984476|FG001|Overall Study|Still on Therapy|2|||
125099539|NCT00602667|449984477|FG002|Overall Study|Still on Therapy|2|||
125099540|NCT00602667|449984475|FG000|Overall Study|Death|0|||
125099541|NCT00602667|449984476|FG001|Overall Study|Death|1|||
125099542|NCT00602667|449984477|FG002|Overall Study|Death|1|||
125099543|NCT00602667|449984475|FG000|Overall Study|Family request|3|||
125099544|NCT00602667|449984476|FG001|Overall Study|Family request|25|||
125099545|NCT00602667|449984477|FG002|Overall Study|Family request|6|||
125099546|NCT00602667|449984475|FG000|Overall Study|Excessive toxicity|1|||
125099547|NCT00602667|449984476|FG001|Overall Study|Excessive toxicity|1|||
125099548|NCT00602667|449984477|FG002|Overall Study|Excessive toxicity|0|||
125099549|NCT00602667|449984475|FG000|Overall Study|Second malignancy|0|||
125099550|NCT00602667|449984476|FG001|Overall Study|Second malignancy|1|||
125099551|NCT00602667|449984477|FG002|Overall Study|Second malignancy|0|||
125099552|NCT00602667|449984475|FG000|Overall Study|Physician Decision|2|||
125099553|NCT00602667|449984476|FG001|Overall Study|Physician Decision|3|||
125099554|NCT00602667|449984477|FG002|Overall Study|Physician Decision|8|||
125099555|NCT00602667|449984475|FG000|Overall Study|Progressive disease|13|||
125099556|NCT00602667|449984476|FG001|Overall Study|Progressive disease|48|||
125099557|NCT00602667|449984477|FG002|Overall Study|Progressive disease|45|||
125099558|NCT00602667|449984475|FG000|Overall Study|Progressive disease prior to therapy|0|||
125099559|NCT00602667|449984476|FG001|Overall Study|Progressive disease prior to therapy|0|||
125099560|NCT00602667|449984477|FG002|Overall Study|Progressive disease prior to therapy|1|||
125099561|NCT04410978|449984483|FG000|Overall Study|Poor compliance to protocol|2|||
125099562|NCT04410978|449984484|FG001|Overall Study|Poor compliance to protocol|4|||
125099563|NCT04410978|449984483|FG000|Overall Study|Withdrawal by Subject|64|||
125099564|NCT04410978|449984484|FG001|Overall Study|Withdrawal by Subject|66|||
125099565|NCT04410978|449984483|FG000|Overall Study|Other|6|||
125099566|NCT04410978|449984484|FG001|Overall Study|Other|7|||
125099567|NCT04410978|449984483|FG000|Overall Study|Missing study status|1|||
125099568|NCT04410978|449984484|FG001|Overall Study|Missing study status|0|||
125099569|NCT05153629|449984486|FG000|Overall Study|Withdrawal by Subject|0|||
125099570|NCT05153629|449984487|FG001|Overall Study|Withdrawal by Subject|2|||
125099571|NCT00885677|449984490|FG000|Overall Study|Death|40|||
125099572|NCT00885677|449984491|FG001|Overall Study|Death|34|||
125099573|NCT00885677|449984490|FG000|Overall Study|Lost to Follow-up|15|||
125099574|NCT00885677|449984491|FG001|Overall Study|Lost to Follow-up|13|||
125099575|NCT00885677|449984490|FG000|Overall Study|Protocol Violation|54|||
125099576|NCT00885677|449984491|FG001|Overall Study|Protocol Violation|54|||
125099577|NCT00885677|449984490|FG000|Overall Study|premature study closure|41|||
125099578|NCT00885677|449984491|FG001|Overall Study|premature study closure|44|||
125099579|NCT00885677|449984490|FG000|Overall Study|device/lead revision or replacement|7|||
125099580|NCT00885677|449984491|FG001|Overall Study|device/lead revision or replacement|6|||
125099581|NCT00885677|449984490|FG000|Overall Study|Heart transplantation|1|||
125099582|NCT00885677|449984491|FG001|Overall Study|Heart transplantation|0|||
125099583|NCT00885677|449984490|FG000|Overall Study|Inclusion/exclusion not met|25|||
125099584|NCT00885677|449984491|FG001|Overall Study|Inclusion/exclusion not met|27|||
125099585|NCT00972309|449984492|FG000|Overall Study|Switched to alternative treatment|0|||
125099586|NCT00972309|449984493|FG001|Overall Study|Switched to alternative treatment|2|||
125099587|NCT00972309|449984492|FG000|Overall Study|Refused further treatment|0|||
125099588|NCT00972309|449984493|FG001|Overall Study|Refused further treatment|1|||
125099589|NCT00972309|449984492|FG000|Overall Study|Late determination of ineligibility|0|||
125099590|NCT00972309|449984493|FG001|Overall Study|Late determination of ineligibility|1|||
125099591|NCT00972309|449984492|FG000|Overall Study|Second malignancy|1|||
125099592|NCT00972309|449984493|FG001|Overall Study|Second malignancy|1|||
125099593|NCT00972309|449984492|FG000|Overall Study|Visa issues|0|||
125099594|NCT00972309|449984493|FG001|Overall Study|Visa issues|1|||
125099595|NCT00972309|449984492|FG000|Overall Study|Secondary cancer (SCC)|0|||
125099596|NCT00972309|449984493|FG001|Overall Study|Secondary cancer (SCC)|1|||
125099597|NCT00972309|449984492|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
125099598|NCT00972309|449984493|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
125099599|NCT00972309|449984492|FG000|Overall Study|Lost to Follow-up|1|||
125099600|NCT00972309|449984493|FG001|Overall Study|Lost to Follow-up|1|||
125099601|NCT00972309|449984492|FG000|Overall Study|Disease progression on study|10|||
125099602|NCT00972309|449984493|FG001|Overall Study|Disease progression on study|4|||
125099603|NCT01233284|449984497|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
125099604|NCT01233284|449984498|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
125099605|NCT01233284|449984499|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
125099606|NCT01233284|449984500|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
125099607|NCT01233284|449984501|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
125099608|NCT01233284|449984497|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
125099609|NCT01233284|449984498|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
125099610|NCT01233284|449984499|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
125099611|NCT01233284|449984500|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
125099612|NCT01233284|449984501|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
125099613|NCT01233284|449984497|FG000|Period 1 (4 Weeks)|Other|0|||
125099614|NCT01233284|449984498|FG001|Period 1 (4 Weeks)|Other|0|||
125099615|NCT01233284|449984499|FG002|Period 1 (4 Weeks)|Other|1|||
125099616|NCT01233284|449984500|FG003|Period 1 (4 Weeks)|Other|0|||
125099617|NCT01233284|449984501|FG004|Period 1 (4 Weeks)|Other|0|||
125099618|NCT01233284|449984497|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125099619|NCT01233284|449984498|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125099620|NCT01233284|449984499|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
125099621|NCT01233284|449984500|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125099622|NCT01233284|449984501|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125099623|NCT01233284|449984497|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
125099624|NCT01233284|449984498|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
125099625|NCT01233284|449984499|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
125099626|NCT01233284|449984500|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
125099627|NCT01233284|449984501|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
125099628|NCT01233284|449984497|FG000|Period 3 (4 Weeks)|Other|0|||
125099629|NCT01233284|449984498|FG001|Period 3 (4 Weeks)|Other|0|||
125099630|NCT01233284|449984499|FG002|Period 3 (4 Weeks)|Other|0|||
125099631|NCT01233284|449984500|FG003|Period 3 (4 Weeks)|Other|1|||
125099632|NCT01233284|449984501|FG004|Period 3 (4 Weeks)|Other|0|||
125099633|NCT01233284|449984497|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
125099634|NCT01233284|449984498|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
125099635|NCT01233284|449984499|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
125099636|NCT01233284|449984500|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
125099637|NCT01233284|449984501|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
125099638|NCT01233284|449984497|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
125099639|NCT01233284|449984498|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
125099640|NCT01233284|449984499|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
125099641|NCT01233284|449984500|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
125099642|NCT01233284|449984501|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
125099643|NCT00157820|449984509|FG000|Randomized|Physician Decision|4|||
125099644|NCT00157820|449984510|FG001|Randomized|Physician Decision|2|||
125099645|NCT00157820|449984511|FG002|Randomized|Physician Decision|3|||
125099646|NCT00157820|449984509|FG000|Randomized|Withdrawal by Subject|1|||
125099647|NCT00157820|449984510|FG001|Randomized|Withdrawal by Subject|2|||
125099648|NCT00157820|449984511|FG002|Randomized|Withdrawal by Subject|3|||
125099649|NCT00157820|449984509|FG000|Randomized|Protocol Violation|2|||
125099650|NCT00157820|449984510|FG001|Randomized|Protocol Violation|1|||
125099651|NCT00157820|449984511|FG002|Randomized|Protocol Violation|2|||
125099652|NCT00157820|449984509|FG000|1st 8 Month|Death|7|||
125099653|NCT00157820|449984510|FG001|1st 8 Month|Death|8|||
125099654|NCT00157820|449984511|FG002|1st 8 Month|Death|3|||
125099655|NCT00157820|449984509|FG000|1st 8 Month|Lost to Follow-up|1|||
125099656|NCT00157820|449984510|FG001|1st 8 Month|Lost to Follow-up|2|||
125099657|NCT00157820|449984511|FG002|1st 8 Month|Lost to Follow-up|1|||
125099658|NCT00157820|449984509|FG000|1st 8 Month|Premature cross-over|0|||
125099659|NCT00157820|449984510|FG001|1st 8 Month|Premature cross-over|2|||
125099660|NCT00157820|449984511|FG002|1st 8 Month|Premature cross-over|2|||
125099661|NCT00157820|449984509|FG000|2nd 8 Months|Death|3|||
125099662|NCT00157820|449984510|FG001|2nd 8 Months|Death|1|||
125099663|NCT00157820|449984511|FG002|2nd 8 Months|Death|3|||
125099664|NCT00157820|449984509|FG000|2nd 8 Months|Lost to Follow-up|1|||
125099665|NCT00157820|449984510|FG001|2nd 8 Months|Lost to Follow-up|5|||
125099666|NCT00157820|449984511|FG002|2nd 8 Months|Lost to Follow-up|2|||
125099667|NCT00157820|449984509|FG000|2nd 8 Months|Premature cross-over|1|||
125099668|NCT00157820|449984510|FG001|2nd 8 Months|Premature cross-over|7|||
125099669|NCT00157820|449984511|FG002|2nd 8 Months|Premature cross-over|9|||
125099670|NCT01721369|449984512|FG000|Overall Study|Not initial etiological diagnosis|12|||
125099671|NCT00563706|449986306|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
125099672|NCT00563706|449986307|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
125099673|NCT00563706|449986308|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
125099674|NCT00563706|449986309|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
125099675|NCT00563706|449986310|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
125099676|NCT00563706|449986311|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
125099677|NCT00563706|449986312|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
125099678|NCT00563706|449986313|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
125099679|NCT00563706|449986314|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
125099680|NCT00563706|449986306|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
125099681|NCT00563706|449986307|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
125099682|NCT00563706|449986308|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
125099683|NCT00563706|449986309|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
125099684|NCT00563706|449986310|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
125099685|NCT00563706|449986311|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
125099686|NCT00563706|449986312|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
125099687|NCT00563706|449986313|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
125099688|NCT00563706|449986314|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
125099689|NCT00563706|449986306|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
125099690|NCT00563706|449986307|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
125099691|NCT00563706|449986308|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
125099692|NCT00563706|449986309|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
125099693|NCT00563706|449986310|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
125099694|NCT00563706|449986311|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
125099695|NCT00563706|449986312|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
125099696|NCT00563706|449986313|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
125099697|NCT00563706|449986314|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
125099698|NCT00563706|449986306|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
125099699|NCT00563706|449986307|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
125099700|NCT00563706|449986308|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
125099701|NCT00563706|449986309|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
125099702|NCT00563706|449986310|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
125099703|NCT00563706|449986311|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
125099704|NCT00563706|449986312|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
125099705|NCT00563706|449986313|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
125099706|NCT00563706|449986314|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
125099707|NCT00563706|449986306|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
125099708|NCT00563706|449986307|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
125099709|NCT00563706|449986308|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
125099710|NCT00563706|449986309|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
125099711|NCT00563706|449986310|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
125099712|NCT00563706|449986311|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
125099713|NCT00563706|449986312|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
125099714|NCT00563706|449986313|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
125099715|NCT00563706|449986314|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
125099716|NCT00299546|449986315|FG000|Overall Study|Death|3|||
125099717|NCT00299546|449986316|FG001|Overall Study|Death|2|||
125099718|NCT00299546|449986317|FG002|Overall Study|Death|0|||
125099719|NCT00299546|449986315|FG000|Overall Study|Lost to Follow-up|2|||
125099720|NCT00299546|449986316|FG001|Overall Study|Lost to Follow-up|2|||
125099721|NCT00299546|449986317|FG002|Overall Study|Lost to Follow-up|5|||
125099722|NCT00299546|449986315|FG000|Overall Study|Adverse Event|37|||
125099723|NCT00299546|449986316|FG001|Overall Study|Adverse Event|22|||
125099724|NCT00299546|449986317|FG002|Overall Study|Adverse Event|27|||
125099725|NCT00299546|449986315|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
125099726|NCT00299546|449986316|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
125099727|NCT00299546|449986317|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
125099728|NCT00299546|449986315|FG000|Overall Study|Other|24|||
125099729|NCT00299546|449986316|FG001|Overall Study|Other|26|||
125099730|NCT00299546|449986317|FG002|Overall Study|Other|19|||
125099731|NCT00299546|449986315|FG000|Overall Study|Not treated|0|||
125099732|NCT00299546|449986316|FG001|Overall Study|Not treated|1|||
125099733|NCT00299546|449986317|FG002|Overall Study|Not treated|1|||
125099734|NCT03099265|449986318|FG000|Overall Study|Adverse Event|1|||
125099735|NCT02526017|449986319|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
125099736|NCT02526017|449986320|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
125099737|NCT02526017|449986321|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
125099738|NCT02526017|449986322|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
125099739|NCT02526017|449986323|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
125099740|NCT02526017|449986324|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
125099741|NCT02526017|449986325|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
125099742|NCT02526017|449986326|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
125099743|NCT02526017|449986327|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
125099744|NCT02674568|449986331|FG000|Overall Study|Withdrawal by Subject|5|||
125099745|NCT02674568|449986331|FG000|Overall Study|Death|303|||
125099746|NCT02674568|449986331|FG000|Overall Study|Physician Decision|2|||
125099747|NCT02674568|449986331|FG000|Overall Study|Lost to Follow-up|9|||
125099748|NCT02674568|449986331|FG000|Overall Study|Other, Not Specified|20|||
125099749|NCT00396318|449986332|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
125099750|NCT00938392|449986333|FG000|Overall Study|Adverse Event|0|||
125099751|NCT00938392|449986334|FG001|Overall Study|Adverse Event|1|||
125099752|NCT00938392|449986333|FG000|Overall Study|Withdrawal by Subject|0|||
125099753|NCT00938392|449986334|FG001|Overall Study|Withdrawal by Subject|1|||
125099754|NCT00938392|449986333|FG000|Overall Study|Lost to Follow-up|2|||
125099755|NCT00938392|449986334|FG001|Overall Study|Lost to Follow-up|2|||
125099756|NCT00124709|449986335|FG000|Overall Study|Randomized but did not take medication|3|||
125099757|NCT00124709|449986336|FG001|Overall Study|Randomized but did not take medication|1|||
125099758|NCT00124709|449986335|FG000|Overall Study|Adverse Event|3|||
125099759|NCT00124709|449986336|FG001|Overall Study|Adverse Event|0|||
125099760|NCT00124709|449986335|FG000|Overall Study|Lack of Efficacy|5|||
125099761|NCT00124709|449986336|FG001|Overall Study|Lack of Efficacy|10|||
125099762|NCT00124709|449986335|FG000|Overall Study|Protocol Violation|3|||
125099763|NCT00124709|449986336|FG001|Overall Study|Protocol Violation|5|||
125099764|NCT00124709|449986335|FG000|Overall Study|Withdrawal by Subject|127|||
125099765|NCT00124709|449986336|FG001|Overall Study|Withdrawal by Subject|136|||
125099766|NCT00124709|449986335|FG000|Overall Study|Lost to Follow-up|114|||
125099767|NCT00124709|449986336|FG001|Overall Study|Lost to Follow-up|120|||
125099768|NCT01728376|449986337|FG000|Overall Study|Adverse Event|1|||
125099769|NCT01728376|449986338|FG001|Overall Study|Adverse Event|1|||
125099770|NCT01728376|449986339|FG002|Overall Study|Adverse Event|1|||
125099771|NCT01728376|449986340|FG003|Overall Study|Adverse Event|1|||
125099772|NCT01728376|449986341|FG004|Overall Study|Adverse Event|1|||
125099773|NCT01728376|449986342|FG005|Overall Study|Adverse Event|0|||
125099774|NCT01728376|449986337|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
125099775|NCT01728376|449986338|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
125099776|NCT01728376|449986339|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
125099777|NCT01728376|449986340|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
125099778|NCT01728376|449986341|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
125099779|NCT01728376|449986342|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
125099780|NCT01728376|449986337|FG000|Overall Study|No relevant bacteria|2|||
125099781|NCT01728376|449986338|FG001|Overall Study|No relevant bacteria|0|||
125099782|NCT01728376|449986339|FG002|Overall Study|No relevant bacteria|0|||
125099783|NCT01728376|449986340|FG003|Overall Study|No relevant bacteria|0|||
125099784|NCT01728376|449986341|FG004|Overall Study|No relevant bacteria|1|||
125099785|NCT01728376|449986342|FG005|Overall Study|No relevant bacteria|1|||
125099786|NCT01728376|449986337|FG000|Overall Study|Did not receive treatment|0|||
125099787|NCT01728376|449986338|FG001|Overall Study|Did not receive treatment|1|||
125099788|NCT01728376|449986339|FG002|Overall Study|Did not receive treatment|0|||
125099789|NCT01728376|449986340|FG003|Overall Study|Did not receive treatment|0|||
125099790|NCT01728376|449986341|FG004|Overall Study|Did not receive treatment|0|||
125099791|NCT01728376|449986342|FG005|Overall Study|Did not receive treatment|0|||
125099792|NCT01728376|449986337|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
125099793|NCT01728376|449986338|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
125099794|NCT01728376|449986339|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
125099795|NCT01728376|449986340|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
125099796|NCT01728376|449986341|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
125099797|NCT01728376|449986342|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
125099798|NCT04341727|449986355|FG000|Overall Study|Withdrawal by Subject|0|||
125099799|NCT04341727|449986356|FG001|Overall Study|Withdrawal by Subject|0|||
125099800|NCT04341727|449986357|FG002|Overall Study|Withdrawal by Subject|1|||
125099801|NCT04341727|449986358|FG003|Overall Study|Withdrawal by Subject|0|||
125099802|NCT04341727|449986355|FG000|Overall Study|Lost to Follow-up|0|||
125099803|NCT04341727|449986356|FG001|Overall Study|Lost to Follow-up|0|||
125099804|NCT04341727|449986357|FG002|Overall Study|Lost to Follow-up|0|||
125099805|NCT04341727|449986358|FG003|Overall Study|Lost to Follow-up|1|||
125099806|NCT05604521|449986359|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
125099807|NCT05604521|449986360|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
125099808|NCT05604521|449986359|FG000|Overall Study|Adverse Event|1|||
125099809|NCT05604521|449986360|FG001|Overall Study|Adverse Event|0|||
125099810|NCT01491737|449986361|FG000|Overall Study|Withdrawal by Subject|20|||
125099811|NCT01491737|449986362|FG001|Overall Study|Withdrawal by Subject|17|||
125099812|NCT01491737|449986361|FG000|Overall Study|Lost to Follow-up|2|||
125099813|NCT01491737|449986362|FG001|Overall Study|Lost to Follow-up|10|||
125099814|NCT01491737|449986361|FG000|Overall Study|Death|63|||
125099815|NCT01491737|449986362|FG001|Overall Study|Death|57|||
125099816|NCT01491737|449986361|FG000|Overall Study|Study Termination by Sponsor|36|||
125099817|NCT01491737|449986362|FG001|Overall Study|Study Termination by Sponsor|36|||
125099818|NCT01491737|449986361|FG000|Overall Study|Reason Not Specified|8|||
125099819|NCT01491737|449986362|FG001|Overall Study|Reason Not Specified|9|||
125099820|NCT04311411|449986363|FG000|Overall Study|Adverse Event|2|||
125099821|NCT04311411|449986364|FG001|Overall Study|Adverse Event|3|||
125099822|NCT04311411|449986365|FG002|Overall Study|Adverse Event|2|||
125099823|NCT04311411|449986363|FG000|Overall Study|Withdrawal by Subject|3|||
125099824|NCT04311411|449986364|FG001|Overall Study|Withdrawal by Subject|3|||
125099825|NCT04311411|449986365|FG002|Overall Study|Withdrawal by Subject|0|||
125099826|NCT01976663|449986366|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
125099827|NCT01976663|449986366|FG000|Overall Study|Personal Reasons|6|||
125099828|NCT01976663|449986366|FG000|Overall Study|Withdrawal by Subject|4|||
125099829|NCT01976663|449986366|FG000|Overall Study|Screen Failure|3|||
125099830|NCT01976663|449986366|FG000|Overall Study|Adverse Event|2|||
125099831|NCT01976663|449986366|FG000|Overall Study|Lost to Follow-up|3|||
125099832|NCT01817764|449986367|FG000|Overall Study|Adverse Event|7|||
125099833|NCT01817764|449986368|FG001|Overall Study|Adverse Event|10|||
125099834|NCT01817764|449986367|FG000|Overall Study|Lack of Efficacy|9|||
125099835|NCT01817764|449986368|FG001|Overall Study|Lack of Efficacy|7|||
125099836|NCT01817764|449986367|FG000|Overall Study|Protocol Violation|7|||
125099837|NCT01817764|449986368|FG001|Overall Study|Protocol Violation|5|||
125099838|NCT01817764|449986367|FG000|Overall Study|Lost to Follow-up|1|||
125099839|NCT01817764|449986368|FG001|Overall Study|Lost to Follow-up|4|||
125099840|NCT01817764|449986367|FG000|Overall Study|Withdrawal by Subject|10|||
125099841|NCT01817764|449986368|FG001|Overall Study|Withdrawal by Subject|12|||
125099842|NCT04888377|449986369|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
125099843|NCT04888377|449986370|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
125099844|NCT04888377|449986369|FG000|Overall Study|Physician Decision|6|||
125099845|NCT04888377|449986370|FG001|Overall Study|Physician Decision|6|||
125099846|NCT04888377|449986369|FG000|Overall Study|Withdrawal by Subject|7|||
125099847|NCT04888377|449986370|FG001|Overall Study|Withdrawal by Subject|3|||
125099848|NCT05644756|449986371|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
125099849|NCT05644756|449986371|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
125099850|NCT00478933|449986376|FG000|Overall Study|Protocol Violation|22|||
125099851|NCT00478933|449986376|FG000|Overall Study|Informed consent not verified|3|||
125099852|NCT00478933|449986376|FG000|Overall Study|Inadequate data available|53|||
125099853|NCT03586427|449986379|FG000|Overall Study|Lost to Follow-up|0|||
125099854|NCT03586427|449986380|FG001|Overall Study|Lost to Follow-up|3|||
125099855|NCT03586427|449986381|FG002|Overall Study|Lost to Follow-up|1|||
125099856|NCT03586427|449986382|FG003|Overall Study|Lost to Follow-up|3|||
125099857|NCT03586427|449986383|FG004|Overall Study|Lost to Follow-up|3|||
125099858|NCT03586427|449986379|FG000|Overall Study|Withdrawal by Subject|0|||
125099859|NCT03586427|449986380|FG001|Overall Study|Withdrawal by Subject|1|||
125099860|NCT03586427|449986381|FG002|Overall Study|Withdrawal by Subject|2|||
125099861|NCT03586427|449986382|FG003|Overall Study|Withdrawal by Subject|1|||
125099862|NCT03586427|449986383|FG004|Overall Study|Withdrawal by Subject|1|||
125099863|NCT03586427|449986379|FG000|Overall Study|Adverse Event|0|||
125099864|NCT03586427|449986380|FG001|Overall Study|Adverse Event|0|||
125099865|NCT03586427|449986381|FG002|Overall Study|Adverse Event|1|||
125099866|NCT03586427|449986382|FG003|Overall Study|Adverse Event|0|||
125099867|NCT03586427|449986383|FG004|Overall Study|Adverse Event|0|||
125099868|NCT03586427|449986379|FG000|Overall Study|Protocol Violation|0|||
125099869|NCT03586427|449986380|FG001|Overall Study|Protocol Violation|0|||
125099870|NCT03586427|449986381|FG002|Overall Study|Protocol Violation|1|||
125099871|NCT03586427|449986382|FG003|Overall Study|Protocol Violation|0|||
125099872|NCT03586427|449986383|FG004|Overall Study|Protocol Violation|1|||
125099873|NCT03586427|449986379|FG000|Overall Study|Noncompliance with study drug|0|||
125099874|NCT03586427|449986380|FG001|Overall Study|Noncompliance with study drug|0|||
125099875|NCT03586427|449986381|FG002|Overall Study|Noncompliance with study drug|1|||
125099876|NCT03586427|449986382|FG003|Overall Study|Noncompliance with study drug|0|||
125099877|NCT03586427|449986383|FG004|Overall Study|Noncompliance with study drug|0|||
124875341|NCT02799472|449165938|FG000|Overall Study|Lost to Follow-up|0|||
125099878|NCT00494234|449986384|FG000|Overall Study|Withdrawal by Subject|1|||
125099879|NCT00494234|449986385|FG001|Overall Study|Withdrawal by Subject|0|||
125099880|NCT00494234|449986384|FG000|Overall Study|Disease progression|11|||
125099881|NCT00494234|449986385|FG001|Overall Study|Disease progression|8|||
125099882|NCT00494234|449986384|FG000|Overall Study|Death|2|||
125099883|NCT00494234|449986385|FG001|Overall Study|Death|1|||
125099884|NCT00423137|449986386|FG000|Overall Study|Lost to Follow-up|0|||
125099885|NCT00423137|449986387|FG001|Overall Study|Lost to Follow-up|0|||
125099886|NCT00423137|449986388|FG002|Overall Study|Lost to Follow-up|1|||
125099887|NCT00423137|449986389|FG003|Overall Study|Lost to Follow-up|0|||
125099888|NCT00423137|449986386|FG000|Overall Study|Protocol Violation|0|||
125099889|NCT00423137|449986387|FG001|Overall Study|Protocol Violation|0|||
125099890|NCT00423137|449986388|FG002|Overall Study|Protocol Violation|0|||
125099891|NCT00423137|449986389|FG003|Overall Study|Protocol Violation|1|||
125099892|NCT00423137|449986386|FG000|Overall Study|Adverse Event Study disease worse|1|||
125099893|NCT00423137|449986387|FG001|Overall Study|Adverse Event Study disease worse|0|||
125099894|NCT00423137|449986388|FG002|Overall Study|Adverse Event Study disease worse|3|||
125099895|NCT00423137|449986389|FG003|Overall Study|Adverse Event Study disease worse|1|||
125099896|NCT00423137|449986386|FG000|Overall Study|Adverse Event Other|0|||
125099897|NCT00423137|449986387|FG001|Overall Study|Adverse Event Other|0|||
125099898|NCT00423137|449986388|FG002|Overall Study|Adverse Event Other|2|||
125099899|NCT00423137|449986389|FG003|Overall Study|Adverse Event Other|0|||
125099900|NCT00593385|449986394|FG000|Overall Study|Death|14|||
125099901|NCT00593385|449986394|FG000|Overall Study|Lost to Follow-up|17|||
125099902|NCT00593385|449986394|FG000|Overall Study|Withdrawal by Subject|9|||
125099903|NCT01298362|449986402|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
125099904|NCT01298362|449986403|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
125099905|NCT00762073|449986406|FG000|Overall Study|Lack of Efficacy|1|||
125099906|NCT00762073|449986407|FG001|Overall Study|Lack of Efficacy|1|||
125099907|NCT00762073|449986408|FG002|Overall Study|Lack of Efficacy|0|||
125099908|NCT00762073|449986409|FG003|Overall Study|Lack of Efficacy|0|||
125099909|NCT00762073|449986406|FG000|Overall Study|Adverse Event|1|||
125099910|NCT00762073|449986407|FG001|Overall Study|Adverse Event|0|||
125099911|NCT00762073|449986408|FG002|Overall Study|Adverse Event|1|||
125099912|NCT00762073|449986409|FG003|Overall Study|Adverse Event|1|||
125099913|NCT00762073|449986406|FG000|Overall Study|Significant Subject Noncompliance|0|||
125099914|NCT00762073|449986407|FG001|Overall Study|Significant Subject Noncompliance|1|||
125099915|NCT00762073|449986408|FG002|Overall Study|Significant Subject Noncompliance|0|||
125099916|NCT00762073|449986409|FG003|Overall Study|Significant Subject Noncompliance|1|||
125099917|NCT00762073|449986406|FG000|Overall Study|Withdrawal by Subject|1|||
125099918|NCT00762073|449986407|FG001|Overall Study|Withdrawal by Subject|2|||
125099919|NCT00762073|449986408|FG002|Overall Study|Withdrawal by Subject|1|||
125099920|NCT00762073|449986409|FG003|Overall Study|Withdrawal by Subject|1|||
125099921|NCT00762073|449986406|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
125099922|NCT00762073|449986407|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
125099923|NCT00762073|449986408|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
125099924|NCT00762073|449986409|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
125099925|NCT00326625|449986411|FG000|Overall Study|Adverse Event|20|||
125099926|NCT00326625|449986412|FG001|Overall Study|Adverse Event|9|||
125099927|NCT00326625|449986411|FG000|Overall Study|Withdrawal by Subject|15|||
125099928|NCT00326625|449986412|FG001|Overall Study|Withdrawal by Subject|12|||
125099929|NCT00326625|449986411|FG000|Overall Study|Death|18|||
125099930|NCT00326625|449986412|FG001|Overall Study|Death|16|||
125099931|NCT00326625|449986411|FG000|Overall Study|Lost to Follow-up|1|||
125099932|NCT00326625|449986412|FG001|Overall Study|Lost to Follow-up|0|||
125099933|NCT00326625|449986411|FG000|Overall Study|prescheduled medical intervention|0|||
125099934|NCT00326625|449986412|FG001|Overall Study|prescheduled medical intervention|1|||
125099935|NCT01265875|449986413|FG000|Overall Study|Uncooperative/unreliable|1|||
125099936|NCT05275673|449986414|FG000|Overall Study|Study Termination by Sponsor|2|||
125099937|NCT05275673|449986415|FG001|Overall Study|Study Termination by Sponsor|3|||
125099938|NCT05275673|449986414|FG000|Overall Study|Death|1|||
125099939|NCT05275673|449986415|FG001|Overall Study|Death|0|||
125099940|NCT05275673|449986414|FG000|Overall Study|Withdrawal by Subject|1|||
125099941|NCT05275673|449986415|FG001|Overall Study|Withdrawal by Subject|0|||
125099942|NCT04456998|449986416|FG000|Overall Study|Adverse Event|0|||
125099943|NCT04456998|449986417|FG001|Overall Study|Adverse Event|4|||
125099944|NCT04456998|449986416|FG000|Overall Study|Protocol Deviation|0|||
125099945|NCT04456998|449986417|FG001|Overall Study|Protocol Deviation|1|||
125099946|NCT04456998|449986416|FG000|Overall Study|Withdrawal by Subject|0|||
125099947|NCT04456998|449986417|FG001|Overall Study|Withdrawal by Subject|1|||
125099948|NCT00400985|449986418|FG000|Overall Study|Withdrawal by Subject|5|||
125099949|NCT00400985|449986418|FG000|Overall Study|system modification|8|||
125099950|NCT00400985|449986418|FG000|Overall Study|Death|30|||
125099951|NCT00400985|449986418|FG000|Overall Study|Lost to Follow-up|9|||
125099952|NCT03792633|449986423|FG000|Overall Study|Alternative Treatment|17|||
125099953|NCT03792633|449986424|FG001|Overall Study|Alternative Treatment|19|||
125099954|NCT03792633|449986423|FG000|Overall Study|Death|2|||
125099955|NCT03792633|449986424|FG001|Overall Study|Death|0|||
125099956|NCT03792633|449986423|FG000|Overall Study|Disease progression|8|||
125099957|NCT03792633|449986424|FG001|Overall Study|Disease progression|9|||
125011685|NCT03200366|449668395|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
125011686|NCT03200366|449668396|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
125011687|NCT03200366|449668397|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
125011688|NCT03200366|449668395|FG000|9 Month Post-Baseline Interview|Death|1|||
125011689|NCT03200366|449668396|FG001|9 Month Post-Baseline Interview|Death|1|||
125011690|NCT03200366|449668397|FG002|9 Month Post-Baseline Interview|Death|1|||
125011691|NCT03200366|449668395|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
125011692|NCT03200366|449668396|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
125011693|NCT03200366|449668397|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
125011694|NCT03200366|449668395|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
125011695|NCT03200366|449668396|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
125011696|NCT03200366|449668397|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
125011697|NCT03200366|449668395|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
125011698|NCT03200366|449668396|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
125011699|NCT03200366|449668397|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
125011700|NCT03201458|449668398|FG000|Overall Study|No longer eligible|2|||
125011701|NCT03201458|449668399|FG001|Overall Study|No longer eligible|5|||
125011702|NCT03201458|449668398|FG000|Overall Study|Health event before starting|1|||
125011703|NCT03201458|449668399|FG001|Overall Study|Health event before starting|0|||
125011704|NCT03201458|449668398|FG000|Overall Study|Physician Decision|1|||
125011705|NCT03201458|449668399|FG001|Overall Study|Physician Decision|0|||
125011706|NCT00750737|449668402|FG000|Overall Study|Withdrawal by Subject|3|||
125099958|NCT03792633|449986423|FG000|Overall Study|Lost to Follow-up|1|||
125099959|NCT03792633|449986424|FG001|Overall Study|Lost to Follow-up|1|||
125099960|NCT03792633|449986423|FG000|Overall Study|Screen fail|1|||
125099961|NCT03792633|449986424|FG001|Overall Study|Screen fail|0|||
125099962|NCT03792633|449986423|FG000|Overall Study|Second malignancy|0|||
125099963|NCT03792633|449986424|FG001|Overall Study|Second malignancy|1|||
125099964|NCT03179462|449986427|FG000|Overall Study|screening failure|1|||
125099965|NCT03179462|449986428|FG001|Overall Study|screening failure|2|||
125099966|NCT03179462|449986429|FG002|Overall Study|screening failure|0|||
125099967|NCT03743571|449986432|FG000|Overall Study|Withdrawal by Subject|1|||
125099968|NCT03743571|449986433|FG001|Overall Study|Withdrawal by Subject|1|||
125099969|NCT03743571|449986432|FG000|Overall Study|Lost to Follow-up|1|||
125099970|NCT03743571|449986433|FG001|Overall Study|Lost to Follow-up|2|||
125099971|NCT04115488|449986434|FG000|Overall Study|Adverse Event|8|||
125099972|NCT04115488|449986435|FG001|Overall Study|Adverse Event|4|||
125099973|NCT04115488|449986434|FG000|Overall Study|Withdrawal by Subject|3|||
125099974|NCT04115488|449986435|FG001|Overall Study|Withdrawal by Subject|6|||
125099975|NCT04115488|449986434|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
125099976|NCT04115488|449986435|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
125099977|NCT04115488|449986434|FG000|Overall Study|Patient 's location change|1|||
125099978|NCT04115488|449986435|FG001|Overall Study|Patient 's location change|0|||
125099979|NCT04115488|449986434|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
125099980|NCT04115488|449986435|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
125099981|NCT01058707|449986448|FG000|Overall Study|Disease Progression|15|||
125099982|NCT01058707|449986449|FG001|Overall Study|Disease Progression|20|||
125099983|NCT01058707|449986450|FG002|Overall Study|Disease Progression|20|||
125099984|NCT01058707|449986451|FG003|Overall Study|Disease Progression|15|||
125099985|NCT01058707|449986452|FG004|Overall Study|Disease Progression|23|||
125099986|NCT01058707|449986453|FG005|Overall Study|Disease Progression|10|||
125099987|NCT01058707|449986454|FG006|Overall Study|Disease Progression|12|||
125099988|NCT01058707|449986448|FG000|Overall Study|Adverse Event|11|||
125099989|NCT01058707|449986449|FG001|Overall Study|Adverse Event|4|||
125099990|NCT01058707|449986450|FG002|Overall Study|Adverse Event|7|||
125099991|NCT01058707|449986451|FG003|Overall Study|Adverse Event|6|||
125099992|NCT01058707|449986452|FG004|Overall Study|Adverse Event|7|||
125099993|NCT01058707|449986453|FG005|Overall Study|Adverse Event|3|||
125099994|NCT01058707|449986454|FG006|Overall Study|Adverse Event|1|||
125099995|NCT01058707|449986448|FG000|Overall Study|Subject Decision|5|||
125099996|NCT01058707|449986449|FG001|Overall Study|Subject Decision|3|||
125099997|NCT01058707|449986450|FG002|Overall Study|Subject Decision|3|||
125099998|NCT01058707|449986451|FG003|Overall Study|Subject Decision|1|||
125099999|NCT01058707|449986452|FG004|Overall Study|Subject Decision|2|||
125011707|NCT00750737|449668403|FG001|Overall Study|Withdrawal by Subject|3|||
125011708|NCT04707157|449668405|FG000|Overall Study|Adverse Event|12|||
125011709|NCT04707157|449668406|FG001|Overall Study|Adverse Event|3|||
125011710|NCT04707157|449668405|FG000|Overall Study|Lost to Follow-up|2|||
125011711|NCT04707157|449668406|FG001|Overall Study|Lost to Follow-up|0|||
124875342|NCT02799472|449165939|FG001|Overall Study|Lost to Follow-up|1|||
125011712|NCT04707157|449668405|FG000|Overall Study|Sponsor's decision|1|||
125100000|NCT01058707|449986453|FG005|Overall Study|Subject Decision|3|||
125100001|NCT01058707|449986454|FG006|Overall Study|Subject Decision|6|||
125100002|NCT01058707|449986448|FG000|Overall Study|Lost to Follow-up|0|||
125100003|NCT01058707|449986449|FG001|Overall Study|Lost to Follow-up|0|||
125100004|NCT01058707|449986450|FG002|Overall Study|Lost to Follow-up|1|||
125100005|NCT01058707|449986451|FG003|Overall Study|Lost to Follow-up|0|||
125100006|NCT01058707|449986452|FG004|Overall Study|Lost to Follow-up|0|||
125100007|NCT01058707|449986453|FG005|Overall Study|Lost to Follow-up|0|||
125100008|NCT01058707|449986454|FG006|Overall Study|Lost to Follow-up|0|||
125100009|NCT01058707|449986448|FG000|Overall Study|Reason Not Specified|0|||
125100010|NCT01058707|449986449|FG001|Overall Study|Reason Not Specified|3|||
125100011|NCT01058707|449986450|FG002|Overall Study|Reason Not Specified|2|||
125100012|NCT01058707|449986451|FG003|Overall Study|Reason Not Specified|0|||
125100013|NCT01058707|449986452|FG004|Overall Study|Reason Not Specified|7|||
125100014|NCT01058707|449986453|FG005|Overall Study|Reason Not Specified|1|||
125100015|NCT01058707|449986454|FG006|Overall Study|Reason Not Specified|7|||
125100016|NCT01821391|449986457|FG000|Overall Study|Adverse Event|1|||
125100017|NCT01821391|449986458|FG001|Overall Study|Adverse Event|0|||
125100018|NCT00828009|449986460|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
125100019|NCT00828009|449986460|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
125100020|NCT00828009|449986460|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
125100021|NCT00828009|449986460|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
125100022|NCT00828009|449986460|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
125100023|NCT00828009|449986460|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
125100024|NCT00828009|449986460|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
125100025|NCT00828009|449986460|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
125100026|NCT00828009|449986460|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
125100027|NCT00828009|449986460|FG000|Step 2 - Maintenance Therapy|Death|1|||
125100028|NCT00828009|449986460|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
125100029|NCT00828009|449986460|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
125100030|NCT00828009|449986460|FG000|Step 2 - Maintenance Therapy|Other|1|||
125100031|NCT04880850|449986461|FG000|Overall Study|Death|2|||
125100032|NCT04880850|449986462|FG001|Overall Study|Death|1|||
125100033|NCT04880850|449986461|FG000|Overall Study|Lost to Follow-up|3|||
125100034|NCT04880850|449986462|FG001|Overall Study|Lost to Follow-up|6|||
125100035|NCT04880850|449986461|FG000|Overall Study|Physician Decision|2|||
125100036|NCT04880850|449986462|FG001|Overall Study|Physician Decision|1|||
125100037|NCT04880850|449986461|FG000|Overall Study|Withdrawal by Subject|9|||
125100038|NCT04880850|449986462|FG001|Overall Study|Withdrawal by Subject|10|||
125100039|NCT03417102|449986463|FG000|Overall Study|Adverse Event|0|||
125100040|NCT03417102|449986464|FG001|Overall Study|Adverse Event|1|||
125100041|NCT03417102|449986463|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
125100042|NCT03417102|449986464|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
125100043|NCT03417102|449986463|FG000|Overall Study|Other|0|||
125100044|NCT03417102|449986464|FG001|Overall Study|Other|1|||
125100045|NCT00526227|449986466|FG000|Overall Study|Device not implanted|1|||
125100046|NCT00526227|449986466|FG000|Overall Study|Death|1|||
125100047|NCT03222856|449986469|FG000|Overall Study|Adverse Event|6|||
125100048|NCT03222856|449986469|FG000|Overall Study|Death|1|||
125100049|NCT03280628|449987893|FG000|Overall Study|Lost to Follow-up|8|||
125100050|NCT03280628|449987894|FG001|Overall Study|Lost to Follow-up|6|||
125100051|NCT03280628|449987895|FG002|Overall Study|Lost to Follow-up|11|||
125100052|NCT01361308|449987898|FG000|Overall Study|Withdrawal by Subject|9|||
125100053|NCT01361308|449987899|FG001|Overall Study|Withdrawal by Subject|13|||
125100054|NCT01361308|449987898|FG000|Overall Study|Physician Decision|3|||
125100055|NCT01361308|449987899|FG001|Overall Study|Physician Decision|3|||
125100056|NCT01361308|449987898|FG000|Overall Study|Lack of Efficacy|2|||
125100057|NCT01361308|449987899|FG001|Overall Study|Lack of Efficacy|0|||
125100058|NCT01361308|449987898|FG000|Overall Study|Protocol Violation|1|||
125100059|NCT01361308|449987899|FG001|Overall Study|Protocol Violation|0|||
125100060|NCT01361308|449987898|FG000|Overall Study|Lost to Follow-up|5|||
125100061|NCT01361308|449987899|FG001|Overall Study|Lost to Follow-up|4|||
125100062|NCT01361308|449987898|FG000|Overall Study|Adverse Event|8|||
125100063|NCT01361308|449987899|FG001|Overall Study|Adverse Event|4|||
125100064|NCT01361308|449987898|FG000|Overall Study|Eligibility Criteria Not Met|2|||
125100065|NCT01361308|449987899|FG001|Overall Study|Eligibility Criteria Not Met|3|||
125100066|NCT01361308|449987898|FG000|Overall Study|Failed C-SSRS|5|||
125100067|NCT01361308|449987899|FG001|Overall Study|Failed C-SSRS|2|||
125100068|NCT01361308|449987898|FG000|Overall Study|Other|0|||
125100069|NCT01361308|449987899|FG001|Overall Study|Other|1|||
125100070|NCT03839693|449987904|FG000|Overall Study|Lost to Follow-up|0|||
125100071|NCT03839693|449987905|FG001|Overall Study|Lost to Follow-up|2|||
125100072|NCT03839693|449987906|FG002|Overall Study|Lost to Follow-up|2|||
125100073|NCT03839693|449987904|FG000|Overall Study|Withdrawal by Subject|1|||
124875343|NCT01226511|449165940|FG000|Acute Treatment Period|Adverse Event|7|||
125100074|NCT03839693|449987905|FG001|Overall Study|Withdrawal by Subject|0|||
125100075|NCT03839693|449987906|FG002|Overall Study|Withdrawal by Subject|2|||
125100076|NCT03839693|449987904|FG000|Overall Study|subject moved out of the area|1|||
125100077|NCT03839693|449987905|FG001|Overall Study|subject moved out of the area|0|||
125100078|NCT03839693|449987906|FG002|Overall Study|subject moved out of the area|0|||
125100079|NCT00700115|449987915|FG000|Overall Study|Withdrawal by Subject|1|||
125011713|NCT04707157|449668406|FG001|Overall Study|Sponsor's decision|0|||
125011714|NCT04707157|449668405|FG000|Overall Study|Physician Decision|8|||
125011715|NCT04707157|449668406|FG001|Overall Study|Physician Decision|5|||
125011716|NCT04707157|449668405|FG000|Overall Study|Protocol Deviation|1|||
125011717|NCT04707157|449668406|FG001|Overall Study|Protocol Deviation|0|||
125011718|NCT04707157|449668405|FG000|Overall Study|Withdrawal by Subject|1|||
125011719|NCT04707157|449668406|FG001|Overall Study|Withdrawal by Subject|1|||
125011720|NCT01543828|449668407|FG000|Treatment 2|Lost to Follow-up|1|||
125011721|NCT01543828|449668408|FG001|Treatment 2|Lost to Follow-up|0|||
125011722|NCT00804570|449668409|FG000|Overall Study|Adverse Event|14|||
125011723|NCT00804570|449668410|FG001|Overall Study|Adverse Event|7|||
125011724|NCT00804570|449668409|FG000|Overall Study|Lack of Efficacy|0|||
125011725|NCT00804570|449668410|FG001|Overall Study|Lack of Efficacy|1|||
125011726|NCT00804570|449668409|FG000|Overall Study|Lost to Follow-up|18|||
125011727|NCT00804570|449668410|FG001|Overall Study|Lost to Follow-up|21|||
125011728|NCT00804570|449668409|FG000|Overall Study|Entry criteria not met|5|||
125011729|NCT00804570|449668410|FG001|Overall Study|Entry criteria not met|5|||
125011730|NCT00804570|449668409|FG000|Overall Study|Protocol Violation|12|||
125011731|NCT00804570|449668410|FG001|Overall Study|Protocol Violation|16|||
125011732|NCT00804570|449668409|FG000|Overall Study|Physician Decision|1|||
125011733|NCT00804570|449668410|FG001|Overall Study|Physician Decision|2|||
125011734|NCT00804570|449668409|FG000|Overall Study|Sponsor decision|1|||
125011735|NCT00804570|449668410|FG001|Overall Study|Sponsor decision|4|||
125011736|NCT00804570|449668409|FG000|Overall Study|Withdrawal by Subject|21|||
125011737|NCT00804570|449668410|FG001|Overall Study|Withdrawal by Subject|38|||
125011738|NCT00290342|449668411|FG000|Overall Study|Other|0|||
125011739|NCT00290342|449668412|FG001|Overall Study|Other|1|||
125011740|NCT00290342|449668411|FG000|Overall Study|Withdrawal by Subject|6|||
125011741|NCT00290342|449668412|FG001|Overall Study|Withdrawal by Subject|4|||
125011742|NCT00290342|449668411|FG000|Overall Study|Lost to Follow-up|1|||
125011743|NCT00290342|449668412|FG001|Overall Study|Lost to Follow-up|0|||
125011744|NCT01056510|449668415|FG000|Overall Study|Dropout Before Start of Treatment|1|||
125011745|NCT01056510|449668416|FG001|Overall Study|Dropout Before Start of Treatment|1|||
125011746|NCT01056510|449668415|FG000|Overall Study|Withdrawal by Subject|4|||
125011747|NCT01056510|449668416|FG001|Overall Study|Withdrawal by Subject|2|||
125011748|NCT01056510|449668415|FG000|Overall Study|Death|29|||
125011749|NCT01056510|449668416|FG001|Overall Study|Death|34|||
125011750|NCT01056510|449668415|FG000|Overall Study|Noncompliance|1|||
125011751|NCT01056510|449668416|FG001|Overall Study|Noncompliance|3|||
125011752|NCT01056510|449668415|FG000|Overall Study|Physician Decision|4|||
125011753|NCT01056510|449668416|FG001|Overall Study|Physician Decision|5|||
125011754|NCT01056510|449668415|FG000|Overall Study|Lost to Follow-up|5|||
125011755|NCT01056510|449668416|FG001|Overall Study|Lost to Follow-up|6|||
125011756|NCT01056510|449668415|FG000|Overall Study|Other|10|||
125011757|NCT01056510|449668416|FG001|Overall Study|Other|12|||
125011758|NCT01056510|449668415|FG000|Overall Study|Missing|0|||
125011759|NCT01056510|449668416|FG001|Overall Study|Missing|1|||
125011760|NCT00243386|449668417|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
125011761|NCT00243386|449668418|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
125011762|NCT00243386|449668419|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
125011763|NCT00243386|449668417|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
125011764|NCT00243386|449668418|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
125011765|NCT00243386|449668419|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
125011766|NCT00243386|449668417|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
125011767|NCT00243386|449668418|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
125011768|NCT00243386|449668419|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
125011769|NCT00243386|449668417|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
125011770|NCT00243386|449668418|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
125011771|NCT00243386|449668419|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
125011772|NCT00243386|449668417|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
125011773|NCT00243386|449668418|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
125011774|NCT00243386|449668419|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
125011775|NCT00243386|449668417|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
125011776|NCT00243386|449668418|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
125011777|NCT00243386|449668419|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
125011778|NCT00243386|449668417|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
125011779|NCT00243386|449668418|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
125011780|NCT00243386|449668419|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
125011781|NCT00243386|449668417|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
125011782|NCT00243386|449668418|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
125011783|NCT00243386|449668419|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
125011784|NCT02285998|449668420|FG000|Overall Study|Adverse Event|9|||
125011785|NCT02285998|449668421|FG001|Overall Study|Adverse Event|8|||
125011786|NCT02285998|449668420|FG000|Overall Study|Physician Decision|1|||
124875344|NCT01226511|449165941|FG001|Acute Treatment Period|Adverse Event|6|||
124875345|NCT01226511|449165940|FG000|Acute Treatment Period|Lack of Efficacy|2|||
124875346|NCT01226511|449165941|FG001|Acute Treatment Period|Lack of Efficacy|1|||
124875347|NCT01226511|449165940|FG000|Acute Treatment Period|Lost to Follow-up|3|||
124875348|NCT01226511|449165941|FG001|Acute Treatment Period|Lost to Follow-up|6|||
124875349|NCT01226511|449165940|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
124875350|NCT01226511|449165941|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
124875351|NCT01226511|449165940|FG000|Acute Treatment Period|Protocol Violation|5|||
124875352|NCT01226511|449165941|FG001|Acute Treatment Period|Protocol Violation|5|||
124875353|NCT01226511|449165940|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
125011787|NCT02285998|449668421|FG001|Overall Study|Physician Decision|2|||
125011788|NCT02285998|449668420|FG000|Overall Study|Lost to Follow-up|176|||
125011789|NCT02285998|449668421|FG001|Overall Study|Lost to Follow-up|172|||
125011790|NCT02285998|449668420|FG000|Overall Study|Withdrawal by Subject|53|||
125011791|NCT02285998|449668421|FG001|Overall Study|Withdrawal by Subject|61|||
125011792|NCT02285998|449668420|FG000|Overall Study|Other Reasons|7|||
125011793|NCT02285998|449668421|FG001|Overall Study|Other Reasons|10|||
125011794|NCT00545298|449668422|FG000|Overall Study|Issues with Standard of Care|2|||
125011795|NCT00545298|449668423|FG001|Overall Study|Issues with Standard of Care|0|||
125011796|NCT00545298|449668424|FG002|Overall Study|Issues with Standard of Care|1|||
125011797|NCT01820364|449668432|FG000|Part I: LGX818|Death|1|||
125011798|NCT01820364|449668433|FG001|Part I: LGX818|Death|0|||
125011799|NCT01820364|449668432|FG000|Part I: LGX818|Administrative Problems|3|||
125011800|NCT01820364|449668433|FG001|Part I: LGX818|Administrative Problems|0|||
125011801|NCT01820364|449668432|FG000|Part I: LGX818|Adverse Event|6|||
125011802|NCT01820364|449668433|FG001|Part I: LGX818|Adverse Event|0|||
125011803|NCT01820364|449668432|FG000|Part I: LGX818|Disease Progression|4|||
125011804|NCT01820364|449668433|FG001|Part I: LGX818|Disease Progression|0|||
125011805|NCT01820364|449668432|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
125011806|NCT01820364|449668433|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
125011807|NCT01793142|449668434|FG000|Overall Study|Randomized not treated|7|||
125011808|NCT03451084|449668435|FG000|Overall Study|Withdrawal by Subject|2|||
125011809|NCT03451084|449668436|FG001|Overall Study|Withdrawal by Subject|1|||
125011810|NCT03451084|449668437|FG002|Overall Study|Withdrawal by Subject|2|||
125011811|NCT03451084|449668438|FG003|Overall Study|Withdrawal by Subject|1|||
125011812|NCT03451084|449668435|FG000|Overall Study|Disease recurrence|0|||
125011813|NCT03451084|449668436|FG001|Overall Study|Disease recurrence|2|||
125011814|NCT03451084|449668437|FG002|Overall Study|Disease recurrence|0|||
125011815|NCT03451084|449668438|FG003|Overall Study|Disease recurrence|0|||
125011816|NCT03451084|449668435|FG000|Overall Study|Lack of Efficacy|0|||
125011817|NCT03451084|449668436|FG001|Overall Study|Lack of Efficacy|3|||
125011818|NCT03451084|449668437|FG002|Overall Study|Lack of Efficacy|0|||
125011819|NCT03451084|449668438|FG003|Overall Study|Lack of Efficacy|1|||
125011820|NCT03451084|449668435|FG000|Overall Study|Death|1|||
125011821|NCT03451084|449668436|FG001|Overall Study|Death|0|||
125011822|NCT03451084|449668437|FG002|Overall Study|Death|2|||
125011823|NCT03451084|449668438|FG003|Overall Study|Death|0|||
125011824|NCT03451084|449668435|FG000|Overall Study|Physician Decision|0|||
125011825|NCT03451084|449668436|FG001|Overall Study|Physician Decision|0|||
125011826|NCT03451084|449668437|FG002|Overall Study|Physician Decision|2|||
125011827|NCT03451084|449668438|FG003|Overall Study|Physician Decision|2|||
125011828|NCT03451084|449668435|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
125011829|NCT03451084|449668436|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
125011830|NCT03451084|449668437|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
125011831|NCT03451084|449668438|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
125011832|NCT04995055|449668444|FG000|Period 1|COVID-19 Related|1|||
125011833|NCT04995055|449668445|FG001|Period 1|COVID-19 Related|0|||
125011834|NCT04995055|449668444|FG000|Period 1|Withdrawal by Subject|0|||
125011835|NCT04995055|449668445|FG001|Period 1|Withdrawal by Subject|1|||
125011836|NCT04995055|449668444|FG000|Period 1|Subject discontinued due to timing|4|||
125011837|NCT04995055|449668445|FG001|Period 1|Subject discontinued due to timing|4|||
125011838|NCT03418129|449668448|FG000|Overall Study|Lost to Follow-up|11|||
125011839|NCT03418129|449668449|FG001|Overall Study|Lost to Follow-up|20|||
125011840|NCT03418129|449668450|FG002|Overall Study|Lost to Follow-up|15|||
125011841|NCT03418129|449668448|FG000|Overall Study|Withdrawal by Subject|3|||
125011842|NCT03418129|449668449|FG001|Overall Study|Withdrawal by Subject|6|||
125011843|NCT03418129|449668450|FG002|Overall Study|Withdrawal by Subject|4|||
125011844|NCT01553188|449668454|FG000|Overall Study|Patient choice|1|||
125011845|NCT01553188|449668455|FG001|Overall Study|Patient choice|0|||
124875354|NCT01226511|449165941|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
124875355|NCT01226511|449165940|FG000|Extension Treatment Period|Adverse Event|8|||
125011846|NCT01553188|449668456|FG002|Overall Study|Patient choice|0|||
125011847|NCT01553188|449668457|FG003|Overall Study|Patient choice|0|||
125011848|NCT01553188|449668454|FG000|Overall Study|Intercurrent illness and adverse event|0|||
125011849|NCT01553188|449668455|FG001|Overall Study|Intercurrent illness and adverse event|1|||
125011850|NCT01553188|449668456|FG002|Overall Study|Intercurrent illness and adverse event|2|||
124875356|NCT01226511|449165941|FG001|Extension Treatment Period|Adverse Event|8|||
124875357|NCT01226511|449165940|FG000|Extension Treatment Period|Lack of Efficacy|3|||
124875358|NCT01226511|449165941|FG001|Extension Treatment Period|Lack of Efficacy|2|||
124875359|NCT01226511|449165940|FG000|Extension Treatment Period|Lost to Follow-up|4|||
124875360|NCT01226511|449165941|FG001|Extension Treatment Period|Lost to Follow-up|3|||
124875361|NCT01226511|449165940|FG000|Extension Treatment Period|Protocol Violation|2|||
124875362|NCT01226511|449165941|FG001|Extension Treatment Period|Protocol Violation|2|||
124875363|NCT01226511|449165940|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
124875364|NCT01226511|449165941|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
124875365|NCT01226511|449165940|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
124875366|NCT01226511|449165941|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
124875367|NCT01226511|449165940|FG000|Extension Treatment Period|Sponsor Decision|1|||
124875368|NCT01226511|449165941|FG001|Extension Treatment Period|Sponsor Decision|1|||
124875369|NCT01226511|449165940|FG000|Taper Period|Adverse Event|1|||
124875370|NCT01226511|449165941|FG001|Taper Period|Adverse Event|0|||
124875371|NCT01226511|449165940|FG000|Taper Period|Lost to Follow-up|2|||
125011851|NCT01553188|449668457|FG003|Overall Study|Intercurrent illness and adverse event|0|||
125011852|NCT01066585|449668458|FG000|Overall Study|Protocol Violation|1|||
125011853|NCT01066585|449668459|FG001|Overall Study|Protocol Violation|0|||
125011854|NCT01066585|449668458|FG000|Overall Study|Withdrawal by Subject|0|||
125011855|NCT01066585|449668459|FG001|Overall Study|Withdrawal by Subject|3|||
125011856|NCT04126083|449668460|FG000|Overall Study|Withdrawal by Subject|1|||
125011857|NCT01279850|449668461|FG000|Overall Study|Protocol Violation|50|||
125011858|NCT01279850|449668461|FG000|Overall Study|No Drug Administration Information|7|||
125011859|NCT01279850|449668461|FG000|Overall Study|No Visit After Treatment|34|||
125011860|NCT01131520|449668462|FG000|Overall Study|Computer problem|1|||
125011861|NCT01131520|449668463|FG001|Overall Study|Computer problem|0|||
125011862|NCT01131520|449668462|FG000|Overall Study|Counselor not available|0|||
125011863|NCT01131520|449668463|FG001|Overall Study|Counselor not available|3|||
125011864|NCT01131520|449668462|FG000|Overall Study|Subject changed history after enrollment|0|||
125011865|NCT01131520|449668463|FG001|Overall Study|Subject changed history after enrollment|1|||
125011866|NCT02186847|449668464|FG000|Overall Study|Protocol Violation|3|||
125011867|NCT02186847|449668465|FG001|Overall Study|Protocol Violation|0|||
125011868|NCT03416153|449668466|FG000|Overall Study|Physician Decision|1|||
125011869|NCT03416153|449668467|FG001|Overall Study|Physician Decision|1|||
125011870|NCT03416153|449668466|FG000|Overall Study|Withdrawal by Subject|1|||
125011871|NCT03416153|449668467|FG001|Overall Study|Withdrawal by Subject|0|||
125011872|NCT01617460|449669904|FG000|Overall Study|Adverse Event|10|||
125011873|NCT01617460|449669904|FG000|Overall Study|Physician Decision|16|||
125011874|NCT01617460|449669904|FG000|Overall Study|Protocol Violation|5|||
125011875|NCT01617460|449669904|FG000|Overall Study|Withdrawal by Subject|9|||
125011876|NCT03703882|449669905|FG000|Overall Study|Adverse Event|1|||
125011877|NCT03703882|449669906|FG001|Overall Study|Adverse Event|0|||
125011878|NCT03703882|449669905|FG000|Overall Study|Lost to Follow-up|0|||
125011879|NCT03703882|449669906|FG001|Overall Study|Lost to Follow-up|2|||
125011880|NCT03703882|449669905|FG000|Overall Study|Non-compliance with study drug|0|||
125011881|NCT03703882|449669906|FG001|Overall Study|Non-compliance with study drug|1|||
125011882|NCT03703882|449669905|FG000|Overall Study|Physician Decision|0|||
125011883|NCT03703882|449669906|FG001|Overall Study|Physician Decision|1|||
125011884|NCT03703882|449669905|FG000|Overall Study|Progressive disease|1|||
125011885|NCT03703882|449669906|FG001|Overall Study|Progressive disease|0|||
125011886|NCT03703882|449669905|FG000|Overall Study|Withdrawal by parent/guardian|1|||
125011887|NCT03703882|449669906|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125011888|NCT03703882|449669905|FG000|Overall Study|Starting another treatment|0|||
125011889|NCT03703882|449669906|FG001|Overall Study|Starting another treatment|1|||
125011890|NCT03703882|449669905|FG000|Overall Study|noncompliance with study procedures|0|||
125011891|NCT03703882|449669906|FG001|Overall Study|noncompliance with study procedures|1|||
125011892|NCT00666458|449669912|FG000|Overall Study|Adverse Event|8|||
125011893|NCT00666458|449669913|FG001|Overall Study|Adverse Event|7|||
125011894|NCT00666458|449669912|FG000|Overall Study|Withdrawal by Subject|5|||
125011895|NCT00666458|449669913|FG001|Overall Study|Withdrawal by Subject|4|||
125011896|NCT00666458|449669912|FG000|Overall Study|Lost to Follow-up|0|||
125011897|NCT00666458|449669913|FG001|Overall Study|Lost to Follow-up|3|||
125011898|NCT00666458|449669912|FG000|Overall Study|Administrative reason by sponsor|1|||
125011899|NCT00666458|449669913|FG001|Overall Study|Administrative reason by sponsor|1|||
124875372|NCT01226511|449165941|FG001|Taper Period|Lost to Follow-up|2|||
124875373|NCT01226511|449165940|FG000|Taper Period|Protocol Violation|1|||
124875374|NCT01226511|449165941|FG001|Taper Period|Protocol Violation|0|||
124875375|NCT01226511|449165940|FG000|Taper Period|Parent/Caregiver Decision|1|||
125011900|NCT00666458|449669912|FG000|Overall Study|Incorrect enrollment|7|||
125011901|NCT00666458|449669913|FG001|Overall Study|Incorrect enrollment|1|||
125011902|NCT00666458|449669912|FG000|Overall Study|Study specific discontinuation criteria|14|||
125011903|NCT00666458|449669913|FG001|Overall Study|Study specific discontinuation criteria|7|||
125011904|NCT00666458|449669912|FG000|Overall Study|Severe non-compliance to the protocol|1|||
125011905|NCT00666458|449669913|FG001|Overall Study|Severe non-compliance to the protocol|1|||
125011906|NCT00666458|449669912|FG000|Overall Study|Safety reasons|1|||
125011907|NCT00666458|449669913|FG001|Overall Study|Safety reasons|0|||
125011908|NCT00666458|449669912|FG000|Overall Study|Medical history of anemia|1|||
125011909|NCT00666458|449669913|FG001|Overall Study|Medical history of anemia|0|||
125011910|NCT02222207|449669914|FG000|Overall Study|Death|1|||
125011911|NCT02222207|449669914|FG000|Overall Study|Other reasons|2|||
125011912|NCT02222207|449669914|FG000|Overall Study|Adverse Event|1|||
125011913|NCT02982954|449669915|FG000|Overall Study|Death|55|||
125011914|NCT02982954|449669916|FG001|Overall Study|Death|29|||
125011915|NCT02982954|449669917|FG002|Overall Study|Death|15|||
125011916|NCT02982954|449669918|FG003|Overall Study|Death|20|||
125011917|NCT02982954|449669915|FG000|Overall Study|Lost to Follow-up|2|||
125100080|NCT00700115|449987916|FG001|Overall Study|Withdrawal by Subject|0|||
125100081|NCT00700115|449987915|FG000|Overall Study|Lost to Follow-up|0|||
125100082|NCT00700115|449987916|FG001|Overall Study|Lost to Follow-up|1|||
125100083|NCT02503215|449987917|FG000|Overall Study|Unable to wear compression stockings|1|||
125100084|NCT02503215|449987917|FG000|Overall Study|Unable to use positive airway pressure|2|||
125100085|NCT02983305|449987922|FG000|Overall Study|incomplete data|2|||
125100086|NCT02983305|449987923|FG001|Overall Study|incomplete data|0|||
125100087|NCT00706901|449987924|FG000|Overall Study|Lost to Follow-up|2|||
125100088|NCT00706901|449987925|FG001|Overall Study|Lost to Follow-up|3|||
125100089|NCT00706901|449987926|FG002|Overall Study|Lost to Follow-up|2|||
125100090|NCT00706901|449987924|FG000|Overall Study|Withdrawal by Subject|4|||
125100091|NCT00706901|449987925|FG001|Overall Study|Withdrawal by Subject|2|||
125100092|NCT00706901|449987926|FG002|Overall Study|Withdrawal by Subject|5|||
125100093|NCT00706901|449987924|FG000|Overall Study|In Jail|1|||
125100094|NCT00706901|449987925|FG001|Overall Study|In Jail|0|||
125100095|NCT00706901|449987926|FG002|Overall Study|In Jail|1|||
125100096|NCT00706901|449987924|FG000|Overall Study|Death|1|||
125100097|NCT00706901|449987925|FG001|Overall Study|Death|0|||
125100098|NCT00706901|449987926|FG002|Overall Study|Death|0|||
125100099|NCT03433482|449987927|FG000|Overall Study|Lost to Follow-up|1|||
125100100|NCT03433482|449987928|FG001|Overall Study|Lost to Follow-up|0|||
125100101|NCT03433482|449987929|FG002|Overall Study|Lost to Follow-up|1|||
125100102|NCT03433482|449987930|FG003|Overall Study|Lost to Follow-up|1|||
125100103|NCT03433482|449987927|FG000|Overall Study|Withdrawal by Subject|0|||
125100104|NCT03433482|449987928|FG001|Overall Study|Withdrawal by Subject|0|||
125100105|NCT03433482|449987929|FG002|Overall Study|Withdrawal by Subject|1|||
125100106|NCT03433482|449987930|FG003|Overall Study|Withdrawal by Subject|0|||
125100107|NCT03433482|449987927|FG000|Overall Study|Unknown reason|0|||
125100108|NCT03433482|449987928|FG001|Overall Study|Unknown reason|0|||
125100109|NCT03433482|449987929|FG002|Overall Study|Unknown reason|2|||
125100110|NCT03433482|449987930|FG003|Overall Study|Unknown reason|0|||
125100111|NCT01646268|449987931|FG000|Overall Study|Adverse Event|6|||
125100112|NCT01646268|449987932|FG001|Overall Study|Adverse Event|7|||
125100113|NCT01646268|449987931|FG000|Overall Study|Lack of Efficacy|1|||
125100114|NCT01646268|449987932|FG001|Overall Study|Lack of Efficacy|3|||
125100115|NCT01646268|449987931|FG000|Overall Study|Protocol Violation|0|||
125100116|NCT01646268|449987932|FG001|Overall Study|Protocol Violation|1|||
125100117|NCT01646268|449987931|FG000|Overall Study|Withdrawal by Subject|2|||
125100118|NCT01646268|449987932|FG001|Overall Study|Withdrawal by Subject|5|||
125100119|NCT01646268|449987931|FG000|Overall Study|Other|2|||
125100120|NCT01646268|449987932|FG001|Overall Study|Other|0|||
125100121|NCT01519635|449987937|FG000|Overall Study|Withdrawal by Subject|0|||
125100122|NCT01519635|449987938|FG001|Overall Study|Withdrawal by Subject|1|||
125100123|NCT01519635|449987937|FG000|Overall Study|No possibility to put a catheter|1|||
125100124|NCT01519635|449987938|FG001|Overall Study|No possibility to put a catheter|2|||
125100125|NCT01300741|449987939|FG000|Overall Study|Lens deposits|1|||
125100126|NCT01300741|449987939|FG000|Overall Study|Lost to Follow-up|1|||
125100127|NCT01300741|449987939|FG000|Overall Study|Discomfort|1|||
125100128|NCT02325414|449987940|FG000|Overall Study|Withdrawal by Subject|3|||
125100129|NCT02325414|449987941|FG001|Overall Study|Withdrawal by Subject|1|||
125011918|NCT02982954|449669916|FG001|Overall Study|Lost to Follow-up|1|||
125100130|NCT02325414|449987940|FG000|Overall Study|Lost to Follow-up|5|||
125100131|NCT02325414|449987941|FG001|Overall Study|Lost to Follow-up|5|||
125100132|NCT00560573|449987943|FG000|Overall Study|Death|4|||
125100133|NCT00560573|449987944|FG001|Overall Study|Death|1|||
125100134|NCT00560573|449987945|FG002|Overall Study|Death|4|||
125100135|NCT00560573|449987946|FG003|Overall Study|Death|5|||
125100136|NCT00560573|449987947|FG004|Overall Study|Death|1|||
125100137|NCT00560573|449987948|FG005|Overall Study|Death|10|||
125100138|NCT00560573|449987943|FG000|Overall Study|Lost to Follow-up|0|||
125100139|NCT00560573|449987944|FG001|Overall Study|Lost to Follow-up|0|||
125011919|NCT02982954|449669917|FG002|Overall Study|Lost to Follow-up|0|||
125100140|NCT00560573|449987945|FG002|Overall Study|Lost to Follow-up|0|||
125100141|NCT00560573|449987946|FG003|Overall Study|Lost to Follow-up|1|||
124875376|NCT01226511|449165941|FG001|Taper Period|Parent/Caregiver Decision|1|||
124875377|NCT00674570|449165943|FG000|Overall Study|Withdrawal by Subject|0|||
125011920|NCT02982954|449669918|FG003|Overall Study|Lost to Follow-up|0|||
125011921|NCT02982954|449669915|FG000|Overall Study|Participant withdrew consent|7|||
125011922|NCT02982954|449669916|FG001|Overall Study|Participant withdrew consent|5|||
125011923|NCT02982954|449669917|FG002|Overall Study|Participant withdrew consent|1|||
125011924|NCT02982954|449669918|FG003|Overall Study|Participant withdrew consent|1|||
125011925|NCT02982954|449669915|FG000|Overall Study|Other reasons|42|||
125011926|NCT02982954|449669916|FG001|Overall Study|Other reasons|17|||
125011927|NCT02982954|449669917|FG002|Overall Study|Other reasons|12|||
125011928|NCT02982954|449669918|FG003|Overall Study|Other reasons|3|||
125011929|NCT02982954|449669915|FG000|Overall Study|Premature site closure|0|||
125011930|NCT02982954|449669916|FG001|Overall Study|Premature site closure|0|||
125011931|NCT02982954|449669917|FG002|Overall Study|Premature site closure|0|||
125011932|NCT02982954|449669918|FG003|Overall Study|Premature site closure|1|||
125011933|NCT00747643|449669922|FG000|Overall Study|Withdrawal by Subject|36|||
125011934|NCT00747643|449669923|FG001|Overall Study|Withdrawal by Subject|27|||
125011935|NCT00750698|449669924|FG000|Overall Study|Withdrawal by Subject|1|||
125011936|NCT00750698|449669925|FG001|Overall Study|Withdrawal by Subject|0|||
125011937|NCT00750698|449669924|FG000|Overall Study|Progressive disease|5|||
125011938|NCT00750698|449669925|FG001|Overall Study|Progressive disease|2|||
125011939|NCT01417195|449669926|FG000|Overall Study|Stimulation failure|1|||
125011940|NCT01417195|449669927|FG001|Overall Study|Stimulation failure|0|||
125011941|NCT01417195|449669926|FG000|Overall Study|No embryos for transfer|0|||
125011942|NCT01417195|449669927|FG001|Overall Study|No embryos for transfer|1|||
125011943|NCT01417195|449669926|FG000|Overall Study|No transfer due to risk of OHSS|1|||
125011944|NCT01417195|449669927|FG001|Overall Study|No transfer due to risk of OHSS|0|||
125011945|NCT01417195|449669926|FG000|Overall Study|No transfer due to elevated progesterone|1|||
125011946|NCT01417195|449669927|FG001|Overall Study|No transfer due to elevated progesterone|0|||
125011947|NCT03357731|449669928|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
125011948|NCT03357731|449669929|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
125011949|NCT03357731|449669930|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
125011950|NCT03357731|449669931|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
125011951|NCT03357731|449669932|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
125011952|NCT03357731|449669933|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
125011953|NCT03357731|449669928|FG000|Overall Study|Acute bradycardia and hypotension|0|||
125011954|NCT03357731|449669929|FG001|Overall Study|Acute bradycardia and hypotension|0|||
125011955|NCT03357731|449669930|FG002|Overall Study|Acute bradycardia and hypotension|0|||
125011956|NCT03357731|449669931|FG003|Overall Study|Acute bradycardia and hypotension|1|||
125011957|NCT03357731|449669932|FG004|Overall Study|Acute bradycardia and hypotension|0|||
125011958|NCT03357731|449669933|FG005|Overall Study|Acute bradycardia and hypotension|0|||
125011959|NCT03357731|449669928|FG000|Overall Study|Adverse Event|0|||
125011960|NCT03357731|449669929|FG001|Overall Study|Adverse Event|0|||
125011961|NCT03357731|449669930|FG002|Overall Study|Adverse Event|0|||
125011962|NCT03357731|449669931|FG003|Overall Study|Adverse Event|0|||
125011963|NCT03357731|449669932|FG004|Overall Study|Adverse Event|0|||
125011964|NCT03357731|449669933|FG005|Overall Study|Adverse Event|1|||
125011965|NCT03357731|449669928|FG000|Overall Study|Hypotension|0|||
125011966|NCT03357731|449669929|FG001|Overall Study|Hypotension|0|||
125011967|NCT03357731|449669930|FG002|Overall Study|Hypotension|1|||
125011968|NCT03357731|449669931|FG003|Overall Study|Hypotension|1|||
125011969|NCT03357731|449669932|FG004|Overall Study|Hypotension|0|||
125011970|NCT03357731|449669933|FG005|Overall Study|Hypotension|0|||
125011971|NCT03357731|449669928|FG000|Overall Study|Lost to Follow-up|0|||
125011972|NCT03357731|449669929|FG001|Overall Study|Lost to Follow-up|0|||
125011973|NCT03357731|449669930|FG002|Overall Study|Lost to Follow-up|0|||
125011974|NCT03357731|449669931|FG003|Overall Study|Lost to Follow-up|1|||
125011975|NCT03357731|449669932|FG004|Overall Study|Lost to Follow-up|0|||
125011976|NCT03357731|449669933|FG005|Overall Study|Lost to Follow-up|0|||
125011977|NCT01239342|449669934|FG000|Overall Study|Adverse Event|1|||
125011978|NCT01239342|449669935|FG001|Overall Study|Adverse Event|0|||
125011979|NCT01239342|449669934|FG000|Overall Study|Withdrawal by Subject|1|||
125011980|NCT01239342|449669935|FG001|Overall Study|Withdrawal by Subject|5|||
125011981|NCT01239342|449669934|FG000|Overall Study|Reason Unknown|1|||
125011982|NCT01239342|449669935|FG001|Overall Study|Reason Unknown|1|||
125011983|NCT02918864|449669938|FG000|Overall Study|Withdrawal by Subject|1|||
125011984|NCT02918864|449669939|FG001|Overall Study|Withdrawal by Subject|1|||
125011985|NCT02918864|449669938|FG000|Overall Study|Lost to Follow-up|3|||
125011986|NCT02918864|449669939|FG001|Overall Study|Lost to Follow-up|2|||
124875378|NCT00674570|449165944|FG001|Overall Study|Withdrawal by Subject|2|||
125011987|NCT03577730|449669942|FG000|Overall Study|Physician Decision|3|||
125011988|NCT03577730|449669943|FG001|Overall Study|Physician Decision|1|||
125011989|NCT03577730|449669942|FG000|Overall Study|Did not receive allocated intervention|1|||
125011990|NCT03577730|449669943|FG001|Overall Study|Did not receive allocated intervention|0|||
125011991|NCT02634151|449669944|FG000|Overall Study|Withdrawal by Subject|1|||
125011992|NCT02634151|449669945|FG001|Overall Study|Withdrawal by Subject|0|||
125100142|NCT00560573|449987947|FG004|Overall Study|Lost to Follow-up|1|||
125100143|NCT00560573|449987948|FG005|Overall Study|Lost to Follow-up|0|||
125100144|NCT00560573|449987943|FG000|Overall Study|Withdrawal by Subject|0|||
125100145|NCT00560573|449987944|FG001|Overall Study|Withdrawal by Subject|0|||
125100146|NCT00560573|449987945|FG002|Overall Study|Withdrawal by Subject|0|||
125100147|NCT00560573|449987946|FG003|Overall Study|Withdrawal by Subject|1|||
125100148|NCT00560573|449987947|FG004|Overall Study|Withdrawal by Subject|1|||
125100149|NCT00560573|449987948|FG005|Overall Study|Withdrawal by Subject|0|||
125100150|NCT00560573|449987943|FG000|Overall Study|Other|2|||
125100151|NCT00560573|449987944|FG001|Overall Study|Other|2|||
125100152|NCT00560573|449987945|FG002|Overall Study|Other|2|||
125100153|NCT00560573|449987946|FG003|Overall Study|Other|3|||
125100154|NCT00560573|449987947|FG004|Overall Study|Other|3|||
125100155|NCT00560573|449987948|FG005|Overall Study|Other|3|||
125100156|NCT00560573|449987943|FG000|Overall Study|Enrolled, not treated|0|||
125100157|NCT00560573|449987944|FG001|Overall Study|Enrolled, not treated|0|||
125100158|NCT00560573|449987945|FG002|Overall Study|Enrolled, not treated|0|||
125100159|NCT00560573|449987946|FG003|Overall Study|Enrolled, not treated|0|||
125100160|NCT00560573|449987947|FG004|Overall Study|Enrolled, not treated|1|||
125100161|NCT00560573|449987948|FG005|Overall Study|Enrolled, not treated|0|||
125100162|NCT00726882|449987949|FG000|Overall Study|Withdrawal by Subject|5|||
125100163|NCT00726882|449987949|FG000|Overall Study|Lost to Follow-up|7|||
125100164|NCT00726882|449987949|FG000|Overall Study|Other|10|||
125100165|NCT01339273|449987950|FG000|Overall Study|Lost to Follow-up|8|||
125100166|NCT01339273|449987951|FG001|Overall Study|Lost to Follow-up|8|||
125100167|NCT00347776|449987952|FG000|1.5 Month Follow-up|Death|2|||
125100168|NCT00347776|449987953|FG001|1.5 Month Follow-up|Death|0|||
125100169|NCT00347776|449987954|FG002|1.5 Month Follow-up|Death|0|||
125100170|NCT00347776|449987952|FG000|1.5 Month Follow-up|reached the endpoint|12|||
125100171|NCT00347776|449987953|FG001|1.5 Month Follow-up|reached the endpoint|8|||
125100172|NCT00347776|449987954|FG002|1.5 Month Follow-up|reached the endpoint|12|||
125100173|NCT00347776|449987952|FG000|6 Month Follow-up|Death|2|||
125100174|NCT00347776|449987953|FG001|6 Month Follow-up|Death|1|||
125100175|NCT00347776|449987954|FG002|6 Month Follow-up|Death|3|||
125100176|NCT00347776|449987952|FG000|6 Month Follow-up|reached endpont|20|||
125100177|NCT00347776|449987953|FG001|6 Month Follow-up|reached endpont|12|||
125100178|NCT00347776|449987954|FG002|6 Month Follow-up|reached endpont|15|||
125100179|NCT00347776|449987952|FG000|12 Month Follow-up|Lost to Follow-up|7|||
125100180|NCT00347776|449987953|FG001|12 Month Follow-up|Lost to Follow-up|6|||
125100181|NCT00347776|449987954|FG002|12 Month Follow-up|Lost to Follow-up|6|||
125100182|NCT00347776|449987952|FG000|12 Month Follow-up|Death|3|||
125100183|NCT00347776|449987953|FG001|12 Month Follow-up|Death|4|||
125100184|NCT00347776|449987954|FG002|12 Month Follow-up|Death|4|||
125100185|NCT00347776|449987952|FG000|12 Month Follow-up|Reached endpoint|13|||
125100186|NCT00347776|449987953|FG001|12 Month Follow-up|Reached endpoint|6|||
125100187|NCT00347776|449987954|FG002|12 Month Follow-up|Reached endpoint|9|||
125100188|NCT00594568|449987955|FG000|Initial Treatment|Adverse Event|51|||
125100189|NCT00594568|449987956|FG001|Initial Treatment|Adverse Event|121|||
125100190|NCT00594568|449987957|FG002|Initial Treatment|Adverse Event|144|||
125100191|NCT00594568|449987955|FG000|Initial Treatment|Death|6|||
125100192|NCT00594568|449987956|FG001|Initial Treatment|Death|11|||
125100193|NCT00594568|449987957|FG002|Initial Treatment|Death|15|||
125100194|NCT00594568|449987955|FG000|Initial Treatment|Lost to Follow-up|4|||
125100195|NCT00594568|449987956|FG001|Initial Treatment|Lost to Follow-up|1|||
125100196|NCT00594568|449987957|FG002|Initial Treatment|Lost to Follow-up|4|||
125100197|NCT00594568|449987955|FG000|Initial Treatment|Physician Decision|3|||
125100198|NCT00594568|449987956|FG001|Initial Treatment|Physician Decision|2|||
125100199|NCT00594568|449987957|FG002|Initial Treatment|Physician Decision|4|||
125100200|NCT00594568|449987955|FG000|Initial Treatment|Protocol Violation|2|||
125100201|NCT00594568|449987956|FG001|Initial Treatment|Protocol Violation|2|||
125100202|NCT00594568|449987957|FG002|Initial Treatment|Protocol Violation|5|||
125100203|NCT00594568|449987955|FG000|Initial Treatment|Withdrawal by Subject|25|||
125100204|NCT00594568|449987956|FG001|Initial Treatment|Withdrawal by Subject|31|||
125100205|NCT00594568|449987957|FG002|Initial Treatment|Withdrawal by Subject|46|||
125100206|NCT00594568|449987955|FG000|Initial Treatment|Sponsor decision|193|||
125100207|NCT00594568|449987956|FG001|Initial Treatment|Sponsor decision|142|||
125100208|NCT00594568|449987957|FG002|Initial Treatment|Sponsor decision|147|||
125100209|NCT00594568|449987955|FG000|Initial Treatment|Caregiver decision|21|||
125100210|NCT00594568|449987956|FG001|Initial Treatment|Caregiver decision|36|||
125100211|NCT00594568|449987957|FG002|Initial Treatment|Caregiver decision|36|||
125100212|NCT00594568|449987955|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
125100213|NCT00594568|449987956|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
125100214|NCT00594568|449987957|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
125100215|NCT00594568|449987955|FG000|Initial Treatment|Entry criteria exclusion|0|||
125100216|NCT00594568|449987956|FG001|Initial Treatment|Entry criteria exclusion|1|||
125100217|NCT00594568|449987957|FG002|Initial Treatment|Entry criteria exclusion|1|||
125100218|NCT00594568|449987955|FG000|Delayed Start|Death|0|||
125100219|NCT00594568|449987956|FG001|Delayed Start|Death|0|||
125100220|NCT00594568|449987957|FG002|Delayed Start|Death|1|||
125100221|NCT00594568|449987955|FG000|Delayed Start|Adverse Event|12|||
125100222|NCT00594568|449987956|FG001|Delayed Start|Adverse Event|2|||
125100223|NCT00594568|449987957|FG002|Delayed Start|Adverse Event|2|||
125100224|NCT00594568|449987955|FG000|Delayed Start|Withdrawal by Subject|4|||
125100225|NCT00594568|449987956|FG001|Delayed Start|Withdrawal by Subject|3|||
125100226|NCT00594568|449987957|FG002|Delayed Start|Withdrawal by Subject|0|||
125100227|NCT00594568|449987955|FG000|Delayed Start|Physician Decision|0|||
125100228|NCT00594568|449987956|FG001|Delayed Start|Physician Decision|0|||
125100229|NCT00594568|449987957|FG002|Delayed Start|Physician Decision|1|||
125100230|NCT00594568|449987955|FG000|Delayed Start|Lost to Follow-up|0|||
125100231|NCT00594568|449987956|FG001|Delayed Start|Lost to Follow-up|0|||
125100232|NCT00594568|449987957|FG002|Delayed Start|Lost to Follow-up|1|||
125100233|NCT00594568|449987955|FG000|Delayed Start|Caregiver Decision|5|||
125100234|NCT00594568|449987956|FG001|Delayed Start|Caregiver Decision|6|||
125100235|NCT00594568|449987957|FG002|Delayed Start|Caregiver Decision|2|||
125100236|NCT00594568|449987955|FG000|Delayed Start|Sponsor Decision|77|||
125100237|NCT00594568|449987956|FG001|Delayed Start|Sponsor Decision|66|||
125100238|NCT00594568|449987957|FG002|Delayed Start|Sponsor Decision|59|||
125100239|NCT00594568|449987955|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
125100240|NCT00594568|449987956|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
125100241|NCT00594568|449987957|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
125100242|NCT00594568|449987955|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
125100243|NCT00594568|449987956|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
125100244|NCT00594568|449987957|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
125100245|NCT00594568|449987955|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
125100246|NCT00594568|449987956|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
125100247|NCT00594568|449987957|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
125100248|NCT00594568|449987955|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
125100249|NCT00594568|449987956|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
125100250|NCT00594568|449987957|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
125100251|NCT00594568|449987955|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
125100252|NCT00594568|449987956|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
125100253|NCT00594568|449987957|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
125100254|NCT00594568|449987955|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
125100255|NCT00594568|449987956|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
125100256|NCT00594568|449987957|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
125100257|NCT04478994|449987958|FG000|Overall Study|Withdrawal by Subject|1|||
125100258|NCT04478994|449987959|FG001|Overall Study|Withdrawal by Subject|1|||
125100259|NCT01100073|449987960|FG000|Overall Study|Lack of Efficacy|4|||
125100260|NCT01100073|449987960|FG000|Overall Study|Insufficient Tolerability|21|||
125100261|NCT01100073|449987960|FG000|Overall Study|Withdrawal by Subject|13|||
125100262|NCT01100073|449987960|FG000|Overall Study|Lost to Follow-up|39|||
125100263|NCT01100073|449987960|FG000|Overall Study|Lack of effect + patient's wish|2|||
125100264|NCT01100073|449987960|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
125100265|NCT01100073|449987960|FG000|Overall Study|Other|8|||
125100266|NCT01100073|449987960|FG000|Overall Study|Missing|5|||
125100267|NCT00518531|449987961|FG000|Treatment Period 1|Adverse Event|5|||
125100268|NCT00518531|449987962|FG001|Treatment Period 1|Adverse Event|0|||
125100269|NCT00518531|449987961|FG000|Treatment Period 1|Lost to Follow-up|5|||
125100270|NCT00518531|449987962|FG001|Treatment Period 1|Lost to Follow-up|3|||
125100271|NCT00518531|449987961|FG000|Treatment Period 1|Physician Decision|1|||
125100272|NCT00518531|449987962|FG001|Treatment Period 1|Physician Decision|0|||
125100273|NCT00518531|449987961|FG000|Treatment Period 1|Protocol Violation|2|||
125100274|NCT00518531|449987962|FG001|Treatment Period 1|Protocol Violation|0|||
125100275|NCT00518531|449987961|FG000|Treatment Period 1|Withdrawal by Subject|4|||
125100276|NCT00518531|449987962|FG001|Treatment Period 1|Withdrawal by Subject|6|||
125100277|NCT00518531|449987961|FG000|Treatment Period 1|Early crossover|1|||
125100278|NCT00518531|449987962|FG001|Treatment Period 1|Early crossover|3|||
125100279|NCT00518531|449987961|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125100280|NCT00518531|449987962|FG001|Treatment Period 2|Withdrawal by Subject|8|||
125100281|NCT00518531|449987961|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
125100282|NCT00518531|449987962|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
125100283|NCT00518531|449987961|FG000|Treatment Period 2|Adverse Event|1|||
125100284|NCT00518531|449987962|FG001|Treatment Period 2|Adverse Event|7|||
125100285|NCT00518531|449987961|FG000|Treatment Period 2|Protocol-specified criteria|0|||
125100286|NCT00518531|449987962|FG001|Treatment Period 2|Protocol-specified criteria|1|||
125100287|NCT00518531|449987961|FG000|Treatment Period 2|Non-compliance|1|||
125100288|NCT00518531|449987962|FG001|Treatment Period 2|Non-compliance|2|||
125100289|NCT01656850|449987963|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
125100290|NCT01656850|449987964|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
125100291|NCT00602927|449987967|FG000|Period 1: 13 Days|Protocol Violation|2|||
125100292|NCT00602927|449987968|FG001|Period 1: 13 Days|Protocol Violation|4|||
125100293|NCT00602927|449987967|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
125100294|NCT00602927|449987968|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
125100295|NCT00602927|449987967|FG000|Period 1: 13 Days|Time|1|||
125100296|NCT00602927|449987968|FG001|Period 1: 13 Days|Time|0|||
125100297|NCT00602927|449987967|FG000|Period 1: 13 Days|Claustrophobia|0|||
125100298|NCT00602927|449987968|FG001|Period 1: 13 Days|Claustrophobia|1|||
125100299|NCT00602927|449987967|FG000|Period 2: 14 Days|Protocol Violation|0|||
125100300|NCT00602927|449987968|FG001|Period 2: 14 Days|Protocol Violation|2|||
125100301|NCT00602927|449987967|FG000|Period 3: 13 Days|Protocol Violation|0|||
125100302|NCT00602927|449987968|FG001|Period 3: 13 Days|Protocol Violation|1|||
125100303|NCT00602927|449987967|FG000|Period 3: 13 Days|MRI data quality|2|||
125100304|NCT00602927|449987968|FG001|Period 3: 13 Days|MRI data quality|2|||
125100305|NCT01741259|449987974|FG000|Overall Study|Protocol Violation|6|||
124875379|NCT00674570|449165945|FG002|Overall Study|Withdrawal by Subject|0|||
124875380|NCT01337986|449165946|FG000|Overall Study|Adverse Event|2|||
124875381|NCT01337986|449165947|FG001|Overall Study|Adverse Event|2|||
124875382|NCT01337986|449165946|FG000|Overall Study|Lost to Follow-up|1|||
124875383|NCT01337986|449165947|FG001|Overall Study|Lost to Follow-up|0|||
125011993|NCT02634151|449669944|FG000|Overall Study|Non-Compliance|0|||
125011994|NCT02634151|449669945|FG001|Overall Study|Non-Compliance|1|||
125011995|NCT02634151|449669944|FG000|Overall Study|Other|0|||
125011996|NCT02634151|449669945|FG001|Overall Study|Other|1|||
125011997|NCT04640272|449669946|FG000|Overall Study|Subject moved out of area|1|||
125011998|NCT00751400|449669951|FG000|Overall Study|Lost to Follow-up|10|||
125011999|NCT00441974|449669956|FG000|Overall Study|Adverse Event|6|||
125012000|NCT00441974|449669956|FG000|Overall Study|Consent Withdrawn|35|||
125012001|NCT00441974|449669956|FG000|Overall Study|Lost to Follow-up|80|||
125012002|NCT00441974|449669956|FG000|Overall Study|Protocol Violation|7|||
125012003|NCT02770547|449669957|FG000|Overall Study|Patient non-compliant|1|||
125012004|NCT02770547|449669958|FG001|Overall Study|Patient non-compliant|0|||
125012005|NCT02770547|449669957|FG000|Overall Study|Adverse Event|0|||
125012006|NCT02770547|449669958|FG001|Overall Study|Adverse Event|1|||
125012007|NCT01148537|449669959|FG000|Overall Study|Withdrawal by Subject|1|||
125012008|NCT01148537|449669960|FG001|Overall Study|Withdrawal by Subject|0|||
125012009|NCT01148537|449669961|FG002|Overall Study|Withdrawal by Subject|2|||
125012010|NCT01148537|449669959|FG000|Overall Study|Adverse Event|2|||
125012011|NCT01148537|449669960|FG001|Overall Study|Adverse Event|0|||
125012012|NCT01148537|449669961|FG002|Overall Study|Adverse Event|1|||
125012013|NCT03134599|449669963|FG000|Week 1|Lost to Follow-up|0|||
125012014|NCT03134599|449669964|FG001|Week 1|Lost to Follow-up|0|||
125012015|NCT03134599|449669965|FG002|Week 1|Lost to Follow-up|0|||
125012016|NCT03134599|449669966|FG003|Week 1|Lost to Follow-up|0|||
125012017|NCT03134599|449669967|FG004|Week 1|Lost to Follow-up|1|||
125012018|NCT03134599|449669968|FG005|Week 1|Lost to Follow-up|0|||
125012019|NCT03134599|449669963|FG000|Week 2|Lost to Follow-up|1|||
125012020|NCT03134599|449669964|FG001|Week 2|Lost to Follow-up|0|||
125012021|NCT03134599|449669965|FG002|Week 2|Lost to Follow-up|0|||
125012022|NCT03134599|449669966|FG003|Week 2|Lost to Follow-up|1|||
125012023|NCT03134599|449669967|FG004|Week 2|Lost to Follow-up|1|||
125012024|NCT03134599|449669968|FG005|Week 2|Lost to Follow-up|0|||
125012025|NCT03134599|449669963|FG000|Week 3|Lost to Follow-up|0|||
125012026|NCT03134599|449669964|FG001|Week 3|Lost to Follow-up|0|||
125012027|NCT03134599|449669965|FG002|Week 3|Lost to Follow-up|0|||
125012028|NCT03134599|449669966|FG003|Week 3|Lost to Follow-up|1|||
125012029|NCT03134599|449669967|FG004|Week 3|Lost to Follow-up|0|||
125012030|NCT03134599|449669968|FG005|Week 3|Lost to Follow-up|1|||
125012031|NCT00393887|449669969|FG000|Overall Study|Physician Decision|5|||
125012032|NCT00393887|449669970|FG001|Overall Study|Physician Decision|0|||
125012033|NCT00393887|449669969|FG000|Overall Study|Lost to Follow-up|11|||
125012034|NCT00393887|449669970|FG001|Overall Study|Lost to Follow-up|9|||
125012035|NCT02018822|449669974|FG000|Overall Study|filling replaced by crown|0|||
125012036|NCT02018822|449669975|FG001|Overall Study|filling replaced by crown|1|||
125012037|NCT02018822|449669976|FG002|Overall Study|filling replaced by crown|0|||
125012038|NCT02018822|449669974|FG000|Overall Study|Physician Decision|0|||
125012039|NCT02018822|449669975|FG001|Overall Study|Physician Decision|1|||
125012040|NCT02018822|449669976|FG002|Overall Study|Physician Decision|1|||
125012041|NCT02018822|449669974|FG000|Overall Study|Lost to Follow-up|6|||
125012042|NCT02018822|449669975|FG001|Overall Study|Lost to Follow-up|6|||
125100306|NCT01741259|449987975|FG001|Overall Study|Protocol Violation|4|||
125100307|NCT01741259|449987974|FG000|Overall Study|Withdrawal by Subject|0|||
125100308|NCT01741259|449987975|FG001|Overall Study|Withdrawal by Subject|2|||
125100309|NCT03722849|449987985|FG000|Overall Study|Withdrawal by Subject|1|||
125100310|NCT03722849|449987986|FG001|Overall Study|Withdrawal by Subject|1|||
125100311|NCT04633434|449987989|FG000|Overall Study|Lost to Follow-up|32|||
125012043|NCT02018822|449669976|FG002|Overall Study|Lost to Follow-up|5|||
125012044|NCT00715026|449669977|FG000|Overall Study|Withdrawal by Subject|5|||
125012045|NCT00715026|449669977|FG000|Overall Study|Lost to Follow-up|3|||
125012046|NCT00715026|449669977|FG000|Overall Study|Protocol Violation|1|||
125012047|NCT00715026|449669977|FG000|Overall Study|Surgery done on non-study consented hip|1|||
125012048|NCT04744207|449669981|FG000|Treatment|Withdrawal by Subject|2|||
125012049|NCT04744207|449669982|FG001|Treatment|Withdrawal by Subject|0|||
125012050|NCT04744207|449669981|FG000|Treatment|Adverse Event|1|||
125012051|NCT04744207|449669982|FG001|Treatment|Adverse Event|2|||
125100312|NCT04633434|449987990|FG001|Overall Study|Lost to Follow-up|32|||
125100313|NCT04882085|449988010|FG000|Overall Study|Death|6|||
125100314|NCT04882085|449988011|FG001|Overall Study|Death|9|||
125100315|NCT04882085|449988010|FG000|Overall Study|Withdrawal by Subject|0|||
125100316|NCT04882085|449988011|FG001|Overall Study|Withdrawal by Subject|3|||
125100317|NCT04882085|449988010|FG000|Overall Study|Randomized not treated|1|||
125100318|NCT04882085|449988011|FG001|Overall Study|Randomized not treated|0|||
125100319|NCT00965562|449988015|FG000|Overall Study|Lost to Follow-up|1|||
125100320|NCT00965562|449988016|FG001|Overall Study|Lost to Follow-up|2|||
125100321|NCT00965562|449988017|FG002|Overall Study|Lost to Follow-up|3|||
125100322|NCT00965562|449988015|FG000|Overall Study|Withdrawal by Subject|2|||
125100323|NCT00965562|449988016|FG001|Overall Study|Withdrawal by Subject|2|||
125100324|NCT00965562|449988017|FG002|Overall Study|Withdrawal by Subject|0|||
125100325|NCT00816166|449988018|FG000|Overall Study|Lost to Follow-up|6|||
125100326|NCT00816166|449988019|FG001|Overall Study|Lost to Follow-up|10|||
125100327|NCT00816166|449988018|FG000|Overall Study|Death|4|||
125100328|NCT00816166|449988019|FG001|Overall Study|Death|2|||
125100329|NCT02756182|449988020|FG000|Overall Study|StudyTechnical Difficulties|4|||
125100330|NCT01608321|449988030|FG000|Overall Study|Withdrawal by Subject|1|||
125100331|NCT01608321|449988031|FG001|Overall Study|Withdrawal by Subject|0|||
125100332|NCT02062385|449988032|FG000|Overall Study|Adverse Event|19|||
125100333|NCT02062385|449988033|FG001|Overall Study|Adverse Event|13|||
125100334|NCT02062385|449988034|FG002|Overall Study|Adverse Event|1|||
125100335|NCT02062385|449988035|FG003|Overall Study|Adverse Event|0|||
125100336|NCT02062385|449988032|FG000|Overall Study|Protocol Violation|1|||
125100337|NCT02062385|449988033|FG001|Overall Study|Protocol Violation|0|||
125100338|NCT02062385|449988034|FG002|Overall Study|Protocol Violation|0|||
125100339|NCT02062385|449988035|FG003|Overall Study|Protocol Violation|0|||
125100340|NCT02062385|449988032|FG000|Overall Study|Incomplete EPI by database lock|2|||
125100341|NCT02062385|449988033|FG001|Overall Study|Incomplete EPI by database lock|0|||
125100342|NCT02062385|449988034|FG002|Overall Study|Incomplete EPI by database lock|0|||
125100343|NCT02062385|449988035|FG003|Overall Study|Incomplete EPI by database lock|0|||
125100344|NCT02062385|449988032|FG000|Overall Study|Moved|10|||
125100345|NCT02062385|449988033|FG001|Overall Study|Moved|11|||
125100346|NCT02062385|449988034|FG002|Overall Study|Moved|1|||
125100347|NCT02062385|449988035|FG003|Overall Study|Moved|0|||
125100348|NCT02062385|449988032|FG000|Overall Study|Withdrawn by parent/guardian|46|||
125100349|NCT02062385|449988033|FG001|Overall Study|Withdrawn by parent/guardian|41|||
125100350|NCT02062385|449988034|FG002|Overall Study|Withdrawn by parent/guardian|9|||
125100351|NCT02062385|449988035|FG003|Overall Study|Withdrawn by parent/guardian|8|||
125100352|NCT02062385|449988032|FG000|Overall Study|Death|0|||
125100353|NCT02062385|449988033|FG001|Overall Study|Death|0|||
125100354|NCT02062385|449988034|FG002|Overall Study|Death|0|||
125100355|NCT02062385|449988035|FG003|Overall Study|Death|1|||
125100356|NCT02062385|449988032|FG000|Overall Study|Lost to Follow-up|0|||
125100357|NCT02062385|449988033|FG001|Overall Study|Lost to Follow-up|0|||
125100358|NCT02062385|449988034|FG002|Overall Study|Lost to Follow-up|1|||
125100359|NCT02062385|449988035|FG003|Overall Study|Lost to Follow-up|0|||
125100360|NCT01319994|449989561|FG000|Overall Study|Protocol Violation|7|||
125100361|NCT01319994|449989562|FG001|Overall Study|Protocol Violation|6|||
125100362|NCT01340794|449989563|FG000|Overall Study|Withdrawal by Subject|0|||
125100363|NCT01340794|449989564|FG001|Overall Study|Withdrawal by Subject|1|||
125100364|NCT01118949|449989567|FG000|Overall Study|Adverse Event|5|||
125100365|NCT01118949|449989567|FG000|Overall Study|Withdrawal by Subject|4|||
125100366|NCT00685763|449989572|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
125100367|NCT00685763|449989572|FG000|Overall Study|Protocol Violation|1|||
125100368|NCT00698009|449989573|FG000|Overall Study|Withdrawal by Subject|1|||
125100369|NCT00057330|449989579|FG000|Overall Study|Adverse Event|9|||
125100370|NCT00057330|449989580|FG001|Overall Study|Adverse Event|12|||
125100371|NCT00057330|449989579|FG000|Overall Study|Death|1|||
125100372|NCT00057330|449989580|FG001|Overall Study|Death|0|||
125100373|NCT00057330|449989579|FG000|Overall Study|Protocol Violation|1|||
125100374|NCT00057330|449989580|FG001|Overall Study|Protocol Violation|1|||
125100375|NCT00057330|449989579|FG000|Overall Study|Withdrawal by Subject|115|||
125100376|NCT00057330|449989580|FG001|Overall Study|Withdrawal by Subject|84|||
125100377|NCT00057330|449989579|FG000|Overall Study|Lost to Follow-up|745|||
125100378|NCT00057330|449989580|FG001|Overall Study|Lost to Follow-up|617|||
125100379|NCT00057330|449989579|FG000|Overall Study|Physician Decision|1|||
125100380|NCT00057330|449989580|FG001|Overall Study|Physician Decision|0|||
125100381|NCT00057330|449989579|FG000|Overall Study|Other|260|||
125100382|NCT00057330|449989580|FG001|Overall Study|Other|206|||
125100383|NCT00471237|449989581|FG000|Overall Study|Adverse Event|6|||
125100384|NCT00471237|449989582|FG001|Overall Study|Adverse Event|5|||
125100385|NCT00471237|449989583|FG002|Overall Study|Adverse Event|4|||
125100386|NCT00471237|449989584|FG003|Overall Study|Adverse Event|8|||
125100387|NCT00471237|449989585|FG004|Overall Study|Adverse Event|7|||
125100388|NCT00471237|449989586|FG005|Overall Study|Adverse Event|5|||
125100389|NCT00471237|449989587|FG006|Overall Study|Adverse Event|0|||
125100390|NCT00471237|449989581|FG000|Overall Study|Lost to Follow-up|1|||
125100391|NCT00471237|449989582|FG001|Overall Study|Lost to Follow-up|1|||
125100392|NCT00471237|449989583|FG002|Overall Study|Lost to Follow-up|0|||
125100393|NCT00471237|449989584|FG003|Overall Study|Lost to Follow-up|2|||
125100394|NCT00471237|449989585|FG004|Overall Study|Lost to Follow-up|3|||
125100395|NCT00471237|449989586|FG005|Overall Study|Lost to Follow-up|0|||
125100396|NCT00471237|449989587|FG006|Overall Study|Lost to Follow-up|0|||
125100397|NCT00471237|449989581|FG000|Overall Study|Protocol Violation|3|||
125100398|NCT00471237|449989582|FG001|Overall Study|Protocol Violation|6|||
125100399|NCT00471237|449989583|FG002|Overall Study|Protocol Violation|3|||
125100400|NCT00471237|449989584|FG003|Overall Study|Protocol Violation|2|||
125100401|NCT00471237|449989585|FG004|Overall Study|Protocol Violation|2|||
125100402|NCT00471237|449989586|FG005|Overall Study|Protocol Violation|4|||
125100403|NCT00471237|449989587|FG006|Overall Study|Protocol Violation|1|||
125100404|NCT00471237|449989581|FG000|Overall Study|Withdrawal by Subject|8|||
125100405|NCT00471237|449989582|FG001|Overall Study|Withdrawal by Subject|6|||
125100406|NCT00471237|449989583|FG002|Overall Study|Withdrawal by Subject|5|||
125100407|NCT00471237|449989584|FG003|Overall Study|Withdrawal by Subject|8|||
125100408|NCT00471237|449989585|FG004|Overall Study|Withdrawal by Subject|7|||
125100409|NCT00471237|449989586|FG005|Overall Study|Withdrawal by Subject|4|||
125100410|NCT00471237|449989587|FG006|Overall Study|Withdrawal by Subject|2|||
125100411|NCT00471237|449989581|FG000|Overall Study|Sponsor terminated study|20|||
125100412|NCT00471237|449989582|FG001|Overall Study|Sponsor terminated study|23|||
125100413|NCT00471237|449989583|FG002|Overall Study|Sponsor terminated study|19|||
125100414|NCT00471237|449989584|FG003|Overall Study|Sponsor terminated study|22|||
125100415|NCT00471237|449989585|FG004|Overall Study|Sponsor terminated study|18|||
125100416|NCT00471237|449989586|FG005|Overall Study|Sponsor terminated study|24|||
125100417|NCT00471237|449989587|FG006|Overall Study|Sponsor terminated study|0|||
125100418|NCT00471237|449989581|FG000|Overall Study|Non-compliance|0|||
125100419|NCT00471237|449989582|FG001|Overall Study|Non-compliance|1|||
125100420|NCT00471237|449989583|FG002|Overall Study|Non-compliance|0|||
125100421|NCT00471237|449989584|FG003|Overall Study|Non-compliance|1|||
125100422|NCT00471237|449989585|FG004|Overall Study|Non-compliance|0|||
125100423|NCT00471237|449989586|FG005|Overall Study|Non-compliance|0|||
125100424|NCT00471237|449989587|FG006|Overall Study|Non-compliance|0|||
125100425|NCT00471237|449989581|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
125100426|NCT00471237|449989582|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
125100427|NCT00471237|449989583|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
125100428|NCT00471237|449989584|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
125100429|NCT00471237|449989585|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
125100430|NCT00471237|449989586|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
125100431|NCT00471237|449989587|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
125100432|NCT00471237|449989581|FG000|Overall Study|Early stopping due to non-efficacy|1|||
125100433|NCT00471237|449989582|FG001|Overall Study|Early stopping due to non-efficacy|0|||
125100434|NCT00471237|449989583|FG002|Overall Study|Early stopping due to non-efficacy|0|||
125100435|NCT00471237|449989584|FG003|Overall Study|Early stopping due to non-efficacy|0|||
125100436|NCT00471237|449989585|FG004|Overall Study|Early stopping due to non-efficacy|1|||
125100437|NCT00471237|449989586|FG005|Overall Study|Early stopping due to non-efficacy|0|||
125100438|NCT00471237|449989587|FG006|Overall Study|Early stopping due to non-efficacy|0|||
125100439|NCT00471237|449989581|FG000|Overall Study|Participant planned to travel to abraod|1|||
125100440|NCT00471237|449989582|FG001|Overall Study|Participant planned to travel to abraod|0|||
125100441|NCT00471237|449989583|FG002|Overall Study|Participant planned to travel to abraod|0|||
125100442|NCT00471237|449989584|FG003|Overall Study|Participant planned to travel to abraod|0|||
125100443|NCT00471237|449989585|FG004|Overall Study|Participant planned to travel to abraod|0|||
125100444|NCT00471237|449989586|FG005|Overall Study|Participant planned to travel to abraod|1|||
125100445|NCT00471237|449989587|FG006|Overall Study|Participant planned to travel to abraod|0|||
125100446|NCT00471237|449989581|FG000|Overall Study|High parathyroid hormone|0|||
125100447|NCT00471237|449989582|FG001|Overall Study|High parathyroid hormone|0|||
125100448|NCT00471237|449989583|FG002|Overall Study|High parathyroid hormone|1|||
125100449|NCT00471237|449989584|FG003|Overall Study|High parathyroid hormone|0|||
125100450|NCT00471237|449989585|FG004|Overall Study|High parathyroid hormone|0|||
125100451|NCT00471237|449989586|FG005|Overall Study|High parathyroid hormone|0|||
125100452|NCT00471237|449989587|FG006|Overall Study|High parathyroid hormone|0|||
125100453|NCT00471237|449989581|FG000|Overall Study|Participant lost medication|0|||
125100454|NCT00471237|449989582|FG001|Overall Study|Participant lost medication|0|||
125100455|NCT00471237|449989583|FG002|Overall Study|Participant lost medication|0|||
125100456|NCT00471237|449989584|FG003|Overall Study|Participant lost medication|0|||
125100457|NCT00471237|449989585|FG004|Overall Study|Participant lost medication|1|||
125100458|NCT00471237|449989586|FG005|Overall Study|Participant lost medication|0|||
125100459|NCT00471237|449989587|FG006|Overall Study|Participant lost medication|0|||
125100460|NCT00471237|449989581|FG000|Overall Study|Administration of prohibited medicine|0|||
125100461|NCT00471237|449989582|FG001|Overall Study|Administration of prohibited medicine|0|||
125100462|NCT00471237|449989583|FG002|Overall Study|Administration of prohibited medicine|0|||
125100463|NCT00471237|449989584|FG003|Overall Study|Administration of prohibited medicine|0|||
125100464|NCT00471237|449989585|FG004|Overall Study|Administration of prohibited medicine|1|||
125100465|NCT00471237|449989586|FG005|Overall Study|Administration of prohibited medicine|0|||
125100466|NCT00471237|449989587|FG006|Overall Study|Administration of prohibited medicine|0|||
125100467|NCT00471237|449989581|FG000|Overall Study|Participant shifted residence|0|||
125100468|NCT00471237|449989582|FG001|Overall Study|Participant shifted residence|0|||
125100469|NCT00471237|449989583|FG002|Overall Study|Participant shifted residence|0|||
125100470|NCT00471237|449989584|FG003|Overall Study|Participant shifted residence|0|||
125100471|NCT00471237|449989585|FG004|Overall Study|Participant shifted residence|1|||
125100472|NCT00471237|449989586|FG005|Overall Study|Participant shifted residence|0|||
125100473|NCT00471237|449989587|FG006|Overall Study|Participant shifted residence|0|||
125100474|NCT00471237|449989581|FG000|Overall Study|Participant's decision|0|||
125100475|NCT00471237|449989582|FG001|Overall Study|Participant's decision|0|||
125100476|NCT00471237|449989583|FG002|Overall Study|Participant's decision|0|||
125100477|NCT00471237|449989584|FG003|Overall Study|Participant's decision|0|||
125100478|NCT00471237|449989585|FG004|Overall Study|Participant's decision|0|||
125100479|NCT00471237|449989586|FG005|Overall Study|Participant's decision|1|||
125100480|NCT00471237|449989587|FG006|Overall Study|Participant's decision|0|||
125100481|NCT01605370|449989592|FG000|Overall Study|Adverse Event|1|||
125100482|NCT01605370|449989593|FG001|Overall Study|Adverse Event|0|||
125100483|NCT00627094|449989594|FG000|Overall Study|Adverse Event|8|||
125100484|NCT00627094|449989595|FG001|Overall Study|Adverse Event|7|||
125100485|NCT00627094|449989594|FG000|Overall Study|Lost to Follow-up|1|||
125100486|NCT00627094|449989595|FG001|Overall Study|Lost to Follow-up|0|||
125100487|NCT00627094|449989594|FG000|Overall Study|Withdrawal by Subject|1|||
125100488|NCT00627094|449989595|FG001|Overall Study|Withdrawal by Subject|1|||
125100489|NCT00627094|449989594|FG000|Overall Study|ulcer healed|1|||
125100490|NCT00627094|449989595|FG001|Overall Study|ulcer healed|7|||
125100491|NCT00627094|449989594|FG000|Overall Study|Other reason|1|||
125100492|NCT00627094|449989595|FG001|Overall Study|Other reason|0|||
125100493|NCT01353586|449989598|FG000|Overall Study|Procedure terminated prior to ablation|3|||
125100494|NCT01353586|449989599|FG001|Overall Study|Procedure terminated prior to ablation|0|||
125100495|NCT01353586|449989598|FG000|Overall Study|Never had insertion of study catheter|4|||
125100496|NCT01353586|449989599|FG001|Overall Study|Never had insertion of study catheter|1|||
125100497|NCT01353586|449989598|FG000|Overall Study|Neurological exam not done|0|||
125100498|NCT01353586|449989599|FG001|Overall Study|Neurological exam not done|1|||
125100499|NCT00585468|449989600|FG000|First Intervention|Withdrawal by Subject|1|||
125100500|NCT00585468|449989601|FG001|First Intervention|Withdrawal by Subject|1|||
125100501|NCT00943826|449989611|FG000|Concurrent Phase|Adverse Event|50|||
125100502|NCT00943826|449989612|FG001|Concurrent Phase|Adverse Event|27|||
125100503|NCT00943826|449989611|FG000|Concurrent Phase|Withdrew consent|3|||
125100504|NCT00943826|449989612|FG001|Concurrent Phase|Withdrew consent|7|||
125100505|NCT00943826|449989611|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
125100506|NCT00943826|449989612|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
125100507|NCT00943826|449989611|FG000|Concurrent Phase|Administrative reasons|2|||
125100508|NCT00943826|449989612|FG001|Concurrent Phase|Administrative reasons|1|||
125100509|NCT00943826|449989611|FG000|Concurrent Phase|Protocol Violation|1|||
125100510|NCT00943826|449989612|FG001|Concurrent Phase|Protocol Violation|0|||
125100511|NCT00943826|449989611|FG000|Maintenance Phase|Adverse Event|31|||
125100512|NCT00943826|449989612|FG001|Maintenance Phase|Adverse Event|30|||
125100513|NCT00943826|449989611|FG000|Maintenance Phase|Withdrew consent|2|||
125100514|NCT00943826|449989612|FG001|Maintenance Phase|Withdrew consent|4|||
125100515|NCT00943826|449989611|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
125100516|NCT00943826|449989612|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
125100517|NCT00943826|449989611|FG000|Maintenance Phase|Administrative reasons|4|||
125100518|NCT00943826|449989612|FG001|Maintenance Phase|Administrative reasons|1|||
125100519|NCT00943826|449989611|FG000|Maintenance Phase|Failure to return|0|||
125100520|NCT00943826|449989612|FG001|Maintenance Phase|Failure to return|1|||
125100521|NCT00943826|449989611|FG000|Monotherapy Phase|Adverse Event|42|||
125100522|NCT00943826|449989612|FG001|Monotherapy Phase|Adverse Event|5|||
125100523|NCT00943826|449989611|FG000|Monotherapy Phase|Administrative reasons|11|||
125100524|NCT00943826|449989612|FG001|Monotherapy Phase|Administrative reasons|5|||
125100525|NCT00943826|449989611|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
125100526|NCT00943826|449989612|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
125100527|NCT00943826|449989611|FG000|Monotherapy Phase|Withdrew Consent|2|||
125100528|NCT00943826|449989612|FG001|Monotherapy Phase|Withdrew Consent|3|||
125100529|NCT00943826|449989611|FG000|Monotherapy Phase|Failure to return|2|||
125100530|NCT00943826|449989612|FG001|Monotherapy Phase|Failure to return|1|||
125100531|NCT00943826|449989611|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
125100532|NCT00943826|449989612|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
125100533|NCT00943826|449989611|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
125100534|NCT00943826|449989612|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
125100535|NCT00943826|449989611|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
125100536|NCT00943826|449989612|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
125100537|NCT00943826|449989611|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
125100538|NCT00943826|449989612|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
125100539|NCT00807040|449989617|FG000|Overall Study|Death|24|||
125100540|NCT00807040|449989618|FG001|Overall Study|Death|29|||
125100541|NCT00807040|449989617|FG000|Overall Study|Withdrawal by Subject|8|||
125100542|NCT00807040|449989618|FG001|Overall Study|Withdrawal by Subject|6|||
125100543|NCT00807040|449989617|FG000|Overall Study|Lost to Follow-up|4|||
125100544|NCT00807040|449989618|FG001|Overall Study|Lost to Follow-up|6|||
125100545|NCT00625846|449989619|FG000|Overall Study|Withdrawal by Subject|2|||
125100546|NCT00625846|449989620|FG001|Overall Study|Withdrawal by Subject|0|||
125100547|NCT00625846|449989621|FG002|Overall Study|Withdrawal by Subject|1|||
125100548|NCT00625846|449989622|FG003|Overall Study|Withdrawal by Subject|2|||
125100549|NCT01870921|449989626|FG000|Overall Study|Subject decision|80|||
125100550|NCT01870921|449989626|FG000|Overall Study|Severe non-compliance to protocol|7|||
125100551|NCT01870921|449989626|FG000|Overall Study|Subject Lost to Follow up|2|||
125100552|NCT01870921|449989626|FG000|Overall Study|Other|1|||
125100553|NCT04409509|449989627|FG000|Overall Study|Failure to meet randomization requirement|1|||
125100554|NCT04409509|449989628|FG001|Overall Study|Failure to meet randomization requirement|0|||
125100555|NCT04409509|449989627|FG000|Overall Study|Adverse Event|0|||
125100556|NCT04409509|449989628|FG001|Overall Study|Adverse Event|1|||
125100557|NCT04409509|449989627|FG000|Overall Study|Death|11|||
125100558|NCT04409509|449989628|FG001|Overall Study|Death|10|||
125100559|NCT04409509|449989627|FG000|Overall Study|Non-compliance with study drug|0|||
125100560|NCT04409509|449989628|FG001|Overall Study|Non-compliance with study drug|1|||
125100561|NCT04409509|449989627|FG000|Overall Study|Lost to Follow-up|0|||
125100562|NCT04409509|449989628|FG001|Overall Study|Lost to Follow-up|3|||
125100563|NCT04409509|449989627|FG000|Overall Study|Withdrawal by Subject|0|||
125100564|NCT04409509|449989628|FG001|Overall Study|Withdrawal by Subject|3|||
125100565|NCT04409509|449989627|FG000|Overall Study|Randomized by mistake|0|||
125100566|NCT04409509|449989628|FG001|Overall Study|Randomized by mistake|1|||
125100567|NCT04409509|449989627|FG000|Overall Study|Other|1|||
125100568|NCT04409509|449989628|FG001|Overall Study|Other|1|||
125100569|NCT02279888|449989629|FG000|Overall Study|Death|326|||
125100570|NCT02279888|449989629|FG000|Overall Study|Withdrawal by Subject|38|||
125100571|NCT02279888|449989629|FG000|Overall Study|Lost to Follow-up|21|||
125100572|NCT02279888|449989629|FG000|Overall Study|Physician Decision|62|||
125100573|NCT02279888|449989629|FG000|Overall Study|Subject Non-compliance|43|||
125100574|NCT02279888|449989629|FG000|Overall Study|Not implanted|14|||
125100575|NCT02279888|449989629|FG000|Overall Study|Visit not performed|26|||
125100576|NCT02335411|449989630|FG000|Overall Study|Death|223|||
125100577|NCT02335411|449989631|FG001|Overall Study|Death|22|||
125100578|NCT02335411|449989632|FG002|Overall Study|Death|26|||
125100579|NCT02335411|449989630|FG000|Overall Study|Physician Decision|3|||
125100580|NCT02335411|449989631|FG001|Overall Study|Physician Decision|0|||
125100581|NCT02335411|449989632|FG002|Overall Study|Physician Decision|0|||
125100582|NCT02335411|449989630|FG000|Overall Study|Protocol Violation|1|||
125100583|NCT02335411|449989631|FG001|Overall Study|Protocol Violation|0|||
125100584|NCT02335411|449989632|FG002|Overall Study|Protocol Violation|0|||
125100585|NCT02335411|449989630|FG000|Overall Study|Withdrawal by Subject|11|||
125100586|NCT02335411|449989631|FG001|Overall Study|Withdrawal by Subject|0|||
125100587|NCT02335411|449989632|FG002|Overall Study|Withdrawal by Subject|3|||
125100588|NCT02335411|449989630|FG000|Overall Study|Sponsor Decision|12|||
125100589|NCT02335411|449989631|FG001|Overall Study|Sponsor Decision|3|||
125100590|NCT02335411|449989632|FG002|Overall Study|Sponsor Decision|2|||
125100591|NCT02335411|449989630|FG000|Overall Study|Adverse Event|9|||
125100592|NCT02335411|449989631|FG001|Overall Study|Adverse Event|0|||
125100593|NCT02335411|449989632|FG002|Overall Study|Adverse Event|0|||
125100594|NCT01891669|449989633|FG000|Overall Study|Death|0|||
125100595|NCT01891669|449989634|FG001|Overall Study|Death|0|||
125100596|NCT01891669|449989635|FG002|Overall Study|Death|0|||
125100597|NCT01891669|449989636|FG003|Overall Study|Death|0|||
125100598|NCT01891669|449989637|FG004|Overall Study|Death|0|||
125100599|NCT01891669|449989638|FG005|Overall Study|Death|0|||
125100600|NCT01891669|449989639|FG006|Overall Study|Death|0|||
125100601|NCT01891669|449989640|FG007|Overall Study|Death|1|||
125100602|NCT01891669|449989641|FG008|Overall Study|Death|0|||
125100603|NCT01891669|449989642|FG009|Overall Study|Death|1|||
124875384|NCT01337986|449165946|FG000|Overall Study|Protocol Violation|0|||
125100604|NCT01891669|449989633|FG000|Overall Study|Withdrawal by Subject|1|||
125100605|NCT01891669|449989634|FG001|Overall Study|Withdrawal by Subject|1|||
125100606|NCT01891669|449989635|FG002|Overall Study|Withdrawal by Subject|0|||
125100607|NCT01891669|449989636|FG003|Overall Study|Withdrawal by Subject|0|||
125100608|NCT01891669|449989637|FG004|Overall Study|Withdrawal by Subject|0|||
125100609|NCT01891669|449989638|FG005|Overall Study|Withdrawal by Subject|0|||
125100610|NCT01891669|449989639|FG006|Overall Study|Withdrawal by Subject|1|||
125100611|NCT01891669|449989640|FG007|Overall Study|Withdrawal by Subject|2|||
125100612|NCT01891669|449989641|FG008|Overall Study|Withdrawal by Subject|1|||
124875385|NCT01337986|449165947|FG001|Overall Study|Protocol Violation|3|||
125100613|NCT01891669|449989642|FG009|Overall Study|Withdrawal by Subject|1|||
125100614|NCT01891669|449989633|FG000|Overall Study|Other|1|||
125100615|NCT01891669|449989634|FG001|Overall Study|Other|0|||
125100616|NCT01891669|449989635|FG002|Overall Study|Other|0|||
125100617|NCT01891669|449989636|FG003|Overall Study|Other|0|||
125100618|NCT01891669|449989637|FG004|Overall Study|Other|0|||
125100619|NCT01891669|449989638|FG005|Overall Study|Other|0|||
125100620|NCT01891669|449989639|FG006|Overall Study|Other|0|||
125100621|NCT01891669|449989640|FG007|Overall Study|Other|1|||
125100622|NCT01891669|449989641|FG008|Overall Study|Other|0|||
125100623|NCT01891669|449989642|FG009|Overall Study|Other|0|||
125100624|NCT03075826|449989644|FG000|Overall Study|Withdrawal by Subject|1|||
125100625|NCT03075826|449989644|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
125100626|NCT00650806|449989645|FG000|Overall Study|Adverse Event|0|||
125100627|NCT00650806|449989646|FG001|Overall Study|Adverse Event|5|||
125100628|NCT00650806|449989647|FG002|Overall Study|Adverse Event|3|||
125100629|NCT00650806|449989648|FG003|Overall Study|Adverse Event|4|||
124875386|NCT04461795|449165949|FG000|Overall Study|Lost to Follow-up|2|||
124875387|NCT04461795|449165949|FG000|Overall Study|Withdrawal by Subject|2|||
124875388|NCT04461795|449165949|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
124875389|NCT00058422|449165950|FG000|Overall Study|Not treated|2|||
124875390|NCT00185640|449165951|FG000|Overall Study|Not Eligible|4|||
124875391|NCT00185640|449165951|FG000|Overall Study|Withdrawal by Subject|3|||
124875392|NCT00185640|449165951|FG000|Overall Study|Death|138|||
124875393|NCT01520402|449165954|FG000|Overall Study|Withdrawal by Subject|2|||
124875394|NCT01520402|449165954|FG000|Overall Study|Physician Decision|3|||
124875395|NCT01722162|449165956|FG000|Overall Study|Withdrawal by Subject|1|||
124875396|NCT01722162|449165957|FG001|Overall Study|Withdrawal by Subject|1|||
124875397|NCT01722162|449165956|FG000|Overall Study|Found ineligible|1|||
124875398|NCT01722162|449165957|FG001|Overall Study|Found ineligible|0|||
124875399|NCT01722162|449165956|FG000|Overall Study|Unrelated to study adverse event|2|||
124875400|NCT01722162|449165957|FG001|Overall Study|Unrelated to study adverse event|2|||
124875401|NCT01722162|449165956|FG000|Overall Study|Adverse Event|1|||
124875402|NCT01722162|449165957|FG001|Overall Study|Adverse Event|1|||
124875403|NCT01722162|449165956|FG000|Overall Study|Insurance denial post enrollment|0|||
124875404|NCT01722162|449165957|FG001|Overall Study|Insurance denial post enrollment|1|||
124875405|NCT01722162|449165956|FG000|Overall Study|Noncompliance|0|||
124875406|NCT01722162|449165957|FG001|Overall Study|Noncompliance|1|||
124875407|NCT03124199|449165958|FG000|Overall Study|Lost to Follow-up|4|||
124875408|NCT04074590|449165959|FG000|Overall Study|Adverse Event|1|||
124875409|NCT04074590|449165960|FG001|Overall Study|Adverse Event|0|||
124875410|NCT04074590|449165959|FG000|Overall Study|Physician Decision|1|||
124875411|NCT04074590|449165960|FG001|Overall Study|Physician Decision|0|||
124875412|NCT04074590|449165959|FG000|Overall Study|Withdrawal by Subject|2|||
124875413|NCT04074590|449165960|FG001|Overall Study|Withdrawal by Subject|0|||
124875414|NCT00691132|449165964|FG000|Overall Study|Adverse Event|2|||
124875415|NCT00691132|449165965|FG001|Overall Study|Adverse Event|3|||
124875416|NCT00691132|449165964|FG000|Overall Study|Withdrawal by Subject|10|||
124875417|NCT00691132|449165965|FG001|Overall Study|Withdrawal by Subject|10|||
124875418|NCT02719990|449165972|FG000|Overall Study|Physician Decision|2|||
124875419|NCT02719990|449165972|FG000|Overall Study|Withdrawal by Subject|2|||
124875420|NCT02719990|449165972|FG000|Overall Study|Study Terminated By Sponsor|32|||
124875421|NCT02010632|449165973|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
124875422|NCT02010632|449165974|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
124875423|NCT06387472|449165978|FG000|Overall Study|Withdrawal by Subject|1|||
124875424|NCT06387472|449165978|FG000|Overall Study|Lost to Follow-up|2|||
124875425|NCT06387472|449165978|FG000|Overall Study|Physician Decision|1|||
124875426|NCT01061333|449165980|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
124875427|NCT01061333|449165981|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
124875428|NCT02044848|449168508|FG000|Overall Study|Administrative Problems|2|||
124875429|NCT02044848|449168509|FG001|Overall Study|Administrative Problems|3|||
124875430|NCT00045708|449168510|FG000|Phase 1|early progressive disease|0|||
124875431|NCT00045708|449168511|FG001|Phase 1|early progressive disease|1|||
124875432|NCT00045708|449168512|FG002|Phase 1|early progressive disease|0|||
124875433|NCT01679236|449168513|FG000|Overall Study|Lost to Follow-up|15|||
125100630|NCT00650806|449989645|FG000|Overall Study|Lost to Follow-up|7|||
125100631|NCT00650806|449989646|FG001|Overall Study|Lost to Follow-up|6|||
125100632|NCT00650806|449989647|FG002|Overall Study|Lost to Follow-up|11|||
124875434|NCT01679236|449168514|FG001|Overall Study|Lost to Follow-up|15|||
125100633|NCT00650806|449989648|FG003|Overall Study|Lost to Follow-up|10|||
125100634|NCT00650806|449989645|FG000|Overall Study|Protocol Violation|0|||
125100635|NCT00650806|449989646|FG001|Overall Study|Protocol Violation|0|||
124875435|NCT03237858|449168518|FG000|Overall Study|Death|19|||
124875436|NCT03237858|449168518|FG000|Overall Study|Withdrawal by Subject|37|||
124875437|NCT01160484|449168519|FG000|Overall Study|Lack of Efficacy|9|||
124875438|NCT01160484|449168519|FG000|Overall Study|Adverse Event|6|||
124875439|NCT01160484|449168519|FG000|Overall Study|Withdrawal by Subject|2|||
124875440|NCT01160484|449168519|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
124875441|NCT00803101|449168520|FG000|Overall Study|Death / Serious Adverse Event|4|||
125100636|NCT00650806|449989647|FG002|Overall Study|Protocol Violation|0|||
125100637|NCT00650806|449989648|FG003|Overall Study|Protocol Violation|1|||
124875442|NCT00803101|449168521|FG001|Overall Study|Death / Serious Adverse Event|6|||
124875443|NCT00803101|449168520|FG000|Overall Study|Withdrawal by Subject|6|||
124875444|NCT00803101|449168521|FG001|Overall Study|Withdrawal by Subject|4|||
124875445|NCT00803101|449168520|FG000|Overall Study|Lost to Follow-up|2|||
124875446|NCT00803101|449168521|FG001|Overall Study|Lost to Follow-up|2|||
124875447|NCT00803101|449168520|FG000|Overall Study|Protocol Violation|1|||
124875448|NCT00803101|449168521|FG001|Overall Study|Protocol Violation|7|||
124875449|NCT00803101|449168520|FG000|Overall Study|Surgery finished outside protocol window|1|||
124875450|NCT00803101|449168521|FG001|Overall Study|Surgery finished outside protocol window|1|||
124875451|NCT00803101|449168520|FG000|Overall Study|Patient died outside SAE report period|1|||
124875452|NCT00803101|449168521|FG001|Overall Study|Patient died outside SAE report period|0|||
124875453|NCT00803101|449168520|FG000|Overall Study|Patient did not attend scheduled visit|2|||
124875454|NCT00803101|449168521|FG001|Overall Study|Patient did not attend scheduled visit|1|||
124875455|NCT00803101|449168520|FG000|Overall Study|Patient did not have surgery|1|||
124875456|NCT00803101|449168521|FG001|Overall Study|Patient did not have surgery|1|||
124875457|NCT01782742|449168522|FG000|Double-blind Treatment Phase|Adverse Event|1|||
124875458|NCT01782742|449168523|FG001|Double-blind Treatment Phase|Adverse Event|0|||
124875459|NCT01679301|449168526|FG000|Screening Period|screen failure|3|||
124875460|NCT01679301|449168527|FG001|Screening Period|screen failure|0|||
124875461|NCT01679301|449168528|FG002|Screening Period|screen failure|0|||
124875462|NCT04858802|449168529|FG000|Overall Study|Lost to Follow-up|1|||
124875463|NCT04858802|449168530|FG001|Overall Study|Lost to Follow-up|1|||
124875464|NCT04858802|449168529|FG000|Overall Study|Withdrawal by Subject|1|||
124875465|NCT04858802|449168530|FG001|Overall Study|Withdrawal by Subject|1|||
124875466|NCT02026232|449168531|FG000|Overall Study|incomplete visit/missing data|3|||
124875467|NCT02026232|449168532|FG001|Overall Study|incomplete visit/missing data|2|||
124875468|NCT01529008|449168533|FG000|Bone Marrow Harvesting|Physician Decision|1|||
124875469|NCT01529008|449168534|FG001|Bone Marrow Harvesting|Physician Decision|1|||
124875470|NCT01529008|449168533|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
124875471|NCT01529008|449168534|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
124875472|NCT01529008|449168533|FG000|Treatment|Adverse Event|6|||
124875473|NCT01529008|449168534|FG001|Treatment|Adverse Event|0|||
124875474|NCT01529008|449168533|FG000|Treatment|Other|3|||
124875475|NCT01529008|449168534|FG001|Treatment|Other|1|||
124875476|NCT01529008|449168533|FG000|Efficacy Analysis|Protocol Violation|2|||
124875477|NCT01529008|449168534|FG001|Efficacy Analysis|Protocol Violation|0|||
124875478|NCT01529008|449168533|FG000|Efficacy Analysis|Physician Decision|0|||
124875479|NCT01529008|449168534|FG001|Efficacy Analysis|Physician Decision|1|||
124875480|NCT01529008|449168533|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
124875481|NCT01529008|449168534|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
124875482|NCT02305381|449168535|FG000|Overall Study|Unclassified|5|||
124875483|NCT02305381|449168536|FG001|Overall Study|Unclassified|5|||
124875484|NCT02305381|449168537|FG002|Overall Study|Unclassified|7|||
124875485|NCT05056870|449168540|FG000|Period 1|Site COVID-19 Related|3|||
124875486|NCT05056870|449168541|FG001|Period 1|Site COVID-19 Related|3|||
124875487|NCT05056870|449168540|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
124875488|NCT05056870|449168541|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
124875489|NCT05056870|449168540|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
124875490|NCT05056870|449168541|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
124875491|NCT05056870|449168540|FG000|Period 2|COVID-19 Related|1|||
124875492|NCT05056870|449168541|FG001|Period 2|COVID-19 Related|0|||
124875493|NCT05056870|449168540|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
124875494|NCT05056870|449168541|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
124875495|NCT05044325|449168542|FG000|Part A:Treatment Period 1|Adverse Event|0|||
124875496|NCT05044325|449168543|FG001|Part A:Treatment Period 1|Adverse Event|0|||
124875497|NCT05044325|449168544|FG002|Part A:Treatment Period 1|Adverse Event|0|||
124875498|NCT05044325|449168545|FG003|Part A:Treatment Period 1|Adverse Event|0|||
124875499|NCT05044325|449168546|FG004|Part A:Treatment Period 1|Adverse Event|0|||
124875500|NCT05044325|449168547|FG005|Part A:Treatment Period 1|Adverse Event|1|||
124875501|NCT05044325|449168548|FG006|Part A:Treatment Period 1|Adverse Event|0|||
124875502|NCT05044325|449168549|FG007|Part A:Treatment Period 1|Adverse Event|1|||
124875503|NCT05044325|449168550|FG008|Part A:Treatment Period 1|Adverse Event|0|||
124875504|NCT05044325|449168551|FG009|Part A:Treatment Period 1|Adverse Event|0|||
124875505|NCT05044325|449168542|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
124875506|NCT05044325|449168543|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
124875507|NCT05044325|449168544|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
124875508|NCT05044325|449168545|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
124875509|NCT05044325|449168546|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
124875510|NCT05044325|449168547|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
124875511|NCT05044325|449168548|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
124875512|NCT05044325|449168549|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
124875513|NCT05044325|449168550|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
125100638|NCT00650806|449989645|FG000|Overall Study|Pregnancy|0|||
124875514|NCT05044325|449168551|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
124875515|NCT05044325|449168542|FG000|Part A:Treatment Period 1|Physician Decision|0|||
124875516|NCT05044325|449168543|FG001|Part A:Treatment Period 1|Physician Decision|0|||
124875517|NCT05044325|449168544|FG002|Part A:Treatment Period 1|Physician Decision|0|||
124875518|NCT05044325|449168545|FG003|Part A:Treatment Period 1|Physician Decision|0|||
124875519|NCT05044325|449168546|FG004|Part A:Treatment Period 1|Physician Decision|0|||
124875520|NCT05044325|449168547|FG005|Part A:Treatment Period 1|Physician Decision|0|||
124875521|NCT05044325|449168548|FG006|Part A:Treatment Period 1|Physician Decision|1|||
124875522|NCT05044325|449168549|FG007|Part A:Treatment Period 1|Physician Decision|0|||
124875523|NCT05044325|449168550|FG008|Part A:Treatment Period 1|Physician Decision|0|||
124875524|NCT05044325|449168551|FG009|Part A:Treatment Period 1|Physician Decision|0|||
124875525|NCT05044325|449168542|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
124875526|NCT05044325|449168543|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
124875527|NCT05044325|449168544|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
124875528|NCT05044325|449168545|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
124875529|NCT05044325|449168546|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
124875530|NCT05044325|449168547|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
124875531|NCT05044325|449168548|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
124875532|NCT05044325|449168549|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
124875533|NCT05044325|449168550|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
124875534|NCT05044325|449168551|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
124875535|NCT05044325|449168542|FG000|Part A:Treatment Period 2|Adverse Event|0|||
124875536|NCT05044325|449168543|FG001|Part A:Treatment Period 2|Adverse Event|1|||
124875537|NCT05044325|449168544|FG002|Part A:Treatment Period 2|Adverse Event|0|||
124875538|NCT05044325|449168545|FG003|Part A:Treatment Period 2|Adverse Event|0|||
124875539|NCT05044325|449168546|FG004|Part A:Treatment Period 2|Adverse Event|1|||
124875540|NCT05044325|449168547|FG005|Part A:Treatment Period 2|Adverse Event|1|||
124875541|NCT05044325|449168548|FG006|Part A:Treatment Period 2|Adverse Event|0|||
124875542|NCT05044325|449168549|FG007|Part A:Treatment Period 2|Adverse Event|0|||
124875543|NCT05044325|449168550|FG008|Part A:Treatment Period 2|Adverse Event|0|||
124875544|NCT05044325|449168551|FG009|Part A:Treatment Period 2|Adverse Event|0|||
124875545|NCT05044325|449168542|FG000|Part A:Treatment Period 2|Physician Decision|0|||
124875546|NCT05044325|449168543|FG001|Part A:Treatment Period 2|Physician Decision|0|||
124875547|NCT05044325|449168544|FG002|Part A:Treatment Period 2|Physician Decision|0|||
124875548|NCT05044325|449168545|FG003|Part A:Treatment Period 2|Physician Decision|0|||
124875549|NCT05044325|449168546|FG004|Part A:Treatment Period 2|Physician Decision|0|||
124875550|NCT05044325|449168547|FG005|Part A:Treatment Period 2|Physician Decision|1|||
124875551|NCT05044325|449168548|FG006|Part A:Treatment Period 2|Physician Decision|0|||
124875552|NCT05044325|449168549|FG007|Part A:Treatment Period 2|Physician Decision|0|||
124875553|NCT05044325|449168550|FG008|Part A:Treatment Period 2|Physician Decision|0|||
124875554|NCT05044325|449168551|FG009|Part A:Treatment Period 2|Physician Decision|0|||
124875555|NCT05044325|449168542|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
124875556|NCT05044325|449168543|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
124875557|NCT05044325|449168544|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
124875558|NCT05044325|449168545|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
124875559|NCT05044325|449168546|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
124875560|NCT05044325|449168547|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
124875561|NCT05044325|449168548|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
124875562|NCT05044325|449168549|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
124875563|NCT05044325|449168550|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
124875564|NCT05044325|449168551|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
124875565|NCT02243202|449168552|FG000|Overall Study|Adverse Event|5|||
124875566|NCT02243202|449168553|FG001|Overall Study|Adverse Event|6|||
124875567|NCT02243202|449168554|FG002|Overall Study|Adverse Event|10|||
124875568|NCT02243202|449168555|FG003|Overall Study|Adverse Event|4|||
124875569|NCT02243202|449168552|FG000|Overall Study|Lost to Follow-up|9|||
124875570|NCT02243202|449168553|FG001|Overall Study|Lost to Follow-up|9|||
124875571|NCT02243202|449168554|FG002|Overall Study|Lost to Follow-up|14|||
125100639|NCT00650806|449989646|FG001|Overall Study|Pregnancy|0|||
125100640|NCT00650806|449989647|FG002|Overall Study|Pregnancy|0|||
125100641|NCT00650806|449989648|FG003|Overall Study|Pregnancy|1|||
125100642|NCT00650806|449989645|FG000|Overall Study|Withdrawal by Subject|7|||
125100643|NCT00650806|449989646|FG001|Overall Study|Withdrawal by Subject|5|||
124875572|NCT02243202|449168555|FG003|Overall Study|Lost to Follow-up|11|||
124875573|NCT02243202|449168552|FG000|Overall Study|Protocol Violation|3|||
124875574|NCT02243202|449168553|FG001|Overall Study|Protocol Violation|1|||
124875575|NCT02243202|449168554|FG002|Overall Study|Protocol Violation|2|||
124875576|NCT02243202|449168555|FG003|Overall Study|Protocol Violation|1|||
124875577|NCT02243202|449168552|FG000|Overall Study|Withdrawal by Subject|7|||
124875578|NCT02243202|449168553|FG001|Overall Study|Withdrawal by Subject|6|||
124875579|NCT02243202|449168554|FG002|Overall Study|Withdrawal by Subject|4|||
125100644|NCT00650806|449989647|FG002|Overall Study|Withdrawal by Subject|8|||
124875580|NCT02243202|449168555|FG003|Overall Study|Withdrawal by Subject|4|||
124875581|NCT02243202|449168552|FG000|Overall Study|Other|1|||
124875582|NCT02243202|449168553|FG001|Overall Study|Other|3|||
124875583|NCT02243202|449168554|FG002|Overall Study|Other|1|||
124875584|NCT02243202|449168555|FG003|Overall Study|Other|2|||
124875585|NCT02243202|449168552|FG000|Overall Study|Randomized but not received treatment|0|||
124875586|NCT02243202|449168553|FG001|Overall Study|Randomized but not received treatment|0|||
124875587|NCT02243202|449168554|FG002|Overall Study|Randomized but not received treatment|0|||
124875588|NCT02243202|449168555|FG003|Overall Study|Randomized but not received treatment|1|||
124875589|NCT00991341|449168557|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
124875590|NCT00991341|449168558|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
124875591|NCT00991341|449168557|FG000|Overall Study|Death|3|||
124875592|NCT00991341|449168558|FG001|Overall Study|Death|0|||
124875593|NCT00991341|449168557|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
124875594|NCT00991341|449168558|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
124875595|NCT00991341|449168557|FG000|Overall Study|Physician Decision|1|||
125012052|NCT01617070|449669985|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
125012053|NCT05289570|449669991|FG000|Overall Study|Physician Decision|1|||
124875596|NCT00991341|449168558|FG001|Overall Study|Physician Decision|2|||
124875597|NCT00991341|449168557|FG000|Overall Study|Withdrawal by Subject|3|||
125012054|NCT02230384|449669994|FG000|Phase 1|Lost to Follow-up|1|||
125012055|NCT02230384|449669995|FG001|Phase 1|Lost to Follow-up|0|||
125012056|NCT02230384|449669994|FG000|Phase 1|Physician Decision|0|||
125012057|NCT02230384|449669995|FG001|Phase 1|Physician Decision|1|||
125012058|NCT02230384|449669994|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
125012059|NCT02230384|449669995|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
125012060|NCT02230384|449669994|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
125012061|NCT02230384|449669995|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
125012062|NCT02230384|449669994|FG000|Phase 2 - Switch|Adverse Event|2|||
125012063|NCT02230384|449669995|FG001|Phase 2 - Switch|Adverse Event|0|||
125012064|NCT00777101|449669996|FG000|Overall Study|Death|48|||
125012065|NCT00777101|449669997|FG001|Overall Study|Death|43|||
125012066|NCT00777101|449669996|FG000|Overall Study|Withdrawal by Subject|11|||
125012067|NCT00777101|449669997|FG001|Overall Study|Withdrawal by Subject|6|||
125012068|NCT00777101|449669996|FG000|Overall Study|Lost to Follow-up|2|||
125012069|NCT00777101|449669997|FG001|Overall Study|Lost to Follow-up|1|||
125012070|NCT00777101|449669996|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
125012071|NCT00777101|449669997|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
125012072|NCT00777101|449669996|FG000|Overall Study|Failed to Return|0|||
125012073|NCT00777101|449669997|FG001|Overall Study|Failed to Return|1|||
125012074|NCT00808236|449669998|FG000|Overall Study|Was not resuscitated|50|||
125012075|NCT00808236|449669999|FG001|Overall Study|Was not resuscitated|56|||
125012076|NCT00808236|449669998|FG000|Overall Study|Pre-defined exclusion|13|||
125012077|NCT00808236|449669999|FG001|Overall Study|Pre-defined exclusion|3|||
125012078|NCT00808236|449669998|FG000|Overall Study|Lost to Follow-up|1|||
125012079|NCT00808236|449669999|FG001|Overall Study|Lost to Follow-up|1|||
125012080|NCT00808236|449669998|FG000|Overall Study|Physician Decision|0|||
125012081|NCT00808236|449669999|FG001|Overall Study|Physician Decision|1|||
125012082|NCT00808236|449669998|FG000|Overall Study|Death|18|||
125012083|NCT00808236|449669999|FG001|Overall Study|Death|30|||
125012084|NCT00961220|449670000|FG000|Overall Study|Adverse Event|3|||
125012085|NCT00961220|449670000|FG000|Overall Study|Lack of Efficacy|1|||
125012086|NCT00961220|449670000|FG000|Overall Study|No IV access for O6BG|1|||
125012087|NCT00961220|449670000|FG000|Overall Study|O6BG no longer supplied|1|||
125012088|NCT00961220|449670000|FG000|Overall Study|Complete Response prior to 12 courses|1|||
125012089|NCT05376215|449670001|FG000|Overall Study|Withdrawal by Subject|2|||
125012090|NCT05376215|449670002|FG001|Overall Study|Withdrawal by Subject|1|||
125012091|NCT05376215|449670001|FG000|Overall Study|Lost to Follow-up|0|||
125012092|NCT05376215|449670002|FG001|Overall Study|Lost to Follow-up|1|||
125012093|NCT01301950|449670009|FG000|Overall Study|Surgery was cancelled by patient|0|||
125012094|NCT01301950|449670010|FG001|Overall Study|Surgery was cancelled by patient|1|||
125012095|NCT04247061|449670020|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
125012096|NCT04247061|449670020|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
125012097|NCT04247061|449670020|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
125012098|NCT03610724|449670021|FG000|Overall Study|Death|17|||
125012099|NCT03610724|449670021|FG000|Overall Study|Lost to Follow-up|1|||
125012100|NCT03610724|449670021|FG000|Overall Study|Physician Decision|1|||
125012101|NCT03610724|449670021|FG000|Overall Study|Died prior to infusion|1|||
125012102|NCT01473563|449670022|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
125012103|NCT01519765|449670023|FG000|Overall Study|Adverse Event|0|||
125012104|NCT01519765|449670024|FG001|Overall Study|Adverse Event|1|||
125012105|NCT01519765|449670023|FG000|Overall Study|Lack of Efficacy|2|||
125012106|NCT01519765|449670024|FG001|Overall Study|Lack of Efficacy|0|||
124875598|NCT00991341|449168558|FG001|Overall Study|Withdrawal by Subject|4|||
125012107|NCT01519765|449670023|FG000|Overall Study|Protocol Violation|1|||
125012108|NCT01519765|449670024|FG001|Overall Study|Protocol Violation|0|||
125100645|NCT00650806|449989648|FG003|Overall Study|Withdrawal by Subject|6|||
125100646|NCT00650806|449989645|FG000|Overall Study|Noncompliance with study drug regimen|1|||
125100647|NCT00650806|449989646|FG001|Overall Study|Noncompliance with study drug regimen|1|||
125100648|NCT00650806|449989647|FG002|Overall Study|Noncompliance with study drug regimen|0|||
125100649|NCT00650806|449989648|FG003|Overall Study|Noncompliance with study drug regimen|0|||
125100650|NCT00650806|449989645|FG000|Overall Study|Study terminated by sponsor|2|||
125100651|NCT00650806|449989646|FG001|Overall Study|Study terminated by sponsor|3|||
125100652|NCT00650806|449989647|FG002|Overall Study|Study terminated by sponsor|5|||
125100653|NCT00650806|449989648|FG003|Overall Study|Study terminated by sponsor|4|||
125100654|NCT00650806|449989645|FG000|Overall Study|Other|1|||
125100655|NCT00650806|449989646|FG001|Overall Study|Other|1|||
125100656|NCT00650806|449989647|FG002|Overall Study|Other|2|||
125100657|NCT00650806|449989648|FG003|Overall Study|Other|0|||
125100658|NCT03707145|449989649|FG000|Overall Study|Lost to Follow-up|0|||
125100659|NCT03707145|449989650|FG001|Overall Study|Lost to Follow-up|1|||
125100660|NCT03707145|449989651|FG002|Overall Study|Lost to Follow-up|1|||
125100661|NCT03707145|449989652|FG003|Overall Study|Lost to Follow-up|0|||
125100662|NCT04636437|449989653|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
125100663|NCT04636437|449989654|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
125100664|NCT04636437|449989655|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
125100665|NCT04636437|449989653|FG000|Overall Study|Started weight loss drug/program|2|||
125100666|NCT04636437|449989654|FG001|Overall Study|Started weight loss drug/program|1|||
125100667|NCT04636437|449989655|FG002|Overall Study|Started weight loss drug/program|1|||
125100668|NCT04636437|449989653|FG000|Overall Study|Lost to Follow-up|3|||
125100669|NCT04636437|449989654|FG001|Overall Study|Lost to Follow-up|1|||
125100670|NCT04636437|449989655|FG002|Overall Study|Lost to Follow-up|4|||
125100671|NCT04636437|449989653|FG000|Overall Study|Participant or physician decision|3|||
125100672|NCT04636437|449989654|FG001|Overall Study|Participant or physician decision|1|||
125100673|NCT04636437|449989655|FG002|Overall Study|Participant or physician decision|1|||
125100674|NCT00352664|449989657|FG000|Overall Study|Withdrawal by Subject|7|||
125100675|NCT00352664|449989658|FG001|Overall Study|Withdrawal by Subject|0|||
125100676|NCT03075215|449989661|FG000|12-Month Primary Endpoint|Death|152|||
125100677|NCT03075215|449989661|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
125100678|NCT03075215|449989661|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
125100679|NCT03075215|449989661|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
125100680|NCT02146365|449989662|FG000|Overall Study|Lost to Follow-up|2|||
125100681|NCT02146365|449989663|FG001|Overall Study|Lost to Follow-up|1|||
125012109|NCT01519765|449670023|FG000|Overall Study|Withdrawal by Subject|0|||
125100682|NCT02146365|449989664|FG002|Overall Study|Lost to Follow-up|3|||
125100683|NCT02146365|449989665|FG003|Overall Study|Lost to Follow-up|3|||
125100684|NCT02146365|449989666|FG004|Overall Study|Lost to Follow-up|1|||
125100685|NCT02146365|449989667|FG005|Overall Study|Lost to Follow-up|1|||
125100686|NCT02146365|449989668|FG006|Overall Study|Lost to Follow-up|0|||
125100687|NCT02146365|449989669|FG007|Overall Study|Lost to Follow-up|1|||
125100688|NCT02146365|449989662|FG000|Overall Study|Withdrawal by Subject|1|||
125100689|NCT02146365|449989663|FG001|Overall Study|Withdrawal by Subject|2|||
125100690|NCT02146365|449989664|FG002|Overall Study|Withdrawal by Subject|1|||
125100691|NCT02146365|449989665|FG003|Overall Study|Withdrawal by Subject|5|||
125100692|NCT02146365|449989666|FG004|Overall Study|Withdrawal by Subject|1|||
125100693|NCT02146365|449989667|FG005|Overall Study|Withdrawal by Subject|0|||
125100694|NCT02146365|449989668|FG006|Overall Study|Withdrawal by Subject|0|||
125100695|NCT02146365|449989669|FG007|Overall Study|Withdrawal by Subject|0|||
125100696|NCT02146365|449989662|FG000|Overall Study|Unable to Comply with Protocol|0|||
125100697|NCT02146365|449989663|FG001|Overall Study|Unable to Comply with Protocol|1|||
125100698|NCT02146365|449989664|FG002|Overall Study|Unable to Comply with Protocol|1|||
125100699|NCT02146365|449989665|FG003|Overall Study|Unable to Comply with Protocol|0|||
125100700|NCT02146365|449989666|FG004|Overall Study|Unable to Comply with Protocol|0|||
125100701|NCT02146365|449989667|FG005|Overall Study|Unable to Comply with Protocol|0|||
125100702|NCT02146365|449989668|FG006|Overall Study|Unable to Comply with Protocol|0|||
125100703|NCT02146365|449989669|FG007|Overall Study|Unable to Comply with Protocol|0|||
125100704|NCT02146365|449989662|FG000|Overall Study|Other|1|||
125100705|NCT02146365|449989663|FG001|Overall Study|Other|0|||
125100706|NCT02146365|449989664|FG002|Overall Study|Other|2|||
125100707|NCT02146365|449989665|FG003|Overall Study|Other|1|||
125100708|NCT02146365|449989666|FG004|Overall Study|Other|0|||
125100709|NCT02146365|449989667|FG005|Overall Study|Other|0|||
125100710|NCT02146365|449989668|FG006|Overall Study|Other|0|||
125012110|NCT01519765|449670024|FG001|Overall Study|Withdrawal by Subject|1|||
125012111|NCT00786565|449670025|FG000|Enrollment Prior to Surgery|Site Closed|3|||
125012112|NCT00786565|449670025|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
125012113|NCT00786565|449670025|FG000|Post Surgery|Abnormal macular pucker|1|||
125012114|NCT00786565|449670025|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
125012115|NCT05248295|449670033|FG000|Overall Study|found ineligible|4|||
125012116|NCT05248295|449670034|FG001|Overall Study|found ineligible|1|||
125012117|NCT05248295|449670033|FG000|Overall Study|Withdrawal by Subject|0|||
125100711|NCT02146365|449989669|FG007|Overall Study|Other|0|||
125100712|NCT01843660|449989670|FG000|Overall Study|Other|30|||
125100713|NCT01977482|449989671|FG000|Overall Study|Adverse Event|0|||
125100714|NCT01977482|449989672|FG001|Overall Study|Adverse Event|1|||
125100715|NCT01977482|449989673|FG002|Overall Study|Adverse Event|1|||
125100716|NCT01977482|449989674|FG003|Overall Study|Adverse Event|0|||
125100717|NCT01977482|449989675|FG004|Overall Study|Adverse Event|2|||
125100718|NCT01977482|449989676|FG005|Overall Study|Adverse Event|0|||
125100719|NCT01977482|449989671|FG000|Overall Study|Lost to Follow-up|1|||
125100720|NCT01977482|449989672|FG001|Overall Study|Lost to Follow-up|0|||
125100721|NCT01977482|449989673|FG002|Overall Study|Lost to Follow-up|0|||
125100722|NCT01977482|449989674|FG003|Overall Study|Lost to Follow-up|0|||
125100723|NCT01977482|449989675|FG004|Overall Study|Lost to Follow-up|0|||
125100724|NCT01977482|449989676|FG005|Overall Study|Lost to Follow-up|0|||
125100725|NCT01977482|449989671|FG000|Overall Study|Physician Decision|0|||
125100726|NCT01977482|449989672|FG001|Overall Study|Physician Decision|1|||
125100727|NCT01977482|449989673|FG002|Overall Study|Physician Decision|0|||
125100728|NCT01977482|449989674|FG003|Overall Study|Physician Decision|0|||
125100729|NCT01977482|449989675|FG004|Overall Study|Physician Decision|0|||
125100730|NCT01977482|449989676|FG005|Overall Study|Physician Decision|0|||
125100731|NCT01977482|449989671|FG000|Overall Study|Protocol Violation|0|||
125100732|NCT01977482|449989672|FG001|Overall Study|Protocol Violation|0|||
125100733|NCT01977482|449989673|FG002|Overall Study|Protocol Violation|1|||
125100734|NCT01977482|449989674|FG003|Overall Study|Protocol Violation|0|||
125100735|NCT01977482|449989675|FG004|Overall Study|Protocol Violation|0|||
125100736|NCT01977482|449989676|FG005|Overall Study|Protocol Violation|0|||
125100737|NCT01977482|449989671|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
125100738|NCT01977482|449989672|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
125100739|NCT01977482|449989673|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
125100740|NCT01977482|449989674|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
125100741|NCT01977482|449989675|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
125100742|NCT01977482|449989676|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
125100743|NCT01977482|449989671|FG000|Overall Study|Withdrawal by Subject|2|||
125100744|NCT01977482|449989672|FG001|Overall Study|Withdrawal by Subject|4|||
125100745|NCT01977482|449989673|FG002|Overall Study|Withdrawal by Subject|1|||
125100746|NCT01977482|449989674|FG003|Overall Study|Withdrawal by Subject|3|||
125100747|NCT01977482|449989675|FG004|Overall Study|Withdrawal by Subject|1|||
125100748|NCT01977482|449989676|FG005|Overall Study|Withdrawal by Subject|5|||
125100749|NCT00209560|449989677|FG000|Overall Study|Lack of Efficacy|1|||
125100750|NCT00209560|449989678|FG001|Overall Study|Lack of Efficacy|0|||
125100751|NCT00795886|449989679|FG000|Overall Study|Death|10|||
125100752|NCT05554471|449989689|FG000|Overall Study|Physician Decision|2|||
125100753|NCT05554471|449989690|FG001|Overall Study|Physician Decision|1|||
125100754|NCT05554471|449989689|FG000|Overall Study|Lost to Follow-up|2|||
125100755|NCT05554471|449989690|FG001|Overall Study|Lost to Follow-up|1|||
125100756|NCT05554471|449989689|FG000|Overall Study|Death|0|||
125100757|NCT05554471|449989690|FG001|Overall Study|Death|1|||
125100758|NCT03188991|449989691|FG000|Overall Study|Withdrawal by Subject|0|||
125100759|NCT03188991|449989692|FG001|Overall Study|Withdrawal by Subject|0|||
125100760|NCT03188991|449989693|FG002|Overall Study|Withdrawal by Subject|0|||
125100761|NCT03188991|449989694|FG003|Overall Study|Withdrawal by Subject|1|||
125100762|NCT04502862|449989697|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
125100763|NCT04502862|449989698|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
125100764|NCT04502862|449989697|FG000|Overall Study|Withdrawal by Subject|1|||
125100765|NCT04502862|449989698|FG001|Overall Study|Withdrawal by Subject|0|||
125100766|NCT04502862|449989697|FG000|Overall Study|Adverse Event|1|||
125100767|NCT04502862|449989698|FG001|Overall Study|Adverse Event|1|||
125100768|NCT00848965|449990996|FG000|Overall Study|Adverse Event|1|||
125100769|NCT00848965|449990996|FG000|Overall Study|Withdrawal by Subject|1|||
125100770|NCT01976104|449990997|FG000|Overall Study|Adverse Event|0|||
125100771|NCT01976104|449990998|FG001|Overall Study|Adverse Event|0|||
125100772|NCT01976104|449990999|FG002|Overall Study|Adverse Event|1|||
125100773|NCT01976104|449991000|FG003|Overall Study|Adverse Event|0|||
125100774|NCT01976104|449990997|FG000|Overall Study|Lost to Follow-up|3|||
125100775|NCT01976104|449990998|FG001|Overall Study|Lost to Follow-up|0|||
125100776|NCT01976104|449990999|FG002|Overall Study|Lost to Follow-up|1|||
125100777|NCT01976104|449991000|FG003|Overall Study|Lost to Follow-up|1|||
125100778|NCT01976104|449990997|FG000|Overall Study|Subject Choice|0|||
125100779|NCT01976104|449990998|FG001|Overall Study|Subject Choice|1|||
125100780|NCT01976104|449990999|FG002|Overall Study|Subject Choice|0|||
125100781|NCT01976104|449991000|FG003|Overall Study|Subject Choice|1|||
125100782|NCT01976104|449990997|FG000|Overall Study|Withdrawal by Subject|3|||
125100783|NCT01976104|449990998|FG001|Overall Study|Withdrawal by Subject|0|||
125100784|NCT01976104|449990999|FG002|Overall Study|Withdrawal by Subject|0|||
125100785|NCT01976104|449991000|FG003|Overall Study|Withdrawal by Subject|1|||
125100786|NCT01976104|449990997|FG000|Overall Study|Other|0|||
125100787|NCT01976104|449990998|FG001|Overall Study|Other|1|||
125100788|NCT01976104|449990999|FG002|Overall Study|Other|0|||
125100789|NCT01976104|449991000|FG003|Overall Study|Other|0|||
125012118|NCT05248295|449670034|FG001|Overall Study|Withdrawal by Subject|1|||
125012119|NCT05248295|449670033|FG000|Overall Study|Data loss: audio recording error|1|||
125012120|NCT05248295|449670034|FG001|Overall Study|Data loss: audio recording error|1|||
125012121|NCT03021499|449670035|FG000|Overall Study|Adverse Event|1|||
125012122|NCT03021499|449670036|FG001|Overall Study|Adverse Event|0|||
125012123|NCT03021499|449670035|FG000|Overall Study|Death|1|||
125012124|NCT03021499|449670036|FG001|Overall Study|Death|5|||
125012125|NCT03021499|449670035|FG000|Overall Study|Lack of Efficacy|0|||
125012126|NCT03021499|449670036|FG001|Overall Study|Lack of Efficacy|1|||
125012127|NCT03021499|449670035|FG000|Overall Study|Lost to Follow-up|1|||
125012128|NCT03021499|449670036|FG001|Overall Study|Lost to Follow-up|3|||
125012129|NCT03021499|449670035|FG000|Overall Study|Physician Decision|2|||
125012130|NCT03021499|449670036|FG001|Overall Study|Physician Decision|3|||
125012131|NCT03021499|449670035|FG000|Overall Study|Pregnancy|1|||
125012132|NCT03021499|449670036|FG001|Overall Study|Pregnancy|0|||
125012133|NCT03021499|449670035|FG000|Overall Study|Withdrawal by Subject|7|||
125012134|NCT03021499|449670036|FG001|Overall Study|Withdrawal by Subject|14|||
125012135|NCT03021499|449670035|FG000|Overall Study|Prohibited medication required|1|||
125012136|NCT03021499|449670036|FG001|Overall Study|Prohibited medication required|0|||
125012137|NCT03021499|449670035|FG000|Overall Study|Protocol non-compliance|1|||
125012138|NCT03021499|449670036|FG001|Overall Study|Protocol non-compliance|1|||
125012139|NCT03021499|449670035|FG000|Overall Study|None of the above|0|||
125012140|NCT03021499|449670036|FG001|Overall Study|None of the above|4|||
125012141|NCT03021499|449670035|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
125012142|NCT03021499|449670036|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
125012143|NCT01210690|449670037|FG000|Overall Study|Adverse Event|7|||
125012144|NCT01210690|449670037|FG000|Overall Study|Lack of Efficacy|12|||
125012145|NCT01210690|449670037|FG000|Overall Study|Lost to Follow-up|3|||
125012146|NCT01210690|449670037|FG000|Overall Study|Disease Remission|1|||
125012147|NCT01210690|449670037|FG000|Overall Study|Withdrawal by Subject|1|||
125012148|NCT01210690|449670037|FG000|Overall Study|Patient refused to swallow|1|||
125012149|NCT01210690|449670037|FG000|Overall Study|Patient could not take glucose|1|||
125012150|NCT00470054|449670038|FG000|Overall Study|Ineligible|1|||
125012151|NCT04869345|449670045|FG000|Overall Study|Lost to Follow-up|8|||
125012152|NCT04869345|449670046|FG001|Overall Study|Lost to Follow-up|3|||
125012153|NCT00528021|449670050|FG000|Overall Study|Lack of Efficacy|17|||
125012154|NCT00528021|449670051|FG001|Overall Study|Lack of Efficacy|13|||
125012155|NCT00528021|449670052|FG002|Overall Study|Lack of Efficacy|7|||
125012156|NCT00528021|449670053|FG003|Overall Study|Lack of Efficacy|9|||
125012157|NCT04050982|449670054|FG000|Overall Study|Did not meet eligibility criteria|0|||
125012158|NCT04050982|449670055|FG001|Overall Study|Did not meet eligibility criteria|1|||
125012159|NCT04050982|449670056|FG002|Overall Study|Did not meet eligibility criteria|0|||
125012160|NCT04050982|449670054|FG000|Overall Study|Withdrawal by Subject|1|||
125012161|NCT04050982|449670055|FG001|Overall Study|Withdrawal by Subject|0|||
125012162|NCT04050982|449670056|FG002|Overall Study|Withdrawal by Subject|0|||
125012163|NCT04050982|449670054|FG000|Overall Study|Unable to enroll on platform|1|||
125012164|NCT04050982|449670055|FG001|Overall Study|Unable to enroll on platform|0|||
125012165|NCT04050982|449670056|FG002|Overall Study|Unable to enroll on platform|0|||
125012166|NCT05054114|449670057|FG000|Overall Study|Protocol Violation|13|||
125012167|NCT05054114|449670058|FG001|Overall Study|Protocol Violation|1|||
125012168|NCT05054114|449670057|FG000|Overall Study|Pregnancy|0|||
125012169|NCT05054114|449670058|FG001|Overall Study|Pregnancy|1|||
125012170|NCT00733954|449670059|FG000|Overall Study|Lost to Follow-up|5|||
125012171|NCT00733954|449670060|FG001|Overall Study|Lost to Follow-up|2|||
125012172|NCT00733954|449670059|FG000|Overall Study|Protocol Violation|1|||
125012173|NCT00733954|449670060|FG001|Overall Study|Protocol Violation|0|||
125012174|NCT00733954|449670059|FG000|Overall Study|Withdrawal by Subject|2|||
125012175|NCT00733954|449670060|FG001|Overall Study|Withdrawal by Subject|0|||
125012176|NCT02663453|449670061|FG000|Overall Study|Death|4|||
125012177|NCT02663453|449670062|FG001|Overall Study|Death|4|||
125012178|NCT02663453|449670061|FG000|Overall Study|Withdrawal by Subject|1|||
125012179|NCT02663453|449670062|FG001|Overall Study|Withdrawal by Subject|0|||
125012180|NCT03557281|449671705|FG000|Overall Study|Investigator discretion|0|||
125012181|NCT03557281|449671706|FG001|Overall Study|Investigator discretion|0|||
125012182|NCT03557281|449671707|FG002|Overall Study|Investigator discretion|1|||
125012183|NCT03557281|449671708|FG003|Overall Study|Investigator discretion|0|||
124875599|NCT00246337|449168559|FG000|Overall Study|Lost to Follow-up|3|||
124875600|NCT00246337|449168560|FG001|Overall Study|Lost to Follow-up|0|||
124875601|NCT00246337|449168561|FG002|Overall Study|Lost to Follow-up|0|||
124875602|NCT00246337|449168562|FG003|Overall Study|Lost to Follow-up|0|||
124875603|NCT00246337|449168563|FG004|Overall Study|Lost to Follow-up|2|||
124875604|NCT00246337|449168564|FG005|Overall Study|Lost to Follow-up|2|||
124875605|NCT00246337|449168565|FG006|Overall Study|Lost to Follow-up|1|||
124875606|NCT00246337|449168566|FG007|Overall Study|Lost to Follow-up|2|||
124875607|NCT00246337|449168567|FG008|Overall Study|Lost to Follow-up|0|||
124875608|NCT00246337|449168559|FG000|Overall Study|Protocol Violation|1|||
124875609|NCT00246337|449168560|FG001|Overall Study|Protocol Violation|0|||
124875610|NCT00246337|449168561|FG002|Overall Study|Protocol Violation|0|||
124875611|NCT00246337|449168562|FG003|Overall Study|Protocol Violation|0|||
124875612|NCT00246337|449168563|FG004|Overall Study|Protocol Violation|1|||
124875613|NCT00246337|449168564|FG005|Overall Study|Protocol Violation|0|||
124875614|NCT00246337|449168565|FG006|Overall Study|Protocol Violation|1|||
124875615|NCT00246337|449168566|FG007|Overall Study|Protocol Violation|1|||
124875616|NCT00246337|449168567|FG008|Overall Study|Protocol Violation|0|||
124875617|NCT00246337|449168559|FG000|Overall Study|Withdrawal by Subject|2|||
124875618|NCT00246337|449168560|FG001|Overall Study|Withdrawal by Subject|0|||
124875619|NCT00246337|449168561|FG002|Overall Study|Withdrawal by Subject|0|||
124875620|NCT00246337|449168562|FG003|Overall Study|Withdrawal by Subject|0|||
124875621|NCT00246337|449168563|FG004|Overall Study|Withdrawal by Subject|0|||
124875622|NCT00246337|449168564|FG005|Overall Study|Withdrawal by Subject|0|||
124875623|NCT00246337|449168565|FG006|Overall Study|Withdrawal by Subject|1|||
124875624|NCT00246337|449168566|FG007|Overall Study|Withdrawal by Subject|1|||
124875625|NCT00246337|449168567|FG008|Overall Study|Withdrawal by Subject|0|||
124875626|NCT00246337|449168559|FG000|Overall Study|Lack of Qualifying Event|8|||
124875627|NCT00246337|449168560|FG001|Overall Study|Lack of Qualifying Event|2|||
125012184|NCT03557281|449671709|FG004|Overall Study|Investigator discretion|0|||
125012185|NCT03557281|449671705|FG000|Overall Study|Withdrawal by Subject|0|||
125012186|NCT03557281|449671706|FG001|Overall Study|Withdrawal by Subject|1|||
125012187|NCT03557281|449671707|FG002|Overall Study|Withdrawal by Subject|1|||
125012188|NCT03557281|449671708|FG003|Overall Study|Withdrawal by Subject|1|||
125012189|NCT03557281|449671709|FG004|Overall Study|Withdrawal by Subject|2|||
125012190|NCT03557281|449671705|FG000|Overall Study|Randomized, but did not receive treatment|0|||
125012191|NCT03557281|449671706|FG001|Overall Study|Randomized, but did not receive treatment|0|||
125012192|NCT03557281|449671707|FG002|Overall Study|Randomized, but did not receive treatment|0|||
125012193|NCT03557281|449671708|FG003|Overall Study|Randomized, but did not receive treatment|0|||
125012194|NCT03557281|449671709|FG004|Overall Study|Randomized, but did not receive treatment|1|||
125012195|NCT00402649|449671710|FG000|Overall Study|Lost to Follow-up|1|||
125012196|NCT00402649|449671710|FG000|Overall Study|Withdrawal by Subject|1|||
125012197|NCT01999465|449671711|FG000|Overall Study|Lost to Follow-up|0|||
125012198|NCT01999465|449671712|FG001|Overall Study|Lost to Follow-up|2|||
125012199|NCT01999465|449671711|FG000|Overall Study|Protocol Violation|0|||
125012200|NCT01999465|449671712|FG001|Overall Study|Protocol Violation|1|||
125012201|NCT01308008|449671721|FG000|4 Weeks|Illness, disinterest, time|9|||
125012202|NCT01308008|449671722|FG001|4 Weeks|Illness, disinterest, time|2|||
125012203|NCT00573430|449671730|FG000|Overall Study|Incorrect enrollment of randomization|0|||
125012204|NCT00573430|449671731|FG001|Overall Study|Incorrect enrollment of randomization|4|||
125012205|NCT00573430|449671732|FG002|Overall Study|Incorrect enrollment of randomization|3|||
125012206|NCT00573430|449671730|FG000|Overall Study|Adverse Event|0|||
125012207|NCT00573430|449671731|FG001|Overall Study|Adverse Event|0|||
125012208|NCT00573430|449671732|FG002|Overall Study|Adverse Event|2|||
125012209|NCT00573430|449671730|FG000|Overall Study|Withdrawal by Subject|1|||
125012210|NCT00573430|449671731|FG001|Overall Study|Withdrawal by Subject|0|||
125012211|NCT00573430|449671732|FG002|Overall Study|Withdrawal by Subject|1|||
125012212|NCT00573430|449671730|FG000|Overall Study|Protocol Violation|0|||
125012213|NCT00573430|449671731|FG001|Overall Study|Protocol Violation|1|||
125012214|NCT00573430|449671732|FG002|Overall Study|Protocol Violation|1|||
125012215|NCT00573430|449671730|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125012216|NCT00573430|449671731|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125012217|NCT00573430|449671732|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
125012218|NCT04962022|449671736|FG000|Period 1|Withdrawal by Subject|1|||
125012219|NCT04962022|449671737|FG001|Period 1|Withdrawal by Subject|0|||
125012220|NCT01146873|449671743|FG000|Overall Study|Transfer out|0|||
125012221|NCT01146873|449671744|FG001|Overall Study|Transfer out|6|||
125012222|NCT01967628|449671745|FG000|Overall Study|Withdrawal by Subject|2|||
125012223|NCT01967628|449671746|FG001|Overall Study|Withdrawal by Subject|0|||
125012224|NCT01967628|449671745|FG000|Overall Study|Unable to complete bronchoscopy|4|||
125012225|NCT01967628|449671746|FG001|Overall Study|Unable to complete bronchoscopy|6|||
124875628|NCT00246337|449168561|FG002|Overall Study|Lack of Qualifying Event|1|||
124875629|NCT00246337|449168562|FG003|Overall Study|Lack of Qualifying Event|1|||
124875630|NCT00246337|449168563|FG004|Overall Study|Lack of Qualifying Event|1|||
124875631|NCT00246337|449168564|FG005|Overall Study|Lack of Qualifying Event|3|||
124875632|NCT00246337|449168565|FG006|Overall Study|Lack of Qualifying Event|3|||
124875633|NCT00246337|449168566|FG007|Overall Study|Lack of Qualifying Event|2|||
124875634|NCT00246337|449168567|FG008|Overall Study|Lack of Qualifying Event|5|||
124875635|NCT00246337|449168559|FG000|Overall Study|Site Terminated|10|||
124875636|NCT00246337|449168560|FG001|Overall Study|Site Terminated|0|||
124875637|NCT00246337|449168561|FG002|Overall Study|Site Terminated|0|||
124875638|NCT00246337|449168562|FG003|Overall Study|Site Terminated|0|||
124875639|NCT00246337|449168563|FG004|Overall Study|Site Terminated|0|||
124875640|NCT00246337|449168564|FG005|Overall Study|Site Terminated|7|||
124875641|NCT00246337|449168565|FG006|Overall Study|Site Terminated|1|||
124875642|NCT00246337|449168566|FG007|Overall Study|Site Terminated|6|||
124875643|NCT00246337|449168567|FG008|Overall Study|Site Terminated|2|||
124875644|NCT00246337|449168559|FG000|Overall Study|Abnormal baseline lab values|7|||
124875645|NCT00246337|449168560|FG001|Overall Study|Abnormal baseline lab values|0|||
124875646|NCT00246337|449168561|FG002|Overall Study|Abnormal baseline lab values|2|||
124875647|NCT00246337|449168562|FG003|Overall Study|Abnormal baseline lab values|0|||
124875648|NCT00246337|449168563|FG004|Overall Study|Abnormal baseline lab values|0|||
124875649|NCT00246337|449168564|FG005|Overall Study|Abnormal baseline lab values|2|||
124875650|NCT00246337|449168565|FG006|Overall Study|Abnormal baseline lab values|2|||
124875651|NCT00246337|449168566|FG007|Overall Study|Abnormal baseline lab values|0|||
124875652|NCT00246337|449168567|FG008|Overall Study|Abnormal baseline lab values|4|||
124875653|NCT00246337|449168559|FG000|Overall Study|Overwhelmed|0|||
124875654|NCT00246337|449168560|FG001|Overall Study|Overwhelmed|0|||
124875655|NCT00246337|449168561|FG002|Overall Study|Overwhelmed|0|||
124875656|NCT00246337|449168562|FG003|Overall Study|Overwhelmed|0|||
124875657|NCT00246337|449168563|FG004|Overall Study|Overwhelmed|0|||
124875658|NCT00246337|449168564|FG005|Overall Study|Overwhelmed|1|||
125012226|NCT01967628|449671745|FG000|Overall Study|Lost to Follow-up|1|||
125012227|NCT01967628|449671746|FG001|Overall Study|Lost to Follow-up|0|||
125012228|NCT01967628|449671745|FG000|Overall Study|Low protein concentration in sample|20|||
125012229|NCT01967628|449671746|FG001|Overall Study|Low protein concentration in sample|25|||
125012230|NCT01356407|449671747|FG000|Overall Study|Lost to Follow-up|2|||
125012231|NCT01356407|449671748|FG001|Overall Study|Lost to Follow-up|0|||
125012232|NCT01356407|449671747|FG000|Overall Study|Patient Withdrew Consent|2|||
125012233|NCT01356407|449671748|FG001|Overall Study|Patient Withdrew Consent|1|||
125012234|NCT01356407|449671747|FG000|Overall Study|Could not afford IMP administration|0|||
125012235|NCT01356407|449671748|FG001|Overall Study|Could not afford IMP administration|1|||
125012236|NCT01356407|449671747|FG000|Overall Study|Not complete Endoscopy|2|||
125012237|NCT01356407|449671748|FG001|Overall Study|Not complete Endoscopy|2|||
125012238|NCT02055820|449671749|FG000|Phase I: Dose-Finding|Death|1|||
125012239|NCT02055820|449671750|FG001|Phase I: Dose-Finding|Death|0|||
125012240|NCT02055820|449671751|FG002|Phase I: Dose-Finding|Death|1|||
125012241|NCT02055820|449671752|FG003|Phase I: Dose-Finding|Death|2|||
125012242|NCT02055820|449671753|FG004|Phase I: Dose-Finding|Death|0|||
125012243|NCT02055820|449671754|FG005|Phase I: Dose-Finding|Death|1|||
125012244|NCT02055820|449671755|FG006|Phase I: Dose-Finding|Death|1|||
125012245|NCT02055820|449671756|FG007|Phase I: Dose-Finding|Death|0|||
125012246|NCT02055820|449671757|FG008|Phase I: Dose-Finding|Death|0|||
125012247|NCT02055820|449671758|FG009|Phase I: Dose-Finding|Death|0|||
125012248|NCT02055820|449671749|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
125012249|NCT02055820|449671750|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
125012250|NCT02055820|449671751|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
125012251|NCT02055820|449671752|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
125012252|NCT02055820|449671753|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
125012253|NCT02055820|449671754|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
125012254|NCT02055820|449671755|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
125012255|NCT02055820|449671756|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
125012256|NCT02055820|449671757|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
125012257|NCT02055820|449671758|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
125012258|NCT02055820|449671749|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
125012259|NCT02055820|449671750|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
125012260|NCT02055820|449671751|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
125012261|NCT02055820|449671752|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
125012262|NCT02055820|449671753|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
124875659|NCT00246337|449168565|FG006|Overall Study|Overwhelmed|0|||
125012263|NCT02055820|449671754|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
125012264|NCT02055820|449671755|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
125012265|NCT02055820|449671756|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
125012266|NCT02055820|449671757|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
125012267|NCT02055820|449671758|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
125012268|NCT02055820|449671749|FG000|Phase II: Expansion|Death|0|||
125012269|NCT02055820|449671750|FG001|Phase II: Expansion|Death|0|||
125012270|NCT02055820|449671751|FG002|Phase II: Expansion|Death|0|||
125012271|NCT02055820|449671752|FG003|Phase II: Expansion|Death|0|||
125012272|NCT02055820|449671753|FG004|Phase II: Expansion|Death|33|||
125012273|NCT02055820|449671754|FG005|Phase II: Expansion|Death|0|||
125012274|NCT02055820|449671755|FG006|Phase II: Expansion|Death|0|||
125012275|NCT02055820|449671756|FG007|Phase II: Expansion|Death|0|||
125012276|NCT02055820|449671757|FG008|Phase II: Expansion|Death|0|||
125012277|NCT02055820|449671758|FG009|Phase II: Expansion|Death|0|||
125012278|NCT02055820|449671749|FG000|Phase II: Expansion|Lost to Follow-up|0|||
125012279|NCT02055820|449671750|FG001|Phase II: Expansion|Lost to Follow-up|0|||
125012280|NCT02055820|449671751|FG002|Phase II: Expansion|Lost to Follow-up|0|||
125012281|NCT02055820|449671752|FG003|Phase II: Expansion|Lost to Follow-up|0|||
125012282|NCT02055820|449671753|FG004|Phase II: Expansion|Lost to Follow-up|4|||
125012283|NCT02055820|449671754|FG005|Phase II: Expansion|Lost to Follow-up|0|||
125012284|NCT02055820|449671755|FG006|Phase II: Expansion|Lost to Follow-up|0|||
125012285|NCT02055820|449671756|FG007|Phase II: Expansion|Lost to Follow-up|0|||
125012286|NCT02055820|449671757|FG008|Phase II: Expansion|Lost to Follow-up|0|||
125012287|NCT02055820|449671758|FG009|Phase II: Expansion|Lost to Follow-up|0|||
125012288|NCT02055820|449671749|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
125012289|NCT02055820|449671750|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
125012290|NCT02055820|449671751|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
125012291|NCT02055820|449671752|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
125012292|NCT02055820|449671753|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
125012293|NCT02055820|449671754|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
125012294|NCT02055820|449671755|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
125012295|NCT02055820|449671756|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
125012296|NCT02055820|449671757|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
125012297|NCT02055820|449671758|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
125012298|NCT01389752|449671761|FG000|Study Period 1|Sponsor decision|0|||
125012299|NCT01389752|449671762|FG001|Study Period 1|Sponsor decision|2|||
125012300|NCT01389752|449671761|FG000|Study Period 2|Sponsor decision|1|||
125012301|NCT01389752|449671762|FG001|Study Period 2|Sponsor decision|0|||
125012302|NCT01157364|449671767|FG000|Overall Study|Other Reasons|1|||
125012303|NCT01157364|449671768|FG001|Overall Study|Other Reasons|1|||
125012304|NCT01157364|449671769|FG002|Overall Study|Other Reasons|2|||
125012305|NCT01157364|449671770|FG003|Overall Study|Other Reasons|1|||
125012306|NCT01157364|449671771|FG004|Overall Study|Other Reasons|0|||
125012307|NCT01157364|449671772|FG005|Overall Study|Other Reasons|0|||
125012308|NCT01157364|449671767|FG000|Overall Study|Personal Reasons|0|||
125012309|NCT01157364|449671768|FG001|Overall Study|Personal Reasons|2|||
125012310|NCT01157364|449671769|FG002|Overall Study|Personal Reasons|0|||
125012311|NCT01157364|449671770|FG003|Overall Study|Personal Reasons|0|||
125012312|NCT01157364|449671771|FG004|Overall Study|Personal Reasons|1|||
125012313|NCT01157364|449671772|FG005|Overall Study|Personal Reasons|1|||
125012314|NCT01157364|449671767|FG000|Overall Study|Lost to Follow-up|1|||
125012315|NCT01157364|449671768|FG001|Overall Study|Lost to Follow-up|0|||
125012316|NCT01157364|449671769|FG002|Overall Study|Lost to Follow-up|1|||
125012317|NCT01157364|449671770|FG003|Overall Study|Lost to Follow-up|0|||
125012318|NCT01157364|449671771|FG004|Overall Study|Lost to Follow-up|0|||
125012319|NCT01157364|449671772|FG005|Overall Study|Lost to Follow-up|0|||
125012320|NCT01157364|449671767|FG000|Overall Study|Lack of Efficacy|0|||
125012321|NCT01157364|449671768|FG001|Overall Study|Lack of Efficacy|0|||
125012322|NCT01157364|449671769|FG002|Overall Study|Lack of Efficacy|0|||
125012323|NCT01157364|449671770|FG003|Overall Study|Lack of Efficacy|1|||
125012324|NCT01157364|449671771|FG004|Overall Study|Lack of Efficacy|0|||
125012325|NCT01157364|449671772|FG005|Overall Study|Lack of Efficacy|0|||
125012326|NCT01157364|449671767|FG000|Overall Study|Adverse Event|0|||
125012327|NCT01157364|449671768|FG001|Overall Study|Adverse Event|1|||
125012328|NCT01157364|449671769|FG002|Overall Study|Adverse Event|1|||
125012329|NCT01157364|449671770|FG003|Overall Study|Adverse Event|0|||
125012330|NCT01157364|449671771|FG004|Overall Study|Adverse Event|1|||
125012331|NCT01157364|449671772|FG005|Overall Study|Adverse Event|0|||
125012332|NCT04251910|449671786|FG000|Overall Study|Covid 19 lockdown|0|||
125012333|NCT04251910|449671787|FG001|Overall Study|Covid 19 lockdown|5|||
125012334|NCT04251910|449671788|FG002|Overall Study|Covid 19 lockdown|0|||
125012335|NCT04251910|449671789|FG003|Overall Study|Covid 19 lockdown|4|||
125012336|NCT04251910|449671790|FG004|Overall Study|Covid 19 lockdown|0|||
125012337|NCT04251910|449671791|FG005|Overall Study|Covid 19 lockdown|0|||
125012338|NCT04251910|449671786|FG000|Overall Study|Assisted living facility was closed|0|||
125012339|NCT04251910|449671787|FG001|Overall Study|Assisted living facility was closed|0|||
125012340|NCT04251910|449671788|FG002|Overall Study|Assisted living facility was closed|0|||
124875660|NCT00246337|449168566|FG007|Overall Study|Overwhelmed|0|||
124875661|NCT00246337|449168567|FG008|Overall Study|Overwhelmed|0|||
124875662|NCT00246337|449168559|FG000|Overall Study|Protocol Violator|1|||
124875663|NCT00246337|449168560|FG001|Overall Study|Protocol Violator|0|||
124875664|NCT00246337|449168561|FG002|Overall Study|Protocol Violator|0|||
124875665|NCT00246337|449168562|FG003|Overall Study|Protocol Violator|0|||
124875666|NCT00246337|449168563|FG004|Overall Study|Protocol Violator|0|||
124875667|NCT00246337|449168564|FG005|Overall Study|Protocol Violator|0|||
124875668|NCT00246337|449168565|FG006|Overall Study|Protocol Violator|0|||
124875669|NCT00246337|449168566|FG007|Overall Study|Protocol Violator|0|||
124875670|NCT00246337|449168567|FG008|Overall Study|Protocol Violator|0|||
124875671|NCT00246337|449168559|FG000|Overall Study|Reported as completing trial in error|0|||
124875672|NCT00246337|449168560|FG001|Overall Study|Reported as completing trial in error|0|||
124875673|NCT00246337|449168561|FG002|Overall Study|Reported as completing trial in error|0|||
124875674|NCT00246337|449168562|FG003|Overall Study|Reported as completing trial in error|0|||
124875675|NCT00246337|449168563|FG004|Overall Study|Reported as completing trial in error|0|||
124875676|NCT00246337|449168564|FG005|Overall Study|Reported as completing trial in error|0|||
124875677|NCT00246337|449168565|FG006|Overall Study|Reported as completing trial in error|0|||
124875678|NCT00246337|449168566|FG007|Overall Study|Reported as completing trial in error|1|||
124875679|NCT00246337|449168567|FG008|Overall Study|Reported as completing trial in error|0|||
124875680|NCT01966003|449168568|FG000|Overall Study|Death|43|||
124875681|NCT01966003|449168569|FG001|Overall Study|Death|36|||
124875682|NCT01966003|449168568|FG000|Overall Study|Protocol Violation|6|||
124875683|NCT01966003|449168569|FG001|Overall Study|Protocol Violation|4|||
124875684|NCT01966003|449168568|FG000|Overall Study|Lost to Follow-up|4|||
124875685|NCT01966003|449168569|FG001|Overall Study|Lost to Follow-up|3|||
124875686|NCT01966003|449168568|FG000|Overall Study|Physician Decision|12|||
124875687|NCT01966003|449168569|FG001|Overall Study|Physician Decision|13|||
124875688|NCT01966003|449168568|FG000|Overall Study|Withdrawal by Subject|29|||
124875689|NCT01966003|449168569|FG001|Overall Study|Withdrawal by Subject|19|||
124875690|NCT01966003|449168568|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
124875691|NCT01966003|449168569|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
124875692|NCT01966003|449168568|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
124875693|NCT01966003|449168569|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
124875694|NCT01966003|449168568|FG000|Overall Study|Other|1|||
124875695|NCT01966003|449168569|FG001|Overall Study|Other|1|||
124875696|NCT03633929|449168571|FG000|Overall Study|Lost to Follow-up|1|||
124875697|NCT03633929|449168571|FG000|Overall Study|Did not login to software. Did not participate|3|||
124875698|NCT02287584|449168575|FG000|the Double-blind Phase|Adverse Event|17|||
124875699|NCT02287584|449168576|FG001|the Double-blind Phase|Adverse Event|17|||
124875700|NCT02287584|449168577|FG002|the Double-blind Phase|Adverse Event|12|||
124875701|NCT02287584|449168578|FG003|the Double-blind Phase|Adverse Event|0|||
124875702|NCT02287584|449168579|FG004|the Double-blind Phase|Adverse Event|0|||
124875703|NCT02287584|449168580|FG005|the Double-blind Phase|Adverse Event|0|||
124875704|NCT02287584|449168575|FG000|the Double-blind Phase|Lack of Efficacy|18|||
124875705|NCT02287584|449168576|FG001|the Double-blind Phase|Lack of Efficacy|8|||
124875706|NCT02287584|449168577|FG002|the Double-blind Phase|Lack of Efficacy|8|||
124875707|NCT02287584|449168578|FG003|the Double-blind Phase|Lack of Efficacy|0|||
124875708|NCT02287584|449168579|FG004|the Double-blind Phase|Lack of Efficacy|0|||
124875709|NCT02287584|449168580|FG005|the Double-blind Phase|Lack of Efficacy|0|||
124875710|NCT02287584|449168575|FG000|the Double-blind Phase|Lost to Follow-up|0|||
124875711|NCT02287584|449168576|FG001|the Double-blind Phase|Lost to Follow-up|1|||
124875712|NCT02287584|449168577|FG002|the Double-blind Phase|Lost to Follow-up|1|||
124875713|NCT02287584|449168578|FG003|the Double-blind Phase|Lost to Follow-up|0|||
124875714|NCT02287584|449168579|FG004|the Double-blind Phase|Lost to Follow-up|0|||
124875715|NCT02287584|449168580|FG005|the Double-blind Phase|Lost to Follow-up|0|||
124875716|NCT02287584|449168575|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
124875717|NCT02287584|449168576|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
124875718|NCT02287584|449168577|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
124875719|NCT02287584|449168578|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
124875720|NCT02287584|449168579|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
124875721|NCT02287584|449168580|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
124875722|NCT02287584|449168575|FG000|the Double-blind Phase|Pregnancy|0|||
124875723|NCT02287584|449168576|FG001|the Double-blind Phase|Pregnancy|1|||
124875724|NCT02287584|449168577|FG002|the Double-blind Phase|Pregnancy|0|||
124875725|NCT02287584|449168578|FG003|the Double-blind Phase|Pregnancy|0|||
124875726|NCT02287584|449168579|FG004|the Double-blind Phase|Pregnancy|0|||
124875727|NCT02287584|449168580|FG005|the Double-blind Phase|Pregnancy|0|||
124875728|NCT02287584|449168575|FG000|the Double-blind Phase|Protocol Violation|0|||
124875729|NCT02287584|449168576|FG001|the Double-blind Phase|Protocol Violation|3|||
124875730|NCT02287584|449168577|FG002|the Double-blind Phase|Protocol Violation|0|||
124875731|NCT02287584|449168578|FG003|the Double-blind Phase|Protocol Violation|0|||
124875732|NCT02287584|449168579|FG004|the Double-blind Phase|Protocol Violation|0|||
124875733|NCT02287584|449168580|FG005|the Double-blind Phase|Protocol Violation|0|||
124875734|NCT02287584|449168575|FG000|the Double-blind Phase|other reasons|0|||
125012341|NCT04251910|449671789|FG003|Overall Study|Assisted living facility was closed|0|||
125012342|NCT04251910|449671790|FG004|Overall Study|Assisted living facility was closed|1|||
125012343|NCT04251910|449671791|FG005|Overall Study|Assisted living facility was closed|0|||
125012344|NCT00841568|449671794|FG000|Overall Study|Adverse Event|1|||
125012345|NCT00841568|449671794|FG000|Overall Study|Death|1|||
125012346|NCT00841568|449671794|FG000|Overall Study|Withdrawal by Subject|2|||
125012347|NCT00841568|449671794|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
125012348|NCT00133991|449671795|FG000|Overall Study|Death|4|||
125012349|NCT03002155|449671796|FG000|Overall Study|Lost to Follow-up|1|||
125012350|NCT03002155|449671797|FG001|Overall Study|Lost to Follow-up|2|||
125012351|NCT03002155|449671796|FG000|Overall Study|Withdrawal by Subject|1|||
125012352|NCT03002155|449671797|FG001|Overall Study|Withdrawal by Subject|0|||
125012353|NCT03002155|449671796|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
125012354|NCT03002155|449671797|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
125012355|NCT00978029|449671798|FG000|Overall Study|Adverse Event|1|||
125012356|NCT00978029|449671799|FG001|Overall Study|Adverse Event|2|||
125012357|NCT00978029|449671800|FG002|Overall Study|Adverse Event|5|||
125012358|NCT00978029|449671798|FG000|Overall Study|Withdrawal by Subject|0|||
125012359|NCT00978029|449671799|FG001|Overall Study|Withdrawal by Subject|0|||
125012360|NCT00978029|449671800|FG002|Overall Study|Withdrawal by Subject|1|||
125012361|NCT00978029|449671798|FG000|Overall Study|Protocol Violation|0|||
125012362|NCT00978029|449671799|FG001|Overall Study|Protocol Violation|1|||
125012363|NCT00978029|449671800|FG002|Overall Study|Protocol Violation|0|||
125012364|NCT01087775|449671801|FG000|Overall Study|failed inclusion criteria|2|||
125012365|NCT00825162|449671808|FG000|Overall Study|Withdrawal by Subject|11|||
125012366|NCT00825162|449671809|FG001|Overall Study|Withdrawal by Subject|13|||
125012367|NCT00825162|449671810|FG002|Overall Study|Withdrawal by Subject|3|||
125012368|NCT00825162|449671808|FG000|Overall Study|Lost to Follow-up|9|||
125012369|NCT00825162|449671809|FG001|Overall Study|Lost to Follow-up|6|||
125012370|NCT00825162|449671810|FG002|Overall Study|Lost to Follow-up|3|||
125012371|NCT00825162|449671808|FG000|Overall Study|Physician Decision|2|||
125012372|NCT00825162|449671809|FG001|Overall Study|Physician Decision|0|||
125012373|NCT00825162|449671810|FG002|Overall Study|Physician Decision|0|||
125012374|NCT00825162|449671808|FG000|Overall Study|Move away from the study area|1|||
125012375|NCT00825162|449671809|FG001|Overall Study|Move away from the study area|0|||
125012376|NCT00825162|449671810|FG002|Overall Study|Move away from the study area|0|||
125012377|NCT00825162|449671808|FG000|Overall Study|Unable to attend the study visit|5|||
125012378|NCT00825162|449671809|FG001|Overall Study|Unable to attend the study visit|2|||
125012379|NCT00825162|449671810|FG002|Overall Study|Unable to attend the study visit|0|||
125012380|NCT00964743|449671811|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
125012381|NCT00781911|449671812|FG000|Overall Study|Adverse Event|4|||
125012382|NCT00781911|449671813|FG001|Overall Study|Adverse Event|4|||
125012383|NCT00781911|449671812|FG000|Overall Study|Withdrawal by Subject|1|||
125012384|NCT00781911|449671813|FG001|Overall Study|Withdrawal by Subject|2|||
125012385|NCT00781911|449671812|FG000|Overall Study|Physician Decision|0|||
125012386|NCT00781911|449671813|FG001|Overall Study|Physician Decision|2|||
125012387|NCT00781911|449671812|FG000|Overall Study|Sponsor Decision|1|||
125012388|NCT00781911|449671813|FG001|Overall Study|Sponsor Decision|0|||
125012389|NCT03317795|449671816|FG000|Overall Study|IUD Expulsion|1|||
125012390|NCT03317795|449671817|FG001|Overall Study|IUD Expulsion|0|||
125012391|NCT03317795|449671816|FG000|Overall Study|Lost to Follow-up|1|||
125012392|NCT03317795|449671817|FG001|Overall Study|Lost to Follow-up|3|||
125012393|NCT03317795|449671816|FG000|Overall Study|Treatment change|0|||
125012394|NCT03317795|449671817|FG001|Overall Study|Treatment change|3|||
125012395|NCT03317795|449671816|FG000|Overall Study|Intolerance of medication|0|||
125012396|NCT03317795|449671817|FG001|Overall Study|Intolerance of medication|1|||
125012397|NCT00939783|449671818|FG000|Overall Study|Death|6|||
125012398|NCT00939783|449671818|FG000|Overall Study|Adverse Event|39|||
125012399|NCT00939783|449671818|FG000|Overall Study|Study Terminated by Sponsor|498|||
125012400|NCT00939783|449671818|FG000|Overall Study|Withdrawal by Subject|78|||
125012401|NCT00939783|449671818|FG000|Overall Study|Other|16|||
125012402|NCT00939783|449671818|FG000|Overall Study|Lost to Follow-up|8|||
125012403|NCT00939783|449671818|FG000|Overall Study|Protocol Violation|3|||
125012404|NCT00939783|449671818|FG000|Overall Study|Enrolled but not treated|1|||
125012405|NCT01549002|449671825|FG000|Overall Study|Excessive pain|0|||
125012406|NCT01549002|449671826|FG001|Overall Study|Excessive pain|2|||
125012407|NCT01549002|449671825|FG000|Overall Study|Moderate sedation required|0|||
125012408|NCT01549002|449671826|FG001|Overall Study|Moderate sedation required|2|||
125012409|NCT01251367|449671831|FG000|Overall Study|Protocol Violation|1|||
125012410|NCT01251367|449671831|FG000|Overall Study|Lack of Efficacy|2|||
125012411|NCT01251367|449671831|FG000|Overall Study|Adverse Event|19|||
125012412|NCT01251367|449671831|FG000|Overall Study|Withdrawal by Subject|36|||
125012413|NCT01251367|449671831|FG000|Overall Study|Lost to Follow-up|5|||
125012414|NCT01251367|449671831|FG000|Overall Study|Subject Required Alternative Treatment|7|||
125012415|NCT01251367|449671831|FG000|Overall Study|No Study Drug Available|1|||
125012416|NCT01251367|449671831|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
124875735|NCT02287584|449168576|FG001|the Double-blind Phase|other reasons|0|||
124875736|NCT02287584|449168577|FG002|the Double-blind Phase|other reasons|1|||
124875737|NCT02287584|449168578|FG003|the Double-blind Phase|other reasons|0|||
124875738|NCT02287584|449168579|FG004|the Double-blind Phase|other reasons|0|||
124875739|NCT02287584|449168580|FG005|the Double-blind Phase|other reasons|0|||
124875740|NCT02287584|449168575|FG000|the Open-label Phase|Did not receive drug|0|||
124875741|NCT02287584|449168576|FG001|the Open-label Phase|Did not receive drug|0|||
124875742|NCT02287584|449168577|FG002|the Open-label Phase|Did not receive drug|0|||
124875743|NCT02287584|449168578|FG003|the Open-label Phase|Did not receive drug|7|||
124875744|NCT02287584|449168579|FG004|the Open-label Phase|Did not receive drug|6|||
124875745|NCT02287584|449168580|FG005|the Open-label Phase|Did not receive drug|4|||
124875746|NCT02287584|449168575|FG000|the Open-label Phase|Adverse Event|0|||
124875747|NCT02287584|449168576|FG001|the Open-label Phase|Adverse Event|0|||
124875748|NCT02287584|449168577|FG002|the Open-label Phase|Adverse Event|0|||
124875749|NCT02287584|449168578|FG003|the Open-label Phase|Adverse Event|15|||
124875750|NCT02287584|449168579|FG004|the Open-label Phase|Adverse Event|12|||
124875751|NCT02287584|449168580|FG005|the Open-label Phase|Adverse Event|16|||
124875752|NCT02287584|449168575|FG000|the Open-label Phase|Lack of Efficacy|0|||
124875753|NCT02287584|449168576|FG001|the Open-label Phase|Lack of Efficacy|0|||
124875754|NCT02287584|449168577|FG002|the Open-label Phase|Lack of Efficacy|0|||
124875755|NCT02287584|449168578|FG003|the Open-label Phase|Lack of Efficacy|8|||
124875756|NCT02287584|449168579|FG004|the Open-label Phase|Lack of Efficacy|3|||
124875757|NCT02287584|449168580|FG005|the Open-label Phase|Lack of Efficacy|7|||
124875758|NCT02287584|449168575|FG000|the Open-label Phase|Lost to Follow-up|0|||
124875759|NCT02287584|449168576|FG001|the Open-label Phase|Lost to Follow-up|0|||
124875760|NCT02287584|449168577|FG002|the Open-label Phase|Lost to Follow-up|0|||
124875761|NCT02287584|449168578|FG003|the Open-label Phase|Lost to Follow-up|4|||
124875762|NCT02287584|449168579|FG004|the Open-label Phase|Lost to Follow-up|1|||
124875763|NCT02287584|449168580|FG005|the Open-label Phase|Lost to Follow-up|2|||
124875764|NCT02287584|449168575|FG000|the Open-label Phase|Withdrawal by Subject|0|||
124875765|NCT02287584|449168576|FG001|the Open-label Phase|Withdrawal by Subject|0|||
124875766|NCT02287584|449168577|FG002|the Open-label Phase|Withdrawal by Subject|0|||
124875767|NCT02287584|449168578|FG003|the Open-label Phase|Withdrawal by Subject|18|||
124875768|NCT02287584|449168579|FG004|the Open-label Phase|Withdrawal by Subject|29|||
124875769|NCT02287584|449168580|FG005|the Open-label Phase|Withdrawal by Subject|21|||
124875770|NCT02287584|449168575|FG000|the Open-label Phase|non-compliance|0|||
124875771|NCT02287584|449168576|FG001|the Open-label Phase|non-compliance|0|||
124875772|NCT02287584|449168577|FG002|the Open-label Phase|non-compliance|0|||
124875773|NCT02287584|449168578|FG003|the Open-label Phase|non-compliance|2|||
124875774|NCT02287584|449168579|FG004|the Open-label Phase|non-compliance|5|||
124875775|NCT02287584|449168580|FG005|the Open-label Phase|non-compliance|1|||
124875776|NCT02287584|449168575|FG000|the Open-label Phase|other reasons|0|||
124875777|NCT02287584|449168576|FG001|the Open-label Phase|other reasons|0|||
124875778|NCT02287584|449168577|FG002|the Open-label Phase|other reasons|0|||
124875779|NCT02287584|449168578|FG003|the Open-label Phase|other reasons|3|||
124875780|NCT02287584|449168579|FG004|the Open-label Phase|other reasons|6|||
124875781|NCT02287584|449168580|FG005|the Open-label Phase|other reasons|6|||
124875782|NCT02798211|449168589|FG000|Period 1|Adverse Event|1|||
124875783|NCT02798211|449168590|FG001|Period 1|Adverse Event|1|||
124875784|NCT02798211|449168591|FG002|Period 1|Adverse Event|0|||
124875785|NCT02798211|449168592|FG003|Period 1|Adverse Event|0|||
124875786|NCT02798211|449168593|FG004|Period 1|Adverse Event|0|||
124875787|NCT02798211|449168594|FG005|Period 1|Adverse Event|0|||
124875788|NCT02798211|449168589|FG000|Period 1|Lost to Follow-up|2|||
124875789|NCT02798211|449168590|FG001|Period 1|Lost to Follow-up|1|||
124875790|NCT02798211|449168591|FG002|Period 1|Lost to Follow-up|0|||
124875791|NCT02798211|449168592|FG003|Period 1|Lost to Follow-up|0|||
124875792|NCT02798211|449168593|FG004|Period 1|Lost to Follow-up|0|||
124875793|NCT02798211|449168594|FG005|Period 1|Lost to Follow-up|0|||
124875794|NCT02798211|449168589|FG000|Period 1|Protocol Violation|0|||
124875795|NCT02798211|449168590|FG001|Period 1|Protocol Violation|0|||
124875796|NCT02798211|449168591|FG002|Period 1|Protocol Violation|2|||
124875797|NCT02798211|449168592|FG003|Period 1|Protocol Violation|0|||
124875798|NCT02798211|449168593|FG004|Period 1|Protocol Violation|0|||
124875799|NCT02798211|449168594|FG005|Period 1|Protocol Violation|0|||
124875800|NCT02798211|449168589|FG000|Period 1|Withdrawal by Subject|1|||
124875801|NCT02798211|449168590|FG001|Period 1|Withdrawal by Subject|1|||
124875802|NCT02798211|449168591|FG002|Period 1|Withdrawal by Subject|0|||
124875803|NCT02798211|449168592|FG003|Period 1|Withdrawal by Subject|0|||
124875804|NCT02798211|449168593|FG004|Period 1|Withdrawal by Subject|0|||
124875805|NCT02798211|449168594|FG005|Period 1|Withdrawal by Subject|0|||
124875806|NCT02798211|449168589|FG000|Period 1|Death|0|||
124875807|NCT02798211|449168590|FG001|Period 1|Death|0|||
124875808|NCT02798211|449168591|FG002|Period 1|Death|1|||
124875809|NCT02798211|449168592|FG003|Period 1|Death|0|||
124875810|NCT02798211|449168593|FG004|Period 1|Death|0|||
124875811|NCT02798211|449168594|FG005|Period 1|Death|0|||
124875812|NCT02798211|449168589|FG000|Period 1|Withdrawal of Informed Consent|2|||
124875813|NCT02798211|449168590|FG001|Period 1|Withdrawal of Informed Consent|7|||
124875814|NCT02798211|449168591|FG002|Period 1|Withdrawal of Informed Consent|3|||
124875815|NCT02798211|449168592|FG003|Period 1|Withdrawal of Informed Consent|0|||
124875816|NCT02798211|449168593|FG004|Period 1|Withdrawal of Informed Consent|0|||
124875817|NCT02798211|449168594|FG005|Period 1|Withdrawal of Informed Consent|0|||
124875818|NCT02798211|449168589|FG000|Period 2|Withdrawal by Subject|2|||
124875819|NCT02798211|449168590|FG001|Period 2|Withdrawal by Subject|0|||
124875820|NCT02798211|449168591|FG002|Period 2|Withdrawal by Subject|0|||
124875821|NCT02798211|449168592|FG003|Period 2|Withdrawal by Subject|0|||
124875822|NCT02798211|449168593|FG004|Period 2|Withdrawal by Subject|2|||
125100790|NCT01317199|449991001|FG000|Dose-escalation Phase 1|Physician Decision|5|||
125100791|NCT01317199|449991002|FG001|Dose-escalation Phase 1|Physician Decision|0|||
125100792|NCT01317199|449991003|FG002|Dose-escalation Phase 1|Physician Decision|0|||
125100793|NCT01317199|449991004|FG003|Dose-escalation Phase 1|Physician Decision|0|||
125100794|NCT01317199|449991001|FG000|Dose-escalation Phase 1|Disease progression|1|||
125100795|NCT01317199|449991002|FG001|Dose-escalation Phase 1|Disease progression|0|||
125100796|NCT01317199|449991003|FG002|Dose-escalation Phase 1|Disease progression|0|||
125100797|NCT01317199|449991004|FG003|Dose-escalation Phase 1|Disease progression|0|||
125100798|NCT01317199|449991001|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
125100799|NCT01317199|449991002|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
125100800|NCT01317199|449991003|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
125100801|NCT01317199|449991004|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
125100802|NCT01317199|449991001|FG000|Randomized Phase 2|Disease progression|0|||
125100803|NCT01317199|449991002|FG001|Randomized Phase 2|Disease progression|3|||
125100804|NCT01317199|449991003|FG002|Randomized Phase 2|Disease progression|7|||
125100805|NCT01317199|449991004|FG003|Randomized Phase 2|Disease progression|5|||
125100806|NCT01317199|449991001|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
125100807|NCT01317199|449991002|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
125100808|NCT01317199|449991003|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
125100809|NCT01317199|449991004|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
125100810|NCT01317199|449991001|FG000|Randomized Phase 2|Adverse Event|0|||
125100811|NCT01317199|449991002|FG001|Randomized Phase 2|Adverse Event|0|||
125100812|NCT01317199|449991003|FG002|Randomized Phase 2|Adverse Event|0|||
125100813|NCT01317199|449991004|FG003|Randomized Phase 2|Adverse Event|1|||
125100814|NCT01317199|449991001|FG000|Randomized Phase 2|Comorbidities|0|||
125100815|NCT01317199|449991002|FG001|Randomized Phase 2|Comorbidities|2|||
125100816|NCT01317199|449991003|FG002|Randomized Phase 2|Comorbidities|2|||
125100817|NCT01317199|449991004|FG003|Randomized Phase 2|Comorbidities|2|||
125100818|NCT01317199|449991001|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
125100819|NCT01317199|449991002|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
125100820|NCT01317199|449991003|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
125100821|NCT01317199|449991004|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
125100822|NCT01317199|449991001|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
125100823|NCT01317199|449991002|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
125100824|NCT01317199|449991003|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
125100825|NCT01317199|449991004|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
125100826|NCT01317199|449991001|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
125100827|NCT01317199|449991002|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
125100828|NCT01317199|449991003|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
125100829|NCT01317199|449991004|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
125100830|NCT01317199|449991001|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
125100831|NCT01317199|449991002|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
125100832|NCT01317199|449991003|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
125100833|NCT01317199|449991004|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
125100834|NCT01353209|449991005|FG000|Overall Study|Adverse Event|1|||
125100835|NCT01353209|449991006|FG001|Overall Study|Adverse Event|1|||
125100836|NCT01301625|449991018|FG000|Overall Study|Death|5|||
125100837|NCT01301625|449991018|FG000|Overall Study|Not Due|21|||
125100838|NCT01301625|449991018|FG000|Overall Study|Expected|8|||
125100839|NCT01301625|449991018|FG000|Overall Study|Lost to Follow-up|1|||
125100840|NCT03237325|449991022|FG000|Overall Study|Lost to Follow-up|3|||
124875823|NCT02798211|449168594|FG005|Period 2|Withdrawal by Subject|2|||
124875824|NCT02798211|449168589|FG000|Period 2|Adverse Event|5|||
124875825|NCT02798211|449168590|FG001|Period 2|Adverse Event|0|||
125100841|NCT03237325|449991023|FG001|Overall Study|Lost to Follow-up|5|||
125100842|NCT03237325|449991022|FG000|Overall Study|Physician Decision|2|||
125100843|NCT03237325|449991023|FG001|Overall Study|Physician Decision|4|||
125100844|NCT03237325|449991022|FG000|Overall Study|Withdrawal by Subject|9|||
124875826|NCT02798211|449168591|FG002|Period 2|Adverse Event|0|||
124875827|NCT02798211|449168592|FG003|Period 2|Adverse Event|0|||
124875828|NCT02798211|449168593|FG004|Period 2|Adverse Event|1|||
124875829|NCT02798211|449168594|FG005|Period 2|Adverse Event|0|||
125100845|NCT03237325|449991023|FG001|Overall Study|Withdrawal by Subject|12|||
125100846|NCT03237325|449991022|FG000|Overall Study|Noncompliance with Study Procedures|1|||
125100847|NCT03237325|449991023|FG001|Overall Study|Noncompliance with Study Procedures|1|||
124875830|NCT02798211|449168589|FG000|Period 2|Lack of Efficacy|1|||
124875831|NCT02798211|449168590|FG001|Period 2|Lack of Efficacy|0|||
124875832|NCT02798211|449168591|FG002|Period 2|Lack of Efficacy|0|||
124875833|NCT02798211|449168592|FG003|Period 2|Lack of Efficacy|1|||
124875834|NCT02798211|449168593|FG004|Period 2|Lack of Efficacy|0|||
124875835|NCT02798211|449168594|FG005|Period 2|Lack of Efficacy|1|||
124875836|NCT02798211|449168589|FG000|Period 2|Lost to Follow-up|3|||
124875837|NCT02798211|449168590|FG001|Period 2|Lost to Follow-up|0|||
124875838|NCT02798211|449168591|FG002|Period 2|Lost to Follow-up|0|||
124875839|NCT02798211|449168592|FG003|Period 2|Lost to Follow-up|0|||
124875840|NCT02798211|449168593|FG004|Period 2|Lost to Follow-up|2|||
124875841|NCT02798211|449168594|FG005|Period 2|Lost to Follow-up|0|||
124875842|NCT02798211|449168589|FG000|Period 2|Physician Decision|1|||
124875843|NCT02798211|449168590|FG001|Period 2|Physician Decision|0|||
124875844|NCT02798211|449168591|FG002|Period 2|Physician Decision|0|||
124875845|NCT02798211|449168592|FG003|Period 2|Physician Decision|1|||
124875846|NCT02798211|449168593|FG004|Period 2|Physician Decision|1|||
124875847|NCT02798211|449168594|FG005|Period 2|Physician Decision|0|||
124875848|NCT02798211|449168589|FG000|Period 2|Pregnancy|0|||
124875849|NCT02798211|449168590|FG001|Period 2|Pregnancy|0|||
124875850|NCT02798211|449168591|FG002|Period 2|Pregnancy|0|||
124875851|NCT02798211|449168592|FG003|Period 2|Pregnancy|2|||
124875852|NCT02798211|449168593|FG004|Period 2|Pregnancy|0|||
124875853|NCT02798211|449168594|FG005|Period 2|Pregnancy|0|||
124875854|NCT02798211|449168589|FG000|Period 2|Technical problems|1|||
124875855|NCT02798211|449168590|FG001|Period 2|Technical problems|0|||
124875856|NCT02798211|449168591|FG002|Period 2|Technical problems|0|||
124875857|NCT02798211|449168592|FG003|Period 2|Technical problems|1|||
124875858|NCT02798211|449168593|FG004|Period 2|Technical problems|0|||
124875859|NCT02798211|449168594|FG005|Period 2|Technical problems|0|||
124875860|NCT02798211|449168589|FG000|Period 2|Withdrawal of Informed Consent|1|||
124875861|NCT02798211|449168590|FG001|Period 2|Withdrawal of Informed Consent|0|||
124875862|NCT02798211|449168591|FG002|Period 2|Withdrawal of Informed Consent|0|||
124875863|NCT02798211|449168592|FG003|Period 2|Withdrawal of Informed Consent|2|||
124875864|NCT02798211|449168593|FG004|Period 2|Withdrawal of Informed Consent|2|||
124875865|NCT02798211|449168594|FG005|Period 2|Withdrawal of Informed Consent|3|||
124875866|NCT01982435|449168595|FG000|Overall Study|Adverse Event|1|||
124875867|NCT01982435|449168596|FG001|Overall Study|Adverse Event|0|||
124875868|NCT05292534|449168597|FG000|Overall Study|Protocol Violation|3|||
124875869|NCT05292534|449168598|FG001|Overall Study|Protocol Violation|4|||
124875870|NCT05292534|449168597|FG000|Overall Study|Withdrawal by Subject|0|||
124875871|NCT05292534|449168598|FG001|Overall Study|Withdrawal by Subject|1|||
124875872|NCT04887948|449168599|FG000|Overall Study|Death|1|||
124875873|NCT04887948|449168600|FG001|Overall Study|Death|0|||
124875874|NCT04887948|449168601|FG002|Overall Study|Death|0|||
124875875|NCT04887948|449168599|FG000|Overall Study|Lost to Follow-up|1|||
124875876|NCT04887948|449168600|FG001|Overall Study|Lost to Follow-up|0|||
124875877|NCT04887948|449168601|FG002|Overall Study|Lost to Follow-up|3|||
124875878|NCT04887948|449168599|FG000|Overall Study|Physician Decision|0|||
124875879|NCT04887948|449168600|FG001|Overall Study|Physician Decision|4|||
124875880|NCT04887948|449168601|FG002|Overall Study|Physician Decision|1|||
124875881|NCT04887948|449168599|FG000|Overall Study|Protocol Violation|1|||
124875882|NCT04887948|449168600|FG001|Overall Study|Protocol Violation|1|||
124875883|NCT04887948|449168601|FG002|Overall Study|Protocol Violation|0|||
124875884|NCT04887948|449168599|FG000|Overall Study|Withdrawal by Subject|0|||
124875885|NCT04887948|449168600|FG001|Overall Study|Withdrawal by Subject|6|||
124875886|NCT04887948|449168601|FG002|Overall Study|Withdrawal by Subject|1|||
124875887|NCT04887948|449168599|FG000|Overall Study|No longer met eligibility criteria|1|||
124875888|NCT04887948|449168600|FG001|Overall Study|No longer met eligibility criteria|2|||
124875889|NCT04887948|449168601|FG002|Overall Study|No longer met eligibility criteria|1|||
124875890|NCT04887948|449168599|FG000|Overall Study|Other|2|||
124875891|NCT04887948|449168600|FG001|Overall Study|Other|1|||
124875892|NCT04887948|449168601|FG002|Overall Study|Other|1|||
124875893|NCT03086018|449168603|FG000|Final Testing for End of Trial|Adverse Event|1|||
124875894|NCT03086018|449168603|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
124875895|NCT01782872|449168604|FG000|Overall Study|Protocol Violation|0|||
124875896|NCT01782872|449168605|FG001|Overall Study|Protocol Violation|0|||
124875897|NCT01782872|449168606|FG002|Overall Study|Protocol Violation|0|||
124875898|NCT01782872|449168607|FG003|Overall Study|Protocol Violation|1|||
124875899|NCT01782872|449168604|FG000|Overall Study|Withdrawal by Subject|0|||
124875900|NCT01782872|449168605|FG001|Overall Study|Withdrawal by Subject|1|||
124875901|NCT01782872|449168606|FG002|Overall Study|Withdrawal by Subject|0|||
124875902|NCT01782872|449168607|FG003|Overall Study|Withdrawal by Subject|0|||
124875903|NCT01892345|449168608|FG000|Overall Study|Adverse Event|0|||
124875904|NCT01892345|449168609|FG001|Overall Study|Adverse Event|2|||
124875905|NCT01892345|449168608|FG000|Overall Study|Death|1|||
125012417|NCT01251367|449671831|FG000|Overall Study|End of Study Visit Performed in Error|1|||
125012418|NCT02255409|449671832|FG000|Overall Study|Administrative Reason|3|||
124875906|NCT01892345|449168609|FG001|Overall Study|Death|0|||
124875907|NCT01892345|449168608|FG000|Overall Study|Lost to Follow-up|3|||
124875908|NCT01892345|449168609|FG001|Overall Study|Lost to Follow-up|0|||
124875909|NCT01892345|449168608|FG000|Overall Study|Withdrawal by Subject|12|||
124875910|NCT01892345|449168609|FG001|Overall Study|Withdrawal by Subject|1|||
124875911|NCT00638235|449168610|FG000|Overall Study|Lost to Follow-up|31|||
124875912|NCT00638235|449168611|FG001|Overall Study|Lost to Follow-up|3|||
124875913|NCT00638235|449168612|FG002|Overall Study|Lost to Follow-up|18|||
124875914|NCT00638235|449168613|FG003|Overall Study|Lost to Follow-up|10|||
124875915|NCT00638235|449168614|FG004|Overall Study|Lost to Follow-up|13|||
124875916|NCT00638235|449168615|FG005|Overall Study|Lost to Follow-up|26|||
124875917|NCT00638235|449168616|FG006|Overall Study|Lost to Follow-up|0|||
124875918|NCT00638235|449168617|FG007|Overall Study|Lost to Follow-up|1|||
124875919|NCT00638235|449168618|FG008|Overall Study|Lost to Follow-up|18|||
124875920|NCT02748694|449168619|FG000|Overall Study|Voluntary Withdrawal|0|||
124875921|NCT02748694|449168620|FG001|Overall Study|Voluntary Withdrawal|0|||
124875922|NCT02748694|449168621|FG002|Overall Study|Voluntary Withdrawal|0|||
124875923|NCT02748694|449168622|FG003|Overall Study|Voluntary Withdrawal|0|||
124875924|NCT02748694|449168623|FG004|Overall Study|Voluntary Withdrawal|0|||
124875925|NCT02748694|449168624|FG005|Overall Study|Voluntary Withdrawal|0|||
124875926|NCT02748694|449168625|FG006|Overall Study|Voluntary Withdrawal|0|||
124875927|NCT02748694|449168626|FG007|Overall Study|Voluntary Withdrawal|0|||
124875928|NCT02748694|449168627|FG008|Overall Study|Voluntary Withdrawal|0|||
124875929|NCT02748694|449168628|FG009|Overall Study|Voluntary Withdrawal|0|||
124875930|NCT02748694|449168629|FG010|Overall Study|Voluntary Withdrawal|0|||
124875931|NCT02748694|449168630|FG011|Overall Study|Voluntary Withdrawal|0|||
124875932|NCT02748694|449168631|FG012|Overall Study|Voluntary Withdrawal|0|||
124875933|NCT02748694|449168632|FG013|Overall Study|Voluntary Withdrawal|0|||
124875934|NCT02748694|449168633|FG014|Overall Study|Voluntary Withdrawal|2|||
124875935|NCT01473381|449168634|FG000|Overall Study|Adverse Event|8|||
124875936|NCT01473381|449168635|FG001|Overall Study|Adverse Event|20|||
124875937|NCT01473381|449168636|FG002|Overall Study|Adverse Event|25|||
124875938|NCT01473381|449168637|FG003|Overall Study|Adverse Event|17|||
124875939|NCT01473381|449168634|FG000|Overall Study|Insufficient Therapeutic Response|10|||
124875940|NCT01473381|449168635|FG001|Overall Study|Insufficient Therapeutic Response|1|||
124875941|NCT01473381|449168636|FG002|Overall Study|Insufficient Therapeutic Response|2|||
124875942|NCT01473381|449168637|FG003|Overall Study|Insufficient Therapeutic Response|3|||
124875943|NCT01473381|449168634|FG000|Overall Study|Protocol Violation|17|||
124875944|NCT01473381|449168635|FG001|Overall Study|Protocol Violation|23|||
124875945|NCT01473381|449168636|FG002|Overall Study|Protocol Violation|19|||
124875946|NCT01473381|449168637|FG003|Overall Study|Protocol Violation|17|||
124875947|NCT01473381|449168634|FG000|Overall Study|Withdrawal of Consent|20|||
124875948|NCT01473381|449168635|FG001|Overall Study|Withdrawal of Consent|21|||
124875949|NCT01473381|449168636|FG002|Overall Study|Withdrawal of Consent|20|||
124875950|NCT01473381|449168637|FG003|Overall Study|Withdrawal of Consent|26|||
124875951|NCT01473381|449168634|FG000|Overall Study|Lost to Follow-up|25|||
124875952|NCT01473381|449168635|FG001|Overall Study|Lost to Follow-up|28|||
124875953|NCT01473381|449168636|FG002|Overall Study|Lost to Follow-up|35|||
124875954|NCT01473381|449168637|FG003|Overall Study|Lost to Follow-up|23|||
124875955|NCT01473381|449168634|FG000|Overall Study|Other Reasons|0|||
124875956|NCT01473381|449168635|FG001|Overall Study|Other Reasons|0|||
124875957|NCT01473381|449168636|FG002|Overall Study|Other Reasons|1|||
124875958|NCT01473381|449168637|FG003|Overall Study|Other Reasons|3|||
124875959|NCT02487810|449168641|FG000|Overall Study|Withdrawal by Subject|1|||
124875960|NCT02487810|449168642|FG001|Overall Study|Withdrawal by Subject|0|||
124875961|NCT01889186|449168643|FG000|Overall Study|Adverse event- not related to progression|18|||
124875962|NCT01889186|449168644|FG001|Overall Study|Adverse event- not related to progression|5|||
124875963|NCT01889186|449168643|FG000|Overall Study|Adverse event- related to progression|7|||
124875964|NCT01889186|449168644|FG001|Overall Study|Adverse event- related to progression|2|||
124875965|NCT01889186|449168643|FG000|Overall Study|COVID-19 logistical restrictions|1|||
125100848|NCT03237325|449991022|FG000|Overall Study|Termination by Sponsor|0|||
125100849|NCT03237325|449991023|FG001|Overall Study|Termination by Sponsor|1|||
125100850|NCT03237325|449991022|FG000|Overall Study|Reason other than described|0|||
125100851|NCT03237325|449991023|FG001|Overall Study|Reason other than described|2|||
125100852|NCT02684370|449991024|FG000|Part A|Adverse Event|2|||
125100853|NCT02684370|449991025|FG001|Part A|Adverse Event|0|||
125100854|NCT02684370|449991026|FG002|Part A|Adverse Event|1|||
125100855|NCT02684370|449991027|FG003|Part A|Adverse Event|0|||
124875966|NCT01889186|449168644|FG001|Overall Study|COVID-19 logistical restrictions|0|||
124875967|NCT01889186|449168643|FG000|Overall Study|Investigator request|1|||
124875968|NCT01889186|449168644|FG001|Overall Study|Investigator request|1|||
124875969|NCT01889186|449168643|FG000|Overall Study|Progressive disease- Richter's|12|||
124875970|NCT01889186|449168644|FG001|Overall Study|Progressive disease- Richter's|7|||
125100856|NCT02684370|449991028|FG004|Part A|Adverse Event|0|||
124875971|NCT01889186|449168643|FG000|Overall Study|Progressive disease per protocol|46|||
124875972|NCT01889186|449168644|FG001|Overall Study|Progressive disease per protocol|17|||
124875973|NCT01889186|449168643|FG000|Overall Study|Stem cell transplant|2|||
124875974|NCT01889186|449168644|FG001|Overall Study|Stem cell transplant|1|||
125100857|NCT02684370|449991029|FG005|Part A|Adverse Event|0|||
124875975|NCT01889186|449168643|FG000|Overall Study|Withdrew consent|2|||
124875976|NCT01889186|449168644|FG001|Overall Study|Withdrew consent|3|||
124875977|NCT01889186|449168643|FG000|Overall Study|Other, not specified|18|||
124875978|NCT01889186|449168644|FG001|Overall Study|Other, not specified|15|||
124875979|NCT02569437|449168649|FG000|Overall Study|Lost to Follow-up|12|||
124875980|NCT02569437|449168650|FG001|Overall Study|Lost to Follow-up|14|||
124875981|NCT00441701|449168651|FG000|Overall Study|Adverse Event|3|||
124875982|NCT00441701|449168652|FG001|Overall Study|Adverse Event|2|||
124875983|NCT00441701|449168653|FG002|Overall Study|Adverse Event|1|||
124875984|NCT00441701|449168654|FG003|Overall Study|Adverse Event|0|||
124875985|NCT00441701|449168655|FG004|Overall Study|Adverse Event|2|||
124875986|NCT00441701|449168656|FG005|Overall Study|Adverse Event|2|||
124875987|NCT00441701|449168657|FG006|Overall Study|Adverse Event|0|||
125100858|NCT02684370|449991024|FG000|Part A|Lost to Follow-up|1|||
125100859|NCT02684370|449991025|FG001|Part A|Lost to Follow-up|1|||
125100860|NCT02684370|449991026|FG002|Part A|Lost to Follow-up|0|||
125100861|NCT02684370|449991027|FG003|Part A|Lost to Follow-up|0|||
125100862|NCT02684370|449991028|FG004|Part A|Lost to Follow-up|0|||
125100863|NCT02684370|449991029|FG005|Part A|Lost to Follow-up|0|||
125100864|NCT02684370|449991024|FG000|Part A|Subject Withdrawal|1|||
125100865|NCT02684370|449991025|FG001|Part A|Subject Withdrawal|0|||
125100866|NCT02684370|449991026|FG002|Part A|Subject Withdrawal|3|||
125100867|NCT02684370|449991027|FG003|Part A|Subject Withdrawal|0|||
125100868|NCT02684370|449991028|FG004|Part A|Subject Withdrawal|0|||
125100869|NCT02684370|449991029|FG005|Part A|Subject Withdrawal|0|||
125100870|NCT02684370|449991024|FG000|Part A|Other|0|||
125100871|NCT02684370|449991025|FG001|Part A|Other|0|||
125100872|NCT02684370|449991026|FG002|Part A|Other|1|||
125100873|NCT02684370|449991027|FG003|Part A|Other|0|||
125100874|NCT02684370|449991028|FG004|Part A|Other|0|||
125100875|NCT02684370|449991029|FG005|Part A|Other|0|||
125100876|NCT02684370|449991024|FG000|Part B|Adverse Event|0|||
125100877|NCT02684370|449991025|FG001|Part B|Adverse Event|0|||
125100878|NCT02684370|449991026|FG002|Part B|Adverse Event|0|||
124875988|NCT00441701|449168658|FG007|Overall Study|Adverse Event|0|||
124875989|NCT00441701|449168659|FG008|Overall Study|Adverse Event|0|||
124875990|NCT00441701|449168660|FG009|Overall Study|Adverse Event|0|||
124875991|NCT00441701|449168651|FG000|Overall Study|Lack of Efficacy|2|||
125100879|NCT02684370|449991027|FG003|Part B|Adverse Event|0|||
125100880|NCT02684370|449991028|FG004|Part B|Adverse Event|2|||
124875992|NCT00441701|449168652|FG001|Overall Study|Lack of Efficacy|0|||
124875993|NCT00441701|449168653|FG002|Overall Study|Lack of Efficacy|2|||
124875994|NCT00441701|449168654|FG003|Overall Study|Lack of Efficacy|2|||
125100881|NCT02684370|449991029|FG005|Part B|Adverse Event|1|||
125100882|NCT02684370|449991024|FG000|Part B|Lost to Follow-up|0|||
125100883|NCT02684370|449991025|FG001|Part B|Lost to Follow-up|0|||
124875995|NCT00441701|449168655|FG004|Overall Study|Lack of Efficacy|0|||
124875996|NCT00441701|449168656|FG005|Overall Study|Lack of Efficacy|1|||
124875997|NCT00441701|449168657|FG006|Overall Study|Lack of Efficacy|0|||
124875998|NCT00441701|449168658|FG007|Overall Study|Lack of Efficacy|0|||
124875999|NCT00441701|449168659|FG008|Overall Study|Lack of Efficacy|0|||
124876000|NCT00441701|449168660|FG009|Overall Study|Lack of Efficacy|0|||
124876001|NCT00441701|449168651|FG000|Overall Study|Withdrawal by Subject|0|||
124876002|NCT00441701|449168652|FG001|Overall Study|Withdrawal by Subject|2|||
124876003|NCT00441701|449168653|FG002|Overall Study|Withdrawal by Subject|1|||
124876004|NCT00441701|449168654|FG003|Overall Study|Withdrawal by Subject|1|||
124876005|NCT00441701|449168655|FG004|Overall Study|Withdrawal by Subject|0|||
124876006|NCT00441701|449168656|FG005|Overall Study|Withdrawal by Subject|0|||
124876007|NCT00441701|449168657|FG006|Overall Study|Withdrawal by Subject|0|||
124876008|NCT00441701|449168658|FG007|Overall Study|Withdrawal by Subject|0|||
124876009|NCT00441701|449168659|FG008|Overall Study|Withdrawal by Subject|0|||
124876010|NCT00441701|449168660|FG009|Overall Study|Withdrawal by Subject|0|||
124876011|NCT00077064|449168661|FG000|Overall Study|Adverse Event|0|||
124876012|NCT00077064|449168662|FG001|Overall Study|Adverse Event|4|||
124876013|NCT00077064|449168661|FG000|Overall Study|Patient refusal|0|||
124876014|NCT00077064|449168662|FG001|Overall Study|Patient refusal|2|||
124876015|NCT04710927|449168666|FG000|Overall Study|Lost to Follow-up|7|||
124876016|NCT04710927|449168667|FG001|Overall Study|Lost to Follow-up|6|||
124876017|NCT04710927|449168668|FG002|Overall Study|Lost to Follow-up|5|||
124876018|NCT02007434|449168671|FG000|Overall Study|Lost to Follow-up|0|||
124876019|NCT02007434|449168672|FG001|Overall Study|Lost to Follow-up|1|||
124876020|NCT02007434|449168673|FG002|Overall Study|Lost to Follow-up|0|||
124876021|NCT02007434|449168674|FG003|Overall Study|Lost to Follow-up|0|||
124876022|NCT02007434|449168675|FG004|Overall Study|Lost to Follow-up|0|||
124876023|NCT02007434|449168676|FG005|Overall Study|Lost to Follow-up|0|||
124876024|NCT02007434|449168677|FG006|Overall Study|Lost to Follow-up|0|||
124876025|NCT02007434|449168678|FG007|Overall Study|Lost to Follow-up|0|||
124876026|NCT02007434|449168671|FG000|Overall Study|Non-compliance|1|||
124876027|NCT02007434|449168672|FG001|Overall Study|Non-compliance|0|||
124876028|NCT02007434|449168673|FG002|Overall Study|Non-compliance|1|||
124876029|NCT02007434|449168674|FG003|Overall Study|Non-compliance|0|||
124876030|NCT02007434|449168675|FG004|Overall Study|Non-compliance|0|||
124876031|NCT02007434|449168676|FG005|Overall Study|Non-compliance|0|||
124876032|NCT02007434|449168677|FG006|Overall Study|Non-compliance|0|||
124876033|NCT02007434|449168678|FG007|Overall Study|Non-compliance|0|||
124876034|NCT01287611|449168679|FG000|Overall Study|Lost to Follow-up|29|||
124876035|NCT01287611|449168680|FG001|Overall Study|Lost to Follow-up|16|||
124876036|NCT01287611|449168679|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
124876037|NCT01287611|449168680|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
125100884|NCT02684370|449991026|FG002|Part B|Lost to Follow-up|0|||
125100885|NCT02684370|449991027|FG003|Part B|Lost to Follow-up|1|||
125100886|NCT02684370|449991028|FG004|Part B|Lost to Follow-up|2|||
125100887|NCT02684370|449991029|FG005|Part B|Lost to Follow-up|5|||
125100888|NCT02684370|449991024|FG000|Part B|Subject Withdrawal|0|||
125100889|NCT02684370|449991025|FG001|Part B|Subject Withdrawal|0|||
125100890|NCT02684370|449991026|FG002|Part B|Subject Withdrawal|0|||
125100891|NCT02684370|449991027|FG003|Part B|Subject Withdrawal|1|||
125100892|NCT02684370|449991028|FG004|Part B|Subject Withdrawal|1|||
125100893|NCT02684370|449991029|FG005|Part B|Subject Withdrawal|2|||
125100894|NCT04221373|449991030|FG000|Overall Study|Physician Decision|4|||
125100895|NCT04221373|449991031|FG001|Overall Study|Physician Decision|0|||
125100896|NCT00183170|449991037|FG000|First Intervention|Did not complete study|1|||
125100897|NCT00183170|449991038|FG001|First Intervention|Did not complete study|0|||
125100898|NCT00183170|449991037|FG000|First Intervention|Did not meet targeted BrAC|1|||
124876038|NCT02192970|449168683|FG000|Overall Study|Lost to Follow-up|6|||
124876039|NCT02192970|449168684|FG001|Overall Study|Lost to Follow-up|0|||
124876040|NCT03299686|449168697|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
124876041|NCT03299686|449168698|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
124876042|NCT03299686|449168697|FG000|Treatment Epoch|Physician Decision|1|||
124876043|NCT03299686|449168698|FG001|Treatment Epoch|Physician Decision|0|||
124876044|NCT03299686|449168697|FG000|Treatment Epoch|Adverse Event|8|||
125100899|NCT00183170|449991038|FG001|First Intervention|Did not meet targeted BrAC|0|||
125100900|NCT00183170|449991037|FG000|Washout 1 Week|Did not complete study|6|||
124876045|NCT03299686|449168698|FG001|Treatment Epoch|Adverse Event|4|||
124876046|NCT03299686|449168697|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
124876047|NCT03299686|449168698|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
125100901|NCT00183170|449991038|FG001|Washout 1 Week|Did not complete study|8|||
125100902|NCT00183170|449991037|FG000|Second Intervention|Did not complete study|1|||
124876048|NCT03745222|449168699|FG000|Overall Study|Withdrawal by Subject|0|||
124876049|NCT03745222|449168700|FG001|Overall Study|Withdrawal by Subject|1|||
124876050|NCT03745222|449168701|FG002|Overall Study|Withdrawal by Subject|0|||
124876051|NCT01959347|449168702|FG000|Overall Study|Protocol Violation|9|||
124876052|NCT01959347|449168703|FG001|Overall Study|Protocol Violation|7|||
124876053|NCT03954743|449168704|FG000|Overall Study|Adverse Event|1|||
125100903|NCT00183170|449991038|FG001|Second Intervention|Did not complete study|0|||
124876054|NCT03954743|449168705|FG001|Overall Study|Adverse Event|0|||
124876055|NCT03954743|449168704|FG000|Overall Study|Lost to Follow-up|6|||
124876056|NCT03954743|449168705|FG001|Overall Study|Lost to Follow-up|4|||
124876057|NCT03954743|449168704|FG000|Overall Study|Protocol Violation|1|||
124876058|NCT03954743|449168705|FG001|Overall Study|Protocol Violation|0|||
124876059|NCT03954743|449168704|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
124876060|NCT03954743|449168705|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
124876061|NCT03954743|449168704|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
124876062|NCT03954743|449168705|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
124876063|NCT00860067|449168708|FG000|Overall Study|Lost to Follow-up|46|||
124876064|NCT00860067|449168709|FG001|Overall Study|Lost to Follow-up|9|||
124876065|NCT00860067|449168710|FG002|Overall Study|Lost to Follow-up|9|||
124876066|NCT00860067|449168708|FG000|Overall Study|Withdrawal by Subject|4|||
124876067|NCT00860067|449168709|FG001|Overall Study|Withdrawal by Subject|0|||
124876068|NCT00860067|449168710|FG002|Overall Study|Withdrawal by Subject|0|||
124876069|NCT00860067|449168708|FG000|Overall Study|Pregnancy|1|||
124876070|NCT00860067|449168709|FG001|Overall Study|Pregnancy|0|||
124876071|NCT00860067|449168710|FG002|Overall Study|Pregnancy|0|||
124876072|NCT01282801|449168711|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
124876073|NCT01282801|449168712|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
124876074|NCT02387996|449168715|FG000|Overall Study|Disease Progression|167|||
124876075|NCT02387996|449168715|FG000|Overall Study|Study Drug Toxicity|31|||
124876076|NCT02387996|449168715|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
124876077|NCT02387996|449168715|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
124876078|NCT02387996|449168715|FG000|Overall Study|Subject Withdrew Consent|5|||
124876079|NCT02387996|449168715|FG000|Overall Study|Lost to Follow-up|1|||
124876080|NCT02387996|449168715|FG000|Overall Study|Poor/Non-Compliance|1|||
124876081|NCT02387996|449168715|FG000|Overall Study|Other Reasons|5|||
124876082|NCT02387996|449168715|FG000|Overall Study|Death|1|||
124876083|NCT01060553|449168716|FG000|Overall Study|Lost to Follow-up|3|||
124876084|NCT01060553|449168717|FG001|Overall Study|Lost to Follow-up|5|||
124876085|NCT01060553|449168716|FG000|Overall Study|Withdrawal by Subject|5|||
124876086|NCT01060553|449168717|FG001|Overall Study|Withdrawal by Subject|5|||
124876087|NCT01060553|449168716|FG000|Overall Study|Lack of Efficacy|1|||
124876088|NCT01060553|449168717|FG001|Overall Study|Lack of Efficacy|0|||
124876089|NCT04707196|449168720|FG000|Overall Study|Withdrawal by Subject|9|||
124876090|NCT04707196|449168721|FG001|Overall Study|Withdrawal by Subject|6|||
124876091|NCT04707196|449168720|FG000|Overall Study|Lost to Follow-up|1|||
124876092|NCT04707196|449168721|FG001|Overall Study|Lost to Follow-up|0|||
124876093|NCT04707196|449168720|FG000|Overall Study|Protocol Violation|4|||
124876094|NCT04707196|449168721|FG001|Overall Study|Protocol Violation|1|||
124876095|NCT04707196|449168720|FG000|Overall Study|Adverse Event|2|||
124876096|NCT04707196|449168721|FG001|Overall Study|Adverse Event|2|||
124876097|NCT04707196|449168720|FG000|Overall Study|Death|3|||
124876098|NCT04707196|449168721|FG001|Overall Study|Death|1|||
124876099|NCT04707196|449168720|FG000|Overall Study|Non-compliance with study drug|1|||
124876100|NCT04707196|449168721|FG001|Overall Study|Non-compliance with study drug|0|||
124876101|NCT04707196|449168720|FG000|Overall Study|Progressive disease|9|||
124876102|NCT04707196|449168721|FG001|Overall Study|Progressive disease|10|||
124876103|NCT01862796|449168722|FG000|Overall Study|Prohibited medications|0|||
124876104|NCT01862796|449168723|FG001|Overall Study|Prohibited medications|0|||
124876105|NCT01862796|449168724|FG002|Overall Study|Prohibited medications|1|||
124876106|NCT05375955|449168742|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
124876107|NCT05375955|449168743|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
124876108|NCT05375955|449168744|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
124876109|NCT05375955|449168745|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
124876110|NCT05375955|449168746|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
124876111|NCT05375955|449168747|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
124876112|NCT05375955|449168748|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
124876113|NCT05375955|449168742|FG000|Treatment (12 Weeks)|Physician Decision|4|||
124876114|NCT05375955|449168743|FG001|Treatment (12 Weeks)|Physician Decision|1|||
124876115|NCT05375955|449168744|FG002|Treatment (12 Weeks)|Physician Decision|3|||
124876116|NCT05375955|449168745|FG003|Treatment (12 Weeks)|Physician Decision|0|||
124876117|NCT05375955|449168746|FG004|Treatment (12 Weeks)|Physician Decision|0|||
124876118|NCT05375955|449168747|FG005|Treatment (12 Weeks)|Physician Decision|1|||
124876119|NCT05375955|449168748|FG006|Treatment (12 Weeks)|Physician Decision|0|||
124876120|NCT05375955|449168742|FG000|Treatment (12 Weeks)|Other|0|||
124876121|NCT05375955|449168743|FG001|Treatment (12 Weeks)|Other|1|||
124876122|NCT05375955|449168744|FG002|Treatment (12 Weeks)|Other|0|||
124876123|NCT05375955|449168745|FG003|Treatment (12 Weeks)|Other|0|||
124876124|NCT05375955|449168746|FG004|Treatment (12 Weeks)|Other|0|||
124876125|NCT05375955|449168747|FG005|Treatment (12 Weeks)|Other|0|||
124876126|NCT05375955|449168748|FG006|Treatment (12 Weeks)|Other|0|||
124876127|NCT05375955|449168742|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
124876128|NCT05375955|449168743|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
124876129|NCT05375955|449168744|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
124876130|NCT05375955|449168745|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
124876131|NCT05375955|449168746|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
124876132|NCT05375955|449168747|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
124876133|NCT05375955|449168748|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
124876134|NCT05375955|449168742|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
124876135|NCT05375955|449168743|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
124876136|NCT05375955|449168744|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
124876137|NCT05375955|449168745|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
124876138|NCT05375955|449168746|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
124876139|NCT05375955|449168747|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
124876140|NCT05375955|449168748|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
124876141|NCT05375955|449168742|FG000|Treatment (12 Weeks)|Pregnancy|0|||
124876142|NCT05375955|449168743|FG001|Treatment (12 Weeks)|Pregnancy|0|||
124876143|NCT05375955|449168744|FG002|Treatment (12 Weeks)|Pregnancy|1|||
124876144|NCT05375955|449168745|FG003|Treatment (12 Weeks)|Pregnancy|0|||
124876145|NCT05375955|449168746|FG004|Treatment (12 Weeks)|Pregnancy|0|||
124876146|NCT05375955|449168747|FG005|Treatment (12 Weeks)|Pregnancy|0|||
124876147|NCT05375955|449168748|FG006|Treatment (12 Weeks)|Pregnancy|0|||
124876148|NCT05375955|449168742|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
124876149|NCT05375955|449168743|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
124876150|NCT05375955|449168744|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
124876151|NCT05375955|449168745|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
124876152|NCT05375955|449168746|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
124876153|NCT05375955|449168747|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
124876154|NCT05375955|449168748|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
124876155|NCT05375955|449168742|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
124876156|NCT05375955|449168743|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
124876157|NCT05375955|449168744|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
124876158|NCT05375955|449168745|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
124876159|NCT05375955|449168746|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
124876160|NCT05375955|449168747|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
124876161|NCT05375955|449168748|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
124876162|NCT05375955|449168742|FG000|Follow-up (up to 5 Weeks)|Other|0|||
124876163|NCT05375955|449168743|FG001|Follow-up (up to 5 Weeks)|Other|1|||
124876164|NCT05375955|449168744|FG002|Follow-up (up to 5 Weeks)|Other|0|||
124876165|NCT05375955|449168745|FG003|Follow-up (up to 5 Weeks)|Other|0|||
124876166|NCT05375955|449168746|FG004|Follow-up (up to 5 Weeks)|Other|0|||
124876167|NCT05375955|449168747|FG005|Follow-up (up to 5 Weeks)|Other|0|||
124876168|NCT05375955|449168748|FG006|Follow-up (up to 5 Weeks)|Other|0|||
124876169|NCT05375955|449168742|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
124876170|NCT05375955|449168743|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
124876171|NCT05375955|449168744|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
124876172|NCT05375955|449168745|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
124876173|NCT05375955|449168746|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
124876174|NCT05375955|449168747|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
124876175|NCT05375955|449168748|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
124876176|NCT05375955|449168742|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
124876177|NCT05375955|449168743|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
124876178|NCT05375955|449168744|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
124876179|NCT05375955|449168745|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
125100904|NCT00183170|449991037|FG000|Second Intervention|Did not meet targeted BrAC|0|||
124876180|NCT05375955|449168746|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
124876181|NCT05375955|449168747|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
124876182|NCT05375955|449168748|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
124876183|NCT01320943|449168749|FG000|Overall Study|Lost to Follow-up|1|||
124876184|NCT01320943|449168750|FG001|Overall Study|Lost to Follow-up|0|||
124876185|NCT01320943|449168749|FG000|Overall Study|Physician Decision|0|||
124876186|NCT01320943|449168750|FG001|Overall Study|Physician Decision|1|||
124876187|NCT01320943|449168749|FG000|Overall Study|Randomized but not Treated|0|||
124876188|NCT01320943|449168750|FG001|Overall Study|Randomized but not Treated|1|||
124876189|NCT00733980|449168751|FG000|Overall Study|Adverse Event|5|||
124876190|NCT00733980|449168752|FG001|Overall Study|Adverse Event|2|||
125012419|NCT02255409|449671833|FG001|Overall Study|Administrative Reason|7|||
125012420|NCT02255409|449671832|FG000|Overall Study|Withdrawal by Subject|1|||
125012421|NCT02255409|449671833|FG001|Overall Study|Withdrawal by Subject|5|||
125012422|NCT02255409|449671832|FG000|Overall Study|Lost to Follow-up|10|||
125012423|NCT02255409|449671833|FG001|Overall Study|Lost to Follow-up|19|||
125012424|NCT02016820|449671836|FG000|Overall Study|Lost to Follow-up|2|||
125012425|NCT02016820|449671837|FG001|Overall Study|Lost to Follow-up|4|||
125012426|NCT02424253|449671838|FG000|Overall Study|Other, unspecified|1|||
125012427|NCT02424253|449671839|FG001|Overall Study|Other, unspecified|0|||
125012428|NCT02424253|449671838|FG000|Overall Study|Compliance problems|1|||
125012429|NCT02424253|449671839|FG001|Overall Study|Compliance problems|0|||
125100905|NCT00183170|449991038|FG001|Second Intervention|Did not meet targeted BrAC|2|||
125100906|NCT04983589|449991039|FG000|Overall Study|Withdrawal by Subject|0|||
125100907|NCT04983589|449991040|FG001|Overall Study|Withdrawal by Subject|3|||
125100908|NCT04983589|449991039|FG000|Overall Study|COVID-19 Infection|1|||
125100909|NCT04983589|449991040|FG001|Overall Study|COVID-19 Infection|0|||
125100910|NCT04983589|449991039|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
125100911|NCT04983589|449991040|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
125100912|NCT00924820|449991041|FG000|Overall Study|Death|2|||
125100913|NCT00924820|449991041|FG000|Overall Study|Ineligible, Screen Failure|5|||
125100914|NCT00761969|449991042|FG000|Overall Study|Death|112|||
125100915|NCT00761969|449991043|FG001|Overall Study|Death|47|||
125100916|NCT00761969|449991042|FG000|Overall Study|Lost to Follow-up|88|||
125100917|NCT00761969|449991043|FG001|Overall Study|Lost to Follow-up|93|||
125100918|NCT00978120|449991044|FG000|Overall Study|Death|0|||
125100919|NCT00978120|449991045|FG001|Overall Study|Death|0|||
124876191|NCT00733980|449168751|FG000|Overall Study|Lack of Efficacy|0|||
124876192|NCT00733980|449168752|FG001|Overall Study|Lack of Efficacy|1|||
125100920|NCT00978120|449991046|FG002|Overall Study|Death|0|||
125100921|NCT00978120|449991047|FG003|Overall Study|Death|1|||
125100922|NCT00978120|449991044|FG000|Overall Study|Lost to Follow-up|0|||
125100923|NCT00978120|449991045|FG001|Overall Study|Lost to Follow-up|0|||
125100924|NCT00978120|449991046|FG002|Overall Study|Lost to Follow-up|3|||
125100925|NCT00978120|449991047|FG003|Overall Study|Lost to Follow-up|0|||
125100926|NCT00978120|449991044|FG000|Overall Study|Withdrawal by Subject|2|||
125100927|NCT00978120|449991045|FG001|Overall Study|Withdrawal by Subject|0|||
125100928|NCT00978120|449991046|FG002|Overall Study|Withdrawal by Subject|0|||
125100929|NCT00978120|449991047|FG003|Overall Study|Withdrawal by Subject|0|||
125100930|NCT00978120|449991044|FG000|Overall Study|Moved out of state|0|||
125100931|NCT00978120|449991045|FG001|Overall Study|Moved out of state|0|||
125100932|NCT00978120|449991046|FG002|Overall Study|Moved out of state|0|||
125100933|NCT00978120|449991047|FG003|Overall Study|Moved out of state|1|||
125100934|NCT01068418|449991050|FG000|Overall Study|Physician Decision|12|||
125100935|NCT02181673|449991057|FG000|Up to Week 24|Adverse Event|2|||
124876193|NCT00733980|449168751|FG000|Overall Study|Protocol Violation|2|||
124876194|NCT00733980|449168752|FG001|Overall Study|Protocol Violation|1|||
124876195|NCT00733980|449168751|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
124876196|NCT00733980|449168752|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
124876197|NCT00733980|449168751|FG000|Overall Study|Lost to Follow-up|6|||
124876198|NCT00733980|449168752|FG001|Overall Study|Lost to Follow-up|11|||
124876199|NCT00733980|449168751|FG000|Overall Study|Physician Decision|2|||
124876200|NCT00733980|449168752|FG001|Overall Study|Physician Decision|3|||
124876201|NCT00733980|449168751|FG000|Overall Study|Withdrawal by Subject|6|||
124876202|NCT00733980|449168752|FG001|Overall Study|Withdrawal by Subject|2|||
124876203|NCT00779779|449168753|FG000|Overall Study|Adverse Event|1|||
124876204|NCT00779779|449168753|FG000|Overall Study|Protocol Violation|14|||
124876205|NCT00779779|449168753|FG000|Overall Study|Withdrawal by Subject|4|||
124876206|NCT00779779|449168753|FG000|Overall Study|Lost to Follow-up|5|||
124876207|NCT00404495|449168754|FG000|Overall Study|Death|37|||
124876208|NCT00404495|449168755|FG001|Overall Study|Death|11|||
124876209|NCT00404495|449168754|FG000|Overall Study|Lost to Follow-up|5|||
124876210|NCT00404495|449168755|FG001|Overall Study|Lost to Follow-up|0|||
125012430|NCT02424253|449671838|FG000|Overall Study|Physician Decision|2|||
125012431|NCT02424253|449671839|FG001|Overall Study|Physician Decision|0|||
124876211|NCT00404495|449168754|FG000|Overall Study|Other|1|||
125100936|NCT02181673|449991058|FG001|Up to Week 24|Adverse Event|0|||
125100937|NCT02181673|449991059|FG002|Up to Week 24|Adverse Event|3|||
125100938|NCT02181673|449991057|FG000|Up to Week 24|Death|1|||
125100939|NCT02181673|449991058|FG001|Up to Week 24|Death|0|||
125100940|NCT02181673|449991059|FG002|Up to Week 24|Death|0|||
125100941|NCT02181673|449991057|FG000|Up to Week 24|Lack of Efficacy|1|||
125100942|NCT02181673|449991058|FG001|Up to Week 24|Lack of Efficacy|0|||
125100943|NCT02181673|449991059|FG002|Up to Week 24|Lack of Efficacy|0|||
125100944|NCT02181673|449991057|FG000|Up to Week 24|Lost to Follow-up|1|||
125100945|NCT02181673|449991058|FG001|Up to Week 24|Lost to Follow-up|0|||
125100946|NCT02181673|449991059|FG002|Up to Week 24|Lost to Follow-up|0|||
125100947|NCT02181673|449991057|FG000|Up to Week 24|Physician Decision|0|||
125100948|NCT02181673|449991058|FG001|Up to Week 24|Physician Decision|0|||
125100949|NCT02181673|449991059|FG002|Up to Week 24|Physician Decision|3|||
125100950|NCT02181673|449991057|FG000|Up to Week 24|Withdrawal by Subject|10|||
125100951|NCT02181673|449991058|FG001|Up to Week 24|Withdrawal by Subject|0|||
125100952|NCT02181673|449991059|FG002|Up to Week 24|Withdrawal by Subject|1|||
125100953|NCT02181673|449991057|FG000|Up to Week 24|Other|2|||
125100954|NCT02181673|449991058|FG001|Up to Week 24|Other|0|||
125100955|NCT02181673|449991059|FG002|Up to Week 24|Other|3|||
125100956|NCT02181673|449991057|FG000|Up to Week 24|Randomized not Treated|0|||
125100957|NCT02181673|449991058|FG001|Up to Week 24|Randomized not Treated|0|||
125100958|NCT02181673|449991059|FG002|Up to Week 24|Randomized not Treated|1|||
125100959|NCT02181673|449991057|FG000|Week 24-Week 60|Adverse Event|0|||
125100960|NCT02181673|449991058|FG001|Week 24-Week 60|Adverse Event|4|||
125100961|NCT02181673|449991059|FG002|Week 24-Week 60|Adverse Event|10|||
125100962|NCT02181673|449991057|FG000|Week 24-Week 60|Other|0|||
125100963|NCT02181673|449991058|FG001|Week 24-Week 60|Other|2|||
125100964|NCT02181673|449991059|FG002|Week 24-Week 60|Other|1|||
125100965|NCT02181673|449991057|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
125100966|NCT02181673|449991058|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
125100967|NCT02181673|449991059|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
125100968|NCT02181673|449991057|FG000|Week 24-Week 60|Pregnancy|0|||
124876212|NCT00404495|449168755|FG001|Overall Study|Other|0|||
125012432|NCT02424253|449671838|FG000|Overall Study|Lack of Efficacy|0|||
125012433|NCT02424253|449671839|FG001|Overall Study|Lack of Efficacy|7|||
125012434|NCT02424253|449671838|FG000|Overall Study|Adverse Event|2|||
125012435|NCT02424253|449671839|FG001|Overall Study|Adverse Event|0|||
125012436|NCT02424253|449671838|FG000|Overall Study|Consent withdrawn by subject|4|||
125012437|NCT02424253|449671839|FG001|Overall Study|Consent withdrawn by subject|1|||
125012438|NCT02424253|449671838|FG000|Overall Study|Lost to Follow-up|1|||
125012439|NCT02424253|449671839|FG001|Overall Study|Lost to Follow-up|1|||
125100969|NCT02181673|449991058|FG001|Week 24-Week 60|Pregnancy|0|||
125100970|NCT02181673|449991059|FG002|Week 24-Week 60|Pregnancy|1|||
125100971|NCT02181673|449991057|FG000|Week 24-Week 60|Lack of Efficacy|0|||
124876213|NCT00404495|449168754|FG000|Overall Study|Withdrawal by Subject|1|||
125012440|NCT00473343|449671840|FG000|Overall Study|Adverse Event|9|||
125100972|NCT02181673|449991058|FG001|Week 24-Week 60|Lack of Efficacy|0|||
125100973|NCT02181673|449991059|FG002|Week 24-Week 60|Lack of Efficacy|1|||
125100974|NCT02181673|449991057|FG000|Week 24-Week 60|Lost to Follow-up|0|||
124876214|NCT00404495|449168755|FG001|Overall Study|Withdrawal by Subject|0|||
124876215|NCT01493960|449170583|FG000|Overall Study|Adverse Event|0|||
124876216|NCT01493960|449170584|FG001|Overall Study|Adverse Event|1|||
125012441|NCT00473343|449671840|FG000|Overall Study|Lost to Follow-up|8|||
125100975|NCT02181673|449991058|FG001|Week 24-Week 60|Lost to Follow-up|0|||
125100976|NCT02181673|449991059|FG002|Week 24-Week 60|Lost to Follow-up|1|||
125012442|NCT00473343|449671840|FG000|Overall Study|Treatment failure|27|||
125100977|NCT02181673|449991057|FG000|Week 24-Week 60|Physician Decision|0|||
125100978|NCT02181673|449991058|FG001|Week 24-Week 60|Physician Decision|0|||
124876217|NCT01493960|449170583|FG000|Overall Study|Lack of Efficacy|15|||
124876218|NCT01493960|449170584|FG001|Overall Study|Lack of Efficacy|9|||
124876219|NCT01493960|449170583|FG000|Overall Study|Protocol Violation|3|||
124876220|NCT01493960|449170584|FG001|Overall Study|Protocol Violation|0|||
124876221|NCT01493960|449170583|FG000|Overall Study|Withdrawal by Subject|10|||
124876222|NCT01493960|449170584|FG001|Overall Study|Withdrawal by Subject|4|||
124876223|NCT01493960|449170583|FG000|Overall Study|Non-specified|4|||
124876224|NCT01493960|449170584|FG001|Overall Study|Non-specified|4|||
124876225|NCT00975221|449170589|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
124876226|NCT00975221|449170590|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
124876227|NCT00975221|449170589|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
124876228|NCT00975221|449170590|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
124876229|NCT00975221|449170589|FG000|Titration Phase (Weeks 1-12)|Other|0|||
124876230|NCT00975221|449170590|FG001|Titration Phase (Weeks 1-12)|Other|1|||
124876231|NCT00975221|449170589|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
124876232|NCT00975221|449170590|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
124876233|NCT00975221|449170589|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
124876234|NCT00975221|449170590|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
124876235|NCT00975221|449170589|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
124876236|NCT00975221|449170590|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
124876237|NCT03935217|449170593|FG000|Overall Study|Adverse Event|1|||
124876238|NCT03935217|449170594|FG001|Overall Study|Adverse Event|0|||
124876239|NCT03935217|449170593|FG000|Overall Study|Lost to Follow-up|0|||
124876240|NCT03935217|449170594|FG001|Overall Study|Lost to Follow-up|1|||
124876241|NCT03935217|449170593|FG000|Overall Study|Withdrawal by Subject|0|||
124876242|NCT03935217|449170594|FG001|Overall Study|Withdrawal by Subject|2|||
124876243|NCT03559218|449170595|FG000|Overall Study|Withdrawal by Subject|1|||
124876244|NCT03559218|449170596|FG001|Overall Study|Withdrawal by Subject|0|||
124876245|NCT02790073|449170598|FG000|Overall Study|Death|1|||
124876246|NCT02790073|449170598|FG000|Overall Study|Withdrawal from HD|1|||
124876247|NCT02790073|449170598|FG000|Overall Study|Withdrawal by Subject|1|||
124876248|NCT02487498|449170602|FG000|Period: Period 1|Adverse Event|2|||
124876249|NCT02487498|449170603|FG001|Period: Period 1|Adverse Event|4|||
124876250|NCT02487498|449170602|FG000|Period: Period 1|Subject/guardian decision|2|||
124876251|NCT02487498|449170603|FG001|Period: Period 1|Subject/guardian decision|4|||
124876252|NCT02487498|449170602|FG000|Period: Period 1|Lost to Follow-up|0|||
124876253|NCT02487498|449170603|FG001|Period: Period 1|Lost to Follow-up|2|||
124876254|NCT02487498|449170602|FG000|Period: Period 1|Lack of Efficacy|1|||
124876255|NCT02487498|449170603|FG001|Period: Period 1|Lack of Efficacy|0|||
124876256|NCT02487498|449170602|FG000|Period: Period 1|Physician Decision|0|||
124876257|NCT02487498|449170603|FG001|Period: Period 1|Physician Decision|1|||
124876258|NCT02487498|449170602|FG000|Period: Period 1|Protocol deviation|1|||
124876259|NCT02487498|449170603|FG001|Period: Period 1|Protocol deviation|0|||
124876260|NCT02487498|449170602|FG000|Period: Washout|Subject/guardian decision|0|||
124876261|NCT02487498|449170603|FG001|Period: Washout|Subject/guardian decision|5|||
124876262|NCT02487498|449170602|FG000|Period: Washout|Lack of Efficacy|1|||
124876263|NCT02487498|449170603|FG001|Period: Washout|Lack of Efficacy|1|||
124876264|NCT02487498|449170602|FG000|Period: Washout|Physician Decision|1|||
124876265|NCT02487498|449170603|FG001|Period: Washout|Physician Decision|0|||
124876266|NCT02487498|449170602|FG000|Period: Washout|Non-compliance with study treatment|0|||
124876267|NCT02487498|449170603|FG001|Period: Washout|Non-compliance with study treatment|1|||
124876268|NCT02487498|449170602|FG000|Period: Period 2|Adverse Event|2|||
124876269|NCT02487498|449170603|FG001|Period: Period 2|Adverse Event|2|||
124876270|NCT02487498|449170602|FG000|Period: Period 2|Subject/guardian decision|2|||
124876271|NCT02487498|449170603|FG001|Period: Period 2|Subject/guardian decision|1|||
124876272|NCT02487498|449170602|FG000|Period: Period 2|Lost to Follow-up|1|||
124876273|NCT02487498|449170603|FG001|Period: Period 2|Lost to Follow-up|1|||
124876274|NCT02487498|449170602|FG000|Period: Period 2|Death|0|||
124876275|NCT02487498|449170603|FG001|Period: Period 2|Death|1|||
125012443|NCT00473343|449671840|FG000|Overall Study|Withdrew consent|3|||
125012444|NCT00473343|449671840|FG000|Overall Study|Other un-specified reason|3|||
125012445|NCT02290873|449671847|FG000|Overall Study|Withdrawal by Subject|0|||
125012446|NCT02290873|449671848|FG001|Overall Study|Withdrawal by Subject|1|||
125012447|NCT02290873|449671849|FG002|Overall Study|Withdrawal by Subject|1|||
125012448|NCT02290873|449671847|FG000|Overall Study|Nellcor device error|1|||
125012449|NCT02290873|449671848|FG001|Overall Study|Nellcor device error|0|||
124876276|NCT02487498|449170602|FG000|Period: Period 2|Physician Decision|1|||
124876277|NCT02487498|449170603|FG001|Period: Period 2|Physician Decision|0|||
124876278|NCT00676130|449170606|FG000|Overall Study|Lost to Follow-up|0|||
124876279|NCT00676130|449170607|FG001|Overall Study|Lost to Follow-up|1|||
124876280|NCT00676130|449170606|FG000|Overall Study|Found ineligible|3|||
125012450|NCT02290873|449671849|FG002|Overall Study|Nellcor device error|0|||
124876281|NCT00676130|449170607|FG001|Overall Study|Found ineligible|2|||
124876282|NCT00676130|449170606|FG000|Overall Study|Withdrawal by Subject|0|||
125012451|NCT02290873|449671847|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
124876283|NCT00676130|449170607|FG001|Overall Study|Withdrawal by Subject|1|||
124876284|NCT00755222|449170608|FG000|Overall Study|Withdrawal by Subject|4|||
124876285|NCT00755222|449170609|FG001|Overall Study|Withdrawal by Subject|2|||
124876286|NCT00755222|449170608|FG000|Overall Study|Adverse Event|2|||
124876287|NCT00755222|449170609|FG001|Overall Study|Adverse Event|0|||
124876288|NCT00755222|449170608|FG000|Overall Study|Protocol Violation|2|||
124876289|NCT00755222|449170609|FG001|Overall Study|Protocol Violation|0|||
124876290|NCT01330316|449170625|FG000|Overall Study|Adverse Event|2|||
124876291|NCT01330316|449170626|FG001|Overall Study|Adverse Event|2|||
124876292|NCT01330316|449170625|FG000|Overall Study|Lack of Efficacy|0|||
124876293|NCT01330316|449170626|FG001|Overall Study|Lack of Efficacy|10|||
124876294|NCT01330316|449170625|FG000|Overall Study|Lost to Follow-up|0|||
124876295|NCT01330316|449170626|FG001|Overall Study|Lost to Follow-up|1|||
124876296|NCT01330316|449170625|FG000|Overall Study|Withdrawal by Subject|0|||
124876297|NCT01330316|449170626|FG001|Overall Study|Withdrawal by Subject|1|||
124876298|NCT01330316|449170625|FG000|Overall Study|other than above|0|||
124876299|NCT01330316|449170626|FG001|Overall Study|other than above|1|||
124876300|NCT03010462|449170627|FG000|Overall Study|Withdrawal by Subject|3|||
124876301|NCT03010462|449170628|FG001|Overall Study|Withdrawal by Subject|1|||
124876302|NCT02207725|449170629|FG000|Overall Study|Did Not Receive Treatment|0|||
124876303|NCT02207725|449170630|FG001|Overall Study|Did Not Receive Treatment|1|||
124876304|NCT02207725|449170631|FG002|Overall Study|Did Not Receive Treatment|1|||
124876305|NCT02207725|449170632|FG003|Overall Study|Did Not Receive Treatment|1|||
124876306|NCT03145766|449170633|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
124876307|NCT03145766|449170634|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
124876308|NCT03145766|449170635|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
124876309|NCT03145766|449170636|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
124876310|NCT03145766|449170637|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
124876311|NCT03145766|449170633|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
124876312|NCT03145766|449170634|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
125012452|NCT02290873|449671848|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
125012453|NCT02290873|449671849|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
125012454|NCT02290873|449671847|FG000|Overall Study|Protocol Violation|0|||
125012455|NCT02290873|449671848|FG001|Overall Study|Protocol Violation|0|||
125012456|NCT02290873|449671849|FG002|Overall Study|Protocol Violation|1|||
125012457|NCT01136655|449671850|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
125012458|NCT01136655|449671850|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
125012459|NCT01136655|449671850|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
125012460|NCT01136655|449671850|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
125012461|NCT01378104|449671854|FG000|Overall Study|Adverse Event|8|||
125012462|NCT01378104|449671855|FG001|Overall Study|Adverse Event|8|||
125012463|NCT01378104|449671854|FG000|Overall Study|Lack of Efficacy|7|||
125012464|NCT01378104|449671855|FG001|Overall Study|Lack of Efficacy|5|||
125012465|NCT01378104|449671854|FG000|Overall Study|Withdrawal by Subject|12|||
125012466|NCT01378104|449671855|FG001|Overall Study|Withdrawal by Subject|13|||
125012467|NCT02287623|449671856|FG000|Overall Study|Protocol Violation|0|||
125012468|NCT02287623|449671857|FG001|Overall Study|Protocol Violation|1|||
125012469|NCT02700997|449671858|FG000|Overall Study|Did not undergo CT imaging|1|||
125012470|NCT02700997|449671858|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
125012471|NCT02354222|449671859|FG000|Overall Study|Adverse Event|0|||
125012472|NCT02354222|449671860|FG001|Overall Study|Adverse Event|3|||
125012473|NCT02354222|449671859|FG000|Overall Study|Physician Decision|1|||
125012474|NCT02354222|449671860|FG001|Overall Study|Physician Decision|1|||
125012475|NCT02354222|449671859|FG000|Overall Study|Pregnancy|1|||
125012476|NCT02354222|449671860|FG001|Overall Study|Pregnancy|0|||
125012477|NCT02354222|449671859|FG000|Overall Study|Withdrawal by Subject|2|||
125012478|NCT02354222|449671860|FG001|Overall Study|Withdrawal by Subject|3|||
125012479|NCT02354222|449671859|FG000|Overall Study|Conflict with the stopping criteria|0|||
125012480|NCT02354222|449671860|FG001|Overall Study|Conflict with the stopping criteria|4|||
125012481|NCT01342484|449671863|FG000|Overall Study|Other Reasons|1|||
125012482|NCT01342484|449671864|FG001|Overall Study|Other Reasons|0|||
125012483|NCT01342484|449671865|FG002|Overall Study|Other Reasons|0|||
125012484|NCT01342484|449671863|FG000|Overall Study|Protocol Violation|0|||
125012485|NCT01342484|449671864|FG001|Overall Study|Protocol Violation|0|||
125012486|NCT01342484|449671865|FG002|Overall Study|Protocol Violation|1|||
125012487|NCT01342484|449671863|FG000|Overall Study|Withdrawal by Subject|1|||
125012488|NCT01342484|449671864|FG001|Overall Study|Withdrawal by Subject|0|||
125012489|NCT01342484|449671865|FG002|Overall Study|Withdrawal by Subject|0|||
125012490|NCT01840579|449671866|FG000|Overall Study|Status not recorded|0|||
125012491|NCT01840579|449671867|FG001|Overall Study|Status not recorded|0|||
125012492|NCT01840579|449671868|FG002|Overall Study|Status not recorded|2|||
125012493|NCT01840579|449671869|FG003|Overall Study|Status not recorded|3|||
124876313|NCT03145766|449170635|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
124876314|NCT03145766|449170636|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
124876315|NCT03145766|449170637|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
124876316|NCT03145766|449170633|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
124876317|NCT03145766|449170634|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
124876318|NCT03145766|449170635|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
124876319|NCT03145766|449170636|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
124876320|NCT03145766|449170637|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
124876321|NCT03145766|449170633|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
124876322|NCT03145766|449170634|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
124876323|NCT03145766|449170635|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
124876324|NCT03145766|449170636|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
124876325|NCT03145766|449170637|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
124876326|NCT03145766|449170633|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
124876327|NCT03145766|449170634|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
124876328|NCT03145766|449170635|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
124876329|NCT03145766|449170636|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
124876330|NCT03145766|449170637|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
124876331|NCT03145766|449170633|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
124876332|NCT03145766|449170634|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
124876333|NCT03145766|449170635|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
124876334|NCT03145766|449170636|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
124876335|NCT03145766|449170637|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
124876336|NCT03145766|449170633|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
124876337|NCT03145766|449170634|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
124876338|NCT03145766|449170635|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
124876339|NCT03145766|449170636|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
124876340|NCT03145766|449170637|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
124876341|NCT01492686|449170641|FG000|Double-blind Phase|Adverse Event|0|||
124876342|NCT01492686|449170642|FG001|Double-blind Phase|Adverse Event|2|||
124876343|NCT01492686|449170641|FG000|Double-blind Phase|Physician Decision|0|||
124876344|NCT01492686|449170642|FG001|Double-blind Phase|Physician Decision|1|||
124876345|NCT01492686|449170641|FG000|Double-blind Phase|Withdrawal by Subject|0|||
124876346|NCT01492686|449170642|FG001|Double-blind Phase|Withdrawal by Subject|2|||
124876347|NCT01492686|449170641|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
124876348|NCT01492686|449170642|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
124876349|NCT01492686|449170641|FG000|Open-label Phase|Adverse Event|1|||
124876350|NCT01492686|449170642|FG001|Open-label Phase|Adverse Event|2|||
124876351|NCT01492686|449170641|FG000|Open-label Phase|Physician Decision|1|||
124876352|NCT01492686|449170642|FG001|Open-label Phase|Physician Decision|0|||
124876353|NCT01492686|449170641|FG000|Open-label Phase|Withdrawal by Subject|6|||
124876354|NCT01492686|449170642|FG001|Open-label Phase|Withdrawal by Subject|7|||
124876355|NCT01492686|449170641|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
124876356|NCT01492686|449170642|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
124876357|NCT04026165|449170650|FG000|Run-in Placebo Period|Enrollment Error|13|||
124876358|NCT04026165|449170651|FG001|Run-in Placebo Period|Enrollment Error|0|||
124876359|NCT04026165|449170652|FG002|Run-in Placebo Period|Enrollment Error|0|||
124876360|NCT04026165|449170653|FG003|Run-in Placebo Period|Enrollment Error|0|||
124876361|NCT04026165|449170650|FG000|Run-in Placebo Period|Run-in Failure|4|||
124876362|NCT04026165|449170651|FG001|Run-in Placebo Period|Run-in Failure|0|||
124876363|NCT04026165|449170652|FG002|Run-in Placebo Period|Run-in Failure|0|||
124876364|NCT04026165|449170653|FG003|Run-in Placebo Period|Run-in Failure|0|||
125012494|NCT01840579|449671870|FG004|Overall Study|Status not recorded|4|||
125012495|NCT01840579|449671871|FG005|Overall Study|Status not recorded|3|||
125012496|NCT01840579|449671872|FG006|Overall Study|Status not recorded|0|||
125012497|NCT01840579|449671873|FG007|Overall Study|Status not recorded|3|||
125012498|NCT01840579|449671874|FG008|Overall Study|Status not recorded|3|||
125012499|NCT01840579|449671875|FG009|Overall Study|Status not recorded|3|||
125012500|NCT01840579|449671866|FG000|Overall Study|Progressive disease|3|||
125012501|NCT01840579|449671867|FG001|Overall Study|Progressive disease|5|||
125012502|NCT01840579|449671868|FG002|Overall Study|Progressive disease|0|||
125012503|NCT01840579|449671869|FG003|Overall Study|Progressive disease|0|||
125012504|NCT01840579|449671870|FG004|Overall Study|Progressive disease|0|||
124876365|NCT04026165|449170650|FG000|Run-in Placebo Period|Protocol Violation|2|||
124876366|NCT04026165|449170651|FG001|Run-in Placebo Period|Protocol Violation|0|||
124876367|NCT04026165|449170652|FG002|Run-in Placebo Period|Protocol Violation|0|||
124876368|NCT04026165|449170653|FG003|Run-in Placebo Period|Protocol Violation|0|||
124876369|NCT04026165|449170650|FG000|Run-in Placebo Period|Withdrew Consent|2|||
124876370|NCT04026165|449170651|FG001|Run-in Placebo Period|Withdrew Consent|0|||
124876371|NCT04026165|449170652|FG002|Run-in Placebo Period|Withdrew Consent|0|||
124876372|NCT04026165|449170653|FG003|Run-in Placebo Period|Withdrew Consent|0|||
125012505|NCT01840579|449671871|FG005|Overall Study|Progressive disease|0|||
124876373|NCT04026165|449170650|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
124876374|NCT04026165|449170651|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
124876375|NCT04026165|449170652|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
124876376|NCT04026165|449170653|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
124876377|NCT04026165|449170650|FG000|Run-in SEL Period|Run-in Failure|0|||
124876378|NCT04026165|449170651|FG001|Run-in SEL Period|Run-in Failure|26|||
124876379|NCT04026165|449170652|FG002|Run-in SEL Period|Run-in Failure|0|||
124876380|NCT04026165|449170653|FG003|Run-in SEL Period|Run-in Failure|0|||
124876381|NCT04026165|449170650|FG000|Run-in SEL Period|Withdrew Consent|0|||
124876382|NCT04026165|449170651|FG001|Run-in SEL Period|Withdrew Consent|10|||
124876383|NCT04026165|449170652|FG002|Run-in SEL Period|Withdrew Consent|0|||
124876384|NCT04026165|449170653|FG003|Run-in SEL Period|Withdrew Consent|0|||
124876385|NCT04026165|449170650|FG000|Run-in SEL Period|Enrollment Error|0|||
124876386|NCT04026165|449170651|FG001|Run-in SEL Period|Enrollment Error|4|||
124876387|NCT04026165|449170652|FG002|Run-in SEL Period|Enrollment Error|0|||
124876388|NCT04026165|449170653|FG003|Run-in SEL Period|Enrollment Error|0|||
124876389|NCT04026165|449170650|FG000|Run-in SEL Period|Protocol Violation|0|||
124876390|NCT04026165|449170651|FG001|Run-in SEL Period|Protocol Violation|3|||
124876391|NCT04026165|449170652|FG002|Run-in SEL Period|Protocol Violation|0|||
124876392|NCT04026165|449170653|FG003|Run-in SEL Period|Protocol Violation|0|||
124876393|NCT04026165|449170650|FG000|Run-in SEL Period|Investigator's Discretion|0|||
124876394|NCT04026165|449170651|FG001|Run-in SEL Period|Investigator's Discretion|2|||
124876395|NCT04026165|449170652|FG002|Run-in SEL Period|Investigator's Discretion|0|||
124876396|NCT04026165|449170653|FG003|Run-in SEL Period|Investigator's Discretion|0|||
124876397|NCT04026165|449170650|FG000|Run-in SEL Period|Death|0|||
124876398|NCT04026165|449170651|FG001|Run-in SEL Period|Death|1|||
124876399|NCT04026165|449170652|FG002|Run-in SEL Period|Death|0|||
124876400|NCT04026165|449170653|FG003|Run-in SEL Period|Death|0|||
124876401|NCT04026165|449170650|FG000|Randomized Period|Withdrew Consent|0|||
125012506|NCT01840579|449671872|FG006|Overall Study|Progressive disease|0|||
125012507|NCT01840579|449671873|FG007|Overall Study|Progressive disease|0|||
125012508|NCT01840579|449671874|FG008|Overall Study|Progressive disease|0|||
125012509|NCT01840579|449671875|FG009|Overall Study|Progressive disease|0|||
125100979|NCT02181673|449991059|FG002|Week 24-Week 60|Physician Decision|1|||
125100980|NCT03155269|449991060|FG000|Overall Study|Withdrawal by Subject|4|||
125100981|NCT03155269|449991061|FG001|Overall Study|Withdrawal by Subject|5|||
125012510|NCT01840579|449671866|FG000|Overall Study|Ongoing in study|0|||
125012511|NCT01840579|449671867|FG001|Overall Study|Ongoing in study|1|||
125012512|NCT01840579|449671868|FG002|Overall Study|Ongoing in study|0|||
125012513|NCT01840579|449671869|FG003|Overall Study|Ongoing in study|0|||
125012514|NCT01840579|449671870|FG004|Overall Study|Ongoing in study|0|||
125012515|NCT01840579|449671871|FG005|Overall Study|Ongoing in study|0|||
125012516|NCT01840579|449671872|FG006|Overall Study|Ongoing in study|0|||
125012517|NCT01840579|449671873|FG007|Overall Study|Ongoing in study|0|||
125012518|NCT01840579|449671874|FG008|Overall Study|Ongoing in study|0|||
125012519|NCT01840579|449671875|FG009|Overall Study|Ongoing in study|0|||
125012520|NCT01840579|449671866|FG000|Overall Study|Death|0|||
125012521|NCT01840579|449671867|FG001|Overall Study|Death|0|||
125012522|NCT01840579|449671868|FG002|Overall Study|Death|0|||
125012523|NCT01840579|449671869|FG003|Overall Study|Death|0|||
125012524|NCT01840579|449671870|FG004|Overall Study|Death|0|||
125012525|NCT01840579|449671871|FG005|Overall Study|Death|1|||
125012526|NCT01840579|449671872|FG006|Overall Study|Death|0|||
125012527|NCT01840579|449671873|FG007|Overall Study|Death|0|||
125012528|NCT01840579|449671874|FG008|Overall Study|Death|0|||
125012529|NCT01840579|449671875|FG009|Overall Study|Death|0|||
125012530|NCT01840579|449671866|FG000|Overall Study|Adverse Event|0|||
125012531|NCT01840579|449671867|FG001|Overall Study|Adverse Event|1|||
125012532|NCT01840579|449671868|FG002|Overall Study|Adverse Event|0|||
125012533|NCT01840579|449671869|FG003|Overall Study|Adverse Event|0|||
125012534|NCT01840579|449671870|FG004|Overall Study|Adverse Event|0|||
125012535|NCT01840579|449671871|FG005|Overall Study|Adverse Event|0|||
125012536|NCT01840579|449671872|FG006|Overall Study|Adverse Event|0|||
125012537|NCT01840579|449671873|FG007|Overall Study|Adverse Event|0|||
125012538|NCT01840579|449671874|FG008|Overall Study|Adverse Event|0|||
125012539|NCT01840579|449671875|FG009|Overall Study|Adverse Event|0|||
125012540|NCT01840579|449671866|FG000|Overall Study|Follow-up ended by Sponsor|0|||
125012541|NCT01840579|449671867|FG001|Overall Study|Follow-up ended by Sponsor|0|||
124876402|NCT04026165|449170651|FG001|Randomized Period|Withdrew Consent|0|||
125012542|NCT01840579|449671868|FG002|Overall Study|Follow-up ended by Sponsor|0|||
125012543|NCT01840579|449671869|FG003|Overall Study|Follow-up ended by Sponsor|0|||
124876403|NCT04026165|449170652|FG002|Randomized Period|Withdrew Consent|5|||
124876404|NCT04026165|449170653|FG003|Randomized Period|Withdrew Consent|8|||
124876405|NCT04026165|449170650|FG000|Randomized Period|Death|0|||
124876406|NCT04026165|449170651|FG001|Randomized Period|Death|0|||
124876407|NCT04026165|449170652|FG002|Randomized Period|Death|5|||
124876408|NCT04026165|449170653|FG003|Randomized Period|Death|7|||
125012544|NCT01840579|449671870|FG004|Overall Study|Follow-up ended by Sponsor|0|||
125100982|NCT03155269|449991060|FG000|Overall Study|Lost to Follow-up|1|||
125012545|NCT01840579|449671871|FG005|Overall Study|Follow-up ended by Sponsor|0|||
125012546|NCT01840579|449671872|FG006|Overall Study|Follow-up ended by Sponsor|2|||
125012547|NCT01840579|449671873|FG007|Overall Study|Follow-up ended by Sponsor|0|||
125012548|NCT01840579|449671874|FG008|Overall Study|Follow-up ended by Sponsor|0|||
125012549|NCT01840579|449671875|FG009|Overall Study|Follow-up ended by Sponsor|0|||
125012550|NCT00432042|449671876|FG000|Overall Study|Protocol Violation|2|||
125012551|NCT00432042|449671877|FG001|Overall Study|Protocol Violation|0|||
125012552|NCT00432042|449671878|FG002|Overall Study|Protocol Violation|0|||
125012553|NCT00432042|449671876|FG000|Overall Study|Withdrawal by Subject|0|||
125012554|NCT00432042|449671877|FG001|Overall Study|Withdrawal by Subject|0|||
125012555|NCT00432042|449671878|FG002|Overall Study|Withdrawal by Subject|2|||
125012556|NCT00432042|449671876|FG000|Overall Study|Lost to Follow-up|5|||
125012557|NCT00432042|449671877|FG001|Overall Study|Lost to Follow-up|1|||
125012558|NCT00432042|449671878|FG002|Overall Study|Lost to Follow-up|0|||
125012559|NCT00980200|449672949|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
125012560|NCT00980200|449672950|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
125012561|NCT00980200|449672951|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
125012562|NCT00980200|449672952|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
125012563|NCT00980200|449672953|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
125012564|NCT00980200|449672949|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
125012565|NCT00980200|449672950|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
125012566|NCT00980200|449672951|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
125012567|NCT00980200|449672952|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
125012568|NCT00980200|449672953|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
125012569|NCT00457015|449672954|FG000|Overall Study|Left study site against medical advice|0|||
125012570|NCT00457015|449672955|FG001|Overall Study|Left study site against medical advice|1|||
125012571|NCT01611974|449672956|FG000|Overall Study|Death|10|||
125012572|NCT01611974|449672957|FG001|Overall Study|Death|12|||
125012573|NCT01611974|449672958|FG002|Overall Study|Death|10|||
125012574|NCT01611974|449672956|FG000|Overall Study|Lost to Follow-up|0|||
125012575|NCT01611974|449672957|FG001|Overall Study|Lost to Follow-up|1|||
125012576|NCT01611974|449672958|FG002|Overall Study|Lost to Follow-up|0|||
125012577|NCT01611974|449672956|FG000|Overall Study|Physician Decision|5|||
125012578|NCT01611974|449672957|FG001|Overall Study|Physician Decision|1|||
125012579|NCT01611974|449672958|FG002|Overall Study|Physician Decision|2|||
125012580|NCT01611974|449672956|FG000|Overall Study|Withdrawal by Subject|0|||
125012581|NCT01611974|449672957|FG001|Overall Study|Withdrawal by Subject|1|||
125012582|NCT01611974|449672958|FG002|Overall Study|Withdrawal by Subject|4|||
125012583|NCT00916357|449672959|FG000|Period 1|Withdrawal by Subject|1|||
125012584|NCT00916357|449672960|FG001|Period 1|Withdrawal by Subject|0|||
125012585|NCT00916357|449672961|FG002|Period 1|Withdrawal by Subject|0|||
125012586|NCT00916357|449672962|FG003|Period 1|Withdrawal by Subject|0|||
125012587|NCT00916357|449672963|FG004|Period 1|Withdrawal by Subject|0|||
125012588|NCT00916357|449672964|FG005|Period 1|Withdrawal by Subject|0|||
125012589|NCT00916357|449672959|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
125012590|NCT00916357|449672960|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
125012591|NCT00916357|449672961|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
125012592|NCT00916357|449672962|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
125012593|NCT00916357|449672963|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
125012594|NCT00916357|449672964|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
125012595|NCT01773109|449672965|FG000|Overall Study|Symptomatic Progression|2|||
125012596|NCT01773109|449672965|FG000|Overall Study|Death|1|||
125012597|NCT04766021|449672969|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
125012598|NCT04766021|449672969|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
125012599|NCT02257372|449672970|FG000|Overall Study|Adverse Event|3|||
125012600|NCT02257372|449672971|FG001|Overall Study|Adverse Event|7|||
125012601|NCT02257372|449672970|FG000|Overall Study|Lack of Efficacy|2|||
125012602|NCT02257372|449672971|FG001|Overall Study|Lack of Efficacy|1|||
125012603|NCT02257372|449672970|FG000|Overall Study|Protocol Violation|1|||
125012604|NCT02257372|449672971|FG001|Overall Study|Protocol Violation|1|||
125012605|NCT02257372|449672970|FG000|Overall Study|Lost to Follow-up|0|||
125012606|NCT02257372|449672971|FG001|Overall Study|Lost to Follow-up|1|||
125012607|NCT02257372|449672970|FG000|Overall Study|Withdrew consent|1|||
125012608|NCT02257372|449672971|FG001|Overall Study|Withdrew consent|0|||
125012609|NCT00789529|449672972|FG000|Overall Study|Withdrawal by Subject|0|||
125012610|NCT00789529|449672973|FG001|Overall Study|Withdrawal by Subject|1|||
125012611|NCT00789529|449672972|FG000|Overall Study|Other Reason|1|||
125012612|NCT00789529|449672973|FG001|Overall Study|Other Reason|0|||
125012613|NCT01230242|449672978|FG000|Overall Study|Physician Decision|2|||
125012614|NCT01230242|449672978|FG000|Overall Study|Withdrawal by Subject|1|||
125012615|NCT04329702|449672982|FG000|Overall Study|illness|3|||
125012616|NCT04329702|449672983|FG001|Overall Study|illness|4|||
125012617|NCT04329702|449672984|FG002|Overall Study|illness|0|||
125012618|NCT04329702|449672982|FG000|Overall Study|Lost to Follow-up|0|||
125012619|NCT04329702|449672983|FG001|Overall Study|Lost to Follow-up|0|||
125012620|NCT04329702|449672984|FG002|Overall Study|Lost to Follow-up|2|||
125012621|NCT04329702|449672982|FG000|Overall Study|Death|0|||
125100983|NCT03155269|449991061|FG001|Overall Study|Lost to Follow-up|2|||
125100984|NCT00138658|449991062|FG000|Overall Study|Adverse Event|23|||
125100985|NCT00138658|449991062|FG000|Overall Study|Death|1|||
125100986|NCT00138658|449991062|FG000|Overall Study|Disease Progression|21|||
125100987|NCT00138658|449991062|FG000|Overall Study|Physician Decision|11|||
125100988|NCT00138658|449991062|FG000|Overall Study|Withdrawal by Subject|5|||
125100989|NCT03733301|449991065|FG000|Overall Study|Screen Fail|1|||
125100990|NCT03733301|449991066|FG001|Overall Study|Screen Fail|0|||
125100991|NCT03733301|449991067|FG002|Overall Study|Screen Fail|0|||
125100992|NCT03733301|449991065|FG000|Overall Study|Non-compliance|1|||
125100993|NCT03733301|449991066|FG001|Overall Study|Non-compliance|0|||
125100994|NCT03733301|449991067|FG002|Overall Study|Non-compliance|0|||
125100995|NCT03733301|449991065|FG000|Overall Study|Lack of Efficacy|2|||
125100996|NCT03733301|449991066|FG001|Overall Study|Lack of Efficacy|3|||
125100997|NCT03733301|449991067|FG002|Overall Study|Lack of Efficacy|0|||
125100998|NCT03733301|449991065|FG000|Overall Study|Adverse Event|0|||
125100999|NCT03733301|449991066|FG001|Overall Study|Adverse Event|1|||
125101000|NCT03733301|449991067|FG002|Overall Study|Adverse Event|3|||
125101001|NCT03733301|449991065|FG000|Overall Study|Withdrawal by Subject|3|||
125101002|NCT03733301|449991066|FG001|Overall Study|Withdrawal by Subject|5|||
125101003|NCT03733301|449991067|FG002|Overall Study|Withdrawal by Subject|1|||
125101004|NCT04637815|449991068|FG000|Overall Study|Death|1|||
125101005|NCT04637815|449991069|FG001|Overall Study|Death|0|||
125101006|NCT04637815|449991068|FG000|Overall Study|Lost to Follow-up|5|||
125101007|NCT04637815|449991069|FG001|Overall Study|Lost to Follow-up|2|||
125101008|NCT00337727|449991070|FG000|Overall Study|Adverse Event|5|||
125101009|NCT00337727|449991071|FG001|Overall Study|Adverse Event|3|||
125101010|NCT00337727|449991070|FG000|Overall Study|Lost to Follow-up|5|||
125101011|NCT00337727|449991071|FG001|Overall Study|Lost to Follow-up|4|||
125101012|NCT00337727|449991070|FG000|Overall Study|Physician Decision|1|||
125101013|NCT00337727|449991071|FG001|Overall Study|Physician Decision|0|||
125101014|NCT00337727|449991070|FG000|Overall Study|Protocol Violation|4|||
125101015|NCT00337727|449991071|FG001|Overall Study|Protocol Violation|0|||
125101016|NCT00337727|449991070|FG000|Overall Study|Withdrawal by Subject|3|||
125101017|NCT00337727|449991071|FG001|Overall Study|Withdrawal by Subject|5|||
125101018|NCT00320801|449991072|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
125101019|NCT00320801|449991073|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
125101020|NCT00320801|449991074|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
125101021|NCT00320801|449991075|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
125101022|NCT00320801|449991072|FG000|Open-label Run-in Period|Adverse Event|33|||
125101023|NCT00320801|449991073|FG001|Open-label Run-in Period|Adverse Event|0|||
125101024|NCT00320801|449991074|FG002|Open-label Run-in Period|Adverse Event|0|||
125101025|NCT00320801|449991075|FG003|Open-label Run-in Period|Adverse Event|0|||
125101026|NCT00320801|449991072|FG000|Open-label Run-in Period|Administrative|10|||
125101027|NCT00320801|449991073|FG001|Open-label Run-in Period|Administrative|0|||
124876409|NCT04026165|449170650|FG000|Randomized Period|Investigator's Discretion|0|||
124876410|NCT04026165|449170651|FG001|Randomized Period|Investigator's Discretion|0|||
124876411|NCT04026165|449170652|FG002|Randomized Period|Investigator's Discretion|2|||
124876412|NCT04026165|449170653|FG003|Randomized Period|Investigator's Discretion|2|||
124876413|NCT04026165|449170650|FG000|Randomized Period|Lost to Follow-up|0|||
124876414|NCT04026165|449170651|FG001|Randomized Period|Lost to Follow-up|0|||
124876415|NCT04026165|449170652|FG002|Randomized Period|Lost to Follow-up|2|||
124876416|NCT04026165|449170653|FG003|Randomized Period|Lost to Follow-up|2|||
124876417|NCT02255357|449170654|FG000|Overall Study|Physician Decision|10|||
124876418|NCT02255357|449170655|FG001|Overall Study|Physician Decision|24|||
124876419|NCT05061537|449170656|FG000|Treatment Phase|Progressive disease|0|||
124876420|NCT05061537|449170657|FG001|Treatment Phase|Progressive disease|1|||
124876421|NCT05061537|449170658|FG002|Treatment Phase|Progressive disease|2|||
124876422|NCT05061537|449170659|FG003|Treatment Phase|Progressive disease|0|||
124876423|NCT05061537|449170660|FG004|Treatment Phase|Progressive disease|0|||
124876424|NCT05061537|449170656|FG000|Treatment Phase|Adverse Event|0|||
124876425|NCT05061537|449170657|FG001|Treatment Phase|Adverse Event|0|||
124876426|NCT05061537|449170658|FG002|Treatment Phase|Adverse Event|2|||
124876427|NCT05061537|449170659|FG003|Treatment Phase|Adverse Event|0|||
124876428|NCT05061537|449170660|FG004|Treatment Phase|Adverse Event|0|||
124876429|NCT05061537|449170656|FG000|Treatment Phase|Global deterioration of health status|0|||
124876430|NCT05061537|449170657|FG001|Treatment Phase|Global deterioration of health status|1|||
124876431|NCT05061537|449170658|FG002|Treatment Phase|Global deterioration of health status|0|||
125101028|NCT00320801|449991074|FG002|Open-label Run-in Period|Administrative|0|||
125101029|NCT00320801|449991075|FG003|Open-label Run-in Period|Administrative|0|||
125101030|NCT00320801|449991072|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
124876432|NCT05061537|449170659|FG003|Treatment Phase|Global deterioration of health status|0|||
124876433|NCT05061537|449170660|FG004|Treatment Phase|Global deterioration of health status|0|||
124876434|NCT05061537|449170656|FG000|Follow up|Other|2|||
124876435|NCT05061537|449170657|FG001|Follow up|Other|0|||
124876436|NCT05061537|449170658|FG002|Follow up|Other|2|||
124876437|NCT05061537|449170659|FG003|Follow up|Other|0|||
124876438|NCT05061537|449170660|FG004|Follow up|Other|0|||
124876439|NCT05061537|449170656|FG000|Follow up|Study terminated by sponsor|0|||
124876440|NCT05061537|449170657|FG001|Follow up|Study terminated by sponsor|0|||
124876441|NCT05061537|449170658|FG002|Follow up|Study terminated by sponsor|2|||
124876442|NCT05061537|449170659|FG003|Follow up|Study terminated by sponsor|0|||
124876443|NCT05061537|449170660|FG004|Follow up|Study terminated by sponsor|0|||
124876444|NCT05061537|449170656|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
124876445|NCT05061537|449170657|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
124876446|NCT05061537|449170658|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
125101031|NCT00320801|449991073|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
125101032|NCT00320801|449991074|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
125101033|NCT00320801|449991075|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
125101034|NCT00320801|449991072|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
125101035|NCT00320801|449991073|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
125101036|NCT00320801|449991074|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
125101037|NCT00320801|449991075|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
125101038|NCT00320801|449991072|FG000|Open-label Run-in Period|Did not qualify|1|||
125101039|NCT00320801|449991073|FG001|Open-label Run-in Period|Did not qualify|0|||
125101040|NCT00320801|449991074|FG002|Open-label Run-in Period|Did not qualify|0|||
125101041|NCT00320801|449991075|FG003|Open-label Run-in Period|Did not qualify|0|||
125101042|NCT00320801|449991072|FG000|Double-blind Phase|Withdrawal by Subject|0|||
125101043|NCT00320801|449991073|FG001|Double-blind Phase|Withdrawal by Subject|0|||
125101044|NCT00320801|449991074|FG002|Double-blind Phase|Withdrawal by Subject|1|||
125101045|NCT00320801|449991075|FG003|Double-blind Phase|Withdrawal by Subject|0|||
125101046|NCT00320801|449991072|FG000|Double-blind Phase|Adverse Event|0|||
125101047|NCT00320801|449991073|FG001|Double-blind Phase|Adverse Event|2|||
125101048|NCT00320801|449991074|FG002|Double-blind Phase|Adverse Event|8|||
125101049|NCT00320801|449991075|FG003|Double-blind Phase|Adverse Event|0|||
125101050|NCT00320801|449991072|FG000|Double-blind Phase|Administrative|0|||
125101051|NCT00320801|449991073|FG001|Double-blind Phase|Administrative|0|||
125101052|NCT00320801|449991074|FG002|Double-blind Phase|Administrative|4|||
125101053|NCT00320801|449991075|FG003|Double-blind Phase|Administrative|0|||
125101054|NCT00320801|449991072|FG000|Double-blind Phase|Lack of Efficacy|0|||
124876447|NCT05061537|449170659|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
124876448|NCT05061537|449170660|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
124876449|NCT05061537|449170656|FG000|Long-term Follow-up|Death|0|||
124876450|NCT05061537|449170657|FG001|Long-term Follow-up|Death|1|||
124876451|NCT05061537|449170658|FG002|Long-term Follow-up|Death|0|||
124876452|NCT05061537|449170659|FG003|Long-term Follow-up|Death|0|||
124876453|NCT05061537|449170660|FG004|Long-term Follow-up|Death|0|||
124876454|NCT01674621|449170671|FG000|Overall Study|Adverse Event|3|||
124876455|NCT01674621|449170672|FG001|Overall Study|Adverse Event|2|||
125101055|NCT00320801|449991073|FG001|Double-blind Phase|Lack of Efficacy|9|||
125101056|NCT00320801|449991074|FG002|Double-blind Phase|Lack of Efficacy|1|||
125101057|NCT00320801|449991075|FG003|Double-blind Phase|Lack of Efficacy|0|||
124876456|NCT01674621|449170673|FG002|Overall Study|Adverse Event|5|||
124876457|NCT01674621|449170674|FG003|Overall Study|Adverse Event|5|||
124876458|NCT01674621|449170675|FG004|Overall Study|Adverse Event|1|||
124876459|NCT01674621|449170671|FG000|Overall Study|Inability to Complete Study Procedures|0|||
124876460|NCT01674621|449170672|FG001|Overall Study|Inability to Complete Study Procedures|0|||
124876461|NCT01674621|449170673|FG002|Overall Study|Inability to Complete Study Procedures|0|||
124876462|NCT01674621|449170674|FG003|Overall Study|Inability to Complete Study Procedures|0|||
124876463|NCT01674621|449170675|FG004|Overall Study|Inability to Complete Study Procedures|2|||
124876464|NCT01674621|449170671|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
124876465|NCT01674621|449170672|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
124876466|NCT01674621|449170673|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
124876467|NCT01674621|449170674|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
124876468|NCT01674621|449170675|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
124876469|NCT01674621|449170671|FG000|Overall Study|Withdrawal by Subject|2|||
124876470|NCT01674621|449170672|FG001|Overall Study|Withdrawal by Subject|5|||
124876471|NCT01674621|449170673|FG002|Overall Study|Withdrawal by Subject|2|||
124876472|NCT01674621|449170674|FG003|Overall Study|Withdrawal by Subject|0|||
124876473|NCT01674621|449170675|FG004|Overall Study|Withdrawal by Subject|1|||
124876474|NCT01674621|449170671|FG000|Overall Study|Other than specified|0|||
124876475|NCT01674621|449170672|FG001|Overall Study|Other than specified|1|||
124876476|NCT01674621|449170673|FG002|Overall Study|Other than specified|0|||
124876477|NCT01674621|449170674|FG003|Overall Study|Other than specified|0|||
124876478|NCT01674621|449170675|FG004|Overall Study|Other than specified|2|||
124876479|NCT01859793|449170676|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
124876480|NCT01859793|449170677|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
124876481|NCT01859793|449170676|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
124876482|NCT01859793|449170677|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
124876483|NCT01859793|449170676|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
124876484|NCT01859793|449170677|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
124876485|NCT01859793|449170676|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
124876486|NCT01859793|449170677|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
124876487|NCT01735396|449170678|FG000|Overall Study|not evaluable|1|||
124876488|NCT01148862|449170679|FG000|Second Intervention|Withdrawal by Subject|0|||
124876489|NCT01148862|449170680|FG001|Second Intervention|Withdrawal by Subject|2|||
124876490|NCT03724396|449170682|FG000|Overall Study|Lost to Follow-up|1|||
124876491|NCT03724396|449170683|FG001|Overall Study|Lost to Follow-up|1|||
124876492|NCT03724396|449170682|FG000|Overall Study|Withdrawal by Subject|1|||
124876493|NCT03724396|449170683|FG001|Overall Study|Withdrawal by Subject|0|||
124876494|NCT05158296|449170684|FG000|Overall Study|Sponsor Decision|2|||
124876495|NCT05158296|449170685|FG001|Overall Study|Sponsor Decision|3|||
124876496|NCT05158296|449170686|FG002|Overall Study|Sponsor Decision|2|||
124876497|NCT02404389|449170687|FG000|Overall Study|Adverse Event|1|||
124876498|NCT02404389|449170688|FG001|Overall Study|Adverse Event|0|||
124876499|NCT02404389|449170689|FG002|Overall Study|Adverse Event|1|||
124876500|NCT02404389|449170690|FG003|Overall Study|Adverse Event|0|||
124876501|NCT02404389|449170691|FG004|Overall Study|Adverse Event|2|||
124876502|NCT02404389|449170687|FG000|Overall Study|Subject/guardian decision|1|||
124876503|NCT02404389|449170688|FG001|Overall Study|Subject/guardian decision|0|||
124876504|NCT02404389|449170689|FG002|Overall Study|Subject/guardian decision|0|||
124876505|NCT02404389|449170690|FG003|Overall Study|Subject/guardian decision|1|||
124876506|NCT02404389|449170691|FG004|Overall Study|Subject/guardian decision|1|||
124876507|NCT00652938|449170698|FG000|Overall Study|Adverse Event|1|||
124876508|NCT00652938|449170699|FG001|Overall Study|Adverse Event|0|||
124876509|NCT00652938|449170700|FG002|Overall Study|Adverse Event|2|||
125012622|NCT04329702|449672983|FG001|Overall Study|Death|2|||
125012623|NCT04329702|449672984|FG002|Overall Study|Death|0|||
125012624|NCT01438489|449672985|FG000|Overall Study|Lost to Follow-up|4|||
125012625|NCT01438489|449672986|FG001|Overall Study|Lost to Follow-up|2|||
125012626|NCT01438489|449672987|FG002|Overall Study|Lost to Follow-up|2|||
125012627|NCT01438489|449672985|FG000|Overall Study|Withdrawal by Subject|11|||
125012628|NCT01438489|449672986|FG001|Overall Study|Withdrawal by Subject|3|||
125012629|NCT01438489|449672987|FG002|Overall Study|Withdrawal by Subject|8|||
125012630|NCT01438489|449672985|FG000|Overall Study|Death|0|||
125012631|NCT01438489|449672986|FG001|Overall Study|Death|0|||
124876510|NCT00652938|449170698|FG000|Overall Study|Withdrawal by Subject|0|||
125012632|NCT01438489|449672987|FG002|Overall Study|Death|1|||
124876511|NCT00652938|449170699|FG001|Overall Study|Withdrawal by Subject|6|||
124876512|NCT00652938|449170700|FG002|Overall Study|Withdrawal by Subject|1|||
124876513|NCT00652938|449170698|FG000|Overall Study|Lost to Follow-up|0|||
124876514|NCT00652938|449170699|FG001|Overall Study|Lost to Follow-up|0|||
124876515|NCT00652938|449170700|FG002|Overall Study|Lost to Follow-up|2|||
124876516|NCT00652938|449170698|FG000|Overall Study|fear of blood sampling|0|||
124876517|NCT00652938|449170699|FG001|Overall Study|fear of blood sampling|1|||
124876518|NCT00652938|449170700|FG002|Overall Study|fear of blood sampling|0|||
125012633|NCT01438489|449672985|FG000|Overall Study|Sponsor decision|4|||
124876519|NCT01412801|449170701|FG000|Overall Study|Death|0|||
124876520|NCT01412801|449170702|FG001|Overall Study|Death|1|||
124876521|NCT01412801|449170703|FG002|Overall Study|Death|0|||
124876522|NCT01412801|449170704|FG003|Overall Study|Death|4|||
124876523|NCT01412801|449170705|FG004|Overall Study|Death|2|||
124876524|NCT01412801|449170706|FG005|Overall Study|Death|2|||
124876525|NCT01412801|449170701|FG000|Overall Study|Lost to Follow-up|1|||
125012634|NCT01438489|449672986|FG001|Overall Study|Sponsor decision|1|||
125012635|NCT01438489|449672987|FG002|Overall Study|Sponsor decision|4|||
125012636|NCT01438489|449672985|FG000|Overall Study|Subject choice/Subject moved|2|||
125012637|NCT01438489|449672986|FG001|Overall Study|Subject choice/Subject moved|1|||
125012638|NCT01438489|449672987|FG002|Overall Study|Subject choice/Subject moved|1|||
125012639|NCT01438489|449672985|FG000|Overall Study|Investigator decision|0|||
125012640|NCT01438489|449672986|FG001|Overall Study|Investigator decision|1|||
125012641|NCT01438489|449672987|FG002|Overall Study|Investigator decision|0|||
125012642|NCT01438489|449672985|FG000|Overall Study|AE/SAEs|2|||
125012643|NCT01438489|449672986|FG001|Overall Study|AE/SAEs|1|||
125012644|NCT01438489|449672987|FG002|Overall Study|AE/SAEs|1|||
125012645|NCT01438489|449672985|FG000|Overall Study|Received prohibited medication|1|||
125012646|NCT01438489|449672986|FG001|Overall Study|Received prohibited medication|0|||
125012647|NCT01438489|449672987|FG002|Overall Study|Received prohibited medication|0|||
125012648|NCT01438489|449672985|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
125012649|NCT01438489|449672986|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
125012650|NCT01438489|449672987|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
125012651|NCT01438489|449672985|FG000|Overall Study|Inadequate venous access|0|||
125012652|NCT01438489|449672986|FG001|Overall Study|Inadequate venous access|2|||
125012653|NCT01438489|449672987|FG002|Overall Study|Inadequate venous access|0|||
125012654|NCT00766532|449672988|FG000|Overall Study|Protocol Violation|2|||
125012655|NCT02037295|449672989|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
125012656|NCT02037295|449672990|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
125012657|NCT02037295|449672991|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
125012658|NCT02037295|449672992|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
125012659|NCT01140451|449672993|FG000|Overall Study|Withdrawal by Subject|26|||
125012660|NCT01140451|449672994|FG001|Overall Study|Withdrawal by Subject|33|||
125012661|NCT01140451|449672993|FG000|Overall Study|Adverse Event|2|||
125012662|NCT01140451|449672994|FG001|Overall Study|Adverse Event|6|||
125012663|NCT01140451|449672993|FG000|Overall Study|Physician Decision|5|||
125012664|NCT01140451|449672994|FG001|Overall Study|Physician Decision|3|||
125012665|NCT01140451|449672993|FG000|Overall Study|Lost to Follow-up|2|||
125012666|NCT01140451|449672994|FG001|Overall Study|Lost to Follow-up|0|||
125012667|NCT01140451|449672993|FG000|Overall Study|Participants Planning Pregnancy|3|||
125012668|NCT01140451|449672994|FG001|Overall Study|Participants Planning Pregnancy|0|||
125012669|NCT00960661|449672998|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
125012670|NCT00960661|449672999|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
125012671|NCT00960661|449673000|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
125012672|NCT00960661|449672998|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
125012673|NCT00960661|449672999|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
125012674|NCT00960661|449673000|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
125012675|NCT00960661|449672998|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
125012676|NCT00960661|449672999|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
125012677|NCT00960661|449673000|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
125012678|NCT00960661|449672998|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
125012679|NCT00960661|449672999|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
125012680|NCT00960661|449673000|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
125012681|NCT00960661|449672998|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
125012682|NCT00960661|449672999|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
125012683|NCT00960661|449673000|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
125012684|NCT00960661|449672998|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
125012685|NCT00960661|449672999|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
125012686|NCT00960661|449673000|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
125012687|NCT00960661|449672998|FG000|Interventional Phase|Adverse Event|0|||
125012688|NCT00960661|449672999|FG001|Interventional Phase|Adverse Event|17|||
125012689|NCT00960661|449673000|FG002|Interventional Phase|Adverse Event|8|||
125012690|NCT00960661|449672998|FG000|Interventional Phase|Death|0|||
125012691|NCT00960661|449672999|FG001|Interventional Phase|Death|1|||
125012692|NCT00960661|449673000|FG002|Interventional Phase|Death|0|||
125012693|NCT00960661|449672998|FG000|Interventional Phase|Lost to Follow-up|0|||
125012694|NCT00960661|449672999|FG001|Interventional Phase|Lost to Follow-up|0|||
125012695|NCT00960661|449673000|FG002|Interventional Phase|Lost to Follow-up|2|||
125012696|NCT00960661|449672998|FG000|Interventional Phase|entry criteria not met|0|||
124876526|NCT01412801|449170702|FG001|Overall Study|Lost to Follow-up|2|||
124876527|NCT01412801|449170703|FG002|Overall Study|Lost to Follow-up|4|||
124876528|NCT01412801|449170704|FG003|Overall Study|Lost to Follow-up|0|||
125101058|NCT00320801|449991072|FG000|Extension Phase|Withdrawal by Subject|0|||
125101059|NCT00320801|449991073|FG001|Extension Phase|Withdrawal by Subject|0|||
125101060|NCT00320801|449991074|FG002|Extension Phase|Withdrawal by Subject|0|||
125101061|NCT00320801|449991075|FG003|Extension Phase|Withdrawal by Subject|6|||
125101062|NCT00320801|449991072|FG000|Extension Phase|Adverse Event|0|||
125101063|NCT00320801|449991073|FG001|Extension Phase|Adverse Event|0|||
125101064|NCT00320801|449991074|FG002|Extension Phase|Adverse Event|0|||
125101065|NCT00320801|449991075|FG003|Extension Phase|Adverse Event|8|||
125101066|NCT00320801|449991072|FG000|Extension Phase|Administrative|0|||
125101067|NCT00320801|449991073|FG001|Extension Phase|Administrative|0|||
125101068|NCT00320801|449991074|FG002|Extension Phase|Administrative|0|||
125101069|NCT00320801|449991075|FG003|Extension Phase|Administrative|29|||
125101070|NCT00320801|449991072|FG000|Extension Phase|Lack of Efficacy|0|||
125101071|NCT00320801|449991073|FG001|Extension Phase|Lack of Efficacy|0|||
125101072|NCT00320801|449991074|FG002|Extension Phase|Lack of Efficacy|0|||
125101073|NCT00320801|449991075|FG003|Extension Phase|Lack of Efficacy|2|||
125101074|NCT00320801|449991072|FG000|Extension Phase|Lost to Follow-up|0|||
125101075|NCT00320801|449991073|FG001|Extension Phase|Lost to Follow-up|0|||
125101076|NCT00320801|449991074|FG002|Extension Phase|Lost to Follow-up|0|||
125101077|NCT00320801|449991075|FG003|Extension Phase|Lost to Follow-up|3|||
125101078|NCT00577031|449991076|FG000|Overall Study|Adverse Event|52|||
125101079|NCT00577031|449991076|FG000|Overall Study|Progression of disease|93|||
125101080|NCT00577031|449991076|FG000|Overall Study|Protocol Violation|5|||
125101081|NCT00577031|449991076|FG000|Overall Study|Participant withdrew consent|13|||
125101082|NCT00577031|449991076|FG000|Overall Study|Participant non-compliance|5|||
125101083|NCT00577031|449991076|FG000|Overall Study|Need for surgery|17|||
125101084|NCT00577031|449991076|FG000|Overall Study|Medical decision|14|||
125101085|NCT00577031|449991076|FG000|Overall Study|Death|6|||
125101086|NCT06067191|449991077|FG000|Overall Study|Withdrawal by Subject|0|||
125101087|NCT06067191|449991078|FG001|Overall Study|Withdrawal by Subject|1|||
125101088|NCT04764669|449991080|FG000|Overall Study|Adverse Event|1|||
125101089|NCT04764669|449991081|FG001|Overall Study|Adverse Event|0|||
125101090|NCT04764669|449991082|FG002|Overall Study|Adverse Event|1|||
125101091|NCT04764669|449991083|FG003|Overall Study|Adverse Event|0|||
125101092|NCT04764669|449991080|FG000|Overall Study|Subject Choice|0|||
125101093|NCT04764669|449991081|FG001|Overall Study|Subject Choice|0|||
125101094|NCT04764669|449991082|FG002|Overall Study|Subject Choice|1|||
125101095|NCT04764669|449991083|FG003|Overall Study|Subject Choice|0|||
125101096|NCT04764669|449991080|FG000|Overall Study|Withdrawal by Subject|2|||
125101097|NCT04764669|449991081|FG001|Overall Study|Withdrawal by Subject|0|||
125101098|NCT04764669|449991082|FG002|Overall Study|Withdrawal by Subject|0|||
125101099|NCT04764669|449991083|FG003|Overall Study|Withdrawal by Subject|0|||
125101100|NCT00890409|449991086|FG000|Overall Study|Lost to Follow-up|20|||
125101101|NCT00890409|449991087|FG001|Overall Study|Lost to Follow-up|21|||
125101102|NCT01067339|449991088|FG000|Overall Study|Withdrawal by Subject|6|||
125101103|NCT01067339|449991089|FG001|Overall Study|Withdrawal by Subject|5|||
125101104|NCT00455923|449991092|FG000|Overall Study|Pregnancy|0|||
125101105|NCT00455923|449991093|FG001|Overall Study|Pregnancy|2|||
125101106|NCT00455923|449991092|FG000|Overall Study|Other|3|||
125101107|NCT00455923|449991093|FG001|Overall Study|Other|1|||
125101108|NCT00769132|449991096|FG000|Period 1|Adverse Event|1|||
125101109|NCT00769132|449991097|FG001|Period 1|Adverse Event|0|||
125101110|NCT00769132|449991098|FG002|Period 1|Adverse Event|0|||
125101111|NCT00769132|449991099|FG003|Period 1|Adverse Event|1|||
125101112|NCT00769132|449991096|FG000|Period 2|Withdrawal by Subject|0|||
125101113|NCT00769132|449991097|FG001|Period 2|Withdrawal by Subject|0|||
125101114|NCT00769132|449991098|FG002|Period 2|Withdrawal by Subject|0|||
125101115|NCT00769132|449991099|FG003|Period 2|Withdrawal by Subject|1|||
125101116|NCT00769132|449991096|FG000|Period 3|Withdrawal by Subject|1|||
125101117|NCT00769132|449991097|FG001|Period 3|Withdrawal by Subject|0|||
125101118|NCT00769132|449991098|FG002|Period 3|Withdrawal by Subject|0|||
125101119|NCT00769132|449991099|FG003|Period 3|Withdrawal by Subject|0|||
125101120|NCT00769132|449991096|FG000|Period 4|Withdrawal by Subject|0|||
125101121|NCT00769132|449991097|FG001|Period 4|Withdrawal by Subject|1|||
125101122|NCT00769132|449991098|FG002|Period 4|Withdrawal by Subject|0|||
125101123|NCT00769132|449991099|FG003|Period 4|Withdrawal by Subject|0|||
125101124|NCT02230332|449991100|FG000|Overall Study|Adverse Event|2|||
125101125|NCT02230332|449991101|FG001|Overall Study|Adverse Event|1|||
125101126|NCT02230332|449991100|FG000|Overall Study|Lost to Follow-up|1|||
125101127|NCT02230332|449991101|FG001|Overall Study|Lost to Follow-up|0|||
125101128|NCT02230332|449991100|FG000|Overall Study|Protocol Violation|1|||
125101129|NCT02230332|449991101|FG001|Overall Study|Protocol Violation|0|||
125101130|NCT00877799|449991103|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
125101131|NCT00877799|449991104|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
125101132|NCT00877799|449991105|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
125101133|NCT00877799|449991106|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
125101134|NCT00877799|449991107|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
125101135|NCT00877799|449991103|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
125101136|NCT00877799|449991104|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
124876529|NCT01412801|449170705|FG004|Overall Study|Lost to Follow-up|1|||
124876530|NCT01412801|449170706|FG005|Overall Study|Lost to Follow-up|1|||
124876531|NCT01412801|449170701|FG000|Overall Study|Withdrawal by Subject|3|||
124876532|NCT01412801|449170702|FG001|Overall Study|Withdrawal by Subject|2|||
124876533|NCT01412801|449170703|FG002|Overall Study|Withdrawal by Subject|1|||
124876534|NCT01412801|449170704|FG003|Overall Study|Withdrawal by Subject|0|||
124876535|NCT01412801|449170705|FG004|Overall Study|Withdrawal by Subject|0|||
124876536|NCT01412801|449170706|FG005|Overall Study|Withdrawal by Subject|0|||
124876537|NCT01412801|449170701|FG000|Overall Study|Relocated to another area|0|||
124876538|NCT01412801|449170702|FG001|Overall Study|Relocated to another area|0|||
124876539|NCT01412801|449170703|FG002|Overall Study|Relocated to another area|2|||
124876540|NCT01412801|449170704|FG003|Overall Study|Relocated to another area|0|||
124876541|NCT01412801|449170705|FG004|Overall Study|Relocated to another area|0|||
124876542|NCT01412801|449170706|FG005|Overall Study|Relocated to another area|0|||
124876543|NCT02978443|449170707|FG000|Overall Study|Withdrawal by Subject|1|||
124876544|NCT02978443|449170707|FG000|Overall Study|Adverse Event|3|||
124876545|NCT02978443|449170707|FG000|Overall Study|Disease Progression on study|6|||
124876546|NCT02978443|449170707|FG000|Overall Study|Death|1|||
124876547|NCT02978443|449170707|FG000|Overall Study|Physician Decision|1|||
124876548|NCT02978443|449170707|FG000|Overall Study|Switch to alternative therapy|1|||
124876549|NCT02978443|449170707|FG000|Overall Study|Refused further treatment|1|||
124876550|NCT01547299|449170708|FG000|Overall Study|Withdrawal by Subject|2|||
124876551|NCT01547299|449170709|FG001|Overall Study|Withdrawal by Subject|2|||
124876552|NCT01987817|449170710|FG000|Overall Study|Adverse Event|4|||
124876553|NCT01987817|449170711|FG001|Overall Study|Adverse Event|0|||
124876554|NCT01987817|449170710|FG000|Overall Study|Withdrawal by Subject|1|||
124876555|NCT01987817|449170711|FG001|Overall Study|Withdrawal by Subject|1|||
124876556|NCT01987817|449170710|FG000|Overall Study|Physician Decision|1|||
124876557|NCT01987817|449170711|FG001|Overall Study|Physician Decision|0|||
124876558|NCT01576718|449170712|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
124876559|NCT01576718|449170713|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124876560|NCT01576718|449170714|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124876561|NCT01576718|449170715|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124876562|NCT01576718|449170716|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124876563|NCT01576718|449170717|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124876564|NCT01576718|449170718|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124876565|NCT01576718|449170712|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
124876566|NCT01576718|449170713|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124876567|NCT01576718|449170714|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124876568|NCT01576718|449170715|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124876569|NCT01576718|449170716|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124876570|NCT01576718|449170717|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124876571|NCT01576718|449170718|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124876572|NCT01576718|449170712|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
124876573|NCT01576718|449170713|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124876574|NCT01576718|449170714|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124876575|NCT01576718|449170715|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124876576|NCT01576718|449170716|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125012697|NCT00960661|449672999|FG001|Interventional Phase|entry criteria not met|3|||
125012698|NCT00960661|449673000|FG002|Interventional Phase|entry criteria not met|0|||
125012699|NCT00960661|449672998|FG000|Interventional Phase|Protocol Violation|0|||
125012700|NCT00960661|449672999|FG001|Interventional Phase|Protocol Violation|7|||
125012701|NCT00960661|449673000|FG002|Interventional Phase|Protocol Violation|2|||
125012702|NCT00960661|449672998|FG000|Interventional Phase|Withdrawal by Subject|0|||
125012703|NCT00960661|449672999|FG001|Interventional Phase|Withdrawal by Subject|18|||
125012704|NCT00960661|449673000|FG002|Interventional Phase|Withdrawal by Subject|29|||
125012705|NCT00960661|449672998|FG000|Interventional Phase|Physician Decision|0|||
125012706|NCT00960661|449672999|FG001|Interventional Phase|Physician Decision|3|||
125012707|NCT00960661|449673000|FG002|Interventional Phase|Physician Decision|5|||
125012708|NCT00960661|449672998|FG000|Interventional Phase|sponsor decision|0|||
125012709|NCT00960661|449672999|FG001|Interventional Phase|sponsor decision|1|||
125012710|NCT00960661|449673000|FG002|Interventional Phase|sponsor decision|0|||
125012711|NCT00960661|449672998|FG000|Interventional Phase|Lack of Efficacy|0|||
125012712|NCT00960661|449672999|FG001|Interventional Phase|Lack of Efficacy|2|||
125012713|NCT00960661|449673000|FG002|Interventional Phase|Lack of Efficacy|0|||
124876577|NCT01576718|449170717|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124876578|NCT01576718|449170718|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124876579|NCT01576718|449170712|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
124876580|NCT01576718|449170713|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124876581|NCT01576718|449170714|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124876582|NCT01576718|449170715|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124876583|NCT01576718|449170716|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124876584|NCT01576718|449170717|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124876585|NCT01576718|449170718|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124876586|NCT01576718|449170712|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
124876587|NCT01576718|449170713|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124876588|NCT01576718|449170714|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124876589|NCT01576718|449170715|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124876590|NCT01576718|449170716|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124876591|NCT01576718|449170717|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124876592|NCT01576718|449170718|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124876593|NCT01576718|449170712|FG000|Treatment Period|Adverse Event|0|||
124876594|NCT01576718|449170713|FG001|Treatment Period|Adverse Event|1|||
124876595|NCT01576718|449170714|FG002|Treatment Period|Adverse Event|1|||
124876596|NCT01576718|449170715|FG003|Treatment Period|Adverse Event|1|||
124876597|NCT01576718|449170716|FG004|Treatment Period|Adverse Event|1|||
124876598|NCT01576718|449170717|FG005|Treatment Period|Adverse Event|1|||
124876599|NCT01576718|449170718|FG006|Treatment Period|Adverse Event|0|||
124876600|NCT01576718|449170712|FG000|Treatment Period|Withdrawal by Subject|0|||
124876601|NCT01576718|449170713|FG001|Treatment Period|Withdrawal by Subject|1|||
124876602|NCT01576718|449170714|FG002|Treatment Period|Withdrawal by Subject|1|||
124876603|NCT01576718|449170715|FG003|Treatment Period|Withdrawal by Subject|0|||
124876604|NCT01576718|449170716|FG004|Treatment Period|Withdrawal by Subject|2|||
124876605|NCT01576718|449170717|FG005|Treatment Period|Withdrawal by Subject|4|||
124876606|NCT01576718|449170718|FG006|Treatment Period|Withdrawal by Subject|2|||
124876607|NCT01576718|449170712|FG000|Treatment Period|Physician Decision|0|||
124876608|NCT01576718|449170713|FG001|Treatment Period|Physician Decision|1|||
124876609|NCT01576718|449170714|FG002|Treatment Period|Physician Decision|1|||
124876610|NCT01576718|449170715|FG003|Treatment Period|Physician Decision|1|||
124876611|NCT01576718|449170716|FG004|Treatment Period|Physician Decision|1|||
124876612|NCT01576718|449170717|FG005|Treatment Period|Physician Decision|0|||
124876613|NCT01576718|449170718|FG006|Treatment Period|Physician Decision|0|||
124876614|NCT01576718|449170712|FG000|Treatment Period|Protocol Violation|0|||
124876615|NCT01576718|449170713|FG001|Treatment Period|Protocol Violation|5|||
124876616|NCT01576718|449170714|FG002|Treatment Period|Protocol Violation|4|||
124876617|NCT01576718|449170715|FG003|Treatment Period|Protocol Violation|10|||
124876618|NCT01576718|449170716|FG004|Treatment Period|Protocol Violation|6|||
124876619|NCT01576718|449170717|FG005|Treatment Period|Protocol Violation|8|||
124876620|NCT01576718|449170718|FG006|Treatment Period|Protocol Violation|12|||
124876621|NCT01576718|449170712|FG000|Treatment Period|Sponsor request|0|||
124876622|NCT01576718|449170713|FG001|Treatment Period|Sponsor request|1|||
125012714|NCT02699892|449673001|FG000|Overall Study|Other|36|||
125101137|NCT00877799|449991105|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
125101138|NCT00877799|449991106|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
125101139|NCT00877799|449991107|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
125101140|NCT00877799|449991103|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
125012715|NCT01324232|449673008|FG000|Overall Study|Protocol Violation|0|||
125012716|NCT01324232|449673009|FG001|Overall Study|Protocol Violation|0|||
125012717|NCT01324232|449673010|FG002|Overall Study|Protocol Violation|0|||
125012718|NCT01324232|449673011|FG003|Overall Study|Protocol Violation|2|||
125012719|NCT01324232|449673008|FG000|Overall Study|Missing|0|||
125012720|NCT01324232|449673009|FG001|Overall Study|Missing|0|||
125012721|NCT01324232|449673010|FG002|Overall Study|Missing|1|||
125012722|NCT01324232|449673011|FG003|Overall Study|Missing|0|||
125012723|NCT01324232|449673008|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
125012724|NCT01324232|449673009|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
125012725|NCT01324232|449673010|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
125012726|NCT01324232|449673011|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
125012727|NCT01324232|449673008|FG000|Overall Study|Lack of Efficacy|2|||
125012728|NCT01324232|449673009|FG001|Overall Study|Lack of Efficacy|1|||
125012729|NCT01324232|449673010|FG002|Overall Study|Lack of Efficacy|2|||
125012730|NCT01324232|449673011|FG003|Overall Study|Lack of Efficacy|2|||
125012731|NCT01324232|449673008|FG000|Overall Study|Participant Refused Medication|0|||
125012732|NCT01324232|449673009|FG001|Overall Study|Participant Refused Medication|1|||
125012733|NCT01324232|449673010|FG002|Overall Study|Participant Refused Medication|0|||
125012734|NCT01324232|449673011|FG003|Overall Study|Participant Refused Medication|0|||
124876623|NCT01576718|449170714|FG002|Treatment Period|Sponsor request|0|||
124876624|NCT01576718|449170715|FG003|Treatment Period|Sponsor request|0|||
124876625|NCT01576718|449170716|FG004|Treatment Period|Sponsor request|0|||
124876626|NCT01576718|449170717|FG005|Treatment Period|Sponsor request|1|||
124876627|NCT01576718|449170718|FG006|Treatment Period|Sponsor request|0|||
124876628|NCT01576718|449170712|FG000|Treatment Period|Met stopping criteria|0|||
125012735|NCT01324232|449673008|FG000|Overall Study|Intercurrent illness|0|||
124876629|NCT01576718|449170713|FG001|Treatment Period|Met stopping criteria|16|||
124876630|NCT01576718|449170714|FG002|Treatment Period|Met stopping criteria|13|||
124876631|NCT01576718|449170715|FG003|Treatment Period|Met stopping criteria|19|||
124876632|NCT01576718|449170716|FG004|Treatment Period|Met stopping criteria|16|||
124876633|NCT01576718|449170717|FG005|Treatment Period|Met stopping criteria|33|||
124876634|NCT01576718|449170718|FG006|Treatment Period|Met stopping criteria|15|||
124876635|NCT01576718|449170712|FG000|Treatment Period|Lost to Follow-up|0|||
124876636|NCT01576718|449170713|FG001|Treatment Period|Lost to Follow-up|0|||
124876637|NCT01576718|449170714|FG002|Treatment Period|Lost to Follow-up|0|||
125012736|NCT01324232|449673009|FG001|Overall Study|Intercurrent illness|0|||
125012737|NCT01324232|449673010|FG002|Overall Study|Intercurrent illness|0|||
125012738|NCT01324232|449673011|FG003|Overall Study|Intercurrent illness|1|||
125012739|NCT01324232|449673008|FG000|Overall Study|Adverse Event|2|||
125012740|NCT01324232|449673009|FG001|Overall Study|Adverse Event|5|||
125012741|NCT01324232|449673010|FG002|Overall Study|Adverse Event|6|||
125012742|NCT01324232|449673011|FG003|Overall Study|Adverse Event|6|||
125012743|NCT01324232|449673008|FG000|Overall Study|Withdrawal by Subject|0|||
125012744|NCT01324232|449673009|FG001|Overall Study|Withdrawal by Subject|3|||
125012745|NCT01324232|449673010|FG002|Overall Study|Withdrawal by Subject|4|||
125012746|NCT01324232|449673011|FG003|Overall Study|Withdrawal by Subject|0|||
125012747|NCT01324232|449673008|FG000|Overall Study|Lost to Follow-up|1|||
125012748|NCT01324232|449673009|FG001|Overall Study|Lost to Follow-up|0|||
125012749|NCT01324232|449673010|FG002|Overall Study|Lost to Follow-up|0|||
125012750|NCT01324232|449673011|FG003|Overall Study|Lost to Follow-up|0|||
125012751|NCT00661531|449673012|FG000|Overall Study|Withdrawal by Subject|3|||
125012752|NCT02614859|449673013|FG000|Overall Study|Physician Decision|0|||
125012753|NCT02614859|449673014|FG001|Overall Study|Physician Decision|1|||
125012754|NCT02184195|449673015|FG000|Overall Study|Patient decision|5|||
125012755|NCT02184195|449673016|FG001|Overall Study|Patient decision|2|||
125012756|NCT02184195|449673015|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125012757|NCT02184195|449673016|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
125012758|NCT02184195|449673015|FG000|Overall Study|Death|67|||
125012759|NCT02184195|449673016|FG001|Overall Study|Death|44|||
125012760|NCT02184195|449673015|FG000|Overall Study|Lost to Follow-up|1|||
125012761|NCT02184195|449673016|FG001|Overall Study|Lost to Follow-up|5|||
125012762|NCT02184195|449673015|FG000|Overall Study|Other|0|||
125012763|NCT02184195|449673016|FG001|Overall Study|Other|3|||
125012764|NCT01227044|449673017|FG000|Overall Study|Lost to Follow-up|5|||
125012765|NCT01227044|449673018|FG001|Overall Study|Lost to Follow-up|7|||
125101141|NCT00877799|449991104|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
125101142|NCT00877799|449991105|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
125101143|NCT00877799|449991106|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
125101144|NCT00877799|449991107|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
125101145|NCT00877799|449991103|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
125101146|NCT00877799|449991104|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
125101147|NCT00877799|449991105|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
125101148|NCT00877799|449991106|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
125101149|NCT00877799|449991107|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
125101150|NCT00877799|449991103|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
125101151|NCT00877799|449991104|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
125101152|NCT00877799|449991105|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
125101153|NCT00877799|449991106|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
125101154|NCT00877799|449991107|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
125101155|NCT04054011|449991108|FG000|Overall Study|COVID|3|||
125101156|NCT00669110|449991112|FG000|Overall Study|Adverse Event|4|||
125101157|NCT00669110|449991113|FG001|Overall Study|Adverse Event|3|||
125101158|NCT00669110|449991112|FG000|Overall Study|Caregiver request|3|||
125101159|NCT00669110|449991113|FG001|Overall Study|Caregiver request|2|||
125101160|NCT00669110|449991112|FG000|Overall Study|Physician Decision|0|||
125101161|NCT00669110|449991113|FG001|Overall Study|Physician Decision|1|||
125101162|NCT00669110|449991112|FG000|Overall Study|Lost to Follow-up|1|||
125101163|NCT00669110|449991113|FG001|Overall Study|Lost to Follow-up|0|||
125101164|NCT00669110|449991112|FG000|Overall Study|Protocol Violation|0|||
124876638|NCT01576718|449170715|FG003|Treatment Period|Lost to Follow-up|0|||
124876639|NCT01576718|449170716|FG004|Treatment Period|Lost to Follow-up|1|||
124876640|NCT01576718|449170717|FG005|Treatment Period|Lost to Follow-up|0|||
125101165|NCT00669110|449991113|FG001|Overall Study|Protocol Violation|5|||
125101166|NCT00669110|449991112|FG000|Overall Study|Withdrawal by Subject|0|||
124876641|NCT01576718|449170718|FG006|Treatment Period|Lost to Follow-up|0|||
124876642|NCT01576718|449170712|FG000|Treatment Period|Noncompliance to study medication|0|||
124876643|NCT01576718|449170713|FG001|Treatment Period|Noncompliance to study medication|0|||
124876644|NCT01576718|449170714|FG002|Treatment Period|Noncompliance to study medication|0|||
124876645|NCT01576718|449170715|FG003|Treatment Period|Noncompliance to study medication|0|||
124876646|NCT01576718|449170716|FG004|Treatment Period|Noncompliance to study medication|0|||
124876647|NCT01576718|449170717|FG005|Treatment Period|Noncompliance to study medication|1|||
124876648|NCT01576718|449170718|FG006|Treatment Period|Noncompliance to study medication|1|||
124876649|NCT01336621|449170719|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
124876650|NCT01336621|449170719|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
124876651|NCT01336621|449170719|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
124876652|NCT01336621|449170719|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
124876653|NCT01336621|449170719|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
124876654|NCT01336621|449170719|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
124876655|NCT01336621|449170719|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
124876656|NCT01336621|449170719|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
124876657|NCT01336621|449170719|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
124876658|NCT01336621|449170719|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
124876659|NCT01336621|449170719|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
124876660|NCT01336621|449170719|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
125101167|NCT00669110|449991113|FG001|Overall Study|Withdrawal by Subject|2|||
125101168|NCT00127192|449991114|FG000|Overall Study|Adverse Event|0|||
125101169|NCT00127192|449991115|FG001|Overall Study|Adverse Event|1|||
125101170|NCT00127192|449991116|FG002|Overall Study|Adverse Event|1|||
125101171|NCT00127192|449991117|FG003|Overall Study|Adverse Event|1|||
125101172|NCT00127192|449991118|FG004|Overall Study|Adverse Event|0|||
125101173|NCT00127192|449991114|FG000|Overall Study|Lack of Efficacy|2|||
125101174|NCT00127192|449991115|FG001|Overall Study|Lack of Efficacy|0|||
125101175|NCT00127192|449991116|FG002|Overall Study|Lack of Efficacy|0|||
125101176|NCT00127192|449991117|FG003|Overall Study|Lack of Efficacy|0|||
125101177|NCT00127192|449991118|FG004|Overall Study|Lack of Efficacy|2|||
125101178|NCT00127192|449991114|FG000|Overall Study|Withdrawal by Subject|0|||
125101179|NCT00127192|449991115|FG001|Overall Study|Withdrawal by Subject|0|||
125101180|NCT00127192|449991116|FG002|Overall Study|Withdrawal by Subject|1|||
125101181|NCT00127192|449991117|FG003|Overall Study|Withdrawal by Subject|0|||
125101182|NCT00127192|449991118|FG004|Overall Study|Withdrawal by Subject|3|||
125101183|NCT00127192|449991114|FG000|Overall Study|Adverse event in pre-treatment period|1|||
125101184|NCT00127192|449991115|FG001|Overall Study|Adverse event in pre-treatment period|0|||
125101185|NCT00127192|449991116|FG002|Overall Study|Adverse event in pre-treatment period|0|||
125101186|NCT00127192|449991117|FG003|Overall Study|Adverse event in pre-treatment period|0|||
125101187|NCT00127192|449991118|FG004|Overall Study|Adverse event in pre-treatment period|0|||
125101188|NCT00227591|449991121|FG000|Overall Study|Withdrawal by Subject|1|||
125101189|NCT00077766|449991122|FG000|Overall Study|Adverse Event|1|||
125101190|NCT00077766|449991123|FG001|Overall Study|Adverse Event|1|||
125101191|NCT00077766|449991122|FG000|Overall Study|Withdrawal by Subject|4|||
125101192|NCT00077766|449991123|FG001|Overall Study|Withdrawal by Subject|3|||
125101193|NCT00077766|449991122|FG000|Overall Study|Death|12|||
125101194|NCT00077766|449991123|FG001|Overall Study|Death|10|||
125101195|NCT00077766|449991122|FG000|Overall Study|Lost to Follow-up|2|||
125101196|NCT00077766|449991123|FG001|Overall Study|Lost to Follow-up|0|||
125101197|NCT00077766|449991122|FG000|Overall Study|Protocol Violation|1|||
125101198|NCT00077766|449991123|FG001|Overall Study|Protocol Violation|0|||
125101199|NCT00077766|449991122|FG000|Overall Study|Kidney Transplantation|9|||
125101200|NCT00077766|449991123|FG001|Overall Study|Kidney Transplantation|5|||
125101201|NCT00077766|449991122|FG000|Overall Study|Transplantation|5|||
125101202|NCT00077766|449991123|FG001|Overall Study|Transplantation|1|||
125101203|NCT00077766|449991122|FG000|Overall Study|Investigators Discretion|1|||
125101204|NCT00077766|449991123|FG001|Overall Study|Investigators Discretion|0|||
125101205|NCT00077766|449991122|FG000|Overall Study|Participant's decision|1|||
125101206|NCT00077766|449991123|FG001|Overall Study|Participant's decision|0|||
125101207|NCT00077766|449991122|FG000|Overall Study|Dialysis Discontinued|1|||
125101208|NCT00077766|449991123|FG001|Overall Study|Dialysis Discontinued|0|||
125101209|NCT00077766|449991122|FG000|Overall Study|Dialysis|0|||
125101210|NCT00077766|449991123|FG001|Overall Study|Dialysis|1|||
125101211|NCT00077766|449991122|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
125101212|NCT00077766|449991123|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
125101213|NCT00077766|449991122|FG000|Overall Study|Started Nocturnal Dialysis|0|||
124876661|NCT01336621|449170719|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
125101214|NCT00077766|449991123|FG001|Overall Study|Started Nocturnal Dialysis|1|||
125101215|NCT00077766|449991122|FG000|Overall Study|Stop Dialysis|0|||
124876662|NCT01336621|449170719|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
124876663|NCT00682643|449170724|FG000|Overall Study|Adverse Event|12|||
124876664|NCT00682643|449170725|FG001|Overall Study|Adverse Event|23|||
124876665|NCT00682643|449170724|FG000|Overall Study|Lack of Efficacy|2|||
124876666|NCT00682643|449170725|FG001|Overall Study|Lack of Efficacy|0|||
124876667|NCT00682643|449170724|FG000|Overall Study|Protocol Violation|38|||
124876668|NCT00682643|449170725|FG001|Overall Study|Protocol Violation|76|||
124876669|NCT00682643|449170724|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
124876670|NCT00682643|449170725|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
124876671|NCT00682643|449170724|FG000|Overall Study|Lost to Follow-up|1|||
124876672|NCT00682643|449170725|FG001|Overall Study|Lost to Follow-up|6|||
124876673|NCT00682643|449170724|FG000|Overall Study|Physician Decision|2|||
124876674|NCT00682643|449170725|FG001|Overall Study|Physician Decision|6|||
124876675|NCT00682643|449170724|FG000|Overall Study|Withdrawal by Subject|19|||
124876676|NCT00682643|449170725|FG001|Overall Study|Withdrawal by Subject|53|||
124876677|NCT00682643|449170724|FG000|Overall Study|Did Not Receive Study Drug|1|||
124876678|NCT00682643|449170725|FG001|Overall Study|Did Not Receive Study Drug|1|||
124876679|NCT00263328|449170729|FG000|Overall Study|Death|0|||
124876680|NCT00263328|449170730|FG001|Overall Study|Death|0|||
124876681|NCT00263328|449170731|FG002|Overall Study|Death|1|||
124876682|NCT00263328|449170729|FG000|Overall Study|Lost to Follow-up|1|||
124876683|NCT00263328|449170730|FG001|Overall Study|Lost to Follow-up|1|||
124876684|NCT00263328|449170731|FG002|Overall Study|Lost to Follow-up|0|||
124876685|NCT00263328|449170729|FG000|Overall Study|Withdrawal by Subject|3|||
124876686|NCT00263328|449170730|FG001|Overall Study|Withdrawal by Subject|0|||
124876687|NCT00263328|449170731|FG002|Overall Study|Withdrawal by Subject|1|||
124876688|NCT00263328|449170729|FG000|Overall Study|Other|3|||
124876689|NCT00263328|449170730|FG001|Overall Study|Other|0|||
124876690|NCT00263328|449170731|FG002|Overall Study|Other|1|||
124876691|NCT00263328|449170729|FG000|Overall Study|Adverse Event|1|||
124876692|NCT00263328|449170730|FG001|Overall Study|Adverse Event|1|||
124876693|NCT00263328|449170731|FG002|Overall Study|Adverse Event|4|||
124876694|NCT00622180|449170732|FG000|Overall Study|Lost to Follow-up|1|||
124876695|NCT00622180|449170733|FG001|Overall Study|Lost to Follow-up|2|||
124876696|NCT04512066|449170736|FG000|Double-blind Treatment Period|Adverse Event|6|||
124876697|NCT04512066|449170737|FG001|Double-blind Treatment Period|Adverse Event|4|||
125012766|NCT01227044|449673017|FG000|Overall Study|Discontinued Intervention|1|||
125012767|NCT01227044|449673018|FG001|Overall Study|Discontinued Intervention|2|||
125012768|NCT00583362|449673019|FG000|Overall Study|Adverse Event|44|||
125012769|NCT00583362|449673019|FG000|Overall Study|Lack of Efficacy|22|||
124876698|NCT04512066|449170738|FG002|Double-blind Treatment Period|Adverse Event|5|||
124876699|NCT04512066|449170739|FG003|Double-blind Treatment Period|Adverse Event|1|||
124876700|NCT04512066|449170740|FG004|Double-blind Treatment Period|Adverse Event|0|||
124876701|NCT04512066|449170741|FG005|Double-blind Treatment Period|Adverse Event|0|||
125012770|NCT00583362|449673019|FG000|Overall Study|Lost to Follow-up|4|||
124876702|NCT04512066|449170736|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
124876703|NCT04512066|449170737|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
124876704|NCT04512066|449170738|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
125012771|NCT00583362|449673019|FG000|Overall Study|Non-compliance with study drug|28|||
125012772|NCT00583362|449673019|FG000|Overall Study|Pregnancy|7|||
124876705|NCT04512066|449170739|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
124876706|NCT04512066|449170740|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
124876707|NCT04512066|449170741|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
124876708|NCT04512066|449170736|FG000|Double-blind Treatment Period|Physician Decision|1|||
124876709|NCT04512066|449170737|FG001|Double-blind Treatment Period|Physician Decision|0|||
124876710|NCT04512066|449170738|FG002|Double-blind Treatment Period|Physician Decision|1|||
124876711|NCT04512066|449170739|FG003|Double-blind Treatment Period|Physician Decision|0|||
124876712|NCT04512066|449170740|FG004|Double-blind Treatment Period|Physician Decision|0|||
124876713|NCT04512066|449170741|FG005|Double-blind Treatment Period|Physician Decision|0|||
124876714|NCT04512066|449170736|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
124876715|NCT04512066|449170737|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
124876716|NCT04512066|449170738|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
124876717|NCT04512066|449170739|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
124876718|NCT04512066|449170740|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
124876719|NCT04512066|449170741|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
124876720|NCT04512066|449170736|FG000|Extension Period|Adverse Event|0|||
124876721|NCT04512066|449170737|FG001|Extension Period|Adverse Event|1|||
124876722|NCT04512066|449170738|FG002|Extension Period|Adverse Event|4|||
124876723|NCT04512066|449170739|FG003|Extension Period|Adverse Event|3|||
124876724|NCT04512066|449170740|FG004|Extension Period|Adverse Event|1|||
124876725|NCT04512066|449170741|FG005|Extension Period|Adverse Event|3|||
124876726|NCT04512066|449170736|FG000|Extension Period|Death|0|||
124876727|NCT04512066|449170737|FG001|Extension Period|Death|0|||
124876728|NCT04512066|449170738|FG002|Extension Period|Death|0|||
124876729|NCT04512066|449170739|FG003|Extension Period|Death|0|||
124876730|NCT04512066|449170740|FG004|Extension Period|Death|0|||
124876731|NCT04512066|449170741|FG005|Extension Period|Death|1|||
124876732|NCT04512066|449170736|FG000|Extension Period|Lack of Efficacy|0|||
124876733|NCT04512066|449170737|FG001|Extension Period|Lack of Efficacy|4|||
124876734|NCT04512066|449170738|FG002|Extension Period|Lack of Efficacy|4|||
124876735|NCT04512066|449170739|FG003|Extension Period|Lack of Efficacy|1|||
124876736|NCT04512066|449170740|FG004|Extension Period|Lack of Efficacy|3|||
124876737|NCT04512066|449170741|FG005|Extension Period|Lack of Efficacy|3|||
124876738|NCT04512066|449170736|FG000|Extension Period|Lost to Follow-up|0|||
124876739|NCT04512066|449170737|FG001|Extension Period|Lost to Follow-up|1|||
124876740|NCT04512066|449170738|FG002|Extension Period|Lost to Follow-up|5|||
124876741|NCT04512066|449170739|FG003|Extension Period|Lost to Follow-up|2|||
124876742|NCT04512066|449170740|FG004|Extension Period|Lost to Follow-up|3|||
124876743|NCT04512066|449170741|FG005|Extension Period|Lost to Follow-up|2|||
124876744|NCT04512066|449170736|FG000|Extension Period|Non-compliance with study drug|0|||
124876745|NCT04512066|449170737|FG001|Extension Period|Non-compliance with study drug|1|||
124876746|NCT04512066|449170738|FG002|Extension Period|Non-compliance with study drug|0|||
124876747|NCT04512066|449170739|FG003|Extension Period|Non-compliance with study drug|0|||
124876748|NCT04512066|449170740|FG004|Extension Period|Non-compliance with study drug|0|||
124876749|NCT04512066|449170741|FG005|Extension Period|Non-compliance with study drug|1|||
124876750|NCT04512066|449170736|FG000|Extension Period|Other|0|||
124876751|NCT04512066|449170737|FG001|Extension Period|Other|2|||
124876752|NCT04512066|449170738|FG002|Extension Period|Other|0|||
124876753|NCT04512066|449170739|FG003|Extension Period|Other|0|||
124876754|NCT04512066|449170740|FG004|Extension Period|Other|0|||
124876755|NCT04512066|449170741|FG005|Extension Period|Other|0|||
124876756|NCT04512066|449170736|FG000|Extension Period|Physician Decision|0|||
124876757|NCT04512066|449170737|FG001|Extension Period|Physician Decision|2|||
124876758|NCT04512066|449170738|FG002|Extension Period|Physician Decision|0|||
124876759|NCT04512066|449170739|FG003|Extension Period|Physician Decision|1|||
124876760|NCT04512066|449170740|FG004|Extension Period|Physician Decision|1|||
125101216|NCT00077766|449991123|FG001|Overall Study|Stop Dialysis|1|||
125101217|NCT00077766|449991122|FG000|Overall Study|Participants Vacation|2|||
125101218|NCT00077766|449991123|FG001|Overall Study|Participants Vacation|1|||
125101219|NCT01886105|449991124|FG000|Overall Study|Lack of Efficacy|3|||
125101220|NCT03843775|449991127|FG000|Overall Study|Adverse Event|1|||
125101221|NCT03843775|449991128|FG001|Overall Study|Adverse Event|1|||
125101222|NCT03843775|449991127|FG000|Overall Study|Lack of Efficacy|2|||
124876761|NCT04512066|449170741|FG005|Extension Period|Physician Decision|0|||
124876762|NCT04512066|449170736|FG000|Extension Period|Withdrawal by Subject|0|||
124876763|NCT04512066|449170737|FG001|Extension Period|Withdrawal by Subject|3|||
124876764|NCT04512066|449170738|FG002|Extension Period|Withdrawal by Subject|7|||
124876765|NCT04512066|449170739|FG003|Extension Period|Withdrawal by Subject|11|||
125101223|NCT03843775|449991128|FG001|Overall Study|Lack of Efficacy|6|||
125101224|NCT03843775|449991127|FG000|Overall Study|Withdrawal by Subject|0|||
124876766|NCT04512066|449170740|FG004|Extension Period|Withdrawal by Subject|8|||
124876767|NCT04512066|449170741|FG005|Extension Period|Withdrawal by Subject|4|||
124876768|NCT01833143|449170742|FG000|Overall Study|Not Treated|1|||
124876769|NCT03995784|449170743|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
124876770|NCT00284141|449172815|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
124876771|NCT00284141|449172815|FG000|Overall Study|Adverse Event|19|||
124876772|NCT00284141|449172815|FG000|Overall Study|Participant's request|9|||
124876773|NCT00284141|449172815|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
124876774|NCT00284141|449172815|FG000|Overall Study|Clinical deterioration / death|2|||
124876775|NCT00284141|449172815|FG000|Overall Study|General decline|1|||
124876776|NCT00284141|449172815|FG000|Overall Study|Pneumonia|1|||
124876777|NCT00284141|449172815|FG000|Overall Study|Did not take study medication|2|||
124876778|NCT00284141|449172815|FG000|Overall Study|Ongoing treatment|2|||
124876779|NCT00332332|449172816|FG000|Overall Study|Adverse Event|13|||
124876780|NCT00332332|449172816|FG000|Overall Study|Death|1|||
124876781|NCT00332332|449172816|FG000|Overall Study|Withdrawal by Subject|8|||
124876782|NCT00332332|449172816|FG000|Overall Study|Physician Decision|1|||
124876783|NCT00332332|449172816|FG000|Overall Study|Lost to Follow-up|3|||
124876784|NCT00332332|449172816|FG000|Overall Study|Protocol deviation|4|||
124876785|NCT00332332|449172816|FG000|Overall Study|Noncompliance|2|||
124876786|NCT00332332|449172816|FG000|Overall Study|Disease progression|2|||
124876787|NCT00332332|449172816|FG000|Overall Study|Other|18|||
124876788|NCT00332332|449172816|FG000|Overall Study|Did not receive study treatment|16|||
124876789|NCT01108458|449172817|FG000|Overall Study|Withdrawal by Subject|1|||
124876790|NCT01382602|449172818|FG000|Overall Study|Protocol Violation|0|||
124876791|NCT01382602|449172819|FG001|Overall Study|Protocol Violation|3|||
124876792|NCT01382602|449172818|FG000|Overall Study|Withdrawal by Subject|0|||
124876793|NCT01382602|449172819|FG001|Overall Study|Withdrawal by Subject|1|||
124876794|NCT04170686|449172820|FG000|Screening|Physician Decision|12|||
124876795|NCT04170686|449172821|FG001|Screening|Physician Decision|13|||
124876796|NCT04170686|449172820|FG000|Randomization and Treatment|Lost to Follow-up|26|||
124876797|NCT04170686|449172821|FG001|Randomization and Treatment|Lost to Follow-up|15|||
124876798|NCT03328143|449172822|FG000|Overall Study|Declined|3|||
124876799|NCT03328143|449172822|FG000|Overall Study|Required increased sedation|4|||
124876800|NCT03328143|449172822|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
124876801|NCT03328143|449172822|FG000|Overall Study|Surgery cancelled|1|||
124876802|NCT02801669|449172823|FG000|Overall Study|Death|66|||
124876803|NCT02801669|449172824|FG001|Overall Study|Death|69|||
124876804|NCT02801669|449172823|FG000|Overall Study|Withdrawal by Subject|81|||
124876805|NCT02801669|449172824|FG001|Overall Study|Withdrawal by Subject|77|||
124876806|NCT02801669|449172823|FG000|Overall Study|Other|4|||
124876807|NCT02801669|449172824|FG001|Overall Study|Other|6|||
124876808|NCT02696564|449172825|FG000|Overall Study|Death|1|||
124876809|NCT02696564|449172826|FG001|Overall Study|Death|2|||
124876810|NCT02696564|449172825|FG000|Overall Study|Withdrawal by Subject|3|||
124876811|NCT02696564|449172826|FG001|Overall Study|Withdrawal by Subject|2|||
124876812|NCT02696564|449172825|FG000|Overall Study|Lost to Follow-up|3|||
124876813|NCT02696564|449172826|FG001|Overall Study|Lost to Follow-up|3|||
124876814|NCT02696564|449172825|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
124876815|NCT02696564|449172826|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
124876816|NCT02696564|449172825|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
124876817|NCT02696564|449172826|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
124876818|NCT02696564|449172825|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
124876819|NCT02696564|449172826|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
124876820|NCT02696564|449172825|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
124876821|NCT02696564|449172826|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
124876822|NCT02696564|449172825|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
124876823|NCT02696564|449172826|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
124876824|NCT00615264|449172828|FG000|Overall Study|Withdrawal by Subject|17|||
125101225|NCT03843775|449991128|FG001|Overall Study|Withdrawal by Subject|1|||
124876825|NCT00615264|449172829|FG001|Overall Study|Withdrawal by Subject|19|||
124876826|NCT00615264|449172828|FG000|Overall Study|Lost to Follow-up|6|||
124876827|NCT00615264|449172829|FG001|Overall Study|Lost to Follow-up|13|||
124876828|NCT00615264|449172828|FG000|Overall Study|Adverse Event|8|||
124876829|NCT00615264|449172829|FG001|Overall Study|Adverse Event|5|||
124876830|NCT00615264|449172828|FG000|Overall Study|Death|1|||
124876831|NCT00615264|449172829|FG001|Overall Study|Death|1|||
124876832|NCT00615264|449172828|FG000|Overall Study|Protocol Violation|11|||
124876833|NCT00615264|449172829|FG001|Overall Study|Protocol Violation|7|||
124876834|NCT00615264|449172828|FG000|Overall Study|Not defined|7|||
124876835|NCT00615264|449172829|FG001|Overall Study|Not defined|4|||
124876836|NCT00615264|449172828|FG000|Overall Study|Dermal Hypersensitivity|0|||
124876837|NCT00615264|449172829|FG001|Overall Study|Dermal Hypersensitivity|3|||
125101226|NCT04150107|449991131|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
125101227|NCT04150107|449991132|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
125101228|NCT04150107|449991131|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
125101229|NCT04150107|449991132|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
125210689|NCT04299048|450395637|FG000|Overall Study|Global deterioration of health status|2|||
125210690|NCT04299048|450395637|FG000|Overall Study|Enrolled and not treated|1|||
125210691|NCT01706575|450395638|FG000|Overall Study|Participant Withdrew Consent|4|||
125210692|NCT01706575|450395638|FG000|Overall Study|Lost to Follow-up|2|||
125210693|NCT01706575|450395638|FG000|Overall Study|Started but not Treated|6|||
125210694|NCT02536781|450395655|FG000|Overall Study|Lost to Follow-up|2|||
125210695|NCT02536781|450395656|FG001|Overall Study|Lost to Follow-up|0|||
125210696|NCT03423147|450395657|FG000|Overall Study|Lost to Follow-up|5|||
125210697|NCT03423147|450395658|FG001|Overall Study|Lost to Follow-up|8|||
124876838|NCT03430063|449172830|FG000|Overall Study|Adverse Event|0|||
125210698|NCT03423147|450395657|FG000|Overall Study|Withdrawal by Subject|1|||
124876839|NCT03430063|449172831|FG001|Overall Study|Adverse Event|1|||
124876840|NCT03430063|449172832|FG002|Overall Study|Adverse Event|0|||
124876841|NCT03430063|449172830|FG000|Overall Study|Death|3|||
124876842|NCT03430063|449172831|FG001|Overall Study|Death|2|||
124876843|NCT03430063|449172832|FG002|Overall Study|Death|3|||
124876844|NCT03430063|449172830|FG000|Overall Study|Lost to Follow-up|0|||
124876845|NCT03430063|449172831|FG001|Overall Study|Lost to Follow-up|1|||
124876846|NCT03430063|449172832|FG002|Overall Study|Lost to Follow-up|0|||
124876847|NCT03430063|449172830|FG000|Overall Study|Withdrawal by Subject|0|||
124876848|NCT03430063|449172831|FG001|Overall Study|Withdrawal by Subject|0|||
124876849|NCT03430063|449172832|FG002|Overall Study|Withdrawal by Subject|1|||
124876850|NCT03430063|449172830|FG000|Overall Study|Withdrawal of consent|3|||
124876851|NCT03430063|449172831|FG001|Overall Study|Withdrawal of consent|1|||
124876852|NCT03430063|449172832|FG002|Overall Study|Withdrawal of consent|2|||
124876853|NCT03430063|449172830|FG000|Overall Study|Progressive disease|1|||
124876854|NCT03430063|449172831|FG001|Overall Study|Progressive disease|2|||
124876855|NCT03430063|449172832|FG002|Overall Study|Progressive disease|1|||
124876856|NCT03430063|449172830|FG000|Overall Study|Other un-specified|1|||
124876857|NCT03430063|449172831|FG001|Overall Study|Other un-specified|1|||
124876858|NCT03430063|449172832|FG002|Overall Study|Other un-specified|0|||
124876859|NCT03430063|449172830|FG000|Overall Study|Randomized, but never treated|0|||
124876860|NCT03430063|449172831|FG001|Overall Study|Randomized, but never treated|0|||
124876861|NCT03430063|449172832|FG002|Overall Study|Randomized, but never treated|1|||
124876862|NCT02228395|449172837|FG000|First Intervention Period|No longer willing to participate|1|||
124876863|NCT02228395|449172838|FG001|First Intervention Period|No longer willing to participate|0|||
124876864|NCT02228395|449172839|FG002|First Intervention Period|No longer willing to participate|0|||
124876865|NCT02228395|449172837|FG000|First Intervention Period|Unable to comply with study dates|0|||
124876866|NCT02228395|449172838|FG001|First Intervention Period|Unable to comply with study dates|1|||
124876867|NCT02228395|449172839|FG002|First Intervention Period|Unable to comply with study dates|1|||
124876868|NCT00985985|449172840|FG000|Overall Study|Adverse Event|4|||
124876869|NCT00985985|449172841|FG001|Overall Study|Adverse Event|2|||
124876870|NCT00985985|449172842|FG002|Overall Study|Adverse Event|2|||
124876871|NCT00985985|449172843|FG003|Overall Study|Adverse Event|2|||
124876872|NCT00985985|449172840|FG000|Overall Study|Lost to Follow-up|4|||
124876873|NCT00985985|449172841|FG001|Overall Study|Lost to Follow-up|11|||
124876874|NCT00985985|449172842|FG002|Overall Study|Lost to Follow-up|2|||
124876875|NCT00985985|449172843|FG003|Overall Study|Lost to Follow-up|3|||
124876876|NCT00985985|449172840|FG000|Overall Study|Protocol Violation|1|||
124876877|NCT00985985|449172841|FG001|Overall Study|Protocol Violation|2|||
124876878|NCT00985985|449172842|FG002|Overall Study|Protocol Violation|0|||
124876879|NCT00985985|449172843|FG003|Overall Study|Protocol Violation|1|||
124876880|NCT00985985|449172840|FG000|Overall Study|Lack of Efficacy|5|||
124876881|NCT00985985|449172841|FG001|Overall Study|Lack of Efficacy|6|||
124876882|NCT00985985|449172842|FG002|Overall Study|Lack of Efficacy|1|||
124876883|NCT00985985|449172843|FG003|Overall Study|Lack of Efficacy|3|||
125101230|NCT04455620|449991133|FG000|Overall Study|Withdrawal by Subject|0|||
124876884|NCT00985985|449172840|FG000|Overall Study|Withdrawal by Subject|4|||
124876885|NCT00985985|449172841|FG001|Overall Study|Withdrawal by Subject|2|||
124876886|NCT00985985|449172842|FG002|Overall Study|Withdrawal by Subject|2|||
124876887|NCT00985985|449172843|FG003|Overall Study|Withdrawal by Subject|2|||
124876888|NCT00985985|449172840|FG000|Overall Study|Other Reason|6|||
124876889|NCT00985985|449172841|FG001|Overall Study|Other Reason|1|||
124876890|NCT00985985|449172842|FG002|Overall Study|Other Reason|4|||
124876891|NCT00985985|449172843|FG003|Overall Study|Other Reason|2|||
124876892|NCT00509236|449172844|FG000|Overall Study|Adverse Event|7|||
124876893|NCT00509236|449172845|FG001|Overall Study|Adverse Event|9|||
124876894|NCT00509236|449172844|FG000|Overall Study|Withdrawal by Subject|5|||
124876895|NCT00509236|449172845|FG001|Overall Study|Withdrawal by Subject|10|||
124876896|NCT00509236|449172844|FG000|Overall Study|Protocol Violation|3|||
124876897|NCT00509236|449172845|FG001|Overall Study|Protocol Violation|0|||
125210699|NCT03423147|450395658|FG001|Overall Study|Withdrawal by Subject|0|||
125210700|NCT03423147|450395657|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
125210701|NCT03423147|450395658|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
125210702|NCT03423147|450395657|FG000|Overall Study|Age < 18|1|||
125210703|NCT03423147|450395658|FG001|Overall Study|Age < 18|0|||
125210704|NCT03423147|450395657|FG000|Overall Study|No Trial of Labor|0|||
125210705|NCT03423147|450395658|FG001|Overall Study|No Trial of Labor|1|||
125210706|NCT02069093|450395659|FG000|Overall Study|Disease progression|14|||
125210707|NCT02069093|450395659|FG000|Overall Study|New cancer therapy|1|||
125101231|NCT04455620|449991134|FG001|Overall Study|Withdrawal by Subject|0|||
125101232|NCT04455620|449991135|FG002|Overall Study|Withdrawal by Subject|2|||
125101233|NCT04455620|449991136|FG003|Overall Study|Withdrawal by Subject|0|||
125101234|NCT04455620|449991137|FG004|Overall Study|Withdrawal by Subject|1|||
125101235|NCT04455620|449991133|FG000|Overall Study|Lost to Follow-up|0|||
125101236|NCT04455620|449991134|FG001|Overall Study|Lost to Follow-up|0|||
125101237|NCT04455620|449991135|FG002|Overall Study|Lost to Follow-up|1|||
125101238|NCT04455620|449991136|FG003|Overall Study|Lost to Follow-up|1|||
125101239|NCT04455620|449991137|FG004|Overall Study|Lost to Follow-up|0|||
125101240|NCT04455620|449991133|FG000|Overall Study|Death|1|||
125101241|NCT04455620|449991134|FG001|Overall Study|Death|6|||
125101242|NCT04455620|449991135|FG002|Overall Study|Death|20|||
125101243|NCT04455620|449991136|FG003|Overall Study|Death|1|||
125101244|NCT04455620|449991137|FG004|Overall Study|Death|7|||
125012773|NCT00583362|449673019|FG000|Overall Study|Miscommunication of visit window|5|||
125012774|NCT00583362|449673019|FG000|Overall Study|Current site closed|7|||
125012775|NCT00583362|449673019|FG000|Overall Study|Subject not dosed in LBSL99|1|||
125012776|NCT00583362|449673019|FG000|Overall Study|Subject moved out of the country/state|2|||
125012777|NCT00583362|449673019|FG000|Overall Study|Missed visits due to staff changes|1|||
125012778|NCT00583362|449673019|FG000|Overall Study|Misunderstanding of protocol|1|||
125012779|NCT00583362|449673019|FG000|Overall Study|Behavioral problems and non-compliance|1|||
125012780|NCT00583362|449673019|FG000|Overall Study|Sponsor request due to missed doses|1|||
125012781|NCT00583362|449673019|FG000|Overall Study|Physician Decision|19|||
125012782|NCT00583362|449673019|FG000|Overall Study|Protocol Violation|2|||
125012783|NCT00583362|449673019|FG000|Overall Study|Withdrawal by Subject|57|||
125012784|NCT02370615|449673020|FG000|Overall Study|Adverse Event|1|||
125012785|NCT02370615|449673021|FG001|Overall Study|Adverse Event|0|||
125012786|NCT00645593|449673022|FG000|Overall Study|Later found to be ineligible|1|||
125012787|NCT00645593|449673023|FG001|Overall Study|Later found to be ineligible|0|||
125012788|NCT01585272|449673024|FG000|Overall Study|Adverse Event|22|||
125012789|NCT01585272|449673024|FG000|Overall Study|Protocol Violation|7|||
125012790|NCT01585272|449673024|FG000|Overall Study|Withdrawal by Subject|10|||
125012791|NCT02577146|449673029|FG000|Overall Study|Lost to Follow-up|8|||
125012792|NCT02577146|449673029|FG000|Overall Study|Physician Decision|3|||
125012793|NCT02577146|449673029|FG000|Overall Study|Screen Failure|17|||
125012794|NCT03765138|449673030|FG000|Overall Study|Lost to Follow-up|1|||
125012795|NCT01970501|449673031|FG000|Overall Study|Discontinuation of study by sponsor|16|||
125101245|NCT04455620|449991133|FG000|Overall Study|Study Termination|0|||
125210708|NCT02069093|450395659|FG000|Overall Study|Death|1|||
125012796|NCT01970501|449673032|FG001|Overall Study|Discontinuation of study by sponsor|14|||
125012797|NCT01970501|449673031|FG000|Overall Study|Withdrawal by Subject|6|||
125101246|NCT04455620|449991134|FG001|Overall Study|Study Termination|2|||
125101247|NCT04455620|449991135|FG002|Overall Study|Study Termination|1|||
125210709|NCT02069093|450395659|FG000|Overall Study|Administrative problems|1|||
124876898|NCT00509236|449172844|FG000|Overall Study|Excluded Medication|1|||
124876899|NCT00509236|449172845|FG001|Overall Study|Excluded Medication|1|||
124876900|NCT00509236|449172844|FG000|Overall Study|Scheduled Kidney Transplant|1|||
124876901|NCT00509236|449172845|FG001|Overall Study|Scheduled Kidney Transplant|0|||
124876902|NCT00792103|449172846|FG000|Overall Study|Enrolled, not treated|15|||
124876903|NCT00792103|449172846|FG000|Overall Study|Lost to Follow-up|17|||
124876904|NCT00792103|449172846|FG000|Overall Study|Adverse Event|25|||
124876905|NCT00792103|449172846|FG000|Overall Study|Withdrawal by Subject|52|||
124876906|NCT00792103|449172846|FG000|Overall Study|Protocol Violation|10|||
124876907|NCT00792103|449172846|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
124876908|NCT03587142|449172847|FG000|Overall Study|Lost to Follow-up|5|||
124876909|NCT03587142|449172848|FG001|Overall Study|Lost to Follow-up|3|||
124876910|NCT03587142|449172847|FG000|Overall Study|Did not complete the f4 visit|3|||
124876911|NCT03587142|449172848|FG001|Overall Study|Did not complete the f4 visit|7|||
124876912|NCT02768662|449172849|FG000|Overall Study|Adverse Event|1|||
124876913|NCT02768662|449172849|FG000|Overall Study|Lost to Follow-up|4|||
124876914|NCT02768662|449172849|FG000|Overall Study|Withdrawal by Subject|3|||
124876915|NCT02768662|449172849|FG000|Overall Study|Study terminated by Sponsor|78|||
124876916|NCT03673462|449172850|FG000|Overall Study|Adverse Event|11|||
124876917|NCT03673462|449172851|FG001|Overall Study|Adverse Event|1|||
124876918|NCT03673462|449172850|FG000|Overall Study|Protocol Violation|25|||
124876919|NCT03673462|449172851|FG001|Overall Study|Protocol Violation|11|||
124876920|NCT03673462|449172850|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
124876921|NCT03673462|449172851|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
124876922|NCT03673462|449172850|FG000|Overall Study|Lost to Follow-up|102|||
124876923|NCT03673462|449172851|FG001|Overall Study|Lost to Follow-up|19|||
124876924|NCT03502616|449172852|FG000|Up to Week 16|Withdrawal by Subject|1|||
124876925|NCT03502616|449172853|FG001|Up to Week 16|Withdrawal by Subject|2|||
124876926|NCT03502616|449172852|FG000|Up to Week 16|Lost to Follow-up|0|||
124876927|NCT03502616|449172853|FG001|Up to Week 16|Lost to Follow-up|1|||
124876928|NCT03502616|449172852|FG000|Up to Week 16|Randomized, but not treated|1|||
124876929|NCT03502616|449172853|FG001|Up to Week 16|Randomized, but not treated|0|||
124876930|NCT03502616|449172852|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
124876931|NCT03502616|449172853|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
124876932|NCT03502616|449172852|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
124876933|NCT03502616|449172853|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
124876934|NCT00770432|449172858|FG000|Overall Study|Other|4|||
124876935|NCT00770432|449172859|FG001|Overall Study|Other|6|||
124876936|NCT00770432|449172858|FG000|Overall Study|Non-compliance|0|||
124876937|NCT00770432|449172859|FG001|Overall Study|Non-compliance|1|||
124876938|NCT01364597|449172860|FG000|Overall Study|Adverse Event|4|||
124876939|NCT01364597|449172861|FG001|Overall Study|Adverse Event|5|||
124876940|NCT01364597|449172862|FG002|Overall Study|Adverse Event|16|||
124876941|NCT01364597|449172863|FG003|Overall Study|Adverse Event|7|||
124876942|NCT01364597|449172860|FG000|Overall Study|Lack of Efficacy|4|||
125012798|NCT01970501|449673032|FG001|Overall Study|Withdrawal by Subject|7|||
125012799|NCT01970501|449673031|FG000|Overall Study|Adverse Event|2|||
125012800|NCT01970501|449673032|FG001|Overall Study|Adverse Event|4|||
125012801|NCT01970501|449673031|FG000|Overall Study|Death|1|||
125012802|NCT01970501|449673032|FG001|Overall Study|Death|3|||
125012803|NCT01970501|449673031|FG000|Overall Study|Physician Decision|2|||
125012804|NCT01970501|449673032|FG001|Overall Study|Physician Decision|0|||
125012805|NCT03803059|449673034|FG000|Overall Study|Protocol Violation|2|||
125012806|NCT03803059|449673034|FG000|Overall Study|Lost to Follow-up|1|||
125012807|NCT04013529|449673037|FG000|Overall Study|Withdrawal by Subject|1|||
125012808|NCT04013529|449673038|FG001|Overall Study|Withdrawal by Subject|1|||
125012809|NCT03116698|449673039|FG000|Overall Study|Adverse Event|1|||
125012810|NCT03116698|449673040|FG001|Overall Study|Adverse Event|1|||
125012811|NCT03116698|449673041|FG002|Overall Study|Adverse Event|1|||
125012812|NCT03116698|449673042|FG003|Overall Study|Adverse Event|0|||
125012813|NCT03116698|449673039|FG000|Overall Study|Withdrawal by Subject|1|||
125012814|NCT03116698|449673040|FG001|Overall Study|Withdrawal by Subject|4|||
125012815|NCT03116698|449673041|FG002|Overall Study|Withdrawal by Subject|5|||
125012816|NCT03116698|449673042|FG003|Overall Study|Withdrawal by Subject|2|||
125012817|NCT03116698|449673039|FG000|Overall Study|Lost to Follow-up|2|||
125012818|NCT03116698|449673040|FG001|Overall Study|Lost to Follow-up|0|||
125012819|NCT03116698|449673041|FG002|Overall Study|Lost to Follow-up|0|||
124876943|NCT01364597|449172861|FG001|Overall Study|Lack of Efficacy|4|||
124876944|NCT01364597|449172862|FG002|Overall Study|Lack of Efficacy|23|||
124876945|NCT01364597|449172863|FG003|Overall Study|Lack of Efficacy|8|||
124876946|NCT01364597|449172860|FG000|Overall Study|Protocol Violation|0|||
124876947|NCT01364597|449172861|FG001|Overall Study|Protocol Violation|0|||
124876948|NCT01364597|449172862|FG002|Overall Study|Protocol Violation|2|||
124876949|NCT01364597|449172863|FG003|Overall Study|Protocol Violation|0|||
124876950|NCT01364597|449172860|FG000|Overall Study|Lost to Follow-up|0|||
124876951|NCT01364597|449172861|FG001|Overall Study|Lost to Follow-up|0|||
124876952|NCT01364597|449172862|FG002|Overall Study|Lost to Follow-up|5|||
124876953|NCT01364597|449172863|FG003|Overall Study|Lost to Follow-up|3|||
124876954|NCT01364597|449172860|FG000|Overall Study|Withdrawal by Subject|4|||
124876955|NCT01364597|449172861|FG001|Overall Study|Withdrawal by Subject|1|||
124876956|NCT01364597|449172862|FG002|Overall Study|Withdrawal by Subject|18|||
124876957|NCT01364597|449172863|FG003|Overall Study|Withdrawal by Subject|6|||
124876958|NCT01364597|449172860|FG000|Overall Study|Non compliance|1|||
124876959|NCT01364597|449172861|FG001|Overall Study|Non compliance|0|||
124876960|NCT01364597|449172862|FG002|Overall Study|Non compliance|1|||
124876961|NCT01364597|449172863|FG003|Overall Study|Non compliance|0|||
124876962|NCT01364597|449172860|FG000|Overall Study|Lack of compliance|1|||
124876963|NCT01364597|449172861|FG001|Overall Study|Lack of compliance|0|||
124876964|NCT01364597|449172862|FG002|Overall Study|Lack of compliance|0|||
124876965|NCT01364597|449172863|FG003|Overall Study|Lack of compliance|0|||
124876966|NCT01364597|449172860|FG000|Overall Study|End of treatment epilepsy|1|||
124876967|NCT01364597|449172861|FG001|Overall Study|End of treatment epilepsy|0|||
124876968|NCT01364597|449172862|FG002|Overall Study|End of treatment epilepsy|0|||
124876969|NCT01364597|449172863|FG003|Overall Study|End of treatment epilepsy|0|||
124876970|NCT01364597|449172860|FG000|Overall Study|No Seizures|1|||
124876971|NCT01364597|449172861|FG001|Overall Study|No Seizures|0|||
124876972|NCT01364597|449172862|FG002|Overall Study|No Seizures|0|||
124876973|NCT01364597|449172863|FG003|Overall Study|No Seizures|0|||
124876974|NCT01364597|449172860|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
124876975|NCT01364597|449172861|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
124876976|NCT01364597|449172862|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
124876977|NCT01364597|449172863|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
124876978|NCT01364597|449172860|FG000|Overall Study|Cure|1|||
124876979|NCT01364597|449172861|FG001|Overall Study|Cure|0|||
124876980|NCT01364597|449172862|FG002|Overall Study|Cure|0|||
124876981|NCT01364597|449172863|FG003|Overall Study|Cure|0|||
124876982|NCT01364597|449172860|FG000|Overall Study|Patient was moving|0|||
124876983|NCT01364597|449172861|FG001|Overall Study|Patient was moving|1|||
124876984|NCT01364597|449172862|FG002|Overall Study|Patient was moving|0|||
124876985|NCT01364597|449172863|FG003|Overall Study|Patient was moving|0|||
124876986|NCT01364597|449172860|FG000|Overall Study|Seizures resolved|0|||
124876987|NCT01364597|449172861|FG001|Overall Study|Seizures resolved|0|||
124876988|NCT01364597|449172862|FG002|Overall Study|Seizures resolved|1|||
124876989|NCT01364597|449172863|FG003|Overall Study|Seizures resolved|0|||
124876990|NCT01364597|449172860|FG000|Overall Study|Patient became seizure-free after surgery|0|||
124876991|NCT01364597|449172861|FG001|Overall Study|Patient became seizure-free after surgery|0|||
124876992|NCT01364597|449172862|FG002|Overall Study|Patient became seizure-free after surgery|1|||
124876993|NCT01364597|449172863|FG003|Overall Study|Patient became seizure-free after surgery|0|||
124876994|NCT01364597|449172860|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
124876995|NCT01364597|449172861|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
124876996|NCT01364597|449172862|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
124876997|NCT01364597|449172863|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
124876998|NCT01364597|449172860|FG000|Overall Study|Patient cured from Epilepsy|0|||
124876999|NCT01364597|449172861|FG001|Overall Study|Patient cured from Epilepsy|0|||
124877000|NCT01364597|449172862|FG002|Overall Study|Patient cured from Epilepsy|1|||
124877001|NCT01364597|449172863|FG003|Overall Study|Patient cured from Epilepsy|0|||
124877002|NCT01364597|449172860|FG000|Overall Study|Investigator decision|0|||
124877003|NCT01364597|449172861|FG001|Overall Study|Investigator decision|0|||
124877004|NCT01364597|449172862|FG002|Overall Study|Investigator decision|1|||
124877005|NCT01364597|449172863|FG003|Overall Study|Investigator decision|0|||
124877006|NCT01364597|449172860|FG000|Overall Study|Sponsor recommended discontinuation|0|||
124877007|NCT01364597|449172861|FG001|Overall Study|Sponsor recommended discontinuation|0|||
124877008|NCT01364597|449172862|FG002|Overall Study|Sponsor recommended discontinuation|0|||
124877009|NCT01364597|449172863|FG003|Overall Study|Sponsor recommended discontinuation|1|||
124877010|NCT01364597|449172860|FG000|Overall Study|Parents went abroad with the patient|0|||
124877011|NCT01364597|449172861|FG001|Overall Study|Parents went abroad with the patient|0|||
124877012|NCT01364597|449172862|FG002|Overall Study|Parents went abroad with the patient|1|||
124877013|NCT01364597|449172863|FG003|Overall Study|Parents went abroad with the patient|0|||
124877014|NCT01364597|449172860|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
124877015|NCT01364597|449172861|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
124877016|NCT01364597|449172862|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
124877017|NCT01364597|449172863|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
125101248|NCT04455620|449991136|FG003|Overall Study|Study Termination|0|||
124877018|NCT01364597|449172860|FG000|Overall Study|BRV administration dropout|0|||
124877019|NCT01364597|449172861|FG001|Overall Study|BRV administration dropout|0|||
125101249|NCT04455620|449991137|FG004|Overall Study|Study Termination|6|||
124877020|NCT01364597|449172862|FG002|Overall Study|BRV administration dropout|1|||
124877021|NCT01364597|449172863|FG003|Overall Study|BRV administration dropout|0|||
124877022|NCT01364597|449172860|FG000|Overall Study|Dropout|0|||
124877023|NCT01364597|449172861|FG001|Overall Study|Dropout|0|||
124877024|NCT01364597|449172862|FG002|Overall Study|Dropout|3|||
124877025|NCT01364597|449172863|FG003|Overall Study|Dropout|1|||
125101250|NCT02851069|449991139|FG000|Overall Study|Failure to Return|3|||
124877026|NCT01364597|449172860|FG000|Overall Study|Unreliable subject|0|||
124877027|NCT01364597|449172861|FG001|Overall Study|Unreliable subject|0|||
124877028|NCT01364597|449172862|FG002|Overall Study|Unreliable subject|0|||
124877029|NCT01364597|449172863|FG003|Overall Study|Unreliable subject|1|||
124877030|NCT01364597|449172860|FG000|Overall Study|Other|0|||
124877031|NCT01364597|449172861|FG001|Overall Study|Other|0|||
124877032|NCT01364597|449172862|FG002|Overall Study|Other|0|||
124877033|NCT01364597|449172863|FG003|Overall Study|Other|1|||
124877034|NCT01498822|449172864|FG000|Overall Study|Protocol Violation|8|||
125101251|NCT02851069|449991139|FG000|Overall Study|Other|3|||
125101252|NCT03539952|449991145|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
125101253|NCT03539952|449991146|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
125101254|NCT03539952|449991145|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
125101255|NCT03539952|449991146|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
125101256|NCT03539952|449991145|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
125101257|NCT03539952|449991146|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
125101258|NCT03539952|449991145|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
125101259|NCT03539952|449991146|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
125101260|NCT03539952|449991145|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
125101261|NCT03539952|449991146|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
125101262|NCT03539952|449991145|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
125101263|NCT03539952|449991146|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
124877035|NCT01498822|449172865|FG001|Overall Study|Protocol Violation|4|||
124877036|NCT01498822|449172864|FG000|Overall Study|Other Reason|5|||
125101264|NCT03539952|449991145|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
125101265|NCT03539952|449991146|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
125101266|NCT02087865|449992449|FG000|Overall Study|Withdrawal by Subject|6|||
125101267|NCT02087865|449992450|FG001|Overall Study|Withdrawal by Subject|0|||
125101268|NCT02087865|449992451|FG002|Overall Study|Withdrawal by Subject|1|||
125101269|NCT02087865|449992449|FG000|Overall Study|Lost to Follow-up|0|||
125101270|NCT02087865|449992450|FG001|Overall Study|Lost to Follow-up|0|||
125101271|NCT02087865|449992451|FG002|Overall Study|Lost to Follow-up|1|||
125101272|NCT02087865|449992449|FG000|Overall Study|Drug Non-compliance|0|||
125101273|NCT02087865|449992450|FG001|Overall Study|Drug Non-compliance|2|||
125101274|NCT02087865|449992451|FG002|Overall Study|Drug Non-compliance|0|||
125101275|NCT02087865|449992449|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
125101276|NCT02087865|449992450|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
125101277|NCT02087865|449992451|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
125101278|NCT01392469|449992454|FG000|Overall Study|Adverse Event|2|||
125101279|NCT01392469|449992454|FG000|Overall Study|Withdrawal by Subject|1|||
125101280|NCT01392469|449992454|FG000|Overall Study|Protocol Violation|1|||
125101281|NCT03255226|449992455|FG000|Overall Study|Adverse Event|2|||
125101282|NCT03255226|449992455|FG000|Overall Study|Physician Decision|3|||
125101283|NCT03255226|449992455|FG000|Overall Study|Withdrawal by Subject|1|||
124877037|NCT01498822|449172865|FG001|Overall Study|Other Reason|2|||
125101284|NCT03255226|449992455|FG000|Overall Study|Serum or blood sodium increased|4|||
125101285|NCT03255226|449992455|FG000|Overall Study|Serum or blood potassium increased|4|||
125101286|NCT01035229|449992456|FG000|Overall Study|Adverse Event|61|||
125101287|NCT01035229|449992457|FG001|Overall Study|Adverse Event|14|||
125101288|NCT01035229|449992456|FG000|Overall Study|Withdrawal by Subject|20|||
125101289|NCT01035229|449992457|FG001|Overall Study|Withdrawal by Subject|7|||
124877038|NCT01498822|449172864|FG000|Overall Study|Lack of Efficacy|7|||
124877039|NCT01498822|449172865|FG001|Overall Study|Lack of Efficacy|2|||
125101290|NCT01035229|449992456|FG000|Overall Study|Lost to Follow-up|1|||
125101291|NCT01035229|449992457|FG001|Overall Study|Lost to Follow-up|0|||
125101292|NCT01035229|449992456|FG000|Overall Study|Administrative problems|1|||
125101293|NCT01035229|449992457|FG001|Overall Study|Administrative problems|1|||
125101294|NCT01035229|449992456|FG000|Overall Study|Death|13|||
125101295|NCT01035229|449992457|FG001|Overall Study|Death|5|||
125101296|NCT01035229|449992456|FG000|Overall Study|New cancer therapy|2|||
125101297|NCT01035229|449992457|FG001|Overall Study|New cancer therapy|0|||
125101298|NCT01035229|449992456|FG000|Overall Study|Protocol Violation|0|||
125101299|NCT01035229|449992457|FG001|Overall Study|Protocol Violation|2|||
125101300|NCT01035229|449992456|FG000|Overall Study|Sponsor's decision to end study|3|||
125101301|NCT01035229|449992457|FG001|Overall Study|Sponsor's decision to end study|3|||
125101302|NCT01035229|449992456|FG000|Overall Study|Disease Progression|261|||
125101303|NCT01035229|449992457|FG001|Overall Study|Disease Progression|152|||
125101304|NCT00564486|449992460|FG000|Overall Study|Adverse Event|0|||
125101305|NCT00564486|449992461|FG001|Overall Study|Adverse Event|1|||
125101306|NCT00564486|449992462|FG002|Overall Study|Adverse Event|0|||
125101307|NCT00564486|449992463|FG003|Overall Study|Adverse Event|0|||
125101308|NCT00564486|449992460|FG000|Overall Study|Withdrawal by Subject|4|||
125101309|NCT00564486|449992461|FG001|Overall Study|Withdrawal by Subject|0|||
125101310|NCT00564486|449992462|FG002|Overall Study|Withdrawal by Subject|0|||
125101311|NCT00564486|449992463|FG003|Overall Study|Withdrawal by Subject|5|||
125101312|NCT00564486|449992460|FG000|Overall Study|Subject refused to have blood drawn|0|||
125101313|NCT00564486|449992461|FG001|Overall Study|Subject refused to have blood drawn|0|||
125101314|NCT00564486|449992462|FG002|Overall Study|Subject refused to have blood drawn|1|||
125210710|NCT02069093|450395659|FG000|Overall Study|Withdrawal by Subject|2|||
124877040|NCT01498822|449172864|FG000|Overall Study|AE, non-serious non-fatal|8|||
124877041|NCT01498822|449172865|FG001|Overall Study|AE, non-serious non-fatal|17|||
124877042|NCT01498822|449172864|FG000|Overall Study|SAE, non-fatal|2|||
124877043|NCT01498822|449172865|FG001|Overall Study|SAE, non-fatal|2|||
124877044|NCT01498822|449172864|FG000|Overall Study|Adverse Event, serious fatal|1|||
124877045|NCT01498822|449172865|FG001|Overall Study|Adverse Event, serious fatal|1|||
124877046|NCT01498822|449172864|FG000|Overall Study|Withdrawal by Subject|15|||
124877047|NCT01498822|449172865|FG001|Overall Study|Withdrawal by Subject|25|||
124877048|NCT01498822|449172864|FG000|Overall Study|Lost to Follow-up|8|||
124877049|NCT01498822|449172865|FG001|Overall Study|Lost to Follow-up|3|||
124877050|NCT03579290|449172873|FG000|Overall Study|Lost to Follow-up|9|||
124877051|NCT03131960|449172876|FG000|Overall Study|Adverse Event|0|||
124877052|NCT03131960|449172877|FG001|Overall Study|Adverse Event|1|||
124877053|NCT04404478|449172879|FG000|Overall Study|Withdrawal by Subject|1|||
124877054|NCT04404478|449172880|FG001|Overall Study|Withdrawal by Subject|3|||
124877055|NCT02904902|449172881|FG000|Overall Study|Withdrawal by Subject|1|||
124877056|NCT02002182|449172884|FG000|Overall Study|Withdraw from study|3|||
124877057|NCT02002182|449172885|FG001|Overall Study|Withdraw from study|1|||
124877058|NCT02002182|449172884|FG000|Overall Study|Health Reasons|1|||
124877059|NCT02002182|449172885|FG001|Overall Study|Health Reasons|0|||
124877060|NCT02002182|449172884|FG000|Overall Study|Death|1|||
124877061|NCT02002182|449172885|FG001|Overall Study|Death|0|||
124877062|NCT01597505|449172888|FG000|Overall Study|Physician Decision|5|||
124877063|NCT01597505|449172889|FG001|Overall Study|Physician Decision|0|||
124877064|NCT01597505|449172888|FG000|Overall Study|Adverse Event|19|||
124877065|NCT01597505|449172889|FG001|Overall Study|Adverse Event|7|||
124877066|NCT01597505|449172888|FG000|Overall Study|Lost to Follow-up|4|||
124877067|NCT01597505|449172889|FG001|Overall Study|Lost to Follow-up|2|||
124877068|NCT01597505|449172888|FG000|Overall Study|Withdrawal by Subject|10|||
124877069|NCT01597505|449172889|FG001|Overall Study|Withdrawal by Subject|18|||
124877070|NCT01597505|449172888|FG000|Overall Study|Other|5|||
124877071|NCT01597505|449172889|FG001|Overall Study|Other|6|||
124877072|NCT01597505|449172888|FG000|Overall Study|Missing|1|||
124877073|NCT01597505|449172889|FG001|Overall Study|Missing|0|||
124877074|NCT00895622|449172899|FG000|Overall Study|Protocol Violation|5|||
124877075|NCT00895622|449172900|FG001|Overall Study|Protocol Violation|4|||
124877076|NCT00895622|449172901|FG002|Overall Study|Protocol Violation|4|||
124877077|NCT01490125|449172902|FG000|Period I|Adverse Event|4|||
124877078|NCT01490125|449172903|FG001|Period I|Adverse Event|1|||
124877079|NCT01490125|449172904|FG002|Period I|Adverse Event|1|||
124877080|NCT01490125|449172905|FG003|Period I|Adverse Event|3|||
124877081|NCT01490125|449172906|FG004|Period I|Adverse Event|2|||
124877082|NCT01490125|449172907|FG005|Period I|Adverse Event|4|||
124877083|NCT01490125|449172902|FG000|Period I|Protocol Violation|1|||
124877084|NCT01490125|449172903|FG001|Period I|Protocol Violation|1|||
124877085|NCT01490125|449172904|FG002|Period I|Protocol Violation|1|||
124877086|NCT01490125|449172905|FG003|Period I|Protocol Violation|1|||
124877087|NCT01490125|449172906|FG004|Period I|Protocol Violation|0|||
124877088|NCT01490125|449172907|FG005|Period I|Protocol Violation|0|||
124877089|NCT01490125|449172902|FG000|Period I|Withdrawal by Subject|1|||
125101315|NCT00564486|449992463|FG003|Overall Study|Subject refused to have blood drawn|0|||
125101316|NCT00564486|449992460|FG000|Overall Study|Lost to Follow-up|3|||
125101317|NCT00564486|449992461|FG001|Overall Study|Lost to Follow-up|0|||
124877090|NCT01490125|449172903|FG001|Period I|Withdrawal by Subject|3|||
124877091|NCT01490125|449172904|FG002|Period I|Withdrawal by Subject|2|||
124877092|NCT01490125|449172905|FG003|Period I|Withdrawal by Subject|1|||
124877093|NCT01490125|449172906|FG004|Period I|Withdrawal by Subject|2|||
124877094|NCT01490125|449172907|FG005|Period I|Withdrawal by Subject|1|||
125101318|NCT00564486|449992462|FG002|Overall Study|Lost to Follow-up|2|||
125101319|NCT00564486|449992463|FG003|Overall Study|Lost to Follow-up|2|||
124877095|NCT01490125|449172902|FG000|Period II|Adverse Event|2|||
124877096|NCT01490125|449172903|FG001|Period II|Adverse Event|3|||
124877097|NCT01490125|449172904|FG002|Period II|Adverse Event|2|||
124877098|NCT01490125|449172905|FG003|Period II|Adverse Event|2|||
124877099|NCT01490125|449172906|FG004|Period II|Adverse Event|4|||
124877100|NCT01490125|449172907|FG005|Period II|Adverse Event|2|||
124877101|NCT01490125|449172902|FG000|Period II|Protocol Violation|0|||
124877102|NCT01490125|449172903|FG001|Period II|Protocol Violation|0|||
124877103|NCT01490125|449172904|FG002|Period II|Protocol Violation|1|||
124877104|NCT01490125|449172905|FG003|Period II|Protocol Violation|1|||
124877105|NCT01490125|449172906|FG004|Period II|Protocol Violation|0|||
124877106|NCT01490125|449172907|FG005|Period II|Protocol Violation|0|||
124877107|NCT01490125|449172902|FG000|Period II|Lost to Follow-up|0|||
124877108|NCT01490125|449172903|FG001|Period II|Lost to Follow-up|1|||
124877109|NCT01490125|449172904|FG002|Period II|Lost to Follow-up|0|||
124877110|NCT01490125|449172905|FG003|Period II|Lost to Follow-up|0|||
124877111|NCT01490125|449172906|FG004|Period II|Lost to Follow-up|0|||
124877112|NCT01490125|449172907|FG005|Period II|Lost to Follow-up|0|||
124877113|NCT01490125|449172902|FG000|Period II|Withdrawal by Subject|1|||
124877114|NCT01490125|449172903|FG001|Period II|Withdrawal by Subject|0|||
124877115|NCT01490125|449172904|FG002|Period II|Withdrawal by Subject|0|||
124877116|NCT01490125|449172905|FG003|Period II|Withdrawal by Subject|0|||
124877117|NCT01490125|449172906|FG004|Period II|Withdrawal by Subject|0|||
124877118|NCT01490125|449172907|FG005|Period II|Withdrawal by Subject|0|||
124877119|NCT01490125|449172902|FG000|Period III|Adverse Event|3|||
124877120|NCT01490125|449172903|FG001|Period III|Adverse Event|1|||
124877121|NCT01490125|449172904|FG002|Period III|Adverse Event|0|||
124877122|NCT01490125|449172905|FG003|Period III|Adverse Event|1|||
124877123|NCT01490125|449172906|FG004|Period III|Adverse Event|0|||
124877124|NCT01490125|449172907|FG005|Period III|Adverse Event|0|||
124877125|NCT01490125|449172902|FG000|Period III|Death|0|||
124877126|NCT01490125|449172903|FG001|Period III|Death|0|||
124877127|NCT01490125|449172904|FG002|Period III|Death|0|||
124877128|NCT01490125|449172905|FG003|Period III|Death|1|||
124877129|NCT01490125|449172906|FG004|Period III|Death|0|||
124877130|NCT01490125|449172907|FG005|Period III|Death|0|||
124877131|NCT01490125|449172902|FG000|Period III|Lack of Efficacy|0|||
124877132|NCT01490125|449172903|FG001|Period III|Lack of Efficacy|0|||
124877133|NCT01490125|449172904|FG002|Period III|Lack of Efficacy|0|||
124877134|NCT01490125|449172905|FG003|Period III|Lack of Efficacy|0|||
124877135|NCT01490125|449172906|FG004|Period III|Lack of Efficacy|1|||
124877136|NCT01490125|449172907|FG005|Period III|Lack of Efficacy|0|||
124877137|NCT02237508|449172909|FG000|Overall Study|Withdrawal by Subject|0|||
124877138|NCT02237508|449172910|FG001|Overall Study|Withdrawal by Subject|2|||
124877139|NCT02237508|449172911|FG002|Overall Study|Withdrawal by Subject|0|||
124877140|NCT02237508|449172912|FG003|Overall Study|Withdrawal by Subject|1|||
124877141|NCT02237508|449172913|FG004|Overall Study|Withdrawal by Subject|0|||
124877142|NCT02237508|449172914|FG005|Overall Study|Withdrawal by Subject|1|||
124877143|NCT02237508|449172915|FG006|Overall Study|Withdrawal by Subject|1|||
124877144|NCT02237508|449172916|FG007|Overall Study|Withdrawal by Subject|0|||
124877145|NCT02237508|449172917|FG008|Overall Study|Withdrawal by Subject|1|||
124877146|NCT02237508|449172918|FG009|Overall Study|Withdrawal by Subject|0|||
124877147|NCT02237508|449172909|FG000|Overall Study|Physician Decision|0|||
124877148|NCT02237508|449172910|FG001|Overall Study|Physician Decision|1|||
124877149|NCT02237508|449172911|FG002|Overall Study|Physician Decision|0|||
124877150|NCT02237508|449172912|FG003|Overall Study|Physician Decision|0|||
124877151|NCT02237508|449172913|FG004|Overall Study|Physician Decision|0|||
124877152|NCT02237508|449172914|FG005|Overall Study|Physician Decision|0|||
124877153|NCT02237508|449172915|FG006|Overall Study|Physician Decision|0|||
124877154|NCT02237508|449172916|FG007|Overall Study|Physician Decision|0|||
124877155|NCT02237508|449172917|FG008|Overall Study|Physician Decision|0|||
124877156|NCT02237508|449172918|FG009|Overall Study|Physician Decision|0|||
124877157|NCT02237508|449172909|FG000|Overall Study|Protocol Violation|0|||
124877158|NCT02237508|449172910|FG001|Overall Study|Protocol Violation|0|||
124877159|NCT02237508|449172911|FG002|Overall Study|Protocol Violation|1|||
124877160|NCT02237508|449172912|FG003|Overall Study|Protocol Violation|0|||
124877161|NCT02237508|449172913|FG004|Overall Study|Protocol Violation|0|||
124877162|NCT02237508|449172914|FG005|Overall Study|Protocol Violation|0|||
124877163|NCT02237508|449172915|FG006|Overall Study|Protocol Violation|0|||
124877164|NCT02237508|449172916|FG007|Overall Study|Protocol Violation|0|||
124877165|NCT02237508|449172917|FG008|Overall Study|Protocol Violation|0|||
124877166|NCT02237508|449172918|FG009|Overall Study|Protocol Violation|0|||
124877167|NCT04954586|449172919|FG000|Overall Study|Withdrawal by Subject|5|||
124877168|NCT04000594|449172920|FG000|Overall Study|Withdrawal by Subject|1|||
124877169|NCT04000594|449172921|FG001|Overall Study|Withdrawal by Subject|0|||
125012820|NCT03116698|449673042|FG003|Overall Study|Lost to Follow-up|0|||
125012821|NCT03116698|449673039|FG000|Overall Study|Physician Decision|1|||
125012822|NCT03116698|449673040|FG001|Overall Study|Physician Decision|1|||
125012823|NCT03116698|449673041|FG002|Overall Study|Physician Decision|0|||
125012824|NCT03116698|449673042|FG003|Overall Study|Physician Decision|0|||
125012825|NCT03116698|449673039|FG000|Overall Study|Protocol Violation|1|||
125012826|NCT03116698|449673040|FG001|Overall Study|Protocol Violation|0|||
125012827|NCT03116698|449673041|FG002|Overall Study|Protocol Violation|0|||
125012828|NCT03116698|449673042|FG003|Overall Study|Protocol Violation|0|||
125012829|NCT03116698|449673039|FG000|Overall Study|Death|0|||
124877170|NCT04000594|449172922|FG002|Overall Study|Withdrawal by Subject|0|||
124877171|NCT04522180|449172923|FG000|Overall Study|Investigator judgement|3|||
124877172|NCT04522180|449172924|FG001|Overall Study|Investigator judgement|4|||
124877173|NCT04522180|449172923|FG000|Overall Study|Voluntary withdrawal|1|||
124877174|NCT04522180|449172924|FG001|Overall Study|Voluntary withdrawal|0|||
124877175|NCT04522180|449172923|FG000|Overall Study|Pregnancy|0|||
124877176|NCT04522180|449172924|FG001|Overall Study|Pregnancy|1|||
124877177|NCT04522180|449172923|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
124877178|NCT04522180|449172924|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
124877179|NCT04522180|449172923|FG000|Overall Study|Reason not specified|8|||
124877180|NCT04522180|449172924|FG001|Overall Study|Reason not specified|5|||
124877181|NCT01905046|449172925|FG000|Months 13-24|Withdrawal by Subject|10|||
124877182|NCT01905046|449172926|FG001|Months 13-24|Withdrawal by Subject|10|||
124877183|NCT01905046|449172925|FG000|Months 13-24|Adverse Event|3|||
124877184|NCT01905046|449172926|FG001|Months 13-24|Adverse Event|2|||
124877185|NCT01905046|449172925|FG000|Months 13-24|Protocol Violation|3|||
124877186|NCT01905046|449172926|FG001|Months 13-24|Protocol Violation|3|||
124877187|NCT01905046|449172925|FG000|Months 13-24|Physician Decision|1|||
124877188|NCT01905046|449172926|FG001|Months 13-24|Physician Decision|0|||
124877189|NCT03489057|449172931|FG000|Overall Study|Lost to Follow-up|16|||
124877190|NCT03489057|449172932|FG001|Overall Study|Lost to Follow-up|16|||
124877191|NCT03489057|449172933|FG002|Overall Study|Lost to Follow-up|14|||
124877192|NCT03489057|449172934|FG003|Overall Study|Lost to Follow-up|14|||
124877193|NCT03489057|449172931|FG000|Overall Study|Withdrawal by Subject|12|||
124877194|NCT03489057|449172932|FG001|Overall Study|Withdrawal by Subject|12|||
124877195|NCT03489057|449172933|FG002|Overall Study|Withdrawal by Subject|8|||
124877196|NCT03489057|449172934|FG003|Overall Study|Withdrawal by Subject|8|||
124877197|NCT03489057|449172931|FG000|Overall Study|Protocol Violation|7|||
124877198|NCT03489057|449172932|FG001|Overall Study|Protocol Violation|7|||
124877199|NCT03489057|449172933|FG002|Overall Study|Protocol Violation|2|||
124877200|NCT03489057|449172934|FG003|Overall Study|Protocol Violation|2|||
124877201|NCT01368900|449172937|FG000|Overall Study|Lost to Follow-up|7|||
124877202|NCT04027348|449172940|FG000|Overall Study|Adverse Event|2|||
124877203|NCT02487472|449172941|FG000|Overall Study|Did not complete telephonic interviews|9|||
124877204|NCT02487472|449172941|FG000|Overall Study|Other|2|||
124877205|NCT02277743|449172942|FG000|Overall Study|Protocol Violation|1|||
124877206|NCT02277743|449172943|FG001|Overall Study|Protocol Violation|1|||
124877207|NCT02277743|449172944|FG002|Overall Study|Protocol Violation|1|||
124877208|NCT02277743|449172942|FG000|Overall Study|Adverse Event|10|||
124877209|NCT02277743|449172943|FG001|Overall Study|Adverse Event|6|||
124877210|NCT02277743|449172944|FG002|Overall Study|Adverse Event|6|||
124877211|NCT02277743|449172942|FG000|Overall Study|Lack of Efficacy|11|||
124877212|NCT02277743|449172943|FG001|Overall Study|Lack of Efficacy|4|||
124877213|NCT02277743|449172944|FG002|Overall Study|Lack of Efficacy|3|||
124877214|NCT02277743|449172942|FG000|Overall Study|Other than specified above|18|||
124877215|NCT02277743|449172943|FG001|Overall Study|Other than specified above|5|||
124877216|NCT02277743|449172944|FG002|Overall Study|Other than specified above|16|||
124877217|NCT01224158|449172945|FG000|Overall Study|Withdrawal by Subject|1|||
124877218|NCT01224158|449172946|FG001|Overall Study|Withdrawal by Subject|0|||
124877219|NCT02055157|449172949|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
124877220|NCT02055157|449172950|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
124877221|NCT02055157|449172951|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
124877222|NCT02055157|449172952|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
124877223|NCT02055157|449172949|FG000|Initial 6 Months|Adverse Event|0|||
124877224|NCT02055157|449172950|FG001|Initial 6 Months|Adverse Event|0|||
124877225|NCT02055157|449172951|FG002|Initial 6 Months|Adverse Event|0|||
124877226|NCT02055157|449172952|FG003|Initial 6 Months|Adverse Event|1|||
124877227|NCT02055157|449172949|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
124877228|NCT02055157|449172950|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
124877229|NCT02055157|449172951|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
124877230|NCT02055157|449172952|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
124877231|NCT02055157|449172949|FG000|18-month Extension|Investigator decision|0|||
124877232|NCT02055157|449172950|FG001|18-month Extension|Investigator decision|1|||
124877233|NCT02055157|449172951|FG002|18-month Extension|Investigator decision|0|||
124877234|NCT02055157|449172952|FG003|18-month Extension|Investigator decision|0|||
124877235|NCT02055157|449172949|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
124877236|NCT02055157|449172950|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
124877237|NCT02055157|449172951|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
124877238|NCT02055157|449172952|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
124877239|NCT03976466|449172953|FG000|Overall Study|Lost to Follow-up|1|||
125101320|NCT03862807|449992468|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
125101321|NCT04362761|449992469|FG000|Part A (48 Weeks)|Adverse Event|2|||
124877240|NCT03976466|449172954|FG001|Overall Study|Lost to Follow-up|3|||
124877241|NCT00733499|449172955|FG000|Pre-operative|Protocol Violation|0|||
124877242|NCT00733499|449172956|FG001|Pre-operative|Protocol Violation|1|||
124877243|NCT00733499|449172955|FG000|3 Months Follow-up|Death|1|||
124877244|NCT00733499|449172956|FG001|3 Months Follow-up|Death|2|||
124877245|NCT00733499|449172955|FG000|6 Months Follow-up|Death|0|||
124877246|NCT00733499|449172956|FG001|6 Months Follow-up|Death|2|||
124877247|NCT00733499|449172955|FG000|6 Months Follow-up|Adverse Event|0|||
124877248|NCT00733499|449172956|FG001|6 Months Follow-up|Adverse Event|1|||
124877249|NCT00733499|449172955|FG000|12 Months Follow-up|Death|2|||
124877250|NCT00733499|449172956|FG001|12 Months Follow-up|Death|1|||
124877251|NCT00733499|449172955|FG000|24 Months Follow-up|Death|0|||
124877252|NCT00733499|449172956|FG001|24 Months Follow-up|Death|1|||
124877253|NCT00733499|449172955|FG000|5 Year Followup|Adverse Event|2|||
124877254|NCT00733499|449172956|FG001|5 Year Followup|Adverse Event|2|||
124877255|NCT00733499|449172955|FG000|5 Year Followup|Non device related AE|0|||
124877256|NCT00733499|449172956|FG001|5 Year Followup|Non device related AE|1|||
124877257|NCT00733499|449172955|FG000|5 Year Followup|Revision of Study Implant|0|||
124877258|NCT00733499|449172956|FG001|5 Year Followup|Revision of Study Implant|1|||
124877259|NCT00733499|449172955|FG000|5 Year Followup|Lost to Follow-up|2|||
124877260|NCT00733499|449172956|FG001|5 Year Followup|Lost to Follow-up|0|||
124877261|NCT00733499|449172955|FG000|5 Year Followup|Death|13|||
124877262|NCT00733499|449172956|FG001|5 Year Followup|Death|19|||
124877263|NCT00733499|449172955|FG000|5 Year Followup|missing, unable to locate|0|||
124877264|NCT00733499|449172956|FG001|5 Year Followup|missing, unable to locate|1|||
124877265|NCT00733499|449172955|FG000|5 Year Followup|Withdrawal by Subject|4|||
124877266|NCT00733499|449172956|FG001|5 Year Followup|Withdrawal by Subject|1|||
124877267|NCT00733499|449172955|FG000|10 Year Followup|Death|9|||
124877268|NCT00733499|449172956|FG001|10 Year Followup|Death|7|||
124877269|NCT00733499|449172955|FG000|10 Year Followup|Adverse Event|3|||
124877270|NCT00733499|449172956|FG001|10 Year Followup|Adverse Event|3|||
124877271|NCT00733499|449172955|FG000|10 Year Followup|Lost to Follow-up|3|||
124877272|NCT00733499|449172956|FG001|10 Year Followup|Lost to Follow-up|2|||
124877273|NCT00733499|449172955|FG000|10 Year Followup|Withdrawal by Subject|5|||
124877274|NCT00733499|449172956|FG001|10 Year Followup|Withdrawal by Subject|5|||
124877275|NCT00733499|449172955|FG000|10 Year Followup|missing, unable to locate|0|||
124877276|NCT00733499|449172956|FG001|10 Year Followup|missing, unable to locate|2|||
124877277|NCT01552954|449172957|FG000|Overall Study|Adverse Event|1|||
124877278|NCT01552954|449172958|FG001|Overall Study|Adverse Event|2|||
124877279|NCT01552954|449172957|FG000|Overall Study|Lost to Follow-up|1|||
124877280|NCT01552954|449172958|FG001|Overall Study|Lost to Follow-up|1|||
124877281|NCT01552954|449172957|FG000|Overall Study|Withdrawal by Subject|1|||
125012830|NCT03116698|449673040|FG001|Overall Study|Death|0|||
125012831|NCT03116698|449673041|FG002|Overall Study|Death|2|||
125012832|NCT03116698|449673042|FG003|Overall Study|Death|0|||
125012833|NCT00788372|449673043|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
125012834|NCT00788372|449673043|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
125012835|NCT00788372|449673043|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
125012836|NCT00788372|449673043|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
125012837|NCT00788372|449673043|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
125012838|NCT00788372|449673043|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
125012839|NCT00788372|449673043|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
125012840|NCT02116777|449673046|FG000|Overall Study|Adverse Event|0|||
125012841|NCT02116777|449673047|FG001|Overall Study|Adverse Event|0|||
125012842|NCT02116777|449673048|FG002|Overall Study|Adverse Event|0|||
125012843|NCT02116777|449673049|FG003|Overall Study|Adverse Event|0|||
125012844|NCT02116777|449673050|FG004|Overall Study|Adverse Event|2|||
125012845|NCT02116777|449673051|FG005|Overall Study|Adverse Event|2|||
125012846|NCT02116777|449673052|FG006|Overall Study|Adverse Event|0|||
125012847|NCT02116777|449673046|FG000|Overall Study|Death|0|||
125012848|NCT02116777|449673047|FG001|Overall Study|Death|0|||
125012849|NCT02116777|449673048|FG002|Overall Study|Death|0|||
125012850|NCT02116777|449673049|FG003|Overall Study|Death|1|||
125012851|NCT02116777|449673050|FG004|Overall Study|Death|0|||
125012852|NCT02116777|449673051|FG005|Overall Study|Death|0|||
125012853|NCT02116777|449673052|FG006|Overall Study|Death|0|||
125012854|NCT02116777|449673046|FG000|Overall Study|Lack of Efficacy|3|||
125012855|NCT02116777|449673047|FG001|Overall Study|Lack of Efficacy|3|||
125012856|NCT02116777|449673048|FG002|Overall Study|Lack of Efficacy|3|||
125012857|NCT02116777|449673049|FG003|Overall Study|Lack of Efficacy|8|||
125012858|NCT02116777|449673050|FG004|Overall Study|Lack of Efficacy|4|||
125012859|NCT02116777|449673051|FG005|Overall Study|Lack of Efficacy|1|||
125012860|NCT02116777|449673052|FG006|Overall Study|Lack of Efficacy|9|||
125012861|NCT02116777|449673046|FG000|Overall Study|Physician Decision|0|||
125012862|NCT02116777|449673047|FG001|Overall Study|Physician Decision|0|||
124877282|NCT01552954|449172958|FG001|Overall Study|Withdrawal by Subject|1|||
124877283|NCT01552954|449172957|FG000|Overall Study|Protocol Violation|1|||
124877284|NCT01552954|449172958|FG001|Overall Study|Protocol Violation|2|||
124877285|NCT01552954|449172957|FG000|Overall Study|diagnosed DM|1|||
124877286|NCT01552954|449172958|FG001|Overall Study|diagnosed DM|0|||
125012863|NCT02116777|449673048|FG002|Overall Study|Physician Decision|0|||
125012864|NCT02116777|449673049|FG003|Overall Study|Physician Decision|2|||
125012865|NCT02116777|449673050|FG004|Overall Study|Physician Decision|0|||
125012866|NCT02116777|449673051|FG005|Overall Study|Physician Decision|0|||
124877287|NCT03929562|449172959|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
125012867|NCT02116777|449673052|FG006|Overall Study|Physician Decision|0|||
124877288|NCT03929562|449172960|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
124877289|NCT03929562|449172959|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
124877290|NCT03929562|449172960|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
124877291|NCT03929562|449172959|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
124877292|NCT03929562|449172960|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
124877293|NCT04843930|449172961|FG000|Randomization|Withdrawal by Subject|6|||
124877294|NCT04843930|449172962|FG001|Randomization|Withdrawal by Subject|6|||
124877295|NCT04843930|449172963|FG002|Randomization|Withdrawal by Subject|0|||
124877296|NCT04843930|449172964|FG003|Randomization|Withdrawal by Subject|0|||
124877297|NCT04843930|449172961|FG000|Week 6 Assessment|Adverse Event|3|||
124877298|NCT04843930|449172962|FG001|Week 6 Assessment|Adverse Event|0|||
124877299|NCT04843930|449172963|FG002|Week 6 Assessment|Adverse Event|0|||
124877300|NCT04843930|449172964|FG003|Week 6 Assessment|Adverse Event|0|||
124877301|NCT04843930|449172961|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
124877302|NCT04843930|449172962|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
124877303|NCT04843930|449172963|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
124877304|NCT04843930|449172964|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
124877305|NCT04843930|449172961|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
124877306|NCT04843930|449172962|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
124877307|NCT04843930|449172963|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
124877308|NCT04843930|449172964|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
124877309|NCT01931735|449172965|FG000|Randomized Phase|Lost to Follow-up|2|||
124877310|NCT01931735|449172966|FG001|Randomized Phase|Lost to Follow-up|2|||
124877311|NCT01931735|449172967|FG002|Randomized Phase|Lost to Follow-up|5|||
124877312|NCT01931735|449172968|FG003|Randomized Phase|Lost to Follow-up|0|||
124877313|NCT01931735|449172965|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
124877314|NCT01931735|449172966|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
124877315|NCT01931735|449172967|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
124877316|NCT01931735|449172968|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
124877317|NCT01931735|449172965|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
124877318|NCT01931735|449172966|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
124877319|NCT01931735|449172967|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
124877320|NCT01931735|449172968|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
124877321|NCT02552238|449172975|FG000|Overall Study|Withdrawal by Subject|2|||
124877322|NCT02552238|449172975|FG000|Overall Study|Adverse Event|2|||
124877323|NCT02036645|449172976|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877324|NCT02036645|449172977|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877325|NCT02036645|449172978|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877326|NCT02036645|449172979|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877327|NCT02036645|449172980|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877328|NCT02036645|449172981|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877329|NCT02036645|449172982|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
124877330|NCT02036645|449172983|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877331|NCT02036645|449172984|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877332|NCT02036645|449172985|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877333|NCT02036645|449172986|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877334|NCT02036645|449172987|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877335|NCT02036645|449172976|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
124877336|NCT02036645|449172977|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
124877337|NCT02036645|449172978|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
124877338|NCT02036645|449172979|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
124877339|NCT02036645|449172980|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
124877340|NCT02036645|449172981|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125012868|NCT02116777|449673046|FG000|Overall Study|Protocol Violation|0|||
125012869|NCT02116777|449673047|FG001|Overall Study|Protocol Violation|0|||
125012870|NCT02116777|449673048|FG002|Overall Study|Protocol Violation|0|||
125012871|NCT02116777|449673049|FG003|Overall Study|Protocol Violation|1|||
125012872|NCT02116777|449673050|FG004|Overall Study|Protocol Violation|0|||
124877341|NCT02036645|449172982|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
124877342|NCT02036645|449172983|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
124877343|NCT02036645|449172984|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
124877344|NCT02036645|449172985|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
124877345|NCT02036645|449172986|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
124877346|NCT02036645|449172987|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125012873|NCT02116777|449673051|FG005|Overall Study|Protocol Violation|0|||
125101322|NCT04362761|449992469|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
125101323|NCT04362761|449992469|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
125101324|NCT04362761|449992469|FG000|Part A (48 Weeks)|Other|5|||
125101325|NCT04362761|449992469|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
125101326|NCT04362761|449992469|FG000|Part B (86 Weeks)|Other|4|||
125101327|NCT00684645|449992470|FG000|Overall Study|Death|2|||
125101328|NCT00684645|449992470|FG000|Overall Study|Progressive disease|67|||
125101329|NCT00684645|449992470|FG000|Overall Study|Adverse Event|27|||
125101330|NCT00684645|449992470|FG000|Overall Study|Lost to Follow-up|3|||
125101331|NCT00684645|449992470|FG000|Overall Study|Other|15|||
125101332|NCT02856282|449992479|FG000|Overall Study|Withdrawal by Subject|1|||
125101333|NCT02074982|449992480|FG000|Overall Study|Adverse Event|15|||
125101334|NCT02074982|449992481|FG001|Overall Study|Adverse Event|7|||
125101335|NCT02074982|449992480|FG000|Overall Study|Lack of Efficacy|6|||
125101336|NCT02074982|449992481|FG001|Overall Study|Lack of Efficacy|1|||
125101337|NCT02074982|449992480|FG000|Overall Study|Lost to Follow-up|9|||
125101338|NCT02074982|449992481|FG001|Overall Study|Lost to Follow-up|10|||
125101339|NCT02074982|449992480|FG000|Overall Study|Non-compliance with study treatment|0|||
125101340|NCT02074982|449992481|FG001|Overall Study|Non-compliance with study treatment|2|||
125101341|NCT02074982|449992480|FG000|Overall Study|Physician Decision|1|||
125101342|NCT02074982|449992481|FG001|Overall Study|Physician Decision|1|||
125101343|NCT02074982|449992480|FG000|Overall Study|Pregnancy|1|||
125101344|NCT02074982|449992481|FG001|Overall Study|Pregnancy|2|||
125101345|NCT02074982|449992480|FG000|Overall Study|Protocol deviation|4|||
125101346|NCT02074982|449992481|FG001|Overall Study|Protocol deviation|3|||
125101347|NCT02074982|449992480|FG000|Overall Study|Technical problems|0|||
125101348|NCT02074982|449992481|FG001|Overall Study|Technical problems|2|||
125101349|NCT02074982|449992480|FG000|Overall Study|Subject/guardian decision|15|||
125101350|NCT02074982|449992481|FG001|Overall Study|Subject/guardian decision|24|||
125101351|NCT02074982|449992480|FG000|Overall Study|Death|0|||
125101352|NCT02074982|449992481|FG001|Overall Study|Death|2|||
125101353|NCT00798707|449992489|FG000|Overall Study|Adverse Event|6|||
125101354|NCT00798707|449992490|FG001|Overall Study|Adverse Event|8|||
125101355|NCT00798707|449992491|FG002|Overall Study|Adverse Event|8|||
125101356|NCT00798707|449992489|FG000|Overall Study|Failed to return|2|||
125101357|NCT00798707|449992490|FG001|Overall Study|Failed to return|2|||
125101358|NCT00798707|449992491|FG002|Overall Study|Failed to return|0|||
125101359|NCT00798707|449992489|FG000|Overall Study|Investigator|0|||
125101360|NCT00798707|449992490|FG001|Overall Study|Investigator|1|||
125101361|NCT00798707|449992491|FG002|Overall Study|Investigator|2|||
125101362|NCT00798707|449992489|FG000|Overall Study|Lack of Efficacy|2|||
125101363|NCT00798707|449992490|FG001|Overall Study|Lack of Efficacy|2|||
125101364|NCT00798707|449992491|FG002|Overall Study|Lack of Efficacy|1|||
125101365|NCT00798707|449992489|FG000|Overall Study|Lost to Follow-up|5|||
125101366|NCT00798707|449992490|FG001|Overall Study|Lost to Follow-up|6|||
125101367|NCT00798707|449992491|FG002|Overall Study|Lost to Follow-up|6|||
125101368|NCT00798707|449992489|FG000|Overall Study|Other|0|||
125101369|NCT00798707|449992490|FG001|Overall Study|Other|1|||
125101370|NCT00798707|449992491|FG002|Overall Study|Other|0|||
125101371|NCT00798707|449992489|FG000|Overall Study|Protocol Violation|4|||
125101372|NCT00798707|449992490|FG001|Overall Study|Protocol Violation|0|||
125101373|NCT00798707|449992491|FG002|Overall Study|Protocol Violation|2|||
125101374|NCT00798707|449992489|FG000|Overall Study|Withdrawal by Subject|3|||
125101375|NCT00798707|449992490|FG001|Overall Study|Withdrawal by Subject|8|||
125101376|NCT00798707|449992491|FG002|Overall Study|Withdrawal by Subject|2|||
125101377|NCT00798707|449992489|FG000|Overall Study|Randomized not treated|4|||
125101378|NCT00798707|449992490|FG001|Overall Study|Randomized not treated|5|||
125101379|NCT00798707|449992491|FG002|Overall Study|Randomized not treated|1|||
125101380|NCT02525627|449992494|FG000|Overall Study|Revision|1|||
125101381|NCT02525627|449992495|FG001|Overall Study|Revision|1|||
125101382|NCT02525627|449992494|FG000|Overall Study|Withdrawal by Subject|1|||
124877347|NCT01778556|449172988|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
124877348|NCT01778556|449172989|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
124877349|NCT01778556|449172988|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
124877350|NCT01778556|449172989|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
124877351|NCT01778556|449172988|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
124877352|NCT01778556|449172989|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
124877353|NCT01778556|449172988|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
124877354|NCT01778556|449172989|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
124877355|NCT03188120|449172990|FG000|Overall Study|Adverse Event|4|||
124877356|NCT03188120|449172990|FG000|Overall Study|Insufficient Effectiveness|8|||
124877357|NCT03188120|449172990|FG000|Overall Study|Improved|12|||
124877358|NCT03188120|449172990|FG000|Overall Study|Lost to Follow-up|7|||
124877359|NCT03188120|449172990|FG000|Overall Study|Other than specified|3|||
124877360|NCT03188120|449172990|FG000|Overall Study|No visit after the first visit|13|||
124877361|NCT00782496|449172991|FG000|Overall Study|Lost to Follow-up|14|||
124877362|NCT00782496|449172992|FG001|Overall Study|Lost to Follow-up|15|||
124877363|NCT01874145|449172998|FG000|Core Period|Non-compliance|1|||
124877364|NCT01874145|449172999|FG001|Core Period|Non-compliance|0|||
124877365|NCT01874145|449172998|FG000|Core Period|Protocol Violation|1|||
124877366|NCT01874145|449172999|FG001|Core Period|Protocol Violation|1|||
124877367|NCT01874145|449172998|FG000|Core Period|Physician Decision|1|||
124877368|NCT01874145|449172999|FG001|Core Period|Physician Decision|1|||
124877369|NCT01874145|449172998|FG000|Core Period|Adverse Event|0|||
124877370|NCT01874145|449172999|FG001|Core Period|Adverse Event|1|||
124877371|NCT01874145|449172998|FG000|Core Period|Withdrawal by Subject|0|||
124877372|NCT01874145|449172999|FG001|Core Period|Withdrawal by Subject|4|||
124877373|NCT01874145|449172998|FG000|Extension Period|Adverse Event|3|||
124877374|NCT01874145|449172999|FG001|Extension Period|Adverse Event|2|||
124877375|NCT01874145|449172998|FG000|Extension Period|Withdrawal by Subject|2|||
124877376|NCT01874145|449172999|FG001|Extension Period|Withdrawal by Subject|1|||
124877377|NCT01874145|449172998|FG000|Extension Period|Lost to Follow-up|1|||
124877378|NCT01874145|449172999|FG001|Extension Period|Lost to Follow-up|1|||
124877379|NCT02178566|449173000|FG000|Overall Study|patient did not complete due to noncompliance|0|||
124877380|NCT02178566|449173001|FG001|Overall Study|patient did not complete due to noncompliance|1|||
124877381|NCT02070484|449173006|FG000|Overall Study|Withdrawal by Subject|1|||
124877382|NCT02070484|449173007|FG001|Overall Study|Withdrawal by Subject|0|||
124877383|NCT02658630|449173010|FG000|Overall Study|Withdrawal by Subject|4|||
124877384|NCT03238300|449173011|FG000|Baseline (Before Intervention)|Physician Decision|0|||
124877385|NCT03238300|449173012|FG001|Baseline (Before Intervention)|Physician Decision|1|||
124877386|NCT03238300|449173011|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
124877387|NCT03238300|449173012|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
124877388|NCT03238300|449173011|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
124877389|NCT03238300|449173012|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
124877390|NCT03238300|449173011|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
124877391|NCT03238300|449173012|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
124877392|NCT03520400|449173015|FG000|Overall Study|Physician Decision|15|||
124877393|NCT03520400|449173016|FG001|Overall Study|Physician Decision|7|||
124877394|NCT01654601|449173017|FG000|1st Administration|Withdrawal by Subject|2|||
124877395|NCT01654601|449173018|FG001|1st Administration|Withdrawal by Subject|0|||
124877396|NCT01654601|449173017|FG000|1st Administration|Protocol Violation|0|||
124877397|NCT01654601|449173018|FG001|1st Administration|Protocol Violation|2|||
124877398|NCT01654601|449173017|FG000|2nd Administration|Adverse Event|1|||
125101383|NCT02525627|449992495|FG001|Overall Study|Withdrawal by Subject|2|||
125101384|NCT02525627|449992494|FG000|Overall Study|Death|1|||
125101385|NCT02525627|449992495|FG001|Overall Study|Death|0|||
124877399|NCT01654601|449173018|FG001|2nd Administration|Adverse Event|0|||
124877400|NCT01654601|449173017|FG000|2nd Administration|Protocol Violation|0|||
124877401|NCT01654601|449173018|FG001|2nd Administration|Protocol Violation|1|||
124877402|NCT04398537|449173019|FG000|Overall Study|Physician Decision|10|||
124877403|NCT04398537|449173020|FG001|Overall Study|Physician Decision|15|||
124877404|NCT01862991|449175209|FG000|Overall Study|Lost to Follow-up|2|||
124877405|NCT01862991|449175210|FG001|Overall Study|Lost to Follow-up|1|||
124877406|NCT01862991|449175211|FG002|Overall Study|Lost to Follow-up|1|||
124877407|NCT01862991|449175209|FG000|Overall Study|Protocol Violation|1|||
124877408|NCT01862991|449175210|FG001|Overall Study|Protocol Violation|0|||
124877409|NCT01862991|449175211|FG002|Overall Study|Protocol Violation|0|||
124877410|NCT01572389|449175213|FG000|Overall Study|Death|1|||
124877411|NCT01572389|449175214|FG001|Overall Study|Death|3|||
124877412|NCT01572389|449175213|FG000|Overall Study|Withdrawal by Subject|14|||
124877413|NCT01572389|449175214|FG001|Overall Study|Withdrawal by Subject|2|||
124877414|NCT01572389|449175213|FG000|Overall Study|Lost to Follow-up|25|||
124877415|NCT01572389|449175214|FG001|Overall Study|Lost to Follow-up|14|||
124877416|NCT01572389|449175213|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
124877417|NCT01572389|449175214|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
125101386|NCT02525627|449992494|FG000|Overall Study|Site terminated|11|||
124877418|NCT01287520|449175215|FG000|Overall Study|Adverse Event|2|||
124877419|NCT01287520|449175216|FG001|Overall Study|Adverse Event|2|||
124877420|NCT01287520|449175217|FG002|Overall Study|Adverse Event|2|||
124877421|NCT01287520|449175218|FG003|Overall Study|Adverse Event|1|||
124877422|NCT01287520|449175219|FG004|Overall Study|Adverse Event|1|||
124877423|NCT01287520|449175220|FG005|Overall Study|Adverse Event|2|||
124877424|NCT01287520|449175221|FG006|Overall Study|Adverse Event|0|||
124877425|NCT01287520|449175222|FG007|Overall Study|Adverse Event|2|||
124877426|NCT01287520|449175223|FG008|Overall Study|Adverse Event|0|||
124877427|NCT01287520|449175215|FG000|Overall Study|Physician Decision|1|||
124877428|NCT01287520|449175216|FG001|Overall Study|Physician Decision|1|||
124877429|NCT01287520|449175217|FG002|Overall Study|Physician Decision|2|||
124877430|NCT01287520|449175218|FG003|Overall Study|Physician Decision|0|||
124877431|NCT01287520|449175219|FG004|Overall Study|Physician Decision|1|||
124877432|NCT01287520|449175220|FG005|Overall Study|Physician Decision|1|||
124877433|NCT01287520|449175221|FG006|Overall Study|Physician Decision|0|||
124877434|NCT01287520|449175222|FG007|Overall Study|Physician Decision|1|||
124877435|NCT01287520|449175223|FG008|Overall Study|Physician Decision|0|||
124877436|NCT01287520|449175215|FG000|Overall Study|Progressive disease|0|||
124877437|NCT01287520|449175216|FG001|Overall Study|Progressive disease|4|||
124877438|NCT01287520|449175217|FG002|Overall Study|Progressive disease|1|||
124877439|NCT01287520|449175218|FG003|Overall Study|Progressive disease|6|||
124877440|NCT01287520|449175219|FG004|Overall Study|Progressive disease|1|||
124877441|NCT01287520|449175220|FG005|Overall Study|Progressive disease|0|||
124877442|NCT01287520|449175221|FG006|Overall Study|Progressive disease|2|||
125101387|NCT02525627|449992495|FG001|Overall Study|Site terminated|10|||
125101388|NCT03746080|449992496|FG000|Overall Study|In follow up|2|||
124877443|NCT01287520|449175222|FG007|Overall Study|Progressive disease|2|||
125101389|NCT03746080|449992496|FG000|Overall Study|Death|15|||
125101390|NCT02094573|449992497|FG000|Overall Study|Adverse Event|4|||
125101391|NCT02094573|449992498|FG001|Overall Study|Adverse Event|14|||
125101392|NCT02094573|449992497|FG000|Overall Study|Clinical Progressive Disease|9|||
125101393|NCT02094573|449992498|FG001|Overall Study|Clinical Progressive Disease|13|||
125101394|NCT02094573|449992497|FG000|Overall Study|Death|11|||
125101395|NCT02094573|449992498|FG001|Overall Study|Death|3|||
125101396|NCT02094573|449992497|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
125101397|NCT02094573|449992498|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
125101398|NCT02094573|449992497|FG000|Overall Study|Non-compliance with Study Drug|1|||
125101399|NCT02094573|449992498|FG001|Overall Study|Non-compliance with Study Drug|1|||
125101400|NCT02094573|449992497|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
125101401|NCT02094573|449992498|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
125101402|NCT02094573|449992497|FG000|Overall Study|Physician Decision|4|||
125101403|NCT02094573|449992498|FG001|Overall Study|Physician Decision|4|||
125101404|NCT02094573|449992497|FG000|Overall Study|Site Terminated by Sponsor|10|||
125101405|NCT02094573|449992498|FG001|Overall Study|Site Terminated by Sponsor|17|||
125101406|NCT02094573|449992497|FG000|Overall Study|Withdrawal by Subject|6|||
125101407|NCT02094573|449992498|FG001|Overall Study|Withdrawal by Subject|8|||
125101408|NCT02094573|449992497|FG000|Overall Study|Randomized but not Treated|3|||
125101409|NCT02094573|449992498|FG001|Overall Study|Randomized but not Treated|0|||
125101410|NCT01473589|449992499|FG000|Overall Study|Adverse Event|1|||
125101411|NCT01473589|449992500|FG001|Overall Study|Adverse Event|1|||
125101412|NCT01473589|449992499|FG000|Overall Study|Death|2|||
125101413|NCT01473589|449992500|FG001|Overall Study|Death|0|||
125101414|NCT01473589|449992499|FG000|Overall Study|Lost to Follow-up|2|||
125101415|NCT01473589|449992500|FG001|Overall Study|Lost to Follow-up|2|||
125101416|NCT01473589|449992499|FG000|Overall Study|Protocol Violation|1|||
125101417|NCT01473589|449992500|FG001|Overall Study|Protocol Violation|0|||
125101418|NCT01473589|449992499|FG000|Overall Study|Withdrawal by Subject|5|||
125101419|NCT01473589|449992500|FG001|Overall Study|Withdrawal by Subject|11|||
125101420|NCT01473589|449992499|FG000|Overall Study|Physician Decision|0|||
125101421|NCT01473589|449992500|FG001|Overall Study|Physician Decision|1|||
124877444|NCT01287520|449175223|FG008|Overall Study|Progressive disease|4|||
125101422|NCT01473589|449992499|FG000|Overall Study|Entry criteria not met|0|||
125101423|NCT01473589|449992500|FG001|Overall Study|Entry criteria not met|1|||
125101424|NCT03256526|449992501|FG000|Overall Study|Adverse Event|1|||
124877445|NCT01287520|449175215|FG000|Overall Study|Withdrawal by Subject|0|||
124877446|NCT01287520|449175216|FG001|Overall Study|Withdrawal by Subject|0|||
124877447|NCT01287520|449175217|FG002|Overall Study|Withdrawal by Subject|0|||
125101425|NCT03256526|449992502|FG001|Overall Study|Adverse Event|0|||
125101426|NCT03256526|449992503|FG002|Overall Study|Adverse Event|1|||
124877448|NCT01287520|449175218|FG003|Overall Study|Withdrawal by Subject|0|||
124877449|NCT01287520|449175219|FG004|Overall Study|Withdrawal by Subject|0|||
124877450|NCT01287520|449175220|FG005|Overall Study|Withdrawal by Subject|1|||
124877451|NCT01287520|449175221|FG006|Overall Study|Withdrawal by Subject|0|||
124877452|NCT01287520|449175222|FG007|Overall Study|Withdrawal by Subject|0|||
125101427|NCT03256526|449992501|FG000|Overall Study|Lost to Follow-up|1|||
125101428|NCT03256526|449992502|FG001|Overall Study|Lost to Follow-up|0|||
125101429|NCT03256526|449992503|FG002|Overall Study|Lost to Follow-up|2|||
125012874|NCT02116777|449673052|FG006|Overall Study|Protocol Violation|0|||
125012875|NCT02116777|449673046|FG000|Overall Study|Withdrawal by Subject|0|||
125012876|NCT02116777|449673047|FG001|Overall Study|Withdrawal by Subject|0|||
125012877|NCT02116777|449673048|FG002|Overall Study|Withdrawal by Subject|0|||
125012878|NCT02116777|449673049|FG003|Overall Study|Withdrawal by Subject|1|||
125012879|NCT02116777|449673050|FG004|Overall Study|Withdrawal by Subject|0|||
125012880|NCT02116777|449673051|FG005|Overall Study|Withdrawal by Subject|0|||
125012881|NCT02116777|449673052|FG006|Overall Study|Withdrawal by Subject|0|||
125012882|NCT00102960|449673054|FG000|Overall Study|Death|23|||
125012883|NCT00102960|449673055|FG001|Overall Study|Death|11|||
125012884|NCT00102960|449673056|FG002|Overall Study|Death|11|||
125012885|NCT00102960|449673054|FG000|Overall Study|Lost to Follow-up|6|||
125012886|NCT00102960|449673055|FG001|Overall Study|Lost to Follow-up|12|||
125012887|NCT00102960|449673056|FG002|Overall Study|Lost to Follow-up|16|||
125012888|NCT00102960|449673054|FG000|Overall Study|Withdrawal by Subject|1|||
125012889|NCT00102960|449673055|FG001|Overall Study|Withdrawal by Subject|0|||
125012890|NCT00102960|449673056|FG002|Overall Study|Withdrawal by Subject|1|||
125012891|NCT01849874|449674712|FG000|Overall Study|Death|89|||
125012892|NCT01849874|449674713|FG001|Overall Study|Death|42|||
125012893|NCT01849874|449674712|FG000|Overall Study|Withdrawal by Subject|17|||
125012894|NCT01849874|449674713|FG001|Overall Study|Withdrawal by Subject|16|||
125012895|NCT01849874|449674712|FG000|Overall Study|Lost to Follow-up|3|||
125012896|NCT01849874|449674713|FG001|Overall Study|Lost to Follow-up|2|||
125012897|NCT01849874|449674712|FG000|Overall Study|Study Termination By Sponsor|93|||
125012898|NCT01849874|449674713|FG001|Overall Study|Study Termination By Sponsor|48|||
125012899|NCT01849874|449674712|FG000|Overall Study|Completed as per protocol amendment 6|3|||
125012900|NCT01849874|449674713|FG001|Overall Study|Completed as per protocol amendment 6|0|||
125012901|NCT01849874|449674712|FG000|Overall Study|Physician Decision|7|||
125012902|NCT01849874|449674713|FG001|Overall Study|Physician Decision|1|||
125012903|NCT01849874|449674712|FG000|Overall Study|Other|16|||
125012904|NCT01849874|449674713|FG001|Overall Study|Other|4|||
125012905|NCT02104583|449674714|FG000|Overall Study|New ICD or CRT-D implanted|2|||
125012906|NCT02104583|449674715|FG001|Overall Study|New ICD or CRT-D implanted|0|||
125012907|NCT02104583|449674716|FG002|Overall Study|New ICD or CRT-D implanted|1|||
125012908|NCT02104583|449674717|FG003|Overall Study|New ICD or CRT-D implanted|0|||
125012909|NCT02104583|449674718|FG004|Overall Study|New ICD or CRT-D implanted|0|||
125012910|NCT02104583|449674714|FG000|Overall Study|Death|2|||
125012911|NCT02104583|449674715|FG001|Overall Study|Death|1|||
125012912|NCT02104583|449674716|FG002|Overall Study|Death|3|||
125012913|NCT02104583|449674717|FG003|Overall Study|Death|3|||
125012914|NCT02104583|449674718|FG004|Overall Study|Death|5|||
125012915|NCT02104583|449674714|FG000|Overall Study|Subject required cardiac ablation|6|||
125012916|NCT02104583|449674715|FG001|Overall Study|Subject required cardiac ablation|4|||
125012917|NCT02104583|449674716|FG002|Overall Study|Subject required cardiac ablation|4|||
125012918|NCT02104583|449674717|FG003|Overall Study|Subject required cardiac ablation|5|||
125012919|NCT02104583|449674718|FG004|Overall Study|Subject required cardiac ablation|4|||
125012920|NCT02104583|449674714|FG000|Overall Study|Subject required prohibited medication|0|||
125012921|NCT02104583|449674715|FG001|Overall Study|Subject required prohibited medication|1|||
125012922|NCT02104583|449674716|FG002|Overall Study|Subject required prohibited medication|1|||
125012923|NCT02104583|449674717|FG003|Overall Study|Subject required prohibited medication|0|||
125012924|NCT02104583|449674718|FG004|Overall Study|Subject required prohibited medication|1|||
125012925|NCT02104583|449674714|FG000|Overall Study|Withdrew Consent|3|||
125012926|NCT02104583|449674715|FG001|Overall Study|Withdrew Consent|2|||
125012927|NCT02104583|449674716|FG002|Overall Study|Withdrew Consent|0|||
125012928|NCT02104583|449674717|FG003|Overall Study|Withdrew Consent|2|||
125012929|NCT02104583|449674718|FG004|Overall Study|Withdrew Consent|1|||
125012930|NCT02104583|449674714|FG000|Overall Study|Investigator's Discretion|1|||
125012931|NCT02104583|449674715|FG001|Overall Study|Investigator's Discretion|0|||
125012932|NCT02104583|449674716|FG002|Overall Study|Investigator's Discretion|0|||
125012933|NCT02104583|449674717|FG003|Overall Study|Investigator's Discretion|0|||
125012934|NCT02104583|449674718|FG004|Overall Study|Investigator's Discretion|0|||
125012935|NCT02104583|449674714|FG000|Overall Study|Protocol Violation|0|||
125012936|NCT02104583|449674715|FG001|Overall Study|Protocol Violation|0|||
125012937|NCT02104583|449674716|FG002|Overall Study|Protocol Violation|1|||
125012938|NCT02104583|449674717|FG003|Overall Study|Protocol Violation|0|||
125101430|NCT01160770|449992504|FG000|Overall Study|Adverse Event|10|||
125101431|NCT01160770|449992504|FG000|Overall Study|Protocol Violation|2|||
125101432|NCT01160770|449992504|FG000|Overall Study|Subject/parent/caregiver request|33|||
125101433|NCT01160770|449992504|FG000|Overall Study|Physician Decision|1|||
125101434|NCT01160770|449992504|FG000|Overall Study|Lost to Follow-up|7|||
125101435|NCT01160770|449992504|FG000|Overall Study|Study termination or sponsor request|1|||
125101436|NCT01160770|449992504|FG000|Overall Study|Death|9|||
125101437|NCT01160770|449992504|FG000|Overall Study|Lack of Efficacy|15|||
125101438|NCT01160770|449992504|FG000|Overall Study|Other Reasons|1|||
125101439|NCT03606109|449992508|FG000|Overall Study|Lost to Follow-up|2|||
125101440|NCT03606109|449992509|FG001|Overall Study|Lost to Follow-up|1|||
125101441|NCT03669640|449992510|FG000|Overall Study|Study Terminated by Sponsor|0|||
125101442|NCT03669640|449992511|FG001|Overall Study|Study Terminated by Sponsor|0|||
125101443|NCT03669640|449992512|FG002|Overall Study|Study Terminated by Sponsor|0|||
125101444|NCT03669640|449992513|FG003|Overall Study|Study Terminated by Sponsor|0|||
125101445|NCT03669640|449992514|FG004|Overall Study|Study Terminated by Sponsor|1|||
125101446|NCT03669640|449992515|FG005|Overall Study|Study Terminated by Sponsor|0|||
125101447|NCT03669640|449992510|FG000|Overall Study|Lost to Follow-up|0|||
125101448|NCT03669640|449992511|FG001|Overall Study|Lost to Follow-up|0|||
125101449|NCT03669640|449992512|FG002|Overall Study|Lost to Follow-up|2|||
125101450|NCT03669640|449992513|FG003|Overall Study|Lost to Follow-up|0|||
125101451|NCT03669640|449992514|FG004|Overall Study|Lost to Follow-up|0|||
125101452|NCT03669640|449992515|FG005|Overall Study|Lost to Follow-up|0|||
125101453|NCT03669640|449992510|FG000|Overall Study|Death|0|||
125101454|NCT03669640|449992511|FG001|Overall Study|Death|0|||
125101455|NCT03669640|449992512|FG002|Overall Study|Death|1|||
125101456|NCT03669640|449992513|FG003|Overall Study|Death|0|||
125101457|NCT03669640|449992514|FG004|Overall Study|Death|0|||
125101458|NCT03669640|449992515|FG005|Overall Study|Death|0|||
125101459|NCT03669640|449992510|FG000|Overall Study|Withdrawal by Subject|1|||
125101460|NCT03669640|449992511|FG001|Overall Study|Withdrawal by Subject|2|||
125101461|NCT03669640|449992512|FG002|Overall Study|Withdrawal by Subject|1|||
125101462|NCT03669640|449992513|FG003|Overall Study|Withdrawal by Subject|0|||
125101463|NCT03669640|449992514|FG004|Overall Study|Withdrawal by Subject|1|||
125101464|NCT03669640|449992515|FG005|Overall Study|Withdrawal by Subject|3|||
125101465|NCT03669640|449992510|FG000|Overall Study|Protocol Violation|1|||
125101466|NCT03669640|449992511|FG001|Overall Study|Protocol Violation|0|||
125101467|NCT03669640|449992512|FG002|Overall Study|Protocol Violation|0|||
125101468|NCT03669640|449992513|FG003|Overall Study|Protocol Violation|0|||
125101469|NCT03669640|449992514|FG004|Overall Study|Protocol Violation|0|||
125101470|NCT03669640|449992515|FG005|Overall Study|Protocol Violation|0|||
125101471|NCT03669640|449992510|FG000|Overall Study|Physician Decision|0|||
125101472|NCT03669640|449992511|FG001|Overall Study|Physician Decision|2|||
125101473|NCT03669640|449992512|FG002|Overall Study|Physician Decision|0|||
125101474|NCT03669640|449992513|FG003|Overall Study|Physician Decision|0|||
125101475|NCT03669640|449992514|FG004|Overall Study|Physician Decision|0|||
125101476|NCT03669640|449992515|FG005|Overall Study|Physician Decision|0|||
125101477|NCT03669640|449992510|FG000|Overall Study|Disease Relapse|1|||
125101478|NCT03669640|449992511|FG001|Overall Study|Disease Relapse|0|||
125101479|NCT03669640|449992512|FG002|Overall Study|Disease Relapse|0|||
125101480|NCT03669640|449992513|FG003|Overall Study|Disease Relapse|0|||
125101481|NCT03669640|449992514|FG004|Overall Study|Disease Relapse|0|||
125101482|NCT03669640|449992515|FG005|Overall Study|Disease Relapse|0|||
125101483|NCT03669640|449992510|FG000|Overall Study|Adverse Event|2|||
125101484|NCT03669640|449992511|FG001|Overall Study|Adverse Event|1|||
125101485|NCT03669640|449992512|FG002|Overall Study|Adverse Event|0|||
125101486|NCT03669640|449992513|FG003|Overall Study|Adverse Event|0|||
125101487|NCT03669640|449992514|FG004|Overall Study|Adverse Event|1|||
125101488|NCT03669640|449992515|FG005|Overall Study|Adverse Event|0|||
125101489|NCT05553600|449992516|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
125101490|NCT05553600|449992517|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
125101491|NCT05553600|449992518|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
125101492|NCT05553600|449992519|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
125101493|NCT05553600|449992516|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
125101494|NCT05553600|449992517|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
125101495|NCT05553600|449992518|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
125101496|NCT05553600|449992519|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
125101497|NCT05553600|449992516|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
125101498|NCT05553600|449992517|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
125101499|NCT05553600|449992518|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
125101500|NCT05553600|449992519|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
125101501|NCT05553600|449992516|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
125101502|NCT05553600|449992517|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
125101503|NCT05553600|449992518|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
124877453|NCT01287520|449175223|FG008|Overall Study|Withdrawal by Subject|1|||
124877454|NCT00708435|449175224|FG000|Overall Study|Death / Serious Adverse Event|10|||
124877455|NCT00708435|449175225|FG001|Overall Study|Death / Serious Adverse Event|5|||
124877456|NCT00708435|449175224|FG000|Overall Study|Lost to Follow-up|9|||
124877457|NCT00708435|449175225|FG001|Overall Study|Lost to Follow-up|4|||
124877458|NCT00708435|449175224|FG000|Overall Study|Withdrawal by Subject|3|||
124877459|NCT00708435|449175225|FG001|Overall Study|Withdrawal by Subject|7|||
124877460|NCT00708435|449175224|FG000|Overall Study|Adverse Event|1|||
124877461|NCT00708435|449175225|FG001|Overall Study|Adverse Event|0|||
124877462|NCT00708435|449175224|FG000|Overall Study|Protocol Violation|0|||
124877463|NCT00708435|449175225|FG001|Overall Study|Protocol Violation|1|||
124877464|NCT00708435|449175224|FG000|Overall Study|Intervention by primary care physician|1|||
124877465|NCT00708435|449175225|FG001|Overall Study|Intervention by primary care physician|0|||
124877466|NCT00708435|449175224|FG000|Overall Study|Refused hospitalization|1|||
124877467|NCT00708435|449175225|FG001|Overall Study|Refused hospitalization|0|||
124877468|NCT01691521|449175231|FG000|Overall Study|Adverse Event|4|||
124877469|NCT01691521|449175232|FG001|Overall Study|Adverse Event|0|||
124877470|NCT01691521|449175233|FG002|Overall Study|Adverse Event|1|||
124877471|NCT01691521|449175231|FG000|Overall Study|Lack of Efficacy|1|||
124877472|NCT01691521|449175232|FG001|Overall Study|Lack of Efficacy|1|||
124877473|NCT01691521|449175233|FG002|Overall Study|Lack of Efficacy|2|||
124877474|NCT01691521|449175231|FG000|Overall Study|Protocol Violation|0|||
124877475|NCT01691521|449175232|FG001|Overall Study|Protocol Violation|3|||
124877476|NCT01691521|449175233|FG002|Overall Study|Protocol Violation|0|||
124877477|NCT01691521|449175231|FG000|Overall Study|Lost to Follow-up|0|||
124877478|NCT01691521|449175232|FG001|Overall Study|Lost to Follow-up|2|||
124877479|NCT01691521|449175233|FG002|Overall Study|Lost to Follow-up|2|||
124877480|NCT01691521|449175231|FG000|Overall Study|Physician Decision|2|||
124877481|NCT01691521|449175232|FG001|Overall Study|Physician Decision|1|||
124877482|NCT01691521|449175233|FG002|Overall Study|Physician Decision|0|||
124877483|NCT01691521|449175231|FG000|Overall Study|Withdrawal by Subject|5|||
124877484|NCT01691521|449175232|FG001|Overall Study|Withdrawal by Subject|9|||
124877485|NCT01691521|449175233|FG002|Overall Study|Withdrawal by Subject|4|||
124877486|NCT04503096|449175234|FG000|Overall Study|Withdrawal by Subject|3|||
124877487|NCT01480596|449175235|FG000|Overall Study|Adverse Event|3|||
124877488|NCT01480596|449175236|FG001|Overall Study|Adverse Event|0|||
124877489|NCT01480596|449175235|FG000|Overall Study|MG exacerbation or change in medication|2|||
124877490|NCT01480596|449175236|FG001|Overall Study|MG exacerbation or change in medication|2|||
124877491|NCT02343003|449175238|FG000|Overall Study|Withdrawal by Subject|9|||
124877492|NCT02343003|449175239|FG001|Overall Study|Withdrawal by Subject|4|||
124877493|NCT02343003|449175238|FG000|Overall Study|Lost to Follow-up|5|||
124877494|NCT02343003|449175239|FG001|Overall Study|Lost to Follow-up|1|||
124877495|NCT02343003|449175238|FG000|Overall Study|Protocol Violation|1|||
124877496|NCT02343003|449175239|FG001|Overall Study|Protocol Violation|0|||
124877497|NCT02343003|449175238|FG000|Overall Study|Death|0|||
124877498|NCT02343003|449175239|FG001|Overall Study|Death|1|||
124877499|NCT02343003|449175238|FG000|Overall Study|exclusion criteria met|1|||
124877500|NCT02343003|449175239|FG001|Overall Study|exclusion criteria met|1|||
124877501|NCT02343003|449175238|FG000|Overall Study|terminated by sponsor|2|||
124877502|NCT02343003|449175239|FG001|Overall Study|terminated by sponsor|0|||
124877503|NCT01153269|449175241|FG000|Overall Study|Withdrawal by Subject|1|||
124877504|NCT01153269|449175241|FG000|Overall Study|Antiretroviral therapy break|1|||
124877505|NCT00988221|449175244|FG000|Part I|Adverse Event|0|||
125101504|NCT05553600|449992519|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
125101505|NCT05553600|449992516|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
125101506|NCT05553600|449992517|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
125101507|NCT05553600|449992518|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
125101508|NCT05553600|449992519|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
124877506|NCT00988221|449175245|FG001|Part I|Adverse Event|1|||
124877507|NCT00988221|449175246|FG002|Part I|Adverse Event|2|||
124877508|NCT00988221|449175247|FG003|Part I|Adverse Event|0|||
124877509|NCT00988221|449175244|FG000|Part I|Insufficient Therapeutic Response|4|||
124877510|NCT00988221|449175245|FG001|Part I|Insufficient Therapeutic Response|6|||
124877511|NCT00988221|449175246|FG002|Part I|Insufficient Therapeutic Response|5|||
124877512|NCT00988221|449175247|FG003|Part I|Insufficient Therapeutic Response|0|||
124877513|NCT00988221|449175244|FG000|Part I|Refused Treatment|0|||
124877514|NCT00988221|449175245|FG001|Part I|Refused Treatment|2|||
124877515|NCT00988221|449175246|FG002|Part I|Refused Treatment|1|||
124877516|NCT00988221|449175247|FG003|Part I|Refused Treatment|0|||
124877517|NCT00988221|449175244|FG000|Part I|Lost to Follow-up|0|||
124877518|NCT00988221|449175245|FG001|Part I|Lost to Follow-up|1|||
124877519|NCT00988221|449175246|FG002|Part I|Lost to Follow-up|0|||
124877520|NCT00988221|449175247|FG003|Part I|Lost to Follow-up|0|||
124877521|NCT00988221|449175244|FG000|Part II|Adverse Event|1|||
125101509|NCT05553600|449992516|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
124877522|NCT00988221|449175245|FG001|Part II|Adverse Event|0|||
124877523|NCT00988221|449175246|FG002|Part II|Adverse Event|0|||
124877524|NCT00988221|449175247|FG003|Part II|Adverse Event|1|||
124877525|NCT00988221|449175244|FG000|Part II|Withdrawal by Subject|0|||
124877526|NCT00988221|449175245|FG001|Part II|Withdrawal by Subject|0|||
124877527|NCT00988221|449175246|FG002|Part II|Withdrawal by Subject|2|||
124877528|NCT00988221|449175247|FG003|Part II|Withdrawal by Subject|2|||
124877529|NCT00988221|449175244|FG000|Part II|Reason not Specified|0|||
124877530|NCT00988221|449175245|FG001|Part II|Reason not Specified|0|||
124877531|NCT00988221|449175246|FG002|Part II|Reason not Specified|1|||
124877532|NCT00988221|449175247|FG003|Part II|Reason not Specified|0|||
124877533|NCT00988221|449175244|FG000|Part III|Adverse Event|1|||
124877534|NCT00988221|449175245|FG001|Part III|Adverse Event|0|||
124877535|NCT00988221|449175246|FG002|Part III|Adverse Event|1|||
124877536|NCT00988221|449175247|FG003|Part III|Adverse Event|0|||
124877537|NCT00988221|449175244|FG000|Part III|Insufficient Therapeutic Response|0|||
124877538|NCT00988221|449175245|FG001|Part III|Insufficient Therapeutic Response|1|||
124877539|NCT00988221|449175246|FG002|Part III|Insufficient Therapeutic Response|1|||
124877540|NCT00988221|449175247|FG003|Part III|Insufficient Therapeutic Response|0|||
124877541|NCT00988221|449175244|FG000|Part III|Refused Treatment|0|||
124877542|NCT00988221|449175245|FG001|Part III|Refused Treatment|0|||
124877543|NCT00988221|449175246|FG002|Part III|Refused Treatment|1|||
124877544|NCT00988221|449175247|FG003|Part III|Refused Treatment|0|||
124877545|NCT02756832|449175250|FG000|Overall Study|Lost for Observation after Baseline|6|||
124877546|NCT02756832|449175250|FG000|Overall Study|Lost for Observation|13|||
124877547|NCT02756832|449175250|FG000|Overall Study|Patient's Unwillingness|12|||
124877548|NCT02756832|449175250|FG000|Overall Study|Insufficient Efficacy|2|||
124877549|NCT02756832|449175250|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
124877550|NCT02756832|449175250|FG000|Overall Study|Reason not Specified|9|||
124877551|NCT02756832|449175250|FG000|Overall Study|Protocol Deviation|10|||
124877552|NCT01781390|449175251|FG000|Overall Study|Withdrawal of Consent|0|||
124877553|NCT01781390|449175252|FG001|Overall Study|Withdrawal of Consent|3|||
124877554|NCT01781390|449175253|FG002|Overall Study|Withdrawal of Consent|1|||
125012939|NCT02104583|449674718|FG004|Overall Study|Protocol Violation|0|||
125012940|NCT02104583|449674714|FG000|Overall Study|Adverse Event|3|||
125012941|NCT02104583|449674715|FG001|Overall Study|Adverse Event|3|||
125012942|NCT02104583|449674716|FG002|Overall Study|Adverse Event|6|||
125012943|NCT02104583|449674717|FG003|Overall Study|Adverse Event|6|||
125012944|NCT02104583|449674718|FG004|Overall Study|Adverse Event|1|||
125012945|NCT02104583|449674714|FG000|Overall Study|Lost to Follow-up|1|||
125012946|NCT02104583|449674715|FG001|Overall Study|Lost to Follow-up|0|||
125012947|NCT02104583|449674716|FG002|Overall Study|Lost to Follow-up|0|||
125012948|NCT02104583|449674717|FG003|Overall Study|Lost to Follow-up|0|||
125012949|NCT02104583|449674718|FG004|Overall Study|Lost to Follow-up|0|||
125012950|NCT02104583|449674714|FG000|Overall Study|Randomized but Never Treated|0|||
125012951|NCT02104583|449674715|FG001|Overall Study|Randomized but Never Treated|0|||
125012952|NCT02104583|449674716|FG002|Overall Study|Randomized but Never Treated|0|||
125012953|NCT02104583|449674717|FG003|Overall Study|Randomized but Never Treated|1|||
125012954|NCT02104583|449674718|FG004|Overall Study|Randomized but Never Treated|0|||
125012955|NCT02347098|449674719|FG000|Overall Study|Death|1|||
125012956|NCT02347098|449674720|FG001|Overall Study|Death|0|||
125012957|NCT02347098|449674719|FG000|Overall Study|Withdrawal by Subject|1|||
125012958|NCT02347098|449674720|FG001|Overall Study|Withdrawal by Subject|0|||
125012959|NCT02347098|449674719|FG000|Overall Study|Lost to Follow-up|2|||
125012960|NCT02347098|449674720|FG001|Overall Study|Lost to Follow-up|2|||
125012961|NCT02347098|449674719|FG000|Overall Study|Refuse Follow-up Visit|1|||
125012962|NCT02347098|449674720|FG001|Overall Study|Refuse Follow-up Visit|5|||
125012963|NCT02347098|449674719|FG000|Overall Study|no visit due to illness|2|||
125012964|NCT02347098|449674720|FG001|Overall Study|no visit due to illness|1|||
125012965|NCT02187172|449674721|FG000|Overall Study|Lost to Follow-up|1|||
125012966|NCT02187172|449674722|FG001|Overall Study|Lost to Follow-up|2|||
125012967|NCT02187172|449674721|FG000|Overall Study|Lack of Efficacy|1|||
125012968|NCT02187172|449674722|FG001|Overall Study|Lack of Efficacy|2|||
125012969|NCT02187172|449674721|FG000|Overall Study|Adverse Event|0|||
125012970|NCT02187172|449674722|FG001|Overall Study|Adverse Event|1|||
124877555|NCT01781390|449175251|FG000|Overall Study|Lost to Follow-up|1|||
124877556|NCT01781390|449175252|FG001|Overall Study|Lost to Follow-up|1|||
124877557|NCT01781390|449175253|FG002|Overall Study|Lost to Follow-up|1|||
124877558|NCT01781390|449175251|FG000|Overall Study|Adverse Event|1|||
125012971|NCT02187172|449674721|FG000|Overall Study|Physician Decision|1|||
125012972|NCT02187172|449674722|FG001|Overall Study|Physician Decision|1|||
125012973|NCT02830880|449674726|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
125012974|NCT02830880|449674726|FG000|Overall Study|Death|1|||
125012975|NCT02830880|449674726|FG000|Overall Study|Physician Decision|1|||
124877559|NCT01781390|449175252|FG001|Overall Study|Adverse Event|2|||
124877560|NCT01781390|449175253|FG002|Overall Study|Adverse Event|1|||
124877561|NCT01781390|449175251|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
124877562|NCT01781390|449175252|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
125101510|NCT05553600|449992517|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
125101511|NCT05553600|449992518|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
125101512|NCT05553600|449992519|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
125101513|NCT05553600|449992516|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
125101514|NCT05553600|449992517|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
125101515|NCT05553600|449992518|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
125101516|NCT05553600|449992519|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
125101517|NCT05553600|449992516|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
125101518|NCT05553600|449992517|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
125101519|NCT05553600|449992518|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
125101520|NCT05553600|449992519|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
125101521|NCT05553600|449992516|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
125101522|NCT05553600|449992517|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
125101523|NCT05553600|449992518|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
125101524|NCT05553600|449992519|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
125101525|NCT05553600|449992516|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
125101526|NCT05553600|449992517|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
125101527|NCT05553600|449992518|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
125101528|NCT05553600|449992519|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
124877563|NCT01781390|449175253|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
124877564|NCT01216163|449175257|FG000|Overall Study|Withdrawal by Subject|1|||
124877565|NCT01216163|449175258|FG001|Overall Study|Withdrawal by Subject|1|||
124877566|NCT01216163|449175259|FG002|Overall Study|Withdrawal by Subject|0|||
124877567|NCT03879408|449175260|FG000|Overall Study|Lost to Follow-up|0|||
124877568|NCT03879408|449175261|FG001|Overall Study|Lost to Follow-up|3|||
124877569|NCT03879408|449175262|FG002|Overall Study|Lost to Follow-up|2|||
124877570|NCT03879408|449175263|FG003|Overall Study|Lost to Follow-up|1|||
124877571|NCT03879408|449175264|FG004|Overall Study|Lost to Follow-up|0|||
124877572|NCT03879408|449175260|FG000|Overall Study|Withdrawal by Subject|2|||
124877573|NCT03879408|449175261|FG001|Overall Study|Withdrawal by Subject|1|||
124877574|NCT03879408|449175262|FG002|Overall Study|Withdrawal by Subject|1|||
124877575|NCT03879408|449175263|FG003|Overall Study|Withdrawal by Subject|0|||
124877576|NCT03879408|449175264|FG004|Overall Study|Withdrawal by Subject|1|||
124877577|NCT00728962|449175265|FG000|Implant Placement Surgery|Adverse Event|8|||
124877578|NCT00728962|449175265|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
124877579|NCT00728962|449175265|FG000|Implant Placement Surgery|Protocol Violation|1|||
124877580|NCT00728962|449175265|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
124877581|NCT00728962|449175265|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
124877582|NCT05807919|449175266|FG000|Overall Study|Received antibiotics - excluded|0|||
124877583|NCT05807919|449175267|FG001|Overall Study|Received antibiotics - excluded|1|||
124877584|NCT05807919|449175266|FG000|Overall Study|Withdrawal by Subject|0|||
124877585|NCT05807919|449175267|FG001|Overall Study|Withdrawal by Subject|3|||
124877586|NCT05807919|449175266|FG000|Overall Study|Adverse Event|1|||
124877587|NCT05807919|449175267|FG001|Overall Study|Adverse Event|1|||
124877588|NCT02739347|449175272|FG000|Overall Study|Adverse Event|3|||
124877589|NCT02739347|449175273|FG001|Overall Study|Adverse Event|0|||
124877590|NCT02739347|449175272|FG000|Overall Study|Protocol Violation|0|||
124877591|NCT02739347|449175273|FG001|Overall Study|Protocol Violation|1|||
124877592|NCT02739347|449175272|FG000|Overall Study|Lost to Follow-up|0|||
124877593|NCT02739347|449175273|FG001|Overall Study|Lost to Follow-up|2|||
124877594|NCT03324880|449175277|FG000|Overall Study|Adverse Event|0|||
124877595|NCT03324880|449175278|FG001|Overall Study|Adverse Event|2|||
124877596|NCT03324880|449175277|FG000|Overall Study|Withdrawal by Subject|2|||
124877597|NCT03324880|449175278|FG001|Overall Study|Withdrawal by Subject|2|||
124877598|NCT03324880|449175277|FG000|Overall Study|Lost to Follow-up|0|||
124877599|NCT03324880|449175278|FG001|Overall Study|Lost to Follow-up|1|||
124877600|NCT03324880|449175277|FG000|Overall Study|Product Recall|0|||
124877601|NCT03324880|449175278|FG001|Overall Study|Product Recall|1|||
125012976|NCT02646982|449674727|FG000|Overall Study|Adverse Event|1|||
125012977|NCT02646982|449674728|FG001|Overall Study|Adverse Event|1|||
125012978|NCT02646982|449674727|FG000|Overall Study|Withdrawal by Subject|2|||
125012979|NCT02646982|449674728|FG001|Overall Study|Withdrawal by Subject|1|||
125012980|NCT03551509|449674737|FG000|Overall Study|Lost to Follow-up|0|||
125012981|NCT03551509|449674738|FG001|Overall Study|Lost to Follow-up|1|||
125012982|NCT03551509|449674739|FG002|Overall Study|Lost to Follow-up|0|||
125012983|NCT01040351|449674740|FG000|Overall Study|poor ovarian response|1|||
125012984|NCT01040351|449674741|FG001|Overall Study|poor ovarian response|2|||
125012985|NCT01230307|449674742|FG000|Overall Study|LVAD Placement|0|||
125012986|NCT01230307|449674743|FG001|Overall Study|LVAD Placement|2|||
125012987|NCT01918007|449674751|FG000|Overall Study|Baseline oximetry not acceptable|11|||
125012988|NCT01918007|449674752|FG001|Overall Study|Baseline oximetry not acceptable|7|||
125012989|NCT01918007|449674751|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
125012990|NCT01918007|449674752|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
125012991|NCT01918007|449674751|FG000|Overall Study|Lost to Follow-up|4|||
125012992|NCT01918007|449674752|FG001|Overall Study|Lost to Follow-up|7|||
125012993|NCT01732796|449674753|FG000|Overall Study|Adverse Event|16|||
125012994|NCT01732796|449674754|FG001|Overall Study|Adverse Event|16|||
125012995|NCT01732796|449674755|FG002|Overall Study|Adverse Event|4|||
125012996|NCT01732796|449674753|FG000|Overall Study|Lack of Efficacy|21|||
125012997|NCT01732796|449674754|FG001|Overall Study|Lack of Efficacy|18|||
125012998|NCT01732796|449674755|FG002|Overall Study|Lack of Efficacy|5|||
125012999|NCT01732796|449674753|FG000|Overall Study|Lost to Follow-up|2|||
125013000|NCT01732796|449674754|FG001|Overall Study|Lost to Follow-up|0|||
125013001|NCT01732796|449674755|FG002|Overall Study|Lost to Follow-up|0|||
125013002|NCT01732796|449674753|FG000|Overall Study|Withdrawal by Subject|6|||
125013003|NCT01732796|449674754|FG001|Overall Study|Withdrawal by Subject|8|||
125013004|NCT01732796|449674755|FG002|Overall Study|Withdrawal by Subject|2|||
125013005|NCT01732796|449674753|FG000|Overall Study|Other reason not defined above|1|||
125013006|NCT01732796|449674754|FG001|Overall Study|Other reason not defined above|0|||
125013007|NCT01732796|449674755|FG002|Overall Study|Other reason not defined above|2|||
124877602|NCT03300570|449175279|FG000|Overall Study|Adverse Event|0|||
124877603|NCT03300570|449175280|FG001|Overall Study|Adverse Event|1|||
124877604|NCT03300570|449175279|FG000|Overall Study|Withdrawal by Subject|1|||
124877605|NCT03300570|449175280|FG001|Overall Study|Withdrawal by Subject|0|||
124877606|NCT03300570|449175279|FG000|Overall Study|Inadequate bowel prep|1|||
124877607|NCT03300570|449175280|FG001|Overall Study|Inadequate bowel prep|0|||
125013008|NCT00530270|449674760|FG000|Overall Study|Protocol Violation|1|||
125013009|NCT00530270|449674761|FG001|Overall Study|Protocol Violation|0|||
125013010|NCT03972969|449674765|FG000|3-month Follow-up|Death|1|||
125013011|NCT03972969|449674766|FG001|3-month Follow-up|Death|1|||
125013012|NCT03972969|449674767|FG002|3-month Follow-up|Death|0|||
125013013|NCT03972969|449674765|FG000|6-month Follow-up|Death|1|||
124877608|NCT00116272|449175281|FG000|Overall Study|Lost to Follow-up|11|||
124877609|NCT00116272|449175282|FG001|Overall Study|Lost to Follow-up|6|||
124877610|NCT01235403|449175284|FG000|Overall Study|Adverse Event|14|||
124877611|NCT01235403|449175284|FG000|Overall Study|Lost to Follow-up|2|||
124877612|NCT01235403|449175284|FG000|Overall Study|Withdrawal by Subject|4|||
124877613|NCT01235403|449175284|FG000|Overall Study|Lack of Efficacy|2|||
124877614|NCT01235403|449175284|FG000|Overall Study|Other reasons for premature termination|4|||
124877615|NCT02296190|449175287|FG000|Overall Study|Lost to Follow-up|0|||
124877616|NCT02296190|449175288|FG001|Overall Study|Lost to Follow-up|0|||
124877617|NCT02296190|449175289|FG002|Overall Study|Lost to Follow-up|0|||
124877618|NCT02296190|449175290|FG003|Overall Study|Lost to Follow-up|0|||
124877619|NCT02296190|449175291|FG004|Overall Study|Lost to Follow-up|1|||
124877620|NCT02296190|449175292|FG005|Overall Study|Lost to Follow-up|0|||
124877621|NCT02296190|449175287|FG000|Overall Study|Failure to induce PSVT|6|||
124877622|NCT02296190|449175288|FG001|Overall Study|Failure to induce PSVT|10|||
124877623|NCT02296190|449175289|FG002|Overall Study|Failure to induce PSVT|5|||
124877624|NCT02296190|449175290|FG003|Overall Study|Failure to induce PSVT|13|||
124877625|NCT02296190|449175291|FG004|Overall Study|Failure to induce PSVT|8|||
124877626|NCT02296190|449175292|FG005|Overall Study|Failure to induce PSVT|0|||
124877627|NCT02296190|449175287|FG000|Overall Study|Physician Decision|1|||
124877628|NCT02296190|449175288|FG001|Overall Study|Physician Decision|1|||
124877629|NCT02296190|449175289|FG002|Overall Study|Physician Decision|0|||
124877630|NCT02296190|449175290|FG003|Overall Study|Physician Decision|1|||
125101529|NCT05553600|449992516|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
125101530|NCT05553600|449992517|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
124877631|NCT02296190|449175291|FG004|Overall Study|Physician Decision|2|||
125101531|NCT05553600|449992518|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
125101532|NCT05553600|449992519|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
125101533|NCT05553600|449992516|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
125101534|NCT05553600|449992517|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
125101535|NCT05553600|449992518|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
125101536|NCT05553600|449992519|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
125101537|NCT02116309|449992524|FG000|Overall Study|Lost to Follow-up|0|||
125101538|NCT02116309|449992525|FG001|Overall Study|Lost to Follow-up|1|||
125101539|NCT03710824|449992526|FG000|Overall Study|Withdrawal by Subject|1|||
125101540|NCT03710824|449992526|FG000|Overall Study|Lost to Follow-up|3|||
125101541|NCT03710824|449992526|FG000|Overall Study|Adverse Event|25|||
125101542|NCT03710824|449992526|FG000|Overall Study|Treatment discontinuation|2|||
125101543|NCT02329834|449992527|FG000|Overall Study|Physician Decision|1|||
125101544|NCT02329834|449992528|FG001|Overall Study|Physician Decision|0|||
125101545|NCT00578448|449992529|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
125101546|NCT00578448|449992529|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
125101547|NCT00578448|449992529|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
125101548|NCT00578448|449992529|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
125101549|NCT05102162|449992534|FG000|Overall Study|Withdrawal by Subject|3|||
125101550|NCT05102162|449992535|FG001|Overall Study|Withdrawal by Subject|0|||
125101551|NCT05102162|449992534|FG000|Overall Study|Baseline cultures negative|4|||
125101552|NCT05102162|449992535|FG001|Overall Study|Baseline cultures negative|2|||
125101553|NCT05102162|449992534|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
125101554|NCT05102162|449992535|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
125101555|NCT05102162|449992534|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
125101556|NCT05102162|449992535|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
125101557|NCT01165424|449992536|FG000|Overall Study|Clinical adverse experiences|1|||
125101558|NCT01165424|449992536|FG000|Overall Study|Laboratory adverse experiences|1|||
125101559|NCT01165424|449992536|FG000|Overall Study|Did not meet entry criteria|1|||
125101560|NCT01165424|449992536|FG000|Overall Study|Participant moved (relocated)|1|||
125101561|NCT00557830|449992537|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
125101562|NCT00557830|449992538|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
125101563|NCT00557830|449992539|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
125101564|NCT00557830|449992537|FG000|Screening Treatment Phase|Adverse Event|2|||
124877632|NCT02296190|449175292|FG005|Overall Study|Physician Decision|0|||
124877633|NCT02296190|449175287|FG000|Overall Study|Withdrawal by Subject|0|||
124877634|NCT02296190|449175288|FG001|Overall Study|Withdrawal by Subject|1|||
124877635|NCT02296190|449175289|FG002|Overall Study|Withdrawal by Subject|0|||
124877636|NCT02296190|449175290|FG003|Overall Study|Withdrawal by Subject|0|||
124877637|NCT02296190|449175291|FG004|Overall Study|Withdrawal by Subject|0|||
124877638|NCT02296190|449175292|FG005|Overall Study|Withdrawal by Subject|0|||
124877639|NCT02296190|449175287|FG000|Overall Study|PSVT < 5 minutes|5|||
125101565|NCT00557830|449992538|FG001|Screening Treatment Phase|Adverse Event|0|||
125101566|NCT00557830|449992539|FG002|Screening Treatment Phase|Adverse Event|0|||
125101567|NCT00557830|449992537|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
124877640|NCT02296190|449175288|FG001|Overall Study|PSVT < 5 minutes|6|||
124877641|NCT02296190|449175289|FG002|Overall Study|PSVT < 5 minutes|6|||
124877642|NCT02296190|449175290|FG003|Overall Study|PSVT < 5 minutes|6|||
124877643|NCT02296190|449175291|FG004|Overall Study|PSVT < 5 minutes|5|||
124877644|NCT02296190|449175292|FG005|Overall Study|PSVT < 5 minutes|0|||
124877645|NCT02296190|449175287|FG000|Overall Study|Patient was given Propofol|0|||
124877646|NCT02296190|449175288|FG001|Overall Study|Patient was given Propofol|1|||
124877647|NCT02296190|449175289|FG002|Overall Study|Patient was given Propofol|0|||
124877648|NCT02296190|449175290|FG003|Overall Study|Patient was given Propofol|1|||
124877649|NCT02296190|449175291|FG004|Overall Study|Patient was given Propofol|0|||
124877650|NCT02296190|449175292|FG005|Overall Study|Patient was given Propofol|0|||
124877651|NCT02296190|449175287|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
124877652|NCT02296190|449175288|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
124877653|NCT02296190|449175289|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
124877654|NCT02296190|449175290|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
124877655|NCT02296190|449175291|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
124877656|NCT02296190|449175292|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
124877657|NCT02296190|449175287|FG000|Overall Study|Blood pressure <100 after sedation|0|||
124877658|NCT02296190|449175288|FG001|Overall Study|Blood pressure <100 after sedation|0|||
124877659|NCT02296190|449175289|FG002|Overall Study|Blood pressure <100 after sedation|0|||
124877660|NCT02296190|449175290|FG003|Overall Study|Blood pressure <100 after sedation|1|||
124877661|NCT02296190|449175291|FG004|Overall Study|Blood pressure <100 after sedation|0|||
124877662|NCT02296190|449175292|FG005|Overall Study|Blood pressure <100 after sedation|0|||
124877663|NCT02296190|449175287|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
124877664|NCT02296190|449175288|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
124877665|NCT02296190|449175289|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
124877666|NCT02296190|449175290|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
124877667|NCT02296190|449175291|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
125101568|NCT00557830|449992538|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
125101569|NCT00557830|449992539|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
125101570|NCT00538473|449992541|FG000|Overall Study|Adverse Event|1|||
125101571|NCT00538473|449992542|FG001|Overall Study|Adverse Event|0|||
125101572|NCT01833897|449992543|FG000|Overall Study|Lack of Efficacy|1|||
125101573|NCT02184988|449992549|FG000|Overall Study|Pregnancy|2|||
124877668|NCT02296190|449175292|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
124877669|NCT02296190|449175287|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
124877670|NCT02296190|449175288|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
124877671|NCT02296190|449175289|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
124877672|NCT02296190|449175290|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
124877673|NCT02296190|449175291|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
124877674|NCT02296190|449175292|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
124877675|NCT02296190|449175287|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
124877676|NCT02296190|449175288|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
124877677|NCT02296190|449175289|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
124877678|NCT02296190|449175290|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
124877679|NCT02296190|449175291|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
124877680|NCT02296190|449175292|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
124877681|NCT02296190|449175287|FG000|Overall Study|Lab result not available in time|1|||
124877682|NCT02296190|449175288|FG001|Overall Study|Lab result not available in time|0|||
124877683|NCT02296190|449175289|FG002|Overall Study|Lab result not available in time|0|||
124877684|NCT02296190|449175290|FG003|Overall Study|Lab result not available in time|0|||
124877685|NCT02296190|449175291|FG004|Overall Study|Lab result not available in time|0|||
124877686|NCT02296190|449175292|FG005|Overall Study|Lab result not available in time|0|||
124877687|NCT00990340|449175293|FG000|First 14-day Treatment|Not Compliant|2|||
124877688|NCT00990340|449175294|FG001|First 14-day Treatment|Not Compliant|1|||
124877689|NCT00990340|449175293|FG000|First 14-day Treatment|Lost to Follow-up|2|||
124877690|NCT00990340|449175294|FG001|First 14-day Treatment|Lost to Follow-up|1|||
124877691|NCT00990340|449175293|FG000|First 14-day Treatment|Protocol Violation|2|||
124877692|NCT00990340|449175294|FG001|First 14-day Treatment|Protocol Violation|2|||
124877693|NCT04615182|449175295|FG000|Overall Study|Re-transplanted|2|||
124877694|NCT04615182|449175295|FG000|Overall Study|Protocol Violation|6|||
124877695|NCT04615182|449175295|FG000|Overall Study|Death|6|||
124877696|NCT04615182|449175295|FG000|Overall Study|Death and protocol violation|1|||
124877697|NCT00402337|449175300|FG000|Overall Study|Adverse Event|0|||
124877698|NCT00402337|449175301|FG001|Overall Study|Adverse Event|2|||
124877699|NCT00402337|449175302|FG002|Overall Study|Adverse Event|2|||
124877700|NCT00402337|449175303|FG003|Overall Study|Adverse Event|3|||
124877701|NCT00402337|449175304|FG004|Overall Study|Adverse Event|2|||
124877702|NCT00402337|449175300|FG000|Overall Study|Noncompliance|0|||
124877703|NCT00402337|449175301|FG001|Overall Study|Noncompliance|0|||
124877704|NCT00402337|449175302|FG002|Overall Study|Noncompliance|0|||
124877705|NCT00402337|449175303|FG003|Overall Study|Noncompliance|0|||
124877706|NCT00402337|449175304|FG004|Overall Study|Noncompliance|2|||
124877707|NCT00402337|449175300|FG000|Overall Study|Withdrawal by Subject|5|||
124877708|NCT00402337|449175301|FG001|Overall Study|Withdrawal by Subject|3|||
124877709|NCT00402337|449175302|FG002|Overall Study|Withdrawal by Subject|1|||
124877710|NCT00402337|449175303|FG003|Overall Study|Withdrawal by Subject|6|||
124877711|NCT00402337|449175304|FG004|Overall Study|Withdrawal by Subject|4|||
124877712|NCT00402337|449175300|FG000|Overall Study|Lost to Follow-up|0|||
124877713|NCT00402337|449175301|FG001|Overall Study|Lost to Follow-up|0|||
124877714|NCT00402337|449175302|FG002|Overall Study|Lost to Follow-up|1|||
124877715|NCT00402337|449175303|FG003|Overall Study|Lost to Follow-up|2|||
124877716|NCT00402337|449175304|FG004|Overall Study|Lost to Follow-up|0|||
124877717|NCT00402337|449175300|FG000|Overall Study|Physician Decision|0|||
124877718|NCT00402337|449175301|FG001|Overall Study|Physician Decision|0|||
124877719|NCT00402337|449175302|FG002|Overall Study|Physician Decision|0|||
124877720|NCT00402337|449175303|FG003|Overall Study|Physician Decision|1|||
124877721|NCT00402337|449175304|FG004|Overall Study|Physician Decision|0|||
124877722|NCT00402337|449175300|FG000|Overall Study|Other Reason|0|||
124877723|NCT00402337|449175301|FG001|Overall Study|Other Reason|1|||
125013014|NCT03972969|449674766|FG001|6-month Follow-up|Death|1|||
125013015|NCT03972969|449674767|FG002|6-month Follow-up|Death|1|||
125013016|NCT03972969|449674765|FG000|6-month Follow-up|Lost to Follow-up|2|||
125013017|NCT03972969|449674766|FG001|6-month Follow-up|Lost to Follow-up|2|||
125013018|NCT03972969|449674767|FG002|6-month Follow-up|Lost to Follow-up|2|||
125013019|NCT01399788|449674769|FG000|First Intervention Period|Adverse Event|1|||
125013020|NCT01399788|449674770|FG001|First Intervention Period|Adverse Event|0|||
124877724|NCT00402337|449175302|FG002|Overall Study|Other Reason|0|||
124877725|NCT00402337|449175303|FG003|Overall Study|Other Reason|0|||
124877726|NCT00402337|449175304|FG004|Overall Study|Other Reason|0|||
124877727|NCT02821819|449175305|FG000|Overall Study|Protocol Violation|1|||
124877728|NCT00110890|449175309|FG000|Overall Study|Adverse Event|30|||
124877729|NCT00110890|449175310|FG001|Overall Study|Adverse Event|7|||
124877730|NCT00110890|449175309|FG000|Overall Study|Death|16|||
124877731|NCT00110890|449175310|FG001|Overall Study|Death|9|||
124877732|NCT00110890|449175309|FG000|Overall Study|Lost to Follow-up|3|||
124877733|NCT00110890|449175310|FG001|Overall Study|Lost to Follow-up|1|||
125013021|NCT02919436|449674771|FG000|Overall Study|Did not undergo surgery|16|||
125013022|NCT02919436|449674772|FG001|Overall Study|Did not undergo surgery|20|||
124877734|NCT00110890|449175309|FG000|Overall Study|Physician Decision|4|||
124877735|NCT00110890|449175310|FG001|Overall Study|Physician Decision|5|||
124877736|NCT00110890|449175309|FG000|Overall Study|Withdrawal by Subject|17|||
125013023|NCT02919436|449674771|FG000|Overall Study|Enrolled before trial registration|44|||
124877737|NCT00110890|449175310|FG001|Overall Study|Withdrawal by Subject|5|||
124877738|NCT00110890|449175309|FG000|Overall Study|Protocol Deviation|1|||
124877739|NCT00110890|449175310|FG001|Overall Study|Protocol Deviation|0|||
124877740|NCT00110890|449175309|FG000|Overall Study|Noncompliance|10|||
124877741|NCT00110890|449175310|FG001|Overall Study|Noncompliance|0|||
124877742|NCT00110890|449175309|FG000|Overall Study|Kidney Transplant|16|||
124877743|NCT00110890|449175310|FG001|Overall Study|Kidney Transplant|12|||
124877744|NCT00110890|449175309|FG000|Overall Study|Invest. Product Commercially Available|217|||
124877745|NCT00110890|449175310|FG001|Overall Study|Invest. Product Commercially Available|110|||
124877746|NCT00110890|449175309|FG000|Overall Study|Other|34|||
124877747|NCT00110890|449175310|FG001|Overall Study|Other|23|||
124877748|NCT00110890|449175309|FG000|Overall Study|Ineligibility determined|3|||
124877749|NCT00110890|449175310|FG001|Overall Study|Ineligibility determined|0|||
124877750|NCT00110890|449175309|FG000|Overall Study|Requirement for alternative therapy|0|||
124877751|NCT00110890|449175310|FG001|Overall Study|Requirement for alternative therapy|1|||
124877752|NCT00110890|449175309|FG000|Overall Study|Disease progression|0|||
124877753|NCT00110890|449175310|FG001|Overall Study|Disease progression|1|||
124877754|NCT00110890|449175309|FG000|Overall Study|Parathyroidectomy|0|||
124877755|NCT00110890|449175310|FG001|Overall Study|Parathyroidectomy|1|||
124877756|NCT00110890|449175309|FG000|Overall Study|Did not enter follow-up phase|10|||
124877757|NCT00110890|449175310|FG001|Overall Study|Did not enter follow-up phase|4|||
124877758|NCT01975220|449175311|FG000|Test Period 1|Not treated|0|||
124877759|NCT01975220|449175312|FG001|Test Period 1|Not treated|1|||
124877760|NCT01975220|449175313|FG002|Test Period 1|Not treated|0|||
124877761|NCT01975220|449175314|FG003|Test Period 1|Not treated|0|||
124877762|NCT01975220|449175315|FG004|Test Period 1|Not treated|0|||
124877763|NCT01975220|449175316|FG005|Test Period 1|Not treated|0|||
124877764|NCT02839343|449175317|FG000|Overall Study|Withdrawal by Subject|3|||
124877765|NCT02839343|449175318|FG001|Overall Study|Withdrawal by Subject|1|||
124877766|NCT02839343|449175317|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
124877767|NCT02839343|449175318|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
124877768|NCT02839343|449175317|FG000|Overall Study|Adverse Event|1|||
124877769|NCT02839343|449175318|FG001|Overall Study|Adverse Event|0|||
124877770|NCT01852058|449175319|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
124877771|NCT01852058|449175320|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877772|NCT01852058|449175321|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877773|NCT01852058|449175322|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877774|NCT01852058|449175323|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877775|NCT01852058|449175324|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877776|NCT01852058|449175325|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877777|NCT01852058|449175326|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877778|NCT01852058|449175327|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877779|NCT01852058|449175328|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877780|NCT01852058|449175329|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877781|NCT01852058|449175330|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877782|NCT01852058|449175319|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877783|NCT01852058|449175320|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877784|NCT01852058|449175321|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877785|NCT01852058|449175322|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877786|NCT01852058|449175323|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
124877787|NCT01852058|449175324|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877788|NCT01852058|449175325|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877789|NCT01852058|449175326|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877790|NCT01852058|449175327|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877791|NCT01852058|449175328|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877792|NCT01852058|449175329|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877793|NCT01852058|449175330|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877794|NCT01852058|449175319|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
124877795|NCT01852058|449175320|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
124877796|NCT01852058|449175321|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
124877797|NCT01852058|449175322|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
124877798|NCT01852058|449175323|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
124877799|NCT01852058|449175324|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
124877800|NCT01852058|449175325|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
124877801|NCT01852058|449175326|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
124877802|NCT01852058|449175327|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
124877803|NCT01852058|449175328|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
124877804|NCT01852058|449175329|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
124877805|NCT01852058|449175330|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
124877806|NCT01852058|449175319|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877807|NCT01852058|449175320|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877808|NCT01852058|449175321|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877809|NCT01852058|449175322|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877810|NCT01852058|449175323|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
125101574|NCT02184988|449992549|FG000|Overall Study|Adverse Event|2|||
124877811|NCT01852058|449175324|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877812|NCT01852058|449175325|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877813|NCT01852058|449175326|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877814|NCT01852058|449175327|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877815|NCT01852058|449175328|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877816|NCT01852058|449175329|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877817|NCT01852058|449175330|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877818|NCT01852058|449175319|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
124877819|NCT01852058|449175320|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
124877820|NCT01852058|449175321|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
124877821|NCT01852058|449175322|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
124877822|NCT01852058|449175323|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
124877823|NCT01852058|449175324|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
124877824|NCT01852058|449175325|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
124877825|NCT01852058|449175326|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
124877826|NCT01852058|449175327|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
124877827|NCT01852058|449175328|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
124877828|NCT01852058|449175329|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
124877829|NCT01852058|449175330|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
124877830|NCT01852058|449175319|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877831|NCT01852058|449175320|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877832|NCT01852058|449175321|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877833|NCT01852058|449175322|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
124877834|NCT01852058|449175323|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877835|NCT01852058|449175324|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877836|NCT01852058|449175325|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877837|NCT01852058|449175326|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877838|NCT01852058|449175327|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877839|NCT01852058|449175328|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877840|NCT01852058|449175329|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877841|NCT01852058|449175330|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877842|NCT01852058|449175319|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
124877843|NCT01852058|449175320|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
124877844|NCT01852058|449175321|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
124877845|NCT01852058|449175322|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
124877846|NCT01852058|449175323|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
124877847|NCT01852058|449175324|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
124877848|NCT01852058|449175325|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
124877849|NCT01852058|449175326|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
124877850|NCT01852058|449175327|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
124877851|NCT01852058|449175328|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
124877852|NCT01852058|449175329|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
124877853|NCT01852058|449175330|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
124877854|NCT01852058|449175319|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877855|NCT01852058|449175320|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877856|NCT01852058|449175321|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877857|NCT01852058|449175322|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877858|NCT01852058|449175323|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877859|NCT01852058|449175324|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877860|NCT01852058|449175325|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877861|NCT01852058|449175326|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
124877862|NCT01852058|449175327|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877863|NCT01852058|449175328|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877864|NCT01852058|449175329|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877865|NCT01852058|449175330|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877866|NCT01852058|449175319|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877867|NCT01852058|449175320|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877868|NCT01852058|449175321|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877869|NCT01852058|449175322|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877870|NCT01852058|449175323|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877871|NCT01852058|449175324|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877872|NCT01852058|449175325|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877873|NCT01852058|449175326|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877874|NCT01852058|449175327|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
124877875|NCT01852058|449175328|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877876|NCT01852058|449175329|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877877|NCT01852058|449175330|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877878|NCT01301274|449175334|FG000|Overall Study|Physician Decision|2|||
125101575|NCT02184988|449992549|FG000|Overall Study|moving away/travelling/unable to complet|6|||
125101576|NCT02184988|449992549|FG000|Overall Study|work scheduling issues|4|||
125101577|NCT02184988|449992549|FG000|Overall Study|various other reasons|9|||
125101578|NCT02184988|449992549|FG000|Overall Study|Lost to Follow-up|32|||
125101579|NCT00690573|449992558|FG000|Overall Study|Lack of Efficacy|8|||
125101580|NCT00690573|449992558|FG000|Overall Study|Withdrawal by Subject|1|||
125101581|NCT01283282|449992559|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
125101582|NCT01283282|449992560|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
125101583|NCT01283282|449992559|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
125101584|NCT01283282|449992560|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
125101585|NCT01283282|449992559|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
125101586|NCT01283282|449992560|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
125101587|NCT00777920|449992561|FG000|Overall Study|Adverse Event|39|||
125101588|NCT00777920|449992561|FG000|Overall Study|Withdrawal of Consent|4|||
125101589|NCT00777920|449992561|FG000|Overall Study|Lost to Follow-up|1|||
125101590|NCT00777920|449992561|FG000|Overall Study|Investigator's discretion|1|||
125101591|NCT00777920|449992561|FG000|Overall Study|Clinical status did not improve|1|||
125101592|NCT00777920|449992561|FG000|Overall Study|Other, not specified|4|||
125101593|NCT00483717|449992562|FG000|Overall Study|Protocol Violation|5|||
125101594|NCT00483717|449992563|FG001|Overall Study|Protocol Violation|7|||
125101595|NCT00483717|449992562|FG000|Overall Study|Time of dosing missing|1|||
125101596|NCT00483717|449992563|FG001|Overall Study|Time of dosing missing|1|||
125101597|NCT00483717|449992562|FG000|Overall Study|No treatment for migraine|16|||
125101598|NCT00483717|449992563|FG001|Overall Study|No treatment for migraine|13|||
125101599|NCT00483717|449992562|FG000|Overall Study|Lost to Follow-up|1|||
125101600|NCT00483717|449992563|FG001|Overall Study|Lost to Follow-up|0|||
125101601|NCT00483717|449992562|FG000|Overall Study|Withdrawal by Subject|1|||
125101602|NCT00483717|449992563|FG001|Overall Study|Withdrawal by Subject|0|||
125101603|NCT03878108|449992564|FG000|Overall Study|Adverse Event|1|||
125101604|NCT03878108|449992565|FG001|Overall Study|Adverse Event|0|||
125101605|NCT01682681|449992566|FG000|Overall Study|Lack of Efficacy|62|||
125101606|NCT01682681|449992566|FG000|Overall Study|Withdrawal by Subject|1|||
125101607|NCT01682681|449992566|FG000|Overall Study|Moved to other hospital|10|||
125101608|NCT01682681|449992566|FG000|Overall Study|Lost to Follow-up|174|||
125101609|NCT01682681|449992566|FG000|Overall Study|Adverse Event|46|||
125101610|NCT01682681|449992566|FG000|Overall Study|tapering of topiramate|5|||
125101611|NCT01682681|449992566|FG000|Overall Study|Other|21|||
125101612|NCT01682681|449992566|FG000|Overall Study|Low compliance|13|||
125101613|NCT00975000|449992567|FG000|Overall Study|Other|1|||
125101614|NCT00975000|449992568|FG001|Overall Study|Other|0|||
125101615|NCT00975000|449992567|FG000|Overall Study|Adverse Event|1|||
125101616|NCT00975000|449992568|FG001|Overall Study|Adverse Event|1|||
125101617|NCT00975000|449992567|FG000|Overall Study|Withdrawal by Subject|2|||
125101618|NCT00975000|449992568|FG001|Overall Study|Withdrawal by Subject|2|||
125101619|NCT00975000|449992567|FG000|Overall Study|Lost to Follow-up|0|||
125101620|NCT00975000|449992568|FG001|Overall Study|Lost to Follow-up|1|||
125101621|NCT00975000|449992567|FG000|Overall Study|Protocol-specified Criteria|1|||
125101622|NCT00975000|449992568|FG001|Overall Study|Protocol-specified Criteria|0|||
125101623|NCT00975000|449992567|FG000|Overall Study|Non-compliance|0|||
125101624|NCT00975000|449992568|FG001|Overall Study|Non-compliance|1|||
125101625|NCT01525407|449992569|FG000|Overall Study|Change in recipient treatment plan|2|||
125101626|NCT01525407|449992570|FG001|Overall Study|Change in recipient treatment plan|2|||
125101627|NCT01525407|449992569|FG000|Overall Study|Withdrawal by Subject|0|||
125101628|NCT01525407|449992570|FG001|Overall Study|Withdrawal by Subject|1|||
125101629|NCT01525407|449992569|FG000|Overall Study|Transplant was delayed|0|||
125101630|NCT01525407|449992570|FG001|Overall Study|Transplant was delayed|1|||
125101631|NCT01525407|449992569|FG000|Overall Study|Delay in Transplant|1|||
125101632|NCT01525407|449992570|FG001|Overall Study|Delay in Transplant|0|||
125101633|NCT01819467|449994023|FG000|Overall Study|Physician Decision|20|||
125101634|NCT01819467|449994024|FG001|Overall Study|Physician Decision|9|||
125101635|NCT02875340|449994026|FG000|Overall Study|Death|2|||
125101636|NCT02875340|449994026|FG000|Overall Study|Withdrawal by Subject|2|||
125101637|NCT02875340|449994026|FG000|Overall Study|Physician Decision|3|||
125101638|NCT02875340|449994026|FG000|Overall Study|Adverse Event|1|||
125101639|NCT01607398|449994029|FG000|Overall Study|Adverse Event|0|||
125101640|NCT01607398|449994030|FG001|Overall Study|Adverse Event|2|||
125101641|NCT01607398|449994029|FG000|Overall Study|Severe COPD|2|||
125101642|NCT01607398|449994030|FG001|Overall Study|Severe COPD|0|||
125101643|NCT03457727|449994031|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
125101644|NCT03457727|449994032|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
125101645|NCT03457727|449994033|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
125101646|NCT03457727|449994034|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
125101647|NCT00929201|449994035|FG000|Period 1|Withdrawal by Subject|0|||
125101648|NCT00929201|449994036|FG001|Period 1|Withdrawal by Subject|1|||
125101649|NCT01299272|449994039|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
125101650|NCT01299272|449994040|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
125101651|NCT01299272|449994041|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
125101652|NCT01299272|449994042|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
125101653|NCT01299272|449994039|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
125101654|NCT01299272|449994040|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
125101655|NCT01299272|449994041|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
125101656|NCT01299272|449994042|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
125101657|NCT01299272|449994039|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
125101658|NCT01299272|449994040|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
125101659|NCT01299272|449994041|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
125101660|NCT01299272|449994042|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
125101661|NCT01299272|449994039|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
125101662|NCT01299272|449994040|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
125101663|NCT01299272|449994041|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
125101664|NCT01299272|449994042|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
125101665|NCT01299272|449994039|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
125101666|NCT01299272|449994040|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
125101667|NCT01299272|449994041|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
125101668|NCT01299272|449994042|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
125101669|NCT01299272|449994039|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
125101670|NCT01299272|449994040|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
125101671|NCT01299272|449994041|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
125101672|NCT01299272|449994042|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
125101673|NCT01299272|449994039|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
125101674|NCT01299272|449994040|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
125101675|NCT01299272|449994041|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
125101676|NCT01299272|449994042|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
125101677|NCT01299272|449994039|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
125101678|NCT01299272|449994040|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
125101679|NCT01299272|449994041|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
125101680|NCT01299272|449994042|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
125101681|NCT01299272|449994039|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
125101682|NCT01299272|449994040|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
125101683|NCT01299272|449994041|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
125101684|NCT01299272|449994042|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
125101685|NCT01299272|449994039|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
125101686|NCT01299272|449994040|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
125101687|NCT01299272|449994041|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
125101688|NCT01299272|449994042|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
125101689|NCT01299272|449994039|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
125101690|NCT01299272|449994040|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
125101691|NCT01299272|449994041|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
125101692|NCT01299272|449994042|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
125101693|NCT01299272|449994039|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
125101694|NCT01299272|449994040|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
125101695|NCT01299272|449994041|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
125101696|NCT01299272|449994042|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
125101697|NCT01299272|449994039|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
125101698|NCT01299272|449994040|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
125101699|NCT01299272|449994041|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
125101700|NCT01299272|449994042|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
125101701|NCT01299272|449994039|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
125101702|NCT01299272|449994040|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
125101703|NCT01299272|449994041|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
125101704|NCT01299272|449994042|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
125101705|NCT01299272|449994039|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
125101706|NCT01299272|449994040|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
125101707|NCT01299272|449994041|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
125101708|NCT01299272|449994042|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
125101709|NCT01299272|449994039|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
125101710|NCT01299272|449994040|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
125210711|NCT02069093|450395659|FG000|Overall Study|Abnormal laboratory values|1|||
124877879|NCT01301274|449175335|FG001|Overall Study|Physician Decision|1|||
124877880|NCT00661661|449175336|FG000|Overall Study|Adverse Event|99|||
124877881|NCT00661661|449175337|FG001|Overall Study|Adverse Event|24|||
124877882|NCT00661661|449175336|FG000|Overall Study|Lack of Efficacy|3|||
124877883|NCT00661661|449175337|FG001|Overall Study|Lack of Efficacy|2|||
124877884|NCT00661661|449175336|FG000|Overall Study|Lost to Follow-up|0|||
124877885|NCT00661661|449175337|FG001|Overall Study|Lost to Follow-up|1|||
124877886|NCT00661661|449175336|FG000|Overall Study|Withdrawal by Subject|15|||
124877887|NCT00661661|449175337|FG001|Overall Study|Withdrawal by Subject|5|||
124877888|NCT00661661|449175336|FG000|Overall Study|Other|22|||
124877889|NCT00661661|449175337|FG001|Overall Study|Other|7|||
124877890|NCT00661661|449175336|FG000|Overall Study|Not assigned treatment|1|||
124877891|NCT00661661|449175337|FG001|Overall Study|Not assigned treatment|0|||
124877892|NCT01893827|449175338|FG000|Overall Study|Lost to Follow-up|19|||
124877893|NCT01893827|449175339|FG001|Overall Study|Lost to Follow-up|26|||
124877894|NCT04182880|449175340|FG000|Overall Study|Pregnancy|1|||
124877895|NCT04182880|449175341|FG001|Overall Study|Pregnancy|0|||
124877896|NCT03389477|449175342|FG000|Step 1|Withdrawal by Subject|1|||
124877897|NCT03389477|449175343|FG001|Step 1|Withdrawal by Subject|0|||
124877898|NCT03389477|449175342|FG000|Step 2|Withdrawal by Subject|1|||
124877899|NCT03389477|449175343|FG001|Step 2|Withdrawal by Subject|2|||
124877900|NCT03389477|449175342|FG000|Step 2|Disease progression|1|||
124877901|NCT03389477|449175343|FG001|Step 2|Disease progression|0|||
124877902|NCT03389477|449175342|FG000|Step 2|Death|0|||
124877903|NCT03389477|449175343|FG001|Step 2|Death|1|||
124877904|NCT03389477|449175342|FG000|Step 2|Poor performance status and nutrition|0|||
124877905|NCT03389477|449175343|FG001|Step 2|Poor performance status and nutrition|1|||
124877906|NCT03389477|449175342|FG000|Step 3|Withdrawal after 3 cycles|0|||
124877907|NCT03389477|449175343|FG001|Step 3|Withdrawal after 3 cycles|1|||
124877908|NCT03389477|449175342|FG000|Step 3|Still receiving active treatment|4|||
124877909|NCT03389477|449175343|FG001|Step 3|Still receiving active treatment|0|||
124877910|NCT03389477|449175342|FG000|Step 3|Progressive disease after 2 cycles|1|||
124877911|NCT03389477|449175343|FG001|Step 3|Progressive disease after 2 cycles|0|||
124877912|NCT03403426|449175348|FG000|Overall Study|Death|1|||
124877913|NCT03403426|449175348|FG000|Overall Study|Lost to Follow-up|2|||
124877914|NCT00445679|449175351|FG000|Overall Study|Adverse Event|22|||
124877915|NCT00445679|449175352|FG001|Overall Study|Adverse Event|12|||
124877916|NCT00445679|449175353|FG002|Overall Study|Adverse Event|30|||
124877917|NCT00445679|449175354|FG003|Overall Study|Adverse Event|19|||
124877918|NCT00445679|449175351|FG000|Overall Study|Failed to return|1|||
124877919|NCT00445679|449175352|FG001|Overall Study|Failed to return|3|||
124877920|NCT00445679|449175353|FG002|Overall Study|Failed to return|2|||
124877921|NCT00445679|449175354|FG003|Overall Study|Failed to return|2|||
124877922|NCT00445679|449175351|FG000|Overall Study|Physician Decision|0|||
124877923|NCT00445679|449175352|FG001|Overall Study|Physician Decision|0|||
124877924|NCT00445679|449175353|FG002|Overall Study|Physician Decision|1|||
124877925|NCT00445679|449175354|FG003|Overall Study|Physician Decision|0|||
124877926|NCT00445679|449175351|FG000|Overall Study|Lost to Follow-up|10|||
124877927|NCT00445679|449175352|FG001|Overall Study|Lost to Follow-up|6|||
124877928|NCT00445679|449175353|FG002|Overall Study|Lost to Follow-up|6|||
124877929|NCT00445679|449175354|FG003|Overall Study|Lost to Follow-up|5|||
124877930|NCT00445679|449175351|FG000|Overall Study|Compliance|3|||
125101711|NCT01299272|449994041|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
125101712|NCT01299272|449994042|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
125101713|NCT01299272|449994039|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
125101714|NCT01299272|449994040|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
125101715|NCT01299272|449994041|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
125101716|NCT01299272|449994042|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
124877931|NCT00445679|449175352|FG001|Overall Study|Compliance|2|||
124877932|NCT00445679|449175353|FG002|Overall Study|Compliance|1|||
125101717|NCT01299272|449994039|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
125101718|NCT01299272|449994040|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
124877933|NCT00445679|449175354|FG003|Overall Study|Compliance|2|||
124877934|NCT00445679|449175351|FG000|Overall Study|Withdrawal of Informed Consent|0|||
124877935|NCT00445679|449175352|FG001|Overall Study|Withdrawal of Informed Consent|0|||
124877936|NCT00445679|449175353|FG002|Overall Study|Withdrawal of Informed Consent|1|||
124877937|NCT00445679|449175354|FG003|Overall Study|Withdrawal of Informed Consent|0|||
124877938|NCT00445679|449175351|FG000|Overall Study|Protocol Violation|2|||
124877939|NCT00445679|449175352|FG001|Overall Study|Protocol Violation|3|||
124877940|NCT00445679|449175353|FG002|Overall Study|Protocol Violation|3|||
124877941|NCT00445679|449175354|FG003|Overall Study|Protocol Violation|1|||
124877942|NCT00445679|449175351|FG000|Overall Study|Withdrawal by Subject|8|||
124877943|NCT00445679|449175352|FG001|Overall Study|Withdrawal by Subject|14|||
125210712|NCT02069093|450395659|FG000|Overall Study|Adverse Event|10|||
124877944|NCT00445679|449175353|FG002|Overall Study|Withdrawal by Subject|20|||
124877945|NCT00445679|449175354|FG003|Overall Study|Withdrawal by Subject|18|||
124877946|NCT00445679|449175351|FG000|Overall Study|Lack of Efficacy|2|||
124877947|NCT00445679|449175352|FG001|Overall Study|Lack of Efficacy|6|||
124877948|NCT00445679|449175353|FG002|Overall Study|Lack of Efficacy|2|||
124877949|NCT00445679|449175354|FG003|Overall Study|Lack of Efficacy|0|||
124877950|NCT02636270|449175356|FG000|Overall Study|Adverse Event|1|||
124877951|NCT02636270|449175357|FG001|Overall Study|Adverse Event|0|||
124877952|NCT02636270|449175358|FG002|Overall Study|Adverse Event|0|||
124877953|NCT02636270|449175356|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
124877954|NCT02636270|449175357|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
124877955|NCT02636270|449175358|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
124877956|NCT01119898|449175359|FG000|Overall Study|Adverse Event|4|||
124877957|NCT01119898|449175360|FG001|Overall Study|Adverse Event|5|||
124877958|NCT01119898|449175359|FG000|Overall Study|Withdrawal by Subject|1|||
124877959|NCT01119898|449175360|FG001|Overall Study|Withdrawal by Subject|4|||
124877960|NCT01119898|449175359|FG000|Overall Study|Lack of Efficacy|0|||
124877961|NCT01119898|449175360|FG001|Overall Study|Lack of Efficacy|2|||
124877962|NCT01119898|449175359|FG000|Overall Study|Protocol Violation|1|||
124877963|NCT01119898|449175360|FG001|Overall Study|Protocol Violation|1|||
124877964|NCT01119898|449175359|FG000|Overall Study|Medical procedure|1|||
124877965|NCT01119898|449175360|FG001|Overall Study|Medical procedure|0|||
124877966|NCT01119898|449175359|FG000|Overall Study|Randomized in error did not participate|1|||
124877967|NCT01119898|449175360|FG001|Overall Study|Randomized in error did not participate|0|||
124877968|NCT01806584|449175361|FG000|Overall Study|Adverse Event|2|||
124877969|NCT01806584|449175362|FG001|Overall Study|Adverse Event|1|||
124877970|NCT01806584|449175361|FG000|Overall Study|Death|1|||
124877971|NCT01806584|449175362|FG001|Overall Study|Death|0|||
124877972|NCT01806584|449175361|FG000|Overall Study|Lost to Follow-up|0|||
124877973|NCT01806584|449175362|FG001|Overall Study|Lost to Follow-up|2|||
124877974|NCT01806584|449175361|FG000|Overall Study|Study terminated by sponsor|9|||
124877975|NCT01806584|449175362|FG001|Overall Study|Study terminated by sponsor|14|||
124877976|NCT01806584|449175361|FG000|Overall Study|Withdrawal by Subject|1|||
124877977|NCT01806584|449175362|FG001|Overall Study|Withdrawal by Subject|1|||
124877978|NCT01806584|449175361|FG000|Overall Study|Other unspecified|1|||
124877979|NCT01806584|449175362|FG001|Overall Study|Other unspecified|0|||
124877980|NCT03021668|449175363|FG000|Overall Study|Physician Decision|0|||
124877981|NCT03021668|449175364|FG001|Overall Study|Physician Decision|1|||
124877982|NCT00909428|449175365|FG000|Overall Study|Lost to Follow-up|13|||
125013024|NCT02919436|449674772|FG001|Overall Study|Enrolled before trial registration|33|||
125101719|NCT01299272|449994041|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
125101720|NCT01299272|449994042|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
124877983|NCT00909428|449175366|FG001|Overall Study|Lost to Follow-up|10|||
125013025|NCT03699007|449674774|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
125013026|NCT03699007|449674775|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
125013027|NCT03699007|449674774|FG000|6-month Follow Up|Lost to Follow-up|2|||
125013028|NCT03699007|449674775|FG001|6-month Follow Up|Lost to Follow-up|3|||
125013029|NCT04718974|449674778|FG000|Overall Study|Death|0|||
125013030|NCT04718974|449674779|FG001|Overall Study|Death|2|||
125013031|NCT04718974|449674778|FG000|Overall Study|Lost to Follow-up|10|||
125013032|NCT04718974|449674779|FG001|Overall Study|Lost to Follow-up|20|||
125013033|NCT04718974|449674778|FG000|Overall Study|Transferred out|2|||
125013034|NCT04718974|449674779|FG001|Overall Study|Transferred out|4|||
125013035|NCT03259074|449674780|FG000|Overall Study|Adverse Event|9|||
125013036|NCT03259074|449674781|FG001|Overall Study|Adverse Event|12|||
125013037|NCT03259074|449674782|FG002|Overall Study|Adverse Event|8|||
125013038|NCT03259074|449674780|FG000|Overall Study|Death|1|||
125013039|NCT03259074|449674781|FG001|Overall Study|Death|1|||
125013040|NCT03259074|449674782|FG002|Overall Study|Death|3|||
125013041|NCT03259074|449674780|FG000|Overall Study|Lost to Follow-up|2|||
125013042|NCT03259074|449674781|FG001|Overall Study|Lost to Follow-up|4|||
125013043|NCT03259074|449674782|FG002|Overall Study|Lost to Follow-up|3|||
125013044|NCT03259074|449674780|FG000|Overall Study|New Therapy For Study Indication|1|||
125013045|NCT03259074|449674781|FG001|Overall Study|New Therapy For Study Indication|2|||
125013046|NCT03259074|449674782|FG002|Overall Study|New Therapy For Study Indication|2|||
125013047|NCT03259074|449674780|FG000|Overall Study|Physician Decision|4|||
125013048|NCT03259074|449674781|FG001|Overall Study|Physician Decision|12|||
125013049|NCT03259074|449674782|FG002|Overall Study|Physician Decision|10|||
125013050|NCT03259074|449674780|FG000|Overall Study|Pregnancy|1|||
125013051|NCT03259074|449674781|FG001|Overall Study|Pregnancy|1|||
125210713|NCT02028169|450395660|FG000|Overall Study|Lost to Follow-up|21|||
124877984|NCT00909428|449175367|FG002|Overall Study|Lost to Follow-up|9|||
124877985|NCT01122381|449175368|FG000|Overall Study|study terminated early|0|||
124877986|NCT01122381|449175369|FG001|Overall Study|study terminated early|1|||
124877987|NCT03474549|449175370|FG000|Overall Study|Death|31|||
124877988|NCT03474549|449175370|FG000|Overall Study|Lost to Follow-up|4|||
124877989|NCT03474549|449175370|FG000|Overall Study|Withdrawal by Subject|2|||
125013052|NCT03259074|449674782|FG002|Overall Study|Pregnancy|0|||
125013053|NCT03259074|449674780|FG000|Overall Study|Progressive Disease|1|||
124877990|NCT03445065|449175375|FG000|Overall Study|Withdrawal by Subject|3|||
124877991|NCT03445065|449175376|FG001|Overall Study|Withdrawal by Subject|6|||
124877992|NCT03445065|449175377|FG002|Overall Study|Withdrawal by Subject|2|||
124877993|NCT03445065|449175378|FG003|Overall Study|Withdrawal by Subject|2|||
124877994|NCT03445065|449175375|FG000|Overall Study|Other|4|||
124877995|NCT03445065|449175376|FG001|Overall Study|Other|3|||
124877996|NCT03445065|449175377|FG002|Overall Study|Other|3|||
124877997|NCT03445065|449175378|FG003|Overall Study|Other|1|||
124877998|NCT03315130|449175379|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
124877999|NCT03315130|449175380|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
124878000|NCT03315130|449175381|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
124878001|NCT03315130|449175382|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
124878002|NCT03315130|449175379|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
124878003|NCT03315130|449175380|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
124878004|NCT03315130|449175381|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
124878005|NCT03315130|449175382|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
124878006|NCT03315130|449175379|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
124878007|NCT03315130|449175380|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
124878008|NCT03315130|449175381|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
124878009|NCT03315130|449175382|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
124878010|NCT03315130|449175379|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
124878011|NCT03315130|449175380|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
124878012|NCT03315130|449175381|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
124878013|NCT03315130|449175382|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
124878014|NCT03315130|449175379|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
124878015|NCT03315130|449175380|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
124878016|NCT03315130|449175381|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
124878017|NCT03315130|449175382|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
124878018|NCT03315130|449175379|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
124878019|NCT03315130|449175380|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
124878020|NCT03315130|449175381|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
124878021|NCT03315130|449175382|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
124878022|NCT03535337|449175389|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
124878023|NCT03535337|449175390|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
124878024|NCT03535337|449175391|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
124878025|NCT03535337|449175392|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
124878026|NCT03535337|449175393|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
124878027|NCT03535337|449175394|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
124878028|NCT03535337|449175395|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
124878029|NCT03535337|449175396|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
124878030|NCT03535337|449175397|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
124878031|NCT03535337|449175398|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
124878032|NCT02089230|449175399|FG000|Overall Study|Death|0|||
124878033|NCT02089230|449175400|FG001|Overall Study|Death|0|||
124878034|NCT02089230|449175401|FG002|Overall Study|Death|2|||
124878035|NCT02089230|449175399|FG000|Overall Study|Seeking Alternative Therapy|0|||
124878036|NCT02089230|449175400|FG001|Overall Study|Seeking Alternative Therapy|0|||
124878037|NCT02089230|449175401|FG002|Overall Study|Seeking Alternative Therapy|4|||
124878038|NCT02272725|449175402|FG000|Overall Study|equipment malfunction|2|||
124878039|NCT02272725|449175403|FG001|Overall Study|equipment malfunction|0|||
124878040|NCT03610737|449177250|FG000|Overall Study|Withdrawal by Subject|1|||
124878041|NCT03610737|449177251|FG001|Overall Study|Withdrawal by Subject|5|||
124878042|NCT03610737|449177250|FG000|Overall Study|Death|1|||
124878043|NCT03610737|449177251|FG001|Overall Study|Death|0|||
124878044|NCT03610737|449177250|FG000|Overall Study|Not treated|5|||
124878045|NCT03610737|449177251|FG001|Overall Study|Not treated|2|||
124878046|NCT03610737|449177250|FG000|Overall Study|Missed Visit|1|||
125101721|NCT01299272|449994039|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
125101722|NCT01299272|449994040|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
125101723|NCT01299272|449994041|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
125101724|NCT01299272|449994042|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
125101725|NCT01299272|449994039|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
125101726|NCT01299272|449994040|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
125101727|NCT01299272|449994041|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
124878047|NCT03610737|449177251|FG001|Overall Study|Missed Visit|2|||
124878048|NCT02991482|449177252|FG000|Overall Study|Disease progression|56|||
124878049|NCT02991482|449177253|FG001|Overall Study|Disease progression|47|||
124878050|NCT02991482|449177252|FG000|Overall Study|Death|4|||
124878051|NCT02991482|449177253|FG001|Overall Study|Death|4|||
124878052|NCT02991482|449177252|FG000|Overall Study|Adverse Event|1|||
124878053|NCT02991482|449177253|FG001|Overall Study|Adverse Event|6|||
124878054|NCT02991482|449177252|FG000|Overall Study|Patient decision|1|||
125101728|NCT01299272|449994042|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
124878055|NCT02991482|449177253|FG001|Overall Study|Patient decision|1|||
124878056|NCT02991482|449177252|FG000|Overall Study|Physician Decision|0|||
124878057|NCT02991482|449177253|FG001|Overall Study|Physician Decision|6|||
124878058|NCT02991482|449177252|FG000|Overall Study|Clinical deterioration|1|||
124878059|NCT02991482|449177253|FG001|Overall Study|Clinical deterioration|0|||
124878060|NCT02991482|449177252|FG000|Overall Study|Patient feeling too unwell|1|||
124878061|NCT02991482|449177253|FG001|Overall Study|Patient feeling too unwell|0|||
124878062|NCT02991482|449177252|FG000|Overall Study|Worsening of performance status|0|||
124878063|NCT02991482|449177253|FG001|Overall Study|Worsening of performance status|1|||
124878064|NCT02991482|449177252|FG000|Overall Study|Death prior to study drug initiation|1|||
124878065|NCT02991482|449177253|FG001|Overall Study|Death prior to study drug initiation|0|||
124878066|NCT02991482|449177252|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
124878067|NCT02991482|449177253|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
124878068|NCT02396537|449177254|FG000|Overall Study|Protocol Violation|0|||
124878069|NCT02396537|449177255|FG001|Overall Study|Protocol Violation|1|||
124878070|NCT00871403|449177256|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
124878071|NCT00871403|449177257|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
124878072|NCT00871403|449177258|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
124878073|NCT00871403|449177256|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
124878074|NCT00871403|449177257|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
124878075|NCT00871403|449177258|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
124878076|NCT00871403|449177256|FG000|Combination Treatment Phase|Adverse Event|0|||
124878077|NCT00871403|449177257|FG001|Combination Treatment Phase|Adverse Event|17|||
124878078|NCT00871403|449177258|FG002|Combination Treatment Phase|Adverse Event|2|||
124878079|NCT00871403|449177256|FG000|Combination Treatment Phase|Disease Progression|0|||
124878080|NCT00871403|449177257|FG001|Combination Treatment Phase|Disease Progression|8|||
124878081|NCT00871403|449177258|FG002|Combination Treatment Phase|Disease Progression|5|||
124878082|NCT00871403|449177256|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
124878083|NCT00871403|449177257|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
124878084|NCT00871403|449177258|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
124878085|NCT00871403|449177256|FG000|Combination Treatment Phase|Physician Decision|0|||
124878086|NCT00871403|449177257|FG001|Combination Treatment Phase|Physician Decision|1|||
124878087|NCT00871403|449177258|FG002|Combination Treatment Phase|Physician Decision|3|||
124878088|NCT00871403|449177256|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
124878089|NCT00871403|449177257|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
124878090|NCT00871403|449177258|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
124878091|NCT00871403|449177256|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
124878092|NCT00871403|449177257|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
124878093|NCT00871403|449177258|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
124878094|NCT00787319|449177259|FG000|Overall Study|Lost to Follow-up|2|||
124878095|NCT00787319|449177259|FG000|Overall Study|Withdrawal by Subject|15|||
124878096|NCT00787319|449177259|FG000|Overall Study|Adverse Event|3|||
124878097|NCT00787319|449177259|FG000|Overall Study|Objective progression or relapse|30|||
125013054|NCT03259074|449674781|FG001|Overall Study|Progressive Disease|0|||
125013055|NCT03259074|449674782|FG002|Overall Study|Progressive Disease|0|||
124878098|NCT00787319|449177259|FG000|Overall Study|Lack of Efficacy|1|||
124878099|NCT00787319|449177259|FG000|Overall Study|Budget exhausted/exceeded|1|||
124878100|NCT00787319|449177259|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
124878101|NCT00787319|449177259|FG000|Overall Study|No health insurance reimbursement|2|||
125013056|NCT03259074|449674780|FG000|Overall Study|Protocol Deviation|1|||
125013057|NCT03259074|449674781|FG001|Overall Study|Protocol Deviation|1|||
125013058|NCT03259074|449674782|FG002|Overall Study|Protocol Deviation|3|||
125013059|NCT03259074|449674780|FG000|Overall Study|Subject/Guardian Decision|13|||
125013060|NCT03259074|449674781|FG001|Overall Study|Subject/Guardian Decision|16|||
125013061|NCT03259074|449674782|FG002|Overall Study|Subject/Guardian Decision|14|||
125013062|NCT01780662|449674783|FG000|Overall Study|Adverse Event|1|||
125013063|NCT01780662|449674784|FG001|Overall Study|Adverse Event|0|||
125013064|NCT01780662|449674785|FG002|Overall Study|Adverse Event|2|||
125013065|NCT01780662|449674783|FG000|Overall Study|Physician Decision|0|||
125013066|NCT01780662|449674784|FG001|Overall Study|Physician Decision|5|||
125013067|NCT01780662|449674785|FG002|Overall Study|Physician Decision|7|||
125013068|NCT01780662|449674783|FG000|Overall Study|Protocol Violation|0|||
125013069|NCT01780662|449674784|FG001|Overall Study|Protocol Violation|1|||
125013070|NCT01780662|449674785|FG002|Overall Study|Protocol Violation|0|||
125013071|NCT01780662|449674783|FG000|Overall Study|Ineligible|0|||
125013072|NCT01780662|449674784|FG001|Overall Study|Ineligible|0|||
125013073|NCT01780662|449674785|FG002|Overall Study|Ineligible|1|||
125013074|NCT00183274|449674788|FG000|Phase 1: Open-Label|Adverse Event|31|||
125101729|NCT01299272|449994039|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
125101730|NCT01299272|449994040|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
125101731|NCT01299272|449994041|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
125101732|NCT01299272|449994042|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
125101733|NCT01299272|449994039|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
125101734|NCT01299272|449994040|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
125101735|NCT01299272|449994041|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
125101736|NCT01299272|449994042|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
125101737|NCT01299272|449994039|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
125101738|NCT01299272|449994040|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
125101739|NCT01299272|449994041|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
125101740|NCT01299272|449994042|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
125101741|NCT01299272|449994039|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
125101742|NCT01299272|449994040|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
125101743|NCT01299272|449994041|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
124878102|NCT00787319|449177259|FG000|Overall Study|Stabilized disease findings|3|||
124878103|NCT00787319|449177259|FG000|Overall Study|Inactive disease|5|||
124878104|NCT02312856|449177260|FG000|Overall Study|Death|1|||
124878105|NCT02312856|449177260|FG000|Overall Study|Lost to Follow-up|3|||
124878106|NCT01932294|449177261|FG000|Overall Study|Death|43|||
124878107|NCT01932294|449177261|FG000|Overall Study|Lost to Follow-up|8|||
124878108|NCT01932294|449177261|FG000|Overall Study|VAD Implantation|20|||
124878109|NCT01932294|449177261|FG000|Overall Study|Heart Transplantation|16|||
124878110|NCT01932294|449177261|FG000|Overall Study|Transferred to other hospitals|12|||
124878111|NCT04415151|449177262|FG000|Overall Study|Death|1|||
124878112|NCT04415151|449177263|FG001|Overall Study|Death|1|||
124878113|NCT04415151|449177262|FG000|Overall Study|Withdrawal by Subject|1|||
124878114|NCT04415151|449177263|FG001|Overall Study|Withdrawal by Subject|0|||
124878115|NCT03075904|449177269|FG000|Overall Study|Physician Decision|3|||
124878116|NCT03075904|449177269|FG000|Overall Study|Need for Medication not Permitted|1|||
124878117|NCT00659984|449177270|FG000|Overall Study|Adverse Event|1|||
124878118|NCT00927355|449177273|FG000|Overall Study|Adverse Event|1|||
124878119|NCT00927355|449177274|FG001|Overall Study|Adverse Event|1|||
124878120|NCT01800201|449177275|FG000|Overall Study|Withdrawal by Subject|2|||
124878121|NCT01800201|449177276|FG001|Overall Study|Withdrawal by Subject|0|||
124878122|NCT01800201|449177275|FG000|Overall Study|patient privacy concerns|1|||
124878123|NCT01800201|449177276|FG001|Overall Study|patient privacy concerns|1|||
124878124|NCT01800201|449177275|FG000|Overall Study|did not want to use device|0|||
124878125|NCT01800201|449177276|FG001|Overall Study|did not want to use device|1|||
124878126|NCT01800201|449177275|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
124878127|NCT01800201|449177276|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
124878128|NCT03541044|449177277|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
124878129|NCT03541044|449177278|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
124878130|NCT03541044|449177277|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
124878131|NCT03541044|449177278|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
124878132|NCT02635724|449177279|FG000|Overall Study|Withdrawal by Subject|0|||
124878133|NCT02635724|449177280|FG001|Overall Study|Withdrawal by Subject|1|||
124878134|NCT02635724|449177281|FG002|Overall Study|Withdrawal by Subject|0|||
124878135|NCT01446796|449177288|FG000|Overall Study|Withdrawal by Subject|1|||
124878136|NCT01446796|449177289|FG001|Overall Study|Withdrawal by Subject|0|||
124878137|NCT02424591|449177290|FG000|Overall Study|Protocol Violation|2|||
124878138|NCT02424591|449177291|FG001|Overall Study|Protocol Violation|3|||
124878139|NCT00312702|449177292|FG000|Immunization Phase|Lost to Follow-up|0|||
124878140|NCT00312702|449177293|FG001|Immunization Phase|Lost to Follow-up|1|||
124878141|NCT00312702|449177294|FG002|Immunization Phase|Lost to Follow-up|0|||
124878142|NCT01453348|449177295|FG000|Overall Study|Death|0|||
124878143|NCT01453348|449177296|FG001|Overall Study|Death|0|||
124878144|NCT01453348|449177297|FG002|Overall Study|Death|1|||
124878145|NCT01453348|449177295|FG000|Overall Study|Withdrawal by Subject|0|||
124878146|NCT01453348|449177296|FG001|Overall Study|Withdrawal by Subject|1|||
124878147|NCT01453348|449177297|FG002|Overall Study|Withdrawal by Subject|0|||
124878148|NCT01453348|449177295|FG000|Overall Study|Protocol Violation|1|||
124878149|NCT01453348|449177296|FG001|Overall Study|Protocol Violation|0|||
124878150|NCT01453348|449177297|FG002|Overall Study|Protocol Violation|0|||
124878151|NCT04359771|449177299|FG000|Overall Study|Lack of Efficacy|2|||
124878152|NCT04359771|449177300|FG001|Overall Study|Lack of Efficacy|2|||
124878153|NCT04581200|449177303|FG000|Overall Study|Lost to Follow-up|6|||
124878154|NCT04581200|449177304|FG001|Overall Study|Lost to Follow-up|5|||
124878155|NCT00622713|449177307|FG000|Overall Study|Adverse Event|35|||
124878156|NCT00622713|449177307|FG000|Overall Study|Administrative problems|4|||
124878157|NCT00622713|449177307|FG000|Overall Study|Withdrawal by Subject|11|||
124878158|NCT00622713|449177307|FG000|Overall Study|Lost to Follow-up|5|||
124878159|NCT00622713|449177307|FG000|Overall Study|Death|2|||
125013075|NCT00183274|449674789|FG001|Phase 1: Open-Label|Adverse Event|0|||
125013076|NCT00183274|449674790|FG002|Phase 1: Open-Label|Adverse Event|0|||
125013077|NCT00183274|449674791|FG003|Phase 1: Open-Label|Adverse Event|0|||
125013078|NCT00183274|449674792|FG004|Phase 1: Open-Label|Adverse Event|0|||
125013079|NCT00183274|449674793|FG005|Phase 1: Open-Label|Adverse Event|0|||
125013080|NCT00183274|449674788|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
125013081|NCT00183274|449674789|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
125013082|NCT00183274|449674790|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
125013083|NCT00183274|449674791|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
125013084|NCT00183274|449674792|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
125013085|NCT00183274|449674793|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
124878160|NCT00622713|449177307|FG000|Overall Study|Subject no longer required study drug|1|||
125013086|NCT00183274|449674788|FG000|Phase 1: Open-Label|Protocol Violation|11|||
125013087|NCT00183274|449674789|FG001|Phase 1: Open-Label|Protocol Violation|0|||
125210714|NCT02028169|450395660|FG000|Overall Study|Lack of Efficacy|2|||
124878161|NCT00622713|449177307|FG000|Overall Study|Did not meet eligibility criteria|1|||
124878162|NCT01462162|449177308|FG000|Overall Study|Adverse Event|5|||
124878163|NCT01462162|449177308|FG000|Overall Study|Lack of Efficacy|4|||
124878164|NCT01462162|449177308|FG000|Overall Study|Abnormal laboratory parameters|1|||
124878165|NCT01462162|449177308|FG000|Overall Study|Other|2|||
125013088|NCT00183274|449674790|FG002|Phase 1: Open-Label|Protocol Violation|0|||
125013089|NCT00183274|449674791|FG003|Phase 1: Open-Label|Protocol Violation|0|||
125013090|NCT00183274|449674792|FG004|Phase 1: Open-Label|Protocol Violation|0|||
125013091|NCT00183274|449674793|FG005|Phase 1: Open-Label|Protocol Violation|0|||
125013092|NCT00183274|449674788|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
125013093|NCT00183274|449674789|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
125013094|NCT00183274|449674790|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
125013095|NCT00183274|449674791|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
124878166|NCT03485911|449177309|FG000|Part 1|Perceived lack of efficacy|1|||
124878167|NCT03485911|449177310|FG001|Part 1|Perceived lack of efficacy|1|||
124878168|NCT03485911|449177311|FG002|Part 1|Perceived lack of efficacy|2|||
124878169|NCT03485911|449177312|FG003|Part 1|Perceived lack of efficacy|0|||
124878170|NCT03485911|449177309|FG000|Part 1|Subject withdrew consent|0|||
124878171|NCT03485911|449177310|FG001|Part 1|Subject withdrew consent|1|||
124878172|NCT03485911|449177311|FG002|Part 1|Subject withdrew consent|0|||
124878173|NCT03485911|449177312|FG003|Part 1|Subject withdrew consent|1|||
124878174|NCT03485911|449177309|FG000|Part 1|Lab abnormalities/AEs|3|||
124878175|NCT03485911|449177310|FG001|Part 1|Lab abnormalities/AEs|1|||
124878176|NCT03485911|449177311|FG002|Part 1|Lab abnormalities/AEs|1|||
124878177|NCT03485911|449177312|FG003|Part 1|Lab abnormalities/AEs|0|||
124878178|NCT03485911|449177309|FG000|Part 1|Withdrew Consent prior to dosing|0|||
124878179|NCT03485911|449177310|FG001|Part 1|Withdrew Consent prior to dosing|0|||
124878180|NCT03485911|449177311|FG002|Part 1|Withdrew Consent prior to dosing|0|||
124878181|NCT03485911|449177312|FG003|Part 1|Withdrew Consent prior to dosing|1|||
125101744|NCT01299272|449994042|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
125101745|NCT01299272|449994039|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
125101746|NCT01299272|449994040|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
125101747|NCT01299272|449994041|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
125101748|NCT01299272|449994042|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
125101749|NCT00464308|449994043|FG000|Overall Study|Adverse Event|22|||
125101750|NCT00464308|449994044|FG001|Overall Study|Adverse Event|27|||
125101751|NCT00464308|449994045|FG002|Overall Study|Adverse Event|16|||
125101752|NCT00464308|449994043|FG000|Overall Study|Lost to Follow-up|29|||
125101753|NCT00464308|449994044|FG001|Overall Study|Lost to Follow-up|19|||
125101754|NCT00464308|449994045|FG002|Overall Study|Lost to Follow-up|20|||
125101755|NCT00464308|449994043|FG000|Overall Study|Patient discontinued and other reasons|17|||
125101756|NCT00464308|449994044|FG001|Overall Study|Patient discontinued and other reasons|17|||
125101757|NCT00464308|449994045|FG002|Overall Study|Patient discontinued and other reasons|23|||
125101758|NCT00464308|449994043|FG000|Overall Study|Physician Decision|1|||
125101759|NCT00464308|449994044|FG001|Overall Study|Physician Decision|0|||
125101760|NCT00464308|449994045|FG002|Overall Study|Physician Decision|0|||
125101761|NCT01513759|449994046|FG000|Overall Study|Protocol Violation|4|||
125101762|NCT01513759|449994046|FG000|Overall Study|Death during catheter placement|1|||
125101763|NCT00630994|449994047|FG000|Overall Study|Adverse Event|1|||
125101764|NCT00630994|449994047|FG000|Overall Study|Disease Progression|1|||
125101765|NCT00630994|449994047|FG000|Overall Study|Lack of Efficacy|1|||
125101766|NCT00630994|449994047|FG000|Overall Study|Other|1|||
125101767|NCT03533608|449994048|FG000|Overall Study|Withdrawal by Subject|3|||
125101768|NCT03533608|449994048|FG000|Overall Study|Physician Decision|2|||
125101769|NCT03286426|449994049|FG000|Overall Study|Physician Decision|3|||
125101770|NCT03514121|449994050|FG000|Overall Study|Withdrawal by Subject|0|||
125101771|NCT03514121|449994051|FG001|Overall Study|Withdrawal by Subject|0|||
125101772|NCT03514121|449994052|FG002|Overall Study|Withdrawal by Subject|0|||
125101773|NCT03514121|449994053|FG003|Overall Study|Withdrawal by Subject|0|||
125101774|NCT03514121|449994054|FG004|Overall Study|Withdrawal by Subject|1|||
125101775|NCT03514121|449994055|FG005|Overall Study|Withdrawal by Subject|2|||
125101776|NCT03514121|449994056|FG006|Overall Study|Withdrawal by Subject|1|||
125101777|NCT03514121|449994057|FG007|Overall Study|Withdrawal by Subject|1|||
125101778|NCT03514121|449994058|FG008|Overall Study|Withdrawal by Subject|7|||
125101779|NCT03514121|449994059|FG009|Overall Study|Withdrawal by Subject|2|||
125101780|NCT03514121|449994050|FG000|Overall Study|Death|0|||
125101781|NCT03514121|449994051|FG001|Overall Study|Death|0|||
125101782|NCT03514121|449994052|FG002|Overall Study|Death|0|||
125101783|NCT03514121|449994053|FG003|Overall Study|Death|0|||
125101784|NCT03514121|449994054|FG004|Overall Study|Death|0|||
125101785|NCT03514121|449994055|FG005|Overall Study|Death|3|||
124878182|NCT03485911|449177309|FG000|Part 1|Other NOS|0|||
124878183|NCT03485911|449177310|FG001|Part 1|Other NOS|0|||
124878184|NCT03485911|449177311|FG002|Part 1|Other NOS|0|||
124878185|NCT03485911|449177312|FG003|Part 1|Other NOS|1|||
124878186|NCT03485911|449177309|FG000|Part 2|Perceived lack of efficacy|5|||
125101786|NCT03514121|449994056|FG006|Overall Study|Death|2|||
125101787|NCT03514121|449994057|FG007|Overall Study|Death|1|||
125101788|NCT03514121|449994058|FG008|Overall Study|Death|26|||
125101789|NCT03514121|449994059|FG009|Overall Study|Death|3|||
125101790|NCT03514121|449994050|FG000|Overall Study|Lost to Follow-up|0|||
125101791|NCT03514121|449994051|FG001|Overall Study|Lost to Follow-up|0|||
125101792|NCT03514121|449994052|FG002|Overall Study|Lost to Follow-up|1|||
124878187|NCT03485911|449177310|FG001|Part 2|Perceived lack of efficacy|3|||
124878188|NCT03485911|449177311|FG002|Part 2|Perceived lack of efficacy|0|||
124878189|NCT03485911|449177312|FG003|Part 2|Perceived lack of efficacy|2|||
124878190|NCT03485911|449177309|FG000|Part 2|Subject withdrew consent|1|||
124878191|NCT03485911|449177310|FG001|Part 2|Subject withdrew consent|0|||
124878192|NCT03485911|449177311|FG002|Part 2|Subject withdrew consent|2|||
125101793|NCT03514121|449994053|FG003|Overall Study|Lost to Follow-up|0|||
125101794|NCT03514121|449994054|FG004|Overall Study|Lost to Follow-up|0|||
124878193|NCT03485911|449177312|FG003|Part 2|Subject withdrew consent|1|||
124878194|NCT03485911|449177309|FG000|Part 2|Lab abnormalities/AEs|1|||
124878195|NCT03485911|449177310|FG001|Part 2|Lab abnormalities/AEs|2|||
124878196|NCT03485911|449177311|FG002|Part 2|Lab abnormalities/AEs|0|||
124878197|NCT03485911|449177312|FG003|Part 2|Lab abnormalities/AEs|0|||
124878198|NCT03485911|449177309|FG000|Part 2|Other NOS|0|||
124878199|NCT03485911|449177310|FG001|Part 2|Other NOS|1|||
124878200|NCT03485911|449177311|FG002|Part 2|Other NOS|0|||
124878201|NCT03485911|449177312|FG003|Part 2|Other NOS|0|||
124878202|NCT03485911|449177309|FG000|Part 2|Intercurrent illness/new medical condition|1|||
124878203|NCT03485911|449177310|FG001|Part 2|Intercurrent illness/new medical condition|0|||
124878204|NCT03485911|449177311|FG002|Part 2|Intercurrent illness/new medical condition|0|||
124878205|NCT03485911|449177312|FG003|Part 2|Intercurrent illness/new medical condition|0|||
124878206|NCT03485911|449177309|FG000|Part 2|Investigator judgement|1|||
124878207|NCT03485911|449177310|FG001|Part 2|Investigator judgement|0|||
124878208|NCT03485911|449177311|FG002|Part 2|Investigator judgement|0|||
124878209|NCT03485911|449177312|FG003|Part 2|Investigator judgement|0|||
124878210|NCT03485911|449177309|FG000|Part 3|Perceived lack of efficacy|2|||
124878211|NCT03485911|449177310|FG001|Part 3|Perceived lack of efficacy|2|||
124878212|NCT03485911|449177311|FG002|Part 3|Perceived lack of efficacy|2|||
124878213|NCT03485911|449177312|FG003|Part 3|Perceived lack of efficacy|0|||
124878214|NCT03485911|449177309|FG000|Part 3|Subject withdrew consent|1|||
124878215|NCT03485911|449177310|FG001|Part 3|Subject withdrew consent|4|||
124878216|NCT03485911|449177311|FG002|Part 3|Subject withdrew consent|0|||
124878217|NCT03485911|449177312|FG003|Part 3|Subject withdrew consent|1|||
124878218|NCT03485911|449177309|FG000|Part 3|Lab abnormalities/AEs|1|||
124878219|NCT03485911|449177310|FG001|Part 3|Lab abnormalities/AEs|1|||
124878220|NCT03485911|449177311|FG002|Part 3|Lab abnormalities/AEs|0|||
124878221|NCT03485911|449177312|FG003|Part 3|Lab abnormalities/AEs|2|||
124878222|NCT03485911|449177309|FG000|Part 3|Other NOS|1|||
124878223|NCT03485911|449177310|FG001|Part 3|Other NOS|1|||
124878224|NCT03485911|449177311|FG002|Part 3|Other NOS|0|||
124878225|NCT03485911|449177312|FG003|Part 3|Other NOS|0|||
124878226|NCT03485911|449177309|FG000|Part 3|Intercurrent illness/new medical condition|0|||
124878227|NCT03485911|449177310|FG001|Part 3|Intercurrent illness/new medical condition|1|||
124878228|NCT03485911|449177311|FG002|Part 3|Intercurrent illness/new medical condition|1|||
124878229|NCT03485911|449177312|FG003|Part 3|Intercurrent illness/new medical condition|0|||
124878230|NCT03485911|449177309|FG000|Part 3|Sponsor discontinuation|1|||
124878231|NCT03485911|449177310|FG001|Part 3|Sponsor discontinuation|0|||
125101795|NCT03514121|449994055|FG005|Overall Study|Lost to Follow-up|0|||
124878232|NCT03485911|449177311|FG002|Part 3|Sponsor discontinuation|0|||
124878233|NCT03485911|449177312|FG003|Part 3|Sponsor discontinuation|0|||
124878234|NCT03485911|449177309|FG000|Part 3|Berotralstat provided by alternative means|13|||
124878235|NCT03485911|449177310|FG001|Part 3|Berotralstat provided by alternative means|13|||
124878236|NCT03485911|449177311|FG002|Part 3|Berotralstat provided by alternative means|7|||
124878237|NCT03485911|449177312|FG003|Part 3|Berotralstat provided by alternative means|7|||
124878238|NCT00909480|449177313|FG000|Overall Study|Adverse Event|5|||
124878239|NCT00909480|449177314|FG001|Overall Study|Adverse Event|3|||
125101796|NCT03514121|449994056|FG006|Overall Study|Lost to Follow-up|0|||
125101797|NCT03514121|449994057|FG007|Overall Study|Lost to Follow-up|0|||
125101798|NCT03514121|449994058|FG008|Overall Study|Lost to Follow-up|1|||
125101799|NCT03514121|449994059|FG009|Overall Study|Lost to Follow-up|0|||
124878240|NCT00909480|449177313|FG000|Overall Study|Protocol Violation|6|||
124878241|NCT00909480|449177314|FG001|Overall Study|Protocol Violation|8|||
124878242|NCT00909480|449177313|FG000|Overall Study|Withdrawal criteria|9|||
124878243|NCT00909480|449177314|FG001|Overall Study|Withdrawal criteria|11|||
124878244|NCT00909480|449177313|FG000|Overall Study|Unclassified|18|||
124878245|NCT00909480|449177314|FG001|Overall Study|Unclassified|19|||
124878246|NCT01215357|449177315|FG000|Overall Study|Withdrawal by Subject|3|||
124878247|NCT01215357|449177315|FG000|Overall Study|Protocol Violation|9|||
124878248|NCT05266963|449177321|FG000|Drug Period A|Withdrawal by Subject|0|||
125101800|NCT03514121|449994050|FG000|Overall Study|Adverse Event|0|||
125101801|NCT03514121|449994051|FG001|Overall Study|Adverse Event|0|||
124878249|NCT05266963|449177322|FG001|Drug Period A|Withdrawal by Subject|1|||
125101802|NCT03514121|449994052|FG002|Overall Study|Adverse Event|0|||
124878250|NCT04296890|449177328|FG000|Overall Study|Withdrawal by Subject|1|||
124878251|NCT04296890|449177328|FG000|Overall Study|Death|62|||
124878252|NCT04296890|449177328|FG000|Overall Study|Lost to Follow-up|3|||
124878253|NCT04296890|449177328|FG000|Overall Study|Other than specified|2|||
124878254|NCT05400746|449177329|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
124878255|NCT05400746|449177330|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
124878256|NCT05400746|449177331|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
124878257|NCT05454410|449177332|FG000|Overall Study|Withdrawal by Subject|0|||
124878258|NCT05454410|449177333|FG001|Overall Study|Withdrawal by Subject|0|||
124878259|NCT05454410|449177334|FG002|Overall Study|Withdrawal by Subject|1|||
124878260|NCT05454410|449177335|FG003|Overall Study|Withdrawal by Subject|1|||
124878261|NCT05004688|449177337|FG000|Overall Study|Protocol Violation|7|||
125101803|NCT03514121|449994053|FG003|Overall Study|Adverse Event|0|||
125101804|NCT03514121|449994054|FG004|Overall Study|Adverse Event|0|||
124878262|NCT05004688|449177337|FG000|Overall Study|Physician Decision|2|||
124878263|NCT05004688|449177337|FG000|Overall Study|Withdrawal by Subject|2|||
124878264|NCT01395823|449177349|FG000|Overall Study|Death|4|||
124878265|NCT01395823|449177350|FG001|Overall Study|Death|4|||
124878266|NCT01395823|449177349|FG000|Overall Study|Physician Decision|3|||
124878267|NCT01395823|449177350|FG001|Overall Study|Physician Decision|1|||
124878268|NCT01395823|449177349|FG000|Overall Study|Lost to Follow-up|1|||
124878269|NCT01395823|449177350|FG001|Overall Study|Lost to Follow-up|0|||
124878270|NCT01395823|449177349|FG000|Overall Study|Transplant|1|||
124878271|NCT01395823|449177350|FG001|Overall Study|Transplant|0|||
124878272|NCT01395823|449177349|FG000|Overall Study|GI symptoms|1|||
124878273|NCT01395823|449177350|FG001|Overall Study|GI symptoms|0|||
124878274|NCT01395823|449177349|FG000|Overall Study|Withdrawal by Subject|5|||
124878275|NCT01395823|449177350|FG001|Overall Study|Withdrawal by Subject|4|||
124878276|NCT05076149|449177351|FG000|Overall Study|Adverse Event|3|||
124878277|NCT05076149|449177352|FG001|Overall Study|Adverse Event|9|||
124878278|NCT05076149|449177351|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
124878279|NCT05076149|449177352|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
124878280|NCT05076149|449177351|FG000|Overall Study|Lost to Follow-up|0|||
124878281|NCT05076149|449177352|FG001|Overall Study|Lost to Follow-up|1|||
124878282|NCT05076149|449177351|FG000|Overall Study|Commercial drug is available for participant|0|||
124878283|NCT05076149|449177352|FG001|Overall Study|Commercial drug is available for participant|1|||
124878284|NCT05076149|449177351|FG000|Overall Study|Other non compliance|1|||
124878285|NCT05076149|449177352|FG001|Overall Study|Other non compliance|1|||
124878286|NCT05076149|449177351|FG000|Overall Study|Physician Decision|0|||
124878287|NCT05076149|449177352|FG001|Overall Study|Physician Decision|1|||
124878288|NCT05076149|449177351|FG000|Overall Study|Other|5|||
124878289|NCT05076149|449177352|FG001|Overall Study|Other|4|||
124878290|NCT00717314|449177353|FG000|Overall Study|Adverse Event|3|||
124878291|NCT00717314|449177354|FG001|Overall Study|Adverse Event|2|||
124878292|NCT00717314|449177353|FG000|Overall Study|Protocol Violation|1|||
124878293|NCT00717314|449177354|FG001|Overall Study|Protocol Violation|0|||
124878294|NCT00717314|449177353|FG000|Overall Study|Lost to Follow-up|1|||
124878295|NCT00717314|449177354|FG001|Overall Study|Lost to Follow-up|5|||
124878296|NCT00717314|449177353|FG000|Overall Study|Withdrawal by Subject|1|||
124878297|NCT00717314|449177354|FG001|Overall Study|Withdrawal by Subject|3|||
124878298|NCT02087501|449177355|FG000|Overall Study|Death|7|||
124878299|NCT02087501|449177355|FG000|Overall Study|Open repair of aneurysm|1|||
124878300|NCT02087501|449177355|FG000|Overall Study|Lost to Follow-up|2|||
124878301|NCT00094328|449177357|FG000|Overall Study|Lost to Follow-up|1|||
124878302|NCT03682705|449177358|FG000|Overall Study|Adverse Event|1|||
124878303|NCT03682705|449177359|FG001|Overall Study|Adverse Event|1|||
124878304|NCT03682705|449177360|FG002|Overall Study|Adverse Event|1|||
124878305|NCT03682705|449177361|FG003|Overall Study|Adverse Event|0|||
124878306|NCT03682705|449177362|FG004|Overall Study|Adverse Event|1|||
124878307|NCT03682705|449177363|FG005|Overall Study|Adverse Event|1|||
124878308|NCT03682705|449177358|FG000|Overall Study|Withdrawal by Subject|1|||
124878309|NCT03682705|449177359|FG001|Overall Study|Withdrawal by Subject|3|||
124878310|NCT03682705|449177360|FG002|Overall Study|Withdrawal by Subject|2|||
124878311|NCT03682705|449177361|FG003|Overall Study|Withdrawal by Subject|4|||
124878312|NCT03682705|449177362|FG004|Overall Study|Withdrawal by Subject|0|||
124878313|NCT03682705|449177363|FG005|Overall Study|Withdrawal by Subject|1|||
124878314|NCT03682705|449177358|FG000|Overall Study|Other, not specified|0|||
125101805|NCT03514121|449994055|FG005|Overall Study|Adverse Event|0|||
125101806|NCT03514121|449994056|FG006|Overall Study|Adverse Event|1|||
124878315|NCT03682705|449177359|FG001|Overall Study|Other, not specified|0|||
125101807|NCT03514121|449994057|FG007|Overall Study|Adverse Event|0|||
125101808|NCT03514121|449994058|FG008|Overall Study|Adverse Event|0|||
125101809|NCT03514121|449994059|FG009|Overall Study|Adverse Event|0|||
125101810|NCT03514121|449994050|FG000|Overall Study|Other|0|||
125101811|NCT03514121|449994051|FG001|Overall Study|Other|1|||
125101812|NCT03514121|449994052|FG002|Overall Study|Other|1|||
125101813|NCT03514121|449994053|FG003|Overall Study|Other|0|||
125101814|NCT03514121|449994054|FG004|Overall Study|Other|1|||
124878316|NCT03682705|449177360|FG002|Overall Study|Other, not specified|0|||
124878317|NCT03682705|449177361|FG003|Overall Study|Other, not specified|1|||
124878318|NCT03682705|449177362|FG004|Overall Study|Other, not specified|2|||
125101815|NCT03514121|449994055|FG005|Overall Study|Other|2|||
125101816|NCT03514121|449994056|FG006|Overall Study|Other|3|||
124878319|NCT03682705|449177363|FG005|Overall Study|Other, not specified|0|||
124878320|NCT03682705|449177358|FG000|Overall Study|Lost to Follow-up|0|||
124878321|NCT03682705|449177359|FG001|Overall Study|Lost to Follow-up|0|||
124878322|NCT03682705|449177360|FG002|Overall Study|Lost to Follow-up|0|||
124878323|NCT03682705|449177361|FG003|Overall Study|Lost to Follow-up|0|||
124878324|NCT03682705|449177362|FG004|Overall Study|Lost to Follow-up|3|||
124878325|NCT03682705|449177363|FG005|Overall Study|Lost to Follow-up|0|||
124878326|NCT00117156|449177364|FG000|Overall Study|Adverse Event|9|||
124878327|NCT00117156|449177364|FG000|Overall Study|Physician Decision|1|||
124878328|NCT00117156|449177364|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
124878329|NCT01919970|449177365|FG000|Overall Study|Withdrawal by Subject|3|||
124878330|NCT01919970|449177366|FG001|Overall Study|Withdrawal by Subject|0|||
124878331|NCT04043962|449177367|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
124878332|NCT04043962|449177367|FG000|Post-Treatment|Withdrawal by Subject|5|||
124878333|NCT04043962|449177367|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
124878334|NCT04631705|449177370|FG000|Overall Study|Withdrawal by Subject|0|||
124878335|NCT04631705|449177371|FG001|Overall Study|Withdrawal by Subject|0|||
124878336|NCT04631705|449177372|FG002|Overall Study|Withdrawal by Subject|0|||
124878337|NCT04631705|449177373|FG003|Overall Study|Withdrawal by Subject|0|||
124878338|NCT04631705|449177374|FG004|Overall Study|Withdrawal by Subject|0|||
124878339|NCT04631705|449177375|FG005|Overall Study|Withdrawal by Subject|0|||
124878340|NCT04631705|449177376|FG006|Overall Study|Withdrawal by Subject|1|||
124878341|NCT04631705|449177377|FG007|Overall Study|Withdrawal by Subject|0|||
124878342|NCT04631705|449177378|FG008|Overall Study|Withdrawal by Subject|0|||
124878343|NCT02130284|449177379|FG000|Overall Study|Withdrawal by Subject|3|||
124878344|NCT02130284|449177379|FG000|Overall Study|Subject Withdrew Consent|1|||
124878345|NCT02130284|449177379|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
124878346|NCT02130284|449177379|FG000|Overall Study|Subject was screened as backup for study|3|||
124878347|NCT02130284|449177379|FG000|Overall Study|Screen Failure|1|||
124878348|NCT01875185|449177380|FG000|Overall Study|study was terminated|52|||
124878349|NCT01875185|449177381|FG001|Overall Study|study was terminated|48|||
124878350|NCT01521884|449177382|FG000|Overall Study|Non Responders|10|||
124878351|NCT01521884|449177382|FG000|Overall Study|Adverse Event|5|||
124878352|NCT01521884|449177382|FG000|Overall Study|Pregnancy|1|||
124878353|NCT01521884|449177382|FG000|Overall Study|Withdrawal by Subject|1|||
124878354|NCT01521884|449177382|FG000|Overall Study|Physician Decision|2|||
124878355|NCT01521884|449177382|FG000|Overall Study|Protocol Violation|3|||
124878356|NCT01521884|449177382|FG000|Overall Study|Participant non-eligible|1|||
124878357|NCT01521884|449177382|FG000|Overall Study|Lost to Follow-up|4|||
124878358|NCT03565068|449177383|FG000|Overall Study|Protocol Violation|0|||
124878359|NCT03565068|449177384|FG001|Overall Study|Protocol Violation|0|||
124878360|NCT03565068|449177385|FG002|Overall Study|Protocol Violation|0|||
124878361|NCT03565068|449177386|FG003|Overall Study|Protocol Violation|0|||
124878362|NCT03565068|449177387|FG004|Overall Study|Protocol Violation|1|||
124878363|NCT03565068|449177388|FG005|Overall Study|Protocol Violation|0|||
124878364|NCT03565068|449177389|FG006|Overall Study|Protocol Violation|0|||
124878365|NCT03565068|449177390|FG007|Overall Study|Protocol Violation|1|||
124878366|NCT03565068|449177391|FG008|Overall Study|Protocol Violation|0|||
125013096|NCT00183274|449674792|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
125013097|NCT00183274|449674793|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
125013098|NCT00183274|449674788|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
125013099|NCT00183274|449674789|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
125013100|NCT00183274|449674790|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
125013101|NCT00183274|449674791|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
125013102|NCT00183274|449674792|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
125013103|NCT00183274|449674793|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
125013104|NCT00183274|449674788|FG000|Phase 1: Open-Label|Other|9|||
125013105|NCT00183274|449674789|FG001|Phase 1: Open-Label|Other|0|||
125013106|NCT00183274|449674790|FG002|Phase 1: Open-Label|Other|0|||
125013107|NCT00183274|449674791|FG003|Phase 1: Open-Label|Other|0|||
125013108|NCT00183274|449674792|FG004|Phase 1: Open-Label|Other|0|||
125013109|NCT00183274|449674793|FG005|Phase 1: Open-Label|Other|0|||
125013110|NCT00183274|449674788|FG000|Phase 2: Double-Blind|Relapsed|0|||
125013111|NCT00183274|449674789|FG001|Phase 2: Double-Blind|Relapsed|8|||
125013112|NCT00183274|449674790|FG002|Phase 2: Double-Blind|Relapsed|29|||
125013113|NCT00183274|449674791|FG003|Phase 2: Double-Blind|Relapsed|0|||
125013114|NCT00183274|449674792|FG004|Phase 2: Double-Blind|Relapsed|0|||
125013115|NCT00183274|449674793|FG005|Phase 2: Double-Blind|Relapsed|0|||
125013116|NCT00183274|449674788|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
125013117|NCT00183274|449674789|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
125013118|NCT00183274|449674790|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
125013119|NCT00183274|449674791|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
125013120|NCT00183274|449674792|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
125013121|NCT00183274|449674793|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
125101817|NCT03514121|449994057|FG007|Overall Study|Other|2|||
124878367|NCT03565068|449177383|FG000|Overall Study|Sponsor decision|0|||
124878368|NCT03565068|449177384|FG001|Overall Study|Sponsor decision|0|||
124878369|NCT03565068|449177385|FG002|Overall Study|Sponsor decision|0|||
125101818|NCT03514121|449994058|FG008|Overall Study|Other|7|||
125101819|NCT03514121|449994059|FG009|Overall Study|Other|3|||
124878370|NCT03565068|449177386|FG003|Overall Study|Sponsor decision|0|||
124878371|NCT03565068|449177387|FG004|Overall Study|Sponsor decision|1|||
124878372|NCT03565068|449177388|FG005|Overall Study|Sponsor decision|1|||
124878373|NCT03565068|449177389|FG006|Overall Study|Sponsor decision|0|||
124878374|NCT03565068|449177390|FG007|Overall Study|Sponsor decision|0|||
124878375|NCT03565068|449177391|FG008|Overall Study|Sponsor decision|0|||
124878376|NCT03565068|449177383|FG000|Overall Study|Withdrawal by Subject|0|||
125013122|NCT00183274|449674788|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
125013123|NCT00183274|449674789|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
125013124|NCT00183274|449674790|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
125013125|NCT00183274|449674791|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
125013126|NCT00183274|449674792|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
125013127|NCT00183274|449674793|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
125013128|NCT00183274|449674788|FG000|Phase 3: Double-Blind|Relapsed|0|||
125013129|NCT00183274|449674789|FG001|Phase 3: Double-Blind|Relapsed|0|||
125013130|NCT00183274|449674790|FG002|Phase 3: Double-Blind|Relapsed|0|||
125013131|NCT00183274|449674791|FG003|Phase 3: Double-Blind|Relapsed|1|||
125013132|NCT00183274|449674792|FG004|Phase 3: Double-Blind|Relapsed|11|||
125013133|NCT00183274|449674793|FG005|Phase 3: Double-Blind|Relapsed|2|||
125013134|NCT04081363|449674796|FG000|Overall Study|Withdrawal by Subject|1|||
125013135|NCT04081363|449674797|FG001|Overall Study|Withdrawal by Subject|0|||
125013136|NCT02409290|449674798|FG000|Overall Study|Protocol Violation|3|||
125013137|NCT02409290|449674799|FG001|Overall Study|Protocol Violation|6|||
125013138|NCT02409290|449674800|FG002|Overall Study|Protocol Violation|9|||
125013139|NCT02409290|449674801|FG003|Overall Study|Protocol Violation|4|||
125013140|NCT02409290|449674798|FG000|Overall Study|No positive culture/no baseline sample|3|||
125013141|NCT02409290|449674799|FG001|Overall Study|No positive culture/no baseline sample|9|||
125013142|NCT02409290|449674800|FG002|Overall Study|No positive culture/no baseline sample|6|||
125013143|NCT02409290|449674801|FG003|Overall Study|No positive culture/no baseline sample|5|||
125013144|NCT02409290|449674798|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
125013145|NCT02409290|449674799|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
125013146|NCT02409290|449674800|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
125013147|NCT02409290|449674801|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
125013148|NCT00708500|449674802|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
125013149|NCT00708500|449674803|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
125013150|NCT00708500|449674804|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
125013151|NCT00708500|449674802|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
125013152|NCT00708500|449674803|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
125013153|NCT00708500|449674804|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
125013154|NCT00708500|449674802|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
125013155|NCT00708500|449674803|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
125013156|NCT00708500|449674804|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
125013157|NCT00708500|449674802|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
125013158|NCT00708500|449674803|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
125013159|NCT00708500|449674804|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
125013160|NCT00708500|449674802|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
125013161|NCT00708500|449674803|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
125013162|NCT00708500|449674804|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
125013163|NCT00708500|449674802|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
125013164|NCT00708500|449674803|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
124878377|NCT03565068|449177384|FG001|Overall Study|Withdrawal by Subject|0|||
124878378|NCT03565068|449177385|FG002|Overall Study|Withdrawal by Subject|1|||
124878379|NCT03565068|449177386|FG003|Overall Study|Withdrawal by Subject|0|||
124878380|NCT03565068|449177387|FG004|Overall Study|Withdrawal by Subject|2|||
124878381|NCT03565068|449177388|FG005|Overall Study|Withdrawal by Subject|0|||
124878382|NCT03565068|449177389|FG006|Overall Study|Withdrawal by Subject|1|||
124878383|NCT03565068|449177390|FG007|Overall Study|Withdrawal by Subject|5|||
124878384|NCT03565068|449177391|FG008|Overall Study|Withdrawal by Subject|1|||
124878385|NCT03565068|449177383|FG000|Overall Study|Physician Decision|0|||
124878386|NCT03565068|449177384|FG001|Overall Study|Physician Decision|0|||
124878387|NCT03565068|449177385|FG002|Overall Study|Physician Decision|0|||
124878388|NCT03565068|449177386|FG003|Overall Study|Physician Decision|0|||
125013165|NCT00708500|449674804|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
125013166|NCT00708500|449674802|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
125013167|NCT00708500|449674803|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
125013168|NCT00708500|449674804|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
125013169|NCT00708500|449674802|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
125013170|NCT00708500|449674803|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
125013171|NCT00708500|449674804|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
125013172|NCT00708500|449674802|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
125013173|NCT00708500|449674803|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
125013174|NCT00708500|449674804|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
125013175|NCT00708500|449674802|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
125013176|NCT00708500|449674803|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
125013177|NCT00708500|449674804|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
125013178|NCT00708500|449674802|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
125013179|NCT00708500|449674803|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
125013180|NCT00708500|449674804|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
125013181|NCT00708500|449674802|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
125013182|NCT00708500|449674803|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
125013183|NCT00708500|449674804|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
125013184|NCT00708500|449674802|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
125013185|NCT00708500|449674803|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
125013186|NCT00708500|449674804|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
125013187|NCT00708500|449674802|FG000|FOLLOWUP|Adverse Event|0|||
125013188|NCT00708500|449674803|FG001|FOLLOWUP|Adverse Event|1|||
125013189|NCT00708500|449674804|FG002|FOLLOWUP|Adverse Event|0|||
125013190|NCT00708500|449674802|FG000|FOLLOWUP|Lost to Follow-up|1|||
125013191|NCT00708500|449674803|FG001|FOLLOWUP|Lost to Follow-up|6|||
125013192|NCT00708500|449674804|FG002|FOLLOWUP|Lost to Follow-up|4|||
125013193|NCT00708500|449674802|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
125013194|NCT00708500|449674803|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
125013195|NCT00708500|449674804|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
125013196|NCT00708500|449674802|FG000|FOLLOWUP|Subject withdrew consent|31|||
125013197|NCT00708500|449674803|FG001|FOLLOWUP|Subject withdrew consent|4|||
125013198|NCT00708500|449674804|FG002|FOLLOWUP|Subject withdrew consent|5|||
125013199|NCT00708500|449674802|FG000|FOLLOWUP|Non-compliance with protocol|5|||
125013200|NCT00708500|449674803|FG001|FOLLOWUP|Non-compliance with protocol|0|||
125013201|NCT00708500|449674804|FG002|FOLLOWUP|Non-compliance with protocol|1|||
125013202|NCT00618410|449674809|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
125013203|NCT00618410|449674810|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
125013204|NCT00705783|449674813|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
125013205|NCT00705783|449674814|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
125013206|NCT00705783|449674815|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
125013207|NCT00705783|449674813|FG000|Conversion Phase|Lost to Follow-up|13|||
125013208|NCT00705783|449674814|FG001|Conversion Phase|Lost to Follow-up|0|||
125013209|NCT00705783|449674815|FG002|Conversion Phase|Lost to Follow-up|0|||
125013210|NCT00705783|449674813|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
125013211|NCT00705783|449674814|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
125013212|NCT00705783|449674815|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
125013213|NCT00705783|449674813|FG000|Conversion Phase|Withdrawn by Investigator|4|||
125101820|NCT03514121|449994050|FG000|Overall Study|Study termination by Sponsor|0|||
125101821|NCT03514121|449994051|FG001|Overall Study|Study termination by Sponsor|0|||
124878389|NCT03565068|449177387|FG004|Overall Study|Physician Decision|0|||
124878390|NCT03565068|449177388|FG005|Overall Study|Physician Decision|0|||
124878391|NCT03565068|449177389|FG006|Overall Study|Physician Decision|0|||
124878392|NCT03565068|449177390|FG007|Overall Study|Physician Decision|1|||
124878393|NCT03565068|449177391|FG008|Overall Study|Physician Decision|0|||
124878394|NCT03565068|449177383|FG000|Overall Study|Lost to Follow-up|0|||
124878395|NCT03565068|449177384|FG001|Overall Study|Lost to Follow-up|0|||
124878396|NCT03565068|449177385|FG002|Overall Study|Lost to Follow-up|0|||
124878397|NCT03565068|449177386|FG003|Overall Study|Lost to Follow-up|0|||
124878398|NCT03565068|449177387|FG004|Overall Study|Lost to Follow-up|0|||
124878399|NCT03565068|449177388|FG005|Overall Study|Lost to Follow-up|0|||
124878400|NCT03565068|449177389|FG006|Overall Study|Lost to Follow-up|0|||
124878401|NCT03565068|449177390|FG007|Overall Study|Lost to Follow-up|1|||
124878402|NCT03565068|449177391|FG008|Overall Study|Lost to Follow-up|0|||
124878403|NCT00085202|449177392|FG000|Overall Study|Still on therapy|2|||
124878404|NCT00085202|449177393|FG001|Overall Study|Still on therapy|0|||
124878405|NCT00085202|449177392|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
124878406|NCT00085202|449177393|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
124878407|NCT00085202|449177392|FG000|Overall Study|Excessive toxicity|6|||
124878408|NCT00085202|449177393|FG001|Overall Study|Excessive toxicity|5|||
124878409|NCT00085202|449177392|FG000|Overall Study|Non-specified|3|||
124878410|NCT00085202|449177393|FG001|Overall Study|Non-specified|5|||
124878411|NCT00085202|449177392|FG000|Overall Study|Withdrawal by Subject|2|||
124878412|NCT00085202|449177393|FG001|Overall Study|Withdrawal by Subject|1|||
124878413|NCT00085202|449177392|FG000|Overall Study|Physician Decision|4|||
124878414|NCT00085202|449177393|FG001|Overall Study|Physician Decision|1|||
124878415|NCT00085202|449177392|FG000|Overall Study|Progressive disease|1|||
124878416|NCT00085202|449177393|FG001|Overall Study|Progressive disease|11|||
124878417|NCT01435655|449177399|FG000|Overall Study|Death|2|||
124878418|NCT01435655|449177399|FG000|Overall Study|Other|1|||
124878419|NCT01436201|449177400|FG000|Overall Study|Adverse Event|2|||
124878420|NCT01436201|449177400|FG000|Overall Study|Withdrawal by Subject|1|||
124878421|NCT01436201|449177400|FG000|Overall Study|Protocol Violation|1|||
124878422|NCT01353222|449177402|FG000|Overall Study|Death|30|||
124878423|NCT01353222|449177403|FG001|Overall Study|Death|30|||
124878424|NCT01353222|449177402|FG000|Overall Study|Withdrawal by Subject|8|||
124878425|NCT01353222|449177403|FG001|Overall Study|Withdrawal by Subject|5|||
124878426|NCT01353222|449177402|FG000|Overall Study|Study Terminated|31|||
124878427|NCT01353222|449177403|FG001|Overall Study|Study Terminated|37|||
124878428|NCT01353222|449177402|FG000|Overall Study|Site closed research department|1|||
124878429|NCT01353222|449177403|FG001|Overall Study|Site closed research department|0|||
124878430|NCT00116844|449177404|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
124878431|NCT00116844|449177405|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
124878432|NCT00116844|449177404|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
124878433|NCT00116844|449177405|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
124878434|NCT00116844|449177404|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
124878435|NCT00116844|449177405|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
124878436|NCT00116844|449177404|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
124878437|NCT00116844|449177405|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
124878438|NCT00116844|449177404|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
124878439|NCT00116844|449177405|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
124878440|NCT00116844|449177404|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
124878441|NCT00116844|449177405|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
125101822|NCT03514121|449994052|FG002|Overall Study|Study termination by Sponsor|0|||
125101823|NCT03514121|449994053|FG003|Overall Study|Study termination by Sponsor|0|||
125101824|NCT03514121|449994054|FG004|Overall Study|Study termination by Sponsor|0|||
125101825|NCT03514121|449994055|FG005|Overall Study|Study termination by Sponsor|0|||
125101826|NCT03514121|449994056|FG006|Overall Study|Study termination by Sponsor|0|||
125101827|NCT03514121|449994057|FG007|Overall Study|Study termination by Sponsor|0|||
124878442|NCT00116844|449177404|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
124878443|NCT00116844|449177405|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
124878444|NCT00116844|449177404|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
124878445|NCT00116844|449177405|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
124878446|NCT00116844|449177404|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
124878447|NCT00116844|449177405|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
124878448|NCT00738101|449177409|FG000|Overall Study|Physician Decision|5|||
124878449|NCT00738101|449177409|FG000|Overall Study|Death|1|||
124878450|NCT00738101|449177409|FG000|Overall Study|Repeat enrollment|1|||
124878451|NCT02202434|449179253|FG000|Overall Study|Death|70|||
124878452|NCT02202434|449179254|FG001|Overall Study|Death|39|||
125101828|NCT03514121|449994058|FG008|Overall Study|Study termination by Sponsor|11|||
124878453|NCT02202434|449179255|FG002|Overall Study|Death|13|||
124878454|NCT02202434|449179256|FG003|Overall Study|Death|27|||
124878455|NCT02202434|449179253|FG000|Overall Study|Lost to Follow-up|1|||
124878456|NCT02202434|449179254|FG001|Overall Study|Lost to Follow-up|1|||
124878457|NCT02202434|449179255|FG002|Overall Study|Lost to Follow-up|1|||
124878458|NCT02202434|449179256|FG003|Overall Study|Lost to Follow-up|0|||
124878459|NCT02202434|449179253|FG000|Overall Study|Physician Decision|2|||
124878460|NCT02202434|449179254|FG001|Overall Study|Physician Decision|3|||
124878461|NCT02202434|449179255|FG002|Overall Study|Physician Decision|0|||
124878462|NCT02202434|449179256|FG003|Overall Study|Physician Decision|0|||
124878463|NCT02202434|449179253|FG000|Overall Study|Withdrawal by Subject|13|||
124878464|NCT02202434|449179254|FG001|Overall Study|Withdrawal by Subject|14|||
124878465|NCT02202434|449179255|FG002|Overall Study|Withdrawal by Subject|1|||
124878466|NCT02202434|449179256|FG003|Overall Study|Withdrawal by Subject|4|||
124878467|NCT02202434|449179253|FG000|Overall Study|Completed Study|1|||
124878468|NCT02202434|449179254|FG001|Overall Study|Completed Study|0|||
124878469|NCT02202434|449179255|FG002|Overall Study|Completed Study|0|||
124878470|NCT02202434|449179256|FG003|Overall Study|Completed Study|0|||
124878471|NCT02202434|449179253|FG000|Overall Study|Visit Missed|21|||
124878472|NCT02202434|449179254|FG001|Overall Study|Visit Missed|12|||
124878473|NCT02202434|449179255|FG002|Overall Study|Visit Missed|0|||
124878474|NCT02202434|449179256|FG003|Overall Study|Visit Missed|5|||
124878475|NCT02202434|449179253|FG000|Overall Study|Other|1|||
124878476|NCT02202434|449179254|FG001|Overall Study|Other|0|||
124878477|NCT02202434|449179255|FG002|Overall Study|Other|0|||
124878478|NCT02202434|449179256|FG003|Overall Study|Other|1|||
124878479|NCT03075501|449179257|FG000|Overall Study|Scheduling difficulties|15|||
124878480|NCT03075501|449179258|FG001|Overall Study|Scheduling difficulties|9|||
124878481|NCT01062763|449179262|FG000|Overall Study|Adverse Event|3|||
124878482|NCT01062763|449179263|FG001|Overall Study|Adverse Event|4|||
124878483|NCT02494921|449179264|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
124878484|NCT02494921|449179265|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
124878485|NCT02494921|449179266|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
124878486|NCT02494921|449179267|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
124878487|NCT02494921|449179268|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
124878488|NCT02494921|449179264|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
124878489|NCT02494921|449179265|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
124878490|NCT02494921|449179266|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
124878491|NCT02494921|449179267|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
124878492|NCT02494921|449179268|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
124878493|NCT02494921|449179264|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
124878494|NCT02494921|449179265|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
124878495|NCT02494921|449179266|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
124878496|NCT02494921|449179267|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
124878497|NCT02494921|449179268|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
124878498|NCT02714868|449179269|FG000|Overall Study|Withdrawal by Subject|3|||
124878499|NCT02714868|449179270|FG001|Overall Study|Withdrawal by Subject|0|||
124878500|NCT02714868|449179269|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
124878501|NCT02714868|449179270|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
124878502|NCT02714868|449179269|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
124878503|NCT02714868|449179270|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
124878504|NCT03505476|449179276|FG000|Overall Study|Physician Decision|18|||
124878505|NCT03505476|449179276|FG000|Overall Study|Device Malfunctioned|101|||
124878506|NCT03505476|449179276|FG000|Overall Study|Data Corrupt|6|||
124878507|NCT03505476|449179276|FG000|Overall Study|Device application insufficiant|3|||
124878508|NCT00539643|449179277|FG000|Overall Study|Adverse Event|1|||
124878509|NCT00539643|449179278|FG001|Overall Study|Adverse Event|0|||
124878510|NCT00539643|449179277|FG000|Overall Study|Death|2|||
124878511|NCT00539643|449179278|FG001|Overall Study|Death|1|||
124878512|NCT00539643|449179277|FG000|Overall Study|Physician Decision|3|||
124878513|NCT00539643|449179278|FG001|Overall Study|Physician Decision|1|||
124878514|NCT00539643|449179277|FG000|Overall Study|Withdrawal by Subject|0|||
124878515|NCT00539643|449179278|FG001|Overall Study|Withdrawal by Subject|1|||
124878516|NCT02508532|449179281|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
124878517|NCT02508532|449179282|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
124878518|NCT02508532|449179283|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
124878519|NCT02508532|449179284|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
124878520|NCT02508532|449179285|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
124878521|NCT02508532|449179286|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
124878522|NCT02508532|449179287|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
124878523|NCT02508532|449179288|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
124878524|NCT02508532|449179289|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
125101829|NCT03514121|449994059|FG009|Overall Study|Study termination by Sponsor|3|||
125101830|NCT03514121|449994050|FG000|Overall Study|Investigator decision|0|||
125101831|NCT03514121|449994051|FG001|Overall Study|Investigator decision|0|||
125101832|NCT03514121|449994052|FG002|Overall Study|Investigator decision|0|||
125101833|NCT03514121|449994053|FG003|Overall Study|Investigator decision|0|||
125101834|NCT03514121|449994054|FG004|Overall Study|Investigator decision|0|||
125101835|NCT03514121|449994055|FG005|Overall Study|Investigator decision|0|||
125101836|NCT03514121|449994056|FG006|Overall Study|Investigator decision|0|||
125101837|NCT03514121|449994057|FG007|Overall Study|Investigator decision|0|||
125101838|NCT03514121|449994058|FG008|Overall Study|Investigator decision|1|||
125101839|NCT03514121|449994059|FG009|Overall Study|Investigator decision|0|||
125101840|NCT03286400|449994063|FG000|Overall Study|Death|10|||
125101841|NCT03286400|449994063|FG000|Overall Study|Lost to Follow-up|10|||
125101842|NCT03286400|449994063|FG000|Overall Study|Physician Decision|1|||
125101843|NCT03286400|449994063|FG000|Overall Study|Scheduling difficulty|4|||
125101844|NCT00826176|449994066|FG000|Overall Study|Lost to Follow-up|1|||
125101845|NCT00826176|449994067|FG001|Overall Study|Lost to Follow-up|0|||
125101846|NCT00826176|449994066|FG000|Overall Study|Subject Withdrew Consent|3|||
125101847|NCT00826176|449994067|FG001|Overall Study|Subject Withdrew Consent|0|||
125101848|NCT00826176|449994066|FG000|Overall Study|Administrative|9|||
125101849|NCT00826176|449994067|FG001|Overall Study|Administrative|0|||
125101850|NCT00297882|449994072|FG000|Day 14|Lack of Efficacy|12|||
125101851|NCT00297882|449994073|FG001|Day 14|Lack of Efficacy|49|||
125101852|NCT00297882|449994072|FG000|Day 28|Lost to Follow-up|13|||
125101853|NCT00297882|449994073|FG001|Day 28|Lost to Follow-up|23|||
125101854|NCT00297882|449994072|FG000|Day 28|Lack of Efficacy|3|||
125101855|NCT00297882|449994073|FG001|Day 28|Lack of Efficacy|0|||
125101856|NCT04484805|449994074|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
125101857|NCT04484805|449994075|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
125101858|NCT04484805|449994074|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
125101859|NCT04484805|449994075|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
125101860|NCT04242264|449994076|FG000|Overall Study|Lost to Follow-up|2|||
125101861|NCT04242264|449994077|FG001|Overall Study|Lost to Follow-up|2|||
125101862|NCT04242264|449994078|FG002|Overall Study|Lost to Follow-up|1|||
125101863|NCT04242264|449994079|FG003|Overall Study|Lost to Follow-up|1|||
125101864|NCT04242264|449994076|FG000|Overall Study|Withdrawal by Subject|1|||
125101865|NCT04242264|449994077|FG001|Overall Study|Withdrawal by Subject|0|||
125101866|NCT04242264|449994078|FG002|Overall Study|Withdrawal by Subject|0|||
125101867|NCT04242264|449994079|FG003|Overall Study|Withdrawal by Subject|0|||
125101868|NCT04139642|449994081|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
125101869|NCT04139642|449994082|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
125101870|NCT00433771|449994084|FG000|Overall Study|screen fail|14|||
125101871|NCT00433771|449994084|FG000|Overall Study|Treated and later found to be ineligible|2|||
125101872|NCT00433771|449994084|FG000|Overall Study|Death|2|||
125101873|NCT00433771|449994084|FG000|Overall Study|Failure to deploy stent|1|||
125101874|NCT00539006|449994088|FG000|Pre-treatment|Other|0|||
125101875|NCT00539006|449994089|FG001|Pre-treatment|Other|1|||
125101876|NCT00539006|449994090|FG002|Pre-treatment|Other|0|||
125101877|NCT00539006|449994091|FG003|Pre-treatment|Other|0|||
125101878|NCT00539006|449994088|FG000|Treatment Period 1|Lost to Follow-up|0|||
125101879|NCT00539006|449994089|FG001|Treatment Period 1|Lost to Follow-up|0|||
125101880|NCT00539006|449994090|FG002|Treatment Period 1|Lost to Follow-up|1|||
125101881|NCT00539006|449994091|FG003|Treatment Period 1|Lost to Follow-up|0|||
125101882|NCT00539006|449994088|FG000|Treatment Period 1|Protocol Violation|0|||
125101883|NCT00539006|449994089|FG001|Treatment Period 1|Protocol Violation|0|||
125101884|NCT00539006|449994090|FG002|Treatment Period 1|Protocol Violation|1|||
125101885|NCT00539006|449994091|FG003|Treatment Period 1|Protocol Violation|0|||
125101886|NCT00539006|449994088|FG000|Treatment Period 1|Lack of Efficacy|0|||
125101887|NCT00539006|449994089|FG001|Treatment Period 1|Lack of Efficacy|0|||
125101888|NCT00539006|449994090|FG002|Treatment Period 1|Lack of Efficacy|0|||
125101889|NCT00539006|449994091|FG003|Treatment Period 1|Lack of Efficacy|1|||
125101890|NCT00539006|449994088|FG000|Washout|Adverse Event|2|||
125101891|NCT00539006|449994089|FG001|Washout|Adverse Event|1|||
125101892|NCT00539006|449994090|FG002|Washout|Adverse Event|0|||
125101893|NCT00539006|449994091|FG003|Washout|Adverse Event|0|||
125101894|NCT00539006|449994088|FG000|Washout|Protocol Violation|1|||
125101895|NCT00539006|449994089|FG001|Washout|Protocol Violation|1|||
125101896|NCT00539006|449994090|FG002|Washout|Protocol Violation|0|||
125101897|NCT00539006|449994091|FG003|Washout|Protocol Violation|0|||
125101898|NCT00539006|449994088|FG000|Washout|Withdrawal by Subject|0|||
125101899|NCT00539006|449994089|FG001|Washout|Withdrawal by Subject|2|||
125101900|NCT00539006|449994090|FG002|Washout|Withdrawal by Subject|0|||
125101901|NCT00539006|449994091|FG003|Washout|Withdrawal by Subject|0|||
125101902|NCT00539006|449994088|FG000|Washout|Failed to meet continuation criteria|16|||
125101903|NCT00539006|449994089|FG001|Washout|Failed to meet continuation criteria|5|||
125101904|NCT00539006|449994090|FG002|Washout|Failed to meet continuation criteria|14|||
125013214|NCT00705783|449674814|FG001|Conversion Phase|Withdrawn by Investigator|0|||
125101905|NCT00539006|449994091|FG003|Washout|Failed to meet continuation criteria|6|||
125101906|NCT00539006|449994088|FG000|Washout|Other|1|||
125101907|NCT00539006|449994089|FG001|Washout|Other|1|||
125101908|NCT00539006|449994090|FG002|Washout|Other|2|||
125101909|NCT00539006|449994091|FG003|Washout|Other|3|||
125101910|NCT00539006|449994088|FG000|Treatment Period 2|Protocol Violation|1|||
125101911|NCT00539006|449994089|FG001|Treatment Period 2|Protocol Violation|0|||
125101912|NCT00539006|449994090|FG002|Treatment Period 2|Protocol Violation|0|||
125101913|NCT00539006|449994091|FG003|Treatment Period 2|Protocol Violation|0|||
125101914|NCT00539006|449994088|FG000|Treatment Period 2|Other|0|||
125101915|NCT00539006|449994089|FG001|Treatment Period 2|Other|1|||
125101916|NCT00539006|449994090|FG002|Treatment Period 2|Other|0|||
125101917|NCT00539006|449994091|FG003|Treatment Period 2|Other|0|||
125101918|NCT02353572|449994092|FG000|Overall Study|Withdrawal by Subject|1|||
125101919|NCT02353572|449994092|FG000|Overall Study|Study terminated|2|||
125101920|NCT01036594|449994100|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
125101921|NCT01036594|449994101|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
125101922|NCT01036594|449994100|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
125101923|NCT01036594|449994101|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
125101924|NCT01036594|449994100|FG000|Week 12 Evaluation|Adverse Event|5|||
125101925|NCT01036594|449994101|FG001|Week 12 Evaluation|Adverse Event|0|||
125101926|NCT01036594|449994100|FG000|Week 12 Evaluation|Physician Decision|1|||
125101927|NCT01036594|449994101|FG001|Week 12 Evaluation|Physician Decision|0|||
125101928|NCT01036594|449994100|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
125101929|NCT01036594|449994101|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
125101930|NCT01036594|449994100|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
125101931|NCT01036594|449994101|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
125101932|NCT01036594|449994100|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
125101933|NCT01036594|449994101|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
125101934|NCT01036594|449994100|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
125101935|NCT01036594|449994101|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
125101936|NCT01036594|449994100|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
125101937|NCT01036594|449994101|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
125101938|NCT01244516|449994104|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
125101939|NCT01244516|449994105|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
125101940|NCT01244516|449994106|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
125101941|NCT01244516|449994104|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
125101942|NCT01244516|449994105|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
125101943|NCT01244516|449994106|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
125101944|NCT01244516|449994104|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
125101945|NCT01244516|449994105|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
125101946|NCT01244516|449994106|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
125101947|NCT01244516|449994104|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
125101948|NCT01244516|449994105|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
125101949|NCT01244516|449994106|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
125101950|NCT01244516|449994104|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
125101951|NCT01244516|449994105|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
125101952|NCT01244516|449994106|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
125101953|NCT01244516|449994104|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
125101954|NCT01244516|449994105|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
125101955|NCT01244516|449994106|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
125101956|NCT01244516|449994104|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
125101957|NCT01244516|449994105|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
125101958|NCT01244516|449994106|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
125101959|NCT00244881|449994113|FG000|Overall Study|Withdrawal by Subject|3|||
125013215|NCT00705783|449674815|FG002|Conversion Phase|Withdrawn by Investigator|0|||
125013216|NCT00705783|449674813|FG000|Conversion Phase|Withdrew Consent|24|||
125013217|NCT00705783|449674814|FG001|Conversion Phase|Withdrew Consent|0|||
125013218|NCT00705783|449674815|FG002|Conversion Phase|Withdrew Consent|0|||
125013219|NCT00705783|449674813|FG000|Conversion Phase|Protocol Deviation|2|||
125013220|NCT00705783|449674814|FG001|Conversion Phase|Protocol Deviation|0|||
125013221|NCT00705783|449674815|FG002|Conversion Phase|Protocol Deviation|0|||
125013222|NCT00705783|449674813|FG000|Conversion Phase|Adverse Event|11|||
125101960|NCT03664024|449994114|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
125101961|NCT03664024|449994114|FG000|Overall Study|Lost to Follow-up|2|||
125101962|NCT03664024|449994114|FG000|Overall Study|Withdrawal by Subject|2|||
125101963|NCT03664024|449994114|FG000|Overall Study|Death|80|||
125013223|NCT00705783|449674814|FG001|Conversion Phase|Adverse Event|0|||
125101964|NCT03159611|449994115|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
125101965|NCT03159611|449994116|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
125101966|NCT03159611|449994115|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
124878525|NCT02508532|449179281|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
124878526|NCT02508532|449179282|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
124878527|NCT02508532|449179283|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
124878528|NCT02508532|449179284|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
124878529|NCT02508532|449179285|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
124878530|NCT02508532|449179286|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
124878531|NCT02508532|449179287|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
124878532|NCT02508532|449179288|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
124878533|NCT02508532|449179289|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
124878534|NCT02508532|449179281|FG000|Part 2 - Treatment|Disease Progression|0|||
124878535|NCT02508532|449179282|FG001|Part 2 - Treatment|Disease Progression|0|||
124878536|NCT02508532|449179283|FG002|Part 2 - Treatment|Disease Progression|0|||
124878537|NCT02508532|449179284|FG003|Part 2 - Treatment|Disease Progression|0|||
124878538|NCT02508532|449179285|FG004|Part 2 - Treatment|Disease Progression|0|||
124878539|NCT02508532|449179286|FG005|Part 2 - Treatment|Disease Progression|0|||
124878540|NCT02508532|449179287|FG006|Part 2 - Treatment|Disease Progression|0|||
124878541|NCT02508532|449179288|FG007|Part 2 - Treatment|Disease Progression|0|||
124878542|NCT02508532|449179289|FG008|Part 2 - Treatment|Disease Progression|118|||
124878543|NCT02508532|449179281|FG000|Part 2 - Treatment|Adverse Event|0|||
124878544|NCT02508532|449179282|FG001|Part 2 - Treatment|Adverse Event|0|||
124878545|NCT02508532|449179283|FG002|Part 2 - Treatment|Adverse Event|0|||
124878546|NCT02508532|449179284|FG003|Part 2 - Treatment|Adverse Event|0|||
124878547|NCT02508532|449179285|FG004|Part 2 - Treatment|Adverse Event|0|||
124878548|NCT02508532|449179286|FG005|Part 2 - Treatment|Adverse Event|0|||
124878549|NCT02508532|449179287|FG006|Part 2 - Treatment|Adverse Event|0|||
124878550|NCT02508532|449179288|FG007|Part 2 - Treatment|Adverse Event|0|||
124878551|NCT02508532|449179289|FG008|Part 2 - Treatment|Adverse Event|49|||
124878552|NCT02508532|449179281|FG000|Part 2 - Treatment|Physician Decision|0|||
124878553|NCT02508532|449179282|FG001|Part 2 - Treatment|Physician Decision|0|||
124878554|NCT02508532|449179283|FG002|Part 2 - Treatment|Physician Decision|0|||
125101967|NCT03159611|449994116|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
125101968|NCT03159611|449994115|FG000|Overall Study|Protocol Violation|7|||
125101969|NCT03159611|449994116|FG001|Overall Study|Protocol Violation|4|||
125101970|NCT03159611|449994115|FG000|Overall Study|Adverse Event|1|||
125101971|NCT03159611|449994116|FG001|Overall Study|Adverse Event|0|||
125101972|NCT03159611|449994115|FG000|Overall Study|Withdrawal by Subject|1|||
125101973|NCT03159611|449994116|FG001|Overall Study|Withdrawal by Subject|1|||
125101974|NCT03159611|449994115|FG000|Overall Study|Non-compliance with protocol requirement|3|||
125101975|NCT03159611|449994116|FG001|Overall Study|Non-compliance with protocol requirement|2|||
125101976|NCT03159611|449994115|FG000|Overall Study|Inability to perform procedures|1|||
125101977|NCT03159611|449994116|FG001|Overall Study|Inability to perform procedures|0|||
125101978|NCT02057549|449994118|FG000|Overall Study|Lost to Follow-up|1|||
125101979|NCT02057549|449994119|FG001|Overall Study|Lost to Follow-up|0|||
125101980|NCT02057549|449994118|FG000|Overall Study|Physician Decision|1|||
125101981|NCT02057549|449994119|FG001|Overall Study|Physician Decision|0|||
125101982|NCT02057549|449994118|FG000|Overall Study|Withdrawal by Subject|1|||
125101983|NCT02057549|449994119|FG001|Overall Study|Withdrawal by Subject|0|||
125101984|NCT01418365|449994120|FG000|First Intervention|Withdrawal by Subject|0|||
125101985|NCT01418365|449994121|FG001|First Intervention|Withdrawal by Subject|1|||
125101986|NCT01418365|449994120|FG000|First Intervention|Non-compliance|1|||
125101987|NCT01418365|449994121|FG001|First Intervention|Non-compliance|0|||
125101988|NCT01418365|449994120|FG000|Second Intervention|Withdrawal by Subject|0|||
125101989|NCT01418365|449994121|FG001|Second Intervention|Withdrawal by Subject|1|||
125101990|NCT03319368|449994122|FG000|Overall Study|Discharge swabs not collected from resident|57|||
125101991|NCT03319368|449994123|FG001|Overall Study|Discharge swabs not collected from resident|46|||
125101992|NCT03000075|449994124|FG000|Part A|Adverse Event|4|||
125101993|NCT03000075|449994125|FG001|Part A|Adverse Event|0|||
125101994|NCT03000075|449994126|FG002|Part A|Adverse Event|0|||
125101995|NCT03000075|449994127|FG003|Part A|Adverse Event|0|||
124878555|NCT02508532|449179284|FG003|Part 2 - Treatment|Physician Decision|0|||
124878556|NCT02508532|449179285|FG004|Part 2 - Treatment|Physician Decision|0|||
124878557|NCT02508532|449179286|FG005|Part 2 - Treatment|Physician Decision|0|||
124878558|NCT02508532|449179287|FG006|Part 2 - Treatment|Physician Decision|0|||
124878559|NCT02508532|449179288|FG007|Part 2 - Treatment|Physician Decision|0|||
125101996|NCT03000075|449994128|FG004|Part A|Adverse Event|0|||
125101997|NCT03000075|449994129|FG005|Part A|Adverse Event|0|||
125101998|NCT03000075|449994130|FG006|Part A|Adverse Event|0|||
124878560|NCT02508532|449179289|FG008|Part 2 - Treatment|Physician Decision|12|||
124878561|NCT02508532|449179281|FG000|Part 2 - Treatment|Administrative|0|||
124878562|NCT02508532|449179282|FG001|Part 2 - Treatment|Administrative|0|||
125210715|NCT02028169|450395660|FG000|Overall Study|Withdrawal by Subject|2|||
125210716|NCT02028169|450395660|FG000|Overall Study|Adverse Event|1|||
125210717|NCT02028169|450395660|FG000|Overall Study|Cessation of Drug|1|||
125210718|NCT02028169|450395660|FG000|Overall Study|Concomitant Medication Usage|1|||
125210719|NCT02258334|450395661|FG000|Overall Study|Adverse Event|1|||
125210720|NCT02258334|450395662|FG001|Overall Study|Adverse Event|0|||
124878563|NCT02508532|449179283|FG002|Part 2 - Treatment|Administrative|0|||
125210721|NCT02258334|450395663|FG002|Overall Study|Adverse Event|0|||
125210722|NCT02258334|450395664|FG003|Overall Study|Adverse Event|0|||
125210723|NCT00862459|450395665|FG000|Overall Study|Lost to Follow-up|1|||
125210724|NCT00862459|450395666|FG001|Overall Study|Lost to Follow-up|2|||
125210725|NCT00862459|450395667|FG002|Overall Study|Lost to Follow-up|2|||
125210726|NCT00862459|450395665|FG000|Overall Study|Protocol Violation|1|||
125210727|NCT00862459|450395666|FG001|Overall Study|Protocol Violation|0|||
125210728|NCT00862459|450395667|FG002|Overall Study|Protocol Violation|0|||
125210729|NCT00862459|450395665|FG000|Overall Study|Withdrawal by Subject|1|||
125210730|NCT00862459|450395666|FG001|Overall Study|Withdrawal by Subject|1|||
125210731|NCT00862459|450395667|FG002|Overall Study|Withdrawal by Subject|3|||
125210732|NCT00862459|450395665|FG000|Overall Study|Adverse Event|0|||
125210733|NCT00862459|450395666|FG001|Overall Study|Adverse Event|1|||
125210734|NCT00862459|450395667|FG002|Overall Study|Adverse Event|0|||
125210735|NCT00862459|450395665|FG000|Overall Study|Personal reasons|1|||
125210736|NCT00862459|450395666|FG001|Overall Study|Personal reasons|0|||
125210737|NCT00862459|450395667|FG002|Overall Study|Personal reasons|0|||
125210738|NCT00862459|450395665|FG000|Overall Study|Operation|1|||
125210739|NCT00862459|450395666|FG001|Overall Study|Operation|1|||
124878564|NCT02508532|449179284|FG003|Part 2 - Treatment|Administrative|0|||
124878565|NCT02508532|449179285|FG004|Part 2 - Treatment|Administrative|0|||
124878566|NCT02508532|449179286|FG005|Part 2 - Treatment|Administrative|0|||
124878567|NCT02508532|449179287|FG006|Part 2 - Treatment|Administrative|0|||
124878568|NCT02508532|449179288|FG007|Part 2 - Treatment|Administrative|0|||
124878569|NCT02508532|449179289|FG008|Part 2 - Treatment|Administrative|3|||
124878570|NCT02508532|449179281|FG000|Part 2 - Treatment|Sponsor Decision|0|||
124878571|NCT02508532|449179282|FG001|Part 2 - Treatment|Sponsor Decision|0|||
124878572|NCT02508532|449179283|FG002|Part 2 - Treatment|Sponsor Decision|0|||
124878573|NCT02508532|449179284|FG003|Part 2 - Treatment|Sponsor Decision|0|||
124878574|NCT02508532|449179285|FG004|Part 2 - Treatment|Sponsor Decision|0|||
124878575|NCT02508532|449179286|FG005|Part 2 - Treatment|Sponsor Decision|0|||
124878576|NCT02508532|449179287|FG006|Part 2 - Treatment|Sponsor Decision|0|||
124878577|NCT02508532|449179288|FG007|Part 2 - Treatment|Sponsor Decision|0|||
124878578|NCT02508532|449179289|FG008|Part 2 - Treatment|Sponsor Decision|28|||
124878579|NCT02508532|449179281|FG000|Part 2 - Treatment|Death|0|||
124878580|NCT02508532|449179282|FG001|Part 2 - Treatment|Death|0|||
124878581|NCT02508532|449179283|FG002|Part 2 - Treatment|Death|0|||
124878582|NCT02508532|449179284|FG003|Part 2 - Treatment|Death|0|||
124878583|NCT02508532|449179285|FG004|Part 2 - Treatment|Death|0|||
124878584|NCT02508532|449179286|FG005|Part 2 - Treatment|Death|0|||
124878585|NCT02508532|449179287|FG006|Part 2 - Treatment|Death|0|||
124878586|NCT02508532|449179288|FG007|Part 2 - Treatment|Death|0|||
124878587|NCT02508532|449179289|FG008|Part 2 - Treatment|Death|1|||
124878588|NCT02508532|449179281|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
124878589|NCT02508532|449179282|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
124878590|NCT02508532|449179283|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
124878591|NCT02508532|449179284|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
124878592|NCT02508532|449179285|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
124878593|NCT02508532|449179286|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
124878594|NCT02508532|449179287|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
124878595|NCT02508532|449179288|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
124878596|NCT02508532|449179289|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
124878597|NCT02508532|449179281|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
124878598|NCT02508532|449179282|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
124878599|NCT02508532|449179283|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
124878600|NCT02508532|449179284|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
124878601|NCT02508532|449179285|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
124878602|NCT02508532|449179286|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
124878603|NCT02508532|449179287|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
124878604|NCT02508532|449179288|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
124878605|NCT02508532|449179289|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
124878606|NCT02508532|449179281|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
124878607|NCT02508532|449179282|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
124878608|NCT02508532|449179283|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
124878609|NCT02508532|449179284|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
124878610|NCT02508532|449179285|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
124878611|NCT02508532|449179286|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
124878612|NCT02508532|449179287|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
124878613|NCT02508532|449179288|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
124878614|NCT02508532|449179289|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
124878615|NCT02508532|449179281|FG000|Part 1 and Part 2 End of Study|Death|0|||
124878616|NCT02508532|449179282|FG001|Part 1 and Part 2 End of Study|Death|4|||
124878617|NCT02508532|449179283|FG002|Part 1 and Part 2 End of Study|Death|2|||
124878618|NCT02508532|449179284|FG003|Part 1 and Part 2 End of Study|Death|4|||
124878619|NCT02508532|449179285|FG004|Part 1 and Part 2 End of Study|Death|3|||
124878620|NCT02508532|449179286|FG005|Part 1 and Part 2 End of Study|Death|0|||
124878621|NCT02508532|449179287|FG006|Part 1 and Part 2 End of Study|Death|0|||
124878622|NCT02508532|449179288|FG007|Part 1 and Part 2 End of Study|Death|1|||
124878623|NCT02508532|449179289|FG008|Part 1 and Part 2 End of Study|Death|111|||
124878624|NCT02508532|449179281|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
124878625|NCT02508532|449179282|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
124878626|NCT02508532|449179283|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
124878627|NCT02508532|449179284|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
124878628|NCT02508532|449179285|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
124878629|NCT02508532|449179286|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
124878630|NCT02508532|449179287|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
125013224|NCT00705783|449674815|FG002|Conversion Phase|Adverse Event|0|||
125013225|NCT00705783|449674813|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
125013226|NCT00705783|449674814|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
125013227|NCT00705783|449674815|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
125013228|NCT00705783|449674813|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
125013229|NCT00705783|449674814|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
125101999|NCT03000075|449994124|FG000|Part B|Not dosed due to AE|0|||
124878631|NCT02508532|449179288|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
124878632|NCT02508532|449179289|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
124878633|NCT02508532|449179281|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
124878634|NCT02508532|449179282|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
124878635|NCT02508532|449179283|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
124878636|NCT02508532|449179284|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
124878637|NCT02508532|449179285|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
124878638|NCT02508532|449179286|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
124878639|NCT02508532|449179287|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
124878640|NCT02508532|449179288|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
124878641|NCT02508532|449179289|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
124878642|NCT02508532|449179281|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
124878643|NCT02508532|449179282|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
124878644|NCT02508532|449179283|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
124878645|NCT02508532|449179284|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
124878646|NCT02508532|449179285|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
124878647|NCT02508532|449179286|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
124878648|NCT02508532|449179287|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
124878649|NCT02508532|449179288|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
124878650|NCT02508532|449179289|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
124878651|NCT02508532|449179281|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
124878652|NCT02508532|449179282|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
124878653|NCT02508532|449179283|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
125013230|NCT00705783|449674815|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
125013231|NCT00705783|449674813|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
125013232|NCT00705783|449674814|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
125013233|NCT00705783|449674815|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
125013234|NCT00705783|449674813|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
125013235|NCT00705783|449674814|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
125013236|NCT00705783|449674815|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
125013237|NCT00705783|449674813|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
125013238|NCT00705783|449674814|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
125013239|NCT00705783|449674815|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
125013240|NCT00705783|449674813|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
125013241|NCT00705783|449674814|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
125013242|NCT00705783|449674815|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
125013243|NCT00705783|449674813|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
125013244|NCT00705783|449674814|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
125013245|NCT00705783|449674815|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
125013246|NCT00705783|449674813|FG000|Oral Stabilization Phase|Adverse Event|14|||
125013247|NCT00705783|449674814|FG001|Oral Stabilization Phase|Adverse Event|0|||
125013248|NCT00705783|449674815|FG002|Oral Stabilization Phase|Adverse Event|0|||
125013249|NCT00705783|449674813|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
125013250|NCT00705783|449674814|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
125013251|NCT00705783|449674815|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
125013252|NCT00705783|449674813|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
125013253|NCT00705783|449674814|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
125013254|NCT00705783|449674815|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
125013255|NCT00705783|449674813|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
125013256|NCT00705783|449674814|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
125013257|NCT00705783|449674815|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
125013258|NCT00705783|449674813|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
125013259|NCT00705783|449674814|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
125013260|NCT00705783|449674815|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
125013261|NCT00705783|449674813|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
125013262|NCT00705783|449674814|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
125013263|NCT00705783|449674815|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
125013264|NCT00705783|449674813|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
125013265|NCT00705783|449674814|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
125013266|NCT00705783|449674815|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
125013267|NCT00705783|449674813|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
125210740|NCT00862459|450395667|FG002|Overall Study|Operation|0|||
125210741|NCT00862459|450395665|FG000|Overall Study|Intravenous (IV) site problems|1|||
125210742|NCT00862459|450395666|FG001|Overall Study|Intravenous (IV) site problems|0|||
125210743|NCT00862459|450395667|FG002|Overall Study|Intravenous (IV) site problems|1|||
125210744|NCT00862459|450395665|FG000|Overall Study|Unable to hold still for imaging|0|||
125210745|NCT00862459|450395666|FG001|Overall Study|Unable to hold still for imaging|1|||
125210746|NCT00862459|450395667|FG002|Overall Study|Unable to hold still for imaging|0|||
125210747|NCT00862459|450395665|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
125210748|NCT00862459|450395666|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
125210749|NCT00862459|450395667|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
125210750|NCT00862459|450395665|FG000|Overall Study|Administrative problems|0|||
125210751|NCT00862459|450395666|FG001|Overall Study|Administrative problems|1|||
125210752|NCT00862459|450395667|FG002|Overall Study|Administrative problems|0|||
125210753|NCT04907227|450395672|FG000|Overall Study|Death|12|||
125210754|NCT04907227|450395673|FG001|Overall Study|Death|8|||
125210755|NCT04907227|450395672|FG000|Overall Study|Withdrawal by Subject|2|||
125210756|NCT04907227|450395673|FG001|Overall Study|Withdrawal by Subject|2|||
125210757|NCT04907227|450395672|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
125210758|NCT04907227|450395673|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
125210759|NCT04907227|450395672|FG000|Overall Study|Sponsor Decision|25|||
125102000|NCT03000075|449994125|FG001|Part B|Not dosed due to AE|0|||
125102001|NCT03000075|449994126|FG002|Part B|Not dosed due to AE|0|||
125102002|NCT03000075|449994127|FG003|Part B|Not dosed due to AE|0|||
125102003|NCT03000075|449994128|FG004|Part B|Not dosed due to AE|0|||
125102004|NCT03000075|449994129|FG005|Part B|Not dosed due to AE|2|||
125102005|NCT03000075|449994130|FG006|Part B|Not dosed due to AE|1|||
125102006|NCT03000075|449994124|FG000|Part B|Adverse Event|0|||
125102007|NCT03000075|449994125|FG001|Part B|Adverse Event|0|||
125102008|NCT03000075|449994126|FG002|Part B|Adverse Event|0|||
125102009|NCT03000075|449994127|FG003|Part B|Adverse Event|0|||
125102010|NCT03000075|449994128|FG004|Part B|Adverse Event|1|||
125102011|NCT03000075|449994129|FG005|Part B|Adverse Event|0|||
125102012|NCT03000075|449994130|FG006|Part B|Adverse Event|0|||
125102013|NCT00440193|449994131|FG000|Treatment Period|Adverse Event|74|||
125102014|NCT00440193|449994132|FG001|Treatment Period|Adverse Event|67|||
125102015|NCT00440193|449994131|FG000|Treatment Period|Death|19|||
125102016|NCT00440193|449994132|FG001|Treatment Period|Death|22|||
125102017|NCT00440193|449994131|FG000|Treatment Period|Lack of Efficacy|0|||
125102018|NCT00440193|449994132|FG001|Treatment Period|Lack of Efficacy|1|||
125102019|NCT00440193|449994131|FG000|Treatment Period|Lost to Follow-up|12|||
125102020|NCT00440193|449994132|FG001|Treatment Period|Lost to Follow-up|18|||
125102021|NCT00440193|449994131|FG000|Treatment Period|Physician Decision|3|||
125102022|NCT00440193|449994132|FG001|Treatment Period|Physician Decision|6|||
125102023|NCT00440193|449994131|FG000|Treatment Period|Protocol Violation|16|||
125102024|NCT00440193|449994132|FG001|Treatment Period|Protocol Violation|19|||
125102025|NCT00440193|449994131|FG000|Treatment Period|Withdrawal by Subject|36|||
125102026|NCT00440193|449994132|FG001|Treatment Period|Withdrawal by Subject|77|||
125102027|NCT00440193|449994131|FG000|Treatment Period|Clinical endpoint reached|28|||
125102028|NCT00440193|449994132|FG001|Treatment Period|Clinical endpoint reached|25|||
125102029|NCT00440193|449994131|FG000|Treatment Period|Study terminated by sponsor|102|||
125102030|NCT00440193|449994132|FG001|Treatment Period|Study terminated by sponsor|94|||
125102031|NCT00440193|449994131|FG000|Treatment Period|Protocol driven decision point|2|||
125102032|NCT00440193|449994132|FG001|Treatment Period|Protocol driven decision point|2|||
125102033|NCT00440193|449994131|FG000|Treatment Period|Switch to commercial drug|0|||
125102034|NCT00440193|449994132|FG001|Treatment Period|Switch to commercial drug|2|||
125102035|NCT00440193|449994131|FG000|Treatment Period|Technical problems|1|||
125102036|NCT00440193|449994132|FG001|Treatment Period|Technical problems|1|||
125102037|NCT00440193|449994131|FG000|Treatment Period|Participant convenience|5|||
125102038|NCT00440193|449994132|FG001|Treatment Period|Participant convenience|2|||
125102039|NCT00440193|449994131|FG000|Treatment Period|Participant did not receive treatment|7|||
125102040|NCT00440193|449994132|FG001|Treatment Period|Participant did not receive treatment|13|||
125102041|NCT00440193|449994131|FG000|Treatment Period|Site closed by investigator|0|||
125102042|NCT00440193|449994132|FG001|Treatment Period|Site closed by investigator|2|||
125102043|NCT00440193|449994131|FG000|Observational Period|Adverse Event|2|||
125102044|NCT00440193|449994132|FG001|Observational Period|Adverse Event|2|||
125102045|NCT00440193|449994131|FG000|Observational Period|Death|15|||
125102046|NCT00440193|449994132|FG001|Observational Period|Death|20|||
125102047|NCT00440193|449994131|FG000|Observational Period|Lost to Follow-up|12|||
125102048|NCT00440193|449994132|FG001|Observational Period|Lost to Follow-up|8|||
125210760|NCT04907227|450395673|FG001|Overall Study|Sponsor Decision|30|||
125210761|NCT04907227|450395672|FG000|Overall Study|Physician Decision|1|||
125210762|NCT04907227|450395673|FG001|Overall Study|Physician Decision|0|||
125102049|NCT00440193|449994131|FG000|Observational Period|Protocol Violation|1|||
125102050|NCT00440193|449994132|FG001|Observational Period|Protocol Violation|0|||
125210763|NCT02240069|450395674|FG000|Overall Study|Withdrawal by Subject|5|||
125210764|NCT02240069|450395675|FG001|Overall Study|Withdrawal by Subject|5|||
125102051|NCT00440193|449994131|FG000|Observational Period|Withdrawal by Subject|11|||
124878654|NCT02508532|449179284|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
124878655|NCT02508532|449179285|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
124878656|NCT02508532|449179286|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
124878657|NCT02508532|449179287|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
125102052|NCT00440193|449994132|FG001|Observational Period|Withdrawal by Subject|8|||
125102053|NCT00440193|449994131|FG000|Observational Period|Physician Decision|1|||
125102054|NCT00440193|449994132|FG001|Observational Period|Physician Decision|0|||
125102055|NCT00440193|449994131|FG000|Observational Period|Clinical endpoint reached|1|||
125102056|NCT00440193|449994132|FG001|Observational Period|Clinical endpoint reached|0|||
125102057|NCT00440193|449994131|FG000|Observational Period|Participant convenience|2|||
125102058|NCT00440193|449994132|FG001|Observational Period|Participant convenience|0|||
125102059|NCT00530621|449994138|FG000|Overall Study|Adverse Event|11|||
125102060|NCT00530621|449994139|FG001|Overall Study|Adverse Event|8|||
125102061|NCT00530621|449994138|FG000|Overall Study|Physician Decision|2|||
125102062|NCT00530621|449994139|FG001|Overall Study|Physician Decision|4|||
125102063|NCT00530621|449994138|FG000|Overall Study|Progressive Disease (PD)|47|||
125102064|NCT00530621|449994139|FG001|Overall Study|Progressive Disease (PD)|40|||
125102065|NCT00530621|449994138|FG000|Overall Study|Sponsor Decision|12|||
125102066|NCT00530621|449994139|FG001|Overall Study|Sponsor Decision|15|||
125102067|NCT00530621|449994138|FG000|Overall Study|Subject Decision|4|||
125102068|NCT00530621|449994139|FG001|Overall Study|Subject Decision|7|||
125102069|NCT00530621|449994138|FG000|Overall Study|Death|3|||
125102070|NCT00530621|449994139|FG001|Overall Study|Death|6|||
125102071|NCT00530621|449994138|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
125102072|NCT00530621|449994139|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
125102073|NCT00518011|449994140|FG000|Overall Study|Death|1|||
125102074|NCT00518011|449994141|FG001|Overall Study|Death|1|||
125102075|NCT00518011|449994140|FG000|Overall Study|Adverse Event|2|||
125102076|NCT00518011|449994141|FG001|Overall Study|Adverse Event|3|||
125102077|NCT00518011|449994140|FG000|Overall Study|Disease Progression|2|||
125102078|NCT00518011|449994141|FG001|Overall Study|Disease Progression|2|||
125102079|NCT00518011|449994140|FG000|Overall Study|Other Reasons|3|||
125102080|NCT00518011|449994141|FG001|Overall Study|Other Reasons|2|||
125102081|NCT00518011|449994140|FG000|Overall Study|Withdrawal by Subject|1|||
125102082|NCT00518011|449994141|FG001|Overall Study|Withdrawal by Subject|0|||
125102083|NCT03409328|449994142|FG000|Overall Study|Lost to Follow-up|6|||
125102084|NCT03409328|449994143|FG001|Overall Study|Lost to Follow-up|3|||
125102085|NCT03930615|449994146|FG000|Overall Study|Death|9|||
125102086|NCT03930615|449994147|FG001|Overall Study|Death|3|||
125102087|NCT03930615|449994146|FG000|Overall Study|Lost to Follow-up|1|||
125102088|NCT03930615|449994147|FG001|Overall Study|Lost to Follow-up|2|||
125102089|NCT03930615|449994146|FG000|Overall Study|Physician Decision|3|||
125102090|NCT03930615|449994147|FG001|Overall Study|Physician Decision|4|||
125102091|NCT03930615|449994146|FG000|Overall Study|Withdrawal by Subject|13|||
125102092|NCT03930615|449994147|FG001|Overall Study|Withdrawal by Subject|2|||
125102093|NCT03930615|449994146|FG000|Overall Study|Not treated|1|||
125102094|NCT03930615|449994147|FG001|Overall Study|Not treated|1|||
125102095|NCT04797637|449994155|FG000|Overall Study|Lost to Follow-up|23|||
125102096|NCT04797637|449994156|FG001|Overall Study|Lost to Follow-up|32|||
125102097|NCT04797637|449994155|FG000|Overall Study|Withdrawal by Subject|0|||
125102098|NCT04797637|449994156|FG001|Overall Study|Withdrawal by Subject|1|||
125102099|NCT02061293|449994157|FG000|Overall Study|Elevated Blood Pressure|1|||
125102100|NCT02061293|449994158|FG001|Overall Study|Elevated Blood Pressure|1|||
125102101|NCT00648739|449995449|FG000|Overall Study|Adverse Event|1|||
125102102|NCT00648739|449995450|FG001|Overall Study|Adverse Event|0|||
125102103|NCT00648739|449995451|FG002|Overall Study|Adverse Event|1|||
125102104|NCT00648739|449995452|FG003|Overall Study|Adverse Event|2|||
125102105|NCT00648739|449995453|FG004|Overall Study|Adverse Event|1|||
125102106|NCT00648739|449995454|FG005|Overall Study|Adverse Event|0|||
125102107|NCT00648739|449995455|FG006|Overall Study|Adverse Event|0|||
125102108|NCT00648739|449995449|FG000|Overall Study|Withdrawal by Subject|1|||
125102109|NCT00648739|449995450|FG001|Overall Study|Withdrawal by Subject|0|||
125102110|NCT00648739|449995451|FG002|Overall Study|Withdrawal by Subject|1|||
125102111|NCT00648739|449995452|FG003|Overall Study|Withdrawal by Subject|0|||
125102112|NCT00648739|449995453|FG004|Overall Study|Withdrawal by Subject|0|||
125102113|NCT00648739|449995454|FG005|Overall Study|Withdrawal by Subject|2|||
125102114|NCT00648739|449995455|FG006|Overall Study|Withdrawal by Subject|0|||
125102115|NCT00648739|449995449|FG000|Overall Study|Lack of Efficacy|0|||
125102116|NCT00648739|449995450|FG001|Overall Study|Lack of Efficacy|0|||
125102117|NCT00648739|449995451|FG002|Overall Study|Lack of Efficacy|0|||
125102118|NCT00648739|449995452|FG003|Overall Study|Lack of Efficacy|0|||
125102119|NCT00648739|449995453|FG004|Overall Study|Lack of Efficacy|1|||
125102120|NCT00648739|449995454|FG005|Overall Study|Lack of Efficacy|2|||
125102121|NCT00648739|449995455|FG006|Overall Study|Lack of Efficacy|0|||
125102122|NCT00648739|449995449|FG000|Overall Study|Investigator Considered it Advisable|0|||
125102123|NCT00648739|449995450|FG001|Overall Study|Investigator Considered it Advisable|0|||
125102124|NCT00648739|449995451|FG002|Overall Study|Investigator Considered it Advisable|0|||
125102125|NCT00648739|449995452|FG003|Overall Study|Investigator Considered it Advisable|0|||
125102126|NCT00648739|449995453|FG004|Overall Study|Investigator Considered it Advisable|0|||
125102127|NCT00648739|449995454|FG005|Overall Study|Investigator Considered it Advisable|1|||
125102128|NCT00648739|449995455|FG006|Overall Study|Investigator Considered it Advisable|1|||
125102129|NCT00648739|449995449|FG000|Overall Study|Death|0|||
125102130|NCT00648739|449995450|FG001|Overall Study|Death|1|||
125102131|NCT00648739|449995451|FG002|Overall Study|Death|0|||
125102132|NCT00648739|449995452|FG003|Overall Study|Death|0|||
125102133|NCT00648739|449995453|FG004|Overall Study|Death|0|||
125102134|NCT00648739|449995454|FG005|Overall Study|Death|0|||
125102135|NCT00648739|449995455|FG006|Overall Study|Death|0|||
125102136|NCT00648739|449995449|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
125102137|NCT00648739|449995450|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
125102138|NCT00648739|449995451|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
125102139|NCT00648739|449995452|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
125102140|NCT00648739|449995453|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
125102141|NCT00648739|449995454|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
125102142|NCT00648739|449995455|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
125102143|NCT00648739|449995449|FG000|Overall Study|Follow-up Visits Not Completed|0|||
125102144|NCT00648739|449995450|FG001|Overall Study|Follow-up Visits Not Completed|1|||
125102145|NCT00648739|449995451|FG002|Overall Study|Follow-up Visits Not Completed|0|||
125102146|NCT00648739|449995452|FG003|Overall Study|Follow-up Visits Not Completed|0|||
125102147|NCT00648739|449995453|FG004|Overall Study|Follow-up Visits Not Completed|0|||
125102148|NCT00648739|449995454|FG005|Overall Study|Follow-up Visits Not Completed|0|||
125102149|NCT00648739|449995455|FG006|Overall Study|Follow-up Visits Not Completed|0|||
125102150|NCT00242567|449995460|FG000|Overall Study|Adverse Event|70|||
125102151|NCT00242567|449995461|FG001|Overall Study|Adverse Event|43|||
125102152|NCT00242567|449995460|FG000|Overall Study|Disease Progression|17|||
125102153|NCT00242567|449995461|FG001|Overall Study|Disease Progression|22|||
125102154|NCT00242567|449995460|FG000|Overall Study|Symptomatic deterioration|9|||
125102155|NCT00242567|449995461|FG001|Overall Study|Symptomatic deterioration|3|||
125102156|NCT00242567|449995460|FG000|Overall Study|Lack of Efficacy|2|||
125102157|NCT00242567|449995461|FG001|Overall Study|Lack of Efficacy|2|||
125102158|NCT00242567|449995460|FG000|Overall Study|Lost to Follow-up|9|||
125102159|NCT00242567|449995461|FG001|Overall Study|Lost to Follow-up|19|||
125102160|NCT00242567|449995460|FG000|Overall Study|Withdrawal by Subject|33|||
125102161|NCT00242567|449995461|FG001|Overall Study|Withdrawal by Subject|28|||
125102162|NCT00242567|449995460|FG000|Overall Study|Protocol Violation|12|||
125102163|NCT00242567|449995461|FG001|Overall Study|Protocol Violation|12|||
125102164|NCT00242567|449995460|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
125102165|NCT00242567|449995461|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
125102166|NCT00242567|449995460|FG000|Overall Study|Other|14|||
125102167|NCT00242567|449995461|FG001|Overall Study|Other|9|||
125102168|NCT04930536|449995464|FG000|Overall Study|Adverse Event|1|||
125102169|NCT04930536|449995465|FG001|Overall Study|Adverse Event|0|||
125102170|NCT04930536|449995464|FG000|Overall Study|Disease Progression|2|||
125102171|NCT04930536|449995465|FG001|Overall Study|Disease Progression|0|||
125102172|NCT04930536|449995464|FG000|Overall Study|Patient Decision|4|||
125102173|NCT04930536|449995465|FG001|Overall Study|Patient Decision|2|||
125102174|NCT04930536|449995464|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
125102175|NCT04930536|449995465|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
125102176|NCT01432600|449995466|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
125102177|NCT01432600|449995467|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
125102178|NCT01432600|449995468|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
125102179|NCT03079869|449995477|FG000|Overall Study|Adverse Event|6|||
125102180|NCT03079869|449995478|FG001|Overall Study|Adverse Event|8|||
125102181|NCT03079869|449995477|FG000|Overall Study|Withdrawal by Subject|4|||
125102182|NCT03079869|449995478|FG001|Overall Study|Withdrawal by Subject|1|||
125102183|NCT03079869|449995477|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
125102184|NCT03079869|449995478|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
125102185|NCT02411110|449995479|FG000|Treatment Period 1|Adverse Event|4|||
125102186|NCT02411110|449995480|FG001|Treatment Period 1|Adverse Event|2|||
125102187|NCT02411110|449995479|FG000|Treatment Period 1|Lost to Follow-up|1|||
125102188|NCT02411110|449995480|FG001|Treatment Period 1|Lost to Follow-up|0|||
125102189|NCT02411110|449995479|FG000|Treatment Period 1|Personal Reasons|2|||
125102190|NCT02411110|449995480|FG001|Treatment Period 1|Personal Reasons|5|||
124878658|NCT02508532|449179288|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
124878659|NCT02508532|449179289|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
124878660|NCT02508532|449179281|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
124878661|NCT02508532|449179282|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
124878662|NCT02508532|449179283|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
124878663|NCT02508532|449179284|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
124878664|NCT02508532|449179285|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
124878665|NCT02508532|449179286|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
124878666|NCT02508532|449179287|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
124878667|NCT02508532|449179288|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
124878668|NCT02508532|449179289|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
124878669|NCT03097861|449179290|FG000|Overall Study|Adverse Event|3|||
124878670|NCT03097861|449179291|FG001|Overall Study|Adverse Event|8|||
124878671|NCT03097861|449179292|FG002|Overall Study|Adverse Event|4|||
124878672|NCT03097861|449179290|FG000|Overall Study|Investigator Decision|0|||
124878673|NCT03097861|449179291|FG001|Overall Study|Investigator Decision|1|||
124878674|NCT03097861|449179292|FG002|Overall Study|Investigator Decision|0|||
124878675|NCT03097861|449179290|FG000|Overall Study|Lost to Follow-up|0|||
124878676|NCT03097861|449179291|FG001|Overall Study|Lost to Follow-up|7|||
124878677|NCT03097861|449179292|FG002|Overall Study|Lost to Follow-up|1|||
124878678|NCT03097861|449179290|FG000|Overall Study|Withdrawal by Subject|1|||
124878679|NCT03097861|449179291|FG001|Overall Study|Withdrawal by Subject|5|||
124878680|NCT03097861|449179292|FG002|Overall Study|Withdrawal by Subject|3|||
124878681|NCT03097861|449179290|FG000|Overall Study|Reason not provided|3|||
124878682|NCT03097861|449179291|FG001|Overall Study|Reason not provided|1|||
124878683|NCT03097861|449179292|FG002|Overall Study|Reason not provided|1|||
124878684|NCT02281760|449179293|FG000|Overall Study|Withdrawal by Subject|1|||
124878685|NCT01576367|449179294|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124878686|NCT01576367|449179294|FG000|Overall Study|Moved to commercial use after 6 months|1|||
124878687|NCT00954733|449179298|FG000|Overall Study|blood gas machine did not work|1|||
124878688|NCT03592277|449179299|FG000|Overall Study|Withdrawal by Subject|6|||
124878689|NCT03592277|449179300|FG001|Overall Study|Withdrawal by Subject|8|||
124878690|NCT03528174|449179301|FG000|Overall Study|Adverse Event|1|||
124878691|NCT03528174|449179301|FG000|Overall Study|sensors dislodged|1|||
124878692|NCT03002038|449179302|FG000|Overall Study|Adverse Event|3|||
124878693|NCT03002038|449179303|FG001|Overall Study|Adverse Event|1|||
124878694|NCT03002038|449179302|FG000|Overall Study|Withdrawal by Subject|8|||
124878695|NCT03002038|449179303|FG001|Overall Study|Withdrawal by Subject|4|||
124878696|NCT03002038|449179302|FG000|Overall Study|Immigration to another region|0|||
124878697|NCT03002038|449179303|FG001|Overall Study|Immigration to another region|2|||
124878698|NCT01719237|449179311|FG000|Overall Study|Physician Decision|0|||
124878699|NCT01719237|449179312|FG001|Overall Study|Physician Decision|1|||
124878700|NCT02712398|449179313|FG000|Overall Study|Withdrawal by Subject|6|||
124878701|NCT02712398|449179313|FG000|Overall Study|Lost to Follow-up|6|||
124878702|NCT02712398|449179313|FG000|Overall Study|Sponsor Decision|1|||
124878703|NCT02712398|449179313|FG000|Overall Study|Physician Decision|1|||
124878704|NCT02712398|449179313|FG000|Overall Study|Death|2|||
124878705|NCT02712398|449179313|FG000|Overall Study|Re-operation|21|||
124878706|NCT01725386|449179315|FG000|Overall Study|Death|84|||
124878707|NCT01725386|449179316|FG001|Overall Study|Death|40|||
124878708|NCT01725386|449179315|FG000|Overall Study|Lost to Follow-up|81|||
124878709|NCT01725386|449179316|FG001|Overall Study|Lost to Follow-up|6|||
124878710|NCT01725386|449179315|FG000|Overall Study|Withdrawal by Subject|10|||
124878711|NCT01725386|449179316|FG001|Overall Study|Withdrawal by Subject|0|||
124878712|NCT03812536|449179321|FG000|Overall Study|Protocol Violation|2|||
124878713|NCT03812536|449179322|FG001|Overall Study|Protocol Violation|0|||
124878714|NCT03812536|449179321|FG000|Overall Study|Withdrawal by Subject|1|||
124878715|NCT03812536|449179322|FG001|Overall Study|Withdrawal by Subject|1|||
124878716|NCT02914314|449179323|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
125013268|NCT00705783|449674814|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
125013269|NCT00705783|449674815|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
125013270|NCT00705783|449674813|FG000|Depot Stabilization Phase|Adverse Event|17|||
125013271|NCT00705783|449674814|FG001|Depot Stabilization Phase|Adverse Event|0|||
125013272|NCT00705783|449674815|FG002|Depot Stabilization Phase|Adverse Event|0|||
125013273|NCT00705783|449674813|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
125013274|NCT00705783|449674814|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
125013275|NCT00705783|449674815|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
125013276|NCT00705783|449674813|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
125013277|NCT00705783|449674814|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
125013278|NCT00705783|449674815|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
125013279|NCT00705783|449674813|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
124878717|NCT02914314|449179324|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
124878718|NCT02914314|449179325|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
124878719|NCT02914314|449179326|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
125102191|NCT02411110|449995479|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
125102192|NCT02411110|449995480|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
125102193|NCT02411110|449995479|FG000|Treatment Period 2|Adverse Event|1|||
125102194|NCT02411110|449995480|FG001|Treatment Period 2|Adverse Event|0|||
125102195|NCT02411110|449995479|FG000|Treatment Period 2|Lost to Follow-up|0|||
125102196|NCT02411110|449995480|FG001|Treatment Period 2|Lost to Follow-up|2|||
125102197|NCT02411110|449995479|FG000|Treatment Period 2|Personal Reasons|0|||
125102198|NCT02411110|449995480|FG001|Treatment Period 2|Personal Reasons|2|||
125102199|NCT03292731|449995481|FG000|Overall Study|Protocol Violation|4|||
125102200|NCT03292731|449995482|FG001|Overall Study|Protocol Violation|11|||
125102201|NCT03292731|449995483|FG002|Overall Study|Protocol Violation|1|||
125102202|NCT03901352|449995487|FG000|Double-blind Phase|Adverse Event|6|||
125102203|NCT03901352|449995488|FG001|Double-blind Phase|Adverse Event|4|||
125102204|NCT03901352|449995487|FG000|Double-blind Phase|Death|1|||
125102205|NCT03901352|449995488|FG001|Double-blind Phase|Death|0|||
125102206|NCT03901352|449995487|FG000|Double-blind Phase|Lack of Efficacy|0|||
125102207|NCT03901352|449995488|FG001|Double-blind Phase|Lack of Efficacy|1|||
125102208|NCT03901352|449995487|FG000|Double-blind Phase|Protocol Violation|0|||
125102209|NCT03901352|449995488|FG001|Double-blind Phase|Protocol Violation|1|||
125102210|NCT03901352|449995487|FG000|Double-blind Phase|Withdrawal by Subject|10|||
125102211|NCT03901352|449995488|FG001|Double-blind Phase|Withdrawal by Subject|8|||
125102212|NCT03901352|449995487|FG000|Open-label Extension Phase|Adverse Event|24|||
125102213|NCT03901352|449995488|FG001|Open-label Extension Phase|Adverse Event|0|||
125102214|NCT03901352|449995487|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
125102215|NCT03901352|449995488|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
125102216|NCT03901352|449995487|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
125102217|NCT03901352|449995488|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
125102218|NCT03901352|449995487|FG000|Open-label Extension Phase|Other|1|||
125102219|NCT03901352|449995488|FG001|Open-label Extension Phase|Other|0|||
125102220|NCT02871921|449995493|FG000|Overall Study|Withdrawal by Subject|34|||
125102221|NCT02871921|449995494|FG001|Overall Study|Withdrawal by Subject|27|||
125102222|NCT02871921|449995495|FG002|Overall Study|Withdrawal by Subject|27|||
125102223|NCT02871921|449995496|FG003|Overall Study|Withdrawal by Subject|30|||
125102224|NCT00824993|449995506|FG000|Overall Study|Withdrawal by Subject|1|||
125102225|NCT00824993|449995507|FG001|Overall Study|Withdrawal by Subject|1|||
125102226|NCT00824993|449995506|FG000|Overall Study|Malignancy Relapse|9|||
125102227|NCT00824993|449995507|FG001|Overall Study|Malignancy Relapse|10|||
125102228|NCT00824993|449995506|FG000|Overall Study|Rapid Bone Loss|0|||
125102229|NCT00824993|449995507|FG001|Overall Study|Rapid Bone Loss|1|||
125102230|NCT00824993|449995506|FG000|Overall Study|Non-Compliant|2|||
125102231|NCT00824993|449995507|FG001|Overall Study|Non-Compliant|1|||
125102232|NCT00824993|449995506|FG000|Overall Study|Insurance Issue|2|||
125102233|NCT00824993|449995507|FG001|Overall Study|Insurance Issue|1|||
125102234|NCT00824993|449995506|FG000|Overall Study|Death|0|||
125102235|NCT00824993|449995507|FG001|Overall Study|Death|3|||
125102236|NCT02596009|449995508|FG000|Overall Study|Administrative problems|0|||
125102237|NCT02596009|449995509|FG001|Overall Study|Administrative problems|1|||
125102238|NCT02596009|449995510|FG002|Overall Study|Administrative problems|0|||
124878720|NCT02914314|449179323|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
125013280|NCT00705783|449674814|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
125013281|NCT00705783|449674815|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
125013282|NCT00705783|449674813|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
125013283|NCT00705783|449674814|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
125013284|NCT00705783|449674815|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
125013285|NCT00705783|449674813|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
125013286|NCT00705783|449674814|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
125013287|NCT00705783|449674815|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
125013288|NCT00705783|449674813|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
125013289|NCT00705783|449674814|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
125102239|NCT02596009|449995511|FG003|Overall Study|Administrative problems|0|||
125102240|NCT02596009|449995512|FG004|Overall Study|Administrative problems|0|||
125102241|NCT02596009|449995513|FG005|Overall Study|Administrative problems|0|||
124878721|NCT02914314|449179324|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
124878722|NCT02914314|449179325|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
124878723|NCT02914314|449179326|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
124878724|NCT02914314|449179323|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
124878725|NCT02914314|449179324|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
124878726|NCT02914314|449179325|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
124878727|NCT02914314|449179326|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
124878728|NCT02914314|449179323|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
124878729|NCT02914314|449179324|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
124878730|NCT02914314|449179325|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
124878731|NCT02914314|449179326|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
124878732|NCT02914314|449179323|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
124878733|NCT02914314|449179324|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
124878734|NCT02914314|449179325|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
124878735|NCT02914314|449179326|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
124878736|NCT01306201|449179329|FG000|Overall Study|Arrhythmia|4|||
124878737|NCT01306201|449179329|FG000|Overall Study|Files could not be processed|3|||
124878738|NCT01306201|449179329|FG000|Overall Study|Files unreadable|3|||
124878739|NCT04702568|449179330|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
124878740|NCT04702568|449179331|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
124878741|NCT04702568|449179330|FG000|Overall Study|Pregnancy|1|||
124878742|NCT04702568|449179331|FG001|Overall Study|Pregnancy|0|||
124878743|NCT04702568|449179330|FG000|Overall Study|Bone marrow transplant|1|||
124878744|NCT04702568|449179331|FG001|Overall Study|Bone marrow transplant|0|||
124878745|NCT04702568|449179330|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
124878746|NCT04702568|449179331|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
124878747|NCT04702568|449179330|FG000|Overall Study|Withdrawal by Subject|0|||
124878748|NCT04702568|449179331|FG001|Overall Study|Withdrawal by Subject|2|||
124878749|NCT04599101|449179336|FG000|Overall Study|Lost to Follow-up|5|||
124878750|NCT04599101|449179337|FG001|Overall Study|Lost to Follow-up|5|||
124878751|NCT00098254|449179340|FG000|Overall Study|Adverse Event|2|||
124878752|NCT00098254|449179340|FG000|Overall Study|Death|1|||
124878753|NCT04146896|449179341|FG000|Overall Study|Adverse Event|5|||
124878754|NCT04146896|449179342|FG001|Overall Study|Adverse Event|8|||
124878755|NCT04146896|449179341|FG000|Overall Study|Lack of Efficacy|3|||
124878756|NCT04146896|449179342|FG001|Overall Study|Lack of Efficacy|2|||
124878757|NCT04146896|449179341|FG000|Overall Study|Lost to Follow-up|0|||
124878758|NCT04146896|449179342|FG001|Overall Study|Lost to Follow-up|1|||
124878759|NCT04146896|449179341|FG000|Overall Study|Non-compliance|5|||
124878760|NCT04146896|449179342|FG001|Overall Study|Non-compliance|4|||
124878761|NCT04146896|449179341|FG000|Overall Study|Withdrawal by Subject|3|||
124878762|NCT04146896|449179342|FG001|Overall Study|Withdrawal by Subject|5|||
124878763|NCT04146896|449179341|FG000|Overall Study|Randomized in error|1|||
124878764|NCT04146896|449179342|FG001|Overall Study|Randomized in error|2|||
124878765|NCT02118337|449179343|FG000|Overall Study|Other|1|||
124878766|NCT02118337|449179344|FG001|Overall Study|Other|0|||
124878767|NCT02118337|449179345|FG002|Overall Study|Other|0|||
124878768|NCT02118337|449179346|FG003|Overall Study|Other|0|||
124878769|NCT02118337|449179347|FG004|Overall Study|Other|2|||
124878770|NCT02118337|449179348|FG005|Overall Study|Other|3|||
124878771|NCT02118337|449179349|FG006|Overall Study|Other|1|||
124878772|NCT02118337|449179350|FG007|Overall Study|Other|28|||
124878773|NCT02118337|449179351|FG008|Overall Study|Other|15|||
124878774|NCT02118337|449179343|FG000|Overall Study|Lost to Follow-up|0|||
125102242|NCT02998645|449995514|FG000|Treatment Period 1|Adverse Event|6|||
125102243|NCT02998645|449995514|FG000|Treatment Period 1|Death|5|||
125102244|NCT02998645|449995514|FG000|Treatment Period 1|Technical Problems|4|||
125102245|NCT02998645|449995514|FG000|Treatment Period 1|Lack of Efficacy|2|||
124878775|NCT02118337|449179344|FG001|Overall Study|Lost to Follow-up|0|||
124878776|NCT02118337|449179345|FG002|Overall Study|Lost to Follow-up|0|||
124878777|NCT02118337|449179346|FG003|Overall Study|Lost to Follow-up|0|||
124878778|NCT02118337|449179347|FG004|Overall Study|Lost to Follow-up|0|||
124878779|NCT02118337|449179348|FG005|Overall Study|Lost to Follow-up|0|||
124878780|NCT02118337|449179349|FG006|Overall Study|Lost to Follow-up|0|||
124878781|NCT02118337|449179350|FG007|Overall Study|Lost to Follow-up|1|||
124878782|NCT02118337|449179351|FG008|Overall Study|Lost to Follow-up|0|||
124878783|NCT02118337|449179343|FG000|Overall Study|Withdrawal by Subject|1|||
124878784|NCT02118337|449179344|FG001|Overall Study|Withdrawal by Subject|3|||
125102246|NCT02998645|449995514|FG000|Treatment Period 1|Progressive disease|1|||
124878785|NCT02118337|449179345|FG002|Overall Study|Withdrawal by Subject|2|||
124878786|NCT02118337|449179346|FG003|Overall Study|Withdrawal by Subject|1|||
124878787|NCT02118337|449179347|FG004|Overall Study|Withdrawal by Subject|2|||
124878788|NCT02118337|449179348|FG005|Overall Study|Withdrawal by Subject|2|||
124878789|NCT02118337|449179349|FG006|Overall Study|Withdrawal by Subject|1|||
124878790|NCT02118337|449179350|FG007|Overall Study|Withdrawal by Subject|4|||
124878791|NCT02118337|449179351|FG008|Overall Study|Withdrawal by Subject|2|||
125013290|NCT00705783|449674815|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
125013291|NCT00705783|449674813|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
125013292|NCT00705783|449674814|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
125013293|NCT00705783|449674815|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
125013294|NCT00705783|449674813|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
125013295|NCT00705783|449674814|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
125013296|NCT00705783|449674815|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
125013297|NCT00705783|449674813|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
125013298|NCT00705783|449674814|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
125013299|NCT00705783|449674815|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
125013300|NCT00705783|449674813|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
125013301|NCT00705783|449674814|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
125013302|NCT00705783|449674815|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
125013303|NCT00705783|449674813|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
125013304|NCT00705783|449674814|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
125013305|NCT00705783|449674815|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
125013306|NCT03029143|449674821|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
124878792|NCT02118337|449179343|FG000|Overall Study|Death|2|||
124878793|NCT02118337|449179344|FG001|Overall Study|Death|2|||
124878794|NCT02118337|449179345|FG002|Overall Study|Death|1|||
124878795|NCT02118337|449179346|FG003|Overall Study|Death|2|||
124878796|NCT02118337|449179347|FG004|Overall Study|Death|5|||
124878797|NCT02118337|449179348|FG005|Overall Study|Death|1|||
124878798|NCT02118337|449179349|FG006|Overall Study|Death|2|||
124878799|NCT02118337|449179350|FG007|Overall Study|Death|9|||
124878800|NCT02118337|449179351|FG008|Overall Study|Death|4|||
124878801|NCT01515189|449179353|FG000|Induction|Disease Progression|109|||
124878802|NCT01515189|449179354|FG001|Induction|Disease Progression|155|||
124878803|NCT01515189|449179353|FG000|Induction|Study drug toxicity|86|||
124878804|NCT01515189|449179354|FG001|Induction|Study drug toxicity|36|||
124878805|NCT01515189|449179353|FG000|Induction|Death|24|||
124878806|NCT01515189|449179354|FG001|Induction|Death|17|||
124878807|NCT01515189|449179353|FG000|Induction|Adverse Event|14|||
124878808|NCT01515189|449179354|FG001|Induction|Adverse Event|9|||
124878809|NCT01515189|449179353|FG000|Induction|Withdrawal by Subject|3|||
124878810|NCT01515189|449179354|FG001|Induction|Withdrawal by Subject|9|||
124878811|NCT01515189|449179353|FG000|Induction|No longer meets study criteria|0|||
124878812|NCT01515189|449179354|FG001|Induction|No longer meets study criteria|2|||
124878813|NCT01515189|449179353|FG000|Induction|Lost to Follow-up|1|||
124878814|NCT01515189|449179354|FG001|Induction|Lost to Follow-up|0|||
124878815|NCT01515189|449179353|FG000|Induction|Other|0|||
124878816|NCT01515189|449179354|FG001|Induction|Other|4|||
124878817|NCT01515189|449179353|FG000|First Re-Induction Phase|Disease progression|6|||
124878818|NCT01515189|449179354|FG001|First Re-Induction Phase|Disease progression|14|||
124878819|NCT01515189|449179353|FG000|First Re-Induction Phase|Study drug toxicity|5|||
124878820|NCT01515189|449179354|FG001|First Re-Induction Phase|Study drug toxicity|0|||
124878821|NCT01515189|449179353|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
124878822|NCT01515189|449179354|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
124878823|NCT01515189|449179353|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
124878824|NCT01515189|449179354|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
124878825|NCT01515189|449179353|FG000|First Re-Induction Phase|Other|1|||
124878826|NCT01515189|449179354|FG001|First Re-Induction Phase|Other|0|||
124878827|NCT01126060|449179355|FG000|Overall Study|Protocol Violation|0|||
124878828|NCT01126060|449179356|FG001|Overall Study|Protocol Violation|2|||
124878829|NCT04838613|449179358|FG000|Overall Study|Withdrawal by Subject|3|||
124878830|NCT04838613|449179359|FG001|Overall Study|Withdrawal by Subject|6|||
124878831|NCT04838613|449179358|FG000|Overall Study|Protocol Deviation|3|||
124878832|NCT04838613|449179359|FG001|Overall Study|Protocol Deviation|2|||
124878833|NCT04838613|449179358|FG000|Overall Study|Technical Problems|0|||
124878834|NCT04838613|449179359|FG001|Overall Study|Technical Problems|5|||
124878835|NCT04838613|449179358|FG000|Overall Study|Physician Decision|2|||
124878836|NCT04838613|449179359|FG001|Overall Study|Physician Decision|0|||
124878837|NCT01686581|449179360|FG000|Overall Study|Side-effects or Health Problems|15|||
124878838|NCT01686581|449179360|FG000|Overall Study|Lack of Efficacy|90|||
124878839|NCT01686581|449179360|FG000|Overall Study|Participant Concerned about Risks|6|||
124878840|NCT01686581|449179360|FG000|Overall Study|Thinks Injections Too Painful|8|||
124878841|NCT01686581|449179360|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
124878842|NCT01686581|449179360|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
124878843|NCT01686581|449179360|FG000|Overall Study|Thinks it is Inconvenient|17|||
124878844|NCT01686581|449179360|FG000|Overall Study|Other Miscellaneous Reasons|36|||
125013307|NCT03029143|449674822|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
125013308|NCT03029143|449674823|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
125013309|NCT03029143|449674821|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
125013310|NCT03029143|449674822|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
125013311|NCT03029143|449674823|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
125013312|NCT03029143|449674821|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
125013313|NCT03029143|449674822|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
125013314|NCT03029143|449674823|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
125013315|NCT03029143|449674821|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
125013316|NCT03029143|449674822|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
125013317|NCT03029143|449674823|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
124878845|NCT01686581|449179360|FG000|Overall Study|Reason Missing|1|||
125013318|NCT03029143|449674821|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
125013319|NCT03029143|449674822|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
125013320|NCT03029143|449674823|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
124878846|NCT02217280|449179363|FG000|Overall Study|Withdrawal by Subject|2|||
124878847|NCT02217280|449179363|FG000|Overall Study|Post-consent sceen fail|2|||
124878848|NCT00736489|449179366|FG000|Period 1|Lost to Follow-up|1|||
124878849|NCT00736489|449179367|FG001|Period 1|Lost to Follow-up|0|||
124878850|NCT00736489|449179368|FG002|Period 1|Lost to Follow-up|0|||
124878851|NCT00736489|449179369|FG003|Period 1|Lost to Follow-up|0|||
124878852|NCT00736489|449179370|FG004|Period 1|Lost to Follow-up|0|||
124878853|NCT00736489|449179371|FG005|Period 1|Lost to Follow-up|0|||
124878854|NCT00736489|449179366|FG000|Period 1|Withdrawal by Subject|0|||
124878855|NCT00736489|449179367|FG001|Period 1|Withdrawal by Subject|0|||
124878856|NCT00736489|449179368|FG002|Period 1|Withdrawal by Subject|0|||
124878857|NCT00736489|449179369|FG003|Period 1|Withdrawal by Subject|0|||
124878858|NCT00736489|449179370|FG004|Period 1|Withdrawal by Subject|0|||
124878859|NCT00736489|449179371|FG005|Period 1|Withdrawal by Subject|1|||
124878860|NCT01933880|449179372|FG000|Overall Study|Withdrawal by Subject|5|||
124878861|NCT01933880|449179373|FG001|Overall Study|Withdrawal by Subject|0|||
124878862|NCT01933880|449179372|FG000|Overall Study|Lack of Efficacy|1|||
124878863|NCT01933880|449179373|FG001|Overall Study|Lack of Efficacy|0|||
124878864|NCT01933880|449179372|FG000|Overall Study|Concomitant medication Interference|0|||
124878865|NCT01933880|449179373|FG001|Overall Study|Concomitant medication Interference|1|||
124878866|NCT01933880|449179372|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
124878867|NCT01933880|449179373|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
124878868|NCT01933880|449179372|FG000|Overall Study|Other|4|||
124878869|NCT01933880|449179373|FG001|Overall Study|Other|0|||
124878870|NCT01933880|449179372|FG000|Overall Study|Protocol Violation|1|||
124878871|NCT01933880|449179373|FG001|Overall Study|Protocol Violation|0|||
124878872|NCT02395133|449179374|FG000|Overall Study|Adverse Event|4|||
124878873|NCT02395133|449179375|FG001|Overall Study|Adverse Event|1|||
124878874|NCT02395133|449179376|FG002|Overall Study|Adverse Event|3|||
124878875|NCT02395133|449179377|FG003|Overall Study|Adverse Event|0|||
124878876|NCT02395133|449179374|FG000|Overall Study|Lack of Efficacy|1|||
124878877|NCT02395133|449179375|FG001|Overall Study|Lack of Efficacy|0|||
124878878|NCT02395133|449179376|FG002|Overall Study|Lack of Efficacy|1|||
124878879|NCT02395133|449179377|FG003|Overall Study|Lack of Efficacy|1|||
124878880|NCT02395133|449179374|FG000|Overall Study|Protocol Violation|1|||
124878881|NCT02395133|449179375|FG001|Overall Study|Protocol Violation|1|||
124878882|NCT02395133|449179376|FG002|Overall Study|Protocol Violation|0|||
124878883|NCT02395133|449179377|FG003|Overall Study|Protocol Violation|3|||
124878884|NCT02395133|449179374|FG000|Overall Study|Lost to Follow-up|0|||
124878885|NCT02395133|449179375|FG001|Overall Study|Lost to Follow-up|1|||
124878886|NCT02395133|449179376|FG002|Overall Study|Lost to Follow-up|1|||
124878887|NCT02395133|449179377|FG003|Overall Study|Lost to Follow-up|0|||
124878888|NCT02395133|449179374|FG000|Overall Study|Pregnancy|0|||
124878889|NCT02395133|449179375|FG001|Overall Study|Pregnancy|0|||
124878890|NCT02395133|449179376|FG002|Overall Study|Pregnancy|3|||
124878891|NCT02395133|449179377|FG003|Overall Study|Pregnancy|0|||
124878892|NCT02395133|449179374|FG000|Overall Study|Consent withdrawn with no reason given|1|||
124878893|NCT02395133|449179375|FG001|Overall Study|Consent withdrawn with no reason given|3|||
124878894|NCT02395133|449179376|FG002|Overall Study|Consent withdrawn with no reason given|0|||
124878895|NCT02395133|449179377|FG003|Overall Study|Consent withdrawn with no reason given|2|||
124878896|NCT02395133|449179374|FG000|Overall Study|Consent withdrawn with personal reason|0|||
124878897|NCT02395133|449179375|FG001|Overall Study|Consent withdrawn with personal reason|1|||
124878898|NCT02395133|449179376|FG002|Overall Study|Consent withdrawn with personal reason|0|||
124878899|NCT02395133|449179377|FG003|Overall Study|Consent withdrawn with personal reason|3|||
124878900|NCT02395133|449179374|FG000|Overall Study|Sponsor decision|2|||
124878901|NCT02395133|449179375|FG001|Overall Study|Sponsor decision|0|||
124878902|NCT02395133|449179376|FG002|Overall Study|Sponsor decision|0|||
124878903|NCT02395133|449179377|FG003|Overall Study|Sponsor decision|1|||
124878904|NCT02395133|449179374|FG000|Overall Study|Other than specified above|5|||
124878905|NCT02395133|449179375|FG001|Overall Study|Other than specified above|2|||
124878906|NCT02395133|449179376|FG002|Overall Study|Other than specified above|2|||
124878907|NCT02395133|449179377|FG003|Overall Study|Other than specified above|4|||
124878908|NCT00962247|449179378|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
124878909|NCT00962247|449179378|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
125013321|NCT03029143|449674821|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
125013322|NCT03029143|449674822|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
125013323|NCT03029143|449674823|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
125013324|NCT03029143|449674821|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
125013325|NCT03029143|449674822|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
125013326|NCT03029143|449674823|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
125013327|NCT03029143|449674821|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125013328|NCT03029143|449674822|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
125013329|NCT03029143|449674823|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
125013330|NCT03029143|449674821|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
125013331|NCT03029143|449674822|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
125013332|NCT03029143|449674823|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
124878910|NCT02234063|449179379|FG000|Overall Study|Lost to Follow-up|235|||
124878911|NCT02234063|449179380|FG001|Overall Study|Lost to Follow-up|42|||
124878912|NCT02234063|449179379|FG000|Overall Study|Withdrawal by Subject|20|||
124878913|NCT02234063|449179380|FG001|Overall Study|Withdrawal by Subject|1|||
124878914|NCT02946918|449179381|FG000|Overall Study|Patient unblinded himself|1|||
124878915|NCT02946918|449179382|FG001|Overall Study|Patient unblinded himself|0|||
124878916|NCT02946918|449179381|FG000|Overall Study|Physician Decision|0|||
125013333|NCT03029143|449674821|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
125013334|NCT03029143|449674822|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
124878917|NCT02946918|449179382|FG001|Overall Study|Physician Decision|2|||
124878918|NCT02946918|449179381|FG000|Overall Study|Ran out of study medication|0|||
124878919|NCT02946918|449179382|FG001|Overall Study|Ran out of study medication|1|||
124878920|NCT01125722|449179383|FG000|Overall Study|Withdrawal by Subject|2|||
124878921|NCT01125722|449179384|FG001|Overall Study|Withdrawal by Subject|1|||
124878922|NCT01125722|449179383|FG000|Overall Study|Lost to Follow-up|1|||
124878923|NCT01125722|449179384|FG001|Overall Study|Lost to Follow-up|0|||
124878924|NCT00069784|449179385|FG000|Overall Study|Adverse Event|105|||
124878925|NCT00069784|449179386|FG001|Overall Study|Adverse Event|0|||
124878926|NCT00069784|449179385|FG000|Overall Study|Withdrawal by Subject|1090|||
124878927|NCT00069784|449179386|FG001|Overall Study|Withdrawal by Subject|0|||
124878928|NCT00069784|449179385|FG000|Overall Study|Other|17|||
124878929|NCT00069784|449179386|FG001|Overall Study|Other|0|||
124878930|NCT00709059|449179394|FG000|Overall Study|Lost to Follow-up|34|||
124878931|NCT00709059|449179394|FG000|Overall Study|Withdrawal by Subject|19|||
124878932|NCT00709059|449179394|FG000|Overall Study|Physician Decision|7|||
124878933|NCT00709059|449179394|FG000|Overall Study|Disease complication|3|||
124878934|NCT00709059|449179394|FG000|Overall Study|Side effects|20|||
124878935|NCT00709059|449179394|FG000|Overall Study|Serious side effects|11|||
124878936|NCT01786330|449179395|FG000|Overall Study|Withdrawal by Subject|0|||
124878937|NCT01786330|449179396|FG001|Overall Study|Withdrawal by Subject|1|||
124878938|NCT01786330|449179395|FG000|Overall Study|Lost to Follow-up|0|||
124878939|NCT01786330|449179396|FG001|Overall Study|Lost to Follow-up|1|||
124878940|NCT01786330|449179395|FG000|Overall Study|Excluded intraoperatively|0|||
124878941|NCT01786330|449179396|FG001|Overall Study|Excluded intraoperatively|1|||
124878942|NCT01786330|449179395|FG000|Overall Study|Protocol Violation|1|||
124878943|NCT01786330|449179396|FG001|Overall Study|Protocol Violation|0|||
124878944|NCT02172625|449179397|FG000|Overall Study|Adverse Event|0|||
124878945|NCT02172625|449179398|FG001|Overall Study|Adverse Event|1|||
124878946|NCT02172625|449179397|FG000|Overall Study|Pregnancy|0|||
124878947|NCT02172625|449179398|FG001|Overall Study|Pregnancy|1|||
124878948|NCT02172625|449179397|FG000|Overall Study|car accident|0|||
124878949|NCT02172625|449179398|FG001|Overall Study|car accident|1|||
124878950|NCT00976703|449180940|FG000|Overall Study|Physician Decision|1|||
124878951|NCT00976703|449180941|FG001|Overall Study|Physician Decision|1|||
124878952|NCT00976703|449180940|FG000|Overall Study|ineligible for study|2|||
124878953|NCT00976703|449180941|FG001|Overall Study|ineligible for study|2|||
124878954|NCT00369681|449180944|FG000|Overall Study|Death|1|||
124878955|NCT03585296|449180948|FG000|Overall Study|Adverse Event|1|||
124878956|NCT03585296|449180948|FG000|Overall Study|Lost to Follow-up|2|||
124878957|NCT03585296|449180948|FG000|Overall Study|Withdrawal by Subject|2|||
124878958|NCT00462670|449180952|FG000|Overall Study|Adverse Event|3|||
124878959|NCT00462670|449180953|FG001|Overall Study|Adverse Event|5|||
124878960|NCT00462670|449180952|FG000|Overall Study|Lack of Efficacy|1|||
124878961|NCT00462670|449180953|FG001|Overall Study|Lack of Efficacy|0|||
125013335|NCT03029143|449674823|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
125013336|NCT03029143|449674821|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
125013337|NCT03029143|449674822|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
125013338|NCT03029143|449674823|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
125013339|NCT00974675|449674824|FG000|Overall Study|Adverse Event|2|||
125013340|NCT00974675|449674825|FG001|Overall Study|Adverse Event|1|||
125013341|NCT00974675|449674826|FG002|Overall Study|Adverse Event|1|||
125013342|NCT00974675|449674827|FG003|Overall Study|Adverse Event|1|||
125013343|NCT00974675|449674824|FG000|Overall Study|Physician Decision|0|||
125013344|NCT00974675|449674825|FG001|Overall Study|Physician Decision|0|||
125013345|NCT00974675|449674826|FG002|Overall Study|Physician Decision|1|||
125013346|NCT00974675|449674827|FG003|Overall Study|Physician Decision|0|||
125013347|NCT00974675|449674824|FG000|Overall Study|Participant on holiday; unable to attend|0|||
125102247|NCT02998645|449995514|FG000|Treatment Period 1|Subject/guardian decision|1|||
125102248|NCT02998645|449995514|FG000|Treatment Period 2|Lack of Efficacy|5|||
124878962|NCT00462670|449180952|FG000|Overall Study|Protocol Violation|1|||
124878963|NCT00462670|449180953|FG001|Overall Study|Protocol Violation|0|||
124878964|NCT00462670|449180952|FG000|Overall Study|Resolution of signs and symptoms|0|||
124878965|NCT00462670|449180953|FG001|Overall Study|Resolution of signs and symptoms|2|||
124878966|NCT00633932|449180954|FG000|Overall Study|Adverse Event|1|||
124878967|NCT00633932|449180955|FG001|Overall Study|Adverse Event|3|||
124878968|NCT00633932|449180956|FG002|Overall Study|Adverse Event|4|||
125013348|NCT00974675|449674825|FG001|Overall Study|Participant on holiday; unable to attend|0|||
124878969|NCT00633932|449180954|FG000|Overall Study|Withdrawal by Subject|3|||
124878970|NCT00633932|449180955|FG001|Overall Study|Withdrawal by Subject|9|||
124878971|NCT00633932|449180956|FG002|Overall Study|Withdrawal by Subject|1|||
124878972|NCT00633932|449180954|FG000|Overall Study|Lost to Follow-up|1|||
124878973|NCT00633932|449180955|FG001|Overall Study|Lost to Follow-up|0|||
124878974|NCT00633932|449180956|FG002|Overall Study|Lost to Follow-up|2|||
124878975|NCT00633932|449180954|FG000|Overall Study|Protocol Violation|5|||
124878976|NCT00633932|449180955|FG001|Overall Study|Protocol Violation|2|||
124878977|NCT00633932|449180956|FG002|Overall Study|Protocol Violation|3|||
124878978|NCT00633932|449180954|FG000|Overall Study|Physician Decision|0|||
124878979|NCT00633932|449180955|FG001|Overall Study|Physician Decision|0|||
124878980|NCT00633932|449180956|FG002|Overall Study|Physician Decision|1|||
124878981|NCT00633932|449180954|FG000|Overall Study|Doctor's judgement|1|||
124878982|NCT00633932|449180955|FG001|Overall Study|Doctor's judgement|0|||
124878983|NCT00633932|449180956|FG002|Overall Study|Doctor's judgement|0|||
124878984|NCT00633932|449180954|FG000|Overall Study|Moved Away|1|||
124878985|NCT00633932|449180955|FG001|Overall Study|Moved Away|0|||
124878986|NCT00633932|449180956|FG002|Overall Study|Moved Away|0|||
124878987|NCT00482274|449180958|FG000|Overall Study|Adverse Event|1|||
124878988|NCT02948959|449180959|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
124878989|NCT02948959|449180960|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
124878990|NCT02948959|449180959|FG000|52 Weeks Treatment Period|Adverse Event|2|||
124878991|NCT02948959|449180960|FG001|52 Weeks Treatment Period|Adverse Event|5|||
124878992|NCT02948959|449180959|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
124878993|NCT02948959|449180960|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
124878994|NCT02948959|449180959|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
124878995|NCT02948959|449180960|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
124878996|NCT02948959|449180959|FG000|52 Weeks Treatment Period|Randomized by error|0|||
124878997|NCT02948959|449180960|FG001|52 Weeks Treatment Period|Randomized by error|5|||
124878998|NCT02948959|449180959|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
124878999|NCT02948959|449180960|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
124879000|NCT02948959|449180959|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
124879001|NCT02948959|449180960|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
124879002|NCT02948959|449180959|FG000|52 Weeks Treatment Period|Change of residence location|0|||
124879003|NCT02948959|449180960|FG001|52 Weeks Treatment Period|Change of residence location|1|||
124879004|NCT02948959|449180959|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
124879005|NCT02948959|449180960|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
124879006|NCT02948959|449180959|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
125102249|NCT02998645|449995514|FG000|Treatment Period 2|Adverse Event|2|||
125102250|NCT02998645|449995514|FG000|Treatment Period 2|Progressive disease|2|||
125102251|NCT02998645|449995514|FG000|Treatment Period 2|Physician Decision|1|||
125102252|NCT04611152|449995518|FG000|Overall Study|Adverse Event|9|||
125102253|NCT04611152|449995519|FG001|Overall Study|Adverse Event|8|||
125102254|NCT04611152|449995518|FG000|Overall Study|Non-compliance with study schedule|1|||
125102255|NCT04611152|449995519|FG001|Overall Study|Non-compliance with study schedule|3|||
125102256|NCT04611152|449995518|FG000|Overall Study|Withdrawal by Subject|5|||
125102257|NCT04611152|449995519|FG001|Overall Study|Withdrawal by Subject|6|||
125102258|NCT04611152|449995518|FG000|Overall Study|Lost to Follow-up|11|||
125102259|NCT04611152|449995519|FG001|Overall Study|Lost to Follow-up|2|||
125102260|NCT03644927|449995520|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
125102261|NCT03644927|449995521|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
125102262|NCT00956813|449995522|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
125102263|NCT00956813|449995523|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
125102264|NCT00956813|449995522|FG000|Flaxseed and Placebo|Ineligible|3|||
125102265|NCT00956813|449995523|FG001|Flaxseed and Placebo|Ineligible|1|||
125102266|NCT01275170|449995528|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
125102267|NCT01275170|449995529|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
125102268|NCT01275170|449995530|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
125102269|NCT01275170|449995531|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
125102270|NCT01275170|449995532|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
125102271|NCT01275170|449995533|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
125102272|NCT01275170|449995534|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
125102273|NCT01275170|449995535|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
125102274|NCT02864953|449995536|FG000|Overall Study|Adverse Event|22|||
124879007|NCT02948959|449180960|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
124879008|NCT02948959|449180959|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
124879009|NCT02948959|449180960|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
124879010|NCT02948959|449180959|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
124879011|NCT02948959|449180960|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
124879012|NCT02948959|449180959|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
124879013|NCT02948959|449180960|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
124879014|NCT02948959|449180959|FG000|12 Weeks Follow-up Period|Study site closure|1|||
124879015|NCT02948959|449180960|FG001|12 Weeks Follow-up Period|Study site closure|0|||
124879016|NCT00154310|449180965|FG000|Overall Study|Adverse Event|19|||
124879017|NCT00154310|449180966|FG001|Overall Study|Adverse Event|9|||
125210765|NCT02240069|450395676|FG002|Overall Study|Withdrawal by Subject|2|||
124879018|NCT00154310|449180965|FG000|Overall Study|Lack of Efficacy|5|||
124879019|NCT00154310|449180966|FG001|Overall Study|Lack of Efficacy|4|||
124879020|NCT00154310|449180965|FG000|Overall Study|Protocol Violation|4|||
124879021|NCT00154310|449180966|FG001|Overall Study|Protocol Violation|2|||
124879022|NCT00154310|449180965|FG000|Overall Study|Withdrawal by Subject|9|||
124879023|NCT00154310|449180966|FG001|Overall Study|Withdrawal by Subject|3|||
124879024|NCT00154310|449180965|FG000|Overall Study|Lost to Follow-up|0|||
124879025|NCT00154310|449180966|FG001|Overall Study|Lost to Follow-up|8|||
124879026|NCT00154310|449180965|FG000|Overall Study|Administrative problems|0|||
124879027|NCT00154310|449180966|FG001|Overall Study|Administrative problems|1|||
124879028|NCT00154310|449180965|FG000|Overall Study|Death|0|||
124879029|NCT00154310|449180966|FG001|Overall Study|Death|1|||
124879030|NCT01346514|449180971|FG000|Overall Study|Lost to Follow-up|19|||
124879031|NCT01346514|449180972|FG001|Overall Study|Lost to Follow-up|30|||
124879032|NCT01346514|449180971|FG000|Overall Study|Withdrawal by Subject|7|||
124879033|NCT01346514|449180972|FG001|Overall Study|Withdrawal by Subject|3|||
124879034|NCT01346514|449180971|FG000|Overall Study|Death|3|||
124879035|NCT01346514|449180972|FG001|Overall Study|Death|4|||
124879036|NCT01054573|449180983|FG000|Overall Study|Adverse Event|1|||
124879037|NCT01054573|449180984|FG001|Overall Study|Adverse Event|0|||
124879038|NCT01054573|449180985|FG002|Overall Study|Adverse Event|1|||
124879039|NCT01054573|449180986|FG003|Overall Study|Adverse Event|1|||
124879040|NCT01054573|449180983|FG000|Overall Study|Lost to Follow-up|0|||
124879041|NCT01054573|449180984|FG001|Overall Study|Lost to Follow-up|2|||
124879042|NCT01054573|449180985|FG002|Overall Study|Lost to Follow-up|0|||
124879043|NCT01054573|449180986|FG003|Overall Study|Lost to Follow-up|0|||
124879044|NCT01054573|449180983|FG000|Overall Study|Withdrawal by Subject|0|||
124879045|NCT01054573|449180984|FG001|Overall Study|Withdrawal by Subject|2|||
124879046|NCT01054573|449180985|FG002|Overall Study|Withdrawal by Subject|2|||
124879047|NCT01054573|449180986|FG003|Overall Study|Withdrawal by Subject|1|||
124879048|NCT00979602|449180987|FG000|Overall Study|Serious Adverse Event|5|||
124879049|NCT00979602|449180988|FG001|Overall Study|Serious Adverse Event|3|||
124879050|NCT00979602|449180987|FG000|Overall Study|Protocol Violation|3|||
124879051|NCT00979602|449180988|FG001|Overall Study|Protocol Violation|0|||
124879052|NCT00979602|449180987|FG000|Overall Study|Withdrawal by Subject|31|||
124879053|NCT00979602|449180988|FG001|Overall Study|Withdrawal by Subject|25|||
124879054|NCT00979602|449180987|FG000|Overall Study|Lost to Follow-up|100|||
124879055|NCT00979602|449180988|FG001|Overall Study|Lost to Follow-up|96|||
124879056|NCT00979602|449180987|FG000|Overall Study|Migrated/moved from study area|3|||
124879057|NCT00979602|449180988|FG001|Overall Study|Migrated/moved from study area|6|||
124879058|NCT00979602|449180987|FG000|Overall Study|Others|3|||
124879059|NCT00979602|449180988|FG001|Overall Study|Others|3|||
124879060|NCT00152009|449180989|FG000|Overall Study|Adverse Event|9|||
124879061|NCT00152009|449180990|FG001|Overall Study|Adverse Event|13|||
124879062|NCT00152009|449180991|FG002|Overall Study|Adverse Event|20|||
124879063|NCT00152009|449180992|FG003|Overall Study|Adverse Event|1|||
124879064|NCT00152009|449180989|FG000|Overall Study|Protocol Violation|3|||
124879065|NCT00152009|449180990|FG001|Overall Study|Protocol Violation|0|||
124879066|NCT00152009|449180991|FG002|Overall Study|Protocol Violation|0|||
124879067|NCT00152009|449180992|FG003|Overall Study|Protocol Violation|1|||
125013349|NCT00974675|449674826|FG002|Overall Study|Participant on holiday; unable to attend|0|||
125013350|NCT00974675|449674827|FG003|Overall Study|Participant on holiday; unable to attend|1|||
125013351|NCT02121262|449674830|FG000|Overall Study|Adverse Event|6|||
125013352|NCT02121262|449674831|FG001|Overall Study|Adverse Event|3|||
125013353|NCT02121262|449674830|FG000|Overall Study|Lack of Efficacy|3|||
125013354|NCT02121262|449674831|FG001|Overall Study|Lack of Efficacy|0|||
124879068|NCT00152009|449180989|FG000|Overall Study|Withdrawal by Subject|2|||
124879069|NCT00152009|449180990|FG001|Overall Study|Withdrawal by Subject|3|||
125013355|NCT02121262|449674830|FG000|Overall Study|Personal Reasons|19|||
125013356|NCT02121262|449674831|FG001|Overall Study|Personal Reasons|5|||
125013357|NCT02121262|449674830|FG000|Overall Study|Protocol Violation|1|||
125013358|NCT02121262|449674831|FG001|Overall Study|Protocol Violation|1|||
124879070|NCT00152009|449180991|FG002|Overall Study|Withdrawal by Subject|4|||
124879071|NCT00152009|449180992|FG003|Overall Study|Withdrawal by Subject|9|||
124879072|NCT00152009|449180989|FG000|Overall Study|Lost to Follow-up|2|||
124879073|NCT00152009|449180990|FG001|Overall Study|Lost to Follow-up|4|||
124879074|NCT00152009|449180991|FG002|Overall Study|Lost to Follow-up|3|||
124879075|NCT00152009|449180992|FG003|Overall Study|Lost to Follow-up|3|||
124879076|NCT00152009|449180989|FG000|Overall Study|Lack of Efficacy|8|||
124879077|NCT00152009|449180990|FG001|Overall Study|Lack of Efficacy|6|||
124879078|NCT00152009|449180991|FG002|Overall Study|Lack of Efficacy|7|||
124879079|NCT00152009|449180992|FG003|Overall Study|Lack of Efficacy|15|||
124879080|NCT00152009|449180989|FG000|Overall Study|ECG abnormalities|2|||
124879081|NCT00152009|449180990|FG001|Overall Study|ECG abnormalities|2|||
124879082|NCT00152009|449180991|FG002|Overall Study|ECG abnormalities|2|||
124879083|NCT00152009|449180992|FG003|Overall Study|ECG abnormalities|1|||
124879084|NCT00152009|449180989|FG000|Overall Study|Sponsor's decision|3|||
124879085|NCT00152009|449180990|FG001|Overall Study|Sponsor's decision|3|||
124879086|NCT00152009|449180991|FG002|Overall Study|Sponsor's decision|1|||
124879087|NCT00152009|449180992|FG003|Overall Study|Sponsor's decision|3|||
124879088|NCT00393523|449180993|FG000|Overall Study|Lost to Follow-up|0|||
124879089|NCT00393523|449180994|FG001|Overall Study|Lost to Follow-up|0|||
124879090|NCT00393523|449180995|FG002|Overall Study|Lost to Follow-up|0|||
124879091|NCT00393523|449180996|FG003|Overall Study|Lost to Follow-up|2|||
124879092|NCT00393523|449180997|FG004|Overall Study|Lost to Follow-up|1|||
124879093|NCT00393523|449180993|FG000|Overall Study|Protocol Violation|6|||
124879094|NCT00393523|449180994|FG001|Overall Study|Protocol Violation|2|||
124879095|NCT00393523|449180995|FG002|Overall Study|Protocol Violation|0|||
124879096|NCT00393523|449180996|FG003|Overall Study|Protocol Violation|1|||
124879097|NCT00393523|449180997|FG004|Overall Study|Protocol Violation|0|||
124879098|NCT00393523|449180993|FG000|Overall Study|Withdrawal by Subject|6|||
124879099|NCT00393523|449180994|FG001|Overall Study|Withdrawal by Subject|7|||
124879100|NCT00393523|449180995|FG002|Overall Study|Withdrawal by Subject|2|||
124879101|NCT00393523|449180996|FG003|Overall Study|Withdrawal by Subject|3|||
124879102|NCT00393523|449180997|FG004|Overall Study|Withdrawal by Subject|0|||
124879103|NCT00393523|449180993|FG000|Overall Study|Difficulties in specimen collection|0|||
124879104|NCT00393523|449180994|FG001|Overall Study|Difficulties in specimen collection|0|||
124879105|NCT00393523|449180995|FG002|Overall Study|Difficulties in specimen collection|1|||
124879106|NCT00393523|449180996|FG003|Overall Study|Difficulties in specimen collection|0|||
124879107|NCT00393523|449180997|FG004|Overall Study|Difficulties in specimen collection|0|||
124879108|NCT00393523|449180993|FG000|Overall Study|Vaccine supply issue|0|||
124879109|NCT00393523|449180994|FG001|Overall Study|Vaccine supply issue|0|||
124879110|NCT00393523|449180995|FG002|Overall Study|Vaccine supply issue|1|||
125102275|NCT02864953|449995537|FG001|Overall Study|Adverse Event|19|||
125102276|NCT02864953|449995536|FG000|Overall Study|Withdrawal by Subject|1|||
125102277|NCT02864953|449995537|FG001|Overall Study|Withdrawal by Subject|0|||
125102278|NCT02864953|449995536|FG000|Overall Study|Physician Decision|4|||
125102279|NCT02864953|449995537|FG001|Overall Study|Physician Decision|2|||
125102280|NCT02864953|449995536|FG000|Overall Study|Death|3|||
125102281|NCT02864953|449995537|FG001|Overall Study|Death|13|||
125102282|NCT02864953|449995536|FG000|Overall Study|Reason not specified|14|||
125102283|NCT02864953|449995537|FG001|Overall Study|Reason not specified|12|||
125102284|NCT02864953|449995536|FG000|Overall Study|Withdrew Prior to Dosing|9|||
125102285|NCT02864953|449995537|FG001|Overall Study|Withdrew Prior to Dosing|8|||
125102286|NCT01023022|449995540|FG000|Overall Study|Death|5|||
125102287|NCT01023022|449995540|FG000|Overall Study|Lost to Follow-up|7|||
125102288|NCT01023022|449995540|FG000|Overall Study|due to technical issues|2|||
125102289|NCT03917654|449995541|FG000|Year 1|Withdrawal by Subject|1|||
124879111|NCT00393523|449180996|FG003|Overall Study|Vaccine supply issue|0|||
124879112|NCT00393523|449180997|FG004|Overall Study|Vaccine supply issue|0|||
124879113|NCT00423852|449181002|FG000|Overall Study|Removed pior to the high-dose portion|3|||
124879114|NCT04772053|449181003|FG000|Overall Study|Physician Decision|2|||
124879115|NCT04772053|449181003|FG000|Overall Study|Withdrawal by Subject|3|||
124879116|NCT04772053|449181003|FG000|Overall Study|Study Terminated by Sponsor|1|||
124879117|NCT03787680|449181008|FG000|Overall Study|Physician Decision|2|||
124879118|NCT03787680|449181009|FG001|Overall Study|Physician Decision|3|||
124879119|NCT03787680|449181008|FG000|Overall Study|Adverse Event|7|||
124879120|NCT03787680|449181009|FG001|Overall Study|Adverse Event|3|||
124879121|NCT03787680|449181008|FG000|Overall Study|Withdrawal by Subject|2|||
124879122|NCT03787680|449181009|FG001|Overall Study|Withdrawal by Subject|1|||
124879123|NCT02541383|449181010|FG000|Overall Study|Death|50|||
124879124|NCT02541383|449181011|FG001|Overall Study|Death|37|||
124879125|NCT02541383|449181012|FG002|Overall Study|Death|48|||
124879126|NCT02541383|449181013|FG003|Overall Study|Death|41|||
124879127|NCT02541383|449181014|FG004|Overall Study|Death|21|||
124879128|NCT02541383|449181015|FG005|Overall Study|Death|25|||
124879129|NCT02541383|449181010|FG000|Overall Study|Lost to Follow-up|5|||
124879130|NCT02541383|449181011|FG001|Overall Study|Lost to Follow-up|3|||
124879131|NCT02541383|449181012|FG002|Overall Study|Lost to Follow-up|1|||
125102290|NCT03917654|449995542|FG001|Year 1|Withdrawal by Subject|0|||
125102291|NCT03917654|449995543|FG002|Year 1|Withdrawal by Subject|0|||
125102292|NCT03917654|449995544|FG003|Year 1|Withdrawal by Subject|0|||
125102293|NCT03917654|449995545|FG004|Year 1|Withdrawal by Subject|0|||
125102294|NCT03917654|449995546|FG005|Year 1|Withdrawal by Subject|1|||
125102295|NCT03917654|449995547|FG006|Year 1|Withdrawal by Subject|6|||
124879132|NCT02541383|449181013|FG003|Overall Study|Lost to Follow-up|1|||
124879133|NCT02541383|449181014|FG004|Overall Study|Lost to Follow-up|3|||
124879134|NCT02541383|449181015|FG005|Overall Study|Lost to Follow-up|0|||
124879135|NCT02541383|449181010|FG000|Overall Study|Consent withdrawn|5|||
124879136|NCT02541383|449181011|FG001|Overall Study|Consent withdrawn|6|||
124879137|NCT02541383|449181012|FG002|Overall Study|Consent withdrawn|1|||
124879138|NCT02541383|449181013|FG003|Overall Study|Consent withdrawn|1|||
124879139|NCT02541383|449181014|FG004|Overall Study|Consent withdrawn|0|||
125102296|NCT03917654|449995548|FG007|Year 1|Withdrawal by Subject|2|||
125102297|NCT03917654|449995549|FG008|Year 1|Withdrawal by Subject|5|||
124879140|NCT02541383|449181015|FG005|Overall Study|Consent withdrawn|0|||
124879141|NCT02541383|449181010|FG000|Overall Study|Sponsor's decision|1|||
125013359|NCT02121262|449674830|FG000|Overall Study|Participant Dropped-out|0|||
125013360|NCT02121262|449674831|FG001|Overall Study|Participant Dropped-out|1|||
125013361|NCT02121262|449674830|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
125013362|NCT02121262|449674831|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
125013363|NCT02121262|449674830|FG000|Overall Study|Consent Withdrawn|1|||
125013364|NCT02121262|449674831|FG001|Overall Study|Consent Withdrawn|0|||
125013365|NCT02025907|449674837|FG000|Overall Study|Lack of Efficacy|1|||
125013366|NCT02025907|449674838|FG001|Overall Study|Lack of Efficacy|0|||
125013367|NCT02025907|449674837|FG000|Overall Study|Withdrawal by Subject|15|||
125013368|NCT02025907|449674838|FG001|Overall Study|Withdrawal by Subject|8|||
125013369|NCT02025907|449674837|FG000|Overall Study|Protocol Violation|2|||
125013370|NCT02025907|449674838|FG001|Overall Study|Protocol Violation|0|||
125013371|NCT02025907|449674837|FG000|Overall Study|Physician Decision|2|||
125013372|NCT02025907|449674838|FG001|Overall Study|Physician Decision|0|||
125013373|NCT02025907|449674837|FG000|Overall Study|Lost to Follow-up|2|||
125013374|NCT02025907|449674838|FG001|Overall Study|Lost to Follow-up|2|||
125013375|NCT02025907|449674837|FG000|Overall Study|Adverse Event|3|||
125013376|NCT02025907|449674838|FG001|Overall Study|Adverse Event|1|||
125013377|NCT02025907|449674837|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
125013378|NCT02025907|449674838|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
125013379|NCT02411539|449674839|FG000|Overall Study|Lost to Follow-up|2|||
125013380|NCT02411539|449674840|FG001|Overall Study|Lost to Follow-up|0|||
125013381|NCT02411539|449674839|FG000|Overall Study|Confounding medical condition|0|||
125013382|NCT02411539|449674840|FG001|Overall Study|Confounding medical condition|1|||
125013383|NCT00282334|449674841|FG000|Overall Study|Withdrawal by Subject|8|||
125013384|NCT00282334|449674842|FG001|Overall Study|Withdrawal by Subject|5|||
125013385|NCT03681119|449674843|FG000|Overall Study|No specific reason|4|||
125013386|NCT03681119|449674844|FG001|Overall Study|No specific reason|0|||
125013387|NCT03681119|449674843|FG000|Overall Study|Sickness|2|||
125013388|NCT03681119|449674844|FG001|Overall Study|Sickness|0|||
124879142|NCT02541383|449181011|FG001|Overall Study|Sponsor's decision|1|||
124879143|NCT02541383|449181012|FG002|Overall Study|Sponsor's decision|0|||
125013389|NCT00879645|449674846|FG000|Overall Study|Adverse Event|1|||
125013390|NCT00879645|449674847|FG001|Overall Study|Adverse Event|0|||
125013391|NCT00879645|449674848|FG002|Overall Study|Adverse Event|0|||
125013392|NCT00879645|449674849|FG003|Overall Study|Adverse Event|0|||
125013393|NCT03631732|449674852|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
125013394|NCT03631732|449674853|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
125013395|NCT03631732|449674852|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
125013396|NCT03631732|449674853|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
125013397|NCT03631732|449674852|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
124879144|NCT02541383|449181013|FG003|Overall Study|Sponsor's decision|0|||
124879145|NCT02541383|449181014|FG004|Overall Study|Sponsor's decision|0|||
124879146|NCT02541383|449181015|FG005|Overall Study|Sponsor's decision|0|||
124879147|NCT05458024|449181018|FG000|Overall Study|Withdrawal by Subject|1|||
124879148|NCT05458024|449181019|FG001|Overall Study|Withdrawal by Subject|1|||
124879149|NCT05229653|449181021|FG000|Overall Study|Lost to Follow-up|1|||
124879150|NCT05229653|449181022|FG001|Overall Study|Lost to Follow-up|0|||
124879151|NCT01845974|449181023|FG000|Overall Study|screen failure|1|||
124879152|NCT01845974|449181024|FG001|Overall Study|screen failure|0|||
124879153|NCT02667886|449181025|FG000|Dose Escalation (Part A)|Adverse Event|1|||
124879154|NCT02667886|449181026|FG001|Dose Escalation (Part A)|Adverse Event|3|||
124879155|NCT02667886|449181027|FG002|Dose Escalation (Part A)|Adverse Event|1|||
124879156|NCT02667886|449181028|FG003|Dose Escalation (Part A)|Adverse Event|0|||
124879157|NCT02667886|449181029|FG004|Dose Escalation (Part A)|Adverse Event|0|||
124879158|NCT02667886|449181025|FG000|Dose Escalation (Part A)|Disease Progression|1|||
124879159|NCT02667886|449181026|FG001|Dose Escalation (Part A)|Disease Progression|4|||
124879160|NCT02667886|449181027|FG002|Dose Escalation (Part A)|Disease Progression|3|||
124879161|NCT02667886|449181028|FG003|Dose Escalation (Part A)|Disease Progression|0|||
124879162|NCT02667886|449181029|FG004|Dose Escalation (Part A)|Disease Progression|0|||
124879163|NCT02667886|449181025|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
124879164|NCT02667886|449181026|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
124879165|NCT02667886|449181027|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
124879166|NCT02667886|449181028|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
124879167|NCT02667886|449181029|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
124879168|NCT02667886|449181025|FG000|Dose Expansion (Part B)|Adverse Event|0|||
124879169|NCT02667886|449181026|FG001|Dose Expansion (Part B)|Adverse Event|0|||
124879170|NCT02667886|449181027|FG002|Dose Expansion (Part B)|Adverse Event|0|||
124879171|NCT02667886|449181028|FG003|Dose Expansion (Part B)|Adverse Event|9|||
124879172|NCT02667886|449181029|FG004|Dose Expansion (Part B)|Adverse Event|0|||
124879173|NCT02667886|449181025|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
124879174|NCT02667886|449181026|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
124879175|NCT02667886|449181027|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
124879176|NCT02667886|449181028|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
124879177|NCT02667886|449181029|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
124879178|NCT02667886|449181025|FG000|Dose Expansion (Part B)|Disease Progression|0|||
124879179|NCT02667886|449181026|FG001|Dose Expansion (Part B)|Disease Progression|0|||
124879180|NCT02667886|449181027|FG002|Dose Expansion (Part B)|Disease Progression|0|||
124879181|NCT02667886|449181028|FG003|Dose Expansion (Part B)|Disease Progression|38|||
124879182|NCT02667886|449181029|FG004|Dose Expansion (Part B)|Disease Progression|0|||
124879183|NCT02667886|449181025|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
124879184|NCT02667886|449181026|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
124879185|NCT02667886|449181027|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
124879186|NCT02667886|449181028|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
124879187|NCT02667886|449181029|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
124879188|NCT02667886|449181025|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
124879189|NCT02667886|449181026|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
124879190|NCT02667886|449181027|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
124879191|NCT02667886|449181028|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
125102298|NCT03917654|449995550|FG009|Year 1|Withdrawal by Subject|3|||
125102299|NCT03917654|449995551|FG010|Year 1|Withdrawal by Subject|1|||
125102300|NCT03917654|449995552|FG011|Year 1|Withdrawal by Subject|0|||
125102301|NCT03917654|449995541|FG000|Year 1|Travel|0|||
125102302|NCT03917654|449995542|FG001|Year 1|Travel|1|||
125102303|NCT03917654|449995543|FG002|Year 1|Travel|1|||
125102304|NCT03917654|449995544|FG003|Year 1|Travel|0|||
125102305|NCT03917654|449995545|FG004|Year 1|Travel|4|||
125102306|NCT03917654|449995546|FG005|Year 1|Travel|4|||
125102307|NCT03917654|449995547|FG006|Year 1|Travel|10|||
124879192|NCT02667886|449181029|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
124879193|NCT02667886|449181025|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
124879194|NCT02667886|449181026|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
124879195|NCT02667886|449181027|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
124879196|NCT02667886|449181028|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
124879197|NCT02667886|449181029|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
124879198|NCT00594217|449181030|FG000|Overall Study|Withdrawal by Subject|1|||
124879199|NCT00594217|449181031|FG001|Overall Study|Withdrawal by Subject|3|||
124879200|NCT03635489|449181032|FG000|Overall Study|Death|19|||
124879201|NCT03635489|449181033|FG001|Overall Study|Death|13|||
124879202|NCT03635489|449181032|FG000|Overall Study|Lost to Follow-up|1|||
124879203|NCT03635489|449181033|FG001|Overall Study|Lost to Follow-up|2|||
125102308|NCT03917654|449995548|FG007|Year 1|Travel|8|||
125102309|NCT03917654|449995549|FG008|Year 1|Travel|2|||
125102310|NCT03917654|449995550|FG009|Year 1|Travel|5|||
125102311|NCT03917654|449995551|FG010|Year 1|Travel|3|||
125102312|NCT03917654|449995552|FG011|Year 1|Travel|3|||
125102313|NCT03917654|449995541|FG000|Year 1|Subject moved away from site|0|||
124879204|NCT03635489|449181032|FG000|Overall Study|Withdrawal by Subject|1|||
124879205|NCT03635489|449181033|FG001|Overall Study|Withdrawal by Subject|2|||
124879206|NCT03635489|449181032|FG000|Overall Study|Study Ended by Sponsor|28|||
124879207|NCT03635489|449181033|FG001|Overall Study|Study Ended by Sponsor|34|||
124879208|NCT00943306|449181034|FG000|Overall Study|Physician Decision|1|||
124879209|NCT00943306|449181034|FG000|Overall Study|Death|1|||
124879210|NCT00943306|449181034|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
124879211|NCT01036022|449181035|FG000|Overall Study|Adverse Event|1|||
124879212|NCT01036022|449181036|FG001|Overall Study|Adverse Event|3|||
124879213|NCT01036022|449181037|FG002|Overall Study|Adverse Event|2|||
124879214|NCT01036022|449181038|FG003|Overall Study|Adverse Event|1|||
124879215|NCT01036022|449181039|FG004|Overall Study|Adverse Event|0|||
124879216|NCT01036022|449181040|FG005|Overall Study|Adverse Event|2|||
124879217|NCT01036022|449181035|FG000|Overall Study|Lack of Efficacy|1|||
124879218|NCT01036022|449181036|FG001|Overall Study|Lack of Efficacy|1|||
124879219|NCT01036022|449181037|FG002|Overall Study|Lack of Efficacy|1|||
124879220|NCT01036022|449181038|FG003|Overall Study|Lack of Efficacy|0|||
124879221|NCT01036022|449181039|FG004|Overall Study|Lack of Efficacy|1|||
124879222|NCT01036022|449181040|FG005|Overall Study|Lack of Efficacy|1|||
124879223|NCT01036022|449181035|FG000|Overall Study|Physician Decision|0|||
124879224|NCT01036022|449181036|FG001|Overall Study|Physician Decision|0|||
124879225|NCT01036022|449181037|FG002|Overall Study|Physician Decision|1|||
124879226|NCT01036022|449181038|FG003|Overall Study|Physician Decision|0|||
124879227|NCT01036022|449181039|FG004|Overall Study|Physician Decision|0|||
124879228|NCT01036022|449181040|FG005|Overall Study|Physician Decision|0|||
124879229|NCT01036022|449181035|FG000|Overall Study|Withdrawal by Subject|0|||
124879230|NCT01036022|449181036|FG001|Overall Study|Withdrawal by Subject|0|||
124879231|NCT01036022|449181037|FG002|Overall Study|Withdrawal by Subject|0|||
124879232|NCT01036022|449181038|FG003|Overall Study|Withdrawal by Subject|1|||
125013398|NCT03631732|449674853|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
125013399|NCT03631732|449674852|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
125013400|NCT03631732|449674853|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
125013401|NCT03631732|449674852|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
125013402|NCT03631732|449674853|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
125013403|NCT03631732|449674852|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
125013404|NCT03631732|449674853|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
125013405|NCT03631732|449674852|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
125013406|NCT03631732|449674853|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
125013407|NCT03631732|449674852|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
125013408|NCT03631732|449674853|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
125013409|NCT03631732|449674852|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
125013410|NCT03631732|449674853|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
125013411|NCT03631732|449674852|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
125013412|NCT03631732|449674853|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
125013413|NCT04288154|449674854|FG000|Overall Study|Withdrawal by Subject|9|||
125013414|NCT04288154|449674855|FG001|Overall Study|Withdrawal by Subject|9|||
125013415|NCT01624662|449674861|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
125013416|NCT01624662|449674862|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
125013417|NCT01624662|449674863|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
125013418|NCT01624662|449674864|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
125013419|NCT01624662|449674861|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
125013420|NCT01624662|449674862|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
125013421|NCT01624662|449674863|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
125013422|NCT01624662|449674864|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
125013423|NCT01624662|449674861|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
125013424|NCT01624662|449674862|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
125013425|NCT01624662|449674863|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
125013426|NCT01624662|449674864|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
124879233|NCT01036022|449181039|FG004|Overall Study|Withdrawal by Subject|2|||
124879234|NCT01036022|449181040|FG005|Overall Study|Withdrawal by Subject|0|||
124879235|NCT00576732|449181041|FG000|DOUBLE BLIND|Adverse Event|0|||
125013427|NCT01624662|449674861|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
125013428|NCT01624662|449674862|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
125013429|NCT01624662|449674863|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
125210766|NCT03723070|450395677|FG000|Overall Study|Lost to Follow-up|2|||
124879236|NCT00576732|449181042|FG001|DOUBLE BLIND|Adverse Event|0|||
124879237|NCT00576732|449181043|FG002|DOUBLE BLIND|Adverse Event|1|||
124879238|NCT00576732|449181044|FG003|DOUBLE BLIND|Adverse Event|0|||
124879239|NCT00576732|449181045|FG004|DOUBLE BLIND|Adverse Event|0|||
124879240|NCT00576732|449181046|FG005|DOUBLE BLIND|Adverse Event|0|||
124879241|NCT00576732|449181041|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
124879242|NCT00576732|449181042|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
124879243|NCT00576732|449181043|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
124879244|NCT00576732|449181044|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
124879245|NCT00576732|449181045|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
124879246|NCT00576732|449181046|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
124879247|NCT00576732|449181041|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
124879248|NCT00576732|449181042|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
124879249|NCT00576732|449181043|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
124879250|NCT00576732|449181044|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
124879251|NCT00576732|449181045|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
124879252|NCT00576732|449181046|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
124879253|NCT00576732|449181041|FG000|DOUBLE BLIND|OTHER|0|||
124879254|NCT00576732|449181042|FG001|DOUBLE BLIND|OTHER|2|||
124879255|NCT00576732|449181043|FG002|DOUBLE BLIND|OTHER|1|||
124879256|NCT00576732|449181044|FG003|DOUBLE BLIND|OTHER|0|||
125013430|NCT01624662|449674864|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
125013431|NCT01624662|449674861|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
125013432|NCT01624662|449674862|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
125013433|NCT01624662|449674863|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
125013434|NCT01624662|449674864|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
125013435|NCT01624662|449674861|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
125013436|NCT01624662|449674862|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
125013437|NCT01624662|449674863|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
125013438|NCT01624662|449674864|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
125013439|NCT01624662|449674861|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
125013440|NCT01624662|449674862|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
125013441|NCT01624662|449674863|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
125013442|NCT01624662|449674864|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
125013443|NCT01135498|449676749|FG000|Overall Study|Adverse Event|20|||
125013444|NCT01135498|449676749|FG000|Overall Study|Progressive disease|38|||
125013445|NCT01135498|449676749|FG000|Overall Study|Investigator judgement|25|||
125013446|NCT01135498|449676749|FG000|Overall Study|Withdrawal by Subject|4|||
125013447|NCT01135498|449676749|FG000|Overall Study|Death|1|||
125013448|NCT01135498|449676749|FG000|Overall Study|Ongoing at time of analysis|2|||
125013449|NCT00530894|449676755|FG000|Overall Study|Death|84|||
125013450|NCT00530894|449676756|FG001|Overall Study|Death|89|||
125013451|NCT00530894|449676757|FG002|Overall Study|Death|55|||
125013452|NCT00530894|449676758|FG003|Overall Study|Death|89|||
125013453|NCT00530894|449676755|FG000|Overall Study|Lost to Follow-up|1|||
125013454|NCT00530894|449676756|FG001|Overall Study|Lost to Follow-up|3|||
125013455|NCT00530894|449676757|FG002|Overall Study|Lost to Follow-up|0|||
125013456|NCT00530894|449676758|FG003|Overall Study|Lost to Follow-up|0|||
125013457|NCT00530894|449676755|FG000|Overall Study|Withdrawal by Subject|1|||
125013458|NCT00530894|449676756|FG001|Overall Study|Withdrawal by Subject|23|||
125013459|NCT00530894|449676757|FG002|Overall Study|Withdrawal by Subject|0|||
125013460|NCT00530894|449676758|FG003|Overall Study|Withdrawal by Subject|5|||
125013461|NCT00530894|449676755|FG000|Overall Study|Alive and censored prior to 1 year|2|||
125013462|NCT00530894|449676756|FG001|Overall Study|Alive and censored prior to 1 year|0|||
125013463|NCT00530894|449676757|FG002|Overall Study|Alive and censored prior to 1 year|0|||
125013464|NCT00530894|449676758|FG003|Overall Study|Alive and censored prior to 1 year|0|||
125013465|NCT02256540|449676759|FG000|Overall Study|Withdrawal by Subject|0|||
125013466|NCT02256540|449676760|FG001|Overall Study|Withdrawal by Subject|1|||
125013467|NCT02256540|449676761|FG002|Overall Study|Withdrawal by Subject|1|||
125013468|NCT02256540|449676759|FG000|Overall Study|Back pain preventing exercise|0|||
125013469|NCT02256540|449676760|FG001|Overall Study|Back pain preventing exercise|0|||
125013470|NCT02256540|449676761|FG002|Overall Study|Back pain preventing exercise|1|||
125013471|NCT03923426|449676762|FG000|Overall Study|Other|19|||
125013472|NCT03923426|449676762|FG000|Overall Study|Lost to Follow-up|16|||
125013473|NCT03923426|449676762|FG000|Overall Study|Death|107|||
125013474|NCT03923426|449676762|FG000|Overall Study|Incomplete response to question|13|||
125013475|NCT00769002|449676763|FG000|Overall Study|Study was not completed, no data|9|||
125013476|NCT00769002|449676764|FG001|Overall Study|Study was not completed, no data|9|||
125013477|NCT00838331|449676779|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
125013478|NCT00264875|449676780|FG000|Overall Study|Adverse Event|6|||
125013479|NCT00264875|449676780|FG000|Overall Study|Lost to Follow-up|6|||
125013480|NCT00264875|449676780|FG000|Overall Study|Protocol Violation|11|||
125013481|NCT00264875|449676780|FG000|Overall Study|Withdrawal by Subject|7|||
124879257|NCT00576732|449181045|FG004|DOUBLE BLIND|OTHER|0|||
124879258|NCT00576732|449181046|FG005|DOUBLE BLIND|OTHER|0|||
124879259|NCT00576732|449181041|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
124879260|NCT00576732|449181042|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
125102314|NCT03917654|449995542|FG001|Year 1|Subject moved away from site|1|||
125102315|NCT03917654|449995543|FG002|Year 1|Subject moved away from site|0|||
125102316|NCT03917654|449995544|FG003|Year 1|Subject moved away from site|0|||
125102317|NCT03917654|449995545|FG004|Year 1|Subject moved away from site|0|||
125102318|NCT03917654|449995546|FG005|Year 1|Subject moved away from site|0|||
125102319|NCT03917654|449995547|FG006|Year 1|Subject moved away from site|1|||
125102320|NCT03917654|449995548|FG007|Year 1|Subject moved away from site|2|||
125102321|NCT03917654|449995549|FG008|Year 1|Subject moved away from site|1|||
125102322|NCT03917654|449995550|FG009|Year 1|Subject moved away from site|0|||
125102323|NCT03917654|449995551|FG010|Year 1|Subject moved away from site|0|||
125102324|NCT03917654|449995552|FG011|Year 1|Subject moved away from site|3|||
125102325|NCT03917654|449995541|FG000|Year 1|Spouse/Family member request|0|||
125102326|NCT03917654|449995542|FG001|Year 1|Spouse/Family member request|0|||
125102327|NCT03917654|449995543|FG002|Year 1|Spouse/Family member request|1|||
125102328|NCT03917654|449995544|FG003|Year 1|Spouse/Family member request|0|||
125102329|NCT03917654|449995545|FG004|Year 1|Spouse/Family member request|1|||
125102330|NCT03917654|449995546|FG005|Year 1|Spouse/Family member request|0|||
125102331|NCT03917654|449995547|FG006|Year 1|Spouse/Family member request|0|||
125102332|NCT03917654|449995548|FG007|Year 1|Spouse/Family member request|2|||
125102333|NCT03917654|449995549|FG008|Year 1|Spouse/Family member request|0|||
125102334|NCT03917654|449995550|FG009|Year 1|Spouse/Family member request|0|||
125102335|NCT03917654|449995551|FG010|Year 1|Spouse/Family member request|0|||
125102336|NCT03917654|449995552|FG011|Year 1|Spouse/Family member request|1|||
125102337|NCT03917654|449995541|FG000|Year 1|Death|0|||
125102338|NCT03917654|449995542|FG001|Year 1|Death|0|||
125102339|NCT03917654|449995543|FG002|Year 1|Death|0|||
125102340|NCT03917654|449995544|FG003|Year 1|Death|0|||
125102341|NCT03917654|449995545|FG004|Year 1|Death|0|||
125102342|NCT03917654|449995546|FG005|Year 1|Death|0|||
125102343|NCT03917654|449995547|FG006|Year 1|Death|0|||
125102344|NCT03917654|449995548|FG007|Year 1|Death|0|||
125102345|NCT03917654|449995549|FG008|Year 1|Death|1|||
125102346|NCT03917654|449995550|FG009|Year 1|Death|1|||
125102347|NCT03917654|449995551|FG010|Year 1|Death|0|||
125102348|NCT03917654|449995552|FG011|Year 1|Death|0|||
125102349|NCT03917654|449995541|FG000|Year 1|Lost to Follow-up|0|||
125102350|NCT03917654|449995542|FG001|Year 1|Lost to Follow-up|0|||
125102351|NCT03917654|449995543|FG002|Year 1|Lost to Follow-up|0|||
125102352|NCT03917654|449995544|FG003|Year 1|Lost to Follow-up|0|||
125102353|NCT03917654|449995545|FG004|Year 1|Lost to Follow-up|0|||
125102354|NCT03917654|449995546|FG005|Year 1|Lost to Follow-up|0|||
125102355|NCT03917654|449995547|FG006|Year 1|Lost to Follow-up|2|||
125102356|NCT03917654|449995548|FG007|Year 1|Lost to Follow-up|0|||
125102357|NCT03917654|449995549|FG008|Year 1|Lost to Follow-up|0|||
125102358|NCT03917654|449995550|FG009|Year 1|Lost to Follow-up|0|||
125102359|NCT03917654|449995551|FG010|Year 1|Lost to Follow-up|0|||
125102360|NCT03917654|449995552|FG011|Year 1|Lost to Follow-up|0|||
125102361|NCT03917654|449995541|FG000|Year 1|Missed visits|0|||
125102362|NCT03917654|449995542|FG001|Year 1|Missed visits|0|||
125102363|NCT03917654|449995543|FG002|Year 1|Missed visits|0|||
125102364|NCT03917654|449995544|FG003|Year 1|Missed visits|0|||
125102365|NCT03917654|449995545|FG004|Year 1|Missed visits|0|||
125102366|NCT03917654|449995546|FG005|Year 1|Missed visits|0|||
125102367|NCT03917654|449995547|FG006|Year 1|Missed visits|0|||
125102368|NCT03917654|449995548|FG007|Year 1|Missed visits|0|||
125102369|NCT03917654|449995549|FG008|Year 1|Missed visits|0|||
125102370|NCT03917654|449995550|FG009|Year 1|Missed visits|0|||
125102371|NCT03917654|449995551|FG010|Year 1|Missed visits|1|||
125102372|NCT03917654|449995552|FG011|Year 1|Missed visits|1|||
125102373|NCT03917654|449995541|FG000|Year 1|Pregnancy|0|||
125102374|NCT03917654|449995542|FG001|Year 1|Pregnancy|0|||
125102375|NCT03917654|449995543|FG002|Year 1|Pregnancy|0|||
125102376|NCT03917654|449995544|FG003|Year 1|Pregnancy|0|||
125102377|NCT03917654|449995545|FG004|Year 1|Pregnancy|0|||
125102378|NCT03917654|449995546|FG005|Year 1|Pregnancy|0|||
125102379|NCT03917654|449995547|FG006|Year 1|Pregnancy|0|||
125102380|NCT03917654|449995548|FG007|Year 1|Pregnancy|1|||
125102381|NCT03917654|449995549|FG008|Year 1|Pregnancy|0|||
125102382|NCT03917654|449995550|FG009|Year 1|Pregnancy|1|||
125102383|NCT03917654|449995551|FG010|Year 1|Pregnancy|0|||
125102384|NCT03917654|449995552|FG011|Year 1|Pregnancy|0|||
125102385|NCT03917654|449995541|FG000|Year 2|Travel|1|||
125102386|NCT03917654|449995542|FG001|Year 2|Travel|0|||
125102387|NCT03917654|449995543|FG002|Year 2|Travel|0|||
125102388|NCT03917654|449995544|FG003|Year 2|Travel|0|||
125102389|NCT03917654|449995545|FG004|Year 2|Travel|1|||
125102390|NCT03917654|449995546|FG005|Year 2|Travel|1|||
125102391|NCT03917654|449995547|FG006|Year 2|Travel|2|||
125102392|NCT03917654|449995548|FG007|Year 2|Travel|1|||
125102393|NCT03917654|449995549|FG008|Year 2|Travel|0|||
125102394|NCT03917654|449995550|FG009|Year 2|Travel|1|||
125102395|NCT03917654|449995551|FG010|Year 2|Travel|0|||
125102396|NCT03917654|449995552|FG011|Year 2|Travel|1|||
125102397|NCT03917654|449995541|FG000|Year 2|Married|1|||
125102398|NCT03917654|449995542|FG001|Year 2|Married|0|||
125102399|NCT03917654|449995543|FG002|Year 2|Married|0|||
125102400|NCT03917654|449995544|FG003|Year 2|Married|0|||
125102401|NCT03917654|449995545|FG004|Year 2|Married|0|||
124879261|NCT00576732|449181043|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
124879262|NCT00576732|449181044|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
124879263|NCT00576732|449181045|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
124879264|NCT00576732|449181046|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
124879265|NCT00576732|449181041|FG000|DOUBLE BLIND|Protocol Violation|1|||
124879266|NCT00576732|449181042|FG001|DOUBLE BLIND|Protocol Violation|0|||
124879267|NCT00576732|449181043|FG002|DOUBLE BLIND|Protocol Violation|0|||
124879268|NCT00576732|449181044|FG003|DOUBLE BLIND|Protocol Violation|0|||
124879269|NCT00576732|449181045|FG004|DOUBLE BLIND|Protocol Violation|0|||
124879270|NCT00576732|449181046|FG005|DOUBLE BLIND|Protocol Violation|0|||
124879271|NCT00576732|449181041|FG000|OPEN LABEL|Adverse Event|0|||
124879272|NCT00576732|449181042|FG001|OPEN LABEL|Adverse Event|0|||
124879273|NCT00576732|449181043|FG002|OPEN LABEL|Adverse Event|0|||
124879274|NCT00576732|449181044|FG003|OPEN LABEL|Adverse Event|4|||
124879275|NCT00576732|449181045|FG004|OPEN LABEL|Adverse Event|0|||
124879276|NCT00576732|449181046|FG005|OPEN LABEL|Adverse Event|1|||
124879277|NCT00576732|449181041|FG000|OPEN LABEL|Lost to Follow-up|0|||
124879278|NCT00576732|449181042|FG001|OPEN LABEL|Lost to Follow-up|0|||
124879279|NCT00576732|449181043|FG002|OPEN LABEL|Lost to Follow-up|0|||
124879280|NCT00576732|449181044|FG003|OPEN LABEL|Lost to Follow-up|2|||
124879281|NCT00576732|449181045|FG004|OPEN LABEL|Lost to Follow-up|1|||
124879282|NCT00576732|449181046|FG005|OPEN LABEL|Lost to Follow-up|1|||
124879283|NCT00576732|449181041|FG000|OPEN LABEL|Withdrawal by Subject|0|||
124879284|NCT00576732|449181042|FG001|OPEN LABEL|Withdrawal by Subject|0|||
124879285|NCT00576732|449181043|FG002|OPEN LABEL|Withdrawal by Subject|0|||
124879286|NCT00576732|449181044|FG003|OPEN LABEL|Withdrawal by Subject|1|||
124879287|NCT00576732|449181045|FG004|OPEN LABEL|Withdrawal by Subject|0|||
124879288|NCT00576732|449181046|FG005|OPEN LABEL|Withdrawal by Subject|1|||
124879289|NCT00576732|449181041|FG000|OPEN LABEL|OTHER|0|||
124879290|NCT00576732|449181042|FG001|OPEN LABEL|OTHER|0|||
124879291|NCT00576732|449181043|FG002|OPEN LABEL|OTHER|0|||
124879292|NCT00576732|449181044|FG003|OPEN LABEL|OTHER|0|||
124879293|NCT00576732|449181045|FG004|OPEN LABEL|OTHER|0|||
124879294|NCT00576732|449181046|FG005|OPEN LABEL|OTHER|2|||
124879295|NCT00576732|449181041|FG000|OPEN LABEL|Lack of Efficacy|0|||
124879296|NCT00576732|449181042|FG001|OPEN LABEL|Lack of Efficacy|0|||
124879297|NCT00576732|449181043|FG002|OPEN LABEL|Lack of Efficacy|0|||
124879298|NCT00576732|449181044|FG003|OPEN LABEL|Lack of Efficacy|2|||
124879299|NCT00576732|449181045|FG004|OPEN LABEL|Lack of Efficacy|2|||
124879300|NCT00576732|449181046|FG005|OPEN LABEL|Lack of Efficacy|3|||
124879301|NCT00576732|449181041|FG000|OPEN LABEL|Protocol Violation|0|||
124879302|NCT00576732|449181042|FG001|OPEN LABEL|Protocol Violation|0|||
124879303|NCT00576732|449181043|FG002|OPEN LABEL|Protocol Violation|0|||
124879304|NCT00576732|449181044|FG003|OPEN LABEL|Protocol Violation|2|||
124879305|NCT00576732|449181045|FG004|OPEN LABEL|Protocol Violation|1|||
124879306|NCT00576732|449181046|FG005|OPEN LABEL|Protocol Violation|0|||
124879307|NCT05096208|449181049|FG000|Overall Study|Lost to Follow-up|3|||
124879308|NCT05096208|449181050|FG001|Overall Study|Lost to Follow-up|5|||
124879309|NCT05096208|449181051|FG002|Overall Study|Lost to Follow-up|5|||
124879310|NCT05096208|449181052|FG003|Overall Study|Lost to Follow-up|2|||
124879311|NCT05096208|449181049|FG000|Overall Study|Withdrawal by Subject|0|||
124879312|NCT05096208|449181050|FG001|Overall Study|Withdrawal by Subject|1|||
124879313|NCT05096208|449181051|FG002|Overall Study|Withdrawal by Subject|2|||
124879314|NCT05096208|449181052|FG003|Overall Study|Withdrawal by Subject|3|||
124879315|NCT05096208|449181049|FG000|Overall Study|No longer met eligibility criteria|1|||
124879316|NCT05096208|449181050|FG001|Overall Study|No longer met eligibility criteria|0|||
124879317|NCT05096208|449181051|FG002|Overall Study|No longer met eligibility criteria|0|||
124879318|NCT05096208|449181052|FG003|Overall Study|No longer met eligibility criteria|0|||
124879319|NCT05096208|449181049|FG000|Overall Study|Other|0|||
124879320|NCT05096208|449181050|FG001|Overall Study|Other|0|||
124879321|NCT05096208|449181051|FG002|Overall Study|Other|1|||
124879322|NCT05096208|449181052|FG003|Overall Study|Other|0|||
124879323|NCT02213328|449181054|FG000|Overall Study|Withdrawal by Subject|10|||
124879324|NCT02213328|449181054|FG000|Overall Study|Physician Decision|2|||
124879325|NCT02213328|449181054|FG000|Overall Study|Lost to Follow-up|16|||
125013482|NCT01500278|449676781|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
125013483|NCT01500278|449676782|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
125013484|NCT01500278|449676781|FG000|Week 0 - Week 12|Protocol Violation|10|||
125013485|NCT01500278|449676782|FG001|Week 0 - Week 12|Protocol Violation|16|||
125013486|NCT01500278|449676781|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
125013487|NCT01500278|449676782|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
125013488|NCT01500278|449676781|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
125013489|NCT01500278|449676782|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
125013490|NCT01500278|449676781|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
125013491|NCT01500278|449676782|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
125013492|NCT01500278|449676781|FG000|Week 0 - Week 12|Patient decision|1|||
125013493|NCT01500278|449676782|FG001|Week 0 - Week 12|Patient decision|0|||
125013494|NCT01500278|449676781|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
125013495|NCT01500278|449676782|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
125013496|NCT01500278|449676781|FG000|Week 0 - Week 12|Investigator decision|1|||
124879326|NCT02487095|449181059|FG000|Dose Expansion|Unable to scan/restage participant|0|||
124879327|NCT02487095|449181060|FG001|Dose Expansion|Unable to scan/restage participant|0|||
124879328|NCT02487095|449181061|FG002|Dose Expansion|Unable to scan/restage participant|0|||
124879329|NCT02487095|449181062|FG003|Dose Expansion|Unable to scan/restage participant|0|||
124879330|NCT02487095|449181063|FG004|Dose Expansion|Unable to scan/restage participant|1|||
124879331|NCT01807650|449181064|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
124879332|NCT01807650|449181064|FG000|Overall Study|Adverse Event|5|||
125102402|NCT03917654|449995546|FG005|Year 2|Married|0|||
125102403|NCT03917654|449995547|FG006|Year 2|Married|1|||
125102404|NCT03917654|449995548|FG007|Year 2|Married|1|||
125102405|NCT03917654|449995549|FG008|Year 2|Married|0|||
124879333|NCT01807650|449181064|FG000|Overall Study|Other|2|||
124879334|NCT02969525|449181069|FG000|Double-Blind Period|Adverse Event|0|||
124879335|NCT02969525|449181070|FG001|Double-Blind Period|Adverse Event|0|||
124879336|NCT02969525|449181071|FG002|Double-Blind Period|Adverse Event|1|||
124879337|NCT02969525|449181072|FG003|Double-Blind Period|Adverse Event|1|||
124879338|NCT02969525|449181073|FG004|Double-Blind Period|Adverse Event|0|||
124879339|NCT02969525|449181074|FG005|Double-Blind Period|Adverse Event|0|||
124879340|NCT02969525|449181075|FG006|Double-Blind Period|Adverse Event|0|||
124879341|NCT02969525|449181076|FG007|Double-Blind Period|Adverse Event|0|||
124879342|NCT02969525|449181077|FG008|Double-Blind Period|Adverse Event|0|||
124879343|NCT02969525|449181078|FG009|Double-Blind Period|Adverse Event|0|||
124879344|NCT02969525|449181079|FG010|Double-Blind Period|Adverse Event|0|||
124879345|NCT02969525|449181080|FG011|Double-Blind Period|Adverse Event|0|||
124879346|NCT02969525|449181069|FG000|Double-Blind Period|LOW EGFR|0|||
124879347|NCT02969525|449181070|FG001|Double-Blind Period|LOW EGFR|0|||
125102406|NCT03917654|449995550|FG009|Year 2|Married|0|||
124879348|NCT02969525|449181071|FG002|Double-Blind Period|LOW EGFR|0|||
124879349|NCT02969525|449181072|FG003|Double-Blind Period|LOW EGFR|1|||
124879350|NCT02969525|449181073|FG004|Double-Blind Period|LOW EGFR|0|||
124879351|NCT02969525|449181074|FG005|Double-Blind Period|LOW EGFR|0|||
124879352|NCT02969525|449181075|FG006|Double-Blind Period|LOW EGFR|0|||
124879353|NCT02969525|449181076|FG007|Double-Blind Period|LOW EGFR|0|||
124879354|NCT02969525|449181077|FG008|Double-Blind Period|LOW EGFR|0|||
124879355|NCT02969525|449181078|FG009|Double-Blind Period|LOW EGFR|0|||
124879356|NCT02969525|449181079|FG010|Double-Blind Period|LOW EGFR|0|||
124879357|NCT02969525|449181080|FG011|Double-Blind Period|LOW EGFR|0|||
124879358|NCT02969525|449181069|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
124879359|NCT02969525|449181070|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
124879360|NCT02969525|449181071|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
124879361|NCT02969525|449181072|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
124879362|NCT02969525|449181073|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125102407|NCT03917654|449995551|FG010|Year 2|Married|0|||
125102408|NCT03917654|449995552|FG011|Year 2|Married|0|||
125102409|NCT03917654|449995541|FG000|Year 2|Subject moved away from site|1|||
125102410|NCT03917654|449995542|FG001|Year 2|Subject moved away from site|0|||
125102411|NCT03917654|449995543|FG002|Year 2|Subject moved away from site|0|||
125102412|NCT03917654|449995544|FG003|Year 2|Subject moved away from site|0|||
125102413|NCT03917654|449995545|FG004|Year 2|Subject moved away from site|1|||
125102414|NCT03917654|449995546|FG005|Year 2|Subject moved away from site|0|||
125102415|NCT03917654|449995547|FG006|Year 2|Subject moved away from site|2|||
125102416|NCT03917654|449995548|FG007|Year 2|Subject moved away from site|3|||
125102417|NCT03917654|449995549|FG008|Year 2|Subject moved away from site|0|||
125102418|NCT03917654|449995550|FG009|Year 2|Subject moved away from site|2|||
125102419|NCT03917654|449995551|FG010|Year 2|Subject moved away from site|0|||
125102420|NCT03917654|449995552|FG011|Year 2|Subject moved away from site|1|||
125102421|NCT03917654|449995541|FG000|Year 2|Year 2 Screening failure|0|||
125102422|NCT03917654|449995542|FG001|Year 2|Year 2 Screening failure|1|||
125102423|NCT03917654|449995543|FG002|Year 2|Year 2 Screening failure|0|||
125102424|NCT03917654|449995544|FG003|Year 2|Year 2 Screening failure|0|||
125102425|NCT03917654|449995545|FG004|Year 2|Year 2 Screening failure|2|||
125102426|NCT03917654|449995546|FG005|Year 2|Year 2 Screening failure|0|||
125102427|NCT03917654|449995547|FG006|Year 2|Year 2 Screening failure|4|||
124879363|NCT02969525|449181074|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
124879364|NCT02969525|449181075|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
124879365|NCT02969525|449181076|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
124879366|NCT02969525|449181077|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
124879367|NCT02969525|449181078|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
124879368|NCT02969525|449181079|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125102428|NCT03917654|449995548|FG007|Year 2|Year 2 Screening failure|3|||
125102429|NCT03917654|449995549|FG008|Year 2|Year 2 Screening failure|10|||
125102430|NCT03917654|449995550|FG009|Year 2|Year 2 Screening failure|2|||
125102431|NCT03917654|449995551|FG010|Year 2|Year 2 Screening failure|1|||
125102432|NCT03917654|449995552|FG011|Year 2|Year 2 Screening failure|1|||
124879369|NCT02969525|449181080|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
124879370|NCT02969525|449181069|FG000|Dose-Blind Period|Adverse Event|0|||
124879371|NCT02969525|449181070|FG001|Dose-Blind Period|Adverse Event|0|||
124879372|NCT02969525|449181071|FG002|Dose-Blind Period|Adverse Event|0|||
124879373|NCT02969525|449181072|FG003|Dose-Blind Period|Adverse Event|0|||
124879374|NCT02969525|449181073|FG004|Dose-Blind Period|Adverse Event|0|||
124879375|NCT02969525|449181074|FG005|Dose-Blind Period|Adverse Event|0|||
124879376|NCT02969525|449181075|FG006|Dose-Blind Period|Adverse Event|0|||
124879377|NCT02969525|449181076|FG007|Dose-Blind Period|Adverse Event|0|||
124879378|NCT02969525|449181077|FG008|Dose-Blind Period|Adverse Event|0|||
124879379|NCT02969525|449181078|FG009|Dose-Blind Period|Adverse Event|1|||
124879380|NCT02969525|449181079|FG010|Dose-Blind Period|Adverse Event|1|||
124879381|NCT02969525|449181080|FG011|Dose-Blind Period|Adverse Event|1|||
124879382|NCT02969525|449181069|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
124879383|NCT02969525|449181070|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
124879384|NCT02969525|449181071|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
124879385|NCT02969525|449181072|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
124879386|NCT02969525|449181073|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
125102433|NCT03917654|449995541|FG000|Year 2|Death|0|||
125102434|NCT03917654|449995542|FG001|Year 2|Death|0|||
125102435|NCT03917654|449995543|FG002|Year 2|Death|0|||
125102436|NCT03917654|449995544|FG003|Year 2|Death|0|||
125102437|NCT03917654|449995545|FG004|Year 2|Death|0|||
125102438|NCT03917654|449995546|FG005|Year 2|Death|1|||
125102439|NCT03917654|449995547|FG006|Year 2|Death|0|||
125102440|NCT03917654|449995548|FG007|Year 2|Death|0|||
125102441|NCT03917654|449995549|FG008|Year 2|Death|1|||
125102442|NCT03917654|449995550|FG009|Year 2|Death|1|||
125102443|NCT03917654|449995551|FG010|Year 2|Death|0|||
125102444|NCT03917654|449995552|FG011|Year 2|Death|0|||
124879387|NCT02969525|449181074|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
124879388|NCT02969525|449181075|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
124879389|NCT02969525|449181076|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
124879390|NCT02969525|449181077|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
124879391|NCT02969525|449181078|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
124879392|NCT02969525|449181079|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
124879393|NCT02969525|449181080|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
125102445|NCT03917654|449995541|FG000|Year 2|Withdrawal by Subject|0|||
125102446|NCT03917654|449995542|FG001|Year 2|Withdrawal by Subject|0|||
125102447|NCT03917654|449995543|FG002|Year 2|Withdrawal by Subject|0|||
125102448|NCT03917654|449995544|FG003|Year 2|Withdrawal by Subject|0|||
125102449|NCT03917654|449995545|FG004|Year 2|Withdrawal by Subject|0|||
125102450|NCT03917654|449995546|FG005|Year 2|Withdrawal by Subject|0|||
124879394|NCT02969525|449181069|FG000|Dose-Blind Period|Non-cooperating patient|0|||
124879395|NCT02969525|449181070|FG001|Dose-Blind Period|Non-cooperating patient|0|||
124879396|NCT02969525|449181071|FG002|Dose-Blind Period|Non-cooperating patient|0|||
124879397|NCT02969525|449181072|FG003|Dose-Blind Period|Non-cooperating patient|0|||
124879398|NCT02969525|449181073|FG004|Dose-Blind Period|Non-cooperating patient|0|||
124879399|NCT02969525|449181074|FG005|Dose-Blind Period|Non-cooperating patient|0|||
124879400|NCT02969525|449181075|FG006|Dose-Blind Period|Non-cooperating patient|0|||
124879401|NCT02969525|449181076|FG007|Dose-Blind Period|Non-cooperating patient|0|||
124879402|NCT02969525|449181077|FG008|Dose-Blind Period|Non-cooperating patient|0|||
124879403|NCT02969525|449181078|FG009|Dose-Blind Period|Non-cooperating patient|0|||
124879404|NCT02969525|449181079|FG010|Dose-Blind Period|Non-cooperating patient|0|||
124879405|NCT02969525|449181080|FG011|Dose-Blind Period|Non-cooperating patient|1|||
124879406|NCT02969525|449181069|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
124879407|NCT02969525|449181070|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
124879408|NCT02969525|449181071|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
124879409|NCT02969525|449181072|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
124879410|NCT02969525|449181073|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
124879411|NCT02969525|449181074|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125102451|NCT03917654|449995547|FG006|Year 2|Withdrawal by Subject|3|||
125102452|NCT03917654|449995548|FG007|Year 2|Withdrawal by Subject|0|||
125102453|NCT03917654|449995549|FG008|Year 2|Withdrawal by Subject|2|||
125210767|NCT03723070|450395677|FG000|Overall Study|Physician Decision|1|||
124879412|NCT02969525|449181075|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
124879413|NCT02969525|449181076|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
124879414|NCT02969525|449181077|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
124879415|NCT02969525|449181078|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
124879416|NCT02969525|449181079|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
124879417|NCT02969525|449181080|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125102454|NCT03917654|449995550|FG009|Year 2|Withdrawal by Subject|5|||
125102455|NCT03917654|449995551|FG010|Year 2|Withdrawal by Subject|0|||
125102456|NCT03917654|449995552|FG011|Year 2|Withdrawal by Subject|0|||
125102457|NCT03917654|449995541|FG000|Year 2|Spouse/family member request|0|||
125102458|NCT03917654|449995542|FG001|Year 2|Spouse/family member request|0|||
125102459|NCT03917654|449995543|FG002|Year 2|Spouse/family member request|0|||
125102460|NCT03917654|449995544|FG003|Year 2|Spouse/family member request|0|||
125102461|NCT03917654|449995545|FG004|Year 2|Spouse/family member request|0|||
125102462|NCT03917654|449995546|FG005|Year 2|Spouse/family member request|0|||
125102463|NCT03917654|449995547|FG006|Year 2|Spouse/family member request|1|||
125102464|NCT03917654|449995548|FG007|Year 2|Spouse/family member request|0|||
125102465|NCT03917654|449995549|FG008|Year 2|Spouse/family member request|0|||
125102466|NCT03917654|449995550|FG009|Year 2|Spouse/family member request|0|||
125102467|NCT03917654|449995551|FG010|Year 2|Spouse/family member request|0|||
125102468|NCT03917654|449995552|FG011|Year 2|Spouse/family member request|0|||
125102469|NCT03917654|449995541|FG000|Year 2|Lost to Follow-up|0|||
125102470|NCT03917654|449995542|FG001|Year 2|Lost to Follow-up|0|||
125102471|NCT03917654|449995543|FG002|Year 2|Lost to Follow-up|0|||
125102472|NCT03917654|449995544|FG003|Year 2|Lost to Follow-up|0|||
125102473|NCT03917654|449995545|FG004|Year 2|Lost to Follow-up|0|||
125102474|NCT03917654|449995546|FG005|Year 2|Lost to Follow-up|0|||
125102475|NCT03917654|449995547|FG006|Year 2|Lost to Follow-up|1|||
125102476|NCT03917654|449995548|FG007|Year 2|Lost to Follow-up|0|||
125102477|NCT03917654|449995549|FG008|Year 2|Lost to Follow-up|1|||
125102478|NCT03917654|449995550|FG009|Year 2|Lost to Follow-up|0|||
124879418|NCT00524030|449181081|FG000|Overall Study|Lack of Efficacy|10|||
124879419|NCT00524030|449181082|FG001|Overall Study|Lack of Efficacy|24|||
124879420|NCT00524030|449181081|FG000|Overall Study|Lost to Follow-up|0|||
124879421|NCT00524030|449181082|FG001|Overall Study|Lost to Follow-up|2|||
124879422|NCT00524030|449181081|FG000|Overall Study|Withdrawal by Subject|3|||
124879423|NCT00524030|449181082|FG001|Overall Study|Withdrawal by Subject|8|||
124879424|NCT00524030|449181081|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
124879425|NCT00524030|449181082|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
124879426|NCT00524030|449181081|FG000|Overall Study|Protocol Violation|0|||
124879427|NCT00524030|449181082|FG001|Overall Study|Protocol Violation|1|||
124879428|NCT00524030|449181081|FG000|Overall Study|Pregnancy|1|||
125102479|NCT03917654|449995551|FG010|Year 2|Lost to Follow-up|0|||
125102480|NCT03917654|449995552|FG011|Year 2|Lost to Follow-up|1|||
125102481|NCT03917654|449995541|FG000|Year 2|Adverse Event|0|||
125102482|NCT03917654|449995542|FG001|Year 2|Adverse Event|0|||
125102483|NCT03917654|449995543|FG002|Year 2|Adverse Event|0|||
125102484|NCT03917654|449995544|FG003|Year 2|Adverse Event|0|||
125102485|NCT03917654|449995545|FG004|Year 2|Adverse Event|0|||
125102486|NCT03917654|449995546|FG005|Year 2|Adverse Event|0|||
125102487|NCT03917654|449995547|FG006|Year 2|Adverse Event|0|||
125102488|NCT03917654|449995548|FG007|Year 2|Adverse Event|0|||
125102489|NCT03917654|449995549|FG008|Year 2|Adverse Event|0|||
125102490|NCT03917654|449995550|FG009|Year 2|Adverse Event|1|||
125102491|NCT03917654|449995551|FG010|Year 2|Adverse Event|0|||
125102492|NCT03917654|449995552|FG011|Year 2|Adverse Event|0|||
125102493|NCT00905437|449995554|FG000|Overall Study|Adverse Event|3|||
125102494|NCT00905437|449995555|FG001|Overall Study|Adverse Event|2|||
125102495|NCT00905437|449995554|FG000|Overall Study|Lost to Follow-up|0|||
125102496|NCT00905437|449995555|FG001|Overall Study|Lost to Follow-up|1|||
125102497|NCT00905437|449995554|FG000|Overall Study|Withdrawal by Subject|0|||
125102498|NCT00905437|449995555|FG001|Overall Study|Withdrawal by Subject|1|||
125102499|NCT00905437|449995554|FG000|Overall Study|Other|5|||
125102500|NCT00905437|449995555|FG001|Overall Study|Other|6|||
125102501|NCT03252015|449995558|FG000|Overall Study|Withdrawal by Subject|0|||
125102502|NCT03252015|449995559|FG001|Overall Study|Withdrawal by Subject|1|||
125102503|NCT03252015|449995560|FG002|Overall Study|Withdrawal by Subject|1|||
125102504|NCT03252015|449995561|FG003|Overall Study|Withdrawal by Subject|0|||
125102505|NCT03252015|449995558|FG000|Overall Study|Adverse Event|1|||
125102506|NCT03252015|449995559|FG001|Overall Study|Adverse Event|0|||
125102507|NCT03252015|449995560|FG002|Overall Study|Adverse Event|0|||
125102508|NCT03252015|449995561|FG003|Overall Study|Adverse Event|1|||
125102509|NCT01329562|449995562|FG000|Overall Study|Protocol Violation|5|||
125102510|NCT01329562|449995563|FG001|Overall Study|Protocol Violation|3|||
125102511|NCT01329562|449995562|FG000|Overall Study|Lost to Follow-up|1|||
125102512|NCT01329562|449995563|FG001|Overall Study|Lost to Follow-up|1|||
125102513|NCT01329562|449995562|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
125102514|NCT01329562|449995563|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
124879429|NCT00524030|449181082|FG001|Overall Study|Pregnancy|0|||
124879430|NCT00524030|449181081|FG000|Overall Study|Adverse Event|3|||
124879431|NCT00524030|449181082|FG001|Overall Study|Adverse Event|21|||
125102515|NCT01329562|449995562|FG000|Overall Study|Physician Decision|0|||
125102516|NCT01329562|449995563|FG001|Overall Study|Physician Decision|1|||
125102517|NCT03128931|449995564|FG000|Overall Study|Physician Decision|1|||
125102518|NCT03128931|449995564|FG000|Overall Study|Equipment Issues|3|||
125102519|NCT00061568|449995567|FG000|Overall Study|Lost to Follow-up|12|||
125102520|NCT00061568|449995568|FG001|Overall Study|Lost to Follow-up|0|||
125102521|NCT00061568|449995567|FG000|Overall Study|Death|6|||
125102522|NCT00061568|449995568|FG001|Overall Study|Death|0|||
125102523|NCT00061568|449995567|FG000|Overall Study|Withdrawal by Subject|1|||
125102524|NCT00061568|449995568|FG001|Overall Study|Withdrawal by Subject|0|||
125102525|NCT01071278|449995572|FG000|Overall Study|Premature Discontinuation|254|||
125102526|NCT01071278|449995572|FG000|Overall Study|Completion Status Unknown|459|||
125102527|NCT00903409|449995573|FG000|Overall Study|Adverse Event|11|||
125102528|NCT00903409|449995574|FG001|Overall Study|Adverse Event|9|||
125102529|NCT00903409|449995573|FG000|Overall Study|Non-compliance with Protocol|1|||
125102530|NCT00903409|449995574|FG001|Overall Study|Non-compliance with Protocol|1|||
125102531|NCT00903409|449995573|FG000|Overall Study|Laboratory Abnormality|2|||
125102532|NCT00903409|449995574|FG001|Overall Study|Laboratory Abnormality|0|||
125102533|NCT00903409|449995573|FG000|Overall Study|Withdrawal by Subject|8|||
124879432|NCT00524030|449181081|FG000|Overall Study|Death|0|||
124879433|NCT00524030|449181082|FG001|Overall Study|Death|1|||
124879434|NCT01816763|449182445|FG000|Overall Study|The main reason for an incomplete survey|4|||
124879435|NCT01816763|449182446|FG001|Overall Study|The main reason for an incomplete survey|15|||
124879436|NCT01816763|449182447|FG002|Overall Study|The main reason for an incomplete survey|11|||
124879437|NCT00311155|449182450|FG000|Overall Study|Adverse Event|21|||
124879438|NCT00311155|449182450|FG000|Overall Study|Withdrawal by Subject|17|||
124879439|NCT00311155|449182450|FG000|Overall Study|Did not meet entry criteria|55|||
124879440|NCT00429494|449182452|FG000|Overall Study|Withdrawal by Subject|9|||
124879441|NCT00429494|449182452|FG000|Overall Study|Death|6|||
124879442|NCT02392611|449182457|FG000|Overall Study|Adverse Event|0|||
125102534|NCT00903409|449995574|FG001|Overall Study|Withdrawal by Subject|8|||
125102535|NCT00903409|449995573|FG000|Overall Study|Other|2|||
125102536|NCT00903409|449995574|FG001|Overall Study|Other|3|||
125102537|NCT00903409|449995573|FG000|Overall Study|Lost to Follow-up|2|||
125102538|NCT00903409|449995574|FG001|Overall Study|Lost to Follow-up|6|||
125102539|NCT00797316|449995575|FG000|Overall Study|Administrative problems|1|||
125102540|NCT00797316|449995576|FG001|Overall Study|Administrative problems|0|||
125102541|NCT00797316|449995575|FG000|Overall Study|Adverse Event|5|||
125102542|NCT00797316|449995576|FG001|Overall Study|Adverse Event|3|||
125102543|NCT00797316|449995575|FG000|Overall Study|Lost to Follow-up|4|||
125102544|NCT00797316|449995576|FG001|Overall Study|Lost to Follow-up|8|||
125102545|NCT00797316|449995575|FG000|Overall Study|Protocol Deviation|1|||
125102546|NCT00797316|449995576|FG001|Overall Study|Protocol Deviation|2|||
125102547|NCT00797316|449995575|FG000|Overall Study|Patient withdrew consent|12|||
125102548|NCT00797316|449995576|FG001|Overall Study|Patient withdrew consent|6|||
125102549|NCT00797316|449995575|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125102550|NCT00797316|449995576|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
125102551|NCT03239340|449995579|FG000|Overall Study|Other|26|||
125102552|NCT03239340|449995579|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
125102553|NCT03239340|449995579|FG000|Overall Study|Death|40|||
125102554|NCT03239340|449995579|FG000|Overall Study|Lost to Follow-up|2|||
125102555|NCT03239340|449995579|FG000|Overall Study|Physician Decision|16|||
125102556|NCT03239340|449995579|FG000|Overall Study|Withdrawal by Subject|27|||
125102557|NCT04066894|449995583|FG000|Overall Study|Lack of Efficacy|1|||
125102558|NCT04066894|449995583|FG000|Overall Study|Screen Failure|1|||
125102559|NCT03494816|449995584|FG000|Overall Study|Protocol Violation|2|||
125102560|NCT03494816|449995584|FG000|Overall Study|Physician Decision|2|||
125102561|NCT03494816|449995584|FG000|Overall Study|Did not start trial treatment|1|||
125102562|NCT03494816|449995584|FG000|Overall Study|Adverse Event|1|||
125102563|NCT00314262|449995585|FG000|Overall Study|Adverse Event|2|||
125102564|NCT00314262|449995585|FG000|Overall Study|Withdrawal by Subject|2|||
125102565|NCT00314262|449995585|FG000|Overall Study|Physician Decision|1|||
125102566|NCT01126359|449995586|FG000|First Intervention (20-minutes)|Physician Decision|0|||
125102567|NCT01126359|449995587|FG001|First Intervention (20-minutes)|Physician Decision|1|||
125102568|NCT00902486|449995588|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
125102569|NCT00902486|449995589|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
125102570|NCT00902486|449995590|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
125102571|NCT00902486|449995591|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
125102572|NCT00902486|449995592|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
125102573|NCT00902486|449995593|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
125102574|NCT00902486|449995588|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
125102575|NCT00902486|449995589|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
125102576|NCT00902486|449995590|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
124879443|NCT02392611|449182458|FG001|Overall Study|Adverse Event|0|||
125102577|NCT00902486|449995591|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
125102578|NCT00902486|449995592|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
124879444|NCT02392611|449182459|FG002|Overall Study|Adverse Event|0|||
124879445|NCT02392611|449182460|FG003|Overall Study|Adverse Event|1|||
125102579|NCT00902486|449995593|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
125102580|NCT00902486|449995588|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
125102581|NCT00902486|449995589|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
125102582|NCT00902486|449995590|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
125102583|NCT00902486|449995591|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
125102584|NCT00902486|449995592|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
125102585|NCT00902486|449995593|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
125102586|NCT00902486|449995588|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
125102587|NCT00902486|449995589|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
125102588|NCT00902486|449995590|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
125102589|NCT00902486|449995591|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
125102590|NCT00902486|449995592|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
125102591|NCT00902486|449995593|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
125102592|NCT00902486|449995588|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
125102593|NCT00902486|449995589|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
125102594|NCT00902486|449995590|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
125102595|NCT00902486|449995591|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
125102596|NCT00902486|449995592|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
125102597|NCT00902486|449995593|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
125102598|NCT00902486|449995588|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
125102599|NCT00902486|449995589|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
125102600|NCT00902486|449995590|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
125102601|NCT00902486|449995591|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
125102602|NCT00902486|449995592|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
125102603|NCT00902486|449995593|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
125102604|NCT00902486|449995588|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
125102605|NCT00902486|449995589|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
125102606|NCT00902486|449995590|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
125102607|NCT00902486|449995591|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
125102608|NCT00902486|449995592|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
125102609|NCT00902486|449995593|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
125102610|NCT00902486|449995588|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
125102611|NCT00902486|449995589|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
125102612|NCT00902486|449995590|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
125102613|NCT00902486|449995591|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
125102614|NCT00902486|449995592|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
125102615|NCT00902486|449995593|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
125102616|NCT00902486|449995588|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
125102617|NCT00902486|449995589|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
125102618|NCT00902486|449995590|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
125102619|NCT00902486|449995591|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
125102620|NCT00902486|449995592|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
125102621|NCT00902486|449995593|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
125102622|NCT00902486|449995588|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
125102623|NCT00902486|449995589|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
125102624|NCT00902486|449995590|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
125102625|NCT00902486|449995591|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
125102626|NCT00902486|449995592|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
125102627|NCT00902486|449995593|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
125102628|NCT00902486|449995588|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
125102629|NCT00902486|449995589|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
125102630|NCT00902486|449995590|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
124879446|NCT02392611|449182461|FG004|Overall Study|Adverse Event|0|||
124879447|NCT02392611|449182462|FG005|Overall Study|Adverse Event|0|||
124879448|NCT02392611|449182463|FG006|Overall Study|Adverse Event|0|||
125102631|NCT00902486|449995591|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
125102632|NCT00902486|449995592|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
125102633|NCT00902486|449995593|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
125102634|NCT02332655|449995594|FG000|Overall Study|Lack of Efficacy|1|||
125102635|NCT03505606|449997659|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
125102636|NCT03505606|449997660|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
125102637|NCT03505606|449997661|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
125102638|NCT03505606|449997659|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
124879449|NCT02392611|449182464|FG007|Overall Study|Adverse Event|0|||
124879450|NCT02392611|449182465|FG008|Overall Study|Adverse Event|0|||
124879451|NCT02392611|449182457|FG000|Overall Study|Progressive disease|0|||
124879452|NCT02392611|449182458|FG001|Overall Study|Progressive disease|0|||
124879453|NCT02392611|449182459|FG002|Overall Study|Progressive disease|0|||
125013497|NCT01500278|449676782|FG001|Week 0 - Week 12|Investigator decision|0|||
125013498|NCT01500278|449676781|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
125013499|NCT01500278|449676782|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
125013500|NCT01500278|449676781|FG000|Week 0 - Week 12|Sponsor decision|1|||
125013501|NCT01500278|449676782|FG001|Week 0 - Week 12|Sponsor decision|0|||
125013502|NCT01500278|449676781|FG000|Week 0 - Week 12|Personal reason|0|||
125013503|NCT01500278|449676782|FG001|Week 0 - Week 12|Personal reason|1|||
125013504|NCT01500278|449676781|FG000|Week 0 - Week 12|Other serious disease|0|||
125013505|NCT01500278|449676782|FG001|Week 0 - Week 12|Other serious disease|1|||
125013506|NCT01500278|449676781|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
125013507|NCT01500278|449676782|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
125013508|NCT01500278|449676781|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
125013509|NCT01500278|449676782|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
125013510|NCT01500278|449676781|FG000|Week 13 - Week 104|Protocol Violation|6|||
125013511|NCT01500278|449676782|FG001|Week 13 - Week 104|Protocol Violation|6|||
125013512|NCT01500278|449676781|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
125013513|NCT01500278|449676782|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
125013514|NCT01500278|449676781|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
125013515|NCT01500278|449676782|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
125013516|NCT01500278|449676781|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
125013517|NCT01500278|449676782|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
125013518|NCT01500278|449676781|FG000|Week 13 - Week 104|Non/bad compliance|7|||
125013519|NCT01500278|449676782|FG001|Week 13 - Week 104|Non/bad compliance|5|||
125013520|NCT01500278|449676781|FG000|Week 13 - Week 104|Recurrent infections|1|||
125013521|NCT01500278|449676782|FG001|Week 13 - Week 104|Recurrent infections|0|||
125013522|NCT01500278|449676781|FG000|Week 13 - Week 104|False positive test|1|||
125013523|NCT01500278|449676782|FG001|Week 13 - Week 104|False positive test|2|||
125013524|NCT01500278|449676781|FG000|Week 13 - Week 104|Sponsor request|4|||
125013525|NCT01500278|449676782|FG001|Week 13 - Week 104|Sponsor request|0|||
125013526|NCT01500278|449676781|FG000|Week 13 - Week 104|Withdrawn in error|1|||
125013527|NCT01500278|449676782|FG001|Week 13 - Week 104|Withdrawn in error|0|||
124879454|NCT02392611|449182460|FG003|Overall Study|Progressive disease|2|||
124879455|NCT02392611|449182461|FG004|Overall Study|Progressive disease|1|||
124879456|NCT02392611|449182462|FG005|Overall Study|Progressive disease|0|||
124879457|NCT02392611|449182463|FG006|Overall Study|Progressive disease|0|||
124879458|NCT02392611|449182464|FG007|Overall Study|Progressive disease|0|||
124879459|NCT02392611|449182465|FG008|Overall Study|Progressive disease|0|||
124879460|NCT02392611|449182457|FG000|Overall Study|Death|1|||
124879461|NCT02392611|449182458|FG001|Overall Study|Death|0|||
124879462|NCT02392611|449182459|FG002|Overall Study|Death|0|||
124879463|NCT02392611|449182460|FG003|Overall Study|Death|0|||
124879464|NCT02392611|449182461|FG004|Overall Study|Death|0|||
124879465|NCT02392611|449182462|FG005|Overall Study|Death|1|||
124879466|NCT02392611|449182463|FG006|Overall Study|Death|0|||
124879467|NCT02392611|449182464|FG007|Overall Study|Death|0|||
124879468|NCT02392611|449182465|FG008|Overall Study|Death|0|||
124879469|NCT02392611|449182457|FG000|Overall Study|Withdrawal by Subject|0|||
125013528|NCT01500278|449676781|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
125013529|NCT01500278|449676782|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
125013530|NCT01500278|449676781|FG000|Week 13 - Week 104|Protocol deviation|1|||
125013531|NCT01500278|449676782|FG001|Week 13 - Week 104|Protocol deviation|0|||
125013532|NCT01500278|449676781|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
125013533|NCT01500278|449676782|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
125013534|NCT01500278|449676781|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
125013535|NCT01500278|449676782|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
125013536|NCT01500278|449676781|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
125013537|NCT01500278|449676782|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
125013538|NCT01500278|449676781|FG000|Week 13 - Week 104|Relocation|0|||
125013539|NCT01500278|449676782|FG001|Week 13 - Week 104|Relocation|1|||
125013540|NCT01500278|449676781|FG000|Week 13 - Week 104|Sponsor decision|0|||
125013541|NCT01500278|449676782|FG001|Week 13 - Week 104|Sponsor decision|2|||
125013542|NCT01500278|449676781|FG000|Week 13 - Week 104|Medical monitor decision|0|||
125013543|NCT01500278|449676782|FG001|Week 13 - Week 104|Medical monitor decision|2|||
125013544|NCT01500278|449676781|FG000|Week 13 - Week 104|Personal reason|0|||
125013545|NCT01500278|449676782|FG001|Week 13 - Week 104|Personal reason|1|||
125013546|NCT01500278|449676781|FG000|Week 13 - Week 104|Not completed|0|||
125013547|NCT01500278|449676782|FG001|Week 13 - Week 104|Not completed|1|||
125013548|NCT01500278|449676781|FG000|Week 13 - Week 104|Death|2|||
125013549|NCT01500278|449676782|FG001|Week 13 - Week 104|Death|4|||
125013550|NCT01500278|449676781|FG000|Week 13 - Week 104|Adverse Event|54|||
125013551|NCT01500278|449676782|FG001|Week 13 - Week 104|Adverse Event|54|||
125013552|NCT01709435|449676786|FG000|Overall Study|Adverse Event|1|||
125013553|NCT01709435|449676787|FG001|Overall Study|Adverse Event|1|||
125013554|NCT01709435|449676788|FG002|Overall Study|Adverse Event|1|||
125013555|NCT01709435|449676789|FG003|Overall Study|Adverse Event|0|||
125013556|NCT01709435|449676790|FG004|Overall Study|Adverse Event|0|||
125013557|NCT01709435|449676791|FG005|Overall Study|Adverse Event|1|||
125013558|NCT01709435|449676786|FG000|Overall Study|Lack of Efficacy|5|||
125013559|NCT01709435|449676787|FG001|Overall Study|Lack of Efficacy|7|||
125013560|NCT01709435|449676788|FG002|Overall Study|Lack of Efficacy|2|||
125013561|NCT01709435|449676789|FG003|Overall Study|Lack of Efficacy|2|||
125013562|NCT01709435|449676790|FG004|Overall Study|Lack of Efficacy|6|||
125013563|NCT01709435|449676791|FG005|Overall Study|Lack of Efficacy|3|||
125013564|NCT01709435|449676786|FG000|Overall Study|Physician Decision|0|||
125013565|NCT01709435|449676787|FG001|Overall Study|Physician Decision|1|||
125013566|NCT01709435|449676788|FG002|Overall Study|Physician Decision|0|||
125013567|NCT01709435|449676789|FG003|Overall Study|Physician Decision|1|||
125013568|NCT01709435|449676790|FG004|Overall Study|Physician Decision|2|||
125013569|NCT01709435|449676791|FG005|Overall Study|Physician Decision|0|||
125013570|NCT01709435|449676786|FG000|Overall Study|Withdrawal by Subject|0|||
125013571|NCT01709435|449676787|FG001|Overall Study|Withdrawal by Subject|0|||
125013572|NCT01709435|449676788|FG002|Overall Study|Withdrawal by Subject|3|||
125013573|NCT01709435|449676789|FG003|Overall Study|Withdrawal by Subject|0|||
125013574|NCT01709435|449676790|FG004|Overall Study|Withdrawal by Subject|2|||
125013575|NCT01709435|449676791|FG005|Overall Study|Withdrawal by Subject|2|||
124879470|NCT02392611|449182458|FG001|Overall Study|Withdrawal by Subject|0|||
124879471|NCT02392611|449182459|FG002|Overall Study|Withdrawal by Subject|0|||
124879472|NCT02392611|449182460|FG003|Overall Study|Withdrawal by Subject|1|||
124879473|NCT02392611|449182461|FG004|Overall Study|Withdrawal by Subject|0|||
124879474|NCT02392611|449182462|FG005|Overall Study|Withdrawal by Subject|0|||
125013576|NCT00053417|449676792|FG000|Overall Study|Adverse Event|1|||
125013577|NCT00053417|449676793|FG001|Overall Study|Adverse Event|0|||
125013578|NCT00053417|449676794|FG002|Overall Study|Adverse Event|1|||
125013579|NCT00053417|449676795|FG003|Overall Study|Adverse Event|5|||
125013580|NCT00053417|449676792|FG000|Overall Study|Non-Compliance|0|||
125013581|NCT00053417|449676793|FG001|Overall Study|Non-Compliance|0|||
125013582|NCT00053417|449676794|FG002|Overall Study|Non-Compliance|0|||
125013583|NCT00053417|449676795|FG003|Overall Study|Non-Compliance|1|||
124879475|NCT02392611|449182463|FG006|Overall Study|Withdrawal by Subject|0|||
125102639|NCT03505606|449997660|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
125102640|NCT03505606|449997661|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
125102641|NCT03505606|449997659|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
125102642|NCT03505606|449997660|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
125102643|NCT03505606|449997661|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
125102644|NCT03505606|449997659|FG000|Overall Study|Poor compliance with refractive correction|0|||
125102645|NCT03505606|449997660|FG001|Overall Study|Poor compliance with refractive correction|0|||
125102646|NCT03505606|449997661|FG002|Overall Study|Poor compliance with refractive correction|1|||
125102647|NCT03505606|449997659|FG000|Overall Study|Insufficient anisometropia|0|||
125102648|NCT03505606|449997660|FG001|Overall Study|Insufficient anisometropia|0|||
125102649|NCT03505606|449997661|FG002|Overall Study|Insufficient anisometropia|2|||
125102650|NCT03505606|449997659|FG000|Overall Study|Ectopia Lentis|0|||
125102651|NCT03505606|449997660|FG001|Overall Study|Ectopia Lentis|0|||
125102652|NCT03505606|449997661|FG002|Overall Study|Ectopia Lentis|1|||
125102653|NCT03505606|449997659|FG000|Overall Study|alternation of amblyopic eye|0|||
125102654|NCT03505606|449997660|FG001|Overall Study|alternation of amblyopic eye|1|||
125102655|NCT03505606|449997661|FG002|Overall Study|alternation of amblyopic eye|0|||
125102656|NCT01808508|449997689|FG000|Overall Study|Lost to Follow-up|1|||
125102657|NCT01808508|449997690|FG001|Overall Study|Lost to Follow-up|0|||
125102658|NCT01808508|449997691|FG002|Overall Study|Lost to Follow-up|0|||
125102659|NCT01017731|449997692|FG000|Overall Study|Lost to Follow-up|2|||
125102660|NCT01017731|449997692|FG000|Overall Study|Withdrawal by Subject|3|||
125102661|NCT01017731|449997692|FG000|Overall Study|Physician Decision|2|||
125102662|NCT01017731|449997692|FG000|Overall Study|Adverse Event|1|||
125102663|NCT05378269|449997693|FG000|Overall Study|Protocol Violation|1|||
125102664|NCT05378269|449997694|FG001|Overall Study|Protocol Violation|0|||
125102665|NCT05378269|449997695|FG002|Overall Study|Protocol Violation|2|||
125102666|NCT05378269|449997696|FG003|Overall Study|Protocol Violation|0|||
125102667|NCT05378269|449997697|FG004|Overall Study|Protocol Violation|0|||
125102668|NCT00359073|449997698|FG000|Overall Study|Withdrawal by Subject|1|||
125102669|NCT00359073|449997699|FG001|Overall Study|Withdrawal by Subject|1|||
125102670|NCT00359073|449997698|FG000|Overall Study|Eligibility criteria no longer met|3|||
125102671|NCT00359073|449997699|FG001|Overall Study|Eligibility criteria no longer met|0|||
125102672|NCT00359073|449997698|FG000|Overall Study|developed RV16 antibody|0|||
125102673|NCT00359073|449997699|FG001|Overall Study|developed RV16 antibody|1|||
125102674|NCT03387423|449997702|FG000|Overall Study|Lost to Follow-up|16|||
125102675|NCT03387423|449997703|FG001|Overall Study|Lost to Follow-up|12|||
125102676|NCT03387423|449997704|FG002|Overall Study|Lost to Follow-up|1|||
125102677|NCT03387423|449997705|FG003|Overall Study|Lost to Follow-up|0|||
125102678|NCT03387423|449997702|FG000|Overall Study|Other|0|||
125102679|NCT03387423|449997703|FG001|Overall Study|Other|3|||
125102680|NCT03387423|449997704|FG002|Overall Study|Other|0|||
125102681|NCT03387423|449997705|FG003|Overall Study|Other|0|||
125102682|NCT03387423|449997702|FG000|Overall Study|Administrative Reason|166|||
125102683|NCT03387423|449997703|FG001|Overall Study|Administrative Reason|89|||
125102684|NCT03387423|449997704|FG002|Overall Study|Administrative Reason|17|||
125102685|NCT03387423|449997705|FG003|Overall Study|Administrative Reason|19|||
125102686|NCT03387423|449997702|FG000|Overall Study|Revocation Consent|76|||
125102687|NCT03387423|449997703|FG001|Overall Study|Revocation Consent|32|||
125102688|NCT03387423|449997704|FG002|Overall Study|Revocation Consent|3|||
125102689|NCT03387423|449997705|FG003|Overall Study|Revocation Consent|5|||
125102690|NCT01371006|449997706|FG000|Overall Study|Adverse Event|1|||
125102691|NCT01371006|449997707|FG001|Overall Study|Adverse Event|0|||
125102692|NCT01721200|449997708|FG000|Overall Study|Lost to Follow-up|3|||
125102693|NCT01721200|449997709|FG001|Overall Study|Lost to Follow-up|5|||
124879476|NCT02392611|449182464|FG007|Overall Study|Withdrawal by Subject|0|||
124879477|NCT02392611|449182465|FG008|Overall Study|Withdrawal by Subject|0|||
124879478|NCT02392611|449182457|FG000|Overall Study|Lost to Follow-up|0|||
124879479|NCT02392611|449182458|FG001|Overall Study|Lost to Follow-up|0|||
125013584|NCT00053417|449676792|FG000|Overall Study|Withdrawal by Subject|0|||
125013585|NCT00053417|449676793|FG001|Overall Study|Withdrawal by Subject|1|||
125013586|NCT00053417|449676794|FG002|Overall Study|Withdrawal by Subject|0|||
125013587|NCT00053417|449676795|FG003|Overall Study|Withdrawal by Subject|0|||
125013588|NCT00053417|449676792|FG000|Overall Study|Lost to Follow-up|1|||
125013589|NCT00053417|449676793|FG001|Overall Study|Lost to Follow-up|1|||
125013590|NCT00053417|449676794|FG002|Overall Study|Lost to Follow-up|0|||
125013591|NCT00053417|449676795|FG003|Overall Study|Lost to Follow-up|0|||
125013592|NCT02182687|449676802|FG000|Overall Study|Withdrawal by Subject|4|||
125013593|NCT02182687|449676803|FG001|Overall Study|Withdrawal by Subject|0|||
125013594|NCT02182687|449676802|FG000|Overall Study|Adverse Event|1|||
125013595|NCT02182687|449676803|FG001|Overall Study|Adverse Event|0|||
125013596|NCT02182687|449676802|FG000|Overall Study|Lost to Follow-up|0|||
125013597|NCT02182687|449676803|FG001|Overall Study|Lost to Follow-up|1|||
125013598|NCT01297270|449676804|FG000|Overall Study|Adverse Event|19|||
125013599|NCT01297270|449676805|FG001|Overall Study|Adverse Event|32|||
125013600|NCT01297270|449676806|FG002|Overall Study|Adverse Event|5|||
125013601|NCT01297270|449676804|FG000|Overall Study|Lack of Efficacy|15|||
125013602|NCT01297270|449676805|FG001|Overall Study|Lack of Efficacy|17|||
125013603|NCT01297270|449676806|FG002|Overall Study|Lack of Efficacy|15|||
125013604|NCT01297270|449676804|FG000|Overall Study|Lost to Follow-up|1|||
125013605|NCT01297270|449676805|FG001|Overall Study|Lost to Follow-up|2|||
125013606|NCT01297270|449676806|FG002|Overall Study|Lost to Follow-up|1|||
125013607|NCT01297270|449676804|FG000|Overall Study|Protocol Violation|0|||
125013608|NCT01297270|449676805|FG001|Overall Study|Protocol Violation|2|||
125013609|NCT01297270|449676806|FG002|Overall Study|Protocol Violation|0|||
125013610|NCT01297270|449676804|FG000|Overall Study|Withdrawal by Subject|7|||
125013611|NCT01297270|449676805|FG001|Overall Study|Withdrawal by Subject|15|||
125013612|NCT01297270|449676806|FG002|Overall Study|Withdrawal by Subject|7|||
125013613|NCT01297270|449676804|FG000|Overall Study|Other reason not defined above|3|||
125013614|NCT01297270|449676805|FG001|Overall Study|Other reason not defined above|3|||
125013615|NCT01297270|449676806|FG002|Overall Study|Other reason not defined above|1|||
125013616|NCT01297270|449676804|FG000|Overall Study|Not treated|0|||
125013617|NCT01297270|449676805|FG001|Overall Study|Not treated|1|||
125013618|NCT01297270|449676806|FG002|Overall Study|Not treated|0|||
125013619|NCT02863809|449676809|FG000|Overall Study|Adverse Event|8|||
125013620|NCT02863809|449676810|FG001|Overall Study|Adverse Event|8|||
125013621|NCT02863809|449676809|FG000|Overall Study|Withdrawal by Subject|0|||
125013622|NCT02863809|449676810|FG001|Overall Study|Withdrawal by Subject|1|||
125013623|NCT02863809|449676809|FG000|Overall Study|Lost to Follow-up|1|||
125013624|NCT02863809|449676810|FG001|Overall Study|Lost to Follow-up|1|||
125013625|NCT02863809|449676809|FG000|Overall Study|Death|1|||
125013626|NCT02863809|449676810|FG001|Overall Study|Death|0|||
125013627|NCT02829138|449676811|FG000|Overall Study|Withdrawal by Subject|1|||
125013628|NCT02829138|449676812|FG001|Overall Study|Withdrawal by Subject|0|||
125013629|NCT01394627|449676813|FG000|First Intervention (1 Day)|poor intravenous access|0|||
125013630|NCT01394627|449676814|FG001|First Intervention (1 Day)|poor intravenous access|1|||
125013631|NCT01394627|449676813|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
125013632|NCT01394627|449676814|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
125013633|NCT01765920|449676815|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
125013634|NCT01765920|449676816|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
125013635|NCT01765920|449676815|FG000|Overall Study|Patient code disclosure|0|||
125013636|NCT01765920|449676816|FG001|Overall Study|Patient code disclosure|1|||
125013637|NCT01081249|449676817|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
125013638|NCT01081249|449676818|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
125013639|NCT04041284|449676821|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
125013640|NCT04041284|449676822|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
125013641|NCT04041284|449676821|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
125013642|NCT04041284|449676822|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
125013643|NCT04041284|449676821|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
125013644|NCT04041284|449676822|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
125013645|NCT04041284|449676821|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
125013646|NCT04041284|449676822|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
125013647|NCT04041284|449676821|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
125013648|NCT04041284|449676822|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
125013649|NCT04041284|449676821|FG000|DB Phase (12 Weeks)|Other than specified|1|||
125013650|NCT04041284|449676822|FG001|DB Phase (12 Weeks)|Other than specified|0|||
125013651|NCT04041284|449676821|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
125013652|NCT04041284|449676822|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
125013653|NCT04041284|449676821|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
125013654|NCT04041284|449676822|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
125013655|NCT04041284|449676821|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
125013656|NCT04041284|449676822|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
124879480|NCT02392611|449182459|FG002|Overall Study|Lost to Follow-up|0|||
124879481|NCT02392611|449182460|FG003|Overall Study|Lost to Follow-up|0|||
124879482|NCT02392611|449182461|FG004|Overall Study|Lost to Follow-up|0|||
124879483|NCT02392611|449182462|FG005|Overall Study|Lost to Follow-up|0|||
124879484|NCT02392611|449182463|FG006|Overall Study|Lost to Follow-up|1|||
124879485|NCT02392611|449182464|FG007|Overall Study|Lost to Follow-up|0|||
124879486|NCT02392611|449182465|FG008|Overall Study|Lost to Follow-up|0|||
124879487|NCT02392611|449182457|FG000|Overall Study|Enrolled, not treated|0|||
124879488|NCT02392611|449182458|FG001|Overall Study|Enrolled, not treated|0|||
124879489|NCT02392611|449182459|FG002|Overall Study|Enrolled, not treated|0|||
124879490|NCT02392611|449182460|FG003|Overall Study|Enrolled, not treated|2|||
124879491|NCT02392611|449182461|FG004|Overall Study|Enrolled, not treated|0|||
124879492|NCT02392611|449182462|FG005|Overall Study|Enrolled, not treated|0|||
124879493|NCT02392611|449182463|FG006|Overall Study|Enrolled, not treated|0|||
124879494|NCT02392611|449182464|FG007|Overall Study|Enrolled, not treated|0|||
124879495|NCT02392611|449182465|FG008|Overall Study|Enrolled, not treated|0|||
124879496|NCT02110732|449182481|FG000|Overall Study|Physician Decision|5|||
124879497|NCT02110732|449182482|FG001|Overall Study|Physician Decision|2|||
124879498|NCT02110732|449182481|FG000|Overall Study|Lost to Follow-up|1|||
124879499|NCT02110732|449182482|FG001|Overall Study|Lost to Follow-up|1|||
124879500|NCT04836858|449182483|FG000|Overall Study|Adverse Event|0|||
124879501|NCT04836858|449182484|FG001|Overall Study|Adverse Event|0|||
124879502|NCT04836858|449182485|FG002|Overall Study|Adverse Event|0|||
124879503|NCT04836858|449182486|FG003|Overall Study|Adverse Event|1|||
124879504|NCT04836858|449182483|FG000|Overall Study|Lost to Follow-up|1|||
124879505|NCT04836858|449182484|FG001|Overall Study|Lost to Follow-up|0|||
125102694|NCT03926728|449997710|FG000|Overall Study|Withdrawal by Subject|0|||
125102695|NCT03926728|449997711|FG001|Overall Study|Withdrawal by Subject|1|||
125102696|NCT03926728|449997712|FG002|Overall Study|Withdrawal by Subject|1|||
125102697|NCT03926728|449997713|FG003|Overall Study|Withdrawal by Subject|0|||
125102698|NCT03926728|449997714|FG004|Overall Study|Withdrawal by Subject|0|||
125102699|NCT03926728|449997715|FG005|Overall Study|Withdrawal by Subject|1|||
125102700|NCT03926728|449997716|FG006|Overall Study|Withdrawal by Subject|1|||
125102701|NCT03926728|449997717|FG007|Overall Study|Withdrawal by Subject|0|||
125102702|NCT03926728|449997718|FG008|Overall Study|Withdrawal by Subject|0|||
125102703|NCT03926728|449997719|FG009|Overall Study|Withdrawal by Subject|1|||
125102704|NCT03926728|449997720|FG010|Overall Study|Withdrawal by Subject|0|||
125102705|NCT03926728|449997721|FG011|Overall Study|Withdrawal by Subject|0|||
125102706|NCT02729545|449997724|FG000|Overall Study|Pregnancy|1|||
125102707|NCT02729545|449997725|FG001|Overall Study|Pregnancy|1|||
125102708|NCT02729545|449997724|FG000|Overall Study|Lost to Follow-up|0|||
125102709|NCT02729545|449997725|FG001|Overall Study|Lost to Follow-up|1|||
125102710|NCT02729545|449997724|FG000|Overall Study|Withdrawal by Subject|2|||
125102711|NCT02729545|449997725|FG001|Overall Study|Withdrawal by Subject|3|||
125102712|NCT01956123|449997728|FG000|COS Cycle 2|Protocol Violation|8|||
125102713|NCT01956123|449997729|FG001|COS Cycle 2|Protocol Violation|3|||
125102714|NCT01956123|449997730|FG002|COS Cycle 2|Protocol Violation|0|||
125102715|NCT01956123|449997731|FG003|COS Cycle 2|Protocol Violation|0|||
125102716|NCT01956123|449997728|FG000|COS Cycle 2|Adverse Event|3|||
125102717|NCT01956123|449997729|FG001|COS Cycle 2|Adverse Event|4|||
125102718|NCT01956123|449997730|FG002|COS Cycle 2|Adverse Event|0|||
125102719|NCT01956123|449997731|FG003|COS Cycle 2|Adverse Event|0|||
125102720|NCT01956123|449997728|FG000|COS Cycle 2|Personal Reasons|2|||
125102721|NCT01956123|449997729|FG001|COS Cycle 2|Personal Reasons|0|||
125102722|NCT01956123|449997730|FG002|COS Cycle 2|Personal Reasons|0|||
125102723|NCT01956123|449997731|FG003|COS Cycle 2|Personal Reasons|0|||
125102724|NCT01956123|449997728|FG000|COS Cycle 2|Withdrawal by Subject|1|||
125102725|NCT01956123|449997729|FG001|COS Cycle 2|Withdrawal by Subject|0|||
125102726|NCT01956123|449997730|FG002|COS Cycle 2|Withdrawal by Subject|0|||
124879506|NCT04836858|449182485|FG002|Overall Study|Lost to Follow-up|0|||
124879507|NCT04836858|449182486|FG003|Overall Study|Lost to Follow-up|0|||
124879508|NCT04836858|449182483|FG000|Overall Study|Subject/Guardian decision|3|||
124879509|NCT04836858|449182484|FG001|Overall Study|Subject/Guardian decision|0|||
124879510|NCT04836858|449182485|FG002|Overall Study|Subject/Guardian decision|0|||
124879511|NCT04836858|449182486|FG003|Overall Study|Subject/Guardian decision|1|||
124879512|NCT04836858|449182483|FG000|Overall Study|Randomized but not treated|4|||
124879513|NCT04836858|449182484|FG001|Overall Study|Randomized but not treated|0|||
125102727|NCT01956123|449997731|FG003|COS Cycle 2|Withdrawal by Subject|0|||
125102728|NCT01956123|449997728|FG000|COS Cycle 3|Protocol Violation|0|||
125102729|NCT01956123|449997729|FG001|COS Cycle 3|Protocol Violation|0|||
125102730|NCT01956123|449997730|FG002|COS Cycle 3|Protocol Violation|2|||
125102731|NCT01956123|449997731|FG003|COS Cycle 3|Protocol Violation|1|||
125102732|NCT01956123|449997728|FG000|COS Cycle 3|Adverse Event|0|||
125102733|NCT01956123|449997729|FG001|COS Cycle 3|Adverse Event|0|||
125102734|NCT01956123|449997730|FG002|COS Cycle 3|Adverse Event|3|||
125102735|NCT01956123|449997731|FG003|COS Cycle 3|Adverse Event|0|||
125102736|NCT01956123|449997728|FG000|COS Cycle 3|Personal Reasons|0|||
125102737|NCT01956123|449997729|FG001|COS Cycle 3|Personal Reasons|0|||
125102738|NCT01956123|449997730|FG002|COS Cycle 3|Personal Reasons|1|||
124879514|NCT04836858|449182485|FG002|Overall Study|Randomized but not treated|0|||
124879515|NCT04836858|449182486|FG003|Overall Study|Randomized but not treated|0|||
125013657|NCT04041284|449676821|FG000|OL Phase (12 Weeks)|Other than specified|6|||
125013658|NCT04041284|449676822|FG001|OL Phase (12 Weeks)|Other than specified|2|||
125013659|NCT00563186|449676823|FG000|Overall Study|LOS<48 hours|97|||
125013660|NCT00563186|449676824|FG001|Overall Study|LOS<48 hours|74|||
125013661|NCT00563186|449676823|FG000|Overall Study|Incomplete data|1|||
125013662|NCT00563186|449676824|FG001|Overall Study|Incomplete data|1|||
125013663|NCT01087905|449676825|FG000|Overall Study|Lost to Follow-up|24|||
125013664|NCT01087905|449676826|FG001|Overall Study|Lost to Follow-up|28|||
125013665|NCT01087905|449676827|FG002|Overall Study|Lost to Follow-up|18|||
125013666|NCT01087905|449676828|FG003|Overall Study|Lost to Follow-up|31|||
125013667|NCT01087905|449676829|FG004|Overall Study|Lost to Follow-up|27|||
125013668|NCT01087905|449676830|FG005|Overall Study|Lost to Follow-up|25|||
125013669|NCT01087905|449676831|FG006|Overall Study|Lost to Follow-up|20|||
125013670|NCT01087905|449676832|FG007|Overall Study|Lost to Follow-up|24|||
125013671|NCT01087905|449676825|FG000|Overall Study|Withdrawal by Subject|5|||
125013672|NCT01087905|449676826|FG001|Overall Study|Withdrawal by Subject|4|||
125013673|NCT01087905|449676827|FG002|Overall Study|Withdrawal by Subject|4|||
125013674|NCT01087905|449676828|FG003|Overall Study|Withdrawal by Subject|5|||
125013675|NCT01087905|449676829|FG004|Overall Study|Withdrawal by Subject|4|||
125013676|NCT01087905|449676830|FG005|Overall Study|Withdrawal by Subject|3|||
125013677|NCT01087905|449676831|FG006|Overall Study|Withdrawal by Subject|3|||
125013678|NCT01087905|449676832|FG007|Overall Study|Withdrawal by Subject|5|||
125013679|NCT01347554|449676833|FG000|Overall Study|Lack of Efficacy|7|||
125013680|NCT01347554|449676834|FG001|Overall Study|Lack of Efficacy|11|||
125013681|NCT00886600|449676835|FG000|Double-blind Monotherapy|Adverse Event|1|||
125013682|NCT00886600|449676836|FG001|Double-blind Monotherapy|Adverse Event|1|||
125013683|NCT00886600|449676837|FG002|Double-blind Monotherapy|Adverse Event|1|||
125013684|NCT00886600|449676838|FG003|Double-blind Monotherapy|Adverse Event|1|||
125013685|NCT00886600|449676835|FG000|Double-blind Monotherapy|Protocol Violation|0|||
125013686|NCT00886600|449676836|FG001|Double-blind Monotherapy|Protocol Violation|0|||
125013687|NCT00886600|449676837|FG002|Double-blind Monotherapy|Protocol Violation|0|||
125013688|NCT00886600|449676838|FG003|Double-blind Monotherapy|Protocol Violation|1|||
125013689|NCT00886600|449676835|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
125013690|NCT00886600|449676836|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
125013691|NCT00886600|449676837|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
125013692|NCT00886600|449676838|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
125013693|NCT00886600|449676835|FG000|Combination Therapy Period|Adverse Event|0|||
125013694|NCT00886600|449676836|FG001|Combination Therapy Period|Adverse Event|0|||
125013695|NCT00886600|449676837|FG002|Combination Therapy Period|Adverse Event|1|||
125013696|NCT00886600|449676838|FG003|Combination Therapy Period|Adverse Event|0|||
125013697|NCT00886600|449676835|FG000|Combination Therapy Period|Protocol Violation|0|||
125013698|NCT00886600|449676836|FG001|Combination Therapy Period|Protocol Violation|0|||
125013699|NCT00886600|449676837|FG002|Combination Therapy Period|Protocol Violation|1|||
125013700|NCT00886600|449676838|FG003|Combination Therapy Period|Protocol Violation|0|||
125013701|NCT01439204|449676839|FG000|Overall Study|Withdrawal by Subject|0|||
125013702|NCT01439204|449676840|FG001|Overall Study|Withdrawal by Subject|1|||
125013703|NCT01439204|449676839|FG000|Overall Study|Lost to Follow-up|0|||
125013704|NCT01439204|449676840|FG001|Overall Study|Lost to Follow-up|2|||
125013705|NCT01439204|449676839|FG000|Overall Study|No longer meets study criteria|1|||
125013706|NCT01439204|449676840|FG001|Overall Study|No longer meets study criteria|0|||
125013707|NCT01439204|449676839|FG000|Overall Study|poor/non-compliance|3|||
125013708|NCT01439204|449676840|FG001|Overall Study|poor/non-compliance|0|||
125013709|NCT03917823|449676844|FG000|Overall Study|Lost to Follow-up|1|||
125013710|NCT03917823|449676845|FG001|Overall Study|Lost to Follow-up|1|||
125013711|NCT03917823|449676844|FG000|Overall Study|Withdrawal by Subject|0|||
125013712|NCT03917823|449676845|FG001|Overall Study|Withdrawal by Subject|1|||
125013713|NCT03775421|449676846|FG000|Overall Study|Lost to Follow-up|2|||
125013714|NCT03775421|449676846|FG000|Overall Study|Withdrawal by Subject|10|||
125013715|NCT03775421|449676846|FG000|Overall Study|Physician Decision|3|||
125013716|NCT03775421|449676846|FG000|Overall Study|Death|1|||
125013717|NCT03775421|449676846|FG000|Overall Study|Study Terminated by Sponsor|94|||
125013718|NCT00135668|449676847|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
125013719|NCT00135668|449676848|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
125013720|NCT00135668|449676849|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
125102739|NCT01956123|449997731|FG003|COS Cycle 3|Personal Reasons|0|||
125102740|NCT01956123|449997728|FG000|COS Cycle 3|Withdrawal by Subject|0|||
125102741|NCT01956123|449997729|FG001|COS Cycle 3|Withdrawal by Subject|0|||
125102742|NCT01956123|449997730|FG002|COS Cycle 3|Withdrawal by Subject|0|||
125102743|NCT01956123|449997731|FG003|COS Cycle 3|Withdrawal by Subject|1|||
125102744|NCT00398632|449997732|FG000|Overall Study|Withdrawal by Subject|1|||
125102745|NCT00398632|449997732|FG000|Overall Study|Lack of Efficacy|1|||
125102746|NCT02118896|449997733|FG000|Overall Study|Death|4|||
125102747|NCT02118896|449997734|FG001|Overall Study|Death|0|||
125102748|NCT02118896|449997735|FG002|Overall Study|Death|4|||
125102749|NCT02118896|449997736|FG003|Overall Study|Death|6|||
125102750|NCT02118896|449997737|FG004|Overall Study|Death|3|||
125102751|NCT02118896|449997738|FG005|Overall Study|Death|1|||
125102752|NCT02118896|449997739|FG006|Overall Study|Death|0|||
125102753|NCT02118896|449997740|FG007|Overall Study|Death|0|||
125102754|NCT02118896|449997741|FG008|Overall Study|Death|0|||
125102755|NCT02118896|449997742|FG009|Overall Study|Death|0|||
125102756|NCT02118896|449997733|FG000|Overall Study|Adverse Event|5|||
125102757|NCT02118896|449997734|FG001|Overall Study|Adverse Event|4|||
125102758|NCT02118896|449997735|FG002|Overall Study|Adverse Event|4|||
125102759|NCT02118896|449997736|FG003|Overall Study|Adverse Event|5|||
125102760|NCT02118896|449997737|FG004|Overall Study|Adverse Event|5|||
125102761|NCT02118896|449997738|FG005|Overall Study|Adverse Event|9|||
125102762|NCT02118896|449997739|FG006|Overall Study|Adverse Event|1|||
125102763|NCT02118896|449997740|FG007|Overall Study|Adverse Event|1|||
125102764|NCT02118896|449997741|FG008|Overall Study|Adverse Event|4|||
125102765|NCT02118896|449997742|FG009|Overall Study|Adverse Event|0|||
125102766|NCT02118896|449997733|FG000|Overall Study|Consent withdrawn|2|||
125102767|NCT02118896|449997734|FG001|Overall Study|Consent withdrawn|0|||
125102768|NCT02118896|449997735|FG002|Overall Study|Consent withdrawn|3|||
125102769|NCT02118896|449997736|FG003|Overall Study|Consent withdrawn|4|||
125102770|NCT02118896|449997737|FG004|Overall Study|Consent withdrawn|1|||
125102771|NCT02118896|449997738|FG005|Overall Study|Consent withdrawn|4|||
125102772|NCT02118896|449997739|FG006|Overall Study|Consent withdrawn|0|||
125102773|NCT02118896|449997740|FG007|Overall Study|Consent withdrawn|0|||
125102774|NCT02118896|449997741|FG008|Overall Study|Consent withdrawn|0|||
125102775|NCT02118896|449997742|FG009|Overall Study|Consent withdrawn|0|||
125102776|NCT02118896|449997733|FG000|Overall Study|Non-compliance|2|||
125102777|NCT02118896|449997734|FG001|Overall Study|Non-compliance|1|||
125102778|NCT02118896|449997735|FG002|Overall Study|Non-compliance|1|||
125102779|NCT02118896|449997736|FG003|Overall Study|Non-compliance|5|||
125102780|NCT02118896|449997737|FG004|Overall Study|Non-compliance|0|||
125102781|NCT02118896|449997738|FG005|Overall Study|Non-compliance|1|||
125102782|NCT02118896|449997739|FG006|Overall Study|Non-compliance|0|||
125102783|NCT02118896|449997740|FG007|Overall Study|Non-compliance|1|||
124879516|NCT00597714|449182489|FG000|Overall Study|Death|56|||
124879517|NCT00597714|449182490|FG001|Overall Study|Death|46|||
124879518|NCT00597714|449182491|FG002|Overall Study|Death|0|||
124879519|NCT00597714|449182489|FG000|Overall Study|Recipient death|0|||
124879520|NCT00597714|449182490|FG001|Overall Study|Recipient death|0|||
124879521|NCT00597714|449182491|FG002|Overall Study|Recipient death|10|||
124879522|NCT01350141|449182492|FG000|Overall Study|Lost to Follow-up|1|||
125102784|NCT02118896|449997741|FG008|Overall Study|Non-compliance|0|||
125102785|NCT02118896|449997742|FG009|Overall Study|Non-compliance|0|||
125102786|NCT02118896|449997733|FG000|Overall Study|Pregnancy|1|||
125102787|NCT02118896|449997734|FG001|Overall Study|Pregnancy|1|||
125102788|NCT02118896|449997735|FG002|Overall Study|Pregnancy|0|||
125102789|NCT02118896|449997736|FG003|Overall Study|Pregnancy|0|||
125102790|NCT02118896|449997737|FG004|Overall Study|Pregnancy|1|||
125102791|NCT02118896|449997738|FG005|Overall Study|Pregnancy|3|||
125102792|NCT02118896|449997739|FG006|Overall Study|Pregnancy|1|||
125102793|NCT02118896|449997740|FG007|Overall Study|Pregnancy|0|||
125102794|NCT02118896|449997741|FG008|Overall Study|Pregnancy|0|||
125102795|NCT02118896|449997742|FG009|Overall Study|Pregnancy|0|||
125102796|NCT02118896|449997733|FG000|Overall Study|Lost to Follow-up|1|||
125102797|NCT02118896|449997734|FG001|Overall Study|Lost to Follow-up|2|||
125102798|NCT02118896|449997735|FG002|Overall Study|Lost to Follow-up|1|||
124879523|NCT01350141|449182493|FG001|Overall Study|Lost to Follow-up|0|||
124879524|NCT01350141|449182494|FG002|Overall Study|Lost to Follow-up|1|||
125102799|NCT02118896|449997736|FG003|Overall Study|Lost to Follow-up|0|||
124879525|NCT01350141|449182492|FG000|Overall Study|Withdrawal by Subject|1|||
124879526|NCT01350141|449182493|FG001|Overall Study|Withdrawal by Subject|0|||
125102800|NCT02118896|449997737|FG004|Overall Study|Lost to Follow-up|2|||
125102801|NCT02118896|449997738|FG005|Overall Study|Lost to Follow-up|1|||
125102802|NCT02118896|449997739|FG006|Overall Study|Lost to Follow-up|0|||
125102803|NCT02118896|449997740|FG007|Overall Study|Lost to Follow-up|0|||
125102804|NCT02118896|449997741|FG008|Overall Study|Lost to Follow-up|0|||
125102805|NCT02118896|449997742|FG009|Overall Study|Lost to Follow-up|0|||
125102806|NCT02118896|449997733|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
125102807|NCT02118896|449997734|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
125102808|NCT02118896|449997735|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
125102809|NCT02118896|449997736|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
124879527|NCT01350141|449182494|FG002|Overall Study|Withdrawal by Subject|0|||
124879528|NCT01350141|449182492|FG000|Overall Study|Randomized but not treated|1|||
124879529|NCT01350141|449182493|FG001|Overall Study|Randomized but not treated|0|||
124879530|NCT01350141|449182494|FG002|Overall Study|Randomized but not treated|0|||
124879531|NCT00519896|449182495|FG000|Overall Study|Protocol Violation|1|||
124879532|NCT00519896|449182495|FG000|Overall Study|Adverse Event|1|||
124879533|NCT00810082|449182496|FG000|Overall Study|Lost to Follow-up|0|||
124879534|NCT00810082|449182497|FG001|Overall Study|Lost to Follow-up|4|||
124879535|NCT01588990|449182498|FG000|Phase A|Withdrawal by Subject|5|||
124879536|NCT01588990|449182498|FG000|Phase A|Physician Decision|11|||
124879537|NCT01588990|449182498|FG000|Phase A|Other|14|||
124879538|NCT01588990|449182498|FG000|Phase A|Lost to Follow-up|1|||
124879539|NCT01588990|449182498|FG000|Phase A|Death|5|||
124879540|NCT01588990|449182498|FG000|Phase A|Adverse Event|28|||
124879541|NCT01588990|449182498|FG000|Phase A|Still on therapy at end of study|6|||
124879542|NCT01588990|449182498|FG000|Phase B|Adverse Event|2|||
124879543|NCT01588990|449182498|FG000|Phase B|Still on therapy at end of study|5|||
124879544|NCT01588990|449182498|FG000|Phase B|Withdrawal by Subject|3|||
124879545|NCT01588990|449182498|FG000|Phase B|Physician Decision|4|||
124879546|NCT01588990|449182498|FG000|Phase B|Other|2|||
125102810|NCT02118896|449997737|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
125102811|NCT02118896|449997738|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
125102812|NCT02118896|449997739|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
125102813|NCT02118896|449997740|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
125102814|NCT02118896|449997741|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
124879547|NCT02367716|449182499|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
124879548|NCT01641926|449182507|FG000|Overall Study|Adverse Event|5|||
124879549|NCT01641926|449182508|FG001|Overall Study|Adverse Event|2|||
124879550|NCT01641926|449182509|FG002|Overall Study|Adverse Event|3|||
125013721|NCT00135668|449676850|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
125013722|NCT00205855|449676855|FG000|Overall Study|Only received temporary implants|16|||
125013723|NCT00205855|449676855|FG000|Overall Study|Withdrawal by Subject|5|||
125013724|NCT00455013|449676856|FG000|Short Term Period|Adverse Event|2|||
125013725|NCT00455013|449676857|FG001|Short Term Period|Adverse Event|5|||
125013726|NCT00455013|449676858|FG002|Short Term Period|Adverse Event|0|||
125013727|NCT00455013|449676856|FG000|Short Term Period|Withdrawal by Subject|0|||
125013728|NCT00455013|449676857|FG001|Short Term Period|Withdrawal by Subject|0|||
125013729|NCT00455013|449676858|FG002|Short Term Period|Withdrawal by Subject|1|||
125013730|NCT00455013|449676856|FG000|Short Term Period|Lack of Efficacy|4|||
125013731|NCT00455013|449676857|FG001|Short Term Period|Lack of Efficacy|0|||
125013732|NCT00455013|449676858|FG002|Short Term Period|Lack of Efficacy|0|||
125013733|NCT00455013|449676856|FG000|Short Term Period|Other|0|||
125013734|NCT00455013|449676857|FG001|Short Term Period|Other|0|||
125013735|NCT00455013|449676858|FG002|Short Term Period|Other|1|||
125013736|NCT00455013|449676856|FG000|Long Term Extension (LTE)|Adverse Event|0|||
125013737|NCT00455013|449676857|FG001|Long Term Extension (LTE)|Adverse Event|1|||
125013738|NCT00455013|449676858|FG002|Long Term Extension (LTE)|Adverse Event|1|||
125013739|NCT00455013|449676856|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
125013740|NCT00455013|449676857|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
125013741|NCT00455013|449676858|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
125013742|NCT00455013|449676856|FG000|Long Term Extension (LTE)|Death|1|||
125013743|NCT00455013|449676857|FG001|Long Term Extension (LTE)|Death|1|||
125013744|NCT00455013|449676858|FG002|Long Term Extension (LTE)|Death|0|||
125013745|NCT00455013|449676856|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
125013746|NCT00455013|449676857|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
125013747|NCT00455013|449676858|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
125013748|NCT00455013|449676856|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
125013749|NCT00455013|449676857|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
125013750|NCT00455013|449676858|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
125013751|NCT00455013|449676856|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
125013752|NCT00455013|449676857|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
125013753|NCT00455013|449676858|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
125013754|NCT00455013|449676856|FG000|Long Term Extension (LTE)|non-specified|0|||
125013755|NCT00455013|449676857|FG001|Long Term Extension (LTE)|non-specified|0|||
125013756|NCT00455013|449676858|FG002|Long Term Extension (LTE)|non-specified|1|||
125013757|NCT02739620|449676861|FG000|Overall Study|Lost to Follow-up|3|||
125013758|NCT02739620|449676862|FG001|Overall Study|Lost to Follow-up|1|||
125013759|NCT02739620|449676861|FG000|Overall Study|Adverse Event|0|||
125013760|NCT02739620|449676862|FG001|Overall Study|Adverse Event|1|||
125013761|NCT02873936|449676863|FG000|Overall Study|Withdrew Consent|4|||
125013762|NCT02873936|449676864|FG001|Overall Study|Withdrew Consent|11|||
125013763|NCT02873936|449676865|FG002|Overall Study|Withdrew Consent|20|||
125013764|NCT02873936|449676863|FG000|Overall Study|Investigator's Discretion|3|||
125013765|NCT02873936|449676864|FG001|Overall Study|Investigator's Discretion|5|||
125013766|NCT02873936|449676865|FG002|Overall Study|Investigator's Discretion|4|||
125013767|NCT02873936|449676863|FG000|Overall Study|Adverse Event|3|||
125013768|NCT02873936|449676864|FG001|Overall Study|Adverse Event|5|||
125102815|NCT02118896|449997742|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
125102816|NCT02118896|449997733|FG000|Overall Study|Prohibited medication|0|||
125102817|NCT02118896|449997734|FG001|Overall Study|Prohibited medication|0|||
125102818|NCT02118896|449997735|FG002|Overall Study|Prohibited medication|0|||
125102819|NCT02118896|449997736|FG003|Overall Study|Prohibited medication|0|||
125102820|NCT02118896|449997737|FG004|Overall Study|Prohibited medication|1|||
125102821|NCT02118896|449997738|FG005|Overall Study|Prohibited medication|3|||
125102822|NCT02118896|449997739|FG006|Overall Study|Prohibited medication|0|||
125102823|NCT02118896|449997740|FG007|Overall Study|Prohibited medication|0|||
125102824|NCT02118896|449997741|FG008|Overall Study|Prohibited medication|0|||
125102825|NCT02118896|449997742|FG009|Overall Study|Prohibited medication|0|||
125102826|NCT02118896|449997733|FG000|Overall Study|Miscellaneous|1|||
125102827|NCT02118896|449997734|FG001|Overall Study|Miscellaneous|2|||
125102828|NCT02118896|449997735|FG002|Overall Study|Miscellaneous|0|||
125102829|NCT02118896|449997736|FG003|Overall Study|Miscellaneous|2|||
125102830|NCT02118896|449997737|FG004|Overall Study|Miscellaneous|0|||
125102831|NCT02118896|449997738|FG005|Overall Study|Miscellaneous|4|||
125102832|NCT02118896|449997739|FG006|Overall Study|Miscellaneous|0|||
125102833|NCT02118896|449997740|FG007|Overall Study|Miscellaneous|0|||
125102834|NCT02118896|449997741|FG008|Overall Study|Miscellaneous|0|||
125102835|NCT02118896|449997742|FG009|Overall Study|Miscellaneous|0|||
125102836|NCT02050373|449997746|FG000|Overall Study|Adverse Event|4|||
125102837|NCT02050373|449997747|FG001|Overall Study|Adverse Event|7|||
125102838|NCT02050373|449997746|FG000|Overall Study|Death|3|||
125102839|NCT02050373|449997747|FG001|Overall Study|Death|3|||
125102840|NCT00572910|449997750|FG000|Overall Study|Adverse Event|1|||
125102841|NCT00572910|449997751|FG001|Overall Study|Adverse Event|2|||
125102842|NCT00572910|449997752|FG002|Overall Study|Adverse Event|0|||
125102843|NCT00572910|449997753|FG003|Overall Study|Adverse Event|2|||
125102844|NCT00572910|449997754|FG004|Overall Study|Adverse Event|0|||
125102845|NCT00572910|449997755|FG005|Overall Study|Adverse Event|0|||
125102846|NCT00572910|449997756|FG006|Overall Study|Adverse Event|4|||
125102847|NCT00572910|449997757|FG007|Overall Study|Adverse Event|2|||
125102848|NCT00572910|449997758|FG008|Overall Study|Adverse Event|1|||
125102849|NCT00572910|449997759|FG009|Overall Study|Adverse Event|3|||
125102850|NCT00572910|449997760|FG010|Overall Study|Adverse Event|2|||
125102851|NCT00572910|449997750|FG000|Overall Study|Lost to Follow-up|0|||
125102852|NCT00572910|449997751|FG001|Overall Study|Lost to Follow-up|1|||
125102853|NCT00572910|449997752|FG002|Overall Study|Lost to Follow-up|1|||
125102854|NCT00572910|449997753|FG003|Overall Study|Lost to Follow-up|2|||
125102855|NCT00572910|449997754|FG004|Overall Study|Lost to Follow-up|1|||
125102856|NCT00572910|449997755|FG005|Overall Study|Lost to Follow-up|0|||
125102857|NCT00572910|449997756|FG006|Overall Study|Lost to Follow-up|0|||
125102858|NCT00572910|449997757|FG007|Overall Study|Lost to Follow-up|0|||
125102859|NCT00572910|449997758|FG008|Overall Study|Lost to Follow-up|0|||
125102860|NCT00572910|449997759|FG009|Overall Study|Lost to Follow-up|1|||
125102861|NCT00572910|449997760|FG010|Overall Study|Lost to Follow-up|0|||
125102862|NCT00572910|449997750|FG000|Overall Study|Withdrawal by Subject|3|||
125102863|NCT00572910|449997751|FG001|Overall Study|Withdrawal by Subject|0|||
125102864|NCT00572910|449997752|FG002|Overall Study|Withdrawal by Subject|1|||
125102865|NCT00572910|449997753|FG003|Overall Study|Withdrawal by Subject|0|||
125102866|NCT00572910|449997754|FG004|Overall Study|Withdrawal by Subject|1|||
125102867|NCT00572910|449997755|FG005|Overall Study|Withdrawal by Subject|3|||
125102868|NCT00572910|449997756|FG006|Overall Study|Withdrawal by Subject|0|||
125102869|NCT00572910|449997757|FG007|Overall Study|Withdrawal by Subject|2|||
125102870|NCT00572910|449997758|FG008|Overall Study|Withdrawal by Subject|2|||
125102871|NCT00572910|449997759|FG009|Overall Study|Withdrawal by Subject|2|||
125102872|NCT00572910|449997760|FG010|Overall Study|Withdrawal by Subject|1|||
125102873|NCT00592007|449997765|FG000|Overall Study|Withdrawal by Subject|1|||
125102874|NCT00592007|449997765|FG000|Overall Study|patient ineligible (out of lab range)|1|||
125102875|NCT01569074|449997769|FG000|Overall Study|Study stopped|6|||
125102876|NCT01569074|449997770|FG001|Overall Study|Study stopped|6|||
125102877|NCT01569074|449997771|FG002|Overall Study|Study stopped|8|||
125102878|NCT01569074|449997772|FG003|Overall Study|Study stopped|7|||
125102879|NCT01569074|449997773|FG004|Overall Study|Study stopped|7|||
125102880|NCT01569074|449997769|FG000|Overall Study|Study-specific discontinuation criteria|0|||
125102881|NCT01569074|449997770|FG001|Overall Study|Study-specific discontinuation criteria|1|||
125102882|NCT01569074|449997771|FG002|Overall Study|Study-specific discontinuation criteria|0|||
125102883|NCT01569074|449997772|FG003|Overall Study|Study-specific discontinuation criteria|0|||
125102884|NCT01569074|449997773|FG004|Overall Study|Study-specific discontinuation criteria|0|||
125102885|NCT01569074|449997769|FG000|Overall Study|Severe non-compliance to protocol|0|||
125102886|NCT01569074|449997770|FG001|Overall Study|Severe non-compliance to protocol|0|||
125102887|NCT01569074|449997771|FG002|Overall Study|Severe non-compliance to protocol|1|||
125102888|NCT01569074|449997772|FG003|Overall Study|Severe non-compliance to protocol|0|||
125102889|NCT01569074|449997773|FG004|Overall Study|Severe non-compliance to protocol|0|||
125102890|NCT01569074|449997769|FG000|Overall Study|eg change in circumstances|0|||
125102891|NCT01569074|449997770|FG001|Overall Study|eg change in circumstances|2|||
125102892|NCT01569074|449997771|FG002|Overall Study|eg change in circumstances|0|||
125102893|NCT01569074|449997772|FG003|Overall Study|eg change in circumstances|1|||
125102894|NCT01569074|449997773|FG004|Overall Study|eg change in circumstances|1|||
125102895|NCT01569074|449997769|FG000|Overall Study|Adverse Event|1|||
125102896|NCT01569074|449997770|FG001|Overall Study|Adverse Event|0|||
125102897|NCT01569074|449997771|FG002|Overall Study|Adverse Event|3|||
125102898|NCT01569074|449997772|FG003|Overall Study|Adverse Event|0|||
125102899|NCT01569074|449997773|FG004|Overall Study|Adverse Event|0|||
125102900|NCT01803464|449997774|FG000|Overall Study|Incomplete data|0|||
125102901|NCT01803464|449997775|FG001|Overall Study|Incomplete data|0|||
125102902|NCT01803464|449997776|FG002|Overall Study|Incomplete data|4|||
125102903|NCT01803464|449997777|FG003|Overall Study|Incomplete data|0|||
125102904|NCT01803464|449997774|FG000|Overall Study|Withdrawal by Subject|1|||
125102905|NCT01803464|449997775|FG001|Overall Study|Withdrawal by Subject|0|||
125102906|NCT01803464|449997776|FG002|Overall Study|Withdrawal by Subject|0|||
125102907|NCT01803464|449997777|FG003|Overall Study|Withdrawal by Subject|0|||
125102908|NCT02860039|449997783|FG000|Overall Study|Death|4|||
125102909|NCT02860039|449997784|FG001|Overall Study|Death|0|||
125102910|NCT02860039|449997783|FG000|Overall Study|Lost to Follow-up|2|||
125102911|NCT02860039|449997784|FG001|Overall Study|Lost to Follow-up|2|||
125102912|NCT02860039|449997783|FG000|Overall Study|Protocol Violation|3|||
125102913|NCT02860039|449997784|FG001|Overall Study|Protocol Violation|1|||
125102914|NCT02860039|449997783|FG000|Overall Study|Withdrawal by Subject|1|||
125102915|NCT02860039|449997784|FG001|Overall Study|Withdrawal by Subject|0|||
125102916|NCT02860039|449997783|FG000|Overall Study|Not otherwise eligible|1|||
125102917|NCT02860039|449997784|FG001|Overall Study|Not otherwise eligible|1|||
125102918|NCT01360021|449997785|FG000|Overall Study|Eligibility criteria + other|2|||
125102919|NCT01360021|449997786|FG001|Overall Study|Eligibility criteria + other|1|||
125102920|NCT01360021|449997787|FG002|Overall Study|Eligibility criteria + other|1|||
124879551|NCT01641926|449182510|FG003|Overall Study|Adverse Event|1|||
124879552|NCT01641926|449182507|FG000|Overall Study|Lost to Follow-up|2|||
124879553|NCT01641926|449182508|FG001|Overall Study|Lost to Follow-up|2|||
124879554|NCT01641926|449182509|FG002|Overall Study|Lost to Follow-up|1|||
125102921|NCT01360021|449997785|FG000|Overall Study|Protocol Violation|0|||
125102922|NCT01360021|449997786|FG001|Overall Study|Protocol Violation|0|||
125102923|NCT01360021|449997787|FG002|Overall Study|Protocol Violation|1|||
125102924|NCT01360021|449997785|FG000|Overall Study|Withdrawal by Subject|4|||
125102925|NCT01360021|449997786|FG001|Overall Study|Withdrawal by Subject|0|||
125102926|NCT01360021|449997787|FG002|Overall Study|Withdrawal by Subject|2|||
125102927|NCT01360021|449997785|FG000|Overall Study|Adverse Event|2|||
124879555|NCT01641926|449182510|FG003|Overall Study|Lost to Follow-up|0|||
124879556|NCT01641926|449182507|FG000|Overall Study|Physician Decision|6|||
124879557|NCT01641926|449182508|FG001|Overall Study|Physician Decision|5|||
124879558|NCT01641926|449182509|FG002|Overall Study|Physician Decision|0|||
124879559|NCT01641926|449182510|FG003|Overall Study|Physician Decision|1|||
124879560|NCT01641926|449182507|FG000|Overall Study|Protocol Violation|1|||
124879561|NCT01641926|449182508|FG001|Overall Study|Protocol Violation|0|||
124879562|NCT01641926|449182509|FG002|Overall Study|Protocol Violation|0|||
124879563|NCT01641926|449182510|FG003|Overall Study|Protocol Violation|1|||
125102928|NCT01360021|449997786|FG001|Overall Study|Adverse Event|3|||
125102929|NCT01360021|449997787|FG002|Overall Study|Adverse Event|3|||
125102930|NCT01257737|449997789|FG000|Overall Study|Lost to Follow-up|1|||
125102931|NCT01257737|449997790|FG001|Overall Study|Lost to Follow-up|2|||
125102932|NCT01257737|449997789|FG000|Overall Study|Liver transplant|1|||
125102933|NCT01257737|449997790|FG001|Overall Study|Liver transplant|0|||
125102934|NCT01257737|449997789|FG000|Overall Study|Relocation out of the country|0|||
125102935|NCT01257737|449997790|FG001|Overall Study|Relocation out of the country|1|||
125102936|NCT01257737|449997789|FG000|Overall Study|Withdrew from study|0|||
125102937|NCT01257737|449997790|FG001|Overall Study|Withdrew from study|1|||
125102938|NCT03170271|449997794|FG000|Overall Study|Adverse Event|7|||
125102939|NCT03170271|449997795|FG001|Overall Study|Adverse Event|2|||
125102940|NCT03170271|449997794|FG000|Overall Study|Lost to Follow-up|0|||
125102941|NCT03170271|449997795|FG001|Overall Study|Lost to Follow-up|1|||
125102942|NCT03170271|449997794|FG000|Overall Study|Physician Decision|1|||
125102943|NCT03170271|449997795|FG001|Overall Study|Physician Decision|0|||
125102944|NCT03170271|449997794|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
125102945|NCT03170271|449997795|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
125102946|NCT03170271|449997794|FG000|Overall Study|Withdrawal by Subject|17|||
125102947|NCT03170271|449997795|FG001|Overall Study|Withdrawal by Subject|5|||
125102948|NCT03170271|449997794|FG000|Overall Study|Other|2|||
125102949|NCT03170271|449997795|FG001|Overall Study|Other|2|||
125102950|NCT03170271|449997794|FG000|Overall Study|Randomized in error|4|||
125102951|NCT03170271|449997795|FG001|Overall Study|Randomized in error|0|||
125102952|NCT04935931|449997798|FG000|Overall Study|Withdrawal by Subject|1|||
125102953|NCT05168657|449997799|FG000|Overall Study|Adverse Event|0|||
125102954|NCT05168657|449997800|FG001|Overall Study|Adverse Event|0|||
125102955|NCT05168657|449997801|FG002|Overall Study|Adverse Event|1|||
125102956|NCT05168657|449997802|FG003|Overall Study|Adverse Event|0|||
125102957|NCT05168657|449997803|FG004|Overall Study|Adverse Event|0|||
125102958|NCT05168657|449997804|FG005|Overall Study|Adverse Event|0|||
125102959|NCT05168657|449997805|FG006|Overall Study|Adverse Event|0|||
125102960|NCT05168657|449997806|FG007|Overall Study|Adverse Event|0|||
125102961|NCT00424632|449997809|FG000|Overall Study|Death|0|||
125102962|NCT00424632|449997810|FG001|Overall Study|Death|0|||
125102963|NCT00424632|449997811|FG002|Overall Study|Death|0|||
125102964|NCT00424632|449997812|FG003|Overall Study|Death|0|||
125102965|NCT00424632|449997813|FG004|Overall Study|Death|0|||
125102966|NCT00424632|449997814|FG005|Overall Study|Death|2|||
125102967|NCT00424632|449997815|FG006|Overall Study|Death|0|||
125102968|NCT00424632|449997816|FG007|Overall Study|Death|0|||
125102969|NCT00424632|449997817|FG008|Overall Study|Death|0|||
125102970|NCT00424632|449997818|FG009|Overall Study|Death|0|||
125102971|NCT00424632|449997809|FG000|Overall Study|Adverse Event|0|||
125102972|NCT00424632|449997810|FG001|Overall Study|Adverse Event|0|||
125102973|NCT00424632|449997811|FG002|Overall Study|Adverse Event|0|||
125102974|NCT00424632|449997812|FG003|Overall Study|Adverse Event|0|||
125102975|NCT00424632|449997813|FG004|Overall Study|Adverse Event|0|||
125102976|NCT00424632|449997814|FG005|Overall Study|Adverse Event|0|||
125102977|NCT00424632|449997815|FG006|Overall Study|Adverse Event|0|||
125102978|NCT00424632|449997816|FG007|Overall Study|Adverse Event|0|||
125102979|NCT00424632|449997817|FG008|Overall Study|Adverse Event|3|||
125102980|NCT00424632|449997818|FG009|Overall Study|Adverse Event|2|||
125102981|NCT00424632|449997809|FG000|Overall Study|Global deterioration of health status|0|||
125102982|NCT00424632|449997810|FG001|Overall Study|Global deterioration of health status|0|||
125102983|NCT00424632|449997811|FG002|Overall Study|Global deterioration of health status|0|||
125102984|NCT00424632|449997812|FG003|Overall Study|Global deterioration of health status|1|||
125102985|NCT00424632|449997813|FG004|Overall Study|Global deterioration of health status|1|||
125102986|NCT00424632|449997814|FG005|Overall Study|Global deterioration of health status|0|||
125102987|NCT00424632|449997815|FG006|Overall Study|Global deterioration of health status|0|||
125102988|NCT00424632|449997816|FG007|Overall Study|Global deterioration of health status|0|||
125102989|NCT00424632|449997817|FG008|Overall Study|Global deterioration of health status|0|||
125102990|NCT00424632|449997818|FG009|Overall Study|Global deterioration of health status|0|||
125102991|NCT00424632|449997809|FG000|Overall Study|Objective progression or relapse|1|||
125102992|NCT00424632|449997810|FG001|Overall Study|Objective progression or relapse|1|||
125102993|NCT00424632|449997811|FG002|Overall Study|Objective progression or relapse|1|||
125102994|NCT00424632|449997812|FG003|Overall Study|Objective progression or relapse|2|||
125102995|NCT00424632|449997813|FG004|Overall Study|Objective progression or relapse|2|||
125102996|NCT00424632|449997814|FG005|Overall Study|Objective progression or relapse|13|||
125102997|NCT00424632|449997815|FG006|Overall Study|Objective progression or relapse|7|||
125102998|NCT00424632|449997816|FG007|Overall Study|Objective progression or relapse|3|||
125102999|NCT00424632|449997817|FG008|Overall Study|Objective progression or relapse|12|||
125103000|NCT00424632|449997818|FG009|Overall Study|Objective progression or relapse|4|||
125103001|NCT00424632|449997809|FG000|Overall Study|Other|0|||
125103002|NCT00424632|449997810|FG001|Overall Study|Other|0|||
125103003|NCT00424632|449997811|FG002|Overall Study|Other|0|||
125103004|NCT00424632|449997812|FG003|Overall Study|Other|1|||
125103005|NCT00424632|449997813|FG004|Overall Study|Other|0|||
124879564|NCT01641926|449182507|FG000|Overall Study|Withdrawal by Subject|13|||
124879565|NCT01641926|449182508|FG001|Overall Study|Withdrawal by Subject|5|||
124879566|NCT01641926|449182509|FG002|Overall Study|Withdrawal by Subject|6|||
124879567|NCT01641926|449182510|FG003|Overall Study|Withdrawal by Subject|1|||
125013769|NCT02873936|449676865|FG002|Overall Study|Adverse Event|3|||
125013770|NCT02873936|449676863|FG000|Overall Study|Protocol Violation|0|||
125013771|NCT02873936|449676864|FG001|Overall Study|Protocol Violation|1|||
125013772|NCT02873936|449676865|FG002|Overall Study|Protocol Violation|3|||
125013773|NCT02873936|449676863|FG000|Overall Study|Lost to Follow-up|1|||
125013774|NCT02873936|449676864|FG001|Overall Study|Lost to Follow-up|1|||
125013775|NCT02873936|449676865|FG002|Overall Study|Lost to Follow-up|1|||
125013776|NCT02873936|449676863|FG000|Overall Study|Non-compliance With Study Drug|1|||
125013777|NCT02873936|449676864|FG001|Overall Study|Non-compliance With Study Drug|0|||
125013778|NCT02873936|449676865|FG002|Overall Study|Non-compliance With Study Drug|1|||
125013779|NCT02873936|449676863|FG000|Overall Study|Randomized but not Dosed|1|||
125013780|NCT02873936|449676864|FG001|Overall Study|Randomized but not Dosed|0|||
125013781|NCT02873936|449676865|FG002|Overall Study|Randomized but not Dosed|0|||
125013782|NCT05513625|449676866|FG000|Overall Study|Withdrawal by Subject|1|||
125013783|NCT00754793|449676867|FG000|Overall Study|voluntary withdrawn from study|0|||
125013784|NCT00754793|449676868|FG001|Overall Study|voluntary withdrawn from study|1|||
125013785|NCT01225731|449676870|FG000|Part 1|Did not meet eligibility criteria|1|||
125013786|NCT01225731|449676871|FG001|Part 1|Did not meet eligibility criteria|0|||
125013787|NCT01225731|449676872|FG002|Part 1|Did not meet eligibility criteria|0|||
125013788|NCT01225731|449676873|FG003|Part 1|Did not meet eligibility criteria|0|||
125013789|NCT01225731|449676874|FG004|Part 1|Did not meet eligibility criteria|1|||
125013790|NCT01225731|449676875|FG005|Part 1|Did not meet eligibility criteria|0|||
125013791|NCT01225731|449676876|FG006|Part 1|Did not meet eligibility criteria|0|||
125013792|NCT01225731|449676877|FG007|Part 1|Did not meet eligibility criteria|0|||
125013793|NCT01225731|449676878|FG008|Part 1|Did not meet eligibility criteria|0|||
125013794|NCT01225731|449676879|FG009|Part 1|Did not meet eligibility criteria|0|||
125013795|NCT01225731|449676880|FG010|Part 1|Did not meet eligibility criteria|0|||
125013796|NCT01225731|449676881|FG011|Part 1|Did not meet eligibility criteria|0|||
125013797|NCT01225731|449676882|FG012|Part 1|Did not meet eligibility criteria|0|||
125013798|NCT01225731|449676870|FG000|Part 1|Adverse Event|1|||
124879568|NCT01641926|449182507|FG000|Overall Study|Not Treated|1|||
124879569|NCT01641926|449182508|FG001|Overall Study|Not Treated|1|||
124879570|NCT01641926|449182509|FG002|Overall Study|Not Treated|1|||
124879571|NCT01641926|449182510|FG003|Overall Study|Not Treated|0|||
124879572|NCT01111838|449182511|FG000|Overall Study|Patient Ineligible|2|||
124879573|NCT01111838|449182511|FG000|Overall Study|Not Treated|3|||
124879574|NCT01111838|449182511|FG000|Overall Study|Clinical deterioration|1|||
124879575|NCT01111838|449182511|FG000|Overall Study|Other Complicating Disease|1|||
124879576|NCT03303469|449182512|FG000|Overall Study|Lost to Follow-up|2|||
124879577|NCT02567825|449182519|FG000|Overall Study|No follow-up post-randomization|5|||
124879578|NCT02567825|449182520|FG001|Overall Study|No follow-up post-randomization|1|||
124879579|NCT02567825|449182519|FG000|Overall Study|Follow-up less than 23 months|16|||
124879580|NCT02567825|449182520|FG001|Overall Study|Follow-up less than 23 months|20|||
124879581|NCT04741802|449182522|FG000|Overall Study|Death|1|||
124879582|NCT04741802|449182522|FG000|Overall Study|Lost to Follow-up|11|||
124879583|NCT01785563|449182525|FG000|Overall Study|Physician Decision|10|||
124879584|NCT01785563|449182525|FG000|Overall Study|Withdrawal by Subject|1|||
124879585|NCT01785563|449182525|FG000|Overall Study|Protocol Violation|2|||
124879586|NCT01540565|449182526|FG000|Overall Study|Ineligible|2|||
124879587|NCT04399356|449182527|FG000|Overall Study|Lost to Follow-up|1|||
124879588|NCT04399356|449182528|FG001|Overall Study|Lost to Follow-up|1|||
124879589|NCT04399356|449182527|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
124879590|NCT04399356|449182528|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
124879591|NCT04399356|449182527|FG000|Overall Study|Withdrawal by Subject|1|||
124879592|NCT04399356|449182528|FG001|Overall Study|Withdrawal by Subject|0|||
125013799|NCT01225731|449676871|FG001|Part 1|Adverse Event|2|||
125013800|NCT01225731|449676872|FG002|Part 1|Adverse Event|1|||
125013801|NCT01225731|449676873|FG003|Part 1|Adverse Event|1|||
125013802|NCT01225731|449676874|FG004|Part 1|Adverse Event|1|||
125013803|NCT01225731|449676875|FG005|Part 1|Adverse Event|0|||
125013804|NCT01225731|449676876|FG006|Part 1|Adverse Event|0|||
125013805|NCT01225731|449676877|FG007|Part 1|Adverse Event|0|||
125013806|NCT01225731|449676878|FG008|Part 1|Adverse Event|0|||
125013807|NCT01225731|449676879|FG009|Part 1|Adverse Event|0|||
125013808|NCT01225731|449676880|FG010|Part 1|Adverse Event|0|||
125013809|NCT01225731|449676881|FG011|Part 1|Adverse Event|0|||
125013810|NCT01225731|449676882|FG012|Part 1|Adverse Event|0|||
125013811|NCT01225731|449676870|FG000|Part 1|Withdrawal by Subject|0|||
125013812|NCT01225731|449676871|FG001|Part 1|Withdrawal by Subject|3|||
125013813|NCT01225731|449676872|FG002|Part 1|Withdrawal by Subject|0|||
125013814|NCT01225731|449676873|FG003|Part 1|Withdrawal by Subject|0|||
125013815|NCT01225731|449676874|FG004|Part 1|Withdrawal by Subject|4|||
125013816|NCT01225731|449676875|FG005|Part 1|Withdrawal by Subject|0|||
125013817|NCT01225731|449676876|FG006|Part 1|Withdrawal by Subject|0|||
125013818|NCT01225731|449676877|FG007|Part 1|Withdrawal by Subject|0|||
125013819|NCT01225731|449676878|FG008|Part 1|Withdrawal by Subject|0|||
125013820|NCT01225731|449676879|FG009|Part 1|Withdrawal by Subject|0|||
125013821|NCT01225731|449676880|FG010|Part 1|Withdrawal by Subject|0|||
125013822|NCT01225731|449676881|FG011|Part 1|Withdrawal by Subject|0|||
125013823|NCT01225731|449676882|FG012|Part 1|Withdrawal by Subject|0|||
125013824|NCT01225731|449676870|FG000|Part 1|Protocol Violation|0|||
125013825|NCT01225731|449676871|FG001|Part 1|Protocol Violation|0|||
125013826|NCT01225731|449676872|FG002|Part 1|Protocol Violation|0|||
125013827|NCT01225731|449676873|FG003|Part 1|Protocol Violation|1|||
125013828|NCT01225731|449676874|FG004|Part 1|Protocol Violation|0|||
125013829|NCT01225731|449676875|FG005|Part 1|Protocol Violation|0|||
125013830|NCT01225731|449676876|FG006|Part 1|Protocol Violation|0|||
125013831|NCT01225731|449676877|FG007|Part 1|Protocol Violation|0|||
125013832|NCT01225731|449676878|FG008|Part 1|Protocol Violation|0|||
125013833|NCT01225731|449676879|FG009|Part 1|Protocol Violation|0|||
125013834|NCT01225731|449676880|FG010|Part 1|Protocol Violation|0|||
125013835|NCT01225731|449676881|FG011|Part 1|Protocol Violation|0|||
125013836|NCT01225731|449676882|FG012|Part 1|Protocol Violation|0|||
125013837|NCT01225731|449676870|FG000|Part 2|Protocol Violation|0|||
125013838|NCT01225731|449676871|FG001|Part 2|Protocol Violation|0|||
124879593|NCT01834222|449182533|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
124879594|NCT04251065|449182534|FG000|Overall Study|Death|2|||
124879595|NCT04251065|449182534|FG000|Overall Study|Lack of Efficacy|3|||
124879596|NCT04251065|449182534|FG000|Overall Study|Death|1|||
125013839|NCT01225731|449676872|FG002|Part 2|Protocol Violation|0|||
125013840|NCT01225731|449676873|FG003|Part 2|Protocol Violation|0|||
125013841|NCT01225731|449676874|FG004|Part 2|Protocol Violation|0|||
125013842|NCT01225731|449676875|FG005|Part 2|Protocol Violation|1|||
125013843|NCT01225731|449676876|FG006|Part 2|Protocol Violation|0|||
124879597|NCT04091360|449182535|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
124879598|NCT04091360|449182536|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
124879599|NCT04091360|449182537|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
125013844|NCT01225731|449676877|FG007|Part 2|Protocol Violation|0|||
125013845|NCT01225731|449676878|FG008|Part 2|Protocol Violation|1|||
125013846|NCT01225731|449676879|FG009|Part 2|Protocol Violation|0|||
125013847|NCT01225731|449676880|FG010|Part 2|Protocol Violation|0|||
125013848|NCT01225731|449676881|FG011|Part 2|Protocol Violation|0|||
125013849|NCT01225731|449676882|FG012|Part 2|Protocol Violation|0|||
124879600|NCT04091360|449182538|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
124879601|NCT04091360|449182539|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
124879602|NCT04091360|449182540|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
124879603|NCT04091360|449182541|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
124879604|NCT04091360|449182542|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
124879605|NCT04091360|449182543|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
124879606|NCT04091360|449182544|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
124879607|NCT04091360|449182535|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
124879608|NCT04091360|449182536|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
124879609|NCT04091360|449182537|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
124879610|NCT04091360|449182538|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
124879611|NCT04091360|449182539|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
124879612|NCT04091360|449182540|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
124879613|NCT04091360|449182541|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
124879614|NCT04091360|449182542|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
124879615|NCT04091360|449182543|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
124879616|NCT04091360|449182544|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
124879617|NCT04091360|449182535|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
124879618|NCT04091360|449182536|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
124879619|NCT04091360|449182537|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
124879620|NCT04091360|449182538|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
124879621|NCT04091360|449182539|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
124879622|NCT04091360|449182540|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
124879623|NCT04091360|449182541|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
124879624|NCT04091360|449182542|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
124879625|NCT04091360|449182543|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
124879626|NCT04091360|449182544|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
124879627|NCT00980005|449182547|FG000|Overall Study|Withdrawal by Subject|6|||
124879628|NCT00980005|449182548|FG001|Overall Study|Withdrawal by Subject|17|||
124879629|NCT00980005|449182547|FG000|Overall Study|Lost to Follow-up|37|||
124879630|NCT00980005|449182548|FG001|Overall Study|Lost to Follow-up|43|||
124879631|NCT00980005|449182547|FG000|Overall Study|Other|4|||
125013850|NCT01225731|449676870|FG000|Part 2|Adverse Event|0|||
125103006|NCT00424632|449997814|FG005|Overall Study|Other|0|||
125103007|NCT00424632|449997815|FG006|Overall Study|Other|0|||
125103008|NCT00424632|449997816|FG007|Overall Study|Other|0|||
125103009|NCT00424632|449997817|FG008|Overall Study|Other|1|||
125103010|NCT00424632|449997818|FG009|Overall Study|Other|0|||
125103011|NCT01984229|449997819|FG000|Safety Follow-up Period|Adverse Event|1|||
125103012|NCT01984229|449997820|FG001|Safety Follow-up Period|Adverse Event|1|||
125103013|NCT01984229|449997819|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
125103014|NCT01984229|449997820|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
125103015|NCT02325739|449997821|FG000|Phase I Part|Adverse Event|1|||
125103016|NCT02325739|449997822|FG001|Phase I Part|Adverse Event|0|||
125103017|NCT02325739|449997823|FG002|Phase I Part|Adverse Event|1|||
125103018|NCT02325739|449997824|FG003|Phase I Part|Adverse Event|2|||
125103019|NCT02325739|449997825|FG004|Phase I Part|Adverse Event|3|||
125103020|NCT02325739|449997826|FG005|Phase I Part|Adverse Event|1|||
125103021|NCT02325739|449997827|FG006|Phase I Part|Adverse Event|0|||
125103022|NCT02325739|449997828|FG007|Phase I Part|Adverse Event|2|||
125103023|NCT02325739|449997829|FG008|Phase I Part|Adverse Event|0|||
125103024|NCT02325739|449997830|FG009|Phase I Part|Adverse Event|0|||
125103025|NCT02325739|449997831|FG010|Phase I Part|Adverse Event|0|||
125103026|NCT02325739|449997821|FG000|Phase I Part|Progressive disease|9|||
125103027|NCT02325739|449997822|FG001|Phase I Part|Progressive disease|6|||
125103028|NCT02325739|449997823|FG002|Phase I Part|Progressive disease|3|||
125103029|NCT02325739|449997824|FG003|Phase I Part|Progressive disease|23|||
125103030|NCT02325739|449997825|FG004|Phase I Part|Progressive disease|14|||
125103031|NCT02325739|449997826|FG005|Phase I Part|Progressive disease|6|||
125103032|NCT02325739|449997827|FG006|Phase I Part|Progressive disease|6|||
125103033|NCT02325739|449997828|FG007|Phase I Part|Progressive disease|3|||
125103034|NCT02325739|449997829|FG008|Phase I Part|Progressive disease|0|||
125103035|NCT02325739|449997830|FG009|Phase I Part|Progressive disease|0|||
125103036|NCT02325739|449997831|FG010|Phase I Part|Progressive disease|0|||
125103037|NCT02325739|449997821|FG000|Phase I Part|Subject/guardian decision|1|||
125103038|NCT02325739|449997822|FG001|Phase I Part|Subject/guardian decision|0|||
125103039|NCT02325739|449997823|FG002|Phase I Part|Subject/guardian decision|1|||
125103040|NCT02325739|449997824|FG003|Phase I Part|Subject/guardian decision|1|||
125103041|NCT02325739|449997825|FG004|Phase I Part|Subject/guardian decision|0|||
125103042|NCT02325739|449997826|FG005|Phase I Part|Subject/guardian decision|0|||
125103043|NCT02325739|449997827|FG006|Phase I Part|Subject/guardian decision|0|||
125103044|NCT02325739|449997828|FG007|Phase I Part|Subject/guardian decision|1|||
125103045|NCT02325739|449997829|FG008|Phase I Part|Subject/guardian decision|0|||
125103046|NCT02325739|449997830|FG009|Phase I Part|Subject/guardian decision|0|||
125103047|NCT02325739|449997831|FG010|Phase I Part|Subject/guardian decision|0|||
125103048|NCT02325739|449997821|FG000|Phase I Part|Death|0|||
125103049|NCT02325739|449997822|FG001|Phase I Part|Death|0|||
125103050|NCT02325739|449997823|FG002|Phase I Part|Death|0|||
125103051|NCT02325739|449997824|FG003|Phase I Part|Death|0|||
125103052|NCT02325739|449997825|FG004|Phase I Part|Death|2|||
125103053|NCT02325739|449997826|FG005|Phase I Part|Death|0|||
125103054|NCT02325739|449997827|FG006|Phase I Part|Death|0|||
125103055|NCT02325739|449997828|FG007|Phase I Part|Death|0|||
125103056|NCT02325739|449997829|FG008|Phase I Part|Death|0|||
125103057|NCT02325739|449997830|FG009|Phase I Part|Death|0|||
124879632|NCT00980005|449182548|FG001|Overall Study|Other|3|||
124879633|NCT00572624|449182549|FG000|Overall Study|Lost to Follow-up|10|||
124879634|NCT00572624|449182550|FG001|Overall Study|Lost to Follow-up|4|||
124879635|NCT00572624|449182549|FG000|Overall Study|Wanted to do a different diet program|1|||
124879636|NCT00572624|449182550|FG001|Overall Study|Wanted to do a different diet program|0|||
124879637|NCT00572624|449182549|FG000|Overall Study|Medication change|1|||
124879638|NCT00572624|449182550|FG001|Overall Study|Medication change|0|||
124879639|NCT00572624|449182549|FG000|Overall Study|Started a new job-- no time for study|1|||
124879640|NCT00572624|449182550|FG001|Overall Study|Started a new job-- no time for study|0|||
124879641|NCT00572624|449182549|FG000|Overall Study|Admitted to being a smoker|1|||
124879642|NCT00572624|449182550|FG001|Overall Study|Admitted to being a smoker|0|||
124879643|NCT00572624|449182549|FG000|Overall Study|Refused to do the stress test|1|||
124879644|NCT00572624|449182550|FG001|Overall Study|Refused to do the stress test|0|||
124879645|NCT00572624|449182549|FG000|Overall Study|Problem with vascular access|1|||
124879646|NCT00572624|449182550|FG001|Overall Study|Problem with vascular access|0|||
124879647|NCT00572624|449182549|FG000|Overall Study|Health issues unrelated to the study|1|||
124879648|NCT00572624|449182550|FG001|Overall Study|Health issues unrelated to the study|0|||
124879649|NCT00744263|449182551|FG000|Overall Study|Death|3006|||
124879650|NCT00744263|449182552|FG001|Overall Study|Death|3005|||
124879651|NCT00744263|449182551|FG000|Overall Study|Lost to Follow-up|2038|||
124879652|NCT00744263|449182552|FG001|Overall Study|Lost to Follow-up|2135|||
124879653|NCT00744263|449182551|FG000|Overall Study|Withdrawal by Subject|166|||
124879654|NCT00744263|449182552|FG001|Overall Study|Withdrawal by Subject|150|||
124879655|NCT00744263|449182551|FG000|Overall Study|Physician Decision|20|||
124879656|NCT00744263|449182552|FG001|Overall Study|Physician Decision|23|||
124879657|NCT00744263|449182551|FG000|Overall Study|Protocol Violation|3|||
124879658|NCT00744263|449182552|FG001|Overall Study|Protocol Violation|5|||
124879659|NCT00744263|449182551|FG000|Overall Study|Adverse Event|1|||
124879660|NCT00744263|449182552|FG001|Overall Study|Adverse Event|0|||
124879661|NCT00744263|449182551|FG000|Overall Study|Other|2|||
124879662|NCT00744263|449182552|FG001|Overall Study|Other|2|||
124879663|NCT00130793|449182555|FG000|Overall Study|Lost to Follow-up|1|||
124879664|NCT00130793|449182556|FG001|Overall Study|Lost to Follow-up|4|||
124879665|NCT00130793|449182555|FG000|Overall Study|Withdrew consent|2|||
124879666|NCT00130793|449182556|FG001|Overall Study|Withdrew consent|0|||
124879667|NCT00211237|449182557|FG000|Baseline|Withdrew|1|||
124879668|NCT00211237|449182558|FG001|Baseline|Withdrew|3|||
124879669|NCT00211237|449182559|FG002|Baseline|Withdrew|0|||
124879670|NCT00211237|449182557|FG000|Baseline|Refused random assignment|1|||
124879671|NCT00211237|449182558|FG001|Baseline|Refused random assignment|0|||
124879672|NCT00211237|449182559|FG002|Baseline|Refused random assignment|0|||
124879673|NCT00211237|449182557|FG000|1 Month|Death|2|||
124879674|NCT00211237|449182558|FG001|1 Month|Death|1|||
124879675|NCT00211237|449182559|FG002|1 Month|Death|0|||
124879676|NCT00211237|449182557|FG000|1 Month|Lost to Follow-up|0|||
124879677|NCT00211237|449182558|FG001|1 Month|Lost to Follow-up|2|||
124879678|NCT00211237|449182559|FG002|1 Month|Lost to Follow-up|0|||
124879679|NCT00211237|449182557|FG000|1 Month|Withdrew|0|||
124879680|NCT00211237|449182558|FG001|1 Month|Withdrew|4|||
124879681|NCT00211237|449182559|FG002|1 Month|Withdrew|0|||
124879682|NCT00211237|449182557|FG000|1 Month|Additional surgery needed|1|||
124879683|NCT00211237|449182558|FG001|1 Month|Additional surgery needed|0|||
124879684|NCT00211237|449182559|FG002|1 Month|Additional surgery needed|0|||
124879685|NCT00211237|449182557|FG000|1 Month|Non-medical problem|0|||
124879686|NCT00211237|449182558|FG001|1 Month|Non-medical problem|2|||
124879687|NCT00211237|449182559|FG002|1 Month|Non-medical problem|0|||
124879688|NCT00211237|449182557|FG000|3 Months|Death|7|||
124879689|NCT00211237|449182558|FG001|3 Months|Death|3|||
125103058|NCT02325739|449997831|FG010|Phase I Part|Death|0|||
124879690|NCT00211237|449182559|FG002|3 Months|Death|0|||
124879691|NCT00211237|449182557|FG000|3 Months|Could not comply with protocol|1|||
124879692|NCT00211237|449182558|FG001|3 Months|Could not comply with protocol|0|||
125103059|NCT02325739|449997821|FG000|Phase II Part|Adverse Event|0|||
124879693|NCT00211237|449182559|FG002|3 Months|Could not comply with protocol|0|||
124879694|NCT00211237|449182557|FG000|3 Months|Withdrew|0|||
124879695|NCT00211237|449182558|FG001|3 Months|Withdrew|1|||
124879696|NCT00211237|449182559|FG002|3 Months|Withdrew|0|||
124879697|NCT00211237|449182557|FG000|3 Months|Non-medical problem|0|||
124879698|NCT00211237|449182558|FG001|3 Months|Non-medical problem|0|||
124879699|NCT00211237|449182559|FG002|3 Months|Non-medical problem|1|||
124879700|NCT00211237|449182557|FG000|6 Months|Death|6|||
124879701|NCT00211237|449182558|FG001|6 Months|Death|0|||
124879702|NCT00211237|449182559|FG002|6 Months|Death|3|||
124879703|NCT00211237|449182557|FG000|6 Months|Lost to Follow-up|2|||
124879704|NCT00211237|449182558|FG001|6 Months|Lost to Follow-up|0|||
124879705|NCT00211237|449182559|FG002|6 Months|Lost to Follow-up|0|||
124879706|NCT00211237|449182557|FG000|6 Months|Could not comply with protocol|0|||
124879707|NCT00211237|449182558|FG001|6 Months|Could not comply with protocol|2|||
124879708|NCT00211237|449182559|FG002|6 Months|Could not comply with protocol|0|||
124879709|NCT00211237|449182557|FG000|12 Months|Death|8|||
124879710|NCT00211237|449182558|FG001|12 Months|Death|2|||
124879711|NCT00211237|449182559|FG002|12 Months|Death|3|||
124879712|NCT00211237|449182557|FG000|12 Months|Lost to Follow-up|1|||
124879713|NCT00211237|449182558|FG001|12 Months|Lost to Follow-up|0|||
124879714|NCT00211237|449182559|FG002|12 Months|Lost to Follow-up|1|||
124879715|NCT00211237|449182557|FG000|12 Months|Withdrew|0|||
124879716|NCT00211237|449182558|FG001|12 Months|Withdrew|0|||
124879717|NCT00211237|449182559|FG002|12 Months|Withdrew|1|||
124879718|NCT00211237|449182557|FG000|12 Months|unrelated medical problem|0|||
124879719|NCT00211237|449182558|FG001|12 Months|unrelated medical problem|0|||
124879720|NCT00211237|449182559|FG002|12 Months|unrelated medical problem|1|||
124879721|NCT01013792|449182564|FG000|Overall Study|Study suspended|2|||
124879722|NCT01013792|449182565|FG001|Overall Study|Study suspended|1|||
124879723|NCT01013792|449182564|FG000|Overall Study|Adverse Event|0|||
124879724|NCT01013792|449182565|FG001|Overall Study|Adverse Event|3|||
124879725|NCT01013792|449182564|FG000|Overall Study|Lost to Follow-up|0|||
124879726|NCT01013792|449182565|FG001|Overall Study|Lost to Follow-up|1|||
124879727|NCT02100722|449182569|FG000|Overall Study|Withdrawal pre-procedure|4|||
124879728|NCT02100722|449182570|FG001|Overall Study|Withdrawal pre-procedure|9|||
124879729|NCT02100722|449182569|FG000|Overall Study|Withdrawal post-procedure|0|||
124879730|NCT02100722|449182570|FG001|Overall Study|Withdrawal post-procedure|3|||
124879731|NCT02100722|449182569|FG000|Overall Study|Lost to Follow-up|2|||
124879732|NCT02100722|449182570|FG001|Overall Study|Lost to Follow-up|2|||
124879733|NCT02100722|449182569|FG000|Overall Study|Continuing on study|751|||
124879734|NCT02100722|449182570|FG001|Overall Study|Continuing on study|729|||
124879735|NCT03500640|449182575|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
124879736|NCT03500640|449182576|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
124879737|NCT03500640|449182577|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
124879738|NCT03500640|449182575|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
124879739|NCT03500640|449182576|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
124879740|NCT03500640|449182577|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
124879741|NCT03500640|449182575|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
124879742|NCT03500640|449182576|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
124879743|NCT03500640|449182577|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
124879744|NCT03500640|449182575|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
124879745|NCT03500640|449182576|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
124879746|NCT03500640|449182577|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
124879747|NCT03500640|449182575|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
124879748|NCT03500640|449182576|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
124879749|NCT03500640|449182577|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
124879750|NCT03500640|449182575|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
124879751|NCT03500640|449182576|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
124879752|NCT03500640|449182577|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
124879753|NCT03500640|449182575|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
124879754|NCT03500640|449182576|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
124879755|NCT03500640|449182577|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
124879756|NCT03500640|449182575|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
124879757|NCT03500640|449182576|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
124879758|NCT03500640|449182577|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
125103060|NCT02325739|449997822|FG001|Phase II Part|Adverse Event|0|||
124879759|NCT03500640|449182575|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
124879760|NCT03500640|449182576|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
124879761|NCT03500640|449182577|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
124879762|NCT03500640|449182575|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
124879763|NCT03500640|449182576|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
124879764|NCT03500640|449182577|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
124879765|NCT01650519|449182578|FG000|Overall Study|Withdrawal by Subject|1|||
124879766|NCT01650519|449182579|FG001|Overall Study|Withdrawal by Subject|0|||
124879767|NCT01279343|449182582|FG000|Overall Study|Did not receive treatment|2|||
124879768|NCT01279343|449182583|FG001|Overall Study|Did not receive treatment|6|||
124879769|NCT01250119|449184093|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
124879770|NCT01250119|449184094|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
124879771|NCT01250119|449184093|FG000|Diagnostic Phase|Participants Not Tested|44|||
124879772|NCT01250119|449184094|FG001|Diagnostic Phase|Participants Not Tested|0|||
124879773|NCT01250119|449184093|FG000|Treatment Phase|Progressive Disease|0|||
124879774|NCT01250119|449184094|FG001|Treatment Phase|Progressive Disease|32|||
124879775|NCT01250119|449184093|FG000|Treatment Phase|Death|0|||
124879776|NCT01250119|449184094|FG001|Treatment Phase|Death|2|||
124879777|NCT01250119|449184093|FG000|Treatment Phase|Withdrawal by Subject|0|||
124879778|NCT01250119|449184094|FG001|Treatment Phase|Withdrawal by Subject|1|||
124879779|NCT01250119|449184093|FG000|Treatment Phase|Adverse Event|0|||
124879780|NCT01250119|449184094|FG001|Treatment Phase|Adverse Event|2|||
124879781|NCT01250119|449184093|FG000|Treatment Phase|Unknown reason|0|||
124879782|NCT01250119|449184094|FG001|Treatment Phase|Unknown reason|4|||
124879783|NCT02887989|449184098|FG000|Overall Study|Withdrawal by Subject|8|||
124879784|NCT02887989|449184099|FG001|Overall Study|Withdrawal by Subject|11|||
124879785|NCT02887989|449184098|FG000|Overall Study|Death|1|||
124879786|NCT02887989|449184099|FG001|Overall Study|Death|0|||
124879787|NCT05648357|449184100|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
124879788|NCT00255346|449184101|FG000|Overall Study|Adverse Event|1|||
124879789|NCT00255346|449184102|FG001|Overall Study|Adverse Event|0|||
124879790|NCT00255346|449184103|FG002|Overall Study|Adverse Event|0|||
124879791|NCT00255346|449184104|FG003|Overall Study|Adverse Event|0|||
124879792|NCT00255346|449184105|FG004|Overall Study|Adverse Event|0|||
124879793|NCT00409786|449184108|FG000|Overall Study|Withdrawal by Subject|3|||
124879794|NCT02440594|449184112|FG000|Overall Study|Lost to Follow-up|34|||
124879795|NCT02440594|449184113|FG001|Overall Study|Lost to Follow-up|33|||
124879796|NCT02440594|449184114|FG002|Overall Study|Lost to Follow-up|54|||
124879797|NCT02440594|449184115|FG003|Overall Study|Lost to Follow-up|47|||
124879798|NCT02440594|449184116|FG004|Overall Study|Lost to Follow-up|5|||
124879799|NCT02440594|449184117|FG005|Overall Study|Lost to Follow-up|4|||
124879800|NCT02440594|449184118|FG006|Overall Study|Lost to Follow-up|28|||
124879801|NCT02440594|449184119|FG007|Overall Study|Lost to Follow-up|48|||
124879802|NCT02440594|449184112|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
124879803|NCT02440594|449184113|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
124879804|NCT02440594|449184114|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
124879805|NCT02440594|449184115|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
124879806|NCT02440594|449184116|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
124879807|NCT02440594|449184117|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
124879808|NCT02440594|449184118|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
124879809|NCT02440594|449184119|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
124879810|NCT02440594|449184112|FG000|Overall Study|Withdrawal by Subject|81|||
124879811|NCT02440594|449184113|FG001|Overall Study|Withdrawal by Subject|67|||
124879812|NCT02440594|449184114|FG002|Overall Study|Withdrawal by Subject|59|||
124879813|NCT02440594|449184115|FG003|Overall Study|Withdrawal by Subject|38|||
124879814|NCT02440594|449184116|FG004|Overall Study|Withdrawal by Subject|2|||
124879815|NCT02440594|449184117|FG005|Overall Study|Withdrawal by Subject|2|||
124879816|NCT02440594|449184118|FG006|Overall Study|Withdrawal by Subject|7|||
124879817|NCT02440594|449184119|FG007|Overall Study|Withdrawal by Subject|7|||
124879818|NCT02440594|449184112|FG000|Overall Study|Administratively w/drawn|3|||
124879819|NCT02440594|449184113|FG001|Overall Study|Administratively w/drawn|2|||
124879820|NCT02440594|449184114|FG002|Overall Study|Administratively w/drawn|0|||
124879821|NCT02440594|449184115|FG003|Overall Study|Administratively w/drawn|0|||
124879822|NCT02440594|449184116|FG004|Overall Study|Administratively w/drawn|0|||
124879823|NCT02440594|449184117|FG005|Overall Study|Administratively w/drawn|0|||
124879824|NCT02440594|449184118|FG006|Overall Study|Administratively w/drawn|2|||
124879825|NCT02440594|449184119|FG007|Overall Study|Administratively w/drawn|1|||
125013851|NCT01225731|449676871|FG001|Part 2|Adverse Event|0|||
125013852|NCT01225731|449676872|FG002|Part 2|Adverse Event|0|||
125013853|NCT01225731|449676873|FG003|Part 2|Adverse Event|0|||
124879826|NCT00584805|449184120|FG000|Overall Study|No longer at risk of exposure|39|||
124879827|NCT00584805|449184120|FG000|Overall Study|Relocation|36|||
124879828|NCT00584805|449184120|FG000|Overall Study|Withdrawal by Subject|18|||
124879829|NCT00584805|449184120|FG000|Overall Study|Non-compliance|1|||
124879830|NCT00584805|449184120|FG000|Overall Study|Lost to follow up|3|||
124879831|NCT00584805|449184120|FG000|Overall Study|Screen failures|2|||
124879832|NCT01993823|449184121|FG000|Overall Study|Requested by the patient|6|||
124879833|NCT01993823|449184122|FG001|Overall Study|Requested by the patient|11|||
124879834|NCT01993823|449184121|FG000|Overall Study|Protocol Violation|0|||
124879835|NCT01993823|449184122|FG001|Overall Study|Protocol Violation|1|||
124879836|NCT01993823|449184121|FG000|Overall Study|Lost to Follow-up|1|||
125013854|NCT01225731|449676874|FG004|Part 2|Adverse Event|0|||
125013855|NCT01225731|449676875|FG005|Part 2|Adverse Event|0|||
124879837|NCT01993823|449184122|FG001|Overall Study|Lost to Follow-up|4|||
124879838|NCT02341456|449184123|FG000|Overall Study|Disease progression|2|||
124879839|NCT02341456|449184124|FG001|Overall Study|Disease progression|3|||
124879840|NCT02341456|449184125|FG002|Overall Study|Disease progression|1|||
124879841|NCT02341456|449184123|FG000|Overall Study|Death|1|||
124879842|NCT02341456|449184124|FG001|Overall Study|Death|1|||
124879843|NCT02341456|449184125|FG002|Overall Study|Death|1|||
124879844|NCT02341456|449184123|FG000|Overall Study|Withdrawal by Subject|0|||
124879845|NCT02341456|449184124|FG001|Overall Study|Withdrawal by Subject|1|||
124879846|NCT02341456|449184125|FG002|Overall Study|Withdrawal by Subject|1|||
124879847|NCT02341456|449184123|FG000|Overall Study|Moved to local access programme.|0|||
124879848|NCT02341456|449184124|FG001|Overall Study|Moved to local access programme.|1|||
124879849|NCT02341456|449184125|FG002|Overall Study|Moved to local access programme.|1|||
124879850|NCT02341456|449184123|FG000|Overall Study|Physician Decision|1|||
124879851|NCT02341456|449184124|FG001|Overall Study|Physician Decision|0|||
124879852|NCT02341456|449184125|FG002|Overall Study|Physician Decision|0|||
124879853|NCT00301080|449184127|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
124879854|NCT00301080|449184128|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
124879855|NCT00301080|449184129|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
124879856|NCT00301080|449184130|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
124879857|NCT00301080|449184131|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
124879858|NCT03066622|449184133|FG000|Overall Study|Lost to Follow-up|24|||
124879859|NCT03066622|449184134|FG001|Overall Study|Lost to Follow-up|25|||
124879860|NCT03066622|449184133|FG000|Overall Study|Withdrawal by Subject|2|||
124879861|NCT03066622|449184134|FG001|Overall Study|Withdrawal by Subject|1|||
124879862|NCT00641719|449184135|FG000|Overall Study|Lack of Efficacy|1|||
124879863|NCT00641719|449184136|FG001|Overall Study|Lack of Efficacy|2|||
124879864|NCT00641719|449184135|FG000|Overall Study|Adverse Event|24|||
124879865|NCT00641719|449184136|FG001|Overall Study|Adverse Event|29|||
124879866|NCT00641719|449184135|FG000|Overall Study|Withdrawal by Subject|4|||
124879867|NCT00641719|449184136|FG001|Overall Study|Withdrawal by Subject|4|||
124879868|NCT00641719|449184135|FG000|Overall Study|Reason Not Specified|1|||
124879869|NCT00641719|449184136|FG001|Overall Study|Reason Not Specified|2|||
124879870|NCT03469349|449184137|FG000|Overall Study|Withdrawal by Subject|1|||
124879871|NCT03469349|449184138|FG001|Overall Study|Withdrawal by Subject|3|||
124879872|NCT03469349|449184137|FG000|Overall Study|Progressive Disease|0|||
124879873|NCT03469349|449184138|FG001|Overall Study|Progressive Disease|1|||
124879874|NCT03469349|449184137|FG000|Overall Study|Lost to Follow-up|2|||
124879875|NCT03469349|449184138|FG001|Overall Study|Lost to Follow-up|2|||
124879876|NCT03469349|449184137|FG000|Overall Study|Adverse Event|2|||
124879877|NCT03469349|449184138|FG001|Overall Study|Adverse Event|4|||
124879878|NCT02306265|449184139|FG000|Overall Study|Withdrawal by Subject|1|||
124879879|NCT04488003|449184140|FG000|Assessed for Eligibility|Screen Failure|24|||
124879880|NCT04488003|449184141|FG001|Assessed for Eligibility|Screen Failure|0|||
124879881|NCT04488003|449184142|FG002|Assessed for Eligibility|Screen Failure|0|||
124879882|NCT04488003|449184140|FG000|Assessed for Eligibility|Adverse Event|1|||
124879883|NCT04488003|449184141|FG001|Assessed for Eligibility|Adverse Event|0|||
124879884|NCT04488003|449184142|FG002|Assessed for Eligibility|Adverse Event|0|||
124879885|NCT04488003|449184140|FG000|Assessed for Eligibility|Death|1|||
124879886|NCT04488003|449184141|FG001|Assessed for Eligibility|Death|0|||
124879887|NCT04488003|449184142|FG002|Assessed for Eligibility|Death|0|||
124879888|NCT04488003|449184140|FG000|Assessed for Eligibility|Physician Decision|1|||
124879889|NCT04488003|449184141|FG001|Assessed for Eligibility|Physician Decision|0|||
124879890|NCT04488003|449184142|FG002|Assessed for Eligibility|Physician Decision|0|||
124879891|NCT04488003|449184140|FG000|Allocated to Treatment|Progressive Disease|51|||
124879892|NCT04488003|449184141|FG001|Allocated to Treatment|Progressive Disease|0|||
124879893|NCT04488003|449184142|FG002|Allocated to Treatment|Progressive Disease|0|||
124879894|NCT04488003|449184140|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
124879895|NCT04488003|449184141|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
124879896|NCT04488003|449184142|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
124879897|NCT04488003|449184140|FG000|Allocated to Treatment|Adverse Event|6|||
124879898|NCT04488003|449184141|FG001|Allocated to Treatment|Adverse Event|0|||
124879899|NCT04488003|449184142|FG002|Allocated to Treatment|Adverse Event|0|||
124879900|NCT04488003|449184140|FG000|Allocated to Treatment|Other|5|||
124879901|NCT04488003|449184141|FG001|Allocated to Treatment|Other|0|||
124879902|NCT04488003|449184142|FG002|Allocated to Treatment|Other|0|||
124879903|NCT04488003|449184140|FG000|Allocated to Treatment|Physician Decision|4|||
124879904|NCT04488003|449184141|FG001|Allocated to Treatment|Physician Decision|0|||
125013856|NCT01225731|449676876|FG006|Part 2|Adverse Event|4|||
124879905|NCT04488003|449184142|FG002|Allocated to Treatment|Physician Decision|0|||
124879906|NCT04488003|449184140|FG000|Allocated to Treatment|Death|4|||
124879907|NCT04488003|449184141|FG001|Allocated to Treatment|Death|0|||
124879908|NCT04488003|449184142|FG002|Allocated to Treatment|Death|0|||
124879909|NCT03447730|449184143|FG000|Overall Study|Adverse Event|0|||
124879910|NCT03447730|449184144|FG001|Overall Study|Adverse Event|2|||
124879911|NCT03447730|449184145|FG002|Overall Study|Adverse Event|0|||
125013857|NCT01225731|449676877|FG007|Part 2|Adverse Event|4|||
124879912|NCT00692406|449184151|FG000|Overall Study|PI dropped, bad data|57|||
124879913|NCT04145037|449184152|FG000|Overall Study|Study terminated|2|||
124879914|NCT04145037|449184153|FG001|Overall Study|Study terminated|0|||
124879915|NCT04145037|449184152|FG000|Overall Study|Withdrawal by Subject|1|||
124879916|NCT04145037|449184153|FG001|Overall Study|Withdrawal by Subject|0|||
124879917|NCT04145037|449184152|FG000|Overall Study|Lost to Follow-up|1|||
124879918|NCT04145037|449184153|FG001|Overall Study|Lost to Follow-up|0|||
124879919|NCT02307513|449184156|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
124879920|NCT02307513|449184157|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
124879921|NCT02307513|449184156|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
124879922|NCT02307513|449184157|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
124879923|NCT02307513|449184156|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
124879924|NCT02307513|449184157|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
124879925|NCT02307513|449184156|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
124879926|NCT02307513|449184157|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
124879927|NCT02307513|449184156|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
124879928|NCT02307513|449184157|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
124879929|NCT02307513|449184156|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
124879930|NCT02307513|449184157|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
124879931|NCT02307513|449184156|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
124879932|NCT02307513|449184157|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
124879933|NCT02307513|449184156|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
124879934|NCT02307513|449184157|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
124879935|NCT02307513|449184156|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
124879936|NCT02307513|449184157|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
124879937|NCT02307513|449184156|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
124879938|NCT02307513|449184157|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
124879939|NCT02307513|449184156|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
124879940|NCT02307513|449184157|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
124879941|NCT02307513|449184156|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
124879942|NCT02307513|449184157|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
124879943|NCT02307513|449184156|FG000|Long-term Extension|Physician Decision|1|||
124879944|NCT02307513|449184157|FG001|Long-term Extension|Physician Decision|0|||
124879945|NCT05952297|449184159|FG000|Overall Study|Withdrawal by Subject|1|||
124879946|NCT05952297|449184160|FG001|Overall Study|Withdrawal by Subject|0|||
124879947|NCT00525265|449184163|FG000|Overall Study|Protocol Violation|1|||
124879948|NCT00525265|449184164|FG001|Overall Study|Protocol Violation|0|||
124879949|NCT03107377|449184165|FG000|Overall Study|Adverse Event|3|||
124879950|NCT03107377|449184166|FG001|Overall Study|Adverse Event|3|||
124879951|NCT03107377|449184165|FG000|Overall Study|Protocol Violation|9|||
124879952|NCT03107377|449184166|FG001|Overall Study|Protocol Violation|12|||
124879953|NCT03107377|449184165|FG000|Overall Study|Physician Decision|3|||
124879954|NCT03107377|449184166|FG001|Overall Study|Physician Decision|6|||
124879955|NCT03107377|449184165|FG000|Overall Study|Pregnancy|7|||
124879956|NCT03107377|449184166|FG001|Overall Study|Pregnancy|7|||
124879957|NCT03107377|449184165|FG000|Overall Study|Withdrawal by Subject|16|||
125103061|NCT02325739|449997823|FG002|Phase II Part|Adverse Event|0|||
125103062|NCT02325739|449997824|FG003|Phase II Part|Adverse Event|0|||
125103063|NCT02325739|449997825|FG004|Phase II Part|Adverse Event|0|||
125103064|NCT02325739|449997826|FG005|Phase II Part|Adverse Event|0|||
124879958|NCT03107377|449184166|FG001|Overall Study|Withdrawal by Subject|22|||
124879959|NCT03107377|449184165|FG000|Overall Study|Lost to Follow-up|37|||
124879960|NCT03107377|449184166|FG001|Overall Study|Lost to Follow-up|34|||
124879961|NCT03107377|449184165|FG000|Overall Study|Other reason not specified|16|||
124879962|NCT03107377|449184166|FG001|Overall Study|Other reason not specified|15|||
124879963|NCT00453102|449184167|FG000|Overall Study|Withdrawal by Subject|2|||
124879964|NCT05796518|449184170|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
124879965|NCT02690077|449184173|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
124879966|NCT02690077|449184174|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
124879967|NCT02690077|449184173|FG000|Overall Study|Withdrawal by Subject|0|||
124879968|NCT02690077|449184174|FG001|Overall Study|Withdrawal by Subject|5|||
124879969|NCT02690077|449184173|FG000|Overall Study|Excluded by IRB|0|||
124879970|NCT02690077|449184174|FG001|Overall Study|Excluded by IRB|2|||
125103065|NCT02325739|449997827|FG006|Phase II Part|Adverse Event|0|||
125103066|NCT02325739|449997828|FG007|Phase II Part|Adverse Event|0|||
125103067|NCT02325739|449997829|FG008|Phase II Part|Adverse Event|4|||
124879971|NCT05672680|449184175|FG000|Overall Study|Patient Did Not Complete the Form|5|||
124879972|NCT05672680|449184176|FG001|Overall Study|Patient Did Not Complete the Form|4|||
124879973|NCT05672680|449184175|FG000|Overall Study|Procedure Aborted|1|||
124879974|NCT05672680|449184176|FG001|Overall Study|Procedure Aborted|0|||
124879975|NCT05408468|449184177|FG000|Overall Study|Lost to Follow-up|3|||
124879976|NCT05408468|449184178|FG001|Overall Study|Lost to Follow-up|1|||
124879977|NCT05408468|449184177|FG000|Overall Study|Physician Decision|1|||
124879978|NCT05408468|449184178|FG001|Overall Study|Physician Decision|0|||
124879979|NCT05408468|449184177|FG000|Overall Study|Overwhelmed by clinical situation|3|||
124879980|NCT05408468|449184178|FG001|Overall Study|Overwhelmed by clinical situation|0|||
124879981|NCT05408468|449184177|FG000|Overall Study|Personal illness precluding participation|1|||
124879982|NCT05408468|449184178|FG001|Overall Study|Personal illness precluding participation|0|||
124879983|NCT05408468|449184177|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
124879984|NCT05408468|449184178|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
124879985|NCT00747123|449184179|FG000|Overall Study|Investigator's request|0|||
124879986|NCT00747123|449184180|FG001|Overall Study|Investigator's request|0|||
124879987|NCT00747123|449184181|FG002|Overall Study|Investigator's request|1|||
124879988|NCT00747123|449184182|FG003|Overall Study|Investigator's request|0|||
124879989|NCT00747123|449184179|FG000|Overall Study|Withdrew consent|0|||
124879990|NCT00747123|449184180|FG001|Overall Study|Withdrew consent|1|||
124879991|NCT00747123|449184181|FG002|Overall Study|Withdrew consent|0|||
124879992|NCT00747123|449184182|FG003|Overall Study|Withdrew consent|0|||
124879993|NCT00747123|449184179|FG000|Overall Study|Adverse Event|0|||
124879994|NCT00747123|449184180|FG001|Overall Study|Adverse Event|1|||
124879995|NCT00747123|449184181|FG002|Overall Study|Adverse Event|0|||
124879996|NCT00747123|449184182|FG003|Overall Study|Adverse Event|1|||
124879997|NCT04186403|449184183|FG000|Overall Study|Adverse Event|1|||
124879998|NCT04186403|449184184|FG001|Overall Study|Adverse Event|8|||
124879999|NCT04186403|449184183|FG000|Overall Study|Lost to Follow-up|7|||
124880000|NCT04186403|449184184|FG001|Overall Study|Lost to Follow-up|3|||
124880001|NCT04186403|449184183|FG000|Overall Study|Physician Decision|1|||
124880002|NCT04186403|449184184|FG001|Overall Study|Physician Decision|0|||
124880003|NCT04186403|449184183|FG000|Overall Study|Withdrawal by Subject|7|||
124880004|NCT04186403|449184184|FG001|Overall Study|Withdrawal by Subject|8|||
124880005|NCT04186403|449184183|FG000|Overall Study|Other: Not Related to Covid-19|3|||
124880006|NCT04186403|449184184|FG001|Overall Study|Other: Not Related to Covid-19|0|||
124880007|NCT00405639|449184196|FG000|Overall Study|Withdrawal by Subject|1|||
124880008|NCT00405639|449184197|FG001|Overall Study|Withdrawal by Subject|0|||
124880009|NCT00405639|449184196|FG000|Overall Study|Adverse Event|1|||
124880010|NCT00405639|449184197|FG001|Overall Study|Adverse Event|0|||
124880011|NCT00405639|449184196|FG000|Overall Study|Seizure prior to receiving BNP|1|||
124880012|NCT00405639|449184197|FG001|Overall Study|Seizure prior to receiving BNP|0|||
124880013|NCT01483937|449184198|FG000|Overall Study|Withdrawal by Subject|4|||
124880014|NCT01483937|449184199|FG001|Overall Study|Withdrawal by Subject|3|||
124880015|NCT00265330|449184200|FG000|Overall Study|Adverse Event|41|||
124880016|NCT00265330|449184200|FG000|Overall Study|Lost to Follow-up|8|||
124880017|NCT00265330|449184200|FG000|Overall Study|Withdrawal by Subject|34|||
124880018|NCT00265330|449184200|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
124880019|NCT00265330|449184200|FG000|Overall Study|Lack of Efficacy|4|||
124880020|NCT00265330|449184200|FG000|Overall Study|Family Scheduling Conflicts|1|||
124880021|NCT00265330|449184200|FG000|Overall Study|Began Taking Formulary Geodon|1|||
124880022|NCT00265330|449184200|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
124880023|NCT00265330|449184200|FG000|Overall Study|Site Closed by Sponsor|1|||
124880024|NCT00265330|449184200|FG000|Overall Study|Principal Investigators Request|1|||
124880025|NCT00265330|449184200|FG000|Overall Study|Withdrew Consent|1|||
124880026|NCT00265330|449184200|FG000|Overall Study|Protocol Violation|1|||
124880027|NCT03108157|449184203|FG000|Overall Study|Protocol Violation|15|||
124880028|NCT03108157|449184204|FG001|Overall Study|Protocol Violation|4|||
124880029|NCT04534114|449184205|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
124880030|NCT04534114|449184206|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
124880031|NCT04534114|449184207|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
124880032|NCT04534114|449184208|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
124880033|NCT04534114|449184205|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
125103068|NCT02325739|449997830|FG009|Phase II Part|Adverse Event|5|||
125103069|NCT02325739|449997831|FG010|Phase II Part|Adverse Event|1|||
124880034|NCT04534114|449184206|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
125103070|NCT02325739|449997821|FG000|Phase II Part|Physician Decision|0|||
125103071|NCT02325739|449997822|FG001|Phase II Part|Physician Decision|0|||
125103072|NCT02325739|449997823|FG002|Phase II Part|Physician Decision|0|||
124880035|NCT04534114|449184207|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
124880036|NCT04534114|449184208|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
125103073|NCT02325739|449997824|FG003|Phase II Part|Physician Decision|0|||
124880037|NCT04534114|449184205|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
124880038|NCT04534114|449184206|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
124880039|NCT04534114|449184207|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
124880040|NCT04534114|449184208|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
125103074|NCT02325739|449997825|FG004|Phase II Part|Physician Decision|0|||
125103075|NCT02325739|449997826|FG005|Phase II Part|Physician Decision|0|||
125103076|NCT02325739|449997827|FG006|Phase II Part|Physician Decision|0|||
125013858|NCT01225731|449676878|FG008|Part 2|Adverse Event|2|||
125013859|NCT01225731|449676879|FG009|Part 2|Adverse Event|0|||
125013860|NCT01225731|449676880|FG010|Part 2|Adverse Event|0|||
124880041|NCT04534114|449184205|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
124880042|NCT04534114|449184206|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
124880043|NCT04534114|449184207|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
124880044|NCT04534114|449184208|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
124880045|NCT04534114|449184205|FG000|Main Treatment Period|Physician Decision|0|||
124880046|NCT04534114|449184206|FG001|Main Treatment Period|Physician Decision|0|||
124880047|NCT04534114|449184207|FG002|Main Treatment Period|Physician Decision|0|||
124880048|NCT04534114|449184208|FG003|Main Treatment Period|Physician Decision|1|||
124880049|NCT04534114|449184205|FG000|Main Treatment Period|Death|1|||
124880050|NCT04534114|449184206|FG001|Main Treatment Period|Death|0|||
124880051|NCT04534114|449184207|FG002|Main Treatment Period|Death|0|||
124880052|NCT04534114|449184208|FG003|Main Treatment Period|Death|1|||
124880053|NCT04534114|449184205|FG000|Main Treatment Period|Other reason|1|||
124880054|NCT04534114|449184206|FG001|Main Treatment Period|Other reason|1|||
124880055|NCT04534114|449184207|FG002|Main Treatment Period|Other reason|0|||
124880056|NCT04534114|449184208|FG003|Main Treatment Period|Other reason|0|||
124880057|NCT04534114|449184205|FG000|Main Treatment Period|Participant decision|1|||
124880058|NCT04534114|449184206|FG001|Main Treatment Period|Participant decision|3|||
124880059|NCT04534114|449184207|FG002|Main Treatment Period|Participant decision|3|||
124880060|NCT04534114|449184208|FG003|Main Treatment Period|Participant decision|1|||
124880061|NCT04534114|449184205|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
124880062|NCT04534114|449184206|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
124880063|NCT04534114|449184207|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
124880064|NCT04534114|449184208|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
124880065|NCT04534114|449184205|FG000|Main Treatment Period|Adverse Event|4|||
124880066|NCT04534114|449184206|FG001|Main Treatment Period|Adverse Event|2|||
124880067|NCT04534114|449184207|FG002|Main Treatment Period|Adverse Event|1|||
124880068|NCT04534114|449184208|FG003|Main Treatment Period|Adverse Event|2|||
124880069|NCT04534114|449184205|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
124880070|NCT04534114|449184206|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
124880071|NCT04534114|449184207|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
124880072|NCT04534114|449184208|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
124880073|NCT04534114|449184205|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
124880074|NCT04534114|449184206|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
124880075|NCT04534114|449184207|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
124880076|NCT04534114|449184208|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
124880077|NCT04534114|449184205|FG000|Extension Treatment Period|Other reason|0|||
124880078|NCT04534114|449184206|FG001|Extension Treatment Period|Other reason|1|||
124880079|NCT04534114|449184207|FG002|Extension Treatment Period|Other reason|0|||
124880080|NCT04534114|449184208|FG003|Extension Treatment Period|Other reason|0|||
124880081|NCT04534114|449184205|FG000|Extension Treatment Period|Death|0|||
124880082|NCT04534114|449184206|FG001|Extension Treatment Period|Death|0|||
124880083|NCT04534114|449184207|FG002|Extension Treatment Period|Death|1|||
124880084|NCT04534114|449184208|FG003|Extension Treatment Period|Death|2|||
124880085|NCT04534114|449184205|FG000|Extension Treatment Period|Adverse Event|0|||
124880086|NCT04534114|449184206|FG001|Extension Treatment Period|Adverse Event|1|||
124880087|NCT04534114|449184207|FG002|Extension Treatment Period|Adverse Event|0|||
124880088|NCT04534114|449184208|FG003|Extension Treatment Period|Adverse Event|1|||
124880089|NCT04534114|449184205|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
124880090|NCT04534114|449184206|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
124880091|NCT04534114|449184207|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
124880092|NCT04534114|449184208|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
124880093|NCT03287414|449184209|FG000|Treatment Epoch|Adverse Event|0|||
124880094|NCT03287414|449184210|FG001|Treatment Epoch|Adverse Event|1|||
124880095|NCT03287414|449184209|FG000|Treatment Epoch|Study terminated by sponsor|2|||
124880096|NCT03287414|449184210|FG001|Treatment Epoch|Study terminated by sponsor|2|||
124880097|NCT03287414|449184209|FG000|Treatment Epoch|Subject/Guardian decision|4|||
124880098|NCT03287414|449184210|FG001|Treatment Epoch|Subject/Guardian decision|0|||
124880099|NCT03287414|449184209|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
124880100|NCT03287414|449184210|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
125013861|NCT01225731|449676881|FG011|Part 2|Adverse Event|0|||
124880101|NCT03287414|449184209|FG000|Treatment Epoch|Withdrawal by Subject|1|||
125013862|NCT01225731|449676882|FG012|Part 2|Adverse Event|0|||
124880102|NCT03287414|449184210|FG001|Treatment Epoch|Withdrawal by Subject|0|||
124880103|NCT03287414|449184209|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
124880104|NCT03287414|449184210|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
125013863|NCT01225731|449676870|FG000|Part 2|Lack of Efficacy|0|||
125013864|NCT01225731|449676871|FG001|Part 2|Lack of Efficacy|0|||
125013865|NCT01225731|449676872|FG002|Part 2|Lack of Efficacy|0|||
125013866|NCT01225731|449676873|FG003|Part 2|Lack of Efficacy|0|||
125013867|NCT01225731|449676874|FG004|Part 2|Lack of Efficacy|0|||
124880105|NCT03287414|449184209|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
124880106|NCT03287414|449184210|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
124880107|NCT02759185|449184211|FG000|Stage 1|Adverse Event|0|||
124880108|NCT02759185|449184212|FG001|Stage 1|Adverse Event|1|||
124880109|NCT02759185|449184213|FG002|Stage 1|Adverse Event|3|||
124880110|NCT02759185|449184214|FG003|Stage 1|Adverse Event|0|||
124880111|NCT02759185|449184215|FG004|Stage 1|Adverse Event|0|||
124880112|NCT02759185|449184216|FG005|Stage 1|Adverse Event|0|||
124880113|NCT02759185|449184217|FG006|Stage 1|Adverse Event|0|||
124880114|NCT02759185|449184211|FG000|Stage 1|Withdrawal by Subject|1|||
124880115|NCT02759185|449184212|FG001|Stage 1|Withdrawal by Subject|0|||
124880116|NCT02759185|449184213|FG002|Stage 1|Withdrawal by Subject|0|||
124880117|NCT02759185|449184214|FG003|Stage 1|Withdrawal by Subject|0|||
124880118|NCT02759185|449184215|FG004|Stage 1|Withdrawal by Subject|0|||
124880119|NCT02759185|449184216|FG005|Stage 1|Withdrawal by Subject|0|||
124880120|NCT02759185|449184217|FG006|Stage 1|Withdrawal by Subject|0|||
124880121|NCT02759185|449184211|FG000|Stage 2|Adverse Event|0|||
124880122|NCT02759185|449184212|FG001|Stage 2|Adverse Event|0|||
124880123|NCT02759185|449184213|FG002|Stage 2|Adverse Event|0|||
124880124|NCT02759185|449184214|FG003|Stage 2|Adverse Event|0|||
124880125|NCT02759185|449184215|FG004|Stage 2|Adverse Event|1|||
124880126|NCT02759185|449184216|FG005|Stage 2|Adverse Event|2|||
124880127|NCT02759185|449184217|FG006|Stage 2|Adverse Event|0|||
124880128|NCT02759185|449184211|FG000|Stage 2|Withdrawal by Subject|0|||
124880129|NCT02759185|449184212|FG001|Stage 2|Withdrawal by Subject|0|||
124880130|NCT02759185|449184213|FG002|Stage 2|Withdrawal by Subject|0|||
124880131|NCT02759185|449184214|FG003|Stage 2|Withdrawal by Subject|0|||
124880132|NCT02759185|449184215|FG004|Stage 2|Withdrawal by Subject|1|||
124880133|NCT02759185|449184216|FG005|Stage 2|Withdrawal by Subject|1|||
124880134|NCT02759185|449184217|FG006|Stage 2|Withdrawal by Subject|1|||
124880135|NCT02613221|449184220|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
124880136|NCT02613221|449184220|FG000|Overall Study|Adverse Event|2|||
124880137|NCT02613221|449184220|FG000|Overall Study|Voluntary Discontinuation|1|||
124880138|NCT02613221|449184220|FG000|Overall Study|Delayed Treatment|1|||
124880139|NCT02613221|449184220|FG000|Overall Study|Enrolled but Not Treated|1|||
124880140|NCT02668016|449184223|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
124880141|NCT02668016|449184223|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
124880142|NCT02668016|449184223|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
124880143|NCT02668016|449184223|FG000|Month 4|Withdrawal due to severe symptoms|1|||
124880144|NCT02668016|449184223|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
124880145|NCT02668016|449184223|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
124880146|NCT02668016|449184223|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
124880147|NCT02668016|449184223|FG000|Month 6|Withdrawal due to severe symptoms|2|||
124880148|NCT02668016|449184223|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
124880149|NCT02668016|449184223|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
124880150|NCT02668016|449184223|FG000|Month 8|Withdrawal due to severe symptoms|1|||
124880151|NCT02668016|449184223|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
124880152|NCT02668016|449184223|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
124880153|NCT02668016|449184223|FG000|Month 10|Withdrawal due to severe symptoms|1|||
124880154|NCT02668016|449184223|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
124880155|NCT00399763|449184228|FG000|Overall Study|Lost to Follow-up|2|||
124880156|NCT00399763|449184229|FG001|Overall Study|Lost to Follow-up|3|||
124880157|NCT05067933|449184237|FG000|Overall Study|Withdrawal by Subject|2|||
124880158|NCT05067933|449184238|FG001|Overall Study|Withdrawal by Subject|0|||
124880159|NCT05067933|449184239|FG002|Overall Study|Withdrawal by Subject|0|||
124880160|NCT05067933|449184240|FG003|Overall Study|Withdrawal by Subject|0|||
124880161|NCT05067933|449184241|FG004|Overall Study|Withdrawal by Subject|0|||
124880162|NCT05067933|449184242|FG005|Overall Study|Withdrawal by Subject|0|||
124880163|NCT05067933|449184237|FG000|Overall Study|Lost to Follow-up|1|||
124880164|NCT05067933|449184238|FG001|Overall Study|Lost to Follow-up|1|||
124880165|NCT05067933|449184239|FG002|Overall Study|Lost to Follow-up|1|||
124880166|NCT05067933|449184240|FG003|Overall Study|Lost to Follow-up|2|||
124880167|NCT05067933|449184241|FG004|Overall Study|Lost to Follow-up|1|||
124880168|NCT05067933|449184242|FG005|Overall Study|Lost to Follow-up|0|||
124880169|NCT05067933|449184237|FG000|Overall Study|Miscellaneous|1|||
124880170|NCT05067933|449184238|FG001|Overall Study|Miscellaneous|0|||
124880171|NCT05067933|449184239|FG002|Overall Study|Miscellaneous|0|||
124880172|NCT05067933|449184240|FG003|Overall Study|Miscellaneous|0|||
124880173|NCT05067933|449184241|FG004|Overall Study|Miscellaneous|0|||
124880174|NCT05067933|449184242|FG005|Overall Study|Miscellaneous|0|||
125103077|NCT02325739|449997828|FG007|Phase II Part|Physician Decision|0|||
124880175|NCT05067933|449184237|FG000|Overall Study|Death|0|||
124880176|NCT05067933|449184238|FG001|Overall Study|Death|0|||
124880177|NCT05067933|449184239|FG002|Overall Study|Death|0|||
124880178|NCT05067933|449184240|FG003|Overall Study|Death|1|||
124880179|NCT05067933|449184241|FG004|Overall Study|Death|0|||
124880180|NCT05067933|449184242|FG005|Overall Study|Death|0|||
124880181|NCT01065350|449184248|FG000|Overall Study|Received incorrect drug allocation|0|||
124880182|NCT01065350|449184249|FG001|Overall Study|Received incorrect drug allocation|1|||
124880183|NCT01657266|449184253|FG000|Overall Study|Lost to Follow-up|2|||
124880184|NCT01657266|449184254|FG001|Overall Study|Lost to Follow-up|2|||
124880185|NCT01657266|449184253|FG000|Overall Study|Adverse Event|2|||
124880186|NCT01657266|449184254|FG001|Overall Study|Adverse Event|3|||
124880187|NCT03443713|449184264|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
124880188|NCT03443713|449184265|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
124880189|NCT03443713|449184266|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
124880190|NCT01672853|449184269|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
124880191|NCT01672853|449184270|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
124880192|NCT01672853|449184271|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
124880193|NCT01672853|449184269|FG000|Overall Study|Pregnancy|0|||
124880194|NCT01672853|449184270|FG001|Overall Study|Pregnancy|1|||
124880195|NCT01672853|449184271|FG002|Overall Study|Pregnancy|0|||
124880196|NCT01672853|449184269|FG000|Overall Study|Investigator's Discretion|1|||
124880197|NCT01672853|449184270|FG001|Overall Study|Investigator's Discretion|0|||
124880198|NCT01672853|449184271|FG002|Overall Study|Investigator's Discretion|0|||
124880199|NCT01672853|449184269|FG000|Overall Study|Withdrew Consent|5|||
124880200|NCT01672853|449184270|FG001|Overall Study|Withdrew Consent|5|||
124880201|NCT01672853|449184271|FG002|Overall Study|Withdrew Consent|5|||
124880202|NCT01672853|449184269|FG000|Overall Study|Adverse Event|4|||
124880203|NCT01672853|449184270|FG001|Overall Study|Adverse Event|6|||
124880204|NCT01672853|449184271|FG002|Overall Study|Adverse Event|8|||
124880205|NCT01672853|449184269|FG000|Overall Study|Lost to Follow-up|0|||
124880206|NCT01672853|449184270|FG001|Overall Study|Lost to Follow-up|1|||
124880207|NCT01672853|449184271|FG002|Overall Study|Lost to Follow-up|0|||
124880208|NCT01672853|449184269|FG000|Overall Study|Randomized but Never Treated|0|||
124880209|NCT01672853|449184270|FG001|Overall Study|Randomized but Never Treated|0|||
124880210|NCT01672853|449184271|FG002|Overall Study|Randomized but Never Treated|1|||
124880211|NCT02944656|449184273|FG000|Overall Study|No longer eligible|3|||
124880212|NCT02944656|449184274|FG001|Overall Study|No longer eligible|0|||
124880213|NCT02944656|449184273|FG000|Overall Study|Lost to Follow-up|7|||
124880214|NCT02944656|449184274|FG001|Overall Study|Lost to Follow-up|10|||
124880215|NCT02243631|449185467|FG000|Overall Study|no synovial fluid on second aspirate|0|||
124880216|NCT02243631|449185468|FG001|Overall Study|no synovial fluid on second aspirate|1|||
124880217|NCT01992549|449185471|FG000|Overall Study|Lost to Follow-up|2|||
124880218|NCT01992549|449185471|FG000|Overall Study|Serious Adverse Event|1|||
124880219|NCT01992549|449185471|FG000|Overall Study|Product Switch to Extend Half Life|1|||
124880220|NCT01590771|449185472|FG000|Overall Study|Other Protocol Specified Criteria|5|||
124880221|NCT01590771|449185473|FG001|Overall Study|Other Protocol Specified Criteria|14|||
124880222|NCT01590771|449185472|FG000|Overall Study|Withdrawal by Subject|8|||
124880223|NCT01590771|449185473|FG001|Overall Study|Withdrawal by Subject|15|||
124880224|NCT01590771|449185472|FG000|Overall Study|Protocol Violation|1|||
124880225|NCT01590771|449185473|FG001|Overall Study|Protocol Violation|2|||
124880226|NCT01590771|449185472|FG000|Overall Study|Lost to Follow-up|1|||
124880227|NCT01590771|449185473|FG001|Overall Study|Lost to Follow-up|1|||
124880228|NCT01590771|449185472|FG000|Overall Study|Lack of Efficacy|1|||
124880229|NCT01590771|449185473|FG001|Overall Study|Lack of Efficacy|0|||
124880230|NCT01590771|449185472|FG000|Overall Study|Adverse Event|3|||
124880231|NCT01590771|449185473|FG001|Overall Study|Adverse Event|7|||
124880232|NCT01785628|449185474|FG000|Overall Study|Lost to Follow-up|2|||
124880233|NCT01785628|449185475|FG001|Overall Study|Lost to Follow-up|3|||
124880234|NCT00840996|449185476|FG000|Overall Study|Withdrawal by Subject|1|||
125103078|NCT02325739|449997829|FG008|Phase II Part|Physician Decision|0|||
125103079|NCT02325739|449997830|FG009|Phase II Part|Physician Decision|1|||
124880235|NCT00840996|449185477|FG001|Overall Study|Withdrawal by Subject|0|||
124880236|NCT01900054|449185478|FG000|Overall Study|Physician Decision|1|||
124880237|NCT01900054|449185478|FG000|Overall Study|Withdrawal by Subject|1|||
124880238|NCT03285295|449185481|FG000|Alinity s HBsAg|Protocol Violation|11|||
124880239|NCT03285295|449185482|FG001|Alinity s HBsAg|Protocol Violation|0|||
124880240|NCT03285295|449185483|FG002|Alinity s HBsAg|Protocol Violation|0|||
124880241|NCT03285295|449185484|FG003|Alinity s HBsAg|Protocol Violation|0|||
124880242|NCT03285295|449185485|FG004|Alinity s HBsAg|Protocol Violation|0|||
124880243|NCT03285295|449185481|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
124880244|NCT03285295|449185482|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
124880245|NCT03285295|449185483|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
124880246|NCT03285295|449185484|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
124880247|NCT03285295|449185485|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
125103080|NCT02325739|449997831|FG010|Phase II Part|Physician Decision|0|||
124880248|NCT03285295|449185481|FG000|Alinity s HBsAg|No Results Generated|74|||
124880249|NCT03285295|449185482|FG001|Alinity s HBsAg|No Results Generated|6|||
124880250|NCT03285295|449185483|FG002|Alinity s HBsAg|No Results Generated|0|||
125013868|NCT01225731|449676875|FG005|Part 2|Lack of Efficacy|1|||
125013869|NCT01225731|449676876|FG006|Part 2|Lack of Efficacy|0|||
125013870|NCT01225731|449676877|FG007|Part 2|Lack of Efficacy|12|||
125013871|NCT01225731|449676878|FG008|Part 2|Lack of Efficacy|3|||
125013872|NCT01225731|449676879|FG009|Part 2|Lack of Efficacy|0|||
125013873|NCT01225731|449676880|FG010|Part 2|Lack of Efficacy|0|||
125013874|NCT01225731|449676881|FG011|Part 2|Lack of Efficacy|0|||
125013875|NCT01225731|449676882|FG012|Part 2|Lack of Efficacy|0|||
125013876|NCT01225731|449676870|FG000|Part 2|Pregnancy|0|||
125013877|NCT01225731|449676871|FG001|Part 2|Pregnancy|0|||
125013878|NCT01225731|449676872|FG002|Part 2|Pregnancy|0|||
125013879|NCT01225731|449676873|FG003|Part 2|Pregnancy|0|||
125013880|NCT01225731|449676874|FG004|Part 2|Pregnancy|0|||
125013881|NCT01225731|449676875|FG005|Part 2|Pregnancy|0|||
125013882|NCT01225731|449676876|FG006|Part 2|Pregnancy|1|||
125013883|NCT01225731|449676877|FG007|Part 2|Pregnancy|0|||
125013884|NCT01225731|449676878|FG008|Part 2|Pregnancy|1|||
125013885|NCT01225731|449676879|FG009|Part 2|Pregnancy|0|||
125013886|NCT01225731|449676880|FG010|Part 2|Pregnancy|0|||
125013887|NCT01225731|449676881|FG011|Part 2|Pregnancy|0|||
125013888|NCT01225731|449676882|FG012|Part 2|Pregnancy|0|||
125103081|NCT02325739|449997821|FG000|Phase II Part|Progressive disease|0|||
125103082|NCT02325739|449997822|FG001|Phase II Part|Progressive disease|0|||
125103083|NCT02325739|449997823|FG002|Phase II Part|Progressive disease|0|||
125103084|NCT02325739|449997824|FG003|Phase II Part|Progressive disease|0|||
125103085|NCT02325739|449997825|FG004|Phase II Part|Progressive disease|0|||
125103086|NCT02325739|449997826|FG005|Phase II Part|Progressive disease|0|||
125103087|NCT02325739|449997827|FG006|Phase II Part|Progressive disease|0|||
125103088|NCT02325739|449997828|FG007|Phase II Part|Progressive disease|0|||
125103089|NCT02325739|449997829|FG008|Phase II Part|Progressive disease|22|||
125103090|NCT02325739|449997830|FG009|Phase II Part|Progressive disease|29|||
125103091|NCT02325739|449997831|FG010|Phase II Part|Progressive disease|18|||
125103092|NCT02325739|449997821|FG000|Phase II Part|Subject/guardian decision|0|||
125103093|NCT02325739|449997822|FG001|Phase II Part|Subject/guardian decision|0|||
125103094|NCT02325739|449997823|FG002|Phase II Part|Subject/guardian decision|0|||
125103095|NCT02325739|449997824|FG003|Phase II Part|Subject/guardian decision|0|||
125103096|NCT02325739|449997825|FG004|Phase II Part|Subject/guardian decision|0|||
125103097|NCT02325739|449997826|FG005|Phase II Part|Subject/guardian decision|0|||
125103098|NCT02325739|449997827|FG006|Phase II Part|Subject/guardian decision|0|||
124880251|NCT03285295|449185484|FG003|Alinity s HBsAg|No Results Generated|0|||
124880252|NCT03285295|449185485|FG004|Alinity s HBsAg|No Results Generated|0|||
124880253|NCT03285295|449185481|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
124880254|NCT03285295|449185482|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
124880255|NCT03285295|449185483|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
124880256|NCT03285295|449185484|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
124880257|NCT03285295|449185485|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
124880258|NCT03285295|449185481|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
125103099|NCT02325739|449997828|FG007|Phase II Part|Subject/guardian decision|0|||
125103100|NCT02325739|449997829|FG008|Phase II Part|Subject/guardian decision|4|||
125103101|NCT02325739|449997830|FG009|Phase II Part|Subject/guardian decision|1|||
125103102|NCT02325739|449997831|FG010|Phase II Part|Subject/guardian decision|1|||
125103103|NCT03728257|449997833|FG000|Overall Study|Death|3|||
125103104|NCT03728257|449997834|FG001|Overall Study|Death|0|||
125103105|NCT00621309|449997836|FG000|Overall Study|Withdrawal by Subject|2|||
125103106|NCT00621309|449997837|FG001|Overall Study|Withdrawal by Subject|0|||
125103107|NCT00621309|449997838|FG002|Overall Study|Withdrawal by Subject|1|||
125103108|NCT00621309|449997839|FG003|Overall Study|Withdrawal by Subject|1|||
125103109|NCT00621309|449997840|FG004|Overall Study|Withdrawal by Subject|1|||
125103110|NCT00621309|449997841|FG005|Overall Study|Withdrawal by Subject|1|||
125103111|NCT01306968|449997844|FG000|Overall Study|Lost to Follow-up|1|||
125103112|NCT01306968|449997845|FG001|Overall Study|Lost to Follow-up|1|||
125103113|NCT01306968|449997846|FG002|Overall Study|Lost to Follow-up|0|||
125103114|NCT01306968|449997847|FG003|Overall Study|Lost to Follow-up|0|||
125103115|NCT01306968|449997844|FG000|Overall Study|Physician Decision|0|||
125103116|NCT01306968|449997845|FG001|Overall Study|Physician Decision|1|||
125103117|NCT01306968|449997846|FG002|Overall Study|Physician Decision|0|||
125103118|NCT01306968|449997847|FG003|Overall Study|Physician Decision|0|||
125103119|NCT01306968|449997844|FG000|Overall Study|Relocated and left active duty|0|||
125103120|NCT01306968|449997845|FG001|Overall Study|Relocated and left active duty|1|||
125103121|NCT01306968|449997846|FG002|Overall Study|Relocated and left active duty|1|||
125103122|NCT01306968|449997847|FG003|Overall Study|Relocated and left active duty|1|||
125103123|NCT01306968|449997844|FG000|Overall Study|Withdrew - time commitment|0|||
125103124|NCT01306968|449997845|FG001|Overall Study|Withdrew - time commitment|0|||
125103125|NCT01306968|449997846|FG002|Overall Study|Withdrew - time commitment|0|||
125103126|NCT01306968|449997847|FG003|Overall Study|Withdrew - time commitment|2|||
125103127|NCT01306968|449997844|FG000|Overall Study|Withdrew over privacy concerns|0|||
125103128|NCT01306968|449997845|FG001|Overall Study|Withdrew over privacy concerns|0|||
125103129|NCT01306968|449997846|FG002|Overall Study|Withdrew over privacy concerns|0|||
125103130|NCT01306968|449997847|FG003|Overall Study|Withdrew over privacy concerns|1|||
125103131|NCT04993339|449997848|FG000|Overall Study|Lost to Follow-up|0|||
125103132|NCT04993339|449997849|FG001|Overall Study|Lost to Follow-up|1|||
125103133|NCT04993339|449997848|FG000|Overall Study|no MRI scan|3|||
125103134|NCT04993339|449997849|FG001|Overall Study|no MRI scan|1|||
125103135|NCT03868059|449997851|FG000|Overall Study|Adverse Event|3|||
125103136|NCT03868059|449997851|FG000|Overall Study|Lost to Follow-up|3|||
125103137|NCT03868059|449997851|FG000|Overall Study|Withdrawal by Subject|6|||
125103138|NCT02949219|449997852|FG000|Overall Study|Withdrawal by Subject|1|||
125103139|NCT02044094|449997869|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
125103140|NCT02044094|449997869|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
125103141|NCT02044094|449997869|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
124880259|NCT03285295|449185482|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
124880260|NCT03285295|449185483|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
124880261|NCT03285295|449185484|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
124880262|NCT03285295|449185485|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
125103142|NCT02044094|449997869|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
125103143|NCT02044094|449997869|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
125013889|NCT01225731|449676870|FG000|Part 2|Lost to Follow-up|0|||
125013890|NCT01225731|449676871|FG001|Part 2|Lost to Follow-up|0|||
125013891|NCT01225731|449676872|FG002|Part 2|Lost to Follow-up|0|||
125013892|NCT01225731|449676873|FG003|Part 2|Lost to Follow-up|0|||
125013893|NCT01225731|449676874|FG004|Part 2|Lost to Follow-up|0|||
125013894|NCT01225731|449676875|FG005|Part 2|Lost to Follow-up|0|||
125013895|NCT01225731|449676876|FG006|Part 2|Lost to Follow-up|0|||
125013896|NCT01225731|449676877|FG007|Part 2|Lost to Follow-up|3|||
125013897|NCT01225731|449676878|FG008|Part 2|Lost to Follow-up|1|||
125013898|NCT01225731|449676879|FG009|Part 2|Lost to Follow-up|0|||
125013899|NCT01225731|449676880|FG010|Part 2|Lost to Follow-up|0|||
125013900|NCT01225731|449676881|FG011|Part 2|Lost to Follow-up|0|||
125013901|NCT01225731|449676882|FG012|Part 2|Lost to Follow-up|0|||
125013902|NCT01225731|449676870|FG000|Part 2|Physician Decision|0|||
125013903|NCT01225731|449676871|FG001|Part 2|Physician Decision|0|||
125013904|NCT01225731|449676872|FG002|Part 2|Physician Decision|0|||
125013905|NCT01225731|449676873|FG003|Part 2|Physician Decision|0|||
125013906|NCT01225731|449676874|FG004|Part 2|Physician Decision|0|||
125013907|NCT01225731|449676875|FG005|Part 2|Physician Decision|0|||
125013908|NCT01225731|449676876|FG006|Part 2|Physician Decision|0|||
125013909|NCT01225731|449676877|FG007|Part 2|Physician Decision|2|||
125013910|NCT01225731|449676878|FG008|Part 2|Physician Decision|2|||
125013911|NCT01225731|449676879|FG009|Part 2|Physician Decision|0|||
125013912|NCT01225731|449676880|FG010|Part 2|Physician Decision|0|||
125013913|NCT01225731|449676881|FG011|Part 2|Physician Decision|0|||
125013914|NCT01225731|449676882|FG012|Part 2|Physician Decision|0|||
125013915|NCT01225731|449676870|FG000|Part 2|Withdrawal by Subject|0|||
125013916|NCT01225731|449676871|FG001|Part 2|Withdrawal by Subject|0|||
125013917|NCT01225731|449676872|FG002|Part 2|Withdrawal by Subject|0|||
125013918|NCT01225731|449676873|FG003|Part 2|Withdrawal by Subject|0|||
125013919|NCT01225731|449676874|FG004|Part 2|Withdrawal by Subject|0|||
125013920|NCT01225731|449676875|FG005|Part 2|Withdrawal by Subject|1|||
125013921|NCT01225731|449676876|FG006|Part 2|Withdrawal by Subject|3|||
125013922|NCT01225731|449676877|FG007|Part 2|Withdrawal by Subject|4|||
125013923|NCT01225731|449676878|FG008|Part 2|Withdrawal by Subject|1|||
125013924|NCT01225731|449676879|FG009|Part 2|Withdrawal by Subject|0|||
125013925|NCT01225731|449676880|FG010|Part 2|Withdrawal by Subject|0|||
125013926|NCT01225731|449676881|FG011|Part 2|Withdrawal by Subject|0|||
125013927|NCT01225731|449676882|FG012|Part 2|Withdrawal by Subject|0|||
125013928|NCT01225731|449676870|FG000|Part 3|Adverse Event|0|||
125013929|NCT01225731|449676871|FG001|Part 3|Adverse Event|0|||
125013930|NCT01225731|449676872|FG002|Part 3|Adverse Event|0|||
125013931|NCT01225731|449676873|FG003|Part 3|Adverse Event|0|||
125013932|NCT01225731|449676874|FG004|Part 3|Adverse Event|0|||
125013933|NCT01225731|449676875|FG005|Part 3|Adverse Event|0|||
125013934|NCT01225731|449676876|FG006|Part 3|Adverse Event|0|||
125013935|NCT01225731|449676877|FG007|Part 3|Adverse Event|0|||
124880263|NCT03285295|449185481|FG000|Alinity s HTLV I/II|No Results Generated|70|||
124880264|NCT03285295|449185482|FG001|Alinity s HTLV I/II|No Results Generated|0|||
124880265|NCT03285295|449185483|FG002|Alinity s HTLV I/II|No Results Generated|0|||
124880266|NCT03285295|449185484|FG003|Alinity s HTLV I/II|No Results Generated|0|||
124880267|NCT03285295|449185485|FG004|Alinity s HTLV I/II|No Results Generated|0|||
124880268|NCT03285295|449185481|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
124880269|NCT03285295|449185482|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
124880270|NCT03285295|449185483|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
125013936|NCT01225731|449676878|FG008|Part 3|Adverse Event|0|||
125013937|NCT01225731|449676879|FG009|Part 3|Adverse Event|0|||
125013938|NCT01225731|449676880|FG010|Part 3|Adverse Event|1|||
125013939|NCT01225731|449676881|FG011|Part 3|Adverse Event|1|||
125013940|NCT01225731|449676882|FG012|Part 3|Adverse Event|0|||
125013941|NCT01225731|449676870|FG000|Part 3|Lost to Follow-up|0|||
125013942|NCT01225731|449676871|FG001|Part 3|Lost to Follow-up|0|||
125013943|NCT01225731|449676872|FG002|Part 3|Lost to Follow-up|0|||
125013944|NCT01225731|449676873|FG003|Part 3|Lost to Follow-up|0|||
125013945|NCT01225731|449676874|FG004|Part 3|Lost to Follow-up|0|||
125013946|NCT01225731|449676875|FG005|Part 3|Lost to Follow-up|0|||
125013947|NCT01225731|449676876|FG006|Part 3|Lost to Follow-up|0|||
125013948|NCT01225731|449676877|FG007|Part 3|Lost to Follow-up|0|||
125013949|NCT01225731|449676878|FG008|Part 3|Lost to Follow-up|0|||
125013950|NCT01225731|449676879|FG009|Part 3|Lost to Follow-up|0|||
125013951|NCT01225731|449676880|FG010|Part 3|Lost to Follow-up|1|||
125013952|NCT01225731|449676881|FG011|Part 3|Lost to Follow-up|2|||
125013953|NCT01225731|449676882|FG012|Part 3|Lost to Follow-up|1|||
125013954|NCT01225731|449676870|FG000|Part 3|Physician Decision|0|||
125013955|NCT01225731|449676871|FG001|Part 3|Physician Decision|0|||
125013956|NCT01225731|449676872|FG002|Part 3|Physician Decision|0|||
125013957|NCT01225731|449676873|FG003|Part 3|Physician Decision|0|||
125013958|NCT01225731|449676874|FG004|Part 3|Physician Decision|0|||
125013959|NCT01225731|449676875|FG005|Part 3|Physician Decision|0|||
125013960|NCT01225731|449676876|FG006|Part 3|Physician Decision|0|||
125013961|NCT01225731|449676877|FG007|Part 3|Physician Decision|0|||
125013962|NCT01225731|449676878|FG008|Part 3|Physician Decision|0|||
125013963|NCT01225731|449676879|FG009|Part 3|Physician Decision|0|||
125013964|NCT01225731|449676880|FG010|Part 3|Physician Decision|0|||
125013965|NCT01225731|449676881|FG011|Part 3|Physician Decision|1|||
125013966|NCT01225731|449676882|FG012|Part 3|Physician Decision|2|||
124880271|NCT03285295|449185484|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
124880272|NCT03285295|449185485|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
125013967|NCT01225731|449676870|FG000|Part 3|Withdrawal by Subject|0|||
125013968|NCT01225731|449676871|FG001|Part 3|Withdrawal by Subject|0|||
125013969|NCT01225731|449676872|FG002|Part 3|Withdrawal by Subject|0|||
125103144|NCT02044094|449997869|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
125103145|NCT02044094|449997869|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
125103146|NCT02044094|449997869|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
125103147|NCT03353415|449997872|FG000|Masked CGM Wear|Lost to Follow-up|2|||
125103148|NCT03353415|449997872|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
125103149|NCT02392377|449997873|FG000|Overall Study|Withdrawal by Subject|0|||
125103150|NCT02392377|449997874|FG001|Overall Study|Withdrawal by Subject|1|||
125103151|NCT01298661|449997877|FG000|Overall Study|Withdrawal by Subject|2|||
125103152|NCT01298661|449997878|FG001|Overall Study|Withdrawal by Subject|0|||
125103153|NCT01298661|449997879|FG002|Overall Study|Withdrawal by Subject|2|||
125103154|NCT03515837|450000541|FG000|Overall Study|Death|219|||
125103155|NCT03515837|450000542|FG001|Overall Study|Death|227|||
125103156|NCT03515837|450000541|FG000|Overall Study|Lost to Follow-up|0|||
125103157|NCT03515837|450000542|FG001|Overall Study|Lost to Follow-up|1|||
125103158|NCT03515837|450000541|FG000|Overall Study|Withdrawal by Subject|0|||
125103159|NCT03515837|450000542|FG001|Overall Study|Withdrawal by Subject|4|||
125103160|NCT03515837|450000541|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
125103161|NCT03515837|450000542|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
125103162|NCT01964898|450000543|FG000|Overall Study|ineligible post-randomization|1|||
125103163|NCT01964898|450000544|FG001|Overall Study|ineligible post-randomization|1|||
125103164|NCT01964898|450000543|FG000|Overall Study|did not receive the allocated interventi|2|||
125103165|NCT01964898|450000544|FG001|Overall Study|did not receive the allocated interventi|1|||
125103166|NCT01964898|450000543|FG000|Overall Study|Lost to Follow-up|3|||
125103167|NCT01964898|450000544|FG001|Overall Study|Lost to Follow-up|5|||
125103168|NCT01964898|450000543|FG000|Overall Study|Withdrawal by Subject|1|||
125103169|NCT01964898|450000544|FG001|Overall Study|Withdrawal by Subject|0|||
125103170|NCT02325401|450000545|FG000|Overall Study|Withdrawal by Subject|0|||
125103171|NCT02325401|450000546|FG001|Overall Study|Withdrawal by Subject|1|||
125103172|NCT02325401|450000547|FG002|Overall Study|Withdrawal by Subject|1|||
125103173|NCT03526679|450000548|FG000|Overall Study|still under treatment|2|||
125103174|NCT02545868|450000549|FG000|Overall Study|Lack of Efficacy|1|||
125103175|NCT02545868|450000550|FG001|Overall Study|Lack of Efficacy|1|||
125103176|NCT02545868|450000551|FG002|Overall Study|Lack of Efficacy|0|||
125103177|NCT02545868|450000549|FG000|Overall Study|Lost to Follow-up|1|||
125103178|NCT02545868|450000550|FG001|Overall Study|Lost to Follow-up|5|||
125103179|NCT02545868|450000551|FG002|Overall Study|Lost to Follow-up|1|||
125103180|NCT02545868|450000549|FG000|Overall Study|Non-compliance|1|||
125103181|NCT02545868|450000550|FG001|Overall Study|Non-compliance|1|||
125103182|NCT02545868|450000551|FG002|Overall Study|Non-compliance|1|||
125103183|NCT02545868|450000549|FG000|Overall Study|Treatment change|21|||
125103184|NCT02545868|450000550|FG001|Overall Study|Treatment change|19|||
125103185|NCT02545868|450000551|FG002|Overall Study|Treatment change|22|||
125103186|NCT02545868|450000549|FG000|Overall Study|Physician Decision|1|||
125013970|NCT01225731|449676873|FG003|Part 3|Withdrawal by Subject|0|||
125013971|NCT01225731|449676874|FG004|Part 3|Withdrawal by Subject|0|||
125013972|NCT01225731|449676875|FG005|Part 3|Withdrawal by Subject|0|||
125013973|NCT01225731|449676876|FG006|Part 3|Withdrawal by Subject|0|||
125013974|NCT01225731|449676877|FG007|Part 3|Withdrawal by Subject|0|||
125013975|NCT01225731|449676878|FG008|Part 3|Withdrawal by Subject|0|||
125013976|NCT01225731|449676879|FG009|Part 3|Withdrawal by Subject|0|||
125013977|NCT01225731|449676880|FG010|Part 3|Withdrawal by Subject|4|||
125013978|NCT01225731|449676881|FG011|Part 3|Withdrawal by Subject|6|||
125013979|NCT01225731|449676882|FG012|Part 3|Withdrawal by Subject|4|||
125013980|NCT00917150|449676887|FG000|Overall Study|Adverse Event|12|||
125013981|NCT00917150|449676888|FG001|Overall Study|Adverse Event|7|||
125013982|NCT00917150|449676889|FG002|Overall Study|Adverse Event|12|||
125013983|NCT00917150|449676890|FG003|Overall Study|Adverse Event|11|||
125013984|NCT00917150|449676887|FG000|Overall Study|Death|1|||
125013985|NCT00917150|449676888|FG001|Overall Study|Death|4|||
125013986|NCT00917150|449676889|FG002|Overall Study|Death|3|||
125013987|NCT00917150|449676890|FG003|Overall Study|Death|2|||
125013988|NCT00917150|449676887|FG000|Overall Study|Lost to Follow-up|1|||
125013989|NCT00917150|449676888|FG001|Overall Study|Lost to Follow-up|0|||
125013990|NCT00917150|449676889|FG002|Overall Study|Lost to Follow-up|4|||
125013991|NCT00917150|449676890|FG003|Overall Study|Lost to Follow-up|2|||
125103187|NCT02545868|450000550|FG001|Overall Study|Physician Decision|1|||
125103188|NCT02545868|450000551|FG002|Overall Study|Physician Decision|1|||
125103189|NCT02545868|450000549|FG000|Overall Study|Withdrawal by Subject|6|||
125103190|NCT02545868|450000550|FG001|Overall Study|Withdrawal by Subject|7|||
125103191|NCT02545868|450000551|FG002|Overall Study|Withdrawal by Subject|9|||
125013992|NCT00917150|449676887|FG000|Overall Study|Physician Decision|0|||
125013993|NCT00917150|449676888|FG001|Overall Study|Physician Decision|2|||
125013994|NCT00917150|449676889|FG002|Overall Study|Physician Decision|0|||
125013995|NCT00917150|449676890|FG003|Overall Study|Physician Decision|1|||
125103192|NCT04465916|450000556|FG000|Overall Study|Withdrawal by Subject|0|||
125103193|NCT04465916|450000557|FG001|Overall Study|Withdrawal by Subject|1|||
125013996|NCT00917150|449676887|FG000|Overall Study|Protocol Violation|5|||
125103194|NCT00468312|450000559|FG000|Overall Study|Adverse Event|2|||
125103195|NCT00468312|450000560|FG001|Overall Study|Adverse Event|1|||
125103196|NCT00468312|450000559|FG000|Overall Study|Lack of Efficacy|0|||
125103197|NCT00468312|450000560|FG001|Overall Study|Lack of Efficacy|1|||
125103198|NCT00468312|450000559|FG000|Overall Study|Withdrawal by Subject|0|||
125103199|NCT00468312|450000560|FG001|Overall Study|Withdrawal by Subject|1|||
125103200|NCT00468312|450000559|FG000|Overall Study|Protocol Violation|2|||
125103201|NCT00468312|450000560|FG001|Overall Study|Protocol Violation|1|||
125103202|NCT00468312|450000559|FG000|Overall Study|Did not meet protocol eligibility|0|||
125103203|NCT00468312|450000560|FG001|Overall Study|Did not meet protocol eligibility|1|||
125103204|NCT01052038|450000561|FG000|Overall Study|Lost to Follow-up|2|||
125103205|NCT01052038|450000562|FG001|Overall Study|Lost to Follow-up|3|||
125103206|NCT01052038|450000563|FG002|Overall Study|Lost to Follow-up|1|||
124880273|NCT03285295|449185481|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
124880274|NCT03285295|449185482|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
124880275|NCT03285295|449185483|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
124880276|NCT03285295|449185484|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
124880277|NCT03285295|449185485|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
125103207|NCT01052038|450000561|FG000|Overall Study|Protocol Violation|2|||
125103208|NCT01052038|450000562|FG001|Overall Study|Protocol Violation|3|||
125103209|NCT01052038|450000563|FG002|Overall Study|Protocol Violation|3|||
125103210|NCT03976076|450000564|FG000|Overall Study|Withdrawal by Subject|2|||
125103211|NCT01325701|450000565|FG000|Overall Study|Adverse Event|12|||
125103212|NCT01325701|450000566|FG001|Overall Study|Adverse Event|0|||
125103213|NCT01325701|450000565|FG000|Overall Study|Protocol Violation|1|||
125103214|NCT01325701|450000566|FG001|Overall Study|Protocol Violation|0|||
125103215|NCT01325701|450000565|FG000|Overall Study|Physician Decision|2|||
125103216|NCT01325701|450000566|FG001|Overall Study|Physician Decision|2|||
125103217|NCT01325701|450000565|FG000|Overall Study|Withdrawal by Subject|2|||
125103218|NCT01325701|450000566|FG001|Overall Study|Withdrawal by Subject|1|||
125103219|NCT01325701|450000565|FG000|Overall Study|Rollerover Extension Study|4|||
125103220|NCT01325701|450000566|FG001|Overall Study|Rollerover Extension Study|0|||
125103221|NCT01643928|450000573|FG000|Overall Study|Lost to Follow-up|1|||
125103222|NCT01643928|450000574|FG001|Overall Study|Lost to Follow-up|0|||
125103223|NCT01643928|450000575|FG002|Overall Study|Lost to Follow-up|2|||
125103224|NCT01643928|450000576|FG003|Overall Study|Lost to Follow-up|0|||
125103225|NCT01643928|450000577|FG004|Overall Study|Lost to Follow-up|0|||
125103226|NCT01643928|450000573|FG000|Overall Study|Withdrawal by Subject|2|||
125103227|NCT01643928|450000574|FG001|Overall Study|Withdrawal by Subject|0|||
125103228|NCT01643928|450000575|FG002|Overall Study|Withdrawal by Subject|0|||
125103229|NCT01643928|450000576|FG003|Overall Study|Withdrawal by Subject|1|||
125103230|NCT01643928|450000577|FG004|Overall Study|Withdrawal by Subject|0|||
125103231|NCT01643928|450000573|FG000|Overall Study|Pregnancy|0|||
125103232|NCT01643928|450000574|FG001|Overall Study|Pregnancy|0|||
125103233|NCT01643928|450000575|FG002|Overall Study|Pregnancy|0|||
125103234|NCT01643928|450000576|FG003|Overall Study|Pregnancy|1|||
125103235|NCT01643928|450000577|FG004|Overall Study|Pregnancy|0|||
125103236|NCT01643928|450000573|FG000|Overall Study|Other|5|||
125103237|NCT01643928|450000574|FG001|Overall Study|Other|1|||
125103238|NCT01643928|450000575|FG002|Overall Study|Other|1|||
125103239|NCT01643928|450000576|FG003|Overall Study|Other|0|||
125103240|NCT01643928|450000577|FG004|Overall Study|Other|0|||
125103241|NCT01643928|450000573|FG000|Overall Study|Adverse Event|2|||
125103242|NCT01643928|450000574|FG001|Overall Study|Adverse Event|1|||
124880278|NCT03285295|449185481|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
125103243|NCT01643928|450000575|FG002|Overall Study|Adverse Event|0|||
125103244|NCT01643928|450000576|FG003|Overall Study|Adverse Event|1|||
125103245|NCT01643928|450000577|FG004|Overall Study|Adverse Event|2|||
124880279|NCT03285295|449185482|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
125103246|NCT03692078|450000578|FG000|Overall Study|Adverse Event|0|||
125103247|NCT03692078|450000579|FG001|Overall Study|Adverse Event|0|||
125103248|NCT03692078|450000580|FG002|Overall Study|Adverse Event|0|||
125103249|NCT03692078|450000581|FG003|Overall Study|Adverse Event|0|||
125103250|NCT03692078|450000582|FG004|Overall Study|Adverse Event|0|||
125103251|NCT03692078|450000583|FG005|Overall Study|Adverse Event|1|||
125103252|NCT03692078|450000584|FG006|Overall Study|Adverse Event|0|||
125103253|NCT03692078|450000578|FG000|Overall Study|Enrollment Closed|5|||
125103254|NCT03692078|450000579|FG001|Overall Study|Enrollment Closed|0|||
125103255|NCT03692078|450000580|FG002|Overall Study|Enrollment Closed|0|||
125103256|NCT03692078|450000581|FG003|Overall Study|Enrollment Closed|0|||
125103257|NCT03692078|450000582|FG004|Overall Study|Enrollment Closed|0|||
125103258|NCT03692078|450000583|FG005|Overall Study|Enrollment Closed|0|||
125103259|NCT03692078|450000584|FG006|Overall Study|Enrollment Closed|0|||
125103260|NCT03692078|450000578|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
125103261|NCT03692078|450000579|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
125103262|NCT03692078|450000580|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
125103263|NCT03692078|450000581|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
125103264|NCT03692078|450000582|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
125103265|NCT03692078|450000583|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
125103266|NCT03692078|450000584|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
125103267|NCT03692078|450000578|FG000|Overall Study|Withdrawal by Subject|0|||
125103268|NCT03692078|450000579|FG001|Overall Study|Withdrawal by Subject|2|||
125103269|NCT03692078|450000580|FG002|Overall Study|Withdrawal by Subject|0|||
125103270|NCT03692078|450000581|FG003|Overall Study|Withdrawal by Subject|1|||
125103271|NCT03692078|450000582|FG004|Overall Study|Withdrawal by Subject|5|||
125103272|NCT03692078|450000583|FG005|Overall Study|Withdrawal by Subject|3|||
125103273|NCT03692078|450000584|FG006|Overall Study|Withdrawal by Subject|3|||
125103274|NCT01005680|450000585|FG000|Overall Study|Lost to Follow-up|4|||
125103275|NCT01005680|450000586|FG001|Overall Study|Lost to Follow-up|6|||
125103276|NCT01005680|450000585|FG000|Overall Study|Withdrawal by Subject|1|||
125103277|NCT01005680|450000586|FG001|Overall Study|Withdrawal by Subject|4|||
125103278|NCT01005680|450000585|FG000|Overall Study|Physician Decision|1|||
125103279|NCT01005680|450000586|FG001|Overall Study|Physician Decision|1|||
125103280|NCT03576131|450000587|FG000|Overall Study|Investigator decision|0|||
125103281|NCT03576131|450000588|FG001|Overall Study|Investigator decision|0|||
125103282|NCT03576131|450000589|FG002|Overall Study|Investigator decision|0|||
125103283|NCT03576131|450000590|FG003|Overall Study|Investigator decision|1|||
125103284|NCT03576131|450000591|FG004|Overall Study|Investigator decision|0|||
125103285|NCT03576131|450000592|FG005|Overall Study|Investigator decision|1|||
125103286|NCT03576131|450000593|FG006|Overall Study|Investigator decision|0|||
125103287|NCT03576131|450000594|FG007|Overall Study|Investigator decision|0|||
125103288|NCT03576131|450000587|FG000|Overall Study|Withdrawal by Subject|1|||
125103289|NCT03576131|450000588|FG001|Overall Study|Withdrawal by Subject|1|||
125103290|NCT03576131|450000589|FG002|Overall Study|Withdrawal by Subject|0|||
125103291|NCT03576131|450000590|FG003|Overall Study|Withdrawal by Subject|1|||
125103292|NCT03576131|450000591|FG004|Overall Study|Withdrawal by Subject|2|||
125103293|NCT03576131|450000592|FG005|Overall Study|Withdrawal by Subject|3|||
125103294|NCT03576131|450000593|FG006|Overall Study|Withdrawal by Subject|1|||
125103295|NCT03576131|450000594|FG007|Overall Study|Withdrawal by Subject|0|||
125103296|NCT03576131|450000587|FG000|Overall Study|Death|3|||
125103297|NCT03576131|450000588|FG001|Overall Study|Death|3|||
125103298|NCT03576131|450000589|FG002|Overall Study|Death|1|||
125103299|NCT03576131|450000590|FG003|Overall Study|Death|5|||
125103300|NCT03576131|450000591|FG004|Overall Study|Death|4|||
125103301|NCT03576131|450000592|FG005|Overall Study|Death|1|||
125103302|NCT03576131|450000593|FG006|Overall Study|Death|0|||
125103303|NCT03576131|450000594|FG007|Overall Study|Death|1|||
125103304|NCT03576131|450000587|FG000|Overall Study|New anti-cancer treatment|5|||
125103305|NCT03576131|450000588|FG001|Overall Study|New anti-cancer treatment|1|||
125103306|NCT03576131|450000589|FG002|Overall Study|New anti-cancer treatment|2|||
125103307|NCT03576131|450000590|FG003|Overall Study|New anti-cancer treatment|3|||
125103308|NCT03576131|450000591|FG004|Overall Study|New anti-cancer treatment|0|||
125103309|NCT03576131|450000592|FG005|Overall Study|New anti-cancer treatment|0|||
125103310|NCT03576131|450000593|FG006|Overall Study|New anti-cancer treatment|0|||
125103311|NCT03576131|450000594|FG007|Overall Study|New anti-cancer treatment|0|||
125103312|NCT03576131|450000587|FG000|Overall Study|Unspecified reason|0|||
125103313|NCT03576131|450000588|FG001|Overall Study|Unspecified reason|0|||
125103314|NCT03576131|450000589|FG002|Overall Study|Unspecified reason|1|||
125103315|NCT03576131|450000590|FG003|Overall Study|Unspecified reason|1|||
125103316|NCT03576131|450000591|FG004|Overall Study|Unspecified reason|1|||
125103317|NCT03576131|450000592|FG005|Overall Study|Unspecified reason|1|||
125103318|NCT03576131|450000593|FG006|Overall Study|Unspecified reason|0|||
125103319|NCT03576131|450000594|FG007|Overall Study|Unspecified reason|0|||
125103320|NCT03576131|450000587|FG000|Overall Study|Subject non-compliance|0|||
125103321|NCT03576131|450000588|FG001|Overall Study|Subject non-compliance|0|||
125103322|NCT03576131|450000589|FG002|Overall Study|Subject non-compliance|0|||
125103323|NCT03576131|450000590|FG003|Overall Study|Subject non-compliance|0|||
125103324|NCT03576131|450000591|FG004|Overall Study|Subject non-compliance|0|||
125103325|NCT03576131|450000592|FG005|Overall Study|Subject non-compliance|1|||
125103326|NCT03576131|450000593|FG006|Overall Study|Subject non-compliance|0|||
125103327|NCT03576131|450000594|FG007|Overall Study|Subject non-compliance|0|||
125103328|NCT03069365|450000611|FG000|Overall Study|Adverse Event|1|||
125103329|NCT01965431|450000612|FG000|Overall Study|Adverse Event|0|||
125103330|NCT01965431|450000613|FG001|Overall Study|Adverse Event|1|||
125103331|NCT01965431|450000614|FG002|Overall Study|Adverse Event|0|||
125103332|NCT01965431|450000615|FG003|Overall Study|Adverse Event|0|||
125103333|NCT01965431|450000616|FG004|Overall Study|Adverse Event|0|||
125103334|NCT01965431|450000617|FG005|Overall Study|Adverse Event|0|||
125103335|NCT01965431|450000612|FG000|Overall Study|Other than stated above|6|||
125103336|NCT01965431|450000613|FG001|Overall Study|Other than stated above|5|||
125103337|NCT01965431|450000614|FG002|Overall Study|Other than stated above|6|||
125103338|NCT01965431|450000615|FG003|Overall Study|Other than stated above|6|||
125103339|NCT01965431|450000616|FG004|Overall Study|Other than stated above|6|||
125103340|NCT01965431|450000617|FG005|Overall Study|Other than stated above|6|||
125103341|NCT04635631|450000618|FG000|Overall Study|Adverse Event|1|||
125217426|NCT01348100|450423520|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
125103342|NCT04635631|450000618|FG000|Overall Study|Progressive disease|13|||
125103343|NCT04635631|450000618|FG000|Overall Study|Withdrawal by Subject|1|||
125103344|NCT03901339|450000620|FG000|Overall Study|Death|220|||
125013997|NCT00917150|449676888|FG001|Overall Study|Protocol Violation|5|||
125103345|NCT03901339|450000621|FG001|Overall Study|Death|192|||
125013998|NCT00917150|449676889|FG002|Overall Study|Protocol Violation|3|||
125013999|NCT00917150|449676890|FG003|Overall Study|Protocol Violation|5|||
125014000|NCT00917150|449676887|FG000|Overall Study|Withdrawal by Subject|15|||
125014001|NCT00917150|449676888|FG001|Overall Study|Withdrawal by Subject|16|||
125014002|NCT00917150|449676889|FG002|Overall Study|Withdrawal by Subject|18|||
125014003|NCT00917150|449676890|FG003|Overall Study|Withdrawal by Subject|11|||
125014004|NCT00917150|449676887|FG000|Overall Study|Other than specified|3|||
125014005|NCT00917150|449676888|FG001|Overall Study|Other than specified|3|||
125014006|NCT00917150|449676889|FG002|Overall Study|Other than specified|2|||
125014007|NCT00917150|449676890|FG003|Overall Study|Other than specified|2|||
125014008|NCT03891264|449676891|FG000|Overall Study|Adverse Event|1|||
125014009|NCT03891264|449676891|FG000|Overall Study|Withdrawal by Subject|2|||
125014010|NCT03891264|449676891|FG000|Overall Study|Physician Decision|2|||
125103346|NCT03901339|450000620|FG000|Overall Study|Informed consent withdrawn|13|||
125103347|NCT03901339|450000621|FG001|Overall Study|Informed consent withdrawn|40|||
125103348|NCT03901339|450000620|FG000|Overall Study|Sponsor request|30|||
125103349|NCT03901339|450000621|FG001|Overall Study|Sponsor request|23|||
125103350|NCT03901339|450000620|FG000|Overall Study|Reason not specified|5|||
125103351|NCT03901339|450000621|FG001|Overall Study|Reason not specified|7|||
125103352|NCT03901339|450000620|FG000|Overall Study|Lost to Follow-up|4|||
125103353|NCT03901339|450000621|FG001|Overall Study|Lost to Follow-up|7|||
125103354|NCT03901339|450000620|FG000|Overall Study|Covid19|0|||
125103355|NCT03901339|450000621|FG001|Overall Study|Covid19|2|||
125103356|NCT02886494|450000622|FG000|Overall Study|Adverse Event|1|||
125103357|NCT02886494|450000623|FG001|Overall Study|Adverse Event|0|||
125103358|NCT02886494|450000622|FG000|Overall Study|Withdrawal by Subject|12|||
125103359|NCT02886494|450000623|FG001|Overall Study|Withdrawal by Subject|3|||
125103360|NCT02886494|450000622|FG000|Overall Study|Protocol Violation|4|||
125103361|NCT02886494|450000623|FG001|Overall Study|Protocol Violation|1|||
125103362|NCT00457418|450000624|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
125103363|NCT00457418|450000624|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
125103364|NCT00457418|450000624|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
125103365|NCT00457418|450000624|FG000|Post PK Maintenance|Adverse Event|10|||
125103366|NCT00457418|450000624|FG000|Post PK Maintenance|Progression of Disease|6|||
125103367|NCT00457418|450000624|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
125103368|NCT00457418|450000624|FG000|Post PK Maintenance|Lost to Follow-up|1|||
125103369|NCT01785472|450000625|FG000|Overall Study|Adverse Event|5|||
125103370|NCT01785472|450000626|FG001|Overall Study|Adverse Event|4|||
125103371|NCT01785472|450000627|FG002|Overall Study|Adverse Event|6|||
125103372|NCT01785472|450000625|FG000|Overall Study|Lack of Efficacy|2|||
125103373|NCT01785472|450000626|FG001|Overall Study|Lack of Efficacy|0|||
125103374|NCT01785472|450000627|FG002|Overall Study|Lack of Efficacy|1|||
125103375|NCT01785472|450000625|FG000|Overall Study|Lost to Follow-up|1|||
125103376|NCT01785472|450000626|FG001|Overall Study|Lost to Follow-up|2|||
125103377|NCT01785472|450000627|FG002|Overall Study|Lost to Follow-up|0|||
125103378|NCT01785472|450000625|FG000|Overall Study|Physician Decision|1|||
125103379|NCT01785472|450000626|FG001|Overall Study|Physician Decision|1|||
125103380|NCT01785472|450000627|FG002|Overall Study|Physician Decision|1|||
125103381|NCT01785472|450000625|FG000|Overall Study|Protocol deviation|0|||
125103382|NCT01785472|450000626|FG001|Overall Study|Protocol deviation|2|||
125103383|NCT01785472|450000627|FG002|Overall Study|Protocol deviation|2|||
125103384|NCT01785472|450000625|FG000|Overall Study|Subject/guardian decision|15|||
125103385|NCT01785472|450000626|FG001|Overall Study|Subject/guardian decision|10|||
125103386|NCT01785472|450000627|FG002|Overall Study|Subject/guardian decision|11|||
125103387|NCT01785472|450000625|FG000|Overall Study|Technical problems|0|||
125103388|NCT01785472|450000626|FG001|Overall Study|Technical problems|0|||
125103389|NCT01785472|450000627|FG002|Overall Study|Technical problems|1|||
125103390|NCT00595127|450000628|FG000|Overall Study|Death|6|||
125103391|NCT00595127|450000628|FG000|Overall Study|Relapsed|3|||
125103392|NCT00595127|450000628|FG000|Overall Study|joined another trial|1|||
125103393|NCT02086968|450000630|FG000|Overall Study|Adverse Event|1|||
125103394|NCT02086968|450000631|FG001|Overall Study|Adverse Event|5|||
125103395|NCT02086968|450000630|FG000|Overall Study|Lost to Follow-up|2|||
125103396|NCT02086968|450000631|FG001|Overall Study|Lost to Follow-up|3|||
125103397|NCT02086968|450000630|FG000|Overall Study|Study drug received outside protocol|0|||
125103398|NCT02086968|450000631|FG001|Overall Study|Study drug received outside protocol|1|||
125103399|NCT02086968|450000630|FG000|Overall Study|Physician Decision|4|||
125103400|NCT02086968|450000631|FG001|Overall Study|Physician Decision|0|||
125103401|NCT02086968|450000630|FG000|Overall Study|Withdrawal by Subject|1|||
125103402|NCT02086968|450000631|FG001|Overall Study|Withdrawal by Subject|4|||
125103403|NCT03099161|450000632|FG000|Overall Study|Adverse Event|0|||
125103404|NCT03099161|450000633|FG001|Overall Study|Adverse Event|0|||
125103405|NCT03099161|450000634|FG002|Overall Study|Adverse Event|2|||
125103406|NCT03099161|450000632|FG000|Overall Study|Physician Decision|2|||
125103407|NCT03099161|450000633|FG001|Overall Study|Physician Decision|0|||
125103408|NCT03099161|450000634|FG002|Overall Study|Physician Decision|0|||
125103409|NCT03099161|450000632|FG000|Overall Study|Progressive Disease|1|||
125103410|NCT03099161|450000633|FG001|Overall Study|Progressive Disease|4|||
125103411|NCT03099161|450000634|FG002|Overall Study|Progressive Disease|1|||
125103412|NCT02723786|450000635|FG000|Overall Study|Lost to Follow-up|1|||
125103413|NCT03123120|450000636|FG000|Overall Study|Lost to Follow-up|0|||
125103414|NCT03123120|450000637|FG001|Overall Study|Lost to Follow-up|1|||
125103415|NCT03123120|450000636|FG000|Overall Study|Withdrawal by Subject|0|||
125103416|NCT03123120|450000637|FG001|Overall Study|Withdrawal by Subject|1|||
125103417|NCT00203892|450000638|FG000|Overall Study|Physician Decision|1|||
125103418|NCT00203892|450000639|FG001|Overall Study|Physician Decision|2|||
125103419|NCT00203892|450000640|FG002|Overall Study|Physician Decision|0|||
125103420|NCT00203892|450000638|FG000|Overall Study|Death|1|||
125103421|NCT00203892|450000639|FG001|Overall Study|Death|0|||
125103422|NCT00203892|450000640|FG002|Overall Study|Death|0|||
125103423|NCT00806416|450000641|FG000|Period 1 - Part I|Adverse Event|0|||
125103424|NCT00806416|450000642|FG001|Period 1 - Part I|Adverse Event|1|||
125103425|NCT00806416|450000643|FG002|Period 1 - Part I|Adverse Event|0|||
125103426|NCT00806416|450000644|FG003|Period 1 - Part I|Adverse Event|0|||
125103427|NCT00806416|450000641|FG000|Period 1 - Part I|Lost to Follow-up|0|||
125103428|NCT00806416|450000642|FG001|Period 1 - Part I|Lost to Follow-up|2|||
125103429|NCT00806416|450000643|FG002|Period 1 - Part I|Lost to Follow-up|0|||
125103430|NCT00806416|450000644|FG003|Period 1 - Part I|Lost to Follow-up|0|||
125103431|NCT00806416|450000641|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
125103432|NCT00806416|450000642|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
125103433|NCT00806416|450000643|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
125103434|NCT00806416|450000644|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
125103435|NCT00806416|450000641|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
125103436|NCT00806416|450000642|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
125103437|NCT00806416|450000643|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
125103438|NCT00806416|450000644|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
125103439|NCT03359473|450000656|FG000|Overall Study|Adverse Event|0|||
125103440|NCT03359473|450000657|FG001|Overall Study|Adverse Event|2|||
125103441|NCT03359473|450000658|FG002|Overall Study|Adverse Event|5|||
125103442|NCT03359473|450000659|FG003|Overall Study|Adverse Event|3|||
125103443|NCT03359473|450000656|FG000|Overall Study|Lost to Follow-up|0|||
125103444|NCT03359473|450000657|FG001|Overall Study|Lost to Follow-up|1|||
125103445|NCT03359473|450000658|FG002|Overall Study|Lost to Follow-up|0|||
125103446|NCT03359473|450000659|FG003|Overall Study|Lost to Follow-up|0|||
125103447|NCT03359473|450000656|FG000|Overall Study|Physician Decision|0|||
125103448|NCT03359473|450000657|FG001|Overall Study|Physician Decision|1|||
125103449|NCT03359473|450000658|FG002|Overall Study|Physician Decision|0|||
125103450|NCT03359473|450000659|FG003|Overall Study|Physician Decision|1|||
125103451|NCT03359473|450000656|FG000|Overall Study|Withdrawal by Subject|1|||
125103452|NCT03359473|450000657|FG001|Overall Study|Withdrawal by Subject|2|||
125103453|NCT03359473|450000658|FG002|Overall Study|Withdrawal by Subject|1|||
125103454|NCT03359473|450000659|FG003|Overall Study|Withdrawal by Subject|0|||
125103455|NCT03359473|450000656|FG000|Overall Study|Protocol-defined stopping criteria|1|||
125103456|NCT03359473|450000657|FG001|Overall Study|Protocol-defined stopping criteria|0|||
125103457|NCT03359473|450000658|FG002|Overall Study|Protocol-defined stopping criteria|0|||
125103458|NCT03359473|450000659|FG003|Overall Study|Protocol-defined stopping criteria|1|||
125103459|NCT05302414|450000660|FG000|Pretest to Posttest|Lost to Follow-up|12|||
125103460|NCT05302414|450000661|FG001|Pretest to Posttest|Lost to Follow-up|8|||
125103461|NCT05302414|450000662|FG002|Pretest to Posttest|Lost to Follow-up|8|||
125103462|NCT05302414|450000660|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
125103463|NCT05302414|450000661|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
125103464|NCT05302414|450000662|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
125103465|NCT01610284|450000663|FG000|Randomization Phase|Adverse Event|1|||
125103466|NCT01610284|450000664|FG001|Randomization Phase|Adverse Event|0|||
125103467|NCT01610284|450000663|FG000|Randomization Phase|Physician Decision|1|||
125103468|NCT01610284|450000664|FG001|Randomization Phase|Physician Decision|1|||
125103469|NCT01610284|450000663|FG000|Randomization Phase|Death|0|||
125103470|NCT01610284|450000664|FG001|Randomization Phase|Death|1|||
125103471|NCT01610284|450000663|FG000|Treatment Phase|Adverse Event|80|||
125103472|NCT01610284|450000664|FG001|Treatment Phase|Adverse Event|12|||
125103473|NCT01610284|450000663|FG000|Treatment Phase|Lost to Follow-up|1|||
125103474|NCT01610284|450000664|FG001|Treatment Phase|Lost to Follow-up|0|||
125103475|NCT01610284|450000663|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
125103476|NCT01610284|450000664|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
125103477|NCT01610284|450000663|FG000|Treatment Phase|Physician Decision|27|||
125103478|NCT01610284|450000664|FG001|Treatment Phase|Physician Decision|24|||
125103479|NCT01610284|450000663|FG000|Treatment Phase|Progressive Disease|377|||
125103480|NCT01610284|450000664|FG001|Treatment Phase|Progressive Disease|486|||
125103481|NCT01610284|450000663|FG000|Treatment Phase|Protocol Deviation|2|||
125103482|NCT01610284|450000664|FG001|Treatment Phase|Protocol Deviation|3|||
125103483|NCT01610284|450000663|FG000|Treatment Phase|Study terminated by Sponsor|18|||
125103484|NCT01610284|450000664|FG001|Treatment Phase|Study terminated by Sponsor|15|||
125103485|NCT01610284|450000663|FG000|Treatment Phase|Subject/Guardian Decision|55|||
125103486|NCT01610284|450000664|FG001|Treatment Phase|Subject/Guardian Decision|23|||
125103487|NCT01610284|450000663|FG000|Treatment Phase|Death|6|||
125103488|NCT01610284|450000664|FG001|Treatment Phase|Death|5|||
125103489|NCT01610284|450000663|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
125103490|NCT01610284|450000664|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
125103491|NCT01610284|450000663|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
125103492|NCT01610284|450000664|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
125103493|NCT01610284|450000663|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
125103494|NCT01610284|450000664|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
125103495|NCT01610284|450000663|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
125103496|NCT01610284|450000664|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
125103497|NCT01610284|450000663|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
125103498|NCT01610284|450000664|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
125103499|NCT01610284|450000663|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
125103500|NCT01610284|450000664|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
125103501|NCT01102972|450000667|FG000|Overall Study|Adverse Event|8|||
125103502|NCT01102972|450000668|FG001|Overall Study|Adverse Event|2|||
125103503|NCT01102972|450000667|FG000|Overall Study|Lack of Efficacy|2|||
125103504|NCT01102972|450000668|FG001|Overall Study|Lack of Efficacy|1|||
125103505|NCT01102972|450000667|FG000|Overall Study|Protocol Violation|1|||
125103506|NCT01102972|450000668|FG001|Overall Study|Protocol Violation|0|||
125103507|NCT01102972|450000667|FG000|Overall Study|Lost to Follow-up|10|||
125103508|NCT01102972|450000668|FG001|Overall Study|Lost to Follow-up|5|||
125103509|NCT01102972|450000667|FG000|Overall Study|Investigator Discretion|2|||
125103510|NCT01102972|450000668|FG001|Overall Study|Investigator Discretion|0|||
125103511|NCT01102972|450000667|FG000|Overall Study|Withdrawal by Subject|6|||
125103512|NCT01102972|450000668|FG001|Overall Study|Withdrawal by Subject|6|||
125103513|NCT01856257|450000669|FG000|Overall Study|Death|2|||
125103514|NCT01856257|450000670|FG001|Overall Study|Death|0|||
125103515|NCT01856257|450000671|FG002|Overall Study|Death|0|||
125103516|NCT01856257|450000672|FG003|Overall Study|Death|0|||
125103517|NCT01856257|450000669|FG000|Overall Study|Physician Decision|0|||
125103518|NCT01856257|450000670|FG001|Overall Study|Physician Decision|0|||
125103519|NCT01856257|450000671|FG002|Overall Study|Physician Decision|0|||
125103520|NCT01856257|450000672|FG003|Overall Study|Physician Decision|1|||
125103521|NCT01856257|450000669|FG000|Overall Study|Withdrawal by Subject|1|||
125103522|NCT01856257|450000670|FG001|Overall Study|Withdrawal by Subject|1|||
125103523|NCT01856257|450000671|FG002|Overall Study|Withdrawal by Subject|0|||
125103524|NCT01856257|450000672|FG003|Overall Study|Withdrawal by Subject|0|||
125103525|NCT01856257|450000669|FG000|Overall Study|Donor complication|0|||
124880280|NCT03285295|449185483|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
124880281|NCT03285295|449185484|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
125014011|NCT01692275|449676892|FG000|Overall Study|Lost to Follow-up|57|||
125014012|NCT01692275|449676893|FG001|Overall Study|Lost to Follow-up|48|||
125014013|NCT01692275|449676892|FG000|Overall Study|Withdrawal by Subject|9|||
125014014|NCT01692275|449676893|FG001|Overall Study|Withdrawal by Subject|11|||
125014015|NCT01033825|449676894|FG000|Overall Study|Withdrawal by Subject|2|||
125014016|NCT01033825|449676895|FG001|Overall Study|Withdrawal by Subject|3|||
125014017|NCT01033825|449676896|FG002|Overall Study|Withdrawal by Subject|2|||
125014018|NCT01033825|449676897|FG003|Overall Study|Withdrawal by Subject|1|||
125014019|NCT01033825|449676898|FG004|Overall Study|Withdrawal by Subject|1|||
125014020|NCT01033825|449676899|FG005|Overall Study|Withdrawal by Subject|0|||
125014021|NCT01033825|449676900|FG006|Overall Study|Withdrawal by Subject|0|||
125014022|NCT01033825|449676894|FG000|Overall Study|Adverse Event|0|||
125014023|NCT01033825|449676895|FG001|Overall Study|Adverse Event|0|||
125014024|NCT01033825|449676896|FG002|Overall Study|Adverse Event|0|||
125014025|NCT01033825|449676897|FG003|Overall Study|Adverse Event|1|||
125014026|NCT01033825|449676898|FG004|Overall Study|Adverse Event|0|||
125014027|NCT01033825|449676899|FG005|Overall Study|Adverse Event|0|||
125014028|NCT01033825|449676900|FG006|Overall Study|Adverse Event|0|||
125014029|NCT01033825|449676894|FG000|Overall Study|Protocol Violation|1|||
125014030|NCT01033825|449676895|FG001|Overall Study|Protocol Violation|0|||
125014031|NCT01033825|449676896|FG002|Overall Study|Protocol Violation|0|||
125014032|NCT01033825|449676897|FG003|Overall Study|Protocol Violation|0|||
125014033|NCT01033825|449676898|FG004|Overall Study|Protocol Violation|0|||
125014034|NCT01033825|449676899|FG005|Overall Study|Protocol Violation|0|||
124880282|NCT03285295|449185485|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
125014035|NCT01033825|449676900|FG006|Overall Study|Protocol Violation|0|||
125014036|NCT01033825|449676894|FG000|Overall Study|Other|0|||
125014037|NCT01033825|449676895|FG001|Overall Study|Other|0|||
125014038|NCT01033825|449676896|FG002|Overall Study|Other|0|||
125014039|NCT01033825|449676897|FG003|Overall Study|Other|0|||
125014040|NCT01033825|449676898|FG004|Overall Study|Other|1|||
125014041|NCT01033825|449676899|FG005|Overall Study|Other|0|||
125014042|NCT01033825|449676900|FG006|Overall Study|Other|0|||
124880283|NCT03285295|449185481|FG000|Alinity s Anti-HCV|No Results Generated|71|||
124880284|NCT03285295|449185482|FG001|Alinity s Anti-HCV|No Results Generated|0|||
125103526|NCT01856257|450000670|FG001|Overall Study|Donor complication|0|||
125103527|NCT01856257|450000671|FG002|Overall Study|Donor complication|0|||
125103528|NCT01856257|450000672|FG003|Overall Study|Donor complication|1|||
125103529|NCT01125358|450000676|FG000|Overall Study|Adverse Event|3|||
125103530|NCT01125358|450000677|FG001|Overall Study|Adverse Event|0|||
125103531|NCT01125358|450000678|FG002|Overall Study|Adverse Event|0|||
125103532|NCT01125358|450000679|FG003|Overall Study|Adverse Event|2|||
125103533|NCT01125358|450000676|FG000|Overall Study|Perceived Lack of Efficacy|6|||
125103534|NCT01125358|450000677|FG001|Overall Study|Perceived Lack of Efficacy|3|||
125103535|NCT01125358|450000678|FG002|Overall Study|Perceived Lack of Efficacy|7|||
125103536|NCT01125358|450000679|FG003|Overall Study|Perceived Lack of Efficacy|4|||
125103537|NCT01125358|450000676|FG000|Overall Study|Protocol Violation|1|||
125103538|NCT01125358|450000677|FG001|Overall Study|Protocol Violation|0|||
125103539|NCT01125358|450000678|FG002|Overall Study|Protocol Violation|0|||
125103540|NCT01125358|450000679|FG003|Overall Study|Protocol Violation|0|||
125103541|NCT01125358|450000676|FG000|Overall Study|Sponsor Decision|0|||
125103542|NCT01125358|450000677|FG001|Overall Study|Sponsor Decision|0|||
125103543|NCT01125358|450000678|FG002|Overall Study|Sponsor Decision|1|||
125103544|NCT01125358|450000679|FG003|Overall Study|Sponsor Decision|1|||
125103545|NCT01125358|450000676|FG000|Overall Study|Withdrawal by Subject|2|||
125103546|NCT01125358|450000677|FG001|Overall Study|Withdrawal by Subject|1|||
125103547|NCT01125358|450000678|FG002|Overall Study|Withdrawal by Subject|1|||
125103548|NCT01125358|450000679|FG003|Overall Study|Withdrawal by Subject|1|||
125103549|NCT01157065|450000680|FG000|Overall Study|Death|0|||
125103550|NCT01157065|450000681|FG001|Overall Study|Death|1|||
125103551|NCT01060007|450000684|FG000|Overall Study|Withdrawal by Subject|1|||
125103552|NCT01060007|450000684|FG000|Overall Study|Inevaluable for response at surgery|3|||
125103553|NCT00742859|450000685|FG000|Overall Study|Adverse Event|5|||
125103554|NCT00742859|450000686|FG001|Overall Study|Adverse Event|6|||
125103555|NCT00742859|450000687|FG002|Overall Study|Adverse Event|3|||
125103556|NCT00742859|450000688|FG003|Overall Study|Adverse Event|1|||
125103557|NCT00742859|450000685|FG000|Overall Study|Death|1|||
125103558|NCT00742859|450000686|FG001|Overall Study|Death|0|||
125103559|NCT00742859|450000687|FG002|Overall Study|Death|0|||
125103560|NCT00742859|450000688|FG003|Overall Study|Death|1|||
125103561|NCT00742859|450000685|FG000|Overall Study|Physician Decision|1|||
125103562|NCT00742859|450000686|FG001|Overall Study|Physician Decision|2|||
125103563|NCT00742859|450000687|FG002|Overall Study|Physician Decision|0|||
124880285|NCT03285295|449185483|FG002|Alinity s Anti-HCV|No Results Generated|0|||
125103564|NCT00742859|450000688|FG003|Overall Study|Physician Decision|0|||
125103565|NCT00742859|450000685|FG000|Overall Study|Withdrawal by Subject|4|||
125103566|NCT00742859|450000686|FG001|Overall Study|Withdrawal by Subject|2|||
125103567|NCT00742859|450000687|FG002|Overall Study|Withdrawal by Subject|4|||
125103568|NCT00742859|450000688|FG003|Overall Study|Withdrawal by Subject|1|||
125103569|NCT00742859|450000685|FG000|Overall Study|Endpoint|0|||
125103570|NCT00742859|450000686|FG001|Overall Study|Endpoint|1|||
125103571|NCT00742859|450000687|FG002|Overall Study|Endpoint|1|||
125103572|NCT00742859|450000688|FG003|Overall Study|Endpoint|2|||
125103573|NCT00742859|450000685|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
125103574|NCT00742859|450000686|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
125103575|NCT00742859|450000687|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
125103576|NCT00742859|450000688|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
125103577|NCT00742859|450000685|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
125103578|NCT00742859|450000686|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
125103579|NCT00742859|450000687|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
125103580|NCT00742859|450000688|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
125103581|NCT00742859|450000685|FG000|Overall Study|Sponsor request patient out of town|0|||
125103582|NCT00742859|450000686|FG001|Overall Study|Sponsor request patient out of town|0|||
125103583|NCT00742859|450000687|FG002|Overall Study|Sponsor request patient out of town|1|||
125103584|NCT00742859|450000688|FG003|Overall Study|Sponsor request patient out of town|1|||
125103585|NCT00742859|450000685|FG000|Overall Study|Site error|0|||
125103586|NCT00742859|450000686|FG001|Overall Study|Site error|0|||
125103587|NCT00742859|450000687|FG002|Overall Study|Site error|1|||
125103588|NCT00742859|450000688|FG003|Overall Study|Site error|1|||
125103589|NCT00962013|450000693|FG000|Overall Study|Did not have surgery|1|||
125103590|NCT00962013|450000693|FG000|Overall Study|Death|8|||
125103591|NCT00962013|450000693|FG000|Overall Study|Lost to Follow-up|12|||
125103592|NCT00962013|450000693|FG000|Overall Study|Unable/Unwilling to return|6|||
125103593|NCT00962013|450000693|FG000|Overall Study|Withdrawal by Subject|8|||
125103594|NCT00962013|450000693|FG000|Overall Study|Removal of study device|3|||
125103595|NCT00962013|450000693|FG000|Overall Study|Site Termination|24|||
125103596|NCT00962013|450000693|FG000|Overall Study|No 5 year evaluation|6|||
125103597|NCT04527549|450000694|FG000|Overall Study|Withdrawal by Subject|1|||
125103598|NCT04527549|450000695|FG001|Overall Study|Withdrawal by Subject|1|||
125103599|NCT00445458|450000708|FG000|Overall Study|Disease Progression|3|||
125103600|NCT00445458|450000709|FG001|Overall Study|Disease Progression|4|||
125103601|NCT00445458|450000710|FG002|Overall Study|Disease Progression|54|||
124880286|NCT03285295|449185484|FG003|Alinity s Anti-HCV|No Results Generated|0|||
124880287|NCT03285295|449185485|FG004|Alinity s Anti-HCV|No Results Generated|0|||
125103602|NCT00445458|450000711|FG003|Overall Study|Disease Progression|27|||
125103603|NCT00445458|450000708|FG000|Overall Study|Withdrawal by Subject|0|||
125103604|NCT00445458|450000709|FG001|Overall Study|Withdrawal by Subject|0|||
125103605|NCT00445458|450000710|FG002|Overall Study|Withdrawal by Subject|7|||
125103606|NCT00445458|450000711|FG003|Overall Study|Withdrawal by Subject|0|||
125103607|NCT00445458|450000708|FG000|Overall Study|Adverse Event|0|||
125103608|NCT00445458|450000709|FG001|Overall Study|Adverse Event|0|||
125103609|NCT00445458|450000710|FG002|Overall Study|Adverse Event|3|||
125103610|NCT00445458|450000711|FG003|Overall Study|Adverse Event|0|||
125103611|NCT00445458|450000708|FG000|Overall Study|Death|0|||
125103612|NCT00445458|450000709|FG001|Overall Study|Death|1|||
125103613|NCT00445458|450000710|FG002|Overall Study|Death|2|||
125103614|NCT00445458|450000711|FG003|Overall Study|Death|0|||
125103615|NCT00445458|450000708|FG000|Overall Study|Physician Decision|0|||
124880288|NCT03285295|449185481|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
125103616|NCT00445458|450000709|FG001|Overall Study|Physician Decision|0|||
125103617|NCT00445458|450000710|FG002|Overall Study|Physician Decision|1|||
125103618|NCT00445458|450000711|FG003|Overall Study|Physician Decision|1|||
125103619|NCT00445458|450000708|FG000|Overall Study|Surgery|0|||
125103620|NCT00445458|450000709|FG001|Overall Study|Surgery|0|||
125103621|NCT00445458|450000710|FG002|Overall Study|Surgery|1|||
125103622|NCT00445458|450000711|FG003|Overall Study|Surgery|0|||
125103623|NCT00728988|450000714|FG000|Overall Study|Not Treated|2|||
125103624|NCT00728988|450000715|FG001|Overall Study|Not Treated|2|||
125103625|NCT00728988|450000714|FG000|Overall Study|Death|1|||
125103626|NCT00728988|450000715|FG001|Overall Study|Death|1|||
124880289|NCT03285295|449185482|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
124880290|NCT03285295|449185483|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
124880291|NCT03285295|449185484|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
124880292|NCT03285295|449185485|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
124880293|NCT03285295|449185481|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
124880294|NCT03285295|449185482|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
125014043|NCT03099187|449676901|FG000|Double-blind Treatment|Adverse Event|19|||
125103627|NCT00728988|450000714|FG000|Overall Study|Adverse Event|3|||
125103628|NCT00728988|450000715|FG001|Overall Study|Adverse Event|2|||
125103629|NCT00728988|450000714|FG000|Overall Study|Other|85|||
125103630|NCT00728988|450000715|FG001|Overall Study|Other|77|||
125103631|NCT00728988|450000714|FG000|Overall Study|Withdrawal by Subject|2|||
125103632|NCT00728988|450000715|FG001|Overall Study|Withdrawal by Subject|6|||
125103633|NCT03186794|450000721|FG000|Overall Study|Physician Decision|2|||
125103634|NCT03186794|450000721|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
125103635|NCT00111007|450000723|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
125103636|NCT00111007|450000724|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
125103637|NCT00111007|450000723|FG000|Double-blind (DB) Treatment|Death|5|||
125103638|NCT00111007|450000724|FG001|Double-blind (DB) Treatment|Death|2|||
125103639|NCT00111007|450000723|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
125103640|NCT00111007|450000724|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
125103641|NCT00111007|450000723|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
125103642|NCT00111007|450000724|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
125103643|NCT00111007|450000723|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
125103644|NCT00111007|450000724|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
125103645|NCT00111007|450000723|FG000|Double-blind (DB) Treatment|Relapse|1|||
125103646|NCT00111007|450000724|FG001|Double-blind (DB) Treatment|Relapse|0|||
125103647|NCT00111007|450000723|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
125103648|NCT00111007|450000724|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
125103649|NCT00111007|450000723|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
125103650|NCT00111007|450000724|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
125103651|NCT00111007|450000723|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
124880295|NCT03285295|449185483|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
125103652|NCT00111007|450000724|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
125103653|NCT00111007|450000723|FG000|Active Follow-up|Adverse Event|1|||
125103654|NCT00111007|450000724|FG001|Active Follow-up|Adverse Event|0|||
124880296|NCT03285295|449185484|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
124880297|NCT03285295|449185485|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
125014044|NCT03099187|449676902|FG001|Double-blind Treatment|Adverse Event|1|||
125014045|NCT03099187|449676903|FG002|Double-blind Treatment|Adverse Event|0|||
125014046|NCT03099187|449676904|FG003|Double-blind Treatment|Adverse Event|0|||
125014047|NCT03099187|449676901|FG000|Double-blind Treatment|Death|1|||
125014048|NCT03099187|449676902|FG001|Double-blind Treatment|Death|3|||
125014049|NCT03099187|449676903|FG002|Double-blind Treatment|Death|0|||
125014050|NCT03099187|449676904|FG003|Double-blind Treatment|Death|0|||
125014051|NCT03099187|449676901|FG000|Double-blind Treatment|Lack of Efficacy|1|||
125014052|NCT03099187|449676902|FG001|Double-blind Treatment|Lack of Efficacy|0|||
125014053|NCT03099187|449676903|FG002|Double-blind Treatment|Lack of Efficacy|0|||
125014054|NCT03099187|449676904|FG003|Double-blind Treatment|Lack of Efficacy|0|||
125014055|NCT03099187|449676901|FG000|Double-blind Treatment|Physician Decision|2|||
125014056|NCT03099187|449676902|FG001|Double-blind Treatment|Physician Decision|1|||
125014057|NCT03099187|449676903|FG002|Double-blind Treatment|Physician Decision|0|||
125014058|NCT03099187|449676904|FG003|Double-blind Treatment|Physician Decision|0|||
125014059|NCT03099187|449676901|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
125014060|NCT03099187|449676902|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
125014061|NCT03099187|449676903|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
125014062|NCT03099187|449676904|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
125014063|NCT03099187|449676901|FG000|Double-blind Treatment|Lung transplantation|0|||
125014064|NCT03099187|449676902|FG001|Double-blind Treatment|Lung transplantation|1|||
125014065|NCT03099187|449676903|FG002|Double-blind Treatment|Lung transplantation|0|||
125014066|NCT03099187|449676904|FG003|Double-blind Treatment|Lung transplantation|0|||
125014067|NCT03099187|449676901|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
125014068|NCT03099187|449676902|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
125014069|NCT03099187|449676903|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
125014070|NCT03099187|449676904|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
125014071|NCT03099187|449676901|FG000|Double-blind Treatment|Disease progression|0|||
125014072|NCT03099187|449676902|FG001|Double-blind Treatment|Disease progression|1|||
125014073|NCT03099187|449676903|FG002|Double-blind Treatment|Disease progression|0|||
125014074|NCT03099187|449676904|FG003|Double-blind Treatment|Disease progression|0|||
125014075|NCT03099187|449676901|FG000|Double-blind Treatment|Randomization error|0|||
125014076|NCT03099187|449676902|FG001|Double-blind Treatment|Randomization error|2|||
125014077|NCT03099187|449676903|FG002|Double-blind Treatment|Randomization error|0|||
125014078|NCT03099187|449676904|FG003|Double-blind Treatment|Randomization error|0|||
125014079|NCT03099187|449676901|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
125014080|NCT03099187|449676902|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
125014081|NCT03099187|449676903|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
125014082|NCT03099187|449676904|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
125014083|NCT03099187|449676901|FG000|12-month Safety Follow-up|Adverse Event|0|||
125014084|NCT03099187|449676902|FG001|12-month Safety Follow-up|Adverse Event|0|||
125014085|NCT03099187|449676903|FG002|12-month Safety Follow-up|Adverse Event|5|||
125014086|NCT03099187|449676904|FG003|12-month Safety Follow-up|Adverse Event|12|||
125014087|NCT03099187|449676901|FG000|12-month Safety Follow-up|Death|0|||
125014088|NCT03099187|449676902|FG001|12-month Safety Follow-up|Death|0|||
125014089|NCT03099187|449676903|FG002|12-month Safety Follow-up|Death|7|||
125014090|NCT03099187|449676904|FG003|12-month Safety Follow-up|Death|9|||
125014091|NCT03099187|449676901|FG000|12-month Safety Follow-up|Lung transplantation|0|||
125014092|NCT03099187|449676902|FG001|12-month Safety Follow-up|Lung transplantation|0|||
125014093|NCT03099187|449676903|FG002|12-month Safety Follow-up|Lung transplantation|2|||
125014094|NCT03099187|449676904|FG003|12-month Safety Follow-up|Lung transplantation|1|||
125014095|NCT03099187|449676901|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
125014096|NCT03099187|449676902|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
125014097|NCT03099187|449676903|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
125014098|NCT03099187|449676904|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
125014099|NCT03099187|449676901|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
125014100|NCT03099187|449676902|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
125014101|NCT03099187|449676903|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
125014102|NCT03099187|449676904|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
125014103|NCT03099187|449676901|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
125014104|NCT03099187|449676902|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
125014105|NCT03099187|449676903|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
125014106|NCT03099187|449676904|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
125014107|NCT03099187|449676901|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
125014108|NCT03099187|449676902|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
125014109|NCT03099187|449676903|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
125014110|NCT03099187|449676904|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
125014111|NCT01100437|449676905|FG000|Titration/Stabilization|Adverse Event|0|||
125014112|NCT01100437|449676906|FG001|Titration/Stabilization|Adverse Event|0|||
125103655|NCT00111007|450000723|FG000|Active Follow-up|Death|2|||
125103656|NCT00111007|450000724|FG001|Active Follow-up|Death|0|||
125103657|NCT00111007|450000723|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
125103658|NCT00111007|450000724|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
125103659|NCT00111007|450000723|FG000|Long Term Follow-up|Death|34|||
125103660|NCT00111007|450000724|FG001|Long Term Follow-up|Death|39|||
125103661|NCT00111007|450000723|FG000|Long Term Follow-up|Lost to Follow-up|1|||
125103662|NCT00111007|450000724|FG001|Long Term Follow-up|Lost to Follow-up|1|||
125103663|NCT00111007|450000723|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
125103664|NCT00111007|450000724|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
125103665|NCT00111007|450000723|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
125103666|NCT00111007|450000724|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
125103667|NCT00111007|450000723|FG000|Long Term Follow-up|Missing|10|||
125103668|NCT00111007|450000724|FG001|Long Term Follow-up|Missing|3|||
125103669|NCT02380248|450000725|FG000|Overall Study|Lost to Follow-up|11|||
125103670|NCT02380248|450000725|FG000|Overall Study|Withdrawal by Subject|3|||
125103671|NCT00605839|450000726|FG000|Overall Study|Protocol Violation|1|||
125103672|NCT00605839|450000727|FG001|Overall Study|Protocol Violation|0|||
125103673|NCT00605839|450000728|FG002|Overall Study|Protocol Violation|0|||
125103674|NCT01381068|450000729|FG000|Overall Study|Death|1|||
125103675|NCT01381068|450000730|FG001|Overall Study|Death|0|||
125103676|NCT00752895|450000737|FG000|Overall Study|Withdrawal by Subject|8|||
125103677|NCT00752895|450000738|FG001|Overall Study|Withdrawal by Subject|3|||
125103678|NCT00083226|450000739|FG000|Overall Study|Lack of Efficacy|19|||
125103679|NCT00083226|450000739|FG000|Overall Study|Adverse Event|9|||
125103680|NCT00083226|450000739|FG000|Overall Study|Death|4|||
125103681|NCT00083226|450000739|FG000|Overall Study|Withdrawal by Subject|4|||
125103682|NCT00083226|450000739|FG000|Overall Study|Other|2|||
125103683|NCT00083226|450000739|FG000|Overall Study|ineligible or not receiving treatment|4|||
125103684|NCT03443973|450002205|FG000|Double-blind Treatment Period|Adverse Event|5|||
125103685|NCT03443973|450002206|FG001|Double-blind Treatment Period|Adverse Event|19|||
125103686|NCT03443973|450002207|FG002|Double-blind Treatment Period|Adverse Event|0|||
125103687|NCT03443973|450002208|FG003|Double-blind Treatment Period|Adverse Event|0|||
125103688|NCT03443973|450002205|FG000|Double-blind Treatment Period|Death|5|||
125103689|NCT03443973|450002206|FG001|Double-blind Treatment Period|Death|7|||
125103690|NCT03443973|450002207|FG002|Double-blind Treatment Period|Death|0|||
125103691|NCT03443973|450002208|FG003|Double-blind Treatment Period|Death|0|||
125103692|NCT03443973|450002205|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
125103693|NCT03443973|450002206|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
125103694|NCT03443973|450002207|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
125103695|NCT03443973|450002208|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
125103696|NCT03443973|450002205|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
125103697|NCT03443973|450002206|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
125103698|NCT03443973|450002207|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
125103699|NCT03443973|450002208|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
125103700|NCT03443973|450002205|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
125103701|NCT03443973|450002206|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
125103702|NCT03443973|450002207|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
125103703|NCT03443973|450002208|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
125103704|NCT03443973|450002205|FG000|Double-blind Treatment Period|Physician Decision|5|||
125103705|NCT03443973|450002206|FG001|Double-blind Treatment Period|Physician Decision|6|||
125103706|NCT03443973|450002207|FG002|Double-blind Treatment Period|Physician Decision|0|||
125103707|NCT03443973|450002208|FG003|Double-blind Treatment Period|Physician Decision|0|||
125103708|NCT03443973|450002205|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
125103709|NCT03443973|450002206|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
125103710|NCT03443973|450002207|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
125103711|NCT03443973|450002208|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
125103712|NCT03443973|450002205|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
125103713|NCT03443973|450002206|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
125103714|NCT03443973|450002207|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
125103715|NCT03443973|450002208|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
125103716|NCT03443973|450002205|FG000|Open-label Extension Period|Reason Not Specified|0|||
125103717|NCT03443973|450002206|FG001|Open-label Extension Period|Reason Not Specified|0|||
125103718|NCT03443973|450002207|FG002|Open-label Extension Period|Reason Not Specified|3|||
125103719|NCT03443973|450002208|FG003|Open-label Extension Period|Reason Not Specified|0|||
125103720|NCT03443973|450002205|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
125103721|NCT03443973|450002206|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
125103722|NCT03443973|450002207|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
125103723|NCT03443973|450002208|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
125103724|NCT02209454|450002212|FG000|Second Period|Adverse Event|1|||
125103725|NCT02209454|450002213|FG001|Second Period|Adverse Event|0|||
125103726|NCT00366678|450002218|FG000|Infant Series|Withdrawal by Subject|8|||
125103727|NCT00366678|450002219|FG001|Infant Series|Withdrawal by Subject|6|||
125103728|NCT00366678|450002220|FG002|Infant Series|Withdrawal by Subject|0|||
125103729|NCT00366678|450002218|FG000|Infant Series|Protocol Violation|4|||
125103730|NCT00366678|450002219|FG001|Infant Series|Protocol Violation|3|||
125103731|NCT00366678|450002220|FG002|Infant Series|Protocol Violation|0|||
125103732|NCT00366678|450002218|FG000|Infant Series|Failed to return|1|||
125103733|NCT00366678|450002219|FG001|Infant Series|Failed to return|1|||
125103734|NCT00366678|450002220|FG002|Infant Series|Failed to return|0|||
125103735|NCT00366678|450002218|FG000|Infant Series|Adverse Event|1|||
125103736|NCT00366678|450002219|FG001|Infant Series|Adverse Event|0|||
124880298|NCT03285295|449185481|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
124880299|NCT03285295|449185482|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
124880300|NCT03285295|449185483|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
124880301|NCT03285295|449185484|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
124880302|NCT03285295|449185485|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
124880303|NCT03285295|449185481|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
125103737|NCT00366678|450002220|FG002|Infant Series|Adverse Event|0|||
125103738|NCT00366678|450002218|FG000|After Infant|Withdrawal by Subject|8|||
125103739|NCT00366678|450002219|FG001|After Infant|Withdrawal by Subject|4|||
125103740|NCT00366678|450002220|FG002|After Infant|Withdrawal by Subject|0|||
125103741|NCT00366678|450002218|FG000|After Infant|Lost to Follow-up|2|||
124880304|NCT03285295|449185482|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
124880305|NCT03285295|449185483|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
124880306|NCT03285295|449185484|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
124880307|NCT03285295|449185485|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
124880308|NCT03285295|449185481|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
124880309|NCT03285295|449185482|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
124880310|NCT03285295|449185483|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
124880311|NCT03285295|449185484|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
125014113|NCT01100437|449676907|FG002|Titration/Stabilization|Adverse Event|4|||
125014114|NCT01100437|449676905|FG000|Titration/Stabilization|Non-compliance|0|||
125014115|NCT01100437|449676906|FG001|Titration/Stabilization|Non-compliance|0|||
125014116|NCT01100437|449676907|FG002|Titration/Stabilization|Non-compliance|1|||
125014117|NCT01100437|449676905|FG000|Titration/Stabilization|Sponsor canceled study|0|||
125014118|NCT01100437|449676906|FG001|Titration/Stabilization|Sponsor canceled study|0|||
125014119|NCT01100437|449676907|FG002|Titration/Stabilization|Sponsor canceled study|1|||
125014120|NCT01100437|449676905|FG000|Maintenance|Withdrawal by Subject|0|||
125014121|NCT01100437|449676906|FG001|Maintenance|Withdrawal by Subject|0|||
125014122|NCT01100437|449676907|FG002|Maintenance|Withdrawal by Subject|1|||
125014123|NCT01100437|449676905|FG000|Maintenance|Sponsor termination of study|0|||
125014124|NCT01100437|449676906|FG001|Maintenance|Sponsor termination of study|0|||
125014125|NCT01100437|449676907|FG002|Maintenance|Sponsor termination of study|1|||
125014126|NCT00894556|449676910|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
125014127|NCT00894556|449676911|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
125014128|NCT00894556|449676912|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
125014129|NCT00894556|449676913|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
125014130|NCT00894556|449676910|FG000|Treatment Phase|Lost to Follow-up|2|||
125014131|NCT00894556|449676911|FG001|Treatment Phase|Lost to Follow-up|3|||
125014132|NCT00894556|449676912|FG002|Treatment Phase|Lost to Follow-up|1|||
125014133|NCT00894556|449676913|FG003|Treatment Phase|Lost to Follow-up|0|||
125014134|NCT00894556|449676910|FG000|Treatment Phase|Lack of Qualifying Event|2|||
125014135|NCT00894556|449676911|FG001|Treatment Phase|Lack of Qualifying Event|1|||
125014136|NCT00894556|449676912|FG002|Treatment Phase|Lack of Qualifying Event|0|||
125014137|NCT00894556|449676913|FG003|Treatment Phase|Lack of Qualifying Event|0|||
125014138|NCT01439555|449676914|FG000|Overall Study|Protocol Violation|1|||
125014139|NCT03077685|449676917|FG000|Overall Study|Lost to Follow-up|0|||
125014140|NCT03077685|449676918|FG001|Overall Study|Lost to Follow-up|0|||
125014141|NCT03077685|449676919|FG002|Overall Study|Lost to Follow-up|0|||
125014142|NCT03077685|449676920|FG003|Overall Study|Lost to Follow-up|0|||
125014143|NCT03077685|449676921|FG004|Overall Study|Lost to Follow-up|1|||
125014144|NCT03077685|449676917|FG000|Overall Study|Death|0|||
125014145|NCT03077685|449676918|FG001|Overall Study|Death|0|||
125014146|NCT03077685|449676919|FG002|Overall Study|Death|1|||
125014147|NCT03077685|449676920|FG003|Overall Study|Death|1|||
125014148|NCT03077685|449676921|FG004|Overall Study|Death|3|||
125014149|NCT03077685|449676917|FG000|Overall Study|Withdrawal by Subject|0|||
125014150|NCT03077685|449676918|FG001|Overall Study|Withdrawal by Subject|0|||
125014151|NCT03077685|449676919|FG002|Overall Study|Withdrawal by Subject|0|||
125014152|NCT03077685|449676920|FG003|Overall Study|Withdrawal by Subject|2|||
125014153|NCT03077685|449676921|FG004|Overall Study|Withdrawal by Subject|1|||
125014154|NCT03077685|449676917|FG000|Overall Study|Physician Decision|0|||
125014155|NCT03077685|449676918|FG001|Overall Study|Physician Decision|0|||
125014156|NCT03077685|449676919|FG002|Overall Study|Physician Decision|1|||
125014157|NCT03077685|449676920|FG003|Overall Study|Physician Decision|0|||
125014158|NCT03077685|449676921|FG004|Overall Study|Physician Decision|3|||
125014159|NCT03077685|449676917|FG000|Overall Study|Disease Progression|1|||
125103742|NCT00366678|450002219|FG001|After Infant|Lost to Follow-up|1|||
124880312|NCT03285295|449185485|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
124880313|NCT03285295|449185481|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
125014160|NCT03077685|449676918|FG001|Overall Study|Disease Progression|0|||
125014161|NCT03077685|449676919|FG002|Overall Study|Disease Progression|0|||
125014162|NCT03077685|449676920|FG003|Overall Study|Disease Progression|2|||
125014163|NCT03077685|449676921|FG004|Overall Study|Disease Progression|1|||
125014164|NCT03077685|449676917|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
125014165|NCT03077685|449676918|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
125014166|NCT03077685|449676919|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
125014167|NCT03077685|449676920|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
125103743|NCT00366678|450002220|FG002|After Infant|Lost to Follow-up|0|||
125103744|NCT00366678|450002218|FG000|After Infant|Failed to return|5|||
125103745|NCT00366678|450002219|FG001|After Infant|Failed to return|5|||
125103746|NCT00366678|450002220|FG002|After Infant|Failed to return|0|||
125103747|NCT00366678|450002218|FG000|After Infant|Adverse Event|1|||
125103748|NCT00366678|450002219|FG001|After Infant|Adverse Event|0|||
125103749|NCT00366678|450002220|FG002|After Infant|Adverse Event|0|||
125103750|NCT00366678|450002218|FG000|After Infant|Protocol Violation|1|||
125103751|NCT00366678|450002219|FG001|After Infant|Protocol Violation|0|||
125103752|NCT00366678|450002220|FG002|After Infant|Protocol Violation|0|||
125103753|NCT00366678|450002218|FG000|Toddler Dose|Protocol Violation|2|||
125103754|NCT00366678|450002219|FG001|Toddler Dose|Protocol Violation|1|||
125103755|NCT00366678|450002220|FG002|Toddler Dose|Protocol Violation|0|||
124880314|NCT03285295|449185482|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
125103756|NCT00366678|450002218|FG000|Toddler Dose|Failed to return|1|||
125103757|NCT00366678|450002219|FG001|Toddler Dose|Failed to return|0|||
125103758|NCT00366678|450002220|FG002|Toddler Dose|Failed to return|0|||
125103759|NCT00366678|450002218|FG000|Toddler Dose|Withdrawal by Subject|1|||
125103760|NCT00366678|450002219|FG001|Toddler Dose|Withdrawal by Subject|0|||
125103761|NCT00366678|450002220|FG002|Toddler Dose|Withdrawal by Subject|0|||
125103762|NCT00366678|450002218|FG000|Toddler Dose|protocol deviation|1|||
125103763|NCT00366678|450002219|FG001|Toddler Dose|protocol deviation|0|||
125103764|NCT00366678|450002220|FG002|Toddler Dose|protocol deviation|0|||
125103765|NCT04292171|450002221|FG000|Overall Study|Pharmacy error|2|||
125103766|NCT04292171|450002222|FG001|Overall Study|Pharmacy error|0|||
125103767|NCT04292171|450002221|FG000|Overall Study|Delivered prior to procedure|0|||
125103768|NCT04292171|450002222|FG001|Overall Study|Delivered prior to procedure|1|||
125103769|NCT01777191|450002223|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
125103770|NCT01777191|450002224|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
125103771|NCT01777191|450002223|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
125103772|NCT01777191|450002224|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
125103773|NCT01777191|450002223|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
125103774|NCT01777191|450002224|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
125103775|NCT01777191|450002223|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
125103776|NCT01777191|450002224|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
125103777|NCT01777191|450002223|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
125103778|NCT01777191|450002224|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
125103779|NCT01777191|450002223|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
125103780|NCT01777191|450002224|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
125103781|NCT01777191|450002223|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
125103782|NCT01777191|450002224|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
125103783|NCT01777191|450002223|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
125103784|NCT01777191|450002224|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
125103785|NCT01777191|450002223|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
125103786|NCT01777191|450002224|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
125103787|NCT01777191|450002223|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
125103788|NCT01777191|450002224|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
125103789|NCT01777191|450002223|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
125103790|NCT01777191|450002224|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
125103791|NCT00388674|450002232|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
125103792|NCT00388674|450002233|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
125103793|NCT00388674|450002232|FG000|Initial Treatment|Adverse Event|22|||
125103794|NCT00388674|450002233|FG001|Initial Treatment|Adverse Event|87|||
125103795|NCT00388674|450002232|FG000|Initial Treatment|Death|215|||
125103796|NCT00388674|450002233|FG001|Initial Treatment|Death|216|||
125103797|NCT00388674|450002232|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
125103798|NCT00388674|450002233|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
125103799|NCT00388674|450002232|FG000|Initial Treatment|HCC|12|||
125103800|NCT00388674|450002233|FG001|Initial Treatment|HCC|20|||
125103801|NCT00388674|450002232|FG000|Initial Treatment|Lost to Follow-up|526|||
125103802|NCT00388674|450002233|FG001|Initial Treatment|Lost to Follow-up|624|||
125103803|NCT00388674|450002232|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
124880315|NCT03285295|449185483|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
125103804|NCT00388674|450002233|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
125103805|NCT00388674|450002232|FG000|Initial Treatment|Never Treated with Study Medication|1|||
125103806|NCT00388674|450002233|FG001|Initial Treatment|Never Treated with Study Medication|7|||
124880316|NCT03285295|449185484|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
125103807|NCT00388674|450002232|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
125103808|NCT00388674|450002233|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
125103809|NCT00388674|450002232|FG000|Initial Treatment|Not Defined|125|||
125103810|NCT00388674|450002233|FG001|Initial Treatment|Not Defined|172|||
125103811|NCT00388674|450002232|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
125103812|NCT00388674|450002233|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
125103813|NCT00388674|450002232|FG000|Initial Treatment|Pregnancy|26|||
125103814|NCT00388674|450002233|FG001|Initial Treatment|Pregnancy|16|||
125103815|NCT00388674|450002232|FG000|Initial Treatment|Study Drug Toxicity|5|||
125103816|NCT00388674|450002233|FG001|Initial Treatment|Study Drug Toxicity|92|||
125103817|NCT00388674|450002232|FG000|Initial Treatment|Participant Request|501|||
125103818|NCT00388674|450002233|FG001|Initial Treatment|Participant Request|673|||
125103819|NCT00388674|450002232|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
125103820|NCT00388674|450002233|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
125103821|NCT00388674|450002232|FG000|Initial Treatment|Not Reported|10|||
125103822|NCT00388674|450002233|FG001|Initial Treatment|Not Reported|12|||
125103823|NCT00388674|450002232|FG000|End of Study|Administrative Reason By Sponsor|299|||
125103824|NCT00388674|450002233|FG001|End of Study|Administrative Reason By Sponsor|253|||
125103825|NCT00388674|450002232|FG000|End of Study|Death|239|||
125103826|NCT00388674|450002233|FG001|End of Study|Death|262|||
125103827|NCT00388674|450002232|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
125103828|NCT00388674|450002233|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
125103829|NCT00388674|450002232|FG000|End of Study|HCC|8|||
125103830|NCT00388674|450002233|FG001|End of Study|HCC|7|||
125103831|NCT00388674|450002232|FG000|End of Study|Lost to Follow-up|587|||
125103832|NCT00388674|450002233|FG001|End of Study|Lost to Follow-up|715|||
125103833|NCT00388674|450002232|FG000|End of Study|Malignancy (Non-HCC)|1|||
125103834|NCT00388674|450002233|FG001|End of Study|Malignancy (Non-HCC)|1|||
125103835|NCT00388674|450002232|FG000|End of Study|Non-Study Related Comorbidities|3|||
125103836|NCT00388674|450002233|FG001|End of Study|Non-Study Related Comorbidities|4|||
125103837|NCT00388674|450002232|FG000|End of Study|Not Defined|135|||
125103838|NCT00388674|450002233|FG001|End of Study|Not Defined|214|||
125103839|NCT00388674|450002232|FG000|End of Study|Participant Withdrew Consent|437|||
125103840|NCT00388674|450002233|FG001|End of Study|Participant Withdrew Consent|673|||
125103841|NCT00388674|450002232|FG000|End of Study|No Off-Treatment Status Data|22|||
125103842|NCT00388674|450002233|FG001|End of Study|No Off-Treatment Status Data|30|||
125103843|NCT00388674|450002232|FG000|End of Study|Not Reported|0|||
125103844|NCT00388674|450002233|FG001|End of Study|Not Reported|1|||
125103845|NCT00759174|450002234|FG000|Overall Study|Other|0|||
125103846|NCT00759174|450002235|FG001|Overall Study|Other|2|||
125103847|NCT01890109|450002236|FG000|Overall Study|Withdrawal by Subject|0|||
125103848|NCT01890109|450002237|FG001|Overall Study|Withdrawal by Subject|3|||
125103849|NCT01890109|450002236|FG000|Overall Study|Lost to Follow-up|1|||
124880317|NCT03285295|449185485|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
125103850|NCT01890109|450002237|FG001|Overall Study|Lost to Follow-up|2|||
125103851|NCT00568776|450002240|FG000|Overall Study|Adverse Event|8|||
125103852|NCT00568776|450002241|FG001|Overall Study|Adverse Event|8|||
125103853|NCT00568776|450002242|FG002|Overall Study|Adverse Event|10|||
125103854|NCT00568776|450002243|FG003|Overall Study|Adverse Event|8|||
125103855|NCT00568776|450002240|FG000|Overall Study|Death|0|||
125103856|NCT00568776|450002241|FG001|Overall Study|Death|1|||
125103857|NCT00568776|450002242|FG002|Overall Study|Death|4|||
125103858|NCT00568776|450002243|FG003|Overall Study|Death|3|||
125103859|NCT00568776|450002240|FG000|Overall Study|Physician Decision|0|||
125103860|NCT00568776|450002241|FG001|Overall Study|Physician Decision|2|||
125103861|NCT00568776|450002242|FG002|Overall Study|Physician Decision|0|||
125103862|NCT00568776|450002243|FG003|Overall Study|Physician Decision|0|||
125103863|NCT00568776|450002240|FG000|Overall Study|Lack of Efficacy|2|||
125103864|NCT00568776|450002241|FG001|Overall Study|Lack of Efficacy|2|||
125103865|NCT00568776|450002242|FG002|Overall Study|Lack of Efficacy|2|||
125103866|NCT00568776|450002243|FG003|Overall Study|Lack of Efficacy|4|||
125103867|NCT00568776|450002240|FG000|Overall Study|Lost to Follow-up|1|||
125103868|NCT00568776|450002241|FG001|Overall Study|Lost to Follow-up|1|||
125103869|NCT00568776|450002242|FG002|Overall Study|Lost to Follow-up|1|||
125103870|NCT00568776|450002243|FG003|Overall Study|Lost to Follow-up|1|||
125103871|NCT00568776|450002240|FG000|Overall Study|Protocol Violation|1|||
125103872|NCT00568776|450002241|FG001|Overall Study|Protocol Violation|0|||
125103873|NCT00568776|450002242|FG002|Overall Study|Protocol Violation|1|||
125103874|NCT00568776|450002243|FG003|Overall Study|Protocol Violation|1|||
125103875|NCT00568776|450002240|FG000|Overall Study|Withdrawal by Subject|13|||
125103876|NCT00568776|450002241|FG001|Overall Study|Withdrawal by Subject|15|||
125103877|NCT00568776|450002242|FG002|Overall Study|Withdrawal by Subject|13|||
125103878|NCT00568776|450002243|FG003|Overall Study|Withdrawal by Subject|7|||
124880318|NCT03285295|449185481|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
124880319|NCT03285295|449185482|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
125014168|NCT03077685|449676921|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
125103879|NCT00568776|450002240|FG000|Overall Study|Loss of Caregiver|0|||
125103880|NCT00568776|450002241|FG001|Overall Study|Loss of Caregiver|2|||
125103881|NCT00568776|450002242|FG002|Overall Study|Loss of Caregiver|1|||
125103882|NCT00568776|450002243|FG003|Overall Study|Loss of Caregiver|2|||
125103883|NCT00568776|450002240|FG000|Overall Study|Sponsor Decision|2|||
125103884|NCT00568776|450002241|FG001|Overall Study|Sponsor Decision|2|||
125103885|NCT00568776|450002242|FG002|Overall Study|Sponsor Decision|41|||
125103886|NCT00568776|450002243|FG003|Overall Study|Sponsor Decision|42|||
125103887|NCT00568776|450002240|FG000|Overall Study|Miscellaeneous|3|||
125103888|NCT00568776|450002241|FG001|Overall Study|Miscellaeneous|3|||
125103889|NCT00568776|450002242|FG002|Overall Study|Miscellaeneous|1|||
125103890|NCT00568776|450002243|FG003|Overall Study|Miscellaeneous|4|||
125103891|NCT00996632|450002244|FG000|Overall Study|Physician Decision|0|||
125103892|NCT00996632|450002245|FG001|Overall Study|Physician Decision|0|||
125103893|NCT02861534|450002248|FG000|Overall Study|Death|541|||
125103894|NCT02861534|450002249|FG001|Overall Study|Death|552|||
125103895|NCT02861534|450002248|FG000|Overall Study|Lost to Follow-up|14|||
125103896|NCT02861534|450002249|FG001|Overall Study|Lost to Follow-up|14|||
125103897|NCT02861534|450002248|FG000|Overall Study|Site Terminated by Sponsor|4|||
125103898|NCT02861534|450002249|FG001|Overall Study|Site Terminated by Sponsor|3|||
125103899|NCT02861534|450002248|FG000|Overall Study|Withdrawal by Subject|15|||
125103900|NCT02861534|450002249|FG001|Overall Study|Withdrawal by Subject|18|||
125103901|NCT02780115|450002250|FG000|Overall Study|Withdrawal by Subject|0|||
125103902|NCT02780115|450002251|FG001|Overall Study|Withdrawal by Subject|1|||
125103903|NCT02780115|450002252|FG002|Overall Study|Withdrawal by Subject|1|||
125103904|NCT02780115|450002253|FG003|Overall Study|Withdrawal by Subject|0|||
125103905|NCT02780115|450002254|FG004|Overall Study|Withdrawal by Subject|0|||
125103906|NCT02780115|450002250|FG000|Overall Study|Adverse Event|0|||
125103907|NCT02780115|450002251|FG001|Overall Study|Adverse Event|0|||
125103908|NCT02780115|450002252|FG002|Overall Study|Adverse Event|0|||
125103909|NCT02780115|450002253|FG003|Overall Study|Adverse Event|1|||
125103910|NCT02780115|450002254|FG004|Overall Study|Adverse Event|1|||
125014169|NCT03077685|449676917|FG000|Overall Study|Subject entered hospice care|0|||
125014170|NCT03077685|449676918|FG001|Overall Study|Subject entered hospice care|0|||
125014171|NCT03077685|449676919|FG002|Overall Study|Subject entered hospice care|0|||
125014172|NCT03077685|449676920|FG003|Overall Study|Subject entered hospice care|0|||
125014173|NCT03077685|449676921|FG004|Overall Study|Subject entered hospice care|1|||
125014174|NCT01246583|449676927|FG000|Overall Study|Lost to Follow-up|0|||
125014175|NCT01246583|449676928|FG001|Overall Study|Lost to Follow-up|0|||
125014176|NCT01246583|449676929|FG002|Overall Study|Lost to Follow-up|0|||
125014177|NCT01246583|449676930|FG003|Overall Study|Lost to Follow-up|1|||
125103911|NCT01179191|450002255|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
125014178|NCT01246583|449676927|FG000|Overall Study|Protocol Violation|0|||
125014179|NCT01246583|449676928|FG001|Overall Study|Protocol Violation|0|||
125014180|NCT01246583|449676929|FG002|Overall Study|Protocol Violation|1|||
125014181|NCT01246583|449676930|FG003|Overall Study|Protocol Violation|0|||
125014182|NCT01246583|449676927|FG000|Overall Study|Withdrawal by Subject|1|||
125014183|NCT01246583|449676928|FG001|Overall Study|Withdrawal by Subject|0|||
125014184|NCT01246583|449676929|FG002|Overall Study|Withdrawal by Subject|0|||
125014185|NCT01246583|449676930|FG003|Overall Study|Withdrawal by Subject|0|||
125014186|NCT01806779|449676934|FG000|Overall Study|Physician Decision|2|||
125014187|NCT01806779|449676935|FG001|Overall Study|Physician Decision|0|||
125014188|NCT01806779|449676936|FG002|Overall Study|Physician Decision|1|||
125014189|NCT01806779|449676934|FG000|Overall Study|Lack of Efficacy|1|||
125014190|NCT01806779|449676935|FG001|Overall Study|Lack of Efficacy|1|||
125014191|NCT01806779|449676936|FG002|Overall Study|Lack of Efficacy|0|||
125014192|NCT01806779|449676934|FG000|Overall Study|Lost to Follow-up|19|||
125014193|NCT01806779|449676935|FG001|Overall Study|Lost to Follow-up|20|||
125014194|NCT01806779|449676936|FG002|Overall Study|Lost to Follow-up|0|||
124880320|NCT03285295|449185483|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
124880321|NCT03285295|449185484|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
124880322|NCT03285295|449185485|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
125014195|NCT01806779|449676934|FG000|Overall Study|Withdrawal by Subject|20|||
125014196|NCT01806779|449676935|FG001|Overall Study|Withdrawal by Subject|23|||
125014197|NCT01806779|449676936|FG002|Overall Study|Withdrawal by Subject|22|||
125014198|NCT04294901|449676939|FG000|Overall Study|Death|86|||
125014199|NCT04294901|449676940|FG001|Overall Study|Death|110|||
125014200|NCT04294901|449676939|FG000|Overall Study|Provider did not have historical control patients|581|||
125014201|NCT04294901|449676940|FG001|Overall Study|Provider did not have historical control patients|0|||
125014202|NCT04294901|449676939|FG000|Overall Study|Provider did not have intervention patients|0|||
125014203|NCT04294901|449676940|FG001|Overall Study|Provider did not have intervention patients|98|||
125014204|NCT04218201|449678713|FG000|Overall Study|Death|0|||
125014205|NCT04218201|449678714|FG001|Overall Study|Death|0|||
125014206|NCT04218201|449678715|FG002|Overall Study|Death|2|||
125014207|NCT04218201|449678716|FG003|Overall Study|Death|0|||
125014208|NCT04218201|449678713|FG000|Overall Study|Unable to contact participant|4|||
125014209|NCT04218201|449678714|FG001|Overall Study|Unable to contact participant|0|||
125014210|NCT04218201|449678715|FG002|Overall Study|Unable to contact participant|3|||
125014211|NCT04218201|449678716|FG003|Overall Study|Unable to contact participant|0|||
125014212|NCT04218201|449678713|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
125014213|NCT04218201|449678714|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
125014214|NCT04218201|449678715|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
125014215|NCT04218201|449678716|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
125014216|NCT04218201|449678713|FG000|Overall Study|Withdrawal by Subject|2|||
125014217|NCT04218201|449678714|FG001|Overall Study|Withdrawal by Subject|0|||
125014218|NCT04218201|449678715|FG002|Overall Study|Withdrawal by Subject|0|||
125014219|NCT04218201|449678716|FG003|Overall Study|Withdrawal by Subject|0|||
125014220|NCT04218201|449678713|FG000|Overall Study|PCP plans to leave practice|0|||
125014221|NCT04218201|449678714|FG001|Overall Study|PCP plans to leave practice|8|||
125014222|NCT04218201|449678715|FG002|Overall Study|PCP plans to leave practice|0|||
125014223|NCT04218201|449678716|FG003|Overall Study|PCP plans to leave practice|5|||
125014224|NCT04218201|449678713|FG000|Overall Study|Reduced panel|0|||
125014225|NCT04218201|449678714|FG001|Overall Study|Reduced panel|0|||
125014226|NCT04218201|449678715|FG002|Overall Study|Reduced panel|0|||
125014227|NCT04218201|449678716|FG003|Overall Study|Reduced panel|1|||
125014228|NCT04218201|449678713|FG000|Overall Study|No longer interested in participating|0|||
125014229|NCT04218201|449678714|FG001|Overall Study|No longer interested in participating|1|||
125014230|NCT04218201|449678715|FG002|Overall Study|No longer interested in participating|0|||
125014231|NCT04218201|449678716|FG003|Overall Study|No longer interested in participating|0|||
124880323|NCT03285295|449185481|FG000|Alinity s Anti-HBc|No Results Generated|70|||
125103912|NCT01179191|450002255|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
125103913|NCT01179191|450002255|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
125103914|NCT01179191|450002255|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
125103915|NCT01179191|450002255|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
125103916|NCT01179191|450002255|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
125103917|NCT01179191|450002255|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
125103918|NCT01179191|450002255|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
125103919|NCT01179191|450002255|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
125103920|NCT01179191|450002255|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
125103921|NCT01179191|450002255|FG000|Maintenance Phase (8 Weeks)|Other|66|||
125103922|NCT00916617|450002256|FG000|Overall Study|Adverse Event|3|||
125103923|NCT00916617|450002257|FG001|Overall Study|Adverse Event|2|||
125103924|NCT00916617|450002258|FG002|Overall Study|Adverse Event|6|||
125103925|NCT00916617|450002259|FG003|Overall Study|Adverse Event|3|||
125103926|NCT00916617|450002256|FG000|Overall Study|Withdrawal by Subject|3|||
125103927|NCT00916617|450002257|FG001|Overall Study|Withdrawal by Subject|2|||
125103928|NCT00916617|450002258|FG002|Overall Study|Withdrawal by Subject|0|||
125103929|NCT00916617|450002259|FG003|Overall Study|Withdrawal by Subject|1|||
125103930|NCT00916617|450002256|FG000|Overall Study|Caregiver Request|3|||
125103931|NCT00916617|450002257|FG001|Overall Study|Caregiver Request|2|||
125103932|NCT00916617|450002258|FG002|Overall Study|Caregiver Request|1|||
125103933|NCT00916617|450002259|FG003|Overall Study|Caregiver Request|0|||
125103934|NCT00916617|450002256|FG000|Overall Study|Physician Decision|1|||
125103935|NCT00916617|450002257|FG001|Overall Study|Physician Decision|1|||
125103936|NCT00916617|450002258|FG002|Overall Study|Physician Decision|0|||
125103937|NCT00916617|450002259|FG003|Overall Study|Physician Decision|0|||
125103938|NCT00916617|450002256|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
125103939|NCT00916617|450002257|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
125103940|NCT00916617|450002258|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
125103941|NCT00916617|450002259|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
125103942|NCT00916617|450002256|FG000|Overall Study|Lost to Follow-up|2|||
125103943|NCT00916617|450002257|FG001|Overall Study|Lost to Follow-up|1|||
125103944|NCT00916617|450002258|FG002|Overall Study|Lost to Follow-up|0|||
125103945|NCT00916617|450002259|FG003|Overall Study|Lost to Follow-up|0|||
125103946|NCT00916617|450002256|FG000|Overall Study|Lack of Efficacy|1|||
125103947|NCT00916617|450002257|FG001|Overall Study|Lack of Efficacy|0|||
125103948|NCT00916617|450002258|FG002|Overall Study|Lack of Efficacy|0|||
125103949|NCT00916617|450002259|FG003|Overall Study|Lack of Efficacy|0|||
125103950|NCT00916617|450002256|FG000|Overall Study|Other|2|||
125103951|NCT00916617|450002257|FG001|Overall Study|Other|0|||
125103952|NCT00916617|450002258|FG002|Overall Study|Other|0|||
125103953|NCT00916617|450002259|FG003|Overall Study|Other|2|||
125103954|NCT01988337|450002262|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
125103955|NCT00556166|450002270|FG000|Overall Study|Withdrawal by Subject|1|||
125103956|NCT03466060|450002271|FG000|Period 1|Test Lens Damage|0|||
125103957|NCT03466060|450002272|FG001|Period 1|Test Lens Damage|2|||
125103958|NCT03466060|450002273|FG002|Period 1|Test Lens Damage|0|||
125103959|NCT03466060|450002274|FG003|Period 1|Test Lens Damage|0|||
124880324|NCT03285295|449185482|FG001|Alinity s Anti-HBc|No Results Generated|0|||
124880325|NCT03285295|449185483|FG002|Alinity s Anti-HBc|No Results Generated|0|||
125103960|NCT03466060|450002275|FG004|Period 1|Test Lens Damage|0|||
125103961|NCT03466060|450002276|FG005|Period 1|Test Lens Damage|0|||
125103962|NCT03466060|450002271|FG000|Period 1|Withdrawal by Subject|0|||
125103963|NCT03466060|450002272|FG001|Period 1|Withdrawal by Subject|0|||
125103964|NCT03466060|450002273|FG002|Period 1|Withdrawal by Subject|2|||
125103965|NCT03466060|450002274|FG003|Period 1|Withdrawal by Subject|0|||
125103966|NCT03466060|450002275|FG004|Period 1|Withdrawal by Subject|0|||
125103967|NCT03466060|450002276|FG005|Period 1|Withdrawal by Subject|0|||
125103968|NCT03466060|450002271|FG000|Period 1|Lost to Follow-up|0|||
125103969|NCT03466060|450002272|FG001|Period 1|Lost to Follow-up|0|||
125103970|NCT03466060|450002273|FG002|Period 1|Lost to Follow-up|0|||
125103971|NCT03466060|450002274|FG003|Period 1|Lost to Follow-up|1|||
125103972|NCT03466060|450002275|FG004|Period 1|Lost to Follow-up|0|||
125103973|NCT03466060|450002276|FG005|Period 1|Lost to Follow-up|0|||
125103974|NCT03466060|450002271|FG000|Period 1|Grade 2 Conjunctivitis|0|||
125103975|NCT03466060|450002272|FG001|Period 1|Grade 2 Conjunctivitis|0|||
125103976|NCT03466060|450002273|FG002|Period 1|Grade 2 Conjunctivitis|1|||
125103977|NCT03466060|450002274|FG003|Period 1|Grade 2 Conjunctivitis|0|||
125103978|NCT03466060|450002275|FG004|Period 1|Grade 2 Conjunctivitis|0|||
125103979|NCT03466060|450002276|FG005|Period 1|Grade 2 Conjunctivitis|0|||
125103980|NCT03466060|450002271|FG000|Period 2|Lens Handling Difficulties|0|||
125103981|NCT03466060|450002272|FG001|Period 2|Lens Handling Difficulties|0|||
125103982|NCT03466060|450002273|FG002|Period 2|Lens Handling Difficulties|1|||
125103983|NCT03466060|450002274|FG003|Period 2|Lens Handling Difficulties|0|||
125103984|NCT03466060|450002275|FG004|Period 2|Lens Handling Difficulties|0|||
125103985|NCT03466060|450002276|FG005|Period 2|Lens Handling Difficulties|0|||
125103986|NCT01612780|450002277|FG000|Overall Study|Treatment not completed|1|||
125103987|NCT01612780|450002277|FG000|Overall Study|Withdrawal by Subject|5|||
125103988|NCT03345485|450002280|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
125103989|NCT03345485|450002281|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
125103990|NCT03345485|450002282|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
125103991|NCT03345485|450002283|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
125014232|NCT03723707|449678723|FG000|Overall Study|Death|32|||
125014233|NCT03723707|449678724|FG001|Overall Study|Death|32|||
125014234|NCT03723707|449678723|FG000|Overall Study|Admitted to long term care|12|||
125014235|NCT03723707|449678724|FG001|Overall Study|Admitted to long term care|12|||
125014236|NCT03723707|449678723|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
125014237|NCT03723707|449678724|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
125014238|NCT03723707|449678723|FG000|Overall Study|Lost to Follow-up|40|||
125014239|NCT03723707|449678724|FG001|Overall Study|Lost to Follow-up|22|||
125014240|NCT03723707|449678723|FG000|Overall Study|Discontinued after study closure|24|||
125014241|NCT03723707|449678724|FG001|Overall Study|Discontinued after study closure|12|||
125014242|NCT05121480|449678725|FG000|Overall Study|Lack of Efficacy|2|||
125014243|NCT05121480|449678726|FG001|Overall Study|Lack of Efficacy|2|||
125014244|NCT05121480|449678727|FG002|Overall Study|Lack of Efficacy|1|||
125014245|NCT05121480|449678728|FG003|Overall Study|Lack of Efficacy|4|||
125014246|NCT05121480|449678729|FG004|Overall Study|Lack of Efficacy|0|||
125014247|NCT05121480|449678730|FG005|Overall Study|Lack of Efficacy|1|||
125014248|NCT05121480|449678731|FG006|Overall Study|Lack of Efficacy|0|||
125014249|NCT05121480|449678732|FG007|Overall Study|Lack of Efficacy|2|||
125014250|NCT05121480|449678725|FG000|Overall Study|Treatment Failure|0|||
125014251|NCT05121480|449678726|FG001|Overall Study|Treatment Failure|2|||
125014252|NCT05121480|449678727|FG002|Overall Study|Treatment Failure|0|||
125014253|NCT05121480|449678728|FG003|Overall Study|Treatment Failure|1|||
125014254|NCT05121480|449678729|FG004|Overall Study|Treatment Failure|0|||
125014255|NCT05121480|449678730|FG005|Overall Study|Treatment Failure|0|||
125014256|NCT05121480|449678731|FG006|Overall Study|Treatment Failure|0|||
125014257|NCT05121480|449678732|FG007|Overall Study|Treatment Failure|0|||
125014258|NCT05121480|449678725|FG000|Overall Study|Adverse Event|0|||
125014259|NCT05121480|449678726|FG001|Overall Study|Adverse Event|1|||
125014260|NCT05121480|449678727|FG002|Overall Study|Adverse Event|0|||
125014261|NCT05121480|449678728|FG003|Overall Study|Adverse Event|5|||
125014262|NCT05121480|449678729|FG004|Overall Study|Adverse Event|3|||
125014263|NCT05121480|449678730|FG005|Overall Study|Adverse Event|2|||
125014264|NCT05121480|449678731|FG006|Overall Study|Adverse Event|0|||
125014265|NCT05121480|449678732|FG007|Overall Study|Adverse Event|4|||
125014266|NCT05121480|449678725|FG000|Overall Study|Withdrawal by Subject|4|||
125014267|NCT05121480|449678726|FG001|Overall Study|Withdrawal by Subject|9|||
125014268|NCT05121480|449678727|FG002|Overall Study|Withdrawal by Subject|1|||
125014269|NCT05121480|449678728|FG003|Overall Study|Withdrawal by Subject|8|||
125014270|NCT05121480|449678729|FG004|Overall Study|Withdrawal by Subject|0|||
125014271|NCT05121480|449678730|FG005|Overall Study|Withdrawal by Subject|9|||
125014272|NCT05121480|449678731|FG006|Overall Study|Withdrawal by Subject|0|||
125014273|NCT05121480|449678732|FG007|Overall Study|Withdrawal by Subject|4|||
125014274|NCT05121480|449678725|FG000|Overall Study|Non-compliance with the protocol|0|||
125014275|NCT05121480|449678726|FG001|Overall Study|Non-compliance with the protocol|0|||
125014276|NCT05121480|449678727|FG002|Overall Study|Non-compliance with the protocol|0|||
125014277|NCT05121480|449678728|FG003|Overall Study|Non-compliance with the protocol|0|||
125014278|NCT05121480|449678729|FG004|Overall Study|Non-compliance with the protocol|1|||
125014279|NCT05121480|449678730|FG005|Overall Study|Non-compliance with the protocol|6|||
125014280|NCT05121480|449678731|FG006|Overall Study|Non-compliance with the protocol|0|||
125014281|NCT05121480|449678732|FG007|Overall Study|Non-compliance with the protocol|1|||
125103992|NCT03345485|450002284|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
125014282|NCT05121480|449678725|FG000|Overall Study|Lost to Follow-up|0|||
125014283|NCT05121480|449678726|FG001|Overall Study|Lost to Follow-up|4|||
125014284|NCT05121480|449678727|FG002|Overall Study|Lost to Follow-up|1|||
125014285|NCT05121480|449678728|FG003|Overall Study|Lost to Follow-up|3|||
125014286|NCT05121480|449678729|FG004|Overall Study|Lost to Follow-up|1|||
125014287|NCT05121480|449678730|FG005|Overall Study|Lost to Follow-up|1|||
125014288|NCT05121480|449678731|FG006|Overall Study|Lost to Follow-up|1|||
125014289|NCT05121480|449678732|FG007|Overall Study|Lost to Follow-up|4|||
125014290|NCT05121480|449678725|FG000|Overall Study|Physician Decision|0|||
125014291|NCT05121480|449678726|FG001|Overall Study|Physician Decision|0|||
125014292|NCT05121480|449678727|FG002|Overall Study|Physician Decision|0|||
125014293|NCT05121480|449678728|FG003|Overall Study|Physician Decision|0|||
125014294|NCT05121480|449678729|FG004|Overall Study|Physician Decision|0|||
125014295|NCT05121480|449678730|FG005|Overall Study|Physician Decision|1|||
125014296|NCT05121480|449678731|FG006|Overall Study|Physician Decision|0|||
125014297|NCT05121480|449678732|FG007|Overall Study|Physician Decision|1|||
125014298|NCT05121480|449678725|FG000|Overall Study|Other Reason|0|||
125014299|NCT05121480|449678726|FG001|Overall Study|Other Reason|0|||
125014300|NCT05121480|449678727|FG002|Overall Study|Other Reason|0|||
125014301|NCT05121480|449678728|FG003|Overall Study|Other Reason|0|||
125014302|NCT05121480|449678729|FG004|Overall Study|Other Reason|0|||
125014303|NCT05121480|449678730|FG005|Overall Study|Other Reason|1|||
125014304|NCT05121480|449678731|FG006|Overall Study|Other Reason|1|||
125014305|NCT05121480|449678732|FG007|Overall Study|Other Reason|1|||
125014306|NCT02831673|449678735|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
125014307|NCT02831673|449678736|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
125014308|NCT02831673|449678737|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
125103993|NCT03345485|450002285|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
125103994|NCT03345485|450002286|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
125103995|NCT03345485|450002287|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
125103996|NCT03345485|450002288|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
125103997|NCT03345485|450002289|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
125103998|NCT03345485|450002290|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
125103999|NCT03345485|450002291|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
125104000|NCT03345485|450002292|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
125104001|NCT02985515|450002293|FG000|Olfaction Testing|Lost to Follow-up|0|||
125104002|NCT02985515|450002294|FG001|Olfaction Testing|Lost to Follow-up|5|||
125104003|NCT02985515|450002293|FG000|Olfaction Testing|Protocol Violation|0|||
125104004|NCT02985515|450002294|FG001|Olfaction Testing|Protocol Violation|3|||
125104005|NCT03972709|450002300|FG000|Overall Study|Withdrawal by Subject|18|||
125104006|NCT03972709|450002301|FG001|Overall Study|Withdrawal by Subject|7|||
125104007|NCT03972709|450002302|FG002|Overall Study|Withdrawal by Subject|14|||
125104008|NCT03972709|450002300|FG000|Overall Study|Study Terminated by Sponsor|48|||
125104009|NCT03972709|450002301|FG001|Overall Study|Study Terminated by Sponsor|25|||
125104010|NCT03972709|450002302|FG002|Overall Study|Study Terminated by Sponsor|50|||
125104011|NCT03972709|450002300|FG000|Overall Study|Physician Decision|1|||
125104012|NCT03972709|450002301|FG001|Overall Study|Physician Decision|0|||
125104013|NCT03972709|450002302|FG002|Overall Study|Physician Decision|0|||
125104014|NCT03972709|450002300|FG000|Overall Study|COVID-19|0|||
125104015|NCT03972709|450002301|FG001|Overall Study|COVID-19|1|||
125104016|NCT03972709|450002302|FG002|Overall Study|COVID-19|1|||
125104017|NCT03972709|450002300|FG000|Overall Study|Lost to Follow-up|6|||
125104018|NCT03972709|450002301|FG001|Overall Study|Lost to Follow-up|1|||
124880326|NCT03285295|449185484|FG003|Alinity s Anti-HBc|No Results Generated|0|||
125014309|NCT02831673|449678738|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
125014310|NCT02831673|449678739|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
125014311|NCT02831673|449678735|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
125014312|NCT02831673|449678736|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
125014313|NCT02831673|449678737|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
125014314|NCT02831673|449678738|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
125104019|NCT03972709|450002302|FG002|Overall Study|Lost to Follow-up|2|||
125104020|NCT03972709|450002300|FG000|Overall Study|Death|5|||
125104021|NCT03972709|450002301|FG001|Overall Study|Death|1|||
125104022|NCT03972709|450002302|FG002|Overall Study|Death|4|||
125104023|NCT03972709|450002300|FG000|Overall Study|Adverse Event|3|||
125104024|NCT03972709|450002301|FG001|Overall Study|Adverse Event|1|||
125104025|NCT03972709|450002302|FG002|Overall Study|Adverse Event|4|||
125104026|NCT03972709|450002300|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
125104027|NCT03972709|450002301|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
125104028|NCT03972709|450002302|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
125104029|NCT03972709|450002300|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
125104030|NCT03972709|450002301|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
125104031|NCT03972709|450002302|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
125104032|NCT03972709|450002300|FG000|Overall Study|Subject Unable to be Contacted|0|||
125104033|NCT03972709|450002301|FG001|Overall Study|Subject Unable to be Contacted|1|||
125104034|NCT03972709|450002302|FG002|Overall Study|Subject Unable to be Contacted|0|||
125104035|NCT03972709|450002300|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
125104036|NCT03972709|450002301|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
125104037|NCT03972709|450002302|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
125104038|NCT03972709|450002300|FG000|Overall Study|Subject Moved|0|||
125104039|NCT03972709|450002301|FG001|Overall Study|Subject Moved|1|||
125104040|NCT03972709|450002302|FG002|Overall Study|Subject Moved|0|||
125104041|NCT03972709|450002300|FG000|Overall Study|Missed Study Visits|1|||
125104042|NCT03972709|450002301|FG001|Overall Study|Missed Study Visits|0|||
125104043|NCT03972709|450002302|FG002|Overall Study|Missed Study Visits|0|||
125104044|NCT01339000|450002305|FG000|Overall Study|study closed due to lack of drug supply|1|||
125104045|NCT01339000|450002306|FG001|Overall Study|study closed due to lack of drug supply|0|||
125104046|NCT00938015|450002308|FG000|Overall Study|Death|2|||
125104047|NCT00938015|450002308|FG000|Overall Study|Lost to Follow-up|32|||
125104048|NCT00938015|450002308|FG000|Overall Study|Adverse Event|32|||
125104049|NCT00938015|450002308|FG000|Overall Study|Non-responder|52|||
125104050|NCT00938015|450002308|FG000|Overall Study|Reason not related to Etanercept|29|||
125104051|NCT02341482|450002309|FG000|Overall Study|Adverse Event|1|||
125104052|NCT00834366|450002312|FG000|Treatment Period 1|Adverse Event|1|||
125104053|NCT00834366|450002313|FG001|Treatment Period 1|Adverse Event|1|||
125104054|NCT00090259|450002314|FG000|Overall Study|Lost to Follow-up|30|||
125104055|NCT00090259|450002315|FG001|Overall Study|Lost to Follow-up|26|||
125104056|NCT00090259|450002314|FG000|Overall Study|Withdrawal by Subject|21|||
125104057|NCT00090259|450002315|FG001|Overall Study|Withdrawal by Subject|15|||
125104058|NCT00090259|450002314|FG000|Overall Study|Investigator site closed|11|||
125104059|NCT00090259|450002315|FG001|Overall Study|Investigator site closed|7|||
125104060|NCT00960687|450002318|FG000|Washout Period of 7 Days|Adverse Event|3|||
125104061|NCT00960687|450002319|FG001|Washout Period of 7 Days|Adverse Event|2|||
125104062|NCT00960687|450002318|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
125104063|NCT00960687|450002319|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
125104064|NCT00285012|450002320|FG000|Assigned to Study Treatment (Tx)|Other|2|||
125104065|NCT00285012|450002321|FG001|Assigned to Study Treatment (Tx)|Other|3|||
125104066|NCT00285012|450002320|FG000|Received Study Tx|Death|2|||
125104067|NCT00285012|450002321|FG001|Received Study Tx|Death|1|||
125104068|NCT00285012|450002320|FG000|Received Study Tx|Adverse Event|5|||
125104069|NCT00285012|450002321|FG001|Received Study Tx|Adverse Event|11|||
125104070|NCT00285012|450002320|FG000|Received Study Tx|Lack of Efficacy|0|||
125104071|NCT00285012|450002321|FG001|Received Study Tx|Lack of Efficacy|3|||
125104072|NCT00285012|450002320|FG000|Received Study Tx|Lost to Follow-up|29|||
125104073|NCT00285012|450002321|FG001|Received Study Tx|Lost to Follow-up|31|||
125104074|NCT00285012|450002320|FG000|Received Study Tx|Withdrawal by Subject|31|||
125104075|NCT00285012|450002321|FG001|Received Study Tx|Withdrawal by Subject|43|||
125104076|NCT00285012|450002320|FG000|Received Study Tx|Other|5|||
125104077|NCT00285012|450002321|FG001|Received Study Tx|Other|5|||
125104078|NCT02873195|450002322|FG000|Overall Study|Ineligible|5|||
125104079|NCT02873195|450002323|FG001|Overall Study|Ineligible|0|||
125104080|NCT05004181|450002324|FG000|Overall Study|Withdrawal of consent|0|||
125104081|NCT05004181|450002325|FG001|Overall Study|Withdrawal of consent|0|||
125104082|NCT05004181|450002326|FG002|Overall Study|Withdrawal of consent|1|||
125104083|NCT05004181|450002327|FG003|Overall Study|Withdrawal of consent|3|||
125104084|NCT05004181|450002328|FG004|Overall Study|Withdrawal of consent|3|||
124880327|NCT03285295|449185485|FG004|Alinity s Anti-HBc|No Results Generated|0|||
124880328|NCT03285295|449185481|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
125014315|NCT02831673|449678739|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
125014316|NCT02831673|449678735|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
125014317|NCT02831673|449678736|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
125014318|NCT02831673|449678737|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
125014319|NCT02831673|449678738|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
125014320|NCT02831673|449678739|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
125014321|NCT02831673|449678735|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
125014322|NCT02831673|449678736|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
125014323|NCT02831673|449678737|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
125014324|NCT02831673|449678738|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
124880329|NCT03285295|449185482|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
124880330|NCT03285295|449185483|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
124880331|NCT03285295|449185484|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
124880332|NCT03285295|449185485|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
124880333|NCT03285295|449185481|FG000|Alinity s Chagas|Protocol Violation|76|||
124880334|NCT03285295|449185482|FG001|Alinity s Chagas|Protocol Violation|0|||
124880335|NCT03285295|449185483|FG002|Alinity s Chagas|Protocol Violation|0|||
124880336|NCT03285295|449185484|FG003|Alinity s Chagas|Protocol Violation|0|||
124880337|NCT03285295|449185485|FG004|Alinity s Chagas|Protocol Violation|0|||
124880338|NCT03285295|449185481|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
124880339|NCT03285295|449185482|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
124880340|NCT03285295|449185483|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
124880341|NCT03285295|449185484|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
124880342|NCT03285295|449185485|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
124880343|NCT03285295|449185481|FG000|Alinity s Chagas|No Results Generated|105|||
124880344|NCT03285295|449185482|FG001|Alinity s Chagas|No Results Generated|0|||
124880345|NCT03285295|449185483|FG002|Alinity s Chagas|No Results Generated|0|||
124880346|NCT03285295|449185484|FG003|Alinity s Chagas|No Results Generated|0|||
124880347|NCT03285295|449185485|FG004|Alinity s Chagas|No Results Generated|0|||
124880348|NCT03285295|449185481|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
124880349|NCT03285295|449185482|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
124880350|NCT03285295|449185483|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
124880351|NCT03285295|449185484|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
124880352|NCT03285295|449185485|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
124880353|NCT02746575|449185486|FG000|Overall Study|Surgery cancelled or time chaned|13|||
124880354|NCT02746575|449185486|FG000|Overall Study|Received epidural|10|||
124880355|NCT02746575|449185486|FG000|Overall Study|Withdrawal by Subject|3|||
124880356|NCT02746575|449185486|FG000|Overall Study|Bradycardia/hypotension|9|||
124880357|NCT02746575|449185486|FG000|Overall Study|Study paused|8|||
124880358|NCT02746575|449185486|FG000|Overall Study|put on beta-blocker|3|||
124880359|NCT02746575|449185486|FG000|Overall Study|type of surgery|1|||
124880360|NCT02746575|449185486|FG000|Overall Study|typ of surgery|1|||
124880361|NCT02746575|449185486|FG000|Overall Study|PI unavailable|1|||
124880362|NCT02746575|449185486|FG000|Overall Study|Unknown history of CVA|1|||
124880363|NCT00957931|449185488|FG000|Overall Study|Death|4|||
124880364|NCT00857805|449185489|FG000|Overall Study|Withdrawal by Subject|1|||
124880365|NCT00857805|449185490|FG001|Overall Study|Withdrawal by Subject|1|||
124880366|NCT04867785|449185491|FG000|Overall Study|Adverse Event|1|||
125014325|NCT02831673|449678739|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
125014326|NCT02831673|449678735|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
125014327|NCT02831673|449678736|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
125014328|NCT02831673|449678737|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
125014329|NCT02831673|449678738|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
125014330|NCT02831673|449678739|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
125014331|NCT02831673|449678735|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
125014332|NCT02831673|449678736|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
125014333|NCT02831673|449678737|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
125014334|NCT02831673|449678738|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
125014335|NCT02831673|449678739|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
125014336|NCT02831673|449678735|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
125014337|NCT02831673|449678736|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
125014338|NCT02831673|449678737|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
125014339|NCT02831673|449678738|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
125014340|NCT02831673|449678739|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
125014341|NCT02831673|449678735|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
125014342|NCT02831673|449678736|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
125014343|NCT02831673|449678737|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
125014344|NCT02831673|449678738|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
124880367|NCT04867785|449185492|FG001|Overall Study|Adverse Event|0|||
124880368|NCT04867785|449185493|FG002|Overall Study|Adverse Event|1|||
124880369|NCT04867785|449185494|FG003|Overall Study|Adverse Event|0|||
124880370|NCT04867785|449185495|FG004|Overall Study|Adverse Event|0|||
124880371|NCT04867785|449185496|FG005|Overall Study|Adverse Event|0|||
124880372|NCT04867785|449185497|FG006|Overall Study|Adverse Event|0|||
124880373|NCT04867785|449185498|FG007|Overall Study|Adverse Event|2|||
124880374|NCT04867785|449185491|FG000|Overall Study|Lost to Follow-up|4|||
124880375|NCT04867785|449185492|FG001|Overall Study|Lost to Follow-up|4|||
124880376|NCT04867785|449185493|FG002|Overall Study|Lost to Follow-up|3|||
124880377|NCT04867785|449185494|FG003|Overall Study|Lost to Follow-up|2|||
124880378|NCT04867785|449185495|FG004|Overall Study|Lost to Follow-up|0|||
124880379|NCT04867785|449185496|FG005|Overall Study|Lost to Follow-up|1|||
124880380|NCT04867785|449185497|FG006|Overall Study|Lost to Follow-up|0|||
124880381|NCT04867785|449185498|FG007|Overall Study|Lost to Follow-up|1|||
124880382|NCT04867785|449185491|FG000|Overall Study|Withdrawal by Subject|6|||
124880383|NCT04867785|449185492|FG001|Overall Study|Withdrawal by Subject|2|||
124880384|NCT04867785|449185493|FG002|Overall Study|Withdrawal by Subject|2|||
124880385|NCT04867785|449185494|FG003|Overall Study|Withdrawal by Subject|1|||
124880386|NCT04867785|449185495|FG004|Overall Study|Withdrawal by Subject|2|||
124880387|NCT04867785|449185496|FG005|Overall Study|Withdrawal by Subject|0|||
124880388|NCT04867785|449185497|FG006|Overall Study|Withdrawal by Subject|2|||
124880389|NCT04867785|449185498|FG007|Overall Study|Withdrawal by Subject|5|||
124880390|NCT04867785|449185491|FG000|Overall Study|Physician Decision|0|||
124880391|NCT04867785|449185492|FG001|Overall Study|Physician Decision|0|||
124880392|NCT04867785|449185493|FG002|Overall Study|Physician Decision|0|||
124880393|NCT04867785|449185494|FG003|Overall Study|Physician Decision|0|||
124880394|NCT04867785|449185495|FG004|Overall Study|Physician Decision|0|||
124880395|NCT04867785|449185496|FG005|Overall Study|Physician Decision|0|||
124880396|NCT04867785|449185497|FG006|Overall Study|Physician Decision|0|||
124880397|NCT04867785|449185498|FG007|Overall Study|Physician Decision|1|||
124880398|NCT04867785|449185491|FG000|Overall Study|Inadvertent Enrollment|0|||
124880399|NCT04867785|449185492|FG001|Overall Study|Inadvertent Enrollment|0|||
124880400|NCT04867785|449185493|FG002|Overall Study|Inadvertent Enrollment|0|||
124880401|NCT04867785|449185494|FG003|Overall Study|Inadvertent Enrollment|1|||
124880402|NCT04867785|449185495|FG004|Overall Study|Inadvertent Enrollment|1|||
124880403|NCT04867785|449185496|FG005|Overall Study|Inadvertent Enrollment|0|||
124880404|NCT04867785|449185497|FG006|Overall Study|Inadvertent Enrollment|0|||
124880405|NCT04867785|449185498|FG007|Overall Study|Inadvertent Enrollment|1|||
124880406|NCT04867785|449185491|FG000|Overall Study|Eligibility Criteria Not Met|0|||
124880407|NCT04867785|449185492|FG001|Overall Study|Eligibility Criteria Not Met|0|||
124880408|NCT04867785|449185493|FG002|Overall Study|Eligibility Criteria Not Met|0|||
124880409|NCT04867785|449185494|FG003|Overall Study|Eligibility Criteria Not Met|0|||
124880410|NCT04867785|449185495|FG004|Overall Study|Eligibility Criteria Not Met|0|||
124880411|NCT04867785|449185496|FG005|Overall Study|Eligibility Criteria Not Met|0|||
124880412|NCT04867785|449185497|FG006|Overall Study|Eligibility Criteria Not Met|0|||
124880413|NCT04867785|449185498|FG007|Overall Study|Eligibility Criteria Not Met|1|||
125014345|NCT02831673|449678739|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
125014346|NCT02831673|449678735|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
125014347|NCT02831673|449678736|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
125014348|NCT02831673|449678737|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
125014349|NCT02831673|449678738|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
125014350|NCT02831673|449678739|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
125014351|NCT02831673|449678735|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
125014352|NCT02831673|449678736|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
125014353|NCT02831673|449678737|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
125014354|NCT02831673|449678738|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
125014355|NCT02831673|449678739|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
125014356|NCT02831673|449678735|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
125014357|NCT02831673|449678736|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
125014358|NCT02831673|449678737|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
125014359|NCT02831673|449678738|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
125014360|NCT02831673|449678739|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
125014361|NCT02831673|449678735|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
125014362|NCT02831673|449678736|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
125014363|NCT02831673|449678737|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
125014364|NCT02831673|449678738|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
125014365|NCT02831673|449678739|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
125014366|NCT02831673|449678735|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
125014367|NCT02831673|449678736|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
125014368|NCT02831673|449678737|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
125014369|NCT02831673|449678738|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
124880414|NCT01289041|449185499|FG000|Overall Study|Adverse Event|24|||
124880415|NCT01289041|449185499|FG000|Overall Study|Physician Decision|1|||
124880416|NCT01289041|449185499|FG000|Overall Study|Progressive Disease|41|||
124880417|NCT01289041|449185499|FG000|Overall Study|Withdrawal by Subject|3|||
124880418|NCT01289041|449185499|FG000|Overall Study|Death|1|||
124880419|NCT03239873|449185506|FG000|Overall Study|Lost to Follow-up|15|||
124880420|NCT03239873|449185507|FG001|Overall Study|Lost to Follow-up|16|||
124880421|NCT03239873|449185506|FG000|Overall Study|Physician Decision|1|||
124880422|NCT03239873|449185507|FG001|Overall Study|Physician Decision|0|||
124880423|NCT03239873|449185506|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
124880424|NCT03239873|449185507|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
124880425|NCT03239873|449185506|FG000|Overall Study|Withdrawal by Subject|2|||
124880426|NCT03239873|449185507|FG001|Overall Study|Withdrawal by Subject|0|||
124880427|NCT03239873|449185506|FG000|Overall Study|Contraindication to study medication|1|||
124880428|NCT03239873|449185507|FG001|Overall Study|Contraindication to study medication|0|||
124880429|NCT03239873|449185506|FG000|Overall Study|Protocol Violation|1|||
124880430|NCT03239873|449185507|FG001|Overall Study|Protocol Violation|0|||
124880431|NCT02670538|449185512|FG000|Overall Study|Withdrawal of Consent|8|||
124880432|NCT02670538|449185513|FG001|Overall Study|Withdrawal of Consent|6|||
124880433|NCT02670538|449185514|FG002|Overall Study|Withdrawal of Consent|5|||
124880434|NCT02670538|449185512|FG000|Overall Study|Lost to Follow-up|8|||
124880435|NCT02670538|449185513|FG001|Overall Study|Lost to Follow-up|12|||
124880436|NCT02670538|449185514|FG002|Overall Study|Lost to Follow-up|7|||
124880437|NCT02670538|449185512|FG000|Overall Study|Adverse Event|5|||
124880438|NCT02670538|449185513|FG001|Overall Study|Adverse Event|5|||
124880439|NCT02670538|449185514|FG002|Overall Study|Adverse Event|11|||
124880440|NCT02670538|449185512|FG000|Overall Study|Lack of Efficacy|7|||
124880441|NCT02670538|449185513|FG001|Overall Study|Lack of Efficacy|1|||
124880442|NCT02670538|449185514|FG002|Overall Study|Lack of Efficacy|2|||
124880443|NCT02670538|449185512|FG000|Overall Study|Protocol Violation|3|||
124880444|NCT02670538|449185513|FG001|Overall Study|Protocol Violation|4|||
124880445|NCT02670538|449185514|FG002|Overall Study|Protocol Violation|1|||
124880446|NCT02670538|449185512|FG000|Overall Study|Noncompliance with Study Drug|1|||
124880447|NCT02670538|449185513|FG001|Overall Study|Noncompliance with Study Drug|3|||
124880448|NCT02670538|449185514|FG002|Overall Study|Noncompliance with Study Drug|2|||
124880449|NCT02670538|449185512|FG000|Overall Study|Other Miscellaneous Reasons|0|||
124880450|NCT02670538|449185513|FG001|Overall Study|Other Miscellaneous Reasons|1|||
124880451|NCT02670538|449185514|FG002|Overall Study|Other Miscellaneous Reasons|2|||
124880452|NCT00674323|449185515|FG000|Overall Study|Adverse Event|0|||
124880453|NCT00674323|449185516|FG001|Overall Study|Adverse Event|1|||
124880454|NCT00674323|449185517|FG002|Overall Study|Adverse Event|0|||
124880455|NCT00674323|449185515|FG000|Overall Study|Protocol Violation|1|||
124880456|NCT00674323|449185516|FG001|Overall Study|Protocol Violation|0|||
125104085|NCT05004181|450002329|FG005|Overall Study|Withdrawal of consent|0|||
125104086|NCT05004181|450002330|FG006|Overall Study|Withdrawal of consent|30|||
125104087|NCT05004181|450002331|FG007|Overall Study|Withdrawal of consent|9|||
125104088|NCT05004181|450002332|FG008|Overall Study|Withdrawal of consent|3|||
125104089|NCT05004181|450002333|FG009|Overall Study|Withdrawal of consent|2|||
125104090|NCT05004181|450002334|FG010|Overall Study|Withdrawal of consent|5|||
125104091|NCT05004181|450002335|FG011|Overall Study|Withdrawal of consent|1|||
125104092|NCT05004181|450002324|FG000|Overall Study|Lost to Follow-up|2|||
125104093|NCT05004181|450002325|FG001|Overall Study|Lost to Follow-up|4|||
125104094|NCT05004181|450002326|FG002|Overall Study|Lost to Follow-up|2|||
125104095|NCT05004181|450002327|FG003|Overall Study|Lost to Follow-up|3|||
125104096|NCT05004181|450002328|FG004|Overall Study|Lost to Follow-up|5|||
125104097|NCT05004181|450002329|FG005|Overall Study|Lost to Follow-up|2|||
125104098|NCT05004181|450002330|FG006|Overall Study|Lost to Follow-up|15|||
125104099|NCT05004181|450002331|FG007|Overall Study|Lost to Follow-up|12|||
125104100|NCT05004181|450002332|FG008|Overall Study|Lost to Follow-up|38|||
125104101|NCT05004181|450002333|FG009|Overall Study|Lost to Follow-up|6|||
125104102|NCT05004181|450002334|FG010|Overall Study|Lost to Follow-up|6|||
125104103|NCT05004181|450002335|FG011|Overall Study|Lost to Follow-up|0|||
124880457|NCT00674323|449185517|FG002|Overall Study|Protocol Violation|0|||
124880458|NCT02045433|449185522|FG000|Overall Study|Withdrawal by Subject|1|||
124880459|NCT01112514|449185523|FG000|Overall Study|Lost to Follow-up|1|||
125104104|NCT05004181|450002324|FG000|Overall Study|Death|0|||
125104105|NCT05004181|450002325|FG001|Overall Study|Death|0|||
125104106|NCT05004181|450002326|FG002|Overall Study|Death|0|||
125104107|NCT05004181|450002327|FG003|Overall Study|Death|0|||
124880460|NCT02176421|449185524|FG000|Overall Study|Lost to Follow-up|4|||
124880461|NCT02176421|449185524|FG000|Overall Study|Adverse Event|1|||
124880462|NCT02145078|449185527|FG000|Overall Study|Death|1|||
125104108|NCT05004181|450002328|FG004|Overall Study|Death|0|||
124880463|NCT02145078|449185527|FG000|Overall Study|Reason not given|3|||
124880464|NCT01077362|449185528|FG000|Overall Study|Lack of Efficacy|13|||
124880465|NCT01077362|449185529|FG001|Overall Study|Lack of Efficacy|8|||
124880466|NCT01077362|449185530|FG002|Overall Study|Lack of Efficacy|10|||
124880467|NCT01077362|449185528|FG000|Overall Study|Lost to Follow-up|1|||
124880468|NCT01077362|449185529|FG001|Overall Study|Lost to Follow-up|0|||
124880469|NCT01077362|449185530|FG002|Overall Study|Lost to Follow-up|3|||
124880470|NCT01077362|449185528|FG000|Overall Study|Adverse Event|12|||
124880471|NCT01077362|449185529|FG001|Overall Study|Adverse Event|7|||
124880472|NCT01077362|449185530|FG002|Overall Study|Adverse Event|4|||
124880473|NCT01077362|449185528|FG000|Overall Study|Withdrawal by Subject|5|||
124880474|NCT01077362|449185529|FG001|Overall Study|Withdrawal by Subject|3|||
124880475|NCT01077362|449185530|FG002|Overall Study|Withdrawal by Subject|5|||
124880476|NCT01077362|449185528|FG000|Overall Study|Other|0|||
124880477|NCT01077362|449185529|FG001|Overall Study|Other|1|||
124880478|NCT01077362|449185530|FG002|Overall Study|Other|2|||
124880479|NCT01872910|449185531|FG000|Overall Study|Lost to Follow-up|2|||
124880480|NCT01872910|449185532|FG001|Overall Study|Lost to Follow-up|0|||
124880481|NCT01872910|449185533|FG002|Overall Study|Lost to Follow-up|2|||
124880482|NCT01872910|449185534|FG003|Overall Study|Lost to Follow-up|0|||
124880483|NCT01872910|449185535|FG004|Overall Study|Lost to Follow-up|0|||
124880484|NCT01872910|449185536|FG005|Overall Study|Lost to Follow-up|0|||
124880485|NCT03101241|449185541|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
124880486|NCT03101241|449185542|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
124880487|NCT03101241|449185541|FG000|Overall Study|Participant withdrew consent|3|||
124880488|NCT03101241|449185542|FG001|Overall Study|Participant withdrew consent|1|||
124880489|NCT03101241|449185541|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
124880490|NCT03101241|449185542|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
124880491|NCT03101241|449185541|FG000|Overall Study|Lost to Follow-up|2|||
124880492|NCT03101241|449185542|FG001|Overall Study|Lost to Follow-up|0|||
124880493|NCT03101241|449185541|FG000|Overall Study|Lack of Efficacy|0|||
124880494|NCT03101241|449185542|FG001|Overall Study|Lack of Efficacy|1|||
124880495|NCT03101241|449185541|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
124880496|NCT03101241|449185542|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
124880497|NCT01678820|449185544|FG000|Overall Study|Study Terminated by Sponsor|45|||
124880498|NCT01678820|449185545|FG001|Overall Study|Study Terminated by Sponsor|43|||
124880499|NCT01678820|449185546|FG002|Overall Study|Study Terminated by Sponsor|43|||
124880500|NCT01678820|449185544|FG000|Overall Study|Withdrawal by Subject|2|||
124880501|NCT01678820|449185545|FG001|Overall Study|Withdrawal by Subject|5|||
125014370|NCT02831673|449678739|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
125014371|NCT02831673|449678735|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
125014372|NCT02831673|449678736|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
125014373|NCT02831673|449678737|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
125014374|NCT02831673|449678738|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
125014375|NCT02831673|449678739|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
125014376|NCT02831673|449678735|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
125014377|NCT02831673|449678736|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
125014378|NCT02831673|449678737|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
125014379|NCT02831673|449678738|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
125014380|NCT02831673|449678739|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
125014381|NCT02831673|449678735|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
125014382|NCT02831673|449678736|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
125014383|NCT02831673|449678737|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
125014384|NCT02831673|449678738|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
124880502|NCT01678820|449185546|FG002|Overall Study|Withdrawal by Subject|2|||
124880503|NCT01678820|449185544|FG000|Overall Study|Protocol Specified Criteria|2|||
124880504|NCT01678820|449185545|FG001|Overall Study|Protocol Specified Criteria|3|||
124880505|NCT01678820|449185546|FG002|Overall Study|Protocol Specified Criteria|1|||
124880506|NCT01678820|449185544|FG000|Overall Study|Adverse Event|2|||
124880507|NCT01678820|449185545|FG001|Overall Study|Adverse Event|2|||
124880508|NCT01678820|449185546|FG002|Overall Study|Adverse Event|2|||
124880509|NCT01678820|449185544|FG000|Overall Study|Lost to Follow-up|7|||
125104109|NCT05004181|450002329|FG005|Overall Study|Death|0|||
125104110|NCT05004181|450002330|FG006|Overall Study|Death|1|||
125104111|NCT05004181|450002331|FG007|Overall Study|Death|0|||
125104112|NCT05004181|450002332|FG008|Overall Study|Death|2|||
125104113|NCT05004181|450002333|FG009|Overall Study|Death|0|||
125104114|NCT05004181|450002334|FG010|Overall Study|Death|0|||
124880510|NCT01678820|449185545|FG001|Overall Study|Lost to Follow-up|2|||
124880511|NCT01678820|449185546|FG002|Overall Study|Lost to Follow-up|2|||
124880512|NCT01678820|449185544|FG000|Overall Study|Non-compliance with study drug|0|||
124880513|NCT01678820|449185545|FG001|Overall Study|Non-compliance with study drug|1|||
124880514|NCT01678820|449185546|FG002|Overall Study|Non-compliance with study drug|0|||
124880515|NCT01678820|449185544|FG000|Overall Study|Physician Decision|0|||
124880516|NCT01678820|449185545|FG001|Overall Study|Physician Decision|0|||
124880517|NCT01678820|449185546|FG002|Overall Study|Physician Decision|1|||
124880518|NCT01678820|449185544|FG000|Overall Study|Protocol Violation|4|||
124880519|NCT01678820|449185545|FG001|Overall Study|Protocol Violation|5|||
124880520|NCT01678820|449185546|FG002|Overall Study|Protocol Violation|4|||
124880521|NCT01678820|449185544|FG000|Overall Study|Not treated with double-blind study drug|0|||
124880522|NCT01678820|449185545|FG001|Overall Study|Not treated with double-blind study drug|2|||
124880523|NCT01678820|449185546|FG002|Overall Study|Not treated with double-blind study drug|2|||
125014385|NCT02831673|449678739|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
125014386|NCT02831673|449678735|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
125014387|NCT02831673|449678736|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
125014388|NCT02831673|449678737|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
125014389|NCT02831673|449678738|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
125014390|NCT02831673|449678739|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
125014391|NCT02831673|449678735|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
125014392|NCT02831673|449678736|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
125014393|NCT02831673|449678737|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
125014394|NCT02831673|449678738|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
125014395|NCT02831673|449678739|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
125014396|NCT02831673|449678735|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
125014397|NCT02831673|449678736|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
125014398|NCT02831673|449678737|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
125014399|NCT02831673|449678738|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
125014400|NCT02831673|449678739|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
125014401|NCT02831673|449678735|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
125014402|NCT02831673|449678736|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
125014403|NCT02831673|449678737|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
125014404|NCT02831673|449678738|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
125014405|NCT02831673|449678739|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
125014406|NCT02356562|449678741|FG000|Overall Study|Withdrawal by Subject|0|||
125014407|NCT02356562|449678742|FG001|Overall Study|Withdrawal by Subject|1|||
125014408|NCT02356562|449678741|FG000|Overall Study|Re-entered treatment in a previous study|1|||
125014409|NCT02356562|449678742|FG001|Overall Study|Re-entered treatment in a previous study|0|||
125014410|NCT02356562|449678741|FG000|Overall Study|site closure|1|||
125014411|NCT02356562|449678742|FG001|Overall Study|site closure|0|||
125014412|NCT01351389|449678751|FG000|Overall Study|Withdrawal by Subject|7|||
125014413|NCT01351389|449678752|FG001|Overall Study|Withdrawal by Subject|0|||
125014414|NCT01351389|449678751|FG000|Overall Study|did not complete intervention|23|||
125014415|NCT01351389|449678752|FG001|Overall Study|did not complete intervention|15|||
125014416|NCT00713700|449678753|FG000|Overall Study|Lost to Follow-up|3|||
125014417|NCT00713700|449678753|FG000|Overall Study|Withdrawal by Subject|1|||
125014418|NCT03719690|449678754|FG000|Overall Study|Withdrawal by Subject|5|||
125014419|NCT03719690|449678755|FG001|Overall Study|Withdrawal by Subject|10|||
125014420|NCT03719690|449678754|FG000|Overall Study|Death|40|||
125014421|NCT03719690|449678755|FG001|Overall Study|Death|149|||
125014422|NCT03719690|449678754|FG000|Overall Study|Miscellaneous|12|||
125014423|NCT03719690|449678755|FG001|Overall Study|Miscellaneous|56|||
125014424|NCT03719690|449678754|FG000|Overall Study|Lost to Follow-up|2|||
125014425|NCT03719690|449678755|FG001|Overall Study|Lost to Follow-up|18|||
125014426|NCT03719690|449678754|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
125014427|NCT03719690|449678755|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
125014428|NCT00847912|449678756|FG000|Overall Study|Protocol Violation|6|||
125014429|NCT00847912|449678757|FG001|Overall Study|Protocol Violation|7|||
125014430|NCT00847912|449678756|FG000|Overall Study|Withdrawal by Subject|3|||
125014431|NCT00847912|449678757|FG001|Overall Study|Withdrawal by Subject|6|||
125014432|NCT01074190|449678764|FG000|Overall Study|Emergency Cesarean Delivery|1|||
125014433|NCT01074190|449678765|FG001|Overall Study|Emergency Cesarean Delivery|2|||
125014434|NCT01074190|449678766|FG002|Overall Study|Emergency Cesarean Delivery|1|||
125217427|NCT01348100|450423521|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124880524|NCT05778526|449185551|FG000|Overall Study|Lost to Follow-up|0|||
124880525|NCT05778526|449185552|FG001|Overall Study|Lost to Follow-up|1|||
124880526|NCT05778526|449185553|FG002|Overall Study|Lost to Follow-up|3|||
124880527|NCT05778526|449185551|FG000|Overall Study|Protocol Violation|0|||
125014435|NCT01074190|449678764|FG000|Overall Study|Protocol Violation|2|||
125014436|NCT01074190|449678765|FG001|Overall Study|Protocol Violation|1|||
124880528|NCT05778526|449185552|FG001|Overall Study|Protocol Violation|0|||
124880529|NCT05778526|449185553|FG002|Overall Study|Protocol Violation|8|||
124880530|NCT00510458|449185568|FG000|Overall Study|5 year not evaluable/missed|21|||
124880531|NCT00510458|449185568|FG000|Overall Study|Death|1|||
124880532|NCT00510458|449185568|FG000|Overall Study|Terminated|14|||
124880533|NCT00510458|449185568|FG000|Overall Study|Lost to Follow-up|6|||
124880534|NCT00510458|449185568|FG000|Overall Study|Withdrawal by Subject|3|||
124880535|NCT00510458|449185568|FG000|Overall Study|Revision|2|||
124880536|NCT01861522|449185569|FG000|Overall Study|Adverse Event|1|||
124880537|NCT01861522|449185570|FG001|Overall Study|Adverse Event|0|||
124880538|NCT01861522|449185569|FG000|Overall Study|Withdrawal by Subject|2|||
124880539|NCT01861522|449185570|FG001|Overall Study|Withdrawal by Subject|0|||
124880540|NCT02716038|449185571|FG000|Overall Study|Not evaluable|1|||
124880541|NCT02716038|449185571|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
124880542|NCT02716038|449185571|FG000|Overall Study|Unresectable|3|||
124880543|NCT04006925|449185572|FG000|Overall Study|Side effects|2|||
124880544|NCT04006925|449185573|FG001|Overall Study|Side effects|0|||
124880545|NCT03757234|449185576|FG000|Overall Study|Adverse Event|0|||
124880546|NCT03757234|449185577|FG001|Overall Study|Adverse Event|0|||
124880547|NCT03757234|449185578|FG002|Overall Study|Adverse Event|0|||
124880548|NCT03757234|449185579|FG003|Overall Study|Adverse Event|0|||
124880549|NCT03757234|449185580|FG004|Overall Study|Adverse Event|1|||
124880550|NCT03757234|449185576|FG000|Overall Study|Lost to Follow-up|1|||
124880551|NCT03757234|449185577|FG001|Overall Study|Lost to Follow-up|0|||
124880552|NCT03757234|449185578|FG002|Overall Study|Lost to Follow-up|0|||
124880553|NCT03757234|449185579|FG003|Overall Study|Lost to Follow-up|0|||
124880554|NCT03757234|449185580|FG004|Overall Study|Lost to Follow-up|1|||
124880555|NCT03757234|449185576|FG000|Overall Study|Withdrawal by Subject|1|||
124880556|NCT03757234|449185577|FG001|Overall Study|Withdrawal by Subject|1|||
124880557|NCT03757234|449185578|FG002|Overall Study|Withdrawal by Subject|0|||
124880558|NCT03757234|449185579|FG003|Overall Study|Withdrawal by Subject|1|||
124880559|NCT03757234|449185580|FG004|Overall Study|Withdrawal by Subject|2|||
124880560|NCT03757234|449185576|FG000|Overall Study|Other|1|||
125104115|NCT05004181|450002335|FG011|Overall Study|Death|0|||
125104116|NCT05004181|450002324|FG000|Overall Study|Physician Decision|0|||
125104117|NCT05004181|450002325|FG001|Overall Study|Physician Decision|0|||
125104118|NCT05004181|450002326|FG002|Overall Study|Physician Decision|0|||
125104119|NCT05004181|450002327|FG003|Overall Study|Physician Decision|0|||
125104120|NCT05004181|450002328|FG004|Overall Study|Physician Decision|0|||
125104121|NCT05004181|450002329|FG005|Overall Study|Physician Decision|0|||
125104122|NCT05004181|450002330|FG006|Overall Study|Physician Decision|2|||
125104123|NCT05004181|450002331|FG007|Overall Study|Physician Decision|0|||
125104124|NCT05004181|450002332|FG008|Overall Study|Physician Decision|7|||
125104125|NCT05004181|450002333|FG009|Overall Study|Physician Decision|0|||
125104126|NCT05004181|450002334|FG010|Overall Study|Physician Decision|0|||
125104127|NCT05004181|450002335|FG011|Overall Study|Physician Decision|0|||
125104128|NCT05004181|450002324|FG000|Overall Study|Withdrawal by Subject|2|||
125104129|NCT05004181|450002325|FG001|Overall Study|Withdrawal by Subject|3|||
125104130|NCT05004181|450002326|FG002|Overall Study|Withdrawal by Subject|2|||
125104131|NCT05004181|450002327|FG003|Overall Study|Withdrawal by Subject|2|||
125104132|NCT05004181|450002328|FG004|Overall Study|Withdrawal by Subject|4|||
125104133|NCT05004181|450002329|FG005|Overall Study|Withdrawal by Subject|2|||
125104134|NCT05004181|450002330|FG006|Overall Study|Withdrawal by Subject|4|||
125104135|NCT05004181|450002331|FG007|Overall Study|Withdrawal by Subject|22|||
125104136|NCT05004181|450002332|FG008|Overall Study|Withdrawal by Subject|8|||
125104137|NCT05004181|450002333|FG009|Overall Study|Withdrawal by Subject|1|||
125104138|NCT05004181|450002334|FG010|Overall Study|Withdrawal by Subject|3|||
125104139|NCT05004181|450002335|FG011|Overall Study|Withdrawal by Subject|2|||
125104140|NCT05004181|450002324|FG000|Overall Study|Protocol Violation|2|||
125104141|NCT05004181|450002325|FG001|Overall Study|Protocol Violation|3|||
125104142|NCT05004181|450002326|FG002|Overall Study|Protocol Violation|0|||
124880561|NCT03757234|449185577|FG001|Overall Study|Other|1|||
124880562|NCT03757234|449185578|FG002|Overall Study|Other|0|||
125104143|NCT05004181|450002327|FG003|Overall Study|Protocol Violation|0|||
125104144|NCT05004181|450002328|FG004|Overall Study|Protocol Violation|1|||
125104145|NCT05004181|450002329|FG005|Overall Study|Protocol Violation|0|||
125104146|NCT05004181|450002330|FG006|Overall Study|Protocol Violation|16|||
125104147|NCT05004181|450002331|FG007|Overall Study|Protocol Violation|18|||
125104148|NCT05004181|450002332|FG008|Overall Study|Protocol Violation|2|||
125104149|NCT05004181|450002333|FG009|Overall Study|Protocol Violation|2|||
125104150|NCT05004181|450002334|FG010|Overall Study|Protocol Violation|2|||
124880563|NCT03757234|449185579|FG003|Overall Study|Other|0|||
124880564|NCT03757234|449185580|FG004|Overall Study|Other|0|||
124880565|NCT01555164|449185582|FG000|Overall Study|Adverse Event|5|||
124880566|NCT01555164|449185583|FG001|Overall Study|Adverse Event|7|||
124880567|NCT01555164|449185582|FG000|Overall Study|Hyperglycemia|0|||
124880568|NCT01555164|449185583|FG001|Overall Study|Hyperglycemia|1|||
124880569|NCT01555164|449185582|FG000|Overall Study|Investigator's Discretion|2|||
124880570|NCT01555164|449185583|FG001|Overall Study|Investigator's Discretion|2|||
125104151|NCT05004181|450002335|FG011|Overall Study|Protocol Violation|1|||
124880571|NCT01555164|449185582|FG000|Overall Study|Lost to Follow-up|4|||
124880572|NCT01555164|449185583|FG001|Overall Study|Lost to Follow-up|3|||
124880573|NCT01555164|449185582|FG000|Overall Study|Protocol Violation|9|||
124880574|NCT01555164|449185583|FG001|Overall Study|Protocol Violation|5|||
124880575|NCT01555164|449185582|FG000|Overall Study|Subject Non-compliance|14|||
124880576|NCT01555164|449185583|FG001|Overall Study|Subject Non-compliance|6|||
124880577|NCT01555164|449185582|FG000|Overall Study|Subject Withdrew Consent|6|||
124880578|NCT01555164|449185583|FG001|Overall Study|Subject Withdrew Consent|11|||
124880579|NCT01396317|449185584|FG000|Overall Study|Adverse Event|1|||
124880580|NCT01396317|449185585|FG001|Overall Study|Adverse Event|0|||
124880581|NCT01709305|449185586|FG000|Phase 1|Clinical Adverse Event|80|||
124880582|NCT01709305|449185587|FG001|Phase 1|Clinical Adverse Event|0|||
124880583|NCT01709305|449185588|FG002|Phase 1|Clinical Adverse Event|0|||
124880584|NCT01709305|449185589|FG003|Phase 1|Clinical Adverse Event|0|||
124880585|NCT01709305|449185590|FG004|Phase 1|Clinical Adverse Event|0|||
124880586|NCT01709305|449185586|FG000|Phase 1|Death|2|||
124880587|NCT01709305|449185587|FG001|Phase 1|Death|0|||
124880588|NCT01709305|449185588|FG002|Phase 1|Death|0|||
124880589|NCT01709305|449185589|FG003|Phase 1|Death|0|||
124880590|NCT01709305|449185590|FG004|Phase 1|Death|0|||
124880591|NCT01709305|449185586|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
124880592|NCT01709305|449185587|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
124880593|NCT01709305|449185588|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
124880594|NCT01709305|449185589|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
124880595|NCT01709305|449185590|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
124880596|NCT01709305|449185586|FG000|Phase 1|Laboratory Adverse Event|16|||
124880597|NCT01709305|449185587|FG001|Phase 1|Laboratory Adverse Event|0|||
124880598|NCT01709305|449185588|FG002|Phase 1|Laboratory Adverse Event|0|||
124880599|NCT01709305|449185589|FG003|Phase 1|Laboratory Adverse Event|0|||
124880600|NCT01709305|449185590|FG004|Phase 1|Laboratory Adverse Event|0|||
124880601|NCT01709305|449185586|FG000|Phase 1|Lost to Follow-up|147|||
124880602|NCT01709305|449185587|FG001|Phase 1|Lost to Follow-up|0|||
124880603|NCT01709305|449185588|FG002|Phase 1|Lost to Follow-up|0|||
124880604|NCT01709305|449185589|FG003|Phase 1|Lost to Follow-up|0|||
125104152|NCT05004181|450002324|FG000|Overall Study|Not further specified|1|||
125104153|NCT05004181|450002325|FG001|Overall Study|Not further specified|0|||
125104154|NCT05004181|450002326|FG002|Overall Study|Not further specified|0|||
125104155|NCT05004181|450002327|FG003|Overall Study|Not further specified|0|||
125104156|NCT05004181|450002328|FG004|Overall Study|Not further specified|0|||
125104157|NCT05004181|450002329|FG005|Overall Study|Not further specified|0|||
125104158|NCT05004181|450002330|FG006|Overall Study|Not further specified|1|||
125104159|NCT05004181|450002331|FG007|Overall Study|Not further specified|0|||
125104160|NCT05004181|450002332|FG008|Overall Study|Not further specified|2|||
125104161|NCT05004181|450002333|FG009|Overall Study|Not further specified|1|||
125104162|NCT05004181|450002334|FG010|Overall Study|Not further specified|0|||
125104163|NCT05004181|450002335|FG011|Overall Study|Not further specified|1|||
125104164|NCT00633217|450002336|FG000|Overall Study|Adverse Event|5|||
125104165|NCT00633217|450002337|FG001|Overall Study|Adverse Event|9|||
125104166|NCT00633217|450002336|FG000|Overall Study|Lack of Efficacy|0|||
125104167|NCT00633217|450002337|FG001|Overall Study|Lack of Efficacy|2|||
125104168|NCT00633217|450002336|FG000|Overall Study|Protocol Violation|3|||
125104169|NCT00633217|450002337|FG001|Overall Study|Protocol Violation|7|||
125104170|NCT00633217|450002336|FG000|Overall Study|Lost to Follow-up|2|||
125104171|NCT00633217|450002337|FG001|Overall Study|Lost to Follow-up|2|||
125104172|NCT00633217|450002336|FG000|Overall Study|Investigator Discretion|2|||
125104173|NCT00633217|450002337|FG001|Overall Study|Investigator Discretion|0|||
125104174|NCT00633217|450002336|FG000|Overall Study|Withdrew Consent|3|||
125104175|NCT00633217|450002337|FG001|Overall Study|Withdrew Consent|3|||
125104176|NCT00096031|450002338|FG000|Overall Study|Adverse Event|3|||
125104177|NCT00096031|450002338|FG000|Overall Study|Lack of Efficacy|42|||
125104178|NCT00096031|450002338|FG000|Overall Study|Death|4|||
125104179|NCT00096031|450002338|FG000|Overall Study|Withdrawal by Subject|1|||
125104180|NCT00096031|450002338|FG000|Overall Study|Ineligible|8|||
125104181|NCT00096031|450002338|FG000|Overall Study|Not protocol specified|5|||
125104182|NCT00909857|450002339|FG000|Overall Study|Withdrawal by Subject|6|||
125104183|NCT00909857|450002340|FG001|Overall Study|Withdrawal by Subject|10|||
124880605|NCT01709305|449185590|FG004|Phase 1|Lost to Follow-up|0|||
125104184|NCT00909857|450002339|FG000|Overall Study|Adverse Event|5|||
125104185|NCT00909857|450002340|FG001|Overall Study|Adverse Event|5|||
125104186|NCT00909857|450002339|FG000|Overall Study|Lost to Follow-up|2|||
124880606|NCT01709305|449185586|FG000|Phase 1|Travel, moving, etc.|30|||
124880607|NCT01709305|449185587|FG001|Phase 1|Travel, moving, etc.|0|||
124880608|NCT01709305|449185588|FG002|Phase 1|Travel, moving, etc.|0|||
124880609|NCT01709305|449185589|FG003|Phase 1|Travel, moving, etc.|0|||
124880610|NCT01709305|449185590|FG004|Phase 1|Travel, moving, etc.|0|||
124880611|NCT01709305|449185586|FG000|Phase 1|Physician Decision|13|||
125104187|NCT00909857|450002340|FG001|Overall Study|Lost to Follow-up|5|||
125104188|NCT00909857|450002339|FG000|Overall Study|Protocol Violation|2|||
125104189|NCT00909857|450002340|FG001|Overall Study|Protocol Violation|1|||
125104190|NCT00909857|450002339|FG000|Overall Study|Pregnancy|1|||
125104191|NCT00909857|450002340|FG001|Overall Study|Pregnancy|0|||
125104192|NCT00909857|450002339|FG000|Overall Study|Other|1|||
125104193|NCT00909857|450002340|FG001|Overall Study|Other|0|||
125104194|NCT00909857|450002339|FG000|Overall Study|Did not receive study medication|19|||
125104195|NCT00909857|450002340|FG001|Overall Study|Did not receive study medication|24|||
125104196|NCT00604175|450002341|FG000|Entry Through Week 28|Death|2|||
125104197|NCT00604175|450002342|FG001|Entry Through Week 28|Death|0|||
125104198|NCT00604175|450002343|FG002|Entry Through Week 28|Death|0|||
125104199|NCT00604175|450002341|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
125104200|NCT00604175|450002342|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
125104201|NCT00604175|450002343|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
125104202|NCT00604175|450002341|FG000|Entry Through Week 28|Lost to Follow-up|4|||
125104203|NCT00604175|450002342|FG001|Entry Through Week 28|Lost to Follow-up|3|||
125104204|NCT00604175|450002343|FG002|Entry Through Week 28|Lost to Follow-up|0|||
125104205|NCT00604175|450002341|FG000|Entry Through Week 28|Ineligible|1|||
125104206|NCT00604175|450002342|FG001|Entry Through Week 28|Ineligible|0|||
124880612|NCT01709305|449185587|FG001|Phase 1|Physician Decision|0|||
124880613|NCT01709305|449185588|FG002|Phase 1|Physician Decision|0|||
124880614|NCT01709305|449185589|FG003|Phase 1|Physician Decision|0|||
124880615|NCT01709305|449185590|FG004|Phase 1|Physician Decision|0|||
124880616|NCT01709305|449185586|FG000|Phase 1|Protocol Violation|118|||
124880617|NCT01709305|449185587|FG001|Phase 1|Protocol Violation|0|||
124880618|NCT01709305|449185588|FG002|Phase 1|Protocol Violation|0|||
124880619|NCT01709305|449185589|FG003|Phase 1|Protocol Violation|0|||
124880620|NCT01709305|449185590|FG004|Phase 1|Protocol Violation|0|||
124880621|NCT01709305|449185586|FG000|Phase 1|Withdrawal by Subject|218|||
124880622|NCT01709305|449185587|FG001|Phase 1|Withdrawal by Subject|0|||
124880623|NCT01709305|449185588|FG002|Phase 1|Withdrawal by Subject|0|||
124880624|NCT01709305|449185589|FG003|Phase 1|Withdrawal by Subject|0|||
124880625|NCT01709305|449185590|FG004|Phase 1|Withdrawal by Subject|0|||
124880626|NCT01709305|449185586|FG000|Phase 2|Clinical Adverse Event|0|||
124880627|NCT01709305|449185587|FG001|Phase 2|Clinical Adverse Event|10|||
124880628|NCT01709305|449185588|FG002|Phase 2|Clinical Adverse Event|10|||
124880629|NCT01709305|449185589|FG003|Phase 2|Clinical Adverse Event|6|||
125014437|NCT01074190|449678766|FG002|Overall Study|Protocol Violation|0|||
125014438|NCT01074190|449678764|FG000|Overall Study|Delivered in under 90 minutes|0|||
125014439|NCT01074190|449678765|FG001|Overall Study|Delivered in under 90 minutes|2|||
125104207|NCT00604175|450002343|FG002|Entry Through Week 28|Ineligible|0|||
125104208|NCT00604175|450002341|FG000|Entry Through Week 28|Did not start intervention|2|||
125104209|NCT00604175|450002342|FG001|Entry Through Week 28|Did not start intervention|0|||
125104210|NCT00604175|450002343|FG002|Entry Through Week 28|Did not start intervention|1|||
125104211|NCT00604175|450002341|FG000|Week 29 Through Week 72|Death|0|||
125104212|NCT00604175|450002342|FG001|Week 29 Through Week 72|Death|0|||
125104213|NCT00604175|450002343|FG002|Week 29 Through Week 72|Death|1|||
125104214|NCT00604175|450002341|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
125104215|NCT00604175|450002342|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
125104216|NCT00604175|450002343|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
125104217|NCT00604175|450002341|FG000|Week 29 Through Week 72|Site closure|0|||
125104218|NCT00604175|450002342|FG001|Week 29 Through Week 72|Site closure|1|||
125104219|NCT00604175|450002343|FG002|Week 29 Through Week 72|Site closure|0|||
125104220|NCT00604175|450002341|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
125104221|NCT00604175|450002342|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
125104222|NCT00604175|450002343|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
125104223|NCT03205163|450002344|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
125104224|NCT03205163|450002345|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
125104225|NCT05257109|450002346|FG000|Overall Study|Withdrawal by Subject|1|||
125104226|NCT05257109|450002347|FG001|Overall Study|Withdrawal by Subject|0|||
125104227|NCT05257109|450002348|FG002|Overall Study|Withdrawal by Subject|0|||
125104228|NCT05257109|450002349|FG003|Overall Study|Withdrawal by Subject|0|||
125104229|NCT03993288|450004066|FG000|Overall Study|Lost to Follow-up|2|||
125104230|NCT03993288|450004067|FG001|Overall Study|Lost to Follow-up|1|||
124880630|NCT01709305|449185590|FG004|Phase 2|Clinical Adverse Event|11|||
124880631|NCT01709305|449185586|FG000|Phase 2|Death|0|||
124880632|NCT01709305|449185587|FG001|Phase 2|Death|0|||
124880633|NCT01709305|449185588|FG002|Phase 2|Death|1|||
124880634|NCT01709305|449185589|FG003|Phase 2|Death|0|||
125014440|NCT01074190|449678766|FG002|Overall Study|Delivered in under 90 minutes|1|||
125014441|NCT01074190|449678764|FG000|Overall Study|Subject withdrew consent|1|||
125014442|NCT01074190|449678765|FG001|Overall Study|Subject withdrew consent|1|||
125014443|NCT01074190|449678766|FG002|Overall Study|Subject withdrew consent|1|||
125014444|NCT00732303|449678767|FG000|Overall Study|Study Terminated|2|||
125014445|NCT03882970|449678768|FG000|Overall Study|Adverse Event|5|||
125014446|NCT03882970|449678769|FG001|Overall Study|Adverse Event|7|||
125014447|NCT03882970|449678770|FG002|Overall Study|Adverse Event|3|||
125014448|NCT03882970|449678771|FG003|Overall Study|Adverse Event|1|||
125014449|NCT03882970|449678768|FG000|Overall Study|Death|1|||
125014450|NCT03882970|449678769|FG001|Overall Study|Death|2|||
125014451|NCT03882970|449678770|FG002|Overall Study|Death|1|||
125014452|NCT03882970|449678771|FG003|Overall Study|Death|1|||
125014453|NCT03882970|449678768|FG000|Overall Study|Lost to Follow-up|8|||
125104231|NCT03993288|450004066|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
125104232|NCT03993288|450004067|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
125104233|NCT03993288|450004066|FG000|Overall Study|wrong randomization|0|||
124880635|NCT01709305|449185590|FG004|Phase 2|Death|0|||
124880636|NCT01709305|449185586|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
124880637|NCT01709305|449185587|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
125014454|NCT03882970|449678769|FG001|Overall Study|Lost to Follow-up|9|||
125014455|NCT03882970|449678770|FG002|Overall Study|Lost to Follow-up|5|||
124880638|NCT01709305|449185588|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
124880639|NCT01709305|449185589|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
125014456|NCT03882970|449678771|FG003|Overall Study|Lost to Follow-up|5|||
125014457|NCT03882970|449678768|FG000|Overall Study|Physician Decision|0|||
125014458|NCT03882970|449678769|FG001|Overall Study|Physician Decision|2|||
124880640|NCT01709305|449185590|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
124880641|NCT01709305|449185586|FG000|Phase 2|Laboratory Adverse Event|0|||
124880642|NCT01709305|449185587|FG001|Phase 2|Laboratory Adverse Event|1|||
124880643|NCT01709305|449185588|FG002|Phase 2|Laboratory Adverse Event|0|||
124880644|NCT01709305|449185589|FG003|Phase 2|Laboratory Adverse Event|1|||
124880645|NCT01709305|449185590|FG004|Phase 2|Laboratory Adverse Event|1|||
124880646|NCT01709305|449185586|FG000|Phase 2|Lost to Follow-up|0|||
124880647|NCT01709305|449185587|FG001|Phase 2|Lost to Follow-up|10|||
124880648|NCT01709305|449185588|FG002|Phase 2|Lost to Follow-up|6|||
124880649|NCT01709305|449185589|FG003|Phase 2|Lost to Follow-up|9|||
124880650|NCT01709305|449185590|FG004|Phase 2|Lost to Follow-up|5|||
124880651|NCT01709305|449185586|FG000|Phase 2|Travel, moving, etc.|0|||
124880652|NCT01709305|449185587|FG001|Phase 2|Travel, moving, etc.|2|||
124880653|NCT01709305|449185588|FG002|Phase 2|Travel, moving, etc.|3|||
124880654|NCT01709305|449185589|FG003|Phase 2|Travel, moving, etc.|3|||
124880655|NCT01709305|449185590|FG004|Phase 2|Travel, moving, etc.|5|||
124880656|NCT01709305|449185586|FG000|Phase 2|Physician Decision|0|||
124880657|NCT01709305|449185587|FG001|Phase 2|Physician Decision|2|||
124880658|NCT01709305|449185588|FG002|Phase 2|Physician Decision|0|||
124880659|NCT01709305|449185589|FG003|Phase 2|Physician Decision|1|||
124880660|NCT01709305|449185590|FG004|Phase 2|Physician Decision|2|||
124880661|NCT01709305|449185586|FG000|Phase 2|Protocol Violation|0|||
124880662|NCT01709305|449185587|FG001|Phase 2|Protocol Violation|19|||
124880663|NCT01709305|449185588|FG002|Phase 2|Protocol Violation|19|||
124880664|NCT01709305|449185589|FG003|Phase 2|Protocol Violation|13|||
124880665|NCT01709305|449185590|FG004|Phase 2|Protocol Violation|9|||
124880666|NCT01709305|449185586|FG000|Phase 2|Withdrawal by Subject|0|||
124880667|NCT01709305|449185587|FG001|Phase 2|Withdrawal by Subject|8|||
124880668|NCT01709305|449185588|FG002|Phase 2|Withdrawal by Subject|6|||
124880669|NCT01709305|449185589|FG003|Phase 2|Withdrawal by Subject|15|||
124880670|NCT01709305|449185590|FG004|Phase 2|Withdrawal by Subject|12|||
124880671|NCT02294474|449185593|FG000|Overall Study|Adverse Event|7|||
124880672|NCT02294474|449185594|FG001|Overall Study|Adverse Event|7|||
124880673|NCT02294474|449185593|FG000|Overall Study|Lack of Efficacy|2|||
124880674|NCT02294474|449185594|FG001|Overall Study|Lack of Efficacy|1|||
124880675|NCT02294474|449185593|FG000|Overall Study|Protocol Violation|4|||
124880676|NCT02294474|449185594|FG001|Overall Study|Protocol Violation|2|||
124880677|NCT02294474|449185593|FG000|Overall Study|Other than specified above|12|||
124880678|NCT02294474|449185594|FG001|Overall Study|Other than specified above|12|||
124880679|NCT00171873|449185595|FG000|Overall Study|Withdrawal by Subject|4|||
124880680|NCT00171873|449185596|FG001|Overall Study|Withdrawal by Subject|2|||
124880681|NCT00171873|449185595|FG000|Overall Study|Adverse Event|5|||
124880682|NCT00171873|449185596|FG001|Overall Study|Adverse Event|0|||
124880683|NCT00171873|449185595|FG000|Overall Study|Switched to Octreotide|0|||
124880684|NCT00171873|449185596|FG001|Overall Study|Switched to Octreotide|1|||
124880685|NCT05200936|449185597|FG000|Overall Study|Withdrawal by Subject|2|||
124880686|NCT05200936|449185598|FG001|Overall Study|Withdrawal by Subject|2|||
124880687|NCT05200936|449185597|FG000|Overall Study|Lost to Follow-up|2|||
125104234|NCT03993288|450004067|FG001|Overall Study|wrong randomization|1|||
125104235|NCT03993288|450004066|FG000|Overall Study|improper enrollment|0|||
125104236|NCT03993288|450004067|FG001|Overall Study|improper enrollment|1|||
125104237|NCT03993288|450004066|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
125104238|NCT03993288|450004067|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
125104239|NCT03993288|450004066|FG000|Overall Study|developed SAE|2|||
125104240|NCT03993288|450004067|FG001|Overall Study|developed SAE|0|||
125104241|NCT03993288|450004066|FG000|Overall Study|consent withdrawal|1|||
124880688|NCT05200936|449185598|FG001|Overall Study|Lost to Follow-up|0|||
124880689|NCT05200936|449185597|FG000|Overall Study|Pregnancy|0|||
124880690|NCT05200936|449185598|FG001|Overall Study|Pregnancy|1|||
124880691|NCT00118898|449185600|FG000|Overall Study|Death|6|||
124880692|NCT00118898|449185601|FG001|Overall Study|Death|11|||
124880693|NCT00118898|449185602|FG002|Overall Study|Death|6|||
124880694|NCT00118898|449185603|FG003|Overall Study|Death|8|||
124880695|NCT00118898|449185600|FG000|Overall Study|Lost to Follow-up|26|||
124880696|NCT00118898|449185601|FG001|Overall Study|Lost to Follow-up|34|||
125104242|NCT03993288|450004067|FG001|Overall Study|consent withdrawal|0|||
124880697|NCT00118898|449185602|FG002|Overall Study|Lost to Follow-up|33|||
125104243|NCT03993288|450004066|FG000|Overall Study|did not follow the treatment schedule|1|||
124880698|NCT00118898|449185603|FG003|Overall Study|Lost to Follow-up|33|||
124880699|NCT00118898|449185600|FG000|Overall Study|Withdrawal by Subject|10|||
125104244|NCT03993288|450004067|FG001|Overall Study|did not follow the treatment schedule|0|||
125104245|NCT03993288|450004066|FG000|Overall Study|did not follow the treatment regimen|1|||
125104246|NCT03993288|450004067|FG001|Overall Study|did not follow the treatment regimen|0|||
125104247|NCT03993288|450004066|FG000|Overall Study|Adverse Event|1|||
125104248|NCT03993288|450004067|FG001|Overall Study|Adverse Event|0|||
125104249|NCT03993288|450004066|FG000|Overall Study|Withdrawal by Subject|1|||
125104250|NCT03993288|450004067|FG001|Overall Study|Withdrawal by Subject|1|||
125104251|NCT00915473|450004068|FG000|Screening|Withdrawal by Subject|1|||
125104252|NCT00915473|450004069|FG001|Screening|Withdrawal by Subject|0|||
125104253|NCT00915473|450004068|FG000|4-week Follow Up|Lost to Follow-up|1|||
125104254|NCT00915473|450004069|FG001|4-week Follow Up|Lost to Follow-up|5|||
125104255|NCT01389024|450004070|FG000|Overall Study|Withdrawal by Subject|0|||
124880700|NCT00118898|449185601|FG001|Overall Study|Withdrawal by Subject|5|||
124880701|NCT00118898|449185602|FG002|Overall Study|Withdrawal by Subject|8|||
124880702|NCT00118898|449185603|FG003|Overall Study|Withdrawal by Subject|8|||
124880703|NCT00118898|449185600|FG000|Overall Study|Site Closure|33|||
124880704|NCT00118898|449185601|FG001|Overall Study|Site Closure|31|||
124880705|NCT00118898|449185602|FG002|Overall Study|Site Closure|28|||
124880706|NCT00118898|449185603|FG003|Overall Study|Site Closure|37|||
124880707|NCT00118898|449185600|FG000|Overall Study|Severe debilitation|1|||
124880708|NCT00118898|449185601|FG001|Overall Study|Severe debilitation|4|||
124880709|NCT00118898|449185602|FG002|Overall Study|Severe debilitation|6|||
124880710|NCT00118898|449185603|FG003|Overall Study|Severe debilitation|4|||
124880711|NCT00118898|449185600|FG000|Overall Study|Not compliant with requirements|11|||
124880712|NCT00118898|449185601|FG001|Overall Study|Not compliant with requirements|13|||
124880713|NCT00118898|449185602|FG002|Overall Study|Not compliant with requirements|11|||
124880714|NCT00118898|449185603|FG003|Overall Study|Not compliant with requirements|11|||
124880715|NCT00118898|449185600|FG000|Overall Study|Not able to get to clinic|34|||
124880716|NCT00118898|449185601|FG001|Overall Study|Not able to get to clinic|43|||
124880717|NCT00118898|449185602|FG002|Overall Study|Not able to get to clinic|31|||
124880718|NCT00118898|449185603|FG003|Overall Study|Not able to get to clinic|40|||
124880719|NCT01338012|449185604|FG000|Overall Study|Death|4|||
124880720|NCT01338012|449185604|FG000|Overall Study|Study terminated|4|||
124880721|NCT05879198|449185605|FG000|Overall Study|Lost to Follow-up|1|||
124880722|NCT02073097|449185606|FG000|Overall Study|Adverse Event|0|||
124880723|NCT02073097|449185607|FG001|Overall Study|Adverse Event|0|||
124880724|NCT02073097|449185608|FG002|Overall Study|Adverse Event|0|||
124880725|NCT02073097|449185609|FG003|Overall Study|Adverse Event|0|||
124880726|NCT02073097|449185610|FG004|Overall Study|Adverse Event|0|||
124880727|NCT02073097|449185611|FG005|Overall Study|Adverse Event|0|||
124880728|NCT02073097|449185612|FG006|Overall Study|Adverse Event|0|||
124880729|NCT02073097|449185613|FG007|Overall Study|Adverse Event|2|||
124880730|NCT02073097|449185606|FG000|Overall Study|Withdrawal by Subject|0|||
124880731|NCT02073097|449185607|FG001|Overall Study|Withdrawal by Subject|0|||
124880732|NCT02073097|449185608|FG002|Overall Study|Withdrawal by Subject|0|||
124880733|NCT02073097|449185609|FG003|Overall Study|Withdrawal by Subject|0|||
124880734|NCT02073097|449185610|FG004|Overall Study|Withdrawal by Subject|0|||
124880735|NCT02073097|449185611|FG005|Overall Study|Withdrawal by Subject|0|||
124880736|NCT02073097|449185612|FG006|Overall Study|Withdrawal by Subject|0|||
124880737|NCT02073097|449185613|FG007|Overall Study|Withdrawal by Subject|2|||
124880738|NCT02073097|449185606|FG000|Overall Study|Death|0|||
124880739|NCT02073097|449185607|FG001|Overall Study|Death|0|||
124880740|NCT02073097|449185608|FG002|Overall Study|Death|0|||
124880741|NCT02073097|449185609|FG003|Overall Study|Death|0|||
124880742|NCT02073097|449185610|FG004|Overall Study|Death|0|||
124880743|NCT02073097|449185611|FG005|Overall Study|Death|0|||
124880744|NCT02073097|449185612|FG006|Overall Study|Death|0|||
124880745|NCT02073097|449185613|FG007|Overall Study|Death|1|||
124880746|NCT02073097|449185606|FG000|Overall Study|Physician Decision|0|||
124880747|NCT02073097|449185607|FG001|Overall Study|Physician Decision|0|||
124880748|NCT02073097|449185608|FG002|Overall Study|Physician Decision|0|||
124880749|NCT02073097|449185609|FG003|Overall Study|Physician Decision|0|||
124880750|NCT02073097|449185610|FG004|Overall Study|Physician Decision|0|||
124880751|NCT02073097|449185611|FG005|Overall Study|Physician Decision|0|||
124880752|NCT02073097|449185612|FG006|Overall Study|Physician Decision|0|||
124880753|NCT02073097|449185613|FG007|Overall Study|Physician Decision|1|||
124880754|NCT01693692|449185614|FG000|Overall Study|Withdrawal by Subject|12|||
124880755|NCT01693692|449185615|FG001|Overall Study|Withdrawal by Subject|10|||
124880756|NCT01693692|449185616|FG002|Overall Study|Withdrawal by Subject|11|||
124880757|NCT01693692|449185614|FG000|Overall Study|Adverse Event|7|||
124880758|NCT01693692|449185615|FG001|Overall Study|Adverse Event|14|||
124880759|NCT01693692|449185616|FG002|Overall Study|Adverse Event|9|||
124880760|NCT01693692|449185614|FG000|Overall Study|Physician Decision|0|||
124880761|NCT01693692|449185615|FG001|Overall Study|Physician Decision|0|||
124880762|NCT01693692|449185616|FG002|Overall Study|Physician Decision|1|||
124880763|NCT01693692|449185614|FG000|Overall Study|Protocol Violation|5|||
124880764|NCT01693692|449185615|FG001|Overall Study|Protocol Violation|4|||
124880765|NCT01693692|449185616|FG002|Overall Study|Protocol Violation|6|||
124880766|NCT01693692|449185614|FG000|Overall Study|Lost to Follow-up|2|||
124880767|NCT01693692|449185615|FG001|Overall Study|Lost to Follow-up|2|||
124880768|NCT01693692|449185616|FG002|Overall Study|Lost to Follow-up|3|||
124880769|NCT01693692|449185614|FG000|Overall Study|Other|4|||
124880770|NCT01693692|449185615|FG001|Overall Study|Other|4|||
124880771|NCT01693692|449185616|FG002|Overall Study|Other|6|||
124880772|NCT00663117|449186940|FG000|Overall Study|Lack of Efficacy|1|||
124880773|NCT00663117|449186941|FG001|Overall Study|Lack of Efficacy|0|||
124880774|NCT04022889|449186950|FG000|Stage 1: Period 1|Adverse Event|1|||
124880775|NCT04022889|449186951|FG001|Stage 1: Period 1|Adverse Event|0|||
124880776|NCT04022889|449186952|FG002|Stage 1: Period 1|Adverse Event|0|||
124880777|NCT04022889|449186950|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
125014459|NCT03882970|449678770|FG002|Overall Study|Physician Decision|2|||
125014460|NCT03882970|449678771|FG003|Overall Study|Physician Decision|2|||
125014461|NCT03882970|449678768|FG000|Overall Study|Protocol Violation|2|||
125014462|NCT03882970|449678769|FG001|Overall Study|Protocol Violation|0|||
125014463|NCT03882970|449678770|FG002|Overall Study|Protocol Violation|0|||
125014464|NCT03882970|449678771|FG003|Overall Study|Protocol Violation|0|||
125014465|NCT03882970|449678768|FG000|Overall Study|Withdrawal by Subject|8|||
125014466|NCT03882970|449678769|FG001|Overall Study|Withdrawal by Subject|17|||
125014467|NCT03882970|449678770|FG002|Overall Study|Withdrawal by Subject|7|||
125014468|NCT03882970|449678771|FG003|Overall Study|Withdrawal by Subject|22|||
125014469|NCT03882970|449678768|FG000|Overall Study|Personal Reason|2|||
125014470|NCT03882970|449678769|FG001|Overall Study|Personal Reason|3|||
124880778|NCT04022889|449186951|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
124880779|NCT04022889|449186952|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
124880780|NCT04022889|449186950|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
124880781|NCT04022889|449186951|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
124880782|NCT04022889|449186952|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
124880783|NCT04022889|449186950|FG000|Stage 2|Screen Failure|0|||
124880784|NCT04022889|449186951|FG001|Stage 2|Screen Failure|0|||
124880785|NCT04022889|449186952|FG002|Stage 2|Screen Failure|3|||
124880786|NCT04022889|449186950|FG000|Stage 2|Ineligible for apheresis donation|0|||
124880787|NCT04022889|449186951|FG001|Stage 2|Ineligible for apheresis donation|0|||
124880788|NCT04022889|449186952|FG002|Stage 2|Ineligible for apheresis donation|2|||
124880789|NCT04022889|449186950|FG000|Stage 2|Adverse Event|0|||
124880790|NCT04022889|449186951|FG001|Stage 2|Adverse Event|0|||
124880791|NCT04022889|449186952|FG002|Stage 2|Adverse Event|2|||
124880792|NCT04022889|449186950|FG000|Stage 2|Protocol Violation|0|||
124880793|NCT04022889|449186951|FG001|Stage 2|Protocol Violation|0|||
124880794|NCT04022889|449186952|FG002|Stage 2|Protocol Violation|1|||
124880795|NCT04022889|449186950|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
124880796|NCT04022889|449186951|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
124880797|NCT04022889|449186952|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
124880798|NCT00605319|449186954|FG000|Overall Study|Adverse Event|6|||
124880799|NCT01478113|449186955|FG000|Overall Study|Withdrawal by Subject|0|||
124880800|NCT01478113|449186956|FG001|Overall Study|Withdrawal by Subject|1|||
124880801|NCT01478113|449186955|FG000|Overall Study|Physician Decision|1|||
124880802|NCT01478113|449186956|FG001|Overall Study|Physician Decision|0|||
124880803|NCT03093428|449186959|FG000|Overall Study|Not eligible for treatment|2|||
124880804|NCT03093428|449186960|FG001|Overall Study|Not eligible for treatment|1|||
124880805|NCT03093428|449186959|FG000|Overall Study|Progression|14|||
124880806|NCT03093428|449186960|FG001|Overall Study|Progression|4|||
124880807|NCT03093428|449186959|FG000|Overall Study|Death|1|||
124880808|NCT03093428|449186960|FG001|Overall Study|Death|0|||
124880809|NCT03093428|449186959|FG000|Overall Study|Adverse Event|1|||
124880810|NCT03093428|449186960|FG001|Overall Study|Adverse Event|0|||
124880811|NCT03093428|449186959|FG000|Overall Study|Withdrawal by Subject|1|||
124880812|NCT03093428|449186960|FG001|Overall Study|Withdrawal by Subject|1|||
124880813|NCT03980184|449186961|FG000|Overall Study|Dropped out before treatment|2|||
124880814|NCT03980184|449186962|FG001|Overall Study|Dropped out before treatment|2|||
124880815|NCT03980184|449186961|FG000|Overall Study|Lost to Follow-up|11|||
124880816|NCT03980184|449186962|FG001|Overall Study|Lost to Follow-up|13|||
124880817|NCT01616771|449186963|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
124880818|NCT04041440|449186964|FG000|Overall Study|Withdrawal by Subject|0|||
124880819|NCT04041440|449186965|FG001|Overall Study|Withdrawal by Subject|1|||
124880820|NCT04041440|449186964|FG000|Overall Study|Lost to Follow-up|0|||
124880821|NCT04041440|449186965|FG001|Overall Study|Lost to Follow-up|1|||
124880822|NCT01381874|449186966|FG000|Overall Study|Lost to Follow-up|1|||
124880823|NCT01381874|449186967|FG001|Overall Study|Lost to Follow-up|1|||
124880824|NCT01381874|449186968|FG002|Overall Study|Lost to Follow-up|0|||
124880825|NCT01381874|449186966|FG000|Overall Study|Withdrawal by Subject|9|||
124880826|NCT01381874|449186967|FG001|Overall Study|Withdrawal by Subject|10|||
124880827|NCT01381874|449186968|FG002|Overall Study|Withdrawal by Subject|9|||
124880828|NCT01381874|449186966|FG000|Overall Study|Other|67|||
124880829|NCT01381874|449186967|FG001|Overall Study|Other|52|||
124880830|NCT01381874|449186968|FG002|Overall Study|Other|67|||
124880831|NCT02247804|449186969|FG000|Treatment Period 1|Adverse Event|9|||
124880832|NCT02247804|449186970|FG001|Treatment Period 1|Adverse Event|2|||
124880833|NCT02247804|449186971|FG002|Treatment Period 1|Adverse Event|0|||
124880834|NCT02247804|449186969|FG000|Treatment Period 1|Lack of Efficacy|0|||
124880835|NCT02247804|449186970|FG001|Treatment Period 1|Lack of Efficacy|0|||
124880836|NCT02247804|449186971|FG002|Treatment Period 1|Lack of Efficacy|2|||
124880837|NCT02247804|449186969|FG000|Treatment Period 1|Lost to Follow-up|1|||
124880838|NCT02247804|449186970|FG001|Treatment Period 1|Lost to Follow-up|0|||
124880839|NCT02247804|449186971|FG002|Treatment Period 1|Lost to Follow-up|2|||
124880840|NCT02247804|449186969|FG000|Treatment Period 1|Personal Reasons|7|||
124880841|NCT02247804|449186970|FG001|Treatment Period 1|Personal Reasons|1|||
124880842|NCT02247804|449186971|FG002|Treatment Period 1|Personal Reasons|2|||
124880843|NCT02247804|449186969|FG000|Treatment Period 1|Protocol Deviation|0|||
124880844|NCT02247804|449186970|FG001|Treatment Period 1|Protocol Deviation|0|||
124880845|NCT02247804|449186971|FG002|Treatment Period 1|Protocol Deviation|1|||
124880846|NCT02247804|449186969|FG000|Treatment Period 1|Randomized but not Treated|5|||
124880847|NCT02247804|449186970|FG001|Treatment Period 1|Randomized but not Treated|1|||
124880848|NCT02247804|449186971|FG002|Treatment Period 1|Randomized but not Treated|1|||
124880849|NCT02247804|449186969|FG000|Treatment Period 2|Adverse Event|6|||
124880850|NCT02247804|449186970|FG001|Treatment Period 2|Adverse Event|3|||
124880851|NCT02247804|449186971|FG002|Treatment Period 2|Adverse Event|3|||
124880852|NCT02247804|449186969|FG000|Treatment Period 2|Lack of Efficacy|0|||
124880853|NCT02247804|449186970|FG001|Treatment Period 2|Lack of Efficacy|0|||
124880854|NCT02247804|449186971|FG002|Treatment Period 2|Lack of Efficacy|1|||
124880855|NCT02247804|449186969|FG000|Treatment Period 2|Lost to Follow-up|0|||
124880856|NCT02247804|449186970|FG001|Treatment Period 2|Lost to Follow-up|1|||
124880857|NCT02247804|449186971|FG002|Treatment Period 2|Lost to Follow-up|1|||
124880858|NCT02247804|449186969|FG000|Treatment Period 2|Personal Reasons|2|||
124880859|NCT02247804|449186970|FG001|Treatment Period 2|Personal Reasons|1|||
124880860|NCT02247804|449186971|FG002|Treatment Period 2|Personal Reasons|1|||
124880861|NCT02247804|449186969|FG000|Treatment Period 2|Reason not Specified|0|||
124880862|NCT02247804|449186970|FG001|Treatment Period 2|Reason not Specified|0|||
124880863|NCT02247804|449186971|FG002|Treatment Period 2|Reason not Specified|2|||
124880864|NCT02247804|449186969|FG000|Treatment Period 3|Adverse Event|4|||
124880865|NCT02247804|449186970|FG001|Treatment Period 3|Adverse Event|3|||
124880866|NCT02247804|449186971|FG002|Treatment Period 3|Adverse Event|3|||
124880867|NCT02247804|449186969|FG000|Treatment Period 3|Lack of Efficacy|0|||
124880868|NCT02247804|449186970|FG001|Treatment Period 3|Lack of Efficacy|1|||
124880869|NCT02247804|449186971|FG002|Treatment Period 3|Lack of Efficacy|0|||
124880870|NCT02247804|449186969|FG000|Treatment Period 3|Lost to Follow-up|1|||
124880871|NCT02247804|449186970|FG001|Treatment Period 3|Lost to Follow-up|2|||
124880872|NCT02247804|449186971|FG002|Treatment Period 3|Lost to Follow-up|2|||
124880873|NCT02247804|449186969|FG000|Treatment Period 3|Personal Reasons|4|||
124880874|NCT02247804|449186970|FG001|Treatment Period 3|Personal Reasons|3|||
124880875|NCT02247804|449186971|FG002|Treatment Period 3|Personal Reasons|2|||
124880876|NCT02247804|449186969|FG000|Treatment Period 3|Reason not Specified|2|||
124880877|NCT02247804|449186970|FG001|Treatment Period 3|Reason not Specified|1|||
124880878|NCT02247804|449186971|FG002|Treatment Period 3|Reason not Specified|3|||
124880879|NCT02917265|449186978|FG000|Overall Study|Physician Decision|1|||
125104256|NCT01389024|450004071|FG001|Overall Study|Withdrawal by Subject|1|||
125104257|NCT01389024|450004070|FG000|Overall Study|Lost to Follow-up|1|||
124880880|NCT02917265|449186979|FG001|Overall Study|Physician Decision|0|||
124880881|NCT02917265|449186978|FG000|Overall Study|Withdrawal by Subject|1|||
124880882|NCT02917265|449186979|FG001|Overall Study|Withdrawal by Subject|0|||
125104258|NCT01389024|450004071|FG001|Overall Study|Lost to Follow-up|0|||
124880883|NCT01737996|449186981|FG000|Overall Study|Adverse Event|0|||
124880884|NCT01737996|449186982|FG001|Overall Study|Adverse Event|1|||
124880885|NCT01737996|449186983|FG002|Overall Study|Adverse Event|1|||
124880886|NCT01737996|449186981|FG000|Overall Study|Withdrawal by Subject|0|||
124880887|NCT01737996|449186982|FG001|Overall Study|Withdrawal by Subject|0|||
124880888|NCT01737996|449186983|FG002|Overall Study|Withdrawal by Subject|1|||
124880889|NCT00452413|449186984|FG000|Overall Study|Progressive Disease|4|||
124880890|NCT00452413|449186985|FG001|Overall Study|Progressive Disease|11|||
124880891|NCT00452413|449186986|FG002|Overall Study|Progressive Disease|30|||
124880892|NCT00452413|449186984|FG000|Overall Study|Withdrawal by Subject|0|||
124880893|NCT00452413|449186985|FG001|Overall Study|Withdrawal by Subject|1|||
124880894|NCT00452413|449186986|FG002|Overall Study|Withdrawal by Subject|4|||
124880895|NCT00452413|449186984|FG000|Overall Study|Adverse Event|0|||
124880896|NCT00452413|449186985|FG001|Overall Study|Adverse Event|0|||
124880897|NCT00452413|449186986|FG002|Overall Study|Adverse Event|5|||
124880898|NCT00452413|449186984|FG000|Overall Study|Physician Decision|0|||
125014471|NCT03882970|449678770|FG002|Overall Study|Personal Reason|1|||
125014472|NCT03882970|449678771|FG003|Overall Study|Personal Reason|3|||
125014473|NCT02830776|449678785|FG000|Overall Study|Lost to Follow-up|1|||
125014474|NCT00607386|449678786|FG000|Overall Study|Physician Decision|1|||
125014475|NCT00440947|449678787|FG000|36-Week Induction Phase|Adverse Event|16|||
125014476|NCT00440947|449678788|FG001|36-Week Induction Phase|Adverse Event|0|||
125014477|NCT00440947|449678789|FG002|36-Week Induction Phase|Adverse Event|0|||
125014478|NCT00440947|449678790|FG003|36-Week Induction Phase|Adverse Event|0|||
125014479|NCT00440947|449678791|FG004|36-Week Induction Phase|Adverse Event|0|||
125014480|NCT00440947|449678787|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
125014481|NCT00440947|449678788|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
125014482|NCT00440947|449678789|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
125014483|NCT00440947|449678790|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
125014484|NCT00440947|449678791|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
125014485|NCT00440947|449678787|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
125014486|NCT00440947|449678788|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
125014487|NCT00440947|449678789|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
125014488|NCT00440947|449678790|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
125014489|NCT00440947|449678791|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
125014490|NCT00440947|449678787|FG000|36-Week Induction Phase|Non-compliance|10|||
125014491|NCT00440947|449678788|FG001|36-Week Induction Phase|Non-compliance|0|||
125014492|NCT00440947|449678789|FG002|36-Week Induction Phase|Non-compliance|0|||
125014493|NCT00440947|449678790|FG003|36-Week Induction Phase|Non-compliance|0|||
125014494|NCT00440947|449678791|FG004|36-Week Induction Phase|Non-compliance|0|||
125014495|NCT00440947|449678787|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
125014496|NCT00440947|449678788|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
125014497|NCT00440947|449678789|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
125014498|NCT00440947|449678790|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
125014499|NCT00440947|449678791|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
125014500|NCT00440947|449678787|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
125014501|NCT00440947|449678788|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
125014502|NCT00440947|449678789|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
125014503|NCT00440947|449678790|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
125014504|NCT00440947|449678791|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
125014505|NCT00440947|449678787|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
125014506|NCT00440947|449678788|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
125014507|NCT00440947|449678789|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
125014508|NCT00440947|449678790|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
125014509|NCT00440947|449678791|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
125014510|NCT00440947|449678787|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
125014511|NCT00440947|449678788|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
125014512|NCT00440947|449678789|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
125014513|NCT00440947|449678790|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
125014514|NCT00440947|449678791|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
125014515|NCT00440947|449678787|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
125014516|NCT00440947|449678788|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
125014517|NCT00440947|449678789|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
125014518|NCT00440947|449678790|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
125014519|NCT00440947|449678791|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
125014520|NCT00440947|449678787|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
125014521|NCT00440947|449678788|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
125014522|NCT00440947|449678789|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
125014523|NCT00440947|449678790|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
125014524|NCT00440947|449678791|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
124880899|NCT00452413|449186985|FG001|Overall Study|Physician Decision|0|||
124880900|NCT00452413|449186986|FG002|Overall Study|Physician Decision|4|||
124880901|NCT00452413|449186984|FG000|Overall Study|Death due to study disease|0|||
124880902|NCT00452413|449186985|FG001|Overall Study|Death due to study disease|0|||
124880903|NCT00452413|449186986|FG002|Overall Study|Death due to study disease|2|||
124880904|NCT00452413|449186984|FG000|Overall Study|Death due to adverse event (AE)|0|||
124880905|NCT00452413|449186985|FG001|Overall Study|Death due to adverse event (AE)|0|||
124880906|NCT00452413|449186986|FG002|Overall Study|Death due to adverse event (AE)|1|||
124880907|NCT00452413|449186984|FG000|Overall Study|On treatment|0|||
124880908|NCT00452413|449186985|FG001|Overall Study|On treatment|0|||
124880909|NCT00452413|449186986|FG002|Overall Study|On treatment|3|||
124880910|NCT03119610|449186988|FG000|Overall Study|Adverse Event|1|||
124880911|NCT03119610|449186989|FG001|Overall Study|Adverse Event|0|||
124880912|NCT03119610|449186988|FG000|Overall Study|Lost to Follow-up|0|||
124880913|NCT03119610|449186989|FG001|Overall Study|Lost to Follow-up|1|||
124880914|NCT00114634|449186990|FG000|Overall Study|failure to return forms|3|||
124880915|NCT03283696|449186991|FG000|Overall Study|Physician Decision|5|||
124880916|NCT03283696|449186992|FG001|Overall Study|Physician Decision|6|||
124880917|NCT03283696|449186991|FG000|Overall Study|Withdrawal by Subject|2|||
124880918|NCT03283696|449186992|FG001|Overall Study|Withdrawal by Subject|0|||
124880919|NCT02765490|449186993|FG000|Overall Study|Lost to Follow-up|1|||
124880920|NCT02765490|449186994|FG001|Overall Study|Lost to Follow-up|1|||
124880921|NCT02765490|449186993|FG000|Overall Study|Other|0|||
124880922|NCT02765490|449186994|FG001|Overall Study|Other|1|||
124880923|NCT02765490|449186993|FG000|Overall Study|Death|0|||
124880924|NCT02765490|449186994|FG001|Overall Study|Death|1|||
124880925|NCT01350505|449186995|FG000|Overall Study|Lost to Follow-up|4|||
124880926|NCT00007475|449186996|FG000|Overall Study|Withdrawal by Subject|1|||
124880927|NCT00007475|449186997|FG001|Overall Study|Withdrawal by Subject|0|||
124880928|NCT00007475|449186998|FG002|Overall Study|Withdrawal by Subject|0|||
124880929|NCT00007475|449186999|FG003|Overall Study|Withdrawal by Subject|0|||
124880930|NCT00007475|449186996|FG000|Overall Study|Adverse Event|3|||
124880931|NCT00007475|449186997|FG001|Overall Study|Adverse Event|0|||
124880932|NCT00007475|449186998|FG002|Overall Study|Adverse Event|0|||
124880933|NCT00007475|449186999|FG003|Overall Study|Adverse Event|0|||
124880934|NCT01512745|449187000|FG000|Overall Study|Adverse Event|22|||
124880935|NCT01512745|449187001|FG001|Overall Study|Adverse Event|3|||
124880936|NCT01512745|449187000|FG000|Overall Study|Death|9|||
124880937|NCT01512745|449187001|FG001|Overall Study|Death|13|||
124880938|NCT01512745|449187000|FG000|Overall Study|Withdrawal by Subject|2|||
124880939|NCT01512745|449187001|FG001|Overall Study|Withdrawal by Subject|2|||
124880940|NCT01512745|449187000|FG000|Overall Study|Lost to Follow-up|4|||
124880941|NCT01512745|449187001|FG001|Overall Study|Lost to Follow-up|0|||
124880942|NCT01512745|449187000|FG000|Overall Study|Lack of Efficacy|2|||
124880943|NCT01512745|449187001|FG001|Overall Study|Lack of Efficacy|2|||
125104259|NCT00819091|450004072|FG000|Overall Study|Adverse Event|3|||
125104260|NCT00819091|450004073|FG001|Overall Study|Adverse Event|5|||
125104261|NCT00819091|450004072|FG000|Overall Study|Protocol Violation|0|||
125104262|NCT00819091|450004073|FG001|Overall Study|Protocol Violation|1|||
125104263|NCT00819091|450004072|FG000|Overall Study|Lost to Follow-up|2|||
125104264|NCT00819091|450004073|FG001|Overall Study|Lost to Follow-up|0|||
125104265|NCT00819091|450004072|FG000|Overall Study|Withdrawal by Subject|1|||
125104266|NCT00819091|450004073|FG001|Overall Study|Withdrawal by Subject|2|||
125104267|NCT00819091|450004072|FG000|Overall Study|Other|1|||
125104268|NCT00819091|450004073|FG001|Overall Study|Other|2|||
125104269|NCT01461369|450004076|FG000|Overall Study|Lack of Efficacy|2|||
125104270|NCT01461369|450004077|FG001|Overall Study|Lack of Efficacy|0|||
124880944|NCT01512745|449187000|FG000|Overall Study|Protocol Violation|1|||
124880945|NCT01512745|449187001|FG001|Overall Study|Protocol Violation|0|||
124880946|NCT02357810|449187002|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
124880947|NCT02357810|449187002|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
124880948|NCT02357810|449187002|FG000|Reached 12 Weeks Response|Adverse Event|5|||
124880949|NCT02357810|449187002|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
125104271|NCT01461369|450004078|FG002|Overall Study|Lack of Efficacy|6|||
124880950|NCT02357810|449187002|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
124880951|NCT02357810|449187002|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
124880952|NCT02357810|449187002|FG000|Reached 12 Weeks Response|Death|1|||
124880953|NCT02357810|449187002|FG000|Reached 12 Weeks Response|Physician Decision|1|||
125104272|NCT01461369|450004076|FG000|Overall Study|Lost to Follow-up|0|||
125104273|NCT01461369|450004077|FG001|Overall Study|Lost to Follow-up|0|||
125104274|NCT01461369|450004078|FG002|Overall Study|Lost to Follow-up|3|||
125014525|NCT00440947|449678787|FG000|36-Week Induction Phase|Incarceration|3|||
125014526|NCT00440947|449678788|FG001|36-Week Induction Phase|Incarceration|0|||
125014527|NCT00440947|449678789|FG002|36-Week Induction Phase|Incarceration|0|||
125014528|NCT00440947|449678790|FG003|36-Week Induction Phase|Incarceration|0|||
125014529|NCT00440947|449678791|FG004|36-Week Induction Phase|Incarceration|0|||
125014530|NCT00440947|449678787|FG000|36-Week Induction Phase|Pregnancy|1|||
125014531|NCT00440947|449678788|FG001|36-Week Induction Phase|Pregnancy|0|||
125014532|NCT00440947|449678789|FG002|36-Week Induction Phase|Pregnancy|0|||
125014533|NCT00440947|449678790|FG003|36-Week Induction Phase|Pregnancy|0|||
125014534|NCT00440947|449678791|FG004|36-Week Induction Phase|Pregnancy|0|||
125014535|NCT00440947|449678787|FG000|48-Week Randomization Phase|Adverse Event|0|||
125014536|NCT00440947|449678788|FG001|48-Week Randomization Phase|Adverse Event|2|||
125014537|NCT00440947|449678789|FG002|48-Week Randomization Phase|Adverse Event|5|||
125014538|NCT00440947|449678790|FG003|48-Week Randomization Phase|Adverse Event|0|||
125014539|NCT00440947|449678791|FG004|48-Week Randomization Phase|Adverse Event|0|||
125014540|NCT00440947|449678787|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
125014541|NCT00440947|449678788|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
125014542|NCT00440947|449678789|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
125014543|NCT00440947|449678790|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
125014544|NCT00440947|449678791|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
125014545|NCT00440947|449678787|FG000|48-Week Randomization Phase|Non-compliance|0|||
125014546|NCT00440947|449678788|FG001|48-Week Randomization Phase|Non-compliance|3|||
125014547|NCT00440947|449678789|FG002|48-Week Randomization Phase|Non-compliance|4|||
125014548|NCT00440947|449678790|FG003|48-Week Randomization Phase|Non-compliance|0|||
125014549|NCT00440947|449678791|FG004|48-Week Randomization Phase|Non-compliance|0|||
125014550|NCT00440947|449678787|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
125014551|NCT00440947|449678788|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
125014552|NCT00440947|449678789|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
125014553|NCT00440947|449678790|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
125014554|NCT00440947|449678791|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
125014555|NCT00440947|449678787|FG000|48-Week Randomization Phase|Protocol Violation|0|||
125014556|NCT00440947|449678788|FG001|48-Week Randomization Phase|Protocol Violation|0|||
125014557|NCT00440947|449678789|FG002|48-Week Randomization Phase|Protocol Violation|1|||
125014558|NCT00440947|449678790|FG003|48-Week Randomization Phase|Protocol Violation|0|||
125014559|NCT00440947|449678791|FG004|48-Week Randomization Phase|Protocol Violation|0|||
125014560|NCT00440947|449678787|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
125014561|NCT00440947|449678788|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
125014562|NCT00440947|449678789|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
125014563|NCT00440947|449678790|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
125014564|NCT00440947|449678791|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
125014565|NCT00440947|449678787|FG000|48-Week Randomization Phase|Pregnancy|0|||
125014566|NCT00440947|449678788|FG001|48-Week Randomization Phase|Pregnancy|0|||
125014567|NCT00440947|449678789|FG002|48-Week Randomization Phase|Pregnancy|1|||
125014568|NCT00440947|449678790|FG003|48-Week Randomization Phase|Pregnancy|0|||
125014569|NCT00440947|449678791|FG004|48-Week Randomization Phase|Pregnancy|0|||
125014570|NCT00440947|449678787|FG000|48-Week Randomization Phase|Incarceration|0|||
125014571|NCT00440947|449678788|FG001|48-Week Randomization Phase|Incarceration|3|||
125014572|NCT00440947|449678789|FG002|48-Week Randomization Phase|Incarceration|0|||
125014573|NCT00440947|449678790|FG003|48-Week Randomization Phase|Incarceration|0|||
125014574|NCT00440947|449678791|FG004|48-Week Randomization Phase|Incarceration|0|||
125014575|NCT00440947|449678787|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
125014576|NCT00440947|449678788|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
125014577|NCT00440947|449678789|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
125014578|NCT00440947|449678790|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
125014579|NCT00440947|449678791|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
125014580|NCT00440947|449678787|FG000|48-Week Randomization Phase|Physician Decision|0|||
125104275|NCT01461369|450004076|FG000|Overall Study|Adverse Event|9|||
125104276|NCT01461369|450004077|FG001|Overall Study|Adverse Event|12|||
125104277|NCT01461369|450004078|FG002|Overall Study|Adverse Event|4|||
125104278|NCT01461369|450004076|FG000|Overall Study|Protocol Violation|1|||
125104279|NCT01461369|450004077|FG001|Overall Study|Protocol Violation|2|||
124880954|NCT02357810|449187002|FG000|Reached 12 Weeks Response|Other|1|||
124880955|NCT02357810|449187002|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
124880956|NCT02357810|449187002|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
124880957|NCT02357810|449187002|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
124880958|NCT02357810|449187002|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
124880959|NCT02357810|449187002|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
124880960|NCT02357810|449187002|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
124880961|NCT01617005|449187004|FG000|Overall Study|Pregnancy|1|||
124880962|NCT01617005|449187004|FG000|Overall Study|Lack of motivation for treatment|1|||
124880963|NCT01225822|449187014|FG000|Overall Study|Adverse Event|13|||
124880964|NCT01225822|449187015|FG001|Overall Study|Adverse Event|31|||
124880965|NCT01225822|449187016|FG002|Overall Study|Adverse Event|18|||
124880966|NCT01225822|449187017|FG003|Overall Study|Adverse Event|23|||
124880967|NCT01225822|449187018|FG004|Overall Study|Adverse Event|14|||
124880968|NCT01225822|449187014|FG000|Overall Study|Protocol Violation|6|||
124880969|NCT01225822|449187015|FG001|Overall Study|Protocol Violation|8|||
124880970|NCT01225822|449187016|FG002|Overall Study|Protocol Violation|6|||
124880971|NCT01225822|449187017|FG003|Overall Study|Protocol Violation|7|||
124880972|NCT01225822|449187018|FG004|Overall Study|Protocol Violation|4|||
124880973|NCT01225822|449187014|FG000|Overall Study|Lost to Follow-up|0|||
124880974|NCT01225822|449187015|FG001|Overall Study|Lost to Follow-up|0|||
124880975|NCT01225822|449187016|FG002|Overall Study|Lost to Follow-up|0|||
124880976|NCT01225822|449187017|FG003|Overall Study|Lost to Follow-up|1|||
124880977|NCT01225822|449187018|FG004|Overall Study|Lost to Follow-up|0|||
124880978|NCT01225822|449187014|FG000|Overall Study|Withdrawal by Subject|6|||
124880979|NCT01225822|449187015|FG001|Overall Study|Withdrawal by Subject|7|||
124880980|NCT01225822|449187016|FG002|Overall Study|Withdrawal by Subject|7|||
124880981|NCT01225822|449187017|FG003|Overall Study|Withdrawal by Subject|11|||
124880982|NCT01225822|449187018|FG004|Overall Study|Withdrawal by Subject|6|||
124880983|NCT01225822|449187014|FG000|Overall Study|Other|13|||
124880984|NCT01225822|449187015|FG001|Overall Study|Other|10|||
124880985|NCT01225822|449187016|FG002|Overall Study|Other|7|||
124880986|NCT01225822|449187017|FG003|Overall Study|Other|10|||
124880987|NCT01225822|449187018|FG004|Overall Study|Other|7|||
124880988|NCT05644353|449187019|FG000|Overall Study|Physician Decision|1|||
124880989|NCT05644353|449187020|FG001|Overall Study|Physician Decision|0|||
124880990|NCT05644353|449187021|FG002|Overall Study|Physician Decision|0|||
124880991|NCT05644353|449187022|FG003|Overall Study|Physician Decision|0|||
124880992|NCT05644353|449187023|FG004|Overall Study|Physician Decision|0|||
124880993|NCT05644353|449187024|FG005|Overall Study|Physician Decision|0|||
124880994|NCT05644353|449187019|FG000|Overall Study|Protocol Violation|1|||
124880995|NCT05644353|449187020|FG001|Overall Study|Protocol Violation|0|||
124880996|NCT05644353|449187021|FG002|Overall Study|Protocol Violation|0|||
124880997|NCT05644353|449187022|FG003|Overall Study|Protocol Violation|0|||
124880998|NCT05644353|449187023|FG004|Overall Study|Protocol Violation|0|||
124880999|NCT05644353|449187024|FG005|Overall Study|Protocol Violation|0|||
124881000|NCT05644353|449187019|FG000|Overall Study|Withdrawal by Subject|0|||
124881001|NCT05644353|449187020|FG001|Overall Study|Withdrawal by Subject|2|||
124881002|NCT05644353|449187021|FG002|Overall Study|Withdrawal by Subject|0|||
124881003|NCT05644353|449187022|FG003|Overall Study|Withdrawal by Subject|0|||
124881004|NCT05644353|449187023|FG004|Overall Study|Withdrawal by Subject|1|||
124881005|NCT05644353|449187024|FG005|Overall Study|Withdrawal by Subject|0|||
124881006|NCT05644353|449187019|FG000|Overall Study|Lost to Follow-up|0|||
124881007|NCT05644353|449187020|FG001|Overall Study|Lost to Follow-up|0|||
124881008|NCT05644353|449187021|FG002|Overall Study|Lost to Follow-up|1|||
125104280|NCT01461369|450004078|FG002|Overall Study|Protocol Violation|2|||
125104281|NCT01461369|450004076|FG000|Overall Study|Withdrawal by Subject|1|||
124881009|NCT05644353|449187022|FG003|Overall Study|Lost to Follow-up|0|||
124881010|NCT05644353|449187023|FG004|Overall Study|Lost to Follow-up|0|||
124881011|NCT05644353|449187024|FG005|Overall Study|Lost to Follow-up|0|||
124881012|NCT01407354|449187025|FG000|First Intervention|Withdrawal by Subject|0|||
124881013|NCT01407354|449187026|FG001|First Intervention|Withdrawal by Subject|2|||
124881014|NCT01407354|449187025|FG000|First Intervention|Adverse Event|1|||
124881015|NCT01407354|449187026|FG001|First Intervention|Adverse Event|0|||
124881016|NCT01407354|449187025|FG000|First Intervention|Physician Decision|1|||
124881017|NCT01407354|449187026|FG001|First Intervention|Physician Decision|0|||
124881018|NCT02204579|449187028|FG000|Overall Study|Screen failures|2|||
124881019|NCT02778399|449187029|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
125104282|NCT01461369|450004077|FG001|Overall Study|Withdrawal by Subject|3|||
125104283|NCT01461369|450004078|FG002|Overall Study|Withdrawal by Subject|2|||
124881020|NCT02778399|449187030|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
124881021|NCT02778399|449187031|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
124881022|NCT02778399|449187032|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
124881023|NCT02778399|449187033|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
124881024|NCT02778399|449187034|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
124881025|NCT02778399|449187029|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
124881026|NCT02778399|449187030|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
124881027|NCT02778399|449187031|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
124881028|NCT02778399|449187032|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
124881029|NCT02778399|449187033|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
124881030|NCT02778399|449187034|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
124881031|NCT02778399|449187029|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
124881032|NCT02778399|449187030|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
124881033|NCT02778399|449187031|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
124881034|NCT02778399|449187032|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
124881035|NCT02778399|449187033|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
124881036|NCT02778399|449187034|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
124881037|NCT02778399|449187029|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
124881038|NCT02778399|449187030|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
124881039|NCT02778399|449187031|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
124881040|NCT02778399|449187032|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
124881041|NCT02778399|449187033|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
124881042|NCT02778399|449187034|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
124881043|NCT02778399|449187029|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
124881044|NCT02778399|449187030|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
124881045|NCT02778399|449187031|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
124881046|NCT02778399|449187032|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
124881047|NCT02778399|449187033|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
124881048|NCT02778399|449187034|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
124881049|NCT02778399|449187029|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
124881050|NCT02778399|449187030|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
124881051|NCT02778399|449187031|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
124881052|NCT02778399|449187032|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
124881053|NCT02778399|449187033|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
124881054|NCT02778399|449187034|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
124881055|NCT02778399|449187029|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
124881056|NCT02778399|449187030|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
124881057|NCT02778399|449187031|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
124881058|NCT02778399|449187032|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
124881059|NCT02778399|449187033|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
124881060|NCT02778399|449187034|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
124881061|NCT02778399|449187029|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
124881062|NCT02778399|449187030|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
124881063|NCT02778399|449187031|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
124881064|NCT02778399|449187032|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
124881065|NCT02778399|449187033|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
124881066|NCT02778399|449187034|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
124881067|NCT02778399|449187029|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
124881068|NCT02778399|449187030|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
124881069|NCT02778399|449187031|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
124881070|NCT02778399|449187032|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
124881071|NCT02778399|449187033|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
124881072|NCT02778399|449187034|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
124881073|NCT02778399|449187029|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
124881074|NCT02778399|449187030|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
124881075|NCT02778399|449187031|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
124881076|NCT02778399|449187032|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
124881077|NCT02778399|449187033|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
124881078|NCT02778399|449187034|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
124881079|NCT02778399|449187029|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
125014581|NCT00440947|449678788|FG001|48-Week Randomization Phase|Physician Decision|2|||
125014582|NCT00440947|449678789|FG002|48-Week Randomization Phase|Physician Decision|0|||
125014583|NCT00440947|449678790|FG003|48-Week Randomization Phase|Physician Decision|0|||
125014584|NCT00440947|449678791|FG004|48-Week Randomization Phase|Physician Decision|0|||
125014585|NCT00440947|449678787|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
125014586|NCT00440947|449678788|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
125014587|NCT00440947|449678789|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
125014588|NCT00440947|449678790|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
125014589|NCT00440947|449678791|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
124881080|NCT02778399|449187030|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
124881081|NCT02778399|449187031|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
124881082|NCT02778399|449187032|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
124881083|NCT02778399|449187033|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
124881084|NCT02778399|449187034|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
124881085|NCT00612534|449187037|FG000|Overall Study|Adverse Event|0|||
124881086|NCT00612534|449187038|FG001|Overall Study|Adverse Event|4|||
124881087|NCT00612534|449187039|FG002|Overall Study|Adverse Event|2|||
124881088|NCT00612534|449187040|FG003|Overall Study|Adverse Event|1|||
124881089|NCT00612534|449187037|FG000|Overall Study|Lack of Efficacy|13|||
124881090|NCT00612534|449187038|FG001|Overall Study|Lack of Efficacy|12|||
124881091|NCT00612534|449187039|FG002|Overall Study|Lack of Efficacy|5|||
124881092|NCT00612534|449187040|FG003|Overall Study|Lack of Efficacy|16|||
124881093|NCT00612534|449187037|FG000|Overall Study|Other Reason|0|||
124881094|NCT00612534|449187038|FG001|Overall Study|Other Reason|1|||
124881095|NCT00612534|449187039|FG002|Overall Study|Other Reason|0|||
124881096|NCT00612534|449187040|FG003|Overall Study|Other Reason|0|||
124881097|NCT03916744|449187041|FG000|Overall Study|Withdrawal by Subject|0|||
124881098|NCT03916744|449187042|FG001|Overall Study|Withdrawal by Subject|1|||
124881099|NCT03916744|449187043|FG002|Overall Study|Withdrawal by Subject|2|||
124881100|NCT02223754|449187044|FG000|Period 1|Adverse Event|1|||
124881101|NCT02223754|449187045|FG001|Period 1|Adverse Event|0|||
124881102|NCT02223754|449187044|FG000|Period 1|Lost to Follow-up|0|||
124881103|NCT02223754|449187045|FG001|Period 1|Lost to Follow-up|1|||
124881104|NCT02223754|449187044|FG000|Period 1|Protocol Violation|2|||
124881105|NCT02223754|449187045|FG001|Period 1|Protocol Violation|4|||
124881106|NCT02223754|449187044|FG000|Period 1|Withdrawal by Subject|0|||
124881107|NCT02223754|449187045|FG001|Period 1|Withdrawal by Subject|4|||
124881108|NCT02223754|449187044|FG000|Period 1|Test Article No Longer Available|1|||
124881109|NCT02223754|449187045|FG001|Period 1|Test Article No Longer Available|5|||
124881110|NCT02223754|449187044|FG000|Period 1|Unsatisfactory Visual Response|0|||
124881111|NCT02223754|449187045|FG001|Period 1|Unsatisfactory Visual Response|1|||
124881112|NCT02223754|449187044|FG000|Period 2|Adverse Event|0|||
125104284|NCT00734617|450004085|FG000|Overall Study|Adverse Event|4|||
125104285|NCT00734617|450004086|FG001|Overall Study|Adverse Event|7|||
125104286|NCT00734617|450004085|FG000|Overall Study|Withdrawal by Subject|103|||
125104287|NCT00734617|450004086|FG001|Overall Study|Withdrawal by Subject|95|||
125104288|NCT02367729|450004087|FG000|Overall Study|Organic disorder diagnosed|2|||
125104289|NCT02367729|450004088|FG001|Overall Study|Organic disorder diagnosed|1|||
125104290|NCT02367729|450004087|FG000|Overall Study|Adverse Event|1|||
125104291|NCT02367729|450004088|FG001|Overall Study|Adverse Event|2|||
125104292|NCT02367729|450004087|FG000|Overall Study|Withdrawal by Subject|0|||
125104293|NCT02367729|450004088|FG001|Overall Study|Withdrawal by Subject|5|||
125104294|NCT02742818|450004098|FG000|Overall Study|Adverse Event|0|||
125104295|NCT02742818|450004099|FG001|Overall Study|Adverse Event|1|||
125104296|NCT02742818|450004098|FG000|Overall Study|Protocol Violation|0|||
124881113|NCT02223754|449187045|FG001|Period 2|Adverse Event|1|||
124881114|NCT02223754|449187044|FG000|Period 2|Protocol Violation|1|||
124881115|NCT02223754|449187045|FG001|Period 2|Protocol Violation|0|||
125104297|NCT02742818|450004099|FG001|Overall Study|Protocol Violation|1|||
125104298|NCT01260194|450004100|FG000|Overall Study|Withdrawal of Consent|1|||
125104299|NCT04854707|450004102|FG000|Overall Study|Lack of Efficacy|78|||
124881116|NCT02223754|449187044|FG000|Period 2|Lens Discomfort|1|||
124881117|NCT02223754|449187045|FG001|Period 2|Lens Discomfort|1|||
124881118|NCT02223754|449187044|FG000|Period 2|Lost to Follow-up|1|||
124881119|NCT02223754|449187045|FG001|Period 2|Lost to Follow-up|0|||
124881120|NCT02223754|449187044|FG000|Period 2|Test Article No Longer Available|0|||
124881121|NCT02223754|449187045|FG001|Period 2|Test Article No Longer Available|1|||
124881122|NCT01008475|449187046|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
124881123|NCT01008475|449187047|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
124881124|NCT01008475|449187048|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
124881125|NCT01008475|449187049|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
124881126|NCT01008475|449187050|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
124881127|NCT01008475|449187051|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
124881128|NCT01008475|449187052|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
124881129|NCT03556358|449187054|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
124881130|NCT03556358|449187055|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
124881131|NCT03556358|449187054|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
124881132|NCT03556358|449187055|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
124881133|NCT03556358|449187054|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
124881134|NCT03556358|449187055|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
124881135|NCT03556358|449187054|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
124881136|NCT03556358|449187055|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
124881137|NCT03556358|449187054|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
124881138|NCT03556358|449187055|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
124881139|NCT03556358|449187054|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
124881140|NCT03556358|449187055|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
124881141|NCT03556358|449187054|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
124881142|NCT03556358|449187055|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
124881143|NCT02917941|449187058|FG000|Treatment Period|Adverse Event|11|||
124881144|NCT02917941|449187058|FG000|Treatment Period|Progressive Disease|11|||
124881145|NCT02917941|449187058|FG000|Treatment Period|Reason not Specified|2|||
124881146|NCT02917941|449187058|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
124881147|NCT02917941|449187058|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
124881148|NCT01351025|449187059|FG000|Week 0 - 20|Lost to Follow-up|2|||
124881149|NCT01351025|449187060|FG001|Week 0 - 20|Lost to Follow-up|1|||
124881150|NCT01351025|449187059|FG000|Week 0 - 20|Withdrawal by Subject|1|||
124881151|NCT01351025|449187060|FG001|Week 0 - 20|Withdrawal by Subject|0|||
124881152|NCT01351025|449187059|FG000|Week 24 - 44|Lost to Follow-up|0|||
124881153|NCT01351025|449187060|FG001|Week 24 - 44|Lost to Follow-up|2|||
124881154|NCT01351025|449187059|FG000|Week 24 - 44|Site closed|0|||
124881155|NCT01351025|449187060|FG001|Week 24 - 44|Site closed|1|||
124881156|NCT01351025|449187059|FG000|Week 24 - 44|unable to get to clinic|1|||
124881157|NCT01351025|449187060|FG001|Week 24 - 44|unable to get to clinic|1|||
124881158|NCT03573908|449187065|FG000|Treatment Period|Adverse Event|4|||
124881159|NCT03573908|449187066|FG001|Treatment Period|Adverse Event|9|||
124881160|NCT03573908|449187067|FG002|Treatment Period|Adverse Event|0|||
124881161|NCT03573908|449187068|FG003|Treatment Period|Adverse Event|0|||
124881162|NCT03573908|449187069|FG004|Treatment Period|Adverse Event|0|||
124881163|NCT03573908|449187065|FG000|Treatment Period|Protocol Violation|1|||
124881164|NCT03573908|449187066|FG001|Treatment Period|Protocol Violation|0|||
124881165|NCT03573908|449187067|FG002|Treatment Period|Protocol Violation|0|||
124881166|NCT03573908|449187068|FG003|Treatment Period|Protocol Violation|0|||
124881167|NCT03573908|449187069|FG004|Treatment Period|Protocol Violation|0|||
124881168|NCT03573908|449187065|FG000|Treatment Period|Withdrawal by Subject|7|||
124881169|NCT03573908|449187066|FG001|Treatment Period|Withdrawal by Subject|5|||
124881170|NCT03573908|449187067|FG002|Treatment Period|Withdrawal by Subject|0|||
124881171|NCT03573908|449187068|FG003|Treatment Period|Withdrawal by Subject|0|||
124881172|NCT03573908|449187069|FG004|Treatment Period|Withdrawal by Subject|0|||
124881173|NCT03573908|449187065|FG000|Treatment Period|Lost to Follow-up|7|||
124881174|NCT03573908|449187066|FG001|Treatment Period|Lost to Follow-up|6|||
124881175|NCT03573908|449187067|FG002|Treatment Period|Lost to Follow-up|0|||
125104300|NCT04854707|450004103|FG001|Overall Study|Lack of Efficacy|59|||
125104301|NCT04854707|450004104|FG002|Overall Study|Lack of Efficacy|30|||
125104302|NCT05674721|450004114|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
124881176|NCT03573908|449187068|FG003|Treatment Period|Lost to Follow-up|0|||
125104303|NCT05674721|450004115|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
124881177|NCT03573908|449187069|FG004|Treatment Period|Lost to Follow-up|0|||
124881178|NCT03573908|449187065|FG000|Treatment Period|Pregnancy|1|||
124881179|NCT03573908|449187066|FG001|Treatment Period|Pregnancy|0|||
124881180|NCT03573908|449187067|FG002|Treatment Period|Pregnancy|0|||
124881181|NCT03573908|449187068|FG003|Treatment Period|Pregnancy|0|||
124881182|NCT03573908|449187069|FG004|Treatment Period|Pregnancy|0|||
124881183|NCT03573908|449187065|FG000|Treatment Period|Other, Not Specified|4|||
124881184|NCT03573908|449187066|FG001|Treatment Period|Other, Not Specified|6|||
124881185|NCT03573908|449187067|FG002|Treatment Period|Other, Not Specified|0|||
124881186|NCT03573908|449187068|FG003|Treatment Period|Other, Not Specified|0|||
124881187|NCT03573908|449187069|FG004|Treatment Period|Other, Not Specified|0|||
124881188|NCT03573908|449187065|FG000|Randomized Withdrawal Period|Adverse Event|0|||
124881189|NCT03573908|449187066|FG001|Randomized Withdrawal Period|Adverse Event|0|||
124881190|NCT03573908|449187067|FG002|Randomized Withdrawal Period|Adverse Event|3|||
124881191|NCT03573908|449187068|FG003|Randomized Withdrawal Period|Adverse Event|0|||
124881192|NCT03573908|449187069|FG004|Randomized Withdrawal Period|Adverse Event|0|||
124881193|NCT03573908|449187065|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124881194|NCT03573908|449187066|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124881195|NCT03573908|449187067|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124881196|NCT03573908|449187068|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124881197|NCT03573908|449187069|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
124881198|NCT03573908|449187065|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
124881199|NCT03573908|449187066|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
124881200|NCT03573908|449187067|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
124881201|NCT03573908|449187068|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
124881202|NCT03573908|449187069|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
124881203|NCT03573908|449187065|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
124881204|NCT03573908|449187066|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
124881205|NCT03573908|449187067|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
124881206|NCT03573908|449187068|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
124881207|NCT03573908|449187069|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
124881208|NCT02669095|449187072|FG000|Overall Study|Adverse Event|1|||
124881209|NCT02669095|449187073|FG001|Overall Study|Adverse Event|0|||
124881210|NCT02669095|449187072|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
124881211|NCT02669095|449187073|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
124881212|NCT02669095|449187072|FG000|Overall Study|Torn Lens|0|||
124881213|NCT02669095|449187073|FG001|Overall Study|Torn Lens|1|||
124881214|NCT02669095|449187072|FG000|Overall Study|Visit 5 assessments not completed|0|||
124881215|NCT02669095|449187073|FG001|Overall Study|Visit 5 assessments not completed|1|||
124881216|NCT00926003|449187074|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
124881217|NCT00926003|449187075|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
124881218|NCT00926003|449187076|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
124881219|NCT00926003|449187074|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
124881220|NCT00926003|449187075|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
124881221|NCT00926003|449187076|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
124881222|NCT00539279|449187083|FG000|Treatment|Withdrawal by Subject|10|||
124881223|NCT00539279|449187084|FG001|Treatment|Withdrawal by Subject|8|||
124881224|NCT00539279|449187083|FG000|Treatment|Death|1|||
124881225|NCT00539279|449187084|FG001|Treatment|Death|0|||
124881226|NCT00539279|449187083|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
124881227|NCT00539279|449187084|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
124881228|NCT00539279|449187083|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
124881229|NCT00539279|449187084|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
124881230|NCT02769065|449189394|FG000|Overall Study|Voluntary Withdrawal|1|||
124881231|NCT02769065|449189395|FG001|Overall Study|Voluntary Withdrawal|0|||
124881232|NCT02769065|449189396|FG002|Overall Study|Voluntary Withdrawal|0|||
124881233|NCT02769065|449189397|FG003|Overall Study|Voluntary Withdrawal|0|||
124881234|NCT02769065|449189398|FG004|Overall Study|Voluntary Withdrawal|0|||
124881235|NCT02769065|449189399|FG005|Overall Study|Voluntary Withdrawal|0|||
124881236|NCT02769065|449189400|FG006|Overall Study|Voluntary Withdrawal|0|||
124881237|NCT02769065|449189401|FG007|Overall Study|Voluntary Withdrawal|0|||
124881238|NCT02769065|449189402|FG008|Overall Study|Voluntary Withdrawal|0|||
124881239|NCT02769065|449189403|FG009|Overall Study|Voluntary Withdrawal|0|||
124881240|NCT02769065|449189404|FG010|Overall Study|Voluntary Withdrawal|0|||
124881241|NCT02769065|449189405|FG011|Overall Study|Voluntary Withdrawal|0|||
124881242|NCT02769065|449189406|FG012|Overall Study|Voluntary Withdrawal|0|||
125014590|NCT00440947|449678787|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
125014591|NCT00440947|449678788|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
125014592|NCT00440947|449678789|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
125014593|NCT00440947|449678790|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
124881243|NCT02769065|449189407|FG013|Overall Study|Voluntary Withdrawal|0|||
124881244|NCT02769065|449189408|FG014|Overall Study|Voluntary Withdrawal|0|||
124881245|NCT02769065|449189409|FG015|Overall Study|Voluntary Withdrawal|0|||
124881246|NCT02769065|449189410|FG016|Overall Study|Voluntary Withdrawal|0|||
124881247|NCT02769065|449189411|FG017|Overall Study|Voluntary Withdrawal|0|||
124881248|NCT02769065|449189412|FG018|Overall Study|Voluntary Withdrawal|0|||
124881249|NCT02769065|449189413|FG019|Overall Study|Voluntary Withdrawal|0|||
124881250|NCT02769065|449189414|FG020|Overall Study|Voluntary Withdrawal|0|||
124881251|NCT02769065|449189415|FG021|Overall Study|Voluntary Withdrawal|0|||
124881252|NCT02769065|449189416|FG022|Overall Study|Voluntary Withdrawal|0|||
124881253|NCT02769065|449189417|FG023|Overall Study|Voluntary Withdrawal|0|||
124881254|NCT02769065|449189418|FG024|Overall Study|Voluntary Withdrawal|0|||
124881255|NCT02769065|449189419|FG025|Overall Study|Voluntary Withdrawal|0|||
124881256|NCT02769065|449189420|FG026|Overall Study|Voluntary Withdrawal|0|||
124881257|NCT02769065|449189421|FG027|Overall Study|Voluntary Withdrawal|0|||
124881258|NCT02769065|449189422|FG028|Overall Study|Voluntary Withdrawal|0|||
124881259|NCT02769065|449189423|FG029|Overall Study|Voluntary Withdrawal|0|||
124881260|NCT02769065|449189394|FG000|Overall Study|Reason Not Specified|0|||
124881261|NCT02769065|449189395|FG001|Overall Study|Reason Not Specified|0|||
124881262|NCT02769065|449189396|FG002|Overall Study|Reason Not Specified|0|||
124881263|NCT02769065|449189397|FG003|Overall Study|Reason Not Specified|0|||
124881264|NCT02769065|449189398|FG004|Overall Study|Reason Not Specified|0|||
124881265|NCT02769065|449189399|FG005|Overall Study|Reason Not Specified|0|||
124881266|NCT02769065|449189400|FG006|Overall Study|Reason Not Specified|1|||
124881267|NCT02769065|449189401|FG007|Overall Study|Reason Not Specified|0|||
124881268|NCT02769065|449189402|FG008|Overall Study|Reason Not Specified|0|||
124881269|NCT02769065|449189403|FG009|Overall Study|Reason Not Specified|0|||
124881270|NCT02769065|449189404|FG010|Overall Study|Reason Not Specified|0|||
124881271|NCT02769065|449189405|FG011|Overall Study|Reason Not Specified|0|||
124881272|NCT02769065|449189406|FG012|Overall Study|Reason Not Specified|0|||
124881273|NCT02769065|449189407|FG013|Overall Study|Reason Not Specified|0|||
124881274|NCT02769065|449189408|FG014|Overall Study|Reason Not Specified|0|||
124881275|NCT02769065|449189409|FG015|Overall Study|Reason Not Specified|0|||
124881276|NCT02769065|449189410|FG016|Overall Study|Reason Not Specified|0|||
124881277|NCT02769065|449189411|FG017|Overall Study|Reason Not Specified|0|||
124881278|NCT02769065|449189412|FG018|Overall Study|Reason Not Specified|0|||
124881279|NCT02769065|449189413|FG019|Overall Study|Reason Not Specified|0|||
124881280|NCT02769065|449189414|FG020|Overall Study|Reason Not Specified|0|||
124881281|NCT02769065|449189415|FG021|Overall Study|Reason Not Specified|0|||
124881282|NCT02769065|449189416|FG022|Overall Study|Reason Not Specified|0|||
124881283|NCT02769065|449189417|FG023|Overall Study|Reason Not Specified|0|||
124881284|NCT02769065|449189418|FG024|Overall Study|Reason Not Specified|0|||
124881285|NCT02769065|449189419|FG025|Overall Study|Reason Not Specified|0|||
124881286|NCT02769065|449189420|FG026|Overall Study|Reason Not Specified|0|||
124881287|NCT02769065|449189421|FG027|Overall Study|Reason Not Specified|0|||
124881288|NCT02769065|449189422|FG028|Overall Study|Reason Not Specified|0|||
124881289|NCT02769065|449189423|FG029|Overall Study|Reason Not Specified|0|||
124881290|NCT02769065|449189394|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881291|NCT02769065|449189395|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881292|NCT02769065|449189396|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881293|NCT02769065|449189397|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881294|NCT02769065|449189398|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881295|NCT02769065|449189399|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881296|NCT02769065|449189400|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881297|NCT02769065|449189401|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881298|NCT02769065|449189402|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881299|NCT02769065|449189403|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881300|NCT02769065|449189404|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
124881301|NCT02769065|449189405|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881302|NCT02769065|449189406|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881303|NCT02769065|449189407|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881304|NCT02769065|449189408|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881305|NCT02769065|449189409|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881306|NCT02769065|449189410|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881307|NCT02769065|449189411|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881308|NCT02769065|449189412|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881309|NCT02769065|449189413|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881310|NCT02769065|449189414|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881311|NCT02769065|449189415|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881312|NCT02769065|449189416|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881313|NCT02769065|449189417|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
125104304|NCT05674721|450004114|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
125104305|NCT05674721|450004115|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
125104306|NCT05013749|450004124|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
125104307|NCT05013749|450004125|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
125104308|NCT05013749|450004124|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
125104309|NCT05013749|450004125|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
125104310|NCT02017535|450004128|FG000|Overall Study|Withdrawal by Subject|1|||
125104311|NCT02017535|450004129|FG001|Overall Study|Withdrawal by Subject|0|||
124881314|NCT02769065|449189418|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881315|NCT02769065|449189419|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881316|NCT02769065|449189420|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881317|NCT02769065|449189421|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881318|NCT02769065|449189422|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881319|NCT02769065|449189423|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881320|NCT02764775|449189426|FG000|Overall Study|Death|1|||
124881321|NCT02764775|449189426|FG000|Overall Study|Lost to Follow-up|2|||
124881322|NCT02764775|449189426|FG000|Overall Study|Withdrawal by Subject|3|||
124881323|NCT00767104|449189429|FG000|Overall Study|Lost to Follow-up|1|||
124881324|NCT00767104|449189430|FG001|Overall Study|Lost to Follow-up|2|||
124881325|NCT01186328|449189438|FG000|Overall Study|Death|1|||
124881326|NCT01186328|449189439|FG001|Overall Study|Death|0|||
124881327|NCT01186328|449189440|FG002|Overall Study|Death|0|||
124881328|NCT03015116|449189443|FG000|Overall Study|Lost to Follow-up|3|||
124881329|NCT03015116|449189444|FG001|Overall Study|Lost to Follow-up|0|||
124881330|NCT03015116|449189445|FG002|Overall Study|Lost to Follow-up|2|||
124881331|NCT03015116|449189443|FG000|Overall Study|Withdrawal by Subject|3|||
124881332|NCT03015116|449189444|FG001|Overall Study|Withdrawal by Subject|1|||
124881333|NCT03015116|449189445|FG002|Overall Study|Withdrawal by Subject|0|||
124881334|NCT03015116|449189443|FG000|Overall Study|Subject has New Medical Status|1|||
124881335|NCT03015116|449189444|FG001|Overall Study|Subject has New Medical Status|0|||
124881336|NCT03015116|449189445|FG002|Overall Study|Subject has New Medical Status|0|||
124881337|NCT03015116|449189443|FG000|Overall Study|Physician Decision|0|||
124881338|NCT03015116|449189444|FG001|Overall Study|Physician Decision|1|||
124881339|NCT03015116|449189445|FG002|Overall Study|Physician Decision|0|||
124881340|NCT02200939|449189450|FG000|Overall Study|Participant withdrew consent|0|||
124881341|NCT02200939|449189451|FG001|Overall Study|Participant withdrew consent|1|||
124881342|NCT02200939|449189450|FG000|Overall Study|Lost to Follow-up|2|||
124881343|NCT02200939|449189451|FG001|Overall Study|Lost to Follow-up|9|||
124881344|NCT02200939|449189450|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
124881345|NCT02200939|449189451|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
124881346|NCT02762981|449189452|FG000|Overall Study|Adverse Event|2|||
124881347|NCT02762981|449189453|FG001|Overall Study|Adverse Event|3|||
124881348|NCT02762981|449189454|FG002|Overall Study|Adverse Event|1|||
124881349|NCT02762981|449189455|FG003|Overall Study|Adverse Event|1|||
124881350|NCT02762981|449189456|FG004|Overall Study|Adverse Event|3|||
124881351|NCT02762981|449189452|FG000|Overall Study|Physician Decision|0|||
124881352|NCT02762981|449189453|FG001|Overall Study|Physician Decision|1|||
124881353|NCT02762981|449189454|FG002|Overall Study|Physician Decision|0|||
124881354|NCT02762981|449189455|FG003|Overall Study|Physician Decision|0|||
124881355|NCT02762981|449189456|FG004|Overall Study|Physician Decision|1|||
124881356|NCT02762981|449189452|FG000|Overall Study|Disease progression|11|||
124881357|NCT02762981|449189453|FG001|Overall Study|Disease progression|23|||
124881358|NCT02762981|449189454|FG002|Overall Study|Disease progression|4|||
124881359|NCT02762981|449189455|FG003|Overall Study|Disease progression|10|||
124881360|NCT02762981|449189456|FG004|Overall Study|Disease progression|1|||
124881361|NCT02762981|449189452|FG000|Overall Study|Enrolled not treated|1|||
124881362|NCT02762981|449189453|FG001|Overall Study|Enrolled not treated|5|||
124881363|NCT02762981|449189454|FG002|Overall Study|Enrolled not treated|0|||
124881364|NCT02762981|449189455|FG003|Overall Study|Enrolled not treated|2|||
124881365|NCT02762981|449189456|FG004|Overall Study|Enrolled not treated|0|||
124881366|NCT02762981|449189452|FG000|Overall Study|Other|2|||
124881367|NCT02762981|449189453|FG001|Overall Study|Other|3|||
124881368|NCT02762981|449189454|FG002|Overall Study|Other|1|||
124881369|NCT02762981|449189455|FG003|Overall Study|Other|0|||
124881370|NCT02762981|449189456|FG004|Overall Study|Other|0|||
124881371|NCT02762981|449189452|FG000|Overall Study|Missing|1|||
124881372|NCT02762981|449189453|FG001|Overall Study|Missing|0|||
124881373|NCT02762981|449189454|FG002|Overall Study|Missing|0|||
124881374|NCT02762981|449189455|FG003|Overall Study|Missing|0|||
124881375|NCT02762981|449189456|FG004|Overall Study|Missing|0|||
124881376|NCT02762981|449189452|FG000|Overall Study|Withdrawal by Subject|0|||
124881377|NCT02762981|449189453|FG001|Overall Study|Withdrawal by Subject|5|||
124881378|NCT02762981|449189454|FG002|Overall Study|Withdrawal by Subject|1|||
124881379|NCT02762981|449189455|FG003|Overall Study|Withdrawal by Subject|3|||
124881380|NCT02762981|449189456|FG004|Overall Study|Withdrawal by Subject|0|||
124881381|NCT01382940|449189457|FG000|Overall Study|Adverse Event|19|||
124881382|NCT01382940|449189457|FG000|Overall Study|Lost to Follow-up|4|||
124881383|NCT01382940|449189457|FG000|Overall Study|Physician Decision|7|||
124881384|NCT01382940|449189457|FG000|Overall Study|Withdrawal by Subject|23|||
124881385|NCT01382940|449189457|FG000|Overall Study|Protocol Violation|20|||
124881386|NCT00244374|449189460|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
124881387|NCT00244374|449189461|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
124881388|NCT00244374|449189462|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
124881389|NCT00244374|449189463|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
124881390|NCT00244374|449189464|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
124881391|NCT00244374|449189460|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
124881392|NCT00244374|449189461|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
124881393|NCT00244374|449189462|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
124881394|NCT00244374|449189463|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
124881395|NCT00244374|449189464|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
124881396|NCT00244374|449189460|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
124881397|NCT00244374|449189461|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
124881398|NCT00244374|449189462|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
124881399|NCT00244374|449189463|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
124881400|NCT00244374|449189464|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
124881401|NCT00244374|449189460|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
124881402|NCT00244374|449189461|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
124881403|NCT00244374|449189462|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
124881404|NCT00244374|449189463|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
124881405|NCT00244374|449189464|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
124881406|NCT00244374|449189460|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
124881407|NCT00244374|449189461|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
124881408|NCT00244374|449189462|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
124881409|NCT00244374|449189463|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
124881410|NCT00244374|449189464|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
124881411|NCT00244374|449189460|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
124881412|NCT00244374|449189461|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
124881413|NCT00244374|449189462|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
124881414|NCT00244374|449189463|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
124881415|NCT00244374|449189464|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
124881416|NCT00244374|449189460|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
124881417|NCT00244374|449189461|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
124881418|NCT00244374|449189462|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
124881419|NCT00244374|449189463|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
124881420|NCT00244374|449189464|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
124881421|NCT00244374|449189460|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
124881422|NCT00244374|449189461|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
124881423|NCT00244374|449189462|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
124881424|NCT00244374|449189463|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
124881425|NCT00244374|449189464|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
124881426|NCT00244374|449189460|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
124881427|NCT00244374|449189461|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
124881428|NCT00244374|449189462|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
124881429|NCT00244374|449189463|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
124881430|NCT00244374|449189464|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
124881431|NCT00976482|449189465|FG000|Overall Study|Death|208|||
124881432|NCT00976482|449189465|FG000|Overall Study|Withdrawal by Subject|45|||
124881433|NCT00976482|449189465|FG000|Overall Study|Center terminated|1|||
124881434|NCT00976482|449189465|FG000|Overall Study|Protocol Violation|5|||
124881435|NCT00720902|449189468|FG000|Overall Study|Withdrawal by Subject|1|||
124881436|NCT00720902|449189469|FG001|Overall Study|Withdrawal by Subject|0|||
124881437|NCT00720902|449189468|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
124881438|NCT00720902|449189469|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
124881439|NCT01486758|449189470|FG000|Overall Study|Lost to Follow-up|0|||
124881440|NCT01486758|449189471|FG001|Overall Study|Lost to Follow-up|1|||
124881441|NCT02254408|449189479|FG000|Overall Study|Randomized But Not Treated|1|||
125014594|NCT00440947|449678791|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
124881442|NCT02254408|449189480|FG001|Overall Study|Randomized But Not Treated|3|||
124881443|NCT02254408|449189479|FG000|Overall Study|Adverse Event|1|||
124881444|NCT02254408|449189480|FG001|Overall Study|Adverse Event|0|||
124881445|NCT02254408|449189479|FG000|Overall Study|Death|2|||
124881446|NCT02254408|449189480|FG001|Overall Study|Death|3|||
124881447|NCT02254408|449189479|FG000|Overall Study|Investigator's Discretion|0|||
124881448|NCT02254408|449189480|FG001|Overall Study|Investigator's Discretion|1|||
124881449|NCT02254408|449189479|FG000|Overall Study|Withdrawal by Subject|3|||
124881450|NCT02254408|449189480|FG001|Overall Study|Withdrawal by Subject|3|||
124881451|NCT02254408|449189479|FG000|Overall Study|Lost to Follow-up|1|||
124881452|NCT02254408|449189480|FG001|Overall Study|Lost to Follow-up|0|||
124881453|NCT02914184|449189482|FG000|Overall Study|Lost to Follow-up|7|||
124881454|NCT02914184|449189483|FG001|Overall Study|Lost to Follow-up|10|||
124881455|NCT02914184|449189484|FG002|Overall Study|Lost to Follow-up|8|||
124881456|NCT02914184|449189485|FG003|Overall Study|Lost to Follow-up|7|||
124881457|NCT02914184|449189482|FG000|Overall Study|Withdrawal by Subject|4|||
124881458|NCT02914184|449189483|FG001|Overall Study|Withdrawal by Subject|2|||
124881459|NCT02914184|449189484|FG002|Overall Study|Withdrawal by Subject|7|||
124881460|NCT02914184|449189485|FG003|Overall Study|Withdrawal by Subject|3|||
124881461|NCT02914184|449189482|FG000|Overall Study|Other|1|||
124881462|NCT02914184|449189483|FG001|Overall Study|Other|0|||
124881463|NCT02914184|449189484|FG002|Overall Study|Other|0|||
124881464|NCT02914184|449189485|FG003|Overall Study|Other|0|||
124881465|NCT02914184|449189482|FG000|Overall Study|Migrated/moved from the study area|2|||
124881466|NCT02914184|449189483|FG001|Overall Study|Migrated/moved from the study area|1|||
124881467|NCT02914184|449189484|FG002|Overall Study|Migrated/moved from the study area|2|||
124881468|NCT02914184|449189485|FG003|Overall Study|Migrated/moved from the study area|1|||
124881469|NCT00798174|449189486|FG000|Overall Study|inability to implant azygos coil|3|||
124881470|NCT00798174|449189487|FG001|Overall Study|inability to implant azygos coil|3|||
124881471|NCT00798174|449189486|FG000|Overall Study|Inability to sedate for DFT testing|1|||
124881472|NCT00798174|449189487|FG001|Overall Study|Inability to sedate for DFT testing|0|||
124881473|NCT01642602|449189493|FG000|Overall Study|Adverse Event|2|||
124881474|NCT01460160|449189494|FG000|Treatment Phase|Lack of Efficacy|3|||
124881475|NCT01460160|449189494|FG000|Treatment Phase|Study Drug Toxicity|2|||
124881476|NCT01460160|449189494|FG000|Treatment Phase|Adverse Event|8|||
124881477|NCT01460160|449189494|FG000|Treatment Phase|Withdrawal by Subject|4|||
124881478|NCT01460160|449189494|FG000|Treatment Phase|Death|2|||
124881479|NCT01460160|449189494|FG000|Treatment Phase|Other reasons|9|||
124881480|NCT01460160|449189494|FG000|Follow-up Phase|Withdrawal by Subject|4|||
124881481|NCT01460160|449189494|FG000|Follow-up Phase|Death|14|||
124881482|NCT01460160|449189494|FG000|Follow-up Phase|Lost to Follow-up|7|||
124881483|NCT01460160|449189494|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
124881484|NCT01460160|449189494|FG000|Follow-up Phase|Other and not reported reasons|5|||
124881485|NCT00100932|449189495|FG000|Overall Study|Adverse Event|11|||
124881486|NCT00100932|449189496|FG001|Overall Study|Adverse Event|2|||
124881487|NCT00100932|449189495|FG000|Overall Study|Withdrawal by Subject|6|||
124881488|NCT00100932|449189496|FG001|Overall Study|Withdrawal by Subject|0|||
124881489|NCT00100932|449189495|FG000|Overall Study|Progressive Disease|44|||
124881490|NCT00100932|449189496|FG001|Overall Study|Progressive Disease|18|||
124881491|NCT00100932|449189495|FG000|Overall Study|Physician Decision|7|||
124881492|NCT00100932|449189496|FG001|Overall Study|Physician Decision|5|||
124881493|NCT00100932|449189495|FG000|Overall Study|Other|5|||
124881494|NCT00100932|449189496|FG001|Overall Study|Other|2|||
124881495|NCT00744328|449189497|FG000|Overall Study|Lost to Follow-up|2|||
124881496|NCT00744328|449189498|FG001|Overall Study|Lost to Follow-up|5|||
124881497|NCT00744328|449189499|FG002|Overall Study|Lost to Follow-up|3|||
124881498|NCT00744328|449189497|FG000|Overall Study|Withdrawal by Subject|5|||
124881499|NCT00744328|449189498|FG001|Overall Study|Withdrawal by Subject|3|||
124881500|NCT00744328|449189499|FG002|Overall Study|Withdrawal by Subject|4|||
124881501|NCT00744328|449189497|FG000|Overall Study|Found ineligible after randomization|0|||
124881502|NCT00744328|449189498|FG001|Overall Study|Found ineligible after randomization|0|||
124881503|NCT00744328|449189499|FG002|Overall Study|Found ineligible after randomization|1|||
124881504|NCT02387216|449189502|FG000|Overall Study|Progressive disease|2|||
124881505|NCT02387216|449189503|FG001|Overall Study|Progressive disease|0|||
124881506|NCT02387216|449189502|FG000|Overall Study|Withdrawal by Subject|3|||
125014595|NCT00440947|449678787|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
125014596|NCT00440947|449678788|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
125014597|NCT00440947|449678789|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
125014598|NCT00440947|449678790|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
125014599|NCT00440947|449678791|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
124881507|NCT02387216|449189503|FG001|Overall Study|Withdrawal by Subject|5|||
124881508|NCT02387216|449189502|FG000|Overall Study|Physician Decision|2|||
124881509|NCT02387216|449189503|FG001|Overall Study|Physician Decision|0|||
124881510|NCT02387216|449189502|FG000|Overall Study|Sponsor Decision|28|||
124881511|NCT02387216|449189503|FG001|Overall Study|Sponsor Decision|12|||
124881512|NCT02387216|449189502|FG000|Overall Study|Death|60|||
124881513|NCT02387216|449189503|FG001|Overall Study|Death|23|||
124881514|NCT02387216|449189502|FG000|Overall Study|Other|5|||
124881515|NCT02387216|449189503|FG001|Overall Study|Other|4|||
124881516|NCT02387216|449189502|FG000|Overall Study|Lost to Follow-up|0|||
124881517|NCT02387216|449189503|FG001|Overall Study|Lost to Follow-up|3|||
124881518|NCT00557622|449189507|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
124881519|NCT00557622|449189508|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
124881520|NCT00557622|449189507|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
124881521|NCT00557622|449189508|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
124881522|NCT00557622|449189507|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
124881523|NCT00557622|449189508|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
124881524|NCT01539863|449189509|FG000|Overall Study|Lost to Follow-up|5|||
124881525|NCT01539863|449189510|FG001|Overall Study|Lost to Follow-up|4|||
124881526|NCT01468922|449189513|FG000|Overall Study|Screening failure|0|||
124881527|NCT01468922|449189514|FG001|Overall Study|Screening failure|0|||
124881528|NCT01468922|449189515|FG002|Overall Study|Screening failure|0|||
124881529|NCT01468922|449189516|FG003|Overall Study|Screening failure|0|||
124881530|NCT01468922|449189517|FG004|Overall Study|Screening failure|0|||
124881531|NCT01468922|449189518|FG005|Overall Study|Screening failure|0|||
124881532|NCT01468922|449189519|FG006|Overall Study|Screening failure|0|||
124881533|NCT01468922|449189520|FG007|Overall Study|Screening failure|0|||
124881534|NCT01468922|449189521|FG008|Overall Study|Screening failure|1|||
124881535|NCT01468922|449189513|FG000|Overall Study|Per patient choice|1|||
124881536|NCT01468922|449189514|FG001|Overall Study|Per patient choice|0|||
124881537|NCT01468922|449189515|FG002|Overall Study|Per patient choice|0|||
124881538|NCT01468922|449189516|FG003|Overall Study|Per patient choice|0|||
124881539|NCT01468922|449189517|FG004|Overall Study|Per patient choice|0|||
124881540|NCT01468922|449189518|FG005|Overall Study|Per patient choice|0|||
124881541|NCT01468922|449189519|FG006|Overall Study|Per patient choice|0|||
124881542|NCT01468922|449189520|FG007|Overall Study|Per patient choice|0|||
124881543|NCT01468922|449189521|FG008|Overall Study|Per patient choice|0|||
124881544|NCT01468922|449189513|FG000|Overall Study|Switched to alternative treatment|1|||
124881545|NCT01468922|449189514|FG001|Overall Study|Switched to alternative treatment|0|||
124881546|NCT01468922|449189515|FG002|Overall Study|Switched to alternative treatment|0|||
124881547|NCT01468922|449189516|FG003|Overall Study|Switched to alternative treatment|0|||
124881548|NCT01468922|449189517|FG004|Overall Study|Switched to alternative treatment|1|||
124881549|NCT01468922|449189518|FG005|Overall Study|Switched to alternative treatment|0|||
124881550|NCT01468922|449189519|FG006|Overall Study|Switched to alternative treatment|0|||
124881551|NCT01468922|449189520|FG007|Overall Study|Switched to alternative treatment|0|||
124881552|NCT01468922|449189521|FG008|Overall Study|Switched to alternative treatment|0|||
124881553|NCT01468922|449189513|FG000|Overall Study|Enrolled on new protocol|0|||
124881554|NCT01468922|449189514|FG001|Overall Study|Enrolled on new protocol|0|||
124881555|NCT01468922|449189515|FG002|Overall Study|Enrolled on new protocol|0|||
124881556|NCT01468922|449189516|FG003|Overall Study|Enrolled on new protocol|0|||
124881557|NCT01468922|449189517|FG004|Overall Study|Enrolled on new protocol|1|||
124881558|NCT01468922|449189518|FG005|Overall Study|Enrolled on new protocol|0|||
124881559|NCT01468922|449189519|FG006|Overall Study|Enrolled on new protocol|0|||
124881560|NCT01468922|449189520|FG007|Overall Study|Enrolled on new protocol|0|||
124881561|NCT01468922|449189521|FG008|Overall Study|Enrolled on new protocol|0|||
124881562|NCT01468922|449189513|FG000|Overall Study|Adverse Event|0|||
124881563|NCT01468922|449189514|FG001|Overall Study|Adverse Event|0|||
124881564|NCT01468922|449189515|FG002|Overall Study|Adverse Event|0|||
124881565|NCT01468922|449189516|FG003|Overall Study|Adverse Event|0|||
124881566|NCT01468922|449189517|FG004|Overall Study|Adverse Event|0|||
124881567|NCT01468922|449189518|FG005|Overall Study|Adverse Event|0|||
124881568|NCT01468922|449189519|FG006|Overall Study|Adverse Event|0|||
124881569|NCT01468922|449189520|FG007|Overall Study|Adverse Event|1|||
124881570|NCT01468922|449189521|FG008|Overall Study|Adverse Event|0|||
124881571|NCT01468922|449189513|FG000|Overall Study|Infection of blood|0|||
124881572|NCT01468922|449189514|FG001|Overall Study|Infection of blood|0|||
124881573|NCT01468922|449189515|FG002|Overall Study|Infection of blood|0|||
124881574|NCT01468922|449189516|FG003|Overall Study|Infection of blood|0|||
124881575|NCT01468922|449189517|FG004|Overall Study|Infection of blood|0|||
124881576|NCT01468922|449189518|FG005|Overall Study|Infection of blood|0|||
124881577|NCT01468922|449189519|FG006|Overall Study|Infection of blood|0|||
124881578|NCT01468922|449189520|FG007|Overall Study|Infection of blood|1|||
124881579|NCT01468922|449189521|FG008|Overall Study|Infection of blood|0|||
124881580|NCT01468922|449189513|FG000|Overall Study|Patient choice - surgery|0|||
124881581|NCT01468922|449189514|FG001|Overall Study|Patient choice - surgery|0|||
124881582|NCT01468922|449189515|FG002|Overall Study|Patient choice - surgery|0|||
124881583|NCT01468922|449189516|FG003|Overall Study|Patient choice - surgery|0|||
124881584|NCT01468922|449189517|FG004|Overall Study|Patient choice - surgery|0|||
124881585|NCT01468922|449189518|FG005|Overall Study|Patient choice - surgery|0|||
124881586|NCT01468922|449189519|FG006|Overall Study|Patient choice - surgery|0|||
124881587|NCT01468922|449189520|FG007|Overall Study|Patient choice - surgery|1|||
124881588|NCT01468922|449189521|FG008|Overall Study|Patient choice - surgery|0|||
124881589|NCT01468922|449189513|FG000|Overall Study|Refused further treatment|0|||
124881590|NCT01468922|449189514|FG001|Overall Study|Refused further treatment|0|||
124881591|NCT01468922|449189515|FG002|Overall Study|Refused further treatment|0|||
124881592|NCT01468922|449189516|FG003|Overall Study|Refused further treatment|0|||
124881593|NCT01468922|449189517|FG004|Overall Study|Refused further treatment|0|||
124881594|NCT01468922|449189518|FG005|Overall Study|Refused further treatment|0|||
124881595|NCT01468922|449189519|FG006|Overall Study|Refused further treatment|0|||
124881596|NCT01468922|449189520|FG007|Overall Study|Refused further treatment|1|||
124881597|NCT01468922|449189521|FG008|Overall Study|Refused further treatment|0|||
124881598|NCT02563522|449189527|FG000|Overall Study|Adverse Event|2|||
124881599|NCT02563522|449189528|FG001|Overall Study|Adverse Event|3|||
124881600|NCT02563522|449189527|FG000|Overall Study|Lost to Follow-up|1|||
124881601|NCT02563522|449189528|FG001|Overall Study|Lost to Follow-up|0|||
124881602|NCT02563522|449189527|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
124881603|NCT02563522|449189528|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
124881604|NCT00675506|449189529|FG000|Overall Study|Lost to Follow-up|1|||
124881605|NCT00675506|449189530|FG001|Overall Study|Lost to Follow-up|5|||
124881606|NCT00675506|449189529|FG000|Overall Study|Lost interest|3|||
124881607|NCT00675506|449189530|FG001|Overall Study|Lost interest|5|||
124881608|NCT00675506|449189529|FG000|Overall Study|Elevated fasting glucose|2|||
124881609|NCT00675506|449189530|FG001|Overall Study|Elevated fasting glucose|1|||
124881610|NCT00675506|449189529|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
124881611|NCT00675506|449189530|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
124881612|NCT00675506|449189529|FG000|Overall Study|Elevated IGF-1|2|||
124881613|NCT00675506|449189530|FG001|Overall Study|Elevated IGF-1|0|||
124881614|NCT00675506|449189529|FG000|Overall Study|Hypersensitivity Reaction|1|||
124881615|NCT00675506|449189530|FG001|Overall Study|Hypersensitivity Reaction|0|||
124881616|NCT00675506|449189529|FG000|Overall Study|Disclosed history of cancer|1|||
124881617|NCT00675506|449189530|FG001|Overall Study|Disclosed history of cancer|0|||
124881618|NCT00675506|449189529|FG000|Overall Study|Declined participation|1|||
124881619|NCT00675506|449189530|FG001|Overall Study|Declined participation|0|||
124881620|NCT00675506|449189529|FG000|Overall Study|Schedule conflict|0|||
124881621|NCT00675506|449189530|FG001|Overall Study|Schedule conflict|1|||
124881622|NCT00936221|449189531|FG000|Overall Study|Withdrawal by Subject|1|||
124881623|NCT00936221|449189532|FG001|Overall Study|Withdrawal by Subject|1|||
124881624|NCT03820323|449189533|FG000|Overall Study|Lost to Follow-up|2|||
124881625|NCT03820323|449189534|FG001|Overall Study|Lost to Follow-up|1|||
124881626|NCT03820323|449189533|FG000|Overall Study|Missed 12-month visit|22|||
124881627|NCT03820323|449189534|FG001|Overall Study|Missed 12-month visit|14|||
125014600|NCT00440947|449678787|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
125014601|NCT00440947|449678788|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
125014602|NCT00440947|449678789|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
125014603|NCT00440947|449678790|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
125014604|NCT00440947|449678791|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
125014605|NCT00440947|449678787|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
125014606|NCT00440947|449678788|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
125014607|NCT00440947|449678789|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
124881628|NCT03820323|449189533|FG000|Overall Study|Death|2|||
124881629|NCT03820323|449189534|FG001|Overall Study|Death|1|||
124881630|NCT03820323|449189533|FG000|Overall Study|Transferred out|13|||
124881631|NCT03820323|449189534|FG001|Overall Study|Transferred out|11|||
124881632|NCT03820323|449189533|FG000|Overall Study|Terminated|0|||
124881633|NCT03820323|449189534|FG001|Overall Study|Terminated|3|||
124881634|NCT03820323|449189533|FG000|Overall Study|Withdrawal by Subject|1|||
124881635|NCT03820323|449189534|FG001|Overall Study|Withdrawal by Subject|6|||
124881636|NCT03151395|449189535|FG000|Overall Study|Adverse Event|2|||
124881637|NCT03151395|449189535|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
124881638|NCT03151395|449189535|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
124881639|NCT03151395|449189535|FG000|Overall Study|Unspecified reason|4|||
124881640|NCT00879996|449189536|FG000|Overall Study|Lost to Follow-up|7|||
124881641|NCT00879996|449189537|FG001|Overall Study|Lost to Follow-up|6|||
124881642|NCT00879996|449189536|FG000|Overall Study|non-compliance|6|||
124881643|NCT00879996|449189537|FG001|Overall Study|non-compliance|4|||
124881644|NCT00879996|449189536|FG000|Overall Study|Physician Decision|1|||
124881645|NCT00879996|449189537|FG001|Overall Study|Physician Decision|2|||
124881646|NCT00879996|449189536|FG000|Overall Study|psychiatric problem|0|||
124881647|NCT00879996|449189537|FG001|Overall Study|psychiatric problem|1|||
124881648|NCT00879996|449189536|FG000|Overall Study|put on parole|1|||
124881649|NCT00879996|449189537|FG001|Overall Study|put on parole|0|||
124881650|NCT02597933|449189538|FG000|Overall Study|Withdrawal by Subject|7|||
124881651|NCT02597933|449189539|FG001|Overall Study|Withdrawal by Subject|5|||
124881652|NCT02597933|449189538|FG000|Overall Study|Protocol Violation|2|||
124881653|NCT02597933|449189539|FG001|Overall Study|Protocol Violation|2|||
124881654|NCT02597933|449189538|FG000|Overall Study|Adverse Event|20|||
124881655|NCT02597933|449189539|FG001|Overall Study|Adverse Event|28|||
124881656|NCT02597933|449189538|FG000|Overall Study|Not treated|2|||
124881657|NCT02597933|449189539|FG001|Overall Study|Not treated|2|||
124881658|NCT02597933|449189538|FG000|Overall Study|Other than stated above|7|||
124881659|NCT02597933|449189539|FG001|Overall Study|Other than stated above|14|||
124881660|NCT01107743|449189545|FG000|Overall Study|Protocol Violation|46|||
124881661|NCT00308737|449189546|FG000|Overall Study|Adverse Event|104|||
124881662|NCT00308737|449189547|FG001|Overall Study|Adverse Event|9|||
124881663|NCT00308737|449189548|FG002|Overall Study|Adverse Event|0|||
124881664|NCT00308737|449189546|FG000|Overall Study|Death|4|||
124881665|NCT00308737|449189547|FG001|Overall Study|Death|3|||
124881666|NCT00308737|449189548|FG002|Overall Study|Death|0|||
124881667|NCT00308737|449189546|FG000|Overall Study|Lost to Follow-up|56|||
124881668|NCT00308737|449189547|FG001|Overall Study|Lost to Follow-up|80|||
124881669|NCT00308737|449189548|FG002|Overall Study|Lost to Follow-up|5|||
124881670|NCT00308737|449189546|FG000|Overall Study|Physician Decision|15|||
124881671|NCT00308737|449189547|FG001|Overall Study|Physician Decision|2|||
124881672|NCT00308737|449189548|FG002|Overall Study|Physician Decision|1|||
124881673|NCT00308737|449189546|FG000|Overall Study|Protocol Violation|34|||
124881674|NCT00308737|449189547|FG001|Overall Study|Protocol Violation|9|||
124881675|NCT00308737|449189548|FG002|Overall Study|Protocol Violation|5|||
124881676|NCT00308737|449189546|FG000|Overall Study|Withdrawal by Subject|218|||
124881677|NCT00308737|449189547|FG001|Overall Study|Withdrawal by Subject|166|||
124881678|NCT00308737|449189548|FG002|Overall Study|Withdrawal by Subject|18|||
124881679|NCT00308737|449189546|FG000|Overall Study|Various|32|||
124881680|NCT00308737|449189547|FG001|Overall Study|Various|20|||
124881681|NCT00308737|449189548|FG002|Overall Study|Various|8|||
124881682|NCT04078035|449189551|FG000|Session 2|Lost to Follow-up|3|||
124881683|NCT04078035|449189552|FG001|Session 2|Lost to Follow-up|1|||
124881684|NCT04078035|449189551|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
124881685|NCT04078035|449189552|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
124881686|NCT02954458|449189555|FG000|Overall Study|Adverse Event|0|||
124881687|NCT02954458|449189556|FG001|Overall Study|Adverse Event|0|||
124881688|NCT02954458|449189557|FG002|Overall Study|Adverse Event|0|||
124881689|NCT02954458|449189558|FG003|Overall Study|Adverse Event|1|||
124881690|NCT02954458|449189555|FG000|Overall Study|Withdrawal by Subject|0|||
124881691|NCT02954458|449189556|FG001|Overall Study|Withdrawal by Subject|0|||
124881692|NCT02954458|449189557|FG002|Overall Study|Withdrawal by Subject|0|||
124881693|NCT02954458|449189558|FG003|Overall Study|Withdrawal by Subject|1|||
124881694|NCT02954458|449189555|FG000|Overall Study|Physician Decision|0|||
124881695|NCT02954458|449189556|FG001|Overall Study|Physician Decision|0|||
124881696|NCT02954458|449189557|FG002|Overall Study|Physician Decision|1|||
124881697|NCT02954458|449189558|FG003|Overall Study|Physician Decision|1|||
124881698|NCT02954458|449189555|FG000|Overall Study|Lost to Follow-up|1|||
124881699|NCT02954458|449189556|FG001|Overall Study|Lost to Follow-up|0|||
125104312|NCT02017535|450004130|FG002|Overall Study|Withdrawal by Subject|0|||
125104313|NCT02017535|450004131|FG003|Overall Study|Withdrawal by Subject|0|||
124881700|NCT02954458|449189557|FG002|Overall Study|Lost to Follow-up|0|||
124881701|NCT02954458|449189558|FG003|Overall Study|Lost to Follow-up|1|||
124881702|NCT02954458|449189555|FG000|Overall Study|Death|0|||
124881703|NCT02954458|449189556|FG001|Overall Study|Death|0|||
124881704|NCT02954458|449189557|FG002|Overall Study|Death|0|||
125104314|NCT01393626|450004132|FG000|Overall Study|Adverse Event|2|||
125104315|NCT01393626|450004133|FG001|Overall Study|Adverse Event|1|||
124881705|NCT02954458|449189558|FG003|Overall Study|Death|1|||
124881706|NCT02954458|449189555|FG000|Overall Study|Other|0|||
124881707|NCT02954458|449189556|FG001|Overall Study|Other|0|||
124881708|NCT02954458|449189557|FG002|Overall Study|Other|0|||
124881709|NCT02954458|449189558|FG003|Overall Study|Other|7|||
124881710|NCT01396395|449189564|FG000|Overall Study|Withdrawal by Subject|10|||
124881711|NCT01396395|449189565|FG001|Overall Study|Withdrawal by Subject|12|||
124881712|NCT01396395|449189564|FG000|Overall Study|Protocol Violation|3|||
124881713|NCT01396395|449189565|FG001|Overall Study|Protocol Violation|1|||
124881714|NCT01396395|449189564|FG000|Overall Study|Adverse Event|10|||
125104316|NCT01393626|450004134|FG002|Overall Study|Adverse Event|5|||
124881715|NCT01396395|449189565|FG001|Overall Study|Adverse Event|2|||
124881716|NCT01396395|449189564|FG000|Overall Study|Lost to Follow-up|17|||
124881717|NCT01396395|449189565|FG001|Overall Study|Lost to Follow-up|11|||
124881718|NCT01396395|449189564|FG000|Overall Study|Other|0|||
124881719|NCT01396395|449189565|FG001|Overall Study|Other|1|||
124881720|NCT02460263|449189567|FG000|Transition Period|Withdrawal by Subject|1|||
124881721|NCT02460263|449189567|FG000|Transition Period|Death|1|||
124881722|NCT03176238|449189570|FG000|Overall Study|Unacceptable AEs|15|||
124881723|NCT03176238|449189571|FG001|Overall Study|Unacceptable AEs|8|||
124881724|NCT03176238|449189570|FG000|Overall Study|Abnormal lab value(s)|2|||
124881725|NCT03176238|449189571|FG001|Overall Study|Abnormal lab value(s)|0|||
124881726|NCT03176238|449189570|FG000|Overall Study|Inter-current illness|0|||
124881727|NCT03176238|449189571|FG001|Overall Study|Inter-current illness|1|||
124881728|NCT03176238|449189570|FG000|Overall Study|Consent withdrawal|14|||
124881729|NCT03176238|449189571|FG001|Overall Study|Consent withdrawal|2|||
124881730|NCT03176238|449189570|FG000|Overall Study|Lost to Follow-up|3|||
124881731|NCT03176238|449189571|FG001|Overall Study|Lost to Follow-up|0|||
124881732|NCT03176238|449189570|FG000|Overall Study|Administrative problems|1|||
124881733|NCT03176238|449189571|FG001|Overall Study|Administrative problems|0|||
124881734|NCT03176238|449189570|FG000|Overall Study|Death|3|||
124881735|NCT03176238|449189571|FG001|Overall Study|Death|0|||
124881736|NCT03176238|449189570|FG000|Overall Study|Disease Progression|133|||
124881737|NCT03176238|449189571|FG001|Overall Study|Disease Progression|22|||
124881738|NCT03176238|449189570|FG000|Overall Study|Tx duration completed per EAP|0|||
124881739|NCT03176238|449189571|FG001|Overall Study|Tx duration completed per EAP|1|||
124881740|NCT03176238|449189570|FG000|Overall Study|Patient is switched to commercial drug|16|||
124881741|NCT03176238|449189571|FG001|Overall Study|Patient is switched to commercial drug|1|||
124881742|NCT03176238|449189570|FG000|Overall Study|Protocol Violation|1|||
124881743|NCT03176238|449189571|FG001|Overall Study|Protocol Violation|0|||
124881744|NCT03176238|449189570|FG000|Overall Study|Changes in the patient's condition|2|||
124881745|NCT03176238|449189571|FG001|Overall Study|Changes in the patient's condition|1|||
124881746|NCT03176238|449189570|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
124881747|NCT03176238|449189571|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
124881748|NCT04524598|449189572|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
124881749|NCT04524598|449189573|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
124881750|NCT04524598|449189574|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
124881751|NCT04524598|449189575|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
124881752|NCT04524598|449189576|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
124881753|NCT04524598|449189572|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
124881754|NCT04524598|449189573|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
124881755|NCT04524598|449189574|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
124881756|NCT04524598|449189575|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
124881757|NCT04524598|449189576|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
124881758|NCT04524598|449189572|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
124881759|NCT04524598|449189573|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
124881760|NCT04524598|449189574|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
124881761|NCT04524598|449189575|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
124881762|NCT04524598|449189576|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
124881763|NCT04524598|449189572|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
124881764|NCT04524598|449189573|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
125014608|NCT00440947|449678790|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
125014609|NCT00440947|449678791|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
125014610|NCT00440947|449678787|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
125014611|NCT00440947|449678788|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
125014612|NCT00440947|449678789|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
125014613|NCT00440947|449678790|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
125014614|NCT00440947|449678791|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
125014615|NCT00440947|449678787|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
125014616|NCT00440947|449678788|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
125014617|NCT00440947|449678789|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
125014618|NCT00440947|449678790|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
125014619|NCT00440947|449678791|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
125014620|NCT00440947|449678787|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
125014621|NCT00440947|449678788|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
125014622|NCT00440947|449678789|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
125014623|NCT00440947|449678790|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
124881765|NCT04524598|449189574|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
124881766|NCT04524598|449189575|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
124881767|NCT04524598|449189576|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
124881768|NCT04524598|449189572|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
125104317|NCT01393626|450004135|FG003|Overall Study|Adverse Event|0|||
124881769|NCT04524598|449189573|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
124881770|NCT04524598|449189574|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
124881771|NCT04524598|449189575|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
124881772|NCT04524598|449189576|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
124881773|NCT04524598|449189572|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
124881774|NCT04524598|449189573|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
124881775|NCT04524598|449189574|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
124881776|NCT04524598|449189575|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
124881777|NCT04524598|449189576|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
124881778|NCT04524598|449189572|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
124881779|NCT04524598|449189573|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
124881780|NCT04524598|449189574|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
124881781|NCT04524598|449189575|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
124881782|NCT04524598|449189576|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
124881783|NCT04395183|449189577|FG000|Overall Study|Withdrawal by Subject|1|||
124881784|NCT04395183|449189578|FG001|Overall Study|Withdrawal by Subject|0|||
124881785|NCT04395183|449189579|FG002|Overall Study|Withdrawal by Subject|2|||
124881786|NCT04395183|449189580|FG003|Overall Study|Withdrawal by Subject|2|||
124881787|NCT02569710|449189582|FG000|Overall Study|Adverse Event|1|||
124881788|NCT02569710|449189583|FG001|Overall Study|Adverse Event|0|||
124881789|NCT02569710|449189584|FG002|Overall Study|Adverse Event|0|||
124881790|NCT02569710|449189585|FG003|Overall Study|Adverse Event|0|||
124881791|NCT02569710|449189586|FG004|Overall Study|Adverse Event|0|||
124881792|NCT02569710|449189587|FG005|Overall Study|Adverse Event|0|||
124881793|NCT02569710|449189588|FG006|Overall Study|Adverse Event|0|||
125104318|NCT01393626|450004132|FG000|Overall Study|Did not meet entrance criteria|1|||
125104319|NCT01393626|450004133|FG001|Overall Study|Did not meet entrance criteria|0|||
125104320|NCT01393626|450004134|FG002|Overall Study|Did not meet entrance criteria|0|||
125104321|NCT01393626|450004135|FG003|Overall Study|Did not meet entrance criteria|0|||
125104322|NCT01393626|450004132|FG000|Overall Study|Lack of Efficacy|6|||
125104323|NCT01393626|450004133|FG001|Overall Study|Lack of Efficacy|6|||
125104324|NCT01393626|450004134|FG002|Overall Study|Lack of Efficacy|4|||
125104325|NCT01393626|450004135|FG003|Overall Study|Lack of Efficacy|1|||
125104326|NCT01393626|450004132|FG000|Overall Study|Lost to Follow-up|1|||
125104327|NCT01393626|450004133|FG001|Overall Study|Lost to Follow-up|1|||
125104328|NCT01393626|450004134|FG002|Overall Study|Lost to Follow-up|1|||
125104329|NCT01393626|450004135|FG003|Overall Study|Lost to Follow-up|0|||
125104330|NCT01393626|450004132|FG000|Overall Study|Withdrawal by Subject|6|||
125104331|NCT01393626|450004133|FG001|Overall Study|Withdrawal by Subject|4|||
125104332|NCT01393626|450004134|FG002|Overall Study|Withdrawal by Subject|0|||
125104333|NCT01393626|450004135|FG003|Overall Study|Withdrawal by Subject|0|||
125104334|NCT01393626|450004132|FG000|Overall Study|Other|1|||
125104335|NCT01393626|450004133|FG001|Overall Study|Other|0|||
125104336|NCT01393626|450004134|FG002|Overall Study|Other|0|||
125104337|NCT01393626|450004135|FG003|Overall Study|Other|0|||
125104338|NCT01393626|450004132|FG000|Overall Study|Protocol Violation|1|||
125104339|NCT01393626|450004133|FG001|Overall Study|Protocol Violation|0|||
125104340|NCT01393626|450004134|FG002|Overall Study|Protocol Violation|2|||
125104341|NCT01393626|450004135|FG003|Overall Study|Protocol Violation|0|||
125104342|NCT03506425|450004136|FG000|Overall Study|Adverse Event|1|||
125104343|NCT03506425|450004137|FG001|Overall Study|Adverse Event|3|||
125104344|NCT03506425|450004138|FG002|Overall Study|Adverse Event|0|||
125104345|NCT03506425|450004136|FG000|Overall Study|Death|1|||
125104346|NCT03506425|450004137|FG001|Overall Study|Death|0|||
125104347|NCT03506425|450004138|FG002|Overall Study|Death|0|||
125104348|NCT03506425|450004136|FG000|Overall Study|Withdrawal by Subject|0|||
125104349|NCT03506425|450004137|FG001|Overall Study|Withdrawal by Subject|0|||
125104350|NCT03506425|450004138|FG002|Overall Study|Withdrawal by Subject|1|||
125104351|NCT02643394|450004141|FG000|Overall Study|Protocol Violation|4|||
125104352|NCT02643394|450004142|FG001|Overall Study|Protocol Violation|5|||
125104353|NCT04088734|450004143|FG000|Overall Study|Other, Not Specified|5|||
125104354|NCT03083639|450004150|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
125104355|NCT03083639|450004151|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
124881794|NCT02569710|449189589|FG007|Overall Study|Adverse Event|0|||
125104356|NCT03083639|450004150|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
125104357|NCT03083639|450004151|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
125104358|NCT02125734|450004152|FG000|Period 2|Adverse Event|0|||
125104359|NCT02125734|450004153|FG001|Period 2|Adverse Event|1|||
125104360|NCT01591499|450004154|FG000|Baseline Visit|Withdrawal by Subject|0|||
125104361|NCT01591499|450004155|FG001|Baseline Visit|Withdrawal by Subject|2|||
125104362|NCT01591499|450004156|FG002|Baseline Visit|Withdrawal by Subject|0|||
125104363|NCT01591499|450004157|FG003|Baseline Visit|Withdrawal by Subject|2|||
124881795|NCT02569710|449189590|FG008|Overall Study|Adverse Event|0|||
124881796|NCT02569710|449189591|FG009|Overall Study|Adverse Event|0|||
124881797|NCT02569710|449189582|FG000|Overall Study|Lost to Follow-up|0|||
124881798|NCT02569710|449189583|FG001|Overall Study|Lost to Follow-up|0|||
124881799|NCT02569710|449189584|FG002|Overall Study|Lost to Follow-up|0|||
124881800|NCT02569710|449189585|FG003|Overall Study|Lost to Follow-up|0|||
124881801|NCT02569710|449189586|FG004|Overall Study|Lost to Follow-up|0|||
124881802|NCT02569710|449189587|FG005|Overall Study|Lost to Follow-up|0|||
124881803|NCT02569710|449189588|FG006|Overall Study|Lost to Follow-up|1|||
124881804|NCT02569710|449189589|FG007|Overall Study|Lost to Follow-up|0|||
124881805|NCT02569710|449189590|FG008|Overall Study|Lost to Follow-up|1|||
124881806|NCT02569710|449189591|FG009|Overall Study|Lost to Follow-up|0|||
124881807|NCT02569710|449189582|FG000|Overall Study|Virologic failure|0|||
124881808|NCT02569710|449189583|FG001|Overall Study|Virologic failure|0|||
124881809|NCT02569710|449189584|FG002|Overall Study|Virologic failure|0|||
124881810|NCT02569710|449189585|FG003|Overall Study|Virologic failure|0|||
124881811|NCT02569710|449189586|FG004|Overall Study|Virologic failure|1|||
124881812|NCT02569710|449189587|FG005|Overall Study|Virologic failure|0|||
124881813|NCT02569710|449189588|FG006|Overall Study|Virologic failure|1|||
124881814|NCT02569710|449189589|FG007|Overall Study|Virologic failure|0|||
124881815|NCT02569710|449189590|FG008|Overall Study|Virologic failure|0|||
124881816|NCT02569710|449189591|FG009|Overall Study|Virologic failure|0|||
124881817|NCT02569710|449189582|FG000|Overall Study|Withdrawal by Subject|0|||
124881818|NCT02569710|449189583|FG001|Overall Study|Withdrawal by Subject|0|||
124881819|NCT02569710|449189584|FG002|Overall Study|Withdrawal by Subject|0|||
124881820|NCT02569710|449189585|FG003|Overall Study|Withdrawal by Subject|0|||
124881821|NCT02569710|449189586|FG004|Overall Study|Withdrawal by Subject|0|||
124881822|NCT02569710|449189587|FG005|Overall Study|Withdrawal by Subject|1|||
124881823|NCT02569710|449189588|FG006|Overall Study|Withdrawal by Subject|0|||
124881824|NCT02569710|449189589|FG007|Overall Study|Withdrawal by Subject|0|||
124881825|NCT02569710|449189590|FG008|Overall Study|Withdrawal by Subject|0|||
124881826|NCT02569710|449189591|FG009|Overall Study|Withdrawal by Subject|0|||
124881827|NCT04152343|449189592|FG000|Overall Study|Transplanted|5|||
124881828|NCT04152343|449189592|FG000|Overall Study|Death|20|||
124881829|NCT04152343|449189592|FG000|Overall Study|Lost to Follow-up|3|||
124881830|NCT00550550|449189593|FG000|Overall Study|Adverse Event|13|||
124881831|NCT00550550|449189594|FG001|Overall Study|Adverse Event|5|||
124881832|NCT00550550|449189593|FG000|Overall Study|Treatment Failure|0|||
124881833|NCT00550550|449189594|FG001|Overall Study|Treatment Failure|1|||
124881834|NCT00550550|449189593|FG000|Overall Study|Lost to Follow-up|4|||
124881835|NCT00550550|449189594|FG001|Overall Study|Lost to Follow-up|0|||
124881836|NCT00550550|449189593|FG000|Overall Study|Withdrawal by Subject|10|||
124881837|NCT00550550|449189594|FG001|Overall Study|Withdrawal by Subject|8|||
124881838|NCT00550550|449189593|FG000|Overall Study|Protocol Violation|5|||
124881839|NCT00550550|449189594|FG001|Overall Study|Protocol Violation|14|||
124881840|NCT00550550|449189593|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
124881841|NCT00550550|449189594|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
124881842|NCT00550550|449189593|FG000|Overall Study|Randomized But Not Treated|1|||
124881843|NCT00550550|449189594|FG001|Overall Study|Randomized But Not Treated|0|||
124881844|NCT01965938|449189599|FG000|Overall Study|Withdrawal by Subject|1|||
124881845|NCT01965938|449189600|FG001|Overall Study|Withdrawal by Subject|0|||
124881846|NCT02090634|449189601|FG000|Overall Study|Lost to Follow-up|0|||
124881847|NCT02090634|449189602|FG001|Overall Study|Lost to Follow-up|1|||
124881848|NCT02090634|449189601|FG000|Overall Study|Death|0|||
124881849|NCT02090634|449189602|FG001|Overall Study|Death|1|||
124881850|NCT02090634|449189601|FG000|Overall Study|Protocol Violation|3|||
124881851|NCT02090634|449189602|FG001|Overall Study|Protocol Violation|1|||
124881852|NCT02090634|449189601|FG000|Overall Study|Adverse Event|2|||
124881853|NCT02090634|449189602|FG001|Overall Study|Adverse Event|0|||
124881854|NCT01164228|449189603|FG000|Overall Study|Progression|24|||
124881855|NCT01164228|449189604|FG001|Overall Study|Progression|25|||
124881856|NCT01164228|449189603|FG000|Overall Study|Adverse Event|13|||
124881857|NCT01164228|449189604|FG001|Overall Study|Adverse Event|7|||
124881858|NCT01164228|449189603|FG000|Overall Study|Death|1|||
124881859|NCT01164228|449189604|FG001|Overall Study|Death|1|||
124881860|NCT01164228|449189603|FG000|Overall Study|Withdrawal by Subject|2|||
124881861|NCT01164228|449189604|FG001|Overall Study|Withdrawal by Subject|0|||
124881862|NCT01164228|449189603|FG000|Overall Study|Physician Decision|1|||
124881863|NCT01164228|449189604|FG001|Overall Study|Physician Decision|2|||
124881864|NCT01164228|449189603|FG000|Overall Study|Symptomatic deterioration|1|||
124881865|NCT01164228|449189604|FG001|Overall Study|Symptomatic deterioration|0|||
124881866|NCT01164228|449189603|FG000|Overall Study|Never started treatment|1|||
124881867|NCT01164228|449189604|FG001|Overall Study|Never started treatment|3|||
124881868|NCT01164228|449189603|FG000|Overall Study|Ineligible|1|||
124881869|NCT01164228|449189604|FG001|Overall Study|Ineligible|0|||
124881870|NCT02936037|449191050|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
124881871|NCT02936037|449191051|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
124881872|NCT02936037|449191050|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
124881873|NCT02936037|449191051|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
125014624|NCT00440947|449678791|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
125014625|NCT00440947|449678787|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
125014626|NCT00440947|449678788|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
124881874|NCT02936037|449191050|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
124881875|NCT02936037|449191051|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
124881876|NCT02936037|449191050|FG000|Double-Blind Treatment Period|Death|0|||
124881877|NCT02936037|449191051|FG001|Double-Blind Treatment Period|Death|1|||
125014627|NCT00440947|449678789|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
125014628|NCT00440947|449678790|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
125014629|NCT00440947|449678791|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
124881878|NCT02936037|449191050|FG000|Double-Blind Treatment Period|Adverse Event|11|||
124881879|NCT02936037|449191051|FG001|Double-Blind Treatment Period|Adverse Event|11|||
124881880|NCT02936037|449191050|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
124881881|NCT02936037|449191051|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
124881882|NCT02936037|449191050|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
124881883|NCT02936037|449191051|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
124881884|NCT02936037|449191050|FG000|Open Label Extension|Adverse Event|0|||
124881885|NCT02936037|449191051|FG001|Open Label Extension|Adverse Event|3|||
124881886|NCT02936037|449191050|FG000|Open Label Extension|Other|0|||
124881887|NCT02936037|449191051|FG001|Open Label Extension|Other|3|||
124881888|NCT02936037|449191050|FG000|Open Label Extension|Withdrawal by Subject|0|||
124881889|NCT02936037|449191051|FG001|Open Label Extension|Withdrawal by Subject|4|||
124881890|NCT04567693|449191052|FG000|Overall Study|Death|0|||
124881891|NCT04567693|449191053|FG001|Overall Study|Death|0|||
124881892|NCT04567693|449191054|FG002|Overall Study|Death|2|||
124881893|NCT04567693|449191052|FG000|Overall Study|Lost to Follow-up|1|||
124881894|NCT04567693|449191053|FG001|Overall Study|Lost to Follow-up|0|||
124881895|NCT04567693|449191054|FG002|Overall Study|Lost to Follow-up|2|||
124881896|NCT04567693|449191052|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
124881897|NCT04567693|449191053|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
124881898|NCT04567693|449191054|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
124881899|NCT03462706|449191055|FG000|Overall Study|Polyp was pedunculated|1|||
124881900|NCT03462706|449191056|FG001|Overall Study|Polyp was pedunculated|0|||
124881901|NCT03462706|449191057|FG002|Overall Study|Polyp was pedunculated|1|||
124881902|NCT03462706|449191058|FG003|Overall Study|Polyp was pedunculated|0|||
124881903|NCT03462706|449191055|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
124881904|NCT03462706|449191056|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
124881905|NCT03462706|449191057|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
124881906|NCT03462706|449191058|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
124881907|NCT04105972|449191063|FG000|Overall Study|Adverse Event|2|||
124881908|NCT04105972|449191064|FG001|Overall Study|Adverse Event|1|||
124881909|NCT01161472|449191065|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
124881910|NCT01161472|449191066|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
124881911|NCT01161472|449191067|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
124881912|NCT01161472|449191068|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
124881913|NCT00067990|449191077|FG000|Overall Study|Death|5|||
124881914|NCT00067990|449191078|FG001|Overall Study|Death|7|||
124881915|NCT00067990|449191077|FG000|Overall Study|ESRD, Non IF/TA|1|||
124881916|NCT00067990|449191078|FG001|Overall Study|ESRD, Non IF/TA|3|||
124881917|NCT00067990|449191077|FG000|Overall Study|Withdrawal by Subject|4|||
124881918|NCT00067990|449191078|FG001|Overall Study|Withdrawal by Subject|12|||
124881919|NCT01118455|449191079|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
124881920|NCT01118455|449191080|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
124881921|NCT03327402|449191085|FG000|Overall Study|Withdrawal by Subject|1|||
124881922|NCT03327402|449191085|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
124881923|NCT03810313|449191086|FG000|Overall Study|Study terminated by sponsor|164|||
124881924|NCT03810313|449191087|FG001|Overall Study|Study terminated by sponsor|159|||
124881925|NCT03810313|449191086|FG000|Overall Study|Subject decision|10|||
124881926|NCT03810313|449191087|FG001|Overall Study|Subject decision|11|||
124881927|NCT03810313|449191086|FG000|Overall Study|Lost to Follow-up|3|||
124881928|NCT03810313|449191087|FG001|Overall Study|Lost to Follow-up|3|||
124881929|NCT03810313|449191086|FG000|Overall Study|Adverse Event|2|||
124881930|NCT03810313|449191087|FG001|Overall Study|Adverse Event|1|||
124881931|NCT03810313|449191086|FG000|Overall Study|Death|2|||
124881932|NCT03810313|449191087|FG001|Overall Study|Death|1|||
124881933|NCT03810313|449191086|FG000|Overall Study|Physician Decision|0|||
124881934|NCT03810313|449191087|FG001|Overall Study|Physician Decision|1|||
124881935|NCT00422799|449191090|FG000|Overall Study|Withdrawal by Subject|6|||
124881936|NCT00422799|449191090|FG000|Overall Study|Adverse Event|7|||
124881937|NCT03029780|449191092|FG000|Overall Study|Disease Progression|20|||
124881938|NCT03029780|449191093|FG001|Overall Study|Disease Progression|22|||
124881939|NCT03029780|449191092|FG000|Overall Study|Study Drug Toxicity|15|||
124881940|NCT03029780|449191093|FG001|Overall Study|Study Drug Toxicity|11|||
124881941|NCT03029780|449191092|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
124881942|NCT03029780|449191093|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
124881943|NCT03029780|449191092|FG000|Overall Study|Participant request to discontinue study treatment|4|||
124881944|NCT03029780|449191093|FG001|Overall Study|Participant request to discontinue study treatment|1|||
124881945|NCT03029780|449191092|FG000|Overall Study|Maximum clinical benefit|1|||
124881946|NCT03029780|449191093|FG001|Overall Study|Maximum clinical benefit|0|||
124881947|NCT03029780|449191092|FG000|Overall Study|Participant no longer meets study criteria|0|||
124881948|NCT03029780|449191093|FG001|Overall Study|Participant no longer meets study criteria|1|||
124881949|NCT03029780|449191092|FG000|Overall Study|Other reasons|6|||
124881950|NCT03029780|449191093|FG001|Overall Study|Other reasons|6|||
124881951|NCT03029780|449191092|FG000|Overall Study|Not reported|1|||
124881952|NCT03029780|449191093|FG001|Overall Study|Not reported|1|||
124881953|NCT03029780|449191092|FG000|Overall Study|Death|2|||
124881954|NCT03029780|449191093|FG001|Overall Study|Death|6|||
124881955|NCT03560258|449191094|FG000|Overall Study|Lost to Follow-up|3|||
124881956|NCT03560258|449191095|FG001|Overall Study|Lost to Follow-up|0|||
124881957|NCT03560258|449191096|FG002|Overall Study|Lost to Follow-up|0|||
124881958|NCT03560258|449191094|FG000|Overall Study|Protocol Violation|0|||
124881959|NCT03560258|449191095|FG001|Overall Study|Protocol Violation|1|||
124881960|NCT03560258|449191096|FG002|Overall Study|Protocol Violation|0|||
124881961|NCT03560258|449191094|FG000|Overall Study|Withdrawal by Subject|0|||
124881962|NCT03560258|449191095|FG001|Overall Study|Withdrawal by Subject|0|||
124881963|NCT03560258|449191096|FG002|Overall Study|Withdrawal by Subject|1|||
124881964|NCT04498247|449191099|FG000|Overall Study|Lost to Follow-up|0|||
124881965|NCT04498247|449191100|FG001|Overall Study|Lost to Follow-up|0|||
124881966|NCT04498247|449191101|FG002|Overall Study|Lost to Follow-up|0|||
124881967|NCT04498247|449191102|FG003|Overall Study|Lost to Follow-up|1|||
124881968|NCT04498247|449191103|FG004|Overall Study|Lost to Follow-up|0|||
124881969|NCT04498247|449191104|FG005|Overall Study|Lost to Follow-up|0|||
124881970|NCT04498247|449191105|FG006|Overall Study|Lost to Follow-up|0|||
124881971|NCT04498247|449191106|FG007|Overall Study|Lost to Follow-up|0|||
124881972|NCT04498247|449191099|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
124881973|NCT04498247|449191100|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
124881974|NCT04498247|449191101|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
124881975|NCT04498247|449191102|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
124881976|NCT04498247|449191103|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
124881977|NCT04498247|449191104|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
124881978|NCT04498247|449191105|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
124881979|NCT04498247|449191106|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
124881980|NCT04498247|449191099|FG000|Overall Study|Withdrawal by Subject|0|||
124881981|NCT04498247|449191100|FG001|Overall Study|Withdrawal by Subject|8|||
124881982|NCT04498247|449191101|FG002|Overall Study|Withdrawal by Subject|0|||
124881983|NCT04498247|449191102|FG003|Overall Study|Withdrawal by Subject|7|||
124881984|NCT04498247|449191103|FG004|Overall Study|Withdrawal by Subject|0|||
124881985|NCT04498247|449191104|FG005|Overall Study|Withdrawal by Subject|0|||
124881986|NCT04498247|449191105|FG006|Overall Study|Withdrawal by Subject|1|||
124881987|NCT04498247|449191106|FG007|Overall Study|Withdrawal by Subject|0|||
124881988|NCT04498247|449191099|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
124881989|NCT04498247|449191100|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
124881990|NCT04498247|449191101|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
124881991|NCT04498247|449191102|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
124881992|NCT04498247|449191103|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
124881993|NCT04498247|449191104|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
124881994|NCT04498247|449191105|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
124881995|NCT04498247|449191106|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
124881996|NCT02086162|449191107|FG000|Overall Study|Withdrawal by Subject|4|||
124881997|NCT02086162|449191108|FG001|Overall Study|Withdrawal by Subject|4|||
124881998|NCT02086162|449191107|FG000|Overall Study|moved|1|||
124881999|NCT02086162|449191108|FG001|Overall Study|moved|1|||
124882000|NCT02086162|449191107|FG000|Overall Study|Lost to Follow-up|4|||
124882001|NCT02086162|449191108|FG001|Overall Study|Lost to Follow-up|2|||
124882002|NCT02086162|449191107|FG000|Overall Study|Death|1|||
124882003|NCT02086162|449191108|FG001|Overall Study|Death|0|||
124882004|NCT01248962|449191109|FG000|Overall Study|Withdrawal by Subject|1|||
124882005|NCT01248962|449191110|FG001|Overall Study|Withdrawal by Subject|1|||
124882006|NCT01248962|449191109|FG000|Overall Study|Adverse Event|2|||
124882007|NCT01248962|449191110|FG001|Overall Study|Adverse Event|1|||
124882008|NCT01248962|449191109|FG000|Overall Study|Complete Response after 4 Cycles|1|||
124882009|NCT01248962|449191110|FG001|Overall Study|Complete Response after 4 Cycles|0|||
124882010|NCT01248962|449191109|FG000|Overall Study|Complete Response after 3 Cycles|0|||
124882011|NCT01248962|449191110|FG001|Overall Study|Complete Response after 3 Cycles|1|||
124882012|NCT01248962|449191109|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
124882013|NCT01248962|449191110|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
124882014|NCT01027364|449191111|FG000|Overall Study|Adverse Event|1|||
124882015|NCT01027364|449191112|FG001|Overall Study|Adverse Event|0|||
124882016|NCT01027364|449191113|FG002|Overall Study|Adverse Event|1|||
124882017|NCT01027364|449191114|FG003|Overall Study|Adverse Event|0|||
124882018|NCT01027364|449191111|FG000|Overall Study|Lost to Follow-up|1|||
124882019|NCT01027364|449191112|FG001|Overall Study|Lost to Follow-up|0|||
124882020|NCT01027364|449191113|FG002|Overall Study|Lost to Follow-up|0|||
124882021|NCT01027364|449191114|FG003|Overall Study|Lost to Follow-up|0|||
124882022|NCT01027364|449191111|FG000|Overall Study|Protocol Violation|1|||
124882023|NCT01027364|449191112|FG001|Overall Study|Protocol Violation|0|||
124882024|NCT01027364|449191113|FG002|Overall Study|Protocol Violation|0|||
124882025|NCT01027364|449191114|FG003|Overall Study|Protocol Violation|1|||
124882026|NCT01027364|449191111|FG000|Overall Study|Withdrawal by Subject|1|||
125104364|NCT01591499|450004154|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
125104365|NCT01591499|450004155|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
125104366|NCT01591499|450004156|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
125104367|NCT01591499|450004157|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
125104368|NCT01591499|450004154|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
125104369|NCT01591499|450004155|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
125104370|NCT01591499|450004156|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
125104371|NCT01591499|450004157|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
125104372|NCT02704130|450004158|FG000|Overall Study|Physician Decision|5|||
125104373|NCT02704130|450004159|FG001|Overall Study|Physician Decision|3|||
124882027|NCT01027364|449191112|FG001|Overall Study|Withdrawal by Subject|2|||
124882028|NCT01027364|449191113|FG002|Overall Study|Withdrawal by Subject|0|||
124882029|NCT01027364|449191114|FG003|Overall Study|Withdrawal by Subject|0|||
124882030|NCT00245856|449191121|FG000|Period Two|Withdrawal by Subject|0|||
124882031|NCT00245856|449191122|FG001|Period Two|Withdrawal by Subject|1|||
124882032|NCT01003184|449191123|FG000|Overall Study|Adverse Event|12|||
124882033|NCT01003184|449191124|FG001|Overall Study|Adverse Event|5|||
124882034|NCT01003184|449191123|FG000|Overall Study|Lost to Follow-up|1|||
124882035|NCT01003184|449191124|FG001|Overall Study|Lost to Follow-up|0|||
124882036|NCT01003184|449191123|FG000|Overall Study|Loss of glucose control|1|||
124882037|NCT01003184|449191124|FG001|Overall Study|Loss of glucose control|1|||
124882038|NCT01003184|449191123|FG000|Overall Study|Protocol Violation|3|||
124882039|NCT01003184|449191124|FG001|Overall Study|Protocol Violation|0|||
124882040|NCT01003184|449191123|FG000|Overall Study|Withdrawal by Subject|1|||
124882041|NCT01003184|449191124|FG001|Overall Study|Withdrawal by Subject|6|||
124882042|NCT01003184|449191123|FG000|Overall Study|Physician Decision|1|||
124882043|NCT01003184|449191124|FG001|Overall Study|Physician Decision|0|||
124882044|NCT03662997|449191127|FG000|Overall Study|Adverse Event|0|||
124882045|NCT03662997|449191128|FG001|Overall Study|Adverse Event|2|||
124882046|NCT03662997|449191129|FG002|Overall Study|Adverse Event|0|||
124882047|NCT03662997|449191130|FG003|Overall Study|Adverse Event|0|||
124882048|NCT01719224|449191131|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
124882049|NCT01719224|449191132|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
124882050|NCT03853317|449191137|FG000|Overall Study|Progressive Disease|5|||
124882051|NCT03853317|449191137|FG000|Overall Study|Adverse Event|1|||
124882052|NCT03853317|449191137|FG000|Overall Study|Death|1|||
124882053|NCT03853317|449191137|FG000|Overall Study|other event|2|||
124882054|NCT00406419|449191140|FG000|Overall Study|Death|3|||
124882055|NCT00406419|449191141|FG001|Overall Study|Death|1|||
124882056|NCT00406419|449191142|FG002|Overall Study|Death|4|||
124882057|NCT00406419|449191140|FG000|Overall Study|Protocol Violation|6|||
124882058|NCT00406419|449191141|FG001|Overall Study|Protocol Violation|2|||
124882059|NCT00406419|449191142|FG002|Overall Study|Protocol Violation|5|||
124882060|NCT00406419|449191140|FG000|Overall Study|Study Terminated by Sponsor|260|||
124882061|NCT00406419|449191141|FG001|Overall Study|Study Terminated by Sponsor|288|||
124882062|NCT00406419|449191142|FG002|Overall Study|Study Terminated by Sponsor|282|||
124882063|NCT00406419|449191140|FG000|Overall Study|Withdrawal by Subject|17|||
124882064|NCT00406419|449191141|FG001|Overall Study|Withdrawal by Subject|24|||
124882065|NCT00406419|449191142|FG002|Overall Study|Withdrawal by Subject|26|||
124882066|NCT00406419|449191140|FG000|Overall Study|Lack of Efficacy|12|||
124882067|NCT00406419|449191141|FG001|Overall Study|Lack of Efficacy|1|||
124882068|NCT00406419|449191142|FG002|Overall Study|Lack of Efficacy|6|||
124882069|NCT00406419|449191140|FG000|Overall Study|Non-Compliance with Study Drug|5|||
124882070|NCT00406419|449191141|FG001|Overall Study|Non-Compliance with Study Drug|6|||
124882071|NCT00406419|449191142|FG002|Overall Study|Non-Compliance with Study Drug|3|||
124882072|NCT00406419|449191140|FG000|Overall Study|Adverse Event|10|||
124882073|NCT00406419|449191141|FG001|Overall Study|Adverse Event|12|||
124882074|NCT00406419|449191142|FG002|Overall Study|Adverse Event|16|||
124882075|NCT00406419|449191140|FG000|Overall Study|Lost to Follow-up|11|||
124882076|NCT00406419|449191141|FG001|Overall Study|Lost to Follow-up|10|||
124882077|NCT00406419|449191142|FG002|Overall Study|Lost to Follow-up|5|||
124882078|NCT01535274|449191143|FG000|Overall Study|Determined to be ineligible|0|||
124882079|NCT01535274|449191144|FG001|Overall Study|Determined to be ineligible|1|||
124882080|NCT01535274|449191143|FG000|Overall Study|Misallocated to propofol intervention|0|||
124882081|NCT01535274|449191144|FG001|Overall Study|Misallocated to propofol intervention|1|||
124882082|NCT03679767|449191145|FG000|Overall Study|Death|16|||
124882083|NCT03679767|449191146|FG001|Overall Study|Death|11|||
125104374|NCT02666768|450004160|FG000|Overall Study|Withdrawal by Subject|4|||
124882084|NCT03679767|449191147|FG002|Overall Study|Death|17|||
125104375|NCT03940742|450004161|FG000|Overall Study|Lost to Follow-up|0|||
125014630|NCT00440947|449678787|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
125014631|NCT00440947|449678788|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
125014632|NCT00440947|449678789|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
125014633|NCT00440947|449678790|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
125014634|NCT00440947|449678791|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
125014635|NCT00440947|449678787|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
125014636|NCT00440947|449678788|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
125014637|NCT00440947|449678789|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
125014638|NCT00440947|449678790|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
125014639|NCT00440947|449678791|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
125014640|NCT00440947|449678787|FG000|Optional 60-Week Extension Phase|Other|0|||
125014641|NCT00440947|449678788|FG001|Optional 60-Week Extension Phase|Other|0|||
125014642|NCT00440947|449678789|FG002|Optional 60-Week Extension Phase|Other|0|||
125014643|NCT00440947|449678790|FG003|Optional 60-Week Extension Phase|Other|1|||
125014644|NCT00440947|449678791|FG004|Optional 60-Week Extension Phase|Other|0|||
125014645|NCT00440947|449678787|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
125014646|NCT00440947|449678788|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
125014647|NCT00440947|449678789|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
125014648|NCT00440947|449678790|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
125014649|NCT00440947|449678791|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
125014650|NCT00440947|449678787|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
125014651|NCT00440947|449678788|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
125014652|NCT00440947|449678789|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
125014653|NCT00440947|449678790|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
125014654|NCT00440947|449678791|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
125014655|NCT02716987|449678792|FG000|Overall Study|Ligand synthesis failure|0|||
125014656|NCT02716987|449678793|FG001|Overall Study|Ligand synthesis failure|0|||
125014657|NCT02716987|449678794|FG002|Overall Study|Ligand synthesis failure|1|||
125014658|NCT02716987|449678795|FG003|Overall Study|Ligand synthesis failure|0|||
125014659|NCT02716987|449678796|FG004|Overall Study|Ligand synthesis failure|0|||
125014660|NCT02716987|449678797|FG005|Overall Study|Ligand synthesis failure|0|||
125014661|NCT02716987|449678792|FG000|Overall Study|Withdrawal by Subject|0|||
125014662|NCT02716987|449678793|FG001|Overall Study|Withdrawal by Subject|0|||
125014663|NCT02716987|449678794|FG002|Overall Study|Withdrawal by Subject|0|||
125014664|NCT02716987|449678795|FG003|Overall Study|Withdrawal by Subject|0|||
125014665|NCT02716987|449678796|FG004|Overall Study|Withdrawal by Subject|1|||
125014666|NCT02716987|449678797|FG005|Overall Study|Withdrawal by Subject|1|||
125014667|NCT03223428|449678801|FG000|Overall Study|No longer taking Xermelo|27|||
125014668|NCT03223428|449678801|FG000|Overall Study|Declined Consent|1|||
125014669|NCT03223428|449678801|FG000|Overall Study|Non-responders|56|||
125014670|NCT03223428|449678801|FG000|Overall Study|Withdrawal by Subject|14|||
125014671|NCT01834274|449678802|FG000|Overall Study|Study Termination|41|||
125014672|NCT01834274|449678803|FG001|Overall Study|Study Termination|38|||
125014673|NCT01834274|449678802|FG000|Overall Study|Withdrawal by Subject|1|||
125014674|NCT01834274|449678803|FG001|Overall Study|Withdrawal by Subject|1|||
125014675|NCT01834274|449678802|FG000|Overall Study|Lost to Follow-up|3|||
125014676|NCT01834274|449678803|FG001|Overall Study|Lost to Follow-up|1|||
125014677|NCT01834274|449678802|FG000|Overall Study|Other|2|||
125014678|NCT01834274|449678803|FG001|Overall Study|Other|1|||
125014679|NCT02813694|449678814|FG000|Overall Study|Physician Decision|0|||
125014680|NCT02813694|449678815|FG001|Overall Study|Physician Decision|1|||
125014681|NCT02813694|449678814|FG000|Overall Study|Withdrawal by Subject|10|||
125014682|NCT02813694|449678815|FG001|Overall Study|Withdrawal by Subject|9|||
125014683|NCT02813694|449678814|FG000|Overall Study|Lost to Follow-up|1|||
125014684|NCT02813694|449678815|FG001|Overall Study|Lost to Follow-up|1|||
125014685|NCT02813694|449678814|FG000|Overall Study|Death|3|||
125014686|NCT02813694|449678815|FG001|Overall Study|Death|3|||
125014687|NCT02813694|449678814|FG000|Overall Study|Randomized- did not receive study drug|2|||
125014688|NCT02813694|449678815|FG001|Overall Study|Randomized- did not receive study drug|0|||
125014689|NCT02813694|449678814|FG000|Overall Study|Patient hospitalized|1|||
125014690|NCT02813694|449678815|FG001|Overall Study|Patient hospitalized|0|||
125014691|NCT01265797|449678816|FG000|Run-in Month|Withdrawal by Subject|0|||
125014692|NCT01265797|449678817|FG001|Run-in Month|Withdrawal by Subject|4|||
125014693|NCT01265797|449678816|FG000|Run-in Month|1st seizure during run-in month|0|||
125014694|NCT01265797|449678817|FG001|Run-in Month|1st seizure during run-in month|1|||
125014695|NCT01265797|449678816|FG000|Blinded Month|Lack of Efficacy|5|||
125014696|NCT01265797|449678817|FG001|Blinded Month|Lack of Efficacy|0|||
124882085|NCT03679767|449191148|FG003|Overall Study|Death|10|||
124882086|NCT03679767|449191145|FG000|Overall Study|Lost to Follow-up|1|||
124882087|NCT03679767|449191146|FG001|Overall Study|Lost to Follow-up|1|||
124882088|NCT03679767|449191147|FG002|Overall Study|Lost to Follow-up|1|||
124882089|NCT03679767|449191148|FG003|Overall Study|Lost to Follow-up|1|||
124882090|NCT03679767|449191145|FG000|Overall Study|Withdrawal by Subject|0|||
124882091|NCT03679767|449191146|FG001|Overall Study|Withdrawal by Subject|0|||
124882092|NCT03679767|449191147|FG002|Overall Study|Withdrawal by Subject|0|||
124882093|NCT03679767|449191148|FG003|Overall Study|Withdrawal by Subject|1|||
124882094|NCT03679767|449191145|FG000|Overall Study|Follow-up Completed|18|||
124882095|NCT03679767|449191146|FG001|Overall Study|Follow-up Completed|11|||
124882096|NCT03679767|449191147|FG002|Overall Study|Follow-up Completed|11|||
124882097|NCT03679767|449191148|FG003|Overall Study|Follow-up Completed|20|||
124882098|NCT03679767|449191145|FG000|Overall Study|Entered Hospice Care|0|||
124882099|NCT03679767|449191146|FG001|Overall Study|Entered Hospice Care|0|||
124882100|NCT03679767|449191147|FG002|Overall Study|Entered Hospice Care|0|||
124882101|NCT03679767|449191148|FG003|Overall Study|Entered Hospice Care|1|||
124882102|NCT03679767|449191145|FG000|Overall Study|Progressive Disease|0|||
124882103|NCT03679767|449191146|FG001|Overall Study|Progressive Disease|0|||
124882104|NCT03679767|449191147|FG002|Overall Study|Progressive Disease|0|||
124882105|NCT03679767|449191148|FG003|Overall Study|Progressive Disease|1|||
124882106|NCT00882921|449191153|FG000|Overall Study|Death|2|||
124882107|NCT00882921|449191153|FG000|Overall Study|Other|3|||
124882108|NCT00882921|449191153|FG000|Overall Study|Lost to Follow-up|2|||
124882109|NCT00882921|449191153|FG000|Overall Study|Termination By Investigator|3|||
124882110|NCT00882921|449191153|FG000|Overall Study|Withdrawal Of Consent|1|||
124882111|NCT02009696|449191154|FG000|Overall Study|Withdrawal by Subject|2|||
124882112|NCT05490329|449191155|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
124882113|NCT05490329|449191156|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
124882114|NCT05490329|449191155|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
124882115|NCT05490329|449191156|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
124882116|NCT05490329|449191155|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
124882117|NCT05490329|449191156|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
124882118|NCT00447954|449191157|FG000|Overall Study|Adverse Event|0|||
124882119|NCT00447954|449191158|FG001|Overall Study|Adverse Event|2|||
124882120|NCT00447954|449191159|FG002|Overall Study|Adverse Event|0|||
124882121|NCT00447954|449191157|FG000|Overall Study|Withdrawal by Subject|0|||
124882122|NCT00447954|449191158|FG001|Overall Study|Withdrawal by Subject|1|||
124882123|NCT00447954|449191159|FG002|Overall Study|Withdrawal by Subject|1|||
124882124|NCT00447954|449191157|FG000|Overall Study|Lost to Follow-up|0|||
125104376|NCT03940742|450004162|FG001|Overall Study|Lost to Follow-up|0|||
124882125|NCT00447954|449191158|FG001|Overall Study|Lost to Follow-up|1|||
124882126|NCT00447954|449191159|FG002|Overall Study|Lost to Follow-up|0|||
124882127|NCT00447954|449191157|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
124882128|NCT00447954|449191158|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
124882129|NCT00447954|449191159|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
124882130|NCT00856661|449191160|FG000|Overall Study|Death|15|||
124882131|NCT00856661|449191161|FG001|Overall Study|Death|18|||
124882132|NCT00856661|449191160|FG000|Overall Study|Protocol Violation|2|||
124882133|NCT00856661|449191161|FG001|Overall Study|Protocol Violation|1|||
124882134|NCT00856661|449191160|FG000|Overall Study|Withdrawal by Subject|1|||
124882135|NCT00856661|449191161|FG001|Overall Study|Withdrawal by Subject|2|||
124882136|NCT00856661|449191160|FG000|Overall Study|Lost to Follow-up|1|||
124882137|NCT00856661|449191161|FG001|Overall Study|Lost to Follow-up|3|||
125104377|NCT03940742|450004163|FG002|Overall Study|Lost to Follow-up|0|||
125104378|NCT03940742|450004164|FG003|Overall Study|Lost to Follow-up|1|||
125104379|NCT02032823|450004167|FG000|Overall Study|Death|75|||
125104380|NCT02032823|450004168|FG001|Overall Study|Death|109|||
125104381|NCT02032823|450004167|FG000|Overall Study|Lost to Follow-up|18|||
124882138|NCT00856661|449191160|FG000|Overall Study|Physician Judgement|8|||
124882139|NCT00856661|449191161|FG001|Overall Study|Physician Judgement|5|||
124882140|NCT02120664|449191162|FG000|Overall Study|Withdrawal by Subject|0|||
124882141|NCT02120664|449191163|FG001|Overall Study|Withdrawal by Subject|0|||
124882142|NCT02120664|449191164|FG002|Overall Study|Withdrawal by Subject|0|||
124882143|NCT02120664|449191165|FG003|Overall Study|Withdrawal by Subject|1|||
124882144|NCT02120664|449191166|FG004|Overall Study|Withdrawal by Subject|0|||
124882145|NCT00105586|449191167|FG000|Overall Study|Adverse Event|4|||
124882146|NCT00105586|449191168|FG001|Overall Study|Adverse Event|3|||
124882147|NCT00105586|449191167|FG000|Overall Study|Physician Decision|13|||
125104382|NCT02032823|450004168|FG001|Overall Study|Lost to Follow-up|17|||
124882148|NCT00105586|449191168|FG001|Overall Study|Physician Decision|13|||
124882149|NCT02306122|449191169|FG000|Initial Physician Randomization|Physician Decision|0|||
124882150|NCT02306122|449191170|FG001|Initial Physician Randomization|Physician Decision|0|||
125104383|NCT02032823|450004167|FG000|Overall Study|Withdrawal by Subject|70|||
124882151|NCT02306122|449191171|FG002|Initial Physician Randomization|Physician Decision|0|||
124882152|NCT02306122|449191172|FG003|Initial Physician Randomization|Physician Decision|0|||
124882153|NCT02306122|449191173|FG004|Initial Physician Randomization|Physician Decision|0|||
124882154|NCT02306122|449191174|FG005|Initial Physician Randomization|Physician Decision|0|||
124882155|NCT02306122|449191175|FG006|Initial Physician Randomization|Physician Decision|0|||
124882156|NCT02306122|449191176|FG007|Initial Physician Randomization|Physician Decision|0|||
124882157|NCT02306122|449191177|FG008|Initial Physician Randomization|Physician Decision|1|||
124882158|NCT02306122|449191178|FG009|Initial Physician Randomization|Physician Decision|0|||
125104384|NCT02032823|450004168|FG001|Overall Study|Withdrawal by Subject|53|||
125104385|NCT02032823|450004167|FG000|Overall Study|Ongoing study at data cut-off|755|||
125104386|NCT02032823|450004168|FG001|Overall Study|Ongoing study at data cut-off|731|||
125104387|NCT02032823|450004167|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
125104388|NCT02032823|450004168|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
125104389|NCT03889197|450004169|FG000|Overall Study|Withdrawal by Subject|1|||
125104390|NCT03889197|450004170|FG001|Overall Study|Withdrawal by Subject|0|||
125104391|NCT03889197|450004169|FG000|Overall Study|Physician Decision|0|||
125104392|NCT03889197|450004170|FG001|Overall Study|Physician Decision|1|||
125104393|NCT03889197|450004169|FG000|Overall Study|met exclusion criteria|0|||
125104394|NCT03889197|450004170|FG001|Overall Study|met exclusion criteria|1|||
125104395|NCT03889197|450004169|FG000|Overall Study|Protocol Violation|1|||
125104396|NCT03889197|450004170|FG001|Overall Study|Protocol Violation|0|||
125104397|NCT05246111|450004171|FG000|Period 01|NOT ELIGIBLE IC5|1|||
125104398|NCT05246111|450004172|FG001|Period 01|NOT ELIGIBLE IC5|0|||
125104399|NCT03078192|450004174|FG000|Overall Study|Withdrawal by Subject|2|||
125104400|NCT03078192|450004175|FG001|Overall Study|Withdrawal by Subject|1|||
125104401|NCT03078192|450004174|FG000|Overall Study|screen failure|0|||
125104402|NCT03078192|450004175|FG001|Overall Study|screen failure|3|||
125104403|NCT02508649|450004178|FG000|Overall Study|Withdrawal by Subject|4|||
125104404|NCT02508649|450004179|FG001|Overall Study|Withdrawal by Subject|6|||
125104405|NCT02508649|450004180|FG002|Overall Study|Withdrawal by Subject|5|||
125104406|NCT02508649|450004181|FG003|Overall Study|Withdrawal by Subject|6|||
125104407|NCT02508649|450004178|FG000|Overall Study|Investigator withdrew the subject|1|||
125104408|NCT02508649|450004179|FG001|Overall Study|Investigator withdrew the subject|2|||
125104409|NCT02508649|450004180|FG002|Overall Study|Investigator withdrew the subject|1|||
125104410|NCT02508649|450004181|FG003|Overall Study|Investigator withdrew the subject|0|||
125104411|NCT02508649|450004178|FG000|Overall Study|Post randomization screening failure|12|||
125104412|NCT02508649|450004179|FG001|Overall Study|Post randomization screening failure|4|||
125104413|NCT02508649|450004180|FG002|Overall Study|Post randomization screening failure|9|||
125104414|NCT02508649|450004181|FG003|Overall Study|Post randomization screening failure|3|||
125104415|NCT02508649|450004178|FG000|Overall Study|Lost to Follow-up|1|||
125104416|NCT02508649|450004179|FG001|Overall Study|Lost to Follow-up|1|||
125104417|NCT02508649|450004180|FG002|Overall Study|Lost to Follow-up|0|||
125104418|NCT02508649|450004181|FG003|Overall Study|Lost to Follow-up|1|||
125104419|NCT03594175|450004189|FG000|Overall Study|Not treated|8|||
125104420|NCT03594175|450004190|FG001|Overall Study|Not treated|1|||
125104421|NCT03594175|450004191|FG002|Overall Study|Not treated|5|||
125104422|NCT03594175|450004189|FG000|Overall Study|Adverse Event|3|||
125104423|NCT03594175|450004190|FG001|Overall Study|Adverse Event|0|||
125104424|NCT03594175|450004191|FG002|Overall Study|Adverse Event|0|||
125104425|NCT03594175|450004189|FG000|Overall Study|Withdrawal by Subject|3|||
125104426|NCT03594175|450004190|FG001|Overall Study|Withdrawal by Subject|0|||
125104427|NCT03594175|450004191|FG002|Overall Study|Withdrawal by Subject|0|||
125104428|NCT03594175|450004189|FG000|Overall Study|Protocol Violation|2|||
125104429|NCT03594175|450004190|FG001|Overall Study|Protocol Violation|2|||
125104430|NCT03594175|450004191|FG002|Overall Study|Protocol Violation|2|||
125104431|NCT01915498|450004192|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
125104432|NCT01915498|450004193|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
125104433|NCT01915498|450004194|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
125104434|NCT01915498|450004195|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
125104435|NCT01915498|450004196|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
125104436|NCT01915498|450004197|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
125104437|NCT01915498|450004198|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
125104438|NCT01915498|450004199|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
124882159|NCT02306122|449191179|FG010|Initial Physician Randomization|Physician Decision|0|||
125104439|NCT01915498|450004200|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
125104440|NCT01915498|450004201|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
125104441|NCT01915498|450004202|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
125104442|NCT01915498|450004203|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
125104443|NCT01915498|450004204|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
125104444|NCT01915498|450004205|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
124882160|NCT00886639|449191180|FG000|Overall Study|acute exacerbation|14|||
124882161|NCT00886639|449191180|FG000|Overall Study|non-compliance|2|||
124882162|NCT03203694|449191181|FG000|Overall Study|Withdrawal by Subject|2|||
124882163|NCT03203694|449191182|FG001|Overall Study|Withdrawal by Subject|0|||
124882164|NCT03203694|449191183|FG002|Overall Study|Withdrawal by Subject|0|||
124882165|NCT03203694|449191184|FG003|Overall Study|Withdrawal by Subject|0|||
124882166|NCT03203694|449191185|FG004|Overall Study|Withdrawal by Subject|0|||
124882167|NCT03203694|449191186|FG005|Overall Study|Withdrawal by Subject|0|||
124882168|NCT00735644|449191189|FG000|Overall Study|Did not receive study vaccine|0|||
124882169|NCT00735644|449191190|FG001|Overall Study|Did not receive study vaccine|1|||
124882170|NCT00735644|449191191|FG002|Overall Study|Did not receive study vaccine|0|||
124882171|NCT00735644|449191192|FG003|Overall Study|Did not receive study vaccine|0|||
124882172|NCT00735644|449191193|FG004|Overall Study|Did not receive study vaccine|0|||
124882173|NCT00735644|449191189|FG000|Overall Study|Withdrawal by Subject|0|||
124882174|NCT00735644|449191190|FG001|Overall Study|Withdrawal by Subject|1|||
124882175|NCT00735644|449191191|FG002|Overall Study|Withdrawal by Subject|1|||
124882176|NCT00735644|449191192|FG003|Overall Study|Withdrawal by Subject|1|||
124882177|NCT00735644|449191193|FG004|Overall Study|Withdrawal by Subject|0|||
124882178|NCT02961374|449191194|FG000|Overall Study|Adverse Event|4|||
124882179|NCT01518946|449191201|FG000|Open-label Phase|Other|4|||
124882180|NCT01518946|449191202|FG001|Open-label Phase|Other|0|||
124882181|NCT01518946|449191203|FG002|Open-label Phase|Other|0|||
124882182|NCT01518946|449191201|FG000|Randomized Phase (First Intervention)|Other|0|||
124882183|NCT01518946|449191202|FG001|Randomized Phase (First Intervention)|Other|1|||
124882184|NCT01518946|449191203|FG002|Randomized Phase (First Intervention)|Other|0|||
124882185|NCT00384059|449191204|FG000|Infant Series|Not consented|2|||
124882186|NCT00384059|449191205|FG001|Infant Series|Not consented|6|||
124882187|NCT00384059|449191204|FG000|Infant Series|Withdrawal by Subject|2|||
124882188|NCT00384059|449191205|FG001|Infant Series|Withdrawal by Subject|2|||
124882189|NCT00384059|449191204|FG000|Infant Series|Adverse Event|1|||
124882190|NCT00384059|449191205|FG001|Infant Series|Adverse Event|2|||
124882191|NCT00384059|449191204|FG000|Infant Series|Protocol Violation|1|||
124882192|NCT00384059|449191205|FG001|Infant Series|Protocol Violation|2|||
124882193|NCT00384059|449191204|FG000|Infant Series|Lost to Follow-up|0|||
124882194|NCT00384059|449191205|FG001|Infant Series|Lost to Follow-up|1|||
124882195|NCT00384059|449191204|FG000|After Infant Series|Protocol Violation|2|||
124882196|NCT00384059|449191205|FG001|After Infant Series|Protocol Violation|3|||
124882197|NCT00384059|449191204|FG000|After Infant Series|Withdrawal by Subject|2|||
124882198|NCT00384059|449191205|FG001|After Infant Series|Withdrawal by Subject|2|||
124882199|NCT00384059|449191204|FG000|After Infant Series|Failed to Return|0|||
124882200|NCT00384059|449191205|FG001|After Infant Series|Failed to Return|2|||
124882201|NCT00384059|449191204|FG000|After Infant Series|Adverse Event|0|||
124882202|NCT00384059|449191205|FG001|After Infant Series|Adverse Event|1|||
124882203|NCT00384059|449191204|FG000|After Infant Series|Physician Decision|0|||
124882204|NCT00384059|449191205|FG001|After Infant Series|Physician Decision|1|||
124882205|NCT00384059|449191204|FG000|After Infant Series|Lost to Follow-up|0|||
124882206|NCT00384059|449191205|FG001|After Infant Series|Lost to Follow-up|1|||
124882207|NCT00384059|449191204|FG000|Toddler Dose|Lost to Follow-up|1|||
124882208|NCT00384059|449191205|FG001|Toddler Dose|Lost to Follow-up|1|||
124882209|NCT00384059|449191204|FG000|Toddler Dose|Failed to return|0|||
124882210|NCT00384059|449191205|FG001|Toddler Dose|Failed to return|1|||
124882211|NCT02714205|449191206|FG000|Overall Study|Cannot tolerate medication|1|||
124882212|NCT02714205|449191207|FG001|Overall Study|Cannot tolerate medication|0|||
124882213|NCT02714205|449191206|FG000|Overall Study|Adverse Event|2|||
124882214|NCT02714205|449191207|FG001|Overall Study|Adverse Event|0|||
124882215|NCT02714205|449191206|FG000|Overall Study|Too busy|1|||
124882216|NCT02714205|449191207|FG001|Overall Study|Too busy|0|||
124882217|NCT02714205|449191206|FG000|Overall Study|Incomplete outcome data|0|||
124882218|NCT02714205|449191207|FG001|Overall Study|Incomplete outcome data|1|||
124882219|NCT00381641|449191210|FG000|Overall Study|Withdrawal by Subject|0|||
124882220|NCT00381641|449191211|FG001|Overall Study|Withdrawal by Subject|2|||
124882221|NCT01598298|449191212|FG000|Overall Study|Not eligible|5|||
124882222|NCT01598298|449191213|FG001|Overall Study|Not eligible|5|||
124882223|NCT01598298|449191212|FG000|Overall Study|Adverse Event|21|||
124882224|NCT01598298|449191213|FG001|Overall Study|Adverse Event|19|||
124882225|NCT01598298|449191212|FG000|Overall Study|Progression/relapse|0|||
124882226|NCT01598298|449191213|FG001|Overall Study|Progression/relapse|2|||
124882227|NCT01598298|449191212|FG000|Overall Study|Withdrawal by Subject|10|||
124882228|NCT01598298|449191213|FG001|Overall Study|Withdrawal by Subject|15|||
124882229|NCT01598298|449191212|FG000|Overall Study|Other reason (not protocol specified)|4|||
125014697|NCT01265797|449678816|FG000|Blinded Month|Lost to Follow-up|1|||
124882230|NCT01598298|449191213|FG001|Overall Study|Other reason (not protocol specified)|0|||
124882231|NCT04287868|449191214|FG000|Overall Study|Screening fail|1|||
124882232|NCT04287868|449191215|FG001|Overall Study|Screening fail|0|||
124882233|NCT03813147|449191216|FG000|Overall Study|Lack of Efficacy|4|||
124882234|NCT03813147|449191217|FG001|Overall Study|Lack of Efficacy|4|||
124882235|NCT03813147|449191216|FG000|Overall Study|Physician Decision|2|||
124882236|NCT03813147|449191217|FG001|Overall Study|Physician Decision|1|||
124882237|NCT00553202|449193188|FG000|Overall Study|Death|16|||
124882238|NCT00553202|449193188|FG000|Overall Study|Lost to Follow-up|1|||
124882239|NCT00553202|449193188|FG000|Overall Study|Physician Decision|28|||
124882240|NCT00553202|449193188|FG000|Overall Study|Withdrawal by Subject|1|||
124882241|NCT00553202|449193188|FG000|Overall Study|No donor identified|16|||
124882242|NCT00553202|449193188|FG000|Overall Study|Fails to meet organ function|6|||
124882243|NCT04651114|449193189|FG000|Overall Study|Withdrawal by Subject|8|||
124882244|NCT01923896|449193194|FG000|Overall Study|Adverse Event|1|||
124882245|NCT01923896|449193195|FG001|Overall Study|Adverse Event|0|||
124882246|NCT00592319|449193198|FG000|Overall Study|Lost to Follow-up|0|||
124882247|NCT00592319|449193199|FG001|Overall Study|Lost to Follow-up|3|||
124882248|NCT00235443|449193202|FG000|Overall Study|Adverse Event|4|||
124882249|NCT00235443|449193203|FG001|Overall Study|Adverse Event|12|||
124882250|NCT00235443|449193204|FG002|Overall Study|Adverse Event|17|||
124882251|NCT00235443|449193205|FG003|Overall Study|Adverse Event|44|||
124882252|NCT00235443|449193206|FG004|Overall Study|Adverse Event|10|||
124882253|NCT00235443|449193207|FG005|Overall Study|Adverse Event|15|||
124882254|NCT00235443|449193202|FG000|Overall Study|Lack of Efficacy|0|||
124882255|NCT00235443|449193203|FG001|Overall Study|Lack of Efficacy|1|||
124882256|NCT00235443|449193204|FG002|Overall Study|Lack of Efficacy|5|||
124882257|NCT00235443|449193205|FG003|Overall Study|Lack of Efficacy|12|||
124882258|NCT00235443|449193206|FG004|Overall Study|Lack of Efficacy|2|||
124882259|NCT00235443|449193207|FG005|Overall Study|Lack of Efficacy|9|||
124882260|NCT00235443|449193202|FG000|Overall Study|Withdrawal by Subject|3|||
124882261|NCT00235443|449193203|FG001|Overall Study|Withdrawal by Subject|9|||
124882262|NCT00235443|449193204|FG002|Overall Study|Withdrawal by Subject|25|||
124882263|NCT00235443|449193205|FG003|Overall Study|Withdrawal by Subject|24|||
124882264|NCT00235443|449193206|FG004|Overall Study|Withdrawal by Subject|10|||
124882265|NCT00235443|449193207|FG005|Overall Study|Withdrawal by Subject|12|||
124882266|NCT00235443|449193202|FG000|Overall Study|Lost to Follow-up|0|||
124882267|NCT00235443|449193203|FG001|Overall Study|Lost to Follow-up|8|||
124882268|NCT00235443|449193204|FG002|Overall Study|Lost to Follow-up|6|||
124882269|NCT00235443|449193205|FG003|Overall Study|Lost to Follow-up|6|||
124882270|NCT00235443|449193206|FG004|Overall Study|Lost to Follow-up|4|||
124882271|NCT00235443|449193207|FG005|Overall Study|Lost to Follow-up|3|||
124882272|NCT00235443|449193202|FG000|Overall Study|Unsatisfactory compliance|0|||
124882273|NCT00235443|449193203|FG001|Overall Study|Unsatisfactory compliance|2|||
124882274|NCT00235443|449193204|FG002|Overall Study|Unsatisfactory compliance|3|||
124882275|NCT00235443|449193205|FG003|Overall Study|Unsatisfactory compliance|4|||
124882276|NCT00235443|449193206|FG004|Overall Study|Unsatisfactory compliance|1|||
125210768|NCT03723070|450395677|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
125210769|NCT02208050|450395678|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
125210770|NCT02208050|450395679|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
124882277|NCT00235443|449193207|FG005|Overall Study|Unsatisfactory compliance|0|||
124882278|NCT00235443|449193202|FG000|Overall Study|Other reasons for premature termination|1|||
125014698|NCT01265797|449678817|FG001|Blinded Month|Lost to Follow-up|0|||
125014699|NCT01265797|449678816|FG000|Blinded Month|Protocol Violation|2|||
125014700|NCT01265797|449678817|FG001|Blinded Month|Protocol Violation|1|||
124882279|NCT00235443|449193203|FG001|Overall Study|Other reasons for premature termination|6|||
124882280|NCT00235443|449193204|FG002|Overall Study|Other reasons for premature termination|6|||
124882281|NCT00235443|449193205|FG003|Overall Study|Other reasons for premature termination|7|||
124882282|NCT00235443|449193206|FG004|Overall Study|Other reasons for premature termination|3|||
124882283|NCT00235443|449193207|FG005|Overall Study|Other reasons for premature termination|6|||
124882284|NCT00474929|449193211|FG000|Overall Study|Withdrawal by Subject|0|||
125014701|NCT01265797|449678816|FG000|Blinded Month|Adverse Event|2|||
125014702|NCT01265797|449678817|FG001|Blinded Month|Adverse Event|0|||
125014703|NCT01265797|449678816|FG000|Blinded Month|Diary data incomplete|0|||
125014704|NCT01265797|449678817|FG001|Blinded Month|Diary data incomplete|1|||
125014705|NCT01265797|449678816|FG000|Open Label Month|Lost to Follow-up|0|||
125014706|NCT01265797|449678817|FG001|Open Label Month|Lost to Follow-up|1|||
125014707|NCT02980224|449678818|FG000|Overall Study|Adverse Event|4|||
124882285|NCT00474929|449193212|FG001|Overall Study|Withdrawal by Subject|1|||
124882286|NCT00474929|449193213|FG002|Overall Study|Withdrawal by Subject|0|||
125014708|NCT02980224|449678819|FG001|Overall Study|Adverse Event|1|||
125014709|NCT02980224|449678818|FG000|Overall Study|Withdrawal by Subject|0|||
125014710|NCT02980224|449678819|FG001|Overall Study|Withdrawal by Subject|2|||
125014711|NCT00606320|449678820|FG000|Overall Study|Adverse Event|3|||
125014712|NCT00606320|449678820|FG000|Overall Study|Lack of Efficacy|5|||
125014713|NCT00606320|449678820|FG000|Overall Study|Physician Decision|7|||
125014714|NCT00606320|449678820|FG000|Overall Study|Protocol Violation|8|||
124882287|NCT00474929|449193214|FG003|Overall Study|Withdrawal by Subject|0|||
124882288|NCT00474929|449193215|FG004|Overall Study|Withdrawal by Subject|0|||
124882289|NCT00474929|449193211|FG000|Overall Study|Unrelated medical condition|0|||
124882290|NCT00474929|449193212|FG001|Overall Study|Unrelated medical condition|0|||
124882291|NCT00474929|449193213|FG002|Overall Study|Unrelated medical condition|1|||
124882292|NCT00474929|449193214|FG003|Overall Study|Unrelated medical condition|0|||
124882293|NCT00474929|449193215|FG004|Overall Study|Unrelated medical condition|0|||
124882294|NCT00474929|449193211|FG000|Overall Study|Physician Decision|0|||
124882295|NCT00474929|449193212|FG001|Overall Study|Physician Decision|0|||
124882296|NCT00474929|449193213|FG002|Overall Study|Physician Decision|1|||
124882297|NCT00474929|449193214|FG003|Overall Study|Physician Decision|2|||
124882298|NCT00474929|449193215|FG004|Overall Study|Physician Decision|0|||
124882299|NCT03029247|449193218|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
124882300|NCT03029247|449193219|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
124882301|NCT03029247|449193218|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
124882302|NCT03029247|449193219|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
124882303|NCT03029247|449193218|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
124882304|NCT03029247|449193219|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
124882305|NCT03029247|449193218|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
124882306|NCT03029247|449193219|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
124882307|NCT02593305|449193222|FG000|Post 1|Comparison only group. No intervention.|0|||
124882308|NCT02593305|449193223|FG001|Post 1|Comparison only group. No intervention.|0|||
124882309|NCT02593305|449193224|FG002|Post 1|Comparison only group. No intervention.|10|||
124882310|NCT01190215|449193225|FG000|Up to Month 6|Lost to Follow-up|2|||
124882311|NCT01190215|449193226|FG001|Up to Month 6|Lost to Follow-up|0|||
124882312|NCT00003511|449193228|FG000|Overall Study|Not evaluable|4|||
124882313|NCT00041756|449193247|FG000|Overall Study|Adverse Event|4|||
124882314|NCT00041756|449193248|FG001|Overall Study|Adverse Event|10|||
124882315|NCT00041756|449193249|FG002|Overall Study|Adverse Event|6|||
124882316|NCT00041756|449193250|FG003|Overall Study|Adverse Event|11|||
124882317|NCT00041756|449193251|FG004|Overall Study|Adverse Event|34|||
124882318|NCT00041756|449193247|FG000|Overall Study|Protocol Violation|1|||
124882319|NCT00041756|449193248|FG001|Overall Study|Protocol Violation|1|||
124882320|NCT00041756|449193249|FG002|Overall Study|Protocol Violation|2|||
124882321|NCT00041756|449193250|FG003|Overall Study|Protocol Violation|2|||
124882322|NCT00041756|449193251|FG004|Overall Study|Protocol Violation|1|||
124882323|NCT00041756|449193247|FG000|Overall Study|Withdrawal by Subject|3|||
125014715|NCT00606320|449678820|FG000|Overall Study|Withdrawal by Subject|10|||
125014716|NCT00606320|449678820|FG000|Overall Study|Progression to depressive phase|4|||
125014717|NCT04839380|449678821|FG000|Overall Study|Withdrawal by Subject|2|||
125014718|NCT04839380|449678821|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
125014719|NCT02937818|449678824|FG000|Overall Study|Participants decision|2|||
125014720|NCT02937818|449678825|FG001|Overall Study|Participants decision|1|||
125014721|NCT02937818|449678826|FG002|Overall Study|Participants decision|1|||
125014722|NCT02937818|449678827|FG003|Overall Study|Participants decision|1|||
125014723|NCT02937818|449678824|FG000|Overall Study|Adverse Event|2|||
125014724|NCT02937818|449678825|FG001|Overall Study|Adverse Event|4|||
125014725|NCT02937818|449678826|FG002|Overall Study|Adverse Event|1|||
125014726|NCT02937818|449678827|FG003|Overall Study|Adverse Event|1|||
125014727|NCT02937818|449678824|FG000|Overall Study|Disease progression|17|||
125014728|NCT02937818|449678825|FG001|Overall Study|Disease progression|15|||
125014729|NCT02937818|449678826|FG002|Overall Study|Disease progression|7|||
125014730|NCT02937818|449678827|FG003|Overall Study|Disease progression|19|||
125014731|NCT02937818|449678824|FG000|Overall Study|Condition under investigation worsened|0|||
125014732|NCT02937818|449678825|FG001|Overall Study|Condition under investigation worsened|0|||
125014733|NCT02937818|449678826|FG002|Overall Study|Condition under investigation worsened|1|||
125014734|NCT02937818|449678827|FG003|Overall Study|Condition under investigation worsened|0|||
125014735|NCT01015768|449678829|FG000|Overall Study|Some subject data unuseable|4|||
125014736|NCT01015768|449678830|FG001|Overall Study|Some subject data unuseable|4|||
125014737|NCT02943564|449678831|FG000|Overall Study|Miscellaneous Reasons|0|||
125014738|NCT02943564|449678832|FG001|Overall Study|Miscellaneous Reasons|0|||
125014739|NCT02943564|449678833|FG002|Overall Study|Miscellaneous Reasons|3|||
125014740|NCT02943564|449678831|FG000|Overall Study|Site terminated by sponsor|0|||
124882324|NCT00041756|449193248|FG001|Overall Study|Withdrawal by Subject|3|||
124882325|NCT00041756|449193249|FG002|Overall Study|Withdrawal by Subject|4|||
124882326|NCT00041756|449193250|FG003|Overall Study|Withdrawal by Subject|2|||
125014741|NCT02943564|449678832|FG001|Overall Study|Site terminated by sponsor|1|||
125014742|NCT02943564|449678833|FG002|Overall Study|Site terminated by sponsor|0|||
125014743|NCT02943564|449678831|FG000|Overall Study|Non-compliance with study drug|0|||
125014744|NCT02943564|449678832|FG001|Overall Study|Non-compliance with study drug|1|||
125014745|NCT02943564|449678833|FG002|Overall Study|Non-compliance with study drug|0|||
125014746|NCT02943564|449678831|FG000|Overall Study|Pregnancy|0|||
125014747|NCT02943564|449678832|FG001|Overall Study|Pregnancy|1|||
125014748|NCT02943564|449678833|FG002|Overall Study|Pregnancy|1|||
124882327|NCT00041756|449193251|FG004|Overall Study|Withdrawal by Subject|3|||
124882328|NCT00041756|449193247|FG000|Overall Study|Lost to Follow-up|0|||
125014749|NCT02943564|449678831|FG000|Overall Study|Protocol Violation|2|||
125014750|NCT02943564|449678832|FG001|Overall Study|Protocol Violation|2|||
125014751|NCT02943564|449678833|FG002|Overall Study|Protocol Violation|2|||
124882329|NCT00041756|449193248|FG001|Overall Study|Lost to Follow-up|1|||
124882330|NCT00041756|449193249|FG002|Overall Study|Lost to Follow-up|0|||
124882331|NCT00041756|449193250|FG003|Overall Study|Lost to Follow-up|1|||
124882332|NCT00041756|449193251|FG004|Overall Study|Lost to Follow-up|0|||
124882333|NCT00041756|449193247|FG000|Overall Study|Unable to meet protocol criteria|0|||
124882334|NCT00041756|449193248|FG001|Overall Study|Unable to meet protocol criteria|0|||
124882335|NCT00041756|449193249|FG002|Overall Study|Unable to meet protocol criteria|1|||
124882336|NCT00041756|449193250|FG003|Overall Study|Unable to meet protocol criteria|0|||
124882337|NCT00041756|449193251|FG004|Overall Study|Unable to meet protocol criteria|1|||
124882338|NCT00041756|449193247|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
124882339|NCT00041756|449193248|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
124882340|NCT00041756|449193249|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
124882341|NCT00041756|449193250|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
124882342|NCT00041756|449193251|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
124882343|NCT00603265|449193252|FG000|Overall Study|Adverse Event|2|||
124882344|NCT00603265|449193253|FG001|Overall Study|Adverse Event|11|||
124882345|NCT00603265|449193254|FG002|Overall Study|Adverse Event|1|||
124882346|NCT00603265|449193252|FG000|Overall Study|Withdrawal by Subject|1|||
124882347|NCT00603265|449193253|FG001|Overall Study|Withdrawal by Subject|2|||
124882348|NCT00603265|449193254|FG002|Overall Study|Withdrawal by Subject|1|||
124882349|NCT00603265|449193252|FG000|Overall Study|Lack of Efficacy|3|||
124882350|NCT00603265|449193253|FG001|Overall Study|Lack of Efficacy|0|||
124882351|NCT00603265|449193254|FG002|Overall Study|Lack of Efficacy|3|||
124882352|NCT00603265|449193252|FG000|Overall Study|Lost to Follow-up|0|||
124882353|NCT00603265|449193253|FG001|Overall Study|Lost to Follow-up|1|||
124882354|NCT00603265|449193254|FG002|Overall Study|Lost to Follow-up|0|||
124882355|NCT00603265|449193252|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
124882356|NCT00603265|449193253|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
124882357|NCT00603265|449193254|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
124882358|NCT00603265|449193252|FG000|Overall Study|Participant Left Country, No Responses|0|||
124882359|NCT00603265|449193253|FG001|Overall Study|Participant Left Country, No Responses|1|||
124882360|NCT00603265|449193254|FG002|Overall Study|Participant Left Country, No Responses|0|||
124882361|NCT00603265|449193252|FG000|Overall Study|Protocol Violation|1|||
124882362|NCT00603265|449193253|FG001|Overall Study|Protocol Violation|0|||
124882363|NCT00603265|449193254|FG002|Overall Study|Protocol Violation|0|||
124882364|NCT02002884|449193255|FG000|Main Period (MP)|Other|0|||
124882365|NCT02002884|449193256|FG001|Main Period (MP)|Other|3|||
124882366|NCT02002884|449193257|FG002|Main Period (MP)|Other|3|||
124882367|NCT02002884|449193258|FG003|Main Period (MP)|Other|0|||
124882368|NCT02002884|449193255|FG000|Main Period (MP)|Adverse Event|0|||
124882369|NCT02002884|449193256|FG001|Main Period (MP)|Adverse Event|1|||
124882370|NCT02002884|449193257|FG002|Main Period (MP)|Adverse Event|1|||
124882371|NCT02002884|449193258|FG003|Main Period (MP)|Adverse Event|0|||
124882372|NCT02002884|449193255|FG000|Main Period (MP)|Withdrawal by Subject|6|||
124882373|NCT02002884|449193256|FG001|Main Period (MP)|Withdrawal by Subject|2|||
124882374|NCT02002884|449193257|FG002|Main Period (MP)|Withdrawal by Subject|2|||
124882375|NCT02002884|449193258|FG003|Main Period (MP)|Withdrawal by Subject|0|||
124882376|NCT02002884|449193255|FG000|Main Period (MP)|Lost to Follow-up|0|||
124882377|NCT02002884|449193256|FG001|Main Period (MP)|Lost to Follow-up|0|||
124882378|NCT02002884|449193257|FG002|Main Period (MP)|Lost to Follow-up|2|||
124882379|NCT02002884|449193258|FG003|Main Period (MP)|Lost to Follow-up|0|||
124882380|NCT02002884|449193255|FG000|Open-Label Extension Period (OLEX)|Other|0|||
124882381|NCT02002884|449193256|FG001|Open-Label Extension Period (OLEX)|Other|0|||
124882382|NCT02002884|449193257|FG002|Open-Label Extension Period (OLEX)|Other|0|||
124882383|NCT02002884|449193258|FG003|Open-Label Extension Period (OLEX)|Other|24|||
124882384|NCT02002884|449193255|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
124882385|NCT02002884|449193256|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
124882386|NCT02002884|449193257|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
124882387|NCT02002884|449193258|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
124882388|NCT02002884|449193255|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
124882389|NCT02002884|449193256|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
124882390|NCT02002884|449193257|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
124882391|NCT02002884|449193258|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
124882392|NCT02002884|449193255|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
124882393|NCT02002884|449193256|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
124882394|NCT02002884|449193257|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
124882395|NCT02002884|449193258|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
124882396|NCT02002884|449193255|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
124882397|NCT02002884|449193256|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
124882398|NCT02002884|449193257|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
124882399|NCT02002884|449193258|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
124882400|NCT02966002|449193259|FG000|Overall Study|Withdrawal by Subject|2|||
124882401|NCT02966002|449193259|FG000|Overall Study|Adverse Event|1|||
124882402|NCT02966002|449193259|FG000|Overall Study|Lost to Follow-up|1|||
124882403|NCT02291432|449193265|FG000|Overall Study|Withdrawal by Subject|2|||
124882404|NCT03377790|449193266|FG000|Overall Study|Withdrawal by Subject|1|||
124882405|NCT03377790|449193267|FG001|Overall Study|Withdrawal by Subject|0|||
124882406|NCT03377790|449193266|FG000|Overall Study|Adverse Event|1|||
124882407|NCT03377790|449193267|FG001|Overall Study|Adverse Event|0|||
124882408|NCT03377790|449193266|FG000|Overall Study|Lost to Follow-up|0|||
124882409|NCT03377790|449193267|FG001|Overall Study|Lost to Follow-up|2|||
124882410|NCT03377790|449193266|FG000|Overall Study|Randomized but not treated|1|||
124882411|NCT03377790|449193267|FG001|Overall Study|Randomized but not treated|0|||
124882412|NCT03377790|449193266|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
124882413|NCT03377790|449193267|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
124882414|NCT02632786|449193271|FG000|Overall Study|Adverse Event|2|||
124882415|NCT02632786|449193272|FG001|Overall Study|Adverse Event|1|||
124882416|NCT02632786|449193271|FG000|Overall Study|Death|3|||
124882417|NCT02632786|449193272|FG001|Overall Study|Death|2|||
124882418|NCT02632786|449193271|FG000|Overall Study|Physician Decision|5|||
124882419|NCT02632786|449193272|FG001|Overall Study|Physician Decision|4|||
124882420|NCT02632786|449193271|FG000|Overall Study|Withdrawal by Subject|1|||
124882421|NCT02632786|449193272|FG001|Overall Study|Withdrawal by Subject|0|||
124882422|NCT01454830|449193276|FG000|Overall Study|Withdrawal by Subject|4|||
124882423|NCT01454830|449193277|FG001|Overall Study|Withdrawal by Subject|4|||
124882424|NCT01454830|449193276|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
124882425|NCT01454830|449193277|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
124882426|NCT01454830|449193276|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
124882427|NCT01454830|449193277|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
124882428|NCT01454830|449193276|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
124882429|NCT01454830|449193277|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
124882430|NCT01454830|449193276|FG000|Overall Study|Withdrawal - no polysomnography|3|||
124882431|NCT01454830|449193277|FG001|Overall Study|Withdrawal - no polysomnography|2|||
124882432|NCT00152763|449193278|FG000|Overall Study|Death|4|||
125014752|NCT02943564|449678831|FG000|Overall Study|Lost to Follow-up|1|||
125014753|NCT02943564|449678832|FG001|Overall Study|Lost to Follow-up|0|||
125014754|NCT02943564|449678833|FG002|Overall Study|Lost to Follow-up|0|||
125014755|NCT02943564|449678831|FG000|Overall Study|Withdrawal by Subject|6|||
125014756|NCT02943564|449678832|FG001|Overall Study|Withdrawal by Subject|5|||
125014757|NCT02943564|449678833|FG002|Overall Study|Withdrawal by Subject|2|||
125014758|NCT02943564|449678831|FG000|Overall Study|Adverse Event|1|||
125014759|NCT02943564|449678832|FG001|Overall Study|Adverse Event|2|||
125014760|NCT02943564|449678833|FG002|Overall Study|Adverse Event|1|||
125014761|NCT02943564|449678831|FG000|Overall Study|Lack of Efficacy|0|||
125014762|NCT02943564|449678832|FG001|Overall Study|Lack of Efficacy|1|||
125014763|NCT02943564|449678833|FG002|Overall Study|Lack of Efficacy|0|||
125014764|NCT01073267|449678836|FG000|Overall Study|Disease Progression|3|||
125014765|NCT00577642|449678837|FG000|Overall Study|Clinical Disease Progression|1|||
125014766|NCT01505634|449678842|FG000|Overall Study|Withdrawal by Subject|2|||
124882433|NCT00152763|449193279|FG001|Overall Study|Death|1|||
124882434|NCT00152763|449193280|FG002|Overall Study|Death|2|||
125014767|NCT01505634|449678843|FG001|Overall Study|Withdrawal by Subject|5|||
125014768|NCT01505634|449678844|FG002|Overall Study|Withdrawal by Subject|1|||
125014769|NCT01505634|449678842|FG000|Overall Study|Physician Decision|1|||
125014770|NCT01505634|449678843|FG001|Overall Study|Physician Decision|1|||
124882435|NCT00152763|449193281|FG003|Overall Study|Death|1|||
124882436|NCT00152763|449193278|FG000|Overall Study|Lost to Follow-up|6|||
124882437|NCT00152763|449193279|FG001|Overall Study|Lost to Follow-up|4|||
124882438|NCT00152763|449193280|FG002|Overall Study|Lost to Follow-up|2|||
124882439|NCT00152763|449193281|FG003|Overall Study|Lost to Follow-up|13|||
124882440|NCT00569803|449193282|FG000|Overall Study|Lost to Follow-up|1|||
124882441|NCT00569803|449193283|FG001|Overall Study|Lost to Follow-up|0|||
124882442|NCT00569803|449193284|FG002|Overall Study|Lost to Follow-up|0|||
124882443|NCT00569803|449193285|FG003|Overall Study|Lost to Follow-up|0|||
124882444|NCT00569803|449193286|FG004|Overall Study|Lost to Follow-up|0|||
124882445|NCT00569803|449193287|FG005|Overall Study|Lost to Follow-up|0|||
124882446|NCT00569803|449193288|FG006|Overall Study|Lost to Follow-up|0|||
124882447|NCT00569803|449193289|FG007|Overall Study|Lost to Follow-up|0|||
124882448|NCT00569803|449193282|FG000|Overall Study|injection syringe leaked during dosing|0|||
124882449|NCT00569803|449193283|FG001|Overall Study|injection syringe leaked during dosing|0|||
124882450|NCT00569803|449193284|FG002|Overall Study|injection syringe leaked during dosing|0|||
124882451|NCT00569803|449193285|FG003|Overall Study|injection syringe leaked during dosing|1|||
124882452|NCT00569803|449193286|FG004|Overall Study|injection syringe leaked during dosing|0|||
124882453|NCT00569803|449193287|FG005|Overall Study|injection syringe leaked during dosing|0|||
124882454|NCT00569803|449193288|FG006|Overall Study|injection syringe leaked during dosing|0|||
124882455|NCT00569803|449193289|FG007|Overall Study|injection syringe leaked during dosing|0|||
124882456|NCT00569803|449193282|FG000|Overall Study|Withdrawal by Subject|0|||
124882457|NCT00569803|449193283|FG001|Overall Study|Withdrawal by Subject|0|||
124882458|NCT00569803|449193284|FG002|Overall Study|Withdrawal by Subject|0|||
124882459|NCT00569803|449193285|FG003|Overall Study|Withdrawal by Subject|0|||
124882460|NCT00569803|449193286|FG004|Overall Study|Withdrawal by Subject|0|||
124882461|NCT00569803|449193287|FG005|Overall Study|Withdrawal by Subject|0|||
124882462|NCT00569803|449193288|FG006|Overall Study|Withdrawal by Subject|0|||
124882463|NCT00569803|449193289|FG007|Overall Study|Withdrawal by Subject|1|||
124882464|NCT01235975|449193290|FG000|Overall Study|Serious Adverse Event|0|||
124882465|NCT01235975|449193291|FG001|Overall Study|Serious Adverse Event|1|||
124882466|NCT01235975|449193290|FG000|Overall Study|Withdrawal by Subject|8|||
124882467|NCT01235975|449193291|FG001|Overall Study|Withdrawal by Subject|2|||
124882468|NCT01235975|449193290|FG000|Overall Study|Migrated/moved from study area|2|||
124882469|NCT01235975|449193291|FG001|Overall Study|Migrated/moved from study area|1|||
124882470|NCT01235975|449193290|FG000|Overall Study|Lost to Follow-up|7|||
124882471|NCT01235975|449193291|FG001|Overall Study|Lost to Follow-up|3|||
124882472|NCT00791921|449193294|FG000|Overall Study|Protocol planed|24|||
124882473|NCT00791921|449193295|FG001|Overall Study|Protocol planed|88|||
124882474|NCT00791921|449193294|FG000|Overall Study|Withdrawal by Subject|1|||
124882475|NCT00791921|449193295|FG001|Overall Study|Withdrawal by Subject|2|||
124882476|NCT00791921|449193294|FG000|Overall Study|Adverse Event|8|||
124882477|NCT00791921|449193295|FG001|Overall Study|Adverse Event|2|||
124882478|NCT00791921|449193294|FG000|Overall Study|Lack of Efficacy|0|||
124882479|NCT00791921|449193295|FG001|Overall Study|Lack of Efficacy|2|||
124882480|NCT00791921|449193294|FG000|Overall Study|Lack of study drug administration|1|||
124882481|NCT00791921|449193295|FG001|Overall Study|Lack of study drug administration|1|||
124882482|NCT00791921|449193294|FG000|Overall Study|Reason other than those above|0|||
124882483|NCT00791921|449193295|FG001|Overall Study|Reason other than those above|1|||
124882484|NCT01965158|449193297|FG000|Overall Study|Adverse Event|14|||
124882485|NCT01965158|449193298|FG001|Overall Study|Adverse Event|5|||
124882486|NCT01965158|449193297|FG000|Overall Study|Withdrawal by Subject|16|||
124882487|NCT01965158|449193298|FG001|Overall Study|Withdrawal by Subject|24|||
124882488|NCT01965158|449193297|FG000|Overall Study|Lost to Follow-up|7|||
124882489|NCT01965158|449193298|FG001|Overall Study|Lost to Follow-up|5|||
124882490|NCT01965158|449193297|FG000|Overall Study|Protocol Violation|1|||
124882491|NCT01965158|449193298|FG001|Overall Study|Protocol Violation|1|||
124882492|NCT01965158|449193297|FG000|Overall Study|Other - Miscellaneous|3|||
124882493|NCT01965158|449193298|FG001|Overall Study|Other - Miscellaneous|0|||
124882494|NCT00474175|449193299|FG000|Overall Study|Lack of Efficacy|0|||
124882495|NCT00474175|449193300|FG001|Overall Study|Lack of Efficacy|0|||
124882496|NCT00474175|449193301|FG002|Overall Study|Lack of Efficacy|1|||
124882497|NCT00474175|449193299|FG000|Overall Study|Withdrawal by Subject|0|||
124882498|NCT00474175|449193300|FG001|Overall Study|Withdrawal by Subject|1|||
124882499|NCT00474175|449193301|FG002|Overall Study|Withdrawal by Subject|1|||
124882500|NCT00474175|449193299|FG000|Overall Study|Ineligible|1|||
124882501|NCT00474175|449193300|FG001|Overall Study|Ineligible|3|||
124882502|NCT00474175|449193301|FG002|Overall Study|Ineligible|1|||
124882503|NCT00474175|449193299|FG000|Overall Study|Protocol Violation|0|||
124882504|NCT00474175|449193300|FG001|Overall Study|Protocol Violation|2|||
124882505|NCT00474175|449193301|FG002|Overall Study|Protocol Violation|1|||
124882506|NCT00474175|449193299|FG000|Overall Study|Administrative|0|||
125014771|NCT01505634|449678844|FG002|Overall Study|Physician Decision|0|||
125014772|NCT01505634|449678842|FG000|Overall Study|Adverse Event|1|||
125014773|NCT01505634|449678843|FG001|Overall Study|Adverse Event|0|||
125014774|NCT01505634|449678844|FG002|Overall Study|Adverse Event|0|||
125014775|NCT01505634|449678842|FG000|Overall Study|Insufficient supply of drug at site|1|||
124882507|NCT00474175|449193300|FG001|Overall Study|Administrative|1|||
124882508|NCT00474175|449193301|FG002|Overall Study|Administrative|0|||
124882509|NCT01619787|449193304|FG000|Overall Study|Lost to Follow-up|5|||
124882510|NCT01130883|449193305|FG000|Overall Study|Patient Noncompliance|6|||
124882511|NCT01130883|449193305|FG000|Overall Study|Reason Unknown|1|||
124882512|NCT01130883|449193305|FG000|Overall Study|Adverse Event|3|||
124882513|NCT02091739|449193313|FG000|MP: 16 Weeks|Adverse Event|1|||
124882514|NCT02091739|449193314|FG001|MP: 16 Weeks|Adverse Event|1|||
124882515|NCT02091739|449193315|FG002|MP: 16 Weeks|Adverse Event|1|||
124882516|NCT02091739|449193316|FG003|MP: 16 Weeks|Adverse Event|0|||
124882517|NCT02091739|449193317|FG004|MP: 16 Weeks|Adverse Event|0|||
124882518|NCT02091739|449193313|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
124882519|NCT02091739|449193314|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
124882520|NCT02091739|449193315|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
124882521|NCT02091739|449193316|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
124882522|NCT02091739|449193317|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
124882523|NCT02091739|449193313|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
124882524|NCT02091739|449193314|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
124882525|NCT02091739|449193315|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
124882526|NCT02091739|449193316|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
124882527|NCT02091739|449193317|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
124882528|NCT02091739|449193313|FG000|EP: 48 Weeks|Other|0|||
124882529|NCT02091739|449193314|FG001|EP: 48 Weeks|Other|0|||
124882530|NCT02091739|449193315|FG002|EP: 48 Weeks|Other|0|||
124882531|NCT02091739|449193316|FG003|EP: 48 Weeks|Other|1|||
124882532|NCT02091739|449193317|FG004|EP: 48 Weeks|Other|0|||
124882533|NCT02091739|449193313|FG000|EP: 48 Weeks|Death|0|||
124882534|NCT02091739|449193314|FG001|EP: 48 Weeks|Death|0|||
124882535|NCT02091739|449193315|FG002|EP: 48 Weeks|Death|0|||
124882536|NCT02091739|449193316|FG003|EP: 48 Weeks|Death|3|||
124882537|NCT02091739|449193317|FG004|EP: 48 Weeks|Death|2|||
124882538|NCT02091739|449193313|FG000|EP: 48 Weeks|Adverse Event|0|||
124882539|NCT02091739|449193314|FG001|EP: 48 Weeks|Adverse Event|0|||
124882540|NCT02091739|449193315|FG002|EP: 48 Weeks|Adverse Event|0|||
124882541|NCT02091739|449193316|FG003|EP: 48 Weeks|Adverse Event|2|||
124882542|NCT02091739|449193317|FG004|EP: 48 Weeks|Adverse Event|6|||
124882543|NCT02091739|449193313|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
124882544|NCT02091739|449193314|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
124882545|NCT02091739|449193315|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
124882546|NCT02091739|449193316|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
124882547|NCT02091739|449193317|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
124882548|NCT00192023|449193320|FG000|Period III - Double-Blind|Adverse Event|3|||
124882549|NCT00192023|449193321|FG001|Period III - Double-Blind|Adverse Event|0|||
124882550|NCT00192023|449193320|FG000|Period III - Double-Blind|Physician Decision|2|||
124882551|NCT00192023|449193321|FG001|Period III - Double-Blind|Physician Decision|0|||
124882552|NCT00192023|449193320|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
124882553|NCT00192023|449193321|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
124882554|NCT00192023|449193320|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
124882555|NCT00192023|449193321|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
124882556|NCT00192023|449193320|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
124882557|NCT00192023|449193321|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
124882558|NCT00192023|449193320|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
124882559|NCT00192023|449193321|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
124882560|NCT00192023|449193320|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
124882561|NCT00192023|449193321|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
124882562|NCT00192023|449193320|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
124882563|NCT00192023|449193321|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
124882564|NCT00192023|449193320|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
124882565|NCT00192023|449193321|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
124882566|NCT00192023|449193320|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
124882567|NCT00192023|449193321|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
124882568|NCT02912468|449193323|FG000|Overall Study|Adverse Event|3|||
124882569|NCT02912468|449193324|FG001|Overall Study|Adverse Event|2|||
124882570|NCT02912468|449193323|FG000|Overall Study|Withdrawal by Subject|6|||
124882571|NCT02912468|449193324|FG001|Overall Study|Withdrawal by Subject|2|||
124882572|NCT02912468|449193323|FG000|Overall Study|Randomized and not treated|0|||
124882573|NCT02912468|449193324|FG001|Overall Study|Randomized and not treated|1|||
124882574|NCT01320735|449193325|FG000|Overall Study|Adverse Event|3|||
124882575|NCT01320735|449193325|FG000|Overall Study|Withdrawal by Subject|3|||
125014776|NCT01505634|449678843|FG001|Overall Study|Insufficient supply of drug at site|0|||
124882576|NCT01320735|449193325|FG000|Overall Study|Lost to Follow-up|13|||
124882577|NCT01320735|449193325|FG000|Overall Study|Administrative Reason|6|||
124882578|NCT01320735|449193325|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
124882579|NCT01320735|449193325|FG000|Overall Study|Protocol Violation|1|||
124882580|NCT01320735|449193325|FG000|Overall Study|Other|1|||
125104445|NCT01915498|450004206|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
125104446|NCT01915498|450004207|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
125104447|NCT01915498|450004208|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
125104448|NCT01915498|450004209|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
125104449|NCT01915498|450004210|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
125104450|NCT01915498|450004192|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125104451|NCT01915498|450004193|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125210771|NCT01810783|450395682|FG000|Overall Study|Adverse Event|32|||
124882581|NCT01320735|449193325|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
124882582|NCT01320735|449193325|FG000|Overall Study|Investigator Unable to be Contacted|17|||
124882583|NCT01290822|449193326|FG000|Overall Study|Withdrawal by Subject|1|||
124882584|NCT01290822|449193326|FG000|Overall Study|Physician Decision|10|||
124882585|NCT00089895|449193329|FG000|Overall Study|Consent Withdrawn|11|||
124882586|NCT00089895|449193330|FG001|Overall Study|Consent Withdrawn|14|||
124882587|NCT00089895|449193329|FG000|Overall Study|Technical reason|7|||
124882588|NCT00089895|449193330|FG001|Overall Study|Technical reason|2|||
124882589|NCT00089895|449193329|FG000|Overall Study|Surgery|0|||
124882590|NCT00089895|449193330|FG001|Overall Study|Surgery|1|||
124882591|NCT00089895|449193329|FG000|Overall Study|Bleeding|0|||
124882592|NCT00089895|449193330|FG001|Overall Study|Bleeding|2|||
124882593|NCT00089895|449193329|FG000|Overall Study|Physician Decision|3|||
124882594|NCT00089895|449193330|FG001|Overall Study|Physician Decision|7|||
124882595|NCT00089895|449193329|FG000|Overall Study|Exclusion criteria met|6|||
124882596|NCT00089895|449193330|FG001|Overall Study|Exclusion criteria met|6|||
124882597|NCT00089895|449193329|FG000|Overall Study|Not otherwise specified|4|||
124882598|NCT00089895|449193330|FG001|Overall Study|Not otherwise specified|8|||
124882599|NCT00089895|449193329|FG000|Overall Study|Missing|4|||
124882600|NCT00089895|449193330|FG001|Overall Study|Missing|2|||
124882601|NCT02301156|449193331|FG000|Overall Study|Adverse Event|13|||
124882602|NCT02301156|449193332|FG001|Overall Study|Adverse Event|14|||
124882603|NCT02301156|449193331|FG000|Overall Study|Death|1|||
124882604|NCT02301156|449193332|FG001|Overall Study|Death|5|||
124882605|NCT02301156|449193331|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
124882606|NCT02301156|449193332|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
124882607|NCT02301156|449193331|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
124882608|NCT02301156|449193332|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
124882609|NCT02301156|449193331|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
124882610|NCT02301156|449193332|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
124882611|NCT02301156|449193331|FG000|Overall Study|Reason not Specified|6|||
124882612|NCT02301156|449193332|FG001|Overall Study|Reason not Specified|3|||
124882613|NCT03734991|449193336|FG000|Overall Study|Adverse Event|4|||
124882614|NCT03734991|449193337|FG001|Overall Study|Adverse Event|0|||
124882615|NCT03734991|449193336|FG000|Overall Study|Lost to Follow-up|4|||
124882616|NCT03734991|449193337|FG001|Overall Study|Lost to Follow-up|0|||
124882617|NCT03734991|449193336|FG000|Overall Study|Physician Decision|0|||
124882618|NCT03734991|449193337|FG001|Overall Study|Physician Decision|1|||
124882619|NCT03734991|449193336|FG000|Overall Study|Pregnancy|1|||
124882620|NCT03734991|449193337|FG001|Overall Study|Pregnancy|0|||
124882621|NCT03734991|449193336|FG000|Overall Study|Withdrawal by Subject|6|||
124882622|NCT03734991|449193337|FG001|Overall Study|Withdrawal by Subject|3|||
124882623|NCT03734991|449193336|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
124882624|NCT03734991|449193337|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
124882625|NCT03734991|449193336|FG000|Overall Study|Other|2|||
124882626|NCT03734991|449193337|FG001|Overall Study|Other|2|||
124882627|NCT02638623|449193338|FG000|Overall Study|Surgery timing|5|||
124882628|NCT02638623|449193339|FG001|Overall Study|Surgery timing|6|||
124882629|NCT02638623|449193338|FG000|Overall Study|Not given intervention|2|||
124882630|NCT02638623|449193339|FG001|Overall Study|Not given intervention|0|||
124882631|NCT01103960|449193348|FG000|Overall Study|Adverse Event|2|||
124882632|NCT01103960|449193349|FG001|Overall Study|Adverse Event|1|||
124882633|NCT01103960|449193348|FG000|Overall Study|Withdrawal by Subject|2|||
124882634|NCT01103960|449193349|FG001|Overall Study|Withdrawal by Subject|1|||
124882635|NCT01103960|449193348|FG000|Overall Study|Other|1|||
124882636|NCT01103960|449193349|FG001|Overall Study|Other|0|||
124882637|NCT00147225|449193350|FG000|Overall Study|Withdrawal by Subject|1|||
124882638|NCT00147225|449193351|FG001|Overall Study|Withdrawal by Subject|0|||
124882639|NCT00147225|449193352|FG002|Overall Study|Withdrawal by Subject|1|||
124882640|NCT00147225|449193353|FG003|Overall Study|Withdrawal by Subject|0|||
125104452|NCT01915498|450004194|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125104453|NCT01915498|450004195|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125104454|NCT01915498|450004196|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125104455|NCT01915498|450004197|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
124882641|NCT00147225|449193354|FG004|Overall Study|Withdrawal by Subject|0|||
124882642|NCT00147225|449193355|FG005|Overall Study|Withdrawal by Subject|1|||
124882643|NCT00147225|449193350|FG000|Overall Study|Adverse Event|0|||
124882644|NCT00147225|449193351|FG001|Overall Study|Adverse Event|0|||
124882645|NCT00147225|449193352|FG002|Overall Study|Adverse Event|1|||
125104456|NCT01915498|450004198|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
124882646|NCT00147225|449193353|FG003|Overall Study|Adverse Event|1|||
124882647|NCT00147225|449193354|FG004|Overall Study|Adverse Event|0|||
124882648|NCT00147225|449193355|FG005|Overall Study|Adverse Event|0|||
124882649|NCT00147225|449193350|FG000|Overall Study|Screen Failure|0|||
124882650|NCT00147225|449193351|FG001|Overall Study|Screen Failure|0|||
124882651|NCT00147225|449193352|FG002|Overall Study|Screen Failure|0|||
124882652|NCT00147225|449193353|FG003|Overall Study|Screen Failure|0|||
124882653|NCT00147225|449193354|FG004|Overall Study|Screen Failure|1|||
124882654|NCT00147225|449193355|FG005|Overall Study|Screen Failure|0|||
124882655|NCT00147225|449193350|FG000|Overall Study|Chemotherapy Changed|0|||
124882656|NCT00147225|449193351|FG001|Overall Study|Chemotherapy Changed|0|||
124882657|NCT00147225|449193352|FG002|Overall Study|Chemotherapy Changed|0|||
124882658|NCT00147225|449193353|FG003|Overall Study|Chemotherapy Changed|0|||
124882659|NCT00147225|449193354|FG004|Overall Study|Chemotherapy Changed|0|||
124882660|NCT00147225|449193355|FG005|Overall Study|Chemotherapy Changed|1|||
124882661|NCT01032044|449193358|FG000|Overall Study|Protocol Violation|14|||
124882662|NCT01032044|449193359|FG001|Overall Study|Protocol Violation|8|||
124882663|NCT01032044|449193358|FG000|Overall Study|Adverse Event|0|||
124882664|NCT01032044|449193359|FG001|Overall Study|Adverse Event|1|||
124882665|NCT01032044|449193358|FG000|Overall Study|Lost to Follow-up|11|||
124882666|NCT01032044|449193359|FG001|Overall Study|Lost to Follow-up|11|||
124882667|NCT02875834|449193360|FG000|Open-label Phase|Withdrawal by Subject|3|||
124882668|NCT02875834|449193361|FG001|Open-label Phase|Withdrawal by Subject|0|||
124882669|NCT02875834|449193362|FG002|Open-label Phase|Withdrawal by Subject|0|||
124882670|NCT02875834|449193363|FG003|Open-label Phase|Withdrawal by Subject|0|||
124882671|NCT02875834|449193360|FG000|Open-label Phase|(Not collected)|4|||
124882672|NCT02875834|449193361|FG001|Open-label Phase|(Not collected)|0|||
124882673|NCT02875834|449193362|FG002|Open-label Phase|(Not collected)|0|||
124882674|NCT02875834|449193363|FG003|Open-label Phase|(Not collected)|0|||
124882675|NCT02875834|449193360|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
124882676|NCT02875834|449193361|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
124882677|NCT02875834|449193362|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
124882678|NCT02875834|449193363|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
124882679|NCT02875834|449193360|FG000|Randomized Treatment Phase|Protocol Violation|0|||
124882680|NCT02875834|449193361|FG001|Randomized Treatment Phase|Protocol Violation|2|||
125104457|NCT01915498|450004199|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125104458|NCT01915498|450004200|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125104459|NCT01915498|450004201|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
125104460|NCT01915498|450004202|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125104461|NCT01915498|450004203|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125104462|NCT01915498|450004204|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125104463|NCT01915498|450004205|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
125104464|NCT01915498|450004206|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
125104465|NCT01915498|450004207|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
125104466|NCT01915498|450004208|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
125104467|NCT01915498|450004209|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
125104468|NCT01915498|450004210|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125104469|NCT01915498|450004192|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
125104470|NCT01915498|450004193|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125104471|NCT01915498|450004194|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125104472|NCT01915498|450004195|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125104473|NCT01915498|450004196|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125104474|NCT01915498|450004197|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
125104475|NCT01915498|450004198|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125104476|NCT01915498|450004199|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125104477|NCT01915498|450004200|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125104478|NCT01915498|450004201|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125104479|NCT01915498|450004202|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125104480|NCT01915498|450004203|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125104481|NCT01915498|450004204|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125104482|NCT01915498|450004205|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125104483|NCT01915498|450004206|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
125104484|NCT01915498|450004207|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125104485|NCT01915498|450004208|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
124882681|NCT02875834|449193362|FG002|Randomized Treatment Phase|Protocol Violation|0|||
124882682|NCT02875834|449193363|FG003|Randomized Treatment Phase|Protocol Violation|0|||
125104486|NCT01915498|450004209|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
125104487|NCT01915498|450004210|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125104488|NCT01915498|450004192|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125104489|NCT01915498|450004193|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125104490|NCT01915498|450004194|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125104491|NCT01915498|450004195|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
124882683|NCT02875834|449193360|FG000|Randomized Treatment Phase|(Not collected)|0|||
124882684|NCT02875834|449193361|FG001|Randomized Treatment Phase|(Not collected)|9|||
124882685|NCT02875834|449193362|FG002|Randomized Treatment Phase|(Not collected)|10|||
124882686|NCT02875834|449193363|FG003|Randomized Treatment Phase|(Not collected)|9|||
124882687|NCT03311230|449193364|FG000|Overall Study|Withdrawal by Subject|1|||
124882688|NCT03311230|449193365|FG001|Overall Study|Withdrawal by Subject|4|||
124882689|NCT03311230|449193366|FG002|Overall Study|Withdrawal by Subject|2|||
124882690|NCT03311230|449193367|FG003|Overall Study|Withdrawal by Subject|7|||
124882691|NCT03311230|449193364|FG000|Overall Study|Unrelated injury|0|||
124882692|NCT03311230|449193365|FG001|Overall Study|Unrelated injury|1|||
124882693|NCT03311230|449193366|FG002|Overall Study|Unrelated injury|0|||
124882694|NCT03311230|449193367|FG003|Overall Study|Unrelated injury|0|||
124882695|NCT02998021|449193368|FG000|Overall Study|Withdrawal by Subject|3|||
124882696|NCT02998021|449193369|FG001|Overall Study|Withdrawal by Subject|1|||
124882697|NCT02998021|449193368|FG000|Overall Study|unsafe home|0|||
124882698|NCT02998021|449193369|FG001|Overall Study|unsafe home|1|||
124882699|NCT01302938|449193370|FG000|Overall Study|Withdrawal by Subject|1|||
124882700|NCT01302938|449193371|FG001|Overall Study|Withdrawal by Subject|0|||
124882701|NCT01302938|449193370|FG000|Overall Study|Adverse Event|1|||
124882702|NCT01302938|449193371|FG001|Overall Study|Adverse Event|0|||
124882703|NCT03342053|449193372|FG000|Overall Study|Adverse Event|2|||
124882704|NCT03342053|449193373|FG001|Overall Study|Adverse Event|0|||
124882705|NCT03342053|449193372|FG000|Overall Study|Withdrawal by Subject|0|||
124882706|NCT03342053|449193373|FG001|Overall Study|Withdrawal by Subject|1|||
124882707|NCT01233609|449193374|FG000|Overall Study|Death|1|||
124882708|NCT01233609|449193375|FG001|Overall Study|Death|0|||
124882709|NCT01233609|449193374|FG000|Overall Study|Lost to Follow-up|3|||
124882710|NCT01233609|449193375|FG001|Overall Study|Lost to Follow-up|1|||
124882711|NCT01233609|449193374|FG000|Overall Study|Adverse Event|2|||
124882712|NCT01233609|449193375|FG001|Overall Study|Adverse Event|1|||
124882713|NCT01233609|449193374|FG000|Overall Study|Withdrawal by Subject|3|||
124882714|NCT01233609|449193375|FG001|Overall Study|Withdrawal by Subject|0|||
124882715|NCT01167179|449195002|FG000|Overall Study|disease recurrence|4|||
124882716|NCT01167179|449195003|FG001|Overall Study|disease recurrence|4|||
124882717|NCT01167179|449195002|FG000|Overall Study|Death|4|||
124882718|NCT01167179|449195003|FG001|Overall Study|Death|10|||
124882719|NCT01167179|449195002|FG000|Overall Study|Withdrawal by Subject|1|||
124882720|NCT01167179|449195003|FG001|Overall Study|Withdrawal by Subject|2|||
124882721|NCT01167179|449195002|FG000|Overall Study|diverse|6|||
124882722|NCT01167179|449195003|FG001|Overall Study|diverse|5|||
124882723|NCT03017235|449195004|FG000|Overall Study|Withdrawal by Subject|4|||
124882724|NCT03017235|449195005|FG001|Overall Study|Withdrawal by Subject|3|||
124882725|NCT03017235|449195004|FG000|Overall Study|Lost to Follow-up|2|||
124882726|NCT03017235|449195005|FG001|Overall Study|Lost to Follow-up|7|||
124882727|NCT03017235|449195004|FG000|Overall Study|Adverse Event|0|||
124882728|NCT03017235|449195005|FG001|Overall Study|Adverse Event|1|||
124882729|NCT03017235|449195004|FG000|Overall Study|Protocol Violation|2|||
124882730|NCT03017235|449195005|FG001|Overall Study|Protocol Violation|1|||
124882731|NCT03017235|449195004|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
124882732|NCT03017235|449195005|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
124882733|NCT02248961|449195009|FG000|Overall Study|Adverse Event|1|||
124882734|NCT02248961|449195010|FG001|Overall Study|Adverse Event|0|||
124882735|NCT02248961|449195009|FG000|Overall Study|Withdrawal by Subject|1|||
124882736|NCT02248961|449195010|FG001|Overall Study|Withdrawal by Subject|2|||
124882737|NCT02248961|449195009|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
124882738|NCT02248961|449195010|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
124882739|NCT00453310|449195013|FG000|Overall Study|Progression of Disease|10|||
124882740|NCT03321513|449195016|FG000|Overall Study|Death|11|||
124882741|NCT03321513|449195017|FG001|Overall Study|Death|5|||
124882742|NCT03321513|449195016|FG000|Overall Study|Withdrawal by Subject|5|||
124882743|NCT03321513|449195017|FG001|Overall Study|Withdrawal by Subject|10|||
124882744|NCT03321513|449195016|FG000|Overall Study|Lost to Follow-up|10|||
124882745|NCT03321513|449195017|FG001|Overall Study|Lost to Follow-up|11|||
124882746|NCT01976364|449195018|FG000|Main Study (36 Months)|Adverse Event|63|||
124882747|NCT01976364|449195019|FG001|Main Study (36 Months)|Adverse Event|0|||
125014777|NCT01505634|449678844|FG002|Overall Study|Insufficient supply of drug at site|0|||
125014778|NCT01505634|449678842|FG000|Overall Study|Protocol Violation|2|||
125014779|NCT01505634|449678843|FG001|Overall Study|Protocol Violation|0|||
125014780|NCT01505634|449678844|FG002|Overall Study|Protocol Violation|0|||
125014781|NCT01505634|449678842|FG000|Overall Study|Lost to Follow-up|1|||
125014782|NCT01505634|449678843|FG001|Overall Study|Lost to Follow-up|4|||
125014783|NCT01505634|449678844|FG002|Overall Study|Lost to Follow-up|4|||
125014784|NCT01505634|449678842|FG000|Overall Study|Death|1|||
124882748|NCT01976364|449195020|FG002|Main Study (36 Months)|Adverse Event|0|||
124882749|NCT01976364|449195018|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
125014785|NCT01505634|449678843|FG001|Overall Study|Death|0|||
125014786|NCT01505634|449678844|FG002|Overall Study|Death|0|||
125014787|NCT01505634|449678842|FG000|Overall Study|In a conflict zone|0|||
125014788|NCT01505634|449678843|FG001|Overall Study|In a conflict zone|0|||
124882750|NCT01976364|449195019|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
124882751|NCT01976364|449195020|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
125014789|NCT01505634|449678844|FG002|Overall Study|In a conflict zone|1|||
124882752|NCT01976364|449195018|FG000|Main Study (36 Months)|Other|13|||
124882753|NCT01976364|449195019|FG001|Main Study (36 Months)|Other|0|||
124882754|NCT01976364|449195020|FG002|Main Study (36 Months)|Other|0|||
124882755|NCT01976364|449195018|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
124882756|NCT01976364|449195019|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
124882757|NCT01976364|449195020|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
124882758|NCT01976364|449195018|FG000|Main Study (36 Months)|Medication error|1|||
124882759|NCT01976364|449195019|FG001|Main Study (36 Months)|Medication error|0|||
124882760|NCT01976364|449195020|FG002|Main Study (36 Months)|Medication error|0|||
124882761|NCT01976364|449195018|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
124882762|NCT01976364|449195019|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
124882763|NCT01976364|449195020|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
124882764|NCT01976364|449195018|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
124882765|NCT01976364|449195019|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
124882766|NCT01976364|449195020|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
124882767|NCT01976364|449195018|FG000|Main Study (36 Months)|Protocol Violation|13|||
124882768|NCT01976364|449195019|FG001|Main Study (36 Months)|Protocol Violation|0|||
124882769|NCT01976364|449195020|FG002|Main Study (36 Months)|Protocol Violation|0|||
124882770|NCT01976364|449195018|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
124882771|NCT01976364|449195019|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
124882772|NCT01976364|449195020|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
124882773|NCT01976364|449195018|FG000|Main Study (36 Months)|Death|5|||
124882774|NCT01976364|449195019|FG001|Main Study (36 Months)|Death|0|||
124882775|NCT01976364|449195020|FG002|Main Study (36 Months)|Death|0|||
124882776|NCT01976364|449195018|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
124882777|NCT01976364|449195019|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
124882778|NCT01976364|449195020|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
124882779|NCT01976364|449195018|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
124882780|NCT01976364|449195019|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
124882781|NCT01976364|449195020|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
124882782|NCT01976364|449195018|FG000|Sub-study (12 Months)|Protocol Violation|0|||
124882783|NCT01976364|449195019|FG001|Sub-study (12 Months)|Protocol Violation|1|||
124882784|NCT01976364|449195020|FG002|Sub-study (12 Months)|Protocol Violation|1|||
124882785|NCT01976364|449195018|FG000|Sub-study (12 Months)|Adverse Event|0|||
124882786|NCT01976364|449195019|FG001|Sub-study (12 Months)|Adverse Event|4|||
124882787|NCT01976364|449195020|FG002|Sub-study (12 Months)|Adverse Event|3|||
124882788|NCT02757521|449195021|FG000|Overall Study|Adverse Event|1|||
124882789|NCT02757521|449195022|FG001|Overall Study|Adverse Event|0|||
124882790|NCT00768430|449195023|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
124882791|NCT00768430|449195024|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
124882792|NCT02318719|449195025|FG000|Double-blind Phase|Adverse Event|7|||
124882793|NCT02318719|449195026|FG001|Double-blind Phase|Adverse Event|6|||
124882794|NCT02318719|449195027|FG002|Double-blind Phase|Adverse Event|12|||
124882795|NCT02318719|449195028|FG003|Double-blind Phase|Adverse Event|4|||
124882796|NCT02318719|449195029|FG004|Double-blind Phase|Adverse Event|0|||
124882797|NCT02318719|449195025|FG000|Double-blind Phase|Lack of Efficacy|5|||
124882798|NCT02318719|449195026|FG001|Double-blind Phase|Lack of Efficacy|0|||
124882799|NCT02318719|449195027|FG002|Double-blind Phase|Lack of Efficacy|1|||
124882800|NCT02318719|449195028|FG003|Double-blind Phase|Lack of Efficacy|1|||
124882801|NCT02318719|449195029|FG004|Double-blind Phase|Lack of Efficacy|0|||
124882802|NCT02318719|449195025|FG000|Double-blind Phase|Protocol Violation|0|||
124882803|NCT02318719|449195026|FG001|Double-blind Phase|Protocol Violation|1|||
124882804|NCT02318719|449195027|FG002|Double-blind Phase|Protocol Violation|3|||
124882805|NCT02318719|449195028|FG003|Double-blind Phase|Protocol Violation|0|||
124882806|NCT02318719|449195029|FG004|Double-blind Phase|Protocol Violation|0|||
124882807|NCT02318719|449195025|FG000|Double-blind Phase|Withdrawal by Subject|25|||
124882808|NCT02318719|449195026|FG001|Double-blind Phase|Withdrawal by Subject|7|||
124882809|NCT02318719|449195027|FG002|Double-blind Phase|Withdrawal by Subject|9|||
124882810|NCT02318719|449195028|FG003|Double-blind Phase|Withdrawal by Subject|10|||
124882811|NCT02318719|449195029|FG004|Double-blind Phase|Withdrawal by Subject|0|||
124882812|NCT02318719|449195025|FG000|Double-blind Phase|Other|1|||
124882813|NCT02318719|449195026|FG001|Double-blind Phase|Other|2|||
124882814|NCT02318719|449195027|FG002|Double-blind Phase|Other|0|||
124882815|NCT02318719|449195028|FG003|Double-blind Phase|Other|0|||
124882816|NCT02318719|449195029|FG004|Double-blind Phase|Other|0|||
124882817|NCT02318719|449195025|FG000|Open-label Extension Phase|Adverse Event|0|||
125014790|NCT02054897|449678845|FG000|Overall Study|Withdrawal by Subject|2|||
125014791|NCT02054897|449678846|FG001|Overall Study|Withdrawal by Subject|0|||
125014792|NCT02054897|449678847|FG002|Overall Study|Withdrawal by Subject|2|||
125014793|NCT02054897|449678845|FG000|Overall Study|Missing follow-up information|3|||
125014794|NCT02054897|449678846|FG001|Overall Study|Missing follow-up information|5|||
125014795|NCT02054897|449678847|FG002|Overall Study|Missing follow-up information|3|||
124882818|NCT02318719|449195026|FG001|Open-label Extension Phase|Adverse Event|0|||
124882819|NCT02318719|449195027|FG002|Open-label Extension Phase|Adverse Event|0|||
125014796|NCT02054897|449678845|FG000|Overall Study|Lost to Follow-up|4|||
125014797|NCT02054897|449678846|FG001|Overall Study|Lost to Follow-up|2|||
124882820|NCT02318719|449195028|FG003|Open-label Extension Phase|Adverse Event|0|||
124882821|NCT02318719|449195029|FG004|Open-label Extension Phase|Adverse Event|15|||
124882822|NCT02318719|449195025|FG000|Open-label Extension Phase|Death|0|||
124882823|NCT02318719|449195026|FG001|Open-label Extension Phase|Death|0|||
124882824|NCT02318719|449195027|FG002|Open-label Extension Phase|Death|0|||
124882825|NCT02318719|449195028|FG003|Open-label Extension Phase|Death|0|||
124882826|NCT02318719|449195029|FG004|Open-label Extension Phase|Death|1|||
124882827|NCT02318719|449195025|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
124882828|NCT02318719|449195026|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
124882829|NCT02318719|449195027|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
124882830|NCT02318719|449195028|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
124882831|NCT02318719|449195029|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
124882832|NCT02318719|449195025|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
124882833|NCT02318719|449195026|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
124882834|NCT02318719|449195027|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
124882835|NCT02318719|449195028|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
124882836|NCT02318719|449195029|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
124882837|NCT02318719|449195025|FG000|Open-label Extension Phase|Other|0|||
124882838|NCT02318719|449195026|FG001|Open-label Extension Phase|Other|0|||
124882839|NCT02318719|449195027|FG002|Open-label Extension Phase|Other|0|||
124882840|NCT02318719|449195028|FG003|Open-label Extension Phase|Other|0|||
124882841|NCT02318719|449195029|FG004|Open-label Extension Phase|Other|7|||
124882842|NCT05340751|449195032|FG000|Overall Study|Physician Decision|3|||
124882843|NCT02961881|449195045|FG000|Overall Study|Adverse Event|1|||
124882844|NCT02961881|449195046|FG001|Overall Study|Adverse Event|2|||
124882845|NCT02961881|449195047|FG002|Overall Study|Adverse Event|2|||
124882846|NCT02961881|449195048|FG003|Overall Study|Adverse Event|0|||
124882847|NCT02961881|449195049|FG004|Overall Study|Adverse Event|1|||
124882848|NCT02961881|449195045|FG000|Overall Study|Participant request|0|||
124882849|NCT02961881|449195046|FG001|Overall Study|Participant request|2|||
124882850|NCT02961881|449195047|FG002|Overall Study|Participant request|0|||
124882851|NCT02961881|449195048|FG003|Overall Study|Participant request|0|||
124882852|NCT02961881|449195049|FG004|Overall Study|Participant request|0|||
124882853|NCT02961881|449195045|FG000|Overall Study|Disease progression|1|||
124882854|NCT02961881|449195046|FG001|Overall Study|Disease progression|0|||
124882855|NCT02961881|449195047|FG002|Overall Study|Disease progression|1|||
124882856|NCT02961881|449195048|FG003|Overall Study|Disease progression|0|||
124882857|NCT02961881|449195049|FG004|Overall Study|Disease progression|0|||
124882858|NCT01973491|449195050|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
124882859|NCT01973491|449195050|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
124882860|NCT01973491|449195050|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
124882861|NCT01928225|449195051|FG000|Overall Study|Pregnancy|1|||
124882862|NCT01928225|449195052|FG001|Overall Study|Pregnancy|0|||
124882863|NCT01928225|449195051|FG000|Overall Study|basaloid cervical cancer|1|||
124882864|NCT01928225|449195052|FG001|Overall Study|basaloid cervical cancer|0|||
124882865|NCT01928225|449195051|FG000|Overall Study|Lost to Follow-up|1|||
124882866|NCT01928225|449195052|FG001|Overall Study|Lost to Follow-up|3|||
124882867|NCT04250337|449195053|FG000|Overall Study|Adverse Event|0|||
124882868|NCT04250337|449195054|FG001|Overall Study|Adverse Event|3|||
124882869|NCT04250337|449195053|FG000|Overall Study|Lack of Efficacy|1|||
124882870|NCT04250337|449195054|FG001|Overall Study|Lack of Efficacy|3|||
124882871|NCT04250337|449195053|FG000|Overall Study|Physician Decision|1|||
124882872|NCT04250337|449195054|FG001|Overall Study|Physician Decision|0|||
124882873|NCT04250337|449195053|FG000|Overall Study|Protocol Deviation|2|||
124882874|NCT04250337|449195054|FG001|Overall Study|Protocol Deviation|2|||
124882875|NCT04250337|449195053|FG000|Overall Study|Withdrawal by Subject|4|||
124882876|NCT04250337|449195054|FG001|Overall Study|Withdrawal by Subject|3|||
124882877|NCT03321006|449195057|FG000|Overall Study|Death|1|||
124882878|NCT03321006|449195058|FG001|Overall Study|Death|0|||
124882879|NCT03321006|449195057|FG000|Overall Study|Lack of Efficacy|1|||
124882880|NCT03321006|449195058|FG001|Overall Study|Lack of Efficacy|0|||
124882881|NCT00365378|449195059|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
124882882|NCT00365378|449195060|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
124882883|NCT00365378|449195061|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
124882884|NCT00365378|449195059|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
124882885|NCT00365378|449195060|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
124882886|NCT00365378|449195061|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
124882887|NCT00365378|449195059|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
125014798|NCT02054897|449678847|FG002|Overall Study|Lost to Follow-up|7|||
125014799|NCT02054897|449678845|FG000|Overall Study|Randomized but not exposed|1|||
125014800|NCT02054897|449678846|FG001|Overall Study|Randomized but not exposed|0|||
125014801|NCT02054897|449678847|FG002|Overall Study|Randomized but not exposed|0|||
124882888|NCT00365378|449195060|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
124882889|NCT00365378|449195061|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
124882890|NCT00365378|449195059|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
124882891|NCT00365378|449195060|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
124882892|NCT00365378|449195061|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
124882893|NCT00365378|449195059|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
124882894|NCT00365378|449195060|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
124882895|NCT00365378|449195061|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
124882896|NCT00365378|449195059|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
124882897|NCT00365378|449195060|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
124882898|NCT00365378|449195061|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
124882899|NCT00365378|449195059|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
124882900|NCT00365378|449195060|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
124882901|NCT00365378|449195061|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
124882902|NCT00365378|449195059|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
124882903|NCT00365378|449195060|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
124882904|NCT00365378|449195061|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
124882905|NCT00365378|449195059|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
124882906|NCT00365378|449195060|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
124882907|NCT00365378|449195061|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
124882908|NCT00365378|449195059|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
124882909|NCT00365378|449195060|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
124882910|NCT00365378|449195061|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
124882911|NCT00365378|449195059|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
124882912|NCT00365378|449195060|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
124882913|NCT00365378|449195061|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
124882914|NCT00365378|449195059|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
124882915|NCT00365378|449195060|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
124882916|NCT00365378|449195061|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
124882917|NCT00365378|449195059|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
124882918|NCT00365378|449195060|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
124882919|NCT00365378|449195061|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
125104492|NCT01915498|450004196|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125104493|NCT01915498|450004197|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125104494|NCT01915498|450004198|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125104495|NCT01915498|450004199|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125104496|NCT01915498|450004200|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125104497|NCT01915498|450004201|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125104498|NCT01915498|450004202|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
125104499|NCT01915498|450004203|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125104500|NCT01915498|450004204|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125104501|NCT01915498|450004205|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
125104502|NCT01915498|450004206|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125104503|NCT01915498|450004207|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125104504|NCT01915498|450004208|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
125104505|NCT01915498|450004209|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
125104506|NCT01915498|450004210|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125104507|NCT01915498|450004192|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
125104508|NCT01915498|450004193|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
125104509|NCT01915498|450004194|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
125104510|NCT01915498|450004195|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
125104511|NCT01915498|450004196|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
125104512|NCT01915498|450004197|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
125104513|NCT01915498|450004198|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
125104514|NCT01915498|450004199|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
125104515|NCT01915498|450004200|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
125104516|NCT01915498|450004201|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
125104517|NCT01915498|450004202|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
125104518|NCT01915498|450004203|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
125104519|NCT01915498|450004204|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
125104520|NCT01915498|450004205|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
125104521|NCT01915498|450004206|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
124882920|NCT00365378|449195059|FG000|Extension|Adverse Event|0|||
124882921|NCT00365378|449195060|FG001|Extension|Adverse Event|0|||
124882922|NCT00365378|449195061|FG002|Extension|Adverse Event|1|||
124882923|NCT00365378|449195059|FG000|Extension|Moved|0|||
124882924|NCT00365378|449195060|FG001|Extension|Moved|0|||
124882925|NCT00365378|449195061|FG002|Extension|Moved|8|||
125104522|NCT01915498|450004207|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
125104523|NCT01915498|450004208|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
125104524|NCT01915498|450004209|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
125104525|NCT01915498|450004210|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
125104526|NCT01915498|450004192|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
125104527|NCT01915498|450004193|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
125104528|NCT01915498|450004194|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
125104529|NCT01915498|450004195|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
125104530|NCT01915498|450004196|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
125104531|NCT01915498|450004197|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
125104532|NCT01915498|450004198|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
125104533|NCT01915498|450004199|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
125104534|NCT01915498|450004200|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
125104535|NCT01915498|450004201|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
125104536|NCT01915498|450004202|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
125104537|NCT01915498|450004203|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
125104538|NCT01915498|450004204|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
125104539|NCT01915498|450004205|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
125104540|NCT01915498|450004206|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
125104541|NCT01915498|450004207|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
125104542|NCT01915498|450004208|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
125104543|NCT01915498|450004209|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
125104544|NCT01915498|450004210|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
125104545|NCT01915498|450004192|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125104546|NCT01915498|450004193|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125104547|NCT01915498|450004194|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125104548|NCT01915498|450004195|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125104549|NCT01915498|450004196|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
125104550|NCT01915498|450004197|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125104551|NCT01915498|450004198|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125104552|NCT01915498|450004199|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125104553|NCT01915498|450004200|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125104554|NCT01915498|450004201|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
125104555|NCT01915498|450004202|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125104556|NCT01915498|450004203|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125104557|NCT01915498|450004204|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125104558|NCT01915498|450004205|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125104559|NCT01915498|450004206|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125104560|NCT01915498|450004207|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125104561|NCT01915498|450004208|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125104562|NCT01915498|450004209|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125104563|NCT01915498|450004210|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125104564|NCT01915498|450004192|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
125104565|NCT01915498|450004193|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
125104566|NCT01915498|450004194|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
125104567|NCT01915498|450004195|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
125104568|NCT01915498|450004196|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
125104569|NCT01915498|450004197|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
125104570|NCT01915498|450004198|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
125104571|NCT01915498|450004199|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
125104572|NCT01915498|450004200|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
125104573|NCT01915498|450004201|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
125104574|NCT01915498|450004202|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
125104575|NCT01915498|450004203|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
125104576|NCT01915498|450004204|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
125104577|NCT01915498|450004205|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
125104578|NCT01915498|450004206|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
125104579|NCT01915498|450004207|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
125104580|NCT01915498|450004208|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
125104581|NCT01915498|450004209|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
125104582|NCT01915498|450004210|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
125104583|NCT01915498|450004192|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125104584|NCT01915498|450004193|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125104585|NCT01915498|450004194|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125104586|NCT01915498|450004195|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125104587|NCT01915498|450004196|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125014802|NCT00794157|449678848|FG000|Overall Study|Adverse Event|4|||
125014803|NCT00794157|449678849|FG001|Overall Study|Adverse Event|1|||
125014804|NCT00794157|449678850|FG002|Overall Study|Adverse Event|8|||
125014805|NCT00794157|449678848|FG000|Overall Study|Subject withdrew consent|2|||
125014806|NCT00794157|449678849|FG001|Overall Study|Subject withdrew consent|0|||
125014807|NCT00794157|449678850|FG002|Overall Study|Subject withdrew consent|3|||
125014808|NCT00794157|449678848|FG000|Overall Study|Lost to Follow-up|2|||
125014809|NCT00794157|449678849|FG001|Overall Study|Lost to Follow-up|0|||
125014810|NCT00794157|449678850|FG002|Overall Study|Lost to Follow-up|1|||
125104588|NCT01915498|450004197|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125014811|NCT00794157|449678848|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125014812|NCT00794157|449678849|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124882926|NCT00365378|449195059|FG000|Extension|Lost to Follow-up|0|||
124882927|NCT00365378|449195060|FG001|Extension|Lost to Follow-up|0|||
124882928|NCT00365378|449195061|FG002|Extension|Lost to Follow-up|57|||
124882929|NCT00365378|449195059|FG000|Extension|Protocol Violation|0|||
124882930|NCT00365378|449195060|FG001|Extension|Protocol Violation|0|||
124882931|NCT00365378|449195061|FG002|Extension|Protocol Violation|2|||
124882932|NCT00365378|449195059|FG000|Extension|Withdrawal by Subject|0|||
124882933|NCT00365378|449195060|FG001|Extension|Withdrawal by Subject|0|||
124882934|NCT00365378|449195061|FG002|Extension|Withdrawal by Subject|98|||
124882935|NCT00365378|449195059|FG000|Extension|Other|0|||
124882936|NCT00365378|449195060|FG001|Extension|Other|0|||
124882937|NCT00365378|449195061|FG002|Extension|Other|31|||
124882938|NCT04161807|449195067|FG000|Overall Study|Withdrawal by Subject|2|||
124882939|NCT04161807|449195067|FG000|Overall Study|Performed only 1 treatment|2|||
124882940|NCT02006121|449195068|FG000|Double Blind Phase|Adverse Event|6|||
124882941|NCT02006121|449195069|FG001|Double Blind Phase|Adverse Event|0|||
124882942|NCT02006121|449195068|FG000|Double Blind Phase|Lack of Efficacy|1|||
124882943|NCT02006121|449195069|FG001|Double Blind Phase|Lack of Efficacy|16|||
124882944|NCT02006121|449195068|FG000|Double Blind Phase|Withdrawal by Subject|3|||
124882945|NCT02006121|449195069|FG001|Double Blind Phase|Withdrawal by Subject|4|||
124882946|NCT02006121|449195068|FG000|Double Blind Phase|Non-compliance with study drug|1|||
124882947|NCT02006121|449195069|FG001|Double Blind Phase|Non-compliance with study drug|3|||
124882948|NCT02006121|449195068|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
124882949|NCT02006121|449195069|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
124882950|NCT02006121|449195068|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
124882951|NCT02006121|449195069|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
124882952|NCT02006121|449195068|FG000|Open Label Phase|Adverse Event|15|||
124882953|NCT02006121|449195069|FG001|Open Label Phase|Adverse Event|0|||
124882954|NCT02006121|449195068|FG000|Open Label Phase|Lack of Efficacy|2|||
124882955|NCT02006121|449195069|FG001|Open Label Phase|Lack of Efficacy|0|||
124882956|NCT02006121|449195068|FG000|Open Label Phase|Protocol Violation|2|||
124882957|NCT02006121|449195069|FG001|Open Label Phase|Protocol Violation|0|||
124882958|NCT02006121|449195068|FG000|Open Label Phase|Withdrawal by Subject|3|||
124882959|NCT02006121|449195069|FG001|Open Label Phase|Withdrawal by Subject|0|||
124882960|NCT02006121|449195068|FG000|Open Label Phase|Non-compliance with study drug|3|||
124882961|NCT02006121|449195069|FG001|Open Label Phase|Non-compliance with study drug|0|||
124882962|NCT04789577|449195070|FG000|Overall Study|Withdrawal by Subject|1|||
124882963|NCT04789577|449195071|FG001|Overall Study|Withdrawal by Subject|1|||
124882964|NCT04789577|449195072|FG002|Overall Study|Withdrawal by Subject|1|||
124882965|NCT04789577|449195073|FG003|Overall Study|Withdrawal by Subject|3|||
124882966|NCT04789577|449195074|FG004|Overall Study|Withdrawal by Subject|1|||
124882967|NCT04789577|449195075|FG005|Overall Study|Withdrawal by Subject|7|||
124882968|NCT04789577|449195076|FG006|Overall Study|Withdrawal by Subject|1|||
124882969|NCT04789577|449195070|FG000|Overall Study|Lost to Follow-up|7|||
124882970|NCT04789577|449195071|FG001|Overall Study|Lost to Follow-up|12|||
124882971|NCT04789577|449195072|FG002|Overall Study|Lost to Follow-up|7|||
124882972|NCT04789577|449195073|FG003|Overall Study|Lost to Follow-up|10|||
124882973|NCT04789577|449195074|FG004|Overall Study|Lost to Follow-up|8|||
124882974|NCT04789577|449195075|FG005|Overall Study|Lost to Follow-up|6|||
124882975|NCT04789577|449195076|FG006|Overall Study|Lost to Follow-up|10|||
124882976|NCT04789577|449195070|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
124882977|NCT04789577|449195071|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
124882978|NCT04789577|449195072|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
124882979|NCT04789577|449195073|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
124882980|NCT04789577|449195074|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
124882981|NCT04789577|449195075|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
124882982|NCT04789577|449195076|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
124882983|NCT04789577|449195070|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
124882984|NCT04789577|449195071|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
124882985|NCT04789577|449195072|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
124882986|NCT04789577|449195073|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
125014813|NCT00794157|449678850|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
125014814|NCT00794157|449678848|FG000|Overall Study|Administrative problems|1|||
125014815|NCT00794157|449678849|FG001|Overall Study|Administrative problems|7|||
125014816|NCT00794157|449678850|FG002|Overall Study|Administrative problems|4|||
124882987|NCT04789577|449195074|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
124882988|NCT04789577|449195075|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
125014817|NCT00794157|449678848|FG000|Overall Study|Abnormal test procedure result(s)|0|||
124882989|NCT04789577|449195076|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
124882990|NCT02693834|449195085|FG000|Baseline Measurement|Withdrawal by Subject|1|||
124882991|NCT02693834|449195086|FG001|Baseline Measurement|Withdrawal by Subject|0|||
125014818|NCT00794157|449678849|FG001|Overall Study|Abnormal test procedure result(s)|1|||
124882992|NCT02693834|449195085|FG000|Baseline Measurement|Adverse Event|1|||
125014819|NCT00794157|449678850|FG002|Overall Study|Abnormal test procedure result(s)|0|||
124882993|NCT02693834|449195086|FG001|Baseline Measurement|Adverse Event|0|||
124882994|NCT02693834|449195085|FG000|Week 2 Practice|Adverse Event|0|||
124882995|NCT02693834|449195086|FG001|Week 2 Practice|Adverse Event|1|||
124882996|NCT04848662|449195089|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
124882997|NCT04848662|449195090|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
124882998|NCT03000673|449195091|FG000|Overall Study|Withdrawal by Subject|1|||
124882999|NCT03000673|449195092|FG001|Overall Study|Withdrawal by Subject|0|||
124883000|NCT03000673|449195093|FG002|Overall Study|Withdrawal by Subject|0|||
124883001|NCT03000673|449195094|FG003|Overall Study|Withdrawal by Subject|0|||
124883002|NCT01121484|449195095|FG000|Overall Study|Adverse Event|12|||
124883003|NCT01121484|449195096|FG001|Overall Study|Adverse Event|5|||
124883004|NCT01121484|449195095|FG000|Overall Study|Lack of Efficacy|3|||
124883005|NCT01121484|449195096|FG001|Overall Study|Lack of Efficacy|11|||
124883006|NCT01121484|449195095|FG000|Overall Study|Lost to Follow-up|5|||
124883007|NCT01121484|449195096|FG001|Overall Study|Lost to Follow-up|9|||
124883008|NCT01121484|449195095|FG000|Overall Study|Physician Decision|0|||
124883009|NCT01121484|449195096|FG001|Overall Study|Physician Decision|3|||
124883010|NCT01121484|449195095|FG000|Overall Study|Protocol Violation|1|||
124883011|NCT01121484|449195096|FG001|Overall Study|Protocol Violation|0|||
124883012|NCT01121484|449195095|FG000|Overall Study|Withdrawal by Subject|8|||
124883013|NCT01121484|449195096|FG001|Overall Study|Withdrawal by Subject|7|||
124883014|NCT01121484|449195095|FG000|Overall Study|Discontinuation of study by sponsor|0|||
124883015|NCT01121484|449195096|FG001|Overall Study|Discontinuation of study by sponsor|1|||
124883016|NCT01121484|449195095|FG000|Overall Study|Other|3|||
124883017|NCT01121484|449195096|FG001|Overall Study|Other|3|||
124883018|NCT01121484|449195095|FG000|Overall Study|Randomized, not treated|1|||
124883019|NCT01121484|449195096|FG001|Overall Study|Randomized, not treated|4|||
124883020|NCT00562978|449195097|FG000|Overall Study|Patient had imaging dose only|1|||
124883021|NCT00562978|449195098|FG001|Overall Study|Patient had imaging dose only|11|||
124883022|NCT01348776|449195104|FG000|Overall Study|Lost to Follow-up|3|||
124883023|NCT01463293|449195108|FG000|Overall Study|Lost to Follow-up|1|||
124883024|NCT01463293|449195109|FG001|Overall Study|Lost to Follow-up|4|||
124883025|NCT01463293|449195110|FG002|Overall Study|Lost to Follow-up|5|||
124883026|NCT01463293|449195108|FG000|Overall Study|Adverse Event|1|||
124883027|NCT01463293|449195109|FG001|Overall Study|Adverse Event|2|||
124883028|NCT01463293|449195110|FG002|Overall Study|Adverse Event|0|||
124883029|NCT01463293|449195108|FG000|Overall Study|Withdrawal by Subject|4|||
124883030|NCT01463293|449195109|FG001|Overall Study|Withdrawal by Subject|10|||
124883031|NCT01463293|449195110|FG002|Overall Study|Withdrawal by Subject|5|||
124883032|NCT01463293|449195108|FG000|Overall Study|Other|0|||
124883033|NCT01463293|449195109|FG001|Overall Study|Other|0|||
124883034|NCT01463293|449195110|FG002|Overall Study|Other|2|||
124883035|NCT00779584|449195119|FG000|Overall Study|Protocol Violation|0|||
124883036|NCT00779584|449195120|FG001|Overall Study|Protocol Violation|0|||
124883037|NCT00779584|449195121|FG002|Overall Study|Protocol Violation|0|||
124883038|NCT00779584|449195122|FG003|Overall Study|Protocol Violation|0|||
124883039|NCT00779584|449195123|FG004|Overall Study|Protocol Violation|0|||
124883040|NCT00779584|449195124|FG005|Overall Study|Protocol Violation|1|||
124883041|NCT00779584|449195125|FG006|Overall Study|Protocol Violation|0|||
124883042|NCT00779584|449195126|FG007|Overall Study|Protocol Violation|0|||
124883043|NCT00779584|449195127|FG008|Overall Study|Protocol Violation|0|||
124883044|NCT00779584|449195119|FG000|Overall Study|Withdrawal by Subject|1|||
124883045|NCT00779584|449195120|FG001|Overall Study|Withdrawal by Subject|1|||
124883046|NCT00779584|449195121|FG002|Overall Study|Withdrawal by Subject|2|||
124883047|NCT00779584|449195122|FG003|Overall Study|Withdrawal by Subject|0|||
124883048|NCT00779584|449195123|FG004|Overall Study|Withdrawal by Subject|0|||
124883049|NCT00779584|449195124|FG005|Overall Study|Withdrawal by Subject|2|||
124883050|NCT00779584|449195125|FG006|Overall Study|Withdrawal by Subject|1|||
125104589|NCT01915498|450004198|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125104590|NCT01915498|450004199|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125104591|NCT01915498|450004200|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125104592|NCT01915498|450004201|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125104593|NCT01915498|450004202|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
124883051|NCT00779584|449195126|FG007|Overall Study|Withdrawal by Subject|0|||
124883052|NCT00779584|449195127|FG008|Overall Study|Withdrawal by Subject|0|||
124883053|NCT00779584|449195119|FG000|Overall Study|Lost to Follow-up|0|||
124883054|NCT00779584|449195120|FG001|Overall Study|Lost to Follow-up|0|||
124883055|NCT00779584|449195121|FG002|Overall Study|Lost to Follow-up|0|||
124883056|NCT00779584|449195122|FG003|Overall Study|Lost to Follow-up|0|||
124883057|NCT00779584|449195123|FG004|Overall Study|Lost to Follow-up|1|||
124883058|NCT00779584|449195124|FG005|Overall Study|Lost to Follow-up|0|||
124883059|NCT00779584|449195125|FG006|Overall Study|Lost to Follow-up|0|||
124883060|NCT00779584|449195126|FG007|Overall Study|Lost to Follow-up|0|||
124883061|NCT00779584|449195127|FG008|Overall Study|Lost to Follow-up|0|||
124883062|NCT00779584|449195119|FG000|Overall Study|Progression of Disease|0|||
124883063|NCT00779584|449195120|FG001|Overall Study|Progression of Disease|1|||
124883064|NCT00779584|449195121|FG002|Overall Study|Progression of Disease|2|||
124883065|NCT00779584|449195122|FG003|Overall Study|Progression of Disease|6|||
124883066|NCT00779584|449195123|FG004|Overall Study|Progression of Disease|5|||
124883067|NCT00779584|449195124|FG005|Overall Study|Progression of Disease|1|||
124883068|NCT00779584|449195125|FG006|Overall Study|Progression of Disease|4|||
124883069|NCT00779584|449195126|FG007|Overall Study|Progression of Disease|2|||
124883070|NCT00779584|449195127|FG008|Overall Study|Progression of Disease|1|||
124883071|NCT00779584|449195119|FG000|Overall Study|Adverse Event|1|||
124883072|NCT00779584|449195120|FG001|Overall Study|Adverse Event|0|||
124883073|NCT00779584|449195121|FG002|Overall Study|Adverse Event|2|||
124883074|NCT00779584|449195122|FG003|Overall Study|Adverse Event|0|||
124883075|NCT00779584|449195123|FG004|Overall Study|Adverse Event|0|||
124883076|NCT00779584|449195124|FG005|Overall Study|Adverse Event|0|||
124883077|NCT00779584|449195125|FG006|Overall Study|Adverse Event|2|||
124883078|NCT00779584|449195126|FG007|Overall Study|Adverse Event|1|||
124883079|NCT00779584|449195127|FG008|Overall Study|Adverse Event|1|||
124883080|NCT00779584|449195119|FG000|Overall Study|Symptomatic Deterioration|1|||
124883081|NCT00779584|449195120|FG001|Overall Study|Symptomatic Deterioration|1|||
124883082|NCT00779584|449195121|FG002|Overall Study|Symptomatic Deterioration|1|||
124883083|NCT00779584|449195122|FG003|Overall Study|Symptomatic Deterioration|0|||
124883084|NCT00779584|449195123|FG004|Overall Study|Symptomatic Deterioration|0|||
124883085|NCT00779584|449195124|FG005|Overall Study|Symptomatic Deterioration|1|||
124883086|NCT00779584|449195125|FG006|Overall Study|Symptomatic Deterioration|1|||
125014820|NCT00794157|449678848|FG000|Overall Study|Protocol deviation|0|||
125014821|NCT00794157|449678849|FG001|Overall Study|Protocol deviation|1|||
125014822|NCT00794157|449678850|FG002|Overall Study|Protocol deviation|1|||
125014823|NCT00401375|449678852|FG000|Overall Study|Protocol Violation|2|||
125014824|NCT00401375|449678853|FG001|Overall Study|Protocol Violation|2|||
125014825|NCT00401375|449678854|FG002|Overall Study|Protocol Violation|1|||
124883087|NCT00779584|449195126|FG007|Overall Study|Symptomatic Deterioration|0|||
124883088|NCT00779584|449195127|FG008|Overall Study|Symptomatic Deterioration|0|||
124883089|NCT00779584|449195119|FG000|Overall Study|Ongoing in Study|0|||
124883090|NCT00779584|449195120|FG001|Overall Study|Ongoing in Study|0|||
124883091|NCT00779584|449195121|FG002|Overall Study|Ongoing in Study|0|||
124883092|NCT00779584|449195122|FG003|Overall Study|Ongoing in Study|0|||
124883093|NCT00779584|449195123|FG004|Overall Study|Ongoing in Study|1|||
124883094|NCT00779584|449195124|FG005|Overall Study|Ongoing in Study|1|||
124883095|NCT00779584|449195125|FG006|Overall Study|Ongoing in Study|0|||
124883096|NCT00779584|449195126|FG007|Overall Study|Ongoing in Study|0|||
124883097|NCT00779584|449195127|FG008|Overall Study|Ongoing in Study|0|||
124883098|NCT02878213|449195132|FG000|Overall Study|Withdrawal by Subject|2|||
124883099|NCT02878213|449195132|FG000|Overall Study|Adverse Event|1|||
124883100|NCT01913639|449195133|FG000|Overall Study|Not Eligible|3|||
124883101|NCT04986982|449195138|FG000|Overall Study|Withdrawal by Subject|3|||
124883102|NCT04986982|449195139|FG001|Overall Study|Withdrawal by Subject|1|||
124883103|NCT04986982|449195138|FG000|Overall Study|Lack of Efficacy|0|||
124883104|NCT04986982|449195139|FG001|Overall Study|Lack of Efficacy|2|||
124883105|NCT04986982|449195138|FG000|Overall Study|Ineligibility|3|||
124883106|NCT04986982|449195139|FG001|Overall Study|Ineligibility|0|||
124883107|NCT04986982|449195138|FG000|Overall Study|Adverse Event|4|||
124883108|NCT04986982|449195139|FG001|Overall Study|Adverse Event|4|||
124883109|NCT04986982|449195138|FG000|Overall Study|Lost to Follow-up|0|||
124883110|NCT04986982|449195139|FG001|Overall Study|Lost to Follow-up|1|||
125014826|NCT00401375|449678852|FG000|Overall Study|Adverse Event|6|||
125014827|NCT00401375|449678853|FG001|Overall Study|Adverse Event|11|||
125014828|NCT00401375|449678854|FG002|Overall Study|Adverse Event|10|||
124883111|NCT04986982|449195138|FG000|Overall Study|Sponsor's discretion|1|||
124883112|NCT04986982|449195139|FG001|Overall Study|Sponsor's discretion|0|||
124883113|NCT01155661|449195140|FG000|Overall Study|Adverse Event|101|||
124883114|NCT01155661|449195140|FG000|Overall Study|Death|1|||
124883115|NCT01155661|449195140|FG000|Overall Study|Lack of Efficacy|32|||
125014829|NCT00401375|449678852|FG000|Overall Study|Withdrawal by Subject|9|||
125014830|NCT00401375|449678853|FG001|Overall Study|Withdrawal by Subject|7|||
125014831|NCT00401375|449678854|FG002|Overall Study|Withdrawal by Subject|7|||
125014832|NCT00401375|449678852|FG000|Overall Study|Lost to Follow-up|0|||
125104594|NCT01915498|450004203|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
124883116|NCT01155661|449195140|FG000|Overall Study|Lost to Follow-up|22|||
124883117|NCT01155661|449195140|FG000|Overall Study|Physician Decision|3|||
124883118|NCT01155661|449195140|FG000|Overall Study|Protocol Violation|35|||
125014833|NCT00401375|449678853|FG001|Overall Study|Lost to Follow-up|1|||
124883119|NCT01155661|449195140|FG000|Overall Study|Withdrawal by Subject|73|||
124883120|NCT01155661|449195140|FG000|Overall Study|Sponsor Decision|13|||
124883121|NCT01370005|449195141|FG000|Overall Study|Not treated|1|||
124883122|NCT01370005|449195142|FG001|Overall Study|Not treated|0|||
124883123|NCT01370005|449195143|FG002|Overall Study|Not treated|0|||
124883124|NCT01370005|449195141|FG000|Overall Study|Adverse Event|5|||
124883125|NCT01370005|449195142|FG001|Overall Study|Adverse Event|5|||
125014834|NCT00401375|449678854|FG002|Overall Study|Lost to Follow-up|1|||
124883126|NCT01370005|449195143|FG002|Overall Study|Adverse Event|6|||
124883127|NCT01370005|449195141|FG000|Overall Study|Lack of Efficacy|1|||
124883128|NCT01370005|449195142|FG001|Overall Study|Lack of Efficacy|0|||
124883129|NCT01370005|449195143|FG002|Overall Study|Lack of Efficacy|0|||
124883130|NCT01370005|449195141|FG000|Overall Study|Non compliant with protocol|0|||
124883131|NCT01370005|449195142|FG001|Overall Study|Non compliant with protocol|1|||
124883132|NCT01370005|449195143|FG002|Overall Study|Non compliant with protocol|2|||
124883133|NCT01370005|449195141|FG000|Overall Study|Lost to Follow-up|1|||
124883134|NCT01370005|449195142|FG001|Overall Study|Lost to Follow-up|1|||
124883135|NCT01370005|449195143|FG002|Overall Study|Lost to Follow-up|1|||
124883136|NCT01370005|449195141|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
124883137|NCT01370005|449195142|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
124883138|NCT01370005|449195143|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
124883139|NCT01370005|449195141|FG000|Overall Study|Other reason not defined above|3|||
124883140|NCT01370005|449195142|FG001|Overall Study|Other reason not defined above|0|||
124883141|NCT01370005|449195143|FG002|Overall Study|Other reason not defined above|2|||
124883142|NCT02302066|449195144|FG000|Overall Study|Adverse Event|1|||
124883143|NCT02302066|449195145|FG001|Overall Study|Adverse Event|1|||
124883144|NCT02302066|449195146|FG002|Overall Study|Adverse Event|3|||
124883145|NCT02302066|449195147|FG003|Overall Study|Adverse Event|0|||
124883146|NCT02302066|449195144|FG000|Overall Study|Lost to Follow-up|4|||
124883147|NCT02302066|449195145|FG001|Overall Study|Lost to Follow-up|5|||
124883148|NCT02302066|449195146|FG002|Overall Study|Lost to Follow-up|24|||
124883149|NCT02302066|449195147|FG003|Overall Study|Lost to Follow-up|7|||
124883150|NCT02302066|449195144|FG000|Overall Study|Withdrawal by Subject|25|||
124883151|NCT02302066|449195145|FG001|Overall Study|Withdrawal by Subject|58|||
124883152|NCT02302066|449195146|FG002|Overall Study|Withdrawal by Subject|124|||
124883153|NCT02302066|449195147|FG003|Overall Study|Withdrawal by Subject|33|||
124883154|NCT02302066|449195144|FG000|Overall Study|Pregnancy|2|||
124883155|NCT02302066|449195145|FG001|Overall Study|Pregnancy|10|||
124883156|NCT02302066|449195146|FG002|Overall Study|Pregnancy|12|||
124883157|NCT02302066|449195147|FG003|Overall Study|Pregnancy|0|||
124883158|NCT02302066|449195144|FG000|Overall Study|Reason Not Specified|1|||
124883159|NCT02302066|449195145|FG001|Overall Study|Reason Not Specified|1|||
124883160|NCT02302066|449195146|FG002|Overall Study|Reason Not Specified|9|||
124883161|NCT02302066|449195147|FG003|Overall Study|Reason Not Specified|1|||
124883162|NCT02049710|449195148|FG000|Overall Study|Lost to Follow-up|319|||
124883163|NCT02049710|449195149|FG001|Overall Study|Lost to Follow-up|324|||
124883164|NCT00874432|449195153|FG000|Overall Study|Withdrawal by Subject|1|||
124883165|NCT00874432|449195154|FG001|Overall Study|Withdrawal by Subject|0|||
124883166|NCT00874432|449195155|FG002|Overall Study|Withdrawal by Subject|0|||
124883167|NCT00874432|449195156|FG003|Overall Study|Withdrawal by Subject|0|||
124883168|NCT00874432|449195153|FG000|Overall Study|Physician Decision|1|||
124883169|NCT00874432|449195154|FG001|Overall Study|Physician Decision|0|||
124883170|NCT00874432|449195155|FG002|Overall Study|Physician Decision|0|||
124883171|NCT00874432|449195156|FG003|Overall Study|Physician Decision|0|||
124883172|NCT00874432|449195153|FG000|Overall Study|Other|1|||
124883173|NCT00874432|449195154|FG001|Overall Study|Other|2|||
124883174|NCT00874432|449195155|FG002|Overall Study|Other|8|||
124883175|NCT00874432|449195156|FG003|Overall Study|Other|3|||
124883176|NCT03713021|449195157|FG000|Overall Study|Did not have CT sim scan available|6|||
125014835|NCT00401375|449678852|FG000|Overall Study|Other than specified|2|||
125014836|NCT00401375|449678853|FG001|Overall Study|Other than specified|1|||
125014837|NCT00401375|449678854|FG002|Overall Study|Other than specified|3|||
125014838|NCT00401375|449678852|FG000|Overall Study|Randomized but not treated|3|||
125014839|NCT00401375|449678853|FG001|Overall Study|Randomized but not treated|3|||
125014840|NCT00401375|449678854|FG002|Overall Study|Randomized but not treated|3|||
125014841|NCT00361270|449678855|FG000|Overall Study|Death|0|||
125014842|NCT00361270|449678856|FG001|Overall Study|Death|0|||
125014843|NCT00361270|449678857|FG002|Overall Study|Death|0|||
125210772|NCT01810783|450395682|FG000|Overall Study|Withdrawal by Subject|22|||
124883177|NCT03713021|449195157|FG000|Overall Study|Not eligible|4|||
124883178|NCT03713021|449195157|FG000|Overall Study|Issues with TraceIT markers|5|||
124883179|NCT03391960|449195163|FG000|Overall Study|Protocol Violation|0|||
124883180|NCT03391960|449195164|FG001|Overall Study|Protocol Violation|0|||
124883181|NCT01158378|449197100|FG000|Overall Study|Death|4|||
124883182|NCT01158378|449197101|FG001|Overall Study|Death|5|||
124883183|NCT01158378|449197100|FG000|Overall Study|Lost to Follow-up|2|||
125014844|NCT00361270|449678858|FG003|Overall Study|Death|2|||
125014845|NCT00361270|449678855|FG000|Overall Study|Lost to Follow-up|4|||
124883184|NCT01158378|449197101|FG001|Overall Study|Lost to Follow-up|4|||
125014846|NCT00361270|449678856|FG001|Overall Study|Lost to Follow-up|1|||
124883185|NCT01158378|449197100|FG000|Overall Study|Withdrawal by Subject|4|||
124883186|NCT01158378|449197101|FG001|Overall Study|Withdrawal by Subject|0|||
124883187|NCT02593539|449197102|FG000|Overall Study|Adverse Event|1|||
124883188|NCT01282476|449197103|FG000|Overall Study|Death|11|||
124883189|NCT00437125|449197104|FG000|Overall Study|Adverse Event|12|||
124883190|NCT00437125|449197104|FG000|Overall Study|Death|1|||
124883191|NCT00437125|449197104|FG000|Overall Study|Clinical Relapse|1|||
124883192|NCT00437125|449197104|FG000|Overall Study|Lack of Efficacy|1|||
124883193|NCT00437125|449197104|FG000|Overall Study|Lost to Follow-up|1|||
124883194|NCT00437125|449197104|FG000|Overall Study|Withdrawal by Subject|13|||
124883195|NCT00437125|449197104|FG000|Overall Study|Withdrawal by Caregiver|2|||
124883196|NCT00437125|449197104|FG000|Overall Study|Physician Decision|1|||
124883197|NCT00649389|449197107|FG000|Overall Study|Adverse Event|22|||
124883198|NCT00649389|449197108|FG001|Overall Study|Adverse Event|46|||
124883199|NCT00649389|449197109|FG002|Overall Study|Adverse Event|38|||
124883200|NCT00649389|449197110|FG003|Overall Study|Adverse Event|48|||
124883201|NCT00649389|449197107|FG000|Overall Study|Lost to Follow-up|15|||
124883202|NCT00649389|449197108|FG001|Overall Study|Lost to Follow-up|17|||
124883203|NCT00649389|449197109|FG002|Overall Study|Lost to Follow-up|21|||
124883204|NCT00649389|449197110|FG003|Overall Study|Lost to Follow-up|26|||
124883205|NCT00649389|449197107|FG000|Overall Study|Protocol Violation|11|||
124883206|NCT00649389|449197108|FG001|Overall Study|Protocol Violation|13|||
124883207|NCT00649389|449197109|FG002|Overall Study|Protocol Violation|9|||
124883208|NCT00649389|449197110|FG003|Overall Study|Protocol Violation|8|||
124883209|NCT00649389|449197107|FG000|Overall Study|Withdrawal by Subject|20|||
124883210|NCT00649389|449197108|FG001|Overall Study|Withdrawal by Subject|21|||
124883211|NCT00649389|449197109|FG002|Overall Study|Withdrawal by Subject|19|||
124883212|NCT00649389|449197110|FG003|Overall Study|Withdrawal by Subject|23|||
124883213|NCT00649389|449197107|FG000|Overall Study|Other|3|||
124883214|NCT00649389|449197108|FG001|Overall Study|Other|9|||
124883215|NCT00649389|449197109|FG002|Overall Study|Other|1|||
124883216|NCT00649389|449197110|FG003|Overall Study|Other|6|||
124883217|NCT01267825|449197113|FG000|Overall Study|study terminated. no data collected.|1|||
124883218|NCT01267825|449197114|FG001|Overall Study|study terminated. no data collected.|0|||
124883219|NCT01806740|449197115|FG000|Overall Study|Withdrawal by Subject|4|||
124883220|NCT01806740|449197115|FG000|Overall Study|Physician Decision|1|||
124883221|NCT01806740|449197115|FG000|Overall Study|Patient's refusal of treatment|1|||
124883222|NCT04666922|449197116|FG000|Overall Study|Withdrawal by Subject|1|||
124883223|NCT04666922|449197117|FG001|Overall Study|Withdrawal by Subject|0|||
124883224|NCT04666922|449197118|FG002|Overall Study|Withdrawal by Subject|0|||
124883225|NCT04666922|449197119|FG003|Overall Study|Withdrawal by Subject|0|||
124883226|NCT04666922|449197120|FG004|Overall Study|Withdrawal by Subject|0|||
124883227|NCT04666922|449197121|FG005|Overall Study|Withdrawal by Subject|0|||
124883228|NCT04666922|449197122|FG006|Overall Study|Withdrawal by Subject|0|||
124883229|NCT03722264|449197128|FG000|Overall Study|Physician Decision|3|||
124883230|NCT00871351|449197129|FG000|Overall Study|Withdrawal by Subject|1|||
124883231|NCT00871351|449197130|FG001|Overall Study|Withdrawal by Subject|0|||
124883232|NCT00871351|449197131|FG002|Overall Study|Withdrawal by Subject|0|||
124883233|NCT00871351|449197129|FG000|Overall Study|Adverse Event|3|||
124883234|NCT00871351|449197130|FG001|Overall Study|Adverse Event|1|||
125014847|NCT00361270|449678857|FG002|Overall Study|Lost to Follow-up|0|||
125014848|NCT00361270|449678858|FG003|Overall Study|Lost to Follow-up|0|||
125014849|NCT00361270|449678855|FG000|Overall Study|Physician Decision|0|||
125014850|NCT00361270|449678856|FG001|Overall Study|Physician Decision|0|||
125014851|NCT00361270|449678857|FG002|Overall Study|Physician Decision|1|||
125014852|NCT00361270|449678858|FG003|Overall Study|Physician Decision|0|||
125014853|NCT00361270|449678855|FG000|Overall Study|Protocol Violation|9|||
125014854|NCT00361270|449678856|FG001|Overall Study|Protocol Violation|4|||
125014855|NCT00361270|449678857|FG002|Overall Study|Protocol Violation|5|||
125014856|NCT00361270|449678858|FG003|Overall Study|Protocol Violation|4|||
125014857|NCT00361270|449678855|FG000|Overall Study|Withdrawal by Subject|6|||
125014858|NCT00361270|449678856|FG001|Overall Study|Withdrawal by Subject|6|||
124883235|NCT00871351|449197131|FG002|Overall Study|Adverse Event|0|||
124883236|NCT02959671|449197133|FG000|Overall Study|Adverse Event|2|||
125014859|NCT00361270|449678857|FG002|Overall Study|Withdrawal by Subject|3|||
124883237|NCT02959671|449197133|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
124883238|NCT02791490|449197134|FG000|Overall Study|Lost to Follow-up|1|||
124883239|NCT02791490|449197135|FG001|Overall Study|Lost to Follow-up|2|||
124883240|NCT02791490|449197134|FG000|Overall Study|Withdrawal by Subject|2|||
124883241|NCT02791490|449197135|FG001|Overall Study|Withdrawal by Subject|6|||
125014860|NCT00361270|449678858|FG003|Overall Study|Withdrawal by Subject|7|||
125014861|NCT00361270|449678855|FG000|Overall Study|Afraid of Hypnosis|1|||
125014862|NCT00361270|449678856|FG001|Overall Study|Afraid of Hypnosis|2|||
124883242|NCT01984424|449197136|FG000|Overall Study|Withdrawal by Subject|3|||
124883243|NCT01984424|449197137|FG001|Overall Study|Withdrawal by Subject|5|||
124883244|NCT01984424|449197136|FG000|Overall Study|Sponsor Decision|0|||
124883245|NCT01984424|449197137|FG001|Overall Study|Sponsor Decision|1|||
124883246|NCT01984424|449197136|FG000|Overall Study|Lost to Follow-up|0|||
124883247|NCT01984424|449197137|FG001|Overall Study|Lost to Follow-up|1|||
124883248|NCT00077636|449197138|FG000|Overall Study|Refused Treatment|9|||
124883249|NCT00077636|449197139|FG001|Overall Study|Refused Treatment|31|||
124883250|NCT00077636|449197138|FG000|Overall Study|Admin|3|||
124883251|NCT00077636|449197139|FG001|Overall Study|Admin|3|||
124883252|NCT00077636|449197138|FG000|Overall Study|Withdrawal by Subject|2|||
124883253|NCT00077636|449197139|FG001|Overall Study|Withdrawal by Subject|2|||
124883254|NCT00077636|449197138|FG000|Overall Study|Adverse Event|17|||
124883255|NCT00077636|449197139|FG001|Overall Study|Adverse Event|34|||
124883256|NCT00077636|449197138|FG000|Overall Study|Protocol Violation|0|||
124883257|NCT00077636|449197139|FG001|Overall Study|Protocol Violation|2|||
124883258|NCT00077636|449197138|FG000|Overall Study|Lost to Follow-up|10|||
124883259|NCT00077636|449197139|FG001|Overall Study|Lost to Follow-up|18|||
124883260|NCT00077636|449197138|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
124883261|NCT00077636|449197139|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
124883262|NCT02032173|449197140|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
124883263|NCT03661996|449197143|FG000|Overall Study|Adverse Event|0|||
124883264|NCT03661996|449197144|FG001|Overall Study|Adverse Event|0|||
124883265|NCT03661996|449197145|FG002|Overall Study|Adverse Event|1|||
124883266|NCT03661996|449197146|FG003|Overall Study|Adverse Event|1|||
124883267|NCT03661996|449197147|FG004|Overall Study|Adverse Event|0|||
124883268|NCT03661996|449197143|FG000|Overall Study|Lost to Follow-up|5|||
124883269|NCT03661996|449197144|FG001|Overall Study|Lost to Follow-up|1|||
124883270|NCT03661996|449197145|FG002|Overall Study|Lost to Follow-up|2|||
124883271|NCT03661996|449197146|FG003|Overall Study|Lost to Follow-up|2|||
124883272|NCT03661996|449197147|FG004|Overall Study|Lost to Follow-up|6|||
124883273|NCT03661996|449197143|FG000|Overall Study|Physician Decision|1|||
124883274|NCT03661996|449197144|FG001|Overall Study|Physician Decision|1|||
124883275|NCT03661996|449197145|FG002|Overall Study|Physician Decision|1|||
124883276|NCT03661996|449197146|FG003|Overall Study|Physician Decision|2|||
124883277|NCT03661996|449197147|FG004|Overall Study|Physician Decision|0|||
124883278|NCT03661996|449197143|FG000|Overall Study|Protocol Violation|0|||
124883279|NCT03661996|449197144|FG001|Overall Study|Protocol Violation|0|||
124883280|NCT03661996|449197145|FG002|Overall Study|Protocol Violation|0|||
124883281|NCT03661996|449197146|FG003|Overall Study|Protocol Violation|0|||
124883282|NCT03661996|449197147|FG004|Overall Study|Protocol Violation|1|||
124883283|NCT03661996|449197143|FG000|Overall Study|Withdrawal by Subject|3|||
124883284|NCT03661996|449197144|FG001|Overall Study|Withdrawal by Subject|5|||
124883285|NCT03661996|449197145|FG002|Overall Study|Withdrawal by Subject|1|||
124883286|NCT03661996|449197146|FG003|Overall Study|Withdrawal by Subject|7|||
124883287|NCT03661996|449197147|FG004|Overall Study|Withdrawal by Subject|7|||
124883288|NCT03661996|449197143|FG000|Overall Study|Sponsors Decision|2|||
124883289|NCT03661996|449197144|FG001|Overall Study|Sponsors Decision|0|||
124883290|NCT03661996|449197145|FG002|Overall Study|Sponsors Decision|0|||
124883291|NCT03661996|449197146|FG003|Overall Study|Sponsors Decision|0|||
124883292|NCT03661996|449197147|FG004|Overall Study|Sponsors Decision|0|||
124883293|NCT03661996|449197143|FG000|Overall Study|Other|1|||
124883294|NCT03661996|449197144|FG001|Overall Study|Other|1|||
124883295|NCT03661996|449197145|FG002|Overall Study|Other|1|||
124883296|NCT03661996|449197146|FG003|Overall Study|Other|1|||
125104595|NCT01915498|450004204|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
124883297|NCT03661996|449197147|FG004|Overall Study|Other|0|||
125104596|NCT01915498|450004205|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125104597|NCT01915498|450004206|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
124883298|NCT01993017|449197148|FG000|Overall Study|Death|23|||
124883299|NCT01993017|449197149|FG001|Overall Study|Death|26|||
124883300|NCT01993017|449197150|FG002|Overall Study|Death|18|||
124883301|NCT01993017|449197148|FG000|Overall Study|Could not be contacted|43|||
124883302|NCT01993017|449197149|FG001|Overall Study|Could not be contacted|42|||
124883303|NCT01993017|449197150|FG002|Overall Study|Could not be contacted|38|||
124883304|NCT01993017|449197148|FG000|Overall Study|Dropped out|19|||
124883305|NCT01993017|449197149|FG001|Overall Study|Dropped out|6|||
124883306|NCT01993017|449197150|FG002|Overall Study|Dropped out|11|||
124883307|NCT01993017|449197148|FG000|Overall Study|Other reasons|17|||
124883308|NCT01993017|449197149|FG001|Overall Study|Other reasons|11|||
124883309|NCT01993017|449197150|FG002|Overall Study|Other reasons|7|||
124883310|NCT01993017|449197148|FG000|Overall Study|Ineligible after randomization|4|||
124883311|NCT01993017|449197149|FG001|Overall Study|Ineligible after randomization|5|||
124883312|NCT01993017|449197150|FG002|Overall Study|Ineligible after randomization|5|||
124883313|NCT00068380|449197151|FG000|Overall Study|Withdrawal by Subject|3|||
124883314|NCT00068380|449197151|FG000|Overall Study|Adverse Event|2|||
124883315|NCT00917267|449197159|FG000|Overall Study|Adverse Event|15|||
124883316|NCT00917267|449197160|FG001|Overall Study|Adverse Event|36|||
124883317|NCT00917267|449197159|FG000|Overall Study|Physician Decision|2|||
124883318|NCT00917267|449197160|FG001|Overall Study|Physician Decision|4|||
124883319|NCT00917267|449197159|FG000|Overall Study|Protocol Violation|9|||
124883320|NCT00917267|449197160|FG001|Overall Study|Protocol Violation|18|||
124883321|NCT00917267|449197159|FG000|Overall Study|Withdrawal by Subject|5|||
124883322|NCT00917267|449197160|FG001|Overall Study|Withdrawal by Subject|12|||
124883323|NCT00917267|449197159|FG000|Overall Study|Lost to follow up|0|||
124883324|NCT00917267|449197160|FG001|Overall Study|Lost to follow up|2|||
124883325|NCT00917267|449197159|FG000|Overall Study|Entry Criteria Not Met|1|||
124883326|NCT00917267|449197160|FG001|Overall Study|Entry Criteria Not Met|0|||
124883327|NCT00917267|449197159|FG000|Overall Study|Sponsor Decision|5|||
124883328|NCT00917267|449197160|FG001|Overall Study|Sponsor Decision|5|||
124883329|NCT00917267|449197159|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
124883330|NCT00917267|449197160|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
124883331|NCT02960763|449197161|FG000|Step 1|Withdrawal by Subject|10|||
124883332|NCT02960763|449197162|FG001|Step 1|Withdrawal by Subject|8|||
124883333|NCT02960763|449197163|FG002|Step 1|Withdrawal by Subject|13|||
124883334|NCT02960763|449197164|FG003|Step 1|Withdrawal by Subject|0|||
124883335|NCT02960763|449197165|FG004|Step 1|Withdrawal by Subject|0|||
124883336|NCT02960763|449197161|FG000|Step 1|Lost to Follow-up|7|||
124883337|NCT02960763|449197162|FG001|Step 1|Lost to Follow-up|9|||
124883338|NCT02960763|449197163|FG002|Step 1|Lost to Follow-up|12|||
124883339|NCT02960763|449197164|FG003|Step 1|Lost to Follow-up|0|||
124883340|NCT02960763|449197165|FG004|Step 1|Lost to Follow-up|0|||
124883341|NCT02960763|449197161|FG000|Step 1|Death|1|||
124883342|NCT02960763|449197162|FG001|Step 1|Death|1|||
124883343|NCT02960763|449197163|FG002|Step 1|Death|1|||
124883344|NCT02960763|449197164|FG003|Step 1|Death|0|||
124883345|NCT02960763|449197165|FG004|Step 1|Death|0|||
124883346|NCT02960763|449197161|FG000|Step 1|Investigator discretion|1|||
124883347|NCT02960763|449197162|FG001|Step 1|Investigator discretion|0|||
124883348|NCT02960763|449197163|FG002|Step 1|Investigator discretion|1|||
124883349|NCT02960763|449197164|FG003|Step 1|Investigator discretion|0|||
124883350|NCT02960763|449197165|FG004|Step 1|Investigator discretion|0|||
124883351|NCT02960763|449197161|FG000|Step 1|Other|0|||
125014863|NCT00361270|449678857|FG002|Overall Study|Afraid of Hypnosis|0|||
125014864|NCT00361270|449678858|FG003|Overall Study|Afraid of Hypnosis|0|||
125014865|NCT00361270|449678855|FG000|Overall Study|Problems with Transportation|4|||
125014866|NCT00361270|449678856|FG001|Overall Study|Problems with Transportation|0|||
125014867|NCT00361270|449678857|FG002|Overall Study|Problems with Transportation|0|||
125014868|NCT00361270|449678858|FG003|Overall Study|Problems with Transportation|0|||
125014869|NCT00361270|449678855|FG000|Overall Study|Adverse Event|0|||
125014870|NCT00361270|449678856|FG001|Overall Study|Adverse Event|1|||
125014871|NCT00361270|449678857|FG002|Overall Study|Adverse Event|1|||
125014872|NCT00361270|449678858|FG003|Overall Study|Adverse Event|0|||
125014873|NCT00950664|449678859|FG000|First Intervention|Lost to Follow-up|1|||
125014874|NCT00950664|449678860|FG001|First Intervention|Lost to Follow-up|3|||
125014875|NCT00950664|449678859|FG000|First Intervention|Withdrawal by Subject|2|||
125014876|NCT00950664|449678860|FG001|First Intervention|Withdrawal by Subject|2|||
124883352|NCT02960763|449197162|FG001|Step 1|Other|0|||
124883353|NCT02960763|449197163|FG002|Step 1|Other|1|||
124883354|NCT02960763|449197164|FG003|Step 1|Other|0|||
124883355|NCT02960763|449197165|FG004|Step 1|Other|0|||
124883356|NCT02960763|449197161|FG000|Step 2|Withdrawal by Subject|0|||
124883357|NCT02960763|449197162|FG001|Step 2|Withdrawal by Subject|0|||
124883358|NCT02960763|449197163|FG002|Step 2|Withdrawal by Subject|0|||
124883359|NCT02960763|449197164|FG003|Step 2|Withdrawal by Subject|7|||
124883360|NCT02960763|449197165|FG004|Step 2|Withdrawal by Subject|3|||
124883361|NCT02960763|449197161|FG000|Step 2|Lost to Follow-up|0|||
124883362|NCT02960763|449197162|FG001|Step 2|Lost to Follow-up|0|||
124883363|NCT02960763|449197163|FG002|Step 2|Lost to Follow-up|0|||
124883364|NCT02960763|449197164|FG003|Step 2|Lost to Follow-up|4|||
124883365|NCT02960763|449197165|FG004|Step 2|Lost to Follow-up|1|||
124883366|NCT02960763|449197161|FG000|Step 2|Investigator discretion|0|||
124883367|NCT02960763|449197162|FG001|Step 2|Investigator discretion|0|||
124883368|NCT02960763|449197163|FG002|Step 2|Investigator discretion|0|||
124883369|NCT02960763|449197164|FG003|Step 2|Investigator discretion|0|||
124883370|NCT02960763|449197165|FG004|Step 2|Investigator discretion|1|||
124883371|NCT00312858|449197169|FG000|Overall Study|Adverse Event|0|||
124883372|NCT00312858|449197170|FG001|Overall Study|Adverse Event|1|||
124883373|NCT00312858|449197169|FG000|Overall Study|Lost to Follow-up|25|||
124883374|NCT00312858|449197170|FG001|Overall Study|Lost to Follow-up|42|||
124883375|NCT00312858|449197169|FG000|Overall Study|Protocol Violation|3|||
124883376|NCT00312858|449197170|FG001|Overall Study|Protocol Violation|8|||
124883377|NCT00312858|449197169|FG000|Overall Study|Withdraw by Participant|20|||
124883378|NCT00312858|449197170|FG001|Overall Study|Withdraw by Participant|20|||
124883379|NCT00312858|449197169|FG000|Overall Study|Participant Moved|11|||
124883380|NCT00312858|449197170|FG001|Overall Study|Participant Moved|10|||
124883381|NCT00312858|449197169|FG000|Overall Study|Other|9|||
124883382|NCT00312858|449197170|FG001|Overall Study|Other|12|||
124883383|NCT01868035|449197171|FG000|Overall Study|Lost to Follow-up|3|||
124883384|NCT01868035|449197171|FG000|Overall Study|Withdrawal by Subject|1|||
124883385|NCT01868035|449197171|FG000|Overall Study|Progressive Disease|2|||
124883386|NCT01868035|449197171|FG000|Overall Study|Non-compliance|1|||
124883387|NCT00432835|449197172|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
124883388|NCT00432835|449197173|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
124883389|NCT00423293|449197174|FG000|Overall Study|Ineligible / No protocol treatment|11|||
124883390|NCT01912222|449197175|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
124883391|NCT01912222|449197176|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
124883392|NCT01912222|449197177|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
124883393|NCT01912222|449197175|FG000|Part B: Treatment Period|Progressive disease|10|||
124883394|NCT01912222|449197176|FG001|Part B: Treatment Period|Progressive disease|12|||
124883395|NCT01912222|449197177|FG002|Part B: Treatment Period|Progressive disease|15|||
124883396|NCT01912222|449197175|FG000|Part B: Treatment Period|Adverse Event|1|||
124883397|NCT01912222|449197176|FG001|Part B: Treatment Period|Adverse Event|2|||
124883398|NCT01912222|449197177|FG002|Part B: Treatment Period|Adverse Event|3|||
124883399|NCT01912222|449197175|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
124883400|NCT01912222|449197176|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
124883401|NCT01912222|449197177|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
124883402|NCT04399551|449197178|FG000|Overall Study|Adverse Event|15|||
124883403|NCT04399551|449197178|FG000|Overall Study|Withdrawal by Subject|6|||
124883404|NCT04399551|449197178|FG000|Overall Study|Physician Decision|3|||
124883405|NCT04399551|449197178|FG000|Overall Study|Lost to Follow-up|2|||
124883406|NCT04399551|449197178|FG000|Overall Study|Protocol Deviation|2|||
124883407|NCT01014975|449197179|FG000|Overall Study|Withdrawal by Subject|1|||
124883408|NCT01014975|449197180|FG001|Overall Study|Withdrawal by Subject|0|||
124883409|NCT01014975|449197181|FG002|Overall Study|Withdrawal by Subject|1|||
124883410|NCT01014975|449197179|FG000|Overall Study|Death|3|||
124883411|NCT01014975|449197180|FG001|Overall Study|Death|3|||
124883412|NCT01014975|449197181|FG002|Overall Study|Death|4|||
124883413|NCT01014975|449197179|FG000|Overall Study|Lost to Follow-up|0|||
124883414|NCT01014975|449197180|FG001|Overall Study|Lost to Follow-up|0|||
124883415|NCT01014975|449197181|FG002|Overall Study|Lost to Follow-up|1|||
124883416|NCT01336634|449197184|FG000|Overall Study|Study closed/terminated|5|||
124883417|NCT01336634|449197185|FG001|Overall Study|Study closed/terminated|6|||
124883418|NCT01336634|449197186|FG002|Overall Study|Study closed/terminated|6|||
124883419|NCT01336634|449197184|FG000|Overall Study|Lost to Follow-up|2|||
124883420|NCT01336634|449197185|FG001|Overall Study|Lost to Follow-up|1|||
124883421|NCT01336634|449197186|FG002|Overall Study|Lost to Follow-up|1|||
125014877|NCT00677014|449678862|FG000|Overall Study|Lost to Follow-up|20|||
124883422|NCT01336634|449197184|FG000|Overall Study|Physician Decision|1|||
124883423|NCT01336634|449197185|FG001|Overall Study|Physician Decision|1|||
124883424|NCT01336634|449197186|FG002|Overall Study|Physician Decision|0|||
124883425|NCT01336634|449197184|FG000|Overall Study|Withdrawal by Subject|6|||
124883426|NCT01336634|449197185|FG001|Overall Study|Withdrawal by Subject|0|||
124883427|NCT01336634|449197186|FG002|Overall Study|Withdrawal by Subject|2|||
124883428|NCT01863043|449197187|FG000|Overall Study|Death|6|||
124883429|NCT01863043|449197188|FG001|Overall Study|Death|1|||
124883430|NCT01863043|449197187|FG000|Overall Study|Withdrawal by Subject|0|||
124883431|NCT01863043|449197188|FG001|Overall Study|Withdrawal by Subject|2|||
124883432|NCT01863043|449197187|FG000|Overall Study|Adverse Event|7|||
124883433|NCT01863043|449197188|FG001|Overall Study|Adverse Event|8|||
124883434|NCT01863043|449197187|FG000|Overall Study|exclusion criteria found after enrollment|0|||
124883435|NCT01863043|449197188|FG001|Overall Study|exclusion criteria found after enrollment|1|||
124883436|NCT00854295|449197191|FG000|Overall Study|Death|7|||
124883437|NCT00854295|449197192|FG001|Overall Study|Death|0|||
124883438|NCT00854295|449197193|FG002|Overall Study|Death|1|||
124883439|NCT00854295|449197194|FG003|Overall Study|Death|1|||
124883440|NCT00854295|449197191|FG000|Overall Study|Adverse Event|6|||
124883441|NCT00854295|449197192|FG001|Overall Study|Adverse Event|1|||
124883442|NCT00854295|449197193|FG002|Overall Study|Adverse Event|1|||
124883443|NCT00854295|449197194|FG003|Overall Study|Adverse Event|3|||
124883444|NCT00854295|449197191|FG000|Overall Study|Lost to Follow-up|18|||
124883445|NCT00854295|449197192|FG001|Overall Study|Lost to Follow-up|5|||
124883446|NCT00854295|449197193|FG002|Overall Study|Lost to Follow-up|21|||
124883447|NCT00854295|449197194|FG003|Overall Study|Lost to Follow-up|21|||
124883448|NCT00854295|449197191|FG000|Overall Study|Physician Decision|10|||
124883449|NCT00854295|449197192|FG001|Overall Study|Physician Decision|0|||
124883450|NCT00854295|449197193|FG002|Overall Study|Physician Decision|0|||
124883451|NCT00854295|449197194|FG003|Overall Study|Physician Decision|0|||
124883452|NCT03154359|449197195|FG000|Overall Study|Adverse Event|1|||
124883453|NCT03154359|449197195|FG000|Overall Study|Lack of Efficacy|2|||
124883454|NCT03154359|449197195|FG000|Overall Study|Lost to Follow-up|3|||
124883455|NCT03154359|449197195|FG000|Overall Study|Physician Decision|3|||
124883456|NCT03154359|449197195|FG000|Overall Study|Protocol Violation|4|||
124883457|NCT03154359|449197195|FG000|Overall Study|Withdrawal by Subject|5|||
124883458|NCT03154359|449197195|FG000|Overall Study|Disruption of study due to COVID-19|4|||
124883459|NCT05033743|449197196|FG000|Overall Study|Lost to Follow-up|1|||
124883460|NCT05033743|449197196|FG000|Overall Study|Protocol Violation|2|||
124883461|NCT05033743|449197196|FG000|Overall Study|Withdrawal by Subject|1|||
124883462|NCT00885352|449197199|FG000|Overall Study|Adverse Event|2|||
124883463|NCT00885352|449197200|FG001|Overall Study|Adverse Event|3|||
124883464|NCT00885352|449197199|FG000|Overall Study|Lost to Follow-up|2|||
124883465|NCT00885352|449197200|FG001|Overall Study|Lost to Follow-up|2|||
124883466|NCT00885352|449197199|FG000|Overall Study|Physician Decision|0|||
124883467|NCT00885352|449197200|FG001|Overall Study|Physician Decision|3|||
124883468|NCT00885352|449197199|FG000|Overall Study|Protocol Violation|0|||
124883469|NCT00885352|449197200|FG001|Overall Study|Protocol Violation|2|||
124883470|NCT00885352|449197199|FG000|Overall Study|Withdrawal by Subject|1|||
124883471|NCT00885352|449197200|FG001|Overall Study|Withdrawal by Subject|5|||
125104598|NCT01915498|450004207|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125104599|NCT01915498|450004208|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125104600|NCT01915498|450004209|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125104601|NCT01915498|450004210|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125104602|NCT01915498|450004192|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
125104603|NCT01915498|450004193|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
125104604|NCT01915498|450004194|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
125104605|NCT01915498|450004195|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
125104606|NCT01915498|450004196|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
125104607|NCT01915498|450004197|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
125104608|NCT01915498|450004198|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
125104609|NCT01915498|450004199|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
125104610|NCT01915498|450004200|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
125104611|NCT01915498|450004201|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
125104612|NCT01915498|450004202|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
125104613|NCT01915498|450004203|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
125104614|NCT01915498|450004204|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
125104615|NCT01915498|450004205|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
125104616|NCT01915498|450004206|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
125104617|NCT01915498|450004207|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
125104618|NCT01915498|450004208|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
125104619|NCT01915498|450004209|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
125104620|NCT01915498|450004210|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
125104621|NCT01915498|450004192|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
125104622|NCT01915498|450004193|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
124883472|NCT00885352|449197199|FG000|Overall Study|Contradiction to study medication|0|||
124883473|NCT00885352|449197200|FG001|Overall Study|Contradiction to study medication|2|||
124883474|NCT00885352|449197199|FG000|Overall Study|Excluded medication|2|||
124883475|NCT00885352|449197200|FG001|Overall Study|Excluded medication|2|||
124883476|NCT00885352|449197199|FG000|Overall Study|Lab abnormalities|1|||
124883477|NCT00885352|449197200|FG001|Overall Study|Lab abnormalities|1|||
124883478|NCT00152971|449197206|FG000|Overall Study|Adverse Event|12|||
124883479|NCT00152971|449197207|FG001|Overall Study|Adverse Event|10|||
124883480|NCT00152971|449197208|FG002|Overall Study|Adverse Event|9|||
125104623|NCT01915498|450004194|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
124883481|NCT00152971|449197206|FG000|Overall Study|Protocol Violation|10|||
124883482|NCT00152971|449197207|FG001|Overall Study|Protocol Violation|11|||
124883483|NCT00152971|449197208|FG002|Overall Study|Protocol Violation|8|||
124883484|NCT00152971|449197206|FG000|Overall Study|Lost to Follow-up|17|||
124883485|NCT00152971|449197207|FG001|Overall Study|Lost to Follow-up|14|||
124883486|NCT00152971|449197208|FG002|Overall Study|Lost to Follow-up|13|||
124883487|NCT00152971|449197206|FG000|Overall Study|Withdrawal by Subject|9|||
124883488|NCT00152971|449197207|FG001|Overall Study|Withdrawal by Subject|8|||
124883489|NCT00152971|449197208|FG002|Overall Study|Withdrawal by Subject|14|||
124883490|NCT00152971|449197206|FG000|Overall Study|Other|3|||
124883491|NCT00152971|449197207|FG001|Overall Study|Other|5|||
124883492|NCT00152971|449197208|FG002|Overall Study|Other|5|||
124883493|NCT00152971|449197206|FG000|Treatment|Adverse Event|49|||
124883494|NCT00152971|449197207|FG001|Treatment|Adverse Event|40|||
124883495|NCT00152971|449197208|FG002|Treatment|Adverse Event|54|||
124883496|NCT00152971|449197206|FG000|Treatment|Protocol Violation|8|||
124883497|NCT00152971|449197207|FG001|Treatment|Protocol Violation|6|||
124883498|NCT00152971|449197208|FG002|Treatment|Protocol Violation|10|||
124883499|NCT00152971|449197206|FG000|Treatment|Lost to Follow-up|1|||
124883500|NCT00152971|449197207|FG001|Treatment|Lost to Follow-up|2|||
124883501|NCT00152971|449197208|FG002|Treatment|Lost to Follow-up|1|||
124883502|NCT00152971|449197206|FG000|Treatment|Withdrawal by Subject|4|||
124883503|NCT00152971|449197207|FG001|Treatment|Withdrawal by Subject|4|||
124883504|NCT00152971|449197208|FG002|Treatment|Withdrawal by Subject|5|||
124883505|NCT00152971|449197206|FG000|Treatment|Other|9|||
124883506|NCT00152971|449197207|FG001|Treatment|Other|11|||
124883507|NCT00152971|449197208|FG002|Treatment|Other|10|||
124883508|NCT03292146|449197209|FG000|Baseline to 12 Months|Relocation|1|||
124883509|NCT03292146|449197210|FG001|Baseline to 12 Months|Relocation|0|||
124883510|NCT03292146|449197209|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
124883511|NCT03292146|449197210|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
124883512|NCT03292146|449197209|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
124883513|NCT03292146|449197210|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
124883514|NCT03292146|449197209|FG000|12 Months to 24 Months|Planning pregnancy|2|||
124883515|NCT03292146|449197210|FG001|12 Months to 24 Months|Planning pregnancy|2|||
124883516|NCT03292146|449197209|FG000|12 Months to 24 Months|Personal reasons|1|||
124883517|NCT03292146|449197210|FG001|12 Months to 24 Months|Personal reasons|0|||
124883518|NCT03292146|449197209|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
124883519|NCT03292146|449197210|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
124883520|NCT00366301|449197213|FG000|Overall Study|Lost to Follow-up|4|||
124883521|NCT00366301|449197214|FG001|Overall Study|Lost to Follow-up|4|||
124883522|NCT00366301|449197215|FG002|Overall Study|Lost to Follow-up|3|||
124883523|NCT00366301|449197216|FG003|Overall Study|Lost to Follow-up|7|||
124883524|NCT00366301|449197213|FG000|Overall Study|Withdrawal by Subject|4|||
124883525|NCT00366301|449197214|FG001|Overall Study|Withdrawal by Subject|2|||
124883526|NCT00366301|449197215|FG002|Overall Study|Withdrawal by Subject|1|||
124883527|NCT00366301|449197216|FG003|Overall Study|Withdrawal by Subject|1|||
124883528|NCT01076088|449197223|FG000|Overall Study|Adverse Event|1|||
124883529|NCT01076088|449197224|FG001|Overall Study|Adverse Event|6|||
124883530|NCT01076088|449197225|FG002|Overall Study|Adverse Event|3|||
124883531|NCT01076088|449197226|FG003|Overall Study|Adverse Event|2|||
124883532|NCT01076088|449197227|FG004|Overall Study|Adverse Event|3|||
124883533|NCT01076088|449197228|FG005|Overall Study|Adverse Event|3|||
124883534|NCT01076088|449197223|FG000|Overall Study|Lost to Follow-up|1|||
124883535|NCT01076088|449197224|FG001|Overall Study|Lost to Follow-up|1|||
124883536|NCT01076088|449197225|FG002|Overall Study|Lost to Follow-up|0|||
124883537|NCT01076088|449197226|FG003|Overall Study|Lost to Follow-up|1|||
124883538|NCT01076088|449197227|FG004|Overall Study|Lost to Follow-up|1|||
124883539|NCT01076088|449197228|FG005|Overall Study|Lost to Follow-up|2|||
124883540|NCT01076088|449197223|FG000|Overall Study|Non-compliance with study drug|0|||
124883541|NCT01076088|449197224|FG001|Overall Study|Non-compliance with study drug|0|||
124883542|NCT01076088|449197225|FG002|Overall Study|Non-compliance with study drug|0|||
124883543|NCT01076088|449197226|FG003|Overall Study|Non-compliance with study drug|1|||
124883544|NCT01076088|449197227|FG004|Overall Study|Non-compliance with study drug|0|||
124883545|NCT01076088|449197228|FG005|Overall Study|Non-compliance with study drug|0|||
124883546|NCT01076088|449197223|FG000|Overall Study|Physician Decision|1|||
124883547|NCT01076088|449197224|FG001|Overall Study|Physician Decision|3|||
124883548|NCT01076088|449197225|FG002|Overall Study|Physician Decision|0|||
124883549|NCT01076088|449197226|FG003|Overall Study|Physician Decision|1|||
124883550|NCT01076088|449197227|FG004|Overall Study|Physician Decision|1|||
124883551|NCT01076088|449197228|FG005|Overall Study|Physician Decision|0|||
124883552|NCT01076088|449197223|FG000|Overall Study|Withdrawal by Subject|8|||
124883553|NCT01076088|449197224|FG001|Overall Study|Withdrawal by Subject|8|||
124883554|NCT01076088|449197225|FG002|Overall Study|Withdrawal by Subject|14|||
125014878|NCT00677014|449678863|FG001|Overall Study|Lost to Follow-up|12|||
125014879|NCT00677014|449678864|FG002|Overall Study|Lost to Follow-up|24|||
125014880|NCT00677014|449678862|FG000|Overall Study|Death|6|||
125014881|NCT00677014|449678863|FG001|Overall Study|Death|15|||
125014882|NCT00677014|449678864|FG002|Overall Study|Death|7|||
125014883|NCT00677014|449678862|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
125014884|NCT00677014|449678863|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
125014885|NCT00677014|449678864|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
125014886|NCT02374099|449678865|FG000|Overall Study|Adverse Event|1|||
125014887|NCT02374099|449678866|FG001|Overall Study|Adverse Event|0|||
125014888|NCT02374099|449678865|FG000|Overall Study|Progressive Disease|35|||
125014889|NCT02374099|449678866|FG001|Overall Study|Progressive Disease|40|||
125014890|NCT02374099|449678865|FG000|Overall Study|Withdrawal by Subject|5|||
125014891|NCT02374099|449678866|FG001|Overall Study|Withdrawal by Subject|1|||
125014892|NCT02374099|449678865|FG000|Overall Study|Miscellaneous|2|||
125014893|NCT02374099|449678866|FG001|Overall Study|Miscellaneous|3|||
125014894|NCT02374099|449678865|FG000|Overall Study|Randomized, but not treated|2|||
125014895|NCT02374099|449678866|FG001|Overall Study|Randomized, but not treated|1|||
125014896|NCT02374099|449678865|FG000|Overall Study|Study Terminated by Sponsor|3|||
125014897|NCT02374099|449678866|FG001|Overall Study|Study Terminated by Sponsor|4|||
125014898|NCT00081159|449678867|FG000|Overall Study|Withdrawal by Subject|0|||
125014899|NCT00081159|449678868|FG001|Overall Study|Withdrawal by Subject|3|||
125014900|NCT00081159|449678867|FG000|Overall Study|Myelosuppression prior to treatment|0|||
125014901|NCT00081159|449678868|FG001|Overall Study|Myelosuppression prior to treatment|1|||
125014902|NCT00081159|449678867|FG000|Overall Study|Lost to Follow-up|2|||
125014903|NCT00081159|449678868|FG001|Overall Study|Lost to Follow-up|1|||
125014904|NCT01553136|449678874|FG000|Overall Study|Adverse Event|3|||
125104624|NCT01915498|450004195|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
125104625|NCT01915498|450004196|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
125014905|NCT01553136|449678875|FG001|Overall Study|Adverse Event|2|||
125014906|NCT01553136|449678874|FG000|Overall Study|Withdrawal by Subject|2|||
125014907|NCT01553136|449678875|FG001|Overall Study|Withdrawal by Subject|3|||
125014908|NCT01553136|449678874|FG000|Overall Study|Lost to Follow-up|4|||
125014909|NCT01553136|449678875|FG001|Overall Study|Lost to Follow-up|10|||
125014910|NCT01553136|449678874|FG000|Overall Study|Physician Decision|2|||
125104626|NCT01915498|450004197|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
124883555|NCT01076088|449197226|FG003|Overall Study|Withdrawal by Subject|10|||
124883556|NCT01076088|449197227|FG004|Overall Study|Withdrawal by Subject|11|||
124883557|NCT01076088|449197228|FG005|Overall Study|Withdrawal by Subject|17|||
124883558|NCT01076088|449197223|FG000|Overall Study|Other protocol specified criteria|0|||
124883559|NCT01076088|449197224|FG001|Overall Study|Other protocol specified criteria|0|||
124883560|NCT01076088|449197225|FG002|Overall Study|Other protocol specified criteria|0|||
124883561|NCT01076088|449197226|FG003|Overall Study|Other protocol specified criteria|0|||
124883562|NCT01076088|449197227|FG004|Overall Study|Other protocol specified criteria|0|||
124883563|NCT01076088|449197228|FG005|Overall Study|Other protocol specified criteria|1|||
124883564|NCT03306043|449197232|FG000|Overall Study|Adverse Event|1|||
124883565|NCT03306043|449197232|FG000|Overall Study|Lost to Follow-up|1|||
124883566|NCT03306043|449197232|FG000|Overall Study|Withdrawal by Subject|2|||
124883567|NCT00785538|449197246|FG000|Treatment Period|Adverse Event|1|||
124883568|NCT00785538|449197247|FG001|Treatment Period|Adverse Event|2|||
124883569|NCT00785538|449197248|FG002|Treatment Period|Adverse Event|2|||
124883570|NCT00785538|449197249|FG003|Treatment Period|Adverse Event|0|||
124883571|NCT00785538|449197246|FG000|Treatment Period|Withdrawal by Subject|0|||
124883572|NCT00785538|449197247|FG001|Treatment Period|Withdrawal by Subject|0|||
124883573|NCT00785538|449197248|FG002|Treatment Period|Withdrawal by Subject|0|||
124883574|NCT00785538|449197249|FG003|Treatment Period|Withdrawal by Subject|1|||
124883575|NCT02494206|449197250|FG000|Overall Study|Adverse Event|1|||
124883576|NCT02494206|449197250|FG000|Overall Study|Disease Progression|1|||
124883577|NCT04276090|449197251|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
124883578|NCT04276090|449197252|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
124883579|NCT01799720|449197253|FG000|Overall Study|Withdrawal by Subject|3|||
124883580|NCT01799720|449197254|FG001|Overall Study|Withdrawal by Subject|0|||
124883581|NCT01799720|449197255|FG002|Overall Study|Withdrawal by Subject|0|||
124883582|NCT01799720|449197253|FG000|Overall Study|Protocol Violation|0|||
124883583|NCT01799720|449197254|FG001|Overall Study|Protocol Violation|1|||
124883584|NCT01799720|449197255|FG002|Overall Study|Protocol Violation|0|||
124883585|NCT01799720|449197253|FG000|Overall Study|Pregnancy|0|||
124883586|NCT01799720|449197254|FG001|Overall Study|Pregnancy|0|||
124883587|NCT01799720|449197255|FG002|Overall Study|Pregnancy|1|||
124883588|NCT01234649|449197256|FG000|Overall Study|Withdrawal by Subject|32|||
124883589|NCT01234649|449197257|FG001|Overall Study|Withdrawal by Subject|26|||
124883590|NCT01234649|449197256|FG000|Overall Study|Pregnancy|6|||
124883591|NCT01234649|449197257|FG001|Overall Study|Pregnancy|6|||
124883592|NCT01234649|449197256|FG000|Overall Study|intolerant to side effects|4|||
124883593|NCT01234649|449197257|FG001|Overall Study|intolerant to side effects|3|||
124883594|NCT01234649|449197256|FG000|Overall Study|Allergic reaction|1|||
124883595|NCT01234649|449197257|FG001|Overall Study|Allergic reaction|0|||
124883596|NCT01234649|449197256|FG000|Overall Study|Lack of Efficacy|0|||
124883597|NCT01234649|449197257|FG001|Overall Study|Lack of Efficacy|3|||
124883598|NCT00318149|449197258|FG000|Overall Study|Adverse Event|0|||
124883599|NCT00318149|449197259|FG001|Overall Study|Adverse Event|0|||
124883600|NCT00318149|449197260|FG002|Overall Study|Adverse Event|0|||
124883601|NCT00318149|449197261|FG003|Overall Study|Adverse Event|0|||
124883602|NCT00318149|449197262|FG004|Overall Study|Adverse Event|0|||
124883603|NCT00318149|449197263|FG005|Overall Study|Adverse Event|2|||
124883604|NCT00785707|449197265|FG000|Overall Study|Lost to Follow-up|7|||
124883605|NCT02322814|449197266|FG000|Overall Study|Death|7|||
124883606|NCT02322814|449197267|FG001|Overall Study|Death|29|||
124883607|NCT02322814|449197268|FG002|Overall Study|Death|32|||
124883608|NCT02322814|449197269|FG003|Overall Study|Death|23|||
124883609|NCT02322814|449197270|FG004|Overall Study|Death|14|||
124883610|NCT02322814|449197266|FG000|Overall Study|Lost to Follow-up|1|||
125014911|NCT01553136|449678875|FG001|Overall Study|Physician Decision|3|||
124883611|NCT02322814|449197267|FG001|Overall Study|Lost to Follow-up|3|||
124883612|NCT02322814|449197268|FG002|Overall Study|Lost to Follow-up|3|||
124883613|NCT02322814|449197269|FG003|Overall Study|Lost to Follow-up|1|||
124883614|NCT02322814|449197270|FG004|Overall Study|Lost to Follow-up|0|||
124883615|NCT02322814|449197266|FG000|Overall Study|Various Reasons|2|||
124883616|NCT02322814|449197267|FG001|Overall Study|Various Reasons|0|||
124883617|NCT02322814|449197268|FG002|Overall Study|Various Reasons|1|||
124883618|NCT02322814|449197269|FG003|Overall Study|Various Reasons|1|||
124883619|NCT02322814|449197270|FG004|Overall Study|Various Reasons|0|||
124883620|NCT02322814|449197266|FG000|Overall Study|Progressive Disease|0|||
124883621|NCT02322814|449197267|FG001|Overall Study|Progressive Disease|0|||
124883622|NCT02322814|449197268|FG002|Overall Study|Progressive Disease|0|||
124883623|NCT02322814|449197269|FG003|Overall Study|Progressive Disease|1|||
124883624|NCT02322814|449197270|FG004|Overall Study|Progressive Disease|1|||
124883625|NCT02322814|449197266|FG000|Overall Study|Protocol Violation|1|||
124883626|NCT02322814|449197267|FG001|Overall Study|Protocol Violation|0|||
124883627|NCT02322814|449197268|FG002|Overall Study|Protocol Violation|0|||
124883628|NCT02322814|449197269|FG003|Overall Study|Protocol Violation|0|||
124883629|NCT02322814|449197270|FG004|Overall Study|Protocol Violation|0|||
124883630|NCT02322814|449197266|FG000|Overall Study|Study Terminated by Sponsor|0|||
124883631|NCT02322814|449197267|FG001|Overall Study|Study Terminated by Sponsor|7|||
124883632|NCT02322814|449197268|FG002|Overall Study|Study Terminated by Sponsor|9|||
124883633|NCT02322814|449197269|FG003|Overall Study|Study Terminated by Sponsor|5|||
124883634|NCT02322814|449197270|FG004|Overall Study|Study Terminated by Sponsor|13|||
124883635|NCT02322814|449197266|FG000|Overall Study|Withdrawal by Subject|5|||
124883636|NCT02322814|449197267|FG001|Overall Study|Withdrawal by Subject|4|||
124883637|NCT02322814|449197268|FG002|Overall Study|Withdrawal by Subject|2|||
124883638|NCT02322814|449197269|FG003|Overall Study|Withdrawal by Subject|1|||
124883639|NCT02322814|449197270|FG004|Overall Study|Withdrawal by Subject|3|||
124883640|NCT00118092|449197271|FG000|Overall Study|Withdrawal by Subject|1|||
124883641|NCT00118092|449197271|FG000|Overall Study|Protocol Violation|1|||
124883642|NCT02459093|449197272|FG000|Overall Study|Protocol Violation|6|||
124883643|NCT02459093|449197273|FG001|Overall Study|Protocol Violation|11|||
124883644|NCT02459093|449197272|FG000|Overall Study|Lost to Follow-up|6|||
124883645|NCT02459093|449197273|FG001|Overall Study|Lost to Follow-up|7|||
124883646|NCT00591864|449197274|FG000|Overall Study|Incomplete Imaging|5|||
124883647|NCT01871558|449197275|FG000|Overall Study|Other reason|0|||
124883648|NCT01871558|449197276|FG001|Overall Study|Other reason|1|||
124883649|NCT01871558|449197275|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
124883650|NCT01871558|449197276|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
124883651|NCT01871558|449197275|FG000|Overall Study|Withdrawal by Subject|2|||
124883652|NCT01871558|449197276|FG001|Overall Study|Withdrawal by Subject|0|||
124883653|NCT02401308|449197279|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
124883654|NCT02401308|449197280|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
124883655|NCT02736968|449197281|FG000|Overall Study|Lost to Follow-up|0|||
124883656|NCT02736968|449197282|FG001|Overall Study|Lost to Follow-up|0|||
124883657|NCT02736968|449197283|FG002|Overall Study|Lost to Follow-up|0|||
124883658|NCT02736968|449197284|FG003|Overall Study|Lost to Follow-up|0|||
124883659|NCT02736968|449197285|FG004|Overall Study|Lost to Follow-up|0|||
124883660|NCT02736968|449197286|FG005|Overall Study|Lost to Follow-up|0|||
124883661|NCT02736968|449197287|FG006|Overall Study|Lost to Follow-up|5|||
124883662|NCT02736968|449197288|FG007|Overall Study|Lost to Follow-up|2|||
124883663|NCT02736968|449197281|FG000|Overall Study|COVID-19 Pandemic|0|||
124883664|NCT02736968|449197282|FG001|Overall Study|COVID-19 Pandemic|0|||
124883665|NCT02736968|449197283|FG002|Overall Study|COVID-19 Pandemic|0|||
124883666|NCT02736968|449197284|FG003|Overall Study|COVID-19 Pandemic|0|||
124883667|NCT02736968|449197285|FG004|Overall Study|COVID-19 Pandemic|0|||
124883668|NCT02736968|449197286|FG005|Overall Study|COVID-19 Pandemic|0|||
124883669|NCT02736968|449197287|FG006|Overall Study|COVID-19 Pandemic|2|||
124883670|NCT02736968|449197288|FG007|Overall Study|COVID-19 Pandemic|0|||
124883671|NCT02736968|449197281|FG000|Overall Study|Withdrawal by Subject|0|||
124883672|NCT02736968|449197282|FG001|Overall Study|Withdrawal by Subject|0|||
124883673|NCT02736968|449197283|FG002|Overall Study|Withdrawal by Subject|0|||
124883674|NCT02736968|449197284|FG003|Overall Study|Withdrawal by Subject|0|||
124883675|NCT02736968|449197285|FG004|Overall Study|Withdrawal by Subject|0|||
124883676|NCT02736968|449197286|FG005|Overall Study|Withdrawal by Subject|0|||
124883677|NCT02736968|449197287|FG006|Overall Study|Withdrawal by Subject|1|||
124883678|NCT02736968|449197288|FG007|Overall Study|Withdrawal by Subject|0|||
124883679|NCT02041923|449197291|FG000|Overall Study|Lost to Follow-up|26|||
124883680|NCT02041923|449197292|FG001|Overall Study|Lost to Follow-up|30|||
124883681|NCT01734434|449197293|FG000|Overall Study|Death Infant|3|||
124883682|NCT01734434|449197294|FG001|Overall Study|Death Infant|1|||
124883683|NCT01734434|449197295|FG002|Overall Study|Death Infant|17|||
124883684|NCT01734434|449197296|FG003|Overall Study|Death Infant|5|||
124883685|NCT01734434|449197293|FG000|Overall Study|Lost to Follow-up|2|||
124883686|NCT01734434|449197294|FG001|Overall Study|Lost to Follow-up|9|||
124883687|NCT01734434|449197295|FG002|Overall Study|Lost to Follow-up|67|||
124883688|NCT01734434|449197296|FG003|Overall Study|Lost to Follow-up|11|||
124883689|NCT01734434|449197293|FG000|Overall Study|No Live Birth|1|||
124883690|NCT01734434|449197294|FG001|Overall Study|No Live Birth|2|||
124883691|NCT01734434|449197295|FG002|Overall Study|No Live Birth|32|||
124883692|NCT01734434|449197296|FG003|Overall Study|No Live Birth|6|||
124883693|NCT01734434|449197293|FG000|Overall Study|Withdrawal by Subject|4|||
124883694|NCT01734434|449197294|FG001|Overall Study|Withdrawal by Subject|0|||
124883695|NCT01734434|449197295|FG002|Overall Study|Withdrawal by Subject|8|||
124883696|NCT01734434|449197296|FG003|Overall Study|Withdrawal by Subject|1|||
124883697|NCT01734434|449197293|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
124883698|NCT01734434|449197294|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
124883699|NCT01734434|449197295|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
124883700|NCT01734434|449197296|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
124883701|NCT01734434|449197293|FG000|Overall Study|Subject Not Reachable|0|||
125104627|NCT01915498|450004198|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
124883702|NCT01734434|449197294|FG001|Overall Study|Subject Not Reachable|0|||
124883703|NCT01734434|449197295|FG002|Overall Study|Subject Not Reachable|1|||
124883704|NCT01734434|449197296|FG003|Overall Study|Subject Not Reachable|0|||
124883705|NCT01734434|449197293|FG000|Overall Study|Treatment Defaulter|0|||
124883706|NCT01734434|449197294|FG001|Overall Study|Treatment Defaulter|0|||
124883707|NCT01734434|449197295|FG002|Overall Study|Treatment Defaulter|1|||
124883708|NCT01734434|449197296|FG003|Overall Study|Treatment Defaulter|0|||
124883709|NCT01734434|449197293|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
124883710|NCT01734434|449197294|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
124883711|NCT01734434|449197295|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
124883712|NCT01734434|449197296|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
124883713|NCT01734434|449197293|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
124883714|NCT01734434|449197294|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
124883715|NCT01734434|449197295|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
124883716|NCT01734434|449197296|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
124883717|NCT04921969|449197297|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
124883718|NCT04921969|449197298|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
124883719|NCT04921969|449197299|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
124883720|NCT04921969|449197300|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
124883721|NCT04921969|449197301|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
124883722|NCT04921969|449197302|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
124883723|NCT04921969|449197303|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
124883724|NCT04921969|449197297|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
124883725|NCT04921969|449197298|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124883726|NCT04921969|449197299|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124883727|NCT04921969|449197300|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124883728|NCT04921969|449197301|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124883729|NCT04921969|449197302|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124883730|NCT04921969|449197303|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124883731|NCT04921969|449197297|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
124883732|NCT04921969|449197298|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
124883733|NCT04921969|449197299|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
124883734|NCT04921969|449197300|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124883735|NCT04921969|449197301|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124883736|NCT04921969|449197302|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124883737|NCT04921969|449197303|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124883738|NCT04921969|449197297|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
124883739|NCT04921969|449197298|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
124883740|NCT04921969|449197299|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
124883741|NCT04921969|449197300|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
124883742|NCT04921969|449197301|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
124883743|NCT04921969|449197302|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
124883744|NCT04921969|449197303|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
124883745|NCT04921969|449197297|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
124883746|NCT04921969|449197298|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
124883747|NCT04921969|449197299|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
124883748|NCT04921969|449197300|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
124883749|NCT04921969|449197301|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
124883750|NCT04921969|449197302|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
124883751|NCT04921969|449197303|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
124883752|NCT04921969|449197297|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
124883753|NCT04921969|449197298|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
124883754|NCT04921969|449197299|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
124883755|NCT04921969|449197300|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124883756|NCT04921969|449197301|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124883757|NCT04921969|449197302|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124883758|NCT04921969|449197303|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124883759|NCT04921969|449197297|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
124883760|NCT04921969|449197298|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
124883761|NCT04921969|449197299|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
124883762|NCT04921969|449197300|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
125014912|NCT01553136|449678874|FG000|Overall Study|Scheduling Difficulties|5|||
125014913|NCT01553136|449678875|FG001|Overall Study|Scheduling Difficulties|4|||
125014914|NCT03921424|449678883|FG000|Overall Study|Lost to Follow-up|0|||
125014915|NCT03921424|449678884|FG001|Overall Study|Lost to Follow-up|1|||
125014916|NCT03921424|449678883|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
125014917|NCT03921424|449678884|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
124883763|NCT04921969|449197301|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
124883764|NCT04921969|449197302|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
125014918|NCT02581202|449678887|FG000|Overall Study|Lack of Efficacy|2|||
125014919|NCT02581202|449678887|FG000|Overall Study|Withdrawal by Subject|4|||
125104628|NCT01915498|450004199|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
125104629|NCT01915498|450004200|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
125104630|NCT01915498|450004201|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
125104631|NCT01915498|450004202|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
125104632|NCT01915498|450004203|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
125104633|NCT01915498|450004204|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
125104634|NCT01915498|450004205|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
125104635|NCT01915498|450004206|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
125104636|NCT01915498|450004207|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
125104637|NCT01915498|450004208|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
125104638|NCT01915498|450004209|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
125104639|NCT01915498|450004210|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
125104640|NCT01915498|450004192|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125104641|NCT01915498|450004193|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125104642|NCT01915498|450004194|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125104643|NCT01915498|450004195|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125104644|NCT01915498|450004196|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125104645|NCT01915498|450004197|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125104646|NCT01915498|450004198|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125104647|NCT01915498|450004199|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125104648|NCT01915498|450004200|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125104649|NCT01915498|450004201|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125104650|NCT01915498|450004202|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125104651|NCT01915498|450004203|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125104652|NCT01915498|450004204|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125104653|NCT01915498|450004205|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125104654|NCT01915498|450004206|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125104655|NCT01915498|450004207|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125104656|NCT01915498|450004208|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125104657|NCT01915498|450004209|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125104658|NCT01915498|450004210|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
125104659|NCT01915498|450004192|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125104660|NCT01915498|450004193|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125104661|NCT01915498|450004194|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125104662|NCT01915498|450004195|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125104663|NCT01915498|450004196|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125104664|NCT01915498|450004197|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125104665|NCT01915498|450004198|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125104666|NCT01915498|450004199|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125104667|NCT01915498|450004200|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125104668|NCT01915498|450004201|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125104669|NCT01915498|450004202|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125104670|NCT01915498|450004203|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125104671|NCT01915498|450004204|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125104672|NCT01915498|450004205|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125104673|NCT01915498|450004206|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125104674|NCT01915498|450004207|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125104675|NCT01915498|450004208|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125104676|NCT01915498|450004209|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125104677|NCT01915498|450004210|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
125104678|NCT01915498|450004192|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125104679|NCT01915498|450004193|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125104680|NCT01915498|450004194|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125104681|NCT01915498|450004195|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125104682|NCT01915498|450004196|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125104683|NCT01915498|450004197|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125104684|NCT01915498|450004198|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125104685|NCT01915498|450004199|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125104686|NCT01915498|450004200|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125104687|NCT01915498|450004201|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125104688|NCT01915498|450004202|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125104689|NCT01915498|450004203|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125104690|NCT01915498|450004204|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125210773|NCT01810783|450395682|FG000|Overall Study|Lack of Efficacy|12|||
124883765|NCT04921969|449197303|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
124883766|NCT04921969|449197297|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
124883767|NCT04921969|449197298|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
124883768|NCT04921969|449197299|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
124883769|NCT04921969|449197300|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
124883770|NCT04921969|449197301|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
124883771|NCT04921969|449197302|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
124883772|NCT04921969|449197303|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
124883773|NCT04921969|449197297|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
124883774|NCT04921969|449197298|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
124883775|NCT04921969|449197299|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
124883776|NCT04921969|449197300|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
124883777|NCT04921969|449197301|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
124883778|NCT04921969|449197302|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
124883779|NCT04921969|449197303|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
124883780|NCT04921969|449197297|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
124883781|NCT04921969|449197298|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
124883782|NCT04921969|449197299|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
124883783|NCT04921969|449197300|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
124883784|NCT04921969|449197301|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
124883785|NCT04921969|449197302|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
124883786|NCT04921969|449197303|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
124883787|NCT04921969|449197297|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
124883788|NCT04921969|449197298|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
124883789|NCT04921969|449197299|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
124883790|NCT04921969|449197300|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
124883791|NCT04921969|449197301|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
124883792|NCT04921969|449197302|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
124883793|NCT04921969|449197303|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
124883794|NCT04921969|449197297|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
124883795|NCT04921969|449197298|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
124883796|NCT04921969|449197299|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
124883797|NCT04921969|449197300|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
124883798|NCT04921969|449197301|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
124883799|NCT04921969|449197302|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
124883800|NCT04921969|449197303|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
124883801|NCT04921969|449197297|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
124883802|NCT04921969|449197298|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
124883803|NCT04921969|449197299|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
124883804|NCT04921969|449197300|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
124883805|NCT04921969|449197301|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
124883806|NCT04921969|449197302|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
124883807|NCT04921969|449197303|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
124883808|NCT04921969|449197297|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
124883809|NCT04921969|449197298|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
124883810|NCT04921969|449197299|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
124883811|NCT04921969|449197300|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
124883812|NCT04921969|449197301|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
124883813|NCT04921969|449197302|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
124883814|NCT04921969|449197303|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
124883815|NCT04921969|449197297|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
124883816|NCT04921969|449197298|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
124883817|NCT04921969|449197299|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
124883818|NCT04921969|449197300|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
124883819|NCT04921969|449197301|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
124883820|NCT04921969|449197302|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
124883821|NCT04921969|449197303|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
124883822|NCT01340482|449198617|FG000|Overall Study|Adverse Event|2|||
124883823|NCT01340482|449198618|FG001|Overall Study|Adverse Event|0|||
125104691|NCT01915498|450004205|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125104692|NCT01915498|450004206|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125104693|NCT01915498|450004207|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
124883824|NCT01340482|449198619|FG002|Overall Study|Adverse Event|0|||
124883825|NCT03518658|449198620|FG000|Overall Study|Other|51|||
124883826|NCT03518658|449198621|FG001|Overall Study|Other|0|||
124883827|NCT02105636|449198625|FG000|Pre-Treatment|Disease Progression|1|||
124883828|NCT02105636|449198626|FG001|Pre-Treatment|Disease Progression|0|||
125104694|NCT01915498|450004208|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
124883829|NCT02105636|449198625|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
124883830|NCT02105636|449198626|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
124883831|NCT02105636|449198625|FG000|Pre-Treatment|Participant withdrew consent|0|||
124883832|NCT02105636|449198626|FG001|Pre-Treatment|Participant withdrew consent|6|||
125014920|NCT02581202|449678887|FG000|Overall Study|Lost to Follow-up|5|||
125014921|NCT02581202|449678887|FG000|Overall Study|Pregnancy|3|||
125014922|NCT02595450|449678894|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
125014923|NCT02595450|449678894|FG000|Overall Study|Enrolled, but not treated|8|||
125014924|NCT01934556|449678896|FG000|Overall Study|Withdrawal by Subject|0|||
125014925|NCT01934556|449678897|FG001|Overall Study|Withdrawal by Subject|1|||
125014926|NCT01934556|449678898|FG002|Overall Study|Withdrawal by Subject|1|||
125014927|NCT01934556|449678896|FG000|Overall Study|Lost to Follow-up|4|||
125014928|NCT01934556|449678897|FG001|Overall Study|Lost to Follow-up|10|||
125014929|NCT01934556|449678898|FG002|Overall Study|Lost to Follow-up|7|||
125014930|NCT01934556|449678896|FG000|Overall Study|Death|1|||
125014931|NCT01934556|449678897|FG001|Overall Study|Death|5|||
125014932|NCT01934556|449678898|FG002|Overall Study|Death|2|||
125014933|NCT05038020|449678899|FG000|Overall Study|Early Termination|3|||
125014934|NCT05038020|449678900|FG001|Overall Study|Early Termination|0|||
125014935|NCT03770260|449680575|FG000|Overall Study|Disease progression|0|||
125014936|NCT03770260|449680576|FG001|Overall Study|Disease progression|1|||
125014937|NCT03770260|449680577|FG002|Overall Study|Disease progression|0|||
125014938|NCT03770260|449680578|FG003|Overall Study|Disease progression|0|||
125014939|NCT04649255|449680581|FG000|Overall Study|Death|9|||
125014940|NCT04649255|449680581|FG000|Overall Study|Withdrawal by Subject|1|||
125014941|NCT00075400|449680585|FG000|Overall Study|Ineligible: wrong primary|1|||
125014942|NCT00075400|449680585|FG000|Overall Study|Never treated|2|||
125014943|NCT01652885|449680586|FG000|Overall Study|Adverse Event|1|||
125014944|NCT00490568|449680587|FG000|Overall Study|Adverse Event|116|||
125014945|NCT00490568|449680587|FG000|Overall Study|Lost to Follow-up|13|||
125014946|NCT00490568|449680587|FG000|Overall Study|Protocol Violation|45|||
125014947|NCT00490568|449680587|FG000|Overall Study|Withdrawal by Subject|135|||
125014948|NCT00490568|449680587|FG000|Overall Study|Still in the study at termination|974|||
125014949|NCT00490568|449680587|FG000|Overall Study|Other|1|||
125014950|NCT00490568|449680587|FG000|Overall Study|Exclusion criteria met|1|||
125014951|NCT00490568|449680587|FG000|Overall Study|Caregiver related|20|||
125014952|NCT00490568|449680587|FG000|Overall Study|Abnormal ECG|25|||
125014953|NCT00490568|449680587|FG000|Overall Study|Participant refused follow-up|9|||
125014954|NCT00490568|449680587|FG000|Overall Study|Legal representative withdrew consent|1|||
125014955|NCT00490568|449680587|FG000|Overall Study|Disease progression|4|||
125014956|NCT00490568|449680587|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
125014957|NCT00490568|449680587|FG000|Overall Study|Investigator decision|3|||
125014958|NCT00490568|449680587|FG000|Overall Study|Non-Compliance|7|||
125014959|NCT00490568|449680587|FG000|Overall Study|Efficacy related|3|||
125014960|NCT00490568|449680587|FG000|Overall Study|Participant died|1|||
125014961|NCT00490568|449680587|FG000|Overall Study|Participant withdrawal due to surgery|1|||
125014962|NCT01395394|449680588|FG000|Baseline Study Visit|Protocol Violation|1|||
125014963|NCT01395394|449680589|FG001|Baseline Study Visit|Protocol Violation|0|||
125014964|NCT01395394|449680590|FG002|Baseline Study Visit|Protocol Violation|0|||
125014965|NCT03451773|449680593|FG000|Overall Study|Death on study|1|||
125014966|NCT03451773|449680594|FG001|Overall Study|Death on study|5|||
125014967|NCT03451773|449680593|FG000|Overall Study|Death during follow-up period|0|||
125014968|NCT03451773|449680594|FG001|Overall Study|Death during follow-up period|1|||
125014969|NCT03468855|449680595|FG000|Overall Study|Adverse Event|2|||
125014970|NCT03468855|449680595|FG000|Overall Study|Lost to Follow-up|5|||
125014971|NCT03468855|449680595|FG000|Overall Study|Withdrawal by Subject|3|||
125014972|NCT03468855|449680595|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
125014973|NCT01908101|449680596|FG000|Overall Study|Physician Decision|1|||
125014974|NCT01908101|449680596|FG000|Overall Study|Withdrawal by Subject|1|||
125014975|NCT01908101|449680596|FG000|Overall Study|Incorrect Diagnosis|2|||
125014976|NCT01908101|449680596|FG000|Overall Study|Incorrect Starting Dose|1|||
125014977|NCT01908101|449680596|FG000|Overall Study|Did not complete the first cycle|4|||
125014978|NCT00412750|449680598|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125014979|NCT00412750|449680599|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125014980|NCT00412750|449680600|FG002|Overall Study|Abnormal laboratory value(s)|0|||
125014981|NCT00412750|449680598|FG000|Overall Study|Administrative problems|21|||
125014982|NCT00412750|449680599|FG001|Overall Study|Administrative problems|17|||
125014983|NCT00412750|449680600|FG002|Overall Study|Administrative problems|14|||
125014984|NCT00412750|449680598|FG000|Overall Study|Adverse Event|8|||
125014985|NCT00412750|449680599|FG001|Overall Study|Adverse Event|3|||
125014986|NCT00412750|449680600|FG002|Overall Study|Adverse Event|3|||
124883833|NCT02105636|449198625|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
124883834|NCT02105636|449198626|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
124883835|NCT02105636|449198625|FG000|Treatment|Study Drug Toxicity|14|||
124883836|NCT02105636|449198626|FG001|Treatment|Study Drug Toxicity|10|||
124883837|NCT02105636|449198625|FG000|Treatment|Adverse event unrelated to study drug|19|||
124883838|NCT02105636|449198626|FG001|Treatment|Adverse event unrelated to study drug|3|||
124883839|NCT02105636|449198625|FG000|Treatment|Participant request to discontinue study treatment|8|||
124883840|NCT02105636|449198626|FG001|Treatment|Participant request to discontinue study treatment|6|||
124883841|NCT02105636|449198625|FG000|Treatment|Participant withdrew consent|5|||
124883842|NCT02105636|449198626|FG001|Treatment|Participant withdrew consent|1|||
124883843|NCT02105636|449198625|FG000|Treatment|Lost to Follow-up|1|||
124883844|NCT02105636|449198626|FG001|Treatment|Lost to Follow-up|0|||
124883845|NCT02105636|449198625|FG000|Treatment|Maximum Clinical Benefit|1|||
124883846|NCT02105636|449198626|FG001|Treatment|Maximum Clinical Benefit|3|||
124883847|NCT02105636|449198625|FG000|Treatment|Poor/Non-compliance|0|||
124883848|NCT02105636|449198626|FG001|Treatment|Poor/Non-compliance|1|||
124883849|NCT02105636|449198625|FG000|Treatment|Participant no longer meets study criteria|1|||
124883850|NCT02105636|449198626|FG001|Treatment|Participant no longer meets study criteria|0|||
124883851|NCT02105636|449198625|FG000|Treatment|Other reasons|1|||
124883852|NCT02105636|449198626|FG001|Treatment|Other reasons|0|||
124883853|NCT02105636|449198625|FG000|Treatment|Disease Progression|185|||
124883854|NCT02105636|449198626|FG001|Treatment|Disease Progression|87|||
124883855|NCT00744237|449198627|FG000|Overall Study|Lack of Efficacy|1|||
124883856|NCT00744237|449198628|FG001|Overall Study|Lack of Efficacy|1|||
124883857|NCT00744237|449198629|FG002|Overall Study|Lack of Efficacy|0|||
124883858|NCT00744237|449198627|FG000|Overall Study|Withdrawal by Subject|9|||
124883859|NCT00744237|449198628|FG001|Overall Study|Withdrawal by Subject|5|||
124883860|NCT00744237|449198629|FG002|Overall Study|Withdrawal by Subject|3|||
124883861|NCT00744237|449198627|FG000|Overall Study|Lost to Follow-up|1|||
124883862|NCT00744237|449198628|FG001|Overall Study|Lost to Follow-up|1|||
124883863|NCT00744237|449198629|FG002|Overall Study|Lost to Follow-up|1|||
124883864|NCT00744237|449198627|FG000|Overall Study|Protocol Violation|3|||
124883865|NCT00744237|449198628|FG001|Overall Study|Protocol Violation|4|||
124883866|NCT00744237|449198629|FG002|Overall Study|Protocol Violation|3|||
124883867|NCT00744237|449198627|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
124883868|NCT00744237|449198628|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
124883869|NCT00744237|449198629|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
124883870|NCT00744237|449198627|FG000|Overall Study|Dosing Error|1|||
124883871|NCT00744237|449198628|FG001|Overall Study|Dosing Error|0|||
124883872|NCT00744237|449198629|FG002|Overall Study|Dosing Error|1|||
124883873|NCT00744237|449198627|FG000|Overall Study|Study Drug Error|1|||
124883874|NCT00744237|449198628|FG001|Overall Study|Study Drug Error|0|||
124883875|NCT00744237|449198629|FG002|Overall Study|Study Drug Error|0|||
124883876|NCT00744237|449198627|FG000|Overall Study|Prohibited Concomitant Medication|0|||
124883877|NCT00744237|449198628|FG001|Overall Study|Prohibited Concomitant Medication|0|||
124883878|NCT00744237|449198629|FG002|Overall Study|Prohibited Concomitant Medication|1|||
124883879|NCT00744237|449198627|FG000|Overall Study|Poor Compliance|0|||
124883880|NCT00744237|449198628|FG001|Overall Study|Poor Compliance|2|||
124883881|NCT00744237|449198629|FG002|Overall Study|Poor Compliance|0|||
124883882|NCT00744237|449198627|FG000|Overall Study|Administrative. Site Closed|1|||
124883883|NCT00744237|449198628|FG001|Overall Study|Administrative. Site Closed|1|||
124883884|NCT00744237|449198629|FG002|Overall Study|Administrative. Site Closed|1|||
124883885|NCT00744237|449198627|FG000|Overall Study|Adverse Event|9|||
124883886|NCT00744237|449198628|FG001|Overall Study|Adverse Event|13|||
124883887|NCT00744237|449198629|FG002|Overall Study|Adverse Event|5|||
124883888|NCT00802659|449198631|FG000|Overall Study|Physician Decision|0|||
124883889|NCT00802659|449198632|FG001|Overall Study|Physician Decision|1|||
124883890|NCT00802659|449198633|FG002|Overall Study|Physician Decision|0|||
124883891|NCT00802659|449198634|FG003|Overall Study|Physician Decision|0|||
124883892|NCT01912781|449198636|FG000|Overall Study|Withdrawal by Subject|2|||
125014987|NCT00412750|449680598|FG000|Overall Study|Lost to Follow-up|1|||
124883893|NCT01912781|449198637|FG001|Overall Study|Withdrawal by Subject|0|||
124883894|NCT04537897|449198643|FG000|Overall Study|Other than listed|0|||
124883895|NCT04537897|449198644|FG001|Overall Study|Other than listed|0|||
125014988|NCT00412750|449680599|FG001|Overall Study|Lost to Follow-up|0|||
124883896|NCT04537897|449198645|FG002|Overall Study|Other than listed|0|||
124883897|NCT04537897|449198646|FG003|Overall Study|Other than listed|0|||
124883898|NCT04537897|449198647|FG004|Overall Study|Other than listed|0|||
124883899|NCT04537897|449198648|FG005|Overall Study|Other than listed|0|||
124883900|NCT04537897|449198649|FG006|Overall Study|Other than listed|1|||
125014989|NCT00412750|449680600|FG002|Overall Study|Lost to Follow-up|1|||
124883901|NCT04537897|449198650|FG007|Overall Study|Other than listed|0|||
124883902|NCT04537897|449198651|FG008|Overall Study|Other than listed|0|||
124883903|NCT04537897|449198643|FG000|Overall Study|Adverse Event|0|||
124883904|NCT04537897|449198644|FG001|Overall Study|Adverse Event|0|||
124883905|NCT04537897|449198645|FG002|Overall Study|Adverse Event|0|||
125104695|NCT01915498|450004209|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125104696|NCT01915498|450004210|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
125104697|NCT01907516|450004211|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
125104698|NCT01907516|450004212|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
125104699|NCT01907516|450004211|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
125104700|NCT01907516|450004212|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
125104701|NCT01907516|450004211|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
125104702|NCT01907516|450004212|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
125104703|NCT01907516|450004211|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
125104704|NCT01907516|450004212|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
125104705|NCT04278872|450004215|FG000|Overall Study|Adverse Event|1|||
125104706|NCT04278872|450004216|FG001|Overall Study|Adverse Event|0|||
125104707|NCT04278872|450004215|FG000|Overall Study|Protocol Violation|0|||
125104708|NCT04278872|450004216|FG001|Overall Study|Protocol Violation|1|||
125104709|NCT04278872|450004215|FG000|Overall Study|Study Termination|2|||
125104710|NCT04278872|450004216|FG001|Overall Study|Study Termination|0|||
125104711|NCT00891527|450005742|FG000|Overall Study|Withdrawal by Subject|2|||
125104712|NCT02953262|450005745|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
125104713|NCT02953262|450005746|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
125104714|NCT02953262|450005747|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
125104715|NCT02953262|450005748|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
125104716|NCT00740480|450005749|FG000|Overall Study|Adverse Event|1|||
125104717|NCT00740480|450005749|FG000|Overall Study|Physician Decision|1|||
125104718|NCT03349437|450005754|FG000|Screening|Screen Fail|4|||
125104719|NCT03349437|450005755|FG001|Screening|Screen Fail|0|||
125104720|NCT03349437|450005756|FG002|Screening|Screen Fail|0|||
125104721|NCT03349437|450005754|FG000|Screening|Withdrawn|1|||
125104722|NCT03349437|450005755|FG001|Screening|Withdrawn|0|||
125104723|NCT03349437|450005756|FG002|Screening|Withdrawn|0|||
125104724|NCT02406742|450005757|FG000|Overall Study|Progression of Disease|5|||
125104725|NCT02406742|450005758|FG001|Overall Study|Progression of Disease|1|||
125104726|NCT02406742|450005759|FG002|Overall Study|Progression of Disease|6|||
125104727|NCT02406742|450005757|FG000|Overall Study|Adverse Event|3|||
125104728|NCT02406742|450005758|FG001|Overall Study|Adverse Event|0|||
125104729|NCT02406742|450005759|FG002|Overall Study|Adverse Event|2|||
125104730|NCT02406742|450005757|FG000|Overall Study|Death|1|||
125104731|NCT02406742|450005758|FG001|Overall Study|Death|0|||
125104732|NCT02406742|450005759|FG002|Overall Study|Death|0|||
125104733|NCT02406742|450005757|FG000|Overall Study|Lack of Efficacy|0|||
125104734|NCT02406742|450005758|FG001|Overall Study|Lack of Efficacy|0|||
125104735|NCT02406742|450005759|FG002|Overall Study|Lack of Efficacy|1|||
125104736|NCT02406742|450005757|FG000|Overall Study|Withdrawal by Participant|1|||
125104737|NCT02406742|450005758|FG001|Overall Study|Withdrawal by Participant|2|||
125104738|NCT02406742|450005759|FG002|Overall Study|Withdrawal by Participant|0|||
125104739|NCT02406742|450005757|FG000|Overall Study|Physician Decision|1|||
125104740|NCT02406742|450005758|FG001|Overall Study|Physician Decision|2|||
125104741|NCT02406742|450005759|FG002|Overall Study|Physician Decision|1|||
125104742|NCT02406742|450005757|FG000|Overall Study|Transition to other treatment|2|||
125104743|NCT02406742|450005758|FG001|Overall Study|Transition to other treatment|0|||
125104744|NCT02406742|450005759|FG002|Overall Study|Transition to other treatment|1|||
125104745|NCT02406742|450005757|FG000|Overall Study|Other Reasons|1|||
125104746|NCT02406742|450005758|FG001|Overall Study|Other Reasons|11|||
125104747|NCT02406742|450005759|FG002|Overall Study|Other Reasons|5|||
125104748|NCT01563029|450005762|FG000|Overall Study|Adverse Event|1|||
125104749|NCT01563029|450005763|FG001|Overall Study|Adverse Event|0|||
125104750|NCT01563029|450005764|FG002|Overall Study|Adverse Event|1|||
125104751|NCT01563029|450005765|FG003|Overall Study|Adverse Event|2|||
125104752|NCT01563029|450005766|FG004|Overall Study|Adverse Event|1|||
125104753|NCT01563029|450005762|FG000|Overall Study|Lack of Efficacy|42|||
125104754|NCT01563029|450005763|FG001|Overall Study|Lack of Efficacy|16|||
125104755|NCT01563029|450005764|FG002|Overall Study|Lack of Efficacy|23|||
125104756|NCT01563029|450005765|FG003|Overall Study|Lack of Efficacy|21|||
125104757|NCT01563029|450005766|FG004|Overall Study|Lack of Efficacy|19|||
125104758|NCT01563029|450005762|FG000|Overall Study|Protocol Violation|1|||
125104759|NCT01563029|450005763|FG001|Overall Study|Protocol Violation|2|||
125210774|NCT01810783|450395682|FG000|Overall Study|Lost to Follow-up|10|||
125014990|NCT00412750|449680598|FG000|Overall Study|Withdrawal by Subject|0|||
125014991|NCT00412750|449680599|FG001|Overall Study|Withdrawal by Subject|1|||
125014992|NCT00412750|449680600|FG002|Overall Study|Withdrawal by Subject|2|||
125014993|NCT00412750|449680598|FG000|Overall Study|Lack of Efficacy|0|||
125014994|NCT00412750|449680599|FG001|Overall Study|Lack of Efficacy|0|||
125014995|NCT00412750|449680600|FG002|Overall Study|Lack of Efficacy|3|||
125014996|NCT04091087|449680603|FG000|Overall Study|Not treated|1|||
125014997|NCT04091087|449680604|FG001|Overall Study|Not treated|0|||
125014998|NCT04091087|449680603|FG000|Overall Study|Adverse Event|4|||
125014999|NCT04091087|449680604|FG001|Overall Study|Adverse Event|4|||
125015000|NCT04091087|449680603|FG000|Overall Study|Protocol Violation|0|||
125015001|NCT04091087|449680604|FG001|Overall Study|Protocol Violation|1|||
125015002|NCT04091087|449680603|FG000|Overall Study|Withdrawal by Subject|5|||
125015003|NCT04091087|449680604|FG001|Overall Study|Withdrawal by Subject|2|||
125015004|NCT05440539|449680606|FG000|Overall Study|Lost to Follow-up|4|||
125015005|NCT05440539|449680607|FG001|Overall Study|Lost to Follow-up|4|||
125015006|NCT05440539|449680606|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
125015007|NCT05440539|449680607|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
125015008|NCT03808077|449680608|FG000|Overall Study|Physician Decision|2|||
125210775|NCT01810783|450395682|FG000|Overall Study|Protocol Violation|5|||
125015009|NCT03808077|449680609|FG001|Overall Study|Physician Decision|3|||
124883906|NCT04537897|449198646|FG003|Overall Study|Adverse Event|1|||
124883907|NCT04537897|449198647|FG004|Overall Study|Adverse Event|0|||
124883908|NCT04537897|449198648|FG005|Overall Study|Adverse Event|0|||
124883909|NCT04537897|449198649|FG006|Overall Study|Adverse Event|0|||
124883910|NCT04537897|449198650|FG007|Overall Study|Adverse Event|0|||
124883911|NCT04537897|449198651|FG008|Overall Study|Adverse Event|0|||
124883912|NCT04537897|449198643|FG000|Overall Study|Withdrawal by Subject|0|||
124883913|NCT04537897|449198644|FG001|Overall Study|Withdrawal by Subject|1|||
124883914|NCT04537897|449198645|FG002|Overall Study|Withdrawal by Subject|0|||
124883915|NCT04537897|449198646|FG003|Overall Study|Withdrawal by Subject|0|||
124883916|NCT04537897|449198647|FG004|Overall Study|Withdrawal by Subject|0|||
124883917|NCT04537897|449198648|FG005|Overall Study|Withdrawal by Subject|0|||
124883918|NCT04537897|449198649|FG006|Overall Study|Withdrawal by Subject|0|||
124883919|NCT04537897|449198650|FG007|Overall Study|Withdrawal by Subject|0|||
124883920|NCT04537897|449198651|FG008|Overall Study|Withdrawal by Subject|0|||
124883921|NCT00197028|449198655|FG000|Overall Study|Adverse Event|2|||
124883922|NCT00197028|449198656|FG001|Overall Study|Adverse Event|2|||
124883923|NCT00197028|449198655|FG000|Overall Study|Protocol Violation|2|||
124883924|NCT00197028|449198656|FG001|Overall Study|Protocol Violation|1|||
124883925|NCT00197028|449198655|FG000|Overall Study|Withdrawal by Subject|8|||
124883926|NCT00197028|449198656|FG001|Overall Study|Withdrawal by Subject|12|||
124883927|NCT00197028|449198655|FG000|Overall Study|Lost to Follow-up|1|||
124883928|NCT00197028|449198656|FG001|Overall Study|Lost to Follow-up|0|||
124883929|NCT00197028|449198655|FG000|Overall Study|Other|3|||
124883930|NCT00197028|449198656|FG001|Overall Study|Other|6|||
124883931|NCT00669903|449198661|FG000|Overall Study|Adverse Event|0|||
124883932|NCT00669903|449198662|FG001|Overall Study|Adverse Event|1|||
124883933|NCT00669903|449198663|FG002|Overall Study|Adverse Event|3|||
124883934|NCT00669903|449198664|FG003|Overall Study|Adverse Event|1|||
124883935|NCT00669903|449198661|FG000|Overall Study|Withdrawal by Subject|0|||
124883936|NCT00669903|449198662|FG001|Overall Study|Withdrawal by Subject|2|||
124883937|NCT00669903|449198663|FG002|Overall Study|Withdrawal by Subject|2|||
124883938|NCT00669903|449198664|FG003|Overall Study|Withdrawal by Subject|2|||
124883939|NCT00669903|449198661|FG000|Overall Study|Lost to Follow-up|1|||
125015010|NCT03808077|449680608|FG000|Overall Study|Withdrawal by Subject|1|||
125015011|NCT03808077|449680609|FG001|Overall Study|Withdrawal by Subject|0|||
125015012|NCT03808077|449680608|FG000|Overall Study|Equipment Issues|2|||
125015013|NCT03808077|449680609|FG001|Overall Study|Equipment Issues|1|||
125015014|NCT04152161|449680610|FG000|Overall Study|Death|0|||
125015015|NCT04152161|449680611|FG001|Overall Study|Death|1|||
125015016|NCT04152161|449680610|FG000|Overall Study|Physician Decision|0|||
125015017|NCT04152161|449680611|FG001|Overall Study|Physician Decision|1|||
125015018|NCT04152161|449680610|FG000|Overall Study|Lost to Follow-up|9|||
125015019|NCT04152161|449680611|FG001|Overall Study|Lost to Follow-up|3|||
125015020|NCT04152161|449680610|FG000|Overall Study|Protocol Violation|1|||
125015021|NCT04152161|449680611|FG001|Overall Study|Protocol Violation|0|||
125015022|NCT04152161|449680610|FG000|Overall Study|Withdrawal by Subject|29|||
125015023|NCT04152161|449680611|FG001|Overall Study|Withdrawal by Subject|28|||
125015024|NCT04152161|449680610|FG000|Overall Study|Sponsor termination of study|750|||
125015025|NCT04152161|449680611|FG001|Overall Study|Sponsor termination of study|755|||
125015026|NCT04152161|449680610|FG000|Overall Study|Other|20|||
125015027|NCT04152161|449680611|FG001|Overall Study|Other|18|||
125015028|NCT00001379|449680612|FG000|Initial Treatment|Disease progression|21|||
125015029|NCT00001379|449680613|FG001|Initial Treatment|Disease progression|3|||
125015030|NCT00001379|449680614|FG002|Initial Treatment|Disease progression|0|||
125015031|NCT00001379|449680615|FG003|Initial Treatment|Disease progression|0|||
125015032|NCT00001379|449680612|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
125015033|NCT00001379|449680613|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
125015034|NCT00001379|449680614|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
125015035|NCT00001379|449680615|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
125015036|NCT00001379|449680612|FG000|Initial Treatment|Received alternative treatment|2|||
125015037|NCT00001379|449680613|FG001|Initial Treatment|Received alternative treatment|1|||
125015038|NCT00001379|449680614|FG002|Initial Treatment|Received alternative treatment|0|||
125015039|NCT00001379|449680615|FG003|Initial Treatment|Received alternative treatment|0|||
125015040|NCT00001379|449680612|FG000|Initial Treatment|Refused further treatment|2|||
125015041|NCT00001379|449680613|FG001|Initial Treatment|Refused further treatment|0|||
125015042|NCT00001379|449680614|FG002|Initial Treatment|Refused further treatment|0|||
125015043|NCT00001379|449680615|FG003|Initial Treatment|Refused further treatment|0|||
125015044|NCT00001379|449680612|FG000|Initial Treatment|Did not receive protocol treatment|0|||
125015045|NCT00001379|449680613|FG001|Initial Treatment|Did not receive protocol treatment|0|||
125015046|NCT00001379|449680614|FG002|Initial Treatment|Did not receive protocol treatment|5|||
124883940|NCT00669903|449198662|FG001|Overall Study|Lost to Follow-up|1|||
124883941|NCT00669903|449198663|FG002|Overall Study|Lost to Follow-up|0|||
124883942|NCT00669903|449198664|FG003|Overall Study|Lost to Follow-up|1|||
125104760|NCT01563029|450005764|FG002|Overall Study|Protocol Violation|3|||
125104761|NCT01563029|450005765|FG003|Overall Study|Protocol Violation|1|||
125104762|NCT01563029|450005766|FG004|Overall Study|Protocol Violation|3|||
125104763|NCT01563029|450005762|FG000|Overall Study|Protocol defined stopping criteria|1|||
125104764|NCT01563029|450005763|FG001|Overall Study|Protocol defined stopping criteria|0|||
125104765|NCT01563029|450005764|FG002|Overall Study|Protocol defined stopping criteria|0|||
125104766|NCT01563029|450005765|FG003|Overall Study|Protocol defined stopping criteria|0|||
125104767|NCT01563029|450005766|FG004|Overall Study|Protocol defined stopping criteria|0|||
125104768|NCT01563029|450005762|FG000|Overall Study|Lost to Follow-up|1|||
125104769|NCT01563029|450005763|FG001|Overall Study|Lost to Follow-up|0|||
125104770|NCT01563029|450005764|FG002|Overall Study|Lost to Follow-up|1|||
125104771|NCT01563029|450005765|FG003|Overall Study|Lost to Follow-up|1|||
125104772|NCT01563029|450005766|FG004|Overall Study|Lost to Follow-up|1|||
125104773|NCT01563029|450005762|FG000|Overall Study|Physician Decision|3|||
125104774|NCT01563029|450005763|FG001|Overall Study|Physician Decision|5|||
125104775|NCT01563029|450005764|FG002|Overall Study|Physician Decision|2|||
125104776|NCT01563029|450005765|FG003|Overall Study|Physician Decision|4|||
125104777|NCT01563029|450005766|FG004|Overall Study|Physician Decision|2|||
125104778|NCT01563029|450005762|FG000|Overall Study|Withdrawal by Subject|4|||
125104779|NCT01563029|450005763|FG001|Overall Study|Withdrawal by Subject|1|||
125104780|NCT01563029|450005764|FG002|Overall Study|Withdrawal by Subject|3|||
125104781|NCT01563029|450005765|FG003|Overall Study|Withdrawal by Subject|4|||
125104782|NCT01563029|450005766|FG004|Overall Study|Withdrawal by Subject|3|||
125104783|NCT01569594|450005767|FG000|Overall Study|Physician Decision|4|||
125104784|NCT01569594|450005767|FG000|Overall Study|Death|13|||
125104785|NCT01569594|450005767|FG000|Overall Study|Lost to Follow-up|22|||
125104786|NCT01569594|450005767|FG000|Overall Study|Adverse Event|2|||
125104787|NCT01569594|450005767|FG000|Overall Study|Withdrawal by Subject|13|||
125104788|NCT01569594|450005767|FG000|Overall Study|Other|4|||
125104789|NCT01569594|450005767|FG000|Overall Study|No ECM used|9|||
125104790|NCT01826201|450005772|FG000|Overall Study|Non compliance with protocol|4|||
125104791|NCT01615822|450005773|FG000|Period 1|Withdrawal by Subject|0|||
125104792|NCT01615822|450005774|FG001|Period 1|Withdrawal by Subject|1|||
125104793|NCT01615822|450005775|FG002|Period 1|Withdrawal by Subject|0|||
125104794|NCT01615822|450005773|FG000|Period 1|Adverse Event|1|||
125104795|NCT01615822|450005774|FG001|Period 1|Adverse Event|1|||
125104796|NCT01615822|450005775|FG002|Period 1|Adverse Event|0|||
125104797|NCT01615822|450005773|FG000|Period 2|Lost to Follow-up|0|||
125104798|NCT01615822|450005774|FG001|Period 2|Lost to Follow-up|1|||
125104799|NCT01615822|450005775|FG002|Period 2|Lost to Follow-up|2|||
125104800|NCT00537056|450005778|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
125104801|NCT02628418|450005783|FG000|Overall Study|Lost to Follow-up|1|||
125104802|NCT02628418|450005784|FG001|Overall Study|Lost to Follow-up|2|||
125104803|NCT01071083|450005785|FG000|Overall Study|Adverse Event|1|||
125104804|NCT01071083|450005786|FG001|Overall Study|Adverse Event|0|||
125104805|NCT01071083|450005787|FG002|Overall Study|Adverse Event|1|||
125104806|NCT01071083|450005788|FG003|Overall Study|Adverse Event|0|||
125104807|NCT01071083|450005789|FG004|Overall Study|Adverse Event|1|||
125104808|NCT01071083|450005785|FG000|Overall Study|Withdrawal by Subject|3|||
125104809|NCT01071083|450005786|FG001|Overall Study|Withdrawal by Subject|0|||
125104810|NCT01071083|450005787|FG002|Overall Study|Withdrawal by Subject|2|||
125104811|NCT01071083|450005788|FG003|Overall Study|Withdrawal by Subject|0|||
125104812|NCT01071083|450005789|FG004|Overall Study|Withdrawal by Subject|3|||
125104813|NCT01071083|450005785|FG000|Overall Study|Physician Decision|1|||
125104814|NCT01071083|450005786|FG001|Overall Study|Physician Decision|0|||
125104815|NCT01071083|450005787|FG002|Overall Study|Physician Decision|0|||
125104816|NCT01071083|450005788|FG003|Overall Study|Physician Decision|1|||
125104817|NCT01071083|450005789|FG004|Overall Study|Physician Decision|1|||
125104818|NCT01071083|450005785|FG000|Overall Study|Early Rescue|1|||
125104819|NCT01071083|450005786|FG001|Overall Study|Early Rescue|0|||
125104820|NCT01071083|450005787|FG002|Overall Study|Early Rescue|0|||
125104821|NCT01071083|450005788|FG003|Overall Study|Early Rescue|0|||
125104822|NCT01071083|450005789|FG004|Overall Study|Early Rescue|1|||
125104823|NCT01071083|450005785|FG000|Overall Study|Subject Moved|0|||
125104824|NCT01071083|450005786|FG001|Overall Study|Subject Moved|1|||
125104825|NCT01071083|450005787|FG002|Overall Study|Subject Moved|0|||
125104826|NCT01071083|450005788|FG003|Overall Study|Subject Moved|0|||
125104827|NCT01071083|450005789|FG004|Overall Study|Subject Moved|0|||
125104828|NCT01071083|450005785|FG000|Overall Study|Images Not Usable (Motion)|0|||
125104829|NCT01071083|450005786|FG001|Overall Study|Images Not Usable (Motion)|1|||
125104830|NCT01071083|450005787|FG002|Overall Study|Images Not Usable (Motion)|0|||
125104831|NCT01071083|450005788|FG003|Overall Study|Images Not Usable (Motion)|0|||
125104832|NCT01071083|450005789|FG004|Overall Study|Images Not Usable (Motion)|0|||
125104833|NCT01071083|450005785|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
125104834|NCT01071083|450005786|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
125104835|NCT01071083|450005787|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
125104836|NCT01071083|450005788|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
125104837|NCT01071083|450005789|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
125104838|NCT01071083|450005785|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
125104839|NCT01071083|450005786|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
125104840|NCT01071083|450005787|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
125104841|NCT01071083|450005788|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
125104842|NCT01071083|450005789|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
125104843|NCT01071083|450005785|FG000|Overall Study|Subject Refused to Continue|1|||
125104844|NCT01071083|450005786|FG001|Overall Study|Subject Refused to Continue|0|||
125104845|NCT01071083|450005787|FG002|Overall Study|Subject Refused to Continue|0|||
125104846|NCT01071083|450005788|FG003|Overall Study|Subject Refused to Continue|0|||
125104847|NCT01071083|450005789|FG004|Overall Study|Subject Refused to Continue|0|||
125104848|NCT04732728|450005790|FG000|Overall Study|Death|12|||
125104849|NCT04732728|450005790|FG000|Overall Study|Withdrawn|136|||
125104850|NCT03891875|450005791|FG000|Overall Study|Withdrawal by Subject|20|||
125104851|NCT03891875|450005792|FG001|Overall Study|Withdrawal by Subject|3|||
125104852|NCT03891875|450005791|FG000|Overall Study|Adverse Event|10|||
125104853|NCT03891875|450005792|FG001|Overall Study|Adverse Event|4|||
125104854|NCT03891875|450005791|FG000|Overall Study|Physician Decision|1|||
125104855|NCT03891875|450005792|FG001|Overall Study|Physician Decision|1|||
125104856|NCT03891875|450005791|FG000|Overall Study|Protocol Violation|1|||
125104857|NCT03891875|450005792|FG001|Overall Study|Protocol Violation|0|||
125104858|NCT03891875|450005791|FG000|Overall Study|Lost to Follow-up|1|||
124883943|NCT00669903|449198661|FG000|Overall Study|Protocol Violation|0|||
125104859|NCT03891875|450005792|FG001|Overall Study|Lost to Follow-up|0|||
125104860|NCT03891875|450005791|FG000|Overall Study|COVID-19 infection|1|||
125104861|NCT03891875|450005792|FG001|Overall Study|COVID-19 infection|0|||
125104862|NCT02426125|450005797|FG000|Overall Study|Lost to Follow-up|14|||
125104863|NCT02426125|450005798|FG001|Overall Study|Lost to Follow-up|12|||
125104864|NCT02426125|450005797|FG000|Overall Study|Withdrawal by Subject|13|||
125104865|NCT02426125|450005798|FG001|Overall Study|Withdrawal by Subject|14|||
125104866|NCT02426125|450005797|FG000|Overall Study|Death|185|||
125104867|NCT02426125|450005798|FG001|Overall Study|Death|200|||
125104868|NCT02426125|450005797|FG000|Overall Study|Randomized, But Never Treated|5|||
124883944|NCT00669903|449198662|FG001|Overall Study|Protocol Violation|1|||
124883945|NCT00669903|449198663|FG002|Overall Study|Protocol Violation|0|||
124883946|NCT00669903|449198664|FG003|Overall Study|Protocol Violation|0|||
124883947|NCT01827254|449198667|FG000|Overall Study|Death|10|||
124883948|NCT01827254|449198667|FG000|Overall Study|Case report form not completed|4|||
124883949|NCT01827254|449198667|FG000|Overall Study|Invalidated centre|3|||
124883950|NCT01827254|449198667|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
124883951|NCT01827254|449198667|FG000|Overall Study|Did not complete re-challenge|1|||
124883952|NCT01827254|449198667|FG000|Overall Study|Disease progression|36|||
124883953|NCT01827254|449198667|FG000|Overall Study|Intolerance to treatment|4|||
124883954|NCT01923389|449198668|FG000|Overall Study|Protocol Violation|1|||
124883955|NCT01923389|449198669|FG001|Overall Study|Protocol Violation|0|||
124883956|NCT01613027|449198675|FG000|Overall Study|Lost to Follow-up|5|||
124883957|NCT01613027|449198675|FG000|Overall Study|Switched Physician|1|||
125104869|NCT02426125|450005798|FG001|Overall Study|Randomized, But Never Treated|2|||
125104870|NCT02858076|450005799|FG000|Overall Study|Death|6|||
125104871|NCT02858076|450005800|FG001|Overall Study|Death|3|||
125104872|NCT02858076|450005799|FG000|Overall Study|Withdrawal by Subject|1|||
125104873|NCT02858076|450005800|FG001|Overall Study|Withdrawal by Subject|5|||
125104874|NCT02858076|450005799|FG000|Overall Study|Lost to Follow-up|2|||
125104875|NCT02858076|450005800|FG001|Overall Study|Lost to Follow-up|7|||
125104876|NCT02858076|450005799|FG000|Overall Study|Completed Out of Window|1|||
125104877|NCT02858076|450005800|FG001|Overall Study|Completed Out of Window|3|||
125104878|NCT00096200|450005801|FG000|Overall Study|Adverse Event|0|||
124883958|NCT01613027|449198675|FG000|Overall Study|Lack of Efficacy|1|||
125104879|NCT00096200|450005802|FG001|Overall Study|Adverse Event|4|||
125015047|NCT00001379|449680615|FG003|Initial Treatment|Did not receive protocol treatment|0|||
125015048|NCT00001379|449680612|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
125015049|NCT00001379|449680613|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
125015050|NCT00001379|449680614|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
125015051|NCT00001379|449680615|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
125015052|NCT00001379|449680612|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
125015053|NCT00001379|449680613|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
125015054|NCT00001379|449680614|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
125015055|NCT00001379|449680615|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
125015056|NCT00001379|449680612|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
125015057|NCT00001379|449680613|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
125015058|NCT00001379|449680614|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
125015059|NCT00001379|449680615|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
125015060|NCT00001379|449680612|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
125015061|NCT00001379|449680613|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
125015062|NCT00001379|449680614|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
125015063|NCT00001379|449680615|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
125015064|NCT00001379|449680612|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
125015065|NCT00001379|449680613|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
125104880|NCT00096200|450005803|FG002|Overall Study|Adverse Event|0|||
125015066|NCT00001379|449680614|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
125015067|NCT00001379|449680615|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
125015068|NCT03246958|449680616|FG000|Overall Study|Withdrawal by Subject|0|||
125015069|NCT03246958|449680617|FG001|Overall Study|Withdrawal by Subject|1|||
125015070|NCT03246958|449680618|FG002|Overall Study|Withdrawal by Subject|0|||
125015071|NCT03246958|449680619|FG003|Overall Study|Withdrawal by Subject|0|||
125015072|NCT03246958|449680620|FG004|Overall Study|Withdrawal by Subject|0|||
125015073|NCT03246958|449680621|FG005|Overall Study|Withdrawal by Subject|1|||
125015074|NCT03246958|449680622|FG006|Overall Study|Withdrawal by Subject|0|||
125015075|NCT03246958|449680616|FG000|Overall Study|Progression|13|||
125015076|NCT03246958|449680617|FG001|Overall Study|Progression|9|||
125015077|NCT03246958|449680618|FG002|Overall Study|Progression|3|||
125015078|NCT03246958|449680619|FG003|Overall Study|Progression|2|||
125015079|NCT03246958|449680620|FG004|Overall Study|Progression|1|||
125015080|NCT03246958|449680621|FG005|Overall Study|Progression|2|||
125015081|NCT03246958|449680622|FG006|Overall Study|Progression|1|||
125015082|NCT03246958|449680616|FG000|Overall Study|Adverse Event|2|||
125015083|NCT03246958|449680617|FG001|Overall Study|Adverse Event|2|||
125015084|NCT03246958|449680618|FG002|Overall Study|Adverse Event|0|||
125015085|NCT03246958|449680619|FG003|Overall Study|Adverse Event|1|||
125015086|NCT03246958|449680620|FG004|Overall Study|Adverse Event|1|||
125015087|NCT03246958|449680621|FG005|Overall Study|Adverse Event|0|||
125015088|NCT03246958|449680622|FG006|Overall Study|Adverse Event|2|||
125015089|NCT03246958|449680616|FG000|Overall Study|Death|0|||
125015090|NCT03246958|449680617|FG001|Overall Study|Death|1|||
125015091|NCT03246958|449680618|FG002|Overall Study|Death|0|||
125015092|NCT03246958|449680619|FG003|Overall Study|Death|0|||
125015093|NCT03246958|449680620|FG004|Overall Study|Death|0|||
125015094|NCT03246958|449680621|FG005|Overall Study|Death|0|||
125015095|NCT03246958|449680622|FG006|Overall Study|Death|0|||
125015096|NCT03246958|449680616|FG000|Overall Study|Physician Decision|0|||
125015097|NCT03246958|449680617|FG001|Overall Study|Physician Decision|0|||
125015098|NCT03246958|449680618|FG002|Overall Study|Physician Decision|0|||
125015099|NCT03246958|449680619|FG003|Overall Study|Physician Decision|1|||
125015100|NCT03246958|449680620|FG004|Overall Study|Physician Decision|0|||
124883959|NCT01613027|449198675|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
124883960|NCT00545363|449198676|FG000|Overall Study|Adverse Event|6|||
124883961|NCT00545363|449198677|FG001|Overall Study|Adverse Event|7|||
124883962|NCT00545363|449198676|FG000|Overall Study|Withdrawal by Subject|6|||
124883963|NCT00545363|449198677|FG001|Overall Study|Withdrawal by Subject|5|||
124883964|NCT00545363|449198676|FG000|Overall Study|Non-compliance|3|||
124883965|NCT00545363|449198677|FG001|Overall Study|Non-compliance|1|||
124883966|NCT00545363|449198676|FG000|Overall Study|Did not meet entry criteria|1|||
124883967|NCT00545363|449198677|FG001|Overall Study|Did not meet entry criteria|1|||
124883968|NCT00545363|449198676|FG000|Overall Study|Lost to Follow-up|2|||
124883969|NCT00545363|449198677|FG001|Overall Study|Lost to Follow-up|0|||
124883970|NCT00545363|449198676|FG000|Overall Study|Other|1|||
124883971|NCT00545363|449198677|FG001|Overall Study|Other|1|||
124883972|NCT00951509|449198678|FG000|Overall Study|Withdrawal by Subject|2|||
124883973|NCT03125941|449198680|FG000|Overall Study|did not receive intervention|1|||
124883974|NCT03125941|449198681|FG001|Overall Study|did not receive intervention|2|||
124883975|NCT00582491|449198682|FG000|Overall Study|Withdrawal by Subject|1|||
124883976|NCT00582491|449198683|FG001|Overall Study|Withdrawal by Subject|0|||
124883977|NCT04192630|449198684|FG000|Overall Study|Discontinued before surgery|2|||
124883978|NCT04192630|449198685|FG001|Overall Study|Discontinued before surgery|0|||
124883979|NCT04192630|449198684|FG000|Overall Study|Discontinued after surgery|5|||
124883980|NCT04192630|449198685|FG001|Overall Study|Discontinued after surgery|3|||
124883981|NCT01193582|449198686|FG000|Vaccination Series|Withdrawal by Subject|11|||
124883982|NCT01193582|449198687|FG001|Vaccination Series|Withdrawal by Subject|13|||
124883983|NCT01193582|449198688|FG002|Vaccination Series|Withdrawal by Subject|8|||
124883984|NCT01193582|449198689|FG003|Vaccination Series|Withdrawal by Subject|3|||
124883985|NCT01193582|449198686|FG000|12 Month Follow-up|Death|0|||
124883986|NCT01193582|449198687|FG001|12 Month Follow-up|Death|0|||
124883987|NCT01193582|449198688|FG002|12 Month Follow-up|Death|1|||
124883988|NCT01193582|449198689|FG003|12 Month Follow-up|Death|0|||
124883989|NCT01193582|449198686|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
124883990|NCT01193582|449198687|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
124883991|NCT01193582|449198688|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
124883992|NCT01193582|449198689|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
124883993|NCT01425632|449198690|FG000|Overall Study|Adverse Event|0|||
124883994|NCT01425632|449198691|FG001|Overall Study|Adverse Event|1|||
124883995|NCT01425632|449198692|FG002|Overall Study|Adverse Event|1|||
124883996|NCT01425632|449198690|FG000|Overall Study|Physician Decision|1|||
124883997|NCT01425632|449198691|FG001|Overall Study|Physician Decision|0|||
124883998|NCT01425632|449198692|FG002|Overall Study|Physician Decision|0|||
124883999|NCT01425632|449198690|FG000|Overall Study|Protocol Violation|0|||
124884000|NCT01425632|449198691|FG001|Overall Study|Protocol Violation|0|||
124884001|NCT01425632|449198692|FG002|Overall Study|Protocol Violation|2|||
124884002|NCT01425632|449198690|FG000|Overall Study|Withdrawal by Subject|0|||
124884003|NCT01425632|449198691|FG001|Overall Study|Withdrawal by Subject|0|||
124884004|NCT01425632|449198692|FG002|Overall Study|Withdrawal by Subject|1|||
124884005|NCT03632434|449198698|FG000|Overall Study|Withdrawal by Subject|2|||
124884006|NCT01751113|449198699|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
124884007|NCT01751113|449198700|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
124884008|NCT01751113|449198701|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
124884009|NCT01751113|449198702|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
124884010|NCT01751113|449198703|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
124884011|NCT01751113|449198704|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
124884012|NCT01751113|449198699|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
124884013|NCT01751113|449198700|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
124884014|NCT01751113|449198701|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
124884015|NCT01751113|449198702|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
124884016|NCT01751113|449198703|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
124884017|NCT01751113|449198704|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
124884018|NCT01551303|449198705|FG000|Overall Study|failed awareness check on vision test|4|||
124884019|NCT01551303|449198706|FG001|Overall Study|failed awareness check on vision test|7|||
124884020|NCT01208415|449198709|FG000|Overall Study|Death|1|||
124884021|NCT01208415|449198709|FG000|Overall Study|Lost to Follow-up|2|||
124884022|NCT01208415|449198709|FG000|Overall Study|Withdrawal by Subject|3|||
124884023|NCT01208415|449198709|FG000|Overall Study|Device not placed|1|||
124884024|NCT01208415|449198709|FG000|Overall Study|Still be eligible for follow-up|33|||
124884025|NCT01115491|449198710|FG000|Overall Study|Death|22|||
124884026|NCT01115491|449198710|FG000|Overall Study|Adverse Event|3|||
125015101|NCT03246958|449680621|FG005|Overall Study|Physician Decision|0|||
125015102|NCT03246958|449680622|FG006|Overall Study|Physician Decision|0|||
125015103|NCT03246958|449680616|FG000|Overall Study|Never start treatment|1|||
124884027|NCT01115491|449198710|FG000|Overall Study|Lost to Follow-up|3|||
125015104|NCT03246958|449680617|FG001|Overall Study|Never start treatment|0|||
124884028|NCT01115491|449198710|FG000|Overall Study|Withdrawal by Subject|1|||
124884029|NCT01115491|449198710|FG000|Overall Study|Physician Decision|1|||
124884030|NCT04297241|449198711|FG000|Overall Study|Withdrawal by Subject|1|||
124884031|NCT04297241|449198711|FG000|Overall Study|Adverse Event|1|||
124884032|NCT04297241|449198711|FG000|Overall Study|Physician Decision|3|||
124884033|NCT03856996|449198712|FG000|Overall Study|Withdrawal by Subject|1|||
124884034|NCT03856996|449198713|FG001|Overall Study|Withdrawal by Subject|0|||
124884035|NCT03856996|449198712|FG000|Overall Study|Lost to Follow-up|0|||
124884036|NCT03856996|449198713|FG001|Overall Study|Lost to Follow-up|1|||
124884037|NCT03856996|449198712|FG000|Overall Study|Adverse Event|1|||
124884038|NCT03856996|449198713|FG001|Overall Study|Adverse Event|1|||
124884039|NCT03856996|449198712|FG000|Overall Study|Other|1|||
124884040|NCT03856996|449198713|FG001|Overall Study|Other|0|||
124884041|NCT01003639|449198714|FG000|Overall Study|Lost to Follow-up|6|||
124884042|NCT01003639|449198715|FG001|Overall Study|Lost to Follow-up|9|||
124884043|NCT01003639|449198714|FG000|Overall Study|Withdrawal by Subject|9|||
124884044|NCT01003639|449198715|FG001|Overall Study|Withdrawal by Subject|5|||
124884045|NCT01003639|449198714|FG000|Overall Study|Lack of Efficacy|1|||
124884046|NCT01003639|449198715|FG001|Overall Study|Lack of Efficacy|6|||
124884047|NCT01003639|449198714|FG000|Overall Study|Adverse Event|0|||
124884048|NCT01003639|449198715|FG001|Overall Study|Adverse Event|1|||
124884049|NCT01003639|449198714|FG000|Overall Study|Protocol Violation|0|||
124884050|NCT01003639|449198715|FG001|Overall Study|Protocol Violation|1|||
124884051|NCT01003639|449198714|FG000|Overall Study|Physician Decision|1|||
124884052|NCT01003639|449198715|FG001|Overall Study|Physician Decision|0|||
124884053|NCT04362137|449198717|FG000|Overall Study|Death|9|||
124884054|NCT04362137|449198718|FG001|Overall Study|Death|3|||
124884055|NCT04362137|449198717|FG000|Overall Study|Patient decision|6|||
124884056|NCT04362137|449198718|FG001|Overall Study|Patient decision|3|||
124884057|NCT04362137|449198717|FG000|Overall Study|Adverse Event|1|||
124884058|NCT04362137|449198718|FG001|Overall Study|Adverse Event|0|||
124884059|NCT04362137|449198717|FG000|Overall Study|Lost to Follow-up|1|||
124884060|NCT04362137|449198718|FG001|Overall Study|Lost to Follow-up|0|||
124884061|NCT04362137|449198717|FG000|Overall Study|Protocol deviation|1|||
124884062|NCT04362137|449198718|FG001|Overall Study|Protocol deviation|0|||
124884063|NCT02262260|449198726|FG000|Overall Study|Adverse Event|4|||
124884064|NCT02262260|449198727|FG001|Overall Study|Adverse Event|1|||
124884065|NCT02262260|449198726|FG000|Overall Study|Withdrawal of consent|4|||
124884066|NCT02262260|449198727|FG001|Overall Study|Withdrawal of consent|2|||
124884067|NCT02262260|449198726|FG000|Overall Study|Lost to Follow-up|1|||
124884068|NCT02262260|449198727|FG001|Overall Study|Lost to Follow-up|2|||
124884069|NCT02262260|449198726|FG000|Overall Study|Protocol deviation|2|||
124884070|NCT02262260|449198727|FG001|Overall Study|Protocol deviation|5|||
124884071|NCT01794117|449198729|FG000|Overall Study|Adverse Event|1|||
124884072|NCT01794117|449198730|FG001|Overall Study|Adverse Event|0|||
124884073|NCT01794117|449198731|FG002|Overall Study|Adverse Event|0|||
124884074|NCT01794117|449198732|FG003|Overall Study|Adverse Event|0|||
124884075|NCT01794117|449198729|FG000|Overall Study|Participant noncompliance|0|||
124884076|NCT01794117|449198730|FG001|Overall Study|Participant noncompliance|1|||
124884077|NCT01794117|449198731|FG002|Overall Study|Participant noncompliance|0|||
124884078|NCT01794117|449198732|FG003|Overall Study|Participant noncompliance|0|||
124884079|NCT01794117|449198729|FG000|Overall Study|Refused further treatment|0|||
124884080|NCT01794117|449198730|FG001|Overall Study|Refused further treatment|2|||
124884081|NCT01794117|449198731|FG002|Overall Study|Refused further treatment|0|||
124884082|NCT01794117|449198732|FG003|Overall Study|Refused further treatment|0|||
124884083|NCT00514046|449198738|FG000|Overall Study|transferred to another protocol|2|||
124884084|NCT00514046|449198739|FG001|Overall Study|transferred to another protocol|1|||
124884085|NCT00514046|449198740|FG002|Overall Study|transferred to another protocol|3|||
124884086|NCT00514046|449198741|FG003|Overall Study|transferred to another protocol|0|||
124884087|NCT00514046|449198742|FG004|Overall Study|transferred to another protocol|1|||
124884088|NCT00514046|449198743|FG005|Overall Study|transferred to another protocol|0|||
124884089|NCT00514046|449198744|FG006|Overall Study|transferred to another protocol|0|||
124884090|NCT00514046|449198745|FG007|Overall Study|transferred to another protocol|0|||
124884091|NCT00514046|449198746|FG008|Overall Study|transferred to another protocol|0|||
124884092|NCT00514046|449198738|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
125104881|NCT00096200|450005801|FG000|Overall Study|Withdrawal by Subject|1|||
125104882|NCT00096200|450005802|FG001|Overall Study|Withdrawal by Subject|2|||
124884093|NCT00514046|449198739|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
124884094|NCT00514046|449198740|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
125104883|NCT00096200|450005803|FG002|Overall Study|Withdrawal by Subject|0|||
124884095|NCT00514046|449198741|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
124884096|NCT00514046|449198742|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
124884097|NCT00514046|449198743|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
124884098|NCT00514046|449198744|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
124884099|NCT00514046|449198745|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
124884100|NCT00514046|449198746|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
124884101|NCT00514046|449198738|FG000|Overall Study|Disease progression on study|0|||
124884102|NCT00514046|449198739|FG001|Overall Study|Disease progression on study|0|||
124884103|NCT00514046|449198740|FG002|Overall Study|Disease progression on study|2|||
124884104|NCT00514046|449198741|FG003|Overall Study|Disease progression on study|0|||
124884105|NCT00514046|449198742|FG004|Overall Study|Disease progression on study|0|||
124884106|NCT00514046|449198743|FG005|Overall Study|Disease progression on study|1|||
124884107|NCT00514046|449198744|FG006|Overall Study|Disease progression on study|0|||
124884108|NCT00514046|449198745|FG007|Overall Study|Disease progression on study|0|||
124884109|NCT00514046|449198746|FG008|Overall Study|Disease progression on study|0|||
124884110|NCT00655551|449198747|FG000|All Periods Combined|Adverse Event|0|||
124884111|NCT00655551|449198748|FG001|All Periods Combined|Adverse Event|3|||
124884112|NCT00655551|449198749|FG002|All Periods Combined|Adverse Event|4|||
124884113|NCT00655551|449198747|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
124884114|NCT00655551|449198748|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
124884115|NCT00655551|449198749|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
124884116|NCT00655551|449198747|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
124884117|NCT00655551|449198748|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
124884118|NCT00655551|449198749|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
124884119|NCT00655551|449198747|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
124884120|NCT00655551|449198748|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
124884121|NCT00655551|449198749|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
124884122|NCT00876460|449198750|FG000|Combination Therapy Phase|Progressive disease|2|||
124884123|NCT00876460|449198751|FG001|Combination Therapy Phase|Progressive disease|3|||
124884124|NCT00876460|449198752|FG002|Combination Therapy Phase|Progressive disease|3|||
124884125|NCT00876460|449198753|FG003|Combination Therapy Phase|Progressive disease|3|||
124884126|NCT00876460|449198754|FG004|Combination Therapy Phase|Progressive disease|3|||
124884127|NCT00876460|449198755|FG005|Combination Therapy Phase|Progressive disease|1|||
124884128|NCT00876460|449198756|FG006|Combination Therapy Phase|Progressive disease|1|||
124884129|NCT00876460|449198757|FG007|Combination Therapy Phase|Progressive disease|1|||
124884130|NCT00876460|449198750|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
124884131|NCT00876460|449198751|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
124884132|NCT00876460|449198752|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
124884133|NCT00876460|449198753|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
124884134|NCT00876460|449198754|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
124884135|NCT00876460|449198755|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
124884136|NCT00876460|449198756|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
124884137|NCT00876460|449198757|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
124884138|NCT00876460|449198750|FG000|Combination Therapy Phase|Adverse Event|0|||
124884139|NCT00876460|449198751|FG001|Combination Therapy Phase|Adverse Event|2|||
124884140|NCT00876460|449198752|FG002|Combination Therapy Phase|Adverse Event|0|||
124884141|NCT00876460|449198753|FG003|Combination Therapy Phase|Adverse Event|2|||
124884142|NCT00876460|449198754|FG004|Combination Therapy Phase|Adverse Event|2|||
124884143|NCT00876460|449198755|FG005|Combination Therapy Phase|Adverse Event|0|||
124884144|NCT00876460|449198756|FG006|Combination Therapy Phase|Adverse Event|3|||
124884145|NCT00876460|449198757|FG007|Combination Therapy Phase|Adverse Event|2|||
124884146|NCT00876460|449198750|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
124884147|NCT00876460|449198751|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
124884148|NCT00876460|449198752|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
124884149|NCT00876460|449198753|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
125015105|NCT03246958|449680618|FG002|Overall Study|Never start treatment|0|||
125015106|NCT03246958|449680619|FG003|Overall Study|Never start treatment|0|||
124884150|NCT00876460|449198754|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
124884151|NCT00876460|449198755|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
125015107|NCT03246958|449680620|FG004|Overall Study|Never start treatment|0|||
125015108|NCT03246958|449680621|FG005|Overall Study|Never start treatment|0|||
125015109|NCT03246958|449680622|FG006|Overall Study|Never start treatment|0|||
125015110|NCT03246958|449680616|FG000|Overall Study|Over enrollment|0|||
125015111|NCT03246958|449680617|FG001|Overall Study|Over enrollment|2|||
125015112|NCT03246958|449680618|FG002|Overall Study|Over enrollment|0|||
125015113|NCT03246958|449680619|FG003|Overall Study|Over enrollment|0|||
125015114|NCT03246958|449680620|FG004|Overall Study|Over enrollment|0|||
125015115|NCT03246958|449680621|FG005|Overall Study|Over enrollment|0|||
125015116|NCT03246958|449680622|FG006|Overall Study|Over enrollment|0|||
125015117|NCT03703102|449680623|FG000|Overall Study|Adverse Event|4|||
125015118|NCT03703102|449680624|FG001|Overall Study|Adverse Event|3|||
125015119|NCT03703102|449680625|FG002|Overall Study|Adverse Event|7|||
124884152|NCT00876460|449198756|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
125015120|NCT03703102|449680626|FG003|Overall Study|Adverse Event|3|||
124884153|NCT00876460|449198757|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
124884154|NCT00876460|449198750|FG000|Combination Therapy Phase|Other reason not defined above|0|||
124884155|NCT00876460|449198751|FG001|Combination Therapy Phase|Other reason not defined above|0|||
124884156|NCT00876460|449198752|FG002|Combination Therapy Phase|Other reason not defined above|0|||
124884157|NCT00876460|449198753|FG003|Combination Therapy Phase|Other reason not defined above|0|||
124884158|NCT00876460|449198754|FG004|Combination Therapy Phase|Other reason not defined above|0|||
124884159|NCT00876460|449198755|FG005|Combination Therapy Phase|Other reason not defined above|0|||
124884160|NCT00876460|449198756|FG006|Combination Therapy Phase|Other reason not defined above|1|||
124884161|NCT00876460|449198757|FG007|Combination Therapy Phase|Other reason not defined above|2|||
124884162|NCT00876460|449198750|FG000|Combination Therapy Phase|Not treated|0|||
124884163|NCT00876460|449198751|FG001|Combination Therapy Phase|Not treated|0|||
124884164|NCT00876460|449198752|FG002|Combination Therapy Phase|Not treated|0|||
124884165|NCT00876460|449198753|FG003|Combination Therapy Phase|Not treated|0|||
124884166|NCT00876460|449198754|FG004|Combination Therapy Phase|Not treated|0|||
124884167|NCT00876460|449198755|FG005|Combination Therapy Phase|Not treated|0|||
124884168|NCT00876460|449198756|FG006|Combination Therapy Phase|Not treated|1|||
124884169|NCT00876460|449198757|FG007|Combination Therapy Phase|Not treated|0|||
124884170|NCT00876460|449198750|FG000|Mono Therapy Phase|Progressive disease|0|||
124884171|NCT00876460|449198751|FG001|Mono Therapy Phase|Progressive disease|0|||
124884172|NCT00876460|449198752|FG002|Mono Therapy Phase|Progressive disease|0|||
124884173|NCT00876460|449198753|FG003|Mono Therapy Phase|Progressive disease|0|||
124884174|NCT00876460|449198754|FG004|Mono Therapy Phase|Progressive disease|2|||
124884175|NCT00876460|449198755|FG005|Mono Therapy Phase|Progressive disease|0|||
124884176|NCT00876460|449198756|FG006|Mono Therapy Phase|Progressive disease|1|||
124884177|NCT00876460|449198757|FG007|Mono Therapy Phase|Progressive disease|3|||
124884178|NCT00876460|449198750|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
124884179|NCT00876460|449198751|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
124884180|NCT00876460|449198752|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
124884181|NCT00876460|449198753|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
124884182|NCT00876460|449198754|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
124884183|NCT00876460|449198755|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
124884184|NCT00876460|449198756|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
124884185|NCT00876460|449198757|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
124884186|NCT00876460|449198750|FG000|Mono Therapy Phase|Adverse Event|0|||
124884187|NCT00876460|449198751|FG001|Mono Therapy Phase|Adverse Event|0|||
124884188|NCT00876460|449198752|FG002|Mono Therapy Phase|Adverse Event|0|||
124884189|NCT00876460|449198753|FG003|Mono Therapy Phase|Adverse Event|1|||
124884190|NCT00876460|449198754|FG004|Mono Therapy Phase|Adverse Event|0|||
124884191|NCT00876460|449198755|FG005|Mono Therapy Phase|Adverse Event|0|||
124884192|NCT00876460|449198756|FG006|Mono Therapy Phase|Adverse Event|0|||
124884193|NCT00876460|449198757|FG007|Mono Therapy Phase|Adverse Event|0|||
124884194|NCT01567865|449198762|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
124884195|NCT01567865|449198763|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
124884196|NCT01567865|449198764|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
124884197|NCT01567865|449198765|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
124884198|NCT01567865|449198762|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
124884199|NCT01567865|449198763|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
124884200|NCT01567865|449198764|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
124884201|NCT01567865|449198765|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
124884202|NCT00309608|449198766|FG000|Overall Study|Adverse Event|1|||
124884203|NCT00309608|449198767|FG001|Overall Study|Adverse Event|5|||
124884204|NCT00309608|449198768|FG002|Overall Study|Adverse Event|3|||
124884205|NCT00309608|449198769|FG003|Overall Study|Adverse Event|2|||
124884206|NCT00309608|449198770|FG004|Overall Study|Adverse Event|3|||
124884207|NCT00309608|449198766|FG000|Overall Study|Protocol Violation|2|||
124884208|NCT00309608|449198767|FG001|Overall Study|Protocol Violation|0|||
124884209|NCT00309608|449198768|FG002|Overall Study|Protocol Violation|0|||
124884210|NCT00309608|449198769|FG003|Overall Study|Protocol Violation|0|||
124884211|NCT00309608|449198770|FG004|Overall Study|Protocol Violation|0|||
124884212|NCT00309608|449198766|FG000|Overall Study|Lost to Follow-up|0|||
124884213|NCT00309608|449198767|FG001|Overall Study|Lost to Follow-up|0|||
124884214|NCT00309608|449198768|FG002|Overall Study|Lost to Follow-up|2|||
124884215|NCT00309608|449198769|FG003|Overall Study|Lost to Follow-up|0|||
124884216|NCT00309608|449198770|FG004|Overall Study|Lost to Follow-up|1|||
124884217|NCT00309608|449198766|FG000|Overall Study|Withdrawal by Subject|1|||
124884218|NCT00309608|449198767|FG001|Overall Study|Withdrawal by Subject|4|||
124884219|NCT00309608|449198768|FG002|Overall Study|Withdrawal by Subject|2|||
124884220|NCT00309608|449198769|FG003|Overall Study|Withdrawal by Subject|0|||
124884221|NCT00309608|449198770|FG004|Overall Study|Withdrawal by Subject|0|||
124884222|NCT00309608|449198766|FG000|Overall Study|Other incl. Lack of efficacy|10|||
124884223|NCT00309608|449198767|FG001|Overall Study|Other incl. Lack of efficacy|4|||
124884224|NCT00309608|449198768|FG002|Overall Study|Other incl. Lack of efficacy|3|||
124884225|NCT00309608|449198769|FG003|Overall Study|Other incl. Lack of efficacy|4|||
124884226|NCT00309608|449198770|FG004|Overall Study|Other incl. Lack of efficacy|0|||
124884227|NCT00621296|449198777|FG000|Overall Study|Adverse Event|2|||
124884228|NCT00621296|449198777|FG000|Overall Study|Lack of Efficacy|1|||
124884229|NCT00621296|449198777|FG000|Overall Study|Physician Decision|7|||
124884230|NCT00621296|449198777|FG000|Overall Study|Unmatch Criteria|1|||
124884231|NCT00621296|449198777|FG000|Overall Study|Stopping Criteria|3|||
124884232|NCT01051063|449198778|FG000|Overall Study|Death|2|||
124884233|NCT01051063|449198779|FG001|Overall Study|Death|2|||
124884234|NCT01051063|449198778|FG000|Overall Study|Withdrawal by Subject|1|||
124884235|NCT01051063|449198779|FG001|Overall Study|Withdrawal by Subject|1|||
124884236|NCT01051063|449198778|FG000|Overall Study|Termination of the study|5|||
124884237|NCT01051063|449198779|FG001|Overall Study|Termination of the study|0|||
124884238|NCT01051063|449198778|FG000|Overall Study|Moved from the study site area|1|||
124884239|NCT01051063|449198779|FG001|Overall Study|Moved from the study site area|0|||
124884240|NCT01051063|449198778|FG000|Overall Study|Other|1|||
124884241|NCT01051063|449198779|FG001|Overall Study|Other|0|||
124884242|NCT01051063|449198778|FG000|Overall Study|Lost to Follow-up|0|||
124884243|NCT01051063|449198779|FG001|Overall Study|Lost to Follow-up|1|||
124884244|NCT03857841|449198783|FG000|Overall Study|Death|1|||
124884245|NCT03857841|449198784|FG001|Overall Study|Death|0|||
124884246|NCT03857841|449198785|FG002|Overall Study|Death|0|||
124884247|NCT03857841|449198786|FG003|Overall Study|Death|0|||
124884248|NCT03857841|449198783|FG000|Overall Study|Study Terminated by Sponsor|1|||
124884249|NCT03857841|449198784|FG001|Overall Study|Study Terminated by Sponsor|0|||
124884250|NCT03857841|449198785|FG002|Overall Study|Study Terminated by Sponsor|0|||
124884251|NCT03857841|449198786|FG003|Overall Study|Study Terminated by Sponsor|0|||
124884252|NCT00386308|449200485|FG000|Overall Study|Adverse Event|3|||
124884253|NCT00386308|449200486|FG001|Overall Study|Adverse Event|3|||
124884254|NCT00386308|449200485|FG000|Overall Study|Protocol Violation|2|||
124884255|NCT00386308|449200486|FG001|Overall Study|Protocol Violation|5|||
124884256|NCT00386308|449200485|FG000|Overall Study|Lack of Efficacy|0|||
124884257|NCT00386308|449200486|FG001|Overall Study|Lack of Efficacy|2|||
124884258|NCT00386308|449200485|FG000|Overall Study|Lost to Follow-up|10|||
124884259|NCT00386308|449200486|FG001|Overall Study|Lost to Follow-up|6|||
124884260|NCT00386308|449200485|FG000|Overall Study|Withdrawal by Subject|6|||
124884261|NCT00386308|449200486|FG001|Overall Study|Withdrawal by Subject|2|||
124884262|NCT00386308|449200485|FG000|Overall Study|Other Event|8|||
124884263|NCT00386308|449200486|FG001|Overall Study|Other Event|1|||
124884264|NCT02906683|449200487|FG000|Overall Study|Adverse Event|0|||
124884265|NCT02906683|449200488|FG001|Overall Study|Adverse Event|1|||
124884266|NCT02906683|449200489|FG002|Overall Study|Adverse Event|0|||
124884267|NCT02906683|449200487|FG000|Overall Study|Physician Decision|0|||
124884268|NCT02906683|449200488|FG001|Overall Study|Physician Decision|1|||
124884269|NCT02906683|449200489|FG002|Overall Study|Physician Decision|1|||
124884270|NCT02906683|449200487|FG000|Overall Study|Withdrawal by Subject|0|||
124884271|NCT02906683|449200488|FG001|Overall Study|Withdrawal by Subject|2|||
124884272|NCT02906683|449200489|FG002|Overall Study|Withdrawal by Subject|1|||
124884273|NCT02906683|449200487|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
124884274|NCT02906683|449200488|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
124884275|NCT02906683|449200489|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
124884276|NCT02906683|449200487|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
124884277|NCT02906683|449200488|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
124884278|NCT02906683|449200489|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
124884279|NCT02781506|449200490|FG000|Overall Study|Adverse Event|5|||
124884280|NCT01242176|449200491|FG000|Washout Period of 7 Days|Adverse Event|0|||
124884281|NCT01242176|449200492|FG001|Washout Period of 7 Days|Adverse Event|2|||
124884282|NCT01242176|449200491|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
124884283|NCT01242176|449200492|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
124884284|NCT02802319|449200495|FG000|Overall Study|Physician Decision|2|||
124884285|NCT02802319|449200496|FG001|Overall Study|Physician Decision|1|||
124884286|NCT02802319|449200495|FG000|Overall Study|Lost to Follow-up|0|||
124884287|NCT02802319|449200496|FG001|Overall Study|Lost to Follow-up|4|||
124884288|NCT03545113|449200497|FG000|Overall Study|Surgery Cancelled|1|||
124884289|NCT03545113|449200498|FG001|Overall Study|Surgery Cancelled|0|||
124884290|NCT03545113|449200497|FG000|Overall Study|Death|1|||
124884291|NCT03545113|449200498|FG001|Overall Study|Death|0|||
124884292|NCT03545113|449200497|FG000|Overall Study|Adverse Event|2|||
124884293|NCT03545113|449200498|FG001|Overall Study|Adverse Event|0|||
124884294|NCT03545113|449200497|FG000|Overall Study|Received different surgery|1|||
124884295|NCT03545113|449200498|FG001|Overall Study|Received different surgery|0|||
124884296|NCT01683994|449200501|FG000|Overall Study|Withdrawal by Subject|1|||
124884297|NCT01683994|449200502|FG001|Overall Study|Withdrawal by Subject|0|||
124884298|NCT01683994|449200503|FG002|Overall Study|Withdrawal by Subject|0|||
124884299|NCT01683994|449200504|FG003|Overall Study|Withdrawal by Subject|1|||
124884300|NCT01683994|449200505|FG004|Overall Study|Withdrawal by Subject|0|||
124884301|NCT01683994|449200501|FG000|Overall Study|Intercurrent illness|0|||
124884302|NCT01683994|449200502|FG001|Overall Study|Intercurrent illness|0|||
124884303|NCT01683994|449200503|FG002|Overall Study|Intercurrent illness|0|||
124884304|NCT01683994|449200504|FG003|Overall Study|Intercurrent illness|2|||
124884305|NCT01683994|449200505|FG004|Overall Study|Intercurrent illness|1|||
124884306|NCT00999661|449200506|FG000|Overall Study|Lost to Follow-up|59|||
124884307|NCT00999661|449200506|FG000|Overall Study|Adverse Event|1|||
124884308|NCT00999661|449200506|FG000|Overall Study|Withdrawal by Subject|1|||
124884309|NCT00999661|449200506|FG000|Overall Study|Not meeting eligibility criteria|9|||
124884310|NCT03638635|449200508|FG000|Initial Hospitalization|Study terminated prematurely|0|||
124884311|NCT03638635|449200509|FG001|Initial Hospitalization|Study terminated prematurely|1|||
124884312|NCT03638635|449200508|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
124884313|NCT03638635|449200509|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
124884314|NCT03638635|449200508|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
124884315|NCT03638635|449200509|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
124884316|NCT00313911|449200512|FG000|Overall Study|Serious adverse event|6|||
124884317|NCT00313911|449200513|FG001|Overall Study|Serious adverse event|1|||
124884318|NCT00313911|449200512|FG000|Overall Study|Adverse Event|2|||
124884319|NCT00313911|449200513|FG001|Overall Study|Adverse Event|3|||
124884320|NCT00313911|449200512|FG000|Overall Study|Protocol Violation|19|||
124884321|NCT00313911|449200513|FG001|Overall Study|Protocol Violation|10|||
124884322|NCT00313911|449200512|FG000|Overall Study|Lost to Follow-up|27|||
124884323|NCT00313911|449200513|FG001|Overall Study|Lost to Follow-up|14|||
124884324|NCT00313911|449200512|FG000|Overall Study|Withdrawal by Subject|39|||
124884325|NCT00313911|449200513|FG001|Overall Study|Withdrawal by Subject|12|||
124884326|NCT00313911|449200512|FG000|Overall Study|Did not meet age criteria|1|||
124884327|NCT00313911|449200513|FG001|Overall Study|Did not meet age criteria|1|||
124884328|NCT01987596|449200516|FG000|Overall Study|Physician Decision|1|||
124884329|NCT01987596|449200517|FG001|Overall Study|Physician Decision|0|||
124884330|NCT01987596|449200516|FG000|Overall Study|Progressive Disease; missing all period|0|||
124884331|NCT01987596|449200517|FG001|Overall Study|Progressive Disease; missing all period|1|||
124884332|NCT01533714|449200519|FG000|Overall Study|Adverse Event|0|||
124884333|NCT01533714|449200520|FG001|Overall Study|Adverse Event|1|||
124884334|NCT01533714|449200521|FG002|Overall Study|Adverse Event|2|||
124884335|NCT01533714|449200522|FG003|Overall Study|Adverse Event|2|||
124884336|NCT01533714|449200523|FG004|Overall Study|Adverse Event|2|||
124884337|NCT01533714|449200524|FG005|Overall Study|Adverse Event|1|||
124884338|NCT01533714|449200519|FG000|Overall Study|Lack of Efficacy|0|||
124884339|NCT01533714|449200520|FG001|Overall Study|Lack of Efficacy|0|||
124884340|NCT01533714|449200521|FG002|Overall Study|Lack of Efficacy|0|||
124884341|NCT01533714|449200522|FG003|Overall Study|Lack of Efficacy|0|||
124884342|NCT01533714|449200523|FG004|Overall Study|Lack of Efficacy|0|||
124884343|NCT01533714|449200524|FG005|Overall Study|Lack of Efficacy|1|||
124884344|NCT01533714|449200519|FG000|Overall Study|Withdrawal by Subject|0|||
124884345|NCT01533714|449200520|FG001|Overall Study|Withdrawal by Subject|1|||
124884346|NCT01533714|449200521|FG002|Overall Study|Withdrawal by Subject|0|||
124884347|NCT01533714|449200522|FG003|Overall Study|Withdrawal by Subject|1|||
124884348|NCT01533714|449200523|FG004|Overall Study|Withdrawal by Subject|1|||
124884349|NCT01533714|449200524|FG005|Overall Study|Withdrawal by Subject|0|||
124884350|NCT01533714|449200519|FG000|Overall Study|Exclusion criteria|0|||
124884351|NCT01533714|449200520|FG001|Overall Study|Exclusion criteria|1|||
124884352|NCT01533714|449200521|FG002|Overall Study|Exclusion criteria|0|||
124884353|NCT01533714|449200522|FG003|Overall Study|Exclusion criteria|0|||
124884354|NCT01533714|449200523|FG004|Overall Study|Exclusion criteria|0|||
124884355|NCT01533714|449200524|FG005|Overall Study|Exclusion criteria|0|||
124884356|NCT01533714|449200519|FG000|Overall Study|Positive for purified protein derivative|0|||
124884357|NCT01533714|449200520|FG001|Overall Study|Positive for purified protein derivative|0|||
124884358|NCT01533714|449200521|FG002|Overall Study|Positive for purified protein derivative|1|||
124884359|NCT01533714|449200522|FG003|Overall Study|Positive for purified protein derivative|0|||
124884360|NCT01533714|449200523|FG004|Overall Study|Positive for purified protein derivative|1|||
124884361|NCT01533714|449200524|FG005|Overall Study|Positive for purified protein derivative|0|||
124884362|NCT01533714|449200519|FG000|Overall Study|Withdrawal criteria|0|||
124884363|NCT01533714|449200520|FG001|Overall Study|Withdrawal criteria|0|||
124884364|NCT01533714|449200521|FG002|Overall Study|Withdrawal criteria|1|||
124884365|NCT01533714|449200522|FG003|Overall Study|Withdrawal criteria|0|||
124884366|NCT01533714|449200523|FG004|Overall Study|Withdrawal criteria|3|||
124884367|NCT01533714|449200524|FG005|Overall Study|Withdrawal criteria|1|||
124884368|NCT01533714|449200519|FG000|Overall Study|Ineligibility reason|0|||
124884369|NCT01533714|449200520|FG001|Overall Study|Ineligibility reason|0|||
124884370|NCT01533714|449200521|FG002|Overall Study|Ineligibility reason|0|||
124884371|NCT01533714|449200522|FG003|Overall Study|Ineligibility reason|1|||
124884372|NCT01533714|449200523|FG004|Overall Study|Ineligibility reason|0|||
124884373|NCT01533714|449200524|FG005|Overall Study|Ineligibility reason|0|||
124884374|NCT00251927|449200529|FG000|Overall Study|Adverse Event|3|||
124884375|NCT00251927|449200530|FG001|Overall Study|Adverse Event|15|||
124884376|NCT00251927|449200529|FG000|Overall Study|Lack of Efficacy|22|||
125104884|NCT00096200|450005801|FG000|Overall Study|Ineligible pathology|0|||
125104885|NCT00096200|450005802|FG001|Overall Study|Ineligible pathology|1|||
125104886|NCT00096200|450005803|FG002|Overall Study|Ineligible pathology|0|||
125104887|NCT00664066|450005804|FG000|Overall Study|Study terminated|3|||
125104888|NCT01495793|450005808|FG000|Overall Study|Lost to Follow-up|1|||
125104889|NCT01495793|450005808|FG000|Overall Study|Violation of inclusion criteria|1|||
125104890|NCT03014570|450005811|FG000|Overall Study|COVID-19 Restrictions|38|||
125104891|NCT03014570|450005812|FG001|Overall Study|COVID-19 Restrictions|24|||
125104892|NCT03014570|450005811|FG000|Overall Study|Death|70|||
125104893|NCT03014570|450005812|FG001|Overall Study|Death|79|||
125104894|NCT03014570|450005811|FG000|Overall Study|Transfer from facility|11|||
125104895|NCT03014570|450005812|FG001|Overall Study|Transfer from facility|14|||
125104896|NCT03014570|450005811|FG000|Overall Study|Hospitalized|5|||
125104897|NCT03014570|450005812|FG001|Overall Study|Hospitalized|3|||
125104898|NCT03014570|450005811|FG000|Overall Study|Transfer within facility|1|||
125104899|NCT03014570|450005812|FG001|Overall Study|Transfer within facility|0|||
125104900|NCT03014570|450005811|FG000|Overall Study|Site refusal|0|||
125104901|NCT03014570|450005812|FG001|Overall Study|Site refusal|11|||
125104902|NCT03701516|450005818|FG000|Period 1|Lost to Follow-up|0|||
125104903|NCT03701516|450005819|FG001|Period 1|Lost to Follow-up|1|||
125104904|NCT03701516|450005818|FG000|Period 1|Adverse Event|0|||
124884377|NCT00251927|449200530|FG001|Overall Study|Lack of Efficacy|16|||
125104905|NCT03701516|450005819|FG001|Period 1|Adverse Event|2|||
125104906|NCT03701516|450005818|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
124884378|NCT00251927|449200529|FG000|Overall Study|Lost to Follow-up|22|||
124884379|NCT00251927|449200530|FG001|Overall Study|Lost to Follow-up|8|||
124884380|NCT00251927|449200529|FG000|Overall Study|Protocol Violation|1|||
125104907|NCT03701516|450005819|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
124884381|NCT00251927|449200530|FG001|Overall Study|Protocol Violation|2|||
124884382|NCT00251927|449200529|FG000|Overall Study|Pregnancy|2|||
124884383|NCT00251927|449200530|FG001|Overall Study|Pregnancy|0|||
124884384|NCT00251927|449200529|FG000|Overall Study|Withdrawal by Subject|40|||
124884385|NCT00251927|449200530|FG001|Overall Study|Withdrawal by Subject|25|||
124884386|NCT00251927|449200529|FG000|Overall Study|Study-specific discont. achieved|13|||
124884387|NCT00251927|449200530|FG001|Overall Study|Study-specific discont. achieved|2|||
124884388|NCT00251927|449200529|FG000|Overall Study|Study procedure non-compliance|5|||
124884389|NCT00251927|449200530|FG001|Overall Study|Study procedure non-compliance|6|||
124884390|NCT02406261|449200535|FG000|Period 1|Lost to Follow-up|2|||
124884391|NCT02406261|449200536|FG001|Period 1|Lost to Follow-up|0|||
124884392|NCT02406261|449200535|FG000|Period 1|Adverse Event|1|||
124884393|NCT02406261|449200536|FG001|Period 1|Adverse Event|0|||
124884394|NCT02406261|449200535|FG000|Period 2|Physician Decision|0|||
124884395|NCT02406261|449200536|FG001|Period 2|Physician Decision|1|||
124884396|NCT02406261|449200535|FG000|Period 2|Protocol Violation|0|||
124884397|NCT02406261|449200536|FG001|Period 2|Protocol Violation|1|||
124884398|NCT02406261|449200535|FG000|Period 2|Withdrawal by Subject|0|||
124884399|NCT02406261|449200536|FG001|Period 2|Withdrawal by Subject|1|||
124884400|NCT02222896|449200539|FG000|Abdomen|Did not qualify|34|||
124884401|NCT02222896|449200540|FG001|Abdomen|Did not qualify|10|||
124884402|NCT02222896|449200541|FG002|Abdomen|Did not qualify|32|||
124884403|NCT02222896|449200539|FG000|Groin|Did not qualify|43|||
124884404|NCT02222896|449200540|FG001|Groin|Did not qualify|9|||
124884405|NCT02222896|449200541|FG002|Groin|Did not qualify|40|||
124884406|NCT02441946|449200542|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
124884407|NCT02441946|449200543|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
124884408|NCT02441946|449200544|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
124884409|NCT02441946|449200542|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
124884410|NCT02441946|449200543|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
124884411|NCT02441946|449200544|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
124884412|NCT02441946|449200542|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
124884413|NCT02441946|449200543|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
124884414|NCT02441946|449200544|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
124884415|NCT02441946|449200542|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
124884416|NCT02441946|449200543|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
124884417|NCT02441946|449200544|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
124884418|NCT02441946|449200542|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
124884419|NCT02441946|449200543|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
125015121|NCT03703102|449680627|FG004|Overall Study|Adverse Event|13|||
125015122|NCT03703102|449680623|FG000|Overall Study|Lack of Efficacy|4|||
125015123|NCT03703102|449680624|FG001|Overall Study|Lack of Efficacy|0|||
125015124|NCT03703102|449680625|FG002|Overall Study|Lack of Efficacy|1|||
125015125|NCT03703102|449680626|FG003|Overall Study|Lack of Efficacy|4|||
125015126|NCT03703102|449680627|FG004|Overall Study|Lack of Efficacy|1|||
125015127|NCT03703102|449680623|FG000|Overall Study|Lost to Follow-up|0|||
125015128|NCT03703102|449680624|FG001|Overall Study|Lost to Follow-up|0|||
125015129|NCT03703102|449680625|FG002|Overall Study|Lost to Follow-up|1|||
125015130|NCT03703102|449680626|FG003|Overall Study|Lost to Follow-up|2|||
125015131|NCT03703102|449680627|FG004|Overall Study|Lost to Follow-up|2|||
125015132|NCT03703102|449680623|FG000|Overall Study|Physician Decision|2|||
125015133|NCT03703102|449680624|FG001|Overall Study|Physician Decision|2|||
125015134|NCT03703102|449680625|FG002|Overall Study|Physician Decision|2|||
125015135|NCT03703102|449680626|FG003|Overall Study|Physician Decision|2|||
125015136|NCT03703102|449680627|FG004|Overall Study|Physician Decision|4|||
125015137|NCT03703102|449680623|FG000|Overall Study|Withdrawal by Subject|7|||
125015138|NCT03703102|449680624|FG001|Overall Study|Withdrawal by Subject|5|||
125015139|NCT03703102|449680625|FG002|Overall Study|Withdrawal by Subject|5|||
125015140|NCT03703102|449680626|FG003|Overall Study|Withdrawal by Subject|5|||
125015141|NCT03703102|449680627|FG004|Overall Study|Withdrawal by Subject|9|||
125015142|NCT03703102|449680623|FG000|Overall Study|Ineligibility|0|||
125015143|NCT03703102|449680624|FG001|Overall Study|Ineligibility|0|||
125015144|NCT03703102|449680625|FG002|Overall Study|Ineligibility|1|||
125015145|NCT03703102|449680626|FG003|Overall Study|Ineligibility|0|||
125015146|NCT03703102|449680627|FG004|Overall Study|Ineligibility|0|||
125015147|NCT03703102|449680623|FG000|Overall Study|Protocol Deviation|4|||
125015148|NCT03703102|449680624|FG001|Overall Study|Protocol Deviation|4|||
125015149|NCT03703102|449680625|FG002|Overall Study|Protocol Deviation|3|||
125015150|NCT03703102|449680626|FG003|Overall Study|Protocol Deviation|0|||
125015151|NCT03703102|449680627|FG004|Overall Study|Protocol Deviation|0|||
125015152|NCT03703102|449680623|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125015153|NCT03703102|449680624|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125015154|NCT03703102|449680625|FG002|Overall Study|Non-Compliance with Study Drug|2|||
125015155|NCT03703102|449680626|FG003|Overall Study|Non-Compliance with Study Drug|1|||
125015156|NCT03703102|449680627|FG004|Overall Study|Non-Compliance with Study Drug|4|||
125015157|NCT02311153|449680628|FG000|Overall Study|Lost to Follow-up|5|||
125015158|NCT02311153|449680629|FG001|Overall Study|Lost to Follow-up|7|||
124884420|NCT02441946|449200544|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
124884421|NCT02441946|449200542|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
124884422|NCT02441946|449200543|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
124884423|NCT02441946|449200544|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
124884424|NCT02441946|449200542|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
124884425|NCT02441946|449200543|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
124884426|NCT02441946|449200544|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
124884427|NCT02441946|449200542|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
124884428|NCT02441946|449200543|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
124884429|NCT02441946|449200544|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
124884430|NCT02441946|449200542|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
124884431|NCT02441946|449200543|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
124884432|NCT02441946|449200544|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
124884433|NCT02441946|449200542|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
124884434|NCT02441946|449200543|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
124884435|NCT02441946|449200544|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
124884436|NCT02441946|449200542|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
124884437|NCT02441946|449200543|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
124884438|NCT02441946|449200544|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
124884439|NCT02111213|449200545|FG000|Overall Study|Withdrawal by Subject|3|||
124884440|NCT02111213|449200546|FG001|Overall Study|Withdrawal by Subject|2|||
124884441|NCT02111213|449200545|FG000|Overall Study|Lost to Follow-up|3|||
124884442|NCT02111213|449200546|FG001|Overall Study|Lost to Follow-up|4|||
124884443|NCT02226172|449200553|FG000|Overall Study|Participant refused further follow-up|4|||
124884444|NCT02226172|449200553|FG000|Overall Study|Other|5|||
124884445|NCT02226172|449200553|FG000|Overall Study|Death|1|||
124884446|NCT02226172|449200553|FG000|Overall Study|Study terminated by sponsor|1|||
124884447|NCT02226172|449200553|FG000|Overall Study|Adverse Event|6|||
124884448|NCT01865617|449200554|FG000|Overall Study|Death|27|||
124884449|NCT01865617|449200555|FG001|Overall Study|Death|3|||
124884450|NCT01865617|449200556|FG002|Overall Study|Death|1|||
124884451|NCT01865617|449200557|FG003|Overall Study|Death|1|||
124884452|NCT01865617|449200558|FG004|Overall Study|Death|5|||
124884453|NCT01865617|449200559|FG005|Overall Study|Death|1|||
124884454|NCT01865617|449200560|FG006|Overall Study|Death|11|||
124884455|NCT01865617|449200561|FG007|Overall Study|Death|1|||
124884456|NCT01865617|449200562|FG008|Overall Study|Death|11|||
124884457|NCT01865617|449200563|FG009|Overall Study|Death|3|||
124884458|NCT01865617|449200564|FG010|Overall Study|Death|32|||
124884459|NCT01865617|449200565|FG011|Overall Study|Death|6|||
124884460|NCT01865617|449200566|FG012|Overall Study|Death|13|||
124884461|NCT01865617|449200554|FG000|Overall Study|Lost to Follow-up|2|||
124884462|NCT01865617|449200555|FG001|Overall Study|Lost to Follow-up|0|||
124884463|NCT01865617|449200556|FG002|Overall Study|Lost to Follow-up|0|||
124884464|NCT01865617|449200557|FG003|Overall Study|Lost to Follow-up|0|||
124884465|NCT01865617|449200558|FG004|Overall Study|Lost to Follow-up|0|||
124884466|NCT01865617|449200559|FG005|Overall Study|Lost to Follow-up|0|||
124884467|NCT01865617|449200560|FG006|Overall Study|Lost to Follow-up|0|||
124884468|NCT01865617|449200561|FG007|Overall Study|Lost to Follow-up|0|||
124884469|NCT01865617|449200562|FG008|Overall Study|Lost to Follow-up|0|||
124884470|NCT01865617|449200563|FG009|Overall Study|Lost to Follow-up|0|||
124884471|NCT01865617|449200564|FG010|Overall Study|Lost to Follow-up|0|||
124884472|NCT01865617|449200565|FG011|Overall Study|Lost to Follow-up|0|||
124884473|NCT01865617|449200566|FG012|Overall Study|Lost to Follow-up|0|||
124884474|NCT01865617|449200554|FG000|Overall Study|Withdrawal by Subject|1|||
124884475|NCT01865617|449200555|FG001|Overall Study|Withdrawal by Subject|0|||
124884476|NCT01865617|449200556|FG002|Overall Study|Withdrawal by Subject|0|||
124884477|NCT01865617|449200557|FG003|Overall Study|Withdrawal by Subject|0|||
124884478|NCT01865617|449200558|FG004|Overall Study|Withdrawal by Subject|0|||
124884479|NCT01865617|449200559|FG005|Overall Study|Withdrawal by Subject|0|||
124884480|NCT01865617|449200560|FG006|Overall Study|Withdrawal by Subject|0|||
124884481|NCT01865617|449200561|FG007|Overall Study|Withdrawal by Subject|0|||
124884482|NCT01865617|449200562|FG008|Overall Study|Withdrawal by Subject|0|||
124884483|NCT01865617|449200563|FG009|Overall Study|Withdrawal by Subject|0|||
124884484|NCT01865617|449200564|FG010|Overall Study|Withdrawal by Subject|0|||
124884485|NCT01865617|449200565|FG011|Overall Study|Withdrawal by Subject|0|||
124884486|NCT01865617|449200566|FG012|Overall Study|Withdrawal by Subject|0|||
124884487|NCT01865617|449200554|FG000|Overall Study|Patient proceeded to new therapy|0|||
124884488|NCT01865617|449200555|FG001|Overall Study|Patient proceeded to new therapy|0|||
124884489|NCT01865617|449200556|FG002|Overall Study|Patient proceeded to new therapy|0|||
124884490|NCT01865617|449200557|FG003|Overall Study|Patient proceeded to new therapy|0|||
124884491|NCT01865617|449200558|FG004|Overall Study|Patient proceeded to new therapy|2|||
124884492|NCT01865617|449200559|FG005|Overall Study|Patient proceeded to new therapy|0|||
124884493|NCT01865617|449200560|FG006|Overall Study|Patient proceeded to new therapy|0|||
124884494|NCT01865617|449200561|FG007|Overall Study|Patient proceeded to new therapy|0|||
124884495|NCT01865617|449200562|FG008|Overall Study|Patient proceeded to new therapy|0|||
124884496|NCT01865617|449200563|FG009|Overall Study|Patient proceeded to new therapy|0|||
124884497|NCT01865617|449200564|FG010|Overall Study|Patient proceeded to new therapy|0|||
124884498|NCT01865617|449200565|FG011|Overall Study|Patient proceeded to new therapy|0|||
124884499|NCT01865617|449200566|FG012|Overall Study|Patient proceeded to new therapy|0|||
124884500|NCT01865617|449200554|FG000|Overall Study|Other|0|||
124884501|NCT01865617|449200555|FG001|Overall Study|Other|0|||
124884502|NCT01865617|449200556|FG002|Overall Study|Other|0|||
124884503|NCT01865617|449200557|FG003|Overall Study|Other|0|||
124884504|NCT01865617|449200558|FG004|Overall Study|Other|0|||
124884505|NCT01865617|449200559|FG005|Overall Study|Other|0|||
124884506|NCT01865617|449200560|FG006|Overall Study|Other|1|||
124884507|NCT01865617|449200561|FG007|Overall Study|Other|0|||
124884508|NCT01865617|449200562|FG008|Overall Study|Other|0|||
124884509|NCT01865617|449200563|FG009|Overall Study|Other|0|||
124884510|NCT01865617|449200564|FG010|Overall Study|Other|0|||
124884511|NCT01865617|449200565|FG011|Overall Study|Other|0|||
124884512|NCT01865617|449200566|FG012|Overall Study|Other|0|||
124884513|NCT00258440|449200571|FG000|Overall Study|Withdrawal by Subject|0|||
124884514|NCT00258440|449200572|FG001|Overall Study|Withdrawal by Subject|0|||
124884515|NCT00258440|449200573|FG002|Overall Study|Withdrawal by Subject|1|||
124884516|NCT00737061|449200574|FG000|Waiting Period|Lost to Follow-up|6|||
124884517|NCT00737061|449200574|FG000|Waiting Period|Withdrawal by Subject|1|||
124884518|NCT00737061|449200574|FG000|Waiting Period|Bilateral placement failure|34|||
124884519|NCT00737061|449200574|FG000|Waiting Period|Deemed patent following HSG|26|||
124884520|NCT00737061|449200574|FG000|Waiting Period|Alternative contraception failure|3|||
124884521|NCT00737061|449200574|FG000|Waiting Period|Elected surgical tubal ligation|5|||
124884522|NCT00737061|449200574|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
124884523|NCT00737061|449200574|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
124884524|NCT00737061|449200574|FG000|1 Year Wearing Period|Discontinued reilance|3|||
124884525|NCT00737061|449200574|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
124884526|NCT00439179|449200575|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
124884527|NCT00439179|449200576|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
124884528|NCT00439179|449200577|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
124884529|NCT00439179|449200578|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
124884530|NCT01844115|449200579|FG000|Overall Study|Adverse Event|4|||
124884531|NCT01844115|449200580|FG001|Overall Study|Adverse Event|22|||
124884532|NCT01844115|449200579|FG000|Overall Study|Lack of Efficacy|1|||
124884533|NCT01844115|449200580|FG001|Overall Study|Lack of Efficacy|4|||
124884534|NCT01844115|449200579|FG000|Overall Study|Protocol Violation|12|||
124884535|NCT01844115|449200580|FG001|Overall Study|Protocol Violation|10|||
124884536|NCT01844115|449200579|FG000|Overall Study|Withdrawal by Subject|11|||
124884537|NCT01844115|449200580|FG001|Overall Study|Withdrawal by Subject|11|||
124884538|NCT01844115|449200579|FG000|Overall Study|Lost to Follow-up|11|||
124884539|NCT01844115|449200580|FG001|Overall Study|Lost to Follow-up|10|||
124884540|NCT01844115|449200579|FG000|Overall Study|Pregnancy|0|||
124884541|NCT01844115|449200580|FG001|Overall Study|Pregnancy|1|||
124884542|NCT00758160|449200581|FG000|Overall Study|No Longer Requires Study Medication|4|||
124884543|NCT00758160|449200581|FG000|Overall Study|Administration Problems|3|||
124884544|NCT00758160|449200581|FG000|Overall Study|Adverse Event|15|||
124884545|NCT00758160|449200581|FG000|Overall Study|Lack of Efficacy|10|||
124884546|NCT00758160|449200581|FG000|Overall Study|Lost to Follow-up|14|||
124884547|NCT00758160|449200581|FG000|Overall Study|Protocol Violation|12|||
124884548|NCT00758160|449200581|FG000|Overall Study|Withdrawal by Subject|8|||
124884549|NCT00993317|449200582|FG000|Overall Study|Adverse Event|2|||
124884550|NCT00993317|449200583|FG001|Overall Study|Adverse Event|4|||
124884551|NCT00993317|449200582|FG000|Overall Study|Lack of Efficacy|18|||
124884552|NCT00993317|449200583|FG001|Overall Study|Lack of Efficacy|18|||
124884553|NCT00993317|449200582|FG000|Overall Study|Withdrawal by Subject|0|||
124884554|NCT00993317|449200583|FG001|Overall Study|Withdrawal by Subject|2|||
125015159|NCT01379274|449680630|FG000|Overall Study|funding withdrawn|1|||
125015160|NCT00405067|449680635|FG000|Overall Study|Adverse Event|4|||
125015161|NCT00405067|449680636|FG001|Overall Study|Adverse Event|9|||
125015162|NCT00405067|449680637|FG002|Overall Study|Adverse Event|4|||
124884555|NCT00993317|449200582|FG000|Overall Study|Investigator's opinion|0|||
124884556|NCT00993317|449200583|FG001|Overall Study|Investigator's opinion|1|||
124884557|NCT00993317|449200582|FG000|Overall Study|Early study termination at the site|1|||
124884558|NCT00993317|449200583|FG001|Overall Study|Early study termination at the site|0|||
124884559|NCT02153359|449200584|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
124884560|NCT02153359|449200585|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
124884561|NCT04422639|449200586|FG000|Overall Study|Death|1|||
124884562|NCT04422639|449200587|FG001|Overall Study|Death|0|||
124884563|NCT04422639|449200586|FG000|Overall Study|study closed prior to completion of FU visits|0|||
124884564|NCT04422639|449200587|FG001|Overall Study|study closed prior to completion of FU visits|2|||
125015163|NCT00405067|449680635|FG000|Overall Study|Lost to Follow-up|0|||
125015164|NCT00405067|449680636|FG001|Overall Study|Lost to Follow-up|0|||
124884565|NCT01964521|449200588|FG000|Overall Study|Lost to Follow-up|4|||
124884566|NCT01372605|449200589|FG000|Overall Study|Death|1|||
124884567|NCT01372605|449200590|FG001|Overall Study|Death|2|||
124884568|NCT01372605|449200589|FG000|Overall Study|Lost to Follow-up|2|||
124884569|NCT01372605|449200590|FG001|Overall Study|Lost to Follow-up|1|||
124884570|NCT01372605|449200589|FG000|Overall Study|Withdrawal by Subject|4|||
124884571|NCT01372605|449200590|FG001|Overall Study|Withdrawal by Subject|7|||
124884572|NCT01372605|449200589|FG000|Overall Study|Moved|3|||
124884573|NCT01372605|449200590|FG001|Overall Study|Moved|0|||
124884574|NCT01372605|449200589|FG000|Overall Study|Changed medical home|2|||
124884575|NCT01372605|449200590|FG001|Overall Study|Changed medical home|0|||
124884576|NCT01108510|449200591|FG000|Overall Study|Randomized but Not Treated|5|||
124884577|NCT01108510|449200592|FG001|Overall Study|Randomized but Not Treated|1|||
124884578|NCT01108510|449200591|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
124884579|NCT01108510|449200592|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
124884580|NCT01108510|449200591|FG000|Overall Study|Adverse Event|26|||
124884581|NCT01108510|449200592|FG001|Overall Study|Adverse Event|19|||
124884582|NCT01108510|449200591|FG000|Overall Study|Lost to Follow-up|20|||
124884583|NCT01108510|449200592|FG001|Overall Study|Lost to Follow-up|17|||
124884584|NCT01108510|449200591|FG000|Overall Study|Withdrew Consent|21|||
124884585|NCT01108510|449200592|FG001|Overall Study|Withdrew Consent|15|||
124884586|NCT01108510|449200591|FG000|Overall Study|Investigator's Discretion|12|||
124884587|NCT01108510|449200592|FG001|Overall Study|Investigator's Discretion|10|||
124884588|NCT01108510|449200591|FG000|Overall Study|Participant Noncompliance|5|||
124884589|NCT01108510|449200592|FG001|Overall Study|Participant Noncompliance|7|||
124884590|NCT01108510|449200591|FG000|Overall Study|Lack of Efficacy|3|||
124884591|NCT01108510|449200592|FG001|Overall Study|Lack of Efficacy|0|||
124884592|NCT01108510|449200591|FG000|Overall Study|Pregnancy|0|||
124884593|NCT01108510|449200592|FG001|Overall Study|Pregnancy|3|||
124884594|NCT01108510|449200591|FG000|Overall Study|Death|1|||
124884595|NCT01108510|449200592|FG001|Overall Study|Death|1|||
124884596|NCT02796963|449200593|FG000|Overall Study|Lost to Follow-up|89|||
124884597|NCT02796963|449200594|FG001|Overall Study|Lost to Follow-up|76|||
124884598|NCT02796963|449200595|FG002|Overall Study|Lost to Follow-up|69|||
124884599|NCT02796963|449200596|FG003|Overall Study|Lost to Follow-up|72|||
124884600|NCT01258660|449200597|FG000|Overall Study|Adverse Event|2|||
124884601|NCT01258660|449200598|FG001|Overall Study|Adverse Event|4|||
124884602|NCT01258660|449200597|FG000|Overall Study|Withdrawal by Subject|3|||
124884603|NCT01258660|449200598|FG001|Overall Study|Withdrawal by Subject|0|||
124884604|NCT01258660|449200597|FG000|Overall Study|due to relocation|2|||
124884605|NCT01258660|449200598|FG001|Overall Study|due to relocation|0|||
124884606|NCT01258660|449200597|FG000|Overall Study|Protocol Violation|0|||
124884607|NCT01258660|449200598|FG001|Overall Study|Protocol Violation|1|||
124884608|NCT01258660|449200597|FG000|Overall Study|Invalid for primary analysis data set|4|||
124884609|NCT01258660|449200598|FG001|Overall Study|Invalid for primary analysis data set|6|||
125015165|NCT00405067|449680637|FG002|Overall Study|Lost to Follow-up|1|||
125015166|NCT01650636|449680638|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
125015167|NCT01650636|449680639|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
125015168|NCT01650636|449680638|FG000|Washout up to 5 Months|Physician Decision|2|||
125015169|NCT01650636|449680639|FG001|Washout up to 5 Months|Physician Decision|2|||
125015170|NCT01650636|449680638|FG000|Washout up to 5 Months|Death|1|||
125015171|NCT01650636|449680639|FG001|Washout up to 5 Months|Death|0|||
125015172|NCT01650636|449680638|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
125015173|NCT01650636|449680639|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
125015174|NCT01650636|449680638|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
125015175|NCT01650636|449680639|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
125015176|NCT01650636|449680638|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
125015177|NCT01650636|449680639|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
125015178|NCT01560780|449680641|FG000|Overall Study|Death|2|||
125015179|NCT01560780|449680642|FG001|Overall Study|Death|1|||
125015180|NCT01560780|449680641|FG000|Overall Study|Patient Preference|11|||
125015181|NCT01560780|449680642|FG001|Overall Study|Patient Preference|11|||
125015182|NCT03363321|449680643|FG000|Overall Study|Withdrawal by Subject|0|||
125015183|NCT03363321|449680644|FG001|Overall Study|Withdrawal by Subject|1|||
125015184|NCT03363321|449680645|FG002|Overall Study|Withdrawal by Subject|0|||
125015185|NCT03363321|449680646|FG003|Overall Study|Withdrawal by Subject|1|||
125015186|NCT03363321|449680647|FG004|Overall Study|Withdrawal by Subject|0|||
125015187|NCT01577186|449680648|FG000|Overall Study|Adverse Event|23|||
124884610|NCT01775930|449200606|FG000|Overall Study|Futility stopping boundary met|1|||
124884611|NCT00363896|449200608|FG000|Overall Study|Withdrawal by Subject|29|||
125015188|NCT01577186|449680648|FG000|Overall Study|Death|1|||
124884612|NCT00363896|449200609|FG001|Overall Study|Withdrawal by Subject|16|||
125015189|NCT01577186|449680648|FG000|Overall Study|Lost to Follow-up|28|||
125015190|NCT01577186|449680648|FG000|Overall Study|Withdrawal by Subject|35|||
125015191|NCT01577186|449680648|FG000|Overall Study|Insufficient Response|18|||
124884613|NCT00363896|449200608|FG000|Overall Study|Adverse Event|24|||
124884614|NCT00363896|449200609|FG001|Overall Study|Adverse Event|13|||
124884615|NCT00363896|449200608|FG000|Overall Study|COPD exacerbation|13|||
124884616|NCT00363896|449200609|FG001|Overall Study|COPD exacerbation|7|||
125015192|NCT01577186|449680648|FG000|Overall Study|Ineligible to Continue|15|||
125015193|NCT01577186|449680648|FG000|Overall Study|Non-Compliant|8|||
125015194|NCT01577186|449680648|FG000|Overall Study|Other|2|||
125015195|NCT00957008|449680652|FG000|Overall Study|Withdrawal by Subject|13|||
125015196|NCT00957008|449680653|FG001|Overall Study|Withdrawal by Subject|10|||
125015197|NCT00957008|449680654|FG002|Overall Study|Withdrawal by Subject|12|||
125015198|NCT00957008|449680655|FG003|Overall Study|Withdrawal by Subject|16|||
125015199|NCT00957008|449680652|FG000|Overall Study|Lost to Follow-up|3|||
124884617|NCT00363896|449200608|FG000|Overall Study|Lack of Efficacy|12|||
124884618|NCT00363896|449200609|FG001|Overall Study|Lack of Efficacy|8|||
124884619|NCT00363896|449200608|FG000|Overall Study|Protocol Violation|6|||
124884620|NCT00363896|449200609|FG001|Overall Study|Protocol Violation|1|||
124884621|NCT00363896|449200608|FG000|Overall Study|Lost to Follow-up|3|||
124884622|NCT00363896|449200609|FG001|Overall Study|Lost to Follow-up|0|||
124884623|NCT00363896|449200608|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
124884624|NCT00363896|449200609|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
124884625|NCT00363896|449200608|FG000|Overall Study|Other|1|||
124884626|NCT00363896|449200609|FG001|Overall Study|Other|2|||
124884627|NCT00924469|449200615|FG000|Overall Study|Adverse Event|2|||
124884628|NCT00924469|449200616|FG001|Overall Study|Adverse Event|0|||
124884629|NCT00924469|449200615|FG000|Overall Study|Withdrawal by Subject|0|||
124884630|NCT00924469|449200616|FG001|Overall Study|Withdrawal by Subject|1|||
124884631|NCT00924469|449200615|FG000|Overall Study|Lost to Follow-up|0|||
124884632|NCT00924469|449200616|FG001|Overall Study|Lost to Follow-up|1|||
124884633|NCT03044353|449200617|FG000|Overall Study|Adverse Event|0|||
124884634|NCT03044353|449200618|FG001|Overall Study|Adverse Event|1|||
124884635|NCT03044353|449200619|FG002|Overall Study|Adverse Event|0|||
124884636|NCT01464255|449200631|FG000|Overall Study|unresolve corneal staining|0|||
124884637|NCT01464255|449200632|FG001|Overall Study|unresolve corneal staining|1|||
124884638|NCT03051659|449200633|FG000|Treatment Period|Withdrawal by Subject|0|||
124884639|NCT03051659|449200634|FG001|Treatment Period|Withdrawal by Subject|2|||
124884640|NCT03051659|449200633|FG000|Survival Follow-up|Lost to Follow-up|23|||
124884641|NCT03051659|449200634|FG001|Survival Follow-up|Lost to Follow-up|22|||
124884642|NCT00786474|449200635|FG000|Overall Study|Death|5|||
124884643|NCT00786474|449200636|FG001|Overall Study|Death|4|||
124884644|NCT00786474|449200635|FG000|Overall Study|Withdrawal by Subject|23|||
124884645|NCT00786474|449200636|FG001|Overall Study|Withdrawal by Subject|31|||
124884646|NCT00786474|449200635|FG000|Overall Study|Lost to Follow-up|3|||
124884647|NCT00786474|449200636|FG001|Overall Study|Lost to Follow-up|3|||
124884648|NCT00786474|449200635|FG000|Overall Study|Physician Decision|2|||
124884649|NCT00786474|449200636|FG001|Overall Study|Physician Decision|1|||
124884650|NCT00786474|449200635|FG000|Overall Study|Other|4|||
124884651|NCT00786474|449200636|FG001|Overall Study|Other|4|||
124884652|NCT02733042|449200637|FG000|Overall Study|Adverse Event|1|||
124884653|NCT02733042|449200638|FG001|Overall Study|Adverse Event|0|||
124884654|NCT02733042|449200639|FG002|Overall Study|Adverse Event|1|||
124884655|NCT02733042|449200640|FG003|Overall Study|Adverse Event|1|||
124884656|NCT02733042|449200641|FG004|Overall Study|Adverse Event|0|||
124884657|NCT02733042|449200642|FG005|Overall Study|Adverse Event|0|||
124884658|NCT02733042|449200643|FG006|Overall Study|Adverse Event|0|||
124884659|NCT02733042|449200644|FG007|Overall Study|Adverse Event|0|||
124884660|NCT02733042|449200645|FG008|Overall Study|Adverse Event|0|||
124884661|NCT02733042|449200646|FG009|Overall Study|Adverse Event|0|||
124884662|NCT02733042|449200647|FG010|Overall Study|Adverse Event|2|||
124884663|NCT02733042|449200648|FG011|Overall Study|Adverse Event|2|||
124884664|NCT02733042|449200649|FG012|Overall Study|Adverse Event|0|||
124884665|NCT02733042|449200650|FG013|Overall Study|Adverse Event|2|||
124884666|NCT02733042|449200651|FG014|Overall Study|Adverse Event|0|||
124884667|NCT02733042|449200652|FG015|Overall Study|Adverse Event|0|||
124884668|NCT02733042|449200653|FG016|Overall Study|Adverse Event|0|||
124884669|NCT02733042|449200654|FG017|Overall Study|Adverse Event|1|||
124884670|NCT02733042|449200655|FG018|Overall Study|Adverse Event|0|||
124884671|NCT02733042|449200637|FG000|Overall Study|Progressive Disease|2|||
124884672|NCT02733042|449200638|FG001|Overall Study|Progressive Disease|1|||
124884673|NCT02733042|449200639|FG002|Overall Study|Progressive Disease|3|||
124884674|NCT02733042|449200640|FG003|Overall Study|Progressive Disease|1|||
124884675|NCT02733042|449200641|FG004|Overall Study|Progressive Disease|2|||
124884676|NCT02733042|449200642|FG005|Overall Study|Progressive Disease|3|||
124884677|NCT02733042|449200643|FG006|Overall Study|Progressive Disease|0|||
124884678|NCT02733042|449200644|FG007|Overall Study|Progressive Disease|3|||
124884679|NCT02733042|449200645|FG008|Overall Study|Progressive Disease|3|||
124884680|NCT02733042|449200646|FG009|Overall Study|Progressive Disease|2|||
124884681|NCT02733042|449200647|FG010|Overall Study|Progressive Disease|2|||
124884682|NCT02733042|449200648|FG011|Overall Study|Progressive Disease|2|||
124884683|NCT02733042|449200649|FG012|Overall Study|Progressive Disease|8|||
124884684|NCT02733042|449200650|FG013|Overall Study|Progressive Disease|1|||
124884685|NCT02733042|449200651|FG014|Overall Study|Progressive Disease|4|||
124884686|NCT02733042|449200652|FG015|Overall Study|Progressive Disease|7|||
124884687|NCT02733042|449200653|FG016|Overall Study|Progressive Disease|2|||
124884688|NCT02733042|449200654|FG017|Overall Study|Progressive Disease|3|||
124884689|NCT02733042|449200655|FG018|Overall Study|Progressive Disease|4|||
124884690|NCT02733042|449200637|FG000|Overall Study|Withdrawal by Subject|0|||
124884691|NCT02733042|449200638|FG001|Overall Study|Withdrawal by Subject|1|||
124884692|NCT02733042|449200639|FG002|Overall Study|Withdrawal by Subject|2|||
124884693|NCT02733042|449200640|FG003|Overall Study|Withdrawal by Subject|1|||
125015200|NCT00957008|449680653|FG001|Overall Study|Lost to Follow-up|1|||
125015201|NCT00957008|449680654|FG002|Overall Study|Lost to Follow-up|3|||
125015202|NCT00957008|449680655|FG003|Overall Study|Lost to Follow-up|4|||
125015203|NCT00957008|449680652|FG000|Overall Study|Physician Decision|1|||
125015204|NCT00957008|449680653|FG001|Overall Study|Physician Decision|0|||
125015205|NCT00957008|449680654|FG002|Overall Study|Physician Decision|1|||
124884694|NCT02733042|449200641|FG004|Overall Study|Withdrawal by Subject|1|||
125015206|NCT00957008|449680655|FG003|Overall Study|Physician Decision|1|||
125015207|NCT00957008|449680652|FG000|Overall Study|Relocated; Family conflict|4|||
125015208|NCT00957008|449680653|FG001|Overall Study|Relocated; Family conflict|1|||
125015209|NCT00957008|449680654|FG002|Overall Study|Relocated; Family conflict|1|||
124884695|NCT02733042|449200642|FG005|Overall Study|Withdrawal by Subject|0|||
124884696|NCT02733042|449200643|FG006|Overall Study|Withdrawal by Subject|0|||
124884697|NCT02733042|449200644|FG007|Overall Study|Withdrawal by Subject|0|||
124884698|NCT02733042|449200645|FG008|Overall Study|Withdrawal by Subject|1|||
124884699|NCT02733042|449200646|FG009|Overall Study|Withdrawal by Subject|1|||
124884700|NCT02733042|449200647|FG010|Overall Study|Withdrawal by Subject|0|||
124884701|NCT02733042|449200648|FG011|Overall Study|Withdrawal by Subject|2|||
124884702|NCT02733042|449200649|FG012|Overall Study|Withdrawal by Subject|1|||
124884703|NCT02733042|449200650|FG013|Overall Study|Withdrawal by Subject|1|||
124884704|NCT02733042|449200651|FG014|Overall Study|Withdrawal by Subject|0|||
124884705|NCT02733042|449200652|FG015|Overall Study|Withdrawal by Subject|0|||
124884706|NCT02733042|449200653|FG016|Overall Study|Withdrawal by Subject|0|||
124884707|NCT02733042|449200654|FG017|Overall Study|Withdrawal by Subject|0|||
124884708|NCT02733042|449200655|FG018|Overall Study|Withdrawal by Subject|0|||
124884709|NCT02733042|449200637|FG000|Overall Study|Other Reasons|0|||
124884710|NCT02733042|449200638|FG001|Overall Study|Other Reasons|0|||
124884711|NCT02733042|449200639|FG002|Overall Study|Other Reasons|1|||
124884712|NCT02733042|449200640|FG003|Overall Study|Other Reasons|0|||
124884713|NCT02733042|449200641|FG004|Overall Study|Other Reasons|0|||
124884714|NCT02733042|449200642|FG005|Overall Study|Other Reasons|0|||
124884715|NCT02733042|449200643|FG006|Overall Study|Other Reasons|0|||
124884716|NCT02733042|449200644|FG007|Overall Study|Other Reasons|0|||
124884717|NCT02733042|449200645|FG008|Overall Study|Other Reasons|0|||
124884718|NCT02733042|449200646|FG009|Overall Study|Other Reasons|1|||
124884719|NCT02733042|449200647|FG010|Overall Study|Other Reasons|1|||
124884720|NCT02733042|449200648|FG011|Overall Study|Other Reasons|0|||
124884721|NCT02733042|449200649|FG012|Overall Study|Other Reasons|0|||
124884722|NCT02733042|449200650|FG013|Overall Study|Other Reasons|0|||
124884723|NCT02733042|449200651|FG014|Overall Study|Other Reasons|0|||
124884724|NCT02733042|449200652|FG015|Overall Study|Other Reasons|1|||
124884725|NCT02733042|449200653|FG016|Overall Study|Other Reasons|0|||
124884726|NCT02733042|449200654|FG017|Overall Study|Other Reasons|1|||
124884727|NCT02733042|449200655|FG018|Overall Study|Other Reasons|0|||
124884728|NCT02733042|449200637|FG000|Overall Study|Death|0|||
124884729|NCT02733042|449200638|FG001|Overall Study|Death|0|||
124884730|NCT02733042|449200639|FG002|Overall Study|Death|0|||
124884731|NCT02733042|449200640|FG003|Overall Study|Death|0|||
124884732|NCT02733042|449200641|FG004|Overall Study|Death|0|||
124884733|NCT02733042|449200642|FG005|Overall Study|Death|0|||
124884734|NCT02733042|449200643|FG006|Overall Study|Death|1|||
124884735|NCT02733042|449200644|FG007|Overall Study|Death|0|||
124884736|NCT02733042|449200645|FG008|Overall Study|Death|1|||
124884737|NCT02733042|449200646|FG009|Overall Study|Death|0|||
124884738|NCT02733042|449200647|FG010|Overall Study|Death|1|||
124884739|NCT02733042|449200648|FG011|Overall Study|Death|0|||
124884740|NCT02733042|449200649|FG012|Overall Study|Death|0|||
124884741|NCT02733042|449200650|FG013|Overall Study|Death|0|||
124884742|NCT02733042|449200651|FG014|Overall Study|Death|1|||
124884743|NCT02733042|449200652|FG015|Overall Study|Death|2|||
124884744|NCT02733042|449200653|FG016|Overall Study|Death|0|||
124884745|NCT02733042|449200654|FG017|Overall Study|Death|0|||
124884746|NCT02733042|449200655|FG018|Overall Study|Death|0|||
125015210|NCT00957008|449680655|FG003|Overall Study|Relocated; Family conflict|3|||
125015211|NCT00631020|449680656|FG000|Overall Study|Lost to Follow-up|7|||
125015212|NCT00631020|449680656|FG000|Overall Study|Incarcerated|1|||
125015213|NCT03221751|449680660|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
125015214|NCT03221751|449680661|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
125015215|NCT03571646|449680662|FG000|Overall Study|Adverse Event|1|||
125015216|NCT03571646|449680663|FG001|Overall Study|Adverse Event|0|||
125015217|NCT03571646|449680662|FG000|Overall Study|Withdrawal by Subject|1|||
125015218|NCT03571646|449680663|FG001|Overall Study|Withdrawal by Subject|1|||
125015219|NCT03548935|449680664|FG000|Overall Study|Withdrawal by Subject|26|||
125015220|NCT03548935|449680665|FG001|Overall Study|Withdrawal by Subject|17|||
125015221|NCT03548935|449680664|FG000|Overall Study|Lost to Follow-up|39|||
125015222|NCT03548935|449680665|FG001|Overall Study|Lost to Follow-up|28|||
125015223|NCT03548935|449680664|FG000|Overall Study|Death|1|||
125015224|NCT03548935|449680665|FG001|Overall Study|Death|1|||
124884747|NCT00960752|449200656|FG000|Overall Study|Adverse Event|0|||
124884748|NCT00960752|449200657|FG001|Overall Study|Adverse Event|0|||
124884749|NCT00960752|449200658|FG002|Overall Study|Adverse Event|1|||
124884750|NCT00960752|449200656|FG000|Overall Study|Progression|0|||
124884751|NCT00960752|449200657|FG001|Overall Study|Progression|0|||
125015225|NCT00763815|449680666|FG000|Overall Study|Adverse Event|14|||
125015226|NCT00763815|449680667|FG001|Overall Study|Adverse Event|29|||
125015227|NCT00763815|449680666|FG000|Overall Study|Lack of Efficacy|10|||
124884752|NCT00960752|449200658|FG002|Overall Study|Progression|1|||
124884753|NCT02180438|449200664|FG000|Overall Study|Lost to Follow-up|1|||
124884754|NCT00180713|449200667|FG000|Overall Study|Withdrawal by Subject|2|||
124884755|NCT00180713|449200668|FG001|Overall Study|Withdrawal by Subject|0|||
124884756|NCT00180713|449200667|FG000|Overall Study|Adverse Event|3|||
124884757|NCT00180713|449200668|FG001|Overall Study|Adverse Event|3|||
124884758|NCT01091428|449202469|FG000|Phase 1|Progressive Disease|24|||
124884759|NCT01091428|449202470|FG001|Phase 1|Progressive Disease|8|||
124884760|NCT01091428|449202471|FG002|Phase 1|Progressive Disease|0|||
124884761|NCT01091428|449202472|FG003|Phase 1|Progressive Disease|0|||
124884762|NCT01091428|449202469|FG000|Phase 1|Symptomatic Deterioration|3|||
124884763|NCT01091428|449202470|FG001|Phase 1|Symptomatic Deterioration|2|||
124884764|NCT01091428|449202471|FG002|Phase 1|Symptomatic Deterioration|0|||
124884765|NCT01091428|449202472|FG003|Phase 1|Symptomatic Deterioration|0|||
124884766|NCT01091428|449202469|FG000|Phase 1|Adverse Event|2|||
124884767|NCT01091428|449202470|FG001|Phase 1|Adverse Event|0|||
124884768|NCT01091428|449202471|FG002|Phase 1|Adverse Event|0|||
124884769|NCT01091428|449202472|FG003|Phase 1|Adverse Event|0|||
124884770|NCT01091428|449202469|FG000|Phase 1|Withdrawal by Subject|7|||
124884771|NCT01091428|449202470|FG001|Phase 1|Withdrawal by Subject|0|||
124884772|NCT01091428|449202471|FG002|Phase 1|Withdrawal by Subject|0|||
124884773|NCT01091428|449202472|FG003|Phase 1|Withdrawal by Subject|0|||
124884774|NCT01091428|449202469|FG000|Phase 1|Reason not specified|0|||
124884775|NCT01091428|449202470|FG001|Phase 1|Reason not specified|1|||
124884776|NCT01091428|449202471|FG002|Phase 1|Reason not specified|0|||
124884777|NCT01091428|449202472|FG003|Phase 1|Reason not specified|0|||
124884778|NCT01091428|449202469|FG000|Phase 1|Single-Patient IND|2|||
124884779|NCT01091428|449202470|FG001|Phase 1|Single-Patient IND|0|||
124884780|NCT01091428|449202471|FG002|Phase 1|Single-Patient IND|0|||
124884781|NCT01091428|449202472|FG003|Phase 1|Single-Patient IND|0|||
124884782|NCT01091428|449202469|FG000|Phase 2|Progressive Disease|0|||
124884783|NCT01091428|449202470|FG001|Phase 2|Progressive Disease|0|||
124884784|NCT01091428|449202471|FG002|Phase 2|Progressive Disease|44|||
124884785|NCT01091428|449202472|FG003|Phase 2|Progressive Disease|46|||
124884786|NCT01091428|449202469|FG000|Phase 2|Symptomatic Deterioration|0|||
124884787|NCT01091428|449202470|FG001|Phase 2|Symptomatic Deterioration|0|||
124884788|NCT01091428|449202471|FG002|Phase 2|Symptomatic Deterioration|1|||
124884789|NCT01091428|449202472|FG003|Phase 2|Symptomatic Deterioration|6|||
124884790|NCT01091428|449202469|FG000|Phase 2|Adverse Event|0|||
124884791|NCT01091428|449202470|FG001|Phase 2|Adverse Event|0|||
124884792|NCT01091428|449202471|FG002|Phase 2|Adverse Event|12|||
124884793|NCT01091428|449202472|FG003|Phase 2|Adverse Event|5|||
124884794|NCT01091428|449202469|FG000|Phase 2|Withdrawal by Subject|0|||
124884795|NCT01091428|449202470|FG001|Phase 2|Withdrawal by Subject|0|||
124884796|NCT01091428|449202471|FG002|Phase 2|Withdrawal by Subject|9|||
124884797|NCT01091428|449202472|FG003|Phase 2|Withdrawal by Subject|8|||
124884798|NCT01091428|449202469|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
124884799|NCT01091428|449202470|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
124884800|NCT01091428|449202471|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
124884801|NCT01091428|449202472|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
124884802|NCT01091428|449202469|FG000|Phase 2|Reason not specified|0|||
124884803|NCT01091428|449202470|FG001|Phase 2|Reason not specified|0|||
124884804|NCT01091428|449202471|FG002|Phase 2|Reason not specified|4|||
124884805|NCT01091428|449202472|FG003|Phase 2|Reason not specified|3|||
124884806|NCT01091428|449202469|FG000|Phase 2|Physician Decision|0|||
124884807|NCT01091428|449202470|FG001|Phase 2|Physician Decision|0|||
124884808|NCT01091428|449202471|FG002|Phase 2|Physician Decision|2|||
124884809|NCT01091428|449202472|FG003|Phase 2|Physician Decision|0|||
124884810|NCT02531295|449202473|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
124884811|NCT02531295|449202474|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
125015228|NCT00763815|449680667|FG001|Overall Study|Lack of Efficacy|11|||
125015229|NCT00763815|449680666|FG000|Overall Study|Poor Compliance to Protocol|6|||
125015230|NCT00763815|449680667|FG001|Overall Study|Poor Compliance to Protocol|6|||
125015231|NCT00763815|449680666|FG000|Overall Study|Lost to Follow-up|2|||
125015232|NCT00763815|449680667|FG001|Overall Study|Lost to Follow-up|4|||
125015233|NCT00763815|449680666|FG000|Overall Study|Early Termination|1|||
125015234|NCT00763815|449680667|FG001|Overall Study|Early Termination|0|||
125015235|NCT00763815|449680666|FG000|Overall Study|Familial and Personal Reasons|9|||
125015236|NCT00763815|449680667|FG001|Overall Study|Familial and Personal Reasons|16|||
125015237|NCT00763815|449680666|FG000|Overall Study|Physician Decision|1|||
125015238|NCT00763815|449680667|FG001|Overall Study|Physician Decision|0|||
125015239|NCT00763815|449680666|FG000|Overall Study|Withdrawal by Subject|7|||
125015240|NCT00763815|449680667|FG001|Overall Study|Withdrawal by Subject|12|||
125015241|NCT00763815|449680666|FG000|Overall Study|Protocol Violation|2|||
125015242|NCT00763815|449680667|FG001|Overall Study|Protocol Violation|5|||
124884812|NCT02531295|449202475|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
124884813|NCT02531295|449202476|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
124884814|NCT02531295|449202477|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
124884815|NCT02531295|449202478|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
124884816|NCT04424290|449202480|FG000|Overall Study|Not treated|0|||
125015243|NCT00763815|449680666|FG000|Overall Study|Sponsor's Decision|0|||
124884817|NCT04424290|449202481|FG001|Overall Study|Not treated|0|||
124884818|NCT04424290|449202482|FG002|Overall Study|Not treated|1|||
125015244|NCT00763815|449680667|FG001|Overall Study|Sponsor's Decision|1|||
125015245|NCT00283595|449680668|FG000|Overall Study|Withdrawal by Subject|1|||
124884819|NCT04424290|449202483|FG003|Overall Study|Not treated|0|||
124884820|NCT04424290|449202484|FG004|Overall Study|Not treated|1|||
124884821|NCT04424290|449202480|FG000|Overall Study|Adverse Event|0|||
124884822|NCT04424290|449202481|FG001|Overall Study|Adverse Event|0|||
124884823|NCT04424290|449202482|FG002|Overall Study|Adverse Event|0|||
124884824|NCT04424290|449202483|FG003|Overall Study|Adverse Event|2|||
124884825|NCT04424290|449202484|FG004|Overall Study|Adverse Event|0|||
124884826|NCT04424290|449202480|FG000|Overall Study|Withdrawal by Subject|0|||
124884827|NCT04424290|449202481|FG001|Overall Study|Withdrawal by Subject|0|||
124884828|NCT04424290|449202482|FG002|Overall Study|Withdrawal by Subject|0|||
124884829|NCT04424290|449202483|FG003|Overall Study|Withdrawal by Subject|0|||
124884830|NCT04424290|449202484|FG004|Overall Study|Withdrawal by Subject|1|||
124884831|NCT04424290|449202480|FG000|Overall Study|Other than listed|0|||
124884832|NCT04424290|449202481|FG001|Overall Study|Other than listed|0|||
124884833|NCT04424290|449202482|FG002|Overall Study|Other than listed|0|||
124884834|NCT04424290|449202483|FG003|Overall Study|Other than listed|1|||
124884835|NCT04424290|449202484|FG004|Overall Study|Other than listed|0|||
124884836|NCT00806624|449202491|FG000|Overall Study|Adverse Event|2|||
124884837|NCT00806624|449202492|FG001|Overall Study|Adverse Event|8|||
124884838|NCT00806624|449202493|FG002|Overall Study|Adverse Event|0|||
124884839|NCT00806624|449202491|FG000|Overall Study|Death|0|||
124884840|NCT00806624|449202492|FG001|Overall Study|Death|1|||
124884841|NCT00806624|449202493|FG002|Overall Study|Death|1|||
124884842|NCT00806624|449202491|FG000|Overall Study|Lost to Follow-up|1|||
124884843|NCT00806624|449202492|FG001|Overall Study|Lost to Follow-up|0|||
124884844|NCT00806624|449202493|FG002|Overall Study|Lost to Follow-up|1|||
124884845|NCT00806624|449202491|FG000|Overall Study|Withdrawal by Subject|6|||
124884846|NCT00806624|449202492|FG001|Overall Study|Withdrawal by Subject|3|||
124884847|NCT00806624|449202493|FG002|Overall Study|Withdrawal by Subject|3|||
124884848|NCT00806624|449202491|FG000|Overall Study|discontinued before start of treatment|0|||
124884849|NCT00806624|449202492|FG001|Overall Study|discontinued before start of treatment|0|||
124884850|NCT00806624|449202493|FG002|Overall Study|discontinued before start of treatment|1|||
124884851|NCT00467142|449202498|FG000|Overall Study|Withdrawal by Subject|1|||
124884852|NCT00467142|449202498|FG000|Overall Study|Adverse Event|1|||
124884853|NCT00467142|449202498|FG000|Overall Study|Protocol Violation|1|||
124884854|NCT02771210|449202499|FG000|Period 1|Adverse Event|5|||
124884855|NCT02771210|449202500|FG001|Period 1|Adverse Event|3|||
124884856|NCT02771210|449202499|FG000|Period 1|Lack of Efficacy|3|||
124884857|NCT02771210|449202500|FG001|Period 1|Lack of Efficacy|6|||
124884858|NCT02771210|449202499|FG000|Period 1|Lost to Follow-up|2|||
124884859|NCT02771210|449202500|FG001|Period 1|Lost to Follow-up|0|||
124884860|NCT02771210|449202499|FG000|Period 1|Physician Decision|0|||
124884861|NCT02771210|449202500|FG001|Period 1|Physician Decision|1|||
124884862|NCT02771210|449202499|FG000|Period 1|Withdrawal by Subject|0|||
124884863|NCT02771210|449202500|FG001|Period 1|Withdrawal by Subject|3|||
124884864|NCT02771210|449202499|FG000|Period 1|Withdrawal of informed consent|1|||
124884865|NCT02771210|449202500|FG001|Period 1|Withdrawal of informed consent|5|||
124884866|NCT02771210|449202499|FG000|Period 2|Adverse Event|1|||
124884867|NCT02771210|449202500|FG001|Period 2|Adverse Event|0|||
124884868|NCT02771210|449202499|FG000|Period 2|Lack of Efficacy|0|||
124884869|NCT02771210|449202500|FG001|Period 2|Lack of Efficacy|1|||
124884870|NCT02771210|449202499|FG000|Period 2|Withdrawal by Subject|1|||
124884871|NCT02771210|449202500|FG001|Period 2|Withdrawal by Subject|0|||
124884872|NCT02771210|449202499|FG000|Period 2|Withdrawal of informed consent|0|||
124884873|NCT02771210|449202500|FG001|Period 2|Withdrawal of informed consent|2|||
124884874|NCT00684762|449202507|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
124884875|NCT00684762|449202508|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
124884876|NCT02572817|449202509|FG000|Overall Study|Death|6|||
124884877|NCT02572817|449202510|FG001|Overall Study|Death|3|||
124884878|NCT02572817|449202509|FG000|Overall Study|Lost to Follow-up|3|||
124884879|NCT02572817|449202510|FG001|Overall Study|Lost to Follow-up|3|||
124884880|NCT00119262|449202513|FG000|Overall Study|Lack of Efficacy|0|||
124884881|NCT00119262|449202514|FG001|Overall Study|Lack of Efficacy|3|||
124884882|NCT00119262|449202513|FG000|Overall Study|Withdrawal by Subject|12|||
124884883|NCT00119262|449202514|FG001|Overall Study|Withdrawal by Subject|11|||
124884884|NCT00119262|449202513|FG000|Overall Study|Adverse Event|33|||
124884885|NCT00119262|449202514|FG001|Overall Study|Adverse Event|35|||
124884886|NCT00119262|449202513|FG000|Overall Study|other disease|0|||
124884887|NCT00119262|449202514|FG001|Overall Study|other disease|2|||
124884888|NCT00119262|449202513|FG000|Overall Study|ineligble|1|||
124884889|NCT00119262|449202514|FG001|Overall Study|ineligble|2|||
124884890|NCT00119262|449202513|FG000|Overall Study|others|0|||
124884891|NCT00119262|449202514|FG001|Overall Study|others|5|||
124884892|NCT00734214|449202515|FG000|Overall Study|Withdrawal by Subject|3|||
124884893|NCT00734214|449202516|FG001|Overall Study|Withdrawal by Subject|4|||
124884894|NCT00734214|449202515|FG000|Overall Study|MD withdrawal|1|||
124884895|NCT00734214|449202516|FG001|Overall Study|MD withdrawal|0|||
124884896|NCT00630058|449202522|FG000|Overall Study|Adverse Event|1|||
124884897|NCT00630058|449202523|FG001|Overall Study|Adverse Event|1|||
124884898|NCT00630058|449202522|FG000|Overall Study|Withdrawal by Subject|0|||
124884899|NCT00630058|449202523|FG001|Overall Study|Withdrawal by Subject|1|||
124884900|NCT00630058|449202522|FG000|Overall Study|stopping criteria|3|||
124884901|NCT00630058|449202523|FG001|Overall Study|stopping criteria|2|||
124884902|NCT01651936|449202524|FG000|Base Study|Adverse Event|3|||
124884903|NCT01651936|449202525|FG001|Base Study|Adverse Event|0|||
124884904|NCT01651936|449202526|FG002|Base Study|Adverse Event|0|||
124884905|NCT01651936|449202524|FG000|Base Study|Withdrawal by Subject|1|||
124884906|NCT01651936|449202525|FG001|Base Study|Withdrawal by Subject|1|||
124884907|NCT01651936|449202526|FG002|Base Study|Withdrawal by Subject|0|||
124884908|NCT01651936|449202524|FG000|Base Study|Early Escape|2|||
124884909|NCT01651936|449202525|FG001|Base Study|Early Escape|8|||
124884910|NCT01651936|449202526|FG002|Base Study|Early Escape|0|||
124884911|NCT01651936|449202524|FG000|Base Study|Study terminated by sponsor|21|||
124884912|NCT01651936|449202525|FG001|Base Study|Study terminated by sponsor|16|||
124884913|NCT01651936|449202526|FG002|Base Study|Study terminated by sponsor|0|||
124884914|NCT01651936|449202524|FG000|Extension Study|Lack of Efficacy|0|||
124884915|NCT01651936|449202525|FG001|Extension Study|Lack of Efficacy|0|||
124884916|NCT01651936|449202526|FG002|Extension Study|Lack of Efficacy|1|||
124884917|NCT01651936|449202524|FG000|Extension Study|Study terminated by sponsor|0|||
124884918|NCT01651936|449202525|FG001|Extension Study|Study terminated by sponsor|0|||
124884919|NCT01651936|449202526|FG002|Extension Study|Study terminated by sponsor|13|||
124884920|NCT02141659|449202530|FG000|Overall Study|Major Protocol Deviation|0|||
124884921|NCT02141659|449202531|FG001|Overall Study|Major Protocol Deviation|1|||
124884922|NCT02141659|449202532|FG002|Overall Study|Major Protocol Deviation|0|||
124884923|NCT02141659|449202533|FG003|Overall Study|Major Protocol Deviation|0|||
124884924|NCT02141659|449202534|FG004|Overall Study|Major Protocol Deviation|0|||
124884925|NCT02141659|449202535|FG005|Overall Study|Major Protocol Deviation|0|||
124884926|NCT02141659|449202530|FG000|Overall Study|Lack of Efficacy|0|||
124884927|NCT02141659|449202531|FG001|Overall Study|Lack of Efficacy|0|||
124884928|NCT02141659|449202532|FG002|Overall Study|Lack of Efficacy|0|||
124884929|NCT02141659|449202533|FG003|Overall Study|Lack of Efficacy|0|||
124884930|NCT02141659|449202534|FG004|Overall Study|Lack of Efficacy|0|||
124884931|NCT02141659|449202535|FG005|Overall Study|Lack of Efficacy|1|||
124884932|NCT02141659|449202530|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
124884933|NCT02141659|449202531|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
124884934|NCT02141659|449202532|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
124884935|NCT02141659|449202533|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
124884936|NCT02141659|449202534|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
124884937|NCT02141659|449202535|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
124884938|NCT02340520|449202536|FG000|Overall Study|Lost to Follow-up|1|||
124884939|NCT02340520|449202536|FG000|Overall Study|Patient did not take drug as specified|1|||
124884940|NCT02340520|449202536|FG000|Overall Study|Withdrawal by Subject|1|||
124884941|NCT01231503|449202537|FG000|Overall Study|Adverse Event|0|||
124884942|NCT01231503|449202538|FG001|Overall Study|Adverse Event|0|||
124884943|NCT01231503|449202539|FG002|Overall Study|Adverse Event|0|||
124884944|NCT01231503|449202540|FG003|Overall Study|Adverse Event|0|||
124884945|NCT01231503|449202541|FG004|Overall Study|Adverse Event|0|||
124884946|NCT01231503|449202542|FG005|Overall Study|Adverse Event|1|||
124884947|NCT01231503|449202543|FG006|Overall Study|Adverse Event|0|||
124884948|NCT01231503|449202544|FG007|Overall Study|Adverse Event|0|||
125015246|NCT00283595|449680669|FG001|Overall Study|Withdrawal by Subject|2|||
125015247|NCT01263639|449680670|FG000|Overall Study|Lost to Follow-up|66|||
125015248|NCT01263639|449680671|FG001|Overall Study|Lost to Follow-up|70|||
125015249|NCT01263639|449680670|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
124884949|NCT01231503|449202537|FG000|Overall Study|Adverse event, serious fatal|0|||
124884950|NCT01231503|449202538|FG001|Overall Study|Adverse event, serious fatal|0|||
125015250|NCT01263639|449680671|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
125015251|NCT01576549|449680672|FG000|Overall Study|Sponsor Decision|2|||
125015252|NCT04951037|449680673|FG000|Overall Study|Lost to Follow-up|16|||
125015253|NCT04951037|449680673|FG000|Overall Study|Withdrawal by Subject|5|||
125015254|NCT04951037|449680673|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
125015255|NCT05630937|449680674|FG000|Overall Study|Study terminated by sponsor|1|||
125015256|NCT05630937|449680675|FG001|Overall Study|Study terminated by sponsor|1|||
125015257|NCT05630937|449680676|FG002|Overall Study|Study terminated by sponsor|8|||
125015258|NCT05630937|449680677|FG003|Overall Study|Study terminated by sponsor|0|||
125015259|NCT05630937|449680674|FG000|Overall Study|Lost to Follow-up|0|||
124884951|NCT01231503|449202539|FG002|Overall Study|Adverse event, serious fatal|1|||
124884952|NCT01231503|449202540|FG003|Overall Study|Adverse event, serious fatal|1|||
124884953|NCT01231503|449202541|FG004|Overall Study|Adverse event, serious fatal|0|||
124884954|NCT01231503|449202542|FG005|Overall Study|Adverse event, serious fatal|1|||
124884955|NCT01231503|449202543|FG006|Overall Study|Adverse event, serious fatal|0|||
124884956|NCT01231503|449202544|FG007|Overall Study|Adverse event, serious fatal|0|||
124884957|NCT01231503|449202537|FG000|Overall Study|Withdrawal by Subject|6|||
124884958|NCT01231503|449202538|FG001|Overall Study|Withdrawal by Subject|3|||
125015260|NCT05630937|449680675|FG001|Overall Study|Lost to Follow-up|0|||
124884959|NCT01231503|449202539|FG002|Overall Study|Withdrawal by Subject|3|||
124884960|NCT01231503|449202540|FG003|Overall Study|Withdrawal by Subject|1|||
124884961|NCT01231503|449202541|FG004|Overall Study|Withdrawal by Subject|3|||
124884962|NCT01231503|449202542|FG005|Overall Study|Withdrawal by Subject|5|||
124884963|NCT01231503|449202543|FG006|Overall Study|Withdrawal by Subject|1|||
124884964|NCT01231503|449202544|FG007|Overall Study|Withdrawal by Subject|2|||
124884965|NCT01231503|449202537|FG000|Overall Study|Lost to Follow-up|8|||
124884966|NCT01231503|449202538|FG001|Overall Study|Lost to Follow-up|10|||
124884967|NCT01231503|449202539|FG002|Overall Study|Lost to Follow-up|8|||
124884968|NCT01231503|449202540|FG003|Overall Study|Lost to Follow-up|5|||
124884969|NCT01231503|449202541|FG004|Overall Study|Lost to Follow-up|7|||
124884970|NCT01231503|449202542|FG005|Overall Study|Lost to Follow-up|9|||
124884971|NCT01231503|449202543|FG006|Overall Study|Lost to Follow-up|6|||
124884972|NCT01231503|449202544|FG007|Overall Study|Lost to Follow-up|6|||
124884973|NCT01231503|449202537|FG000|Overall Study|Protocol Violation|0|||
124884974|NCT01231503|449202538|FG001|Overall Study|Protocol Violation|0|||
124884975|NCT01231503|449202539|FG002|Overall Study|Protocol Violation|0|||
124884976|NCT01231503|449202540|FG003|Overall Study|Protocol Violation|1|||
124884977|NCT01231503|449202541|FG004|Overall Study|Protocol Violation|0|||
124884978|NCT01231503|449202542|FG005|Overall Study|Protocol Violation|0|||
124884979|NCT01231503|449202543|FG006|Overall Study|Protocol Violation|0|||
124884980|NCT01231503|449202544|FG007|Overall Study|Protocol Violation|0|||
124884981|NCT01586338|449202545|FG000|Overall Study|Adverse Event|3|||
124884982|NCT01586338|449202545|FG000|Overall Study|Lost to Follow-up|1|||
124884983|NCT01586338|449202545|FG000|Overall Study|Withdrawal by participant|3|||
124884984|NCT01586338|449202545|FG000|Overall Study|Other|1|||
124884985|NCT00284089|449202546|FG000|Multiple Dose Phase|Adverse Event|1|||
124884986|NCT00284089|449202547|FG001|Multiple Dose Phase|Adverse Event|0|||
124884987|NCT00284089|449202548|FG002|Multiple Dose Phase|Adverse Event|1|||
124884988|NCT00284089|449202549|FG003|Multiple Dose Phase|Adverse Event|1|||
124884989|NCT00284089|449202546|FG000|Multiple Dose Phase|Protocol Violation|0|||
124884990|NCT00284089|449202547|FG001|Multiple Dose Phase|Protocol Violation|0|||
124884991|NCT00284089|449202548|FG002|Multiple Dose Phase|Protocol Violation|1|||
124884992|NCT00284089|449202549|FG003|Multiple Dose Phase|Protocol Violation|0|||
124884993|NCT00284089|449202546|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
124884994|NCT00284089|449202547|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
124884995|NCT00284089|449202548|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
124884996|NCT00284089|449202549|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
124884997|NCT00284089|449202546|FG000|Multiple Dose Phase|Death|0|||
124884998|NCT00284089|449202547|FG001|Multiple Dose Phase|Death|0|||
124884999|NCT00284089|449202548|FG002|Multiple Dose Phase|Death|1|||
124885000|NCT00284089|449202549|FG003|Multiple Dose Phase|Death|1|||
124885001|NCT00284089|449202546|FG000|Extension Phase|Adverse Event|0|||
124885002|NCT00284089|449202547|FG001|Extension Phase|Adverse Event|0|||
124885003|NCT00284089|449202548|FG002|Extension Phase|Adverse Event|2|||
124885004|NCT00284089|449202549|FG003|Extension Phase|Adverse Event|2|||
124885005|NCT00284089|449202546|FG000|Extension Phase|condition no longer requires study drug|2|||
124885006|NCT00284089|449202547|FG001|Extension Phase|condition no longer requires study drug|0|||
124885007|NCT00284089|449202548|FG002|Extension Phase|condition no longer requires study drug|2|||
124885008|NCT00284089|449202549|FG003|Extension Phase|condition no longer requires study drug|7|||
124885009|NCT00284089|449202546|FG000|Extension Phase|Protocol Violation|0|||
124885010|NCT00284089|449202547|FG001|Extension Phase|Protocol Violation|0|||
124885011|NCT00284089|449202548|FG002|Extension Phase|Protocol Violation|1|||
124885012|NCT00284089|449202549|FG003|Extension Phase|Protocol Violation|0|||
124885013|NCT00284089|449202546|FG000|Extension Phase|Withdrawal by Subject|0|||
124885014|NCT00284089|449202547|FG001|Extension Phase|Withdrawal by Subject|0|||
124885015|NCT00284089|449202548|FG002|Extension Phase|Withdrawal by Subject|1|||
124885016|NCT00284089|449202549|FG003|Extension Phase|Withdrawal by Subject|3|||
124885017|NCT01146574|449202552|FG000|Overall Study|Death|0|||
125015261|NCT05630937|449680676|FG002|Overall Study|Lost to Follow-up|1|||
125015262|NCT05630937|449680677|FG003|Overall Study|Lost to Follow-up|0|||
125015263|NCT05630937|449680674|FG000|Overall Study|Enrolled but not treated|0|||
125015264|NCT05630937|449680675|FG001|Overall Study|Enrolled but not treated|0|||
125015265|NCT05630937|449680676|FG002|Overall Study|Enrolled but not treated|0|||
125015266|NCT05630937|449680677|FG003|Overall Study|Enrolled but not treated|1|||
125015267|NCT01604265|449680680|FG000|Overall Study|Adverse Event|1|||
124885018|NCT01146574|449202553|FG001|Overall Study|Death|1|||
124885019|NCT01146574|449202554|FG002|Overall Study|Death|1|||
124885020|NCT01146574|449202555|FG003|Overall Study|Death|0|||
124885021|NCT01146574|449202556|FG004|Overall Study|Death|0|||
125015268|NCT01604265|449680681|FG001|Overall Study|Adverse Event|0|||
125015269|NCT01604265|449680680|FG000|Overall Study|Withdrawal by Subject|1|||
125015270|NCT01604265|449680681|FG001|Overall Study|Withdrawal by Subject|0|||
125015271|NCT02706873|449680682|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
124885022|NCT01146574|449202557|FG005|Overall Study|Death|0|||
124885023|NCT01146574|449202558|FG006|Overall Study|Death|0|||
124885024|NCT01146574|449202552|FG000|Overall Study|Other reasons|0|||
124885025|NCT01146574|449202553|FG001|Overall Study|Other reasons|0|||
124885026|NCT01146574|449202554|FG002|Overall Study|Other reasons|3|||
124885027|NCT01146574|449202555|FG003|Overall Study|Other reasons|0|||
124885028|NCT01146574|449202556|FG004|Overall Study|Other reasons|0|||
124885029|NCT01146574|449202557|FG005|Overall Study|Other reasons|0|||
124885030|NCT01146574|449202558|FG006|Overall Study|Other reasons|0|||
124885031|NCT01146574|449202552|FG000|Overall Study|Kidney transplant|0|||
124885032|NCT01146574|449202553|FG001|Overall Study|Kidney transplant|0|||
124885033|NCT01146574|449202554|FG002|Overall Study|Kidney transplant|1|||
124885034|NCT01146574|449202555|FG003|Overall Study|Kidney transplant|1|||
124885035|NCT01146574|449202556|FG004|Overall Study|Kidney transplant|0|||
124885036|NCT01146574|449202557|FG005|Overall Study|Kidney transplant|0|||
124885037|NCT01146574|449202558|FG006|Overall Study|Kidney transplant|0|||
124885038|NCT01146574|449202552|FG000|Overall Study|Withdrew consent|0|||
124885039|NCT01146574|449202553|FG001|Overall Study|Withdrew consent|0|||
124885040|NCT01146574|449202554|FG002|Overall Study|Withdrew consent|1|||
124885041|NCT01146574|449202555|FG003|Overall Study|Withdrew consent|1|||
124885042|NCT01146574|449202556|FG004|Overall Study|Withdrew consent|2|||
124885043|NCT01146574|449202557|FG005|Overall Study|Withdrew consent|1|||
124885044|NCT01146574|449202558|FG006|Overall Study|Withdrew consent|1|||
124885045|NCT03053492|449202559|FG000|Overall Study|Adverse Event|1|||
124885046|NCT03053492|449202560|FG001|Overall Study|Adverse Event|1|||
124885047|NCT03053492|449202559|FG000|Overall Study|Withdrawal by Subject|7|||
124885048|NCT03053492|449202560|FG001|Overall Study|Withdrawal by Subject|5|||
124885049|NCT01868074|449202561|FG000|Overall Study|Lost to Follow-up|3|||
124885050|NCT01868074|449202562|FG001|Overall Study|Lost to Follow-up|2|||
124885051|NCT01868074|449202561|FG000|Overall Study|Withdrawal by Subject|4|||
124885052|NCT01868074|449202562|FG001|Overall Study|Withdrawal by Subject|2|||
124885053|NCT01544491|449202563|FG000|Overall Study|Withdrawal by Subject|3|||
124885054|NCT01544491|449202564|FG001|Overall Study|Withdrawal by Subject|2|||
124885055|NCT01544491|449202563|FG000|Overall Study|Lost to Follow-up|0|||
124885056|NCT01544491|449202564|FG001|Overall Study|Lost to Follow-up|1|||
124885057|NCT01544491|449202563|FG000|Overall Study|administrative problems|2|||
124885058|NCT01544491|449202564|FG001|Overall Study|administrative problems|0|||
124885059|NCT00967018|449202565|FG000|Overall Study|Adverse Event|2|||
124885060|NCT00967018|449202565|FG000|Overall Study|Physician Decision|7|||
124885061|NCT00967018|449202565|FG000|Overall Study|Lost to Follow-up|2|||
124885062|NCT00967018|449202565|FG000|Overall Study|Withdrawal by Subject|1|||
124885063|NCT00967018|449202565|FG000|Overall Study|Miscellaneous Reasons|9|||
124885064|NCT04642469|449202571|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
124885065|NCT04642469|449202572|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
124885066|NCT04642469|449202571|FG000|Overall Study|Death|1|||
124885067|NCT04642469|449202572|FG001|Overall Study|Death|2|||
124885068|NCT04642469|449202571|FG000|Overall Study|Study/site closed following amendment 1|11|||
124885069|NCT04642469|449202572|FG001|Overall Study|Study/site closed following amendment 1|11|||
124885070|NCT04642469|449202571|FG000|Overall Study|Other|1|||
124885071|NCT04642469|449202572|FG001|Overall Study|Other|1|||
124885072|NCT04642469|449202571|FG000|Overall Study|Withdrawal by Subject|1|||
124885073|NCT04642469|449202572|FG001|Overall Study|Withdrawal by Subject|0|||
124885074|NCT00680056|449202574|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
124885075|NCT00680056|449202575|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
124885076|NCT00680056|449202574|FG000|Second Intervention|Protocol Violation|3|||
125104908|NCT03701516|450005818|FG000|Period 1|Non Compliance to Protocol|2|||
125104909|NCT03701516|450005819|FG001|Period 1|Non Compliance to Protocol|1|||
125104910|NCT03701516|450005818|FG000|Period 1|Withdrawal by Subject|0|||
125104911|NCT03701516|450005819|FG001|Period 1|Withdrawal by Subject|1|||
125104912|NCT03701516|450005818|FG000|Period 2|failed to meet all eligibility creiteria|1|||
125104913|NCT03701516|450005819|FG001|Period 2|failed to meet all eligibility creiteria|0|||
125104914|NCT03701516|450005818|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
125104915|NCT03701516|450005819|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
125104916|NCT00478673|450005820|FG000|30-Days Post-Procedure|Death|2|||
125104917|NCT00478673|450005820|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
125104918|NCT00478673|450005820|FG000|30-Days Post-Procedure|Missed Visit|7|||
125104919|NCT00478673|450005820|FG000|12-Months Post-Procedure|Death|23|||
125104920|NCT00478673|450005820|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
125104921|NCT00478673|450005820|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
125104922|NCT00478673|450005820|FG000|12-Months Post-Procedure|Missed Visit|25|||
125104923|NCT00478673|450005820|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
125104924|NCT00981019|450005821|FG000|Overall Study|Did not respond|65|||
125104925|NCT00981019|450005821|FG000|Overall Study|Did not match target population|94|||
125104926|NCT00981019|450005821|FG000|Overall Study|Inadvertent exclusion|239|||
125104927|NCT00981019|450005821|FG000|Overall Study|Hit the survey after closure|79|||
124885077|NCT00680056|449202575|FG001|Second Intervention|Protocol Violation|1|||
124885078|NCT01088529|449202576|FG000|Overall Study|Did not receive study treatment|0|||
125104928|NCT00358670|450005822|FG000|Overall Study|Adverse Event|26|||
125104929|NCT00358670|450005823|FG001|Overall Study|Adverse Event|29|||
124885079|NCT01088529|449202577|FG001|Overall Study|Did not receive study treatment|1|||
124885080|NCT01821898|449202578|FG000|Overall Study|Withdrawal by Subject|2|||
124885081|NCT01821898|449202579|FG001|Overall Study|Withdrawal by Subject|1|||
124885082|NCT00337662|449202582|FG000|Study Period II|Lost to Follow-up|0|||
124885083|NCT00337662|449202583|FG001|Study Period II|Lost to Follow-up|0|||
124885084|NCT00337662|449202584|FG002|Study Period II|Lost to Follow-up|0|||
124885085|NCT00337662|449202585|FG003|Study Period II|Lost to Follow-up|35|||
124885086|NCT00337662|449202582|FG000|Study Period II|Withdrawal by Subject|0|||
124885087|NCT00337662|449202583|FG001|Study Period II|Withdrawal by Subject|0|||
124885088|NCT00337662|449202584|FG002|Study Period II|Withdrawal by Subject|0|||
124885089|NCT00337662|449202585|FG003|Study Period II|Withdrawal by Subject|20|||
124885090|NCT00337662|449202582|FG000|Study Period II|Adverse Event|0|||
124885091|NCT00337662|449202583|FG001|Study Period II|Adverse Event|0|||
124885092|NCT00337662|449202584|FG002|Study Period II|Adverse Event|0|||
124885093|NCT00337662|449202585|FG003|Study Period II|Adverse Event|16|||
124885094|NCT00337662|449202582|FG000|Study Period II|Physician Decision|0|||
124885095|NCT00337662|449202583|FG001|Study Period II|Physician Decision|0|||
124885096|NCT00337662|449202584|FG002|Study Period II|Physician Decision|0|||
124885097|NCT00337662|449202585|FG003|Study Period II|Physician Decision|13|||
124885098|NCT00337662|449202582|FG000|Study Period II|Entry Criteria Not Met|0|||
124885099|NCT00337662|449202583|FG001|Study Period II|Entry Criteria Not Met|0|||
124885100|NCT00337662|449202584|FG002|Study Period II|Entry Criteria Not Met|0|||
124885101|NCT00337662|449202585|FG003|Study Period II|Entry Criteria Not Met|6|||
124885102|NCT00337662|449202582|FG000|Study Period II|Protocol Violation|0|||
124885103|NCT00337662|449202583|FG001|Study Period II|Protocol Violation|0|||
124885104|NCT00337662|449202584|FG002|Study Period II|Protocol Violation|0|||
124885105|NCT00337662|449202585|FG003|Study Period II|Protocol Violation|6|||
124885106|NCT00337662|449202582|FG000|Study Period II|Lack of Efficacy|0|||
124885107|NCT00337662|449202583|FG001|Study Period II|Lack of Efficacy|0|||
124885108|NCT00337662|449202584|FG002|Study Period II|Lack of Efficacy|0|||
124885109|NCT00337662|449202585|FG003|Study Period II|Lack of Efficacy|7|||
124885110|NCT00337662|449202582|FG000|Study Period II|Sponsor Decision|0|||
124885111|NCT00337662|449202583|FG001|Study Period II|Sponsor Decision|0|||
124885112|NCT00337662|449202584|FG002|Study Period II|Sponsor Decision|0|||
124885113|NCT00337662|449202585|FG003|Study Period II|Sponsor Decision|2|||
124885114|NCT00337662|449202582|FG000|Study Period II|Parent/Caregiver Decision|0|||
124885115|NCT00337662|449202583|FG001|Study Period II|Parent/Caregiver Decision|0|||
124885116|NCT00337662|449202584|FG002|Study Period II|Parent/Caregiver Decision|0|||
124885117|NCT00337662|449202585|FG003|Study Period II|Parent/Caregiver Decision|1|||
124885118|NCT00337662|449202582|FG000|Study Period III|Lost to Follow-up|14|||
124885119|NCT00337662|449202583|FG001|Study Period III|Lost to Follow-up|16|||
124885120|NCT00337662|449202584|FG002|Study Period III|Lost to Follow-up|14|||
124885121|NCT00337662|449202585|FG003|Study Period III|Lost to Follow-up|0|||
124885122|NCT00337662|449202582|FG000|Study Period III|Withdrawal by Subject|18|||
124885123|NCT00337662|449202583|FG001|Study Period III|Withdrawal by Subject|14|||
124885124|NCT00337662|449202584|FG002|Study Period III|Withdrawal by Subject|12|||
124885125|NCT00337662|449202585|FG003|Study Period III|Withdrawal by Subject|0|||
124885126|NCT00337662|449202582|FG000|Study Period III|Adverse Event|9|||
124885127|NCT00337662|449202583|FG001|Study Period III|Adverse Event|10|||
124885128|NCT00337662|449202584|FG002|Study Period III|Adverse Event|8|||
124885129|NCT00337662|449202585|FG003|Study Period III|Adverse Event|0|||
124885130|NCT00337662|449202582|FG000|Study Period III|Protocol Violation|3|||
124885131|NCT00337662|449202583|FG001|Study Period III|Protocol Violation|8|||
124885132|NCT00337662|449202584|FG002|Study Period III|Protocol Violation|2|||
124885133|NCT00337662|449202585|FG003|Study Period III|Protocol Violation|0|||
124885134|NCT00337662|449202582|FG000|Study Period III|Physician Decision|6|||
124885135|NCT00337662|449202583|FG001|Study Period III|Physician Decision|5|||
124885136|NCT00337662|449202584|FG002|Study Period III|Physician Decision|0|||
124885137|NCT00337662|449202585|FG003|Study Period III|Physician Decision|0|||
124885138|NCT00337662|449202582|FG000|Study Period III|Entry Criteria Not Met|4|||
124885139|NCT00337662|449202583|FG001|Study Period III|Entry Criteria Not Met|1|||
124885140|NCT00337662|449202584|FG002|Study Period III|Entry Criteria Not Met|3|||
124885141|NCT00337662|449202585|FG003|Study Period III|Entry Criteria Not Met|0|||
124885142|NCT00337662|449202582|FG000|Study Period III|Lack of Efficacy|4|||
124885143|NCT00337662|449202583|FG001|Study Period III|Lack of Efficacy|4|||
124885144|NCT00337662|449202584|FG002|Study Period III|Lack of Efficacy|2|||
124885145|NCT00337662|449202585|FG003|Study Period III|Lack of Efficacy|0|||
124885146|NCT00337662|449202582|FG000|Study Period III|Parent/Caregiver Decision|0|||
124885147|NCT00337662|449202583|FG001|Study Period III|Parent/Caregiver Decision|0|||
124885148|NCT00337662|449202584|FG002|Study Period III|Parent/Caregiver Decision|2|||
124885149|NCT00337662|449202585|FG003|Study Period III|Parent/Caregiver Decision|0|||
124885150|NCT00337662|449202582|FG000|Study Period III|Sponsor Decision|1|||
124885151|NCT00337662|449202583|FG001|Study Period III|Sponsor Decision|0|||
124885152|NCT00337662|449202584|FG002|Study Period III|Sponsor Decision|1|||
124885153|NCT00337662|449202585|FG003|Study Period III|Sponsor Decision|0|||
124885154|NCT00337662|449202582|FG000|Study Period III|Clinical Relapse|1|||
125015272|NCT02706873|449680683|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
125015273|NCT02706873|449680684|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
125015274|NCT02706873|449680685|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
125015275|NCT02706873|449680682|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
124885155|NCT00337662|449202583|FG001|Study Period III|Clinical Relapse|0|||
124885156|NCT00337662|449202584|FG002|Study Period III|Clinical Relapse|0|||
124885157|NCT00337662|449202585|FG003|Study Period III|Clinical Relapse|0|||
124885158|NCT03691948|449202587|FG000|Overall Study|Lost to Follow-up|1|||
124885159|NCT03691948|449202588|FG001|Overall Study|Lost to Follow-up|3|||
124885160|NCT02344537|449202589|FG000|Overall Study|Protocol Violation|1|||
124885161|NCT02344537|449202590|FG001|Overall Study|Protocol Violation|1|||
124885162|NCT02344537|449202589|FG000|Overall Study|Subject started another treatment after wk 6|1|||
124885163|NCT02344537|449202590|FG001|Overall Study|Subject started another treatment after wk 6|0|||
124885164|NCT02344537|449202589|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
124885165|NCT02344537|449202590|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
124885166|NCT02611830|449202592|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
124885167|NCT02611830|449202593|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
124885168|NCT02611830|449202594|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
124885169|NCT02611830|449202595|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
124885170|NCT02611830|449202592|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
124885171|NCT02611830|449202593|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
124885172|NCT02611830|449202594|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
124885173|NCT02611830|449202595|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
124885174|NCT02611830|449202592|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
124885175|NCT02611830|449202593|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
124885176|NCT02611830|449202594|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
124885177|NCT02611830|449202595|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
124885178|NCT02611830|449202592|FG000|OL Induction Phase|Lack of Efficacy|9|||
124885179|NCT02611830|449202593|FG001|OL Induction Phase|Lack of Efficacy|0|||
124885180|NCT02611830|449202594|FG002|OL Induction Phase|Lack of Efficacy|0|||
124885181|NCT02611830|449202595|FG003|OL Induction Phase|Lack of Efficacy|0|||
124885182|NCT02611830|449202592|FG000|OL Induction Phase|Reason not specified|3|||
124885183|NCT02611830|449202593|FG001|OL Induction Phase|Reason not specified|0|||
124885184|NCT02611830|449202594|FG002|OL Induction Phase|Reason not specified|0|||
124885185|NCT02611830|449202595|FG003|OL Induction Phase|Reason not specified|0|||
124885186|NCT02611830|449202592|FG000|Maintenance Phase|Lack of Efficacy|0|||
124885187|NCT02611830|449202593|FG001|Maintenance Phase|Lack of Efficacy|29|||
124885188|NCT02611830|449202594|FG002|Maintenance Phase|Lack of Efficacy|18|||
124885189|NCT02611830|449202595|FG003|Maintenance Phase|Lack of Efficacy|6|||
124885190|NCT02611830|449202592|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
124885191|NCT02611830|449202593|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
124885192|NCT02611830|449202594|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
124885193|NCT02611830|449202595|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
124885194|NCT02611830|449202592|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
124885195|NCT02611830|449202593|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
124885196|NCT02611830|449202594|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
124885197|NCT02611830|449202595|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
124885198|NCT02611830|449202592|FG000|Maintenance Phase|Lost to Follow-up|0|||
124885199|NCT02611830|449202593|FG001|Maintenance Phase|Lost to Follow-up|0|||
124885200|NCT02611830|449202594|FG002|Maintenance Phase|Lost to Follow-up|0|||
124885201|NCT02611830|449202595|FG003|Maintenance Phase|Lost to Follow-up|1|||
124885202|NCT02611830|449202592|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
124885203|NCT02611830|449202593|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
124885204|NCT02611830|449202594|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
124885205|NCT02611830|449202595|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
124885206|NCT02611830|449202592|FG000|Maintenance Phase|Pregnancy|0|||
124885207|NCT02611830|449202593|FG001|Maintenance Phase|Pregnancy|0|||
124885208|NCT02611830|449202594|FG002|Maintenance Phase|Pregnancy|1|||
124885209|NCT02611830|449202595|FG003|Maintenance Phase|Pregnancy|0|||
124885210|NCT02611830|449202592|FG000|Maintenance Phase|Reason not specified|0|||
124885211|NCT02611830|449202593|FG001|Maintenance Phase|Reason not specified|1|||
124885212|NCT02611830|449202594|FG002|Maintenance Phase|Reason not specified|4|||
124885213|NCT02611830|449202595|FG003|Maintenance Phase|Reason not specified|0|||
125104930|NCT00358670|450005822|FG000|Overall Study|Lack of Efficacy|20|||
124885214|NCT02058290|449202599|FG000|Overall Study|Protocol Violation|2|||
124885215|NCT02058290|449202600|FG001|Overall Study|Protocol Violation|1|||
124885216|NCT02058290|449202599|FG000|Overall Study|Physician Decision|1|||
124885217|NCT02058290|449202600|FG001|Overall Study|Physician Decision|0|||
124885218|NCT02058290|449202599|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
124885219|NCT02058290|449202600|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
124885220|NCT02058290|449202599|FG000|Overall Study|Withdrawal by Subject|0|||
124885221|NCT02058290|449202600|FG001|Overall Study|Withdrawal by Subject|1|||
124885222|NCT03012061|449202603|FG000|Overall Study|Withdrawal by Subject|1|||
124885223|NCT03012061|449202604|FG001|Overall Study|Withdrawal by Subject|5|||
124885224|NCT03012061|449202605|FG002|Overall Study|Withdrawal by Subject|4|||
124885225|NCT03012061|449202603|FG000|Overall Study|Investigator Site Closed|1|||
124885226|NCT03012061|449202604|FG001|Overall Study|Investigator Site Closed|2|||
124885227|NCT03012061|449202605|FG002|Overall Study|Investigator Site Closed|0|||
124885228|NCT03012061|449202603|FG000|Overall Study|Lost to Follow-up|2|||
124885229|NCT03012061|449202604|FG001|Overall Study|Lost to Follow-up|1|||
124885230|NCT03012061|449202605|FG002|Overall Study|Lost to Follow-up|0|||
124885231|NCT03012061|449202603|FG000|Overall Study|Study closed/ Terminated|0|||
124885232|NCT03012061|449202604|FG001|Overall Study|Study closed/ Terminated|0|||
124885233|NCT03012061|449202605|FG002|Overall Study|Study closed/ Terminated|1|||
124885234|NCT03012061|449202603|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
124885235|NCT03012061|449202604|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
124885236|NCT03012061|449202605|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
124885237|NCT03012061|449202603|FG000|Overall Study|Protocol Violation|0|||
124885238|NCT03012061|449202604|FG001|Overall Study|Protocol Violation|0|||
124885239|NCT03012061|449202605|FG002|Overall Study|Protocol Violation|2|||
124885240|NCT03012061|449202603|FG000|Overall Study|Lack of Efficacy|0|||
124885241|NCT03012061|449202604|FG001|Overall Study|Lack of Efficacy|1|||
124885242|NCT03012061|449202605|FG002|Overall Study|Lack of Efficacy|0|||
124885243|NCT03012061|449202603|FG000|Overall Study|Adverse Event|2|||
124885244|NCT03012061|449202604|FG001|Overall Study|Adverse Event|0|||
124885245|NCT03012061|449202605|FG002|Overall Study|Adverse Event|0|||
124885246|NCT02696902|449202606|FG000|Overall Study|Lost to Follow-up|0|||
124885247|NCT02696902|449202607|FG001|Overall Study|Lost to Follow-up|1|||
124885248|NCT02696902|449202608|FG002|Overall Study|Lost to Follow-up|1|||
124885249|NCT02696902|449202606|FG000|Overall Study|Withdrawal by Subject|0|||
124885250|NCT02696902|449202607|FG001|Overall Study|Withdrawal by Subject|0|||
124885251|NCT02696902|449202608|FG002|Overall Study|Withdrawal by Subject|1|||
124885252|NCT02696902|449202606|FG000|Overall Study|Death|19|||
124885253|NCT02696902|449202607|FG001|Overall Study|Death|3|||
124885254|NCT02696902|449202608|FG002|Overall Study|Death|24|||
124885255|NCT02696902|449202606|FG000|Overall Study|Participant not fit post-randomization|0|||
124885256|NCT02696902|449202607|FG001|Overall Study|Participant not fit post-randomization|0|||
124885257|NCT02696902|449202608|FG002|Overall Study|Participant not fit post-randomization|1|||
124885258|NCT02696902|449202606|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
124885259|NCT02696902|449202607|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
124885260|NCT02696902|449202608|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
124885261|NCT02696902|449202606|FG000|Overall Study|Principal investigator's decision|1|||
124885262|NCT02696902|449202607|FG001|Overall Study|Principal investigator's decision|0|||
124885263|NCT02696902|449202608|FG002|Overall Study|Principal investigator's decision|0|||
124885264|NCT02696902|449202606|FG000|Overall Study|Sponsor's decision|1|||
124885265|NCT02696902|449202607|FG001|Overall Study|Sponsor's decision|0|||
124885266|NCT02696902|449202608|FG002|Overall Study|Sponsor's decision|0|||
124885267|NCT02696902|449202606|FG000|Overall Study|Transferred to other hospital|1|||
124885268|NCT02696902|449202607|FG001|Overall Study|Transferred to other hospital|0|||
124885269|NCT02696902|449202608|FG002|Overall Study|Transferred to other hospital|0|||
124885270|NCT01291225|449202610|FG000|Overall Study|Lost to Follow-up|85|||
124885271|NCT01291225|449202611|FG001|Overall Study|Lost to Follow-up|39|||
124885272|NCT01267253|449202612|FG000|Overall Study|Ineligible - required test not done|1|||
124885273|NCT01267253|449202612|FG000|Overall Study|Inevaluable-never received study treatme|2|||
124885274|NCT02855164|449202615|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
124885275|NCT02855164|449202616|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
124885276|NCT02855164|449202617|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
124885277|NCT02855164|449202618|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
124885278|NCT02855164|449202619|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
124885279|NCT02855164|449202620|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
125015276|NCT02706873|449680683|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
125015277|NCT02706873|449680684|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
125015278|NCT02706873|449680685|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
125015279|NCT02706873|449680682|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
125015280|NCT02706873|449680683|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
125015281|NCT02706873|449680684|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
124885280|NCT02855164|449202621|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
124885281|NCT02855164|449202622|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
124885282|NCT02855164|449202615|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
124885283|NCT02855164|449202616|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
124885284|NCT02855164|449202617|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
124885285|NCT02855164|449202618|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
124885286|NCT02855164|449202619|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
124885287|NCT02855164|449202620|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
124885288|NCT02855164|449202621|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
124885289|NCT02855164|449202622|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
124885290|NCT02855164|449202615|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
124885291|NCT02855164|449202616|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
124885292|NCT02855164|449202617|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
124885293|NCT02855164|449202618|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
124885294|NCT02855164|449202619|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
124885295|NCT02855164|449202620|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
124885296|NCT02855164|449202621|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
124885297|NCT02855164|449202622|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
124885298|NCT02855164|449202615|FG000|Part C (Randomized Set)|Adverse Event|0|||
124885299|NCT02855164|449202616|FG001|Part C (Randomized Set)|Adverse Event|0|||
124885300|NCT02855164|449202617|FG002|Part C (Randomized Set)|Adverse Event|0|||
124885301|NCT02855164|449202618|FG003|Part C (Randomized Set)|Adverse Event|0|||
124885302|NCT02855164|449202619|FG004|Part C (Randomized Set)|Adverse Event|0|||
124885303|NCT02855164|449202620|FG005|Part C (Randomized Set)|Adverse Event|5|||
124885304|NCT02855164|449202621|FG006|Part C (Randomized Set)|Adverse Event|9|||
124885305|NCT02855164|449202622|FG007|Part C (Randomized Set)|Adverse Event|2|||
124885306|NCT02855164|449202615|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
124885307|NCT02855164|449202616|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
124885308|NCT02855164|449202617|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
124885309|NCT02855164|449202618|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
124885310|NCT02855164|449202619|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
124885311|NCT02855164|449202620|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
124885312|NCT02855164|449202621|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
124885313|NCT02855164|449202622|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
124885314|NCT02855164|449202615|FG000|Part C (Randomized Set)|Physician Decision|0|||
124885315|NCT02855164|449202616|FG001|Part C (Randomized Set)|Physician Decision|0|||
124885316|NCT02855164|449202617|FG002|Part C (Randomized Set)|Physician Decision|0|||
124885317|NCT02855164|449202618|FG003|Part C (Randomized Set)|Physician Decision|0|||
124885318|NCT02855164|449202619|FG004|Part C (Randomized Set)|Physician Decision|0|||
124885319|NCT02855164|449202620|FG005|Part C (Randomized Set)|Physician Decision|1|||
124885320|NCT02855164|449202621|FG006|Part C (Randomized Set)|Physician Decision|0|||
124885321|NCT02855164|449202622|FG007|Part C (Randomized Set)|Physician Decision|1|||
124885322|NCT02855164|449202615|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
124885323|NCT02855164|449202616|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
124885324|NCT02855164|449202617|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
124885325|NCT02855164|449202618|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
124885326|NCT02855164|449202619|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
124885327|NCT02855164|449202620|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
124885328|NCT02855164|449202621|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
124885329|NCT02855164|449202622|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
124885330|NCT00383240|449202623|FG000|Overall Study|Adverse Event|4|||
124885331|NCT00383240|449202624|FG001|Overall Study|Adverse Event|6|||
124885332|NCT00383240|449202625|FG002|Overall Study|Adverse Event|9|||
124885333|NCT00383240|449202626|FG003|Overall Study|Adverse Event|7|||
124885334|NCT00383240|449202623|FG000|Overall Study|Treatment Failure|8|||
124885335|NCT00383240|449202624|FG001|Overall Study|Treatment Failure|13|||
124885336|NCT00383240|449202625|FG002|Overall Study|Treatment Failure|47|||
124885337|NCT00383240|449202626|FG003|Overall Study|Treatment Failure|46|||
124885338|NCT00383240|449202623|FG000|Overall Study|Lost to Follow-up|3|||
124885339|NCT00383240|449202624|FG001|Overall Study|Lost to Follow-up|0|||
124885340|NCT00383240|449202625|FG002|Overall Study|Lost to Follow-up|0|||
124885341|NCT00383240|449202626|FG003|Overall Study|Lost to Follow-up|2|||
124885342|NCT00383240|449202623|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
124885343|NCT00383240|449202624|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
124885344|NCT00383240|449202625|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
124885345|NCT00383240|449202626|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
124885346|NCT00383240|449202623|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
124885347|NCT00383240|449202624|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
124885348|NCT00383240|449202625|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
124885349|NCT00383240|449202626|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
124885350|NCT00383240|449202623|FG000|Overall Study|Protocol Violation|4|||
124885351|NCT00383240|449202624|FG001|Overall Study|Protocol Violation|5|||
124885352|NCT00383240|449202625|FG002|Overall Study|Protocol Violation|9|||
124885353|NCT00383240|449202626|FG003|Overall Study|Protocol Violation|6|||
124885354|NCT00383240|449202623|FG000|Overall Study|Did not meet protocol eligibility|9|||
124885355|NCT00383240|449202624|FG001|Overall Study|Did not meet protocol eligibility|4|||
124885356|NCT00383240|449202625|FG002|Overall Study|Did not meet protocol eligibility|9|||
124885357|NCT00383240|449202626|FG003|Overall Study|Did not meet protocol eligibility|3|||
124885358|NCT00383240|449202623|FG000|Overall Study|Administrative|1|||
124885359|NCT00383240|449202624|FG001|Overall Study|Administrative|1|||
124885360|NCT00383240|449202625|FG002|Overall Study|Administrative|0|||
124885361|NCT00383240|449202626|FG003|Overall Study|Administrative|0|||
124885362|NCT02601937|449202627|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
124885363|NCT02601937|449202628|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
124885364|NCT02601937|449202629|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
124885365|NCT02601937|449202630|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
124885366|NCT02601937|449202631|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
124885367|NCT02601937|449202632|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
124885368|NCT02601937|449202633|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
124885369|NCT02601937|449202634|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
124885370|NCT02601937|449202635|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
124885371|NCT02601937|449202636|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
124885372|NCT02601937|449202637|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
124885373|NCT02601937|449202627|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
124885374|NCT02601937|449202628|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
124885375|NCT02601937|449202629|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
124885376|NCT02601937|449202630|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
124885377|NCT02601937|449202631|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
124885378|NCT02601937|449202632|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
124885379|NCT02601937|449202633|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
124885380|NCT02601937|449202634|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
124885381|NCT02601937|449202635|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
124885382|NCT02601937|449202636|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
124885383|NCT02601937|449202637|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
124885384|NCT02601937|449202627|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
124885385|NCT02601937|449202628|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
124885386|NCT02601937|449202629|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
124885387|NCT02601937|449202630|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
124885388|NCT02601937|449202631|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
124885389|NCT02601937|449202632|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
124885390|NCT02601937|449202633|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
124885391|NCT02601937|449202634|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
124885392|NCT02601937|449202635|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
124885393|NCT02601937|449202636|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
124885394|NCT02601937|449202637|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
124885395|NCT02601937|449202627|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
124885396|NCT02601937|449202628|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
124885397|NCT02601937|449202629|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
124885398|NCT02601937|449202630|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
124885399|NCT02601937|449202631|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
124885400|NCT02601937|449202632|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
124885401|NCT02601937|449202633|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
124885402|NCT02601937|449202634|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
124885403|NCT02601937|449202635|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
124885404|NCT02601937|449202636|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
124885405|NCT02601937|449202637|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
124885406|NCT02601937|449202627|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
124885407|NCT02601937|449202628|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
124885408|NCT02601937|449202629|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
124885409|NCT02601937|449202630|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
124885410|NCT02601937|449202631|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
124885411|NCT02601937|449202632|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
124885412|NCT02601937|449202633|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125015282|NCT02706873|449680685|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
125015283|NCT02706873|449680682|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
125015284|NCT02706873|449680683|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
125015285|NCT02706873|449680684|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
125015286|NCT02706873|449680685|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
125015287|NCT02706873|449680682|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
125015288|NCT02706873|449680683|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
125015289|NCT02706873|449680684|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
125015290|NCT02706873|449680685|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
125015291|NCT02706873|449680682|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
125015292|NCT02706873|449680683|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
125015293|NCT02706873|449680684|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
124885413|NCT02601937|449202634|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125015294|NCT02706873|449680685|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
125015295|NCT02706873|449680682|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
124885414|NCT02601937|449202635|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
124885415|NCT02601937|449202636|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
124885416|NCT02601937|449202637|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
124885417|NCT02601937|449202627|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
124885418|NCT02601937|449202628|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
124885419|NCT02601937|449202629|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
124885420|NCT02601937|449202630|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
124885421|NCT02601937|449202631|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
124885422|NCT02601937|449202632|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
124885423|NCT02601937|449202633|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
124885424|NCT02601937|449202634|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
124885425|NCT02601937|449202635|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
124885426|NCT02601937|449202636|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
124885427|NCT02601937|449202637|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
124885428|NCT02601937|449202627|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
124885429|NCT02601937|449202628|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
124885430|NCT02601937|449202629|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
124885431|NCT02601937|449202630|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
124885432|NCT02601937|449202631|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
124885433|NCT02601937|449202632|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
124885434|NCT02601937|449202633|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
124885435|NCT02601937|449202634|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
124885436|NCT02601937|449202635|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
124885437|NCT02601937|449202636|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
124885438|NCT02601937|449202637|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
124885439|NCT02601937|449202627|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
124885440|NCT02601937|449202628|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
124885441|NCT02601937|449202629|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
124885442|NCT02601937|449202630|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
124885443|NCT02601937|449202631|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
124885444|NCT02601937|449202632|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
124885445|NCT02601937|449202633|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
124885446|NCT02601937|449202634|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
124885447|NCT02601937|449202635|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
124885448|NCT02601937|449202636|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
124885449|NCT02601937|449202637|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
124885450|NCT02601937|449202627|FG000|Period 2: Dose Expansion Cohort|Other|0|||
124885451|NCT02601937|449202628|FG001|Period 2: Dose Expansion Cohort|Other|0|||
124885452|NCT02601937|449202629|FG002|Period 2: Dose Expansion Cohort|Other|0|||
124885453|NCT02601937|449202630|FG003|Period 2: Dose Expansion Cohort|Other|0|||
124885454|NCT02601937|449202631|FG004|Period 2: Dose Expansion Cohort|Other|0|||
124885455|NCT02601937|449202632|FG005|Period 2: Dose Expansion Cohort|Other|0|||
124885456|NCT02601937|449202633|FG006|Period 2: Dose Expansion Cohort|Other|0|||
124885457|NCT02601937|449202634|FG007|Period 2: Dose Expansion Cohort|Other|0|||
124885458|NCT02601937|449202635|FG008|Period 2: Dose Expansion Cohort|Other|2|||
124885459|NCT02601937|449202636|FG009|Period 2: Dose Expansion Cohort|Other|2|||
124885460|NCT02601937|449202637|FG010|Period 2: Dose Expansion Cohort|Other|0|||
124885461|NCT02601937|449202627|FG000|Period 2: Dose Expansion Cohort|Death|0|||
124885462|NCT02601937|449202628|FG001|Period 2: Dose Expansion Cohort|Death|0|||
124885463|NCT02601937|449202629|FG002|Period 2: Dose Expansion Cohort|Death|0|||
124885464|NCT02601937|449202630|FG003|Period 2: Dose Expansion Cohort|Death|0|||
124885465|NCT02601937|449202631|FG004|Period 2: Dose Expansion Cohort|Death|0|||
124885466|NCT02601937|449202632|FG005|Period 2: Dose Expansion Cohort|Death|0|||
124885467|NCT02601937|449202633|FG006|Period 2: Dose Expansion Cohort|Death|0|||
124885468|NCT02601937|449202634|FG007|Period 2: Dose Expansion Cohort|Death|0|||
124885469|NCT02601937|449202635|FG008|Period 2: Dose Expansion Cohort|Death|1|||
124885470|NCT02601937|449202636|FG009|Period 2: Dose Expansion Cohort|Death|0|||
124885471|NCT02601937|449202637|FG010|Period 2: Dose Expansion Cohort|Death|0|||
124885472|NCT02924389|449202638|FG000|Overall Study|Lost to Follow-up|1|||
124885473|NCT02924389|449202639|FG001|Overall Study|Lost to Follow-up|0|||
124885474|NCT02924389|449202638|FG000|Overall Study|Physician Decision|2|||
124885475|NCT02924389|449202639|FG001|Overall Study|Physician Decision|0|||
124885476|NCT02924389|449202638|FG000|Overall Study|Withdrawal by Subject|3|||
124885477|NCT02924389|449202639|FG001|Overall Study|Withdrawal by Subject|0|||
124885478|NCT02924389|449202638|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
124885479|NCT02924389|449202639|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
124885480|NCT03918239|449204346|FG000|Overall Study|Lost to Follow-up|3|||
124885481|NCT03918239|449204347|FG001|Overall Study|Lost to Follow-up|1|||
124885482|NCT03918239|449204346|FG000|Overall Study|Pregnancy|0|||
124885483|NCT03918239|449204347|FG001|Overall Study|Pregnancy|2|||
124885484|NCT03918239|449204346|FG000|Overall Study|Withdrawal by Subject|3|||
124885485|NCT03918239|449204347|FG001|Overall Study|Withdrawal by Subject|3|||
124885486|NCT03918239|449204346|FG000|Overall Study|positive urine drug screening results|4|||
124885487|NCT03918239|449204347|FG001|Overall Study|positive urine drug screening results|1|||
124885488|NCT04249336|449204350|FG000|Overall Study|Lost to Follow-up|3|||
124885489|NCT04249336|449204351|FG001|Overall Study|Lost to Follow-up|3|||
124885490|NCT04249336|449204352|FG002|Overall Study|Lost to Follow-up|3|||
124885491|NCT04249336|449204353|FG003|Overall Study|Lost to Follow-up|3|||
124885492|NCT02930122|449204354|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
124885493|NCT02930122|449204355|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
124885494|NCT03390036|449204356|FG000|Overall Study|Lost to Follow-up|1|||
124885495|NCT03390036|449204357|FG001|Overall Study|Lost to Follow-up|0|||
125015296|NCT02706873|449680683|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
125015297|NCT02706873|449680684|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
125015298|NCT02706873|449680685|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
125015299|NCT02706873|449680682|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
125015300|NCT02706873|449680683|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
125015301|NCT02706873|449680684|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
125015302|NCT02706873|449680685|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
125015303|NCT02706873|449680682|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
125015304|NCT02706873|449680683|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
125015305|NCT02706873|449680684|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
125015306|NCT02706873|449680685|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
124885496|NCT03390036|449204358|FG002|Overall Study|Lost to Follow-up|0|||
124885497|NCT03390036|449204356|FG000|Overall Study|Lack of Efficacy|1|||
124885498|NCT03390036|449204357|FG001|Overall Study|Lack of Efficacy|0|||
124885499|NCT03390036|449204358|FG002|Overall Study|Lack of Efficacy|0|||
124885500|NCT00358215|449204359|FG000|Overall Study|Ineligibility determined|4|||
124885501|NCT00358215|449204360|FG001|Overall Study|Ineligibility determined|3|||
125015307|NCT02706873|449680682|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
125015308|NCT02706873|449680683|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
124885502|NCT00358215|449204359|FG000|Overall Study|Adverse Event|83|||
124885503|NCT00358215|449204360|FG001|Overall Study|Adverse Event|65|||
124885504|NCT00358215|449204359|FG000|Overall Study|Withdrawal by Subject|111|||
124885505|NCT00358215|449204360|FG001|Overall Study|Withdrawal by Subject|102|||
124885506|NCT00358215|449204359|FG000|Overall Study|Participant request|65|||
124885507|NCT00358215|449204360|FG001|Overall Study|Participant request|64|||
124885508|NCT00358215|449204359|FG000|Overall Study|Physician Decision|47|||
124885509|NCT00358215|449204360|FG001|Overall Study|Physician Decision|39|||
124885510|NCT00358215|449204359|FG000|Overall Study|Lost to Follow-up|16|||
124885511|NCT00358215|449204360|FG001|Overall Study|Lost to Follow-up|22|||
124885512|NCT00358215|449204359|FG000|Overall Study|Death|265|||
124885513|NCT00358215|449204360|FG001|Overall Study|Death|281|||
124885514|NCT00358215|449204359|FG000|Overall Study|Protocol Violation|64|||
124885515|NCT00358215|449204360|FG001|Overall Study|Protocol Violation|59|||
124885516|NCT00358215|449204359|FG000|Overall Study|Pregnancy|1|||
124885517|NCT00358215|449204360|FG001|Overall Study|Pregnancy|0|||
124885518|NCT00358215|449204359|FG000|Overall Study|Other|21|||
124885519|NCT00358215|449204360|FG001|Overall Study|Other|14|||
124885520|NCT00358215|449204359|FG000|Overall Study|Did not receive investigational product|2|||
124885521|NCT00358215|449204360|FG001|Overall Study|Did not receive investigational product|3|||
124885522|NCT04329104|449204361|FG000|Efficacy Study|Withdrawal by Subject|0|||
124885523|NCT04329104|449204362|FG001|Efficacy Study|Withdrawal by Subject|0|||
124885524|NCT04329104|449204363|FG002|Efficacy Study|Withdrawal by Subject|0|||
124885525|NCT04329104|449204364|FG003|Efficacy Study|Withdrawal by Subject|5|||
124885526|NCT04329104|449204365|FG004|Efficacy Study|Withdrawal by Subject|6|||
124885527|NCT04329104|449204366|FG005|Efficacy Study|Withdrawal by Subject|8|||
124885528|NCT03884231|449204367|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
124885529|NCT03884231|449204367|FG000|Overall Study|Subject Withdrew Consent|1|||
124885530|NCT03884231|449204367|FG000|Overall Study|MRI Scan Not Performed|1|||
124885531|NCT01853254|449204368|FG000|Overall Study|Abnormal Laboratory Test|1|||
124885532|NCT01853254|449204368|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
124885533|NCT01853254|449204368|FG000|Overall Study|Death|1|||
124885534|NCT01853254|449204368|FG000|Overall Study|Failure to Return|43|||
124885535|NCT01853254|449204368|FG000|Overall Study|Insufficient Therapeutic Response|22|||
124885536|NCT01853254|449204368|FG000|Overall Study|Refusal of Treatment|1|||
124885537|NCT01853254|449204368|FG000|Overall Study|Other Protocol Violation|1|||
124885538|NCT01853254|449204368|FG000|Overall Study|Withdrawal of Consent|16|||
124885539|NCT01853254|449204368|FG000|Overall Study|Administrative/Other|16|||
124885540|NCT01017120|449204378|FG000|Overall Study|Adverse Event|9|||
124885541|NCT01017120|449204379|FG001|Overall Study|Adverse Event|0|||
124885542|NCT01017120|449204378|FG000|Overall Study|Lost to Follow-up|13|||
124885543|NCT01017120|449204379|FG001|Overall Study|Lost to Follow-up|11|||
124885544|NCT01017120|449204378|FG000|Overall Study|Lack of Efficacy|1|||
124885545|NCT01017120|449204379|FG001|Overall Study|Lack of Efficacy|0|||
124885546|NCT01017120|449204378|FG000|Overall Study|Withdrawal by Subject|39|||
124885547|NCT01017120|449204379|FG001|Overall Study|Withdrawal by Subject|21|||
124885548|NCT01017120|449204378|FG000|Overall Study|Pregnancy|1|||
124885549|NCT01017120|449204379|FG001|Overall Study|Pregnancy|1|||
124885550|NCT01017120|449204378|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
124885551|NCT01017120|449204379|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
124885552|NCT01017120|449204378|FG000|Overall Study|Relocated Out of Town|0|||
124885553|NCT01017120|449204379|FG001|Overall Study|Relocated Out of Town|2|||
124885554|NCT01017120|449204378|FG000|Overall Study|Protocol Violation|1|||
124885555|NCT01017120|449204379|FG001|Overall Study|Protocol Violation|0|||
124885556|NCT01017120|449204378|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
124885557|NCT01017120|449204379|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
124885558|NCT01087723|449204381|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
124885559|NCT01087723|449204382|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
124885560|NCT01087723|449204381|FG000|Overall Study|Withdrawal by Subject|10|||
125015309|NCT02706873|449680684|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
125015310|NCT02706873|449680685|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
125015311|NCT02706873|449680682|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
125015312|NCT02706873|449680683|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
125015313|NCT02706873|449680684|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
125015314|NCT02706873|449680685|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
125015315|NCT02706873|449680682|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
125015316|NCT02706873|449680683|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
125015317|NCT02706873|449680684|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
125015318|NCT02706873|449680685|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
124885561|NCT01087723|449204382|FG001|Overall Study|Withdrawal by Subject|13|||
124885562|NCT01087723|449204381|FG000|Overall Study|Physician Decision|2|||
124885563|NCT01087723|449204382|FG001|Overall Study|Physician Decision|0|||
124885564|NCT01087723|449204381|FG000|Overall Study|Lost to Follow-up|1|||
124885565|NCT01087723|449204382|FG001|Overall Study|Lost to Follow-up|4|||
124885566|NCT01087723|449204381|FG000|Overall Study|Reason Not Specified|1|||
125104931|NCT00358670|450005823|FG001|Overall Study|Lack of Efficacy|23|||
125104932|NCT00358670|450005822|FG000|Overall Study|Protocol Violation|6|||
125104933|NCT00358670|450005823|FG001|Overall Study|Protocol Violation|9|||
125104934|NCT00358670|450005822|FG000|Overall Study|Lost to Follow-up|4|||
125104935|NCT00358670|450005823|FG001|Overall Study|Lost to Follow-up|5|||
125104936|NCT00358670|450005822|FG000|Overall Study|Withdrawal by Subject|13|||
125104937|NCT00358670|450005823|FG001|Overall Study|Withdrawal by Subject|24|||
124885567|NCT01087723|449204382|FG001|Overall Study|Reason Not Specified|2|||
124885568|NCT00289770|449204386|FG000|Year 15|Withdrawal by Subject|1|||
124885569|NCT01702428|449204387|FG000|Overall Study|Adverse Event|2|||
124885570|NCT01702428|449204388|FG001|Overall Study|Adverse Event|0|||
124885571|NCT01702428|449204389|FG002|Overall Study|Adverse Event|0|||
124885572|NCT01702428|449204390|FG003|Overall Study|Adverse Event|0|||
124885573|NCT01702428|449204387|FG000|Overall Study|Lost to Follow-up|33|||
124885574|NCT01702428|449204388|FG001|Overall Study|Lost to Follow-up|41|||
124885575|NCT01702428|449204389|FG002|Overall Study|Lost to Follow-up|37|||
124885576|NCT01702428|449204390|FG003|Overall Study|Lost to Follow-up|44|||
124885577|NCT01702428|449204387|FG000|Overall Study|Parents cannot assist to site|1|||
124885578|NCT01702428|449204388|FG001|Overall Study|Parents cannot assist to site|0|||
124885579|NCT01702428|449204389|FG002|Overall Study|Parents cannot assist to site|1|||
124885580|NCT01702428|449204390|FG003|Overall Study|Parents cannot assist to site|0|||
124885581|NCT01702428|449204387|FG000|Overall Study|Lost Coverage|0|||
124885582|NCT01702428|449204388|FG001|Overall Study|Lost Coverage|0|||
124885583|NCT01702428|449204389|FG002|Overall Study|Lost Coverage|0|||
124885584|NCT01702428|449204390|FG003|Overall Study|Lost Coverage|1|||
124885585|NCT01702428|449204387|FG000|Overall Study|Lost Health Plan|3|||
124885586|NCT01702428|449204388|FG001|Overall Study|Lost Health Plan|5|||
124885587|NCT01702428|449204389|FG002|Overall Study|Lost Health Plan|0|||
124885588|NCT01702428|449204390|FG003|Overall Study|Lost Health Plan|2|||
124885589|NCT01702428|449204387|FG000|Overall Study|Mother transferred care|0|||
124885590|NCT01702428|449204388|FG001|Overall Study|Mother transferred care|1|||
124885591|NCT01702428|449204389|FG002|Overall Study|Mother transferred care|0|||
124885592|NCT01702428|449204390|FG003|Overall Study|Mother transferred care|0|||
124885593|NCT01702428|449204387|FG000|Overall Study|Parents too busy|1|||
124885594|NCT01702428|449204388|FG001|Overall Study|Parents too busy|0|||
124885595|NCT01702428|449204389|FG002|Overall Study|Parents too busy|0|||
124885596|NCT01702428|449204390|FG003|Overall Study|Parents too busy|0|||
124885597|NCT01702428|449204387|FG000|Overall Study|Protocol Violation|3|||
124885598|NCT01702428|449204388|FG001|Overall Study|Protocol Violation|0|||
124885599|NCT01702428|449204389|FG002|Overall Study|Protocol Violation|1|||
124885600|NCT01702428|449204390|FG003|Overall Study|Protocol Violation|0|||
124885601|NCT01702428|449204387|FG000|Overall Study|Withdrawal by Subject|21|||
124885602|NCT01702428|449204388|FG001|Overall Study|Withdrawal by Subject|23|||
124885603|NCT01702428|449204389|FG002|Overall Study|Withdrawal by Subject|14|||
124885604|NCT01702428|449204390|FG003|Overall Study|Withdrawal by Subject|10|||
124885605|NCT00154063|449204393|FG000|Overall Study|Adverse Event|4|||
124885606|NCT00154063|449204394|FG001|Overall Study|Adverse Event|8|||
124885607|NCT00154063|449204393|FG000|Overall Study|Protocol Violation|1|||
124885608|NCT00154063|449204394|FG001|Overall Study|Protocol Violation|1|||
124885609|NCT00154063|449204393|FG000|Overall Study|Investigator or Sponsor Request|0|||
124885610|NCT00154063|449204394|FG001|Overall Study|Investigator or Sponsor Request|1|||
125015319|NCT02706873|449680682|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
125015320|NCT02706873|449680683|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
125015321|NCT02706873|449680684|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
125015322|NCT02706873|449680685|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
125015323|NCT00586495|449680691|FG000|Treatment Period|Adverse Event|11|||
125015324|NCT00586495|449680691|FG000|Treatment Period|Death|1|||
125015325|NCT00586495|449680691|FG000|Treatment Period|Protocol Violation|1|||
125015326|NCT00586495|449680691|FG000|Treatment Period|Withdrawal by Subject|1|||
125015327|NCT00586495|449680691|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
125015328|NCT00586495|449680691|FG000|Treatment Period|Switch to commercial drug|10|||
125015329|NCT00586495|449680691|FG000|Follow-up|Death|40|||
125104938|NCT00358670|450005822|FG000|Overall Study|Protocol Defined Clinical Event|0|||
125104939|NCT00358670|450005823|FG001|Overall Study|Protocol Defined Clinical Event|1|||
124885611|NCT00154063|449204393|FG000|Overall Study|Withdrawal by Subject|4|||
124885612|NCT00154063|449204394|FG001|Overall Study|Withdrawal by Subject|9|||
124885613|NCT00154063|449204393|FG000|Overall Study|Other|3|||
124885614|NCT00154063|449204394|FG001|Overall Study|Other|3|||
124885615|NCT02091869|449204395|FG000|Overall Study|Withdrawal by Subject|0|||
124885616|NCT02091869|449204396|FG001|Overall Study|Withdrawal by Subject|3|||
124885617|NCT01804673|449204397|FG000|Overall Study|Adverse Event|4|||
125015330|NCT00586495|449680691|FG000|Follow-up|Lost to Follow-up|1|||
125104940|NCT00358670|450005822|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
124885618|NCT01804673|449204397|FG000|Overall Study|Withdrawal by Subject|1|||
124885619|NCT01804673|449204397|FG000|Overall Study|Lack of Efficacy|9|||
124885620|NCT01804673|449204397|FG000|Overall Study|Change to Oral Therapy|37|||
125015331|NCT00586495|449680691|FG000|Follow-up|Withdrawal by Subject|4|||
125015332|NCT00586495|449680691|FG000|Follow-up|Protocol driven decision point|37|||
124885621|NCT01804673|449204397|FG000|Overall Study|No Further Therapy Required|84|||
124885622|NCT01804673|449204397|FG000|Overall Study|Use of Prohibited Medication|1|||
124885623|NCT01804673|449204397|FG000|Overall Study|Other|4|||
124885624|NCT00451217|449204407|FG000|Overall Study|Lost to Follow-up|0|||
124885625|NCT00451217|449204408|FG001|Overall Study|Lost to Follow-up|1|||
124885626|NCT00451217|449204409|FG002|Overall Study|Lost to Follow-up|1|||
124885627|NCT00451217|449204410|FG003|Overall Study|Lost to Follow-up|1|||
124885628|NCT00451217|449204407|FG000|Overall Study|Withdrawal by Subject|1|||
124885629|NCT00451217|449204408|FG001|Overall Study|Withdrawal by Subject|0|||
124885630|NCT00451217|449204409|FG002|Overall Study|Withdrawal by Subject|0|||
124885631|NCT00451217|449204410|FG003|Overall Study|Withdrawal by Subject|0|||
124885632|NCT00451217|449204407|FG000|Overall Study|Not Treated|1|||
124885633|NCT00451217|449204408|FG001|Overall Study|Not Treated|1|||
124885634|NCT00451217|449204409|FG002|Overall Study|Not Treated|3|||
124885635|NCT00451217|449204410|FG003|Overall Study|Not Treated|4|||
124885636|NCT00358150|449204411|FG000|Overall Study|Adverse Event|3|||
124885637|NCT00358150|449204411|FG000|Overall Study|Withdrawal by Subject|1|||
124885638|NCT00358150|449204411|FG000|Overall Study|Undefined|3|||
124885639|NCT04668989|449204412|FG000|First Intervention|Covid-19 related self-isolation|0|||
124885640|NCT04668989|449204413|FG001|First Intervention|Covid-19 related self-isolation|1|||
124885641|NCT04668989|449204412|FG000|Second Intervention|Adverse Event|0|||
124885642|NCT04668989|449204413|FG001|Second Intervention|Adverse Event|1|||
124885643|NCT01622348|449204418|FG000|Overall Study|Withdrawal by Subject|1|||
124885644|NCT01622348|449204419|FG001|Overall Study|Withdrawal by Subject|0|||
124885645|NCT01622348|449204420|FG002|Overall Study|Withdrawal by Subject|1|||
124885646|NCT00179010|449204421|FG000|Overall Study|Muscle probe defective|1|||
124885647|NCT00179010|449204422|FG001|Overall Study|Muscle probe defective|1|||
124885648|NCT00179010|449204421|FG000|Overall Study|Failure to place arterial line|0|||
124885649|NCT00179010|449204422|FG001|Overall Study|Failure to place arterial line|1|||
124885650|NCT01592695|449204431|FG000|Overall Study|Lost to Follow-up|8|||
124885651|NCT01592695|449204432|FG001|Overall Study|Lost to Follow-up|4|||
124885652|NCT01763788|449204444|FG000|Overall Study|Lost to Follow-up|0|||
124885653|NCT01763788|449204445|FG001|Overall Study|Lost to Follow-up|0|||
124885654|NCT01763788|449204446|FG002|Overall Study|Lost to Follow-up|1|||
124885655|NCT01763788|449204447|FG003|Overall Study|Lost to Follow-up|0|||
124885656|NCT03893825|449204448|FG000|Overall Study|Death|2|||
124885657|NCT03893825|449204449|FG001|Overall Study|Death|1|||
124885658|NCT03893825|449204448|FG000|Overall Study|Adverse Event|0|||
124885659|NCT03893825|449204449|FG001|Overall Study|Adverse Event|2|||
124885660|NCT03893825|449204448|FG000|Overall Study|Withdrawal by Subject|19|||
124885661|NCT03893825|449204449|FG001|Overall Study|Withdrawal by Subject|21|||
124885662|NCT03893825|449204448|FG000|Overall Study|Protocol deviation|1|||
124885663|NCT03893825|449204449|FG001|Overall Study|Protocol deviation|0|||
124885664|NCT03893825|449204448|FG000|Overall Study|Lost to Follow-up|10|||
124885665|NCT03893825|449204449|FG001|Overall Study|Lost to Follow-up|10|||
124885666|NCT03893825|449204448|FG000|Overall Study|Other than specified|7|||
124885667|NCT03893825|449204449|FG001|Overall Study|Other than specified|6|||
124885668|NCT02086552|449204452|FG000|Overall Study|Withdrawal by Subject|1|||
124885669|NCT00708305|449204453|FG000|Period 1|Protocol Violation|1|||
124885670|NCT00708305|449204454|FG001|Period 1|Protocol Violation|0|||
124885671|NCT00708305|449204455|FG002|Period 1|Protocol Violation|1|||
124885672|NCT00708305|449204456|FG003|Period 1|Protocol Violation|0|||
124885673|NCT00708305|449204453|FG000|Period 1|Other Reason|0|||
124885674|NCT00708305|449204454|FG001|Period 1|Other Reason|0|||
124885675|NCT00708305|449204455|FG002|Period 1|Other Reason|0|||
124885676|NCT00708305|449204456|FG003|Period 1|Other Reason|2|||
124885677|NCT00708305|449204453|FG000|Period 2|Lost to Follow-up|0|||
124885678|NCT00708305|449204454|FG001|Period 2|Lost to Follow-up|1|||
124885679|NCT00708305|449204455|FG002|Period 2|Lost to Follow-up|0|||
124885680|NCT00708305|449204456|FG003|Period 2|Lost to Follow-up|0|||
124885681|NCT00708305|449204453|FG000|Period 2|Protocol Violation|0|||
124885682|NCT00708305|449204454|FG001|Period 2|Protocol Violation|1|||
124885683|NCT00708305|449204455|FG002|Period 2|Protocol Violation|0|||
124885684|NCT00708305|449204456|FG003|Period 2|Protocol Violation|0|||
124885685|NCT00708305|449204453|FG000|Period 2|Other Reason|1|||
124885686|NCT00708305|449204454|FG001|Period 2|Other Reason|0|||
124885687|NCT00708305|449204455|FG002|Period 2|Other Reason|0|||
124885688|NCT00708305|449204456|FG003|Period 2|Other Reason|1|||
124885689|NCT00708305|449204453|FG000|Period 3|Protocol Violation|0|||
124885690|NCT00708305|449204454|FG001|Period 3|Protocol Violation|2|||
124885691|NCT00708305|449204455|FG002|Period 3|Protocol Violation|0|||
124885692|NCT00708305|449204456|FG003|Period 3|Protocol Violation|0|||
124885693|NCT00708305|449204453|FG000|Period 3|Other Reason|1|||
124885694|NCT00708305|449204454|FG001|Period 3|Other Reason|0|||
124885695|NCT00708305|449204455|FG002|Period 3|Other Reason|0|||
124885696|NCT00708305|449204456|FG003|Period 3|Other Reason|0|||
124885697|NCT02823964|449204461|FG000|Overall Study|Adverse Event|2|||
124885698|NCT02823964|449204461|FG000|Overall Study|Physician Decision|1|||
124885699|NCT02823964|449204461|FG000|Overall Study|Lack of Efficacy|1|||
124885700|NCT02823964|449204461|FG000|Overall Study|Withdrawal by Subject|1|||
124885701|NCT04012814|449204464|FG000|Overall Study|Lost to Follow-up|4|||
124885702|NCT04012814|449204464|FG000|Overall Study|Withdrawal by Subject|2|||
124885703|NCT04012814|449204464|FG000|Overall Study|Protocol Violation|1|||
124885704|NCT04012814|449204464|FG000|Overall Study|Adverse Event|1|||
124885705|NCT00390455|449204465|FG000|Overall Study|Adverse Event|17|||
124885706|NCT00390455|449204466|FG001|Overall Study|Adverse Event|3|||
124885707|NCT00390455|449204465|FG000|Overall Study|Withdrawal by Subject|8|||
124885708|NCT00390455|449204466|FG001|Overall Study|Withdrawal by Subject|8|||
124885709|NCT00390455|449204465|FG000|Overall Study|Alternate Treatment|0|||
124885710|NCT00390455|449204466|FG001|Overall Study|Alternate Treatment|1|||
124885711|NCT00390455|449204465|FG000|Overall Study|Other Medical Reasons|7|||
124885712|NCT00390455|449204466|FG001|Overall Study|Other Medical Reasons|11|||
124885713|NCT04397523|449204467|FG000|Overall Study|Lost to Follow-up|3|||
124885714|NCT04397523|449204467|FG000|Overall Study|Transfer from/to other hospital|8|||
124885715|NCT01275196|449204468|FG000|Overall Study|Adverse Event|3|||
124885716|NCT01275196|449204469|FG001|Overall Study|Adverse Event|5|||
124885717|NCT01275196|449204468|FG000|Overall Study|Withdrawal by Subject|4|||
124885718|NCT01275196|449204469|FG001|Overall Study|Withdrawal by Subject|5|||
124885719|NCT01275196|449204468|FG000|Overall Study|Lost to Follow-up|1|||
124885720|NCT01275196|449204469|FG001|Overall Study|Lost to Follow-up|0|||
124885721|NCT01275196|449204468|FG000|Overall Study|Disease Progression|6|||
124885722|NCT01275196|449204469|FG001|Overall Study|Disease Progression|5|||
124885723|NCT01275196|449204468|FG000|Overall Study|Protocol Violation|1|||
124885724|NCT01275196|449204469|FG001|Overall Study|Protocol Violation|0|||
124885725|NCT01275196|449204468|FG000|Overall Study|Suboptimal response/treatment failure|5|||
124885726|NCT01275196|449204469|FG001|Overall Study|Suboptimal response/treatment failure|6|||
124885727|NCT02838628|449204500|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
124885728|NCT02838628|449204501|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
124885729|NCT02838628|449204500|FG000|Recurrence Follow-up Period|Adverse Event|1|||
124885730|NCT02838628|449204501|FG001|Recurrence Follow-up Period|Adverse Event|0|||
124885731|NCT02838628|449204500|FG000|Recurrence Follow-up Period|Non-compliance|0|||
124885732|NCT02838628|449204501|FG001|Recurrence Follow-up Period|Non-compliance|1|||
124885733|NCT02838628|449204500|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
124885734|NCT02838628|449204501|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
124885735|NCT02838628|449204500|FG000|Recurrence Follow-up Period|Other un-specified|1|||
124885736|NCT02838628|449204501|FG001|Recurrence Follow-up Period|Other un-specified|1|||
124885737|NCT05033080|449204504|FG000|Overall Study|Adverse Event|4|||
124885738|NCT05033080|449204505|FG001|Overall Study|Adverse Event|4|||
124885739|NCT05033080|449204504|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
124885740|NCT05033080|449204505|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
124885741|NCT05033080|449204504|FG000|Overall Study|Lost to Follow-up|1|||
124885742|NCT05033080|449204505|FG001|Overall Study|Lost to Follow-up|0|||
124885743|NCT05033080|449204504|FG000|Overall Study|Other non-compliance|0|||
124885744|NCT05033080|449204505|FG001|Overall Study|Other non-compliance|1|||
124885745|NCT05033080|449204504|FG000|Overall Study|Physician Decision|0|||
124885746|NCT05033080|449204505|FG001|Overall Study|Physician Decision|1|||
124885747|NCT05033080|449204504|FG000|Overall Study|Other|1|||
125015333|NCT00586495|449680691|FG000|Follow-up|Switch to commercial drug|10|||
125015334|NCT02595723|449680692|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
125015335|NCT02595723|449680693|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
125015336|NCT02595723|449680694|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
125015337|NCT02595723|449680692|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
125015338|NCT02595723|449680693|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
125015339|NCT02595723|449680694|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
125015340|NCT00004259|449680695|FG000|Overall Study|Protocol Violation|1|||
125015341|NCT00004259|449680696|FG001|Overall Study|Protocol Violation|2|||
125015342|NCT00004259|449680697|FG002|Overall Study|Protocol Violation|0|||
125015343|NCT00004259|449680698|FG003|Overall Study|Protocol Violation|0|||
125015344|NCT00004259|449680695|FG000|Overall Study|Withdrawal by Subject|0|||
124885748|NCT05033080|449204505|FG001|Overall Study|Other|1|||
124885749|NCT03560245|449204506|FG000|Overall Study|Withdrawal by Subject|3|||
124885750|NCT03560245|449204507|FG001|Overall Study|Withdrawal by Subject|2|||
124885751|NCT03560245|449204506|FG000|Overall Study|Adverse Event|1|||
124885752|NCT03560245|449204507|FG001|Overall Study|Adverse Event|1|||
124885753|NCT03560245|449204506|FG000|Overall Study|Protocol Violation|1|||
124885754|NCT03560245|449204507|FG001|Overall Study|Protocol Violation|0|||
124885755|NCT03560245|449204506|FG000|Overall Study|Death|0|||
124885756|NCT03560245|449204507|FG001|Overall Study|Death|1|||
124885757|NCT03560245|449204506|FG000|Overall Study|Lost to Follow-up|0|||
124885758|NCT03560245|449204507|FG001|Overall Study|Lost to Follow-up|1|||
124885759|NCT03560245|449204506|FG000|Overall Study|Physician Decision|0|||
124885760|NCT03560245|449204507|FG001|Overall Study|Physician Decision|1|||
124885761|NCT03560245|449204506|FG000|Overall Study|Other|0|||
124885762|NCT03560245|449204507|FG001|Overall Study|Other|1|||
124885763|NCT01265823|449204508|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
125015345|NCT00004259|449680696|FG001|Overall Study|Withdrawal by Subject|2|||
125015346|NCT00004259|449680697|FG002|Overall Study|Withdrawal by Subject|0|||
124885764|NCT01265823|449204508|FG000|Overall Study|Failure to Return|4|||
124885765|NCT01265823|449204508|FG000|Overall Study|Protocol Violation|1|||
124885766|NCT01265823|449204508|FG000|Overall Study|Participant Request|1|||
124885767|NCT01018563|449204519|FG000|Overall Study|Termination of the study by Sponsor|2|||
124885768|NCT01018563|449204520|FG001|Overall Study|Termination of the study by Sponsor|1|||
124885769|NCT00903786|449204523|FG000|Overall Study|Physician Decision|6|||
124885770|NCT00903786|449204523|FG000|Overall Study|Lack of Efficacy|5|||
124885771|NCT00903786|449204523|FG000|Overall Study|Reason other than lack of efficacy|4|||
124885772|NCT05822921|449204530|FG000|Overall Study|Lost to Follow-up|1|||
124885773|NCT05822921|449204531|FG001|Overall Study|Lost to Follow-up|1|||
124885774|NCT03406702|449204532|FG000|Overall Study|Missed Day 27 Dosing|1|||
124885775|NCT01857622|449204533|FG000|Overall Study|Adverse Event|5|||
124885776|NCT01857622|449204534|FG001|Overall Study|Adverse Event|0|||
124885777|NCT01857622|449204535|FG002|Overall Study|Adverse Event|2|||
124885778|NCT01857622|449204533|FG000|Overall Study|Physician Decision|1|||
124885779|NCT01857622|449204534|FG001|Overall Study|Physician Decision|0|||
124885780|NCT01857622|449204535|FG002|Overall Study|Physician Decision|0|||
124885781|NCT01857622|449204533|FG000|Overall Study|Protocol Violation|4|||
124885782|NCT01857622|449204534|FG001|Overall Study|Protocol Violation|1|||
124885783|NCT01857622|449204535|FG002|Overall Study|Protocol Violation|0|||
124885784|NCT01857622|449204533|FG000|Overall Study|Withdrawal by Subject|1|||
124885785|NCT01857622|449204534|FG001|Overall Study|Withdrawal by Subject|0|||
124885786|NCT01857622|449204535|FG002|Overall Study|Withdrawal by Subject|0|||
124885787|NCT04213989|449206455|FG000|Overall Study|Withdrawal by Subject|3|||
125015347|NCT00004259|449680698|FG003|Overall Study|Withdrawal by Subject|0|||
125015348|NCT00996944|449680699|FG000|Double-blind Treatment Period|Adverse Event|2|||
125015349|NCT00996944|449680700|FG001|Double-blind Treatment Period|Adverse Event|1|||
125015350|NCT00996944|449680699|FG000|Double-blind Treatment Period|Protocol Violation|1|||
125015351|NCT00996944|449680700|FG001|Double-blind Treatment Period|Protocol Violation|0|||
125015352|NCT00996944|449680699|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
125015353|NCT00996944|449680700|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
125015354|NCT00996944|449680699|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
125015355|NCT00996944|449680700|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
125015356|NCT00996944|449680699|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
125015357|NCT00996944|449680700|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
125015358|NCT00769184|449680701|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
125015359|NCT00769184|449680702|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
125015360|NCT00769184|449680701|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
125015361|NCT00769184|449680702|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
125015362|NCT00769184|449680701|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
125015363|NCT00769184|449680702|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
125015364|NCT00531752|449680705|FG000|First Double-blind Intervention Period|Adverse Event|2|||
125015365|NCT00531752|449680706|FG001|First Double-blind Intervention Period|Adverse Event|0|||
125015366|NCT00531752|449680707|FG002|First Double-blind Intervention Period|Adverse Event|1|||
125015367|NCT00531752|449680708|FG003|First Double-blind Intervention Period|Adverse Event|1|||
125015368|NCT00531752|449680705|FG000|First Double-blind Intervention Period|Other|1|||
125015369|NCT00531752|449680706|FG001|First Double-blind Intervention Period|Other|4|||
125015370|NCT00531752|449680707|FG002|First Double-blind Intervention Period|Other|4|||
125015371|NCT00531752|449680708|FG003|First Double-blind Intervention Period|Other|0|||
125015372|NCT00531752|449680705|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
125015373|NCT00531752|449680706|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
125015374|NCT00531752|449680707|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
125015375|NCT00531752|449680708|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
125015376|NCT00531752|449680705|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
125015377|NCT00531752|449680706|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
125015378|NCT00531752|449680707|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
125015379|NCT00531752|449680708|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
125015380|NCT00531752|449680705|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
125015381|NCT00531752|449680706|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
125015382|NCT00531752|449680707|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
125015383|NCT00531752|449680708|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
125015384|NCT00531752|449680705|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
125015385|NCT00531752|449680706|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
125015386|NCT00531752|449680707|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
125015387|NCT00531752|449680708|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
124885788|NCT04213989|449206456|FG001|Overall Study|Withdrawal by Subject|2|||
124885789|NCT04213989|449206455|FG000|Overall Study|Physician Decision|1|||
124885790|NCT04213989|449206456|FG001|Overall Study|Physician Decision|0|||
124885791|NCT04213989|449206455|FG000|Overall Study|Lost to Follow-up|0|||
124885792|NCT04213989|449206456|FG001|Overall Study|Lost to Follow-up|4|||
124885793|NCT01024959|449206460|FG000|Overall Study|ineligible|12|||
124885794|NCT01024959|449206460|FG000|Overall Study|results not evaluable|12|||
124885795|NCT01024959|449206460|FG000|Overall Study|missing results required for analysis|17|||
124885796|NCT00636792|449206461|FG000|Overall Study|Adverse Event|16|||
124885797|NCT00636792|449206461|FG000|Overall Study|Physician Decision|7|||
124885798|NCT00636792|449206461|FG000|Overall Study|Progressive Disease|4|||
124885799|NCT00636792|449206461|FG000|Overall Study|Withdrawal by Subject|3|||
124885800|NCT00636792|449206461|FG000|Overall Study|Other|3|||
124885801|NCT00709592|449206464|FG000|Overall Study|Unable to proceed to transplant|0|||
124885802|NCT00709592|449206465|FG001|Overall Study|Unable to proceed to transplant|1|||
124885803|NCT01950273|449206466|FG000|Overall Study|Protocol Violation|1|||
124885804|NCT01950273|449206467|FG001|Overall Study|Protocol Violation|0|||
124885805|NCT01950273|449206466|FG000|Overall Study|Withdrawal by Subject|2|||
124885806|NCT01950273|449206467|FG001|Overall Study|Withdrawal by Subject|0|||
124885807|NCT01950273|449206466|FG000|Overall Study|Other not defined above|1|||
124885808|NCT01950273|449206467|FG001|Overall Study|Other not defined above|0|||
124885809|NCT00472186|449206468|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
124885810|NCT00472186|449206469|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
124885811|NCT01254565|449206470|FG000|Overall Study|Non-compliance to Study Procedures|0|||
124885812|NCT01254565|449206471|FG001|Overall Study|Non-compliance to Study Procedures|0|||
124885813|NCT01254565|449206472|FG002|Overall Study|Non-compliance to Study Procedures|0|||
124885814|NCT01254565|449206473|FG003|Overall Study|Non-compliance to Study Procedures|0|||
124885815|NCT01254565|449206474|FG004|Overall Study|Non-compliance to Study Procedures|1|||
124885816|NCT01254565|449206475|FG005|Overall Study|Non-compliance to Study Procedures|0|||
124885817|NCT01254565|449206470|FG000|Overall Study|Did not Receive Treatment|1|||
124885818|NCT01254565|449206471|FG001|Overall Study|Did not Receive Treatment|1|||
124885819|NCT01254565|449206472|FG002|Overall Study|Did not Receive Treatment|0|||
124885820|NCT01254565|449206473|FG003|Overall Study|Did not Receive Treatment|0|||
124885821|NCT01254565|449206474|FG004|Overall Study|Did not Receive Treatment|3|||
124885822|NCT01254565|449206475|FG005|Overall Study|Did not Receive Treatment|4|||
124885823|NCT01254565|449206470|FG000|Overall Study|Other|0|||
124885824|NCT01254565|449206471|FG001|Overall Study|Other|0|||
124885825|NCT01254565|449206472|FG002|Overall Study|Other|0|||
124885826|NCT01254565|449206473|FG003|Overall Study|Other|1|||
124885827|NCT01254565|449206474|FG004|Overall Study|Other|0|||
124885828|NCT01254565|449206475|FG005|Overall Study|Other|0|||
124885829|NCT00178256|449206476|FG000|Overall Study|Adverse Event|2|||
124885830|NCT00178256|449206477|FG001|Overall Study|Adverse Event|0|||
124885831|NCT00178256|449206478|FG002|Overall Study|Adverse Event|0|||
124885832|NCT00178256|449206479|FG003|Overall Study|Adverse Event|0|||
124885833|NCT00178256|449206476|FG000|Overall Study|Death|0|||
124885834|NCT00178256|449206477|FG001|Overall Study|Death|1|||
124885835|NCT00178256|449206478|FG002|Overall Study|Death|0|||
124885836|NCT00178256|449206479|FG003|Overall Study|Death|1|||
124885837|NCT00178256|449206476|FG000|Overall Study|Cancer progression|2|||
124885838|NCT00178256|449206477|FG001|Overall Study|Cancer progression|0|||
124885839|NCT00178256|449206478|FG002|Overall Study|Cancer progression|0|||
124885840|NCT00178256|449206479|FG003|Overall Study|Cancer progression|1|||
124885841|NCT04076020|449206483|FG000|Overall Study|Death|4|||
124885842|NCT04076020|449206484|FG001|Overall Study|Death|6|||
124885843|NCT04076020|449206483|FG000|Overall Study|Withdrawal by Subject|12|||
124885844|NCT04076020|449206484|FG001|Overall Study|Withdrawal by Subject|8|||
124885845|NCT02310126|449206486|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
124885846|NCT02310126|449206487|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
124885847|NCT02310126|449206486|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
124885848|NCT02310126|449206487|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
124885849|NCT02761629|449206494|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
124885850|NCT02761629|449206495|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
124885851|NCT02761629|449206494|FG000|Overall Study|Insufficient Therapeutic Response|2|||
124885852|NCT02761629|449206495|FG001|Overall Study|Insufficient Therapeutic Response|7|||
124885853|NCT02761629|449206494|FG000|Overall Study|Failure to Return|2|||
124885854|NCT02761629|449206495|FG001|Overall Study|Failure to Return|4|||
124885855|NCT02761629|449206494|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
124885856|NCT02761629|449206495|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
124885857|NCT02761629|449206494|FG000|Overall Study|Protocol Violation|2|||
125015388|NCT00531752|449680705|FG000|Second Double-blind Intervention Period|Other|1|||
125015389|NCT00531752|449680706|FG001|Second Double-blind Intervention Period|Other|1|||
124885858|NCT02761629|449206495|FG001|Overall Study|Protocol Violation|2|||
124885859|NCT02761629|449206494|FG000|Overall Study|Withdrawal by Subject|0|||
124885860|NCT02761629|449206495|FG001|Overall Study|Withdrawal by Subject|3|||
124885861|NCT02761629|449206494|FG000|Overall Study|Other|0|||
124885862|NCT02761629|449206495|FG001|Overall Study|Other|2|||
124885863|NCT02761629|449206494|FG000|Overall Study|Lost to Follow-up|4|||
124885864|NCT02761629|449206495|FG001|Overall Study|Lost to Follow-up|1|||
124885865|NCT02761629|449206494|FG000|Overall Study|Randomized But Not Treated|8|||
124885866|NCT02761629|449206495|FG001|Overall Study|Randomized But Not Treated|4|||
124885867|NCT02001974|449206498|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
124885868|NCT02001974|449206499|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
124885869|NCT02001974|449206500|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
124885870|NCT02001974|449206498|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
124885871|NCT02001974|449206499|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
124885872|NCT02001974|449206500|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
124885873|NCT02001974|449206498|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
124885874|NCT02001974|449206499|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
124885875|NCT02001974|449206500|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
124885876|NCT02001974|449206498|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
124885877|NCT02001974|449206499|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
124885878|NCT02001974|449206500|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
124885879|NCT00672958|449206501|FG000|Overall Study|Adverse Event|11|||
124885880|NCT00672958|449206502|FG001|Overall Study|Adverse Event|9|||
124885881|NCT00672958|449206501|FG000|Overall Study|Lack of Efficacy|6|||
124885882|NCT00672958|449206502|FG001|Overall Study|Lack of Efficacy|11|||
124885883|NCT00672958|449206501|FG000|Overall Study|Non-compliance with study drug|2|||
124885884|NCT00672958|449206502|FG001|Overall Study|Non-compliance with study drug|3|||
124885885|NCT00672958|449206501|FG000|Overall Study|Protocol deviations|11|||
124885886|NCT00672958|449206502|FG001|Overall Study|Protocol deviations|5|||
124885887|NCT00672958|449206501|FG000|Overall Study|Voluntary withdrawal|12|||
124885888|NCT00672958|449206502|FG001|Overall Study|Voluntary withdrawal|8|||
124885889|NCT00672958|449206501|FG000|Overall Study|Lost to Follow-up|22|||
124885890|NCT00672958|449206502|FG001|Overall Study|Lost to Follow-up|17|||
124885891|NCT00672958|449206501|FG000|Overall Study|Reason not specified|0|||
124885892|NCT00672958|449206502|FG001|Overall Study|Reason not specified|3|||
124885893|NCT01380990|449206503|FG000|Overall Study|Treatment Failure|1|||
124885894|NCT01380990|449206504|FG001|Overall Study|Treatment Failure|0|||
124885895|NCT01380990|449206503|FG000|Overall Study|Death|0|||
124885896|NCT01380990|449206504|FG001|Overall Study|Death|1|||
124885897|NCT02374593|449206506|FG000|Overall Study|non-compliant|2|||
124885898|NCT02374593|449206507|FG001|Overall Study|non-compliant|0|||
124885899|NCT04267614|449206508|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
124885900|NCT04267614|449206508|FG000|Overall Study|Lost to Follow-up|115|||
124885901|NCT00210119|449206509|FG000|Overall Study|Protocol Violation|1|||
124885902|NCT00210119|449206509|FG000|Overall Study|Withdrawal by Subject|1|||
124885903|NCT04827134|449206510|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
124885904|NCT04827134|449206511|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
124885905|NCT04827134|449206512|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
124885906|NCT04827134|449206513|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
124885907|NCT01830881|449206514|FG000|Overall Study|Changed decision to have an abortion|0|||
124885908|NCT01830881|449206515|FG001|Overall Study|Changed decision to have an abortion|1|||
124885909|NCT00988351|449206516|FG000|Overall Study|Withdrawal by Subject|8|||
124885910|NCT00988351|449206517|FG001|Overall Study|Withdrawal by Subject|0|||
124885911|NCT00988351|449206516|FG000|Overall Study|Lost to Follow-up|6|||
124885912|NCT00988351|449206517|FG001|Overall Study|Lost to Follow-up|9|||
124885913|NCT00988351|449206516|FG000|Overall Study|not using CPAP|5|||
124885914|NCT00988351|449206517|FG001|Overall Study|not using CPAP|3|||
124885915|NCT02038764|449206518|FG000|Overall Study|Adverse Event|0|||
124885916|NCT02038764|449206519|FG001|Overall Study|Adverse Event|0|||
124885917|NCT02038764|449206520|FG002|Overall Study|Adverse Event|1|||
124885918|NCT02038764|449206521|FG003|Overall Study|Adverse Event|0|||
124885919|NCT02038764|449206522|FG004|Overall Study|Adverse Event|0|||
124885920|NCT02038764|449206518|FG000|Overall Study|Lost to Follow-up|0|||
124885921|NCT02038764|449206519|FG001|Overall Study|Lost to Follow-up|1|||
124885922|NCT02038764|449206520|FG002|Overall Study|Lost to Follow-up|0|||
124885923|NCT02038764|449206521|FG003|Overall Study|Lost to Follow-up|0|||
124885924|NCT02038764|449206522|FG004|Overall Study|Lost to Follow-up|0|||
125015390|NCT00531752|449680707|FG002|Second Double-blind Intervention Period|Other|0|||
125015391|NCT00531752|449680708|FG003|Second Double-blind Intervention Period|Other|0|||
124885925|NCT02038764|449206518|FG000|Overall Study|Withdrawal by Subject|0|||
124885926|NCT02038764|449206519|FG001|Overall Study|Withdrawal by Subject|0|||
124885927|NCT02038764|449206520|FG002|Overall Study|Withdrawal by Subject|0|||
124885928|NCT02038764|449206521|FG003|Overall Study|Withdrawal by Subject|0|||
124885929|NCT02038764|449206522|FG004|Overall Study|Withdrawal by Subject|1|||
124885930|NCT02038764|449206518|FG000|Overall Study|Other|1|||
124885931|NCT02038764|449206519|FG001|Overall Study|Other|0|||
124885932|NCT02038764|449206520|FG002|Overall Study|Other|1|||
124885933|NCT02038764|449206521|FG003|Overall Study|Other|0|||
124885934|NCT02038764|449206522|FG004|Overall Study|Other|0|||
124885935|NCT04844918|449206526|FG000|Overall Study|Adverse Event|7|||
124885936|NCT04844918|449206527|FG001|Overall Study|Adverse Event|8|||
124885937|NCT04844918|449206528|FG002|Overall Study|Adverse Event|5|||
124885938|NCT04844918|449206526|FG000|Overall Study|Physician Decision|0|||
124885939|NCT04844918|449206527|FG001|Overall Study|Physician Decision|1|||
124885940|NCT04844918|449206528|FG002|Overall Study|Physician Decision|0|||
124885941|NCT04844918|449206526|FG000|Overall Study|Withdrawal by Subject|6|||
124885942|NCT04844918|449206527|FG001|Overall Study|Withdrawal by Subject|3|||
124885943|NCT04844918|449206528|FG002|Overall Study|Withdrawal by Subject|3|||
124885944|NCT04844918|449206526|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
124885945|NCT04844918|449206527|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
124885946|NCT04844918|449206528|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
124885947|NCT01927731|449206543|FG000|Overall Study|Graft Failure|1|||
124885948|NCT01927731|449206544|FG001|Overall Study|Graft Failure|2|||
124885949|NCT01927731|449206543|FG000|Overall Study|Physician Decision|2|||
124885950|NCT01927731|449206544|FG001|Overall Study|Physician Decision|3|||
124885951|NCT01927731|449206543|FG000|Overall Study|Withdrawal by Subject|0|||
124885952|NCT01927731|449206544|FG001|Overall Study|Withdrawal by Subject|2|||
124885953|NCT01927731|449206543|FG000|Overall Study|Death|0|||
124885954|NCT01927731|449206544|FG001|Overall Study|Death|3|||
124885955|NCT01388530|449206545|FG000|Overall Study|Lost to Follow-up|5|||
124885956|NCT02743793|449206548|FG000|Overall Study|Death|1|||
124885957|NCT02743793|449206549|FG001|Overall Study|Death|1|||
124885958|NCT02743793|449206548|FG000|Overall Study|Withdrawal by Subject|0|||
124885959|NCT02743793|449206549|FG001|Overall Study|Withdrawal by Subject|1|||
124885960|NCT02743793|449206548|FG000|Overall Study|Screen Failure|4|||
124885961|NCT02743793|449206549|FG001|Overall Study|Screen Failure|0|||
124885962|NCT02743793|449206548|FG000|Overall Study|No Primary Care Physician|0|||
124885963|NCT02743793|449206549|FG001|Overall Study|No Primary Care Physician|1|||
124885964|NCT02743793|449206548|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
124885965|NCT02743793|449206549|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
124885966|NCT02743793|449206548|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
124885967|NCT02743793|449206549|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
124885968|NCT02065570|449206550|FG000|Induction Study|Adverse Event|5|||
124885969|NCT02065570|449206551|FG001|Induction Study|Adverse Event|12|||
124885970|NCT02065570|449206552|FG002|Induction Study|Adverse Event|0|||
124885971|NCT02065570|449206553|FG003|Induction Study|Adverse Event|0|||
124885972|NCT02065570|449206550|FG000|Induction Study|Withdrawal by Subject|2|||
124885973|NCT02065570|449206551|FG001|Induction Study|Withdrawal by Subject|3|||
124885974|NCT02065570|449206552|FG002|Induction Study|Withdrawal by Subject|0|||
124885975|NCT02065570|449206553|FG003|Induction Study|Withdrawal by Subject|0|||
124885976|NCT02065570|449206550|FG000|Induction Study|Lost to Follow-up|1|||
124885977|NCT02065570|449206551|FG001|Induction Study|Lost to Follow-up|1|||
124885978|NCT02065570|449206552|FG002|Induction Study|Lost to Follow-up|0|||
124885979|NCT02065570|449206553|FG003|Induction Study|Lost to Follow-up|0|||
124885980|NCT02065570|449206550|FG000|Induction Study|Other, Not Specified|6|||
124885981|NCT02065570|449206551|FG001|Induction Study|Other, Not Specified|5|||
124885982|NCT02065570|449206552|FG002|Induction Study|Other, Not Specified|0|||
124885983|NCT02065570|449206553|FG003|Induction Study|Other, Not Specified|0|||
124885984|NCT02065570|449206550|FG000|Maintenance Study|Adverse Event|0|||
124885985|NCT02065570|449206551|FG001|Maintenance Study|Adverse Event|0|||
124885986|NCT02065570|449206552|FG002|Maintenance Study|Adverse Event|8|||
124885987|NCT02065570|449206553|FG003|Maintenance Study|Adverse Event|8|||
124885988|NCT02065570|449206550|FG000|Maintenance Study|Withdrawal by Subject|0|||
124885989|NCT02065570|449206551|FG001|Maintenance Study|Withdrawal by Subject|0|||
124885990|NCT02065570|449206552|FG002|Maintenance Study|Withdrawal by Subject|1|||
124885991|NCT02065570|449206553|FG003|Maintenance Study|Withdrawal by Subject|4|||
125015392|NCT00531752|449680705|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
125015393|NCT00531752|449680706|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
125015394|NCT00531752|449680707|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
125015395|NCT00531752|449680708|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
125015396|NCT00531752|449680705|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
124885992|NCT02065570|449206550|FG000|Maintenance Study|Lost to Follow-up|0|||
124885993|NCT02065570|449206551|FG001|Maintenance Study|Lost to Follow-up|0|||
124885994|NCT02065570|449206552|FG002|Maintenance Study|Lost to Follow-up|2|||
124885995|NCT02065570|449206553|FG003|Maintenance Study|Lost to Follow-up|2|||
124885996|NCT02065570|449206550|FG000|Maintenance Study|Other, Not Specified|0|||
124885997|NCT02065570|449206551|FG001|Maintenance Study|Other, Not Specified|0|||
124885998|NCT02065570|449206552|FG002|Maintenance Study|Other, Not Specified|11|||
124885999|NCT02065570|449206553|FG003|Maintenance Study|Other, Not Specified|5|||
124886000|NCT02293837|449206556|FG000|Overall Study|Lost to Follow-up|0|||
124886001|NCT02293837|449206557|FG001|Overall Study|Lost to Follow-up|2|||
124886002|NCT02293837|449206558|FG002|Overall Study|Lost to Follow-up|1|||
125104941|NCT00358670|450005823|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
125104942|NCT00358670|450005822|FG000|Overall Study|Administrative|153|||
125104943|NCT00358670|450005823|FG001|Overall Study|Administrative|125|||
125104944|NCT05083559|450005824|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
125104945|NCT05083559|450005825|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
125104946|NCT05083559|450005824|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
125104947|NCT05083559|450005825|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
125104948|NCT05083559|450005824|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
125104949|NCT05083559|450005825|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
125104950|NCT03428217|450005827|FG000|Overall Study|Death|89|||
125104951|NCT03428217|450005828|FG001|Overall Study|Death|93|||
125104952|NCT03428217|450005827|FG000|Overall Study|Withdrawal by Subject|8|||
125104953|NCT03428217|450005828|FG001|Overall Study|Withdrawal by Subject|7|||
125104954|NCT03428217|450005827|FG000|Overall Study|Lost to Follow-up|1|||
125104955|NCT03428217|450005828|FG001|Overall Study|Lost to Follow-up|3|||
125104956|NCT03428217|450005827|FG000|Overall Study|Study terminated by sponsor|124|||
125104957|NCT03428217|450005828|FG001|Overall Study|Study terminated by sponsor|118|||
125104958|NCT03428217|450005827|FG000|Overall Study|Other, Not Specified|1|||
125104959|NCT03428217|450005828|FG001|Overall Study|Other, Not Specified|0|||
125104960|NCT05899218|450005829|FG000|Overall Study|Lost to Follow-up|2|||
125104961|NCT05899218|450005830|FG001|Overall Study|Lost to Follow-up|2|||
124886003|NCT02293837|449206559|FG003|Overall Study|Lost to Follow-up|0|||
124886004|NCT02293837|449206556|FG000|Overall Study|Withdrawal by Subject|2|||
124886005|NCT02293837|449206557|FG001|Overall Study|Withdrawal by Subject|1|||
124886006|NCT02293837|449206558|FG002|Overall Study|Withdrawal by Subject|2|||
124886007|NCT02293837|449206559|FG003|Overall Study|Withdrawal by Subject|1|||
124886008|NCT02293837|449206556|FG000|Overall Study|COVID-19 Related|1|||
124886009|NCT02293837|449206557|FG001|Overall Study|COVID-19 Related|1|||
124886010|NCT02293837|449206558|FG002|Overall Study|COVID-19 Related|0|||
124886011|NCT02293837|449206559|FG003|Overall Study|COVID-19 Related|0|||
124886012|NCT02293837|449206556|FG000|Overall Study|Participant ill and could not be infused|0|||
124886013|NCT02293837|449206557|FG001|Overall Study|Participant ill and could not be infused|0|||
124886014|NCT02293837|449206558|FG002|Overall Study|Participant ill and could not be infused|1|||
124886015|NCT02293837|449206559|FG003|Overall Study|Participant ill and could not be infused|0|||
124886016|NCT04779242|449206560|FG000|Overall Study|Adverse Event|1|||
124886017|NCT04779242|449206561|FG001|Overall Study|Adverse Event|1|||
124886018|NCT04779242|449206560|FG000|Overall Study|Lost to Follow-up|2|||
124886019|NCT04779242|449206561|FG001|Overall Study|Lost to Follow-up|4|||
124886020|NCT04779242|449206560|FG000|Overall Study|Withdrawal by Subject|7|||
124886021|NCT04779242|449206561|FG001|Overall Study|Withdrawal by Subject|9|||
124886022|NCT04779242|449206560|FG000|Overall Study|Death|6|||
124886023|NCT04779242|449206561|FG001|Overall Study|Death|6|||
124886024|NCT04779242|449206560|FG000|Overall Study|COVID-19 related reasons|2|||
124886025|NCT04779242|449206561|FG001|Overall Study|COVID-19 related reasons|1|||
124886026|NCT04779242|449206560|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
124886027|NCT04779242|449206561|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
124886028|NCT04779242|449206560|FG000|Overall Study|Martial Law in Ukraine|2|||
124886029|NCT04779242|449206561|FG001|Overall Study|Martial Law in Ukraine|3|||
124886030|NCT03285113|449206564|FG000|Overall Study|Unable to implant leads|2|||
124886031|NCT00849680|449206567|FG000|Overall Study|Adverse Event|0|||
124886032|NCT00849680|449206568|FG001|Overall Study|Adverse Event|0|||
124886033|NCT00849680|449206569|FG002|Overall Study|Adverse Event|0|||
124886034|NCT00849680|449206570|FG003|Overall Study|Adverse Event|0|||
124886035|NCT00849680|449206571|FG004|Overall Study|Adverse Event|0|||
124886036|NCT00849680|449206572|FG005|Overall Study|Adverse Event|0|||
124886037|NCT00849680|449206573|FG006|Overall Study|Adverse Event|2|||
124886038|NCT00849680|449206574|FG007|Overall Study|Adverse Event|0|||
124886039|NCT00849680|449206567|FG000|Overall Study|Lost to Follow-up|7|||
124886040|NCT00849680|449206568|FG001|Overall Study|Lost to Follow-up|3|||
124886041|NCT00849680|449206569|FG002|Overall Study|Lost to Follow-up|12|||
124886042|NCT00849680|449206570|FG003|Overall Study|Lost to Follow-up|11|||
124886043|NCT00849680|449206571|FG004|Overall Study|Lost to Follow-up|8|||
124886044|NCT00849680|449206572|FG005|Overall Study|Lost to Follow-up|11|||
124886045|NCT00849680|449206573|FG006|Overall Study|Lost to Follow-up|12|||
124886046|NCT00849680|449206574|FG007|Overall Study|Lost to Follow-up|5|||
125015397|NCT00531752|449680706|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
125015398|NCT00531752|449680707|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
125015399|NCT00531752|449680708|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
125015400|NCT02821715|449680709|FG000|Overall Study|Protocol Violation|1|||
125015401|NCT02821715|449680710|FG001|Overall Study|Protocol Violation|0|||
125015402|NCT02821715|449680711|FG002|Overall Study|Protocol Violation|0|||
125015403|NCT02821715|449680712|FG003|Overall Study|Protocol Violation|0|||
125015404|NCT02821715|449680713|FG004|Overall Study|Protocol Violation|0|||
125015405|NCT02821715|449680714|FG005|Overall Study|Protocol Violation|0|||
125015406|NCT00640328|449680715|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
125015407|NCT00640328|449680716|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
125015408|NCT00640328|449680717|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
125015409|NCT00640328|449680718|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
125015410|NCT00640328|449680719|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
125015411|NCT00640328|449680720|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
125015412|NCT00640328|449680715|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
125015413|NCT00640328|449680716|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
125015414|NCT00640328|449680717|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
125104962|NCT05899218|450005829|FG000|Overall Study|deemed ineligible out of country|1|||
125104963|NCT05899218|450005830|FG001|Overall Study|deemed ineligible out of country|0|||
125104964|NCT03151226|450005831|FG000|Overall Study|Withdrawal by Subject|2|||
125104965|NCT03151226|450005831|FG000|Overall Study|not wear device correctly|1|||
125104966|NCT02304302|450005834|FG000|Overall Study|Adverse Event|2|||
124886047|NCT00849680|449206567|FG000|Overall Study|Subject moved|1|||
124886048|NCT00849680|449206568|FG001|Overall Study|Subject moved|0|||
124886049|NCT00849680|449206569|FG002|Overall Study|Subject moved|3|||
124886050|NCT00849680|449206570|FG003|Overall Study|Subject moved|1|||
124886051|NCT00849680|449206571|FG004|Overall Study|Subject moved|0|||
125104967|NCT02304302|450005835|FG001|Overall Study|Adverse Event|3|||
124886052|NCT00849680|449206572|FG005|Overall Study|Subject moved|2|||
124886053|NCT00849680|449206573|FG006|Overall Study|Subject moved|2|||
124886054|NCT00849680|449206574|FG007|Overall Study|Subject moved|2|||
124886055|NCT00849680|449206567|FG000|Overall Study|Withdrawal by Subject|2|||
124886056|NCT00849680|449206568|FG001|Overall Study|Withdrawal by Subject|0|||
124886057|NCT00849680|449206569|FG002|Overall Study|Withdrawal by Subject|0|||
124886058|NCT00849680|449206570|FG003|Overall Study|Withdrawal by Subject|2|||
124886059|NCT00849680|449206571|FG004|Overall Study|Withdrawal by Subject|2|||
124886060|NCT00849680|449206572|FG005|Overall Study|Withdrawal by Subject|2|||
124886061|NCT00849680|449206573|FG006|Overall Study|Withdrawal by Subject|1|||
124886062|NCT00849680|449206574|FG007|Overall Study|Withdrawal by Subject|1|||
124886063|NCT00849680|449206567|FG000|Overall Study|Subject unable to comply with protocol|1|||
124886064|NCT00849680|449206568|FG001|Overall Study|Subject unable to comply with protocol|0|||
124886065|NCT00849680|449206569|FG002|Overall Study|Subject unable to comply with protocol|0|||
124886066|NCT00849680|449206570|FG003|Overall Study|Subject unable to comply with protocol|0|||
124886067|NCT00849680|449206571|FG004|Overall Study|Subject unable to comply with protocol|0|||
124886068|NCT00849680|449206572|FG005|Overall Study|Subject unable to comply with protocol|0|||
124886069|NCT00849680|449206573|FG006|Overall Study|Subject unable to comply with protocol|0|||
124886070|NCT00849680|449206574|FG007|Overall Study|Subject unable to comply with protocol|0|||
124886071|NCT01461993|449206576|FG000|Overall Study|Withdrawal by Subject|60|||
124886072|NCT01461993|449206577|FG001|Overall Study|Withdrawal by Subject|53|||
124886073|NCT01461993|449206578|FG002|Overall Study|Withdrawal by Subject|16|||
124886074|NCT01461993|449206576|FG000|Overall Study|Lost to Follow-up|44|||
124886075|NCT01461993|449206577|FG001|Overall Study|Lost to Follow-up|48|||
124886076|NCT01461993|449206578|FG002|Overall Study|Lost to Follow-up|22|||
124886077|NCT01461993|449206576|FG000|Overall Study|Protocol Violation|10|||
124886078|NCT01461993|449206577|FG001|Overall Study|Protocol Violation|9|||
124886079|NCT01461993|449206578|FG002|Overall Study|Protocol Violation|7|||
124886080|NCT01461993|449206576|FG000|Overall Study|Adverse Event|9|||
124886081|NCT01461993|449206577|FG001|Overall Study|Adverse Event|11|||
124886082|NCT01461993|449206578|FG002|Overall Study|Adverse Event|3|||
124886083|NCT01461993|449206576|FG000|Overall Study|No longer met eligibility criteria|13|||
124886084|NCT01461993|449206577|FG001|Overall Study|No longer met eligibility criteria|18|||
124886085|NCT01461993|449206578|FG002|Overall Study|No longer met eligibility criteria|10|||
124886086|NCT01461993|449206576|FG000|Overall Study|Did not meet entrance criteria|2|||
124886087|NCT01461993|449206577|FG001|Overall Study|Did not meet entrance criteria|3|||
124886088|NCT01461993|449206578|FG002|Overall Study|Did not meet entrance criteria|0|||
124886089|NCT01461993|449206576|FG000|Overall Study|Other|13|||
124886090|NCT01461993|449206577|FG001|Overall Study|Other|15|||
124886091|NCT01461993|449206578|FG002|Overall Study|Other|6|||
124886092|NCT00219141|449206580|FG000|Overall Study|Adverse Event|4|||
124886093|NCT00219141|449206581|FG001|Overall Study|Adverse Event|10|||
124886094|NCT00219141|449206582|FG002|Overall Study|Adverse Event|5|||
124886095|NCT00219141|449206580|FG000|Overall Study|Lack of Efficacy|3|||
124886096|NCT00219141|449206581|FG001|Overall Study|Lack of Efficacy|2|||
124886097|NCT00219141|449206582|FG002|Overall Study|Lack of Efficacy|0|||
124886098|NCT00219141|449206580|FG000|Overall Study|Administrative problems|0|||
124886099|NCT00219141|449206581|FG001|Overall Study|Administrative problems|1|||
124886100|NCT00219141|449206582|FG002|Overall Study|Administrative problems|0|||
124886101|NCT00219141|449206580|FG000|Overall Study|Lost to Follow-up|2|||
124886102|NCT00219141|449206581|FG001|Overall Study|Lost to Follow-up|4|||
124886103|NCT00219141|449206582|FG002|Overall Study|Lost to Follow-up|1|||
124886104|NCT00219141|449206580|FG000|Overall Study|Protocol Violation|3|||
124886105|NCT00219141|449206581|FG001|Overall Study|Protocol Violation|1|||
124886106|NCT00219141|449206582|FG002|Overall Study|Protocol Violation|1|||
124886107|NCT00219141|449206580|FG000|Overall Study|Withdrawal by Subject|1|||
124886108|NCT00219141|449206581|FG001|Overall Study|Withdrawal by Subject|3|||
124886109|NCT00219141|449206582|FG002|Overall Study|Withdrawal by Subject|5|||
124886110|NCT00219141|449206580|FG000|Overall Study|Condition no longer requires study drug|1|||
124886111|NCT00219141|449206581|FG001|Overall Study|Condition no longer requires study drug|0|||
124886112|NCT00219141|449206582|FG002|Overall Study|Condition no longer requires study drug|0|||
124886113|NCT02066532|449206585|FG000|Phase II|Withdrawal by Subject|1|||
124886114|NCT02066532|449206586|FG001|Phase II|Withdrawal by Subject|0|||
124886115|NCT02066532|449206587|FG002|Phase II|Withdrawal by Subject|0|||
124886116|NCT02066532|449206588|FG003|Phase II|Withdrawal by Subject|0|||
124886117|NCT01263106|449206595|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
124886118|NCT01263106|449206596|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
124886119|NCT01680458|449206602|FG000|Overall Study|Protocol Violation|3|||
124886120|NCT00544544|449206609|FG000|Overall Study|Withdrawal by Subject|1|||
124886121|NCT00544544|449206609|FG000|Overall Study|Adverse Event|1|||
124886122|NCT00544544|449206609|FG000|Overall Study|Lost to Follow-up|1|||
124886123|NCT04318093|449206614|FG000|Overall Study|Adverse Event|2|||
124886124|NCT04318093|449206615|FG001|Overall Study|Adverse Event|2|||
124886125|NCT04318093|449206614|FG000|Overall Study|Participant withdrew consent|1|||
124886126|NCT04318093|449206615|FG001|Overall Study|Participant withdrew consent|0|||
124886127|NCT04318093|449206614|FG000|Overall Study|Other reasons|0|||
124886128|NCT04318093|449206615|FG001|Overall Study|Other reasons|1|||
124886129|NCT00127413|449206619|FG000|Overall Study|Lost to Follow-up|6|||
124886130|NCT00127413|449206620|FG001|Overall Study|Lost to Follow-up|4|||
124886131|NCT00127413|449206621|FG002|Overall Study|Lost to Follow-up|8|||
124886132|NCT00127413|449206622|FG003|Overall Study|Lost to Follow-up|2|||
124886133|NCT00547911|449206625|FG000|Overall Study|Adverse Event|0|||
124886134|NCT00547911|449206626|FG001|Overall Study|Adverse Event|0|||
124886135|NCT00547911|449206627|FG002|Overall Study|Adverse Event|0|||
124886136|NCT00547911|449206628|FG003|Overall Study|Adverse Event|1|||
124886137|NCT00547911|449206629|FG004|Overall Study|Adverse Event|0|||
124886138|NCT00547911|449206630|FG005|Overall Study|Adverse Event|0|||
124886139|NCT01644474|449206632|FG000|Overall Study|Poor compliance to protocol|1|||
124886140|NCT01644474|449206633|FG001|Overall Study|Poor compliance to protocol|0|||
124886141|NCT01644474|449206632|FG000|Overall Study|Consent withdrawn by participant|0|||
124886142|NCT01644474|449206633|FG001|Overall Study|Consent withdrawn by participant|1|||
124886143|NCT01644474|449206632|FG000|Overall Study|Participant moved|0|||
124886144|NCT01644474|449206633|FG001|Overall Study|Participant moved|1|||
124886145|NCT01644474|449206632|FG000|Overall Study|Adverse Event|4|||
124886146|NCT01644474|449206633|FG001|Overall Study|Adverse Event|5|||
124886147|NCT01644474|449206632|FG000|Overall Study|Site scheduling error|1|||
124886148|NCT01644474|449206633|FG001|Overall Study|Site scheduling error|1|||
124886149|NCT01644474|449206632|FG000|Overall Study|Protocol Violation|1|||
124886150|NCT01644474|449206633|FG001|Overall Study|Protocol Violation|0|||
124886151|NCT02023879|449206634|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
124886152|NCT02023879|449206635|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
124886153|NCT02023879|449206636|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
124886154|NCT02023879|449206634|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
124886155|NCT02023879|449206635|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
124886156|NCT02023879|449206636|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
124886157|NCT02023879|449206634|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
124886158|NCT02023879|449206635|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
124886159|NCT02023879|449206636|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
124886160|NCT02023879|449206634|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
124886161|NCT02023879|449206635|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
124886162|NCT02023879|449206636|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
124886163|NCT02023879|449206634|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
124886164|NCT02023879|449206635|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
124886165|NCT02023879|449206636|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
124886166|NCT02023879|449206634|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
124886167|NCT02023879|449206635|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
124886168|NCT02023879|449206636|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
124886169|NCT02023879|449206634|FG000|Extension Open Label Treatment|Adverse Event|1|||
124886170|NCT02023879|449206635|FG001|Extension Open Label Treatment|Adverse Event|7|||
124886171|NCT02023879|449206636|FG002|Extension Open Label Treatment|Adverse Event|3|||
124886172|NCT02023879|449206634|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
124886173|NCT02023879|449206635|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
124886174|NCT02023879|449206636|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
124886175|NCT02023879|449206634|FG000|Extension Open Label Treatment|Participant moved|1|||
124886176|NCT02023879|449206635|FG001|Extension Open Label Treatment|Participant moved|2|||
124886177|NCT02023879|449206636|FG002|Extension Open Label Treatment|Participant moved|0|||
124886178|NCT02023879|449206634|FG000|Extension Open Label Treatment|Other than specified above|2|||
124886179|NCT02023879|449206635|FG001|Extension Open Label Treatment|Other than specified above|7|||
124886180|NCT02023879|449206636|FG002|Extension Open Label Treatment|Other than specified above|2|||
124886181|NCT02044458|449206640|FG000|Overall Study|Protocol Violation|3|||
124886182|NCT02044458|449206641|FG001|Overall Study|Protocol Violation|8|||
124886183|NCT03363659|449206642|FG000|Overall Study|Adverse Event|1|||
124886184|NCT03363659|449206642|FG000|Overall Study|Screen fail|1|||
124886185|NCT03363659|449206642|FG000|Overall Study|Withdrawal by Subject|1|||
124886186|NCT03872388|449206643|FG000|Overall Study|Disease Progression|0|||
124886187|NCT03872388|449206644|FG001|Overall Study|Disease Progression|0|||
124886188|NCT03872388|449206645|FG002|Overall Study|Disease Progression|0|||
124886189|NCT03872388|449206646|FG003|Overall Study|Disease Progression|0|||
124886190|NCT03872388|449206647|FG004|Overall Study|Disease Progression|0|||
124886191|NCT03872388|449206648|FG005|Overall Study|Disease Progression|0|||
124886192|NCT03872388|449206649|FG006|Overall Study|Disease Progression|1|||
124886193|NCT03872388|449206650|FG007|Overall Study|Disease Progression|1|||
124886194|NCT01040780|449209495|FG000|Overall Study|Protocol Violation|1|||
124886195|NCT01040780|449209496|FG001|Overall Study|Protocol Violation|3|||
124886196|NCT00802737|449209497|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
124886197|NCT00802737|449209498|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
124886198|NCT00802737|449209499|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
124886199|NCT00802737|449209497|FG000|Overall Study|Death|6|||
124886200|NCT00802737|449209498|FG001|Overall Study|Death|5|||
124886201|NCT00802737|449209499|FG002|Overall Study|Death|1|||
124886202|NCT00802737|449209497|FG000|Overall Study|Adverse Event|1|||
124886203|NCT00802737|449209498|FG001|Overall Study|Adverse Event|0|||
124886204|NCT00802737|449209499|FG002|Overall Study|Adverse Event|0|||
124886205|NCT00802737|449209497|FG000|Overall Study|Received Prohibited Therapy|1|||
124886206|NCT00802737|449209498|FG001|Overall Study|Received Prohibited Therapy|0|||
124886207|NCT00802737|449209499|FG002|Overall Study|Received Prohibited Therapy|0|||
124886208|NCT00802737|449209497|FG000|Overall Study|Ongoing CLL-Treatment|0|||
124886209|NCT00802737|449209498|FG001|Overall Study|Ongoing CLL-Treatment|1|||
124886210|NCT00802737|449209499|FG002|Overall Study|Ongoing CLL-Treatment|0|||
124886211|NCT00802737|449209497|FG000|Overall Study|Participant too Unwell|0|||
124886212|NCT00802737|449209498|FG001|Overall Study|Participant too Unwell|2|||
124886213|NCT00802737|449209499|FG002|Overall Study|Participant too Unwell|0|||
124886214|NCT03864926|449209507|FG000|Overall Study|Death|0|||
124886215|NCT03864926|449209508|FG001|Overall Study|Death|2|||
124886216|NCT00445601|449209509|FG000|Overall Study|Withdrawal by Subject|11|||
124886217|NCT00445601|449209510|FG001|Overall Study|Withdrawal by Subject|11|||
124886218|NCT00445601|449209509|FG000|Overall Study|TURBT Complication|12|||
124886219|NCT00445601|449209510|FG001|Overall Study|TURBT Complication|8|||
124886220|NCT00445601|449209509|FG000|Overall Study|Incorrect Disease Status|6|||
124886221|NCT00445601|449209510|FG001|Overall Study|Incorrect Disease Status|6|||
124886222|NCT00445601|449209509|FG000|Overall Study|Drug Delivery Issue|2|||
124886223|NCT00445601|449209510|FG001|Overall Study|Drug Delivery Issue|2|||
124886224|NCT00445601|449209509|FG000|Overall Study|Adverse Event|2|||
124886225|NCT00445601|449209510|FG001|Overall Study|Adverse Event|0|||
124886226|NCT00445601|449209509|FG000|Overall Study|Death prior to TURBT|0|||
124886227|NCT00445601|449209510|FG001|Overall Study|Death prior to TURBT|1|||
124886228|NCT01625910|449209517|FG000|Overall Study|Lost to Follow-up|3|||
124886229|NCT01625910|449209518|FG001|Overall Study|Lost to Follow-up|4|||
124886230|NCT02959138|449209519|FG000|Overall Study|Enrolled but Never Treated|0|||
124886231|NCT02959138|449209520|FG001|Overall Study|Enrolled but Never Treated|1|||
124886232|NCT02959138|449209521|FG002|Overall Study|Enrolled but Never Treated|0|||
124886233|NCT02391038|449209522|FG000|Overall Study|Progressive disease|3|||
124886234|NCT02391038|449209523|FG001|Overall Study|Progressive disease|3|||
124886235|NCT02391038|449209524|FG002|Overall Study|Progressive disease|6|||
124886236|NCT01681368|449209533|FG000|Overall Study|Refused further treatment|1|||
124886237|NCT01681368|449209533|FG000|Overall Study|Refused further follow up|1|||
124886238|NCT01189890|449209534|FG000|Overall Study|Adverse Event|3|||
124886239|NCT01189890|449209535|FG001|Overall Study|Adverse Event|4|||
125104968|NCT02304302|450005834|FG000|Overall Study|Lost to Follow-up|1|||
125104969|NCT02304302|450005835|FG001|Overall Study|Lost to Follow-up|4|||
125104970|NCT02304302|450005834|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
125104971|NCT02304302|450005835|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
125104972|NCT00391118|450005836|FG000|Overall Study|Adverse Event|3|||
125104973|NCT00391118|450005837|FG001|Overall Study|Adverse Event|10|||
125104974|NCT00391118|450005838|FG002|Overall Study|Adverse Event|7|||
125104975|NCT00391118|450005836|FG000|Overall Study|Lost to Follow-up|0|||
124886240|NCT01189890|449209534|FG000|Overall Study|Lack of Efficacy|7|||
124886241|NCT01189890|449209535|FG001|Overall Study|Lack of Efficacy|2|||
124886242|NCT01189890|449209534|FG000|Overall Study|Lost to Follow-up|1|||
124886243|NCT01189890|449209535|FG001|Overall Study|Lost to Follow-up|7|||
124886244|NCT01189890|449209534|FG000|Overall Study|Protocol Violation|1|||
124886245|NCT01189890|449209535|FG001|Overall Study|Protocol Violation|5|||
125104976|NCT00391118|450005837|FG001|Overall Study|Lost to Follow-up|2|||
125104977|NCT00391118|450005838|FG002|Overall Study|Lost to Follow-up|3|||
124886246|NCT01189890|449209534|FG000|Overall Study|Withdrawal by Subject|15|||
124886247|NCT01189890|449209535|FG001|Overall Study|Withdrawal by Subject|11|||
124886248|NCT01189890|449209534|FG000|Overall Study|Non Compliance|0|||
124886249|NCT01189890|449209535|FG001|Overall Study|Non Compliance|1|||
124886250|NCT01189890|449209534|FG000|Overall Study|Physician Decision|5|||
124886251|NCT01189890|449209535|FG001|Overall Study|Physician Decision|4|||
124886252|NCT01189890|449209534|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
124886253|NCT01189890|449209535|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
124886254|NCT00593554|449209536|FG000|Overall Study|Death|1|||
124886255|NCT00593554|449209537|FG001|Overall Study|Death|2|||
124886256|NCT00593554|449209536|FG000|Overall Study|Physician Decision|0|||
124886257|NCT00593554|449209537|FG001|Overall Study|Physician Decision|1|||
124886258|NCT00593554|449209536|FG000|Overall Study|Withdrawal by Subject|1|||
124886259|NCT00593554|449209537|FG001|Overall Study|Withdrawal by Subject|0|||
124886260|NCT00593554|449209536|FG000|Overall Study|Disease Progression|1|||
124886261|NCT00593554|449209537|FG001|Overall Study|Disease Progression|2|||
124886262|NCT02254421|449209540|FG000|Overall Study|Randomized but Not Treated|1|||
124886263|NCT02254421|449209541|FG001|Overall Study|Randomized but Not Treated|0|||
124886264|NCT02254421|449209540|FG000|Overall Study|Death|0|||
124886265|NCT02254421|449209541|FG001|Overall Study|Death|2|||
124886266|NCT02254421|449209540|FG000|Overall Study|Withdrew Consent|1|||
124886267|NCT02254421|449209541|FG001|Overall Study|Withdrew Consent|1|||
124886268|NCT00839917|449209544|FG000|Overall Study|Lost to Follow-up|1|||
124886269|NCT00839917|449209545|FG001|Overall Study|Lost to Follow-up|0|||
124886270|NCT00839917|449209544|FG000|Overall Study|Did not receive vaccine|0|||
124886271|NCT00839917|449209545|FG001|Overall Study|Did not receive vaccine|1|||
124886272|NCT01129336|449209546|FG000|Overall Study|Protocol Violation|1|||
124886273|NCT01129336|449209547|FG001|Overall Study|Protocol Violation|0|||
124886274|NCT01129336|449209546|FG000|Overall Study|Disease Progression|1|||
124886275|NCT01129336|449209547|FG001|Overall Study|Disease Progression|4|||
124886276|NCT01129336|449209546|FG000|Overall Study|Lost to Follow-up|1|||
124886277|NCT01129336|449209547|FG001|Overall Study|Lost to Follow-up|0|||
124886278|NCT01129336|449209546|FG000|Overall Study|Withdrawal by Subject|7|||
124886279|NCT01129336|449209547|FG001|Overall Study|Withdrawal by Subject|4|||
124886280|NCT01129336|449209546|FG000|Overall Study|Adverse Event|0|||
124886281|NCT01129336|449209547|FG001|Overall Study|Adverse Event|1|||
124886282|NCT01129336|449209546|FG000|Overall Study|Missing Study Completion Status|2|||
124886283|NCT01129336|449209547|FG001|Overall Study|Missing Study Completion Status|3|||
124886284|NCT01129336|449209546|FG000|Overall Study|Death|0|||
124886285|NCT01129336|449209547|FG001|Overall Study|Death|4|||
124886286|NCT00867490|449209548|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
124886287|NCT00867490|449209548|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
124886288|NCT00867490|449209548|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
124886289|NCT00867490|449209548|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
124886290|NCT00867490|449209548|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
124886291|NCT03354637|449209553|FG000|Double-blind Period|Protocol Violation|2|||
124886292|NCT03354637|449209554|FG001|Double-blind Period|Protocol Violation|0|||
124886293|NCT03354637|449209555|FG002|Double-blind Period|Protocol Violation|0|||
124886294|NCT03354637|449209553|FG000|Double-blind Period|Adverse Event|1|||
124886295|NCT03354637|449209554|FG001|Double-blind Period|Adverse Event|2|||
125104978|NCT00391118|450005836|FG000|Overall Study|Withdrawal by Subject|0|||
125104979|NCT00391118|450005837|FG001|Overall Study|Withdrawal by Subject|9|||
124886296|NCT03354637|449209555|FG002|Double-blind Period|Adverse Event|0|||
125104980|NCT00391118|450005838|FG002|Overall Study|Withdrawal by Subject|1|||
125104981|NCT00391118|450005836|FG000|Overall Study|Death|0|||
124886297|NCT03354637|449209553|FG000|Double-blind Period|Lost to Follow-up|3|||
124886298|NCT03354637|449209554|FG001|Double-blind Period|Lost to Follow-up|4|||
124886299|NCT03354637|449209555|FG002|Double-blind Period|Lost to Follow-up|3|||
124886300|NCT03354637|449209553|FG000|Double-blind Period|Withdrawal by Subject|10|||
124886301|NCT03354637|449209554|FG001|Double-blind Period|Withdrawal by Subject|6|||
124886302|NCT03354637|449209555|FG002|Double-blind Period|Withdrawal by Subject|4|||
124886303|NCT03354637|449209553|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
124886304|NCT03354637|449209554|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
124886305|NCT03354637|449209555|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
124886306|NCT03354637|449209553|FG000|Open Label Extension|Adverse Event|0|||
124886307|NCT03354637|449209554|FG001|Open Label Extension|Adverse Event|0|||
124886308|NCT03354637|449209555|FG002|Open Label Extension|Adverse Event|1|||
124886309|NCT03354637|449209553|FG000|Open Label Extension|Lost to Follow-up|0|||
125104982|NCT00391118|450005837|FG001|Overall Study|Death|1|||
124886310|NCT03354637|449209554|FG001|Open Label Extension|Lost to Follow-up|0|||
124886311|NCT03354637|449209555|FG002|Open Label Extension|Lost to Follow-up|2|||
124886312|NCT03354637|449209553|FG000|Open Label Extension|Withdrawal by Subject|0|||
124886313|NCT03354637|449209554|FG001|Open Label Extension|Withdrawal by Subject|0|||
124886314|NCT03354637|449209555|FG002|Open Label Extension|Withdrawal by Subject|5|||
124886315|NCT03354637|449209553|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
124886316|NCT03354637|449209554|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
124886317|NCT03354637|449209555|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
125015415|NCT00640328|449680718|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
125015416|NCT00640328|449680719|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
124886318|NCT03354637|449209553|FG000|Open Label Extension|Subject Noncompliance|0|||
125015417|NCT00640328|449680720|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
125015418|NCT00640328|449680715|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
125015419|NCT00640328|449680716|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
125015420|NCT00640328|449680717|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
125015421|NCT00640328|449680718|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
125015422|NCT00640328|449680719|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
125015423|NCT00640328|449680720|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
124886319|NCT03354637|449209554|FG001|Open Label Extension|Subject Noncompliance|0|||
124886320|NCT03354637|449209555|FG002|Open Label Extension|Subject Noncompliance|1|||
124886321|NCT03354637|449209553|FG000|Open Label Extension|Lack of Efficacy|0|||
124886322|NCT03354637|449209554|FG001|Open Label Extension|Lack of Efficacy|0|||
124886323|NCT03354637|449209555|FG002|Open Label Extension|Lack of Efficacy|1|||
124886324|NCT03354637|449209553|FG000|Open Label Extension|Physician Decision|0|||
124886325|NCT03354637|449209554|FG001|Open Label Extension|Physician Decision|0|||
124886326|NCT03354637|449209555|FG002|Open Label Extension|Physician Decision|1|||
124886327|NCT02726399|449209556|FG000|Overall Study|Participant Non-Compliance|1|||
124886328|NCT02726399|449209556|FG000|Overall Study|Adverse Event|2|||
124886329|NCT02726399|449209556|FG000|Overall Study|Progression of disease|4|||
124886330|NCT02564055|449209557|FG000|Overall Study|Adverse Event|1|||
124886331|NCT02564055|449209558|FG001|Overall Study|Adverse Event|0|||
124886332|NCT02564055|449209559|FG002|Overall Study|Adverse Event|4|||
124886333|NCT02564055|449209560|FG003|Overall Study|Adverse Event|1|||
124886334|NCT02564055|449209561|FG004|Overall Study|Adverse Event|4|||
124886335|NCT02564055|449209562|FG005|Overall Study|Adverse Event|1|||
124886336|NCT02564055|449209557|FG000|Overall Study|Protocol Violation|1|||
125015424|NCT00640328|449680715|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
125015425|NCT00640328|449680716|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
125015426|NCT00640328|449680717|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
125015427|NCT00640328|449680718|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
125015428|NCT00640328|449680719|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
125015429|NCT00640328|449680720|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
125015430|NCT01326546|449680721|FG000|Overall Study|Lost to Follow-up|8|||
125015431|NCT01326546|449680722|FG001|Overall Study|Lost to Follow-up|7|||
125015432|NCT01326546|449680721|FG000|Overall Study|Protocol Violation|3|||
125015433|NCT01326546|449680722|FG001|Overall Study|Protocol Violation|4|||
125015434|NCT01326546|449680721|FG000|Overall Study|Pregnancy|0|||
125015435|NCT01326546|449680722|FG001|Overall Study|Pregnancy|1|||
125015436|NCT01326546|449680721|FG000|Overall Study|Adverse Event|1|||
125015437|NCT01326546|449680722|FG001|Overall Study|Adverse Event|0|||
125015438|NCT01326546|449680721|FG000|Overall Study|Withdrawal by Subject|5|||
125015439|NCT01326546|449680722|FG001|Overall Study|Withdrawal by Subject|1|||
125015440|NCT03152019|449680723|FG000|Overall Study|Adverse Event|0|||
125015441|NCT03152019|449680724|FG001|Overall Study|Adverse Event|1|||
125015442|NCT04294719|449680725|FG000|Overall Study|Withdrawal by Subject|1|||
125015443|NCT01714687|449680726|FG000|Overall Study|Withdrawal by Subject|1|||
125015444|NCT01714687|449680727|FG001|Overall Study|Withdrawal by Subject|0|||
125015445|NCT01714687|449680726|FG000|Overall Study|Lost to Follow-up|2|||
124886337|NCT02564055|449209558|FG001|Overall Study|Protocol Violation|0|||
124886338|NCT02564055|449209559|FG002|Overall Study|Protocol Violation|0|||
124886339|NCT02564055|449209560|FG003|Overall Study|Protocol Violation|0|||
124886340|NCT02564055|449209561|FG004|Overall Study|Protocol Violation|0|||
124886341|NCT02564055|449209562|FG005|Overall Study|Protocol Violation|0|||
124886342|NCT02564055|449209557|FG000|Overall Study|Reached stopping criteria|0|||
124886343|NCT02564055|449209558|FG001|Overall Study|Reached stopping criteria|0|||
124886344|NCT02564055|449209559|FG002|Overall Study|Reached stopping criteria|0|||
124886345|NCT02564055|449209560|FG003|Overall Study|Reached stopping criteria|0|||
124886346|NCT02564055|449209561|FG004|Overall Study|Reached stopping criteria|0|||
124886347|NCT02564055|449209562|FG005|Overall Study|Reached stopping criteria|1|||
124886348|NCT02564055|449209557|FG000|Overall Study|Lost to Follow-up|0|||
124886349|NCT02564055|449209558|FG001|Overall Study|Lost to Follow-up|1|||
124886350|NCT02564055|449209559|FG002|Overall Study|Lost to Follow-up|4|||
124886351|NCT02564055|449209560|FG003|Overall Study|Lost to Follow-up|2|||
124886352|NCT02564055|449209561|FG004|Overall Study|Lost to Follow-up|1|||
124886353|NCT02564055|449209562|FG005|Overall Study|Lost to Follow-up|0|||
124886354|NCT02564055|449209557|FG000|Overall Study|Physician Decision|0|||
124886355|NCT02564055|449209558|FG001|Overall Study|Physician Decision|0|||
124886356|NCT02564055|449209559|FG002|Overall Study|Physician Decision|1|||
124886357|NCT02564055|449209560|FG003|Overall Study|Physician Decision|0|||
124886358|NCT02564055|449209561|FG004|Overall Study|Physician Decision|0|||
124886359|NCT02564055|449209562|FG005|Overall Study|Physician Decision|0|||
124886360|NCT02564055|449209557|FG000|Overall Study|Withdrawal by Subject|4|||
124886361|NCT02564055|449209558|FG001|Overall Study|Withdrawal by Subject|4|||
124886362|NCT02564055|449209559|FG002|Overall Study|Withdrawal by Subject|3|||
124886363|NCT02564055|449209560|FG003|Overall Study|Withdrawal by Subject|3|||
124886364|NCT02564055|449209561|FG004|Overall Study|Withdrawal by Subject|10|||
124886365|NCT02564055|449209562|FG005|Overall Study|Withdrawal by Subject|10|||
124886366|NCT04747275|449209563|FG000|Overall Study|Study terminated|0|||
124886367|NCT04747275|449209564|FG001|Overall Study|Study terminated|1|||
125015446|NCT01714687|449680727|FG001|Overall Study|Lost to Follow-up|4|||
125015447|NCT01979536|449680728|FG000|Overall Study|Physician Decision|2|||
125015448|NCT01979536|449680729|FG001|Overall Study|Physician Decision|3|||
125015449|NCT01979536|449680728|FG000|Overall Study|Withdrawal by Subject|0|||
125015450|NCT01979536|449680729|FG001|Overall Study|Withdrawal by Subject|1|||
125015451|NCT01979536|449680728|FG000|Overall Study|Refusal|0|||
125015452|NCT01979536|449680729|FG001|Overall Study|Refusal|1|||
125015453|NCT01979536|449680728|FG000|Overall Study|Relapse|0|||
125015454|NCT01979536|449680729|FG001|Overall Study|Relapse|1|||
125015455|NCT01979536|449680728|FG000|Overall Study|Study terminated by Sponsor|0|||
125015456|NCT01979536|449680729|FG001|Overall Study|Study terminated by Sponsor|1|||
125015457|NCT01979536|449680728|FG000|Overall Study|Did not start treatment|0|||
125015458|NCT01979536|449680729|FG001|Overall Study|Did not start treatment|1|||
125015459|NCT00609791|449682516|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
125015460|NCT02484911|449682517|FG000|Overall Study|Withdrawal by Subject|2|||
125015461|NCT02484911|449682518|FG001|Overall Study|Withdrawal by Subject|1|||
125015462|NCT02484911|449682517|FG000|Overall Study|Protocol Violation|2|||
125015463|NCT02484911|449682518|FG001|Overall Study|Protocol Violation|1|||
125015464|NCT04129528|449682519|FG000|Overall Study|Adverse Event|1|||
125015465|NCT04129528|449682520|FG001|Overall Study|Adverse Event|0|||
125015466|NCT04129528|449682519|FG000|Overall Study|Physician Decision|1|||
125015467|NCT04129528|449682520|FG001|Overall Study|Physician Decision|1|||
125015468|NCT04129528|449682519|FG000|Overall Study|Withdrawal by Subject|1|||
125015469|NCT04129528|449682520|FG001|Overall Study|Withdrawal by Subject|1|||
125015470|NCT01964352|449682525|FG000|Overall Study|Adverse Event|13|||
125015471|NCT01964352|449682526|FG001|Overall Study|Adverse Event|3|||
125015472|NCT01964352|449682527|FG002|Overall Study|Adverse Event|4|||
125015473|NCT01964352|449682528|FG003|Overall Study|Adverse Event|3|||
125015474|NCT01964352|449682525|FG000|Overall Study|Lack of Efficacy|6|||
125015475|NCT01964352|449682526|FG001|Overall Study|Lack of Efficacy|0|||
125015476|NCT01964352|449682527|FG002|Overall Study|Lack of Efficacy|0|||
125015477|NCT01964352|449682528|FG003|Overall Study|Lack of Efficacy|0|||
125015478|NCT01964352|449682525|FG000|Overall Study|Protocol Violation|2|||
125015479|NCT01964352|449682526|FG001|Overall Study|Protocol Violation|4|||
125015480|NCT01964352|449682527|FG002|Overall Study|Protocol Violation|0|||
125015481|NCT01964352|449682528|FG003|Overall Study|Protocol Violation|2|||
125015482|NCT01964352|449682525|FG000|Overall Study|Lost to Follow-up|1|||
125015483|NCT01964352|449682526|FG001|Overall Study|Lost to Follow-up|0|||
125015484|NCT01964352|449682527|FG002|Overall Study|Lost to Follow-up|0|||
124886368|NCT00531011|449209566|FG000|Overall Study|Withdrawal by Subject|2|||
124886369|NCT00531011|449209567|FG001|Overall Study|Withdrawal by Subject|4|||
125015485|NCT01964352|449682528|FG003|Overall Study|Lost to Follow-up|1|||
125015486|NCT01964352|449682525|FG000|Overall Study|Withdrawal by Subject|4|||
125015487|NCT01964352|449682526|FG001|Overall Study|Withdrawal by Subject|2|||
125015488|NCT01964352|449682527|FG002|Overall Study|Withdrawal by Subject|1|||
124886370|NCT00531011|449209566|FG000|Overall Study|Death|1|||
125015489|NCT01964352|449682528|FG003|Overall Study|Withdrawal by Subject|0|||
124886371|NCT00531011|449209567|FG001|Overall Study|Death|0|||
125015490|NCT01964352|449682525|FG000|Overall Study|Other than stated above|0|||
125015491|NCT01964352|449682526|FG001|Overall Study|Other than stated above|2|||
125015492|NCT01964352|449682527|FG002|Overall Study|Other than stated above|1|||
125104983|NCT00391118|450005838|FG002|Overall Study|Death|0|||
125104984|NCT00391118|450005836|FG000|Overall Study|Physician Decision|0|||
124886372|NCT00531011|449209566|FG000|Overall Study|Lost to Follow-up|1|||
124886373|NCT00531011|449209567|FG001|Overall Study|Lost to Follow-up|0|||
124886374|NCT00531011|449209566|FG000|Overall Study|Physician Decision|0|||
124886375|NCT00531011|449209567|FG001|Overall Study|Physician Decision|3|||
124886376|NCT03268590|449209568|FG000|Overall Study|Previously unknown exclusion criteria|1|||
124886377|NCT00919893|449209575|FG000|Overall Study|Protocol Violation|19|||
124886378|NCT00919893|449209576|FG001|Overall Study|Protocol Violation|9|||
124886379|NCT01375959|449209577|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
124886380|NCT01375959|449209578|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
124886381|NCT01375959|449209577|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
125104985|NCT00391118|450005837|FG001|Overall Study|Physician Decision|3|||
125104986|NCT00391118|450005838|FG002|Overall Study|Physician Decision|0|||
125104987|NCT00391118|450005836|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
125104988|NCT00391118|450005837|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
125104989|NCT00391118|450005838|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
125104990|NCT00391118|450005836|FG000|Overall Study|Progressive Disease|7|||
124886382|NCT01375959|449209578|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
124886383|NCT01375959|449209577|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
124886384|NCT01375959|449209578|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
125104991|NCT00391118|450005837|FG001|Overall Study|Progressive Disease|26|||
124886385|NCT04254679|449209579|FG000|Overall Study|Protocol Violation|1|||
124886386|NCT04254679|449209580|FG001|Overall Study|Protocol Violation|1|||
125104992|NCT00391118|450005838|FG002|Overall Study|Progressive Disease|43|||
125104993|NCT00391118|450005836|FG000|Overall Study|Sponsor Decision|0|||
125104994|NCT00391118|450005837|FG001|Overall Study|Sponsor Decision|1|||
125104995|NCT00391118|450005838|FG002|Overall Study|Sponsor Decision|3|||
125104996|NCT00391118|450005836|FG000|Overall Study|Protocol Violation|1|||
124886387|NCT04254679|449209579|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
124886388|NCT04254679|449209580|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
124886389|NCT00794820|449209581|FG000|Overall Study|Adverse Event|11|||
124886390|NCT00794820|449209581|FG000|Overall Study|Secondary Malignancies|2|||
124886391|NCT00794820|449209581|FG000|Overall Study|Resistant Disease|2|||
124886392|NCT00794820|449209581|FG000|Overall Study|Ineligible/Screen Failure|1|||
124886393|NCT03537261|449209585|FG000|Overall Study|Lost to Follow-up|4|||
124886394|NCT03537261|449209586|FG001|Overall Study|Lost to Follow-up|5|||
124886395|NCT03537261|449209585|FG000|Overall Study|Withdrawal by Subject|4|||
124886396|NCT03537261|449209586|FG001|Overall Study|Withdrawal by Subject|6|||
124886397|NCT03537261|449209585|FG000|Overall Study|Did not return study questionnaires|0|||
124886398|NCT03537261|449209586|FG001|Overall Study|Did not return study questionnaires|1|||
124886399|NCT03237013|449209587|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
124886400|NCT03237013|449209588|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
124886401|NCT03237013|449209589|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
124886402|NCT00502996|449209592|FG000|Overall Study|Lost to Follow-up|9|||
124886403|NCT00502996|449209592|FG000|Overall Study|Protocol Violation|2|||
124886404|NCT00502996|449209592|FG000|Overall Study|Treatment failure|25|||
124886405|NCT00502996|449209592|FG000|Overall Study|Withdrawal Informed Consent|6|||
125104997|NCT00391118|450005837|FG001|Overall Study|Protocol Violation|0|||
125104998|NCT00391118|450005838|FG002|Overall Study|Protocol Violation|0|||
125104999|NCT05473247|450005839|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
125105000|NCT01345058|450005840|FG000|Overall Study|Withdrawal by Subject|1|||
125105001|NCT01345058|450005841|FG001|Overall Study|Withdrawal by Subject|0|||
125105002|NCT01345058|450005840|FG000|Overall Study|Participant Reported Increase in Events|1|||
125105003|NCT01345058|450005841|FG001|Overall Study|Participant Reported Increase in Events|0|||
125105004|NCT01345058|450005840|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
125105005|NCT01345058|450005841|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
125105006|NCT01345058|450005840|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
125105007|NCT01345058|450005841|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
125105008|NCT01345058|450005840|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
125105009|NCT01345058|450005841|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
125105010|NCT01892020|450005847|FG000|Period 1|Adverse Event|1|||
125105011|NCT01892020|450005848|FG001|Period 1|Adverse Event|1|||
125105012|NCT01892020|450005847|FG000|Period 1|Protocol Violation|2|||
125105013|NCT01892020|450005848|FG001|Period 1|Protocol Violation|4|||
125105014|NCT01892020|450005847|FG000|Period 1|Unclassified|0|||
125105015|NCT01892020|450005848|FG001|Period 1|Unclassified|1|||
125105016|NCT01892020|450005847|FG000|Period 2|Protocol Violation|1|||
125105017|NCT01892020|450005848|FG001|Period 2|Protocol Violation|0|||
125105018|NCT00402779|450005849|FG000|Overall Study|Screen Failure|77|||
125105019|NCT00402779|450005850|FG001|Overall Study|Screen Failure|76|||
125105020|NCT03107715|450005852|FG000|Overall Study|did not deliver at the home hospital|4|||
125105021|NCT03107715|450005853|FG001|Overall Study|did not deliver at the home hospital|6|||
125105022|NCT03107715|450005852|FG000|Overall Study|infant stillborn|0|||
125105023|NCT03107715|450005853|FG001|Overall Study|infant stillborn|1|||
125105024|NCT02149199|450005854|FG000|Overall Study|Study specific withdrawal criteria|4|||
125105025|NCT02149199|450005855|FG001|Overall Study|Study specific withdrawal criteria|21|||
125105026|NCT02149199|450005856|FG002|Overall Study|Study specific withdrawal criteria|6|||
125105027|NCT02149199|450005854|FG000|Overall Study|Other|20|||
125105028|NCT02149199|450005855|FG001|Overall Study|Other|25|||
125105029|NCT02149199|450005856|FG002|Overall Study|Other|20|||
125105030|NCT02149199|450005854|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
125105031|NCT02149199|450005855|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
124886406|NCT00502996|449209592|FG000|Overall Study|Adverse Event|2|||
124886407|NCT01729728|449209593|FG000|Overall Study|Adverse Event|0|||
124886408|NCT01729728|449209594|FG001|Overall Study|Adverse Event|6|||
124886409|NCT01729728|449209595|FG002|Overall Study|Adverse Event|0|||
124886410|NCT01729728|449209593|FG000|Overall Study|Protocol Violation|1|||
124886411|NCT01729728|449209594|FG001|Overall Study|Protocol Violation|0|||
124886412|NCT01729728|449209595|FG002|Overall Study|Protocol Violation|1|||
124886413|NCT02500979|449209596|FG000|Period 1|Hyperglycemia|1|||
125105032|NCT02149199|450005856|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
125105033|NCT02149199|450005854|FG000|Overall Study|Withdrawal by Subject|75|||
125105034|NCT02149199|450005855|FG001|Overall Study|Withdrawal by Subject|93|||
125105035|NCT02149199|450005856|FG002|Overall Study|Withdrawal by Subject|77|||
124886414|NCT02500979|449209597|FG001|Period 1|Hyperglycemia|0|||
124886415|NCT02500979|449209596|FG000|Period 1|Severe non-compliance to protocol|0|||
125105036|NCT02149199|450005854|FG000|Overall Study|Protocol Violation|16|||
124886416|NCT02500979|449209597|FG001|Period 1|Severe non-compliance to protocol|1|||
124886417|NCT02500979|449209596|FG000|Period 1|Adverse Event|1|||
124886418|NCT02500979|449209597|FG001|Period 1|Adverse Event|0|||
124886419|NCT02500979|449209596|FG000|Period 1|Subject decision|2|||
124886420|NCT02500979|449209597|FG001|Period 1|Subject decision|0|||
124886421|NCT02500979|449209596|FG000|Period 2|Change in risk|1|||
124886422|NCT02500979|449209597|FG001|Period 2|Change in risk|0|||
124886423|NCT00610675|449209598|FG000|Overall Study|Untreated|4|||
124886424|NCT00610675|449209598|FG000|Overall Study|Adverse Event|67|||
124886425|NCT00610675|449209598|FG000|Overall Study|Insufficient Effect|31|||
125105037|NCT02149199|450005855|FG001|Overall Study|Protocol Violation|13|||
125105038|NCT02149199|450005856|FG002|Overall Study|Protocol Violation|15|||
125105039|NCT02149199|450005854|FG000|Overall Study|Lost to Follow-up|3|||
125105040|NCT02149199|450005855|FG001|Overall Study|Lost to Follow-up|12|||
125105041|NCT02149199|450005856|FG002|Overall Study|Lost to Follow-up|11|||
125105042|NCT02149199|450005854|FG000|Overall Study|Death|0|||
125105043|NCT02149199|450005855|FG001|Overall Study|Death|0|||
125105044|NCT02149199|450005856|FG002|Overall Study|Death|1|||
125105045|NCT02149199|450005854|FG000|Overall Study|Adverse Event|6|||
125105046|NCT02149199|450005855|FG001|Overall Study|Adverse Event|15|||
125105047|NCT02149199|450005856|FG002|Overall Study|Adverse Event|9|||
125105048|NCT03252756|450005857|FG000|Overall Study|Protocol Violation|2|||
125105049|NCT03252756|450005858|FG001|Overall Study|Protocol Violation|4|||
125105050|NCT03252756|450005857|FG000|Overall Study|COVID-19 Pandemic|1|||
125105051|NCT03252756|450005858|FG001|Overall Study|COVID-19 Pandemic|1|||
125105052|NCT03252756|450005857|FG000|Overall Study|Study Drug Expiration|0|||
125105053|NCT03252756|450005858|FG001|Overall Study|Study Drug Expiration|1|||
125105054|NCT01500434|450005861|FG000|Overall Study|Death|1|||
125105055|NCT01500434|450005861|FG000|Overall Study|Withdrawal by Subject|1|||
125105056|NCT01500434|450005861|FG000|Overall Study|Missed 12-month follow-up|5|||
125105057|NCT04881448|450005865|FG000|Overall Study|Study cancelled by sponsor|220|||
125105058|NCT04881448|450005865|FG000|Overall Study|Withdrawal by Subject|2|||
125105059|NCT04881448|450005865|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
125105060|NCT02662556|450005866|FG000|Overall Study|Adverse Event|4|||
125105061|NCT02662556|450005866|FG000|Overall Study|Lack of Efficacy|4|||
125105062|NCT00005879|450005871|FG000|Overall Study|Withdrawal by Subject|8|||
125105063|NCT00005879|450005872|FG001|Overall Study|Withdrawal by Subject|10|||
125105064|NCT05022121|450005876|FG000|Overall Study|Lack of Efficacy|1|||
125105065|NCT05022121|450005877|FG001|Overall Study|Lack of Efficacy|0|||
125105066|NCT05022121|450005876|FG000|Overall Study|Lost to Follow-up|0|||
125105067|NCT05022121|450005877|FG001|Overall Study|Lost to Follow-up|2|||
125105068|NCT02395536|450005882|FG000|Overall Study|Lost to Follow-up|4|||
125105069|NCT02395536|450005883|FG001|Overall Study|Lost to Follow-up|4|||
125105070|NCT02395536|450005882|FG000|Overall Study|Death|2|||
125105071|NCT02395536|450005883|FG001|Overall Study|Death|0|||
125105072|NCT02395536|450005882|FG000|Overall Study|Physician Decision|4|||
125105073|NCT02395536|450005883|FG001|Overall Study|Physician Decision|6|||
125105074|NCT02395536|450005882|FG000|Overall Study|Withdrawal by Subject|9|||
125105075|NCT02395536|450005883|FG001|Overall Study|Withdrawal by Subject|17|||
125105076|NCT02395536|450005882|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
125105077|NCT02395536|450005883|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
125105078|NCT02395536|450005882|FG000|Overall Study|Insurance issue|0|||
125105079|NCT02395536|450005883|FG001|Overall Study|Insurance issue|1|||
125105080|NCT00131937|450005884|FG000|Overall Study|Adverse Event|3|||
124886426|NCT00610675|449209598|FG000|Overall Study|Withdrawal by Subject|28|||
124886427|NCT00610675|449209598|FG000|Overall Study|Reasons unrelated to trial|27|||
124886428|NCT00610675|449209598|FG000|Overall Study|Lack of Compliance|7|||
125105081|NCT00131937|450005884|FG000|Overall Study|Withdrawal by Subject|2|||
124886429|NCT00610675|449209598|FG000|Overall Study|Lost to Follow-up|31|||
124886430|NCT00610675|449209598|FG000|Overall Study|Other reason (not specified)|25|||
125105082|NCT00131937|450005884|FG000|Overall Study|Physician Decision|1|||
125105083|NCT00131937|450005884|FG000|Overall Study|Disease Progression|7|||
125105084|NCT00131937|450005884|FG000|Overall Study|Alternative therapy|1|||
125105085|NCT01186744|450008072|FG000|Overall Study|Lack of Efficacy|156|||
124886431|NCT01316692|449209601|FG000|Overall Study|Adverse Event|5|||
125105086|NCT01186744|450008073|FG001|Overall Study|Lack of Efficacy|99|||
125105087|NCT01186744|450008074|FG002|Overall Study|Lack of Efficacy|0|||
124886432|NCT01316692|449209601|FG000|Overall Study|Disease Progression|7|||
124886433|NCT01536145|449209608|FG000|Overall Study|Progressive disease|3|||
124886434|NCT01536145|449209609|FG001|Overall Study|Progressive disease|4|||
124886435|NCT01536145|449209610|FG002|Overall Study|Progressive disease|1|||
124886436|NCT01536145|449209611|FG003|Overall Study|Progressive disease|2|||
124886437|NCT01536145|449209612|FG004|Overall Study|Progressive disease|1|||
124886438|NCT01536145|449209613|FG005|Overall Study|Progressive disease|2|||
124886439|NCT01536145|449209614|FG006|Overall Study|Progressive disease|1|||
124886440|NCT01536145|449209615|FG007|Overall Study|Progressive disease|2|||
124886441|NCT01536145|449209616|FG008|Overall Study|Progressive disease|1|||
124886442|NCT01536145|449209617|FG009|Overall Study|Progressive disease|3|||
124886443|NCT01536145|449209618|FG010|Overall Study|Progressive disease|3|||
124886444|NCT01536145|449209608|FG000|Overall Study|Withdrawal by Subject|0|||
124886445|NCT01536145|449209609|FG001|Overall Study|Withdrawal by Subject|0|||
124886446|NCT01536145|449209610|FG002|Overall Study|Withdrawal by Subject|1|||
124886447|NCT01536145|449209611|FG003|Overall Study|Withdrawal by Subject|0|||
124886448|NCT01536145|449209612|FG004|Overall Study|Withdrawal by Subject|0|||
124886449|NCT01536145|449209613|FG005|Overall Study|Withdrawal by Subject|1|||
125015493|NCT01964352|449682528|FG003|Overall Study|Other than stated above|2|||
124886450|NCT01536145|449209614|FG006|Overall Study|Withdrawal by Subject|0|||
125015494|NCT00477165|449682529|FG000|Overall Study|Adverse Event|7|||
125015495|NCT00477165|449682530|FG001|Overall Study|Adverse Event|2|||
125015496|NCT00105443|449682531|FG000|Double-Blind Treatment|Adverse Event|1|||
124886451|NCT01536145|449209615|FG007|Overall Study|Withdrawal by Subject|0|||
124886452|NCT01536145|449209616|FG008|Overall Study|Withdrawal by Subject|2|||
124886453|NCT01536145|449209617|FG009|Overall Study|Withdrawal by Subject|0|||
124886454|NCT01536145|449209618|FG010|Overall Study|Withdrawal by Subject|2|||
124886455|NCT01536145|449209608|FG000|Overall Study|Other|0|||
124886456|NCT01536145|449209609|FG001|Overall Study|Other|0|||
124886457|NCT01536145|449209610|FG002|Overall Study|Other|0|||
124886458|NCT01536145|449209611|FG003|Overall Study|Other|0|||
124886459|NCT01536145|449209612|FG004|Overall Study|Other|1|||
124886460|NCT01536145|449209613|FG005|Overall Study|Other|0|||
124886461|NCT01536145|449209614|FG006|Overall Study|Other|0|||
124886462|NCT01536145|449209615|FG007|Overall Study|Other|0|||
124886463|NCT01536145|449209616|FG008|Overall Study|Other|0|||
124886464|NCT01536145|449209617|FG009|Overall Study|Other|3|||
124886465|NCT01536145|449209618|FG010|Overall Study|Other|2|||
124886466|NCT01536145|449209608|FG000|Overall Study|Death|0|||
124886467|NCT01536145|449209609|FG001|Overall Study|Death|0|||
124886468|NCT01536145|449209610|FG002|Overall Study|Death|0|||
124886469|NCT01536145|449209611|FG003|Overall Study|Death|0|||
124886470|NCT01536145|449209612|FG004|Overall Study|Death|0|||
124886471|NCT01536145|449209613|FG005|Overall Study|Death|0|||
124886472|NCT01536145|449209614|FG006|Overall Study|Death|1|||
124886473|NCT01536145|449209615|FG007|Overall Study|Death|0|||
124886474|NCT01536145|449209616|FG008|Overall Study|Death|0|||
125105088|NCT01186744|450008075|FG003|Overall Study|Lack of Efficacy|2|||
125105089|NCT01186744|450008076|FG004|Overall Study|Lack of Efficacy|2|||
124886475|NCT01536145|449209617|FG009|Overall Study|Death|0|||
124886476|NCT01536145|449209618|FG010|Overall Study|Death|0|||
124886477|NCT01536145|449209608|FG000|Overall Study|Adverse Event|0|||
124886478|NCT01536145|449209609|FG001|Overall Study|Adverse Event|0|||
124886479|NCT01536145|449209610|FG002|Overall Study|Adverse Event|0|||
124886480|NCT01536145|449209611|FG003|Overall Study|Adverse Event|0|||
125105090|NCT01186744|450008077|FG005|Overall Study|Lack of Efficacy|5|||
124886481|NCT01536145|449209612|FG004|Overall Study|Adverse Event|0|||
124886482|NCT01536145|449209613|FG005|Overall Study|Adverse Event|0|||
124886483|NCT01536145|449209614|FG006|Overall Study|Adverse Event|0|||
124886484|NCT01536145|449209615|FG007|Overall Study|Adverse Event|2|||
124886485|NCT01536145|449209616|FG008|Overall Study|Adverse Event|0|||
124886486|NCT01536145|449209617|FG009|Overall Study|Adverse Event|0|||
124886487|NCT01536145|449209618|FG010|Overall Study|Adverse Event|3|||
124886488|NCT00579982|449209619|FG000|Overall Study|Adverse Event|4|||
124886489|NCT00579982|449209619|FG000|Overall Study|Protocol Violation|4|||
124886490|NCT05199233|449209620|FG000|Overall Study|Lack of Efficacy|1|||
125015497|NCT00105443|449682532|FG001|Double-Blind Treatment|Adverse Event|0|||
125015498|NCT00105443|449682533|FG002|Double-Blind Treatment|Adverse Event|0|||
125015499|NCT00105443|449682534|FG003|Double-Blind Treatment|Adverse Event|0|||
124886491|NCT02443103|449209623|FG000|Overall Study|Adverse Event|2|||
124886492|NCT02443103|449209623|FG000|Overall Study|Noncompliance|1|||
124886493|NCT01630590|449209624|FG000|Overall Study|Adverse Event|9|||
124886494|NCT01630590|449209624|FG000|Overall Study|Lack of Efficacy|37|||
124886495|NCT01630590|449209624|FG000|Overall Study|Withdrawal by Subject|4|||
124886496|NCT01630590|449209624|FG000|Overall Study|2nd primary tumor|2|||
125015500|NCT00105443|449682531|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
124886497|NCT01630590|449209624|FG000|Overall Study|Automobile accident|1|||
125210776|NCT01810783|450395682|FG000|Overall Study|Non-compliance with IMP|4|||
125210777|NCT01810783|450395682|FG000|Overall Study|Adminstrative or other reason(s)|23|||
124886498|NCT01630590|449209624|FG000|Overall Study|Maximum benefit|4|||
124886499|NCT02366936|449209625|FG000|Overall Study|Withdrawal by Subject|2|||
124886500|NCT02366936|449209625|FG000|Overall Study|Lost to Follow-up|4|||
125015501|NCT00105443|449682532|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
125015502|NCT00105443|449682533|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
125015503|NCT00105443|449682534|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
125015504|NCT00105443|449682531|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
125015505|NCT00105443|449682532|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
125015506|NCT00105443|449682533|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
125105091|NCT01186744|450008072|FG000|Overall Study|Protocol Violation|1|||
125015507|NCT00105443|449682534|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
125015508|NCT00105443|449682531|FG000|Double-Blind Treatment|Physician Decision|1|||
125015509|NCT00105443|449682532|FG001|Double-Blind Treatment|Physician Decision|0|||
125015510|NCT00105443|449682533|FG002|Double-Blind Treatment|Physician Decision|2|||
125015511|NCT00105443|449682534|FG003|Double-Blind Treatment|Physician Decision|0|||
125015512|NCT00105443|449682531|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
125015513|NCT00105443|449682532|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
125015514|NCT00105443|449682533|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
125015515|NCT00105443|449682534|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
125015516|NCT00105443|449682531|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
124886501|NCT02366936|449209625|FG000|Overall Study|Physician Decision|2|||
124886502|NCT03358329|449209628|FG000|Overall Study|Lost to Follow-up|2|||
124886503|NCT03358329|449209628|FG000|Overall Study|Withdrawal by Subject|2|||
124886504|NCT01313923|449209629|FG000|Overall Study|Physician Decision|3|||
124886505|NCT02471404|449209630|FG000|Overall Study|Adverse Event|7|||
124886506|NCT02471404|449209631|FG001|Overall Study|Adverse Event|1|||
124886507|NCT02471404|449209632|FG002|Overall Study|Adverse Event|2|||
124886508|NCT02471404|449209630|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
124886509|NCT02471404|449209631|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
124886510|NCT02471404|449209632|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
124886511|NCT02471404|449209630|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
124886512|NCT02471404|449209631|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
124886513|NCT02471404|449209632|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
124886514|NCT02471404|449209630|FG000|Overall Study|Lost to Follow-up|1|||
124886515|NCT02471404|449209631|FG001|Overall Study|Lost to Follow-up|1|||
124886516|NCT02471404|449209632|FG002|Overall Study|Lost to Follow-up|3|||
124886517|NCT02471404|449209630|FG000|Overall Study|Protocol Violation|1|||
124886518|NCT02471404|449209631|FG001|Overall Study|Protocol Violation|0|||
125015517|NCT00105443|449682532|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
125015518|NCT00105443|449682533|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
125015519|NCT00105443|449682534|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
124886519|NCT02471404|449209632|FG002|Overall Study|Protocol Violation|0|||
124886520|NCT02471404|449209630|FG000|Overall Study|Withdrawal by Subject|8|||
125105092|NCT01186744|450008073|FG001|Overall Study|Protocol Violation|2|||
124886521|NCT02471404|449209631|FG001|Overall Study|Withdrawal by Subject|4|||
124886522|NCT02471404|449209632|FG002|Overall Study|Withdrawal by Subject|5|||
124886523|NCT02471404|449209630|FG000|Overall Study|Other reasons not specified|10|||
124886524|NCT02471404|449209631|FG001|Overall Study|Other reasons not specified|7|||
124886525|NCT02471404|449209632|FG002|Overall Study|Other reasons not specified|12|||
124886526|NCT02982720|449209633|FG000|Overall Study|Adverse Event|3|||
124886527|NCT02982720|449209633|FG000|Overall Study|Death|1|||
124886528|NCT00305864|449209636|FG000|Overall Study|Ineligible / No protocol treatment|0|||
124886529|NCT00305864|449209637|FG001|Overall Study|Ineligible / No protocol treatment|1|||
124886530|NCT00305864|449209638|FG002|Overall Study|Ineligible / No protocol treatment|1|||
124886531|NCT00305864|449209639|FG003|Overall Study|Ineligible / No protocol treatment|13|||
124886532|NCT02836613|449209642|FG000|Overall Study|Accidental drowning|1|||
124886533|NCT02836613|449209643|FG001|Overall Study|Accidental drowning|0|||
124886534|NCT02836613|449209642|FG000|Overall Study|Lost to Follow-up|0|||
124886535|NCT02836613|449209643|FG001|Overall Study|Lost to Follow-up|1|||
124886536|NCT02836613|449209642|FG000|Overall Study|Withdrawal by Subject|0|||
124886537|NCT02836613|449209643|FG001|Overall Study|Withdrawal by Subject|2|||
124886538|NCT03881059|449209644|FG000|Treatment Period - Part A|Adverse Event|1|||
124886539|NCT03881059|449209645|FG001|Treatment Period - Part A|Adverse Event|3|||
124886540|NCT03881059|449209646|FG002|Treatment Period - Part A|Adverse Event|4|||
124886541|NCT03881059|449209644|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
124886542|NCT03881059|449209645|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
124886543|NCT03881059|449209646|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
124886544|NCT03881059|449209644|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
124886545|NCT03881059|449209645|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
124886546|NCT03881059|449209646|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
124886547|NCT03881059|449209644|FG000|Treatment Period - Part A|Other reasons|2|||
124886548|NCT03881059|449209645|FG001|Treatment Period - Part A|Other reasons|1|||
124886549|NCT03881059|449209646|FG002|Treatment Period - Part A|Other reasons|0|||
124886550|NCT03881059|449209644|FG000|Treatment Period - Part B|Adverse Event|0|||
124886551|NCT03881059|449209645|FG001|Treatment Period - Part B|Adverse Event|0|||
124886552|NCT03881059|449209646|FG002|Treatment Period - Part B|Adverse Event|3|||
124886553|NCT03881059|449209644|FG000|Treatment Period - Part B|Death|0|||
124886554|NCT03881059|449209645|FG001|Treatment Period - Part B|Death|1|||
124886555|NCT03881059|449209646|FG002|Treatment Period - Part B|Death|1|||
124886556|NCT03881059|449209644|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
124886557|NCT03881059|449209645|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
124886558|NCT03881059|449209646|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
124886559|NCT03881059|449209644|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
125105093|NCT01186744|450008074|FG002|Overall Study|Protocol Violation|0|||
124886560|NCT03881059|449209645|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
124886561|NCT03881059|449209646|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
124886562|NCT03881059|449209644|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
124886563|NCT03881059|449209645|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
124886564|NCT03881059|449209646|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
124886565|NCT03881059|449209644|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
124886566|NCT03881059|449209645|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
124886567|NCT03881059|449209646|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
124886568|NCT03881059|449209644|FG000|Treatment Period - Part B|Other reasons|4|||
124886569|NCT03881059|449209645|FG001|Treatment Period - Part B|Other reasons|3|||
124886570|NCT03881059|449209646|FG002|Treatment Period - Part B|Other reasons|3|||
124886571|NCT05284019|449209647|FG000|Overall Study|Study terminated|2|||
124886572|NCT05284019|449209648|FG001|Overall Study|Study terminated|2|||
124886573|NCT05284019|449209649|FG002|Overall Study|Study terminated|2|||
124886574|NCT05284019|449209650|FG003|Overall Study|Study terminated|5|||
124886575|NCT05284019|449209651|FG004|Overall Study|Study terminated|15|||
124886576|NCT05284019|449209647|FG000|Overall Study|Withdrawal by Subject|0|||
124886577|NCT05284019|449209648|FG001|Overall Study|Withdrawal by Subject|0|||
124886578|NCT05284019|449209649|FG002|Overall Study|Withdrawal by Subject|0|||
124886579|NCT05284019|449209650|FG003|Overall Study|Withdrawal by Subject|1|||
124886580|NCT05284019|449209651|FG004|Overall Study|Withdrawal by Subject|1|||
124886581|NCT05284019|449209647|FG000|Overall Study|Lost to Follow-up|1|||
124886582|NCT05284019|449209648|FG001|Overall Study|Lost to Follow-up|0|||
124886583|NCT05284019|449209649|FG002|Overall Study|Lost to Follow-up|0|||
124886584|NCT05284019|449209650|FG003|Overall Study|Lost to Follow-up|2|||
125105094|NCT01186744|450008075|FG003|Overall Study|Protocol Violation|1|||
124886585|NCT05284019|449209651|FG004|Overall Study|Lost to Follow-up|1|||
124886586|NCT00287469|449209652|FG000|Overall Study|serious adverse event|1|||
124886587|NCT00287469|449209653|FG001|Overall Study|serious adverse event|6|||
124886588|NCT00287469|449209652|FG000|Overall Study|Adverse Event|1|||
124886589|NCT00287469|449209653|FG001|Overall Study|Adverse Event|1|||
124886590|NCT00287469|449209652|FG000|Overall Study|moved from area|144|||
124886591|NCT00287469|449209653|FG001|Overall Study|moved from area|138|||
124886592|NCT00287469|449209652|FG000|Overall Study|Lost to Follow-up|74|||
124886593|NCT00287469|449209653|FG001|Overall Study|Lost to Follow-up|69|||
124886594|NCT01266993|449209656|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
124886595|NCT01266993|449209657|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
124886596|NCT01266993|449209656|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
124886597|NCT01266993|449209657|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
124886598|NCT02942004|449209658|FG000|Overall Study|Withdrawal by Subject|0|||
124886599|NCT02942004|449209659|FG001|Overall Study|Withdrawal by Subject|2|||
124886600|NCT02942004|449209660|FG002|Overall Study|Withdrawal by Subject|3|||
124886601|NCT02942004|449209658|FG000|Overall Study|Lost to Follow-up|1|||
124886602|NCT02942004|449209659|FG001|Overall Study|Lost to Follow-up|1|||
124886603|NCT02942004|449209660|FG002|Overall Study|Lost to Follow-up|2|||
124886604|NCT02942004|449209658|FG000|Overall Study|Randomized but not dosed|3|||
124886605|NCT02942004|449209659|FG001|Overall Study|Randomized but not dosed|9|||
124886606|NCT02942004|449209660|FG002|Overall Study|Randomized but not dosed|4|||
124886607|NCT03382600|449209661|FG000|Overall Study|Adverse Event|3|||
124886608|NCT03382600|449209662|FG001|Overall Study|Adverse Event|3|||
124886609|NCT03382600|449209661|FG000|Overall Study|Clinical Disease Progression|2|||
124886610|NCT03382600|449209662|FG001|Overall Study|Clinical Disease Progression|4|||
124886611|NCT03382600|449209661|FG000|Overall Study|Radiological Progression|40|||
124886612|NCT03382600|449209662|FG001|Overall Study|Radiological Progression|31|||
124886613|NCT03382600|449209661|FG000|Overall Study|Withdrawal by Subject|0|||
124886614|NCT03382600|449209662|FG001|Overall Study|Withdrawal by Subject|1|||
124886615|NCT03382600|449209661|FG000|Overall Study|Other|9|||
124886616|NCT03382600|449209662|FG001|Overall Study|Other|7|||
124886617|NCT01448044|449209663|FG000|Treatment Period|Adverse Event|4|||
124886618|NCT01448044|449209664|FG001|Treatment Period|Adverse Event|3|||
124886619|NCT01448044|449209663|FG000|Treatment Period|Lack of Efficacy|5|||
124886620|NCT01448044|449209664|FG001|Treatment Period|Lack of Efficacy|12|||
124886621|NCT01448044|449209663|FG000|Treatment Period|Subject requested discontinue study drug|1|||
124886622|NCT01448044|449209664|FG001|Treatment Period|Subject requested discontinue study drug|0|||
124886623|NCT01448044|449209663|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
124886624|NCT01448044|449209664|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
124886625|NCT01448044|449209663|FG000|Treatment Period|Participant does not meet study criteria|1|||
124886626|NCT01448044|449209664|FG001|Treatment Period|Participant does not meet study criteria|0|||
124886627|NCT01448044|449209663|FG000|Treatment Period|Lost to Follow-up|2|||
124886628|NCT01448044|449209664|FG001|Treatment Period|Lost to Follow-up|1|||
124886629|NCT01448044|449209663|FG000|Treatment Period|Other reason|2|||
124886630|NCT01448044|449209664|FG001|Treatment Period|Other reason|0|||
124886631|NCT01448044|449209663|FG000|Follow Up Period|Withdrawal by Subject|1|||
125105095|NCT01186744|450008076|FG004|Overall Study|Protocol Violation|1|||
125105096|NCT01186744|450008077|FG005|Overall Study|Protocol Violation|2|||
125105097|NCT01186744|450008072|FG000|Overall Study|Lost to Follow-up|15|||
125105098|NCT01186744|450008073|FG001|Overall Study|Lost to Follow-up|16|||
125105099|NCT01186744|450008074|FG002|Overall Study|Lost to Follow-up|2|||
125105100|NCT01186744|450008075|FG003|Overall Study|Lost to Follow-up|1|||
125105101|NCT01186744|450008076|FG004|Overall Study|Lost to Follow-up|1|||
125105102|NCT01186744|450008077|FG005|Overall Study|Lost to Follow-up|4|||
125105103|NCT01186744|450008072|FG000|Overall Study|Screen failure|1|||
125105104|NCT01186744|450008073|FG001|Overall Study|Screen failure|1|||
125105105|NCT01186744|450008074|FG002|Overall Study|Screen failure|0|||
125105106|NCT01186744|450008075|FG003|Overall Study|Screen failure|1|||
125105107|NCT01186744|450008076|FG004|Overall Study|Screen failure|0|||
125105108|NCT01186744|450008077|FG005|Overall Study|Screen failure|0|||
125105109|NCT01186744|450008072|FG000|Overall Study|Withdrawal by Subject|14|||
125105110|NCT01186744|450008073|FG001|Overall Study|Withdrawal by Subject|10|||
124886632|NCT01448044|449209664|FG001|Follow Up Period|Withdrawal by Subject|1|||
124886633|NCT01448044|449209663|FG000|Follow Up Period|Lost to Follow-up|6|||
125105111|NCT01186744|450008074|FG002|Overall Study|Withdrawal by Subject|2|||
125105112|NCT01186744|450008075|FG003|Overall Study|Withdrawal by Subject|5|||
125105113|NCT01186744|450008076|FG004|Overall Study|Withdrawal by Subject|0|||
125105114|NCT01186744|450008077|FG005|Overall Study|Withdrawal by Subject|6|||
125105115|NCT01186744|450008072|FG000|Overall Study|Study terminated by Sponsor|1|||
124886634|NCT01448044|449209664|FG001|Follow Up Period|Lost to Follow-up|2|||
124886635|NCT01448044|449209663|FG000|Follow Up Period|Other|5|||
125105116|NCT01186744|450008073|FG001|Overall Study|Study terminated by Sponsor|0|||
125105117|NCT01186744|450008074|FG002|Overall Study|Study terminated by Sponsor|0|||
125105118|NCT01186744|450008075|FG003|Overall Study|Study terminated by Sponsor|0|||
125105119|NCT01186744|450008076|FG004|Overall Study|Study terminated by Sponsor|0|||
124886636|NCT01448044|449209664|FG001|Follow Up Period|Other|11|||
125105120|NCT01186744|450008077|FG005|Overall Study|Study terminated by Sponsor|0|||
125015520|NCT00105443|449682531|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
125015521|NCT00105443|449682532|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
125015522|NCT00105443|449682533|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
125015523|NCT00105443|449682534|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
125015524|NCT00105443|449682531|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
124886637|NCT01000376|449209667|FG000|Cycle 1 Day 1|Adverse Event|1|||
125015525|NCT00105443|449682532|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
125015526|NCT00105443|449682533|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
125015527|NCT00105443|449682534|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
125015528|NCT00105443|449682531|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
125015529|NCT00105443|449682532|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
125015530|NCT00105443|449682533|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
125015531|NCT00105443|449682534|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
125015532|NCT00105443|449682531|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
125015533|NCT00105443|449682532|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
125015534|NCT00105443|449682533|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
125105121|NCT01186744|450008072|FG000|Overall Study|Other|9|||
124886638|NCT01000376|449209668|FG001|Cycle 1 Day 1|Adverse Event|0|||
124886639|NCT01000376|449209667|FG000|Cycle 1 Day 1|Progressive Disease|1|||
124886640|NCT01000376|449209668|FG001|Cycle 1 Day 1|Progressive Disease|0|||
124886641|NCT00507026|449209669|FG000|Overall Study|Lack of Efficacy|6|||
124886642|NCT00507026|449209670|FG001|Overall Study|Lack of Efficacy|4|||
124886643|NCT00507026|449209671|FG002|Overall Study|Lack of Efficacy|21|||
124886644|NCT00507026|449209669|FG000|Overall Study|Withdrawal by Subject|2|||
125015535|NCT00105443|449682534|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
125015536|NCT00105443|449682531|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
125015537|NCT00105443|449682532|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
125015538|NCT00105443|449682533|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
125015539|NCT00105443|449682534|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
125015540|NCT00105443|449682531|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
125015541|NCT00105443|449682532|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
125015542|NCT00105443|449682533|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
125015543|NCT00105443|449682534|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
125015544|NCT00105443|449682531|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
125015545|NCT00105443|449682532|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
124886645|NCT00507026|449209670|FG001|Overall Study|Withdrawal by Subject|0|||
124886646|NCT00507026|449209671|FG002|Overall Study|Withdrawal by Subject|0|||
124886647|NCT00507026|449209669|FG000|Overall Study|Investigator Decision|1|||
124886648|NCT00507026|449209670|FG001|Overall Study|Investigator Decision|0|||
124886649|NCT00507026|449209671|FG002|Overall Study|Investigator Decision|0|||
124886650|NCT00507026|449209669|FG000|Overall Study|Adverse Event|2|||
124886651|NCT00507026|449209670|FG001|Overall Study|Adverse Event|0|||
124886652|NCT00507026|449209671|FG002|Overall Study|Adverse Event|0|||
124886653|NCT00507026|449209669|FG000|Overall Study|Protocol Violation|1|||
124886654|NCT00507026|449209670|FG001|Overall Study|Protocol Violation|0|||
124886655|NCT00507026|449209671|FG002|Overall Study|Protocol Violation|0|||
124886656|NCT00507026|449209669|FG000|Overall Study|Other|1|||
124886657|NCT00507026|449209670|FG001|Overall Study|Other|0|||
124886658|NCT00507026|449209671|FG002|Overall Study|Other|0|||
124886659|NCT00896454|449209672|FG000|Overall Study|Death|10|||
124886660|NCT00896454|449209672|FG000|Overall Study|Adverse Event|8|||
124886661|NCT00896454|449209672|FG000|Overall Study|Disease Progression|5|||
124886662|NCT00896454|449209672|FG000|Overall Study|Other|4|||
124886663|NCT00896454|449209672|FG000|Overall Study|Requirement for alternative therapy|3|||
124886664|NCT00896454|449209672|FG000|Overall Study|Ongoing in study|2|||
124886665|NCT00896454|449209672|FG000|Overall Study|Withdrawal by Subject|1|||
124886666|NCT03688711|449209675|FG000|Overall Study|Withdrawal by Subject|0|||
124886667|NCT03688711|449209676|FG001|Overall Study|Withdrawal by Subject|1|||
124886668|NCT02500316|449209686|FG000|Overall Study|Adverse Event|3|||
124886669|NCT02500316|449209686|FG000|Overall Study|Lost to Follow-up|2|||
124886670|NCT02500316|449209686|FG000|Overall Study|Protocol Violation|1|||
124886671|NCT02500316|449209686|FG000|Overall Study|Withdrawal by Subject|15|||
124886672|NCT02500316|449209686|FG000|Overall Study|Final height achieved|5|||
124886673|NCT02500316|449209686|FG000|Overall Study|Due to war activity|1|||
124886674|NCT01406717|449209687|FG000|Overall Study|Subject non-compliance|4|||
124886675|NCT01406717|449209688|FG001|Overall Study|Subject non-compliance|3|||
124886676|NCT01406717|449209687|FG000|Overall Study|Protocol Violation|5|||
124886677|NCT01406717|449209688|FG001|Overall Study|Protocol Violation|1|||
124886678|NCT01406717|449209687|FG000|Overall Study|Lost to Follow-up|14|||
124886679|NCT01406717|449209688|FG001|Overall Study|Lost to Follow-up|8|||
124886680|NCT01406717|449209687|FG000|Overall Study|Withdrawal by Subject|19|||
124886681|NCT01406717|449209688|FG001|Overall Study|Withdrawal by Subject|15|||
124886682|NCT01406717|449209687|FG000|Overall Study|Adverse Event|1|||
124886683|NCT01406717|449209688|FG001|Overall Study|Adverse Event|2|||
124886684|NCT01406717|449209687|FG000|Overall Study|Lack of Efficacy|0|||
124886685|NCT01406717|449209688|FG001|Overall Study|Lack of Efficacy|1|||
124886686|NCT01406717|449209687|FG000|Overall Study|Non-completion of visit activity|0|||
124886687|NCT01406717|449209688|FG001|Overall Study|Non-completion of visit activity|1|||
124886688|NCT03257995|449209689|FG000|Overall Study|Adverse Event|0|||
124886689|NCT03257995|449209690|FG001|Overall Study|Adverse Event|1|||
124886690|NCT03257995|449209691|FG002|Overall Study|Adverse Event|0|||
124886691|NCT03257995|449209692|FG003|Overall Study|Adverse Event|0|||
124886692|NCT03257995|449209693|FG004|Overall Study|Adverse Event|0|||
124886693|NCT03257995|449209694|FG005|Overall Study|Adverse Event|0|||
124886694|NCT03257995|449209689|FG000|Overall Study|Protocol deviation|0|||
124886695|NCT03257995|449209690|FG001|Overall Study|Protocol deviation|0|||
124886696|NCT03257995|449209691|FG002|Overall Study|Protocol deviation|0|||
124886697|NCT03257995|449209692|FG003|Overall Study|Protocol deviation|0|||
124886698|NCT03257995|449209693|FG004|Overall Study|Protocol deviation|0|||
124886699|NCT03257995|449209694|FG005|Overall Study|Protocol deviation|2|||
124886700|NCT01556763|449209699|FG000|Overall Study|Withdrawal by Subject|0|||
124886701|NCT01556763|449209700|FG001|Overall Study|Withdrawal by Subject|1|||
124886702|NCT01556763|449209701|FG002|Overall Study|Withdrawal by Subject|0|||
124886703|NCT04170296|449209702|FG000|Overall Study|Adverse Event|1|||
124886704|NCT04170296|449209703|FG001|Overall Study|Adverse Event|0|||
124886705|NCT04170296|449209702|FG000|Overall Study|Withdrawal by Subject|3|||
124886706|NCT04170296|449209703|FG001|Overall Study|Withdrawal by Subject|2|||
124886707|NCT04170296|449209702|FG000|Overall Study|Lost to Follow-up|4|||
124886708|NCT04170296|449209703|FG001|Overall Study|Lost to Follow-up|2|||
124886709|NCT00195715|449209704|FG000|Overall Study|Adverse Event|122|||
124886710|NCT00195715|449209704|FG000|Overall Study|Withdrawal by Subject|58|||
124886711|NCT00195715|449209704|FG000|Overall Study|Lost to Follow-up|27|||
124886712|NCT00195715|449209704|FG000|Overall Study|Protocol Violation|13|||
124886713|NCT00195715|449209704|FG000|Overall Study|Lack of Efficacy|93|||
124886714|NCT00195715|449209704|FG000|Overall Study|Pregnancy|14|||
124886715|NCT00195715|449209704|FG000|Overall Study|Investigative site closure|8|||
124886716|NCT00195715|449209704|FG000|Overall Study|Subject moved/relocated|7|||
124886717|NCT00195715|449209704|FG000|Overall Study|Subject non-compliance|6|||
124886718|NCT00195715|449209704|FG000|Overall Study|Subject started commercial Humira|5|||
124886719|NCT00195715|449209704|FG000|Overall Study|Subject choice|3|||
124886720|NCT00195715|449209704|FG000|Overall Study|Loss of response/no improvement|3|||
124886721|NCT00195715|449209704|FG000|Overall Study|Sponsor stopped study|1|||
125105122|NCT01186744|450008073|FG001|Overall Study|Other|10|||
125105123|NCT01186744|450008074|FG002|Overall Study|Other|1|||
125105124|NCT01186744|450008075|FG003|Overall Study|Other|2|||
125105125|NCT01186744|450008076|FG004|Overall Study|Other|1|||
125105126|NCT01186744|450008077|FG005|Overall Study|Other|5|||
125105127|NCT01186744|450008072|FG000|Overall Study|Adverse Event|10|||
125105128|NCT01186744|450008073|FG001|Overall Study|Adverse Event|14|||
125105129|NCT01186744|450008074|FG002|Overall Study|Adverse Event|1|||
125105130|NCT01186744|450008075|FG003|Overall Study|Adverse Event|0|||
125105131|NCT01186744|450008076|FG004|Overall Study|Adverse Event|1|||
125105132|NCT01186744|450008077|FG005|Overall Study|Adverse Event|4|||
125105133|NCT01186744|450008072|FG000|Overall Study|Death|1|||
125105134|NCT01186744|450008073|FG001|Overall Study|Death|0|||
125105135|NCT01186744|450008074|FG002|Overall Study|Death|0|||
125105136|NCT01186744|450008075|FG003|Overall Study|Death|0|||
125105137|NCT01186744|450008076|FG004|Overall Study|Death|0|||
125105138|NCT01186744|450008077|FG005|Overall Study|Death|0|||
125105139|NCT01020773|450008080|FG000|Overall Study|Withdrawal by Subject|4|||
125105140|NCT01020773|450008081|FG001|Overall Study|Withdrawal by Subject|3|||
125105141|NCT02675426|450008082|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
124886722|NCT00195715|449209704|FG000|Overall Study|Administrative reasons|2|||
124886723|NCT00195715|449209704|FG000|Overall Study|Investigator's decision|2|||
124886724|NCT00195715|449209704|FG000|Overall Study|Subject wants to get pregnant|4|||
124886725|NCT00195715|449209704|FG000|Overall Study|Use of prohibited medication|2|||
124886726|NCT00195715|449209704|FG000|Overall Study|Planned surgery|2|||
124886727|NCT00195715|449209704|FG000|Overall Study|Increased infection rate|1|||
124886728|NCT00195715|449209704|FG000|Overall Study|Ineligible|1|||
124886729|NCT00195715|449209704|FG000|Overall Study|Colonic stricture|1|||
124886730|NCT00195715|449209704|FG000|Overall Study|Sponsor discontinued trial|1|||
124886731|NCT00195715|449209704|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
125105142|NCT02675426|450008083|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
124886732|NCT00845871|449209705|FG000|Assessment Period|Adverse Event|2|||
124886733|NCT00845871|449209705|FG000|Assessment Period|Abnormal laboratory values|1|||
124886734|NCT00845871|449209705|FG000|Assessment Period|Abnormal test procedure results|1|||
124886735|NCT00845871|449209705|FG000|Assessment Period|Patient withdrew consent|3|||
124886736|NCT01370603|449209707|FG000|Period 1|Adverse Event|5|||
124886737|NCT01370603|449209708|FG001|Period 1|Adverse Event|3|||
124886738|NCT01370603|449209707|FG000|Period 1|Lost to Follow-up|2|||
124886739|NCT01370603|449209708|FG001|Period 1|Lost to Follow-up|0|||
124886740|NCT01370603|449209707|FG000|Period 1|Protocol Violation|2|||
124886741|NCT01370603|449209708|FG001|Period 1|Protocol Violation|2|||
124886742|NCT01370603|449209707|FG000|Period 1|Withdrawal by Subject|5|||
124886743|NCT01370603|449209708|FG001|Period 1|Withdrawal by Subject|5|||
124886744|NCT01370603|449209707|FG000|Crossover Washout|Adverse Event|2|||
124886745|NCT01370603|449209708|FG001|Crossover Washout|Adverse Event|1|||
124886746|NCT01370603|449209707|FG000|Crossover Washout|Lost to Follow-up|2|||
124886747|NCT01370603|449209708|FG001|Crossover Washout|Lost to Follow-up|0|||
124886748|NCT01370603|449209707|FG000|Crossover Washout|Protocol Violation|1|||
124886749|NCT01370603|449209708|FG001|Crossover Washout|Protocol Violation|0|||
124886750|NCT01370603|449209707|FG000|Crossover Washout|Withdrawal by Subject|4|||
124886751|NCT01370603|449209708|FG001|Crossover Washout|Withdrawal by Subject|1|||
124886752|NCT01370603|449209707|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
124886753|NCT01370603|449209708|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
124886754|NCT01370603|449209707|FG000|Period 2|Adverse Event|1|||
124886755|NCT01370603|449209708|FG001|Period 2|Adverse Event|4|||
124886756|NCT01370603|449209707|FG000|Period 2|Lost to Follow-up|1|||
124886757|NCT01370603|449209708|FG001|Period 2|Lost to Follow-up|0|||
124886758|NCT01370603|449209707|FG000|Period 2|Withdrawal by Subject|1|||
124886759|NCT01370603|449209708|FG001|Period 2|Withdrawal by Subject|0|||
124886760|NCT04039503|449209710|FG000|Overall Study|Adverse Event|3|||
124886761|NCT04039503|449209711|FG001|Overall Study|Adverse Event|0|||
124886762|NCT04039503|449209712|FG002|Overall Study|Adverse Event|2|||
124886763|NCT04039503|449209713|FG003|Overall Study|Adverse Event|0|||
124886764|NCT04039503|449209710|FG000|Overall Study|Lost to Follow-up|0|||
125015546|NCT00105443|449682533|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
125015547|NCT00105443|449682534|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
125015548|NCT00105443|449682531|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
125015549|NCT00105443|449682532|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
124886765|NCT04039503|449209711|FG001|Overall Study|Lost to Follow-up|0|||
124886766|NCT04039503|449209712|FG002|Overall Study|Lost to Follow-up|1|||
124886767|NCT04039503|449209713|FG003|Overall Study|Lost to Follow-up|0|||
124886768|NCT04039503|449209710|FG000|Overall Study|Protocol Violation|0|||
124886769|NCT04039503|449209711|FG001|Overall Study|Protocol Violation|1|||
124886770|NCT04039503|449209712|FG002|Overall Study|Protocol Violation|2|||
124886771|NCT04039503|449209713|FG003|Overall Study|Protocol Violation|1|||
124886772|NCT04039503|449209710|FG000|Overall Study|Withdrawal by Subject|4|||
124886773|NCT04039503|449209711|FG001|Overall Study|Withdrawal by Subject|3|||
124886774|NCT04039503|449209712|FG002|Overall Study|Withdrawal by Subject|5|||
124886775|NCT04039503|449209713|FG003|Overall Study|Withdrawal by Subject|2|||
124886776|NCT01163747|449209714|FG000|Overall Study|Adverse Event|0|||
124886777|NCT01163747|449209715|FG001|Overall Study|Adverse Event|5|||
124886778|NCT01163747|449209714|FG000|Overall Study|Insufficient Therapeutic Response|0|||
124886779|NCT01163747|449209715|FG001|Overall Study|Insufficient Therapeutic Response|1|||
124886780|NCT01163747|449209714|FG000|Overall Study|Protocol Violation|0|||
124886781|NCT01163747|449209715|FG001|Overall Study|Protocol Violation|1|||
124886782|NCT01163747|449209714|FG000|Overall Study|Refused Treatment|6|||
124886783|NCT01163747|449209715|FG001|Overall Study|Refused Treatment|4|||
124886784|NCT03681639|449211619|FG000|Overall Study|Death|4|||
124886785|NCT03681639|449211619|FG000|Overall Study|Lost to Follow-up|2|||
124886786|NCT03681639|449211619|FG000|Overall Study|Withdrawal by Subject|1|||
124886787|NCT03681639|449211619|FG000|Overall Study|Adverse Event|2|||
124886788|NCT00654940|449211620|FG000|Period 1|Adverse Event|0|||
124886789|NCT00654940|449211621|FG001|Period 1|Adverse Event|1|||
124886790|NCT00654940|449211620|FG000|Period 1|Intolerable Pain Level|1|||
124886791|NCT00654940|449211621|FG001|Period 1|Intolerable Pain Level|0|||
124886792|NCT00581113|449211622|FG000|Overall Study|Withdrawal by Subject|0|||
124886793|NCT00581113|449211623|FG001|Overall Study|Withdrawal by Subject|1|||
124886794|NCT01818141|449211624|FG000|Overall Study|Withdrawal by Subject|2|||
124886795|NCT01818141|449211625|FG001|Overall Study|Withdrawal by Subject|0|||
124886796|NCT01818141|449211624|FG000|Overall Study|No baseline C.diff colonies|1|||
124886797|NCT01818141|449211625|FG001|Overall Study|No baseline C.diff colonies|1|||
124886798|NCT01818141|449211624|FG000|Overall Study|Lost to Follow-up|0|||
124886799|NCT01818141|449211625|FG001|Overall Study|Lost to Follow-up|2|||
124886800|NCT00619476|449211626|FG000|Overall Study|Adverse Event|12|||
124886801|NCT00619476|449211627|FG001|Overall Study|Adverse Event|6|||
124886802|NCT00619476|449211628|FG002|Overall Study|Adverse Event|12|||
124886803|NCT00619476|449211629|FG003|Overall Study|Adverse Event|16|||
124886804|NCT00619476|449211626|FG000|Overall Study|Lack of Efficacy|6|||
124886805|NCT00619476|449211627|FG001|Overall Study|Lack of Efficacy|1|||
124886806|NCT00619476|449211628|FG002|Overall Study|Lack of Efficacy|1|||
124886807|NCT00619476|449211629|FG003|Overall Study|Lack of Efficacy|4|||
124886808|NCT00619476|449211626|FG000|Overall Study|Protocol Violation|5|||
124886809|NCT00619476|449211627|FG001|Overall Study|Protocol Violation|4|||
124886810|NCT00619476|449211628|FG002|Overall Study|Protocol Violation|4|||
124886811|NCT00619476|449211629|FG003|Overall Study|Protocol Violation|9|||
124886812|NCT00619476|449211626|FG000|Overall Study|Lost to Follow-up|1|||
124886813|NCT00619476|449211627|FG001|Overall Study|Lost to Follow-up|2|||
124886814|NCT00619476|449211628|FG002|Overall Study|Lost to Follow-up|0|||
124886815|NCT00619476|449211629|FG003|Overall Study|Lost to Follow-up|1|||
124886816|NCT00619476|449211626|FG000|Overall Study|Investigator Discretion|2|||
124886817|NCT00619476|449211627|FG001|Overall Study|Investigator Discretion|2|||
124886818|NCT00619476|449211628|FG002|Overall Study|Investigator Discretion|2|||
124886819|NCT00619476|449211629|FG003|Overall Study|Investigator Discretion|0|||
124886820|NCT00619476|449211626|FG000|Overall Study|Withdrawal by Subject|5|||
124886821|NCT00619476|449211627|FG001|Overall Study|Withdrawal by Subject|7|||
124886822|NCT00619476|449211628|FG002|Overall Study|Withdrawal by Subject|5|||
124886823|NCT00619476|449211629|FG003|Overall Study|Withdrawal by Subject|4|||
124886824|NCT03204695|449211633|FG000|Overall Study|Death|1|||
124886825|NCT03204695|449211633|FG000|Overall Study|Participant was treated with another device|1|||
124886826|NCT03204695|449211633|FG000|Overall Study|Physician Decision|2|||
124886827|NCT04834362|449211634|FG000|Overall Study|Death|1|||
124886828|NCT04834362|449211635|FG001|Overall Study|Death|2|||
124886829|NCT01349829|449211638|FG000|Overall Study|Lost to Follow-up|4|||
124886830|NCT01349829|449211639|FG001|Overall Study|Lost to Follow-up|8|||
124886831|NCT01349829|449211638|FG000|Overall Study|Consent withdrawal|3|||
124886832|NCT01349829|449211639|FG001|Overall Study|Consent withdrawal|8|||
124886833|NCT01349829|449211638|FG000|Overall Study|Migrated/moved|2|||
124886834|NCT01349829|449211639|FG001|Overall Study|Migrated/moved|7|||
124886835|NCT03095599|449211640|FG000|Overall Study|Withdrawal by Subject|1|||
124886836|NCT03095599|449211641|FG001|Overall Study|Withdrawal by Subject|0|||
124886837|NCT03095599|449211640|FG000|Overall Study|Lost to Follow-up|1|||
124886838|NCT03095599|449211641|FG001|Overall Study|Lost to Follow-up|0|||
124886839|NCT03095599|449211640|FG000|Overall Study|Withdrawal prior to vaccination|1|||
124886840|NCT03095599|449211641|FG001|Overall Study|Withdrawal prior to vaccination|0|||
124886841|NCT00742885|449211643|FG000|Overall Study|Lost to Follow-up|1|||
124886842|NCT00742885|449211644|FG001|Overall Study|Lost to Follow-up|0|||
124886843|NCT04781647|449211645|FG000|Overall Study|Study terminated by Sponsor|11|||
124886844|NCT04781647|449211646|FG001|Overall Study|Study terminated by Sponsor|9|||
124886845|NCT04781647|449211647|FG002|Overall Study|Study terminated by Sponsor|9|||
124886846|NCT04781647|449211645|FG000|Overall Study|Withdrawal by Subject|1|||
124886847|NCT04781647|449211646|FG001|Overall Study|Withdrawal by Subject|2|||
124886848|NCT04781647|449211647|FG002|Overall Study|Withdrawal by Subject|0|||
124886849|NCT04781647|449211645|FG000|Overall Study|Adverse Event|0|||
124886850|NCT04781647|449211646|FG001|Overall Study|Adverse Event|1|||
124886851|NCT04781647|449211647|FG002|Overall Study|Adverse Event|1|||
124886852|NCT04781647|449211645|FG000|Overall Study|Protocol Violation|1|||
124886853|NCT04781647|449211646|FG001|Overall Study|Protocol Violation|0|||
124886854|NCT04781647|449211647|FG002|Overall Study|Protocol Violation|0|||
124886855|NCT04781647|449211645|FG000|Overall Study|Pregnancy|0|||
124886856|NCT04781647|449211646|FG001|Overall Study|Pregnancy|0|||
124886857|NCT04781647|449211647|FG002|Overall Study|Pregnancy|1|||
124886858|NCT04781647|449211645|FG000|Overall Study|Virology rebounded|1|||
124886859|NCT04781647|449211646|FG001|Overall Study|Virology rebounded|0|||
124886860|NCT04781647|449211647|FG002|Overall Study|Virology rebounded|0|||
124886861|NCT01811563|449211648|FG000|Overall Study|Lost to Follow-up|5|||
124886862|NCT01811563|449211649|FG001|Overall Study|Lost to Follow-up|2|||
124886863|NCT01811563|449211648|FG000|Overall Study|Incorrect Randomization procedure|0|||
124886864|NCT01811563|449211649|FG001|Overall Study|Incorrect Randomization procedure|1|||
124886865|NCT00329719|449211650|FG000|Overall Study|Lost to Follow-up|0|||
124886866|NCT00329719|449211651|FG001|Overall Study|Lost to Follow-up|0|||
124886867|NCT00329719|449211652|FG002|Overall Study|Lost to Follow-up|0|||
124886868|NCT00329719|449211653|FG003|Overall Study|Lost to Follow-up|1|||
124886869|NCT01995357|449211656|FG000|Period 5|Lack of Efficacy|1|||
124886870|NCT01995357|449211657|FG001|Period 5|Lack of Efficacy|0|||
124886871|NCT01995357|449211658|FG002|Period 5|Lack of Efficacy|0|||
124886872|NCT01995357|449211659|FG003|Period 5|Lack of Efficacy|0|||
124886873|NCT01995357|449211660|FG004|Period 5|Lack of Efficacy|0|||
124886874|NCT01995357|449211661|FG005|Period 5|Lack of Efficacy|0|||
124886875|NCT01995357|449211656|FG000|Period 5|Adverse Event|1|||
124886876|NCT01995357|449211657|FG001|Period 5|Adverse Event|0|||
124886877|NCT01995357|449211658|FG002|Period 5|Adverse Event|1|||
124886878|NCT01995357|449211659|FG003|Period 5|Adverse Event|0|||
124886879|NCT01995357|449211660|FG004|Period 5|Adverse Event|0|||
124886880|NCT01995357|449211661|FG005|Period 5|Adverse Event|0|||
124886881|NCT01807221|449211664|FG000|Overall Study|Progressive disease|1|||
124886882|NCT01807221|449211665|FG001|Overall Study|Progressive disease|0|||
124886883|NCT01807221|449211666|FG002|Overall Study|Progressive disease|1|||
124886884|NCT01807221|449211667|FG003|Overall Study|Progressive disease|0|||
124886885|NCT01807221|449211668|FG004|Overall Study|Progressive disease|0|||
124886886|NCT01807221|449211669|FG005|Overall Study|Progressive disease|0|||
124886887|NCT01807221|449211664|FG000|Overall Study|Death|7|||
124886888|NCT01807221|449211665|FG001|Overall Study|Death|9|||
124886889|NCT01807221|449211666|FG002|Overall Study|Death|4|||
124886890|NCT01807221|449211667|FG003|Overall Study|Death|2|||
124886891|NCT01807221|449211668|FG004|Overall Study|Death|1|||
124886892|NCT01807221|449211669|FG005|Overall Study|Death|6|||
124886893|NCT01807221|449211664|FG000|Overall Study|Physician Decision|2|||
124886894|NCT01807221|449211665|FG001|Overall Study|Physician Decision|1|||
124886895|NCT01807221|449211666|FG002|Overall Study|Physician Decision|0|||
124886896|NCT01807221|449211667|FG003|Overall Study|Physician Decision|0|||
124886897|NCT01807221|449211668|FG004|Overall Study|Physician Decision|0|||
124886898|NCT01807221|449211669|FG005|Overall Study|Physician Decision|0|||
124886899|NCT01807221|449211664|FG000|Overall Study|Adverse Event|33|||
124886900|NCT01807221|449211665|FG001|Overall Study|Adverse Event|22|||
124886901|NCT01807221|449211666|FG002|Overall Study|Adverse Event|26|||
124886902|NCT01807221|449211667|FG003|Overall Study|Adverse Event|25|||
124886903|NCT01807221|449211668|FG004|Overall Study|Adverse Event|18|||
124886904|NCT01807221|449211669|FG005|Overall Study|Adverse Event|21|||
124886905|NCT01807221|449211664|FG000|Overall Study|Protocol Violation|0|||
124886906|NCT01807221|449211665|FG001|Overall Study|Protocol Violation|2|||
124886907|NCT01807221|449211666|FG002|Overall Study|Protocol Violation|1|||
124886908|NCT01807221|449211667|FG003|Overall Study|Protocol Violation|2|||
124886909|NCT01807221|449211668|FG004|Overall Study|Protocol Violation|0|||
124886910|NCT01807221|449211669|FG005|Overall Study|Protocol Violation|1|||
124886911|NCT01807221|449211664|FG000|Overall Study|Non-compliance|1|||
124886912|NCT01807221|449211665|FG001|Overall Study|Non-compliance|2|||
125015550|NCT00105443|449682533|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
125015551|NCT00105443|449682534|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
125015552|NCT00105443|449682531|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
125015553|NCT00105443|449682532|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
124886913|NCT01807221|449211666|FG002|Overall Study|Non-compliance|0|||
124886914|NCT01807221|449211667|FG003|Overall Study|Non-compliance|1|||
124886915|NCT01807221|449211668|FG004|Overall Study|Non-compliance|0|||
124886916|NCT01807221|449211669|FG005|Overall Study|Non-compliance|0|||
124886917|NCT01807221|449211664|FG000|Overall Study|Logistical difficulties|0|||
124886918|NCT01807221|449211665|FG001|Overall Study|Logistical difficulties|1|||
124886919|NCT01807221|449211666|FG002|Overall Study|Logistical difficulties|0|||
124886920|NCT01807221|449211667|FG003|Overall Study|Logistical difficulties|0|||
124886921|NCT01807221|449211668|FG004|Overall Study|Logistical difficulties|1|||
124886922|NCT01807221|449211669|FG005|Overall Study|Logistical difficulties|0|||
124886923|NCT01807221|449211664|FG000|Overall Study|Withdrawal by Subject|33|||
124886924|NCT01807221|449211665|FG001|Overall Study|Withdrawal by Subject|15|||
124886925|NCT01807221|449211666|FG002|Overall Study|Withdrawal by Subject|8|||
124886926|NCT01807221|449211667|FG003|Overall Study|Withdrawal by Subject|14|||
124886927|NCT01807221|449211668|FG004|Overall Study|Withdrawal by Subject|16|||
124886928|NCT01807221|449211669|FG005|Overall Study|Withdrawal by Subject|13|||
124886929|NCT01807221|449211664|FG000|Overall Study|Sponsor decision|2|||
124886930|NCT01807221|449211665|FG001|Overall Study|Sponsor decision|0|||
124886931|NCT01807221|449211666|FG002|Overall Study|Sponsor decision|1|||
124886932|NCT01807221|449211667|FG003|Overall Study|Sponsor decision|1|||
124886933|NCT01807221|449211668|FG004|Overall Study|Sponsor decision|0|||
124886934|NCT01807221|449211669|FG005|Overall Study|Sponsor decision|0|||
124886935|NCT01807221|449211664|FG000|Overall Study|Lost to Follow-up|1|||
124886936|NCT01807221|449211665|FG001|Overall Study|Lost to Follow-up|0|||
124886937|NCT01807221|449211666|FG002|Overall Study|Lost to Follow-up|2|||
124886938|NCT01807221|449211667|FG003|Overall Study|Lost to Follow-up|1|||
124886939|NCT01807221|449211668|FG004|Overall Study|Lost to Follow-up|0|||
124886940|NCT01807221|449211669|FG005|Overall Study|Lost to Follow-up|0|||
124886941|NCT02609659|449211670|FG000|Overall Study|Adverse Event|1|||
124886942|NCT02609659|449211670|FG000|Overall Study|Lost to Follow-up|6|||
124886943|NCT02609659|449211670|FG000|Overall Study|Other|1|||
124886944|NCT01155388|449211671|FG000|Overall Study|Adverse Event|1|||
124886945|NCT01155388|449211672|FG001|Overall Study|Adverse Event|0|||
124886946|NCT01004250|449211673|FG000|Induction Therapy Period|Adverse Event|10|||
124886947|NCT01004250|449211673|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
124886948|NCT01004250|449211673|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
124886949|NCT01004250|449211673|FG000|Induction Therapy Period|Physician Decision|2|||
124886950|NCT01004250|449211673|FG000|Maintenance Therapy Period|Adverse Event|15|||
124886951|NCT01004250|449211673|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
124886952|NCT01004250|449211673|FG000|Maintenance Therapy Period|Protocol Violation|1|||
124886953|NCT01004250|449211673|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
124886954|NCT01004250|449211673|FG000|Maintenance Therapy Period|Physician Decision|4|||
124886955|NCT01004250|449211673|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
124886956|NCT03943589|449211674|FG000|Overall Study|Death|1|||
124886957|NCT03943589|449211674|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
124886958|NCT00900627|449211675|FG000|Overall Study|Condition under investigation worsened|4|||
124886959|NCT00900627|449211676|FG001|Overall Study|Condition under investigation worsened|0|||
124886960|NCT00900627|449211677|FG002|Overall Study|Condition under investigation worsened|5|||
124886961|NCT00900627|449211678|FG003|Overall Study|Condition under investigation worsened|3|||
124886962|NCT00900627|449211679|FG004|Overall Study|Condition under investigation worsened|0|||
124886963|NCT00900627|449211680|FG005|Overall Study|Condition under investigation worsened|0|||
124886964|NCT00900627|449211675|FG000|Overall Study|Withdrawal by Subject|1|||
124886965|NCT00900627|449211676|FG001|Overall Study|Withdrawal by Subject|0|||
124886966|NCT00900627|449211677|FG002|Overall Study|Withdrawal by Subject|1|||
124886967|NCT00900627|449211678|FG003|Overall Study|Withdrawal by Subject|0|||
125105143|NCT02675426|450008084|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
125105144|NCT02675426|450008085|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
125105145|NCT02675426|450008082|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
125105146|NCT02675426|450008083|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
125105147|NCT02675426|450008084|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
125105148|NCT02675426|450008085|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
125105149|NCT02675426|450008082|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
125105150|NCT02675426|450008083|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
125105151|NCT02675426|450008084|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
125105152|NCT02675426|450008085|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
125105153|NCT02675426|450008082|FG000|Period 1: Week 1 to Week 12|Other|2|||
125105154|NCT02675426|450008083|FG001|Period 1: Week 1 to Week 12|Other|1|||
125105155|NCT02675426|450008084|FG002|Period 1: Week 1 to Week 12|Other|0|||
125105156|NCT02675426|450008085|FG003|Period 1: Week 1 to Week 12|Other|2|||
124886968|NCT00900627|449211679|FG004|Overall Study|Withdrawal by Subject|1|||
124886969|NCT00900627|449211680|FG005|Overall Study|Withdrawal by Subject|2|||
124886970|NCT00900627|449211675|FG000|Overall Study|Adverse Event|1|||
124886971|NCT00900627|449211676|FG001|Overall Study|Adverse Event|2|||
124886972|NCT00900627|449211677|FG002|Overall Study|Adverse Event|0|||
124886973|NCT00900627|449211678|FG003|Overall Study|Adverse Event|3|||
124886974|NCT00900627|449211679|FG004|Overall Study|Adverse Event|0|||
124886975|NCT00900627|449211680|FG005|Overall Study|Adverse Event|0|||
124886976|NCT00900627|449211675|FG000|Overall Study|Death|0|||
124886977|NCT00900627|449211676|FG001|Overall Study|Death|0|||
125105157|NCT02675426|450008082|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
125105158|NCT02675426|450008083|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
124886978|NCT00900627|449211677|FG002|Overall Study|Death|0|||
124886979|NCT00900627|449211678|FG003|Overall Study|Death|0|||
124886980|NCT00900627|449211679|FG004|Overall Study|Death|28|||
124886981|NCT00900627|449211680|FG005|Overall Study|Death|24|||
124886982|NCT00373295|449211681|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
124886983|NCT00373295|449211682|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
124886984|NCT00373295|449211683|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
124886985|NCT00373295|449211684|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
124886986|NCT00373295|449211685|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
124886987|NCT00373295|449211686|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
124886988|NCT00830947|449211687|FG000|Overall Study|Lost to Follow-up|4|||
124886989|NCT00830947|449211688|FG001|Overall Study|Lost to Follow-up|4|||
124886990|NCT02291289|449211689|FG000|Induction Treatment|Withdrawal by Subject|0|||
124886991|NCT02291289|449211690|FG001|Induction Treatment|Withdrawal by Subject|0|||
124886992|NCT02291289|449211691|FG002|Induction Treatment|Withdrawal by Subject|0|||
124886993|NCT02291289|449211692|FG003|Induction Treatment|Withdrawal by Subject|24|||
124886994|NCT02291289|449211693|FG004|Induction Treatment|Withdrawal by Subject|0|||
124886995|NCT02291289|449211694|FG005|Induction Treatment|Withdrawal by Subject|0|||
124886996|NCT02291289|449211695|FG006|Induction Treatment|Withdrawal by Subject|0|||
124886997|NCT02291289|449211696|FG007|Induction Treatment|Withdrawal by Subject|0|||
124886998|NCT02291289|449211697|FG008|Induction Treatment|Withdrawal by Subject|0|||
124886999|NCT02291289|449211698|FG009|Induction Treatment|Withdrawal by Subject|18|||
124887000|NCT02291289|449211699|FG010|Induction Treatment|Withdrawal by Subject|0|||
124887001|NCT02291289|449211700|FG011|Induction Treatment|Withdrawal by Subject|0|||
124887002|NCT02291289|449211701|FG012|Induction Treatment|Withdrawal by Subject|0|||
124887003|NCT02291289|449211689|FG000|Induction Treatment|Adverse Event|0|||
124887004|NCT02291289|449211690|FG001|Induction Treatment|Adverse Event|0|||
124887005|NCT02291289|449211691|FG002|Induction Treatment|Adverse Event|0|||
124887006|NCT02291289|449211692|FG003|Induction Treatment|Adverse Event|3|||
124887007|NCT02291289|449211693|FG004|Induction Treatment|Adverse Event|0|||
124887008|NCT02291289|449211694|FG005|Induction Treatment|Adverse Event|0|||
124887009|NCT02291289|449211695|FG006|Induction Treatment|Adverse Event|0|||
124887010|NCT02291289|449211696|FG007|Induction Treatment|Adverse Event|0|||
124887011|NCT02291289|449211697|FG008|Induction Treatment|Adverse Event|0|||
124887012|NCT02291289|449211698|FG009|Induction Treatment|Adverse Event|1|||
124887013|NCT02291289|449211699|FG010|Induction Treatment|Adverse Event|0|||
124887014|NCT02291289|449211700|FG011|Induction Treatment|Adverse Event|0|||
124887015|NCT02291289|449211701|FG012|Induction Treatment|Adverse Event|0|||
124887016|NCT02291289|449211689|FG000|Induction Treatment|Death|25|||
124887017|NCT02291289|449211690|FG001|Induction Treatment|Death|0|||
124887018|NCT02291289|449211691|FG002|Induction Treatment|Death|0|||
124887019|NCT02291289|449211692|FG003|Induction Treatment|Death|111|||
124887020|NCT02291289|449211693|FG004|Induction Treatment|Death|0|||
124887021|NCT02291289|449211694|FG005|Induction Treatment|Death|0|||
124887022|NCT02291289|449211695|FG006|Induction Treatment|Death|1|||
124887023|NCT02291289|449211696|FG007|Induction Treatment|Death|0|||
124887024|NCT02291289|449211697|FG008|Induction Treatment|Death|0|||
124887025|NCT02291289|449211698|FG009|Induction Treatment|Death|82|||
124887026|NCT02291289|449211699|FG010|Induction Treatment|Death|0|||
124887027|NCT02291289|449211700|FG011|Induction Treatment|Death|0|||
124887028|NCT02291289|449211701|FG012|Induction Treatment|Death|0|||
124887029|NCT02291289|449211689|FG000|Induction Treatment|Lost to Follow-up|1|||
124887030|NCT02291289|449211690|FG001|Induction Treatment|Lost to Follow-up|0|||
124887031|NCT02291289|449211691|FG002|Induction Treatment|Lost to Follow-up|0|||
124887032|NCT02291289|449211692|FG003|Induction Treatment|Lost to Follow-up|12|||
124887033|NCT02291289|449211693|FG004|Induction Treatment|Lost to Follow-up|0|||
124887034|NCT02291289|449211694|FG005|Induction Treatment|Lost to Follow-up|0|||
125105159|NCT02675426|450008084|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
125105160|NCT02675426|450008085|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
125105161|NCT02675426|450008082|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
125105162|NCT02675426|450008083|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
125105163|NCT02675426|450008084|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
125105164|NCT02675426|450008085|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
124887035|NCT02291289|449211695|FG006|Induction Treatment|Lost to Follow-up|0|||
124887036|NCT02291289|449211696|FG007|Induction Treatment|Lost to Follow-up|0|||
124887037|NCT02291289|449211697|FG008|Induction Treatment|Lost to Follow-up|0|||
124887038|NCT02291289|449211698|FG009|Induction Treatment|Lost to Follow-up|9|||
124887039|NCT02291289|449211699|FG010|Induction Treatment|Lost to Follow-up|0|||
125105165|NCT02675426|450008082|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
124887040|NCT02291289|449211700|FG011|Induction Treatment|Lost to Follow-up|0|||
124887041|NCT02291289|449211701|FG012|Induction Treatment|Lost to Follow-up|0|||
124887042|NCT02291289|449211689|FG000|Induction Treatment|Non-Compliance|0|||
124887043|NCT02291289|449211690|FG001|Induction Treatment|Non-Compliance|0|||
124887044|NCT02291289|449211691|FG002|Induction Treatment|Non-Compliance|0|||
124887045|NCT02291289|449211692|FG003|Induction Treatment|Non-Compliance|1|||
124887046|NCT02291289|449211693|FG004|Induction Treatment|Non-Compliance|0|||
124887047|NCT02291289|449211694|FG005|Induction Treatment|Non-Compliance|0|||
125105166|NCT02675426|450008083|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
125105167|NCT02675426|450008084|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
125105168|NCT02675426|450008085|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
125105169|NCT02675426|450008082|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
125105170|NCT02675426|450008083|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
125105171|NCT02675426|450008084|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
125105172|NCT02675426|450008085|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
125105173|NCT02675426|450008082|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
125105174|NCT02675426|450008083|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
125105175|NCT02675426|450008084|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
125105176|NCT02675426|450008085|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
125105177|NCT02675426|450008082|FG000|Period 2: Week 12 to Week 260|Other|8|||
125105178|NCT02675426|450008083|FG001|Period 2: Week 12 to Week 260|Other|12|||
125105179|NCT02675426|450008084|FG002|Period 2: Week 12 to Week 260|Other|23|||
125105180|NCT02675426|450008085|FG003|Period 2: Week 12 to Week 260|Other|15|||
125105181|NCT00953927|450008086|FG000|Overall Study|Lost to Follow-up|61|||
125105182|NCT00953927|450008087|FG001|Overall Study|Lost to Follow-up|65|||
124887048|NCT02291289|449211695|FG006|Induction Treatment|Non-Compliance|0|||
125105183|NCT00953927|450008086|FG000|Overall Study|Withdrawal by Subject|36|||
125105184|NCT00953927|450008087|FG001|Overall Study|Withdrawal by Subject|25|||
125105185|NCT00953927|450008086|FG000|Overall Study|Death|7|||
125105186|NCT00953927|450008087|FG001|Overall Study|Death|4|||
125105187|NCT00953927|450008086|FG000|Overall Study|Other study discontinuation|1|||
125105188|NCT00953927|450008087|FG001|Overall Study|Other study discontinuation|1|||
125105189|NCT01652573|450008088|FG000|Overall Study|Adverse Event|0|||
125105190|NCT01652573|450008089|FG001|Overall Study|Adverse Event|1|||
125105191|NCT00934622|450008090|FG000|Overall Study|Lost to Follow-up|7|||
125105192|NCT00934622|450008090|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
125105193|NCT01856686|450008095|FG000|Overall Study|Lost to Follow-up|5|||
125105194|NCT01856686|450008096|FG001|Overall Study|Lost to Follow-up|11|||
125105195|NCT03284424|450008097|FG000|Overall Study|Death|70|||
125105196|NCT03284424|450008098|FG001|Overall Study|Death|24|||
125105197|NCT03284424|450008097|FG000|Overall Study|Lost to Follow-up|3|||
125105198|NCT03284424|450008098|FG001|Overall Study|Lost to Follow-up|1|||
125105199|NCT03284424|450008097|FG000|Overall Study|Physician Decision|1|||
125105200|NCT03284424|450008098|FG001|Overall Study|Physician Decision|2|||
125105201|NCT03284424|450008097|FG000|Overall Study|Withdrawal by Subject|4|||
125105202|NCT03284424|450008098|FG001|Overall Study|Withdrawal by Subject|5|||
125105203|NCT03284424|450008097|FG000|Overall Study|Sponsor's decision|27|||
125105204|NCT03284424|450008098|FG001|Overall Study|Sponsor's decision|22|||
125105205|NCT00602979|450008101|FG000|Overall Study|Lost to Follow-up|3|||
125105206|NCT00602979|450008102|FG001|Overall Study|Lost to Follow-up|2|||
124887049|NCT02291289|449211696|FG007|Induction Treatment|Non-Compliance|0|||
124887050|NCT02291289|449211697|FG008|Induction Treatment|Non-Compliance|0|||
124887051|NCT02291289|449211698|FG009|Induction Treatment|Non-Compliance|1|||
124887052|NCT02291289|449211699|FG010|Induction Treatment|Non-Compliance|0|||
124887053|NCT02291289|449211700|FG011|Induction Treatment|Non-Compliance|0|||
124887054|NCT02291289|449211701|FG012|Induction Treatment|Non-Compliance|0|||
124887055|NCT02291289|449211689|FG000|Induction Treatment|Reason Not Specified|0|||
124887056|NCT02291289|449211690|FG001|Induction Treatment|Reason Not Specified|0|||
124887057|NCT02291289|449211691|FG002|Induction Treatment|Reason Not Specified|0|||
124887058|NCT02291289|449211692|FG003|Induction Treatment|Reason Not Specified|4|||
124887059|NCT02291289|449211693|FG004|Induction Treatment|Reason Not Specified|0|||
124887060|NCT02291289|449211694|FG005|Induction Treatment|Reason Not Specified|0|||
124887061|NCT02291289|449211695|FG006|Induction Treatment|Reason Not Specified|0|||
124887062|NCT02291289|449211696|FG007|Induction Treatment|Reason Not Specified|0|||
124887063|NCT02291289|449211697|FG008|Induction Treatment|Reason Not Specified|0|||
124887064|NCT02291289|449211698|FG009|Induction Treatment|Reason Not Specified|7|||
124887065|NCT02291289|449211699|FG010|Induction Treatment|Reason Not Specified|0|||
124887066|NCT02291289|449211700|FG011|Induction Treatment|Reason Not Specified|0|||
124887067|NCT02291289|449211701|FG012|Induction Treatment|Reason Not Specified|0|||
124887068|NCT02291289|449211689|FG000|Induction Treatment|Physician Decision|0|||
124887069|NCT02291289|449211690|FG001|Induction Treatment|Physician Decision|0|||
124887070|NCT02291289|449211691|FG002|Induction Treatment|Physician Decision|0|||
124887071|NCT02291289|449211692|FG003|Induction Treatment|Physician Decision|3|||
124887072|NCT02291289|449211693|FG004|Induction Treatment|Physician Decision|0|||
124887073|NCT02291289|449211694|FG005|Induction Treatment|Physician Decision|0|||
124887074|NCT02291289|449211695|FG006|Induction Treatment|Physician Decision|0|||
124887075|NCT02291289|449211696|FG007|Induction Treatment|Physician Decision|0|||
125105207|NCT00602979|450008103|FG002|Overall Study|Lost to Follow-up|3|||
125105208|NCT00602979|450008104|FG003|Overall Study|Lost to Follow-up|2|||
125105209|NCT00602979|450008105|FG004|Overall Study|Lost to Follow-up|3|||
125105210|NCT00602979|450008101|FG000|Overall Study|Failed Intubation|0|||
125105211|NCT00602979|450008102|FG001|Overall Study|Failed Intubation|1|||
124887076|NCT02291289|449211697|FG008|Induction Treatment|Physician Decision|0|||
124887077|NCT02291289|449211698|FG009|Induction Treatment|Physician Decision|1|||
124887078|NCT02291289|449211699|FG010|Induction Treatment|Physician Decision|0|||
124887079|NCT02291289|449211700|FG011|Induction Treatment|Physician Decision|0|||
124887080|NCT02291289|449211701|FG012|Induction Treatment|Physician Decision|0|||
124887081|NCT02291289|449211689|FG000|Induction Treatment|Protocol Violation|0|||
124887082|NCT02291289|449211690|FG001|Induction Treatment|Protocol Violation|0|||
124887083|NCT02291289|449211691|FG002|Induction Treatment|Protocol Violation|0|||
124887084|NCT02291289|449211692|FG003|Induction Treatment|Protocol Violation|3|||
124887085|NCT02291289|449211693|FG004|Induction Treatment|Protocol Violation|0|||
124887086|NCT02291289|449211694|FG005|Induction Treatment|Protocol Violation|0|||
124887087|NCT02291289|449211695|FG006|Induction Treatment|Protocol Violation|0|||
124887088|NCT02291289|449211696|FG007|Induction Treatment|Protocol Violation|0|||
124887089|NCT02291289|449211697|FG008|Induction Treatment|Protocol Violation|0|||
124887090|NCT02291289|449211698|FG009|Induction Treatment|Protocol Violation|2|||
124887091|NCT02291289|449211699|FG010|Induction Treatment|Protocol Violation|0|||
124887092|NCT02291289|449211700|FG011|Induction Treatment|Protocol Violation|0|||
124887093|NCT02291289|449211701|FG012|Induction Treatment|Protocol Violation|0|||
124887094|NCT02291289|449211689|FG000|Induction Treatment|Missing|4|||
124887095|NCT02291289|449211690|FG001|Induction Treatment|Missing|0|||
124887096|NCT02291289|449211691|FG002|Induction Treatment|Missing|0|||
124887097|NCT02291289|449211692|FG003|Induction Treatment|Missing|14|||
124887098|NCT02291289|449211693|FG004|Induction Treatment|Missing|0|||
124887099|NCT02291289|449211694|FG005|Induction Treatment|Missing|0|||
124887100|NCT02291289|449211695|FG006|Induction Treatment|Missing|0|||
124887101|NCT02291289|449211696|FG007|Induction Treatment|Missing|0|||
124887102|NCT02291289|449211697|FG008|Induction Treatment|Missing|0|||
124887103|NCT02291289|449211698|FG009|Induction Treatment|Missing|54|||
124887104|NCT02291289|449211699|FG010|Induction Treatment|Missing|0|||
124887105|NCT02291289|449211700|FG011|Induction Treatment|Missing|0|||
124887106|NCT02291289|449211701|FG012|Induction Treatment|Missing|0|||
124887107|NCT02291289|449211689|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
124887108|NCT02291289|449211690|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
124887109|NCT02291289|449211691|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
124887110|NCT02291289|449211692|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
124887111|NCT02291289|449211693|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
125015554|NCT00105443|449682533|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
125015555|NCT00105443|449682534|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
125015556|NCT00105443|449682531|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
124887112|NCT02291289|449211694|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
124887113|NCT02291289|449211695|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
124887114|NCT02291289|449211696|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
124887115|NCT02291289|449211697|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
124887116|NCT02291289|449211698|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
124887117|NCT02291289|449211699|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
124887118|NCT02291289|449211700|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
124887119|NCT02291289|449211701|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
124887120|NCT02291289|449211689|FG000|Maintenance Treatment Phase|Death|0|||
125015557|NCT00105443|449682532|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
125015558|NCT00105443|449682533|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
125015559|NCT00105443|449682534|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
125015560|NCT00105443|449682531|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
125015561|NCT00105443|449682532|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
125015562|NCT00105443|449682533|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
125015563|NCT00105443|449682534|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
125015564|NCT00105443|449682531|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
125015565|NCT00105443|449682532|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
125015566|NCT00105443|449682533|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
125015567|NCT00105443|449682534|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
125015568|NCT00105443|449682531|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
125015569|NCT00105443|449682532|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
125015570|NCT00105443|449682533|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
125015571|NCT00105443|449682534|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
125015572|NCT02135692|449682535|FG000|Overall Study|Adverse Event|3|||
125015573|NCT02135692|449682535|FG000|Overall Study|Lack of Efficacy|2|||
125015574|NCT02135692|449682535|FG000|Overall Study|Protocol Violation|2|||
125015575|NCT02135692|449682535|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
125015576|NCT02135692|449682535|FG000|Overall Study|Product commercially available|159|||
124887121|NCT02291289|449211690|FG001|Maintenance Treatment Phase|Death|29|||
125105212|NCT00602979|450008103|FG002|Overall Study|Failed Intubation|0|||
125105213|NCT00602979|450008104|FG003|Overall Study|Failed Intubation|1|||
125105214|NCT00602979|450008105|FG004|Overall Study|Failed Intubation|0|||
125105215|NCT02962739|450008106|FG000|Overall Study|Withdrawal by Subject|0|||
124887122|NCT02291289|449211691|FG002|Maintenance Treatment Phase|Death|16|||
124887123|NCT02291289|449211692|FG003|Maintenance Treatment Phase|Death|0|||
124887124|NCT02291289|449211693|FG004|Maintenance Treatment Phase|Death|188|||
124887125|NCT02291289|449211694|FG005|Maintenance Treatment Phase|Death|107|||
124887126|NCT02291289|449211695|FG006|Maintenance Treatment Phase|Death|0|||
124887127|NCT02291289|449211696|FG007|Maintenance Treatment Phase|Death|1|||
124887128|NCT02291289|449211697|FG008|Maintenance Treatment Phase|Death|1|||
124887129|NCT02291289|449211698|FG009|Maintenance Treatment Phase|Death|0|||
124887130|NCT02291289|449211699|FG010|Maintenance Treatment Phase|Death|46|||
124887131|NCT02291289|449211700|FG011|Maintenance Treatment Phase|Death|19|||
124887132|NCT02291289|449211701|FG012|Maintenance Treatment Phase|Death|0|||
124887133|NCT02291289|449211689|FG000|Maintenance Treatment Phase|Adverse Event|0|||
124887134|NCT02291289|449211690|FG001|Maintenance Treatment Phase|Adverse Event|0|||
124887135|NCT02291289|449211691|FG002|Maintenance Treatment Phase|Adverse Event|0|||
124887136|NCT02291289|449211692|FG003|Maintenance Treatment Phase|Adverse Event|0|||
124887137|NCT02291289|449211693|FG004|Maintenance Treatment Phase|Adverse Event|1|||
124887138|NCT02291289|449211694|FG005|Maintenance Treatment Phase|Adverse Event|1|||
124887139|NCT02291289|449211695|FG006|Maintenance Treatment Phase|Adverse Event|0|||
124887140|NCT02291289|449211696|FG007|Maintenance Treatment Phase|Adverse Event|0|||
124887141|NCT02291289|449211697|FG008|Maintenance Treatment Phase|Adverse Event|0|||
124887142|NCT02291289|449211698|FG009|Maintenance Treatment Phase|Adverse Event|0|||
124887143|NCT02291289|449211699|FG010|Maintenance Treatment Phase|Adverse Event|0|||
124887144|NCT02291289|449211700|FG011|Maintenance Treatment Phase|Adverse Event|0|||
124887145|NCT02291289|449211701|FG012|Maintenance Treatment Phase|Adverse Event|0|||
124887146|NCT02291289|449211689|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
124887147|NCT02291289|449211690|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
124887148|NCT02291289|449211691|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
124887149|NCT02291289|449211692|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
124887150|NCT02291289|449211693|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
124887151|NCT02291289|449211694|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
124887152|NCT02291289|449211695|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
124887153|NCT02291289|449211696|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
124887154|NCT02291289|449211697|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
124887155|NCT02291289|449211698|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
124887156|NCT02291289|449211699|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
124887157|NCT02291289|449211700|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
124887158|NCT02291289|449211701|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
124887159|NCT02291289|449211689|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
124887160|NCT02291289|449211690|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
124887161|NCT02291289|449211691|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
124887162|NCT02291289|449211692|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
124887163|NCT02291289|449211693|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
124887164|NCT02291289|449211694|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
124887165|NCT02291289|449211695|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
124887166|NCT02291289|449211696|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
124887167|NCT02291289|449211697|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
124887168|NCT02291289|449211698|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
124887169|NCT02291289|449211699|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
124887170|NCT02291289|449211700|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
124887171|NCT02291289|449211701|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
124887172|NCT02291289|449211689|FG000|Maintenance Treatment Phase|Physician Decision|0|||
124887173|NCT02291289|449211690|FG001|Maintenance Treatment Phase|Physician Decision|2|||
124887174|NCT02291289|449211691|FG002|Maintenance Treatment Phase|Physician Decision|0|||
124887175|NCT02291289|449211692|FG003|Maintenance Treatment Phase|Physician Decision|0|||
124887176|NCT02291289|449211693|FG004|Maintenance Treatment Phase|Physician Decision|3|||
124887177|NCT02291289|449211694|FG005|Maintenance Treatment Phase|Physician Decision|0|||
124887178|NCT02291289|449211695|FG006|Maintenance Treatment Phase|Physician Decision|0|||
124887179|NCT02291289|449211696|FG007|Maintenance Treatment Phase|Physician Decision|0|||
124887180|NCT02291289|449211697|FG008|Maintenance Treatment Phase|Physician Decision|0|||
124887181|NCT02291289|449211698|FG009|Maintenance Treatment Phase|Physician Decision|0|||
124887182|NCT02291289|449211699|FG010|Maintenance Treatment Phase|Physician Decision|1|||
124887183|NCT02291289|449211700|FG011|Maintenance Treatment Phase|Physician Decision|3|||
124887184|NCT02291289|449211701|FG012|Maintenance Treatment Phase|Physician Decision|0|||
124887185|NCT02291289|449211689|FG000|Maintenance Treatment Phase|Not Treated|0|||
124887186|NCT02291289|449211690|FG001|Maintenance Treatment Phase|Not Treated|0|||
124887187|NCT02291289|449211691|FG002|Maintenance Treatment Phase|Not Treated|2|||
124887188|NCT02291289|449211692|FG003|Maintenance Treatment Phase|Not Treated|0|||
124887189|NCT02291289|449211693|FG004|Maintenance Treatment Phase|Not Treated|0|||
124887190|NCT02291289|449211694|FG005|Maintenance Treatment Phase|Not Treated|0|||
124887191|NCT02291289|449211695|FG006|Maintenance Treatment Phase|Not Treated|0|||
125015577|NCT02135692|449682535|FG000|Overall Study|Study closed/terminated|153|||
125015578|NCT02135692|449682535|FG000|Overall Study|Lost to Follow-up|4|||
125015579|NCT02135692|449682535|FG000|Overall Study|Withdrawal by Subject|15|||
124887192|NCT02291289|449211696|FG007|Maintenance Treatment Phase|Not Treated|0|||
124887193|NCT02291289|449211697|FG008|Maintenance Treatment Phase|Not Treated|0|||
124887194|NCT02291289|449211698|FG009|Maintenance Treatment Phase|Not Treated|0|||
125105216|NCT02962739|450008107|FG001|Overall Study|Withdrawal by Subject|1|||
124887195|NCT02291289|449211699|FG010|Maintenance Treatment Phase|Not Treated|0|||
124887196|NCT02291289|449211700|FG011|Maintenance Treatment Phase|Not Treated|0|||
125105217|NCT02962739|450008108|FG002|Overall Study|Withdrawal by Subject|0|||
125105218|NCT02962739|450008109|FG003|Overall Study|Withdrawal by Subject|0|||
124887197|NCT02291289|449211701|FG012|Maintenance Treatment Phase|Not Treated|0|||
124887198|NCT02291289|449211689|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887199|NCT02291289|449211690|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
124887200|NCT02291289|449211691|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887201|NCT02291289|449211692|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887202|NCT02291289|449211693|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887203|NCT02291289|449211694|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887204|NCT02291289|449211695|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887205|NCT02291289|449211696|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887206|NCT02291289|449211697|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887207|NCT02291289|449211698|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887208|NCT02291289|449211699|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887209|NCT02291289|449211700|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887210|NCT02291289|449211701|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887211|NCT02291289|449211689|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
124887212|NCT02291289|449211690|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
124887213|NCT02291289|449211691|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
124887214|NCT02291289|449211692|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
124887215|NCT02291289|449211693|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
124887216|NCT02291289|449211694|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
124887217|NCT02291289|449211695|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
124887218|NCT02291289|449211696|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
124887219|NCT02291289|449211697|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
124887220|NCT02291289|449211698|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
124887221|NCT02291289|449211699|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
124887222|NCT02291289|449211700|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
124887223|NCT02291289|449211701|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
124887224|NCT02291289|449211689|FG000|Early Disease Progression|Death|0|||
124887225|NCT02291289|449211690|FG001|Early Disease Progression|Death|0|||
124887226|NCT02291289|449211691|FG002|Early Disease Progression|Death|0|||
124887227|NCT02291289|449211692|FG003|Early Disease Progression|Death|0|||
124887228|NCT02291289|449211693|FG004|Early Disease Progression|Death|0|||
124887229|NCT02291289|449211694|FG005|Early Disease Progression|Death|0|||
124887230|NCT02291289|449211695|FG006|Early Disease Progression|Death|0|||
124887231|NCT02291289|449211696|FG007|Early Disease Progression|Death|0|||
124887232|NCT02291289|449211697|FG008|Early Disease Progression|Death|0|||
124887233|NCT02291289|449211698|FG009|Early Disease Progression|Death|0|||
124887234|NCT02291289|449211699|FG010|Early Disease Progression|Death|0|||
124887235|NCT02291289|449211700|FG011|Early Disease Progression|Death|0|||
124887236|NCT02291289|449211701|FG012|Early Disease Progression|Death|10|||
124887237|NCT02291289|449211689|FG000|Early Disease Progression|Lost to Follow-up|0|||
124887238|NCT02291289|449211690|FG001|Early Disease Progression|Lost to Follow-up|0|||
124887239|NCT02291289|449211691|FG002|Early Disease Progression|Lost to Follow-up|0|||
124887240|NCT02291289|449211692|FG003|Early Disease Progression|Lost to Follow-up|0|||
124887241|NCT02291289|449211693|FG004|Early Disease Progression|Lost to Follow-up|0|||
124887242|NCT02291289|449211694|FG005|Early Disease Progression|Lost to Follow-up|0|||
124887243|NCT02291289|449211695|FG006|Early Disease Progression|Lost to Follow-up|0|||
124887244|NCT02291289|449211696|FG007|Early Disease Progression|Lost to Follow-up|0|||
124887245|NCT02291289|449211697|FG008|Early Disease Progression|Lost to Follow-up|0|||
124887246|NCT02291289|449211698|FG009|Early Disease Progression|Lost to Follow-up|0|||
124887247|NCT02291289|449211699|FG010|Early Disease Progression|Lost to Follow-up|0|||
124887248|NCT02291289|449211700|FG011|Early Disease Progression|Lost to Follow-up|0|||
124887249|NCT02291289|449211701|FG012|Early Disease Progression|Lost to Follow-up|1|||
124887250|NCT00962585|449211706|FG000|Overall Study|Adverse Event|0|||
124887251|NCT00962585|449211707|FG001|Overall Study|Adverse Event|2|||
124887252|NCT00962585|449211708|FG002|Overall Study|Adverse Event|1|||
124887253|NCT00962585|449211709|FG003|Overall Study|Adverse Event|0|||
124887254|NCT00962585|449211706|FG000|Overall Study|Lost to Follow-up|3|||
124887255|NCT00962585|449211707|FG001|Overall Study|Lost to Follow-up|0|||
124887256|NCT00962585|449211708|FG002|Overall Study|Lost to Follow-up|1|||
124887257|NCT00962585|449211709|FG003|Overall Study|Lost to Follow-up|0|||
124887258|NCT00962585|449211706|FG000|Overall Study|Protocol Violation|0|||
124887259|NCT00962585|449211707|FG001|Overall Study|Protocol Violation|0|||
124887260|NCT00962585|449211708|FG002|Overall Study|Protocol Violation|1|||
124887261|NCT00962585|449211709|FG003|Overall Study|Protocol Violation|0|||
124887262|NCT00962585|449211706|FG000|Overall Study|Withdrawal by Subject|1|||
124887263|NCT00962585|449211707|FG001|Overall Study|Withdrawal by Subject|0|||
124887264|NCT00962585|449211708|FG002|Overall Study|Withdrawal by Subject|0|||
124887265|NCT00962585|449211709|FG003|Overall Study|Withdrawal by Subject|0|||
124887266|NCT00962585|449211706|FG000|Overall Study|Withdrew Consent|2|||
124887267|NCT00962585|449211707|FG001|Overall Study|Withdrew Consent|0|||
124887268|NCT00962585|449211708|FG002|Overall Study|Withdrew Consent|0|||
124887269|NCT00962585|449211709|FG003|Overall Study|Withdrew Consent|0|||
124887270|NCT00594906|449211714|FG000|Overall Study|Physician Decision|1|||
124887271|NCT00594906|449211715|FG001|Overall Study|Physician Decision|0|||
124887272|NCT00594906|449211714|FG000|Overall Study|Physician Decision|0|||
124887273|NCT00594906|449211715|FG001|Overall Study|Physician Decision|1|||
124887274|NCT00594906|449211714|FG000|Overall Study|Death|0|||
124887275|NCT00594906|449211715|FG001|Overall Study|Death|1|||
124887276|NCT04430335|449211718|FG000|Overall Study|Withdrawal by Subject|1|||
124887277|NCT02139982|449211721|FG000|Overall Study|Lack of Efficacy|0|||
124887278|NCT02139982|449211722|FG001|Overall Study|Lack of Efficacy|1|||
124887279|NCT02139982|449211723|FG002|Overall Study|Lack of Efficacy|0|||
124887280|NCT02139982|449211724|FG003|Overall Study|Lack of Efficacy|1|||
124887281|NCT02139982|449211725|FG004|Overall Study|Lack of Efficacy|0|||
124887282|NCT02139982|449211726|FG005|Overall Study|Lack of Efficacy|0|||
124887283|NCT02139982|449211727|FG006|Overall Study|Lack of Efficacy|0|||
124887284|NCT02139982|449211728|FG007|Overall Study|Lack of Efficacy|0|||
124887285|NCT02139982|449211729|FG008|Overall Study|Lack of Efficacy|0|||
124887286|NCT02139982|449211730|FG009|Overall Study|Lack of Efficacy|0|||
124887287|NCT02206152|449211763|FG000|Pre-Randomization|Withdrawal by Subject|2|||
124887288|NCT00478608|449211764|FG000|Overall Study|Adverse Event|1|||
124887289|NCT00478608|449211764|FG000|Overall Study|Serious Adverse Event|14|||
124887290|NCT00478608|449211764|FG000|Overall Study|Withdrawal by Subject|2|||
124887291|NCT00478608|449211764|FG000|Overall Study|Protocol Violation|3|||
124887292|NCT02080520|449211766|FG000|Overall Study|Self-reported symptoms|5|||
124887293|NCT02080520|449211767|FG001|Overall Study|Self-reported symptoms|6|||
124887294|NCT02080520|449211766|FG000|Overall Study|Unable to contact|2|||
124887295|NCT02080520|449211767|FG001|Overall Study|Unable to contact|1|||
124887296|NCT02080520|449211766|FG000|Overall Study|Initiated aspirin|2|||
124887297|NCT02080520|449211767|FG001|Overall Study|Initiated aspirin|0|||
124887298|NCT02080520|449211766|FG000|Overall Study|Atrial fibrillation|1|||
124887299|NCT02080520|449211767|FG001|Overall Study|Atrial fibrillation|1|||
124887300|NCT02080520|449211766|FG000|Overall Study|Cancer|1|||
124887301|NCT02080520|449211767|FG001|Overall Study|Cancer|2|||
124887302|NCT02080520|449211766|FG000|Overall Study|Not interested in study|1|||
124887303|NCT02080520|449211767|FG001|Overall Study|Not interested in study|3|||
124887304|NCT02080520|449211766|FG000|Overall Study|Too busy|1|||
124887305|NCT02080520|449211767|FG001|Overall Study|Too busy|1|||
125015580|NCT01157078|449682536|FG000|Overall Study|Withdrawal by Subject|12|||
125015581|NCT01157078|449682537|FG001|Overall Study|Withdrawal by Subject|14|||
125015582|NCT01157078|449682536|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
125015583|NCT01157078|449682537|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
124887306|NCT02080520|449211766|FG000|Overall Study|Work-related injury|1|||
124887307|NCT02080520|449211767|FG001|Overall Study|Work-related injury|0|||
124887308|NCT02080520|449211766|FG000|Overall Study|Personal reasons|0|||
125015584|NCT01157078|449682536|FG000|Overall Study|Adverse Event|6|||
125015585|NCT01157078|449682537|FG001|Overall Study|Adverse Event|6|||
125015586|NCT01157078|449682536|FG000|Overall Study|Severe non-compliance to protocol|2|||
125015587|NCT01157078|449682537|FG001|Overall Study|Severe non-compliance to protocol|4|||
125015588|NCT01157078|449682536|FG000|Overall Study|Condition under investigation worsened|0|||
125015589|NCT01157078|449682537|FG001|Overall Study|Condition under investigation worsened|1|||
125105219|NCT02962739|450008110|FG004|Overall Study|Withdrawal by Subject|0|||
124887309|NCT02080520|449211767|FG001|Overall Study|Personal reasons|3|||
125105220|NCT02962739|450008111|FG005|Overall Study|Withdrawal by Subject|0|||
125105221|NCT02962739|450008106|FG000|Overall Study|Protocol Violation|0|||
124887310|NCT01394250|449211773|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
124887311|NCT01394250|449211774|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
124887312|NCT01394250|449211773|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
124887313|NCT01394250|449211774|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
124887314|NCT03230864|449211778|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
124887315|NCT03230864|449211779|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
124887316|NCT03230864|449211780|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
124887317|NCT03230864|449211781|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
124887318|NCT03230864|449211778|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
124887319|NCT03230864|449211779|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
124887320|NCT03230864|449211780|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
124887321|NCT03230864|449211781|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
124887322|NCT03230864|449211778|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
124887323|NCT03230864|449211779|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
124887324|NCT03230864|449211780|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
124887325|NCT03230864|449211781|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
124887326|NCT03230864|449211778|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
124887327|NCT03230864|449211779|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
124887328|NCT03230864|449211780|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
124887329|NCT03230864|449211781|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
124887330|NCT03230864|449211778|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
124887331|NCT03230864|449211779|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
124887332|NCT03230864|449211780|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
124887333|NCT03230864|449211781|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
124887334|NCT03230864|449211778|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
124887335|NCT03230864|449211779|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
124887336|NCT03230864|449211780|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
124887337|NCT03230864|449211781|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
124887338|NCT03230864|449211778|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
124887339|NCT03230864|449211779|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
124887340|NCT03230864|449211780|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
124887341|NCT03230864|449211781|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
124887342|NCT03230864|449211778|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
124887343|NCT03230864|449211779|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
124887344|NCT03230864|449211780|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
124887345|NCT03230864|449211781|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
124887346|NCT03230864|449211778|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
124887347|NCT03230864|449211779|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
124887348|NCT03230864|449211780|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
125105222|NCT02962739|450008107|FG001|Overall Study|Protocol Violation|0|||
125105223|NCT02962739|450008108|FG002|Overall Study|Protocol Violation|1|||
125105224|NCT02962739|450008109|FG003|Overall Study|Protocol Violation|0|||
125105225|NCT02962739|450008110|FG004|Overall Study|Protocol Violation|1|||
125105226|NCT02962739|450008111|FG005|Overall Study|Protocol Violation|0|||
125105227|NCT01268683|450008115|FG000|Overall Study|Lost to Follow-up|1|||
125105228|NCT01268683|450008115|FG000|Overall Study|Death|1|||
125105229|NCT02216214|450008116|FG000|Overall Study|Randomized Never Received Study Drug|1|||
125105230|NCT02216214|450008117|FG001|Overall Study|Randomized Never Received Study Drug|0|||
125105231|NCT02216214|450008116|FG000|Overall Study|Adverse Event|10|||
125105232|NCT02216214|450008117|FG001|Overall Study|Adverse Event|8|||
125105233|NCT02216214|450008116|FG000|Overall Study|Lack of Efficacy|2|||
125105234|NCT02216214|450008117|FG001|Overall Study|Lack of Efficacy|2|||
125105235|NCT02216214|450008116|FG000|Overall Study|Lost to Follow-up|3|||
125105236|NCT02216214|450008117|FG001|Overall Study|Lost to Follow-up|2|||
125105237|NCT02216214|450008116|FG000|Overall Study|Protocol Violation|4|||
125105238|NCT02216214|450008117|FG001|Overall Study|Protocol Violation|2|||
125105239|NCT02216214|450008116|FG000|Overall Study|Withdrawal by Subject|22|||
125105240|NCT02216214|450008117|FG001|Overall Study|Withdrawal by Subject|20|||
125105241|NCT02216214|450008116|FG000|Overall Study|Study Terminated By Sponsor|0|||
125105242|NCT02216214|450008117|FG001|Overall Study|Study Terminated By Sponsor|1|||
125105243|NCT02216214|450008116|FG000|Overall Study|Miscellaneous|1|||
125105244|NCT02216214|450008117|FG001|Overall Study|Miscellaneous|1|||
125105245|NCT00713830|450008118|FG000|Overall Study|Adverse Event|23|||
125105246|NCT00713830|450008119|FG001|Overall Study|Adverse Event|71|||
125105247|NCT00713830|450008118|FG000|Overall Study|Lack of Efficacy|24|||
125105248|NCT00713830|450008119|FG001|Overall Study|Lack of Efficacy|16|||
125105249|NCT00713830|450008118|FG000|Overall Study|Lost to Follow-up|2|||
125105250|NCT00713830|450008119|FG001|Overall Study|Lost to Follow-up|9|||
125105251|NCT00713830|450008118|FG000|Overall Study|Withdrawal by Subject|13|||
125105252|NCT00713830|450008119|FG001|Overall Study|Withdrawal by Subject|23|||
125105253|NCT00713830|450008118|FG000|Overall Study|Poor Compliance to Protocol|7|||
125105254|NCT00713830|450008119|FG001|Overall Study|Poor Compliance to Protocol|14|||
125105255|NCT00713830|450008118|FG000|Overall Study|Familial and Personal Reasons|9|||
125105256|NCT00713830|450008119|FG001|Overall Study|Familial and Personal Reasons|34|||
125105257|NCT00713830|450008118|FG000|Overall Study|Sponsor Decision|4|||
125105258|NCT00713830|450008119|FG001|Overall Study|Sponsor Decision|10|||
124887349|NCT03230864|449211781|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
124887350|NCT03230864|449211778|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
124887351|NCT03230864|449211779|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
124887352|NCT03230864|449211780|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
124887353|NCT03230864|449211781|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
124887354|NCT00432679|449211786|FG000|Overall Study|Adverse Event|2|||
124887355|NCT00432679|449211787|FG001|Overall Study|Adverse Event|1|||
124887356|NCT00432679|449211786|FG000|Overall Study|Withdrawal by Subject|3|||
124887357|NCT00432679|449211787|FG001|Overall Study|Withdrawal by Subject|2|||
124887358|NCT01177813|449211793|FG000|Overall Study|Adverse Event|8|||
124887359|NCT01177813|449211794|FG001|Overall Study|Adverse Event|2|||
124887360|NCT01177813|449211795|FG002|Overall Study|Adverse Event|4|||
124887361|NCT01177813|449211796|FG003|Overall Study|Adverse Event|6|||
124887362|NCT01177813|449211797|FG004|Overall Study|Adverse Event|3|||
124887363|NCT01177813|449211793|FG000|Overall Study|Lack of Efficacy|1|||
124887364|NCT01177813|449211794|FG001|Overall Study|Lack of Efficacy|0|||
124887365|NCT01177813|449211795|FG002|Overall Study|Lack of Efficacy|0|||
124887366|NCT01177813|449211796|FG003|Overall Study|Lack of Efficacy|0|||
124887367|NCT01177813|449211797|FG004|Overall Study|Lack of Efficacy|0|||
124887368|NCT01177813|449211793|FG000|Overall Study|Protocol Violation|3|||
124887369|NCT01177813|449211794|FG001|Overall Study|Protocol Violation|2|||
124887370|NCT01177813|449211795|FG002|Overall Study|Protocol Violation|2|||
124887371|NCT01177813|449211796|FG003|Overall Study|Protocol Violation|0|||
124887372|NCT01177813|449211797|FG004|Overall Study|Protocol Violation|1|||
124887373|NCT01177813|449211793|FG000|Overall Study|Lost to Follow-up|12|||
124887374|NCT01177813|449211794|FG001|Overall Study|Lost to Follow-up|5|||
124887375|NCT01177813|449211795|FG002|Overall Study|Lost to Follow-up|6|||
124887376|NCT01177813|449211796|FG003|Overall Study|Lost to Follow-up|3|||
124887377|NCT01177813|449211797|FG004|Overall Study|Lost to Follow-up|0|||
124887378|NCT01177813|449211793|FG000|Overall Study|Withdrawal by Subject|12|||
124887379|NCT01177813|449211794|FG001|Overall Study|Withdrawal by Subject|7|||
124887380|NCT01177813|449211795|FG002|Overall Study|Withdrawal by Subject|6|||
124887381|NCT01177813|449211796|FG003|Overall Study|Withdrawal by Subject|5|||
124887382|NCT01177813|449211797|FG004|Overall Study|Withdrawal by Subject|3|||
124887383|NCT01177813|449211793|FG000|Overall Study|Other reason not defined above|5|||
124887384|NCT01177813|449211794|FG001|Overall Study|Other reason not defined above|2|||
124887385|NCT01177813|449211795|FG002|Overall Study|Other reason not defined above|2|||
124887386|NCT01177813|449211796|FG003|Overall Study|Other reason not defined above|3|||
124887387|NCT01177813|449211797|FG004|Overall Study|Other reason not defined above|2|||
124887388|NCT00109928|449211800|FG000|Overall Study|Adverse Event|2|||
124887389|NCT00109928|449211800|FG000|Overall Study|Progression|6|||
124887390|NCT00109928|449211800|FG000|Overall Study|Death|2|||
124887391|NCT00109928|449211800|FG000|Overall Study|not protocol specified|2|||
124887392|NCT00109928|449211800|FG000|Overall Study|not eligible|1|||
124887393|NCT01196104|449211801|FG000|Overall Study|Lost to Follow-up|1|||
124887394|NCT01196104|449211802|FG001|Overall Study|Lost to Follow-up|0|||
124887395|NCT01196104|449211801|FG000|Overall Study|Physician Decision|0|||
124887396|NCT01196104|449211802|FG001|Overall Study|Physician Decision|1|||
124887397|NCT01196104|449211801|FG000|Overall Study|Withdrawal by Subject|3|||
124887398|NCT01196104|449211802|FG001|Overall Study|Withdrawal by Subject|3|||
124887399|NCT01196104|449211801|FG000|Overall Study|Various|0|||
124887400|NCT01196104|449211802|FG001|Overall Study|Various|1|||
124887401|NCT00983619|449211803|FG000|Overall Study|Lost to Follow-up|0|||
124887402|NCT00983619|449211804|FG001|Overall Study|Lost to Follow-up|1|||
124887403|NCT00983619|449211805|FG002|Overall Study|Lost to Follow-up|0|||
124887404|NCT00983619|449211806|FG003|Overall Study|Lost to Follow-up|0|||
124887405|NCT00983619|449211807|FG004|Overall Study|Lost to Follow-up|0|||
124887406|NCT00983619|449211808|FG005|Overall Study|Lost to Follow-up|2|||
124887407|NCT00983619|449211809|FG006|Overall Study|Lost to Follow-up|0|||
124887408|NCT00983619|449211810|FG007|Overall Study|Lost to Follow-up|0|||
124887409|NCT00983619|449211811|FG008|Overall Study|Lost to Follow-up|0|||
124887410|NCT00983619|449211812|FG009|Overall Study|Lost to Follow-up|0|||
124887411|NCT00983619|449211813|FG010|Overall Study|Lost to Follow-up|0|||
124887412|NCT00983619|449211814|FG011|Overall Study|Lost to Follow-up|2|||
125015590|NCT01157078|449682536|FG000|Overall Study|Lack of Efficacy|2|||
125015591|NCT01157078|449682537|FG001|Overall Study|Lack of Efficacy|0|||
125015592|NCT01157078|449682536|FG000|Overall Study|Study-specific withdrawal criteria|2|||
125015593|NCT01157078|449682537|FG001|Overall Study|Study-specific withdrawal criteria|2|||
125015594|NCT01157078|449682536|FG000|Overall Study|Lost to Follow-up|7|||
124887413|NCT00983619|449211803|FG000|Overall Study|Withdrawal by Subject|2|||
124887414|NCT00983619|449211804|FG001|Overall Study|Withdrawal by Subject|1|||
124887415|NCT00983619|449211805|FG002|Overall Study|Withdrawal by Subject|1|||
124887416|NCT00983619|449211806|FG003|Overall Study|Withdrawal by Subject|3|||
124887417|NCT00983619|449211807|FG004|Overall Study|Withdrawal by Subject|1|||
124887418|NCT00983619|449211808|FG005|Overall Study|Withdrawal by Subject|23|||
124887419|NCT00983619|449211809|FG006|Overall Study|Withdrawal by Subject|0|||
124887420|NCT00983619|449211810|FG007|Overall Study|Withdrawal by Subject|0|||
125015595|NCT01157078|449682537|FG001|Overall Study|Lost to Follow-up|5|||
124887421|NCT00983619|449211811|FG008|Overall Study|Withdrawal by Subject|0|||
124887422|NCT00983619|449211812|FG009|Overall Study|Withdrawal by Subject|0|||
124887423|NCT00983619|449211813|FG010|Overall Study|Withdrawal by Subject|1|||
124887424|NCT00983619|449211814|FG011|Overall Study|Withdrawal by Subject|1|||
124887425|NCT00983619|449211803|FG000|Overall Study|Death|0|||
124887426|NCT00983619|449211804|FG001|Overall Study|Death|2|||
124887427|NCT00983619|449211805|FG002|Overall Study|Death|2|||
124887428|NCT00983619|449211806|FG003|Overall Study|Death|1|||
124887429|NCT00983619|449211807|FG004|Overall Study|Death|2|||
124887430|NCT00983619|449211808|FG005|Overall Study|Death|30|||
124887431|NCT00983619|449211809|FG006|Overall Study|Death|1|||
124887432|NCT00983619|449211810|FG007|Overall Study|Death|0|||
124887433|NCT00983619|449211811|FG008|Overall Study|Death|1|||
124887434|NCT00983619|449211812|FG009|Overall Study|Death|2|||
124887435|NCT00983619|449211813|FG010|Overall Study|Death|9|||
124887436|NCT00983619|449211814|FG011|Overall Study|Death|8|||
124887437|NCT00983619|449211803|FG000|Overall Study|Other|1|||
124887438|NCT00983619|449211804|FG001|Overall Study|Other|0|||
124887439|NCT00983619|449211805|FG002|Overall Study|Other|0|||
124887440|NCT00983619|449211806|FG003|Overall Study|Other|1|||
124887441|NCT00983619|449211807|FG004|Overall Study|Other|0|||
124887442|NCT00983619|449211808|FG005|Overall Study|Other|12|||
124887443|NCT00983619|449211809|FG006|Overall Study|Other|2|||
124887444|NCT00983619|449211810|FG007|Overall Study|Other|2|||
124887445|NCT00983619|449211811|FG008|Overall Study|Other|0|||
124887446|NCT00983619|449211812|FG009|Overall Study|Other|1|||
124887447|NCT00983619|449211813|FG010|Overall Study|Other|1|||
124887448|NCT00983619|449211814|FG011|Overall Study|Other|0|||
124887449|NCT03772314|449211815|FG000|Overall Study|Adverse Event|7|||
124887450|NCT03772314|449211816|FG001|Overall Study|Adverse Event|2|||
124887451|NCT01284140|449211821|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
124887452|NCT01284140|449211822|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
124887453|NCT01284140|449211821|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
124887454|NCT01284140|449211822|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
124887455|NCT00088205|449211823|FG000|Overall Study|Adverse Event|4|||
124887456|NCT00088205|449211823|FG000|Overall Study|Progressive Disease|51|||
124887457|NCT00088205|449211823|FG000|Overall Study|Physician Decision|1|||
124887458|NCT00088205|449211823|FG000|Overall Study|Death Due to Study Disease|4|||
124887459|NCT03192215|449211824|FG000|Overall Study|Death|28|||
124887460|NCT03192215|449211825|FG001|Overall Study|Death|23|||
124887461|NCT03192215|449211824|FG000|Overall Study|Lost to Follow-up|10|||
124887462|NCT03192215|449211825|FG001|Overall Study|Lost to Follow-up|15|||
124887463|NCT03192215|449211824|FG000|Overall Study|Withdrawal by Subject|49|||
124887464|NCT03192215|449211825|FG001|Overall Study|Withdrawal by Subject|48|||
124887465|NCT03192215|449211824|FG000|Overall Study|Other as reported in analysis|4|||
124887466|NCT03192215|449211825|FG001|Overall Study|Other as reported in analysis|1|||
124887467|NCT02061761|449211829|FG000|Overall Study|Disease progression|2|||
124887468|NCT02061761|449211830|FG001|Overall Study|Disease progression|8|||
124887469|NCT02061761|449211831|FG002|Overall Study|Disease progression|4|||
124887470|NCT02061761|449211832|FG003|Overall Study|Disease progression|5|||
124887471|NCT02061761|449211833|FG004|Overall Study|Disease progression|9|||
124887472|NCT02061761|449211834|FG005|Overall Study|Disease progression|3|||
124887473|NCT02061761|449211835|FG006|Overall Study|Disease progression|1|||
124887474|NCT02061761|449211836|FG007|Overall Study|Disease progression|2|||
124887475|NCT02061761|449211837|FG008|Overall Study|Disease progression|28|||
124887476|NCT02061761|449211829|FG000|Overall Study|Study Drug toxicity|0|||
124887477|NCT02061761|449211830|FG001|Overall Study|Study Drug toxicity|0|||
124887478|NCT02061761|449211831|FG002|Overall Study|Study Drug toxicity|0|||
124887479|NCT02061761|449211832|FG003|Overall Study|Study Drug toxicity|0|||
124887480|NCT02061761|449211833|FG004|Overall Study|Study Drug toxicity|0|||
124887481|NCT02061761|449211834|FG005|Overall Study|Study Drug toxicity|1|||
124887482|NCT02061761|449211835|FG006|Overall Study|Study Drug toxicity|0|||
124887483|NCT02061761|449211836|FG007|Overall Study|Study Drug toxicity|2|||
124887484|NCT02061761|449211837|FG008|Overall Study|Study Drug toxicity|6|||
124887485|NCT02061761|449211829|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
124887486|NCT02061761|449211830|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
124887487|NCT02061761|449211831|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
124887488|NCT02061761|449211832|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
124887489|NCT02061761|449211833|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
124887490|NCT02061761|449211834|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
124887491|NCT02061761|449211835|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
124887492|NCT02061761|449211836|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
124887493|NCT02061761|449211837|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
125015596|NCT01157078|449682536|FG000|Overall Study|Other|2|||
124887494|NCT02061761|449211829|FG000|Overall Study|Participant request to discontinue study treatment|0|||
124887495|NCT02061761|449211830|FG001|Overall Study|Participant request to discontinue study treatment|0|||
124887496|NCT02061761|449211831|FG002|Overall Study|Participant request to discontinue study treatment|2|||
124887497|NCT02061761|449211832|FG003|Overall Study|Participant request to discontinue study treatment|2|||
124887498|NCT02061761|449211833|FG004|Overall Study|Participant request to discontinue study treatment|0|||
124887499|NCT02061761|449211834|FG005|Overall Study|Participant request to discontinue study treatment|1|||
124887500|NCT02061761|449211835|FG006|Overall Study|Participant request to discontinue study treatment|0|||
124887501|NCT02061761|449211836|FG007|Overall Study|Participant request to discontinue study treatment|0|||
124887502|NCT02061761|449211837|FG008|Overall Study|Participant request to discontinue study treatment|2|||
124887503|NCT02061761|449211829|FG000|Overall Study|Withdrawal by Subject|0|||
124887504|NCT02061761|449211830|FG001|Overall Study|Withdrawal by Subject|0|||
124887505|NCT02061761|449211831|FG002|Overall Study|Withdrawal by Subject|0|||
124887506|NCT02061761|449211832|FG003|Overall Study|Withdrawal by Subject|0|||
124887507|NCT02061761|449211833|FG004|Overall Study|Withdrawal by Subject|0|||
124887508|NCT02061761|449211834|FG005|Overall Study|Withdrawal by Subject|0|||
124887509|NCT02061761|449211835|FG006|Overall Study|Withdrawal by Subject|0|||
124887510|NCT02061761|449211836|FG007|Overall Study|Withdrawal by Subject|0|||
124887511|NCT02061761|449211837|FG008|Overall Study|Withdrawal by Subject|2|||
124887512|NCT02061761|449211829|FG000|Overall Study|Maximum clinical benefit|0|||
124887513|NCT02061761|449211830|FG001|Overall Study|Maximum clinical benefit|0|||
124887514|NCT02061761|449211831|FG002|Overall Study|Maximum clinical benefit|0|||
124887515|NCT02061761|449211832|FG003|Overall Study|Maximum clinical benefit|1|||
124887516|NCT02061761|449211833|FG004|Overall Study|Maximum clinical benefit|0|||
124887517|NCT02061761|449211834|FG005|Overall Study|Maximum clinical benefit|0|||
124887518|NCT02061761|449211835|FG006|Overall Study|Maximum clinical benefit|0|||
124887519|NCT02061761|449211836|FG007|Overall Study|Maximum clinical benefit|0|||
124887520|NCT02061761|449211837|FG008|Overall Study|Maximum clinical benefit|6|||
124887521|NCT02061761|449211829|FG000|Overall Study|Participant no longer meets study criteria|0|||
124887522|NCT02061761|449211830|FG001|Overall Study|Participant no longer meets study criteria|0|||
124887523|NCT02061761|449211831|FG002|Overall Study|Participant no longer meets study criteria|0|||
124887524|NCT02061761|449211832|FG003|Overall Study|Participant no longer meets study criteria|0|||
124887525|NCT02061761|449211833|FG004|Overall Study|Participant no longer meets study criteria|0|||
124887526|NCT02061761|449211834|FG005|Overall Study|Participant no longer meets study criteria|0|||
124887527|NCT02061761|449211835|FG006|Overall Study|Participant no longer meets study criteria|0|||
124887528|NCT02061761|449211836|FG007|Overall Study|Participant no longer meets study criteria|0|||
124887529|NCT02061761|449211837|FG008|Overall Study|Participant no longer meets study criteria|1|||
124887530|NCT02061761|449211829|FG000|Overall Study|Other reasons|0|||
124887531|NCT02061761|449211830|FG001|Overall Study|Other reasons|0|||
124887532|NCT02061761|449211831|FG002|Overall Study|Other reasons|0|||
124887533|NCT02061761|449211832|FG003|Overall Study|Other reasons|0|||
124887534|NCT02061761|449211833|FG004|Overall Study|Other reasons|2|||
124887535|NCT02061761|449211834|FG005|Overall Study|Other reasons|0|||
124887536|NCT02061761|449211835|FG006|Overall Study|Other reasons|0|||
124887537|NCT02061761|449211836|FG007|Overall Study|Other reasons|0|||
124887538|NCT02061761|449211837|FG008|Overall Study|Other reasons|6|||
124887539|NCT02337478|449211838|FG000|Overall Study|Lack of Efficacy|5|||
124887540|NCT02258464|449211839|FG000|Overall Study|Progressive disease (PD)|9|||
124887541|NCT02258464|449211840|FG001|Overall Study|Progressive disease (PD)|17|||
124887542|NCT02258464|449211839|FG000|Overall Study|Study drug never administered|1|||
124887543|NCT02258464|449211840|FG001|Overall Study|Study drug never administered|1|||
124887544|NCT02258464|449211839|FG000|Overall Study|AE not related to clinical PD|1|||
124887545|NCT02258464|449211840|FG001|Overall Study|AE not related to clinical PD|3|||
124887546|NCT02258464|449211839|FG000|Overall Study|Withdrawal by Subject|5|||
124887547|NCT02258464|449211840|FG001|Overall Study|Withdrawal by Subject|4|||
124887548|NCT02258464|449211839|FG000|Overall Study|AE related to clinical PD|1|||
124887549|NCT02258464|449211840|FG001|Overall Study|AE related to clinical PD|0|||
124887550|NCT04714216|449213609|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
124887551|NCT04714216|449213609|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
124887552|NCT01755689|449213614|FG000|Overall Study|Withdrawal by Subject|1|||
124887553|NCT01755689|449213615|FG001|Overall Study|Withdrawal by Subject|3|||
124887554|NCT01755689|449213616|FG002|Overall Study|Withdrawal by Subject|2|||
124887555|NCT01755689|449213617|FG003|Overall Study|Withdrawal by Subject|1|||
124887556|NCT01755689|449213618|FG004|Overall Study|Withdrawal by Subject|1|||
125015597|NCT01157078|449682537|FG001|Overall Study|Other|4|||
125015598|NCT04429061|449682540|FG000|Overall Study|Lost to Follow-up|62|||
125015599|NCT04429061|449682541|FG001|Overall Study|Lost to Follow-up|87|||
124887557|NCT01755689|449213614|FG000|Overall Study|Migrated/moved from study area|0|||
124887558|NCT01755689|449213615|FG001|Overall Study|Migrated/moved from study area|1|||
124887559|NCT01755689|449213616|FG002|Overall Study|Migrated/moved from study area|1|||
124887560|NCT01755689|449213617|FG003|Overall Study|Migrated/moved from study area|1|||
124887561|NCT01755689|449213618|FG004|Overall Study|Migrated/moved from study area|1|||
125015600|NCT04429061|449682540|FG000|Overall Study|Withdrawal by Subject|3|||
125015601|NCT04429061|449682541|FG001|Overall Study|Withdrawal by Subject|4|||
124887562|NCT01755689|449213614|FG000|Overall Study|Lost to Follow-up|1|||
124887563|NCT01755689|449213615|FG001|Overall Study|Lost to Follow-up|0|||
124887564|NCT01755689|449213616|FG002|Overall Study|Lost to Follow-up|1|||
124887565|NCT01755689|449213617|FG003|Overall Study|Lost to Follow-up|0|||
124887566|NCT01755689|449213618|FG004|Overall Study|Lost to Follow-up|2|||
124887567|NCT01755689|449213614|FG000|Overall Study|Pregnancy|1|||
124887568|NCT01755689|449213615|FG001|Overall Study|Pregnancy|1|||
124887569|NCT01755689|449213616|FG002|Overall Study|Pregnancy|2|||
124887570|NCT01755689|449213617|FG003|Overall Study|Pregnancy|4|||
124887571|NCT01755689|449213618|FG004|Overall Study|Pregnancy|2|||
124887572|NCT01327547|449213619|FG000|Overall Study|Adverse Event|4|||
124887573|NCT01327547|449213620|FG001|Overall Study|Adverse Event|1|||
124887574|NCT01327547|449213619|FG000|Overall Study|Death|1|||
124887575|NCT01327547|449213620|FG001|Overall Study|Death|2|||
124887576|NCT01327547|449213619|FG000|Overall Study|Lost to Follow-up|6|||
124887577|NCT01327547|449213620|FG001|Overall Study|Lost to Follow-up|6|||
124887578|NCT01327547|449213619|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
124887579|NCT01327547|449213620|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
124887580|NCT01327547|449213619|FG000|Overall Study|Withdrawal by Subject|3|||
124887581|NCT01327547|449213620|FG001|Overall Study|Withdrawal by Subject|7|||
124887582|NCT01327547|449213619|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
124887583|NCT01327547|449213620|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
124887584|NCT01327547|449213619|FG000|Overall Study|Protocol Violation|1|||
124887585|NCT01327547|449213620|FG001|Overall Study|Protocol Violation|0|||
124887586|NCT01327547|449213619|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
124887587|NCT01327547|449213620|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
124887588|NCT01327547|449213619|FG000|Overall Study|Required prohibited medication|2|||
124887589|NCT01327547|449213620|FG001|Overall Study|Required prohibited medication|0|||
124887590|NCT01327547|449213619|FG000|Overall Study|Non-compliance with study procedures|1|||
124887591|NCT01327547|449213620|FG001|Overall Study|Non-compliance with study procedures|0|||
124887592|NCT01327547|449213619|FG000|Overall Study|By investigator in subject's interest|0|||
124887593|NCT01327547|449213620|FG001|Overall Study|By investigator in subject's interest|1|||
124887594|NCT02462083|449213621|FG000|Overall Study|Sponsor request|39|||
124887595|NCT02462083|449213621|FG000|Overall Study|Withdrawal by Subject|87|||
124887596|NCT02462083|449213621|FG000|Overall Study|Lost to Follow-up|41|||
124887597|NCT02462083|449213621|FG000|Overall Study|Lack of Efficacy|151|||
124887598|NCT02462083|449213621|FG000|Overall Study|Pregnancy|1|||
124887599|NCT02462083|449213621|FG000|Overall Study|Protocol Violation|6|||
124887600|NCT02462083|449213621|FG000|Overall Study|Adverse Event|33|||
124887601|NCT02462083|449213621|FG000|Overall Study|Worsening condition|16|||
124887602|NCT02462083|449213621|FG000|Overall Study|Other than specified|45|||
124887603|NCT01642186|449213624|FG000|Overall Study|Death|0|||
124887604|NCT01642186|449213625|FG001|Overall Study|Death|2|||
124887605|NCT01642186|449213626|FG002|Overall Study|Death|2|||
124887606|NCT01642186|449213624|FG000|Overall Study|Lost to Follow-up|0|||
124887607|NCT01642186|449213625|FG001|Overall Study|Lost to Follow-up|0|||
124887608|NCT01642186|449213626|FG002|Overall Study|Lost to Follow-up|1|||
124887609|NCT01668147|449213627|FG000|Overall Study|Withdrawal by Subject|6|||
124887610|NCT00590980|449213633|FG000|Overall Study|Did not meet all inclusion criteria|10|||
124887611|NCT03699124|449213634|FG000|Overall Study|Adverse Event|6|||
124887612|NCT03699124|449213635|FG001|Overall Study|Adverse Event|5|||
124887613|NCT03699124|449213636|FG002|Overall Study|Adverse Event|2|||
124887614|NCT03699124|449213634|FG000|Overall Study|Death|0|||
124887615|NCT03699124|449213635|FG001|Overall Study|Death|2|||
124887616|NCT03699124|449213636|FG002|Overall Study|Death|0|||
124887617|NCT03699124|449213634|FG000|Overall Study|Lost to Follow-up|20|||
124887618|NCT03699124|449213635|FG001|Overall Study|Lost to Follow-up|16|||
124887619|NCT03699124|449213636|FG002|Overall Study|Lost to Follow-up|15|||
124887620|NCT03699124|449213634|FG000|Overall Study|Protocol Violation|1|||
124887621|NCT03699124|449213635|FG001|Overall Study|Protocol Violation|0|||
124887622|NCT03699124|449213636|FG002|Overall Study|Protocol Violation|0|||
124887623|NCT03699124|449213634|FG000|Overall Study|Withdrawal by Subject|13|||
124887624|NCT03699124|449213635|FG001|Overall Study|Withdrawal by Subject|14|||
124887625|NCT03699124|449213636|FG002|Overall Study|Withdrawal by Subject|13|||
124887626|NCT03699124|449213634|FG000|Overall Study|Other reasons|5|||
124887627|NCT03699124|449213635|FG001|Overall Study|Other reasons|3|||
124887628|NCT03699124|449213636|FG002|Overall Study|Other reasons|10|||
124887629|NCT00506285|449213637|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
124887630|NCT00506285|449213638|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
124887631|NCT00506285|449213637|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
124887632|NCT00506285|449213638|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
124887633|NCT00506285|449213637|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
124887634|NCT00506285|449213638|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
124887635|NCT00506285|449213637|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
124887636|NCT00506285|449213638|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
124887637|NCT00506285|449213637|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
124887638|NCT00506285|449213638|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
124887639|NCT01089556|449213639|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
124887640|NCT01089556|449213640|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
124887641|NCT01089556|449213641|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
124887642|NCT01089556|449213642|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
124887643|NCT01089556|449213643|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
124887644|NCT01089556|449213644|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
124887645|NCT01089556|449213639|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
124887646|NCT01089556|449213640|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
124887647|NCT01089556|449213641|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
124887648|NCT01089556|449213642|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
124887649|NCT01089556|449213643|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
124887650|NCT01089556|449213644|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
124887651|NCT01089556|449213639|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
124887652|NCT01089556|449213640|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
124887653|NCT01089556|449213641|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
124887654|NCT01089556|449213642|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
124887655|NCT01089556|449213643|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
124887656|NCT01089556|449213644|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
124887657|NCT01089556|449213639|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
124887658|NCT01089556|449213640|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
124887659|NCT01089556|449213641|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
124887660|NCT01089556|449213642|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
124887661|NCT01089556|449213643|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
124887662|NCT01089556|449213644|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
124887663|NCT01089556|449213639|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
124887664|NCT01089556|449213640|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
124887665|NCT01089556|449213641|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
124887666|NCT01089556|449213642|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
124887667|NCT01089556|449213643|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
124887668|NCT01089556|449213644|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
124887669|NCT01089556|449213639|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
124887670|NCT01089556|449213640|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
124887671|NCT01089556|449213641|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
124887672|NCT01089556|449213642|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
124887673|NCT01089556|449213643|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
124887674|NCT01089556|449213644|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
124887675|NCT01089556|449213639|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
124887676|NCT01089556|449213640|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
124887677|NCT01089556|449213641|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
124887678|NCT01089556|449213642|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
124887679|NCT01089556|449213643|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
124887680|NCT01089556|449213644|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
124887681|NCT01089556|449213639|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
124887682|NCT01089556|449213640|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
124887683|NCT01089556|449213641|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
124887684|NCT01089556|449213642|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
124887685|NCT01089556|449213643|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
124887686|NCT01089556|449213644|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
124887687|NCT01089556|449213639|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
124887688|NCT01089556|449213640|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
124887689|NCT01089556|449213641|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
124887690|NCT01089556|449213642|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
124887691|NCT01089556|449213643|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
124887692|NCT01089556|449213644|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
124887693|NCT01089556|449213639|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
124887694|NCT01089556|449213640|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
124887695|NCT01089556|449213641|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
124887696|NCT01089556|449213642|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
124887697|NCT01089556|449213643|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
124887698|NCT01089556|449213644|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
124887699|NCT01089556|449213639|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
124887700|NCT01089556|449213640|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
124887701|NCT01089556|449213641|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
124887702|NCT01089556|449213642|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
124887703|NCT01089556|449213643|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
124887704|NCT01089556|449213644|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
124887705|NCT01089556|449213639|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
125105259|NCT03981614|450008120|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
124887706|NCT01089556|449213640|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
124887707|NCT01089556|449213641|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
125105260|NCT03981614|450008121|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
124887708|NCT01089556|449213642|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
124887709|NCT01089556|449213643|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
124887710|NCT01089556|449213644|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
124887711|NCT01089556|449213639|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
124887712|NCT01089556|449213640|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
124887713|NCT01089556|449213641|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
124887714|NCT01089556|449213642|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
124887715|NCT01089556|449213643|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
124887716|NCT01089556|449213644|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
124887717|NCT01089556|449213639|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
124887718|NCT01089556|449213640|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
124887719|NCT01089556|449213641|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
124887720|NCT01089556|449213642|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
124887721|NCT01089556|449213643|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
124887722|NCT01089556|449213644|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
124887723|NCT01089556|449213639|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
124887724|NCT01089556|449213640|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
124887725|NCT01089556|449213641|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
124887726|NCT01089556|449213642|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
124887727|NCT01089556|449213643|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
124887728|NCT01089556|449213644|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
124887729|NCT01238575|449213645|FG000|Overall Study|Lack of Efficacy|2|||
124887730|NCT01238575|449213646|FG001|Overall Study|Lack of Efficacy|4|||
124887731|NCT01238575|449213645|FG000|Overall Study|Adverse Event|2|||
124887732|NCT01238575|449213646|FG001|Overall Study|Adverse Event|0|||
124887733|NCT03405662|449213647|FG000|Overall Study|COVID-19 restriction|1|||
124887734|NCT03405662|449213648|FG001|Overall Study|COVID-19 restriction|0|||
124887735|NCT03405662|449213647|FG000|Overall Study|unblinding|0|||
124887736|NCT03405662|449213648|FG001|Overall Study|unblinding|1|||
124887737|NCT03405662|449213647|FG000|Overall Study|placement in memory care facility|0|||
124887738|NCT03405662|449213648|FG001|Overall Study|placement in memory care facility|2|||
124887739|NCT01555021|449213651|FG000|Overall Study|Lost to Follow-up|1|||
124887740|NCT01555021|449213652|FG001|Overall Study|Lost to Follow-up|2|||
124887741|NCT03875911|449213655|FG000|Overall Study|Lost to Follow-up|3|||
124887742|NCT03875911|449213656|FG001|Overall Study|Lost to Follow-up|6|||
124887743|NCT03875911|449213657|FG002|Overall Study|Lost to Follow-up|2|||
124887744|NCT03875911|449213655|FG000|Overall Study|Surgery cancelled|1|||
124887745|NCT03875911|449213656|FG001|Overall Study|Surgery cancelled|0|||
124887746|NCT03875911|449213657|FG002|Overall Study|Surgery cancelled|1|||
124887747|NCT03875911|449213655|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
124887748|NCT03875911|449213656|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
124887749|NCT03875911|449213657|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
124887750|NCT00750893|449213660|FG000|Overall Study|Adverse Event|5|||
124887751|NCT00750893|449213660|FG000|Overall Study|Withdrawal by Subject|10|||
124887752|NCT00750893|449213660|FG000|Overall Study|Lost to Follow-up|510|||
124887753|NCT00750893|449213660|FG000|Overall Study|Other|17|||
124887754|NCT03824938|449213661|FG000|Overall Study|Withdrawal by Subject|2|||
124887755|NCT03824938|449213662|FG001|Overall Study|Withdrawal by Subject|1|||
124887756|NCT03824938|449213663|FG002|Overall Study|Withdrawal by Subject|0|||
124887757|NCT03824938|449213664|FG003|Overall Study|Withdrawal by Subject|2|||
124887758|NCT03824938|449213665|FG004|Overall Study|Withdrawal by Subject|0|||
124887759|NCT03824938|449213666|FG005|Overall Study|Withdrawal by Subject|1|||
124887760|NCT03824938|449213661|FG000|Overall Study|Lost to Follow-up|0|||
124887761|NCT03824938|449213662|FG001|Overall Study|Lost to Follow-up|1|||
124887762|NCT03824938|449213663|FG002|Overall Study|Lost to Follow-up|0|||
124887763|NCT03824938|449213664|FG003|Overall Study|Lost to Follow-up|0|||
124887764|NCT03824938|449213665|FG004|Overall Study|Lost to Follow-up|1|||
124887765|NCT03824938|449213666|FG005|Overall Study|Lost to Follow-up|0|||
124887766|NCT02420327|449213670|FG000|Overall Study|Adverse Event|7|||
124887767|NCT02420327|449213670|FG000|Overall Study|Pregnancy|1|||
124887768|NCT02420327|449213670|FG000|Overall Study|Withdrawal by Subject|6|||
124887769|NCT02420327|449213670|FG000|Overall Study|Lost to Follow-up|1|||
124887770|NCT02420327|449213670|FG000|Overall Study|Protocol Violation|1|||
124887771|NCT00065468|449213673|FG000|Overall Study|Death|172|||
124887772|NCT00065468|449213674|FG001|Overall Study|Death|169|||
124887773|NCT00065468|449213675|FG002|Overall Study|Death|171|||
124887774|NCT00065468|449213673|FG000|Overall Study|Withdrawal by Subject|3|||
124887775|NCT00065468|449213674|FG001|Overall Study|Withdrawal by Subject|4|||
124887776|NCT00065468|449213675|FG002|Overall Study|Withdrawal by Subject|5|||
124887777|NCT00065468|449213673|FG000|Overall Study|Lost to Follow-up|5|||
124887778|NCT00065468|449213674|FG001|Overall Study|Lost to Follow-up|3|||
125105261|NCT03981614|450008122|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
124887779|NCT00065468|449213675|FG002|Overall Study|Lost to Follow-up|2|||
124887780|NCT00065468|449213673|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
124887781|NCT00065468|449213674|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
124887782|NCT00065468|449213675|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
124887783|NCT00065468|449213673|FG000|Overall Study|Disease progression|0|||
124887784|NCT00065468|449213674|FG001|Overall Study|Disease progression|0|||
124887785|NCT00065468|449213675|FG002|Overall Study|Disease progression|1|||
124887786|NCT00065468|449213673|FG000|Overall Study|Other|14|||
124887787|NCT00065468|449213674|FG001|Overall Study|Other|24|||
124887788|NCT00065468|449213675|FG002|Overall Study|Other|18|||
124887789|NCT01225835|449213676|FG000|Overall Study|Completed protocol|2|||
124887790|NCT01225835|449213677|FG001|Overall Study|Completed protocol|1|||
124887791|NCT01225835|449213676|FG000|Overall Study|Did not meet hCG criterion|2|||
124887792|NCT01225835|449213677|FG001|Overall Study|Did not meet hCG criterion|0|||
124887793|NCT01225835|449213676|FG000|Overall Study|Adverse Event|2|||
124887794|NCT01225835|449213677|FG001|Overall Study|Adverse Event|1|||
124887795|NCT01225835|449213676|FG000|Overall Study|Other|1|||
124887796|NCT01225835|449213677|FG001|Overall Study|Other|1|||
124887797|NCT02589392|449213678|FG000|Overall Study|Adverse Event|1|||
124887798|NCT02589392|449213679|FG001|Overall Study|Adverse Event|1|||
124887799|NCT02589392|449213678|FG000|Overall Study|Withdrawal by Subject|1|||
124887800|NCT02589392|449213679|FG001|Overall Study|Withdrawal by Subject|2|||
124887801|NCT02589392|449213678|FG000|Overall Study|Protocol Violation|1|||
124887802|NCT02589392|449213679|FG001|Overall Study|Protocol Violation|1|||
124887803|NCT02589392|449213678|FG000|Overall Study|Lost to Follow-up|2|||
124887804|NCT02589392|449213679|FG001|Overall Study|Lost to Follow-up|2|||
124887805|NCT02589392|449213678|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
124887806|NCT02589392|449213679|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
124887807|NCT02207374|449213686|FG000|Overall Study|Withdrawal by Subject|5|||
124887808|NCT02207374|449213687|FG001|Overall Study|Withdrawal by Subject|9|||
124887809|NCT02207374|449213688|FG002|Overall Study|Withdrawal by Subject|4|||
124887810|NCT02207374|449213686|FG000|Overall Study|Death|1|||
125015602|NCT00879229|449682547|FG000|Overall Study|Study terminated by Sponsor|13|||
124887811|NCT02207374|449213687|FG001|Overall Study|Death|0|||
124887812|NCT02207374|449213688|FG002|Overall Study|Death|1|||
124887813|NCT02207374|449213686|FG000|Overall Study|Missing follow-up information|0|||
124887814|NCT02207374|449213687|FG001|Overall Study|Missing follow-up information|1|||
124887815|NCT02207374|449213688|FG002|Overall Study|Missing follow-up information|1|||
124887816|NCT02087150|449213689|FG000|Overall Study|Death|0|||
124887817|NCT02087150|449213690|FG001|Overall Study|Death|1|||
124887818|NCT02087150|449213691|FG002|Overall Study|Death|0|||
124887819|NCT02087150|449213689|FG000|Overall Study|Lost to Follow-up|6|||
124887820|NCT02087150|449213690|FG001|Overall Study|Lost to Follow-up|13|||
124887821|NCT02087150|449213691|FG002|Overall Study|Lost to Follow-up|7|||
124887822|NCT02087150|449213689|FG000|Overall Study|Withdrawal by Subject|2|||
124887823|NCT02087150|449213690|FG001|Overall Study|Withdrawal by Subject|5|||
124887824|NCT02087150|449213691|FG002|Overall Study|Withdrawal by Subject|3|||
124887825|NCT02087150|449213689|FG000|Overall Study|Physician Decision|0|||
124887826|NCT02087150|449213690|FG001|Overall Study|Physician Decision|1|||
124887827|NCT02087150|449213691|FG002|Overall Study|Physician Decision|0|||
124887828|NCT02087150|449213689|FG000|Overall Study|Procedure not done|1|||
124887829|NCT02087150|449213690|FG001|Overall Study|Procedure not done|13|||
124887830|NCT02087150|449213691|FG002|Overall Study|Procedure not done|0|||
124887831|NCT02087150|449213689|FG000|Overall Study|F/U not completed w/in study window|0|||
124887832|NCT02087150|449213690|FG001|Overall Study|F/U not completed w/in study window|0|||
124887833|NCT02087150|449213691|FG002|Overall Study|F/U not completed w/in study window|1|||
124887834|NCT02087150|449213689|FG000|Overall Study|Other|1|||
124887835|NCT02087150|449213690|FG001|Overall Study|Other|0|||
124887836|NCT02087150|449213691|FG002|Overall Study|Other|0|||
124887837|NCT02087150|449213689|FG000|Overall Study|Pt moved out of town|0|||
124887838|NCT02087150|449213690|FG001|Overall Study|Pt moved out of town|1|||
124887839|NCT02087150|449213691|FG002|Overall Study|Pt moved out of town|0|||
124887840|NCT02372058|449213693|FG000|Overall Study|Withdrawal by Subject|3|||
124887841|NCT00972179|449213695|FG000|Overall Study|Noncompliance|1|||
124887842|NCT00972179|449213696|FG001|Overall Study|Noncompliance|0|||
124887843|NCT00972179|449213697|FG002|Overall Study|Noncompliance|0|||
124887844|NCT00972179|449213698|FG003|Overall Study|Noncompliance|0|||
124887845|NCT00972179|449213699|FG004|Overall Study|Noncompliance|1|||
124887846|NCT00972179|449213700|FG005|Overall Study|Noncompliance|0|||
124887847|NCT00972179|449213701|FG006|Overall Study|Noncompliance|1|||
124887848|NCT00972179|449213695|FG000|Overall Study|Withdrawal by Subject|0|||
125015603|NCT00879229|449682548|FG001|Overall Study|Study terminated by Sponsor|12|||
125015604|NCT00879229|449682547|FG000|Overall Study|Death|4|||
125015605|NCT00879229|449682548|FG001|Overall Study|Death|2|||
125015606|NCT00879229|449682547|FG000|Overall Study|Adverse Event|2|||
125015607|NCT00879229|449682548|FG001|Overall Study|Adverse Event|0|||
125015608|NCT00879229|449682547|FG000|Overall Study|Withdrawal by Subject|1|||
125015609|NCT00879229|449682548|FG001|Overall Study|Withdrawal by Subject|0|||
125015610|NCT00879229|449682547|FG000|Overall Study|Clinical status did not improve|1|||
125015611|NCT00879229|449682548|FG001|Overall Study|Clinical status did not improve|0|||
124887849|NCT00972179|449213696|FG001|Overall Study|Withdrawal by Subject|3|||
125015612|NCT00879229|449682547|FG000|Overall Study|Other|1|||
125015613|NCT00879229|449682548|FG001|Overall Study|Other|0|||
125015614|NCT01097746|449682549|FG000|Overall Study|Adverse Event|4|||
125015615|NCT01097746|449682549|FG000|Overall Study|taken off study before any treatment given|1|||
125015616|NCT00390546|449682556|FG000|Overall Study|Renal impairment|1|||
124887850|NCT00972179|449213697|FG002|Overall Study|Withdrawal by Subject|0|||
124887851|NCT00972179|449213698|FG003|Overall Study|Withdrawal by Subject|1|||
125015617|NCT00390546|449682557|FG001|Overall Study|Renal impairment|0|||
125015618|NCT00390546|449682556|FG000|Overall Study|Physician Decision|5|||
125015619|NCT00390546|449682557|FG001|Overall Study|Physician Decision|5|||
124887852|NCT00972179|449213699|FG004|Overall Study|Withdrawal by Subject|0|||
124887853|NCT00972179|449213700|FG005|Overall Study|Withdrawal by Subject|0|||
124887854|NCT00972179|449213701|FG006|Overall Study|Withdrawal by Subject|2|||
124887855|NCT00972179|449213695|FG000|Overall Study|Administrative Decision|0|||
124887856|NCT00972179|449213696|FG001|Overall Study|Administrative Decision|0|||
124887857|NCT00972179|449213697|FG002|Overall Study|Administrative Decision|0|||
124887858|NCT00972179|449213698|FG003|Overall Study|Administrative Decision|0|||
124887859|NCT00972179|449213699|FG004|Overall Study|Administrative Decision|1|||
124887860|NCT00972179|449213700|FG005|Overall Study|Administrative Decision|0|||
124887861|NCT00972179|449213701|FG006|Overall Study|Administrative Decision|0|||
124887862|NCT00972179|449213695|FG000|Overall Study|Lost to Follow-up|0|||
124887863|NCT00972179|449213696|FG001|Overall Study|Lost to Follow-up|0|||
124887864|NCT00972179|449213697|FG002|Overall Study|Lost to Follow-up|1|||
124887865|NCT00972179|449213698|FG003|Overall Study|Lost to Follow-up|0|||
124887866|NCT00972179|449213699|FG004|Overall Study|Lost to Follow-up|0|||
124887867|NCT00972179|449213700|FG005|Overall Study|Lost to Follow-up|3|||
124887868|NCT00972179|449213701|FG006|Overall Study|Lost to Follow-up|1|||
124887869|NCT02584855|449213705|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
124887870|NCT02584855|449213706|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
124887871|NCT02584855|449213707|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
124887872|NCT02584855|449213708|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
124887873|NCT02584855|449213709|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
124887874|NCT02584855|449213710|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
124887875|NCT02584855|449213705|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
124887876|NCT02584855|449213706|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
124887877|NCT02584855|449213707|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
124887878|NCT02584855|449213708|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
124887879|NCT02584855|449213709|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
124887880|NCT02584855|449213710|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
124887881|NCT02584855|449213705|FG000|Open-Label Treatment Period|Adverse Event|14|||
124887882|NCT02584855|449213706|FG001|Open-Label Treatment Period|Adverse Event|0|||
124887883|NCT02584855|449213707|FG002|Open-Label Treatment Period|Adverse Event|0|||
124887884|NCT02584855|449213708|FG003|Open-Label Treatment Period|Adverse Event|0|||
124887885|NCT02584855|449213709|FG004|Open-Label Treatment Period|Adverse Event|0|||
124887886|NCT02584855|449213710|FG005|Open-Label Treatment Period|Adverse Event|0|||
124887887|NCT02584855|449213705|FG000|Open-Label Treatment Period|Death|2|||
124887888|NCT02584855|449213706|FG001|Open-Label Treatment Period|Death|0|||
124887889|NCT02584855|449213707|FG002|Open-Label Treatment Period|Death|0|||
124887890|NCT02584855|449213708|FG003|Open-Label Treatment Period|Death|0|||
124887891|NCT02584855|449213709|FG004|Open-Label Treatment Period|Death|0|||
124887892|NCT02584855|449213710|FG005|Open-Label Treatment Period|Death|0|||
124887893|NCT02584855|449213705|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
125015620|NCT00631371|449682558|FG000|Overall Study|Lost to Follow-up|24|||
125015621|NCT00631371|449682559|FG001|Overall Study|Lost to Follow-up|19|||
125015622|NCT00631371|449682558|FG000|Overall Study|Other reason|5|||
125015623|NCT00631371|449682559|FG001|Overall Study|Other reason|12|||
125015624|NCT00631371|449682558|FG000|Overall Study|subject request|38|||
125015625|NCT00631371|449682559|FG001|Overall Study|subject request|45|||
125015626|NCT00631371|449682558|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
125015627|NCT00631371|449682559|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
124887894|NCT02584855|449213706|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
124887895|NCT02584855|449213707|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
124887896|NCT02584855|449213708|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
124887897|NCT02584855|449213709|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
124887898|NCT02584855|449213710|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
124887899|NCT02584855|449213705|FG000|Open-Label Treatment Period|Protocol Violation|1|||
124887900|NCT02584855|449213706|FG001|Open-Label Treatment Period|Protocol Violation|0|||
124887901|NCT02584855|449213707|FG002|Open-Label Treatment Period|Protocol Violation|0|||
124887902|NCT02584855|449213708|FG003|Open-Label Treatment Period|Protocol Violation|0|||
124887903|NCT02584855|449213709|FG004|Open-Label Treatment Period|Protocol Violation|0|||
124887904|NCT02584855|449213710|FG005|Open-Label Treatment Period|Protocol Violation|0|||
125015628|NCT00631371|449682558|FG000|Overall Study|Death|263|||
125015629|NCT00631371|449682559|FG001|Overall Study|Death|239|||
124887905|NCT02584855|449213705|FG000|Open-Label Treatment Period|No PI Available|2|||
124887906|NCT02584855|449213706|FG001|Open-Label Treatment Period|No PI Available|0|||
124887907|NCT02584855|449213707|FG002|Open-Label Treatment Period|No PI Available|0|||
124887908|NCT02584855|449213708|FG003|Open-Label Treatment Period|No PI Available|0|||
124887909|NCT02584855|449213709|FG004|Open-Label Treatment Period|No PI Available|0|||
124887910|NCT02584855|449213710|FG005|Open-Label Treatment Period|No PI Available|0|||
124887911|NCT02584855|449213705|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
124887912|NCT02584855|449213706|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
124887913|NCT02584855|449213707|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
124887914|NCT02584855|449213708|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
124887915|NCT02584855|449213709|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
124887916|NCT02584855|449213710|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
124887917|NCT02584855|449213705|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
124887918|NCT02584855|449213706|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
124887919|NCT02584855|449213707|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
124887920|NCT02584855|449213708|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
124887921|NCT02584855|449213709|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
124887922|NCT02584855|449213710|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
124887923|NCT02584855|449213705|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
124887924|NCT02584855|449213706|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
124887925|NCT02584855|449213707|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
124887926|NCT02584855|449213708|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
124887927|NCT02584855|449213709|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
124887928|NCT02584855|449213710|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
124887929|NCT02584855|449213705|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
124887930|NCT02584855|449213706|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
124887931|NCT02584855|449213707|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
124887932|NCT02584855|449213708|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
124887933|NCT02584855|449213709|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
124887934|NCT02584855|449213710|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
124887935|NCT02584855|449213705|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
124887936|NCT02584855|449213706|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
124887937|NCT02584855|449213707|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
124887938|NCT02584855|449213708|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
124887939|NCT02584855|449213709|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
124887940|NCT02584855|449213710|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
124887941|NCT02584855|449213705|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
124887942|NCT02584855|449213706|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
124887943|NCT02584855|449213707|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
124887944|NCT02584855|449213708|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
124887945|NCT02584855|449213709|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
124887946|NCT02584855|449213710|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
124887947|NCT02584855|449213705|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
124887948|NCT02584855|449213706|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
124887949|NCT02584855|449213707|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
124887950|NCT02584855|449213708|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
124887951|NCT02584855|449213709|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
124887952|NCT02584855|449213710|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
124887953|NCT02138747|449213711|FG000|Treatment Period 1|Adverse Event|10|||
124887954|NCT02138747|449213712|FG001|Treatment Period 1|Adverse Event|14|||
125015630|NCT00812214|449682568|FG000|Overall Study|Lost to Follow-up|3|||
125015631|NCT00812214|449682569|FG001|Overall Study|Lost to Follow-up|1|||
125015632|NCT02145741|449682571|FG000|Overall Study|Progressive disease|3|||
125015633|NCT02145741|449682572|FG001|Overall Study|Progressive disease|6|||
125015634|NCT02145741|449682573|FG002|Overall Study|Progressive disease|6|||
124887955|NCT02138747|449213713|FG002|Treatment Period 1|Adverse Event|2|||
124887956|NCT02138747|449213714|FG003|Treatment Period 1|Adverse Event|1|||
124887957|NCT02138747|449213711|FG000|Treatment Period 1|Lost to Follow-up|0|||
125015635|NCT02145741|449682571|FG000|Overall Study|quality issue with the administered drug|3|||
125105262|NCT00499252|450008123|FG000|Overall Study|Adverse Event|3|||
125015636|NCT02145741|449682572|FG001|Overall Study|quality issue with the administered drug|0|||
125015637|NCT02145741|449682573|FG002|Overall Study|quality issue with the administered drug|0|||
124887958|NCT02138747|449213712|FG001|Treatment Period 1|Lost to Follow-up|1|||
124887959|NCT02138747|449213713|FG002|Treatment Period 1|Lost to Follow-up|1|||
124887960|NCT02138747|449213714|FG003|Treatment Period 1|Lost to Follow-up|0|||
124887961|NCT02138747|449213711|FG000|Treatment Period 1|Protocol Violation|0|||
124887962|NCT02138747|449213712|FG001|Treatment Period 1|Protocol Violation|2|||
124887963|NCT02138747|449213713|FG002|Treatment Period 1|Protocol Violation|0|||
124887964|NCT02138747|449213714|FG003|Treatment Period 1|Protocol Violation|0|||
124887965|NCT02138747|449213711|FG000|Treatment Period 1|Withdrawal by Subject|8|||
124887966|NCT02138747|449213712|FG001|Treatment Period 1|Withdrawal by Subject|4|||
124887967|NCT02138747|449213713|FG002|Treatment Period 1|Withdrawal by Subject|1|||
124887968|NCT02138747|449213714|FG003|Treatment Period 1|Withdrawal by Subject|3|||
124887969|NCT02138747|449213711|FG000|Treatment Period 1|Other - Miscellaneous|2|||
124887970|NCT02138747|449213712|FG001|Treatment Period 1|Other - Miscellaneous|4|||
124887971|NCT02138747|449213713|FG002|Treatment Period 1|Other - Miscellaneous|0|||
124887972|NCT02138747|449213714|FG003|Treatment Period 1|Other - Miscellaneous|0|||
124887973|NCT02138747|449213711|FG000|Treatment Period 2|Adverse Event|6|||
124887974|NCT02138747|449213712|FG001|Treatment Period 2|Adverse Event|3|||
124887975|NCT02138747|449213713|FG002|Treatment Period 2|Adverse Event|1|||
124887976|NCT02138747|449213714|FG003|Treatment Period 2|Adverse Event|1|||
124887977|NCT02138747|449213711|FG000|Treatment Period 2|Lost to Follow-up|2|||
124887978|NCT02138747|449213712|FG001|Treatment Period 2|Lost to Follow-up|0|||
124887979|NCT02138747|449213713|FG002|Treatment Period 2|Lost to Follow-up|0|||
124887980|NCT02138747|449213714|FG003|Treatment Period 2|Lost to Follow-up|0|||
124887981|NCT02138747|449213711|FG000|Treatment Period 2|Protocol Violation|1|||
124887982|NCT02138747|449213712|FG001|Treatment Period 2|Protocol Violation|0|||
124887983|NCT02138747|449213713|FG002|Treatment Period 2|Protocol Violation|0|||
124887984|NCT02138747|449213714|FG003|Treatment Period 2|Protocol Violation|0|||
124887985|NCT02138747|449213711|FG000|Treatment Period 2|Withdrawal by Subject|5|||
124887986|NCT02138747|449213712|FG001|Treatment Period 2|Withdrawal by Subject|4|||
124887987|NCT02138747|449213713|FG002|Treatment Period 2|Withdrawal by Subject|1|||
124887988|NCT02138747|449213714|FG003|Treatment Period 2|Withdrawal by Subject|2|||
124887989|NCT02138747|449213711|FG000|Treatment Period 2|Other - Miscellaneous|3|||
124887990|NCT02138747|449213712|FG001|Treatment Period 2|Other - Miscellaneous|0|||
124887991|NCT02138747|449213713|FG002|Treatment Period 2|Other - Miscellaneous|0|||
124887992|NCT02138747|449213714|FG003|Treatment Period 2|Other - Miscellaneous|0|||
124887993|NCT00932646|449213715|FG000|Overall Study|Adverse Event|2|||
124887994|NCT00932646|449213716|FG001|Overall Study|Adverse Event|1|||
124887995|NCT00932646|449213717|FG002|Overall Study|Adverse Event|1|||
124887996|NCT00932646|449213718|FG003|Overall Study|Adverse Event|1|||
124887997|NCT00932646|449213715|FG000|Overall Study|Lost to Follow-up|2|||
124887998|NCT00932646|449213716|FG001|Overall Study|Lost to Follow-up|1|||
124887999|NCT00932646|449213717|FG002|Overall Study|Lost to Follow-up|0|||
124888000|NCT00932646|449213718|FG003|Overall Study|Lost to Follow-up|0|||
124888001|NCT00932646|449213715|FG000|Overall Study|Withdrawal by Subject|1|||
124888002|NCT00932646|449213716|FG001|Overall Study|Withdrawal by Subject|1|||
124888003|NCT00932646|449213717|FG002|Overall Study|Withdrawal by Subject|3|||
124888004|NCT00932646|449213718|FG003|Overall Study|Withdrawal by Subject|0|||
124888005|NCT00653263|449213719|FG000|Overall Study|Withdrawal by Subject|1|||
124888006|NCT00653263|449213719|FG000|Overall Study|Physician Decision|1|||
124888007|NCT02285595|449213723|FG000|Overall Study|Lost to Follow-up|14|||
124888008|NCT02285595|449213723|FG000|Overall Study|Withdrawal by Subject|1|||
124888009|NCT00064025|449213734|FG000|Overall Study|Ineligible|4|||
124888010|NCT00064025|449213734|FG000|Overall Study|Inevaluable|3|||
124888011|NCT02468934|449213737|FG000|Overall Study|Withdrawal by Subject|4|||
124888012|NCT02468934|449213737|FG000|Overall Study|Screen Failure|3|||
124888013|NCT00641186|449213742|FG000|Overall Study|Adverse Event|3|||
124888014|NCT02218489|449213745|FG000|Overall Study|Withdrawal by Subject|4|||
124888015|NCT02218489|449213746|FG001|Overall Study|Withdrawal by Subject|3|||
124888016|NCT02218489|449213745|FG000|Overall Study|Lost to Follow-up|1|||
124888017|NCT02218489|449213746|FG001|Overall Study|Lost to Follow-up|0|||
124888018|NCT02404493|449213747|FG000|Overall Study|Adverse Event|1|||
124888019|NCT02404493|449213748|FG001|Overall Study|Adverse Event|1|||
124888020|NCT02388074|449213749|FG000|Overall Study|Lost in Transit|2|||
124888021|NCT02388074|449213749|FG000|Overall Study|Sample Not Returned|1|||
125105263|NCT00499252|450008123|FG000|Overall Study|Refused further treatment|2|||
124888022|NCT00003458|449213750|FG000|Overall Study|Not evaluable|4|||
124888023|NCT02133924|449213751|FG000|Overall Study|Death|38|||
124888024|NCT02133924|449213751|FG000|Overall Study|Physician Decision|1|||
124888025|NCT02133924|449213751|FG000|Overall Study|Withdrawal by Subject|3|||
124888026|NCT01254890|449213752|FG000|Overall Study|Ineligible|0|||
124888027|NCT01254890|449213753|FG001|Overall Study|Ineligible|3|||
124888028|NCT01254890|449213752|FG000|Overall Study|Withdrawal by Subject|1|||
124888029|NCT01254890|449213753|FG001|Overall Study|Withdrawal by Subject|2|||
124888030|NCT01254890|449213752|FG000|Overall Study|Disease Progression|0|||
124888031|NCT01254890|449213753|FG001|Overall Study|Disease Progression|5|||
124888032|NCT04157686|449213754|FG000|Overall Study|Adverse Event|1|||
124888033|NCT04157686|449213755|FG001|Overall Study|Adverse Event|0|||
124888034|NCT04157686|449213756|FG002|Overall Study|Adverse Event|1|||
124888035|NCT04157686|449213757|FG003|Overall Study|Adverse Event|0|||
124888036|NCT04157686|449213758|FG004|Overall Study|Adverse Event|1|||
124888037|NCT04157686|449213759|FG005|Overall Study|Adverse Event|0|||
124888038|NCT04157686|449213760|FG006|Overall Study|Adverse Event|0|||
124888039|NCT04157686|449213761|FG007|Overall Study|Adverse Event|0|||
124888040|NCT04157686|449213754|FG000|Overall Study|Pregnancy|0|||
124888041|NCT04157686|449213755|FG001|Overall Study|Pregnancy|1|||
124888042|NCT04157686|449213756|FG002|Overall Study|Pregnancy|3|||
124888043|NCT04157686|449213757|FG003|Overall Study|Pregnancy|0|||
124888044|NCT04157686|449213758|FG004|Overall Study|Pregnancy|0|||
124888045|NCT04157686|449213759|FG005|Overall Study|Pregnancy|0|||
124888046|NCT04157686|449213760|FG006|Overall Study|Pregnancy|3|||
124888047|NCT04157686|449213761|FG007|Overall Study|Pregnancy|0|||
124888048|NCT04157686|449213754|FG000|Overall Study|Lost to Follow-up|1|||
124888049|NCT04157686|449213755|FG001|Overall Study|Lost to Follow-up|2|||
124888050|NCT04157686|449213756|FG002|Overall Study|Lost to Follow-up|8|||
124888051|NCT04157686|449213757|FG003|Overall Study|Lost to Follow-up|6|||
124888052|NCT04157686|449213758|FG004|Overall Study|Lost to Follow-up|6|||
124888053|NCT04157686|449213759|FG005|Overall Study|Lost to Follow-up|3|||
124888054|NCT04157686|449213760|FG006|Overall Study|Lost to Follow-up|7|||
124888055|NCT04157686|449213761|FG007|Overall Study|Lost to Follow-up|9|||
124888056|NCT04157686|449213754|FG000|Overall Study|Lack of Efficacy|0|||
124888057|NCT04157686|449213755|FG001|Overall Study|Lack of Efficacy|0|||
124888058|NCT04157686|449213756|FG002|Overall Study|Lack of Efficacy|0|||
124888059|NCT04157686|449213757|FG003|Overall Study|Lack of Efficacy|0|||
124888060|NCT04157686|449213758|FG004|Overall Study|Lack of Efficacy|0|||
124888061|NCT04157686|449213759|FG005|Overall Study|Lack of Efficacy|2|||
124888062|NCT04157686|449213760|FG006|Overall Study|Lack of Efficacy|0|||
124888063|NCT04157686|449213761|FG007|Overall Study|Lack of Efficacy|1|||
124888064|NCT04157686|449213754|FG000|Overall Study|Withdrawal by Subject|10|||
124888065|NCT04157686|449213755|FG001|Overall Study|Withdrawal by Subject|10|||
124888066|NCT04157686|449213756|FG002|Overall Study|Withdrawal by Subject|12|||
124888067|NCT04157686|449213757|FG003|Overall Study|Withdrawal by Subject|20|||
124888068|NCT04157686|449213758|FG004|Overall Study|Withdrawal by Subject|12|||
124888069|NCT04157686|449213759|FG005|Overall Study|Withdrawal by Subject|11|||
124888070|NCT04157686|449213760|FG006|Overall Study|Withdrawal by Subject|18|||
124888071|NCT04157686|449213761|FG007|Overall Study|Withdrawal by Subject|24|||
124888072|NCT04157686|449213754|FG000|Overall Study|Physician Decision|0|||
124888073|NCT04157686|449213755|FG001|Overall Study|Physician Decision|0|||
124888074|NCT04157686|449213756|FG002|Overall Study|Physician Decision|1|||
124888075|NCT04157686|449213757|FG003|Overall Study|Physician Decision|0|||
124888076|NCT04157686|449213758|FG004|Overall Study|Physician Decision|1|||
124888077|NCT04157686|449213759|FG005|Overall Study|Physician Decision|0|||
124888078|NCT04157686|449213760|FG006|Overall Study|Physician Decision|3|||
124888079|NCT04157686|449213761|FG007|Overall Study|Physician Decision|0|||
124888080|NCT04157686|449213754|FG000|Overall Study|Death|0|||
124888081|NCT04157686|449213755|FG001|Overall Study|Death|0|||
124888082|NCT04157686|449213756|FG002|Overall Study|Death|0|||
124888083|NCT04157686|449213757|FG003|Overall Study|Death|2|||
124888084|NCT04157686|449213758|FG004|Overall Study|Death|0|||
124888085|NCT04157686|449213759|FG005|Overall Study|Death|0|||
124888086|NCT04157686|449213760|FG006|Overall Study|Death|0|||
125105264|NCT00499252|450008123|FG000|Overall Study|Ineligible|4|||
125105265|NCT00499252|450008123|FG000|Overall Study|<no further label>|3|||
125105266|NCT00566631|450008124|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
125105267|NCT00566631|450008124|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
125105268|NCT00566631|450008124|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
125105269|NCT00566631|450008124|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
125105270|NCT00566631|450008124|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
124888087|NCT04157686|449213761|FG007|Overall Study|Death|0|||
124888088|NCT04157686|449213754|FG000|Overall Study|Protocol Violation|0|||
124888089|NCT04157686|449213755|FG001|Overall Study|Protocol Violation|0|||
125105271|NCT00566631|450008124|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
124888090|NCT04157686|449213756|FG002|Overall Study|Protocol Violation|0|||
124888091|NCT04157686|449213757|FG003|Overall Study|Protocol Violation|0|||
124888092|NCT04157686|449213758|FG004|Overall Study|Protocol Violation|1|||
124888093|NCT04157686|449213759|FG005|Overall Study|Protocol Violation|0|||
124888094|NCT04157686|449213760|FG006|Overall Study|Protocol Violation|0|||
124888095|NCT04157686|449213761|FG007|Overall Study|Protocol Violation|0|||
124888096|NCT04157686|449213754|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
124888097|NCT04157686|449213755|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
124888098|NCT04157686|449213756|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
124888099|NCT04157686|449213757|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
124888100|NCT04157686|449213758|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
124888101|NCT04157686|449213759|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
124888102|NCT04157686|449213760|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
124888103|NCT04157686|449213761|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
125105272|NCT00566631|450008124|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
124888104|NCT01216293|449213762|FG000|Main Study|Adverse Event|1|||
124888105|NCT01216293|449213763|FG001|Main Study|Adverse Event|4|||
124888106|NCT01216293|449213764|FG002|Main Study|Adverse Event|2|||
124888107|NCT01216293|449213762|FG000|Main Study|Major Protocol Deviation|1|||
124888108|NCT01216293|449213763|FG001|Main Study|Major Protocol Deviation|0|||
124888109|NCT01216293|449213764|FG002|Main Study|Major Protocol Deviation|1|||
124888110|NCT01216293|449213762|FG000|Main Study|Lost to Follow-up|3|||
124888111|NCT01216293|449213763|FG001|Main Study|Lost to Follow-up|1|||
124888112|NCT01216293|449213764|FG002|Main Study|Lost to Follow-up|0|||
124888113|NCT01216293|449213762|FG000|Main Study|Voluntary Withdrawal|2|||
124888114|NCT01216293|449213763|FG001|Main Study|Voluntary Withdrawal|2|||
124888115|NCT01216293|449213764|FG002|Main Study|Voluntary Withdrawal|2|||
124888116|NCT01216293|449213762|FG000|Main Study|Other Reason Not Specified|0|||
124888117|NCT01216293|449213763|FG001|Main Study|Other Reason Not Specified|1|||
124888118|NCT01216293|449213764|FG002|Main Study|Other Reason Not Specified|1|||
124888119|NCT01216293|449213762|FG000|Main Study|Randomized, Not Treated|1|||
124888120|NCT01216293|449213763|FG001|Main Study|Randomized, Not Treated|0|||
124888121|NCT01216293|449213764|FG002|Main Study|Randomized, Not Treated|0|||
124888122|NCT01216293|449213762|FG000|Calcium Absorption Substudy|Adverse Event|0|||
124888123|NCT01216293|449213763|FG001|Calcium Absorption Substudy|Adverse Event|2|||
124888124|NCT01216293|449213764|FG002|Calcium Absorption Substudy|Adverse Event|0|||
124888125|NCT01216293|449213762|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
124888126|NCT01216293|449213763|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
124888127|NCT01216293|449213764|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
124888128|NCT01216293|449213762|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
124888129|NCT01216293|449213763|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
124888130|NCT01216293|449213764|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
124888131|NCT01023308|449215389|FG000|Overall Study|Abnormal test proceedure results|3|||
124888132|NCT01023308|449215390|FG001|Overall Study|Abnormal test proceedure results|8|||
124888133|NCT01023308|449215389|FG000|Overall Study|Administrative problems|2|||
125015638|NCT01192022|449682574|FG000|Overall Study|Withdrawal of Consent|3|||
125015639|NCT01192022|449682575|FG001|Overall Study|Withdrawal of Consent|1|||
125015640|NCT01192022|449682576|FG002|Overall Study|Withdrawal of Consent|0|||
125015641|NCT01192022|449682577|FG003|Overall Study|Withdrawal of Consent|0|||
125015642|NCT01192022|449682578|FG004|Overall Study|Withdrawal of Consent|0|||
125015643|NCT01192022|449682574|FG000|Overall Study|Lost to Follow-up|4|||
125015644|NCT01192022|449682575|FG001|Overall Study|Lost to Follow-up|2|||
125015645|NCT01192022|449682576|FG002|Overall Study|Lost to Follow-up|1|||
125015646|NCT01192022|449682577|FG003|Overall Study|Lost to Follow-up|1|||
125015647|NCT01192022|449682578|FG004|Overall Study|Lost to Follow-up|0|||
125015648|NCT01192022|449682574|FG000|Overall Study|Adverse Event|1|||
125015649|NCT01192022|449682575|FG001|Overall Study|Adverse Event|0|||
125015650|NCT01192022|449682576|FG002|Overall Study|Adverse Event|0|||
125015651|NCT01192022|449682577|FG003|Overall Study|Adverse Event|0|||
125015652|NCT01192022|449682578|FG004|Overall Study|Adverse Event|0|||
125015653|NCT01192022|449682574|FG000|Overall Study|Fatal Adverse Event|4|||
125015654|NCT01192022|449682575|FG001|Overall Study|Fatal Adverse Event|6|||
125015655|NCT01192022|449682576|FG002|Overall Study|Fatal Adverse Event|0|||
125015656|NCT01192022|449682577|FG003|Overall Study|Fatal Adverse Event|0|||
125015657|NCT01192022|449682578|FG004|Overall Study|Fatal Adverse Event|1|||
125015658|NCT01192022|449682574|FG000|Overall Study|Physician withdrew-patient hardship|1|||
125015659|NCT01192022|449682575|FG001|Overall Study|Physician withdrew-patient hardship|0|||
125015660|NCT01192022|449682576|FG002|Overall Study|Physician withdrew-patient hardship|0|||
125015661|NCT01192022|449682577|FG003|Overall Study|Physician withdrew-patient hardship|0|||
125015662|NCT01192022|449682578|FG004|Overall Study|Physician withdrew-patient hardship|0|||
125015663|NCT01192022|449682574|FG000|Overall Study|Patient too sick from chemotherapy|0|||
125015664|NCT01192022|449682575|FG001|Overall Study|Patient too sick from chemotherapy|1|||
125015665|NCT01192022|449682576|FG002|Overall Study|Patient too sick from chemotherapy|0|||
125015666|NCT01192022|449682577|FG003|Overall Study|Patient too sick from chemotherapy|0|||
125015667|NCT01192022|449682578|FG004|Overall Study|Patient too sick from chemotherapy|0|||
124888134|NCT01023308|449215390|FG001|Overall Study|Administrative problems|1|||
125015668|NCT01192022|449682574|FG000|Overall Study|Patient needed surgery|0|||
124888135|NCT01023308|449215389|FG000|Overall Study|Adverse Event|130|||
124888136|NCT01023308|449215390|FG001|Overall Study|Adverse Event|66|||
124888137|NCT01023308|449215389|FG000|Overall Study|Death|21|||
124888138|NCT01023308|449215390|FG001|Overall Study|Death|17|||
124888139|NCT01023308|449215389|FG000|Overall Study|Disease progression|82|||
125015669|NCT01192022|449682575|FG001|Overall Study|Patient needed surgery|1|||
125015670|NCT01192022|449682576|FG002|Overall Study|Patient needed surgery|0|||
125015671|NCT01192022|449682577|FG003|Overall Study|Patient needed surgery|0|||
125015672|NCT01192022|449682578|FG004|Overall Study|Patient needed surgery|0|||
125015673|NCT01192022|449682574|FG000|Overall Study|Parents did not allow all follow up|0|||
124888140|NCT01023308|449215390|FG001|Overall Study|Disease progression|153|||
124888141|NCT01023308|449215389|FG000|Overall Study|New Cancer therapy|4|||
124888142|NCT01023308|449215390|FG001|Overall Study|New Cancer therapy|7|||
124888143|NCT01023308|449215389|FG000|Overall Study|Protocol Violation|3|||
124888144|NCT01023308|449215390|FG001|Overall Study|Protocol Violation|4|||
124888145|NCT01023308|449215389|FG000|Overall Study|Untreated|5|||
124888146|NCT01023308|449215390|FG001|Overall Study|Untreated|5|||
124888147|NCT01023308|449215389|FG000|Overall Study|Lost to Follow-up|1|||
124888148|NCT01023308|449215390|FG001|Overall Study|Lost to Follow-up|0|||
124888149|NCT01023308|449215389|FG000|Overall Study|Withdrawal by Subject|34|||
124888150|NCT01023308|449215390|FG001|Overall Study|Withdrawal by Subject|18|||
124888151|NCT00551213|449215391|FG000|Overall Study|Adverse Event|6|||
124888152|NCT00551213|449215392|FG001|Overall Study|Adverse Event|3|||
124888153|NCT00551213|449215391|FG000|Overall Study|Progressive Disease|41|||
124888154|NCT00551213|449215392|FG001|Overall Study|Progressive Disease|12|||
124888155|NCT00551213|449215391|FG000|Overall Study|Withdrawal by Subject|2|||
124888156|NCT00551213|449215392|FG001|Overall Study|Withdrawal by Subject|0|||
124888157|NCT00551213|449215391|FG000|Overall Study|Not Treated|1|||
124888158|NCT00551213|449215392|FG001|Overall Study|Not Treated|2|||
124888159|NCT01383993|449215393|FG000|Overall Study|Adverse Event|1|||
124888160|NCT01383993|449215394|FG001|Overall Study|Adverse Event|1|||
124888161|NCT01383993|449215395|FG002|Overall Study|Adverse Event|0|||
124888162|NCT01383993|449215393|FG000|Overall Study|Withdrawal by Subject|0|||
124888163|NCT01383993|449215394|FG001|Overall Study|Withdrawal by Subject|0|||
124888164|NCT01383993|449215395|FG002|Overall Study|Withdrawal by Subject|1|||
124888165|NCT01383993|449215393|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
124888166|NCT01383993|449215394|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
124888167|NCT01383993|449215395|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
124888168|NCT02561455|449215398|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
124888169|NCT02561455|449215399|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
124888170|NCT02561455|449215400|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
124888171|NCT02561455|449215401|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
124888172|NCT02561455|449215398|FG000|Overall Study|Withdrawal by Subject|1|||
124888173|NCT02561455|449215399|FG001|Overall Study|Withdrawal by Subject|0|||
124888174|NCT02561455|449215400|FG002|Overall Study|Withdrawal by Subject|1|||
124888175|NCT02561455|449215401|FG003|Overall Study|Withdrawal by Subject|0|||
124888176|NCT02561455|449215398|FG000|Overall Study|Disease Progression|0|||
124888177|NCT02561455|449215399|FG001|Overall Study|Disease Progression|1|||
124888178|NCT02561455|449215400|FG002|Overall Study|Disease Progression|0|||
124888179|NCT02561455|449215401|FG003|Overall Study|Disease Progression|0|||
124888180|NCT00262743|449215402|FG000|Overall Study|Adverse Event|0|||
124888181|NCT00262743|449215403|FG001|Overall Study|Adverse Event|9|||
124888182|NCT00262743|449215402|FG000|Overall Study|Disease progression|0|||
124888183|NCT00262743|449215403|FG001|Overall Study|Disease progression|3|||
125105273|NCT00566631|450008124|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
125105274|NCT00566631|450008124|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
124888186|NCT03249376|449215429|FG000|Overall Study|Adverse Event|11|||
124888187|NCT03249376|449215430|FG001|Overall Study|Adverse Event|5|||
124888188|NCT03249376|449215429|FG000|Overall Study|Lack of Efficacy|2|||
124888189|NCT03249376|449215430|FG001|Overall Study|Lack of Efficacy|4|||
124888190|NCT03249376|449215429|FG000|Overall Study|Protocol Violation|3|||
124888191|NCT03249376|449215430|FG001|Overall Study|Protocol Violation|2|||
124888192|NCT03249376|449215429|FG000|Overall Study|Physician Decision|0|||
124888193|NCT03249376|449215430|FG001|Overall Study|Physician Decision|2|||
124888194|NCT03249376|449215429|FG000|Overall Study|Withdrawal by Subject|3|||
124888195|NCT03249376|449215430|FG001|Overall Study|Withdrawal by Subject|9|||
124888196|NCT03249376|449215429|FG000|Overall Study|LTFU|2|||
124888197|NCT03249376|449215430|FG001|Overall Study|LTFU|1|||
124888198|NCT01154036|449215431|FG000|Phase I|Physician Decision|0|||
124888199|NCT01154036|449215432|FG001|Phase I|Physician Decision|1|||
124888200|NCT01154036|449215433|FG002|Phase I|Physician Decision|0|||
124888201|NCT01154036|449215434|FG003|Phase I|Physician Decision|0|||
124888202|NCT01154036|449215435|FG004|Phase I|Physician Decision|0|||
124888203|NCT01154036|449215436|FG005|Phase I|Physician Decision|0|||
124888204|NCT01154036|449215437|FG006|Phase I|Physician Decision|0|||
124888205|NCT01154036|449215438|FG007|Phase I|Physician Decision|0|||
124888206|NCT01154036|449215431|FG000|Phase I|Lost to Follow-up|0|||
124888207|NCT01154036|449215432|FG001|Phase I|Lost to Follow-up|3|||
124888208|NCT01154036|449215433|FG002|Phase I|Lost to Follow-up|6|||
124888209|NCT01154036|449215434|FG003|Phase I|Lost to Follow-up|0|||
124888210|NCT01154036|449215435|FG004|Phase I|Lost to Follow-up|0|||
124888211|NCT01154036|449215436|FG005|Phase I|Lost to Follow-up|0|||
124888212|NCT01154036|449215437|FG006|Phase I|Lost to Follow-up|0|||
124888213|NCT01154036|449215438|FG007|Phase I|Lost to Follow-up|0|||
124888214|NCT01154036|449215431|FG000|Phase I|Protocol Violation|0|||
124888215|NCT01154036|449215432|FG001|Phase I|Protocol Violation|3|||
124888216|NCT01154036|449215433|FG002|Phase I|Protocol Violation|9|||
124888217|NCT01154036|449215434|FG003|Phase I|Protocol Violation|0|||
124888218|NCT01154036|449215435|FG004|Phase I|Protocol Violation|0|||
124888219|NCT01154036|449215436|FG005|Phase I|Protocol Violation|0|||
124888220|NCT01154036|449215437|FG006|Phase I|Protocol Violation|0|||
124888221|NCT01154036|449215438|FG007|Phase I|Protocol Violation|0|||
124888222|NCT01154036|449215431|FG000|Phase I|Withdrawal by Subject|2|||
124888223|NCT01154036|449215432|FG001|Phase I|Withdrawal by Subject|10|||
124888224|NCT01154036|449215433|FG002|Phase I|Withdrawal by Subject|29|||
124888225|NCT01154036|449215434|FG003|Phase I|Withdrawal by Subject|0|||
124888226|NCT01154036|449215435|FG004|Phase I|Withdrawal by Subject|0|||
124888227|NCT01154036|449215436|FG005|Phase I|Withdrawal by Subject|0|||
124888228|NCT01154036|449215437|FG006|Phase I|Withdrawal by Subject|0|||
124888229|NCT01154036|449215438|FG007|Phase I|Withdrawal by Subject|0|||
124888230|NCT01154036|449215431|FG000|Phase I|Adverse Event|1|||
124888231|NCT01154036|449215432|FG001|Phase I|Adverse Event|11|||
124888232|NCT01154036|449215433|FG002|Phase I|Adverse Event|12|||
124888233|NCT01154036|449215434|FG003|Phase I|Adverse Event|0|||
124888234|NCT01154036|449215435|FG004|Phase I|Adverse Event|0|||
124888235|NCT01154036|449215436|FG005|Phase I|Adverse Event|0|||
124888236|NCT01154036|449215437|FG006|Phase I|Adverse Event|0|||
124888237|NCT01154036|449215438|FG007|Phase I|Adverse Event|0|||
124888238|NCT01154036|449215431|FG000|Phase II|Adverse Event|0|||
124888239|NCT01154036|449215432|FG001|Phase II|Adverse Event|0|||
124888240|NCT01154036|449215433|FG002|Phase II|Adverse Event|0|||
124888241|NCT01154036|449215434|FG003|Phase II|Adverse Event|0|||
124888242|NCT01154036|449215435|FG004|Phase II|Adverse Event|1|||
124888243|NCT01154036|449215436|FG005|Phase II|Adverse Event|1|||
124888244|NCT01154036|449215437|FG006|Phase II|Adverse Event|1|||
124888245|NCT01154036|449215438|FG007|Phase II|Adverse Event|1|||
124888246|NCT01154036|449215431|FG000|Phase II|Physician Decision|0|||
124888247|NCT01154036|449215432|FG001|Phase II|Physician Decision|0|||
124888248|NCT01154036|449215433|FG002|Phase II|Physician Decision|0|||
124888249|NCT01154036|449215434|FG003|Phase II|Physician Decision|0|||
124888250|NCT01154036|449215435|FG004|Phase II|Physician Decision|0|||
124888251|NCT01154036|449215436|FG005|Phase II|Physician Decision|0|||
124888252|NCT01154036|449215437|FG006|Phase II|Physician Decision|1|||
124888253|NCT01154036|449215438|FG007|Phase II|Physician Decision|0|||
124888254|NCT01154036|449215431|FG000|Phase II|Lost to Follow-up|0|||
124888255|NCT01154036|449215432|FG001|Phase II|Lost to Follow-up|0|||
124888256|NCT01154036|449215433|FG002|Phase II|Lost to Follow-up|0|||
124888257|NCT01154036|449215434|FG003|Phase II|Lost to Follow-up|1|||
124888258|NCT01154036|449215435|FG004|Phase II|Lost to Follow-up|2|||
124888259|NCT01154036|449215436|FG005|Phase II|Lost to Follow-up|0|||
124888260|NCT01154036|449215437|FG006|Phase II|Lost to Follow-up|2|||
125105275|NCT00566631|450008124|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
125105276|NCT00566631|450008124|FG000|Part 2: Extension Phase|Adverse Event|11|||
124888261|NCT01154036|449215438|FG007|Phase II|Lost to Follow-up|1|||
124888262|NCT01154036|449215431|FG000|Phase II|Protocol Violation|0|||
124888263|NCT01154036|449215432|FG001|Phase II|Protocol Violation|0|||
124888264|NCT01154036|449215433|FG002|Phase II|Protocol Violation|0|||
124888265|NCT01154036|449215434|FG003|Phase II|Protocol Violation|0|||
124888266|NCT01154036|449215435|FG004|Phase II|Protocol Violation|1|||
124888267|NCT01154036|449215436|FG005|Phase II|Protocol Violation|2|||
124888268|NCT01154036|449215437|FG006|Phase II|Protocol Violation|0|||
124888269|NCT01154036|449215438|FG007|Phase II|Protocol Violation|0|||
124888270|NCT01154036|449215431|FG000|Phase II|Withdrawal by Subject|0|||
124888271|NCT01154036|449215432|FG001|Phase II|Withdrawal by Subject|0|||
124888272|NCT01154036|449215433|FG002|Phase II|Withdrawal by Subject|0|||
124888273|NCT01154036|449215434|FG003|Phase II|Withdrawal by Subject|0|||
124888274|NCT01154036|449215435|FG004|Phase II|Withdrawal by Subject|4|||
124888275|NCT01154036|449215436|FG005|Phase II|Withdrawal by Subject|2|||
124888276|NCT01154036|449215437|FG006|Phase II|Withdrawal by Subject|5|||
124888277|NCT01154036|449215438|FG007|Phase II|Withdrawal by Subject|4|||
124888278|NCT01349907|449215439|FG000|Overall Study|Adverse Event|37|||
124888279|NCT01349907|449215440|FG001|Overall Study|Adverse Event|11|||
124888280|NCT01349907|449215439|FG000|Overall Study|Treatment failure|13|||
124888281|NCT01349907|449215440|FG001|Overall Study|Treatment failure|4|||
124888282|NCT01349907|449215439|FG000|Overall Study|Lost to Follow-up|25|||
124888283|NCT01349907|449215440|FG001|Overall Study|Lost to Follow-up|6|||
124888284|NCT01349907|449215439|FG000|Overall Study|Withdrawal by Subject|30|||
124888285|NCT01349907|449215440|FG001|Overall Study|Withdrawal by Subject|8|||
124888286|NCT01349907|449215439|FG000|Overall Study|Protocol Violation|33|||
124888287|NCT01349907|449215440|FG001|Overall Study|Protocol Violation|13|||
124888288|NCT01349907|449215439|FG000|Overall Study|Administrative|1|||
124888289|NCT01349907|449215440|FG001|Overall Study|Administrative|1|||
124888290|NCT01591460|449215443|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
124888291|NCT01591460|449215443|FG000|Overall Study|Futility Rule (Week 12)|7|||
124888292|NCT01591460|449215443|FG000|Overall Study|Futility Rule (Week 24)|3|||
124888293|NCT01591460|449215443|FG000|Overall Study|Rebound or Breakthrough|3|||
124888294|NCT01591460|449215443|FG000|Overall Study|Treatment Discontinued by Error|1|||
124888295|NCT01591460|449215443|FG000|Overall Study|Lost to Follow-up|1|||
124888296|NCT01591460|449215443|FG000|Overall Study|Noncompliance|1|||
124888297|NCT01591460|449215443|FG000|Overall Study|Participant Refusal|3|||
124888298|NCT01591460|449215443|FG000|Overall Study|Withdrawal by Subject|1|||
124888299|NCT01591460|449215443|FG000|Overall Study|Protocol Violation|1|||
124888300|NCT04102540|449215446|FG000|Overall Study|Withdrawn by PI|2|||
124888301|NCT04102540|449215446|FG000|Overall Study|Lost to Follow-up|6|||
124888302|NCT01744496|449215447|FG000|Titration Period|Adverse Event|2|||
125015674|NCT01192022|449682575|FG001|Overall Study|Parents did not allow all follow up|0|||
125015675|NCT01192022|449682576|FG002|Overall Study|Parents did not allow all follow up|0|||
125015676|NCT01192022|449682577|FG003|Overall Study|Parents did not allow all follow up|1|||
125015677|NCT01192022|449682578|FG004|Overall Study|Parents did not allow all follow up|0|||
125015678|NCT00129766|449682580|FG000|Overall Study|Death|3|||
124888303|NCT01744496|449215448|FG001|Titration Period|Adverse Event|1|||
124888304|NCT01744496|449215447|FG000|Titration Period|Personal reasons|0|||
124888305|NCT01744496|449215448|FG001|Titration Period|Personal reasons|1|||
124888306|NCT01744496|449215447|FG000|Maintenance Period|Adverse Event|1|||
124888307|NCT01744496|449215448|FG001|Maintenance Period|Adverse Event|3|||
124888308|NCT01744496|449215447|FG000|Maintenance Period|Protocol Violation|1|||
124888309|NCT01744496|449215448|FG001|Maintenance Period|Protocol Violation|0|||
124888310|NCT01744496|449215447|FG000|Maintenance Period|Withdrawal by Subject|1|||
125015679|NCT00129766|449682581|FG001|Overall Study|Death|8|||
125015680|NCT00129766|449682580|FG000|Overall Study|Withdrawal of consent|31|||
125015681|NCT00129766|449682581|FG001|Overall Study|Withdrawal of consent|30|||
124888311|NCT01744496|449215448|FG001|Maintenance Period|Withdrawal by Subject|1|||
124888312|NCT01744496|449215447|FG000|Maintenance Period|Subject left town|1|||
124888313|NCT01744496|449215448|FG001|Maintenance Period|Subject left town|0|||
124888314|NCT01567163|449215449|FG000|Overall Study|Progressive Disease|2|||
124888315|NCT01567163|449215449|FG000|Overall Study|Lost to Follow-up|2|||
124888316|NCT01364727|449215457|FG000|Overall Study|Not Eligible|2|||
124888317|NCT01009047|449215459|FG000|Overall Study|Adverse Event|5|||
124888318|NCT01009047|449215460|FG001|Overall Study|Adverse Event|0|||
124888319|NCT01009047|449215459|FG000|Overall Study|Lost to Follow-up|0|||
124888320|NCT01009047|449215460|FG001|Overall Study|Lost to Follow-up|2|||
124888321|NCT01009047|449215459|FG000|Overall Study|Lack of Efficacy|4|||
124888322|NCT01009047|449215460|FG001|Overall Study|Lack of Efficacy|11|||
124888323|NCT01009047|449215459|FG000|Overall Study|Withdrawal by consent|16|||
124888324|NCT01009047|449215460|FG001|Overall Study|Withdrawal by consent|11|||
125105277|NCT00566631|450008124|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
125105278|NCT00566631|450008124|FG000|Part 2: Extension Phase|Death|1|||
125105279|NCT00566631|450008124|FG000|Part 2: Extension Phase|Other|5|||
125105280|NCT03387735|450008125|FG000|Overall Study|Lost to Follow-up|4|||
125105281|NCT03387735|450008126|FG001|Overall Study|Lost to Follow-up|8|||
125105282|NCT03387735|450008125|FG000|Overall Study|Death|4|||
125105283|NCT03387735|450008126|FG001|Overall Study|Death|8|||
125105284|NCT03020966|450008128|FG000|Overall Study|Withdrawal by Subject|2|||
125105285|NCT03020966|450008129|FG001|Overall Study|Withdrawal by Subject|0|||
125105286|NCT03747939|450008133|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
125105287|NCT03747939|450008134|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
125105288|NCT03747939|450008135|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
125105289|NCT03747939|450008136|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
125105290|NCT03747939|450008133|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
125105291|NCT03747939|450008134|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
125105292|NCT03747939|450008135|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
125105293|NCT03747939|450008136|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
125105294|NCT03747939|450008133|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
125105295|NCT03747939|450008134|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
125105296|NCT03747939|450008135|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
125105297|NCT03747939|450008136|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
125105298|NCT03747939|450008133|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
125105299|NCT03747939|450008134|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
125105300|NCT03747939|450008135|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
125105301|NCT03747939|450008136|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
125105302|NCT03747939|450008133|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
125105303|NCT03747939|450008134|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
125105304|NCT03747939|450008135|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
125105305|NCT03747939|450008136|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
125105306|NCT03747939|450008133|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
125105307|NCT03747939|450008134|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
125105308|NCT03747939|450008135|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
125105309|NCT03747939|450008136|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
125105310|NCT03747939|450008133|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
125105311|NCT03747939|450008134|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
125105312|NCT03747939|450008135|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
125105313|NCT03747939|450008136|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
125105314|NCT03747939|450008133|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
125105315|NCT03747939|450008134|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
125105316|NCT03747939|450008135|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
125105317|NCT03747939|450008136|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
125105318|NCT03747939|450008133|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
125105319|NCT03747939|450008134|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
125105320|NCT03747939|450008135|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
125105321|NCT03747939|450008136|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
124888325|NCT01009047|449215459|FG000|Overall Study|Other|3|||
124888326|NCT01009047|449215460|FG001|Overall Study|Other|2|||
124888327|NCT04716881|449215461|FG000|Overall Study|Adverse Event|1|||
124888328|NCT04716881|449215461|FG000|Overall Study|Lost to Follow-up|1|||
124888329|NCT01558674|449215464|FG000|Part 1|Study Terminated by Sponsor|10|||
124888330|NCT01558674|449215465|FG001|Part 1|Study Terminated by Sponsor|0|||
124888331|NCT01558674|449215464|FG000|Part 1|Withdrawal by Subject|1|||
124888332|NCT01558674|449215465|FG001|Part 1|Withdrawal by Subject|0|||
124888333|NCT04147260|449215466|FG000|Overall Study|Adverse Event|1|||
124888334|NCT04147260|449215467|FG001|Overall Study|Adverse Event|0|||
124888335|NCT04147260|449215468|FG002|Overall Study|Adverse Event|1|||
124888336|NCT04147260|449215469|FG003|Overall Study|Adverse Event|2|||
124888337|NCT04147260|449215470|FG004|Overall Study|Adverse Event|0|||
124888338|NCT04147260|449215466|FG000|Overall Study|Withdrawal by Subject|0|||
124888339|NCT04147260|449215467|FG001|Overall Study|Withdrawal by Subject|0|||
124888340|NCT04147260|449215468|FG002|Overall Study|Withdrawal by Subject|1|||
124888341|NCT04147260|449215469|FG003|Overall Study|Withdrawal by Subject|1|||
124888342|NCT04147260|449215470|FG004|Overall Study|Withdrawal by Subject|0|||
124888343|NCT01734850|449215473|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
124888344|NCT01734850|449215474|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
124888345|NCT01734850|449215475|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
124888346|NCT01734850|449215473|FG000|Overall Study|Not infused due to manufacturing failure|0|||
124888347|NCT01734850|449215474|FG001|Overall Study|Not infused due to manufacturing failure|0|||
124888348|NCT01734850|449215475|FG002|Overall Study|Not infused due to manufacturing failure|1|||
125015682|NCT00129766|449682580|FG000|Overall Study|Lost to Follow-up|26|||
125015683|NCT00129766|449682581|FG001|Overall Study|Lost to Follow-up|21|||
125015684|NCT03865706|449682583|FG000|Overall Study|Death|0|||
125015685|NCT03865706|449682584|FG001|Overall Study|Death|3|||
125015686|NCT03865706|449682585|FG002|Overall Study|Death|1|||
125015687|NCT01594853|449682586|FG000|Overall Study|Withdrawal by Subject|1|||
125015688|NCT01594853|449682587|FG001|Overall Study|Withdrawal by Subject|1|||
125015689|NCT01594853|449682586|FG000|Overall Study|Lost to Follow-up|1|||
125015690|NCT01594853|449682587|FG001|Overall Study|Lost to Follow-up|1|||
125015691|NCT01594853|449682586|FG000|Overall Study|noncompliance with exercise|0|||
125015692|NCT01594853|449682587|FG001|Overall Study|noncompliance with exercise|1|||
125015693|NCT03709654|449682588|FG000|Overall Study|Lost to Follow-up|1|||
125015694|NCT03709654|449682589|FG001|Overall Study|Lost to Follow-up|1|||
125015695|NCT03709654|449682588|FG000|Overall Study|Withdrawal by Subject|1|||
125015696|NCT03709654|449682589|FG001|Overall Study|Withdrawal by Subject|1|||
124888349|NCT02204293|449215476|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
124888350|NCT02204293|449215477|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
124888351|NCT02204293|449215478|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
124888352|NCT02204293|449215479|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
124888353|NCT02204293|449215480|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
124888354|NCT02204293|449215481|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
124888355|NCT02204293|449215476|FG000|Core Study Part I|Adverse Event|1|||
124888356|NCT02204293|449215477|FG001|Core Study Part I|Adverse Event|0|||
124888357|NCT02204293|449215478|FG002|Core Study Part I|Adverse Event|0|||
124888358|NCT02204293|449215479|FG003|Core Study Part I|Adverse Event|0|||
124888359|NCT02204293|449215480|FG004|Core Study Part I|Adverse Event|0|||
124888360|NCT02204293|449215481|FG005|Core Study Part I|Adverse Event|0|||
124888361|NCT02204293|449215476|FG000|Core Study Part I|Physician Decision|0|||
124888362|NCT02204293|449215477|FG001|Core Study Part I|Physician Decision|3|||
124888363|NCT02204293|449215478|FG002|Core Study Part I|Physician Decision|0|||
124888364|NCT02204293|449215479|FG003|Core Study Part I|Physician Decision|0|||
125015697|NCT03709654|449682588|FG000|Overall Study|Adverse Event|1|||
125015698|NCT03709654|449682589|FG001|Overall Study|Adverse Event|0|||
125015699|NCT02631200|449682592|FG000|First Period|Death|1|||
125015700|NCT02631200|449682593|FG001|First Period|Death|2|||
125015701|NCT02631200|449682592|FG000|First Period|Patient ill-health|2|||
125015702|NCT02631200|449682593|FG001|First Period|Patient ill-health|4|||
125015703|NCT02631200|449682592|FG000|First Period|Withdrawal by Subject|4|||
125015704|NCT02631200|449682593|FG001|First Period|Withdrawal by Subject|1|||
125015705|NCT02631200|449682592|FG000|Deferred Period|Death|0|||
125015706|NCT02631200|449682593|FG001|Deferred Period|Death|1|||
125015707|NCT02631200|449682592|FG000|Deferred Period|Received kidney transplant|0|||
125015708|NCT02631200|449682593|FG001|Deferred Period|Received kidney transplant|1|||
125015709|NCT02631200|449682592|FG000|Deferred Period|Withdrawal by Subject|0|||
125015710|NCT02631200|449682593|FG001|Deferred Period|Withdrawal by Subject|2|||
125015711|NCT02631200|449682592|FG000|Deferred Period|Lost to Follow-up|0|||
125015712|NCT02631200|449682593|FG001|Deferred Period|Lost to Follow-up|1|||
125015713|NCT01081912|449682595|FG000|Conversion/Titration|Adverse Event|47|||
125015714|NCT01081912|449682596|FG001|Conversion/Titration|Adverse Event|0|||
125015715|NCT01081912|449682597|FG002|Conversion/Titration|Adverse Event|0|||
125015716|NCT01081912|449682595|FG000|Conversion/Titration|Lack of Efficacy|17|||
125015717|NCT01081912|449682596|FG001|Conversion/Titration|Lack of Efficacy|0|||
125015718|NCT01081912|449682597|FG002|Conversion/Titration|Lack of Efficacy|0|||
125015719|NCT01081912|449682595|FG000|Conversion/Titration|Lost to Follow-up|5|||
125015720|NCT01081912|449682596|FG001|Conversion/Titration|Lost to Follow-up|0|||
125015721|NCT01081912|449682597|FG002|Conversion/Titration|Lost to Follow-up|0|||
125015722|NCT01081912|449682595|FG000|Conversion/Titration|Physician Decision|2|||
125015723|NCT01081912|449682596|FG001|Conversion/Titration|Physician Decision|0|||
125015724|NCT01081912|449682597|FG002|Conversion/Titration|Physician Decision|0|||
125015725|NCT01081912|449682595|FG000|Conversion/Titration|Protocol Violation|67|||
125015726|NCT01081912|449682596|FG001|Conversion/Titration|Protocol Violation|0|||
125015727|NCT01081912|449682597|FG002|Conversion/Titration|Protocol Violation|0|||
125015728|NCT01081912|449682595|FG000|Conversion/Titration|Withdrawal by Subject|23|||
125015729|NCT01081912|449682596|FG001|Conversion/Titration|Withdrawal by Subject|0|||
125015730|NCT01081912|449682597|FG002|Conversion/Titration|Withdrawal by Subject|0|||
125015731|NCT01081912|449682595|FG000|Conversion/Titration|Non-Compliance|47|||
124888365|NCT02204293|449215480|FG004|Core Study Part I|Physician Decision|0|||
124888366|NCT02204293|449215481|FG005|Core Study Part I|Physician Decision|0|||
124888367|NCT02204293|449215476|FG000|LTE Phase|Study Suspended|0|||
125015732|NCT01081912|449682596|FG001|Conversion/Titration|Non-Compliance|0|||
125015733|NCT01081912|449682597|FG002|Conversion/Titration|Non-Compliance|0|||
125015734|NCT01081912|449682595|FG000|Maintenance Treatment|Adverse Event|0|||
125015735|NCT01081912|449682596|FG001|Maintenance Treatment|Adverse Event|2|||
125015736|NCT01081912|449682597|FG002|Maintenance Treatment|Adverse Event|12|||
125015737|NCT01081912|449682595|FG000|Maintenance Treatment|Lack of Efficacy|0|||
124888368|NCT02204293|449215477|FG001|LTE Phase|Study Suspended|0|||
124888369|NCT02204293|449215478|FG002|LTE Phase|Study Suspended|0|||
124888370|NCT02204293|449215479|FG003|LTE Phase|Study Suspended|0|||
124888371|NCT02204293|449215480|FG004|LTE Phase|Study Suspended|0|||
124888372|NCT02204293|449215481|FG005|LTE Phase|Study Suspended|7|||
124888373|NCT01990300|449215482|FG000|Overall Study|Case Report Forms Uncollected|89|||
124888374|NCT01990300|449215482|FG000|Overall Study|Protocol Deviation|53|||
124888375|NCT02019602|449215484|FG000|Screening Period|Ineligibility|4|||
124888376|NCT02019602|449215485|FG001|Screening Period|Ineligibility|0|||
124888377|NCT02019602|449215484|FG000|Screening Period|Adverse Event|1|||
124888378|NCT02019602|449215485|FG001|Screening Period|Adverse Event|0|||
124888379|NCT00322374|449215486|FG000|Starting Dose|Physician Decision|2|||
124888380|NCT00322374|449215487|FG001|Starting Dose|Physician Decision|0|||
124888381|NCT00322374|449215488|FG002|Starting Dose|Physician Decision|0|||
124888382|NCT00322374|449215489|FG003|Starting Dose|Physician Decision|0|||
124888383|NCT00322374|449215486|FG000|Starting Dose|Study Drug Toxicity|4|||
124888384|NCT00322374|449215487|FG001|Starting Dose|Study Drug Toxicity|0|||
124888385|NCT00322374|449215488|FG002|Starting Dose|Study Drug Toxicity|0|||
124888386|NCT00322374|449215489|FG003|Starting Dose|Study Drug Toxicity|0|||
124888387|NCT00322374|449215486|FG000|First Escalation|Documented Disease Progression|0|||
124888388|NCT00322374|449215487|FG001|First Escalation|Documented Disease Progression|6|||
124888389|NCT00322374|449215488|FG002|First Escalation|Documented Disease Progression|0|||
124888390|NCT00322374|449215489|FG003|First Escalation|Documented Disease Progression|0|||
124888391|NCT00322374|449215486|FG000|First Escalation|Physician Decision|0|||
124888392|NCT00322374|449215487|FG001|First Escalation|Physician Decision|12|||
124888393|NCT00322374|449215488|FG002|First Escalation|Physician Decision|0|||
124888394|NCT00322374|449215489|FG003|First Escalation|Physician Decision|0|||
124888395|NCT00322374|449215486|FG000|First Escalation|Study Drug Toxicity|0|||
124888396|NCT00322374|449215487|FG001|First Escalation|Study Drug Toxicity|11|||
125015738|NCT01081912|449682596|FG001|Maintenance Treatment|Lack of Efficacy|14|||
125015739|NCT01081912|449682597|FG002|Maintenance Treatment|Lack of Efficacy|64|||
125015740|NCT01081912|449682595|FG000|Maintenance Treatment|Lost to Follow-up|0|||
125015741|NCT01081912|449682596|FG001|Maintenance Treatment|Lost to Follow-up|1|||
125015742|NCT01081912|449682597|FG002|Maintenance Treatment|Lost to Follow-up|0|||
125015743|NCT01081912|449682595|FG000|Maintenance Treatment|Physician Decision|0|||
125015744|NCT01081912|449682596|FG001|Maintenance Treatment|Physician Decision|0|||
125015745|NCT01081912|449682597|FG002|Maintenance Treatment|Physician Decision|1|||
125015746|NCT01081912|449682595|FG000|Maintenance Treatment|Protocol Violation|0|||
125015747|NCT01081912|449682596|FG001|Maintenance Treatment|Protocol Violation|1|||
125015748|NCT01081912|449682597|FG002|Maintenance Treatment|Protocol Violation|2|||
125015749|NCT01081912|449682595|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
125015750|NCT01081912|449682596|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
125015751|NCT01081912|449682597|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
125015752|NCT01081912|449682595|FG000|Maintenance Treatment|Non-Compliance|0|||
125015753|NCT01081912|449682596|FG001|Maintenance Treatment|Non-Compliance|4|||
125015754|NCT01081912|449682597|FG002|Maintenance Treatment|Non-Compliance|7|||
125015755|NCT01081912|449682595|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
125015756|NCT01081912|449682596|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
125015757|NCT01081912|449682597|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
125015758|NCT03776175|449682600|FG000|Treatment Period (42 Days)|Adverse Event|0|||
125015759|NCT03776175|449682601|FG001|Treatment Period (42 Days)|Adverse Event|1|||
125015760|NCT03776175|449682602|FG002|Treatment Period (42 Days)|Adverse Event|1|||
125015761|NCT03776175|449682603|FG003|Treatment Period (42 Days)|Adverse Event|0|||
125015762|NCT03776175|449682600|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
125015763|NCT03776175|449682601|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
125015764|NCT03776175|449682602|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
125015765|NCT03776175|449682603|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
125015766|NCT03776175|449682600|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
125015767|NCT03776175|449682601|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
125015768|NCT03776175|449682602|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
125015769|NCT03776175|449682603|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
125015770|NCT03776175|449682600|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
125015771|NCT03776175|449682601|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
125015772|NCT03776175|449682602|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
125015773|NCT03776175|449682603|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
125015774|NCT03776175|449682600|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
125015775|NCT03776175|449682601|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
125015776|NCT03776175|449682602|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
125015777|NCT03776175|449682603|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
125015778|NCT03776175|449682600|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
125015779|NCT03776175|449682601|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
125015780|NCT03776175|449682602|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
125015781|NCT03776175|449682603|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
125015782|NCT04677712|449682604|FG000|Overall Study|Lost to Follow-up|0|||
125015783|NCT04677712|449682605|FG001|Overall Study|Lost to Follow-up|1|||
125015784|NCT04677712|449682606|FG002|Overall Study|Lost to Follow-up|0|||
125015785|NCT04677712|449682607|FG003|Overall Study|Lost to Follow-up|0|||
125105322|NCT03747939|450008133|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
125015786|NCT04677712|449682608|FG004|Overall Study|Lost to Follow-up|0|||
125015787|NCT04677712|449682609|FG005|Overall Study|Lost to Follow-up|0|||
125015788|NCT00711100|449682610|FG000|Overall Study|Lack of Efficacy|5|||
125015789|NCT00711100|449682610|FG000|Overall Study|Withdrawal by Subject|8|||
125015790|NCT02513329|449682611|FG000|Overall Study|Lost to Follow-up|5|||
124888397|NCT00322374|449215488|FG002|First Escalation|Study Drug Toxicity|0|||
124888398|NCT00322374|449215489|FG003|First Escalation|Study Drug Toxicity|0|||
124888399|NCT00322374|449215486|FG000|First Escalation|Participant Request|0|||
124888400|NCT00322374|449215487|FG001|First Escalation|Participant Request|1|||
124888401|NCT00322374|449215488|FG002|First Escalation|Participant Request|0|||
124888402|NCT00322374|449215489|FG003|First Escalation|Participant Request|0|||
124888403|NCT00322374|449215486|FG000|Second Escalation|Physician Decision|0|||
124888404|NCT00322374|449215487|FG001|Second Escalation|Physician Decision|0|||
124888405|NCT00322374|449215488|FG002|Second Escalation|Physician Decision|5|||
124888406|NCT00322374|449215489|FG003|Second Escalation|Physician Decision|0|||
124888407|NCT00322374|449215486|FG000|Second Escalation|Study Drug Toxicity|0|||
124888408|NCT00322374|449215487|FG001|Second Escalation|Study Drug Toxicity|0|||
124888409|NCT00322374|449215488|FG002|Second Escalation|Study Drug Toxicity|1|||
124888410|NCT00322374|449215489|FG003|Second Escalation|Study Drug Toxicity|0|||
124888411|NCT02397460|449215492|FG000|Treatment Period 2|Adverse Event|0|||
125015791|NCT02513329|449682612|FG001|Overall Study|Lost to Follow-up|2|||
125015792|NCT01294670|449682613|FG000|Overall Study|Not treated|1|||
125015793|NCT01294670|449682614|FG001|Overall Study|Not treated|0|||
125015794|NCT01294670|449682615|FG002|Overall Study|Not treated|0|||
125015795|NCT01294670|449682616|FG003|Overall Study|Not treated|0|||
125015796|NCT01294670|449682617|FG004|Overall Study|Not treated|0|||
125015797|NCT02083380|449682620|FG000|Overall Study|Lack of Efficacy|68|||
125015798|NCT02083380|449682621|FG001|Overall Study|Lack of Efficacy|79|||
125015799|NCT02083380|449682622|FG002|Overall Study|Lack of Efficacy|64|||
125015800|NCT02083380|449682620|FG000|Overall Study|Withdrawal by Subject|9|||
125015801|NCT02083380|449682621|FG001|Overall Study|Withdrawal by Subject|3|||
125015802|NCT02083380|449682622|FG002|Overall Study|Withdrawal by Subject|7|||
125015803|NCT02083380|449682620|FG000|Overall Study|Physician Decision|1|||
125015804|NCT02083380|449682621|FG001|Overall Study|Physician Decision|6|||
125015805|NCT02083380|449682622|FG002|Overall Study|Physician Decision|3|||
125015806|NCT02083380|449682620|FG000|Overall Study|Adverse Event|0|||
125015807|NCT02083380|449682621|FG001|Overall Study|Adverse Event|0|||
125015808|NCT02083380|449682622|FG002|Overall Study|Adverse Event|1|||
125015809|NCT02083380|449682620|FG000|Overall Study|Lost to Follow-up|5|||
125015810|NCT02083380|449682621|FG001|Overall Study|Lost to Follow-up|3|||
125015811|NCT02083380|449682622|FG002|Overall Study|Lost to Follow-up|3|||
125015812|NCT02083380|449682620|FG000|Overall Study|Other|8|||
125015813|NCT02083380|449682621|FG001|Overall Study|Other|4|||
125015814|NCT02083380|449682622|FG002|Overall Study|Other|6|||
125015815|NCT02412787|449682623|FG000|Overall Study|Withdrawal by Subject|9|||
125015816|NCT02412787|449682623|FG000|Overall Study|Participation Terminated by Investigator|1|||
125015817|NCT02412787|449682623|FG000|Overall Study|Site Terminated by Sponsor|21|||
125015818|NCT02412787|449682623|FG000|Overall Study|Technical Problems|1|||
125015819|NCT02412787|449682623|FG000|Overall Study|Reason Not Specified|1|||
125015820|NCT01032915|449682627|FG000|Overall Study|Adverse Event|2|||
125015821|NCT01032915|449682628|FG001|Overall Study|Adverse Event|2|||
125015822|NCT01032915|449682629|FG002|Overall Study|Adverse Event|1|||
125015823|NCT01032915|449682630|FG003|Overall Study|Adverse Event|1|||
125015824|NCT01032915|449682627|FG000|Overall Study|Abnormal test procedure result|0|||
125105323|NCT03747939|450008134|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
125015825|NCT01032915|449682628|FG001|Overall Study|Abnormal test procedure result|0|||
125105324|NCT03747939|450008135|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
125105325|NCT03747939|450008136|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
125105326|NCT03747939|450008133|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
125105327|NCT03747939|450008134|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
125105328|NCT03747939|450008135|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
125105329|NCT03747939|450008136|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
125105330|NCT03747939|450008133|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
125105331|NCT03747939|450008134|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
125105332|NCT03747939|450008135|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
125105333|NCT03747939|450008136|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
125105334|NCT03747939|450008133|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
125105335|NCT03747939|450008134|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
125105336|NCT03747939|450008135|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
125105337|NCT03747939|450008136|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
125105338|NCT03747939|450008133|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
125105339|NCT03747939|450008134|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
125105340|NCT03747939|450008135|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
125105341|NCT03747939|450008136|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
125105342|NCT01215955|450008137|FG000|Overall Study|Adverse Event|1|||
125105343|NCT01215955|450008138|FG001|Overall Study|Adverse Event|4|||
125105344|NCT01215955|450008139|FG002|Overall Study|Adverse Event|2|||
125105345|NCT01215955|450008140|FG003|Overall Study|Adverse Event|3|||
125105346|NCT01215955|450008137|FG000|Overall Study|Death|2|||
125105347|NCT01215955|450008138|FG001|Overall Study|Death|0|||
125105348|NCT01215955|450008139|FG002|Overall Study|Death|1|||
125105349|NCT01215955|450008140|FG003|Overall Study|Death|3|||
125105350|NCT01215955|450008137|FG000|Overall Study|Entry Criteria Not Met|1|||
125105351|NCT01215955|450008138|FG001|Overall Study|Entry Criteria Not Met|3|||
125105352|NCT01215955|450008139|FG002|Overall Study|Entry Criteria Not Met|4|||
125105353|NCT01215955|450008140|FG003|Overall Study|Entry Criteria Not Met|7|||
125105354|NCT01215955|450008137|FG000|Overall Study|Lack of Efficacy|1|||
125105355|NCT01215955|450008138|FG001|Overall Study|Lack of Efficacy|2|||
125105356|NCT01215955|450008139|FG002|Overall Study|Lack of Efficacy|1|||
125105357|NCT01215955|450008140|FG003|Overall Study|Lack of Efficacy|0|||
125105358|NCT01215955|450008137|FG000|Overall Study|Lost to Follow-up|4|||
125105359|NCT01215955|450008138|FG001|Overall Study|Lost to Follow-up|4|||
125105360|NCT01215955|450008139|FG002|Overall Study|Lost to Follow-up|8|||
125105361|NCT01215955|450008140|FG003|Overall Study|Lost to Follow-up|9|||
125105362|NCT01215955|450008137|FG000|Overall Study|Physician Decision|4|||
125105363|NCT01215955|450008138|FG001|Overall Study|Physician Decision|10|||
125105364|NCT01215955|450008139|FG002|Overall Study|Physician Decision|8|||
125105365|NCT01215955|450008140|FG003|Overall Study|Physician Decision|11|||
125105366|NCT01215955|450008137|FG000|Overall Study|Protocol Violation|17|||
125105367|NCT01215955|450008138|FG001|Overall Study|Protocol Violation|13|||
125105368|NCT01215955|450008139|FG002|Overall Study|Protocol Violation|8|||
125105369|NCT01215955|450008140|FG003|Overall Study|Protocol Violation|8|||
125105370|NCT01215955|450008137|FG000|Overall Study|Sponsor Decision|1|||
125105371|NCT01215955|450008138|FG001|Overall Study|Sponsor Decision|2|||
125105372|NCT01215955|450008139|FG002|Overall Study|Sponsor Decision|0|||
125105373|NCT01215955|450008140|FG003|Overall Study|Sponsor Decision|1|||
125105374|NCT01215955|450008137|FG000|Overall Study|Withdrawal by Subject|14|||
125105375|NCT01215955|450008138|FG001|Overall Study|Withdrawal by Subject|15|||
125105376|NCT01215955|450008139|FG002|Overall Study|Withdrawal by Subject|13|||
125105377|NCT01215955|450008140|FG003|Overall Study|Withdrawal by Subject|9|||
125105378|NCT01215955|450008137|FG000|Overall Study|Quality Issues|0|||
125105379|NCT01215955|450008138|FG001|Overall Study|Quality Issues|0|||
125105380|NCT01215955|450008139|FG002|Overall Study|Quality Issues|3|||
125105381|NCT01215955|450008140|FG003|Overall Study|Quality Issues|2|||
125105382|NCT02494583|450008143|FG000|Overall Study|Death|224|||
125105383|NCT02494583|450008144|FG001|Overall Study|Death|214|||
125105384|NCT02494583|450008145|FG002|Overall Study|Death|225|||
125105385|NCT02494583|450008143|FG000|Overall Study|Lost to Follow-up|1|||
125105386|NCT02494583|450008144|FG001|Overall Study|Lost to Follow-up|0|||
125105387|NCT02494583|450008145|FG002|Overall Study|Lost to Follow-up|0|||
125105388|NCT02494583|450008143|FG000|Overall Study|Protocol Violation|1|||
125105389|NCT02494583|450008144|FG001|Overall Study|Protocol Violation|2|||
125105390|NCT02494583|450008145|FG002|Overall Study|Protocol Violation|0|||
125105391|NCT02494583|450008143|FG000|Overall Study|Screen Failure|0|||
125105392|NCT02494583|450008144|FG001|Overall Study|Screen Failure|1|||
125105393|NCT02494583|450008145|FG002|Overall Study|Screen Failure|0|||
125105394|NCT02494583|450008143|FG000|Overall Study|Transferred to Extension Study|15|||
125105395|NCT02494583|450008144|FG001|Overall Study|Transferred to Extension Study|15|||
125105396|NCT02494583|450008145|FG002|Overall Study|Transferred to Extension Study|6|||
125105397|NCT02494583|450008143|FG000|Overall Study|Did Not Continue on Extension Study|8|||
125105398|NCT02494583|450008144|FG001|Overall Study|Did Not Continue on Extension Study|10|||
125105399|NCT02494583|450008145|FG002|Overall Study|Did Not Continue on Extension Study|4|||
124888412|NCT02397460|449215493|FG001|Treatment Period 2|Adverse Event|0|||
124888413|NCT02397460|449215494|FG002|Treatment Period 2|Adverse Event|0|||
124888414|NCT02397460|449215495|FG003|Treatment Period 2|Adverse Event|0|||
124888415|NCT02397460|449215496|FG004|Treatment Period 2|Adverse Event|0|||
125105400|NCT02494583|450008143|FG000|Overall Study|Withdrawal by Subject|7|||
125105401|NCT02494583|450008144|FG001|Overall Study|Withdrawal by Subject|15|||
125105402|NCT02494583|450008145|FG002|Overall Study|Withdrawal by Subject|15|||
125105403|NCT02072174|450008146|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
125105404|NCT02072174|450008147|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
125105405|NCT02072174|450008146|FG000|Overall Study|Protocol Violation|16|||
125105406|NCT02072174|450008147|FG001|Overall Study|Protocol Violation|23|||
125105407|NCT02072174|450008146|FG000|Overall Study|Physician Decision|0|||
125105408|NCT02072174|450008147|FG001|Overall Study|Physician Decision|1|||
125105409|NCT02072174|450008146|FG000|Overall Study|Non-compliance with protocol requirement|2|||
125105410|NCT02072174|450008147|FG001|Overall Study|Non-compliance with protocol requirement|0|||
125105411|NCT02756078|450008150|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
125105412|NCT02756078|450008151|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
125105413|NCT02756078|450008150|FG000|Period 1|Lost to Follow-up|0|||
125105414|NCT02756078|450008151|FG001|Period 1|Lost to Follow-up|2|||
125105415|NCT02756078|450008150|FG000|Period 1|Protocol Violation|0|||
125105416|NCT02756078|450008151|FG001|Period 1|Protocol Violation|1|||
125105417|NCT02756078|450008150|FG000|Period 1|Adverse Event|1|||
125105418|NCT02756078|450008151|FG001|Period 1|Adverse Event|10|||
125105419|NCT02756078|450008150|FG000|Period 1|Withdrawal by Subject|6|||
125105420|NCT02756078|450008151|FG001|Period 1|Withdrawal by Subject|6|||
125105421|NCT02756078|450008150|FG000|Period 1|Lens Discomfort|2|||
125105422|NCT02756078|450008151|FG001|Period 1|Lens Discomfort|2|||
125105423|NCT02756078|450008150|FG000|Period 2|Adverse Event|3|||
125105424|NCT02756078|450008151|FG001|Period 2|Adverse Event|5|||
125105425|NCT02756078|450008150|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
125105426|NCT02756078|450008151|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
125105427|NCT02756078|450008150|FG000|Period 2|Withdrawal by Subject|3|||
125105428|NCT02756078|450008151|FG001|Period 2|Withdrawal by Subject|1|||
125105429|NCT05349188|450008152|FG000|Overall Study|Withdrawal by Subject|1|||
125105430|NCT05349188|450008153|FG001|Overall Study|Withdrawal by Subject|0|||
125105431|NCT00943384|450008154|FG000|Overall Study|Dispositioned prior to treatment|23|||
125105432|NCT00943384|450008154|FG000|Overall Study|Treated off protocol-protocol violation|5|||
125105433|NCT00943384|450008154|FG000|Overall Study|Lost to Follow-up|16|||
125105434|NCT00943384|450008154|FG000|Overall Study|Withdrawal by Subject|5|||
125105435|NCT00835068|450008155|FG000|Overall Study|Death|1|||
125105436|NCT00835068|450008156|FG001|Overall Study|Death|0|||
125105437|NCT00835068|450008155|FG000|Overall Study|Adverse Event|0|||
125105438|NCT00835068|450008156|FG001|Overall Study|Adverse Event|1|||
125105439|NCT00835068|450008155|FG000|Overall Study|Other|8|||
125105440|NCT00835068|450008156|FG001|Overall Study|Other|0|||
125105441|NCT00835068|450008155|FG000|Overall Study|Withdrawal by Subject|1|||
125105442|NCT00835068|450008156|FG001|Overall Study|Withdrawal by Subject|0|||
125105443|NCT02575807|450008157|FG000|Overall Study|Death|8|||
125105444|NCT02575807|450008158|FG001|Overall Study|Death|3|||
125105445|NCT02575807|450008159|FG002|Overall Study|Death|7|||
125105446|NCT02575807|450008160|FG003|Overall Study|Death|0|||
125105447|NCT02575807|450008161|FG004|Overall Study|Death|1|||
125105448|NCT02575807|450008157|FG000|Overall Study|Study terminated by Sponsor|0|||
125105449|NCT02575807|450008158|FG001|Overall Study|Study terminated by Sponsor|1|||
125105450|NCT02575807|450008159|FG002|Overall Study|Study terminated by Sponsor|7|||
125105451|NCT02575807|450008160|FG003|Overall Study|Study terminated by Sponsor|0|||
125105452|NCT02575807|450008161|FG004|Overall Study|Study terminated by Sponsor|1|||
125105453|NCT02575807|450008157|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
125105454|NCT02575807|450008158|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
125105455|NCT02575807|450008159|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
125105456|NCT02575807|450008160|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
125105457|NCT02575807|450008161|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
125105458|NCT02575807|450008157|FG000|Overall Study|Terminated due to physician decision|0|||
125105459|NCT02575807|450008158|FG001|Overall Study|Terminated due to physician decision|0|||
125105460|NCT02575807|450008159|FG002|Overall Study|Terminated due to physician decision|1|||
125105461|NCT02575807|450008160|FG003|Overall Study|Terminated due to physician decision|0|||
125105462|NCT02575807|450008161|FG004|Overall Study|Terminated due to physician decision|0|||
125105463|NCT02575807|450008157|FG000|Overall Study|Subject ineligible - medical implant|0|||
124888416|NCT02397460|449215497|FG005|Treatment Period 2|Adverse Event|0|||
125105464|NCT02575807|450008158|FG001|Overall Study|Subject ineligible - medical implant|0|||
124888417|NCT02397460|449215498|FG006|Treatment Period 2|Adverse Event|0|||
125105465|NCT02575807|450008159|FG002|Overall Study|Subject ineligible - medical implant|0|||
125105466|NCT02575807|450008160|FG003|Overall Study|Subject ineligible - medical implant|1|||
125105467|NCT02575807|450008161|FG004|Overall Study|Subject ineligible - medical implant|0|||
124888418|NCT02397460|449215499|FG007|Treatment Period 2|Adverse Event|1|||
124888419|NCT02397460|449215492|FG000|Treatment Period 4|Adverse Event|0|||
125105468|NCT02575807|450008157|FG000|Overall Study|Withdrawal by Subject|0|||
124888420|NCT02397460|449215493|FG001|Treatment Period 4|Adverse Event|1|||
125015826|NCT01032915|449682629|FG002|Overall Study|Abnormal test procedure result|1|||
125015827|NCT01032915|449682630|FG003|Overall Study|Abnormal test procedure result|0|||
125015828|NCT01032915|449682627|FG000|Overall Study|Withdrawal by Subject|0|||
125015829|NCT01032915|449682628|FG001|Overall Study|Withdrawal by Subject|3|||
125015830|NCT01032915|449682629|FG002|Overall Study|Withdrawal by Subject|1|||
125015831|NCT01032915|449682630|FG003|Overall Study|Withdrawal by Subject|1|||
125015832|NCT01032915|449682627|FG000|Overall Study|Administrative reasons|5|||
125015833|NCT01032915|449682628|FG001|Overall Study|Administrative reasons|6|||
125015834|NCT01032915|449682629|FG002|Overall Study|Administrative reasons|4|||
124888421|NCT02397460|449215494|FG002|Treatment Period 4|Adverse Event|0|||
124888422|NCT02397460|449215495|FG003|Treatment Period 4|Adverse Event|0|||
124888423|NCT02397460|449215496|FG004|Treatment Period 4|Adverse Event|0|||
124888424|NCT02397460|449215497|FG005|Treatment Period 4|Adverse Event|0|||
124888425|NCT02397460|449215498|FG006|Treatment Period 4|Adverse Event|0|||
124888426|NCT02397460|449215499|FG007|Treatment Period 4|Adverse Event|0|||
124888427|NCT02397460|449215492|FG000|Treatment Period 4|Physician Decision|0|||
124888428|NCT02397460|449215493|FG001|Treatment Period 4|Physician Decision|0|||
124888429|NCT02397460|449215494|FG002|Treatment Period 4|Physician Decision|0|||
124888430|NCT02397460|449215495|FG003|Treatment Period 4|Physician Decision|0|||
124888431|NCT02397460|449215496|FG004|Treatment Period 4|Physician Decision|1|||
124888432|NCT02397460|449215497|FG005|Treatment Period 4|Physician Decision|0|||
124888433|NCT02397460|449215498|FG006|Treatment Period 4|Physician Decision|0|||
124888434|NCT02397460|449215499|FG007|Treatment Period 4|Physician Decision|0|||
124888435|NCT02213055|449215500|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
125015835|NCT01032915|449682630|FG003|Overall Study|Administrative reasons|4|||
125015836|NCT01032915|449682627|FG000|Overall Study|Protocol Violation|1|||
125015837|NCT01032915|449682628|FG001|Overall Study|Protocol Violation|0|||
125015838|NCT01032915|449682629|FG002|Overall Study|Protocol Violation|0|||
125015839|NCT01032915|449682630|FG003|Overall Study|Protocol Violation|1|||
125015840|NCT02915523|449682631|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
125015841|NCT02915523|449682632|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
125015842|NCT02915523|449682633|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
125015843|NCT02915523|449682634|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
125015844|NCT02915523|449682631|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
125015845|NCT02915523|449682632|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
125015846|NCT02915523|449682633|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
125015847|NCT02915523|449682634|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
125015848|NCT02915523|449682631|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
125015849|NCT02915523|449682632|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
125015850|NCT02915523|449682633|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
125015851|NCT02915523|449682634|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
125015852|NCT02915523|449682631|FG000|Expansion Phase (Phase 2)|Death|0|||
125015853|NCT02915523|449682632|FG001|Expansion Phase (Phase 2)|Death|0|||
125015854|NCT02915523|449682633|FG002|Expansion Phase (Phase 2)|Death|26|||
125015855|NCT02915523|449682634|FG003|Expansion Phase (Phase 2)|Death|53|||
125015856|NCT02915523|449682631|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
125015857|NCT02915523|449682632|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
125015858|NCT02915523|449682633|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
125015859|NCT02915523|449682634|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
125015860|NCT02915523|449682631|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
125015861|NCT02915523|449682632|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
125015862|NCT02915523|449682633|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
125015863|NCT02915523|449682634|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
125015864|NCT02915523|449682631|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
125015865|NCT02915523|449682632|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
125015866|NCT02915523|449682633|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
125015867|NCT02915523|449682634|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
125015868|NCT00930761|449682635|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
125015869|NCT00930761|449682636|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
125015870|NCT00930761|449682635|FG000|Overall Study|less than 3 music therapy sessions|0|||
125015871|NCT00930761|449682636|FG001|Overall Study|less than 3 music therapy sessions|3|||
125015872|NCT00915681|449682637|FG000|Overall Study|Screening failures|46|||
125015873|NCT01118351|449682638|FG000|Overall Study|Adverse Event|3|||
125015874|NCT01118351|449682638|FG000|Overall Study|Withdrawal by Subject|1|||
124888436|NCT02213055|449215501|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
124888437|NCT02213055|449215500|FG000|Overall Study|Protocol was not Followed during Study|1|||
124888438|NCT02213055|449215501|FG001|Overall Study|Protocol was not Followed during Study|0|||
124888439|NCT02213055|449215500|FG000|Overall Study|Documentation Issue at Enrollment|1|||
124888440|NCT02213055|449215501|FG001|Overall Study|Documentation Issue at Enrollment|0|||
124888441|NCT02213055|449215500|FG000|Overall Study|Documentation Issue during Study|10|||
124888442|NCT02213055|449215501|FG001|Overall Study|Documentation Issue during Study|0|||
125015875|NCT00811135|449682639|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
125015876|NCT00811135|449682639|FG000|Overall Study|Death|3|||
125015877|NCT00811135|449682639|FG000|Overall Study|Protocol Violation|2|||
125015878|NCT00811135|449682639|FG000|Overall Study|Violation of Selection Criteria|1|||
125015879|NCT00811135|449682639|FG000|Overall Study|Refused Treatment|1|||
125015880|NCT00811135|449682639|FG000|Overall Study|Withdrawal by Subject|3|||
125015881|NCT00811135|449682639|FG000|Overall Study|Administrative/Other Unspecified|11|||
125015882|NCT00811135|449682639|FG000|Overall Study|Ongoing|59|||
125015883|NCT04677959|449682642|FG000|Overall Study|Adverse Event|1|||
125015884|NCT04677959|449682643|FG001|Overall Study|Adverse Event|9|||
125015885|NCT04677959|449682642|FG000|Overall Study|Withdrawal by Subject|2|||
125015886|NCT04677959|449682643|FG001|Overall Study|Withdrawal by Subject|15|||
125015887|NCT04677959|449682642|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125015888|NCT04677959|449682643|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125015889|NCT04677959|449682642|FG000|Overall Study|Non-compliance with study drug|0|||
125015890|NCT04677959|449682643|FG001|Overall Study|Non-compliance with study drug|2|||
125015891|NCT04677959|449682642|FG000|Overall Study|Protocol deviation|0|||
125015892|NCT04677959|449682643|FG001|Overall Study|Protocol deviation|11|||
125015893|NCT04677959|449682642|FG000|Overall Study|Lost to Follow-up|9|||
125015894|NCT04677959|449682643|FG001|Overall Study|Lost to Follow-up|13|||
125015895|NCT04677959|449682642|FG000|Overall Study|Other than specified|0|||
125015896|NCT04677959|449682643|FG001|Overall Study|Other than specified|8|||
125015897|NCT01970995|449682644|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
125015898|NCT01970995|449682645|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
125015899|NCT01970995|449682646|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
125015900|NCT01970995|449682644|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
125015901|NCT01970995|449682645|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
125015902|NCT01970995|449682646|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
125015903|NCT00845728|449682647|FG000|Overall Study|Abnormal laboratory value (s)|2|||
125015904|NCT00845728|449682648|FG001|Overall Study|Abnormal laboratory value (s)|2|||
125015905|NCT00845728|449682647|FG000|Overall Study|Patient's inability to use the device|4|||
125015906|NCT00845728|449682648|FG001|Overall Study|Patient's inability to use the device|6|||
125015907|NCT00845728|449682647|FG000|Overall Study|Abnormal test procedure result (s)|7|||
125015908|NCT00845728|449682648|FG001|Overall Study|Abnormal test procedure result (s)|2|||
125015909|NCT00845728|449682647|FG000|Overall Study|Lost to Follow-up|22|||
125015910|NCT00845728|449682648|FG001|Overall Study|Lost to Follow-up|13|||
125015911|NCT00845728|449682647|FG000|Overall Study|Death|24|||
125015912|NCT00845728|449682648|FG001|Overall Study|Death|26|||
125015913|NCT00845728|449682647|FG000|Overall Study|Administrative Problems|34|||
125015914|NCT00845728|449682648|FG001|Overall Study|Administrative Problems|26|||
125015915|NCT00845728|449682647|FG000|Overall Study|Protocol Violation|36|||
125015916|NCT00845728|449682648|FG001|Overall Study|Protocol Violation|24|||
125015917|NCT00845728|449682647|FG000|Overall Study|Lack of Efficacy|51|||
125015918|NCT00845728|449682648|FG001|Overall Study|Lack of Efficacy|39|||
125015919|NCT00845728|449682647|FG000|Overall Study|Adverse Event|101|||
125015920|NCT00845728|449682648|FG001|Overall Study|Adverse Event|96|||
125015921|NCT00845728|449682647|FG000|Overall Study|Withdrawal by Subject|105|||
125015922|NCT00845728|449682648|FG001|Overall Study|Withdrawal by Subject|108|||
125105469|NCT02575807|450008158|FG001|Overall Study|Withdrawal by Subject|0|||
125105470|NCT02575807|450008159|FG002|Overall Study|Withdrawal by Subject|1|||
124888443|NCT02213055|449215500|FG000|Overall Study|Did not have Live Lice|8|||
124888444|NCT02213055|449215501|FG001|Overall Study|Did not have Live Lice|0|||
124888445|NCT02213055|449215500|FG000|Overall Study|Had another Treatment during the Study|3|||
124888446|NCT02213055|449215501|FG001|Overall Study|Had another Treatment during the Study|0|||
124888447|NCT02213055|449215500|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
124888448|NCT02213055|449215501|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
124888449|NCT02213055|449215500|FG000|Overall Study|Did not Return to School|5|||
124888450|NCT02213055|449215501|FG001|Overall Study|Did not Return to School|0|||
124888451|NCT01024751|449215502|FG000|Enrolled Participants|Ineligible at baseline|3|||
124888452|NCT01024751|449215503|FG001|Enrolled Participants|Ineligible at baseline|4|||
124888453|NCT01024751|449215502|FG000|Eligible Participants|Withdrawal by Subject|0|||
124888454|NCT01024751|449215503|FG001|Eligible Participants|Withdrawal by Subject|1|||
124888455|NCT01024751|449215502|FG000|Eligible Participants|Lost to Follow-up|0|||
124888456|NCT01024751|449215503|FG001|Eligible Participants|Lost to Follow-up|1|||
124888457|NCT01024751|449215502|FG000|Eligible Participants|Ineligible|0|||
124888458|NCT01024751|449215503|FG001|Eligible Participants|Ineligible|1|||
124888459|NCT01141660|449215504|FG000|Overall Study|Physician Decision|0|||
124888460|NCT01141660|449215505|FG001|Overall Study|Physician Decision|12|||
124888461|NCT01848834|449215506|FG000|Overall Study|Adverse Event|3|||
124888462|NCT01848834|449215507|FG001|Overall Study|Adverse Event|11|||
124888463|NCT01848834|449215508|FG002|Overall Study|Adverse Event|3|||
124888464|NCT01848834|449215509|FG003|Overall Study|Adverse Event|5|||
124888465|NCT01848834|449215510|FG004|Overall Study|Adverse Event|9|||
124888466|NCT01848834|449215506|FG000|Overall Study|Death|2|||
124888467|NCT01848834|449215507|FG001|Overall Study|Death|11|||
124888468|NCT01848834|449215508|FG002|Overall Study|Death|1|||
124888469|NCT01848834|449215509|FG003|Overall Study|Death|8|||
124888470|NCT01848834|449215510|FG004|Overall Study|Death|27|||
124888471|NCT01848834|449215506|FG000|Overall Study|Excluded Medication|5|||
124888472|NCT01848834|449215507|FG001|Overall Study|Excluded Medication|4|||
124888473|NCT01848834|449215508|FG002|Overall Study|Excluded Medication|3|||
124888474|NCT01848834|449215509|FG003|Overall Study|Excluded Medication|6|||
125015923|NCT02599961|449682652|FG000|Overall Study|Withdrawal by Subject|1|||
125015924|NCT02599961|449682652|FG000|Overall Study|Subject Non-Compliance|2|||
125015925|NCT02599961|449682652|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
124888475|NCT01848834|449215510|FG004|Overall Study|Excluded Medication|6|||
124888476|NCT01848834|449215506|FG000|Overall Study|Lost to Follow-up|5|||
125015926|NCT02599961|449682652|FG000|Overall Study|Other, Not Specified|3|||
125015927|NCT00464334|449682653|FG000|Overall Study|Adverse Event|0|||
125015928|NCT00464334|449682654|FG001|Overall Study|Adverse Event|0|||
125015929|NCT00464334|449682655|FG002|Overall Study|Adverse Event|0|||
125015930|NCT00464334|449682656|FG003|Overall Study|Adverse Event|1|||
125015931|NCT00464334|449682657|FG004|Overall Study|Adverse Event|1|||
125015932|NCT00464334|449682658|FG005|Overall Study|Adverse Event|1|||
125015933|NCT00464334|449682659|FG006|Overall Study|Adverse Event|0|||
125015934|NCT00464334|449682660|FG007|Overall Study|Adverse Event|0|||
125015935|NCT00464334|449682661|FG008|Overall Study|Adverse Event|2|||
125015936|NCT00464334|449682662|FG009|Overall Study|Adverse Event|1|||
125015937|NCT00464334|449682663|FG010|Overall Study|Adverse Event|2|||
125015938|NCT00464334|449682653|FG000|Overall Study|Lack of Efficacy|0|||
125015939|NCT00464334|449682654|FG001|Overall Study|Lack of Efficacy|1|||
125015940|NCT00464334|449682655|FG002|Overall Study|Lack of Efficacy|0|||
125015941|NCT00464334|449682656|FG003|Overall Study|Lack of Efficacy|0|||
125015942|NCT00464334|449682657|FG004|Overall Study|Lack of Efficacy|0|||
124888477|NCT01848834|449215507|FG001|Overall Study|Lost to Follow-up|5|||
124888478|NCT01848834|449215508|FG002|Overall Study|Lost to Follow-up|3|||
124888479|NCT01848834|449215509|FG003|Overall Study|Lost to Follow-up|0|||
124888480|NCT01848834|449215510|FG004|Overall Study|Lost to Follow-up|3|||
124888481|NCT01848834|449215506|FG000|Overall Study|Physician Decision|1|||
124888482|NCT01848834|449215507|FG001|Overall Study|Physician Decision|3|||
124888483|NCT01848834|449215508|FG002|Overall Study|Physician Decision|4|||
124888484|NCT01848834|449215509|FG003|Overall Study|Physician Decision|0|||
125015943|NCT00464334|449682658|FG005|Overall Study|Lack of Efficacy|0|||
125015944|NCT00464334|449682659|FG006|Overall Study|Lack of Efficacy|0|||
125015945|NCT00464334|449682660|FG007|Overall Study|Lack of Efficacy|0|||
124888485|NCT01848834|449215510|FG004|Overall Study|Physician Decision|11|||
125015946|NCT00464334|449682661|FG008|Overall Study|Lack of Efficacy|0|||
124888486|NCT01848834|449215506|FG000|Overall Study|Protocol Violation|0|||
124888487|NCT01848834|449215507|FG001|Overall Study|Protocol Violation|0|||
124888488|NCT01848834|449215508|FG002|Overall Study|Protocol Violation|0|||
124888489|NCT01848834|449215509|FG003|Overall Study|Protocol Violation|0|||
124888490|NCT01848834|449215510|FG004|Overall Study|Protocol Violation|1|||
125105471|NCT02575807|450008160|FG003|Overall Study|Withdrawal by Subject|1|||
125105472|NCT02575807|450008161|FG004|Overall Study|Withdrawal by Subject|2|||
125105473|NCT02180659|450008162|FG000|Overall Study|Adverse Event|1|||
125105474|NCT02180659|450008163|FG001|Overall Study|Adverse Event|0|||
125105475|NCT02180659|450008162|FG000|Overall Study|Lost to Follow-up|4|||
125105476|NCT02180659|450008163|FG001|Overall Study|Lost to Follow-up|2|||
125105477|NCT02180659|450008162|FG000|Overall Study|Subject incarcerated during conduct|1|||
125105478|NCT02180659|450008163|FG001|Overall Study|Subject incarcerated during conduct|0|||
125105479|NCT02180659|450008162|FG000|Overall Study|Withdrawal by Subject|0|||
125105480|NCT02180659|450008163|FG001|Overall Study|Withdrawal by Subject|2|||
125105481|NCT02180659|450008162|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
125105482|NCT02180659|450008163|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
125105483|NCT00481871|450008166|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
125105484|NCT00481871|450008167|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
125105485|NCT00481871|450008168|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
125105486|NCT00481871|450008169|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
125105487|NCT00481871|450008170|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
125105488|NCT03332212|450008171|FG000|Overall Study|Not treated|0|||
125105489|NCT03332212|450008172|FG001|Overall Study|Not treated|1|||
125105490|NCT03332212|450008173|FG002|Overall Study|Not treated|0|||
125105491|NCT03332212|450008174|FG003|Overall Study|Not treated|0|||
125105492|NCT03332212|450008171|FG000|Overall Study|Adverse Event|0|||
125105493|NCT03332212|450008172|FG001|Overall Study|Adverse Event|0|||
125105494|NCT03332212|450008173|FG002|Overall Study|Adverse Event|0|||
125105495|NCT03332212|450008174|FG003|Overall Study|Adverse Event|1|||
125105496|NCT03332212|450008171|FG000|Overall Study|worsening of disease under study|1|||
125105497|NCT03332212|450008172|FG001|Overall Study|worsening of disease under study|1|||
125105498|NCT03332212|450008173|FG002|Overall Study|worsening of disease under study|0|||
125105499|NCT03332212|450008174|FG003|Overall Study|worsening of disease under study|0|||
125105500|NCT02058368|450008179|FG000|Overall Study|Adverse Event|15|||
125105501|NCT02058368|450008180|FG001|Overall Study|Adverse Event|20|||
125105502|NCT02058368|450008179|FG000|Overall Study|Lack of Efficacy|0|||
125105503|NCT02058368|450008180|FG001|Overall Study|Lack of Efficacy|1|||
125105504|NCT02058368|450008179|FG000|Overall Study|Protocol Violation|0|||
125105505|NCT02058368|450008180|FG001|Overall Study|Protocol Violation|4|||
125105506|NCT02058368|450008179|FG000|Overall Study|Lost to Follow-up|2|||
125105507|NCT02058368|450008180|FG001|Overall Study|Lost to Follow-up|0|||
125105508|NCT02058368|450008179|FG000|Overall Study|Physician Decision|2|||
125105509|NCT02058368|450008180|FG001|Overall Study|Physician Decision|3|||
125105510|NCT02058368|450008179|FG000|Overall Study|Withdrawal by Subject|22|||
124888491|NCT01848834|449215506|FG000|Overall Study|Sponsor Decision|1|||
125105511|NCT02058368|450008180|FG001|Overall Study|Withdrawal by Subject|26|||
125105512|NCT01652872|450008183|FG000|Overall Study|Death|36|||
125105513|NCT01652872|450008184|FG001|Overall Study|Death|39|||
125105514|NCT01652872|450008183|FG000|Overall Study|Lost to Follow-up|28|||
125105515|NCT01652872|450008184|FG001|Overall Study|Lost to Follow-up|23|||
125105516|NCT01652872|450008183|FG000|Overall Study|Decision by sponsor|5|||
125105517|NCT01652872|450008184|FG001|Overall Study|Decision by sponsor|7|||
125105518|NCT01652872|450008183|FG000|Overall Study|Withdrawal by Subject|76|||
125105519|NCT01652872|450008184|FG001|Overall Study|Withdrawal by Subject|84|||
125105520|NCT04529096|450008187|FG000|Overall Study|Adverse Event|6|||
125105521|NCT04529096|450008188|FG001|Overall Study|Adverse Event|1|||
125105522|NCT04529096|450008187|FG000|Overall Study|Lack of Efficacy|1|||
125105523|NCT04529096|450008188|FG001|Overall Study|Lack of Efficacy|0|||
125105524|NCT04529096|450008187|FG000|Overall Study|Lost to Follow-up|1|||
125105525|NCT04529096|450008188|FG001|Overall Study|Lost to Follow-up|1|||
125105526|NCT04529096|450008187|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125105527|NCT04529096|450008188|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125105528|NCT04529096|450008187|FG000|Overall Study|Physician Decision|1|||
125105529|NCT04529096|450008188|FG001|Overall Study|Physician Decision|3|||
125105530|NCT04529096|450008187|FG000|Overall Study|Withdrawal by Subject|5|||
125105531|NCT04529096|450008188|FG001|Overall Study|Withdrawal by Subject|0|||
125105532|NCT01216319|450008189|FG000|Overall Study|Lost to Follow-up|2|||
125105533|NCT01216319|450008189|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
125105534|NCT00390572|450008193|FG000|Overall Study|Lost to Follow-up|8|||
125105535|NCT00390572|450008194|FG001|Overall Study|Lost to Follow-up|4|||
125105536|NCT00390572|450008193|FG000|Overall Study|health condition|0|||
125105537|NCT00390572|450008194|FG001|Overall Study|health condition|1|||
125105538|NCT02392559|450008195|FG000|Overall Study|Withdrawal by Subject|0|||
125105539|NCT02392559|450008196|FG001|Overall Study|Withdrawal by Subject|1|||
125105540|NCT01966107|450008197|FG000|Overall Study|excluded from FAS|21|||
125105541|NCT01966107|450008198|FG001|Overall Study|excluded from FAS|20|||
125105542|NCT01966107|450008197|FG000|Overall Study|discontinued treatment|345|||
125105543|NCT01966107|450008198|FG001|Overall Study|discontinued treatment|372|||
125105544|NCT01966107|450008197|FG000|Overall Study|due to study closure|164|||
125105545|NCT01966107|450008198|FG001|Overall Study|due to study closure|186|||
125105546|NCT01966107|450008197|FG000|Overall Study|withdrew from the study|272|||
125105547|NCT01966107|450008198|FG001|Overall Study|withdrew from the study|303|||
125105548|NCT00532779|450008199|FG000|Overall Study|Adverse Event|122|||
125105549|NCT00532779|450008200|FG001|Overall Study|Adverse Event|112|||
125105550|NCT00532779|450008201|FG002|Overall Study|Adverse Event|56|||
125105551|NCT00532779|450008199|FG000|Overall Study|Lost to Follow-up|76|||
125105552|NCT00532779|450008200|FG001|Overall Study|Lost to Follow-up|65|||
125105553|NCT00532779|450008201|FG002|Overall Study|Lost to Follow-up|66|||
125105554|NCT00532779|450008199|FG000|Overall Study|Withdrawal by Subject|63|||
125105555|NCT00532779|450008200|FG001|Overall Study|Withdrawal by Subject|60|||
125105556|NCT00532779|450008201|FG002|Overall Study|Withdrawal by Subject|90|||
125105557|NCT00532779|450008199|FG000|Overall Study|Lack of Efficacy|12|||
124888492|NCT01848834|449215507|FG001|Overall Study|Sponsor Decision|1|||
124888493|NCT01848834|449215508|FG002|Overall Study|Sponsor Decision|0|||
124888494|NCT01848834|449215509|FG003|Overall Study|Sponsor Decision|1|||
124888495|NCT01848834|449215510|FG004|Overall Study|Sponsor Decision|1|||
124888496|NCT01848834|449215506|FG000|Overall Study|Withdrawal by Subject|2|||
125105558|NCT00532779|450008200|FG001|Overall Study|Lack of Efficacy|12|||
125105559|NCT00532779|450008201|FG002|Overall Study|Lack of Efficacy|40|||
125105560|NCT00532779|450008199|FG000|Overall Study|Protocol Violation|5|||
125105561|NCT00532779|450008200|FG001|Overall Study|Protocol Violation|9|||
125105562|NCT00532779|450008201|FG002|Overall Study|Protocol Violation|7|||
125105563|NCT00532779|450008199|FG000|Overall Study|Pregnancy|2|||
125105564|NCT00532779|450008200|FG001|Overall Study|Pregnancy|5|||
125105565|NCT00532779|450008201|FG002|Overall Study|Pregnancy|3|||
125105566|NCT00532779|450008199|FG000|Overall Study|Death|0|||
125105567|NCT00532779|450008200|FG001|Overall Study|Death|1|||
125105568|NCT00532779|450008201|FG002|Overall Study|Death|0|||
125105569|NCT00532779|450008199|FG000|Overall Study|Drug noncompliance, moved, other|14|||
125105570|NCT00532779|450008200|FG001|Overall Study|Drug noncompliance, moved, other|23|||
125105571|NCT00532779|450008201|FG002|Overall Study|Drug noncompliance, moved, other|29|||
124888497|NCT01848834|449215507|FG001|Overall Study|Withdrawal by Subject|13|||
125105572|NCT00689273|450008202|FG000|Overall Study|Adverse Event|3|||
125105573|NCT00689273|450008203|FG001|Overall Study|Adverse Event|1|||
125105574|NCT00689273|450008202|FG000|Overall Study|Lack of Efficacy|3|||
124888498|NCT01848834|449215508|FG002|Overall Study|Withdrawal by Subject|10|||
125105575|NCT00689273|450008203|FG001|Overall Study|Lack of Efficacy|0|||
124888499|NCT01848834|449215509|FG003|Overall Study|Withdrawal by Subject|6|||
125105576|NCT00689273|450008202|FG000|Overall Study|Lost to Follow-up|0|||
125105577|NCT00689273|450008203|FG001|Overall Study|Lost to Follow-up|2|||
124888500|NCT01848834|449215510|FG004|Overall Study|Withdrawal by Subject|36|||
124888501|NCT02040090|449215513|FG000|Overall Study|Adverse Event|2|||
124888502|NCT02040090|449215514|FG001|Overall Study|Adverse Event|0|||
125015947|NCT00464334|449682662|FG009|Overall Study|Lack of Efficacy|0|||
125015948|NCT00464334|449682663|FG010|Overall Study|Lack of Efficacy|0|||
125015949|NCT00464334|449682653|FG000|Overall Study|Lost to Follow-up|0|||
125015950|NCT00464334|449682654|FG001|Overall Study|Lost to Follow-up|0|||
125015951|NCT00464334|449682655|FG002|Overall Study|Lost to Follow-up|1|||
125015952|NCT00464334|449682656|FG003|Overall Study|Lost to Follow-up|0|||
125015953|NCT00464334|449682657|FG004|Overall Study|Lost to Follow-up|1|||
125015954|NCT00464334|449682658|FG005|Overall Study|Lost to Follow-up|0|||
125015955|NCT00464334|449682659|FG006|Overall Study|Lost to Follow-up|1|||
125015956|NCT00464334|449682660|FG007|Overall Study|Lost to Follow-up|0|||
125015957|NCT00464334|449682661|FG008|Overall Study|Lost to Follow-up|0|||
125015958|NCT00464334|449682662|FG009|Overall Study|Lost to Follow-up|0|||
125015959|NCT00464334|449682663|FG010|Overall Study|Lost to Follow-up|2|||
125015960|NCT00464334|449682653|FG000|Overall Study|Progressive Disease|0|||
125015961|NCT00464334|449682654|FG001|Overall Study|Progressive Disease|0|||
124888503|NCT02040090|449215513|FG000|Overall Study|Physician Decision|1|||
124888504|NCT02040090|449215514|FG001|Overall Study|Physician Decision|0|||
125015962|NCT00464334|449682655|FG002|Overall Study|Progressive Disease|0|||
125015963|NCT00464334|449682656|FG003|Overall Study|Progressive Disease|0|||
125015964|NCT00464334|449682657|FG004|Overall Study|Progressive Disease|0|||
125015965|NCT00464334|449682658|FG005|Overall Study|Progressive Disease|1|||
125015966|NCT00464334|449682659|FG006|Overall Study|Progressive Disease|0|||
125105578|NCT00689273|450008202|FG000|Overall Study|Other|6|||
125105579|NCT00689273|450008203|FG001|Overall Study|Other|2|||
125105580|NCT00689273|450008202|FG000|Overall Study|Randomized but not Treated|1|||
125105581|NCT00689273|450008203|FG001|Overall Study|Randomized but not Treated|0|||
125105582|NCT01238172|450008204|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
125105583|NCT01238172|450008205|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
125105584|NCT01238172|450008204|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
125105585|NCT01238172|450008205|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
125105586|NCT01556165|450008206|FG000|Overall Study|Adverse Event|5|||
125105587|NCT01556165|450008207|FG001|Overall Study|Adverse Event|3|||
125105588|NCT01556165|450008206|FG000|Overall Study|Protocol Violation|0|||
125105589|NCT01556165|450008207|FG001|Overall Study|Protocol Violation|3|||
125105590|NCT01556165|450008206|FG000|Overall Study|Withdrawal of Consent|7|||
125105591|NCT01556165|450008207|FG001|Overall Study|Withdrawal of Consent|1|||
125105592|NCT02531698|450008208|FG000|Overall Study|Adverse Event|2|||
125105593|NCT02531698|450008209|FG001|Overall Study|Adverse Event|1|||
125105594|NCT02531698|450008208|FG000|Overall Study|Withdrawal by Subject|6|||
125105595|NCT02531698|450008209|FG001|Overall Study|Withdrawal by Subject|1|||
125105596|NCT02531698|450008208|FG000|Overall Study|Protocol Violation|2|||
125105597|NCT02531698|450008209|FG001|Overall Study|Protocol Violation|0|||
125105598|NCT02531698|450008208|FG000|Overall Study|Lost to Follow-up|1|||
125105599|NCT02531698|450008209|FG001|Overall Study|Lost to Follow-up|0|||
125105600|NCT00701558|450008210|FG000|Overall Study|Death|7|||
125105601|NCT00701558|450008210|FG000|Overall Study|Lost to Follow-up|8|||
125105602|NCT01640964|450008211|FG000|Overall Study|Lost to Follow-up|0|||
125105603|NCT01640964|450008212|FG001|Overall Study|Lost to Follow-up|0|||
125105604|NCT01640964|450008213|FG002|Overall Study|Lost to Follow-up|1|||
125105605|NCT01640964|450008211|FG000|Overall Study|Protocol Deviation|1|||
125105606|NCT01640964|450008212|FG001|Overall Study|Protocol Deviation|1|||
125105607|NCT01640964|450008213|FG002|Overall Study|Protocol Deviation|2|||
125105608|NCT02787746|450008214|FG000|Overall Study|Adverse Event|42|||
125105609|NCT02787746|450008214|FG000|Overall Study|Withdrawal by Subject|65|||
125105610|NCT02787746|450008214|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
125105611|NCT04822701|450008217|FG000|Overall Study|Not treated|2|||
125105612|NCT04822701|450008218|FG001|Overall Study|Not treated|0|||
125105613|NCT04822701|450008217|FG000|Overall Study|Lost to Follow-up|1|||
125105614|NCT04822701|450008218|FG001|Overall Study|Lost to Follow-up|0|||
125105615|NCT04822701|450008217|FG000|Overall Study|Withdrawal by Subject|1|||
125015967|NCT00464334|449682660|FG007|Overall Study|Progressive Disease|0|||
125015968|NCT00464334|449682661|FG008|Overall Study|Progressive Disease|1|||
125015969|NCT00464334|449682662|FG009|Overall Study|Progressive Disease|0|||
125015970|NCT00464334|449682663|FG010|Overall Study|Progressive Disease|0|||
125015971|NCT00464334|449682653|FG000|Overall Study|Study Terminated by Sponsor|0|||
125015972|NCT00464334|449682654|FG001|Overall Study|Study Terminated by Sponsor|0|||
125015973|NCT00464334|449682655|FG002|Overall Study|Study Terminated by Sponsor|0|||
125015974|NCT00464334|449682656|FG003|Overall Study|Study Terminated by Sponsor|1|||
125015975|NCT00464334|449682657|FG004|Overall Study|Study Terminated by Sponsor|0|||
125015976|NCT00464334|449682658|FG005|Overall Study|Study Terminated by Sponsor|0|||
125015977|NCT00464334|449682659|FG006|Overall Study|Study Terminated by Sponsor|0|||
125015978|NCT00464334|449682660|FG007|Overall Study|Study Terminated by Sponsor|0|||
125015979|NCT00464334|449682661|FG008|Overall Study|Study Terminated by Sponsor|0|||
125015980|NCT00464334|449682662|FG009|Overall Study|Study Terminated by Sponsor|0|||
125015981|NCT00464334|449682663|FG010|Overall Study|Study Terminated by Sponsor|0|||
125015982|NCT00464334|449682653|FG000|Overall Study|Withdrawal by Subject|1|||
125015983|NCT00464334|449682654|FG001|Overall Study|Withdrawal by Subject|7|||
125015984|NCT00464334|449682655|FG002|Overall Study|Withdrawal by Subject|4|||
125015985|NCT00464334|449682656|FG003|Overall Study|Withdrawal by Subject|2|||
125015986|NCT00464334|449682657|FG004|Overall Study|Withdrawal by Subject|2|||
125015987|NCT00464334|449682658|FG005|Overall Study|Withdrawal by Subject|2|||
125015988|NCT00464334|449682659|FG006|Overall Study|Withdrawal by Subject|2|||
125015989|NCT00464334|449682660|FG007|Overall Study|Withdrawal by Subject|1|||
125015990|NCT00464334|449682661|FG008|Overall Study|Withdrawal by Subject|3|||
125015991|NCT00464334|449682662|FG009|Overall Study|Withdrawal by Subject|0|||
125015992|NCT00464334|449682663|FG010|Overall Study|Withdrawal by Subject|0|||
125105616|NCT04822701|450008218|FG001|Overall Study|Withdrawal by Subject|0|||
125105617|NCT02038959|450009892|FG000|Overall Study|Withdrawal by Subject|6|||
125105618|NCT02038959|450009893|FG001|Overall Study|Withdrawal by Subject|8|||
125105619|NCT01788163|450009901|FG000|Overall Study|Other|53|||
125105620|NCT01788163|450009902|FG001|Overall Study|Other|0|||
125105621|NCT01788163|450009903|FG002|Overall Study|Other|0|||
124888505|NCT02040090|449215513|FG000|Overall Study|Withdrawal by Subject|0|||
124888506|NCT02040090|449215514|FG001|Overall Study|Withdrawal by Subject|1|||
124888507|NCT02040090|449215513|FG000|Overall Study|Lost to Follow-up|0|||
124888508|NCT02040090|449215514|FG001|Overall Study|Lost to Follow-up|1|||
124888509|NCT04894903|449215515|FG000|Overall Study|Death|1|||
124888510|NCT04894903|449215516|FG001|Overall Study|Death|0|||
124888511|NCT04894903|449215515|FG000|Overall Study|Pregnancy|1|||
124888512|NCT04894903|449215516|FG001|Overall Study|Pregnancy|0|||
124888513|NCT04894903|449215515|FG000|Overall Study|Withdrawal by Subject|1|||
124888514|NCT04894903|449215516|FG001|Overall Study|Withdrawal by Subject|1|||
124888515|NCT04894903|449215515|FG000|Overall Study|moved or exited health system|1|||
124888516|NCT04894903|449215516|FG001|Overall Study|moved or exited health system|3|||
124888517|NCT00776100|449215524|FG000|Overall Study|Disease Progression|1|||
124888518|NCT00776100|449215525|FG001|Overall Study|Disease Progression|0|||
124888519|NCT03567993|449215528|FG000|Overall Study|Lost to Follow-up|4|||
124888520|NCT03567993|449215529|FG001|Overall Study|Lost to Follow-up|2|||
124888521|NCT03567993|449215528|FG000|Overall Study|Death|1|||
124888522|NCT03567993|449215529|FG001|Overall Study|Death|1|||
124888523|NCT03567993|449215528|FG000|Overall Study|Withdrawal by Subject|1|||
124888524|NCT03567993|449215529|FG001|Overall Study|Withdrawal by Subject|0|||
124888525|NCT04793464|449215530|FG000|Overall Study|Lost to Follow-up|458|||
124888526|NCT04793464|449215531|FG001|Overall Study|Lost to Follow-up|168|||
125015993|NCT01422915|449682672|FG000|Overall Study|Adverse Event|1|||
125015994|NCT01152021|449682674|FG000|Overall Study|Adverse Event|4|||
125015995|NCT01152021|449682675|FG001|Overall Study|Adverse Event|4|||
125015996|NCT01152021|449682674|FG000|Overall Study|Study drug had expired|1|||
125015997|NCT01152021|449682675|FG001|Overall Study|Study drug had expired|0|||
125015998|NCT01152021|449682674|FG000|Overall Study|Physician Decision|1|||
125015999|NCT01152021|449682675|FG001|Overall Study|Physician Decision|1|||
125016000|NCT01152021|449682674|FG000|Overall Study|No access to study drug in Pharmacy|0|||
125016001|NCT01152021|449682675|FG001|Overall Study|No access to study drug in Pharmacy|1|||
125016002|NCT00517829|449682676|FG000|Overall Study|Adverse Event|22|||
125016003|NCT00517829|449682677|FG001|Overall Study|Adverse Event|34|||
125016004|NCT00517829|449682676|FG000|Overall Study|Disease Progression|39|||
125016005|NCT00517829|449682677|FG001|Overall Study|Disease Progression|32|||
125016006|NCT00517829|449682676|FG000|Overall Study|Patient Request|6|||
125016007|NCT00517829|449682677|FG001|Overall Study|Patient Request|5|||
125016008|NCT00517829|449682676|FG000|Overall Study|Investigator Request|5|||
125016009|NCT00517829|449682677|FG001|Overall Study|Investigator Request|3|||
125016010|NCT00517829|449682676|FG000|Overall Study|Other|3|||
125016011|NCT00517829|449682677|FG001|Overall Study|Other|1|||
125016012|NCT00385255|449682678|FG000|Overall Study|Serious Adverse Event|1|||
125016013|NCT00385255|449682679|FG001|Overall Study|Serious Adverse Event|2|||
125016014|NCT00385255|449682678|FG000|Overall Study|Protocol Violation|0|||
125016015|NCT00385255|449682679|FG001|Overall Study|Protocol Violation|4|||
125016016|NCT00385255|449682678|FG000|Overall Study|Withdrawal by Subject|0|||
125016017|NCT00385255|449682679|FG001|Overall Study|Withdrawal by Subject|8|||
125016018|NCT00385255|449682678|FG000|Overall Study|Migrated/moved from study area|0|||
125016019|NCT00385255|449682679|FG001|Overall Study|Migrated/moved from study area|1|||
125016020|NCT00385255|449682678|FG000|Overall Study|Lost to Follow-up|20|||
125016021|NCT00385255|449682679|FG001|Overall Study|Lost to Follow-up|58|||
125016022|NCT02443883|449682680|FG000|Overall Study|Adverse Event|0|||
124888527|NCT04793464|449215532|FG002|Overall Study|Lost to Follow-up|5|||
124888528|NCT04793464|449215530|FG000|Overall Study|Withdrawal by Subject|43|||
124888529|NCT04793464|449215531|FG001|Overall Study|Withdrawal by Subject|15|||
124888530|NCT04793464|449215532|FG002|Overall Study|Withdrawal by Subject|0|||
124888531|NCT05221749|449215535|FG000|Overall Study|Lost to Follow-up|2|||
124888532|NCT05221749|449215536|FG001|Overall Study|Lost to Follow-up|3|||
124888533|NCT00519636|449215537|FG000|Treatment Period 1|Adverse Event|1|||
125016023|NCT02443883|449682681|FG001|Overall Study|Adverse Event|1|||
125105622|NCT01788163|450009904|FG003|Overall Study|Other|0|||
125105623|NCT01788163|450009905|FG004|Overall Study|Other|0|||
125105624|NCT01788163|450009906|FG005|Overall Study|Other|7|||
125105625|NCT01788163|450009907|FG006|Overall Study|Other|1|||
125105626|NCT01788163|450009908|FG007|Overall Study|Other|48|||
125105627|NCT01788163|450009909|FG008|Overall Study|Other|15|||
125105628|NCT01788163|450009901|FG000|Overall Study|Withdrawal by Subject|2|||
125105629|NCT01788163|450009902|FG001|Overall Study|Withdrawal by Subject|0|||
125105630|NCT01788163|450009903|FG002|Overall Study|Withdrawal by Subject|0|||
125105631|NCT01788163|450009904|FG003|Overall Study|Withdrawal by Subject|0|||
125105632|NCT01788163|450009905|FG004|Overall Study|Withdrawal by Subject|0|||
125105633|NCT01788163|450009906|FG005|Overall Study|Withdrawal by Subject|0|||
125105634|NCT01788163|450009907|FG006|Overall Study|Withdrawal by Subject|0|||
125105635|NCT01788163|450009908|FG007|Overall Study|Withdrawal by Subject|0|||
125105636|NCT01788163|450009909|FG008|Overall Study|Withdrawal by Subject|1|||
125105637|NCT00545441|450009910|FG000|Overall Study|Fistula draining at 6 months|2|||
125105638|NCT00545441|450009911|FG001|Overall Study|Fistula draining at 6 months|4|||
125105639|NCT00545441|450009910|FG000|Overall Study|Lost to Follow-up|9|||
125105640|NCT00545441|450009911|FG001|Overall Study|Lost to Follow-up|5|||
125105641|NCT00545441|450009910|FG000|Overall Study|Technical failure|0|||
125105642|NCT00545441|450009911|FG001|Overall Study|Technical failure|1|||
125105643|NCT00545441|450009910|FG000|Overall Study|Withdrawal by Subject|1|||
125105644|NCT00545441|450009911|FG001|Overall Study|Withdrawal by Subject|1|||
125105645|NCT00545441|450009910|FG000|Overall Study|Persistence or recurrence of fistula|5|||
125105646|NCT00545441|450009911|FG001|Overall Study|Persistence or recurrence of fistula|2|||
125105647|NCT00545441|450009910|FG000|Overall Study|Patients were not treated|1|||
125105648|NCT00545441|450009911|FG001|Overall Study|Patients were not treated|3|||
125105649|NCT00265239|450009912|FG000|Overall Study|Adverse Event|2|||
125105650|NCT00265239|450009913|FG001|Overall Study|Adverse Event|1|||
125105651|NCT02803138|450009918|FG000|Overall Study|Failure to return|38|||
125105652|NCT02803138|450009918|FG000|Overall Study|Insufficient virological response|2|||
125105653|NCT02803138|450009918|FG000|Overall Study|Withdrawn consent|1|||
125105654|NCT02803138|450009918|FG000|Overall Study|Death|1|||
125105655|NCT02803138|450009918|FG000|Overall Study|Other, not specified|28|||
125105656|NCT00424515|450009919|FG000|Overall Study|Progressive Disease|10|||
125105657|NCT00424515|450009920|FG001|Overall Study|Progressive Disease|11|||
125105658|NCT00424515|450009919|FG000|Overall Study|Adverse Event|0|||
125105659|NCT00424515|450009920|FG001|Overall Study|Adverse Event|1|||
125105660|NCT00424515|450009919|FG000|Overall Study|Intercurrent Illness|0|||
125105661|NCT00424515|450009920|FG001|Overall Study|Intercurrent Illness|1|||
125105662|NCT00424515|450009919|FG000|Overall Study|Withdrawal by Subject|1|||
125105663|NCT00424515|450009920|FG001|Overall Study|Withdrawal by Subject|0|||
125016024|NCT02443883|449682682|FG002|Overall Study|Adverse Event|0|||
125016025|NCT02443883|449682683|FG003|Overall Study|Adverse Event|0|||
125016026|NCT02443883|449682680|FG000|Overall Study|Lost to Follow-up|3|||
125016027|NCT02443883|449682681|FG001|Overall Study|Lost to Follow-up|2|||
125016028|NCT02443883|449682682|FG002|Overall Study|Lost to Follow-up|1|||
125016029|NCT02443883|449682683|FG003|Overall Study|Lost to Follow-up|0|||
125016030|NCT02443883|449682680|FG000|Overall Study|Physician Decision|1|||
125016031|NCT02443883|449682681|FG001|Overall Study|Physician Decision|1|||
125016032|NCT02443883|449682682|FG002|Overall Study|Physician Decision|0|||
125016033|NCT02443883|449682683|FG003|Overall Study|Physician Decision|3|||
125016034|NCT02443883|449682680|FG000|Overall Study|Withdrawal by Subject|1|||
125016035|NCT02443883|449682681|FG001|Overall Study|Withdrawal by Subject|0|||
125016036|NCT02443883|449682682|FG002|Overall Study|Withdrawal by Subject|0|||
125016037|NCT02443883|449682683|FG003|Overall Study|Withdrawal by Subject|2|||
125105664|NCT00267020|450009921|FG000|Overall Study|Adverse Event|22|||
124888534|NCT00519636|449215538|FG001|Treatment Period 1|Adverse Event|0|||
124888535|NCT00519636|449215539|FG002|Treatment Period 1|Adverse Event|1|||
124888536|NCT00519636|449215540|FG003|Treatment Period 1|Adverse Event|0|||
124888537|NCT00519636|449215537|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
124888538|NCT00519636|449215538|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
124888539|NCT00519636|449215539|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
124888540|NCT00519636|449215540|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
124888541|NCT00519636|449215537|FG000|Washout Period|Adverse Event|2|||
124888542|NCT00519636|449215538|FG001|Washout Period|Adverse Event|1|||
124888543|NCT00519636|449215539|FG002|Washout Period|Adverse Event|1|||
124888544|NCT00519636|449215540|FG003|Washout Period|Adverse Event|0|||
125016038|NCT02443883|449682680|FG000|Overall Study|Randomized, but never treated|1|||
125016039|NCT02443883|449682681|FG001|Overall Study|Randomized, but never treated|0|||
125016040|NCT02443883|449682682|FG002|Overall Study|Randomized, but never treated|0|||
125016041|NCT02443883|449682683|FG003|Overall Study|Randomized, but never treated|0|||
125016042|NCT00506883|449682695|FG000|Overall Study|Lost to Follow-up|1|||
125016043|NCT00506883|449682696|FG001|Overall Study|Lost to Follow-up|1|||
125016044|NCT00506883|449682697|FG002|Overall Study|Lost to Follow-up|1|||
125016045|NCT00506883|449682695|FG000|Overall Study|Withdrawal by Subject|1|||
125016046|NCT00506883|449682696|FG001|Overall Study|Withdrawal by Subject|0|||
125016047|NCT00506883|449682697|FG002|Overall Study|Withdrawal by Subject|1|||
125016048|NCT00506883|449682695|FG000|Overall Study|Lack of Efficacy|0|||
125016049|NCT00506883|449682696|FG001|Overall Study|Lack of Efficacy|1|||
125016050|NCT00506883|449682697|FG002|Overall Study|Lack of Efficacy|1|||
125016051|NCT00506883|449682695|FG000|Overall Study|Other|5|||
125016052|NCT00506883|449682696|FG001|Overall Study|Other|1|||
125016053|NCT00506883|449682697|FG002|Overall Study|Other|1|||
125016054|NCT01445951|449682698|FG000|Overall Study|Adverse Event|16|||
125016055|NCT01445951|449682699|FG001|Overall Study|Adverse Event|9|||
125016056|NCT01445951|449682700|FG002|Overall Study|Adverse Event|0|||
125016057|NCT01445951|449682698|FG000|Overall Study|Protocol Violation|2|||
125016058|NCT01445951|449682699|FG001|Overall Study|Protocol Violation|2|||
125016059|NCT01445951|449682700|FG002|Overall Study|Protocol Violation|2|||
125016060|NCT01445951|449682698|FG000|Overall Study|Withdrawal by Subject|21|||
125016061|NCT01445951|449682699|FG001|Overall Study|Withdrawal by Subject|16|||
125016062|NCT01445951|449682700|FG002|Overall Study|Withdrawal by Subject|8|||
125016063|NCT01445951|449682698|FG000|Overall Study|Physician Decision|3|||
124888545|NCT00519636|449215537|FG000|Washout Period|Lost to Follow-up|1|||
125016064|NCT01445951|449682699|FG001|Overall Study|Physician Decision|1|||
125016065|NCT01445951|449682700|FG002|Overall Study|Physician Decision|0|||
125016066|NCT01445951|449682698|FG000|Overall Study|Lost to Follow-up|1|||
125016067|NCT01445951|449682699|FG001|Overall Study|Lost to Follow-up|2|||
125016068|NCT01445951|449682700|FG002|Overall Study|Lost to Follow-up|4|||
125016069|NCT01445951|449682698|FG000|Overall Study|Pregnancy|0|||
125016070|NCT01445951|449682699|FG001|Overall Study|Pregnancy|1|||
125016071|NCT01445951|449682700|FG002|Overall Study|Pregnancy|4|||
125105665|NCT00267020|450009922|FG001|Overall Study|Adverse Event|5|||
125105666|NCT00267020|450009921|FG000|Overall Study|Death|2|||
125105667|NCT00267020|450009922|FG001|Overall Study|Death|1|||
125105668|NCT00267020|450009921|FG000|Overall Study|Withdrawal by Subject|17|||
125105669|NCT00267020|450009922|FG001|Overall Study|Withdrawal by Subject|7|||
125105670|NCT00267020|450009921|FG000|Overall Study|Physician Decision|3|||
125105671|NCT00267020|450009922|FG001|Overall Study|Physician Decision|2|||
125105672|NCT00267020|450009921|FG000|Overall Study|Disease Progression|39|||
125105673|NCT00267020|450009922|FG001|Overall Study|Disease Progression|25|||
125105674|NCT00267020|450009921|FG000|Overall Study|Unrelated Complication|1|||
125105675|NCT00267020|450009922|FG001|Overall Study|Unrelated Complication|1|||
125105676|NCT00267020|450009921|FG000|Overall Study|Sponsor Request|1|||
125105677|NCT00267020|450009922|FG001|Overall Study|Sponsor Request|0|||
125105678|NCT00267020|450009921|FG000|Overall Study|Other|1|||
125105679|NCT00267020|450009922|FG001|Overall Study|Other|2|||
125105680|NCT04071366|450009923|FG000|Part 1: Open-label (29 Days)|Death|4|||
125105681|NCT04071366|450009924|FG001|Part 1: Open-label (29 Days)|Death|2|||
125105682|NCT04071366|450009925|FG002|Part 1: Open-label (29 Days)|Death|8|||
125105683|NCT04071366|450009926|FG003|Part 1: Open-label (29 Days)|Death|0|||
125105684|NCT04071366|450009927|FG004|Part 1: Open-label (29 Days)|Death|0|||
125016072|NCT01445951|449682698|FG000|Overall Study|Death|0|||
125105685|NCT04071366|450009923|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
125105686|NCT04071366|450009924|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
125105687|NCT04071366|450009925|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
125105688|NCT04071366|450009926|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
125105689|NCT04071366|450009927|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
125105690|NCT04071366|450009923|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
125105691|NCT04071366|450009924|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
125105692|NCT04071366|450009925|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
125105693|NCT04071366|450009926|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
125105694|NCT04071366|450009927|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
125105695|NCT04071366|450009923|FG000|Part 2: Randomized (29 Days)|Death|0|||
125105696|NCT04071366|450009924|FG001|Part 2: Randomized (29 Days)|Death|0|||
125105697|NCT04071366|450009925|FG002|Part 2: Randomized (29 Days)|Death|0|||
125105698|NCT04071366|450009926|FG003|Part 2: Randomized (29 Days)|Death|2|||
125105699|NCT04071366|450009927|FG004|Part 2: Randomized (29 Days)|Death|2|||
125105700|NCT04071366|450009923|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
125016073|NCT01445951|449682699|FG001|Overall Study|Death|0|||
125016074|NCT01445951|449682700|FG002|Overall Study|Death|1|||
125016075|NCT01445951|449682698|FG000|Overall Study|Non-compliance with study drug|1|||
125016076|NCT01445951|449682699|FG001|Overall Study|Non-compliance with study drug|2|||
125016077|NCT01445951|449682700|FG002|Overall Study|Non-compliance with study drug|0|||
125016078|NCT01445951|449682698|FG000|Overall Study|Non-compliance with protocol|0|||
125016079|NCT01445951|449682699|FG001|Overall Study|Non-compliance with protocol|1|||
125016080|NCT01445951|449682700|FG002|Overall Study|Non-compliance with protocol|0|||
125016081|NCT01445951|449682698|FG000|Overall Study|Sponsor decision - subject travel|0|||
125016082|NCT01445951|449682699|FG001|Overall Study|Sponsor decision - subject travel|1|||
125016083|NCT01445951|449682700|FG002|Overall Study|Sponsor decision - subject travel|0|||
125016084|NCT01445951|449682698|FG000|Overall Study|Cough|0|||
125016085|NCT01445951|449682699|FG001|Overall Study|Cough|1|||
125016086|NCT01445951|449682700|FG002|Overall Study|Cough|0|||
125016087|NCT00254501|449682709|FG000|Overall Study|Lost to Follow-up|1|||
125016088|NCT00254501|449682710|FG001|Overall Study|Lost to Follow-up|1|||
125016089|NCT00923130|449682711|FG000|Overall Study|Stopped treatment due to progression|17|||
125016090|NCT00923130|449682711|FG000|Overall Study|Death|1|||
125016091|NCT00923130|449682711|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
125105701|NCT04071366|450009924|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
125105702|NCT04071366|450009925|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
125105703|NCT04071366|450009926|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
125105704|NCT04071366|450009927|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
125105705|NCT04071366|450009923|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
125105706|NCT04071366|450009924|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
125105707|NCT04071366|450009925|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
125105708|NCT04071366|450009926|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
125105709|NCT04071366|450009927|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
125105710|NCT04071366|450009923|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
125105711|NCT04071366|450009924|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
125105712|NCT04071366|450009925|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
125105713|NCT04071366|450009926|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
125105714|NCT04071366|450009927|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
125105715|NCT04071366|450009923|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
125105716|NCT04071366|450009924|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
125105717|NCT04071366|450009925|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
125105718|NCT04071366|450009926|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
125105719|NCT04071366|450009927|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
125105720|NCT04071366|450009923|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
125105721|NCT04071366|450009924|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
125105722|NCT04071366|450009925|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
125105723|NCT04071366|450009926|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
125105724|NCT04071366|450009927|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
125105725|NCT04071366|450009923|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
125105726|NCT04071366|450009924|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
125105727|NCT04071366|450009925|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
125105728|NCT04071366|450009926|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
125105729|NCT04071366|450009927|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
125105730|NCT00021229|450009928|FG000|Overall Study|Adverse Event|10|||
125105731|NCT00021229|450009929|FG001|Overall Study|Adverse Event|5|||
125105732|NCT00021229|450009930|FG002|Overall Study|Adverse Event|2|||
125105733|NCT00021229|450009928|FG000|Overall Study|Death|0|||
125105734|NCT00021229|450009929|FG001|Overall Study|Death|1|||
125105735|NCT00021229|450009930|FG002|Overall Study|Death|0|||
125105736|NCT00021229|450009928|FG000|Overall Study|Withdrawal by Subject|7|||
125105737|NCT00021229|450009929|FG001|Overall Study|Withdrawal by Subject|7|||
125105738|NCT00021229|450009930|FG002|Overall Study|Withdrawal by Subject|1|||
125105739|NCT00021229|450009928|FG000|Overall Study|Progressive Disease|15|||
125105740|NCT00021229|450009929|FG001|Overall Study|Progressive Disease|19|||
125105741|NCT00021229|450009930|FG002|Overall Study|Progressive Disease|12|||
125105742|NCT00021229|450009928|FG000|Overall Study|Protocol Violation|1|||
125105743|NCT00021229|450009929|FG001|Overall Study|Protocol Violation|1|||
125105744|NCT00021229|450009930|FG002|Overall Study|Protocol Violation|0|||
125105745|NCT00021229|450009928|FG000|Overall Study|Physician Decision|0|||
125105746|NCT00021229|450009929|FG001|Overall Study|Physician Decision|0|||
125105747|NCT00021229|450009930|FG002|Overall Study|Physician Decision|1|||
125105748|NCT00021229|450009928|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
125105749|NCT00021229|450009929|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
125105750|NCT00021229|450009930|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
125105751|NCT02237118|450009931|FG000|Overall Study|Protocol Violation|0|||
125105752|NCT02237118|450009932|FG001|Overall Study|Protocol Violation|1|||
125105753|NCT02237118|450009931|FG000|Overall Study|consent withdrawn|1|||
125105754|NCT02237118|450009932|FG001|Overall Study|consent withdrawn|0|||
125105755|NCT00399490|450009933|FG000|Overall Study|Adverse Event|19|||
125105756|NCT00399490|450009933|FG000|Overall Study|Lack of Efficacy|31|||
125105757|NCT00399490|450009933|FG000|Overall Study|Lost to Follow-up|5|||
125105758|NCT00399490|450009933|FG000|Overall Study|Withdrawal by Subject|18|||
125105759|NCT00399490|450009933|FG000|Overall Study|Other|25|||
125105760|NCT02499406|450009934|FG000|Overall Study|missed 3 treatment sessions|4|||
125105761|NCT00902265|450009935|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
125105762|NCT00902265|450009935|FG000|Overall Study|Adverse Event|2|||
125105763|NCT00902265|450009935|FG000|Overall Study|Lack of Efficacy|2|||
125105764|NCT00902265|450009935|FG000|Overall Study|Protocol Violation|1|||
125105765|NCT04701658|450009936|FG000|Overall Study|Lost to Follow-up|6|||
125105766|NCT02866695|450009939|FG000|Overall Study|Adverse Event|1|||
125105767|NCT02866695|450009939|FG000|Overall Study|Lost to Follow-up|1|||
125105768|NCT03224234|450009940|FG000|Main Study|Lost to Follow-up|5|||
125105769|NCT03224234|450009941|FG001|Main Study|Lost to Follow-up|5|||
125105770|NCT05016765|450009942|FG000|Overall Study|Lost to Follow-up|4|||
124888546|NCT00519636|449215538|FG001|Washout Period|Lost to Follow-up|0|||
124888547|NCT00519636|449215539|FG002|Washout Period|Lost to Follow-up|0|||
124888548|NCT00519636|449215540|FG003|Washout Period|Lost to Follow-up|0|||
125016092|NCT00923130|449682711|FG000|Overall Study|Switched to alternative treatment|2|||
125016093|NCT00923130|449682711|FG000|Overall Study|Refused further treatment|2|||
125016094|NCT00513409|449684253|FG000|Overall Study|Adverse Event|0|||
125016095|NCT00513409|449684254|FG001|Overall Study|Adverse Event|1|||
125016096|NCT00513409|449684253|FG000|Overall Study|Withdrawal by Subject|0|||
125016097|NCT00513409|449684254|FG001|Overall Study|Withdrawal by Subject|2|||
125016098|NCT00513409|449684253|FG000|Overall Study|Lost to Follow-up|0|||
125016099|NCT00513409|449684254|FG001|Overall Study|Lost to Follow-up|1|||
125016100|NCT00513409|449684253|FG000|Overall Study|Physician Decision|1|||
125016101|NCT00513409|449684254|FG001|Overall Study|Physician Decision|0|||
125016102|NCT00513409|449684253|FG000|Overall Study|Visit 3 not done|1|||
125016103|NCT00513409|449684254|FG001|Overall Study|Visit 3 not done|2|||
125016104|NCT03189446|449684255|FG000|Overall Study|Adverse Event|2|||
125016105|NCT03189446|449684255|FG000|Overall Study|Withdrawal by Subject|2|||
125016106|NCT03189446|449684255|FG000|Overall Study|Physician Decision|1|||
125016107|NCT05634577|449684256|FG000|Overall Study|Lost to Follow-up|1|||
125016108|NCT05634577|449684256|FG000|Overall Study|Withdrawal by Subject|1|||
125016109|NCT04839978|449684257|FG000|Overall Study|Lost to Follow-up|135|||
125016110|NCT04839978|449684258|FG001|Overall Study|Lost to Follow-up|147|||
125016111|NCT00781456|449684259|FG000|Overall Study|Adverse Event|3|||
125016112|NCT00781456|449684260|FG001|Overall Study|Adverse Event|3|||
125016113|NCT00781456|449684259|FG000|Overall Study|Withdrawal by Subject|3|||
125016114|NCT00781456|449684260|FG001|Overall Study|Withdrawal by Subject|5|||
125016115|NCT00781456|449684259|FG000|Overall Study|Protocol Violation|4|||
125016116|NCT00781456|449684260|FG001|Overall Study|Protocol Violation|1|||
125016117|NCT00781456|449684259|FG000|Overall Study|Noncompliance With Protocol|1|||
125016118|NCT00781456|449684260|FG001|Overall Study|Noncompliance With Protocol|1|||
125016119|NCT00781456|449684259|FG000|Overall Study|Lost to Follow-up|10|||
125016120|NCT00781456|449684260|FG001|Overall Study|Lost to Follow-up|5|||
125016121|NCT00781456|449684259|FG000|Overall Study|Other Reason, Unknown|0|||
125016122|NCT00781456|449684260|FG001|Overall Study|Other Reason, Unknown|1|||
125016123|NCT01902966|449684261|FG000|Overall Study|Death|1|||
125016124|NCT01902966|449684261|FG000|Overall Study|Physician Decision|1|||
125016125|NCT01902966|449684261|FG000|Overall Study|Withdrawal by Subject|1|||
125016126|NCT00783094|449684262|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
125016127|NCT00783094|449684263|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
125016128|NCT00783094|449684264|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
125016129|NCT00783094|449684262|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
125016130|NCT00783094|449684263|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
125016131|NCT00783094|449684264|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
125016132|NCT00783094|449684262|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
125016133|NCT00783094|449684263|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
125016134|NCT00783094|449684264|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
125016135|NCT00783094|449684262|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
125016136|NCT00783094|449684263|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
125016137|NCT00783094|449684264|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
125016138|NCT00783094|449684262|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
125016139|NCT00783094|449684263|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
125016140|NCT00783094|449684264|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
125016141|NCT00783094|449684262|FG000|Open-Label Extension Period|Adverse Event|12|||
125016142|NCT00783094|449684263|FG001|Open-Label Extension Period|Adverse Event|7|||
125016143|NCT00783094|449684264|FG002|Open-Label Extension Period|Adverse Event|16|||
125016144|NCT00783094|449684262|FG000|Open-Label Extension Period|Death|0|||
125016145|NCT00783094|449684263|FG001|Open-Label Extension Period|Death|0|||
125016146|NCT00783094|449684264|FG002|Open-Label Extension Period|Death|1|||
125016147|NCT00783094|449684262|FG000|Open-Label Extension Period|Protocol Violation|4|||
125016148|NCT00783094|449684263|FG001|Open-Label Extension Period|Protocol Violation|5|||
125016149|NCT00783094|449684264|FG002|Open-Label Extension Period|Protocol Violation|7|||
125016150|NCT00783094|449684262|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
125016151|NCT00783094|449684263|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
125016152|NCT00783094|449684264|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
125105771|NCT01346501|450009946|FG000|Overall Study|Initiated Other Biological Agents|3|||
124888549|NCT00519636|449215537|FG000|Washout Period|Protocol Violation|0|||
125105772|NCT01346501|450009947|FG001|Overall Study|Initiated Other Biological Agents|1|||
125105773|NCT01346501|450009946|FG000|Overall Study|Other|8|||
125105774|NCT01346501|450009947|FG001|Overall Study|Other|12|||
125105775|NCT02564952|450009948|FG000|Overall Study|Adverse Event|6|||
125105776|NCT02564952|450009948|FG000|Overall Study|Lost to Follow-up|1|||
125105777|NCT02564952|450009948|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
125105778|NCT02564952|450009948|FG000|Overall Study|Withdrawal by Subject|1|||
125105779|NCT02564952|450009948|FG000|Overall Study|Low Efficacy|1|||
125105780|NCT02564952|450009948|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
125105781|NCT00756652|450009949|FG000|Original Phase|Withdrawal by Subject|864|||
125105782|NCT00756652|450009950|FG001|Original Phase|Withdrawal by Subject|23|||
125105783|NCT00756652|450009949|FG000|Original Phase|Lost to Follow-up|601|||
125105784|NCT00756652|450009950|FG001|Original Phase|Lost to Follow-up|0|||
125105785|NCT00756652|450009949|FG000|Original Phase|Other Discontinuation|797|||
124888550|NCT00519636|449215538|FG001|Washout Period|Protocol Violation|0|||
124888551|NCT00519636|449215539|FG002|Washout Period|Protocol Violation|1|||
124888552|NCT00519636|449215540|FG003|Washout Period|Protocol Violation|2|||
124888553|NCT00519636|449215537|FG000|Washout Period|Withdrawal by Subject|1|||
124888554|NCT00519636|449215538|FG001|Washout Period|Withdrawal by Subject|0|||
125105786|NCT00756652|450009950|FG001|Original Phase|Other Discontinuation|5|||
125105787|NCT00756652|450009949|FG000|Original Phase|Participant Noncompliance|18622|||
125105788|NCT00756652|450009950|FG001|Original Phase|Participant Noncompliance|424|||
125105789|NCT00756652|450009949|FG000|Original Phase|Unknown Discontinuation Reason|2|||
125105790|NCT00756652|450009950|FG001|Original Phase|Unknown Discontinuation Reason|0|||
125105791|NCT00756652|450009949|FG000|Original Phase|Participants without data|3259|||
125105792|NCT00756652|450009950|FG001|Original Phase|Participants without data|466|||
125105793|NCT00756652|450009949|FG000|Original Phase|Death|168|||
125105794|NCT00756652|450009950|FG001|Original Phase|Death|1|||
125105795|NCT00756652|450009949|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
125105796|NCT00756652|450009950|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
125105797|NCT00756652|450009949|FG000|Re-Op Phase|Withdrawal by Subject|62|||
125105798|NCT00756652|450009950|FG001|Re-Op Phase|Withdrawal by Subject|0|||
125105799|NCT00756652|450009949|FG000|Re-Op Phase|Death|6|||
125105800|NCT00756652|450009950|FG001|Re-Op Phase|Death|0|||
125105801|NCT00756652|450009949|FG000|Re-Op Phase|Lost to Follow-up|340|||
125105802|NCT00756652|450009950|FG001|Re-Op Phase|Lost to Follow-up|0|||
125105803|NCT00756652|450009949|FG000|Re-Op Phase|Site Closed|2454|||
125105804|NCT00756652|450009950|FG001|Re-Op Phase|Site Closed|0|||
125105805|NCT00756652|450009949|FG000|Re-Op Phase|Withdrawn after explant|14|||
125105806|NCT00756652|450009950|FG001|Re-Op Phase|Withdrawn after explant|0|||
125105807|NCT01850108|450009951|FG000|Overall Study|Lost to Follow-up|4|||
125105808|NCT01850108|450009951|FG000|Overall Study|Not eligible|1|||
125105809|NCT01850108|450009951|FG000|Overall Study|Failed engraftment|2|||
125105810|NCT01850108|450009951|FG000|Overall Study|Physician Decision|1|||
125105811|NCT00038467|450009952|FG000|Overall Study|Adverse Event|170|||
125105812|NCT00038467|450009953|FG001|Overall Study|Adverse Event|145|||
125105813|NCT00038467|450009952|FG000|Overall Study|Withdrawal by Subject|150|||
125105814|NCT00038467|450009953|FG001|Overall Study|Withdrawal by Subject|107|||
125105815|NCT00038467|450009952|FG000|Overall Study|Protocol Violation|19|||
124888555|NCT00519636|449215539|FG002|Washout Period|Withdrawal by Subject|1|||
125105816|NCT00038467|450009953|FG001|Overall Study|Protocol Violation|22|||
125105817|NCT00038467|450009952|FG000|Overall Study|Death|22|||
125105818|NCT00038467|450009953|FG001|Overall Study|Death|16|||
125105819|NCT00038467|450009952|FG000|Overall Study|Lost to Follow-up|15|||
125105820|NCT00038467|450009953|FG001|Overall Study|Lost to Follow-up|10|||
125105821|NCT00038467|450009952|FG000|Overall Study|Recurrence|109|||
125105822|NCT00038467|450009953|FG001|Overall Study|Recurrence|179|||
125105823|NCT00038467|450009952|FG000|Overall Study|Randomized, but not treated|31|||
125105824|NCT00038467|450009953|FG001|Overall Study|Randomized, but not treated|35|||
125105825|NCT00038467|450009952|FG000|Overall Study|Other|26|||
124888556|NCT00519636|449215540|FG003|Washout Period|Withdrawal by Subject|0|||
125105826|NCT00038467|450009953|FG001|Overall Study|Other|28|||
125105827|NCT01988493|450009954|FG000|Overall Study|Randomized but not treated|0|||
125105828|NCT01988493|450009955|FG001|Overall Study|Randomized but not treated|0|||
125105829|NCT01988493|450009956|FG002|Overall Study|Randomized but not treated|0|||
125105830|NCT01988493|450009957|FG003|Overall Study|Randomized but not treated|0|||
125105831|NCT01988493|450009958|FG004|Overall Study|Randomized but not treated|1|||
125105832|NCT01523301|450009959|FG000|Overall Study|Adverse Event|25|||
125105833|NCT01523301|450009960|FG001|Overall Study|Adverse Event|16|||
125105834|NCT01523301|450009959|FG000|Overall Study|Lack of Efficacy|0|||
125105835|NCT01523301|450009960|FG001|Overall Study|Lack of Efficacy|2|||
125105836|NCT01523301|450009959|FG000|Overall Study|Protocol Violation|3|||
125105837|NCT01523301|450009960|FG001|Overall Study|Protocol Violation|4|||
125105838|NCT01523301|450009959|FG000|Overall Study|Lost to Follow-up|1|||
125105839|NCT01523301|450009960|FG001|Overall Study|Lost to Follow-up|0|||
125105840|NCT01523301|450009959|FG000|Overall Study|Withdrawal by Subject|6|||
125105841|NCT01523301|450009960|FG001|Overall Study|Withdrawal by Subject|8|||
125105842|NCT01523301|450009959|FG000|Overall Study|Other Reason|0|||
125105843|NCT01523301|450009960|FG001|Overall Study|Other Reason|2|||
125105844|NCT01447628|450009963|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
125105845|NCT01447628|450009964|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
125105846|NCT01447628|450009965|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
125105847|NCT01447628|450009966|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
125105848|NCT00185731|450009967|FG000|Overall Study|Withdrawal by Subject|1|||
125105849|NCT00185731|450009967|FG000|Overall Study|Not Eligible|1|||
125105850|NCT03087773|450009968|FG000|Overall Study|Withdrawal by Subject|8|||
125105851|NCT03087773|450009969|FG001|Overall Study|Withdrawal by Subject|4|||
125105852|NCT03087773|450009968|FG000|Overall Study|Lost to Follow-up|12|||
125105853|NCT03087773|450009969|FG001|Overall Study|Lost to Follow-up|8|||
125105854|NCT01787188|450009974|FG000|Overall Study|Adverse Event|2|||
125105855|NCT01787188|450009975|FG001|Overall Study|Adverse Event|4|||
125105856|NCT01787188|450009976|FG002|Overall Study|Adverse Event|6|||
125105857|NCT01787188|450009974|FG000|Overall Study|Lack of Efficacy|7|||
125105858|NCT01787188|450009975|FG001|Overall Study|Lack of Efficacy|3|||
125105859|NCT01787188|450009976|FG002|Overall Study|Lack of Efficacy|5|||
125105860|NCT01787188|450009974|FG000|Overall Study|Non-compliance with Study Drug|0|||
125105861|NCT01787188|450009975|FG001|Overall Study|Non-compliance with Study Drug|1|||
125105862|NCT01787188|450009976|FG002|Overall Study|Non-compliance with Study Drug|0|||
125105863|NCT01787188|450009974|FG000|Overall Study|Withdrawal by Subject|4|||
125105864|NCT01787188|450009975|FG001|Overall Study|Withdrawal by Subject|3|||
125105865|NCT01787188|450009976|FG002|Overall Study|Withdrawal by Subject|2|||
125105866|NCT01787188|450009974|FG000|Overall Study|Protocol Violation|3|||
125105867|NCT01787188|450009975|FG001|Overall Study|Protocol Violation|2|||
125105868|NCT01787188|450009976|FG002|Overall Study|Protocol Violation|3|||
125105869|NCT01787188|450009974|FG000|Overall Study|Lost to Follow-up|1|||
125105870|NCT01787188|450009975|FG001|Overall Study|Lost to Follow-up|2|||
125105871|NCT01787188|450009976|FG002|Overall Study|Lost to Follow-up|2|||
125105872|NCT01787188|450009974|FG000|Overall Study|Other, including patient moved|0|||
125105873|NCT01787188|450009975|FG001|Overall Study|Other, including patient moved|3|||
125105874|NCT01787188|450009976|FG002|Overall Study|Other, including patient moved|0|||
125105875|NCT03151707|450009979|FG000|Overall Study|Lost to Follow-up|6|||
125105876|NCT01308762|450009980|FG000|Overall Study|Protocol Violation|0|||
125105877|NCT01308762|450009981|FG001|Overall Study|Protocol Violation|1|||
125105878|NCT01308762|450009982|FG002|Overall Study|Protocol Violation|0|||
125105879|NCT02617446|450009983|FG000|Overall Study|Withdrawal by Subject|0|||
125105880|NCT02617446|450009984|FG001|Overall Study|Withdrawal by Subject|2|||
125105881|NCT02617446|450009985|FG002|Overall Study|Withdrawal by Subject|0|||
125105882|NCT02617446|450009983|FG000|Overall Study|Adverse Event|1|||
125105883|NCT02617446|450009984|FG001|Overall Study|Adverse Event|0|||
125105884|NCT02617446|450009985|FG002|Overall Study|Adverse Event|5|||
125105885|NCT02617446|450009983|FG000|Overall Study|Lost to Follow-up|3|||
125105886|NCT02617446|450009984|FG001|Overall Study|Lost to Follow-up|0|||
125105887|NCT02617446|450009985|FG002|Overall Study|Lost to Follow-up|0|||
125105888|NCT02617446|450009983|FG000|Overall Study|Death|0|||
125105889|NCT02617446|450009984|FG001|Overall Study|Death|0|||
125105890|NCT02617446|450009985|FG002|Overall Study|Death|2|||
125105891|NCT00530088|450009986|FG000|Overall Study|Disease Progression|4|||
125105892|NCT00530088|450009986|FG000|Overall Study|Physician Decision|4|||
125105893|NCT00530088|450009986|FG000|Overall Study|Other Not Specified|2|||
125105894|NCT00902278|450009987|FG000|Overall Study|Physician Decision|1|||
125105895|NCT00902278|450009988|FG001|Overall Study|Physician Decision|0|||
125105896|NCT00902278|450009989|FG002|Overall Study|Physician Decision|2|||
125105897|NCT00902278|450009990|FG003|Overall Study|Physician Decision|0|||
125105898|NCT00902278|450009991|FG004|Overall Study|Physician Decision|1|||
125105899|NCT00902278|450009987|FG000|Overall Study|Lost to Follow-up|3|||
125105900|NCT00902278|450009988|FG001|Overall Study|Lost to Follow-up|2|||
125105901|NCT00902278|450009989|FG002|Overall Study|Lost to Follow-up|3|||
125105902|NCT00902278|450009990|FG003|Overall Study|Lost to Follow-up|0|||
125105903|NCT00902278|450009991|FG004|Overall Study|Lost to Follow-up|1|||
125105904|NCT02362646|450009992|FG000|Overall Study|Death|15|||
125105905|NCT02362646|450009993|FG001|Overall Study|Death|8|||
125105906|NCT02362646|450009992|FG000|Overall Study|Withdrawal by Subject|2|||
125105907|NCT02362646|450009993|FG001|Overall Study|Withdrawal by Subject|2|||
125105908|NCT02362646|450009992|FG000|Overall Study|received transplant|21|||
125105909|NCT02362646|450009993|FG001|Overall Study|received transplant|14|||
125105910|NCT00865306|450009994|FG000|Controlled Trial|Lost to Follow-up|1|||
125105911|NCT00865306|450009995|FG001|Controlled Trial|Lost to Follow-up|1|||
125105912|NCT00865306|450009994|FG000|Controlled Trial|Difficulty commuting|2|||
125105913|NCT00865306|450009995|FG001|Controlled Trial|Difficulty commuting|0|||
125105914|NCT00865306|450009994|FG000|Controlled Trial|Improved btw baseline and first session|1|||
125105915|NCT00865306|450009995|FG001|Controlled Trial|Improved btw baseline and first session|0|||
125105916|NCT00865306|450009994|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
125105917|NCT00865306|450009995|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
125105918|NCT00865306|450009994|FG000|Controlled Trial|Withdrawal by Subject|0|||
125105919|NCT00865306|450009995|FG001|Controlled Trial|Withdrawal by Subject|1|||
125105920|NCT02181842|450009997|FG000|Overall Study|Case Report Forms Uncollected|2|||
125105921|NCT00929864|450009998|FG000|Overall Study|Death|1|||
125105922|NCT00929864|450009999|FG001|Overall Study|Death|1|||
125105923|NCT00929864|450009998|FG000|Overall Study|Adverse Event|11|||
125105924|NCT00929864|450009999|FG001|Overall Study|Adverse Event|30|||
125105925|NCT00929864|450009998|FG000|Overall Study|Lack of Efficacy|19|||
125105926|NCT00929864|450009999|FG001|Overall Study|Lack of Efficacy|16|||
125105927|NCT00929864|450009998|FG000|Overall Study|Lost to Follow-up|7|||
125105928|NCT00929864|450009999|FG001|Overall Study|Lost to Follow-up|12|||
125105929|NCT00929864|450009998|FG000|Overall Study|Withdrawal by Subject|20|||
125105930|NCT00929864|450009999|FG001|Overall Study|Withdrawal by Subject|9|||
125105931|NCT00929864|450009998|FG000|Overall Study|No longer met criteria|2|||
125105932|NCT00929864|450009999|FG001|Overall Study|No longer met criteria|1|||
125105933|NCT00929864|450009998|FG000|Overall Study|Poor or non-compliance|3|||
125105934|NCT00929864|450009999|FG001|Overall Study|Poor or non-compliance|3|||
125105935|NCT00929864|450009998|FG000|Overall Study|Pregnancy|0|||
125105936|NCT00929864|450009999|FG001|Overall Study|Pregnancy|3|||
125016153|NCT00783094|449684262|FG000|Open-Label Extension Period|Physician Decision|4|||
125016154|NCT00783094|449684263|FG001|Open-Label Extension Period|Physician Decision|2|||
125016155|NCT00783094|449684264|FG002|Open-Label Extension Period|Physician Decision|3|||
125016156|NCT00783094|449684262|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
125016157|NCT00783094|449684263|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
125016158|NCT00783094|449684264|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
125016159|NCT00876187|449684267|FG000|Overall Study|Adverse Event|14|||
125016160|NCT00876187|449684268|FG001|Overall Study|Adverse Event|12|||
125016161|NCT00876187|449684269|FG002|Overall Study|Adverse Event|19|||
125016162|NCT00876187|449684270|FG003|Overall Study|Adverse Event|29|||
125105937|NCT00929864|450009998|FG000|Overall Study|Administrative reason by Sponsor|1|||
125105938|NCT00929864|450009999|FG001|Overall Study|Administrative reason by Sponsor|1|||
125105939|NCT00929864|450009998|FG000|Overall Study|Non-specified|2|||
125105940|NCT00929864|450009999|FG001|Overall Study|Non-specified|7|||
125105941|NCT03454672|450010011|FG000|Overall Study|Adverse Event|1|||
125105942|NCT03454672|450010012|FG001|Overall Study|Adverse Event|1|||
125105943|NCT03454672|450010011|FG000|Overall Study|Lost to Follow-up|1|||
125105944|NCT03454672|450010012|FG001|Overall Study|Lost to Follow-up|3|||
125105945|NCT03454672|450010011|FG000|Overall Study|painful|1|||
125105946|NCT03454672|450010012|FG001|Overall Study|painful|2|||
125105947|NCT03454672|450010011|FG000|Overall Study|Non-compliance|2|||
125105948|NCT03454672|450010012|FG001|Overall Study|Non-compliance|4|||
125016163|NCT00876187|449684271|FG004|Overall Study|Adverse Event|10|||
125016164|NCT00876187|449684267|FG000|Overall Study|Lack of Efficacy|59|||
125016165|NCT00876187|449684268|FG001|Overall Study|Lack of Efficacy|34|||
125016166|NCT00876187|449684269|FG002|Overall Study|Lack of Efficacy|45|||
125016167|NCT00876187|449684270|FG003|Overall Study|Lack of Efficacy|34|||
125016168|NCT00876187|449684271|FG004|Overall Study|Lack of Efficacy|59|||
125016169|NCT00876187|449684267|FG000|Overall Study|Lost to Follow-up|9|||
125016170|NCT00876187|449684268|FG001|Overall Study|Lost to Follow-up|10|||
125016171|NCT00876187|449684269|FG002|Overall Study|Lost to Follow-up|8|||
125016172|NCT00876187|449684270|FG003|Overall Study|Lost to Follow-up|8|||
125016173|NCT00876187|449684271|FG004|Overall Study|Lost to Follow-up|11|||
125016174|NCT00876187|449684267|FG000|Overall Study|Protocol Violation|6|||
125016175|NCT00876187|449684268|FG001|Overall Study|Protocol Violation|7|||
125016176|NCT00876187|449684269|FG002|Overall Study|Protocol Violation|7|||
125016177|NCT00876187|449684270|FG003|Overall Study|Protocol Violation|6|||
125016178|NCT00876187|449684271|FG004|Overall Study|Protocol Violation|3|||
125016179|NCT00876187|449684267|FG000|Overall Study|Withdrawal by Subject|16|||
125016180|NCT00876187|449684268|FG001|Overall Study|Withdrawal by Subject|26|||
125016181|NCT00876187|449684269|FG002|Overall Study|Withdrawal by Subject|32|||
125016182|NCT00876187|449684270|FG003|Overall Study|Withdrawal by Subject|38|||
125016183|NCT00876187|449684271|FG004|Overall Study|Withdrawal by Subject|37|||
125016184|NCT00876187|449684267|FG000|Overall Study|Entered extension study|101|||
125016185|NCT00876187|449684268|FG001|Overall Study|Entered extension study|120|||
125016186|NCT00876187|449684269|FG002|Overall Study|Entered extension study|156|||
125016187|NCT00876187|449684270|FG003|Overall Study|Entered extension study|151|||
125016188|NCT00876187|449684271|FG004|Overall Study|Entered extension study|144|||
125016189|NCT00876187|449684267|FG000|Overall Study|Randomized but not treated|3|||
125016190|NCT00876187|449684268|FG001|Overall Study|Randomized but not treated|1|||
125016191|NCT00876187|449684269|FG002|Overall Study|Randomized but not treated|3|||
125016192|NCT00876187|449684270|FG003|Overall Study|Randomized but not treated|2|||
125016193|NCT00876187|449684271|FG004|Overall Study|Randomized but not treated|3|||
125016194|NCT00876187|449684267|FG000|Overall Study|Other|2|||
125016195|NCT00876187|449684268|FG001|Overall Study|Other|5|||
125016196|NCT00876187|449684269|FG002|Overall Study|Other|9|||
125016197|NCT00876187|449684270|FG003|Overall Study|Other|7|||
125016198|NCT00876187|449684271|FG004|Overall Study|Other|4|||
125016199|NCT03287219|449684272|FG000|Overall Study|Protocol Violation|0|||
125016200|NCT03287219|449684273|FG001|Overall Study|Protocol Violation|2|||
125016201|NCT03245450|449684285|FG000|Overall Study|Radiological disease progression|3|||
125016202|NCT03245450|449684286|FG001|Overall Study|Radiological disease progression|3|||
125016203|NCT03245450|449684287|FG002|Overall Study|Radiological disease progression|2|||
125016204|NCT03245450|449684288|FG003|Overall Study|Radiological disease progression|2|||
125016205|NCT03245450|449684289|FG004|Overall Study|Radiological disease progression|7|||
125016206|NCT03245450|449684290|FG005|Overall Study|Radiological disease progression|6|||
125016207|NCT03245450|449684291|FG006|Overall Study|Radiological disease progression|6|||
125016208|NCT03245450|449684285|FG000|Overall Study|Clinical disease progression|0|||
125016209|NCT03245450|449684286|FG001|Overall Study|Clinical disease progression|0|||
125016210|NCT03245450|449684287|FG002|Overall Study|Clinical disease progression|1|||
125016211|NCT03245450|449684288|FG003|Overall Study|Clinical disease progression|0|||
125016212|NCT03245450|449684289|FG004|Overall Study|Clinical disease progression|0|||
125016213|NCT03245450|449684290|FG005|Overall Study|Clinical disease progression|2|||
125016214|NCT03245450|449684291|FG006|Overall Study|Clinical disease progression|0|||
125016215|NCT03245450|449684285|FG000|Overall Study|Other|0|||
125016216|NCT03245450|449684286|FG001|Overall Study|Other|0|||
125016217|NCT03245450|449684287|FG002|Overall Study|Other|0|||
125016218|NCT03245450|449684288|FG003|Overall Study|Other|1|||
125016219|NCT03245450|449684289|FG004|Overall Study|Other|1|||
125016220|NCT03245450|449684290|FG005|Overall Study|Other|1|||
125016221|NCT03245450|449684291|FG006|Overall Study|Other|1|||
125016222|NCT03245450|449684285|FG000|Overall Study|Withdrawal by Subject|0|||
125016223|NCT03245450|449684286|FG001|Overall Study|Withdrawal by Subject|1|||
125016224|NCT03245450|449684287|FG002|Overall Study|Withdrawal by Subject|0|||
125016225|NCT03245450|449684288|FG003|Overall Study|Withdrawal by Subject|0|||
125016226|NCT03245450|449684289|FG004|Overall Study|Withdrawal by Subject|0|||
125016227|NCT03245450|449684290|FG005|Overall Study|Withdrawal by Subject|0|||
125016228|NCT03245450|449684291|FG006|Overall Study|Withdrawal by Subject|0|||
125016229|NCT03245450|449684285|FG000|Overall Study|Adverse Event|0|||
125016230|NCT03245450|449684286|FG001|Overall Study|Adverse Event|0|||
125016231|NCT03245450|449684287|FG002|Overall Study|Adverse Event|0|||
125016232|NCT03245450|449684288|FG003|Overall Study|Adverse Event|0|||
125016233|NCT03245450|449684289|FG004|Overall Study|Adverse Event|1|||
125016234|NCT03245450|449684290|FG005|Overall Study|Adverse Event|0|||
124888557|NCT00519636|449215537|FG000|Washout Period|Failed to meet continuation criteria|14|||
124888558|NCT00519636|449215538|FG001|Washout Period|Failed to meet continuation criteria|11|||
124888559|NCT00519636|449215539|FG002|Washout Period|Failed to meet continuation criteria|9|||
124888560|NCT00519636|449215540|FG003|Washout Period|Failed to meet continuation criteria|3|||
124888561|NCT00519636|449215537|FG000|Washout Period|Out of pollen area > 48 hours|1|||
124888562|NCT00519636|449215538|FG001|Washout Period|Out of pollen area > 48 hours|0|||
124888563|NCT00519636|449215539|FG002|Washout Period|Out of pollen area > 48 hours|0|||
124888564|NCT00519636|449215540|FG003|Washout Period|Out of pollen area > 48 hours|0|||
125105949|NCT03454672|450010011|FG000|Overall Study|personal reasons|3|||
125105950|NCT03454672|450010012|FG001|Overall Study|personal reasons|2|||
125105951|NCT03454672|450010011|FG000|Overall Study|Withdrawal by Subject|1|||
125105952|NCT03454672|450010012|FG001|Overall Study|Withdrawal by Subject|0|||
125105953|NCT03985293|450010014|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
125105954|NCT03985293|450010015|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
125105955|NCT03985293|450010016|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
125105956|NCT03985293|450010017|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
125105957|NCT03985293|450010018|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
125105958|NCT03985293|450010019|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
125105959|NCT03985293|450010014|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
125105960|NCT03985293|450010015|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
125105961|NCT03985293|450010016|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
125105962|NCT03985293|450010017|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
125105963|NCT03985293|450010018|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
125105964|NCT03985293|450010019|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
125105965|NCT03985293|450010014|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
125105966|NCT03985293|450010015|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
125105967|NCT03985293|450010016|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
125105968|NCT03985293|450010017|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
125105969|NCT03985293|450010018|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
125105970|NCT03985293|450010019|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
125105971|NCT03985293|450010014|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
125105972|NCT03985293|450010015|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
125105973|NCT03985293|450010016|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
125105974|NCT03985293|450010017|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
125105975|NCT03985293|450010018|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
125105976|NCT03985293|450010019|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
125105977|NCT03985293|450010014|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
125105978|NCT03985293|450010015|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
125105979|NCT03985293|450010016|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
125105980|NCT03985293|450010017|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
125105981|NCT03985293|450010018|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
125105982|NCT03985293|450010019|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
125105983|NCT03985293|450010014|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
125105984|NCT03985293|450010015|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
125105985|NCT03985293|450010016|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
125105986|NCT03985293|450010017|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
125105987|NCT03985293|450010018|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
125105988|NCT03985293|450010019|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
125105989|NCT03985293|450010014|FG000|FOLLOW-UP|Lost to Follow-up|0|||
125105990|NCT03985293|450010015|FG001|FOLLOW-UP|Lost to Follow-up|0|||
125105991|NCT03985293|450010016|FG002|FOLLOW-UP|Lost to Follow-up|1|||
125105992|NCT03985293|450010017|FG003|FOLLOW-UP|Lost to Follow-up|0|||
125105993|NCT03985293|450010018|FG004|FOLLOW-UP|Lost to Follow-up|0|||
125105994|NCT03985293|450010019|FG005|FOLLOW-UP|Lost to Follow-up|0|||
125105995|NCT03302299|450011614|FG000|Overall Study|Protocol Violation|1|||
124888565|NCT00519636|449215537|FG000|Washout Period|Participating in study at another site|1|||
124888566|NCT00519636|449215538|FG001|Washout Period|Participating in study at another site|0|||
124888567|NCT00519636|449215539|FG002|Washout Period|Participating in study at another site|0|||
124888568|NCT00519636|449215540|FG003|Washout Period|Participating in study at another site|0|||
125105996|NCT00858234|450011615|FG000|Overall Study|Adverse Event|6|||
125105997|NCT00858234|450011615|FG000|Overall Study|Progressive disease|2|||
125105998|NCT00858234|450011615|FG000|Overall Study|Status unknown|1|||
125105999|NCT04318535|450011616|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
125106000|NCT04318535|450011617|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
125106001|NCT04318535|450011618|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
125106002|NCT01678924|450011620|FG000|Overall Study|Adverse Event|1|||
125106003|NCT01678924|450011621|FG001|Overall Study|Adverse Event|1|||
125106004|NCT01678924|450011622|FG002|Overall Study|Adverse Event|0|||
125106005|NCT01678924|450011623|FG003|Overall Study|Adverse Event|1|||
125106006|NCT01678924|450011620|FG000|Overall Study|Lack of Efficacy|7|||
125106007|NCT01678924|450011621|FG001|Overall Study|Lack of Efficacy|2|||
125106008|NCT01678924|450011622|FG002|Overall Study|Lack of Efficacy|0|||
125106009|NCT01678924|450011623|FG003|Overall Study|Lack of Efficacy|5|||
125106010|NCT01678924|450011620|FG000|Overall Study|Lost to Follow-up|0|||
125106011|NCT01678924|450011621|FG001|Overall Study|Lost to Follow-up|4|||
125106012|NCT01678924|450011622|FG002|Overall Study|Lost to Follow-up|0|||
125106013|NCT01678924|450011623|FG003|Overall Study|Lost to Follow-up|2|||
125106014|NCT01678924|450011620|FG000|Overall Study|Personal Reasons|2|||
125106015|NCT01678924|450011621|FG001|Overall Study|Personal Reasons|2|||
125106016|NCT01678924|450011622|FG002|Overall Study|Personal Reasons|2|||
125106017|NCT01678924|450011623|FG003|Overall Study|Personal Reasons|7|||
125106018|NCT01678924|450011620|FG000|Overall Study|Withdrawal by Subject|0|||
125106019|NCT01678924|450011621|FG001|Overall Study|Withdrawal by Subject|3|||
125106020|NCT01678924|450011622|FG002|Overall Study|Withdrawal by Subject|0|||
125106021|NCT01678924|450011623|FG003|Overall Study|Withdrawal by Subject|2|||
125106022|NCT01678924|450011620|FG000|Overall Study|Unable to attend scheduled visits|0|||
125106023|NCT01678924|450011621|FG001|Overall Study|Unable to attend scheduled visits|0|||
125106024|NCT01678924|450011622|FG002|Overall Study|Unable to attend scheduled visits|0|||
125106025|NCT01678924|450011623|FG003|Overall Study|Unable to attend scheduled visits|1|||
125106026|NCT00640614|450011626|FG000|Overall Study|Lost to Follow-up|1|||
125106027|NCT00640614|450011627|FG001|Overall Study|Lost to Follow-up|0|||
125106028|NCT00529802|450011628|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
125106029|NCT00529802|450011628|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
125106030|NCT00529802|450011628|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
125106031|NCT00529802|450011628|FG000|Evaluable for Primary Endpoint|Death|1|||
125106032|NCT00529802|450011628|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
125106033|NCT00529802|450011628|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
125106034|NCT00529802|450011628|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
125106035|NCT02428231|450011634|FG000|Overall Study|Other|10|||
125106036|NCT02428231|450011635|FG001|Overall Study|Other|16|||
125106037|NCT02428231|450011634|FG000|Overall Study|Required Symptomatic Therapy|0|||
125106038|NCT02428231|450011635|FG001|Overall Study|Required Symptomatic Therapy|1|||
125106039|NCT02428231|450011634|FG000|Overall Study|Adverse Event|3|||
125106040|NCT02428231|450011635|FG001|Overall Study|Adverse Event|0|||
125106041|NCT02156466|450011638|FG000|Overall Study|Adverse Event|0|||
125106042|NCT02156466|450011639|FG001|Overall Study|Adverse Event|0|||
125106043|NCT02156466|450011640|FG002|Overall Study|Adverse Event|1|||
125106044|NCT02156466|450011641|FG003|Overall Study|Adverse Event|1|||
125106045|NCT02156466|450011642|FG004|Overall Study|Adverse Event|0|||
125106046|NCT02156466|450011638|FG000|Overall Study|Quantiferon Positivity|0|||
125106047|NCT02156466|450011639|FG001|Overall Study|Quantiferon Positivity|0|||
125106048|NCT02156466|450011640|FG002|Overall Study|Quantiferon Positivity|0|||
125106049|NCT02156466|450011641|FG003|Overall Study|Quantiferon Positivity|1|||
125106050|NCT02156466|450011642|FG004|Overall Study|Quantiferon Positivity|0|||
125016235|NCT03245450|449684291|FG006|Overall Study|Adverse Event|2|||
125016236|NCT02429414|449684292|FG000|Overall Study|Physician Decision|0|||
125016237|NCT02429414|449684293|FG001|Overall Study|Physician Decision|1|||
125016238|NCT01784861|449684294|FG000|Overall Study|Adverse Event|0|||
125016239|NCT01784861|449684295|FG001|Overall Study|Adverse Event|0|||
125016240|NCT01784861|449684296|FG002|Overall Study|Adverse Event|1|||
125016241|NCT01784861|449684297|FG003|Overall Study|Adverse Event|2|||
125016242|NCT01784861|449684298|FG004|Overall Study|Adverse Event|1|||
125016243|NCT01784861|449684299|FG005|Overall Study|Adverse Event|0|||
125016244|NCT01784861|449684294|FG000|Overall Study|Withdrawal by Subject|0|||
125016245|NCT01784861|449684295|FG001|Overall Study|Withdrawal by Subject|0|||
125016246|NCT01784861|449684296|FG002|Overall Study|Withdrawal by Subject|0|||
125016247|NCT01784861|449684297|FG003|Overall Study|Withdrawal by Subject|1|||
125016248|NCT01784861|449684298|FG004|Overall Study|Withdrawal by Subject|0|||
125016249|NCT01784861|449684299|FG005|Overall Study|Withdrawal by Subject|0|||
125016250|NCT01784861|449684294|FG000|Overall Study|Physician Decision|0|||
125016251|NCT01784861|449684295|FG001|Overall Study|Physician Decision|0|||
125016252|NCT01784861|449684296|FG002|Overall Study|Physician Decision|0|||
125016253|NCT01784861|449684297|FG003|Overall Study|Physician Decision|2|||
125106051|NCT01784419|450011643|FG000|Overall Study|Adverse Event|3|||
125106052|NCT02253654|450011644|FG000|Overall Study|Withdrawal by Subject|12|||
125106053|NCT02253654|450011645|FG001|Overall Study|Withdrawal by Subject|4|||
125106054|NCT02253654|450011644|FG000|Overall Study|Decision by Sponsor|1|||
125106055|NCT02253654|450011645|FG001|Overall Study|Decision by Sponsor|1|||
125106056|NCT02253654|450011644|FG000|Overall Study|Lost to Follow-up|2|||
125016254|NCT01784861|449684298|FG004|Overall Study|Physician Decision|0|||
125016255|NCT01784861|449684299|FG005|Overall Study|Physician Decision|1|||
125016256|NCT02432235|449684300|FG000|Overall Study|Death|1|||
125016257|NCT02432235|449684301|FG001|Overall Study|Death|1|||
125016258|NCT02432235|449684302|FG002|Overall Study|Death|2|||
125106057|NCT02253654|450011645|FG001|Overall Study|Lost to Follow-up|5|||
124888569|NCT00519636|449215537|FG000|Washout Period|Non-compliant|0|||
125106058|NCT02253654|450011644|FG000|Overall Study|Death|4|||
125106059|NCT02253654|450011645|FG001|Overall Study|Death|7|||
125106060|NCT02253654|450011644|FG000|Overall Study|Did Not Receive Study Treatment|4|||
125106061|NCT02253654|450011645|FG001|Overall Study|Did Not Receive Study Treatment|1|||
125106062|NCT03456726|450011648|FG000|Overall Study|Disease Progression|6|||
125106063|NCT03456726|450011649|FG001|Overall Study|Disease Progression|1|||
125106064|NCT03456726|450011648|FG000|Overall Study|Adverse Event|4|||
125106065|NCT03456726|450011649|FG001|Overall Study|Adverse Event|2|||
125106066|NCT03456726|450011648|FG000|Overall Study|Withdrawal by Subject|1|||
125106067|NCT03456726|450011649|FG001|Overall Study|Withdrawal by Subject|0|||
125106068|NCT03456726|450011648|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
125106069|NCT03456726|450011649|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
125106070|NCT04470622|450011650|FG000|Overall Study|Withdrawal by Subject|0|||
125106071|NCT04470622|450011651|FG001|Overall Study|Withdrawal by Subject|1|||
125106072|NCT04470622|450011650|FG000|Overall Study|Screen Failure|0|||
125106073|NCT04470622|450011651|FG001|Overall Study|Screen Failure|1|||
125106074|NCT04470622|450011650|FG000|Overall Study|Death|0|||
125106075|NCT04470622|450011651|FG001|Overall Study|Death|1|||
125106076|NCT02576054|450011652|FG000|Overall Study|Withdrawal by Subject|1|||
125106077|NCT01190098|450011653|FG000|Overall Study|Adverse Event|2|||
125106078|NCT01190098|450011654|FG001|Overall Study|Adverse Event|0|||
125106079|NCT01190098|450011653|FG000|Overall Study|Patient coomorbidity|0|||
125106080|NCT01190098|450011654|FG001|Overall Study|Patient coomorbidity|1|||
125106081|NCT01190098|450011653|FG000|Overall Study|Lack of transportation|1|||
125106082|NCT01190098|450011654|FG001|Overall Study|Lack of transportation|0|||
124888570|NCT00519636|449215538|FG001|Washout Period|Non-compliant|1|||
124888571|NCT00519636|449215539|FG002|Washout Period|Non-compliant|0|||
124888572|NCT00519636|449215540|FG003|Washout Period|Non-compliant|0|||
124888573|NCT00519636|449215537|FG000|Washout Period|Per doctors request|0|||
124888574|NCT00519636|449215538|FG001|Washout Period|Per doctors request|1|||
124888575|NCT00519636|449215539|FG002|Washout Period|Per doctors request|0|||
124888576|NCT00519636|449215540|FG003|Washout Period|Per doctors request|0|||
124888577|NCT00519636|449215537|FG000|Washout Period|Subject randomized in error|0|||
124888578|NCT00519636|449215538|FG001|Washout Period|Subject randomized in error|0|||
124888579|NCT00519636|449215539|FG002|Washout Period|Subject randomized in error|1|||
124888580|NCT00519636|449215540|FG003|Washout Period|Subject randomized in error|0|||
124888581|NCT00519636|449215537|FG000|Washout Period|Prohibited medications|0|||
124888582|NCT00519636|449215538|FG001|Washout Period|Prohibited medications|0|||
124888583|NCT00519636|449215539|FG002|Washout Period|Prohibited medications|1|||
124888584|NCT00519636|449215540|FG003|Washout Period|Prohibited medications|0|||
124888585|NCT00519636|449215537|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
124888586|NCT00519636|449215538|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
124888587|NCT00519636|449215539|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
124888588|NCT00519636|449215540|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
124888589|NCT00519636|449215537|FG000|Treatment Period 2|Subject randomized in error|0|||
124888590|NCT00519636|449215538|FG001|Treatment Period 2|Subject randomized in error|1|||
124888591|NCT00519636|449215539|FG002|Treatment Period 2|Subject randomized in error|0|||
124888592|NCT00519636|449215540|FG003|Treatment Period 2|Subject randomized in error|0|||
124888593|NCT00519636|449215537|FG000|Treatment Period 2|Per doctors request|0|||
124888594|NCT00519636|449215538|FG001|Treatment Period 2|Per doctors request|0|||
124888595|NCT00519636|449215539|FG002|Treatment Period 2|Per doctors request|1|||
124888596|NCT00519636|449215540|FG003|Treatment Period 2|Per doctors request|0|||
124888597|NCT00519636|449215537|FG000|Treatment Period 2|Subject misrandomized|0|||
124888598|NCT00519636|449215538|FG001|Treatment Period 2|Subject misrandomized|0|||
124888599|NCT00519636|449215539|FG002|Treatment Period 2|Subject misrandomized|0|||
124888600|NCT00519636|449215540|FG003|Treatment Period 2|Subject misrandomized|1|||
124888601|NCT00519636|449215537|FG000|Post Study Period|Subject randomized in error|0|||
124888602|NCT00519636|449215538|FG001|Post Study Period|Subject randomized in error|0|||
124888603|NCT00519636|449215539|FG002|Post Study Period|Subject randomized in error|0|||
124888604|NCT00519636|449215540|FG003|Post Study Period|Subject randomized in error|1|||
124888605|NCT01671748|449215547|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
125106083|NCT01190098|450011653|FG000|Overall Study|Other|0|||
124888606|NCT01671748|449215548|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
124888607|NCT01671748|449215547|FG000|4 Week run-in Phase|Adverse Event|1|||
124888608|NCT01671748|449215548|FG001|4 Week run-in Phase|Adverse Event|0|||
124888609|NCT01671748|449215547|FG000|4 Week run-in Phase|Not eligible|9|||
124888610|NCT01671748|449215548|FG001|4 Week run-in Phase|Not eligible|0|||
125106084|NCT01190098|450011654|FG001|Overall Study|Other|1|||
125106085|NCT02957682|450011655|FG000|Overall Study|Adverse Event|64|||
125106086|NCT02957682|450011656|FG001|Overall Study|Adverse Event|67|||
125106087|NCT02957682|450011655|FG000|Overall Study|Poor Compliance to Protocol|30|||
125106088|NCT02957682|450011656|FG001|Overall Study|Poor Compliance to Protocol|26|||
125106089|NCT02957682|450011655|FG000|Overall Study|Physician Decision|4|||
125106090|NCT02957682|450011656|FG001|Overall Study|Physician Decision|4|||
125106091|NCT02957682|450011655|FG000|Overall Study|Study Terminated by Sponsor|4|||
124888611|NCT02169830|449216773|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
124888612|NCT02169830|449216774|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
124888613|NCT02169830|449216775|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
124888614|NCT02169830|449216773|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
124888615|NCT02169830|449216774|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
124888616|NCT02169830|449216775|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
124888617|NCT02169830|449216773|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
124888618|NCT02169830|449216774|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
124888619|NCT02169830|449216775|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
124888620|NCT02169830|449216773|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
124888621|NCT02169830|449216774|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
124888622|NCT02169830|449216775|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
124888623|NCT02169830|449216773|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
124888624|NCT02169830|449216774|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
124888625|NCT02169830|449216775|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
124888626|NCT02555371|449216776|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
124888627|NCT02555371|449216777|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
124888628|NCT02555371|449216778|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
124888629|NCT02555371|449216779|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
124888630|NCT02555371|449216780|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
124888631|NCT02555371|449216776|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
124888632|NCT02555371|449216777|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
124888633|NCT02555371|449216778|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
124888634|NCT02555371|449216779|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
125106092|NCT02957682|450011656|FG001|Overall Study|Study Terminated by Sponsor|3|||
125106093|NCT02957682|450011655|FG000|Overall Study|Subject Moved|10|||
125106094|NCT02957682|450011656|FG001|Overall Study|Subject Moved|16|||
125106095|NCT02957682|450011655|FG000|Overall Study|Withdrawal by Subject|64|||
125106096|NCT02957682|450011656|FG001|Overall Study|Withdrawal by Subject|33|||
125106097|NCT02957682|450011655|FG000|Overall Study|Related to IMP Administration|3|||
125106098|NCT02957682|450011656|FG001|Overall Study|Related to IMP Administration|6|||
125106099|NCT02957682|450011655|FG000|Overall Study|Non-disclosed|16|||
125106100|NCT02957682|450011656|FG001|Overall Study|Non-disclosed|12|||
125106101|NCT02957682|450011655|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
125106102|NCT02957682|450011656|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
125106103|NCT04651218|450011657|FG000|Overall Study|Withdrawal by Subject|0|||
125106104|NCT04651218|450011658|FG001|Overall Study|Withdrawal by Subject|2|||
125106105|NCT00765999|450011659|FG000|Overall Study|Adverse Event|203|||
125106106|NCT00765999|450011659|FG000|Overall Study|Insufficient Therapeutic Response|100|||
125106107|NCT00765999|450011659|FG000|Overall Study|Protocol Violation|95|||
125106108|NCT00765999|450011659|FG000|Overall Study|Consent Withdrawn|202|||
125106109|NCT00765999|450011659|FG000|Overall Study|Lost to Follow-up|131|||
125106110|NCT00765999|450011659|FG000|Overall Study|Study Terminated by Sponsor|2|||
125106111|NCT00765999|450011659|FG000|Overall Study|Other Miscellaneous Reasons|51|||
125106112|NCT00414011|450011660|FG000|Overall Study|Physician Decision|3|||
125106113|NCT00414011|450011660|FG000|Overall Study|Withdrawal by Subject|2|||
125106114|NCT02476851|450011661|FG000|Overall Study|Protocol Violation|1|||
125106115|NCT02476851|450011662|FG001|Overall Study|Protocol Violation|1|||
125106116|NCT01399125|450011663|FG000|Overall Study|Adverse Event|32|||
125106117|NCT01399125|450011664|FG001|Overall Study|Adverse Event|30|||
125106118|NCT01399125|450011663|FG000|Overall Study|Abnormal Lab values|0|||
125106119|NCT01399125|450011664|FG001|Overall Study|Abnormal Lab values|1|||
125106120|NCT01399125|450011663|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
125106121|NCT01399125|450011664|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
125106122|NCT01399125|450011663|FG000|Overall Study|Withdrawal by Subject|5|||
125106123|NCT01399125|450011664|FG001|Overall Study|Withdrawal by Subject|8|||
125106124|NCT01399125|450011663|FG000|Overall Study|Lost to Follow-up|2|||
125106125|NCT01399125|450011664|FG001|Overall Study|Lost to Follow-up|3|||
125106126|NCT01399125|450011663|FG000|Overall Study|Administrative Problems|7|||
125106127|NCT01399125|450011664|FG001|Overall Study|Administrative Problems|11|||
125106128|NCT01399125|450011663|FG000|Overall Study|Death|0|||
125106129|NCT01399125|450011664|FG001|Overall Study|Death|1|||
124888635|NCT02555371|449216780|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
124888636|NCT02555371|449216776|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
124888637|NCT02555371|449216777|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
124888638|NCT02555371|449216778|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
124888639|NCT02555371|449216779|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
124888640|NCT02555371|449216780|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
124888641|NCT02555371|449216776|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
124888642|NCT02555371|449216777|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
124888643|NCT02555371|449216778|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
124888644|NCT02555371|449216779|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
124888645|NCT02555371|449216780|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
124888646|NCT02555371|449216776|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
124888647|NCT02555371|449216777|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
124888648|NCT02555371|449216778|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
124888649|NCT02555371|449216779|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
124888650|NCT02555371|449216780|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
124888651|NCT02555371|449216776|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
124888652|NCT02555371|449216777|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
124888653|NCT02555371|449216778|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
124888654|NCT02555371|449216779|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
124888655|NCT02555371|449216780|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
124888656|NCT02555371|449216776|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
124888657|NCT02555371|449216777|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
124888658|NCT02555371|449216778|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
124888659|NCT02555371|449216779|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
124888660|NCT02555371|449216780|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
124888661|NCT02555371|449216776|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
125106130|NCT01399125|450011663|FG000|Overall Study|Protocol Deviation|5|||
125106131|NCT01399125|450011664|FG001|Overall Study|Protocol Deviation|2|||
125106132|NCT00647426|450011667|FG000|Overall Study|Withdrawal by Subject|2|||
125106133|NCT03343054|450011672|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
125106134|NCT03343054|450011673|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
125106135|NCT03343054|450011674|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
125106136|NCT03343054|450011672|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
125106137|NCT03343054|450011673|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
125106138|NCT03343054|450011674|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
125106139|NCT03343054|450011672|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
125106140|NCT03343054|450011673|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
125106141|NCT03343054|450011674|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
125106142|NCT03343054|450011672|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
125106143|NCT03343054|450011673|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
125106144|NCT03343054|450011674|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
125106145|NCT03578276|450011675|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
125106146|NCT03578276|450011676|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
125106147|NCT02626182|450011677|FG000|Overall Study|Adverse Event|2|||
125106148|NCT02626182|450011678|FG001|Overall Study|Adverse Event|0|||
125106149|NCT00883740|450011679|FG000|First Intervention|Lost to Follow-up|1|||
125106150|NCT00883740|450011680|FG001|First Intervention|Lost to Follow-up|0|||
125106151|NCT00883740|450011679|FG000|First Intervention|No longer willing to participate|2|||
125106152|NCT00883740|450011680|FG001|First Intervention|No longer willing to participate|0|||
125106153|NCT00883740|450011679|FG000|First Intervention|Protocol Violation|3|||
125106154|NCT00883740|450011680|FG001|First Intervention|Protocol Violation|6|||
125106155|NCT00883740|450011679|FG000|First Intervention|Adverse Event|1|||
125106156|NCT00883740|450011680|FG001|First Intervention|Adverse Event|2|||
125106157|NCT00883740|450011679|FG000|Second Intervention|Protocol Violation|1|||
125106158|NCT00883740|450011680|FG001|Second Intervention|Protocol Violation|0|||
125106159|NCT00883740|450011679|FG000|Second Intervention|No longer willing to participate|0|||
125106160|NCT00883740|450011680|FG001|Second Intervention|No longer willing to participate|1|||
125106161|NCT00981409|450011681|FG000|Overall Study|Adverse Event|4|||
125106162|NCT00981409|450011682|FG001|Overall Study|Adverse Event|0|||
125106163|NCT00981409|450011681|FG000|Overall Study|Protocol Violation|0|||
125106164|NCT00981409|450011682|FG001|Overall Study|Protocol Violation|1|||
125106165|NCT00981409|450011681|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
125106166|NCT00981409|450011682|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
125106167|NCT03869684|450011691|FG000|Overall Study|Adverse Event|0|||
125106168|NCT03869684|450011692|FG001|Overall Study|Adverse Event|3|||
125106169|NCT03869684|450011693|FG002|Overall Study|Adverse Event|1|||
125106170|NCT03869684|450011691|FG000|Overall Study|Withdrawal by Subject|1|||
125106171|NCT03869684|450011692|FG001|Overall Study|Withdrawal by Subject|0|||
125106172|NCT03869684|450011693|FG002|Overall Study|Withdrawal by Subject|0|||
125106173|NCT03869684|450011691|FG000|Overall Study|Lost to Follow-up|1|||
125106174|NCT03869684|450011692|FG001|Overall Study|Lost to Follow-up|0|||
125106175|NCT03869684|450011693|FG002|Overall Study|Lost to Follow-up|0|||
125106176|NCT03869684|450011691|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
125106177|NCT03869684|450011692|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
125106178|NCT03869684|450011693|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
125106179|NCT00078312|450011694|FG000|Overall Study|Adverse Event|43|||
125106180|NCT00078312|450011694|FG000|Overall Study|Lack of Efficacy|15|||
125106181|NCT00078312|450011694|FG000|Overall Study|Lost to Follow-up|41|||
125106182|NCT00078312|450011694|FG000|Overall Study|Physician Decision|9|||
125106183|NCT00078312|450011694|FG000|Overall Study|Protocol Violation|3|||
125106184|NCT00078312|450011694|FG000|Overall Study|Withdrawal by Subject|33|||
125106185|NCT00078312|450011694|FG000|Overall Study|Miscellaneous|33|||
125106186|NCT04840901|450011695|FG000|Overall Study|Lost to Follow-up|3|||
125106187|NCT04840901|450011696|FG001|Overall Study|Lost to Follow-up|1|||
125106188|NCT04840901|450011695|FG000|Overall Study|Moved|1|||
125106189|NCT04840901|450011696|FG001|Overall Study|Moved|0|||
125106190|NCT04840901|450011695|FG000|Overall Study|Unable to comply with study schedule|0|||
125106191|NCT04840901|450011696|FG001|Overall Study|Unable to comply with study schedule|1|||
125106192|NCT04840901|450011695|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
125106193|NCT04840901|450011696|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
125106194|NCT05354206|450011697|FG000|Overall Study|Withdrawal by Subject|1|||
125106195|NCT05354206|450011698|FG001|Overall Study|Withdrawal by Subject|0|||
125106196|NCT04285983|450011699|FG000|Overall Study|Protocol Violation|6|||
125106197|NCT04936334|450011700|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
125106198|NCT00422058|450011701|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
125106199|NCT00422058|450011702|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
125106200|NCT00422058|450011703|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
125106201|NCT00422058|450011704|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
125016259|NCT02432235|449684303|FG003|Overall Study|Death|2|||
125106202|NCT00422058|450011705|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
125106203|NCT00422058|450011706|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
125106204|NCT00422058|450011701|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
125106205|NCT00422058|450011702|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
125106206|NCT00422058|450011703|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
125106207|NCT00422058|450011704|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
125106208|NCT00422058|450011705|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
125106209|NCT00422058|450011706|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
125106210|NCT00422058|450011701|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
125106211|NCT00422058|450011702|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
125106212|NCT00422058|450011703|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
125106213|NCT00422058|450011704|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
125106214|NCT00422058|450011705|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
125106215|NCT00422058|450011706|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
125106216|NCT00422058|450011701|FG000|Double-Blind, Week 0-20|Other|11|||
125106217|NCT00422058|450011702|FG001|Double-Blind, Week 0-20|Other|3|||
125106218|NCT00422058|450011703|FG002|Double-Blind, Week 0-20|Other|8|||
125106219|NCT00422058|450011704|FG003|Double-Blind, Week 0-20|Other|8|||
125106220|NCT00422058|450011705|FG004|Double-Blind, Week 0-20|Other|4|||
125106221|NCT00422058|450011706|FG005|Double-Blind, Week 0-20|Other|10|||
125106222|NCT00422058|450011701|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
125106223|NCT00422058|450011702|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
125106224|NCT00422058|450011703|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
125106225|NCT00422058|450011704|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
125016260|NCT02432235|449684304|FG004|Overall Study|Death|1|||
125016261|NCT02432235|449684305|FG005|Overall Study|Death|3|||
125016262|NCT02432235|449684306|FG006|Overall Study|Death|11|||
125016263|NCT02432235|449684307|FG007|Overall Study|Death|15|||
125016264|NCT02432235|449684308|FG008|Overall Study|Death|15|||
125016265|NCT02432235|449684309|FG009|Overall Study|Death|3|||
125016266|NCT02432235|449684310|FG010|Overall Study|Death|1|||
125016267|NCT02432235|449684311|FG011|Overall Study|Death|0|||
125016268|NCT02432235|449684300|FG000|Overall Study|Withdrawal by Subject|0|||
125016269|NCT02432235|449684301|FG001|Overall Study|Withdrawal by Subject|1|||
125016270|NCT02432235|449684302|FG002|Overall Study|Withdrawal by Subject|0|||
125016271|NCT02432235|449684303|FG003|Overall Study|Withdrawal by Subject|0|||
125016272|NCT02432235|449684304|FG004|Overall Study|Withdrawal by Subject|0|||
125016273|NCT02432235|449684305|FG005|Overall Study|Withdrawal by Subject|2|||
125016274|NCT02432235|449684306|FG006|Overall Study|Withdrawal by Subject|5|||
125016275|NCT02432235|449684307|FG007|Overall Study|Withdrawal by Subject|3|||
125016276|NCT02432235|449684308|FG008|Overall Study|Withdrawal by Subject|1|||
125016277|NCT02432235|449684309|FG009|Overall Study|Withdrawal by Subject|0|||
125016278|NCT02432235|449684310|FG010|Overall Study|Withdrawal by Subject|0|||
125016279|NCT02432235|449684311|FG011|Overall Study|Withdrawal by Subject|0|||
125016280|NCT02432235|449684300|FG000|Overall Study|Lost to Follow-up|0|||
125016281|NCT02432235|449684301|FG001|Overall Study|Lost to Follow-up|0|||
125016282|NCT02432235|449684302|FG002|Overall Study|Lost to Follow-up|0|||
125016283|NCT02432235|449684303|FG003|Overall Study|Lost to Follow-up|0|||
125016284|NCT02432235|449684304|FG004|Overall Study|Lost to Follow-up|0|||
125016285|NCT02432235|449684305|FG005|Overall Study|Lost to Follow-up|1|||
125016286|NCT02432235|449684306|FG006|Overall Study|Lost to Follow-up|0|||
125016287|NCT02432235|449684307|FG007|Overall Study|Lost to Follow-up|0|||
125016288|NCT02432235|449684308|FG008|Overall Study|Lost to Follow-up|1|||
125016289|NCT02432235|449684309|FG009|Overall Study|Lost to Follow-up|0|||
125016290|NCT02432235|449684310|FG010|Overall Study|Lost to Follow-up|0|||
125016291|NCT02432235|449684311|FG011|Overall Study|Lost to Follow-up|0|||
125016292|NCT02432235|449684300|FG000|Overall Study|Miscellaneous|0|||
125016293|NCT02432235|449684301|FG001|Overall Study|Miscellaneous|0|||
125016294|NCT02432235|449684302|FG002|Overall Study|Miscellaneous|0|||
125016295|NCT02432235|449684303|FG003|Overall Study|Miscellaneous|0|||
125106226|NCT00422058|450011705|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
125106227|NCT00422058|450011706|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
125106228|NCT00422058|450011701|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
125016296|NCT02432235|449684304|FG004|Overall Study|Miscellaneous|1|||
125016297|NCT02432235|449684305|FG005|Overall Study|Miscellaneous|6|||
125016298|NCT02432235|449684306|FG006|Overall Study|Miscellaneous|2|||
125016299|NCT02432235|449684307|FG007|Overall Study|Miscellaneous|2|||
125016300|NCT02432235|449684308|FG008|Overall Study|Miscellaneous|4|||
125016301|NCT02432235|449684309|FG009|Overall Study|Miscellaneous|0|||
125016302|NCT02432235|449684310|FG010|Overall Study|Miscellaneous|0|||
125016303|NCT02432235|449684311|FG011|Overall Study|Miscellaneous|1|||
125016304|NCT00794677|449684319|FG000|First Intervention|Withdrawal by Subject|2|||
125016305|NCT00794677|449684320|FG001|First Intervention|Withdrawal by Subject|0|||
125016306|NCT01965262|449684332|FG000|Second Intervention (7 Days)|Discontinued|0|||
125016307|NCT01965262|449684333|FG001|Second Intervention (7 Days)|Discontinued|1|||
125016308|NCT01965262|449684332|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
125016309|NCT01965262|449684333|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
125016310|NCT01965262|449684332|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
125016311|NCT01965262|449684333|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
125016312|NCT00143312|449684334|FG000|Overall Study|Death|11|||
125016313|NCT00143312|449684334|FG000|Overall Study|Adverse Event|2|||
125016314|NCT00143312|449684334|FG000|Overall Study|Lost to Follow-up|1|||
125016315|NCT00143312|449684334|FG000|Overall Study|Other|1|||
125016316|NCT00143312|449684334|FG000|Overall Study|Withdrawal by Subject|1|||
125016317|NCT01029366|449684335|FG000|Overall Study|Withdrawal by Subject|1|||
125016318|NCT01029366|449684336|FG001|Overall Study|Withdrawal by Subject|0|||
125016319|NCT01029366|449684335|FG000|Overall Study|Death|1|||
125016320|NCT01029366|449684336|FG001|Overall Study|Death|1|||
125016321|NCT01029366|449684335|FG000|Overall Study|disease progression|2|||
125016322|NCT01029366|449684336|FG001|Overall Study|disease progression|0|||
125016323|NCT01029366|449684335|FG000|Overall Study|manufacturing failure|0|||
125016324|NCT01029366|449684336|FG001|Overall Study|manufacturing failure|1|||
125016325|NCT00906087|449684342|FG000|Initial Washout|Withdrawal by Subject|1|||
125016326|NCT00906087|449684342|FG000|Initial Washout|Physician Decision|1|||
125016327|NCT00796315|449684347|FG000|Overall Study|Protocol Violation|0|||
125016328|NCT00796315|449684348|FG001|Overall Study|Protocol Violation|1|||
125016329|NCT00796315|449684349|FG002|Overall Study|Protocol Violation|0|||
125016330|NCT01627860|449684354|FG000|Overall Study|Adverse Event|9|||
125016331|NCT01627860|449684355|FG001|Overall Study|Adverse Event|4|||
125016332|NCT01627860|449684354|FG000|Overall Study|Withdrawal by Subject|2|||
125016333|NCT01627860|449684355|FG001|Overall Study|Withdrawal by Subject|1|||
125016334|NCT01627860|449684354|FG000|Overall Study|Seizure frequency doubled|0|||
125016335|NCT01627860|449684355|FG001|Overall Study|Seizure frequency doubled|1|||
125016336|NCT01627860|449684354|FG000|Overall Study|Protocol Violation|1|||
125016337|NCT01627860|449684355|FG001|Overall Study|Protocol Violation|0|||
125016338|NCT03215771|449684356|FG000|Overall Study|Withdrawal by Subject|2|||
125016339|NCT03215771|449684356|FG000|Overall Study|Physician Decision|1|||
125016340|NCT02039375|449684357|FG000|Overall Study|Lost to Follow-up|2|||
125016341|NCT04770389|449684358|FG000|Overall Study|Adverse Event|1|||
125016342|NCT04770389|449684359|FG001|Overall Study|Adverse Event|2|||
125016343|NCT04770389|449684360|FG002|Overall Study|Adverse Event|0|||
125016344|NCT04770389|449684361|FG003|Overall Study|Adverse Event|1|||
125016345|NCT04770389|449684358|FG000|Overall Study|Withdrawal by Subject|0|||
125016346|NCT04770389|449684359|FG001|Overall Study|Withdrawal by Subject|2|||
125016347|NCT04770389|449684360|FG002|Overall Study|Withdrawal by Subject|1|||
125016348|NCT04770389|449684361|FG003|Overall Study|Withdrawal by Subject|0|||
125016349|NCT04770389|449684358|FG000|Overall Study|Failed attempt to draw blood|1|||
125016350|NCT04770389|449684359|FG001|Overall Study|Failed attempt to draw blood|0|||
125016351|NCT04770389|449684360|FG002|Overall Study|Failed attempt to draw blood|0|||
125016352|NCT04770389|449684361|FG003|Overall Study|Failed attempt to draw blood|0|||
125016353|NCT04770389|449684358|FG000|Overall Study|Left the country|0|||
125016354|NCT04770389|449684359|FG001|Overall Study|Left the country|0|||
125016355|NCT04770389|449684360|FG002|Overall Study|Left the country|1|||
125016356|NCT04770389|449684361|FG003|Overall Study|Left the country|2|||
125016357|NCT04770389|449684358|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
125016358|NCT04770389|449684359|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
125016359|NCT04770389|449684360|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
125016360|NCT04770389|449684361|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
125016361|NCT04770389|449684358|FG000|Overall Study|Lost to Follow-up|0|||
125016362|NCT04770389|449684359|FG001|Overall Study|Lost to Follow-up|0|||
125016363|NCT04770389|449684360|FG002|Overall Study|Lost to Follow-up|0|||
125016364|NCT04770389|449684361|FG003|Overall Study|Lost to Follow-up|1|||
125016365|NCT04770389|449684358|FG000|Overall Study|Moved away from study site|0|||
125016366|NCT04770389|449684359|FG001|Overall Study|Moved away from study site|1|||
125016367|NCT04770389|449684360|FG002|Overall Study|Moved away from study site|0|||
125016368|NCT04770389|449684361|FG003|Overall Study|Moved away from study site|0|||
125016369|NCT00689871|449684366|FG000|Overall Study|Lost to Follow-up|123|||
125016370|NCT00689871|449684367|FG001|Overall Study|Lost to Follow-up|13|||
124888662|NCT02555371|449216777|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
124888663|NCT02555371|449216778|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
125016371|NCT00689871|449684368|FG002|Overall Study|Lost to Follow-up|37|||
125016372|NCT00689871|449684369|FG003|Overall Study|Lost to Follow-up|1|||
125016373|NCT00689871|449684366|FG000|Overall Study|Explanted of All Study Devices|36|||
125016374|NCT00689871|449684367|FG001|Overall Study|Explanted of All Study Devices|25|||
125016375|NCT00689871|449684368|FG002|Overall Study|Explanted of All Study Devices|29|||
125016376|NCT00689871|449684369|FG003|Overall Study|Explanted of All Study Devices|3|||
125016377|NCT00689871|449684366|FG000|Overall Study|Withdrawal by Subject|13|||
125016378|NCT00689871|449684367|FG001|Overall Study|Withdrawal by Subject|3|||
125016379|NCT00689871|449684368|FG002|Overall Study|Withdrawal by Subject|4|||
125016380|NCT00689871|449684369|FG003|Overall Study|Withdrawal by Subject|1|||
125016381|NCT00689871|449684366|FG000|Overall Study|Death|1|||
125016382|NCT00689871|449684367|FG001|Overall Study|Death|10|||
125016383|NCT00689871|449684368|FG002|Overall Study|Death|2|||
125016384|NCT00689871|449684369|FG003|Overall Study|Death|2|||
125016385|NCT00689871|449684366|FG000|Overall Study|Physician Decision|2|||
125016386|NCT00689871|449684367|FG001|Overall Study|Physician Decision|1|||
125016387|NCT00689871|449684368|FG002|Overall Study|Physician Decision|1|||
125016388|NCT00689871|449684369|FG003|Overall Study|Physician Decision|0|||
125016389|NCT00889265|449684374|FG000|Overall Study|Adverse Event|1|||
125016390|NCT00889265|449684374|FG000|Overall Study|Lost to Follow-up|5|||
125016391|NCT00889265|449684374|FG000|Overall Study|Protocol Violation|1|||
125016392|NCT00250835|449684377|FG000|Overall Study|Withdrawal by Subject|1|||
125016393|NCT03885089|449684379|FG000|Overall Study|No informed consent for publication of study results|2|||
125016394|NCT04489888|449684382|FG000|Overall Study|Death|75|||
125016395|NCT04489888|449684382|FG000|Overall Study|Sponsor Decision|26|||
125016396|NCT03349099|449684385|FG000|Overall Study|Physician Decision|3|||
125016397|NCT03349099|449684386|FG001|Overall Study|Physician Decision|4|||
125016398|NCT03349099|449684385|FG000|Overall Study|Stone migrated from the kidney|1|||
125016399|NCT03349099|449684386|FG001|Overall Study|Stone migrated from the kidney|0|||
125016400|NCT00278993|449684387|FG000|Overall Study|Adverse Event|24|||
125016401|NCT00278993|449684387|FG000|Overall Study|Withdrawal by Subject|5|||
125016402|NCT00278993|449684387|FG000|Overall Study|Progressive Disease|65|||
125016403|NCT00278993|449684387|FG000|Overall Study|Physician Decision|9|||
125016404|NCT00278993|449684387|FG000|Overall Study|Not Otherwise Specified|4|||
125016405|NCT02043548|449684391|FG000|Overall Study|Lack of Efficacy|1|||
125016406|NCT02043548|449684392|FG001|Overall Study|Lack of Efficacy|0|||
125016407|NCT02043548|449684391|FG000|Overall Study|Adverse Event|0|||
125016408|NCT02043548|449684392|FG001|Overall Study|Adverse Event|1|||
125016409|NCT01430455|449684398|FG000|Overall Study|Withdrawal by Subject|1|||
125016410|NCT01430455|449684398|FG000|Overall Study|Switched to follow-up phase|1|||
125016411|NCT03829657|449684400|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
125016412|NCT03829657|449684401|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
125016413|NCT03829657|449684402|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
125016414|NCT03829657|449684403|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
125016415|NCT03829657|449684404|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
125016416|NCT03829657|449684400|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
125016417|NCT03829657|449684401|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
125016418|NCT03829657|449684402|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
125016419|NCT03829657|449684403|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
125016420|NCT03829657|449684404|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
125016421|NCT03829657|449684400|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
125016422|NCT03829657|449684401|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
125016423|NCT03829657|449684402|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
125016424|NCT03829657|449684403|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
125016425|NCT03829657|449684404|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
125016426|NCT03829657|449684400|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
125016427|NCT03829657|449684401|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
125016428|NCT03829657|449684402|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
125016429|NCT03829657|449684403|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
125016430|NCT03829657|449684404|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
125016431|NCT03829657|449684400|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
125016432|NCT03829657|449684401|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
125016433|NCT03829657|449684402|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
125016434|NCT03829657|449684403|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
125016435|NCT03829657|449684404|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
125016436|NCT03829657|449684400|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
125016437|NCT03829657|449684401|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
124888664|NCT02555371|449216779|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
124888665|NCT02555371|449216780|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
124888666|NCT02555371|449216776|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
124888667|NCT02555371|449216777|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
124888668|NCT02555371|449216778|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
124888669|NCT02555371|449216779|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
125016438|NCT03829657|449684402|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
125016439|NCT03829657|449684403|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
125016440|NCT03829657|449684404|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
125016441|NCT03829657|449684400|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
125016442|NCT03829657|449684401|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
125016443|NCT03829657|449684402|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
125016444|NCT03829657|449684403|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
125016445|NCT03829657|449684404|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
125016446|NCT03829657|449684400|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
125016447|NCT03829657|449684401|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
125016448|NCT03829657|449684402|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
125016449|NCT03829657|449684403|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
125016450|NCT03829657|449684404|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
125016451|NCT03829657|449684400|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
125016452|NCT03829657|449684401|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
125016453|NCT03829657|449684402|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
125016454|NCT03829657|449684403|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
125016455|NCT03829657|449684404|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
125016456|NCT03829657|449684400|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
125016457|NCT03829657|449684401|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
125016458|NCT03829657|449684402|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
125016459|NCT03829657|449684403|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
125016460|NCT03829657|449684404|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
125016461|NCT04194528|449684405|FG000|Overall Study|Adverse Event|1|||
125016462|NCT01014689|449684408|FG000|Overall Study|Lack of Efficacy|0|||
125016463|NCT01014689|449684409|FG001|Overall Study|Lack of Efficacy|1|||
125016464|NCT01014689|449684408|FG000|Overall Study|Adverse Event|3|||
125016465|NCT01014689|449684409|FG001|Overall Study|Adverse Event|0|||
125016466|NCT01014689|449684408|FG000|Overall Study|Withdrawal by Subject|5|||
125016467|NCT01014689|449684409|FG001|Overall Study|Withdrawal by Subject|4|||
125016468|NCT01014689|449684408|FG000|Overall Study|Protocol Violation|1|||
125016469|NCT01014689|449684409|FG001|Overall Study|Protocol Violation|1|||
125016470|NCT01014689|449684408|FG000|Overall Study|Lost to Follow-up|3|||
125016471|NCT01014689|449684409|FG001|Overall Study|Lost to Follow-up|7|||
125016472|NCT01014689|449684408|FG000|Overall Study|Pregnancy|1|||
125016473|NCT01014689|449684409|FG001|Overall Study|Pregnancy|0|||
125016474|NCT00333359|449684411|FG000|Overall Study|Adverse Event|29|||
125016475|NCT00333359|449684412|FG001|Overall Study|Adverse Event|35|||
125016476|NCT00333359|449684411|FG000|Overall Study|Withdrawal by Subject|19|||
125016477|NCT00333359|449684412|FG001|Overall Study|Withdrawal by Subject|37|||
125016478|NCT00333359|449684411|FG000|Overall Study|Physician Decision|2|||
125016479|NCT00333359|449684412|FG001|Overall Study|Physician Decision|2|||
125016480|NCT00333359|449684411|FG000|Overall Study|Protocol Non-compliance|2|||
125016481|NCT00333359|449684412|FG001|Overall Study|Protocol Non-compliance|8|||
125016482|NCT00333359|449684411|FG000|Overall Study|Lost to Follow-up|15|||
125016483|NCT00333359|449684412|FG001|Overall Study|Lost to Follow-up|25|||
125016484|NCT00333359|449684411|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
125016485|NCT00333359|449684412|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
125016486|NCT00333359|449684411|FG000|Overall Study|Treatment Failure|3|||
125016487|NCT00333359|449684412|FG001|Overall Study|Treatment Failure|8|||
125016488|NCT00333359|449684411|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
125016489|NCT00333359|449684412|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
124888670|NCT02555371|449216780|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
125016490|NCT01394939|449685455|FG000|Overall Study|Adverse Event|1|||
125016491|NCT01394939|449685456|FG001|Overall Study|Adverse Event|3|||
125106229|NCT00422058|450011702|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
125106230|NCT00422058|450011703|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
125106231|NCT00422058|450011704|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
125106232|NCT00422058|450011705|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
125106233|NCT00422058|450011706|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
125106234|NCT00422058|450011701|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
125106235|NCT00422058|450011702|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
125106236|NCT00422058|450011703|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
125106237|NCT00422058|450011704|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
125106238|NCT00422058|450011705|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
125106239|NCT00422058|450011706|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
125106240|NCT00422058|450011701|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
125106241|NCT00422058|450011702|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
125106242|NCT00422058|450011703|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
125106243|NCT00422058|450011704|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
125106244|NCT00422058|450011705|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
125106245|NCT00422058|450011706|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
125106246|NCT00422058|450011701|FG000|Open-Label Extension, Week 20-104|Other|13|||
125106247|NCT00422058|450011702|FG001|Open-Label Extension, Week 20-104|Other|14|||
125106248|NCT00422058|450011703|FG002|Open-Label Extension, Week 20-104|Other|6|||
125106249|NCT00422058|450011704|FG003|Open-Label Extension, Week 20-104|Other|13|||
125106250|NCT00422058|450011705|FG004|Open-Label Extension, Week 20-104|Other|16|||
125106251|NCT00422058|450011706|FG005|Open-Label Extension, Week 20-104|Other|18|||
125106252|NCT00627458|450011709|FG000|Overall Study|Migrated from study area|1|||
125106253|NCT00627458|450011710|FG001|Overall Study|Migrated from study area|0|||
125106254|NCT00627458|450011711|FG002|Overall Study|Migrated from study area|1|||
125106255|NCT00627458|450011709|FG000|Overall Study|Withdrawal by Subject|2|||
125106256|NCT00627458|450011710|FG001|Overall Study|Withdrawal by Subject|6|||
125106257|NCT00627458|450011711|FG002|Overall Study|Withdrawal by Subject|5|||
125106258|NCT00627458|450011709|FG000|Overall Study|Lost to Follow-up|1|||
125106259|NCT00627458|450011710|FG001|Overall Study|Lost to Follow-up|1|||
125106260|NCT00627458|450011711|FG002|Overall Study|Lost to Follow-up|0|||
125106261|NCT02587325|450011715|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
125106262|NCT02587325|450011716|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
125106263|NCT02587325|450011717|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
125106264|NCT02587325|450011718|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
125106265|NCT02587325|450011719|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
125106266|NCT02587325|450011715|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
125106267|NCT02587325|450011716|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
125106268|NCT02587325|450011717|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
125106269|NCT02587325|450011718|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
125106270|NCT02587325|450011719|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
125106271|NCT02587325|450011715|FG000|32-Week Optional Extension Part|Adverse Event|0|||
125106272|NCT02587325|450011716|FG001|32-Week Optional Extension Part|Adverse Event|0|||
125106273|NCT02587325|450011717|FG002|32-Week Optional Extension Part|Adverse Event|1|||
125106274|NCT02587325|450011718|FG003|32-Week Optional Extension Part|Adverse Event|0|||
125106275|NCT02587325|450011719|FG004|32-Week Optional Extension Part|Adverse Event|0|||
125106276|NCT02587325|450011715|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
125106277|NCT02587325|450011716|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
125106278|NCT02587325|450011717|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
125106279|NCT02587325|450011718|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
125106280|NCT02587325|450011719|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
125106281|NCT01831596|450011720|FG000|Overall Study|Other|8|||
125106282|NCT01898884|450011723|FG000|Multiple Dose Period|Adverse Event|0|||
125106283|NCT01898884|450011724|FG001|Multiple Dose Period|Adverse Event|0|||
125106284|NCT01898884|450011725|FG002|Multiple Dose Period|Adverse Event|0|||
125106285|NCT01898884|450011726|FG003|Multiple Dose Period|Adverse Event|0|||
125106286|NCT01898884|450011727|FG004|Multiple Dose Period|Adverse Event|0|||
125106287|NCT01898884|450011728|FG005|Multiple Dose Period|Adverse Event|0|||
125106288|NCT01898884|450011729|FG006|Multiple Dose Period|Adverse Event|1|||
124888671|NCT02555371|449216776|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
124888672|NCT02555371|449216777|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
125016492|NCT01394939|449685457|FG002|Overall Study|Adverse Event|0|||
125016493|NCT01394939|449685458|FG003|Overall Study|Adverse Event|2|||
125016494|NCT01394939|449685455|FG000|Overall Study|Death|0|||
125016495|NCT01394939|449685456|FG001|Overall Study|Death|2|||
125016496|NCT01394939|449685457|FG002|Overall Study|Death|0|||
125016497|NCT01394939|449685458|FG003|Overall Study|Death|0|||
125016498|NCT01394939|449685455|FG000|Overall Study|Physician Decision|0|||
125016499|NCT01394939|449685456|FG001|Overall Study|Physician Decision|1|||
125016500|NCT01394939|449685457|FG002|Overall Study|Physician Decision|0|||
125016501|NCT01394939|449685458|FG003|Overall Study|Physician Decision|0|||
125016502|NCT01394939|449685455|FG000|Overall Study|Withdrawal by Subject|0|||
125016503|NCT01394939|449685456|FG001|Overall Study|Withdrawal by Subject|2|||
125016504|NCT01394939|449685457|FG002|Overall Study|Withdrawal by Subject|0|||
125016505|NCT01394939|449685458|FG003|Overall Study|Withdrawal by Subject|2|||
125016506|NCT01394939|449685455|FG000|Overall Study|Others|0|||
125016507|NCT01394939|449685456|FG001|Overall Study|Others|2|||
125016508|NCT01394939|449685457|FG002|Overall Study|Others|0|||
125016509|NCT01394939|449685458|FG003|Overall Study|Others|3|||
125016510|NCT01339559|449685462|FG000|Overall Study|Adverse Event|92|||
125016511|NCT01339559|449685462|FG000|Overall Study|Death|5|||
125016512|NCT01339559|449685462|FG000|Overall Study|Lack of Efficacy|164|||
125016513|NCT01339559|449685462|FG000|Overall Study|Lost to Follow-up|22|||
125016514|NCT01339559|449685462|FG000|Overall Study|Subject choice|89|||
125016515|NCT01339559|449685462|FG000|Overall Study|Protocol Violation|15|||
125016516|NCT01339559|449685462|FG000|Overall Study|Study closure at site|1|||
125016517|NCT01339559|449685462|FG000|Overall Study|Incarcerated|2|||
125016518|NCT01339559|449685462|FG000|Overall Study|Epilepsy surgery|1|||
125016519|NCT01339559|449685462|FG000|Overall Study|Pregnancy planned|2|||
125016520|NCT01339559|449685462|FG000|Overall Study|Left the country|1|||
125016521|NCT01339559|449685462|FG000|Overall Study|Investigator decision|2|||
125016522|NCT01339559|449685462|FG000|Overall Study|Patient didn't wish to continue|1|||
125016523|NCT01339559|449685462|FG000|Overall Study|PI decision|1|||
125016524|NCT00414453|449685463|FG000|Overall Study|Abnormal lab work|16|||
125016525|NCT00290433|449685469|FG000|Overall Study|Disease Progression|13|||
125016526|NCT00290433|449685469|FG000|Overall Study|Adverse Event|14|||
125016527|NCT00290433|449685469|FG000|Overall Study|Withdrawal by Subject|1|||
125016528|NCT00290433|449685469|FG000|Overall Study|Non-Compliance|1|||
125016529|NCT00290433|449685469|FG000|Overall Study|Congestive Heart Failure|1|||
125016530|NCT00290433|449685469|FG000|Overall Study|Transplant in CR|5|||
125016531|NCT00290433|449685469|FG000|Overall Study|Unrelated Infection/Death|1|||
125016532|NCT05098041|449685473|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
125016533|NCT03948178|449685474|FG000|Overall Study|Protocol Violation|1|||
125016534|NCT03948178|449685474|FG000|Overall Study|Lost to Follow-up|2|||
125016535|NCT03948178|449685474|FG000|Overall Study|Withdrawal by Subject|2|||
125016536|NCT03948178|449685474|FG000|Overall Study|Reason not known|2|||
125016537|NCT03948178|449685474|FG000|Overall Study|Personal reason|14|||
125016538|NCT03948178|449685474|FG000|Overall Study|Disease progression|30|||
125016539|NCT03948178|449685474|FG000|Overall Study|Adverse Event|12|||
125016540|NCT03948178|449685474|FG000|Overall Study|Sponsor terminated study|164|||
125016541|NCT00382993|449685475|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
125016542|NCT00382993|449685476|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
125016543|NCT00382993|449685475|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
125016544|NCT00382993|449685476|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
125016545|NCT00382993|449685475|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
125016546|NCT00382993|449685476|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
125016547|NCT00382993|449685475|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
125016548|NCT00382993|449685476|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
125016549|NCT00382993|449685475|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
125016550|NCT00382993|449685476|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
125016551|NCT00382993|449685475|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
125016552|NCT00382993|449685476|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
125016553|NCT00382993|449685475|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
125016554|NCT00382993|449685476|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
125016555|NCT00382993|449685475|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
125106289|NCT01898884|450011730|FG007|Multiple Dose Period|Adverse Event|0|||
125016556|NCT00382993|449685476|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
125016557|NCT00382993|449685475|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
125016558|NCT00382993|449685476|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
125016559|NCT00382993|449685475|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
125016560|NCT00382993|449685476|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
125106290|NCT01898884|450011731|FG008|Multiple Dose Period|Adverse Event|0|||
125106291|NCT01898884|450011723|FG000|Multiple Dose Period|Randomized Not Treated|0|||
125106292|NCT01898884|450011724|FG001|Multiple Dose Period|Randomized Not Treated|0|||
125106293|NCT01898884|450011725|FG002|Multiple Dose Period|Randomized Not Treated|0|||
125106294|NCT01898884|450011726|FG003|Multiple Dose Period|Randomized Not Treated|0|||
125106295|NCT01898884|450011727|FG004|Multiple Dose Period|Randomized Not Treated|0|||
125106296|NCT01898884|450011728|FG005|Multiple Dose Period|Randomized Not Treated|0|||
125106297|NCT01898884|450011729|FG006|Multiple Dose Period|Randomized Not Treated|0|||
125106298|NCT01898884|450011730|FG007|Multiple Dose Period|Randomized Not Treated|0|||
125106299|NCT01898884|450011731|FG008|Multiple Dose Period|Randomized Not Treated|1|||
125106300|NCT01336608|450013417|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
125106301|NCT01336608|450013418|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125106302|NCT01336608|450013419|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125106303|NCT01336608|450013420|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125106304|NCT01336608|450013417|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
125106305|NCT01336608|450013418|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125106306|NCT01336608|450013419|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125106307|NCT01336608|450013420|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125106308|NCT01336608|450013417|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
125106309|NCT01336608|450013418|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
125106310|NCT01336608|450013419|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
125106311|NCT01336608|450013420|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
125106312|NCT01336608|450013417|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
125106313|NCT01336608|450013418|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
125106314|NCT01336608|450013419|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
125106315|NCT01336608|450013420|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
125106316|NCT01336608|450013417|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
125106317|NCT01336608|450013418|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125106318|NCT01336608|450013419|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125106319|NCT01336608|450013420|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125106320|NCT01336608|450013417|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
125106321|NCT01336608|450013418|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
125106322|NCT01336608|450013419|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
125106323|NCT01336608|450013420|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
125106324|NCT01336608|450013417|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125106325|NCT01336608|450013418|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
125106326|NCT01336608|450013419|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125106327|NCT01336608|450013420|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125106328|NCT01336608|450013417|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
125106329|NCT01336608|450013418|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
125106330|NCT01336608|450013419|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
125106331|NCT01336608|450013420|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
125106332|NCT01336608|450013417|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
125106333|NCT01336608|450013418|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
125106334|NCT01336608|450013419|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
125106335|NCT01336608|450013420|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
125106336|NCT01336608|450013417|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
125106337|NCT01336608|450013418|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
125106338|NCT01336608|450013419|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
125106339|NCT01336608|450013420|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
125106340|NCT01336608|450013417|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125106341|NCT01336608|450013418|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
125106342|NCT01336608|450013419|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125106343|NCT01336608|450013420|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125106344|NCT01336608|450013417|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
125106345|NCT01336608|450013418|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
125106346|NCT01336608|450013419|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
125106347|NCT01336608|450013420|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
125106348|NCT01336608|450013417|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
125106349|NCT01336608|450013418|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
125106350|NCT01336608|450013419|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
125106351|NCT01336608|450013420|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
125106352|NCT00080288|450013421|FG000|Overall Study|Adverse Event|7|||
125106353|NCT00080288|450013422|FG001|Overall Study|Adverse Event|4|||
125106354|NCT00080288|450013421|FG000|Overall Study|Lost to Follow-up|3|||
125106355|NCT00080288|450013422|FG001|Overall Study|Lost to Follow-up|5|||
125106356|NCT00080288|450013421|FG000|Overall Study|Physician Decision|6|||
125106357|NCT00080288|450013422|FG001|Overall Study|Physician Decision|2|||
125106358|NCT00080288|450013421|FG000|Overall Study|Withdrawal by Subject|3|||
125106359|NCT00080288|450013422|FG001|Overall Study|Withdrawal by Subject|16|||
125106360|NCT00080288|450013421|FG000|Overall Study|Miscellaneous|11|||
125106361|NCT00080288|450013422|FG001|Overall Study|Miscellaneous|11|||
125106362|NCT03044431|450013423|FG000|Overall Study|Lost to Follow-up|59|||
125106363|NCT02328547|450013424|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
125106364|NCT02328547|450013425|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
125106365|NCT02328547|450013424|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
125106366|NCT02328547|450013425|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
125106367|NCT00344305|450013429|FG000|Overall Study|Lost to Follow-up|2|||
125106368|NCT00344305|450013430|FG001|Overall Study|Lost to Follow-up|0|||
125106369|NCT00344305|450013429|FG000|Overall Study|Participant was not contacted in window|0|||
125106370|NCT00344305|450013430|FG001|Overall Study|Participant was not contacted in window|1|||
125106371|NCT01726335|450013437|FG000|Overall Study|Lost to Follow-up|2|||
125106372|NCT01726335|450013437|FG000|Overall Study|Withdrawal by Subject|15|||
125106373|NCT01726335|450013437|FG000|Overall Study|Adverse Event|4|||
125106374|NCT01726335|450013437|FG000|Overall Study|Lost to Follow-up|2|||
125106375|NCT01726335|450013437|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
125106376|NCT01796860|450013442|FG000|Overall Study|Withdrawal by Subject|3|||
125106377|NCT02703454|450013451|FG000|Overall Study|Not treated|1|||
125106378|NCT02703454|450013452|FG001|Overall Study|Not treated|3|||
125106379|NCT02703454|450013451|FG000|Overall Study|Withdrawal by Subject|4|||
125106380|NCT02703454|450013452|FG001|Overall Study|Withdrawal by Subject|3|||
125106381|NCT02703454|450013451|FG000|Overall Study|Lost to Follow-up|1|||
125106382|NCT02703454|450013452|FG001|Overall Study|Lost to Follow-up|2|||
125106383|NCT02703454|450013451|FG000|Overall Study|Study discontinuation|5|||
125106384|NCT02703454|450013452|FG001|Overall Study|Study discontinuation|8|||
125106385|NCT00791154|450013453|FG000|Overall Study|Noncompliance|0|||
125106386|NCT00791154|450013454|FG001|Overall Study|Noncompliance|1|||
125106387|NCT00791154|450013455|FG002|Overall Study|Noncompliance|0|||
125106388|NCT00791154|450013456|FG003|Overall Study|Noncompliance|0|||
125106389|NCT00791154|450013457|FG004|Overall Study|Noncompliance|1|||
125106390|NCT00791154|450013458|FG005|Overall Study|Noncompliance|1|||
125106391|NCT00791154|450013459|FG006|Overall Study|Noncompliance|1|||
125106392|NCT00791154|450013453|FG000|Overall Study|Adverse Event|0|||
125106393|NCT00791154|450013454|FG001|Overall Study|Adverse Event|0|||
125106394|NCT00791154|450013455|FG002|Overall Study|Adverse Event|0|||
125106395|NCT00791154|450013456|FG003|Overall Study|Adverse Event|0|||
125106396|NCT00791154|450013457|FG004|Overall Study|Adverse Event|2|||
125106397|NCT00791154|450013458|FG005|Overall Study|Adverse Event|0|||
125106398|NCT00791154|450013459|FG006|Overall Study|Adverse Event|1|||
125106399|NCT00791154|450013453|FG000|Overall Study|Full Consent withdrawn|1|||
125106400|NCT00791154|450013454|FG001|Overall Study|Full Consent withdrawn|3|||
125106401|NCT00791154|450013455|FG002|Overall Study|Full Consent withdrawn|0|||
125106402|NCT00791154|450013456|FG003|Overall Study|Full Consent withdrawn|0|||
125106403|NCT00791154|450013457|FG004|Overall Study|Full Consent withdrawn|1|||
125106404|NCT00791154|450013458|FG005|Overall Study|Full Consent withdrawn|3|||
125106405|NCT00791154|450013459|FG006|Overall Study|Full Consent withdrawn|1|||
125106406|NCT00791154|450013453|FG000|Overall Study|Lost to Follow-up|0|||
125106407|NCT00791154|450013454|FG001|Overall Study|Lost to Follow-up|0|||
125106408|NCT00791154|450013455|FG002|Overall Study|Lost to Follow-up|0|||
125106409|NCT00791154|450013456|FG003|Overall Study|Lost to Follow-up|1|||
125106410|NCT00791154|450013457|FG004|Overall Study|Lost to Follow-up|2|||
125106411|NCT00791154|450013458|FG005|Overall Study|Lost to Follow-up|0|||
125106412|NCT00791154|450013459|FG006|Overall Study|Lost to Follow-up|4|||
125106413|NCT00791154|450013453|FG000|Overall Study|Death|5|||
125106414|NCT00791154|450013454|FG001|Overall Study|Death|4|||
125106415|NCT00791154|450013455|FG002|Overall Study|Death|4|||
124888673|NCT02555371|449216778|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
124888674|NCT02555371|449216779|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
125106416|NCT00791154|450013456|FG003|Overall Study|Death|7|||
125106417|NCT00791154|450013457|FG004|Overall Study|Death|54|||
125106418|NCT00791154|450013458|FG005|Overall Study|Death|54|||
125106419|NCT00791154|450013459|FG006|Overall Study|Death|52|||
124888675|NCT02555371|449216780|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
124888676|NCT02555371|449216776|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
125106420|NCT00791154|450013453|FG000|Overall Study|Other event|0|||
125106421|NCT00791154|450013454|FG001|Overall Study|Other event|0|||
125106422|NCT00791154|450013455|FG002|Overall Study|Other event|2|||
125106423|NCT00791154|450013456|FG003|Overall Study|Other event|0|||
125106424|NCT00791154|450013457|FG004|Overall Study|Other event|2|||
125106425|NCT00791154|450013458|FG005|Overall Study|Other event|4|||
125106426|NCT00791154|450013459|FG006|Overall Study|Other event|2|||
125106427|NCT02284373|450013460|FG000|Overall Study|Withdrawal by Subject|0|||
125106428|NCT02284373|450013461|FG001|Overall Study|Withdrawal by Subject|1|||
125106429|NCT02284373|450013462|FG002|Overall Study|Withdrawal by Subject|0|||
125106430|NCT02284373|450013460|FG000|Overall Study|Other|0|||
125106431|NCT02284373|450013461|FG001|Overall Study|Other|1|||
125106432|NCT02284373|450013462|FG002|Overall Study|Other|0|||
125106433|NCT02284373|450013460|FG000|Overall Study|Lost to Follow-up|0|||
125106434|NCT02284373|450013461|FG001|Overall Study|Lost to Follow-up|1|||
125106435|NCT02284373|450013462|FG002|Overall Study|Lost to Follow-up|0|||
125106436|NCT01508325|450013467|FG000|Overall Study|Withdrawal by Subject|8|||
125106437|NCT01508325|450013468|FG001|Overall Study|Withdrawal by Subject|9|||
125106438|NCT01508325|450013467|FG000|Overall Study|Protocol Violation|0|||
125106439|NCT01508325|450013468|FG001|Overall Study|Protocol Violation|3|||
125106440|NCT01508325|450013467|FG000|Overall Study|Physician Decision|2|||
125106441|NCT01508325|450013468|FG001|Overall Study|Physician Decision|1|||
125106442|NCT01508325|450013467|FG000|Overall Study|Adverse Event|1|||
125106443|NCT01508325|450013468|FG001|Overall Study|Adverse Event|0|||
125106444|NCT01508325|450013467|FG000|Overall Study|Lost to Follow-up|5|||
125106445|NCT01508325|450013468|FG001|Overall Study|Lost to Follow-up|6|||
125106446|NCT01508325|450013467|FG000|Overall Study|Other|2|||
125106447|NCT01508325|450013468|FG001|Overall Study|Other|2|||
125106448|NCT03543046|450013469|FG000|Overall Study|Adverse Event|1|||
125106449|NCT03543046|450013470|FG001|Overall Study|Adverse Event|1|||
125106450|NCT03543046|450013469|FG000|Overall Study|Physician Decision|1|||
125106451|NCT03543046|450013470|FG001|Overall Study|Physician Decision|1|||
125106452|NCT03543046|450013469|FG000|Overall Study|Protocol Violation|1|||
125106453|NCT03543046|450013470|FG001|Overall Study|Protocol Violation|0|||
125106454|NCT01227954|450013471|FG000|Overall Study|Protocol Violation|6|||
125106455|NCT01227954|450013471|FG000|Overall Study|No protocol treatment|7|||
125106456|NCT01296152|450013472|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
125106457|NCT01414062|450013477|FG000|Overall Study|Lost to Follow-up|3|||
125106458|NCT01414062|450013478|FG001|Overall Study|Lost to Follow-up|2|||
125106459|NCT01414062|450013477|FG000|Overall Study|Left Country|1|||
125106460|NCT01414062|450013478|FG001|Overall Study|Left Country|1|||
125106461|NCT01414062|450013477|FG000|Overall Study|Family Disapproval|1|||
125106462|NCT01414062|450013478|FG001|Overall Study|Family Disapproval|0|||
125106463|NCT01414062|450013477|FG000|Overall Study|Withdrawal by Subject|0|||
125106464|NCT01414062|450013478|FG001|Overall Study|Withdrawal by Subject|1|||
125106465|NCT04057118|450013481|FG000|Overall Study|Adverse Event|1|||
125106466|NCT04057118|450013482|FG001|Overall Study|Adverse Event|0|||
125106467|NCT04057118|450013483|FG002|Overall Study|Adverse Event|1|||
125106468|NCT04057118|450013484|FG003|Overall Study|Adverse Event|1|||
125106469|NCT04057118|450013481|FG000|Overall Study|Physician Decision|0|||
125106470|NCT04057118|450013482|FG001|Overall Study|Physician Decision|0|||
125106471|NCT04057118|450013483|FG002|Overall Study|Physician Decision|1|||
125106472|NCT04057118|450013484|FG003|Overall Study|Physician Decision|1|||
125106473|NCT04057118|450013481|FG000|Overall Study|Withdrawal by Subject|2|||
125106474|NCT04057118|450013482|FG001|Overall Study|Withdrawal by Subject|2|||
125106475|NCT04057118|450013483|FG002|Overall Study|Withdrawal by Subject|0|||
125106476|NCT04057118|450013484|FG003|Overall Study|Withdrawal by Subject|2|||
125106477|NCT04057118|450013481|FG000|Overall Study|Not Specific|0|||
125106478|NCT04057118|450013482|FG001|Overall Study|Not Specific|0|||
125106479|NCT04057118|450013483|FG002|Overall Study|Not Specific|1|||
125106480|NCT04057118|450013484|FG003|Overall Study|Not Specific|1|||
125106481|NCT02787785|450013487|FG000|Overall Study|Death|3|||
125106482|NCT02787785|450013488|FG001|Overall Study|Death|4|||
125106483|NCT02787785|450013487|FG000|Overall Study|Lost to Follow-up|1|||
125106484|NCT02787785|450013488|FG001|Overall Study|Lost to Follow-up|1|||
125106485|NCT02787785|450013487|FG000|Overall Study|Withdrawal by Subject|0|||
125106486|NCT02787785|450013488|FG001|Overall Study|Withdrawal by Subject|5|||
125106487|NCT00110084|450013492|FG000|Overall Study|Adverse Event|9|||
125106488|NCT00110084|450013492|FG000|Overall Study|Death|1|||
125106489|NCT00110084|450013492|FG000|Overall Study|Patient Refusal|10|||
125106490|NCT00110084|450013492|FG000|Overall Study|Alternate Therapy|5|||
125106491|NCT00110084|450013492|FG000|Overall Study|Intercurrent Illness|1|||
125106492|NCT00110084|450013492|FG000|Overall Study|Other|2|||
125106493|NCT00103259|450013493|FG000|Overall Study|Death|3|||
125106494|NCT00103259|450013494|FG001|Overall Study|Death|2|||
124888677|NCT02555371|449216777|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
125106495|NCT00103259|450013493|FG000|Overall Study|Withdrawal by Subject|2|||
125106496|NCT00103259|450013494|FG001|Overall Study|Withdrawal by Subject|3|||
125106497|NCT00103259|450013493|FG000|Overall Study|alternative therapy|1|||
125106498|NCT00103259|450013494|FG001|Overall Study|alternative therapy|0|||
125106499|NCT00103259|450013493|FG000|Overall Study|other (reasons were not specified)|2|||
125106500|NCT00103259|450013494|FG001|Overall Study|other (reasons were not specified)|1|||
125106501|NCT00103259|450013493|FG000|Overall Study|ineligible/no protocol therapy|4|||
125106502|NCT00103259|450013494|FG001|Overall Study|ineligible/no protocol therapy|6|||
125106503|NCT04101721|450013497|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
125106504|NCT04101721|450013498|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
125016561|NCT01046877|449685477|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
125016562|NCT01046877|449685477|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
125016563|NCT02970292|449685480|FG000|Overall Study|Physician Decision|1|||
125016564|NCT02970292|449685481|FG001|Overall Study|Physician Decision|1|||
125016565|NCT02970292|449685480|FG000|Overall Study|Withdrawal by Subject|11|||
125016566|NCT02970292|449685481|FG001|Overall Study|Withdrawal by Subject|5|||
125016567|NCT02970292|449685480|FG000|Overall Study|Noncompliance with study drug|2|||
125016568|NCT02970292|449685481|FG001|Overall Study|Noncompliance with study drug|2|||
125016569|NCT02970292|449685480|FG000|Overall Study|Adverse Event|5|||
125016570|NCT02970292|449685481|FG001|Overall Study|Adverse Event|0|||
125016571|NCT02970292|449685480|FG000|Overall Study|Lack of Efficacy|1|||
125016572|NCT02970292|449685481|FG001|Overall Study|Lack of Efficacy|0|||
125016573|NCT02970292|449685480|FG000|Overall Study|Lost to Follow-up|1|||
125016574|NCT02970292|449685481|FG001|Overall Study|Lost to Follow-up|0|||
125016575|NCT02970292|449685480|FG000|Overall Study|Protocol Violation|2|||
125016576|NCT02970292|449685481|FG001|Overall Study|Protocol Violation|0|||
125016577|NCT02970292|449685480|FG000|Overall Study|Other|1|||
125016578|NCT02970292|449685481|FG001|Overall Study|Other|0|||
125016579|NCT00513500|449685486|FG000|Overall Study|Lost to Follow-up|35|||
125016580|NCT00513500|449685487|FG001|Overall Study|Lost to Follow-up|39|||
125016581|NCT00513500|449685486|FG000|Overall Study|Death|2|||
125016582|NCT00513500|449685487|FG001|Overall Study|Death|1|||
125016583|NCT00513500|449685486|FG000|Overall Study|Hospitalized|4|||
125016584|NCT00513500|449685487|FG001|Overall Study|Hospitalized|14|||
125016585|NCT00749996|449685490|FG000|Overall Study|Lost to Follow-up|7|||
125016586|NCT00749996|449685491|FG001|Overall Study|Lost to Follow-up|4|||
125016587|NCT00749996|449685490|FG000|Overall Study|Withdrawal by Subject|5|||
125016588|NCT00749996|449685491|FG001|Overall Study|Withdrawal by Subject|4|||
125016589|NCT00749996|449685490|FG000|Overall Study|Protocol Violation|2|||
125016590|NCT00749996|449685491|FG001|Overall Study|Protocol Violation|3|||
125016591|NCT00749996|449685490|FG000|Overall Study|Physician Decision|2|||
125016592|NCT00749996|449685491|FG001|Overall Study|Physician Decision|0|||
125016593|NCT00749996|449685490|FG000|Overall Study|Pregnancy|0|||
125016594|NCT00749996|449685491|FG001|Overall Study|Pregnancy|2|||
125016595|NCT00749996|449685490|FG000|Overall Study|Adverse Event|1|||
125016596|NCT00749996|449685491|FG001|Overall Study|Adverse Event|0|||
125016597|NCT00749996|449685490|FG000|Overall Study|Death|1|||
125016598|NCT00749996|449685491|FG001|Overall Study|Death|0|||
125016599|NCT00109707|449685492|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
125016600|NCT00109707|449685493|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
125016601|NCT00109707|449685494|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
125016602|NCT00109707|449685492|FG000|Overall Study|Abnormal laboratory values|1|||
125016603|NCT00109707|449685493|FG001|Overall Study|Abnormal laboratory values|0|||
125016604|NCT00109707|449685494|FG002|Overall Study|Abnormal laboratory values|0|||
125016605|NCT00109707|449685492|FG000|Overall Study|Administrative problems|2|||
125016606|NCT00109707|449685493|FG001|Overall Study|Administrative problems|0|||
125016607|NCT00109707|449685494|FG002|Overall Study|Administrative problems|1|||
125016608|NCT00109707|449685492|FG000|Overall Study|Adverse Event|10|||
125016609|NCT00109707|449685493|FG001|Overall Study|Adverse Event|2|||
125016610|NCT00109707|449685494|FG002|Overall Study|Adverse Event|3|||
125016611|NCT00109707|449685492|FG000|Overall Study|Death|4|||
125016612|NCT00109707|449685493|FG001|Overall Study|Death|0|||
125016613|NCT00109707|449685494|FG002|Overall Study|Death|0|||
125016614|NCT00109707|449685492|FG000|Overall Study|Disease progression|12|||
125016615|NCT00109707|449685493|FG001|Overall Study|Disease progression|4|||
125016616|NCT00109707|449685494|FG002|Overall Study|Disease progression|3|||
125016617|NCT00109707|449685492|FG000|Overall Study|Lost to Follow-up|3|||
125016618|NCT00109707|449685493|FG001|Overall Study|Lost to Follow-up|0|||
125016619|NCT00109707|449685494|FG002|Overall Study|Lost to Follow-up|0|||
125016620|NCT00109707|449685492|FG000|Overall Study|Protocol Violation|1|||
125016621|NCT00109707|449685493|FG001|Overall Study|Protocol Violation|0|||
125016622|NCT00109707|449685494|FG002|Overall Study|Protocol Violation|0|||
125016623|NCT00109707|449685492|FG000|Overall Study|Patient withdrew consent|6|||
125016624|NCT00109707|449685493|FG001|Overall Study|Patient withdrew consent|1|||
125016625|NCT00109707|449685494|FG002|Overall Study|Patient withdrew consent|0|||
125016626|NCT00446511|449685495|FG000|Overall Study|Adverse Event|7|||
125016627|NCT00446511|449685496|FG001|Overall Study|Adverse Event|2|||
125016628|NCT00446511|449685497|FG002|Overall Study|Adverse Event|3|||
125016629|NCT00446511|449685498|FG003|Overall Study|Adverse Event|1|||
125016630|NCT00446511|449685495|FG000|Overall Study|Protocol Violation|0|||
125016631|NCT00446511|449685496|FG001|Overall Study|Protocol Violation|0|||
125016632|NCT00446511|449685497|FG002|Overall Study|Protocol Violation|0|||
125016633|NCT00446511|449685498|FG003|Overall Study|Protocol Violation|1|||
125016634|NCT00446511|449685495|FG000|Overall Study|Withdrawal by Subject|0|||
125016635|NCT00446511|449685496|FG001|Overall Study|Withdrawal by Subject|0|||
125016636|NCT00446511|449685497|FG002|Overall Study|Withdrawal by Subject|0|||
125016637|NCT00446511|449685498|FG003|Overall Study|Withdrawal by Subject|3|||
125106505|NCT04101721|450013497|FG000|Overall Study|Death|0|||
125106506|NCT04101721|450013498|FG001|Overall Study|Death|1|||
125106507|NCT04101721|450013497|FG000|Overall Study|Lost to Follow-up|0|||
125106508|NCT04101721|450013498|FG001|Overall Study|Lost to Follow-up|3|||
125106509|NCT02610842|450013499|FG000|Overall Study|Lost to Follow-up|5|||
125106510|NCT04736576|450013500|FG000|Overall Study|Progressive disease|3|||
125106511|NCT04736576|450013501|FG001|Overall Study|Progressive disease|1|||
125106512|NCT04736576|450013500|FG000|Overall Study|Death|1|||
125106513|NCT04736576|450013501|FG001|Overall Study|Death|0|||
125106514|NCT04330482|450013506|FG000|Overall Study|Lost to Follow-up|2|||
125106515|NCT04330482|450013507|FG001|Overall Study|Lost to Follow-up|1|||
125106516|NCT04330482|450013506|FG000|Overall Study|Withdrawal by Subject|0|||
125106517|NCT04330482|450013507|FG001|Overall Study|Withdrawal by Subject|3|||
125106518|NCT05144477|450013509|FG000|Overall Study|Withdrawal by Subject|1|||
125106519|NCT05144477|450013510|FG001|Overall Study|Withdrawal by Subject|1|||
125106520|NCT03273712|450013511|FG000|Overall Study|Death|5|||
125106521|NCT03273712|450013511|FG000|Overall Study|Adverse Event|1|||
125106522|NCT03273712|450013511|FG000|Overall Study|Disease Progression|1|||
125106523|NCT02268045|450013514|FG000|Overall Study|Death|4|||
125106524|NCT02268045|450013515|FG001|Overall Study|Death|4|||
125106525|NCT02268045|450013514|FG000|Overall Study|Disease Progression|2|||
125106526|NCT02268045|450013515|FG001|Overall Study|Disease Progression|1|||
125106527|NCT02268045|450013514|FG000|Overall Study|Adverse Event|7|||
125106528|NCT02268045|450013515|FG001|Overall Study|Adverse Event|7|||
125106529|NCT02268045|450013514|FG000|Overall Study|Withdrawal by Subject|2|||
125106530|NCT02268045|450013515|FG001|Overall Study|Withdrawal by Subject|6|||
125106531|NCT02268045|450013514|FG000|Overall Study|Physician Decision|0|||
125106532|NCT02268045|450013515|FG001|Overall Study|Physician Decision|1|||
125106533|NCT02268045|450013514|FG000|Overall Study|Protocol Violation|1|||
125106534|NCT02268045|450013515|FG001|Overall Study|Protocol Violation|1|||
125106535|NCT01154673|450013516|FG000|Overall Study|Lost to Follow-up|1|||
125106536|NCT01154673|450013517|FG001|Overall Study|Lost to Follow-up|0|||
125106537|NCT01154673|450013516|FG000|Overall Study|moved out of province|1|||
125106538|NCT01154673|450013517|FG001|Overall Study|moved out of province|0|||
125106539|NCT00646282|450013518|FG000|Overall Study|Protocol terminated|4|||
125106540|NCT00646282|450013519|FG001|Overall Study|Protocol terminated|4|||
125106541|NCT01289990|450013520|FG000|Overall Study|Death|0|||
125106542|NCT01289990|450013521|FG001|Overall Study|Death|0|||
125106543|NCT01289990|450013522|FG002|Overall Study|Death|0|||
125106544|NCT01289990|450013523|FG003|Overall Study|Death|1|||
125106545|NCT01289990|450013524|FG004|Overall Study|Death|2|||
125106546|NCT01289990|450013525|FG005|Overall Study|Death|1|||
125106547|NCT01289990|450013526|FG006|Overall Study|Death|0|||
125106548|NCT01289990|450013527|FG007|Overall Study|Death|0|||
125106549|NCT01289990|450013528|FG008|Overall Study|Death|0|||
125106550|NCT01289990|450013529|FG009|Overall Study|Death|0|||
125106551|NCT01289990|450013530|FG010|Overall Study|Death|0|||
125106552|NCT01289990|450013531|FG011|Overall Study|Death|1|||
125106553|NCT01289990|450013532|FG012|Overall Study|Death|0|||
125106554|NCT01289990|450013520|FG000|Overall Study|Lost to Follow-up|3|||
125106555|NCT01289990|450013521|FG001|Overall Study|Lost to Follow-up|2|||
125106556|NCT01289990|450013522|FG002|Overall Study|Lost to Follow-up|5|||
125106557|NCT01289990|450013523|FG003|Overall Study|Lost to Follow-up|5|||
125106558|NCT01289990|450013524|FG004|Overall Study|Lost to Follow-up|3|||
125106559|NCT01289990|450013525|FG005|Overall Study|Lost to Follow-up|4|||
125106560|NCT01289990|450013526|FG006|Overall Study|Lost to Follow-up|2|||
125106561|NCT01289990|450013527|FG007|Overall Study|Lost to Follow-up|2|||
125106562|NCT01289990|450013528|FG008|Overall Study|Lost to Follow-up|1|||
125106563|NCT01289990|450013529|FG009|Overall Study|Lost to Follow-up|4|||
125106564|NCT01289990|450013530|FG010|Overall Study|Lost to Follow-up|2|||
125106565|NCT01289990|450013531|FG011|Overall Study|Lost to Follow-up|1|||
125106566|NCT01289990|450013532|FG012|Overall Study|Lost to Follow-up|2|||
125106567|NCT01289990|450013520|FG000|Overall Study|Withdrawal by Subject|15|||
125106568|NCT01289990|450013521|FG001|Overall Study|Withdrawal by Subject|14|||
125106569|NCT01289990|450013522|FG002|Overall Study|Withdrawal by Subject|12|||
125106570|NCT01289990|450013523|FG003|Overall Study|Withdrawal by Subject|13|||
125106571|NCT01289990|450013524|FG004|Overall Study|Withdrawal by Subject|8|||
125106572|NCT01289990|450013525|FG005|Overall Study|Withdrawal by Subject|7|||
125106573|NCT01289990|450013526|FG006|Overall Study|Withdrawal by Subject|13|||
125106574|NCT01289990|450013527|FG007|Overall Study|Withdrawal by Subject|9|||
125106575|NCT01289990|450013528|FG008|Overall Study|Withdrawal by Subject|12|||
125106576|NCT01289990|450013529|FG009|Overall Study|Withdrawal by Subject|13|||
125106577|NCT01289990|450013530|FG010|Overall Study|Withdrawal by Subject|11|||
125106578|NCT01289990|450013531|FG011|Overall Study|Withdrawal by Subject|13|||
125106579|NCT01289990|450013532|FG012|Overall Study|Withdrawal by Subject|16|||
125106580|NCT01289990|450013520|FG000|Overall Study|discontinued in preceding trial|18|||
125106581|NCT01289990|450013521|FG001|Overall Study|discontinued in preceding trial|20|||
125106582|NCT01289990|450013522|FG002|Overall Study|discontinued in preceding trial|41|||
125106583|NCT01289990|450013523|FG003|Overall Study|discontinued in preceding trial|17|||
125106584|NCT01289990|450013524|FG004|Overall Study|discontinued in preceding trial|11|||
125106585|NCT01289990|450013525|FG005|Overall Study|discontinued in preceding trial|12|||
125106586|NCT01289990|450013526|FG006|Overall Study|discontinued in preceding trial|18|||
125106587|NCT01289990|450013527|FG007|Overall Study|discontinued in preceding trial|8|||
125106588|NCT01289990|450013528|FG008|Overall Study|discontinued in preceding trial|17|||
125106589|NCT01289990|450013529|FG009|Overall Study|discontinued in preceding trial|21|||
125106590|NCT01289990|450013530|FG010|Overall Study|discontinued in preceding trial|17|||
125106591|NCT01289990|450013531|FG011|Overall Study|discontinued in preceding trial|17|||
125106592|NCT01289990|450013532|FG012|Overall Study|discontinued in preceding trial|24|||
125106593|NCT01289990|450013520|FG000|Overall Study|did not continue in extension|41|||
125106594|NCT01289990|450013521|FG001|Overall Study|did not continue in extension|45|||
125106595|NCT01289990|450013522|FG002|Overall Study|did not continue in extension|51|||
125106596|NCT01289990|450013523|FG003|Overall Study|did not continue in extension|51|||
125106597|NCT01289990|450013524|FG004|Overall Study|did not continue in extension|48|||
125106598|NCT01289990|450013525|FG005|Overall Study|did not continue in extension|50|||
125106599|NCT01289990|450013526|FG006|Overall Study|did not continue in extension|54|||
125106600|NCT01289990|450013527|FG007|Overall Study|did not continue in extension|36|||
125106601|NCT01289990|450013528|FG008|Overall Study|did not continue in extension|44|||
125106602|NCT01289990|450013529|FG009|Overall Study|did not continue in extension|48|||
125106603|NCT01289990|450013530|FG010|Overall Study|did not continue in extension|45|||
125106604|NCT01289990|450013531|FG011|Overall Study|did not continue in extension|34|||
125106605|NCT01289990|450013532|FG012|Overall Study|did not continue in extension|56|||
125106606|NCT01289990|450013520|FG000|Overall Study|Not treated|0|||
125106607|NCT01289990|450013521|FG001|Overall Study|Not treated|0|||
125106608|NCT01289990|450013522|FG002|Overall Study|Not treated|0|||
125106609|NCT01289990|450013523|FG003|Overall Study|Not treated|0|||
125106610|NCT01289990|450013524|FG004|Overall Study|Not treated|0|||
125106611|NCT01289990|450013525|FG005|Overall Study|Not treated|0|||
125106612|NCT01289990|450013526|FG006|Overall Study|Not treated|1|||
125106613|NCT01289990|450013527|FG007|Overall Study|Not treated|0|||
125106614|NCT01289990|450013528|FG008|Overall Study|Not treated|1|||
125106615|NCT01289990|450013529|FG009|Overall Study|Not treated|0|||
125106616|NCT01289990|450013530|FG010|Overall Study|Not treated|1|||
125106617|NCT01289990|450013531|FG011|Overall Study|Not treated|2|||
125106618|NCT01289990|450013532|FG012|Overall Study|Not treated|0|||
125106619|NCT00683904|450013533|FG000|Dose Level 1|Disease progression|2|||
125106620|NCT00683904|450013534|FG001|Dose Level 1|Disease progression|0|||
125106621|NCT00683904|450013533|FG000|Dose Level 1|Adverse Event|1|||
125106622|NCT00683904|450013534|FG001|Dose Level 1|Adverse Event|0|||
125106623|NCT00683904|450013533|FG000|Dose Level 2|Adverse Event|0|||
125106624|NCT00683904|450013534|FG001|Dose Level 2|Adverse Event|2|||
125106625|NCT01488071|450013535|FG000|Overall Study|Adverse Event|15|||
125106626|NCT01488071|450013536|FG001|Overall Study|Adverse Event|23|||
125106627|NCT01488071|450013535|FG000|Overall Study|Lack of Efficacy|11|||
125106628|NCT01488071|450013536|FG001|Overall Study|Lack of Efficacy|17|||
125106629|NCT01488071|450013535|FG000|Overall Study|Non-compliance with study drug|2|||
125106630|NCT01488071|450013536|FG001|Overall Study|Non-compliance with study drug|0|||
125106631|NCT01488071|450013535|FG000|Overall Study|Protocol Violation|5|||
125106632|NCT01488071|450013536|FG001|Overall Study|Protocol Violation|7|||
125106633|NCT01488071|450013535|FG000|Overall Study|Withdrawal of Consent|14|||
125106634|NCT01488071|450013536|FG001|Overall Study|Withdrawal of Consent|12|||
125106635|NCT01488071|450013535|FG000|Overall Study|Lost to Follow-up|1|||
125106636|NCT01488071|450013536|FG001|Overall Study|Lost to Follow-up|0|||
125106637|NCT01488071|450013535|FG000|Overall Study|Administrative or Other Reason(s)|5|||
125106638|NCT01488071|450013536|FG001|Overall Study|Administrative or Other Reason(s)|4|||
125106639|NCT04449354|450013537|FG000|Overall Study|Withdrawal by Subject|1|||
125106640|NCT05789420|450013538|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
125106641|NCT05789420|450013538|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
125106642|NCT02720094|450013539|FG000|Overall Study|Scheduled exit visit/end of study|2|||
125106643|NCT02720094|450013540|FG001|Overall Study|Scheduled exit visit/end of study|1|||
125106644|NCT02720094|450013539|FG000|Overall Study|Death|4|||
125106645|NCT02720094|450013540|FG001|Overall Study|Death|7|||
125106646|NCT02720094|450013539|FG000|Overall Study|Withdrawal by Subject|55|||
125106647|NCT02720094|450013540|FG001|Overall Study|Withdrawal by Subject|56|||
125106648|NCT02720094|450013539|FG000|Overall Study|Lost to Follow-up|2|||
125106649|NCT02720094|450013540|FG001|Overall Study|Lost to Follow-up|7|||
125106650|NCT02720094|450013539|FG000|Overall Study|Physician Decision|1|||
125106651|NCT02720094|450013540|FG001|Overall Study|Physician Decision|3|||
125106652|NCT02720094|450013539|FG000|Overall Study|Inappropriate enrollment|1|||
125106653|NCT02720094|450013540|FG001|Overall Study|Inappropriate enrollment|3|||
125106654|NCT02720094|450013539|FG000|Overall Study|Ongoing|2210|||
125106655|NCT02720094|450013540|FG001|Overall Study|Ongoing|2203|||
125016638|NCT00446511|449685495|FG000|Overall Study|Administrative Problems|3|||
125016639|NCT00446511|449685496|FG001|Overall Study|Administrative Problems|0|||
125016640|NCT00446511|449685497|FG002|Overall Study|Administrative Problems|4|||
125016641|NCT00446511|449685498|FG003|Overall Study|Administrative Problems|1|||
125016642|NCT00606086|449685501|FG000|Overall Study|Adverse Event|1|||
125016643|NCT00606086|449685502|FG001|Overall Study|Adverse Event|1|||
125016644|NCT00606086|449685501|FG000|Overall Study|Lost to Follow-up|4|||
125016645|NCT00606086|449685502|FG001|Overall Study|Lost to Follow-up|8|||
125016646|NCT00606086|449685501|FG000|Overall Study|Protocol Violation|1|||
125016647|NCT00606086|449685502|FG001|Overall Study|Protocol Violation|0|||
125016648|NCT00606086|449685501|FG000|Overall Study|Withdrawal by Subject|5|||
125016649|NCT00606086|449685502|FG001|Overall Study|Withdrawal by Subject|3|||
125016650|NCT00606086|449685501|FG000|Overall Study|Non-compliance|0|||
125016651|NCT00606086|449685502|FG001|Overall Study|Non-compliance|1|||
125016652|NCT00606086|449685501|FG000|Overall Study|Randomized, not treated|1|||
125016653|NCT00606086|449685502|FG001|Overall Study|Randomized, not treated|2|||
125016654|NCT00542269|449685507|FG000|Overall Study|Adverse Event|10|||
125016655|NCT00542269|449685508|FG001|Overall Study|Adverse Event|4|||
125016656|NCT00542269|449685509|FG002|Overall Study|Adverse Event|5|||
125016657|NCT00542269|449685507|FG000|Overall Study|Protocol Violation|1|||
125016658|NCT00542269|449685508|FG001|Overall Study|Protocol Violation|1|||
125016659|NCT00542269|449685509|FG002|Overall Study|Protocol Violation|0|||
125016660|NCT00542269|449685507|FG000|Overall Study|Withdrawal by Subject|1|||
125016661|NCT00542269|449685508|FG001|Overall Study|Withdrawal by Subject|0|||
125016662|NCT00542269|449685509|FG002|Overall Study|Withdrawal by Subject|0|||
125016663|NCT00542269|449685507|FG000|Overall Study|Administrative problems|1|||
125016664|NCT00542269|449685508|FG001|Overall Study|Administrative problems|1|||
125016665|NCT00542269|449685509|FG002|Overall Study|Administrative problems|1|||
125016666|NCT03873714|449685510|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
125016667|NCT00708123|449685511|FG000|Period 1|Protocol Violation|0|||
125016668|NCT00708123|449685512|FG001|Period 1|Protocol Violation|1|||
125016669|NCT00708123|449685513|FG002|Period 1|Protocol Violation|0|||
125016670|NCT00708123|449685514|FG003|Period 1|Protocol Violation|1|||
125016671|NCT00708123|449685515|FG004|Period 1|Protocol Violation|0|||
125016672|NCT00708123|449685511|FG000|Period 1|Adverse Event|0|||
125016673|NCT00708123|449685512|FG001|Period 1|Adverse Event|0|||
125016674|NCT00708123|449685513|FG002|Period 1|Adverse Event|1|||
125016675|NCT00708123|449685514|FG003|Period 1|Adverse Event|0|||
125016676|NCT00708123|449685515|FG004|Period 1|Adverse Event|0|||
125016677|NCT00708123|449685511|FG000|Period 2|Protocol Violation|0|||
125016678|NCT00708123|449685512|FG001|Period 2|Protocol Violation|0|||
125106656|NCT02720094|450013539|FG000|Overall Study|Relocation|1|||
125106657|NCT02720094|450013540|FG001|Overall Study|Relocation|1|||
125106658|NCT01220128|450013541|FG000|Overall Study|Progressive disease|0|||
125106659|NCT01220128|450013542|FG001|Overall Study|Progressive disease|0|||
125106660|NCT01220128|450013543|FG002|Overall Study|Progressive disease|2|||
125106661|NCT01220128|450013544|FG003|Overall Study|Progressive disease|0|||
125106662|NCT01220128|450013545|FG004|Overall Study|Progressive disease|0|||
125106663|NCT01220128|450013546|FG005|Overall Study|Progressive disease|0|||
125106664|NCT01220128|450013547|FG006|Overall Study|Progressive disease|0|||
125106665|NCT01220128|450013541|FG000|Overall Study|Sponsor study termination|0|||
125106666|NCT01220128|450013542|FG001|Overall Study|Sponsor study termination|1|||
125106667|NCT01220128|450013543|FG002|Overall Study|Sponsor study termination|0|||
125106668|NCT01220128|450013544|FG003|Overall Study|Sponsor study termination|0|||
125106669|NCT01220128|450013545|FG004|Overall Study|Sponsor study termination|0|||
125106670|NCT01220128|450013546|FG005|Overall Study|Sponsor study termination|0|||
125106671|NCT01220128|450013547|FG006|Overall Study|Sponsor study termination|1|||
125106672|NCT01220128|450013541|FG000|Overall Study|Adverse event, serious fatal|2|||
125016679|NCT00708123|449685513|FG002|Period 2|Protocol Violation|0|||
125016680|NCT00708123|449685514|FG003|Period 2|Protocol Violation|1|||
125106673|NCT01220128|450013542|FG001|Overall Study|Adverse event, serious fatal|0|||
125016681|NCT00708123|449685515|FG004|Period 2|Protocol Violation|0|||
125016682|NCT00708123|449685511|FG000|Period 2|Other Reason|1|||
125016683|NCT00708123|449685512|FG001|Period 2|Other Reason|0|||
125016684|NCT00708123|449685513|FG002|Period 2|Other Reason|0|||
125016685|NCT00708123|449685514|FG003|Period 2|Other Reason|0|||
125016686|NCT00708123|449685515|FG004|Period 2|Other Reason|0|||
125016687|NCT00708123|449685511|FG000|Period 3|Lost to Follow-up|0|||
125016688|NCT00708123|449685512|FG001|Period 3|Lost to Follow-up|0|||
125016689|NCT00708123|449685513|FG002|Period 3|Lost to Follow-up|1|||
125016690|NCT00708123|449685514|FG003|Period 3|Lost to Follow-up|1|||
125016691|NCT00708123|449685515|FG004|Period 3|Lost to Follow-up|0|||
125106674|NCT01220128|450013543|FG002|Overall Study|Adverse event, serious fatal|0|||
125106675|NCT01220128|450013544|FG003|Overall Study|Adverse event, serious fatal|0|||
125016692|NCT00708123|449685511|FG000|Period 4|Protocol Violation|0|||
125016693|NCT00708123|449685512|FG001|Period 4|Protocol Violation|1|||
125106676|NCT01220128|450013545|FG004|Overall Study|Adverse event, serious fatal|0|||
124888678|NCT02555371|449216778|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
124888679|NCT02555371|449216779|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
124888680|NCT02555371|449216780|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
124888681|NCT02555371|449216776|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
124888682|NCT02555371|449216777|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
124888683|NCT02555371|449216778|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
124888684|NCT02555371|449216779|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
124888685|NCT02555371|449216780|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
124888686|NCT02555371|449216776|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
124888687|NCT02555371|449216777|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
124888688|NCT02555371|449216778|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
125016694|NCT00708123|449685513|FG002|Period 4|Protocol Violation|0|||
125016695|NCT00708123|449685514|FG003|Period 4|Protocol Violation|0|||
125016696|NCT00708123|449685515|FG004|Period 4|Protocol Violation|0|||
125016697|NCT00814892|449685518|FG000|Overall Study|Disease Progression|1|||
125016698|NCT00814892|449685518|FG000|Overall Study|Study Termination|1|||
125106677|NCT01220128|450013546|FG005|Overall Study|Adverse event, serious fatal|0|||
124888689|NCT02555371|449216779|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
124888690|NCT02555371|449216780|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
124888691|NCT02555371|449216776|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
125016699|NCT00845650|449685519|FG000|Overall Study|Withdrawal by Subject|0|||
125016700|NCT00845650|449685520|FG001|Overall Study|Withdrawal by Subject|0|||
125016701|NCT00845650|449685521|FG002|Overall Study|Withdrawal by Subject|0|||
125106678|NCT01220128|450013547|FG006|Overall Study|Adverse event, serious fatal|1|||
125106679|NCT01220128|450013541|FG000|Overall Study|Adverse event, non-fatal|1|||
125106680|NCT01220128|450013542|FG001|Overall Study|Adverse event, non-fatal|0|||
125106681|NCT01220128|450013543|FG002|Overall Study|Adverse event, non-fatal|0|||
125106682|NCT01220128|450013544|FG003|Overall Study|Adverse event, non-fatal|0|||
125106683|NCT01220128|450013545|FG004|Overall Study|Adverse event, non-fatal|0|||
125106684|NCT01220128|450013546|FG005|Overall Study|Adverse event, non-fatal|0|||
125106685|NCT01220128|450013547|FG006|Overall Study|Adverse event, non-fatal|3|||
125106686|NCT01220128|450013541|FG000|Overall Study|Other|0|||
125106687|NCT01220128|450013542|FG001|Overall Study|Other|0|||
125106688|NCT01220128|450013543|FG002|Overall Study|Other|1|||
125106689|NCT01220128|450013544|FG003|Overall Study|Other|0|||
125106690|NCT01220128|450013545|FG004|Overall Study|Other|0|||
125106691|NCT01220128|450013546|FG005|Overall Study|Other|0|||
125106692|NCT01220128|450013547|FG006|Overall Study|Other|0|||
125106693|NCT01220128|450013541|FG000|Overall Study|Consent withdrawn by subject|1|||
125106694|NCT01220128|450013542|FG001|Overall Study|Consent withdrawn by subject|0|||
125106695|NCT01220128|450013543|FG002|Overall Study|Consent withdrawn by subject|0|||
125106696|NCT01220128|450013544|FG003|Overall Study|Consent withdrawn by subject|0|||
125106697|NCT01220128|450013545|FG004|Overall Study|Consent withdrawn by subject|0|||
125106698|NCT01220128|450013546|FG005|Overall Study|Consent withdrawn by subject|0|||
125106699|NCT01220128|450013547|FG006|Overall Study|Consent withdrawn by subject|0|||
125106700|NCT02913261|450013548|FG000|Overall Study|Technical problems|0|||
125106701|NCT02913261|450013549|FG001|Overall Study|Technical problems|1|||
125106702|NCT02913261|450013548|FG000|Overall Study|Lack of Efficacy|32|||
125106703|NCT02913261|450013549|FG001|Overall Study|Lack of Efficacy|69|||
125106704|NCT02913261|450013548|FG000|Overall Study|Adverse Event|27|||
125106705|NCT02913261|450013549|FG001|Overall Study|Adverse Event|5|||
124888692|NCT02555371|449216777|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
125016702|NCT00845650|449685522|FG003|Overall Study|Withdrawal by Subject|0|||
125016703|NCT00845650|449685523|FG004|Overall Study|Withdrawal by Subject|2|||
125016704|NCT00845650|449685524|FG005|Overall Study|Withdrawal by Subject|0|||
125016705|NCT00845650|449685519|FG000|Overall Study|Lost to Follow-up|0|||
125016706|NCT00845650|449685520|FG001|Overall Study|Lost to Follow-up|0|||
125016707|NCT00845650|449685521|FG002|Overall Study|Lost to Follow-up|3|||
125016708|NCT00845650|449685522|FG003|Overall Study|Lost to Follow-up|1|||
125016709|NCT00845650|449685523|FG004|Overall Study|Lost to Follow-up|0|||
125106706|NCT02913261|450013548|FG000|Overall Study|Death|25|||
125016710|NCT00845650|449685524|FG005|Overall Study|Lost to Follow-up|1|||
125106707|NCT02913261|450013549|FG001|Overall Study|Death|22|||
125106708|NCT02913261|450013548|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
125106709|NCT02913261|450013549|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
125106710|NCT02913261|450013548|FG000|Overall Study|Disease relapse|8|||
125106711|NCT02913261|450013549|FG001|Overall Study|Disease relapse|13|||
124888693|NCT02555371|449216778|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
124888694|NCT02555371|449216779|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
124888695|NCT02555371|449216780|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
124888696|NCT00513019|449216781|FG000|Overall Study|Adverse Event|1|||
124888697|NCT00513019|449216782|FG001|Overall Study|Adverse Event|0|||
124888698|NCT00513019|449216781|FG000|Overall Study|Withdrawal by Subject|4|||
124888699|NCT00513019|449216782|FG001|Overall Study|Withdrawal by Subject|5|||
124888700|NCT03615482|449216783|FG000|Overall Study|Death|1|||
124888701|NCT03615482|449216784|FG001|Overall Study|Death|0|||
124888702|NCT03615482|449216783|FG000|Overall Study|Lost to Follow-up|7|||
124888703|NCT03615482|449216784|FG001|Overall Study|Lost to Follow-up|7|||
124888704|NCT03615482|449216783|FG000|Overall Study|Physician Decision|2|||
124888705|NCT03615482|449216784|FG001|Overall Study|Physician Decision|3|||
124888706|NCT03615482|449216783|FG000|Overall Study|Withdrawal by Subject|7|||
124888707|NCT03615482|449216784|FG001|Overall Study|Withdrawal by Subject|7|||
124888708|NCT01500226|449216785|FG000|Overall Study|Adverse Event|31|||
124888709|NCT01500226|449216786|FG001|Overall Study|Adverse Event|38|||
124888710|NCT01500226|449216785|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
124888711|NCT01500226|449216786|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
124888712|NCT01500226|449216785|FG000|Overall Study|Withdrawal by Subject|93|||
124888713|NCT01500226|449216786|FG001|Overall Study|Withdrawal by Subject|96|||
124888714|NCT01500226|449216785|FG000|Overall Study|Death|12|||
125106712|NCT02913261|450013548|FG000|Overall Study|Physician Decision|8|||
125106713|NCT02913261|450013549|FG001|Overall Study|Physician Decision|9|||
125106714|NCT02913261|450013548|FG000|Overall Study|Subject/guardian decision|4|||
125106715|NCT02913261|450013549|FG001|Overall Study|Subject/guardian decision|6|||
125106716|NCT02913261|450013548|FG000|Overall Study|Graft loss|2|||
125106717|NCT02913261|450013549|FG001|Overall Study|Graft loss|0|||
125106718|NCT02340078|450013550|FG000|Overall Study|Protocol Violation|1|||
125106719|NCT00567996|450013554|FG000|Overall Study|Adverse Event|18|||
125106720|NCT00567996|450013555|FG001|Overall Study|Adverse Event|16|||
125106721|NCT00567996|450013556|FG002|Overall Study|Adverse Event|13|||
125106722|NCT00567996|450013554|FG000|Overall Study|Protocol Deviation|9|||
125106723|NCT00567996|450013555|FG001|Overall Study|Protocol Deviation|11|||
125106724|NCT00567996|450013556|FG002|Overall Study|Protocol Deviation|13|||
125106725|NCT00567996|450013554|FG000|Overall Study|Withdrawal by Subject|8|||
125106726|NCT00567996|450013555|FG001|Overall Study|Withdrawal by Subject|12|||
125106727|NCT00567996|450013556|FG002|Overall Study|Withdrawal by Subject|22|||
125106728|NCT00567996|450013554|FG000|Overall Study|Abnormal Lab value(s)|2|||
125106729|NCT00567996|450013555|FG001|Overall Study|Abnormal Lab value(s)|1|||
125106730|NCT00567996|450013556|FG002|Overall Study|Abnormal Lab value(s)|2|||
125106731|NCT00567996|450013554|FG000|Overall Study|Abnormal test procedure result(s)|2|||
125106732|NCT00567996|450013555|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125106733|NCT00567996|450013556|FG002|Overall Study|Abnormal test procedure result(s)|1|||
125106734|NCT00567996|450013554|FG000|Overall Study|Lost to Follow-up|2|||
125106735|NCT00567996|450013555|FG001|Overall Study|Lost to Follow-up|5|||
125106736|NCT00567996|450013556|FG002|Overall Study|Lost to Follow-up|2|||
125106737|NCT00567996|450013554|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125106738|NCT00567996|450013555|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125106739|NCT00567996|450013556|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
125106740|NCT00567996|450013554|FG000|Overall Study|Administrative problems|1|||
125106741|NCT00567996|450013555|FG001|Overall Study|Administrative problems|1|||
125106742|NCT00567996|450013556|FG002|Overall Study|Administrative problems|0|||
125106743|NCT00567996|450013554|FG000|Overall Study|Death|1|||
125106744|NCT00567996|450013555|FG001|Overall Study|Death|0|||
125106745|NCT00567996|450013556|FG002|Overall Study|Death|2|||
125106746|NCT00567996|450013554|FG000|Overall Study|Patient's inability to use the device|0|||
125106747|NCT00567996|450013555|FG001|Overall Study|Patient's inability to use the device|1|||
125106748|NCT00567996|450013556|FG002|Overall Study|Patient's inability to use the device|0|||
125106749|NCT02524665|450013559|FG000|Overall Study|Lost to Follow-up|1|||
125106750|NCT02602080|450013560|FG000|Overall Study|Protocol Violation|6|||
125106751|NCT02602080|450013561|FG001|Overall Study|Protocol Violation|1|||
125106752|NCT02602080|450013562|FG002|Overall Study|Protocol Violation|3|||
125106753|NCT00883129|450013566|FG000|Overall Study|Adverse Event|7|||
125106754|NCT00883129|450013567|FG001|Overall Study|Adverse Event|15|||
125106755|NCT00883129|450013566|FG000|Overall Study|Withdrawal by Subject|8|||
124888715|NCT01500226|449216786|FG001|Overall Study|Death|4|||
124888716|NCT01500226|449216785|FG000|Overall Study|Disease Progression|16|||
124888717|NCT01500226|449216786|FG001|Overall Study|Disease Progression|14|||
124888718|NCT01500226|449216785|FG000|Overall Study|Protocol Violation|53|||
125106756|NCT00883129|450013567|FG001|Overall Study|Withdrawal by Subject|9|||
124888719|NCT01500226|449216786|FG001|Overall Study|Protocol Violation|39|||
125106757|NCT00883129|450013566|FG000|Overall Study|Non-compliance|3|||
125106758|NCT00883129|450013567|FG001|Overall Study|Non-compliance|6|||
125106759|NCT00883129|450013566|FG000|Overall Study|Lost to Follow-up|1|||
124888720|NCT01500226|449216785|FG000|Overall Study|Physician Decision|17|||
124888721|NCT01500226|449216786|FG001|Overall Study|Physician Decision|15|||
124888722|NCT01500226|449216785|FG000|Overall Study|Lack of Efficacy|14|||
124888723|NCT01500226|449216786|FG001|Overall Study|Lack of Efficacy|30|||
124888724|NCT01500226|449216785|FG000|Overall Study|Lost to Follow-up|9|||
124888725|NCT01500226|449216786|FG001|Overall Study|Lost to Follow-up|5|||
124888726|NCT01500226|449216785|FG000|Overall Study|Other Reasons|19|||
124888727|NCT01500226|449216786|FG001|Overall Study|Other Reasons|16|||
124888728|NCT02955277|449216787|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
124888729|NCT02955277|449216788|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
124888730|NCT02955277|449216787|FG000|Post to Follow-up|Lost to Follow-up|8|||
124888731|NCT02955277|449216788|FG001|Post to Follow-up|Lost to Follow-up|11|||
124888732|NCT01809210|449216794|FG000|Overall Study|Withdrawal by Subject|0|||
124888733|NCT01809210|449216795|FG001|Overall Study|Withdrawal by Subject|0|||
124888734|NCT01809210|449216796|FG002|Overall Study|Withdrawal by Subject|1|||
124888735|NCT01809210|449216797|FG003|Overall Study|Withdrawal by Subject|1|||
124888736|NCT01809210|449216798|FG004|Overall Study|Withdrawal by Subject|1|||
124888737|NCT01809210|449216799|FG005|Overall Study|Withdrawal by Subject|0|||
124888738|NCT01809210|449216800|FG006|Overall Study|Withdrawal by Subject|4|||
124888739|NCT01809210|449216794|FG000|Overall Study|Death|1|||
124888740|NCT01809210|449216795|FG001|Overall Study|Death|1|||
124888741|NCT01809210|449216796|FG002|Overall Study|Death|2|||
124888742|NCT01809210|449216797|FG003|Overall Study|Death|0|||
124888743|NCT01809210|449216798|FG004|Overall Study|Death|1|||
124888744|NCT01809210|449216799|FG005|Overall Study|Death|3|||
124888745|NCT01809210|449216800|FG006|Overall Study|Death|1|||
124888746|NCT00504348|449216801|FG000|Overall Study|Adverse Event|3|||
124888747|NCT00504348|449216801|FG000|Overall Study|Lack of Efficacy|4|||
125016711|NCT00845650|449685519|FG000|Overall Study|Sponsor hold on dosing|0|||
125016712|NCT00845650|449685520|FG001|Overall Study|Sponsor hold on dosing|0|||
125016713|NCT00845650|449685521|FG002|Overall Study|Sponsor hold on dosing|0|||
124888748|NCT00504348|449216801|FG000|Overall Study|Physician Decision|1|||
124888749|NCT01118962|449216802|FG000|Overall Study|Adverse Event|2|||
124888750|NCT01118962|449216802|FG000|Overall Study|Lack of Efficacy|1|||
124888751|NCT01118962|449216802|FG000|Overall Study|Protocol Violation|1|||
124888752|NCT01118962|449216802|FG000|Overall Study|Withdrawal by Subject|4|||
124888753|NCT01118962|449216802|FG000|Overall Study|Pregnancy|1|||
124888754|NCT01118962|449216802|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
124888755|NCT03685708|449216807|FG000|Overall Study|Withdrawal by Subject|0|||
124888756|NCT03685708|449216808|FG001|Overall Study|Withdrawal by Subject|0|||
124888757|NCT03685708|449216809|FG002|Overall Study|Withdrawal by Subject|1|||
124888758|NCT03685708|449216807|FG000|Overall Study|Screen Fail|0|||
124888759|NCT03685708|449216808|FG001|Overall Study|Screen Fail|1|||
124888760|NCT03685708|449216809|FG002|Overall Study|Screen Fail|1|||
124888761|NCT03685708|449216807|FG000|Overall Study|COVID 19 Pandemic|1|||
124888762|NCT03685708|449216808|FG001|Overall Study|COVID 19 Pandemic|1|||
124888763|NCT03685708|449216809|FG002|Overall Study|COVID 19 Pandemic|6|||
124888764|NCT03685708|449216807|FG000|Overall Study|Disease Progression|0|||
124888765|NCT03685708|449216808|FG001|Overall Study|Disease Progression|0|||
124888766|NCT03685708|449216809|FG002|Overall Study|Disease Progression|1|||
124888767|NCT00627042|449216813|FG000|Overall Study|Withdrawal by Subject|2|||
124888768|NCT03583541|449216819|FG000|Overall Study|Lost to Follow-up|31|||
124888769|NCT03583541|449216820|FG001|Overall Study|Lost to Follow-up|65|||
124888770|NCT01686932|449216824|FG000|Period 1|Adverse Event|1|||
124888771|NCT01686932|449216825|FG001|Period 1|Adverse Event|1|||
124888772|NCT00393094|449216828|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
124888773|NCT00393094|449216828|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
124888774|NCT01058863|449216829|FG000|Overall Study|Lost to Follow-up|1|||
124888775|NCT01058863|449216829|FG000|Overall Study|Withdrawal by Subject|1|||
124888776|NCT01058863|449216829|FG000|Overall Study|Sponsor requested withdrawal|1|||
124888777|NCT01058863|449216829|FG000|Overall Study|Randomized in error|1|||
124888778|NCT00681187|449216830|FG000|Overall Study|Withdrawal by Subject|1|||
124888779|NCT00681187|449216831|FG001|Overall Study|Withdrawal by Subject|0|||
124888780|NCT00681187|449216830|FG000|Overall Study|Death|0|||
124888781|NCT00681187|449216831|FG001|Overall Study|Death|1|||
124888782|NCT00681187|449216830|FG000|Overall Study|Adverse Event|0|||
124888783|NCT00681187|449216831|FG001|Overall Study|Adverse Event|1|||
124888784|NCT03653416|449216832|FG000|Overall Study|Protocol Violation|6|||
124888785|NCT03653416|449216833|FG001|Overall Study|Protocol Violation|1|||
124888786|NCT04230980|449216834|FG000|Overall Study|Lost to Follow-up|1|||
124888787|NCT04230980|449216835|FG001|Overall Study|Lost to Follow-up|2|||
124888788|NCT04230980|449216834|FG000|Overall Study|Adverse Event|0|||
124888789|NCT04230980|449216835|FG001|Overall Study|Adverse Event|1|||
124888790|NCT02788006|449216837|FG000|Overall Study|Patient not treated|1|||
124888791|NCT03050398|449216840|FG000|Overall Study|Study terminated by sponsor|8|||
124888792|NCT00598481|449216841|FG000|Treatment|Physician Decision|1|||
124888793|NCT03523871|449216842|FG000|Overall Study|Death|1|||
124888794|NCT01994720|449216843|FG000|Overall Study|Withdrawal by Subject|46|||
124888795|NCT01994720|449216844|FG001|Overall Study|Withdrawal by Subject|56|||
124888796|NCT01991197|449216845|FG000|Overall Study|Lost to Follow-up|1|||
124888797|NCT01991197|449216846|FG001|Overall Study|Lost to Follow-up|1|||
124888798|NCT01991197|449216845|FG000|Overall Study|Physician Decision|0|||
124888799|NCT01991197|449216846|FG001|Overall Study|Physician Decision|2|||
124888800|NCT01991197|449216845|FG000|Overall Study|Withdrawal by Subject|2|||
124888801|NCT01991197|449216846|FG001|Overall Study|Withdrawal by Subject|0|||
124888802|NCT04285229|449216850|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
124888803|NCT04285229|449216851|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124888804|NCT04285229|449216852|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124888805|NCT04285229|449216853|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124888806|NCT04285229|449216854|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124888807|NCT04285229|449216855|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124888808|NCT04285229|449216850|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
124888809|NCT04285229|449216851|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
124888810|NCT04285229|449216852|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
124888811|NCT04285229|449216853|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
125106760|NCT00883129|450013567|FG001|Overall Study|Lost to Follow-up|2|||
125106761|NCT00883129|450013566|FG000|Overall Study|Death|1|||
125106762|NCT00883129|450013567|FG001|Overall Study|Death|2|||
125106763|NCT00883129|450013566|FG000|Overall Study|Defined Treatment Failure|0|||
125106764|NCT00883129|450013567|FG001|Overall Study|Defined Treatment Failure|2|||
125106765|NCT03273257|450013568|FG000|Overall Study|Death|0|||
125106766|NCT03273257|450013569|FG001|Overall Study|Death|1|||
125106767|NCT03273257|450013568|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
125106768|NCT03273257|450013569|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
125106769|NCT03273257|450013568|FG000|Overall Study|Study terminated|3|||
125106770|NCT03273257|450013569|FG001|Overall Study|Study terminated|2|||
125106771|NCT04355767|450013571|FG000|Overall Study|Withdrawal by Subject|2|||
125106772|NCT04355767|450013572|FG001|Overall Study|Withdrawal by Subject|2|||
125106773|NCT04355767|450013571|FG000|Overall Study|Death|5|||
125106774|NCT04355767|450013572|FG001|Overall Study|Death|1|||
125106775|NCT01999322|450013573|FG000|Overall Study|Adverse Event|1|||
125106776|NCT01999322|450013574|FG001|Overall Study|Adverse Event|0|||
124888812|NCT04285229|449216854|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
124888813|NCT04285229|449216855|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
124888814|NCT04285229|449216850|FG000|Extended Treatment Period|Adverse Event|0|||
124888815|NCT04285229|449216851|FG001|Extended Treatment Period|Adverse Event|0|||
124888816|NCT04285229|449216852|FG002|Extended Treatment Period|Adverse Event|0|||
124888817|NCT04285229|449216853|FG003|Extended Treatment Period|Adverse Event|1|||
124888818|NCT04285229|449216854|FG004|Extended Treatment Period|Adverse Event|0|||
124888819|NCT04285229|449216855|FG005|Extended Treatment Period|Adverse Event|0|||
124888820|NCT04285229|449216850|FG000|Extended Treatment Period|Physician Decision|0|||
124888821|NCT04285229|449216851|FG001|Extended Treatment Period|Physician Decision|0|||
124888822|NCT04285229|449216852|FG002|Extended Treatment Period|Physician Decision|1|||
124888823|NCT04285229|449216853|FG003|Extended Treatment Period|Physician Decision|0|||
124888824|NCT04285229|449216854|FG004|Extended Treatment Period|Physician Decision|0|||
124888825|NCT04285229|449216855|FG005|Extended Treatment Period|Physician Decision|0|||
124888826|NCT04285229|449216850|FG000|Follow-up Period|Adverse Event|0|||
124888827|NCT04285229|449216851|FG001|Follow-up Period|Adverse Event|0|||
124888828|NCT04285229|449216852|FG002|Follow-up Period|Adverse Event|0|||
124888829|NCT04285229|449216853|FG003|Follow-up Period|Adverse Event|0|||
124888830|NCT04285229|449216854|FG004|Follow-up Period|Adverse Event|1|||
124888831|NCT04285229|449216855|FG005|Follow-up Period|Adverse Event|4|||
124888832|NCT04285229|449216850|FG000|Follow-up Period|Withdrawal by Subject|0|||
124888833|NCT04285229|449216851|FG001|Follow-up Period|Withdrawal by Subject|0|||
124888834|NCT04285229|449216852|FG002|Follow-up Period|Withdrawal by Subject|0|||
125016714|NCT00845650|449685522|FG003|Overall Study|Sponsor hold on dosing|0|||
125016715|NCT00845650|449685523|FG004|Overall Study|Sponsor hold on dosing|1|||
124888835|NCT04285229|449216853|FG003|Follow-up Period|Withdrawal by Subject|0|||
124888836|NCT04285229|449216854|FG004|Follow-up Period|Withdrawal by Subject|0|||
124888837|NCT04285229|449216855|FG005|Follow-up Period|Withdrawal by Subject|5|||
125016716|NCT00845650|449685524|FG005|Overall Study|Sponsor hold on dosing|1|||
125016717|NCT00845650|449685519|FG000|Overall Study|Unable to access IV line|1|||
125016718|NCT00845650|449685520|FG001|Overall Study|Unable to access IV line|0|||
125016719|NCT00845650|449685521|FG002|Overall Study|Unable to access IV line|0|||
125016720|NCT00845650|449685522|FG003|Overall Study|Unable to access IV line|0|||
124888838|NCT04285229|449216850|FG000|Follow-up Period|Covid-19|0|||
124888839|NCT04285229|449216851|FG001|Follow-up Period|Covid-19|0|||
124888840|NCT04285229|449216852|FG002|Follow-up Period|Covid-19|0|||
124888841|NCT04285229|449216853|FG003|Follow-up Period|Covid-19|0|||
124888842|NCT04285229|449216854|FG004|Follow-up Period|Covid-19|0|||
124888843|NCT04285229|449216855|FG005|Follow-up Period|Covid-19|2|||
124888844|NCT04285229|449216850|FG000|Follow-up Period|Physician Decision|0|||
124888845|NCT04285229|449216851|FG001|Follow-up Period|Physician Decision|0|||
124888846|NCT04285229|449216852|FG002|Follow-up Period|Physician Decision|0|||
124888847|NCT04285229|449216853|FG003|Follow-up Period|Physician Decision|0|||
124888848|NCT04285229|449216854|FG004|Follow-up Period|Physician Decision|0|||
124888849|NCT04285229|449216855|FG005|Follow-up Period|Physician Decision|1|||
124888850|NCT00231894|449216856|FG000|Overall Study|Withdrawal by Subject|1|||
124888851|NCT00231894|449216857|FG001|Overall Study|Withdrawal by Subject|1|||
124888852|NCT02025205|449216858|FG000|Overall Study|Withdrawal by Subject|1|||
124888853|NCT02025205|449216859|FG001|Overall Study|Withdrawal by Subject|1|||
124888854|NCT02025205|449216858|FG000|Overall Study|Protocol Violation|2|||
124888855|NCT02025205|449216859|FG001|Overall Study|Protocol Violation|1|||
124888856|NCT02025205|449216858|FG000|Overall Study|Death|0|||
124888857|NCT02025205|449216859|FG001|Overall Study|Death|1|||
124888858|NCT01767129|449216860|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
124888859|NCT01767129|449216861|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
124888860|NCT03389893|449216862|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
124888861|NCT03389893|449216863|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
124888862|NCT03389893|449216864|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
124888863|NCT03389893|449216865|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
124888864|NCT03389893|449216862|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
124888865|NCT03389893|449216863|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
124888866|NCT03389893|449216864|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
124888867|NCT03389893|449216865|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
124888868|NCT03389893|449216862|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
124888869|NCT03389893|449216863|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
124888870|NCT03389893|449216864|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
124888871|NCT03389893|449216865|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
124888872|NCT03389893|449216862|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
124888873|NCT03389893|449216863|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
124888874|NCT03389893|449216864|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
124888875|NCT03389893|449216865|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
124888876|NCT01232556|449216869|FG000|Overall Study|Withdrawal by Subject|21|||
124888877|NCT01232556|449216870|FG001|Overall Study|Withdrawal by Subject|17|||
124888878|NCT01232556|449216869|FG000|Overall Study|Death|97|||
124888879|NCT01232556|449216870|FG001|Overall Study|Death|97|||
124888880|NCT01232556|449216869|FG000|Overall Study|Lost to Follow-up|0|||
124888881|NCT01232556|449216870|FG001|Overall Study|Lost to Follow-up|2|||
124888882|NCT01232556|449216869|FG000|Overall Study|Terminated by Sponsor|35|||
124888883|NCT01232556|449216870|FG001|Overall Study|Terminated by Sponsor|51|||
125106777|NCT02200614|450013575|FG000|Double Blind Treatment|Adverse Event|86|||
125106778|NCT02200614|450013576|FG001|Double Blind Treatment|Adverse Event|48|||
125106779|NCT02200614|450013575|FG000|Double Blind Treatment|Confirmed metastasis|120|||
125106780|NCT02200614|450013576|FG001|Double Blind Treatment|Confirmed metastasis|140|||
125106781|NCT02200614|450013575|FG000|Double Blind Treatment|Judgment of the investigator|59|||
125106782|NCT02200614|450013576|FG001|Double Blind Treatment|Judgment of the investigator|99|||
125106783|NCT02200614|450013575|FG000|Double Blind Treatment|Metastasis by local reading|1|||
125106784|NCT02200614|450013576|FG001|Double Blind Treatment|Metastasis by local reading|3|||
125106785|NCT02200614|450013575|FG000|Double Blind Treatment|Other reason|6|||
124888884|NCT01232556|449216869|FG000|Overall Study|Other|6|||
124888885|NCT01232556|449216870|FG001|Overall Study|Other|4|||
124888886|NCT01473420|449216872|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
124888887|NCT01473420|449216873|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
124888888|NCT01473420|449216872|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
124888889|NCT01473420|449216873|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
124888890|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
124888891|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
124888892|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
124888893|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
125106786|NCT02200614|450013576|FG001|Double Blind Treatment|Other reason|2|||
124888894|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
124888895|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
124888896|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
124888897|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
124888898|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
124888899|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
124888900|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
124888901|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
124888902|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
124888903|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
124888904|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
124888905|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
124888906|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
124888907|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
124888908|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
124888909|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
124888910|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
124888911|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
124888912|NCT00388362|449216883|FG000|Enrolled|Ineligible|1|||
124888913|NCT00388362|449216883|FG000|Enrolled|Adverse Event|9|||
124888914|NCT00388362|449216883|FG000|Enrolled|Death|1|||
124888915|NCT00388362|449216883|FG000|Enrolled|Loss insurance|1|||
124888916|NCT00388362|449216883|FG000|Enrolled|Withdrawal by Subject|1|||
124888917|NCT00388362|449216883|FG000|Remained on Study Median of 514 Days|Death|2|||
124888918|NCT03259373|449216890|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
124888919|NCT03259373|449216891|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
124888920|NCT03259373|449216890|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
124888921|NCT03259373|449216891|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
124888922|NCT03259373|449216890|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
124888923|NCT03259373|449216891|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
124888924|NCT03259373|449216890|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
124888925|NCT03259373|449216891|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
124888926|NCT03259373|449216890|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
124888927|NCT03259373|449216891|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
124888928|NCT03259373|449216890|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
124888929|NCT03259373|449216891|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
124888930|NCT04963062|449216899|FG000|Overall Study|withdrew by the study team|4|||
124888931|NCT04963062|449216900|FG001|Overall Study|withdrew by the study team|2|||
124888932|NCT01857323|449216901|FG000|Overall Study|Adverse Event|1|||
124888933|NCT01857323|449216901|FG000|Overall Study|Withdrawal by Subject|3|||
124888934|NCT01857323|449216901|FG000|Overall Study|Non-compliance|1|||
124888935|NCT01857323|449216901|FG000|Overall Study|Protocol Violation|6|||
124888936|NCT01857323|449216901|FG000|Overall Study|Lost to Follow-up|1|||
124888937|NCT01857323|449216901|FG000|Overall Study|Other|4|||
124888938|NCT01857323|449216901|FG000|Overall Study|Did not complete 180 doses|48|||
124888939|NCT03873246|449216902|FG000|Overall Study|Adverse Event|1|||
124888940|NCT03873246|449216903|FG001|Overall Study|Adverse Event|3|||
124888941|NCT03873246|449216904|FG002|Overall Study|Adverse Event|3|||
124888942|NCT03873246|449216902|FG000|Overall Study|Lost to Follow-up|4|||
124888943|NCT03873246|449216903|FG001|Overall Study|Lost to Follow-up|4|||
124888944|NCT03873246|449216904|FG002|Overall Study|Lost to Follow-up|5|||
124888945|NCT03873246|449216902|FG000|Overall Study|Protocol Violation|0|||
124888946|NCT03873246|449216903|FG001|Overall Study|Protocol Violation|1|||
124888947|NCT03873246|449216904|FG002|Overall Study|Protocol Violation|0|||
124888948|NCT03873246|449216902|FG000|Overall Study|Withdrawal by Subject|0|||
124888949|NCT03873246|449216903|FG001|Overall Study|Withdrawal by Subject|4|||
125016721|NCT00845650|449685523|FG004|Overall Study|Unable to access IV line|0|||
125016722|NCT00845650|449685524|FG005|Overall Study|Unable to access IV line|0|||
125016723|NCT04486950|449685525|FG000|Overall Study|Lost to Follow-up|0|||
125016724|NCT04486950|449685526|FG001|Overall Study|Lost to Follow-up|0|||
125016725|NCT04486950|449685527|FG002|Overall Study|Lost to Follow-up|0|||
125016726|NCT04486950|449685528|FG003|Overall Study|Lost to Follow-up|0|||
125016727|NCT04486950|449685529|FG004|Overall Study|Lost to Follow-up|0|||
124888950|NCT03873246|449216904|FG002|Overall Study|Withdrawal by Subject|1|||
124888951|NCT01368211|449216908|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
124888952|NCT01368211|449216909|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
125016728|NCT04486950|449685530|FG005|Overall Study|Lost to Follow-up|1|||
125016729|NCT04486950|449685531|FG006|Overall Study|Lost to Follow-up|0|||
125016730|NCT00550680|449685534|FG000|Overall Study|Administrative Reasons|1|||
124888953|NCT01987830|449216911|FG000|Overall Study|Never received baseline scan|1|||
124888954|NCT01349660|449216915|FG000|Overall Study|Still Receiving Study Treatment|0|||
124888955|NCT01349660|449216916|FG001|Overall Study|Still Receiving Study Treatment|0|||
124888956|NCT01349660|449216917|FG002|Overall Study|Still Receiving Study Treatment|1|||
124888957|NCT01349660|449216915|FG000|Overall Study|Disease Progression|2|||
124888958|NCT01349660|449216916|FG001|Overall Study|Disease Progression|4|||
124888959|NCT01349660|449216917|FG002|Overall Study|Disease Progression|50|||
124888960|NCT01349660|449216915|FG000|Overall Study|Adverse Event|1|||
124888961|NCT01349660|449216916|FG001|Overall Study|Adverse Event|1|||
124888962|NCT01349660|449216917|FG002|Overall Study|Adverse Event|12|||
124888963|NCT01349660|449216915|FG000|Overall Study|Withdrawal by Subject|2|||
124888964|NCT01349660|449216916|FG001|Overall Study|Withdrawal by Subject|0|||
124888965|NCT01349660|449216917|FG002|Overall Study|Withdrawal by Subject|9|||
124888966|NCT01349660|449216915|FG000|Overall Study|Death|1|||
124888967|NCT01349660|449216916|FG001|Overall Study|Death|1|||
124888968|NCT01349660|449216917|FG002|Overall Study|Death|0|||
124888969|NCT01349660|449216915|FG000|Overall Study|Non-Permitted Interventions|0|||
124888970|NCT01349660|449216916|FG001|Overall Study|Non-Permitted Interventions|0|||
124888971|NCT01349660|449216917|FG002|Overall Study|Non-Permitted Interventions|2|||
124888972|NCT01349660|449216915|FG000|Overall Study|Study Compliance|0|||
124888973|NCT01349660|449216916|FG001|Overall Study|Study Compliance|0|||
124888974|NCT01349660|449216917|FG002|Overall Study|Study Compliance|1|||
124888975|NCT01349660|449216915|FG000|Overall Study|Declining Performance Status|0|||
124888976|NCT01349660|449216916|FG001|Overall Study|Declining Performance Status|0|||
124888977|NCT01349660|449216917|FG002|Overall Study|Declining Performance Status|1|||
124888978|NCT05764239|449216918|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
124888979|NCT05764239|449216918|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
124888980|NCT05764239|449216918|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
124888981|NCT05764239|449216918|FG000|DEP (Part 1)|Adverse Event|1|||
124888982|NCT05764239|449216918|FG000|DEP (Part 1)|Lost to Follow-up|1|||
124888983|NCT05764239|449216918|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
124888984|NCT05764239|449216918|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
125106787|NCT02200614|450013575|FG000|Double Blind Treatment|Personal reason|77|||
125106788|NCT02200614|450013576|FG001|Double Blind Treatment|Personal reason|85|||
125106789|NCT02200614|450013575|FG000|Double Blind Treatment|Protocol deviation|14|||
125106790|NCT02200614|450013576|FG001|Double Blind Treatment|Protocol deviation|7|||
125106791|NCT02200614|450013575|FG000|Double Blind Treatment|Not treated|1|||
125106792|NCT02200614|450013576|FG001|Double Blind Treatment|Not treated|0|||
125106793|NCT02200614|450013575|FG000|Open Label|Adverse Event|41|||
125106794|NCT02200614|450013576|FG001|Open Label|Adverse Event|11|||
125106795|NCT02200614|450013575|FG000|Open Label|Confirmed metastasis|1|||
125106796|NCT02200614|450013576|FG001|Open Label|Confirmed metastasis|0|||
125106797|NCT02200614|450013575|FG000|Open Label|Judgment of the investigator|29|||
125106798|NCT02200614|450013576|FG001|Open Label|Judgment of the investigator|2|||
125106799|NCT02200614|450013575|FG000|Open Label|Metastasis by local reading|138|||
125106800|NCT02200614|450013576|FG001|Open Label|Metastasis by local reading|27|||
125106801|NCT02200614|450013575|FG000|Open Label|Other reason|22|||
125106802|NCT02200614|450013576|FG001|Open Label|Other reason|4|||
125106803|NCT02200614|450013575|FG000|Open Label|Personal reason|60|||
125106804|NCT02200614|450013576|FG001|Open Label|Personal reason|8|||
125106805|NCT02200614|450013575|FG000|Open Label|Protocol deviation|3|||
125106806|NCT02200614|450013576|FG001|Open Label|Protocol deviation|2|||
125106807|NCT02200614|450013575|FG000|Open Label|Missing|2|||
125106808|NCT02200614|450013576|FG001|Open Label|Missing|2|||
125106809|NCT00391092|450015501|FG000|Overall Study|Death|78|||
125106810|NCT00391092|450015502|FG001|Overall Study|Death|81|||
125106811|NCT00391092|450015501|FG000|Overall Study|Lost to Follow-up|13|||
124888985|NCT05764239|449216918|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
124888986|NCT05764239|449216918|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
124888987|NCT00057811|449216919|FG000|Overall Study|Lack of Efficacy|1|||
124888988|NCT00057811|449216920|FG001|Overall Study|Lack of Efficacy|4|||
124888989|NCT00057811|449216919|FG000|Overall Study|Physician Decision|1|||
124888990|NCT00057811|449216920|FG001|Overall Study|Physician Decision|0|||
124888991|NCT00057811|449216919|FG000|Overall Study|Withdrawal by Subject|3|||
124888992|NCT00057811|449216920|FG001|Overall Study|Withdrawal by Subject|4|||
124888993|NCT00057811|449216919|FG000|Overall Study|Ineligible|4|||
124888994|NCT00057811|449216920|FG001|Overall Study|Ineligible|2|||
124888995|NCT00057811|449216919|FG000|Overall Study|Inevaluable|1|||
125106812|NCT00391092|450015502|FG001|Overall Study|Lost to Follow-up|18|||
125106813|NCT00391092|450015501|FG000|Overall Study|Alive on treatment|29|||
125106814|NCT00391092|450015502|FG001|Overall Study|Alive on treatment|33|||
124888996|NCT00057811|449216920|FG001|Overall Study|Inevaluable|2|||
124888997|NCT01475786|449216923|FG000|Overall Study|Adverse Event|0|||
124888998|NCT01475786|449216924|FG001|Overall Study|Adverse Event|1|||
124888999|NCT01475786|449216925|FG002|Overall Study|Adverse Event|0|||
125106815|NCT00391092|450015501|FG000|Overall Study|Alive in follow-up|88|||
124889000|NCT01475786|449216923|FG000|Overall Study|Lost to Follow-up|1|||
124889001|NCT01475786|449216924|FG001|Overall Study|Lost to Follow-up|2|||
124889002|NCT01475786|449216925|FG002|Overall Study|Lost to Follow-up|1|||
124889003|NCT01475786|449216923|FG000|Overall Study|Withdrawal by Subject|0|||
124889004|NCT01475786|449216924|FG001|Overall Study|Withdrawal by Subject|1|||
124889005|NCT01475786|449216925|FG002|Overall Study|Withdrawal by Subject|1|||
124889006|NCT01475786|449216923|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
124889007|NCT01475786|449216924|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
124889008|NCT01475786|449216925|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
124889009|NCT04129580|449218603|FG000|Overall Study|Lost to Follow-up|14|||
124889010|NCT04129580|449218604|FG001|Overall Study|Lost to Follow-up|25|||
124889011|NCT02018861|449218607|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
124889012|NCT02018861|449218608|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
124889013|NCT02018861|449218609|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
124889014|NCT02018861|449218610|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
124889015|NCT02018861|449218611|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
124889016|NCT02018861|449218612|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
124889017|NCT02018861|449218613|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
124889018|NCT02018861|449218614|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
124889019|NCT02018861|449218615|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
124889020|NCT02018861|449218616|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
124889021|NCT02018861|449218607|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
124889022|NCT02018861|449218608|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
124889023|NCT02018861|449218609|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
124889024|NCT02018861|449218610|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
124889025|NCT02018861|449218611|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
124889026|NCT02018861|449218612|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
124889027|NCT02018861|449218613|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
124889028|NCT02018861|449218614|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
124889029|NCT02018861|449218615|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
124889030|NCT02018861|449218616|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
124889031|NCT02018861|449218607|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
124889032|NCT02018861|449218608|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
124889033|NCT02018861|449218609|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
124889034|NCT02018861|449218610|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
124889035|NCT02018861|449218611|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
124889036|NCT02018861|449218612|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
124889037|NCT02018861|449218613|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
125016731|NCT00550680|449685534|FG000|Overall Study|Adverse Event|5|||
125016732|NCT00550680|449685534|FG000|Overall Study|Death|3|||
125016733|NCT00550680|449685534|FG000|Overall Study|Early Improvement|1|||
125016734|NCT00550680|449685534|FG000|Overall Study|Lost to Follow-up|3|||
125016735|NCT00550680|449685534|FG000|Overall Study|Lack of Efficacy|1|||
125016736|NCT00550680|449685534|FG000|Overall Study|Other|10|||
125016737|NCT00550680|449685534|FG000|Overall Study|Protocol Violation|7|||
125016738|NCT00550680|449685534|FG000|Overall Study|Refused Treatment|19|||
125016739|NCT00550680|449685534|FG000|Overall Study|Screen Failure|6|||
125016740|NCT01119248|449685535|FG000|Overall Study|Physician Decision|5|||
125016741|NCT00562354|449685536|FG000|Overall Study|Physician Decision|0|||
125016742|NCT00562354|449685537|FG001|Overall Study|Physician Decision|1|||
125016743|NCT00562354|449685536|FG000|Overall Study|Lost to Follow-up|0|||
125016744|NCT00562354|449685537|FG001|Overall Study|Lost to Follow-up|1|||
125016745|NCT00317109|449685538|FG000|Overall Study|Withdrawal by Subject|2|||
125016746|NCT00317109|449685539|FG001|Overall Study|Withdrawal by Subject|0|||
125016747|NCT00317109|449685538|FG000|Overall Study|Migated/moved from study area|1|||
125016748|NCT00317109|449685539|FG001|Overall Study|Migated/moved from study area|0|||
125016749|NCT03693625|449685541|FG000|Overall Study|Adverse Event|2|||
125016750|NCT03693625|449685542|FG001|Overall Study|Adverse Event|0|||
125016751|NCT03693625|449685541|FG000|Overall Study|Study Terminated By Sponsor|20|||
125016752|NCT03693625|449685542|FG001|Overall Study|Study Terminated By Sponsor|7|||
125016753|NCT03693625|449685541|FG000|Overall Study|Withdrawal by Subject|1|||
125016754|NCT03693625|449685542|FG001|Overall Study|Withdrawal by Subject|1|||
125016755|NCT01508702|449685543|FG000|Overall Study|Adverse Event|7|||
125016756|NCT01508702|449685544|FG001|Overall Study|Adverse Event|3|||
125016757|NCT01508702|449685543|FG000|Overall Study|Gout flare|2|||
125016758|NCT01508702|449685544|FG001|Overall Study|Gout flare|0|||
125016759|NCT01508702|449685543|FG000|Overall Study|Protocol Violation|2|||
125016760|NCT01508702|449685544|FG001|Overall Study|Protocol Violation|1|||
124889038|NCT02018861|449218614|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
125016761|NCT01508702|449685543|FG000|Overall Study|Lost to Follow-up|1|||
125016762|NCT01508702|449685544|FG001|Overall Study|Lost to Follow-up|2|||
124889039|NCT02018861|449218615|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
124889040|NCT02018861|449218616|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
124889041|NCT02018861|449218607|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
124889042|NCT02018861|449218608|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
124889043|NCT02018861|449218609|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
124889044|NCT02018861|449218610|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
124889045|NCT02018861|449218611|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
124889046|NCT02018861|449218612|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
124889047|NCT02018861|449218613|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
124889048|NCT02018861|449218614|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
124889049|NCT02018861|449218615|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
124889050|NCT02018861|449218616|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
124889051|NCT02018861|449218607|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
124889052|NCT02018861|449218608|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
124889053|NCT02018861|449218609|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
124889054|NCT02018861|449218610|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
124889055|NCT02018861|449218611|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
124889056|NCT02018861|449218612|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
124889057|NCT02018861|449218613|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
124889058|NCT02018861|449218614|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
124889059|NCT02018861|449218615|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
124889060|NCT02018861|449218616|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
124889061|NCT02018861|449218607|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
124889062|NCT02018861|449218608|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
124889063|NCT02018861|449218609|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
124889064|NCT02018861|449218610|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
124889065|NCT02018861|449218611|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
124889066|NCT02018861|449218612|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
124889067|NCT02018861|449218613|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
124889068|NCT02018861|449218614|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
124889069|NCT02018861|449218615|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
124889070|NCT02018861|449218616|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
124889071|NCT02018861|449218607|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
124889072|NCT02018861|449218608|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
124889073|NCT02018861|449218609|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
124889074|NCT02018861|449218610|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
124889075|NCT02018861|449218611|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
124889076|NCT02018861|449218612|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
124889077|NCT02018861|449218613|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
124889078|NCT02018861|449218614|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
124889079|NCT02018861|449218615|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
124889080|NCT02018861|449218616|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
124889081|NCT02018861|449218607|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
124889082|NCT02018861|449218608|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
124889083|NCT02018861|449218609|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
125016763|NCT01508702|449685543|FG000|Overall Study|Withdrawal by Subject|11|||
125016764|NCT01508702|449685544|FG001|Overall Study|Withdrawal by Subject|7|||
125016765|NCT01883635|449685546|FG000|Overall Study|Withdrawal by Subject|4|||
125016766|NCT01883635|449685547|FG001|Overall Study|Withdrawal by Subject|0|||
125016767|NCT01187953|449685548|FG000|Overall Study|Death|11|||
125016768|NCT01187953|449685549|FG001|Overall Study|Death|13|||
125016769|NCT01187953|449685548|FG000|Overall Study|Adverse Event|1|||
125016770|NCT01187953|449685549|FG001|Overall Study|Adverse Event|2|||
125016771|NCT01187953|449685548|FG000|Overall Study|Lost to Follow-up|0|||
125016772|NCT01187953|449685549|FG001|Overall Study|Lost to Follow-up|3|||
125016773|NCT01187953|449685548|FG000|Overall Study|Withdrawal by Subject|3|||
125016774|NCT01187953|449685549|FG001|Overall Study|Withdrawal by Subject|3|||
125016775|NCT01464307|449685553|FG000|Main Period|Death|0|||
125016776|NCT01464307|449685554|FG001|Main Period|Death|1|||
125016777|NCT01464307|449685553|FG000|Main Period|Adverse Event|6|||
125016778|NCT01464307|449685554|FG001|Main Period|Adverse Event|1|||
125016779|NCT01464307|449685553|FG000|Main Period|Lack of Efficacy|2|||
125016780|NCT01464307|449685554|FG001|Main Period|Lack of Efficacy|0|||
125016781|NCT01464307|449685553|FG000|Main Period|Withdrawal by Subject|5|||
125016782|NCT01464307|449685554|FG001|Main Period|Withdrawal by Subject|2|||
125016783|NCT01464307|449685553|FG000|Main Period|Predefined discontinuation criteria|2|||
125016784|NCT01464307|449685554|FG001|Main Period|Predefined discontinuation criteria|1|||
125016785|NCT01464307|449685553|FG000|Open-Label Extension Period|Adverse Event|15|||
124889084|NCT02018861|449218610|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
124889085|NCT02018861|449218611|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
124889086|NCT02018861|449218612|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
124889087|NCT02018861|449218613|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
124889088|NCT02018861|449218614|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
124889089|NCT02018861|449218615|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
124889090|NCT02018861|449218616|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
124889091|NCT02018861|449218607|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
124889092|NCT02018861|449218608|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
124889093|NCT02018861|449218609|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
124889094|NCT02018861|449218610|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
124889095|NCT02018861|449218611|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
124889096|NCT02018861|449218612|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
124889097|NCT02018861|449218613|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
124889098|NCT02018861|449218614|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
124889099|NCT02018861|449218615|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
124889100|NCT02018861|449218616|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
124889101|NCT02018861|449218607|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
124889102|NCT02018861|449218608|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
124889103|NCT02018861|449218609|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
124889104|NCT02018861|449218610|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
124889105|NCT02018861|449218611|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
124889106|NCT02018861|449218612|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
124889107|NCT02018861|449218613|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
124889108|NCT02018861|449218614|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
124889109|NCT02018861|449218615|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
124889110|NCT02018861|449218616|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
124889111|NCT02018861|449218607|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
124889112|NCT02018861|449218608|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
124889113|NCT02018861|449218609|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
124889114|NCT02018861|449218610|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
124889115|NCT02018861|449218611|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
124889116|NCT02018861|449218612|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
124889117|NCT02018861|449218613|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
124889118|NCT02018861|449218614|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
124889119|NCT02018861|449218615|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
124889120|NCT02018861|449218616|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
124889121|NCT02018861|449218607|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
124889122|NCT02018861|449218608|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
124889123|NCT02018861|449218609|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
124889124|NCT02018861|449218610|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
124889125|NCT02018861|449218611|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
124889126|NCT02018861|449218612|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
124889127|NCT02018861|449218613|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
124889128|NCT02018861|449218614|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
124889129|NCT02018861|449218615|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
124889130|NCT02018861|449218616|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
124889131|NCT02018861|449218607|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
124889132|NCT02018861|449218608|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
124889133|NCT02018861|449218609|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
124889134|NCT02018861|449218610|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
124889135|NCT02018861|449218611|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
124889136|NCT02018861|449218612|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
124889137|NCT02018861|449218613|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
124889138|NCT02018861|449218614|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
124889139|NCT02018861|449218615|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
124889140|NCT02018861|449218616|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
124889141|NCT01474512|449218621|FG000|Induction Period|Adverse Event|6|||
124889142|NCT01474512|449218622|FG001|Induction Period|Adverse Event|10|||
124889143|NCT01474512|449218623|FG002|Induction Period|Adverse Event|10|||
124889144|NCT01474512|449218624|FG003|Induction Period|Adverse Event|0|||
124889145|NCT01474512|449218625|FG004|Induction Period|Adverse Event|0|||
125016786|NCT01464307|449685554|FG001|Open-Label Extension Period|Adverse Event|0|||
125016787|NCT01464307|449685553|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
125016788|NCT01464307|449685554|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
125016789|NCT01464307|449685553|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
125016790|NCT01464307|449685554|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
125016791|NCT01464307|449685553|FG000|Open-Label Extension Period|Death|1|||
125016792|NCT01464307|449685554|FG001|Open-Label Extension Period|Death|0|||
125016793|NCT01464307|449685553|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
125016794|NCT01464307|449685554|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
125016795|NCT01464307|449685553|FG000|Open-Label Extension Period|Non-compliance|9|||
125016796|NCT01464307|449685554|FG001|Open-Label Extension Period|Non-compliance|0|||
125016797|NCT01464307|449685553|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
125016798|NCT01464307|449685554|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
125016799|NCT00761514|449685559|FG000|Overall Study|Adverse Event|1|||
125016800|NCT00761514|449685559|FG000|Overall Study|Withdrawal by Subject|2|||
125016801|NCT00761514|449685559|FG000|Overall Study|Lost to Follow-up|1|||
125016802|NCT00761514|449685559|FG000|Overall Study|Health insurance didn't cover study drug|1|||
125016803|NCT00761514|449685559|FG000|Overall Study|Problem complying with study visit|1|||
125016804|NCT00761514|449685559|FG000|Overall Study|Unable to pay for medications|1|||
125016805|NCT02457637|449685560|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
125016806|NCT01836783|449685561|FG000|Overall Study|Withdrawal by Subject|0|||
125016807|NCT01836783|449685562|FG001|Overall Study|Withdrawal by Subject|2|||
124889146|NCT01474512|449218626|FG005|Induction Period|Adverse Event|0|||
124889147|NCT01474512|449218627|FG006|Induction Period|Adverse Event|0|||
124889148|NCT01474512|449218628|FG007|Induction Period|Adverse Event|0|||
124889149|NCT01474512|449218629|FG008|Induction Period|Adverse Event|0|||
124889150|NCT01474512|449218630|FG009|Induction Period|Adverse Event|0|||
124889151|NCT01474512|449218631|FG010|Induction Period|Adverse Event|0|||
124889152|NCT01474512|449218632|FG011|Induction Period|Adverse Event|0|||
124889153|NCT01474512|449218633|FG012|Induction Period|Adverse Event|0|||
124889154|NCT01474512|449218634|FG013|Induction Period|Adverse Event|0|||
124889155|NCT01474512|449218635|FG014|Induction Period|Adverse Event|0|||
124889156|NCT01474512|449218636|FG015|Induction Period|Adverse Event|0|||
124889157|NCT01474512|449218637|FG016|Induction Period|Adverse Event|0|||
124889158|NCT01474512|449218638|FG017|Induction Period|Adverse Event|0|||
124889159|NCT01474512|449218621|FG000|Induction Period|Lack of Efficacy|7|||
124889160|NCT01474512|449218622|FG001|Induction Period|Lack of Efficacy|1|||
124889161|NCT01474512|449218623|FG002|Induction Period|Lack of Efficacy|0|||
124889162|NCT01474512|449218624|FG003|Induction Period|Lack of Efficacy|0|||
124889163|NCT01474512|449218625|FG004|Induction Period|Lack of Efficacy|0|||
124889164|NCT01474512|449218626|FG005|Induction Period|Lack of Efficacy|0|||
124889165|NCT01474512|449218627|FG006|Induction Period|Lack of Efficacy|0|||
124889166|NCT01474512|449218628|FG007|Induction Period|Lack of Efficacy|0|||
124889167|NCT01474512|449218629|FG008|Induction Period|Lack of Efficacy|0|||
124889168|NCT01474512|449218630|FG009|Induction Period|Lack of Efficacy|0|||
124889169|NCT01474512|449218631|FG010|Induction Period|Lack of Efficacy|0|||
124889170|NCT01474512|449218632|FG011|Induction Period|Lack of Efficacy|0|||
124889171|NCT01474512|449218633|FG012|Induction Period|Lack of Efficacy|0|||
124889172|NCT01474512|449218634|FG013|Induction Period|Lack of Efficacy|0|||
124889173|NCT01474512|449218635|FG014|Induction Period|Lack of Efficacy|0|||
124889174|NCT01474512|449218636|FG015|Induction Period|Lack of Efficacy|0|||
124889175|NCT01474512|449218637|FG016|Induction Period|Lack of Efficacy|0|||
124889176|NCT01474512|449218638|FG017|Induction Period|Lack of Efficacy|0|||
124889177|NCT01474512|449218621|FG000|Induction Period|Withdrawal by Subject|6|||
124889178|NCT01474512|449218622|FG001|Induction Period|Withdrawal by Subject|6|||
124889179|NCT01474512|449218623|FG002|Induction Period|Withdrawal by Subject|5|||
124889180|NCT01474512|449218624|FG003|Induction Period|Withdrawal by Subject|0|||
124889181|NCT01474512|449218625|FG004|Induction Period|Withdrawal by Subject|0|||
124889182|NCT01474512|449218626|FG005|Induction Period|Withdrawal by Subject|0|||
124889183|NCT01474512|449218627|FG006|Induction Period|Withdrawal by Subject|0|||
124889184|NCT01474512|449218628|FG007|Induction Period|Withdrawal by Subject|0|||
124889185|NCT01474512|449218629|FG008|Induction Period|Withdrawal by Subject|0|||
124889186|NCT01474512|449218630|FG009|Induction Period|Withdrawal by Subject|0|||
124889187|NCT01474512|449218631|FG010|Induction Period|Withdrawal by Subject|0|||
124889188|NCT01474512|449218632|FG011|Induction Period|Withdrawal by Subject|0|||
124889189|NCT01474512|449218633|FG012|Induction Period|Withdrawal by Subject|0|||
124889190|NCT01474512|449218634|FG013|Induction Period|Withdrawal by Subject|0|||
124889191|NCT01474512|449218635|FG014|Induction Period|Withdrawal by Subject|0|||
124889192|NCT01474512|449218636|FG015|Induction Period|Withdrawal by Subject|0|||
124889193|NCT01474512|449218637|FG016|Induction Period|Withdrawal by Subject|0|||
124889194|NCT01474512|449218638|FG017|Induction Period|Withdrawal by Subject|0|||
124889195|NCT01474512|449218621|FG000|Induction Period|Protocol Violation|3|||
124889196|NCT01474512|449218622|FG001|Induction Period|Protocol Violation|6|||
124889197|NCT01474512|449218623|FG002|Induction Period|Protocol Violation|0|||
124889198|NCT01474512|449218624|FG003|Induction Period|Protocol Violation|0|||
124889199|NCT01474512|449218625|FG004|Induction Period|Protocol Violation|0|||
124889200|NCT01474512|449218626|FG005|Induction Period|Protocol Violation|0|||
124889201|NCT01474512|449218627|FG006|Induction Period|Protocol Violation|0|||
124889202|NCT01474512|449218628|FG007|Induction Period|Protocol Violation|0|||
124889203|NCT01474512|449218629|FG008|Induction Period|Protocol Violation|0|||
124889204|NCT01474512|449218630|FG009|Induction Period|Protocol Violation|0|||
124889205|NCT01474512|449218631|FG010|Induction Period|Protocol Violation|0|||
124889206|NCT01474512|449218632|FG011|Induction Period|Protocol Violation|0|||
124889207|NCT01474512|449218633|FG012|Induction Period|Protocol Violation|0|||
124889208|NCT01474512|449218634|FG013|Induction Period|Protocol Violation|0|||
124889209|NCT01474512|449218635|FG014|Induction Period|Protocol Violation|0|||
124889210|NCT01474512|449218636|FG015|Induction Period|Protocol Violation|0|||
125016808|NCT04942925|449685565|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
124889211|NCT01474512|449218637|FG016|Induction Period|Protocol Violation|0|||
124889212|NCT01474512|449218638|FG017|Induction Period|Protocol Violation|0|||
124889213|NCT01474512|449218621|FG000|Induction Period|Sponsor Decision|1|||
124889214|NCT01474512|449218622|FG001|Induction Period|Sponsor Decision|1|||
124889215|NCT01474512|449218623|FG002|Induction Period|Sponsor Decision|1|||
124889216|NCT01474512|449218624|FG003|Induction Period|Sponsor Decision|0|||
124889217|NCT01474512|449218625|FG004|Induction Period|Sponsor Decision|0|||
124889218|NCT01474512|449218626|FG005|Induction Period|Sponsor Decision|0|||
124889219|NCT01474512|449218627|FG006|Induction Period|Sponsor Decision|0|||
124889220|NCT01474512|449218628|FG007|Induction Period|Sponsor Decision|0|||
124889221|NCT01474512|449218629|FG008|Induction Period|Sponsor Decision|0|||
124889222|NCT01474512|449218630|FG009|Induction Period|Sponsor Decision|0|||
125016809|NCT04942925|449685566|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
125016810|NCT04942925|449685565|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
125016811|NCT04942925|449685566|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
125016812|NCT01273883|449685567|FG000|First Intervention|Adverse Event|2|||
125016813|NCT01273883|449685568|FG001|First Intervention|Adverse Event|1|||
125016814|NCT01273883|449685567|FG000|Second Intervention|Lost to Follow-up|1|||
125016815|NCT01273883|449685568|FG001|Second Intervention|Lost to Follow-up|1|||
125016816|NCT01273883|449685567|FG000|Second Intervention|Lack of Efficacy|1|||
125016817|NCT01273883|449685568|FG001|Second Intervention|Lack of Efficacy|0|||
125016818|NCT00159861|449685569|FG000|Core Study - 16 Weeks|Death|3|||
125016819|NCT00159861|449685570|FG001|Core Study - 16 Weeks|Death|0|||
125016820|NCT00159861|449685569|FG000|Core Study - 16 Weeks|Adverse Event|12|||
125016821|NCT00159861|449685570|FG001|Core Study - 16 Weeks|Adverse Event|6|||
125016822|NCT00159861|449685569|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
125016823|NCT00159861|449685570|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
125016824|NCT00159861|449685569|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
125016825|NCT00159861|449685570|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
125016826|NCT00159861|449685569|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
125016827|NCT00159861|449685570|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
125016828|NCT00159861|449685569|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
125016829|NCT00159861|449685570|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
125016830|NCT00159861|449685569|FG000|Extension Study - up to 3 Years|Death|24|||
125016831|NCT00159861|449685570|FG001|Extension Study - up to 3 Years|Death|28|||
125016832|NCT00159861|449685569|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
125016833|NCT00159861|449685570|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
125016834|NCT00159861|449685569|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
125016835|NCT00159861|449685570|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
125016836|NCT00159861|449685569|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
125016837|NCT00159861|449685570|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
125016838|NCT00159861|449685569|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
125016839|NCT00159861|449685570|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
125016840|NCT02867995|449685576|FG000|Overall Study|Withdrawal by Subject|0|||
125016841|NCT02867995|449685577|FG001|Overall Study|Withdrawal by Subject|1|||
124889223|NCT01474512|449218631|FG010|Induction Period|Sponsor Decision|0|||
124889224|NCT01474512|449218632|FG011|Induction Period|Sponsor Decision|0|||
124889225|NCT01474512|449218633|FG012|Induction Period|Sponsor Decision|0|||
124889226|NCT01474512|449218634|FG013|Induction Period|Sponsor Decision|0|||
124889227|NCT01474512|449218635|FG014|Induction Period|Sponsor Decision|0|||
124889228|NCT01474512|449218636|FG015|Induction Period|Sponsor Decision|0|||
124889229|NCT01474512|449218637|FG016|Induction Period|Sponsor Decision|0|||
124889230|NCT01474512|449218638|FG017|Induction Period|Sponsor Decision|0|||
124889231|NCT01474512|449218621|FG000|Induction Period|Lost to Follow-up|1|||
124889232|NCT01474512|449218622|FG001|Induction Period|Lost to Follow-up|0|||
124889233|NCT01474512|449218623|FG002|Induction Period|Lost to Follow-up|2|||
124889234|NCT01474512|449218624|FG003|Induction Period|Lost to Follow-up|0|||
124889235|NCT01474512|449218625|FG004|Induction Period|Lost to Follow-up|0|||
124889236|NCT01474512|449218626|FG005|Induction Period|Lost to Follow-up|0|||
124889237|NCT01474512|449218627|FG006|Induction Period|Lost to Follow-up|0|||
124889238|NCT01474512|449218628|FG007|Induction Period|Lost to Follow-up|0|||
124889239|NCT01474512|449218629|FG008|Induction Period|Lost to Follow-up|0|||
124889240|NCT01474512|449218630|FG009|Induction Period|Lost to Follow-up|0|||
124889241|NCT01474512|449218631|FG010|Induction Period|Lost to Follow-up|0|||
124889242|NCT01474512|449218632|FG011|Induction Period|Lost to Follow-up|0|||
124889243|NCT01474512|449218633|FG012|Induction Period|Lost to Follow-up|0|||
124889244|NCT01474512|449218634|FG013|Induction Period|Lost to Follow-up|0|||
124889245|NCT01474512|449218635|FG014|Induction Period|Lost to Follow-up|0|||
124889246|NCT01474512|449218636|FG015|Induction Period|Lost to Follow-up|0|||
124889247|NCT01474512|449218637|FG016|Induction Period|Lost to Follow-up|0|||
124889248|NCT01474512|449218638|FG017|Induction Period|Lost to Follow-up|0|||
124889249|NCT01474512|449218621|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889250|NCT01474512|449218622|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889251|NCT01474512|449218623|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889252|NCT01474512|449218624|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
124889253|NCT01474512|449218625|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
124889254|NCT01474512|449218626|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
124889255|NCT01474512|449218627|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
124889256|NCT01474512|449218628|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889257|NCT01474512|449218629|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889258|NCT01474512|449218630|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889259|NCT01474512|449218631|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889260|NCT01474512|449218632|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889261|NCT01474512|449218633|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889262|NCT01474512|449218634|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889263|NCT01474512|449218635|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889264|NCT01474512|449218636|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889265|NCT01474512|449218637|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889266|NCT01474512|449218638|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889267|NCT01474512|449218621|FG000|Maintenance Period|Adverse Event|0|||
124889268|NCT01474512|449218622|FG001|Maintenance Period|Adverse Event|0|||
124889269|NCT01474512|449218623|FG002|Maintenance Period|Adverse Event|0|||
124889270|NCT01474512|449218624|FG003|Maintenance Period|Adverse Event|4|||
124889271|NCT01474512|449218625|FG004|Maintenance Period|Adverse Event|2|||
124889272|NCT01474512|449218626|FG005|Maintenance Period|Adverse Event|7|||
124889273|NCT01474512|449218627|FG006|Maintenance Period|Adverse Event|0|||
124889274|NCT01474512|449218628|FG007|Maintenance Period|Adverse Event|19|||
124889275|NCT01474512|449218629|FG008|Maintenance Period|Adverse Event|1|||
124889276|NCT01474512|449218630|FG009|Maintenance Period|Adverse Event|3|||
124889277|NCT01474512|449218631|FG010|Maintenance Period|Adverse Event|0|||
124889278|NCT01474512|449218632|FG011|Maintenance Period|Adverse Event|0|||
124889279|NCT01474512|449218633|FG012|Maintenance Period|Adverse Event|0|||
124889280|NCT01474512|449218634|FG013|Maintenance Period|Adverse Event|0|||
124889281|NCT01474512|449218635|FG014|Maintenance Period|Adverse Event|0|||
124889282|NCT01474512|449218636|FG015|Maintenance Period|Adverse Event|0|||
124889283|NCT01474512|449218637|FG016|Maintenance Period|Adverse Event|0|||
124889284|NCT01474512|449218638|FG017|Maintenance Period|Adverse Event|0|||
124889285|NCT01474512|449218621|FG000|Maintenance Period|Withdrawal by Subject|0|||
124889286|NCT01474512|449218622|FG001|Maintenance Period|Withdrawal by Subject|0|||
124889287|NCT01474512|449218623|FG002|Maintenance Period|Withdrawal by Subject|0|||
124889288|NCT01474512|449218624|FG003|Maintenance Period|Withdrawal by Subject|6|||
124889289|NCT01474512|449218625|FG004|Maintenance Period|Withdrawal by Subject|2|||
124889290|NCT01474512|449218626|FG005|Maintenance Period|Withdrawal by Subject|3|||
124889291|NCT01474512|449218627|FG006|Maintenance Period|Withdrawal by Subject|1|||
124889292|NCT01474512|449218628|FG007|Maintenance Period|Withdrawal by Subject|6|||
124889293|NCT01474512|449218629|FG008|Maintenance Period|Withdrawal by Subject|3|||
124889294|NCT01474512|449218630|FG009|Maintenance Period|Withdrawal by Subject|1|||
124889295|NCT01474512|449218631|FG010|Maintenance Period|Withdrawal by Subject|0|||
124889296|NCT01474512|449218632|FG011|Maintenance Period|Withdrawal by Subject|0|||
124889297|NCT01474512|449218633|FG012|Maintenance Period|Withdrawal by Subject|0|||
124889298|NCT01474512|449218634|FG013|Maintenance Period|Withdrawal by Subject|0|||
124889299|NCT01474512|449218635|FG014|Maintenance Period|Withdrawal by Subject|0|||
124889300|NCT01474512|449218636|FG015|Maintenance Period|Withdrawal by Subject|0|||
124889301|NCT01474512|449218637|FG016|Maintenance Period|Withdrawal by Subject|0|||
124889302|NCT01474512|449218638|FG017|Maintenance Period|Withdrawal by Subject|0|||
124889303|NCT01474512|449218621|FG000|Maintenance Period|Lost to Follow-up|0|||
124889304|NCT01474512|449218622|FG001|Maintenance Period|Lost to Follow-up|0|||
124889305|NCT01474512|449218623|FG002|Maintenance Period|Lost to Follow-up|0|||
124889306|NCT01474512|449218624|FG003|Maintenance Period|Lost to Follow-up|3|||
124889307|NCT01474512|449218625|FG004|Maintenance Period|Lost to Follow-up|3|||
124889308|NCT01474512|449218626|FG005|Maintenance Period|Lost to Follow-up|0|||
124889309|NCT01474512|449218627|FG006|Maintenance Period|Lost to Follow-up|0|||
124889310|NCT01474512|449218628|FG007|Maintenance Period|Lost to Follow-up|2|||
124889311|NCT01474512|449218629|FG008|Maintenance Period|Lost to Follow-up|1|||
124889312|NCT01474512|449218630|FG009|Maintenance Period|Lost to Follow-up|1|||
124889313|NCT01474512|449218631|FG010|Maintenance Period|Lost to Follow-up|0|||
124889314|NCT01474512|449218632|FG011|Maintenance Period|Lost to Follow-up|0|||
124889315|NCT01474512|449218633|FG012|Maintenance Period|Lost to Follow-up|0|||
124889316|NCT01474512|449218634|FG013|Maintenance Period|Lost to Follow-up|0|||
124889317|NCT01474512|449218635|FG014|Maintenance Period|Lost to Follow-up|0|||
124889318|NCT01474512|449218636|FG015|Maintenance Period|Lost to Follow-up|0|||
124889319|NCT01474512|449218637|FG016|Maintenance Period|Lost to Follow-up|0|||
124889320|NCT01474512|449218638|FG017|Maintenance Period|Lost to Follow-up|0|||
124889321|NCT01474512|449218621|FG000|Maintenance Period|Death|0|||
124889322|NCT01474512|449218622|FG001|Maintenance Period|Death|0|||
124889323|NCT01474512|449218623|FG002|Maintenance Period|Death|0|||
124889324|NCT01474512|449218624|FG003|Maintenance Period|Death|0|||
124889325|NCT01474512|449218625|FG004|Maintenance Period|Death|0|||
124889326|NCT01474512|449218626|FG005|Maintenance Period|Death|2|||
124889327|NCT01474512|449218627|FG006|Maintenance Period|Death|0|||
124889328|NCT01474512|449218628|FG007|Maintenance Period|Death|0|||
124889329|NCT01474512|449218629|FG008|Maintenance Period|Death|0|||
124889330|NCT01474512|449218630|FG009|Maintenance Period|Death|0|||
124889331|NCT01474512|449218631|FG010|Maintenance Period|Death|0|||
124889332|NCT01474512|449218632|FG011|Maintenance Period|Death|0|||
124889333|NCT01474512|449218633|FG012|Maintenance Period|Death|0|||
124889334|NCT01474512|449218634|FG013|Maintenance Period|Death|0|||
124889335|NCT01474512|449218635|FG014|Maintenance Period|Death|0|||
124889336|NCT01474512|449218636|FG015|Maintenance Period|Death|0|||
124889337|NCT01474512|449218637|FG016|Maintenance Period|Death|0|||
124889338|NCT01474512|449218638|FG017|Maintenance Period|Death|0|||
124889339|NCT01474512|449218621|FG000|Maintenance Period|Physician Decision|0|||
124889340|NCT01474512|449218622|FG001|Maintenance Period|Physician Decision|0|||
124889341|NCT01474512|449218623|FG002|Maintenance Period|Physician Decision|0|||
124889342|NCT01474512|449218624|FG003|Maintenance Period|Physician Decision|0|||
124889343|NCT01474512|449218625|FG004|Maintenance Period|Physician Decision|0|||
124889344|NCT01474512|449218626|FG005|Maintenance Period|Physician Decision|1|||
124889345|NCT01474512|449218627|FG006|Maintenance Period|Physician Decision|0|||
124889346|NCT01474512|449218628|FG007|Maintenance Period|Physician Decision|2|||
124889347|NCT01474512|449218629|FG008|Maintenance Period|Physician Decision|0|||
124889348|NCT01474512|449218630|FG009|Maintenance Period|Physician Decision|0|||
124889349|NCT01474512|449218631|FG010|Maintenance Period|Physician Decision|0|||
124889350|NCT01474512|449218632|FG011|Maintenance Period|Physician Decision|0|||
124889351|NCT01474512|449218633|FG012|Maintenance Period|Physician Decision|0|||
125106816|NCT00391092|450015502|FG001|Overall Study|Alive in follow-up|84|||
125106817|NCT01901146|450015503|FG000|Neoadjuvant Phase|Death|1|||
125106818|NCT01901146|450015504|FG001|Neoadjuvant Phase|Death|2|||
125106819|NCT01901146|450015505|FG002|Neoadjuvant Phase|Death|0|||
125106820|NCT01901146|450015506|FG003|Neoadjuvant Phase|Death|0|||
125106821|NCT01901146|450015507|FG004|Neoadjuvant Phase|Death|0|||
125106822|NCT01901146|450015503|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
125106823|NCT01901146|450015504|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
125106824|NCT01901146|450015505|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
125106825|NCT01901146|450015506|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
125106826|NCT01901146|450015507|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
125106827|NCT01901146|450015503|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
125106828|NCT01901146|450015504|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
125106829|NCT01901146|450015505|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
125106830|NCT01901146|450015506|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
125106831|NCT01901146|450015507|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
125106832|NCT01901146|450015503|FG000|Neoadjuvant Phase|Physician Decision|1|||
125106833|NCT01901146|450015504|FG001|Neoadjuvant Phase|Physician Decision|2|||
125106834|NCT01901146|450015505|FG002|Neoadjuvant Phase|Physician Decision|0|||
125106835|NCT01901146|450015506|FG003|Neoadjuvant Phase|Physician Decision|0|||
125106836|NCT01901146|450015507|FG004|Neoadjuvant Phase|Physician Decision|0|||
125106837|NCT01901146|450015503|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
125106838|NCT01901146|450015504|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
125106839|NCT01901146|450015505|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
125106840|NCT01901146|450015506|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
125106841|NCT01901146|450015507|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
125106842|NCT01901146|450015503|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
125106843|NCT01901146|450015504|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
125106844|NCT01901146|450015505|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
125106845|NCT01901146|450015506|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
125106846|NCT01901146|450015507|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
125106847|NCT01901146|450015503|FG000|Adjuvant Phase|Other|0|||
125106848|NCT01901146|450015504|FG001|Adjuvant Phase|Other|0|||
125106849|NCT01901146|450015505|FG002|Adjuvant Phase|Other|1|||
125106850|NCT01901146|450015506|FG003|Adjuvant Phase|Other|0|||
125106851|NCT01901146|450015507|FG004|Adjuvant Phase|Other|0|||
125106852|NCT01901146|450015503|FG000|Adjuvant Phase|Death|0|||
125106853|NCT01901146|450015504|FG001|Adjuvant Phase|Death|0|||
125106854|NCT01901146|450015505|FG002|Adjuvant Phase|Death|0|||
125106855|NCT01901146|450015506|FG003|Adjuvant Phase|Death|0|||
125106856|NCT01901146|450015507|FG004|Adjuvant Phase|Death|3|||
125106857|NCT01901146|450015503|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
125106858|NCT01901146|450015504|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
125106859|NCT01901146|450015505|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
125106860|NCT01901146|450015506|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
124889352|NCT01474512|449218634|FG013|Maintenance Period|Physician Decision|0|||
124889353|NCT01474512|449218635|FG014|Maintenance Period|Physician Decision|0|||
124889354|NCT01474512|449218636|FG015|Maintenance Period|Physician Decision|0|||
125106861|NCT01901146|450015507|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
125106862|NCT01901146|450015503|FG000|Adjuvant Phase|Physician Decision|0|||
125106863|NCT01901146|450015504|FG001|Adjuvant Phase|Physician Decision|0|||
125106864|NCT01901146|450015505|FG002|Adjuvant Phase|Physician Decision|9|||
125106865|NCT01901146|450015506|FG003|Adjuvant Phase|Physician Decision|2|||
124889355|NCT01474512|449218637|FG016|Maintenance Period|Physician Decision|0|||
124889356|NCT01474512|449218638|FG017|Maintenance Period|Physician Decision|0|||
124889357|NCT01474512|449218621|FG000|Maintenance Period|Clinical Relapse|0|||
124889358|NCT01474512|449218622|FG001|Maintenance Period|Clinical Relapse|0|||
124889359|NCT01474512|449218623|FG002|Maintenance Period|Clinical Relapse|0|||
124889360|NCT01474512|449218624|FG003|Maintenance Period|Clinical Relapse|1|||
124889361|NCT01474512|449218625|FG004|Maintenance Period|Clinical Relapse|0|||
124889362|NCT01474512|449218626|FG005|Maintenance Period|Clinical Relapse|0|||
124889363|NCT01474512|449218627|FG006|Maintenance Period|Clinical Relapse|0|||
124889364|NCT01474512|449218628|FG007|Maintenance Period|Clinical Relapse|0|||
124889365|NCT01474512|449218629|FG008|Maintenance Period|Clinical Relapse|0|||
124889366|NCT01474512|449218630|FG009|Maintenance Period|Clinical Relapse|0|||
124889367|NCT01474512|449218631|FG010|Maintenance Period|Clinical Relapse|0|||
124889368|NCT01474512|449218632|FG011|Maintenance Period|Clinical Relapse|0|||
124889369|NCT01474512|449218633|FG012|Maintenance Period|Clinical Relapse|0|||
124889370|NCT01474512|449218634|FG013|Maintenance Period|Clinical Relapse|0|||
124889371|NCT01474512|449218635|FG014|Maintenance Period|Clinical Relapse|0|||
124889372|NCT01474512|449218636|FG015|Maintenance Period|Clinical Relapse|0|||
124889373|NCT01474512|449218637|FG016|Maintenance Period|Clinical Relapse|0|||
124889374|NCT01474512|449218638|FG017|Maintenance Period|Clinical Relapse|0|||
124889375|NCT01474512|449218621|FG000|Maintenance Period|Lack of Efficacy|0|||
124889376|NCT01474512|449218622|FG001|Maintenance Period|Lack of Efficacy|0|||
124889377|NCT01474512|449218623|FG002|Maintenance Period|Lack of Efficacy|0|||
124889378|NCT01474512|449218624|FG003|Maintenance Period|Lack of Efficacy|1|||
124889379|NCT01474512|449218625|FG004|Maintenance Period|Lack of Efficacy|0|||
124889380|NCT01474512|449218626|FG005|Maintenance Period|Lack of Efficacy|0|||
124889381|NCT01474512|449218627|FG006|Maintenance Period|Lack of Efficacy|0|||
124889382|NCT01474512|449218628|FG007|Maintenance Period|Lack of Efficacy|11|||
124889383|NCT01474512|449218629|FG008|Maintenance Period|Lack of Efficacy|11|||
124889384|NCT01474512|449218630|FG009|Maintenance Period|Lack of Efficacy|12|||
124889385|NCT01474512|449218631|FG010|Maintenance Period|Lack of Efficacy|0|||
124889386|NCT01474512|449218632|FG011|Maintenance Period|Lack of Efficacy|0|||
124889387|NCT01474512|449218633|FG012|Maintenance Period|Lack of Efficacy|0|||
124889388|NCT01474512|449218634|FG013|Maintenance Period|Lack of Efficacy|0|||
124889389|NCT01474512|449218635|FG014|Maintenance Period|Lack of Efficacy|0|||
124889390|NCT01474512|449218636|FG015|Maintenance Period|Lack of Efficacy|0|||
124889391|NCT01474512|449218637|FG016|Maintenance Period|Lack of Efficacy|0|||
124889392|NCT01474512|449218638|FG017|Maintenance Period|Lack of Efficacy|0|||
124889393|NCT01474512|449218621|FG000|Maintenance Period|Protocol Violation|0|||
124889394|NCT01474512|449218622|FG001|Maintenance Period|Protocol Violation|0|||
124889395|NCT01474512|449218623|FG002|Maintenance Period|Protocol Violation|0|||
124889396|NCT01474512|449218624|FG003|Maintenance Period|Protocol Violation|1|||
124889397|NCT01474512|449218625|FG004|Maintenance Period|Protocol Violation|0|||
124889398|NCT01474512|449218626|FG005|Maintenance Period|Protocol Violation|0|||
124889399|NCT01474512|449218627|FG006|Maintenance Period|Protocol Violation|0|||
124889400|NCT01474512|449218628|FG007|Maintenance Period|Protocol Violation|1|||
124889401|NCT01474512|449218629|FG008|Maintenance Period|Protocol Violation|0|||
124889402|NCT01474512|449218630|FG009|Maintenance Period|Protocol Violation|1|||
124889403|NCT01474512|449218631|FG010|Maintenance Period|Protocol Violation|0|||
124889404|NCT01474512|449218632|FG011|Maintenance Period|Protocol Violation|0|||
124889405|NCT01474512|449218633|FG012|Maintenance Period|Protocol Violation|0|||
124889406|NCT01474512|449218634|FG013|Maintenance Period|Protocol Violation|0|||
124889407|NCT01474512|449218635|FG014|Maintenance Period|Protocol Violation|0|||
124889408|NCT01474512|449218636|FG015|Maintenance Period|Protocol Violation|0|||
124889409|NCT01474512|449218637|FG016|Maintenance Period|Protocol Violation|0|||
124889410|NCT01474512|449218638|FG017|Maintenance Period|Protocol Violation|0|||
124889411|NCT01474512|449218621|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
124889412|NCT01474512|449218622|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
124889413|NCT01474512|449218623|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
124889414|NCT01474512|449218624|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
124889415|NCT01474512|449218625|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
124889416|NCT01474512|449218626|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
124889417|NCT01474512|449218627|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
124889418|NCT01474512|449218628|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
124889419|NCT01474512|449218629|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
124889420|NCT01474512|449218630|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
124889421|NCT01474512|449218631|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
124889422|NCT01474512|449218632|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
125016842|NCT02867995|449685576|FG000|Overall Study|Lost to Follow-up|0|||
125016843|NCT02867995|449685577|FG001|Overall Study|Lost to Follow-up|2|||
125016844|NCT04682405|449687597|FG000|Overall Study|Adverse Event|0|||
125016845|NCT04682405|449687598|FG001|Overall Study|Adverse Event|1|||
125016846|NCT01049035|449687601|FG000|Overall Study|Serious adverse event|0|||
125016847|NCT01049035|449687602|FG001|Overall Study|Serious adverse event|1|||
125016848|NCT01049035|449687603|FG002|Overall Study|Serious adverse event|1|||
124889423|NCT01474512|449218633|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
124889424|NCT01474512|449218634|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
124889425|NCT01474512|449218635|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
124889426|NCT01474512|449218636|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
124889427|NCT01474512|449218637|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
124889428|NCT01474512|449218638|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
124889429|NCT01474512|449218621|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
124889430|NCT01474512|449218622|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
124889431|NCT01474512|449218623|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
124889432|NCT01474512|449218624|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
124889433|NCT01474512|449218625|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
124889434|NCT01474512|449218626|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
124889435|NCT01474512|449218627|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
124889436|NCT01474512|449218628|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
124889437|NCT01474512|449218629|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
124889438|NCT01474512|449218630|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
124889439|NCT01474512|449218631|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
124889440|NCT01474512|449218632|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
124889441|NCT01474512|449218633|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
124889442|NCT01474512|449218634|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
124889443|NCT01474512|449218635|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
124889444|NCT01474512|449218636|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
124889445|NCT01474512|449218637|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
124889446|NCT01474512|449218638|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
124889447|NCT01474512|449218621|FG000|Long-Term Extension Period|Adverse Event|0|||
124889448|NCT01474512|449218622|FG001|Long-Term Extension Period|Adverse Event|0|||
124889449|NCT01474512|449218623|FG002|Long-Term Extension Period|Adverse Event|0|||
124889450|NCT01474512|449218624|FG003|Long-Term Extension Period|Adverse Event|0|||
124889451|NCT01474512|449218625|FG004|Long-Term Extension Period|Adverse Event|0|||
124889452|NCT01474512|449218626|FG005|Long-Term Extension Period|Adverse Event|0|||
124889453|NCT01474512|449218627|FG006|Long-Term Extension Period|Adverse Event|0|||
124889454|NCT01474512|449218628|FG007|Long-Term Extension Period|Adverse Event|0|||
124889455|NCT01474512|449218629|FG008|Long-Term Extension Period|Adverse Event|0|||
124889456|NCT01474512|449218630|FG009|Long-Term Extension Period|Adverse Event|0|||
124889457|NCT01474512|449218631|FG010|Long-Term Extension Period|Adverse Event|0|||
124889458|NCT01474512|449218632|FG011|Long-Term Extension Period|Adverse Event|1|||
124889459|NCT01474512|449218633|FG012|Long-Term Extension Period|Adverse Event|57|||
124889460|NCT01474512|449218634|FG013|Long-Term Extension Period|Adverse Event|58|||
124889461|NCT01474512|449218635|FG014|Long-Term Extension Period|Adverse Event|0|||
124889462|NCT01474512|449218636|FG015|Long-Term Extension Period|Adverse Event|0|||
124889463|NCT01474512|449218637|FG016|Long-Term Extension Period|Adverse Event|0|||
124889464|NCT01474512|449218638|FG017|Long-Term Extension Period|Adverse Event|0|||
124889465|NCT01474512|449218621|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
124889466|NCT01474512|449218622|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
124889467|NCT01474512|449218623|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
124889468|NCT01474512|449218624|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
124889469|NCT01474512|449218625|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
124889470|NCT01474512|449218626|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
124889471|NCT01474512|449218627|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
124889472|NCT01474512|449218628|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
124889473|NCT01474512|449218629|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
124889474|NCT01474512|449218630|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
124889475|NCT01474512|449218631|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
124889476|NCT01474512|449218632|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
124889477|NCT01474512|449218633|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
124889478|NCT01474512|449218634|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
124889479|NCT01474512|449218635|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
124889480|NCT01474512|449218636|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
124889481|NCT01474512|449218637|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
124889482|NCT01474512|449218638|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
124889483|NCT01474512|449218621|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
124889484|NCT01474512|449218622|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
124889485|NCT01474512|449218623|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
124889486|NCT01474512|449218624|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
124889487|NCT01474512|449218625|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
124889488|NCT01474512|449218626|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
124889489|NCT01474512|449218627|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
124889490|NCT01474512|449218628|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
124889491|NCT01474512|449218629|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
124889492|NCT01474512|449218630|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
124889493|NCT01474512|449218631|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
124889494|NCT01474512|449218632|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
124889495|NCT01474512|449218633|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
124889496|NCT01474512|449218634|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
124889497|NCT01474512|449218635|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
124889498|NCT01474512|449218636|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
124889499|NCT01474512|449218637|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
124889500|NCT01474512|449218638|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
124889501|NCT01474512|449218621|FG000|Long-Term Extension Period|Physician Decision|0|||
124889502|NCT01474512|449218622|FG001|Long-Term Extension Period|Physician Decision|0|||
124889503|NCT01474512|449218623|FG002|Long-Term Extension Period|Physician Decision|0|||
124889504|NCT01474512|449218624|FG003|Long-Term Extension Period|Physician Decision|0|||
124889505|NCT01474512|449218625|FG004|Long-Term Extension Period|Physician Decision|0|||
124889506|NCT01474512|449218626|FG005|Long-Term Extension Period|Physician Decision|0|||
124889507|NCT01474512|449218627|FG006|Long-Term Extension Period|Physician Decision|0|||
124889508|NCT01474512|449218628|FG007|Long-Term Extension Period|Physician Decision|0|||
124889509|NCT01474512|449218629|FG008|Long-Term Extension Period|Physician Decision|0|||
124889510|NCT01474512|449218630|FG009|Long-Term Extension Period|Physician Decision|0|||
124889511|NCT01474512|449218631|FG010|Long-Term Extension Period|Physician Decision|0|||
124889512|NCT01474512|449218632|FG011|Long-Term Extension Period|Physician Decision|0|||
124889513|NCT01474512|449218633|FG012|Long-Term Extension Period|Physician Decision|21|||
124889514|NCT01474512|449218634|FG013|Long-Term Extension Period|Physician Decision|21|||
124889515|NCT01474512|449218635|FG014|Long-Term Extension Period|Physician Decision|0|||
124889516|NCT01474512|449218636|FG015|Long-Term Extension Period|Physician Decision|0|||
124889517|NCT01474512|449218637|FG016|Long-Term Extension Period|Physician Decision|0|||
124889518|NCT01474512|449218638|FG017|Long-Term Extension Period|Physician Decision|0|||
124889519|NCT01474512|449218621|FG000|Long-Term Extension Period|Clinical Relapse|0|||
124889520|NCT01474512|449218622|FG001|Long-Term Extension Period|Clinical Relapse|0|||
124889521|NCT01474512|449218623|FG002|Long-Term Extension Period|Clinical Relapse|0|||
124889522|NCT01474512|449218624|FG003|Long-Term Extension Period|Clinical Relapse|0|||
124889523|NCT01474512|449218625|FG004|Long-Term Extension Period|Clinical Relapse|0|||
124889524|NCT01474512|449218626|FG005|Long-Term Extension Period|Clinical Relapse|0|||
124889525|NCT01474512|449218627|FG006|Long-Term Extension Period|Clinical Relapse|0|||
124889526|NCT01474512|449218628|FG007|Long-Term Extension Period|Clinical Relapse|0|||
124889527|NCT01474512|449218629|FG008|Long-Term Extension Period|Clinical Relapse|0|||
124889528|NCT01474512|449218630|FG009|Long-Term Extension Period|Clinical Relapse|0|||
124889529|NCT01474512|449218631|FG010|Long-Term Extension Period|Clinical Relapse|0|||
124889530|NCT01474512|449218632|FG011|Long-Term Extension Period|Clinical Relapse|0|||
124889531|NCT01474512|449218633|FG012|Long-Term Extension Period|Clinical Relapse|9|||
124889532|NCT01474512|449218634|FG013|Long-Term Extension Period|Clinical Relapse|9|||
124889533|NCT01474512|449218635|FG014|Long-Term Extension Period|Clinical Relapse|0|||
125016849|NCT01049035|449687604|FG003|Overall Study|Serious adverse event|2|||
125016850|NCT01049035|449687605|FG004|Overall Study|Serious adverse event|0|||
125016851|NCT01049035|449687606|FG005|Overall Study|Serious adverse event|0|||
125016852|NCT01049035|449687607|FG006|Overall Study|Serious adverse event|0|||
124889534|NCT01474512|449218636|FG015|Long-Term Extension Period|Clinical Relapse|0|||
124889535|NCT01474512|449218637|FG016|Long-Term Extension Period|Clinical Relapse|0|||
125016853|NCT01049035|449687601|FG000|Overall Study|Other adverse event (AE)|0|||
125016854|NCT01049035|449687602|FG001|Overall Study|Other adverse event (AE)|0|||
125016855|NCT01049035|449687603|FG002|Overall Study|Other adverse event (AE)|0|||
125016856|NCT01049035|449687604|FG003|Overall Study|Other adverse event (AE)|1|||
125016857|NCT01049035|449687605|FG004|Overall Study|Other adverse event (AE)|0|||
125016858|NCT01049035|449687606|FG005|Overall Study|Other adverse event (AE)|0|||
125016859|NCT01049035|449687607|FG006|Overall Study|Other adverse event (AE)|0|||
125016860|NCT01049035|449687601|FG000|Overall Study|Non-compliance with the protocol|12|||
125016861|NCT01049035|449687602|FG001|Overall Study|Non-compliance with the protocol|6|||
125016862|NCT01049035|449687603|FG002|Overall Study|Non-compliance with the protocol|14|||
125016863|NCT01049035|449687604|FG003|Overall Study|Non-compliance with the protocol|5|||
125016864|NCT01049035|449687605|FG004|Overall Study|Non-compliance with the protocol|3|||
125016865|NCT01049035|449687606|FG005|Overall Study|Non-compliance with the protocol|4|||
125016866|NCT01049035|449687607|FG006|Overall Study|Non-compliance with the protocol|10|||
125016867|NCT01049035|449687601|FG000|Overall Study|Lost to Follow-up|5|||
125016868|NCT01049035|449687602|FG001|Overall Study|Lost to Follow-up|4|||
124889536|NCT01474512|449218638|FG017|Long-Term Extension Period|Clinical Relapse|0|||
124889537|NCT01474512|449218621|FG000|Long-Term Extension Period|Death|0|||
124889538|NCT01474512|449218622|FG001|Long-Term Extension Period|Death|0|||
124889539|NCT01474512|449218623|FG002|Long-Term Extension Period|Death|0|||
124889540|NCT01474512|449218624|FG003|Long-Term Extension Period|Death|0|||
124889541|NCT01474512|449218625|FG004|Long-Term Extension Period|Death|0|||
124889542|NCT01474512|449218626|FG005|Long-Term Extension Period|Death|0|||
124889543|NCT01474512|449218627|FG006|Long-Term Extension Period|Death|0|||
124889544|NCT01474512|449218628|FG007|Long-Term Extension Period|Death|0|||
124889545|NCT01474512|449218629|FG008|Long-Term Extension Period|Death|0|||
125106866|NCT01901146|450015507|FG004|Adjuvant Phase|Physician Decision|4|||
125106867|NCT01901146|450015503|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
125106868|NCT01901146|450015504|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
125106869|NCT01901146|450015505|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
125106870|NCT01901146|450015506|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
125106871|NCT01901146|450015507|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
125106872|NCT00297492|450015508|FG000|Set Quit Date|Lost to Follow-up|7|||
125106873|NCT00297492|450015509|FG001|Set Quit Date|Lost to Follow-up|13|||
125106874|NCT00297492|450015510|FG002|Set Quit Date|Lost to Follow-up|5|||
125106875|NCT00297492|450015508|FG000|6 Month Follow-up|Lost to Follow-up|63|||
125106876|NCT00297492|450015509|FG001|6 Month Follow-up|Lost to Follow-up|49|||
125106877|NCT00297492|450015510|FG002|6 Month Follow-up|Lost to Follow-up|27|||
125106878|NCT02414854|450015511|FG000|Overall Study|Adverse Event|9|||
125106879|NCT02414854|450015512|FG001|Overall Study|Adverse Event|7|||
125106880|NCT02414854|450015513|FG002|Overall Study|Adverse Event|1|||
125106881|NCT02414854|450015514|FG003|Overall Study|Adverse Event|12|||
125106882|NCT02414854|450015511|FG000|Overall Study|Poor compliance to protocol|1|||
125106883|NCT02414854|450015512|FG001|Overall Study|Poor compliance to protocol|1|||
125106884|NCT02414854|450015513|FG002|Overall Study|Poor compliance to protocol|2|||
125106885|NCT02414854|450015514|FG003|Overall Study|Poor compliance to protocol|2|||
125106886|NCT02414854|450015511|FG000|Overall Study|Other than specified above|12|||
125106887|NCT02414854|450015512|FG001|Overall Study|Other than specified above|37|||
125106888|NCT02414854|450015513|FG002|Overall Study|Other than specified above|17|||
125106889|NCT02414854|450015514|FG003|Overall Study|Other than specified above|37|||
125106890|NCT00606801|450015515|FG000|Intervention|Protocol Violation|3|||
125106891|NCT00606801|450015516|FG001|Intervention|Protocol Violation|3|||
125106892|NCT00303316|450015519|FG000|Overall Study|Protocol Violation|1|||
125106893|NCT00303316|450015520|FG001|Overall Study|Protocol Violation|0|||
125106894|NCT00303316|450015519|FG000|Overall Study|Lost to Follow-up|0|||
125106895|NCT00303316|450015520|FG001|Overall Study|Lost to Follow-up|1|||
125106896|NCT00303316|450015519|FG000|Overall Study|Withdrawal by Subject|1|||
125106897|NCT00303316|450015520|FG001|Overall Study|Withdrawal by Subject|2|||
125106898|NCT02016755|450015523|FG000|Overall Study|Major amputation of index limb|2|||
125106899|NCT02016755|450015523|FG000|Overall Study|Adverse Event|2|||
125106900|NCT02016755|450015523|FG000|Overall Study|Physician Decision|1|||
125106901|NCT02016755|450015523|FG000|Overall Study|Death|2|||
125106902|NCT01396161|450015528|FG000|Overall Study|Withdrawal by Subject|0|||
125106903|NCT01396161|450015529|FG001|Overall Study|Withdrawal by Subject|0|||
125106904|NCT01396161|450015530|FG002|Overall Study|Withdrawal by Subject|0|||
125106905|NCT01396161|450015531|FG003|Overall Study|Withdrawal by Subject|0|||
125106906|NCT01396161|450015532|FG004|Overall Study|Withdrawal by Subject|1|||
124889546|NCT01474512|449218630|FG009|Long-Term Extension Period|Death|0|||
124889547|NCT01474512|449218631|FG010|Long-Term Extension Period|Death|0|||
124889548|NCT01474512|449218632|FG011|Long-Term Extension Period|Death|0|||
125016869|NCT01049035|449687603|FG002|Overall Study|Lost to Follow-up|4|||
125016870|NCT01049035|449687604|FG003|Overall Study|Lost to Follow-up|1|||
125016871|NCT01049035|449687605|FG004|Overall Study|Lost to Follow-up|0|||
125016872|NCT01049035|449687606|FG005|Overall Study|Lost to Follow-up|3|||
125016873|NCT01049035|449687607|FG006|Overall Study|Lost to Follow-up|3|||
125016874|NCT01049035|449687601|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
125016875|NCT01049035|449687602|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
125016876|NCT01049035|449687603|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
125106907|NCT01396161|450015533|FG005|Overall Study|Withdrawal by Subject|0|||
125106908|NCT01396161|450015534|FG006|Overall Study|Withdrawal by Subject|0|||
125106909|NCT01396161|450015528|FG000|Overall Study|Other|0|||
124889549|NCT01474512|449218633|FG012|Long-Term Extension Period|Death|9|||
125016877|NCT01049035|449687604|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
125016878|NCT01049035|449687605|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
125016879|NCT01049035|449687606|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
125106910|NCT01396161|450015529|FG001|Overall Study|Other|0|||
125106911|NCT01396161|450015530|FG002|Overall Study|Other|0|||
125106912|NCT01396161|450015531|FG003|Overall Study|Other|0|||
125106913|NCT01396161|450015532|FG004|Overall Study|Other|0|||
125106914|NCT01396161|450015533|FG005|Overall Study|Other|0|||
124889550|NCT01474512|449218634|FG013|Long-Term Extension Period|Death|9|||
125106915|NCT01396161|450015534|FG006|Overall Study|Other|1|||
125106916|NCT00552617|450015535|FG000|Overall Study|Not Treated|0|||
124889551|NCT01474512|449218635|FG014|Long-Term Extension Period|Death|0|||
124889552|NCT01474512|449218636|FG015|Long-Term Extension Period|Death|0|||
124889553|NCT01474512|449218637|FG016|Long-Term Extension Period|Death|0|||
124889554|NCT01474512|449218638|FG017|Long-Term Extension Period|Death|0|||
124889555|NCT01474512|449218621|FG000|Long-Term Extension Period|Sponsor Decision|0|||
124889556|NCT01474512|449218622|FG001|Long-Term Extension Period|Sponsor Decision|0|||
124889557|NCT01474512|449218623|FG002|Long-Term Extension Period|Sponsor Decision|0|||
124889558|NCT01474512|449218624|FG003|Long-Term Extension Period|Sponsor Decision|0|||
124889559|NCT01474512|449218625|FG004|Long-Term Extension Period|Sponsor Decision|0|||
124889560|NCT01474512|449218626|FG005|Long-Term Extension Period|Sponsor Decision|0|||
124889561|NCT01474512|449218627|FG006|Long-Term Extension Period|Sponsor Decision|0|||
124889562|NCT01474512|449218628|FG007|Long-Term Extension Period|Sponsor Decision|0|||
124889563|NCT01474512|449218629|FG008|Long-Term Extension Period|Sponsor Decision|0|||
124889564|NCT01474512|449218630|FG009|Long-Term Extension Period|Sponsor Decision|0|||
124889565|NCT01474512|449218631|FG010|Long-Term Extension Period|Sponsor Decision|0|||
124889566|NCT01474512|449218632|FG011|Long-Term Extension Period|Sponsor Decision|0|||
124889567|NCT01474512|449218633|FG012|Long-Term Extension Period|Sponsor Decision|6|||
124889568|NCT01474512|449218634|FG013|Long-Term Extension Period|Sponsor Decision|6|||
124889569|NCT01474512|449218635|FG014|Long-Term Extension Period|Sponsor Decision|0|||
124889570|NCT01474512|449218636|FG015|Long-Term Extension Period|Sponsor Decision|0|||
124889571|NCT01474512|449218637|FG016|Long-Term Extension Period|Sponsor Decision|0|||
124889572|NCT01474512|449218638|FG017|Long-Term Extension Period|Sponsor Decision|0|||
124889573|NCT01474512|449218621|FG000|Long-Term Extension Period|Protocol Violation|0|||
124889574|NCT01474512|449218622|FG001|Long-Term Extension Period|Protocol Violation|0|||
124889575|NCT01474512|449218623|FG002|Long-Term Extension Period|Protocol Violation|0|||
124889576|NCT01474512|449218624|FG003|Long-Term Extension Period|Protocol Violation|0|||
124889577|NCT01474512|449218625|FG004|Long-Term Extension Period|Protocol Violation|0|||
124889578|NCT01474512|449218626|FG005|Long-Term Extension Period|Protocol Violation|0|||
124889579|NCT01474512|449218627|FG006|Long-Term Extension Period|Protocol Violation|0|||
124889580|NCT01474512|449218628|FG007|Long-Term Extension Period|Protocol Violation|0|||
124889581|NCT01474512|449218629|FG008|Long-Term Extension Period|Protocol Violation|0|||
124889582|NCT01474512|449218630|FG009|Long-Term Extension Period|Protocol Violation|0|||
124889583|NCT01474512|449218631|FG010|Long-Term Extension Period|Protocol Violation|0|||
124889584|NCT01474512|449218632|FG011|Long-Term Extension Period|Protocol Violation|0|||
124889585|NCT01474512|449218633|FG012|Long-Term Extension Period|Protocol Violation|5|||
124889586|NCT01474512|449218634|FG013|Long-Term Extension Period|Protocol Violation|5|||
124889587|NCT01474512|449218635|FG014|Long-Term Extension Period|Protocol Violation|0|||
124889588|NCT01474512|449218636|FG015|Long-Term Extension Period|Protocol Violation|0|||
124889589|NCT01474512|449218637|FG016|Long-Term Extension Period|Protocol Violation|0|||
124889590|NCT01474512|449218638|FG017|Long-Term Extension Period|Protocol Violation|0|||
124889591|NCT01474512|449218621|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889592|NCT01474512|449218622|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889593|NCT01474512|449218623|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889594|NCT01474512|449218624|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889595|NCT01474512|449218625|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889596|NCT01474512|449218626|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889597|NCT01474512|449218627|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889598|NCT01474512|449218628|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889599|NCT01474512|449218629|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889600|NCT01474512|449218630|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889601|NCT01474512|449218631|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889602|NCT01474512|449218632|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889603|NCT01474512|449218633|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
124889604|NCT01474512|449218634|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
124889605|NCT01474512|449218635|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889606|NCT01474512|449218636|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889607|NCT01474512|449218637|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889608|NCT01474512|449218638|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889609|NCT01474512|449218621|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889610|NCT01474512|449218622|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889611|NCT01474512|449218623|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889612|NCT01474512|449218624|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889613|NCT01474512|449218625|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889614|NCT01474512|449218626|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889615|NCT01474512|449218627|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889616|NCT01474512|449218628|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889617|NCT01474512|449218629|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889618|NCT01474512|449218630|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889619|NCT01474512|449218631|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889620|NCT01474512|449218632|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
124889621|NCT01474512|449218633|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889622|NCT01474512|449218634|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889623|NCT01474512|449218635|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889624|NCT01474512|449218636|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889625|NCT01474512|449218637|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889626|NCT01474512|449218638|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889627|NCT01474512|449218621|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
124889628|NCT01474512|449218622|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
124889629|NCT01474512|449218623|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
124889630|NCT01474512|449218624|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
124889631|NCT01474512|449218625|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
124889632|NCT01474512|449218626|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
124889633|NCT01474512|449218627|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
124889634|NCT01474512|449218628|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
124889635|NCT01474512|449218629|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
124889636|NCT01474512|449218630|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
124889637|NCT01474512|449218631|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
124889638|NCT01474512|449218632|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
124889639|NCT01474512|449218633|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
124889640|NCT01474512|449218634|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
124889641|NCT01474512|449218635|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
124889642|NCT01474512|449218636|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
124889643|NCT01474512|449218637|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
124889644|NCT01474512|449218638|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
124889645|NCT01474512|449218621|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889646|NCT01474512|449218622|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889647|NCT01474512|449218623|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889648|NCT01474512|449218624|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889649|NCT01474512|449218625|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889650|NCT01474512|449218626|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889651|NCT01474512|449218627|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889652|NCT01474512|449218628|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889653|NCT01474512|449218629|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889654|NCT01474512|449218630|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889655|NCT01474512|449218631|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889656|NCT01474512|449218632|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889657|NCT01474512|449218633|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889658|NCT01474512|449218634|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125106917|NCT00552617|450015536|FG001|Overall Study|Not Treated|0|||
125106918|NCT00552617|450015537|FG002|Overall Study|Not Treated|1|||
125106919|NCT00552617|450015538|FG003|Overall Study|Not Treated|0|||
125106920|NCT00552617|450015539|FG004|Overall Study|Not Treated|0|||
125106921|NCT00552617|450015540|FG005|Overall Study|Not Treated|0|||
125106922|NCT00552617|450015541|FG006|Overall Study|Not Treated|0|||
125106923|NCT00552617|450015542|FG007|Overall Study|Not Treated|0|||
125106924|NCT00552617|450015543|FG008|Overall Study|Not Treated|0|||
125106925|NCT00552617|450015544|FG009|Overall Study|Not Treated|1|||
125106926|NCT00552617|450015535|FG000|Overall Study|Lost to Follow-up|0|||
125106927|NCT00552617|450015536|FG001|Overall Study|Lost to Follow-up|0|||
125106928|NCT00552617|450015537|FG002|Overall Study|Lost to Follow-up|0|||
125106929|NCT00552617|450015538|FG003|Overall Study|Lost to Follow-up|1|||
125106930|NCT00552617|450015539|FG004|Overall Study|Lost to Follow-up|0|||
125106931|NCT00552617|450015540|FG005|Overall Study|Lost to Follow-up|2|||
125106932|NCT00552617|450015541|FG006|Overall Study|Lost to Follow-up|0|||
125106933|NCT00552617|450015542|FG007|Overall Study|Lost to Follow-up|0|||
125106934|NCT00552617|450015543|FG008|Overall Study|Lost to Follow-up|2|||
125106935|NCT00552617|450015544|FG009|Overall Study|Lost to Follow-up|0|||
124889659|NCT01474512|449218635|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
124889660|NCT01474512|449218636|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
124889661|NCT01474512|449218637|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
124889662|NCT01474512|449218638|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
125106936|NCT00337129|450015547|FG000|Overall Study|Adverse Event|4|||
125106937|NCT00337129|450015547|FG000|Overall Study|Withdrawal by Subject|1|||
125106938|NCT00337129|450015547|FG000|Overall Study|Lack of Efficacy|32|||
125106939|NCT00337129|450015547|FG000|Overall Study|Death|2|||
125106940|NCT00337129|450015547|FG000|Overall Study|not protocol specified|1|||
125106941|NCT00306852|450015551|FG000|Overall Study|Death|14|||
125106942|NCT00306852|450015552|FG001|Overall Study|Death|14|||
125106943|NCT00306852|450015551|FG000|Overall Study|Lost to Follow-up|15|||
125106944|NCT00306852|450015552|FG001|Overall Study|Lost to Follow-up|24|||
124889663|NCT01474512|449218621|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889664|NCT01474512|449218622|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889665|NCT01474512|449218623|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889666|NCT01474512|449218624|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889667|NCT01474512|449218625|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889668|NCT01474512|449218626|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889669|NCT01474512|449218627|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889670|NCT01474512|449218628|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889671|NCT01474512|449218629|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889672|NCT01474512|449218630|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889673|NCT01474512|449218631|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889674|NCT01474512|449218632|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889675|NCT01474512|449218633|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889676|NCT01474512|449218634|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889677|NCT01474512|449218635|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
124889678|NCT01474512|449218636|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
124889679|NCT01474512|449218637|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
124889680|NCT01474512|449218638|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
124889681|NCT01474512|449218621|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889682|NCT01474512|449218622|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889683|NCT01474512|449218623|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889684|NCT01474512|449218624|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889685|NCT01474512|449218625|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889686|NCT01474512|449218626|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889687|NCT01474512|449218627|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889688|NCT01474512|449218628|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889689|NCT01474512|449218629|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889690|NCT01474512|449218630|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889691|NCT01474512|449218631|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889692|NCT01474512|449218632|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889693|NCT01474512|449218633|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889694|NCT01474512|449218634|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889695|NCT01474512|449218635|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889696|NCT01474512|449218636|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889697|NCT01474512|449218637|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
124889698|NCT01474512|449218638|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
124889699|NCT01474512|449218621|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
124889700|NCT01474512|449218622|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
124889701|NCT01474512|449218623|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
124889702|NCT01474512|449218624|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
124889703|NCT01474512|449218625|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
124889704|NCT01474512|449218626|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
124889705|NCT01474512|449218627|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
124889706|NCT01474512|449218628|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
124889707|NCT01474512|449218629|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
124889708|NCT01474512|449218630|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
124889709|NCT01474512|449218631|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
124889710|NCT01474512|449218632|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
124889711|NCT01474512|449218633|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
124889712|NCT01474512|449218634|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
124889713|NCT01474512|449218635|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
124889714|NCT01474512|449218636|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
124889715|NCT01474512|449218637|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
124889716|NCT01474512|449218638|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
124889717|NCT01474512|449218621|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889718|NCT01474512|449218622|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889719|NCT01474512|449218623|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889720|NCT01474512|449218624|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
125016880|NCT01049035|449687607|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
125016881|NCT02095535|449687608|FG000|Recruitment|Protocol Violation|2|||
125016882|NCT00623480|449687609|FG000|Overall Study|Lost to Follow-up|0|||
125016883|NCT00623480|449687610|FG001|Overall Study|Lost to Follow-up|1|||
125016884|NCT00623480|449687609|FG000|Overall Study|Withdrawal by Subject|2|||
125016885|NCT00623480|449687610|FG001|Overall Study|Withdrawal by Subject|4|||
124889721|NCT01474512|449218625|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889722|NCT01474512|449218626|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889723|NCT01474512|449218627|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889724|NCT01474512|449218628|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889725|NCT01474512|449218629|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889726|NCT01474512|449218630|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889727|NCT01474512|449218631|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889728|NCT01474512|449218632|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
125106945|NCT01467570|450015553|FG000|Overall Study|Lost to Follow-up|8|||
124889729|NCT01474512|449218633|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889730|NCT01474512|449218634|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889731|NCT01474512|449218635|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889732|NCT01474512|449218636|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889733|NCT01474512|449218637|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
124889734|NCT01474512|449218638|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
124889735|NCT01474512|449218621|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
124889736|NCT01474512|449218622|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
124889737|NCT01474512|449218623|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
124889738|NCT01474512|449218624|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
124889739|NCT01474512|449218625|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
124889740|NCT01474512|449218626|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
124889741|NCT01474512|449218627|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
124889742|NCT01474512|449218628|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
124889743|NCT01474512|449218629|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
124889744|NCT01474512|449218630|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
124889745|NCT01474512|449218631|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
124889746|NCT01474512|449218632|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
124889747|NCT01474512|449218633|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
124889748|NCT01474512|449218634|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
124889749|NCT01474512|449218635|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
124889750|NCT01474512|449218636|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
124889751|NCT01474512|449218637|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
124889752|NCT01474512|449218638|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
124889753|NCT01474512|449218621|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889754|NCT01474512|449218622|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889755|NCT01474512|449218623|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889756|NCT01474512|449218624|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889757|NCT01474512|449218625|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889758|NCT01474512|449218626|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889759|NCT01474512|449218627|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889760|NCT01474512|449218628|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889761|NCT01474512|449218629|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889762|NCT01474512|449218630|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889763|NCT01474512|449218631|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889764|NCT01474512|449218632|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889765|NCT01474512|449218633|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889766|NCT01474512|449218634|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889767|NCT01474512|449218635|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
124889768|NCT01474512|449218636|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889769|NCT01474512|449218637|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
124889770|NCT01474512|449218638|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889771|NCT01474512|449218621|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889772|NCT01474512|449218622|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889773|NCT01474512|449218623|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889774|NCT01474512|449218624|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889775|NCT01474512|449218625|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889776|NCT01474512|449218626|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889777|NCT01474512|449218627|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889778|NCT01474512|449218628|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889779|NCT01474512|449218629|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889780|NCT01474512|449218630|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889781|NCT01474512|449218631|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889782|NCT01474512|449218632|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889783|NCT01474512|449218633|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889784|NCT01474512|449218634|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889785|NCT01474512|449218635|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
124889786|NCT01474512|449218636|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125106946|NCT01467570|450015554|FG001|Overall Study|Lost to Follow-up|9|||
125106947|NCT01222715|450015557|FG000|Overall Study|Adverse Event|0|||
125106948|NCT01222715|450015558|FG001|Overall Study|Adverse Event|4|||
124889787|NCT01474512|449218637|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889788|NCT01474512|449218638|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
124889789|NCT01474512|449218621|FG000|Post-Treatment Follow-Up|Death|0|||
124889790|NCT01474512|449218622|FG001|Post-Treatment Follow-Up|Death|0|||
124889791|NCT01474512|449218623|FG002|Post-Treatment Follow-Up|Death|0|||
124889792|NCT01474512|449218624|FG003|Post-Treatment Follow-Up|Death|0|||
124889793|NCT01474512|449218625|FG004|Post-Treatment Follow-Up|Death|0|||
125106949|NCT01222715|450015557|FG000|Overall Study|Death|0|||
124889794|NCT01474512|449218626|FG005|Post-Treatment Follow-Up|Death|0|||
124889795|NCT01474512|449218627|FG006|Post-Treatment Follow-Up|Death|0|||
124889796|NCT01474512|449218628|FG007|Post-Treatment Follow-Up|Death|0|||
124889797|NCT01474512|449218629|FG008|Post-Treatment Follow-Up|Death|0|||
124889798|NCT01474512|449218630|FG009|Post-Treatment Follow-Up|Death|0|||
124889799|NCT01474512|449218631|FG010|Post-Treatment Follow-Up|Death|0|||
124889800|NCT01474512|449218632|FG011|Post-Treatment Follow-Up|Death|0|||
124889801|NCT01474512|449218633|FG012|Post-Treatment Follow-Up|Death|0|||
124889802|NCT01474512|449218634|FG013|Post-Treatment Follow-Up|Death|0|||
124889803|NCT01474512|449218635|FG014|Post-Treatment Follow-Up|Death|0|||
124889804|NCT01474512|449218636|FG015|Post-Treatment Follow-Up|Death|0|||
124889805|NCT01474512|449218637|FG016|Post-Treatment Follow-Up|Death|1|||
124889806|NCT01474512|449218638|FG017|Post-Treatment Follow-Up|Death|0|||
124889807|NCT01890967|449218641|FG000|Overall Study|Adverse Event|3|||
124889808|NCT01890967|449218642|FG001|Overall Study|Adverse Event|3|||
124889809|NCT01890967|449218643|FG002|Overall Study|Adverse Event|3|||
124889810|NCT01890967|449218644|FG003|Overall Study|Adverse Event|2|||
124889811|NCT01890967|449218645|FG004|Overall Study|Adverse Event|1|||
124889812|NCT01890967|449218646|FG005|Overall Study|Adverse Event|7|||
124889813|NCT01890967|449218641|FG000|Overall Study|Death|1|||
124889814|NCT01890967|449218642|FG001|Overall Study|Death|0|||
124889815|NCT01890967|449218643|FG002|Overall Study|Death|0|||
124889816|NCT01890967|449218644|FG003|Overall Study|Death|0|||
124889817|NCT01890967|449218645|FG004|Overall Study|Death|0|||
124889818|NCT01890967|449218646|FG005|Overall Study|Death|0|||
124889819|NCT01890967|449218641|FG000|Overall Study|Lost to Follow-up|1|||
124889820|NCT01890967|449218642|FG001|Overall Study|Lost to Follow-up|1|||
124889821|NCT01890967|449218643|FG002|Overall Study|Lost to Follow-up|1|||
124889822|NCT01890967|449218644|FG003|Overall Study|Lost to Follow-up|1|||
124889823|NCT01890967|449218645|FG004|Overall Study|Lost to Follow-up|0|||
124889824|NCT01890967|449218646|FG005|Overall Study|Lost to Follow-up|1|||
124889825|NCT01890967|449218641|FG000|Overall Study|Protocol Violation|0|||
124889826|NCT01890967|449218642|FG001|Overall Study|Protocol Violation|3|||
124889827|NCT01890967|449218643|FG002|Overall Study|Protocol Violation|3|||
124889828|NCT01890967|449218644|FG003|Overall Study|Protocol Violation|2|||
124889829|NCT01890967|449218645|FG004|Overall Study|Protocol Violation|4|||
124889830|NCT01890967|449218646|FG005|Overall Study|Protocol Violation|1|||
124889831|NCT01890967|449218641|FG000|Overall Study|Sponsor Decision|2|||
124889832|NCT01890967|449218642|FG001|Overall Study|Sponsor Decision|0|||
124889833|NCT01890967|449218643|FG002|Overall Study|Sponsor Decision|1|||
124889834|NCT01890967|449218644|FG003|Overall Study|Sponsor Decision|3|||
124889835|NCT01890967|449218645|FG004|Overall Study|Sponsor Decision|2|||
124889836|NCT01890967|449218646|FG005|Overall Study|Sponsor Decision|3|||
124889837|NCT01890967|449218641|FG000|Overall Study|Withdrawal by Subject|3|||
124889838|NCT01890967|449218642|FG001|Overall Study|Withdrawal by Subject|4|||
124889839|NCT01890967|449218643|FG002|Overall Study|Withdrawal by Subject|2|||
124889840|NCT01890967|449218644|FG003|Overall Study|Withdrawal by Subject|3|||
124889841|NCT01890967|449218645|FG004|Overall Study|Withdrawal by Subject|3|||
124889842|NCT01890967|449218646|FG005|Overall Study|Withdrawal by Subject|1|||
124889843|NCT04006366|449218650|FG000|Overall Study|Withdrawal by Subject|1|||
124889844|NCT01440049|449218654|FG000|Overall Study|Adverse Event|5|||
124889845|NCT00997243|449218655|FG000|Overall Study|Early termination of study by sponsor|7|||
125016886|NCT00623480|449687609|FG000|Overall Study|Lack of Efficacy|1|||
125016887|NCT00623480|449687610|FG001|Overall Study|Lack of Efficacy|0|||
125016888|NCT00623480|449687609|FG000|Overall Study|Non-compliant with study medication|4|||
125016889|NCT00623480|449687610|FG001|Overall Study|Non-compliant with study medication|0|||
125016890|NCT00623480|449687609|FG000|Overall Study|Protocol Violation|0|||
125016891|NCT00623480|449687610|FG001|Overall Study|Protocol Violation|1|||
125016892|NCT00623480|449687609|FG000|Overall Study|Site closed by sponsor|0|||
125016893|NCT00623480|449687610|FG001|Overall Study|Site closed by sponsor|1|||
125016894|NCT01877187|449687611|FG000|Overall Study|Death|2|||
125016895|NCT01877187|449687611|FG000|Overall Study|Withdrawal by Subject|4|||
125016896|NCT01877187|449687611|FG000|Overall Study|Lost to Follow-up|3|||
125016897|NCT01877187|449687611|FG000|Overall Study|Declining clinical status|11|||
125016898|NCT01877187|449687611|FG000|Overall Study|Liver transplant|2|||
124889846|NCT00280293|449218663|FG000|Overall Study|Protocol Violation|3|||
124889847|NCT00280293|449218664|FG001|Overall Study|Protocol Violation|0|||
124889848|NCT00280293|449218663|FG000|Overall Study|Physician Decision|5|||
124889849|NCT00280293|449218664|FG001|Overall Study|Physician Decision|4|||
124889850|NCT00280293|449218663|FG000|Overall Study|Lost to Follow-up|14|||
124889851|NCT00280293|449218664|FG001|Overall Study|Lost to Follow-up|12|||
124889852|NCT00280293|449218663|FG000|Overall Study|Withdrawal by Subject|3|||
124889853|NCT00280293|449218664|FG001|Overall Study|Withdrawal by Subject|5|||
124889854|NCT00280293|449218663|FG000|Overall Study|Incarceration/Legal Reasons|1|||
124889855|NCT00280293|449218664|FG001|Overall Study|Incarceration/Legal Reasons|1|||
124889856|NCT00280293|449218663|FG000|Overall Study|Adverse Event|0|||
124889857|NCT00280293|449218664|FG001|Overall Study|Adverse Event|1|||
124889858|NCT01458249|449218669|FG000|Overall Study|Not treated|1|||
124889859|NCT01458249|449218669|FG000|Overall Study|Adverse Event|4|||
124889860|NCT01458249|449218669|FG000|Overall Study|Other|2|||
124889861|NCT01458249|449218669|FG000|Overall Study|Ongoing|1|||
124889862|NCT02056119|449218672|FG000|Overall Study|Death|1|||
124889863|NCT02056119|449218673|FG001|Overall Study|Death|2|||
124889864|NCT02056119|449218672|FG000|Overall Study|Intubated for less than 24 hrs|2|||
124889865|NCT02056119|449218673|FG001|Overall Study|Intubated for less than 24 hrs|7|||
124889866|NCT02056119|449218672|FG000|Overall Study|No aerosol treatments were given.|3|||
124889867|NCT02056119|449218673|FG001|Overall Study|No aerosol treatments were given.|2|||
124889868|NCT02056119|449218672|FG000|Overall Study|Received Metaneb treatment|0|||
124889869|NCT02056119|449218673|FG001|Overall Study|Received Metaneb treatment|2|||
124889870|NCT02056119|449218672|FG000|Overall Study|Protocol Violation|4|||
124889871|NCT02056119|449218673|FG001|Overall Study|Protocol Violation|7|||
124889872|NCT01348854|449218674|FG000|Overall Study|Lost to Follow-up|2|||
124889873|NCT01348854|449218675|FG001|Overall Study|Lost to Follow-up|1|||
124889874|NCT01348854|449218674|FG000|Overall Study|Withdrawal by Subject|1|||
124889875|NCT01348854|449218675|FG001|Overall Study|Withdrawal by Subject|0|||
124889876|NCT03220737|449218676|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
124889877|NCT03220737|449218677|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
124889878|NCT03220737|449218678|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
124889879|NCT03220737|449218679|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
124889880|NCT03220737|449218680|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
124889881|NCT03220737|449218681|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
124889882|NCT03220737|449218682|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
124889883|NCT03220737|449218676|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
124889884|NCT03220737|449218677|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
124889885|NCT03220737|449218678|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
124889886|NCT03220737|449218679|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
124889887|NCT03220737|449218680|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
124889888|NCT03220737|449218681|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
124889889|NCT03220737|449218682|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
124889890|NCT03220737|449218676|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
124889891|NCT03220737|449218677|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
124889892|NCT03220737|449218678|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
124889893|NCT03220737|449218679|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
124889894|NCT03220737|449218680|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
124889895|NCT03220737|449218681|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
124889896|NCT03220737|449218682|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
124889897|NCT03220737|449218676|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
124889898|NCT03220737|449218677|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
124889899|NCT03220737|449218678|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
124889900|NCT03220737|449218679|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
124889901|NCT03220737|449218680|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
124889902|NCT03220737|449218681|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
124889903|NCT03220737|449218682|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
124889904|NCT03220737|449218676|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
124889905|NCT03220737|449218677|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
124889906|NCT03220737|449218678|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
124889907|NCT03220737|449218679|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
125016899|NCT03548558|449687612|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
125016900|NCT03548558|449687613|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
125016901|NCT03548558|449687614|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
125016902|NCT03548558|449687615|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
125016903|NCT03548558|449687616|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
125016904|NCT03548558|449687617|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
125016905|NCT03548558|449687618|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
125016906|NCT03548558|449687612|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
125016907|NCT03548558|449687613|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
125016908|NCT03548558|449687614|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
125016909|NCT03548558|449687615|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
125016910|NCT03548558|449687616|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
125016911|NCT03548558|449687617|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
125016912|NCT03548558|449687618|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
125016913|NCT03548558|449687612|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
125016914|NCT03548558|449687613|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
125016915|NCT03548558|449687614|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
125016916|NCT03548558|449687615|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
125016917|NCT03548558|449687616|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
125016918|NCT03548558|449687617|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
124889908|NCT03220737|449218680|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
124889909|NCT03220737|449218681|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
125106950|NCT01222715|450015558|FG001|Overall Study|Death|1|||
125106951|NCT01222715|450015557|FG000|Overall Study|Lack of Efficacy|22|||
124889910|NCT03220737|449218682|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
124889911|NCT03220737|449218676|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
124889912|NCT03220737|449218677|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
124889913|NCT03220737|449218678|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
124889914|NCT03220737|449218679|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
124889915|NCT03220737|449218680|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
124889916|NCT03220737|449218681|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
124889917|NCT03220737|449218682|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
124889918|NCT03220737|449218676|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
124889919|NCT03220737|449218677|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
124889920|NCT03220737|449218678|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
124889921|NCT03220737|449218679|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
124889922|NCT03220737|449218680|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
124889923|NCT03220737|449218681|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
124889924|NCT03220737|449218682|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
124889925|NCT03220737|449218676|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
124889926|NCT03220737|449218677|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
124889927|NCT03220737|449218678|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
124889928|NCT03220737|449218679|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
124889929|NCT03220737|449218680|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
124889930|NCT03220737|449218681|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
124889931|NCT03220737|449218682|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
124889932|NCT01720797|449218683|FG000|Overall Study|Withdrawal by Subject|3|||
124889933|NCT01720797|449218684|FG001|Overall Study|Withdrawal by Subject|0|||
124889934|NCT04011384|449218691|FG000|Overall Study|Withdrawal by Subject|2|||
125016919|NCT03548558|449687618|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
125016920|NCT03548558|449687612|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
125016921|NCT03548558|449687613|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
125016922|NCT03548558|449687614|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
125016923|NCT03548558|449687615|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
125016924|NCT03548558|449687616|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
125016925|NCT03548558|449687617|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
125016926|NCT03548558|449687618|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
125016927|NCT03548558|449687612|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
125016928|NCT03548558|449687613|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
125016929|NCT03548558|449687614|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
125016930|NCT03548558|449687615|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
125016931|NCT03548558|449687616|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
125016932|NCT03548558|449687617|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
125016933|NCT03548558|449687618|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
125016934|NCT03548558|449687612|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
125016935|NCT03548558|449687613|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
125016936|NCT03548558|449687614|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
125016937|NCT03548558|449687615|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
125016938|NCT03548558|449687616|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
125016939|NCT03548558|449687617|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
125016940|NCT03548558|449687618|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
125016941|NCT03273166|449687628|FG000|Overall Study|Withdrawn prior to Completion|31|||
125016942|NCT02669017|449687629|FG000|Overall Study|Death|1|||
125016943|NCT02669017|449687630|FG001|Overall Study|Death|2|||
125016944|NCT02669017|449687631|FG002|Overall Study|Death|2|||
125016945|NCT02669017|449687632|FG003|Overall Study|Death|3|||
125016946|NCT02669017|449687633|FG004|Overall Study|Death|8|||
125016947|NCT02669017|449687634|FG005|Overall Study|Death|18|||
125016948|NCT02669017|449687635|FG006|Overall Study|Death|10|||
125016949|NCT02669017|449687636|FG007|Overall Study|Death|47|||
125016950|NCT02669017|449687637|FG008|Overall Study|Death|20|||
125016951|NCT02669017|449687629|FG000|Overall Study|Withdrawal by Subject|0|||
125016952|NCT02669017|449687630|FG001|Overall Study|Withdrawal by Subject|0|||
125016953|NCT02669017|449687631|FG002|Overall Study|Withdrawal by Subject|0|||
125016954|NCT02669017|449687632|FG003|Overall Study|Withdrawal by Subject|1|||
125016955|NCT02669017|449687633|FG004|Overall Study|Withdrawal by Subject|2|||
125016956|NCT02669017|449687634|FG005|Overall Study|Withdrawal by Subject|0|||
125016957|NCT02669017|449687635|FG006|Overall Study|Withdrawal by Subject|0|||
125016958|NCT02669017|449687636|FG007|Overall Study|Withdrawal by Subject|2|||
125016959|NCT02669017|449687637|FG008|Overall Study|Withdrawal by Subject|2|||
125016960|NCT02669017|449687629|FG000|Overall Study|Lost to Follow-up|0|||
124889935|NCT04011384|449218692|FG001|Overall Study|Withdrawal by Subject|0|||
124889936|NCT01094171|449218693|FG000|Overall Study|Lost to Follow-up|2|||
124889937|NCT01094171|449218693|FG000|Overall Study|Informed consent withdrawal|4|||
124889938|NCT01094171|449218693|FG000|Overall Study|Migration from the study area|3|||
124889939|NCT01094171|449218693|FG000|Overall Study|Other|1|||
124889940|NCT00594932|449218694|FG000|First 3 Months|Withdrawal by Subject|1|||
124889941|NCT00594932|449218695|FG001|First 3 Months|Withdrawal by Subject|3|||
124889942|NCT00594932|449218694|FG000|Final 3 Months|Withdrawal by Subject|4|||
124889943|NCT00594932|449218695|FG001|Final 3 Months|Withdrawal by Subject|3|||
124889944|NCT01083160|449218696|FG000|Overall Study|Adverse Event|1|||
124889945|NCT00918749|449218697|FG000|Overall Study|Adverse Event|1|||
124889946|NCT00918749|449218698|FG001|Overall Study|Adverse Event|0|||
124889947|NCT00918749|449218699|FG002|Overall Study|Adverse Event|1|||
124889948|NCT00918749|449218697|FG000|Overall Study|Lost to Follow-up|0|||
124889949|NCT00918749|449218698|FG001|Overall Study|Lost to Follow-up|0|||
124889950|NCT00918749|449218699|FG002|Overall Study|Lost to Follow-up|1|||
124889951|NCT00918749|449218697|FG000|Overall Study|Withdrawal by Subject|5|||
124889952|NCT00918749|449218698|FG001|Overall Study|Withdrawal by Subject|3|||
124889953|NCT00918749|449218699|FG002|Overall Study|Withdrawal by Subject|5|||
124889954|NCT00918749|449218697|FG000|Overall Study|No Study Medication Taken|1|||
124889955|NCT00918749|449218698|FG001|Overall Study|No Study Medication Taken|0|||
124889956|NCT00918749|449218699|FG002|Overall Study|No Study Medication Taken|0|||
124889957|NCT01951092|449218700|FG000|Overall Study|Lost to Follow-up|10|||
124889958|NCT01951092|449218700|FG000|Overall Study|Incarceration|1|||
124889959|NCT01951092|449218700|FG000|Overall Study|Transfer of Care|1|||
124889960|NCT01712789|449218701|FG000|Overall Study|Lack of Efficacy|2|||
124889961|NCT01712789|449218701|FG000|Overall Study|Lost to Follow-up|1|||
124889962|NCT01712789|449218701|FG000|Overall Study|Progressive Disease|504|||
124889963|NCT01712789|449218701|FG000|Overall Study|Death|57|||
124889964|NCT01712789|449218701|FG000|Overall Study|Adverse Event|52|||
124889965|NCT01712789|449218701|FG000|Overall Study|Miscellaneous|31|||
124889966|NCT01712789|449218701|FG000|Overall Study|Withdrawal by Subject|21|||
124889967|NCT01712789|449218701|FG000|Overall Study|Transition to Commercial Treatment|8|||
124889968|NCT01712789|449218701|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
124889969|NCT01708187|449218702|FG000|Overall Study|Lost to Follow-up|0|||
124889970|NCT01708187|449218703|FG001|Overall Study|Lost to Follow-up|1|||
124889971|NCT03055832|449218705|FG000|Week 2|Withdrawal by Subject|1|||
124889972|NCT03055832|449218706|FG001|Week 2|Withdrawal by Subject|0|||
124889973|NCT01152554|449218707|FG000|Overall Study|Withdrawal by Subject|73|||
124889974|NCT01152554|449218708|FG001|Overall Study|Withdrawal by Subject|28|||
124889975|NCT01152554|449218707|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
124889976|NCT01152554|449218708|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
124889977|NCT01152554|449218707|FG000|Overall Study|Adverse Event|67|||
124889978|NCT01152554|449218708|FG001|Overall Study|Adverse Event|14|||
124889979|NCT01152554|449218707|FG000|Overall Study|Severe non-compliance to protocol|36|||
124889980|NCT01152554|449218708|FG001|Overall Study|Severe non-compliance to protocol|14|||
124889981|NCT01152554|449218707|FG000|Overall Study|Condition under investigation worsened|5|||
124889982|NCT01152554|449218708|FG001|Overall Study|Condition under investigation worsened|2|||
124889983|NCT01152554|449218707|FG000|Overall Study|Lack of Efficacy|20|||
124889984|NCT01152554|449218708|FG001|Overall Study|Lack of Efficacy|3|||
124889985|NCT01152554|449218707|FG000|Overall Study|Study-specific withdrawal criteria|17|||
124889986|NCT01152554|449218708|FG001|Overall Study|Study-specific withdrawal criteria|8|||
124889987|NCT01152554|449218707|FG000|Overall Study|Lost to Follow-up|87|||
124889988|NCT01152554|449218708|FG001|Overall Study|Lost to Follow-up|32|||
124889989|NCT01152554|449218707|FG000|Overall Study|Other|28|||
124889990|NCT01152554|449218708|FG001|Overall Study|Other|8|||
124889991|NCT01152554|449218707|FG000|Overall Study|Death|1|||
124889992|NCT01152554|449218708|FG001|Overall Study|Death|1|||
124889993|NCT02117544|449218709|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
124889994|NCT02117544|449218710|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
124889995|NCT01439711|449218711|FG000|Overall Study|Ineligible|13|||
124889996|NCT01439711|449218711|FG000|Overall Study|Cancel|3|||
124889997|NCT01439711|449218711|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
124889998|NCT01439711|449218711|FG000|Overall Study|Adverse Event|5|||
124889999|NCT01439711|449218711|FG000|Overall Study|Withdrawal by Subject|3|||
124890000|NCT01439711|449218711|FG000|Overall Study|Progression During Active Tx|3|||
124890001|NCT01439711|449218711|FG000|Overall Study|Noncompliance|3|||
124890002|NCT01439711|449218711|FG000|Overall Study|No MRI|9|||
124890003|NCT01012973|449218712|FG000|Overall Study|Adverse Event|5|||
124890004|NCT01012973|449218713|FG001|Overall Study|Adverse Event|5|||
124890005|NCT01012973|449218712|FG000|Overall Study|Lack of Efficacy|0|||
124890006|NCT01012973|449218713|FG001|Overall Study|Lack of Efficacy|5|||
124890007|NCT01012973|449218712|FG000|Overall Study|Lost to Follow-up|1|||
124890008|NCT01012973|449218713|FG001|Overall Study|Lost to Follow-up|0|||
124890009|NCT01012973|449218712|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
124890010|NCT01012973|449218713|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
124890011|NCT01012973|449218712|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
124890012|NCT01012973|449218713|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
124890013|NCT01012973|449218712|FG000|Overall Study|Protocol Violation|5|||
124890014|NCT01012973|449218713|FG001|Overall Study|Protocol Violation|2|||
124890015|NCT01012973|449218712|FG000|Overall Study|Withdrawal by Subject|4|||
124890016|NCT01012973|449218713|FG001|Overall Study|Withdrawal by Subject|6|||
124890017|NCT02448719|449218715|FG000|Overall Study|Withdrawal by Subject|0|||
124890018|NCT02448719|449218716|FG001|Overall Study|Withdrawal by Subject|0|||
124890019|NCT02448719|449218717|FG002|Overall Study|Withdrawal by Subject|0|||
124890020|NCT02448719|449218718|FG003|Overall Study|Withdrawal by Subject|0|||
124890021|NCT02448719|449218719|FG004|Overall Study|Withdrawal by Subject|1|||
124890022|NCT02448719|449218720|FG005|Overall Study|Withdrawal by Subject|0|||
124890023|NCT02448719|449218721|FG006|Overall Study|Withdrawal by Subject|0|||
124890024|NCT02448719|449218722|FG007|Overall Study|Withdrawal by Subject|0|||
124890025|NCT02448719|449218723|FG008|Overall Study|Withdrawal by Subject|0|||
124890026|NCT02448719|449218724|FG009|Overall Study|Withdrawal by Subject|0|||
124890027|NCT02448719|449218725|FG010|Overall Study|Withdrawal by Subject|0|||
124890028|NCT00209027|449218726|FG000|Overall Study|study terminated|10|||
124890029|NCT00209027|449218727|FG001|Overall Study|study terminated|0|||
124890030|NCT01932996|449218728|FG000|Overall Study|Protocol Violation|2|||
124890031|NCT01932996|449218729|FG001|Overall Study|Protocol Violation|0|||
124890032|NCT02806336|449218730|FG000|Overall Study|Physician Decision|1|||
124890033|NCT02806336|449218731|FG001|Overall Study|Physician Decision|0|||
124890034|NCT02806336|449218730|FG000|Overall Study|Withdrawal by Subject|2|||
124890035|NCT02806336|449218731|FG001|Overall Study|Withdrawal by Subject|4|||
124890036|NCT02806336|449218730|FG000|Overall Study|COVID-19 research shut down|3|||
124890037|NCT02806336|449218731|FG001|Overall Study|COVID-19 research shut down|4|||
124890038|NCT02806336|449218730|FG000|Overall Study|Lack of Efficacy|0|||
124890039|NCT02806336|449218731|FG001|Overall Study|Lack of Efficacy|1|||
124890040|NCT00895843|449218732|FG000|Overall Study|Protocol Violation|12|||
124890041|NCT00895843|449218733|FG001|Overall Study|Protocol Violation|12|||
124890042|NCT03658811|449218734|FG000|Overall Study|Lost to Follow-up|3|||
124890043|NCT00946647|449218735|FG000|Phase 1 Part|Adverse Event|2|||
124890044|NCT00946647|449218736|FG001|Phase 1 Part|Adverse Event|5|||
124890045|NCT00946647|449218737|FG002|Phase 1 Part|Adverse Event|3|||
124890046|NCT00946647|449218738|FG003|Phase 1 Part|Adverse Event|0|||
124890047|NCT00946647|449218739|FG004|Phase 1 Part|Adverse Event|0|||
124890048|NCT00946647|449218735|FG000|Phase 1 Part|Disease progression|3|||
124890049|NCT00946647|449218736|FG001|Phase 1 Part|Disease progression|6|||
124890050|NCT00946647|449218737|FG002|Phase 1 Part|Disease progression|1|||
124890051|NCT00946647|449218738|FG003|Phase 1 Part|Disease progression|0|||
124890052|NCT00946647|449218739|FG004|Phase 1 Part|Disease progression|0|||
124890053|NCT00946647|449218735|FG000|Phase 1 Part|Withdrawal by Subject|1|||
124890054|NCT00946647|449218736|FG001|Phase 1 Part|Withdrawal by Subject|4|||
124890055|NCT00946647|449218737|FG002|Phase 1 Part|Withdrawal by Subject|3|||
124890056|NCT00946647|449218738|FG003|Phase 1 Part|Withdrawal by Subject|0|||
124890057|NCT00946647|449218739|FG004|Phase 1 Part|Withdrawal by Subject|0|||
124890058|NCT00946647|449218735|FG000|Phase 1 Part|Abnormal values|0|||
124890059|NCT00946647|449218736|FG001|Phase 1 Part|Abnormal values|2|||
124890060|NCT00946647|449218737|FG002|Phase 1 Part|Abnormal values|0|||
124890061|NCT00946647|449218738|FG003|Phase 1 Part|Abnormal values|0|||
124890062|NCT00946647|449218739|FG004|Phase 1 Part|Abnormal values|0|||
124890063|NCT00946647|449218735|FG000|Phase 1 Part|Reason missing|0|||
124890064|NCT00946647|449218736|FG001|Phase 1 Part|Reason missing|1|||
124890065|NCT00946647|449218737|FG002|Phase 1 Part|Reason missing|0|||
124890066|NCT00946647|449218738|FG003|Phase 1 Part|Reason missing|0|||
124890067|NCT00946647|449218739|FG004|Phase 1 Part|Reason missing|0|||
124890068|NCT00946647|449218735|FG000|Phase ll Part|Untreated|0|||
124890069|NCT00946647|449218736|FG001|Phase ll Part|Untreated|0|||
124890070|NCT00946647|449218737|FG002|Phase ll Part|Untreated|0|||
124890071|NCT00946647|449218738|FG003|Phase ll Part|Untreated|0|||
124890072|NCT00946647|449218739|FG004|Phase ll Part|Untreated|2|||
124890073|NCT00946647|449218735|FG000|Phase ll Part|Adverse Event|0|||
124890074|NCT00946647|449218736|FG001|Phase ll Part|Adverse Event|0|||
124890075|NCT00946647|449218737|FG002|Phase ll Part|Adverse Event|0|||
124890076|NCT00946647|449218738|FG003|Phase ll Part|Adverse Event|10|||
124890077|NCT00946647|449218739|FG004|Phase ll Part|Adverse Event|6|||
124890078|NCT00946647|449218735|FG000|Phase ll Part|Withdrawal by Subject|0|||
125106952|NCT01222715|450015558|FG001|Overall Study|Lack of Efficacy|14|||
124890079|NCT00946647|449218736|FG001|Phase ll Part|Withdrawal by Subject|0|||
124890080|NCT00946647|449218737|FG002|Phase ll Part|Withdrawal by Subject|0|||
124890081|NCT00946647|449218738|FG003|Phase ll Part|Withdrawal by Subject|8|||
124890082|NCT00946647|449218739|FG004|Phase ll Part|Withdrawal by Subject|6|||
124890083|NCT00946647|449218735|FG000|Phase ll Part|Administrative problems|0|||
124890084|NCT00946647|449218736|FG001|Phase ll Part|Administrative problems|0|||
124890085|NCT00946647|449218737|FG002|Phase ll Part|Administrative problems|0|||
124890086|NCT00946647|449218738|FG003|Phase ll Part|Administrative problems|3|||
125106953|NCT01222715|450015557|FG000|Overall Study|Physician Decision|12|||
124890087|NCT00946647|449218739|FG004|Phase ll Part|Administrative problems|8|||
124890088|NCT00946647|449218735|FG000|Phase ll Part|Death|0|||
124890089|NCT00946647|449218736|FG001|Phase ll Part|Death|0|||
124890090|NCT00946647|449218737|FG002|Phase ll Part|Death|0|||
124890091|NCT00946647|449218738|FG003|Phase ll Part|Death|7|||
124890092|NCT00946647|449218739|FG004|Phase ll Part|Death|4|||
124890093|NCT00946647|449218735|FG000|Phase ll Part|Disease progression|0|||
124890094|NCT00946647|449218736|FG001|Phase ll Part|Disease progression|0|||
124890095|NCT00946647|449218737|FG002|Phase ll Part|Disease progression|0|||
124890096|NCT00946647|449218738|FG003|Phase ll Part|Disease progression|6|||
124890097|NCT00946647|449218739|FG004|Phase ll Part|Disease progression|14|||
124890098|NCT00946647|449218735|FG000|Phase ll Part|Protocol Violation|0|||
124890099|NCT00946647|449218736|FG001|Phase ll Part|Protocol Violation|0|||
124890100|NCT00946647|449218737|FG002|Phase ll Part|Protocol Violation|0|||
124890101|NCT00946647|449218738|FG003|Phase ll Part|Protocol Violation|4|||
124890102|NCT00946647|449218739|FG004|Phase ll Part|Protocol Violation|2|||
124890103|NCT00946647|449218735|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
124890104|NCT00946647|449218736|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
124890105|NCT00946647|449218737|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
125016961|NCT02669017|449687630|FG001|Overall Study|Lost to Follow-up|0|||
125016962|NCT02669017|449687631|FG002|Overall Study|Lost to Follow-up|0|||
125016963|NCT02669017|449687632|FG003|Overall Study|Lost to Follow-up|0|||
125016964|NCT02669017|449687633|FG004|Overall Study|Lost to Follow-up|0|||
125016965|NCT02669017|449687634|FG005|Overall Study|Lost to Follow-up|0|||
125016966|NCT02669017|449687635|FG006|Overall Study|Lost to Follow-up|0|||
124890106|NCT00946647|449218738|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
124890107|NCT00946647|449218739|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
124890108|NCT03990363|449218740|FG000|Overall Study|Withdrawal by Subject|10|||
124890109|NCT03990363|449218741|FG001|Overall Study|Withdrawal by Subject|9|||
124890110|NCT03990363|449218742|FG002|Overall Study|Withdrawal by Subject|18|||
124890111|NCT03990363|449218743|FG003|Overall Study|Withdrawal by Subject|11|||
124890112|NCT03990363|449218744|FG004|Overall Study|Withdrawal by Subject|9|||
124890113|NCT03990363|449218740|FG000|Overall Study|Physician Decision|1|||
124890114|NCT03990363|449218741|FG001|Overall Study|Physician Decision|0|||
124890115|NCT03990363|449218742|FG002|Overall Study|Physician Decision|0|||
125016967|NCT02669017|449687636|FG007|Overall Study|Lost to Follow-up|0|||
125016968|NCT02669017|449687637|FG008|Overall Study|Lost to Follow-up|1|||
125016969|NCT02669017|449687629|FG000|Overall Study|Miscellaneous|0|||
125016970|NCT02669017|449687630|FG001|Overall Study|Miscellaneous|0|||
125016971|NCT02669017|449687631|FG002|Overall Study|Miscellaneous|0|||
125016972|NCT02669017|449687632|FG003|Overall Study|Miscellaneous|0|||
125016973|NCT02669017|449687633|FG004|Overall Study|Miscellaneous|2|||
125016974|NCT02669017|449687634|FG005|Overall Study|Miscellaneous|1|||
125016975|NCT02669017|449687635|FG006|Overall Study|Miscellaneous|1|||
125016976|NCT02669017|449687636|FG007|Overall Study|Miscellaneous|13|||
125016977|NCT02669017|449687637|FG008|Overall Study|Miscellaneous|2|||
125016978|NCT01289015|449687638|FG000|Overall Study|Protocol Violation|12|||
125016979|NCT01289015|449687639|FG001|Overall Study|Protocol Violation|9|||
125016980|NCT01289015|449687638|FG000|Overall Study|Adverse Event|3|||
125016981|NCT01289015|449687639|FG001|Overall Study|Adverse Event|0|||
125016982|NCT01289015|449687638|FG000|Overall Study|Lost to Follow-up|33|||
125016983|NCT01289015|449687639|FG001|Overall Study|Lost to Follow-up|17|||
125016984|NCT01289015|449687638|FG000|Overall Study|Withdrawal by Subject|17|||
125016985|NCT01289015|449687639|FG001|Overall Study|Withdrawal by Subject|8|||
125016986|NCT01289015|449687638|FG000|Overall Study|Disease progression|1|||
125016987|NCT01289015|449687639|FG001|Overall Study|Disease progression|0|||
125016988|NCT01289015|449687638|FG000|Overall Study|Negative baseline culture and others|33|||
125016989|NCT01289015|449687639|FG001|Overall Study|Negative baseline culture and others|20|||
125016990|NCT02797808|449687644|FG000|Overall Study|Withdrawal by Subject|1|||
125016991|NCT02797808|449687645|FG001|Overall Study|Withdrawal by Subject|1|||
125016992|NCT02797808|449687644|FG000|Overall Study|Physician Decision|6|||
125016993|NCT02797808|449687645|FG001|Overall Study|Physician Decision|2|||
125016994|NCT03509350|449687646|FG000|Overall Study|Withdrawal by Subject|0|||
125016995|NCT03509350|449687647|FG001|Overall Study|Withdrawal by Subject|2|||
125016996|NCT01425203|449687648|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
125016997|NCT01425203|449687649|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
125016998|NCT01425203|449687650|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
124890116|NCT03990363|449218743|FG003|Overall Study|Physician Decision|0|||
124890117|NCT03990363|449218744|FG004|Overall Study|Physician Decision|0|||
124890118|NCT03990363|449218740|FG000|Overall Study|Adverse Event|1|||
124890119|NCT03990363|449218741|FG001|Overall Study|Adverse Event|3|||
124890120|NCT03990363|449218742|FG002|Overall Study|Adverse Event|2|||
124890121|NCT03990363|449218743|FG003|Overall Study|Adverse Event|2|||
124890122|NCT03990363|449218744|FG004|Overall Study|Adverse Event|0|||
125016999|NCT01425203|449687648|FG000|Treatment Phase|Failure at futility timepoint|8|||
125017000|NCT01425203|449687649|FG001|Treatment Phase|Failure at futility timepoint|27|||
124890123|NCT03990363|449218740|FG000|Overall Study|Death|14|||
124890124|NCT03990363|449218741|FG001|Overall Study|Death|8|||
124890125|NCT03990363|449218742|FG002|Overall Study|Death|14|||
124890126|NCT03990363|449218743|FG003|Overall Study|Death|10|||
124890127|NCT03990363|449218744|FG004|Overall Study|Death|11|||
124890128|NCT03990363|449218740|FG000|Overall Study|Failure to meet randomization criteria|0|||
124890129|NCT03990363|449218741|FG001|Overall Study|Failure to meet randomization criteria|1|||
124890130|NCT03990363|449218742|FG002|Overall Study|Failure to meet randomization criteria|1|||
124890131|NCT03990363|449218743|FG003|Overall Study|Failure to meet randomization criteria|0|||
124890132|NCT03990363|449218744|FG004|Overall Study|Failure to meet randomization criteria|0|||
124890133|NCT03990363|449218740|FG000|Overall Study|Lost to Follow-up|0|||
124890134|NCT03990363|449218741|FG001|Overall Study|Lost to Follow-up|0|||
124890135|NCT03990363|449218742|FG002|Overall Study|Lost to Follow-up|0|||
124890136|NCT03990363|449218743|FG003|Overall Study|Lost to Follow-up|1|||
124890137|NCT03990363|449218744|FG004|Overall Study|Lost to Follow-up|2|||
124890138|NCT03990363|449218740|FG000|Overall Study|Non-compliance with study drug|2|||
124890139|NCT03990363|449218741|FG001|Overall Study|Non-compliance with study drug|1|||
124890140|NCT03990363|449218742|FG002|Overall Study|Non-compliance with study drug|2|||
124890141|NCT03990363|449218743|FG003|Overall Study|Non-compliance with study drug|0|||
124890142|NCT03990363|449218744|FG004|Overall Study|Non-compliance with study drug|0|||
124890143|NCT03990363|449218740|FG000|Overall Study|Study terminated by sponsor|0|||
124890144|NCT03990363|449218741|FG001|Overall Study|Study terminated by sponsor|1|||
124890145|NCT03990363|449218742|FG002|Overall Study|Study terminated by sponsor|0|||
124890146|NCT03990363|449218743|FG003|Overall Study|Study terminated by sponsor|0|||
124890147|NCT03990363|449218744|FG004|Overall Study|Study terminated by sponsor|0|||
124890148|NCT03990363|449218740|FG000|Overall Study|Site terminated by sponsor|2|||
124890149|NCT03990363|449218741|FG001|Overall Study|Site terminated by sponsor|1|||
124890150|NCT03990363|449218742|FG002|Overall Study|Site terminated by sponsor|2|||
124890151|NCT03990363|449218743|FG003|Overall Study|Site terminated by sponsor|0|||
124890152|NCT03990363|449218744|FG004|Overall Study|Site terminated by sponsor|2|||
124890153|NCT03990363|449218740|FG000|Overall Study|Not categorized|5|||
124890154|NCT03990363|449218741|FG001|Overall Study|Not categorized|5|||
124890155|NCT03990363|449218742|FG002|Overall Study|Not categorized|3|||
124890156|NCT03990363|449218743|FG003|Overall Study|Not categorized|2|||
124890157|NCT03990363|449218744|FG004|Overall Study|Not categorized|2|||
124890158|NCT00556374|449218746|FG000|Overall Study|Withdrawal by Subject|235|||
124890159|NCT00556374|449218747|FG001|Overall Study|Withdrawal by Subject|205|||
124890160|NCT00556374|449218746|FG000|Overall Study|Death|158|||
124890161|NCT00556374|449218747|FG001|Overall Study|Death|127|||
124890162|NCT00556374|449218746|FG000|Overall Study|Lost to Follow-up|24|||
124890163|NCT00556374|449218747|FG001|Overall Study|Lost to Follow-up|17|||
124890164|NCT00556374|449218746|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
124890165|NCT00556374|449218747|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
124890166|NCT00663962|449218748|FG000|Overall Study|somnolence|1|||
124890167|NCT00663962|449218749|FG001|Overall Study|somnolence|0|||
124890168|NCT02846558|449218754|FG000|Overall Study|Adverse Event|1|||
124890169|NCT02846558|449218755|FG001|Overall Study|Adverse Event|0|||
124890170|NCT02846558|449218756|FG002|Overall Study|Adverse Event|0|||
124890171|NCT02846558|449218757|FG003|Overall Study|Adverse Event|0|||
124890172|NCT02846558|449218754|FG000|Overall Study|Withdrawal by Subject|5|||
124890173|NCT02846558|449218755|FG001|Overall Study|Withdrawal by Subject|4|||
124890174|NCT02846558|449218756|FG002|Overall Study|Withdrawal by Subject|2|||
124890175|NCT02846558|449218757|FG003|Overall Study|Withdrawal by Subject|2|||
124890176|NCT02846558|449218754|FG000|Overall Study|Lost to Follow-up|2|||
125017001|NCT01425203|449687650|FG002|Treatment Phase|Failure at futility timepoint|0|||
124890177|NCT02846558|449218755|FG001|Overall Study|Lost to Follow-up|0|||
124890178|NCT02846558|449218756|FG002|Overall Study|Lost to Follow-up|0|||
124890179|NCT02846558|449218757|FG003|Overall Study|Lost to Follow-up|0|||
124890180|NCT00810641|449218761|FG000|Overall Study|Withdrawal by Subject|0|||
124890181|NCT00810641|449218762|FG001|Overall Study|Withdrawal by Subject|1|||
124890182|NCT00810641|449218763|FG002|Overall Study|Withdrawal by Subject|2|||
124890183|NCT02684903|449218772|FG000|Overall Study|COVID-19 shutdown of lab|4|||
124890184|NCT02684903|449218773|FG001|Overall Study|COVID-19 shutdown of lab|6|||
124890185|NCT02684903|449218772|FG000|Overall Study|Lost to Follow-up|31|||
124890186|NCT02684903|449218773|FG001|Overall Study|Lost to Follow-up|41|||
124890187|NCT00904150|449218774|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
124890188|NCT00904150|449218775|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
124890189|NCT00904150|449218774|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
124890190|NCT00904150|449218775|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
124890191|NCT04212169|449220408|FG000|Overall Study|Adverse Event|0|||
124890192|NCT04212169|449220409|FG001|Overall Study|Adverse Event|0|||
124890193|NCT04212169|449220410|FG002|Overall Study|Adverse Event|0|||
124890194|NCT04212169|449220411|FG003|Overall Study|Adverse Event|2|||
124890195|NCT04212169|449220408|FG000|Overall Study|Lost to Follow-up|1|||
124890196|NCT04212169|449220409|FG001|Overall Study|Lost to Follow-up|0|||
124890197|NCT04212169|449220410|FG002|Overall Study|Lost to Follow-up|0|||
124890198|NCT04212169|449220411|FG003|Overall Study|Lost to Follow-up|2|||
124890199|NCT04212169|449220408|FG000|Overall Study|Withdrawal by Subject|10|||
124890200|NCT04212169|449220409|FG001|Overall Study|Withdrawal by Subject|2|||
124890201|NCT04212169|449220410|FG002|Overall Study|Withdrawal by Subject|5|||
124890202|NCT04212169|449220411|FG003|Overall Study|Withdrawal by Subject|7|||
124890203|NCT04212169|449220408|FG000|Overall Study|Other reason, unspecified|3|||
124890204|NCT04212169|449220409|FG001|Overall Study|Other reason, unspecified|1|||
124890205|NCT04212169|449220410|FG002|Overall Study|Other reason, unspecified|0|||
124890206|NCT04212169|449220411|FG003|Overall Study|Other reason, unspecified|2|||
124890207|NCT02176928|449220412|FG000|Overall Study|Lost to Follow-up|2|||
124890208|NCT02176928|449220413|FG001|Overall Study|Lost to Follow-up|4|||
124890209|NCT00224133|449220414|FG000|Overall Study|Adverse Event|93|||
124890210|NCT00224133|449220414|FG000|Overall Study|Protocol Violation|6|||
124890211|NCT00224133|449220414|FG000|Overall Study|Withdrawal by Subject|33|||
124890212|NCT00224133|449220414|FG000|Overall Study|Lack of Efficacy|58|||
124890213|NCT00224133|449220414|FG000|Overall Study|Lost to Follow-up|21|||
124890214|NCT00224133|449220414|FG000|Overall Study|Physician Decision|1|||
124890215|NCT00224133|449220414|FG000|Overall Study|Other|14|||
124890216|NCT02718417|449220415|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
124890217|NCT02718417|449220416|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
124890218|NCT02718417|449220417|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
124890219|NCT02718417|449220415|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
124890220|NCT02718417|449220416|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
124890221|NCT02718417|449220417|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
124890222|NCT02718417|449220415|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
124890223|NCT02718417|449220416|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
124890224|NCT02718417|449220417|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
124890225|NCT02718417|449220415|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
124890226|NCT02718417|449220416|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
124890227|NCT02718417|449220417|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
124890228|NCT02718417|449220415|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
124890229|NCT02718417|449220416|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
124890230|NCT02718417|449220417|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
124890231|NCT02718417|449220415|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
124890232|NCT02718417|449220416|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
124890233|NCT02718417|449220417|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
124890234|NCT02718417|449220415|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
124890235|NCT02718417|449220416|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
124890236|NCT02718417|449220417|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
124890237|NCT02718417|449220415|FG000|Chemotherapy Phase (CP)|Other|2|||
124890238|NCT02718417|449220416|FG001|Chemotherapy Phase (CP)|Other|0|||
124890239|NCT02718417|449220417|FG002|Chemotherapy Phase (CP)|Other|1|||
124890240|NCT02718417|449220415|FG000|Maintenance Phase (MP)|Adverse Event|21|||
124890241|NCT02718417|449220416|FG001|Maintenance Phase (MP)|Adverse Event|26|||
124890242|NCT02718417|449220417|FG002|Maintenance Phase (MP)|Adverse Event|0|||
124890243|NCT02718417|449220415|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
124890244|NCT02718417|449220416|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
124890245|NCT02718417|449220417|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
124890246|NCT02718417|449220415|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
124890247|NCT02718417|449220416|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
124890248|NCT02718417|449220417|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
124890249|NCT02718417|449220415|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
124890250|NCT02718417|449220416|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
124890251|NCT02718417|449220417|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
124890252|NCT02718417|449220415|FG000|Maintenance Phase (MP)|Physician's decision|6|||
124890253|NCT02718417|449220416|FG001|Maintenance Phase (MP)|Physician's decision|7|||
124890254|NCT02718417|449220417|FG002|Maintenance Phase (MP)|Physician's decision|0|||
124890255|NCT02718417|449220415|FG000|Maintenance Phase (MP)|Progressive disease|100|||
124890256|NCT02718417|449220416|FG001|Maintenance Phase (MP)|Progressive disease|88|||
124890257|NCT02718417|449220417|FG002|Maintenance Phase (MP)|Progressive disease|0|||
124890258|NCT02718417|449220415|FG000|Maintenance Phase (MP)|Other|2|||
124890259|NCT02718417|449220416|FG001|Maintenance Phase (MP)|Other|1|||
124890260|NCT02718417|449220417|FG002|Maintenance Phase (MP)|Other|0|||
124890261|NCT02718417|449220415|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
124890262|NCT02718417|449220416|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
124890263|NCT02718417|449220417|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
124890264|NCT02718417|449220415|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
124890265|NCT02718417|449220416|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
124890266|NCT02718417|449220417|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
124890267|NCT02718417|449220415|FG000|Observation Phase (OP)|Adverse Event|0|||
124890268|NCT02718417|449220416|FG001|Observation Phase (OP)|Adverse Event|0|||
124890269|NCT02718417|449220417|FG002|Observation Phase (OP)|Adverse Event|1|||
124890270|NCT02718417|449220415|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
124890271|NCT02718417|449220416|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
124890272|NCT02718417|449220417|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
124890273|NCT02718417|449220415|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
124890274|NCT02718417|449220416|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
124890275|NCT02718417|449220417|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
124890276|NCT02718417|449220415|FG000|Observation Phase (OP)|Physician Decision|0|||
124890277|NCT02718417|449220416|FG001|Observation Phase (OP)|Physician Decision|0|||
124890278|NCT02718417|449220417|FG002|Observation Phase (OP)|Physician Decision|9|||
124890279|NCT02718417|449220415|FG000|Observation Phase (OP)|Progressive disease|0|||
124890280|NCT02718417|449220416|FG001|Observation Phase (OP)|Progressive disease|0|||
124890281|NCT02718417|449220417|FG002|Observation Phase (OP)|Progressive disease|92|||
124890282|NCT02718417|449220415|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
124890283|NCT02718417|449220416|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
124890284|NCT02718417|449220417|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
124890285|NCT02718417|449220415|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
124890286|NCT02718417|449220416|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
124890287|NCT02718417|449220417|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
124890288|NCT02718417|449220415|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
124890289|NCT02718417|449220416|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
124890290|NCT02718417|449220417|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
124890291|NCT02718417|449220415|FG000|Observation Phase (OP)|Other|0|||
124890292|NCT02718417|449220416|FG001|Observation Phase (OP)|Other|0|||
124890293|NCT02718417|449220417|FG002|Observation Phase (OP)|Other|7|||
124890294|NCT02718417|449220415|FG000|Follow-up Phase|Adverse Event|3|||
124890295|NCT02718417|449220416|FG001|Follow-up Phase|Adverse Event|1|||
124890296|NCT02718417|449220417|FG002|Follow-up Phase|Adverse Event|1|||
124890297|NCT02718417|449220415|FG000|Follow-up Phase|Other|4|||
124890298|NCT02718417|449220416|FG001|Follow-up Phase|Other|6|||
124890299|NCT02718417|449220417|FG002|Follow-up Phase|Other|4|||
125106954|NCT01222715|450015558|FG001|Overall Study|Physician Decision|2|||
125106955|NCT01222715|450015557|FG000|Overall Study|Refusal of further protocol therapy|0|||
125106956|NCT01222715|450015558|FG001|Overall Study|Refusal of further protocol therapy|4|||
125106957|NCT01222715|450015557|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
125106958|NCT01222715|450015558|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
125106959|NCT01222715|450015557|FG000|Overall Study|Ineligible|0|||
125106960|NCT01222715|450015558|FG001|Overall Study|Ineligible|1|||
125106961|NCT01222715|450015557|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
125106962|NCT01222715|450015558|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
125106963|NCT03372369|450015559|FG000|Qualification Period|Withdrawal by Subject|16|||
125106964|NCT03372369|450015560|FG001|Qualification Period|Withdrawal by Subject|13|||
125106965|NCT03372369|450015559|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
125106966|NCT03372369|450015560|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
125106967|NCT03372369|450015559|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
125106968|NCT03372369|450015560|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
125106969|NCT02239601|450015561|FG000|Overall Study|Withdrawal by Subject|3|||
125106970|NCT02239601|450015562|FG001|Overall Study|Withdrawal by Subject|4|||
125106971|NCT02239601|450015561|FG000|Overall Study|Protocol Violation|4|||
125106972|NCT02239601|450015562|FG001|Overall Study|Protocol Violation|2|||
125106973|NCT04682639|450015563|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
125106974|NCT04682639|450015564|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
125106975|NCT04682639|450015565|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
125106976|NCT04682639|450015566|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
125106977|NCT04682639|450015567|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
125106978|NCT04682639|450015563|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
125106979|NCT04682639|450015564|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
125106980|NCT04682639|450015565|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
125106981|NCT04682639|450015566|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125106982|NCT04682639|450015567|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125106983|NCT04682639|450015563|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
125106984|NCT04682639|450015564|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
125106985|NCT04682639|450015565|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125106986|NCT04682639|450015566|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125106987|NCT04682639|450015567|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124890300|NCT02718417|449220415|FG000|Follow-up Phase|Withdrawal by Subject|19|||
124890301|NCT02718417|449220416|FG001|Follow-up Phase|Withdrawal by Subject|17|||
124890302|NCT02718417|449220417|FG002|Follow-up Phase|Withdrawal by Subject|5|||
124890303|NCT02718417|449220415|FG000|Follow-up Phase|Study terminated by sponsor|100|||
124890304|NCT02718417|449220416|FG001|Follow-up Phase|Study terminated by sponsor|138|||
124890305|NCT02718417|449220417|FG002|Follow-up Phase|Study terminated by sponsor|6|||
124890306|NCT02718417|449220415|FG000|Follow-up Phase|Lost to Follow-up|2|||
124890307|NCT02718417|449220416|FG001|Follow-up Phase|Lost to Follow-up|3|||
124890308|NCT02718417|449220417|FG002|Follow-up Phase|Lost to Follow-up|0|||
124890309|NCT02718417|449220415|FG000|Follow-up Phase|Death leading to discontinuation|7|||
124890310|NCT02718417|449220416|FG001|Follow-up Phase|Death leading to discontinuation|7|||
124890311|NCT02718417|449220417|FG002|Follow-up Phase|Death leading to discontinuation|3|||
124890312|NCT02718417|449220415|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
124890313|NCT02718417|449220416|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
124890314|NCT02718417|449220417|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
124890315|NCT02718417|449220415|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
124890316|NCT02718417|449220416|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
124890317|NCT02718417|449220417|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
124890318|NCT02718417|449220415|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
124890319|NCT02718417|449220416|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
124890320|NCT02718417|449220417|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
124890321|NCT02718417|449220415|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
124890322|NCT02718417|449220416|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
124890323|NCT02718417|449220417|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
124890324|NCT02718417|449220415|FG000|Long-term Follow-up Phase|Other|0|||
124890325|NCT02718417|449220416|FG001|Long-term Follow-up Phase|Other|2|||
124890326|NCT02718417|449220417|FG002|Long-term Follow-up Phase|Other|0|||
124890327|NCT02451930|449220418|FG000|Overall Study|Death|0|||
124890328|NCT02451930|449220419|FG001|Overall Study|Death|15|||
124890329|NCT02451930|449220418|FG000|Overall Study|Lost to Follow-up|0|||
124890330|NCT02451930|449220419|FG001|Overall Study|Lost to Follow-up|3|||
124890331|NCT02451930|449220418|FG000|Overall Study|Sponsor Decision|2|||
124890332|NCT02451930|449220419|FG001|Overall Study|Sponsor Decision|10|||
124890333|NCT02451930|449220418|FG000|Overall Study|Withdrawal by Subject|0|||
124890334|NCT02451930|449220419|FG001|Overall Study|Withdrawal by Subject|1|||
124890335|NCT02451930|449220418|FG000|Overall Study|Other|0|||
124890336|NCT02451930|449220419|FG001|Overall Study|Other|1|||
124890337|NCT02268552|449220420|FG000|Part 1|Death|1|||
124890338|NCT02268552|449220421|FG001|Part 1|Death|1|||
124890339|NCT02268552|449220422|FG002|Part 1|Death|1|||
124890340|NCT02268552|449220423|FG003|Part 1|Death|2|||
124890341|NCT02268552|449220424|FG004|Part 1|Death|0|||
124890342|NCT02268552|449220425|FG005|Part 1|Death|0|||
124890343|NCT02268552|449220426|FG006|Part 1|Death|0|||
124890344|NCT02268552|449220420|FG000|Part 1|Subject/guardian decision|0|||
124890345|NCT02268552|449220421|FG001|Part 1|Subject/guardian decision|0|||
124890346|NCT02268552|449220422|FG002|Part 1|Subject/guardian decision|0|||
124890347|NCT02268552|449220423|FG003|Part 1|Subject/guardian decision|1|||
124890348|NCT02268552|449220424|FG004|Part 1|Subject/guardian decision|0|||
124890349|NCT02268552|449220425|FG005|Part 1|Subject/guardian decision|0|||
124890350|NCT02268552|449220426|FG006|Part 1|Subject/guardian decision|0|||
124890351|NCT02268552|449220420|FG000|Part 2|Death|0|||
124890352|NCT02268552|449220421|FG001|Part 2|Death|0|||
124890353|NCT02268552|449220422|FG002|Part 2|Death|0|||
124890354|NCT02268552|449220423|FG003|Part 2|Death|0|||
124890355|NCT02268552|449220424|FG004|Part 2|Death|0|||
124890356|NCT02268552|449220425|FG005|Part 2|Death|0|||
124890357|NCT02268552|449220426|FG006|Part 2|Death|2|||
124890358|NCT02268552|449220420|FG000|Part 2|Subject/guardian decision|0|||
124890359|NCT02268552|449220421|FG001|Part 2|Subject/guardian decision|0|||
124890360|NCT02268552|449220422|FG002|Part 2|Subject/guardian decision|0|||
124890361|NCT02268552|449220423|FG003|Part 2|Subject/guardian decision|0|||
124890362|NCT02268552|449220424|FG004|Part 2|Subject/guardian decision|0|||
124890363|NCT02268552|449220425|FG005|Part 2|Subject/guardian decision|0|||
124890364|NCT02268552|449220426|FG006|Part 2|Subject/guardian decision|1|||
124890365|NCT02268552|449220420|FG000|Part 3 Extension|Death|0|||
125017002|NCT01425203|449687648|FG000|Treatment Phase|Other virologic failure criteria|5|||
125017003|NCT01425203|449687649|FG001|Treatment Phase|Other virologic failure criteria|3|||
125017004|NCT01425203|449687650|FG002|Treatment Phase|Other virologic failure criteria|0|||
124890366|NCT02268552|449220421|FG001|Part 3 Extension|Death|1|||
124890367|NCT02268552|449220422|FG002|Part 3 Extension|Death|1|||
125017005|NCT01425203|449687648|FG000|Treatment Phase|Unidentified reasons|11|||
124890368|NCT02268552|449220423|FG003|Part 3 Extension|Death|1|||
125017006|NCT01425203|449687649|FG001|Treatment Phase|Unidentified reasons|5|||
125017007|NCT01425203|449687650|FG002|Treatment Phase|Unidentified reasons|0|||
124890369|NCT02268552|449220424|FG004|Part 3 Extension|Death|1|||
124890370|NCT02268552|449220425|FG005|Part 3 Extension|Death|1|||
124890371|NCT02268552|449220426|FG006|Part 3 Extension|Death|0|||
125017008|NCT01425203|449687648|FG000|Treatment Phase|Did not receive treatment|0|||
124890372|NCT02268552|449220420|FG000|Part 3 Extension|Early termination of trial|1|||
124890373|NCT02268552|449220421|FG001|Part 3 Extension|Early termination of trial|0|||
124890374|NCT02268552|449220422|FG002|Part 3 Extension|Early termination of trial|0|||
124890375|NCT02268552|449220423|FG003|Part 3 Extension|Early termination of trial|0|||
125017009|NCT01425203|449687649|FG001|Treatment Phase|Did not receive treatment|1|||
125017010|NCT01425203|449687650|FG002|Treatment Phase|Did not receive treatment|0|||
125017011|NCT01425203|449687648|FG000|Crossover Phase|Failure at futility timepoint|0|||
125017012|NCT01425203|449687649|FG001|Crossover Phase|Failure at futility timepoint|0|||
125017013|NCT01425203|449687650|FG002|Crossover Phase|Failure at futility timepoint|3|||
125017014|NCT01425203|449687648|FG000|Crossover Phase|Other virologic failure criteria|0|||
125017015|NCT01425203|449687649|FG001|Crossover Phase|Other virologic failure criteria|0|||
125017016|NCT01425203|449687650|FG002|Crossover Phase|Other virologic failure criteria|3|||
125017017|NCT00535132|449687653|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
125017018|NCT00535132|449687654|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
125017019|NCT00535132|449687653|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
125017020|NCT00535132|449687654|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
125017021|NCT02590588|449687655|FG000|Overall Study|Adverse Event|1|||
125017022|NCT02559687|449687658|FG000|Overall Study|Death|112|||
125017023|NCT02559687|449687658|FG000|Overall Study|Sponsor Decision|5|||
125017024|NCT02559687|449687658|FG000|Overall Study|Withdrawal by Subject|4|||
125017025|NCT03031301|449687661|FG000|Overall Study|Protocol Violation|4|||
125017026|NCT03031301|449687662|FG001|Overall Study|Protocol Violation|8|||
125017027|NCT03031301|449687661|FG000|Overall Study|Withdrawal by Subject|7|||
125017028|NCT03031301|449687662|FG001|Overall Study|Withdrawal by Subject|4|||
125017029|NCT03031301|449687661|FG000|Overall Study|Lost to Follow-up|4|||
125017030|NCT03031301|449687662|FG001|Overall Study|Lost to Follow-up|12|||
125017031|NCT03031301|449687661|FG000|Overall Study|Noncompliance|1|||
125017032|NCT03031301|449687662|FG001|Overall Study|Noncompliance|3|||
125017033|NCT03031301|449687661|FG000|Overall Study|Technical issue|1|||
125017034|NCT03031301|449687662|FG001|Overall Study|Technical issue|1|||
125017035|NCT03031301|449687661|FG000|Overall Study|Adverse Event|1|||
125017036|NCT03031301|449687662|FG001|Overall Study|Adverse Event|0|||
125017037|NCT01857869|449687671|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
125017038|NCT01857869|449687672|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
125017039|NCT01857869|449687673|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
125017040|NCT01857869|449687674|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
125017041|NCT01857869|449687675|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
125017042|NCT01857869|449687676|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
125017043|NCT01857869|449687677|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
125017044|NCT01857869|449687678|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
125017045|NCT01857869|449687679|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
125017046|NCT01857869|449687680|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
125017047|NCT01857869|449687671|FG000|Primary/Challenge Phase|Pregnancy|1|||
125017048|NCT01857869|449687672|FG001|Primary/Challenge Phase|Pregnancy|0|||
125017049|NCT01857869|449687673|FG002|Primary/Challenge Phase|Pregnancy|0|||
125017050|NCT01857869|449687674|FG003|Primary/Challenge Phase|Pregnancy|0|||
125017051|NCT01857869|449687675|FG004|Primary/Challenge Phase|Pregnancy|0|||
125017052|NCT01857869|449687676|FG005|Primary/Challenge Phase|Pregnancy|0|||
125017053|NCT01857869|449687677|FG006|Primary/Challenge Phase|Pregnancy|0|||
125017054|NCT01857869|449687678|FG007|Primary/Challenge Phase|Pregnancy|0|||
125017055|NCT01857869|449687679|FG008|Primary/Challenge Phase|Pregnancy|0|||
125017056|NCT01857869|449687680|FG009|Primary/Challenge Phase|Pregnancy|0|||
125017057|NCT01857869|449687671|FG000|Primary/Challenge Phase|Protocol Violation|1|||
125017058|NCT01857869|449687672|FG001|Primary/Challenge Phase|Protocol Violation|0|||
125017059|NCT01857869|449687673|FG002|Primary/Challenge Phase|Protocol Violation|0|||
125017060|NCT01857869|449687674|FG003|Primary/Challenge Phase|Protocol Violation|0|||
125017061|NCT01857869|449687675|FG004|Primary/Challenge Phase|Protocol Violation|0|||
125017062|NCT01857869|449687676|FG005|Primary/Challenge Phase|Protocol Violation|0|||
125017063|NCT01857869|449687677|FG006|Primary/Challenge Phase|Protocol Violation|0|||
125017064|NCT01857869|449687678|FG007|Primary/Challenge Phase|Protocol Violation|0|||
125017065|NCT01857869|449687679|FG008|Primary/Challenge Phase|Protocol Violation|0|||
125017066|NCT01857869|449687680|FG009|Primary/Challenge Phase|Protocol Violation|0|||
125017067|NCT01857869|449687671|FG000|Primary/Challenge Phase|Other|1|||
125017068|NCT01857869|449687672|FG001|Primary/Challenge Phase|Other|1|||
125017069|NCT01857869|449687673|FG002|Primary/Challenge Phase|Other|0|||
124890376|NCT02268552|449220424|FG004|Part 3 Extension|Early termination of trial|2|||
124890377|NCT02268552|449220425|FG005|Part 3 Extension|Early termination of trial|9|||
124890378|NCT02268552|449220426|FG006|Part 3 Extension|Early termination of trial|11|||
124890379|NCT02268552|449220420|FG000|Part 3 Extension|Subject/guardian decision|0|||
124890380|NCT02268552|449220421|FG001|Part 3 Extension|Subject/guardian decision|0|||
124890381|NCT02268552|449220422|FG002|Part 3 Extension|Subject/guardian decision|0|||
124890382|NCT02268552|449220423|FG003|Part 3 Extension|Subject/guardian decision|0|||
124890383|NCT02268552|449220424|FG004|Part 3 Extension|Subject/guardian decision|0|||
124890384|NCT02268552|449220425|FG005|Part 3 Extension|Subject/guardian decision|0|||
124890385|NCT02268552|449220426|FG006|Part 3 Extension|Subject/guardian decision|1|||
124890386|NCT03415022|449220429|FG000|Overall Study|Withdrawal by Subject|1|||
124890387|NCT03415022|449220430|FG001|Overall Study|Withdrawal by Subject|2|||
124890388|NCT03415022|449220429|FG000|Overall Study|COVID-19 Suspension|2|||
124890389|NCT03415022|449220430|FG001|Overall Study|COVID-19 Suspension|3|||
124890390|NCT03415022|449220429|FG000|Overall Study|Lost to Follow-up|2|||
124890391|NCT03415022|449220430|FG001|Overall Study|Lost to Follow-up|0|||
124890392|NCT04466618|449220431|FG000|Overall Study|Withdrawal by Subject|0|||
124890393|NCT04466618|449220432|FG001|Overall Study|Withdrawal by Subject|1|||
124890394|NCT01676220|449220434|FG000|Overall Study|Randomized But Not Treated|4|||
124890395|NCT01676220|449220435|FG001|Overall Study|Randomized But Not Treated|1|||
124890396|NCT01676220|449220434|FG000|Overall Study|Adverse Event|10|||
124890397|NCT01676220|449220435|FG001|Overall Study|Adverse Event|8|||
124890398|NCT01676220|449220434|FG000|Overall Study|Lack of Efficacy|2|||
124890399|NCT01676220|449220435|FG001|Overall Study|Lack of Efficacy|5|||
124890400|NCT01676220|449220434|FG000|Overall Study|Protocol Violation|11|||
124890401|NCT01676220|449220435|FG001|Overall Study|Protocol Violation|12|||
124890402|NCT01676220|449220434|FG000|Overall Study|Received Rescue Therapy|14|||
124890403|NCT01676220|449220435|FG001|Overall Study|Received Rescue Therapy|22|||
124890404|NCT01676220|449220434|FG000|Overall Study|Personal Reason|34|||
124890405|NCT01676220|449220435|FG001|Overall Study|Personal Reason|45|||
124890406|NCT01676220|449220434|FG000|Overall Study|Lost to Follow-up|11|||
124890407|NCT01676220|449220435|FG001|Overall Study|Lost to Follow-up|18|||
124890408|NCT01676220|449220434|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
124890409|NCT01676220|449220435|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
124890410|NCT01676220|449220434|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
124890411|NCT01676220|449220435|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
124890412|NCT01676220|449220434|FG000|Overall Study|Perceived Lack of Efficacy|3|||
124890413|NCT01676220|449220435|FG001|Overall Study|Perceived Lack of Efficacy|1|||
124890414|NCT01676220|449220434|FG000|Overall Study|Non Serious Hypoglycemia|2|||
124890415|NCT01676220|449220435|FG001|Overall Study|Non Serious Hypoglycemia|0|||
124890416|NCT01676220|449220434|FG000|Overall Study|No More Need of Insulin|1|||
124890417|NCT01676220|449220435|FG001|Overall Study|No More Need of Insulin|0|||
124890418|NCT04496167|449220436|FG000|Overall Study|Adverse Event|6|||
124890419|NCT04496167|449220437|FG001|Overall Study|Adverse Event|2|||
124890420|NCT04496167|449220436|FG000|Overall Study|Withdrawal by Subject|7|||
125017070|NCT01857869|449687674|FG003|Primary/Challenge Phase|Other|0|||
125017071|NCT01857869|449687675|FG004|Primary/Challenge Phase|Other|0|||
125017072|NCT01857869|449687676|FG005|Primary/Challenge Phase|Other|0|||
125017073|NCT01857869|449687677|FG006|Primary/Challenge Phase|Other|0|||
125017074|NCT01857869|449687678|FG007|Primary/Challenge Phase|Other|0|||
125017075|NCT01857869|449687679|FG008|Primary/Challenge Phase|Other|0|||
125017076|NCT01857869|449687680|FG009|Primary/Challenge Phase|Other|0|||
125017077|NCT01857869|449687671|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
125017078|NCT01857869|449687672|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
125017079|NCT01857869|449687673|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
125017080|NCT01857869|449687674|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
125017081|NCT01857869|449687675|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
125017082|NCT01857869|449687676|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
125017083|NCT01857869|449687677|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
125017084|NCT01857869|449687678|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
125017085|NCT01857869|449687679|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
125017086|NCT01857869|449687680|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
125017087|NCT01857869|449687671|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
125017088|NCT01857869|449687672|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
125017089|NCT01857869|449687673|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
125017090|NCT01857869|449687674|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
125017091|NCT01857869|449687675|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
125017092|NCT01857869|449687676|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
125017093|NCT01857869|449687677|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
124890421|NCT04496167|449220437|FG001|Overall Study|Withdrawal by Subject|6|||
124890422|NCT04496167|449220436|FG000|Overall Study|Lost to Follow-up|3|||
124890423|NCT04496167|449220437|FG001|Overall Study|Lost to Follow-up|5|||
124890424|NCT04496167|449220436|FG000|Overall Study|Not Treated|1|||
124890425|NCT04496167|449220437|FG001|Overall Study|Not Treated|2|||
125106988|NCT04682639|450015563|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
124890426|NCT04496167|449220436|FG000|Overall Study|Other Than Specified|1|||
124890427|NCT04496167|449220437|FG001|Overall Study|Other Than Specified|1|||
124890428|NCT02269943|449220438|FG000|Treatment Period|Death|0|||
124890429|NCT02269943|449220439|FG001|Treatment Period|Death|1|||
124890430|NCT02269943|449220438|FG000|Treatment Period|Adverse Event|1|||
124890431|NCT02269943|449220439|FG001|Treatment Period|Adverse Event|10|||
124890432|NCT02269943|449220438|FG000|Treatment Period|Progressive Disease|5|||
124890433|NCT02269943|449220439|FG001|Treatment Period|Progressive Disease|17|||
124890434|NCT02269943|449220438|FG000|Treatment Period|Symptomatic Deterioration|0|||
124890435|NCT02269943|449220439|FG001|Treatment Period|Symptomatic Deterioration|2|||
124890436|NCT02269943|449220438|FG000|Follow-Up Survival Period|Death|3|||
124890437|NCT02269943|449220439|FG001|Follow-Up Survival Period|Death|16|||
124890438|NCT02269943|449220438|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
124890439|NCT02269943|449220439|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
124890440|NCT02269943|449220438|FG000|Follow-Up Survival Period|Alive|2|||
124890441|NCT02269943|449220439|FG001|Follow-Up Survival Period|Alive|8|||
124890442|NCT03541642|449220440|FG000|Overall Study|Withdrawal by Subject|1|||
124890443|NCT03541642|449220441|FG001|Overall Study|Withdrawal by Subject|2|||
124890444|NCT03541642|449220440|FG000|Overall Study|Lost to Follow-up|16|||
124890445|NCT03541642|449220441|FG001|Overall Study|Lost to Follow-up|12|||
124890446|NCT03541642|449220440|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
124890447|NCT03541642|449220441|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
124890448|NCT00873093|449220448|FG000|Overall Study|Adverse Event|0|||
124890449|NCT00873093|449220449|FG001|Overall Study|Adverse Event|2|||
124890450|NCT00873093|449220450|FG002|Overall Study|Adverse Event|0|||
124890451|NCT00873093|449220451|FG003|Overall Study|Adverse Event|0|||
124890452|NCT00873093|449220452|FG004|Overall Study|Adverse Event|0|||
124890453|NCT00873093|449220448|FG000|Overall Study|Death|0|||
124890454|NCT00873093|449220449|FG001|Overall Study|Death|3|||
124890455|NCT00873093|449220450|FG002|Overall Study|Death|2|||
124890456|NCT00873093|449220451|FG003|Overall Study|Death|0|||
124890457|NCT00873093|449220452|FG004|Overall Study|Death|0|||
124890458|NCT00873093|449220448|FG000|Overall Study|Physician Decision|0|||
124890459|NCT00873093|449220449|FG001|Overall Study|Physician Decision|17|||
124890460|NCT00873093|449220450|FG002|Overall Study|Physician Decision|10|||
124890461|NCT00873093|449220451|FG003|Overall Study|Physician Decision|10|||
124890462|NCT00873093|449220452|FG004|Overall Study|Physician Decision|2|||
124890463|NCT00873093|449220448|FG000|Overall Study|Withdrawal by Subject|1|||
124890464|NCT00873093|449220449|FG001|Overall Study|Withdrawal by Subject|4|||
124890465|NCT00873093|449220450|FG002|Overall Study|Withdrawal by Subject|4|||
124890466|NCT00873093|449220451|FG003|Overall Study|Withdrawal by Subject|0|||
124890467|NCT00873093|449220452|FG004|Overall Study|Withdrawal by Subject|0|||
124890468|NCT00873093|449220448|FG000|Overall Study|Ineligible|0|||
124890469|NCT00873093|449220449|FG001|Overall Study|Ineligible|1|||
124890470|NCT00873093|449220450|FG002|Overall Study|Ineligible|0|||
124890471|NCT00873093|449220451|FG003|Overall Study|Ineligible|1|||
124890472|NCT00873093|449220452|FG004|Overall Study|Ineligible|0|||
124890473|NCT00136916|449220453|FG000|Overall Study|Never received study treatment|3|||
124890474|NCT00136916|449220454|FG001|Overall Study|Never received study treatment|5|||
124890475|NCT00136916|449220453|FG000|Overall Study|Death|1|||
124890476|NCT00136916|449220454|FG001|Overall Study|Death|3|||
124890477|NCT00136916|449220453|FG000|Overall Study|Adverse Event|27|||
124890478|NCT00136916|449220454|FG001|Overall Study|Adverse Event|8|||
124890479|NCT00136916|449220453|FG000|Overall Study|Laboratory abnormality|0|||
124890480|NCT00136916|449220454|FG001|Overall Study|Laboratory abnormality|1|||
124890481|NCT00136916|449220453|FG000|Overall Study|Lack of Efficacy|13|||
124890482|NCT00136916|449220454|FG001|Overall Study|Lack of Efficacy|3|||
124890483|NCT00136916|449220453|FG000|Overall Study|Lost to Follow-up|12|||
124890484|NCT00136916|449220454|FG001|Overall Study|Lost to Follow-up|14|||
124890485|NCT00136916|449220453|FG000|Overall Study|Withdrawal by Subject|44|||
125106989|NCT04682639|450015564|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
125106990|NCT04682639|450015565|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
125106991|NCT04682639|450015566|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
125106992|NCT04682639|450015567|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
124890486|NCT00136916|449220454|FG001|Overall Study|Withdrawal by Subject|46|||
124890487|NCT00136916|449220453|FG000|Overall Study|Other|22|||
124890488|NCT00136916|449220454|FG001|Overall Study|Other|24|||
124890489|NCT00136916|449220453|FG000|Overall Study|Discontinued in follow up period|3|||
124890490|NCT00136916|449220454|FG001|Overall Study|Discontinued in follow up period|0|||
124890491|NCT04242875|449220457|FG000|Overall Study|Adverse Event|2|||
124890492|NCT04172987|449220458|FG000|Lead In Period|Adverse Event|1|||
124890493|NCT04172987|449220458|FG000|Lead In Period|Protocol Violation|1|||
124890494|NCT04172987|449220458|FG000|Period 1|Physician Decision|1|||
124890495|NCT04172987|449220458|FG000|Period 2|Adverse Event|5|||
124890496|NCT04172987|449220458|FG000|Period 2|Dosing Termination by Sponsor|4|||
124890497|NCT04179461|449220459|FG000|Overall Study|Lost to Follow-up|4|||
124890498|NCT03285711|449220460|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
124890499|NCT03285711|449220461|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
124890500|NCT03285711|449220462|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
124890501|NCT03285711|449220463|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
124890502|NCT03285711|449220460|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
124890503|NCT03285711|449220461|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
124890504|NCT03285711|449220462|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
124890505|NCT03285711|449220463|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
124890506|NCT03285711|449220460|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
124890507|NCT03285711|449220461|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
124890508|NCT03285711|449220462|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
124890509|NCT03285711|449220463|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
124890510|NCT03285711|449220460|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
124890511|NCT03285711|449220461|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
124890512|NCT03285711|449220462|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
124890513|NCT03285711|449220463|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
124890514|NCT02431533|449220468|FG000|Overall Study|Withdrawal by Subject|1|||
124890515|NCT02431533|449220469|FG001|Overall Study|Withdrawal by Subject|3|||
124890516|NCT02431533|449220468|FG000|Overall Study|Developed Exclusionary criteria|1|||
124890517|NCT02431533|449220469|FG001|Overall Study|Developed Exclusionary criteria|0|||
124890518|NCT02107443|449220470|FG000|Overall Study|Death|42|||
124890519|NCT02107443|449220471|FG001|Overall Study|Death|30|||
124890520|NCT02107443|449220470|FG000|Overall Study|Study Protocol Violation|3|||
124890521|NCT02107443|449220471|FG001|Overall Study|Study Protocol Violation|1|||
124890522|NCT02107443|449220470|FG000|Overall Study|Registered but Not Eligible|0|||
124890523|NCT02107443|449220471|FG001|Overall Study|Registered but Not Eligible|1|||
124890524|NCT02107443|449220470|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
124890525|NCT02107443|449220471|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
124890526|NCT02107443|449220470|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
124890527|NCT02107443|449220471|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
124890528|NCT02107443|449220470|FG000|Overall Study|Withdrawal: Changed Mind|2|||
124890529|NCT02107443|449220471|FG001|Overall Study|Withdrawal: Changed Mind|0|||
124890530|NCT02107443|449220470|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
124890531|NCT02107443|449220471|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
124890532|NCT02107443|449220470|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
124890533|NCT02107443|449220471|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
124890534|NCT02107443|449220470|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
124890535|NCT02107443|449220471|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
124890536|NCT02107443|449220470|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
124890537|NCT02107443|449220471|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
124890538|NCT02107443|449220470|FG000|Overall Study|Withdrawal: Other Medical|9|||
124890539|NCT02107443|449220471|FG001|Overall Study|Withdrawal: Other Medical|5|||
124890540|NCT02107443|449220470|FG000|Overall Study|Withdrawal: Disease Progression|4|||
124890541|NCT02107443|449220471|FG001|Overall Study|Withdrawal: Disease Progression|2|||
124890542|NCT02107443|449220470|FG000|Overall Study|Withdrawal: Personal Issues|0|||
124890543|NCT02107443|449220471|FG001|Overall Study|Withdrawal: Personal Issues|3|||
124890544|NCT01513967|449220473|FG000|Overall Study|Pregnancy|0|||
124890545|NCT01513967|449220474|FG001|Overall Study|Pregnancy|0|||
124890546|NCT01513967|449220475|FG002|Overall Study|Pregnancy|0|||
124890547|NCT01513967|449220476|FG003|Overall Study|Pregnancy|0|||
124890548|NCT01513967|449220477|FG004|Overall Study|Pregnancy|0|||
124890549|NCT01513967|449220478|FG005|Overall Study|Pregnancy|0|||
125106993|NCT04682639|450015563|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
125106994|NCT04682639|450015564|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
125106995|NCT04682639|450015565|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
125106996|NCT04682639|450015566|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
125106997|NCT04682639|450015567|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
124890550|NCT01513967|449220479|FG006|Overall Study|Pregnancy|1|||
124890551|NCT01513967|449220480|FG007|Overall Study|Pregnancy|0|||
124890552|NCT01513967|449220473|FG000|Overall Study|missed a study visit|0|||
124890553|NCT01513967|449220474|FG001|Overall Study|missed a study visit|0|||
124890554|NCT01513967|449220475|FG002|Overall Study|missed a study visit|0|||
124890555|NCT01513967|449220476|FG003|Overall Study|missed a study visit|0|||
124890556|NCT01513967|449220477|FG004|Overall Study|missed a study visit|0|||
124890557|NCT01513967|449220478|FG005|Overall Study|missed a study visit|0|||
124890558|NCT01513967|449220479|FG006|Overall Study|missed a study visit|1|||
124890559|NCT01513967|449220480|FG007|Overall Study|missed a study visit|0|||
124890560|NCT01513967|449220473|FG000|Overall Study|excluded due to positive drug screen|0|||
124890561|NCT01513967|449220474|FG001|Overall Study|excluded due to positive drug screen|0|||
124890562|NCT01513967|449220475|FG002|Overall Study|excluded due to positive drug screen|0|||
124890563|NCT01513967|449220476|FG003|Overall Study|excluded due to positive drug screen|0|||
124890564|NCT01513967|449220477|FG004|Overall Study|excluded due to positive drug screen|0|||
125017094|NCT01857869|449687678|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
125017095|NCT01857869|449687679|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
125017096|NCT01857869|449687680|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
125017097|NCT02898259|449687706|FG000|Overall Study|Adverse Event|0|||
125017098|NCT02898259|449687707|FG001|Overall Study|Adverse Event|0|||
124890565|NCT01513967|449220478|FG005|Overall Study|excluded due to positive drug screen|0|||
124890566|NCT01513967|449220479|FG006|Overall Study|excluded due to positive drug screen|0|||
124890567|NCT01513967|449220480|FG007|Overall Study|excluded due to positive drug screen|2|||
124890568|NCT01513967|449220473|FG000|Overall Study|Physician Decision|0|||
124890569|NCT01513967|449220474|FG001|Overall Study|Physician Decision|0|||
124890570|NCT01513967|449220475|FG002|Overall Study|Physician Decision|0|||
124890571|NCT01513967|449220476|FG003|Overall Study|Physician Decision|0|||
125017099|NCT02898259|449687708|FG002|Overall Study|Adverse Event|1|||
125017100|NCT02898259|449687709|FG003|Overall Study|Adverse Event|0|||
124890572|NCT01513967|449220477|FG004|Overall Study|Physician Decision|0|||
124890573|NCT01513967|449220478|FG005|Overall Study|Physician Decision|1|||
124890574|NCT01513967|449220479|FG006|Overall Study|Physician Decision|0|||
124890575|NCT01513967|449220480|FG007|Overall Study|Physician Decision|0|||
124890576|NCT02906202|449220481|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
124890577|NCT01563978|449220485|FG000|Overall Study|Physician Decision|1|||
124890578|NCT01563978|449220486|FG001|Overall Study|Physician Decision|0|||
124890579|NCT01563978|449220485|FG000|Overall Study|Lost to Follow-up|1|||
124890580|NCT01563978|449220486|FG001|Overall Study|Lost to Follow-up|0|||
124890581|NCT01563978|449220485|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
124890582|NCT01563978|449220486|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
124890583|NCT01563978|449220485|FG000|Overall Study|Adverse Event|1|||
124890584|NCT01563978|449220486|FG001|Overall Study|Adverse Event|2|||
124890585|NCT00729690|449220487|FG000|Overall Study|IT Catheter Malfunction|0|||
125017101|NCT02898259|449687710|FG004|Overall Study|Adverse Event|0|||
125106998|NCT04682639|450015563|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
125106999|NCT04682639|450015564|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
125107000|NCT04682639|450015565|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
125107001|NCT04682639|450015566|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
124890586|NCT00729690|449220488|FG001|Overall Study|IT Catheter Malfunction|2|||
124890587|NCT00729690|449220489|FG002|Overall Study|IT Catheter Malfunction|2|||
125107002|NCT04682639|450015567|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
125107003|NCT04682639|450015563|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
125107004|NCT04682639|450015564|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
125107005|NCT04682639|450015565|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
125107006|NCT04682639|450015566|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
125107007|NCT04682639|450015567|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
125107008|NCT04682639|450015563|FG000|OLE Period (28 Weeks)|Other|1|||
125107009|NCT04682639|450015564|FG001|OLE Period (28 Weeks)|Other|2|||
125107010|NCT04682639|450015565|FG002|OLE Period (28 Weeks)|Other|0|||
125107011|NCT04682639|450015566|FG003|OLE Period (28 Weeks)|Other|0|||
125107012|NCT04682639|450015567|FG004|OLE Period (28 Weeks)|Other|1|||
125107013|NCT04682639|450015563|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
125107014|NCT04682639|450015564|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
125107015|NCT04682639|450015565|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
125107016|NCT04682639|450015566|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
125107017|NCT04682639|450015567|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
125107018|NCT04682639|450015563|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
125107019|NCT04682639|450015564|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
125107020|NCT04682639|450015565|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
125107021|NCT04682639|450015566|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
125107022|NCT04682639|450015567|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
125107023|NCT04682639|450015563|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
125107024|NCT04682639|450015564|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
125107025|NCT04682639|450015565|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
125107026|NCT04682639|450015566|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
125107027|NCT04682639|450015567|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
125107028|NCT04682639|450015563|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
124890588|NCT04562779|449220492|FG000|Overall Study|Lost to Follow-up|7|||
124890589|NCT04562779|449220493|FG001|Overall Study|Lost to Follow-up|5|||
124890590|NCT04562779|449220494|FG002|Overall Study|Lost to Follow-up|10|||
124890591|NCT04562779|449220492|FG000|Overall Study|Protocol Violation|2|||
124890592|NCT04562779|449220493|FG001|Overall Study|Protocol Violation|2|||
125107029|NCT04682639|450015564|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
125107030|NCT04682639|450015565|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
125107031|NCT04682639|450015566|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
125107032|NCT04682639|450015567|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
125107033|NCT01392170|450015568|FG000|Overall Study|Withdrawal by Subject|1|||
125107034|NCT01392170|450015568|FG000|Overall Study|Ineligible|1|||
125107035|NCT02748616|450015586|FG000|Overall Study|Lost to Follow-up|1|||
125107036|NCT02748616|450015586|FG000|Overall Study|Withdrawal by Subject|2|||
124890593|NCT04562779|449220494|FG002|Overall Study|Protocol Violation|0|||
124890594|NCT00333138|449220495|FG000|Core Study (6 Months)|Adverse Event|4|||
124890595|NCT00333138|449220496|FG001|Core Study (6 Months)|Adverse Event|5|||
124890596|NCT00333138|449220497|FG002|Core Study (6 Months)|Adverse Event|8|||
124890597|NCT00333138|449220495|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
124890598|NCT00333138|449220496|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
124890599|NCT00333138|449220497|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
124890600|NCT00333138|449220495|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
124890601|NCT00333138|449220496|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
124890602|NCT00333138|449220497|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
124890603|NCT00333138|449220495|FG000|Core Study (6 Months)|Protocol Violation|1|||
124890604|NCT00333138|449220496|FG001|Core Study (6 Months)|Protocol Violation|0|||
124890605|NCT00333138|449220497|FG002|Core Study (6 Months)|Protocol Violation|1|||
124890606|NCT00333138|449220495|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
124890607|NCT00333138|449220496|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
124890608|NCT00333138|449220497|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
124890609|NCT00333138|449220495|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
124890610|NCT00333138|449220496|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
124890611|NCT00333138|449220497|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
124890612|NCT00333138|449220495|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
124890613|NCT00333138|449220496|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
124890614|NCT00333138|449220497|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
124890615|NCT00333138|449220495|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
124890616|NCT00333138|449220496|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
124890617|NCT00333138|449220497|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
124890618|NCT00333138|449220495|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
124890619|NCT00333138|449220496|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
124890620|NCT00333138|449220497|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
124890621|NCT00333138|449220495|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
124890622|NCT00333138|449220496|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
124890623|NCT00333138|449220497|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
124890624|NCT00333138|449220495|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
124890625|NCT00333138|449220496|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
124890626|NCT00333138|449220497|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
124890627|NCT00333138|449220495|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
124890628|NCT00333138|449220496|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
124890629|NCT00333138|449220497|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
124890630|NCT00333138|449220495|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
124890631|NCT00333138|449220496|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
124890632|NCT00333138|449220497|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
124890633|NCT00333138|449220495|FG000|Extension Study (Month6 to End of Study)|Death|0|||
124890634|NCT00333138|449220496|FG001|Extension Study (Month6 to End of Study)|Death|1|||
124890635|NCT00333138|449220497|FG002|Extension Study (Month6 to End of Study)|Death|0|||
124890636|NCT05593211|449220498|FG000|Overall Study|Withdrawal by Subject|1|||
124890637|NCT03077620|449220502|FG000|Overall Study|Unable to place lumbar catheter|1|||
124890638|NCT03077620|449220503|FG001|Overall Study|Unable to place lumbar catheter|0|||
124890639|NCT03077620|449220504|FG002|Overall Study|Unable to place lumbar catheter|1|||
124890640|NCT03077620|449220505|FG003|Overall Study|Unable to place lumbar catheter|0|||
124890641|NCT03077620|449220502|FG000|Overall Study|Withdrawal by Subject|0|||
124890642|NCT03077620|449220503|FG001|Overall Study|Withdrawal by Subject|1|||
124890643|NCT03077620|449220504|FG002|Overall Study|Withdrawal by Subject|0|||
124890644|NCT03077620|449220505|FG003|Overall Study|Withdrawal by Subject|0|||
124890645|NCT03077620|449220502|FG000|Overall Study|Physician Decision|0|||
124890646|NCT03077620|449220503|FG001|Overall Study|Physician Decision|0|||
125017102|NCT02898259|449687706|FG000|Overall Study|Lack of Efficacy|1|||
125017103|NCT02898259|449687707|FG001|Overall Study|Lack of Efficacy|1|||
125017104|NCT02898259|449687708|FG002|Overall Study|Lack of Efficacy|3|||
125017105|NCT02898259|449687709|FG003|Overall Study|Lack of Efficacy|0|||
125017106|NCT02898259|449687710|FG004|Overall Study|Lack of Efficacy|0|||
125017107|NCT02898259|449687706|FG000|Overall Study|Lost to Follow-up|0|||
125017108|NCT02898259|449687707|FG001|Overall Study|Lost to Follow-up|0|||
125017109|NCT02898259|449687708|FG002|Overall Study|Lost to Follow-up|1|||
124890647|NCT03077620|449220504|FG002|Overall Study|Physician Decision|1|||
124890648|NCT03077620|449220505|FG003|Overall Study|Physician Decision|0|||
124890649|NCT03225846|449220506|FG000|Overall Study|Adverse Event|0|||
124890650|NCT03225846|449220507|FG001|Overall Study|Adverse Event|0|||
124890651|NCT03225846|449220508|FG002|Overall Study|Adverse Event|0|||
124890652|NCT03225846|449220509|FG003|Overall Study|Adverse Event|0|||
124890653|NCT03225846|449220510|FG004|Overall Study|Adverse Event|0|||
124890654|NCT03225846|449220511|FG005|Overall Study|Adverse Event|0|||
124890655|NCT03225846|449220512|FG006|Overall Study|Adverse Event|6|||
124890656|NCT03225846|449220506|FG000|Overall Study|Withdrawal by Subject|0|||
124890657|NCT03225846|449220507|FG001|Overall Study|Withdrawal by Subject|1|||
124890658|NCT03225846|449220508|FG002|Overall Study|Withdrawal by Subject|0|||
124890659|NCT03225846|449220509|FG003|Overall Study|Withdrawal by Subject|0|||
124890660|NCT03225846|449220510|FG004|Overall Study|Withdrawal by Subject|0|||
124890661|NCT03225846|449220511|FG005|Overall Study|Withdrawal by Subject|0|||
124890662|NCT03225846|449220512|FG006|Overall Study|Withdrawal by Subject|0|||
124890663|NCT03225846|449220506|FG000|Overall Study|Death|0|||
124890664|NCT03225846|449220507|FG001|Overall Study|Death|1|||
124890665|NCT03225846|449220508|FG002|Overall Study|Death|0|||
124890666|NCT03225846|449220509|FG003|Overall Study|Death|0|||
124890667|NCT03225846|449220510|FG004|Overall Study|Death|0|||
124890668|NCT03225846|449220511|FG005|Overall Study|Death|0|||
124890669|NCT03225846|449220512|FG006|Overall Study|Death|0|||
124890670|NCT03225846|449220506|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
124890671|NCT03225846|449220507|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
124890672|NCT03225846|449220508|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
124890673|NCT03225846|449220509|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
124890674|NCT03225846|449220510|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
124890675|NCT03225846|449220511|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
124890676|NCT03225846|449220512|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
124890677|NCT03225846|449220506|FG000|Overall Study|Patient decision|0|||
124890678|NCT03225846|449220507|FG001|Overall Study|Patient decision|0|||
124890679|NCT03225846|449220508|FG002|Overall Study|Patient decision|0|||
124890680|NCT03225846|449220509|FG003|Overall Study|Patient decision|0|||
124890681|NCT03225846|449220510|FG004|Overall Study|Patient decision|0|||
125107037|NCT02748616|450015586|FG000|Overall Study|Physician Decision|2|||
125107038|NCT02748616|450015586|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
125107039|NCT00589693|450015587|FG000|Overall Study|randomized in error|12|||
125107040|NCT00589693|450015588|FG001|Overall Study|randomized in error|6|||
125107041|NCT00589693|450015587|FG000|Overall Study|Adverse Event|4|||
125107042|NCT00589693|450015588|FG001|Overall Study|Adverse Event|4|||
125107043|NCT00589693|450015587|FG000|Overall Study|Death|26|||
125107044|NCT00589693|450015588|FG001|Overall Study|Death|16|||
125107045|NCT00589693|450015587|FG000|Overall Study|Lack of Efficacy|0|||
125107046|NCT00589693|450015588|FG001|Overall Study|Lack of Efficacy|1|||
125107047|NCT00589693|450015587|FG000|Overall Study|Lost to Follow-up|1|||
125107048|NCT00589693|450015588|FG001|Overall Study|Lost to Follow-up|0|||
125107049|NCT00589693|450015587|FG000|Overall Study|Physician Decision|0|||
125107050|NCT00589693|450015588|FG001|Overall Study|Physician Decision|1|||
125107051|NCT00589693|450015587|FG000|Overall Study|Protocol Violation|1|||
125107052|NCT00589693|450015588|FG001|Overall Study|Protocol Violation|1|||
125107053|NCT01682512|450015589|FG000|Overall Study|Adverse Event|6|||
125107054|NCT01682512|450015590|FG001|Overall Study|Adverse Event|5|||
125107055|NCT01682512|450015591|FG002|Overall Study|Adverse Event|2|||
125107056|NCT01682512|450015589|FG000|Overall Study|Withdrawal by Subject|2|||
125107057|NCT01682512|450015590|FG001|Overall Study|Withdrawal by Subject|6|||
125107058|NCT01682512|450015591|FG002|Overall Study|Withdrawal by Subject|3|||
125107059|NCT01682512|450015589|FG000|Overall Study|Physician Decision|0|||
125107060|NCT01682512|450015590|FG001|Overall Study|Physician Decision|2|||
125107061|NCT01682512|450015591|FG002|Overall Study|Physician Decision|0|||
124890682|NCT03225846|449220511|FG005|Overall Study|Patient decision|0|||
124890683|NCT03225846|449220512|FG006|Overall Study|Patient decision|1|||
124890684|NCT00238420|449220513|FG000|Overall Study|Protocol Violation|1|||
124890685|NCT00238420|449220514|FG001|Overall Study|Protocol Violation|1|||
124890686|NCT02102464|449220517|FG000|Randomized Study|Withdrawal by Subject|0|||
124890687|NCT02102464|449220518|FG001|Randomized Study|Withdrawal by Subject|1|||
124890688|NCT02102464|449220519|FG002|Randomized Study|Withdrawal by Subject|0|||
125107062|NCT01682512|450015589|FG000|Overall Study|Study terminated by sponsor|46|||
125107063|NCT01682512|450015590|FG001|Overall Study|Study terminated by sponsor|43|||
125107064|NCT01682512|450015591|FG002|Overall Study|Study terminated by sponsor|0|||
124890689|NCT04140890|449220520|FG000|Overall Study|Withdrawal by Subject|0|||
124890690|NCT04140890|449220521|FG001|Overall Study|Withdrawal by Subject|1|||
124890691|NCT03958630|449220522|FG000|Overall Study|Withdrawal by Subject|0|||
124890692|NCT03958630|449220523|FG001|Overall Study|Withdrawal by Subject|0|||
124890693|NCT03958630|449220524|FG002|Overall Study|Withdrawal by Subject|1|||
124890694|NCT03958630|449220522|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
124890695|NCT03958630|449220523|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
124890696|NCT03958630|449220524|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
124890697|NCT00245011|449220527|FG000|Overall Study|Lack of Efficacy|1|||
124890698|NCT03040687|449220528|FG000|Overall Study|Withdrawal by Subject|1|||
124890699|NCT03040687|449220529|FG001|Overall Study|Withdrawal by Subject|0|||
124890700|NCT03040687|449220530|FG002|Overall Study|Withdrawal by Subject|0|||
124890701|NCT02325713|449220537|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890702|NCT02325713|449220538|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890703|NCT02325713|449220539|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890704|NCT02325713|449220540|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890705|NCT02325713|449220541|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890706|NCT02325713|449220542|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890707|NCT02325713|449220543|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890708|NCT02325713|449220544|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890709|NCT02325713|449220545|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890710|NCT02325713|449220546|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890711|NCT02325713|449220547|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
124890712|NCT02325713|449220548|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890713|NCT02325713|449220549|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890714|NCT02325713|449220550|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890715|NCT02325713|449220551|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890716|NCT02325713|449220552|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890717|NCT02325713|449220537|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
124890718|NCT02325713|449220538|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890719|NCT02325713|449220539|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890720|NCT02325713|449220540|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890721|NCT02325713|449220541|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890722|NCT02325713|449220542|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890723|NCT02325713|449220543|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890724|NCT02325713|449220544|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890725|NCT02325713|449220545|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890726|NCT02325713|449220546|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890727|NCT02325713|449220547|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890728|NCT02325713|449220548|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890729|NCT02325713|449220549|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890730|NCT02325713|449220550|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890731|NCT02325713|449220551|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890732|NCT02325713|449220552|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890733|NCT02325713|449220537|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890734|NCT02325713|449220538|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890735|NCT02325713|449220539|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890736|NCT02325713|449220540|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890737|NCT02325713|449220541|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890738|NCT02325713|449220542|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890739|NCT02325713|449220543|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890740|NCT02325713|449220544|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890741|NCT02325713|449220545|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890742|NCT02325713|449220546|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
124890743|NCT02325713|449220547|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
125017110|NCT02898259|449687709|FG003|Overall Study|Lost to Follow-up|0|||
125017111|NCT02898259|449687710|FG004|Overall Study|Lost to Follow-up|0|||
125017112|NCT02898259|449687706|FG000|Overall Study|Transformation before study began|0|||
125017113|NCT02898259|449687707|FG001|Overall Study|Transformation before study began|0|||
125017114|NCT02898259|449687708|FG002|Overall Study|Transformation before study began|0|||
125017115|NCT02898259|449687709|FG003|Overall Study|Transformation before study began|1|||
125017116|NCT02898259|449687710|FG004|Overall Study|Transformation before study began|0|||
125017117|NCT03016325|449687711|FG000|Treatment Period|Participant withdrew consent|0|||
125017118|NCT03016325|449687712|FG001|Treatment Period|Participant withdrew consent|1|||
125107065|NCT01682512|450015589|FG000|Overall Study|Lost to Follow-up|3|||
125107066|NCT01682512|450015590|FG001|Overall Study|Lost to Follow-up|0|||
125017119|NCT03016325|449687713|FG002|Treatment Period|Participant withdrew consent|0|||
125017120|NCT03016325|449687714|FG003|Treatment Period|Participant withdrew consent|0|||
124890744|NCT02325713|449220548|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890745|NCT02325713|449220549|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890746|NCT02325713|449220550|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890747|NCT02325713|449220551|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890748|NCT02325713|449220552|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890749|NCT02353832|449220553|FG000|Overall Study|Ineligible after enrollment|1|||
124890750|NCT02353832|449220553|FG000|Overall Study|Lost to Follow-up|1|||
124890751|NCT00322868|449222545|FG000|Overall Study|disease progression|1|||
124890752|NCT00795132|449222555|FG000|Overall Study|Death|1|||
124890753|NCT00795132|449222555|FG000|Overall Study|Relapse|2|||
124890754|NCT01536262|449222556|FG000|Overall Study|Adverse Event|6|||
124890755|NCT01536262|449222557|FG001|Overall Study|Adverse Event|1|||
124890756|NCT01536262|449222558|FG002|Overall Study|Adverse Event|2|||
124890757|NCT01536262|449222556|FG000|Overall Study|Withdrawal by Subject|1|||
124890758|NCT01536262|449222557|FG001|Overall Study|Withdrawal by Subject|1|||
124890759|NCT01536262|449222558|FG002|Overall Study|Withdrawal by Subject|0|||
124890760|NCT01536262|449222556|FG000|Overall Study|Other than stated above|1|||
124890761|NCT01536262|449222557|FG001|Overall Study|Other than stated above|0|||
124890762|NCT01536262|449222558|FG002|Overall Study|Other than stated above|0|||
124890763|NCT01781611|449222562|FG000|Overall Study|Adverse Event|4|||
124890764|NCT01781611|449222563|FG001|Overall Study|Adverse Event|0|||
124890765|NCT03639675|449222564|FG000|Overall Study|Withdrawal by Subject|1|||
124890766|NCT02459587|449222565|FG000|3-Month Follow-up Assessment|Death|0|||
124890767|NCT02459587|449222566|FG001|3-Month Follow-up Assessment|Death|2|||
124890768|NCT02459587|449222565|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
124890769|NCT02459587|449222566|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
124890770|NCT02459587|449222565|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
124890771|NCT02459587|449222566|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
124890772|NCT02459587|449222565|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
124890773|NCT02459587|449222566|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
124890774|NCT02459587|449222565|FG000|6-month Follow-up Assessment|Death|2|||
124890775|NCT02459587|449222566|FG001|6-month Follow-up Assessment|Death|1|||
124890776|NCT02459587|449222565|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
124890777|NCT02459587|449222566|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
124890778|NCT02459587|449222565|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
124890779|NCT02459587|449222566|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
124890780|NCT02459587|449222565|FG000|12-month Follow-up Assessment|Death|2|||
124890781|NCT02459587|449222566|FG001|12-month Follow-up Assessment|Death|0|||
124890782|NCT02459587|449222565|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
124890783|NCT02459587|449222566|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
124890784|NCT02459587|449222565|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
124890785|NCT02459587|449222566|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
124890786|NCT02459587|449222565|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
124890787|NCT02459587|449222566|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
124890788|NCT02264574|449222567|FG000|Overall Study|Death|21|||
124890789|NCT02264574|449222568|FG001|Overall Study|Death|21|||
124890790|NCT02264574|449222567|FG000|Overall Study|Withdrawal by Subject|8|||
124890791|NCT02264574|449222568|FG001|Overall Study|Withdrawal by Subject|6|||
124890792|NCT02264574|449222567|FG000|Overall Study|Other, Not Specified|0|||
124890793|NCT02264574|449222568|FG001|Overall Study|Other, Not Specified|3|||
124890794|NCT01477749|449222570|FG000|Overall Study|Physician Decision|4|||
124890795|NCT02886728|449222573|FG000|Overall Study|Withdrew Consent|31|||
124890796|NCT02886728|449222574|FG001|Overall Study|Withdrew Consent|13|||
124890797|NCT02886728|449222575|FG002|Overall Study|Withdrew Consent|11|||
124890798|NCT02886728|449222576|FG003|Overall Study|Withdrew Consent|47|||
124890799|NCT02886728|449222573|FG000|Overall Study|Lost to Follow-up|12|||
124890800|NCT02886728|449222574|FG001|Overall Study|Lost to Follow-up|6|||
125107067|NCT01682512|450015591|FG002|Overall Study|Lost to Follow-up|2|||
125107068|NCT01682512|450015589|FG000|Overall Study|Protocol Violation|2|||
125107069|NCT01682512|450015590|FG001|Overall Study|Protocol Violation|3|||
125107070|NCT01682512|450015591|FG002|Overall Study|Protocol Violation|2|||
125107071|NCT01682512|450015589|FG000|Overall Study|Primary lack of efficacy|10|||
125107072|NCT01682512|450015590|FG001|Overall Study|Primary lack of efficacy|7|||
125107073|NCT01682512|450015591|FG002|Overall Study|Primary lack of efficacy|7|||
125107074|NCT01682512|450015589|FG000|Overall Study|Secondary lack of efficacy|1|||
125107075|NCT01682512|450015590|FG001|Overall Study|Secondary lack of efficacy|1|||
124890801|NCT02886728|449222575|FG002|Overall Study|Lost to Follow-up|13|||
124890802|NCT02886728|449222576|FG003|Overall Study|Lost to Follow-up|12|||
124890803|NCT02886728|449222573|FG000|Overall Study|Adverse Event|13|||
124890804|NCT02886728|449222574|FG001|Overall Study|Adverse Event|5|||
124890805|NCT02886728|449222575|FG002|Overall Study|Adverse Event|5|||
124890806|NCT02886728|449222576|FG003|Overall Study|Adverse Event|11|||
124890807|NCT02886728|449222573|FG000|Overall Study|Investigator's Discretion|11|||
124890808|NCT02886728|449222574|FG001|Overall Study|Investigator's Discretion|7|||
125107076|NCT01682512|450015591|FG002|Overall Study|Secondary lack of efficacy|0|||
124890809|NCT02886728|449222575|FG002|Overall Study|Investigator's Discretion|5|||
124890810|NCT02886728|449222576|FG003|Overall Study|Investigator's Discretion|11|||
124890811|NCT02886728|449222573|FG000|Overall Study|Death|3|||
124890812|NCT02886728|449222574|FG001|Overall Study|Death|1|||
124890813|NCT02886728|449222575|FG002|Overall Study|Death|0|||
124890814|NCT02886728|449222576|FG003|Overall Study|Death|0|||
124890815|NCT02886728|449222573|FG000|Overall Study|Protocol Violation|0|||
124890816|NCT02886728|449222574|FG001|Overall Study|Protocol Violation|0|||
124890817|NCT02886728|449222575|FG002|Overall Study|Protocol Violation|0|||
124890818|NCT02886728|449222576|FG003|Overall Study|Protocol Violation|4|||
124890819|NCT02886728|449222573|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124890820|NCT02886728|449222574|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124890821|NCT02886728|449222575|FG002|Overall Study|Non-Compliance with Study Drug|1|||
124890822|NCT02886728|449222576|FG003|Overall Study|Non-Compliance with Study Drug|0|||
124890823|NCT02886728|449222573|FG000|Overall Study|Pregnancy|0|||
124890824|NCT02886728|449222574|FG001|Overall Study|Pregnancy|0|||
124890825|NCT02886728|449222575|FG002|Overall Study|Pregnancy|1|||
124890826|NCT02886728|449222576|FG003|Overall Study|Pregnancy|0|||
124890827|NCT02886728|449222573|FG000|Overall Study|Randomized but Not Dosed|1|||
124890828|NCT02886728|449222574|FG001|Overall Study|Randomized but Not Dosed|0|||
124890829|NCT02886728|449222575|FG002|Overall Study|Randomized but Not Dosed|0|||
124890830|NCT02886728|449222576|FG003|Overall Study|Randomized but Not Dosed|2|||
124890831|NCT00884286|449222577|FG000|Overall Study|Progressive disease|21|||
124890832|NCT00884286|449222578|FG001|Overall Study|Progressive disease|28|||
124890833|NCT00884286|449222577|FG000|Overall Study|Toxicity|4|||
124890834|NCT00884286|449222578|FG001|Overall Study|Toxicity|1|||
124890835|NCT00884286|449222577|FG000|Overall Study|Death|2|||
124890836|NCT00884286|449222578|FG001|Overall Study|Death|2|||
124890837|NCT00884286|449222577|FG000|Overall Study|Physician Decision|1|||
124890838|NCT00884286|449222578|FG001|Overall Study|Physician Decision|0|||
124890839|NCT00884286|449222577|FG000|Overall Study|Septic shock|1|||
124890840|NCT00884286|449222578|FG001|Overall Study|Septic shock|0|||
124890841|NCT00884286|449222577|FG000|Overall Study|Thrombus in right auricle|1|||
124890842|NCT00884286|449222578|FG001|Overall Study|Thrombus in right auricle|0|||
124890843|NCT00884286|449222577|FG000|Overall Study|Not treated|2|||
124890844|NCT00884286|449222578|FG001|Overall Study|Not treated|1|||
124890845|NCT00884286|449222577|FG000|Overall Study|Comprised lung carcinoma|0|||
124890846|NCT00884286|449222578|FG001|Overall Study|Comprised lung carcinoma|1|||
124890847|NCT02118714|449222582|FG000|Overall Study|Lost to Follow-up|2|||
124890848|NCT02118714|449222582|FG000|Overall Study|Protocol Violation|1|||
124890849|NCT01310868|449222583|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
124890850|NCT02411591|449222584|FG000|Overall Study|Adverse Event|0|||
124890851|NCT02411591|449222585|FG001|Overall Study|Adverse Event|4|||
124890852|NCT02411591|449222586|FG002|Overall Study|Adverse Event|2|||
124890853|NCT02411591|449222584|FG000|Overall Study|Withdrawal by Subject|0|||
124890854|NCT02411591|449222585|FG001|Overall Study|Withdrawal by Subject|3|||
124890855|NCT02411591|449222586|FG002|Overall Study|Withdrawal by Subject|0|||
124890856|NCT02411591|449222584|FG000|Overall Study|Physician Decision|0|||
124890857|NCT02411591|449222585|FG001|Overall Study|Physician Decision|3|||
124890858|NCT02411591|449222586|FG002|Overall Study|Physician Decision|1|||
124890859|NCT04227340|449222587|FG000|Overall Study|Withdrawal by Subject|3|||
124890860|NCT01628874|449222588|FG000|Overall Study|Physician Decision|1|||
125017121|NCT03016325|449687715|FG004|Treatment Period|Participant withdrew consent|0|||
125017122|NCT03016325|449687716|FG005|Treatment Period|Participant withdrew consent|0|||
125017123|NCT03016325|449687717|FG006|Treatment Period|Participant withdrew consent|0|||
125017124|NCT03016325|449687718|FG007|Treatment Period|Participant withdrew consent|0|||
125017125|NCT03016325|449687711|FG000|Treatment Period|Death|0|||
125017126|NCT03016325|449687712|FG001|Treatment Period|Death|0|||
125017127|NCT03016325|449687713|FG002|Treatment Period|Death|0|||
125017128|NCT03016325|449687714|FG003|Treatment Period|Death|0|||
125017129|NCT03016325|449687715|FG004|Treatment Period|Death|2|||
124890861|NCT01628874|449222589|FG001|Overall Study|Physician Decision|1|||
124890862|NCT01628874|449222588|FG000|Overall Study|Age >4 months|4|||
125017130|NCT03016325|449687716|FG005|Treatment Period|Death|0|||
125017131|NCT03016325|449687717|FG006|Treatment Period|Death|0|||
125017132|NCT03016325|449687718|FG007|Treatment Period|Death|0|||
124890863|NCT01628874|449222589|FG001|Overall Study|Age >4 months|2|||
124890864|NCT03018106|449222590|FG000|Overall Study|Lost to Follow-up|0|||
124890865|NCT03018106|449222591|FG001|Overall Study|Lost to Follow-up|1|||
124890866|NCT03619174|449222592|FG000|Overall Study|Lost to Follow-up|3|||
124890867|NCT03619174|449222593|FG001|Overall Study|Lost to Follow-up|0|||
124890868|NCT03619174|449222592|FG000|Overall Study|Withdrawal by Subject|4|||
124890869|NCT03619174|449222593|FG001|Overall Study|Withdrawal by Subject|3|||
124890870|NCT03619174|449222592|FG000|Overall Study|Pregnancy|1|||
124890871|NCT03619174|449222593|FG001|Overall Study|Pregnancy|1|||
124890872|NCT03619174|449222592|FG000|Overall Study|Discomfort during treatment|1|||
124890873|NCT03619174|449222593|FG001|Overall Study|Discomfort during treatment|0|||
124890874|NCT03486899|449222594|FG000|Overall Study|Lost to Follow-up|4|||
124890875|NCT03486899|449222595|FG001|Overall Study|Lost to Follow-up|1|||
124890876|NCT03486899|449222596|FG002|Overall Study|Lost to Follow-up|4|||
124890877|NCT03486899|449222597|FG003|Overall Study|Lost to Follow-up|3|||
124890878|NCT03486899|449222594|FG000|Overall Study|Death|1|||
124890879|NCT03486899|449222595|FG001|Overall Study|Death|0|||
124890880|NCT03486899|449222596|FG002|Overall Study|Death|0|||
124890881|NCT03486899|449222597|FG003|Overall Study|Death|1|||
124890882|NCT03486899|449222594|FG000|Overall Study|Adverse Event|0|||
124890883|NCT03486899|449222595|FG001|Overall Study|Adverse Event|2|||
124890884|NCT03486899|449222596|FG002|Overall Study|Adverse Event|0|||
124890885|NCT03486899|449222597|FG003|Overall Study|Adverse Event|2|||
124890886|NCT03486899|449222594|FG000|Overall Study|Withdrawal by Subject|3|||
124890887|NCT03486899|449222595|FG001|Overall Study|Withdrawal by Subject|7|||
124890888|NCT03486899|449222596|FG002|Overall Study|Withdrawal by Subject|4|||
124890889|NCT03486899|449222597|FG003|Overall Study|Withdrawal by Subject|3|||
124890890|NCT03486899|449222594|FG000|Overall Study|Other Reasons|0|||
124890891|NCT03486899|449222595|FG001|Overall Study|Other Reasons|1|||
124890892|NCT03486899|449222596|FG002|Overall Study|Other Reasons|0|||
124890893|NCT03486899|449222597|FG003|Overall Study|Other Reasons|1|||
124890894|NCT01010217|449222598|FG000|Overall Study|Lost to Follow-up|4|||
124890895|NCT01010217|449222599|FG001|Overall Study|Lost to Follow-up|5|||
124890896|NCT01010217|449222600|FG002|Overall Study|Lost to Follow-up|1|||
124890897|NCT01010217|449222601|FG003|Overall Study|Lost to Follow-up|0|||
124890898|NCT01010217|449222602|FG004|Overall Study|Lost to Follow-up|0|||
124890899|NCT01010217|449222598|FG000|Overall Study|Withdrawal by Subject|1|||
124890900|NCT01010217|449222599|FG001|Overall Study|Withdrawal by Subject|0|||
124890901|NCT01010217|449222600|FG002|Overall Study|Withdrawal by Subject|0|||
124890902|NCT01010217|449222601|FG003|Overall Study|Withdrawal by Subject|0|||
124890903|NCT01010217|449222602|FG004|Overall Study|Withdrawal by Subject|0|||
124890904|NCT01010217|449222598|FG000|Overall Study|Physician Decision|0|||
124890905|NCT01010217|449222599|FG001|Overall Study|Physician Decision|0|||
124890906|NCT01010217|449222600|FG002|Overall Study|Physician Decision|0|||
124890907|NCT01010217|449222601|FG003|Overall Study|Physician Decision|6|||
124890908|NCT01010217|449222602|FG004|Overall Study|Physician Decision|3|||
124890909|NCT01782326|449222604|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
124890910|NCT01782326|449222605|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
124890911|NCT01782326|449222604|FG000|Planned Treatment Epoch|Death|29|||
124890912|NCT01782326|449222605|FG001|Planned Treatment Epoch|Death|30|||
124890913|NCT01782326|449222604|FG000|Planned Treatment Epoch|Physician Decision|18|||
124890914|NCT01782326|449222605|FG001|Planned Treatment Epoch|Physician Decision|16|||
124890915|NCT01782326|449222604|FG000|Planned Treatment Epoch|Protocol deviation|2|||
124890916|NCT01782326|449222605|FG001|Planned Treatment Epoch|Protocol deviation|3|||
124890917|NCT01782326|449222604|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
124890918|NCT01782326|449222605|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
124890919|NCT01782326|449222604|FG000|Planned Treatment Epoch|Technical problems|0|||
124890920|NCT01782326|449222605|FG001|Planned Treatment Epoch|Technical problems|4|||
124890921|NCT01782326|449222604|FG000|Double-blind Treatment|Adverse Event|129|||
124890922|NCT01782326|449222605|FG001|Double-blind Treatment|Adverse Event|145|||
124890923|NCT01782326|449222604|FG000|Double-blind Treatment|Subject/guardian decision|111|||
124890924|NCT01782326|449222605|FG001|Double-blind Treatment|Subject/guardian decision|125|||
124890925|NCT01782326|449222604|FG000|Double-blind Treatment|Lack of Efficacy|17|||
124890926|NCT01782326|449222605|FG001|Double-blind Treatment|Lack of Efficacy|22|||
124890927|NCT01782326|449222604|FG000|Double-blind Treatment|Physician Decision|13|||
124890928|NCT01782326|449222605|FG001|Double-blind Treatment|Physician Decision|16|||
124890929|NCT01782326|449222604|FG000|Double-blind Treatment|Protocol deviation|8|||
124890930|NCT01782326|449222605|FG001|Double-blind Treatment|Protocol deviation|7|||
124890931|NCT01782326|449222604|FG000|Double-blind Treatment|Technical problems|0|||
124890932|NCT01782326|449222605|FG001|Double-blind Treatment|Technical problems|5|||
124890933|NCT00738530|449222618|FG000|Overall Study|Death|220|||
124890934|NCT00738530|449222619|FG001|Overall Study|Death|224|||
124890935|NCT00738530|449222618|FG000|Overall Study|Lost to Follow-up|8|||
124890936|NCT00738530|449222619|FG001|Overall Study|Lost to Follow-up|6|||
124890937|NCT00738530|449222618|FG000|Overall Study|Withdrawal by Subject|6|||
124890938|NCT00738530|449222619|FG001|Overall Study|Withdrawal by Subject|8|||
124890939|NCT01628510|449222620|FG000|Overall Study|Withdrawal by Subject|0|||
124890940|NCT01628510|449222621|FG001|Overall Study|Withdrawal by Subject|4|||
124890941|NCT01628510|449222620|FG000|Overall Study|Death|3|||
124890942|NCT01628510|449222621|FG001|Overall Study|Death|1|||
124890943|NCT01653847|449222622|FG000|Overall Study|Withdrawal by Subject|1|||
124890944|NCT01653847|449222623|FG001|Overall Study|Withdrawal by Subject|0|||
124890945|NCT04707391|449222624|FG000|Overall Study|Adverse Event|5|||
124890946|NCT04707391|449222625|FG001|Overall Study|Adverse Event|8|||
124890947|NCT04707391|449222624|FG000|Overall Study|Lost to Follow-up|44|||
124890948|NCT04707391|449222625|FG001|Overall Study|Lost to Follow-up|31|||
124890949|NCT04707391|449222624|FG000|Overall Study|Protocol Violation|1|||
124890950|NCT04707391|449222625|FG001|Overall Study|Protocol Violation|5|||
124890951|NCT04707391|449222624|FG000|Overall Study|Withdrawal by Subject|27|||
124890952|NCT04707391|449222625|FG001|Overall Study|Withdrawal by Subject|25|||
124890953|NCT04707391|449222624|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
124890954|NCT04707391|449222625|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
124890955|NCT04707391|449222624|FG000|Overall Study|Other|0|||
124890956|NCT04707391|449222625|FG001|Overall Study|Other|2|||
124890957|NCT03246672|449222626|FG000|Overall Study|Lost to Follow-up|2|||
124890958|NCT01347645|449222627|FG000|Overall Study|Death|1|||
124890959|NCT01347645|449222628|FG001|Overall Study|Death|5|||
124890960|NCT01347645|449222629|FG002|Overall Study|Death|2|||
124890961|NCT01347645|449222630|FG003|Overall Study|Death|7|||
124890962|NCT01347645|449222631|FG004|Overall Study|Death|7|||
124890963|NCT01347645|449222627|FG000|Overall Study|Lost to Follow-up|1|||
124890964|NCT01347645|449222628|FG001|Overall Study|Lost to Follow-up|1|||
124890965|NCT01347645|449222629|FG002|Overall Study|Lost to Follow-up|0|||
124890966|NCT01347645|449222630|FG003|Overall Study|Lost to Follow-up|1|||
124890967|NCT01347645|449222631|FG004|Overall Study|Lost to Follow-up|1|||
124890968|NCT01347645|449222627|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
124890969|NCT01347645|449222628|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
124890970|NCT01347645|449222629|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
124890971|NCT01347645|449222630|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
124890972|NCT01347645|449222631|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
124890973|NCT01347645|449222627|FG000|Overall Study|Other|1|||
124890974|NCT01347645|449222628|FG001|Overall Study|Other|0|||
124890975|NCT01347645|449222629|FG002|Overall Study|Other|0|||
124890976|NCT01347645|449222630|FG003|Overall Study|Other|0|||
124890977|NCT01347645|449222631|FG004|Overall Study|Other|1|||
124890978|NCT01347645|449222627|FG000|Overall Study|Withdrawal by Subject|0|||
124890979|NCT01347645|449222628|FG001|Overall Study|Withdrawal by Subject|0|||
124890980|NCT01347645|449222629|FG002|Overall Study|Withdrawal by Subject|0|||
124890981|NCT01347645|449222630|FG003|Overall Study|Withdrawal by Subject|3|||
124890982|NCT01347645|449222631|FG004|Overall Study|Withdrawal by Subject|3|||
124890983|NCT01347645|449222627|FG000|Overall Study|Physician Decision|0|||
124890984|NCT01347645|449222628|FG001|Overall Study|Physician Decision|0|||
124890985|NCT01347645|449222629|FG002|Overall Study|Physician Decision|0|||
124890986|NCT01347645|449222630|FG003|Overall Study|Physician Decision|0|||
124890987|NCT01347645|449222631|FG004|Overall Study|Physician Decision|1|||
124890988|NCT01347645|449222627|FG000|Overall Study|Adverse Event|0|||
124890989|NCT01347645|449222628|FG001|Overall Study|Adverse Event|0|||
124890990|NCT01347645|449222629|FG002|Overall Study|Adverse Event|0|||
124890991|NCT01347645|449222630|FG003|Overall Study|Adverse Event|1|||
124890992|NCT01347645|449222631|FG004|Overall Study|Adverse Event|1|||
124890993|NCT01163149|449222633|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
124890994|NCT01163149|449222634|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
124890995|NCT01163149|449222635|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
124890996|NCT01163149|449222633|FG000|Extension Treatment Period|Adverse Event|0|||
124890997|NCT01163149|449222634|FG001|Extension Treatment Period|Adverse Event|1|||
124890998|NCT01163149|449222635|FG002|Extension Treatment Period|Adverse Event|0|||
124890999|NCT01163149|449222633|FG000|Extension Treatment Period|Noncompliance|0|||
124891000|NCT01163149|449222634|FG001|Extension Treatment Period|Noncompliance|0|||
124891001|NCT01163149|449222635|FG002|Extension Treatment Period|Noncompliance|1|||
124891002|NCT01923428|449222644|FG000|Overall Study|Adverse Event|8|||
124891003|NCT01923428|449222645|FG001|Overall Study|Adverse Event|6|||
124891004|NCT01923428|449222646|FG002|Overall Study|Adverse Event|3|||
124891005|NCT01923428|449222647|FG003|Overall Study|Adverse Event|3|||
124891006|NCT01923428|449222644|FG000|Overall Study|Withdrawal by Subject|5|||
124891007|NCT01923428|449222645|FG001|Overall Study|Withdrawal by Subject|3|||
124891008|NCT01923428|449222646|FG002|Overall Study|Withdrawal by Subject|0|||
125107077|NCT01682512|450015589|FG000|Overall Study|Other than stated above|2|||
125107078|NCT01682512|450015590|FG001|Overall Study|Other than stated above|4|||
125107079|NCT01682512|450015591|FG002|Overall Study|Other than stated above|2|||
125107080|NCT00054275|450015592|FG000|Overall Study|Withdrawal by Subject|4|||
124891009|NCT01923428|449222647|FG003|Overall Study|Withdrawal by Subject|4|||
124891010|NCT01923428|449222644|FG000|Overall Study|Lost to Follow-up|2|||
124891011|NCT01923428|449222645|FG001|Overall Study|Lost to Follow-up|1|||
124891012|NCT01923428|449222646|FG002|Overall Study|Lost to Follow-up|5|||
125107081|NCT00054275|450015592|FG000|Overall Study|Adverse Event|5|||
124891013|NCT01923428|449222647|FG003|Overall Study|Lost to Follow-up|0|||
124891014|NCT01923428|449222644|FG000|Overall Study|Protocol Violation|3|||
124891015|NCT01923428|449222645|FG001|Overall Study|Protocol Violation|0|||
124891016|NCT01923428|449222646|FG002|Overall Study|Protocol Violation|2|||
124891017|NCT01923428|449222647|FG003|Overall Study|Protocol Violation|1|||
124891018|NCT01923428|449222644|FG000|Overall Study|Non Compliance to treatment|1|||
124891019|NCT01923428|449222645|FG001|Overall Study|Non Compliance to treatment|2|||
124891020|NCT01923428|449222646|FG002|Overall Study|Non Compliance to treatment|0|||
124891021|NCT01923428|449222647|FG003|Overall Study|Non Compliance to treatment|1|||
124891022|NCT01923428|449222644|FG000|Overall Study|Lack of Efficacy|0|||
124891023|NCT01923428|449222645|FG001|Overall Study|Lack of Efficacy|0|||
124891024|NCT01923428|449222646|FG002|Overall Study|Lack of Efficacy|1|||
124891025|NCT01923428|449222647|FG003|Overall Study|Lack of Efficacy|1|||
124891026|NCT02550873|449222648|FG000|Randomized Double Blind|Adverse Event|3|||
124891027|NCT02550873|449222649|FG001|Randomized Double Blind|Adverse Event|1|||
124891028|NCT02550873|449222650|FG002|Randomized Double Blind|Adverse Event|0|||
124891029|NCT02550873|449222648|FG000|Randomized Double Blind|Disease progression|1|||
124891030|NCT02550873|449222649|FG001|Randomized Double Blind|Disease progression|1|||
124891031|NCT02550873|449222650|FG002|Randomized Double Blind|Disease progression|0|||
124891032|NCT02550873|449222648|FG000|Open Label Extension|Study ongoing|0|||
124891033|NCT02550873|449222649|FG001|Open Label Extension|Study ongoing|0|||
124891034|NCT02550873|449222650|FG002|Open Label Extension|Study ongoing|111|||
124891035|NCT01822353|449222651|FG000|Overall Study|Adverse Event|1|||
124891036|NCT01822353|449222652|FG001|Overall Study|Adverse Event|3|||
124891037|NCT01822353|449222653|FG002|Overall Study|Adverse Event|1|||
124891038|NCT01822353|449222651|FG000|Overall Study|Pregnancy|0|||
124891039|NCT01822353|449222652|FG001|Overall Study|Pregnancy|1|||
124891040|NCT01822353|449222653|FG002|Overall Study|Pregnancy|0|||
124891041|NCT01822353|449222651|FG000|Overall Study|Withdrawal by Subject|3|||
124891042|NCT01822353|449222652|FG001|Overall Study|Withdrawal by Subject|1|||
124891043|NCT01822353|449222653|FG002|Overall Study|Withdrawal by Subject|0|||
124891044|NCT04320615|449222654|FG000|Overall Study|Withdrawal by Subject|4|||
124891045|NCT04320615|449222655|FG001|Overall Study|Withdrawal by Subject|10|||
124891046|NCT04320615|449222654|FG000|Overall Study|Physician Decision|2|||
124891047|NCT04320615|449222655|FG001|Overall Study|Physician Decision|0|||
124891048|NCT04320615|449222654|FG000|Overall Study|Other|2|||
124891049|NCT04320615|449222655|FG001|Overall Study|Other|0|||
124891050|NCT04320615|449222654|FG000|Overall Study|Lost to Follow-up|5|||
124891051|NCT04320615|449222655|FG001|Overall Study|Lost to Follow-up|23|||
124891052|NCT04320615|449222654|FG000|Overall Study|Death|35|||
124891053|NCT04320615|449222655|FG001|Overall Study|Death|71|||
124891054|NCT01449721|449222656|FG000|Overall Study|Physician Decision|0|||
124891055|NCT01449721|449222657|FG001|Overall Study|Physician Decision|1|||
124891056|NCT01449721|449222656|FG000|Overall Study|Physician Decision|0|||
124891057|NCT01449721|449222657|FG001|Overall Study|Physician Decision|1|||
124891058|NCT00885495|449222658|FG000|Overall Study|Adverse Event|1|||
124891059|NCT00885495|449222659|FG001|Overall Study|Adverse Event|2|||
124891060|NCT00885495|449222658|FG000|Overall Study|Protocol Violation|0|||
124891061|NCT00885495|449222659|FG001|Overall Study|Protocol Violation|1|||
124891062|NCT00885495|449222658|FG000|Overall Study|Withdrawal by Subject|1|||
124891063|NCT00885495|449222659|FG001|Overall Study|Withdrawal by Subject|0|||
124891064|NCT01400893|449222660|FG000|Overall Study|Death|27|||
124891065|NCT01400893|449222661|FG001|Overall Study|Death|21|||
124891066|NCT01400893|449222660|FG000|Overall Study|Lost to Follow-up|0|||
124891067|NCT01400893|449222661|FG001|Overall Study|Lost to Follow-up|6|||
124891068|NCT02320721|449222670|FG000|Overall Study|Adverse Event|6|||
124891069|NCT02320721|449222671|FG001|Overall Study|Adverse Event|6|||
124891070|NCT02320721|449222670|FG000|Overall Study|Lack of Efficacy|2|||
124891071|NCT02320721|449222671|FG001|Overall Study|Lack of Efficacy|0|||
124891072|NCT02320721|449222670|FG000|Overall Study|Poor compliance to protocol|3|||
124891073|NCT02320721|449222671|FG001|Overall Study|Poor compliance to protocol|7|||
124891074|NCT02320721|449222670|FG000|Overall Study|Randomized but not treated|0|||
124891075|NCT02320721|449222671|FG001|Overall Study|Randomized but not treated|1|||
124891076|NCT02320721|449222670|FG000|Overall Study|Hypoglycemia|1|||
124891077|NCT02320721|449222671|FG001|Overall Study|Hypoglycemia|0|||
124891078|NCT02320721|449222670|FG000|Overall Study|Other than specified above|15|||
124891079|NCT02320721|449222671|FG001|Overall Study|Other than specified above|20|||
124891080|NCT04630756|449222672|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
124891081|NCT04630756|449222673|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
124891082|NCT04630756|449222674|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
124891083|NCT00847301|449222675|FG000|Overall Study|Adverse Event|35|||
124891084|NCT00847301|449222675|FG000|Overall Study|Switch to other anticoagulants|16|||
124891085|NCT00847301|449222675|FG000|Overall Study|Lost to Follow-up|1|||
124891086|NCT00847301|449222675|FG000|Overall Study|No prescription after hospital discharge|1|||
124891087|NCT00847301|449222675|FG000|Overall Study|Other reason not defined above|1|||
124891088|NCT00996580|449222676|FG000|Overall Study|Adverse Event|466|||
124891089|NCT00996580|449222676|FG000|Overall Study|Lost to Follow-up|480|||
124891090|NCT00996580|449222676|FG000|Overall Study|Noncompliance with the protocol|137|||
124891091|NCT00996580|449222676|FG000|Overall Study|Physician Decision|5|||
124891092|NCT00996580|449222676|FG000|Overall Study|Pregnancy|68|||
124891093|NCT00996580|449222676|FG000|Overall Study|Protocol Violation|16|||
124891094|NCT00996580|449222676|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
124891095|NCT00996580|449222676|FG000|Overall Study|Withdrawal by Subject|217|||
124891096|NCT00996580|449222676|FG000|Overall Study|Other|29|||
124891097|NCT02036515|449222677|FG000|Overall Study|Adverse Event|1|||
124891098|NCT02036515|449222678|FG001|Overall Study|Adverse Event|1|||
124891099|NCT02036515|449222679|FG002|Overall Study|Adverse Event|2|||
124891100|NCT02036515|449222677|FG000|Overall Study|Lost to Follow-up|0|||
124891101|NCT02036515|449222678|FG001|Overall Study|Lost to Follow-up|2|||
124891102|NCT02036515|449222679|FG002|Overall Study|Lost to Follow-up|0|||
124891103|NCT02036515|449222677|FG000|Overall Study|Non-compliance with study drug|0|||
124891104|NCT02036515|449222678|FG001|Overall Study|Non-compliance with study drug|0|||
124891105|NCT02036515|449222679|FG002|Overall Study|Non-compliance with study drug|2|||
124891106|NCT02036515|449222677|FG000|Overall Study|Screen failure|0|||
124891107|NCT02036515|449222678|FG001|Overall Study|Screen failure|2|||
124891108|NCT02036515|449222679|FG002|Overall Study|Screen failure|0|||
124891109|NCT02036515|449222677|FG000|Overall Study|Withdrawal by Subject|4|||
124891110|NCT02036515|449222678|FG001|Overall Study|Withdrawal by Subject|7|||
124891111|NCT02036515|449222679|FG002|Overall Study|Withdrawal by Subject|9|||
124891112|NCT02036515|449222677|FG000|Overall Study|Hyperglycemia|0|||
124891113|NCT02036515|449222678|FG001|Overall Study|Hyperglycemia|0|||
124891114|NCT02036515|449222679|FG002|Overall Study|Hyperglycemia|1|||
124891115|NCT03621982|449222680|FG000|Overall Study|Withdrawal by Subject|1|||
124891116|NCT03621982|449222681|FG001|Overall Study|Withdrawal by Subject|0|||
124891117|NCT03621982|449222682|FG002|Overall Study|Withdrawal by Subject|0|||
124891118|NCT03621982|449222683|FG003|Overall Study|Withdrawal by Subject|1|||
124891119|NCT03621982|449222684|FG004|Overall Study|Withdrawal by Subject|0|||
124891120|NCT03621982|449222685|FG005|Overall Study|Withdrawal by Subject|1|||
124891121|NCT03621982|449222686|FG006|Overall Study|Withdrawal by Subject|1|||
124891122|NCT03621982|449222687|FG007|Overall Study|Withdrawal by Subject|0|||
124891123|NCT03621982|449222688|FG008|Overall Study|Withdrawal by Subject|1|||
124891124|NCT03621982|449222689|FG009|Overall Study|Withdrawal by Subject|0|||
124891125|NCT03621982|449222690|FG010|Overall Study|Withdrawal by Subject|2|||
124891126|NCT03621982|449222691|FG011|Overall Study|Withdrawal by Subject|1|||
124891127|NCT03621982|449222692|FG012|Overall Study|Withdrawal by Subject|2|||
124891128|NCT03621982|449222693|FG013|Overall Study|Withdrawal by Subject|2|||
124891129|NCT03621982|449222680|FG000|Overall Study|Investigator/Sponsor decision|0|||
124891130|NCT03621982|449222681|FG001|Overall Study|Investigator/Sponsor decision|0|||
124891131|NCT03621982|449222682|FG002|Overall Study|Investigator/Sponsor decision|0|||
124891132|NCT03621982|449222683|FG003|Overall Study|Investigator/Sponsor decision|0|||
124891133|NCT03621982|449222684|FG004|Overall Study|Investigator/Sponsor decision|0|||
124891134|NCT03621982|449222685|FG005|Overall Study|Investigator/Sponsor decision|0|||
124891135|NCT03621982|449222686|FG006|Overall Study|Investigator/Sponsor decision|0|||
124891136|NCT03621982|449222687|FG007|Overall Study|Investigator/Sponsor decision|0|||
124891137|NCT03621982|449222688|FG008|Overall Study|Investigator/Sponsor decision|0|||
124891138|NCT03621982|449222689|FG009|Overall Study|Investigator/Sponsor decision|0|||
124891139|NCT03621982|449222690|FG010|Overall Study|Investigator/Sponsor decision|0|||
124891140|NCT03621982|449222691|FG011|Overall Study|Investigator/Sponsor decision|4|||
124891141|NCT03621982|449222692|FG012|Overall Study|Investigator/Sponsor decision|0|||
124891142|NCT03621982|449222693|FG013|Overall Study|Investigator/Sponsor decision|2|||
124891143|NCT03621982|449222680|FG000|Overall Study|Death|2|||
124891144|NCT03621982|449222681|FG001|Overall Study|Death|4|||
124891145|NCT03621982|449222682|FG002|Overall Study|Death|4|||
124891146|NCT03621982|449222683|FG003|Overall Study|Death|3|||
124891147|NCT03621982|449222684|FG004|Overall Study|Death|8|||
124891148|NCT03621982|449222685|FG005|Overall Study|Death|4|||
124891149|NCT03621982|449222686|FG006|Overall Study|Death|6|||
124891150|NCT03621982|449222687|FG007|Overall Study|Death|3|||
124891151|NCT03621982|449222688|FG008|Overall Study|Death|0|||
124891152|NCT03621982|449222689|FG009|Overall Study|Death|3|||
124891153|NCT03621982|449222690|FG010|Overall Study|Death|8|||
124891154|NCT03621982|449222691|FG011|Overall Study|Death|4|||
124891155|NCT03621982|449222692|FG012|Overall Study|Death|2|||
124891156|NCT03621982|449222693|FG013|Overall Study|Death|2|||
124891157|NCT03621982|449222680|FG000|Overall Study|Lost to Follow-up|0|||
124891158|NCT03621982|449222681|FG001|Overall Study|Lost to Follow-up|0|||
124891159|NCT03621982|449222682|FG002|Overall Study|Lost to Follow-up|1|||
125017133|NCT03016325|449687711|FG000|Treatment Period|Participant refuses assessments|0|||
124891160|NCT03621982|449222683|FG003|Overall Study|Lost to Follow-up|0|||
124891161|NCT03621982|449222684|FG004|Overall Study|Lost to Follow-up|0|||
125017134|NCT03016325|449687712|FG001|Treatment Period|Participant refuses assessments|0|||
125017135|NCT03016325|449687713|FG002|Treatment Period|Participant refuses assessments|1|||
124891162|NCT03621982|449222685|FG005|Overall Study|Lost to Follow-up|0|||
124891163|NCT03621982|449222686|FG006|Overall Study|Lost to Follow-up|1|||
125017136|NCT03016325|449687714|FG003|Treatment Period|Participant refuses assessments|0|||
124891164|NCT03621982|449222687|FG007|Overall Study|Lost to Follow-up|0|||
124891165|NCT03621982|449222688|FG008|Overall Study|Lost to Follow-up|0|||
124891166|NCT03621982|449222689|FG009|Overall Study|Lost to Follow-up|1|||
124891167|NCT03621982|449222690|FG010|Overall Study|Lost to Follow-up|0|||
124891168|NCT03621982|449222691|FG011|Overall Study|Lost to Follow-up|0|||
124891169|NCT03621982|449222692|FG012|Overall Study|Lost to Follow-up|0|||
124891170|NCT03621982|449222693|FG013|Overall Study|Lost to Follow-up|0|||
124891171|NCT01544582|449222696|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
124891172|NCT01544582|449222697|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
124891173|NCT01544582|449222698|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
124891174|NCT01544582|449222699|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
124891175|NCT01544582|449222696|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
124891176|NCT01544582|449222697|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
124891177|NCT01544582|449222698|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
124891178|NCT01544582|449222699|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
124891179|NCT01544582|449222696|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
124891180|NCT01544582|449222697|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
124891181|NCT01544582|449222698|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
124891182|NCT01544582|449222699|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
124891183|NCT01544582|449222696|FG000|Analysis Population|Physician Decision|0|||
124891184|NCT01544582|449222697|FG001|Analysis Population|Physician Decision|13|||
124891185|NCT01544582|449222698|FG002|Analysis Population|Physician Decision|10|||
124891186|NCT01544582|449222699|FG003|Analysis Population|Physician Decision|9|||
124891187|NCT01544582|449222696|FG000|Analysis Population|Safety Reason|0|||
124891188|NCT01544582|449222697|FG001|Analysis Population|Safety Reason|33|||
124891189|NCT01544582|449222698|FG002|Analysis Population|Safety Reason|31|||
124891190|NCT01544582|449222699|FG003|Analysis Population|Safety Reason|8|||
124891191|NCT01544582|449222696|FG000|Analysis Population|Effectiveness Reason|0|||
124891192|NCT01544582|449222697|FG001|Analysis Population|Effectiveness Reason|48|||
124891193|NCT01544582|449222698|FG002|Analysis Population|Effectiveness Reason|29|||
124891194|NCT01544582|449222699|FG003|Analysis Population|Effectiveness Reason|12|||
124891195|NCT01544582|449222696|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
124891196|NCT01544582|449222697|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
124891197|NCT01544582|449222698|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
124891198|NCT01544582|449222699|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
124891199|NCT01544582|449222696|FG000|Analysis Population|Lost to Follow-up|0|||
124891200|NCT01544582|449222697|FG001|Analysis Population|Lost to Follow-up|6|||
124891201|NCT01544582|449222698|FG002|Analysis Population|Lost to Follow-up|6|||
124891202|NCT01544582|449222699|FG003|Analysis Population|Lost to Follow-up|5|||
124891203|NCT01544582|449222696|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
124891204|NCT01544582|449222697|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
124891205|NCT01544582|449222698|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
124891206|NCT01544582|449222699|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
124891207|NCT01544582|449222696|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
124891208|NCT01544582|449222697|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
124891209|NCT01544582|449222698|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
124891210|NCT01544582|449222699|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
124891211|NCT01544582|449222696|FG000|Analysis Population|Intolerance|0|||
124891212|NCT01544582|449222697|FG001|Analysis Population|Intolerance|1|||
124891213|NCT01544582|449222698|FG002|Analysis Population|Intolerance|0|||
124891214|NCT01544582|449222699|FG003|Analysis Population|Intolerance|0|||
124891215|NCT01544582|449222696|FG000|Analysis Population|Liver Transplantation|0|||
124891216|NCT01544582|449222697|FG001|Analysis Population|Liver Transplantation|0|||
124891217|NCT01544582|449222698|FG002|Analysis Population|Liver Transplantation|1|||
124891218|NCT01544582|449222699|FG003|Analysis Population|Liver Transplantation|0|||
124891219|NCT01544582|449222696|FG000|Analysis Population|No Social Insurance|0|||
124891220|NCT01544582|449222697|FG001|Analysis Population|No Social Insurance|0|||
124891221|NCT01544582|449222698|FG002|Analysis Population|No Social Insurance|1|||
124891222|NCT01544582|449222699|FG003|Analysis Population|No Social Insurance|0|||
124891223|NCT01544582|449222696|FG000|Analysis Population|Poor Adherence|0|||
124891224|NCT01544582|449222697|FG001|Analysis Population|Poor Adherence|0|||
124891225|NCT01544582|449222698|FG002|Analysis Population|Poor Adherence|1|||
124891226|NCT01544582|449222699|FG003|Analysis Population|Poor Adherence|0|||
125017137|NCT03016325|449687715|FG004|Treatment Period|Participant refuses assessments|0|||
125017138|NCT03016325|449687716|FG005|Treatment Period|Participant refuses assessments|0|||
124891227|NCT01544582|449222696|FG000|Analysis Population|Poor Participant Compliance|0|||
124891228|NCT01544582|449222697|FG001|Analysis Population|Poor Participant Compliance|1|||
124891229|NCT01544582|449222698|FG002|Analysis Population|Poor Participant Compliance|0|||
124891230|NCT01544582|449222699|FG003|Analysis Population|Poor Participant Compliance|0|||
124891231|NCT01544582|449222696|FG000|Analysis Population|Programmed Surgery|0|||
124891232|NCT01544582|449222697|FG001|Analysis Population|Programmed Surgery|1|||
124891233|NCT01544582|449222698|FG002|Analysis Population|Programmed Surgery|0|||
124891234|NCT01544582|449222699|FG003|Analysis Population|Programmed Surgery|0|||
124891235|NCT01544582|449222696|FG000|Analysis Population|Participant in Jail|0|||
124891236|NCT01544582|449222697|FG001|Analysis Population|Participant in Jail|0|||
124891237|NCT01544582|449222698|FG002|Analysis Population|Participant in Jail|1|||
124891238|NCT01544582|449222699|FG003|Analysis Population|Participant in Jail|0|||
124891239|NCT03317379|449222704|FG000|Overall Study|Lost to Follow-up|0|||
124891240|NCT03317379|449222705|FG001|Overall Study|Lost to Follow-up|3|||
124891241|NCT03317379|449222706|FG002|Overall Study|Lost to Follow-up|2|||
124891242|NCT04445155|449222707|FG000|Overall Study|Lost to Follow-up|11|||
124891243|NCT04445155|449222708|FG001|Overall Study|Lost to Follow-up|2|||
124891244|NCT04445155|449222709|FG002|Overall Study|Lost to Follow-up|3|||
124891245|NCT04445155|449222710|FG003|Overall Study|Lost to Follow-up|0|||
124891246|NCT04445155|449222707|FG000|Overall Study|Withdrawal by Subject|8|||
124891247|NCT04445155|449222708|FG001|Overall Study|Withdrawal by Subject|0|||
124891248|NCT04445155|449222709|FG002|Overall Study|Withdrawal by Subject|0|||
124891249|NCT04445155|449222710|FG003|Overall Study|Withdrawal by Subject|0|||
124891250|NCT04445155|449222707|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
124891251|NCT04445155|449222708|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
124891252|NCT04445155|449222709|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
124891253|NCT04445155|449222710|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
124891254|NCT04445155|449222707|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
124891255|NCT04445155|449222708|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
124891256|NCT04445155|449222709|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
124891257|NCT04445155|449222710|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
124891258|NCT00550173|449222711|FG000|Overall Study|Death|45|||
124891259|NCT00550173|449222712|FG001|Overall Study|Death|38|||
124891260|NCT00550173|449222713|FG002|Overall Study|Death|50|||
124891261|NCT00550173|449222711|FG000|Overall Study|Physician Decision|1|||
124891262|NCT00550173|449222712|FG001|Overall Study|Physician Decision|2|||
124891263|NCT00550173|449222713|FG002|Overall Study|Physician Decision|2|||
124891264|NCT00550173|449222711|FG000|Overall Study|Withdrawal by Subject|9|||
124891265|NCT00550173|449222712|FG001|Overall Study|Withdrawal by Subject|12|||
124891266|NCT00550173|449222713|FG002|Overall Study|Withdrawal by Subject|17|||
125107082|NCT00054275|450015592|FG000|Overall Study|Progressive disease in cycle 1|1|||
125107083|NCT00054275|450015592|FG000|Overall Study|Physician Decision|1|||
125107084|NCT02030834|450015600|FG000|Overall Study|Death|4|||
125107085|NCT02030834|450015601|FG001|Overall Study|Death|0|||
125107086|NCT02030834|450015602|FG002|Overall Study|Death|0|||
124891267|NCT00550173|449222711|FG000|Overall Study|Sponsor Decision|13|||
125107087|NCT02030834|450015600|FG000|Overall Study|Manufacturing failure|2|||
125107088|NCT02030834|450015601|FG001|Overall Study|Manufacturing failure|0|||
125107089|NCT02030834|450015602|FG002|Overall Study|Manufacturing failure|1|||
125107090|NCT02030834|450015600|FG000|Overall Study|Disease progression|2|||
125107091|NCT02030834|450015601|FG001|Overall Study|Disease progression|0|||
125107092|NCT02030834|450015602|FG002|Overall Study|Disease progression|2|||
125107093|NCT02030834|450015600|FG000|Overall Study|Lost to Follow-up|1|||
125107094|NCT02030834|450015601|FG001|Overall Study|Lost to Follow-up|0|||
125107095|NCT02030834|450015602|FG002|Overall Study|Lost to Follow-up|0|||
125107096|NCT02030834|450015600|FG000|Overall Study|Withdrawal by Subject|1|||
125107097|NCT02030834|450015601|FG001|Overall Study|Withdrawal by Subject|0|||
125107098|NCT02030834|450015602|FG002|Overall Study|Withdrawal by Subject|0|||
125107099|NCT02030834|450015600|FG000|Overall Study|Lack of funding|1|||
125107100|NCT02030834|450015601|FG001|Overall Study|Lack of funding|0|||
125107101|NCT02030834|450015602|FG002|Overall Study|Lack of funding|0|||
125107102|NCT04333199|450015607|FG000|Evaluated Patients|Lost to Follow-up|0|||
125107103|NCT04333199|450015608|FG001|Evaluated Patients|Lost to Follow-up|1|||
125107104|NCT04333199|450015609|FG002|Evaluated Patients|Lost to Follow-up|2|||
125107105|NCT01155284|450015618|FG000|Overall Study|Withdrawal by Subject|4|||
124891268|NCT00550173|449222712|FG001|Overall Study|Sponsor Decision|7|||
124891269|NCT00550173|449222713|FG002|Overall Study|Sponsor Decision|1|||
125107106|NCT01155284|450015619|FG001|Overall Study|Withdrawal by Subject|3|||
125107107|NCT01155284|450015618|FG000|Overall Study|Lost to Follow-up|1|||
125107108|NCT01155284|450015619|FG001|Overall Study|Lost to Follow-up|2|||
125107109|NCT01155284|450015618|FG000|Overall Study|Physician Decision|1|||
124891270|NCT00550173|449222711|FG000|Overall Study|Lost to Follow-up|4|||
124891271|NCT00550173|449222712|FG001|Overall Study|Lost to Follow-up|4|||
124891272|NCT00550173|449222713|FG002|Overall Study|Lost to Follow-up|3|||
125107110|NCT01155284|450015619|FG001|Overall Study|Physician Decision|0|||
125107111|NCT01155284|450015618|FG000|Overall Study|Adverse Event|1|||
125107112|NCT01155284|450015619|FG001|Overall Study|Adverse Event|0|||
125107113|NCT01766310|450015620|FG000|Overall Study|Lost to Follow-up|1|||
125107114|NCT01766310|450015621|FG001|Overall Study|Lost to Follow-up|3|||
125107115|NCT01556490|450015630|FG000|Randomized Patients Summary|Protocol Violation|22|||
124891273|NCT01556243|449222714|FG000|Overall Study|Ineligible|34|||
124891274|NCT01556243|449222714|FG000|Overall Study|Converted to mastectomy|14|||
124891275|NCT01556243|449222714|FG000|Overall Study|Unable to achieve negative margins|2|||
124891276|NCT01556243|449222714|FG000|Overall Study|Withdrawal by Subject|16|||
124891277|NCT01388543|449222715|FG000|Day 14|Adverse Event|1|||
124891278|NCT01388543|449222716|FG001|Day 14|Adverse Event|4|||
124891279|NCT01213173|449222718|FG000|Overall Study|Protocol Violation|2|||
124891280|NCT01213173|449222719|FG001|Overall Study|Protocol Violation|0|||
124891281|NCT01213173|449222718|FG000|Overall Study|Adverse Event|4|||
124891282|NCT01213173|449222719|FG001|Overall Study|Adverse Event|8|||
124891283|NCT01213173|449222718|FG000|Overall Study|Withdrawal by Subject|5|||
124891284|NCT01213173|449222719|FG001|Overall Study|Withdrawal by Subject|5|||
124891285|NCT01213173|449222718|FG000|Overall Study|Incorrect Enrollment|1|||
124891286|NCT01213173|449222719|FG001|Overall Study|Incorrect Enrollment|3|||
124891287|NCT04880161|449222722|FG000|Overall Study|Withdrawal by Subject|1|||
124891288|NCT04880161|449222723|FG001|Overall Study|Withdrawal by Subject|0|||
124891289|NCT04880161|449222722|FG000|Overall Study|Lack of Compliance|1|||
124891290|NCT04880161|449222723|FG001|Overall Study|Lack of Compliance|1|||
124891291|NCT04880161|449222722|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
124891292|NCT04880161|449222723|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
124891293|NCT04880161|449222722|FG000|Overall Study|Screen Failure|0|||
124891294|NCT04880161|449222723|FG001|Overall Study|Screen Failure|1|||
124891295|NCT01354106|449222724|FG000|Overall Study|Withdrawal by Subject|2|||
124891296|NCT00731042|449224316|FG000|Second Intervention|Did not meet inclusion criteria|0|||
124891297|NCT00731042|449224317|FG001|Second Intervention|Did not meet inclusion criteria|2|||
124891298|NCT02692235|449224318|FG000|Overall Study|Withdrawal by Subject|2|||
124891299|NCT02692235|449224319|FG001|Overall Study|Withdrawal by Subject|1|||
124891300|NCT02692235|449224318|FG000|Overall Study|Adverse Event|1|||
124891301|NCT02692235|449224319|FG001|Overall Study|Adverse Event|2|||
124891302|NCT00802841|449224320|FG000|Overall Study|Administrative problems|1|||
124891303|NCT00802841|449224321|FG001|Overall Study|Administrative problems|0|||
124891304|NCT00802841|449224320|FG000|Overall Study|Lost to Follow-up|2|||
124891305|NCT00802841|449224321|FG001|Overall Study|Lost to Follow-up|1|||
124891306|NCT00802841|449224320|FG000|Overall Study|Death|1|||
124891307|NCT00802841|449224321|FG001|Overall Study|Death|2|||
124891308|NCT00802841|449224320|FG000|Overall Study|Adverse Event|8|||
124891309|NCT00802841|449224321|FG001|Overall Study|Adverse Event|2|||
124891310|NCT00802841|449224320|FG000|Overall Study|Disease progression|7|||
124891311|NCT00802841|449224321|FG001|Overall Study|Disease progression|3|||
124891312|NCT00802841|449224320|FG000|Overall Study|Withdrawal by Subject|9|||
124891313|NCT00802841|449224321|FG001|Overall Study|Withdrawal by Subject|5|||
124891314|NCT00802841|449224320|FG000|Overall Study|Protocol deviation|2|||
124891315|NCT00802841|449224321|FG001|Overall Study|Protocol deviation|6|||
124891316|NCT00802841|449224320|FG000|Overall Study|Treatment duration completed|66|||
124891317|NCT00802841|449224321|FG001|Overall Study|Treatment duration completed|76|||
124891318|NCT02711995|449224324|FG000|Washout (90 Days)|Conflicting medication|1|||
124891319|NCT00107380|449224328|FG000|Overall Study|Adverse Event|7|||
124891320|NCT00107380|449224328|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
124891321|NCT00107380|449224328|FG000|Overall Study|Progression/relapse|4|||
124891322|NCT00107380|449224328|FG000|Overall Study|Death|3|||
124891323|NCT00107380|449224328|FG000|Overall Study|Other - not protocol specified|7|||
124891324|NCT00107380|449224328|FG000|Overall Study|Ineligible|2|||
124891325|NCT03673098|449224329|FG000|Overall Study|Lost to Follow-up|2|||
124891326|NCT03673098|449224330|FG001|Overall Study|Lost to Follow-up|3|||
125107116|NCT01556490|450015631|FG001|Randomized Patients Summary|Protocol Violation|23|||
125107117|NCT01556490|450015630|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
125107118|NCT01556490|450015631|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
125107119|NCT04529499|450015637|FG000|Overall Study|Withdrawal by Subject|9|||
125107120|NCT04529499|450015638|FG001|Overall Study|Withdrawal by Subject|11|||
125107121|NCT04529499|450015637|FG000|Overall Study|Physician Decision|1|||
125107122|NCT04529499|450015638|FG001|Overall Study|Physician Decision|2|||
125107123|NCT04529499|450015637|FG000|Overall Study|Adverse Event|4|||
125107124|NCT04529499|450015638|FG001|Overall Study|Adverse Event|4|||
124891327|NCT03673098|449224329|FG000|Overall Study|Withdrawal by Subject|6|||
124891328|NCT03673098|449224330|FG001|Overall Study|Withdrawal by Subject|1|||
125107125|NCT04529499|450015637|FG000|Overall Study|Death|14|||
125107126|NCT04529499|450015638|FG001|Overall Study|Death|11|||
124891329|NCT03673098|449224329|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
124891330|NCT03673098|449224330|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
124891331|NCT03531905|449224335|FG000|Overall Study|Withdrawal by Subject|3|||
124891332|NCT03531905|449224336|FG001|Overall Study|Withdrawal by Subject|3|||
124891333|NCT03531905|449224337|FG002|Overall Study|Withdrawal by Subject|2|||
125107127|NCT04529499|450015637|FG000|Overall Study|Lost to Follow-up|1|||
125107128|NCT04529499|450015638|FG001|Overall Study|Lost to Follow-up|1|||
125107129|NCT04529499|450015637|FG000|Overall Study|Others|7|||
124891334|NCT03531905|449224335|FG000|Overall Study|Lost to Follow-up|2|||
124891335|NCT03531905|449224336|FG001|Overall Study|Lost to Follow-up|2|||
124891336|NCT03531905|449224337|FG002|Overall Study|Lost to Follow-up|1|||
124891337|NCT03531905|449224335|FG000|Overall Study|Participant was out of town|1|||
124891338|NCT03531905|449224336|FG001|Overall Study|Participant was out of town|0|||
124891339|NCT03531905|449224337|FG002|Overall Study|Participant was out of town|0|||
124891340|NCT03531905|449224335|FG000|Overall Study|Could not speak with the participant|1|||
124891341|NCT03531905|449224336|FG001|Overall Study|Could not speak with the participant|0|||
124891342|NCT03531905|449224337|FG002|Overall Study|Could not speak with the participant|0|||
124891343|NCT01155726|449224338|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
124891344|NCT01155726|449224339|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
124891345|NCT01155726|449224340|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
124891346|NCT01155726|449224341|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
124891347|NCT02724020|449224346|FG000|Overall Study|Death|16|||
124891348|NCT02724020|449224347|FG001|Overall Study|Death|18|||
124891349|NCT02724020|449224348|FG002|Overall Study|Death|19|||
124891350|NCT02724020|449224346|FG000|Overall Study|Lost to Follow-up|0|||
124891351|NCT02724020|449224347|FG001|Overall Study|Lost to Follow-up|3|||
124891352|NCT02724020|449224348|FG002|Overall Study|Lost to Follow-up|0|||
124891353|NCT02724020|449224346|FG000|Overall Study|Site Terminated by Sponsor|15|||
124891354|NCT02724020|449224347|FG001|Overall Study|Site Terminated by Sponsor|8|||
124891355|NCT02724020|449224348|FG002|Overall Study|Site Terminated by Sponsor|8|||
124891356|NCT02724020|449224346|FG000|Overall Study|Withdrawal by Subject|1|||
124891357|NCT02724020|449224347|FG001|Overall Study|Withdrawal by Subject|3|||
124891358|NCT02724020|449224348|FG002|Overall Study|Withdrawal by Subject|5|||
124891359|NCT00425503|449224349|FG000|Overall Study|Adverse Event|2|||
124891360|NCT00425503|449224349|FG000|Overall Study|Protocol Violation|1|||
124891361|NCT00688259|449224350|FG000|Overall Study|Lost to Follow-up|2|||
124891362|NCT00688259|449224351|FG001|Overall Study|Lost to Follow-up|4|||
124891363|NCT00688259|449224350|FG000|Overall Study|Physician Decision|1|||
124891364|NCT00688259|449224351|FG001|Overall Study|Physician Decision|0|||
124891365|NCT00688259|449224350|FG000|Overall Study|Withdrawal by Subject|2|||
124891366|NCT00688259|449224351|FG001|Overall Study|Withdrawal by Subject|0|||
124891367|NCT00688259|449224350|FG000|Overall Study|Declined Interview|2|||
124891368|NCT00688259|449224351|FG001|Overall Study|Declined Interview|3|||
124891369|NCT00688259|449224350|FG000|Overall Study|Hospitalized at Follow-up|0|||
124891370|NCT00688259|449224351|FG001|Overall Study|Hospitalized at Follow-up|1|||
124891371|NCT02954575|449224352|FG000|Overall Study|Withdrawal by Subject|2|||
124891372|NCT02954575|449224352|FG000|Overall Study|Adverse Event|1|||
124891373|NCT02491892|449224354|FG000|Overall Study|Adverse Event|1|||
124891374|NCT02491892|449224355|FG001|Overall Study|Adverse Event|1|||
124891375|NCT02491892|449224354|FG000|Overall Study|Death|1|||
124891376|NCT02491892|449224355|FG001|Overall Study|Death|1|||
124891377|NCT02491892|449224354|FG000|Overall Study|Lack of Efficacy|37|||
124891378|NCT02491892|449224355|FG001|Overall Study|Lack of Efficacy|36|||
124891379|NCT02491892|449224354|FG000|Overall Study|Refused Treatment|1|||
124891380|NCT02491892|449224355|FG001|Overall Study|Refused Treatment|0|||
124891381|NCT02491892|449224354|FG000|Overall Study|Lost to Follow-up|1|||
124891382|NCT02491892|449224355|FG001|Overall Study|Lost to Follow-up|0|||
124891383|NCT01066156|449224356|FG000|Overall Study|ineligible|2|||
124891384|NCT01066156|449224356|FG000|Overall Study|Lost to Follow-up|7|||
124891385|NCT01066156|449224356|FG000|Overall Study|Withdrawal by Subject|1|||
124891386|NCT01734382|449224360|FG000|Part 1|Adverse Event|2|||
124891387|NCT01734382|449224361|FG001|Part 1|Adverse Event|0|||
124891388|NCT01734382|449224362|FG002|Part 1|Adverse Event|0|||
124891389|NCT01734382|449224360|FG000|Part 2|Adverse Event|0|||
124891390|NCT01734382|449224361|FG001|Part 2|Adverse Event|0|||
124891391|NCT01734382|449224362|FG002|Part 2|Adverse Event|1|||
124891392|NCT01734382|449224360|FG000|Part 2|Lack of Efficacy|0|||
124891393|NCT01734382|449224361|FG001|Part 2|Lack of Efficacy|1|||
124891394|NCT01734382|449224362|FG002|Part 2|Lack of Efficacy|1|||
124891395|NCT01734382|449224360|FG000|Part 2|Other|0|||
124891396|NCT01734382|449224361|FG001|Part 2|Other|0|||
124891397|NCT01734382|449224362|FG002|Part 2|Other|1|||
124891398|NCT01734382|449224360|FG000|Part 2|Physician Decision|0|||
124891399|NCT01734382|449224361|FG001|Part 2|Physician Decision|0|||
124891400|NCT01734382|449224362|FG002|Part 2|Physician Decision|3|||
124891401|NCT01734382|449224360|FG000|Part 2|Protocol Violation|0|||
124891402|NCT01734382|449224361|FG001|Part 2|Protocol Violation|1|||
124891403|NCT01734382|449224362|FG002|Part 2|Protocol Violation|0|||
124891404|NCT01734382|449224360|FG000|Part 2|Withdrawal by Subject|0|||
124891405|NCT01734382|449224361|FG001|Part 2|Withdrawal by Subject|0|||
124891406|NCT01734382|449224362|FG002|Part 2|Withdrawal by Subject|1|||
124891407|NCT00661258|449224370|FG000|Overall Study|Death|1|||
124891408|NCT00661258|449224371|FG001|Overall Study|Death|0|||
124891409|NCT00661258|449224370|FG000|Overall Study|caught by police and in detox center|2|||
124891410|NCT00661258|449224371|FG001|Overall Study|caught by police and in detox center|1|||
124891411|NCT03890120|449224372|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
124891412|NCT03890120|449224373|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
124891413|NCT03890120|449224374|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
124891414|NCT03890120|449224375|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
124891415|NCT03890120|449224372|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
124891416|NCT03890120|449224373|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
124891417|NCT03890120|449224374|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
124891418|NCT03890120|449224375|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
124891419|NCT03890120|449224372|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
124891420|NCT03890120|449224373|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
124891421|NCT03890120|449224374|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
124891422|NCT03890120|449224375|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
124891423|NCT03890120|449224372|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
124891424|NCT03890120|449224373|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
124891425|NCT03890120|449224374|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
124891426|NCT03890120|449224375|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
124891427|NCT03890120|449224372|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
124891428|NCT03890120|449224373|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
124891429|NCT03890120|449224374|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
124891430|NCT03890120|449224375|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
124891431|NCT03890120|449224372|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
124891432|NCT03890120|449224373|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
124891433|NCT03890120|449224374|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
124891434|NCT03890120|449224375|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
124891435|NCT03890120|449224372|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
124891436|NCT03890120|449224373|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
124891437|NCT03890120|449224374|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
124891438|NCT03890120|449224375|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
124891439|NCT03890120|449224372|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
124891440|NCT03890120|449224373|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
124891441|NCT03890120|449224374|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
124891442|NCT03890120|449224375|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
124891443|NCT03890120|449224372|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
124891444|NCT03890120|449224373|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
124891445|NCT03890120|449224374|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
124891446|NCT03890120|449224375|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
124891447|NCT03890120|449224372|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
124891448|NCT03890120|449224373|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
124891449|NCT03890120|449224374|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
124891450|NCT03890120|449224375|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
124891451|NCT03890120|449224372|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
124891452|NCT03890120|449224373|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
124891453|NCT03890120|449224374|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
124891454|NCT03890120|449224375|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
124891455|NCT03890120|449224372|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
124891456|NCT03890120|449224373|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
125107130|NCT04529499|450015638|FG001|Overall Study|Others|11|||
125107131|NCT00758706|450015639|FG000|Overall Study|Adverse Event|4|||
125107132|NCT00758706|450015640|FG001|Overall Study|Adverse Event|4|||
125107133|NCT01039584|450015641|FG000|Overall Study|Withdrawal by Subject|4|||
125107134|NCT01039584|450015642|FG001|Overall Study|Withdrawal by Subject|2|||
125107135|NCT01039584|450015643|FG002|Overall Study|Withdrawal by Subject|1|||
125107136|NCT01039584|450015641|FG000|Overall Study|Protocol Violation|10|||
125107137|NCT01039584|450015642|FG001|Overall Study|Protocol Violation|4|||
125107138|NCT01039584|450015643|FG002|Overall Study|Protocol Violation|6|||
124891457|NCT03890120|449224374|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
124891458|NCT03890120|449224375|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
124891459|NCT03890120|449224372|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
124891460|NCT03890120|449224373|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
124891461|NCT03890120|449224374|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
124891462|NCT03890120|449224375|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
124891463|NCT00683449|449224376|FG000|Overall Study|Lost to Follow-up|0|||
124891464|NCT00683449|449224377|FG001|Overall Study|Lost to Follow-up|1|||
124891465|NCT00683449|449224378|FG002|Overall Study|Lost to Follow-up|0|||
124891466|NCT00683449|449224379|FG003|Overall Study|Lost to Follow-up|0|||
124891467|NCT00683449|449224380|FG004|Overall Study|Lost to Follow-up|0|||
124891468|NCT00479674|449224385|FG000|Overall Study|Adverse Event|18|||
124891469|NCT00479674|449224385|FG000|Overall Study|Withdrawal by Subject|6|||
124891470|NCT00479674|449224385|FG000|Overall Study|Physician Decision|14|||
124891471|NCT00479674|449224385|FG000|Overall Study|none provided|3|||
124891472|NCT00146640|449224388|FG000|Overall Study|Adverse Event|12|||
124891473|NCT00146640|449224389|FG001|Overall Study|Adverse Event|10|||
124891474|NCT00146640|449224388|FG000|Overall Study|Medical Reasons|3|||
124891475|NCT00146640|449224389|FG001|Overall Study|Medical Reasons|0|||
124891476|NCT00146640|449224388|FG000|Overall Study|Non-Medical Reasons|8|||
124891477|NCT00146640|449224389|FG001|Overall Study|Non-Medical Reasons|4|||
124891478|NCT02059161|449224392|FG000|Overall Study|Pregnancy|0|||
124891479|NCT02059161|449224393|FG001|Overall Study|Pregnancy|2|||
124891480|NCT02059161|449224392|FG000|Overall Study|Adverse Event|2|||
124891481|NCT02059161|449224393|FG001|Overall Study|Adverse Event|6|||
124891482|NCT02059161|449224392|FG000|Overall Study|Lost to Follow-up|20|||
124891483|NCT02059161|449224393|FG001|Overall Study|Lost to Follow-up|12|||
124891484|NCT02059161|449224392|FG000|Overall Study|Physician Decision|4|||
124891485|NCT02059161|449224393|FG001|Overall Study|Physician Decision|4|||
124891486|NCT02059161|449224392|FG000|Overall Study|Protocol Violation|1|||
124891487|NCT02059161|449224393|FG001|Overall Study|Protocol Violation|1|||
124891488|NCT02059161|449224392|FG000|Overall Study|Withdrawal by Subject|16|||
124891489|NCT02059161|449224393|FG001|Overall Study|Withdrawal by Subject|13|||
124891490|NCT02059161|449224392|FG000|Overall Study|Randomized in error, no study drug|0|||
124891491|NCT02059161|449224393|FG001|Overall Study|Randomized in error, no study drug|1|||
124891492|NCT02059161|449224392|FG000|Overall Study|Non-compliance with study drug|6|||
124891493|NCT02059161|449224393|FG001|Overall Study|Non-compliance with study drug|2|||
124891494|NCT03023332|449224398|FG000|Overall Study|Withdrawal by Subject|10|||
124891495|NCT03023332|449224399|FG001|Overall Study|Withdrawal by Subject|5|||
124891496|NCT03023332|449224400|FG002|Overall Study|Withdrawal by Subject|4|||
124891497|NCT03023332|449224401|FG003|Overall Study|Withdrawal by Subject|7|||
124891498|NCT03023332|449224398|FG000|Overall Study|Lost to Follow-up|13|||
124891499|NCT03023332|449224399|FG001|Overall Study|Lost to Follow-up|16|||
124891500|NCT03023332|449224400|FG002|Overall Study|Lost to Follow-up|8|||
124891501|NCT03023332|449224401|FG003|Overall Study|Lost to Follow-up|13|||
124891502|NCT03023332|449224398|FG000|Overall Study|Death|1|||
124891503|NCT03023332|449224399|FG001|Overall Study|Death|0|||
124891504|NCT03023332|449224400|FG002|Overall Study|Death|0|||
124891505|NCT03023332|449224401|FG003|Overall Study|Death|0|||
124891506|NCT01818700|449224402|FG000|Overall Study|Adverse Event|67|||
124891507|NCT01818700|449224402|FG000|Overall Study|Lack of Efficacy|2|||
124891508|NCT01818700|449224402|FG000|Overall Study|Lost to Follow-up|5|||
124891509|NCT01818700|449224402|FG000|Overall Study|Withdrawal by Subject|27|||
124891510|NCT01818700|449224402|FG000|Overall Study|Protocol Violation|2|||
124891511|NCT01818700|449224402|FG000|Overall Study|Other|1|||
124891512|NCT02408549|449224405|FG000|Overall Study|Adverse Event|15|||
124891513|NCT02408549|449224405|FG000|Overall Study|Death|4|||
124891514|NCT02408549|449224405|FG000|Overall Study|Lack of Efficacy|17|||
124891515|NCT02408549|449224405|FG000|Overall Study|Protocol Violation|4|||
125107139|NCT01039584|450015641|FG000|Overall Study|Lost to Follow-up|5|||
125107140|NCT01039584|450015642|FG001|Overall Study|Lost to Follow-up|3|||
125107141|NCT01039584|450015643|FG002|Overall Study|Lost to Follow-up|4|||
125107142|NCT01039584|450015641|FG000|Overall Study|Negative Baseline culture for Candida|59|||
125107143|NCT01039584|450015642|FG001|Overall Study|Negative Baseline culture for Candida|59|||
125107144|NCT01039584|450015643|FG002|Overall Study|Negative Baseline culture for Candida|24|||
124891516|NCT02408549|449224405|FG000|Overall Study|Lost to Follow-up|6|||
124891517|NCT02408549|449224405|FG000|Overall Study|Consent withdrawn|30|||
125107145|NCT01039584|450015641|FG000|Overall Study|Lack of Efficacy|7|||
125107146|NCT01039584|450015642|FG001|Overall Study|Lack of Efficacy|6|||
124891518|NCT02408549|449224405|FG000|Overall Study|Neurology research program closing at site|1|||
124891519|NCT02408549|449224405|FG000|Overall Study|Site closure|1|||
124891520|NCT02408549|449224405|FG000|Overall Study|Pregnancy|1|||
124891521|NCT02408549|449224405|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
124891522|NCT02408549|449224405|FG000|Overall Study|Subject moved to another place, far from site|1|||
124891523|NCT02408549|449224405|FG000|Overall Study|Study terminated at site|1|||
125107147|NCT01039584|450015643|FG002|Overall Study|Lack of Efficacy|10|||
124891524|NCT01656759|449224406|FG000|Overall Study|Protocol Violation|2|||
124891525|NCT01656759|449224407|FG001|Overall Study|Protocol Violation|3|||
124891526|NCT02687919|449224408|FG000|Overall Study|Withdrawal by Subject|6|||
124891527|NCT02687919|449224409|FG001|Overall Study|Withdrawal by Subject|6|||
124891528|NCT02687919|449224408|FG000|Overall Study|Protocol Violation|2|||
124891529|NCT02687919|449224409|FG001|Overall Study|Protocol Violation|0|||
124891530|NCT01192295|449224410|FG000|Overall Study|Adverse Event|3|||
124891531|NCT01192295|449224411|FG001|Overall Study|Adverse Event|7|||
124891532|NCT01192295|449224410|FG000|Overall Study|Withdrawal by Subject|3|||
124891533|NCT01192295|449224411|FG001|Overall Study|Withdrawal by Subject|4|||
124891534|NCT01192295|449224410|FG000|Overall Study|Lost to Follow-up|0|||
124891535|NCT01192295|449224411|FG001|Overall Study|Lost to Follow-up|1|||
124891536|NCT01192295|449224410|FG000|Overall Study|Lack of Efficacy|0|||
124891537|NCT01192295|449224411|FG001|Overall Study|Lack of Efficacy|5|||
124891538|NCT01192295|449224410|FG000|Overall Study|Administrative|4|||
124891539|NCT01192295|449224411|FG001|Overall Study|Administrative|6|||
124891540|NCT01670500|449224421|FG000|Overall Study|Withdrawal by Subject|1|||
124891541|NCT01670500|449224422|FG001|Overall Study|Withdrawal by Subject|0|||
124891542|NCT03473756|449224423|FG000|Overall Study|Withdrawal by Subject|1|||
124891543|NCT03473756|449224424|FG001|Overall Study|Withdrawal by Subject|4|||
124891544|NCT03473756|449224423|FG000|Overall Study|Adverse Event|6|||
124891545|NCT03473756|449224424|FG001|Overall Study|Adverse Event|7|||
124891546|NCT03473756|449224423|FG000|Overall Study|Lack of Efficacy|3|||
124891547|NCT03473756|449224424|FG001|Overall Study|Lack of Efficacy|10|||
124891548|NCT03473756|449224423|FG000|Overall Study|Physician Decision|0|||
124891549|NCT03473756|449224424|FG001|Overall Study|Physician Decision|2|||
124891550|NCT03473756|449224423|FG000|Overall Study|End of study treatment|0|||
124891551|NCT03473756|449224424|FG001|Overall Study|End of study treatment|2|||
124891552|NCT03473756|449224423|FG000|Overall Study|Lost to Follow-up|0|||
124891553|NCT03473756|449224424|FG001|Overall Study|Lost to Follow-up|1|||
124891554|NCT02148718|449224425|FG000|Overall Study|Protocol Violation|26|||
124891555|NCT02148718|449224425|FG000|Overall Study|Discontinued Study Prematurely|5|||
124891556|NCT00003509|449224426|FG000|Overall Study|Not evaluable|5|||
124891557|NCT02711826|449224427|FG000|Overall Study|Physician Decision|0|||
124891558|NCT02711826|449224428|FG001|Overall Study|Physician Decision|0|||
124891559|NCT02711826|449224429|FG002|Overall Study|Physician Decision|0|||
124891560|NCT02711826|449224430|FG003|Overall Study|Physician Decision|1|||
124891561|NCT02711826|449224431|FG004|Overall Study|Physician Decision|0|||
124891562|NCT02711826|449224427|FG000|Overall Study|Withdrawal by Subject|0|||
124891563|NCT02711826|449224428|FG001|Overall Study|Withdrawal by Subject|1|||
124891564|NCT02711826|449224429|FG002|Overall Study|Withdrawal by Subject|0|||
124891565|NCT02711826|449224430|FG003|Overall Study|Withdrawal by Subject|4|||
124891566|NCT02711826|449224431|FG004|Overall Study|Withdrawal by Subject|0|||
124891567|NCT02711826|449224427|FG000|Overall Study|Failure to manufacture cellular product|0|||
124891568|NCT02711826|449224428|FG001|Overall Study|Failure to manufacture cellular product|0|||
124891569|NCT02711826|449224429|FG002|Overall Study|Failure to manufacture cellular product|5|||
124891570|NCT02711826|449224430|FG003|Overall Study|Failure to manufacture cellular product|0|||
124891571|NCT02711826|449224431|FG004|Overall Study|Failure to manufacture cellular product|0|||
124891572|NCT02711826|449224427|FG000|Overall Study|Infusion canceled for active infection|0|||
124891573|NCT02711826|449224428|FG001|Overall Study|Infusion canceled for active infection|1|||
124891574|NCT02711826|449224429|FG002|Overall Study|Infusion canceled for active infection|0|||
124891575|NCT02711826|449224430|FG003|Overall Study|Infusion canceled for active infection|0|||
124891576|NCT02711826|449224431|FG004|Overall Study|Infusion canceled for active infection|0|||
124891577|NCT02711826|449224427|FG000|Overall Study|Screen failures|0|||
124891578|NCT02711826|449224428|FG001|Overall Study|Screen failures|0|||
124891579|NCT02711826|449224429|FG002|Overall Study|Screen failures|0|||
124891580|NCT02711826|449224430|FG003|Overall Study|Screen failures|4|||
124891581|NCT02711826|449224431|FG004|Overall Study|Screen failures|0|||
124891582|NCT01960790|449224432|FG000|Overall Study|Survey forms could not be recovered|3|||
124891583|NCT01960790|449224432|FG000|Overall Study|Treat with Humira outside survey period|3|||
124891584|NCT01960790|449224432|FG000|Overall Study|Transferred to another hospital|4|||
124891585|NCT01960790|449224432|FG000|Overall Study|Unevaluable for safety|1|||
124891586|NCT02169219|449224435|FG000|Overall Study|Lack of Efficacy|6|||
124891587|NCT02886936|449224442|FG000|Overall Study|Lost to Follow-up|4|||
124891588|NCT02886936|449224443|FG001|Overall Study|Lost to Follow-up|3|||
124891589|NCT02886936|449224444|FG002|Overall Study|Lost to Follow-up|0|||
124891590|NCT04131907|449224446|FG000|Overall Study|Adverse Event|2|||
124891591|NCT04131907|449224447|FG001|Overall Study|Adverse Event|0|||
124891592|NCT04131907|449224448|FG002|Overall Study|Adverse Event|0|||
124891593|NCT04131907|449224446|FG000|Overall Study|Physician Decision|4|||
124891594|NCT04131907|449224447|FG001|Overall Study|Physician Decision|22|||
124891595|NCT04131907|449224448|FG002|Overall Study|Physician Decision|0|||
124891596|NCT04131907|449224446|FG000|Overall Study|Withdrawal by Subject|2|||
124891597|NCT04131907|449224447|FG001|Overall Study|Withdrawal by Subject|0|||
124891598|NCT04131907|449224448|FG002|Overall Study|Withdrawal by Subject|1|||
124891599|NCT04131907|449224446|FG000|Overall Study|Treatment failure|2|||
124891600|NCT04131907|449224447|FG001|Overall Study|Treatment failure|0|||
124891601|NCT04131907|449224448|FG002|Overall Study|Treatment failure|1|||
124891602|NCT04248465|449224449|FG000|Randomized-Controlled Period|Death|12|||
124891603|NCT04248465|449224450|FG001|Randomized-Controlled Period|Death|5|||
124891604|NCT04248465|449224449|FG000|Randomized-Controlled Period|Adverse Event|2|||
124891605|NCT04248465|449224450|FG001|Randomized-Controlled Period|Adverse Event|0|||
124891606|NCT04248465|449224449|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
124891607|NCT04248465|449224450|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
124891608|NCT04248465|449224449|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
124891609|NCT04248465|449224450|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
124891610|NCT04248465|449224449|FG000|Randomized-Controlled Period|Physician Decision|1|||
124891611|NCT04248465|449224450|FG001|Randomized-Controlled Period|Physician Decision|1|||
124891612|NCT04248465|449224449|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
124891613|NCT04248465|449224450|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
124891614|NCT04248465|449224449|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
124891615|NCT04248465|449224450|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
124891616|NCT04248465|449224449|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
124891617|NCT04248465|449224450|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
124891618|NCT05708846|449224451|FG000|Overall Study|Death|5|||
124891619|NCT05708846|449224451|FG000|Overall Study|Withdrawal by Subject|20|||
124891620|NCT00442286|449224452|FG000|Overall Study|Death|2|||
124891621|NCT00442286|449224453|FG001|Overall Study|Death|2|||
124891622|NCT00442286|449224452|FG000|Overall Study|Lost to Follow-up|1|||
124891623|NCT00442286|449224453|FG001|Overall Study|Lost to Follow-up|0|||
124891624|NCT00442286|449224452|FG000|Overall Study|Withdrawal by Subject|2|||
124891625|NCT00442286|449224453|FG001|Overall Study|Withdrawal by Subject|0|||
124891626|NCT00442286|449224452|FG000|Overall Study|System explanted|1|||
124891627|NCT00442286|449224453|FG001|Overall Study|System explanted|0|||
124891628|NCT00442286|449224452|FG000|Overall Study|Patient Injury|1|||
124891629|NCT00442286|449224453|FG001|Overall Study|Patient Injury|0|||
124891630|NCT03428815|449224454|FG000|Overall Study|Lost to Follow-up|2|||
124891631|NCT03428815|449224455|FG001|Overall Study|Lost to Follow-up|2|||
124891632|NCT03428815|449224454|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
124891633|NCT03428815|449224455|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
124891634|NCT03428815|449224454|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
124891635|NCT03428815|449224455|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
124891636|NCT01700348|449224456|FG000|Overall Study|Withdrawal by Subject|22|||
124891637|NCT01700348|449224456|FG000|Overall Study|Lost to Follow-up|1|||
124891638|NCT01778062|449224457|FG000|Overall Study|Adverse Event|1|||
125107148|NCT01039584|450015641|FG000|Overall Study|other|1|||
125107149|NCT01039584|450015642|FG001|Overall Study|other|3|||
125107150|NCT01039584|450015643|FG002|Overall Study|other|1|||
125107151|NCT01039584|450015641|FG000|Overall Study|Pap smear with significant pathology|10|||
125107152|NCT01039584|450015642|FG001|Overall Study|Pap smear with significant pathology|10|||
125107153|NCT01039584|450015643|FG002|Overall Study|Pap smear with significant pathology|3|||
125107154|NCT01039584|450015641|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
125107155|NCT01039584|450015642|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
125107156|NCT01039584|450015643|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
124891639|NCT01778062|449224458|FG001|Overall Study|Adverse Event|3|||
124891640|NCT01778062|449224457|FG000|Overall Study|Consent Withdrawal|1|||
124891641|NCT01778062|449224458|FG001|Overall Study|Consent Withdrawal|5|||
125107157|NCT01494649|450015644|FG000|Overall Study|Lost to Follow-up|0|||
125107158|NCT01494649|450015645|FG001|Overall Study|Lost to Follow-up|1|||
125107159|NCT03467971|450015646|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125107160|NCT03467971|450015647|FG001|Treatment Period 2|Withdrawal by Subject|1|||
124891642|NCT01778062|449224457|FG000|Overall Study|major protocol deviation|4|||
124891643|NCT01778062|449224458|FG001|Overall Study|major protocol deviation|3|||
124891644|NCT01824472|449224459|FG000|Overall Study|Lost to Follow-up|0|||
124891645|NCT01824472|449224460|FG001|Overall Study|Lost to Follow-up|0|||
124891646|NCT01824472|449224461|FG002|Overall Study|Lost to Follow-up|1|||
124891647|NCT01824472|449224459|FG000|Overall Study|Withdrawal by Subject|1|||
124891648|NCT01824472|449224460|FG001|Overall Study|Withdrawal by Subject|5|||
124891649|NCT01824472|449224461|FG002|Overall Study|Withdrawal by Subject|3|||
124891650|NCT01824472|449224459|FG000|Overall Study|Ineligible post randomization&screening|0|||
125107161|NCT01174368|450015650|FG000|Overall Study|Withdrawal by Subject|1|||
124891651|NCT01824472|449224460|FG001|Overall Study|Ineligible post randomization&screening|2|||
124891652|NCT01824472|449224461|FG002|Overall Study|Ineligible post randomization&screening|0|||
124891653|NCT01815736|449224464|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
124891654|NCT01815736|449224465|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
124891655|NCT01815736|449224464|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
125107162|NCT00000135|450015673|FG000|Overall Study|Death|27|||
125107163|NCT00000135|450015674|FG001|Overall Study|Death|14|||
125107164|NCT01311505|450015675|FG000|First Intervention Period|Protocol Violation|0|||
125107165|NCT01311505|450015676|FG001|First Intervention Period|Protocol Violation|1|||
125107166|NCT03022799|450015677|FG000|Overall Study|Adverse Event|0|||
124891656|NCT01815736|449224465|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
124891657|NCT01815736|449224464|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
124891658|NCT01815736|449224465|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
124891659|NCT01815736|449224464|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
124891660|NCT01815736|449224465|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
124891661|NCT01815736|449224464|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
124891662|NCT01815736|449224465|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
124891663|NCT01815736|449224464|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
124891664|NCT01815736|449224465|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
124891665|NCT01815736|449224464|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
124891666|NCT01815736|449224465|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
124891667|NCT01815736|449224464|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
124891668|NCT01815736|449224465|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
124891669|NCT01815736|449224464|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
124891670|NCT01815736|449224465|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
124891671|NCT01815736|449224464|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
124891672|NCT01815736|449224465|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
124891673|NCT01815736|449224464|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
124891674|NCT01815736|449224465|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
124891675|NCT01815736|449224464|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
124891676|NCT01815736|449224465|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
124891677|NCT01815736|449224464|FG000|Extension Treatment Phase- After Week 96|Death|1|||
124891678|NCT01815736|449224465|FG001|Extension Treatment Phase- After Week 96|Death|0|||
124891679|NCT03387514|449224467|FG000|Overall Study|Withdrawal by Subject|2|||
124891680|NCT03387514|449224467|FG000|Overall Study|Physician Decision|1|||
124891681|NCT03387514|449224467|FG000|Overall Study|Lost to Follow-up|2|||
124891682|NCT00394095|449225854|FG000|Screening|Withdrawal by Subject|1|||
124891683|NCT00394095|449225855|FG001|Screening|Withdrawal by Subject|0|||
124891684|NCT00394095|449225854|FG000|Randomized|Withdrawal by Subject|5|||
124891685|NCT00394095|449225855|FG001|Randomized|Withdrawal by Subject|1|||
124891686|NCT00394095|449225854|FG000|Randomized|Adverse Event|1|||
124891687|NCT00394095|449225855|FG001|Randomized|Adverse Event|1|||
124891688|NCT00394095|449225854|FG000|Randomized|Overdose|1|||
124891689|NCT00394095|449225855|FG001|Randomized|Overdose|0|||
124891690|NCT00394095|449225854|FG000|Randomized|Lost to Follow-up|1|||
124891691|NCT00394095|449225855|FG001|Randomized|Lost to Follow-up|2|||
124891692|NCT01646320|449225863|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
124891693|NCT01646320|449225864|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
124891694|NCT01646320|449225863|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
124891695|NCT01646320|449225864|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
124891696|NCT01646320|449225863|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
124891697|NCT01646320|449225864|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
124891698|NCT01646320|449225863|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
124891699|NCT01646320|449225864|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
124891700|NCT01646320|449225863|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
124891701|NCT01646320|449225864|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
124891702|NCT01646320|449225863|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
124891703|NCT01646320|449225864|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
124891704|NCT01646320|449225863|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
124891705|NCT01646320|449225864|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
124891706|NCT01646320|449225863|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
124891707|NCT01646320|449225864|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
124891708|NCT01646320|449225863|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
124891709|NCT01646320|449225864|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
124891710|NCT01646320|449225863|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
124891711|NCT01646320|449225864|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
124891712|NCT01646320|449225863|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
124891713|NCT01646320|449225864|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
124891714|NCT01489020|449225865|FG000|Overall Study|Withdrawal by Subject|1|||
124891715|NCT01489020|449225866|FG001|Overall Study|Withdrawal by Subject|0|||
124891716|NCT01489020|449225867|FG002|Overall Study|Withdrawal by Subject|0|||
124891717|NCT01489020|449225868|FG003|Overall Study|Withdrawal by Subject|0|||
124891718|NCT01489020|449225869|FG004|Overall Study|Withdrawal by Subject|0|||
124891719|NCT01489020|449225870|FG005|Overall Study|Withdrawal by Subject|0|||
124891720|NCT01489020|449225865|FG000|Overall Study|Adverse Event|0|||
124891721|NCT01489020|449225866|FG001|Overall Study|Adverse Event|0|||
124891722|NCT01489020|449225867|FG002|Overall Study|Adverse Event|3|||
125107167|NCT03022799|450015678|FG001|Overall Study|Adverse Event|0|||
125107168|NCT03022799|450015679|FG002|Overall Study|Adverse Event|0|||
124891723|NCT01489020|449225868|FG003|Overall Study|Adverse Event|0|||
124891724|NCT01489020|449225869|FG004|Overall Study|Adverse Event|3|||
124891725|NCT01489020|449225870|FG005|Overall Study|Adverse Event|0|||
124891726|NCT01489020|449225865|FG000|Overall Study|Concomitant disease|0|||
124891727|NCT01489020|449225866|FG001|Overall Study|Concomitant disease|0|||
124891728|NCT01489020|449225867|FG002|Overall Study|Concomitant disease|0|||
124891729|NCT01489020|449225868|FG003|Overall Study|Concomitant disease|0|||
124891730|NCT01489020|449225869|FG004|Overall Study|Concomitant disease|3|||
124891731|NCT01489020|449225870|FG005|Overall Study|Concomitant disease|0|||
124891732|NCT02424344|449225871|FG000|Overall Study|Lack of Efficacy|0|||
124891733|NCT02424344|449225872|FG001|Overall Study|Lack of Efficacy|1|||
124891734|NCT02424344|449225871|FG000|Overall Study|Withdrawal by Subject|2|||
124891735|NCT02424344|449225872|FG001|Overall Study|Withdrawal by Subject|1|||
124891736|NCT02424344|449225871|FG000|Overall Study|Lost to Follow-up|1|||
124891737|NCT02424344|449225872|FG001|Overall Study|Lost to Follow-up|0|||
124891738|NCT02424344|449225871|FG000|Overall Study|Adverse Event|4|||
124891739|NCT02424344|449225872|FG001|Overall Study|Adverse Event|8|||
124891740|NCT01174550|449225873|FG000|Overall Study|Death|75|||
124891741|NCT01174550|449225874|FG001|Overall Study|Death|74|||
124891742|NCT01174550|449225873|FG000|Overall Study|Lost to Follow-up|652|||
124891743|NCT01174550|449225874|FG001|Overall Study|Lost to Follow-up|510|||
124891744|NCT01174550|449225873|FG000|Overall Study|Withdrawal by Subject|543|||
124891745|NCT01174550|449225874|FG001|Overall Study|Withdrawal by Subject|289|||
124891746|NCT05257837|449225875|FG000|Overall Study|Excluded (did not find the guns)|4|||
124891747|NCT05257837|449225876|FG001|Overall Study|Excluded (did not find the guns)|2|||
124891748|NCT05257837|449225877|FG002|Overall Study|Excluded (did not find the guns)|4|||
124891749|NCT05257837|449225878|FG003|Overall Study|Excluded (did not find the guns)|0|||
124891750|NCT01625338|449225879|FG000|Overall Study|Enrolled but not Treated|0|||
124891751|NCT01625338|449225880|FG001|Overall Study|Enrolled but not Treated|0|||
124891752|NCT01625338|449225881|FG002|Overall Study|Enrolled but not Treated|1|||
124891753|NCT01625338|449225879|FG000|Overall Study|Efficacy Failure|27|||
124891754|NCT01625338|449225880|FG001|Overall Study|Efficacy Failure|39|||
124891755|NCT01625338|449225881|FG002|Overall Study|Efficacy Failure|31|||
124891756|NCT01625338|449225879|FG000|Overall Study|Lost to Follow-up|3|||
124891757|NCT01625338|449225880|FG001|Overall Study|Lost to Follow-up|3|||
125107169|NCT03022799|450015680|FG003|Overall Study|Adverse Event|0|||
125107170|NCT03022799|450015681|FG004|Overall Study|Adverse Event|0|||
125107171|NCT03022799|450015682|FG005|Overall Study|Adverse Event|0|||
125107172|NCT03022799|450015683|FG006|Overall Study|Adverse Event|0|||
125107173|NCT03022799|450015684|FG007|Overall Study|Adverse Event|0|||
125107174|NCT03022799|450015685|FG008|Overall Study|Adverse Event|0|||
125107175|NCT03022799|450015686|FG009|Overall Study|Adverse Event|1|||
125107176|NCT03022799|450015687|FG010|Overall Study|Adverse Event|1|||
125107177|NCT03022799|450015688|FG011|Overall Study|Adverse Event|0|||
125107178|NCT03022799|450015689|FG012|Overall Study|Adverse Event|0|||
125107179|NCT00759759|450015690|FG000|Overall Study|didn't return for period 2|1|||
125107180|NCT00759759|450015691|FG001|Overall Study|didn't return for period 2|0|||
125107181|NCT00759759|450015690|FG000|Overall Study|Didn't receive drug in period 2|1|||
125107182|NCT00759759|450015691|FG001|Overall Study|Didn't receive drug in period 2|0|||
125107183|NCT00759759|450015690|FG000|Overall Study|Withdrawal by Subject|2|||
125107184|NCT00759759|450015691|FG001|Overall Study|Withdrawal by Subject|1|||
125107185|NCT01211613|450017171|FG000|Overall Study|Lost to Follow-up|2|||
125107186|NCT01211613|450017172|FG001|Overall Study|Lost to Follow-up|2|||
125107187|NCT01211613|450017173|FG002|Overall Study|Lost to Follow-up|2|||
124891758|NCT01625338|449225881|FG002|Overall Study|Lost to Follow-up|2|||
124891759|NCT01625338|449225879|FG000|Overall Study|Investigator Decision|0|||
124891760|NCT01625338|449225880|FG001|Overall Study|Investigator Decision|2|||
124891761|NCT01625338|449225881|FG002|Overall Study|Investigator Decision|1|||
124891762|NCT01625338|449225879|FG000|Overall Study|Subject Withdrew Consent|1|||
124891763|NCT01625338|449225880|FG001|Overall Study|Subject Withdrew Consent|0|||
124891764|NCT01625338|449225881|FG002|Overall Study|Subject Withdrew Consent|2|||
124891765|NCT01625338|449225879|FG000|Overall Study|Adverse Event|1|||
124891766|NCT01625338|449225880|FG001|Overall Study|Adverse Event|0|||
124891767|NCT01625338|449225881|FG002|Overall Study|Adverse Event|1|||
124891768|NCT01625338|449225879|FG000|Overall Study|Study Discontinued by Sponsor|0|||
124891769|NCT01625338|449225880|FG001|Overall Study|Study Discontinued by Sponsor|0|||
125107188|NCT01211613|450017171|FG000|Overall Study|Withdrawal by Subject|1|||
125107189|NCT01211613|450017172|FG001|Overall Study|Withdrawal by Subject|0|||
125107190|NCT01211613|450017173|FG002|Overall Study|Withdrawal by Subject|0|||
125107191|NCT03853213|450017174|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
125107192|NCT03853213|450017175|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
124891770|NCT01625338|449225881|FG002|Overall Study|Study Discontinued by Sponsor|1|||
124891771|NCT02485353|449225882|FG000|Overall Study|Death|1|||
124891772|NCT02485353|449225882|FG000|Overall Study|Disease Progression|1|||
124891773|NCT03930186|449225883|FG000|Weeks 0 to 16|Adverse Event|6|||
124891774|NCT03930186|449225883|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
124891775|NCT03930186|449225883|FG000|Weeks 16 to 32|Adverse Event|1|||
124891776|NCT03930186|449225883|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
124891777|NCT00557505|449225886|FG000|Overall Study|Death|0|||
124891778|NCT00557505|449225887|FG001|Overall Study|Death|0|||
124891779|NCT00557505|449225888|FG002|Overall Study|Death|0|||
124891780|NCT00557505|449225889|FG003|Overall Study|Death|0|||
124891781|NCT00557505|449225890|FG004|Overall Study|Death|0|||
124891782|NCT00557505|449225891|FG005|Overall Study|Death|0|||
124891783|NCT00557505|449225892|FG006|Overall Study|Death|0|||
124891784|NCT00557505|449225893|FG007|Overall Study|Death|0|||
124891785|NCT00557505|449225894|FG008|Overall Study|Death|1|||
124891786|NCT00557505|449225886|FG000|Overall Study|Adverse Event|0|||
124891787|NCT00557505|449225887|FG001|Overall Study|Adverse Event|0|||
124891788|NCT00557505|449225888|FG002|Overall Study|Adverse Event|1|||
124891789|NCT00557505|449225889|FG003|Overall Study|Adverse Event|0|||
124891790|NCT00557505|449225890|FG004|Overall Study|Adverse Event|0|||
124891791|NCT00557505|449225891|FG005|Overall Study|Adverse Event|0|||
125017139|NCT03016325|449687717|FG006|Treatment Period|Participant refuses assessments|0|||
125017140|NCT03016325|449687718|FG007|Treatment Period|Participant refuses assessments|0|||
125017141|NCT03016325|449687711|FG000|32-Day Follow-Up Period|Death|2|||
125017142|NCT03016325|449687712|FG001|32-Day Follow-Up Period|Death|0|||
125017143|NCT03016325|449687713|FG002|32-Day Follow-Up Period|Death|5|||
125017144|NCT03016325|449687714|FG003|32-Day Follow-Up Period|Death|6|||
125017145|NCT03016325|449687715|FG004|32-Day Follow-Up Period|Death|3|||
125017146|NCT03016325|449687716|FG005|32-Day Follow-Up Period|Death|0|||
125017147|NCT03016325|449687717|FG006|32-Day Follow-Up Period|Death|0|||
125107193|NCT03853213|450017174|FG000|Overall Study|Other (e.g., too busy)|0|||
124891792|NCT00557505|449225892|FG006|Overall Study|Adverse Event|1|||
124891793|NCT00557505|449225893|FG007|Overall Study|Adverse Event|0|||
124891794|NCT00557505|449225894|FG008|Overall Study|Adverse Event|0|||
124891795|NCT00557505|449225886|FG000|Overall Study|Global deterioration of health|1|||
124891796|NCT00557505|449225887|FG001|Overall Study|Global deterioration of health|0|||
124891797|NCT00557505|449225888|FG002|Overall Study|Global deterioration of health|0|||
124891798|NCT00557505|449225889|FG003|Overall Study|Global deterioration of health|0|||
124891799|NCT00557505|449225890|FG004|Overall Study|Global deterioration of health|0|||
124891800|NCT00557505|449225891|FG005|Overall Study|Global deterioration of health|0|||
124891801|NCT00557505|449225892|FG006|Overall Study|Global deterioration of health|0|||
124891802|NCT00557505|449225893|FG007|Overall Study|Global deterioration of health|0|||
124891803|NCT00557505|449225894|FG008|Overall Study|Global deterioration of health|0|||
124891804|NCT00557505|449225886|FG000|Overall Study|Objective progression or relapse|2|||
124891805|NCT00557505|449225887|FG001|Overall Study|Objective progression or relapse|3|||
124891806|NCT00557505|449225888|FG002|Overall Study|Objective progression or relapse|3|||
124891807|NCT00557505|449225889|FG003|Overall Study|Objective progression or relapse|2|||
124891808|NCT00557505|449225890|FG004|Overall Study|Objective progression or relapse|2|||
124891809|NCT00557505|449225891|FG005|Overall Study|Objective progression or relapse|3|||
124891810|NCT00557505|449225892|FG006|Overall Study|Objective progression or relapse|2|||
124891811|NCT00557505|449225893|FG007|Overall Study|Objective progression or relapse|5|||
125107194|NCT03853213|450017175|FG001|Overall Study|Other (e.g., too busy)|2|||
125107195|NCT01458132|450017176|FG000|Overall Study|Other|15|||
125107196|NCT01458132|450017177|FG001|Overall Study|Other|3|||
124891812|NCT00557505|449225894|FG008|Overall Study|Objective progression or relapse|15|||
124891813|NCT00557505|449225886|FG000|Overall Study|Withdrawal by Subject|0|||
124891814|NCT00557505|449225887|FG001|Overall Study|Withdrawal by Subject|0|||
124891815|NCT00557505|449225888|FG002|Overall Study|Withdrawal by Subject|0|||
125017148|NCT03016325|449687718|FG007|32-Day Follow-Up Period|Death|0|||
125017149|NCT03016325|449687711|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
125017150|NCT03016325|449687712|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
125017151|NCT03016325|449687713|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
124891816|NCT00557505|449225889|FG003|Overall Study|Withdrawal by Subject|1|||
124891817|NCT00557505|449225890|FG004|Overall Study|Withdrawal by Subject|0|||
124891818|NCT00557505|449225891|FG005|Overall Study|Withdrawal by Subject|0|||
124891819|NCT00557505|449225892|FG006|Overall Study|Withdrawal by Subject|0|||
124891820|NCT00557505|449225893|FG007|Overall Study|Withdrawal by Subject|0|||
124891821|NCT00557505|449225894|FG008|Overall Study|Withdrawal by Subject|1|||
124891822|NCT04990440|449225905|FG000|Overall Study|Sponsor's Decision|0|||
124891823|NCT04990440|449225906|FG001|Overall Study|Sponsor's Decision|0|||
125017152|NCT03016325|449687714|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
125017153|NCT03016325|449687715|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
125107197|NCT00833976|450017178|FG000|Overall Study|Withdrawal by Subject|5|||
125107198|NCT00833976|450017178|FG000|Overall Study|Lost to Follow-up|4|||
124891824|NCT04990440|449225907|FG002|Overall Study|Sponsor's Decision|1|||
124891825|NCT03712098|449225908|FG000|Overall Study|Lost to Follow-up|3|||
124891826|NCT03712098|449225909|FG001|Overall Study|Lost to Follow-up|7|||
124891827|NCT03712098|449225908|FG000|Overall Study|Withdrawal by Subject|9|||
124891828|NCT03712098|449225909|FG001|Overall Study|Withdrawal by Subject|4|||
124891829|NCT03712098|449225908|FG000|Overall Study|Protocol Violation|2|||
124891830|NCT03712098|449225909|FG001|Overall Study|Protocol Violation|1|||
124891831|NCT00724061|449225912|FG000|Dose Escalation Phase|Adverse Event|2|||
124891832|NCT00724061|449225912|FG000|Dose Escalation Phase|Disease Progression|3|||
124891833|NCT01237678|449225917|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
124891834|NCT01237678|449225918|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
124891835|NCT01237678|449225919|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
124891836|NCT01237678|449225917|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
124891837|NCT01237678|449225918|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
124891838|NCT01237678|449225919|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
124891839|NCT01237678|449225917|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
124891840|NCT01237678|449225918|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
124891841|NCT01237678|449225919|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
124891842|NCT01237678|449225917|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
124891843|NCT01237678|449225918|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
124891844|NCT01237678|449225919|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
124891845|NCT01237678|449225917|FG000|Phase II|Adverse Event|0|||
124891846|NCT01237678|449225918|FG001|Phase II|Adverse Event|39|||
124891847|NCT01237678|449225919|FG002|Phase II|Adverse Event|9|||
124891848|NCT01237678|449225917|FG000|Phase II|Death|0|||
124891849|NCT01237678|449225918|FG001|Phase II|Death|0|||
124891850|NCT01237678|449225919|FG002|Phase II|Death|2|||
124891851|NCT01237678|449225917|FG000|Phase II|Lack of Efficacy|0|||
124891852|NCT01237678|449225918|FG001|Phase II|Lack of Efficacy|25|||
124891853|NCT01237678|449225919|FG002|Phase II|Lack of Efficacy|3|||
124891854|NCT01237678|449225917|FG000|Phase II|Withdrawal by Subject|0|||
124891855|NCT01237678|449225918|FG001|Phase II|Withdrawal by Subject|1|||
124891856|NCT01237678|449225919|FG002|Phase II|Withdrawal by Subject|5|||
124891857|NCT01237678|449225917|FG000|Phase II|Completed Cycles 4-6|0|||
124891858|NCT01237678|449225918|FG001|Phase II|Completed Cycles 4-6|11|||
124891859|NCT01237678|449225919|FG002|Phase II|Completed Cycles 4-6|21|||
124891860|NCT01237678|449225917|FG000|Phase II|Sponsor Decision/Study Closed|0|||
124891861|NCT01237678|449225918|FG001|Phase II|Sponsor Decision/Study Closed|18|||
124891862|NCT01237678|449225919|FG002|Phase II|Sponsor Decision/Study Closed|7|||
124891863|NCT01237678|449225917|FG000|Phase II|Randomized but were not treated|0|||
124891864|NCT01237678|449225918|FG001|Phase II|Randomized but were not treated|4|||
124891865|NCT01237678|449225919|FG002|Phase II|Randomized but were not treated|3|||
124891866|NCT01723826|449225920|FG000|Overall Study|Adverse Event|4|||
124891867|NCT01723826|449225921|FG001|Overall Study|Adverse Event|1|||
124891868|NCT01723826|449225922|FG002|Overall Study|Adverse Event|4|||
124891869|NCT01723826|449225923|FG003|Overall Study|Adverse Event|5|||
124891870|NCT01723826|449225920|FG000|Overall Study|Death according to AE eCRF|2|||
124891871|NCT01723826|449225921|FG001|Overall Study|Death according to AE eCRF|3|||
124891872|NCT01723826|449225922|FG002|Overall Study|Death according to AE eCRF|3|||
124891873|NCT01723826|449225923|FG003|Overall Study|Death according to AE eCRF|7|||
124891874|NCT01723826|449225920|FG000|Overall Study|Lost to Follow-up|1|||
124891875|NCT01723826|449225921|FG001|Overall Study|Lost to Follow-up|3|||
124891876|NCT01723826|449225922|FG002|Overall Study|Lost to Follow-up|1|||
124891877|NCT01723826|449225923|FG003|Overall Study|Lost to Follow-up|1|||
124891878|NCT01723826|449225920|FG000|Overall Study|Non-compliance|0|||
124891879|NCT01723826|449225921|FG001|Overall Study|Non-compliance|1|||
124891880|NCT01723826|449225922|FG002|Overall Study|Non-compliance|3|||
124891881|NCT01723826|449225923|FG003|Overall Study|Non-compliance|3|||
124891882|NCT01723826|449225920|FG000|Overall Study|Non-compliance With Study Drug|0|||
124891883|NCT01723826|449225921|FG001|Overall Study|Non-compliance With Study Drug|1|||
124891884|NCT01723826|449225922|FG002|Overall Study|Non-compliance With Study Drug|0|||
124891885|NCT01723826|449225923|FG003|Overall Study|Non-compliance With Study Drug|0|||
124891886|NCT01723826|449225920|FG000|Overall Study|Other Reason|8|||
124891887|NCT01723826|449225921|FG001|Overall Study|Other Reason|6|||
124891888|NCT01723826|449225922|FG002|Overall Study|Other Reason|12|||
124891889|NCT01723826|449225923|FG003|Overall Study|Other Reason|14|||
124891890|NCT01723826|449225920|FG000|Overall Study|Physician Decision|1|||
124891891|NCT01723826|449225921|FG001|Overall Study|Physician Decision|3|||
124891892|NCT01723826|449225922|FG002|Overall Study|Physician Decision|4|||
124891893|NCT01723826|449225923|FG003|Overall Study|Physician Decision|11|||
124891894|NCT01723826|449225920|FG000|Overall Study|Protocol Violation|1|||
124891895|NCT01723826|449225921|FG001|Overall Study|Protocol Violation|1|||
124891896|NCT01723826|449225922|FG002|Overall Study|Protocol Violation|3|||
124891897|NCT01723826|449225923|FG003|Overall Study|Protocol Violation|1|||
124891898|NCT01723826|449225920|FG000|Overall Study|Withdrawal by Subject|10|||
124891899|NCT01723826|449225921|FG001|Overall Study|Withdrawal by Subject|17|||
124891900|NCT01723826|449225922|FG002|Overall Study|Withdrawal by Subject|27|||
124891901|NCT01723826|449225923|FG003|Overall Study|Withdrawal by Subject|48|||
124891902|NCT01272011|449225924|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
124891903|NCT01272011|449225925|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
124891904|NCT01272011|449225926|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
124891905|NCT01627340|449225927|FG000|Overall Study|Adverse Event|1|||
124891906|NCT01627340|449225928|FG001|Overall Study|Adverse Event|0|||
124891907|NCT01627340|449225927|FG000|Overall Study|Lost to Follow-up|8|||
124891908|NCT01627340|449225928|FG001|Overall Study|Lost to Follow-up|4|||
124891909|NCT01627340|449225927|FG000|Overall Study|Pregnancy|1|||
124891910|NCT01627340|449225928|FG001|Overall Study|Pregnancy|0|||
124891911|NCT01627340|449225927|FG000|Overall Study|Withdrawal by Subject|2|||
124891912|NCT01627340|449225928|FG001|Overall Study|Withdrawal by Subject|0|||
124891913|NCT02013687|449225929|FG000|Overall Study|Lost to Follow-up|0|||
124891914|NCT02013687|449225930|FG001|Overall Study|Lost to Follow-up|0|||
124891915|NCT02013687|449225931|FG002|Overall Study|Lost to Follow-up|1|||
124891916|NCT02013687|449225932|FG003|Overall Study|Lost to Follow-up|0|||
124891917|NCT02013687|449225929|FG000|Overall Study|Protocol Violation|0|||
124891918|NCT02013687|449225930|FG001|Overall Study|Protocol Violation|0|||
124891919|NCT02013687|449225931|FG002|Overall Study|Protocol Violation|0|||
124891920|NCT02013687|449225932|FG003|Overall Study|Protocol Violation|1|||
124891921|NCT02013687|449225929|FG000|Overall Study|Withdrawal by Subject|0|||
124891922|NCT02013687|449225930|FG001|Overall Study|Withdrawal by Subject|0|||
124891923|NCT02013687|449225931|FG002|Overall Study|Withdrawal by Subject|0|||
124891924|NCT02013687|449225932|FG003|Overall Study|Withdrawal by Subject|1|||
124891925|NCT02013687|449225929|FG000|Overall Study|Missed visits due to patient travel|0|||
124891926|NCT02013687|449225930|FG001|Overall Study|Missed visits due to patient travel|0|||
124891927|NCT02013687|449225931|FG002|Overall Study|Missed visits due to patient travel|1|||
124891928|NCT02013687|449225932|FG003|Overall Study|Missed visits due to patient travel|0|||
124891929|NCT01657032|449225933|FG000|Overall Study|Lost to Follow-up|0|||
124891930|NCT01657032|449225934|FG001|Overall Study|Lost to Follow-up|7|||
124891931|NCT03633903|449225935|FG000|Overall Study|Withdrawal by Subject|1|||
124891932|NCT03633903|449225936|FG001|Overall Study|Withdrawal by Subject|2|||
124891933|NCT03633903|449225935|FG000|Overall Study|Lost to Follow-up|5|||
124891934|NCT03633903|449225936|FG001|Overall Study|Lost to Follow-up|5|||
124891935|NCT05968482|449225937|FG000|First Crossover Period|Withdrawal by Subject|0|||
124891936|NCT05968482|449225938|FG001|First Crossover Period|Withdrawal by Subject|0|||
124891937|NCT05968482|449225939|FG002|First Crossover Period|Withdrawal by Subject|1|||
124891938|NCT05968482|449225940|FG003|First Crossover Period|Withdrawal by Subject|0|||
124891939|NCT05968482|449225941|FG004|First Crossover Period|Withdrawal by Subject|0|||
124891940|NCT05968482|449225942|FG005|First Crossover Period|Withdrawal by Subject|0|||
124891941|NCT05968482|449225937|FG000|First Crossover Period|Adverse Event|0|||
124891942|NCT05968482|449225938|FG001|First Crossover Period|Adverse Event|0|||
124891943|NCT05968482|449225939|FG002|First Crossover Period|Adverse Event|0|||
124891944|NCT05968482|449225940|FG003|First Crossover Period|Adverse Event|0|||
124891945|NCT05968482|449225941|FG004|First Crossover Period|Adverse Event|0|||
124891946|NCT05968482|449225942|FG005|First Crossover Period|Adverse Event|1|||
124891947|NCT05968482|449225937|FG000|Second Crossover Period|Withdrawal by Subject|0|||
124891948|NCT05968482|449225938|FG001|Second Crossover Period|Withdrawal by Subject|0|||
124891949|NCT05968482|449225939|FG002|Second Crossover Period|Withdrawal by Subject|0|||
124891950|NCT05968482|449225940|FG003|Second Crossover Period|Withdrawal by Subject|0|||
124891951|NCT05968482|449225941|FG004|Second Crossover Period|Withdrawal by Subject|1|||
124891952|NCT05968482|449225942|FG005|Second Crossover Period|Withdrawal by Subject|0|||
124891953|NCT05968482|449225937|FG000|Third Crossover Period|Adverse Event|0|||
124891954|NCT05968482|449225938|FG001|Third Crossover Period|Adverse Event|0|||
124891955|NCT05968482|449225939|FG002|Third Crossover Period|Adverse Event|0|||
125017154|NCT03016325|449687716|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
125017155|NCT03016325|449687717|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
125017156|NCT03016325|449687718|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
124891956|NCT05968482|449225940|FG003|Third Crossover Period|Adverse Event|0|||
124891957|NCT05968482|449225941|FG004|Third Crossover Period|Adverse Event|1|||
124891958|NCT05968482|449225942|FG005|Third Crossover Period|Adverse Event|0|||
124891959|NCT05968482|449225937|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
124891960|NCT05968482|449225938|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
124891961|NCT05968482|449225939|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
124891962|NCT05968482|449225940|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
124891963|NCT05968482|449225941|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
124891964|NCT05968482|449225942|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
124891965|NCT02559817|449225943|FG000|Treatment Period|Adverse Event|1|||
124891966|NCT02559817|449225944|FG001|Treatment Period|Adverse Event|0|||
124891967|NCT02559817|449225945|FG002|Treatment Period|Adverse Event|1|||
125017157|NCT03016325|449687711|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
124891968|NCT02559817|449225946|FG003|Treatment Period|Adverse Event|0|||
124891969|NCT02559817|449225947|FG004|Treatment Period|Adverse Event|0|||
124891970|NCT02559817|449225943|FG000|Treatment Period|Lack of Efficacy|0|||
124891971|NCT02559817|449225944|FG001|Treatment Period|Lack of Efficacy|1|||
124891972|NCT02559817|449225945|FG002|Treatment Period|Lack of Efficacy|0|||
124891973|NCT02559817|449225946|FG003|Treatment Period|Lack of Efficacy|0|||
124891974|NCT02559817|449225947|FG004|Treatment Period|Lack of Efficacy|0|||
124891975|NCT02559817|449225943|FG000|Treatment Period|Lost to Follow-up|0|||
124891976|NCT02559817|449225944|FG001|Treatment Period|Lost to Follow-up|1|||
124891977|NCT02559817|449225945|FG002|Treatment Period|Lost to Follow-up|0|||
124891978|NCT02559817|449225946|FG003|Treatment Period|Lost to Follow-up|1|||
124891979|NCT02559817|449225947|FG004|Treatment Period|Lost to Follow-up|0|||
124891980|NCT02559817|449225943|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
124891981|NCT02559817|449225944|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
124891982|NCT02559817|449225945|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
124891983|NCT02559817|449225946|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
124891984|NCT02559817|449225947|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
124891985|NCT02559817|449225943|FG000|Treatment Period|Protocol Violation|0|||
124891986|NCT02559817|449225944|FG001|Treatment Period|Protocol Violation|0|||
124891987|NCT02559817|449225945|FG002|Treatment Period|Protocol Violation|0|||
124891988|NCT02559817|449225946|FG003|Treatment Period|Protocol Violation|1|||
124891989|NCT02559817|449225947|FG004|Treatment Period|Protocol Violation|0|||
124891990|NCT00761774|449225952|FG000|Overall Study|Adverse Event|17|||
124891991|NCT00761774|449225952|FG000|Overall Study|Lack of Efficacy|37|||
124891992|NCT00761774|449225952|FG000|Overall Study|Lost to Follow-up|2|||
124891993|NCT00761774|449225952|FG000|Overall Study|Withdrawal by Subject|9|||
124891994|NCT00761774|449225952|FG000|Overall Study|Non-compliance|4|||
124891995|NCT00761774|449225952|FG000|Overall Study|End of study|2|||
124891996|NCT00761774|449225952|FG000|Overall Study|Reclassification of seizures|1|||
124891997|NCT00761774|449225952|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
124891998|NCT00761774|449225952|FG000|Overall Study|Sponsor decision|1|||
124891999|NCT00761774|449225952|FG000|Overall Study|Investigator clinical judgement|1|||
124892000|NCT00761774|449225952|FG000|Overall Study|Patient moved out of study area|1|||
124892001|NCT00761774|449225952|FG000|Overall Study|Coordinator leaving site|1|||
124892002|NCT00761774|449225952|FG000|Overall Study|Subject IP non-compliance|1|||
124892003|NCT00761774|449225952|FG000|Overall Study|IP stopped by hospital physician|1|||
124892004|NCT01925170|449225953|FG000|Overall Study|Unverified cancer status|53|||
124892005|NCT01077024|449225954|FG000|Overall Study|Lost to Follow-up|20|||
124892006|NCT01077024|449225955|FG001|Overall Study|Lost to Follow-up|14|||
124892007|NCT01077024|449225954|FG000|Overall Study|Withdrawal by Subject|0|||
124892008|NCT01077024|449225955|FG001|Overall Study|Withdrawal by Subject|2|||
124892009|NCT01077024|449225954|FG000|Overall Study|Incarcerated|7|||
124892010|NCT01077024|449225955|FG001|Overall Study|Incarcerated|8|||
124892011|NCT01077024|449225954|FG000|Overall Study|Other|4|||
124892012|NCT01077024|449225955|FG001|Overall Study|Other|4|||
124892013|NCT01603121|449225956|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
124892014|NCT01603121|449225957|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
124892015|NCT00577720|449225958|FG000|Overall Study|Adverse Event|2|||
124892016|NCT00577720|449225959|FG001|Overall Study|Adverse Event|1|||
124892017|NCT00577720|449225960|FG002|Overall Study|Adverse Event|0|||
124892018|NCT00577720|449225961|FG003|Overall Study|Adverse Event|4|||
124892019|NCT00577720|449225958|FG000|Overall Study|Lost to Follow-up|0|||
124892020|NCT00577720|449225959|FG001|Overall Study|Lost to Follow-up|0|||
125017158|NCT03016325|449687712|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
125017159|NCT03016325|449687713|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
125017160|NCT03016325|449687714|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
125017161|NCT03016325|449687715|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
125017162|NCT03016325|449687716|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
125017163|NCT03016325|449687717|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
125017164|NCT03016325|449687718|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
125017165|NCT03016325|449687711|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
125017166|NCT03016325|449687712|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
125017167|NCT03016325|449687713|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
125017168|NCT03016325|449687714|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
124892021|NCT00577720|449225960|FG002|Overall Study|Lost to Follow-up|1|||
124892022|NCT00577720|449225961|FG003|Overall Study|Lost to Follow-up|0|||
124892023|NCT00577720|449225958|FG000|Overall Study|Protocol Violation|0|||
124892024|NCT00577720|449225959|FG001|Overall Study|Protocol Violation|0|||
124892025|NCT00577720|449225960|FG002|Overall Study|Protocol Violation|0|||
124892026|NCT00577720|449225961|FG003|Overall Study|Protocol Violation|1|||
124892027|NCT00577720|449225958|FG000|Overall Study|Withdrawal by Subject|2|||
124892028|NCT00577720|449225959|FG001|Overall Study|Withdrawal by Subject|0|||
124892029|NCT00577720|449225960|FG002|Overall Study|Withdrawal by Subject|0|||
124892030|NCT00577720|449225961|FG003|Overall Study|Withdrawal by Subject|2|||
124892031|NCT02839681|449225964|FG000|Overall Study|Death|2|||
125017169|NCT03016325|449687715|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
124892032|NCT00419003|449225965|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
124892033|NCT00419003|449225966|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
124892034|NCT00419003|449225965|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
124892035|NCT00419003|449225966|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
124892036|NCT02531438|449225967|FG000|Overall Study|Adverse Event|7|||
124892037|NCT02531438|449225968|FG001|Overall Study|Adverse Event|9|||
124892038|NCT02531438|449225967|FG000|Overall Study|Lost to Follow-up|0|||
124892039|NCT02531438|449225968|FG001|Overall Study|Lost to Follow-up|3|||
124892040|NCT02531438|449225967|FG000|Overall Study|Withdrawal by Subject|7|||
124892041|NCT02531438|449225968|FG001|Overall Study|Withdrawal by Subject|8|||
124892042|NCT02531438|449225967|FG000|Overall Study|Physician Decision|0|||
124892043|NCT02531438|449225968|FG001|Overall Study|Physician Decision|1|||
124892044|NCT02531438|449225967|FG000|Overall Study|Death|6|||
124892045|NCT02531438|449225968|FG001|Overall Study|Death|3|||
124892046|NCT02531438|449225967|FG000|Overall Study|Randomized, but Not Treated|4|||
124892047|NCT02531438|449225968|FG001|Overall Study|Randomized, but Not Treated|0|||
124892048|NCT02531438|449225967|FG000|Overall Study|Missed EOT/PTE Visit|5|||
124892049|NCT02531438|449225968|FG001|Overall Study|Missed EOT/PTE Visit|2|||
124892050|NCT02531438|449225967|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
124892051|NCT02531438|449225968|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
124892052|NCT00772928|449225969|FG000|Overall Study|Lost to Follow-up|9|||
124892053|NCT00772928|449225970|FG001|Overall Study|Lost to Follow-up|6|||
124892054|NCT00772928|449225969|FG000|Overall Study|Protocol Violation|10|||
124892055|NCT00772928|449225970|FG001|Overall Study|Protocol Violation|12|||
124892056|NCT00772928|449225969|FG000|Overall Study|Withdrawal by Subject|25|||
124892057|NCT00772928|449225970|FG001|Overall Study|Withdrawal by Subject|22|||
124892058|NCT00772928|449225969|FG000|Overall Study|Did not receive vaccine|0|||
124892059|NCT00772928|449225970|FG001|Overall Study|Did not receive vaccine|1|||
124892060|NCT03100838|449225972|FG000|Overall Study|Adverse Event|1|||
124892061|NCT03100838|449225973|FG001|Overall Study|Adverse Event|0|||
124892062|NCT03100838|449225974|FG002|Overall Study|Adverse Event|0|||
124892063|NCT03100838|449225975|FG003|Overall Study|Adverse Event|0|||
124892064|NCT03100838|449225972|FG000|Overall Study|Physician Decision|1|||
124892065|NCT03100838|449225973|FG001|Overall Study|Physician Decision|1|||
124892066|NCT03100838|449225974|FG002|Overall Study|Physician Decision|1|||
124892067|NCT03100838|449225975|FG003|Overall Study|Physician Decision|1|||
124892068|NCT03100838|449225972|FG000|Overall Study|Pregnancy|0|||
124892069|NCT03100838|449225973|FG001|Overall Study|Pregnancy|1|||
124892070|NCT03100838|449225974|FG002|Overall Study|Pregnancy|0|||
124892071|NCT03100838|449225975|FG003|Overall Study|Pregnancy|0|||
124892072|NCT03100838|449225972|FG000|Overall Study|Lost to Follow-up|0|||
124892073|NCT03100838|449225973|FG001|Overall Study|Lost to Follow-up|0|||
124892074|NCT03100838|449225974|FG002|Overall Study|Lost to Follow-up|1|||
124892075|NCT03100838|449225975|FG003|Overall Study|Lost to Follow-up|0|||
124892076|NCT00801242|449225976|FG000|Overall Study|Adverse Event|10|||
124892077|NCT00801242|449225976|FG000|Overall Study|Withdrawal by Subject|13|||
124892078|NCT00801242|449225976|FG000|Overall Study|Protocol Violation|5|||
124892079|NCT00801242|449225976|FG000|Overall Study|Physician Decision|3|||
124892080|NCT00801242|449225976|FG000|Overall Study|Lost to Follow-up|1|||
124892081|NCT00801242|449225976|FG000|Overall Study|Miscellaneous reasons|20|||
124892082|NCT02554513|449225978|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
124892083|NCT02554513|449225979|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
124892084|NCT00184028|449225982|FG000|Overall Study|Death|1|||
124892085|NCT00184028|449225982|FG000|Overall Study|Lack of Efficacy|4|||
124892086|NCT00184028|449225982|FG000|Overall Study|Adverse Event|2|||
124892087|NCT00184028|449225982|FG000|Overall Study|Withdrawal by Subject|1|||
124892088|NCT00184028|449225982|FG000|Overall Study|Non-compliance|2|||
124892089|NCT00162942|449225985|FG000|Overall Study|Adverse Event|10|||
124892090|NCT00162942|449225986|FG001|Overall Study|Adverse Event|6|||
124892091|NCT00162942|449225985|FG000|Overall Study|Death|1|||
124892092|NCT00162942|449225986|FG001|Overall Study|Death|0|||
124892093|NCT00162942|449225985|FG000|Overall Study|Withdrawal by Subject|3|||
124892094|NCT00162942|449225986|FG001|Overall Study|Withdrawal by Subject|6|||
124892095|NCT00162942|449225985|FG000|Overall Study|Physician Decision|1|||
124892096|NCT00162942|449225986|FG001|Overall Study|Physician Decision|0|||
124892097|NCT00162942|449225985|FG000|Overall Study|Enter Open-Label Study|76|||
124892098|NCT00162942|449225986|FG001|Overall Study|Enter Open-Label Study|35|||
124892099|NCT00162942|449225985|FG000|Overall Study|Alternate Therapy|6|||
124892100|NCT00162942|449225986|FG001|Overall Study|Alternate Therapy|2|||
124892101|NCT00162942|449225985|FG000|Overall Study|Lack of Efficacy|1|||
124892102|NCT00162942|449225986|FG001|Overall Study|Lack of Efficacy|0|||
124892103|NCT00162942|449225985|FG000|Overall Study|Flare During Active Treatment|7|||
124892104|NCT00162942|449225986|FG001|Overall Study|Flare During Active Treatment|3|||
124892105|NCT00162942|449225985|FG000|Overall Study|2 or more consecutive treatments missed|1|||
124892106|NCT00162942|449225986|FG001|Overall Study|2 or more consecutive treatments missed|0|||
124892107|NCT01354938|449225987|FG000|Overall Study|Lost to Follow-up|1|||
124892108|NCT01253200|449225988|FG000|Overall Study|Death|1|||
124892109|NCT01253200|449225989|FG001|Overall Study|Death|0|||
124892110|NCT01253200|449225990|FG002|Overall Study|Death|0|||
124892111|NCT01253200|449225991|FG003|Overall Study|Death|0|||
124892112|NCT01253200|449225992|FG004|Overall Study|Death|0|||
124892113|NCT01253200|449225988|FG000|Overall Study|Lost to Follow-up|1|||
124892114|NCT01253200|449225989|FG001|Overall Study|Lost to Follow-up|1|||
124892115|NCT01253200|449225990|FG002|Overall Study|Lost to Follow-up|0|||
124892116|NCT01253200|449225991|FG003|Overall Study|Lost to Follow-up|0|||
124892117|NCT01253200|449225992|FG004|Overall Study|Lost to Follow-up|0|||
124892118|NCT01253200|449225988|FG000|Overall Study|Withdrawal by Subject|2|||
124892119|NCT01253200|449225989|FG001|Overall Study|Withdrawal by Subject|0|||
124892120|NCT01253200|449225990|FG002|Overall Study|Withdrawal by Subject|0|||
124892121|NCT01253200|449225991|FG003|Overall Study|Withdrawal by Subject|0|||
124892122|NCT01253200|449225992|FG004|Overall Study|Withdrawal by Subject|0|||
124892123|NCT01253200|449225988|FG000|Overall Study|Protocol Violation|1|||
124892124|NCT01253200|449225989|FG001|Overall Study|Protocol Violation|4|||
124892125|NCT01253200|449225990|FG002|Overall Study|Protocol Violation|0|||
124892126|NCT01253200|449225991|FG003|Overall Study|Protocol Violation|0|||
124892127|NCT01253200|449225992|FG004|Overall Study|Protocol Violation|5|||
124892128|NCT01253200|449225988|FG000|Overall Study|intents|10|||
124892129|NCT01253200|449225989|FG001|Overall Study|intents|10|||
124892130|NCT01253200|449225990|FG002|Overall Study|intents|1|||
124892131|NCT01253200|449225991|FG003|Overall Study|intents|3|||
124892132|NCT01253200|449225992|FG004|Overall Study|intents|0|||
124892133|NCT01253200|449225988|FG000|Overall Study|Attempts|6|||
124892134|NCT01253200|449225989|FG001|Overall Study|Attempts|4|||
124892135|NCT01253200|449225990|FG002|Overall Study|Attempts|1|||
124892136|NCT01253200|449225991|FG003|Overall Study|Attempts|2|||
124892137|NCT01253200|449225992|FG004|Overall Study|Attempts|0|||
124892138|NCT02335268|449225993|FG000|Overall Study|Physician Decision|5|||
124892139|NCT02335268|449225994|FG001|Overall Study|Physician Decision|1|||
124892140|NCT02335268|449225993|FG000|Overall Study|Lack of Efficacy|2|||
124892141|NCT02335268|449225994|FG001|Overall Study|Lack of Efficacy|1|||
124892142|NCT02335268|449225993|FG000|Overall Study|Adverse Event|5|||
124892143|NCT02335268|449225994|FG001|Overall Study|Adverse Event|2|||
124892144|NCT02335268|449225993|FG000|Overall Study|increase blasts|2|||
124892145|NCT02335268|449225994|FG001|Overall Study|increase blasts|0|||
124892146|NCT02335268|449225993|FG000|Overall Study|Withdrawal by Subject|3|||
124892147|NCT02335268|449225994|FG001|Overall Study|Withdrawal by Subject|2|||
124892148|NCT03785340|449225998|FG000|Overall Study|Lost to Follow-up|2|||
124892149|NCT03785340|449225999|FG001|Overall Study|Lost to Follow-up|0|||
124892150|NCT03785340|449225998|FG000|Overall Study|Adverse Event|1|||
124892151|NCT03785340|449225999|FG001|Overall Study|Adverse Event|0|||
124892152|NCT01700530|449226002|FG000|Overall Study|Withdrawal by Subject|0|||
124892153|NCT01700530|449226003|FG001|Overall Study|Withdrawal by Subject|3|||
124892154|NCT01700530|449226004|FG002|Overall Study|Withdrawal by Subject|1|||
124892155|NCT03289455|449226009|FG000|Overall Study|Death|1|||
124892156|NCT03289455|449226010|FG001|Overall Study|Death|0|||
124892157|NCT03289455|449226011|FG002|Overall Study|Death|0|||
124892158|NCT03289455|449226009|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
124892159|NCT03289455|449226010|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
124892160|NCT03289455|449226011|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
124892161|NCT03289455|449226009|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
124892162|NCT03289455|449226010|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
124892163|NCT03289455|449226011|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
124892164|NCT03289455|449226009|FG000|Overall Study|Progressive disease|3|||
124892165|NCT03289455|449226010|FG001|Overall Study|Progressive disease|4|||
124892166|NCT03289455|449226011|FG002|Overall Study|Progressive disease|5|||
124892167|NCT00333788|449226012|FG000|Overall Study|Adverse Event|44|||
124892168|NCT00333788|449226012|FG000|Overall Study|Lack of Efficacy|80|||
124892169|NCT00333788|449226012|FG000|Overall Study|Lost to Follow-up|2|||
124892170|NCT00333788|449226012|FG000|Overall Study|Withdrawal by Subject|24|||
124892171|NCT00333788|449226012|FG000|Overall Study|Other: Non-compliance|2|||
124892172|NCT00333788|449226012|FG000|Overall Study|Other: Moved|2|||
124892173|NCT00333788|449226012|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
124892174|NCT00333788|449226012|FG000|Overall Study|Other: Investigator decision|1|||
125017170|NCT03016325|449687716|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
124892175|NCT00333788|449226012|FG000|Overall Study|Other: Quality of life concern|1|||
124892176|NCT00333788|449226012|FG000|Overall Study|Other: Sponsor decision|1|||
124892177|NCT00333788|449226012|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
124892178|NCT00333788|449226012|FG000|Overall Study|Other: Medical monitor decision|1|||
124892179|NCT00333788|449226012|FG000|Overall Study|Other: Physician decision|1|||
124892180|NCT00333788|449226012|FG000|Overall Study|Other: Signed consent for another study|1|||
124892181|NCT04951479|449226013|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
124892182|NCT01268059|449227775|FG000|Overall Study|Lost to Follow-up|0|||
124892183|NCT01268059|449227776|FG001|Overall Study|Lost to Follow-up|1|||
124892184|NCT01268059|449227777|FG002|Overall Study|Lost to Follow-up|0|||
124892185|NCT01268059|449227778|FG003|Overall Study|Lost to Follow-up|0|||
124892186|NCT01268059|449227775|FG000|Overall Study|Withdrawal by Subject|7|||
124892187|NCT01268059|449227776|FG001|Overall Study|Withdrawal by Subject|4|||
124892188|NCT01268059|449227777|FG002|Overall Study|Withdrawal by Subject|0|||
124892189|NCT01268059|449227778|FG003|Overall Study|Withdrawal by Subject|0|||
124892190|NCT01268059|449227775|FG000|Overall Study|Death|20|||
124892191|NCT01268059|449227776|FG001|Overall Study|Death|30|||
124892192|NCT01268059|449227777|FG002|Overall Study|Death|3|||
124892193|NCT01268059|449227778|FG003|Overall Study|Death|5|||
124892194|NCT01268059|449227775|FG000|Overall Study|Progression of disease|1|||
124892195|NCT01268059|449227776|FG001|Overall Study|Progression of disease|0|||
124892196|NCT01268059|449227777|FG002|Overall Study|Progression of disease|0|||
124892197|NCT01268059|449227778|FG003|Overall Study|Progression of disease|0|||
124892198|NCT02819479|449227779|FG000|Overall Study|Adverse Event|2|||
124892199|NCT05310084|449227780|FG000|Overall Study|Withdrawal by Subject|2|||
124892200|NCT05310084|449227781|FG001|Overall Study|Withdrawal by Subject|3|||
124892201|NCT05310084|449227780|FG000|Overall Study|Participant availability|0|||
124892202|NCT05310084|449227781|FG001|Overall Study|Participant availability|4|||
124892203|NCT05310084|449227780|FG000|Overall Study|Lost to Follow-up|1|||
124892204|NCT05310084|449227781|FG001|Overall Study|Lost to Follow-up|1|||
124892205|NCT05310084|449227780|FG000|Overall Study|Adverse Event|1|||
124892206|NCT05310084|449227781|FG001|Overall Study|Adverse Event|1|||
124892207|NCT05310084|449227780|FG000|Overall Study|Randomized but not vaccinated|4|||
124892208|NCT05310084|449227781|FG001|Overall Study|Randomized but not vaccinated|2|||
124892209|NCT01021332|449227783|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
124892210|NCT01021332|449227783|FG000|Overall Study|Adverse Event|43|||
124892211|NCT01021332|449227783|FG000|Overall Study|Lack of Efficacy|19|||
124892212|NCT01021332|449227783|FG000|Overall Study|Withdrawal of Consent|23|||
124892213|NCT01021332|449227783|FG000|Overall Study|Lost to Follow-up|4|||
124892214|NCT01021332|449227783|FG000|Overall Study|Protocol Violation|9|||
124892215|NCT01021332|449227783|FG000|Overall Study|Miscellaneous|3|||
124892216|NCT03487666|449227786|FG000|Overall Study|Disease progression|4|||
124892217|NCT03487666|449227787|FG001|Overall Study|Disease progression|2|||
124892218|NCT03487666|449227788|FG002|Overall Study|Disease progression|0|||
124892219|NCT03487666|449227786|FG000|Overall Study|Adverse Event|0|||
124892220|NCT03487666|449227787|FG001|Overall Study|Adverse Event|0|||
124892221|NCT03487666|449227788|FG002|Overall Study|Adverse Event|1|||
124892222|NCT05343455|449227791|FG000|Overall Study|Withdrawal by Subject|4|||
124892223|NCT05343455|449227792|FG001|Overall Study|Withdrawal by Subject|9|||
124892224|NCT05343455|449227793|FG002|Overall Study|Withdrawal by Subject|7|||
124892225|NCT05343455|449227791|FG000|Overall Study|Adverse Event|2|||
124892226|NCT05343455|449227792|FG001|Overall Study|Adverse Event|1|||
124892227|NCT05343455|449227793|FG002|Overall Study|Adverse Event|2|||
124892228|NCT05343455|449227791|FG000|Overall Study|Lost to Follow-up|1|||
124892229|NCT05343455|449227792|FG001|Overall Study|Lost to Follow-up|1|||
124892230|NCT05343455|449227793|FG002|Overall Study|Lost to Follow-up|3|||
124892231|NCT05343455|449227791|FG000|Overall Study|Pregnancy|1|||
124892232|NCT05343455|449227792|FG001|Overall Study|Pregnancy|0|||
124892233|NCT05343455|449227793|FG002|Overall Study|Pregnancy|0|||
124892234|NCT05343455|449227791|FG000|Overall Study|Physician Decision|0|||
124892235|NCT05343455|449227792|FG001|Overall Study|Physician Decision|0|||
124892236|NCT05343455|449227793|FG002|Overall Study|Physician Decision|1|||
124892237|NCT05343455|449227791|FG000|Overall Study|Protocol Violation|0|||
124892238|NCT05343455|449227792|FG001|Overall Study|Protocol Violation|1|||
124892239|NCT05343455|449227793|FG002|Overall Study|Protocol Violation|1|||
124892240|NCT02748512|449227798|FG000|Overall Study|Lost to Follow-up|1|||
124892241|NCT02748512|449227799|FG001|Overall Study|Lost to Follow-up|1|||
124892242|NCT00765362|449227801|FG000|Overall Study|Death|9|||
124892243|NCT00765362|449227801|FG000|Overall Study|Adverse Event|2|||
124892244|NCT00765362|449227801|FG000|Overall Study|Protocol Violation|18|||
124892245|NCT00765362|449227801|FG000|Overall Study|Withdrawal by Subject|13|||
124892246|NCT00765362|449227801|FG000|Overall Study|Lost to Follow-up|95|||
124892247|NCT03019458|449227802|FG000|Overall Study|Death|0|||
124892248|NCT03019458|449227803|FG001|Overall Study|Death|1|||
124892249|NCT00031447|449227804|FG000|Overall Study|Lost to Follow-up|0|||
124892250|NCT00031447|449227805|FG001|Overall Study|Lost to Follow-up|1|||
124892251|NCT00031447|449227804|FG000|Overall Study|Non-compliant|1|||
124892252|NCT00031447|449227805|FG001|Overall Study|Non-compliant|1|||
124892253|NCT00031447|449227804|FG000|Overall Study|Re-activation of Disease|2|||
124892254|NCT00031447|449227805|FG001|Overall Study|Re-activation of Disease|1|||
124892255|NCT00031447|449227804|FG000|Overall Study|Disruption of blinded study drug supply|7|||
124892256|NCT00031447|449227805|FG001|Overall Study|Disruption of blinded study drug supply|4|||
124892257|NCT01636362|449227806|FG000|Overall Study|Physician Decision|6|||
124892258|NCT01636362|449227806|FG000|Overall Study|Subject healed, not returning|1|||
124892259|NCT01636362|449227806|FG000|Overall Study|Withdrawal by Subject|1|||
124892260|NCT01244763|449227807|FG000|Overall Study|Adverse Event|1|||
124892261|NCT01244763|449227808|FG001|Overall Study|Adverse Event|0|||
124892262|NCT01244763|449227809|FG002|Overall Study|Adverse Event|0|||
124892263|NCT01244763|449227810|FG003|Overall Study|Adverse Event|0|||
124892264|NCT01244763|449227811|FG004|Overall Study|Adverse Event|0|||
124892265|NCT01244763|449227812|FG005|Overall Study|Adverse Event|1|||
124892266|NCT01244763|449227807|FG000|Overall Study|Death|1|||
124892267|NCT01244763|449227808|FG001|Overall Study|Death|0|||
124892268|NCT01244763|449227809|FG002|Overall Study|Death|1|||
124892269|NCT01244763|449227810|FG003|Overall Study|Death|0|||
124892270|NCT01244763|449227811|FG004|Overall Study|Death|2|||
124892271|NCT01244763|449227812|FG005|Overall Study|Death|0|||
124892272|NCT01244763|449227807|FG000|Overall Study|Physician Decision|0|||
124892273|NCT01244763|449227808|FG001|Overall Study|Physician Decision|0|||
124892274|NCT01244763|449227809|FG002|Overall Study|Physician Decision|1|||
125017171|NCT03016325|449687717|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
125017172|NCT03016325|449687718|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
125017173|NCT03016325|449687711|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
125017174|NCT03016325|449687712|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
125017175|NCT03016325|449687713|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
124892275|NCT01244763|449227810|FG003|Overall Study|Physician Decision|0|||
124892276|NCT01244763|449227811|FG004|Overall Study|Physician Decision|0|||
124892277|NCT01244763|449227812|FG005|Overall Study|Physician Decision|0|||
124892278|NCT01244763|449227807|FG000|Overall Study|Withdrawal by Subject|1|||
124892279|NCT01244763|449227808|FG001|Overall Study|Withdrawal by Subject|2|||
124892280|NCT01244763|449227809|FG002|Overall Study|Withdrawal by Subject|0|||
124892281|NCT01244763|449227810|FG003|Overall Study|Withdrawal by Subject|1|||
124892282|NCT01244763|449227811|FG004|Overall Study|Withdrawal by Subject|1|||
124892283|NCT01244763|449227812|FG005|Overall Study|Withdrawal by Subject|2|||
124892284|NCT01244763|449227807|FG000|Overall Study|Lost to Follow-up|0|||
124892285|NCT01244763|449227808|FG001|Overall Study|Lost to Follow-up|1|||
124892286|NCT01244763|449227809|FG002|Overall Study|Lost to Follow-up|0|||
125017176|NCT03016325|449687714|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
125017177|NCT03016325|449687715|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
125017178|NCT03016325|449687716|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
124892287|NCT01244763|449227810|FG003|Overall Study|Lost to Follow-up|0|||
124892288|NCT01244763|449227811|FG004|Overall Study|Lost to Follow-up|0|||
124892289|NCT01244763|449227812|FG005|Overall Study|Lost to Follow-up|0|||
124892290|NCT01244763|449227807|FG000|Overall Study|Enrolled into the Extension Study|0|||
124892291|NCT01244763|449227808|FG001|Overall Study|Enrolled into the Extension Study|0|||
124892292|NCT01244763|449227809|FG002|Overall Study|Enrolled into the Extension Study|0|||
124892293|NCT01244763|449227810|FG003|Overall Study|Enrolled into the Extension Study|0|||
124892294|NCT01244763|449227811|FG004|Overall Study|Enrolled into the Extension Study|0|||
124892295|NCT01244763|449227812|FG005|Overall Study|Enrolled into the Extension Study|1|||
124892296|NCT01561079|449227816|FG000|Overall Study|Physician Decision|17|||
124892297|NCT01561079|449227816|FG000|Overall Study|Withdrawal by Subject|59|||
124892298|NCT01561079|449227816|FG000|Overall Study|Protocol Violation|2|||
124892299|NCT00664521|449227822|FG000|Overall Study|Adverse Event|4|||
124892300|NCT00664521|449227823|FG001|Overall Study|Adverse Event|1|||
124892301|NCT00664521|449227822|FG000|Overall Study|Lost to Follow-up|1|||
124892302|NCT00664521|449227823|FG001|Overall Study|Lost to Follow-up|0|||
124892303|NCT00664521|449227822|FG000|Overall Study|Other|1|||
124892304|NCT00664521|449227823|FG001|Overall Study|Other|0|||
124892305|NCT02459964|449227824|FG000|Overall Study|Withdrawal by Subject|0|||
124892306|NCT02459964|449227825|FG001|Overall Study|Withdrawal by Subject|0|||
124892307|NCT02459964|449227826|FG002|Overall Study|Withdrawal by Subject|1|||
124892308|NCT02459964|449227824|FG000|Overall Study|Abnormal EKG changes|0|||
124892309|NCT02459964|449227825|FG001|Overall Study|Abnormal EKG changes|0|||
124892310|NCT02459964|449227826|FG002|Overall Study|Abnormal EKG changes|1|||
124892311|NCT00367237|449227827|FG000|Overall Study|Adverse Event|7|||
125017179|NCT03016325|449687717|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
125017180|NCT03016325|449687718|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
125107199|NCT00833976|450017178|FG000|Overall Study|Did not meet eligibility criteria|41|||
125107200|NCT00833976|450017178|FG000|Overall Study|Physician Decision|1|||
125107201|NCT03911960|450017179|FG000|Overall Study|Lost to Follow-up|5|||
125107202|NCT03911960|450017180|FG001|Overall Study|Lost to Follow-up|3|||
124892312|NCT00367237|449227828|FG001|Overall Study|Adverse Event|2|||
124892313|NCT00367237|449227827|FG000|Overall Study|Lost to Follow-up|1|||
124892314|NCT00367237|449227828|FG001|Overall Study|Lost to Follow-up|0|||
124892315|NCT00367237|449227827|FG000|Overall Study|Withdrawal by Subject|0|||
124892316|NCT00367237|449227828|FG001|Overall Study|Withdrawal by Subject|4|||
125107203|NCT02239692|450017181|FG000|Overall Study|Incomplete colonoscopy|1|||
124892317|NCT00367237|449227827|FG000|Overall Study|Protocol Violation|2|||
124892318|NCT00367237|449227828|FG001|Overall Study|Protocol Violation|5|||
124892319|NCT02800928|449227831|FG000|Overall Study|Withdrawal by Subject|1|||
124892320|NCT02800928|449227832|FG001|Overall Study|Withdrawal by Subject|1|||
124892321|NCT02800928|449227831|FG000|Overall Study|Protocol Violation|1|||
124892322|NCT02800928|449227832|FG001|Overall Study|Protocol Violation|1|||
124892323|NCT00953160|449227845|FG000|Overall Study|Lost to Follow-up|23|||
124892324|NCT00953160|449227845|FG000|Overall Study|Withdrawal by Subject|4|||
124892325|NCT00570661|449227852|FG000|Overall Study|Disease worsening|5|||
124892326|NCT00570661|449227852|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
124892327|NCT00570661|449227852|FG000|Overall Study|Adverse Event|1|||
124892328|NCT01052662|449227855|FG000|Overall Study|Lost to Follow-up|15|||
124892329|NCT01052662|449227856|FG001|Overall Study|Lost to Follow-up|13|||
124892330|NCT01052662|449227857|FG002|Overall Study|Lost to Follow-up|18|||
124892331|NCT01052662|449227855|FG000|Overall Study|Withdrawal by Subject|3|||
124892332|NCT01052662|449227856|FG001|Overall Study|Withdrawal by Subject|2|||
124892333|NCT01052662|449227857|FG002|Overall Study|Withdrawal by Subject|1|||
124892334|NCT01052662|449227855|FG000|Overall Study|Pharmacy issue|1|||
124892335|NCT01052662|449227856|FG001|Overall Study|Pharmacy issue|3|||
124892336|NCT01052662|449227857|FG002|Overall Study|Pharmacy issue|3|||
124892337|NCT01052662|449227855|FG000|Overall Study|Adverse Event|1|||
124892338|NCT01052662|449227856|FG001|Overall Study|Adverse Event|1|||
124892339|NCT01052662|449227857|FG002|Overall Study|Adverse Event|0|||
124892340|NCT01052662|449227855|FG000|Overall Study|Legal Problem|2|||
124892341|NCT01052662|449227856|FG001|Overall Study|Legal Problem|0|||
124892342|NCT01052662|449227857|FG002|Overall Study|Legal Problem|0|||
124892343|NCT01052662|449227855|FG000|Overall Study|Administrative|0|||
124892344|NCT01052662|449227856|FG001|Overall Study|Administrative|3|||
124892345|NCT01052662|449227857|FG002|Overall Study|Administrative|0|||
124892346|NCT02015663|449227859|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
124892347|NCT02015663|449227860|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
124892348|NCT02015663|449227859|FG000|Overall Study|Withdrawal by Subject|1|||
124892349|NCT02015663|449227860|FG001|Overall Study|Withdrawal by Subject|0|||
124892350|NCT02015663|449227859|FG000|Overall Study|Protocol Violation|0|||
124892351|NCT02015663|449227860|FG001|Overall Study|Protocol Violation|1|||
124892352|NCT02015663|449227859|FG000|Overall Study|Adverse Event|3|||
124892353|NCT02015663|449227860|FG001|Overall Study|Adverse Event|0|||
124892354|NCT02015663|449227859|FG000|Overall Study|Administrative problems|10|||
124892355|NCT02015663|449227860|FG001|Overall Study|Administrative problems|11|||
124892356|NCT01113463|449227861|FG000|Overall Study|Physician Decision|5|||
124892357|NCT03293485|449227863|FG000|Overall Study|Death|1|||
124892358|NCT03293485|449227863|FG000|Overall Study|Screen Failure|2|||
124892359|NCT03293485|449227863|FG000|Overall Study|Withdrawal by Subject|2|||
124892360|NCT00087490|449227864|FG000|Overall Study|Death|6|||
124892361|NCT00087490|449227865|FG001|Overall Study|Death|4|||
124892362|NCT00087490|449227864|FG000|Overall Study|Adverse Event|3|||
124892363|NCT00087490|449227865|FG001|Overall Study|Adverse Event|8|||
124892364|NCT00087490|449227864|FG000|Overall Study|Lack of Efficacy|0|||
124892365|NCT00087490|449227865|FG001|Overall Study|Lack of Efficacy|2|||
124892366|NCT00087490|449227864|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
124892367|NCT00087490|449227865|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
124892368|NCT00087490|449227864|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
124892369|NCT00087490|449227865|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
124892370|NCT00087490|449227864|FG000|Overall Study|Randomized but not treated|7|||
124892371|NCT00087490|449227865|FG001|Overall Study|Randomized but not treated|18|||
124892372|NCT02034435|449227866|FG000|Overall Study|Withdrawal by Subject|1|||
124892373|NCT02034435|449227867|FG001|Overall Study|Withdrawal by Subject|0|||
124892374|NCT02034435|449227868|FG002|Overall Study|Withdrawal by Subject|0|||
124892375|NCT02034435|449227869|FG003|Overall Study|Withdrawal by Subject|0|||
124892376|NCT02034435|449227866|FG000|Overall Study|Illness|0|||
124892377|NCT02034435|449227867|FG001|Overall Study|Illness|2|||
124892378|NCT02034435|449227868|FG002|Overall Study|Illness|0|||
124892379|NCT02034435|449227869|FG003|Overall Study|Illness|0|||
124892380|NCT02034435|449227866|FG000|Overall Study|Inadequate IV access|1|||
124892381|NCT02034435|449227867|FG001|Overall Study|Inadequate IV access|0|||
124892382|NCT02034435|449227868|FG002|Overall Study|Inadequate IV access|0|||
124892383|NCT02034435|449227869|FG003|Overall Study|Inadequate IV access|1|||
124892384|NCT03379233|449227870|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
124892385|NCT03379233|449227871|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
124892386|NCT02300311|449227872|FG000|Overall Study|Other than the reason specified|1|||
124892387|NCT02300311|449227873|FG001|Overall Study|Other than the reason specified|0|||
124892388|NCT02300311|449227872|FG000|Overall Study|Refused to continue taking medication|18|||
124892389|NCT02300311|449227873|FG001|Overall Study|Refused to continue taking medication|0|||
124892390|NCT02015195|449227879|FG000|Overall Study|Adverse Event|0|||
124892391|NCT02015195|449227880|FG001|Overall Study|Adverse Event|0|||
124892392|NCT02015195|449227881|FG002|Overall Study|Adverse Event|0|||
124892393|NCT02015195|449227882|FG003|Overall Study|Adverse Event|1|||
124892394|NCT02015195|449227883|FG004|Overall Study|Adverse Event|0|||
124892395|NCT02015195|449227884|FG005|Overall Study|Adverse Event|0|||
124892396|NCT02015195|449227885|FG006|Overall Study|Adverse Event|0|||
124892397|NCT01318811|449227886|FG000|Overall Study|Physician Decision|1|||
124892398|NCT01318811|449227887|FG001|Overall Study|Physician Decision|1|||
124892399|NCT01318811|449227886|FG000|Overall Study|CRRT stopped for head CT|0|||
124892400|NCT01318811|449227887|FG001|Overall Study|CRRT stopped for head CT|1|||
124892401|NCT01318811|449227886|FG000|Overall Study|Death|0|||
124892402|NCT01318811|449227887|FG001|Overall Study|Death|1|||
124892403|NCT01318811|449227886|FG000|Overall Study|CRRT stopped for head MRI|0|||
124892404|NCT01318811|449227887|FG001|Overall Study|CRRT stopped for head MRI|1|||
124892405|NCT00811187|449227888|FG000|Overall Study|Unable to place device / procedure abort|3|||
124892406|NCT00811187|449227889|FG001|Overall Study|Unable to place device / procedure abort|3|||
124892407|NCT00131911|449227890|FG000|Overall Study|Withdrawal by Subject|1|||
124892408|NCT00131911|449227891|FG001|Overall Study|Withdrawal by Subject|0|||
124892409|NCT00329303|449227892|FG000|Overall Study|Lack of Efficacy|1|||
124892410|NCT00329303|449227893|FG001|Overall Study|Lack of Efficacy|0|||
124892411|NCT00329303|449227892|FG000|Overall Study|Decision of the sponsor|0|||
124892412|NCT00329303|449227893|FG001|Overall Study|Decision of the sponsor|1|||
124892413|NCT00329303|449227892|FG000|Overall Study|Patient no longer available|1|||
124892414|NCT00329303|449227893|FG001|Overall Study|Patient no longer available|0|||
124892415|NCT00329303|449227892|FG000|Overall Study|Patient relocated|0|||
124892416|NCT00329303|449227893|FG001|Overall Study|Patient relocated|1|||
124892417|NCT00994279|449227898|FG000|Overall Study|Withdrawal by Subject|2|||
124892418|NCT00994279|449227899|FG001|Overall Study|Withdrawal by Subject|2|||
124892419|NCT00994279|449227898|FG000|Overall Study|Toxicity|1|||
124892420|NCT00994279|449227899|FG001|Overall Study|Toxicity|0|||
124892421|NCT00994279|449227898|FG000|Overall Study|Multiple reasons|1|||
124892422|NCT00994279|449227899|FG001|Overall Study|Multiple reasons|3|||
124892423|NCT04833855|449227900|FG000|Overall Study|Decision by sponsor|0|||
124892424|NCT04833855|449227901|FG001|Overall Study|Decision by sponsor|1|||
124892425|NCT04833855|449227902|FG002|Overall Study|Decision by sponsor|0|||
124892426|NCT04833855|449227903|FG003|Overall Study|Decision by sponsor|0|||
124892427|NCT04833855|449227900|FG000|Overall Study|Withdrawal by Subject|4|||
124892428|NCT04833855|449227901|FG001|Overall Study|Withdrawal by Subject|1|||
124892429|NCT04833855|449227902|FG002|Overall Study|Withdrawal by Subject|3|||
124892430|NCT04833855|449227903|FG003|Overall Study|Withdrawal by Subject|1|||
124892431|NCT04833855|449227900|FG000|Overall Study|Lost to Follow-up|1|||
124892432|NCT04833855|449227901|FG001|Overall Study|Lost to Follow-up|0|||
124892433|NCT04833855|449227902|FG002|Overall Study|Lost to Follow-up|2|||
124892434|NCT04833855|449227903|FG003|Overall Study|Lost to Follow-up|2|||
124892435|NCT04833855|449227900|FG000|Overall Study|Protocol specified criteria|0|||
124892436|NCT04833855|449227901|FG001|Overall Study|Protocol specified criteria|0|||
124892437|NCT04833855|449227902|FG002|Overall Study|Protocol specified criteria|2|||
124892438|NCT04833855|449227903|FG003|Overall Study|Protocol specified criteria|1|||
124892439|NCT03008122|449227904|FG000|Overall Study|Physician Decision|3|||
124892440|NCT03008122|449227905|FG001|Overall Study|Physician Decision|2|||
124892441|NCT03008122|449227906|FG002|Overall Study|Physician Decision|0|||
124892442|NCT03008122|449227904|FG000|Overall Study|Withdrawal by Subject|1|||
124892443|NCT03008122|449227905|FG001|Overall Study|Withdrawal by Subject|3|||
124892444|NCT03008122|449227906|FG002|Overall Study|Withdrawal by Subject|0|||
124892445|NCT03008122|449227904|FG000|Overall Study|Lost to Follow-up|4|||
124892446|NCT03008122|449227905|FG001|Overall Study|Lost to Follow-up|8|||
124892447|NCT03008122|449227906|FG002|Overall Study|Lost to Follow-up|3|||
124892448|NCT03008122|449227904|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
124892449|NCT03008122|449227905|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
124892450|NCT03008122|449227906|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
124892451|NCT03008122|449227904|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
124892452|NCT03008122|449227905|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
124892453|NCT03008122|449227906|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
124892454|NCT03008122|449227904|FG000|Overall Study|Death|0|||
124892455|NCT03008122|449227905|FG001|Overall Study|Death|0|||
124892456|NCT03008122|449227906|FG002|Overall Study|Death|1|||
124892457|NCT04529538|449227908|FG000|Overall Study|Lost to Follow-up|3|||
124892458|NCT04529538|449227909|FG001|Overall Study|Lost to Follow-up|2|||
124892459|NCT04529538|449227910|FG002|Overall Study|Lost to Follow-up|1|||
125017181|NCT03016325|449687711|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
125017182|NCT03016325|449687712|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
124892460|NCT04529538|449227911|FG003|Overall Study|Lost to Follow-up|0|||
124892461|NCT04529538|449227912|FG004|Overall Study|Lost to Follow-up|1|||
124892462|NCT04529538|449227913|FG005|Overall Study|Lost to Follow-up|1|||
124892463|NCT04529538|449227914|FG006|Overall Study|Lost to Follow-up|2|||
124892464|NCT04529538|449227915|FG007|Overall Study|Lost to Follow-up|0|||
125017183|NCT03016325|449687713|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
124892465|NCT04529538|449227908|FG000|Overall Study|Not eligible at enrollment|0|||
124892466|NCT04529538|449227909|FG001|Overall Study|Not eligible at enrollment|1|||
124892467|NCT04529538|449227910|FG002|Overall Study|Not eligible at enrollment|2|||
124892468|NCT04529538|449227911|FG003|Overall Study|Not eligible at enrollment|1|||
124892469|NCT04529538|449227912|FG004|Overall Study|Not eligible at enrollment|0|||
124892470|NCT04529538|449227913|FG005|Overall Study|Not eligible at enrollment|0|||
124892471|NCT04529538|449227914|FG006|Overall Study|Not eligible at enrollment|0|||
124892472|NCT04529538|449227915|FG007|Overall Study|Not eligible at enrollment|1|||
124892473|NCT04529538|449227908|FG000|Overall Study|Withdrawal by Subject|0|||
124892474|NCT04529538|449227909|FG001|Overall Study|Withdrawal by Subject|1|||
124892475|NCT04529538|449227910|FG002|Overall Study|Withdrawal by Subject|1|||
124892476|NCT04529538|449227911|FG003|Overall Study|Withdrawal by Subject|2|||
124892477|NCT04529538|449227912|FG004|Overall Study|Withdrawal by Subject|0|||
124892478|NCT04529538|449227913|FG005|Overall Study|Withdrawal by Subject|2|||
124892479|NCT04529538|449227914|FG006|Overall Study|Withdrawal by Subject|3|||
124892480|NCT04529538|449227915|FG007|Overall Study|Withdrawal by Subject|0|||
124892481|NCT04529538|449227908|FG000|Overall Study|Other|0|||
124892482|NCT04529538|449227909|FG001|Overall Study|Other|1|||
124892483|NCT04529538|449227910|FG002|Overall Study|Other|0|||
124892484|NCT04529538|449227911|FG003|Overall Study|Other|0|||
124892485|NCT04529538|449227912|FG004|Overall Study|Other|0|||
124892486|NCT04529538|449227913|FG005|Overall Study|Other|0|||
124892487|NCT04529538|449227914|FG006|Overall Study|Other|0|||
124892488|NCT04529538|449227915|FG007|Overall Study|Other|0|||
124892489|NCT04529538|449227908|FG000|Overall Study|Adverse Event|0|||
124892490|NCT04529538|449227909|FG001|Overall Study|Adverse Event|0|||
124892491|NCT04529538|449227910|FG002|Overall Study|Adverse Event|0|||
124892492|NCT04529538|449227911|FG003|Overall Study|Adverse Event|1|||
124892493|NCT04529538|449227912|FG004|Overall Study|Adverse Event|0|||
124892494|NCT04529538|449227913|FG005|Overall Study|Adverse Event|0|||
124892495|NCT04529538|449227914|FG006|Overall Study|Adverse Event|0|||
124892496|NCT04529538|449227915|FG007|Overall Study|Adverse Event|0|||
124892497|NCT04529538|449227908|FG000|Overall Study|Protocol Deviation|0|||
124892498|NCT04529538|449227909|FG001|Overall Study|Protocol Deviation|0|||
124892499|NCT04529538|449227910|FG002|Overall Study|Protocol Deviation|0|||
124892500|NCT04529538|449227911|FG003|Overall Study|Protocol Deviation|1|||
124892501|NCT04529538|449227912|FG004|Overall Study|Protocol Deviation|0|||
124892502|NCT04529538|449227913|FG005|Overall Study|Protocol Deviation|0|||
124892503|NCT04529538|449227914|FG006|Overall Study|Protocol Deviation|0|||
124892504|NCT04529538|449227915|FG007|Overall Study|Protocol Deviation|0|||
124892505|NCT04529538|449227908|FG000|Overall Study|Physician Decision|0|||
124892506|NCT04529538|449227909|FG001|Overall Study|Physician Decision|0|||
124892507|NCT04529538|449227910|FG002|Overall Study|Physician Decision|0|||
124892508|NCT04529538|449227911|FG003|Overall Study|Physician Decision|0|||
124892509|NCT04529538|449227912|FG004|Overall Study|Physician Decision|0|||
124892510|NCT04529538|449227913|FG005|Overall Study|Physician Decision|1|||
124892511|NCT04529538|449227914|FG006|Overall Study|Physician Decision|0|||
124892512|NCT04529538|449227915|FG007|Overall Study|Physician Decision|1|||
124892513|NCT02322775|449227916|FG000|Overall Study|Adverse Event|1|||
124892514|NCT02322775|449227917|FG001|Overall Study|Adverse Event|0|||
124892515|NCT02322775|449227916|FG000|Overall Study|Lost to Follow-up|0|||
124892516|NCT02322775|449227917|FG001|Overall Study|Lost to Follow-up|1|||
124892517|NCT02322775|449227916|FG000|Overall Study|Protocol Violation|1|||
124892518|NCT02322775|449227917|FG001|Overall Study|Protocol Violation|0|||
124892519|NCT02322775|449227916|FG000|Overall Study|Withdrawal by Subject|3|||
124892520|NCT02322775|449227917|FG001|Overall Study|Withdrawal by Subject|4|||
124892521|NCT02322775|449227916|FG000|Overall Study|Not willing to perform all FU visits|0|||
124892522|NCT02322775|449227917|FG001|Overall Study|Not willing to perform all FU visits|1|||
124892523|NCT01641861|449227918|FG000|Overall Study|Lost to Follow-up|21|||
124892524|NCT01641861|449227919|FG001|Overall Study|Lost to Follow-up|16|||
124892525|NCT01641861|449227918|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
124892526|NCT01641861|449227919|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
124892527|NCT01641861|449227918|FG000|Overall Study|Died due to drowning|0|||
124892528|NCT01641861|449227919|FG001|Overall Study|Died due to drowning|1|||
124892529|NCT05567952|449229886|FG000|Overall Study|Lost to Follow-up|3|||
124892530|NCT05567952|449229887|FG001|Overall Study|Lost to Follow-up|2|||
124892531|NCT05567952|449229886|FG000|Overall Study|Withdrawal by Subject|6|||
124892532|NCT05567952|449229887|FG001|Overall Study|Withdrawal by Subject|3|||
124892533|NCT05567952|449229886|FG000|Overall Study|Other|3|||
124892534|NCT05567952|449229887|FG001|Overall Study|Other|1|||
124892535|NCT00777803|449229888|FG000|Overall Study|Lost to Follow-up|12|||
124892536|NCT00777803|449229889|FG001|Overall Study|Lost to Follow-up|5|||
124892537|NCT00777803|449229888|FG000|Overall Study|Adverse Event|1|||
124892538|NCT00777803|449229889|FG001|Overall Study|Adverse Event|0|||
124892539|NCT00777803|449229888|FG000|Overall Study|Non-compliance|2|||
124892540|NCT00777803|449229889|FG001|Overall Study|Non-compliance|2|||
124892541|NCT04213846|449229890|FG000|Overall Study|Withdrawal by Subject|7|||
124892542|NCT04213846|449229891|FG001|Overall Study|Withdrawal by Subject|6|||
124892543|NCT04213846|449229890|FG000|Overall Study|Lost to Follow-up|15|||
124892544|NCT04213846|449229891|FG001|Overall Study|Lost to Follow-up|21|||
124892545|NCT04423393|449229892|FG000|Overall Study|Withdrawal by Subject|0|||
124892546|NCT04423393|449229893|FG001|Overall Study|Withdrawal by Subject|0|||
124892547|NCT04423393|449229894|FG002|Overall Study|Withdrawal by Subject|0|||
124892548|NCT04423393|449229895|FG003|Overall Study|Withdrawal by Subject|0|||
124892549|NCT04423393|449229896|FG004|Overall Study|Withdrawal by Subject|0|||
124892550|NCT04423393|449229897|FG005|Overall Study|Withdrawal by Subject|1|||
124892551|NCT04423393|449229898|FG006|Overall Study|Withdrawal by Subject|0|||
124892552|NCT04423393|449229899|FG007|Overall Study|Withdrawal by Subject|0|||
124892553|NCT04423393|449229900|FG008|Overall Study|Withdrawal by Subject|0|||
124892554|NCT04423393|449229901|FG009|Overall Study|Withdrawal by Subject|0|||
124892555|NCT04423393|449229902|FG010|Overall Study|Withdrawal by Subject|0|||
124892556|NCT04423393|449229903|FG011|Overall Study|Withdrawal by Subject|0|||
124892557|NCT04423393|449229904|FG012|Overall Study|Withdrawal by Subject|0|||
124892558|NCT04423393|449229905|FG013|Overall Study|Withdrawal by Subject|1|||
125017184|NCT03016325|449687714|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
125017185|NCT03016325|449687715|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
125017186|NCT03016325|449687716|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
125017187|NCT03016325|449687717|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
125017188|NCT03016325|449687718|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
125017189|NCT03016325|449687711|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
125017190|NCT03016325|449687712|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
125017191|NCT03016325|449687713|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
125017192|NCT03016325|449687714|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
125017193|NCT03016325|449687715|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
124892559|NCT04423393|449229906|FG014|Overall Study|Withdrawal by Subject|0|||
124892560|NCT04423393|449229907|FG015|Overall Study|Withdrawal by Subject|0|||
124892561|NCT04423393|449229908|FG016|Overall Study|Withdrawal by Subject|0|||
125017194|NCT03016325|449687716|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
125017195|NCT03016325|449687717|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
125017196|NCT03016325|449687718|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
125017197|NCT03016325|449687711|FG000|182-Day Follow-Up Period|Death|3|||
124892562|NCT04423393|449229909|FG017|Overall Study|Withdrawal by Subject|0|||
124892563|NCT04423393|449229892|FG000|Overall Study|Sponsor Decision|0|||
124892564|NCT04423393|449229893|FG001|Overall Study|Sponsor Decision|0|||
124892565|NCT04423393|449229894|FG002|Overall Study|Sponsor Decision|0|||
124892566|NCT04423393|449229895|FG003|Overall Study|Sponsor Decision|0|||
124892567|NCT04423393|449229896|FG004|Overall Study|Sponsor Decision|0|||
124892568|NCT04423393|449229897|FG005|Overall Study|Sponsor Decision|0|||
124892569|NCT04423393|449229898|FG006|Overall Study|Sponsor Decision|0|||
124892570|NCT04423393|449229899|FG007|Overall Study|Sponsor Decision|0|||
124892571|NCT04423393|449229900|FG008|Overall Study|Sponsor Decision|0|||
124892572|NCT04423393|449229901|FG009|Overall Study|Sponsor Decision|0|||
124892573|NCT04423393|449229902|FG010|Overall Study|Sponsor Decision|0|||
124892574|NCT04423393|449229903|FG011|Overall Study|Sponsor Decision|0|||
124892575|NCT04423393|449229904|FG012|Overall Study|Sponsor Decision|0|||
124892576|NCT04423393|449229905|FG013|Overall Study|Sponsor Decision|1|||
124892577|NCT04423393|449229906|FG014|Overall Study|Sponsor Decision|0|||
124892578|NCT04423393|449229907|FG015|Overall Study|Sponsor Decision|0|||
124892579|NCT04423393|449229908|FG016|Overall Study|Sponsor Decision|0|||
124892580|NCT04423393|449229909|FG017|Overall Study|Sponsor Decision|0|||
125017198|NCT03016325|449687712|FG001|182-Day Follow-Up Period|Death|3|||
125017199|NCT03016325|449687713|FG002|182-Day Follow-Up Period|Death|11|||
125017200|NCT03016325|449687714|FG003|182-Day Follow-Up Period|Death|12|||
125017201|NCT03016325|449687715|FG004|182-Day Follow-Up Period|Death|9|||
125017202|NCT03016325|449687716|FG005|182-Day Follow-Up Period|Death|0|||
125017203|NCT03016325|449687717|FG006|182-Day Follow-Up Period|Death|0|||
125017204|NCT03016325|449687718|FG007|182-Day Follow-Up Period|Death|1|||
125017205|NCT03016325|449687711|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
125017206|NCT03016325|449687712|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
125107204|NCT02239692|450017182|FG001|Overall Study|Incomplete colonoscopy|2|||
125107205|NCT02239692|450017181|FG000|Overall Study|Adverse Event|0|||
125107206|NCT02239692|450017182|FG001|Overall Study|Adverse Event|1|||
125107207|NCT02239692|450017181|FG000|Overall Study|Physician Decision|0|||
125107208|NCT02239692|450017182|FG001|Overall Study|Physician Decision|1|||
124892581|NCT00432159|449229912|FG000|Overall Study|Death|0|||
124892582|NCT00432159|449229913|FG001|Overall Study|Death|1|||
124892583|NCT00432159|449229914|FG002|Overall Study|Death|0|||
124892584|NCT00432159|449229915|FG003|Overall Study|Death|0|||
124892585|NCT00432159|449229916|FG004|Overall Study|Death|0|||
124892586|NCT00432159|449229912|FG000|Overall Study|Failure|9|||
124892587|NCT00432159|449229913|FG001|Overall Study|Failure|5|||
124892588|NCT00432159|449229914|FG002|Overall Study|Failure|3|||
125107209|NCT02239692|450017181|FG000|Overall Study|Lost to Follow-up|1|||
124892589|NCT00432159|449229915|FG003|Overall Study|Failure|2|||
124892590|NCT00432159|449229916|FG004|Overall Study|Failure|3|||
124892591|NCT00432159|449229912|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
124892592|NCT00432159|449229913|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
124892593|NCT00432159|449229914|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
124892594|NCT00432159|449229915|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
124892595|NCT00432159|449229916|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
124892596|NCT01115998|449229919|FG000|Overall Study|Lost to Follow-up|6|||
124892597|NCT01115998|449229920|FG001|Overall Study|Lost to Follow-up|6|||
124892598|NCT03850444|449229921|FG000|Overall Study|Adverse Event|16|||
124892599|NCT03850444|449229922|FG001|Overall Study|Adverse Event|10|||
124892600|NCT03850444|449229921|FG000|Overall Study|Death|87|||
124892601|NCT03850444|449229922|FG001|Overall Study|Death|107|||
124892602|NCT03850444|449229921|FG000|Overall Study|Lost to Follow-up|1|||
124892603|NCT03850444|449229922|FG001|Overall Study|Lost to Follow-up|1|||
124892604|NCT03850444|449229921|FG000|Overall Study|Withdrawal by Subject|1|||
124892605|NCT03850444|449229922|FG001|Overall Study|Withdrawal by Subject|5|||
124892606|NCT03850444|449229921|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
124892607|NCT03850444|449229922|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
124892608|NCT04096365|449229923|FG000|Overall Study|Adverse Event|1|||
124892609|NCT01598987|449229925|FG000|Baseline to Month 12|Administrative problems|2|||
124892610|NCT01598987|449229925|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
124892611|NCT01598987|449229925|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
124892612|NCT01598987|449229925|FG000|Baseline to 24 Month|Administrative problems|2|||
124892613|NCT01598987|449229925|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
124892614|NCT02107274|449229926|FG000|Treatment vs. Placebo|Adverse Event|3|||
124892615|NCT02107274|449229927|FG001|Treatment vs. Placebo|Adverse Event|0|||
124892616|NCT02107274|449229926|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
124892617|NCT02107274|449229927|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
124892618|NCT02107274|449229926|FG000|Control Phase|Lost to Follow-up|1|||
124892619|NCT02107274|449229927|FG001|Control Phase|Lost to Follow-up|1|||
124892620|NCT02107274|449229926|FG000|Control Phase|Death|2|||
124892621|NCT02107274|449229927|FG001|Control Phase|Death|0|||
124892622|NCT02107274|449229926|FG000|Control Phase|Adverse Event|0|||
124892623|NCT02107274|449229927|FG001|Control Phase|Adverse Event|1|||
124892624|NCT01036087|449229928|FG000|Overall Study|Adverse Event|2|||
124892625|NCT01036087|449229928|FG000|Overall Study|Lack of Efficacy|1|||
124892626|NCT01021878|449229932|FG000|Overall Study|Lost to Follow-up|4|||
124892627|NCT01021878|449229933|FG001|Overall Study|Lost to Follow-up|3|||
124892628|NCT01021878|449229932|FG000|Overall Study|Death|0|||
124892629|NCT01021878|449229933|FG001|Overall Study|Death|1|||
124892630|NCT01021878|449229932|FG000|Overall Study|Adverse Event|6|||
124892631|NCT01021878|449229933|FG001|Overall Study|Adverse Event|5|||
124892632|NCT01021878|449229932|FG000|Overall Study|Transplantation|6|||
124892633|NCT01021878|449229933|FG001|Overall Study|Transplantation|1|||
124892634|NCT05305040|449229937|FG000|Overall Study|Not Dosed|37|||
124892635|NCT05305040|449229938|FG001|Overall Study|Not Dosed|37|||
124892636|NCT05305040|449229937|FG000|Overall Study|Study Closure|34|||
124892637|NCT05305040|449229938|FG001|Overall Study|Study Closure|46|||
124892638|NCT05305040|449229937|FG000|Overall Study|Death|14|||
124892639|NCT05305040|449229938|FG001|Overall Study|Death|13|||
124892640|NCT05305040|449229937|FG000|Overall Study|Withdrawal by Subject|15|||
124892641|NCT05305040|449229938|FG001|Overall Study|Withdrawal by Subject|10|||
124892642|NCT05305040|449229937|FG000|Overall Study|Other|13|||
124892643|NCT05305040|449229938|FG001|Overall Study|Other|10|||
124892644|NCT05305040|449229937|FG000|Overall Study|Primary Malignancy Relapse|3|||
124892645|NCT05305040|449229938|FG001|Overall Study|Primary Malignancy Relapse|4|||
124892646|NCT05305040|449229937|FG000|Overall Study|Adverse Event|3|||
124892647|NCT05305040|449229938|FG001|Overall Study|Adverse Event|3|||
124892648|NCT05305040|449229937|FG000|Overall Study|Lost to Follow-up|2|||
125017207|NCT03016325|449687713|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
125017208|NCT03016325|449687714|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
125017209|NCT03016325|449687715|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
125017210|NCT03016325|449687716|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
125017211|NCT03016325|449687717|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
125017212|NCT03016325|449687718|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
125017213|NCT03016325|449687711|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
124892649|NCT05305040|449229938|FG001|Overall Study|Lost to Follow-up|1|||
124892650|NCT05305040|449229937|FG000|Overall Study|Graft versus host disease|2|||
124892651|NCT05305040|449229938|FG001|Overall Study|Graft versus host disease|0|||
124892652|NCT05305040|449229937|FG000|Overall Study|Investigator's Decision|1|||
124892653|NCT05305040|449229938|FG001|Overall Study|Investigator's Decision|1|||
124892654|NCT05305040|449229937|FG000|Overall Study|COVID-19 Reasons|1|||
124892655|NCT05305040|449229938|FG001|Overall Study|COVID-19 Reasons|0|||
124892656|NCT05406791|449229939|FG000|Overall Study|Lost to Follow-up|13|||
124892657|NCT05406791|449229940|FG001|Overall Study|Lost to Follow-up|10|||
124892658|NCT02297503|449229943|FG000|Overall Study|Withdrawal by Subject|1|||
124892659|NCT02297503|449229944|FG001|Overall Study|Withdrawal by Subject|1|||
124892660|NCT02297503|449229943|FG000|Overall Study|Protocol Violation|1|||
124892661|NCT02297503|449229944|FG001|Overall Study|Protocol Violation|0|||
124892662|NCT02297503|449229943|FG000|Overall Study|Pregnancy|0|||
124892663|NCT02297503|449229944|FG001|Overall Study|Pregnancy|1|||
124892664|NCT02297503|449229943|FG000|Overall Study|Lost to Follow-up|0|||
124892665|NCT02297503|449229944|FG001|Overall Study|Lost to Follow-up|1|||
124892666|NCT02297503|449229943|FG000|Overall Study|Medical reason|0|||
124892667|NCT02297503|449229944|FG001|Overall Study|Medical reason|1|||
124892668|NCT00519779|449229947|FG000|Overall Study|Withdrawal by Subject|0|||
124892669|NCT00519779|449229948|FG001|Overall Study|Withdrawal by Subject|1|||
124892670|NCT03330119|449229949|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
124892671|NCT03330119|449229950|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
124892672|NCT00550732|449229959|FG000|Overall Study|Death|4|||
124892673|NCT00550732|449229959|FG000|Overall Study|Withdrawal by Subject|2|||
124892674|NCT00550732|449229959|FG000|Overall Study|Physician Decision|2|||
124892675|NCT00550732|449229959|FG000|Overall Study|Lost to Follow-up|1|||
124892676|NCT00550732|449229959|FG000|Overall Study|Palliative care|1|||
124892677|NCT00550732|449229959|FG000|Overall Study|Adverse Event|1|||
124892678|NCT03302910|449229965|FG000|Overall Study|Protocol Violation|1|||
124892679|NCT03302910|449229966|FG001|Overall Study|Protocol Violation|0|||
124892680|NCT04004208|449229967|FG000|Overall Study|Withdrawal by parent/guardian|1|||
124892681|NCT04004208|449229968|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124892682|NCT04004208|449229967|FG000|Overall Study|Death|3|||
124892683|NCT04004208|449229968|FG001|Overall Study|Death|0|||
124892684|NCT04004208|449229967|FG000|Overall Study|COVID-19 pandemic|1|||
124892685|NCT04004208|449229968|FG001|Overall Study|COVID-19 pandemic|0|||
124892686|NCT04004208|449229967|FG000|Overall Study|Physician Decision|1|||
124892687|NCT04004208|449229968|FG001|Overall Study|Physician Decision|0|||
124892688|NCT04004208|449229967|FG000|Overall Study|Adverse Event|1|||
124892689|NCT04004208|449229968|FG001|Overall Study|Adverse Event|1|||
124892690|NCT02400307|449229970|FG000|Overall Study|Enrolled and Never Dosed|1|||
124892691|NCT02400307|449229971|FG001|Overall Study|Enrolled and Never Dosed|0|||
124892692|NCT03582137|449229977|FG000|Overall Study|Adverse Event|1|||
124892693|NCT03582137|449229978|FG001|Overall Study|Adverse Event|0|||
124892694|NCT02303574|449229979|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
124892695|NCT02303574|449229980|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
124892696|NCT02303574|449229981|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
124892697|NCT02303574|449229982|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
125017214|NCT03016325|449687712|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
125017215|NCT03016325|449687713|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
125017216|NCT03016325|449687714|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
125017217|NCT03016325|449687715|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
125017218|NCT03016325|449687716|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
125017219|NCT03016325|449687717|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
125017220|NCT03016325|449687718|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
125017221|NCT03016325|449687711|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
125017222|NCT03016325|449687712|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
125017223|NCT03016325|449687713|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
125017224|NCT03016325|449687714|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
125017225|NCT03016325|449687715|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
125017226|NCT03016325|449687716|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
125017227|NCT03016325|449687717|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
125017228|NCT03016325|449687718|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
125017229|NCT03016325|449687711|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
125017230|NCT03016325|449687712|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
125017231|NCT03016325|449687713|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
125017232|NCT03016325|449687714|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
125017233|NCT03016325|449687715|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
125017234|NCT03016325|449687716|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
125017235|NCT03016325|449687717|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
125017236|NCT03016325|449687718|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
125017237|NCT03016325|449687711|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
125017238|NCT03016325|449687712|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
125017239|NCT03016325|449687713|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
125017240|NCT03016325|449687714|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
125107210|NCT02239692|450017182|FG001|Overall Study|Lost to Follow-up|4|||
125107211|NCT02239692|450017181|FG000|Overall Study|Withdrawal by Subject|3|||
124892698|NCT02303574|449229983|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
124892699|NCT02303574|449229984|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
124892700|NCT02303574|449229985|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
124892701|NCT02303574|449229986|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
124892702|NCT02303574|449229987|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
124892703|NCT02303574|449229988|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
124892704|NCT02303574|449229979|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
124892705|NCT02303574|449229980|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
124892706|NCT02303574|449229981|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
124892707|NCT02303574|449229982|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
124892708|NCT02303574|449229983|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
125107212|NCT02239692|450017182|FG001|Overall Study|Withdrawal by Subject|5|||
124892709|NCT02303574|449229984|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
124892710|NCT02303574|449229985|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
125107213|NCT02239692|450017181|FG000|Overall Study|Other reason|1|||
125107214|NCT02239692|450017182|FG001|Overall Study|Other reason|0|||
125107215|NCT01614925|450017184|FG000|Overall Study|Withdrawal by Subject|1|||
125107216|NCT01614925|450017185|FG001|Overall Study|Withdrawal by Subject|0|||
125107217|NCT01614925|450017184|FG000|Overall Study|Protocol Violation|3|||
125107218|NCT01614925|450017185|FG001|Overall Study|Protocol Violation|2|||
125107219|NCT02437890|450017190|FG000|Overall Study|Non-compliance to study drug|0|||
125107220|NCT02437890|450017191|FG001|Overall Study|Non-compliance to study drug|1|||
125107221|NCT02437890|450017192|FG002|Overall Study|Non-compliance to study drug|0|||
125107222|NCT02437890|450017193|FG003|Overall Study|Non-compliance to study drug|0|||
125107223|NCT02437890|450017194|FG004|Overall Study|Non-compliance to study drug|1|||
125107224|NCT02437890|450017190|FG000|Overall Study|Sponsor's decision|1|||
125107225|NCT02437890|450017191|FG001|Overall Study|Sponsor's decision|1|||
125107226|NCT02437890|450017192|FG002|Overall Study|Sponsor's decision|4|||
125107227|NCT02437890|450017193|FG003|Overall Study|Sponsor's decision|0|||
125107228|NCT02437890|450017194|FG004|Overall Study|Sponsor's decision|2|||
125107229|NCT02437890|450017190|FG000|Overall Study|Physician Decision|0|||
125107230|NCT02437890|450017191|FG001|Overall Study|Physician Decision|0|||
125107231|NCT02437890|450017192|FG002|Overall Study|Physician Decision|0|||
125107232|NCT02437890|450017193|FG003|Overall Study|Physician Decision|1|||
125107233|NCT02437890|450017194|FG004|Overall Study|Physician Decision|0|||
125107234|NCT02437890|450017190|FG000|Overall Study|Unable to attend visit(s)|1|||
125107235|NCT02437890|450017191|FG001|Overall Study|Unable to attend visit(s)|0|||
125107236|NCT02437890|450017192|FG002|Overall Study|Unable to attend visit(s)|0|||
125107237|NCT02437890|450017193|FG003|Overall Study|Unable to attend visit(s)|0|||
125107238|NCT02437890|450017194|FG004|Overall Study|Unable to attend visit(s)|0|||
125107239|NCT02437890|450017190|FG000|Overall Study|Lack of Efficacy|1|||
125107240|NCT02437890|450017191|FG001|Overall Study|Lack of Efficacy|3|||
125107241|NCT02437890|450017192|FG002|Overall Study|Lack of Efficacy|0|||
125107242|NCT02437890|450017193|FG003|Overall Study|Lack of Efficacy|3|||
125107243|NCT02437890|450017194|FG004|Overall Study|Lack of Efficacy|1|||
125107244|NCT02437890|450017190|FG000|Overall Study|Adverse Event|4|||
125107245|NCT02437890|450017191|FG001|Overall Study|Adverse Event|9|||
125107246|NCT02437890|450017192|FG002|Overall Study|Adverse Event|5|||
125107247|NCT02437890|450017193|FG003|Overall Study|Adverse Event|11|||
125107248|NCT02437890|450017194|FG004|Overall Study|Adverse Event|7|||
125107249|NCT02437890|450017190|FG000|Overall Study|Withdrawal by Subject|1|||
125107250|NCT02437890|450017191|FG001|Overall Study|Withdrawal by Subject|2|||
125107251|NCT02437890|450017192|FG002|Overall Study|Withdrawal by Subject|6|||
125107252|NCT02437890|450017193|FG003|Overall Study|Withdrawal by Subject|5|||
125107253|NCT02437890|450017194|FG004|Overall Study|Withdrawal by Subject|5|||
125107254|NCT02437890|450017190|FG000|Overall Study|Death|0|||
125107255|NCT02437890|450017191|FG001|Overall Study|Death|0|||
125107256|NCT02437890|450017192|FG002|Overall Study|Death|0|||
125107257|NCT02437890|450017193|FG003|Overall Study|Death|2|||
125107258|NCT02437890|450017194|FG004|Overall Study|Death|0|||
125107259|NCT04723173|450017195|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
125107260|NCT02996448|450017196|FG000|Overall Study|Study terminated due to adverse effects|3|||
124892711|NCT02303574|449229986|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
124892712|NCT02303574|449229987|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
124892713|NCT02303574|449229988|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
124892714|NCT01606189|449229989|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
125107261|NCT01422720|450017197|FG000|Overall Study|Adverse Event|16|||
125107262|NCT01422720|450017197|FG000|Overall Study|Lack of Efficacy|1|||
125107263|NCT01422720|450017197|FG000|Overall Study|Withdrawal by Subject|4|||
125107264|NCT01422720|450017197|FG000|Overall Study|Ineligibility|1|||
125107265|NCT02082262|450017198|FG000|Overall Study|Withdrawal by Subject|3|||
125107266|NCT02082262|450017198|FG000|Overall Study|Adverse Event|48|||
125107267|NCT01586624|450017199|FG000|Overall Study|Adverse Event|3|||
125107268|NCT01586624|450017200|FG001|Overall Study|Adverse Event|0|||
125107269|NCT01586624|450017201|FG002|Overall Study|Adverse Event|2|||
125107270|NCT01586624|450017202|FG003|Overall Study|Adverse Event|1|||
125107271|NCT01586624|450017203|FG004|Overall Study|Adverse Event|3|||
125107272|NCT01586624|450017204|FG005|Overall Study|Adverse Event|3|||
125107273|NCT01586624|450017205|FG006|Overall Study|Adverse Event|2|||
125107274|NCT01586624|450017206|FG007|Overall Study|Adverse Event|3|||
125107275|NCT01586624|450017199|FG000|Overall Study|Physician Decision|0|||
124892715|NCT01606189|449229990|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
124892716|NCT01606189|449229991|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
124892717|NCT01606189|449229992|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
124892718|NCT01606189|449229993|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
124892719|NCT01606189|449229994|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
124892720|NCT01606189|449229989|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
124892721|NCT01606189|449229990|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
124892722|NCT01606189|449229991|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
124892723|NCT01606189|449229992|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
124892724|NCT01606189|449229993|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
124892725|NCT01606189|449229994|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
124892726|NCT02162732|449229995|FG000|Overall Study|Biopsy not performed.|18|||
125017241|NCT03016325|449687715|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
125017242|NCT03016325|449687716|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
125017243|NCT03016325|449687717|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
125017244|NCT03016325|449687718|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
125017245|NCT03016325|449687711|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
125017246|NCT03016325|449687712|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
125017247|NCT03016325|449687713|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
124892727|NCT01167023|449229996|FG000|Overall Study|Lost to Follow-up|0|||
124892728|NCT01167023|449229997|FG001|Overall Study|Lost to Follow-up|1|||
124892729|NCT01167023|449229998|FG002|Overall Study|Lost to Follow-up|1|||
124892730|NCT01167023|449229996|FG000|Overall Study|Screen Failure|0|||
124892731|NCT01167023|449229997|FG001|Overall Study|Screen Failure|1|||
124892732|NCT01167023|449229998|FG002|Overall Study|Screen Failure|0|||
124892733|NCT01167023|449229996|FG000|Overall Study|Sponsor Decision|0|||
124892734|NCT01167023|449229997|FG001|Overall Study|Sponsor Decision|1|||
124892735|NCT01167023|449229998|FG002|Overall Study|Sponsor Decision|0|||
125017248|NCT03016325|449687714|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
125017249|NCT03016325|449687715|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
125017250|NCT03016325|449687716|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
125017251|NCT03016325|449687717|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
125017252|NCT03016325|449687718|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
125017253|NCT03016325|449687711|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
125017254|NCT03016325|449687712|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
125017255|NCT03016325|449687713|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
125017256|NCT03016325|449687714|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
125017257|NCT03016325|449687715|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
125017258|NCT03016325|449687716|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
125017259|NCT03016325|449687717|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
125017260|NCT03016325|449687718|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
125017261|NCT01902290|449687723|FG000|Overall Study|Withdrawal by Subject|19|||
125017262|NCT01902290|449687724|FG001|Overall Study|Withdrawal by Subject|27|||
125017263|NCT01902290|449687723|FG000|Overall Study|Lost to Follow-up|2|||
125017264|NCT01902290|449687724|FG001|Overall Study|Lost to Follow-up|2|||
125017265|NCT01902290|449687723|FG000|Overall Study|Death|1|||
125017266|NCT01902290|449687724|FG001|Overall Study|Death|0|||
125017267|NCT01902290|449687723|FG000|Overall Study|Sponsor Decision|26|||
125017268|NCT01902290|449687724|FG001|Overall Study|Sponsor Decision|24|||
125017269|NCT02199080|449687733|FG000|Overall Study|Protocol Violation|12|||
125017270|NCT02250274|449687734|FG000|Overall Study|Insufficient blood draw amount|7|||
125017271|NCT02250274|449687735|FG001|Overall Study|Insufficient blood draw amount|6|||
125017272|NCT01277549|449687736|FG000|Overall Study|Failed to meet eligibility criteria|13|||
125017273|NCT01277549|449687737|FG001|Overall Study|Failed to meet eligibility criteria|9|||
125017274|NCT01277549|449687736|FG000|Overall Study|Withdrawal by Subject|1|||
125107276|NCT01586624|450017200|FG001|Overall Study|Physician Decision|1|||
125107277|NCT01586624|450017201|FG002|Overall Study|Physician Decision|1|||
125107278|NCT01586624|450017202|FG003|Overall Study|Physician Decision|0|||
125107279|NCT01586624|450017203|FG004|Overall Study|Physician Decision|2|||
125107280|NCT01586624|450017204|FG005|Overall Study|Physician Decision|0|||
125107281|NCT01586624|450017205|FG006|Overall Study|Physician Decision|1|||
125107282|NCT01586624|450017206|FG007|Overall Study|Physician Decision|1|||
125107283|NCT01586624|450017199|FG000|Overall Study|Withdrawal by Subject|0|||
124892736|NCT01167023|449229996|FG000|Overall Study|Withdrawal by Subject|0|||
125017275|NCT01277549|449687737|FG001|Overall Study|Withdrawal by Subject|3|||
125107284|NCT01586624|450017200|FG001|Overall Study|Withdrawal by Subject|0|||
124892737|NCT01167023|449229997|FG001|Overall Study|Withdrawal by Subject|0|||
124892738|NCT01167023|449229998|FG002|Overall Study|Withdrawal by Subject|1|||
125017276|NCT01277549|449687736|FG000|Overall Study|Protocol Violation|10|||
125107285|NCT01586624|450017201|FG002|Overall Study|Withdrawal by Subject|0|||
124892739|NCT00410384|449229999|FG000|Overall Study|Withdrawal by Subject|28|||
124892740|NCT00410384|449230000|FG001|Overall Study|Withdrawal by Subject|17|||
124892741|NCT00410384|449230001|FG002|Overall Study|Withdrawal by Subject|20|||
124892742|NCT00410384|449229999|FG000|Overall Study|Adverse Event|23|||
124892743|NCT00410384|449230000|FG001|Overall Study|Adverse Event|18|||
124892744|NCT00410384|449230001|FG002|Overall Study|Adverse Event|23|||
124892745|NCT00410384|449229999|FG000|Overall Study|Lack of Efficacy|20|||
124892746|NCT00410384|449230000|FG001|Overall Study|Lack of Efficacy|12|||
124892747|NCT00410384|449230001|FG002|Overall Study|Lack of Efficacy|17|||
124892748|NCT00410384|449229999|FG000|Overall Study|Lack of Compliance|2|||
124892749|NCT00410384|449230000|FG001|Overall Study|Lack of Compliance|2|||
124892750|NCT00410384|449230001|FG002|Overall Study|Lack of Compliance|2|||
124892751|NCT00410384|449229999|FG000|Overall Study|Lost to Follow-up|4|||
124892752|NCT00410384|449230000|FG001|Overall Study|Lost to Follow-up|6|||
124892753|NCT00410384|449230001|FG002|Overall Study|Lost to Follow-up|6|||
124892754|NCT00410384|449229999|FG000|Overall Study|Protocol Violation|6|||
124892755|NCT00410384|449230000|FG001|Overall Study|Protocol Violation|6|||
124892756|NCT00410384|449230001|FG002|Overall Study|Protocol Violation|6|||
124892757|NCT00410384|449229999|FG000|Overall Study|Physician Decision|3|||
124892758|NCT00410384|449230000|FG001|Overall Study|Physician Decision|3|||
124892759|NCT00410384|449230001|FG002|Overall Study|Physician Decision|4|||
124892760|NCT00410384|449229999|FG000|Overall Study|Other|3|||
124892761|NCT00410384|449230000|FG001|Overall Study|Other|8|||
124892762|NCT00410384|449230001|FG002|Overall Study|Other|4|||
124892763|NCT02049437|449230004|FG000|Period 1|Adverse Event|1|||
124892764|NCT02049437|449230005|FG001|Period 1|Adverse Event|1|||
124892765|NCT02049437|449230004|FG000|Period 1|Adverse Event|1|||
124892766|NCT02049437|449230005|FG001|Period 1|Adverse Event|0|||
124892767|NCT00630539|449230006|FG000|Overall Study|Adverse Event|1|||
124892768|NCT00630539|449230007|FG001|Overall Study|Adverse Event|3|||
124892769|NCT00630539|449230008|FG002|Overall Study|Adverse Event|1|||
124892770|NCT00630539|449230009|FG003|Overall Study|Adverse Event|2|||
124892771|NCT00630539|449230006|FG000|Overall Study|Withdrawal by Subject|0|||
124892772|NCT00630539|449230007|FG001|Overall Study|Withdrawal by Subject|1|||
124892773|NCT00630539|449230008|FG002|Overall Study|Withdrawal by Subject|0|||
124892774|NCT00630539|449230009|FG003|Overall Study|Withdrawal by Subject|1|||
124892775|NCT03682536|449230019|FG000|Randomization|Withdrawal by Subject|0|||
124892776|NCT03682536|449230020|FG001|Randomization|Withdrawal by Subject|2|||
124892777|NCT03682536|449230019|FG000|Treatment|Other Reasons|8|||
124892778|NCT03682536|449230020|FG001|Treatment|Other Reasons|7|||
124892779|NCT03682536|449230019|FG000|Treatment|Physician Decision|5|||
124892780|NCT03682536|449230020|FG001|Treatment|Physician Decision|5|||
124892781|NCT03682536|449230019|FG000|Treatment|Protocol Violation|1|||
124892782|NCT03682536|449230020|FG001|Treatment|Protocol Violation|0|||
124892783|NCT03682536|449230019|FG000|Treatment|Study Terminated by Sponsor|1|||
124892784|NCT03682536|449230020|FG001|Treatment|Study Terminated by Sponsor|2|||
124892785|NCT03682536|449230019|FG000|Treatment|Lost to Follow-up|0|||
124892786|NCT03682536|449230020|FG001|Treatment|Lost to Follow-up|1|||
124892787|NCT03682536|449230019|FG000|Treatment|Withdrawal by Subject|16|||
124892788|NCT03682536|449230020|FG001|Treatment|Withdrawal by Subject|18|||
124892789|NCT03682536|449230019|FG000|Treatment|Lack of Efficacy|41|||
124892790|NCT03682536|449230020|FG001|Treatment|Lack of Efficacy|68|||
124892791|NCT03682536|449230019|FG000|Treatment|Disease Progression|9|||
124892792|NCT03682536|449230020|FG001|Treatment|Disease Progression|7|||
124892793|NCT03682536|449230019|FG000|Treatment|Adverse Event|9|||
124892794|NCT03682536|449230020|FG001|Treatment|Adverse Event|5|||
124892795|NCT03682536|449230019|FG000|Treatment|Death|14|||
124892796|NCT03682536|449230020|FG001|Treatment|Death|13|||
125017277|NCT01277549|449687737|FG001|Overall Study|Protocol Violation|1|||
125017278|NCT01277549|449687736|FG000|Overall Study|Physician Decision|2|||
125017279|NCT01277549|449687737|FG001|Overall Study|Physician Decision|1|||
125017280|NCT01618214|449687738|FG000|Overall Study|Adverse Event|3|||
125017281|NCT01618214|449687739|FG001|Overall Study|Adverse Event|1|||
124892797|NCT02507219|449230031|FG000|Overall Study|Physician Decision|1|||
124892798|NCT02507219|449230032|FG001|Overall Study|Physician Decision|0|||
124892799|NCT02507219|449230033|FG002|Overall Study|Physician Decision|0|||
124892800|NCT02507219|449230034|FG003|Overall Study|Physician Decision|0|||
124892801|NCT02507219|449230035|FG004|Overall Study|Physician Decision|0|||
124892802|NCT02507219|449230036|FG005|Overall Study|Physician Decision|0|||
124892803|NCT02507219|449230031|FG000|Overall Study|Withdrawal by Subject|0|||
124892804|NCT02507219|449230032|FG001|Overall Study|Withdrawal by Subject|0|||
124892805|NCT02507219|449230033|FG002|Overall Study|Withdrawal by Subject|0|||
124892806|NCT02507219|449230034|FG003|Overall Study|Withdrawal by Subject|0|||
125017282|NCT01618214|449687738|FG000|Overall Study|Lack of Efficacy|1|||
124892807|NCT02507219|449230035|FG004|Overall Study|Withdrawal by Subject|1|||
124892808|NCT02507219|449230036|FG005|Overall Study|Withdrawal by Subject|0|||
124892809|NCT01342887|449230043|FG000|Overall Study|Death|2|||
124892810|NCT00209274|449230044|FG000|Overall Study|Missed visit|3|||
124892811|NCT00209274|449230045|FG001|Overall Study|Missed visit|2|||
124892812|NCT00209274|449230044|FG000|Overall Study|Death|32|||
124892813|NCT00209274|449230045|FG001|Overall Study|Death|15|||
124892814|NCT00209274|449230044|FG000|Overall Study|Withdrawal by Subject|30|||
124892815|NCT00209274|449230045|FG001|Overall Study|Withdrawal by Subject|15|||
124892816|NCT00209274|449230044|FG000|Overall Study|Randomized not treated (RNT)|6|||
124892817|NCT00209274|449230045|FG001|Overall Study|Randomized not treated (RNT)|15|||
124892818|NCT02753530|449230046|FG000|Overall Study|Adverse Event|7|||
124892819|NCT02753530|449230047|FG001|Overall Study|Adverse Event|1|||
124892820|NCT02753530|449230046|FG000|Overall Study|Death|0|||
124892821|NCT02753530|449230047|FG001|Overall Study|Death|1|||
124892822|NCT02753530|449230046|FG000|Overall Study|Physician Decision|0|||
124892823|NCT02753530|449230047|FG001|Overall Study|Physician Decision|1|||
124892824|NCT02753530|449230046|FG000|Overall Study|Protocol Violation|1|||
124892825|NCT02753530|449230047|FG001|Overall Study|Protocol Violation|0|||
124892826|NCT02753530|449230046|FG000|Overall Study|Withdrawal by Subject|4|||
124892827|NCT02753530|449230047|FG001|Overall Study|Withdrawal by Subject|3|||
124892828|NCT00465361|449231914|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
125107286|NCT01586624|450017202|FG003|Overall Study|Withdrawal by Subject|1|||
125107287|NCT01586624|450017203|FG004|Overall Study|Withdrawal by Subject|0|||
125107288|NCT01586624|450017204|FG005|Overall Study|Withdrawal by Subject|0|||
125107289|NCT01586624|450017205|FG006|Overall Study|Withdrawal by Subject|0|||
125107290|NCT01586624|450017206|FG007|Overall Study|Withdrawal by Subject|0|||
125107291|NCT01586624|450017199|FG000|Overall Study|Evidence of disease progression|1|||
125107292|NCT01586624|450017200|FG001|Overall Study|Evidence of disease progression|3|||
125107293|NCT01586624|450017201|FG002|Overall Study|Evidence of disease progression|2|||
125107294|NCT01586624|450017202|FG003|Overall Study|Evidence of disease progression|5|||
125107295|NCT01586624|450017203|FG004|Overall Study|Evidence of disease progression|3|||
125107296|NCT01586624|450017204|FG005|Overall Study|Evidence of disease progression|5|||
125107297|NCT01586624|450017205|FG006|Overall Study|Evidence of disease progression|4|||
125107298|NCT01586624|450017206|FG007|Overall Study|Evidence of disease progression|6|||
125107299|NCT01586624|450017199|FG000|Overall Study|Screen failure (no treatment received)|0|||
125107300|NCT01586624|450017200|FG001|Overall Study|Screen failure (no treatment received)|0|||
125107301|NCT01586624|450017201|FG002|Overall Study|Screen failure (no treatment received)|0|||
125107302|NCT01586624|450017202|FG003|Overall Study|Screen failure (no treatment received)|0|||
125107303|NCT01586624|450017203|FG004|Overall Study|Screen failure (no treatment received)|0|||
125107304|NCT01586624|450017204|FG005|Overall Study|Screen failure (no treatment received)|0|||
125107305|NCT01586624|450017205|FG006|Overall Study|Screen failure (no treatment received)|1|||
125107306|NCT01586624|450017206|FG007|Overall Study|Screen failure (no treatment received)|0|||
125107307|NCT01074307|450017208|FG000|Overall Study|No primary endpoint evaluation|14|||
125107308|NCT01074307|450017209|FG001|Overall Study|No primary endpoint evaluation|6|||
125107309|NCT01074307|450017208|FG000|Overall Study|Exclusion criterion|0|||
125107310|NCT01074307|450017209|FG001|Overall Study|Exclusion criterion|1|||
125107311|NCT01074307|450017208|FG000|Overall Study|Protocol Violation|8|||
125107312|NCT01074307|450017209|FG001|Overall Study|Protocol Violation|5|||
125107313|NCT02162511|450017214|FG000|Overall Study|Lack of Efficacy|0|||
125107314|NCT02162511|450017215|FG001|Overall Study|Lack of Efficacy|0|||
125107315|NCT02162511|450017216|FG002|Overall Study|Lack of Efficacy|2|||
125107316|NCT01160198|450017217|FG000|Overall Study|Withdrawal by Subject|2|||
125107317|NCT01160198|450017218|FG001|Overall Study|Withdrawal by Subject|1|||
125107318|NCT01160198|450017219|FG002|Overall Study|Withdrawal by Subject|0|||
125107319|NCT01160198|450017217|FG000|Overall Study|Adverse Event|0|||
125107320|NCT01160198|450017218|FG001|Overall Study|Adverse Event|1|||
125107321|NCT01160198|450017219|FG002|Overall Study|Adverse Event|0|||
125107322|NCT01160198|450017217|FG000|Overall Study|Lost to Follow-up|0|||
125107323|NCT01160198|450017218|FG001|Overall Study|Lost to Follow-up|1|||
124892829|NCT01333943|449231918|FG000|Overall Study|Known neuropathy|1|||
124892830|NCT01333943|449231919|FG001|Overall Study|Known neuropathy|0|||
124892831|NCT02652130|449231926|FG000|Overall Study|Death|1|||
125107324|NCT01160198|450017219|FG002|Overall Study|Lost to Follow-up|0|||
125107325|NCT01160198|450017217|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
124892832|NCT02028884|449231927|FG000|Double-blind Period|Adverse Event|5|||
124892833|NCT02028884|449231928|FG001|Double-blind Period|Adverse Event|3|||
124892834|NCT02028884|449231929|FG002|Double-blind Period|Adverse Event|0|||
124892835|NCT02028884|449231927|FG000|Double-blind Period|Eligibility Violation|1|||
124892836|NCT02028884|449231928|FG001|Double-blind Period|Eligibility Violation|0|||
124892837|NCT02028884|449231929|FG002|Double-blind Period|Eligibility Violation|0|||
125107326|NCT01160198|450017218|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
125107327|NCT01160198|450017219|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
125017283|NCT01618214|449687739|FG001|Overall Study|Lack of Efficacy|1|||
125017284|NCT01618214|449687738|FG000|Overall Study|Protocol Violation|1|||
125017285|NCT01618214|449687739|FG001|Overall Study|Protocol Violation|4|||
124892838|NCT02028884|449231927|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
124892839|NCT02028884|449231928|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
124892840|NCT02028884|449231929|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
124892841|NCT02028884|449231927|FG000|Double-blind Period|Withdrawal by Subject|2|||
124892842|NCT02028884|449231928|FG001|Double-blind Period|Withdrawal by Subject|0|||
124892843|NCT02028884|449231929|FG002|Double-blind Period|Withdrawal by Subject|0|||
125107328|NCT02766088|450017221|FG000|Overall Study|Sponsor study termination|498|||
125107329|NCT02766088|450017221|FG000|Overall Study|Migrated/moved from the study area|1|||
125107330|NCT02766088|450017221|FG000|Overall Study|Lost to Follow-up|5|||
125107331|NCT02766088|450017221|FG000|Overall Study|Other|1|||
125107332|NCT02766088|450017221|FG000|Overall Study|Death|1|||
125107333|NCT03555890|450017228|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
125107334|NCT03555890|450017229|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
125107335|NCT03555890|450017230|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
125107336|NCT03555890|450017231|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
125107337|NCT01286207|450017234|FG000|Overall Study|Adverse Event|27|||
125107338|NCT01286207|450017235|FG001|Overall Study|Adverse Event|41|||
125107339|NCT01286207|450017236|FG002|Overall Study|Adverse Event|8|||
125107340|NCT01286207|450017234|FG000|Overall Study|Lost to Follow-up|49|||
125107341|NCT01286207|450017235|FG001|Overall Study|Lost to Follow-up|43|||
125107342|NCT01286207|450017236|FG002|Overall Study|Lost to Follow-up|20|||
125107343|NCT01286207|450017234|FG000|Overall Study|Withdrawal by Subject|93|||
125107344|NCT01286207|450017235|FG001|Overall Study|Withdrawal by Subject|79|||
125107345|NCT01286207|450017236|FG002|Overall Study|Withdrawal by Subject|41|||
125107346|NCT01286207|450017234|FG000|Overall Study|Lack of Response|92|||
125107347|NCT01286207|450017235|FG001|Overall Study|Lack of Response|38|||
125107348|NCT01286207|450017236|FG002|Overall Study|Lack of Response|8|||
125107349|NCT01286207|450017234|FG000|Overall Study|Other|37|||
125107350|NCT01286207|450017235|FG001|Overall Study|Other|47|||
125107351|NCT01286207|450017236|FG002|Overall Study|Other|13|||
125107352|NCT01383954|450017237|FG000|Overall Study|Lack of Efficacy|2|||
125107353|NCT01383954|450017237|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
125107354|NCT01383954|450017237|FG000|Overall Study|Adverse Event|1|||
125107355|NCT01383954|450017237|FG000|Overall Study|Reason Not Specified|9|||
125107356|NCT00450177|450017238|FG000|Overall Study|Adverse Event|7|||
125107357|NCT00450177|450017239|FG001|Overall Study|Adverse Event|4|||
125107358|NCT00450177|450017238|FG000|Overall Study|Withdrawal by Subject|1|||
125107359|NCT00450177|450017239|FG001|Overall Study|Withdrawal by Subject|6|||
125107360|NCT00450177|450017238|FG000|Overall Study|Withdrawal by Primary Team|1|||
125107361|NCT00450177|450017239|FG001|Overall Study|Withdrawal by Primary Team|1|||
125107362|NCT00763269|450017241|FG000|Overall Study|Lost to Follow-up|12|||
125107363|NCT00763269|450017242|FG001|Overall Study|Lost to Follow-up|13|||
125107364|NCT03174925|450017245|FG000|Overall Study|Elastographic images not retrievable|2|||
125107365|NCT03174925|450017245|FG000|Overall Study|Elastography image not interpretable|1|||
125107366|NCT04247594|450017246|FG000|Overall Study|Withdrawal by Subject|4|||
125107367|NCT02609178|450017249|FG000|First Crown|Withdrawal by Subject|0|||
125107368|NCT02609178|450017250|FG001|First Crown|Withdrawal by Subject|0|||
125107369|NCT02609178|450017251|FG002|First Crown|Withdrawal by Subject|1|||
125107370|NCT02609178|450017252|FG003|First Crown|Withdrawal by Subject|1|||
125107371|NCT02609178|450017253|FG004|First Crown|Withdrawal by Subject|0|||
125107372|NCT02609178|450017254|FG005|First Crown|Withdrawal by Subject|0|||
125107373|NCT01128153|450017255|FG000|Overall Study|Adverse Event|1|||
125107374|NCT01128153|450017256|FG001|Overall Study|Adverse Event|3|||
125107375|NCT01128153|450017255|FG000|Overall Study|Condition under investigation worsened|8|||
125107376|NCT01128153|450017256|FG001|Overall Study|Condition under investigation worsened|7|||
125107377|NCT01128153|450017255|FG000|Overall Study|Withdrawal by Subject|2|||
125107378|NCT01128153|450017256|FG001|Overall Study|Withdrawal by Subject|3|||
125107379|NCT01128153|450017255|FG000|Overall Study|Incorrect enrolment to study|2|||
125107380|NCT01128153|450017256|FG001|Overall Study|Incorrect enrolment to study|1|||
125107381|NCT01128153|450017255|FG000|Overall Study|Protocol Violation|2|||
125107382|NCT01128153|450017256|FG001|Overall Study|Protocol Violation|0|||
125107383|NCT01128153|450017255|FG000|Overall Study|Developed discontinuation criteria|1|||
125107384|NCT01128153|450017256|FG001|Overall Study|Developed discontinuation criteria|1|||
125107385|NCT03451331|450017257|FG000|Overall Study|Withdrawal by Subject|1|||
125107386|NCT03451331|450017258|FG001|Overall Study|Withdrawal by Subject|0|||
125107387|NCT03451331|450017257|FG000|Overall Study|Unable to start treatment.|1|||
125107388|NCT03451331|450017258|FG001|Overall Study|Unable to start treatment.|1|||
125107389|NCT00572156|450017259|FG000|Overall Study|Adverse Event|3|||
125107390|NCT00572156|450017260|FG001|Overall Study|Adverse Event|1|||
125107391|NCT00572156|450017261|FG002|Overall Study|Adverse Event|5|||
124892844|NCT02028884|449231927|FG000|Open-label Extension Period|Adverse Event|3|||
124892845|NCT02028884|449231928|FG001|Open-label Extension Period|Adverse Event|1|||
124892846|NCT02028884|449231929|FG002|Open-label Extension Period|Adverse Event|0|||
124892847|NCT02028884|449231927|FG000|Open-label Extension Period|Lack of Efficacy|3|||
124892848|NCT02028884|449231928|FG001|Open-label Extension Period|Lack of Efficacy|0|||
124892849|NCT02028884|449231929|FG002|Open-label Extension Period|Lack of Efficacy|0|||
124892850|NCT02028884|449231927|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
125017286|NCT01618214|449687738|FG000|Overall Study|Withdrawal Criteria|1|||
125017287|NCT01618214|449687739|FG001|Overall Study|Withdrawal Criteria|2|||
125017288|NCT01618214|449687738|FG000|Overall Study|Unclassified|4|||
125017289|NCT01618214|449687739|FG001|Overall Study|Unclassified|5|||
125017290|NCT00391222|449687740|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
125107392|NCT00572156|450017262|FG003|Overall Study|Adverse Event|1|||
125107393|NCT00572156|450017259|FG000|Overall Study|Lost to Follow-up|1|||
125107394|NCT00572156|450017260|FG001|Overall Study|Lost to Follow-up|1|||
125107395|NCT00572156|450017261|FG002|Overall Study|Lost to Follow-up|1|||
125107396|NCT00572156|450017262|FG003|Overall Study|Lost to Follow-up|0|||
125107397|NCT00572156|450017259|FG000|Overall Study|Protocol Violation|1|||
125107398|NCT00572156|450017260|FG001|Overall Study|Protocol Violation|2|||
125107399|NCT00572156|450017261|FG002|Overall Study|Protocol Violation|0|||
125107400|NCT00572156|450017262|FG003|Overall Study|Protocol Violation|2|||
125107401|NCT00572156|450017259|FG000|Overall Study|Patient/Parent Decision|1|||
125107402|NCT00572156|450017260|FG001|Overall Study|Patient/Parent Decision|6|||
125107403|NCT00572156|450017261|FG002|Overall Study|Patient/Parent Decision|4|||
125107404|NCT00572156|450017262|FG003|Overall Study|Patient/Parent Decision|3|||
125107405|NCT00572156|450017259|FG000|Overall Study|Sponsor Decision|20|||
125107406|NCT00572156|450017260|FG001|Overall Study|Sponsor Decision|16|||
125107407|NCT00572156|450017261|FG002|Overall Study|Sponsor Decision|17|||
125107408|NCT00572156|450017262|FG003|Overall Study|Sponsor Decision|19|||
125107409|NCT02261974|450017263|FG000|Overall Study|Withdrawal by Subject|3|||
125107410|NCT02261974|450017264|FG001|Overall Study|Withdrawal by Subject|2|||
125107411|NCT02261974|450017263|FG000|Overall Study|Pregnancy|0|||
125107412|NCT02261974|450017264|FG001|Overall Study|Pregnancy|1|||
125107413|NCT02261974|450017263|FG000|Overall Study|Missed treatment cut-off date|6|||
125107414|NCT02261974|450017264|FG001|Overall Study|Missed treatment cut-off date|3|||
125107415|NCT02261974|450017263|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
125107416|NCT02261974|450017264|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
125107417|NCT02261974|450017263|FG000|Overall Study|Lost to Follow-up|2|||
124892851|NCT02028884|449231928|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
124892852|NCT02028884|449231929|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
124892853|NCT02028884|449231927|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
124892854|NCT02028884|449231928|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
124892855|NCT02028884|449231929|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
124892856|NCT02028884|449231927|FG000|Open-label Extension Period|Switched to another treatment option|3|||
124892857|NCT02028884|449231928|FG001|Open-label Extension Period|Switched to another treatment option|0|||
124892858|NCT02028884|449231929|FG002|Open-label Extension Period|Switched to another treatment option|0|||
124892859|NCT00354029|449231930|FG000|Overall Study|Protocol Violation|4|||
124892860|NCT00354029|449231931|FG001|Overall Study|Protocol Violation|2|||
124892861|NCT00723294|449231932|FG000|Overall Study|Lobular histology|2|||
124892862|NCT00723294|449231932|FG000|Overall Study|>25% intraductal component|1|||
124892863|NCT00723294|449231932|FG000|Overall Study|No MRI tumor enhancement|1|||
124892864|NCT00723294|449231932|FG000|Overall Study|1.0-Tesla MRI|1|||
124892865|NCT00723294|449231932|FG000|Overall Study|No cryoabalation|2|||
124892866|NCT00723294|449231932|FG000|Overall Study|Did not undergo surgery|1|||
124892867|NCT00723294|449231932|FG000|Overall Study|Treated prior to registration|1|||
125017291|NCT00391222|449687741|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
125017292|NCT00391222|449687742|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
125017293|NCT00391222|449687743|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
125017294|NCT00391222|449687740|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
125107418|NCT02261974|450017264|FG001|Overall Study|Lost to Follow-up|0|||
125017295|NCT00391222|449687741|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
125017296|NCT00391222|449687742|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
125017297|NCT00391222|449687743|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
125017298|NCT00391222|449687740|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
125017299|NCT00391222|449687741|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
125017300|NCT00391222|449687742|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
125017301|NCT00391222|449687743|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
125017302|NCT00391222|449687740|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
125017303|NCT00391222|449687741|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
125017304|NCT00391222|449687742|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
125017305|NCT00391222|449687743|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
125017306|NCT00391222|449687740|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
125017307|NCT00391222|449687741|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
125017308|NCT00391222|449687742|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
125107419|NCT02261974|450017263|FG000|Overall Study|Adverse Event|1|||
125107420|NCT02261974|450017264|FG001|Overall Study|Adverse Event|0|||
125107421|NCT01347879|450017265|FG000|Overall Study|Adverse Event|0|||
125107422|NCT01347879|450017266|FG001|Overall Study|Adverse Event|12|||
124892868|NCT00723294|449231932|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
124892869|NCT00723294|449231932|FG000|Overall Study|Benign lesion|1|||
125107423|NCT01347879|450017265|FG000|Overall Study|Lost to Follow-up|2|||
125107424|NCT01347879|450017266|FG001|Overall Study|Lost to Follow-up|0|||
125107425|NCT01347879|450017265|FG000|Overall Study|Withdrawal by Subject|3|||
125107426|NCT01347879|450017266|FG001|Overall Study|Withdrawal by Subject|2|||
125107427|NCT01347879|450017265|FG000|Overall Study|Other|2|||
125107428|NCT01347879|450017266|FG001|Overall Study|Other|3|||
125107429|NCT01238822|450017269|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
125107430|NCT00996918|450017270|FG000|Overall Study|Lack of Efficacy|1|||
125107431|NCT00996918|450017271|FG001|Overall Study|Lack of Efficacy|1|||
125107432|NCT00996918|450017272|FG002|Overall Study|Lack of Efficacy|2|||
125107433|NCT00996918|450017273|FG003|Overall Study|Lack of Efficacy|2|||
125107434|NCT00996918|450017274|FG004|Overall Study|Lack of Efficacy|0|||
125107435|NCT00996918|450017270|FG000|Overall Study|Adverse Event|2|||
125107436|NCT00996918|450017271|FG001|Overall Study|Adverse Event|5|||
125107437|NCT00996918|450017272|FG002|Overall Study|Adverse Event|2|||
125107438|NCT00996918|450017273|FG003|Overall Study|Adverse Event|6|||
125107439|NCT00996918|450017274|FG004|Overall Study|Adverse Event|0|||
125107440|NCT00996918|450017270|FG000|Overall Study|Withdrawal by Subject|1|||
125107441|NCT00996918|450017271|FG001|Overall Study|Withdrawal by Subject|4|||
125107442|NCT00996918|450017272|FG002|Overall Study|Withdrawal by Subject|3|||
125107443|NCT00996918|450017273|FG003|Overall Study|Withdrawal by Subject|3|||
125107444|NCT00996918|450017274|FG004|Overall Study|Withdrawal by Subject|2|||
125107445|NCT00996918|450017270|FG000|Overall Study|Physician Decision|1|||
125107446|NCT00996918|450017271|FG001|Overall Study|Physician Decision|0|||
125107447|NCT00996918|450017272|FG002|Overall Study|Physician Decision|0|||
125107448|NCT00996918|450017273|FG003|Overall Study|Physician Decision|0|||
125107449|NCT00996918|450017274|FG004|Overall Study|Physician Decision|0|||
125107450|NCT00996918|450017270|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
125107451|NCT00996918|450017271|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
125107452|NCT00996918|450017272|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
125107453|NCT00996918|450017273|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
125107454|NCT00996918|450017274|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
125107455|NCT00996918|450017270|FG000|Overall Study|Loss of Caregiver|0|||
125107456|NCT00996918|450017271|FG001|Overall Study|Loss of Caregiver|1|||
125107457|NCT00996918|450017272|FG002|Overall Study|Loss of Caregiver|0|||
125107458|NCT00996918|450017273|FG003|Overall Study|Loss of Caregiver|0|||
125107459|NCT00996918|450017274|FG004|Overall Study|Loss of Caregiver|0|||
125107460|NCT00996918|450017270|FG000|Overall Study|Other|3|||
125107461|NCT00996918|450017271|FG001|Overall Study|Other|1|||
125107462|NCT00996918|450017272|FG002|Overall Study|Other|0|||
125107463|NCT00996918|450017273|FG003|Overall Study|Other|0|||
125107464|NCT00996918|450017274|FG004|Overall Study|Other|0|||
125107465|NCT04440007|450017279|FG000|Overall Study|Adverse Event|0|||
125107466|NCT04440007|450017280|FG001|Overall Study|Adverse Event|1|||
125107467|NCT04440007|450017279|FG000|Overall Study|Lost to Follow-up|1|||
125107468|NCT04440007|450017280|FG001|Overall Study|Lost to Follow-up|3|||
125107469|NCT04440007|450017279|FG000|Overall Study|Death|7|||
125107470|NCT04440007|450017280|FG001|Overall Study|Death|2|||
125107471|NCT04440007|450017279|FG000|Overall Study|Physician Decision|1|||
125107472|NCT04440007|450017280|FG001|Overall Study|Physician Decision|1|||
125107473|NCT04440007|450017279|FG000|Overall Study|Withdrawal by Subject|2|||
125107474|NCT04440007|450017280|FG001|Overall Study|Withdrawal by Subject|1|||
125107475|NCT04440007|450017279|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
125107476|NCT04440007|450017280|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
125107477|NCT04440007|450017279|FG000|Overall Study|Discontinued prior to dosing|0|||
125107478|NCT04440007|450017280|FG001|Overall Study|Discontinued prior to dosing|2|||
125107479|NCT00854607|450017281|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
125107480|NCT03959137|450017282|FG000|Overall Study|Protocol Violation|6|||
125107481|NCT00190684|450017283|FG000|Overall Study|Adverse Event|86|||
125107482|NCT00190684|450017283|FG000|Overall Study|Satisfactory response|80|||
125107483|NCT00190684|450017283|FG000|Overall Study|Lack of efficacy|204|||
125107484|NCT00190684|450017283|FG000|Overall Study|Lost to Follow-up|232|||
125107485|NCT00190684|450017283|FG000|Overall Study|Patient moved|60|||
125107486|NCT00190684|450017283|FG000|Overall Study|Patient Decision|432|||
124892870|NCT00723294|449231932|FG000|Overall Study|Withdrawal by Subject|1|||
125107487|NCT00190684|450017283|FG000|Overall Study|Clinical relapse|67|||
124892871|NCT00723294|449231932|FG000|Overall Study|No treatment due to probe failure|1|||
124892872|NCT02403674|449231933|FG000|Base Study|Death|1|||
125107488|NCT00190684|450017283|FG000|Overall Study|Sponsor's decision|17|||
125107489|NCT00190684|450017283|FG000|Overall Study|Physician Decision|84|||
125107490|NCT00190684|450017283|FG000|Overall Study|Protocol Violation|123|||
125107491|NCT00190684|450017283|FG000|Overall Study|Study Period III Completed|103|||
125107492|NCT00190684|450017283|FG000|Overall Study|Study Period V Completed|1|||
125107493|NCT00829439|450017289|FG000|Overall Study|Adverse Event|0|||
125107494|NCT00829439|450017290|FG001|Overall Study|Adverse Event|0|||
125107495|NCT00829439|450017291|FG002|Overall Study|Adverse Event|1|||
125107496|NCT00829439|450017292|FG003|Overall Study|Adverse Event|0|||
124892873|NCT02403674|449231934|FG001|Base Study|Death|4|||
124892874|NCT02403674|449231933|FG000|Base Study|Adverse Event|11|||
124892875|NCT02403674|449231934|FG001|Base Study|Adverse Event|26|||
124892876|NCT02403674|449231933|FG000|Base Study|Lack of Efficacy|31|||
124892877|NCT02403674|449231934|FG001|Base Study|Lack of Efficacy|23|||
124892878|NCT02403674|449231933|FG000|Base Study|Lost to Follow-up|6|||
124892879|NCT02403674|449231934|FG001|Base Study|Lost to Follow-up|8|||
124892880|NCT02403674|449231933|FG000|Base Study|Withdrawal by Subject|10|||
124892881|NCT02403674|449231934|FG001|Base Study|Withdrawal by Subject|17|||
124892882|NCT02403674|449231933|FG000|Base Study|Physician Decision|2|||
124892883|NCT02403674|449231934|FG001|Base Study|Physician Decision|2|||
124892884|NCT02403674|449231933|FG000|Base Study|Pregnancy|2|||
124892885|NCT02403674|449231934|FG001|Base Study|Pregnancy|2|||
124892886|NCT02403674|449231933|FG000|Base Study|Protocol Violation|8|||
124892887|NCT02403674|449231934|FG001|Base Study|Protocol Violation|4|||
124892888|NCT02403674|449231933|FG000|Base Study|Non-Compliance with study drug|1|||
124892889|NCT02403674|449231934|FG001|Base Study|Non-Compliance with study drug|4|||
125107497|NCT00123487|450017293|FG000|Randomized|Death prior to starting treatment|0|||
125107498|NCT00123487|450017294|FG001|Randomized|Death prior to starting treatment|1|||
124892890|NCT02403674|449231933|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
125017309|NCT00391222|449687743|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
125017310|NCT00391222|449687740|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
125017311|NCT00391222|449687741|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
125017312|NCT00391222|449687742|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
125017313|NCT00391222|449687743|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
125017314|NCT00391222|449687740|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
125017315|NCT00391222|449687741|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
125017316|NCT00391222|449687742|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
125017317|NCT00391222|449687743|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
125017318|NCT00391222|449687740|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
125017319|NCT00391222|449687741|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
125017320|NCT00391222|449687742|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
125017321|NCT00391222|449687743|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
125017322|NCT00391222|449687740|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
125017323|NCT00391222|449687741|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
125017324|NCT00391222|449687742|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
125017325|NCT00391222|449687743|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
125017326|NCT00391222|449687740|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
125017327|NCT00391222|449687741|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
125017328|NCT00391222|449687742|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
125017329|NCT00391222|449687743|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
125017330|NCT00391222|449687740|FG000|Period III (Double-Blind Treatment)|Other|6|||
125017331|NCT00391222|449687741|FG001|Period III (Double-Blind Treatment)|Other|1|||
125017332|NCT00391222|449687742|FG002|Period III (Double-Blind Treatment)|Other|6|||
125017333|NCT00391222|449687743|FG003|Period III (Double-Blind Treatment)|Other|0|||
125017334|NCT00574275|449687744|FG000|Overall Study|Randomized but not treated|2|||
125017335|NCT00574275|449687745|FG001|Overall Study|Randomized but not treated|3|||
125017336|NCT00574275|449687744|FG000|Overall Study|Adverse Event|32|||
125017337|NCT00574275|449687745|FG001|Overall Study|Adverse Event|76|||
125017338|NCT00574275|449687744|FG000|Overall Study|Disease progression|160|||
125017339|NCT00574275|449687745|FG001|Overall Study|Disease progression|146|||
125017340|NCT00574275|449687744|FG000|Overall Study|Lost to Follow-up|2|||
125017341|NCT00574275|449687745|FG001|Overall Study|Lost to Follow-up|1|||
125017342|NCT00574275|449687744|FG000|Overall Study|Study stopped based on DMC decision|62|||
125017343|NCT00574275|449687745|FG001|Overall Study|Study stopped based on DMC decision|23|||
125017344|NCT00574275|449687744|FG000|Overall Study|Withdrawal by Subject|15|||
125017345|NCT00574275|449687745|FG001|Overall Study|Withdrawal by Subject|17|||
125017346|NCT00574275|449687744|FG000|Overall Study|Error calculating tumor measurement|1|||
125017347|NCT00574275|449687745|FG001|Overall Study|Error calculating tumor measurement|0|||
125017348|NCT00574275|449687744|FG000|Overall Study|Physician Decision|1|||
125017349|NCT00574275|449687745|FG001|Overall Study|Physician Decision|1|||
125017350|NCT00574275|449687744|FG000|Overall Study|Protocol Violation|0|||
125017351|NCT00574275|449687745|FG001|Overall Study|Protocol Violation|1|||
125017352|NCT00574275|449687744|FG000|Overall Study|Patient and Investigator decision|0|||
125017353|NCT00574275|449687745|FG001|Overall Study|Patient and Investigator decision|1|||
125017354|NCT00574275|449687744|FG000|Overall Study|Insurance change|0|||
125017355|NCT00574275|449687745|FG001|Overall Study|Insurance change|1|||
125017356|NCT00574275|449687744|FG000|Overall Study|Operation for curative intent|0|||
125017357|NCT00574275|449687745|FG001|Overall Study|Operation for curative intent|1|||
125017358|NCT00652366|449687746|FG000|Overall Study|Adverse Event|8|||
125017359|NCT00652366|449687747|FG001|Overall Study|Adverse Event|4|||
125017360|NCT00652366|449687748|FG002|Overall Study|Adverse Event|7|||
125017361|NCT00652366|449687749|FG003|Overall Study|Adverse Event|17|||
125017362|NCT00652366|449687750|FG004|Overall Study|Adverse Event|13|||
125017363|NCT00652366|449687746|FG000|Overall Study|Death|5|||
125017364|NCT00652366|449687747|FG001|Overall Study|Death|4|||
125017365|NCT00652366|449687748|FG002|Overall Study|Death|1|||
125017366|NCT00652366|449687749|FG003|Overall Study|Death|8|||
125017367|NCT00652366|449687750|FG004|Overall Study|Death|5|||
125017368|NCT00652366|449687746|FG000|Overall Study|Lack of Efficacy|84|||
125017369|NCT00652366|449687747|FG001|Overall Study|Lack of Efficacy|58|||
125017370|NCT00652366|449687748|FG002|Overall Study|Lack of Efficacy|53|||
125017371|NCT00652366|449687749|FG003|Overall Study|Lack of Efficacy|133|||
125017372|NCT00652366|449687750|FG004|Overall Study|Lack of Efficacy|13|||
125017373|NCT00652366|449687746|FG000|Overall Study|Violation of Selection Criteria|0|||
125017374|NCT00652366|449687747|FG001|Overall Study|Violation of Selection Criteria|0|||
124892891|NCT02403674|449231934|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
125107499|NCT00123487|450017293|FG000|Randomized|SAE prior to starting treatment|1|||
125107500|NCT00123487|450017294|FG001|Randomized|SAE prior to starting treatment|0|||
125107501|NCT00123487|450017293|FG000|Treated With Study Drug|Adverse Event|23|||
125107502|NCT00123487|450017294|FG001|Treated With Study Drug|Adverse Event|22|||
125107503|NCT00123487|450017293|FG000|Treated With Study Drug|Disease Progression|141|||
125107504|NCT00123487|450017294|FG001|Treated With Study Drug|Disease Progression|122|||
125107505|NCT00123487|450017293|FG000|Treated With Study Drug|Physician Decision|8|||
125107506|NCT00123487|450017294|FG001|Treated With Study Drug|Physician Decision|9|||
125107507|NCT00123487|450017293|FG000|Treated With Study Drug|Other|59|||
125107508|NCT00123487|450017294|FG001|Treated With Study Drug|Other|58|||
125107509|NCT00123487|450017293|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
125107510|NCT00123487|450017294|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
125107511|NCT00123487|450017293|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
125107512|NCT00123487|450017294|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
125107513|NCT00123487|450017293|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
125107514|NCT00123487|450017294|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
125107515|NCT00995488|450017295|FG000|Overall Study|Withdrawal by Subject|1|||
125107516|NCT03672396|450017298|FG000|Overall Study|Withdrawal by Subject|4|||
125107517|NCT03672396|450017298|FG000|Overall Study|Physician Decision|1|||
125107518|NCT03672396|450017298|FG000|Overall Study|Adverse Event|1|||
125107519|NCT04639310|450017303|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
125107520|NCT04639310|450017304|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
125107521|NCT01408576|450018974|FG000|Overall Study|Lack of Efficacy|17|||
125107522|NCT01408576|450018975|FG001|Overall Study|Lack of Efficacy|30|||
125107523|NCT01408576|450018976|FG002|Overall Study|Lack of Efficacy|48|||
125107524|NCT01408576|450018974|FG000|Overall Study|Protocol Violation|1|||
125107525|NCT01408576|450018975|FG001|Overall Study|Protocol Violation|2|||
125107526|NCT01408576|450018976|FG002|Overall Study|Protocol Violation|2|||
125107527|NCT01408576|450018974|FG000|Overall Study|Lost to Follow-up|10|||
125107528|NCT01408576|450018975|FG001|Overall Study|Lost to Follow-up|9|||
125107529|NCT01408576|450018976|FG002|Overall Study|Lost to Follow-up|17|||
125107530|NCT01408576|450018974|FG000|Overall Study|Withdrawal by Subject|34|||
125107531|NCT01408576|450018975|FG001|Overall Study|Withdrawal by Subject|60|||
125107532|NCT01408576|450018976|FG002|Overall Study|Withdrawal by Subject|66|||
125107533|NCT01408576|450018974|FG000|Overall Study|Sponsor terminated study|89|||
125107534|NCT01408576|450018975|FG001|Overall Study|Sponsor terminated study|333|||
125107535|NCT01408576|450018976|FG002|Overall Study|Sponsor terminated study|330|||
125107536|NCT01408576|450018974|FG000|Overall Study|AE, serious fatal|4|||
125107537|NCT01408576|450018975|FG001|Overall Study|AE, serious fatal|4|||
125107538|NCT01408576|450018976|FG002|Overall Study|AE, serious fatal|1|||
125107539|NCT01408576|450018974|FG000|Overall Study|SAE, non-fatal|11|||
125107540|NCT01408576|450018975|FG001|Overall Study|SAE, non-fatal|23|||
125107541|NCT01408576|450018976|FG002|Overall Study|SAE, non-fatal|14|||
125107542|NCT01408576|450018974|FG000|Overall Study|AE, non-serious non-fatal|12|||
125107543|NCT01408576|450018975|FG001|Overall Study|AE, non-serious non-fatal|19|||
125107544|NCT01408576|450018976|FG002|Overall Study|AE, non-serious non-fatal|11|||
125107545|NCT01408576|450018974|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
125107546|NCT01408576|450018975|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
125107547|NCT01408576|450018976|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
125107548|NCT01408576|450018974|FG000|Overall Study|AE, unknown type|0|||
125107549|NCT01408576|450018975|FG001|Overall Study|AE, unknown type|1|||
125107550|NCT01408576|450018976|FG002|Overall Study|AE, unknown type|0|||
125107551|NCT01408576|450018974|FG000|Overall Study|Other|10|||
125107552|NCT01408576|450018975|FG001|Overall Study|Other|16|||
125107553|NCT01408576|450018976|FG002|Overall Study|Other|18|||
125107554|NCT00563524|450018984|FG000|Overall Study|Adverse Event|0|||
125107555|NCT00563524|450018985|FG001|Overall Study|Adverse Event|1|||
125107556|NCT00563524|450018986|FG002|Overall Study|Adverse Event|0|||
125107557|NCT00563524|450018987|FG003|Overall Study|Adverse Event|0|||
125107558|NCT00563524|450018988|FG004|Overall Study|Adverse Event|2|||
125107559|NCT00563524|450018989|FG005|Overall Study|Adverse Event|0|||
125107560|NCT00563524|450018984|FG000|Overall Study|Lost to Follow-up|1|||
125107561|NCT00563524|450018985|FG001|Overall Study|Lost to Follow-up|0|||
125107562|NCT00563524|450018986|FG002|Overall Study|Lost to Follow-up|0|||
125107563|NCT00563524|450018987|FG003|Overall Study|Lost to Follow-up|0|||
125107564|NCT00563524|450018988|FG004|Overall Study|Lost to Follow-up|0|||
125107565|NCT00563524|450018989|FG005|Overall Study|Lost to Follow-up|0|||
125107566|NCT00563524|450018984|FG000|Overall Study|Protocol Violation|0|||
125107567|NCT00563524|450018985|FG001|Overall Study|Protocol Violation|1|||
125107568|NCT00563524|450018986|FG002|Overall Study|Protocol Violation|0|||
125107569|NCT00563524|450018987|FG003|Overall Study|Protocol Violation|0|||
125107570|NCT00563524|450018988|FG004|Overall Study|Protocol Violation|0|||
125107571|NCT00563524|450018989|FG005|Overall Study|Protocol Violation|0|||
125107572|NCT00563524|450018984|FG000|Overall Study|Withdrawal by Subject|1|||
125107573|NCT00563524|450018985|FG001|Overall Study|Withdrawal by Subject|1|||
124892892|NCT02403674|449231933|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
124892893|NCT02403674|449231934|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
124892894|NCT02403674|449231933|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
124892895|NCT02403674|449231934|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
124892896|NCT02403674|449231933|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
124892897|NCT02403674|449231934|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
124892898|NCT02403674|449231933|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
124892899|NCT02403674|449231934|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
124892900|NCT02403674|449231933|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
124892901|NCT02403674|449231934|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
124892902|NCT02403674|449231933|FG000|Study Extension 1 (Open-Label)|Death|1|||
124892903|NCT02403674|449231934|FG001|Study Extension 1 (Open-Label)|Death|0|||
124892904|NCT02403674|449231933|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
124892905|NCT02403674|449231934|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
124892906|NCT02403674|449231933|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
124892907|NCT02403674|449231934|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
124892908|NCT02403674|449231933|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
124892909|NCT02403674|449231934|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
124892910|NCT02403674|449231933|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
124892911|NCT02403674|449231934|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
124892912|NCT02403674|449231933|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
124892913|NCT02403674|449231934|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
124892914|NCT02403674|449231933|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
124892915|NCT02403674|449231934|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
124892916|NCT02403674|449231933|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
124892917|NCT02403674|449231934|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
124892918|NCT02403674|449231933|FG000|Study Extension 2 (Open-Label)|Death|2|||
124892919|NCT02403674|449231934|FG001|Study Extension 2 (Open-Label)|Death|2|||
124892920|NCT02403674|449231933|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
125107574|NCT00563524|450018986|FG002|Overall Study|Withdrawal by Subject|3|||
124892921|NCT02403674|449231934|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
125107575|NCT00563524|450018987|FG003|Overall Study|Withdrawal by Subject|0|||
125107576|NCT00563524|450018988|FG004|Overall Study|Withdrawal by Subject|0|||
125107577|NCT00563524|450018989|FG005|Overall Study|Withdrawal by Subject|1|||
125107578|NCT00817778|450018993|FG000|Overall Study|Adverse Event|1|||
125107579|NCT00817778|450018994|FG001|Overall Study|Adverse Event|0|||
125107580|NCT00817778|450018993|FG000|Overall Study|Withdrawal by Subject|1|||
125107581|NCT00817778|450018994|FG001|Overall Study|Withdrawal by Subject|1|||
125107582|NCT00817778|450018993|FG000|Overall Study|Protocol Violation|0|||
125107583|NCT00817778|450018994|FG001|Overall Study|Protocol Violation|1|||
125107584|NCT00817778|450018993|FG000|Overall Study|Study-specific discontinuation criteria|0|||
124892922|NCT02403674|449231933|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
124892923|NCT02403674|449231934|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
124892924|NCT02403674|449231933|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
124892925|NCT02403674|449231934|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
125107585|NCT00817778|450018994|FG001|Overall Study|Study-specific discontinuation criteria|1|||
125107586|NCT00817778|450018993|FG000|Overall Study|Poor venous access|1|||
125107587|NCT00817778|450018994|FG001|Overall Study|Poor venous access|0|||
125107588|NCT02360397|450018996|FG000|Overall Study|Incomplete screening|3|||
124892926|NCT02403674|449231933|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
124892927|NCT02403674|449231934|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
124892928|NCT02403674|449231933|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
124892929|NCT02403674|449231934|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
124892930|NCT02403674|449231933|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
124892931|NCT02403674|449231934|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
124892932|NCT02403674|449231933|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
124892933|NCT02403674|449231934|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
124892934|NCT00826280|449231936|FG000|Overall Study|Randomized but drug not received|1|||
124892935|NCT00826280|449231937|FG001|Overall Study|Randomized but drug not received|0|||
124892936|NCT00826280|449231938|FG002|Overall Study|Randomized but drug not received|1|||
124892937|NCT00826280|449231936|FG000|Overall Study|Adverse Event|1|||
124892938|NCT00826280|449231937|FG001|Overall Study|Adverse Event|3|||
124892939|NCT00826280|449231938|FG002|Overall Study|Adverse Event|0|||
124892940|NCT00826280|449231936|FG000|Overall Study|Lost to Follow-up|0|||
124892941|NCT00826280|449231937|FG001|Overall Study|Lost to Follow-up|1|||
124892942|NCT00826280|449231938|FG002|Overall Study|Lost to Follow-up|0|||
124892943|NCT00826280|449231936|FG000|Overall Study|Sponsor discontinued subject or study|1|||
124892944|NCT00826280|449231937|FG001|Overall Study|Sponsor discontinued subject or study|0|||
124892945|NCT00826280|449231938|FG002|Overall Study|Sponsor discontinued subject or study|0|||
124892946|NCT00826280|449231936|FG000|Overall Study|Reversible ischemic defect not present|43|||
124892947|NCT00826280|449231937|FG001|Overall Study|Reversible ischemic defect not present|40|||
124892948|NCT00826280|449231938|FG002|Overall Study|Reversible ischemic defect not present|44|||
124892949|NCT00826280|449231936|FG000|Overall Study|Interpretation Failure|1|||
124892950|NCT00826280|449231937|FG001|Overall Study|Interpretation Failure|0|||
124892951|NCT00826280|449231938|FG002|Overall Study|Interpretation Failure|0|||
124892952|NCT00826280|449231936|FG000|Overall Study|Machine Failure|1|||
124892953|NCT00826280|449231937|FG001|Overall Study|Machine Failure|1|||
124892954|NCT00826280|449231938|FG002|Overall Study|Machine Failure|0|||
125107589|NCT02360397|450018996|FG000|Overall Study|Adverse Event|1|||
125107590|NCT01537549|450018997|FG000|Overall Study|Lost to Follow-up|1|||
124892955|NCT00826280|449231936|FG000|Overall Study|One or more non-interpretable scan|0|||
124892956|NCT00826280|449231937|FG001|Overall Study|One or more non-interpretable scan|1|||
124892957|NCT00826280|449231938|FG002|Overall Study|One or more non-interpretable scan|1|||
124892958|NCT03201757|449231939|FG000|Overall Study|Withdrawal by Subject|133|||
124892959|NCT03201757|449231939|FG000|Overall Study|Adverse Event|44|||
125107591|NCT01537549|450018997|FG000|Overall Study|Withdrawal by Subject|2|||
124892960|NCT03201757|449231939|FG000|Overall Study|Lost to Follow-up|37|||
124892961|NCT03201757|449231939|FG000|Overall Study|Pregnancy|2|||
124892962|NCT03201757|449231939|FG000|Overall Study|Lack of Efficacy|1|||
124892963|NCT03201757|449231939|FG000|Overall Study|Protocol Violation|20|||
124892964|NCT03201757|449231939|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
124892965|NCT03201757|449231939|FG000|Overall Study|Not Yet Determined|5|||
124892966|NCT03201757|449231939|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
124892967|NCT03201757|449231939|FG000|Overall Study|Other|20|||
124892968|NCT01254305|449231940|FG000|Overall Study|Adverse Event|6|||
124892969|NCT01254305|449231941|FG001|Overall Study|Adverse Event|3|||
124892970|NCT01254305|449231942|FG002|Overall Study|Adverse Event|2|||
124892971|NCT01254305|449231940|FG000|Overall Study|Lack of Efficacy|1|||
124892972|NCT01254305|449231941|FG001|Overall Study|Lack of Efficacy|0|||
124892973|NCT01254305|449231942|FG002|Overall Study|Lack of Efficacy|1|||
124892974|NCT01254305|449231940|FG000|Overall Study|Protocol Violation|1|||
124892975|NCT01254305|449231941|FG001|Overall Study|Protocol Violation|7|||
124892976|NCT01254305|449231942|FG002|Overall Study|Protocol Violation|3|||
124892977|NCT01254305|449231940|FG000|Overall Study|Withdrawal by Subject|4|||
124892978|NCT01254305|449231941|FG001|Overall Study|Withdrawal by Subject|2|||
124892979|NCT01254305|449231942|FG002|Overall Study|Withdrawal by Subject|4|||
124892980|NCT01254305|449231940|FG000|Overall Study|Lost to Follow-up|10|||
124892981|NCT01254305|449231941|FG001|Overall Study|Lost to Follow-up|6|||
124892982|NCT01254305|449231942|FG002|Overall Study|Lost to Follow-up|5|||
124892983|NCT01254305|449231940|FG000|Overall Study|Other Reasons|0|||
124892984|NCT01254305|449231941|FG001|Overall Study|Other Reasons|0|||
124892985|NCT01254305|449231942|FG002|Overall Study|Other Reasons|2|||
124892986|NCT01511536|449231943|FG000|Phase 1|Other|0|||
124892987|NCT01511536|449231944|FG001|Phase 1|Other|1|||
124892988|NCT01511536|449231945|FG002|Phase 1|Other|0|||
124892989|NCT01511536|449231943|FG000|Phase 2|Other|0|||
124892990|NCT01511536|449231944|FG001|Phase 2|Other|0|||
124892991|NCT01511536|449231945|FG002|Phase 2|Other|9|||
124892992|NCT02703532|449231949|FG000|Overall Study|Withdrawal by Subject|0|||
124892993|NCT02703532|449231950|FG001|Overall Study|Withdrawal by Subject|1|||
124892994|NCT02703532|449231951|FG002|Overall Study|Withdrawal by Subject|0|||
124892995|NCT02703532|449231952|FG003|Overall Study|Withdrawal by Subject|1|||
124892996|NCT02703532|449231949|FG000|Overall Study|Lost to Follow-up|2|||
125107592|NCT02923115|450019005|FG000|Overall Study|Lost to Follow-up|0|||
125107593|NCT02923115|450019006|FG001|Overall Study|Lost to Follow-up|0|||
125107594|NCT02923115|450019007|FG002|Overall Study|Lost to Follow-up|0|||
124892997|NCT02703532|449231950|FG001|Overall Study|Lost to Follow-up|0|||
124892998|NCT02703532|449231951|FG002|Overall Study|Lost to Follow-up|2|||
124892999|NCT02703532|449231952|FG003|Overall Study|Lost to Follow-up|0|||
124893000|NCT03239210|449231953|FG000|Overall Study|Lost to Follow-up|2|||
124893001|NCT03239210|449231954|FG001|Overall Study|Lost to Follow-up|2|||
124893002|NCT03239210|449231953|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
124893003|NCT03239210|449231954|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
124893004|NCT03239210|449231953|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
124893005|NCT03239210|449231954|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
124893006|NCT01403987|449231957|FG000|Overall Study|Residents forgot their secret PIN|18|||
124893007|NCT01403987|449231958|FG001|Overall Study|Residents forgot their secret PIN|17|||
124893008|NCT01403987|449231959|FG002|Overall Study|Residents forgot their secret PIN|18|||
124893009|NCT00751790|449231960|FG000|Overall Study|Lost to Follow-up|1|||
124893010|NCT00751790|449231960|FG000|Overall Study|Death|3|||
124893011|NCT00751790|449231960|FG000|Overall Study|Withdrawal by Subject|1|||
124893012|NCT02179918|449231964|FG000|Overall Study|Death|0|||
124893013|NCT02179918|449231965|FG001|Overall Study|Death|0|||
124893014|NCT02179918|449231966|FG002|Overall Study|Death|0|||
124893015|NCT02179918|449231967|FG003|Overall Study|Death|1|||
124893016|NCT02179918|449231968|FG004|Overall Study|Death|0|||
124893017|NCT02179918|449231964|FG000|Overall Study|Lost to Follow-up|0|||
124893018|NCT02179918|449231965|FG001|Overall Study|Lost to Follow-up|0|||
124893019|NCT02179918|449231966|FG002|Overall Study|Lost to Follow-up|1|||
124893020|NCT02179918|449231967|FG003|Overall Study|Lost to Follow-up|0|||
124893021|NCT02179918|449231968|FG004|Overall Study|Lost to Follow-up|0|||
124893022|NCT02179918|449231964|FG000|Overall Study|Progressive Disease|4|||
124893023|NCT02179918|449231965|FG001|Overall Study|Progressive Disease|1|||
124893024|NCT02179918|449231966|FG002|Overall Study|Progressive Disease|1|||
124893025|NCT02179918|449231967|FG003|Overall Study|Progressive Disease|2|||
124893026|NCT02179918|449231968|FG004|Overall Study|Progressive Disease|6|||
124893027|NCT02179918|449231964|FG000|Overall Study|Other|0|||
124893028|NCT02179918|449231965|FG001|Overall Study|Other|1|||
124893029|NCT02179918|449231966|FG002|Overall Study|Other|0|||
124893030|NCT02179918|449231967|FG003|Overall Study|Other|0|||
124893031|NCT02179918|449231968|FG004|Overall Study|Other|1|||
124893032|NCT02179918|449231964|FG000|Overall Study|Subject refused further follow-up|0|||
124893033|NCT02179918|449231965|FG001|Overall Study|Subject refused further follow-up|1|||
124893034|NCT02179918|449231966|FG002|Overall Study|Subject refused further follow-up|0|||
124893035|NCT02179918|449231967|FG003|Overall Study|Subject refused further follow-up|0|||
124893036|NCT02179918|449231968|FG004|Overall Study|Subject refused further follow-up|1|||
124893037|NCT04337489|449231973|FG000|Overall Study|Withdrawal by Subject|1|||
124893038|NCT00972543|449231974|FG000|Overall Study|Adverse Event|1|||
124893039|NCT00972543|449231975|FG001|Overall Study|Adverse Event|0|||
124893040|NCT00972543|449231974|FG000|Overall Study|Early study termination by sponsor|4|||
124893041|NCT00972543|449231975|FG001|Overall Study|Early study termination by sponsor|1|||
124893042|NCT04537949|449231978|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
124893043|NCT04537949|449231979|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
124893044|NCT04537949|449231980|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
124893045|NCT04537949|449231981|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
124893046|NCT04537949|449231982|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
124893047|NCT04537949|449231983|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
124893048|NCT04537949|449231984|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
124893049|NCT04537949|449231985|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
124893050|NCT04537949|449231978|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
124893051|NCT04537949|449231979|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
124893052|NCT04537949|449231980|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
124893053|NCT04537949|449231981|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
124893054|NCT04537949|449231982|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
124893055|NCT04537949|449231983|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
125017375|NCT00652366|449687748|FG002|Overall Study|Violation of Selection Criteria|1|||
125017376|NCT00652366|449687749|FG003|Overall Study|Violation of Selection Criteria|0|||
125017377|NCT00652366|449687750|FG004|Overall Study|Violation of Selection Criteria|0|||
124893056|NCT04537949|449231984|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
124893057|NCT04537949|449231985|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
124893058|NCT04537949|449231978|FG000|Follow-up Phase|Lost to Follow-up|0|||
124893059|NCT04537949|449231979|FG001|Follow-up Phase|Lost to Follow-up|3|||
124893060|NCT04537949|449231980|FG002|Follow-up Phase|Lost to Follow-up|0|||
125017378|NCT00652366|449687746|FG000|Overall Study|Protocol Violation|1|||
124893061|NCT04537949|449231981|FG003|Follow-up Phase|Lost to Follow-up|0|||
124893062|NCT04537949|449231982|FG004|Follow-up Phase|Lost to Follow-up|0|||
124893063|NCT04537949|449231983|FG005|Follow-up Phase|Lost to Follow-up|0|||
124893064|NCT04537949|449231984|FG006|Follow-up Phase|Lost to Follow-up|0|||
125017379|NCT00652366|449687747|FG001|Overall Study|Protocol Violation|0|||
125017380|NCT00652366|449687748|FG002|Overall Study|Protocol Violation|0|||
125017381|NCT00652366|449687749|FG003|Overall Study|Protocol Violation|0|||
124893065|NCT04537949|449231985|FG007|Follow-up Phase|Lost to Follow-up|0|||
124893066|NCT04537949|449231978|FG000|Follow-up Phase|personal reasons|0|||
124893067|NCT04537949|449231979|FG001|Follow-up Phase|personal reasons|0|||
124893068|NCT04537949|449231980|FG002|Follow-up Phase|personal reasons|0|||
124893069|NCT04537949|449231981|FG003|Follow-up Phase|personal reasons|1|||
124893070|NCT04537949|449231982|FG004|Follow-up Phase|personal reasons|1|||
124893071|NCT04537949|449231983|FG005|Follow-up Phase|personal reasons|0|||
124893072|NCT04537949|449231984|FG006|Follow-up Phase|personal reasons|0|||
124893073|NCT04537949|449231985|FG007|Follow-up Phase|personal reasons|0|||
124893074|NCT04537949|449231978|FG000|Follow-up Phase|Withdrawal by Subject|0|||
125107595|NCT02923115|450019008|FG003|Overall Study|Lost to Follow-up|1|||
125107596|NCT02923115|450019009|FG004|Overall Study|Lost to Follow-up|0|||
125107597|NCT02923115|450019010|FG005|Overall Study|Lost to Follow-up|0|||
125107598|NCT02923115|450019005|FG000|Overall Study|Withdrawal by Subject|0|||
125107599|NCT02923115|450019006|FG001|Overall Study|Withdrawal by Subject|1|||
125107600|NCT02923115|450019007|FG002|Overall Study|Withdrawal by Subject|0|||
125107601|NCT02923115|450019008|FG003|Overall Study|Withdrawal by Subject|0|||
125107602|NCT02923115|450019009|FG004|Overall Study|Withdrawal by Subject|0|||
125107603|NCT02923115|450019010|FG005|Overall Study|Withdrawal by Subject|0|||
125107604|NCT02923115|450019005|FG000|Overall Study|Randomized, but not dosed|0|||
125107605|NCT02923115|450019006|FG001|Overall Study|Randomized, but not dosed|0|||
125107606|NCT02923115|450019007|FG002|Overall Study|Randomized, but not dosed|3|||
125107607|NCT02923115|450019008|FG003|Overall Study|Randomized, but not dosed|1|||
125107608|NCT02923115|450019009|FG004|Overall Study|Randomized, but not dosed|5|||
125107609|NCT02923115|450019010|FG005|Overall Study|Randomized, but not dosed|0|||
125107610|NCT04056299|450019013|FG000|Overall Study|Sponsor discontinued study|3|||
125107611|NCT04056299|450019014|FG001|Overall Study|Sponsor discontinued study|3|||
125107612|NCT00068406|450019016|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
125107613|NCT00068406|450019016|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
125107614|NCT03231709|450019017|FG000|Treatment Period 1|Reason not Specified|0|||
125107615|NCT03231709|450019018|FG001|Treatment Period 1|Reason not Specified|1|||
125107616|NCT03231709|450019017|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
125107617|NCT03231709|450019018|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
125107618|NCT01875991|450019019|FG000|Overall Study|Withdrawal by Subject|6|||
125107619|NCT01875991|450019020|FG001|Overall Study|Withdrawal by Subject|6|||
125107620|NCT01875991|450019019|FG000|Overall Study|Sponsor Decision|1|||
125107621|NCT01875991|450019020|FG001|Overall Study|Sponsor Decision|0|||
125107622|NCT02419469|450019021|FG000|Overall Study|Withdrawal by Subject|1|||
125107623|NCT02454972|450019022|FG000|Overall Study|Progressive disease|17|||
125107624|NCT02454972|450019023|FG001|Overall Study|Progressive disease|16|||
125107625|NCT02454972|450019024|FG002|Overall Study|Progressive disease|59|||
125107626|NCT02454972|450019025|FG003|Overall Study|Progressive disease|23|||
125107627|NCT02454972|450019026|FG004|Overall Study|Progressive disease|16|||
125107628|NCT02454972|450019027|FG005|Overall Study|Progressive disease|12|||
125107629|NCT02454972|450019028|FG006|Overall Study|Progressive disease|19|||
125107630|NCT02454972|450019029|FG007|Overall Study|Progressive disease|27|||
125107631|NCT02454972|450019030|FG008|Overall Study|Progressive disease|0|||
125107632|NCT02454972|450019022|FG000|Overall Study|Death|0|||
125107633|NCT02454972|450019023|FG001|Overall Study|Death|0|||
125107634|NCT02454972|450019024|FG002|Overall Study|Death|5|||
125107635|NCT02454972|450019025|FG003|Overall Study|Death|1|||
125107636|NCT02454972|450019026|FG004|Overall Study|Death|0|||
125107637|NCT02454972|450019027|FG005|Overall Study|Death|0|||
125107638|NCT02454972|450019028|FG006|Overall Study|Death|0|||
124893075|NCT04537949|449231979|FG001|Follow-up Phase|Withdrawal by Subject|0|||
124893076|NCT04537949|449231980|FG002|Follow-up Phase|Withdrawal by Subject|0|||
124893077|NCT04537949|449231981|FG003|Follow-up Phase|Withdrawal by Subject|0|||
124893078|NCT04537949|449231982|FG004|Follow-up Phase|Withdrawal by Subject|1|||
125107639|NCT02454972|450019029|FG007|Overall Study|Death|0|||
125107640|NCT02454972|450019030|FG008|Overall Study|Death|95|||
125107641|NCT02454972|450019022|FG000|Overall Study|Physician Decision|0|||
125107642|NCT02454972|450019023|FG001|Overall Study|Physician Decision|1|||
125107643|NCT02454972|450019024|FG002|Overall Study|Physician Decision|2|||
125107644|NCT02454972|450019025|FG003|Overall Study|Physician Decision|1|||
125107645|NCT02454972|450019026|FG004|Overall Study|Physician Decision|2|||
125107646|NCT02454972|450019027|FG005|Overall Study|Physician Decision|0|||
125107647|NCT02454972|450019028|FG006|Overall Study|Physician Decision|0|||
124893079|NCT04537949|449231983|FG005|Follow-up Phase|Withdrawal by Subject|0|||
124893080|NCT04537949|449231984|FG006|Follow-up Phase|Withdrawal by Subject|0|||
125107648|NCT02454972|450019029|FG007|Overall Study|Physician Decision|1|||
124893081|NCT04537949|449231985|FG007|Follow-up Phase|Withdrawal by Subject|0|||
124893082|NCT04296942|449231987|FG000|Overall Study|Study closure by sponsor|1|||
124893083|NCT04296942|449231988|FG001|Overall Study|Study closure by sponsor|0|||
124893084|NCT04296942|449231989|FG002|Overall Study|Study closure by sponsor|0|||
124893085|NCT02478359|449231992|FG000|Overall Study|Disenrolled from health plan|106|||
124893086|NCT02478359|449231993|FG001|Overall Study|Disenrolled from health plan|65|||
124893087|NCT00562965|449231994|FG000|Overall Study|Withdrawal by Subject|0|||
124893088|NCT00562965|449231995|FG001|Overall Study|Withdrawal by Subject|1|||
124893089|NCT00562965|449231994|FG000|Overall Study|Death|2|||
125107649|NCT02454972|450019030|FG008|Overall Study|Physician Decision|0|||
125107650|NCT02454972|450019022|FG000|Overall Study|Non treatment-related adverse event|2|||
125107651|NCT02454972|450019023|FG001|Overall Study|Non treatment-related adverse event|0|||
124893090|NCT00562965|449231995|FG001|Overall Study|Death|4|||
124893091|NCT00562965|449231994|FG000|Overall Study|Lost to Follow-up|1|||
124893092|NCT00562965|449231995|FG001|Overall Study|Lost to Follow-up|0|||
124893093|NCT00562965|449231994|FG000|Overall Study|Other|0|||
124893094|NCT00562965|449231995|FG001|Overall Study|Other|1|||
124893095|NCT00965484|449231999|FG000|Overall Study|Protocol Violation|1|||
124893096|NCT00965484|449231999|FG000|Overall Study|Withdrawal by Subject|1|||
124893097|NCT00848211|449232000|FG000|Overall Study|Protocol Violation|0|||
124893098|NCT00848211|449232001|FG001|Overall Study|Protocol Violation|1|||
124893099|NCT00848211|449232002|FG002|Overall Study|Protocol Violation|1|||
124893100|NCT00848211|449232003|FG003|Overall Study|Protocol Violation|0|||
124893101|NCT00848211|449232000|FG000|Overall Study|Adverse Event|0|||
124893102|NCT00848211|449232001|FG001|Overall Study|Adverse Event|0|||
124893103|NCT00848211|449232002|FG002|Overall Study|Adverse Event|0|||
124893104|NCT00848211|449232003|FG003|Overall Study|Adverse Event|0|||
124893105|NCT01124617|449232004|FG000|Overall Study|Adverse Event|5|||
124893106|NCT01124617|449232005|FG001|Overall Study|Adverse Event|2|||
124893107|NCT01124617|449232004|FG000|Overall Study|Lack of Efficacy|2|||
124893108|NCT01124617|449232005|FG001|Overall Study|Lack of Efficacy|1|||
124893109|NCT01124617|449232004|FG000|Overall Study|Protocol Violation|1|||
124893110|NCT01124617|449232005|FG001|Overall Study|Protocol Violation|1|||
124893111|NCT01124617|449232004|FG000|Overall Study|Withdrawal by Subject|9|||
124893112|NCT01124617|449232005|FG001|Overall Study|Withdrawal by Subject|1|||
124893113|NCT01124617|449232004|FG000|Overall Study|Other|2|||
124893114|NCT01124617|449232005|FG001|Overall Study|Other|1|||
124893115|NCT00945477|449232006|FG000|Overall Study|Adverse Event|3|||
124893116|NCT00945477|449232006|FG000|Overall Study|Lack of Efficacy|2|||
124893117|NCT00945477|449232006|FG000|Overall Study|Withdrawal by Subject|1|||
125017382|NCT00652366|449687750|FG004|Overall Study|Protocol Violation|0|||
125017383|NCT00652366|449687746|FG000|Overall Study|Refused treatment|3|||
125017384|NCT00652366|449687747|FG001|Overall Study|Refused treatment|7|||
125017385|NCT00652366|449687748|FG002|Overall Study|Refused treatment|6|||
125017386|NCT00652366|449687749|FG003|Overall Study|Refused treatment|17|||
125017387|NCT00652366|449687750|FG004|Overall Study|Refused treatment|5|||
125017388|NCT00652366|449687746|FG000|Overall Study|Other|5|||
125017389|NCT00652366|449687747|FG001|Overall Study|Other|2|||
125017390|NCT00652366|449687748|FG002|Overall Study|Other|3|||
125017391|NCT00652366|449687749|FG003|Overall Study|Other|4|||
125017392|NCT00652366|449687750|FG004|Overall Study|Other|0|||
125017393|NCT03028870|449687754|FG000|Overall Study|Adverse Event|7|||
125017394|NCT03028870|449687755|FG001|Overall Study|Adverse Event|4|||
125017395|NCT03028870|449687756|FG002|Overall Study|Adverse Event|3|||
125017396|NCT03028870|449687757|FG003|Overall Study|Adverse Event|3|||
125017397|NCT03028870|449687754|FG000|Overall Study|Withdrawal by Subject|1|||
125017398|NCT03028870|449687755|FG001|Overall Study|Withdrawal by Subject|1|||
125017399|NCT03028870|449687756|FG002|Overall Study|Withdrawal by Subject|1|||
125017400|NCT03028870|449687757|FG003|Overall Study|Withdrawal by Subject|2|||
125017401|NCT03028870|449687754|FG000|Overall Study|Lost to Follow-up|1|||
125017402|NCT03028870|449687755|FG001|Overall Study|Lost to Follow-up|0|||
125017403|NCT03028870|449687756|FG002|Overall Study|Lost to Follow-up|0|||
125017404|NCT03028870|449687757|FG003|Overall Study|Lost to Follow-up|0|||
125017405|NCT03028870|449687754|FG000|Overall Study|Lack of Efficacy|3|||
125017406|NCT03028870|449687755|FG001|Overall Study|Lack of Efficacy|0|||
125017407|NCT03028870|449687756|FG002|Overall Study|Lack of Efficacy|0|||
125017408|NCT03028870|449687757|FG003|Overall Study|Lack of Efficacy|0|||
125017409|NCT03028870|449687754|FG000|Overall Study|Administrative|5|||
125017410|NCT03028870|449687755|FG001|Overall Study|Administrative|5|||
125017411|NCT03028870|449687756|FG002|Overall Study|Administrative|12|||
125017412|NCT03028870|449687757|FG003|Overall Study|Administrative|4|||
125017413|NCT00137111|449687760|FG000|Total Therapy|Death|35|||
125017414|NCT00137111|449687761|FG001|Total Therapy|Death|0|||
125017415|NCT00137111|449687762|FG002|Total Therapy|Death|0|||
125107652|NCT02454972|450019024|FG002|Overall Study|Non treatment-related adverse event|1|||
125017416|NCT00137111|449687763|FG003|Total Therapy|Death|0|||
125017417|NCT00137111|449687760|FG000|Total Therapy|Non Compliance|5|||
125017418|NCT00137111|449687761|FG001|Total Therapy|Non Compliance|0|||
125017419|NCT00137111|449687762|FG002|Total Therapy|Non Compliance|0|||
125017420|NCT00137111|449687763|FG003|Total Therapy|Non Compliance|0|||
125017421|NCT04703075|449687766|FG000|Overall Study|Adverse Event|11|||
125017422|NCT04703075|449687767|FG001|Overall Study|Adverse Event|7|||
125017423|NCT04703075|449687766|FG000|Overall Study|Lost to Follow-up|6|||
125017424|NCT04703075|449687767|FG001|Overall Study|Lost to Follow-up|12|||
125017425|NCT04703075|449687766|FG000|Overall Study|Physician Decision|3|||
125017426|NCT04703075|449687767|FG001|Overall Study|Physician Decision|0|||
125017427|NCT04703075|449687766|FG000|Overall Study|Moved|0|||
125017428|NCT04703075|449687767|FG001|Overall Study|Moved|2|||
125017429|NCT04703075|449687766|FG000|Overall Study|Index INH Resistant|0|||
125017430|NCT04703075|449687767|FG001|Overall Study|Index INH Resistant|1|||
125017431|NCT04703075|449687766|FG000|Overall Study|Lack of Efficacy|6|||
125017432|NCT04703075|449687767|FG001|Overall Study|Lack of Efficacy|18|||
125017433|NCT02425826|449687768|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
125017434|NCT02425826|449687769|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
125017435|NCT02425826|449687770|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
125017436|NCT02425826|449687768|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
125017437|NCT02425826|449687769|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
125017438|NCT02425826|449687770|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
125017439|NCT02425826|449687768|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
125017440|NCT02425826|449687769|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
125017441|NCT02425826|449687770|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
124893118|NCT00619151|449232007|FG000|Overall Study|Study terminated prior to followup|1|||
124893119|NCT00619151|449232008|FG001|Overall Study|Study terminated prior to followup|0|||
124893120|NCT02825043|449232009|FG000|Overall Study|Lost to Follow-up|4|||
124893121|NCT01982760|449232013|FG000|Overall Study|Physician Decision|1|||
124893122|NCT01982760|449232014|FG001|Overall Study|Physician Decision|0|||
124893123|NCT00859014|449232015|FG000|Overall Study|Death|4|||
124893124|NCT00859014|449232015|FG000|Overall Study|Lost to Follow-up|1|||
124893125|NCT04796935|449232016|FG000|Overall Study|Withdrawal by Subject|0|||
124893126|NCT04796935|449232017|FG001|Overall Study|Withdrawal by Subject|1|||
124893127|NCT04796935|449232016|FG000|Overall Study|Physician Decision|0|||
124893128|NCT04796935|449232017|FG001|Overall Study|Physician Decision|1|||
124893129|NCT04796935|449232016|FG000|Overall Study|Device not available|1|||
124893130|NCT04796935|449232017|FG001|Overall Study|Device not available|0|||
124893131|NCT04796935|449232016|FG000|Overall Study|Trained provider not available|1|||
124893132|NCT04796935|449232017|FG001|Overall Study|Trained provider not available|0|||
124893133|NCT00783718|449232018|FG000|Induction Phase|Adverse Event|4|||
124893134|NCT00783718|449232019|FG001|Induction Phase|Adverse Event|0|||
124893135|NCT00783718|449232020|FG002|Induction Phase|Adverse Event|7|||
124893136|NCT00783718|449232021|FG003|Induction Phase|Adverse Event|0|||
124893137|NCT00783718|449232022|FG004|Induction Phase|Adverse Event|0|||
124893138|NCT00783718|449232023|FG005|Induction Phase|Adverse Event|0|||
124893139|NCT00783718|449232024|FG006|Induction Phase|Adverse Event|0|||
124893140|NCT00783718|449232018|FG000|Induction Phase|Protocol Violation|1|||
124893141|NCT00783718|449232019|FG001|Induction Phase|Protocol Violation|1|||
124893142|NCT00783718|449232020|FG002|Induction Phase|Protocol Violation|6|||
124893143|NCT00783718|449232021|FG003|Induction Phase|Protocol Violation|0|||
124893144|NCT00783718|449232022|FG004|Induction Phase|Protocol Violation|0|||
124893145|NCT00783718|449232023|FG005|Induction Phase|Protocol Violation|0|||
124893146|NCT00783718|449232024|FG006|Induction Phase|Protocol Violation|0|||
124893147|NCT00783718|449232018|FG000|Induction Phase|Lack of Efficacy|5|||
124893148|NCT00783718|449232019|FG001|Induction Phase|Lack of Efficacy|2|||
124893149|NCT00783718|449232020|FG002|Induction Phase|Lack of Efficacy|14|||
124893150|NCT00783718|449232021|FG003|Induction Phase|Lack of Efficacy|0|||
124893151|NCT00783718|449232022|FG004|Induction Phase|Lack of Efficacy|0|||
124893152|NCT00783718|449232023|FG005|Induction Phase|Lack of Efficacy|0|||
124893153|NCT00783718|449232024|FG006|Induction Phase|Lack of Efficacy|0|||
124893154|NCT00783718|449232018|FG000|Induction Phase|Withdrawal by Subject|3|||
124893155|NCT00783718|449232019|FG001|Induction Phase|Withdrawal by Subject|4|||
124893156|NCT00783718|449232020|FG002|Induction Phase|Withdrawal by Subject|8|||
124893157|NCT00783718|449232021|FG003|Induction Phase|Withdrawal by Subject|0|||
124893158|NCT00783718|449232022|FG004|Induction Phase|Withdrawal by Subject|0|||
124893159|NCT00783718|449232023|FG005|Induction Phase|Withdrawal by Subject|0|||
124893160|NCT00783718|449232024|FG006|Induction Phase|Withdrawal by Subject|0|||
124893161|NCT00783718|449232018|FG000|Induction Phase|Lost to Follow-up|1|||
124893162|NCT00783718|449232019|FG001|Induction Phase|Lost to Follow-up|0|||
124893163|NCT00783718|449232020|FG002|Induction Phase|Lost to Follow-up|1|||
124893164|NCT00783718|449232021|FG003|Induction Phase|Lost to Follow-up|0|||
124893165|NCT00783718|449232022|FG004|Induction Phase|Lost to Follow-up|0|||
124893166|NCT00783718|449232023|FG005|Induction Phase|Lost to Follow-up|0|||
124893167|NCT00783718|449232024|FG006|Induction Phase|Lost to Follow-up|0|||
124893168|NCT00783718|449232018|FG000|Maintenance Phase|Adverse Event|12|||
125107653|NCT02454972|450019025|FG003|Overall Study|Non treatment-related adverse event|0|||
125107654|NCT02454972|450019026|FG004|Overall Study|Non treatment-related adverse event|0|||
125107655|NCT02454972|450019027|FG005|Overall Study|Non treatment-related adverse event|1|||
125107656|NCT02454972|450019028|FG006|Overall Study|Non treatment-related adverse event|0|||
125107657|NCT02454972|450019029|FG007|Overall Study|Non treatment-related adverse event|1|||
125107658|NCT02454972|450019030|FG008|Overall Study|Non treatment-related adverse event|0|||
125107659|NCT02454972|450019022|FG000|Overall Study|Treatment-related adverse events|0|||
125107660|NCT02454972|450019023|FG001|Overall Study|Treatment-related adverse events|1|||
125107661|NCT02454972|450019024|FG002|Overall Study|Treatment-related adverse events|1|||
125107662|NCT02454972|450019025|FG003|Overall Study|Treatment-related adverse events|0|||
124893169|NCT00783718|449232019|FG001|Maintenance Phase|Adverse Event|0|||
124893170|NCT00783718|449232020|FG002|Maintenance Phase|Adverse Event|0|||
124893171|NCT00783718|449232021|FG003|Maintenance Phase|Adverse Event|15|||
124893172|NCT00783718|449232022|FG004|Maintenance Phase|Adverse Event|7|||
124893173|NCT00783718|449232023|FG005|Maintenance Phase|Adverse Event|6|||
124893174|NCT00783718|449232024|FG006|Maintenance Phase|Adverse Event|16|||
124893175|NCT00783718|449232018|FG000|Maintenance Phase|Protocol Violation|1|||
124893176|NCT00783718|449232019|FG001|Maintenance Phase|Protocol Violation|0|||
124893177|NCT00783718|449232020|FG002|Maintenance Phase|Protocol Violation|0|||
124893178|NCT00783718|449232021|FG003|Maintenance Phase|Protocol Violation|0|||
124893179|NCT00783718|449232022|FG004|Maintenance Phase|Protocol Violation|0|||
124893180|NCT00783718|449232023|FG005|Maintenance Phase|Protocol Violation|0|||
124893181|NCT00783718|449232024|FG006|Maintenance Phase|Protocol Violation|2|||
124893182|NCT00783718|449232018|FG000|Maintenance Phase|Lack of Efficacy|83|||
124893183|NCT00783718|449232019|FG001|Maintenance Phase|Lack of Efficacy|0|||
124893184|NCT00783718|449232020|FG002|Maintenance Phase|Lack of Efficacy|0|||
124893185|NCT00783718|449232021|FG003|Maintenance Phase|Lack of Efficacy|61|||
124893186|NCT00783718|449232022|FG004|Maintenance Phase|Lack of Efficacy|31|||
124893187|NCT00783718|449232023|FG005|Maintenance Phase|Lack of Efficacy|33|||
125107663|NCT02454972|450019026|FG004|Overall Study|Treatment-related adverse events|2|||
125107664|NCT02454972|450019027|FG005|Overall Study|Treatment-related adverse events|0|||
125107665|NCT02454972|450019028|FG006|Overall Study|Treatment-related adverse events|0|||
125107666|NCT02454972|450019029|FG007|Overall Study|Treatment-related adverse events|2|||
125107667|NCT02454972|450019030|FG008|Overall Study|Treatment-related adverse events|0|||
125107668|NCT02454972|450019022|FG000|Overall Study|Patient moves to compassionate use|0|||
125107669|NCT02454972|450019023|FG001|Overall Study|Patient moves to compassionate use|0|||
125107670|NCT02454972|450019024|FG002|Overall Study|Patient moves to compassionate use|0|||
125107671|NCT02454972|450019025|FG003|Overall Study|Patient moves to compassionate use|0|||
125107672|NCT02454972|450019026|FG004|Overall Study|Patient moves to compassionate use|0|||
125107673|NCT02454972|450019027|FG005|Overall Study|Patient moves to compassionate use|0|||
125107674|NCT02454972|450019028|FG006|Overall Study|Patient moves to compassionate use|2|||
125107675|NCT02454972|450019029|FG007|Overall Study|Patient moves to compassionate use|0|||
125107676|NCT02454972|450019030|FG008|Overall Study|Patient moves to compassionate use|0|||
125107677|NCT02454972|450019022|FG000|Overall Study|Withdrawal by Subject|0|||
125107678|NCT02454972|450019023|FG001|Overall Study|Withdrawal by Subject|1|||
125107679|NCT02454972|450019024|FG002|Overall Study|Withdrawal by Subject|5|||
125107680|NCT02454972|450019025|FG003|Overall Study|Withdrawal by Subject|2|||
125107681|NCT02454972|450019026|FG004|Overall Study|Withdrawal by Subject|3|||
125107682|NCT02454972|450019027|FG005|Overall Study|Withdrawal by Subject|2|||
125107683|NCT02454972|450019028|FG006|Overall Study|Withdrawal by Subject|0|||
125107684|NCT02454972|450019029|FG007|Overall Study|Withdrawal by Subject|1|||
125107685|NCT02454972|450019030|FG008|Overall Study|Withdrawal by Subject|2|||
125107686|NCT02454972|450019022|FG000|Overall Study|Multiple delay/holds on treatment|0|||
125107687|NCT02454972|450019023|FG001|Overall Study|Multiple delay/holds on treatment|0|||
125107688|NCT02454972|450019024|FG002|Overall Study|Multiple delay/holds on treatment|0|||
125107689|NCT02454972|450019025|FG003|Overall Study|Multiple delay/holds on treatment|1|||
125107690|NCT02454972|450019026|FG004|Overall Study|Multiple delay/holds on treatment|0|||
125107691|NCT02454972|450019027|FG005|Overall Study|Multiple delay/holds on treatment|0|||
125107692|NCT02454972|450019028|FG006|Overall Study|Multiple delay/holds on treatment|0|||
125107693|NCT02454972|450019029|FG007|Overall Study|Multiple delay/holds on treatment|0|||
125107694|NCT02454972|450019030|FG008|Overall Study|Multiple delay/holds on treatment|0|||
125107695|NCT02454972|450019022|FG000|Overall Study|Never treated|0|||
125107696|NCT02454972|450019023|FG001|Overall Study|Never treated|0|||
125107697|NCT02454972|450019024|FG002|Overall Study|Never treated|3|||
125107698|NCT02454972|450019025|FG003|Overall Study|Never treated|1|||
125107699|NCT02454972|450019026|FG004|Overall Study|Never treated|1|||
125107700|NCT02454972|450019027|FG005|Overall Study|Never treated|0|||
125107701|NCT02454972|450019028|FG006|Overall Study|Never treated|0|||
125107702|NCT02454972|450019029|FG007|Overall Study|Never treated|0|||
125107703|NCT02454972|450019030|FG008|Overall Study|Never treated|5|||
125107704|NCT02454972|450019022|FG000|Overall Study|Lost to Follow-up|0|||
125107705|NCT02454972|450019023|FG001|Overall Study|Lost to Follow-up|0|||
125107706|NCT02454972|450019024|FG002|Overall Study|Lost to Follow-up|0|||
125107707|NCT02454972|450019025|FG003|Overall Study|Lost to Follow-up|0|||
125107708|NCT02454972|450019026|FG004|Overall Study|Lost to Follow-up|0|||
125107709|NCT02454972|450019027|FG005|Overall Study|Lost to Follow-up|0|||
125107710|NCT02454972|450019028|FG006|Overall Study|Lost to Follow-up|0|||
125107711|NCT02454972|450019029|FG007|Overall Study|Lost to Follow-up|0|||
125107712|NCT02454972|450019030|FG008|Overall Study|Lost to Follow-up|2|||
125107713|NCT02454972|450019022|FG000|Overall Study|Study termination|0|||
125107714|NCT02454972|450019023|FG001|Overall Study|Study termination|0|||
125107715|NCT02454972|450019024|FG002|Overall Study|Study termination|0|||
125107716|NCT02454972|450019025|FG003|Overall Study|Study termination|0|||
125107717|NCT02454972|450019026|FG004|Overall Study|Study termination|0|||
125107718|NCT02454972|450019027|FG005|Overall Study|Study termination|0|||
125107719|NCT02454972|450019028|FG006|Overall Study|Study termination|0|||
125107720|NCT02454972|450019029|FG007|Overall Study|Study termination|0|||
125107721|NCT02454972|450019030|FG008|Overall Study|Study termination|6|||
125107722|NCT01377233|450019031|FG000|Open-label|Adverse Event|1|||
125107723|NCT01377233|450019032|FG001|Open-label|Adverse Event|0|||
125107724|NCT01377233|450019033|FG002|Open-label|Adverse Event|0|||
124893188|NCT00783718|449232024|FG006|Maintenance Phase|Lack of Efficacy|155|||
124893189|NCT00783718|449232018|FG000|Maintenance Phase|Withdrawal by Subject|6|||
125107725|NCT01377233|450019034|FG003|Open-label|Adverse Event|0|||
125107726|NCT01377233|450019035|FG004|Open-label|Adverse Event|0|||
125107727|NCT01377233|450019031|FG000|Open-label|Withdrawal by Subject|3|||
125107728|NCT01377233|450019032|FG001|Open-label|Withdrawal by Subject|0|||
125107729|NCT01377233|450019033|FG002|Open-label|Withdrawal by Subject|0|||
125107730|NCT01377233|450019034|FG003|Open-label|Withdrawal by Subject|0|||
125107731|NCT01377233|450019035|FG004|Open-label|Withdrawal by Subject|0|||
125107732|NCT01377233|450019031|FG000|Double-blind|Adverse Event|0|||
125107733|NCT01377233|450019032|FG001|Double-blind|Adverse Event|1|||
125107734|NCT01377233|450019033|FG002|Double-blind|Adverse Event|2|||
125107735|NCT01377233|450019034|FG003|Double-blind|Adverse Event|2|||
125107736|NCT01377233|450019035|FG004|Double-blind|Adverse Event|0|||
124893190|NCT00783718|449232019|FG001|Maintenance Phase|Withdrawal by Subject|0|||
124893191|NCT00783718|449232020|FG002|Maintenance Phase|Withdrawal by Subject|0|||
124893192|NCT00783718|449232021|FG003|Maintenance Phase|Withdrawal by Subject|2|||
124893193|NCT00783718|449232022|FG004|Maintenance Phase|Withdrawal by Subject|5|||
124893194|NCT00783718|449232023|FG005|Maintenance Phase|Withdrawal by Subject|2|||
124893195|NCT00783718|449232024|FG006|Maintenance Phase|Withdrawal by Subject|20|||
124893196|NCT00783718|449232018|FG000|Maintenance Phase|Lost to Follow-up|3|||
124893197|NCT00783718|449232019|FG001|Maintenance Phase|Lost to Follow-up|0|||
125107737|NCT01377233|450019031|FG000|Double-blind|Protocol Violation|0|||
125107738|NCT01377233|450019032|FG001|Double-blind|Protocol Violation|0|||
125107739|NCT01377233|450019033|FG002|Double-blind|Protocol Violation|0|||
125107740|NCT01377233|450019034|FG003|Double-blind|Protocol Violation|0|||
125107741|NCT01377233|450019035|FG004|Double-blind|Protocol Violation|1|||
125107742|NCT01377233|450019031|FG000|Double-blind|Withdrawal by Subject|0|||
125107743|NCT01377233|450019032|FG001|Double-blind|Withdrawal by Subject|0|||
125107744|NCT01377233|450019033|FG002|Double-blind|Withdrawal by Subject|0|||
125107745|NCT01377233|450019034|FG003|Double-blind|Withdrawal by Subject|1|||
125107746|NCT01377233|450019035|FG004|Double-blind|Withdrawal by Subject|0|||
125107747|NCT01377233|450019031|FG000|Double-blind|Administrative or other|0|||
125107748|NCT01377233|450019032|FG001|Double-blind|Administrative or other|0|||
125107749|NCT01377233|450019033|FG002|Double-blind|Administrative or other|0|||
125107750|NCT01377233|450019034|FG003|Double-blind|Administrative or other|1|||
125107751|NCT01377233|450019035|FG004|Double-blind|Administrative or other|1|||
125107752|NCT01785875|450019036|FG000|Overall Study|Withdrawal by Subject|41|||
125107753|NCT01785875|450019037|FG001|Overall Study|Withdrawal by Subject|34|||
125107754|NCT01785875|450019038|FG002|Overall Study|Withdrawal by Subject|36|||
125107755|NCT01785875|450019036|FG000|Overall Study|Lost to Follow-up|19|||
125107756|NCT01785875|450019037|FG001|Overall Study|Lost to Follow-up|22|||
125107757|NCT01785875|450019038|FG002|Overall Study|Lost to Follow-up|6|||
125107758|NCT01785875|450019036|FG000|Overall Study|Death|27|||
125107759|NCT01785875|450019037|FG001|Overall Study|Death|16|||
125107760|NCT01785875|450019038|FG002|Overall Study|Death|7|||
125107761|NCT01785875|450019036|FG000|Overall Study|Sponsor Decision|0|||
125107762|NCT01785875|450019037|FG001|Overall Study|Sponsor Decision|2|||
125107763|NCT01785875|450019038|FG002|Overall Study|Sponsor Decision|0|||
125107764|NCT01785875|450019036|FG000|Overall Study|Protocol Specified Criteria|207|||
125107765|NCT01785875|450019037|FG001|Overall Study|Protocol Specified Criteria|214|||
125107766|NCT01785875|450019038|FG002|Overall Study|Protocol Specified Criteria|55|||
125107767|NCT01785875|450019036|FG000|Overall Study|Missing|0|||
125107768|NCT01785875|450019037|FG001|Overall Study|Missing|1|||
125107769|NCT01785875|450019038|FG002|Overall Study|Missing|3|||
125107770|NCT04991311|450019041|FG000|Overall Study|Adverse Event|1|||
125107771|NCT00755937|450019042|FG000|Recruitment|Unknown if infliximab received|164|||
125107772|NCT00755937|450019042|FG000|Observational Follow-up|Lost to Follow-up|148|||
125107773|NCT01440595|450019045|FG000|Overall Study|Lost to Follow-up|0|||
125107774|NCT01440595|450019046|FG001|Overall Study|Lost to Follow-up|1|||
125107775|NCT01440595|450019047|FG002|Overall Study|Lost to Follow-up|0|||
125107776|NCT01440595|450019045|FG000|Overall Study|Study terminated by sponsor.|1|||
125107777|NCT01440595|450019046|FG001|Overall Study|Study terminated by sponsor.|2|||
125107778|NCT01440595|450019047|FG002|Overall Study|Study terminated by sponsor.|1|||
125107779|NCT01223196|450019048|FG000|Overall Study|Lost to Follow-up|2|||
125107780|NCT01223196|450019049|FG001|Overall Study|Lost to Follow-up|0|||
125107781|NCT01223196|450019048|FG000|Overall Study|Physician Decision|1|||
125107782|NCT01223196|450019049|FG001|Overall Study|Physician Decision|0|||
125107783|NCT01223196|450019048|FG000|Overall Study|Withdrawal by Subject|1|||
125107784|NCT01223196|450019049|FG001|Overall Study|Withdrawal by Subject|0|||
125107785|NCT05180630|450019055|FG000|First Intervention|Physician Decision|0|||
125107786|NCT05180630|450019056|FG001|First Intervention|Physician Decision|0|||
125107787|NCT05180630|450019057|FG002|First Intervention|Physician Decision|3|||
124893198|NCT00783718|449232020|FG002|Maintenance Phase|Lost to Follow-up|0|||
125107788|NCT01466673|450019058|FG000|Overall Study|Non-compliance with study treatment|2|||
125107789|NCT01466673|450019059|FG001|Overall Study|Non-compliance with study treatment|0|||
124893199|NCT00783718|449232021|FG003|Maintenance Phase|Lost to Follow-up|0|||
125107790|NCT01466673|450019058|FG000|Overall Study|Lost to Follow-up|3|||
125107791|NCT01466673|450019059|FG001|Overall Study|Lost to Follow-up|5|||
125107792|NCT01466673|450019058|FG000|Overall Study|Adverse Event|2|||
125107793|NCT01466673|450019059|FG001|Overall Study|Adverse Event|1|||
125107794|NCT02725671|450019067|FG000|Overall Study|Lost to Follow-up|1|||
125107795|NCT00965263|450019068|FG000|Overall Study|Physician Decision|2|||
125107796|NCT00965263|450019069|FG001|Overall Study|Physician Decision|0|||
125107797|NCT00965263|450019068|FG000|Overall Study|Family emergency|0|||
125107798|NCT00965263|450019069|FG001|Overall Study|Family emergency|1|||
125107799|NCT00965263|450019068|FG000|Overall Study|Protocol Violation|0|||
125107800|NCT00965263|450019069|FG001|Overall Study|Protocol Violation|2|||
125107801|NCT00963599|450019070|FG000|Overall Study|Adverse Event|2|||
125107802|NCT00963599|450019071|FG001|Overall Study|Adverse Event|0|||
125107803|NCT00963599|450019072|FG002|Overall Study|Adverse Event|1|||
125107804|NCT00963599|450019073|FG003|Overall Study|Adverse Event|2|||
125107805|NCT00963599|450019070|FG000|Overall Study|Lack of Efficacy|0|||
125107806|NCT00963599|450019071|FG001|Overall Study|Lack of Efficacy|2|||
125107807|NCT00963599|450019072|FG002|Overall Study|Lack of Efficacy|1|||
125107808|NCT00963599|450019073|FG003|Overall Study|Lack of Efficacy|4|||
125107809|NCT00963599|450019070|FG000|Overall Study|Lost to Follow-up|0|||
125107810|NCT00963599|450019071|FG001|Overall Study|Lost to Follow-up|1|||
125107811|NCT00963599|450019072|FG002|Overall Study|Lost to Follow-up|1|||
125107812|NCT00963599|450019073|FG003|Overall Study|Lost to Follow-up|1|||
125107813|NCT00963599|450019070|FG000|Overall Study|Protocol Violation|2|||
125107814|NCT00963599|450019071|FG001|Overall Study|Protocol Violation|2|||
125107815|NCT00963599|450019072|FG002|Overall Study|Protocol Violation|3|||
125107816|NCT00963599|450019073|FG003|Overall Study|Protocol Violation|4|||
125107817|NCT00963599|450019070|FG000|Overall Study|Withdrawal by Subject|2|||
125107818|NCT00963599|450019071|FG001|Overall Study|Withdrawal by Subject|1|||
125107819|NCT00963599|450019072|FG002|Overall Study|Withdrawal by Subject|3|||
125107820|NCT00963599|450019073|FG003|Overall Study|Withdrawal by Subject|3|||
125107821|NCT03496207|450019076|FG000|Base Study|Adverse Event|0|||
125107822|NCT03496207|450019077|FG001|Base Study|Adverse Event|0|||
125107823|NCT03496207|450019078|FG002|Base Study|Adverse Event|1|||
125107824|NCT03496207|450019079|FG003|Base Study|Adverse Event|1|||
125107825|NCT03496207|450019080|FG004|Base Study|Adverse Event|4|||
125107826|NCT03496207|450019076|FG000|Base Study|Death|0|||
125107827|NCT03496207|450019077|FG001|Base Study|Death|0|||
125107828|NCT03496207|450019078|FG002|Base Study|Death|0|||
125107829|NCT03496207|450019079|FG003|Base Study|Death|0|||
125107830|NCT03496207|450019080|FG004|Base Study|Death|1|||
125107831|NCT03496207|450019076|FG000|Base Study|Withdrawal by Subject|0|||
125107832|NCT03496207|450019077|FG001|Base Study|Withdrawal by Subject|0|||
125107833|NCT03496207|450019078|FG002|Base Study|Withdrawal by Subject|1|||
125107834|NCT03496207|450019079|FG003|Base Study|Withdrawal by Subject|0|||
125107835|NCT03496207|450019080|FG004|Base Study|Withdrawal by Subject|1|||
125107836|NCT03496207|450019076|FG000|Extension Period|Adverse Event|0|||
125107837|NCT03496207|450019077|FG001|Extension Period|Adverse Event|0|||
125107838|NCT03496207|450019078|FG002|Extension Period|Adverse Event|0|||
125107839|NCT03496207|450019079|FG003|Extension Period|Adverse Event|1|||
125107840|NCT03496207|450019080|FG004|Extension Period|Adverse Event|1|||
125107841|NCT03496207|450019076|FG000|Extension Period|Death|1|||
125107842|NCT03496207|450019077|FG001|Extension Period|Death|0|||
125107843|NCT03496207|450019078|FG002|Extension Period|Death|0|||
125107844|NCT03496207|450019079|FG003|Extension Period|Death|1|||
125107845|NCT03496207|450019080|FG004|Extension Period|Death|2|||
125107846|NCT03496207|450019076|FG000|Extension Period|Withdrawal by Subject|1|||
125107847|NCT03496207|450019077|FG001|Extension Period|Withdrawal by Subject|0|||
125107848|NCT03496207|450019078|FG002|Extension Period|Withdrawal by Subject|0|||
125107849|NCT03496207|450019079|FG003|Extension Period|Withdrawal by Subject|1|||
125107850|NCT03496207|450019080|FG004|Extension Period|Withdrawal by Subject|1|||
125107851|NCT03496207|450019076|FG000|Extension Period|Elevated hemoglobin levels|0|||
125107852|NCT03496207|450019077|FG001|Extension Period|Elevated hemoglobin levels|0|||
125107853|NCT03496207|450019078|FG002|Extension Period|Elevated hemoglobin levels|0|||
125107854|NCT03496207|450019079|FG003|Extension Period|Elevated hemoglobin levels|0|||
125107855|NCT03496207|450019080|FG004|Extension Period|Elevated hemoglobin levels|1|||
125107856|NCT02164539|450019081|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
125107857|NCT02164539|450019082|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
125107858|NCT02164539|450019083|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
125107859|NCT02164539|450019084|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
125107860|NCT02164539|450019085|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
125107861|NCT02164539|450019086|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
125107862|NCT02164539|450019087|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
125107863|NCT02164539|450019081|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
125107864|NCT02164539|450019082|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
125107865|NCT02164539|450019083|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
125107866|NCT02164539|450019084|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
125107867|NCT02164539|450019085|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
125107868|NCT02164539|450019086|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
125107869|NCT02164539|450019087|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
124893200|NCT00783718|449232022|FG004|Maintenance Phase|Lost to Follow-up|2|||
124893201|NCT00783718|449232023|FG005|Maintenance Phase|Lost to Follow-up|0|||
124893202|NCT00783718|449232024|FG006|Maintenance Phase|Lost to Follow-up|2|||
124893203|NCT04159896|449232028|FG000|Overall Study|Lack of Efficacy|7|||
124893204|NCT04159896|449232028|FG000|Overall Study|Withdrawal by Subject|1|||
124893205|NCT04159896|449232028|FG000|Overall Study|Adverse Event|1|||
124893206|NCT04159896|449232028|FG000|Overall Study|A transient ischaemic attack|1|||
124893207|NCT02338609|449232029|FG000|Overall Study|Physician Decision|1|||
124893208|NCT02338609|449232029|FG000|Overall Study|Death|1|||
124893209|NCT02223182|449232032|FG000|Double-Blind Period|Adverse Event|0|||
124893210|NCT02223182|449232033|FG001|Double-Blind Period|Adverse Event|2|||
124893211|NCT02223182|449232034|FG002|Double-Blind Period|Adverse Event|1|||
124893212|NCT02223182|449232035|FG003|Double-Blind Period|Adverse Event|0|||
124893213|NCT02223182|449232032|FG000|Double-Blind Period|Withdrawal by Subject|1|||
124893214|NCT02223182|449232033|FG001|Double-Blind Period|Withdrawal by Subject|1|||
124893215|NCT02223182|449232034|FG002|Double-Blind Period|Withdrawal by Subject|1|||
124893216|NCT02223182|449232035|FG003|Double-Blind Period|Withdrawal by Subject|0|||
124893217|NCT02223182|449232032|FG000|Double-Blind Period|Lost to Follow-up|0|||
124893218|NCT02223182|449232033|FG001|Double-Blind Period|Lost to Follow-up|1|||
125017442|NCT02425826|449687768|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
125017443|NCT02425826|449687769|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
125017444|NCT02425826|449687770|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
125017445|NCT02425826|449687768|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
125017446|NCT02425826|449687769|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
125017447|NCT02425826|449687770|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
125017448|NCT02425826|449687768|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
125017449|NCT02425826|449687769|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
125017450|NCT02425826|449687770|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
125017451|NCT02425826|449687768|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
125017452|NCT02425826|449687769|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
125017453|NCT02425826|449687770|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
125017454|NCT02425826|449687768|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
125017455|NCT02425826|449687769|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
125017456|NCT02425826|449687770|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
125017457|NCT02425826|449687768|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
125017458|NCT02425826|449687769|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
125017459|NCT02425826|449687770|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
125017460|NCT02425826|449687768|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
125017461|NCT02425826|449687769|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
125017462|NCT02425826|449687770|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
125017463|NCT02124564|449687775|FG000|Treatment Period|Adverse Event|2|||
125017464|NCT02124564|449687775|FG000|Treatment Period|Lack of Efficacy|3|||
125017465|NCT02124564|449687775|FG000|Treatment Period|Withdrawal by Subject|2|||
125017466|NCT01425008|449687780|FG000|Dose Escalation Phase|Progressive Disease|2|||
125017467|NCT01425008|449687781|FG001|Dose Escalation Phase|Progressive Disease|3|||
125017468|NCT01425008|449687782|FG002|Dose Escalation Phase|Progressive Disease|2|||
125017469|NCT01425008|449687783|FG003|Dose Escalation Phase|Progressive Disease|3|||
125017470|NCT01425008|449687784|FG004|Dose Escalation Phase|Progressive Disease|5|||
125017471|NCT01425008|449687785|FG005|Dose Escalation Phase|Progressive Disease|4|||
125017472|NCT01425008|449687786|FG006|Dose Escalation Phase|Progressive Disease|0|||
125017473|NCT01425008|449687787|FG007|Dose Escalation Phase|Progressive Disease|2|||
125017474|NCT01425008|449687788|FG008|Dose Escalation Phase|Progressive Disease|6|||
125017475|NCT01425008|449687789|FG009|Dose Escalation Phase|Progressive Disease|2|||
125017476|NCT01425008|449687790|FG010|Dose Escalation Phase|Progressive Disease|0|||
125017477|NCT01425008|449687791|FG011|Dose Escalation Phase|Progressive Disease|0|||
125017478|NCT01425008|449687792|FG012|Dose Escalation Phase|Progressive Disease|0|||
125017479|NCT01425008|449687793|FG013|Dose Escalation Phase|Progressive Disease|0|||
125017480|NCT01425008|449687794|FG014|Dose Escalation Phase|Progressive Disease|0|||
125017481|NCT01425008|449687795|FG015|Dose Escalation Phase|Progressive Disease|0|||
125017482|NCT01425008|449687796|FG016|Dose Escalation Phase|Progressive Disease|0|||
125017483|NCT01425008|449687797|FG017|Dose Escalation Phase|Progressive Disease|0|||
125017484|NCT01425008|449687798|FG018|Dose Escalation Phase|Progressive Disease|0|||
125017485|NCT01425008|449687780|FG000|Dose Escalation Phase|Adverse Event|2|||
125017486|NCT01425008|449687781|FG001|Dose Escalation Phase|Adverse Event|0|||
125017487|NCT01425008|449687782|FG002|Dose Escalation Phase|Adverse Event|0|||
124893219|NCT02223182|449232034|FG002|Double-Blind Period|Lost to Follow-up|0|||
124893220|NCT02223182|449232035|FG003|Double-Blind Period|Lost to Follow-up|0|||
124893221|NCT02223182|449232032|FG000|Double-Blind Period|Non Compliance|0|||
124893222|NCT02223182|449232033|FG001|Double-Blind Period|Non Compliance|0|||
124893223|NCT02223182|449232034|FG002|Double-Blind Period|Non Compliance|0|||
124893224|NCT02223182|449232035|FG003|Double-Blind Period|Non Compliance|1|||
124893225|NCT02223182|449232032|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
124893226|NCT02223182|449232033|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
124893227|NCT02223182|449232034|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
124893228|NCT02223182|449232035|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
124893229|NCT02223182|449232032|FG000|Open-Label 500 Period|Adverse Event|1|||
124893230|NCT02223182|449232033|FG001|Open-Label 500 Period|Adverse Event|0|||
124893231|NCT02223182|449232034|FG002|Open-Label 500 Period|Adverse Event|2|||
124893232|NCT02223182|449232035|FG003|Open-Label 500 Period|Adverse Event|1|||
124893233|NCT02223182|449232032|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
124893234|NCT02223182|449232033|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
124893235|NCT02223182|449232034|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
124893236|NCT02223182|449232035|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
124893237|NCT02223182|449232032|FG000|Open-Label 500 Period|Physician Decision|0|||
124893238|NCT02223182|449232033|FG001|Open-Label 500 Period|Physician Decision|0|||
124893239|NCT02223182|449232034|FG002|Open-Label 500 Period|Physician Decision|0|||
124893240|NCT02223182|449232035|FG003|Open-Label 500 Period|Physician Decision|1|||
124893241|NCT02223182|449232032|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
124893242|NCT02223182|449232033|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
124893243|NCT02223182|449232034|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
124893244|NCT02223182|449232035|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
124893245|NCT02223182|449232032|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
124893246|NCT02223182|449232033|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
124893247|NCT02223182|449232034|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
124893248|NCT02223182|449232035|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
124893249|NCT02223182|449232032|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
124893250|NCT02223182|449232033|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
124893251|NCT02223182|449232034|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
124893252|NCT02223182|449232035|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
124893253|NCT02223182|449232032|FG000|Open-Label 300 Period|Non Compliance|0|||
124893254|NCT02223182|449232033|FG001|Open-Label 300 Period|Non Compliance|2|||
124893255|NCT02223182|449232034|FG002|Open-Label 300 Period|Non Compliance|1|||
124893256|NCT02223182|449232035|FG003|Open-Label 300 Period|Non Compliance|0|||
124893257|NCT03714022|449232036|FG000|Overall Study|Adverse Event|1|||
124893258|NCT03714022|449232037|FG001|Overall Study|Adverse Event|0|||
124893259|NCT03714022|449232036|FG000|Overall Study|Consent withdrawal|0|||
124893260|NCT03714022|449232037|FG001|Overall Study|Consent withdrawal|1|||
125107870|NCT02164539|450019081|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
125107871|NCT02164539|450019082|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
124893261|NCT03714022|449232036|FG000|Overall Study|Lost to Follow-up|3|||
124893262|NCT03714022|449232037|FG001|Overall Study|Lost to Follow-up|2|||
124893263|NCT02234310|449232048|FG000|Overall Study|Physician Decision|1|||
124893264|NCT02234310|449232048|FG000|Overall Study|Adverse Event|1|||
124893265|NCT02234310|449232048|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
124893266|NCT02234310|449232048|FG000|Overall Study|Withdrawal by Subject|2|||
124893267|NCT00235495|449232049|FG000|Overall Study|Death|52|||
124893268|NCT00235495|449232050|FG001|Overall Study|Death|42|||
124893269|NCT00235495|449232049|FG000|Overall Study|Withdrawal by Subject|5|||
124893270|NCT00235495|449232050|FG001|Overall Study|Withdrawal by Subject|3|||
124893271|NCT00235495|449232049|FG000|Overall Study|Lost to Follow-up|11|||
125017488|NCT01425008|449687783|FG003|Dose Escalation Phase|Adverse Event|0|||
124893272|NCT00235495|449232050|FG001|Overall Study|Lost to Follow-up|13|||
124893273|NCT00235495|449232049|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
125017489|NCT01425008|449687784|FG004|Dose Escalation Phase|Adverse Event|0|||
125017490|NCT01425008|449687785|FG005|Dose Escalation Phase|Adverse Event|2|||
125017491|NCT01425008|449687786|FG006|Dose Escalation Phase|Adverse Event|0|||
125017492|NCT01425008|449687787|FG007|Dose Escalation Phase|Adverse Event|0|||
125017493|NCT01425008|449687788|FG008|Dose Escalation Phase|Adverse Event|2|||
125017494|NCT01425008|449687789|FG009|Dose Escalation Phase|Adverse Event|0|||
125017495|NCT01425008|449687790|FG010|Dose Escalation Phase|Adverse Event|0|||
125017496|NCT01425008|449687791|FG011|Dose Escalation Phase|Adverse Event|0|||
125017497|NCT01425008|449687792|FG012|Dose Escalation Phase|Adverse Event|0|||
125017498|NCT01425008|449687793|FG013|Dose Escalation Phase|Adverse Event|0|||
125017499|NCT01425008|449687794|FG014|Dose Escalation Phase|Adverse Event|0|||
125017500|NCT01425008|449687795|FG015|Dose Escalation Phase|Adverse Event|0|||
125017501|NCT01425008|449687796|FG016|Dose Escalation Phase|Adverse Event|0|||
124893274|NCT00235495|449232050|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
125107872|NCT02164539|450019083|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
124893275|NCT02192359|449232051|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
124893276|NCT02192359|449232052|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
124893277|NCT02192359|449232053|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
124893278|NCT02192359|449232054|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
124893279|NCT02192359|449232051|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
124893280|NCT02192359|449232052|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
124893281|NCT02192359|449232053|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
124893282|NCT02192359|449232054|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
124893283|NCT02192359|449232051|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
124893284|NCT02192359|449232052|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
124893285|NCT02192359|449232053|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
124893286|NCT02192359|449232054|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
124893287|NCT00114959|449232055|FG000|Overall Study|Lack of Efficacy|6|||
124893288|NCT00114959|449232055|FG000|Overall Study|Physician Decision|1|||
124893289|NCT00114959|449232055|FG000|Overall Study|Death|1|||
124893290|NCT03251378|449232056|FG000|Overall Study|Death|3|||
124893291|NCT03251378|449232057|FG001|Overall Study|Death|2|||
124893292|NCT03251378|449232058|FG002|Overall Study|Death|3|||
124893293|NCT03251378|449232059|FG003|Overall Study|Death|30|||
124893294|NCT03251378|449232060|FG004|Overall Study|Death|24|||
124893295|NCT03251378|449232061|FG005|Overall Study|Death|12|||
124893296|NCT03251378|449232062|FG006|Overall Study|Death|12|||
124893297|NCT03251378|449232056|FG000|Overall Study|Lost to Follow-up|0|||
124893298|NCT03251378|449232057|FG001|Overall Study|Lost to Follow-up|0|||
124893299|NCT03251378|449232058|FG002|Overall Study|Lost to Follow-up|1|||
124893300|NCT03251378|449232059|FG003|Overall Study|Lost to Follow-up|3|||
124893301|NCT03251378|449232060|FG004|Overall Study|Lost to Follow-up|0|||
124893302|NCT03251378|449232061|FG005|Overall Study|Lost to Follow-up|0|||
124893303|NCT03251378|449232062|FG006|Overall Study|Lost to Follow-up|0|||
124893304|NCT03251378|449232056|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
124893305|NCT03251378|449232057|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
124893306|NCT03251378|449232058|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
124893307|NCT03251378|449232059|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
124893308|NCT03251378|449232060|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
124893309|NCT03251378|449232061|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
124893310|NCT03251378|449232062|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
124893311|NCT03251378|449232056|FG000|Overall Study|Progressive disease|2|||
124893312|NCT03251378|449232057|FG001|Overall Study|Progressive disease|0|||
124893313|NCT03251378|449232058|FG002|Overall Study|Progressive disease|0|||
124893314|NCT03251378|449232059|FG003|Overall Study|Progressive disease|1|||
124893315|NCT03251378|449232060|FG004|Overall Study|Progressive disease|0|||
124893316|NCT03251378|449232061|FG005|Overall Study|Progressive disease|0|||
124893317|NCT03251378|449232062|FG006|Overall Study|Progressive disease|0|||
124893318|NCT03251378|449232056|FG000|Overall Study|Physician Decision|0|||
124893319|NCT03251378|449232057|FG001|Overall Study|Physician Decision|2|||
124893320|NCT03251378|449232058|FG002|Overall Study|Physician Decision|0|||
124893321|NCT03251378|449232059|FG003|Overall Study|Physician Decision|0|||
124893322|NCT03251378|449232060|FG004|Overall Study|Physician Decision|0|||
124893323|NCT03251378|449232061|FG005|Overall Study|Physician Decision|0|||
124893324|NCT03251378|449232062|FG006|Overall Study|Physician Decision|0|||
124893325|NCT03251378|449232056|FG000|Overall Study|Other|2|||
124893326|NCT03251378|449232057|FG001|Overall Study|Other|3|||
124893327|NCT03251378|449232058|FG002|Overall Study|Other|2|||
124893328|NCT03251378|449232059|FG003|Overall Study|Other|0|||
124893329|NCT03251378|449232060|FG004|Overall Study|Other|1|||
124893330|NCT03251378|449232061|FG005|Overall Study|Other|1|||
124893331|NCT03251378|449232062|FG006|Overall Study|Other|1|||
124893332|NCT03251378|449232056|FG000|Overall Study|Other|0|||
124893333|NCT03251378|449232057|FG001|Overall Study|Other|0|||
124893334|NCT03251378|449232058|FG002|Overall Study|Other|0|||
124893335|NCT03251378|449232059|FG003|Overall Study|Other|4|||
124893336|NCT03251378|449232060|FG004|Overall Study|Other|13|||
124893337|NCT03251378|449232061|FG005|Overall Study|Other|0|||
124893338|NCT03251378|449232062|FG006|Overall Study|Other|0|||
124893339|NCT04060680|449232065|FG000|Overall Study|Unsuccessful implant|17|||
124893340|NCT04060680|449232066|FG001|Overall Study|Unsuccessful implant|2|||
124893341|NCT04060680|449232065|FG000|Overall Study|Adverse Event|3|||
124893342|NCT04060680|449232066|FG001|Overall Study|Adverse Event|0|||
124893343|NCT04060680|449232065|FG000|Overall Study|Death|2|||
124893344|NCT04060680|449232066|FG001|Overall Study|Death|0|||
124893345|NCT04060680|449232065|FG000|Overall Study|Study product no longer in use|1|||
124893346|NCT04060680|449232066|FG001|Overall Study|Study product no longer in use|0|||
124893347|NCT04060680|449232065|FG000|Overall Study|Withdrawal by Subject|1|||
124893348|NCT04060680|449232066|FG001|Overall Study|Withdrawal by Subject|0|||
125107873|NCT02164539|450019084|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
125107874|NCT02164539|450019085|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
125107875|NCT02164539|450019086|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
125107876|NCT02164539|450019087|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
125107877|NCT02164539|450019081|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
125107878|NCT02164539|450019082|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
125107879|NCT02164539|450019083|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
125107880|NCT02164539|450019084|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
125107881|NCT02164539|450019085|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
125107882|NCT02164539|450019086|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
125107883|NCT02164539|450019087|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
125107884|NCT02164539|450019081|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
124893349|NCT04739423|449232070|FG000|Overall Study|Protocol Violation|0|||
125107885|NCT02164539|450019082|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
125107886|NCT02164539|450019083|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
125107887|NCT02164539|450019084|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
125107888|NCT02164539|450019085|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
125107889|NCT02164539|450019086|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
125107890|NCT02164539|450019087|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
125107891|NCT02164539|450019081|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
125107892|NCT02164539|450019082|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
125107893|NCT02164539|450019083|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
125107894|NCT02164539|450019084|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
125107895|NCT02164539|450019085|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
125107896|NCT02164539|450019086|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
125107897|NCT02164539|450019087|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
125107898|NCT01255722|450019088|FG000|Overall Study|Adverse Event|0|||
125107899|NCT01255722|450019089|FG001|Overall Study|Adverse Event|1|||
125107900|NCT01255722|450019090|FG002|Overall Study|Adverse Event|1|||
125107901|NCT01255722|450019088|FG000|Overall Study|asymptomatic patient|1|||
125107902|NCT01255722|450019089|FG001|Overall Study|asymptomatic patient|0|||
125107903|NCT01255722|450019090|FG002|Overall Study|asymptomatic patient|0|||
125107904|NCT01255722|450019088|FG000|Overall Study|beta-blocker contraindicated|2|||
125107905|NCT01255722|450019089|FG001|Overall Study|beta-blocker contraindicated|0|||
125107906|NCT01255722|450019090|FG002|Overall Study|beta-blocker contraindicated|0|||
125107907|NCT03835975|450019093|FG000|Overall Study|Lost to Follow-up|1|||
125107908|NCT03835975|450019094|FG001|Overall Study|Lost to Follow-up|1|||
125107909|NCT03835975|450019095|FG002|Overall Study|Lost to Follow-up|0|||
125107910|NCT03835975|450019096|FG003|Overall Study|Lost to Follow-up|0|||
125107911|NCT03835975|450019097|FG004|Overall Study|Lost to Follow-up|0|||
125107912|NCT03835975|450019093|FG000|Overall Study|No longer met eligibility criteria|0|||
125107913|NCT03835975|450019094|FG001|Overall Study|No longer met eligibility criteria|1|||
125107914|NCT03835975|450019095|FG002|Overall Study|No longer met eligibility criteria|0|||
125107915|NCT03835975|450019096|FG003|Overall Study|No longer met eligibility criteria|0|||
125107916|NCT03835975|450019097|FG004|Overall Study|No longer met eligibility criteria|0|||
125107917|NCT03835975|450019093|FG000|Overall Study|Protocol Violation|1|||
125107918|NCT03835975|450019094|FG001|Overall Study|Protocol Violation|1|||
125107919|NCT03835975|450019095|FG002|Overall Study|Protocol Violation|2|||
125107920|NCT03835975|450019096|FG003|Overall Study|Protocol Violation|0|||
125107921|NCT03835975|450019097|FG004|Overall Study|Protocol Violation|0|||
125107922|NCT03835975|450019093|FG000|Overall Study|Withdrawal by Subject|1|||
125107923|NCT03835975|450019094|FG001|Overall Study|Withdrawal by Subject|0|||
125107924|NCT03835975|450019095|FG002|Overall Study|Withdrawal by Subject|1|||
125107925|NCT03835975|450019096|FG003|Overall Study|Withdrawal by Subject|1|||
125107926|NCT03835975|450019097|FG004|Overall Study|Withdrawal by Subject|0|||
125107927|NCT00061945|450019098|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
125107928|NCT00061945|450019099|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
125107929|NCT00061945|450019098|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
125107930|NCT00061945|450019099|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
125107931|NCT00061945|450019098|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
125107932|NCT00061945|450019099|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
125107933|NCT00061945|450019098|FG000|Course IV: Alemtuzumab|Early exits|6|||
124893350|NCT04739423|449232071|FG001|Overall Study|Protocol Violation|1|||
124893351|NCT04739423|449232072|FG002|Overall Study|Protocol Violation|0|||
124893352|NCT04739423|449232073|FG003|Overall Study|Protocol Violation|0|||
125107934|NCT00061945|450019099|FG001|Course IV: Alemtuzumab|Early exits|15|||
125107935|NCT01656967|450019101|FG000|Overall Study|faulty monitor|1|||
125107936|NCT01656967|450019102|FG001|Overall Study|faulty monitor|0|||
125107937|NCT01656967|450019101|FG000|Overall Study|unsuccessful ETT insertion|3|||
125107938|NCT01656967|450019102|FG001|Overall Study|unsuccessful ETT insertion|2|||
125107939|NCT00975884|450019103|FG000|Overall Study|Adverse Event|1|||
125107940|NCT00975884|450019104|FG001|Overall Study|Adverse Event|0|||
125107941|NCT00975884|450019103|FG000|Overall Study|Lost to Follow-up|5|||
125107942|NCT00975884|450019104|FG001|Overall Study|Lost to Follow-up|3|||
125107943|NCT00975884|450019103|FG000|Overall Study|Withdrawal by Subject|9|||
125107944|NCT00975884|450019104|FG001|Overall Study|Withdrawal by Subject|9|||
125107945|NCT00975884|450019103|FG000|Overall Study|Other|1|||
125107946|NCT00975884|450019104|FG001|Overall Study|Other|3|||
125107947|NCT05166512|450019105|FG000|Randomized|Lost to Follow-up|2|||
125107948|NCT05166512|450019106|FG001|Randomized|Lost to Follow-up|0|||
125107949|NCT05166512|450019105|FG000|Randomized|Withdrawal by Subject|1|||
125107950|NCT05166512|450019106|FG001|Randomized|Withdrawal by Subject|0|||
125107951|NCT05166512|450019105|FG000|Baseline Data Collection|Lost to Follow-up|0|||
124893353|NCT04739423|449232074|FG004|Overall Study|Protocol Violation|0|||
124893354|NCT04739423|449232075|FG005|Overall Study|Protocol Violation|0|||
124893355|NCT04739423|449232070|FG000|Overall Study|Adverse Event|0|||
124893356|NCT04739423|449232071|FG001|Overall Study|Adverse Event|0|||
124893357|NCT04739423|449232072|FG002|Overall Study|Adverse Event|1|||
124893358|NCT04739423|449232073|FG003|Overall Study|Adverse Event|0|||
125017502|NCT01425008|449687797|FG017|Dose Escalation Phase|Adverse Event|0|||
125017503|NCT01425008|449687798|FG018|Dose Escalation Phase|Adverse Event|0|||
125017504|NCT01425008|449687780|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125017505|NCT01425008|449687781|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125017506|NCT01425008|449687782|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125017507|NCT01425008|449687783|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125017508|NCT01425008|449687784|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
125017509|NCT01425008|449687785|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125017510|NCT01425008|449687786|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
125017511|NCT01425008|449687787|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
125017512|NCT01425008|449687788|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
125017513|NCT01425008|449687789|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125017514|NCT01425008|449687790|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125017515|NCT01425008|449687791|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125017516|NCT01425008|449687792|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125017517|NCT01425008|449687793|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125017518|NCT01425008|449687794|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125017519|NCT01425008|449687795|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125017520|NCT01425008|449687796|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125017521|NCT01425008|449687797|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125017522|NCT01425008|449687798|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125017523|NCT01425008|449687780|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
125017524|NCT01425008|449687781|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
125017525|NCT01425008|449687782|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
125017526|NCT01425008|449687783|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
125017527|NCT01425008|449687784|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
125017528|NCT01425008|449687785|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
125017529|NCT01425008|449687786|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
125017530|NCT01425008|449687787|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
125017531|NCT01425008|449687788|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
125017532|NCT01425008|449687789|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
125017533|NCT01425008|449687790|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
125017534|NCT01425008|449687791|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
125017535|NCT01425008|449687792|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
125017536|NCT01425008|449687793|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
125017537|NCT01425008|449687794|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
125017538|NCT01425008|449687795|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
125017539|NCT01425008|449687796|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
125017540|NCT01425008|449687797|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
125017541|NCT01425008|449687798|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
125017542|NCT01425008|449687780|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
125017543|NCT01425008|449687781|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
125107952|NCT05166512|450019106|FG001|Baseline Data Collection|Lost to Follow-up|3|||
125107953|NCT05166512|450019105|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
125107954|NCT05166512|450019106|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
125107955|NCT05166512|450019105|FG000|Baseline Data Collection|Protocol Violation|2|||
124893359|NCT04739423|449232074|FG004|Overall Study|Adverse Event|1|||
124893360|NCT04739423|449232075|FG005|Overall Study|Adverse Event|0|||
124893361|NCT04739423|449232070|FG000|Overall Study|Withdrawal by Subject|0|||
124893362|NCT04739423|449232071|FG001|Overall Study|Withdrawal by Subject|0|||
124893363|NCT04739423|449232072|FG002|Overall Study|Withdrawal by Subject|0|||
124893364|NCT04739423|449232073|FG003|Overall Study|Withdrawal by Subject|0|||
124893365|NCT04739423|449232074|FG004|Overall Study|Withdrawal by Subject|0|||
124893366|NCT04739423|449232075|FG005|Overall Study|Withdrawal by Subject|1|||
124893367|NCT01007552|449232076|FG000|Overall Study|Withdrawal by Subject|1|||
124893368|NCT00901485|449232082|FG000|Overall Study|Lack of Efficacy|0|||
124893369|NCT00901485|449232083|FG001|Overall Study|Lack of Efficacy|2|||
124893370|NCT00901485|449232082|FG000|Overall Study|Withdrawal by Subject|1|||
124893371|NCT00901485|449232083|FG001|Overall Study|Withdrawal by Subject|2|||
124893372|NCT01929993|449233671|FG000|Overall Study|Protocol Violation|4|||
124893373|NCT01929993|449233672|FG001|Overall Study|Protocol Violation|6|||
124893374|NCT01929993|449233671|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
124893375|NCT01929993|449233672|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
124893376|NCT01852162|449233673|FG000|Overall Study|Adverse Event|1|||
124893377|NCT01852162|449233674|FG001|Overall Study|Adverse Event|0|||
124893378|NCT01852162|449233673|FG000|Overall Study|Withdrawal by Subject|3|||
124893379|NCT01852162|449233674|FG001|Overall Study|Withdrawal by Subject|1|||
124893380|NCT01256476|449233675|FG000|Overall Study|Adverse Event|2|||
124893381|NCT01256476|449233676|FG001|Overall Study|Adverse Event|1|||
124893382|NCT01256476|449233675|FG000|Overall Study|Withdrawal by Subject|2|||
124893383|NCT01256476|449233676|FG001|Overall Study|Withdrawal by Subject|1|||
124893384|NCT01256476|449233675|FG000|Overall Study|Lost to Follow-up|1|||
124893385|NCT01256476|449233676|FG001|Overall Study|Lost to Follow-up|2|||
124893386|NCT01256476|449233675|FG000|Overall Study|Persistent ALT or AST elevation|1|||
124893387|NCT01256476|449233676|FG001|Overall Study|Persistent ALT or AST elevation|0|||
124893388|NCT01256476|449233675|FG000|Overall Study|Physician Decision|0|||
124893389|NCT01256476|449233676|FG001|Overall Study|Physician Decision|1|||
124893390|NCT01256476|449233675|FG000|Overall Study|Subject non-compliance|0|||
124893391|NCT01256476|449233676|FG001|Overall Study|Subject non-compliance|1|||
124893392|NCT01256476|449233675|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
124893393|NCT01256476|449233676|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
124893394|NCT00163215|449233681|FG000|Overall Study|Lack of Efficacy|3|||
124893395|NCT00163215|449233681|FG000|Overall Study|Withdrawal by Subject|5|||
124893396|NCT00163215|449233681|FG000|Overall Study|Other|7|||
124893397|NCT00231179|449233682|FG000|Overall Study|Lost to Follow-up|21|||
125017544|NCT01425008|449687782|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
125107956|NCT05166512|450019106|FG001|Baseline Data Collection|Protocol Violation|0|||
125107957|NCT05166512|450019105|FG000|4 Month Data Collection|Lost to Follow-up|1|||
125017545|NCT01425008|449687783|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
125017546|NCT01425008|449687784|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
125017547|NCT01425008|449687785|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
125017548|NCT01425008|449687786|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
125017549|NCT01425008|449687787|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
125017550|NCT01425008|449687788|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
125017551|NCT01425008|449687789|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
125017552|NCT01425008|449687790|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
125017553|NCT01425008|449687791|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
125017554|NCT01425008|449687792|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
125017555|NCT01425008|449687793|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
125017556|NCT01425008|449687794|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
125017557|NCT01425008|449687795|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
125017558|NCT01425008|449687796|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
125017559|NCT01425008|449687797|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
125017560|NCT01425008|449687798|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
125017561|NCT01425008|449687780|FG000|Dose Escalation Phase|Other|0|||
125017562|NCT01425008|449687781|FG001|Dose Escalation Phase|Other|0|||
125017563|NCT01425008|449687782|FG002|Dose Escalation Phase|Other|0|||
125017564|NCT01425008|449687783|FG003|Dose Escalation Phase|Other|0|||
125017565|NCT01425008|449687784|FG004|Dose Escalation Phase|Other|0|||
125017566|NCT01425008|449687785|FG005|Dose Escalation Phase|Other|0|||
125017567|NCT01425008|449687786|FG006|Dose Escalation Phase|Other|0|||
125017568|NCT01425008|449687787|FG007|Dose Escalation Phase|Other|0|||
125017569|NCT01425008|449687788|FG008|Dose Escalation Phase|Other|1|||
125017570|NCT01425008|449687789|FG009|Dose Escalation Phase|Other|0|||
125017571|NCT01425008|449687790|FG010|Dose Escalation Phase|Other|0|||
124893398|NCT00231179|449233683|FG001|Overall Study|Lost to Follow-up|21|||
124893399|NCT00231179|449233682|FG000|Overall Study|Withdrawal by Subject|3|||
124893400|NCT00231179|449233683|FG001|Overall Study|Withdrawal by Subject|3|||
124893401|NCT02892409|449233684|FG000|Overall Study|Adverse Event|1|||
124893402|NCT02892409|449233685|FG001|Overall Study|Adverse Event|0|||
124893403|NCT02892409|449233684|FG000|Overall Study|Withdrawal by Subject|2|||
124893404|NCT02892409|449233685|FG001|Overall Study|Withdrawal by Subject|1|||
124893405|NCT02123966|449233688|FG000|Overall Study|Intercurrent Illness|1|||
124893406|NCT01460381|449233689|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
124893407|NCT01460381|449233690|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
124893408|NCT04822298|449233692|FG000|Overall Study|Death|3|||
124893409|NCT00852475|449233699|FG000|Overall Study|Lost to Follow-up|3|||
124893410|NCT00852475|449233700|FG001|Overall Study|Lost to Follow-up|4|||
124893411|NCT00515086|449233701|FG000|Overall Study|Adverse Event|1|||
124893412|NCT00515086|449233702|FG001|Overall Study|Adverse Event|1|||
124893413|NCT00515086|449233703|FG002|Overall Study|Adverse Event|2|||
124893414|NCT00515086|449233704|FG003|Overall Study|Adverse Event|3|||
124893415|NCT00515086|449233701|FG000|Overall Study|Administrative|1|||
124893416|NCT00515086|449233702|FG001|Overall Study|Administrative|1|||
124893417|NCT00515086|449233703|FG002|Overall Study|Administrative|0|||
124893418|NCT00515086|449233704|FG003|Overall Study|Administrative|0|||
125017572|NCT01425008|449687791|FG011|Dose Escalation Phase|Other|0|||
125017573|NCT01425008|449687792|FG012|Dose Escalation Phase|Other|0|||
125017574|NCT01425008|449687793|FG013|Dose Escalation Phase|Other|0|||
124893419|NCT00515086|449233701|FG000|Overall Study|Withdrawal by Subject|1|||
125107958|NCT05166512|450019106|FG001|4 Month Data Collection|Lost to Follow-up|0|||
125107959|NCT05166512|450019105|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
125107960|NCT05166512|450019106|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
124893420|NCT00515086|449233702|FG001|Overall Study|Withdrawal by Subject|0|||
124893421|NCT00515086|449233703|FG002|Overall Study|Withdrawal by Subject|0|||
124893422|NCT00515086|449233704|FG003|Overall Study|Withdrawal by Subject|1|||
124893423|NCT00515086|449233701|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
124893424|NCT00515086|449233702|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
124893425|NCT00515086|449233703|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
124893426|NCT00515086|449233704|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
124893427|NCT00515086|449233701|FG000|Overall Study|Lost to Follow-up|1|||
124893428|NCT00515086|449233702|FG001|Overall Study|Lost to Follow-up|0|||
124893429|NCT00515086|449233703|FG002|Overall Study|Lost to Follow-up|0|||
124893430|NCT00515086|449233704|FG003|Overall Study|Lost to Follow-up|0|||
124893431|NCT00515086|449233701|FG000|Overall Study|Study drug no longer required|0|||
124893432|NCT00515086|449233702|FG001|Overall Study|Study drug no longer required|1|||
124893433|NCT00515086|449233703|FG002|Overall Study|Study drug no longer required|0|||
124893434|NCT00515086|449233704|FG003|Overall Study|Study drug no longer required|0|||
124893435|NCT00515086|449233701|FG000|Overall Study|Death|2|||
124893436|NCT00515086|449233702|FG001|Overall Study|Death|0|||
124893437|NCT00515086|449233703|FG002|Overall Study|Death|0|||
124893438|NCT00515086|449233704|FG003|Overall Study|Death|0|||
124893439|NCT02373813|449233705|FG000|Run-In Period|Other, Not Specified|5|||
124893440|NCT02373813|449233706|FG001|Run-In Period|Other, Not Specified|0|||
124893441|NCT02373813|449233707|FG002|Run-In Period|Other, Not Specified|0|||
124893442|NCT02373813|449233708|FG003|Run-In Period|Other, Not Specified|0|||
124893443|NCT02373813|449233705|FG000|Run-In Period|Withdrawal by Subject|16|||
124893444|NCT02373813|449233706|FG001|Run-In Period|Withdrawal by Subject|0|||
124893445|NCT02373813|449233707|FG002|Run-In Period|Withdrawal by Subject|0|||
124893446|NCT02373813|449233708|FG003|Run-In Period|Withdrawal by Subject|0|||
124893447|NCT02373813|449233705|FG000|Run-In Period|Decision by Sponsor|11|||
124893448|NCT02373813|449233706|FG001|Run-In Period|Decision by Sponsor|0|||
124893449|NCT02373813|449233707|FG002|Run-In Period|Decision by Sponsor|0|||
124893450|NCT02373813|449233708|FG003|Run-In Period|Decision by Sponsor|0|||
124893451|NCT02373813|449233705|FG000|Run-In Period|Protocol Violation|75|||
125017575|NCT01425008|449687794|FG014|Dose Escalation Phase|Other|0|||
125017576|NCT01425008|449687795|FG015|Dose Escalation Phase|Other|0|||
125017577|NCT01425008|449687796|FG016|Dose Escalation Phase|Other|0|||
125017578|NCT01425008|449687797|FG017|Dose Escalation Phase|Other|0|||
125017579|NCT01425008|449687798|FG018|Dose Escalation Phase|Other|0|||
125017580|NCT01425008|449687780|FG000|Dose Expansion Phase|Progressive Disease|0|||
125017581|NCT01425008|449687781|FG001|Dose Expansion Phase|Progressive Disease|0|||
125017582|NCT01425008|449687782|FG002|Dose Expansion Phase|Progressive Disease|0|||
125017583|NCT01425008|449687783|FG003|Dose Expansion Phase|Progressive Disease|0|||
125017584|NCT01425008|449687784|FG004|Dose Expansion Phase|Progressive Disease|0|||
125017585|NCT01425008|449687785|FG005|Dose Expansion Phase|Progressive Disease|0|||
125017586|NCT01425008|449687786|FG006|Dose Expansion Phase|Progressive Disease|0|||
125017587|NCT01425008|449687787|FG007|Dose Expansion Phase|Progressive Disease|0|||
125017588|NCT01425008|449687788|FG008|Dose Expansion Phase|Progressive Disease|0|||
125017589|NCT01425008|449687789|FG009|Dose Expansion Phase|Progressive Disease|0|||
125017590|NCT01425008|449687790|FG010|Dose Expansion Phase|Progressive Disease|10|||
125017591|NCT01425008|449687791|FG011|Dose Expansion Phase|Progressive Disease|4|||
125017592|NCT01425008|449687792|FG012|Dose Expansion Phase|Progressive Disease|12|||
125017593|NCT01425008|449687793|FG013|Dose Expansion Phase|Progressive Disease|1|||
125017594|NCT01425008|449687794|FG014|Dose Expansion Phase|Progressive Disease|5|||
125017595|NCT01425008|449687795|FG015|Dose Expansion Phase|Progressive Disease|8|||
125017596|NCT01425008|449687796|FG016|Dose Expansion Phase|Progressive Disease|9|||
125017597|NCT01425008|449687797|FG017|Dose Expansion Phase|Progressive Disease|2|||
125017598|NCT01425008|449687798|FG018|Dose Expansion Phase|Progressive Disease|10|||
125017599|NCT01425008|449687780|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
125017600|NCT01425008|449687781|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
125107961|NCT05166512|450019105|FG000|12 Month Data Collection|Lost to Follow-up|3|||
124893452|NCT02373813|449233706|FG001|Run-In Period|Protocol Violation|0|||
124893453|NCT02373813|449233707|FG002|Run-In Period|Protocol Violation|0|||
124893454|NCT02373813|449233708|FG003|Run-In Period|Protocol Violation|0|||
124893455|NCT02373813|449233705|FG000|Run-In Period|Lost to Follow-up|2|||
124893456|NCT02373813|449233706|FG001|Run-In Period|Lost to Follow-up|0|||
125017601|NCT01425008|449687782|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
125017602|NCT01425008|449687783|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
125017603|NCT01425008|449687784|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
125017604|NCT01425008|449687785|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
124893457|NCT02373813|449233707|FG002|Run-In Period|Lost to Follow-up|0|||
124893458|NCT02373813|449233708|FG003|Run-In Period|Lost to Follow-up|0|||
124893459|NCT02373813|449233705|FG000|Run-In Period|Adverse Event|3|||
124893460|NCT02373813|449233706|FG001|Run-In Period|Adverse Event|0|||
124893461|NCT02373813|449233707|FG002|Run-In Period|Adverse Event|0|||
124893462|NCT02373813|449233708|FG003|Run-In Period|Adverse Event|0|||
124893463|NCT02373813|449233705|FG000|Run-In Period|Noncompliance|1|||
124893464|NCT02373813|449233706|FG001|Run-In Period|Noncompliance|0|||
124893465|NCT02373813|449233707|FG002|Run-In Period|Noncompliance|0|||
124893466|NCT02373813|449233708|FG003|Run-In Period|Noncompliance|0|||
124893467|NCT02373813|449233705|FG000|Run-In Period|Ineligibility Determined|3|||
124893468|NCT02373813|449233706|FG001|Run-In Period|Ineligibility Determined|0|||
124893469|NCT02373813|449233707|FG002|Run-In Period|Ineligibility Determined|0|||
124893470|NCT02373813|449233708|FG003|Run-In Period|Ineligibility Determined|0|||
124893471|NCT02373813|449233705|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
124893472|NCT02373813|449233706|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
124893473|NCT02373813|449233707|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
124893474|NCT02373813|449233708|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
124893475|NCT02373813|449233705|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
124893476|NCT02373813|449233706|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
124893477|NCT02373813|449233707|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
124893478|NCT02373813|449233708|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
124893479|NCT02373813|449233705|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
124893480|NCT02373813|449233706|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
124893481|NCT02373813|449233707|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
124893482|NCT02373813|449233708|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
124893483|NCT02373813|449233705|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124893484|NCT02373813|449233706|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
124893485|NCT02373813|449233707|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
124893486|NCT02373813|449233708|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
124893487|NCT03738241|449233709|FG000|Overall Study|Withdrawal by Subject|0|||
124893488|NCT03738241|449233710|FG001|Overall Study|Withdrawal by Subject|0|||
124893489|NCT03738241|449233711|FG002|Overall Study|Withdrawal by Subject|0|||
124893490|NCT03738241|449233712|FG003|Overall Study|Withdrawal by Subject|0|||
124893491|NCT03738241|449233713|FG004|Overall Study|Withdrawal by Subject|0|||
124893492|NCT03738241|449233714|FG005|Overall Study|Withdrawal by Subject|0|||
124893493|NCT03738241|449233715|FG006|Overall Study|Withdrawal by Subject|0|||
124893494|NCT03738241|449233716|FG007|Overall Study|Withdrawal by Subject|0|||
124893495|NCT03738241|449233717|FG008|Overall Study|Withdrawal by Subject|0|||
124893496|NCT03738241|449233718|FG009|Overall Study|Withdrawal by Subject|1|||
124893497|NCT03738241|449233709|FG000|Overall Study|Physician Decision|0|||
124893498|NCT03738241|449233710|FG001|Overall Study|Physician Decision|0|||
124893499|NCT03738241|449233711|FG002|Overall Study|Physician Decision|0|||
124893500|NCT03738241|449233712|FG003|Overall Study|Physician Decision|0|||
124893501|NCT03738241|449233713|FG004|Overall Study|Physician Decision|0|||
124893502|NCT03738241|449233714|FG005|Overall Study|Physician Decision|0|||
124893503|NCT03738241|449233715|FG006|Overall Study|Physician Decision|0|||
124893504|NCT03738241|449233716|FG007|Overall Study|Physician Decision|0|||
124893505|NCT03738241|449233717|FG008|Overall Study|Physician Decision|1|||
124893506|NCT03738241|449233718|FG009|Overall Study|Physician Decision|0|||
124893507|NCT03738241|449233709|FG000|Overall Study|Adverse Event|1|||
124893508|NCT03738241|449233710|FG001|Overall Study|Adverse Event|0|||
124893509|NCT03738241|449233711|FG002|Overall Study|Adverse Event|0|||
124893510|NCT03738241|449233712|FG003|Overall Study|Adverse Event|0|||
124893511|NCT03738241|449233713|FG004|Overall Study|Adverse Event|0|||
124893512|NCT03738241|449233714|FG005|Overall Study|Adverse Event|0|||
124893513|NCT03738241|449233715|FG006|Overall Study|Adverse Event|0|||
124893514|NCT03738241|449233716|FG007|Overall Study|Adverse Event|0|||
124893515|NCT03738241|449233717|FG008|Overall Study|Adverse Event|0|||
124893516|NCT03738241|449233718|FG009|Overall Study|Adverse Event|0|||
124893517|NCT02788656|449233719|FG000|Overall Study|Withdrawal by Subject|1|||
124893518|NCT02788656|449233720|FG001|Overall Study|Withdrawal by Subject|0|||
124893519|NCT03169361|449233721|FG000|Overall Study|Protocol Violation|32|||
124893520|NCT02263885|449233722|FG000|Overall Study|Withdrawal by Subject|7|||
124893521|NCT02263885|449233722|FG000|Overall Study|Alternative Treatment|3|||
124893522|NCT00088465|449233723|FG000|Overall Study|Withdrawal by Subject|290|||
124893523|NCT00088465|449233723|FG000|Overall Study|Adverse Event|77|||
124893524|NCT00088465|449233723|FG000|Overall Study|Lost to Follow-up|57|||
124893525|NCT00088465|449233723|FG000|Overall Study|Physician Decision|45|||
124893526|NCT00088465|449233723|FG000|Overall Study|Sponsor Decision|37|||
124893527|NCT00088465|449233723|FG000|Overall Study|Lack of Efficacy|27|||
124893528|NCT00088465|449233723|FG000|Overall Study|Protocol Violation|17|||
124893529|NCT00088465|449233723|FG000|Overall Study|Death|11|||
124893530|NCT02688621|449233724|FG000|Overall Study|Pregnancy|1|||
124893531|NCT02688621|449233725|FG001|Overall Study|Pregnancy|3|||
125107962|NCT05166512|450019106|FG001|12 Month Data Collection|Lost to Follow-up|1|||
125107963|NCT05166512|450019105|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
125107964|NCT05166512|450019106|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
125107965|NCT02139306|450019109|FG000|Overall Study|Withdrawal by Subject|4|||
125107966|NCT02139306|450019110|FG001|Overall Study|Withdrawal by Subject|6|||
125107967|NCT02139306|450019109|FG000|Overall Study|Adverse Event|3|||
125107968|NCT02139306|450019110|FG001|Overall Study|Adverse Event|4|||
125107969|NCT02139306|450019109|FG000|Overall Study|Physician Decision|0|||
125107970|NCT02139306|450019110|FG001|Overall Study|Physician Decision|1|||
125107971|NCT02139306|450019109|FG000|Overall Study|Other Unspecified|2|||
125107972|NCT02139306|450019110|FG001|Overall Study|Other Unspecified|3|||
125107973|NCT02139306|450019109|FG000|Overall Study|Protocol Violation|4|||
125107974|NCT02139306|450019110|FG001|Overall Study|Protocol Violation|0|||
125107975|NCT02956005|450019111|FG000|Overall Study|Not eligible|1|||
125107976|NCT02956005|450019111|FG000|Overall Study|Withdrawal by Subject|3|||
125107977|NCT02956005|450019111|FG000|Overall Study|Physician Decision|12|||
125107978|NCT03909971|450019112|FG000|Overall Study|Other Reasons Not Specified|0|||
125107979|NCT03909971|450019113|FG001|Overall Study|Other Reasons Not Specified|1|||
125107980|NCT03909971|450019112|FG000|Overall Study|Global Deterioration of Health Status|2|||
125107981|NCT03909971|450019113|FG001|Overall Study|Global Deterioration of Health Status|1|||
125107982|NCT03909971|450019112|FG000|Overall Study|Progressive Disease|6|||
125107983|NCT03909971|450019113|FG001|Overall Study|Progressive Disease|14|||
125107984|NCT03909971|450019112|FG000|Overall Study|Death|2|||
125107985|NCT03909971|450019113|FG001|Overall Study|Death|6|||
125107986|NCT01185639|450019114|FG000|Overall Study|Progressed and didn't receive therapy|2|||
125107987|NCT01861717|450019119|FG000|Overall Study|Lost to Follow-up|1|||
125107988|NCT01861717|450019119|FG000|Overall Study|Withdrawal by Subject|1|||
125107989|NCT03033069|450019120|FG000|Overall Study|Adverse Event|6|||
125107990|NCT03033069|450019121|FG001|Overall Study|Adverse Event|7|||
125107991|NCT03033069|450019122|FG002|Overall Study|Adverse Event|4|||
125107992|NCT03033069|450019123|FG003|Overall Study|Adverse Event|6|||
125107993|NCT03033069|450019120|FG000|Overall Study|Lack of Efficacy|0|||
125107994|NCT03033069|450019121|FG001|Overall Study|Lack of Efficacy|0|||
125107995|NCT03033069|450019122|FG002|Overall Study|Lack of Efficacy|1|||
125107996|NCT03033069|450019123|FG003|Overall Study|Lack of Efficacy|0|||
125107997|NCT03033069|450019120|FG000|Overall Study|Lost to Follow-up|6|||
125107998|NCT03033069|450019121|FG001|Overall Study|Lost to Follow-up|5|||
125107999|NCT03033069|450019122|FG002|Overall Study|Lost to Follow-up|5|||
124893532|NCT02688621|449233724|FG000|Overall Study|Lost to Follow-up|38|||
124893533|NCT02688621|449233725|FG001|Overall Study|Lost to Follow-up|15|||
124893534|NCT02688621|449233724|FG000|Overall Study|Withdrawal by Subject|1|||
124893535|NCT02688621|449233725|FG001|Overall Study|Withdrawal by Subject|0|||
124893536|NCT00180674|449233728|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
124893537|NCT00180674|449233728|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
124893538|NCT01106976|449233729|FG000|Overall Study|Lost to Follow-up|8|||
124893539|NCT00278564|449233731|FG000|Overall Study|Lack of Efficacy|4|||
124893540|NCT01094743|449233732|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
124893541|NCT02851511|449233733|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
124893542|NCT02851511|449233734|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
124893543|NCT02851511|449233735|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
124893544|NCT02851511|449233736|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
124893545|NCT02851511|449233733|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
124893546|NCT02851511|449233734|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
124893547|NCT02851511|449233735|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
125017605|NCT01425008|449687786|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
124893548|NCT02851511|449233736|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
124893549|NCT02851511|449233733|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
125017606|NCT01425008|449687787|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
124893550|NCT02851511|449233734|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
124893551|NCT02851511|449233735|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
124893552|NCT02851511|449233736|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
124893553|NCT02851511|449233733|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
124893554|NCT02851511|449233734|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
124893555|NCT02851511|449233735|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
124893556|NCT02851511|449233736|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
124893557|NCT02851511|449233733|FG000|Phase I|Physician Decision|0|||
124893558|NCT02851511|449233734|FG001|Phase I|Physician Decision|0|||
124893559|NCT02851511|449233735|FG002|Phase I|Physician Decision|0|||
124893560|NCT02851511|449233736|FG003|Phase I|Physician Decision|1|||
124893561|NCT02851511|449233733|FG000|Phase I|Withdrawal by Subject|2|||
124893562|NCT02851511|449233734|FG001|Phase I|Withdrawal by Subject|1|||
124893563|NCT02851511|449233735|FG002|Phase I|Withdrawal by Subject|0|||
124893564|NCT02851511|449233736|FG003|Phase I|Withdrawal by Subject|3|||
125017607|NCT01425008|449687788|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
125017608|NCT01425008|449687789|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
125017609|NCT01425008|449687790|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
125017610|NCT01425008|449687791|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
125017611|NCT01425008|449687792|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
125017612|NCT01425008|449687793|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
125017613|NCT01425008|449687794|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
125017614|NCT01425008|449687795|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
125017615|NCT01425008|449687796|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
125017616|NCT01425008|449687797|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
125017617|NCT01425008|449687798|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
125017618|NCT01425008|449687780|FG000|Dose Expansion Phase|Other|0|||
125017619|NCT01425008|449687781|FG001|Dose Expansion Phase|Other|0|||
125017620|NCT01425008|449687782|FG002|Dose Expansion Phase|Other|0|||
125017621|NCT01425008|449687783|FG003|Dose Expansion Phase|Other|0|||
125017622|NCT01425008|449687784|FG004|Dose Expansion Phase|Other|0|||
125017623|NCT01425008|449687785|FG005|Dose Expansion Phase|Other|0|||
125017624|NCT01425008|449687786|FG006|Dose Expansion Phase|Other|0|||
125017625|NCT01425008|449687787|FG007|Dose Expansion Phase|Other|0|||
125017626|NCT01425008|449687788|FG008|Dose Expansion Phase|Other|0|||
125017627|NCT01425008|449687789|FG009|Dose Expansion Phase|Other|0|||
125017628|NCT01425008|449687790|FG010|Dose Expansion Phase|Other|0|||
125017629|NCT01425008|449687791|FG011|Dose Expansion Phase|Other|0|||
125017630|NCT01425008|449687792|FG012|Dose Expansion Phase|Other|1|||
125017631|NCT01425008|449687793|FG013|Dose Expansion Phase|Other|0|||
125017632|NCT01425008|449687794|FG014|Dose Expansion Phase|Other|0|||
125017633|NCT01425008|449687795|FG015|Dose Expansion Phase|Other|0|||
125017634|NCT01425008|449687796|FG016|Dose Expansion Phase|Other|2|||
125017635|NCT01425008|449687797|FG017|Dose Expansion Phase|Other|0|||
125017636|NCT01425008|449687798|FG018|Dose Expansion Phase|Other|4|||
124893565|NCT02851511|449233733|FG000|Phase II|Physician Decision|18|||
124893566|NCT02851511|449233734|FG001|Phase II|Physician Decision|16|||
124893567|NCT02851511|449233735|FG002|Phase II|Physician Decision|0|||
124893568|NCT02851511|449233736|FG003|Phase II|Physician Decision|0|||
124893569|NCT02851511|449233733|FG000|Phase II|Withdrawal by Subject|18|||
124893570|NCT02851511|449233734|FG001|Phase II|Withdrawal by Subject|16|||
124893571|NCT02851511|449233735|FG002|Phase II|Withdrawal by Subject|0|||
124893572|NCT02851511|449233736|FG003|Phase II|Withdrawal by Subject|0|||
124893573|NCT02851511|449233733|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
124893574|NCT02851511|449233734|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
124893575|NCT02851511|449233735|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
124893576|NCT02851511|449233736|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
124893577|NCT02851511|449233733|FG000|Phase II|Lost to Follow-up|0|||
124893578|NCT02851511|449233734|FG001|Phase II|Lost to Follow-up|1|||
124893579|NCT02851511|449233735|FG002|Phase II|Lost to Follow-up|0|||
124893580|NCT02851511|449233736|FG003|Phase II|Lost to Follow-up|0|||
124893581|NCT03836664|449233737|FG000|Overall Study|Didn't complete forms and lost drug|3|||
124893582|NCT03836664|449233738|FG001|Overall Study|Didn't complete forms and lost drug|3|||
124893583|NCT01427907|449233739|FG000|Overall Study|Withdrawal by Subject|3|||
124893584|NCT01427907|449233740|FG001|Overall Study|Withdrawal by Subject|4|||
124893585|NCT04003974|449233741|FG000|Overall Study|Missing|1|||
124893586|NCT04003974|449233742|FG001|Overall Study|Missing|0|||
124893587|NCT04003974|449233741|FG000|Overall Study|Withdrawal by Subject|0|||
124893588|NCT04003974|449233742|FG001|Overall Study|Withdrawal by Subject|2|||
124893589|NCT00335153|449233743|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
124893590|NCT00335153|449233743|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
124893591|NCT00335153|449233743|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
125017637|NCT01425008|449687780|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
125017638|NCT01425008|449687781|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
125017639|NCT01425008|449687782|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
125017640|NCT01425008|449687783|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
125017641|NCT01425008|449687784|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
125017642|NCT01425008|449687785|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
125017643|NCT01425008|449687786|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
125017644|NCT01425008|449687787|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
125017645|NCT01425008|449687788|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
125017646|NCT01425008|449687789|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
125017647|NCT01425008|449687790|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
125017648|NCT01425008|449687791|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
125017649|NCT01425008|449687792|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
125017650|NCT01425008|449687793|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
125017651|NCT01425008|449687794|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
125017652|NCT01425008|449687795|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
125017653|NCT01425008|449687796|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
125017654|NCT01425008|449687797|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
125017655|NCT01425008|449687798|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
125017656|NCT01425008|449687780|FG000|Dose Expansion Phase|Adverse Event|0|||
125017657|NCT01425008|449687781|FG001|Dose Expansion Phase|Adverse Event|0|||
125017658|NCT01425008|449687782|FG002|Dose Expansion Phase|Adverse Event|0|||
125017659|NCT01425008|449687783|FG003|Dose Expansion Phase|Adverse Event|0|||
125017660|NCT01425008|449687784|FG004|Dose Expansion Phase|Adverse Event|0|||
125017661|NCT01425008|449687785|FG005|Dose Expansion Phase|Adverse Event|0|||
125017662|NCT01425008|449687786|FG006|Dose Expansion Phase|Adverse Event|0|||
125017663|NCT01425008|449687787|FG007|Dose Expansion Phase|Adverse Event|0|||
125017664|NCT01425008|449687788|FG008|Dose Expansion Phase|Adverse Event|0|||
125017665|NCT01425008|449687789|FG009|Dose Expansion Phase|Adverse Event|0|||
125017666|NCT01425008|449687790|FG010|Dose Expansion Phase|Adverse Event|2|||
125017667|NCT01425008|449687791|FG011|Dose Expansion Phase|Adverse Event|3|||
125017668|NCT01425008|449687792|FG012|Dose Expansion Phase|Adverse Event|3|||
125017669|NCT01425008|449687793|FG013|Dose Expansion Phase|Adverse Event|0|||
125017670|NCT01425008|449687794|FG014|Dose Expansion Phase|Adverse Event|1|||
125017671|NCT01425008|449687795|FG015|Dose Expansion Phase|Adverse Event|1|||
125017672|NCT01425008|449687796|FG016|Dose Expansion Phase|Adverse Event|5|||
125017673|NCT01425008|449687797|FG017|Dose Expansion Phase|Adverse Event|0|||
125017674|NCT01425008|449687798|FG018|Dose Expansion Phase|Adverse Event|3|||
125017675|NCT01425008|449687780|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
125017676|NCT01425008|449687781|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
125017677|NCT01425008|449687782|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
124893592|NCT00335153|449233743|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
124893593|NCT00335153|449233743|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
124893594|NCT00335153|449233743|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
124893595|NCT00335153|449233743|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
124893596|NCT00335153|449233743|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
124893597|NCT00335153|449233743|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
124893598|NCT00335153|449233743|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
124893599|NCT00372528|449233744|FG000|Overall Study|Lack of Efficacy|1|||
124893600|NCT00372528|449233744|FG000|Overall Study|Adverse Event|1|||
124893601|NCT00372528|449233744|FG000|Overall Study|Study Terminated by Sponsor|18|||
124893602|NCT00372528|449233744|FG000|Overall Study|Other|1|||
124893603|NCT02412761|449233745|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
124893604|NCT02412761|449233746|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
124893605|NCT02412761|449233747|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
124893606|NCT02412761|449233748|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
124893607|NCT02412761|449233749|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
124893608|NCT02412761|449233750|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
124893609|NCT02240680|449233751|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
124893610|NCT02240680|449233752|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
124893611|NCT02240680|449233753|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
124893612|NCT02240680|449233754|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
124893613|NCT02240680|449233751|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
124893614|NCT02240680|449233752|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
124893615|NCT02240680|449233753|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
124893616|NCT02240680|449233754|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
124893617|NCT02240680|449233751|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
124893618|NCT02240680|449233752|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
124893619|NCT02240680|449233753|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
124893620|NCT02240680|449233754|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
124893621|NCT02240680|449233751|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
124893622|NCT02240680|449233752|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
124893623|NCT02240680|449233753|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
124893624|NCT02240680|449233754|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
124893625|NCT02240680|449233751|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
124893626|NCT02240680|449233752|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
124893627|NCT02240680|449233753|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
124893628|NCT02240680|449233754|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
124893629|NCT02240680|449233751|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
124893630|NCT02240680|449233752|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
124893631|NCT02240680|449233753|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
124893632|NCT02240680|449233754|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
124893633|NCT02240680|449233751|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
124893634|NCT02240680|449233752|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
124893635|NCT02240680|449233753|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
124893636|NCT02240680|449233754|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
124893637|NCT02240680|449233751|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
124893638|NCT02240680|449233752|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
124893639|NCT02240680|449233753|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
124893640|NCT02240680|449233754|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
124893641|NCT01657682|449233755|FG000|Overall Study|Lost to Follow-up|1|||
124893642|NCT01657682|449233756|FG001|Overall Study|Lost to Follow-up|0|||
124893643|NCT01657682|449233757|FG002|Overall Study|Lost to Follow-up|0|||
124893644|NCT01657682|449233755|FG000|Overall Study|Withdrawal by Subject|0|||
124893645|NCT01657682|449233756|FG001|Overall Study|Withdrawal by Subject|1|||
124893646|NCT01657682|449233757|FG002|Overall Study|Withdrawal by Subject|1|||
124893647|NCT01657682|449233755|FG000|Overall Study|Adverse Event|0|||
125017678|NCT01425008|449687783|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
124893648|NCT01657682|449233756|FG001|Overall Study|Adverse Event|1|||
125017679|NCT01425008|449687784|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
125017680|NCT01425008|449687785|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
125017681|NCT01425008|449687786|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
124893649|NCT01657682|449233757|FG002|Overall Study|Adverse Event|0|||
124893650|NCT01719861|449233758|FG000|Cycle 1|Death|4|||
125108000|NCT03033069|450019123|FG003|Overall Study|Lost to Follow-up|6|||
124893651|NCT01719861|449233758|FG000|Cycle 2|Death|1|||
124893652|NCT03704298|449233759|FG000|Overall Study|Death|3|||
124893653|NCT03704298|449233760|FG001|Overall Study|Death|1|||
124893654|NCT03704298|449233761|FG002|Overall Study|Death|1|||
124893655|NCT03704298|449233762|FG003|Overall Study|Death|0|||
124893656|NCT03704298|449233759|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
124893657|NCT03704298|449233760|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
124893658|NCT03704298|449233761|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
124893659|NCT03704298|449233762|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
124893660|NCT03704298|449233759|FG000|Overall Study|Withdrawal by Subject|1|||
124893661|NCT03704298|449233760|FG001|Overall Study|Withdrawal by Subject|0|||
124893662|NCT03704298|449233761|FG002|Overall Study|Withdrawal by Subject|0|||
124893663|NCT03704298|449233762|FG003|Overall Study|Withdrawal by Subject|0|||
124893664|NCT03704298|449233759|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
124893665|NCT03704298|449233760|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
124893666|NCT03704298|449233761|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
124893667|NCT03704298|449233762|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
124893668|NCT04482855|449233765|FG000|Overall Study|Lost to Follow-up|1|||
124893669|NCT04482855|449233766|FG001|Overall Study|Lost to Follow-up|0|||
124893670|NCT04482855|449233765|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
124893671|NCT04482855|449233766|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
124893672|NCT04482855|449233765|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
124893673|NCT04482855|449233766|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
124893674|NCT03212365|449233767|FG000|Overall Study|Discharged prior to Xa level|12|||
124893675|NCT03212365|449233768|FG001|Overall Study|Discharged prior to Xa level|8|||
124893676|NCT03212365|449233767|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
124893677|NCT03212365|449233768|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
124893678|NCT03212365|449233767|FG000|Overall Study|Refused study medication|3|||
124893679|NCT03212365|449233768|FG001|Overall Study|Refused study medication|0|||
124893680|NCT03212365|449233767|FG000|Overall Study|Initiated heparin infusion on floor|1|||
124893681|NCT03212365|449233768|FG001|Overall Study|Initiated heparin infusion on floor|1|||
124893682|NCT03212365|449233767|FG000|Overall Study|Unexpected return to OR|1|||
124893683|NCT03212365|449233768|FG001|Overall Study|Unexpected return to OR|1|||
124893684|NCT03212365|449233767|FG000|Overall Study|Medication distribution error|1|||
124893685|NCT03212365|449233768|FG001|Overall Study|Medication distribution error|0|||
124893686|NCT03212365|449233767|FG000|Overall Study|Required epidural placement|1|||
124893687|NCT03212365|449233768|FG001|Overall Study|Required epidural placement|0|||
124893688|NCT03212365|449233767|FG000|Overall Study|Withdrawal by Subject|0|||
124893689|NCT03212365|449233768|FG001|Overall Study|Withdrawal by Subject|1|||
124893690|NCT03212365|449233767|FG000|Overall Study|developed acute renal failure|0|||
124893691|NCT03212365|449233768|FG001|Overall Study|developed acute renal failure|1|||
124893692|NCT00819234|449233769|FG000|Overall Study|Withdrawal by Subject|8|||
124893693|NCT00819234|449233770|FG001|Overall Study|Withdrawal by Subject|13|||
124893694|NCT00819234|449233771|FG002|Overall Study|Withdrawal by Subject|6|||
124893695|NCT00819234|449233772|FG003|Overall Study|Withdrawal by Subject|3|||
124893696|NCT00819234|449233773|FG004|Overall Study|Withdrawal by Subject|0|||
124893697|NCT00819234|449233774|FG005|Overall Study|Withdrawal by Subject|4|||
124893698|NCT00819234|449233775|FG006|Overall Study|Withdrawal by Subject|4|||
124893699|NCT00819234|449233776|FG007|Overall Study|Withdrawal by Subject|8|||
124893700|NCT00819234|449233777|FG008|Overall Study|Withdrawal by Subject|5|||
124893701|NCT00819234|449233778|FG009|Overall Study|Withdrawal by Subject|3|||
124893702|NCT00819234|449233769|FG000|Overall Study|Adverse Event|0|||
124893703|NCT00819234|449233770|FG001|Overall Study|Adverse Event|0|||
124893704|NCT00819234|449233771|FG002|Overall Study|Adverse Event|1|||
124893705|NCT00819234|449233772|FG003|Overall Study|Adverse Event|0|||
124893706|NCT00819234|449233773|FG004|Overall Study|Adverse Event|0|||
124893707|NCT00819234|449233774|FG005|Overall Study|Adverse Event|2|||
124893708|NCT00819234|449233775|FG006|Overall Study|Adverse Event|0|||
124893709|NCT00819234|449233776|FG007|Overall Study|Adverse Event|0|||
125017682|NCT01425008|449687787|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
125017683|NCT01425008|449687788|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
125017684|NCT01425008|449687789|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
125017685|NCT01425008|449687790|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
125017686|NCT01425008|449687791|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
125017687|NCT01425008|449687792|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
125017688|NCT01425008|449687793|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
125017689|NCT01425008|449687794|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
125017690|NCT01425008|449687795|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
125017691|NCT01425008|449687796|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
124893710|NCT00819234|449233777|FG008|Overall Study|Adverse Event|0|||
124893711|NCT00819234|449233778|FG009|Overall Study|Adverse Event|0|||
124893712|NCT00819234|449233769|FG000|Overall Study|Physician Decision|0|||
124893713|NCT00819234|449233770|FG001|Overall Study|Physician Decision|0|||
124893714|NCT00819234|449233771|FG002|Overall Study|Physician Decision|0|||
124893715|NCT00819234|449233772|FG003|Overall Study|Physician Decision|1|||
124893716|NCT00819234|449233773|FG004|Overall Study|Physician Decision|0|||
124893717|NCT00819234|449233774|FG005|Overall Study|Physician Decision|0|||
124893718|NCT00819234|449233775|FG006|Overall Study|Physician Decision|0|||
124893719|NCT00819234|449233776|FG007|Overall Study|Physician Decision|0|||
125108001|NCT03033069|450019120|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125108002|NCT03033069|450019121|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125108003|NCT03033069|450019122|FG002|Overall Study|Non-Compliance With Study Drug|1|||
125108004|NCT03033069|450019123|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125108005|NCT03033069|450019120|FG000|Overall Study|Protocol Deviation|0|||
125108006|NCT03033069|450019121|FG001|Overall Study|Protocol Deviation|1|||
125108007|NCT03033069|450019122|FG002|Overall Study|Protocol Deviation|0|||
125108008|NCT03033069|450019123|FG003|Overall Study|Protocol Deviation|0|||
125108009|NCT03033069|450019120|FG000|Overall Study|Withdrawal by Subject|10|||
125108010|NCT03033069|450019121|FG001|Overall Study|Withdrawal by Subject|10|||
125108011|NCT03033069|450019122|FG002|Overall Study|Withdrawal by Subject|11|||
125108012|NCT03033069|450019123|FG003|Overall Study|Withdrawal by Subject|6|||
125108013|NCT03033069|450019120|FG000|Overall Study|Withdrawal By Caregiver|1|||
125108014|NCT03033069|450019121|FG001|Overall Study|Withdrawal By Caregiver|0|||
125108015|NCT03033069|450019122|FG002|Overall Study|Withdrawal By Caregiver|0|||
125108016|NCT03033069|450019123|FG003|Overall Study|Withdrawal By Caregiver|0|||
125108017|NCT03033069|450019120|FG000|Overall Study|Reason not Specified|0|||
125108018|NCT03033069|450019121|FG001|Overall Study|Reason not Specified|1|||
125108019|NCT03033069|450019122|FG002|Overall Study|Reason not Specified|0|||
125108020|NCT03033069|450019123|FG003|Overall Study|Reason not Specified|1|||
125108021|NCT00430638|450019124|FG000|Overall Study|Adverse Event|15|||
125108022|NCT00430638|450019125|FG001|Overall Study|Adverse Event|15|||
125108023|NCT00430638|450019124|FG000|Overall Study|Uncontrolled blood pressure|48|||
125108024|NCT00430638|450019125|FG001|Overall Study|Uncontrolled blood pressure|13|||
125108025|NCT00430638|450019124|FG000|Overall Study|Lost to Follow-up|1|||
125108026|NCT00430638|450019125|FG001|Overall Study|Lost to Follow-up|7|||
125108027|NCT00430638|450019124|FG000|Overall Study|Protocol Violation|6|||
125108028|NCT00430638|450019125|FG001|Overall Study|Protocol Violation|4|||
125108029|NCT00430638|450019124|FG000|Overall Study|Withdrawal by Subject|4|||
125108030|NCT00430638|450019125|FG001|Overall Study|Withdrawal by Subject|6|||
125108031|NCT00430638|450019124|FG000|Overall Study|Non-compliant|2|||
125108032|NCT00430638|450019125|FG001|Overall Study|Non-compliant|1|||
125108033|NCT00430638|450019124|FG000|Overall Study|Other|2|||
125108034|NCT00430638|450019125|FG001|Overall Study|Other|2|||
124893720|NCT00819234|449233777|FG008|Overall Study|Physician Decision|0|||
124893721|NCT00819234|449233778|FG009|Overall Study|Physician Decision|2|||
124893722|NCT00819234|449233769|FG000|Overall Study|Protocol Violation|0|||
125108035|NCT05458895|450019127|FG000|Overall Study|Withdrawal by Subject|8|||
125108036|NCT05458895|450019127|FG000|Overall Study|Lost to Follow-up|17|||
125108037|NCT05458895|450019127|FG000|Overall Study|Pregnancy|2|||
125108038|NCT05458895|450019127|FG000|Overall Study|Withdrawal by Study Team|1|||
125108039|NCT00802529|450020555|FG000|Overall Study|Lost to Follow-up|0|||
125108040|NCT00802529|450020556|FG001|Overall Study|Lost to Follow-up|1|||
125108041|NCT01084603|450020562|FG000|Baseline|Withdrawal by Subject|2|||
124893723|NCT00819234|449233770|FG001|Overall Study|Protocol Violation|0|||
124893724|NCT00819234|449233771|FG002|Overall Study|Protocol Violation|1|||
125108042|NCT01084603|450020562|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
124893725|NCT00819234|449233772|FG003|Overall Study|Protocol Violation|0|||
124893726|NCT00819234|449233773|FG004|Overall Study|Protocol Violation|0|||
124893727|NCT00819234|449233774|FG005|Overall Study|Protocol Violation|0|||
124893728|NCT00819234|449233775|FG006|Overall Study|Protocol Violation|0|||
124893729|NCT00819234|449233776|FG007|Overall Study|Protocol Violation|0|||
124893730|NCT00819234|449233777|FG008|Overall Study|Protocol Violation|0|||
124893731|NCT00819234|449233778|FG009|Overall Study|Protocol Violation|0|||
124893732|NCT00819234|449233769|FG000|Overall Study|Lost to Follow-up|2|||
124893733|NCT00819234|449233770|FG001|Overall Study|Lost to Follow-up|2|||
124893734|NCT00819234|449233771|FG002|Overall Study|Lost to Follow-up|0|||
124893735|NCT00819234|449233772|FG003|Overall Study|Lost to Follow-up|2|||
124893736|NCT00819234|449233773|FG004|Overall Study|Lost to Follow-up|1|||
124893737|NCT00819234|449233774|FG005|Overall Study|Lost to Follow-up|1|||
124893738|NCT00819234|449233775|FG006|Overall Study|Lost to Follow-up|1|||
124893739|NCT00819234|449233776|FG007|Overall Study|Lost to Follow-up|1|||
124893740|NCT00819234|449233777|FG008|Overall Study|Lost to Follow-up|1|||
124893741|NCT00819234|449233778|FG009|Overall Study|Lost to Follow-up|2|||
124893742|NCT05174065|449233779|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
124893743|NCT05174065|449233780|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
124893744|NCT05174065|449233781|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
124893745|NCT05174065|449233779|FG000|Placebo-controlled Period|Other|0|||
124893746|NCT05174065|449233780|FG001|Placebo-controlled Period|Other|1|||
124893747|NCT05174065|449233781|FG002|Placebo-controlled Period|Other|0|||
124893748|NCT05174065|449233779|FG000|Placebo-controlled Period|Adverse Event|1|||
124893749|NCT05174065|449233780|FG001|Placebo-controlled Period|Adverse Event|1|||
124893750|NCT05174065|449233781|FG002|Placebo-controlled Period|Adverse Event|0|||
124893751|NCT05174065|449233779|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
124893752|NCT05174065|449233780|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
124893753|NCT05174065|449233781|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
124893754|NCT05174065|449233779|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
124893755|NCT05174065|449233780|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
124893756|NCT05174065|449233781|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
124893757|NCT05174065|449233779|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
124893758|NCT05174065|449233780|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
124893759|NCT05174065|449233781|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
124893760|NCT00924560|449233785|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
124893761|NCT00924560|449233786|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
124893762|NCT00924560|449233787|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
124893763|NCT00924560|449233785|FG000|Overall Study|Non Compliance with the Protocol|20|||
124893764|NCT00924560|449233786|FG001|Overall Study|Non Compliance with the Protocol|15|||
124893765|NCT00924560|449233787|FG002|Overall Study|Non Compliance with the Protocol|4|||
124893766|NCT00924560|449233785|FG000|Overall Study|Physician Decision|2|||
124893767|NCT00924560|449233786|FG001|Overall Study|Physician Decision|3|||
124893768|NCT00924560|449233787|FG002|Overall Study|Physician Decision|4|||
124893769|NCT00924560|449233785|FG000|Overall Study|Withdrawal by Subject|50|||
124893770|NCT00924560|449233786|FG001|Overall Study|Withdrawal by Subject|44|||
124893771|NCT00924560|449233787|FG002|Overall Study|Withdrawal by Subject|18|||
124893772|NCT00924560|449233785|FG000|Overall Study|Adverse Event|39|||
124893773|NCT00924560|449233786|FG001|Overall Study|Adverse Event|33|||
124893774|NCT00924560|449233787|FG002|Overall Study|Adverse Event|0|||
124893775|NCT00924560|449233785|FG000|Overall Study|Pregnancy|5|||
124893776|NCT00924560|449233786|FG001|Overall Study|Pregnancy|7|||
124893777|NCT00924560|449233787|FG002|Overall Study|Pregnancy|1|||
124893778|NCT00924560|449233785|FG000|Overall Study|Lost to Follow-up|78|||
124893779|NCT00924560|449233786|FG001|Overall Study|Lost to Follow-up|94|||
124893780|NCT00924560|449233787|FG002|Overall Study|Lost to Follow-up|45|||
124893781|NCT00924560|449233785|FG000|Overall Study|Miscellaneous Reasons|13|||
124893782|NCT00924560|449233786|FG001|Overall Study|Miscellaneous Reasons|10|||
125017692|NCT01425008|449687797|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
125017693|NCT01425008|449687798|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
125017694|NCT01425008|449687780|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125017695|NCT01425008|449687781|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124893783|NCT00924560|449233787|FG002|Overall Study|Miscellaneous Reasons|10|||
124893784|NCT02696226|449233789|FG000|Overall Study|Study terminated - lack of enrollment|1|||
124893785|NCT02696226|449233790|FG001|Overall Study|Study terminated - lack of enrollment|0|||
124893786|NCT02696226|449233791|FG002|Overall Study|Study terminated - lack of enrollment|2|||
125017696|NCT01425008|449687782|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125017697|NCT01425008|449687783|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125017698|NCT01425008|449687784|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125017699|NCT01425008|449687785|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124893787|NCT02696226|449233792|FG003|Overall Study|Study terminated - lack of enrollment|0|||
124893788|NCT02909101|449233800|FG000|Overall Study|Lost to Follow-up|1|||
124893789|NCT02909101|449233801|FG001|Overall Study|Lost to Follow-up|1|||
124893790|NCT01221181|449233806|FG000|Overall Study|Lost to Follow-up|1|||
124893791|NCT00429793|449233811|FG000|Overall Study|Improper pre-protocol treatment|3|||
124893792|NCT00429793|449233811|FG000|Overall Study|Required test not done|1|||
124893793|NCT00429793|449233811|FG000|Overall Study|Never treated|1|||
124893794|NCT00429793|449233811|FG000|Overall Study|Non-measurable|1|||
124893795|NCT00097370|449233812|FG000|Stage 1|Adverse Event|3|||
124893796|NCT00097370|449233812|FG000|Stage 1|Withdrawal by Subject|1|||
124893797|NCT00097370|449233812|FG000|Stage 1|Lack of Efficacy|2|||
124893798|NCT00097370|449233812|FG000|Stage 2|Adverse Event|5|||
124893799|NCT00097370|449233812|FG000|Stage 2|Withdrawal by Subject|1|||
124893800|NCT00097370|449233812|FG000|Stage 2|Lack of Efficacy|3|||
124893801|NCT00097370|449233812|FG000|Stage 2|Pregnancy|1|||
124893802|NCT00097370|449233812|FG000|Stage 2|Sponsor Terminated Study|2|||
124893803|NCT00097370|449233812|FG000|Stage 2|Lost to Follow-up|1|||
124893804|NCT00097370|449233812|FG000|Stage 3|Adverse Event|2|||
124893805|NCT00097370|449233812|FG000|Stage 3|Withdrawal by Subject|3|||
124893806|NCT00097370|449233812|FG000|Stage 3|Lack of Efficacy|1|||
124893807|NCT00097370|449233812|FG000|Stage 3|Sponsor Terminated Study|52|||
124893808|NCT00097370|449233812|FG000|Stage 3|Lost to Follow-up|1|||
125108043|NCT01084603|450020562|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
125108044|NCT01084603|450020562|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
125108045|NCT01084603|450020562|FG000|Washout Period 4|Adverse Event|1|||
125108046|NCT03862625|450020564|FG000|Overall Study|Lost to Follow-up|0|||
125108047|NCT03862625|450020565|FG001|Overall Study|Lost to Follow-up|1|||
125108048|NCT01791127|450020566|FG000|Overall Study|Death|356|||
125108049|NCT01791127|450020566|FG000|Overall Study|Patient has withdrawn from study|293|||
125108050|NCT01791127|450020566|FG000|Overall Study|Lost to Follow-up|42|||
125108051|NCT01791127|450020566|FG000|Overall Study|All Siello leads are explanted|31|||
125108052|NCT01791127|450020566|FG000|Overall Study|Completion of 30 day safety registry|1|||
125108053|NCT01791127|450020566|FG000|Overall Study|Study terminated for EP Passion|749|||
125108054|NCT00520494|450020567|FG000|Overall Study|Withdrawal by Subject|1|||
125108055|NCT03471182|450020570|FG000|Overall Study|Withdrawal by Subject|1|||
125108056|NCT03471182|450020571|FG001|Overall Study|Withdrawal by Subject|1|||
125108057|NCT03471182|450020572|FG002|Overall Study|Withdrawal by Subject|0|||
125108058|NCT03471182|450020570|FG000|Overall Study|Technical failure|2|||
125108059|NCT03471182|450020571|FG001|Overall Study|Technical failure|0|||
125108060|NCT03471182|450020572|FG002|Overall Study|Technical failure|0|||
125108061|NCT04440163|450020574|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
125108062|NCT04440163|450020575|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
125108063|NCT04440163|450020576|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
125108064|NCT04440163|450020577|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
125108065|NCT04440163|450020578|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
125108066|NCT04440163|450020579|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
125108067|NCT04440163|450020580|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
125108068|NCT04440163|450020581|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
125108069|NCT04440163|450020574|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
125108070|NCT04440163|450020575|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
125108071|NCT04440163|450020576|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
125108072|NCT04440163|450020577|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
125108073|NCT04440163|450020578|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
125108074|NCT04440163|450020579|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
125108075|NCT04440163|450020580|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
125108076|NCT04440163|450020581|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
125108077|NCT04440163|450020574|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
125108078|NCT04440163|450020575|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
125108079|NCT04440163|450020576|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
125108080|NCT04440163|450020577|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
125108081|NCT04440163|450020578|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
125108082|NCT04440163|450020579|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
125108083|NCT04440163|450020580|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
125108084|NCT04440163|450020581|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
125108085|NCT04440163|450020574|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
124893809|NCT02337361|449233814|FG000|3-month Follow-up|Lost to Follow-up|19|||
124893810|NCT02337361|449233815|FG001|3-month Follow-up|Lost to Follow-up|14|||
124893811|NCT02337361|449233814|FG000|6-month Follow-up|Lost to Follow-up|2|||
124893812|NCT02337361|449233815|FG001|6-month Follow-up|Lost to Follow-up|4|||
124893813|NCT02419755|449233816|FG000|Overall Study|Death|1|||
124893814|NCT02419755|449233817|FG001|Overall Study|Death|3|||
124893815|NCT02419755|449233816|FG000|Overall Study|Relapse|0|||
124893816|NCT02419755|449233817|FG001|Overall Study|Relapse|1|||
124893817|NCT02419755|449233816|FG000|Overall Study|Ineligible|1|||
124893818|NCT02419755|449233817|FG001|Overall Study|Ineligible|0|||
124893819|NCT02419755|449233816|FG000|Overall Study|Withdrawal by Subject|1|||
125108086|NCT04440163|450020575|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
125108087|NCT04440163|450020576|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
125108088|NCT04440163|450020577|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
125108089|NCT04440163|450020578|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
125108090|NCT04440163|450020579|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
125108091|NCT04440163|450020580|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
125108092|NCT04440163|450020581|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
125108093|NCT04440163|450020574|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
125108094|NCT04440163|450020575|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
125108095|NCT04440163|450020576|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
125108096|NCT04440163|450020577|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
125108097|NCT04440163|450020578|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
125108098|NCT04440163|450020579|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
124893820|NCT02419755|449233817|FG001|Overall Study|Withdrawal by Subject|0|||
124893821|NCT02427646|449233818|FG000|Overall Study|Lack of Efficacy|2|||
124893822|NCT02427646|449233819|FG001|Overall Study|Lack of Efficacy|3|||
124893823|NCT02427646|449233818|FG000|Overall Study|Physician Decision|1|||
124893824|NCT02427646|449233819|FG001|Overall Study|Physician Decision|4|||
124893825|NCT02427646|449233818|FG000|Overall Study|Protocol Violation|3|||
124893826|NCT02427646|449233819|FG001|Overall Study|Protocol Violation|3|||
124893827|NCT02427646|449233818|FG000|Overall Study|Bothersome hand weakness|2|||
124893828|NCT02427646|449233819|FG001|Overall Study|Bothersome hand weakness|4|||
124893829|NCT01101542|449233820|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
124893830|NCT01101542|449233820|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
124893831|NCT01101542|449233820|FG000|Year 4 Surveillance Period|Other|287|||
124893832|NCT01101542|449233820|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
124893833|NCT01101542|449233820|FG000|Year 5 Surveillance Period|Pregnancy|1|||
124893834|NCT01101542|449233820|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
124893835|NCT01101542|449233820|FG000|Year 6 Surveillance Period|Pregnancy|1|||
124893836|NCT01101542|449233820|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
124893837|NCT02268396|449235669|FG000|Overall Study|Adverse Event|3|||
124893838|NCT02268396|449235669|FG000|Overall Study|Administrative|2|||
124893839|NCT02268396|449235669|FG000|Overall Study|Withdrawal by Subject|1|||
124893840|NCT02268396|449235669|FG000|Overall Study|Lost to Follow-up|2|||
124893841|NCT02268396|449235669|FG000|Overall Study|Protocol-Specified Criteria|2|||
124893842|NCT02268396|449235669|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
124893843|NCT03660943|449235670|FG000|Overall Study|Adverse Event|5|||
124893844|NCT03660943|449235671|FG001|Overall Study|Adverse Event|3|||
124893845|NCT03660943|449235670|FG000|Overall Study|Death|0|||
124893846|NCT03660943|449235671|FG001|Overall Study|Death|2|||
124893847|NCT03660943|449235670|FG000|Overall Study|Lost to Follow-up|7|||
124893848|NCT03660943|449235671|FG001|Overall Study|Lost to Follow-up|3|||
124893849|NCT03660943|449235670|FG000|Overall Study|Protocol Violation|3|||
124893850|NCT03660943|449235671|FG001|Overall Study|Protocol Violation|5|||
124893851|NCT03660943|449235670|FG000|Overall Study|Withdrawal by Subject|8|||
124893852|NCT03660943|449235671|FG001|Overall Study|Withdrawal by Subject|15|||
124893853|NCT03660943|449235670|FG000|Overall Study|Lack of Efficacy|9|||
124893854|NCT03660943|449235671|FG001|Overall Study|Lack of Efficacy|12|||
124893855|NCT03660943|449235670|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
124893856|NCT03660943|449235671|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
124893857|NCT02491411|449235674|FG000|Overall Study|Physician Decision|4|||
124893858|NCT04034238|449235675|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
124893859|NCT04034238|449235676|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
124893860|NCT04034238|449235677|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
124893861|NCT04034238|449235678|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
124893862|NCT04034238|449235675|FG000|Dose Escalation Phase|Screen failures|0|||
124893863|NCT04034238|449235676|FG001|Dose Escalation Phase|Screen failures|0|||
124893864|NCT04034238|449235677|FG002|Dose Escalation Phase|Screen failures|0|||
124893865|NCT04034238|449235678|FG003|Dose Escalation Phase|Screen failures|2|||
124893866|NCT04034238|449235675|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
125108099|NCT04440163|450020580|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
125108100|NCT04440163|450020581|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
124893867|NCT04034238|449235676|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
124893868|NCT04034238|449235677|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
124893869|NCT04034238|449235678|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
124893870|NCT04034238|449235675|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
124893871|NCT04034238|449235676|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
124893872|NCT04034238|449235677|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
124893873|NCT04034238|449235678|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
124893874|NCT01939158|449235679|FG000|Overall Study|Adverse Event|1|||
124893875|NCT01939158|449235680|FG001|Overall Study|Adverse Event|0|||
124893876|NCT01939158|449235681|FG002|Overall Study|Adverse Event|0|||
124893877|NCT01939158|449235682|FG003|Overall Study|Adverse Event|0|||
124893878|NCT01939158|449235679|FG000|Overall Study|Withdrawal by Subject|22|||
124893879|NCT01939158|449235680|FG001|Overall Study|Withdrawal by Subject|25|||
124893880|NCT01939158|449235681|FG002|Overall Study|Withdrawal by Subject|15|||
124893881|NCT01939158|449235682|FG003|Overall Study|Withdrawal by Subject|17|||
124893882|NCT01939158|449235679|FG000|Overall Study|Migrated/moved from study area|5|||
124893883|NCT01939158|449235680|FG001|Overall Study|Migrated/moved from study area|7|||
124893884|NCT01939158|449235681|FG002|Overall Study|Migrated/moved from study area|3|||
124893885|NCT01939158|449235682|FG003|Overall Study|Migrated/moved from study area|6|||
124893886|NCT01939158|449235679|FG000|Overall Study|Lost to Follow-up|18|||
124893887|NCT01939158|449235680|FG001|Overall Study|Lost to Follow-up|17|||
125108101|NCT04440163|450020574|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
125108102|NCT04440163|450020575|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
125108103|NCT04440163|450020576|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
125108104|NCT04440163|450020577|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
125108105|NCT04440163|450020578|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
125108106|NCT04440163|450020579|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
125108107|NCT04440163|450020580|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
125108108|NCT04440163|450020581|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
125108109|NCT04440163|450020574|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
125108110|NCT04440163|450020575|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
125108111|NCT04440163|450020576|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
125108112|NCT04440163|450020577|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
125108113|NCT04440163|450020578|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
125108114|NCT04440163|450020579|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
125108115|NCT04440163|450020580|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
125108116|NCT04440163|450020581|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
125108117|NCT04440163|450020574|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
125108118|NCT04440163|450020575|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
125108119|NCT04440163|450020576|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
125108120|NCT04440163|450020577|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
125108121|NCT04440163|450020578|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
125108122|NCT04440163|450020579|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
125108123|NCT04440163|450020580|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
125108124|NCT04440163|450020581|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
125108125|NCT04440163|450020574|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
125108126|NCT04440163|450020575|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
125108127|NCT04440163|450020576|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
125108128|NCT04440163|450020577|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
125108129|NCT04440163|450020578|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
125108130|NCT04440163|450020579|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
125108131|NCT04440163|450020580|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
125108132|NCT04440163|450020581|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
125108133|NCT04440163|450020574|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
125108134|NCT04440163|450020575|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
125108135|NCT04440163|450020576|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
125108136|NCT04440163|450020577|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
125108137|NCT04440163|450020578|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
125108138|NCT04440163|450020579|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
125108139|NCT04440163|450020580|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
125108140|NCT04440163|450020581|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
125108141|NCT04440163|450020574|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
125108142|NCT04440163|450020575|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
125108143|NCT04440163|450020576|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
125108144|NCT04440163|450020577|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
125108145|NCT04440163|450020578|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
125108146|NCT04440163|450020579|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
125108147|NCT04440163|450020580|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
124893888|NCT01939158|449235681|FG002|Overall Study|Lost to Follow-up|17|||
124893889|NCT01939158|449235682|FG003|Overall Study|Lost to Follow-up|17|||
124893890|NCT01939158|449235679|FG000|Overall Study|Death|0|||
124893891|NCT01939158|449235680|FG001|Overall Study|Death|0|||
124893892|NCT01939158|449235681|FG002|Overall Study|Death|1|||
124893893|NCT01939158|449235682|FG003|Overall Study|Death|1|||
124893894|NCT01939158|449235679|FG000|Overall Study|No longer meets eligibility criteria|0|||
124893895|NCT01939158|449235680|FG001|Overall Study|No longer meets eligibility criteria|0|||
124893896|NCT01939158|449235681|FG002|Overall Study|No longer meets eligibility criteria|1|||
124893897|NCT01939158|449235682|FG003|Overall Study|No longer meets eligibility criteria|0|||
124893898|NCT01939158|449235679|FG000|Overall Study|Other|1|||
124893899|NCT01939158|449235680|FG001|Overall Study|Other|3|||
124893900|NCT01939158|449235681|FG002|Overall Study|Other|4|||
124893901|NCT01939158|449235682|FG003|Overall Study|Other|3|||
124893902|NCT02065245|449235683|FG000|Infusion 1|Lost to Follow-up|0|||
124893903|NCT02065245|449235684|FG001|Infusion 1|Lost to Follow-up|0|||
124893904|NCT02065245|449235685|FG002|Infusion 1|Lost to Follow-up|0|||
124893905|NCT02065245|449235686|FG003|Infusion 1|Lost to Follow-up|0|||
124893906|NCT02065245|449235687|FG004|Infusion 1|Lost to Follow-up|0|||
124893907|NCT02065245|449235688|FG005|Infusion 1|Lost to Follow-up|0|||
124893908|NCT02065245|449235689|FG006|Infusion 1|Lost to Follow-up|1|||
124893909|NCT02065245|449235683|FG000|Infusion 1|Death|0|||
124893910|NCT02065245|449235684|FG001|Infusion 1|Death|0|||
124893911|NCT02065245|449235685|FG002|Infusion 1|Death|1|||
124893912|NCT02065245|449235686|FG003|Infusion 1|Death|0|||
124893913|NCT02065245|449235687|FG004|Infusion 1|Death|1|||
124893914|NCT02065245|449235688|FG005|Infusion 1|Death|0|||
124893915|NCT02065245|449235689|FG006|Infusion 1|Death|0|||
124893916|NCT02065245|449235683|FG000|Infusion 2|Death|0|||
124893917|NCT02065245|449235684|FG001|Infusion 2|Death|0|||
124893918|NCT02065245|449235685|FG002|Infusion 2|Death|0|||
124893919|NCT02065245|449235686|FG003|Infusion 2|Death|0|||
124893920|NCT02065245|449235687|FG004|Infusion 2|Death|0|||
124893921|NCT02065245|449235688|FG005|Infusion 2|Death|0|||
124893922|NCT02065245|449235689|FG006|Infusion 2|Death|1|||
124893923|NCT02065245|449235683|FG000|Infusion 3|Lost to Follow-up|1|||
124893924|NCT02065245|449235684|FG001|Infusion 3|Lost to Follow-up|1|||
124893925|NCT02065245|449235685|FG002|Infusion 3|Lost to Follow-up|0|||
124893926|NCT02065245|449235686|FG003|Infusion 3|Lost to Follow-up|0|||
124893927|NCT02065245|449235687|FG004|Infusion 3|Lost to Follow-up|0|||
124893928|NCT02065245|449235688|FG005|Infusion 3|Lost to Follow-up|0|||
124893929|NCT02065245|449235689|FG006|Infusion 3|Lost to Follow-up|0|||
124893930|NCT01304706|449235690|FG000|Overall Study|Adverse Event|2|||
124893931|NCT01304706|449235690|FG000|Overall Study|Lack of Efficacy|1|||
124893932|NCT01304706|449235690|FG000|Overall Study|Death|3|||
124893933|NCT01304706|449235690|FG000|Overall Study|Withdrawal by Subject|3|||
124893934|NCT01304706|449235690|FG000|Overall Study|Lost to Follow-up|7|||
124893935|NCT01304706|449235690|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
124893936|NCT01345292|449235693|FG000|Overall Study|Withdrawal by Subject|2|||
124893937|NCT01345292|449235694|FG001|Overall Study|Withdrawal by Subject|0|||
124893938|NCT01345292|449235695|FG002|Overall Study|Withdrawal by Subject|1|||
124893939|NCT01033643|449235698|FG000|Overall Study|Withdrew Consent|0|||
124893940|NCT01033643|449235699|FG001|Overall Study|Withdrew Consent|3|||
124893941|NCT01033643|449235700|FG002|Overall Study|Withdrew Consent|0|||
124893942|NCT01033643|449235701|FG003|Overall Study|Withdrew Consent|0|||
124893943|NCT01033643|449235702|FG004|Overall Study|Withdrew Consent|0|||
124893944|NCT01033643|449235703|FG005|Overall Study|Withdrew Consent|1|||
124893945|NCT02271594|449235713|FG000|Overall Study|Study closed; recruiting failure|19|||
124893946|NCT02271594|449235714|FG001|Overall Study|Study closed; recruiting failure|12|||
124893947|NCT00495469|449235715|FG000|Overall Study|Adverse Event|0|||
124893948|NCT00495469|449235716|FG001|Overall Study|Adverse Event|1|||
124893949|NCT00495469|449235717|FG002|Overall Study|Adverse Event|3|||
125017700|NCT01425008|449687786|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125017701|NCT01425008|449687787|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125017702|NCT01425008|449687788|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124893950|NCT00495469|449235718|FG003|Overall Study|Adverse Event|0|||
124893951|NCT00495469|449235719|FG004|Overall Study|Adverse Event|1|||
124893952|NCT00495469|449235720|FG005|Overall Study|Adverse Event|1|||
124893953|NCT00495469|449235721|FG006|Overall Study|Adverse Event|1|||
125017703|NCT01425008|449687789|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125017704|NCT01425008|449687790|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125017705|NCT01425008|449687791|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125017706|NCT01425008|449687792|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125017707|NCT01425008|449687793|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124893954|NCT00495469|449235715|FG000|Overall Study|Lost to Follow-up|1|||
124893955|NCT00495469|449235716|FG001|Overall Study|Lost to Follow-up|1|||
124893956|NCT00495469|449235717|FG002|Overall Study|Lost to Follow-up|3|||
124893957|NCT00495469|449235718|FG003|Overall Study|Lost to Follow-up|1|||
124893958|NCT00495469|449235719|FG004|Overall Study|Lost to Follow-up|0|||
124893959|NCT00495469|449235720|FG005|Overall Study|Lost to Follow-up|0|||
125017708|NCT01425008|449687794|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124893960|NCT00495469|449235721|FG006|Overall Study|Lost to Follow-up|0|||
124893961|NCT00495469|449235715|FG000|Overall Study|Protocol Violation|0|||
124893962|NCT00495469|449235716|FG001|Overall Study|Protocol Violation|0|||
124893963|NCT00495469|449235717|FG002|Overall Study|Protocol Violation|0|||
124893964|NCT00495469|449235718|FG003|Overall Study|Protocol Violation|0|||
124893965|NCT00495469|449235719|FG004|Overall Study|Protocol Violation|1|||
124893966|NCT00495469|449235720|FG005|Overall Study|Protocol Violation|2|||
124893967|NCT00495469|449235721|FG006|Overall Study|Protocol Violation|0|||
124893968|NCT00495469|449235715|FG000|Overall Study|Withdrawal by Subject|5|||
124893969|NCT00495469|449235716|FG001|Overall Study|Withdrawal by Subject|3|||
124893970|NCT00495469|449235717|FG002|Overall Study|Withdrawal by Subject|1|||
124893971|NCT00495469|449235718|FG003|Overall Study|Withdrawal by Subject|3|||
124893972|NCT00495469|449235719|FG004|Overall Study|Withdrawal by Subject|3|||
124893973|NCT00495469|449235720|FG005|Overall Study|Withdrawal by Subject|2|||
124893974|NCT00495469|449235721|FG006|Overall Study|Withdrawal by Subject|3|||
124893975|NCT00495469|449235715|FG000|Overall Study|Lack of Efficacy|0|||
124893976|NCT00495469|449235716|FG001|Overall Study|Lack of Efficacy|0|||
124893977|NCT00495469|449235717|FG002|Overall Study|Lack of Efficacy|0|||
124893978|NCT00495469|449235718|FG003|Overall Study|Lack of Efficacy|0|||
124893979|NCT00495469|449235719|FG004|Overall Study|Lack of Efficacy|0|||
124893980|NCT00495469|449235720|FG005|Overall Study|Lack of Efficacy|0|||
124893981|NCT00495469|449235721|FG006|Overall Study|Lack of Efficacy|1|||
124893982|NCT00495469|449235715|FG000|Overall Study|Liver function test abnormality|0|||
124893983|NCT00495469|449235716|FG001|Overall Study|Liver function test abnormality|1|||
124893984|NCT00495469|449235717|FG002|Overall Study|Liver function test abnormality|0|||
124893985|NCT00495469|449235718|FG003|Overall Study|Liver function test abnormality|0|||
124893986|NCT00495469|449235719|FG004|Overall Study|Liver function test abnormality|0|||
124893987|NCT00495469|449235720|FG005|Overall Study|Liver function test abnormality|0|||
124893988|NCT00495469|449235721|FG006|Overall Study|Liver function test abnormality|0|||
124893989|NCT00495469|449235715|FG000|Overall Study|ST depression at randomisation in ECG|0|||
124893990|NCT00495469|449235716|FG001|Overall Study|ST depression at randomisation in ECG|1|||
124893991|NCT00495469|449235717|FG002|Overall Study|ST depression at randomisation in ECG|0|||
124893992|NCT00495469|449235718|FG003|Overall Study|ST depression at randomisation in ECG|0|||
125017709|NCT01425008|449687795|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125017710|NCT01425008|449687796|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125017711|NCT01425008|449687797|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125017712|NCT01425008|449687798|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
125017713|NCT00562588|449687799|FG000|Overall Study|Adverse Event|40|||
125017714|NCT00562588|449687800|FG001|Overall Study|Adverse Event|58|||
125017715|NCT00562588|449687799|FG000|Overall Study|Protocol Violation|30|||
125017716|NCT00562588|449687800|FG001|Overall Study|Protocol Violation|26|||
125017717|NCT00562588|449687799|FG000|Overall Study|Lost to Follow-up|12|||
125017718|NCT00562588|449687800|FG001|Overall Study|Lost to Follow-up|4|||
125017719|NCT00562588|449687799|FG000|Overall Study|Withdrawal by Subject|10|||
125017720|NCT00562588|449687800|FG001|Overall Study|Withdrawal by Subject|9|||
125017721|NCT00562588|449687799|FG000|Overall Study|Other|0|||
125017722|NCT00562588|449687800|FG001|Overall Study|Other|2|||
125017723|NCT03315871|449687801|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
125017724|NCT03315871|449687802|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
125017725|NCT03315871|449687803|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
125017726|NCT03315871|449687801|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
125017727|NCT03315871|449687802|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
125017728|NCT03315871|449687803|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
125017729|NCT03315871|449687801|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
125017730|NCT03315871|449687802|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
125017731|NCT03315871|449687803|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
125017732|NCT03315871|449687801|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
125017733|NCT03315871|449687802|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
125017734|NCT03315871|449687803|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
125017735|NCT03315871|449687801|FG000|PROSTVAC + CV301|Progressive disease|0|||
125017736|NCT03315871|449687802|FG001|PROSTVAC + CV301|Progressive disease|0|||
125017737|NCT03315871|449687803|FG002|PROSTVAC + CV301|Progressive disease|1|||
125017738|NCT03315871|449687801|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
125017739|NCT03315871|449687802|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
125017740|NCT03315871|449687803|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
125017741|NCT05032157|449691083|FG000|Overall Study|Adverse Event|12|||
125017742|NCT05032157|449691084|FG001|Overall Study|Adverse Event|7|||
125017743|NCT05032157|449691083|FG000|Overall Study|Pregnancy|0|||
125017744|NCT05032157|449691084|FG001|Overall Study|Pregnancy|2|||
125017745|NCT05032157|449691083|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
125017746|NCT05032157|449691084|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
125017747|NCT05032157|449691083|FG000|Overall Study|Protocol Deviation|8|||
125017748|NCT05032157|449691084|FG001|Overall Study|Protocol Deviation|4|||
125017749|NCT05032157|449691083|FG000|Overall Study|Lost to Follow-up|1|||
125017750|NCT05032157|449691084|FG001|Overall Study|Lost to Follow-up|3|||
125017751|NCT05032157|449691083|FG000|Overall Study|Physician Decision|7|||
125017752|NCT05032157|449691084|FG001|Overall Study|Physician Decision|2|||
124893993|NCT00495469|449235719|FG004|Overall Study|ST depression at randomisation in ECG|0|||
124893994|NCT00495469|449235720|FG005|Overall Study|ST depression at randomisation in ECG|0|||
124893995|NCT00495469|449235721|FG006|Overall Study|ST depression at randomisation in ECG|0|||
124893996|NCT00448864|449235724|FG000|Overall Study|Death|1|||
124893997|NCT00448864|449235725|FG001|Overall Study|Death|0|||
124893998|NCT00448864|449235726|FG002|Overall Study|Death|0|||
124893999|NCT00448864|449235724|FG000|Overall Study|Lost to Follow-up|3|||
124894000|NCT00448864|449235725|FG001|Overall Study|Lost to Follow-up|1|||
124894001|NCT00448864|449235726|FG002|Overall Study|Lost to Follow-up|0|||
124894002|NCT00448864|449235724|FG000|Overall Study|Physician Decision|1|||
124894003|NCT00448864|449235725|FG001|Overall Study|Physician Decision|0|||
124894004|NCT00448864|449235726|FG002|Overall Study|Physician Decision|1|||
124894005|NCT00448864|449235724|FG000|Overall Study|Withdrawal by Subject|0|||
124894006|NCT00448864|449235725|FG001|Overall Study|Withdrawal by Subject|2|||
124894007|NCT00448864|449235726|FG002|Overall Study|Withdrawal by Subject|0|||
124894008|NCT00448864|449235724|FG000|Overall Study|Protocol Violation|0|||
124894009|NCT00448864|449235725|FG001|Overall Study|Protocol Violation|2|||
124894010|NCT00448864|449235726|FG002|Overall Study|Protocol Violation|0|||
124894011|NCT01323660|449235727|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
124894012|NCT01323660|449235728|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
124894013|NCT01323660|449235729|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
124894014|NCT01323660|449235730|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
124894015|NCT01323660|449235731|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
124894016|NCT01323660|449235732|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
124894017|NCT01323660|449235727|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
124894018|NCT01323660|449235728|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
124894019|NCT01323660|449235729|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
124894020|NCT01323660|449235730|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
124894021|NCT01323660|449235731|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
124894022|NCT01323660|449235732|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
124894023|NCT01323660|449235727|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
124894024|NCT01323660|449235728|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
124894025|NCT01323660|449235729|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
124894026|NCT01323660|449235730|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
124894027|NCT01323660|449235731|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
124894028|NCT01323660|449235732|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
124894029|NCT01323660|449235727|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
124894030|NCT01323660|449235728|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
124894031|NCT01323660|449235729|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
124894032|NCT01323660|449235730|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
124894033|NCT01323660|449235731|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
124894034|NCT01323660|449235732|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
124894035|NCT01323660|449235727|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124894036|NCT01323660|449235728|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124894037|NCT01323660|449235729|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124894038|NCT01323660|449235730|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124894039|NCT01323660|449235731|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
124894040|NCT01323660|449235732|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124894041|NCT01323660|449235727|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
124894042|NCT01323660|449235728|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
124894043|NCT01323660|449235729|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
124894044|NCT01323660|449235730|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
124894045|NCT01323660|449235731|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
124894046|NCT01323660|449235732|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
124894047|NCT01323660|449235727|FG000|Washout Period (14 Days)|Adverse Event|0|||
124894048|NCT01323660|449235728|FG001|Washout Period (14 Days)|Adverse Event|0|||
124894049|NCT01323660|449235729|FG002|Washout Period (14 Days)|Adverse Event|0|||
124894050|NCT01323660|449235730|FG003|Washout Period (14 Days)|Adverse Event|0|||
124894051|NCT01323660|449235731|FG004|Washout Period (14 Days)|Adverse Event|1|||
125017753|NCT05032157|449691083|FG000|Overall Study|Patient Decision|38|||
125017754|NCT05032157|449691084|FG001|Overall Study|Patient Decision|19|||
125017755|NCT00150592|449691085|FG000|Overall Study|Adverse Event|4|||
125017756|NCT00150592|449691086|FG001|Overall Study|Adverse Event|1|||
125017757|NCT00150592|449691085|FG000|Overall Study|Protocol Violation|1|||
125017758|NCT00150592|449691086|FG001|Overall Study|Protocol Violation|0|||
124894052|NCT01323660|449235732|FG005|Washout Period (14 Days)|Adverse Event|0|||
124894053|NCT01323660|449235727|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
124894054|NCT01323660|449235728|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
124894055|NCT01323660|449235729|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
124894056|NCT01323660|449235730|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
124894057|NCT01323660|449235731|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
124894058|NCT01323660|449235732|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
125017759|NCT00150592|449691085|FG000|Overall Study|Withdrawal by Subject|1|||
124894059|NCT01323660|449235727|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
124894060|NCT01323660|449235728|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
124894061|NCT01323660|449235729|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
124894062|NCT01323660|449235730|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
124894063|NCT01323660|449235731|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
124894064|NCT01323660|449235732|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
124894065|NCT01323660|449235727|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
124894066|NCT01323660|449235728|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
124894067|NCT01323660|449235729|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
124894068|NCT01323660|449235730|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
124894069|NCT01323660|449235731|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
124894070|NCT01323660|449235732|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
124894071|NCT01323660|449235727|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
124894072|NCT01323660|449235728|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
124894073|NCT01323660|449235729|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
124894074|NCT01323660|449235730|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
124894075|NCT01323660|449235731|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
124894076|NCT01323660|449235732|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
124894077|NCT01323660|449235727|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
124894078|NCT01323660|449235728|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
124894079|NCT01323660|449235729|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
124894080|NCT01323660|449235730|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
124894081|NCT01323660|449235731|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
124894082|NCT01323660|449235732|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
124894083|NCT01323660|449235727|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
124894084|NCT01323660|449235728|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
124894085|NCT01323660|449235729|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
124894086|NCT01323660|449235730|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124894087|NCT01323660|449235731|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
124894088|NCT01323660|449235732|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124894089|NCT04531540|449235735|FG000|Overall Study|Adverse Event|1|||
124894090|NCT04531540|449235735|FG000|Overall Study|Protocol Violation|3|||
124894091|NCT04531540|449235735|FG000|Overall Study|Withdrawal by Subject|4|||
124894092|NCT04531540|449235735|FG000|Overall Study|Found to be Ineligible|1|||
124894093|NCT01575860|449235738|FG000|Overall Study|Withdrawal by Subject|1|||
124894094|NCT01575860|449235738|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
124894095|NCT03606460|449235739|FG000|Overall Study|Lost to Follow-up|1|||
124894096|NCT03606460|449235740|FG001|Overall Study|Lost to Follow-up|8|||
124894097|NCT04170023|449235741|FG000|LTE Period|Withdrawal by Subject|1|||
124894098|NCT04170023|449235742|FG001|LTE Period|Withdrawal by Subject|0|||
124894099|NCT04170023|449235743|FG002|LTE Period|Withdrawal by Subject|0|||
125017760|NCT00150592|449691086|FG001|Overall Study|Withdrawal by Subject|2|||
125017761|NCT00150592|449691085|FG000|Overall Study|Non-compliance|1|||
125017762|NCT00150592|449691086|FG001|Overall Study|Non-compliance|0|||
125017763|NCT03047980|449691087|FG000|Overall Study|Adverse Event|1|||
125017764|NCT00874120|449691092|FG000|First Intervention|Adverse Event|0|||
125017765|NCT00874120|449691093|FG001|First Intervention|Adverse Event|1|||
125017766|NCT00874120|449691092|FG000|First Intervention|Withdrawal by Subject|2|||
125017767|NCT00874120|449691093|FG001|First Intervention|Withdrawal by Subject|0|||
125017768|NCT00874120|449691092|FG000|First Intervention|Lost to Follow-up|0|||
125017769|NCT00874120|449691093|FG001|First Intervention|Lost to Follow-up|1|||
125017770|NCT00874120|449691092|FG000|First Intervention|Protocol Violation|3|||
125017771|NCT00874120|449691093|FG001|First Intervention|Protocol Violation|0|||
125017772|NCT00874120|449691092|FG000|First Intervention|positive drug test|1|||
125017773|NCT00874120|449691093|FG001|First Intervention|positive drug test|0|||
125017774|NCT00874120|449691092|FG000|Second Intervention|Withdrawal by Subject|1|||
125017775|NCT00874120|449691093|FG001|Second Intervention|Withdrawal by Subject|0|||
125017776|NCT00874120|449691092|FG000|Second Intervention|Protocol Violation|1|||
125017777|NCT00874120|449691093|FG001|Second Intervention|Protocol Violation|0|||
125017778|NCT01823679|449691094|FG000|Overall Study|Death|1|||
125017779|NCT02164981|449691095|FG000|Started|Withdrawal by Subject|2|||
124894100|NCT04170023|449235741|FG000|LTE Period|Study Termination|11|||
124894101|NCT04170023|449235742|FG001|LTE Period|Study Termination|11|||
124894102|NCT04170023|449235743|FG002|LTE Period|Study Termination|5|||
125017780|NCT02164981|449691096|FG001|Started|Withdrawal by Subject|1|||
125017781|NCT02164981|449691097|FG002|Started|Withdrawal by Subject|0|||
125017782|NCT02164981|449691095|FG000|Started|Protocol Violation|2|||
125108148|NCT04440163|450020581|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
125108149|NCT04440163|450020574|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
125108150|NCT04440163|450020575|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
125108151|NCT04440163|450020576|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
125108152|NCT04440163|450020577|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
125108153|NCT04440163|450020578|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
125108154|NCT04440163|450020579|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
125108155|NCT04440163|450020580|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
125108156|NCT04440163|450020581|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
125108157|NCT02018042|450020584|FG000|Overall Study|Withdrawal by Subject|1|||
125108158|NCT01954082|450020585|FG000|Overall Study|Study Suspension|42|||
125108159|NCT01954082|450020586|FG001|Overall Study|Study Suspension|36|||
125108160|NCT01954082|450020585|FG000|Overall Study|Adverse Event|10|||
125108161|NCT01954082|450020586|FG001|Overall Study|Adverse Event|4|||
125108162|NCT01954082|450020585|FG000|Overall Study|Intolerance|0|||
125108163|NCT01954082|450020586|FG001|Overall Study|Intolerance|1|||
125108164|NCT01954082|450020585|FG000|Overall Study|Non-compliance|6|||
125108165|NCT01954082|450020586|FG001|Overall Study|Non-compliance|4|||
125108166|NCT01954082|450020585|FG000|Overall Study|Physician Decision|2|||
125108167|NCT01954082|450020586|FG001|Overall Study|Physician Decision|0|||
125108168|NCT01954082|450020585|FG000|Overall Study|Parent Decision|1|||
125108169|NCT01954082|450020586|FG001|Overall Study|Parent Decision|0|||
125108170|NCT01954082|450020585|FG000|Overall Study|Withdrawal by Subject|0|||
125108171|NCT01954082|450020586|FG001|Overall Study|Withdrawal by Subject|1|||
125108172|NCT01954082|450020585|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
125108173|NCT01954082|450020586|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
125108174|NCT01954082|450020585|FG000|Overall Study|Redirection of Care|0|||
125108175|NCT01954082|450020586|FG001|Overall Study|Redirection of Care|2|||
125017783|NCT02164981|449691096|FG001|Started|Protocol Violation|0|||
125017784|NCT02164981|449691097|FG002|Started|Protocol Violation|0|||
125017785|NCT02164981|449691095|FG000|Started|Adverse Event|1|||
125017786|NCT02164981|449691096|FG001|Started|Adverse Event|2|||
125017787|NCT02164981|449691097|FG002|Started|Adverse Event|0|||
125017788|NCT02164981|449691095|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
125017789|NCT02164981|449691096|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
125017790|NCT02164981|449691097|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
125017791|NCT02164981|449691095|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
125017792|NCT02164981|449691096|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
125017793|NCT02164981|449691097|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
125017794|NCT02164981|449691095|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
125017795|NCT02164981|449691096|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
125017796|NCT02164981|449691097|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
125017797|NCT02404103|449691098|FG000|Overall Study|Adverse Event|1|||
125017798|NCT02404103|449691099|FG001|Overall Study|Adverse Event|0|||
125017799|NCT02404103|449691098|FG000|Overall Study|Lost to Follow-up|3|||
125017800|NCT02404103|449691099|FG001|Overall Study|Lost to Follow-up|3|||
125017801|NCT00328627|449691100|FG000|Overall Study|Hyperglycemic Rescue|41|||
125017802|NCT00328627|449691101|FG001|Overall Study|Hyperglycemic Rescue|18|||
125017803|NCT00328627|449691102|FG002|Overall Study|Hyperglycemic Rescue|16|||
125017804|NCT00328627|449691103|FG003|Overall Study|Hyperglycemic Rescue|13|||
125017805|NCT00328627|449691104|FG004|Overall Study|Hyperglycemic Rescue|6|||
125017806|NCT00328627|449691105|FG005|Overall Study|Hyperglycemic Rescue|5|||
125017807|NCT00328627|449691106|FG006|Overall Study|Hyperglycemic Rescue|19|||
125017808|NCT00328627|449691107|FG007|Overall Study|Hyperglycemic Rescue|6|||
125017809|NCT00328627|449691108|FG008|Overall Study|Hyperglycemic Rescue|6|||
125017810|NCT00328627|449691109|FG009|Overall Study|Hyperglycemic Rescue|11|||
125017811|NCT00328627|449691110|FG010|Overall Study|Hyperglycemic Rescue|3|||
125017812|NCT00328627|449691111|FG011|Overall Study|Hyperglycemic Rescue|2|||
125017813|NCT00328627|449691100|FG000|Overall Study|Adverse Event|3|||
125017814|NCT00328627|449691101|FG001|Overall Study|Adverse Event|1|||
125017815|NCT00328627|449691102|FG002|Overall Study|Adverse Event|2|||
125017816|NCT00328627|449691103|FG003|Overall Study|Adverse Event|3|||
125017817|NCT00328627|449691104|FG004|Overall Study|Adverse Event|1|||
125017818|NCT00328627|449691105|FG005|Overall Study|Adverse Event|2|||
125108176|NCT01954082|450020585|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
125108177|NCT01954082|450020586|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
125108178|NCT01954082|450020585|FG000|Overall Study|Comfort Care|0|||
125108179|NCT01954082|450020586|FG001|Overall Study|Comfort Care|1|||
124894103|NCT00372567|449235753|FG000|Phase 3 Study|Adverse Event|5|||
125017819|NCT00328627|449691106|FG006|Overall Study|Adverse Event|1|||
125017820|NCT00328627|449691107|FG007|Overall Study|Adverse Event|2|||
124894104|NCT00372567|449235754|FG001|Phase 3 Study|Adverse Event|1|||
124894105|NCT00372567|449235755|FG002|Phase 3 Study|Adverse Event|1|||
124894106|NCT00372567|449235753|FG000|Phase 3 Study|Death|1|||
124894107|NCT00372567|449235754|FG001|Phase 3 Study|Death|1|||
124894108|NCT00372567|449235755|FG002|Phase 3 Study|Death|0|||
124894109|NCT00372567|449235753|FG000|Phase 3 Study|Protocol Violation|0|||
124894110|NCT00372567|449235754|FG001|Phase 3 Study|Protocol Violation|0|||
124894111|NCT00372567|449235755|FG002|Phase 3 Study|Protocol Violation|1|||
124894112|NCT00372567|449235753|FG000|Phase 3 Study|Objective progression or relapse|10|||
125017821|NCT00328627|449691108|FG008|Overall Study|Adverse Event|0|||
125017822|NCT00328627|449691109|FG009|Overall Study|Adverse Event|7|||
125017823|NCT00328627|449691110|FG010|Overall Study|Adverse Event|5|||
125017824|NCT00328627|449691111|FG011|Overall Study|Adverse Event|4|||
125017825|NCT00328627|449691100|FG000|Overall Study|Protocol Violation|2|||
125017826|NCT00328627|449691101|FG001|Overall Study|Protocol Violation|2|||
125017827|NCT00328627|449691102|FG002|Overall Study|Protocol Violation|2|||
125017828|NCT00328627|449691103|FG003|Overall Study|Protocol Violation|8|||
125017829|NCT00328627|449691104|FG004|Overall Study|Protocol Violation|5|||
125017830|NCT00328627|449691105|FG005|Overall Study|Protocol Violation|5|||
125017831|NCT00328627|449691106|FG006|Overall Study|Protocol Violation|6|||
125017832|NCT00328627|449691107|FG007|Overall Study|Protocol Violation|2|||
125017833|NCT00328627|449691108|FG008|Overall Study|Protocol Violation|1|||
125017834|NCT00328627|449691109|FG009|Overall Study|Protocol Violation|4|||
125017835|NCT00328627|449691110|FG010|Overall Study|Protocol Violation|6|||
125017836|NCT00328627|449691111|FG011|Overall Study|Protocol Violation|2|||
125017837|NCT00328627|449691100|FG000|Overall Study|Lost to Follow-up|4|||
125017838|NCT00328627|449691101|FG001|Overall Study|Lost to Follow-up|2|||
125017839|NCT00328627|449691102|FG002|Overall Study|Lost to Follow-up|2|||
125017840|NCT00328627|449691103|FG003|Overall Study|Lost to Follow-up|4|||
125017841|NCT00328627|449691104|FG004|Overall Study|Lost to Follow-up|0|||
125017842|NCT00328627|449691105|FG005|Overall Study|Lost to Follow-up|2|||
125017843|NCT00328627|449691106|FG006|Overall Study|Lost to Follow-up|3|||
125017844|NCT00328627|449691107|FG007|Overall Study|Lost to Follow-up|0|||
125017845|NCT00328627|449691108|FG008|Overall Study|Lost to Follow-up|3|||
125017846|NCT00328627|449691109|FG009|Overall Study|Lost to Follow-up|2|||
125017847|NCT00328627|449691110|FG010|Overall Study|Lost to Follow-up|0|||
125017848|NCT00328627|449691111|FG011|Overall Study|Lost to Follow-up|1|||
125017849|NCT00328627|449691100|FG000|Overall Study|Withdrawal by Subject|5|||
125017850|NCT00328627|449691101|FG001|Overall Study|Withdrawal by Subject|4|||
125017851|NCT00328627|449691102|FG002|Overall Study|Withdrawal by Subject|5|||
125017852|NCT00328627|449691103|FG003|Overall Study|Withdrawal by Subject|6|||
125017853|NCT00328627|449691104|FG004|Overall Study|Withdrawal by Subject|2|||
125017854|NCT00328627|449691105|FG005|Overall Study|Withdrawal by Subject|5|||
125017855|NCT00328627|449691106|FG006|Overall Study|Withdrawal by Subject|4|||
125017856|NCT00328627|449691107|FG007|Overall Study|Withdrawal by Subject|4|||
125017857|NCT00328627|449691108|FG008|Overall Study|Withdrawal by Subject|4|||
125017858|NCT00328627|449691109|FG009|Overall Study|Withdrawal by Subject|5|||
125017859|NCT00328627|449691110|FG010|Overall Study|Withdrawal by Subject|2|||
125017860|NCT00328627|449691111|FG011|Overall Study|Withdrawal by Subject|7|||
125017861|NCT00328627|449691100|FG000|Overall Study|Pregnancy|0|||
125017862|NCT00328627|449691101|FG001|Overall Study|Pregnancy|1|||
125017863|NCT00328627|449691102|FG002|Overall Study|Pregnancy|0|||
125017864|NCT00328627|449691103|FG003|Overall Study|Pregnancy|0|||
125017865|NCT00328627|449691104|FG004|Overall Study|Pregnancy|0|||
125017866|NCT00328627|449691105|FG005|Overall Study|Pregnancy|0|||
125017867|NCT00328627|449691106|FG006|Overall Study|Pregnancy|0|||
125017868|NCT00328627|449691107|FG007|Overall Study|Pregnancy|0|||
125017869|NCT00328627|449691108|FG008|Overall Study|Pregnancy|0|||
125017870|NCT00328627|449691109|FG009|Overall Study|Pregnancy|0|||
125017871|NCT00328627|449691110|FG010|Overall Study|Pregnancy|0|||
125017872|NCT00328627|449691111|FG011|Overall Study|Pregnancy|0|||
125017873|NCT00328627|449691100|FG000|Overall Study|Physician Decision|4|||
125017874|NCT00328627|449691101|FG001|Overall Study|Physician Decision|3|||
125017875|NCT00328627|449691102|FG002|Overall Study|Physician Decision|1|||
125017876|NCT00328627|449691103|FG003|Overall Study|Physician Decision|2|||
125017877|NCT00328627|449691104|FG004|Overall Study|Physician Decision|1|||
125017878|NCT00328627|449691105|FG005|Overall Study|Physician Decision|1|||
125017879|NCT00328627|449691106|FG006|Overall Study|Physician Decision|1|||
125017880|NCT00328627|449691107|FG007|Overall Study|Physician Decision|0|||
125017881|NCT00328627|449691108|FG008|Overall Study|Physician Decision|3|||
125017882|NCT00328627|449691109|FG009|Overall Study|Physician Decision|2|||
125017883|NCT00328627|449691110|FG010|Overall Study|Physician Decision|1|||
124894113|NCT00372567|449235754|FG001|Phase 3 Study|Objective progression or relapse|13|||
125017884|NCT00328627|449691111|FG011|Overall Study|Physician Decision|0|||
125017885|NCT00328627|449691100|FG000|Overall Study|Other|0|||
125017886|NCT00328627|449691101|FG001|Overall Study|Other|0|||
125017887|NCT00328627|449691102|FG002|Overall Study|Other|0|||
125017888|NCT00328627|449691103|FG003|Overall Study|Other|1|||
125017889|NCT00328627|449691104|FG004|Overall Study|Other|0|||
125017890|NCT00328627|449691105|FG005|Overall Study|Other|0|||
125017891|NCT00328627|449691106|FG006|Overall Study|Other|1|||
125108180|NCT01954082|450020585|FG000|Overall Study|Infant Moved|0|||
125108181|NCT01954082|450020586|FG001|Overall Study|Infant Moved|1|||
125108182|NCT01954082|450020585|FG000|Overall Study|Randomized not Treated|4|||
125108183|NCT01954082|450020586|FG001|Overall Study|Randomized not Treated|2|||
125108184|NCT00707174|450020589|FG000|Overall Study|Adverse Event|1|||
125108185|NCT00707174|450020590|FG001|Overall Study|Adverse Event|6|||
125108186|NCT00707174|450020589|FG000|Overall Study|Withdrawal by Subject|4|||
125108187|NCT00707174|450020590|FG001|Overall Study|Withdrawal by Subject|1|||
125108188|NCT01453374|450020591|FG000|Overall Study|Adverse Event|7|||
125108189|NCT01453374|450020591|FG000|Overall Study|Lack of Efficacy|1|||
125017892|NCT00328627|449691107|FG007|Overall Study|Other|0|||
125017893|NCT00328627|449691108|FG008|Overall Study|Other|0|||
125017894|NCT00328627|449691109|FG009|Overall Study|Other|1|||
125017895|NCT00328627|449691110|FG010|Overall Study|Other|1|||
125017896|NCT00328627|449691111|FG011|Overall Study|Other|0|||
125017897|NCT00522431|449691112|FG000|Overall Study|Adverse Event|5|||
125017898|NCT00522431|449691112|FG000|Overall Study|Protocol Violation|2|||
125017899|NCT00522431|449691112|FG000|Overall Study|Withdrawal by Subject|2|||
125017900|NCT00522431|449691112|FG000|Overall Study|Subject non-compliance|1|||
125017901|NCT00522431|449691112|FG000|Overall Study|Other/unknown|1|||
125017902|NCT01137773|449691113|FG000|Overall Study|Death|3|||
125017903|NCT01137773|449691114|FG001|Overall Study|Death|3|||
125017904|NCT01137773|449691113|FG000|Overall Study|Lost to Follow-up|6|||
125017905|NCT01137773|449691114|FG001|Overall Study|Lost to Follow-up|0|||
125017906|NCT03548051|449691115|FG000|Overall Study|Death|1|||
125017907|NCT03548051|449691116|FG001|Overall Study|Death|1|||
125017908|NCT03548051|449691115|FG000|Overall Study|Withdrawal by Subject|1|||
125017909|NCT03548051|449691116|FG001|Overall Study|Withdrawal by Subject|0|||
125017910|NCT03927105|449691117|FG000|Overall Study|Death|1|||
125017911|NCT03927105|449691117|FG000|Overall Study|In observation for potential re-treatment|2|||
125017912|NCT03927105|449691117|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
125017913|NCT02684981|449691121|FG000|Overall Study|Permanently discontinued the treatment|157|||
125017914|NCT02684981|449691122|FG001|Overall Study|Permanently discontinued the treatment|161|||
125017915|NCT02684981|449691123|FG002|Overall Study|Permanently discontinued the treatment|110|||
125017916|NCT02684981|449691121|FG000|Overall Study|Other|83|||
125017917|NCT02684981|449691122|FG001|Overall Study|Other|49|||
125017918|NCT02684981|449691123|FG002|Overall Study|Other|17|||
125017919|NCT00820898|449691124|FG000|Overall Study|Inelgible - wrong primary site|1|||
125017920|NCT00647556|449691127|FG000|Overall Study|Adverse Event|0|||
125017921|NCT00647556|449691128|FG001|Overall Study|Adverse Event|1|||
125017922|NCT00647556|449691127|FG000|Overall Study|Lost to Follow-up|1|||
125017923|NCT00647556|449691128|FG001|Overall Study|Lost to Follow-up|0|||
125017924|NCT00647556|449691127|FG000|Overall Study|Protocol Violation|0|||
125017925|NCT00647556|449691128|FG001|Overall Study|Protocol Violation|1|||
125017926|NCT00647556|449691127|FG000|Overall Study|Withdrawal by Subject|1|||
125017927|NCT00647556|449691128|FG001|Overall Study|Withdrawal by Subject|0|||
125017928|NCT00647556|449691127|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
125108190|NCT01453374|450020591|FG000|Overall Study|Lost to Follow-up|3|||
125108191|NCT01453374|450020591|FG000|Overall Study|Withdrawal by Subject|5|||
125017929|NCT00647556|449691128|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
125017930|NCT01652287|449691129|FG000|Overall Study|Withdrawal by Subject|2|||
125017931|NCT01652287|449691130|FG001|Overall Study|Withdrawal by Subject|0|||
125017932|NCT00763139|449691131|FG000|Overall Study|Adverse Event|4|||
125017933|NCT00763139|449691132|FG001|Overall Study|Adverse Event|2|||
125108192|NCT01453374|450020591|FG000|Overall Study|Incarcerated|2|||
125108193|NCT00709735|450020599|FG000|Overall Study|Lost to Follow-up|1|||
125108194|NCT00709735|450020600|FG001|Overall Study|Lost to Follow-up|1|||
125108195|NCT00709735|450020599|FG000|Overall Study|Relapse into Opioid Abuse|0|||
125108196|NCT00709735|450020600|FG001|Overall Study|Relapse into Opioid Abuse|1|||
125108197|NCT00709735|450020599|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
125108198|NCT00709735|450020600|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
125108199|NCT00666718|450020601|FG000|Overall Study|Adverse Event|0|||
125108200|NCT00666718|450020602|FG001|Overall Study|Adverse Event|1|||
125108201|NCT00666718|450020601|FG000|Overall Study|Death|1|||
125108202|NCT00666718|450020602|FG001|Overall Study|Death|0|||
125108203|NCT00666718|450020601|FG000|Overall Study|Lost to Follow-up|1|||
125108204|NCT00666718|450020602|FG001|Overall Study|Lost to Follow-up|0|||
125108205|NCT00666718|450020601|FG000|Overall Study|Entry Criteria Not Met|2|||
125108206|NCT00666718|450020602|FG001|Overall Study|Entry Criteria Not Met|0|||
125108207|NCT00666718|450020601|FG000|Overall Study|Protocol Violation|1|||
125108208|NCT00666718|450020602|FG001|Overall Study|Protocol Violation|3|||
125108209|NCT00666718|450020601|FG000|Overall Study|Withdrawal by Subject|7|||
125108210|NCT00666718|450020602|FG001|Overall Study|Withdrawal by Subject|12|||
125108211|NCT00666718|450020601|FG000|Overall Study|Physician Decision|0|||
125108212|NCT00666718|450020602|FG001|Overall Study|Physician Decision|2|||
125108213|NCT00810615|450020605|FG000|Overall Study|Withdrawal by Subject|1|||
125108214|NCT00810615|450020606|FG001|Overall Study|Withdrawal by Subject|1|||
125108215|NCT02525562|450020607|FG000|Overall Study|Death|9|||
124894114|NCT00372567|449235755|FG002|Phase 3 Study|Objective progression or relapse|4|||
124894115|NCT00372567|449235753|FG000|Phase 3 Study|Global deterioration of health status|0|||
124894116|NCT00372567|449235754|FG001|Phase 3 Study|Global deterioration of health status|1|||
124894117|NCT00372567|449235755|FG002|Phase 3 Study|Global deterioration of health status|0|||
124894118|NCT00372567|449235753|FG000|Phase 3 Study|Other|2|||
124894119|NCT00372567|449235754|FG001|Phase 3 Study|Other|2|||
124894120|NCT00372567|449235755|FG002|Phase 3 Study|Other|1|||
124894121|NCT00372567|449235753|FG000|Phase 3 Study|study terminated by sponsor|13|||
124894122|NCT00372567|449235754|FG001|Phase 3 Study|study terminated by sponsor|8|||
124894123|NCT00372567|449235755|FG002|Phase 3 Study|study terminated by sponsor|5|||
124894124|NCT00303303|449235757|FG000|Overall Study|Withdrawal by Subject|0|||
124894125|NCT00303303|449235758|FG001|Overall Study|Withdrawal by Subject|0|||
124894126|NCT00303303|449235759|FG002|Overall Study|Withdrawal by Subject|1|||
124894127|NCT00582790|449235762|FG000|Overall Study|Rapid progression of disease|1|||
124894128|NCT00480441|449235763|FG000|Screening|Not Eligible|37|||
124894129|NCT00480441|449235764|FG001|Screening|Not Eligible|0|||
124894130|NCT00480441|449235765|FG002|Screening|Not Eligible|0|||
124894131|NCT00480441|449235763|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
124894132|NCT00480441|449235764|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
124894133|NCT00480441|449235765|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
125017934|NCT00763139|449691131|FG000|Overall Study|Withdrawal by Subject|0|||
125017935|NCT00763139|449691132|FG001|Overall Study|Withdrawal by Subject|1|||
125017936|NCT00763139|449691131|FG000|Overall Study|med change not allowed by protocol|1|||
125017937|NCT00763139|449691132|FG001|Overall Study|med change not allowed by protocol|0|||
125017938|NCT00179309|449691133|FG000|Treatment|Toxicity|2|||
125017939|NCT00179309|449691134|FG001|Treatment|Toxicity|3|||
125017940|NCT00179309|449691133|FG000|Treatment|Withdrawal by Subject|1|||
125017941|NCT00179309|449691134|FG001|Treatment|Withdrawal by Subject|2|||
125017942|NCT00179309|449691133|FG000|Treatment|Allergy|1|||
125017943|NCT00179309|449691134|FG001|Treatment|Allergy|0|||
125017944|NCT02363686|449691135|FG000|Overall Study|Withdrawal by Subject|22|||
125017945|NCT02363686|449691135|FG000|Overall Study|incomplete FEES examinations|13|||
125017946|NCT01709149|449691140|FG000|Open-label Lead-in Phase|Adverse Event|109|||
125017947|NCT01709149|449691141|FG001|Open-label Lead-in Phase|Adverse Event|0|||
125017948|NCT01709149|449691142|FG002|Open-label Lead-in Phase|Adverse Event|0|||
125017949|NCT01709149|449691140|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
125017950|NCT01709149|449691141|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
125017951|NCT01709149|449691142|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
125017952|NCT01709149|449691140|FG000|Open-label Lead-in Phase|Death|1|||
125017953|NCT01709149|449691141|FG001|Open-label Lead-in Phase|Death|0|||
125017954|NCT01709149|449691142|FG002|Open-label Lead-in Phase|Death|0|||
125017955|NCT01709149|449691140|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
125017956|NCT01709149|449691141|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
125017957|NCT01709149|449691142|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
125017958|NCT01709149|449691140|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
125108216|NCT02525562|450020608|FG001|Overall Study|Death|0|||
124894134|NCT00480441|449235763|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
125017959|NCT01709149|449691141|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
125017960|NCT01709149|449691142|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
125017961|NCT01709149|449691140|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
125017962|NCT01709149|449691141|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
125108217|NCT02525562|450020609|FG002|Overall Study|Death|0|||
125108218|NCT02525562|450020607|FG000|Overall Study|Lost to Follow-up|19|||
125108219|NCT02525562|450020608|FG001|Overall Study|Lost to Follow-up|0|||
125108220|NCT02525562|450020609|FG002|Overall Study|Lost to Follow-up|0|||
125108221|NCT02525562|450020607|FG000|Overall Study|Withdrawal by Subject|37|||
125108222|NCT02525562|450020608|FG001|Overall Study|Withdrawal by Subject|0|||
125108223|NCT02525562|450020609|FG002|Overall Study|Withdrawal by Subject|0|||
125108224|NCT02525562|450020607|FG000|Overall Study|Revision/Removal of Study Device|4|||
125108225|NCT02525562|450020608|FG001|Overall Study|Revision/Removal of Study Device|0|||
125108226|NCT02525562|450020609|FG002|Overall Study|Revision/Removal of Study Device|0|||
125108227|NCT02525562|450020607|FG000|Overall Study|Study Closed by Sponsor|154|||
125108228|NCT02525562|450020608|FG001|Overall Study|Study Closed by Sponsor|0|||
125108229|NCT02525562|450020609|FG002|Overall Study|Study Closed by Sponsor|0|||
125108230|NCT02567266|450020610|FG000|Overall Study|Withdrawal by Subject|10|||
125108231|NCT02567266|450020611|FG001|Overall Study|Withdrawal by Subject|7|||
125108232|NCT02567266|450020612|FG002|Overall Study|Withdrawal by Subject|6|||
125108233|NCT02567266|450020610|FG000|Overall Study|Lost to Follow-up|13|||
125108234|NCT02567266|450020611|FG001|Overall Study|Lost to Follow-up|8|||
125108235|NCT02567266|450020612|FG002|Overall Study|Lost to Follow-up|10|||
125108236|NCT02643966|450020613|FG000|First Screening Round|ineligible|1|||
125108237|NCT02643966|450020613|FG000|First Screening Round|excluded from analysis|2|||
125108238|NCT02643966|450020613|FG000|First Screening Round|Lost to Follow-up|56|||
125108239|NCT02643966|450020613|FG000|First Screening Round|Withdrawal by Subject|28|||
125108240|NCT02643966|450020613|FG000|First Screening Round|Death|1|||
125108241|NCT02643966|450020613|FG000|Between First and Second Screening|Lost to Follow-up|65|||
125108242|NCT02643966|450020613|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
125108243|NCT02643966|450020613|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
125108244|NCT02643966|450020613|FG000|Second Screening Round|Withdrawal by Subject|20|||
125108245|NCT02643966|450020613|FG000|Second Screening Round|Lost to Follow-up|57|||
125108246|NCT02643966|450020613|FG000|Second Screening Round|Physician Decision|2|||
125108247|NCT02643966|450020613|FG000|Second Screening Round|Death|4|||
125108248|NCT02643966|450020613|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
125108249|NCT02643966|450020613|FG000|Between Second and Third Screening|Death|1|||
125108250|NCT02643966|450020613|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
125108251|NCT02643966|450020613|FG000|Third Screening Round|PI excluded|2|||
125108252|NCT02643966|450020613|FG000|Third Screening Round|Lost to Follow-up|241|||
125108253|NCT03611751|450020618|FG000|Pre-treatment|Randomized but not treated|1|||
125108254|NCT03611751|450020619|FG001|Pre-treatment|Randomized but not treated|1|||
125108255|NCT03611751|450020620|FG002|Pre-treatment|Randomized but not treated|0|||
125108256|NCT03611751|450020618|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
125108257|NCT03611751|450020619|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
125108258|NCT03611751|450020620|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
125108259|NCT03611751|450020618|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
125108260|NCT03611751|450020619|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
125108261|NCT03611751|450020620|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
125108262|NCT03611751|450020618|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
125108263|NCT03611751|450020619|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
125108264|NCT03611751|450020620|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
125108265|NCT03611751|450020618|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
125108266|NCT03611751|450020619|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
124894135|NCT00480441|449235764|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
124894136|NCT00480441|449235765|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
124894137|NCT00480441|449235763|FG000|Baseline Functional MRI|physical contraindication|4|||
124894138|NCT00480441|449235764|FG001|Baseline Functional MRI|physical contraindication|0|||
124894139|NCT00480441|449235765|FG002|Baseline Functional MRI|physical contraindication|0|||
124894140|NCT00480441|449235763|FG000|Randomization|Lost to Follow-up|0|||
124894141|NCT00480441|449235764|FG001|Randomization|Lost to Follow-up|7|||
124894142|NCT00480441|449235765|FG002|Randomization|Lost to Follow-up|2|||
124894143|NCT01004263|449235777|FG000|Overall Study|Adverse Event|15|||
124894144|NCT01004263|449235777|FG000|Overall Study|Withdrawal by Subject|58|||
124894145|NCT01004263|449235777|FG000|Overall Study|Protocol Violation|10|||
124894146|NCT01004263|449235777|FG000|Overall Study|Lost to Follow-up|64|||
124894147|NCT01004263|449235777|FG000|Overall Study|Lack of Efficacy|13|||
125108267|NCT03611751|450020620|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
125108268|NCT03611751|450020618|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
125108269|NCT03611751|450020619|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
125108270|NCT03611751|450020620|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
125108271|NCT03611751|450020618|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
125108272|NCT03611751|450020619|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
125108273|NCT03611751|450020620|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
125108274|NCT03611751|450020618|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
125108275|NCT03611751|450020619|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
125108276|NCT03611751|450020620|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
125108277|NCT03611751|450020618|FG000|Treatment Week 0 - Week 16|Death|0|||
125108278|NCT03611751|450020619|FG001|Treatment Week 0 - Week 16|Death|0|||
125108279|NCT03611751|450020620|FG002|Treatment Week 0 - Week 16|Death|1|||
125108280|NCT03611751|450020618|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
125108281|NCT03611751|450020619|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
125108282|NCT03611751|450020620|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
125108283|NCT03611751|450020618|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
125108284|NCT03611751|450020619|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
125108285|NCT03611751|450020620|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
125108286|NCT03611751|450020618|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
125108287|NCT03611751|450020619|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
125108288|NCT03611751|450020620|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
125108289|NCT03611751|450020618|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
125108290|NCT03611751|450020619|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
125108291|NCT03611751|450020620|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
125108292|NCT03611751|450020618|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
125108293|NCT03611751|450020619|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
125108294|NCT03611751|450020620|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
125108295|NCT03611751|450020618|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
125108296|NCT03611751|450020619|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
125108297|NCT03611751|450020620|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
125108298|NCT03611751|450020618|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
125108299|NCT03611751|450020619|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
125108300|NCT03611751|450020620|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
125108301|NCT03611751|450020618|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
125108302|NCT03611751|450020619|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
125108303|NCT03611751|450020620|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
125108304|NCT03611751|450020618|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
125108305|NCT03611751|450020619|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
125108306|NCT03611751|450020620|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
125108307|NCT03611751|450020618|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
125108308|NCT03611751|450020619|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
125108309|NCT03611751|450020620|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
125108310|NCT03611751|450020618|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
125108311|NCT03611751|450020619|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
125108312|NCT03611751|450020620|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
125108313|NCT03611751|450020618|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
125108314|NCT03611751|450020619|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
125108315|NCT03611751|450020620|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
125108316|NCT03611751|450020618|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
125108317|NCT03611751|450020619|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
125108318|NCT03611751|450020620|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
125108319|NCT03611751|450020618|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
125108320|NCT03611751|450020619|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
125108321|NCT03611751|450020620|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
124894148|NCT01004263|449235777|FG000|Overall Study|Pregnancy|2|||
124894149|NCT01004263|449235777|FG000|Overall Study|Physician Decision|15|||
125017963|NCT01709149|449691142|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
125017964|NCT01709149|449691140|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
125017965|NCT01709149|449691141|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
125017966|NCT01709149|449691142|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
125017967|NCT01709149|449691140|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
125017968|NCT01709149|449691141|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
125017969|NCT01709149|449691142|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
125017970|NCT01709149|449691140|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
125017971|NCT01709149|449691141|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
125017972|NCT01709149|449691142|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
125017973|NCT01709149|449691140|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
125017974|NCT01709149|449691141|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
125017975|NCT01709149|449691142|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
125017976|NCT02192827|449691143|FG000|Overall Study|Lost to Follow-up|25|||
125108322|NCT02441179|450020621|FG000|Overall Study|Withdrawal by Subject|1|||
125108323|NCT02441179|450020622|FG001|Overall Study|Withdrawal by Subject|1|||
125108324|NCT02702271|450020623|FG000|Overall Study|Death|36|||
124894150|NCT01004263|449235777|FG000|Overall Study|Lack of Qualifying Event|2|||
124894151|NCT00958009|449235778|FG000|Overall Study|Adverse Event|1|||
125017977|NCT02192827|449691144|FG001|Overall Study|Lost to Follow-up|27|||
125017978|NCT02192827|449691143|FG000|Overall Study|Given additional steroids with admission|13|||
125108325|NCT02702271|450020624|FG001|Overall Study|Death|7|||
125108326|NCT02702271|450020623|FG000|Overall Study|Lost to Follow-up|12|||
124894152|NCT00958009|449235778|FG000|Overall Study|Subject found device difficult to use|1|||
124894153|NCT00558753|449235782|FG000|Overall Study|Lost to Follow-up|5|||
124894154|NCT00558753|449235783|FG001|Overall Study|Lost to Follow-up|7|||
124894155|NCT04668144|449235784|FG000|Overall Study|Protocol Violation|0|||
124894156|NCT04668144|449235785|FG001|Overall Study|Protocol Violation|1|||
124894157|NCT04668144|449235786|FG002|Overall Study|Protocol Violation|2|||
124894158|NCT02929108|449235787|FG000|Overall Study|Hospice patient death|100|||
124894159|NCT02929108|449235788|FG001|Overall Study|Hospice patient death|64|||
124894160|NCT02929108|449235789|FG002|Overall Study|Hospice patient death|28|||
124894161|NCT02929108|449235790|FG003|Overall Study|Hospice patient death|46|||
124894162|NCT02929108|449235791|FG004|Overall Study|Hospice patient death|55|||
124894163|NCT02929108|449235792|FG005|Overall Study|Hospice patient death|28|||
124894164|NCT02929108|449235793|FG006|Overall Study|Hospice patient death|78|||
124894165|NCT01027871|449235794|FG000|Overall Study|Physician Decision|1|||
124894166|NCT01027871|449235795|FG001|Overall Study|Physician Decision|5|||
124894167|NCT01027871|449235796|FG002|Overall Study|Physician Decision|0|||
124894168|NCT01027871|449235794|FG000|Overall Study|Protocol Violation|0|||
124894169|NCT01027871|449235795|FG001|Overall Study|Protocol Violation|2|||
124894170|NCT01027871|449235796|FG002|Overall Study|Protocol Violation|2|||
124894171|NCT01027871|449235794|FG000|Overall Study|Withdrawal by Subject|1|||
124894172|NCT01027871|449235795|FG001|Overall Study|Withdrawal by Subject|2|||
124894173|NCT01027871|449235796|FG002|Overall Study|Withdrawal by Subject|2|||
124894174|NCT01027871|449235794|FG000|Overall Study|Adverse Event|0|||
124894175|NCT01027871|449235795|FG001|Overall Study|Adverse Event|2|||
124894176|NCT01027871|449235796|FG002|Overall Study|Adverse Event|2|||
124894177|NCT01027871|449235794|FG000|Overall Study|Sponsor Decision|0|||
124894178|NCT01027871|449235795|FG001|Overall Study|Sponsor Decision|2|||
124894179|NCT01027871|449235796|FG002|Overall Study|Sponsor Decision|0|||
124894180|NCT01027871|449235794|FG000|Overall Study|Discontinued Prior to Treatment|0|||
124894181|NCT01027871|449235795|FG001|Overall Study|Discontinued Prior to Treatment|0|||
124894182|NCT01027871|449235796|FG002|Overall Study|Discontinued Prior to Treatment|1|||
124894183|NCT01414166|449235797|FG000|Overall Study|Adverse Event|10|||
124894184|NCT01414166|449235798|FG001|Overall Study|Adverse Event|2|||
124894185|NCT01414166|449235797|FG000|Overall Study|Lost to Follow-up|4|||
124894186|NCT01414166|449235798|FG001|Overall Study|Lost to Follow-up|1|||
124894187|NCT01414166|449235797|FG000|Overall Study|Non-compliance with study drug|2|||
124894188|NCT01414166|449235798|FG001|Overall Study|Non-compliance with study drug|0|||
124894189|NCT01414166|449235797|FG000|Overall Study|Physician Decision|2|||
124894190|NCT01414166|449235798|FG001|Overall Study|Physician Decision|0|||
124894191|NCT01414166|449235797|FG000|Overall Study|Protocol Violation|2|||
124894192|NCT01414166|449235798|FG001|Overall Study|Protocol Violation|0|||
124894193|NCT01414166|449235797|FG000|Overall Study|Study terminated by Sponsor|68|||
124894194|NCT01414166|449235798|FG001|Overall Study|Study terminated by Sponsor|75|||
124894195|NCT01414166|449235797|FG000|Overall Study|Withdrawal by Subject|3|||
124894196|NCT01414166|449235798|FG001|Overall Study|Withdrawal by Subject|5|||
124894197|NCT03782727|449235799|FG000|Overall Study|Lost to Follow-up|32|||
124894198|NCT02084082|449235802|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
124894199|NCT02084082|449235803|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
124894200|NCT02084082|449235804|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
124894201|NCT02084082|449235805|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
124894202|NCT02084082|449235802|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
124894203|NCT02084082|449235803|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
124894204|NCT02084082|449235804|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
124894205|NCT02084082|449235805|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
124894206|NCT05705167|449235806|FG000|Overall Study|Randomised but not Treated|0|||
124894207|NCT05705167|449235807|FG001|Overall Study|Randomised but not Treated|2|||
124894208|NCT05705167|449235808|FG002|Overall Study|Randomised but not Treated|0|||
124894209|NCT05705167|449235809|FG003|Overall Study|Randomised but not Treated|7|||
124894210|NCT05705167|449235810|FG004|Overall Study|Randomised but not Treated|0|||
124894211|NCT05705167|449235811|FG005|Overall Study|Randomised but not Treated|0|||
124894212|NCT05705167|449235812|FG006|Overall Study|Randomised but not Treated|0|||
124894213|NCT05705167|449235806|FG000|Overall Study|Death|0|||
124894214|NCT05705167|449235807|FG001|Overall Study|Death|0|||
124894215|NCT05705167|449235808|FG002|Overall Study|Death|3|||
124894216|NCT05705167|449235809|FG003|Overall Study|Death|0|||
124894217|NCT05705167|449235810|FG004|Overall Study|Death|1|||
124894218|NCT05705167|449235811|FG005|Overall Study|Death|1|||
124894219|NCT05705167|449235812|FG006|Overall Study|Death|1|||
124894220|NCT05705167|449235806|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
124894221|NCT05705167|449235807|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
124894222|NCT05705167|449235808|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
124894223|NCT05705167|449235809|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
124894224|NCT05705167|449235810|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
124894225|NCT05705167|449235811|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
124894226|NCT05705167|449235812|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
124894227|NCT04736056|449235813|FG000|Overall Study|Death|0|||
124894228|NCT04736056|449235814|FG001|Overall Study|Death|0|||
124894229|NCT04736056|449235815|FG002|Overall Study|Death|0|||
124894230|NCT04736056|449235816|FG003|Overall Study|Death|1|||
124894231|NCT04736056|449235813|FG000|Overall Study|Lost to Follow-up|1|||
124894232|NCT04736056|449235814|FG001|Overall Study|Lost to Follow-up|0|||
124894233|NCT04736056|449235815|FG002|Overall Study|Lost to Follow-up|1|||
124894234|NCT04736056|449235816|FG003|Overall Study|Lost to Follow-up|1|||
124894235|NCT04736056|449235813|FG000|Overall Study|Withdrawal by Subject|2|||
124894236|NCT04736056|449235814|FG001|Overall Study|Withdrawal by Subject|0|||
124894237|NCT04736056|449235815|FG002|Overall Study|Withdrawal by Subject|0|||
124894238|NCT04736056|449235816|FG003|Overall Study|Withdrawal by Subject|0|||
124894239|NCT04736056|449235813|FG000|Overall Study|Physician Decision|1|||
124894240|NCT04736056|449235814|FG001|Overall Study|Physician Decision|0|||
124894241|NCT04736056|449235815|FG002|Overall Study|Physician Decision|1|||
124894242|NCT04736056|449235816|FG003|Overall Study|Physician Decision|0|||
124894243|NCT02099539|449235823|FG000|Overall Study|Progressive Disease|3|||
124894244|NCT02099539|449235824|FG001|Overall Study|Progressive Disease|2|||
124894245|NCT02099539|449235825|FG002|Overall Study|Progressive Disease|2|||
124894246|NCT02099539|449235826|FG003|Overall Study|Progressive Disease|1|||
124894247|NCT02099539|449235827|FG004|Overall Study|Progressive Disease|4|||
124894248|NCT02099539|449235828|FG005|Overall Study|Progressive Disease|2|||
124894249|NCT02099539|449235829|FG006|Overall Study|Progressive Disease|0|||
124894250|NCT02099539|449235823|FG000|Overall Study|Adverse Event|0|||
124894251|NCT02099539|449235824|FG001|Overall Study|Adverse Event|0|||
124894252|NCT02099539|449235825|FG002|Overall Study|Adverse Event|1|||
124894253|NCT02099539|449235826|FG003|Overall Study|Adverse Event|1|||
124894254|NCT02099539|449235827|FG004|Overall Study|Adverse Event|0|||
124894255|NCT02099539|449235828|FG005|Overall Study|Adverse Event|0|||
124894256|NCT02099539|449235829|FG006|Overall Study|Adverse Event|0|||
124894257|NCT02099539|449235823|FG000|Overall Study|Physician Decision|0|||
124894258|NCT02099539|449235824|FG001|Overall Study|Physician Decision|0|||
124894259|NCT02099539|449235825|FG002|Overall Study|Physician Decision|0|||
124894260|NCT02099539|449235826|FG003|Overall Study|Physician Decision|0|||
124894261|NCT02099539|449235827|FG004|Overall Study|Physician Decision|0|||
125108327|NCT02702271|450020624|FG001|Overall Study|Lost to Follow-up|0|||
124894262|NCT02099539|449235828|FG005|Overall Study|Physician Decision|1|||
124894263|NCT02099539|449235829|FG006|Overall Study|Physician Decision|0|||
124894264|NCT02956967|449235831|FG000|Overall Study|Adverse Event|3|||
124894265|NCT02956967|449235831|FG000|Overall Study|Reason non-related to neutropenia|10|||
124894266|NCT02956967|449235831|FG000|Overall Study|Lost to Follow-up|5|||
124894267|NCT02956967|449235831|FG000|Overall Study|Missing|1|||
124894268|NCT02956967|449235831|FG000|Overall Study|Termination of Nivestim administration|29|||
124894269|NCT01823341|449235840|FG000|Overall Study|Failed run-in|7|||
124894270|NCT01823341|449235840|FG000|Overall Study|Withdrawal by Subject|7|||
124894271|NCT01823341|449235840|FG000|Overall Study|Adverse Event|1|||
124894272|NCT02027935|449235841|FG000|Overall Study|Death|1|||
124894273|NCT02027935|449235841|FG000|Overall Study|Lack of Efficacy|5|||
124894274|NCT02027935|449235841|FG000|Overall Study|Study Closure|1|||
124894275|NCT03590743|449235842|FG000|Overall Study|Withdrawal by Subject|0|||
124894276|NCT03590743|449235843|FG001|Overall Study|Withdrawal by Subject|1|||
124894277|NCT00604786|449235844|FG000|Overall Study|Lost to Follow-up|2|||
124894278|NCT00604786|449235845|FG001|Overall Study|Lost to Follow-up|0|||
124894279|NCT02698436|449235846|FG000|Overall Study|Adverse Event|1|||
124894280|NCT02698436|449235847|FG001|Overall Study|Adverse Event|0|||
124894281|NCT02698436|449235846|FG000|Overall Study|Withdrawal by Subject|3|||
124894282|NCT02698436|449235847|FG001|Overall Study|Withdrawal by Subject|3|||
124894283|NCT02698436|449235846|FG000|Overall Study|Lost to Follow-up|2|||
124894284|NCT02698436|449235847|FG001|Overall Study|Lost to Follow-up|4|||
124894285|NCT02698436|449235846|FG000|Overall Study|Non-compliance with study regimen|1|||
124894286|NCT02698436|449235847|FG001|Overall Study|Non-compliance with study regimen|0|||
124894287|NCT01394991|449235848|FG000|Overall Study|Adverse Event|0|||
124894288|NCT01394991|449235849|FG001|Overall Study|Adverse Event|4|||
124894289|NCT01394991|449235848|FG000|Overall Study|Lack of Efficacy|5|||
124894290|NCT01394991|449235849|FG001|Overall Study|Lack of Efficacy|7|||
124894291|NCT01394991|449235848|FG000|Overall Study|Lost to Follow-up|6|||
124894292|NCT01394991|449235849|FG001|Overall Study|Lost to Follow-up|8|||
124894293|NCT01394991|449235848|FG000|Overall Study|Physician Decision|1|||
124894294|NCT01394991|449235849|FG001|Overall Study|Physician Decision|3|||
124894295|NCT01394991|449235848|FG000|Overall Study|Protocol Violation|1|||
124894296|NCT01394991|449235849|FG001|Overall Study|Protocol Violation|1|||
124894297|NCT01394991|449235848|FG000|Overall Study|Withdrawal by Subject|20|||
124894298|NCT01394991|449235849|FG001|Overall Study|Withdrawal by Subject|17|||
124894299|NCT01394991|449235848|FG000|Overall Study|Chemotherapy Termination|10|||
124894300|NCT01394991|449235849|FG001|Overall Study|Chemotherapy Termination|15|||
124894301|NCT01394991|449235848|FG000|Overall Study|Disease Progression|7|||
124894302|NCT01394991|449235849|FG001|Overall Study|Disease Progression|7|||
124894303|NCT01394991|449235848|FG000|Overall Study|Prematurely Termination of Trial|9|||
124894304|NCT01394991|449235849|FG001|Overall Study|Prematurely Termination of Trial|10|||
124894305|NCT03073005|449235850|FG000|Overall Study|Death|6|||
124894306|NCT03073005|449235851|FG001|Overall Study|Death|0|||
124894307|NCT03073005|449235852|FG002|Overall Study|Death|7|||
124894308|NCT03073005|449235853|FG003|Overall Study|Death|0|||
124894309|NCT03073005|449235850|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
124894310|NCT03073005|449235851|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
124894311|NCT03073005|449235852|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
124894312|NCT03073005|449235853|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
124894313|NCT03073005|449235850|FG000|Overall Study|Lost to Follow-up|2|||
124894314|NCT03073005|449235851|FG001|Overall Study|Lost to Follow-up|2|||
124894315|NCT03073005|449235852|FG002|Overall Study|Lost to Follow-up|1|||
124894316|NCT03073005|449235853|FG003|Overall Study|Lost to Follow-up|2|||
124894317|NCT03073005|449235850|FG000|Overall Study|Withdrawal by Subject|0|||
124894318|NCT03073005|449235851|FG001|Overall Study|Withdrawal by Subject|4|||
124894319|NCT03073005|449235852|FG002|Overall Study|Withdrawal by Subject|4|||
124894320|NCT03073005|449235853|FG003|Overall Study|Withdrawal by Subject|4|||
125017979|NCT02192827|449691144|FG001|Overall Study|Given additional steroids with admission|11|||
125017980|NCT02941627|449691162|FG000|Overall Study|Death|1|||
125017981|NCT02941627|449691162|FG000|Overall Study|Surgical failure|1|||
125017982|NCT02941627|449691162|FG000|Overall Study|cholesteatoma prevented implantation|1|||
125017983|NCT03594227|449691163|FG000|Overall Study|Adverse Event|2|||
124894321|NCT00725010|449235863|FG000|Overall Study|Toxicity|9|||
125017984|NCT03594227|449691164|FG001|Overall Study|Adverse Event|1|||
124894322|NCT00725010|449235863|FG000|Overall Study|Tumor Progression|7|||
124894323|NCT00725010|449235863|FG000|Overall Study|Withdrawal by Subject|2|||
124894324|NCT00725010|449235863|FG000|Overall Study|Death|1|||
124894325|NCT00725010|449235863|FG000|Overall Study|Lost to Follow-up|1|||
124894326|NCT00725010|449235863|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
124894327|NCT00725010|449235863|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
125017985|NCT03594227|449691165|FG002|Overall Study|Adverse Event|0|||
124894328|NCT00725010|449235863|FG000|Overall Study|No further documentation|1|||
124894329|NCT00725010|449235863|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
124894330|NCT01290094|449235864|FG000|Overall Study|Withdrawal by Subject|1|||
124894331|NCT01290094|449235864|FG000|Overall Study|Lost to Follow-up|5|||
124894332|NCT02414828|449235865|FG000|Overall Study|Lost to Follow-up|0|||
124894333|NCT02414828|449235866|FG001|Overall Study|Lost to Follow-up|1|||
124894334|NCT02414828|449235867|FG002|Overall Study|Lost to Follow-up|1|||
124894335|NCT02414828|449235868|FG003|Overall Study|Lost to Follow-up|2|||
124894336|NCT04949399|449235869|FG000|Overall Study|Lost to Follow-up|11|||
124894337|NCT04949399|449235870|FG001|Overall Study|Lost to Follow-up|6|||
124894338|NCT04949399|449235869|FG000|Overall Study|Withdrawal by Subject|2|||
124894339|NCT04949399|449235870|FG001|Overall Study|Withdrawal by Subject|3|||
124894340|NCT04091672|449237620|FG000|Overall Study|Death|6|||
124894341|NCT04091672|449237621|FG001|Overall Study|Death|6|||
125108328|NCT02702271|450020623|FG000|Overall Study|Withdrawal by Subject|8|||
125108329|NCT02702271|450020624|FG001|Overall Study|Withdrawal by Subject|1|||
125108330|NCT02702271|450020623|FG000|Overall Study|Physician Decision|2|||
125108331|NCT02702271|450020624|FG001|Overall Study|Physician Decision|0|||
125108332|NCT02702271|450020623|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
125108333|NCT02702271|450020624|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
125108334|NCT03091400|450020625|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
125108335|NCT03091400|450020626|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
125108336|NCT00051636|450020627|FG000|Period 1 - Core|Adverse Event|2|||
125108337|NCT00051636|450020628|FG001|Period 1 - Core|Adverse Event|2|||
125108338|NCT00051636|450020627|FG000|Period 1 - Core|Protocol Violation|1|||
125108339|NCT00051636|450020628|FG001|Period 1 - Core|Protocol Violation|0|||
125108340|NCT00051636|450020627|FG000|Period 1 - Core|Withdrawal by Subject|1|||
125108341|NCT00051636|450020628|FG001|Period 1 - Core|Withdrawal by Subject|2|||
125108342|NCT00051636|450020627|FG000|Period 1 - Core|Lost to Follow-up|0|||
125108343|NCT00051636|450020628|FG001|Period 1 - Core|Lost to Follow-up|2|||
125108344|NCT00051636|450020627|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
125108345|NCT00051636|450020628|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
125108346|NCT00051636|450020627|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
125108347|NCT00051636|450020628|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
125108348|NCT00051636|450020627|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
125108349|NCT00051636|450020628|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
125108350|NCT00051636|450020627|FG000|Period 2- Extended Observation Period|Death|4|||
125108351|NCT00051636|450020628|FG001|Period 2- Extended Observation Period|Death|5|||
125108352|NCT00051636|450020627|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
125108353|NCT00051636|450020628|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
125108354|NCT00479765|450020629|FG000|Overall Study|study terminated|4|||
125108355|NCT03056001|450020632|FG000|Overall Study|Death|24|||
125108356|NCT01364298|450020633|FG000|Overall Study|Adverse Event|3|||
125108357|NCT01364298|450020634|FG001|Overall Study|Adverse Event|4|||
125108358|NCT01364298|450020633|FG000|Overall Study|Lack of adherence to treatment|1|||
125108359|NCT01364298|450020634|FG001|Overall Study|Lack of adherence to treatment|3|||
125108360|NCT01364298|450020633|FG000|Overall Study|Lack of Efficacy|1|||
125108361|NCT01364298|450020634|FG001|Overall Study|Lack of Efficacy|0|||
125108362|NCT01364298|450020633|FG000|Overall Study|Lost to Follow-up|5|||
125108363|NCT01364298|450020634|FG001|Overall Study|Lost to Follow-up|10|||
125108364|NCT01364298|450020633|FG000|Overall Study|Withdrawal by Subject|3|||
125108365|NCT01364298|450020634|FG001|Overall Study|Withdrawal by Subject|3|||
125108366|NCT01364298|450020633|FG000|Overall Study|Other|1|||
125108367|NCT01364298|450020634|FG001|Overall Study|Other|3|||
125108368|NCT03707522|450020637|FG000|Overall Study|Lost to Follow-up|24|||
125108369|NCT03707522|450020638|FG001|Overall Study|Lost to Follow-up|27|||
125108370|NCT03707522|450020639|FG002|Overall Study|Lost to Follow-up|41|||
125108371|NCT03707522|450020640|FG003|Overall Study|Lost to Follow-up|36|||
125108372|NCT00420849|450020641|FG000|Overall Study|Lack of Efficacy|154|||
125108373|NCT00420849|450020641|FG000|Overall Study|Adverse Event|107|||
125108374|NCT00420849|450020641|FG000|Overall Study|Withdrawal by Subject|28|||
125108375|NCT00420849|450020641|FG000|Overall Study|Death|18|||
125108376|NCT00420849|450020641|FG000|Overall Study|Other|14|||
125108377|NCT00420849|450020641|FG000|Overall Study|Transplant|8|||
125108378|NCT00420849|450020641|FG000|Overall Study|Protocol Violation|1|||
125108379|NCT00420849|450020641|FG000|Overall Study|Lost to Follow-up|1|||
125108380|NCT00659581|450020642|FG000|Overall Study|Adverse Event|1006|||
125108381|NCT00659581|450020642|FG000|Overall Study|Lack of Efficacy|1183|||
125108382|NCT00659581|450020642|FG000|Overall Study|Other|6393|||
125108383|NCT00944125|450020648|FG000|3 to 6 Months|Withdrawal by Subject|0|||
124894342|NCT04091672|449237620|FG000|Overall Study|Lost to Follow-up|7|||
124894343|NCT04091672|449237621|FG001|Overall Study|Lost to Follow-up|7|||
124894344|NCT04091672|449237620|FG000|Overall Study|Withdrawal by Subject|3|||
125108384|NCT00944125|450020649|FG001|3 to 6 Months|Withdrawal by Subject|2|||
125108385|NCT00944125|450020648|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
125108386|NCT00944125|450020649|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
125108387|NCT00446134|450020650|FG000|Overall Study|Adverse Event|7|||
125108388|NCT00446134|450020651|FG001|Overall Study|Adverse Event|17|||
125108389|NCT00446134|450020652|FG002|Overall Study|Adverse Event|13|||
125108390|NCT00446134|450020653|FG003|Overall Study|Adverse Event|18|||
125108391|NCT00446134|450020650|FG000|Overall Study|Lack of Efficacy|19|||
124894345|NCT04091672|449237621|FG001|Overall Study|Withdrawal by Subject|3|||
124894346|NCT04091672|449237620|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
124894347|NCT04091672|449237621|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
124894348|NCT05296629|449237622|FG000|Overall Study|Withdrawal by Subject|3|||
124894349|NCT05296629|449237623|FG001|Overall Study|Withdrawal by Subject|10|||
124894350|NCT05296629|449237624|FG002|Overall Study|Withdrawal by Subject|4|||
124894351|NCT05296629|449237622|FG000|Overall Study|Lost to Follow-up|2|||
124894352|NCT05296629|449237623|FG001|Overall Study|Lost to Follow-up|7|||
124894353|NCT05296629|449237624|FG002|Overall Study|Lost to Follow-up|1|||
124894354|NCT05296629|449237622|FG000|Overall Study|Adverse Event|0|||
124894355|NCT05296629|449237623|FG001|Overall Study|Adverse Event|4|||
124894356|NCT05296629|449237624|FG002|Overall Study|Adverse Event|2|||
124894357|NCT05296629|449237622|FG000|Overall Study|Protocol Violation|0|||
124894358|NCT05296629|449237623|FG001|Overall Study|Protocol Violation|2|||
124894359|NCT05296629|449237624|FG002|Overall Study|Protocol Violation|0|||
124894360|NCT02401529|449237627|FG000|Overall Study|Lost to Follow-up|2|||
124894361|NCT02401529|449237628|FG001|Overall Study|Lost to Follow-up|1|||
124894362|NCT02401529|449237627|FG000|Overall Study|Physician Decision|2|||
124894363|NCT02401529|449237628|FG001|Overall Study|Physician Decision|6|||
124894364|NCT02401529|449237627|FG000|Overall Study|Protocol Violation|5|||
124894365|NCT02401529|449237628|FG001|Overall Study|Protocol Violation|0|||
124894366|NCT02949271|449237633|FG000|Overall Study|Lack of Efficacy|5|||
124894367|NCT02949271|449237634|FG001|Overall Study|Lack of Efficacy|4|||
124894368|NCT02949271|449237633|FG000|Overall Study|Lost to Follow-up|3|||
124894369|NCT02949271|449237634|FG001|Overall Study|Lost to Follow-up|6|||
124894370|NCT02949271|449237633|FG000|Overall Study|Physician Decision|5|||
124894371|NCT02949271|449237634|FG001|Overall Study|Physician Decision|5|||
124894372|NCT02949271|449237633|FG000|Overall Study|Protocol Violation|6|||
124894373|NCT02949271|449237634|FG001|Overall Study|Protocol Violation|3|||
124894374|NCT02949271|449237633|FG000|Overall Study|Withdrawal by Subject|1|||
124894375|NCT02949271|449237634|FG001|Overall Study|Withdrawal by Subject|0|||
124894376|NCT02949271|449237633|FG000|Overall Study|Delivered prior to intervention|7|||
124894377|NCT02949271|449237634|FG001|Overall Study|Delivered prior to intervention|9|||
124894378|NCT02949271|449237633|FG000|Overall Study|Outside the window for cervical dilation|2|||
124894379|NCT02949271|449237634|FG001|Overall Study|Outside the window for cervical dilation|3|||
124894380|NCT01684046|449237635|FG000|Period 1, First 30 Days|Adverse Event|0|||
124894381|NCT01684046|449237636|FG001|Period 1, First 30 Days|Adverse Event|2|||
124894382|NCT01097655|449237637|FG000|Overall Study|Withdrawal by Subject|1|||
124894383|NCT01097655|449237637|FG000|Overall Study|Subject Documented Twice|1|||
124894384|NCT01097655|449237637|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
124894385|NCT05458102|449237638|FG000|Overall Study|Withdrew consent|2|||
124894386|NCT05458102|449237639|FG001|Overall Study|Withdrew consent|0|||
124894387|NCT05458102|449237638|FG000|Overall Study|Adverse Event|1|||
124894388|NCT05458102|449237639|FG001|Overall Study|Adverse Event|0|||
124894389|NCT05458102|449237638|FG000|Overall Study|Enrolled but never treated|1|||
124894390|NCT05458102|449237639|FG001|Overall Study|Enrolled but never treated|0|||
124894391|NCT05458102|449237638|FG000|Overall Study|Protocol Violation|1|||
124894392|NCT05458102|449237639|FG001|Overall Study|Protocol Violation|0|||
125017986|NCT03594227|449691166|FG003|Overall Study|Adverse Event|2|||
125017987|NCT03594227|449691163|FG000|Overall Study|Lost to Follow-up|1|||
125017988|NCT03594227|449691164|FG001|Overall Study|Lost to Follow-up|1|||
125017989|NCT03594227|449691165|FG002|Overall Study|Lost to Follow-up|1|||
125017990|NCT03594227|449691166|FG003|Overall Study|Lost to Follow-up|0|||
125017991|NCT03594227|449691163|FG000|Overall Study|Withdrawal by Subject|1|||
125017992|NCT03594227|449691164|FG001|Overall Study|Withdrawal by Subject|1|||
125017993|NCT03594227|449691165|FG002|Overall Study|Withdrawal by Subject|1|||
125017994|NCT03594227|449691166|FG003|Overall Study|Withdrawal by Subject|1|||
125017995|NCT03594227|449691163|FG000|Overall Study|Pregnancy|0|||
125017996|NCT03594227|449691164|FG001|Overall Study|Pregnancy|1|||
125017997|NCT03594227|449691165|FG002|Overall Study|Pregnancy|0|||
125017998|NCT03594227|449691166|FG003|Overall Study|Pregnancy|0|||
125017999|NCT03594227|449691163|FG000|Overall Study|Sponsor Decision|0|||
125018000|NCT03594227|449691164|FG001|Overall Study|Sponsor Decision|0|||
125018001|NCT03594227|449691165|FG002|Overall Study|Sponsor Decision|0|||
125018002|NCT03594227|449691166|FG003|Overall Study|Sponsor Decision|1|||
125018003|NCT03594227|449691163|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
125018004|NCT03594227|449691164|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
125018005|NCT03594227|449691165|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
125108392|NCT00446134|450020651|FG001|Overall Study|Lack of Efficacy|19|||
124894393|NCT03303105|449237640|FG000|Overall Study|Adverse Event|0|||
124894394|NCT03303105|449237641|FG001|Overall Study|Adverse Event|2|||
124894395|NCT03303105|449237640|FG000|Overall Study|Lack of Efficacy|1|||
124894396|NCT03303105|449237641|FG001|Overall Study|Lack of Efficacy|0|||
124894397|NCT03303105|449237640|FG000|Overall Study|Protocol Violation|1|||
124894398|NCT03303105|449237641|FG001|Overall Study|Protocol Violation|0|||
124894399|NCT03303105|449237640|FG000|Overall Study|Withdrawal by Subject|0|||
124894400|NCT03303105|449237641|FG001|Overall Study|Withdrawal by Subject|2|||
124894401|NCT02790606|449237650|FG000|Overall Study|Death|27|||
124894402|NCT02790606|449237650|FG000|Overall Study|Lost to Follow-up|4|||
125018006|NCT03594227|449691166|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
125018007|NCT00790907|449691167|FG000|Overall Study|Adverse Event|9|||
125018008|NCT00790907|449691168|FG001|Overall Study|Adverse Event|7|||
125018009|NCT00790907|449691169|FG002|Overall Study|Adverse Event|6|||
124894403|NCT02790606|449237650|FG000|Overall Study|Physician Decision|3|||
124894404|NCT02790606|449237650|FG000|Overall Study|Withdrawal by Subject|1|||
124894405|NCT02735915|449237651|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
124894406|NCT02735915|449237651|FG000|Overall Study|Withdrawal following SAE|2|||
124894407|NCT02735915|449237651|FG000|Overall Study|Withdrawal by Subject|1|||
124894408|NCT01789203|449237652|FG000|Overall Study|Adverse Event|2|||
124894409|NCT01789203|449237653|FG001|Overall Study|Adverse Event|2|||
124894410|NCT01789203|449237652|FG000|Overall Study|Withdrawal by Subject|1|||
124894411|NCT01789203|449237653|FG001|Overall Study|Withdrawal by Subject|0|||
124894412|NCT01789203|449237652|FG000|Overall Study|Death|1|||
124894413|NCT01789203|449237653|FG001|Overall Study|Death|0|||
124894414|NCT01789203|449237652|FG000|Overall Study|Protocol Violation|2|||
124894415|NCT01789203|449237653|FG001|Overall Study|Protocol Violation|1|||
124894416|NCT01789203|449237652|FG000|Overall Study|Other|1|||
124894417|NCT01789203|449237653|FG001|Overall Study|Other|1|||
124894418|NCT01789203|449237652|FG000|Overall Study|patient non-adherent|2|||
124894419|NCT01789203|449237653|FG001|Overall Study|patient non-adherent|0|||
124894420|NCT03929302|449237659|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
124894421|NCT03929302|449237660|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
124894422|NCT03929302|449237661|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
124894423|NCT03929302|449237659|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
124894424|NCT03929302|449237660|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
124894425|NCT03929302|449237661|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
124894426|NCT03929302|449237659|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
124894427|NCT03929302|449237660|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
124894428|NCT03929302|449237661|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
124894429|NCT01123161|449237665|FG000|Overall Study|Lost to Follow-up|1|||
124894430|NCT01123161|449237666|FG001|Overall Study|Lost to Follow-up|0|||
124894431|NCT01123161|449237665|FG000|Overall Study|Withdrawal by Subject|1|||
124894432|NCT01123161|449237666|FG001|Overall Study|Withdrawal by Subject|0|||
124894433|NCT00051311|449237669|FG000|Overall Study|Starting new study|0|||
124894434|NCT00051311|449237670|FG001|Overall Study|Starting new study|1|||
124894435|NCT00051311|449237669|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
124894436|NCT00051311|449237670|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
124894437|NCT00051311|449237669|FG000|Overall Study|Death of recipient|8|||
124894438|NCT00051311|449237670|FG001|Overall Study|Death of recipient|8|||
124894439|NCT00051311|449237669|FG000|Overall Study|Recipient taken off study|4|||
124894440|NCT00051311|449237670|FG001|Overall Study|Recipient taken off study|4|||
124894441|NCT00821236|449237674|FG000|Overall Study|Lost to Follow-up|3|||
124894442|NCT00578227|449237677|FG000|Overall Study|Lost to Follow-up|0|||
124894443|NCT00578227|449237678|FG001|Overall Study|Lost to Follow-up|1|||
124894444|NCT00578227|449237679|FG002|Overall Study|Lost to Follow-up|1|||
125018010|NCT00790907|449691167|FG000|Overall Study|Physician Decision|304|||
125018011|NCT00790907|449691168|FG001|Overall Study|Physician Decision|271|||
125018012|NCT00790907|449691169|FG002|Overall Study|Physician Decision|255|||
125018013|NCT00790907|449691167|FG000|Overall Study|Withdrawal by Subject|1|||
125018014|NCT00790907|449691168|FG001|Overall Study|Withdrawal by Subject|7|||
125018015|NCT00790907|449691169|FG002|Overall Study|Withdrawal by Subject|5|||
125018016|NCT00790907|449691167|FG000|Overall Study|Bleeding Event|11|||
125018017|NCT00790907|449691168|FG001|Overall Study|Bleeding Event|16|||
125018018|NCT00790907|449691169|FG002|Overall Study|Bleeding Event|21|||
125018019|NCT00790907|449691167|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
125018020|NCT00790907|449691168|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
125018021|NCT00790907|449691169|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
125018022|NCT00790907|449691167|FG000|Overall Study|Qualifying Condition Not Present|29|||
125018023|NCT00790907|449691168|FG001|Overall Study|Qualifying Condition Not Present|14|||
125018024|NCT00790907|449691169|FG002|Overall Study|Qualifying Condition Not Present|16|||
125018025|NCT00790907|449691167|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
125018026|NCT00790907|449691168|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
125108393|NCT00446134|450020652|FG002|Overall Study|Lack of Efficacy|24|||
124894445|NCT00578227|449237677|FG000|Overall Study|Withdrawal by Subject|5|||
124894446|NCT00578227|449237678|FG001|Overall Study|Withdrawal by Subject|1|||
124894447|NCT00578227|449237679|FG002|Overall Study|Withdrawal by Subject|3|||
124894448|NCT00577629|449237680|FG000|Treatment Period|Death|1|||
124894449|NCT00577629|449237680|FG000|Long Term Follow-Up|Death|15|||
124894450|NCT00577629|449237680|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
124894451|NCT00577629|449237680|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
124894452|NCT00577629|449237680|FG000|Long Term Follow-Up|Physician Decision|1|||
124894453|NCT01605136|449237683|FG000|Study Period|Withdrawal by Subject|2|||
124894454|NCT01605136|449237684|FG001|Study Period|Withdrawal by Subject|0|||
124894455|NCT01605136|449237683|FG000|Study Period|Physician Decision|1|||
124894456|NCT01605136|449237684|FG001|Study Period|Physician Decision|1|||
124894457|NCT01605136|449237683|FG000|Study Period|Lost to Follow-up|0|||
125018027|NCT00790907|449691169|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
124894458|NCT01605136|449237684|FG001|Study Period|Lost to Follow-up|2|||
124894459|NCT01605136|449237683|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
124894460|NCT01605136|449237684|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
124894461|NCT01072929|449237685|FG000|Overall Study|Adverse Event|8|||
124894462|NCT01072929|449237686|FG001|Overall Study|Adverse Event|11|||
124894463|NCT01072929|449237687|FG002|Overall Study|Adverse Event|2|||
124894464|NCT01072929|449237685|FG000|Overall Study|Lack of Efficacy|7|||
124894465|NCT01072929|449237686|FG001|Overall Study|Lack of Efficacy|4|||
124894466|NCT01072929|449237687|FG002|Overall Study|Lack of Efficacy|0|||
124894467|NCT01072929|449237685|FG000|Overall Study|Withdrawal by Subject|7|||
124894468|NCT01072929|449237686|FG001|Overall Study|Withdrawal by Subject|15|||
124894469|NCT01072929|449237687|FG002|Overall Study|Withdrawal by Subject|3|||
124894470|NCT01072929|449237685|FG000|Overall Study|Protocol Violation|13|||
124894471|NCT01072929|449237686|FG001|Overall Study|Protocol Violation|11|||
124894472|NCT01072929|449237687|FG002|Overall Study|Protocol Violation|2|||
124894473|NCT01072929|449237685|FG000|Overall Study|Lost to Follow-up|8|||
124894474|NCT01072929|449237686|FG001|Overall Study|Lost to Follow-up|4|||
125018028|NCT00790907|449691167|FG000|Overall Study|Did Not Receive Study Drug|10|||
125018029|NCT00790907|449691168|FG001|Overall Study|Did Not Receive Study Drug|0|||
125018030|NCT00790907|449691169|FG002|Overall Study|Did Not Receive Study Drug|0|||
125018031|NCT01888640|449691170|FG000|Overall Study|Lost to Follow-up|1|||
125018032|NCT01888640|449691171|FG001|Overall Study|Lost to Follow-up|2|||
125018033|NCT01888640|449691172|FG002|Overall Study|Lost to Follow-up|0|||
125018034|NCT01888640|449691170|FG000|Overall Study|Withdrawal by Subject|15|||
125018035|NCT01888640|449691171|FG001|Overall Study|Withdrawal by Subject|11|||
125018036|NCT01888640|449691172|FG002|Overall Study|Withdrawal by Subject|4|||
125018037|NCT01888640|449691170|FG000|Overall Study|Minimum dose not met|10|||
125018038|NCT01888640|449691171|FG001|Overall Study|Minimum dose not met|16|||
125018039|NCT01888640|449691172|FG002|Overall Study|Minimum dose not met|0|||
125018040|NCT01888640|449691170|FG000|Overall Study|Given wrong unit (placebo)|1|||
125018041|NCT01888640|449691171|FG001|Overall Study|Given wrong unit (placebo)|0|||
125108394|NCT00446134|450020653|FG003|Overall Study|Lack of Efficacy|19|||
125108395|NCT00446134|450020650|FG000|Overall Study|Protocol Violation|0|||
125108396|NCT00446134|450020651|FG001|Overall Study|Protocol Violation|2|||
124894475|NCT01072929|449237687|FG002|Overall Study|Lost to Follow-up|1|||
124894476|NCT01072929|449237685|FG000|Overall Study|Noncompliance with study medication|0|||
124894477|NCT01072929|449237686|FG001|Overall Study|Noncompliance with study medication|3|||
125018042|NCT01888640|449691172|FG002|Overall Study|Given wrong unit (placebo)|0|||
124894478|NCT01072929|449237687|FG002|Overall Study|Noncompliance with study medication|0|||
124894479|NCT01072929|449237685|FG000|Overall Study|Noncompliance with study procedures|1|||
124894480|NCT01072929|449237686|FG001|Overall Study|Noncompliance with study procedures|0|||
124894481|NCT01072929|449237687|FG002|Overall Study|Noncompliance with study procedures|1|||
124894482|NCT01072929|449237685|FG000|Overall Study|Other|0|||
124894483|NCT01072929|449237686|FG001|Overall Study|Other|3|||
124894484|NCT01072929|449237687|FG002|Overall Study|Other|0|||
124894485|NCT00052962|449237690|FG000|Overall Study|Not evaluable|0|||
124894486|NCT00052962|449237691|FG001|Overall Study|Not evaluable|2|||
124894487|NCT00052962|449237690|FG000|Overall Study|Not randomized/not evaluable|1|||
124894488|NCT00052962|449237691|FG001|Overall Study|Not randomized/not evaluable|0|||
124894489|NCT01723774|449237700|FG000|Neoadjuvant|Ki67 > 10%|4|||
124894490|NCT01723774|449237701|FG001|Neoadjuvant|Ki67 > 10%|0|||
124894491|NCT01723774|449237702|FG002|Neoadjuvant|Ki67 > 10%|10|||
124894492|NCT01723774|449237703|FG003|Neoadjuvant|Ki67 > 10%|0|||
124894493|NCT01723774|449237700|FG000|Neoadjuvant|Withdrawal by Subject|3|||
124894494|NCT01723774|449237701|FG001|Neoadjuvant|Withdrawal by Subject|1|||
124894495|NCT01723774|449237702|FG002|Neoadjuvant|Withdrawal by Subject|0|||
124894496|NCT01723774|449237703|FG003|Neoadjuvant|Withdrawal by Subject|0|||
124894497|NCT01723774|449237700|FG000|Neoadjuvant|Disease progression|0|||
124894498|NCT01723774|449237701|FG001|Neoadjuvant|Disease progression|1|||
124894499|NCT01723774|449237702|FG002|Neoadjuvant|Disease progression|1|||
124894500|NCT01723774|449237703|FG003|Neoadjuvant|Disease progression|0|||
124894501|NCT01723774|449237700|FG000|Neoadjuvant|Adverse Event|0|||
124894502|NCT01723774|449237701|FG001|Neoadjuvant|Adverse Event|1|||
124894503|NCT01723774|449237702|FG002|Neoadjuvant|Adverse Event|2|||
124894504|NCT01723774|449237703|FG003|Neoadjuvant|Adverse Event|0|||
124894505|NCT01723774|449237700|FG000|Neoadjuvant|High estradiol|0|||
124894506|NCT01723774|449237701|FG001|Neoadjuvant|High estradiol|1|||
124894507|NCT01723774|449237702|FG002|Neoadjuvant|High estradiol|0|||
124894508|NCT01723774|449237703|FG003|Neoadjuvant|High estradiol|0|||
124894509|NCT02487446|449237707|FG000|Period 1|Physician Decision|0|||
124894510|NCT02487446|449237708|FG001|Period 1|Physician Decision|1|||
124894511|NCT02487446|449237707|FG000|Period 1|Lack of Efficacy|1|||
124894512|NCT02487446|449237708|FG001|Period 1|Lack of Efficacy|0|||
124894513|NCT02487446|449237707|FG000|Period 1|Protocol deviation|3|||
124894514|NCT02487446|449237708|FG001|Period 1|Protocol deviation|2|||
124894515|NCT02487446|449237707|FG000|Period 1|Lost to Follow-up|2|||
124894516|NCT02487446|449237708|FG001|Period 1|Lost to Follow-up|0|||
124894517|NCT02487446|449237707|FG000|Period 1|Withdrawal by Subject|2|||
124894518|NCT02487446|449237708|FG001|Period 1|Withdrawal by Subject|0|||
124894519|NCT02487446|449237707|FG000|Period 1|Adverse Event|5|||
124894520|NCT02487446|449237708|FG001|Period 1|Adverse Event|5|||
124894521|NCT02487446|449237707|FG000|Washout|Lost to Follow-up|0|||
124894522|NCT02487446|449237708|FG001|Washout|Lost to Follow-up|2|||
124894523|NCT02487446|449237707|FG000|Washout|Withdrawal by Subject|1|||
124894524|NCT02487446|449237708|FG001|Washout|Withdrawal by Subject|4|||
124894525|NCT02487446|449237707|FG000|Washout|Adverse Event|2|||
124894526|NCT02487446|449237708|FG001|Washout|Adverse Event|2|||
124894527|NCT02487446|449237707|FG000|Period 2|Protocol deviation|0|||
124894528|NCT02487446|449237708|FG001|Period 2|Protocol deviation|1|||
124894529|NCT02487446|449237707|FG000|Period 2|Lost to Follow-up|1|||
124894530|NCT02487446|449237708|FG001|Period 2|Lost to Follow-up|1|||
124894531|NCT02487446|449237707|FG000|Period 2|Withdrawal by Subject|1|||
124894532|NCT02487446|449237708|FG001|Period 2|Withdrawal by Subject|1|||
124894533|NCT02487446|449237707|FG000|Period 2|Adverse Event|6|||
124894534|NCT02487446|449237708|FG001|Period 2|Adverse Event|2|||
124894535|NCT04438785|449237709|FG000|Overall Study|change of weight, give up intervention|2|||
124894536|NCT04438785|449237710|FG001|Overall Study|change of weight, give up intervention|10|||
124894537|NCT04011033|449237711|FG000|Overall Study|Physician Decision|2|||
124894538|NCT04011033|449237712|FG001|Overall Study|Physician Decision|3|||
124894539|NCT04011033|449237711|FG000|Overall Study|Withdrawal by Subject|1|||
125018043|NCT01888640|449691170|FG000|Overall Study|Excluded for prior TENS|0|||
124894540|NCT04011033|449237712|FG001|Overall Study|Withdrawal by Subject|0|||
124894541|NCT00689104|449237713|FG000|Overall Study|Eligibility criterion not met|5|||
124894542|NCT00689104|449237714|FG001|Overall Study|Eligibility criterion not met|8|||
124894543|NCT00689104|449237715|FG002|Overall Study|Eligibility criterion not met|0|||
124894544|NCT00689104|449237716|FG003|Overall Study|Eligibility criterion not met|4|||
124894545|NCT00689104|449237713|FG000|Overall Study|Adverse Event|13|||
124894546|NCT00689104|449237714|FG001|Overall Study|Adverse Event|25|||
124894547|NCT00689104|449237715|FG002|Overall Study|Adverse Event|16|||
124894548|NCT00689104|449237716|FG003|Overall Study|Adverse Event|24|||
124894549|NCT00689104|449237713|FG000|Overall Study|Lack of Efficacy|5|||
124894550|NCT00689104|449237714|FG001|Overall Study|Lack of Efficacy|6|||
124894551|NCT00689104|449237715|FG002|Overall Study|Lack of Efficacy|2|||
124894552|NCT00689104|449237716|FG003|Overall Study|Lack of Efficacy|3|||
124894553|NCT00689104|449237713|FG000|Overall Study|Withdrawal by Subject|12|||
124894554|NCT00689104|449237714|FG001|Overall Study|Withdrawal by Subject|11|||
125018044|NCT01888640|449691171|FG001|Overall Study|Excluded for prior TENS|1|||
124894555|NCT00689104|449237715|FG002|Overall Study|Withdrawal by Subject|18|||
124894556|NCT00689104|449237716|FG003|Overall Study|Withdrawal by Subject|11|||
124894557|NCT00689104|449237713|FG000|Overall Study|Lost to Follow-up|4|||
124894558|NCT00689104|449237714|FG001|Overall Study|Lost to Follow-up|3|||
124894559|NCT00689104|449237715|FG002|Overall Study|Lost to Follow-up|2|||
124894560|NCT00689104|449237716|FG003|Overall Study|Lost to Follow-up|5|||
124894561|NCT00689104|449237713|FG000|Overall Study|Protocol Violation|2|||
124894562|NCT00689104|449237714|FG001|Overall Study|Protocol Violation|3|||
124894563|NCT00689104|449237715|FG002|Overall Study|Protocol Violation|5|||
124894564|NCT00689104|449237716|FG003|Overall Study|Protocol Violation|3|||
124894565|NCT00689104|449237713|FG000|Overall Study|Randomized but never received study drug|2|||
124894566|NCT00689104|449237714|FG001|Overall Study|Randomized but never received study drug|1|||
124894567|NCT00689104|449237715|FG002|Overall Study|Randomized but never received study drug|1|||
124894568|NCT00689104|449237716|FG003|Overall Study|Randomized but never received study drug|0|||
124894569|NCT00689104|449237713|FG000|Overall Study|Physician Decision|1|||
124894570|NCT00689104|449237714|FG001|Overall Study|Physician Decision|0|||
124894571|NCT00689104|449237715|FG002|Overall Study|Physician Decision|0|||
124894572|NCT00689104|449237716|FG003|Overall Study|Physician Decision|0|||
124894573|NCT00689104|449237713|FG000|Overall Study|Non-compliance with study procedures|0|||
124894574|NCT00689104|449237714|FG001|Overall Study|Non-compliance with study procedures|0|||
124894575|NCT00689104|449237715|FG002|Overall Study|Non-compliance with study procedures|1|||
124894576|NCT00689104|449237716|FG003|Overall Study|Non-compliance with study procedures|0|||
124894577|NCT00814489|449237744|FG000|Overall Study|Other|2|||
124894578|NCT00814489|449237745|FG001|Overall Study|Other|0|||
124894579|NCT00814489|449237746|FG002|Overall Study|Other|1|||
124894580|NCT01712685|449237747|FG000|Overall Study|pt declined to participate before trmt|1|||
124894581|NCT03253653|449237751|FG000|Overall Study|Withdrawal by Subject|4|||
124894582|NCT03253653|449237752|FG001|Overall Study|Withdrawal by Subject|1|||
124894583|NCT03253653|449237751|FG000|Overall Study|Protocol Violation|0|||
124894584|NCT03253653|449237752|FG001|Overall Study|Protocol Violation|5|||
124894585|NCT00662909|449237754|FG000|Overall Study|Adverse Event|17|||
124894586|NCT00662909|449237755|FG001|Overall Study|Adverse Event|18|||
124894587|NCT00662909|449237756|FG002|Overall Study|Adverse Event|19|||
124894588|NCT00662909|449237754|FG000|Overall Study|Lack of Efficacy|9|||
124894589|NCT00662909|449237755|FG001|Overall Study|Lack of Efficacy|1|||
124894590|NCT00662909|449237756|FG002|Overall Study|Lack of Efficacy|5|||
124894591|NCT00662909|449237754|FG000|Overall Study|Withdrawal by Subject|29|||
124894592|NCT00662909|449237755|FG001|Overall Study|Withdrawal by Subject|22|||
124894593|NCT00662909|449237756|FG002|Overall Study|Withdrawal by Subject|16|||
124894594|NCT00662909|449237754|FG000|Overall Study|Lost to Follow-up|2|||
124894595|NCT00662909|449237755|FG001|Overall Study|Lost to Follow-up|9|||
124894596|NCT00662909|449237756|FG002|Overall Study|Lost to Follow-up|3|||
124894597|NCT00662909|449237754|FG000|Overall Study|Protocol Violation|7|||
124894598|NCT00662909|449237755|FG001|Overall Study|Protocol Violation|4|||
124894599|NCT00662909|449237756|FG002|Overall Study|Protocol Violation|5|||
124894600|NCT00662909|449237754|FG000|Overall Study|Randomized- never received study drug|1|||
124894601|NCT00662909|449237755|FG001|Overall Study|Randomized- never received study drug|0|||
124894602|NCT00662909|449237756|FG002|Overall Study|Randomized- never received study drug|0|||
124894603|NCT00662909|449237754|FG000|Overall Study|Non-compliance with study procedures|3|||
124894604|NCT00662909|449237755|FG001|Overall Study|Non-compliance with study procedures|3|||
124894605|NCT00662909|449237756|FG002|Overall Study|Non-compliance with study procedures|2|||
124894606|NCT00662909|449237754|FG000|Overall Study|Physician Decision|1|||
124894607|NCT00662909|449237755|FG001|Overall Study|Physician Decision|1|||
124894608|NCT00662909|449237756|FG002|Overall Study|Physician Decision|2|||
124894609|NCT00662909|449237754|FG000|Overall Study|Eligibility criterion not met|0|||
124894610|NCT00662909|449237755|FG001|Overall Study|Eligibility criterion not met|1|||
124894611|NCT00662909|449237756|FG002|Overall Study|Eligibility criterion not met|1|||
124969498|NCT03520075|449517411|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124969499|NCT03520075|449517412|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
124969500|NCT03520075|449517413|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
124969501|NCT03520075|449517414|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
124969502|NCT03520075|449517415|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124969503|NCT03520075|449517416|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
124969504|NCT03520075|449517417|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124969505|NCT03520075|449517418|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
124969506|NCT03520075|449517419|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124969507|NCT03520075|449517420|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124969508|NCT03520075|449517421|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
124969509|NCT03520075|449517422|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124969510|NCT03520075|449517423|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124969511|NCT03520075|449517424|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124969512|NCT03520075|449517425|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124969513|NCT03520075|449517426|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124969514|NCT03520075|449517427|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124894612|NCT01518257|449239446|FG000|Overall Study|Lost to Follow-up|1|||
124894613|NCT01518257|449239447|FG001|Overall Study|Lost to Follow-up|0|||
124894614|NCT01518257|449239446|FG000|Overall Study|Other Miscellaneous Reason|1|||
124894615|NCT01518257|449239447|FG001|Overall Study|Other Miscellaneous Reason|0|||
124894616|NCT00924664|449239448|FG000|Overall Study|Adverse Event|23|||
124894617|NCT00924664|449239449|FG001|Overall Study|Adverse Event|39|||
124894618|NCT00924664|449239448|FG000|Overall Study|Lack of Efficacy|10|||
124894619|NCT00924664|449239449|FG001|Overall Study|Lack of Efficacy|15|||
124894620|NCT00924664|449239448|FG000|Overall Study|Lost to Follow-up|10|||
124894621|NCT00924664|449239449|FG001|Overall Study|Lost to Follow-up|12|||
124894622|NCT00924664|449239448|FG000|Overall Study|Withdrawal by Subject|47|||
124894623|NCT00924664|449239449|FG001|Overall Study|Withdrawal by Subject|71|||
124894624|NCT00924664|449239448|FG000|Overall Study|Protocol Violation|2|||
125108397|NCT00446134|450020652|FG002|Overall Study|Protocol Violation|1|||
125108398|NCT00446134|450020653|FG003|Overall Study|Protocol Violation|0|||
125108399|NCT00446134|450020650|FG000|Overall Study|Lost to Follow-up|1|||
125108400|NCT00446134|450020651|FG001|Overall Study|Lost to Follow-up|3|||
125108401|NCT00446134|450020652|FG002|Overall Study|Lost to Follow-up|1|||
125108402|NCT00446134|450020653|FG003|Overall Study|Lost to Follow-up|1|||
125108403|NCT00446134|450020650|FG000|Overall Study|Withdrawal by Subject|3|||
125108404|NCT00446134|450020651|FG001|Overall Study|Withdrawal by Subject|3|||
125108405|NCT00446134|450020652|FG002|Overall Study|Withdrawal by Subject|1|||
125108406|NCT00446134|450020653|FG003|Overall Study|Withdrawal by Subject|3|||
125108407|NCT00446134|450020650|FG000|Overall Study|Physician Decision|0|||
125108408|NCT00446134|450020651|FG001|Overall Study|Physician Decision|0|||
124894625|NCT00924664|449239449|FG001|Overall Study|Protocol Violation|5|||
124894626|NCT00924664|449239448|FG000|Overall Study|Pregnancy|1|||
124894627|NCT00924664|449239449|FG001|Overall Study|Pregnancy|1|||
124894628|NCT00924664|449239448|FG000|Overall Study|Death|0|||
124894629|NCT00924664|449239449|FG001|Overall Study|Death|2|||
124894630|NCT00924664|449239448|FG000|Overall Study|Study terminated by sponsor|199|||
124894631|NCT00924664|449239449|FG001|Overall Study|Study terminated by sponsor|330|||
124894632|NCT00924664|449239448|FG000|Overall Study|Other|29|||
124894633|NCT00924664|449239449|FG001|Overall Study|Other|52|||
124894634|NCT00924664|449239448|FG000|Overall Study|Randomized but not Treated|1|||
124894635|NCT00924664|449239449|FG001|Overall Study|Randomized but not Treated|0|||
124894636|NCT03158948|449239451|FG000|Overall Study|Death|1|||
124894637|NCT03158948|449239452|FG001|Overall Study|Death|1|||
124894638|NCT03158948|449239453|FG002|Overall Study|Death|3|||
124894639|NCT03158948|449239454|FG003|Overall Study|Death|2|||
124894640|NCT03158948|449239451|FG000|Overall Study|Physician Decision|0|||
125108409|NCT00446134|450020652|FG002|Overall Study|Physician Decision|0|||
125108410|NCT00446134|450020653|FG003|Overall Study|Physician Decision|2|||
125108411|NCT00446134|450020650|FG000|Overall Study|Adverse Event-Diarrhea|1|||
125108412|NCT00446134|450020651|FG001|Overall Study|Adverse Event-Diarrhea|1|||
125108413|NCT00446134|450020652|FG002|Overall Study|Adverse Event-Diarrhea|2|||
125108414|NCT00446134|450020653|FG003|Overall Study|Adverse Event-Diarrhea|0|||
125108415|NCT00446134|450020650|FG000|Overall Study|Reason Not Completed|3|||
125108416|NCT00446134|450020651|FG001|Overall Study|Reason Not Completed|0|||
125108417|NCT00446134|450020652|FG002|Overall Study|Reason Not Completed|1|||
125108418|NCT00446134|450020653|FG003|Overall Study|Reason Not Completed|2|||
125108419|NCT00743119|450020654|FG000|Overall Study|unreliable|3|||
124894641|NCT03158948|449239452|FG001|Overall Study|Physician Decision|0|||
124894642|NCT03158948|449239453|FG002|Overall Study|Physician Decision|0|||
124894643|NCT03158948|449239454|FG003|Overall Study|Physician Decision|1|||
124894644|NCT02153788|449239455|FG000|Overall Study|Physician Decision|2|||
124894645|NCT02153788|449239456|FG001|Overall Study|Physician Decision|1|||
124894646|NCT04672460|449239457|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
125108420|NCT00743119|450020654|FG000|Overall Study|Withdrawal by Subject|1|||
124894647|NCT04672460|449239458|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
124894648|NCT04672460|449239457|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
124894649|NCT04672460|449239458|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
124894650|NCT04672460|449239457|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
124894651|NCT04672460|449239458|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
124894652|NCT04672460|449239457|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
124894653|NCT04672460|449239458|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
124894654|NCT04672460|449239457|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
124894655|NCT04672460|449239458|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
124894656|NCT04672460|449239457|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
125108421|NCT04816877|450020655|FG000|Overall Study|Withdrawal by Subject|1|||
125108422|NCT04816877|450020656|FG001|Overall Study|Withdrawal by Subject|0|||
124894657|NCT04672460|449239458|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
124894658|NCT04672460|449239457|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
124894659|NCT04672460|449239458|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
124894660|NCT04672460|449239457|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
124894661|NCT04672460|449239458|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
124894662|NCT04672460|449239457|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
125108423|NCT01309828|450020658|FG000|Overall Study|Adverse Event|10|||
125108424|NCT01309828|450020659|FG001|Overall Study|Adverse Event|11|||
125108425|NCT01309828|450020658|FG000|Overall Study|Voluntary Withdrawal|5|||
125108426|NCT01309828|450020659|FG001|Overall Study|Voluntary Withdrawal|4|||
125108427|NCT01309828|450020658|FG000|Overall Study|Major Protocol Deviation|0|||
125108428|NCT01309828|450020659|FG001|Overall Study|Major Protocol Deviation|1|||
125108429|NCT01309828|450020658|FG000|Overall Study|Other|1|||
125108430|NCT01309828|450020659|FG001|Overall Study|Other|0|||
125108431|NCT00295620|450020660|FG000|Overall Study|Lost to Follow-up|9|||
125108432|NCT00295620|450020661|FG001|Overall Study|Lost to Follow-up|5|||
125108433|NCT00295620|450020660|FG000|Overall Study|Withdrawal by Subject|37|||
125108434|NCT00295620|450020661|FG001|Overall Study|Withdrawal by Subject|50|||
125108435|NCT00295620|450020660|FG000|Overall Study|Death|206|||
125108436|NCT00295620|450020661|FG001|Overall Study|Death|207|||
125108437|NCT00295620|450020660|FG000|Overall Study|Other reasons|10|||
125108438|NCT00295620|450020661|FG001|Overall Study|Other reasons|9|||
125108439|NCT00295620|450020660|FG000|Overall Study|Discontinuation by sponsor|580|||
125108440|NCT00295620|450020661|FG001|Overall Study|Discontinuation by sponsor|593|||
125108441|NCT00295620|450020660|FG000|Overall Study|Protocol Violation|30|||
125108442|NCT00295620|450020661|FG001|Overall Study|Protocol Violation|32|||
125108443|NCT02556632|450020664|FG000|Overall Study|Lost to Follow-up|1|||
125108444|NCT02556632|450020665|FG001|Overall Study|Lost to Follow-up|0|||
125108445|NCT02556632|450020666|FG002|Overall Study|Lost to Follow-up|0|||
125108446|NCT02556632|450020664|FG000|Overall Study|Disliked Intervention|1|||
125108447|NCT02556632|450020665|FG001|Overall Study|Disliked Intervention|1|||
125108448|NCT02556632|450020666|FG002|Overall Study|Disliked Intervention|1|||
125108449|NCT02556632|450020664|FG000|Overall Study|No Reason|1|||
125108450|NCT02556632|450020665|FG001|Overall Study|No Reason|0|||
125108451|NCT02556632|450020666|FG002|Overall Study|No Reason|1|||
125108452|NCT02556632|450020664|FG000|Overall Study|Personal Issues|0|||
125108453|NCT02556632|450020665|FG001|Overall Study|Personal Issues|1|||
125108454|NCT02556632|450020666|FG002|Overall Study|Personal Issues|1|||
125108455|NCT02556632|450020664|FG000|Overall Study|Changed Mind|0|||
125108456|NCT02556632|450020665|FG001|Overall Study|Changed Mind|1|||
125108457|NCT02556632|450020666|FG002|Overall Study|Changed Mind|0|||
125108458|NCT02556632|450020664|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
125108459|NCT02556632|450020665|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
125108460|NCT02556632|450020666|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
125108461|NCT02556632|450020664|FG000|Overall Study|Unrelated Adverse Event|1|||
125108462|NCT02556632|450020665|FG001|Overall Study|Unrelated Adverse Event|0|||
125108463|NCT02556632|450020666|FG002|Overall Study|Unrelated Adverse Event|3|||
125108464|NCT02556632|450020664|FG000|Overall Study|Related Adverse Event|0|||
125108465|NCT02556632|450020665|FG001|Overall Study|Related Adverse Event|1|||
125108466|NCT02556632|450020666|FG002|Overall Study|Related Adverse Event|0|||
125108467|NCT02556632|450020664|FG000|Overall Study|Possibly Related Adverse Event|0|||
125108468|NCT02556632|450020665|FG001|Overall Study|Possibly Related Adverse Event|0|||
125108469|NCT02556632|450020666|FG002|Overall Study|Possibly Related Adverse Event|1|||
125108470|NCT02556632|450020664|FG000|Overall Study|Did Not Start RT|0|||
125108471|NCT02556632|450020665|FG001|Overall Study|Did Not Start RT|1|||
125108472|NCT02556632|450020666|FG002|Overall Study|Did Not Start RT|0|||
125108473|NCT02556632|450020664|FG000|Overall Study|Ineligible|0|||
125108474|NCT02556632|450020665|FG001|Overall Study|Ineligible|1|||
125108475|NCT02556632|450020666|FG002|Overall Study|Ineligible|0|||
125108476|NCT02556632|450020664|FG000|Overall Study|Disliked Study Procedures|0|||
125108477|NCT02556632|450020665|FG001|Overall Study|Disliked Study Procedures|0|||
125108478|NCT02556632|450020666|FG002|Overall Study|Disliked Study Procedures|1|||
124894663|NCT04672460|449239458|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
124894664|NCT04672460|449239457|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
124894665|NCT04672460|449239458|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
124894666|NCT04672460|449239457|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
124894667|NCT04672460|449239458|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
124894668|NCT04672460|449239457|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
124894669|NCT04672460|449239458|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
124894670|NCT04672460|449239457|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
124894671|NCT04672460|449239458|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
124894672|NCT04672460|449239457|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
124894673|NCT04672460|449239458|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
124894674|NCT04672460|449239457|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
124894675|NCT04672460|449239458|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
124894676|NCT04672460|449239457|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
124894677|NCT04672460|449239458|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
124894678|NCT04672460|449239457|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
124894679|NCT04672460|449239458|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
124894680|NCT01876043|449239461|FG000|Overall Study|Death|1|||
124894681|NCT01876043|449239461|FG000|Overall Study|Withdrawal by Subject|1|||
124894682|NCT00079937|449239463|FG000|Overall Study|Adverse Event|2|||
124894683|NCT00079937|449239464|FG001|Overall Study|Adverse Event|1|||
124894684|NCT00079937|449239463|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124894685|NCT00079937|449239464|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124894686|NCT00079937|449239463|FG000|Overall Study|Subject no longer requires study drug|3|||
124894687|NCT00079937|449239464|FG001|Overall Study|Subject no longer requires study drug|0|||
124894688|NCT00079937|449239463|FG000|Overall Study|Protocol Violation|8|||
124894689|NCT00079937|449239464|FG001|Overall Study|Protocol Violation|6|||
124894690|NCT00079937|449239463|FG000|Overall Study|Withdrawal by Subject|21|||
124894691|NCT00079937|449239464|FG001|Overall Study|Withdrawal by Subject|7|||
124894692|NCT00079937|449239463|FG000|Overall Study|Lost to Follow-up|12|||
124894693|NCT00079937|449239464|FG001|Overall Study|Lost to Follow-up|5|||
124894694|NCT00079937|449239463|FG000|Overall Study|Administrative problems|22|||
124894695|NCT00079937|449239464|FG001|Overall Study|Administrative problems|11|||
124894696|NCT01616563|449239465|FG000|Overall Study|Lost to Follow-up|40|||
124894697|NCT02206685|449239466|FG000|Overall Study|Surgery cancelled/changed|2|||
124894698|NCT02206685|449239467|FG001|Overall Study|Surgery cancelled/changed|3|||
124894699|NCT02206685|449239466|FG000|Overall Study|Withdrawal by Subject|1|||
124894700|NCT02206685|449239467|FG001|Overall Study|Withdrawal by Subject|2|||
124894701|NCT02206685|449239466|FG000|Overall Study|Protocol Violation|2|||
124894702|NCT02206685|449239467|FG001|Overall Study|Protocol Violation|2|||
124894703|NCT00093795|449239471|FG000|Overall Study|No follow up data|20|||
124894704|NCT00093795|449239472|FG001|Overall Study|No follow up data|16|||
125108479|NCT02556632|450020664|FG000|Overall Study|Treatment or Change Delay|0|||
125108480|NCT02556632|450020665|FG001|Overall Study|Treatment or Change Delay|0|||
125108481|NCT02556632|450020666|FG002|Overall Study|Treatment or Change Delay|1|||
124894705|NCT00093795|449239473|FG002|Overall Study|No follow up data|17|||
124894706|NCT01195675|449239474|FG000|Overall Study|Adverse Event|1|||
124894707|NCT01195675|449239474|FG000|Overall Study|Withdrawal by Subject|2|||
124894708|NCT01106287|449239475|FG000|Overall Study|Adverse Event|1|||
124894709|NCT01106287|449239476|FG001|Overall Study|Adverse Event|0|||
124894710|NCT01106287|449239477|FG002|Overall Study|Adverse Event|0|||
124894711|NCT01106287|449239478|FG003|Overall Study|Adverse Event|0|||
125108482|NCT02574260|450020669|FG000|Overall Study|Disease Progression|1|||
125108483|NCT04523831|450020677|FG000|Overall Study|Lost to Follow-up|15|||
125108484|NCT04523831|450020678|FG001|Overall Study|Lost to Follow-up|17|||
125108485|NCT04523831|450020677|FG000|Overall Study|Death|0|||
124894712|NCT00072475|449239479|FG000|Overall Study|Adverse Event|44|||
124894713|NCT00072475|449239479|FG000|Overall Study|Death|3|||
124894714|NCT00072475|449239479|FG000|Overall Study|Withdrawal by Subject|46|||
124894715|NCT00072475|449239479|FG000|Overall Study|Patient/Investigator Decision|4|||
124894716|NCT04730947|449239480|FG000|Overall Study|Withdrawal by Subject|0|||
124894717|NCT04730947|449239481|FG001|Overall Study|Withdrawal by Subject|1|||
124894718|NCT00940017|449239482|FG000|Overall Study|did not meet entrance criteria|3|||
124894719|NCT00940017|449239482|FG000|Overall Study|Adverse Event|1|||
124894720|NCT01450943|449239483|FG000|Overall Study|Screen failure, loss to follow-up|2|||
124894721|NCT01450943|449239484|FG001|Overall Study|Screen failure, loss to follow-up|7|||
124894722|NCT01450943|449239485|FG002|Overall Study|Screen failure, loss to follow-up|6|||
124894723|NCT05328973|449239491|FG000|Overall Study|Withdrawal by Subject|0|||
125018045|NCT01888640|449691172|FG002|Overall Study|Excluded for prior TENS|0|||
125018046|NCT01888640|449691170|FG000|Overall Study|Researcher Termination of Participant|0|||
125018047|NCT01888640|449691171|FG001|Overall Study|Researcher Termination of Participant|1|||
125018048|NCT01888640|449691172|FG002|Overall Study|Researcher Termination of Participant|1|||
125018049|NCT03436862|449691175|FG000|Overall Study|Adverse Event|4|||
125018050|NCT03436862|449691175|FG000|Overall Study|Progressive Disease|2|||
125018051|NCT02228590|449691177|FG000|Overall Study|Withdrawal by Subject|1|||
125018052|NCT01097863|449691178|FG000|Overall Study|Discomfort|1|||
125018053|NCT01097863|449691179|FG001|Overall Study|Discomfort|0|||
125018054|NCT01097863|449691180|FG002|Overall Study|Discomfort|1|||
125018055|NCT01097863|449691178|FG000|Overall Study|Did not return for final visit|0|||
125018056|NCT01097863|449691179|FG001|Overall Study|Did not return for final visit|0|||
125018057|NCT01097863|449691180|FG002|Overall Study|Did not return for final visit|1|||
125018058|NCT00960843|449691182|FG000|Overall Study|Lost to Follow-up|2|||
125018059|NCT00960843|449691183|FG001|Overall Study|Lost to Follow-up|0|||
125018060|NCT00960843|449691182|FG000|Overall Study|Protocol Violation|0|||
125018061|NCT00960843|449691183|FG001|Overall Study|Protocol Violation|4|||
125018062|NCT00960843|449691182|FG000|Overall Study|Repeated needle dislodgment|0|||
125018063|NCT00960843|449691183|FG001|Overall Study|Repeated needle dislodgment|1|||
125018064|NCT00490451|449691186|FG000|Overall Study|Adverse Event|3|||
125018065|NCT00490451|449691187|FG001|Overall Study|Adverse Event|3|||
125018066|NCT00490451|449691186|FG000|Overall Study|Death|3|||
125018067|NCT00490451|449691187|FG001|Overall Study|Death|1|||
124894724|NCT05328973|449239492|FG001|Overall Study|Withdrawal by Subject|1|||
125018068|NCT00490451|449691186|FG000|Overall Study|Withdrawal by Subject|2|||
125018069|NCT00490451|449691187|FG001|Overall Study|Withdrawal by Subject|0|||
124894725|NCT00946114|449239493|FG000|Overall Study|Death|5|||
125018070|NCT00490451|449691186|FG000|Overall Study|Investigator Decision|1|||
125018071|NCT00490451|449691187|FG001|Overall Study|Investigator Decision|0|||
125018072|NCT00490451|449691186|FG000|Overall Study|Protocol Violation|1|||
125018073|NCT00490451|449691187|FG001|Overall Study|Protocol Violation|0|||
125018074|NCT00490451|449691186|FG000|Overall Study|Progressive Disease|53|||
125018075|NCT00490451|449691187|FG001|Overall Study|Progressive Disease|34|||
124894726|NCT00946114|449239494|FG001|Overall Study|Death|2|||
124894727|NCT00946114|449239493|FG000|Overall Study|Other|1|||
124894728|NCT00946114|449239494|FG001|Overall Study|Other|0|||
124894729|NCT00946114|449239493|FG000|Overall Study|Withdrawal by Subject|2|||
124894730|NCT00946114|449239494|FG001|Overall Study|Withdrawal by Subject|0|||
124894731|NCT01764386|449239498|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
124894732|NCT01764386|449239499|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
124894733|NCT01764386|449239498|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
125018076|NCT01181011|449691188|FG000|Overall Study|Adverse Event|2|||
125018077|NCT01181011|449691188|FG000|Overall Study|Lost to Follow-up|1|||
125018078|NCT02788747|449691189|FG000|Overall Study|Adverse Event|1|||
125018079|NCT02788747|449691190|FG001|Overall Study|Adverse Event|0|||
125018080|NCT02788747|449691191|FG002|Overall Study|Adverse Event|0|||
125018081|NCT01967550|449691192|FG000|Overall Study|Withdrawal by Subject|1|||
125018082|NCT01967550|449691193|FG001|Overall Study|Withdrawal by Subject|0|||
125018083|NCT01967550|449691192|FG000|Overall Study|Adverse Event|2|||
125018084|NCT01967550|449691193|FG001|Overall Study|Adverse Event|0|||
125018085|NCT01967550|449691192|FG000|Overall Study|Protocol Violation|2|||
125018086|NCT01967550|449691193|FG001|Overall Study|Protocol Violation|1|||
125018087|NCT01967550|449691192|FG000|Overall Study|Non Compliance|0|||
125018088|NCT01967550|449691193|FG001|Overall Study|Non Compliance|1|||
125018089|NCT00784654|449691196|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
125018090|NCT00784654|449691197|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
125018091|NCT00784654|449691198|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
125018092|NCT00784654|449691196|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
125018093|NCT00784654|449691197|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
125018094|NCT00784654|449691198|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
125018095|NCT00784654|449691196|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
125018096|NCT00784654|449691197|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
125018097|NCT00784654|449691198|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
124894734|NCT01764386|449239499|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
125018098|NCT00784654|449691196|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
125018099|NCT00784654|449691197|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
125018100|NCT00784654|449691198|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
125018101|NCT00784654|449691196|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
125018102|NCT00784654|449691197|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
124894735|NCT01764386|449239498|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
124894736|NCT01764386|449239499|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
124894737|NCT01764386|449239498|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
124894738|NCT01764386|449239499|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
124894739|NCT01764386|449239498|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
124894740|NCT01764386|449239499|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
124894741|NCT01764386|449239498|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
124894742|NCT01764386|449239499|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
124894743|NCT01764386|449239498|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
124894744|NCT01764386|449239499|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
124894745|NCT01764386|449239498|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
124894746|NCT01764386|449239499|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
124894747|NCT04454567|449239500|FG000|Overall Study|Study Terminated by Sponsor|1|||
124894748|NCT04454567|449239501|FG001|Overall Study|Study Terminated by Sponsor|1|||
124894749|NCT02757885|449239502|FG000|Overall Study|Screen Failures|4|||
124894750|NCT01175707|449239503|FG000|Overall Study|Adverse Event|4|||
124894751|NCT01175707|449239504|FG001|Overall Study|Adverse Event|6|||
124894752|NCT00003377|449239507|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
124894753|NCT00003377|449239508|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
124894754|NCT00003377|449239509|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
124894755|NCT00003377|449239510|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
124894756|NCT00003377|449239511|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
124894757|NCT00003377|449239507|FG000|Period II|Ureteral stent complications|0|||
124894758|NCT00003377|449239508|FG001|Period II|Ureteral stent complications|0|||
124894759|NCT00003377|449239509|FG002|Period II|Ureteral stent complications|0|||
124894760|NCT00003377|449239510|FG003|Period II|Ureteral stent complications|0|||
124894761|NCT00003377|449239511|FG004|Period II|Ureteral stent complications|1|||
124894762|NCT00463151|449239513|FG000|Overall Study|Adverse Event|0|||
124894763|NCT00463151|449239514|FG001|Overall Study|Adverse Event|0|||
124894764|NCT00463151|449239515|FG002|Overall Study|Adverse Event|1|||
124894765|NCT00463151|449239516|FG003|Overall Study|Adverse Event|0|||
124894766|NCT00463151|449239513|FG000|Overall Study|Lack of Efficacy|2|||
124894767|NCT00463151|449239514|FG001|Overall Study|Lack of Efficacy|5|||
124894768|NCT00463151|449239515|FG002|Overall Study|Lack of Efficacy|2|||
124894769|NCT00463151|449239516|FG003|Overall Study|Lack of Efficacy|5|||
124894770|NCT00463151|449239513|FG000|Overall Study|Protocol Violation|0|||
124894771|NCT00463151|449239514|FG001|Overall Study|Protocol Violation|0|||
124894772|NCT00463151|449239515|FG002|Overall Study|Protocol Violation|0|||
124894773|NCT00463151|449239516|FG003|Overall Study|Protocol Violation|1|||
124894774|NCT00463151|449239513|FG000|Overall Study|Withdrawal by Subject|0|||
124894775|NCT00463151|449239514|FG001|Overall Study|Withdrawal by Subject|0|||
124894776|NCT00463151|449239515|FG002|Overall Study|Withdrawal by Subject|0|||
124894777|NCT00463151|449239516|FG003|Overall Study|Withdrawal by Subject|1|||
124894778|NCT05349084|449239517|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
124894779|NCT00688688|449239518|FG000|Overall Study|Eligibility criterion not met|7|||
124894780|NCT00688688|449239519|FG001|Overall Study|Eligibility criterion not met|7|||
124894781|NCT00688688|449239520|FG002|Overall Study|Eligibility criterion not met|10|||
125018103|NCT00784654|449691198|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
125018104|NCT00784654|449691196|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
125018105|NCT00784654|449691197|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
125018106|NCT00784654|449691198|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
125018107|NCT00784654|449691196|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
125018108|NCT00784654|449691197|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
125018109|NCT00784654|449691198|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
125018110|NCT00784654|449691196|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
125018111|NCT00784654|449691197|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
125018112|NCT00784654|449691198|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
125018113|NCT00784654|449691196|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
125018114|NCT00784654|449691197|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
125018115|NCT00784654|449691198|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
125018116|NCT00784654|449691196|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
124894782|NCT00688688|449239518|FG000|Overall Study|Adverse Event|52|||
124894783|NCT00688688|449239519|FG001|Overall Study|Adverse Event|51|||
125018117|NCT00784654|449691197|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
125018118|NCT00784654|449691198|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
125108486|NCT04523831|450020678|FG001|Overall Study|Death|3|||
125108487|NCT04523831|450020677|FG000|Overall Study|Adverse Event|2|||
125108488|NCT04523831|450020678|FG001|Overall Study|Adverse Event|0|||
125108489|NCT02367781|450020683|FG000|Overall Study|Withdrawal by Subject|20|||
125108490|NCT02367781|450020684|FG001|Overall Study|Withdrawal by Subject|13|||
125108491|NCT02367781|450020683|FG000|Overall Study|Protocol Violation|0|||
125108492|NCT02367781|450020684|FG001|Overall Study|Protocol Violation|1|||
125108493|NCT02367781|450020683|FG000|Overall Study|Physician Decision|7|||
125108494|NCT02367781|450020684|FG001|Overall Study|Physician Decision|0|||
125108495|NCT02367781|450020683|FG000|Overall Study|Randomized in Error|5|||
125108496|NCT02367781|450020684|FG001|Overall Study|Randomized in Error|4|||
125108497|NCT02367781|450020683|FG000|Overall Study|Non-Compliance|1|||
125108498|NCT02367781|450020684|FG001|Overall Study|Non-Compliance|0|||
125108499|NCT02367781|450020683|FG000|Overall Study|Lost to Follow-up|1|||
125108500|NCT02367781|450020684|FG001|Overall Study|Lost to Follow-up|2|||
125108501|NCT02367781|450020683|FG000|Overall Study|Death|330|||
125108502|NCT02367781|450020684|FG001|Overall Study|Death|176|||
125108503|NCT02367781|450020683|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
125108504|NCT02367781|450020684|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
125108505|NCT02367781|450020683|FG000|Overall Study|Prolonged Hospitalization|1|||
125108506|NCT02367781|450020684|FG001|Overall Study|Prolonged Hospitalization|0|||
125108507|NCT02367781|450020683|FG000|Overall Study|Death Prior First Dose|1|||
125108508|NCT02367781|450020684|FG001|Overall Study|Death Prior First Dose|0|||
125108509|NCT02367781|450020683|FG000|Overall Study|Administrative-Change Facility|1|||
125108510|NCT02367781|450020684|FG001|Overall Study|Administrative-Change Facility|0|||
125108511|NCT02367781|450020683|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
125108512|NCT02367781|450020684|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
125108513|NCT02367781|450020683|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
125108514|NCT02367781|450020684|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
125108515|NCT02367781|450020683|FG000|Overall Study|Study Terminated by Sponsor|3|||
125108516|NCT02367781|450020684|FG001|Overall Study|Study Terminated by Sponsor|1|||
125108517|NCT02367781|450020683|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
125108518|NCT02367781|450020684|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
125108519|NCT02367781|450020683|FG000|Overall Study|Sponsor Decision|2|||
125108520|NCT02367781|450020684|FG001|Overall Study|Sponsor Decision|0|||
125108521|NCT02367781|450020683|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
125108522|NCT02367781|450020684|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
125108523|NCT02623426|450020685|FG000|Overall Study|Lost to Follow-up|0|||
125108524|NCT02623426|450020686|FG001|Overall Study|Lost to Follow-up|0|||
125108525|NCT02623426|450020687|FG002|Overall Study|Lost to Follow-up|1|||
125108526|NCT02623426|450020685|FG000|Overall Study|Withdrawal by Subject|1|||
125108527|NCT02623426|450020686|FG001|Overall Study|Withdrawal by Subject|2|||
125108528|NCT02623426|450020687|FG002|Overall Study|Withdrawal by Subject|2|||
125108529|NCT03185949|450020690|FG000|ITT Analysis|Withdrawal by Subject|4|||
125108530|NCT03185949|450020691|FG001|ITT Analysis|Withdrawal by Subject|3|||
125108531|NCT03185949|450020690|FG000|PP Analysis|Protocol Violation|2|||
125108532|NCT03185949|450020691|FG001|PP Analysis|Protocol Violation|2|||
125018119|NCT00784654|449691196|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
125018120|NCT00784654|449691197|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
125018121|NCT00784654|449691198|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
125018122|NCT00784654|449691196|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
125018123|NCT00784654|449691197|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
125018124|NCT00784654|449691198|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
125018125|NCT00784654|449691196|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
125018126|NCT00784654|449691197|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
125018127|NCT00784654|449691198|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
125018128|NCT00784654|449691196|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125018129|NCT00784654|449691197|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
125018130|NCT00784654|449691198|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
125018131|NCT00784654|449691196|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
125018132|NCT00784654|449691197|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
125018133|NCT00784654|449691198|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
125018134|NCT00784654|449691196|FG000|Randomized Withdrawal Period|Adverse Event|0|||
125018135|NCT00784654|449691197|FG001|Randomized Withdrawal Period|Adverse Event|1|||
125018136|NCT00784654|449691198|FG002|Randomized Withdrawal Period|Adverse Event|1|||
125018137|NCT00784654|449691196|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
125018138|NCT00784654|449691197|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
125108533|NCT03185949|450020690|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
125108534|NCT03185949|450020691|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
125108535|NCT03724968|450022515|FG000|Overall Study|Insurance issues|0|||
125108536|NCT03724968|450022516|FG001|Overall Study|Insurance issues|1|||
125018139|NCT00784654|449691198|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
125018140|NCT00784654|449691196|FG000|Randomized Withdrawal Period|Family reasons|0|||
125018141|NCT00784654|449691197|FG001|Randomized Withdrawal Period|Family reasons|0|||
125018142|NCT00784654|449691198|FG002|Randomized Withdrawal Period|Family reasons|1|||
125018143|NCT01180660|449691199|FG000|Overall Study|Changed to open surgery|1|||
125018144|NCT01180660|449691200|FG001|Overall Study|Changed to open surgery|0|||
125018145|NCT00844753|449691201|FG000|Overall Study|Lack of Efficacy|1|||
125018146|NCT00844753|449691202|FG001|Overall Study|Lack of Efficacy|0|||
125018147|NCT00844753|449691203|FG002|Overall Study|Lack of Efficacy|2|||
125018148|NCT00844753|449691204|FG003|Overall Study|Lack of Efficacy|2|||
125018149|NCT00844753|449691201|FG000|Overall Study|Adverse Event|3|||
125018150|NCT00844753|449691202|FG001|Overall Study|Adverse Event|2|||
125018151|NCT00844753|449691203|FG002|Overall Study|Adverse Event|5|||
125018152|NCT00844753|449691204|FG003|Overall Study|Adverse Event|5|||
125018153|NCT00844753|449691201|FG000|Overall Study|Lost to Follow-up|1|||
125018154|NCT00844753|449691202|FG001|Overall Study|Lost to Follow-up|1|||
125018155|NCT00844753|449691203|FG002|Overall Study|Lost to Follow-up|0|||
125018156|NCT00844753|449691204|FG003|Overall Study|Lost to Follow-up|1|||
125018157|NCT00844753|449691201|FG000|Overall Study|could not swallow medication|2|||
125018158|NCT00844753|449691202|FG001|Overall Study|could not swallow medication|0|||
125018159|NCT00844753|449691203|FG002|Overall Study|could not swallow medication|0|||
125018160|NCT00844753|449691204|FG003|Overall Study|could not swallow medication|0|||
125018161|NCT00844753|449691201|FG000|Overall Study|Withdrawal by Subject|1|||
125018162|NCT00844753|449691202|FG001|Overall Study|Withdrawal by Subject|0|||
125018163|NCT00844753|449691203|FG002|Overall Study|Withdrawal by Subject|0|||
125018164|NCT00844753|449691204|FG003|Overall Study|Withdrawal by Subject|3|||
125018165|NCT00852995|449691206|FG000|Overall Study|Adverse Event|1|||
125018166|NCT00852995|449691207|FG001|Overall Study|Adverse Event|0|||
125018167|NCT00852995|449691208|FG002|Overall Study|Adverse Event|4|||
125018168|NCT00852995|449691209|FG003|Overall Study|Adverse Event|0|||
125018169|NCT00852995|449691210|FG004|Overall Study|Adverse Event|0|||
125018170|NCT00852995|449691206|FG000|Overall Study|Lost to Follow-up|0|||
125018171|NCT00852995|449691207|FG001|Overall Study|Lost to Follow-up|1|||
125018172|NCT00852995|449691208|FG002|Overall Study|Lost to Follow-up|1|||
125018173|NCT00852995|449691209|FG003|Overall Study|Lost to Follow-up|0|||
125018174|NCT00852995|449691210|FG004|Overall Study|Lost to Follow-up|0|||
125018175|NCT00852995|449691206|FG000|Overall Study|Withdrawal by Subject|4|||
125018176|NCT00852995|449691207|FG001|Overall Study|Withdrawal by Subject|0|||
125018177|NCT00852995|449691208|FG002|Overall Study|Withdrawal by Subject|0|||
125018178|NCT00852995|449691209|FG003|Overall Study|Withdrawal by Subject|1|||
125018179|NCT00852995|449691210|FG004|Overall Study|Withdrawal by Subject|2|||
125018180|NCT00852995|449691206|FG000|Overall Study|Non-Compliance|0|||
125018181|NCT00852995|449691207|FG001|Overall Study|Non-Compliance|0|||
125018182|NCT00852995|449691208|FG002|Overall Study|Non-Compliance|0|||
125018183|NCT00852995|449691209|FG003|Overall Study|Non-Compliance|2|||
125018184|NCT00852995|449691210|FG004|Overall Study|Non-Compliance|0|||
125018185|NCT00852995|449691206|FG000|Overall Study|Progressive Disease|1|||
125018186|NCT00852995|449691207|FG001|Overall Study|Progressive Disease|0|||
125018187|NCT00852995|449691208|FG002|Overall Study|Progressive Disease|0|||
125018188|NCT00852995|449691209|FG003|Overall Study|Progressive Disease|2|||
125018189|NCT00852995|449691210|FG004|Overall Study|Progressive Disease|1|||
125018190|NCT00852995|449691206|FG000|Overall Study|Physician Decision|1|||
125018191|NCT00852995|449691207|FG001|Overall Study|Physician Decision|0|||
125018192|NCT00852995|449691208|FG002|Overall Study|Physician Decision|0|||
125018193|NCT00852995|449691209|FG003|Overall Study|Physician Decision|0|||
125018194|NCT00852995|449691210|FG004|Overall Study|Physician Decision|0|||
125018195|NCT00852995|449691206|FG000|Overall Study|Protocol Violation|0|||
125018196|NCT00852995|449691207|FG001|Overall Study|Protocol Violation|0|||
125018197|NCT00852995|449691208|FG002|Overall Study|Protocol Violation|0|||
125018198|NCT00852995|449691209|FG003|Overall Study|Protocol Violation|0|||
125018199|NCT00852995|449691210|FG004|Overall Study|Protocol Violation|1|||
125108537|NCT03724968|450022515|FG000|Overall Study|Study closed|0|||
125018200|NCT00852995|449691206|FG000|Overall Study|Moved Out of Area|1|||
125018201|NCT00852995|449691207|FG001|Overall Study|Moved Out of Area|0|||
125018202|NCT00852995|449691208|FG002|Overall Study|Moved Out of Area|0|||
125018203|NCT00852995|449691209|FG003|Overall Study|Moved Out of Area|0|||
125018204|NCT00852995|449691210|FG004|Overall Study|Moved Out of Area|0|||
125018205|NCT04418076|449691213|FG000|Overall Study|Death|1|||
125018206|NCT04418076|449691214|FG001|Overall Study|Death|0|||
125018207|NCT04418076|449691215|FG002|Overall Study|Death|0|||
125018208|NCT04418076|449691216|FG003|Overall Study|Death|0|||
125018209|NCT04418076|449691213|FG000|Overall Study|Lost to Follow-up|2|||
124894784|NCT00688688|449239520|FG002|Overall Study|Adverse Event|50|||
124894785|NCT00688688|449239518|FG000|Overall Study|Lack of Efficacy|34|||
125108538|NCT03724968|450022516|FG001|Overall Study|Study closed|1|||
125108539|NCT01142466|450022517|FG000|Overall Study|Adverse Event|2|||
125108540|NCT01142466|450022518|FG001|Overall Study|Adverse Event|1|||
125108541|NCT01142466|450022517|FG000|Overall Study|Withdrawal by Subject|1|||
124894786|NCT00688688|449239519|FG001|Overall Study|Lack of Efficacy|25|||
125018210|NCT04418076|449691214|FG001|Overall Study|Lost to Follow-up|5|||
125018211|NCT04418076|449691215|FG002|Overall Study|Lost to Follow-up|1|||
125018212|NCT04418076|449691216|FG003|Overall Study|Lost to Follow-up|2|||
125018213|NCT04418076|449691213|FG000|Overall Study|Withdrawal by Subject|1|||
125018214|NCT04418076|449691214|FG001|Overall Study|Withdrawal by Subject|0|||
125018215|NCT04418076|449691215|FG002|Overall Study|Withdrawal by Subject|1|||
125018216|NCT04418076|449691216|FG003|Overall Study|Withdrawal by Subject|1|||
125018217|NCT04418076|449691213|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
125018218|NCT04418076|449691214|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
125018219|NCT04418076|449691215|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
125018220|NCT04418076|449691216|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
125018221|NCT01471782|449691217|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
125018222|NCT01471782|449691218|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
125018223|NCT01471782|449691219|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
125018224|NCT01471782|449691220|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
125018225|NCT01471782|449691221|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
124894787|NCT00688688|449239520|FG002|Overall Study|Lack of Efficacy|45|||
124894788|NCT00688688|449239518|FG000|Overall Study|Withdrawal by Subject|66|||
125018226|NCT01471782|449691222|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
125018227|NCT01471782|449691217|FG000|Overall Study|Lack of Efficacy|1|||
125018228|NCT01471782|449691218|FG001|Overall Study|Lack of Efficacy|2|||
124894789|NCT00688688|449239519|FG001|Overall Study|Withdrawal by Subject|75|||
124894790|NCT00688688|449239520|FG002|Overall Study|Withdrawal by Subject|65|||
124894791|NCT00688688|449239518|FG000|Overall Study|Lost to Follow-up|14|||
124894792|NCT00688688|449239519|FG001|Overall Study|Lost to Follow-up|7|||
124894793|NCT00688688|449239520|FG002|Overall Study|Lost to Follow-up|7|||
124894794|NCT00688688|449239518|FG000|Overall Study|Protocol Violation|6|||
124894795|NCT00688688|449239519|FG001|Overall Study|Protocol Violation|9|||
124894796|NCT00688688|449239520|FG002|Overall Study|Protocol Violation|11|||
124894797|NCT00688688|449239518|FG000|Overall Study|Randomized but never received study drug|1|||
124894798|NCT00688688|449239519|FG001|Overall Study|Randomized but never received study drug|0|||
124894799|NCT00688688|449239520|FG002|Overall Study|Randomized but never received study drug|0|||
124894800|NCT00688688|449239518|FG000|Overall Study|Non-compliance with study procedures|5|||
124894801|NCT00688688|449239519|FG001|Overall Study|Non-compliance with study procedures|3|||
124894802|NCT00688688|449239520|FG002|Overall Study|Non-compliance with study procedures|4|||
124894803|NCT00688688|449239518|FG000|Overall Study|Taking exclusionary medications|1|||
124894804|NCT00688688|449239519|FG001|Overall Study|Taking exclusionary medications|0|||
124894805|NCT00688688|449239520|FG002|Overall Study|Taking exclusionary medications|0|||
124894806|NCT00688688|449239518|FG000|Overall Study|Site closure|0|||
124894807|NCT00688688|449239519|FG001|Overall Study|Site closure|1|||
124894808|NCT00688688|449239520|FG002|Overall Study|Site closure|0|||
124894809|NCT00688688|449239518|FG000|Overall Study|Violation of exclusion criterion|0|||
124894810|NCT00688688|449239519|FG001|Overall Study|Violation of exclusion criterion|1|||
124894811|NCT00688688|449239520|FG002|Overall Study|Violation of exclusion criterion|0|||
124894812|NCT03283553|449239523|FG000|Patient Participant Flow|Death|5|||
124894813|NCT03283553|449239524|FG001|Patient Participant Flow|Death|10|||
124894814|NCT03283553|449239523|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
124894815|NCT03283553|449239524|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
124894816|NCT03283553|449239523|FG000|Patient Participant Flow|Lost to Follow-up|1|||
124894817|NCT03283553|449239524|FG001|Patient Participant Flow|Lost to Follow-up|1|||
124894818|NCT03283553|449239523|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
124894819|NCT03283553|449239524|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
124894820|NCT03283553|449239523|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
124894821|NCT03283553|449239524|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
124894822|NCT03283553|449239523|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
124894823|NCT03283553|449239524|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
124894824|NCT03686683|449239525|FG000|Overall Study|Withdrawal by Subject|52|||
124894825|NCT03686683|449239526|FG001|Overall Study|Withdrawal by Subject|32|||
124894826|NCT03686683|449239525|FG000|Overall Study|Lost to Follow-up|23|||
124894827|NCT03686683|449239526|FG001|Overall Study|Lost to Follow-up|19|||
124894828|NCT03686683|449239525|FG000|Overall Study|Adverse Event|1|||
124894829|NCT03686683|449239526|FG001|Overall Study|Adverse Event|0|||
124894830|NCT03686683|449239525|FG000|Overall Study|Death|10|||
124894831|NCT03686683|449239526|FG001|Overall Study|Death|5|||
124894832|NCT03686683|449239525|FG000|Overall Study|Progressive Disease|1|||
124894833|NCT03686683|449239526|FG001|Overall Study|Progressive Disease|1|||
124894834|NCT03686683|449239525|FG000|Overall Study|Noncompliance|1|||
125018229|NCT01471782|449691219|FG002|Overall Study|Lack of Efficacy|1|||
125018230|NCT01471782|449691220|FG003|Overall Study|Lack of Efficacy|1|||
125018231|NCT01471782|449691221|FG004|Overall Study|Lack of Efficacy|5|||
125018232|NCT01471782|449691222|FG005|Overall Study|Lack of Efficacy|18|||
125018233|NCT01471782|449691217|FG000|Overall Study|Adverse Event|1|||
125018234|NCT01471782|449691218|FG001|Overall Study|Adverse Event|1|||
125018235|NCT01471782|449691219|FG002|Overall Study|Adverse Event|2|||
125018236|NCT01471782|449691220|FG003|Overall Study|Adverse Event|2|||
125018237|NCT01471782|449691221|FG004|Overall Study|Adverse Event|3|||
125018238|NCT01471782|449691222|FG005|Overall Study|Adverse Event|1|||
125018239|NCT01471782|449691217|FG000|Overall Study|Other|0|||
125018240|NCT01471782|449691218|FG001|Overall Study|Other|0|||
125018241|NCT01471782|449691219|FG002|Overall Study|Other|1|||
125018242|NCT01471782|449691220|FG003|Overall Study|Other|1|||
125018243|NCT01471782|449691221|FG004|Overall Study|Other|6|||
125018244|NCT01471782|449691222|FG005|Overall Study|Other|5|||
125018245|NCT01471782|449691217|FG000|Overall Study|Change of Chemotherapy|1|||
124894835|NCT03686683|449239526|FG001|Overall Study|Noncompliance|0|||
125018246|NCT01471782|449691218|FG001|Overall Study|Change of Chemotherapy|1|||
125018247|NCT01471782|449691219|FG002|Overall Study|Change of Chemotherapy|0|||
125018248|NCT01471782|449691220|FG003|Overall Study|Change of Chemotherapy|0|||
125018249|NCT01471782|449691221|FG004|Overall Study|Change of Chemotherapy|1|||
125018250|NCT01471782|449691222|FG005|Overall Study|Change of Chemotherapy|4|||
125018251|NCT01471782|449691217|FG000|Overall Study|Disease Relapse|0|||
125018252|NCT01471782|449691218|FG001|Overall Study|Disease Relapse|0|||
124894836|NCT03686683|449239525|FG000|Overall Study|Physician Decision|1|||
125018253|NCT01471782|449691219|FG002|Overall Study|Disease Relapse|0|||
125018254|NCT01471782|449691220|FG003|Overall Study|Disease Relapse|1|||
125018255|NCT01471782|449691221|FG004|Overall Study|Disease Relapse|2|||
124894837|NCT03686683|449239526|FG001|Overall Study|Physician Decision|1|||
124894838|NCT03686683|449239525|FG000|Overall Study|Screen fail post-randomization|1|||
124894839|NCT03686683|449239526|FG001|Overall Study|Screen fail post-randomization|0|||
124894840|NCT03686683|449239525|FG000|Overall Study|Protocol Violation|3|||
124894841|NCT03686683|449239526|FG001|Overall Study|Protocol Violation|0|||
124894842|NCT03686683|449239525|FG000|Overall Study|No data available|1|||
124894843|NCT03686683|449239526|FG001|Overall Study|No data available|0|||
124894844|NCT03255941|449239527|FG000|Overall Study|Not eligible or refused injection|37|||
124894845|NCT03255941|449239528|FG001|Overall Study|Not eligible or refused injection|44|||
124894846|NCT03255941|449239529|FG002|Overall Study|Not eligible or refused injection|5|||
124894847|NCT03255941|449239530|FG003|Overall Study|Not eligible or refused injection|6|||
124894848|NCT03255941|449239527|FG000|Overall Study|Did not complete exit interview|1|||
124894849|NCT03255941|449239528|FG001|Overall Study|Did not complete exit interview|2|||
124894850|NCT03255941|449239529|FG002|Overall Study|Did not complete exit interview|0|||
124894851|NCT03255941|449239530|FG003|Overall Study|Did not complete exit interview|0|||
124894852|NCT00372060|449239531|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
124894853|NCT00372060|449239532|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
124894854|NCT00372060|449239531|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
125018256|NCT01471782|449691222|FG005|Overall Study|Disease Relapse|1|||
125108542|NCT01142466|450022518|FG001|Overall Study|Withdrawal by Subject|1|||
125018257|NCT01471782|449691217|FG000|Overall Study|Physician Decision|0|||
125018258|NCT01471782|449691218|FG001|Overall Study|Physician Decision|0|||
125018259|NCT01471782|449691219|FG002|Overall Study|Physician Decision|0|||
125018260|NCT01471782|449691220|FG003|Overall Study|Physician Decision|0|||
125018261|NCT01471782|449691221|FG004|Overall Study|Physician Decision|3|||
125018262|NCT01471782|449691222|FG005|Overall Study|Physician Decision|8|||
125018263|NCT01471782|449691217|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125018264|NCT01471782|449691218|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125018265|NCT01471782|449691219|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
125018266|NCT01471782|449691220|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
125018267|NCT01471782|449691221|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
125018268|NCT01471782|449691222|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
125018269|NCT01471782|449691217|FG000|Overall Study|Death|0|||
125018270|NCT01471782|449691218|FG001|Overall Study|Death|0|||
125018271|NCT01471782|449691219|FG002|Overall Study|Death|0|||
125018272|NCT01471782|449691220|FG003|Overall Study|Death|0|||
125018273|NCT01471782|449691221|FG004|Overall Study|Death|0|||
125018274|NCT01471782|449691222|FG005|Overall Study|Death|1|||
125018275|NCT01314716|449691223|FG000|Double-Blind Phase|Randomized but not treated|1|||
125018276|NCT01314716|449691224|FG001|Double-Blind Phase|Randomized but not treated|1|||
125018277|NCT01314716|449691223|FG000|Double-Blind Phase|Adverse Event|10|||
125018278|NCT01314716|449691224|FG001|Double-Blind Phase|Adverse Event|4|||
125018279|NCT01314716|449691223|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
125018280|NCT01314716|449691224|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
125018281|NCT01314716|449691223|FG000|Double-Blind Phase|Lost to Follow-up|0|||
125018282|NCT01314716|449691224|FG001|Double-Blind Phase|Lost to Follow-up|1|||
125018283|NCT01314716|449691223|FG000|Double-Blind Phase|Sponsor request|1|||
125018284|NCT01314716|449691224|FG001|Double-Blind Phase|Sponsor request|2|||
125018285|NCT01314716|449691223|FG000|Double-Blind Phase|Physician Decision|0|||
125018286|NCT01314716|449691224|FG001|Double-Blind Phase|Physician Decision|1|||
125018287|NCT01314716|449691223|FG000|Open-Label Phase|Adverse Event|4|||
125018288|NCT01314716|449691224|FG001|Open-Label Phase|Adverse Event|6|||
125018289|NCT01314716|449691223|FG000|Open-Label Phase|Withdrawal by Subject|1|||
125018290|NCT01314716|449691224|FG001|Open-Label Phase|Withdrawal by Subject|2|||
125018291|NCT01314716|449691223|FG000|Open-Label Phase|Physician Decision|5|||
125018292|NCT01314716|449691224|FG001|Open-Label Phase|Physician Decision|4|||
125108543|NCT00681824|450022519|FG000|Overall Study|withdrawn by investigator|0|||
124894855|NCT00372060|449239532|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
125018293|NCT00805480|449691227|FG000|Overall Study|Withdrawal by Subject|13|||
125018294|NCT00805480|449691228|FG001|Overall Study|Withdrawal by Subject|5|||
125018295|NCT00805480|449691229|FG002|Overall Study|Withdrawal by Subject|11|||
125018296|NCT00805480|449691230|FG003|Overall Study|Withdrawal by Subject|5|||
125018297|NCT00805480|449691227|FG000|Overall Study|Lost to Follow-up|1|||
125018298|NCT00805480|449691228|FG001|Overall Study|Lost to Follow-up|2|||
125018299|NCT00805480|449691229|FG002|Overall Study|Lost to Follow-up|0|||
125018300|NCT00805480|449691230|FG003|Overall Study|Lost to Follow-up|0|||
125018301|NCT00805480|449691227|FG000|Overall Study|Adverse Event|0|||
125018302|NCT00805480|449691228|FG001|Overall Study|Adverse Event|0|||
125018303|NCT00805480|449691229|FG002|Overall Study|Adverse Event|1|||
125018304|NCT00805480|449691230|FG003|Overall Study|Adverse Event|0|||
125018305|NCT01452152|449691231|FG000|Overall Study|Study termination by sponsor|5|||
125018306|NCT01452152|449691232|FG001|Overall Study|Study termination by sponsor|0|||
125018307|NCT01452152|449691233|FG002|Overall Study|Study termination by sponsor|4|||
125018308|NCT04099251|449692803|FG000|Pre-Treatment|Other reasons|1|||
125018309|NCT04099251|449692804|FG001|Pre-Treatment|Other reasons|0|||
125018310|NCT04099251|449692803|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
125018311|NCT04099251|449692804|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
125018312|NCT04099251|449692803|FG000|Blinded Treatment Phase|Other reasons|16|||
125018313|NCT04099251|449692804|FG001|Blinded Treatment Phase|Other reasons|7|||
125018314|NCT04099251|449692803|FG000|Blinded Treatment Phase|Disease recurrence|26|||
125018315|NCT04099251|449692804|FG001|Blinded Treatment Phase|Disease recurrence|41|||
125018316|NCT04099251|449692803|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
125018317|NCT04099251|449692804|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
125018318|NCT04099251|449692803|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
125018319|NCT04099251|449692804|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
125018320|NCT04099251|449692803|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
125018321|NCT04099251|449692804|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
125018322|NCT04099251|449692803|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
125018323|NCT04099251|449692804|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
125018324|NCT04099251|449692803|FG000|Blinded Treatment Phase|Death|6|||
125018325|NCT04099251|449692804|FG001|Blinded Treatment Phase|Death|2|||
125018326|NCT04099251|449692803|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
125018327|NCT04099251|449692804|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
125018328|NCT04099251|449692803|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
125018329|NCT04099251|449692804|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
125018330|NCT04099251|449692803|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
125018331|NCT04099251|449692804|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
125018332|NCT04099251|449692803|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
125018333|NCT04099251|449692804|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
125018334|NCT04099251|449692803|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
125018335|NCT04099251|449692804|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
125018336|NCT04099251|449692803|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
125018337|NCT04099251|449692804|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
125018338|NCT04099251|449692803|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
125018339|NCT04099251|449692804|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
125018340|NCT04099251|449692803|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
125018341|NCT04099251|449692804|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
125018342|NCT04099251|449692803|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
125018343|NCT04099251|449692804|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
125018344|NCT01783678|449692805|FG000|Overall Study|Randomized but Not Treated|0|||
125018345|NCT01783678|449692806|FG001|Overall Study|Randomized but Not Treated|0|||
125018346|NCT01783678|449692807|FG002|Overall Study|Randomized but Not Treated|0|||
125018347|NCT01783678|449692808|FG003|Overall Study|Randomized but Not Treated|1|||
125018348|NCT01783678|449692809|FG004|Overall Study|Randomized but Not Treated|0|||
125018349|NCT01783678|449692810|FG005|Overall Study|Randomized but Not Treated|0|||
125018350|NCT01783678|449692805|FG000|Overall Study|Lack of Efficacy|1|||
125018351|NCT01783678|449692806|FG001|Overall Study|Lack of Efficacy|13|||
125018352|NCT01783678|449692807|FG002|Overall Study|Lack of Efficacy|1|||
125018353|NCT01783678|449692808|FG003|Overall Study|Lack of Efficacy|3|||
125018354|NCT01783678|449692809|FG004|Overall Study|Lack of Efficacy|6|||
125018355|NCT01783678|449692810|FG005|Overall Study|Lack of Efficacy|5|||
125018356|NCT01783678|449692805|FG000|Overall Study|Lost to Follow-up|0|||
125018357|NCT01783678|449692806|FG001|Overall Study|Lost to Follow-up|4|||
125018358|NCT01783678|449692807|FG002|Overall Study|Lost to Follow-up|0|||
125018359|NCT01783678|449692808|FG003|Overall Study|Lost to Follow-up|2|||
125018360|NCT01783678|449692809|FG004|Overall Study|Lost to Follow-up|1|||
125018361|NCT01783678|449692810|FG005|Overall Study|Lost to Follow-up|0|||
125018362|NCT01783678|449692805|FG000|Overall Study|Withdrew Consent|1|||
125018363|NCT01783678|449692806|FG001|Overall Study|Withdrew Consent|1|||
125018364|NCT01783678|449692807|FG002|Overall Study|Withdrew Consent|0|||
125018365|NCT01783678|449692808|FG003|Overall Study|Withdrew Consent|2|||
125018366|NCT01783678|449692809|FG004|Overall Study|Withdrew Consent|0|||
125018367|NCT01783678|449692810|FG005|Overall Study|Withdrew Consent|0|||
125018368|NCT01995071|449692811|FG000|Overall Study|Adverse Event|0|||
125018369|NCT01995071|449692812|FG001|Overall Study|Adverse Event|0|||
125018370|NCT01995071|449692813|FG002|Overall Study|Adverse Event|0|||
125018371|NCT01995071|449692814|FG003|Overall Study|Adverse Event|0|||
125018372|NCT01995071|449692815|FG004|Overall Study|Adverse Event|0|||
125018373|NCT01995071|449692816|FG005|Overall Study|Adverse Event|0|||
125018374|NCT01995071|449692817|FG006|Overall Study|Adverse Event|1|||
125018375|NCT01995071|449692818|FG007|Overall Study|Adverse Event|0|||
125018376|NCT01995071|449692819|FG008|Overall Study|Adverse Event|0|||
125018377|NCT01995071|449692820|FG009|Overall Study|Adverse Event|0|||
125018378|NCT01995071|449692821|FG010|Overall Study|Adverse Event|0|||
125018379|NCT01995071|449692822|FG011|Overall Study|Adverse Event|0|||
125018380|NCT01995071|449692811|FG000|Overall Study|Moved|0|||
125018381|NCT01995071|449692812|FG001|Overall Study|Moved|0|||
125018382|NCT01995071|449692813|FG002|Overall Study|Moved|1|||
125018383|NCT01995071|449692814|FG003|Overall Study|Moved|0|||
125018384|NCT01995071|449692815|FG004|Overall Study|Moved|1|||
125018385|NCT01995071|449692816|FG005|Overall Study|Moved|0|||
125018386|NCT01995071|449692817|FG006|Overall Study|Moved|0|||
125018387|NCT01995071|449692818|FG007|Overall Study|Moved|0|||
125018388|NCT01995071|449692819|FG008|Overall Study|Moved|0|||
125018389|NCT01995071|449692820|FG009|Overall Study|Moved|0|||
125018390|NCT01995071|449692821|FG010|Overall Study|Moved|1|||
125018391|NCT01995071|449692822|FG011|Overall Study|Moved|0|||
125018392|NCT01995071|449692811|FG000|Overall Study|Lost to Follow-up|1|||
125018393|NCT01995071|449692812|FG001|Overall Study|Lost to Follow-up|0|||
125018394|NCT01995071|449692813|FG002|Overall Study|Lost to Follow-up|0|||
125018395|NCT01995071|449692814|FG003|Overall Study|Lost to Follow-up|0|||
125018396|NCT01995071|449692815|FG004|Overall Study|Lost to Follow-up|0|||
125018397|NCT01995071|449692816|FG005|Overall Study|Lost to Follow-up|0|||
125018398|NCT01995071|449692817|FG006|Overall Study|Lost to Follow-up|0|||
125018399|NCT01995071|449692818|FG007|Overall Study|Lost to Follow-up|1|||
125108544|NCT00681824|450022520|FG001|Overall Study|withdrawn by investigator|0|||
125108545|NCT00681824|450022521|FG002|Overall Study|withdrawn by investigator|1|||
125108546|NCT00681824|450022519|FG000|Overall Study|scheduling conflict|1|||
125108547|NCT00681824|450022520|FG001|Overall Study|scheduling conflict|0|||
125108548|NCT00681824|450022521|FG002|Overall Study|scheduling conflict|0|||
125108549|NCT00681824|450022519|FG000|Overall Study|Death|0|||
124894856|NCT00372060|449239531|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
124894857|NCT00372060|449239532|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
124894858|NCT00372060|449239531|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
124894859|NCT00372060|449239532|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
124894860|NCT00372060|449239531|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
124894861|NCT00372060|449239532|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
124894862|NCT00372060|449239531|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
124894863|NCT00372060|449239532|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
124894864|NCT05124899|449239534|FG000|Overall Study|Lost to Follow-up|3|||
124894865|NCT00647348|449239536|FG000|Overall Study|Lost to Follow-up|3|||
124894866|NCT00647348|449239537|FG001|Overall Study|Lost to Follow-up|6|||
124894867|NCT01417000|449239544|FG000|Overall Study|Death|59|||
124894868|NCT01417000|449239545|FG001|Overall Study|Death|28|||
124894869|NCT01417000|449239544|FG000|Overall Study|Lost to Follow-up|1|||
124894870|NCT01417000|449239545|FG001|Overall Study|Lost to Follow-up|0|||
124894871|NCT01417000|449239544|FG000|Overall Study|Study Terminated by Sponsor|1|||
124894872|NCT01417000|449239545|FG001|Overall Study|Study Terminated by Sponsor|1|||
124894873|NCT00797225|449239546|FG000|Weeks 1 to 12|Adverse Event|0|||
124894874|NCT00797225|449239547|FG001|Weeks 1 to 12|Adverse Event|0|||
124894875|NCT00797225|449239548|FG002|Weeks 1 to 12|Adverse Event|1|||
124894876|NCT00797225|449239549|FG003|Weeks 1 to 12|Adverse Event|0|||
124894877|NCT00797225|449239550|FG004|Weeks 1 to 12|Adverse Event|0|||
124894878|NCT00797225|449239551|FG005|Weeks 1 to 12|Adverse Event|0|||
124894879|NCT00797225|449239552|FG006|Weeks 1 to 12|Adverse Event|0|||
124894880|NCT00797225|449239553|FG007|Weeks 1 to 12|Adverse Event|0|||
124894881|NCT00797225|449239546|FG000|Weeks 1 to 12|Non-compliance|0|||
124894882|NCT00797225|449239547|FG001|Weeks 1 to 12|Non-compliance|1|||
125108550|NCT00681824|450022520|FG001|Overall Study|Death|1|||
125108551|NCT00681824|450022521|FG002|Overall Study|Death|0|||
125108552|NCT03724916|450022522|FG000|Overall Study|Withdrawal by Subject|0|||
125108553|NCT03724916|450022523|FG001|Overall Study|Withdrawal by Subject|1|||
125108554|NCT03724916|450022524|FG002|Overall Study|Withdrawal by Subject|1|||
125108555|NCT03724916|450022525|FG003|Overall Study|Withdrawal by Subject|2|||
125108556|NCT03724916|450022522|FG000|Overall Study|Randomized but not Treated|1|||
125108557|NCT03724916|450022523|FG001|Overall Study|Randomized but not Treated|0|||
125108558|NCT03724916|450022524|FG002|Overall Study|Randomized but not Treated|0|||
125108559|NCT03724916|450022525|FG003|Overall Study|Randomized but not Treated|0|||
125108560|NCT03591107|450022530|FG000|Overall Study|Same patient in both arms|1|||
125108561|NCT03591107|450022531|FG001|Overall Study|Same patient in both arms|1|||
124894883|NCT00797225|449239548|FG002|Weeks 1 to 12|Non-compliance|0|||
124894884|NCT00797225|449239549|FG003|Weeks 1 to 12|Non-compliance|0|||
124894885|NCT00797225|449239550|FG004|Weeks 1 to 12|Non-compliance|0|||
124894886|NCT00797225|449239551|FG005|Weeks 1 to 12|Non-compliance|0|||
124894887|NCT00797225|449239552|FG006|Weeks 1 to 12|Non-compliance|0|||
124894888|NCT00797225|449239553|FG007|Weeks 1 to 12|Non-compliance|0|||
124894889|NCT00797225|449239546|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
124894890|NCT00797225|449239547|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
124894891|NCT00797225|449239548|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
124894892|NCT00797225|449239549|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
124894893|NCT00797225|449239550|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
124894894|NCT00797225|449239551|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
124894895|NCT00797225|449239552|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
124894896|NCT00797225|449239553|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
124894897|NCT00797225|449239546|FG000|Weeks 1 to 12|Sponsor Decision|1|||
124894898|NCT00797225|449239547|FG001|Weeks 1 to 12|Sponsor Decision|0|||
124894899|NCT00797225|449239548|FG002|Weeks 1 to 12|Sponsor Decision|0|||
124894900|NCT00797225|449239549|FG003|Weeks 1 to 12|Sponsor Decision|0|||
124894901|NCT00797225|449239550|FG004|Weeks 1 to 12|Sponsor Decision|0|||
124894902|NCT00797225|449239551|FG005|Weeks 1 to 12|Sponsor Decision|0|||
124894903|NCT00797225|449239552|FG006|Weeks 1 to 12|Sponsor Decision|0|||
125108562|NCT03591107|450022530|FG000|Overall Study|Sought care at other clinics|0|||
125108563|NCT03591107|450022531|FG001|Overall Study|Sought care at other clinics|2|||
125108564|NCT03591107|450022530|FG000|Overall Study|Discharged from clinic|0|||
124894904|NCT00797225|449239553|FG007|Weeks 1 to 12|Sponsor Decision|0|||
124894905|NCT00797225|449239546|FG000|Weeks 13 to 24|Non-compliance|0|||
124894906|NCT00797225|449239547|FG001|Weeks 13 to 24|Non-compliance|2|||
124894907|NCT00797225|449239548|FG002|Weeks 13 to 24|Non-compliance|0|||
125108565|NCT03591107|450022531|FG001|Overall Study|Discharged from clinic|1|||
125108566|NCT03591107|450022530|FG000|Overall Study|Withdrawal by Subject|0|||
124894908|NCT00797225|449239549|FG003|Weeks 13 to 24|Non-compliance|0|||
124894909|NCT00797225|449239550|FG004|Weeks 13 to 24|Non-compliance|0|||
124894910|NCT00797225|449239551|FG005|Weeks 13 to 24|Non-compliance|0|||
124894911|NCT00797225|449239552|FG006|Weeks 13 to 24|Non-compliance|0|||
124894912|NCT00797225|449239553|FG007|Weeks 13 to 24|Non-compliance|0|||
124894913|NCT00797225|449239546|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
124894914|NCT00797225|449239547|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
124894915|NCT00797225|449239548|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
124894916|NCT00797225|449239549|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
124894917|NCT00797225|449239550|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
124894918|NCT00797225|449239551|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
124894919|NCT00797225|449239552|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
124894920|NCT00797225|449239553|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
124894921|NCT00797225|449239546|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
124894922|NCT00797225|449239547|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
124894923|NCT00797225|449239548|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
124894924|NCT00797225|449239549|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
124894925|NCT00797225|449239550|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
124894926|NCT00797225|449239551|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
124894927|NCT00797225|449239552|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
124894928|NCT00797225|449239553|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
124894929|NCT00797225|449239546|FG000|Weeks 13 to 24|Adverse Event|0|||
124894930|NCT00797225|449239547|FG001|Weeks 13 to 24|Adverse Event|1|||
124894931|NCT00797225|449239548|FG002|Weeks 13 to 24|Adverse Event|0|||
124894932|NCT00797225|449239549|FG003|Weeks 13 to 24|Adverse Event|0|||
124894933|NCT00797225|449239550|FG004|Weeks 13 to 24|Adverse Event|0|||
124894934|NCT00797225|449239551|FG005|Weeks 13 to 24|Adverse Event|0|||
124894935|NCT00797225|449239552|FG006|Weeks 13 to 24|Adverse Event|1|||
124894936|NCT00797225|449239553|FG007|Weeks 13 to 24|Adverse Event|0|||
124894937|NCT00797225|449239546|FG000|Weeks 13 to 24|Sponsor Decision|0|||
124894938|NCT00797225|449239547|FG001|Weeks 13 to 24|Sponsor Decision|0|||
124894939|NCT00797225|449239548|FG002|Weeks 13 to 24|Sponsor Decision|0|||
124894940|NCT00797225|449239549|FG003|Weeks 13 to 24|Sponsor Decision|0|||
124894941|NCT00797225|449239550|FG004|Weeks 13 to 24|Sponsor Decision|0|||
124894942|NCT00797225|449239551|FG005|Weeks 13 to 24|Sponsor Decision|0|||
124894943|NCT00797225|449239552|FG006|Weeks 13 to 24|Sponsor Decision|1|||
124894944|NCT00797225|449239553|FG007|Weeks 13 to 24|Sponsor Decision|0|||
124894945|NCT02954055|449239554|FG000|Overall Study|Did not initiate therapy|6|||
124894946|NCT02954055|449239555|FG001|Overall Study|Did not initiate therapy|1|||
124894947|NCT05489224|449239558|FG000|Treatment Period I|Withdrawal by Subject|6|||
124894948|NCT05489224|449239559|FG001|Treatment Period I|Withdrawal by Subject|5|||
124894949|NCT05489224|449239560|FG002|Treatment Period I|Withdrawal by Subject|0|||
124894950|NCT05489224|449239558|FG000|Treatment Period I|Adverse Event|3|||
124894951|NCT05489224|449239559|FG001|Treatment Period I|Adverse Event|11|||
124894952|NCT05489224|449239560|FG002|Treatment Period I|Adverse Event|0|||
124894953|NCT05489224|449239558|FG000|Treatment Period I|Lost to Follow-up|0|||
124894954|NCT05489224|449239559|FG001|Treatment Period I|Lost to Follow-up|1|||
124894955|NCT05489224|449239560|FG002|Treatment Period I|Lost to Follow-up|0|||
124894956|NCT05489224|449239558|FG000|Treatment Period I|Physician Decision|0|||
124894957|NCT05489224|449239559|FG001|Treatment Period I|Physician Decision|1|||
124894958|NCT05489224|449239560|FG002|Treatment Period I|Physician Decision|0|||
124894959|NCT05489224|449239558|FG000|Treatment Period II up to Week 32|Ongoing|222|||
124894960|NCT05489224|449239559|FG001|Treatment Period II up to Week 32|Ongoing|107|||
124894961|NCT05489224|449239560|FG002|Treatment Period II up to Week 32|Ongoing|107|||
124894962|NCT05489224|449239558|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
124894963|NCT05489224|449239559|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
124894964|NCT05489224|449239560|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
124894965|NCT05489224|449239558|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
124894966|NCT05489224|449239559|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
124894967|NCT05489224|449239560|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
124894968|NCT04640571|449239561|FG000|Overall Study|Withdrawal by Subject|0|||
124894969|NCT04640571|449239562|FG001|Overall Study|Withdrawal by Subject|0|||
124894970|NCT04640571|449239563|FG002|Overall Study|Withdrawal by Subject|0|||
124894971|NCT04640571|449239564|FG003|Overall Study|Withdrawal by Subject|0|||
124894972|NCT04640571|449239565|FG004|Overall Study|Withdrawal by Subject|0|||
124894973|NCT04640571|449239566|FG005|Overall Study|Withdrawal by Subject|2|||
124894974|NCT00832780|449239568|FG000|Overall Study|Death|16|||
124894975|NCT00832780|449239568|FG000|Overall Study|Lost to Follow-up|4|||
124894976|NCT00832780|449239568|FG000|Overall Study|no reason given|2|||
124894977|NCT00832780|449239568|FG000|Overall Study|other complicating condition|2|||
124894978|NCT00832780|449239568|FG000|Overall Study|Physician Decision|1|||
124894979|NCT01767909|449239571|FG000|Overall Study|Withdrawal by Subject|4|||
124894980|NCT01767909|449239572|FG001|Overall Study|Withdrawal by Subject|7|||
124894981|NCT01767909|449239571|FG000|Overall Study|Adverse Event|3|||
124894982|NCT01767909|449239572|FG001|Overall Study|Adverse Event|1|||
124894983|NCT01767909|449239571|FG000|Overall Study|Withdrawal by Study Partner|3|||
124894984|NCT01767909|449239572|FG001|Overall Study|Withdrawal by Study Partner|1|||
124894985|NCT01767909|449239571|FG000|Overall Study|Non-Compliance|2|||
124894986|NCT01767909|449239572|FG001|Overall Study|Non-Compliance|0|||
124894987|NCT01767909|449239571|FG000|Overall Study|Perceived Lack of Efficacy|1|||
124894988|NCT01767909|449239572|FG001|Overall Study|Perceived Lack of Efficacy|0|||
124894989|NCT01767909|449239571|FG000|Overall Study|Investigator Recommendation|0|||
124894990|NCT01767909|449239572|FG001|Overall Study|Investigator Recommendation|1|||
124894991|NCT01767909|449239571|FG000|Overall Study|Lost to Follow-up|0|||
124894992|NCT01767909|449239572|FG001|Overall Study|Lost to Follow-up|1|||
124894993|NCT01767909|449239571|FG000|Overall Study|LP uncessessful|0|||
124894994|NCT01767909|449239572|FG001|Overall Study|LP uncessessful|1|||
124894995|NCT04319094|449239574|FG000|Baseline|Lost to Follow-up|4|||
124894996|NCT04319094|449239575|FG001|Baseline|Lost to Follow-up|5|||
124894997|NCT04319094|449239574|FG000|Baseline|Protocol Violation|0|||
124894998|NCT04319094|449239575|FG001|Baseline|Protocol Violation|3|||
124894999|NCT04319094|449239574|FG000|Baseline|Withdrawal by Subject|2|||
124895000|NCT04319094|449239575|FG001|Baseline|Withdrawal by Subject|1|||
124895001|NCT04319094|449239574|FG000|Post-Intervention|Death|0|||
124895002|NCT04319094|449239575|FG001|Post-Intervention|Death|1|||
124895003|NCT04319094|449239574|FG000|Post-Intervention|Lost to Follow-up|4|||
124895004|NCT04319094|449239575|FG001|Post-Intervention|Lost to Follow-up|4|||
124895005|NCT04319094|449239574|FG000|Post-Intervention|Withdrawal by Subject|8|||
124895006|NCT04319094|449239575|FG001|Post-Intervention|Withdrawal by Subject|5|||
124895007|NCT04319094|449239574|FG000|Post-Intervention|Incomplete Data Collection|1|||
124895008|NCT04319094|449239575|FG001|Post-Intervention|Incomplete Data Collection|3|||
124895009|NCT04319094|449239574|FG000|3-month|Death|1|||
124895010|NCT04319094|449239575|FG001|3-month|Death|0|||
124895011|NCT04319094|449239574|FG000|3-month|Lost to Follow-up|2|||
124895012|NCT04319094|449239575|FG001|3-month|Lost to Follow-up|2|||
124895013|NCT04319094|449239574|FG000|3-month|Withdrawal by Subject|0|||
124895014|NCT04319094|449239575|FG001|3-month|Withdrawal by Subject|3|||
124895015|NCT04319094|449239574|FG000|3-month|Incomplete data collection|9|||
124895016|NCT04319094|449239575|FG001|3-month|Incomplete data collection|7|||
124895017|NCT04319094|449239574|FG000|6-month|Lost to Follow-up|1|||
124895018|NCT04319094|449239575|FG001|6-month|Lost to Follow-up|1|||
124895019|NCT04319094|449239574|FG000|6-month|Withdrawal by Subject|0|||
124895020|NCT04319094|449239575|FG001|6-month|Withdrawal by Subject|3|||
124895021|NCT04319094|449239574|FG000|6-month|Incomplete data collection|14|||
124895022|NCT04319094|449239575|FG001|6-month|Incomplete data collection|9|||
124895023|NCT04319094|449239574|FG000|9-month|Lost to Follow-up|8|||
124895024|NCT04319094|449239575|FG001|9-month|Lost to Follow-up|4|||
124895025|NCT04319094|449239574|FG000|9-month|Withdrawal by Subject|0|||
124895026|NCT04319094|449239575|FG001|9-month|Withdrawal by Subject|1|||
124895027|NCT04319094|449239574|FG000|9-month|Incomplete data collection|8|||
124895028|NCT04319094|449239575|FG001|9-month|Incomplete data collection|5|||
124895029|NCT04319094|449239574|FG000|12-month|Lost to Follow-up|11|||
124895030|NCT04319094|449239575|FG001|12-month|Lost to Follow-up|8|||
124895031|NCT04956692|449239576|FG000|Overall Study|Death|115|||
124895032|NCT04956692|449239577|FG001|Overall Study|Death|47|||
124895033|NCT04956692|449239576|FG000|Overall Study|Lost to Follow-up|0|||
124895034|NCT04956692|449239577|FG001|Overall Study|Lost to Follow-up|1|||
124895035|NCT04956692|449239576|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
124895036|NCT04956692|449239577|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124895037|NCT04956692|449239576|FG000|Overall Study|Withdrawal by Subject|5|||
124895038|NCT04956692|449239577|FG001|Overall Study|Withdrawal by Subject|2|||
124895039|NCT04956692|449239576|FG000|Overall Study|Ongoing in Study|236|||
124895040|NCT04956692|449239577|FG001|Overall Study|Ongoing in Study|123|||
124895041|NCT05780047|449239581|FG000|Overall Study|Did not submit baseline urine test kit|226|||
124895042|NCT05780047|449239581|FG000|Overall Study|Lost to Follow-up|34|||
124895043|NCT05780047|449239581|FG000|Overall Study|Did not submit second urine test kit|124|||
124895044|NCT04873817|449239582|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
124895045|NCT04873817|449239582|FG000|Overall Study|Lost to Follow-up|4|||
124895046|NCT04873817|449239582|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
124895047|NCT04873817|449239582|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
124895048|NCT04873817|449239582|FG000|Overall Study|Other Reasons|3|||
124895049|NCT00665561|449239583|FG000|Overall Study|Death recorded on subject summary pages|75|||
124895050|NCT00665561|449239584|FG001|Overall Study|Death recorded on subject summary pages|75|||
124895051|NCT00665561|449239583|FG000|Overall Study|Does not meet entrance criteria|19|||
124895052|NCT00665561|449239584|FG001|Overall Study|Does not meet entrance criteria|21|||
124895053|NCT00665561|449239583|FG000|Overall Study|Lost to Follow-up|203|||
124895054|NCT00665561|449239584|FG001|Overall Study|Lost to Follow-up|264|||
124895055|NCT00665561|449239583|FG000|Overall Study|Withdrawal by Subject|74|||
124895056|NCT00665561|449239584|FG001|Overall Study|Withdrawal by Subject|65|||
124895057|NCT00665561|449239583|FG000|Overall Study|Other|123|||
124895058|NCT00665561|449239584|FG001|Overall Study|Other|108|||
124895059|NCT00665561|449239583|FG000|Overall Study|Site closed|8|||
124895060|NCT00665561|449239584|FG001|Overall Study|Site closed|0|||
124895061|NCT00665561|449239583|FG000|Overall Study|Withdrawn due to pregnancy|0|||
124895062|NCT00665561|449239584|FG001|Overall Study|Withdrawn due to pregnancy|1|||
124895063|NCT01734811|449239587|FG000|Overall Study|Lost to Follow-up|2|||
124895064|NCT01734811|449239588|FG001|Overall Study|Lost to Follow-up|3|||
124895065|NCT01734811|449239587|FG000|Overall Study|Withdrawal by Subject|2|||
124895066|NCT01734811|449239588|FG001|Overall Study|Withdrawal by Subject|0|||
124895067|NCT00062868|449239589|FG000|Dose Level 1|Death|2|||
124895068|NCT00062868|449239590|FG001|Dose Level 1|Death|0|||
124895069|NCT00062868|449239591|FG002|Dose Level 1|Death|0|||
124895070|NCT00062868|449239592|FG003|Dose Level 1|Death|2|||
124895071|NCT00062868|449239593|FG004|Dose Level 1|Death|0|||
124895072|NCT00062868|449239594|FG005|Dose Level 1|Death|0|||
124895073|NCT00062868|449239595|FG006|Dose Level 1|Death|3|||
124895074|NCT00062868|449239596|FG007|Dose Level 1|Death|0|||
124895075|NCT00062868|449239597|FG008|Dose Level 1|Death|0|||
124895076|NCT00062868|449239598|FG009|Dose Level 1|Death|0|||
124895077|NCT00062868|449239599|FG010|Dose Level 1|Death|0|||
124895078|NCT00062868|449239600|FG011|Dose Level 1|Death|0|||
124895079|NCT00062868|449239601|FG012|Dose Level 1|Death|0|||
124895080|NCT00062868|449239602|FG013|Dose Level 1|Death|0|||
124895081|NCT00062868|449239603|FG014|Dose Level 1|Death|0|||
124895082|NCT00062868|449239604|FG015|Dose Level 1|Death|0|||
124895083|NCT00062868|449239605|FG016|Dose Level 1|Death|0|||
124895084|NCT00062868|449239606|FG017|Dose Level 1|Death|0|||
124895085|NCT00062868|449239607|FG018|Dose Level 1|Death|7|||
124895086|NCT00062868|449239608|FG019|Dose Level 1|Death|0|||
124895087|NCT00062868|449239609|FG020|Dose Level 1|Death|1|||
124895088|NCT00062868|449239589|FG000|Dose Level 1|Lost to Follow-up|0|||
124895089|NCT00062868|449239590|FG001|Dose Level 1|Lost to Follow-up|0|||
124895090|NCT00062868|449239591|FG002|Dose Level 1|Lost to Follow-up|0|||
124895091|NCT00062868|449239592|FG003|Dose Level 1|Lost to Follow-up|0|||
124895092|NCT00062868|449239593|FG004|Dose Level 1|Lost to Follow-up|0|||
124895093|NCT00062868|449239594|FG005|Dose Level 1|Lost to Follow-up|0|||
124895094|NCT00062868|449239595|FG006|Dose Level 1|Lost to Follow-up|0|||
124895095|NCT00062868|449239596|FG007|Dose Level 1|Lost to Follow-up|0|||
124895096|NCT00062868|449239597|FG008|Dose Level 1|Lost to Follow-up|0|||
124895097|NCT00062868|449239598|FG009|Dose Level 1|Lost to Follow-up|0|||
124895098|NCT00062868|449239599|FG010|Dose Level 1|Lost to Follow-up|0|||
124895099|NCT00062868|449239600|FG011|Dose Level 1|Lost to Follow-up|0|||
124895100|NCT00062868|449239601|FG012|Dose Level 1|Lost to Follow-up|1|||
124895101|NCT00062868|449239602|FG013|Dose Level 1|Lost to Follow-up|0|||
124895102|NCT00062868|449239603|FG014|Dose Level 1|Lost to Follow-up|0|||
124895103|NCT00062868|449239604|FG015|Dose Level 1|Lost to Follow-up|0|||
124895104|NCT00062868|449239605|FG016|Dose Level 1|Lost to Follow-up|0|||
124895105|NCT00062868|449239606|FG017|Dose Level 1|Lost to Follow-up|0|||
124895106|NCT00062868|449239607|FG018|Dose Level 1|Lost to Follow-up|2|||
124895107|NCT00062868|449239608|FG019|Dose Level 1|Lost to Follow-up|0|||
124895108|NCT00062868|449239609|FG020|Dose Level 1|Lost to Follow-up|1|||
124895109|NCT00062868|449239589|FG000|Dose Level 2|Death|0|||
124895110|NCT00062868|449239590|FG001|Dose Level 2|Death|3|||
124895111|NCT00062868|449239591|FG002|Dose Level 2|Death|0|||
124895112|NCT00062868|449239592|FG003|Dose Level 2|Death|0|||
124895113|NCT00062868|449239593|FG004|Dose Level 2|Death|2|||
124895114|NCT00062868|449239594|FG005|Dose Level 2|Death|0|||
124895115|NCT00062868|449239595|FG006|Dose Level 2|Death|0|||
124895116|NCT00062868|449239596|FG007|Dose Level 2|Death|0|||
124895117|NCT00062868|449239597|FG008|Dose Level 2|Death|0|||
124895118|NCT00062868|449239598|FG009|Dose Level 2|Death|0|||
124895119|NCT00062868|449239599|FG010|Dose Level 2|Death|1|||
124895120|NCT00062868|449239600|FG011|Dose Level 2|Death|0|||
124895121|NCT00062868|449239601|FG012|Dose Level 2|Death|0|||
124895122|NCT00062868|449239602|FG013|Dose Level 2|Death|0|||
124895123|NCT00062868|449239603|FG014|Dose Level 2|Death|0|||
124895124|NCT00062868|449239604|FG015|Dose Level 2|Death|0|||
124895125|NCT00062868|449239605|FG016|Dose Level 2|Death|2|||
124895126|NCT00062868|449239606|FG017|Dose Level 2|Death|0|||
124895127|NCT00062868|449239607|FG018|Dose Level 2|Death|0|||
124895128|NCT00062868|449239608|FG019|Dose Level 2|Death|0|||
124895129|NCT00062868|449239609|FG020|Dose Level 2|Death|0|||
124895130|NCT00062868|449239589|FG000|Dose Level 2|Lost to Follow-up|0|||
124895131|NCT00062868|449239590|FG001|Dose Level 2|Lost to Follow-up|0|||
124895132|NCT00062868|449239591|FG002|Dose Level 2|Lost to Follow-up|0|||
124895133|NCT00062868|449239592|FG003|Dose Level 2|Lost to Follow-up|0|||
124895134|NCT00062868|449239593|FG004|Dose Level 2|Lost to Follow-up|0|||
124895135|NCT00062868|449239594|FG005|Dose Level 2|Lost to Follow-up|0|||
124895136|NCT00062868|449239595|FG006|Dose Level 2|Lost to Follow-up|0|||
124895137|NCT00062868|449239596|FG007|Dose Level 2|Lost to Follow-up|0|||
124895138|NCT00062868|449239597|FG008|Dose Level 2|Lost to Follow-up|0|||
124895139|NCT00062868|449239598|FG009|Dose Level 2|Lost to Follow-up|0|||
124895140|NCT00062868|449239599|FG010|Dose Level 2|Lost to Follow-up|0|||
124895141|NCT00062868|449239600|FG011|Dose Level 2|Lost to Follow-up|0|||
124895142|NCT00062868|449239601|FG012|Dose Level 2|Lost to Follow-up|0|||
124895143|NCT00062868|449239602|FG013|Dose Level 2|Lost to Follow-up|1|||
124895144|NCT00062868|449239603|FG014|Dose Level 2|Lost to Follow-up|0|||
124895145|NCT00062868|449239604|FG015|Dose Level 2|Lost to Follow-up|0|||
124895146|NCT00062868|449239605|FG016|Dose Level 2|Lost to Follow-up|1|||
124895147|NCT00062868|449239606|FG017|Dose Level 2|Lost to Follow-up|0|||
124895148|NCT00062868|449239607|FG018|Dose Level 2|Lost to Follow-up|0|||
124895149|NCT00062868|449239608|FG019|Dose Level 2|Lost to Follow-up|0|||
124895150|NCT00062868|449239609|FG020|Dose Level 2|Lost to Follow-up|0|||
124895151|NCT00062868|449239589|FG000|Dose Level 3|Death|0|||
124895152|NCT00062868|449239590|FG001|Dose Level 3|Death|0|||
124895153|NCT00062868|449239591|FG002|Dose Level 3|Death|0|||
124895154|NCT00062868|449239592|FG003|Dose Level 3|Death|0|||
125018400|NCT01995071|449692819|FG008|Overall Study|Lost to Follow-up|1|||
125018401|NCT01995071|449692820|FG009|Overall Study|Lost to Follow-up|0|||
124895155|NCT00062868|449239593|FG004|Dose Level 3|Death|0|||
124895156|NCT00062868|449239594|FG005|Dose Level 3|Death|0|||
124895157|NCT00062868|449239595|FG006|Dose Level 3|Death|0|||
124895158|NCT00062868|449239596|FG007|Dose Level 3|Death|0|||
124895159|NCT00062868|449239597|FG008|Dose Level 3|Death|0|||
124895160|NCT00062868|449239598|FG009|Dose Level 3|Death|0|||
124895161|NCT00062868|449239599|FG010|Dose Level 3|Death|0|||
124895162|NCT00062868|449239600|FG011|Dose Level 3|Death|1|||
124895163|NCT00062868|449239601|FG012|Dose Level 3|Death|0|||
124895164|NCT00062868|449239602|FG013|Dose Level 3|Death|0|||
124895165|NCT00062868|449239603|FG014|Dose Level 3|Death|0|||
124895166|NCT00062868|449239604|FG015|Dose Level 3|Death|0|||
124895167|NCT00062868|449239605|FG016|Dose Level 3|Death|0|||
124895168|NCT00062868|449239606|FG017|Dose Level 3|Death|1|||
124895169|NCT00062868|449239607|FG018|Dose Level 3|Death|0|||
124895170|NCT00062868|449239608|FG019|Dose Level 3|Death|0|||
124895171|NCT00062868|449239609|FG020|Dose Level 3|Death|0|||
124895172|NCT00062868|449239589|FG000|Dose Level 3|Lost to Follow-up|0|||
124895173|NCT00062868|449239590|FG001|Dose Level 3|Lost to Follow-up|0|||
124895174|NCT00062868|449239591|FG002|Dose Level 3|Lost to Follow-up|0|||
125018402|NCT01995071|449692821|FG010|Overall Study|Lost to Follow-up|0|||
124895175|NCT00062868|449239592|FG003|Dose Level 3|Lost to Follow-up|0|||
124895176|NCT00062868|449239593|FG004|Dose Level 3|Lost to Follow-up|0|||
124895177|NCT00062868|449239594|FG005|Dose Level 3|Lost to Follow-up|0|||
124895178|NCT00062868|449239595|FG006|Dose Level 3|Lost to Follow-up|0|||
124895179|NCT00062868|449239596|FG007|Dose Level 3|Lost to Follow-up|0|||
124895180|NCT00062868|449239597|FG008|Dose Level 3|Lost to Follow-up|0|||
124895181|NCT00062868|449239598|FG009|Dose Level 3|Lost to Follow-up|0|||
124895182|NCT00062868|449239599|FG010|Dose Level 3|Lost to Follow-up|0|||
124895183|NCT00062868|449239600|FG011|Dose Level 3|Lost to Follow-up|0|||
124895184|NCT00062868|449239601|FG012|Dose Level 3|Lost to Follow-up|0|||
124895185|NCT00062868|449239602|FG013|Dose Level 3|Lost to Follow-up|0|||
124895186|NCT00062868|449239603|FG014|Dose Level 3|Lost to Follow-up|1|||
124895187|NCT00062868|449239604|FG015|Dose Level 3|Lost to Follow-up|0|||
124895188|NCT00062868|449239605|FG016|Dose Level 3|Lost to Follow-up|0|||
124895189|NCT00062868|449239606|FG017|Dose Level 3|Lost to Follow-up|0|||
124895190|NCT00062868|449239607|FG018|Dose Level 3|Lost to Follow-up|0|||
124895191|NCT00062868|449239608|FG019|Dose Level 3|Lost to Follow-up|0|||
124895192|NCT00062868|449239609|FG020|Dose Level 3|Lost to Follow-up|0|||
124895193|NCT00062868|449239589|FG000|Dose Level 3|Withdrew|0|||
124895194|NCT00062868|449239590|FG001|Dose Level 3|Withdrew|0|||
124895195|NCT00062868|449239591|FG002|Dose Level 3|Withdrew|2|||
124895196|NCT00062868|449239592|FG003|Dose Level 3|Withdrew|0|||
124895197|NCT00062868|449239593|FG004|Dose Level 3|Withdrew|0|||
124895198|NCT00062868|449239594|FG005|Dose Level 3|Withdrew|0|||
124895199|NCT00062868|449239595|FG006|Dose Level 3|Withdrew|0|||
124895200|NCT00062868|449239596|FG007|Dose Level 3|Withdrew|0|||
124895201|NCT00062868|449239597|FG008|Dose Level 3|Withdrew|0|||
124895202|NCT00062868|449239598|FG009|Dose Level 3|Withdrew|0|||
124895203|NCT00062868|449239599|FG010|Dose Level 3|Withdrew|0|||
124895204|NCT00062868|449239600|FG011|Dose Level 3|Withdrew|0|||
124895205|NCT00062868|449239601|FG012|Dose Level 3|Withdrew|0|||
124895206|NCT00062868|449239602|FG013|Dose Level 3|Withdrew|0|||
124895207|NCT00062868|449239603|FG014|Dose Level 3|Withdrew|0|||
124895208|NCT00062868|449239604|FG015|Dose Level 3|Withdrew|0|||
124895209|NCT00062868|449239605|FG016|Dose Level 3|Withdrew|0|||
124895210|NCT00062868|449239606|FG017|Dose Level 3|Withdrew|0|||
124895211|NCT00062868|449239607|FG018|Dose Level 3|Withdrew|0|||
124895212|NCT00062868|449239608|FG019|Dose Level 3|Withdrew|0|||
124895213|NCT00062868|449239609|FG020|Dose Level 3|Withdrew|0|||
125018403|NCT01995071|449692822|FG011|Overall Study|Lost to Follow-up|0|||
125018404|NCT01995071|449692811|FG000|Overall Study|Incarcerated|0|||
125018405|NCT01995071|449692812|FG001|Overall Study|Incarcerated|0|||
125018406|NCT01995071|449692813|FG002|Overall Study|Incarcerated|0|||
125018407|NCT01995071|449692814|FG003|Overall Study|Incarcerated|0|||
125018408|NCT01995071|449692815|FG004|Overall Study|Incarcerated|0|||
125018409|NCT01995071|449692816|FG005|Overall Study|Incarcerated|0|||
125018410|NCT01995071|449692817|FG006|Overall Study|Incarcerated|0|||
125018411|NCT01995071|449692818|FG007|Overall Study|Incarcerated|1|||
124895214|NCT00670540|449239614|FG000|Overall Study|ineligible|17|||
124895215|NCT00670540|449239614|FG000|Overall Study|not living in France|348|||
124895216|NCT00670540|449239614|FG000|Overall Study|refused to participate|189|||
124895217|NCT00670540|449239614|FG000|Overall Study|controls randomised for no follow up|2770|||
124895218|NCT00670540|449239614|FG000|Overall Study|missing information inclusion criteria|1|||
124895219|NCT01866917|449239615|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
124895220|NCT01866917|449239616|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
124895221|NCT01515319|449239620|FG000|Overall Study|Withdrawal by Subject|0|||
124895222|NCT01515319|449239621|FG001|Overall Study|Withdrawal by Subject|0|||
124895223|NCT01515319|449239622|FG002|Overall Study|Withdrawal by Subject|0|||
124895224|NCT01515319|449239623|FG003|Overall Study|Withdrawal by Subject|0|||
124895225|NCT01515319|449239624|FG004|Overall Study|Withdrawal by Subject|0|||
124895226|NCT01515319|449239625|FG005|Overall Study|Withdrawal by Subject|0|||
124895227|NCT01515319|449239626|FG006|Overall Study|Withdrawal by Subject|1|||
124895228|NCT01515319|449239627|FG007|Overall Study|Withdrawal by Subject|0|||
125108567|NCT03591107|450022531|FG001|Overall Study|Withdrawal by Subject|1|||
125108568|NCT03836729|450022540|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
125108569|NCT01270841|450022541|FG000|Overall Study|Adverse Event|0|||
125108570|NCT01270841|450022542|FG001|Overall Study|Adverse Event|1|||
125108571|NCT01270841|450022543|FG002|Overall Study|Adverse Event|0|||
125108572|NCT01270841|450022544|FG003|Overall Study|Adverse Event|3|||
125108573|NCT01270841|450022541|FG000|Overall Study|Withdrawal by Subject|3|||
125108574|NCT01270841|450022542|FG001|Overall Study|Withdrawal by Subject|2|||
125108575|NCT01270841|450022543|FG002|Overall Study|Withdrawal by Subject|3|||
125108576|NCT01270841|450022544|FG003|Overall Study|Withdrawal by Subject|3|||
125108577|NCT01270841|450022541|FG000|Overall Study|Lost to Follow-up|3|||
125108578|NCT01270841|450022542|FG001|Overall Study|Lost to Follow-up|1|||
125108579|NCT01270841|450022543|FG002|Overall Study|Lost to Follow-up|4|||
125108580|NCT01270841|450022544|FG003|Overall Study|Lost to Follow-up|2|||
125108581|NCT01270841|450022541|FG000|Overall Study|Physician Decision|0|||
125108582|NCT01270841|450022542|FG001|Overall Study|Physician Decision|1|||
125108583|NCT01270841|450022543|FG002|Overall Study|Physician Decision|0|||
125108584|NCT01270841|450022544|FG003|Overall Study|Physician Decision|0|||
124895229|NCT01515319|449239628|FG008|Overall Study|Withdrawal by Subject|0|||
124895230|NCT01515319|449239629|FG009|Overall Study|Withdrawal by Subject|0|||
124895231|NCT01515319|449239620|FG000|Overall Study|Adverse Event|0|||
124895232|NCT01515319|449239621|FG001|Overall Study|Adverse Event|0|||
124895233|NCT01515319|449239622|FG002|Overall Study|Adverse Event|0|||
124895234|NCT01515319|449239623|FG003|Overall Study|Adverse Event|0|||
124895235|NCT01515319|449239624|FG004|Overall Study|Adverse Event|0|||
124895236|NCT01515319|449239625|FG005|Overall Study|Adverse Event|0|||
124895237|NCT01515319|449239626|FG006|Overall Study|Adverse Event|0|||
124895238|NCT01515319|449239627|FG007|Overall Study|Adverse Event|0|||
124895239|NCT01515319|449239628|FG008|Overall Study|Adverse Event|3|||
124895240|NCT01515319|449239629|FG009|Overall Study|Adverse Event|0|||
124895241|NCT01515319|449239620|FG000|Overall Study|Protocol Violation|0|||
124895242|NCT01515319|449239621|FG001|Overall Study|Protocol Violation|0|||
124895243|NCT01515319|449239622|FG002|Overall Study|Protocol Violation|0|||
124895244|NCT01515319|449239623|FG003|Overall Study|Protocol Violation|0|||
124895245|NCT01515319|449239624|FG004|Overall Study|Protocol Violation|0|||
124895246|NCT01515319|449239625|FG005|Overall Study|Protocol Violation|0|||
124895247|NCT01515319|449239626|FG006|Overall Study|Protocol Violation|0|||
124895248|NCT01515319|449239627|FG007|Overall Study|Protocol Violation|0|||
124895249|NCT01515319|449239628|FG008|Overall Study|Protocol Violation|2|||
124895250|NCT01515319|449239629|FG009|Overall Study|Protocol Violation|0|||
124895251|NCT01449929|449239631|FG000|Randomization Phase 96 Week|Adverse Event|5|||
124895252|NCT01449929|449239632|FG001|Randomization Phase 96 Week|Adverse Event|13|||
124895253|NCT01449929|449239633|FG002|Randomization Phase 96 Week|Adverse Event|0|||
124895254|NCT01449929|449239631|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
124895255|NCT01449929|449239632|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
124895256|NCT01449929|449239633|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
124895257|NCT01449929|449239631|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
124895258|NCT01449929|449239632|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
124895259|NCT01449929|449239633|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
124895260|NCT01449929|449239631|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
125018412|NCT01995071|449692819|FG008|Overall Study|Incarcerated|0|||
125018413|NCT01995071|449692820|FG009|Overall Study|Incarcerated|0|||
125018414|NCT01995071|449692821|FG010|Overall Study|Incarcerated|0|||
125018415|NCT01995071|449692822|FG011|Overall Study|Incarcerated|0|||
125018416|NCT02543528|449692823|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
125018417|NCT02543528|449692824|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
125018418|NCT02543528|449692825|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
125018419|NCT02543528|449692826|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
125018420|NCT02543528|449692827|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
125108585|NCT01270841|450022541|FG000|Overall Study|Did not qualify|6|||
125108586|NCT01270841|450022542|FG001|Overall Study|Did not qualify|3|||
125108587|NCT01270841|450022543|FG002|Overall Study|Did not qualify|4|||
125108588|NCT01270841|450022544|FG003|Overall Study|Did not qualify|5|||
125108589|NCT01270841|450022541|FG000|Overall Study|Protocol Violation|1|||
125108590|NCT01270841|450022542|FG001|Overall Study|Protocol Violation|5|||
125108591|NCT01270841|450022543|FG002|Overall Study|Protocol Violation|0|||
125108592|NCT01270841|450022544|FG003|Overall Study|Protocol Violation|0|||
125108593|NCT01270841|450022541|FG000|Overall Study|Enrolled in error|0|||
124895261|NCT01449929|449239632|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
124895262|NCT01449929|449239633|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
124895263|NCT01449929|449239631|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
124895264|NCT01449929|449239632|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
124895265|NCT01449929|449239633|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
124895266|NCT01449929|449239631|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
124895267|NCT01449929|449239632|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
124895268|NCT01449929|449239633|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
124895269|NCT01449929|449239631|FG000|Randomization Phase 96 Week|Physician Decision|2|||
124895270|NCT01449929|449239632|FG001|Randomization Phase 96 Week|Physician Decision|3|||
124895271|NCT01449929|449239633|FG002|Randomization Phase 96 Week|Physician Decision|0|||
124895272|NCT01449929|449239631|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
124895273|NCT01449929|449239632|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
125108594|NCT01270841|450022542|FG001|Overall Study|Enrolled in error|1|||
125108595|NCT01270841|450022543|FG002|Overall Study|Enrolled in error|0|||
125108596|NCT01270841|450022544|FG003|Overall Study|Enrolled in error|0|||
125108597|NCT04388527|450022545|FG000|Overall Study|Death|14|||
125108598|NCT04388527|450022545|FG000|Overall Study|Withdrawal by Subject|2|||
125108599|NCT04388527|450022545|FG000|Overall Study|Lost to Follow-up|1|||
125108600|NCT00782275|450022546|FG000|Overall Study|Adverse Event|11|||
125108601|NCT00782275|450022546|FG000|Overall Study|Withdrawal by Subject|1|||
125108602|NCT00782275|450022546|FG000|Overall Study|Progressive Disease|21|||
125108603|NCT00782275|450022546|FG000|Overall Study|Physician Decision|4|||
125108604|NCT00782275|450022546|FG000|Overall Study|Not started treatment|1|||
125108605|NCT00782275|450022546|FG000|Overall Study|Other|3|||
125108606|NCT00787566|450022553|FG000|Overall Study|AE related to chemotherapy|0|||
125108607|NCT00787566|450022554|FG001|Overall Study|AE related to chemotherapy|1|||
125108608|NCT00787566|450022555|FG002|Overall Study|AE related to chemotherapy|0|||
125108609|NCT00417027|450022556|FG000|Overall Study|Protocol Violation|0|||
125108610|NCT00417027|450022557|FG001|Overall Study|Protocol Violation|5|||
125108611|NCT00417027|450022558|FG002|Overall Study|Protocol Violation|5|||
125108612|NCT00544557|450022559|FG000|Overall Study|Adverse Event|140|||
125108613|NCT00544557|450022559|FG000|Overall Study|Lack of Efficacy|196|||
125108614|NCT00544557|450022559|FG000|Overall Study|Other|98|||
125108615|NCT01169987|450022565|FG000|Overall Study|Withdrawal by Subject|3|||
125108616|NCT01169987|450022565|FG000|Overall Study|Lost to Follow-up|24|||
125108617|NCT01169987|450022565|FG000|Overall Study|Other|4|||
125108618|NCT00386100|450022566|FG000|Overall Study|Did not receive study medication|6|||
125108619|NCT00386100|450022567|FG001|Overall Study|Did not receive study medication|4|||
125108620|NCT00386100|450022566|FG000|Overall Study|Adverse Event|15|||
125108621|NCT00386100|450022567|FG001|Overall Study|Adverse Event|25|||
125108622|NCT00386100|450022566|FG000|Overall Study|Death|0|||
125108623|NCT00386100|450022567|FG001|Overall Study|Death|1|||
125108624|NCT00386100|450022566|FG000|Overall Study|Insufficient therapeutic effect|30|||
125108625|NCT00386100|450022567|FG001|Overall Study|Insufficient therapeutic effect|6|||
125108626|NCT00386100|450022566|FG000|Overall Study|Lost to Follow-up|29|||
125108627|NCT00386100|450022567|FG001|Overall Study|Lost to Follow-up|29|||
125108628|NCT00386100|450022566|FG000|Overall Study|Non-compliance|18|||
125108629|NCT00386100|450022567|FG001|Overall Study|Non-compliance|19|||
125108630|NCT00386100|450022566|FG000|Overall Study|Protocol Violation|5|||
125108631|NCT00386100|450022567|FG001|Overall Study|Protocol Violation|3|||
125108632|NCT00386100|450022566|FG000|Overall Study|Withdrawal by Subject|32|||
125108633|NCT00386100|450022567|FG001|Overall Study|Withdrawal by Subject|31|||
125108634|NCT00386100|450022566|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
125108635|NCT00386100|450022567|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
125108636|NCT00386100|450022566|FG000|Overall Study|BMD <2.5|1|||
125108637|NCT00386100|450022567|FG001|Overall Study|BMD <2.5|0|||
125108638|NCT00386100|450022566|FG000|Overall Study|Consecutive elevated Hba1C|1|||
125108639|NCT00386100|450022567|FG001|Overall Study|Consecutive elevated Hba1C|0|||
125108640|NCT00386100|450022566|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
125108641|NCT00386100|450022567|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
125108642|NCT00386100|450022566|FG000|Overall Study|Laboratory findings|1|||
125108643|NCT00386100|450022567|FG001|Overall Study|Laboratory findings|0|||
125108644|NCT00386100|450022566|FG000|Overall Study|Participant's concern due to CPK levels|1|||
125108645|NCT00386100|450022567|FG001|Overall Study|Participant's concern due to CPK levels|0|||
124895274|NCT01449929|449239633|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
124895275|NCT01449929|449239631|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
125108646|NCT00386100|450022566|FG000|Overall Study|Participant moving out of state|2|||
125108647|NCT00386100|450022567|FG001|Overall Study|Participant moving out of state|0|||
125108648|NCT00386100|450022566|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
125108649|NCT00386100|450022567|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
124895276|NCT01449929|449239632|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
124895277|NCT01449929|449239633|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
124895278|NCT01449929|449239631|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
124895279|NCT01449929|449239632|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
124895280|NCT01449929|449239633|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
124895281|NCT01449929|449239631|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
124895282|NCT01449929|449239632|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
124895283|NCT01449929|449239633|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
124895284|NCT01871285|449239634|FG000|First Intervention (1 Day)|Adverse Event|1|||
125108650|NCT00386100|450022566|FG000|Overall Study|Didn't meet entry criteria|1|||
125108651|NCT00386100|450022567|FG001|Overall Study|Didn't meet entry criteria|1|||
124895285|NCT01871285|449239635|FG001|First Intervention (1 Day)|Adverse Event|0|||
124895286|NCT01871285|449239636|FG002|First Intervention (1 Day)|Adverse Event|0|||
124895287|NCT01871285|449239637|FG003|First Intervention (1 Day)|Adverse Event|0|||
124895288|NCT01871285|449239634|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
124895289|NCT01871285|449239635|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
124895290|NCT01871285|449239636|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
124895291|NCT01871285|449239637|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
124895292|NCT01959880|449239638|FG000|Overall Study|Withdrawal by Subject|11|||
125018421|NCT02543528|449692823|FG000|Adaptation Period|Lens Handling Difficultes|0|||
125018422|NCT02543528|449692824|FG001|Adaptation Period|Lens Handling Difficultes|0|||
125018423|NCT02543528|449692825|FG002|Adaptation Period|Lens Handling Difficultes|0|||
125018424|NCT02543528|449692826|FG003|Adaptation Period|Lens Handling Difficultes|0|||
125018425|NCT02543528|449692827|FG004|Adaptation Period|Lens Handling Difficultes|8|||
125018426|NCT02543528|449692823|FG000|Adaptation Period|Lost to Follow-up|0|||
125018427|NCT02543528|449692824|FG001|Adaptation Period|Lost to Follow-up|0|||
125018428|NCT02543528|449692825|FG002|Adaptation Period|Lost to Follow-up|0|||
125018429|NCT02543528|449692826|FG003|Adaptation Period|Lost to Follow-up|0|||
125018430|NCT02543528|449692827|FG004|Adaptation Period|Lost to Follow-up|14|||
125018431|NCT02543528|449692823|FG000|Adaptation Period|Adverse Event|0|||
125018432|NCT02543528|449692824|FG001|Adaptation Period|Adverse Event|0|||
125018433|NCT02543528|449692825|FG002|Adaptation Period|Adverse Event|0|||
125018434|NCT02543528|449692826|FG003|Adaptation Period|Adverse Event|0|||
125018435|NCT02543528|449692827|FG004|Adaptation Period|Adverse Event|2|||
125018436|NCT02543528|449692823|FG000|Extended Wear Period|Adverse Event|17|||
125018437|NCT02543528|449692824|FG001|Extended Wear Period|Adverse Event|11|||
125018438|NCT02543528|449692825|FG002|Extended Wear Period|Adverse Event|16|||
125018439|NCT02543528|449692826|FG003|Extended Wear Period|Adverse Event|3|||
125018440|NCT02543528|449692827|FG004|Extended Wear Period|Adverse Event|0|||
125018441|NCT02543528|449692823|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
125018442|NCT02543528|449692824|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
125018443|NCT02543528|449692825|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
125018444|NCT02543528|449692826|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
125018445|NCT02543528|449692827|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
125018446|NCT02543528|449692823|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
125018447|NCT02543528|449692824|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
125018448|NCT02543528|449692825|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
125018449|NCT02543528|449692826|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
125018450|NCT02543528|449692827|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
125018451|NCT02543528|449692823|FG000|Extended Wear Period|Lost to Follow-up|0|||
125018452|NCT02543528|449692824|FG001|Extended Wear Period|Lost to Follow-up|1|||
125018453|NCT02543528|449692825|FG002|Extended Wear Period|Lost to Follow-up|2|||
125018454|NCT02543528|449692826|FG003|Extended Wear Period|Lost to Follow-up|1|||
125018455|NCT02543528|449692827|FG004|Extended Wear Period|Lost to Follow-up|0|||
125018456|NCT02543528|449692823|FG000|Extended Wear Period|Withdrawal by Subject|10|||
125018457|NCT02543528|449692824|FG001|Extended Wear Period|Withdrawal by Subject|9|||
125018458|NCT02543528|449692825|FG002|Extended Wear Period|Withdrawal by Subject|4|||
125018459|NCT02543528|449692826|FG003|Extended Wear Period|Withdrawal by Subject|5|||
124895293|NCT01959880|449239639|FG001|Overall Study|Withdrawal by Subject|13|||
125018460|NCT02543528|449692827|FG004|Extended Wear Period|Withdrawal by Subject|0|||
125108652|NCT00386100|450022566|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
124895294|NCT01959880|449239640|FG002|Overall Study|Withdrawal by Subject|8|||
125108653|NCT00386100|450022567|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
124895295|NCT01959880|449239641|FG003|Overall Study|Withdrawal by Subject|7|||
124895296|NCT01959880|449239638|FG000|Overall Study|Death|1|||
125108654|NCT00386100|450022566|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
125108655|NCT00386100|450022567|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
125108656|NCT00386100|450022566|FG000|Overall Study|Bad metabolic control & patient security|1|||
125108657|NCT00386100|450022567|FG001|Overall Study|Bad metabolic control & patient security|0|||
125108658|NCT00386100|450022566|FG000|Overall Study|Bone loss by DXA bone scan|1|||
125108659|NCT00386100|450022567|FG001|Overall Study|Bone loss by DXA bone scan|0|||
125108660|NCT00386100|450022566|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
125108661|NCT00386100|450022567|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
125108662|NCT00386100|450022566|FG000|Overall Study|7.6% bone loss|1|||
125108663|NCT00386100|450022567|FG001|Overall Study|7.6% bone loss|0|||
125108664|NCT00386100|450022566|FG000|Overall Study|Osteoporosis|0|||
125108665|NCT00386100|450022567|FG001|Overall Study|Osteoporosis|1|||
125108666|NCT00386100|450022566|FG000|Overall Study|Positive pregnancy test|1|||
125108667|NCT00386100|450022567|FG001|Overall Study|Positive pregnancy test|3|||
125108668|NCT00386100|450022566|FG000|Overall Study|Out of country for 5 months|1|||
125108669|NCT00386100|450022567|FG001|Overall Study|Out of country for 5 months|0|||
125108670|NCT00386100|450022566|FG000|Overall Study|Hb1Ac >8%|0|||
125108671|NCT00386100|450022567|FG001|Overall Study|Hb1Ac >8%|1|||
125108672|NCT00386100|450022566|FG000|Overall Study|Participant randomized in error|1|||
125108673|NCT00386100|450022567|FG001|Overall Study|Participant randomized in error|0|||
125108674|NCT00886782|450022571|FG000|Overall Study|Disease progression|3|||
125108675|NCT00886782|450022572|FG001|Overall Study|Disease progression|3|||
125108676|NCT00886782|450022573|FG002|Overall Study|Disease progression|3|||
125108677|NCT00886782|450022571|FG000|Overall Study|Study drug toxicity|0|||
125108678|NCT00886782|450022572|FG001|Overall Study|Study drug toxicity|0|||
125108679|NCT00886782|450022573|FG002|Overall Study|Study drug toxicity|1|||
125108680|NCT00886782|450022571|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
125108681|NCT00886782|450022572|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
125108682|NCT00886782|450022573|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
125108683|NCT01612702|450022574|FG000|Overall Study|Protocol Violation|11|||
125108684|NCT01612702|450022575|FG001|Overall Study|Protocol Violation|11|||
125108685|NCT03636542|450022576|FG000|Overall Study|Lost to Follow-up|1|||
125108686|NCT03636542|450022577|FG001|Overall Study|Lost to Follow-up|1|||
125108687|NCT03636542|450022576|FG000|Overall Study|Physician Decision|0|||
125108688|NCT03636542|450022577|FG001|Overall Study|Physician Decision|1|||
125108689|NCT03636542|450022576|FG000|Overall Study|Withdrawal by Subject|1|||
125108690|NCT03636542|450022577|FG001|Overall Study|Withdrawal by Subject|0|||
125108691|NCT01542736|450022580|FG000|Overall Study|Death|1|||
125108692|NCT03674827|450022581|FG000|Treatment Phase|Adverse Event|0|||
125108693|NCT03674827|450022582|FG001|Treatment Phase|Adverse Event|0|||
125108694|NCT03674827|450022583|FG002|Treatment Phase|Adverse Event|0|||
125108695|NCT03674827|450022584|FG003|Treatment Phase|Adverse Event|0|||
125108696|NCT03674827|450022585|FG004|Treatment Phase|Adverse Event|0|||
125108697|NCT03674827|450022586|FG005|Treatment Phase|Adverse Event|2|||
125108698|NCT03674827|450022581|FG000|Treatment Phase|Death|2|||
125108699|NCT03674827|450022582|FG001|Treatment Phase|Death|0|||
125108700|NCT03674827|450022583|FG002|Treatment Phase|Death|0|||
125108701|NCT03674827|450022584|FG003|Treatment Phase|Death|0|||
125108702|NCT03674827|450022585|FG004|Treatment Phase|Death|1|||
125108703|NCT03674827|450022586|FG005|Treatment Phase|Death|0|||
125108704|NCT03674827|450022581|FG000|Treatment Phase|Progressive Disease|0|||
125108705|NCT03674827|450022582|FG001|Treatment Phase|Progressive Disease|4|||
125108706|NCT03674827|450022583|FG002|Treatment Phase|Progressive Disease|3|||
125108707|NCT03674827|450022584|FG003|Treatment Phase|Progressive Disease|4|||
125108708|NCT03674827|450022585|FG004|Treatment Phase|Progressive Disease|4|||
125108709|NCT03674827|450022586|FG005|Treatment Phase|Progressive Disease|9|||
125108710|NCT03674827|450022581|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
125108711|NCT03674827|450022582|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
125108712|NCT03674827|450022583|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
125108713|NCT03674827|450022584|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
125108714|NCT03674827|450022585|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
124895297|NCT01959880|449239639|FG001|Overall Study|Death|10|||
124895298|NCT01959880|449239640|FG002|Overall Study|Death|1|||
125108715|NCT03674827|450022586|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
125108716|NCT03674827|450022581|FG000|Treatment Phase|Withdrawal by Subject|0|||
125108717|NCT03674827|450022582|FG001|Treatment Phase|Withdrawal by Subject|0|||
125108718|NCT03674827|450022583|FG002|Treatment Phase|Withdrawal by Subject|0|||
125108719|NCT03674827|450022584|FG003|Treatment Phase|Withdrawal by Subject|0|||
125108720|NCT03674827|450022585|FG004|Treatment Phase|Withdrawal by Subject|0|||
124895299|NCT01959880|449239641|FG003|Overall Study|Death|2|||
125108721|NCT03674827|450022586|FG005|Treatment Phase|Withdrawal by Subject|1|||
125108722|NCT03674827|450022581|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
125108723|NCT03674827|450022582|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
125108724|NCT03674827|450022583|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
125108725|NCT03674827|450022584|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
124895300|NCT01959880|449239638|FG000|Overall Study|Lost to Follow-up|95|||
125108726|NCT03674827|450022585|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
125108727|NCT03674827|450022586|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
125108728|NCT03674827|450022581|FG000|Treatment Phase|Other|0|||
125108729|NCT03674827|450022582|FG001|Treatment Phase|Other|1|||
125108730|NCT03674827|450022583|FG002|Treatment Phase|Other|0|||
125108731|NCT03674827|450022584|FG003|Treatment Phase|Other|0|||
125108732|NCT03674827|450022585|FG004|Treatment Phase|Other|0|||
125108733|NCT03674827|450022586|FG005|Treatment Phase|Other|1|||
125108734|NCT03674827|450022581|FG000|Long-Term Follow-up Phase|Death|2|||
125108735|NCT03674827|450022582|FG001|Long-Term Follow-up Phase|Death|4|||
125108736|NCT03674827|450022583|FG002|Long-Term Follow-up Phase|Death|2|||
125108737|NCT03674827|450022584|FG003|Long-Term Follow-up Phase|Death|3|||
125108738|NCT03674827|450022585|FG004|Long-Term Follow-up Phase|Death|2|||
125108739|NCT03674827|450022586|FG005|Long-Term Follow-up Phase|Death|6|||
125108740|NCT03674827|450022581|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
125108741|NCT03674827|450022582|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
125108742|NCT03674827|450022583|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
124895301|NCT01959880|449239639|FG001|Overall Study|Lost to Follow-up|18|||
124895302|NCT01959880|449239640|FG002|Overall Study|Lost to Follow-up|15|||
124895303|NCT01959880|449239641|FG003|Overall Study|Lost to Follow-up|8|||
124895304|NCT01959880|449239638|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
124895305|NCT01959880|449239639|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
124895306|NCT01959880|449239640|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
124895307|NCT01959880|449239641|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
124895308|NCT01959880|449239638|FG000|Overall Study|Study completed early-FDA approved|1003|||
124895309|NCT01959880|449239639|FG001|Overall Study|Study completed early-FDA approved|311|||
124895310|NCT01959880|449239640|FG002|Overall Study|Study completed early-FDA approved|179|||
125108743|NCT03674827|450022584|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
125108744|NCT03674827|450022585|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
125108745|NCT03674827|450022586|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
125108746|NCT03674827|450022581|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
125108747|NCT03674827|450022582|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
125108748|NCT03674827|450022583|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
125108749|NCT03674827|450022584|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
125108750|NCT03674827|450022585|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
125108751|NCT03674827|450022586|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
125108752|NCT01783483|450022587|FG000|Overall Study|Death|3|||
125108753|NCT01783483|450022588|FG001|Overall Study|Death|3|||
125108754|NCT01783483|450022587|FG000|Overall Study|Lost to Follow-up|14|||
125108755|NCT01783483|450022588|FG001|Overall Study|Lost to Follow-up|10|||
125108756|NCT01783483|450022587|FG000|Overall Study|Withdrawal by Subject|2|||
125108757|NCT01783483|450022588|FG001|Overall Study|Withdrawal by Subject|1|||
125108758|NCT01783483|450022587|FG000|Overall Study|Physician Decision|1|||
125108759|NCT01783483|450022588|FG001|Overall Study|Physician Decision|1|||
125108760|NCT04130919|450022591|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
125108761|NCT04130919|450022592|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
124895311|NCT01959880|449239641|FG003|Overall Study|Study completed early-FDA approved|152|||
125108762|NCT04130919|450022593|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
125108763|NCT04130919|450022594|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
125108764|NCT04130919|450022595|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
125108765|NCT04130919|450022596|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
125108766|NCT04130919|450022591|FG000|Blinded Treatment Phase|Adverse Event|0|||
125108767|NCT04130919|450022592|FG001|Blinded Treatment Phase|Adverse Event|0|||
125108768|NCT04130919|450022593|FG002|Blinded Treatment Phase|Adverse Event|1|||
125108769|NCT04130919|450022594|FG003|Blinded Treatment Phase|Adverse Event|0|||
125108770|NCT04130919|450022595|FG004|Blinded Treatment Phase|Adverse Event|0|||
125108771|NCT04130919|450022596|FG005|Blinded Treatment Phase|Adverse Event|0|||
125108772|NCT04130919|450022591|FG000|Blinded Treatment Phase|Disease worsening|0|||
125108773|NCT04130919|450022592|FG001|Blinded Treatment Phase|Disease worsening|0|||
125108774|NCT04130919|450022593|FG002|Blinded Treatment Phase|Disease worsening|1|||
125108775|NCT04130919|450022594|FG003|Blinded Treatment Phase|Disease worsening|0|||
125108776|NCT04130919|450022595|FG004|Blinded Treatment Phase|Disease worsening|0|||
125108777|NCT04130919|450022596|FG005|Blinded Treatment Phase|Disease worsening|0|||
125108778|NCT04130919|450022591|FG000|Blinded Treatment Phase|Investigator's decision|0|||
125108779|NCT04130919|450022592|FG001|Blinded Treatment Phase|Investigator's decision|1|||
125108780|NCT04130919|450022593|FG002|Blinded Treatment Phase|Investigator's decision|0|||
125108781|NCT04130919|450022594|FG003|Blinded Treatment Phase|Investigator's decision|0|||
125108782|NCT04130919|450022595|FG004|Blinded Treatment Phase|Investigator's decision|0|||
125108783|NCT04130919|450022596|FG005|Blinded Treatment Phase|Investigator's decision|0|||
125108784|NCT04130919|450022591|FG000|Blinded Treatment Phase|Withdrew consent|1|||
125108785|NCT04130919|450022592|FG001|Blinded Treatment Phase|Withdrew consent|0|||
125108786|NCT04130919|450022593|FG002|Blinded Treatment Phase|Withdrew consent|0|||
125108787|NCT04130919|450022594|FG003|Blinded Treatment Phase|Withdrew consent|0|||
125108788|NCT04130919|450022595|FG004|Blinded Treatment Phase|Withdrew consent|0|||
125108789|NCT04130919|450022596|FG005|Blinded Treatment Phase|Withdrew consent|0|||
125108790|NCT04130919|450022591|FG000|Open-label Treatment Phase|Withdrew consent|0|||
124895312|NCT01919619|449239642|FG000|Overall Study|Physician Decision|1|||
124895313|NCT01919619|449239643|FG001|Overall Study|Physician Decision|1|||
124895314|NCT04610684|449241246|FG000|Study Treatment|Withdrawal by Subject|1|||
124895315|NCT04610684|449241246|FG000|Study Treatment|Disease Progression|2|||
124895316|NCT04610684|449241246|FG000|Follow up|Death|2|||
124895317|NCT04610684|449241246|FG000|Follow up|Withdrawal by Subject|1|||
124895318|NCT04978363|449241252|FG000|Overall Study|Other medical issues unrelated to the study|0|||
124895319|NCT04978363|449241253|FG001|Overall Study|Other medical issues unrelated to the study|0|||
124895320|NCT04978363|449241254|FG002|Overall Study|Other medical issues unrelated to the study|0|||
124895321|NCT04978363|449241255|FG003|Overall Study|Other medical issues unrelated to the study|0|||
124895322|NCT04978363|449241256|FG004|Overall Study|Other medical issues unrelated to the study|1|||
125108791|NCT04130919|450022592|FG001|Open-label Treatment Phase|Withdrew consent|0|||
125108792|NCT04130919|450022593|FG002|Open-label Treatment Phase|Withdrew consent|0|||
125108793|NCT04130919|450022594|FG003|Open-label Treatment Phase|Withdrew consent|1|||
125108794|NCT04130919|450022595|FG004|Open-label Treatment Phase|Withdrew consent|1|||
125108795|NCT04130919|450022596|FG005|Open-label Treatment Phase|Withdrew consent|1|||
125108796|NCT04130919|450022591|FG000|Open-label Treatment Phase|Disease worsening|0|||
125108797|NCT04130919|450022592|FG001|Open-label Treatment Phase|Disease worsening|0|||
125108798|NCT04130919|450022593|FG002|Open-label Treatment Phase|Disease worsening|0|||
125108799|NCT04130919|450022594|FG003|Open-label Treatment Phase|Disease worsening|1|||
125108800|NCT04130919|450022595|FG004|Open-label Treatment Phase|Disease worsening|0|||
125108801|NCT04130919|450022596|FG005|Open-label Treatment Phase|Disease worsening|1|||
125108802|NCT04130919|450022591|FG000|Open-label Treatment Phase|Investigator's decision|0|||
125108803|NCT04130919|450022592|FG001|Open-label Treatment Phase|Investigator's decision|0|||
125108804|NCT04130919|450022593|FG002|Open-label Treatment Phase|Investigator's decision|0|||
125108805|NCT04130919|450022594|FG003|Open-label Treatment Phase|Investigator's decision|1|||
125108806|NCT04130919|450022595|FG004|Open-label Treatment Phase|Investigator's decision|0|||
125108807|NCT04130919|450022596|FG005|Open-label Treatment Phase|Investigator's decision|0|||
125108808|NCT04130919|450022591|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
125108809|NCT04130919|450022592|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
125108810|NCT04130919|450022593|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
125108811|NCT04130919|450022594|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
125108812|NCT04130919|450022595|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
125108813|NCT04130919|450022596|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
125108814|NCT04130919|450022591|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
125108815|NCT04130919|450022592|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
125108816|NCT04130919|450022593|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
125108817|NCT04130919|450022594|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
125108818|NCT04130919|450022595|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
125108819|NCT04130919|450022596|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
125108820|NCT02624518|450022597|FG000|Overall Study|Physician Decision|1|||
125108821|NCT00370396|450022598|FG000|Overall Study|Withdrawal by Subject|0|||
125108822|NCT00370396|450022599|FG001|Overall Study|Withdrawal by Subject|0|||
125108823|NCT00370396|450022600|FG002|Overall Study|Withdrawal by Subject|1|||
125108824|NCT00370396|450022598|FG000|Overall Study|Lost to Follow-up|11|||
125108825|NCT00370396|450022599|FG001|Overall Study|Lost to Follow-up|1|||
125108826|NCT00370396|450022600|FG002|Overall Study|Lost to Follow-up|0|||
125108827|NCT01462695|450022601|FG000|Overall Study|Adverse Event|1|||
125108828|NCT01462695|450022602|FG001|Overall Study|Adverse Event|1|||
125108829|NCT01462695|450022601|FG000|Overall Study|Death|2|||
125108830|NCT01462695|450022602|FG001|Overall Study|Death|0|||
125108831|NCT01462695|450022601|FG000|Overall Study|Lack of Efficacy|6|||
125108832|NCT01462695|450022602|FG001|Overall Study|Lack of Efficacy|12|||
125108833|NCT01462695|450022601|FG000|Overall Study|Physician Decision|5|||
125108834|NCT01462695|450022602|FG001|Overall Study|Physician Decision|0|||
124895323|NCT04978363|449241257|FG005|Overall Study|Other medical issues unrelated to the study|0|||
125108835|NCT01462695|450022601|FG000|Overall Study|Withdrawal by Subject|2|||
125108836|NCT01462695|450022602|FG001|Overall Study|Withdrawal by Subject|0|||
125108837|NCT01462695|450022601|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
125108838|NCT01462695|450022602|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
125108839|NCT02400905|450022603|FG000|Overall Study|Death|24|||
125108840|NCT02400905|450022603|FG000|Overall Study|Lost to Follow-up|18|||
125108841|NCT02400905|450022603|FG000|Overall Study|Withdrawal by Subject|16|||
125108842|NCT02400905|450022603|FG000|Overall Study|Physician Decision|4|||
125108843|NCT02400905|450022603|FG000|Overall Study|Other|1|||
124895324|NCT04978363|449241258|FG006|Overall Study|Other medical issues unrelated to the study|0|||
125108844|NCT01358708|450022606|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
125108845|NCT01358708|450022607|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125108846|NCT01358708|450022606|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
125108847|NCT01358708|450022607|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
125108848|NCT04363736|450022610|FG000|Overall Study|Withdrawal by Subject|1|||
125108849|NCT04363736|450022611|FG001|Overall Study|Withdrawal by Subject|0|||
125108850|NCT04363736|450022610|FG000|Overall Study|Lost to Follow-up|10|||
125108851|NCT04363736|450022611|FG001|Overall Study|Lost to Follow-up|7|||
125108852|NCT04363736|450022610|FG000|Overall Study|Death|8|||
125108853|NCT04363736|450022611|FG001|Overall Study|Death|6|||
125108854|NCT03125629|450022613|FG000|Overall Study|Withdrawal by Subject|2|||
125108855|NCT03125629|450022613|FG000|Overall Study|Equipment malfunction|1|||
125108856|NCT02176642|450022616|FG000|Overall Study|Withdrawal by Subject|0|||
125108857|NCT02176642|450022617|FG001|Overall Study|Withdrawal by Subject|1|||
125108858|NCT00217971|450022618|FG000|Overall Study|Adverse Event|1|||
125108859|NCT00217971|450022619|FG001|Overall Study|Adverse Event|1|||
125108860|NCT00217971|450022618|FG000|Overall Study|Lost to Follow-up|15|||
125108861|NCT00217971|450022619|FG001|Overall Study|Lost to Follow-up|19|||
125108862|NCT00217971|450022618|FG000|Overall Study|Physician Decision|0|||
125108863|NCT00217971|450022619|FG001|Overall Study|Physician Decision|1|||
125108864|NCT00217971|450022618|FG000|Overall Study|Withdrawal by Subject|7|||
125108865|NCT00217971|450022619|FG001|Overall Study|Withdrawal by Subject|12|||
125108866|NCT00217971|450022618|FG000|Overall Study|non compliant|1|||
125108867|NCT00217971|450022619|FG001|Overall Study|non compliant|0|||
125108868|NCT02989610|450022620|FG000|Overall Study|Withdrawal by Subject|20|||
125108869|NCT02989610|450022620|FG000|Overall Study|Departure of PI from Site|8|||
125108870|NCT02989610|450022620|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
125108871|NCT02989610|450022620|FG000|Overall Study|Lost to Follow-up|3|||
125108872|NCT02989610|450022620|FG000|Overall Study|Death|3|||
125108873|NCT02989610|450022620|FG000|Overall Study|System Explant|3|||
125108874|NCT02989610|450022620|FG000|Overall Study|Subject Non-Compliance|2|||
125108875|NCT02989610|450022620|FG000|Overall Study|System Revision|2|||
125108876|NCT02989610|450022620|FG000|Overall Study|PI Left, Study Closing|1|||
125108877|NCT02989610|450022620|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
125108878|NCT02989610|450022620|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
125108879|NCT01066039|450022626|FG000|Overall Study|Adverse Event|6|||
125108880|NCT01066039|450022626|FG000|Overall Study|Withdrawal by Subject|17|||
125108881|NCT01066039|450022626|FG000|Overall Study|Protocol Violation|2|||
125108882|NCT01066039|450022626|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
125108883|NCT01066039|450022626|FG000|Overall Study|Investigator's Request|1|||
125108884|NCT01066039|450022626|FG000|Overall Study|Dropout due to Insulin Administration|1|||
125108885|NCT01066039|450022626|FG000|Overall Study|Additional Antihypertensive Required|4|||
125108886|NCT01066039|450022626|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
125108887|NCT01066039|450022626|FG000|Overall Study|Failure to Control Blood Pressure|1|||
125108888|NCT01066039|450022626|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
125108889|NCT00808015|450022627|FG000|Overall Study|Death|1|||
125108890|NCT00808015|450022627|FG000|Overall Study|Lack of Efficacy|58|||
125108891|NCT00808015|450022627|FG000|Overall Study|Lost to Follow-up|76|||
125108892|NCT00808015|450022627|FG000|Overall Study|Participants not willing to participate|158|||
125108893|NCT00808015|450022627|FG000|Overall Study|Adverse Event|22|||
125108894|NCT00808015|450022627|FG000|Overall Study|Other|25|||
125108895|NCT00808015|450022627|FG000|Overall Study|Enrolled but not treated|4|||
125108896|NCT04508621|450022628|FG000|Overall Study|Adverse Event|39|||
125108897|NCT04508621|450022629|FG001|Overall Study|Adverse Event|16|||
125108898|NCT04508621|450022628|FG000|Overall Study|Lack of Efficacy|2|||
125108899|NCT04508621|450022629|FG001|Overall Study|Lack of Efficacy|8|||
125108900|NCT04508621|450022628|FG000|Overall Study|Physician Decision|0|||
125108901|NCT04508621|450022629|FG001|Overall Study|Physician Decision|1|||
125108902|NCT04508621|450022628|FG000|Overall Study|Withdrawal by Subject|10|||
125108903|NCT04508621|450022629|FG001|Overall Study|Withdrawal by Subject|14|||
125108904|NCT04508621|450022628|FG000|Overall Study|Lost to Follow-up|12|||
125108905|NCT04508621|450022629|FG001|Overall Study|Lost to Follow-up|9|||
125108906|NCT04508621|450022628|FG000|Overall Study|COVID-19 related crisis|3|||
125108907|NCT04508621|450022629|FG001|Overall Study|COVID-19 related crisis|0|||
125108908|NCT04508621|450022628|FG000|Overall Study|Subject non-compliance|1|||
125108909|NCT04508621|450022629|FG001|Overall Study|Subject non-compliance|0|||
125108910|NCT00084617|450022639|FG000|Overall Study|Withdrawal by Subject|7|||
125108911|NCT00084617|450022639|FG000|Overall Study|Lack of Efficacy|1|||
125108912|NCT00084617|450022639|FG000|Overall Study|Protocol Violation|1|||
125108913|NCT01625286|450022640|FG000|Overall Study|Adverse Event|0|||
125108914|NCT01625286|450022641|FG001|Overall Study|Adverse Event|0|||
125108915|NCT01625286|450022642|FG002|Overall Study|Adverse Event|0|||
125108916|NCT01625286|450022643|FG003|Overall Study|Adverse Event|0|||
125108917|NCT01625286|450022644|FG004|Overall Study|Adverse Event|1|||
125108918|NCT01625286|450022645|FG005|Overall Study|Adverse Event|2|||
125108919|NCT01625286|450022646|FG006|Overall Study|Adverse Event|1|||
125108920|NCT01625286|450022640|FG000|Overall Study|Death|0|||
124895325|NCT04978363|449241259|FG007|Overall Study|Other medical issues unrelated to the study|0|||
124895326|NCT04978363|449241260|FG008|Overall Study|Other medical issues unrelated to the study|0|||
124895327|NCT04978363|449241261|FG009|Overall Study|Other medical issues unrelated to the study|0|||
124895328|NCT04978363|449241262|FG010|Overall Study|Other medical issues unrelated to the study|0|||
124895329|NCT04978363|449241252|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
124895330|NCT04978363|449241253|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
124895331|NCT04978363|449241254|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
124895332|NCT04978363|449241255|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
124895333|NCT04978363|449241256|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
124895334|NCT04978363|449241257|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
124895335|NCT04978363|449241258|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
124895336|NCT04978363|449241259|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
124895337|NCT04978363|449241260|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
124895338|NCT04978363|449241261|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
124895339|NCT04978363|449241262|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
124895340|NCT04978363|449241252|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
124895341|NCT04978363|449241253|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
124895342|NCT04978363|449241254|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
124895343|NCT04978363|449241255|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
124895344|NCT04978363|449241256|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
124895345|NCT04978363|449241257|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
124895346|NCT04978363|449241258|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
124895347|NCT04978363|449241259|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
124895348|NCT04978363|449241260|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
124895349|NCT04978363|449241261|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
124895350|NCT04978363|449241262|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
124895351|NCT01251614|449241263|FG000|Overall Study|Adverse Event|1|||
124895352|NCT01251614|449241264|FG001|Overall Study|Adverse Event|0|||
124895353|NCT01251614|449241265|FG002|Overall Study|Adverse Event|1|||
124895354|NCT01251614|449241263|FG000|Overall Study|Lack of Efficacy|1|||
124895355|NCT01251614|449241264|FG001|Overall Study|Lack of Efficacy|9|||
125108921|NCT01625286|450022641|FG001|Overall Study|Death|0|||
125108922|NCT01625286|450022642|FG002|Overall Study|Death|1|||
125108923|NCT01625286|450022643|FG003|Overall Study|Death|1|||
125108924|NCT01625286|450022644|FG004|Overall Study|Death|0|||
125108925|NCT01625286|450022645|FG005|Overall Study|Death|11|||
124895356|NCT01251614|449241265|FG002|Overall Study|Lack of Efficacy|4|||
124895357|NCT01251614|449241263|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
125108926|NCT01625286|450022646|FG006|Overall Study|Death|16|||
124895358|NCT01251614|449241264|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
124895359|NCT01251614|449241265|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
124895360|NCT01251614|449241263|FG000|Overall Study|Pregnancy|0|||
124895361|NCT01251614|449241264|FG001|Overall Study|Pregnancy|0|||
124895362|NCT01251614|449241265|FG002|Overall Study|Pregnancy|2|||
124895363|NCT01251614|449241263|FG000|Overall Study|Loss of Disease Control|0|||
124895364|NCT01251614|449241264|FG001|Overall Study|Loss of Disease Control|1|||
124895365|NCT01251614|449241265|FG002|Overall Study|Loss of Disease Control|0|||
124895366|NCT01251614|449241263|FG000|Overall Study|Withdrawal by Subject|0|||
124895367|NCT01251614|449241264|FG001|Overall Study|Withdrawal by Subject|2|||
124895368|NCT01251614|449241265|FG002|Overall Study|Withdrawal by Subject|1|||
124895369|NCT01251614|449241263|FG000|Overall Study|Lost to Follow-up|0|||
124895370|NCT01251614|449241264|FG001|Overall Study|Lost to Follow-up|1|||
124895371|NCT01251614|449241265|FG002|Overall Study|Lost to Follow-up|0|||
124895372|NCT00049517|449241266|FG000|Induction|Disease progression|0|||
124895373|NCT00049517|449241267|FG001|Induction|Disease progression|0|||
124895374|NCT00049517|449241268|FG002|Induction|Disease progression|0|||
124895375|NCT00049517|449241269|FG003|Induction|Disease progression|0|||
124895376|NCT00049517|449241270|FG004|Induction|Disease progression|18|||
124895377|NCT00049517|449241271|FG005|Induction|Disease progression|11|||
124895378|NCT00049517|449241266|FG000|Induction|Adverse Event|0|||
124895379|NCT00049517|449241267|FG001|Induction|Adverse Event|0|||
124895380|NCT00049517|449241268|FG002|Induction|Adverse Event|0|||
124895381|NCT00049517|449241269|FG003|Induction|Adverse Event|0|||
124895382|NCT00049517|449241270|FG004|Induction|Adverse Event|5|||
124895383|NCT00049517|449241271|FG005|Induction|Adverse Event|7|||
124895384|NCT00049517|449241266|FG000|Induction|Death|0|||
124895385|NCT00049517|449241267|FG001|Induction|Death|0|||
124895386|NCT00049517|449241268|FG002|Induction|Death|0|||
124895387|NCT00049517|449241269|FG003|Induction|Death|0|||
124895388|NCT00049517|449241270|FG004|Induction|Death|9|||
124895389|NCT00049517|449241271|FG005|Induction|Death|6|||
125108927|NCT01625286|450022640|FG000|Overall Study|Withdrawal by Subject|0|||
125108928|NCT01625286|450022641|FG001|Overall Study|Withdrawal by Subject|1|||
124895390|NCT00049517|449241266|FG000|Induction|Withdrawal by Subject|0|||
124895391|NCT00049517|449241267|FG001|Induction|Withdrawal by Subject|0|||
124895392|NCT00049517|449241268|FG002|Induction|Withdrawal by Subject|0|||
124895393|NCT00049517|449241269|FG003|Induction|Withdrawal by Subject|0|||
124895394|NCT00049517|449241270|FG004|Induction|Withdrawal by Subject|1|||
124895395|NCT00049517|449241271|FG005|Induction|Withdrawal by Subject|3|||
124895396|NCT00049517|449241266|FG000|Induction|Alternative therapy|0|||
124895397|NCT00049517|449241267|FG001|Induction|Alternative therapy|0|||
124895398|NCT00049517|449241268|FG002|Induction|Alternative therapy|0|||
124895399|NCT00049517|449241269|FG003|Induction|Alternative therapy|0|||
124895400|NCT00049517|449241270|FG004|Induction|Alternative therapy|2|||
124895401|NCT00049517|449241271|FG005|Induction|Alternative therapy|2|||
124895402|NCT00049517|449241266|FG000|Induction|Other complicating disease|0|||
124895403|NCT00049517|449241267|FG001|Induction|Other complicating disease|0|||
124895404|NCT00049517|449241268|FG002|Induction|Other complicating disease|0|||
124895405|NCT00049517|449241269|FG003|Induction|Other complicating disease|0|||
124895406|NCT00049517|449241270|FG004|Induction|Other complicating disease|3|||
124895407|NCT00049517|449241271|FG005|Induction|Other complicating disease|0|||
124895408|NCT00049517|449241266|FG000|Induction|Reasons not reported|0|||
124895409|NCT00049517|449241267|FG001|Induction|Reasons not reported|0|||
124895410|NCT00049517|449241268|FG002|Induction|Reasons not reported|0|||
124895411|NCT00049517|449241269|FG003|Induction|Reasons not reported|0|||
124895412|NCT00049517|449241270|FG004|Induction|Reasons not reported|22|||
124895413|NCT00049517|449241271|FG005|Induction|Reasons not reported|25|||
124895414|NCT00049517|449241266|FG000|Conditioning/Transplant|Disease progression|14|||
124895415|NCT00049517|449241267|FG001|Conditioning/Transplant|Disease progression|6|||
124895416|NCT00049517|449241268|FG002|Conditioning/Transplant|Disease progression|10|||
124895417|NCT00049517|449241269|FG003|Conditioning/Transplant|Disease progression|6|||
124895418|NCT00049517|449241270|FG004|Conditioning/Transplant|Disease progression|0|||
124895419|NCT00049517|449241271|FG005|Conditioning/Transplant|Disease progression|0|||
124895420|NCT00049517|449241266|FG000|Conditioning/Transplant|Adverse Event|2|||
124895421|NCT00049517|449241267|FG001|Conditioning/Transplant|Adverse Event|1|||
124895422|NCT00049517|449241268|FG002|Conditioning/Transplant|Adverse Event|4|||
124895423|NCT00049517|449241269|FG003|Conditioning/Transplant|Adverse Event|8|||
124895424|NCT00049517|449241270|FG004|Conditioning/Transplant|Adverse Event|0|||
124895425|NCT00049517|449241271|FG005|Conditioning/Transplant|Adverse Event|0|||
124895426|NCT00049517|449241266|FG000|Conditioning/Transplant|Death|1|||
124895427|NCT00049517|449241267|FG001|Conditioning/Transplant|Death|0|||
124895428|NCT00049517|449241268|FG002|Conditioning/Transplant|Death|0|||
124895429|NCT00049517|449241269|FG003|Conditioning/Transplant|Death|2|||
124895430|NCT00049517|449241270|FG004|Conditioning/Transplant|Death|0|||
124895431|NCT00049517|449241271|FG005|Conditioning/Transplant|Death|0|||
124895432|NCT00049517|449241266|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
124895433|NCT00049517|449241267|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
124895434|NCT00049517|449241268|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
124895435|NCT00049517|449241269|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
124895436|NCT00049517|449241270|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
124895437|NCT00049517|449241271|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
124895438|NCT00049517|449241266|FG000|Conditioning/Transplant|Alternative therapy|4|||
124895439|NCT00049517|449241267|FG001|Conditioning/Transplant|Alternative therapy|4|||
124895440|NCT00049517|449241268|FG002|Conditioning/Transplant|Alternative therapy|2|||
124895441|NCT00049517|449241269|FG003|Conditioning/Transplant|Alternative therapy|1|||
125018461|NCT02049944|449692828|FG000|Overall Study|Protocol Violation|2|||
125018462|NCT01765673|449692829|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
125018463|NCT01042600|449692830|FG000|Overall Study|Ineligible|1|||
125018464|NCT01042600|449692831|FG001|Overall Study|Ineligible|0|||
125018465|NCT00621504|449692837|FG000|Overall Study|Adverse Event|1|||
125018466|NCT00621504|449692838|FG001|Overall Study|Adverse Event|3|||
125018467|NCT00621504|449692837|FG000|Overall Study|At the request of sponsor/investigator|1|||
125018468|NCT00621504|449692838|FG001|Overall Study|At the request of sponsor/investigator|0|||
125018469|NCT00621504|449692837|FG000|Overall Study|Withdrew consent|9|||
125018470|NCT00621504|449692838|FG001|Overall Study|Withdrew consent|6|||
125018471|NCT00621504|449692837|FG000|Overall Study|Lost to Follow-up|8|||
125018472|NCT00621504|449692838|FG001|Overall Study|Lost to Follow-up|10|||
125018473|NCT00621504|449692837|FG000|Overall Study|Other|1|||
125018474|NCT00621504|449692838|FG001|Overall Study|Other|0|||
125018475|NCT00621504|449692837|FG000|Overall Study|Death|6|||
125018476|NCT00621504|449692838|FG001|Overall Study|Death|6|||
125018477|NCT00605085|449692839|FG000|Overall Study|Withdrawal by Subject|8|||
124895442|NCT00049517|449241270|FG004|Conditioning/Transplant|Alternative therapy|1|||
124895443|NCT00049517|449241271|FG005|Conditioning/Transplant|Alternative therapy|0|||
124895444|NCT00049517|449241266|FG000|Conditioning/Transplant|Other complicating disease|2|||
124895445|NCT00049517|449241267|FG001|Conditioning/Transplant|Other complicating disease|0|||
124895446|NCT00049517|449241268|FG002|Conditioning/Transplant|Other complicating disease|0|||
124895447|NCT00049517|449241269|FG003|Conditioning/Transplant|Other complicating disease|4|||
124895448|NCT00049517|449241270|FG004|Conditioning/Transplant|Other complicating disease|0|||
124895449|NCT00049517|449241271|FG005|Conditioning/Transplant|Other complicating disease|1|||
124895450|NCT00049517|449241266|FG000|Conditioning/Transplant|Reasons not reported|25|||
124895451|NCT00049517|449241267|FG001|Conditioning/Transplant|Reasons not reported|31|||
124895452|NCT00049517|449241268|FG002|Conditioning/Transplant|Reasons not reported|18|||
124895453|NCT00049517|449241269|FG003|Conditioning/Transplant|Reasons not reported|15|||
124895454|NCT00049517|449241270|FG004|Conditioning/Transplant|Reasons not reported|5|||
124895455|NCT00049517|449241271|FG005|Conditioning/Transplant|Reasons not reported|5|||
124895456|NCT00256308|449241272|FG000|Overall Study|Death|2|||
124895457|NCT00886613|449241278|FG000|Overall Study|Protocol deviation (Part B)|1|||
124895458|NCT00886613|449241279|FG001|Overall Study|Protocol deviation (Part B)|0|||
124895459|NCT00886613|449241280|FG002|Overall Study|Protocol deviation (Part B)|0|||
124895460|NCT00886613|449241278|FG000|Overall Study|Lost to follow-up (Part B)|1|||
124895461|NCT00886613|449241279|FG001|Overall Study|Lost to follow-up (Part B)|0|||
124895462|NCT00886613|449241280|FG002|Overall Study|Lost to follow-up (Part B)|1|||
124895463|NCT00886613|449241278|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
124895464|NCT00886613|449241279|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
124895465|NCT00886613|449241280|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
124895466|NCT02256969|449241285|FG000|Overall Study|Screenfailed or withdrew|2|||
124895467|NCT02256969|449241286|FG001|Overall Study|Screenfailed or withdrew|1|||
124895468|NCT02256969|449241287|FG002|Overall Study|Screenfailed or withdrew|1|||
124895469|NCT02347943|449241288|FG000|Overall Study|Study was cancelled|140|||
124895470|NCT02347943|449241289|FG001|Overall Study|Study was cancelled|67|||
124895471|NCT02347943|449241290|FG002|Overall Study|Study was cancelled|45|||
124895472|NCT03566680|449241294|FG000|Overall Study|Pregnancy|1|||
124895473|NCT03566680|449241294|FG000|Overall Study|Lost to Follow-up|13|||
124895474|NCT03566680|449241294|FG000|Overall Study|Withdrawal by Subject|3|||
124895475|NCT02374957|449241301|FG000|Overall Study|Patient did not complete forms correctly|1|||
124895476|NCT02374957|449241302|FG001|Overall Study|Patient did not complete forms correctly|0|||
124895477|NCT00748969|449241303|FG000|Overall Study|Withdrawal by Subject|1|||
124895478|NCT00748969|449241304|FG001|Overall Study|Withdrawal by Subject|0|||
124895479|NCT00748969|449241303|FG000|Overall Study|Withdrawal by Subject|0|||
124895480|NCT00748969|449241304|FG001|Overall Study|Withdrawal by Subject|1|||
124895481|NCT02334306|449241305|FG000|Double-blind Period|Adverse Event|0|||
124895482|NCT02334306|449241306|FG001|Double-blind Period|Adverse Event|1|||
124895483|NCT02334306|449241305|FG000|Double-blind Period|Withdrawal by Subject|1|||
124895484|NCT02334306|449241306|FG001|Double-blind Period|Withdrawal by Subject|1|||
124895485|NCT01687270|449241307|FG000|Overall Study|Lack of Efficacy|11|||
124895486|NCT01687270|449241307|FG000|Overall Study|Lost to Follow-up|1|||
124895487|NCT00465985|449241308|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
124895488|NCT00465985|449241309|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
124895489|NCT00465985|449241308|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
124895490|NCT00465985|449241309|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
124895491|NCT00465985|449241308|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
124895492|NCT00465985|449241309|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
124895493|NCT00465985|449241308|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
124895494|NCT00465985|449241309|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
124895495|NCT03302156|449241310|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
124895496|NCT03302156|449241311|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
124895497|NCT03302156|449241312|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
124895498|NCT03532178|449241313|FG000|First Period|Withdrawal by Subject|1|||
124895499|NCT03532178|449241314|FG001|First Period|Withdrawal by Subject|3|||
124895500|NCT03532178|449241313|FG000|First Period|technical issues in data collection Technical issues|0|||
125108929|NCT01625286|450022642|FG002|Overall Study|Withdrawal by Subject|0|||
125108930|NCT01625286|450022643|FG003|Overall Study|Withdrawal by Subject|1|||
125108931|NCT01625286|450022644|FG004|Overall Study|Withdrawal by Subject|0|||
125108932|NCT01625286|450022645|FG005|Overall Study|Withdrawal by Subject|0|||
125108933|NCT01625286|450022646|FG006|Overall Study|Withdrawal by Subject|1|||
125108934|NCT01625286|450022640|FG000|Overall Study|Any reason not specifically recorded|0|||
124895501|NCT03532178|449241314|FG001|First Period|technical issues in data collection Technical issues|1|||
124895502|NCT03532178|449241313|FG000|Second Period|Withdrawal by Subject|1|||
125108935|NCT01625286|450022641|FG001|Overall Study|Any reason not specifically recorded|0|||
125108936|NCT01625286|450022642|FG002|Overall Study|Any reason not specifically recorded|0|||
125108937|NCT01625286|450022643|FG003|Overall Study|Any reason not specifically recorded|0|||
125108938|NCT01625286|450022644|FG004|Overall Study|Any reason not specifically recorded|0|||
125108939|NCT01625286|450022645|FG005|Overall Study|Any reason not specifically recorded|1|||
125108940|NCT01625286|450022646|FG006|Overall Study|Any reason not specifically recorded|0|||
125108941|NCT01625286|450022640|FG000|Overall Study|Progressive disease|6|||
125108942|NCT01625286|450022641|FG001|Overall Study|Progressive disease|3|||
125108943|NCT01625286|450022642|FG002|Overall Study|Progressive disease|4|||
125108944|NCT01625286|450022643|FG003|Overall Study|Progressive disease|5|||
125108945|NCT01625286|450022644|FG004|Overall Study|Progressive disease|5|||
125108946|NCT01625286|450022645|FG005|Overall Study|Progressive disease|0|||
125108947|NCT01625286|450022646|FG006|Overall Study|Progressive disease|0|||
125108948|NCT01625286|450022640|FG000|Overall Study|Lost to Follow-up|0|||
125108949|NCT01625286|450022641|FG001|Overall Study|Lost to Follow-up|0|||
125108950|NCT01625286|450022642|FG002|Overall Study|Lost to Follow-up|0|||
125108951|NCT01625286|450022643|FG003|Overall Study|Lost to Follow-up|0|||
125108952|NCT01625286|450022644|FG004|Overall Study|Lost to Follow-up|0|||
125108953|NCT01625286|450022645|FG005|Overall Study|Lost to Follow-up|0|||
125108954|NCT01625286|450022646|FG006|Overall Study|Lost to Follow-up|1|||
125108955|NCT00928135|450022647|FG000|Overall Study|Withdrawal by Subject|1|||
125108956|NCT00928135|450022648|FG001|Overall Study|Withdrawal by Subject|0|||
125108957|NCT03338673|450022651|FG000|Overall Study|Lost to Follow-up|1|||
125108958|NCT03338673|450022652|FG001|Overall Study|Lost to Follow-up|1|||
125108959|NCT00434148|450022653|FG000|Overall Study|Adverse Event|18|||
125108960|NCT00434148|450022654|FG001|Overall Study|Adverse Event|18|||
125108961|NCT00434148|450022653|FG000|Overall Study|Lack of Efficacy|25|||
125108962|NCT00434148|450022654|FG001|Overall Study|Lack of Efficacy|28|||
125108963|NCT00434148|450022653|FG000|Overall Study|Withdrawal by Subject|15|||
125108964|NCT00434148|450022654|FG001|Overall Study|Withdrawal by Subject|15|||
125108965|NCT00434148|450022653|FG000|Overall Study|Protocol Violation|4|||
125108966|NCT00434148|450022654|FG001|Overall Study|Protocol Violation|0|||
125108967|NCT00434148|450022653|FG000|Overall Study|Administrative problems|6|||
125108968|NCT00434148|450022654|FG001|Overall Study|Administrative problems|10|||
124895503|NCT03532178|449241314|FG001|Second Period|Withdrawal by Subject|1|||
124895504|NCT03532178|449241313|FG000|Second Period|Technical issues|0|||
124895505|NCT03532178|449241314|FG001|Second Period|Technical issues|1|||
124895506|NCT02390557|449241315|FG000|Wave 2|Survey non-respondent|72|||
124895507|NCT02390557|449241316|FG001|Wave 2|Survey non-respondent|41|||
124895508|NCT02390557|449241317|FG002|Wave 2|Survey non-respondent|23|||
124895509|NCT03278028|449241321|FG000|Overall Study|Lost to Follow-up|1|||
124895510|NCT03278028|449241322|FG001|Overall Study|Lost to Follow-up|0|||
124895511|NCT03278028|449241321|FG000|Overall Study|Withdrawal by Subject|3|||
124895512|NCT03278028|449241322|FG001|Overall Study|Withdrawal by Subject|1|||
124895513|NCT03278028|449241321|FG000|Overall Study|Pregnancy|0|||
124895514|NCT03278028|449241322|FG001|Overall Study|Pregnancy|1|||
124895515|NCT01360840|449241323|FG000|Overall Study|Ongoing at data cut-off|10|||
124895516|NCT01360840|449241324|FG001|Overall Study|Ongoing at data cut-off|10|||
124895517|NCT01360840|449241325|FG002|Overall Study|Ongoing at data cut-off|9|||
124895518|NCT00293462|449241326|FG000|Overall Study|Withdrawal by Subject|4|||
124895519|NCT00293462|449241327|FG001|Overall Study|Withdrawal by Subject|3|||
124895520|NCT00293462|449241328|FG002|Overall Study|Withdrawal by Subject|8|||
124895521|NCT00293462|449241326|FG000|Overall Study|Death|1|||
124895522|NCT00293462|449241327|FG001|Overall Study|Death|0|||
124895523|NCT00293462|449241328|FG002|Overall Study|Death|0|||
124895524|NCT00293462|449241326|FG000|Overall Study|Lost to Follow-up|0|||
124895525|NCT00293462|449241327|FG001|Overall Study|Lost to Follow-up|1|||
124895526|NCT00293462|449241328|FG002|Overall Study|Lost to Follow-up|0|||
124895527|NCT00293462|449241326|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
124895528|NCT00293462|449241327|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
124895529|NCT00293462|449241328|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
125108969|NCT00434148|450022653|FG000|Overall Study|Lost to Follow-up|0|||
125108970|NCT00434148|450022654|FG001|Overall Study|Lost to Follow-up|1|||
125108971|NCT00434148|450022653|FG000|Overall Study|Condition no longer requires study drug|1|||
125108972|NCT00434148|450022654|FG001|Overall Study|Condition no longer requires study drug|0|||
124895530|NCT00293462|449241326|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
124895531|NCT00293462|449241327|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
124895532|NCT00293462|449241328|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
124895533|NCT00293462|449241326|FG000|Overall Study|Refuse Radiation Treatment|1|||
125108973|NCT00434148|450022653|FG000|Overall Study|Abnormal test procedure result|0|||
125108974|NCT00434148|450022654|FG001|Overall Study|Abnormal test procedure result|1|||
125108975|NCT00828516|450022657|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
125108976|NCT00990093|450022658|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
125108977|NCT00990093|450022659|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
125108978|NCT00990093|450022658|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
125108979|NCT00990093|450022659|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
124895534|NCT00293462|449241327|FG001|Overall Study|Refuse Radiation Treatment|0|||
124895535|NCT00293462|449241328|FG002|Overall Study|Refuse Radiation Treatment|0|||
124895536|NCT00293462|449241326|FG000|Overall Study|No Show|0|||
124895537|NCT00293462|449241327|FG001|Overall Study|No Show|0|||
124895538|NCT00293462|449241328|FG002|Overall Study|No Show|1|||
124895539|NCT00293462|449241326|FG000|Overall Study|Went back to his home country|0|||
124895540|NCT00293462|449241327|FG001|Overall Study|Went back to his home country|0|||
124895541|NCT00293462|449241328|FG002|Overall Study|Went back to his home country|1|||
125108980|NCT00990093|450022658|FG000|Test Period 1 (1-14 Days)|Other|1|||
124895542|NCT00293462|449241326|FG000|Overall Study|Blood clot after chemotherapy|0|||
124895543|NCT00293462|449241327|FG001|Overall Study|Blood clot after chemotherapy|0|||
124895544|NCT00293462|449241328|FG002|Overall Study|Blood clot after chemotherapy|1|||
124895545|NCT00293462|449241326|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
124895546|NCT00293462|449241327|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
124895547|NCT00293462|449241328|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
124895548|NCT00293462|449241326|FG000|Overall Study|Possible Tracheostomy leakage|0|||
124895549|NCT00293462|449241327|FG001|Overall Study|Possible Tracheostomy leakage|1|||
124895550|NCT00293462|449241328|FG002|Overall Study|Possible Tracheostomy leakage|0|||
124895551|NCT00293462|449241326|FG000|Overall Study|Low radiation dose in oral cavity|0|||
124895552|NCT00293462|449241327|FG001|Overall Study|Low radiation dose in oral cavity|1|||
124895553|NCT00293462|449241328|FG002|Overall Study|Low radiation dose in oral cavity|0|||
124895554|NCT00293462|449241326|FG000|Overall Study|Physician Decision|0|||
124895555|NCT00293462|449241327|FG001|Overall Study|Physician Decision|1|||
124895556|NCT00293462|449241328|FG002|Overall Study|Physician Decision|0|||
124895557|NCT01579578|449241329|FG000|Overall Study|Death|4|||
124895558|NCT01579578|449241330|FG001|Overall Study|Death|1|||
124895559|NCT01579578|449241329|FG000|Overall Study|Lost to Follow-up|1|||
124895560|NCT01579578|449241330|FG001|Overall Study|Lost to Follow-up|1|||
124895561|NCT01579578|449241329|FG000|Overall Study|Withdrawal by Subject|2|||
124895562|NCT01579578|449241330|FG001|Overall Study|Withdrawal by Subject|1|||
124895563|NCT01579578|449241329|FG000|Overall Study|Eligibility criteria|3|||
124895564|NCT01579578|449241330|FG001|Overall Study|Eligibility criteria|9|||
124895565|NCT01579578|449241329|FG000|Overall Study|Ongoing|3|||
124895566|NCT01579578|449241330|FG001|Overall Study|Ongoing|0|||
124895567|NCT01528709|449241331|FG000|Overall Study|Death|2|||
124895568|NCT01528709|449241332|FG001|Overall Study|Death|0|||
124895569|NCT01528709|449241331|FG000|Overall Study|Withdrawal by Subject|10|||
124895570|NCT01528709|449241332|FG001|Overall Study|Withdrawal by Subject|15|||
124895571|NCT01528709|449241331|FG000|Overall Study|allergy|1|||
125108981|NCT00990093|450022659|FG001|Test Period 1 (1-14 Days)|Other|0|||
125108982|NCT00990093|450022658|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
125108983|NCT00990093|450022659|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
125108984|NCT00990093|450022658|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
125108985|NCT00990093|450022659|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
125108986|NCT00990093|450022658|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
125108987|NCT00990093|450022659|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
125108988|NCT00990093|450022658|FG000|Test Period 2 (15-28 Days)|Other|0|||
125108989|NCT00990093|450022659|FG001|Test Period 2 (15-28 Days)|Other|1|||
125108990|NCT04556838|450022662|FG000|Overall Study|Withdrawal by Subject|3|||
125108991|NCT04556838|450022663|FG001|Overall Study|Withdrawal by Subject|1|||
125108992|NCT04556838|450022664|FG002|Overall Study|Withdrawal by Subject|2|||
125108993|NCT04556838|450022662|FG000|Overall Study|Adverse Event|0|||
125108994|NCT04556838|450022663|FG001|Overall Study|Adverse Event|1|||
125108995|NCT04556838|450022664|FG002|Overall Study|Adverse Event|1|||
125108996|NCT04556838|450022662|FG000|Overall Study|Lost to Follow-up|0|||
125108997|NCT04556838|450022663|FG001|Overall Study|Lost to Follow-up|0|||
125108998|NCT04556838|450022664|FG002|Overall Study|Lost to Follow-up|2|||
125108999|NCT04556838|450022662|FG000|Overall Study|Subject travel|0|||
124895572|NCT01528709|449241332|FG001|Overall Study|allergy|0|||
124895573|NCT01813422|449241342|FG000|Overall Study|Withdrawal by Subject|14|||
124895574|NCT01813422|449241343|FG001|Overall Study|Withdrawal by Subject|8|||
124895575|NCT01813422|449241342|FG000|Overall Study|Death|2|||
124895576|NCT01813422|449241343|FG001|Overall Study|Death|3|||
124895577|NCT01813422|449241342|FG000|Overall Study|Sponsor Decision|2|||
124895578|NCT01813422|449241343|FG001|Overall Study|Sponsor Decision|1|||
124895579|NCT01813422|449241342|FG000|Overall Study|Lost to Follow-up|2|||
124895580|NCT01813422|449241343|FG001|Overall Study|Lost to Follow-up|4|||
124895581|NCT01653743|449241344|FG000|Overall Study|Withdrawal by Subject|1|||
125109000|NCT04556838|450022663|FG001|Overall Study|Subject travel|1|||
125109001|NCT04556838|450022664|FG002|Overall Study|Subject travel|0|||
125109002|NCT04556838|450022662|FG000|Overall Study|Physician Decision|1|||
125109003|NCT04556838|450022663|FG001|Overall Study|Physician Decision|0|||
124895582|NCT01653743|449241345|FG001|Overall Study|Withdrawal by Subject|0|||
124895583|NCT01653743|449241344|FG000|Overall Study|Investigator discretion|3|||
125109004|NCT04556838|450022664|FG002|Overall Study|Physician Decision|0|||
125109005|NCT00995930|450022665|FG000|Overall Study|Protocol deviation|2|||
125109006|NCT00995930|450022666|FG001|Overall Study|Protocol deviation|5|||
125109007|NCT00995930|450022665|FG000|Overall Study|Death|0|||
124895584|NCT01653743|449241345|FG001|Overall Study|Investigator discretion|0|||
124895585|NCT04889118|449241347|FG000|Overall Study|Death|33|||
124895586|NCT04889118|449241348|FG001|Overall Study|Death|37|||
124895587|NCT04889118|449241347|FG000|Overall Study|Ongoing in Study|31|||
124895588|NCT04889118|449241348|FG001|Overall Study|Ongoing in Study|30|||
124895589|NCT02397889|449241349|FG000|Overall Study|Physician Decision|1|||
125109008|NCT00995930|450022666|FG001|Overall Study|Death|1|||
125109009|NCT00995930|450022665|FG000|Overall Study|Administrative problems|4|||
125109010|NCT00995930|450022666|FG001|Overall Study|Administrative problems|2|||
124895590|NCT02397889|449241350|FG001|Overall Study|Physician Decision|0|||
124895591|NCT01928940|449241352|FG000|Overall Study|Adverse Event|0|||
124895592|NCT01928940|449241353|FG001|Overall Study|Adverse Event|1|||
124895593|NCT01352507|449241356|FG000|Treatment Period 1|Adverse Event|3|||
124895594|NCT01352507|449241357|FG001|Treatment Period 1|Adverse Event|0|||
124895595|NCT01352507|449241356|FG000|Treatment Period 1|Lost to Follow-up|3|||
124895596|NCT01352507|449241357|FG001|Treatment Period 1|Lost to Follow-up|4|||
124895597|NCT01352507|449241356|FG000|Treatment Period 1|Withdrawal by Subject|7|||
124895598|NCT01352507|449241357|FG001|Treatment Period 1|Withdrawal by Subject|5|||
124895599|NCT01352507|449241356|FG000|Treatment Period 1|Physician Decision|1|||
124895600|NCT01352507|449241357|FG001|Treatment Period 1|Physician Decision|0|||
124895601|NCT01352507|449241356|FG000|Washout Period|Withdrawal by Subject|0|||
124895602|NCT01352507|449241357|FG001|Washout Period|Withdrawal by Subject|1|||
124895603|NCT01352507|449241356|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
124895604|NCT01352507|449241357|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
124895605|NCT01352507|449241356|FG000|Treatment Period 2|Withdrawal by Subject|4|||
125109011|NCT00995930|450022665|FG000|Overall Study|Lost to Follow-up|1|||
125109012|NCT00995930|450022666|FG001|Overall Study|Lost to Follow-up|2|||
124895606|NCT01352507|449241357|FG001|Treatment Period 2|Withdrawal by Subject|3|||
124895607|NCT01352507|449241356|FG000|Treatment Period 2|Lack of Efficacy|1|||
124895608|NCT01352507|449241357|FG001|Treatment Period 2|Lack of Efficacy|0|||
124895609|NCT01511250|449241358|FG000|Overall Study|Withdrawal of Consent|1|||
124895610|NCT01511250|449241359|FG001|Overall Study|Withdrawal of Consent|0|||
124895611|NCT01511250|449241360|FG002|Overall Study|Withdrawal of Consent|0|||
124895612|NCT01511250|449241361|FG003|Overall Study|Withdrawal of Consent|0|||
124895613|NCT01511250|449241362|FG004|Overall Study|Withdrawal of Consent|0|||
124895614|NCT01511250|449241363|FG005|Overall Study|Withdrawal of Consent|0|||
124895615|NCT01511250|449241364|FG006|Overall Study|Withdrawal of Consent|0|||
124895616|NCT01511250|449241365|FG007|Overall Study|Withdrawal of Consent|1|||
124895617|NCT01511250|449241366|FG008|Overall Study|Withdrawal of Consent|1|||
124895618|NCT01511250|449241367|FG009|Overall Study|Withdrawal of Consent|0|||
124895619|NCT01511250|449241358|FG000|Overall Study|Sponsor/Investigator Decision|1|||
125109013|NCT00995930|450022665|FG000|Overall Study|Withdrawal by Subject|3|||
125109014|NCT00995930|450022666|FG001|Overall Study|Withdrawal by Subject|4|||
125109015|NCT00995930|450022665|FG000|Overall Study|Adverse Event|11|||
125109016|NCT00995930|450022666|FG001|Overall Study|Adverse Event|14|||
125109017|NCT05003167|450022669|FG000|Overall Study|Withdrawal by Subject|1|||
124895620|NCT01511250|449241359|FG001|Overall Study|Sponsor/Investigator Decision|0|||
124895621|NCT01511250|449241360|FG002|Overall Study|Sponsor/Investigator Decision|0|||
124895622|NCT01511250|449241361|FG003|Overall Study|Sponsor/Investigator Decision|0|||
124895623|NCT01511250|449241362|FG004|Overall Study|Sponsor/Investigator Decision|0|||
124895624|NCT01511250|449241363|FG005|Overall Study|Sponsor/Investigator Decision|0|||
124895625|NCT01511250|449241364|FG006|Overall Study|Sponsor/Investigator Decision|0|||
124895626|NCT01511250|449241365|FG007|Overall Study|Sponsor/Investigator Decision|0|||
124895627|NCT01511250|449241366|FG008|Overall Study|Sponsor/Investigator Decision|0|||
124895628|NCT01511250|449241367|FG009|Overall Study|Sponsor/Investigator Decision|0|||
124895629|NCT01511250|449241358|FG000|Overall Study|Lost to Follow-up|7|||
124895630|NCT01511250|449241359|FG001|Overall Study|Lost to Follow-up|3|||
124895631|NCT01511250|449241360|FG002|Overall Study|Lost to Follow-up|3|||
125109018|NCT02842086|450022670|FG000|Overall Study|Randomized but Never Treated|6|||
125109019|NCT02842086|450022671|FG001|Overall Study|Randomized but Never Treated|6|||
124895632|NCT01511250|449241361|FG003|Overall Study|Lost to Follow-up|3|||
124895633|NCT01511250|449241362|FG004|Overall Study|Lost to Follow-up|0|||
124895634|NCT01511250|449241363|FG005|Overall Study|Lost to Follow-up|0|||
124895635|NCT01511250|449241364|FG006|Overall Study|Lost to Follow-up|2|||
124895636|NCT01511250|449241365|FG007|Overall Study|Lost to Follow-up|3|||
124895637|NCT01511250|449241366|FG008|Overall Study|Lost to Follow-up|13|||
124895638|NCT01511250|449241367|FG009|Overall Study|Lost to Follow-up|5|||
124895639|NCT01511250|449241358|FG000|Overall Study|Protocol Violation|0|||
124895640|NCT01511250|449241359|FG001|Overall Study|Protocol Violation|2|||
124895641|NCT01511250|449241360|FG002|Overall Study|Protocol Violation|1|||
124895642|NCT01511250|449241361|FG003|Overall Study|Protocol Violation|0|||
124895643|NCT01511250|449241362|FG004|Overall Study|Protocol Violation|0|||
124895644|NCT01511250|449241363|FG005|Overall Study|Protocol Violation|0|||
125109020|NCT02842086|450022670|FG000|Overall Study|Still in Double-Blind Phase|7|||
125109021|NCT02842086|450022671|FG001|Overall Study|Still in Double-Blind Phase|3|||
124895645|NCT01511250|449241364|FG006|Overall Study|Protocol Violation|0|||
124895646|NCT01511250|449241365|FG007|Overall Study|Protocol Violation|0|||
124895647|NCT01511250|449241366|FG008|Overall Study|Protocol Violation|0|||
124895648|NCT01511250|449241367|FG009|Overall Study|Protocol Violation|0|||
124895649|NCT05487703|449241371|FG000|Overall Study|Other|19|||
124895650|NCT05487703|449241371|FG000|Overall Study|Participant not well|5|||
124895651|NCT05487703|449241371|FG000|Overall Study|Insurance Reasons|6|||
124895652|NCT05487703|449241371|FG000|Overall Study|Physician Decision|19|||
124895653|NCT05487703|449241371|FG000|Overall Study|Lack of Efficacy|60|||
124895654|NCT04824131|449241372|FG000|CAB LA Oral Phase|Adverse Event|1|||
124895655|NCT04824131|449241372|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
124895656|NCT04824131|449241372|FG000|Step 3|Withdrawal by Subject|2|||
124895657|NCT04887285|449241373|FG000|Overall Study|Lost to Follow-up|0|||
124895658|NCT04887285|449241374|FG001|Overall Study|Lost to Follow-up|2|||
124895659|NCT04887285|449241375|FG002|Overall Study|Lost to Follow-up|3|||
124895660|NCT04939428|449241376|FG000|Overall Study|Death|0|||
124895661|NCT04939428|449241377|FG001|Overall Study|Death|1|||
124895662|NCT04939428|449241378|FG002|Overall Study|Death|0|||
124895663|NCT04939428|449241376|FG000|Overall Study|Lost to Follow-up|0|||
124895664|NCT04939428|449241377|FG001|Overall Study|Lost to Follow-up|5|||
124895665|NCT04939428|449241378|FG002|Overall Study|Lost to Follow-up|0|||
124895666|NCT04939428|449241376|FG000|Overall Study|Physician Decision|1|||
124895667|NCT04939428|449241377|FG001|Overall Study|Physician Decision|0|||
124895668|NCT04939428|449241378|FG002|Overall Study|Physician Decision|0|||
124895669|NCT04939428|449241376|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
124895670|NCT04939428|449241377|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124895671|NCT04939428|449241378|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124895672|NCT04939428|449241376|FG000|Overall Study|Withdrawal by Subject|10|||
124895673|NCT04939428|449241377|FG001|Overall Study|Withdrawal by Subject|11|||
124895674|NCT04939428|449241378|FG002|Overall Study|Withdrawal by Subject|0|||
124895675|NCT04939428|449241376|FG000|Overall Study|Unkown|6|||
124895676|NCT04939428|449241377|FG001|Overall Study|Unkown|3|||
124895677|NCT04939428|449241378|FG002|Overall Study|Unkown|0|||
124895678|NCT04939428|449241376|FG000|Overall Study|Discotinued per protocol|0|||
124895679|NCT04939428|449241377|FG001|Overall Study|Discotinued per protocol|0|||
124895680|NCT04939428|449241378|FG002|Overall Study|Discotinued per protocol|902|||
124895681|NCT02696785|449241379|FG000|Blinded Treatment Period|Adverse Event|0|||
124895682|NCT02696785|449241380|FG001|Blinded Treatment Period|Adverse Event|1|||
124895683|NCT02696785|449241381|FG002|Blinded Treatment Period|Adverse Event|3|||
124895684|NCT02696785|449241382|FG003|Blinded Treatment Period|Adverse Event|0|||
124895685|NCT02696785|449241379|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
124895686|NCT02696785|449241380|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
124895687|NCT02696785|449241381|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
124895688|NCT02696785|449241382|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
124895689|NCT02696785|449241379|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
124895690|NCT02696785|449241380|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
124895691|NCT02696785|449241381|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
124895692|NCT02696785|449241382|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
125018478|NCT00605085|449692840|FG001|Overall Study|Withdrawal by Subject|5|||
125018479|NCT00605085|449692839|FG000|Overall Study|Adverse Event|9|||
125018480|NCT00605085|449692840|FG001|Overall Study|Adverse Event|5|||
125018481|NCT00605085|449692839|FG000|Overall Study|Pregnancy|2|||
125018482|NCT00605085|449692840|FG001|Overall Study|Pregnancy|0|||
125018483|NCT00605085|449692839|FG000|Overall Study|Protocol Violation|3|||
125018484|NCT00605085|449692840|FG001|Overall Study|Protocol Violation|2|||
125018485|NCT00605085|449692839|FG000|Overall Study|Lost to Follow-up|10|||
125018486|NCT00605085|449692840|FG001|Overall Study|Lost to Follow-up|5|||
125018487|NCT00605085|449692839|FG000|Overall Study|administrative reasons|18|||
125018488|NCT00605085|449692840|FG001|Overall Study|administrative reasons|8|||
125018489|NCT03257267|449692843|FG000|Overall Study|Adverse Event|17|||
125018490|NCT03257267|449692844|FG001|Overall Study|Adverse Event|7|||
125018491|NCT03257267|449692843|FG000|Overall Study|Death|96|||
125018492|NCT03257267|449692844|FG001|Overall Study|Death|98|||
125018493|NCT03257267|449692843|FG000|Overall Study|Lost to Follow-up|2|||
125018494|NCT03257267|449692844|FG001|Overall Study|Lost to Follow-up|2|||
124895693|NCT02696785|449241379|FG000|Blinded Treatment Period|Screen Failure|1|||
124895694|NCT02696785|449241380|FG001|Blinded Treatment Period|Screen Failure|0|||
124895695|NCT02696785|449241381|FG002|Blinded Treatment Period|Screen Failure|0|||
124895696|NCT02696785|449241382|FG003|Blinded Treatment Period|Screen Failure|0|||
124895697|NCT02696785|449241379|FG000|Washout Period|Withdrawal by Subject|0|||
124895698|NCT02696785|449241380|FG001|Washout Period|Withdrawal by Subject|1|||
124895699|NCT02696785|449241381|FG002|Washout Period|Withdrawal by Subject|0|||
124895700|NCT02696785|449241382|FG003|Washout Period|Withdrawal by Subject|0|||
124895701|NCT02696785|449241379|FG000|Washout Period|Lack of Efficacy|0|||
124895702|NCT02696785|449241380|FG001|Washout Period|Lack of Efficacy|1|||
125018495|NCT03257267|449692843|FG000|Overall Study|Non-compliance with Study Drug|0|||
125018496|NCT03257267|449692844|FG001|Overall Study|Non-compliance with Study Drug|2|||
125109022|NCT02842086|450022670|FG000|Overall Study|Adverse Event|18|||
125109023|NCT02842086|450022671|FG001|Overall Study|Adverse Event|20|||
125109024|NCT02842086|450022670|FG000|Overall Study|Death|3|||
125109025|NCT02842086|450022671|FG001|Overall Study|Death|3|||
125109026|NCT02842086|450022670|FG000|Overall Study|Investigator's Discretion|9|||
125109027|NCT02842086|450022671|FG001|Overall Study|Investigator's Discretion|13|||
125109028|NCT02842086|450022670|FG000|Overall Study|Non-Compliance with Study Drug|9|||
125109029|NCT02842086|450022671|FG001|Overall Study|Non-Compliance with Study Drug|8|||
125109030|NCT02842086|450022670|FG000|Overall Study|Protocol Violation|8|||
125109031|NCT02842086|450022671|FG001|Overall Study|Protocol Violation|4|||
125109032|NCT02842086|450022670|FG000|Overall Study|Withdrew Consent|205|||
125109033|NCT02842086|450022671|FG001|Overall Study|Withdrew Consent|194|||
125109034|NCT02842086|450022670|FG000|Overall Study|Lost to Follow-up|274|||
125109035|NCT02842086|450022671|FG001|Overall Study|Lost to Follow-up|236|||
125109036|NCT02842086|450022670|FG000|Overall Study|HIV-1 Infection|5|||
125109037|NCT02842086|450022671|FG001|Overall Study|HIV-1 Infection|6|||
125109038|NCT03751124|450022672|FG000|Overall Study|Adverse Event|4|||
125109039|NCT03751124|450022673|FG001|Overall Study|Adverse Event|3|||
125109040|NCT03751124|450022672|FG000|Overall Study|Protocol Deviation|0|||
125109041|NCT03751124|450022673|FG001|Overall Study|Protocol Deviation|1|||
125109042|NCT03751124|450022672|FG000|Overall Study|Lost to Follow-up|6|||
125109043|NCT03751124|450022673|FG001|Overall Study|Lost to Follow-up|4|||
125109044|NCT03751124|450022672|FG000|Overall Study|Withdrawal by Subject|6|||
125109045|NCT03751124|450022673|FG001|Overall Study|Withdrawal by Subject|8|||
125109046|NCT03751124|450022672|FG000|Overall Study|Lack of Efficacy|1|||
125109047|NCT03751124|450022673|FG001|Overall Study|Lack of Efficacy|1|||
125109048|NCT03751124|450022672|FG000|Overall Study|Pregnancy|0|||
125109049|NCT03751124|450022673|FG001|Overall Study|Pregnancy|1|||
125109050|NCT03751124|450022672|FG000|Overall Study|Other|9|||
125109051|NCT03751124|450022673|FG001|Overall Study|Other|9|||
125109052|NCT03751124|450022672|FG000|Overall Study|Participants who did not receive any study drug|0|||
125109053|NCT03751124|450022673|FG001|Overall Study|Participants who did not receive any study drug|1|||
125109054|NCT00555399|450022684|FG000|Overall Study|Withdrawal by Subject|0|||
125109055|NCT00555399|450022685|FG001|Overall Study|Withdrawal by Subject|0|||
125109056|NCT00555399|450022686|FG002|Overall Study|Withdrawal by Subject|1|||
125109057|NCT00555399|450022687|FG003|Overall Study|Withdrawal by Subject|0|||
125109058|NCT00555399|450022688|FG004|Overall Study|Withdrawal by Subject|0|||
125109059|NCT00555399|450022689|FG005|Overall Study|Withdrawal by Subject|0|||
125109060|NCT00555399|450022690|FG006|Overall Study|Withdrawal by Subject|0|||
125109061|NCT00555399|450022691|FG007|Overall Study|Withdrawal by Subject|0|||
125109062|NCT00555399|450022692|FG008|Overall Study|Withdrawal by Subject|0|||
125109063|NCT00555399|450022693|FG009|Overall Study|Withdrawal by Subject|0|||
125109064|NCT00555399|450022694|FG010|Overall Study|Withdrawal by Subject|0|||
125109065|NCT00555399|450022695|FG011|Overall Study|Withdrawal by Subject|1|||
125109066|NCT00555399|450022684|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
125109067|NCT00555399|450022685|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
125109068|NCT00555399|450022686|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
125109069|NCT00555399|450022687|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
125109070|NCT00555399|450022688|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
125109071|NCT00555399|450022689|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
125109072|NCT00555399|450022690|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
125109073|NCT00555399|450022691|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
125109074|NCT00555399|450022692|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
125109075|NCT00555399|450022693|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
125109076|NCT00555399|450022694|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
125109077|NCT00555399|450022695|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
125109078|NCT05166421|450022696|FG000|Overall Study|Other|3|||
125109079|NCT05166421|450022697|FG001|Overall Study|Other|1|||
125109080|NCT05166421|450022698|FG002|Overall Study|Other|1|||
125109081|NCT05166421|450022696|FG000|Overall Study|Withdrawal by Subject|5|||
125109082|NCT05166421|450022697|FG001|Overall Study|Withdrawal by Subject|3|||
125109083|NCT05166421|450022698|FG002|Overall Study|Withdrawal by Subject|6|||
125109084|NCT05166421|450022696|FG000|Overall Study|Lost to Follow-up|4|||
125109085|NCT05166421|450022697|FG001|Overall Study|Lost to Follow-up|1|||
125109086|NCT05166421|450022698|FG002|Overall Study|Lost to Follow-up|7|||
125109087|NCT01858558|450024288|FG000|Overall Study|Death|1|||
125109088|NCT01858558|450024289|FG001|Overall Study|Death|1|||
125109089|NCT01858558|450024288|FG000|Overall Study|Lost to Follow-up|1|||
125109090|NCT01858558|450024289|FG001|Overall Study|Lost to Follow-up|0|||
125109091|NCT01858558|450024288|FG000|Overall Study|Disease progression|3|||
125109092|NCT01858558|450024289|FG001|Overall Study|Disease progression|1|||
125109093|NCT01858558|450024288|FG000|Overall Study|Product contamination|2|||
125109094|NCT01858558|450024289|FG001|Overall Study|Product contamination|0|||
125109095|NCT01858558|450024288|FG000|Overall Study|Failed expansion of cell product|2|||
125109096|NCT01858558|450024289|FG001|Overall Study|Failed expansion of cell product|0|||
124895703|NCT02696785|449241381|FG002|Washout Period|Lack of Efficacy|0|||
125109097|NCT00343642|450024290|FG000|Overall Study|Lost to Follow-up|0|||
125109098|NCT00343642|450024291|FG001|Overall Study|Lost to Follow-up|1|||
125109099|NCT00343642|450024292|FG002|Overall Study|Lost to Follow-up|0|||
125109100|NCT00343642|450024290|FG000|Overall Study|Pregnancy|1|||
125109101|NCT00343642|450024291|FG001|Overall Study|Pregnancy|0|||
125109102|NCT00343642|450024292|FG002|Overall Study|Pregnancy|2|||
125109103|NCT00343642|450024290|FG000|Overall Study|Withdrawal by Subject|2|||
125109104|NCT00343642|450024291|FG001|Overall Study|Withdrawal by Subject|3|||
125109105|NCT00343642|450024292|FG002|Overall Study|Withdrawal by Subject|4|||
125109106|NCT00343642|450024290|FG000|Overall Study|Adverse Event|0|||
125109107|NCT00343642|450024291|FG001|Overall Study|Adverse Event|0|||
125109108|NCT00343642|450024292|FG002|Overall Study|Adverse Event|1|||
125109109|NCT00343642|450024290|FG000|Overall Study|Flare up|6|||
124895704|NCT02696785|449241382|FG003|Washout Period|Lack of Efficacy|0|||
124895705|NCT02696785|449241379|FG000|Extended Treatment Period|Adverse Event|2|||
124895706|NCT02696785|449241380|FG001|Extended Treatment Period|Adverse Event|3|||
124895707|NCT02696785|449241381|FG002|Extended Treatment Period|Adverse Event|2|||
124895708|NCT02696785|449241382|FG003|Extended Treatment Period|Adverse Event|1|||
124895709|NCT02696785|449241379|FG000|Extended Treatment Period|Lack of Efficacy|0|||
124895710|NCT02696785|449241380|FG001|Extended Treatment Period|Lack of Efficacy|1|||
124895711|NCT02696785|449241381|FG002|Extended Treatment Period|Lack of Efficacy|0|||
124895712|NCT02696785|449241382|FG003|Extended Treatment Period|Lack of Efficacy|0|||
124895713|NCT02696785|449241379|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
124895714|NCT02696785|449241380|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
124895715|NCT02696785|449241381|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
124895716|NCT02696785|449241382|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
124895717|NCT02696785|449241379|FG000|Follow-up Period|Adverse Event|0|||
124895718|NCT02696785|449241380|FG001|Follow-up Period|Adverse Event|0|||
124895719|NCT02696785|449241381|FG002|Follow-up Period|Adverse Event|8|||
124895720|NCT02696785|449241382|FG003|Follow-up Period|Adverse Event|2|||
124895721|NCT02696785|449241379|FG000|Follow-up Period|Lost to Follow-up|0|||
124895722|NCT02696785|449241380|FG001|Follow-up Period|Lost to Follow-up|0|||
124895723|NCT02696785|449241381|FG002|Follow-up Period|Lost to Follow-up|0|||
124895724|NCT02696785|449241382|FG003|Follow-up Period|Lost to Follow-up|1|||
124895725|NCT02696785|449241379|FG000|Follow-up Period|Lack of Efficacy|0|||
124895726|NCT02696785|449241380|FG001|Follow-up Period|Lack of Efficacy|0|||
124895727|NCT02696785|449241381|FG002|Follow-up Period|Lack of Efficacy|0|||
124895728|NCT02696785|449241382|FG003|Follow-up Period|Lack of Efficacy|1|||
124895729|NCT02696785|449241379|FG000|Follow-up Period|Withdrawal by Subject|1|||
124895730|NCT02696785|449241380|FG001|Follow-up Period|Withdrawal by Subject|0|||
124895731|NCT02696785|449241381|FG002|Follow-up Period|Withdrawal by Subject|5|||
124895732|NCT02696785|449241382|FG003|Follow-up Period|Withdrawal by Subject|4|||
124895733|NCT04863898|449241383|FG000|Overall Study|Away from study clinic during intervention training period|2|||
124895734|NCT04863898|449241383|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
124895735|NCT04863898|449241383|FG000|Overall Study|Lost to Follow-up|3|||
124895736|NCT04863898|449241383|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
124895737|NCT04863898|449241383|FG000|Overall Study|No longer employed at clinic|3|||
124895738|NCT00770211|449241384|FG000|Overall Study|Lost to Follow-up|1|||
124895739|NCT00770211|449241385|FG001|Overall Study|Lost to Follow-up|0|||
124895740|NCT00770211|449241384|FG000|Overall Study|Withdrawal by Subject|0|||
124895741|NCT00770211|449241385|FG001|Overall Study|Withdrawal by Subject|2|||
124895742|NCT01822821|449241387|FG000|Overall Study|Eligible surgery cancelled|1|||
124895743|NCT01822821|449241388|FG001|Overall Study|Eligible surgery cancelled|1|||
124895744|NCT01822821|449241387|FG000|Overall Study|Other reasons|1|||
124895745|NCT01822821|449241388|FG001|Overall Study|Other reasons|0|||
124895746|NCT00764868|449241390|FG000|Overall Study|Adverse Event|18|||
124895747|NCT00764868|449241390|FG000|Overall Study|Withdrawal by Subject|31|||
124895748|NCT00764868|449241390|FG000|Overall Study|Non-compliance|16|||
124895749|NCT00764868|449241390|FG000|Overall Study|Lost to Follow-up|25|||
124895750|NCT00764868|449241390|FG000|Overall Study|Lack of Efficacy|5|||
124895751|NCT00764868|449241390|FG000|Overall Study|Subject moved|7|||
125109110|NCT00343642|450024291|FG001|Overall Study|Flare up|4|||
125109111|NCT00343642|450024292|FG002|Overall Study|Flare up|0|||
124895752|NCT00764868|449241390|FG000|Overall Study|Pregnancy|3|||
124895753|NCT00764868|449241390|FG000|Overall Study|Prohibited medication|1|||
124895754|NCT00764868|449241390|FG000|Overall Study|Out of town|1|||
124895755|NCT00764868|449241390|FG000|Overall Study|Misuse and compliance of study drug|1|||
124895756|NCT00764868|449241390|FG000|Overall Study|Subject sent to boarding school|1|||
124895757|NCT00764868|449241390|FG000|Overall Study|Met an exclusion criteria|1|||
124895758|NCT00764868|449241390|FG000|Overall Study|Positive drug screen|2|||
125109112|NCT00569231|450024299|FG000|Overall Study|Study unrelated surgery|1|||
125109113|NCT00569231|450024299|FG000|Overall Study|Airfare expense|2|||
125109114|NCT00569231|450024299|FG000|Overall Study|Withdrawal by Subject|1|||
125109115|NCT00569231|450024299|FG000|Overall Study|Car accident injury|1|||
125109116|NCT00569231|450024299|FG000|Overall Study|Non-compliance|2|||
124895759|NCT00764868|449241390|FG000|Overall Study|Sponsor requested withdrawal|1|||
124895760|NCT03005288|449241393|FG000|Overall Study|Withdrawal by Subject|7|||
124895761|NCT03005288|449241394|FG001|Overall Study|Withdrawal by Subject|5|||
124895762|NCT03005288|449241393|FG000|Overall Study|Lost to Follow-up|0|||
124895763|NCT03005288|449241394|FG001|Overall Study|Lost to Follow-up|1|||
124895764|NCT03005288|449241393|FG000|Overall Study|Adverse Event|5|||
124895765|NCT03005288|449241394|FG001|Overall Study|Adverse Event|0|||
124895766|NCT03005288|449241393|FG000|Overall Study|Protocol deviation|0|||
124895767|NCT03005288|449241394|FG001|Overall Study|Protocol deviation|1|||
124895768|NCT03005288|449241393|FG000|Overall Study|Physician Decision|0|||
124895769|NCT03005288|449241394|FG001|Overall Study|Physician Decision|1|||
124895770|NCT03824236|449241395|FG000|Overall Study|Lost to Follow-up|0|||
124895771|NCT03824236|449241396|FG001|Overall Study|Lost to Follow-up|0|||
124895772|NCT03824236|449241397|FG002|Overall Study|Lost to Follow-up|1|||
124895773|NCT00701311|449241398|FG000|Overall Study|Lack of Efficacy|3|||
124895774|NCT00701311|449241398|FG000|Overall Study|Adverse Event|3|||
124895775|NCT00701311|449241398|FG000|Overall Study|Withdrawal by Subject|2|||
124895776|NCT00359619|449242829|FG000|Overall Study|Adverse Event|0|||
124895777|NCT00359619|449242830|FG001|Overall Study|Adverse Event|0|||
124895778|NCT00359619|449242831|FG002|Overall Study|Adverse Event|1|||
124895779|NCT00359619|449242832|FG003|Overall Study|Adverse Event|0|||
124895780|NCT00359619|449242833|FG004|Overall Study|Adverse Event|0|||
124895781|NCT00359619|449242834|FG005|Overall Study|Adverse Event|0|||
124895782|NCT00359619|449242835|FG006|Overall Study|Adverse Event|1|||
124895783|NCT00359619|449242829|FG000|Overall Study|Withdrawal by Subject|3|||
124895784|NCT00359619|449242830|FG001|Overall Study|Withdrawal by Subject|1|||
124895785|NCT00359619|449242831|FG002|Overall Study|Withdrawal by Subject|4|||
124895786|NCT00359619|449242832|FG003|Overall Study|Withdrawal by Subject|2|||
124895787|NCT00359619|449242833|FG004|Overall Study|Withdrawal by Subject|2|||
124895788|NCT00359619|449242834|FG005|Overall Study|Withdrawal by Subject|0|||
124895789|NCT00359619|449242835|FG006|Overall Study|Withdrawal by Subject|3|||
124895790|NCT00359619|449242829|FG000|Overall Study|Other|1|||
125018497|NCT03257267|449692843|FG000|Overall Study|Participant Decision|35|||
125018498|NCT03257267|449692844|FG001|Overall Study|Participant Decision|43|||
125018499|NCT03257267|449692843|FG000|Overall Study|Sponsor Decision|1|||
125018500|NCT03257267|449692844|FG001|Overall Study|Sponsor Decision|0|||
125018501|NCT03257267|449692843|FG000|Overall Study|Physician Decision|1|||
125018502|NCT03257267|449692844|FG001|Overall Study|Physician Decision|3|||
124895791|NCT00359619|449242830|FG001|Overall Study|Other|0|||
124895792|NCT00359619|449242831|FG002|Overall Study|Other|0|||
125018503|NCT03257267|449692843|FG000|Overall Study|Disease Progression|109|||
125018504|NCT03257267|449692844|FG001|Overall Study|Disease Progression|121|||
125018505|NCT03257267|449692843|FG000|Overall Study|Withdrawal by Subject|8|||
125018506|NCT03257267|449692844|FG001|Overall Study|Withdrawal by Subject|26|||
125018507|NCT03257267|449692843|FG000|Overall Study|Other|0|||
125018508|NCT03257267|449692844|FG001|Overall Study|Other|2|||
125018509|NCT01979523|449692845|FG000|Overall Study|Withdrawal by Subject|1|||
125018510|NCT01979523|449692846|FG001|Overall Study|Withdrawal by Subject|0|||
125018511|NCT03311711|449692847|FG000|Overall Study|Death|1|||
125018512|NCT03311711|449692848|FG001|Overall Study|Death|0|||
125018513|NCT03311711|449692849|FG002|Overall Study|Death|0|||
125018514|NCT03311711|449692850|FG003|Overall Study|Death|0|||
125018515|NCT03311711|449692851|FG004|Overall Study|Death|0|||
125018516|NCT03311711|449692852|FG005|Overall Study|Death|0|||
125018517|NCT03311711|449692853|FG006|Overall Study|Death|1|||
125018518|NCT03311711|449692854|FG007|Overall Study|Death|0|||
125018519|NCT03311711|449692855|FG008|Overall Study|Death|1|||
125018520|NCT03311711|449692856|FG009|Overall Study|Death|0|||
125018521|NCT03311711|449692847|FG000|Overall Study|Death of dyad partner|0|||
125109117|NCT00700310|450024302|FG000|Overall Study|Adverse Event|6|||
125109118|NCT00700310|450024303|FG001|Overall Study|Adverse Event|10|||
125109119|NCT00700310|450024304|FG002|Overall Study|Adverse Event|5|||
124895793|NCT00359619|449242832|FG003|Overall Study|Other|0|||
124895794|NCT00359619|449242833|FG004|Overall Study|Other|0|||
124895795|NCT00359619|449242834|FG005|Overall Study|Other|0|||
124895796|NCT00359619|449242835|FG006|Overall Study|Other|0|||
124895797|NCT00359619|449242829|FG000|Overall Study|Lost to Follow-up|4|||
124895798|NCT00359619|449242830|FG001|Overall Study|Lost to Follow-up|4|||
125018522|NCT03311711|449692848|FG001|Overall Study|Death of dyad partner|1|||
125018523|NCT03311711|449692849|FG002|Overall Study|Death of dyad partner|0|||
124895799|NCT00359619|449242831|FG002|Overall Study|Lost to Follow-up|2|||
124895800|NCT00359619|449242832|FG003|Overall Study|Lost to Follow-up|1|||
125018524|NCT03311711|449692850|FG003|Overall Study|Death of dyad partner|0|||
124895801|NCT00359619|449242833|FG004|Overall Study|Lost to Follow-up|1|||
124895802|NCT00359619|449242834|FG005|Overall Study|Lost to Follow-up|5|||
124895803|NCT00359619|449242835|FG006|Overall Study|Lost to Follow-up|0|||
124895804|NCT01419717|449242836|FG000|Overall Study|Protocol-specified Criteria|62|||
125018525|NCT03311711|449692851|FG004|Overall Study|Death of dyad partner|0|||
125109120|NCT00700310|450024305|FG003|Overall Study|Adverse Event|11|||
124895805|NCT01419717|449242836|FG000|Overall Study|Adverse Event|19|||
124895806|NCT01419717|449242836|FG000|Overall Study|Death|17|||
124895807|NCT01419717|449242836|FG000|Overall Study|Withdrawal by Subject|10|||
124895808|NCT01419717|449242836|FG000|Overall Study|Disease Progression|9|||
124895809|NCT01419717|449242836|FG000|Overall Study|Other|4|||
124895810|NCT01419717|449242836|FG000|Overall Study|Lost to Follow-up|2|||
124895811|NCT01419717|449242836|FG000|Overall Study|Administrative Decision|1|||
124895812|NCT01419717|449242836|FG000|Overall Study|Noncompliance|1|||
124895813|NCT02857283|449242837|FG000|First Exposure|Withdrawal by Subject|1|||
124895814|NCT02857283|449242838|FG001|First Exposure|Withdrawal by Subject|0|||
124895815|NCT05074498|449242843|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
124895816|NCT05074498|449242844|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
124895817|NCT05074498|449242845|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
124895818|NCT05074498|449242846|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
124895819|NCT05074498|449242847|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
124895820|NCT05074498|449242848|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
124895821|NCT05074498|449242843|FG000|Part 1 (Upto Day 104)|Other|1|||
124895822|NCT05074498|449242844|FG001|Part 1 (Upto Day 104)|Other|0|||
124895823|NCT05074498|449242845|FG002|Part 1 (Upto Day 104)|Other|0|||
124895824|NCT05074498|449242846|FG003|Part 1 (Upto Day 104)|Other|0|||
124895825|NCT05074498|449242847|FG004|Part 1 (Upto Day 104)|Other|0|||
124895826|NCT05074498|449242848|FG005|Part 1 (Upto Day 104)|Other|0|||
125109121|NCT00700310|450024302|FG000|Overall Study|Lost to Follow-up|4|||
125109122|NCT00700310|450024303|FG001|Overall Study|Lost to Follow-up|1|||
125109123|NCT00700310|450024304|FG002|Overall Study|Lost to Follow-up|0|||
125109124|NCT00700310|450024305|FG003|Overall Study|Lost to Follow-up|1|||
125109125|NCT00700310|450024302|FG000|Overall Study|Withdrawal by Subject|8|||
125109126|NCT00700310|450024303|FG001|Overall Study|Withdrawal by Subject|9|||
125109127|NCT00700310|450024304|FG002|Overall Study|Withdrawal by Subject|8|||
125109128|NCT00700310|450024305|FG003|Overall Study|Withdrawal by Subject|8|||
125109129|NCT00700310|450024302|FG000|Overall Study|Lack of Efficacy|0|||
125109130|NCT00700310|450024303|FG001|Overall Study|Lack of Efficacy|3|||
125109131|NCT00700310|450024304|FG002|Overall Study|Lack of Efficacy|0|||
125109132|NCT00700310|450024305|FG003|Overall Study|Lack of Efficacy|1|||
125109133|NCT00700310|450024302|FG000|Overall Study|Administrative/Other|1|||
125109134|NCT00700310|450024303|FG001|Overall Study|Administrative/Other|3|||
125109135|NCT00700310|450024304|FG002|Overall Study|Administrative/Other|1|||
125109136|NCT00700310|450024305|FG003|Overall Study|Administrative/Other|3|||
125109137|NCT00700310|450024302|FG000|Overall Study|Randomized, Not Treated|2|||
125109138|NCT00700310|450024303|FG001|Overall Study|Randomized, Not Treated|0|||
125109139|NCT00700310|450024304|FG002|Overall Study|Randomized, Not Treated|2|||
125109140|NCT00700310|450024305|FG003|Overall Study|Randomized, Not Treated|2|||
125109141|NCT03053622|450024311|FG000|Overall Study|Lost to Follow-up|0|||
125109142|NCT03053622|450024312|FG001|Overall Study|Lost to Follow-up|0|||
125109143|NCT03053622|450024313|FG002|Overall Study|Lost to Follow-up|0|||
125109144|NCT03053622|450024314|FG003|Overall Study|Lost to Follow-up|1|||
125109145|NCT02598622|450024315|FG000|Overall Study|Withdrawal by Subject|3|||
125109146|NCT02598622|450024316|FG001|Overall Study|Withdrawal by Subject|0|||
125109147|NCT02598622|450024315|FG000|Overall Study|Physician Decision|3|||
125109148|NCT02598622|450024316|FG001|Overall Study|Physician Decision|0|||
125109149|NCT04575038|450024317|FG000|Overall Study|Withdrawal by Subject|1|||
125109150|NCT04575038|450024318|FG001|Overall Study|Withdrawal by Subject|1|||
125109151|NCT01902134|450024320|FG000|Overall Study|Adverse Event|3|||
125109152|NCT01902134|450024321|FG001|Overall Study|Adverse Event|1|||
125109153|NCT01902134|450024322|FG002|Overall Study|Adverse Event|2|||
125109154|NCT01902134|450024323|FG003|Overall Study|Adverse Event|1|||
125109155|NCT01902134|450024324|FG004|Overall Study|Adverse Event|1|||
125109156|NCT01902134|450024325|FG005|Overall Study|Adverse Event|3|||
124895827|NCT05074498|449242843|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
124895828|NCT05074498|449242844|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
124895829|NCT05074498|449242845|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
124895830|NCT05074498|449242846|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
125109157|NCT01902134|450024320|FG000|Overall Study|Lack of Efficacy|0|||
125109158|NCT01902134|450024321|FG001|Overall Study|Lack of Efficacy|0|||
124895831|NCT05074498|449242847|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
124895832|NCT05074498|449242848|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
125109159|NCT01902134|450024322|FG002|Overall Study|Lack of Efficacy|2|||
125109160|NCT01902134|450024323|FG003|Overall Study|Lack of Efficacy|0|||
125109161|NCT01902134|450024324|FG004|Overall Study|Lack of Efficacy|0|||
125109162|NCT01902134|450024325|FG005|Overall Study|Lack of Efficacy|1|||
124895833|NCT05074498|449242843|FG000|Part 2 (Upto Day 104)|Death|0|||
124895834|NCT05074498|449242844|FG001|Part 2 (Upto Day 104)|Death|0|||
125018526|NCT03311711|449692852|FG005|Overall Study|Death of dyad partner|0|||
125018527|NCT03311711|449692853|FG006|Overall Study|Death of dyad partner|0|||
125018528|NCT03311711|449692854|FG007|Overall Study|Death of dyad partner|1|||
125018529|NCT03311711|449692855|FG008|Overall Study|Death of dyad partner|0|||
125018530|NCT03311711|449692856|FG009|Overall Study|Death of dyad partner|1|||
125018531|NCT03311711|449692847|FG000|Overall Study|Lost to Follow-up|2|||
125018532|NCT03311711|449692848|FG001|Overall Study|Lost to Follow-up|2|||
125018533|NCT03311711|449692849|FG002|Overall Study|Lost to Follow-up|0|||
125018534|NCT03311711|449692850|FG003|Overall Study|Lost to Follow-up|0|||
125018535|NCT03311711|449692851|FG004|Overall Study|Lost to Follow-up|0|||
125018536|NCT03311711|449692852|FG005|Overall Study|Lost to Follow-up|0|||
125018537|NCT03311711|449692853|FG006|Overall Study|Lost to Follow-up|1|||
125018538|NCT03311711|449692854|FG007|Overall Study|Lost to Follow-up|1|||
125018539|NCT03311711|449692855|FG008|Overall Study|Lost to Follow-up|0|||
125018540|NCT03311711|449692856|FG009|Overall Study|Lost to Follow-up|0|||
125018541|NCT03311711|449692847|FG000|Overall Study|Withdrawal by Subject|1|||
125018542|NCT03311711|449692848|FG001|Overall Study|Withdrawal by Subject|1|||
125018543|NCT03311711|449692849|FG002|Overall Study|Withdrawal by Subject|0|||
125018544|NCT03311711|449692850|FG003|Overall Study|Withdrawal by Subject|0|||
125018545|NCT03311711|449692851|FG004|Overall Study|Withdrawal by Subject|0|||
125018546|NCT03311711|449692852|FG005|Overall Study|Withdrawal by Subject|0|||
125018547|NCT03311711|449692853|FG006|Overall Study|Withdrawal by Subject|3|||
125018548|NCT03311711|449692854|FG007|Overall Study|Withdrawal by Subject|3|||
125018549|NCT03311711|449692855|FG008|Overall Study|Withdrawal by Subject|0|||
125018550|NCT03311711|449692856|FG009|Overall Study|Withdrawal by Subject|0|||
125018551|NCT01623271|449692861|FG000|Overall Study|Withdrawal by Subject|2|||
125018552|NCT00706134|449692862|FG000|Overall Study|Adverse Event|8|||
125018553|NCT00706134|449692863|FG001|Overall Study|Adverse Event|7|||
125018554|NCT00706134|449692864|FG002|Overall Study|Adverse Event|2|||
125018555|NCT00706134|449692865|FG003|Overall Study|Adverse Event|3|||
125018556|NCT00706134|449692862|FG000|Overall Study|Lost to Follow-up|0|||
125018557|NCT00706134|449692863|FG001|Overall Study|Lost to Follow-up|1|||
125018558|NCT00706134|449692864|FG002|Overall Study|Lost to Follow-up|0|||
125018559|NCT00706134|449692865|FG003|Overall Study|Lost to Follow-up|0|||
125018560|NCT00706134|449692862|FG000|Overall Study|Protocol Violation|0|||
125018561|NCT00706134|449692863|FG001|Overall Study|Protocol Violation|6|||
125018562|NCT00706134|449692864|FG002|Overall Study|Protocol Violation|0|||
125018563|NCT00706134|449692865|FG003|Overall Study|Protocol Violation|3|||
125018564|NCT00706134|449692862|FG000|Overall Study|Withdrawal by Subject|1|||
125018565|NCT00706134|449692863|FG001|Overall Study|Withdrawal by Subject|2|||
125018566|NCT00706134|449692864|FG002|Overall Study|Withdrawal by Subject|1|||
125018567|NCT00706134|449692865|FG003|Overall Study|Withdrawal by Subject|0|||
125018568|NCT00706134|449692862|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
125018569|NCT00706134|449692863|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
125018570|NCT00706134|449692864|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
125018571|NCT00706134|449692865|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
125018572|NCT00706134|449692862|FG000|Overall Study|Did not meet study criteria|2|||
125018573|NCT00706134|449692863|FG001|Overall Study|Did not meet study criteria|0|||
125018574|NCT00706134|449692864|FG002|Overall Study|Did not meet study criteria|0|||
125018575|NCT00706134|449692865|FG003|Overall Study|Did not meet study criteria|0|||
125018576|NCT01982292|449692866|FG000|Overall Study|Adverse Event|2|||
125018577|NCT01982292|449692867|FG001|Overall Study|Adverse Event|0|||
125018578|NCT01982292|449692866|FG000|Overall Study|Death|1|||
125018579|NCT01982292|449692867|FG001|Overall Study|Death|0|||
125018580|NCT01982292|449692866|FG000|Overall Study|Lost to Follow-up|2|||
125018581|NCT01982292|449692867|FG001|Overall Study|Lost to Follow-up|0|||
125018582|NCT01982292|449692866|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
125018583|NCT01982292|449692867|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
125018584|NCT01982292|449692866|FG000|Overall Study|Protocol Deviation|1|||
125018585|NCT01982292|449692867|FG001|Overall Study|Protocol Deviation|0|||
125018586|NCT01982292|449692866|FG000|Overall Study|Patient/Guardian Decision|3|||
125018587|NCT01982292|449692867|FG001|Overall Study|Patient/Guardian Decision|1|||
125018588|NCT01982292|449692866|FG000|Overall Study|Technical Problems|2|||
125018589|NCT01982292|449692867|FG001|Overall Study|Technical Problems|0|||
125018590|NCT00082888|449692869|FG000|Overall Study|Ineligible|1|||
125109163|NCT01902134|450024320|FG000|Overall Study|Physician Decision|0|||
125109164|NCT01902134|450024321|FG001|Overall Study|Physician Decision|1|||
125109165|NCT01902134|450024322|FG002|Overall Study|Physician Decision|0|||
125109166|NCT01902134|450024323|FG003|Overall Study|Physician Decision|0|||
125109167|NCT01902134|450024324|FG004|Overall Study|Physician Decision|0|||
125109168|NCT01902134|450024325|FG005|Overall Study|Physician Decision|0|||
125109169|NCT01902134|450024320|FG000|Overall Study|Protocol Violation|0|||
125109170|NCT01902134|450024321|FG001|Overall Study|Protocol Violation|0|||
125109171|NCT01902134|450024322|FG002|Overall Study|Protocol Violation|0|||
125109172|NCT01902134|450024323|FG003|Overall Study|Protocol Violation|0|||
125109173|NCT01902134|450024324|FG004|Overall Study|Protocol Violation|0|||
125109174|NCT01902134|450024325|FG005|Overall Study|Protocol Violation|1|||
125109175|NCT01902134|450024320|FG000|Overall Study|Withdrawal by Subject|4|||
125109176|NCT01902134|450024321|FG001|Overall Study|Withdrawal by Subject|8|||
125109177|NCT01902134|450024322|FG002|Overall Study|Withdrawal by Subject|9|||
125109178|NCT01902134|450024323|FG003|Overall Study|Withdrawal by Subject|1|||
125109179|NCT01902134|450024324|FG004|Overall Study|Withdrawal by Subject|5|||
125109180|NCT01902134|450024325|FG005|Overall Study|Withdrawal by Subject|4|||
125109181|NCT01902134|450024320|FG000|Overall Study|no compliance|1|||
125109182|NCT01902134|450024321|FG001|Overall Study|no compliance|0|||
125109183|NCT01902134|450024322|FG002|Overall Study|no compliance|0|||
125109184|NCT01902134|450024323|FG003|Overall Study|no compliance|0|||
125109185|NCT01902134|450024324|FG004|Overall Study|no compliance|0|||
125109186|NCT01902134|450024325|FG005|Overall Study|no compliance|0|||
125109187|NCT01902134|450024320|FG000|Overall Study|Other|0|||
125109188|NCT01902134|450024321|FG001|Overall Study|Other|1|||
125109189|NCT01902134|450024322|FG002|Overall Study|Other|2|||
125109190|NCT01902134|450024323|FG003|Overall Study|Other|0|||
125109191|NCT01902134|450024324|FG004|Overall Study|Other|1|||
125109192|NCT01902134|450024325|FG005|Overall Study|Other|0|||
125109193|NCT00305110|450024326|FG000|Overall Study|Missing data|29|||
125109194|NCT00678379|450024327|FG000|Overall Study|Injection performed after tonsillectomy|2|||
125109195|NCT00678379|450024328|FG001|Overall Study|Injection performed after tonsillectomy|0|||
125109196|NCT00678379|450024329|FG002|Overall Study|Injection performed after tonsillectomy|1|||
125109197|NCT00678379|450024327|FG000|Overall Study|Incomplete Data|4|||
125109198|NCT00678379|450024328|FG001|Overall Study|Incomplete Data|3|||
125109199|NCT00678379|450024329|FG002|Overall Study|Incomplete Data|3|||
125109200|NCT01835470|450024330|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
125109201|NCT01835470|450024330|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
125109202|NCT04335110|450024348|FG000|Overall Study|Withdrawal by Subject|1|||
125109203|NCT04335110|450024349|FG001|Overall Study|Withdrawal by Subject|1|||
125109204|NCT04335110|450024348|FG000|Overall Study|Death|0|||
125109205|NCT04335110|450024349|FG001|Overall Study|Death|1|||
125109206|NCT00350519|450024350|FG000|Overall Study|Death|0|||
125109207|NCT00350519|450024351|FG001|Overall Study|Death|1|||
125109208|NCT00350519|450024350|FG000|Overall Study|Physician Decision|0|||
125109209|NCT00350519|450024351|FG001|Overall Study|Physician Decision|1|||
125109210|NCT00350519|450024350|FG000|Overall Study|Protocol Violation|1|||
125109211|NCT00350519|450024351|FG001|Overall Study|Protocol Violation|2|||
125109212|NCT00350519|450024350|FG000|Overall Study|Withdrawal by Subject|3|||
125109213|NCT00350519|450024351|FG001|Overall Study|Withdrawal by Subject|2|||
125109214|NCT02595528|450024352|FG000|Overall Study|Withdrawal by Subject|1|||
125109215|NCT02595528|450024353|FG001|Overall Study|Withdrawal by Subject|2|||
125109216|NCT02595528|450024354|FG002|Overall Study|Withdrawal by Subject|1|||
124895835|NCT05074498|449242845|FG002|Part 2 (Upto Day 104)|Death|0|||
124895836|NCT05074498|449242846|FG003|Part 2 (Upto Day 104)|Death|0|||
125109217|NCT02595528|450024355|FG003|Overall Study|Withdrawal by Subject|3|||
125109218|NCT02595528|450024352|FG000|Overall Study|Lost to Follow-up|1|||
125109219|NCT02595528|450024353|FG001|Overall Study|Lost to Follow-up|1|||
125109220|NCT02595528|450024354|FG002|Overall Study|Lost to Follow-up|0|||
125109221|NCT02595528|450024355|FG003|Overall Study|Lost to Follow-up|1|||
125109222|NCT00948025|450024356|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
125109223|NCT00948025|450024357|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
125109224|NCT00948025|450024356|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
125109225|NCT00948025|450024357|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
125109226|NCT00948025|450024356|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
124895837|NCT05074498|449242847|FG004|Part 2 (Upto Day 104)|Death|1|||
125109227|NCT00948025|450024357|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
125109228|NCT01637961|450024358|FG000|Overall Study|Ineligible: wrong primary|1|||
125109229|NCT01637961|450024358|FG000|Overall Study|Ineligible: inadequate pathology|1|||
125109230|NCT03101293|450024362|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
125109231|NCT03101293|450024363|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
125109232|NCT03333382|450024369|FG000|Overall Study|Lost to Follow-up|1|||
125109233|NCT03333382|450024370|FG001|Overall Study|Lost to Follow-up|0|||
125109234|NCT00550420|450024371|FG000|Overall Study|Adverse Event|28|||
125109235|NCT00550420|450024371|FG000|Overall Study|Lost to Follow-up|8|||
125109236|NCT00550420|450024371|FG000|Overall Study|Protocol Violation|11|||
125109237|NCT00550420|450024371|FG000|Overall Study|Withdrawal by Subject|30|||
125109238|NCT00550420|450024371|FG000|Overall Study|Still in study at termination|206|||
125109239|NCT00550420|450024371|FG000|Overall Study|Missing|2|||
125109240|NCT00550420|450024371|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
125109241|NCT00550420|450024371|FG000|Overall Study|Investigators opinion|1|||
125109242|NCT00550420|450024371|FG000|Overall Study|Lack of curative effect|1|||
125109243|NCT00550420|450024371|FG000|Overall Study|Unethical stop of enrollment|2|||
125109244|NCT00550420|450024371|FG000|Overall Study|Caregiver's decision to withdraw|1|||
125109245|NCT00550420|450024371|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
125109246|NCT00550420|450024371|FG000|Overall Study|Exclusion criteria|1|||
125109247|NCT00550420|450024371|FG000|Overall Study|Prohibited medicine|1|||
125109248|NCT02773446|450024376|FG000|First Admission|Withdrawal by Subject|0|||
125109249|NCT02773446|450024377|FG001|First Admission|Withdrawal by Subject|0|||
125109250|NCT02773446|450024378|FG002|First Admission|Withdrawal by Subject|0|||
125109251|NCT02773446|450024379|FG003|First Admission|Withdrawal by Subject|1|||
125109252|NCT02773446|450024380|FG004|First Admission|Withdrawal by Subject|0|||
125109253|NCT02773446|450024381|FG005|First Admission|Withdrawal by Subject|0|||
125109254|NCT02773446|450024376|FG000|First Admission|Lost to Follow-up|1|||
125109255|NCT02773446|450024377|FG001|First Admission|Lost to Follow-up|0|||
125109256|NCT02773446|450024378|FG002|First Admission|Lost to Follow-up|0|||
125109257|NCT02773446|450024379|FG003|First Admission|Lost to Follow-up|0|||
125109258|NCT02773446|450024380|FG004|First Admission|Lost to Follow-up|0|||
125109259|NCT02773446|450024381|FG005|First Admission|Lost to Follow-up|0|||
125109260|NCT03237611|450024382|FG000|Overall Study|Withdrawal by Subject|1|||
125109261|NCT03237611|450024382|FG000|Overall Study|Ineligible|1|||
125109262|NCT01613131|450024385|FG000|Overall Study|Withdrawal by Subject|3|||
125109263|NCT01613131|450024386|FG001|Overall Study|Withdrawal by Subject|5|||
125109264|NCT01814761|450024387|FG000|Overall Study|Other Reasons|1|||
125109265|NCT01814761|450024388|FG001|Overall Study|Other Reasons|10|||
125109266|NCT01814761|450024387|FG000|Overall Study|Ocular Adverse Event|6|||
125109267|NCT01814761|450024388|FG001|Overall Study|Ocular Adverse Event|15|||
125109268|NCT01814761|450024387|FG000|Overall Study|Lost to Follow-up|1|||
125109269|NCT01814761|450024388|FG001|Overall Study|Lost to Follow-up|5|||
125109270|NCT03137082|450024389|FG000|Overall Study|Withdrawal by Subject|1|||
125109271|NCT03137082|450024390|FG001|Overall Study|Withdrawal by Subject|1|||
125109272|NCT03137082|450024389|FG000|Overall Study|Lost to Follow-up|1|||
125109273|NCT03137082|450024390|FG001|Overall Study|Lost to Follow-up|0|||
125109274|NCT01020305|450024393|FG000|Overall Study|Adverse Event|2|||
124895838|NCT05074498|449242848|FG005|Part 2 (Upto Day 104)|Death|0|||
124895839|NCT05074498|449242843|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
125109275|NCT01017029|450024397|FG000|Overall Study|Lost to Follow-up|1|||
125109276|NCT01017029|450024398|FG001|Overall Study|Lost to Follow-up|0|||
125109277|NCT01017029|450024397|FG000|Overall Study|Administrative problem|0|||
125109278|NCT01017029|450024398|FG001|Overall Study|Administrative problem|1|||
125109279|NCT01017029|450024397|FG000|Overall Study|Death|3|||
125109280|NCT01017029|450024398|FG001|Overall Study|Death|1|||
125109281|NCT00618774|450024399|FG000|Overall Study|Adverse Event|5|||
125109282|NCT00618774|450024400|FG001|Overall Study|Adverse Event|3|||
125109283|NCT00618774|450024399|FG000|Overall Study|Withdrawal by Subject|1|||
125109284|NCT00618774|450024400|FG001|Overall Study|Withdrawal by Subject|0|||
125109285|NCT02753400|450024402|FG000|Overall Study|Adverse Event|3|||
125109286|NCT02753400|450024403|FG001|Overall Study|Adverse Event|0|||
125109287|NCT02753400|450024402|FG000|Overall Study|Withdrawal by Subject|2|||
125109288|NCT02753400|450024403|FG001|Overall Study|Withdrawal by Subject|1|||
125109289|NCT01415921|450024404|FG000|Overall Study|Adverse Event|0|||
125109290|NCT01415921|450024405|FG001|Overall Study|Adverse Event|1|||
125109291|NCT01415921|450024404|FG000|Overall Study|Physician Decision|1|||
125109292|NCT01415921|450024405|FG001|Overall Study|Physician Decision|1|||
125109293|NCT01415921|450024404|FG000|Overall Study|Withdrawal by Subject|0|||
125109294|NCT01415921|450024405|FG001|Overall Study|Withdrawal by Subject|1|||
125109295|NCT01415921|450024404|FG000|Overall Study|Other|2|||
125109296|NCT01415921|450024405|FG001|Overall Study|Other|0|||
125109297|NCT01830920|450024410|FG000|Overall Study|Adverse Event|1|||
125109298|NCT01830920|450024411|FG001|Overall Study|Adverse Event|0|||
125109299|NCT01830920|450024412|FG002|Overall Study|Adverse Event|1|||
125109300|NCT01830920|450024413|FG003|Overall Study|Adverse Event|0|||
125109301|NCT01830920|450024414|FG004|Overall Study|Adverse Event|0|||
125109302|NCT01830920|450024410|FG000|Overall Study|Withdrawal by Subject|2|||
125109303|NCT01830920|450024411|FG001|Overall Study|Withdrawal by Subject|2|||
125109304|NCT01830920|450024412|FG002|Overall Study|Withdrawal by Subject|1|||
125109305|NCT01830920|450024413|FG003|Overall Study|Withdrawal by Subject|7|||
125109306|NCT01830920|450024414|FG004|Overall Study|Withdrawal by Subject|1|||
125109307|NCT01830920|450024410|FG000|Overall Study|Death|3|||
125109308|NCT01830920|450024411|FG001|Overall Study|Death|3|||
125109309|NCT01830920|450024412|FG002|Overall Study|Death|5|||
125109310|NCT01830920|450024413|FG003|Overall Study|Death|4|||
125109311|NCT01830920|450024414|FG004|Overall Study|Death|4|||
125109312|NCT01830920|450024410|FG000|Overall Study|Other|15|||
125109313|NCT01830920|450024411|FG001|Overall Study|Other|1|||
125109314|NCT01830920|450024412|FG002|Overall Study|Other|1|||
125109315|NCT01830920|450024413|FG003|Overall Study|Other|5|||
125109316|NCT01830920|450024414|FG004|Overall Study|Other|3|||
125109317|NCT03402126|450024417|FG000|Overall Study|Lost to Follow-up|6|||
125109318|NCT03402126|450024417|FG000|Overall Study|Protocol Violation|10|||
125109319|NCT03402126|450024417|FG000|Overall Study|Sponsor request/Study termination|29|||
125109320|NCT03402126|450024417|FG000|Overall Study|Study product no longer in use|1|||
125109321|NCT03402126|450024417|FG000|Overall Study|Technical problems|1|||
125109322|NCT03402126|450024417|FG000|Overall Study|Withdrawal by Subject|6|||
125109323|NCT03402126|450024417|FG000|Overall Study|Physician Decision|2|||
125109324|NCT03402126|450024417|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
125109325|NCT03402126|450024417|FG000|Overall Study|Death|4|||
125109326|NCT00720304|450024418|FG000|Overall Study|Withdrawal by Subject|14|||
125109327|NCT00720304|450024419|FG001|Overall Study|Withdrawal by Subject|1|||
125109328|NCT00720304|450024418|FG000|Overall Study|Death|1|||
125109329|NCT00720304|450024419|FG001|Overall Study|Death|0|||
125109330|NCT00720304|450024418|FG000|Overall Study|Physician Decision|5|||
125109331|NCT00720304|450024419|FG001|Overall Study|Physician Decision|2|||
125109332|NCT00720304|450024418|FG000|Overall Study|Adverse Event|3|||
125109333|NCT00720304|450024419|FG001|Overall Study|Adverse Event|1|||
125109334|NCT00720304|450024418|FG000|Overall Study|Disease progression|6|||
125109335|NCT00720304|450024419|FG001|Overall Study|Disease progression|1|||
125109336|NCT01333475|450024420|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
125109337|NCT01333475|450024421|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
125109338|NCT01333475|450024420|FG000|Overall Study|Toxicity|1|||
125109339|NCT01333475|450024421|FG001|Overall Study|Toxicity|3|||
125109340|NCT02981602|450024422|FG000|Overall Study|Adverse Event|0|||
125109341|NCT02981602|450024423|FG001|Overall Study|Adverse Event|0|||
125109342|NCT02981602|450024424|FG002|Overall Study|Adverse Event|0|||
125109343|NCT02981602|450024425|FG003|Overall Study|Adverse Event|1|||
125109344|NCT02981602|450024426|FG004|Overall Study|Adverse Event|0|||
125109345|NCT01706770|450024429|FG000|Overall Study|Lost to Follow-up|1|||
125109346|NCT01706770|450024430|FG001|Overall Study|Lost to Follow-up|0|||
125109347|NCT01706770|450024429|FG000|Overall Study|Physician Decision|1|||
125109348|NCT01706770|450024430|FG001|Overall Study|Physician Decision|0|||
125109349|NCT00423488|450024431|FG000|Overall Study|No evidence of study drug intake|2|||
125109350|NCT00423488|450024432|FG001|Overall Study|No evidence of study drug intake|1|||
125109351|NCT00423488|450024431|FG000|Overall Study|No post baseline data|3|||
125109352|NCT00423488|450024432|FG001|Overall Study|No post baseline data|0|||
125109353|NCT00527397|450024435|FG000|Overall Study|Adverse Event|3|||
125109354|NCT00527397|450024435|FG000|Overall Study|Lack of Efficacy|1|||
125109355|NCT00527397|450024435|FG000|Overall Study|Protocol Violation|1|||
125109356|NCT00527397|450024435|FG000|Overall Study|Withdrawal by Subject|6|||
125109357|NCT00527397|450024435|FG000|Overall Study|Study terminated by sponsor|13|||
125109358|NCT01749033|450024436|FG000|Overall Study|Did not receive allocated intervention|3|||
125109359|NCT01749033|450024437|FG001|Overall Study|Did not receive allocated intervention|3|||
125109360|NCT01749033|450024438|FG002|Overall Study|Did not receive allocated intervention|0|||
125109361|NCT01749033|450024436|FG000|Overall Study|Lost to Follow-up|0|||
125109362|NCT01749033|450024437|FG001|Overall Study|Lost to Follow-up|2|||
124895840|NCT05074498|449242844|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
125109363|NCT01749033|450024438|FG002|Overall Study|Lost to Follow-up|1|||
125109364|NCT00068237|450024439|FG000|Overall Study|Ineligible|3|||
125109365|NCT00068237|450024439|FG000|Overall Study|No protocol treatment received|2|||
125109366|NCT00383019|450024440|FG000|Overall Study|Adverse Event|5|||
125109367|NCT00383019|450024441|FG001|Overall Study|Adverse Event|1|||
125109368|NCT00383019|450024440|FG000|Overall Study|Withdrawal by Subject|0|||
125109369|NCT00383019|450024441|FG001|Overall Study|Withdrawal by Subject|1|||
125109370|NCT03797222|450024442|FG000|Overall Study|Withdrawal by Subject|1|||
125109371|NCT00725725|450024444|FG000|Overall Study|Adverse Event|1|||
125109372|NCT00725725|450024445|FG001|Overall Study|Adverse Event|3|||
125109373|NCT00725725|450024446|FG002|Overall Study|Adverse Event|2|||
125109374|NCT00725725|450024444|FG000|Overall Study|Lost to Follow-up|2|||
125109375|NCT00725725|450024445|FG001|Overall Study|Lost to Follow-up|0|||
124895841|NCT05074498|449242845|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
124895842|NCT05074498|449242846|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
124895843|NCT05074498|449242847|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
124895844|NCT05074498|449242848|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
124895845|NCT05074498|449242843|FG000|Part 2 (Upto Day 104)|Other|0|||
124895846|NCT05074498|449242844|FG001|Part 2 (Upto Day 104)|Other|0|||
124895847|NCT05074498|449242845|FG002|Part 2 (Upto Day 104)|Other|0|||
124895848|NCT05074498|449242846|FG003|Part 2 (Upto Day 104)|Other|0|||
124895849|NCT05074498|449242847|FG004|Part 2 (Upto Day 104)|Other|1|||
124895850|NCT05074498|449242848|FG005|Part 2 (Upto Day 104)|Other|0|||
124895851|NCT01240356|449242849|FG000|Overall Study|Withdrawal by Subject|2|||
124895852|NCT01240356|449242850|FG001|Overall Study|Withdrawal by Subject|0|||
125109376|NCT00725725|450024446|FG002|Overall Study|Lost to Follow-up|2|||
125109377|NCT00725725|450024444|FG000|Overall Study|Withdrawal by Subject|1|||
125109378|NCT00725725|450024445|FG001|Overall Study|Withdrawal by Subject|0|||
125109379|NCT00725725|450024446|FG002|Overall Study|Withdrawal by Subject|1|||
125109380|NCT00725725|450024444|FG000|Overall Study|Protocol Violation|0|||
125109381|NCT00725725|450024445|FG001|Overall Study|Protocol Violation|1|||
125109382|NCT00725725|450024446|FG002|Overall Study|Protocol Violation|0|||
125109383|NCT00378482|450024447|FG000|Overall Study|Lost to Follow-up|1|||
125109384|NCT00378482|450024447|FG000|Overall Study|Lack of Efficacy|8|||
125109385|NCT00378482|450024447|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
125109386|NCT00378482|450024447|FG000|Overall Study|Withdrawal by Subject|4|||
125109387|NCT00378482|450024447|FG000|Overall Study|Adverse Event|9|||
125109388|NCT01355523|450026130|FG000|Overall Study|Withdrawal by Subject|1|||
125109389|NCT01355523|450026131|FG001|Overall Study|Withdrawal by Subject|4|||
125109390|NCT01355523|450026130|FG000|Overall Study|Lost to Follow-up|0|||
125109391|NCT01355523|450026131|FG001|Overall Study|Lost to Follow-up|2|||
125109392|NCT01355523|450026130|FG000|Overall Study|Protocol Violation|0|||
125109393|NCT01355523|450026131|FG001|Overall Study|Protocol Violation|2|||
125109394|NCT01355523|450026130|FG000|Overall Study|Adverse Event|0|||
125109395|NCT01355523|450026131|FG001|Overall Study|Adverse Event|2|||
125109396|NCT01011907|450026132|FG000|Overall Study|Withdrawal by Subject|13|||
125109397|NCT01011907|450026133|FG001|Overall Study|Withdrawal by Subject|11|||
125109398|NCT01011907|450026132|FG000|Overall Study|Adverse Event|1|||
125109399|NCT01011907|450026133|FG001|Overall Study|Adverse Event|4|||
125109400|NCT01272193|450026134|FG000|Overall Study|Adverse Event|1|||
125109401|NCT01272193|450026135|FG001|Overall Study|Adverse Event|1|||
125109402|NCT01272193|450026134|FG000|Overall Study|Lack of Efficacy|0|||
125109403|NCT01272193|450026135|FG001|Overall Study|Lack of Efficacy|3|||
125109404|NCT01272193|450026134|FG000|Overall Study|Withdrawal Criteria|1|||
125109405|NCT01272193|450026135|FG001|Overall Study|Withdrawal Criteria|1|||
125109406|NCT01272193|450026134|FG000|Overall Study|Unclassified|8|||
125109407|NCT01272193|450026135|FG001|Overall Study|Unclassified|7|||
125109408|NCT01440647|450026138|FG000|Overall Study|Death|2|||
125109409|NCT01440647|450026139|FG001|Overall Study|Death|3|||
125109410|NCT01406873|450026140|FG000|Overall Study|Withdrawal by Subject|1|||
125109411|NCT01406873|450026141|FG001|Overall Study|Withdrawal by Subject|1|||
125109412|NCT00736099|450026143|FG000|Overall Study|Adverse Event|61|||
125109413|NCT00736099|450026144|FG001|Overall Study|Adverse Event|18|||
124895853|NCT01240356|449242849|FG000|Overall Study|MRI contraindication|1|||
125109414|NCT00736099|450026143|FG000|Overall Study|Protocol Violation|10|||
124895854|NCT01240356|449242850|FG001|Overall Study|MRI contraindication|0|||
124895855|NCT01211665|449242853|FG000|Overall Study|Withdrawal by Subject|1|||
124895856|NCT01211665|449242854|FG001|Overall Study|Withdrawal by Subject|0|||
125109415|NCT00736099|450026144|FG001|Overall Study|Protocol Violation|4|||
125109416|NCT00736099|450026143|FG000|Overall Study|Lost to Follow-up|12|||
125109417|NCT00736099|450026144|FG001|Overall Study|Lost to Follow-up|5|||
125109418|NCT00736099|450026143|FG000|Overall Study|Withdrawal by Subject|42|||
125109419|NCT00736099|450026144|FG001|Overall Study|Withdrawal by Subject|13|||
125109420|NCT00736099|450026143|FG000|Overall Study|Lack of Efficacy|15|||
125109421|NCT00736099|450026144|FG001|Overall Study|Lack of Efficacy|8|||
125109422|NCT00736099|450026143|FG000|Overall Study|Other reason|43|||
125109423|NCT00736099|450026144|FG001|Overall Study|Other reason|10|||
125109424|NCT02290028|450026145|FG000|Overall Study|Death|217|||
124895857|NCT01211665|449242853|FG000|Overall Study|Death|1|||
125109425|NCT02290028|450026145|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
125109426|NCT02290028|450026145|FG000|Overall Study|No longer under care of study physician|76|||
125109427|NCT02290028|450026145|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
125109428|NCT02290028|450026145|FG000|Overall Study|Withdrawal by Subject|52|||
125109429|NCT02290028|450026145|FG000|Overall Study|Study site closure|44|||
125109430|NCT02290028|450026145|FG000|Overall Study|Lost to Follow-up|34|||
125109431|NCT02290028|450026145|FG000|Overall Study|Miscellaneous|10|||
125109432|NCT02290028|450026145|FG000|Overall Study|Transition to EP PASSION|1295|||
125109433|NCT02290028|450026145|FG000|Overall Study|Planned study completion at 12 months|257|||
125109434|NCT03202511|450026146|FG000|Overall Study|Withdrawal by Subject|1|||
125109435|NCT03202511|450026147|FG001|Overall Study|Withdrawal by Subject|0|||
125109436|NCT00096382|450026150|FG000|Overall Study|Not treated|1|||
125109437|NCT00096382|450026151|FG001|Overall Study|Not treated|0|||
125109438|NCT00096382|450026150|FG000|Overall Study|Death during treatment|1|||
125109439|NCT00096382|450026151|FG001|Overall Study|Death during treatment|0|||
125109440|NCT00289731|450026153|FG000|Overall Study|Adverse Event|1|||
125109441|NCT00289731|450026154|FG001|Overall Study|Adverse Event|2|||
125109442|NCT00289731|450026155|FG002|Overall Study|Adverse Event|2|||
125109443|NCT00289731|450026153|FG000|Overall Study|Other|1|||
125109444|NCT00289731|450026154|FG001|Overall Study|Other|0|||
125109445|NCT00289731|450026155|FG002|Overall Study|Other|0|||
125109446|NCT04378010|450026156|FG000|Overall Study|Adverse Event|8|||
125109447|NCT04378010|450026157|FG001|Overall Study|Adverse Event|14|||
125109448|NCT04378010|450026158|FG002|Overall Study|Adverse Event|4|||
125109449|NCT04378010|450026156|FG000|Overall Study|Withdrawal by Subject|0|||
125109450|NCT04378010|450026157|FG001|Overall Study|Withdrawal by Subject|2|||
125109451|NCT04378010|450026158|FG002|Overall Study|Withdrawal by Subject|1|||
125109452|NCT04378010|450026156|FG000|Overall Study|Protocol Violation|2|||
125109453|NCT04378010|450026157|FG001|Overall Study|Protocol Violation|1|||
125109454|NCT04378010|450026158|FG002|Overall Study|Protocol Violation|4|||
125109455|NCT04378010|450026156|FG000|Overall Study|Study terminated by Sponsor|22|||
125109456|NCT04378010|450026157|FG001|Overall Study|Study terminated by Sponsor|16|||
125109457|NCT04378010|450026158|FG002|Overall Study|Study terminated by Sponsor|22|||
125109458|NCT04378010|450026156|FG000|Overall Study|Subject inability to complete study visit|0|||
125109459|NCT04378010|450026157|FG001|Overall Study|Subject inability to complete study visit|0|||
125109460|NCT04378010|450026158|FG002|Overall Study|Subject inability to complete study visit|1|||
125109461|NCT04378010|450026156|FG000|Overall Study|Subject never dosed|0|||
125109462|NCT04378010|450026157|FG001|Overall Study|Subject never dosed|1|||
125109463|NCT04378010|450026158|FG002|Overall Study|Subject never dosed|0|||
125109464|NCT02019979|450026159|FG000|Overall Study|study terminated|14|||
125109465|NCT02513459|450026160|FG000|Overall Study|Adverse Event|7|||
125109466|NCT02513459|450026160|FG000|Overall Study|Withdrew consent|5|||
125109467|NCT02513459|450026160|FG000|Overall Study|Loss of efficacy|2|||
125109468|NCT02513459|450026160|FG000|Overall Study|Pregnancy|2|||
125109469|NCT02513459|450026160|FG000|Overall Study|Subject decision|2|||
125109470|NCT02513459|450026160|FG000|Overall Study|Lack of response|1|||
125109471|NCT02513459|450026160|FG000|Overall Study|Reproductive plans|1|||
125109472|NCT02513459|450026160|FG000|Overall Study|Surgery planned-- not done|1|||
125109473|NCT04023994|450026164|FG000|Overall Study|Lost to Follow-up|0|||
125109474|NCT04023994|450026165|FG001|Overall Study|Lost to Follow-up|1|||
125109475|NCT04023994|450026166|FG002|Overall Study|Lost to Follow-up|2|||
125109476|NCT04023994|450026167|FG003|Overall Study|Lost to Follow-up|0|||
125109477|NCT04023994|450026168|FG004|Overall Study|Lost to Follow-up|0|||
125109478|NCT04023994|450026169|FG005|Overall Study|Lost to Follow-up|0|||
125109479|NCT04023994|450026164|FG000|Overall Study|Withdrawal by Subject|0|||
124895858|NCT01211665|449242854|FG001|Overall Study|Death|0|||
124895859|NCT00498186|449242857|FG000|Overall Study|Protocol Violation|10|||
124895860|NCT00498186|449242857|FG000|Overall Study|Lack of Efficacy|31|||
124895861|NCT00498186|449242857|FG000|Overall Study|Adverse Event|89|||
124895862|NCT00498186|449242857|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
124895863|NCT00498186|449242857|FG000|Overall Study|Withdrawal by Subject|18|||
125109480|NCT04023994|450026165|FG001|Overall Study|Withdrawal by Subject|0|||
125109481|NCT04023994|450026166|FG002|Overall Study|Withdrawal by Subject|0|||
125109482|NCT04023994|450026167|FG003|Overall Study|Withdrawal by Subject|1|||
124895864|NCT00498186|449242857|FG000|Overall Study|Lost to Follow-up|3|||
124895865|NCT00498186|449242857|FG000|Overall Study|Other|10|||
124895866|NCT01390857|449242858|FG000|Overall Study|Protocol Violation|2|||
124895867|NCT01390857|449242858|FG000|Overall Study|Lost to Follow-up|1|||
125109483|NCT04023994|450026168|FG004|Overall Study|Withdrawal by Subject|0|||
125109484|NCT04023994|450026169|FG005|Overall Study|Withdrawal by Subject|0|||
125109485|NCT00923195|450026170|FG000|Overall Study|Death|0|||
125109486|NCT00923195|450026171|FG001|Overall Study|Death|1|||
125109487|NCT00467818|450026174|FG000|Overall Study|Adverse Event|1|||
125109488|NCT00467818|450026175|FG001|Overall Study|Adverse Event|0|||
125109489|NCT00467818|450026174|FG000|Overall Study|Lost to Follow-up|2|||
125109490|NCT00467818|450026175|FG001|Overall Study|Lost to Follow-up|2|||
125109491|NCT02143947|450026179|FG000|Overall Study|Lost to Follow-up|4|||
125109492|NCT02143947|450026180|FG001|Overall Study|Lost to Follow-up|2|||
125109493|NCT01244815|450026181|FG000|Overall Study|Not Treated|0|||
125109494|NCT01244815|450026182|FG001|Overall Study|Not Treated|1|||
125109495|NCT01244815|450026183|FG002|Overall Study|Not Treated|0|||
125109496|NCT01244815|450026184|FG003|Overall Study|Not Treated|0|||
125109497|NCT01244815|450026181|FG000|Overall Study|Adverse Event|4|||
125109498|NCT01244815|450026182|FG001|Overall Study|Adverse Event|7|||
125109499|NCT01244815|450026183|FG002|Overall Study|Adverse Event|5|||
125109500|NCT01244815|450026184|FG003|Overall Study|Adverse Event|5|||
125109501|NCT01244815|450026181|FG000|Overall Study|Treatment Failure|0|||
125109502|NCT01244815|450026182|FG001|Overall Study|Treatment Failure|0|||
125109503|NCT01244815|450026183|FG002|Overall Study|Treatment Failure|0|||
125109504|NCT01244815|450026184|FG003|Overall Study|Treatment Failure|1|||
125109505|NCT01244815|450026181|FG000|Overall Study|Lost to Follow-up|3|||
125109506|NCT01244815|450026182|FG001|Overall Study|Lost to Follow-up|2|||
125109507|NCT01244815|450026183|FG002|Overall Study|Lost to Follow-up|3|||
125109508|NCT01244815|450026184|FG003|Overall Study|Lost to Follow-up|2|||
125109509|NCT01244815|450026181|FG000|Overall Study|Withdrawal by Subject|0|||
125109510|NCT01244815|450026182|FG001|Overall Study|Withdrawal by Subject|2|||
125109511|NCT01244815|450026183|FG002|Overall Study|Withdrawal by Subject|0|||
125109512|NCT01244815|450026184|FG003|Overall Study|Withdrawal by Subject|3|||
125109513|NCT01244815|450026181|FG000|Overall Study|Protocol Violation|7|||
125109514|NCT01244815|450026182|FG001|Overall Study|Protocol Violation|4|||
125109515|NCT01244815|450026183|FG002|Overall Study|Protocol Violation|3|||
125109516|NCT01244815|450026184|FG003|Overall Study|Protocol Violation|1|||
125109517|NCT01244815|450026181|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
125109518|NCT01244815|450026182|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
125109519|NCT01244815|450026183|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
125109520|NCT01244815|450026184|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
125109521|NCT01313728|450026186|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
125109522|NCT03876873|450026191|FG000|Overall Study|Physician Decision|0|||
125109523|NCT03876873|450026192|FG001|Overall Study|Physician Decision|1|||
125109524|NCT03547531|450026193|FG000|Overall Study|not coming in data collection : sick|2|||
125109525|NCT03547531|450026194|FG001|Overall Study|not coming in data collection : sick|2|||
125109526|NCT03547531|450026193|FG000|Overall Study|having family occasion|0|||
125109527|NCT03547531|450026194|FG001|Overall Study|having family occasion|2|||
125109528|NCT02117479|450026202|FG000|Overall Study|Death|13|||
125109529|NCT02117479|450026203|FG001|Overall Study|Death|8|||
125109530|NCT02117479|450026202|FG000|Overall Study|Adverse Event|8|||
125109531|NCT02117479|450026203|FG001|Overall Study|Adverse Event|16|||
125109532|NCT02117479|450026202|FG000|Overall Study|Subject decision|8|||
125109533|NCT02117479|450026203|FG001|Overall Study|Subject decision|9|||
125109534|NCT02117479|450026202|FG000|Overall Study|Disease progression|104|||
125109535|NCT02117479|450026203|FG001|Overall Study|Disease progression|108|||
125109536|NCT02117479|450026202|FG000|Overall Study|Noncompliance with study treatment|1|||
125109537|NCT02117479|450026203|FG001|Overall Study|Noncompliance with study treatment|0|||
125109538|NCT02117479|450026202|FG000|Overall Study|Study terminated by the sponsor|4|||
125109539|NCT02117479|450026203|FG001|Overall Study|Study terminated by the sponsor|6|||
125109540|NCT02117479|450026202|FG000|Overall Study|Physician Decision|7|||
125109541|NCT02117479|450026203|FG001|Overall Study|Physician Decision|2|||
125109542|NCT02117479|450026202|FG000|Overall Study|Other unspecified|11|||
125109543|NCT02117479|450026203|FG001|Overall Study|Other unspecified|7|||
125109544|NCT02444182|450026204|FG000|Overall Study|non-compliance|2|||
125109545|NCT02444182|450026205|FG001|Overall Study|non-compliance|1|||
125109546|NCT02444182|450026204|FG000|Overall Study|Lost to Follow-up|0|||
125109547|NCT02444182|450026205|FG001|Overall Study|Lost to Follow-up|4|||
125109548|NCT01959230|450026208|FG000|Overall Study|Failure to follow study procedures|0|||
125109549|NCT01959230|450026209|FG001|Overall Study|Failure to follow study procedures|1|||
125109550|NCT01959230|450026208|FG000|Overall Study|Administrative reasons|2|||
125109551|NCT01959230|450026209|FG001|Overall Study|Administrative reasons|0|||
125109552|NCT01959230|450026208|FG000|Overall Study|Withdrawal by Subject|2|||
125109553|NCT01959230|450026209|FG001|Overall Study|Withdrawal by Subject|0|||
125109554|NCT02487979|450026212|FG000|Overall Study|Physician Decision|2|||
125109555|NCT02487979|450026212|FG000|Overall Study|Withdrawal by Subject|2|||
125109556|NCT02487979|450026212|FG000|Overall Study|Progressive Disease|17|||
125109557|NCT00447694|450026213|FG000|Overall Study|Adverse Event|2|||
125109558|NCT00447694|450026213|FG000|Overall Study|Abnormal laboratory value|1|||
125109559|NCT00447694|450026213|FG000|Overall Study|Abnormal test procedure result|1|||
125109560|NCT00447694|450026213|FG000|Overall Study|Withdrawal by Subject|2|||
125109561|NCT01507831|450026217|FG000|Overall Study|Randomized but not treated|0|||
125109562|NCT01507831|450026218|FG001|Overall Study|Randomized but not treated|3|||
125109563|NCT01507831|450026217|FG000|Overall Study|Adverse Event|48|||
125109564|NCT01507831|450026218|FG001|Overall Study|Adverse Event|113|||
125109565|NCT01507831|450026217|FG000|Overall Study|Death|6|||
125109566|NCT01507831|450026218|FG001|Overall Study|Death|2|||
125109567|NCT01507831|450026217|FG000|Overall Study|Poor compliance to protocol|38|||
125109568|NCT01507831|450026218|FG001|Overall Study|Poor compliance to protocol|60|||
125109569|NCT01507831|450026217|FG000|Overall Study|Physician Decision|0|||
125109570|NCT01507831|450026218|FG001|Overall Study|Physician Decision|4|||
125109571|NCT01507831|450026217|FG000|Overall Study|Participant moved|5|||
125109572|NCT01507831|450026218|FG001|Overall Study|Participant moved|19|||
125109573|NCT01507831|450026217|FG000|Overall Study|Consent withdrawn by participant|34|||
125109574|NCT01507831|450026218|FG001|Overall Study|Consent withdrawn by participant|72|||
125109575|NCT01507831|450026217|FG000|Overall Study|Related to study drug administration|5|||
125109576|NCT01507831|450026218|FG001|Overall Study|Related to study drug administration|14|||
125109577|NCT01507831|450026217|FG000|Overall Study|Last visit outside protocol visit window|51|||
125109578|NCT01507831|450026218|FG001|Overall Study|Last visit outside protocol visit window|143|||
125109579|NCT01507831|450026217|FG000|Overall Study|Selection criteria finally not met|0|||
125109580|NCT01507831|450026218|FG001|Overall Study|Selection criteria finally not met|1|||
125109581|NCT01507831|450026217|FG000|Overall Study|Site closure|0|||
125109582|NCT01507831|450026218|FG001|Overall Study|Site closure|3|||
125109583|NCT01507831|450026217|FG000|Overall Study|Potential lost to follow-up|3|||
125109584|NCT01507831|450026218|FG001|Overall Study|Potential lost to follow-up|0|||
125109585|NCT01507831|450026217|FG000|Overall Study|Other|3|||
125109586|NCT01507831|450026218|FG001|Overall Study|Other|6|||
125109587|NCT04380701|450026220|FG000|Overall Study|Pregnancy|0|||
125109588|NCT04380701|450026221|FG001|Overall Study|Pregnancy|0|||
125109589|NCT04380701|450026222|FG002|Overall Study|Pregnancy|0|||
125109590|NCT04380701|450026223|FG003|Overall Study|Pregnancy|0|||
125109591|NCT04380701|450026224|FG004|Overall Study|Pregnancy|0|||
125109592|NCT04380701|450026225|FG005|Overall Study|Pregnancy|0|||
125109593|NCT04380701|450026226|FG006|Overall Study|Pregnancy|0|||
125109594|NCT04380701|450026227|FG007|Overall Study|Pregnancy|0|||
125109595|NCT04380701|450026228|FG008|Overall Study|Pregnancy|0|||
125109596|NCT04380701|450026229|FG009|Overall Study|Pregnancy|0|||
125109597|NCT04380701|450026230|FG010|Overall Study|Pregnancy|0|||
125109598|NCT04380701|450026231|FG011|Overall Study|Pregnancy|0|||
125109599|NCT04380701|450026232|FG012|Overall Study|Pregnancy|0|||
125109600|NCT04380701|450026233|FG013|Overall Study|Pregnancy|0|||
125109601|NCT04380701|450026234|FG014|Overall Study|Pregnancy|0|||
125109602|NCT04380701|450026235|FG015|Overall Study|Pregnancy|0|||
125109603|NCT04380701|450026236|FG016|Overall Study|Pregnancy|0|||
125109604|NCT04380701|450026237|FG017|Overall Study|Pregnancy|0|||
125109605|NCT04380701|450026238|FG018|Overall Study|Pregnancy|0|||
125109606|NCT04380701|450026239|FG019|Overall Study|Pregnancy|0|||
125109607|NCT04380701|450026240|FG020|Overall Study|Pregnancy|0|||
125109608|NCT04380701|450026241|FG021|Overall Study|Pregnancy|0|||
125109609|NCT04380701|450026242|FG022|Overall Study|Pregnancy|0|||
125109610|NCT04380701|450026243|FG023|Overall Study|Pregnancy|0|||
125109611|NCT04380701|450026244|FG024|Overall Study|Pregnancy|0|||
125109612|NCT04380701|450026245|FG025|Overall Study|Pregnancy|0|||
125109613|NCT04380701|450026246|FG026|Overall Study|Pregnancy|0|||
125109614|NCT04380701|450026247|FG027|Overall Study|Pregnancy|0|||
125109615|NCT04380701|450026248|FG028|Overall Study|Pregnancy|0|||
125109616|NCT04380701|450026249|FG029|Overall Study|Pregnancy|0|||
125109617|NCT04380701|450026250|FG030|Overall Study|Pregnancy|0|||
125109618|NCT04380701|450026251|FG031|Overall Study|Pregnancy|0|||
125109619|NCT04380701|450026252|FG032|Overall Study|Pregnancy|1|||
125109620|NCT04380701|450026253|FG033|Overall Study|Pregnancy|0|||
125109621|NCT04380701|450026220|FG000|Overall Study|Lost to Follow-up|0|||
125109622|NCT04380701|450026221|FG001|Overall Study|Lost to Follow-up|0|||
125109623|NCT04380701|450026222|FG002|Overall Study|Lost to Follow-up|0|||
125109624|NCT04380701|450026223|FG003|Overall Study|Lost to Follow-up|0|||
125109625|NCT04380701|450026224|FG004|Overall Study|Lost to Follow-up|0|||
125109626|NCT04380701|450026225|FG005|Overall Study|Lost to Follow-up|0|||
125109627|NCT04380701|450026226|FG006|Overall Study|Lost to Follow-up|0|||
125109628|NCT04380701|450026227|FG007|Overall Study|Lost to Follow-up|0|||
125109629|NCT04380701|450026228|FG008|Overall Study|Lost to Follow-up|0|||
125109630|NCT04380701|450026229|FG009|Overall Study|Lost to Follow-up|0|||
125109631|NCT04380701|450026230|FG010|Overall Study|Lost to Follow-up|0|||
125109632|NCT04380701|450026231|FG011|Overall Study|Lost to Follow-up|0|||
125109633|NCT04380701|450026232|FG012|Overall Study|Lost to Follow-up|0|||
125109634|NCT04380701|450026233|FG013|Overall Study|Lost to Follow-up|0|||
125109635|NCT04380701|450026234|FG014|Overall Study|Lost to Follow-up|0|||
125109636|NCT04380701|450026235|FG015|Overall Study|Lost to Follow-up|0|||
125109637|NCT04380701|450026236|FG016|Overall Study|Lost to Follow-up|0|||
125109638|NCT04380701|450026237|FG017|Overall Study|Lost to Follow-up|0|||
125109639|NCT04380701|450026238|FG018|Overall Study|Lost to Follow-up|0|||
125109640|NCT04380701|450026239|FG019|Overall Study|Lost to Follow-up|0|||
125109641|NCT04380701|450026240|FG020|Overall Study|Lost to Follow-up|1|||
125109642|NCT04380701|450026241|FG021|Overall Study|Lost to Follow-up|0|||
125109643|NCT04380701|450026242|FG022|Overall Study|Lost to Follow-up|0|||
125109644|NCT04380701|450026243|FG023|Overall Study|Lost to Follow-up|1|||
125109645|NCT04380701|450026244|FG024|Overall Study|Lost to Follow-up|0|||
125109646|NCT04380701|450026245|FG025|Overall Study|Lost to Follow-up|0|||
125109647|NCT04380701|450026246|FG026|Overall Study|Lost to Follow-up|0|||
125109648|NCT04380701|450026247|FG027|Overall Study|Lost to Follow-up|0|||
125109649|NCT04380701|450026248|FG028|Overall Study|Lost to Follow-up|0|||
125109650|NCT04380701|450026249|FG029|Overall Study|Lost to Follow-up|1|||
125109651|NCT04380701|450026250|FG030|Overall Study|Lost to Follow-up|0|||
124895868|NCT01390857|449242858|FG000|Overall Study|No Visit after the First Visit|7|||
124895869|NCT04541186|449242860|FG000|Main Study|Adverse Event|0|||
124895870|NCT04541186|449242861|FG001|Main Study|Adverse Event|0|||
125018591|NCT00082888|449692870|FG001|Overall Study|Ineligible|0|||
125018592|NCT00082888|449692871|FG002|Overall Study|Ineligible|0|||
125018593|NCT01745146|449692873|FG000|Overall Study|Withdrawal by Subject|1|||
125018594|NCT01745146|449692874|FG001|Overall Study|Withdrawal by Subject|3|||
125018595|NCT01745146|449692873|FG000|Overall Study|Lost to Follow-up|2|||
125018596|NCT01745146|449692874|FG001|Overall Study|Lost to Follow-up|0|||
125018597|NCT04623242|449692875|FG000|Overall Study|Withdrawal by Subject|7|||
125018598|NCT04623242|449692876|FG001|Overall Study|Withdrawal by Subject|12|||
125018599|NCT04623242|449692877|FG002|Overall Study|Withdrawal by Subject|5|||
125018600|NCT04623242|449692878|FG003|Overall Study|Withdrawal by Subject|7|||
125018601|NCT04623242|449692879|FG004|Overall Study|Withdrawal by Subject|0|||
125018602|NCT04623242|449692875|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
125018603|NCT04623242|449692876|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
125018604|NCT04623242|449692877|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
125018605|NCT04623242|449692878|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
125018606|NCT04623242|449692879|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
125018607|NCT04623242|449692875|FG000|Overall Study|Subject unblinded to mutation status|0|||
125018608|NCT04623242|449692876|FG001|Overall Study|Subject unblinded to mutation status|0|||
125018609|NCT04623242|449692877|FG002|Overall Study|Subject unblinded to mutation status|0|||
125018610|NCT04623242|449692878|FG003|Overall Study|Subject unblinded to mutation status|13|||
125018611|NCT04623242|449692879|FG004|Overall Study|Subject unblinded to mutation status|0|||
125018612|NCT05594173|449692880|FG000|Overall Study|Adverse Event|1|||
125018613|NCT05594173|449692880|FG000|Overall Study|COVID-19 Pandemic|2|||
125018614|NCT00488982|449692887|FG000|Course 1|Physician Decision|0|||
125018615|NCT00488982|449692888|FG001|Course 1|Physician Decision|2|||
125018616|NCT00488982|449692889|FG002|Course 1|Physician Decision|4|||
125018617|NCT00488982|449692887|FG000|Course 1|Withdrawal by Subject|0|||
125018618|NCT00488982|449692888|FG001|Course 1|Withdrawal by Subject|8|||
125018619|NCT00488982|449692889|FG002|Course 1|Withdrawal by Subject|2|||
125018620|NCT00488982|449692887|FG000|Course 1|nonprotocol therapy|0|||
125018621|NCT00488982|449692888|FG001|Course 1|nonprotocol therapy|2|||
125018622|NCT00488982|449692889|FG002|Course 1|nonprotocol therapy|2|||
125018623|NCT00488982|449692887|FG000|Course 1|Adverse Event|0|||
125018624|NCT00488982|449692888|FG001|Course 1|Adverse Event|0|||
125018625|NCT00488982|449692889|FG002|Course 1|Adverse Event|6|||
125018626|NCT01678144|449692890|FG000|Stage 1: MAR Classic|Adverse Event|1|||
125018627|NCT01780831|449692891|FG000|Overall Study|Withdrawal by Subject|0|||
125018628|NCT01780831|449692892|FG001|Overall Study|Withdrawal by Subject|0|||
125018629|NCT01780831|449692893|FG002|Overall Study|Withdrawal by Subject|4|||
125018630|NCT01780831|449692894|FG003|Overall Study|Withdrawal by Subject|0|||
125018631|NCT01780831|449692891|FG000|Overall Study|Lost to Follow-up|0|||
125018632|NCT01780831|449692892|FG001|Overall Study|Lost to Follow-up|0|||
125018633|NCT01780831|449692893|FG002|Overall Study|Lost to Follow-up|0|||
125018634|NCT01780831|449692894|FG003|Overall Study|Lost to Follow-up|1|||
125018635|NCT02264990|449692895|FG000|Overall Study|Death|255|||
125018636|NCT02264990|449692896|FG001|Overall Study|Death|250|||
125018637|NCT02264990|449692895|FG000|Overall Study|Withdrawal by Subject|4|||
125018638|NCT02264990|449692896|FG001|Overall Study|Withdrawal by Subject|5|||
125018639|NCT02264990|449692895|FG000|Overall Study|Lost to Follow-up|1|||
125018640|NCT02264990|449692896|FG001|Overall Study|Lost to Follow-up|3|||
125018641|NCT02264990|449692895|FG000|Overall Study|Other|0|||
125018642|NCT02264990|449692896|FG001|Overall Study|Other|1|||
125018643|NCT00267748|449692897|FG000|Non-randomized Period|Progressive disease|10|||
125018644|NCT00267748|449692898|FG001|Non-randomized Period|Progressive disease|0|||
125018645|NCT00267748|449692899|FG002|Non-randomized Period|Progressive disease|0|||
125018646|NCT00267748|449692897|FG000|Non-randomized Period|Adverse Event|8|||
125018647|NCT00267748|449692898|FG001|Non-randomized Period|Adverse Event|0|||
125018648|NCT00267748|449692899|FG002|Non-randomized Period|Adverse Event|0|||
125018649|NCT00267748|449692897|FG000|Non-randomized Period|Death|1|||
125018650|NCT00267748|449692898|FG001|Non-randomized Period|Death|0|||
125018651|NCT00267748|449692899|FG002|Non-randomized Period|Death|0|||
125018652|NCT00267748|449692897|FG000|Non-randomized Period|Participant not willing to participate|1|||
125018653|NCT00267748|449692898|FG001|Non-randomized Period|Participant not willing to participate|0|||
125018654|NCT00267748|449692899|FG002|Non-randomized Period|Participant not willing to participate|0|||
125018655|NCT00267748|449692897|FG000|Non-randomized Period|Other|3|||
125018656|NCT00267748|449692898|FG001|Non-randomized Period|Other|0|||
125018657|NCT00267748|449692899|FG002|Non-randomized Period|Other|0|||
125018658|NCT00267748|449692897|FG000|Randomized Period|Death|0|||
125018659|NCT00267748|449692898|FG001|Randomized Period|Death|2|||
125018660|NCT00267748|449692899|FG002|Randomized Period|Death|3|||
125018661|NCT00267748|449692897|FG000|Randomized Period|Adverse Event|0|||
125018662|NCT00267748|449692898|FG001|Randomized Period|Adverse Event|23|||
125018663|NCT00267748|449692899|FG002|Randomized Period|Adverse Event|25|||
125109652|NCT04380701|450026251|FG031|Overall Study|Lost to Follow-up|0|||
125109653|NCT04380701|450026252|FG032|Overall Study|Lost to Follow-up|0|||
125109654|NCT04380701|450026253|FG033|Overall Study|Lost to Follow-up|1|||
125109655|NCT04380701|450026220|FG000|Overall Study|Private reason(s)|0|||
125109656|NCT04380701|450026221|FG001|Overall Study|Private reason(s)|0|||
125109657|NCT04380701|450026222|FG002|Overall Study|Private reason(s)|0|||
125109658|NCT04380701|450026223|FG003|Overall Study|Private reason(s)|0|||
125109659|NCT04380701|450026224|FG004|Overall Study|Private reason(s)|0|||
125109660|NCT04380701|450026225|FG005|Overall Study|Private reason(s)|0|||
125109661|NCT04380701|450026226|FG006|Overall Study|Private reason(s)|1|||
125109662|NCT04380701|450026227|FG007|Overall Study|Private reason(s)|0|||
125109663|NCT04380701|450026228|FG008|Overall Study|Private reason(s)|1|||
125109664|NCT04380701|450026229|FG009|Overall Study|Private reason(s)|1|||
125109665|NCT04380701|450026230|FG010|Overall Study|Private reason(s)|0|||
125109666|NCT04380701|450026231|FG011|Overall Study|Private reason(s)|0|||
125109667|NCT04380701|450026232|FG012|Overall Study|Private reason(s)|0|||
125109668|NCT04380701|450026233|FG013|Overall Study|Private reason(s)|0|||
125109669|NCT04380701|450026234|FG014|Overall Study|Private reason(s)|0|||
125109670|NCT04380701|450026235|FG015|Overall Study|Private reason(s)|0|||
125109671|NCT04380701|450026236|FG016|Overall Study|Private reason(s)|0|||
125109672|NCT04380701|450026237|FG017|Overall Study|Private reason(s)|0|||
125109673|NCT04380701|450026238|FG018|Overall Study|Private reason(s)|0|||
125109674|NCT04380701|450026239|FG019|Overall Study|Private reason(s)|0|||
125109675|NCT04380701|450026240|FG020|Overall Study|Private reason(s)|0|||
125109676|NCT04380701|450026241|FG021|Overall Study|Private reason(s)|0|||
125109677|NCT04380701|450026242|FG022|Overall Study|Private reason(s)|0|||
125109678|NCT04380701|450026243|FG023|Overall Study|Private reason(s)|1|||
125109679|NCT04380701|450026244|FG024|Overall Study|Private reason(s)|0|||
125109680|NCT04380701|450026245|FG025|Overall Study|Private reason(s)|0|||
125109681|NCT04380701|450026246|FG026|Overall Study|Private reason(s)|0|||
125109682|NCT04380701|450026247|FG027|Overall Study|Private reason(s)|0|||
125109683|NCT04380701|450026248|FG028|Overall Study|Private reason(s)|0|||
125109684|NCT04380701|450026249|FG029|Overall Study|Private reason(s)|1|||
125109685|NCT04380701|450026250|FG030|Overall Study|Private reason(s)|0|||
125109686|NCT04380701|450026251|FG031|Overall Study|Private reason(s)|0|||
125109687|NCT04380701|450026252|FG032|Overall Study|Private reason(s)|0|||
125109688|NCT04380701|450026253|FG033|Overall Study|Private reason(s)|0|||
125109689|NCT04380701|450026220|FG000|Overall Study|Withdrawal by Subject|0|||
125109690|NCT04380701|450026221|FG001|Overall Study|Withdrawal by Subject|0|||
125109691|NCT04380701|450026222|FG002|Overall Study|Withdrawal by Subject|0|||
125109692|NCT04380701|450026223|FG003|Overall Study|Withdrawal by Subject|0|||
125109693|NCT04380701|450026224|FG004|Overall Study|Withdrawal by Subject|0|||
125109694|NCT04380701|450026225|FG005|Overall Study|Withdrawal by Subject|0|||
125109695|NCT04380701|450026226|FG006|Overall Study|Withdrawal by Subject|1|||
125109696|NCT04380701|450026227|FG007|Overall Study|Withdrawal by Subject|1|||
125109697|NCT04380701|450026228|FG008|Overall Study|Withdrawal by Subject|0|||
125109698|NCT04380701|450026229|FG009|Overall Study|Withdrawal by Subject|0|||
125109699|NCT04380701|450026230|FG010|Overall Study|Withdrawal by Subject|0|||
125109700|NCT04380701|450026231|FG011|Overall Study|Withdrawal by Subject|1|||
125109701|NCT04380701|450026232|FG012|Overall Study|Withdrawal by Subject|0|||
125109702|NCT04380701|450026233|FG013|Overall Study|Withdrawal by Subject|1|||
125109703|NCT04380701|450026234|FG014|Overall Study|Withdrawal by Subject|0|||
125109704|NCT04380701|450026235|FG015|Overall Study|Withdrawal by Subject|0|||
125109705|NCT04380701|450026236|FG016|Overall Study|Withdrawal by Subject|1|||
125109706|NCT04380701|450026237|FG017|Overall Study|Withdrawal by Subject|0|||
125109707|NCT04380701|450026238|FG018|Overall Study|Withdrawal by Subject|0|||
125109708|NCT04380701|450026239|FG019|Overall Study|Withdrawal by Subject|0|||
125109709|NCT04380701|450026240|FG020|Overall Study|Withdrawal by Subject|0|||
125109710|NCT04380701|450026241|FG021|Overall Study|Withdrawal by Subject|0|||
125109711|NCT04380701|450026242|FG022|Overall Study|Withdrawal by Subject|2|||
125109712|NCT04380701|450026243|FG023|Overall Study|Withdrawal by Subject|2|||
125109713|NCT04380701|450026244|FG024|Overall Study|Withdrawal by Subject|1|||
125109714|NCT04380701|450026245|FG025|Overall Study|Withdrawal by Subject|1|||
125109715|NCT04380701|450026246|FG026|Overall Study|Withdrawal by Subject|0|||
125109716|NCT04380701|450026247|FG027|Overall Study|Withdrawal by Subject|0|||
125109717|NCT04380701|450026248|FG028|Overall Study|Withdrawal by Subject|0|||
125109718|NCT04380701|450026249|FG029|Overall Study|Withdrawal by Subject|0|||
125109719|NCT04380701|450026250|FG030|Overall Study|Withdrawal by Subject|0|||
125109720|NCT04380701|450026251|FG031|Overall Study|Withdrawal by Subject|0|||
125109721|NCT04380701|450026252|FG032|Overall Study|Withdrawal by Subject|0|||
125109722|NCT04380701|450026253|FG033|Overall Study|Withdrawal by Subject|0|||
125109723|NCT04380701|450026220|FG000|Overall Study|Adverse Event|0|||
125109724|NCT04380701|450026221|FG001|Overall Study|Adverse Event|0|||
125109725|NCT04380701|450026222|FG002|Overall Study|Adverse Event|0|||
125109726|NCT04380701|450026223|FG003|Overall Study|Adverse Event|0|||
125109727|NCT04380701|450026224|FG004|Overall Study|Adverse Event|0|||
125109728|NCT04380701|450026225|FG005|Overall Study|Adverse Event|1|||
125109729|NCT04380701|450026226|FG006|Overall Study|Adverse Event|0|||
124895871|NCT04541186|449242862|FG002|Main Study|Adverse Event|4|||
124895872|NCT04541186|449242863|FG003|Main Study|Adverse Event|0|||
124895873|NCT04541186|449242864|FG004|Main Study|Adverse Event|0|||
124895874|NCT04541186|449242860|FG000|Main Study|Investigator Decision|0|||
124895875|NCT04541186|449242861|FG001|Main Study|Investigator Decision|0|||
124895876|NCT04541186|449242862|FG002|Main Study|Investigator Decision|1|||
124895877|NCT04541186|449242863|FG003|Main Study|Investigator Decision|1|||
125018664|NCT00267748|449692897|FG000|Randomized Period|Global deterioration of health status|0|||
125018665|NCT00267748|449692898|FG001|Randomized Period|Global deterioration of health status|6|||
125018666|NCT00267748|449692899|FG002|Randomized Period|Global deterioration of health status|7|||
125018667|NCT00267748|449692897|FG000|Randomized Period|Lost to Follow-up|0|||
125018668|NCT00267748|449692898|FG001|Randomized Period|Lost to Follow-up|1|||
125018669|NCT00267748|449692899|FG002|Randomized Period|Lost to Follow-up|0|||
125018670|NCT00267748|449692897|FG000|Randomized Period|Objective progression or relapse|0|||
125018671|NCT00267748|449692898|FG001|Randomized Period|Objective progression or relapse|77|||
125018672|NCT00267748|449692899|FG002|Randomized Period|Objective progression or relapse|86|||
125018673|NCT00267748|449692897|FG000|Randomized Period|Withdrawal by Subject|0|||
125018674|NCT00267748|449692898|FG001|Randomized Period|Withdrawal by Subject|9|||
125018675|NCT00267748|449692899|FG002|Randomized Period|Withdrawal by Subject|2|||
125018676|NCT00267748|449692897|FG000|Randomized Period|Other|0|||
125018677|NCT00267748|449692898|FG001|Randomized Period|Other|9|||
125018678|NCT00267748|449692899|FG002|Randomized Period|Other|6|||
125018679|NCT00267748|449692897|FG000|Randomized Period|randomized but not treated|0|||
125018680|NCT00267748|449692898|FG001|Randomized Period|randomized but not treated|0|||
125018681|NCT00267748|449692899|FG002|Randomized Period|randomized but not treated|3|||
124895878|NCT04541186|449242864|FG004|Main Study|Investigator Decision|0|||
124895879|NCT04541186|449242860|FG000|Main Study|Withdrawal by Subject|1|||
124895880|NCT04541186|449242861|FG001|Main Study|Withdrawal by Subject|1|||
124895881|NCT04541186|449242862|FG002|Main Study|Withdrawal by Subject|0|||
124895882|NCT04541186|449242863|FG003|Main Study|Withdrawal by Subject|0|||
125109730|NCT04380701|450026227|FG007|Overall Study|Adverse Event|0|||
125109731|NCT04380701|450026228|FG008|Overall Study|Adverse Event|0|||
125109732|NCT04380701|450026229|FG009|Overall Study|Adverse Event|0|||
125109733|NCT04380701|450026230|FG010|Overall Study|Adverse Event|0|||
125109734|NCT04380701|450026231|FG011|Overall Study|Adverse Event|0|||
125109735|NCT04380701|450026232|FG012|Overall Study|Adverse Event|0|||
125109736|NCT04380701|450026233|FG013|Overall Study|Adverse Event|0|||
125109737|NCT04380701|450026234|FG014|Overall Study|Adverse Event|0|||
125109738|NCT04380701|450026235|FG015|Overall Study|Adverse Event|1|||
125109739|NCT04380701|450026236|FG016|Overall Study|Adverse Event|0|||
125109740|NCT04380701|450026237|FG017|Overall Study|Adverse Event|0|||
125109741|NCT04380701|450026238|FG018|Overall Study|Adverse Event|0|||
124895883|NCT04541186|449242864|FG004|Main Study|Withdrawal by Subject|0|||
124895884|NCT04541186|449242860|FG000|Main Study|COVID-19-related Dose Interruption|0|||
124895885|NCT04541186|449242861|FG001|Main Study|COVID-19-related Dose Interruption|0|||
124895886|NCT04541186|449242862|FG002|Main Study|COVID-19-related Dose Interruption|0|||
124895887|NCT04541186|449242863|FG003|Main Study|COVID-19-related Dose Interruption|0|||
124895888|NCT04541186|449242864|FG004|Main Study|COVID-19-related Dose Interruption|1|||
124895889|NCT04541186|449242860|FG000|Main Study|Randomized in Error Not Treated|0|||
124895890|NCT04541186|449242861|FG001|Main Study|Randomized in Error Not Treated|0|||
124895891|NCT04541186|449242862|FG002|Main Study|Randomized in Error Not Treated|1|||
124895892|NCT04541186|449242863|FG003|Main Study|Randomized in Error Not Treated|0|||
124895893|NCT04541186|449242864|FG004|Main Study|Randomized in Error Not Treated|0|||
124895894|NCT04541186|449242860|FG000|Fibrate Expansion Study|Other than Specified|0|||
124895895|NCT04541186|449242861|FG001|Fibrate Expansion Study|Other than Specified|0|||
124895896|NCT04541186|449242862|FG002|Fibrate Expansion Study|Other than Specified|0|||
124895897|NCT04541186|449242863|FG003|Fibrate Expansion Study|Other than Specified|0|||
124895898|NCT04541186|449242864|FG004|Fibrate Expansion Study|Other than Specified|1|||
124895899|NCT00691028|449242865|FG000|Open-label Period|Adverse Event|0|||
124895900|NCT00691028|449242866|FG001|Open-label Period|Adverse Event|0|||
124895901|NCT00691028|449242867|FG002|Open-label Period|Adverse Event|0|||
124895902|NCT00691028|449242868|FG003|Open-label Period|Adverse Event|16|||
124895903|NCT00691028|449242865|FG000|Open-label Period|Withdrawal by Subject|0|||
124895904|NCT00691028|449242866|FG001|Open-label Period|Withdrawal by Subject|0|||
124895905|NCT00691028|449242867|FG002|Open-label Period|Withdrawal by Subject|0|||
124895906|NCT00691028|449242868|FG003|Open-label Period|Withdrawal by Subject|3|||
124895907|NCT00691028|449242865|FG000|Open-label Period|not come to a hospital|0|||
124895908|NCT00691028|449242866|FG001|Open-label Period|not come to a hospital|0|||
124895909|NCT00691028|449242867|FG002|Open-label Period|not come to a hospital|0|||
124895910|NCT00691028|449242868|FG003|Open-label Period|not come to a hospital|1|||
124895911|NCT00691028|449242865|FG000|Double-blind Period|Adverse Event|8|||
124895912|NCT00691028|449242866|FG001|Double-blind Period|Adverse Event|9|||
124895913|NCT00691028|449242867|FG002|Double-blind Period|Adverse Event|6|||
124895914|NCT00691028|449242868|FG003|Double-blind Period|Adverse Event|0|||
124895915|NCT00691028|449242865|FG000|Double-blind Period|Lack of Efficacy|4|||
124895916|NCT00691028|449242866|FG001|Double-blind Period|Lack of Efficacy|3|||
124895917|NCT00691028|449242867|FG002|Double-blind Period|Lack of Efficacy|2|||
124895918|NCT00691028|449242868|FG003|Double-blind Period|Lack of Efficacy|0|||
124895919|NCT00691028|449242865|FG000|Double-blind Period|Withdrawal by Subject|1|||
124895920|NCT00691028|449242866|FG001|Double-blind Period|Withdrawal by Subject|0|||
124895921|NCT00691028|449242867|FG002|Double-blind Period|Withdrawal by Subject|1|||
124895922|NCT00691028|449242868|FG003|Double-blind Period|Withdrawal by Subject|0|||
124895923|NCT00691028|449242865|FG000|Double-blind Period|not come to a hospital.|0|||
124895924|NCT00691028|449242866|FG001|Double-blind Period|not come to a hospital.|1|||
124895925|NCT00691028|449242867|FG002|Double-blind Period|not come to a hospital.|0|||
124895926|NCT00691028|449242868|FG003|Double-blind Period|not come to a hospital.|0|||
124895927|NCT03085017|449242869|FG000|Overall Study|Death|0|||
124895928|NCT03085017|449242870|FG001|Overall Study|Death|3|||
124895929|NCT00058058|449242871|FG000|Overall Study|Withdrawal by Subject|4|||
124895930|NCT00058058|449242871|FG000|Overall Study|Ineligible|20|||
124895931|NCT00058058|449242871|FG000|Overall Study|Claustrophobic|5|||
124895932|NCT00058058|449242871|FG000|Overall Study|technical issues|6|||
124895933|NCT00058058|449242871|FG000|Overall Study|Poor positioning, illness,pain|3|||
124895934|NCT03255018|449242882|FG000|Overall Study|Death on study|0|||
124895935|NCT03255018|449242883|FG001|Overall Study|Death on study|5|||
124895936|NCT03255018|449242882|FG000|Overall Study|Withdrawal by Subject|0|||
124895937|NCT03255018|449242883|FG001|Overall Study|Withdrawal by Subject|2|||
124895938|NCT03681691|449242887|FG000|Overall Study|COVID|1|||
124895939|NCT03681691|449242888|FG001|Overall Study|COVID|0|||
124895940|NCT03681691|449242887|FG000|Overall Study|prolonged bleeding|1|||
124895941|NCT03681691|449242888|FG001|Overall Study|prolonged bleeding|0|||
124895942|NCT03681691|449242887|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
125018682|NCT01294800|449692900|FG000|Overall Study|Adverse Event|7|||
125018683|NCT01294800|449692901|FG001|Overall Study|Adverse Event|6|||
125018684|NCT01294800|449692902|FG002|Overall Study|Adverse Event|12|||
125018685|NCT01294800|449692903|FG003|Overall Study|Adverse Event|5|||
125018686|NCT01294800|449692900|FG000|Overall Study|Subject Withdrew Consent|2|||
125018687|NCT01294800|449692901|FG001|Overall Study|Subject Withdrew Consent|2|||
125018688|NCT01294800|449692902|FG002|Overall Study|Subject Withdrew Consent|2|||
125018689|NCT01294800|449692903|FG003|Overall Study|Subject Withdrew Consent|11|||
125018690|NCT01294800|449692900|FG000|Overall Study|Lost to Follow-up|0|||
125018691|NCT01294800|449692901|FG001|Overall Study|Lost to Follow-up|0|||
125018692|NCT01294800|449692902|FG002|Overall Study|Lost to Follow-up|1|||
125018693|NCT01294800|449692903|FG003|Overall Study|Lost to Follow-up|0|||
125018694|NCT01294800|449692900|FG000|Overall Study|Non-compliance With Protocol|0|||
125018695|NCT01294800|449692901|FG001|Overall Study|Non-compliance With Protocol|1|||
125018696|NCT01294800|449692902|FG002|Overall Study|Non-compliance With Protocol|1|||
125018697|NCT01294800|449692903|FG003|Overall Study|Non-compliance With Protocol|0|||
124895943|NCT03681691|449242888|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
124895944|NCT03432533|449242889|FG000|Overall Study|Lost to Follow-up|1|||
124895945|NCT03432533|449242890|FG001|Overall Study|Lost to Follow-up|2|||
124895946|NCT03432533|449242889|FG000|Overall Study|Withdrawal by Subject|14|||
124895947|NCT03432533|449242890|FG001|Overall Study|Withdrawal by Subject|9|||
124895948|NCT01582243|449242899|FG000|Overall Study|Withdrawal by Subject|1|||
124895949|NCT01582243|449242899|FG000|Overall Study|Adverse Event|1|||
124895950|NCT01582243|449242899|FG000|Overall Study|Lost to Follow-up|1|||
124895951|NCT01674569|449242905|FG000|Overall Study|Adverse Event|0|||
124895952|NCT01674569|449242906|FG001|Overall Study|Adverse Event|2|||
124895953|NCT01674569|449242907|FG002|Overall Study|Adverse Event|0|||
124895954|NCT01674569|449242908|FG003|Overall Study|Adverse Event|1|||
124895955|NCT01674569|449242909|FG004|Overall Study|Adverse Event|2|||
124895956|NCT01674569|449242910|FG005|Overall Study|Adverse Event|2|||
124895957|NCT01674569|449242905|FG000|Overall Study|Protocol Violation|0|||
124895958|NCT01674569|449242906|FG001|Overall Study|Protocol Violation|1|||
124895959|NCT01674569|449242907|FG002|Overall Study|Protocol Violation|1|||
124895960|NCT01674569|449242908|FG003|Overall Study|Protocol Violation|0|||
124895961|NCT01674569|449242909|FG004|Overall Study|Protocol Violation|0|||
124895962|NCT01674569|449242910|FG005|Overall Study|Protocol Violation|0|||
124895963|NCT01674569|449242905|FG000|Overall Study|Withdrawal by Subject|0|||
124895964|NCT01674569|449242906|FG001|Overall Study|Withdrawal by Subject|0|||
124895965|NCT01674569|449242907|FG002|Overall Study|Withdrawal by Subject|1|||
124895966|NCT01674569|449242908|FG003|Overall Study|Withdrawal by Subject|0|||
124895967|NCT01674569|449242909|FG004|Overall Study|Withdrawal by Subject|0|||
124895968|NCT01674569|449242910|FG005|Overall Study|Withdrawal by Subject|0|||
124895969|NCT01119703|449242914|FG000|Overall Study|Adverse Event|0|||
124895970|NCT01119703|449242915|FG001|Overall Study|Adverse Event|1|||
124895971|NCT02096003|449242916|FG000|Overall Study|Protocol Violation|0|||
124895972|NCT02096003|449242917|FG001|Overall Study|Protocol Violation|2|||
124895973|NCT02096003|449242916|FG000|Overall Study|additional surgery|2|||
125018698|NCT01294800|449692900|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
125018699|NCT01294800|449692901|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
125018700|NCT01294800|449692902|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
125018701|NCT01294800|449692903|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
125018702|NCT01662895|449692907|FG000|Overall Study|Lost to Follow-up|0|||
125018703|NCT01662895|449692908|FG001|Overall Study|Lost to Follow-up|1|||
125018704|NCT00797732|449692909|FG000|Overall Study|Withdrawal by Subject|3|||
125018705|NCT00797732|449692910|FG001|Overall Study|Withdrawal by Subject|3|||
125018706|NCT00797732|449692911|FG002|Overall Study|Withdrawal by Subject|0|||
125018707|NCT00797732|449692909|FG000|Overall Study|Lost to Follow-up|1|||
125018708|NCT00797732|449692910|FG001|Overall Study|Lost to Follow-up|0|||
125018709|NCT00797732|449692911|FG002|Overall Study|Lost to Follow-up|0|||
125018710|NCT00797732|449692909|FG000|Overall Study|Death|1|||
125018711|NCT00797732|449692910|FG001|Overall Study|Death|0|||
125018712|NCT00797732|449692911|FG002|Overall Study|Death|0|||
125018713|NCT00797732|449692909|FG000|Overall Study|Not meet inclusion criteria|0|||
125018714|NCT00797732|449692910|FG001|Overall Study|Not meet inclusion criteria|0|||
125018715|NCT00797732|449692911|FG002|Overall Study|Not meet inclusion criteria|7|||
125018716|NCT00797732|449692909|FG000|Overall Study|Excluded due to time constraints|0|||
125018717|NCT00797732|449692910|FG001|Overall Study|Excluded due to time constraints|0|||
125018718|NCT00797732|449692911|FG002|Overall Study|Excluded due to time constraints|24|||
125018719|NCT00797732|449692909|FG000|Overall Study|Refused to Participate|0|||
125018720|NCT00797732|449692910|FG001|Overall Study|Refused to Participate|0|||
125018721|NCT00797732|449692911|FG002|Overall Study|Refused to Participate|123|||
125018722|NCT00401752|449692914|FG000|Overall Study|Adverse Event|2|||
125018723|NCT00401752|449692915|FG001|Overall Study|Adverse Event|5|||
125018724|NCT00401752|449692914|FG000|Overall Study|Withdrawal by Subject|2|||
125018725|NCT00401752|449692915|FG001|Overall Study|Withdrawal by Subject|6|||
125018726|NCT00401752|449692914|FG000|Overall Study|Lost to Follow-up|1|||
125018727|NCT00401752|449692915|FG001|Overall Study|Lost to Follow-up|4|||
125018728|NCT00401752|449692914|FG000|Overall Study|Development of any exclusion criteria|4|||
125018729|NCT00401752|449692915|FG001|Overall Study|Development of any exclusion criteria|2|||
125018730|NCT00401752|449692914|FG000|Overall Study|Physician Decision|1|||
125018731|NCT00401752|449692915|FG001|Overall Study|Physician Decision|1|||
125018732|NCT01895322|449692916|FG000|Overall Study|Adverse Event|1|||
125018733|NCT01895322|449692916|FG000|Overall Study|Withdrawal by Subject|2|||
125018734|NCT01895322|449692916|FG000|Overall Study|Protocol Violation|10|||
125018735|NCT02275338|449692917|FG000|Overall Study|Adverse Event|15|||
125018736|NCT02275338|449692917|FG000|Overall Study|Lack of Efficacy|3|||
125018737|NCT02275338|449692917|FG000|Overall Study|Withdrawal by Subject|4|||
125018738|NCT02275338|449692917|FG000|Overall Study|Disease progression (death)|1|||
124895974|NCT02096003|449242917|FG001|Overall Study|additional surgery|1|||
124895975|NCT01763047|449242920|FG000|Period 1|Test Article Not Available|4|||
124895976|NCT01763047|449242921|FG001|Period 1|Test Article Not Available|1|||
125018739|NCT02275338|449692917|FG000|Overall Study|Ineligible to start Phase 2|4|||
124895977|NCT01763047|449242920|FG000|Period 1|Protocol Violation|4|||
124895978|NCT01763047|449242921|FG001|Period 1|Protocol Violation|4|||
124895979|NCT01763047|449242920|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
124895980|NCT01763047|449242921|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
125109742|NCT04380701|450026239|FG019|Overall Study|Adverse Event|1|||
125109743|NCT04380701|450026240|FG020|Overall Study|Adverse Event|0|||
125109744|NCT04380701|450026241|FG021|Overall Study|Adverse Event|0|||
125109745|NCT04380701|450026242|FG022|Overall Study|Adverse Event|0|||
125109746|NCT04380701|450026243|FG023|Overall Study|Adverse Event|0|||
125109747|NCT04380701|450026244|FG024|Overall Study|Adverse Event|0|||
125109748|NCT04380701|450026245|FG025|Overall Study|Adverse Event|0|||
125109749|NCT04380701|450026246|FG026|Overall Study|Adverse Event|0|||
125109750|NCT04380701|450026247|FG027|Overall Study|Adverse Event|0|||
125109751|NCT04380701|450026248|FG028|Overall Study|Adverse Event|0|||
125109752|NCT04380701|450026249|FG029|Overall Study|Adverse Event|0|||
125109753|NCT04380701|450026250|FG030|Overall Study|Adverse Event|0|||
125109754|NCT04380701|450026251|FG031|Overall Study|Adverse Event|0|||
125109755|NCT04380701|450026252|FG032|Overall Study|Adverse Event|0|||
125109756|NCT04380701|450026253|FG033|Overall Study|Adverse Event|0|||
125109757|NCT04380701|450026220|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
125109758|NCT04380701|450026221|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
125109759|NCT04380701|450026222|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
125109760|NCT04380701|450026223|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
125109761|NCT04380701|450026224|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
125109762|NCT04380701|450026225|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
125109763|NCT04380701|450026226|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
125109764|NCT04380701|450026227|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
124895981|NCT01763047|449242920|FG000|Period 1|Adverse Event|0|||
124895982|NCT01763047|449242921|FG001|Period 1|Adverse Event|1|||
124895983|NCT01763047|449242920|FG000|Period 1|Unsatisfactory Visual Response|0|||
124895984|NCT01763047|449242921|FG001|Period 1|Unsatisfactory Visual Response|3|||
124895985|NCT01763047|449242920|FG000|Period 1|Lens Power Not Available|0|||
124895986|NCT01763047|449242921|FG001|Period 1|Lens Power Not Available|1|||
124895987|NCT01763047|449242920|FG000|Period 1|Study Site office Closed|0|||
124895988|NCT01763047|449242921|FG001|Period 1|Study Site office Closed|1|||
124895989|NCT01763047|449242920|FG000|Period 2|Lens Discomfort|1|||
124895990|NCT01763047|449242921|FG001|Period 2|Lens Discomfort|0|||
124895991|NCT01763047|449242920|FG000|Period 2|No longer meets Eligibility Criteria|1|||
124895992|NCT01763047|449242921|FG001|Period 2|No longer meets Eligibility Criteria|0|||
124895993|NCT01763047|449242920|FG000|Period 2|Study Site office Closed|1|||
124895994|NCT01763047|449242921|FG001|Period 2|Study Site office Closed|1|||
124895995|NCT01763047|449242920|FG000|Period 2|Unsatisfactory Visual Response|1|||
124895996|NCT01763047|449242921|FG001|Period 2|Unsatisfactory Visual Response|1|||
125109765|NCT04380701|450026228|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
125109766|NCT04380701|450026229|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
125109767|NCT04380701|450026230|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
125109768|NCT04380701|450026231|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
125109769|NCT04380701|450026232|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
125109770|NCT04380701|450026233|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
125109771|NCT04380701|450026234|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
125109772|NCT04380701|450026235|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
125109773|NCT04380701|450026236|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
125109774|NCT04380701|450026237|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
125109775|NCT04380701|450026238|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
125109776|NCT04380701|450026239|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
125109777|NCT04380701|450026240|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
125109778|NCT04380701|450026241|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
125109779|NCT04380701|450026242|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
125109780|NCT04380701|450026243|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
124895997|NCT01763047|449242920|FG000|Period 2|Protocol Violation|0|||
124895998|NCT01763047|449242921|FG001|Period 2|Protocol Violation|2|||
125109781|NCT04380701|450026244|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
124895999|NCT01763047|449242920|FG000|Period 2|Unsatisfactory lens Fitting|0|||
124896000|NCT01763047|449242921|FG001|Period 2|Unsatisfactory lens Fitting|1|||
124896001|NCT00916006|449242924|FG000|Overall Study|Adverse Event|1|||
124896002|NCT00916006|449242925|FG001|Overall Study|Adverse Event|1|||
124896003|NCT00916006|449242924|FG000|Overall Study|Withdrawal by Subject|2|||
125109782|NCT04380701|450026245|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
125109783|NCT04380701|450026246|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
125109784|NCT04380701|450026247|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
124896004|NCT00916006|449242925|FG001|Overall Study|Withdrawal by Subject|5|||
124896005|NCT00916006|449242924|FG000|Overall Study|Protocol Violation|0|||
124896006|NCT00916006|449242925|FG001|Overall Study|Protocol Violation|1|||
124896007|NCT01222247|449242931|FG000|Overall Study|Lost to Follow-up|2|||
124896008|NCT01222247|449242932|FG001|Overall Study|Lost to Follow-up|2|||
124896009|NCT04639947|449242933|FG000|Overall Study|Screen fail|1|||
124896010|NCT00877851|449242935|FG000|Overall Study|Lost to Follow-up|5|||
124896011|NCT00877851|449242936|FG001|Overall Study|Lost to Follow-up|5|||
124896012|NCT00877851|449242935|FG000|Overall Study|computer problem|3|||
124896013|NCT00877851|449242936|FG001|Overall Study|computer problem|0|||
124896014|NCT00877851|449242935|FG000|Overall Study|no longer interested in participating|1|||
124896015|NCT00877851|449242936|FG001|Overall Study|no longer interested in participating|0|||
124896016|NCT03424239|449242937|FG000|Overall Study|Withdrawal by Subject|2|||
124896017|NCT02042443|449242945|FG000|Overall Study|Adverse Event|2|||
124896018|NCT02042443|449242946|FG001|Overall Study|Adverse Event|1|||
124896019|NCT02042443|449242945|FG000|Overall Study|Withdrawal by Subject|0|||
124896020|NCT02042443|449242946|FG001|Overall Study|Withdrawal by Subject|1|||
124896021|NCT02042443|449242945|FG000|Overall Study|Progression|21|||
124896022|NCT02042443|449242946|FG001|Overall Study|Progression|17|||
124896023|NCT02042443|449242945|FG000|Overall Study|not protocol specified|1|||
124896024|NCT02042443|449242946|FG001|Overall Study|not protocol specified|1|||
124896025|NCT02042443|449242945|FG000|Overall Study|Not eligible/not analyzable|3|||
124896026|NCT02042443|449242946|FG001|Overall Study|Not eligible/not analyzable|6|||
124896027|NCT02320253|449242947|FG000|Overall Study|Withdrawal by Subject|3|||
124896028|NCT02320253|449242948|FG001|Overall Study|Withdrawal by Subject|0|||
124896029|NCT02320253|449242949|FG002|Overall Study|Withdrawal by Subject|0|||
124896030|NCT02320253|449242947|FG000|Overall Study|Lost to Follow-up|2|||
124896031|NCT02320253|449242948|FG001|Overall Study|Lost to Follow-up|2|||
124896032|NCT02320253|449242949|FG002|Overall Study|Lost to Follow-up|1|||
124896033|NCT02320253|449242947|FG000|Overall Study|Death|1|||
124896034|NCT02320253|449242948|FG001|Overall Study|Death|0|||
124896035|NCT02320253|449242949|FG002|Overall Study|Death|1|||
124896036|NCT04794179|449242950|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
124896037|NCT04794179|449242951|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
124896038|NCT05550337|449242954|FG000|Overall Study|Lack of Efficacy|0|||
124896039|NCT05550337|449242955|FG001|Overall Study|Lack of Efficacy|0|||
124896040|NCT05550337|449242956|FG002|Overall Study|Lack of Efficacy|1|||
124896041|NCT05550337|449242954|FG000|Overall Study|Adverse Event|1|||
124896042|NCT05550337|449242955|FG001|Overall Study|Adverse Event|5|||
125109785|NCT04380701|450026248|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
125109786|NCT04380701|450026249|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
125109787|NCT04380701|450026250|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
125109788|NCT04380701|450026251|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
125109789|NCT04380701|450026252|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
125109790|NCT04380701|450026253|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
125109791|NCT04380701|450026220|FG000|Overall Study|Physician Decision|0|||
125109792|NCT04380701|450026221|FG001|Overall Study|Physician Decision|0|||
125109793|NCT04380701|450026222|FG002|Overall Study|Physician Decision|0|||
125109794|NCT04380701|450026223|FG003|Overall Study|Physician Decision|0|||
125109795|NCT04380701|450026224|FG004|Overall Study|Physician Decision|0|||
125109796|NCT04380701|450026225|FG005|Overall Study|Physician Decision|0|||
125109797|NCT04380701|450026226|FG006|Overall Study|Physician Decision|0|||
125109798|NCT04380701|450026227|FG007|Overall Study|Physician Decision|0|||
125109799|NCT04380701|450026228|FG008|Overall Study|Physician Decision|0|||
125109800|NCT04380701|450026229|FG009|Overall Study|Physician Decision|0|||
125109801|NCT04380701|450026230|FG010|Overall Study|Physician Decision|0|||
125109802|NCT04380701|450026231|FG011|Overall Study|Physician Decision|0|||
125109803|NCT04380701|450026232|FG012|Overall Study|Physician Decision|0|||
125109804|NCT04380701|450026233|FG013|Overall Study|Physician Decision|0|||
125109805|NCT04380701|450026234|FG014|Overall Study|Physician Decision|0|||
125109806|NCT04380701|450026235|FG015|Overall Study|Physician Decision|0|||
125109807|NCT04380701|450026236|FG016|Overall Study|Physician Decision|0|||
124896043|NCT05550337|449242956|FG002|Overall Study|Adverse Event|0|||
124896044|NCT05550337|449242954|FG000|Overall Study|Withdrawal by Subject|8|||
124896045|NCT05550337|449242955|FG001|Overall Study|Withdrawal by Subject|14|||
124896046|NCT05550337|449242956|FG002|Overall Study|Withdrawal by Subject|10|||
124896047|NCT05550337|449242954|FG000|Overall Study|Pregnancy|0|||
124896048|NCT05550337|449242955|FG001|Overall Study|Pregnancy|0|||
124896049|NCT05550337|449242956|FG002|Overall Study|Pregnancy|1|||
124896050|NCT05550337|449242954|FG000|Overall Study|Protocol Violation|1|||
125109808|NCT04380701|450026237|FG017|Overall Study|Physician Decision|0|||
125109809|NCT04380701|450026238|FG018|Overall Study|Physician Decision|0|||
125109810|NCT04380701|450026239|FG019|Overall Study|Physician Decision|0|||
125109811|NCT04380701|450026240|FG020|Overall Study|Physician Decision|0|||
125109812|NCT04380701|450026241|FG021|Overall Study|Physician Decision|0|||
124896051|NCT05550337|449242955|FG001|Overall Study|Protocol Violation|3|||
124896052|NCT05550337|449242956|FG002|Overall Study|Protocol Violation|4|||
124896053|NCT05550337|449242954|FG000|Overall Study|Physician Decision|2|||
125018740|NCT02275338|449692917|FG000|Overall Study|Reason not specified|5|||
125018741|NCT02275338|449692917|FG000|Overall Study|Does not meet entry criteria|1|||
125018742|NCT04607733|449692923|FG000|Overall Study|Lost to Follow-up|1|||
125018743|NCT04607733|449692924|FG001|Overall Study|Lost to Follow-up|0|||
125018744|NCT04607733|449692925|FG002|Overall Study|Lost to Follow-up|0|||
125018745|NCT04607733|449692926|FG003|Overall Study|Lost to Follow-up|1|||
125018746|NCT04607733|449692927|FG004|Overall Study|Lost to Follow-up|1|||
125018747|NCT04607733|449692928|FG005|Overall Study|Lost to Follow-up|0|||
125018748|NCT04607733|449692923|FG000|Overall Study|Withdrawal by Subject|0|||
125018749|NCT04607733|449692924|FG001|Overall Study|Withdrawal by Subject|0|||
125018750|NCT04607733|449692925|FG002|Overall Study|Withdrawal by Subject|0|||
125018751|NCT04607733|449692926|FG003|Overall Study|Withdrawal by Subject|0|||
125018752|NCT04607733|449692927|FG004|Overall Study|Withdrawal by Subject|1|||
125018753|NCT04607733|449692928|FG005|Overall Study|Withdrawal by Subject|0|||
125018754|NCT01827670|449692931|FG000|Overall Study|Withdrawal of Consent|3|||
125018755|NCT01827670|449692932|FG001|Overall Study|Withdrawal of Consent|2|||
125018756|NCT01827670|449692931|FG000|Overall Study|Lost to Follow-up|0|||
125018757|NCT01827670|449692932|FG001|Overall Study|Lost to Follow-up|1|||
125018758|NCT03603496|449692937|FG000|Overall Study|Death|19|||
125018759|NCT03603496|449692938|FG001|Overall Study|Death|24|||
125018760|NCT03603496|449692937|FG000|Overall Study|Lost to Follow-up|141|||
125018761|NCT03603496|449692938|FG001|Overall Study|Lost to Follow-up|141|||
125018762|NCT03603496|449692937|FG000|Overall Study|Withdrawal by Subject|26|||
125018763|NCT03603496|449692938|FG001|Overall Study|Withdrawal by Subject|20|||
125018764|NCT00774345|449692939|FG000|Pre-treatment|Other reasons|2|||
125018765|NCT00774345|449692940|FG001|Pre-treatment|Other reasons|0|||
125018766|NCT00774345|449692939|FG000|Treatment|Adverse Event|61|||
125018767|NCT00774345|449692940|FG001|Treatment|Adverse Event|15|||
125018768|NCT00774345|449692939|FG000|Treatment|Progressive Disease without histologic transformation|51|||
125018769|NCT00774345|449692940|FG001|Treatment|Progressive Disease without histologic transformation|111|||
125018770|NCT00774345|449692939|FG000|Treatment|Progressive Disease with histologic transformation|4|||
125018771|NCT00774345|449692940|FG001|Treatment|Progressive Disease with histologic transformation|2|||
124896054|NCT05550337|449242955|FG001|Overall Study|Physician Decision|1|||
124896055|NCT05550337|449242956|FG002|Overall Study|Physician Decision|1|||
124896056|NCT05550337|449242954|FG000|Overall Study|Lost to Follow-up|16|||
124896057|NCT05550337|449242955|FG001|Overall Study|Lost to Follow-up|11|||
124896058|NCT05550337|449242956|FG002|Overall Study|Lost to Follow-up|11|||
124896059|NCT03115346|449242958|FG000|Overall Study|Did not have AAA surgery|28|||
124896060|NCT03115346|449242959|FG001|Overall Study|Did not have AAA surgery|15|||
124896061|NCT03115346|449242958|FG000|Overall Study|Death|3|||
124896062|NCT03115346|449242959|FG001|Overall Study|Death|1|||
124896063|NCT03115346|449242958|FG000|Overall Study|Withdrawal by Subject|0|||
124896064|NCT03115346|449242959|FG001|Overall Study|Withdrawal by Subject|3|||
124896065|NCT03115346|449242958|FG000|Overall Study|Lost to Follow-up|0|||
124896066|NCT03115346|449242959|FG001|Overall Study|Lost to Follow-up|3|||
124896067|NCT01140347|449242961|FG000|Overall Study|Lost to Follow-up|5|||
124896068|NCT01140347|449242962|FG001|Overall Study|Lost to Follow-up|6|||
124896069|NCT01140347|449242961|FG000|Overall Study|Withdrawal by Subject|13|||
124896070|NCT01140347|449242962|FG001|Overall Study|Withdrawal by Subject|8|||
124896071|NCT00828919|449242963|FG000|Overall Study|Death|0|||
124896072|NCT00828919|449242964|FG001|Overall Study|Death|1|||
124896073|NCT00828919|449242965|FG002|Overall Study|Death|2|||
125018772|NCT00774345|449692939|FG000|Treatment|Withdrawal by Subject|5|||
125018773|NCT00774345|449692940|FG001|Treatment|Withdrawal by Subject|2|||
125018774|NCT00774345|449692939|FG000|Treatment|Lost to Follow-up|1|||
125018775|NCT00774345|449692940|FG001|Treatment|Lost to Follow-up|1|||
125018776|NCT00774345|449692939|FG000|Treatment|Death|4|||
125018777|NCT00774345|449692940|FG001|Treatment|Death|0|||
125018778|NCT00774345|449692939|FG000|Treatment|Other Reasons|32|||
125018779|NCT00774345|449692940|FG001|Treatment|Other Reasons|26|||
125018780|NCT00835237|449692941|FG000|Overall Study|Lost to Follow-up|4|||
125018781|NCT00835237|449692942|FG001|Overall Study|Lost to Follow-up|0|||
125018782|NCT00835237|449692941|FG000|Overall Study|Withdrawal by Subject|2|||
125018783|NCT00835237|449692942|FG001|Overall Study|Withdrawal by Subject|0|||
125018784|NCT01265550|449692943|FG000|Pre Randomization|Withdrawal by Subject|0|||
125018785|NCT01265550|449692944|FG001|Pre Randomization|Withdrawal by Subject|0|||
125018786|NCT01265550|449692945|FG002|Pre Randomization|Withdrawal by Subject|0|||
125018787|NCT01265550|449692946|FG003|Pre Randomization|Withdrawal by Subject|70|||
125018788|NCT01265550|449692943|FG000|Pre Randomization|Technical Exclusions|0|||
125018789|NCT01265550|449692944|FG001|Pre Randomization|Technical Exclusions|0|||
125018790|NCT01265550|449692945|FG002|Pre Randomization|Technical Exclusions|0|||
125018791|NCT01265550|449692946|FG003|Pre Randomization|Technical Exclusions|54|||
125018792|NCT01265550|449692943|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
125018793|NCT01265550|449692944|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
125018794|NCT01265550|449692945|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
125018795|NCT01265550|449692946|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
125018796|NCT01265550|449692943|FG000|Pre Randomization|Non-GERD organic disorders|0|||
125018797|NCT01265550|449692944|FG001|Pre Randomization|Non-GERD organic disorders|0|||
125018798|NCT01265550|449692945|FG002|Pre Randomization|Non-GERD organic disorders|0|||
125018799|NCT01265550|449692946|FG003|Pre Randomization|Non-GERD organic disorders|23|||
125018800|NCT01265550|449692943|FG000|Pre Randomization|Functional heartburn|0|||
125018801|NCT01265550|449692944|FG001|Pre Randomization|Functional heartburn|0|||
125018802|NCT01265550|449692945|FG002|Pre Randomization|Functional heartburn|0|||
125018803|NCT01265550|449692946|FG003|Pre Randomization|Functional heartburn|99|||
125018804|NCT00623428|449692949|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
125018805|NCT00623428|449692950|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
125018806|NCT00623428|449692949|FG000|Treatment Period|Death|0|||
125018807|NCT00623428|449692950|FG001|Treatment Period|Death|1|||
125018808|NCT00623428|449692949|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
125018809|NCT00623428|449692950|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
125018810|NCT00623428|449692949|FG000|Treatment Period|Insufficient therapeutic response|0|||
125018811|NCT00623428|449692950|FG001|Treatment Period|Insufficient therapeutic response|2|||
125018812|NCT00623428|449692949|FG000|Treatment Period|Other|0|||
125018813|NCT00623428|449692950|FG001|Treatment Period|Other|1|||
125018814|NCT00623428|449692949|FG000|Treatment Period|Withdrawal by Subject|0|||
125018815|NCT00623428|449692950|FG001|Treatment Period|Withdrawal by Subject|1|||
125018816|NCT00623428|449692949|FG000|Follow-up Period|Relapse post-treatment|11|||
124896074|NCT00828919|449242966|FG003|Overall Study|Death|0|||
124896075|NCT00828919|449242967|FG004|Overall Study|Death|0|||
124896076|NCT00828919|449242963|FG000|Overall Study|Adverse Event|2|||
124896077|NCT00828919|449242964|FG001|Overall Study|Adverse Event|2|||
125018817|NCT00623428|449692950|FG001|Follow-up Period|Relapse post-treatment|3|||
125018818|NCT00623428|449692949|FG000|Follow-up Period|Failure to return|10|||
125018819|NCT00623428|449692950|FG001|Follow-up Period|Failure to return|2|||
125018820|NCT00623428|449692949|FG000|Follow-up Period|Patient withdrew consent|5|||
125018821|NCT00623428|449692950|FG001|Follow-up Period|Patient withdrew consent|4|||
125018822|NCT00623428|449692949|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
125109813|NCT04380701|450026242|FG022|Overall Study|Physician Decision|0|||
125109814|NCT04380701|450026243|FG023|Overall Study|Physician Decision|0|||
125109815|NCT04380701|450026244|FG024|Overall Study|Physician Decision|2|||
125109816|NCT04380701|450026245|FG025|Overall Study|Physician Decision|0|||
125109817|NCT04380701|450026246|FG026|Overall Study|Physician Decision|0|||
125109818|NCT04380701|450026247|FG027|Overall Study|Physician Decision|0|||
125109819|NCT04380701|450026248|FG028|Overall Study|Physician Decision|0|||
125109820|NCT04380701|450026249|FG029|Overall Study|Physician Decision|0|||
125109821|NCT04380701|450026250|FG030|Overall Study|Physician Decision|0|||
125109822|NCT04380701|450026251|FG031|Overall Study|Physician Decision|0|||
125109823|NCT04380701|450026252|FG032|Overall Study|Physician Decision|0|||
125109824|NCT04380701|450026253|FG033|Overall Study|Physician Decision|0|||
125109825|NCT04380701|450026220|FG000|Overall Study|Death|0|||
125109826|NCT04380701|450026221|FG001|Overall Study|Death|0|||
125109827|NCT04380701|450026222|FG002|Overall Study|Death|0|||
125109828|NCT04380701|450026223|FG003|Overall Study|Death|0|||
125109829|NCT04380701|450026224|FG004|Overall Study|Death|0|||
125109830|NCT04380701|450026225|FG005|Overall Study|Death|0|||
125109831|NCT04380701|450026226|FG006|Overall Study|Death|0|||
125109832|NCT04380701|450026227|FG007|Overall Study|Death|0|||
125109833|NCT04380701|450026228|FG008|Overall Study|Death|0|||
125109834|NCT04380701|450026229|FG009|Overall Study|Death|0|||
125109835|NCT04380701|450026230|FG010|Overall Study|Death|0|||
125109836|NCT04380701|450026231|FG011|Overall Study|Death|0|||
125109837|NCT04380701|450026232|FG012|Overall Study|Death|0|||
125109838|NCT04380701|450026233|FG013|Overall Study|Death|0|||
125109839|NCT04380701|450026234|FG014|Overall Study|Death|0|||
125109840|NCT04380701|450026235|FG015|Overall Study|Death|0|||
125109841|NCT04380701|450026236|FG016|Overall Study|Death|0|||
125109842|NCT04380701|450026237|FG017|Overall Study|Death|0|||
125109843|NCT04380701|450026238|FG018|Overall Study|Death|0|||
124896078|NCT00828919|449242965|FG002|Overall Study|Adverse Event|2|||
124896079|NCT00828919|449242966|FG003|Overall Study|Adverse Event|1|||
124896080|NCT00828919|449242967|FG004|Overall Study|Adverse Event|3|||
124896081|NCT00828919|449242963|FG000|Overall Study|Objective progression or relapse|4|||
124896082|NCT00828919|449242964|FG001|Overall Study|Objective progression or relapse|4|||
124896083|NCT00828919|449242965|FG002|Overall Study|Objective progression or relapse|11|||
124896084|NCT00828919|449242966|FG003|Overall Study|Objective progression or relapse|0|||
124896085|NCT00828919|449242967|FG004|Overall Study|Objective progression or relapse|5|||
124896086|NCT00828919|449242963|FG000|Overall Study|No longer willing to participate in study|0|||
124896087|NCT00828919|449242964|FG001|Overall Study|No longer willing to participate in study|0|||
124896088|NCT00828919|449242965|FG002|Overall Study|No longer willing to participate in study|2|||
124896089|NCT00828919|449242966|FG003|Overall Study|No longer willing to participate in study|0|||
124896090|NCT00828919|449242967|FG004|Overall Study|No longer willing to participate in study|0|||
124896091|NCT00828919|449242963|FG000|Overall Study|Insufficient Clinical Response|0|||
124896092|NCT00828919|449242964|FG001|Overall Study|Insufficient Clinical Response|1|||
124896093|NCT00828919|449242965|FG002|Overall Study|Insufficient Clinical Response|2|||
124896094|NCT00828919|449242966|FG003|Overall Study|Insufficient Clinical Response|0|||
124896095|NCT00828919|449242967|FG004|Overall Study|Insufficient Clinical Response|0|||
124896096|NCT00828919|449242963|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
124896097|NCT00828919|449242964|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
124896098|NCT00828919|449242965|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
124896099|NCT00828919|449242966|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
124896100|NCT00828919|449242967|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
124896101|NCT00828919|449242963|FG000|Overall Study|Other|1|||
124896102|NCT00828919|449242964|FG001|Overall Study|Other|0|||
124896103|NCT00828919|449242965|FG002|Overall Study|Other|1|||
124896104|NCT00828919|449242966|FG003|Overall Study|Other|1|||
124896105|NCT00828919|449242967|FG004|Overall Study|Other|0|||
124896106|NCT00828919|449242963|FG000|Overall Study|Lost to Follow-up|0|||
124896107|NCT00828919|449242964|FG001|Overall Study|Lost to Follow-up|1|||
124896108|NCT00828919|449242965|FG002|Overall Study|Lost to Follow-up|0|||
124896109|NCT00828919|449242966|FG003|Overall Study|Lost to Follow-up|0|||
124896110|NCT00828919|449242967|FG004|Overall Study|Lost to Follow-up|0|||
124896111|NCT02501811|449242969|FG000|Overall Study|Death|1|||
124896112|NCT02501811|449242970|FG001|Overall Study|Death|3|||
124896113|NCT02501811|449242971|FG002|Overall Study|Death|2|||
124896114|NCT02501811|449242972|FG003|Overall Study|Death|3|||
124896115|NCT02501811|449242969|FG000|Overall Study|Withdrawal by Subject|3|||
124896116|NCT02501811|449242970|FG001|Overall Study|Withdrawal by Subject|3|||
125109844|NCT04380701|450026239|FG019|Overall Study|Death|0|||
125109845|NCT04380701|450026240|FG020|Overall Study|Death|0|||
125109846|NCT04380701|450026241|FG021|Overall Study|Death|0|||
125109847|NCT04380701|450026242|FG022|Overall Study|Death|0|||
125109848|NCT04380701|450026243|FG023|Overall Study|Death|0|||
125109849|NCT04380701|450026244|FG024|Overall Study|Death|1|||
125109850|NCT04380701|450026245|FG025|Overall Study|Death|0|||
125109851|NCT04380701|450026246|FG026|Overall Study|Death|0|||
125109852|NCT04380701|450026247|FG027|Overall Study|Death|0|||
125109853|NCT04380701|450026248|FG028|Overall Study|Death|0|||
125109854|NCT04380701|450026249|FG029|Overall Study|Death|0|||
125109855|NCT04380701|450026250|FG030|Overall Study|Death|0|||
125109856|NCT04380701|450026251|FG031|Overall Study|Death|0|||
125109857|NCT04380701|450026252|FG032|Overall Study|Death|0|||
125109858|NCT04380701|450026253|FG033|Overall Study|Death|0|||
125109859|NCT04380701|450026220|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109860|NCT04380701|450026221|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109861|NCT04380701|450026222|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109862|NCT04380701|450026223|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109863|NCT04380701|450026224|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109864|NCT04380701|450026225|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124896117|NCT02501811|449242971|FG002|Overall Study|Withdrawal by Subject|2|||
124896118|NCT02501811|449242972|FG003|Overall Study|Withdrawal by Subject|3|||
124896119|NCT02501811|449242969|FG000|Overall Study|Lost to Follow-up|0|||
124896120|NCT02501811|449242970|FG001|Overall Study|Lost to Follow-up|0|||
124896121|NCT02501811|449242971|FG002|Overall Study|Lost to Follow-up|2|||
124896122|NCT02501811|449242972|FG003|Overall Study|Lost to Follow-up|1|||
124896123|NCT01124162|449244652|FG000|First Intervention|Adverse Event|2|||
124896124|NCT01124162|449244653|FG001|First Intervention|Adverse Event|0|||
125109865|NCT04380701|450026226|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109866|NCT04380701|450026227|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109867|NCT04380701|450026228|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109868|NCT04380701|450026229|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124896125|NCT01124162|449244652|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
124896126|NCT01124162|449244653|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
124896127|NCT02680756|449244654|FG000|Overall Study|Adverse Event|10|||
124896128|NCT02680756|449244655|FG001|Overall Study|Adverse Event|2|||
124896129|NCT02680756|449244654|FG000|Overall Study|Lost to Follow-up|7|||
124896130|NCT02680756|449244655|FG001|Overall Study|Lost to Follow-up|6|||
124896131|NCT02680756|449244654|FG000|Overall Study|Withdrawal by Subject|5|||
124896132|NCT02680756|449244655|FG001|Overall Study|Withdrawal by Subject|5|||
124896133|NCT02680756|449244654|FG000|Overall Study|Physician Decision|4|||
124896134|NCT02680756|449244655|FG001|Overall Study|Physician Decision|1|||
124896135|NCT02680756|449244654|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
124896136|NCT02680756|449244655|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
124896137|NCT02680756|449244654|FG000|Overall Study|Blood transfusion for any reason|0|||
124896138|NCT02680756|449244655|FG001|Overall Study|Blood transfusion for any reason|1|||
124896139|NCT02680756|449244654|FG000|Overall Study|Death|1|||
124896140|NCT02680756|449244655|FG001|Overall Study|Death|0|||
124896141|NCT02680756|449244654|FG000|Overall Study|Protocol Violation|1|||
124896142|NCT02680756|449244655|FG001|Overall Study|Protocol Violation|0|||
124896143|NCT02680756|449244654|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
124896144|NCT02680756|449244655|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
124896145|NCT02680756|449244654|FG000|Overall Study|None of above or not recorded|3|||
124896146|NCT02680756|449244655|FG001|Overall Study|None of above or not recorded|2|||
124896147|NCT03613129|449244656|FG000|Pre-treatment Assessment|Protocol Violation|2|||
124896148|NCT03613129|449244657|FG001|Pre-treatment Assessment|Protocol Violation|0|||
124896149|NCT03613129|449244658|FG002|Pre-treatment Assessment|Protocol Violation|0|||
125109869|NCT04380701|450026230|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109870|NCT04380701|450026231|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109871|NCT04380701|450026232|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109872|NCT04380701|450026233|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109873|NCT04380701|450026234|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109874|NCT04380701|450026235|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109875|NCT04380701|450026236|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109876|NCT04380701|450026237|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109877|NCT04380701|450026238|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109878|NCT04380701|450026239|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109879|NCT04380701|450026240|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109880|NCT04380701|450026241|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
125109881|NCT04380701|450026242|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
125109882|NCT04380701|450026243|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
125109883|NCT04380701|450026244|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
125109884|NCT04380701|450026245|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109885|NCT04380701|450026246|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109886|NCT04380701|450026247|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109887|NCT04380701|450026248|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109888|NCT04380701|450026249|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124896150|NCT03613129|449244659|FG003|Pre-treatment Assessment|Protocol Violation|0|||
125109889|NCT04380701|450026250|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109890|NCT04380701|450026251|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109891|NCT04380701|450026252|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109892|NCT04380701|450026253|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125109893|NCT00363129|450026254|FG000|Overall Study|Withdrawal by Subject|11|||
125109894|NCT00363129|450026255|FG001|Overall Study|Withdrawal by Subject|18|||
125109895|NCT00363129|450026254|FG000|Overall Study|Adverse Event|8|||
125109896|NCT00363129|450026255|FG001|Overall Study|Adverse Event|3|||
125109897|NCT00363129|450026254|FG000|Overall Study|Alternate Treatment|2|||
125109898|NCT00363129|450026255|FG001|Overall Study|Alternate Treatment|4|||
125109899|NCT00363129|450026254|FG000|Overall Study|Other Medical Problems|2|||
125109900|NCT00363129|450026255|FG001|Overall Study|Other Medical Problems|4|||
125109901|NCT00363129|450026254|FG000|Overall Study|Death|0|||
125109902|NCT00363129|450026255|FG001|Overall Study|Death|1|||
125109903|NCT00363129|450026254|FG000|Overall Study|Other Reasons|6|||
125109904|NCT00363129|450026255|FG001|Overall Study|Other Reasons|3|||
124896151|NCT03613129|449244660|FG004|Pre-treatment Assessment|Protocol Violation|0|||
124896152|NCT03613129|449244656|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
125109905|NCT03296553|450026256|FG000|Overall Study|Withdrawal by Subject|1|||
124896153|NCT03613129|449244657|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
124896154|NCT03613129|449244658|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
124896155|NCT03613129|449244659|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
124896156|NCT03613129|449244660|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
124896157|NCT00938340|449244661|FG000|Overall Study|Withdrawal by Subject|3|||
124896158|NCT00938340|449244661|FG000|Overall Study|Protocol Violation|1|||
124896159|NCT00938340|449244661|FG000|Overall Study|Adverse Event|1|||
125109906|NCT03296553|450026257|FG001|Overall Study|Withdrawal by Subject|1|||
125109907|NCT03296553|450026256|FG000|Overall Study|Death|1|||
125109908|NCT03296553|450026257|FG001|Overall Study|Death|0|||
125109909|NCT02713243|450026258|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
125109910|NCT02713243|450026259|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
125109911|NCT02713243|450026258|FG000|Overall Study|Administrative problems|0|||
125109912|NCT02713243|450026259|FG001|Overall Study|Administrative problems|1|||
125109913|NCT02713243|450026258|FG000|Overall Study|Protocol deviation|0|||
125109914|NCT02713243|450026259|FG001|Overall Study|Protocol deviation|1|||
125109915|NCT01619085|450026260|FG000|Overall Study|Adverse Event|231|||
125109916|NCT01619085|450026260|FG000|Overall Study|Protocol Violation|4|||
125109917|NCT01619085|450026260|FG000|Overall Study|Lost to Follow-up|3|||
125109918|NCT01619085|450026260|FG000|Overall Study|Withdrawal by Subject|45|||
125109919|NCT01619085|450026260|FG000|Overall Study|Other than specified|96|||
125109920|NCT01619085|450026260|FG000|Overall Study|Not treated|1|||
125109921|NCT01619085|450026260|FG000|Overall Study|Death|145|||
125109922|NCT03125915|450026261|FG000|1 Month Follow up|Lost to Follow-up|3|||
125109923|NCT03125915|450026262|FG001|1 Month Follow up|Lost to Follow-up|3|||
125109924|NCT03125915|450026263|FG002|1 Month Follow up|Lost to Follow-up|2|||
125109925|NCT03125915|450026264|FG003|1 Month Follow up|Lost to Follow-up|3|||
125109926|NCT03125915|450026261|FG000|3 Month Follow-up|Lost to Follow-up|6|||
125109927|NCT03125915|450026262|FG001|3 Month Follow-up|Lost to Follow-up|4|||
125109928|NCT03125915|450026263|FG002|3 Month Follow-up|Lost to Follow-up|4|||
124896160|NCT04353037|449244662|FG000|Overall Study|Lost to Follow-up|0|||
124896161|NCT04353037|449244663|FG001|Overall Study|Lost to Follow-up|1|||
124896162|NCT04353037|449244664|FG002|Overall Study|Lost to Follow-up|2|||
125109929|NCT03125915|450026264|FG003|3 Month Follow-up|Lost to Follow-up|2|||
125109930|NCT03125915|450026261|FG000|6 Month Follow-up|Lost to Follow-up|7|||
125109931|NCT03125915|450026262|FG001|6 Month Follow-up|Lost to Follow-up|3|||
125109932|NCT03125915|450026263|FG002|6 Month Follow-up|Lost to Follow-up|6|||
125109933|NCT03125915|450026264|FG003|6 Month Follow-up|Lost to Follow-up|3|||
125109934|NCT01458119|450026265|FG000|Overall Study|Physician Decision|4|||
125109935|NCT01458119|450026265|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
125109936|NCT01458119|450026265|FG000|Overall Study|Pregnancy|1|||
125109937|NCT01458119|450026265|FG000|Overall Study|Death|2|||
125109938|NCT01458119|450026265|FG000|Overall Study|Adverse Event|1|||
125109939|NCT01458119|450026265|FG000|Overall Study|Consent Withdrawn by Participant|8|||
125109940|NCT01458119|450026265|FG000|Overall Study|Non-compliance With Study Drug|3|||
125109941|NCT00435825|450026266|FG000|Overall Study|Abnormality of Laboratory Test|0|||
125109942|NCT00435825|450026267|FG001|Overall Study|Abnormality of Laboratory Test|1|||
125109943|NCT00435825|450026268|FG002|Overall Study|Abnormality of Laboratory Test|0|||
125109944|NCT00435825|450026269|FG003|Overall Study|Abnormality of Laboratory Test|0|||
125109945|NCT00435825|450026266|FG000|Overall Study|Insufficient Therapeutic Response|3|||
125109946|NCT00435825|450026267|FG001|Overall Study|Insufficient Therapeutic Response|1|||
125109947|NCT00435825|450026268|FG002|Overall Study|Insufficient Therapeutic Response|0|||
125109948|NCT00435825|450026269|FG003|Overall Study|Insufficient Therapeutic Response|3|||
125109949|NCT00435825|450026266|FG000|Overall Study|Other Protocol Violation|1|||
125109950|NCT00435825|450026267|FG001|Overall Study|Other Protocol Violation|0|||
125109951|NCT00435825|450026268|FG002|Overall Study|Other Protocol Violation|0|||
125109952|NCT00435825|450026269|FG003|Overall Study|Other Protocol Violation|0|||
125109953|NCT00435825|450026266|FG000|Overall Study|Refused treatment|2|||
125109954|NCT00435825|450026267|FG001|Overall Study|Refused treatment|0|||
125109955|NCT00435825|450026268|FG002|Overall Study|Refused treatment|0|||
125109956|NCT00435825|450026269|FG003|Overall Study|Refused treatment|5|||
125109957|NCT00435825|450026266|FG000|Overall Study|Failure to return|5|||
125109958|NCT00435825|450026267|FG001|Overall Study|Failure to return|0|||
125109959|NCT00435825|450026268|FG002|Overall Study|Failure to return|4|||
125109960|NCT00435825|450026269|FG003|Overall Study|Failure to return|0|||
125109961|NCT00435825|450026266|FG000|Overall Study|Did not receive study drug|1|||
125109962|NCT00435825|450026267|FG001|Overall Study|Did not receive study drug|0|||
125109963|NCT00435825|450026268|FG002|Overall Study|Did not receive study drug|2|||
125109964|NCT00435825|450026269|FG003|Overall Study|Did not receive study drug|0|||
125109965|NCT00435825|450026266|FG000|Overall Study|Did not enter follow-up|0|||
124896163|NCT04353037|449244665|FG003|Overall Study|Lost to Follow-up|3|||
125109966|NCT00435825|450026267|FG001|Overall Study|Did not enter follow-up|4|||
125109967|NCT00435825|450026268|FG002|Overall Study|Did not enter follow-up|1|||
125109968|NCT00435825|450026269|FG003|Overall Study|Did not enter follow-up|3|||
125109969|NCT00435825|450026266|FG000|Overall Study|Did not complete full follow-up period|6|||
125109970|NCT00435825|450026267|FG001|Overall Study|Did not complete full follow-up period|6|||
125109971|NCT00435825|450026268|FG002|Overall Study|Did not complete full follow-up period|4|||
125109972|NCT00435825|450026269|FG003|Overall Study|Did not complete full follow-up period|5|||
125109973|NCT01123980|450026272|FG000|Overall Study|Adverse Event|1|||
125109974|NCT01123980|450026273|FG001|Overall Study|Adverse Event|1|||
125109975|NCT01123980|450026272|FG000|Overall Study|Lack of Efficacy|1|||
125109976|NCT01123980|450026273|FG001|Overall Study|Lack of Efficacy|0|||
125109977|NCT01123980|450026272|FG000|Overall Study|Physician Decision|0|||
124896164|NCT04353037|449244662|FG000|Overall Study|Withdrawal by Subject|0|||
124896165|NCT04353037|449244663|FG001|Overall Study|Withdrawal by Subject|2|||
124896166|NCT04353037|449244664|FG002|Overall Study|Withdrawal by Subject|3|||
124896167|NCT04353037|449244665|FG003|Overall Study|Withdrawal by Subject|5|||
124896168|NCT04353037|449244662|FG000|Overall Study|Adverse Event|0|||
124896169|NCT04353037|449244663|FG001|Overall Study|Adverse Event|0|||
124896170|NCT04353037|449244664|FG002|Overall Study|Adverse Event|2|||
124896171|NCT04353037|449244665|FG003|Overall Study|Adverse Event|0|||
124896172|NCT04353037|449244662|FG000|Overall Study|Exposure Change|0|||
124896173|NCT04353037|449244663|FG001|Overall Study|Exposure Change|0|||
124896174|NCT04353037|449244664|FG002|Overall Study|Exposure Change|0|||
124896175|NCT04353037|449244665|FG003|Overall Study|Exposure Change|2|||
124896176|NCT02950545|449244670|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
124896177|NCT02950545|449244671|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
124896178|NCT02950545|449244672|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
124896179|NCT02950545|449244673|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
124896180|NCT02950545|449244674|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
124896181|NCT02950545|449244675|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
124896182|NCT02950545|449244670|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
124896183|NCT02950545|449244671|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
124896184|NCT02950545|449244672|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
124896185|NCT02950545|449244673|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
124896186|NCT02950545|449244674|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
124896187|NCT02950545|449244675|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
124896188|NCT02950545|449244670|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
124896189|NCT02950545|449244671|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
124896190|NCT02950545|449244672|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
124896191|NCT02950545|449244673|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
124896192|NCT02950545|449244674|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
124896193|NCT02950545|449244675|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
124896194|NCT02950545|449244670|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
124896195|NCT02950545|449244671|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
124896196|NCT02950545|449244672|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
124896197|NCT02950545|449244673|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
124896198|NCT02950545|449244674|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
124896199|NCT02950545|449244675|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
124896200|NCT02950545|449244670|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
124896201|NCT02950545|449244671|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
124896202|NCT02950545|449244672|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
124896203|NCT02950545|449244673|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
124896204|NCT02950545|449244674|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
124896205|NCT02950545|449244675|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
124896206|NCT03398356|449244676|FG000|Before Treatment|Lost to Follow-up|1|||
124896207|NCT03398356|449244677|FG001|Before Treatment|Lost to Follow-up|2|||
125018823|NCT00623428|449692950|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
125018824|NCT00623428|449692949|FG000|Follow-up Period|Did not cooperate|0|||
125018825|NCT00623428|449692950|FG001|Follow-up Period|Did not cooperate|3|||
125018826|NCT00623428|449692949|FG000|Follow-up Period|Reason not specified|1|||
125018827|NCT00623428|449692950|FG001|Follow-up Period|Reason not specified|1|||
125018828|NCT00623428|449692949|FG000|Follow-up Period|Death|0|||
125018829|NCT00623428|449692950|FG001|Follow-up Period|Death|1|||
125018830|NCT01692301|449692954|FG000|Overall Study|Adverse Event|15|||
125018831|NCT01692301|449692955|FG001|Overall Study|Adverse Event|12|||
125018832|NCT01692301|449692954|FG000|Overall Study|Death|1|||
125018833|NCT01692301|449692955|FG001|Overall Study|Death|2|||
125018834|NCT01692301|449692954|FG000|Overall Study|Lack of Efficacy|0|||
125018835|NCT01692301|449692955|FG001|Overall Study|Lack of Efficacy|5|||
125018836|NCT01692301|449692954|FG000|Overall Study|Non-compliance with study treatment|1|||
125018837|NCT01692301|449692955|FG001|Overall Study|Non-compliance with study treatment|2|||
125018838|NCT01692301|449692954|FG000|Overall Study|Protocol deviation|9|||
125018839|NCT01692301|449692955|FG001|Overall Study|Protocol deviation|2|||
125018840|NCT01692301|449692954|FG000|Overall Study|Patient/guardian decision|16|||
125018841|NCT01692301|449692955|FG001|Overall Study|Patient/guardian decision|15|||
125018842|NCT01692301|449692954|FG000|Overall Study|Technical problems|0|||
125109978|NCT01123980|450026273|FG001|Overall Study|Physician Decision|1|||
124896208|NCT03398356|449244678|FG002|Before Treatment|Lost to Follow-up|0|||
125018843|NCT01692301|449692955|FG001|Overall Study|Technical problems|1|||
125018844|NCT01692301|449692954|FG000|Overall Study|Physician Decision|2|||
125018845|NCT01692301|449692955|FG001|Overall Study|Physician Decision|2|||
125018846|NCT01692301|449692954|FG000|Overall Study|Lost to Follow-up|1|||
124896209|NCT03398356|449244676|FG000|Before Treatment|drug intolerance|2|||
125018847|NCT01692301|449692955|FG001|Overall Study|Lost to Follow-up|1|||
125109979|NCT01123980|450026272|FG000|Overall Study|Lost to Follow-up|0|||
125109980|NCT01123980|450026273|FG001|Overall Study|Lost to Follow-up|6|||
125109981|NCT01123980|450026272|FG000|Overall Study|Protocol Violation|6|||
125109982|NCT01123980|450026273|FG001|Overall Study|Protocol Violation|6|||
125109983|NCT01123980|450026272|FG000|Overall Study|Withdrawal by Subject|5|||
125109984|NCT01123980|450026273|FG001|Overall Study|Withdrawal by Subject|3|||
125109985|NCT01123980|450026272|FG000|Overall Study|Unclassified|6|||
125109986|NCT01123980|450026273|FG001|Overall Study|Unclassified|7|||
125109987|NCT01225991|450026274|FG000|Overall Study|Withdrawal by Subject|6|||
125109988|NCT00789828|450026275|FG000|Core Period (48 Weeks)|Administrative problems|0|||
125109989|NCT00789828|450026276|FG001|Core Period (48 Weeks)|Administrative problems|1|||
125109990|NCT00789828|450026275|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
125109991|NCT00789828|450026276|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
125109992|NCT00789828|450026275|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
125109993|NCT00789828|450026276|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
125109994|NCT00789828|450026275|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
125109995|NCT00789828|450026276|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
125109996|NCT00789828|450026275|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
125109997|NCT00789828|450026276|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
125109998|NCT00789828|450026275|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
125109999|NCT00789828|450026276|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
125110000|NCT00789828|450026275|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
125110001|NCT00789828|450026276|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
125110002|NCT00789828|450026275|FG000|Open-label Extension Period (4 Years)|Death|1|||
125110003|NCT00789828|450026276|FG001|Open-label Extension Period (4 Years)|Death|0|||
125110004|NCT00789828|450026275|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
125110005|NCT00789828|450026276|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
125110006|NCT00789828|450026275|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
125110007|NCT00789828|450026276|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
125110008|NCT02094937|450026277|FG000|8 Weeks in Period 1|Adverse Event|9|||
125110009|NCT02094937|450026278|FG001|8 Weeks in Period 1|Adverse Event|0|||
125110010|NCT02094937|450026279|FG002|8 Weeks in Period 1|Adverse Event|0|||
125110011|NCT02094937|450026280|FG003|8 Weeks in Period 1|Adverse Event|0|||
125110012|NCT02094937|450026277|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
125110013|NCT02094937|450026278|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
125110014|NCT02094937|450026279|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
124896210|NCT03398356|449244677|FG001|Before Treatment|drug intolerance|1|||
124896211|NCT03398356|449244678|FG002|Before Treatment|drug intolerance|0|||
124896212|NCT03398356|449244676|FG000|Before Treatment|Withdrawal by Subject|0|||
124896213|NCT03398356|449244677|FG001|Before Treatment|Withdrawal by Subject|5|||
124896214|NCT03398356|449244678|FG002|Before Treatment|Withdrawal by Subject|0|||
124896215|NCT03398356|449244676|FG000|Before Treatment|Physician Decision|0|||
124896216|NCT03398356|449244677|FG001|Before Treatment|Physician Decision|0|||
124896217|NCT03398356|449244678|FG002|Before Treatment|Physician Decision|11|||
125110015|NCT02094937|450026280|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
125110016|NCT02094937|450026277|FG000|8 Weeks in Period 1|Protocol Violation|2|||
125110017|NCT02094937|450026278|FG001|8 Weeks in Period 1|Protocol Violation|0|||
125110018|NCT02094937|450026279|FG002|8 Weeks in Period 1|Protocol Violation|0|||
125110019|NCT02094937|450026280|FG003|8 Weeks in Period 1|Protocol Violation|0|||
125110020|NCT02094937|450026277|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
125110021|NCT02094937|450026278|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
125110022|NCT02094937|450026279|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
125110023|NCT02094937|450026280|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
125110024|NCT02094937|450026277|FG000|8 Weeks in Period 1|Physician Decision|1|||
125110025|NCT02094937|450026278|FG001|8 Weeks in Period 1|Physician Decision|0|||
125110026|NCT02094937|450026279|FG002|8 Weeks in Period 1|Physician Decision|0|||
125110027|NCT02094937|450026280|FG003|8 Weeks in Period 1|Physician Decision|0|||
125110028|NCT02094937|450026277|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
125110029|NCT02094937|450026278|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
124896218|NCT03398356|449244676|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
124896219|NCT03398356|449244677|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
125110030|NCT02094937|450026279|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
125110031|NCT02094937|450026280|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
125110032|NCT02094937|450026277|FG000|12 Weeks in Period 2|Adverse Event|0|||
124896220|NCT03398356|449244678|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
124896221|NCT01648283|449244680|FG000|Overall Study|Withdrawal by Subject|14|||
125110033|NCT02094937|450026278|FG001|12 Weeks in Period 2|Adverse Event|2|||
125110034|NCT02094937|450026279|FG002|12 Weeks in Period 2|Adverse Event|4|||
125110035|NCT02094937|450026280|FG003|12 Weeks in Period 2|Adverse Event|1|||
125110036|NCT02094937|450026277|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
125110037|NCT02094937|450026278|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
125110038|NCT02094937|450026279|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
124896222|NCT00530777|449244686|FG000|Overall Study|Lost to Follow-up|0|||
124896223|NCT00530777|449244687|FG001|Overall Study|Lost to Follow-up|1|||
124896224|NCT00530777|449244686|FG000|Overall Study|Death|1|||
124896225|NCT00530777|449244687|FG001|Overall Study|Death|2|||
124896226|NCT00530777|449244686|FG000|Overall Study|Physician Decision|1|||
124896227|NCT00530777|449244687|FG001|Overall Study|Physician Decision|0|||
124896228|NCT00530777|449244686|FG000|Overall Study|Withdrawal by Subject|0|||
124896229|NCT00530777|449244687|FG001|Overall Study|Withdrawal by Subject|1|||
124896230|NCT00530777|449244686|FG000|Overall Study|Unable to adhere to visit schedule|5|||
124896231|NCT00530777|449244687|FG001|Overall Study|Unable to adhere to visit schedule|1|||
124896232|NCT03382821|449244694|FG000|Overall Study|Did not receive allocated intervention.|0|||
124896233|NCT03382821|449244695|FG001|Overall Study|Did not receive allocated intervention.|3|||
124896234|NCT00282438|449244697|FG000|Overall Study|Lack of Efficacy|1|||
124896235|NCT00282438|449244698|FG001|Overall Study|Lack of Efficacy|0|||
124896236|NCT00282438|449244697|FG000|Overall Study|Death|0|||
124896237|NCT00282438|449244698|FG001|Overall Study|Death|1|||
124896238|NCT03178201|449244706|FG000|Overall Study|Off study|5|||
124896239|NCT02095158|449244707|FG000|Overall Study|Adverse Event|14|||
124896240|NCT02095158|449244707|FG000|Overall Study|Lack of Efficacy|3|||
124896241|NCT02095158|449244707|FG000|Overall Study|Pregnancy|1|||
124896242|NCT02095158|449244707|FG000|Overall Study|Lost to Follow-up|20|||
124896243|NCT02095158|449244707|FG000|Overall Study|Personal Reasons|35|||
124896244|NCT02095158|449244707|FG000|Overall Study|Protocol Violation|1|||
124896245|NCT02095158|449244707|FG000|Overall Study|Other Miscellaneous Reasons|1|||
124896246|NCT01008748|449244708|FG000|Overall Study|Lost to Follow-up|80|||
124896247|NCT01008748|449244708|FG000|Overall Study|Other|1|||
124896248|NCT02775435|449244709|FG000|Overall Study|Adverse Event|32|||
124896249|NCT02775435|449244710|FG001|Overall Study|Adverse Event|27|||
124896250|NCT02775435|449244709|FG000|Overall Study|Lost to Follow-up|2|||
124896251|NCT02775435|449244710|FG001|Overall Study|Lost to Follow-up|2|||
125018848|NCT01929408|449692956|FG000|Overall Study|received HCT as initial treatment|8|||
125018849|NCT02109484|449692957|FG000|Overall Study|Lost to Follow-up|0|||
125018850|NCT02109484|449692958|FG001|Overall Study|Lost to Follow-up|0|||
125018851|NCT02109484|449692959|FG002|Overall Study|Lost to Follow-up|0|||
125018852|NCT02109484|449692960|FG003|Overall Study|Lost to Follow-up|1|||
125018853|NCT02109484|449692961|FG004|Overall Study|Lost to Follow-up|1|||
125018854|NCT02109484|449692962|FG005|Overall Study|Lost to Follow-up|0|||
125018855|NCT02109484|449692963|FG006|Overall Study|Lost to Follow-up|1|||
125018856|NCT02109484|449692964|FG007|Overall Study|Lost to Follow-up|0|||
125018857|NCT02109484|449692957|FG000|Overall Study|Withdrawal by Subject|0|||
125018858|NCT02109484|449692958|FG001|Overall Study|Withdrawal by Subject|0|||
125018859|NCT02109484|449692959|FG002|Overall Study|Withdrawal by Subject|0|||
125018860|NCT02109484|449692960|FG003|Overall Study|Withdrawal by Subject|0|||
125018861|NCT02109484|449692961|FG004|Overall Study|Withdrawal by Subject|1|||
125018862|NCT02109484|449692962|FG005|Overall Study|Withdrawal by Subject|1|||
125018863|NCT02109484|449692963|FG006|Overall Study|Withdrawal by Subject|1|||
125018864|NCT02109484|449692964|FG007|Overall Study|Withdrawal by Subject|0|||
125018865|NCT02109484|449692957|FG000|Overall Study|Physician Decision|0|||
125018866|NCT02109484|449692958|FG001|Overall Study|Physician Decision|0|||
125018867|NCT02109484|449692959|FG002|Overall Study|Physician Decision|0|||
125018868|NCT02109484|449692960|FG003|Overall Study|Physician Decision|0|||
125018869|NCT02109484|449692961|FG004|Overall Study|Physician Decision|2|||
125018870|NCT02109484|449692962|FG005|Overall Study|Physician Decision|0|||
125018871|NCT02109484|449692963|FG006|Overall Study|Physician Decision|0|||
125018872|NCT02109484|449692964|FG007|Overall Study|Physician Decision|0|||
125018873|NCT02109484|449692957|FG000|Overall Study|Death|0|||
125018874|NCT02109484|449692958|FG001|Overall Study|Death|0|||
125018875|NCT02109484|449692959|FG002|Overall Study|Death|0|||
125018876|NCT02109484|449692960|FG003|Overall Study|Death|0|||
125018877|NCT02109484|449692961|FG004|Overall Study|Death|0|||
125018878|NCT02109484|449692962|FG005|Overall Study|Death|0|||
125018879|NCT02109484|449692963|FG006|Overall Study|Death|0|||
125018880|NCT02109484|449692964|FG007|Overall Study|Death|2|||
125018881|NCT02109484|449692957|FG000|Overall Study|Moved away from study area|0|||
125018882|NCT02109484|449692958|FG001|Overall Study|Moved away from study area|0|||
125018883|NCT02109484|449692959|FG002|Overall Study|Moved away from study area|0|||
125018884|NCT02109484|449692960|FG003|Overall Study|Moved away from study area|0|||
124896252|NCT02775435|449244709|FG000|Overall Study|Sponsor decision|44|||
124896253|NCT02775435|449244710|FG001|Overall Study|Sponsor decision|19|||
125018885|NCT02109484|449692961|FG004|Overall Study|Moved away from study area|0|||
125018886|NCT02109484|449692962|FG005|Overall Study|Moved away from study area|0|||
125018887|NCT02109484|449692963|FG006|Overall Study|Moved away from study area|1|||
125018888|NCT02109484|449692964|FG007|Overall Study|Moved away from study area|1|||
125018889|NCT00293579|449692969|FG000|Overall Study|Withdrawal by Subject|1|||
125110039|NCT02094937|450026280|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
124896254|NCT02775435|449244709|FG000|Overall Study|Withdrawal by Subject|4|||
124896255|NCT02775435|449244710|FG001|Overall Study|Withdrawal by Subject|9|||
124896256|NCT02775435|449244709|FG000|Overall Study|Death|196|||
125018890|NCT03127384|449692970|FG000|Overall Study|Lost to Follow-up|4|||
124896257|NCT02775435|449244710|FG001|Overall Study|Death|224|||
124896258|NCT02282527|449244711|FG000|Overall Study|Lost to Follow-up|0|||
124896259|NCT02282527|449244712|FG001|Overall Study|Lost to Follow-up|1|||
124896260|NCT02282527|449244711|FG000|Overall Study|Lack of home health aid|1|||
124896261|NCT02282527|449244712|FG001|Overall Study|Lack of home health aid|0|||
124896262|NCT00941031|449244713|FG000|Induction Period|Lack of Efficacy|2|||
124896263|NCT00941031|449244714|FG001|Induction Period|Lack of Efficacy|1|||
124896264|NCT00941031|449244715|FG002|Induction Period|Lack of Efficacy|0|||
124896265|NCT00941031|449244716|FG003|Induction Period|Lack of Efficacy|5|||
124896266|NCT00941031|449244717|FG004|Induction Period|Lack of Efficacy|0|||
124896267|NCT00941031|449244718|FG005|Induction Period|Lack of Efficacy|0|||
124896268|NCT00941031|449244719|FG006|Induction Period|Lack of Efficacy|0|||
124896269|NCT00941031|449244713|FG000|Induction Period|Withdrawal by Subject|1|||
124896270|NCT00941031|449244714|FG001|Induction Period|Withdrawal by Subject|2|||
124896271|NCT00941031|449244715|FG002|Induction Period|Withdrawal by Subject|2|||
124896272|NCT00941031|449244716|FG003|Induction Period|Withdrawal by Subject|2|||
124896273|NCT00941031|449244717|FG004|Induction Period|Withdrawal by Subject|0|||
124896274|NCT00941031|449244718|FG005|Induction Period|Withdrawal by Subject|0|||
124896275|NCT00941031|449244719|FG006|Induction Period|Withdrawal by Subject|0|||
124896276|NCT00941031|449244713|FG000|Induction Period|Adminstative Problems|1|||
124896277|NCT00941031|449244714|FG001|Induction Period|Adminstative Problems|1|||
124896278|NCT00941031|449244715|FG002|Induction Period|Adminstative Problems|1|||
124896279|NCT00941031|449244716|FG003|Induction Period|Adminstative Problems|0|||
124896280|NCT00941031|449244717|FG004|Induction Period|Adminstative Problems|0|||
124896281|NCT00941031|449244718|FG005|Induction Period|Adminstative Problems|0|||
124896282|NCT00941031|449244719|FG006|Induction Period|Adminstative Problems|0|||
124896283|NCT00941031|449244713|FG000|Induction Period|Adverse Event|1|||
124896284|NCT00941031|449244714|FG001|Induction Period|Adverse Event|0|||
124896285|NCT00941031|449244715|FG002|Induction Period|Adverse Event|3|||
124896286|NCT00941031|449244716|FG003|Induction Period|Adverse Event|2|||
124896287|NCT00941031|449244717|FG004|Induction Period|Adverse Event|0|||
124896288|NCT00941031|449244718|FG005|Induction Period|Adverse Event|0|||
124896289|NCT00941031|449244719|FG006|Induction Period|Adverse Event|0|||
124896290|NCT00941031|449244713|FG000|Maintenance Period|Withdrawal by Subject|0|||
124896291|NCT00941031|449244714|FG001|Maintenance Period|Withdrawal by Subject|0|||
124896292|NCT00941031|449244715|FG002|Maintenance Period|Withdrawal by Subject|0|||
124896293|NCT00941031|449244716|FG003|Maintenance Period|Withdrawal by Subject|0|||
124896294|NCT00941031|449244717|FG004|Maintenance Period|Withdrawal by Subject|6|||
124896295|NCT00941031|449244718|FG005|Maintenance Period|Withdrawal by Subject|2|||
124896296|NCT00941031|449244719|FG006|Maintenance Period|Withdrawal by Subject|13|||
124896297|NCT00941031|449244713|FG000|Maintenance Period|Administrative Problems|0|||
124896298|NCT00941031|449244714|FG001|Maintenance Period|Administrative Problems|0|||
124896299|NCT00941031|449244715|FG002|Maintenance Period|Administrative Problems|0|||
124896300|NCT00941031|449244716|FG003|Maintenance Period|Administrative Problems|0|||
124896301|NCT00941031|449244717|FG004|Maintenance Period|Administrative Problems|1|||
124896302|NCT00941031|449244718|FG005|Maintenance Period|Administrative Problems|0|||
124896303|NCT00941031|449244719|FG006|Maintenance Period|Administrative Problems|1|||
124896304|NCT00941031|449244713|FG000|Maintenance Period|Protocol Violation|0|||
124896305|NCT00941031|449244714|FG001|Maintenance Period|Protocol Violation|0|||
125018891|NCT03127384|449692970|FG000|Overall Study|Subject request|2|||
125018892|NCT01026831|449692977|FG000|Overall Study|Adverse Event|4|||
125018893|NCT01026831|449692978|FG001|Overall Study|Adverse Event|3|||
125018894|NCT01026831|449692977|FG000|Overall Study|Lost to Follow-up|2|||
125018895|NCT01026831|449692978|FG001|Overall Study|Lost to Follow-up|0|||
125018896|NCT01026831|449692977|FG000|Overall Study|Physician Decision|1|||
124896306|NCT00941031|449244715|FG002|Maintenance Period|Protocol Violation|0|||
124896307|NCT00941031|449244716|FG003|Maintenance Period|Protocol Violation|0|||
124896308|NCT00941031|449244717|FG004|Maintenance Period|Protocol Violation|0|||
124896309|NCT00941031|449244718|FG005|Maintenance Period|Protocol Violation|0|||
124896310|NCT00941031|449244719|FG006|Maintenance Period|Protocol Violation|1|||
124896311|NCT00941031|449244713|FG000|Maintenance Period|Adverse Event|0|||
124896312|NCT00941031|449244714|FG001|Maintenance Period|Adverse Event|0|||
124896313|NCT00941031|449244715|FG002|Maintenance Period|Adverse Event|0|||
124896314|NCT00941031|449244716|FG003|Maintenance Period|Adverse Event|0|||
124896315|NCT00941031|449244717|FG004|Maintenance Period|Adverse Event|0|||
124896316|NCT00941031|449244718|FG005|Maintenance Period|Adverse Event|2|||
124896317|NCT00941031|449244719|FG006|Maintenance Period|Adverse Event|8|||
124896318|NCT00941031|449244713|FG000|Maintenance Period|Lost to Follow-up|0|||
125018897|NCT01026831|449692978|FG001|Overall Study|Physician Decision|1|||
125110040|NCT02094937|450026277|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
125110041|NCT02094937|450026278|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
125110042|NCT02094937|450026279|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
125110043|NCT02094937|450026280|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
125110044|NCT02094937|450026277|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
125110045|NCT02094937|450026278|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
125110046|NCT02094937|450026279|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
125110047|NCT02094937|450026280|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
125110048|NCT02094937|450026277|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
125110049|NCT02094937|450026278|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
125110050|NCT02094937|450026279|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
125110051|NCT02094937|450026280|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
125110052|NCT01133392|450026281|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
125110053|NCT01133392|450026282|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
125110054|NCT01133392|450026281|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
125110055|NCT01133392|450026282|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
125110056|NCT05788237|450026283|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
125110057|NCT05788237|450026284|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
125110058|NCT05788237|450026285|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
125110059|NCT05788237|450026286|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
125110060|NCT05788237|450026283|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
125110061|NCT05788237|450026284|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
125110062|NCT05788237|450026285|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
125110063|NCT05788237|450026286|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
125110064|NCT05788237|450026283|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
125110065|NCT05788237|450026284|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
125110066|NCT05788237|450026285|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
125110067|NCT05788237|450026286|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
125110068|NCT05788237|450026283|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
125110069|NCT05788237|450026284|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
125110070|NCT05788237|450026285|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
125110071|NCT05788237|450026286|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
125110072|NCT05788237|450026283|FG000|SSA (Approximately 2 Months)|Death|0|||
125110073|NCT05788237|450026284|FG001|SSA (Approximately 2 Months)|Death|1|||
125110074|NCT05788237|450026285|FG002|SSA (Approximately 2 Months)|Death|0|||
125110075|NCT05788237|450026286|FG003|SSA (Approximately 2 Months)|Death|0|||
125110076|NCT05788237|450026283|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
125110077|NCT05788237|450026284|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
125110078|NCT05788237|450026285|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
125110079|NCT05788237|450026286|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
125110080|NCT05788237|450026283|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
125110081|NCT05788237|450026284|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
125110082|NCT05788237|450026285|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
125110083|NCT05788237|450026286|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
125110084|NCT05788237|450026283|FG000|SSB (Approximately 1 Month)|Other|0|||
125110085|NCT05788237|450026284|FG001|SSB (Approximately 1 Month)|Other|0|||
125110086|NCT05788237|450026285|FG002|SSB (Approximately 1 Month)|Other|0|||
125110087|NCT05788237|450026286|FG003|SSB (Approximately 1 Month)|Other|1|||
125110088|NCT00207714|450027467|FG000|Overall Study|Adverse Event|6|||
125110089|NCT00207714|450027468|FG001|Overall Study|Adverse Event|2|||
125110090|NCT00207714|450027469|FG002|Overall Study|Adverse Event|4|||
125110091|NCT00207714|450027470|FG003|Overall Study|Adverse Event|3|||
125110092|NCT00207714|450027471|FG004|Overall Study|Adverse Event|1|||
125110093|NCT00207714|450027467|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
124896319|NCT00941031|449244714|FG001|Maintenance Period|Lost to Follow-up|0|||
125110094|NCT00207714|450027468|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
125110095|NCT00207714|450027469|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
125110096|NCT00207714|450027470|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
125110097|NCT00207714|450027471|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
125110098|NCT00207714|450027467|FG000|Overall Study|Other|3|||
124896320|NCT00941031|449244715|FG002|Maintenance Period|Lost to Follow-up|0|||
125110099|NCT00207714|450027468|FG001|Overall Study|Other|2|||
125110100|NCT00207714|450027469|FG002|Overall Study|Other|5|||
125110101|NCT00207714|450027470|FG003|Overall Study|Other|1|||
125110102|NCT00207714|450027471|FG004|Overall Study|Other|0|||
125110103|NCT03627195|450027472|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
124896321|NCT00941031|449244716|FG003|Maintenance Period|Lost to Follow-up|0|||
124896322|NCT00941031|449244717|FG004|Maintenance Period|Lost to Follow-up|2|||
124896323|NCT00941031|449244718|FG005|Maintenance Period|Lost to Follow-up|2|||
124896324|NCT00941031|449244719|FG006|Maintenance Period|Lost to Follow-up|7|||
124896325|NCT00941031|449244713|FG000|Maintenance Period|Lack of Efficacy|0|||
124896326|NCT00941031|449244714|FG001|Maintenance Period|Lack of Efficacy|0|||
124896327|NCT00941031|449244715|FG002|Maintenance Period|Lack of Efficacy|0|||
124896328|NCT00941031|449244716|FG003|Maintenance Period|Lack of Efficacy|0|||
124896329|NCT00941031|449244717|FG004|Maintenance Period|Lack of Efficacy|0|||
124896330|NCT00941031|449244718|FG005|Maintenance Period|Lack of Efficacy|0|||
124896331|NCT00941031|449244719|FG006|Maintenance Period|Lack of Efficacy|13|||
124896332|NCT03124108|449244721|FG000|Overall Study|Adverse Event|0|||
124896333|NCT03124108|449244722|FG001|Overall Study|Adverse Event|1|||
124896334|NCT03124108|449244723|FG002|Overall Study|Adverse Event|0|||
124896335|NCT00631917|449244724|FG000|Overall Study|Adverse Event|34|||
124896336|NCT00631917|449244725|FG001|Overall Study|Adverse Event|45|||
124896337|NCT00631917|449244724|FG000|Overall Study|Abnormal laboratory value(s)|2|||
124896338|NCT00631917|449244725|FG001|Overall Study|Abnormal laboratory value(s)|1|||
124896339|NCT00631917|449244724|FG000|Overall Study|Abnormal test procedure result(s)|3|||
124896340|NCT00631917|449244725|FG001|Overall Study|Abnormal test procedure result(s)|2|||
124896341|NCT00631917|449244724|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
124896342|NCT00631917|449244725|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
124896343|NCT00631917|449244724|FG000|Overall Study|No longer required study drug|0|||
124896344|NCT00631917|449244725|FG001|Overall Study|No longer required study drug|1|||
124896345|NCT00631917|449244724|FG000|Overall Study|Protocol deviation|6|||
124896346|NCT00631917|449244725|FG001|Overall Study|Protocol deviation|5|||
124896347|NCT00631917|449244724|FG000|Overall Study|Subject withdrew consent|25|||
124896348|NCT00631917|449244725|FG001|Overall Study|Subject withdrew consent|33|||
124896349|NCT00631917|449244724|FG000|Overall Study|Lost to Follow-up|7|||
124896350|NCT00631917|449244725|FG001|Overall Study|Lost to Follow-up|7|||
124896351|NCT00631917|449244724|FG000|Overall Study|Administrative problems|2|||
124896352|NCT00631917|449244725|FG001|Overall Study|Administrative problems|0|||
124896353|NCT00631917|449244724|FG000|Overall Study|Death|1|||
124896354|NCT00631917|449244725|FG001|Overall Study|Death|0|||
124896355|NCT05650333|449244731|FG000|Treatment Period (7 Days)|Adverse Event|1|||
124896356|NCT02403323|449244734|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
124896357|NCT02403323|449244735|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
124896358|NCT02403323|449244736|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
124896359|NCT02403323|449244734|FG000|Part 1: Open Label Extension Period|Death|3|||
124896360|NCT02403323|449244735|FG001|Part 1: Open Label Extension Period|Death|0|||
124896361|NCT02403323|449244736|FG002|Part 1: Open Label Extension Period|Death|0|||
124896362|NCT02403323|449244734|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
124896363|NCT02403323|449244735|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
124896364|NCT02403323|449244736|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
124896365|NCT02403323|449244734|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
124896366|NCT02403323|449244735|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
124896367|NCT02403323|449244736|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
124896368|NCT02403323|449244734|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
124896369|NCT02403323|449244735|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
124896370|NCT02403323|449244736|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
124896371|NCT02403323|449244734|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
124896372|NCT02403323|449244735|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
124896373|NCT02403323|449244736|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
124896374|NCT02403323|449244734|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
125018898|NCT01026831|449692977|FG000|Overall Study|Protocol Violation|0|||
125018899|NCT01026831|449692978|FG001|Overall Study|Protocol Violation|2|||
125018900|NCT01026831|449692977|FG000|Overall Study|Withdrawal by Subject|7|||
125018901|NCT01026831|449692978|FG001|Overall Study|Withdrawal by Subject|5|||
125018902|NCT02500121|449692982|FG000|Overall Study|Lost to Follow-up|0|||
125018903|NCT02500121|449692983|FG001|Overall Study|Lost to Follow-up|1|||
125018904|NCT02500121|449692982|FG000|Overall Study|Withdrawal by Subject|1|||
125018905|NCT02500121|449692983|FG001|Overall Study|Withdrawal by Subject|1|||
125018906|NCT02500121|449692982|FG000|Overall Study|Death|26|||
125018907|NCT02500121|449692983|FG001|Overall Study|Death|24|||
125018908|NCT00498173|449692985|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
125018909|NCT00498173|449692986|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
124896375|NCT02403323|449244735|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
124896376|NCT02403323|449244736|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
124896377|NCT02403323|449244734|FG000|Part 1: Open Label Extension Period|Other|1|||
124896378|NCT02403323|449244735|FG001|Part 1: Open Label Extension Period|Other|0|||
125110104|NCT03627195|450027473|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
125110105|NCT03627195|450027474|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
125110106|NCT03627195|450027475|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
125110107|NCT03627195|450027476|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
125110108|NCT03627195|450027477|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
125110109|NCT00833547|450027482|FG000|Overall Study|Withdrawal by Subject|2|||
125110110|NCT00833547|450027483|FG001|Overall Study|Withdrawal by Subject|2|||
125110111|NCT00686790|450027486|FG000|Overall Study|Adverse Event|2|||
125110112|NCT00686790|450027486|FG000|Overall Study|Withdrawal by Subject|1|||
125110113|NCT00686790|450027486|FG000|Overall Study|Death|1|||
125110114|NCT00686790|450027486|FG000|Overall Study|Lost to Follow-up|12|||
125110115|NCT02082912|450027490|FG000|Overall Study|Physician Decision|0|||
125110116|NCT02082912|450027491|FG001|Overall Study|Physician Decision|1|||
125110117|NCT00697112|450027508|FG000|Overall Study|Adverse Event|8|||
125110118|NCT00697112|450027508|FG000|Overall Study|Lost to Follow-up|1|||
125110119|NCT00697112|450027508|FG000|Overall Study|Did not meet inclusion criteria|1|||
125110120|NCT00736333|450027509|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
125110121|NCT00736333|450027509|FG000|Overall Study|Data Missing|2|||
125110122|NCT00736333|450027509|FG000|Overall Study|Tumor Progression|75|||
125110123|NCT00736333|450027509|FG000|Overall Study|Toxicity|6|||
125110124|NCT00736333|450027509|FG000|Overall Study|Withdrawal by Subject|10|||
125110125|NCT00736333|450027509|FG000|Overall Study|Death|7|||
125110126|NCT00736333|450027509|FG000|Overall Study|Other|4|||
125110127|NCT04126733|450027510|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
125110128|NCT04126733|450027510|FG000|Treatment Period|Adverse Event|8|||
124896379|NCT02403323|449244736|FG002|Part 1: Open Label Extension Period|Other|0|||
124896380|NCT02403323|449244734|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
124896381|NCT02403323|449244735|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
124896382|NCT02403323|449244736|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
124896383|NCT02403323|449244734|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
124896384|NCT02403323|449244735|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
124896385|NCT02403323|449244736|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
124896386|NCT02403323|449244734|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
124896387|NCT02403323|449244735|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
124896388|NCT02403323|449244736|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
125110129|NCT04126733|450027510|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
125110130|NCT04126733|450027510|FG000|Treatment Period|Physician Decision|5|||
125110131|NCT04126733|450027510|FG000|Treatment Period|Death|1|||
125110132|NCT04126733|450027510|FG000|Treatment Period|Other Reasons|2|||
125110133|NCT04126733|450027510|FG000|Active Follow-up Period|Death|13|||
125110134|NCT04126733|450027510|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
125110135|NCT04126733|450027510|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
125110136|NCT04126733|450027510|FG000|Active Follow-up Period|Other Reasons|1|||
125110137|NCT04126733|450027510|FG000|Long-term Follow-up Period|Death|22|||
125110138|NCT04126733|450027510|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
125110139|NCT04126733|450027510|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
124896389|NCT02403323|449244734|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
124896390|NCT02403323|449244735|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
124896391|NCT02403323|449244736|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
124896392|NCT02403323|449244734|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
124896393|NCT02403323|449244735|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
124896394|NCT02403323|449244736|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
124896395|NCT02403323|449244734|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
124896396|NCT02403323|449244735|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
124896397|NCT02403323|449244736|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
124896398|NCT02403323|449244734|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
125110140|NCT02629133|450027512|FG000|Overall Study|Lost to Follow-up|3|||
124896399|NCT02403323|449244735|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
124896400|NCT02403323|449244736|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
125110141|NCT02629133|450027513|FG001|Overall Study|Lost to Follow-up|1|||
125110142|NCT02629133|450027512|FG000|Overall Study|Withdrawal by Subject|1|||
125110143|NCT02629133|450027513|FG001|Overall Study|Withdrawal by Subject|1|||
125110144|NCT03216954|450027514|FG000|Overall Study|Adverse Event|0|||
124896401|NCT02403323|449244734|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
125110145|NCT03216954|450027515|FG001|Overall Study|Adverse Event|0|||
125110146|NCT03216954|450027516|FG002|Overall Study|Adverse Event|1|||
125110147|NCT03216954|450027517|FG003|Overall Study|Adverse Event|0|||
124896402|NCT02403323|449244735|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
124896403|NCT02403323|449244736|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
124896404|NCT02403323|449244734|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
124896405|NCT02403323|449244735|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
124896406|NCT02403323|449244736|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
124896407|NCT02403323|449244734|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
124896408|NCT02403323|449244735|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
124896409|NCT02403323|449244736|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
124896410|NCT03885596|449244737|FG000|Overall Study|Withdrawal by Subject|2|||
124896411|NCT03885596|449244738|FG001|Overall Study|Withdrawal by Subject|1|||
124896412|NCT03885596|449244739|FG002|Overall Study|Withdrawal by Subject|0|||
124896413|NCT03885596|449244740|FG003|Overall Study|Withdrawal by Subject|0|||
124896414|NCT03852433|449244741|FG000|Overall Study|Withdrawal of consent|5|||
124896415|NCT03852433|449244742|FG001|Overall Study|Withdrawal of consent|8|||
124896416|NCT03852433|449244743|FG002|Overall Study|Withdrawal of consent|1|||
124896417|NCT03852433|449244744|FG003|Overall Study|Withdrawal of consent|1|||
124896418|NCT03852433|449244741|FG000|Overall Study|Adverse Event|1|||
124896419|NCT03852433|449244742|FG001|Overall Study|Adverse Event|1|||
124896420|NCT03852433|449244743|FG002|Overall Study|Adverse Event|1|||
124896421|NCT03852433|449244744|FG003|Overall Study|Adverse Event|1|||
124896422|NCT03852433|449244741|FG000|Overall Study|Lost to Follow-up|0|||
124896423|NCT03852433|449244742|FG001|Overall Study|Lost to Follow-up|1|||
124896424|NCT03852433|449244743|FG002|Overall Study|Lost to Follow-up|0|||
124896425|NCT03852433|449244744|FG003|Overall Study|Lost to Follow-up|1|||
124896426|NCT03852433|449244741|FG000|Overall Study|Pregnancy|0|||
124896427|NCT03852433|449244742|FG001|Overall Study|Pregnancy|1|||
125110148|NCT03216954|450027518|FG004|Overall Study|Adverse Event|1|||
125110149|NCT03216954|450027514|FG000|Overall Study|Withdrawal by Subject|2|||
125110150|NCT03216954|450027515|FG001|Overall Study|Withdrawal by Subject|0|||
125110151|NCT03216954|450027516|FG002|Overall Study|Withdrawal by Subject|0|||
124896428|NCT03852433|449244743|FG002|Overall Study|Pregnancy|1|||
124896429|NCT03852433|449244744|FG003|Overall Study|Pregnancy|0|||
124896430|NCT03852433|449244741|FG000|Overall Study|Protocol Violation|0|||
124896431|NCT03852433|449244742|FG001|Overall Study|Protocol Violation|0|||
124896432|NCT03852433|449244743|FG002|Overall Study|Protocol Violation|1|||
124896433|NCT03852433|449244744|FG003|Overall Study|Protocol Violation|1|||
124896434|NCT03852433|449244741|FG000|Overall Study|Death|0|||
124896435|NCT03852433|449244742|FG001|Overall Study|Death|0|||
124896436|NCT03852433|449244743|FG002|Overall Study|Death|1|||
124896437|NCT03852433|449244744|FG003|Overall Study|Death|0|||
124896438|NCT03852433|449244741|FG000|Overall Study|Lack of Efficacy|0|||
124896439|NCT03852433|449244742|FG001|Overall Study|Lack of Efficacy|1|||
124896440|NCT03852433|449244743|FG002|Overall Study|Lack of Efficacy|0|||
124896441|NCT03852433|449244744|FG003|Overall Study|Lack of Efficacy|0|||
124896442|NCT03852433|449244741|FG000|Overall Study|Non-compliance with study drug|0|||
124896443|NCT03852433|449244742|FG001|Overall Study|Non-compliance with study drug|0|||
125110152|NCT03216954|450027517|FG003|Overall Study|Withdrawal by Subject|0|||
125110153|NCT03216954|450027518|FG004|Overall Study|Withdrawal by Subject|0|||
125110154|NCT03216954|450027514|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
125110155|NCT03216954|450027515|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
124896444|NCT03852433|449244743|FG002|Overall Study|Non-compliance with study drug|0|||
124896445|NCT03852433|449244744|FG003|Overall Study|Non-compliance with study drug|1|||
124896446|NCT03852433|449244741|FG000|Overall Study|Physician Decision|1|||
124896447|NCT03852433|449244742|FG001|Overall Study|Physician Decision|0|||
124896448|NCT03852433|449244743|FG002|Overall Study|Physician Decision|0|||
124896449|NCT03852433|449244744|FG003|Overall Study|Physician Decision|0|||
124896450|NCT03852433|449244741|FG000|Overall Study|Randomized but never treated|1|||
125110156|NCT03216954|450027516|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
125110157|NCT03216954|450027517|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
125110158|NCT03216954|450027518|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
124896451|NCT03852433|449244742|FG001|Overall Study|Randomized but never treated|0|||
124896452|NCT03852433|449244743|FG002|Overall Study|Randomized but never treated|0|||
124896453|NCT03852433|449244744|FG003|Overall Study|Randomized but never treated|0|||
124896454|NCT01076335|449244745|FG000|Overall Study|Withdrawal by Subject|3|||
124896455|NCT01076335|449244745|FG000|Overall Study|Withdrawal without treatment|1|||
124896456|NCT02616263|449244746|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
125110159|NCT02598193|450027519|FG000|Overall Study|Adverse Event|13|||
125110160|NCT02598193|450027519|FG000|Overall Study|Withdrawal by Subject|1|||
125110161|NCT02598193|450027519|FG000|Overall Study|Listed in active lung transplant list|1|||
124896457|NCT02616263|449244747|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
124896458|NCT02616263|449244746|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
124896459|NCT02616263|449244747|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
124896460|NCT02616263|449244746|FG000|6 Month to 1.5 Year|Death|1|||
124896461|NCT02616263|449244747|FG001|6 Month to 1.5 Year|Death|0|||
124896462|NCT02616263|449244746|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
124896463|NCT02616263|449244747|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
124896464|NCT02616263|449244746|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
124896465|NCT02616263|449244747|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
124896466|NCT02616263|449244746|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
124896467|NCT02616263|449244747|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
124896468|NCT03686384|449244748|FG000|Overall Study|Lack of Efficacy|4|||
124896469|NCT03686384|449244749|FG001|Overall Study|Lack of Efficacy|13|||
124896470|NCT03686384|449244748|FG000|Overall Study|Lost to Follow-up|3|||
124896471|NCT03686384|449244749|FG001|Overall Study|Lost to Follow-up|0|||
124896472|NCT03686384|449244748|FG000|Overall Study|Physician Decision|0|||
124896473|NCT03686384|449244749|FG001|Overall Study|Physician Decision|1|||
124896474|NCT03686384|449244748|FG000|Overall Study|Took prohibited medication|0|||
124896475|NCT03686384|449244749|FG001|Overall Study|Took prohibited medication|1|||
124896476|NCT02820051|449244752|FG000|Overall Study|Lost to Follow-up|7|||
124896477|NCT02820051|449244753|FG001|Overall Study|Lost to Follow-up|4|||
124896478|NCT00614744|449244759|FG000|Overall Study|Lost to Follow-up|5|||
124896479|NCT00614744|449244760|FG001|Overall Study|Lost to Follow-up|4|||
124896480|NCT00614744|449244759|FG000|Overall Study|Incomplete for Behavior Issues|0|||
124896481|NCT00614744|449244760|FG001|Overall Study|Incomplete for Behavior Issues|2|||
124896482|NCT00768066|449244761|FG000|Overall Study|Did not receive study product injection.|3|||
124896483|NCT00768066|449244762|FG001|Overall Study|Did not receive study product injection.|3|||
124896484|NCT00768066|449244763|FG002|Overall Study|Did not receive study product injection.|0|||
124896485|NCT04831775|449244764|FG000|Overall Study|Lost to Follow-up|11|||
124896486|NCT04831775|449244765|FG001|Overall Study|Lost to Follow-up|13|||
124896487|NCT01737268|449244768|FG000|Overall Study|Adverse Event|6|||
124896488|NCT01737268|449244768|FG000|Overall Study|Worsening of Target Disease|2|||
124896489|NCT01737268|449244768|FG000|Overall Study|In consideration of the patient's safety|1|||
124896490|NCT01458275|449244769|FG000|Overall Study|Adverse Event|3|||
124896491|NCT01458275|449244770|FG001|Overall Study|Adverse Event|4|||
124896492|NCT01458275|449244771|FG002|Overall Study|Adverse Event|1|||
124896493|NCT01458275|449244769|FG000|Overall Study|Lost to Follow-up|3|||
124896494|NCT01458275|449244770|FG001|Overall Study|Lost to Follow-up|2|||
124896495|NCT01458275|449244771|FG002|Overall Study|Lost to Follow-up|5|||
124896496|NCT01458275|449244769|FG000|Overall Study|Protocol Violation|5|||
124896497|NCT01458275|449244770|FG001|Overall Study|Protocol Violation|5|||
124896498|NCT01458275|449244771|FG002|Overall Study|Protocol Violation|2|||
124896499|NCT01458275|449244769|FG000|Overall Study|Withdrawal by Subject|3|||
124896500|NCT01458275|449244770|FG001|Overall Study|Withdrawal by Subject|2|||
124896501|NCT01458275|449244771|FG002|Overall Study|Withdrawal by Subject|1|||
124896502|NCT03697460|449244772|FG000|Overall Study|Withdrawal by Subject|3|||
124896503|NCT03499600|449244779|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
124896504|NCT03499600|449244780|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
124896505|NCT00445692|449244781|FG000|Overall Study|Adverse Event|11|||
124896506|NCT00445692|449244781|FG000|Overall Study|Lack of Efficacy|5|||
124896507|NCT03425539|449244782|FG000|Overall Study|Randomized but not treated|0|||
124896508|NCT03425539|449244783|FG001|Overall Study|Randomized but not treated|1|||
124896509|NCT03425539|449244782|FG000|Overall Study|Adverse Event|2|||
124896510|NCT03425539|449244783|FG001|Overall Study|Adverse Event|2|||
124896511|NCT03425539|449244782|FG000|Overall Study|Withdrawal by Subject|3|||
124896512|NCT03425539|449244783|FG001|Overall Study|Withdrawal by Subject|0|||
124896513|NCT03425539|449244782|FG000|Overall Study|Lost to Follow-up|0|||
124896514|NCT03425539|449244783|FG001|Overall Study|Lost to Follow-up|1|||
124896515|NCT01137292|449244784|FG000|Overall Study|Death|30|||
124896516|NCT01137292|449244784|FG000|Overall Study|Adverse Event|3|||
124896517|NCT01137292|449244784|FG000|Overall Study|Lack of Efficacy|13|||
124896518|NCT01137292|449244784|FG000|Overall Study|Lost to Follow-up|1|||
125110162|NCT02598193|450027519|FG000|Overall Study|Does not want to take Nintedanib|1|||
125110163|NCT02354976|450027525|FG000|Overall Study|Other - reason not specified|1|||
124896519|NCT01137292|449244784|FG000|Overall Study|Other|7|||
124896520|NCT02014558|449244785|FG000|Overall Study|Never Received Study Drug|0|||
124896521|NCT02014558|449244786|FG001|Overall Study|Never Received Study Drug|0|||
124896522|NCT02014558|449244787|FG002|Overall Study|Never Received Study Drug|0|||
124896523|NCT02014558|449244788|FG003|Overall Study|Never Received Study Drug|0|||
124896524|NCT02014558|449244789|FG004|Overall Study|Never Received Study Drug|1|||
124896525|NCT02014558|449244790|FG005|Overall Study|Never Received Study Drug|0|||
124896526|NCT02014558|449244791|FG006|Overall Study|Never Received Study Drug|1|||
124896527|NCT02014558|449244792|FG007|Overall Study|Never Received Study Drug|0|||
124896528|NCT02014558|449244793|FG008|Overall Study|Never Received Study Drug|2|||
124896529|NCT02014558|449244794|FG009|Overall Study|Never Received Study Drug|0|||
125110164|NCT02354976|450027526|FG001|Overall Study|Other - reason not specified|0|||
124896530|NCT02014558|449244795|FG010|Overall Study|Never Received Study Drug|2|||
124896531|NCT02014558|449244796|FG011|Overall Study|Never Received Study Drug|2|||
124896532|NCT02014558|449244797|FG012|Overall Study|Never Received Study Drug|0|||
125110165|NCT02354976|450027527|FG002|Overall Study|Other - reason not specified|1|||
125110166|NCT02354976|450027525|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
125110167|NCT02354976|450027526|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
125110168|NCT02354976|450027527|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
125110169|NCT02354976|450027525|FG000|Overall Study|Adverse Event|1|||
125110170|NCT02354976|450027526|FG001|Overall Study|Adverse Event|0|||
125110171|NCT02354976|450027527|FG002|Overall Study|Adverse Event|2|||
125110172|NCT03726437|450027528|FG000|Overall Study|Lost to Follow-up|85|||
125110173|NCT03726437|450027529|FG001|Overall Study|Lost to Follow-up|76|||
125110174|NCT01896700|450027530|FG000|Overall Study|Adverse Event|4|||
125110175|NCT01896700|450027531|FG001|Overall Study|Adverse Event|5|||
125110176|NCT01896700|450027530|FG000|Overall Study|Withdrawal by Subject|0|||
125210778|NCT01810783|450395682|FG000|Overall Study|Enrolled, not treated|1|||
125110177|NCT01896700|450027531|FG001|Overall Study|Withdrawal by Subject|1|||
125110178|NCT03118765|450027533|FG000|Overall Study|Withdrawal by Subject|0|||
125210779|NCT02134353|450395684|FG000|Overall Study|Adverse Event|10|||
125110179|NCT03118765|450027534|FG001|Overall Study|Withdrawal by Subject|0|||
125110180|NCT03118765|450027535|FG002|Overall Study|Withdrawal by Subject|1|||
125110181|NCT03118765|450027536|FG003|Overall Study|Withdrawal by Subject|0|||
125110182|NCT03118765|450027537|FG004|Overall Study|Withdrawal by Subject|0|||
125110183|NCT03118765|450027533|FG000|Overall Study|Adverse Event|1|||
125110184|NCT03118765|450027534|FG001|Overall Study|Adverse Event|1|||
125110185|NCT03118765|450027535|FG002|Overall Study|Adverse Event|1|||
125110186|NCT03118765|450027536|FG003|Overall Study|Adverse Event|1|||
125110187|NCT03118765|450027537|FG004|Overall Study|Adverse Event|1|||
125110188|NCT03118765|450027533|FG000|Overall Study|Non compliance with Study Procedures|0|||
125110189|NCT03118765|450027534|FG001|Overall Study|Non compliance with Study Procedures|0|||
125110190|NCT03118765|450027535|FG002|Overall Study|Non compliance with Study Procedures|0|||
125110191|NCT03118765|450027536|FG003|Overall Study|Non compliance with Study Procedures|1|||
125110192|NCT03118765|450027537|FG004|Overall Study|Non compliance with Study Procedures|0|||
125110193|NCT03118765|450027533|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
125110194|NCT03118765|450027534|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
125110195|NCT03118765|450027535|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
125110196|NCT03118765|450027536|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
125110197|NCT03118765|450027537|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
125110198|NCT03118765|450027533|FG000|Overall Study|COPD Exacerbation|1|||
125110199|NCT03118765|450027534|FG001|Overall Study|COPD Exacerbation|0|||
125110200|NCT03118765|450027535|FG002|Overall Study|COPD Exacerbation|0|||
125110201|NCT03118765|450027536|FG003|Overall Study|COPD Exacerbation|1|||
125110202|NCT03118765|450027537|FG004|Overall Study|COPD Exacerbation|0|||
124896533|NCT02014558|449244785|FG000|Overall Study|Adverse Event|0|||
124896534|NCT02014558|449244786|FG001|Overall Study|Adverse Event|0|||
124896535|NCT02014558|449244787|FG002|Overall Study|Adverse Event|0|||
124896536|NCT02014558|449244788|FG003|Overall Study|Adverse Event|0|||
124896537|NCT02014558|449244789|FG004|Overall Study|Adverse Event|1|||
125110203|NCT03118765|450027533|FG000|Overall Study|Lost to Follow-up|1|||
125110204|NCT03118765|450027534|FG001|Overall Study|Lost to Follow-up|0|||
125110205|NCT03118765|450027535|FG002|Overall Study|Lost to Follow-up|1|||
125110206|NCT03118765|450027536|FG003|Overall Study|Lost to Follow-up|0|||
125110207|NCT03118765|450027537|FG004|Overall Study|Lost to Follow-up|0|||
125110208|NCT03118765|450027533|FG000|Overall Study|Sponsor Decision|1|||
125110209|NCT03118765|450027534|FG001|Overall Study|Sponsor Decision|0|||
125110210|NCT03118765|450027535|FG002|Overall Study|Sponsor Decision|1|||
125110211|NCT03118765|450027536|FG003|Overall Study|Sponsor Decision|0|||
125110212|NCT03118765|450027537|FG004|Overall Study|Sponsor Decision|1|||
125110213|NCT00849524|450027538|FG000|Overall Study|Lack of Efficacy|3|||
125110214|NCT00879970|450027544|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
125110215|NCT00879970|450027545|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
125110216|NCT00879970|450027546|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
125110217|NCT00879970|450027547|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
125110218|NCT00879970|450027548|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
125110219|NCT00879970|450027544|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
125110220|NCT00879970|450027545|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
125110221|NCT00879970|450027546|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
125110222|NCT00879970|450027547|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
125110223|NCT00879970|450027548|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
125110224|NCT00879970|450027544|FG000|Period 1 TZD Randomization|Death|2|||
125110225|NCT00879970|450027545|FG001|Period 1 TZD Randomization|Death|1|||
125110226|NCT00879970|450027546|FG002|Period 1 TZD Randomization|Death|0|||
125110227|NCT00879970|450027547|FG003|Period 1 TZD Randomization|Death|0|||
124896538|NCT02014558|449244790|FG005|Overall Study|Adverse Event|0|||
124896539|NCT02014558|449244791|FG006|Overall Study|Adverse Event|0|||
124896540|NCT02014558|449244792|FG007|Overall Study|Adverse Event|0|||
124896541|NCT02014558|449244793|FG008|Overall Study|Adverse Event|2|||
124896542|NCT02014558|449244794|FG009|Overall Study|Adverse Event|2|||
125110228|NCT00879970|450027548|FG004|Period 1 TZD Randomization|Death|0|||
125110229|NCT00879970|450027544|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
124896543|NCT02014558|449244795|FG010|Overall Study|Adverse Event|5|||
125110230|NCT00879970|450027545|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
125110231|NCT00879970|450027546|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
125110232|NCT00879970|450027547|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
125110233|NCT00879970|450027548|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
125110234|NCT00879970|450027544|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
125110235|NCT00879970|450027545|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
125110236|NCT00879970|450027546|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
125110237|NCT00879970|450027547|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
124896544|NCT02014558|449244796|FG011|Overall Study|Adverse Event|21|||
124896545|NCT02014558|449244797|FG012|Overall Study|Adverse Event|3|||
124896546|NCT02014558|449244785|FG000|Overall Study|Death|1|||
125110238|NCT00879970|450027548|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
125110239|NCT00879970|450027544|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
125110240|NCT00879970|450027545|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
125110241|NCT00879970|450027546|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
125110242|NCT00879970|450027547|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
125110243|NCT00879970|450027548|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
125110244|NCT00879970|450027544|FG000|Period 2 Vitamin D Randomization|Death|0|||
124896547|NCT02014558|449244786|FG001|Overall Study|Death|0|||
124896548|NCT02014558|449244787|FG002|Overall Study|Death|0|||
124896549|NCT02014558|449244788|FG003|Overall Study|Death|0|||
124896550|NCT02014558|449244789|FG004|Overall Study|Death|0|||
124896551|NCT02014558|449244790|FG005|Overall Study|Death|0|||
124896552|NCT02014558|449244791|FG006|Overall Study|Death|1|||
124896553|NCT02014558|449244792|FG007|Overall Study|Death|1|||
124896554|NCT02014558|449244793|FG008|Overall Study|Death|2|||
124896555|NCT02014558|449244794|FG009|Overall Study|Death|5|||
124896556|NCT02014558|449244795|FG010|Overall Study|Death|5|||
125018910|NCT00498173|449692987|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
125018911|NCT01110200|449692988|FG000|Overall Study|Adverse Event|28|||
125018912|NCT01110200|449692989|FG001|Overall Study|Adverse Event|28|||
125018913|NCT01110200|449692988|FG000|Overall Study|Withdrawal by Subject|25|||
125018914|NCT01110200|449692989|FG001|Overall Study|Withdrawal by Subject|32|||
125018915|NCT01110200|449692988|FG000|Overall Study|Lack of Efficacy|16|||
125018916|NCT01110200|449692989|FG001|Overall Study|Lack of Efficacy|25|||
125018917|NCT01110200|449692988|FG000|Overall Study|Protocol Violation|14|||
125018918|NCT01110200|449692989|FG001|Overall Study|Protocol Violation|12|||
125018919|NCT01110200|449692988|FG000|Overall Study|Physician Decision|13|||
125018920|NCT01110200|449692989|FG001|Overall Study|Physician Decision|17|||
125018921|NCT01110200|449692988|FG000|Overall Study|Lost to Follow-up|10|||
125018922|NCT01110200|449692989|FG001|Overall Study|Lost to Follow-up|7|||
125018923|NCT04518462|449692991|FG000|Overall Study|Withdrawal by Subject|0|||
125018924|NCT04518462|449692992|FG001|Overall Study|Withdrawal by Subject|0|||
125018925|NCT04518462|449692993|FG002|Overall Study|Withdrawal by Subject|1|||
125018926|NCT04518462|449692991|FG000|Overall Study|Physician Decision|1|||
125018927|NCT04518462|449692992|FG001|Overall Study|Physician Decision|1|||
125018928|NCT04518462|449692993|FG002|Overall Study|Physician Decision|0|||
125018929|NCT04311502|449694605|FG000|Overall Study|Death|1|||
125018930|NCT04311502|449694606|FG001|Overall Study|Death|1|||
125018931|NCT04311502|449694607|FG002|Overall Study|Death|1|||
125018932|NCT04311502|449694605|FG000|Overall Study|Lost to Follow-up|2|||
125018933|NCT04311502|449694606|FG001|Overall Study|Lost to Follow-up|3|||
125018934|NCT04311502|449694607|FG002|Overall Study|Lost to Follow-up|0|||
125018935|NCT04311502|449694605|FG000|Overall Study|Participant is in prison|1|||
125018936|NCT04311502|449694606|FG001|Overall Study|Participant is in prison|0|||
125018937|NCT04311502|449694607|FG002|Overall Study|Participant is in prison|0|||
125018938|NCT04311502|449694605|FG000|Overall Study|Participant moved out of country|1|||
125018939|NCT04311502|449694606|FG001|Overall Study|Participant moved out of country|0|||
125018940|NCT04311502|449694607|FG002|Overall Study|Participant moved out of country|0|||
125018941|NCT04311502|449694605|FG000|Overall Study|Withdrawal by Subject|2|||
125018942|NCT04311502|449694606|FG001|Overall Study|Withdrawal by Subject|0|||
125018943|NCT04311502|449694607|FG002|Overall Study|Withdrawal by Subject|0|||
125018944|NCT04311502|449694605|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
125018945|NCT04311502|449694606|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
125018946|NCT04311502|449694607|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
125018947|NCT03040999|449694608|FG000|Overall Study|Lost to Follow-up|2|||
125018948|NCT03040999|449694609|FG001|Overall Study|Lost to Follow-up|2|||
125018949|NCT03040999|449694608|FG000|Overall Study|Withdrawal by Subject|12|||
125018950|NCT03040999|449694609|FG001|Overall Study|Withdrawal by Subject|13|||
125018951|NCT03040999|449694608|FG000|Overall Study|Death|155|||
125018952|NCT03040999|449694609|FG001|Overall Study|Death|171|||
125018953|NCT03040999|449694608|FG000|Overall Study|Physician Decision|0|||
125018954|NCT03040999|449694609|FG001|Overall Study|Physician Decision|3|||
125018955|NCT03368170|449694610|FG000|Overall Study|Adverse Event|2|||
125018956|NCT03368170|449694611|FG001|Overall Study|Adverse Event|1|||
125018957|NCT02068547|449694612|FG000|Overall Study|Lost to Follow-up|3|||
124896557|NCT02014558|449244796|FG011|Overall Study|Death|19|||
124896558|NCT02014558|449244797|FG012|Overall Study|Death|2|||
124896559|NCT02014558|449244785|FG000|Overall Study|Lack of Efficacy|1|||
124896560|NCT02014558|449244786|FG001|Overall Study|Lack of Efficacy|2|||
124896561|NCT02014558|449244787|FG002|Overall Study|Lack of Efficacy|1|||
125018958|NCT02068547|449694613|FG001|Overall Study|Lost to Follow-up|3|||
125018959|NCT02068547|449694612|FG000|Overall Study|Physician Decision|1|||
125018960|NCT02068547|449694613|FG001|Overall Study|Physician Decision|0|||
125018961|NCT03657043|449694614|FG000|Overall Study|Withdrawal by Subject|1|||
125018962|NCT03657043|449694615|FG001|Overall Study|Withdrawal by Subject|1|||
125018963|NCT03657043|449694616|FG002|Overall Study|Withdrawal by Subject|0|||
125018964|NCT03657043|449694617|FG003|Overall Study|Withdrawal by Subject|0|||
125018965|NCT03657043|449694618|FG004|Overall Study|Withdrawal by Subject|4|||
124896562|NCT02014558|449244788|FG003|Overall Study|Lack of Efficacy|1|||
124896563|NCT02014558|449244789|FG004|Overall Study|Lack of Efficacy|0|||
124896564|NCT02014558|449244790|FG005|Overall Study|Lack of Efficacy|0|||
124896565|NCT02014558|449244791|FG006|Overall Study|Lack of Efficacy|1|||
124896566|NCT02014558|449244792|FG007|Overall Study|Lack of Efficacy|3|||
124896567|NCT02014558|449244793|FG008|Overall Study|Lack of Efficacy|3|||
124896568|NCT02014558|449244794|FG009|Overall Study|Lack of Efficacy|3|||
124896569|NCT02014558|449244795|FG010|Overall Study|Lack of Efficacy|16|||
124896570|NCT02014558|449244796|FG011|Overall Study|Lack of Efficacy|8|||
124896571|NCT02014558|449244797|FG012|Overall Study|Lack of Efficacy|5|||
124896572|NCT02014558|449244785|FG000|Overall Study|Lost to Follow-up|0|||
124896573|NCT02014558|449244786|FG001|Overall Study|Lost to Follow-up|0|||
124896574|NCT02014558|449244787|FG002|Overall Study|Lost to Follow-up|0|||
124896575|NCT02014558|449244788|FG003|Overall Study|Lost to Follow-up|0|||
124896576|NCT02014558|449244789|FG004|Overall Study|Lost to Follow-up|0|||
124896577|NCT02014558|449244790|FG005|Overall Study|Lost to Follow-up|0|||
124896578|NCT02014558|449244791|FG006|Overall Study|Lost to Follow-up|0|||
124896579|NCT02014558|449244792|FG007|Overall Study|Lost to Follow-up|0|||
124896580|NCT02014558|449244793|FG008|Overall Study|Lost to Follow-up|0|||
124896581|NCT02014558|449244794|FG009|Overall Study|Lost to Follow-up|0|||
124896582|NCT02014558|449244795|FG010|Overall Study|Lost to Follow-up|1|||
124896583|NCT02014558|449244796|FG011|Overall Study|Lost to Follow-up|0|||
124896584|NCT02014558|449244797|FG012|Overall Study|Lost to Follow-up|0|||
124896585|NCT02014558|449244785|FG000|Overall Study|Progressive Disease|1|||
124896586|NCT02014558|449244786|FG001|Overall Study|Progressive Disease|0|||
124896587|NCT02014558|449244787|FG002|Overall Study|Progressive Disease|1|||
124896588|NCT02014558|449244788|FG003|Overall Study|Progressive Disease|1|||
124896589|NCT02014558|449244789|FG004|Overall Study|Progressive Disease|1|||
124896590|NCT02014558|449244790|FG005|Overall Study|Progressive Disease|2|||
124896591|NCT02014558|449244791|FG006|Overall Study|Progressive Disease|1|||
124896592|NCT02014558|449244792|FG007|Overall Study|Progressive Disease|6|||
124896593|NCT02014558|449244793|FG008|Overall Study|Progressive Disease|5|||
124896594|NCT02014558|449244794|FG009|Overall Study|Progressive Disease|6|||
124896595|NCT02014558|449244795|FG010|Overall Study|Progressive Disease|22|||
124896596|NCT02014558|449244796|FG011|Overall Study|Progressive Disease|31|||
124896597|NCT02014558|449244797|FG012|Overall Study|Progressive Disease|6|||
124896598|NCT02014558|449244785|FG000|Overall Study|Withdrawal by Subject|0|||
124896599|NCT02014558|449244786|FG001|Overall Study|Withdrawal by Subject|0|||
124896600|NCT02014558|449244787|FG002|Overall Study|Withdrawal by Subject|0|||
124896601|NCT02014558|449244788|FG003|Overall Study|Withdrawal by Subject|0|||
124896602|NCT02014558|449244789|FG004|Overall Study|Withdrawal by Subject|1|||
124896603|NCT02014558|449244790|FG005|Overall Study|Withdrawal by Subject|0|||
124896604|NCT02014558|449244791|FG006|Overall Study|Withdrawal by Subject|0|||
124896605|NCT02014558|449244792|FG007|Overall Study|Withdrawal by Subject|0|||
124896606|NCT02014558|449244793|FG008|Overall Study|Withdrawal by Subject|0|||
124896607|NCT02014558|449244794|FG009|Overall Study|Withdrawal by Subject|2|||
124896608|NCT02014558|449244795|FG010|Overall Study|Withdrawal by Subject|6|||
124896609|NCT02014558|449244796|FG011|Overall Study|Withdrawal by Subject|10|||
124896610|NCT02014558|449244797|FG012|Overall Study|Withdrawal by Subject|0|||
124896611|NCT02014558|449244785|FG000|Overall Study|Miscellaneous|2|||
124896612|NCT02014558|449244786|FG001|Overall Study|Miscellaneous|1|||
124896613|NCT02014558|449244787|FG002|Overall Study|Miscellaneous|1|||
124896614|NCT02014558|449244788|FG003|Overall Study|Miscellaneous|1|||
124896615|NCT02014558|449244789|FG004|Overall Study|Miscellaneous|0|||
124896616|NCT02014558|449244790|FG005|Overall Study|Miscellaneous|1|||
124896617|NCT02014558|449244791|FG006|Overall Study|Miscellaneous|0|||
124896618|NCT02014558|449244792|FG007|Overall Study|Miscellaneous|1|||
124896619|NCT02014558|449244793|FG008|Overall Study|Miscellaneous|1|||
124896620|NCT02014558|449244794|FG009|Overall Study|Miscellaneous|3|||
124896621|NCT02014558|449244795|FG010|Overall Study|Miscellaneous|12|||
124896622|NCT02014558|449244796|FG011|Overall Study|Miscellaneous|11|||
124896623|NCT02014558|449244797|FG012|Overall Study|Miscellaneous|1|||
125110245|NCT00879970|450027545|FG001|Period 2 Vitamin D Randomization|Death|0|||
124896624|NCT04580407|449244798|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
124896625|NCT05567159|449244803|FG000|Overall Study|Adverse Event|4|||
124896626|NCT05567159|449244803|FG000|Overall Study|Physician Decision|3|||
124896627|NCT05567159|449244803|FG000|Overall Study|Protocol deviation|1|||
124896628|NCT00672256|449246855|FG000|Overall Study|PI dropped, bad data|44|||
124896629|NCT02072226|449246856|FG000|Overall Study|Lost to Follow-up|11|||
124896630|NCT02072226|449246857|FG001|Overall Study|Lost to Follow-up|7|||
124896631|NCT02072226|449246856|FG000|Overall Study|Patient Non-compliance|2|||
124896632|NCT02072226|449246857|FG001|Overall Study|Patient Non-compliance|3|||
124896633|NCT02072226|449246856|FG000|Overall Study|Death|1|||
124896634|NCT02072226|449246857|FG001|Overall Study|Death|0|||
124896635|NCT02072226|449246856|FG000|Overall Study|Patient Withdrawal of Consent|1|||
124896636|NCT02072226|449246857|FG001|Overall Study|Patient Withdrawal of Consent|0|||
124896637|NCT03635112|449246861|FG000|Overall Study|Adverse Event|5|||
124896638|NCT03635112|449246862|FG001|Overall Study|Adverse Event|9|||
124896639|NCT03635112|449246863|FG002|Overall Study|Adverse Event|14|||
124896640|NCT03635112|449246861|FG000|Overall Study|Lost to Follow-up|1|||
124896641|NCT03635112|449246862|FG001|Overall Study|Lost to Follow-up|0|||
124896642|NCT03635112|449246863|FG002|Overall Study|Lost to Follow-up|1|||
124896643|NCT03635112|449246861|FG000|Overall Study|Physician Decision|5|||
124896644|NCT03635112|449246862|FG001|Overall Study|Physician Decision|7|||
124896645|NCT03635112|449246863|FG002|Overall Study|Physician Decision|5|||
124896646|NCT03635112|449246861|FG000|Overall Study|Protocol Violation|0|||
124896647|NCT03635112|449246862|FG001|Overall Study|Protocol Violation|0|||
124896648|NCT03635112|449246863|FG002|Overall Study|Protocol Violation|1|||
124896649|NCT03635112|449246861|FG000|Overall Study|Study Terminated by Sponsor|11|||
124896650|NCT03635112|449246862|FG001|Overall Study|Study Terminated by Sponsor|17|||
124896651|NCT03635112|449246863|FG002|Overall Study|Study Terminated by Sponsor|21|||
124896652|NCT03635112|449246861|FG000|Overall Study|Withdrawal by Subject|4|||
124896653|NCT03635112|449246862|FG001|Overall Study|Withdrawal by Subject|9|||
124896654|NCT03635112|449246863|FG002|Overall Study|Withdrawal by Subject|7|||
124896655|NCT03635112|449246861|FG000|Overall Study|Miscellaneous|0|||
124896656|NCT03635112|449246862|FG001|Overall Study|Miscellaneous|0|||
124896657|NCT03635112|449246863|FG002|Overall Study|Miscellaneous|1|||
124896658|NCT03006341|449246865|FG000|Overall Study|Not linked in the EMR|25069|||
124896659|NCT03006341|449246866|FG001|Overall Study|Not linked in the EMR|67505|||
124896660|NCT03006341|449246867|FG002|Overall Study|Not linked in the EMR|30993|||
124896661|NCT03006341|449246868|FG003|Overall Study|Not linked in the EMR|10685|||
124896662|NCT03101592|449246869|FG000|Overall Study|participant files could not be located|111|||
124896663|NCT03101592|449246870|FG001|Overall Study|participant files could not be located|170|||
124896664|NCT03101592|449246871|FG002|Overall Study|participant files could not be located|118|||
124896665|NCT01770860|449246872|FG000|Overall Study|Withdrawal by Subject|4|||
124896666|NCT01770860|449246872|FG000|Overall Study|Lost to Follow-up|1|||
124896667|NCT01770860|449246872|FG000|Overall Study|Administrative decision made by the PI|1|||
124896668|NCT00601640|449246876|FG000|Overall Study|Withdrawal by Subject|3|||
124896669|NCT00601640|449246877|FG001|Overall Study|Withdrawal by Subject|0|||
124896670|NCT00601640|449246878|FG002|Overall Study|Withdrawal by Subject|7|||
124896671|NCT00601640|449246876|FG000|Overall Study|Death|1|||
124896672|NCT00601640|449246877|FG001|Overall Study|Death|0|||
124896673|NCT00601640|449246878|FG002|Overall Study|Death|0|||
124896674|NCT00601640|449246876|FG000|Overall Study|Adverse Event|0|||
124896675|NCT00601640|449246877|FG001|Overall Study|Adverse Event|4|||
124896676|NCT00601640|449246878|FG002|Overall Study|Adverse Event|2|||
124896677|NCT00601640|449246876|FG000|Overall Study|intercurrent illness|1|||
124896678|NCT00601640|449246877|FG001|Overall Study|intercurrent illness|0|||
124896679|NCT00601640|449246878|FG002|Overall Study|intercurrent illness|0|||
125018966|NCT03657043|449694614|FG000|Overall Study|Study closure by Sponsor|0|||
125018967|NCT03657043|449694615|FG001|Overall Study|Study closure by Sponsor|2|||
125018968|NCT03657043|449694616|FG002|Overall Study|Study closure by Sponsor|0|||
125018969|NCT03657043|449694617|FG003|Overall Study|Study closure by Sponsor|0|||
125018970|NCT03657043|449694618|FG004|Overall Study|Study closure by Sponsor|17|||
125018971|NCT03657043|449694614|FG000|Overall Study|Lost to Follow-up|0|||
125018972|NCT03657043|449694615|FG001|Overall Study|Lost to Follow-up|0|||
125018973|NCT03657043|449694616|FG002|Overall Study|Lost to Follow-up|0|||
125018974|NCT03657043|449694617|FG003|Overall Study|Lost to Follow-up|0|||
125018975|NCT03657043|449694618|FG004|Overall Study|Lost to Follow-up|4|||
125018976|NCT03657043|449694614|FG000|Overall Study|Death|6|||
125018977|NCT03657043|449694615|FG001|Overall Study|Death|5|||
125018978|NCT03657043|449694616|FG002|Overall Study|Death|0|||
125018979|NCT03657043|449694617|FG003|Overall Study|Death|0|||
125018980|NCT03657043|449694618|FG004|Overall Study|Death|53|||
125018981|NCT03657043|449694614|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
125018982|NCT03657043|449694615|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
125018983|NCT03657043|449694616|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
125018984|NCT03657043|449694617|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
125018985|NCT03657043|449694618|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
125018986|NCT03657043|449694614|FG000|Overall Study|Adverse Event|0|||
125018987|NCT03657043|449694615|FG001|Overall Study|Adverse Event|0|||
125018988|NCT03657043|449694616|FG002|Overall Study|Adverse Event|0|||
125018989|NCT03657043|449694617|FG003|Overall Study|Adverse Event|0|||
125018990|NCT03657043|449694618|FG004|Overall Study|Adverse Event|2|||
125018991|NCT03657043|449694614|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
125018992|NCT03657043|449694615|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
125018993|NCT03657043|449694616|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
125018994|NCT03657043|449694617|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
125018995|NCT03657043|449694618|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
125018996|NCT03657043|449694614|FG000|Overall Study|Withdrawal - declined follow-up|0|||
124896680|NCT00601640|449246876|FG000|Overall Study|change in eligibility status|0|||
125018997|NCT03657043|449694615|FG001|Overall Study|Withdrawal - declined follow-up|0|||
125018998|NCT03657043|449694616|FG002|Overall Study|Withdrawal - declined follow-up|0|||
124896681|NCT00601640|449246877|FG001|Overall Study|change in eligibility status|1|||
124896682|NCT00601640|449246878|FG002|Overall Study|change in eligibility status|1|||
124896683|NCT01872611|449246883|FG000|Overall Study|Adverse Event|3|||
124896684|NCT01872611|449246884|FG001|Overall Study|Adverse Event|1|||
124896685|NCT01872611|449246883|FG000|Overall Study|Adverse Event, prior to treatment|0|||
124896686|NCT01872611|449246884|FG001|Overall Study|Adverse Event, prior to treatment|1|||
124896687|NCT01872611|449246883|FG000|Overall Study|Death|0|||
124896688|NCT01872611|449246884|FG001|Overall Study|Death|1|||
124896689|NCT01872611|449246883|FG000|Overall Study|Death, prior to treatment|0|||
124896690|NCT01872611|449246884|FG001|Overall Study|Death, prior to treatment|1|||
124896691|NCT01872611|449246883|FG000|Overall Study|Lost to Follow-up|8|||
124896692|NCT01872611|449246884|FG001|Overall Study|Lost to Follow-up|1|||
124896693|NCT01872611|449246883|FG000|Overall Study|Physician Decision|1|||
124896694|NCT01872611|449246884|FG001|Overall Study|Physician Decision|0|||
124896695|NCT01872611|449246883|FG000|Overall Study|Withdrawal by Subject|6|||
124896696|NCT01872611|449246884|FG001|Overall Study|Withdrawal by Subject|1|||
124896697|NCT01872611|449246883|FG000|Overall Study|Reason not provided|6|||
124896698|NCT01872611|449246884|FG001|Overall Study|Reason not provided|6|||
124896699|NCT03537651|449246885|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
124896700|NCT03537651|449246885|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
124896701|NCT03537651|449246885|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
124896702|NCT03537651|449246885|FG000|Part A (Up to 96 Weeks)|Other|1|||
124896703|NCT03537651|449246885|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
124896704|NCT03537651|449246885|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
124896705|NCT03537651|449246885|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
124896706|NCT03537651|449246885|FG000|Part B (Up to 192 Weeks)|Other|1|||
124896707|NCT02939183|449246888|FG000|Overall Study|Death|0|||
124896708|NCT02939183|449246889|FG001|Overall Study|Death|0|||
124896709|NCT02939183|449246890|FG002|Overall Study|Death|1|||
124896710|NCT02939183|449246891|FG003|Overall Study|Death|0|||
124896711|NCT02939183|449246892|FG004|Overall Study|Death|0|||
124896712|NCT02939183|449246893|FG005|Overall Study|Death|2|||
124896713|NCT02939183|449246894|FG006|Overall Study|Death|1|||
124896714|NCT02939183|449246895|FG007|Overall Study|Death|0|||
124896715|NCT02939183|449246896|FG008|Overall Study|Death|0|||
124896716|NCT02939183|449246888|FG000|Overall Study|Sponsor decision|0|||
124896717|NCT02939183|449246889|FG001|Overall Study|Sponsor decision|1|||
124896718|NCT02939183|449246890|FG002|Overall Study|Sponsor decision|0|||
124896719|NCT02939183|449246891|FG003|Overall Study|Sponsor decision|1|||
124896720|NCT02939183|449246892|FG004|Overall Study|Sponsor decision|2|||
124896721|NCT02939183|449246893|FG005|Overall Study|Sponsor decision|0|||
124896722|NCT02939183|449246894|FG006|Overall Study|Sponsor decision|3|||
124896723|NCT02939183|449246895|FG007|Overall Study|Sponsor decision|1|||
124896724|NCT02939183|449246896|FG008|Overall Study|Sponsor decision|4|||
124896725|NCT02939183|449246888|FG000|Overall Study|Withdrawal by Subject|0|||
124896726|NCT02939183|449246889|FG001|Overall Study|Withdrawal by Subject|2|||
124896727|NCT02939183|449246890|FG002|Overall Study|Withdrawal by Subject|0|||
124896728|NCT02939183|449246891|FG003|Overall Study|Withdrawal by Subject|1|||
124896729|NCT02939183|449246892|FG004|Overall Study|Withdrawal by Subject|0|||
124896730|NCT02939183|449246893|FG005|Overall Study|Withdrawal by Subject|0|||
124896731|NCT02939183|449246894|FG006|Overall Study|Withdrawal by Subject|2|||
124896732|NCT02939183|449246895|FG007|Overall Study|Withdrawal by Subject|2|||
124896733|NCT02939183|449246896|FG008|Overall Study|Withdrawal by Subject|2|||
124896734|NCT02939183|449246888|FG000|Overall Study|Not treated due to adverse event|0|||
124896735|NCT02939183|449246889|FG001|Overall Study|Not treated due to adverse event|0|||
124896736|NCT02939183|449246890|FG002|Overall Study|Not treated due to adverse event|0|||
124896737|NCT02939183|449246891|FG003|Overall Study|Not treated due to adverse event|1|||
124896738|NCT02939183|449246892|FG004|Overall Study|Not treated due to adverse event|0|||
124896739|NCT02939183|449246893|FG005|Overall Study|Not treated due to adverse event|0|||
124896740|NCT02939183|449246894|FG006|Overall Study|Not treated due to adverse event|1|||
124896741|NCT02939183|449246895|FG007|Overall Study|Not treated due to adverse event|0|||
124896742|NCT02939183|449246896|FG008|Overall Study|Not treated due to adverse event|0|||
125018999|NCT03657043|449694617|FG003|Overall Study|Withdrawal - declined follow-up|0|||
125019000|NCT03657043|449694618|FG004|Overall Study|Withdrawal - declined follow-up|1|||
125019001|NCT02627495|449694621|FG000|Overall Study|Withdrawal by Subject|4|||
125019002|NCT00880893|449694622|FG000|Overall Study|Protocol Violation|13|||
125019003|NCT00880893|449694623|FG001|Overall Study|Protocol Violation|1|||
125019004|NCT00880893|449694622|FG000|Overall Study|Withdrawal by Subject|15|||
125019005|NCT00880893|449694623|FG001|Overall Study|Withdrawal by Subject|11|||
125019006|NCT00880893|449694622|FG000|Overall Study|Lost to Follow-up|76|||
125019007|NCT00880893|449694623|FG001|Overall Study|Lost to Follow-up|33|||
124896743|NCT00654238|449246901|FG000|Overall Study|Screen Failures|4|||
124896744|NCT01446003|449246902|FG000|Period 1|Protocol Violation|2|||
124896745|NCT01446003|449246903|FG001|Period 1|Protocol Violation|0|||
124896746|NCT01446003|449246902|FG000|Period 2|Adverse Event|1|||
124896747|NCT01446003|449246903|FG001|Period 2|Adverse Event|0|||
124896748|NCT00318656|449246904|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
124896749|NCT00318656|449246905|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
124896750|NCT00318656|449246904|FG000|Overall Study|Did not receive any treatment|0|||
124896751|NCT00318656|449246905|FG001|Overall Study|Did not receive any treatment|1|||
124896752|NCT03905135|449246906|FG000|Dose Escalation|Adverse Event|1|||
124896753|NCT03905135|449246907|FG001|Dose Escalation|Adverse Event|1|||
124896754|NCT03905135|449246906|FG000|Dose Escalation|Progressive disease|3|||
124896755|NCT03905135|449246907|FG001|Dose Escalation|Progressive disease|1|||
124896756|NCT03905135|449246906|FG000|Dose Escalation|Intercurrent illness|1|||
124896757|NCT03905135|449246907|FG001|Dose Escalation|Intercurrent illness|0|||
124896758|NCT01740557|449246908|FG000|Overall Study|Ineligible|1|||
124896759|NCT01740557|449246908|FG000|Overall Study|Screen failure|1|||
124896760|NCT00490555|449246913|FG000|Overall Study|noncompliant with drug administration|0|||
124896761|NCT00490555|449246914|FG001|Overall Study|noncompliant with drug administration|0|||
124896762|NCT00490555|449246915|FG002|Overall Study|noncompliant with drug administration|2|||
124896763|NCT00490555|449246916|FG003|Overall Study|noncompliant with drug administration|0|||
124896764|NCT01268566|449246917|FG000|Overall Study|Lost to Follow-up|1|||
124896765|NCT01268566|449246917|FG000|Overall Study|Withdrawal by Subject|12|||
124896766|NCT01268566|449246917|FG000|Overall Study|Death|30|||
124896767|NCT01348087|449246927|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
124896768|NCT01348087|449246927|FG000|Overall Study|Administrative problems|79|||
124896769|NCT01348087|449246927|FG000|Overall Study|protocol deviation|1|||
124896770|NCT01348087|449246927|FG000|Overall Study|Lost to Follow-up|1|||
124896771|NCT01348087|449246927|FG000|Overall Study|Subject withdrew consent|7|||
124896772|NCT01348087|449246927|FG000|Overall Study|Adverse Event|25|||
124896773|NCT01007149|449246928|FG000|Overall Study|Administrative problems|0|||
124896774|NCT01007149|449246929|FG001|Overall Study|Administrative problems|1|||
124896775|NCT01913340|449246930|FG000|Overall Study|Death|2|||
124896776|NCT01913340|449246931|FG001|Overall Study|Death|5|||
124896777|NCT01913340|449246930|FG000|Overall Study|Lost to Follow-up|1|||
124896778|NCT01913340|449246931|FG001|Overall Study|Lost to Follow-up|1|||
124896779|NCT02784704|449246932|FG000|Overall Study|Adverse Event|4|||
124896780|NCT02784704|449246933|FG001|Overall Study|Adverse Event|2|||
124896781|NCT02784704|449246932|FG000|Overall Study|Lost to Follow-up|6|||
124896782|NCT02784704|449246933|FG001|Overall Study|Lost to Follow-up|4|||
124896783|NCT02784704|449246932|FG000|Overall Study|Withdrawal by Subject|1|||
124896784|NCT02784704|449246933|FG001|Overall Study|Withdrawal by Subject|3|||
125019008|NCT00880893|449694622|FG000|Overall Study|Serious adverse event|3|||
125019009|NCT00880893|449694623|FG001|Overall Study|Serious adverse event|0|||
125019010|NCT01736579|449694624|FG000|Overall Study|Termination of Study by Sponsor|2|||
125019011|NCT01736579|449694625|FG001|Overall Study|Termination of Study by Sponsor|2|||
125019012|NCT01408147|449694633|FG000|Overall Study|Withdrawal by Subject|0|||
125019013|NCT01408147|449694634|FG001|Overall Study|Withdrawal by Subject|1|||
125019014|NCT01662440|449694635|FG000|Overall Study|Adverse Event|1|||
125019015|NCT01662440|449694636|FG001|Overall Study|Adverse Event|0|||
125019016|NCT01662440|449694637|FG002|Overall Study|Adverse Event|0|||
125019017|NCT01662440|449694638|FG003|Overall Study|Adverse Event|1|||
125019018|NCT01662440|449694635|FG000|Overall Study|Death|0|||
125019019|NCT01662440|449694636|FG001|Overall Study|Death|1|||
125019020|NCT01662440|449694637|FG002|Overall Study|Death|0|||
125019021|NCT01662440|449694638|FG003|Overall Study|Death|0|||
125019022|NCT01662440|449694635|FG000|Overall Study|Lost to Follow-up|2|||
125019023|NCT01662440|449694636|FG001|Overall Study|Lost to Follow-up|2|||
125019024|NCT01662440|449694637|FG002|Overall Study|Lost to Follow-up|4|||
125019025|NCT01662440|449694638|FG003|Overall Study|Lost to Follow-up|1|||
125019026|NCT01662440|449694635|FG000|Overall Study|Subject moved to another country.|0|||
125019027|NCT01662440|449694636|FG001|Overall Study|Subject moved to another country.|1|||
125019028|NCT01662440|449694637|FG002|Overall Study|Subject moved to another country.|0|||
125019029|NCT01662440|449694638|FG003|Overall Study|Subject moved to another country.|0|||
125019030|NCT01662440|449694635|FG000|Overall Study|Protocol Violation|1|||
125019031|NCT01662440|449694636|FG001|Overall Study|Protocol Violation|0|||
124896785|NCT02784704|449246932|FG000|Overall Study|Subject Non Compliance|2|||
124896786|NCT02784704|449246933|FG001|Overall Study|Subject Non Compliance|0|||
124896787|NCT00603538|449246934|FG000|Overall Study|Adverse Event|0|||
125019032|NCT01662440|449694637|FG002|Overall Study|Protocol Violation|0|||
124896788|NCT00603538|449246935|FG001|Overall Study|Adverse Event|4|||
124896789|NCT00603538|449246936|FG002|Overall Study|Adverse Event|2|||
124896790|NCT00603538|449246934|FG000|Overall Study|Objective progression or relapse|3|||
125019033|NCT01662440|449694638|FG003|Overall Study|Protocol Violation|0|||
125019034|NCT01662440|449694635|FG000|Overall Study|Withdrawal by Subject|5|||
125019035|NCT01662440|449694636|FG001|Overall Study|Withdrawal by Subject|2|||
125110246|NCT00879970|450027546|FG002|Period 2 Vitamin D Randomization|Death|0|||
125110247|NCT00879970|450027547|FG003|Period 2 Vitamin D Randomization|Death|2|||
125110248|NCT00879970|450027548|FG004|Period 2 Vitamin D Randomization|Death|0|||
125110249|NCT01610167|450027549|FG000|Overall Study|Scheduling conflict.|0|||
125110250|NCT01610167|450027550|FG001|Overall Study|Scheduling conflict.|0|||
125110251|NCT01610167|450027551|FG002|Overall Study|Scheduling conflict.|2|||
125110252|NCT01021137|450027553|FG000|Overall Study|Lost to Follow-up|9|||
125110253|NCT01021137|450027554|FG001|Overall Study|Lost to Follow-up|4|||
125110254|NCT01021137|450027555|FG002|Overall Study|Lost to Follow-up|2|||
125110255|NCT01021137|450027556|FG003|Overall Study|Lost to Follow-up|6|||
125110256|NCT01021137|450027553|FG000|Overall Study|Withdrawal by Subject|1|||
125110257|NCT01021137|450027554|FG001|Overall Study|Withdrawal by Subject|0|||
125110258|NCT01021137|450027555|FG002|Overall Study|Withdrawal by Subject|0|||
125110259|NCT01021137|450027556|FG003|Overall Study|Withdrawal by Subject|3|||
125110260|NCT03439293|450027557|FG000|Overall Study|Death|22|||
125110261|NCT03439293|450027557|FG000|Overall Study|Withdrawal by Subject|8|||
125110262|NCT03439293|450027557|FG000|Overall Study|Lost to Follow-up|2|||
125110263|NCT03439293|450027557|FG000|Overall Study|Reason Not Specified|28|||
125110264|NCT03439293|450027557|FG000|Overall Study|Missing|1|||
125110265|NCT02766400|450027563|FG000|Overall Study|Death|1|||
125110266|NCT02766400|450027564|FG001|Overall Study|Death|2|||
125110267|NCT02766400|450027563|FG000|Overall Study|Withdrawal by Subject|1|||
125110268|NCT02766400|450027564|FG001|Overall Study|Withdrawal by Subject|0|||
125110269|NCT03499249|450027571|FG000|Overall Study|Physician Decision|1|||
125110270|NCT01559818|450027578|FG000|Overall Study|Physician Decision|1|||
125110271|NCT01559818|450027578|FG000|Overall Study|Pregnancy|1|||
125110272|NCT01559818|450027578|FG000|Overall Study|Study terminated by Sponsor|4|||
125110273|NCT01559818|450027578|FG000|Overall Study|Withdrawal by Subject|1|||
125110274|NCT04071626|450027579|FG000|Overall Study|Withdrawal by Subject|1|||
125110275|NCT04071626|450027580|FG001|Overall Study|Withdrawal by Subject|1|||
125110276|NCT04071626|450027579|FG000|Overall Study|Protocol Violation|0|||
125110277|NCT04071626|450027580|FG001|Overall Study|Protocol Violation|1|||
125110278|NCT01374906|450027581|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125110279|NCT01374906|450027582|FG001|Overall Study|Abnormal laboratory value(s)|3|||
125110280|NCT01374906|450027581|FG000|Overall Study|Administrative problems|2|||
125110281|NCT01374906|450027582|FG001|Overall Study|Administrative problems|2|||
125110282|NCT01374906|450027581|FG000|Overall Study|Adverse Event|10|||
125110283|NCT01374906|450027582|FG001|Overall Study|Adverse Event|11|||
125110284|NCT01374906|450027581|FG000|Overall Study|Death|0|||
125110285|NCT01374906|450027582|FG001|Overall Study|Death|2|||
125110286|NCT01374906|450027581|FG000|Overall Study|Protocol Violation|2|||
125110287|NCT01374906|450027582|FG001|Overall Study|Protocol Violation|2|||
125110288|NCT01374906|450027581|FG000|Overall Study|Withdrawal by Subject|15|||
125110289|NCT01374906|450027582|FG001|Overall Study|Withdrawal by Subject|9|||
125110290|NCT01374906|450027581|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
125110291|NCT01374906|450027582|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
125110292|NCT02475980|450027585|FG000|Overall Study|Lost to Follow-up|4|||
125110293|NCT02475980|450027585|FG000|Overall Study|Withdrawal by Subject|1|||
125110294|NCT00665626|450027591|FG000|Overall Study|Lack of Efficacy|8|||
125110295|NCT00665626|450027592|FG001|Overall Study|Lack of Efficacy|5|||
125110296|NCT00665626|450027591|FG000|Overall Study|Lost to Follow-up|0|||
125110297|NCT00665626|450027592|FG001|Overall Study|Lost to Follow-up|2|||
125110298|NCT00665626|450027591|FG000|Overall Study|Withdrawal by Subject|0|||
125110299|NCT00665626|450027592|FG001|Overall Study|Withdrawal by Subject|1|||
125110300|NCT00665626|450027591|FG000|Overall Study|Protocol Violation|0|||
125110301|NCT00665626|450027592|FG001|Overall Study|Protocol Violation|2|||
125110302|NCT00665626|450027591|FG000|Overall Study|Adverse Event|1|||
125110303|NCT00665626|450027592|FG001|Overall Study|Adverse Event|9|||
125110304|NCT00665626|450027591|FG000|Overall Study|Due to exclusion criteria|0|||
125110305|NCT00665626|450027592|FG001|Overall Study|Due to exclusion criteria|1|||
125110306|NCT00665626|450027591|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
125110307|NCT00665626|450027592|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
125110308|NCT00665626|450027591|FG000|Overall Study|Unably to comply with dosing regimen|0|||
125110309|NCT00665626|450027592|FG001|Overall Study|Unably to comply with dosing regimen|1|||
125110310|NCT00665626|450027591|FG000|Overall Study|Death|1|||
125110311|NCT00665626|450027592|FG001|Overall Study|Death|0|||
125110312|NCT04147611|450027593|FG000|Overall Study|Physician Decision|0|||
125110313|NCT04147611|450027594|FG001|Overall Study|Physician Decision|1|||
125110314|NCT01010230|450027595|FG000|Overall Study|Withdrawal by Subject|6|||
125110315|NCT01010230|450027596|FG001|Overall Study|Withdrawal by Subject|5|||
125110316|NCT01010230|450027595|FG000|Overall Study|Lost to Follow-up|4|||
125110317|NCT01010230|450027596|FG001|Overall Study|Lost to Follow-up|2|||
125110318|NCT00530439|450027597|FG000|Overall Study|GDM|9|||
125110319|NCT00530439|450027598|FG001|Overall Study|GDM|3|||
125110320|NCT00530439|450027597|FG000|Overall Study|Withdraw|18|||
125110321|NCT00530439|450027598|FG001|Overall Study|Withdraw|14|||
125110322|NCT00530439|450027597|FG000|Overall Study|Missed abortion|1|||
125110323|NCT00530439|450027598|FG001|Overall Study|Missed abortion|4|||
125110324|NCT00530439|450027597|FG000|Overall Study|Misclassification|2|||
125110325|NCT00530439|450027598|FG001|Overall Study|Misclassification|0|||
125110326|NCT00530439|450027597|FG000|Overall Study|Twin pregnancy|0|||
125110327|NCT00530439|450027598|FG001|Overall Study|Twin pregnancy|2|||
125110328|NCT00530439|450027597|FG000|Overall Study|Severe malformation/abortion|0|||
125110329|NCT00530439|450027598|FG001|Overall Study|Severe malformation/abortion|3|||
125110330|NCT01629693|450027601|FG000|Overall Study|Lost to Follow-up|2|||
124896791|NCT00603538|449246935|FG001|Overall Study|Objective progression or relapse|0|||
124896792|NCT00603538|449246936|FG002|Overall Study|Objective progression or relapse|0|||
124896793|NCT05750745|449246938|FG000|Overall Study|Adverse Event|1|||
124896794|NCT05750745|449246939|FG001|Overall Study|Adverse Event|0|||
124896795|NCT05750745|449246940|FG002|Overall Study|Adverse Event|0|||
124896796|NCT05750745|449246938|FG000|Overall Study|Protocol Violation|1|||
124896797|NCT05750745|449246939|FG001|Overall Study|Protocol Violation|0|||
124896798|NCT05750745|449246940|FG002|Overall Study|Protocol Violation|0|||
124896799|NCT05750745|449246938|FG000|Overall Study|Withdrawal by Subject|0|||
124896800|NCT05750745|449246939|FG001|Overall Study|Withdrawal by Subject|1|||
124896801|NCT05750745|449246940|FG002|Overall Study|Withdrawal by Subject|0|||
124896802|NCT00783692|449246946|FG000|Induction Phase|Adverse Event|7|||
124896803|NCT00783692|449246947|FG001|Induction Phase|Adverse Event|9|||
124896804|NCT00783692|449246948|FG002|Induction Phase|Adverse Event|24|||
124896805|NCT00783692|449246949|FG003|Induction Phase|Adverse Event|0|||
124896806|NCT00783692|449246950|FG004|Induction Phase|Adverse Event|0|||
124896807|NCT00783692|449246951|FG005|Induction Phase|Adverse Event|0|||
124896808|NCT00783692|449246952|FG006|Induction Phase|Adverse Event|0|||
124896809|NCT00783692|449246946|FG000|Induction Phase|Protocol Violation|0|||
124896810|NCT00783692|449246947|FG001|Induction Phase|Protocol Violation|0|||
124896811|NCT00783692|449246948|FG002|Induction Phase|Protocol Violation|1|||
124896812|NCT00783692|449246949|FG003|Induction Phase|Protocol Violation|0|||
124896813|NCT00783692|449246950|FG004|Induction Phase|Protocol Violation|0|||
124896814|NCT00783692|449246951|FG005|Induction Phase|Protocol Violation|0|||
124896815|NCT00783692|449246952|FG006|Induction Phase|Protocol Violation|0|||
124896816|NCT00783692|449246946|FG000|Induction Phase|Lack of Efficacy|1|||
124896817|NCT00783692|449246947|FG001|Induction Phase|Lack of Efficacy|3|||
124896818|NCT00783692|449246948|FG002|Induction Phase|Lack of Efficacy|28|||
124896819|NCT00783692|449246949|FG003|Induction Phase|Lack of Efficacy|0|||
124896820|NCT00783692|449246950|FG004|Induction Phase|Lack of Efficacy|0|||
124896821|NCT00783692|449246951|FG005|Induction Phase|Lack of Efficacy|0|||
125019036|NCT01662440|449694637|FG002|Overall Study|Withdrawal by Subject|2|||
125019037|NCT01662440|449694638|FG003|Overall Study|Withdrawal by Subject|2|||
125019038|NCT00112905|449694639|FG000|Overall Study|Adverse Event|4|||
125019039|NCT00112905|449694639|FG000|Overall Study|Death|1|||
125019040|NCT00112905|449694639|FG000|Overall Study|Ineligibility|5|||
125019041|NCT00112905|449694639|FG000|Overall Study|Alternative treatment|1|||
125019042|NCT00112905|449694639|FG000|Overall Study|performance status was deteiorating|1|||
125019043|NCT02600507|449694640|FG000|Overall Study|Adverse Event|3|||
125019044|NCT02600507|449694641|FG001|Overall Study|Adverse Event|15|||
125019045|NCT02600507|449694642|FG002|Overall Study|Adverse Event|5|||
125019046|NCT02600507|449694640|FG000|Overall Study|Lack of Efficacy|3|||
125019047|NCT02600507|449694641|FG001|Overall Study|Lack of Efficacy|8|||
125019048|NCT02600507|449694642|FG002|Overall Study|Lack of Efficacy|5|||
125019049|NCT02600507|449694640|FG000|Overall Study|Lost to Follow-up|3|||
125019050|NCT02600507|449694641|FG001|Overall Study|Lost to Follow-up|5|||
125019051|NCT02600507|449694642|FG002|Overall Study|Lost to Follow-up|2|||
125019052|NCT02600507|449694640|FG000|Overall Study|Protocol Violation|12|||
125019053|NCT02600507|449694641|FG001|Overall Study|Protocol Violation|4|||
125019054|NCT02600507|449694642|FG002|Overall Study|Protocol Violation|4|||
125019055|NCT02600507|449694640|FG000|Overall Study|Physician Decision|1|||
125019056|NCT02600507|449694641|FG001|Overall Study|Physician Decision|0|||
125019057|NCT02600507|449694642|FG002|Overall Study|Physician Decision|1|||
125019058|NCT02600507|449694640|FG000|Overall Study|Withdrawal by Subject|7|||
125019059|NCT02600507|449694641|FG001|Overall Study|Withdrawal by Subject|11|||
125019060|NCT02600507|449694642|FG002|Overall Study|Withdrawal by Subject|7|||
125019061|NCT02600507|449694640|FG000|Overall Study|Other|0|||
125110331|NCT01629693|450027602|FG001|Overall Study|Lost to Follow-up|4|||
125110332|NCT01629693|450027601|FG000|Overall Study|Withdrawal by Subject|2|||
125019062|NCT02600507|449694641|FG001|Overall Study|Other|1|||
124896822|NCT00783692|449246952|FG006|Induction Phase|Lack of Efficacy|0|||
124896823|NCT00783692|449246946|FG000|Induction Phase|Withdrawal by Subject|3|||
125019063|NCT02600507|449694642|FG002|Overall Study|Other|1|||
125019064|NCT04541004|449694643|FG000|Overall Study|Adverse Event|2|||
124896824|NCT00783692|449246947|FG001|Induction Phase|Withdrawal by Subject|9|||
124896825|NCT00783692|449246948|FG002|Induction Phase|Withdrawal by Subject|16|||
125019065|NCT05048719|449694644|FG000|Overall Study|Withdrawal by Subject|2|||
124896826|NCT00783692|449246949|FG003|Induction Phase|Withdrawal by Subject|0|||
124896827|NCT00783692|449246950|FG004|Induction Phase|Withdrawal by Subject|0|||
124896828|NCT00783692|449246951|FG005|Induction Phase|Withdrawal by Subject|0|||
124896829|NCT00783692|449246952|FG006|Induction Phase|Withdrawal by Subject|0|||
124896830|NCT00783692|449246946|FG000|Induction Phase|Lost to Follow-up|0|||
124896831|NCT00783692|449246947|FG001|Induction Phase|Lost to Follow-up|0|||
124896832|NCT00783692|449246948|FG002|Induction Phase|Lost to Follow-up|3|||
124896833|NCT00783692|449246949|FG003|Induction Phase|Lost to Follow-up|0|||
124896834|NCT00783692|449246950|FG004|Induction Phase|Lost to Follow-up|0|||
124896835|NCT00783692|449246951|FG005|Induction Phase|Lost to Follow-up|0|||
124896836|NCT00783692|449246952|FG006|Induction Phase|Lost to Follow-up|0|||
124896837|NCT00783692|449246946|FG000|Induction Phase|Other|0|||
124896838|NCT00783692|449246947|FG001|Induction Phase|Other|0|||
124896839|NCT00783692|449246948|FG002|Induction Phase|Other|2|||
124896840|NCT00783692|449246949|FG003|Induction Phase|Other|0|||
124896841|NCT00783692|449246950|FG004|Induction Phase|Other|0|||
124896842|NCT00783692|449246951|FG005|Induction Phase|Other|0|||
124896843|NCT00783692|449246952|FG006|Induction Phase|Other|0|||
124896844|NCT00783692|449246946|FG000|Maintenance Phase|Adverse Event|7|||
124896845|NCT00783692|449246947|FG001|Maintenance Phase|Adverse Event|0|||
124896846|NCT00783692|449246948|FG002|Maintenance Phase|Adverse Event|0|||
124896847|NCT00783692|449246949|FG003|Maintenance Phase|Adverse Event|15|||
124896848|NCT00783692|449246950|FG004|Maintenance Phase|Adverse Event|12|||
124896849|NCT00783692|449246951|FG005|Maintenance Phase|Adverse Event|9|||
124896850|NCT00783692|449246952|FG006|Maintenance Phase|Adverse Event|38|||
124896851|NCT00783692|449246946|FG000|Maintenance Phase|Protocol Violation|0|||
124896852|NCT00783692|449246947|FG001|Maintenance Phase|Protocol Violation|0|||
124896853|NCT00783692|449246948|FG002|Maintenance Phase|Protocol Violation|0|||
124896854|NCT00783692|449246949|FG003|Maintenance Phase|Protocol Violation|1|||
124896855|NCT00783692|449246950|FG004|Maintenance Phase|Protocol Violation|2|||
124896856|NCT00783692|449246951|FG005|Maintenance Phase|Protocol Violation|3|||
124896857|NCT00783692|449246952|FG006|Maintenance Phase|Protocol Violation|4|||
124896858|NCT00783692|449246946|FG000|Maintenance Phase|Lack of Efficacy|79|||
124896859|NCT00783692|449246947|FG001|Maintenance Phase|Lack of Efficacy|0|||
124896860|NCT00783692|449246948|FG002|Maintenance Phase|Lack of Efficacy|0|||
124896861|NCT00783692|449246949|FG003|Maintenance Phase|Lack of Efficacy|64|||
124896862|NCT00783692|449246950|FG004|Maintenance Phase|Lack of Efficacy|58|||
124896863|NCT00783692|449246951|FG005|Maintenance Phase|Lack of Efficacy|48|||
124896864|NCT00783692|449246952|FG006|Maintenance Phase|Lack of Efficacy|177|||
124896865|NCT00783692|449246946|FG000|Maintenance Phase|Withdrawal by Subject|7|||
124896866|NCT00783692|449246947|FG001|Maintenance Phase|Withdrawal by Subject|0|||
124896867|NCT00783692|449246948|FG002|Maintenance Phase|Withdrawal by Subject|0|||
124896868|NCT00783692|449246949|FG003|Maintenance Phase|Withdrawal by Subject|7|||
124896869|NCT00783692|449246950|FG004|Maintenance Phase|Withdrawal by Subject|6|||
124896870|NCT00783692|449246951|FG005|Maintenance Phase|Withdrawal by Subject|9|||
125110333|NCT01629693|450027602|FG001|Overall Study|Withdrawal by Subject|2|||
125110334|NCT01629693|450027601|FG000|Overall Study|Adverse Event|1|||
125110335|NCT01629693|450027602|FG001|Overall Study|Adverse Event|0|||
125110336|NCT01629693|450027601|FG000|Overall Study|Investigator decision|0|||
125110337|NCT01629693|450027602|FG001|Overall Study|Investigator decision|1|||
125110338|NCT01629693|450027601|FG000|Overall Study|Poor comfort of study lenses|0|||
125110339|NCT01629693|450027602|FG001|Overall Study|Poor comfort of study lenses|2|||
125110340|NCT01629693|450027601|FG000|Overall Study|Subject decision unrelated to AE|0|||
125110341|NCT01629693|450027602|FG001|Overall Study|Subject decision unrelated to AE|1|||
125110342|NCT01529749|450027603|FG000|Overall Study|Lost to Follow-up|0|||
125110343|NCT01529749|450027604|FG001|Overall Study|Lost to Follow-up|1|||
125110344|NCT01529749|450027605|FG002|Overall Study|Lost to Follow-up|1|||
124896871|NCT00783692|449246952|FG006|Maintenance Phase|Withdrawal by Subject|24|||
124896872|NCT00783692|449246946|FG000|Maintenance Phase|Lost to Follow-up|2|||
124896873|NCT00783692|449246947|FG001|Maintenance Phase|Lost to Follow-up|0|||
125110345|NCT01529749|450027606|FG003|Overall Study|Lost to Follow-up|0|||
125110346|NCT01529749|450027603|FG000|Overall Study|Physician Decision|0|||
124896874|NCT00783692|449246948|FG002|Maintenance Phase|Lost to Follow-up|0|||
124896875|NCT00783692|449246949|FG003|Maintenance Phase|Lost to Follow-up|1|||
124896876|NCT00783692|449246950|FG004|Maintenance Phase|Lost to Follow-up|3|||
124896877|NCT00783692|449246951|FG005|Maintenance Phase|Lost to Follow-up|2|||
124896878|NCT00783692|449246952|FG006|Maintenance Phase|Lost to Follow-up|5|||
124896879|NCT00783692|449246946|FG000|Maintenance Phase|Other|0|||
124896880|NCT00783692|449246947|FG001|Maintenance Phase|Other|0|||
124896881|NCT00783692|449246948|FG002|Maintenance Phase|Other|0|||
125110347|NCT01529749|450027604|FG001|Overall Study|Physician Decision|0|||
125110348|NCT01529749|450027605|FG002|Overall Study|Physician Decision|0|||
124896882|NCT00783692|449246949|FG003|Maintenance Phase|Other|1|||
124896883|NCT00783692|449246950|FG004|Maintenance Phase|Other|0|||
125110349|NCT01529749|450027606|FG003|Overall Study|Physician Decision|1|||
125110350|NCT01529749|450027603|FG000|Overall Study|Withdrawal by Subject|0|||
125110351|NCT01529749|450027604|FG001|Overall Study|Withdrawal by Subject|1|||
124896884|NCT00783692|449246951|FG005|Maintenance Phase|Other|1|||
124896885|NCT00783692|449246952|FG006|Maintenance Phase|Other|1|||
124896886|NCT01096056|449246955|FG000|Overall Study|Lost to Follow-up|0|||
124896887|NCT01096056|449246956|FG001|Overall Study|Lost to Follow-up|1|||
124896888|NCT03568162|449246960|FG000|Overall Study|Adverse Event|0|||
124896889|NCT03568162|449246961|FG001|Overall Study|Adverse Event|1|||
124896890|NCT03568162|449246962|FG002|Overall Study|Adverse Event|2|||
124896891|NCT03568162|449246963|FG003|Overall Study|Adverse Event|0|||
124896892|NCT03568162|449246964|FG004|Overall Study|Adverse Event|0|||
124896893|NCT03568162|449246965|FG005|Overall Study|Adverse Event|1|||
124896894|NCT03568162|449246960|FG000|Overall Study|Death|0|||
124896895|NCT03568162|449246961|FG001|Overall Study|Death|0|||
124896896|NCT03568162|449246962|FG002|Overall Study|Death|0|||
124896897|NCT03568162|449246963|FG003|Overall Study|Death|0|||
124896898|NCT03568162|449246964|FG004|Overall Study|Death|1|||
124896899|NCT03568162|449246965|FG005|Overall Study|Death|0|||
124896900|NCT03568162|449246960|FG000|Overall Study|Lost to Follow-up|3|||
124896901|NCT03568162|449246961|FG001|Overall Study|Lost to Follow-up|2|||
124896902|NCT03568162|449246962|FG002|Overall Study|Lost to Follow-up|4|||
124896903|NCT03568162|449246963|FG003|Overall Study|Lost to Follow-up|2|||
124896904|NCT03568162|449246964|FG004|Overall Study|Lost to Follow-up|3|||
124896905|NCT03568162|449246965|FG005|Overall Study|Lost to Follow-up|2|||
124896906|NCT03568162|449246960|FG000|Overall Study|Physician Decision|0|||
124896907|NCT03568162|449246961|FG001|Overall Study|Physician Decision|1|||
124896908|NCT03568162|449246962|FG002|Overall Study|Physician Decision|1|||
124896909|NCT03568162|449246963|FG003|Overall Study|Physician Decision|0|||
124896910|NCT03568162|449246964|FG004|Overall Study|Physician Decision|1|||
124896911|NCT03568162|449246965|FG005|Overall Study|Physician Decision|0|||
124896912|NCT03568162|449246960|FG000|Overall Study|Pregnancy|0|||
124896913|NCT03568162|449246961|FG001|Overall Study|Pregnancy|0|||
124896914|NCT03568162|449246962|FG002|Overall Study|Pregnancy|0|||
124896915|NCT03568162|449246963|FG003|Overall Study|Pregnancy|1|||
124896916|NCT03568162|449246964|FG004|Overall Study|Pregnancy|0|||
124896917|NCT03568162|449246965|FG005|Overall Study|Pregnancy|0|||
124896918|NCT03568162|449246960|FG000|Overall Study|Protocol Violation|1|||
124896919|NCT03568162|449246961|FG001|Overall Study|Protocol Violation|0|||
124896920|NCT03568162|449246962|FG002|Overall Study|Protocol Violation|1|||
124896921|NCT03568162|449246963|FG003|Overall Study|Protocol Violation|1|||
124896922|NCT03568162|449246964|FG004|Overall Study|Protocol Violation|1|||
124896923|NCT03568162|449246965|FG005|Overall Study|Protocol Violation|1|||
124896924|NCT03568162|449246960|FG000|Overall Study|Withdrawal by Subject|15|||
124896925|NCT03568162|449246961|FG001|Overall Study|Withdrawal by Subject|15|||
124896926|NCT03568162|449246962|FG002|Overall Study|Withdrawal by Subject|26|||
124896927|NCT03568162|449246963|FG003|Overall Study|Withdrawal by Subject|22|||
124896928|NCT03568162|449246964|FG004|Overall Study|Withdrawal by Subject|6|||
124896929|NCT03568162|449246965|FG005|Overall Study|Withdrawal by Subject|9|||
124896930|NCT03568162|449246960|FG000|Overall Study|Others|3|||
124896931|NCT03568162|449246961|FG001|Overall Study|Others|4|||
124896932|NCT03568162|449246962|FG002|Overall Study|Others|1|||
124896933|NCT03568162|449246963|FG003|Overall Study|Others|4|||
124896934|NCT03568162|449246964|FG004|Overall Study|Others|2|||
124896935|NCT03568162|449246965|FG005|Overall Study|Others|1|||
124896936|NCT03717194|449246967|FG000|Overall Study|Withdrawal by Subject|2|||
124896937|NCT03717194|449246968|FG001|Overall Study|Withdrawal by Subject|4|||
124896938|NCT03717194|449246967|FG000|Overall Study|Adverse Event|1|||
124896939|NCT03717194|449246968|FG001|Overall Study|Adverse Event|1|||
125110352|NCT01529749|450027605|FG002|Overall Study|Withdrawal by Subject|1|||
125110353|NCT01529749|450027606|FG003|Overall Study|Withdrawal by Subject|0|||
125110354|NCT01529749|450027603|FG000|Overall Study|Protocol Violation|0|||
124896940|NCT01190176|449246972|FG000|Overall Study|Withdrawal by Subject|1|||
124896941|NCT01190176|449246972|FG000|Overall Study|Lost to Follow-up|1|||
124896942|NCT01836458|449246973|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
124896943|NCT01836458|449246974|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124896944|NCT01836458|449246975|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
124896945|NCT01836458|449246976|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
124896946|NCT02081391|449246977|FG000|12-hour Treatment|Withdrawal by Subject|3|||
124896947|NCT02081391|449246978|FG001|12-hour Treatment|Withdrawal by Subject|2|||
124896948|NCT02081391|449246979|FG002|12-hour Treatment|Withdrawal by Subject|0|||
125110355|NCT01529749|450027604|FG001|Overall Study|Protocol Violation|0|||
125110356|NCT01529749|450027605|FG002|Overall Study|Protocol Violation|0|||
124896949|NCT02081391|449246980|FG003|12-hour Treatment|Withdrawal by Subject|0|||
124896950|NCT02081391|449246977|FG000|12-hour Treatment|Physician Decision|4|||
124896951|NCT02081391|449246978|FG001|12-hour Treatment|Physician Decision|1|||
125110357|NCT01529749|450027606|FG003|Overall Study|Protocol Violation|1|||
124896952|NCT02081391|449246979|FG002|12-hour Treatment|Physician Decision|0|||
124896953|NCT02081391|449246980|FG003|12-hour Treatment|Physician Decision|0|||
124896954|NCT02081391|449246977|FG000|12-hour Treatment|Lack of Efficacy|3|||
125019066|NCT05048719|449694645|FG001|Overall Study|Withdrawal by Subject|1|||
125019067|NCT05048719|449694646|FG002|Overall Study|Withdrawal by Subject|3|||
125019068|NCT05048719|449694647|FG003|Overall Study|Withdrawal by Subject|1|||
125019069|NCT05048719|449694648|FG004|Overall Study|Withdrawal by Subject|0|||
125019070|NCT05048719|449694649|FG005|Overall Study|Withdrawal by Subject|2|||
125019071|NCT05048719|449694650|FG006|Overall Study|Withdrawal by Subject|1|||
125019072|NCT05048719|449694651|FG007|Overall Study|Withdrawal by Subject|1|||
125019073|NCT05048719|449694652|FG008|Overall Study|Withdrawal by Subject|0|||
125019074|NCT05048719|449694644|FG000|Overall Study|Death|1|||
125019075|NCT05048719|449694645|FG001|Overall Study|Death|0|||
125019076|NCT05048719|449694646|FG002|Overall Study|Death|0|||
124896955|NCT02081391|449246978|FG001|12-hour Treatment|Lack of Efficacy|0|||
124896956|NCT02081391|449246979|FG002|12-hour Treatment|Lack of Efficacy|0|||
124896957|NCT02081391|449246980|FG003|12-hour Treatment|Lack of Efficacy|0|||
124896958|NCT02081391|449246977|FG000|12-hour Treatment|Adverse Event|4|||
124896959|NCT02081391|449246978|FG001|12-hour Treatment|Adverse Event|2|||
124896960|NCT02081391|449246979|FG002|12-hour Treatment|Adverse Event|0|||
124896961|NCT02081391|449246980|FG003|12-hour Treatment|Adverse Event|0|||
124896962|NCT02081391|449246977|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
124896963|NCT02081391|449246978|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
124896964|NCT02081391|449246979|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
124896965|NCT02081391|449246980|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
124896966|NCT02081391|449246977|FG000|12-hour Treatment|Further reasons|2|||
124896967|NCT02081391|449246978|FG001|12-hour Treatment|Further reasons|1|||
124896968|NCT02081391|449246979|FG002|12-hour Treatment|Further reasons|0|||
124896969|NCT02081391|449246980|FG003|12-hour Treatment|Further reasons|0|||
124896970|NCT02081391|449246977|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
124896971|NCT02081391|449246978|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
124896972|NCT02081391|449246979|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
124896973|NCT02081391|449246980|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
124896974|NCT02081391|449246977|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
124896975|NCT02081391|449246978|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
124896976|NCT02081391|449246979|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
124896977|NCT02081391|449246980|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
124896978|NCT02081391|449246977|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
124896979|NCT02081391|449246978|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
125110358|NCT04385199|450027607|FG000|Overall Study|Withdrawal by Subject|1|||
125110359|NCT04385199|450027608|FG001|Overall Study|Withdrawal by Subject|0|||
124896980|NCT02081391|449246979|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
124896981|NCT02081391|449246980|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
124896982|NCT02081391|449246977|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
124896983|NCT02081391|449246978|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
124896984|NCT02081391|449246979|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
125110360|NCT00860574|450029243|FG000|Overall Study|Death|2|||
125110361|NCT00860574|450029243|FG000|Overall Study|Relapse|1|||
125110362|NCT01246986|450029244|FG000|Overall Study|Lost to Follow-up|0|||
125110363|NCT01246986|450029245|FG001|Overall Study|Lost to Follow-up|1|||
125110364|NCT01246986|450029246|FG002|Overall Study|Lost to Follow-up|3|||
125110365|NCT01246986|450029247|FG003|Overall Study|Lost to Follow-up|0|||
125110366|NCT01246986|450029248|FG004|Overall Study|Lost to Follow-up|0|||
125110367|NCT01246986|450029249|FG005|Overall Study|Lost to Follow-up|1|||
125110368|NCT01246986|450029250|FG006|Overall Study|Lost to Follow-up|0|||
124896985|NCT02081391|449246980|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
124896986|NCT02081391|449246977|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
124896987|NCT02081391|449246978|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
124896988|NCT02081391|449246979|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
124896989|NCT02081391|449246980|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
125110369|NCT01246986|450029244|FG000|Overall Study|Withdrawal by Subject|3|||
125110370|NCT01246986|450029245|FG001|Overall Study|Withdrawal by Subject|4|||
125110371|NCT01246986|450029246|FG002|Overall Study|Withdrawal by Subject|3|||
125110372|NCT01246986|450029247|FG003|Overall Study|Withdrawal by Subject|0|||
125110373|NCT01246986|450029248|FG004|Overall Study|Withdrawal by Subject|4|||
125110374|NCT01246986|450029249|FG005|Overall Study|Withdrawal by Subject|0|||
125110375|NCT01246986|450029250|FG006|Overall Study|Withdrawal by Subject|0|||
124896990|NCT02081391|449246977|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
124896991|NCT02081391|449246978|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
125019077|NCT05048719|449694647|FG003|Overall Study|Death|0|||
125019078|NCT05048719|449694648|FG004|Overall Study|Death|0|||
125019079|NCT05048719|449694649|FG005|Overall Study|Death|0|||
125019080|NCT05048719|449694650|FG006|Overall Study|Death|0|||
125019081|NCT05048719|449694651|FG007|Overall Study|Death|0|||
125019082|NCT05048719|449694652|FG008|Overall Study|Death|0|||
125019083|NCT05048719|449694644|FG000|Overall Study|Adverse Event|0|||
125110376|NCT01335399|450029254|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
124896992|NCT02081391|449246979|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
124896993|NCT02081391|449246980|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
125019084|NCT05048719|449694645|FG001|Overall Study|Adverse Event|1|||
125019085|NCT05048719|449694646|FG002|Overall Study|Adverse Event|2|||
125110377|NCT01335399|450029255|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
125110378|NCT01335399|450029254|FG000|Pre-treatment Period|Participant request to discontinue|0|||
125110379|NCT01335399|450029255|FG001|Pre-treatment Period|Participant request to discontinue|1|||
125210780|NCT02134353|450395685|FG001|Overall Study|Adverse Event|6|||
125110380|NCT01335399|450029254|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
125110381|NCT01335399|450029255|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
125110382|NCT01335399|450029254|FG000|Pre-treatment Period|Consent withdrawal|3|||
125110383|NCT01335399|450029255|FG001|Pre-treatment Period|Consent withdrawal|0|||
125110384|NCT01335399|450029254|FG000|Treatment Period|Disease progression|117|||
124896994|NCT02189863|449246981|FG000|First 2 Weeks|Motion Sickness|4|||
124896995|NCT02189863|449246982|FG001|First 2 Weeks|Motion Sickness|2|||
124896996|NCT01559090|449246983|FG000|Stage I|Withdrawal by Subject|2|||
124896997|NCT01559090|449246984|FG001|Stage I|Withdrawal by Subject|2|||
124896998|NCT01559090|449246985|FG002|Stage I|Withdrawal by Subject|3|||
124896999|NCT01559090|449246983|FG000|Stage II|Withdrawal by Subject|1|||
124897000|NCT01559090|449246984|FG001|Stage II|Withdrawal by Subject|0|||
124897001|NCT01559090|449246985|FG002|Stage II|Withdrawal by Subject|0|||
124897002|NCT03677375|449246986|FG000|Overall Study|Incomplete procedure|8|||
124897003|NCT03677375|449246986|FG000|Overall Study|Adverse Event|3|||
124897004|NCT03677375|449246986|FG000|Overall Study|Physician Decision|1|||
124897005|NCT03971357|449246992|FG000|Overall Study|Lack of Efficacy|0|||
124897006|NCT03971357|449246993|FG001|Overall Study|Lack of Efficacy|1|||
124897007|NCT00430677|449246997|FG000|Short-term Period|Death|1|||
124897008|NCT00430677|449246998|FG001|Short-term Period|Death|1|||
124897009|NCT00430677|449246999|FG002|Short-term Period|Death|5|||
124897010|NCT00430677|449246997|FG000|Short-term Period|Adverse Event|15|||
124897011|NCT00430677|449246998|FG001|Short-term Period|Adverse Event|13|||
124897012|NCT00430677|449246999|FG002|Short-term Period|Adverse Event|9|||
125110385|NCT01335399|450029255|FG001|Treatment Period|Disease progression|145|||
125110386|NCT01335399|450029254|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
125110387|NCT01335399|450029255|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
125110388|NCT01335399|450029254|FG000|Treatment Period|Study drug toxicity|52|||
125110389|NCT01335399|450029255|FG001|Treatment Period|Study drug toxicity|64|||
125110390|NCT01335399|450029254|FG000|Treatment Period|Participant request to discontinue|30|||
125110391|NCT01335399|450029255|FG001|Treatment Period|Participant request to discontinue|22|||
125110392|NCT01335399|450029254|FG000|Treatment Period|Other reasons|30|||
125110393|NCT01335399|450029255|FG001|Treatment Period|Other reasons|30|||
124897013|NCT00430677|449246997|FG000|Short-term Period|Lack of Efficacy|5|||
124897014|NCT00430677|449246998|FG001|Short-term Period|Lack of Efficacy|6|||
125019086|NCT05048719|449694647|FG003|Overall Study|Adverse Event|0|||
125019087|NCT05048719|449694648|FG004|Overall Study|Adverse Event|1|||
125019088|NCT05048719|449694649|FG005|Overall Study|Adverse Event|0|||
125019089|NCT05048719|449694650|FG006|Overall Study|Adverse Event|0|||
125019090|NCT05048719|449694651|FG007|Overall Study|Adverse Event|0|||
125019091|NCT05048719|449694652|FG008|Overall Study|Adverse Event|0|||
125019092|NCT05048719|449694644|FG000|Overall Study|Lost to Follow-up|0|||
125019093|NCT05048719|449694645|FG001|Overall Study|Lost to Follow-up|0|||
124897015|NCT00430677|449246999|FG002|Short-term Period|Lack of Efficacy|4|||
124897016|NCT00430677|449246997|FG000|Short-term Period|Withdrawal by Subject|1|||
124897017|NCT00430677|449246998|FG001|Short-term Period|Withdrawal by Subject|1|||
124897018|NCT00430677|449246999|FG002|Short-term Period|Withdrawal by Subject|2|||
124897019|NCT00430677|449246997|FG000|Short-term Period|Participant no longer met study criteria|1|||
124897020|NCT00430677|449246998|FG001|Short-term Period|Participant no longer met study criteria|1|||
125019094|NCT05048719|449694646|FG002|Overall Study|Lost to Follow-up|1|||
125019095|NCT05048719|449694647|FG003|Overall Study|Lost to Follow-up|3|||
125019096|NCT05048719|449694648|FG004|Overall Study|Lost to Follow-up|1|||
125019097|NCT05048719|449694649|FG005|Overall Study|Lost to Follow-up|1|||
125019098|NCT05048719|449694650|FG006|Overall Study|Lost to Follow-up|1|||
125019099|NCT05048719|449694651|FG007|Overall Study|Lost to Follow-up|1|||
125019100|NCT05048719|449694652|FG008|Overall Study|Lost to Follow-up|0|||
125019101|NCT05048719|449694644|FG000|Overall Study|Physician Decision|0|||
125019102|NCT05048719|449694645|FG001|Overall Study|Physician Decision|0|||
125019103|NCT05048719|449694646|FG002|Overall Study|Physician Decision|0|||
125019104|NCT05048719|449694647|FG003|Overall Study|Physician Decision|0|||
125019105|NCT05048719|449694648|FG004|Overall Study|Physician Decision|0|||
125019106|NCT05048719|449694649|FG005|Overall Study|Physician Decision|0|||
125019107|NCT05048719|449694650|FG006|Overall Study|Physician Decision|0|||
125019108|NCT05048719|449694651|FG007|Overall Study|Physician Decision|1|||
125019109|NCT05048719|449694652|FG008|Overall Study|Physician Decision|1|||
125019110|NCT05048719|449694644|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
125019111|NCT05048719|449694645|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
125019112|NCT05048719|449694646|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
125019113|NCT05048719|449694647|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
125019114|NCT05048719|449694648|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
125019115|NCT05048719|449694649|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
125019116|NCT05048719|449694650|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
125019117|NCT05048719|449694651|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
125019118|NCT05048719|449694652|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
125019119|NCT05048719|449694644|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
125019120|NCT05048719|449694645|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
125019121|NCT05048719|449694646|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
125019122|NCT05048719|449694647|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
125019123|NCT05048719|449694648|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
125019124|NCT05048719|449694649|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
125019125|NCT05048719|449694650|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
125019126|NCT05048719|449694651|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
125019127|NCT05048719|449694652|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
125019128|NCT05048719|449694644|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
125019129|NCT05048719|449694645|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
125019130|NCT05048719|449694646|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
125019131|NCT05048719|449694647|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
125019132|NCT05048719|449694648|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
125019133|NCT05048719|449694649|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
125019134|NCT05048719|449694650|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
125019135|NCT05048719|449694651|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
125019136|NCT05048719|449694652|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
125019137|NCT05048719|449694644|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
125019138|NCT05048719|449694645|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
125019139|NCT05048719|449694646|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
125019140|NCT05048719|449694647|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
125019141|NCT05048719|449694648|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
125019142|NCT05048719|449694649|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
125019143|NCT05048719|449694650|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
125019144|NCT05048719|449694651|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
125019145|NCT05048719|449694652|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
125019146|NCT05048719|449694644|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
125019147|NCT05048719|449694645|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
125019148|NCT05048719|449694646|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
125110394|NCT01335399|450029254|FG000|Treatment Period|Consent withdrawal|10|||
125110395|NCT01335399|450029255|FG001|Treatment Period|Consent withdrawal|7|||
125110396|NCT01335399|450029254|FG000|Treatment Period|Death|7|||
125110397|NCT01335399|450029255|FG001|Treatment Period|Death|6|||
125110398|NCT01335399|450029254|FG000|Treatment Period|Poor/Non-compliance|3|||
125110399|NCT01335399|450029255|FG001|Treatment Period|Poor/Non-compliance|4|||
125110400|NCT01335399|450029254|FG000|Treatment Period|Lost to Follow-up|2|||
125110401|NCT01335399|450029255|FG001|Treatment Period|Lost to Follow-up|2|||
125110402|NCT01335399|450029254|FG000|Treatment Period|Maximum clinical benefit|1|||
125110403|NCT01335399|450029255|FG001|Treatment Period|Maximum clinical benefit|1|||
125110404|NCT01335399|450029254|FG000|Treatment Period|No longer meet study criteria|1|||
125110405|NCT01335399|450029255|FG001|Treatment Period|No longer meet study criteria|1|||
125110406|NCT01335399|450029254|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
125110407|NCT01335399|450029255|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
125110408|NCT01416142|450029256|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
125110409|NCT01416142|450029257|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
125110410|NCT01416142|450029258|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
125110411|NCT02464059|450029259|FG000|Overall Study|Lost to Follow-up|6|||
125110412|NCT00304954|450029262|FG000|Overall Study|Withdrawal by Subject|0|||
125110413|NCT00304954|450029263|FG001|Overall Study|Withdrawal by Subject|0|||
125110414|NCT00304954|450029264|FG002|Overall Study|Withdrawal by Subject|1|||
125110415|NCT00304954|450029265|FG003|Overall Study|Withdrawal by Subject|0|||
125110416|NCT00304954|450029262|FG000|Overall Study|Adverse Event|1|||
125110417|NCT00304954|450029263|FG001|Overall Study|Adverse Event|0|||
125110418|NCT00304954|450029264|FG002|Overall Study|Adverse Event|0|||
125110419|NCT00304954|450029265|FG003|Overall Study|Adverse Event|0|||
125110420|NCT03990389|450029268|FG000|Overall Study|Lost to Follow-up|3|||
125110421|NCT03990389|450029269|FG001|Overall Study|Lost to Follow-up|0|||
125110422|NCT01326702|450029270|FG000|Overall Study|Other|1|||
125110423|NCT01326702|450029271|FG001|Overall Study|Other|0|||
125110424|NCT01326702|450029272|FG002|Overall Study|Other|0|||
125110425|NCT01326702|450029273|FG003|Overall Study|Other|0|||
125110426|NCT01326702|450029274|FG004|Overall Study|Other|0|||
125110427|NCT01326702|450029275|FG005|Overall Study|Other|1|||
125110428|NCT01326702|450029276|FG006|Overall Study|Other|0|||
125110429|NCT01326702|450029270|FG000|Overall Study|progressive disease|1|||
125110430|NCT01326702|450029271|FG001|Overall Study|progressive disease|1|||
125110431|NCT01326702|450029272|FG002|Overall Study|progressive disease|3|||
125110432|NCT01326702|450029273|FG003|Overall Study|progressive disease|1|||
125110433|NCT01326702|450029274|FG004|Overall Study|progressive disease|3|||
125110434|NCT01326702|450029275|FG005|Overall Study|progressive disease|2|||
125110435|NCT01326702|450029276|FG006|Overall Study|progressive disease|3|||
125110436|NCT01326702|450029270|FG000|Overall Study|Death|0|||
125110437|NCT01326702|450029271|FG001|Overall Study|Death|1|||
125110438|NCT01326702|450029272|FG002|Overall Study|Death|0|||
125110439|NCT01326702|450029273|FG003|Overall Study|Death|0|||
125110440|NCT01326702|450029274|FG004|Overall Study|Death|0|||
125110441|NCT01326702|450029275|FG005|Overall Study|Death|0|||
125110442|NCT01326702|450029276|FG006|Overall Study|Death|0|||
125110443|NCT01326702|450029270|FG000|Overall Study|Adverse Event|0|||
125110444|NCT01326702|450029271|FG001|Overall Study|Adverse Event|0|||
125110445|NCT01326702|450029272|FG002|Overall Study|Adverse Event|1|||
125110446|NCT01326702|450029273|FG003|Overall Study|Adverse Event|1|||
125110447|NCT01326702|450029274|FG004|Overall Study|Adverse Event|0|||
125110448|NCT01326702|450029275|FG005|Overall Study|Adverse Event|3|||
125110449|NCT01326702|450029276|FG006|Overall Study|Adverse Event|1|||
125110450|NCT01326702|450029270|FG000|Overall Study|Withdrawal by Subject|0|||
125110451|NCT01326702|450029271|FG001|Overall Study|Withdrawal by Subject|0|||
125110452|NCT01326702|450029272|FG002|Overall Study|Withdrawal by Subject|1|||
125110453|NCT01326702|450029273|FG003|Overall Study|Withdrawal by Subject|0|||
125110454|NCT01326702|450029274|FG004|Overall Study|Withdrawal by Subject|1|||
125110455|NCT01326702|450029275|FG005|Overall Study|Withdrawal by Subject|1|||
125110456|NCT01326702|450029276|FG006|Overall Study|Withdrawal by Subject|3|||
125110457|NCT01326702|450029270|FG000|Overall Study|Not Treated|0|||
125110458|NCT01326702|450029271|FG001|Overall Study|Not Treated|0|||
125110459|NCT01326702|450029272|FG002|Overall Study|Not Treated|0|||
125110460|NCT01326702|450029273|FG003|Overall Study|Not Treated|1|||
125110461|NCT01326702|450029274|FG004|Overall Study|Not Treated|0|||
125110462|NCT01326702|450029275|FG005|Overall Study|Not Treated|1|||
125110463|NCT01326702|450029276|FG006|Overall Study|Not Treated|0|||
125110464|NCT01835132|450029278|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
125110465|NCT00856778|450029279|FG000|Overall Study|Adverse Event|7|||
125110466|NCT00856778|450029279|FG000|Overall Study|Withdrawal by Subject|10|||
125110467|NCT00856778|450029279|FG000|Overall Study|Study deviation|2|||
125110468|NCT00856778|450029279|FG000|Overall Study|Lost to Follow-up|5|||
125110469|NCT03208933|450029280|FG000|Overall Study|Death|3|||
125110470|NCT03208933|450029280|FG000|Overall Study|Withdrawal by Subject|3|||
125110471|NCT03208933|450029280|FG000|Overall Study|Adverse Event|1|||
125110472|NCT03208933|450029280|FG000|Overall Study|Lost to Follow-up|2|||
125110473|NCT03208933|450029280|FG000|Overall Study|Physician Decision|3|||
125110474|NCT03208933|450029280|FG000|Overall Study|Protocol Violation|1|||
125110475|NCT00331773|450029281|FG000|Overall Study|Withdrawal by Subject|6|||
125110476|NCT00331773|450029282|FG001|Overall Study|Withdrawal by Subject|4|||
125110477|NCT00331773|450029281|FG000|Overall Study|Protocol Violation|10|||
125110478|NCT00331773|450029282|FG001|Overall Study|Protocol Violation|3|||
125110479|NCT00379587|450029283|FG000|Overall Study|Lost to Follow-up|2|||
125110480|NCT00525031|450029288|FG000|Overall Study|Disease Progression|1|||
125110481|NCT00525031|450029289|FG001|Overall Study|Disease Progression|1|||
125110482|NCT00830063|450029290|FG000|Overall Study|Adverse Event|7|||
125110483|NCT00830063|450029291|FG001|Overall Study|Adverse Event|13|||
125110484|NCT00830063|450029292|FG002|Overall Study|Adverse Event|16|||
125110485|NCT00830063|450029293|FG003|Overall Study|Adverse Event|13|||
125110486|NCT00830063|450029290|FG000|Overall Study|Death|1|||
125110487|NCT00830063|450029291|FG001|Overall Study|Death|0|||
125110488|NCT00830063|450029292|FG002|Overall Study|Death|0|||
125110489|NCT00830063|450029293|FG003|Overall Study|Death|0|||
125110490|NCT00830063|450029290|FG000|Overall Study|Lost to Follow-up|0|||
125110491|NCT00830063|450029291|FG001|Overall Study|Lost to Follow-up|0|||
125110492|NCT00830063|450029292|FG002|Overall Study|Lost to Follow-up|3|||
125110493|NCT00830063|450029293|FG003|Overall Study|Lost to Follow-up|1|||
125110494|NCT00830063|450029290|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
125110495|NCT00830063|450029291|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
125110496|NCT00830063|450029292|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
125110497|NCT00830063|450029293|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
125110498|NCT00830063|450029290|FG000|Overall Study|Lack of Efficacy|51|||
125110499|NCT00830063|450029291|FG001|Overall Study|Lack of Efficacy|23|||
125110500|NCT00830063|450029292|FG002|Overall Study|Lack of Efficacy|25|||
125110501|NCT00830063|450029293|FG003|Overall Study|Lack of Efficacy|32|||
125110502|NCT00830063|450029290|FG000|Overall Study|Other|5|||
125110503|NCT00830063|450029291|FG001|Overall Study|Other|5|||
125110504|NCT00830063|450029292|FG002|Overall Study|Other|8|||
125110505|NCT00830063|450029293|FG003|Overall Study|Other|6|||
125110506|NCT00830063|450029290|FG000|Overall Study|Withdrawal by Subject|16|||
125110507|NCT00830063|450029291|FG001|Overall Study|Withdrawal by Subject|10|||
125110508|NCT00830063|450029292|FG002|Overall Study|Withdrawal by Subject|16|||
125110509|NCT00830063|450029293|FG003|Overall Study|Withdrawal by Subject|13|||
125110510|NCT00830063|450029290|FG000|Overall Study|Protocol Violation|1|||
125110511|NCT00830063|450029291|FG001|Overall Study|Protocol Violation|0|||
125110512|NCT00830063|450029292|FG002|Overall Study|Protocol Violation|3|||
125110513|NCT00830063|450029293|FG003|Overall Study|Protocol Violation|2|||
125110514|NCT00830063|450029290|FG000|Overall Study|Randomized But Not Treated|0|||
125110515|NCT00830063|450029291|FG001|Overall Study|Randomized But Not Treated|2|||
125110516|NCT00830063|450029292|FG002|Overall Study|Randomized But Not Treated|0|||
125110517|NCT00830063|450029293|FG003|Overall Study|Randomized But Not Treated|2|||
125110518|NCT02140164|450029294|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
125110519|NCT01872689|450029305|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
125110520|NCT01872689|450029306|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
125110521|NCT01872689|450029307|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
125110522|NCT01872689|450029308|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
125110523|NCT01872689|450029305|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
125110524|NCT01872689|450029306|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
125110525|NCT01872689|450029307|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
125110526|NCT01872689|450029308|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
125110527|NCT01872689|450029305|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
125110528|NCT01872689|450029306|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
125110529|NCT01872689|450029307|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
125110530|NCT01872689|450029308|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
124897021|NCT00430677|449246999|FG002|Short-term Period|Participant no longer met study criteria|2|||
124897022|NCT00430677|449246997|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
124897023|NCT00430677|449246998|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
124897024|NCT00430677|449246999|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
124897025|NCT00430677|449246997|FG000|Short-term Period|Pregnancy|0|||
124897026|NCT00430677|449246998|FG001|Short-term Period|Pregnancy|2|||
124897027|NCT00430677|449246999|FG002|Short-term Period|Pregnancy|0|||
124897028|NCT00430677|449246997|FG000|Long-term Extension Period|Death|1|||
124897029|NCT00430677|449246998|FG001|Long-term Extension Period|Death|0|||
124897030|NCT00430677|449246999|FG002|Long-term Extension Period|Death|0|||
124897031|NCT00430677|449246997|FG000|Long-term Extension Period|Adverse Event|3|||
124897032|NCT00430677|449246998|FG001|Long-term Extension Period|Adverse Event|2|||
124897033|NCT00430677|449246999|FG002|Long-term Extension Period|Adverse Event|5|||
124897034|NCT00430677|449246997|FG000|Long-term Extension Period|Lack of Efficacy|5|||
124897035|NCT00430677|449246998|FG001|Long-term Extension Period|Lack of Efficacy|3|||
124897036|NCT00430677|449246999|FG002|Long-term Extension Period|Lack of Efficacy|8|||
124897037|NCT00430677|449246997|FG000|Long-term Extension Period|Lost to Follow-up|1|||
124897038|NCT00430677|449246998|FG001|Long-term Extension Period|Lost to Follow-up|1|||
124897039|NCT00430677|449246999|FG002|Long-term Extension Period|Lost to Follow-up|1|||
124897040|NCT00430677|449246997|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
124897041|NCT00430677|449246998|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
124897042|NCT00430677|449246999|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
124897043|NCT00430677|449246997|FG000|Long-term Extension Period|Pregnancy|1|||
124897044|NCT00430677|449246998|FG001|Long-term Extension Period|Pregnancy|1|||
124897045|NCT00430677|449246999|FG002|Long-term Extension Period|Pregnancy|0|||
124897046|NCT00430677|449246997|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
124897047|NCT00430677|449246998|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
124897048|NCT00430677|449246999|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
124897049|NCT00430677|449246997|FG000|Long-term Extension Period|Other|2|||
124897050|NCT00430677|449246998|FG001|Long-term Extension Period|Other|1|||
124897051|NCT00430677|449246999|FG002|Long-term Extension Period|Other|1|||
124897052|NCT00430677|449246997|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
124897053|NCT00430677|449246998|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
124897054|NCT00430677|449246999|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
125019149|NCT05048719|449694647|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
125019150|NCT05048719|449694648|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
125019151|NCT05048719|449694649|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
125019152|NCT05048719|449694650|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
125019153|NCT05048719|449694651|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
125019154|NCT05048719|449694652|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
125019155|NCT02229552|449694656|FG000|Baseline|Withdrawal by Subject|6|||
125019156|NCT02229552|449694656|FG000|1-year Follow up|Withdrawal by Subject|7|||
125019157|NCT02229552|449694656|FG000|1-year Follow up|Lost to Follow-up|18|||
125019158|NCT02229552|449694656|FG000|2-Year Follow up|Withdrawal by Subject|9|||
125019159|NCT02229552|449694656|FG000|2-Year Follow up|Lost to Follow-up|17|||
125019160|NCT04872101|449694657|FG000|Overall Study|Withdrawal by Subject|10|||
125019161|NCT04872101|449694658|FG001|Overall Study|Withdrawal by Subject|16|||
125019162|NCT04872101|449694657|FG000|Overall Study|Lack of Efficacy|6|||
125019163|NCT04872101|449694658|FG001|Overall Study|Lack of Efficacy|14|||
125019164|NCT04872101|449694657|FG000|Overall Study|Adverse Event|1|||
125019165|NCT04872101|449694658|FG001|Overall Study|Adverse Event|6|||
125019166|NCT04872101|449694657|FG000|Overall Study|Lost to Follow-up|2|||
125019167|NCT04872101|449694658|FG001|Overall Study|Lost to Follow-up|1|||
125019168|NCT04872101|449694657|FG000|Overall Study|Pregnancy|2|||
125019169|NCT04872101|449694658|FG001|Overall Study|Pregnancy|0|||
125019170|NCT04872101|449694657|FG000|Overall Study|Prohibited Medication|1|||
125019171|NCT04872101|449694658|FG001|Overall Study|Prohibited Medication|0|||
125019172|NCT04872101|449694657|FG000|Overall Study|Not dosed|1|||
125019173|NCT04872101|449694658|FG001|Overall Study|Not dosed|0|||
125019174|NCT00971945|449694659|FG000|Overall Study|Progressive Disease|3|||
125019175|NCT00971945|449694659|FG000|Overall Study|Change in treatment policy|1|||
125019176|NCT00971945|449694659|FG000|Overall Study|Other reasons|2|||
125019177|NCT03354663|449694660|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
125019178|NCT03354663|449694660|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
125019179|NCT03354663|449694660|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
125019180|NCT03354663|449694660|FG000|Completed 30-day Visit|Missed Visit|1|||
125019181|NCT03691974|449694661|FG000|Overall Study|Physician Decision|1|||
125019182|NCT03691974|449694662|FG001|Overall Study|Physician Decision|0|||
125019183|NCT03691974|449694661|FG000|Overall Study|Adverse Event|1|||
125019184|NCT03691974|449694662|FG001|Overall Study|Adverse Event|0|||
125019185|NCT03691974|449694661|FG000|Overall Study|Withdrawal by Subject|11|||
125019186|NCT03691974|449694662|FG001|Overall Study|Withdrawal by Subject|9|||
125019187|NCT03691974|449694661|FG000|Overall Study|Protocol Violation|1|||
124897055|NCT01555762|449247000|FG000|Overall Study|No information on Bevacizumab intake|11|||
124897056|NCT01555762|449247000|FG000|Overall Study|Missing start date of infusion|8|||
124897057|NCT01555762|449247000|FG000|Overall Study|75 years old or more ticked No|1|||
124897058|NCT01555762|449247000|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
125019188|NCT03691974|449694662|FG001|Overall Study|Protocol Violation|0|||
125019189|NCT03691974|449694661|FG000|Overall Study|Lost to Follow-up|8|||
125019190|NCT03691974|449694662|FG001|Overall Study|Lost to Follow-up|7|||
125019191|NCT01661140|449694665|FG000|Open-Label Period|Adverse Event|44|||
125019192|NCT01661140|449694666|FG001|Open-Label Period|Adverse Event|0|||
125019193|NCT01661140|449694667|FG002|Open-Label Period|Adverse Event|0|||
125019194|NCT01661140|449694665|FG000|Open-Label Period|Protocol Violation|3|||
125019195|NCT01661140|449694666|FG001|Open-Label Period|Protocol Violation|0|||
125019196|NCT01661140|449694667|FG002|Open-Label Period|Protocol Violation|0|||
125019197|NCT01661140|449694665|FG000|Open-Label Period|Withdrawal by Subject|5|||
125019198|NCT01661140|449694666|FG001|Open-Label Period|Withdrawal by Subject|0|||
125019199|NCT01661140|449694667|FG002|Open-Label Period|Withdrawal by Subject|0|||
125019200|NCT01661140|449694665|FG000|Open-Label Period|Investigator Decision|3|||
125019201|NCT01661140|449694666|FG001|Open-Label Period|Investigator Decision|0|||
125019202|NCT01661140|449694667|FG002|Open-Label Period|Investigator Decision|0|||
125019203|NCT01661140|449694665|FG000|Open-Label Period|Death|1|||
125019204|NCT01661140|449694666|FG001|Open-Label Period|Death|0|||
125019205|NCT01661140|449694667|FG002|Open-Label Period|Death|0|||
125019206|NCT01661140|449694665|FG000|Open-Label Period|Administrative/Other|1|||
125019207|NCT01661140|449694666|FG001|Open-Label Period|Administrative/Other|0|||
125019208|NCT01661140|449694667|FG002|Open-Label Period|Administrative/Other|0|||
125019209|NCT01661140|449694665|FG000|Open-Label Period|Sponsor termination|16|||
125019210|NCT01661140|449694666|FG001|Open-Label Period|Sponsor termination|0|||
125019211|NCT01661140|449694667|FG002|Open-Label Period|Sponsor termination|0|||
125019212|NCT01661140|449694665|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
125019213|NCT01661140|449694666|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
125019214|NCT01661140|449694667|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
125019215|NCT01661140|449694665|FG000|Open-Label Period|Lost to Follow-up|2|||
125019216|NCT01661140|449694666|FG001|Open-Label Period|Lost to Follow-up|0|||
125019217|NCT01661140|449694667|FG002|Open-Label Period|Lost to Follow-up|0|||
125019218|NCT01661140|449694665|FG000|Double-Blind Period|Refused Treatment|0|||
125019219|NCT01661140|449694666|FG001|Double-Blind Period|Refused Treatment|0|||
125019220|NCT01661140|449694667|FG002|Double-Blind Period|Refused Treatment|1|||
125019221|NCT01661140|449694665|FG000|Double-Blind Period|Adverse Event|0|||
125019222|NCT01661140|449694666|FG001|Double-Blind Period|Adverse Event|16|||
125019223|NCT01661140|449694667|FG002|Double-Blind Period|Adverse Event|18|||
125019224|NCT01661140|449694665|FG000|Double-Blind Period|Protocol Violation|0|||
125019225|NCT01661140|449694666|FG001|Double-Blind Period|Protocol Violation|2|||
125019226|NCT01661140|449694667|FG002|Double-Blind Period|Protocol Violation|3|||
125019227|NCT01661140|449694665|FG000|Double-Blind Period|Withdrawal by Subject|0|||
125019228|NCT01661140|449694666|FG001|Double-Blind Period|Withdrawal by Subject|1|||
125019229|NCT01661140|449694667|FG002|Double-Blind Period|Withdrawal by Subject|3|||
125019230|NCT01661140|449694665|FG000|Double-Blind Period|Investigator's Decision|0|||
125019231|NCT01661140|449694666|FG001|Double-Blind Period|Investigator's Decision|1|||
125019232|NCT01661140|449694667|FG002|Double-Blind Period|Investigator's Decision|2|||
125019233|NCT01661140|449694665|FG000|Double-Blind Period|Sponsor Termination|0|||
125019234|NCT01661140|449694666|FG001|Double-Blind Period|Sponsor Termination|14|||
125019235|NCT01661140|449694667|FG002|Double-Blind Period|Sponsor Termination|17|||
125019236|NCT01661140|449694665|FG000|Double-Blind Period|Administrative/Other|0|||
125019237|NCT01661140|449694666|FG001|Double-Blind Period|Administrative/Other|7|||
125019238|NCT01661140|449694667|FG002|Double-Blind Period|Administrative/Other|6|||
125019239|NCT00746252|449694668|FG000|Overall Study|weight gain >7.5 %|1|||
125019240|NCT00746252|449694669|FG001|Overall Study|weight gain >7.5 %|2|||
125019241|NCT02239939|449694670|FG000|Overall Study|Adverse Event|1|||
125019242|NCT02239939|449694671|FG001|Overall Study|Adverse Event|0|||
125019243|NCT02239939|449694670|FG000|Overall Study|Withdrawal by Subject|1|||
125019244|NCT02239939|449694671|FG001|Overall Study|Withdrawal by Subject|1|||
125019245|NCT02239939|449694670|FG000|Overall Study|Lost to Follow-up|0|||
125019246|NCT02239939|449694671|FG001|Overall Study|Lost to Follow-up|1|||
125019247|NCT01659320|449694672|FG000|Overall Study|Withdrawal by Subject|2|||
125019248|NCT01659320|449694672|FG000|Overall Study|Physician Decision|1|||
125019249|NCT01514682|449694673|FG000|Overall Study|Withdrawal by Subject|2|||
125019250|NCT01514682|449694674|FG001|Overall Study|Withdrawal by Subject|3|||
125019251|NCT01514682|449694673|FG000|Overall Study|Physician Decision|4|||
125019252|NCT01514682|449694674|FG001|Overall Study|Physician Decision|3|||
125019253|NCT01870401|449694675|FG000|Overall Study|Death|48|||
125019254|NCT01870401|449694676|FG001|Overall Study|Death|24|||
125019255|NCT01870401|449694675|FG000|Overall Study|Withdrawal by Subject|39|||
125019256|NCT01870401|449694676|FG001|Overall Study|Withdrawal by Subject|26|||
125019257|NCT01870401|449694675|FG000|Overall Study|Lost to Follow-up|19|||
125019258|NCT01870401|449694676|FG001|Overall Study|Lost to Follow-up|14|||
125019259|NCT01870401|449694675|FG000|Overall Study|Other|9|||
124897059|NCT01555762|449247000|FG000|Overall Study|Death linked to progression of disease|165|||
124897060|NCT01555762|449247000|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
125019260|NCT01870401|449694676|FG001|Overall Study|Other|7|||
125019261|NCT01870401|449694675|FG000|Overall Study|On-going in the Study|35|||
125019262|NCT01870401|449694676|FG001|Overall Study|On-going in the Study|25|||
125019263|NCT02105454|449694679|FG000|Overall Study|Withdrawal by Subject|1|||
125019264|NCT00493870|449694681|FG000|Overall Study|Lost to Follow-up|12|||
125019265|NCT00493870|449694682|FG001|Overall Study|Lost to Follow-up|15|||
125019266|NCT00272038|449694683|FG000|Overall Study|withdrew before they received 2 cycles|7|||
125019267|NCT03605680|449694684|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
125019268|NCT03605680|449694685|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
125019269|NCT03605680|449694686|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
125019270|NCT03605680|449694687|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
125019271|NCT03605680|449694684|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
125019272|NCT03605680|449694685|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
125019273|NCT03605680|449694686|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
125019274|NCT03605680|449694687|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
125019275|NCT03605680|449694684|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
125019276|NCT03605680|449694685|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
125019277|NCT03605680|449694686|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
125019278|NCT03605680|449694687|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
125019279|NCT03605680|449694684|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
125019280|NCT03605680|449694685|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
125019281|NCT03605680|449694686|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
125019282|NCT03605680|449694687|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
125019283|NCT03605680|449694684|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
125019284|NCT03605680|449694685|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
125019285|NCT03605680|449694686|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
125019286|NCT03605680|449694687|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
125019287|NCT03605680|449694684|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
125019288|NCT03605680|449694685|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
125019289|NCT03605680|449694686|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
125019290|NCT03605680|449694687|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
125019291|NCT03605680|449694684|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
125019292|NCT03605680|449694685|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
125019293|NCT03605680|449694686|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
125019294|NCT03605680|449694687|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
125019295|NCT03605680|449694684|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
125019296|NCT03605680|449694685|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
125019297|NCT03605680|449694686|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
125019298|NCT03605680|449694687|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
125019299|NCT03605680|449694684|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
125019300|NCT03605680|449694685|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
125019301|NCT03605680|449694686|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
125019302|NCT03605680|449694687|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
125019303|NCT03605680|449694684|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
125019304|NCT03605680|449694685|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
125019305|NCT03605680|449694686|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
125019306|NCT03605680|449694687|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
125019307|NCT03605680|449694684|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
125019308|NCT03605680|449694685|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
125019309|NCT03605680|449694686|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
125019310|NCT03605680|449694687|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
125019311|NCT03605680|449694684|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
125019312|NCT03605680|449694685|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
125019313|NCT03605680|449694686|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
125019314|NCT03605680|449694687|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
125019315|NCT03605680|449694684|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
125110531|NCT01872689|450029305|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
125110532|NCT01872689|450029306|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
125110533|NCT01872689|450029307|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
125110534|NCT01872689|450029308|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
125110535|NCT01872689|450029305|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
125110536|NCT01872689|450029306|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
125110537|NCT01872689|450029307|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
125110538|NCT01872689|450029308|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
125110539|NCT01872689|450029305|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
125110540|NCT01872689|450029306|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
125110541|NCT01872689|450029307|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
125110542|NCT01872689|450029308|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
125110543|NCT01872689|450029305|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
125110544|NCT01872689|450029306|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
125110545|NCT01872689|450029307|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
125110546|NCT01872689|450029308|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
125110547|NCT01872689|450029305|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
125110548|NCT01872689|450029306|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
125110549|NCT01872689|450029307|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
125110550|NCT01872689|450029308|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
125110551|NCT01872689|450029305|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
125110552|NCT01872689|450029306|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
125110553|NCT01872689|450029307|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
125110554|NCT01872689|450029308|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
125110555|NCT01872689|450029305|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
125110556|NCT01872689|450029306|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
125110557|NCT01872689|450029307|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
125110558|NCT01872689|450029308|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
125110559|NCT01872689|450029305|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
125110560|NCT01872689|450029306|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
125110561|NCT01872689|450029307|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
125110562|NCT01872689|450029308|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
125110563|NCT01872689|450029305|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
125110564|NCT01872689|450029306|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
125110565|NCT01872689|450029307|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
125110566|NCT01872689|450029308|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
125110567|NCT01872689|450029305|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
125110568|NCT01872689|450029306|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
125110569|NCT01872689|450029307|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
125110570|NCT01872689|450029308|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
125110571|NCT01872689|450029305|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
125110572|NCT01872689|450029306|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
125110573|NCT01872689|450029307|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
125110574|NCT01872689|450029308|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
125110575|NCT00881959|450029311|FG000|Overall Study|Lost to Follow-up|2|||
125110576|NCT00881959|450029312|FG001|Overall Study|Lost to Follow-up|4|||
125110577|NCT00686374|450029314|FG000|Overall Study|Lack of Efficacy|10|||
125110578|NCT00686374|450029314|FG000|Overall Study|Adverse Event|8|||
125110579|NCT00686374|450029314|FG000|Overall Study|Withdrew consent|5|||
125110580|NCT00686374|450029314|FG000|Overall Study|Lost to Follow-up|1|||
125110581|NCT00686374|450029314|FG000|Overall Study|Missing reason|33|||
125110582|NCT00686374|450029314|FG000|Overall Study|Other, not specified|4|||
125110583|NCT01070966|450029315|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
125110584|NCT01070966|450029315|FG000|Participants for Safety Evaluation|Off-label use|9|||
125110585|NCT01070966|450029315|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
125110586|NCT01070966|450029315|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
125110587|NCT01070966|450029315|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
125110588|NCT01070966|450029315|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
125110589|NCT01070966|450029315|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
125110590|NCT01070966|450029315|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
125110591|NCT01725113|450029316|FG000|Overall Study|Kidney Transplant|1|||
125110592|NCT01725113|450029317|FG001|Overall Study|Kidney Transplant|1|||
125110593|NCT01725113|450029316|FG000|Overall Study|Withdrawal by Subject|0|||
125110594|NCT01725113|450029317|FG001|Overall Study|Withdrawal by Subject|1|||
125110595|NCT01808209|450029318|FG000|Overall Study|Lost to Follow-up|0|||
125110596|NCT01808209|450029319|FG001|Overall Study|Lost to Follow-up|1|||
125110597|NCT03066440|450029320|FG000|Overall Study|Physician Decision|1|||
125110598|NCT03066440|450029321|FG001|Overall Study|Physician Decision|1|||
125110599|NCT03066440|450029320|FG000|Overall Study|Protocol Violation|0|||
125110600|NCT03066440|450029321|FG001|Overall Study|Protocol Violation|2|||
125110601|NCT01106352|450029329|FG000|Overall Study|Subjects untreated|0|||
125110602|NCT01106352|450029330|FG001|Overall Study|Subjects untreated|0|||
125110603|NCT01106352|450029331|FG002|Overall Study|Subjects untreated|0|||
125110604|NCT01106352|450029332|FG003|Overall Study|Subjects untreated|3|||
125110605|NCT01106352|450029333|FG004|Overall Study|Subjects untreated|4|||
125110606|NCT01106352|450029329|FG000|Overall Study|Sponsor Decision|1|||
125110607|NCT01106352|450029330|FG001|Overall Study|Sponsor Decision|0|||
125110608|NCT01106352|450029331|FG002|Overall Study|Sponsor Decision|0|||
125110609|NCT01106352|450029332|FG003|Overall Study|Sponsor Decision|0|||
125110610|NCT01106352|450029333|FG004|Overall Study|Sponsor Decision|0|||
125110611|NCT01106352|450029329|FG000|Overall Study|Too ill to come in for the visit|0|||
125110612|NCT01106352|450029330|FG001|Overall Study|Too ill to come in for the visit|0|||
125110613|NCT01106352|450029331|FG002|Overall Study|Too ill to come in for the visit|1|||
125110614|NCT01106352|450029332|FG003|Overall Study|Too ill to come in for the visit|0|||
125110615|NCT01106352|450029333|FG004|Overall Study|Too ill to come in for the visit|0|||
125110616|NCT01106352|450029329|FG000|Overall Study|Lost to Follow-up|0|||
125110617|NCT01106352|450029330|FG001|Overall Study|Lost to Follow-up|0|||
125110618|NCT01106352|450029331|FG002|Overall Study|Lost to Follow-up|0|||
125110619|NCT01106352|450029332|FG003|Overall Study|Lost to Follow-up|0|||
125110620|NCT01106352|450029333|FG004|Overall Study|Lost to Follow-up|1|||
125110621|NCT01106352|450029329|FG000|Overall Study|Death|0|||
125110622|NCT01106352|450029330|FG001|Overall Study|Death|0|||
125110623|NCT01106352|450029331|FG002|Overall Study|Death|1|||
125110624|NCT01106352|450029332|FG003|Overall Study|Death|3|||
125110625|NCT01106352|450029333|FG004|Overall Study|Death|1|||
125110626|NCT01106352|450029329|FG000|Overall Study|Disease progression|0|||
125110627|NCT01106352|450029330|FG001|Overall Study|Disease progression|0|||
125110628|NCT01106352|450029331|FG002|Overall Study|Disease progression|0|||
125110629|NCT01106352|450029332|FG003|Overall Study|Disease progression|1|||
125110630|NCT01106352|450029333|FG004|Overall Study|Disease progression|0|||
125110631|NCT01106352|450029329|FG000|Overall Study|Withdrawal by Subject|0|||
125110632|NCT01106352|450029330|FG001|Overall Study|Withdrawal by Subject|0|||
125110633|NCT01106352|450029331|FG002|Overall Study|Withdrawal by Subject|0|||
125110634|NCT01106352|450029332|FG003|Overall Study|Withdrawal by Subject|3|||
125110635|NCT01106352|450029333|FG004|Overall Study|Withdrawal by Subject|2|||
125110636|NCT01106352|450029329|FG000|Overall Study|Went on hospice|0|||
125110637|NCT01106352|450029330|FG001|Overall Study|Went on hospice|0|||
125110638|NCT01106352|450029331|FG002|Overall Study|Went on hospice|0|||
125110639|NCT01106352|450029332|FG003|Overall Study|Went on hospice|1|||
125110640|NCT01106352|450029333|FG004|Overall Study|Went on hospice|0|||
125110641|NCT01106352|450029329|FG000|Overall Study|Subject entered hospice|0|||
125110642|NCT01106352|450029330|FG001|Overall Study|Subject entered hospice|0|||
125110643|NCT01106352|450029331|FG002|Overall Study|Subject entered hospice|0|||
125110644|NCT01106352|450029332|FG003|Overall Study|Subject entered hospice|1|||
125110645|NCT01106352|450029333|FG004|Overall Study|Subject entered hospice|0|||
125110646|NCT01106352|450029329|FG000|Overall Study|Home hospice since July 2013|0|||
125110647|NCT01106352|450029330|FG001|Overall Study|Home hospice since July 2013|0|||
125110648|NCT01106352|450029331|FG002|Overall Study|Home hospice since July 2013|0|||
125110649|NCT01106352|450029332|FG003|Overall Study|Home hospice since July 2013|1|||
125110650|NCT01106352|450029333|FG004|Overall Study|Home hospice since July 2013|0|||
125110651|NCT03944707|450029334|FG000|Overall Study|Adverse Event|0|||
124897061|NCT01555762|449247000|FG000|Overall Study|Investigator's decision|10|||
124897062|NCT01555762|449247000|FG000|Overall Study|Participant not wishing to continue|5|||
124897063|NCT01555762|449247000|FG000|Overall Study|Missing data|1|||
124897064|NCT01555762|449247000|FG000|Overall Study|Death linked to an adverse event|14|||
124897065|NCT01333514|449247001|FG000|Overall Study|Withdrawal by Subject|1|||
124897066|NCT01333514|449247002|FG001|Overall Study|Withdrawal by Subject|0|||
124897067|NCT00836810|449247003|FG000|Overall Study|New diagnosis|1|||
124897068|NCT00836810|449247004|FG001|Overall Study|New diagnosis|0|||
125110652|NCT03944707|450029335|FG001|Overall Study|Adverse Event|2|||
125110653|NCT03944707|450029334|FG000|Overall Study|Study terminated by sponsor|12|||
125110654|NCT03944707|450029335|FG001|Overall Study|Study terminated by sponsor|7|||
124897069|NCT00389519|449247007|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
124897070|NCT00389519|449247008|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
124897071|NCT00389519|449247009|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
124897072|NCT00389519|449247010|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
125110655|NCT03944707|450029334|FG000|Overall Study|Subject decision|0|||
125110656|NCT03944707|450029335|FG001|Overall Study|Subject decision|1|||
125110657|NCT00751998|450029343|FG000|Overall Study|Lost to Follow-up|7|||
125110658|NCT00751998|450029343|FG000|Overall Study|Death|11|||
125110659|NCT00751998|450029343|FG000|Overall Study|Withdrawal by Subject|2|||
125110660|NCT01965535|450029344|FG000|Overall Study|Lack of Efficacy|2|||
125110661|NCT01965535|450029345|FG001|Overall Study|Lack of Efficacy|1|||
125110662|NCT02983227|450029346|FG000|Overall Study|Adverse Event|21|||
124897073|NCT00389519|449247007|FG000|Placebo Run-In|Withdrawal by Subject|19|||
124897074|NCT00389519|449247008|FG001|Placebo Run-In|Withdrawal by Subject|0|||
124897075|NCT00389519|449247009|FG002|Placebo Run-In|Withdrawal by Subject|0|||
124897076|NCT00389519|449247010|FG003|Placebo Run-In|Withdrawal by Subject|0|||
124897077|NCT00389519|449247007|FG000|Placebo Run-In|Reason not specified|40|||
124897078|NCT00389519|449247008|FG001|Placebo Run-In|Reason not specified|0|||
124897079|NCT00389519|449247009|FG002|Placebo Run-In|Reason not specified|0|||
124897080|NCT00389519|449247010|FG003|Placebo Run-In|Reason not specified|0|||
124897081|NCT00389519|449247007|FG000|Randomized|Did not receive study drug|2|||
124897082|NCT00389519|449247008|FG001|Randomized|Did not receive study drug|0|||
124897083|NCT00389519|449247009|FG002|Randomized|Did not receive study drug|0|||
124897084|NCT00389519|449247010|FG003|Randomized|Did not receive study drug|0|||
124897085|NCT00389519|449247007|FG000|Treated|Adverse Event|1|||
124897086|NCT00389519|449247008|FG001|Treated|Adverse Event|0|||
124897087|NCT00389519|449247009|FG002|Treated|Adverse Event|0|||
124897088|NCT00389519|449247010|FG003|Treated|Adverse Event|2|||
124897089|NCT00389519|449247007|FG000|Treated|Reason not specified|1|||
124897090|NCT00389519|449247008|FG001|Treated|Reason not specified|1|||
124897091|NCT00389519|449247009|FG002|Treated|Reason not specified|0|||
124897092|NCT00389519|449247010|FG003|Treated|Reason not specified|2|||
124897093|NCT02040844|449247011|FG000|Overall Study|Adverse Event|0|||
124897094|NCT02040844|449247012|FG001|Overall Study|Adverse Event|0|||
124897095|NCT02040844|449247013|FG002|Overall Study|Adverse Event|1|||
124897096|NCT02040844|449247011|FG000|Overall Study|Withdrawal by Subject|16|||
124897097|NCT02040844|449247012|FG001|Overall Study|Withdrawal by Subject|22|||
124897098|NCT02040844|449247013|FG002|Overall Study|Withdrawal by Subject|25|||
124897099|NCT02040844|449247011|FG000|Overall Study|Lost to Follow-up|12|||
124897100|NCT02040844|449247012|FG001|Overall Study|Lost to Follow-up|9|||
124897101|NCT02040844|449247013|FG002|Overall Study|Lost to Follow-up|13|||
124897102|NCT02040844|449247011|FG000|Overall Study|Missing|13|||
124897103|NCT02040844|449247012|FG001|Overall Study|Missing|3|||
124897104|NCT02040844|449247013|FG002|Overall Study|Missing|2|||
124897105|NCT02040844|449247011|FG000|Overall Study|Non-specified|8|||
124897106|NCT02040844|449247012|FG001|Overall Study|Non-specified|2|||
124897107|NCT02040844|449247013|FG002|Overall Study|Non-specified|5|||
124897108|NCT02040844|449247011|FG000|Overall Study|Concomitant medication|1|||
124897109|NCT02040844|449247012|FG001|Overall Study|Concomitant medication|3|||
124897110|NCT02040844|449247013|FG002|Overall Study|Concomitant medication|1|||
124897111|NCT01560949|449247020|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
124897112|NCT01560949|449247020|FG000|Surgery Phase|Physician Decision|3|||
124897113|NCT02068885|449247025|FG000|Overall Study|Withdrew|3|||
124897114|NCT02068885|449247026|FG001|Overall Study|Withdrew|5|||
124897115|NCT02068885|449247027|FG002|Overall Study|Withdrew|8|||
124897116|NCT00681811|449247028|FG000|Overall Study|Adverse Event|1|||
124897117|NCT00681811|449247029|FG001|Overall Study|Adverse Event|1|||
124897118|NCT00681811|449247028|FG000|Overall Study|Withdrawal by Subject|2|||
124897119|NCT00681811|449247029|FG001|Overall Study|Withdrawal by Subject|2|||
124897120|NCT00681811|449247028|FG000|Overall Study|Non-compliance|0|||
124897121|NCT00681811|449247029|FG001|Overall Study|Non-compliance|1|||
124897122|NCT01562743|449247035|FG000|Overall Study|Adverse Event|29|||
124897123|NCT01562743|449247035|FG000|Overall Study|Lack of Efficacy|3|||
124897124|NCT01562743|449247035|FG000|Overall Study|Withdrawal by Subject|13|||
124897125|NCT01562743|449247035|FG000|Overall Study|Protocol Violation|1|||
124897126|NCT01562743|449247035|FG000|Overall Study|Discontinuation criteria|2|||
124897127|NCT01562743|449247035|FG000|Overall Study|Lost to Follow-up|2|||
124897128|NCT01562743|449247035|FG000|Overall Study|Physician Decision|2|||
124897129|NCT04159506|449247036|FG000|Overall Study|Lost to Follow-up|2|||
124897130|NCT04159506|449247037|FG001|Overall Study|Lost to Follow-up|5|||
124897131|NCT02449044|449247038|FG000|Overall Study|Lost to Follow-up|2|||
124897132|NCT02449044|449247038|FG000|Overall Study|Withdrawal by Subject|13|||
124897133|NCT02449044|449247038|FG000|Overall Study|Adverse Event|30|||
124897134|NCT02449044|449247038|FG000|Overall Study|Met Withdrawal Criteria|7|||
124897135|NCT02449044|449247038|FG000|Overall Study|Physician Decision|9|||
124897136|NCT02449044|449247038|FG000|Overall Study|Sponsor Discontinued Trial|3|||
124897137|NCT02624778|449249447|FG000|Overall Study|Lost to Follow-up|0|||
124897138|NCT02624778|449249448|FG001|Overall Study|Lost to Follow-up|0|||
124897139|NCT02624778|449249449|FG002|Overall Study|Lost to Follow-up|1|||
124897140|NCT02624778|449249450|FG003|Overall Study|Lost to Follow-up|0|||
124897141|NCT02624778|449249451|FG004|Overall Study|Lost to Follow-up|0|||
124897142|NCT02624778|449249452|FG005|Overall Study|Lost to Follow-up|0|||
124897143|NCT02624778|449249453|FG006|Overall Study|Lost to Follow-up|0|||
124897144|NCT02624778|449249454|FG007|Overall Study|Lost to Follow-up|0|||
124897145|NCT02624778|449249455|FG008|Overall Study|Lost to Follow-up|0|||
124897146|NCT02624778|449249447|FG000|Overall Study|Withdrawal by Subject|0|||
124897147|NCT02624778|449249448|FG001|Overall Study|Withdrawal by Subject|1|||
124897148|NCT02624778|449249449|FG002|Overall Study|Withdrawal by Subject|0|||
124897149|NCT02624778|449249450|FG003|Overall Study|Withdrawal by Subject|0|||
124897150|NCT02624778|449249451|FG004|Overall Study|Withdrawal by Subject|0|||
124897151|NCT02624778|449249452|FG005|Overall Study|Withdrawal by Subject|1|||
124897152|NCT02624778|449249453|FG006|Overall Study|Withdrawal by Subject|1|||
124897153|NCT02624778|449249454|FG007|Overall Study|Withdrawal by Subject|1|||
124897154|NCT02624778|449249455|FG008|Overall Study|Withdrawal by Subject|1|||
124897155|NCT02624778|449249447|FG000|Overall Study|Adverse Event|0|||
124897156|NCT02624778|449249448|FG001|Overall Study|Adverse Event|0|||
124897157|NCT02624778|449249449|FG002|Overall Study|Adverse Event|0|||
124897158|NCT02624778|449249450|FG003|Overall Study|Adverse Event|0|||
124897159|NCT02624778|449249451|FG004|Overall Study|Adverse Event|0|||
124897160|NCT02624778|449249452|FG005|Overall Study|Adverse Event|0|||
124897161|NCT02624778|449249453|FG006|Overall Study|Adverse Event|0|||
124897162|NCT02624778|449249454|FG007|Overall Study|Adverse Event|0|||
124897163|NCT02624778|449249455|FG008|Overall Study|Adverse Event|2|||
124897164|NCT02624778|449249447|FG000|Overall Study|Death|0|||
124897165|NCT02624778|449249448|FG001|Overall Study|Death|0|||
124897166|NCT02624778|449249449|FG002|Overall Study|Death|0|||
124897167|NCT02624778|449249450|FG003|Overall Study|Death|0|||
124897168|NCT02624778|449249451|FG004|Overall Study|Death|0|||
124897169|NCT02624778|449249452|FG005|Overall Study|Death|0|||
124897170|NCT02624778|449249453|FG006|Overall Study|Death|1|||
124897171|NCT02624778|449249454|FG007|Overall Study|Death|0|||
124897172|NCT02624778|449249455|FG008|Overall Study|Death|0|||
124897173|NCT02624778|449249447|FG000|Overall Study|Physician Decision|0|||
124897174|NCT02624778|449249448|FG001|Overall Study|Physician Decision|0|||
124897175|NCT02624778|449249449|FG002|Overall Study|Physician Decision|0|||
124897176|NCT02624778|449249450|FG003|Overall Study|Physician Decision|0|||
124897177|NCT02624778|449249451|FG004|Overall Study|Physician Decision|0|||
124897178|NCT02624778|449249452|FG005|Overall Study|Physician Decision|0|||
124897179|NCT02624778|449249453|FG006|Overall Study|Physician Decision|0|||
124897180|NCT02624778|449249454|FG007|Overall Study|Physician Decision|3|||
124897181|NCT02624778|449249455|FG008|Overall Study|Physician Decision|3|||
124897182|NCT01537133|449249458|FG000|Overall Study|Withdrawal by Subject|2|||
124897183|NCT01537133|449249459|FG001|Overall Study|Withdrawal by Subject|0|||
124897184|NCT01537133|449249460|FG002|Overall Study|Withdrawal by Subject|0|||
124897185|NCT01537133|449249461|FG003|Overall Study|Withdrawal by Subject|0|||
124897186|NCT01537133|449249458|FG000|Overall Study|Lost to Follow-up|1|||
124897187|NCT01537133|449249459|FG001|Overall Study|Lost to Follow-up|0|||
124897188|NCT01537133|449249460|FG002|Overall Study|Lost to Follow-up|0|||
124897189|NCT01537133|449249461|FG003|Overall Study|Lost to Follow-up|0|||
124897190|NCT01244984|449249466|FG000|Overall Study|Adverse Event|2|||
124897191|NCT01244984|449249467|FG001|Overall Study|Adverse Event|11|||
124897192|NCT01244984|449249468|FG002|Overall Study|Adverse Event|2|||
124897193|NCT01244984|449249466|FG000|Overall Study|Protocol Violation|1|||
124897194|NCT01244984|449249467|FG001|Overall Study|Protocol Violation|0|||
124897195|NCT01244984|449249468|FG002|Overall Study|Protocol Violation|0|||
124897196|NCT01244984|449249466|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
124897197|NCT01244984|449249467|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
124897198|NCT01244984|449249468|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
124897199|NCT01244984|449249466|FG000|Overall Study|Withdrawal by Subject|1|||
124897200|NCT01244984|449249467|FG001|Overall Study|Withdrawal by Subject|2|||
124897201|NCT01244984|449249468|FG002|Overall Study|Withdrawal by Subject|2|||
124897202|NCT01168401|449249469|FG000|Overall Study|Lost to Follow-up|1|||
124897203|NCT01168401|449249470|FG001|Overall Study|Lost to Follow-up|1|||
124897204|NCT01168401|449249471|FG002|Overall Study|Lost to Follow-up|2|||
124897205|NCT01168401|449249472|FG003|Overall Study|Lost to Follow-up|1|||
124897206|NCT01168401|449249473|FG004|Overall Study|Lost to Follow-up|0|||
124897207|NCT01168401|449249474|FG005|Overall Study|Lost to Follow-up|0|||
124897208|NCT01168401|449249475|FG006|Overall Study|Lost to Follow-up|0|||
124897209|NCT01168401|449249476|FG007|Overall Study|Lost to Follow-up|0|||
124897210|NCT01168401|449249477|FG008|Overall Study|Lost to Follow-up|0|||
124897211|NCT01168401|449249478|FG009|Overall Study|Lost to Follow-up|0|||
124897212|NCT01168401|449249479|FG010|Overall Study|Lost to Follow-up|0|||
125110663|NCT02983227|450029347|FG001|Overall Study|Adverse Event|3|||
124897213|NCT01168401|449249469|FG000|Overall Study|Withdrawal by Subject|0|||
124897214|NCT01168401|449249470|FG001|Overall Study|Withdrawal by Subject|0|||
124897215|NCT01168401|449249471|FG002|Overall Study|Withdrawal by Subject|0|||
124897216|NCT01168401|449249472|FG003|Overall Study|Withdrawal by Subject|1|||
124897217|NCT01168401|449249473|FG004|Overall Study|Withdrawal by Subject|0|||
124897218|NCT01168401|449249474|FG005|Overall Study|Withdrawal by Subject|0|||
124897219|NCT01168401|449249475|FG006|Overall Study|Withdrawal by Subject|0|||
124897220|NCT01168401|449249476|FG007|Overall Study|Withdrawal by Subject|0|||
124897221|NCT01168401|449249477|FG008|Overall Study|Withdrawal by Subject|0|||
124897222|NCT01168401|449249478|FG009|Overall Study|Withdrawal by Subject|0|||
124897223|NCT01168401|449249479|FG010|Overall Study|Withdrawal by Subject|0|||
124897224|NCT01149681|449249484|FG000|Overall Study|Withdrawal by Subject|7|||
124897225|NCT01149681|449249484|FG000|Overall Study|Progressive disease|1|||
124897226|NCT01149681|449249484|FG000|Overall Study|Physician Decision|2|||
124897227|NCT01149681|449249484|FG000|Overall Study|adverse events nonrelated study drug|2|||
124897228|NCT03710564|449249485|FG000|Overall Study|Study Terminated by Sponsor|104|||
124897229|NCT03710564|449249486|FG001|Overall Study|Study Terminated by Sponsor|55|||
124897230|NCT03710564|449249485|FG000|Overall Study|Withdrawal by Subject|57|||
124897231|NCT03710564|449249486|FG001|Overall Study|Withdrawal by Subject|25|||
124897232|NCT03710564|449249485|FG000|Overall Study|Death|10|||
124897233|NCT03710564|449249486|FG001|Overall Study|Death|4|||
124897234|NCT03710564|449249485|FG000|Overall Study|Lost to Follow-up|5|||
124897235|NCT03710564|449249486|FG001|Overall Study|Lost to Follow-up|4|||
124897236|NCT03710564|449249485|FG000|Overall Study|Protocol Violation|3|||
124897237|NCT03710564|449249486|FG001|Overall Study|Protocol Violation|2|||
124897238|NCT03710564|449249485|FG000|Overall Study|Adverse Event|3|||
124897239|NCT03710564|449249486|FG001|Overall Study|Adverse Event|0|||
124897240|NCT03710564|449249485|FG000|Overall Study|Physician Decision|2|||
124897241|NCT03710564|449249486|FG001|Overall Study|Physician Decision|3|||
124897242|NCT02993471|449249487|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
124897243|NCT02993471|449249487|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
124897244|NCT00930813|449249488|FG000|Overall Study|Death|4|||
124897245|NCT00930813|449249489|FG001|Overall Study|Death|5|||
124897246|NCT00930813|449249488|FG000|Overall Study|Withdrawal by Subject|2|||
124897247|NCT00930813|449249489|FG001|Overall Study|Withdrawal by Subject|5|||
124897248|NCT00930813|449249488|FG000|Overall Study|Lost to Follow-up|2|||
124897249|NCT00930813|449249489|FG001|Overall Study|Lost to Follow-up|4|||
124897250|NCT03999554|449249496|FG000|Overall Study|Lost to Follow-up|4|||
124897251|NCT03999554|449249497|FG001|Overall Study|Lost to Follow-up|5|||
124897252|NCT03999554|449249498|FG002|Overall Study|Lost to Follow-up|4|||
124897253|NCT03999554|449249499|FG003|Overall Study|Lost to Follow-up|5|||
124897254|NCT03999554|449249500|FG004|Overall Study|Lost to Follow-up|8|||
124897255|NCT03999554|449249496|FG000|Overall Study|Protocol Violation|0|||
124897256|NCT03999554|449249497|FG001|Overall Study|Protocol Violation|0|||
124897257|NCT03999554|449249498|FG002|Overall Study|Protocol Violation|5|||
124897258|NCT03999554|449249499|FG003|Overall Study|Protocol Violation|0|||
124897259|NCT03999554|449249500|FG004|Overall Study|Protocol Violation|0|||
124897260|NCT03999554|449249496|FG000|Overall Study|Pregnancy|0|||
124897261|NCT03999554|449249497|FG001|Overall Study|Pregnancy|0|||
124897262|NCT03999554|449249498|FG002|Overall Study|Pregnancy|1|||
124897263|NCT03999554|449249499|FG003|Overall Study|Pregnancy|0|||
124897264|NCT03999554|449249500|FG004|Overall Study|Pregnancy|0|||
124897265|NCT03999554|449249496|FG000|Overall Study|Withdrawal by Subject|2|||
124897266|NCT03999554|449249497|FG001|Overall Study|Withdrawal by Subject|2|||
124897267|NCT03999554|449249498|FG002|Overall Study|Withdrawal by Subject|2|||
124897268|NCT03999554|449249499|FG003|Overall Study|Withdrawal by Subject|1|||
124897269|NCT03999554|449249500|FG004|Overall Study|Withdrawal by Subject|1|||
124897270|NCT03999554|449249496|FG000|Overall Study|failure to comply with protocol requirements|0|||
124897271|NCT03999554|449249497|FG001|Overall Study|failure to comply with protocol requirements|0|||
124897272|NCT03999554|449249498|FG002|Overall Study|failure to comply with protocol requirements|0|||
124897273|NCT03999554|449249499|FG003|Overall Study|failure to comply with protocol requirements|1|||
124897274|NCT03999554|449249500|FG004|Overall Study|failure to comply with protocol requirements|0|||
124897275|NCT04582877|449249501|FG000|Overall Study|Did not use device measurement|5|||
124897276|NCT04582877|449249501|FG000|Overall Study|No fractional flow reserve test results|2|||
124897277|NCT04582877|449249501|FG000|Overall Study|Protocol Violation|1|||
124897278|NCT00003656|449249502|FG000|Overall Study|Adverse Event|0|||
124897279|NCT00003656|449249503|FG001|Overall Study|Adverse Event|1|||
124897280|NCT03055767|449249504|FG000|Open-Label Period|Lost to Follow-up|0|||
124897281|NCT03055767|449249505|FG001|Open-Label Period|Lost to Follow-up|0|||
124897282|NCT03055767|449249506|FG002|Open-Label Period|Lost to Follow-up|2|||
124897283|NCT03055767|449249507|FG003|Open-Label Period|Lost to Follow-up|0|||
124897284|NCT03055767|449249504|FG000|Open-Label Period|Withdrawal by Subject|0|||
124897285|NCT03055767|449249505|FG001|Open-Label Period|Withdrawal by Subject|0|||
124897286|NCT03055767|449249506|FG002|Open-Label Period|Withdrawal by Subject|0|||
124897287|NCT03055767|449249507|FG003|Open-Label Period|Withdrawal by Subject|1|||
124897288|NCT00763282|449249510|FG000|Overall Study|Withdrawal by Subject|6|||
124897289|NCT00763282|449249511|FG001|Overall Study|Withdrawal by Subject|5|||
124897290|NCT00763282|449249510|FG000|Overall Study|Death|4|||
124897291|NCT00763282|449249511|FG001|Overall Study|Death|3|||
124897292|NCT00763282|449249510|FG000|Overall Study|Lost to Follow-up|22|||
124897293|NCT00763282|449249511|FG001|Overall Study|Lost to Follow-up|26|||
124897294|NCT00742274|449249512|FG000|Overall Study|Death|1|||
124897295|NCT00742274|449249513|FG001|Overall Study|Death|0|||
124897296|NCT00742274|449249512|FG000|Overall Study|Withdrawal by Subject|1|||
124897297|NCT00742274|449249513|FG001|Overall Study|Withdrawal by Subject|2|||
124897298|NCT00742274|449249512|FG000|Overall Study|Removed for medical reasons|1|||
124897299|NCT00742274|449249513|FG001|Overall Study|Removed for medical reasons|1|||
124897300|NCT02974010|449249518|FG000|Overall Study|Lost to Follow-up|3|||
124897301|NCT02974010|449249519|FG001|Overall Study|Lost to Follow-up|1|||
124897302|NCT02974010|449249520|FG002|Overall Study|Lost to Follow-up|0|||
124897303|NCT02974010|449249521|FG003|Overall Study|Lost to Follow-up|0|||
124897304|NCT02974010|449249518|FG000|Overall Study|Withdrawal by Subject|2|||
124897305|NCT02974010|449249519|FG001|Overall Study|Withdrawal by Subject|1|||
124897306|NCT02974010|449249520|FG002|Overall Study|Withdrawal by Subject|0|||
125019316|NCT03605680|449694685|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
125019317|NCT03605680|449694686|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
125019318|NCT03605680|449694687|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
124897307|NCT02974010|449249521|FG003|Overall Study|Withdrawal by Subject|0|||
124897308|NCT02974010|449249518|FG000|Overall Study|Adverse Event|0|||
124897309|NCT02974010|449249519|FG001|Overall Study|Adverse Event|1|||
124897310|NCT02974010|449249520|FG002|Overall Study|Adverse Event|0|||
124897311|NCT02974010|449249521|FG003|Overall Study|Adverse Event|0|||
124897312|NCT02974010|449249518|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
124897313|NCT02974010|449249519|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
124897314|NCT02974010|449249520|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
124897315|NCT02974010|449249521|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
124897316|NCT02974010|449249518|FG000|Overall Study|Lack of Efficacy|0|||
124897317|NCT02974010|449249519|FG001|Overall Study|Lack of Efficacy|0|||
124897318|NCT02974010|449249520|FG002|Overall Study|Lack of Efficacy|1|||
124897319|NCT02974010|449249521|FG003|Overall Study|Lack of Efficacy|0|||
125019319|NCT03605680|449694684|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
124897320|NCT01941316|449249522|FG000|Overall Study|Adverse Event|0|||
124897321|NCT01941316|449249523|FG001|Overall Study|Adverse Event|1|||
124897322|NCT01941316|449249524|FG002|Overall Study|Adverse Event|0|||
124897323|NCT01941316|449249525|FG003|Overall Study|Adverse Event|7|||
124897324|NCT01941316|449249522|FG000|Overall Study|Progressive Disease|3|||
124897325|NCT01941316|449249523|FG001|Overall Study|Progressive Disease|6|||
124897326|NCT01941316|449249524|FG002|Overall Study|Progressive Disease|2|||
124897327|NCT01941316|449249525|FG003|Overall Study|Progressive Disease|29|||
124897328|NCT01941316|449249522|FG000|Overall Study|Withdrawal by Subject|0|||
124897329|NCT01941316|449249523|FG001|Overall Study|Withdrawal by Subject|2|||
124897330|NCT01941316|449249524|FG002|Overall Study|Withdrawal by Subject|1|||
124897331|NCT01941316|449249525|FG003|Overall Study|Withdrawal by Subject|8|||
124897332|NCT01941316|449249522|FG000|Overall Study|Death|0|||
124897333|NCT01941316|449249523|FG001|Overall Study|Death|0|||
124897334|NCT01941316|449249524|FG002|Overall Study|Death|0|||
124897335|NCT01941316|449249525|FG003|Overall Study|Death|3|||
124897336|NCT01941316|449249522|FG000|Overall Study|Physician Decision|0|||
124897337|NCT01941316|449249523|FG001|Overall Study|Physician Decision|0|||
124897338|NCT01941316|449249524|FG002|Overall Study|Physician Decision|0|||
124897339|NCT01941316|449249525|FG003|Overall Study|Physician Decision|3|||
124897340|NCT01941316|449249522|FG000|Overall Study|Protocol Violation|0|||
124897341|NCT01941316|449249523|FG001|Overall Study|Protocol Violation|0|||
124897342|NCT01941316|449249524|FG002|Overall Study|Protocol Violation|0|||
124897343|NCT01941316|449249525|FG003|Overall Study|Protocol Violation|3|||
124897344|NCT01941316|449249522|FG000|Overall Study|Intercurrent illness|0|||
124897345|NCT01941316|449249523|FG001|Overall Study|Intercurrent illness|0|||
124897346|NCT01941316|449249524|FG002|Overall Study|Intercurrent illness|0|||
124897347|NCT01941316|449249525|FG003|Overall Study|Intercurrent illness|1|||
124897348|NCT01941316|449249522|FG000|Overall Study|Other, not specified|0|||
124897349|NCT01941316|449249523|FG001|Overall Study|Other, not specified|0|||
124897350|NCT01941316|449249524|FG002|Overall Study|Other, not specified|0|||
124897351|NCT01941316|449249525|FG003|Overall Study|Other, not specified|1|||
124897352|NCT00320489|449249526|FG000|Overall Study|Adverse Event|26|||
124897353|NCT00320489|449249527|FG001|Overall Study|Adverse Event|25|||
124897354|NCT00320489|449249526|FG000|Overall Study|Clinical Relapse|26|||
124897355|NCT00320489|449249527|FG001|Overall Study|Clinical Relapse|20|||
124897356|NCT00320489|449249526|FG000|Overall Study|Death|0|||
124897357|NCT00320489|449249527|FG001|Overall Study|Death|2|||
124897358|NCT00320489|449249526|FG000|Overall Study|Entry Criteria Exclusion|2|||
124897359|NCT00320489|449249527|FG001|Overall Study|Entry Criteria Exclusion|4|||
124897360|NCT00320489|449249526|FG000|Overall Study|Lack of Efficacy|16|||
124897361|NCT00320489|449249527|FG001|Overall Study|Lack of Efficacy|7|||
124897362|NCT00320489|449249526|FG000|Overall Study|Lost to Follow-up|21|||
124897363|NCT00320489|449249527|FG001|Overall Study|Lost to Follow-up|22|||
124897364|NCT00320489|449249526|FG000|Overall Study|Physician Decision|8|||
124897365|NCT00320489|449249527|FG001|Overall Study|Physician Decision|8|||
124897366|NCT00320489|449249526|FG000|Overall Study|Protocol Violation|4|||
124897367|NCT00320489|449249527|FG001|Overall Study|Protocol Violation|4|||
124897368|NCT00320489|449249526|FG000|Overall Study|Sponsor Decision|3|||
124897369|NCT00320489|449249527|FG001|Overall Study|Sponsor Decision|3|||
124897370|NCT00320489|449249526|FG000|Overall Study|Withdrawal by Subject|39|||
124897371|NCT00320489|449249527|FG001|Overall Study|Withdrawal by Subject|41|||
124897372|NCT03441984|449249528|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897373|NCT03441984|449249529|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897374|NCT03441984|449249530|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
124897375|NCT03441984|449249531|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897376|NCT03441984|449249532|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897377|NCT03441984|449249533|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897378|NCT03441984|449249534|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897379|NCT03441984|449249535|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897380|NCT03441984|449249536|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897381|NCT03441984|449249537|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897382|NCT03441984|449249538|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897383|NCT03441984|449249539|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897384|NCT04088188|449249544|FG000|Overall Study|Withdrawal by Subject|2|||
124897385|NCT04088188|449249545|FG001|Overall Study|Withdrawal by Subject|0|||
124897386|NCT04088188|449249544|FG000|Overall Study|Adverse Event|2|||
124897387|NCT04088188|449249545|FG001|Overall Study|Adverse Event|0|||
124897388|NCT01670019|449249547|FG000|Overall Study|Adverse Event|3|||
124897389|NCT01670019|449249548|FG001|Overall Study|Adverse Event|0|||
124897390|NCT01670019|449249547|FG000|Overall Study|Withdrawal by Subject|6|||
124897391|NCT01670019|449249548|FG001|Overall Study|Withdrawal by Subject|0|||
124897392|NCT00580801|449249549|FG000|Overall Study|Physician Decision|1|||
124897393|NCT00580801|449249550|FG001|Overall Study|Physician Decision|0|||
124897394|NCT00580801|449249551|FG002|Overall Study|Physician Decision|0|||
124897395|NCT00580801|449249549|FG000|Overall Study|Adverse Event|2|||
124897396|NCT00580801|449249550|FG001|Overall Study|Adverse Event|0|||
124897397|NCT00580801|449249551|FG002|Overall Study|Adverse Event|0|||
124897398|NCT00580801|449249549|FG000|Overall Study|Lost to Follow-up|2|||
124897399|NCT00580801|449249550|FG001|Overall Study|Lost to Follow-up|0|||
124897400|NCT00580801|449249551|FG002|Overall Study|Lost to Follow-up|0|||
124897401|NCT00580801|449249549|FG000|Overall Study|Reached a virologic endpoint|0|||
124897402|NCT00580801|449249550|FG001|Overall Study|Reached a virologic endpoint|1|||
124897403|NCT00580801|449249551|FG002|Overall Study|Reached a virologic endpoint|2|||
124897404|NCT00580801|449249549|FG000|Overall Study|Participant non-compliant|0|||
124897405|NCT00580801|449249550|FG001|Overall Study|Participant non-compliant|0|||
124897406|NCT00580801|449249551|FG002|Overall Study|Participant non-compliant|1|||
124897407|NCT00580801|449249549|FG000|Overall Study|Travel|1|||
124897408|NCT00580801|449249550|FG001|Overall Study|Travel|0|||
124897409|NCT00580801|449249551|FG002|Overall Study|Travel|0|||
124897410|NCT03601507|449249552|FG000|Overall Study|Adverse Event|1|||
124897411|NCT02107014|449249555|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
124897412|NCT01981850|449249558|FG000|Main Phase Stage 1|Death|2|||
124897413|NCT01981850|449249559|FG001|Main Phase Stage 1|Death|0|||
124897414|NCT01981850|449249560|FG002|Main Phase Stage 1|Death|0|||
124897415|NCT01981850|449249561|FG003|Main Phase Stage 1|Death|0|||
124897416|NCT01981850|449249562|FG004|Main Phase Stage 1|Death|0|||
124897417|NCT01981850|449249563|FG005|Main Phase Stage 1|Death|0|||
124897418|NCT01981850|449249564|FG006|Main Phase Stage 1|Death|0|||
124897419|NCT01981850|449249565|FG007|Main Phase Stage 1|Death|0|||
124897420|NCT01981850|449249566|FG008|Main Phase Stage 1|Death|0|||
124897421|NCT01981850|449249567|FG009|Main Phase Stage 1|Death|0|||
124897422|NCT01981850|449249558|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
124897423|NCT01981850|449249559|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
124897424|NCT01981850|449249560|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
124897425|NCT01981850|449249561|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
124897426|NCT01981850|449249562|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
124897427|NCT01981850|449249563|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
124897428|NCT01981850|449249564|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
124897429|NCT01981850|449249565|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
124897430|NCT01981850|449249566|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
124897431|NCT01981850|449249567|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
124897432|NCT01981850|449249558|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
124897433|NCT01981850|449249559|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
124897434|NCT01981850|449249560|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
124897435|NCT01981850|449249561|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
124897436|NCT01981850|449249562|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
124897437|NCT01981850|449249563|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
124897438|NCT01981850|449249564|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
124897439|NCT01981850|449249565|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
124897440|NCT01981850|449249566|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
124897441|NCT01981850|449249567|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
124897442|NCT01981850|449249558|FG000|Main Phase Stage 1|Various reasons|0|||
124897443|NCT01981850|449249559|FG001|Main Phase Stage 1|Various reasons|0|||
124897444|NCT01981850|449249560|FG002|Main Phase Stage 1|Various reasons|2|||
124897445|NCT01981850|449249561|FG003|Main Phase Stage 1|Various reasons|0|||
124897446|NCT01981850|449249562|FG004|Main Phase Stage 1|Various reasons|0|||
124897447|NCT01981850|449249563|FG005|Main Phase Stage 1|Various reasons|0|||
124897448|NCT01981850|449249564|FG006|Main Phase Stage 1|Various reasons|0|||
124897449|NCT01981850|449249565|FG007|Main Phase Stage 1|Various reasons|0|||
124897450|NCT01981850|449249566|FG008|Main Phase Stage 1|Various reasons|0|||
124897451|NCT01981850|449249567|FG009|Main Phase Stage 1|Various reasons|0|||
124897452|NCT01981850|449249558|FG000|Main Phase Stage 2|Adverse Event|0|||
124897453|NCT01981850|449249559|FG001|Main Phase Stage 2|Adverse Event|0|||
124897454|NCT01981850|449249560|FG002|Main Phase Stage 2|Adverse Event|0|||
124897455|NCT01981850|449249561|FG003|Main Phase Stage 2|Adverse Event|0|||
124897456|NCT01981850|449249562|FG004|Main Phase Stage 2|Adverse Event|6|||
124897457|NCT01981850|449249563|FG005|Main Phase Stage 2|Adverse Event|5|||
124897458|NCT01981850|449249564|FG006|Main Phase Stage 2|Adverse Event|7|||
124897459|NCT01981850|449249565|FG007|Main Phase Stage 2|Adverse Event|0|||
124897460|NCT01981850|449249566|FG008|Main Phase Stage 2|Adverse Event|0|||
124897461|NCT01981850|449249567|FG009|Main Phase Stage 2|Adverse Event|0|||
124897462|NCT01981850|449249558|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
124897463|NCT01981850|449249559|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
124897464|NCT01981850|449249560|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
124897465|NCT01981850|449249561|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
124897466|NCT01981850|449249562|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
124897467|NCT01981850|449249563|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
124897468|NCT01981850|449249564|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
124897469|NCT01981850|449249565|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
124897470|NCT01981850|449249566|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
124897471|NCT01981850|449249567|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
124897472|NCT01981850|449249558|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
124897473|NCT01981850|449249559|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
124897474|NCT01981850|449249560|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
124897475|NCT01981850|449249561|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
124897476|NCT01981850|449249562|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
124897477|NCT01981850|449249563|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
124897478|NCT01981850|449249564|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
124897479|NCT01981850|449249565|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
124897480|NCT01981850|449249566|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
124897481|NCT01981850|449249567|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
124897482|NCT01981850|449249558|FG000|Main Phase Stage 2|Various reasons|0|||
124897483|NCT01981850|449249559|FG001|Main Phase Stage 2|Various reasons|0|||
124897484|NCT01981850|449249560|FG002|Main Phase Stage 2|Various reasons|0|||
124897485|NCT01981850|449249561|FG003|Main Phase Stage 2|Various reasons|0|||
124897486|NCT01981850|449249562|FG004|Main Phase Stage 2|Various reasons|2|||
124897487|NCT01981850|449249563|FG005|Main Phase Stage 2|Various reasons|0|||
124897488|NCT01981850|449249564|FG006|Main Phase Stage 2|Various reasons|1|||
124897489|NCT01981850|449249565|FG007|Main Phase Stage 2|Various reasons|0|||
124897490|NCT01981850|449249566|FG008|Main Phase Stage 2|Various reasons|0|||
124897491|NCT01981850|449249567|FG009|Main Phase Stage 2|Various reasons|0|||
124897492|NCT01981850|449249558|FG000|Main Phase Stage 2|Progressive Disease|0|||
124897493|NCT01981850|449249559|FG001|Main Phase Stage 2|Progressive Disease|0|||
124897494|NCT01981850|449249560|FG002|Main Phase Stage 2|Progressive Disease|0|||
124897495|NCT01981850|449249561|FG003|Main Phase Stage 2|Progressive Disease|0|||
124897496|NCT01981850|449249562|FG004|Main Phase Stage 2|Progressive Disease|0|||
124897497|NCT01981850|449249563|FG005|Main Phase Stage 2|Progressive Disease|6|||
124897498|NCT01981850|449249564|FG006|Main Phase Stage 2|Progressive Disease|6|||
124897499|NCT01981850|449249565|FG007|Main Phase Stage 2|Progressive Disease|0|||
124897500|NCT01981850|449249566|FG008|Main Phase Stage 2|Progressive Disease|0|||
124897501|NCT01981850|449249567|FG009|Main Phase Stage 2|Progressive Disease|0|||
124897502|NCT01981850|449249558|FG000|Open Label Extension (OLE)|Adverse Event|0|||
124897503|NCT01981850|449249559|FG001|Open Label Extension (OLE)|Adverse Event|0|||
124897504|NCT01981850|449249560|FG002|Open Label Extension (OLE)|Adverse Event|0|||
124897505|NCT01981850|449249561|FG003|Open Label Extension (OLE)|Adverse Event|0|||
124897506|NCT01981850|449249562|FG004|Open Label Extension (OLE)|Adverse Event|0|||
124897507|NCT01981850|449249563|FG005|Open Label Extension (OLE)|Adverse Event|0|||
124897508|NCT01981850|449249564|FG006|Open Label Extension (OLE)|Adverse Event|0|||
124897509|NCT01981850|449249565|FG007|Open Label Extension (OLE)|Adverse Event|2|||
124897510|NCT01981850|449249566|FG008|Open Label Extension (OLE)|Adverse Event|1|||
124897511|NCT01981850|449249567|FG009|Open Label Extension (OLE)|Adverse Event|8|||
124897512|NCT01981850|449249558|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
124897513|NCT01981850|449249559|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
124897514|NCT01981850|449249560|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
124897515|NCT01981850|449249561|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
124897516|NCT01981850|449249562|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
124897517|NCT01981850|449249563|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
124897518|NCT01981850|449249564|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
124897519|NCT01981850|449249565|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
124897520|NCT01981850|449249566|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
124897521|NCT01981850|449249567|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
124897522|NCT01981850|449249558|FG000|Open Label Extension (OLE)|Various reasons|0|||
124897523|NCT01981850|449249559|FG001|Open Label Extension (OLE)|Various reasons|0|||
124897524|NCT01981850|449249560|FG002|Open Label Extension (OLE)|Various reasons|0|||
124897525|NCT01981850|449249561|FG003|Open Label Extension (OLE)|Various reasons|0|||
124897526|NCT01981850|449249562|FG004|Open Label Extension (OLE)|Various reasons|0|||
124897527|NCT01981850|449249563|FG005|Open Label Extension (OLE)|Various reasons|0|||
124897528|NCT01981850|449249564|FG006|Open Label Extension (OLE)|Various reasons|0|||
124897529|NCT01981850|449249565|FG007|Open Label Extension (OLE)|Various reasons|3|||
124897530|NCT01981850|449249566|FG008|Open Label Extension (OLE)|Various reasons|1|||
124897531|NCT01981850|449249567|FG009|Open Label Extension (OLE)|Various reasons|3|||
124897532|NCT01981850|449249558|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
124897533|NCT01981850|449249559|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
124897534|NCT01981850|449249560|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
124897535|NCT01981850|449249561|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
124897536|NCT01981850|449249562|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
124897537|NCT01981850|449249563|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
124897538|NCT01981850|449249564|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
124897539|NCT01981850|449249565|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
124897540|NCT01981850|449249566|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
125019320|NCT03605680|449694685|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
125019321|NCT03605680|449694686|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
124897541|NCT01981850|449249567|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
124897542|NCT01981850|449249558|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
124897543|NCT01981850|449249559|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
124897544|NCT01981850|449249560|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
124897545|NCT01981850|449249561|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
124897546|NCT01981850|449249562|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
124897547|NCT01981850|449249563|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
124897548|NCT01981850|449249564|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
124897549|NCT01981850|449249565|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
124897550|NCT01981850|449249566|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
124897551|NCT01981850|449249567|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
124897552|NCT01981850|449249558|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
124897553|NCT01981850|449249559|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
124897554|NCT01981850|449249560|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
124897555|NCT01981850|449249561|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
124897556|NCT01981850|449249562|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
124897557|NCT01981850|449249563|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
124897558|NCT01981850|449249564|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
124897559|NCT01981850|449249565|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
124897560|NCT01981850|449249566|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
124897561|NCT01981850|449249567|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
124897562|NCT03168438|449249568|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
124897563|NCT03168438|449249569|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
124897564|NCT05015478|449249572|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
124897565|NCT05015478|449249573|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
124897566|NCT05015478|449249574|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
124897567|NCT05015478|449249575|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
124897568|NCT01649427|449249579|FG000|Overall Study|Adverse Event|1|||
124897569|NCT01649427|449249580|FG001|Overall Study|Adverse Event|1|||
124897570|NCT01649427|449249579|FG000|Overall Study|Withdrawal by Subject|8|||
124897571|NCT01649427|449249580|FG001|Overall Study|Withdrawal by Subject|7|||
124897572|NCT01649427|449249579|FG000|Overall Study|Lost to Follow-up|0|||
124897573|NCT01649427|449249580|FG001|Overall Study|Lost to Follow-up|1|||
124897574|NCT01649427|449249579|FG000|Overall Study|Graft loss|0|||
124897575|NCT01649427|449249580|FG001|Overall Study|Graft loss|1|||
124897576|NCT01649427|449249579|FG000|Overall Study|Surgical problems during nephrectomy|2|||
124897577|NCT01649427|449249580|FG001|Overall Study|Surgical problems during nephrectomy|2|||
124897578|NCT02138916|449249581|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
124897579|NCT02138916|449249582|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
124897580|NCT02138916|449249583|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
124897581|NCT02138916|449249581|FG000|Overall Study|Death|14|||
124897582|NCT02138916|449249582|FG001|Overall Study|Death|11|||
124897583|NCT02138916|449249583|FG002|Overall Study|Death|12|||
124897584|NCT02138916|449249581|FG000|Overall Study|Withdrawal by Subject|27|||
124897585|NCT02138916|449249582|FG001|Overall Study|Withdrawal by Subject|31|||
124897586|NCT02138916|449249583|FG002|Overall Study|Withdrawal by Subject|32|||
124897587|NCT02138916|449249581|FG000|Overall Study|Study specific withdrawal criteria|0|||
124897588|NCT02138916|449249582|FG001|Overall Study|Study specific withdrawal criteria|0|||
124897589|NCT02138916|449249583|FG002|Overall Study|Study specific withdrawal criteria|1|||
124897590|NCT02138916|449249581|FG000|Overall Study|incorrect enrolment|1|||
124897591|NCT02138916|449249582|FG001|Overall Study|incorrect enrolment|1|||
124897592|NCT02138916|449249583|FG002|Overall Study|incorrect enrolment|0|||
124897593|NCT02138916|449249581|FG000|Overall Study|Severe non-compliance|1|||
124897594|NCT02138916|449249582|FG001|Overall Study|Severe non-compliance|2|||
124897595|NCT02138916|449249583|FG002|Overall Study|Severe non-compliance|1|||
124897596|NCT02138916|449249581|FG000|Overall Study|Lost to Follow-up|4|||
124897597|NCT02138916|449249582|FG001|Overall Study|Lost to Follow-up|2|||
124897598|NCT02138916|449249583|FG002|Overall Study|Lost to Follow-up|3|||
124897599|NCT02138916|449249581|FG000|Overall Study|Adverse Event|4|||
124897600|NCT02138916|449249582|FG001|Overall Study|Adverse Event|4|||
124897601|NCT02138916|449249583|FG002|Overall Study|Adverse Event|3|||
124897602|NCT00117988|449249588|FG000|Overall Study|Death|3|||
124897603|NCT00117988|449249588|FG000|Overall Study|Adverse Event|1|||
124897604|NCT05196737|449249590|FG000|Non-intervention Week|Lost to Follow-up|2|||
124897605|NCT05196737|449249590|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
124897606|NCT05096884|449249591|FG000|Overall Study|Excluded based on negative tilt table test|4|||
124897607|NCT04927975|449249592|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
124897608|NCT04927975|449249593|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
124897609|NCT04927975|449249594|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
124897610|NCT04927975|449249595|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
124897611|NCT04927975|449249596|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
124897612|NCT04927975|449249597|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
124897613|NCT04927975|449249592|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
124897614|NCT04927975|449249593|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
124897615|NCT04927975|449249594|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
124897616|NCT04927975|449249595|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
124897617|NCT04927975|449249596|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
124897618|NCT04927975|449249597|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
124897619|NCT04927975|449249592|FG000|Period 1 (Baseline-Week 24)|Death|0|||
124897620|NCT04927975|449249593|FG001|Period 1 (Baseline-Week 24)|Death|0|||
124897621|NCT04927975|449249594|FG002|Period 1 (Baseline-Week 24)|Death|0|||
124897622|NCT04927975|449249595|FG003|Period 1 (Baseline-Week 24)|Death|0|||
124897623|NCT04927975|449249596|FG004|Period 1 (Baseline-Week 24)|Death|0|||
124897624|NCT04927975|449249597|FG005|Period 1 (Baseline-Week 24)|Death|1|||
124897625|NCT04927975|449249592|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
124897626|NCT04927975|449249593|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
124897627|NCT04927975|449249594|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
124897628|NCT04927975|449249595|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
124897629|NCT04927975|449249596|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
124897630|NCT04927975|449249597|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
124897631|NCT04927975|449249592|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
124897632|NCT04927975|449249593|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
124897633|NCT04927975|449249594|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
124897634|NCT04927975|449249595|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
124897635|NCT04927975|449249596|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
124897636|NCT04927975|449249597|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
124897637|NCT03781804|449249598|FG000|Overall Study|Adverse Event|2|||
124897638|NCT03781804|449249599|FG001|Overall Study|Adverse Event|2|||
124897639|NCT03781804|449249600|FG002|Overall Study|Adverse Event|3|||
124897640|NCT03781804|449249598|FG000|Overall Study|Lost to Follow-up|1|||
124897641|NCT03781804|449249599|FG001|Overall Study|Lost to Follow-up|1|||
124897642|NCT03781804|449249600|FG002|Overall Study|Lost to Follow-up|2|||
124897643|NCT03781804|449249598|FG000|Overall Study|Lack of Efficacy|4|||
124897644|NCT03781804|449249599|FG001|Overall Study|Lack of Efficacy|2|||
124897645|NCT03781804|449249600|FG002|Overall Study|Lack of Efficacy|9|||
124897646|NCT03781804|449249598|FG000|Overall Study|Protocol Violation|0|||
124897647|NCT03781804|449249599|FG001|Overall Study|Protocol Violation|0|||
124897648|NCT03781804|449249600|FG002|Overall Study|Protocol Violation|1|||
124897649|NCT03781804|449249598|FG000|Overall Study|Withdrawal by Subject|0|||
124897650|NCT03781804|449249599|FG001|Overall Study|Withdrawal by Subject|1|||
124897651|NCT03781804|449249600|FG002|Overall Study|Withdrawal by Subject|1|||
124897652|NCT03781804|449249598|FG000|Overall Study|Reason not provided|2|||
124897653|NCT03781804|449249599|FG001|Overall Study|Reason not provided|2|||
124897654|NCT03781804|449249600|FG002|Overall Study|Reason not provided|0|||
124897655|NCT00337818|449249601|FG000|Overall Study|Lost to Follow-up|289|||
124897656|NCT00337818|449249602|FG001|Overall Study|Lost to Follow-up|91|||
124897657|NCT00337818|449249603|FG002|Overall Study|Lost to Follow-up|107|||
124897658|NCT04678830|449249604|FG000|Overall Study|Lack of Efficacy|2|||
124897659|NCT04678830|449249605|FG001|Overall Study|Lack of Efficacy|0|||
124897660|NCT04678830|449249604|FG000|Overall Study|Withdrawal by Subject|0|||
124897661|NCT04678830|449249605|FG001|Overall Study|Withdrawal by Subject|1|||
124897662|NCT03563053|449249609|FG000|Overall Study|Withdrawal by Subject|17|||
124897663|NCT03563053|449249609|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
124897664|NCT03563053|449249609|FG000|Overall Study|Adverse Event|3|||
124897665|NCT03563053|449249609|FG000|Overall Study|Physician Decision|1|||
124897666|NCT03563053|449249609|FG000|Overall Study|study terminated by sponsor|71|||
124897667|NCT03369951|449249611|FG000|Overall Study|Withdrawal by Subject|3|||
124897668|NCT03369951|449249611|FG000|Overall Study|Death|1|||
124897669|NCT03369951|449249611|FG000|Overall Study|Lost to Follow-up|1|||
124897670|NCT03369951|449249611|FG000|Overall Study|Protocol Violation|1|||
124897671|NCT02926937|449249612|FG000|Overall Study|Adverse Event|0|||
124897672|NCT02926937|449249613|FG001|Overall Study|Adverse Event|1|||
124897673|NCT02926937|449249614|FG002|Overall Study|Adverse Event|1|||
124897674|NCT02926937|449249612|FG000|Overall Study|Poor Compliance to Protocol|1|||
124897675|NCT02926937|449249613|FG001|Overall Study|Poor Compliance to Protocol|0|||
124897676|NCT02926937|449249614|FG002|Overall Study|Poor Compliance to Protocol|0|||
124897677|NCT02926937|449249612|FG000|Overall Study|Lost to Follow-up|4|||
124897678|NCT02926937|449249613|FG001|Overall Study|Lost to Follow-up|5|||
124897679|NCT02926937|449249614|FG002|Overall Study|Lost to Follow-up|0|||
124897680|NCT02926937|449249612|FG000|Overall Study|At the Participant's own Request|11|||
125110664|NCT02983227|450029346|FG000|Overall Study|Death|3|||
124897681|NCT02926937|449249613|FG001|Overall Study|At the Participant's own Request|5|||
125110665|NCT02983227|450029347|FG001|Overall Study|Death|0|||
124897682|NCT02926937|449249614|FG002|Overall Study|At the Participant's own Request|8|||
124897683|NCT02926937|449249612|FG000|Overall Study|Reason not Specified|3|||
124897684|NCT02926937|449249613|FG001|Overall Study|Reason not Specified|4|||
124897685|NCT02926937|449249614|FG002|Overall Study|Reason not Specified|2|||
125110666|NCT02983227|450029346|FG000|Overall Study|Lack of Efficacy|8|||
124897686|NCT00561574|449249615|FG000|Overall Study|Adverse Event|21|||
124897687|NCT00561574|449249616|FG001|Overall Study|Adverse Event|24|||
124897688|NCT00561574|449249615|FG000|Overall Study|Lack of Efficacy|11|||
124897689|NCT00561574|449249616|FG001|Overall Study|Lack of Efficacy|21|||
125110667|NCT02983227|450029347|FG001|Overall Study|Lack of Efficacy|1|||
124897690|NCT00561574|449249615|FG000|Overall Study|Withdrawal by Subject|4|||
124897691|NCT00561574|449249616|FG001|Overall Study|Withdrawal by Subject|4|||
124897692|NCT00561574|449249615|FG000|Overall Study|Reason Unrelated to Trial|6|||
124897693|NCT00561574|449249616|FG001|Overall Study|Reason Unrelated to Trial|2|||
124897694|NCT00561574|449249615|FG000|Overall Study|Lost to Follow-up|1|||
124897695|NCT00561574|449249616|FG001|Overall Study|Lost to Follow-up|0|||
124897696|NCT00561574|449249615|FG000|Overall Study|Other|5|||
124897697|NCT00561574|449249616|FG001|Overall Study|Other|7|||
124897698|NCT00630864|449249621|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
124897699|NCT00630864|449249621|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
124897700|NCT00124982|449249622|FG000|Short-term Period|Death|1|||
124897701|NCT00124982|449249623|FG001|Short-term Period|Death|1|||
124897702|NCT00124982|449249624|FG002|Short-term Period|Death|0|||
124897703|NCT00124982|449249622|FG000|Short-term Period|Adverse Event|17|||
124897704|NCT00124982|449249623|FG001|Short-term Period|Adverse Event|22|||
124897705|NCT00124982|449249624|FG002|Short-term Period|Adverse Event|0|||
124897706|NCT00124982|449249622|FG000|Short-term Period|Lack of Efficacy|32|||
124897707|NCT00124982|449249623|FG001|Short-term Period|Lack of Efficacy|73|||
124897708|NCT00124982|449249624|FG002|Short-term Period|Lack of Efficacy|0|||
124897709|NCT00124982|449249622|FG000|Short-term Period|Lost to Follow-up|8|||
124897710|NCT00124982|449249623|FG001|Short-term Period|Lost to Follow-up|5|||
124897711|NCT00124982|449249624|FG002|Short-term Period|Lost to Follow-up|0|||
124897712|NCT00124982|449249622|FG000|Short-term Period|Withdrawal of Consent|7|||
124897713|NCT00124982|449249623|FG001|Short-term Period|Withdrawal of Consent|9|||
124897714|NCT00124982|449249624|FG002|Short-term Period|Withdrawal of Consent|0|||
124897715|NCT00124982|449249622|FG000|Short-term Period|Poor/Non-compliance|3|||
124897716|NCT00124982|449249623|FG001|Short-term Period|Poor/Non-compliance|1|||
124897717|NCT00124982|449249624|FG002|Short-term Period|Poor/Non-compliance|0|||
124897718|NCT00124982|449249622|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
124897719|NCT00124982|449249623|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
124897720|NCT00124982|449249624|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
124897721|NCT00124982|449249622|FG000|Short-term Period|Participant Decision|1|||
124897722|NCT00124982|449249623|FG001|Short-term Period|Participant Decision|0|||
124897723|NCT00124982|449249624|FG002|Short-term Period|Participant Decision|0|||
124897724|NCT00124982|449249622|FG000|Short-term Period|Participant Chose Own Doctor|0|||
124897725|NCT00124982|449249623|FG001|Short-term Period|Participant Chose Own Doctor|1|||
124897726|NCT00124982|449249624|FG002|Short-term Period|Participant Chose Own Doctor|0|||
124897727|NCT00124982|449249622|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
124897728|NCT00124982|449249623|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
124897729|NCT00124982|449249624|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
124897730|NCT00124982|449249622|FG000|Short-term Period|Participant Had Lymphopenia|1|||
124897731|NCT00124982|449249623|FG001|Short-term Period|Participant Had Lymphopenia|0|||
124897732|NCT00124982|449249624|FG002|Short-term Period|Participant Had Lymphopenia|0|||
124897733|NCT00124982|449249622|FG000|Long-term Period|Death|0|||
124897734|NCT00124982|449249623|FG001|Long-term Period|Death|0|||
124897735|NCT00124982|449249624|FG002|Long-term Period|Death|1|||
124897736|NCT00124982|449249622|FG000|Long-term Period|Adverse Event|0|||
124897737|NCT00124982|449249623|FG001|Long-term Period|Adverse Event|0|||
124897738|NCT00124982|449249624|FG002|Long-term Period|Adverse Event|17|||
124897739|NCT00124982|449249622|FG000|Long-term Period|Lack of Efficacy|0|||
124897740|NCT00124982|449249623|FG001|Long-term Period|Lack of Efficacy|0|||
124897741|NCT00124982|449249624|FG002|Long-term Period|Lack of Efficacy|46|||
124897742|NCT00124982|449249622|FG000|Long-term Period|Lost to Follow-up|0|||
124897743|NCT00124982|449249623|FG001|Long-term Period|Lost to Follow-up|0|||
124897744|NCT00124982|449249624|FG002|Long-term Period|Lost to Follow-up|4|||
124897745|NCT00124982|449249622|FG000|Long-term Period|Withdrawal by Subject|0|||
124897746|NCT00124982|449249623|FG001|Long-term Period|Withdrawal by Subject|0|||
124897747|NCT00124982|449249624|FG002|Long-term Period|Withdrawal by Subject|16|||
124897748|NCT00124982|449249622|FG000|Long-term Period|Pregnancy|0|||
124897749|NCT00124982|449249623|FG001|Long-term Period|Pregnancy|0|||
124897750|NCT00124982|449249624|FG002|Long-term Period|Pregnancy|1|||
124897751|NCT00124982|449249622|FG000|Long-term Period|Poor/Non-compliance|0|||
124897752|NCT00124982|449249623|FG001|Long-term Period|Poor/Non-compliance|0|||
124897753|NCT00124982|449249624|FG002|Long-term Period|Poor/Non-compliance|2|||
124897754|NCT00124982|449249622|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
124897755|NCT00124982|449249623|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
124897756|NCT00124982|449249624|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
124897757|NCT00124982|449249622|FG000|Long-term Period|Neurologist Recommendation|0|||
124897758|NCT00124982|449249623|FG001|Long-term Period|Neurologist Recommendation|0|||
124897759|NCT00124982|449249624|FG002|Long-term Period|Neurologist Recommendation|1|||
124897760|NCT04155424|449249625|FG000|Overall Study|Other than specified|3|||
124897761|NCT04155424|449249625|FG000|Overall Study|Withdrawal by Subject|1|||
124897762|NCT04155424|449249625|FG000|Overall Study|Adverse Event|1|||
124897763|NCT03015740|449249626|FG000|Overall Study|Adverse Event|1|||
124897764|NCT03015740|449249627|FG001|Overall Study|Adverse Event|0|||
124897765|NCT03015740|449249628|FG002|Overall Study|Adverse Event|0|||
124897766|NCT03015740|449249626|FG000|Overall Study|Death|3|||
124897767|NCT03015740|449249627|FG001|Overall Study|Death|5|||
124897768|NCT03015740|449249628|FG002|Overall Study|Death|0|||
124897769|NCT03015740|449249626|FG000|Overall Study|Withdrawal by Subject|2|||
124897770|NCT03015740|449249627|FG001|Overall Study|Withdrawal by Subject|0|||
124897771|NCT03015740|449249628|FG002|Overall Study|Withdrawal by Subject|0|||
124897772|NCT00587288|449251082|FG000|Overall Study|Adverse Event|0|||
124897773|NCT00587288|449251083|FG001|Overall Study|Adverse Event|1|||
124897774|NCT00587288|449251082|FG000|Overall Study|Lack of Efficacy|2|||
124897775|NCT00587288|449251083|FG001|Overall Study|Lack of Efficacy|8|||
124897776|NCT00587288|449251082|FG000|Overall Study|Protocol Violation|1|||
124897777|NCT00587288|449251083|FG001|Overall Study|Protocol Violation|0|||
124897778|NCT00797862|449251084|FG000|Overall Study|Adverse Event|86|||
124897779|NCT00797862|449251085|FG001|Overall Study|Adverse Event|44|||
124897780|NCT00797862|449251086|FG002|Overall Study|Adverse Event|58|||
124897781|NCT00797862|449251084|FG000|Overall Study|Abnormal Test Procedure Result|0|||
124897782|NCT00797862|449251085|FG001|Overall Study|Abnormal Test Procedure Result|1|||
124897783|NCT00797862|449251086|FG002|Overall Study|Abnormal Test Procedure Result|1|||
124897784|NCT00797862|449251084|FG000|Overall Study|Lack of Efficacy|1|||
124897785|NCT00797862|449251085|FG001|Overall Study|Lack of Efficacy|7|||
124897786|NCT00797862|449251086|FG002|Overall Study|Lack of Efficacy|6|||
124897787|NCT00797862|449251084|FG000|Overall Study|No longer required study medication|1|||
124897788|NCT00797862|449251085|FG001|Overall Study|No longer required study medication|0|||
124897789|NCT00797862|449251086|FG002|Overall Study|No longer required study medication|0|||
124897790|NCT00797862|449251084|FG000|Overall Study|Withdrawal by Subject|14|||
124897791|NCT00797862|449251085|FG001|Overall Study|Withdrawal by Subject|7|||
124897792|NCT00797862|449251086|FG002|Overall Study|Withdrawal by Subject|7|||
124897793|NCT00797862|449251084|FG000|Overall Study|Lost to Follow-up|11|||
124897794|NCT00797862|449251085|FG001|Overall Study|Lost to Follow-up|0|||
124897795|NCT00797862|449251086|FG002|Overall Study|Lost to Follow-up|5|||
124897796|NCT00797862|449251084|FG000|Overall Study|Administrative Problem|4|||
124897797|NCT00797862|449251085|FG001|Overall Study|Administrative Problem|0|||
124897798|NCT00797862|449251086|FG002|Overall Study|Administrative Problem|0|||
124897799|NCT00797862|449251084|FG000|Overall Study|Protocol Violation|4|||
124897800|NCT00797862|449251085|FG001|Overall Study|Protocol Violation|6|||
124897801|NCT00797862|449251086|FG002|Overall Study|Protocol Violation|8|||
124897802|NCT00797862|449251084|FG000|Overall Study|Mis-randomized|3|||
124897803|NCT00797862|449251085|FG001|Overall Study|Mis-randomized|3|||
124897804|NCT00797862|449251086|FG002|Overall Study|Mis-randomized|1|||
124897805|NCT00531479|449251087|FG000|Overall Study|Death|68|||
124897806|NCT00531479|449251088|FG001|Overall Study|Death|71|||
124897807|NCT00531479|449251087|FG000|Overall Study|Lost to Follow-up|0|||
124897808|NCT00531479|449251088|FG001|Overall Study|Lost to Follow-up|2|||
124897809|NCT00531479|449251087|FG000|Overall Study|Other|0|||
124897810|NCT00531479|449251088|FG001|Overall Study|Other|1|||
124897811|NCT00531479|449251087|FG000|Overall Study|Withdrawal by Subject|6|||
124897812|NCT00531479|449251088|FG001|Overall Study|Withdrawal by Subject|6|||
124897813|NCT00531479|449251087|FG000|Overall Study|Did not receive treatment|2|||
124897814|NCT00531479|449251088|FG001|Overall Study|Did not receive treatment|3|||
124897815|NCT00409708|449251100|FG000|Treatment|Abnormal test procedure result(s)|1|||
124897816|NCT00409708|449251101|FG001|Treatment|Abnormal test procedure result(s)|0|||
124897817|NCT00409708|449251100|FG000|Treatment|Lack of Efficacy|0|||
124897818|NCT00409708|449251101|FG001|Treatment|Lack of Efficacy|1|||
124897819|NCT00409708|449251100|FG000|Treatment|Protocol Violation|6|||
124897820|NCT00409708|449251101|FG001|Treatment|Protocol Violation|2|||
125019322|NCT03605680|449694687|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
125019323|NCT03605680|449694684|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
124897821|NCT00409708|449251100|FG000|Treatment|Withdrawal by Subject|3|||
125019324|NCT03605680|449694685|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
125019325|NCT03605680|449694686|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
125019326|NCT03605680|449694687|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
125019327|NCT03605680|449694684|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
125019328|NCT03605680|449694685|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
125019329|NCT03605680|449694686|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
125110668|NCT02983227|450029346|FG000|Overall Study|Lost to Follow-up|3|||
125110669|NCT02983227|450029347|FG001|Overall Study|Lost to Follow-up|0|||
124897822|NCT00409708|449251101|FG001|Treatment|Withdrawal by Subject|8|||
124897823|NCT00409708|449251100|FG000|Treatment|Lost to Follow-up|0|||
124897824|NCT00409708|449251101|FG001|Treatment|Lost to Follow-up|6|||
124897825|NCT00409708|449251100|FG000|Treatment|Administrative problems|5|||
124897826|NCT00409708|449251101|FG001|Treatment|Administrative problems|0|||
124897827|NCT00409708|449251100|FG000|Washout|Lack of Efficacy|9|||
124897828|NCT00409708|449251101|FG001|Washout|Lack of Efficacy|1|||
125019330|NCT03605680|449694687|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
125019331|NCT03605680|449694684|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
125019332|NCT03605680|449694685|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
125019333|NCT03605680|449694686|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
125019334|NCT03605680|449694687|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
125019335|NCT03605680|449694684|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
125019336|NCT03605680|449694685|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
125019337|NCT03605680|449694686|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
125019338|NCT03605680|449694687|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
125019339|NCT03605680|449694684|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
125019340|NCT03605680|449694685|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
125019341|NCT03605680|449694686|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
125019342|NCT03605680|449694687|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
125019343|NCT02721355|449694688|FG000|Overall Study|Lost to Follow-up|6|||
125019344|NCT02721355|449694689|FG001|Overall Study|Lost to Follow-up|1|||
125019345|NCT00356278|449694690|FG000|Overall Study|Withdrawal by Subject|25|||
125019346|NCT00356278|449694691|FG001|Overall Study|Withdrawal by Subject|15|||
125019347|NCT00356278|449694692|FG002|Overall Study|Withdrawal by Subject|19|||
125019348|NCT00883337|449694693|FG000|Core Treatment Period|Adverse Event|9|||
125019349|NCT00883337|449694694|FG001|Core Treatment Period|Adverse Event|12|||
125019350|NCT00883337|449694695|FG002|Core Treatment Period|Adverse Event|22|||
125019351|NCT00883337|449694693|FG000|Core Treatment Period|Lack of Efficacy|7|||
125019352|NCT00883337|449694694|FG001|Core Treatment Period|Lack of Efficacy|4|||
124897829|NCT00409708|449251100|FG000|Washout|Protocol Violation|0|||
124897830|NCT00409708|449251101|FG001|Washout|Protocol Violation|1|||
125019353|NCT00883337|449694695|FG002|Core Treatment Period|Lack of Efficacy|2|||
125019354|NCT00883337|449694693|FG000|Core Treatment Period|Lost to Follow-up|1|||
125019355|NCT00883337|449694694|FG001|Core Treatment Period|Lost to Follow-up|1|||
125019356|NCT00883337|449694695|FG002|Core Treatment Period|Lost to Follow-up|0|||
125019357|NCT00883337|449694693|FG000|Core Treatment Period|Withdrawal by Subject|2|||
125019358|NCT00883337|449694694|FG001|Core Treatment Period|Withdrawal by Subject|2|||
125019359|NCT00883337|449694695|FG002|Core Treatment Period|Withdrawal by Subject|6|||
125019360|NCT00883337|449694693|FG000|Core Treatment Period|Wish to be pregnant|1|||
124897831|NCT00409708|449251100|FG000|Washout|Withdrawal by Subject|11|||
124897832|NCT00409708|449251101|FG001|Washout|Withdrawal by Subject|5|||
124897833|NCT00409708|449251100|FG000|Washout|Lost to Follow-up|1|||
124897834|NCT00409708|449251101|FG001|Washout|Lost to Follow-up|3|||
124897835|NCT01474538|449251108|FG000|Treatment Period 1|Death|1|||
124897836|NCT01474538|449251109|FG001|Treatment Period 1|Death|0|||
124897837|NCT01474538|449251108|FG000|Treatment Period 1|Physician Decision|1|||
124897838|NCT01474538|449251109|FG001|Treatment Period 1|Physician Decision|0|||
124897839|NCT01474538|449251108|FG000|Treatment Period 1|Withdrawal by Subject|1|||
124897840|NCT01474538|449251109|FG001|Treatment Period 1|Withdrawal by Subject|3|||
124897841|NCT01474538|449251108|FG000|Treatment Period 1|Protocol Violation|0|||
124897842|NCT01474538|449251109|FG001|Treatment Period 1|Protocol Violation|1|||
124897843|NCT01474538|449251108|FG000|Treatment Period 2|Death|1|||
124897844|NCT01474538|449251109|FG001|Treatment Period 2|Death|0|||
124897845|NCT01474538|449251108|FG000|Treatment Period 2|Adverse Event|1|||
124897846|NCT01474538|449251109|FG001|Treatment Period 2|Adverse Event|1|||
125019361|NCT00883337|449694694|FG001|Core Treatment Period|Wish to be pregnant|2|||
125019362|NCT00883337|449694695|FG002|Core Treatment Period|Wish to be pregnant|1|||
125019363|NCT00883337|449694693|FG000|Core Treatment Period|Poor compliance to protocol|0|||
125019364|NCT00883337|449694694|FG001|Core Treatment Period|Poor compliance to protocol|0|||
125019365|NCT00883337|449694695|FG002|Core Treatment Period|Poor compliance to protocol|1|||
124897847|NCT01474538|449251108|FG000|Treatment Period 2|Withdrawal by Subject|2|||
124897848|NCT01474538|449251109|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124897849|NCT01474538|449251108|FG000|Treatment Period 2|Sponsor decision|1|||
124897850|NCT01474538|449251109|FG001|Treatment Period 2|Sponsor decision|0|||
124897851|NCT01474538|449251108|FG000|Treatment Period 2|Physician Decision|0|||
124897852|NCT01474538|449251109|FG001|Treatment Period 2|Physician Decision|1|||
124897853|NCT01474538|449251108|FG000|Treatment Period 2|Protocol Violation|1|||
124897854|NCT01474538|449251109|FG001|Treatment Period 2|Protocol Violation|0|||
124897855|NCT01456780|449251110|FG000|Overall Study|Lost to Follow-up|3|||
124897856|NCT01456780|449251111|FG001|Overall Study|Lost to Follow-up|3|||
124897857|NCT01456780|449251112|FG002|Overall Study|Lost to Follow-up|0|||
124897858|NCT02501629|449251116|FG000|Overall Study|Death|0|||
124897859|NCT02501629|449251117|FG001|Overall Study|Death|1|||
124897860|NCT02501629|449251116|FG000|Overall Study|Withdrawn from study by sponsor|1|||
124897861|NCT02501629|449251117|FG001|Overall Study|Withdrawn from study by sponsor|0|||
124897862|NCT02501629|449251116|FG000|Overall Study|Early termination by sponsor|1|||
125110670|NCT02983227|450029346|FG000|Overall Study|Multiple Reasons|2|||
124897863|NCT02501629|449251117|FG001|Overall Study|Early termination by sponsor|0|||
125110671|NCT02983227|450029347|FG001|Overall Study|Multiple Reasons|1|||
125110672|NCT02983227|450029346|FG000|Overall Study|Physician Decision|3|||
125110673|NCT02983227|450029347|FG001|Overall Study|Physician Decision|1|||
125110674|NCT02983227|450029346|FG000|Overall Study|Withdrawal by Subject|19|||
125110675|NCT02983227|450029347|FG001|Overall Study|Withdrawal by Subject|8|||
124897864|NCT02501629|449251116|FG000|Overall Study|Withdrawal by Subject|3|||
124897865|NCT02501629|449251117|FG001|Overall Study|Withdrawal by Subject|5|||
124897866|NCT02501629|449251116|FG000|Overall Study|Subject did not return to site|0|||
124897867|NCT02501629|449251117|FG001|Overall Study|Subject did not return to site|1|||
124897868|NCT00868231|449251122|FG000|Treatment Period 1|Adverse Event|0|||
124897869|NCT00868231|449251123|FG001|Treatment Period 1|Adverse Event|0|||
124897870|NCT00868231|449251124|FG002|Treatment Period 1|Adverse Event|0|||
124897871|NCT00868231|449251125|FG003|Treatment Period 1|Adverse Event|0|||
124897872|NCT00868231|449251126|FG004|Treatment Period 1|Adverse Event|1|||
124897873|NCT00868231|449251127|FG005|Treatment Period 1|Adverse Event|0|||
124897874|NCT00868231|449251122|FG000|Treatment Period 2|Adverse Event|1|||
124897875|NCT00868231|449251123|FG001|Treatment Period 2|Adverse Event|0|||
124897876|NCT00868231|449251124|FG002|Treatment Period 2|Adverse Event|0|||
124897877|NCT00868231|449251125|FG003|Treatment Period 2|Adverse Event|0|||
124897878|NCT00868231|449251126|FG004|Treatment Period 2|Adverse Event|0|||
124897879|NCT00868231|449251127|FG005|Treatment Period 2|Adverse Event|0|||
124897880|NCT00868231|449251122|FG000|Treatment Period 3|Adverse Event|0|||
124897881|NCT00868231|449251123|FG001|Treatment Period 3|Adverse Event|0|||
124897882|NCT00868231|449251124|FG002|Treatment Period 3|Adverse Event|1|||
124897883|NCT00868231|449251125|FG003|Treatment Period 3|Adverse Event|0|||
124897884|NCT00868231|449251126|FG004|Treatment Period 3|Adverse Event|0|||
124897885|NCT00868231|449251127|FG005|Treatment Period 3|Adverse Event|0|||
124897886|NCT00349908|449251130|FG000|Overall Study|Withdrawal by Subject|0|||
124897887|NCT00349908|449251131|FG001|Overall Study|Withdrawal by Subject|4|||
124897888|NCT04565249|449251132|FG000|Overall Study|Death|0|||
124897889|NCT04565249|449251133|FG001|Overall Study|Death|0|||
124897890|NCT04565249|449251134|FG002|Overall Study|Death|0|||
124897891|NCT04565249|449251135|FG003|Overall Study|Death|1|||
124897892|NCT03120676|449251136|FG000|Overall Study|Not treated|1|||
124897893|NCT00926393|449251137|FG000|Overall Study|Withdrawal by Subject|1|||
124897894|NCT00926393|449251138|FG001|Overall Study|Withdrawal by Subject|2|||
124897895|NCT00926393|449251137|FG000|Overall Study|Adverse Event|1|||
124897896|NCT00926393|449251138|FG001|Overall Study|Adverse Event|1|||
124897897|NCT02333630|449251139|FG000|Overall Study|Lost to Follow-up|5|||
124897898|NCT02333630|449251140|FG001|Overall Study|Lost to Follow-up|2|||
124897899|NCT05349864|449251141|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
124897900|NCT05349864|449251142|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
124897901|NCT00984282|449251143|FG000|Double Blind Treatment|Adverse Event|40|||
124897902|NCT00984282|449251144|FG001|Double Blind Treatment|Adverse Event|6|||
124897903|NCT00984282|449251143|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
124897904|NCT00984282|449251144|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
124897905|NCT00984282|449251143|FG000|Double Blind Treatment|Physician Decision|1|||
124897906|NCT00984282|449251144|FG001|Double Blind Treatment|Physician Decision|2|||
124897907|NCT00984282|449251143|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
124897908|NCT00984282|449251144|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
124897909|NCT00984282|449251143|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
124897910|NCT00984282|449251144|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
124897911|NCT00984282|449251143|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
124897912|NCT00984282|449251144|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
124897913|NCT00984282|449251143|FG000|Double Blind Treatment|Lost to Follow-up|3|||
124897914|NCT00984282|449251144|FG001|Double Blind Treatment|Lost to Follow-up|0|||
124897915|NCT00984282|449251143|FG000|Double Blind Treatment|Death|8|||
124897916|NCT00984282|449251144|FG001|Double Blind Treatment|Death|4|||
124897917|NCT00984282|449251143|FG000|Double Blind Treatment|Not treated|0|||
124897918|NCT00984282|449251144|FG001|Double Blind Treatment|Not treated|1|||
124897919|NCT00984282|449251143|FG000|Double Blind Treatment|Switched to commercial drug|6|||
125019366|NCT00883337|449694693|FG000|Core Treatment Period|Other than above|0|||
124897920|NCT00984282|449251144|FG001|Double Blind Treatment|Switched to commercial drug|1|||
124897921|NCT00984282|449251143|FG000|Double Blind Treatment|protocol driven decision point|1|||
124897922|NCT00984282|449251144|FG001|Double Blind Treatment|protocol driven decision point|1|||
124897923|NCT00984282|449251143|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
125019367|NCT00883337|449694694|FG001|Core Treatment Period|Other than above|1|||
125019368|NCT00883337|449694695|FG002|Core Treatment Period|Other than above|1|||
125019369|NCT00883337|449694693|FG000|Extension Treatment Period|Adverse Event|8|||
125019370|NCT00883337|449694694|FG001|Extension Treatment Period|Adverse Event|5|||
125019371|NCT00883337|449694695|FG002|Extension Treatment Period|Adverse Event|5|||
125019372|NCT00883337|449694693|FG000|Extension Treatment Period|Lack of Efficacy|8|||
125019373|NCT00883337|449694694|FG001|Extension Treatment Period|Lack of Efficacy|8|||
125110676|NCT00986154|450029348|FG000|Overall Study|Death|136|||
125110677|NCT00986154|450029349|FG001|Overall Study|Death|127|||
124897924|NCT00984282|449251144|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
124897925|NCT00984282|449251143|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
124897926|NCT00984282|449251144|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
124897927|NCT00984282|449251143|FG000|Open-label Treatment|Adverse Event|20|||
124897928|NCT00984282|449251144|FG001|Open-label Treatment|Adverse Event|30|||
124897929|NCT00984282|449251143|FG000|Open-label Treatment|Withdrawal by Subject|6|||
124897930|NCT00984282|449251144|FG001|Open-label Treatment|Withdrawal by Subject|21|||
124897931|NCT00984282|449251143|FG000|Open-label Treatment|Death|7|||
124897932|NCT00984282|449251144|FG001|Open-label Treatment|Death|15|||
124897933|NCT00984282|449251143|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
124897934|NCT00984282|449251144|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
124897935|NCT00984282|449251143|FG000|Open-label Treatment|Lost to Follow-up|1|||
124897936|NCT00984282|449251144|FG001|Open-label Treatment|Lost to Follow-up|1|||
124897937|NCT00984282|449251143|FG000|Open-label Treatment|Patient convenience|1|||
124897938|NCT00984282|449251144|FG001|Open-label Treatment|Patient convenience|0|||
124897939|NCT00984282|449251143|FG000|Open-label Treatment|Non-compliant with study medication|1|||
124897940|NCT00984282|449251144|FG001|Open-label Treatment|Non-compliant with study medication|0|||
124897941|NCT00984282|449251143|FG000|Open-label Treatment|Target lesion removed|0|||
124897942|NCT00984282|449251144|FG001|Open-label Treatment|Target lesion removed|1|||
124897943|NCT00984282|449251143|FG000|Open-label Treatment|Protocol driven decision point|1|||
124897944|NCT00984282|449251144|FG001|Open-label Treatment|Protocol driven decision point|1|||
124897945|NCT00984282|449251143|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
124897946|NCT00984282|449251144|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
124897947|NCT00984282|449251143|FG000|Open-label Treatment|Switched to commercial drug|6|||
124897948|NCT00984282|449251144|FG001|Open-label Treatment|Switched to commercial drug|7|||
124897949|NCT00984282|449251143|FG000|Open-label Treatment|Physician Decision|1|||
124897950|NCT00984282|449251144|FG001|Open-label Treatment|Physician Decision|0|||
124897951|NCT00984282|449251143|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
124897952|NCT00984282|449251144|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
124897953|NCT00984282|449251143|FG000|Long Term Follow-up|Death|27|||
124897954|NCT00984282|449251144|FG001|Long Term Follow-up|Death|68|||
124897955|NCT00984282|449251143|FG000|Long Term Follow-up|Lost to Follow-up|3|||
124897956|NCT00984282|449251144|FG001|Long Term Follow-up|Lost to Follow-up|6|||
124897957|NCT00984282|449251143|FG000|Long Term Follow-up|Protocol driven decision point|25|||
124897958|NCT00984282|449251144|FG001|Long Term Follow-up|Protocol driven decision point|26|||
124897959|NCT00984282|449251143|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
124897960|NCT00984282|449251144|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
124897961|NCT00984282|449251143|FG000|Long Term Follow-up|Switched to commercial drug|4|||
124897962|NCT00984282|449251144|FG001|Long Term Follow-up|Switched to commercial drug|2|||
124897963|NCT00984282|449251143|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
124897964|NCT00984282|449251144|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
124897965|NCT02223793|449251145|FG000|Overall Study|Lost to Follow-up|10|||
124897966|NCT02223793|449251146|FG001|Overall Study|Lost to Follow-up|1|||
124897967|NCT02223793|449251147|FG002|Overall Study|Lost to Follow-up|2|||
124897968|NCT02223793|449251145|FG000|Overall Study|Withdrawal by Subject|3|||
124897969|NCT02223793|449251146|FG001|Overall Study|Withdrawal by Subject|2|||
124897970|NCT02223793|449251147|FG002|Overall Study|Withdrawal by Subject|3|||
124897971|NCT02223793|449251145|FG000|Overall Study|Moved/studycenter unable to participate|4|||
124897972|NCT02223793|449251146|FG001|Overall Study|Moved/studycenter unable to participate|6|||
124897973|NCT02223793|449251147|FG002|Overall Study|Moved/studycenter unable to participate|8|||
124897974|NCT02359435|449251149|FG000|Overall Study|Lost to Follow-up|4|||
124897975|NCT02359435|449251150|FG001|Overall Study|Lost to Follow-up|4|||
124897976|NCT00315055|449251151|FG000|Overall Study|Protocol Violation|2|||
124897977|NCT00315055|449251152|FG001|Overall Study|Protocol Violation|4|||
124897978|NCT00315055|449251151|FG000|Overall Study|Lost to Follow-up|1|||
124897979|NCT00315055|449251152|FG001|Overall Study|Lost to Follow-up|1|||
124897980|NCT01289119|449251157|FG000|Overall Study|Adverse Event|2|||
124897981|NCT01289119|449251158|FG001|Overall Study|Adverse Event|1|||
124897982|NCT01289119|449251159|FG002|Overall Study|Adverse Event|0|||
124897983|NCT01289119|449251160|FG003|Overall Study|Adverse Event|2|||
124897984|NCT01289119|449251161|FG004|Overall Study|Adverse Event|1|||
124897985|NCT01289119|449251162|FG005|Overall Study|Adverse Event|0|||
124897986|NCT01289119|449251157|FG000|Overall Study|Major Protocol Deviation|2|||
124897987|NCT01289119|449251158|FG001|Overall Study|Major Protocol Deviation|1|||
124897988|NCT01289119|449251159|FG002|Overall Study|Major Protocol Deviation|3|||
124897989|NCT01289119|449251160|FG003|Overall Study|Major Protocol Deviation|0|||
124897990|NCT01289119|449251161|FG004|Overall Study|Major Protocol Deviation|2|||
124897991|NCT01289119|449251162|FG005|Overall Study|Major Protocol Deviation|1|||
124897992|NCT01289119|449251157|FG000|Overall Study|Lost to Follow-up|0|||
124897993|NCT01289119|449251158|FG001|Overall Study|Lost to Follow-up|3|||
124897994|NCT01289119|449251159|FG002|Overall Study|Lost to Follow-up|0|||
124897995|NCT01289119|449251160|FG003|Overall Study|Lost to Follow-up|0|||
124897996|NCT01289119|449251161|FG004|Overall Study|Lost to Follow-up|0|||
124897997|NCT01289119|449251162|FG005|Overall Study|Lost to Follow-up|1|||
124897998|NCT01289119|449251157|FG000|Overall Study|Withdrawal by Subject|4|||
124897999|NCT01289119|449251158|FG001|Overall Study|Withdrawal by Subject|2|||
124898000|NCT01289119|449251159|FG002|Overall Study|Withdrawal by Subject|4|||
124898001|NCT01289119|449251160|FG003|Overall Study|Withdrawal by Subject|3|||
124898002|NCT01289119|449251161|FG004|Overall Study|Withdrawal by Subject|1|||
124898003|NCT01289119|449251162|FG005|Overall Study|Withdrawal by Subject|1|||
124898004|NCT01289119|449251157|FG000|Overall Study|Pregnancy|0|||
124898005|NCT01289119|449251158|FG001|Overall Study|Pregnancy|1|||
124898006|NCT01289119|449251159|FG002|Overall Study|Pregnancy|0|||
124898007|NCT01289119|449251160|FG003|Overall Study|Pregnancy|0|||
124898008|NCT01289119|449251161|FG004|Overall Study|Pregnancy|0|||
124898009|NCT01289119|449251162|FG005|Overall Study|Pregnancy|0|||
124898010|NCT01289119|449251157|FG000|Overall Study|Lack of Efficacy|0|||
124898011|NCT01289119|449251158|FG001|Overall Study|Lack of Efficacy|1|||
124898012|NCT01289119|449251159|FG002|Overall Study|Lack of Efficacy|1|||
124898013|NCT01289119|449251160|FG003|Overall Study|Lack of Efficacy|1|||
124898014|NCT01289119|449251161|FG004|Overall Study|Lack of Efficacy|1|||
124898015|NCT01289119|449251162|FG005|Overall Study|Lack of Efficacy|1|||
124898016|NCT01289119|449251157|FG000|Overall Study|Other|1|||
124898017|NCT01289119|449251158|FG001|Overall Study|Other|0|||
124898018|NCT01289119|449251159|FG002|Overall Study|Other|1|||
124898019|NCT01289119|449251160|FG003|Overall Study|Other|0|||
124898020|NCT01289119|449251161|FG004|Overall Study|Other|0|||
124898021|NCT01289119|449251162|FG005|Overall Study|Other|0|||
124898022|NCT01704846|449251163|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124898023|NCT01704846|449251164|FG001|Treatment Period 2|Withdrawal by Subject|1|||
124898024|NCT00530335|449251165|FG000|Overall Study|Adverse Event|3|||
124898025|NCT00530335|449251165|FG000|Overall Study|Protocol Violation|1|||
124898026|NCT00530335|449251165|FG000|Overall Study|Withdrawal by Subject|1|||
124898027|NCT00530335|449251165|FG000|Overall Study|Physician Decision|1|||
124898028|NCT02321540|449251166|FG000|Overall Study|Death|0|||
124898029|NCT02321540|449251167|FG001|Overall Study|Death|1|||
124898030|NCT02321540|449251166|FG000|Overall Study|Progression|3|||
124898031|NCT02321540|449251167|FG001|Overall Study|Progression|9|||
124898032|NCT01649791|449251168|FG000|Overall Study|Disease Progression|2|||
124898033|NCT01649791|449251168|FG000|Overall Study|Adverse Event|1|||
124898034|NCT04577183|449251169|FG000|Overall Study|Death|1|||
124898035|NCT04577183|449251169|FG000|Overall Study|Withdrawal by Subject|3|||
124898036|NCT04577183|449251169|FG000|Overall Study|Early termination|2|||
124898037|NCT01268891|449251175|FG000|Overall Study|Adverse Event|3|||
124898038|NCT01268891|449251176|FG001|Overall Study|Adverse Event|7|||
124898039|NCT01268891|449251175|FG000|Overall Study|Lack of Efficacy|1|||
124898040|NCT01268891|449251176|FG001|Overall Study|Lack of Efficacy|0|||
124898041|NCT01268891|449251175|FG000|Overall Study|Withdrawal of Consent|3|||
124898042|NCT01268891|449251176|FG001|Overall Study|Withdrawal of Consent|1|||
124898043|NCT01268891|449251175|FG000|Overall Study|Administrative or other reason(s)|1|||
124898044|NCT01268891|449251176|FG001|Overall Study|Administrative or other reason(s)|0|||
124898045|NCT00991276|449251177|FG000|First Intervention Period|Adverse Event|0|||
124898046|NCT00991276|449251178|FG001|First Intervention Period|Adverse Event|1|||
124898047|NCT00991276|449251179|FG002|First Intervention Period|Adverse Event|0|||
124898048|NCT00991276|449251180|FG003|First Intervention Period|Adverse Event|1|||
124898049|NCT00991276|449251181|FG004|First Intervention Period|Adverse Event|0|||
124898050|NCT00991276|449251182|FG005|First Intervention Period|Adverse Event|0|||
124898051|NCT00991276|449251177|FG000|First Intervention Period|Protocol Violation|0|||
124898052|NCT00991276|449251178|FG001|First Intervention Period|Protocol Violation|0|||
124898053|NCT00991276|449251179|FG002|First Intervention Period|Protocol Violation|0|||
124898054|NCT00991276|449251180|FG003|First Intervention Period|Protocol Violation|0|||
124898055|NCT00991276|449251181|FG004|First Intervention Period|Protocol Violation|2|||
124898056|NCT00991276|449251182|FG005|First Intervention Period|Protocol Violation|0|||
124898057|NCT00991276|449251177|FG000|First Intervention Period|Insufficient clinical response|0|||
125019374|NCT00883337|449694695|FG002|Extension Treatment Period|Lack of Efficacy|8|||
125019375|NCT00883337|449694693|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
125019376|NCT00883337|449694694|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
124898058|NCT00991276|449251178|FG001|First Intervention Period|Insufficient clinical response|0|||
124898059|NCT00991276|449251179|FG002|First Intervention Period|Insufficient clinical response|0|||
124898060|NCT00991276|449251180|FG003|First Intervention Period|Insufficient clinical response|0|||
124898061|NCT00991276|449251181|FG004|First Intervention Period|Insufficient clinical response|1|||
125019377|NCT00883337|449694695|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
125019378|NCT00883337|449694693|FG000|Extension Treatment Period|Lost to Follow-up|1|||
125019379|NCT00883337|449694694|FG001|Extension Treatment Period|Lost to Follow-up|0|||
124898062|NCT00991276|449251182|FG005|First Intervention Period|Insufficient clinical response|0|||
124898063|NCT00991276|449251177|FG000|First Intervention Period|Other|0|||
124898064|NCT00991276|449251178|FG001|First Intervention Period|Other|0|||
124898065|NCT00991276|449251179|FG002|First Intervention Period|Other|0|||
125019380|NCT00883337|449694695|FG002|Extension Treatment Period|Lost to Follow-up|0|||
124898066|NCT00991276|449251180|FG003|First Intervention Period|Other|1|||
124898067|NCT00991276|449251181|FG004|First Intervention Period|Other|1|||
124898068|NCT00991276|449251182|FG005|First Intervention Period|Other|0|||
124898069|NCT00991276|449251177|FG000|First Intervention Period|Withdrawal by Subject|0|||
124898070|NCT00991276|449251178|FG001|First Intervention Period|Withdrawal by Subject|1|||
124898071|NCT00991276|449251179|FG002|First Intervention Period|Withdrawal by Subject|0|||
124898072|NCT00991276|449251180|FG003|First Intervention Period|Withdrawal by Subject|1|||
124898073|NCT00991276|449251181|FG004|First Intervention Period|Withdrawal by Subject|0|||
124898074|NCT00991276|449251182|FG005|First Intervention Period|Withdrawal by Subject|1|||
124898075|NCT00991276|449251177|FG000|First Intervention Period|Lost to Follow-up|0|||
124898076|NCT00991276|449251178|FG001|First Intervention Period|Lost to Follow-up|1|||
124898077|NCT00991276|449251179|FG002|First Intervention Period|Lost to Follow-up|0|||
124898078|NCT00991276|449251180|FG003|First Intervention Period|Lost to Follow-up|1|||
124898079|NCT00991276|449251181|FG004|First Intervention Period|Lost to Follow-up|0|||
124898080|NCT00991276|449251182|FG005|First Intervention Period|Lost to Follow-up|0|||
124898081|NCT00991276|449251177|FG000|Second Intervention Period|Adverse Event|0|||
124898082|NCT00991276|449251178|FG001|Second Intervention Period|Adverse Event|2|||
124898083|NCT00991276|449251179|FG002|Second Intervention Period|Adverse Event|0|||
124898084|NCT00991276|449251180|FG003|Second Intervention Period|Adverse Event|1|||
124898085|NCT00991276|449251181|FG004|Second Intervention Period|Adverse Event|1|||
124898086|NCT00991276|449251182|FG005|Second Intervention Period|Adverse Event|0|||
124898087|NCT00991276|449251177|FG000|Second Intervention Period|Protocol Violation|1|||
124898088|NCT00991276|449251178|FG001|Second Intervention Period|Protocol Violation|0|||
124898089|NCT00991276|449251179|FG002|Second Intervention Period|Protocol Violation|0|||
124898090|NCT00991276|449251180|FG003|Second Intervention Period|Protocol Violation|0|||
125110678|NCT00986154|450029348|FG000|Overall Study|Lost to Follow-up|7|||
125110679|NCT00986154|450029349|FG001|Overall Study|Lost to Follow-up|4|||
125110680|NCT00986154|450029348|FG000|Overall Study|Withdrawal by Subject|32|||
125110681|NCT00986154|450029349|FG001|Overall Study|Withdrawal by Subject|33|||
125110682|NCT00986154|450029348|FG000|Overall Study|investigator/subject decide not continue|6|||
125110683|NCT00986154|450029349|FG001|Overall Study|investigator/subject decide not continue|3|||
125110684|NCT00986154|450029348|FG000|Overall Study|never received study drug|25|||
125110685|NCT00986154|450029349|FG001|Overall Study|never received study drug|27|||
125110686|NCT00068445|450029352|FG000|Randomization|Cancel|1|||
125110687|NCT00068445|450029353|FG001|Randomization|Cancel|3|||
125110688|NCT00068445|450029352|FG000|Randomization|Ineligible|1|||
125110689|NCT00068445|450029353|FG001|Randomization|Ineligible|1|||
125110690|NCT00068445|450029352|FG000|Treatment|Refused Further Treatment|13|||
125110691|NCT00068445|450029353|FG001|Treatment|Refused Further Treatment|10|||
125110692|NCT00068445|450029352|FG000|Treatment|Adverse Event|7|||
125110693|NCT00068445|450029353|FG001|Treatment|Adverse Event|1|||
125110694|NCT00068445|450029352|FG000|Treatment|Other (Specifics not available)|9|||
125110695|NCT00068445|450029353|FG001|Treatment|Other (Specifics not available)|5|||
125110696|NCT01493531|450029354|FG000|Overall Study|Adverse Event|4|||
125110697|NCT01493531|450029355|FG001|Overall Study|Adverse Event|12|||
125110698|NCT01493531|450029356|FG002|Overall Study|Adverse Event|9|||
125110699|NCT01493531|450029354|FG000|Overall Study|Gout flare|3|||
125110700|NCT01493531|450029355|FG001|Overall Study|Gout flare|0|||
125110701|NCT01493531|450029356|FG002|Overall Study|Gout flare|2|||
125110702|NCT01493531|450029354|FG000|Overall Study|Protocol Violation|8|||
125110703|NCT01493531|450029355|FG001|Overall Study|Protocol Violation|15|||
125110704|NCT01493531|450029356|FG002|Overall Study|Protocol Violation|12|||
125110705|NCT01493531|450029354|FG000|Overall Study|Sponsor terminated study|5|||
125110706|NCT01493531|450029355|FG001|Overall Study|Sponsor terminated study|2|||
125110707|NCT01493531|450029356|FG002|Overall Study|Sponsor terminated study|3|||
125110708|NCT01493531|450029354|FG000|Overall Study|Lost to Follow-up|5|||
125110709|NCT01493531|450029355|FG001|Overall Study|Lost to Follow-up|7|||
125110710|NCT01493531|450029356|FG002|Overall Study|Lost to Follow-up|11|||
125110711|NCT01493531|450029354|FG000|Overall Study|Withdrawal by Subject|16|||
125110712|NCT01493531|450029355|FG001|Overall Study|Withdrawal by Subject|13|||
125110713|NCT01493531|450029356|FG002|Overall Study|Withdrawal by Subject|11|||
125110714|NCT01493531|450029354|FG000|Overall Study|Death|0|||
125110715|NCT01493531|450029355|FG001|Overall Study|Death|1|||
125110716|NCT01493531|450029356|FG002|Overall Study|Death|0|||
125110717|NCT01946282|450029357|FG000|Year 1|Did not return FIT kit|4186|||
125110718|NCT01946282|450029358|FG001|Year 1|Did not return FIT kit|608|||
125110719|NCT01946282|450029359|FG002|Year 1|Did not return FIT kit|654|||
125110720|NCT01946282|450029357|FG000|Year 2|Did not return FIT kit|803|||
124898091|NCT00991276|449251181|FG004|Second Intervention Period|Protocol Violation|0|||
124898092|NCT00991276|449251182|FG005|Second Intervention Period|Protocol Violation|0|||
124898093|NCT00991276|449251177|FG000|Second Intervention Period|Other|0|||
124898094|NCT00991276|449251178|FG001|Second Intervention Period|Other|0|||
125110721|NCT01946282|450029358|FG001|Year 2|Did not return FIT kit|131|||
125110722|NCT01946282|450029359|FG002|Year 2|Did not return FIT kit|115|||
125110723|NCT01946282|450029357|FG000|Year 3|Did not return FIT kit|288|||
125110724|NCT01946282|450029358|FG001|Year 3|Did not return FIT kit|43|||
125110725|NCT01946282|450029359|FG002|Year 3|Did not return FIT kit|30|||
125110726|NCT03031431|450029362|FG000|Overall Study|Infant removed by maternal request|1|||
125110727|NCT01205529|450029363|FG000|Overall Study|Procedure Cancelled|4|||
125110728|NCT01205529|450029363|FG000|Overall Study|Withdrawal by Subject|2|||
125110729|NCT01205529|450029363|FG000|Overall Study|Physician Decision|4|||
125110730|NCT01205529|450029363|FG000|Overall Study|Unstable post op|15|||
124898095|NCT00991276|449251179|FG002|Second Intervention Period|Other|0|||
124898096|NCT00991276|449251180|FG003|Second Intervention Period|Other|1|||
124898097|NCT00991276|449251181|FG004|Second Intervention Period|Other|0|||
124898098|NCT00991276|449251182|FG005|Second Intervention Period|Other|1|||
124898099|NCT00991276|449251177|FG000|Third Intervention Period|Protocol Violation|1|||
124898100|NCT00991276|449251178|FG001|Third Intervention Period|Protocol Violation|0|||
124898101|NCT00991276|449251179|FG002|Third Intervention Period|Protocol Violation|0|||
124898102|NCT00991276|449251180|FG003|Third Intervention Period|Protocol Violation|0|||
124898103|NCT00991276|449251181|FG004|Third Intervention Period|Protocol Violation|0|||
124898104|NCT00991276|449251182|FG005|Third Intervention Period|Protocol Violation|0|||
124898105|NCT00991276|449251177|FG000|Third Intervention Period|Other|0|||
124898106|NCT00991276|449251178|FG001|Third Intervention Period|Other|0|||
124898107|NCT00991276|449251179|FG002|Third Intervention Period|Other|0|||
124898108|NCT00991276|449251180|FG003|Third Intervention Period|Other|0|||
124898109|NCT00991276|449251181|FG004|Third Intervention Period|Other|0|||
124898110|NCT00991276|449251182|FG005|Third Intervention Period|Other|1|||
124898111|NCT00991276|449251177|FG000|Third Intervention Period|Adverse Event|0|||
124898112|NCT00991276|449251178|FG001|Third Intervention Period|Adverse Event|0|||
124898113|NCT00991276|449251179|FG002|Third Intervention Period|Adverse Event|1|||
124898114|NCT00991276|449251180|FG003|Third Intervention Period|Adverse Event|0|||
124898115|NCT00991276|449251181|FG004|Third Intervention Period|Adverse Event|0|||
124898116|NCT00991276|449251182|FG005|Third Intervention Period|Adverse Event|0|||
124898117|NCT00991276|449251177|FG000|Third Intervention Period|Withdrawal by Subject|0|||
124898118|NCT00991276|449251178|FG001|Third Intervention Period|Withdrawal by Subject|0|||
124898119|NCT00991276|449251179|FG002|Third Intervention Period|Withdrawal by Subject|0|||
124898120|NCT00991276|449251180|FG003|Third Intervention Period|Withdrawal by Subject|1|||
124898121|NCT00991276|449251181|FG004|Third Intervention Period|Withdrawal by Subject|0|||
124898122|NCT00991276|449251182|FG005|Third Intervention Period|Withdrawal by Subject|0|||
124898123|NCT01720043|449251184|FG000|Overall Study|Withdrawal by Subject|1|||
124898124|NCT01688973|449251185|FG000|Overall Study|Ineligible|2|||
124898125|NCT01688973|449251186|FG001|Overall Study|Ineligible|3|||
124898126|NCT01516892|449251190|FG000|Overall Study|Adverse Event|25|||
124898127|NCT01516892|449251190|FG000|Overall Study|Lack of Efficacy|35|||
124898128|NCT01516892|449251190|FG000|Overall Study|Pregnancy|5|||
124898129|NCT01516892|449251190|FG000|Overall Study|Lost to Follow-up|82|||
124898130|NCT01516892|449251190|FG000|Overall Study|Subject Withdrew Consent|92|||
124898131|NCT01516892|449251190|FG000|Overall Study|Protocol Violation|60|||
124898132|NCT01516892|449251190|FG000|Overall Study|Other Miscellaneous Reasons|43|||
124898133|NCT01516892|449251190|FG000|Overall Study|Missing|1|||
124898134|NCT02534896|449251195|FG000|Overall Study|Adverse Event|2|||
124898135|NCT02534896|449251196|FG001|Overall Study|Adverse Event|1|||
124898136|NCT02534896|449251197|FG002|Overall Study|Adverse Event|1|||
124898137|NCT02534896|449251195|FG000|Overall Study|Insufficient therapeutic response|2|||
124898138|NCT02534896|449251196|FG001|Overall Study|Insufficient therapeutic response|0|||
124898139|NCT02534896|449251197|FG002|Overall Study|Insufficient therapeutic response|0|||
124898140|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
124898141|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
124898142|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
124898143|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
124898144|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Adverse Event|198|||
124898145|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Adverse Event|0|||
124898146|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Adverse Event|0|||
125110731|NCT01205529|450029363|FG000|Overall Study|No longer met criteria|30|||
125110732|NCT01027884|450029368|FG000|Overall Study|Adverse Event|2|||
125110733|NCT01027884|450029369|FG001|Overall Study|Adverse Event|1|||
125110734|NCT01027884|450029368|FG000|Overall Study|Protocol Violation|1|||
125110735|NCT01027884|450029369|FG001|Overall Study|Protocol Violation|0|||
125110736|NCT01027884|450029368|FG000|Overall Study|Non-compliance|1|||
125110737|NCT01027884|450029369|FG001|Overall Study|Non-compliance|1|||
125110738|NCT01027884|450029368|FG000|Overall Study|Withdrawal by Subject|0|||
125110739|NCT01027884|450029369|FG001|Overall Study|Withdrawal by Subject|1|||
125110740|NCT01027884|450029368|FG000|Overall Study|Lost to Follow-up|0|||
124898147|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Adverse Event|0|||
124898148|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Death|62|||
124898149|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Death|0|||
124898150|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Death|0|||
124898151|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Death|0|||
124898152|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
124898153|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
124898154|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
125110741|NCT01027884|450029369|FG001|Overall Study|Lost to Follow-up|1|||
125110742|NCT01027884|450029368|FG000|Overall Study|Spinal fixation surgery|0|||
125110743|NCT01027884|450029369|FG001|Overall Study|Spinal fixation surgery|3|||
125110744|NCT03670537|450029370|FG000|Overall Study|Protocol Violation|1|||
124898155|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
124898156|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Complicating disease|13|||
124898157|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Complicating disease|0|||
124898158|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Complicating disease|0|||
124898159|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Complicating disease|0|||
124898160|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
124898161|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
124898162|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
124898163|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
124898164|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
124898165|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
124898166|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
124898167|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
124898168|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Non-compliance|4|||
124898169|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Non-compliance|0|||
124898170|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Non-compliance|0|||
124898171|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Non-compliance|0|||
124898172|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Pain|4|||
124898173|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Pain|0|||
124898174|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Pain|0|||
124898175|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Pain|0|||
124898176|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
124898177|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
124898178|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
124898179|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
124898180|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Hospice care|1|||
124898181|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Hospice care|0|||
124898182|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Hospice care|0|||
124898183|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Hospice care|0|||
124898184|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Physician Decision|1|||
124898185|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Physician Decision|0|||
124898186|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Physician Decision|0|||
124898187|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Physician Decision|0|||
124898188|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
124898189|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
124898190|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
124898191|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
124898192|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
124898193|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
124898194|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
124898195|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
124898196|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
124898197|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
124898198|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
124898199|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
124898200|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Death|0|||
124898201|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Death|8|||
124898202|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Death|2|||
124898203|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Death|13|||
124898204|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
124898205|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
124898206|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
124898207|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
124898208|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
124898209|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
124898210|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
124898211|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
124898212|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
124898213|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
124898214|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
124898215|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
124898216|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
124898217|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
124898218|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
124898219|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
124898220|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
124898221|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
124898222|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
124898223|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
125110745|NCT02059187|450029371|FG000|Overall Study|Adverse Event|0|||
125110746|NCT02059187|450029372|FG001|Overall Study|Adverse Event|3|||
124898224|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
124898225|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
124898226|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
124898227|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
124898228|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
124898229|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
124898230|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
124898231|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
124898232|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
124898233|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
124898234|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
124898235|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
124898236|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
124898237|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
124898238|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
124898239|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
124898240|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
124898241|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
124898242|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
124898243|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
124898244|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Pain|0|||
124898245|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Pain|0|||
124898246|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Pain|0|||
124898247|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Pain|1|||
124898248|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
124898249|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
124898250|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
124898251|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
124898252|NCT00711646|449251202|FG000|Overall Study|Adverse Event|6|||
124898253|NCT00711646|449251203|FG001|Overall Study|Adverse Event|1|||
124898254|NCT00711646|449251202|FG000|Overall Study|Withdrawal by Subject|4|||
124898255|NCT00711646|449251203|FG001|Overall Study|Withdrawal by Subject|0|||
124898256|NCT00711646|449251202|FG000|Overall Study|Protocol Violation|0|||
124898257|NCT00711646|449251203|FG001|Overall Study|Protocol Violation|1|||
124898258|NCT00711646|449251202|FG000|Overall Study|Lost to Follow-up|1|||
124898259|NCT00711646|449251203|FG001|Overall Study|Lost to Follow-up|0|||
124898260|NCT00711646|449251202|FG000|Overall Study|administrative decision|0|||
124898261|NCT00711646|449251203|FG001|Overall Study|administrative decision|1|||
124898262|NCT00711646|449251202|FG000|Overall Study|patient non-compliance|1|||
124898263|NCT00711646|449251203|FG001|Overall Study|patient non-compliance|0|||
124898264|NCT04381494|449251204|FG000|Overall Study|Early termination of trial|19|||
124898265|NCT04381494|449251204|FG000|Overall Study|Investigator's discretion|1|||
124898266|NCT04381494|449251204|FG000|Overall Study|Withdrawal by Subject|9|||
124898267|NCT04381494|449251204|FG000|Overall Study|NSCLC disease progression|4|||
124898268|NCT04381494|449251204|FG000|Overall Study|Device-Related Adverse Event|2|||
124898269|NCT04310579|449251205|FG000|Overall Study|Adverse Event|0|||
124898270|NCT04310579|449251206|FG001|Overall Study|Adverse Event|0|||
124898271|NCT04310579|449251207|FG002|Overall Study|Adverse Event|0|||
124898272|NCT04310579|449251208|FG003|Overall Study|Adverse Event|0|||
124898273|NCT04310579|449251209|FG004|Overall Study|Adverse Event|0|||
124898274|NCT04310579|449251210|FG005|Overall Study|Adverse Event|0|||
124898275|NCT04310579|449251211|FG006|Overall Study|Adverse Event|2|||
124898276|NCT04310579|449251212|FG007|Overall Study|Adverse Event|0|||
124898277|NCT04310579|449251213|FG008|Overall Study|Adverse Event|1|||
124898278|NCT04310579|449251214|FG009|Overall Study|Adverse Event|1|||
124898279|NCT04310579|449251215|FG010|Overall Study|Adverse Event|0|||
124898280|NCT04310579|449251205|FG000|Overall Study|Withdrawal by Subject|0|||
124898281|NCT04310579|449251206|FG001|Overall Study|Withdrawal by Subject|0|||
124898282|NCT04310579|449251207|FG002|Overall Study|Withdrawal by Subject|0|||
124898283|NCT04310579|449251208|FG003|Overall Study|Withdrawal by Subject|0|||
124898284|NCT04310579|449251209|FG004|Overall Study|Withdrawal by Subject|0|||
124898285|NCT04310579|449251210|FG005|Overall Study|Withdrawal by Subject|1|||
124898286|NCT04310579|449251211|FG006|Overall Study|Withdrawal by Subject|0|||
124898287|NCT04310579|449251212|FG007|Overall Study|Withdrawal by Subject|0|||
124898288|NCT04310579|449251213|FG008|Overall Study|Withdrawal by Subject|0|||
124898289|NCT04310579|449251214|FG009|Overall Study|Withdrawal by Subject|0|||
124898290|NCT04310579|449251215|FG010|Overall Study|Withdrawal by Subject|0|||
125019381|NCT00883337|449694693|FG000|Extension Treatment Period|Other than above|10|||
124898291|NCT04310579|449251205|FG000|Overall Study|Positive COVID-19 test|0|||
124898292|NCT04310579|449251206|FG001|Overall Study|Positive COVID-19 test|0|||
124898293|NCT04310579|449251207|FG002|Overall Study|Positive COVID-19 test|0|||
124898294|NCT04310579|449251208|FG003|Overall Study|Positive COVID-19 test|0|||
124898295|NCT04310579|449251209|FG004|Overall Study|Positive COVID-19 test|0|||
124898296|NCT04310579|449251210|FG005|Overall Study|Positive COVID-19 test|0|||
124898297|NCT04310579|449251211|FG006|Overall Study|Positive COVID-19 test|0|||
124898298|NCT04310579|449251212|FG007|Overall Study|Positive COVID-19 test|0|||
124898299|NCT04310579|449251213|FG008|Overall Study|Positive COVID-19 test|0|||
124898300|NCT04310579|449251214|FG009|Overall Study|Positive COVID-19 test|0|||
124898301|NCT04310579|449251215|FG010|Overall Study|Positive COVID-19 test|1|||
124898302|NCT02365298|449251216|FG000|Period 2|incorrect Rx dispensed|1|||
124898303|NCT02365298|449251217|FG001|Period 2|incorrect Rx dispensed|0|||
124898304|NCT02365298|449251216|FG000|Period 2|Discontinued at request of Sponsor|1|||
124898305|NCT02365298|449251217|FG001|Period 2|Discontinued at request of Sponsor|0|||
124898306|NCT02365298|449251216|FG000|Period 2|Test Article longer available|0|||
124898307|NCT02365298|449251217|FG001|Period 2|Test Article longer available|1|||
124898308|NCT02365298|449251216|FG000|Period 2|Protocol Violation|0|||
124898309|NCT02365298|449251217|FG001|Period 2|Protocol Violation|1|||
124898310|NCT04555044|449251226|FG000|Overall Study|Adverse Event|0|||
124898311|NCT04555044|449251227|FG001|Overall Study|Adverse Event|1|||
124898312|NCT03722446|449251228|FG000|Overall Study|Protocol Violation|15|||
124898313|NCT03722446|449251229|FG001|Overall Study|Protocol Violation|2|||
124898314|NCT00819910|449251232|FG000|Overall Study|Adverse Event|0|||
124898315|NCT00819910|449251233|FG001|Overall Study|Adverse Event|0|||
124898316|NCT00819910|449251234|FG002|Overall Study|Adverse Event|2|||
124898317|NCT00819910|449251235|FG003|Overall Study|Adverse Event|1|||
124898318|NCT00819910|449251232|FG000|Overall Study|Withdrawal by Subject|1|||
124898319|NCT00819910|449251233|FG001|Overall Study|Withdrawal by Subject|1|||
124898320|NCT00819910|449251234|FG002|Overall Study|Withdrawal by Subject|1|||
124898321|NCT00819910|449251235|FG003|Overall Study|Withdrawal by Subject|0|||
124898322|NCT00819910|449251232|FG000|Overall Study|Lost to Follow-up|1|||
124898323|NCT00819910|449251233|FG001|Overall Study|Lost to Follow-up|0|||
124898324|NCT00819910|449251234|FG002|Overall Study|Lost to Follow-up|0|||
124898325|NCT00819910|449251235|FG003|Overall Study|Lost to Follow-up|0|||
124898326|NCT03102242|449251236|FG000|Overall Study|Adverse Event|2|||
124898327|NCT00946192|449251239|FG000|Overall Study|Lost to Follow-up|6|||
124898328|NCT00946192|449251240|FG001|Overall Study|Lost to Follow-up|11|||
124898329|NCT00946192|449251241|FG002|Overall Study|Lost to Follow-up|9|||
124898330|NCT00946192|449251239|FG000|Overall Study|Withdrawal by Subject|10|||
124898331|NCT00946192|449251240|FG001|Overall Study|Withdrawal by Subject|7|||
124898332|NCT00946192|449251241|FG002|Overall Study|Withdrawal by Subject|3|||
124898333|NCT00946192|449251239|FG000|Overall Study|Did not start medication|2|||
124898334|NCT00946192|449251240|FG001|Overall Study|Did not start medication|0|||
124898335|NCT00946192|449251241|FG002|Overall Study|Did not start medication|0|||
124898336|NCT01080131|449251242|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
124898337|NCT01080131|449251243|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
124898338|NCT01080131|449251242|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
124898339|NCT01080131|449251243|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
124898340|NCT01080131|449251242|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
124898341|NCT01080131|449251243|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
124898342|NCT01080131|449251242|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
124898343|NCT01080131|449251243|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
124898344|NCT01080131|449251242|FG000|Core Study (0- 12 Weeks)|Death|1|||
124898345|NCT01080131|449251243|FG001|Core Study (0- 12 Weeks)|Death|0|||
124898346|NCT01080131|449251242|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
124898347|NCT01080131|449251243|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
124898348|NCT01080131|449251242|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
124898349|NCT01080131|449251243|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
124898350|NCT01080131|449251242|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
124898351|NCT01080131|449251243|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
124898352|NCT01080131|449251242|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
124898353|NCT01080131|449251243|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
125110747|NCT02059187|450029371|FG000|Overall Study|Death|1|||
124898354|NCT01080131|449251242|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
124898355|NCT01080131|449251243|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
124898356|NCT01080131|449251242|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
124898357|NCT01080131|449251243|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
124898358|NCT01080131|449251242|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
124898359|NCT01080131|449251243|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
124898360|NCT01080131|449251242|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
124898361|NCT01080131|449251243|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
124898362|NCT03646669|449253282|FG000|Overall Study|Withdrawal by Subject|5|||
124898363|NCT03646669|449253283|FG001|Overall Study|Withdrawal by Subject|0|||
124898364|NCT03441360|449253286|FG000|Overall Study|Radiological disease progression|5|||
124898365|NCT03441360|449253287|FG001|Overall Study|Radiological disease progression|6|||
124898366|NCT03441360|449253288|FG002|Overall Study|Radiological disease progression|4|||
124898367|NCT03441360|449253286|FG000|Overall Study|Clinical disease progression|2|||
124898368|NCT03441360|449253287|FG001|Overall Study|Clinical disease progression|2|||
124898369|NCT03441360|449253288|FG002|Overall Study|Clinical disease progression|0|||
124898370|NCT03441360|449253286|FG000|Overall Study|Adverse Event|1|||
124898371|NCT03441360|449253287|FG001|Overall Study|Adverse Event|0|||
124898372|NCT03441360|449253288|FG002|Overall Study|Adverse Event|1|||
124898373|NCT00269399|449253289|FG000|Overall Study|Lack of Efficacy|27|||
124898374|NCT00269399|449253290|FG001|Overall Study|Lack of Efficacy|10|||
124898375|NCT00269399|449253289|FG000|Overall Study|Adverse Event|10|||
124898376|NCT00269399|449253290|FG001|Overall Study|Adverse Event|4|||
124898377|NCT00269399|449253289|FG000|Overall Study|Withdrawal by Subject|2|||
124898378|NCT00269399|449253290|FG001|Overall Study|Withdrawal by Subject|5|||
124898379|NCT00269399|449253289|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
124898380|NCT00269399|449253290|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
124898381|NCT00269399|449253289|FG000|Overall Study|Other|0|||
124898382|NCT00269399|449253290|FG001|Overall Study|Other|4|||
124898383|NCT00269399|449253289|FG000|Overall Study|Development of exclusion criteria|0|||
124898384|NCT00269399|449253290|FG001|Overall Study|Development of exclusion criteria|1|||
124898385|NCT03467724|449253292|FG000|Overall Study|Lost to Follow-up|5|||
124898386|NCT03467724|449253292|FG000|Overall Study|Withdrawal by Subject|1|||
124898387|NCT03467724|449253292|FG000|Overall Study|Protocol Violation|1|||
124898388|NCT03467724|449253292|FG000|Overall Study|Adverse Event|1|||
124898389|NCT02049866|449253296|FG000|Overall Study|Withdrawal by Subject|1|||
124898390|NCT02955069|449253298|FG000|Overall Study|Adverse Event|7|||
124898391|NCT02955069|449253299|FG001|Overall Study|Adverse Event|2|||
124898392|NCT02955069|449253298|FG000|Overall Study|Death|7|||
124898393|NCT02955069|449253299|FG001|Overall Study|Death|3|||
124898394|NCT02955069|449253298|FG000|Overall Study|Physician Decision|10|||
124898395|NCT02955069|449253299|FG001|Overall Study|Physician Decision|2|||
124898396|NCT02955069|449253298|FG000|Overall Study|Progressive disease|64|||
124898397|NCT02955069|449253299|FG001|Overall Study|Progressive disease|13|||
124898398|NCT02955069|449253298|FG000|Overall Study|Study terminated by sponsor|4|||
124898399|NCT02955069|449253299|FG001|Overall Study|Study terminated by sponsor|0|||
124898400|NCT02955069|449253298|FG000|Overall Study|Subject/Guardian decision|3|||
124898401|NCT02955069|449253299|FG001|Overall Study|Subject/Guardian decision|1|||
124898402|NCT04148937|449253301|FG000|Overall Study|Withdrawal by Subject|0|||
124898403|NCT04148937|449253302|FG001|Overall Study|Withdrawal by Subject|0|||
124898404|NCT04148937|449253303|FG002|Overall Study|Withdrawal by Subject|0|||
124898405|NCT04148937|449253304|FG003|Overall Study|Withdrawal by Subject|1|||
124898406|NCT04148937|449253305|FG004|Overall Study|Withdrawal by Subject|0|||
124898407|NCT04148937|449253306|FG005|Overall Study|Withdrawal by Subject|1|||
124898408|NCT04148937|449253307|FG006|Overall Study|Withdrawal by Subject|1|||
124898409|NCT04148937|449253308|FG007|Overall Study|Withdrawal by Subject|0|||
124898410|NCT04148937|449253301|FG000|Overall Study|Lost to Follow-up|0|||
124898411|NCT04148937|449253302|FG001|Overall Study|Lost to Follow-up|0|||
124898412|NCT04148937|449253303|FG002|Overall Study|Lost to Follow-up|1|||
124898413|NCT04148937|449253304|FG003|Overall Study|Lost to Follow-up|0|||
124898414|NCT04148937|449253305|FG004|Overall Study|Lost to Follow-up|0|||
124898415|NCT04148937|449253306|FG005|Overall Study|Lost to Follow-up|2|||
124898416|NCT04148937|449253307|FG006|Overall Study|Lost to Follow-up|0|||
124898417|NCT04148937|449253308|FG007|Overall Study|Lost to Follow-up|0|||
124898418|NCT03107611|449253313|FG000|Overall Study|Adverse Event|1|||
124898419|NCT03107611|449253314|FG001|Overall Study|Adverse Event|0|||
124898420|NCT03107611|449253315|FG002|Overall Study|Adverse Event|2|||
124898421|NCT03107611|449253313|FG000|Overall Study|Lost to Follow-up|3|||
124898422|NCT03107611|449253314|FG001|Overall Study|Lost to Follow-up|3|||
124898423|NCT03107611|449253315|FG002|Overall Study|Lost to Follow-up|3|||
124898424|NCT03107611|449253313|FG000|Overall Study|Protocol Violation|0|||
124898425|NCT03107611|449253314|FG001|Overall Study|Protocol Violation|0|||
124898426|NCT03107611|449253315|FG002|Overall Study|Protocol Violation|1|||
124898427|NCT03107611|449253313|FG000|Overall Study|Withdrawal by Subject|1|||
124898428|NCT03107611|449253314|FG001|Overall Study|Withdrawal by Subject|0|||
124898429|NCT03107611|449253315|FG002|Overall Study|Withdrawal by Subject|1|||
124898430|NCT03107611|449253313|FG000|Overall Study|Worsening signs/symptoms|2|||
124898431|NCT03107611|449253314|FG001|Overall Study|Worsening signs/symptoms|1|||
124898432|NCT03107611|449253315|FG002|Overall Study|Worsening signs/symptoms|2|||
124898433|NCT02145182|449253316|FG000|Overall Study|Adverse Event|4|||
124898434|NCT02145182|449253317|FG001|Overall Study|Adverse Event|1|||
124898435|NCT02145182|449253316|FG000|Overall Study|Death|7|||
124898436|NCT02145182|449253317|FG001|Overall Study|Death|7|||
124898437|NCT02145182|449253316|FG000|Overall Study|Lost to Follow-up|2|||
124898438|NCT02145182|449253317|FG001|Overall Study|Lost to Follow-up|2|||
124898439|NCT02145182|449253316|FG000|Overall Study|Pre-transplant Withdrawal|0|||
124898440|NCT02145182|449253317|FG001|Overall Study|Pre-transplant Withdrawal|2|||
124898441|NCT02145182|449253316|FG000|Overall Study|Withdrawal by Subject|5|||
124898442|NCT02145182|449253317|FG001|Overall Study|Withdrawal by Subject|4|||
124898443|NCT00588666|449253319|FG000|Overall Study|Adverse Event|4|||
124898444|NCT02274493|449253320|FG000|Overall Study|Withdrawal by Subject|1|||
124898445|NCT03102710|449253321|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
124898446|NCT03102710|449253322|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
124898447|NCT03102710|449253323|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
124898448|NCT03102710|449253321|FG000|Overall Study|Technical issues during final MRI scan|0|||
124898449|NCT03102710|449253322|FG001|Overall Study|Technical issues during final MRI scan|1|||
124898450|NCT03102710|449253323|FG002|Overall Study|Technical issues during final MRI scan|0|||
124898451|NCT03102710|449253321|FG000|Overall Study|Nausea during MRI scan|0|||
124898452|NCT03102710|449253322|FG001|Overall Study|Nausea during MRI scan|1|||
124898453|NCT03102710|449253323|FG002|Overall Study|Nausea during MRI scan|0|||
124898454|NCT03102710|449253321|FG000|Overall Study|Subject unable to attend final session|0|||
124898455|NCT03102710|449253322|FG001|Overall Study|Subject unable to attend final session|1|||
124898456|NCT03102710|449253323|FG002|Overall Study|Subject unable to attend final session|0|||
124898457|NCT02759731|449253324|FG000|Overall Study|Did not complete treatment.|8|||
124898458|NCT01101165|449253325|FG000|Period 1|Adverse Event|1|||
124898459|NCT01101165|449253326|FG001|Period 1|Adverse Event|2|||
124898460|NCT01101165|449253325|FG000|Period 1|Withdrawal by Subject|0|||
124898461|NCT01101165|449253326|FG001|Period 1|Withdrawal by Subject|2|||
124898462|NCT01101165|449253325|FG000|Period 1|Positive Drug Screen|0|||
124898463|NCT01101165|449253326|FG001|Period 1|Positive Drug Screen|1|||
124898464|NCT01101165|449253325|FG000|Period 1|Lost to Follow-up|1|||
124898465|NCT01101165|449253326|FG001|Period 1|Lost to Follow-up|0|||
124898466|NCT01101165|449253325|FG000|Period 2|Withdrawal by Subject|3|||
124898467|NCT01101165|449253326|FG001|Period 2|Withdrawal by Subject|1|||
124898468|NCT01101165|449253325|FG000|Period 2|Adverse Event|1|||
124898469|NCT01101165|449253326|FG001|Period 2|Adverse Event|0|||
124898470|NCT00335556|449253327|FG000|Overall Study|Death|0|||
124898471|NCT00335556|449253328|FG001|Overall Study|Death|5|||
124898472|NCT00335556|449253329|FG002|Overall Study|Death|0|||
124898473|NCT00335556|449253330|FG003|Overall Study|Death|0|||
125110748|NCT02059187|450029372|FG001|Overall Study|Death|1|||
125110749|NCT02059187|450029371|FG000|Overall Study|Lost to Follow-up|9|||
125110750|NCT02059187|450029372|FG001|Overall Study|Lost to Follow-up|8|||
125110751|NCT02059187|450029371|FG000|Overall Study|Non-compliance with study drug|1|||
125110752|NCT02059187|450029372|FG001|Overall Study|Non-compliance with study drug|0|||
125110753|NCT02059187|450029371|FG000|Overall Study|Physician Decision|1|||
125110754|NCT02059187|450029372|FG001|Overall Study|Physician Decision|2|||
125110755|NCT02059187|450029371|FG000|Overall Study|Protocol Violation|1|||
125110756|NCT02059187|450029372|FG001|Overall Study|Protocol Violation|0|||
125110757|NCT02059187|450029371|FG000|Overall Study|Withdrawal by Subject|12|||
125110758|NCT02059187|450029372|FG001|Overall Study|Withdrawal by Subject|8|||
125110759|NCT03070431|450029373|FG000|Overall Study|Withdrawal by Subject|2|||
125110760|NCT03070431|450029373|FG000|Overall Study|Lost to Follow-up|2|||
125110761|NCT01889862|450029374|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
125110762|NCT01889862|450029375|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
125110763|NCT01889862|450029376|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
125110764|NCT01889862|450029377|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
125110765|NCT01889862|450029378|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
125110766|NCT01889862|450029374|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
125110767|NCT01889862|450029375|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
125110768|NCT01889862|450029376|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
125110769|NCT01889862|450029377|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
125110770|NCT01889862|450029378|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
125110771|NCT01889862|450029374|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
125110772|NCT01889862|450029375|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
125110773|NCT01889862|450029376|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
124898474|NCT00335556|449253331|FG004|Overall Study|Death|1|||
124898475|NCT00335556|449253332|FG005|Overall Study|Death|0|||
124898476|NCT00335556|449253327|FG000|Overall Study|Lack of Efficacy|0|||
124898477|NCT00335556|449253328|FG001|Overall Study|Lack of Efficacy|19|||
124898478|NCT00335556|449253329|FG002|Overall Study|Lack of Efficacy|3|||
124898479|NCT00335556|449253330|FG003|Overall Study|Lack of Efficacy|3|||
124898480|NCT00335556|449253331|FG004|Overall Study|Lack of Efficacy|0|||
124898481|NCT00335556|449253332|FG005|Overall Study|Lack of Efficacy|1|||
124898482|NCT00335556|449253327|FG000|Overall Study|Physician Decision|0|||
124898483|NCT00335556|449253328|FG001|Overall Study|Physician Decision|6|||
124898484|NCT00335556|449253329|FG002|Overall Study|Physician Decision|2|||
125110774|NCT01889862|450029377|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
124898485|NCT00335556|449253330|FG003|Overall Study|Physician Decision|1|||
124898486|NCT00335556|449253331|FG004|Overall Study|Physician Decision|0|||
124898487|NCT00335556|449253332|FG005|Overall Study|Physician Decision|0|||
124898488|NCT00335556|449253327|FG000|Overall Study|Ineligible|2|||
124898489|NCT00335556|449253328|FG001|Overall Study|Ineligible|0|||
124898490|NCT00335556|449253329|FG002|Overall Study|Ineligible|0|||
124898491|NCT00335556|449253330|FG003|Overall Study|Ineligible|0|||
124898492|NCT00335556|449253331|FG004|Overall Study|Ineligible|0|||
124898493|NCT00335556|449253332|FG005|Overall Study|Ineligible|0|||
124898494|NCT00335556|449253327|FG000|Overall Study|Refusal of further protocol therapy|0|||
124898495|NCT00335556|449253328|FG001|Overall Study|Refusal of further protocol therapy|4|||
124898496|NCT00335556|449253329|FG002|Overall Study|Refusal of further protocol therapy|0|||
124898497|NCT00335556|449253330|FG003|Overall Study|Refusal of further protocol therapy|1|||
124898498|NCT00335556|449253331|FG004|Overall Study|Refusal of further protocol therapy|0|||
124898499|NCT00335556|449253332|FG005|Overall Study|Refusal of further protocol therapy|0|||
124898500|NCT01878890|449253333|FG000|Overall Study|Protocol Violation|0|||
124898501|NCT01878890|449253334|FG001|Overall Study|Protocol Violation|1|||
124898502|NCT01878890|449253335|FG002|Overall Study|Protocol Violation|0|||
124898503|NCT01878890|449253336|FG003|Overall Study|Protocol Violation|0|||
124898504|NCT03404843|449253338|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
124898505|NCT03404843|449253339|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
124898506|NCT00567164|449253340|FG000|Overall Study|Withdrawal by Subject|171|||
124898507|NCT00567164|449253341|FG001|Overall Study|Withdrawal by Subject|21|||
124898508|NCT00567164|449253342|FG002|Overall Study|Withdrawal by Subject|17|||
124898509|NCT00567164|449253340|FG000|Overall Study|Protocol Violation|23|||
124898510|NCT00567164|449253341|FG001|Overall Study|Protocol Violation|4|||
124898511|NCT00567164|449253342|FG002|Overall Study|Protocol Violation|2|||
124898512|NCT00567164|449253340|FG000|Overall Study|Adverse Event|92|||
124898513|NCT00567164|449253341|FG001|Overall Study|Adverse Event|13|||
124898514|NCT00567164|449253342|FG002|Overall Study|Adverse Event|9|||
124898515|NCT00567164|449253340|FG000|Overall Study|Death|0|||
124898516|NCT00567164|449253341|FG001|Overall Study|Death|0|||
124898517|NCT00567164|449253342|FG002|Overall Study|Death|1|||
124898518|NCT00567164|449253340|FG000|Overall Study|Lost to Follow-up|202|||
124898519|NCT00567164|449253341|FG001|Overall Study|Lost to Follow-up|23|||
124898520|NCT00567164|449253342|FG002|Overall Study|Lost to Follow-up|21|||
124898521|NCT00567164|449253340|FG000|Overall Study|Pregnancy|20|||
124898522|NCT00567164|449253341|FG001|Overall Study|Pregnancy|4|||
124898523|NCT00567164|449253342|FG002|Overall Study|Pregnancy|6|||
124898524|NCT00567164|449253340|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
124898525|NCT00567164|449253341|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
124898526|NCT00567164|449253342|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
124898527|NCT00567164|449253340|FG000|Overall Study|Missing|1|||
124898528|NCT00567164|449253341|FG001|Overall Study|Missing|0|||
124898529|NCT00567164|449253342|FG002|Overall Study|Missing|0|||
124898530|NCT00502593|449253347|FG000|Overall Study|Withdrawn unspecified reason|1|||
124898531|NCT00502593|449253348|FG001|Overall Study|Withdrawn unspecified reason|1|||
124898532|NCT00502593|449253349|FG002|Overall Study|Withdrawn unspecified reason|3|||
124898533|NCT00502593|449253350|FG003|Overall Study|Withdrawn unspecified reason|1|||
124898534|NCT00502593|449253351|FG004|Overall Study|Withdrawn unspecified reason|2|||
124898535|NCT00502593|449253352|FG005|Overall Study|Withdrawn unspecified reason|0|||
124898536|NCT00502593|449253353|FG006|Overall Study|Withdrawn unspecified reason|2|||
125110775|NCT01889862|450029378|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
125110776|NCT01889862|450029374|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
125110777|NCT01889862|450029375|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
125110778|NCT01889862|450029376|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
125110779|NCT01889862|450029377|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
125110780|NCT01889862|450029378|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
125110781|NCT01889862|450029374|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
125110782|NCT01889862|450029375|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
125110783|NCT01889862|450029376|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
125110784|NCT01889862|450029377|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
125110785|NCT01889862|450029378|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
125110786|NCT01889862|450029374|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
124898537|NCT00502593|449253354|FG007|Overall Study|Withdrawn unspecified reason|0|||
124898538|NCT00502593|449253355|FG008|Overall Study|Withdrawn unspecified reason|0|||
124898539|NCT00502593|449253356|FG009|Overall Study|Withdrawn unspecified reason|0|||
124898540|NCT00502593|449253357|FG010|Overall Study|Withdrawn unspecified reason|0|||
124898541|NCT00502593|449253358|FG011|Overall Study|Withdrawn unspecified reason|0|||
124898542|NCT00502593|449253347|FG000|Overall Study|Withdrawal by Subject|0|||
124898543|NCT00502593|449253348|FG001|Overall Study|Withdrawal by Subject|0|||
124898544|NCT00502593|449253349|FG002|Overall Study|Withdrawal by Subject|6|||
124898545|NCT00502593|449253350|FG003|Overall Study|Withdrawal by Subject|2|||
124898546|NCT00502593|449253351|FG004|Overall Study|Withdrawal by Subject|2|||
125210781|NCT02134353|450395684|FG000|Overall Study|Lost to Follow-up|1|||
124898547|NCT00502593|449253352|FG005|Overall Study|Withdrawal by Subject|0|||
124898548|NCT00502593|449253353|FG006|Overall Study|Withdrawal by Subject|3|||
124898549|NCT00502593|449253354|FG007|Overall Study|Withdrawal by Subject|0|||
124898550|NCT00502593|449253355|FG008|Overall Study|Withdrawal by Subject|3|||
124898551|NCT00502593|449253356|FG009|Overall Study|Withdrawal by Subject|0|||
124898552|NCT00502593|449253357|FG010|Overall Study|Withdrawal by Subject|1|||
124898553|NCT00502593|449253358|FG011|Overall Study|Withdrawal by Subject|0|||
124898554|NCT00502593|449253347|FG000|Overall Study|Lost to Follow-up|2|||
124898555|NCT00502593|449253348|FG001|Overall Study|Lost to Follow-up|1|||
124898556|NCT00502593|449253349|FG002|Overall Study|Lost to Follow-up|1|||
124898557|NCT00502593|449253350|FG003|Overall Study|Lost to Follow-up|1|||
124898558|NCT00502593|449253351|FG004|Overall Study|Lost to Follow-up|0|||
124898559|NCT00502593|449253352|FG005|Overall Study|Lost to Follow-up|0|||
124898560|NCT00502593|449253353|FG006|Overall Study|Lost to Follow-up|0|||
124898561|NCT00502593|449253354|FG007|Overall Study|Lost to Follow-up|0|||
124898562|NCT00502593|449253355|FG008|Overall Study|Lost to Follow-up|3|||
124898563|NCT00502593|449253356|FG009|Overall Study|Lost to Follow-up|0|||
124898564|NCT00502593|449253357|FG010|Overall Study|Lost to Follow-up|1|||
124898565|NCT00502593|449253358|FG011|Overall Study|Lost to Follow-up|0|||
124898566|NCT01664104|449253359|FG000|Overall Study|Adverse Event|6|||
124898567|NCT01664104|449253359|FG000|Overall Study|Lack of Efficacy|2|||
124898568|NCT01664104|449253359|FG000|Overall Study|Withdrawal by Subject|1|||
124898569|NCT01664104|449253359|FG000|Overall Study|Lost to Follow-up|4|||
124898570|NCT01664104|449253359|FG000|Overall Study|Other|1|||
124898571|NCT01664104|449253359|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
124898572|NCT03761784|449253360|FG000|Overall Study|Adverse Event|4|||
124898573|NCT03761784|449253361|FG001|Overall Study|Adverse Event|0|||
124898574|NCT03761784|449253360|FG000|Overall Study|Lost to Follow-up|10|||
124898575|NCT03761784|449253361|FG001|Overall Study|Lost to Follow-up|7|||
124898576|NCT03761784|449253360|FG000|Overall Study|Pregnancy|1|||
124898577|NCT03761784|449253361|FG001|Overall Study|Pregnancy|0|||
124898578|NCT03761784|449253360|FG000|Overall Study|Protocol Violation|2|||
124898579|NCT03761784|449253361|FG001|Overall Study|Protocol Violation|0|||
124898580|NCT03761784|449253360|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
124898581|NCT03761784|449253361|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
124898582|NCT03761784|449253360|FG000|Overall Study|Withdrawal by Subject|9|||
124898583|NCT03761784|449253361|FG001|Overall Study|Withdrawal by Subject|4|||
124898584|NCT03761784|449253360|FG000|Overall Study|Physician Decision|1|||
124898585|NCT03761784|449253361|FG001|Overall Study|Physician Decision|0|||
124898586|NCT03761784|449253360|FG000|Overall Study|Other Than Specified|1|||
124898587|NCT03761784|449253361|FG001|Overall Study|Other Than Specified|0|||
124898588|NCT00586339|449253362|FG000|Overall Study|Withdrawal by Subject|1|||
124898589|NCT00586339|449253363|FG001|Overall Study|Withdrawal by Subject|3|||
124898590|NCT00586339|449253364|FG002|Overall Study|Withdrawal by Subject|1|||
124898591|NCT00586339|449253362|FG000|Overall Study|Migrated/moved from study area|3|||
124898592|NCT00586339|449253363|FG001|Overall Study|Migrated/moved from study area|2|||
124898593|NCT00586339|449253364|FG002|Overall Study|Migrated/moved from study area|4|||
124898594|NCT00586339|449253362|FG000|Overall Study|Lost to Follow-up|3|||
124898595|NCT00586339|449253363|FG001|Overall Study|Lost to Follow-up|2|||
124898596|NCT00586339|449253364|FG002|Overall Study|Lost to Follow-up|1|||
124898597|NCT00197236|449253368|FG000|Overall Study|Adverse Event|1|||
124898598|NCT00197236|449253369|FG001|Overall Study|Adverse Event|0|||
124898599|NCT00197236|449253370|FG002|Overall Study|Adverse Event|1|||
124898600|NCT00197236|449253368|FG000|Overall Study|Lost to Follow-up|5|||
124898601|NCT00197236|449253369|FG001|Overall Study|Lost to Follow-up|14|||
125019382|NCT00883337|449694694|FG001|Extension Treatment Period|Other than above|9|||
125019383|NCT00883337|449694695|FG002|Extension Treatment Period|Other than above|5|||
125019384|NCT00527605|449694696|FG000|Overall Study|Adverse Event|3|||
125019385|NCT00527605|449694697|FG001|Overall Study|Adverse Event|0|||
125019386|NCT00527605|449694696|FG000|Overall Study|Withdrawal by Subject|3|||
125019387|NCT00527605|449694697|FG001|Overall Study|Withdrawal by Subject|7|||
125019388|NCT00527605|449694696|FG000|Overall Study|Lost to Follow-up|6|||
125019389|NCT00527605|449694697|FG001|Overall Study|Lost to Follow-up|2|||
124898602|NCT00197236|449253370|FG002|Overall Study|Lost to Follow-up|6|||
124898603|NCT00197236|449253368|FG000|Overall Study|Protocol Violation|0|||
124898604|NCT00197236|449253369|FG001|Overall Study|Protocol Violation|0|||
124898605|NCT00197236|449253370|FG002|Overall Study|Protocol Violation|1|||
124898606|NCT00197236|449253368|FG000|Overall Study|Withdrawal by Subject|7|||
124898607|NCT00197236|449253369|FG001|Overall Study|Withdrawal by Subject|3|||
124898608|NCT00197236|449253370|FG002|Overall Study|Withdrawal by Subject|11|||
124898609|NCT00197236|449253368|FG000|Overall Study|Study drug/medication expiration|1|||
124898610|NCT00197236|449253369|FG001|Overall Study|Study drug/medication expiration|0|||
124898611|NCT00197236|449253370|FG002|Overall Study|Study drug/medication expiration|3|||
125019390|NCT00527605|449694696|FG000|Overall Study|Protocol Violation|1|||
124898612|NCT00197236|449253368|FG000|Overall Study|Returned out of specified time window|0|||
124898613|NCT00197236|449253369|FG001|Overall Study|Returned out of specified time window|0|||
124898614|NCT00197236|449253370|FG002|Overall Study|Returned out of specified time window|1|||
124898615|NCT00746330|449253371|FG000|Period 1|Abnormal test procedure result|0|||
124898616|NCT00746330|449253372|FG001|Period 1|Abnormal test procedure result|0|||
124898617|NCT00746330|449253373|FG002|Period 1|Abnormal test procedure result|1|||
124898618|NCT00746330|449253374|FG003|Period 1|Abnormal test procedure result|0|||
124898619|NCT02524288|449253375|FG000|Overall Study|Adverse Event|115|||
124898620|NCT02524288|449253375|FG000|Overall Study|Lost to Follow-up|216|||
124898621|NCT02524288|449253375|FG000|Overall Study|Non-Compliance With Protocol|32|||
124898622|NCT02524288|449253375|FG000|Overall Study|Non-Compliance With Study Drug|14|||
124898623|NCT02524288|449253375|FG000|Overall Study|Pregnancy Wish|6|||
124898624|NCT02524288|449253375|FG000|Overall Study|Protocol Violation|6|||
124898625|NCT02524288|449253375|FG000|Overall Study|Screen Failure|2|||
124898626|NCT02524288|449253375|FG000|Overall Study|Site Discontinued Study Participation|1|||
124898627|NCT02524288|449253375|FG000|Overall Study|Study Terminated By Sponsor|1417|||
124898628|NCT02524288|449253375|FG000|Overall Study|Subject Moved|32|||
124898629|NCT02524288|449253375|FG000|Overall Study|Withdrawal by Subject|76|||
125110787|NCT01889862|450029375|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
124898630|NCT02524288|449253375|FG000|Overall Study|Pregnancy|22|||
124898631|NCT02524288|449253375|FG000|Overall Study|Physician Decision|2|||
124898632|NCT00517933|449253376|FG000|Period 1|Death|2|||
124898633|NCT00517933|449253377|FG001|Period 1|Death|1|||
125110788|NCT01889862|450029376|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
125110789|NCT01889862|450029377|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
125110790|NCT01889862|450029378|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
125110791|NCT01889862|450029374|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
125110792|NCT01889862|450029375|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
125110793|NCT01889862|450029376|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
125110794|NCT01889862|450029377|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
125110795|NCT01889862|450029378|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
124898634|NCT00517933|449253376|FG000|Period 1|Adverse Event|4|||
124898635|NCT00517933|449253377|FG001|Period 1|Adverse Event|4|||
124898636|NCT00517933|449253376|FG000|Period 1|Lost to Follow-up|2|||
124898637|NCT00517933|449253377|FG001|Period 1|Lost to Follow-up|0|||
124898638|NCT00517933|449253376|FG000|Period 1|Underwent lung transplant|0|||
124898639|NCT00517933|449253377|FG001|Period 1|Underwent lung transplant|1|||
124898640|NCT00517933|449253376|FG000|Period 2|Death|2|||
124898641|NCT00517933|449253377|FG001|Period 2|Death|4|||
124898642|NCT00517933|449253376|FG000|Period 2|Adverse Event|2|||
124898643|NCT00517933|449253377|FG001|Period 2|Adverse Event|4|||
124898644|NCT00517933|449253376|FG000|Period 2|Physician Decision|1|||
124898645|NCT00517933|449253377|FG001|Period 2|Physician Decision|0|||
124898646|NCT00517933|449253376|FG000|Period 2|Withdrawal by Subject|1|||
124898647|NCT00517933|449253377|FG001|Period 2|Withdrawal by Subject|3|||
124898648|NCT00517933|449253376|FG000|Period 2|Underwent lung transplant|0|||
124898649|NCT00517933|449253377|FG001|Period 2|Underwent lung transplant|2|||
124898650|NCT01835899|449253379|FG000|Overall Study|Adverse Event|0|||
124898651|NCT01835899|449253380|FG001|Overall Study|Adverse Event|0|||
124898652|NCT01835899|449253381|FG002|Overall Study|Adverse Event|1|||
124898653|NCT01835899|449253379|FG000|Overall Study|Other than stated above|0|||
124898654|NCT01835899|449253380|FG001|Overall Study|Other than stated above|1|||
124898655|NCT01835899|449253381|FG002|Overall Study|Other than stated above|0|||
124898656|NCT00121199|449253384|FG000|Overall Study|Adverse Event|11|||
124898657|NCT00121199|449253384|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
124898658|NCT00121199|449253384|FG000|Overall Study|Progression/Relapse|1|||
124898659|NCT00121199|449253384|FG000|Overall Study|Death|3|||
124898660|NCT00121199|449253384|FG000|Overall Study|Other - Not Protocol Specified|3|||
124898661|NCT00121199|449253384|FG000|Overall Study|Ineligible|9|||
124898662|NCT01018511|449253386|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
124898663|NCT01018511|449253387|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
125110796|NCT01889862|450029374|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
124898664|NCT01018511|449253388|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
125110797|NCT01889862|450029375|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
124898665|NCT01018511|449253389|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
124898666|NCT01018511|449253386|FG000|Overall Study|Adverse Event|5|||
124898667|NCT01018511|449253387|FG001|Overall Study|Adverse Event|9|||
124898668|NCT01018511|449253388|FG002|Overall Study|Adverse Event|13|||
124898669|NCT01018511|449253389|FG003|Overall Study|Adverse Event|10|||
124898670|NCT01018511|449253386|FG000|Overall Study|Lack of Efficacy|4|||
124898671|NCT01018511|449253387|FG001|Overall Study|Lack of Efficacy|1|||
124898672|NCT01018511|449253388|FG002|Overall Study|Lack of Efficacy|1|||
124898673|NCT01018511|449253389|FG003|Overall Study|Lack of Efficacy|2|||
124898674|NCT01018511|449253386|FG000|Overall Study|Withdrawal by Subject|6|||
125110798|NCT01889862|450029376|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
124898675|NCT01018511|449253387|FG001|Overall Study|Withdrawal by Subject|5|||
124898676|NCT01018511|449253388|FG002|Overall Study|Withdrawal by Subject|11|||
124898677|NCT01018511|449253389|FG003|Overall Study|Withdrawal by Subject|9|||
124898678|NCT01018511|449253386|FG000|Overall Study|Lost to Follow-up|0|||
124898679|NCT01018511|449253387|FG001|Overall Study|Lost to Follow-up|0|||
124898680|NCT01018511|449253388|FG002|Overall Study|Lost to Follow-up|1|||
124898681|NCT01018511|449253389|FG003|Overall Study|Lost to Follow-up|0|||
124898682|NCT01018511|449253386|FG000|Overall Study|Protocol Violation|5|||
124898683|NCT01018511|449253387|FG001|Overall Study|Protocol Violation|8|||
124898684|NCT01018511|449253388|FG002|Overall Study|Protocol Violation|7|||
124898685|NCT01018511|449253389|FG003|Overall Study|Protocol Violation|9|||
124898686|NCT01018511|449253386|FG000|Overall Study|Miscellaneous|0|||
124898687|NCT01018511|449253387|FG001|Overall Study|Miscellaneous|2|||
124898688|NCT01018511|449253388|FG002|Overall Study|Miscellaneous|0|||
124898689|NCT01018511|449253389|FG003|Overall Study|Miscellaneous|0|||
124898690|NCT04305912|449253391|FG000|First Intervention|COVID-19 Suspension|2|||
124898691|NCT04305912|449253392|FG001|First Intervention|COVID-19 Suspension|0|||
124898692|NCT04305912|449253391|FG000|First Intervention|Withdrawal by Subject|0|||
124898693|NCT04305912|449253392|FG001|First Intervention|Withdrawal by Subject|1|||
124898694|NCT04305912|449253391|FG000|Second Intervention|Adverse Event|0|||
124898695|NCT04305912|449253392|FG001|Second Intervention|Adverse Event|1|||
124898696|NCT04550039|449253393|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
124898697|NCT04550039|449253394|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
124898698|NCT04550039|449253393|FG000|Overall Study|patient self-withdrew from study|0|||
124898699|NCT04550039|449253394|FG001|Overall Study|patient self-withdrew from study|1|||
124898700|NCT04888585|449253395|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
124898701|NCT04888585|449253396|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
124898702|NCT04888585|449253397|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
124898703|NCT04888585|449253398|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
124898704|NCT04888585|449253399|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
124898705|NCT04888585|449253400|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
124898706|NCT04888585|449253401|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
124898707|NCT04888585|449253402|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
124898708|NCT04888585|449253403|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
124898709|NCT04888585|449253404|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
124898710|NCT04888585|449253405|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
124898711|NCT04888585|449253395|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
124898712|NCT04888585|449253396|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
124898713|NCT04888585|449253397|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
124898714|NCT04888585|449253398|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
124898715|NCT04888585|449253399|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
124898716|NCT04888585|449253400|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
124898717|NCT04888585|449253401|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
124898718|NCT04888585|449253402|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
124898719|NCT04888585|449253403|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
124898720|NCT04888585|449253404|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
124898721|NCT04888585|449253405|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
124898722|NCT04888585|449253395|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
124898723|NCT04888585|449253396|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
124898724|NCT04888585|449253397|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
124898725|NCT04888585|449253398|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
124898726|NCT04888585|449253399|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
124898727|NCT04888585|449253400|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
124898728|NCT04888585|449253401|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
124898729|NCT04888585|449253402|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
124898730|NCT04888585|449253403|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
124898731|NCT04888585|449253404|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
124898732|NCT04888585|449253405|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
124898733|NCT04888585|449253395|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
124898734|NCT04888585|449253396|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
124898735|NCT04888585|449253397|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
125110799|NCT01889862|450029377|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
125110800|NCT01889862|450029378|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
124898736|NCT04888585|449253398|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
124898737|NCT04888585|449253399|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
124898738|NCT04888585|449253400|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
124898739|NCT04888585|449253401|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
124898740|NCT04888585|449253402|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
124898741|NCT04888585|449253403|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
124898742|NCT04888585|449253404|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
124898743|NCT04888585|449253405|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
124898744|NCT04888585|449253395|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
124898745|NCT04888585|449253396|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
124898746|NCT04888585|449253397|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
124898747|NCT04888585|449253398|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
124898748|NCT04888585|449253399|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
124898749|NCT04888585|449253400|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
124898750|NCT04888585|449253401|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
124898751|NCT04888585|449253402|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
124898752|NCT04888585|449253403|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
124898753|NCT04888585|449253404|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
124898754|NCT04888585|449253405|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
124898755|NCT04888585|449253395|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
124898756|NCT04888585|449253396|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
124898757|NCT04888585|449253397|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
124898758|NCT04888585|449253398|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
124898759|NCT04888585|449253399|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
124898760|NCT04888585|449253400|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
124898761|NCT04888585|449253401|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
124898762|NCT04888585|449253402|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
124898763|NCT04888585|449253403|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
124898764|NCT04888585|449253404|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
124898765|NCT04888585|449253405|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
124898766|NCT04888585|449253395|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
124898767|NCT04888585|449253396|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
124898768|NCT04888585|449253397|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
124898769|NCT04888585|449253398|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
124898770|NCT04888585|449253399|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
124898771|NCT04888585|449253400|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
124898772|NCT04888585|449253401|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
124898773|NCT04888585|449253402|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
124898774|NCT04888585|449253403|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
124898775|NCT04888585|449253404|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
124898776|NCT04888585|449253405|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
124898777|NCT04888585|449253395|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
124898778|NCT04888585|449253396|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
124898779|NCT04888585|449253397|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
124898780|NCT04888585|449253398|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
124898781|NCT04888585|449253399|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
124898782|NCT04888585|449253400|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
124898783|NCT04888585|449253401|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
124898784|NCT04888585|449253402|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
124898785|NCT04888585|449253403|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
124898786|NCT04888585|449253404|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
124898787|NCT04888585|449253405|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
124898788|NCT02908464|449253407|FG000|Overall Study|Withdrawal by Subject|2|||
124898789|NCT02908464|449253408|FG001|Overall Study|Withdrawal by Subject|1|||
124898790|NCT02908464|449253407|FG000|Overall Study|Found ineligible after randomization|0|||
124898791|NCT02908464|449253408|FG001|Overall Study|Found ineligible after randomization|2|||
124898792|NCT01772719|449253409|FG000|Overall Study|Withdrawal by Subject|3|||
124898793|NCT01772719|449253409|FG000|Overall Study|Adverse Event|2|||
124898794|NCT01772719|449253409|FG000|Overall Study|Protocol Violation|1|||
124898795|NCT01772719|449253409|FG000|Overall Study|Lost to Follow-up|1|||
124898796|NCT01311713|449253410|FG000|Overall Study|Death|0|||
124898797|NCT01311713|449253411|FG001|Overall Study|Death|0|||
124898798|NCT01311713|449253412|FG002|Overall Study|Death|1|||
124898799|NCT01311713|449253413|FG003|Overall Study|Death|1|||
124898800|NCT01311713|449253414|FG004|Overall Study|Death|0|||
124898801|NCT01311713|449253415|FG005|Overall Study|Death|1|||
124898802|NCT01311713|449253416|FG006|Overall Study|Death|0|||
124898803|NCT01311713|449253410|FG000|Overall Study|Adverse Event|0|||
124898804|NCT01311713|449253411|FG001|Overall Study|Adverse Event|1|||
125019391|NCT00527605|449694697|FG001|Overall Study|Protocol Violation|2|||
125019392|NCT01592760|449694698|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
125019393|NCT01592760|449694699|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
124898805|NCT01311713|449253412|FG002|Overall Study|Adverse Event|0|||
125019394|NCT01592760|449694700|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
124898806|NCT01311713|449253413|FG003|Overall Study|Adverse Event|2|||
124898807|NCT01311713|449253414|FG004|Overall Study|Adverse Event|0|||
124898808|NCT01311713|449253415|FG005|Overall Study|Adverse Event|0|||
124898809|NCT01311713|449253416|FG006|Overall Study|Adverse Event|2|||
124898810|NCT01311713|449253410|FG000|Overall Study|Withdrawal by Subject|0|||
124898811|NCT01311713|449253411|FG001|Overall Study|Withdrawal by Subject|1|||
124898812|NCT01311713|449253412|FG002|Overall Study|Withdrawal by Subject|1|||
124898813|NCT01311713|449253413|FG003|Overall Study|Withdrawal by Subject|0|||
124898814|NCT01311713|449253414|FG004|Overall Study|Withdrawal by Subject|0|||
124898815|NCT01311713|449253415|FG005|Overall Study|Withdrawal by Subject|1|||
124898816|NCT01311713|449253416|FG006|Overall Study|Withdrawal by Subject|2|||
124898817|NCT01311713|449253410|FG000|Overall Study|Disease progression|3|||
124898818|NCT01311713|449253411|FG001|Overall Study|Disease progression|4|||
124898819|NCT01311713|449253412|FG002|Overall Study|Disease progression|3|||
124898820|NCT01311713|449253413|FG003|Overall Study|Disease progression|2|||
124898821|NCT01311713|449253414|FG004|Overall Study|Disease progression|4|||
124898822|NCT01311713|449253415|FG005|Overall Study|Disease progression|4|||
124898823|NCT01311713|449253416|FG006|Overall Study|Disease progression|5|||
124898824|NCT01311713|449253410|FG000|Overall Study|Lost to Follow-up|0|||
124898825|NCT01311713|449253411|FG001|Overall Study|Lost to Follow-up|0|||
124898826|NCT01311713|449253412|FG002|Overall Study|Lost to Follow-up|1|||
124898827|NCT01311713|449253413|FG003|Overall Study|Lost to Follow-up|0|||
124898828|NCT01311713|449253414|FG004|Overall Study|Lost to Follow-up|0|||
124898829|NCT01311713|449253415|FG005|Overall Study|Lost to Follow-up|0|||
124898830|NCT01311713|449253416|FG006|Overall Study|Lost to Follow-up|0|||
124898831|NCT01311713|449253410|FG000|Overall Study|Stopped taking study medication|0|||
124898832|NCT01311713|449253411|FG001|Overall Study|Stopped taking study medication|0|||
124898833|NCT01311713|449253412|FG002|Overall Study|Stopped taking study medication|0|||
124898834|NCT01311713|449253413|FG003|Overall Study|Stopped taking study medication|1|||
124898835|NCT01311713|449253414|FG004|Overall Study|Stopped taking study medication|1|||
124898836|NCT01311713|449253415|FG005|Overall Study|Stopped taking study medication|0|||
124898837|NCT01311713|449253416|FG006|Overall Study|Stopped taking study medication|0|||
124898838|NCT01311713|449253410|FG000|Overall Study|Enrolled but not treated|0|||
125019395|NCT04312009|449694701|FG000|Overall Study|Withdrawal by Subject|2|||
125019396|NCT04312009|449694702|FG001|Overall Study|Withdrawal by Subject|1|||
125019397|NCT01485627|449694708|FG000|Overall Study|Patient withdrew|6|||
125019398|NCT01485627|449694709|FG001|Overall Study|Patient withdrew|5|||
125019399|NCT01485627|449694708|FG000|Overall Study|Patient died|3|||
125019400|NCT01485627|449694709|FG001|Overall Study|Patient died|1|||
125019401|NCT01485627|449694708|FG000|Overall Study|Patient lost to followup|0|||
125019402|NCT01485627|449694709|FG001|Overall Study|Patient lost to followup|1|||
125019403|NCT01485627|449694708|FG000|Overall Study|Caregiver withdrew|3|||
125019404|NCT01485627|449694709|FG001|Overall Study|Caregiver withdrew|3|||
125019405|NCT01485627|449694708|FG000|Overall Study|Caregiver lost to follow up|11|||
125019406|NCT01485627|449694709|FG001|Overall Study|Caregiver lost to follow up|12|||
125019407|NCT01485627|449694708|FG000|Overall Study|Caregiver died|1|||
125019408|NCT01485627|449694709|FG001|Overall Study|Caregiver died|0|||
125019409|NCT01485627|449694708|FG000|Overall Study|caregiver was not bereaved|42|||
125019410|NCT01485627|449694709|FG001|Overall Study|caregiver was not bereaved|35|||
125019411|NCT00075504|449694718|FG000|Overall Study|Withdrawal by Subject|9|||
125019412|NCT00075504|449694719|FG001|Overall Study|Withdrawal by Subject|7|||
125019413|NCT01142726|449694720|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
125019414|NCT01142726|449694721|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
125019415|NCT01142726|449694722|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
125019416|NCT01142726|449694720|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
125019417|NCT01142726|449694721|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
124898839|NCT01311713|449253411|FG001|Overall Study|Enrolled but not treated|0|||
124898840|NCT01311713|449253412|FG002|Overall Study|Enrolled but not treated|1|||
124898841|NCT01311713|449253413|FG003|Overall Study|Enrolled but not treated|0|||
124898842|NCT01311713|449253414|FG004|Overall Study|Enrolled but not treated|0|||
124898843|NCT01311713|449253415|FG005|Overall Study|Enrolled but not treated|0|||
124898844|NCT01311713|449253416|FG006|Overall Study|Enrolled but not treated|0|||
124898845|NCT01311713|449253410|FG000|Overall Study|Other than specified|0|||
125019418|NCT01142726|449694722|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
124898846|NCT01311713|449253411|FG001|Overall Study|Other than specified|1|||
124898847|NCT01311713|449253412|FG002|Overall Study|Other than specified|2|||
124898848|NCT01311713|449253413|FG003|Overall Study|Other than specified|0|||
124898849|NCT01311713|449253414|FG004|Overall Study|Other than specified|0|||
124898850|NCT01311713|449253415|FG005|Overall Study|Other than specified|0|||
124898851|NCT01311713|449253416|FG006|Overall Study|Other than specified|0|||
124898852|NCT00299702|449253420|FG000|Overall Study|Death|1|||
124898853|NCT00299702|449253421|FG001|Overall Study|Death|0|||
124898854|NCT00299702|449253420|FG000|Overall Study|Adverse Event|0|||
124898855|NCT00299702|449253421|FG001|Overall Study|Adverse Event|4|||
124898856|NCT00299702|449253420|FG000|Overall Study|Lost to Follow-up|18|||
124898857|NCT00299702|449253421|FG001|Overall Study|Lost to Follow-up|10|||
124898858|NCT00299702|449253420|FG000|Overall Study|Withdrawal by Subject|25|||
124898859|NCT00299702|449253421|FG001|Overall Study|Withdrawal by Subject|23|||
124898860|NCT00299702|449253420|FG000|Overall Study|Pregnancy|0|||
124898861|NCT00299702|449253421|FG001|Overall Study|Pregnancy|1|||
124898862|NCT00299702|449253420|FG000|Overall Study|Insufficient Response|4|||
124898863|NCT00299702|449253421|FG001|Overall Study|Insufficient Response|3|||
124898864|NCT00299702|449253420|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
124898865|NCT00299702|449253421|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
124898866|NCT00751036|449253422|FG000|Overall Study|Disease Progression|28|||
124898867|NCT00751036|449253423|FG001|Overall Study|Disease Progression|29|||
124898868|NCT00751036|449253422|FG000|Overall Study|Adverse Event|6|||
124898869|NCT00751036|449253423|FG001|Overall Study|Adverse Event|4|||
124898870|NCT00751036|449253422|FG000|Overall Study|Administrative Problems|3|||
124898871|NCT00751036|449253423|FG001|Overall Study|Administrative Problems|4|||
124898872|NCT00751036|449253422|FG000|Overall Study|Withdrawal by Subject|5|||
124898873|NCT00751036|449253423|FG001|Overall Study|Withdrawal by Subject|2|||
124898874|NCT00751036|449253422|FG000|Overall Study|Death|3|||
124898875|NCT00751036|449253423|FG001|Overall Study|Death|3|||
124898876|NCT00751036|449253422|FG000|Overall Study|Lost to Follow-up|0|||
125019419|NCT01142726|449694720|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
125019420|NCT01142726|449694721|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
125019421|NCT01142726|449694722|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
125019422|NCT01142726|449694720|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
125019423|NCT01142726|449694721|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
125019424|NCT01142726|449694722|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
125019425|NCT01142726|449694720|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
125019426|NCT01142726|449694721|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
125019427|NCT01142726|449694722|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
125019428|NCT01142726|449694720|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
125019429|NCT01142726|449694721|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
125019430|NCT01142726|449694722|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
125019431|NCT01142726|449694720|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
125019432|NCT01142726|449694721|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
125019433|NCT01142726|449694722|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
125019434|NCT01142726|449694720|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
125019435|NCT01142726|449694721|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
125019436|NCT01142726|449694722|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
125019437|NCT01142726|449694720|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
125019438|NCT01142726|449694721|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
125019439|NCT01142726|449694722|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
125019440|NCT01142726|449694720|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
125019441|NCT01142726|449694721|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
125019442|NCT01142726|449694722|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
125019443|NCT01142726|449694720|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
125019444|NCT01142726|449694721|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
125019445|NCT01142726|449694722|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
125019446|NCT01142726|449694720|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
125019447|NCT01142726|449694721|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
125019448|NCT01142726|449694722|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
125019449|NCT01142726|449694720|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
124898877|NCT00751036|449253423|FG001|Overall Study|Lost to Follow-up|1|||
124898878|NCT00751036|449253422|FG000|Overall Study|Protocol Violation|1|||
124898879|NCT00751036|449253423|FG001|Overall Study|Protocol Violation|0|||
124898880|NCT00751036|449253422|FG000|Overall Study|Missing end of Treatment Page|2|||
124898881|NCT00751036|449253423|FG001|Overall Study|Missing end of Treatment Page|3|||
124898882|NCT05460663|449253424|FG000|Overall Study|Withdrawal by Subject|2|||
124898883|NCT05460663|449253425|FG001|Overall Study|Withdrawal by Subject|5|||
124898884|NCT05273801|449253426|FG000|Overall Study|Physician Decision|1|||
124898885|NCT03820986|449253427|FG000|Overall Study|Death|177|||
124898886|NCT03820986|449253428|FG001|Overall Study|Death|156|||
124898887|NCT03820986|449253427|FG000|Overall Study|Lost to Follow-up|0|||
124898888|NCT03820986|449253428|FG001|Overall Study|Lost to Follow-up|1|||
124898889|NCT03820986|449253427|FG000|Overall Study|Withdrawal by Subject|8|||
124898890|NCT03820986|449253428|FG001|Overall Study|Withdrawal by Subject|3|||
124898891|NCT03820986|449253427|FG000|Overall Study|Ongoing|149|||
124898892|NCT03820986|449253428|FG001|Overall Study|Ongoing|180|||
124898893|NCT01729819|449254693|FG000|Overall Study|Adverse Event|2|||
124898894|NCT01729819|449254694|FG001|Overall Study|Adverse Event|4|||
124898895|NCT01729819|449254693|FG000|Overall Study|Lack of Efficacy|1|||
124898896|NCT01729819|449254694|FG001|Overall Study|Lack of Efficacy|0|||
124898897|NCT01729819|449254693|FG000|Overall Study|Lost to Follow-up|2|||
124898898|NCT01729819|449254694|FG001|Overall Study|Lost to Follow-up|0|||
124898899|NCT01729819|449254693|FG000|Overall Study|Other reason|1|||
124898900|NCT01729819|449254694|FG001|Overall Study|Other reason|0|||
124898901|NCT01729819|449254693|FG000|Overall Study|Protocol Violation|0|||
124898902|NCT01729819|449254694|FG001|Overall Study|Protocol Violation|1|||
124898903|NCT01729819|449254693|FG000|Overall Study|Withdrawal by Subject|0|||
124898904|NCT01729819|449254694|FG001|Overall Study|Withdrawal by Subject|2|||
124898905|NCT04464421|449254699|FG000|Overall Study|Lost to Follow-up|2|||
124898906|NCT04464421|449254700|FG001|Overall Study|Lost to Follow-up|2|||
124898907|NCT01020838|449254702|FG000|Overall Study|Death|90|||
124898908|NCT01020838|449254702|FG000|Overall Study|Adverse Event|1|||
124898909|NCT01020838|449254702|FG000|Overall Study|Withdrawal by Subject|9|||
124898910|NCT01020838|449254702|FG000|Overall Study|Lost to Follow-up|6|||
124898911|NCT01020838|449254702|FG000|Overall Study|Most common: Study ended by sponsor|77|||
124898912|NCT01167426|449254703|FG000|Overall Study|Lost to Follow-up|6|||
124898913|NCT01167426|449254703|FG000|Overall Study|Protocol Violation|1|||
124898914|NCT01167426|449254703|FG000|Overall Study|Withdrawal by Subject|2|||
124898915|NCT01167426|449254703|FG000|Overall Study|Sponsor Decision|1|||
124898916|NCT01908634|449254705|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
124898917|NCT01908634|449254705|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
124898918|NCT04176458|449254706|FG000|Overall Study|Covid 19|4|||
124898919|NCT01570751|449254707|FG000|Period A (16 Weeks)|Protocol Violation|1|||
124898920|NCT01570751|449254708|FG001|Period A (16 Weeks)|Protocol Violation|1|||
124898921|NCT01570751|449254707|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
124898922|NCT01570751|449254708|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
124898923|NCT01570751|449254707|FG000|Period A (16 Weeks)|Unclassified|2|||
124898924|NCT01570751|449254708|FG001|Period A (16 Weeks)|Unclassified|3|||
124898925|NCT01570751|449254707|FG000|Period B (16 Weeks)|Adverse Event|1|||
124898926|NCT01570751|449254708|FG001|Period B (16 Weeks)|Adverse Event|0|||
124898927|NCT01570751|449254707|FG000|Period B (16 Weeks)|Protocol Violation|0|||
124898928|NCT01570751|449254708|FG001|Period B (16 Weeks)|Protocol Violation|1|||
124898929|NCT05790408|449254709|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
124898930|NCT00558363|449254713|FG000|Overall Study|Physician Decision|18|||
124898931|NCT00558363|449254714|FG001|Overall Study|Physician Decision|4|||
124898932|NCT00558363|449254713|FG000|Overall Study|Withdrawal by Subject|11|||
124898933|NCT00558363|449254714|FG001|Overall Study|Withdrawal by Subject|4|||
124898934|NCT00558363|449254713|FG000|Overall Study|Adverse Event|5|||
124898935|NCT00558363|449254714|FG001|Overall Study|Adverse Event|5|||
124898936|NCT00558363|449254713|FG000|Overall Study|Lack of Efficacy|2|||
124898937|NCT00558363|449254714|FG001|Overall Study|Lack of Efficacy|2|||
124898938|NCT00558363|449254713|FG000|Overall Study|Protocol Violation|2|||
124898939|NCT00558363|449254714|FG001|Overall Study|Protocol Violation|1|||
124898940|NCT00558363|449254713|FG000|Overall Study|Lost to Follow-up|0|||
124898941|NCT00558363|449254714|FG001|Overall Study|Lost to Follow-up|1|||
124898942|NCT00558363|449254713|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
125019450|NCT01142726|449694721|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
125019451|NCT01142726|449694722|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
125019452|NCT01142726|449694720|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
125019453|NCT01142726|449694721|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
125019454|NCT01142726|449694722|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
125019455|NCT01142726|449694720|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
125019456|NCT01142726|449694721|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
125019457|NCT01142726|449694722|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
124898943|NCT00558363|449254714|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
124898944|NCT00558363|449254713|FG000|Overall Study|Randomized in Error|1|||
124898945|NCT00558363|449254714|FG001|Overall Study|Randomized in Error|2|||
124898946|NCT00558363|449254713|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
124898947|NCT00558363|449254714|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
124898948|NCT04012853|449254715|FG000|Overall Study|Withdrawal by Subject|1|||
124898949|NCT04012853|449254716|FG001|Overall Study|Withdrawal by Subject|1|||
124898950|NCT04012853|449254715|FG000|Overall Study|Protocol Violation|1|||
124898951|NCT04012853|449254716|FG001|Overall Study|Protocol Violation|0|||
124898952|NCT04012853|449254715|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
124898953|NCT04012853|449254716|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
125110801|NCT01889862|450029374|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
125110802|NCT01889862|450029375|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
125110803|NCT01889862|450029376|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
125110804|NCT01889862|450029377|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
125110805|NCT01889862|450029378|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
125110806|NCT01889862|450029374|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
125110807|NCT01889862|450029375|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
125110808|NCT01889862|450029376|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
125110809|NCT01889862|450029377|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
125110810|NCT01889862|450029378|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
125110811|NCT00845026|450029379|FG000|Study Period III|Adverse Event|23|||
125110812|NCT00845026|450029380|FG001|Study Period III|Adverse Event|19|||
125110813|NCT00845026|450029379|FG000|Study Period III|Perceived lack of efficacy|27|||
125110814|NCT00845026|450029380|FG001|Study Period III|Perceived lack of efficacy|15|||
125110815|NCT00845026|450029379|FG000|Study Period III|Withdrawal by Subject|19|||
125110816|NCT00845026|450029380|FG001|Study Period III|Withdrawal by Subject|15|||
125110817|NCT00845026|450029379|FG000|Study Period III|Entry Criteria not met|8|||
125110818|NCT00845026|450029380|FG001|Study Period III|Entry Criteria not met|11|||
125110819|NCT00845026|450029379|FG000|Study Period III|Lost to Follow-up|4|||
125110820|NCT00845026|450029380|FG001|Study Period III|Lost to Follow-up|5|||
125110821|NCT00845026|450029379|FG000|Study Period III|Protocol Violation|8|||
125110822|NCT00845026|450029380|FG001|Study Period III|Protocol Violation|1|||
125110823|NCT00845026|450029379|FG000|Study Period III|Scheduled conflict|3|||
125110824|NCT00845026|450029380|FG001|Study Period III|Scheduled conflict|1|||
125110825|NCT00845026|450029379|FG000|Study Period III|Subject is moving or has moved|2|||
125110826|NCT00845026|450029380|FG001|Study Period III|Subject is moving or has moved|4|||
125110827|NCT00845026|450029379|FG000|Study Period III|Transportation issues|1|||
125110828|NCT00845026|450029380|FG001|Study Period III|Transportation issues|1|||
125110829|NCT00845026|450029379|FG000|Study Period IV|Adverse Event|4|||
125110830|NCT00845026|450029380|FG001|Study Period IV|Adverse Event|0|||
125110831|NCT00845026|450029379|FG000|Study Period IV|Perceived lack of efficacy|2|||
125110832|NCT00845026|450029380|FG001|Study Period IV|Perceived lack of efficacy|1|||
125110833|NCT00845026|450029379|FG000|Study Period IV|Protocol Violation|3|||
125110834|NCT00845026|450029380|FG001|Study Period IV|Protocol Violation|1|||
125110835|NCT00845026|450029379|FG000|Study Period IV|Lost to Follow-up|1|||
125110836|NCT00845026|450029380|FG001|Study Period IV|Lost to Follow-up|0|||
125110837|NCT00845026|450029379|FG000|Study Period IV|Withdrawal by Subject|4|||
125110838|NCT00845026|450029380|FG001|Study Period IV|Withdrawal by Subject|1|||
125110839|NCT00845026|450029379|FG000|Study Period IV|Entry Criteria Not Met|1|||
125110840|NCT00845026|450029380|FG001|Study Period IV|Entry Criteria Not Met|0|||
125110841|NCT00845026|450029379|FG000|Study Period IV|Subject is moving or has moved|0|||
125110842|NCT00845026|450029380|FG001|Study Period IV|Subject is moving or has moved|1|||
125110843|NCT00845026|450029379|FG000|Study Period IV|Scheduling conflict|1|||
125110844|NCT00845026|450029380|FG001|Study Period IV|Scheduling conflict|0|||
125110845|NCT01325532|450029381|FG000|Overall Study|Withdrawal by Subject|2|||
125110846|NCT01325532|450029382|FG001|Overall Study|Withdrawal by Subject|0|||
125019458|NCT01142726|449694720|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
125019459|NCT01142726|449694721|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
125019460|NCT01142726|449694722|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
125019461|NCT01568593|449694723|FG000|Overall Study|Lack of Efficacy|4|||
125019462|NCT01568593|449694724|FG001|Overall Study|Lack of Efficacy|1|||
125019463|NCT01568593|449694723|FG000|Overall Study|Adverse Event|3|||
125019464|NCT01568593|449694724|FG001|Overall Study|Adverse Event|2|||
125019465|NCT02111993|449694725|FG000|Overall Study|Physician Decision|5|||
125019466|NCT02111993|449694726|FG001|Overall Study|Physician Decision|4|||
125019467|NCT03713944|449694727|FG000|Study Treatment|Patient non-compliance|1|||
125019468|NCT03713944|449694727|FG000|Study Treatment|Alternative Cancer Therapy|3|||
125019469|NCT03713944|449694727|FG000|Study Treatment|Disease Progression|18|||
125019470|NCT03713944|449694727|FG000|Study Treatment|AE/Side Effects/Complications|2|||
125019471|NCT03713944|449694727|FG000|Study Treatment|Death|2|||
125019472|NCT03713944|449694727|FG000|Study Treatment|Withdrawal by Subject|1|||
125019473|NCT03713944|449694727|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
125019474|NCT03713944|449694727|FG000|Study Treatment|Symptomatic Deterioration|2|||
125019475|NCT03713944|449694727|FG000|Follow up|Withdrawal by Subject|2|||
125019476|NCT03713944|449694727|FG000|Follow up|Death|11|||
125019477|NCT03713944|449694727|FG000|Follow up|Study Terminated|3|||
125019478|NCT00419380|449694728|FG000|Overall Study|Lack of Efficacy|1|||
125019479|NCT00419380|449694729|FG001|Overall Study|Lack of Efficacy|7|||
125019480|NCT00419380|449694728|FG000|Overall Study|Physician Decision|0|||
125019481|NCT00419380|449694729|FG001|Overall Study|Physician Decision|1|||
125019482|NCT00419380|449694728|FG000|Overall Study|Lost to Follow-up|0|||
125110847|NCT03012815|450029383|FG000|Overall Study|Lost to Follow-up|1|||
125019483|NCT00419380|449694729|FG001|Overall Study|Lost to Follow-up|1|||
125019484|NCT00419380|449694728|FG000|Overall Study|Withdrawal by Subject|0|||
125019485|NCT00419380|449694729|FG001|Overall Study|Withdrawal by Subject|1|||
125110848|NCT03012815|450029384|FG001|Overall Study|Lost to Follow-up|0|||
125110849|NCT03012815|450029383|FG000|Overall Study|Physician Decision|3|||
125110850|NCT03012815|450029384|FG001|Overall Study|Physician Decision|2|||
125110851|NCT03012815|450029383|FG000|Overall Study|Adverse Event|1|||
124898954|NCT00015457|449254719|FG000|First Intervention|Adverse Event|0|||
124898955|NCT00015457|449254720|FG001|First Intervention|Adverse Event|2|||
124898956|NCT00015457|449254719|FG000|First Intervention|Lack of Efficacy|0|||
124898957|NCT00015457|449254720|FG001|First Intervention|Lack of Efficacy|1|||
124898958|NCT00015457|449254719|FG000|Second Intervention|Withdrawal by Subject|1|||
124898959|NCT00015457|449254720|FG001|Second Intervention|Withdrawal by Subject|0|||
124898960|NCT02317705|449254721|FG000|Overall Study|Withdrawal by Subject|3|||
124898961|NCT02317705|449254721|FG000|Overall Study|Physician Decision|1|||
124898962|NCT02317705|449254721|FG000|Overall Study|Drug not usable|1|||
124898963|NCT02219490|449254722|FG000|Overall Study|Adverse Event|24|||
124898964|NCT02219490|449254722|FG000|Overall Study|Withdrew consent|96|||
124898965|NCT02219490|449254722|FG000|Overall Study|Lost to Follow-up|126|||
124898966|NCT02219490|449254722|FG000|Overall Study|COVID-19 infection|2|||
124898967|NCT02219490|449254722|FG000|Overall Study|COVID-19 logistical restrictions|33|||
124898968|NCT02219490|449254722|FG000|Overall Study|Other, not specified|57|||
124898969|NCT01599325|449254723|FG000|Primary Parent Phase|Adverse Event|5|||
124898970|NCT01599325|449254723|FG000|Primary Parent Phase|Disease Progression|7|||
124898971|NCT01599325|449254723|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
124898972|NCT01599325|449254723|FG000|Primary Parent Phase|Death|13|||
124898973|NCT01599325|449254723|FG000|Primary Parent Phase|Protocol Violation|1|||
124898974|NCT01599325|449254723|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
124898975|NCT01599325|449254723|FG000|Primary Parent Phase|Other|2|||
124898976|NCT01599325|449254723|FG000|Extension Phase|Study Closure|1|||
124898977|NCT01599325|449254723|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
124898978|NCT01599325|449254723|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
124898979|NCT01599325|449254723|FG000|Extension Phase|Disease Progression|1|||
124898980|NCT01599325|449254723|FG000|Extension Phase|Withdrawal by Subject|8|||
124898981|NCT02430532|449254726|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
124898982|NCT02430532|449254727|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
124898983|NCT02430532|449254726|FG000|Overall Study|Consent Withdrawn|0|||
124898984|NCT02430532|449254727|FG001|Overall Study|Consent Withdrawn|2|||
124898985|NCT02430532|449254726|FG000|Overall Study|Adverse Event|0|||
124898986|NCT02430532|449254727|FG001|Overall Study|Adverse Event|1|||
124898987|NCT04109118|449254742|FG000|Overall Study|Lost to Follow-up|3|||
124898988|NCT03235349|449254745|FG000|Overall Study|Adverse Event|1|||
124898989|NCT03235349|449254745|FG000|Overall Study|Other|1|||
124898990|NCT04523181|449254750|FG000|Overall Study|Withdrawal by Subject|4|||
124898991|NCT04523181|449254751|FG001|Overall Study|Withdrawal by Subject|5|||
124898992|NCT04523181|449254750|FG000|Overall Study|Lost to Follow-up|2|||
124898993|NCT04523181|449254751|FG001|Overall Study|Lost to Follow-up|3|||
124898994|NCT04523181|449254750|FG000|Overall Study|Physician Decision|1|||
124898995|NCT04523181|449254751|FG001|Overall Study|Physician Decision|0|||
124898996|NCT04523181|449254750|FG000|Overall Study|Transferred to external facility.|1|||
124898997|NCT04523181|449254751|FG001|Overall Study|Transferred to external facility.|1|||
124898998|NCT04391309|449254752|FG000|Overall Study|Death|1|||
124898999|NCT04391309|449254753|FG001|Overall Study|Death|1|||
124899000|NCT04391309|449254752|FG000|Overall Study|Lost to Follow-up|3|||
124899001|NCT04391309|449254753|FG001|Overall Study|Lost to Follow-up|2|||
124899002|NCT04391309|449254752|FG000|Overall Study|Withdrawal by Subject|2|||
124899003|NCT04391309|449254753|FG001|Overall Study|Withdrawal by Subject|2|||
124899004|NCT01155869|449254754|FG000|Overall Study|Lost to Follow-up|3|||
124899005|NCT01155869|449254755|FG001|Overall Study|Lost to Follow-up|1|||
124899006|NCT03396913|449254757|FG000|Overall Study|Lost to Follow-up|0|||
124899007|NCT03396913|449254758|FG001|Overall Study|Lost to Follow-up|6|||
124899008|NCT05824351|449254759|FG000|Overall Study|Adverse Event|6|||
124899009|NCT00828945|449254760|FG000|Overall Study|Death|4|||
124899010|NCT00828945|449254760|FG000|Overall Study|Participant was missing|1|||
124899011|NCT00828945|449254760|FG000|Overall Study|Other|36|||
124899012|NCT02482233|449254765|FG000|Overall Study|Lost to Follow-up|1|||
124899013|NCT02482233|449254766|FG001|Overall Study|Lost to Follow-up|1|||
124899014|NCT03822351|449254767|FG000|Overall Study|Death|27|||
124899015|NCT03822351|449254768|FG001|Overall Study|Death|23|||
124899016|NCT03822351|449254769|FG002|Overall Study|Death|24|||
124899017|NCT03822351|449254767|FG000|Overall Study|Lost to Follow-up|6|||
124899018|NCT03822351|449254768|FG001|Overall Study|Lost to Follow-up|2|||
124899019|NCT03822351|449254769|FG002|Overall Study|Lost to Follow-up|1|||
124899020|NCT03822351|449254767|FG000|Overall Study|Withdrawal by Subject|10|||
124899021|NCT03822351|449254768|FG001|Overall Study|Withdrawal by Subject|4|||
124899022|NCT03822351|449254769|FG002|Overall Study|Withdrawal by Subject|6|||
124899023|NCT03822351|449254767|FG000|Overall Study|Progressive Disease|2|||
124899024|NCT03822351|449254768|FG001|Overall Study|Progressive Disease|1|||
124899025|NCT03822351|449254769|FG002|Overall Study|Progressive Disease|0|||
125110852|NCT03012815|450029384|FG001|Overall Study|Adverse Event|0|||
125110853|NCT01252238|450029385|FG000|Overall Study|Sponsor terminated study|4|||
124899026|NCT03822351|449254767|FG000|Overall Study|Not Treated|1|||
124899027|NCT03822351|449254768|FG001|Overall Study|Not Treated|1|||
124899028|NCT03822351|449254769|FG002|Overall Study|Not Treated|1|||
124899029|NCT00462943|449254770|FG000|Overall Study|Failure to achieve a response|5|||
124899030|NCT00462943|449254771|FG001|Overall Study|Failure to achieve a response|5|||
124899031|NCT00462943|449254772|FG002|Overall Study|Failure to achieve a response|1|||
124899032|NCT00462943|449254770|FG000|Overall Study|Adverse Event|6|||
124899033|NCT00462943|449254771|FG001|Overall Study|Adverse Event|4|||
124899034|NCT00462943|449254772|FG002|Overall Study|Adverse Event|1|||
124899035|NCT00462943|449254770|FG000|Overall Study|Protocol Violation|1|||
124899036|NCT00462943|449254771|FG001|Overall Study|Protocol Violation|0|||
124899037|NCT00462943|449254772|FG002|Overall Study|Protocol Violation|0|||
124899038|NCT00462943|449254770|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
124899039|NCT00462943|449254771|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
124899040|NCT00462943|449254772|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
124899041|NCT00462943|449254770|FG000|Overall Study|Disease Progression|15|||
124899042|NCT00462943|449254771|FG001|Overall Study|Disease Progression|15|||
124899043|NCT00462943|449254772|FG002|Overall Study|Disease Progression|9|||
124899044|NCT00462943|449254770|FG000|Overall Study|Death|5|||
124899045|NCT00462943|449254771|FG001|Overall Study|Death|2|||
124899046|NCT00462943|449254772|FG002|Overall Study|Death|7|||
124899047|NCT00462943|449254770|FG000|Overall Study|Stem Cell Transplant|1|||
124899048|NCT00462943|449254771|FG001|Overall Study|Stem Cell Transplant|1|||
124899049|NCT00462943|449254772|FG002|Overall Study|Stem Cell Transplant|0|||
124899050|NCT00462943|449254770|FG000|Overall Study|Bone Marrow Transplant|1|||
124899051|NCT00462943|449254771|FG001|Overall Study|Bone Marrow Transplant|0|||
124899052|NCT00462943|449254772|FG002|Overall Study|Bone Marrow Transplant|0|||
124899053|NCT00462943|449254770|FG000|Overall Study|Required Lymphocyte Infusion|1|||
124899054|NCT00462943|449254771|FG001|Overall Study|Required Lymphocyte Infusion|0|||
124899055|NCT00462943|449254772|FG002|Overall Study|Required Lymphocyte Infusion|0|||
124899056|NCT00462943|449254770|FG000|Overall Study|Transplant - not specified|1|||
124899057|NCT00462943|449254771|FG001|Overall Study|Transplant - not specified|0|||
124899058|NCT00462943|449254772|FG002|Overall Study|Transplant - not specified|1|||
124899059|NCT00462943|449254770|FG000|Overall Study|Physician Decision|1|||
125110854|NCT01252238|450029386|FG001|Overall Study|Sponsor terminated study|4|||
125110855|NCT01252238|450029387|FG002|Overall Study|Sponsor terminated study|4|||
125110856|NCT06371079|450029392|FG000|Overall Study|Missing data|88|||
125110857|NCT06371079|450029393|FG001|Overall Study|Missing data|247|||
125110858|NCT03276962|450029395|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
125110859|NCT03276962|450029396|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
125110860|NCT03276962|450029397|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
125110861|NCT03276962|450029398|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
125110862|NCT03276962|450029399|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
125110863|NCT03276962|450029395|FG000|Overall Study|Protocol Deviation|2|||
125110864|NCT03276962|450029396|FG001|Overall Study|Protocol Deviation|0|||
125110865|NCT03276962|450029397|FG002|Overall Study|Protocol Deviation|1|||
125110866|NCT03276962|450029398|FG003|Overall Study|Protocol Deviation|2|||
125110867|NCT03276962|450029399|FG004|Overall Study|Protocol Deviation|1|||
125110868|NCT03276962|450029395|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
125110869|NCT03276962|450029396|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
125110870|NCT03276962|450029397|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
125110871|NCT03276962|450029398|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
125110872|NCT03276962|450029399|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
125110873|NCT03276962|450029395|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
125110874|NCT03276962|450029396|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
125110875|NCT03276962|450029397|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
125110876|NCT03276962|450029398|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
125110877|NCT03276962|450029399|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
125110878|NCT03276962|450029395|FG000|Overall Study|Lost to Follow-up|10|||
125110879|NCT03276962|450029396|FG001|Overall Study|Lost to Follow-up|10|||
125110880|NCT03276962|450029397|FG002|Overall Study|Lost to Follow-up|4|||
125110881|NCT03276962|450029398|FG003|Overall Study|Lost to Follow-up|6|||
125110882|NCT03276962|450029399|FG004|Overall Study|Lost to Follow-up|10|||
125110883|NCT03276962|450029395|FG000|Overall Study|Other|0|||
125110884|NCT03276962|450029396|FG001|Overall Study|Other|2|||
124899060|NCT00462943|449254771|FG001|Overall Study|Physician Decision|0|||
124899061|NCT00462943|449254772|FG002|Overall Study|Physician Decision|0|||
124899062|NCT00462943|449254770|FG000|Overall Study|Withdrawal by Subject|0|||
124899063|NCT00462943|449254771|FG001|Overall Study|Withdrawal by Subject|1|||
124899064|NCT00462943|449254772|FG002|Overall Study|Withdrawal by Subject|0|||
124899065|NCT00813488|449254778|FG000|Titration Period 1|Adverse Event|6|||
124899066|NCT00813488|449254779|FG001|Titration Period 1|Adverse Event|1|||
125110885|NCT03276962|450029397|FG002|Overall Study|Other|0|||
124899067|NCT00813488|449254778|FG000|Titration Period 1|Lack of Efficacy|9|||
124899068|NCT00813488|449254779|FG001|Titration Period 1|Lack of Efficacy|7|||
124899069|NCT00813488|449254778|FG000|Titration Period 1|Withdrawal by Subject|2|||
124899070|NCT00813488|449254779|FG001|Titration Period 1|Withdrawal by Subject|2|||
124899071|NCT00813488|449254778|FG000|Titration Period 1|Protocol Violation|4|||
124899072|NCT00813488|449254779|FG001|Titration Period 1|Protocol Violation|3|||
124899073|NCT00813488|449254778|FG000|Titration Period 1|Non-compliance to study medication|4|||
124899074|NCT00813488|449254779|FG001|Titration Period 1|Non-compliance to study medication|1|||
124899075|NCT00813488|449254778|FG000|Titration Period 1|Non-compliance to study procedures|2|||
124899076|NCT00813488|449254779|FG001|Titration Period 1|Non-compliance to study procedures|2|||
124899077|NCT00813488|449254778|FG000|Titration Period 1|Technical Difficulties|0|||
124899078|NCT00813488|449254779|FG001|Titration Period 1|Technical Difficulties|1|||
124899079|NCT00813488|449254778|FG000|Titration Period 2|Adverse Event|2|||
124899080|NCT00813488|449254779|FG001|Titration Period 2|Adverse Event|3|||
124899081|NCT00813488|449254778|FG000|Titration Period 2|Lack of Efficacy|8|||
124899082|NCT00813488|449254779|FG001|Titration Period 2|Lack of Efficacy|4|||
124899083|NCT00813488|449254778|FG000|Titration Period 2|Protocol Violation|3|||
124899084|NCT00813488|449254779|FG001|Titration Period 2|Protocol Violation|2|||
124899085|NCT00813488|449254778|FG000|Titration Period 2|Lost to Follow-up|1|||
124899086|NCT00813488|449254779|FG001|Titration Period 2|Lost to Follow-up|0|||
124899087|NCT00813488|449254778|FG000|Titration Period 2|Non-compliance with study procedures|2|||
124899088|NCT00813488|449254779|FG001|Titration Period 2|Non-compliance with study procedures|1|||
124899089|NCT00813488|449254778|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
124899090|NCT00813488|449254779|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
124899091|NCT00813488|449254778|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
124899092|NCT00813488|449254779|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
124899093|NCT00813488|449254778|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
124899094|NCT00813488|449254779|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
124899095|NCT00813488|449254778|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
124899096|NCT00813488|449254779|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
124899097|NCT00813488|449254778|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
124899098|NCT00813488|449254779|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
124899099|NCT00813488|449254778|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
124899100|NCT00813488|449254779|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
124899101|NCT00813488|449254778|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
124899102|NCT00813488|449254779|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
124899103|NCT00813488|449254778|FG000|Double-blind Treatment Period 2|Other|1|||
124899104|NCT00813488|449254779|FG001|Double-blind Treatment Period 2|Other|0|||
124899105|NCT00813488|449254778|FG000|Open-label Extension|Adverse Event|1|||
124899106|NCT00813488|449254779|FG001|Open-label Extension|Adverse Event|2|||
124899107|NCT00813488|449254778|FG000|Open-label Extension|Lack of Efficacy|3|||
124899108|NCT00813488|449254779|FG001|Open-label Extension|Lack of Efficacy|0|||
124899109|NCT00813488|449254778|FG000|Open-label Extension|Withdrawal by Subject|0|||
124899110|NCT00813488|449254779|FG001|Open-label Extension|Withdrawal by Subject|2|||
124899111|NCT00813488|449254778|FG000|Open-label Extension|Protocol Violation|1|||
124899112|NCT00813488|449254779|FG001|Open-label Extension|Protocol Violation|2|||
124899113|NCT00813488|449254778|FG000|Open-label Extension|Non-compliance study medication|4|||
124899114|NCT00813488|449254779|FG001|Open-label Extension|Non-compliance study medication|0|||
124899115|NCT00813488|449254778|FG000|Open-label Extension|Non-compliance study procedures|2|||
124899116|NCT00813488|449254779|FG001|Open-label Extension|Non-compliance study procedures|1|||
124899117|NCT00813488|449254778|FG000|Open-label Extension|Other|1|||
124899118|NCT00813488|449254779|FG001|Open-label Extension|Other|0|||
124899119|NCT01729871|449254781|FG000|Overall Study|Adverse Event|7|||
124899120|NCT01729871|449254782|FG001|Overall Study|Adverse Event|7|||
124899121|NCT01729871|449254781|FG000|Overall Study|Death|0|||
124899122|NCT01729871|449254782|FG001|Overall Study|Death|1|||
124899123|NCT01729871|449254781|FG000|Overall Study|Lack of Efficacy|0|||
124899124|NCT01729871|449254782|FG001|Overall Study|Lack of Efficacy|1|||
124899125|NCT01729871|449254781|FG000|Overall Study|Physician Decision|0|||
124899126|NCT01729871|449254782|FG001|Overall Study|Physician Decision|2|||
124899127|NCT01729871|449254781|FG000|Overall Study|Protocol Violation|1|||
124899128|NCT01729871|449254782|FG001|Overall Study|Protocol Violation|0|||
124899129|NCT01729871|449254781|FG000|Overall Study|Withdrawal by Subject|0|||
124899130|NCT01729871|449254782|FG001|Overall Study|Withdrawal by Subject|3|||
124899131|NCT01729871|449254781|FG000|Overall Study|Other|4|||
124899132|NCT01729871|449254782|FG001|Overall Study|Other|9|||
124899133|NCT01143077|449254783|FG000|Overall Study|Lack of Efficacy|0|||
124899134|NCT01143077|449254784|FG001|Overall Study|Lack of Efficacy|2|||
125110886|NCT03276962|450029398|FG003|Overall Study|Other|2|||
125110887|NCT03276962|450029399|FG004|Overall Study|Other|1|||
125110888|NCT00411762|450029400|FG000|Overall Study|Withdrawal by Subject|5|||
125110889|NCT00558519|450029409|FG000|Overall Study|Ph+|20|||
125110890|NCT00558519|450029409|FG000|Overall Study|Ineligible|1|||
125110891|NCT00558519|450029409|FG000|Overall Study|Insufficient data|1|||
125110892|NCT00558519|450029409|FG000|Overall Study|Never received treatment|1|||
125110893|NCT02278952|450029410|FG000|Overall Study|Insufficient Sample|6|||
125110894|NCT00869089|450029413|FG000|Overall Study|Lost to Follow-up|1|||
125110895|NCT00869089|450029413|FG000|Overall Study|Withdrawal by Subject|1|||
125110896|NCT00869089|450029413|FG000|Overall Study|Screen Fail|1|||
124899135|NCT01143077|449254785|FG002|Overall Study|Lack of Efficacy|1|||
124899136|NCT01143077|449254783|FG000|Overall Study|Adverse Event|5|||
124899137|NCT01143077|449254784|FG001|Overall Study|Adverse Event|6|||
124899138|NCT01143077|449254785|FG002|Overall Study|Adverse Event|5|||
124899139|NCT01143077|449254783|FG000|Overall Study|Lost to Follow-up|2|||
124899140|NCT01143077|449254784|FG001|Overall Study|Lost to Follow-up|3|||
124899141|NCT01143077|449254785|FG002|Overall Study|Lost to Follow-up|4|||
124899142|NCT01143077|449254783|FG000|Overall Study|Protocol Violation|2|||
124899143|NCT01143077|449254784|FG001|Overall Study|Protocol Violation|0|||
124899144|NCT01143077|449254785|FG002|Overall Study|Protocol Violation|0|||
124899145|NCT01143077|449254783|FG000|Overall Study|Withdrawal by Subject|4|||
124899146|NCT01143077|449254784|FG001|Overall Study|Withdrawal by Subject|3|||
124899147|NCT01143077|449254785|FG002|Overall Study|Withdrawal by Subject|3|||
124899148|NCT01143077|449254783|FG000|Overall Study|Non-compliance with study drug|0|||
124899149|NCT01143077|449254784|FG001|Overall Study|Non-compliance with study drug|1|||
124899150|NCT01143077|449254785|FG002|Overall Study|Non-compliance with study drug|1|||
124899151|NCT01143077|449254783|FG000|Overall Study|Administrative|1|||
124899152|NCT01143077|449254784|FG001|Overall Study|Administrative|0|||
124899153|NCT01143077|449254785|FG002|Overall Study|Administrative|0|||
124899154|NCT01143077|449254783|FG000|Overall Study|Principal Investigator Decision|2|||
124899155|NCT01143077|449254784|FG001|Overall Study|Principal Investigator Decision|0|||
124899156|NCT01143077|449254785|FG002|Overall Study|Principal Investigator Decision|1|||
124899157|NCT00871429|449254790|FG000|Overall Study|Lost to Follow-up|6|||
124899158|NCT00871429|449254790|FG000|Overall Study|Withdrawal by Subject|17|||
124899159|NCT00871429|449254790|FG000|Overall Study|Questionnaire not completed|1|||
124899160|NCT05526911|449255959|FG000|Overall Study|Adverse Event|2|||
125110897|NCT01963676|450030960|FG000|Overall Study|Withdrawal by Subject|1|||
125110898|NCT01963676|450030961|FG001|Overall Study|Withdrawal by Subject|0|||
124899161|NCT05025449|449255960|FG000|Overall Study|Withdrawal by Subject|1|||
125110899|NCT01246973|450030962|FG000|Overall Study|Other|38|||
125110900|NCT01246973|450030963|FG001|Overall Study|Other|25|||
124899162|NCT05025449|449255960|FG000|Overall Study|Patient emergently taken to operating room|1|||
124899163|NCT00613301|449255961|FG000|Overall Study|Adverse Event|49|||
124899164|NCT00613301|449255961|FG000|Overall Study|Lost to Follow-up|88|||
124899165|NCT00613301|449255961|FG000|Overall Study|Withdrawal by Subject|5|||
124899166|NCT00613301|449255961|FG000|Overall Study|Death|6|||
124899167|NCT00613301|449255961|FG000|Overall Study|Lack of Efficacy|13|||
125110901|NCT01246973|450030962|FG000|Overall Study|Adverse Event|16|||
125110902|NCT01246973|450030963|FG001|Overall Study|Adverse Event|9|||
125110903|NCT01246973|450030962|FG000|Overall Study|Withdrawal by Subject|7|||
125110904|NCT01246973|450030963|FG001|Overall Study|Withdrawal by Subject|13|||
125110905|NCT00766506|450030964|FG000|Overall Study|Use rescue medication after 3 hours|3|||
125110906|NCT00766506|450030965|FG001|Overall Study|Use rescue medication after 3 hours|0|||
125110907|NCT00766506|450030964|FG000|Overall Study|Other|2|||
125110908|NCT00766506|450030965|FG001|Overall Study|Other|2|||
125110909|NCT02496221|450030966|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
125110910|NCT02496221|450030967|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
125110911|NCT02496221|450030966|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
125110912|NCT02496221|450030967|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
125110913|NCT02496221|450030966|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
125110914|NCT02496221|450030967|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
125110915|NCT03262233|450030968|FG000|Overall Study|Withdrawal by Subject|12|||
125110916|NCT03262233|450030969|FG001|Overall Study|Withdrawal by Subject|8|||
125110917|NCT03262233|450030970|FG002|Overall Study|Withdrawal by Subject|21|||
124899168|NCT00613301|449255961|FG000|Overall Study|Physician Decision|2|||
124899169|NCT00613301|449255961|FG000|Overall Study|No data was collected|53|||
124899170|NCT00613301|449255961|FG000|Overall Study|Irregularly enrolled patients|12|||
124899171|NCT00569946|449255962|FG000|Overall Study|Adverse Event|16|||
124899172|NCT00569946|449255962|FG000|Overall Study|Objective Progression or Relapse|42|||
124899173|NCT00569946|449255962|FG000|Overall Study|Global Deterioration of Health Status|1|||
124899174|NCT00470626|449255967|FG000|Overall Study|Lost to Follow-up|10|||
124899175|NCT00470626|449255967|FG000|Overall Study|Withdrawal by Subject|7|||
124899176|NCT01801930|449255972|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
124899177|NCT01801930|449255973|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
124899178|NCT01801930|449255974|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
124899179|NCT01801930|449255975|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
124899180|NCT01801930|449255972|FG000|Overall Study|DLT occurs|0|||
124899181|NCT01801930|449255973|FG001|Overall Study|DLT occurs|1|||
124899182|NCT01801930|449255974|FG002|Overall Study|DLT occurs|0|||
124899183|NCT01801930|449255975|FG003|Overall Study|DLT occurs|0|||
124899184|NCT03396835|449255981|FG000|Overall Study|Withdrawn prior to completion|1|||
124899185|NCT03396835|449255981|FG000|Overall Study|Did not meet criteria for data analysis|1|||
124899186|NCT03721016|449255988|FG000|Overall Study|Adverse Event|0|||
124899187|NCT03721016|449255989|FG001|Overall Study|Adverse Event|1|||
124899188|NCT03721016|449255990|FG002|Overall Study|Adverse Event|1|||
124899189|NCT03721016|449255988|FG000|Overall Study|Withdrawal by Subject|8|||
125110918|NCT03262233|450030971|FG003|Overall Study|Withdrawal by Subject|13|||
125110919|NCT03262233|450030968|FG000|Overall Study|Declined due to shock|1|||
125110920|NCT03262233|450030969|FG001|Overall Study|Declined due to shock|2|||
125110921|NCT03262233|450030970|FG002|Overall Study|Declined due to shock|2|||
125110922|NCT03262233|450030971|FG003|Overall Study|Declined due to shock|3|||
125110923|NCT03262233|450030968|FG000|Overall Study|Protocol Violation|5|||
125110924|NCT03262233|450030969|FG001|Overall Study|Protocol Violation|10|||
125110925|NCT03262233|450030970|FG002|Overall Study|Protocol Violation|2|||
125110926|NCT03262233|450030971|FG003|Overall Study|Protocol Violation|13|||
125110927|NCT03262233|450030968|FG000|Overall Study|data collection artifact|0|||
125110928|NCT03262233|450030969|FG001|Overall Study|data collection artifact|1|||
125110929|NCT03262233|450030970|FG002|Overall Study|data collection artifact|0|||
125110930|NCT03262233|450030971|FG003|Overall Study|data collection artifact|0|||
125110931|NCT01120600|450030974|FG000|Overall Study|Adverse Event|7|||
125110932|NCT01120600|450030975|FG001|Overall Study|Adverse Event|7|||
125110933|NCT01120600|450030974|FG000|Overall Study|Excessive Bone Loss|0|||
125110934|NCT01120600|450030975|FG001|Overall Study|Excessive Bone Loss|4|||
125110935|NCT01120600|450030974|FG000|Overall Study|Lost to Follow-up|1|||
125110936|NCT01120600|450030975|FG001|Overall Study|Lost to Follow-up|3|||
125110937|NCT01120600|450030974|FG000|Overall Study|Physician Decision|1|||
125110938|NCT01120600|450030975|FG001|Overall Study|Physician Decision|3|||
125110939|NCT01120600|450030974|FG000|Overall Study|Protocol Violation|0|||
125110940|NCT01120600|450030975|FG001|Overall Study|Protocol Violation|4|||
124899190|NCT03721016|449255989|FG001|Overall Study|Withdrawal by Subject|16|||
124899191|NCT03721016|449255990|FG002|Overall Study|Withdrawal by Subject|13|||
125110941|NCT01120600|450030974|FG000|Overall Study|Withdrawal by Subject|10|||
125110942|NCT01120600|450030975|FG001|Overall Study|Withdrawal by Subject|11|||
125110943|NCT01165242|450030976|FG000|Overall Study|Unreachable Subjects|1|||
125110944|NCT01165242|450030977|FG001|Overall Study|Unreachable Subjects|0|||
125110945|NCT01165242|450030978|FG002|Overall Study|Unreachable Subjects|0|||
125110946|NCT01165242|450030976|FG000|Overall Study|Incarcerated Subjects|0|||
125110947|NCT01165242|450030977|FG001|Overall Study|Incarcerated Subjects|1|||
125110948|NCT01165242|450030978|FG002|Overall Study|Incarcerated Subjects|0|||
124899192|NCT03721016|449255988|FG000|Overall Study|Lost to Follow-up|4|||
124899193|NCT03721016|449255989|FG001|Overall Study|Lost to Follow-up|6|||
124899194|NCT03721016|449255990|FG002|Overall Study|Lost to Follow-up|5|||
125110949|NCT01165242|450030976|FG000|Overall Study|Visit 2 Declined by Subject|0|||
125110950|NCT01165242|450030977|FG001|Overall Study|Visit 2 Declined by Subject|0|||
125110951|NCT01165242|450030978|FG002|Overall Study|Visit 2 Declined by Subject|1|||
125110952|NCT01165242|450030976|FG000|Overall Study|Withdrawal by Subject|0|||
125110953|NCT01165242|450030977|FG001|Overall Study|Withdrawal by Subject|2|||
124899195|NCT03721016|449255988|FG000|Overall Study|Physician Decision|0|||
124899196|NCT03721016|449255989|FG001|Overall Study|Physician Decision|1|||
124899197|NCT03721016|449255990|FG002|Overall Study|Physician Decision|2|||
124899198|NCT03721016|449255988|FG000|Overall Study|Protocol Violation|0|||
124899199|NCT03721016|449255989|FG001|Overall Study|Protocol Violation|1|||
124899200|NCT03721016|449255990|FG002|Overall Study|Protocol Violation|0|||
124899201|NCT03721016|449255988|FG000|Overall Study|Site terminated by sponsor|3|||
124899202|NCT03721016|449255989|FG001|Overall Study|Site terminated by sponsor|7|||
124899203|NCT03721016|449255990|FG002|Overall Study|Site terminated by sponsor|6|||
124899204|NCT03721016|449255988|FG000|Overall Study|Subject exited early due to COVID-19|1|||
124899205|NCT03721016|449255989|FG001|Overall Study|Subject exited early due to COVID-19|0|||
124899206|NCT03721016|449255990|FG002|Overall Study|Subject exited early due to COVID-19|0|||
124899207|NCT02232178|449255991|FG000|Overall Study|Lost to Follow-up|0|||
124899208|NCT02232178|449255992|FG001|Overall Study|Lost to Follow-up|1|||
124899209|NCT02232178|449255993|FG002|Overall Study|Lost to Follow-up|0|||
124899210|NCT02232178|449255991|FG000|Overall Study|ineligibility|0|||
125110954|NCT01165242|450030978|FG002|Overall Study|Withdrawal by Subject|2|||
125110955|NCT01165242|450030976|FG000|Overall Study|Extended Holiday|0|||
125110956|NCT01165242|450030977|FG001|Overall Study|Extended Holiday|0|||
125110957|NCT01165242|450030978|FG002|Overall Study|Extended Holiday|1|||
125110958|NCT01165242|450030976|FG000|Overall Study|Lost to Follow-up|9|||
125110959|NCT01165242|450030977|FG001|Overall Study|Lost to Follow-up|7|||
125110960|NCT01165242|450030978|FG002|Overall Study|Lost to Follow-up|10|||
125110961|NCT03770000|450030979|FG000|Overall Study|Premature discontinuation due to PD|0|||
125110962|NCT03770000|450030980|FG001|Overall Study|Premature discontinuation due to PD|0|||
125110963|NCT03770000|450030981|FG002|Overall Study|Premature discontinuation due to PD|1|||
125110964|NCT03770000|450030982|FG003|Overall Study|Premature discontinuation due to PD|3|||
125110965|NCT03770000|450030983|FG004|Overall Study|Premature discontinuation due to PD|2|||
125110966|NCT03877237|450030984|FG000|Overall Study|Adverse Event|1|||
125110967|NCT03877237|450030985|FG001|Overall Study|Adverse Event|2|||
125110968|NCT03877237|450030984|FG000|Overall Study|Death|3|||
125110969|NCT03877237|450030985|FG001|Overall Study|Death|2|||
125110970|NCT03877237|450030984|FG000|Overall Study|Physician Decision|1|||
125110971|NCT03877237|450030985|FG001|Overall Study|Physician Decision|0|||
125110972|NCT03877237|450030984|FG000|Overall Study|Withdrawal by Subject|0|||
125110973|NCT03877237|450030985|FG001|Overall Study|Withdrawal by Subject|2|||
125110974|NCT00566098|450030987|FG000|Collection of MILs|Withdrawal by Subject|1|||
125110975|NCT00566098|450030987|FG000|Collection of MILs|Relapsed|1|||
125110976|NCT00566098|450030987|FG000|Generation of MILs Product|Relapsed|1|||
125110977|NCT00566098|450030987|FG000|Administration of ASCT+MILs|Death|10|||
125110978|NCT00566098|450030987|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
125110979|NCT02236754|450030988|FG000|Overall Study|Withdrawal by Subject|1|||
125110980|NCT02236754|450030989|FG001|Overall Study|Withdrawal by Subject|0|||
125110981|NCT00382291|450030990|FG000|Overall Study|Adverse Event|1|||
125110982|NCT00382291|450030991|FG001|Overall Study|Adverse Event|2|||
125110983|NCT00382291|450030992|FG002|Overall Study|Adverse Event|2|||
125110984|NCT00382291|450030990|FG000|Overall Study|Protocol Violation|1|||
125110985|NCT00382291|450030991|FG001|Overall Study|Protocol Violation|0|||
125110986|NCT00382291|450030992|FG002|Overall Study|Protocol Violation|0|||
125110987|NCT00382291|450030990|FG000|Overall Study|Temporary study suspension|2|||
125110988|NCT00382291|450030991|FG001|Overall Study|Temporary study suspension|2|||
125110989|NCT00382291|450030992|FG002|Overall Study|Temporary study suspension|5|||
125110990|NCT00382291|450030990|FG000|Overall Study|Withdrawal by Subject|0|||
125110991|NCT00382291|450030991|FG001|Overall Study|Withdrawal by Subject|2|||
125110992|NCT00382291|450030992|FG002|Overall Study|Withdrawal by Subject|0|||
125110993|NCT00382291|450030990|FG000|Overall Study|Physician Decision|0|||
125110994|NCT00382291|450030991|FG001|Overall Study|Physician Decision|1|||
125110995|NCT00382291|450030992|FG002|Overall Study|Physician Decision|0|||
125110996|NCT00382291|450030990|FG000|Overall Study|Lack of Efficacy|0|||
125110997|NCT00382291|450030991|FG001|Overall Study|Lack of Efficacy|0|||
125110998|NCT00382291|450030992|FG002|Overall Study|Lack of Efficacy|1|||
125110999|NCT00265083|450030997|FG000|Overall Study|Adverse Event|5|||
125111000|NCT00265083|450030998|FG001|Overall Study|Adverse Event|13|||
125111001|NCT00265083|450030999|FG002|Overall Study|Adverse Event|15|||
125111002|NCT00265083|450030997|FG000|Overall Study|Lost to Follow-up|3|||
125111003|NCT00265083|450030998|FG001|Overall Study|Lost to Follow-up|4|||
124899211|NCT02232178|449255992|FG001|Overall Study|ineligibility|0|||
124899212|NCT02232178|449255993|FG002|Overall Study|ineligibility|1|||
125111004|NCT00265083|450030999|FG002|Overall Study|Lost to Follow-up|4|||
125111005|NCT00265083|450030997|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
125111006|NCT00265083|450030998|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
125111007|NCT00265083|450030999|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
125111008|NCT00265083|450030997|FG000|Overall Study|Other|1|||
125111009|NCT00265083|450030998|FG001|Overall Study|Other|12|||
125111010|NCT00265083|450030999|FG002|Overall Study|Other|9|||
125111011|NCT04242186|450031000|FG000|Overall Study|Death|5|||
125111012|NCT00534092|450031001|FG000|Overall Study|Lost to Follow-up|1|||
125111013|NCT00534092|450031002|FG001|Overall Study|Lost to Follow-up|0|||
125111014|NCT00534092|450031001|FG000|Overall Study|personal reasons/family concerns|1|||
125111015|NCT00534092|450031002|FG001|Overall Study|personal reasons/family concerns|0|||
125111016|NCT02323295|450031003|FG000|Overall Study|Adverse Event|0|||
125111017|NCT02323295|450031004|FG001|Overall Study|Adverse Event|1|||
125111018|NCT02323295|450031003|FG000|Overall Study|Withdrawal by Subject|0|||
125111019|NCT02323295|450031004|FG001|Overall Study|Withdrawal by Subject|1|||
125111020|NCT02323295|450031003|FG000|Overall Study|Patient did not have surgery as planned.|0|||
125111021|NCT02323295|450031004|FG001|Overall Study|Patient did not have surgery as planned.|1|||
125111022|NCT01155063|450031005|FG000|Overall Study|Adverse Event|1|||
125111023|NCT01155063|450031005|FG000|Overall Study|Withdrawal by Subject|1|||
125111024|NCT01155063|450031005|FG000|Overall Study|Study terminated by sponsor|87|||
125111025|NCT01314703|450031006|FG000|Overall Study|screen failure and closed enrollment|8|||
125111026|NCT02770716|450031013|FG000|Overall Study|Death|101|||
125111027|NCT02770716|450031014|FG001|Overall Study|Death|45|||
125111028|NCT02770716|450031013|FG000|Overall Study|Withdrawal by Subject|4|||
125111029|NCT02770716|450031014|FG001|Overall Study|Withdrawal by Subject|2|||
125111030|NCT02770716|450031013|FG000|Overall Study|Lost to Follow-up|1|||
125111031|NCT02770716|450031014|FG001|Overall Study|Lost to Follow-up|0|||
125111032|NCT02770716|450031013|FG000|Overall Study|Various reasons|6|||
125111033|NCT02770716|450031014|FG001|Overall Study|Various reasons|2|||
125111034|NCT03989115|450031015|FG000|Overall Study|Withdrawal by Subject|2|||
125111035|NCT03989115|450031016|FG001|Overall Study|Withdrawal by Subject|1|||
125111036|NCT03989115|450031017|FG002|Overall Study|Withdrawal by Subject|3|||
125111037|NCT03989115|450031018|FG003|Overall Study|Withdrawal by Subject|0|||
125111038|NCT03989115|450031019|FG004|Overall Study|Withdrawal by Subject|17|||
125111039|NCT03989115|450031020|FG005|Overall Study|Withdrawal by Subject|1|||
125111040|NCT03989115|450031021|FG006|Overall Study|Withdrawal by Subject|0|||
125111041|NCT03989115|450031022|FG007|Overall Study|Withdrawal by Subject|0|||
125111042|NCT03989115|450031015|FG000|Overall Study|Sponsor decision to terminate the study|1|||
125111043|NCT03989115|450031016|FG001|Overall Study|Sponsor decision to terminate the study|1|||
125111044|NCT03989115|450031017|FG002|Overall Study|Sponsor decision to terminate the study|0|||
125111045|NCT03989115|450031018|FG003|Overall Study|Sponsor decision to terminate the study|1|||
125111046|NCT03989115|450031019|FG004|Overall Study|Sponsor decision to terminate the study|11|||
125111047|NCT03989115|450031020|FG005|Overall Study|Sponsor decision to terminate the study|0|||
125111048|NCT03989115|450031021|FG006|Overall Study|Sponsor decision to terminate the study|2|||
125111049|NCT03989115|450031022|FG007|Overall Study|Sponsor decision to terminate the study|1|||
125111050|NCT03989115|450031015|FG000|Overall Study|Lost to Follow-up|2|||
125111051|NCT03989115|450031016|FG001|Overall Study|Lost to Follow-up|0|||
125111052|NCT03989115|450031017|FG002|Overall Study|Lost to Follow-up|0|||
125111053|NCT03989115|450031018|FG003|Overall Study|Lost to Follow-up|0|||
125111054|NCT03989115|450031019|FG004|Overall Study|Lost to Follow-up|1|||
125111055|NCT03989115|450031020|FG005|Overall Study|Lost to Follow-up|0|||
125111056|NCT03989115|450031021|FG006|Overall Study|Lost to Follow-up|0|||
125111057|NCT03989115|450031022|FG007|Overall Study|Lost to Follow-up|0|||
125111058|NCT03989115|450031015|FG000|Overall Study|Death|2|||
125111059|NCT03989115|450031016|FG001|Overall Study|Death|2|||
125111060|NCT03989115|450031017|FG002|Overall Study|Death|9|||
125111061|NCT03989115|450031018|FG003|Overall Study|Death|6|||
125111062|NCT03989115|450031019|FG004|Overall Study|Death|31|||
125111063|NCT03989115|450031020|FG005|Overall Study|Death|6|||
125111064|NCT03989115|450031021|FG006|Overall Study|Death|2|||
125111065|NCT03989115|450031022|FG007|Overall Study|Death|3|||
125111066|NCT03989115|450031015|FG000|Overall Study|Other|1|||
125111067|NCT03989115|450031016|FG001|Overall Study|Other|2|||
125111068|NCT03989115|450031017|FG002|Overall Study|Other|0|||
125111069|NCT03989115|450031018|FG003|Overall Study|Other|0|||
125111070|NCT03989115|450031019|FG004|Overall Study|Other|5|||
125111071|NCT03989115|450031020|FG005|Overall Study|Other|0|||
125111072|NCT03989115|450031021|FG006|Overall Study|Other|0|||
125111073|NCT03989115|450031022|FG007|Overall Study|Other|0|||
125111074|NCT02499354|450031023|FG000|Overall Study|Withdrawal by Subject|1|||
125111075|NCT02499354|450031024|FG001|Overall Study|Withdrawal by Subject|0|||
125111076|NCT01759381|450031028|FG000|Overall Study|Death|1|||
125111077|NCT01759381|450031029|FG001|Overall Study|Death|0|||
125111078|NCT00447603|450031031|FG000|Screening|Withdrawal by Subject|1|||
125111079|NCT00447603|450031032|FG001|Screening|Withdrawal by Subject|0|||
125111080|NCT00447603|450031033|FG002|Screening|Withdrawal by Subject|0|||
125111081|NCT00447603|450031031|FG000|Screening|Protocol Violation|1|||
125111082|NCT00447603|450031032|FG001|Screening|Protocol Violation|0|||
125111083|NCT00447603|450031033|FG002|Screening|Protocol Violation|0|||
125111084|NCT00447603|450031031|FG000|Screening|Screen Failure|4|||
125111085|NCT00447603|450031032|FG001|Screening|Screen Failure|0|||
125111086|NCT00447603|450031033|FG002|Screening|Screen Failure|0|||
125111087|NCT00447603|450031031|FG000|Screening|Study Terminated by Sponsor|15|||
125111088|NCT00447603|450031032|FG001|Screening|Study Terminated by Sponsor|0|||
125111089|NCT00447603|450031033|FG002|Screening|Study Terminated by Sponsor|0|||
125111090|NCT00447603|450031031|FG000|Filter Period|Adverse Event|0|||
125111091|NCT00447603|450031032|FG001|Filter Period|Adverse Event|0|||
125111092|NCT00447603|450031033|FG002|Filter Period|Adverse Event|1|||
125111093|NCT00447603|450031031|FG000|Filter Period|Screen Failure|0|||
125111094|NCT00447603|450031032|FG001|Filter Period|Screen Failure|3|||
125111095|NCT00447603|450031033|FG002|Filter Period|Screen Failure|4|||
125111096|NCT00447603|450031031|FG000|Filter Period|Study terminated by Sponsor|0|||
125111097|NCT00447603|450031032|FG001|Filter Period|Study terminated by Sponsor|1|||
125111098|NCT00447603|450031033|FG002|Filter Period|Study terminated by Sponsor|10|||
125111099|NCT02410837|450031038|FG000|Overall Study|Death|387|||
125111100|NCT02410837|450031038|FG000|Overall Study|Lost to Follow-up|50|||
125111101|NCT02410837|450031038|FG000|Overall Study|Withdrawal by Subject|44|||
125111102|NCT02410837|450031038|FG000|Overall Study|Physician Decision|6|||
125111103|NCT02410837|450031038|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
125111104|NCT00106028|450031046|FG000|Overall Study|Adverse Event|3|||
124899213|NCT02232178|449255991|FG000|Overall Study|surgical complication|1|||
124899214|NCT02232178|449255992|FG001|Overall Study|surgical complication|0|||
125019486|NCT02703311|449694744|FG000|Overall Study|Death|5|||
125019487|NCT02703311|449694744|FG000|Overall Study|Withdrawal by Subject|3|||
125019488|NCT02069899|449694745|FG000|Overall Study|Adverse Event|6|||
125019489|NCT02069899|449694746|FG001|Overall Study|Adverse Event|0|||
125019490|NCT02069899|449694747|FG002|Overall Study|Adverse Event|1|||
125019491|NCT02069899|449694745|FG000|Overall Study|Withdrawal by Participant|2|||
125019492|NCT02069899|449694746|FG001|Overall Study|Withdrawal by Participant|0|||
125019493|NCT02069899|449694747|FG002|Overall Study|Withdrawal by Participant|0|||
125019494|NCT02069899|449694745|FG000|Overall Study|Lost to Follow-up|1|||
125019495|NCT02069899|449694746|FG001|Overall Study|Lost to Follow-up|0|||
125019496|NCT02069899|449694747|FG002|Overall Study|Lost to Follow-up|1|||
125019497|NCT02069899|449694745|FG000|Overall Study|Other|4|||
125019498|NCT02069899|449694746|FG001|Overall Study|Other|0|||
125019499|NCT02069899|449694747|FG002|Overall Study|Other|0|||
125019500|NCT02069899|449694745|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
125019501|NCT02069899|449694746|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
125019502|NCT02069899|449694747|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
125019503|NCT02069899|449694745|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
125019504|NCT02069899|449694746|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
125019505|NCT02069899|449694747|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
125019506|NCT04417894|449694750|FG000|Overall Study|Lost to Follow-up|3|||
125019507|NCT04417894|449694751|FG001|Overall Study|Lost to Follow-up|0|||
125019508|NCT04417894|449694750|FG000|Overall Study|Withdrawal by Subject|7|||
125019509|NCT04417894|449694751|FG001|Overall Study|Withdrawal by Subject|6|||
125019510|NCT04417894|449694750|FG000|Overall Study|Lack of Efficacy|3|||
125019511|NCT04417894|449694751|FG001|Overall Study|Lack of Efficacy|1|||
125019512|NCT00262873|449694752|FG000|Overall Study|Adverse Event|3|||
125019513|NCT00262873|449694752|FG000|Overall Study|Withdrawal by Subject|5|||
125019514|NCT03440814|449694753|FG000|Overall Study|Adverse Event|2|||
125019515|NCT03440814|449694754|FG001|Overall Study|Adverse Event|1|||
125019516|NCT03440814|449694753|FG000|Overall Study|Lost to Follow-up|2|||
125019517|NCT03440814|449694754|FG001|Overall Study|Lost to Follow-up|0|||
125019518|NCT03440814|449694753|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
125019519|NCT03440814|449694754|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
125019520|NCT02678390|449694755|FG000|AE (1 Day)|Withdrawal by Subject|0|||
125019521|NCT02678390|449694756|FG001|AE (1 Day)|Withdrawal by Subject|1|||
125019522|NCT01632566|449694757|FG000|Overall Study|Withdrawal by Subject|0|||
125019523|NCT01632566|449694758|FG001|Overall Study|Withdrawal by Subject|1|||
125019524|NCT01632566|449694759|FG002|Overall Study|Withdrawal by Subject|0|||
125019525|NCT01632566|449694760|FG003|Overall Study|Withdrawal by Subject|0|||
125019526|NCT01632566|449694761|FG004|Overall Study|Withdrawal by Subject|0|||
125019527|NCT01632566|449694757|FG000|Overall Study|Sponsor Decision|0|||
125019528|NCT01632566|449694758|FG001|Overall Study|Sponsor Decision|2|||
125019529|NCT01632566|449694759|FG002|Overall Study|Sponsor Decision|9|||
125019530|NCT01632566|449694760|FG003|Overall Study|Sponsor Decision|2|||
125019531|NCT01632566|449694761|FG004|Overall Study|Sponsor Decision|2|||
125019532|NCT01318109|449694762|FG000|Overall Study|Adverse Event|0|||
125019533|NCT01318109|449694763|FG001|Overall Study|Adverse Event|2|||
125019534|NCT01318109|449694764|FG002|Overall Study|Adverse Event|0|||
125019535|NCT01318109|449694762|FG000|Overall Study|Withdrawal by Subject|1|||
125019536|NCT01318109|449694763|FG001|Overall Study|Withdrawal by Subject|0|||
125019537|NCT01318109|449694764|FG002|Overall Study|Withdrawal by Subject|0|||
125019538|NCT01318109|449694762|FG000|Overall Study|Schedule Conflict|0|||
125019539|NCT01318109|449694763|FG001|Overall Study|Schedule Conflict|1|||
125019540|NCT01318109|449694764|FG002|Overall Study|Schedule Conflict|0|||
125019541|NCT00264238|449694766|FG000|Overall Study|Protocol Violation|1|||
125019542|NCT01411085|449694767|FG000|Overall Study|Physician Decision|1|||
125019543|NCT01411085|449694767|FG000|Overall Study|Protocol Violation|1|||
125019544|NCT01411085|449694767|FG000|Overall Study|Adverse Event|1|||
125019545|NCT02193074|449694768|FG000|Overall Study|Withdrawal by Subject|1|||
125019546|NCT02193074|449694769|FG001|Overall Study|Withdrawal by Subject|2|||
125019547|NCT02193074|449694768|FG000|Overall Study|Adverse Event|16|||
125019548|NCT02193074|449694769|FG001|Overall Study|Adverse Event|13|||
125019549|NCT01534533|449694770|FG000|Overall Study|Lost to Follow-up|3|||
125019550|NCT01534533|449694771|FG001|Overall Study|Lost to Follow-up|0|||
125111105|NCT00106028|450031047|FG001|Overall Study|Adverse Event|2|||
125019551|NCT01534533|449694772|FG002|Overall Study|Lost to Follow-up|4|||
125019552|NCT01534533|449694773|FG003|Overall Study|Lost to Follow-up|3|||
125019553|NCT01534533|449694770|FG000|Overall Study|Withdrawal by Subject|5|||
125019554|NCT01534533|449694771|FG001|Overall Study|Withdrawal by Subject|3|||
125019555|NCT01534533|449694772|FG002|Overall Study|Withdrawal by Subject|4|||
125111106|NCT00106028|450031046|FG000|Overall Study|Protocol Violation|1|||
125111107|NCT00106028|450031047|FG001|Overall Study|Protocol Violation|1|||
125111108|NCT00106028|450031046|FG000|Overall Study|Withdrawal by Subject|2|||
125111109|NCT00106028|450031047|FG001|Overall Study|Withdrawal by Subject|8|||
125111110|NCT00106028|450031046|FG000|Overall Study|Lost to Follow-up|0|||
125111111|NCT00106028|450031047|FG001|Overall Study|Lost to Follow-up|1|||
125111112|NCT01280981|450031048|FG000|Overall Study|Withdrawal by Subject|11|||
125111113|NCT01280981|450031048|FG000|Overall Study|Protocol Violation|2|||
125111114|NCT01280981|450031048|FG000|Overall Study|Lack of Efficacy|13|||
125111115|NCT01280981|450031048|FG000|Overall Study|Lost to Follow-up|3|||
125111116|NCT01280981|450031048|FG000|Overall Study|Adverse Event|6|||
125111117|NCT01280981|450031048|FG000|Overall Study|Irregular or discontinued menses|3|||
125111118|NCT01280981|450031048|FG000|Overall Study|Failed to return|45|||
125111119|NCT01280981|450031048|FG000|Overall Study|Non-compliance with protocol|3|||
125111120|NCT01280981|450031048|FG000|Overall Study|Withdrawal of consent|3|||
125111121|NCT01280981|450031048|FG000|Overall Study|Elective surgery|2|||
125111122|NCT01280981|450031048|FG000|Overall Study|Study site closure|1|||
125111123|NCT01256398|450031050|FG000|Overall Study|Withdrawal by Subject|1|||
125111124|NCT01238211|450031051|FG000|Overall Study|Continues active treatment|31|||
125111125|NCT01238211|450031051|FG000|Overall Study|Adverse Event|7|||
125111126|NCT01238211|450031051|FG000|Overall Study|Death|4|||
125111127|NCT01238211|450031051|FG000|Overall Study|Relapse/Progression|2|||
125111128|NCT01238211|450031051|FG000|Overall Study|Withdrawal by Subject|7|||
125111129|NCT01238211|450031051|FG000|Overall Study|Non-protocol treatment|4|||
125111130|NCT01238211|450031051|FG000|Overall Study|Investigator/Patient Decision|3|||
125111131|NCT04428502|450031052|FG000|Overall Study|Did not meet entrance criteria|14|||
125111132|NCT03550794|450031055|FG000|Overall Study|No longer met inclusion criteria|1|||
125111133|NCT03550794|450031056|FG001|Overall Study|No longer met inclusion criteria|2|||
125111134|NCT03550794|450031055|FG000|Overall Study|Goals of care changed|1|||
125111135|NCT03550794|450031056|FG001|Overall Study|Goals of care changed|0|||
125111136|NCT03550794|450031055|FG000|Overall Study|Withdrawal by Subject|2|||
125111137|NCT03550794|450031056|FG001|Overall Study|Withdrawal by Subject|0|||
125111138|NCT03550794|450031055|FG000|Overall Study|Death|0|||
125111139|NCT03550794|450031056|FG001|Overall Study|Death|1|||
125111140|NCT00449930|450031057|FG000|Overall Study|Adverse Event|9|||
125111141|NCT00449930|450031058|FG001|Overall Study|Adverse Event|19|||
125111142|NCT00449930|450031057|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
125111143|NCT00449930|450031058|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
125111144|NCT00449930|450031057|FG000|Overall Study|Lack of Efficacy|10|||
125111145|NCT00449930|450031058|FG001|Overall Study|Lack of Efficacy|1|||
125111146|NCT00449930|450031057|FG000|Overall Study|Lost to Follow-up|9|||
125111147|NCT00449930|450031058|FG001|Overall Study|Lost to Follow-up|14|||
125111148|NCT00449930|450031057|FG000|Overall Study|Physician Decision|1|||
125111149|NCT00449930|450031058|FG001|Overall Study|Physician Decision|2|||
125111150|NCT00449930|450031057|FG000|Overall Study|Protocol Violation|14|||
125111151|NCT00449930|450031058|FG001|Overall Study|Protocol Violation|15|||
125111152|NCT00449930|450031057|FG000|Overall Study|Withdrawal by Subject|16|||
125111153|NCT00449930|450031058|FG001|Overall Study|Withdrawal by Subject|23|||
125111154|NCT00449930|450031057|FG000|Overall Study|Glycemic discontinuation criteria|1|||
125111155|NCT00449930|450031058|FG001|Overall Study|Glycemic discontinuation criteria|1|||
125111156|NCT01864525|450031059|FG000|Overall Study|Adverse Event|1|||
125111157|NCT01864525|450031060|FG001|Overall Study|Adverse Event|0|||
125111158|NCT03712228|450031061|FG000|Treatment Period 1|Lack of Efficacy|0|||
125111159|NCT03712228|450031062|FG001|Treatment Period 1|Lack of Efficacy|0|||
125111160|NCT03712228|450031063|FG002|Treatment Period 1|Lack of Efficacy|0|||
125111161|NCT03712228|450031064|FG003|Treatment Period 1|Lack of Efficacy|0|||
125111162|NCT03712228|450031065|FG004|Treatment Period 1|Lack of Efficacy|0|||
125111163|NCT03712228|450031066|FG005|Treatment Period 1|Lack of Efficacy|1|||
125111164|NCT03712228|450031061|FG000|Treatment Period 2|Pregnancy|0|||
125111165|NCT03712228|450031062|FG001|Treatment Period 2|Pregnancy|0|||
125111166|NCT03712228|450031063|FG002|Treatment Period 2|Pregnancy|0|||
125111167|NCT03712228|450031064|FG003|Treatment Period 2|Pregnancy|1|||
125111168|NCT03712228|450031065|FG004|Treatment Period 2|Pregnancy|0|||
125111169|NCT03712228|450031066|FG005|Treatment Period 2|Pregnancy|0|||
125111170|NCT03712228|450031061|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125111171|NCT03712228|450031062|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125111172|NCT03712228|450031063|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125111173|NCT03712228|450031064|FG003|Treatment Period 2|Withdrawal by Subject|1|||
125111174|NCT03712228|450031065|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125111175|NCT03712228|450031066|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125111176|NCT02295280|450031067|FG000|Overall Study|Adverse Event|0|||
125111177|NCT02295280|450031068|FG001|Overall Study|Adverse Event|1|||
125111178|NCT03001011|450031069|FG000|Overall Study|Adverse Event|9|||
125111179|NCT03001011|450031070|FG001|Overall Study|Adverse Event|3|||
125111180|NCT03001011|450031069|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
125111181|NCT03001011|450031070|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
125111182|NCT03001011|450031069|FG000|Overall Study|Other than specified above|3|||
125111183|NCT03001011|450031070|FG001|Overall Study|Other than specified above|8|||
125111184|NCT02875067|450031071|FG000|Overall Study|Withdrawal by Subject|1|||
125111185|NCT02875067|450031071|FG000|Overall Study|Withdrawal by Termination of Study|5|||
125111186|NCT00065065|450031072|FG000|Overall Study|Adverse Event|3|||
125111187|NCT00065065|450031073|FG001|Overall Study|Adverse Event|2|||
125111188|NCT00065065|450031072|FG000|Overall Study|Withdrawal by Subject|1|||
125111189|NCT00065065|450031073|FG001|Overall Study|Withdrawal by Subject|5|||
125111190|NCT00065065|450031072|FG000|Overall Study|Lack of Efficacy|4|||
125111191|NCT00065065|450031073|FG001|Overall Study|Lack of Efficacy|11|||
125111192|NCT00065065|450031072|FG000|Overall Study|Other|2|||
125111193|NCT00065065|450031073|FG001|Overall Study|Other|2|||
125111194|NCT05288673|450031075|FG000|Overall Study|Consent withdrawn by subject|0|||
125111195|NCT05288673|450031076|FG001|Overall Study|Consent withdrawn by subject|0|||
125111196|NCT05288673|450031077|FG002|Overall Study|Consent withdrawn by subject|1|||
125111197|NCT01050673|450031078|FG000|Overall Study|Physician Decision|4|||
125111198|NCT01050673|450031079|FG001|Overall Study|Physician Decision|5|||
125111199|NCT03056352|450031080|FG000|Overall Study|Lost to Follow-up|1|||
125111200|NCT01254045|450031085|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
125111201|NCT01254045|450031086|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
125111202|NCT01254045|450031087|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
125111203|NCT01254045|450031088|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
125111204|NCT01254045|450031089|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
125111205|NCT01254045|450031090|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
125111206|NCT02971605|450031091|FG000|Overall Study|Withdrawal by Subject|1|||
125111207|NCT00597207|450031092|FG000|Overall Study|Lost to Follow-up|5|||
125111208|NCT00597207|450031093|FG001|Overall Study|Lost to Follow-up|7|||
125111209|NCT00520351|450031094|FG000|First Intervention|Withdrawal by Subject|1|||
125111210|NCT00520351|450031095|FG001|First Intervention|Withdrawal by Subject|1|||
125111211|NCT01298596|450031100|FG000|Overall Study|Withdrawal by Subject|1|||
125111212|NCT01298596|450031101|FG001|Overall Study|Withdrawal by Subject|1|||
125111213|NCT01298596|450031100|FG000|Overall Study|Death|5|||
125111214|NCT01298596|450031101|FG001|Overall Study|Death|3|||
125111215|NCT01298596|450031100|FG000|Overall Study|Lost to Follow-up|6|||
125111216|NCT01298596|450031101|FG001|Overall Study|Lost to Follow-up|14|||
125111217|NCT01298596|450031100|FG000|Overall Study|Referred for further management|16|||
125111218|NCT01298596|450031101|FG001|Overall Study|Referred for further management|15|||
125111219|NCT04128696|450031102|FG000|Overall Study|Lost to Follow-up|3|||
125111220|NCT04128696|450031103|FG001|Overall Study|Lost to Follow-up|7|||
125111221|NCT04128696|450031102|FG000|Overall Study|Withdrawal by Subject|12|||
125111222|NCT04128696|450031103|FG001|Overall Study|Withdrawal by Subject|11|||
125111223|NCT04128696|450031102|FG000|Overall Study|Study Closed/Terminated|26|||
125111224|NCT04128696|450031103|FG001|Overall Study|Study Closed/Terminated|38|||
125111225|NCT04128696|450031102|FG000|Overall Study|Physician Decision|2|||
125111226|NCT04128696|450031103|FG001|Overall Study|Physician Decision|3|||
125111227|NCT00585039|450031104|FG000|Overall Study|medication spilled|2|||
125111228|NCT00585039|450031105|FG001|Overall Study|medication spilled|0|||
125111229|NCT02133352|450031114|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
125111230|NCT00579254|450031115|FG000|Overall Study|Lost to Follow-up|39|||
125111231|NCT00579254|450031115|FG000|Overall Study|Discontinued when study terminated|73|||
125111232|NCT02557672|450031116|FG000|Overall Study|Withdrawal by Subject|4|||
125111233|NCT02557672|450031117|FG001|Overall Study|Withdrawal by Subject|2|||
125111234|NCT03705169|450031118|FG000|Overall Study|Lost to Follow-up|0|||
125111235|NCT03705169|450031119|FG001|Overall Study|Lost to Follow-up|0|||
125111236|NCT03705169|450031120|FG002|Overall Study|Lost to Follow-up|0|||
125111237|NCT03705169|450031121|FG003|Overall Study|Lost to Follow-up|2|||
125111238|NCT03705169|450031122|FG004|Overall Study|Lost to Follow-up|0|||
125111239|NCT03705169|450031123|FG005|Overall Study|Lost to Follow-up|2|||
125111240|NCT03705169|450031124|FG006|Overall Study|Lost to Follow-up|1|||
125111241|NCT03705169|450031125|FG007|Overall Study|Lost to Follow-up|0|||
125111242|NCT03705169|450031126|FG008|Overall Study|Lost to Follow-up|0|||
125111243|NCT03705169|450031127|FG009|Overall Study|Lost to Follow-up|1|||
125111244|NCT03705169|450031118|FG000|Overall Study|Adverse Event|0|||
125111245|NCT03705169|450031119|FG001|Overall Study|Adverse Event|0|||
125111246|NCT03705169|450031120|FG002|Overall Study|Adverse Event|0|||
125111247|NCT03705169|450031121|FG003|Overall Study|Adverse Event|1|||
125111248|NCT03705169|450031122|FG004|Overall Study|Adverse Event|0|||
125111249|NCT03705169|450031123|FG005|Overall Study|Adverse Event|0|||
125111250|NCT03705169|450031124|FG006|Overall Study|Adverse Event|0|||
125111251|NCT03705169|450031125|FG007|Overall Study|Adverse Event|0|||
125111252|NCT03705169|450031126|FG008|Overall Study|Adverse Event|0|||
125111253|NCT03705169|450031127|FG009|Overall Study|Adverse Event|0|||
125111254|NCT03705169|450031118|FG000|Overall Study|Site Closure|0|||
125111255|NCT03705169|450031119|FG001|Overall Study|Site Closure|0|||
125111256|NCT03705169|450031120|FG002|Overall Study|Site Closure|0|||
125111257|NCT03705169|450031121|FG003|Overall Study|Site Closure|1|||
125111258|NCT03705169|450031122|FG004|Overall Study|Site Closure|0|||
125111259|NCT03705169|450031123|FG005|Overall Study|Site Closure|0|||
125111260|NCT03705169|450031124|FG006|Overall Study|Site Closure|0|||
125111261|NCT03705169|450031125|FG007|Overall Study|Site Closure|0|||
125111262|NCT03705169|450031126|FG008|Overall Study|Site Closure|0|||
125111263|NCT03705169|450031127|FG009|Overall Study|Site Closure|0|||
125111264|NCT03705169|450031118|FG000|Overall Study|Did not receive study treatment|0|||
125111265|NCT03705169|450031119|FG001|Overall Study|Did not receive study treatment|0|||
125111266|NCT03705169|450031120|FG002|Overall Study|Did not receive study treatment|0|||
125111267|NCT03705169|450031121|FG003|Overall Study|Did not receive study treatment|1|||
125111268|NCT03705169|450031122|FG004|Overall Study|Did not receive study treatment|0|||
125111269|NCT03705169|450031123|FG005|Overall Study|Did not receive study treatment|0|||
125111270|NCT03705169|450031124|FG006|Overall Study|Did not receive study treatment|0|||
125111271|NCT03705169|450031125|FG007|Overall Study|Did not receive study treatment|0|||
125111272|NCT03705169|450031126|FG008|Overall Study|Did not receive study treatment|0|||
125111273|NCT03705169|450031127|FG009|Overall Study|Did not receive study treatment|0|||
125210782|NCT02134353|450395685|FG001|Overall Study|Lost to Follow-up|1|||
125019556|NCT01534533|449694773|FG003|Overall Study|Withdrawal by Subject|1|||
125019557|NCT00691483|449696315|FG000|Overall Study|Adverse Event|14|||
125019558|NCT00691483|449696316|FG001|Overall Study|Adverse Event|6|||
125019559|NCT00691483|449696315|FG000|Overall Study|Lost to Follow-up|17|||
125019560|NCT00691483|449696316|FG001|Overall Study|Lost to Follow-up|10|||
125019561|NCT00691483|449696315|FG000|Overall Study|Withdrawal by Subject|24|||
125019562|NCT00691483|449696316|FG001|Overall Study|Withdrawal by Subject|7|||
125019563|NCT00691483|449696315|FG000|Overall Study|Other known cause|6|||
125019564|NCT00691483|449696316|FG001|Overall Study|Other known cause|1|||
125019565|NCT00691483|449696315|FG000|Overall Study|Randomized by not treated|7|||
125019566|NCT00691483|449696316|FG001|Overall Study|Randomized by not treated|1|||
125019567|NCT01391000|449696318|FG000|Overall Study|Lost to Follow-up|2|||
125019568|NCT01391000|449696319|FG001|Overall Study|Lost to Follow-up|0|||
125019569|NCT00049673|449696320|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
125019570|NCT00049673|449696321|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
125019571|NCT00817531|449696322|FG000|Overall Study|Adverse Event|1|||
125019572|NCT00817531|449696322|FG000|Overall Study|Lack of Efficacy|1|||
125019573|NCT02475681|449696323|FG000|Overall Study|Death|16|||
125019574|NCT02475681|449696324|FG001|Overall Study|Death|6|||
125019575|NCT02475681|449696325|FG002|Overall Study|Death|9|||
125019576|NCT02475681|449696323|FG000|Overall Study|Physician Decision|0|||
125019577|NCT02475681|449696324|FG001|Overall Study|Physician Decision|3|||
125019578|NCT02475681|449696325|FG002|Overall Study|Physician Decision|1|||
125019579|NCT02475681|449696323|FG000|Overall Study|Withdrawal by Subject|12|||
125019580|NCT02475681|449696324|FG001|Overall Study|Withdrawal by Subject|6|||
125019581|NCT02475681|449696325|FG002|Overall Study|Withdrawal by Subject|9|||
125019582|NCT02475681|449696323|FG000|Overall Study|Lost to Follow-up|2|||
125019583|NCT02475681|449696324|FG001|Overall Study|Lost to Follow-up|1|||
125019584|NCT02475681|449696325|FG002|Overall Study|Lost to Follow-up|3|||
125019585|NCT02475681|449696323|FG000|Overall Study|Ongoing in Study|0|||
125019586|NCT02475681|449696324|FG001|Overall Study|Ongoing in Study|163|||
125019587|NCT02475681|449696325|FG002|Overall Study|Ongoing in Study|157|||
125019588|NCT02475681|449696323|FG000|Overall Study|Reasons other than above listed|2|||
125019589|NCT02475681|449696324|FG001|Overall Study|Reasons other than above listed|0|||
125019590|NCT02475681|449696325|FG002|Overall Study|Reasons other than above listed|0|||
125019591|NCT03325673|449696337|FG000|Overall Study|Adverse Event|4|||
125019592|NCT03325673|449696338|FG001|Overall Study|Adverse Event|0|||
125019593|NCT00590590|449696339|FG000|Overall Study|Lack of Efficacy|1|||
125019594|NCT00590590|449696340|FG001|Overall Study|Lack of Efficacy|2|||
125019595|NCT00590590|449696341|FG002|Overall Study|Lack of Efficacy|0|||
125019596|NCT00590590|449696339|FG000|Overall Study|Adverse Event|1|||
125019597|NCT00590590|449696340|FG001|Overall Study|Adverse Event|0|||
125019598|NCT00590590|449696341|FG002|Overall Study|Adverse Event|0|||
125019599|NCT00590590|449696339|FG000|Overall Study|Protocol Violation|0|||
125019600|NCT00590590|449696340|FG001|Overall Study|Protocol Violation|0|||
125019601|NCT00590590|449696341|FG002|Overall Study|Protocol Violation|2|||
125019602|NCT00590590|449696339|FG000|Overall Study|Lost to Follow-up|4|||
125019603|NCT00590590|449696340|FG001|Overall Study|Lost to Follow-up|1|||
125019604|NCT00590590|449696341|FG002|Overall Study|Lost to Follow-up|2|||
125019605|NCT00590590|449696339|FG000|Overall Study|Withdrawal by Subject|0|||
125019606|NCT00590590|449696340|FG001|Overall Study|Withdrawal by Subject|1|||
125019607|NCT00590590|449696341|FG002|Overall Study|Withdrawal by Subject|1|||
125019608|NCT00590590|449696339|FG000|Overall Study|Did not complete due to study closure|1|||
125019609|NCT00590590|449696340|FG001|Overall Study|Did not complete due to study closure|1|||
125019610|NCT00590590|449696341|FG002|Overall Study|Did not complete due to study closure|1|||
125019611|NCT00590590|449696339|FG000|Overall Study|Did not complete study|0|||
125019612|NCT00590590|449696340|FG001|Overall Study|Did not complete study|1|||
125019613|NCT00590590|449696341|FG002|Overall Study|Did not complete study|0|||
125019614|NCT00132132|449696344|FG000|Overall Study|Lost to Follow-up|7|||
125019615|NCT00132132|449696345|FG001|Overall Study|Lost to Follow-up|2|||
125019616|NCT00494091|449696346|FG000|Overall Study|Death|5|||
125019617|NCT00494091|449696347|FG001|Overall Study|Death|54|||
125019618|NCT00494091|449696346|FG000|Overall Study|Lost to Follow-up|0|||
125019619|NCT00494091|449696347|FG001|Overall Study|Lost to Follow-up|4|||
125019620|NCT00494091|449696346|FG000|Overall Study|Other|1|||
125019621|NCT00494091|449696347|FG001|Overall Study|Other|11|||
125019622|NCT00494091|449696346|FG000|Overall Study|Withdrawal by Subject|0|||
125019623|NCT00494091|449696347|FG001|Overall Study|Withdrawal by Subject|7|||
125019624|NCT00452699|449696350|FG000|Overall Study|Adverse Event|10|||
125019625|NCT00452699|449696351|FG001|Overall Study|Adverse Event|3|||
125019626|NCT00452699|449696350|FG000|Overall Study|Lack of Efficacy|6|||
125019627|NCT00452699|449696351|FG001|Overall Study|Lack of Efficacy|4|||
125019628|NCT00452699|449696350|FG000|Overall Study|Lost to Follow-up|6|||
125019629|NCT00452699|449696351|FG001|Overall Study|Lost to Follow-up|9|||
125019630|NCT00452699|449696350|FG000|Overall Study|Protocol Violation|21|||
125019631|NCT00452699|449696351|FG001|Overall Study|Protocol Violation|25|||
125019632|NCT00452699|449696350|FG000|Overall Study|Withdrawal by Subject|26|||
125019633|NCT00452699|449696351|FG001|Overall Study|Withdrawal by Subject|25|||
125019634|NCT00452699|449696350|FG000|Overall Study|Other|12|||
125019635|NCT00452699|449696351|FG001|Overall Study|Other|7|||
125019636|NCT00326898|449696352|FG000|Overall Study|Disease progression|52|||
125019637|NCT00326898|449696353|FG001|Overall Study|Disease progression|54|||
125019638|NCT00326898|449696354|FG002|Overall Study|Disease progression|102|||
125019639|NCT00326898|449696352|FG000|Overall Study|Adverse Event|124|||
125019640|NCT00326898|449696353|FG001|Overall Study|Adverse Event|128|||
125019641|NCT00326898|449696354|FG002|Overall Study|Adverse Event|33|||
125019642|NCT00326898|449696352|FG000|Overall Study|Death|2|||
125019643|NCT00326898|449696353|FG001|Overall Study|Death|0|||
125019644|NCT00326898|449696354|FG002|Overall Study|Death|0|||
125019645|NCT00326898|449696352|FG000|Overall Study|Withdrawal by Subject|134|||
125019646|NCT00326898|449696353|FG001|Overall Study|Withdrawal by Subject|128|||
125019647|NCT00326898|449696354|FG002|Overall Study|Withdrawal by Subject|32|||
125019648|NCT00326898|449696352|FG000|Overall Study|Alternative therapy|1|||
125019649|NCT00326898|449696353|FG001|Overall Study|Alternative therapy|0|||
125019650|NCT00326898|449696354|FG002|Overall Study|Alternative therapy|0|||
125019651|NCT00326898|449696352|FG000|Overall Study|Other complicating disease|5|||
125019652|NCT00326898|449696353|FG001|Overall Study|Other complicating disease|5|||
125019653|NCT00326898|449696354|FG002|Overall Study|Other complicating disease|4|||
125019654|NCT00326898|449696352|FG000|Overall Study|Other/Missing/Unknown|33|||
125019655|NCT00326898|449696353|FG001|Overall Study|Other/Missing/Unknown|28|||
125019656|NCT00326898|449696354|FG002|Overall Study|Other/Missing/Unknown|32|||
125019657|NCT03847987|449696355|FG000|Overall Study|Lost to Follow-up|1|||
125019658|NCT03847987|449696356|FG001|Overall Study|Lost to Follow-up|0|||
125019659|NCT03847987|449696355|FG000|Overall Study|Adverse Event|2|||
125019660|NCT03847987|449696356|FG001|Overall Study|Adverse Event|0|||
125019661|NCT03733392|449696362|FG000|Overall Study|Withdrawal by Subject|11|||
125019662|NCT03733392|449696363|FG001|Overall Study|Withdrawal by Subject|1|||
125019663|NCT03733392|449696362|FG000|Overall Study|Death|1|||
125019664|NCT03733392|449696363|FG001|Overall Study|Death|0|||
125019665|NCT03733392|449696362|FG000|Overall Study|Lost to Follow-up|5|||
125019666|NCT03733392|449696363|FG001|Overall Study|Lost to Follow-up|0|||
125019667|NCT03733392|449696362|FG000|Overall Study|Protocol Violation|0|||
125019668|NCT03733392|449696363|FG001|Overall Study|Protocol Violation|1|||
125019669|NCT03733392|449696362|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
125019670|NCT03733392|449696363|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
125019671|NCT03733392|449696362|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
125019672|NCT03733392|449696363|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
125019673|NCT03733392|449696362|FG000|Overall Study|Patient Non-Compliance|2|||
125019674|NCT03733392|449696363|FG001|Overall Study|Patient Non-Compliance|1|||
125019675|NCT03733392|449696362|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
125019676|NCT03733392|449696363|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
125019677|NCT03733392|449696362|FG000|Overall Study|Withdrawal prior to procedure|5|||
125019678|NCT03733392|449696363|FG001|Overall Study|Withdrawal prior to procedure|2|||
125019679|NCT02615990|449696369|FG000|Overall Study|study terminated|1|||
125019680|NCT02615990|449696370|FG001|Overall Study|study terminated|1|||
125019681|NCT01363986|449696371|FG000|Overall Study|Disease progression|1|||
125019682|NCT01637142|449696372|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
125019683|NCT02111564|449696373|FG000|Overall Study|Death|109|||
125019684|NCT02111564|449696374|FG001|Overall Study|Death|120|||
125019685|NCT02111564|449696373|FG000|Overall Study|Lost to Follow-up|2|||
125019686|NCT02111564|449696374|FG001|Overall Study|Lost to Follow-up|3|||
125019687|NCT02111564|449696373|FG000|Overall Study|Withdrawal by Subject|20|||
125019688|NCT02111564|449696374|FG001|Overall Study|Withdrawal by Subject|20|||
125019689|NCT00687362|449696375|FG000|Overall Study|Protocol Violation|2|||
125019690|NCT00687362|449696375|FG000|Overall Study|Withdrawal by Subject|1|||
125019691|NCT02354703|449696376|FG000|Overall Study|Withdrawal by Subject|1|||
125019692|NCT02354703|449696377|FG001|Overall Study|Withdrawal by Subject|1|||
125019693|NCT02354703|449696378|FG002|Overall Study|Withdrawal by Subject|1|||
125019694|NCT02354703|449696379|FG003|Overall Study|Withdrawal by Subject|1|||
125019695|NCT02354703|449696376|FG000|Overall Study|Lost to Follow-up|2|||
125019696|NCT02354703|449696377|FG001|Overall Study|Lost to Follow-up|7|||
125019697|NCT02354703|449696378|FG002|Overall Study|Lost to Follow-up|9|||
125019698|NCT02354703|449696379|FG003|Overall Study|Lost to Follow-up|2|||
125019699|NCT02354703|449696376|FG000|Overall Study|Adverse Event|0|||
125019700|NCT02354703|449696377|FG001|Overall Study|Adverse Event|0|||
125019701|NCT02354703|449696378|FG002|Overall Study|Adverse Event|1|||
125019702|NCT02354703|449696379|FG003|Overall Study|Adverse Event|0|||
125019703|NCT03468309|449696382|FG000|Overall Study|Lost to Follow-up|4|||
125019704|NCT03468309|449696382|FG000|Overall Study|Withdrawal by Subject|2|||
125019705|NCT01496885|449696394|FG000|Overall Study|Lost to Follow-up|13|||
125111274|NCT03705169|450031118|FG000|Overall Study|Concerns about study visit compliance|0|||
125111275|NCT03705169|450031119|FG001|Overall Study|Concerns about study visit compliance|0|||
125111276|NCT03705169|450031120|FG002|Overall Study|Concerns about study visit compliance|0|||
125111277|NCT03705169|450031121|FG003|Overall Study|Concerns about study visit compliance|1|||
125111278|NCT03705169|450031122|FG004|Overall Study|Concerns about study visit compliance|0|||
125111279|NCT03705169|450031123|FG005|Overall Study|Concerns about study visit compliance|0|||
125111280|NCT03705169|450031124|FG006|Overall Study|Concerns about study visit compliance|0|||
125111281|NCT03705169|450031125|FG007|Overall Study|Concerns about study visit compliance|0|||
125111282|NCT03705169|450031126|FG008|Overall Study|Concerns about study visit compliance|0|||
125111283|NCT03705169|450031127|FG009|Overall Study|Concerns about study visit compliance|0|||
125111284|NCT01690520|450032717|FG000|Overall Study|Death|25|||
125111285|NCT01690520|450032718|FG001|Overall Study|Death|21|||
125111286|NCT01690520|450032717|FG000|Overall Study|Lost to Follow-up|2|||
125111287|NCT01690520|450032718|FG001|Overall Study|Lost to Follow-up|3|||
125111288|NCT01690520|450032717|FG000|Overall Study|Withdrawal by Subject|2|||
125111289|NCT01690520|450032718|FG001|Overall Study|Withdrawal by Subject|0|||
125111290|NCT01690520|450032717|FG000|Overall Study|Relapse|0|||
125111291|NCT01690520|450032718|FG001|Overall Study|Relapse|1|||
125111292|NCT01690520|450032717|FG000|Overall Study|Other|0|||
125111293|NCT01690520|450032718|FG001|Overall Study|Other|1|||
125111294|NCT01690520|450032717|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
125111295|NCT01690520|450032718|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
125111296|NCT04006847|450032719|FG000|Overall Study|Product issue|1|||
125111297|NCT01375010|450032720|FG000|Overall Study|Lost to Follow-up|8|||
125111298|NCT01375010|450032721|FG001|Overall Study|Lost to Follow-up|2|||
125111299|NCT01375010|450032720|FG000|Overall Study|Withdrawal by Subject|4|||
125111300|NCT01375010|450032721|FG001|Overall Study|Withdrawal by Subject|2|||
125111301|NCT02614703|450032722|FG000|Overall Study|Withdrawal by Subject|7|||
125111302|NCT02614703|450032723|FG001|Overall Study|Withdrawal by Subject|1|||
125111303|NCT02402933|450032724|FG000|Overall Study|Withdrawal by Subject|4|||
125111304|NCT02402933|450032724|FG000|Overall Study|Discontinued; Site Termination|10|||
125111305|NCT01681771|450032725|FG000|Overall Study|Lost to Follow-up|4|||
125111306|NCT01681771|450032726|FG001|Overall Study|Lost to Follow-up|2|||
125111307|NCT02919475|450032733|FG000|Overall Study|Adverse Event|3|||
125111308|NCT02919475|450032734|FG001|Overall Study|Adverse Event|3|||
125111309|NCT02919475|450032735|FG002|Overall Study|Adverse Event|3|||
125111310|NCT02919475|450032736|FG003|Overall Study|Adverse Event|9|||
125111311|NCT02919475|450032737|FG004|Overall Study|Adverse Event|2|||
125111312|NCT02919475|450032733|FG000|Overall Study|Death|0|||
125111313|NCT02919475|450032734|FG001|Overall Study|Death|1|||
125111314|NCT02919475|450032735|FG002|Overall Study|Death|0|||
125111315|NCT02919475|450032736|FG003|Overall Study|Death|0|||
125111316|NCT02919475|450032737|FG004|Overall Study|Death|0|||
125111317|NCT02919475|450032733|FG000|Overall Study|Lost to Follow-up|0|||
125111318|NCT02919475|450032734|FG001|Overall Study|Lost to Follow-up|0|||
125111319|NCT02919475|450032735|FG002|Overall Study|Lost to Follow-up|0|||
125111320|NCT02919475|450032736|FG003|Overall Study|Lost to Follow-up|1|||
125111321|NCT02919475|450032737|FG004|Overall Study|Lost to Follow-up|0|||
125111322|NCT02919475|450032733|FG000|Overall Study|Withdrawal by Subject|2|||
125111323|NCT02919475|450032734|FG001|Overall Study|Withdrawal by Subject|3|||
125111324|NCT02919475|450032735|FG002|Overall Study|Withdrawal by Subject|1|||
125111325|NCT02919475|450032736|FG003|Overall Study|Withdrawal by Subject|2|||
125111326|NCT02919475|450032737|FG004|Overall Study|Withdrawal by Subject|2|||
125111327|NCT02919475|450032733|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
125111328|NCT02919475|450032734|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
125111329|NCT02919475|450032735|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
125111330|NCT02919475|450032736|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
125111331|NCT02919475|450032737|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
125111332|NCT02370784|450032739|FG000|Overall Study|Patient started prohibited medication|0|||
125111333|NCT02370784|450032740|FG001|Overall Study|Patient started prohibited medication|1|||
125111334|NCT00775983|450032741|FG000|Overall Study|Protocol Violation|1|||
125111335|NCT00775983|450032742|FG001|Overall Study|Protocol Violation|2|||
125111336|NCT02962882|450032743|FG000|Overall Study|Adverse Event|2|||
125111337|NCT02962882|450032743|FG000|Overall Study|Withdrawal by Subject|2|||
125111338|NCT02962882|450032743|FG000|Overall Study|Transfer from ICU|32|||
125111339|NCT01312779|450032744|FG000|Overall Study|Withdrawal by Subject|2|||
125111340|NCT01312779|450032744|FG000|Overall Study|Death|3|||
125111341|NCT01312779|450032744|FG000|Overall Study|Not Implanted with Device|27|||
125111342|NCT01663714|450032747|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
125111343|NCT01663714|450032747|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
125111344|NCT01663714|450032747|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
125111345|NCT01663714|450032747|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
125111346|NCT01663714|450032747|FG000|Long-Term Follow-Up|Death|4|||
125111347|NCT01663714|450032747|FG000|Long-Term Follow-Up|Non-compliance|1|||
125111348|NCT00597584|450032748|FG000|Overall Study|Adverse Event|4|||
125111349|NCT00597584|450032749|FG001|Overall Study|Adverse Event|2|||
125111350|NCT00597584|450032748|FG000|Overall Study|Death|53|||
125111351|NCT00597584|450032749|FG001|Overall Study|Death|30|||
125111352|NCT00597584|450032748|FG000|Overall Study|Lack of Efficacy|1|||
125111353|NCT00597584|450032749|FG001|Overall Study|Lack of Efficacy|0|||
125111354|NCT00597584|450032748|FG000|Overall Study|Lost to Follow-up|2|||
125111355|NCT00597584|450032749|FG001|Overall Study|Lost to Follow-up|4|||
125111356|NCT00597584|450032748|FG000|Overall Study|Physician Decision|3|||
125111357|NCT00597584|450032749|FG001|Overall Study|Physician Decision|0|||
125111358|NCT00597584|450032748|FG000|Overall Study|Pregnancy|2|||
125111359|NCT00597584|450032749|FG001|Overall Study|Pregnancy|0|||
125111360|NCT00597584|450032748|FG000|Overall Study|Withdrawal by Subject|44|||
125111361|NCT00597584|450032749|FG001|Overall Study|Withdrawal by Subject|12|||
125111362|NCT00597584|450032748|FG000|Overall Study|Discontinued Dialysis|0|||
125111363|NCT00597584|450032749|FG001|Overall Study|Discontinued Dialysis|1|||
125111364|NCT00597584|450032748|FG000|Overall Study|Lost ability to consent|1|||
125111365|NCT00597584|450032749|FG001|Overall Study|Lost ability to consent|1|||
125111366|NCT00597584|450032748|FG000|Overall Study|Never dosed|1|||
125111367|NCT00597584|450032749|FG001|Overall Study|Never dosed|0|||
125111368|NCT00597584|450032748|FG000|Overall Study|Relocation|8|||
125111369|NCT00597584|450032749|FG001|Overall Study|Relocation|6|||
125111370|NCT00597584|450032748|FG000|Overall Study|Renal transplant|9|||
125111371|NCT00597584|450032749|FG001|Overall Study|Renal transplant|7|||
125111372|NCT00660790|450032750|FG000|Baseline to 3 Months|Death|1|||
125111373|NCT00660790|450032750|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
125111374|NCT00660790|450032750|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
125111375|NCT02791659|450032751|FG000|Overall Study|Protocol Violation|0|||
125111376|NCT02791659|450032752|FG001|Overall Study|Protocol Violation|1|||
125111377|NCT03840811|450032753|FG000|Overall Study|Lost to Follow-up|0|||
125111378|NCT03840811|450032754|FG001|Overall Study|Lost to Follow-up|0|||
125111379|NCT03840811|450032755|FG002|Overall Study|Lost to Follow-up|1|||
125111380|NCT01904383|450032756|FG000|Overall Study|CRF not collected|117|||
125111381|NCT01904383|450032756|FG000|Overall Study|Reason not listed|147|||
125111382|NCT01904383|450032756|FG000|Overall Study|Lost to Follow-up|674|||
125111383|NCT01904383|450032756|FG000|Overall Study|Lack of Efficacy|370|||
125111384|NCT01904383|450032756|FG000|Overall Study|Improvement|141|||
125111385|NCT01904383|450032756|FG000|Overall Study|Adverse Event|271|||
125111386|NCT01904383|450032756|FG000|Overall Study|No patient visit after entry|54|||
125111387|NCT01625845|450032757|FG000|Overall Study|Adverse Event|1|||
125111388|NCT01625845|450032758|FG001|Overall Study|Adverse Event|2|||
125111389|NCT01625845|450032757|FG000|Overall Study|Lost to Follow-up|2|||
125111390|NCT01625845|450032758|FG001|Overall Study|Lost to Follow-up|1|||
125111391|NCT01625845|450032757|FG000|Overall Study|Withdrawal by Subject|2|||
125111392|NCT01625845|450032758|FG001|Overall Study|Withdrawal by Subject|0|||
125111393|NCT02853929|450032759|FG000|Overall Study|Lost to Follow-up|3|||
125111394|NCT02853929|450032760|FG001|Overall Study|Lost to Follow-up|0|||
125111395|NCT02853929|450032759|FG000|Overall Study|Withdrawal by Subject|1|||
125111396|NCT02853929|450032760|FG001|Overall Study|Withdrawal by Subject|0|||
125111397|NCT02853929|450032759|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
125111398|NCT02853929|450032760|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
125111399|NCT01294592|450032761|FG000|Overall Study|Adverse Event|28|||
125111400|NCT01294592|450032762|FG001|Overall Study|Adverse Event|13|||
125111401|NCT01294592|450032761|FG000|Overall Study|Lack of Efficacy|7|||
125111402|NCT01294592|450032762|FG001|Overall Study|Lack of Efficacy|5|||
125111403|NCT01294592|450032761|FG000|Overall Study|Protocol Violation|1|||
125111404|NCT01294592|450032762|FG001|Overall Study|Protocol Violation|7|||
125111405|NCT01294592|450032761|FG000|Overall Study|Lost to Follow-up|7|||
125111406|NCT01294592|450032762|FG001|Overall Study|Lost to Follow-up|9|||
125111407|NCT01294592|450032761|FG000|Overall Study|Physician Decision|6|||
125111408|NCT01294592|450032762|FG001|Overall Study|Physician Decision|11|||
125111409|NCT01294592|450032761|FG000|Overall Study|Withdrawal by Subject|28|||
125111410|NCT01294592|450032762|FG001|Overall Study|Withdrawal by Subject|28|||
125111411|NCT02762565|450032763|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
125111412|NCT03549130|450032764|FG000|Overall Study|Adverse Event|0|||
125111413|NCT03549130|450032765|FG001|Overall Study|Adverse Event|1|||
125111414|NCT03549130|450032764|FG000|Overall Study|Lost to Follow-up|0|||
125111415|NCT03549130|450032765|FG001|Overall Study|Lost to Follow-up|1|||
125111416|NCT01113710|450032766|FG000|Overall Study|Adverse Event|64|||
125111417|NCT01113710|450032766|FG000|Overall Study|Lack of Efficacy|41|||
125111418|NCT01113710|450032766|FG000|Overall Study|No Information Available|40|||
125111419|NCT01113710|450032766|FG000|Overall Study|Withdrawal by Subject|28|||
125111420|NCT01113710|450032766|FG000|Overall Study|Lost to Follow-up|20|||
125111421|NCT01113710|450032766|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
125111422|NCT01113710|450032766|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
125111423|NCT01113710|450032766|FG000|Overall Study|Lack of Patient's Compliance|8|||
125111424|NCT01113710|450032766|FG000|Overall Study|Other|7|||
125111425|NCT01113710|450032766|FG000|Overall Study|Adverse Event/Other|5|||
125111426|NCT01113710|450032766|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
125111427|NCT01113710|450032766|FG000|Overall Study|Lack of Efficacy/Other|4|||
125111428|NCT01113710|450032766|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
125111429|NCT01113710|450032766|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
125111430|NCT01113710|450032766|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
125111431|NCT01113710|450032766|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
125111432|NCT01113710|450032766|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
125111433|NCT01113710|450032766|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
125111434|NCT01113710|450032766|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
125111435|NCT01113710|450032766|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
125111436|NCT01113710|450032766|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
125111437|NCT01113710|450032766|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
125111438|NCT01113710|450032766|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
125111439|NCT01113710|450032766|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
125111440|NCT01113710|450032766|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
125111441|NCT00623623|450032767|FG000|Overall Study|Previous enrolment into this study|1|||
125111442|NCT00623623|450032768|FG001|Overall Study|Previous enrolment into this study|1|||
125111443|NCT01078623|450032769|FG000|Treatment Period 1|Adverse Event|1|||
125111444|NCT01078623|450032770|FG001|Treatment Period 1|Adverse Event|1|||
125111445|NCT01078623|450032771|FG002|Treatment Period 1|Adverse Event|1|||
125111446|NCT01078623|450032772|FG003|Treatment Period 1|Adverse Event|0|||
125111447|NCT01078623|450032773|FG004|Treatment Period 1|Adverse Event|0|||
124899215|NCT02232178|449255993|FG002|Overall Study|surgical complication|0|||
124899216|NCT00817635|449255994|FG000|Overall Study|Adverse Event|1|||
124899217|NCT00817635|449255995|FG001|Overall Study|Adverse Event|0|||
125111448|NCT01078623|450032774|FG005|Treatment Period 1|Adverse Event|0|||
125111449|NCT01078623|450032775|FG006|Treatment Period 1|Adverse Event|1|||
125111450|NCT01078623|450032776|FG007|Treatment Period 1|Adverse Event|0|||
125111451|NCT01078623|450032777|FG008|Treatment Period 1|Adverse Event|1|||
125111452|NCT01078623|450032778|FG009|Treatment Period 1|Adverse Event|1|||
125111453|NCT01078623|450032779|FG010|Treatment Period 1|Adverse Event|0|||
125111454|NCT01078623|450032780|FG011|Treatment Period 1|Adverse Event|0|||
125111455|NCT01078623|450032781|FG012|Treatment Period 1|Adverse Event|0|||
125111456|NCT01078623|450032782|FG013|Treatment Period 1|Adverse Event|0|||
125111457|NCT01078623|450032783|FG014|Treatment Period 1|Adverse Event|0|||
125111458|NCT01078623|450032784|FG015|Treatment Period 1|Adverse Event|0|||
125111459|NCT01078623|450032785|FG016|Treatment Period 1|Adverse Event|0|||
125111460|NCT01078623|450032786|FG017|Treatment Period 1|Adverse Event|0|||
125111461|NCT01078623|450032787|FG018|Treatment Period 1|Adverse Event|0|||
125111462|NCT01078623|450032788|FG019|Treatment Period 1|Adverse Event|0|||
125111463|NCT01078623|450032769|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125111464|NCT01078623|450032770|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125111465|NCT01078623|450032771|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125111466|NCT01078623|450032772|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125111467|NCT01078623|450032773|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125111468|NCT01078623|450032774|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125111469|NCT01078623|450032775|FG006|Treatment Period 1|Withdrawal by Subject|0|||
125111470|NCT01078623|450032776|FG007|Treatment Period 1|Withdrawal by Subject|1|||
125111471|NCT01078623|450032777|FG008|Treatment Period 1|Withdrawal by Subject|0|||
125111472|NCT01078623|450032778|FG009|Treatment Period 1|Withdrawal by Subject|0|||
125111473|NCT01078623|450032779|FG010|Treatment Period 1|Withdrawal by Subject|1|||
125111474|NCT01078623|450032780|FG011|Treatment Period 1|Withdrawal by Subject|0|||
125111475|NCT01078623|450032781|FG012|Treatment Period 1|Withdrawal by Subject|0|||
125111476|NCT01078623|450032782|FG013|Treatment Period 1|Withdrawal by Subject|0|||
125111477|NCT01078623|450032783|FG014|Treatment Period 1|Withdrawal by Subject|0|||
125111478|NCT01078623|450032784|FG015|Treatment Period 1|Withdrawal by Subject|0|||
124899218|NCT00817635|449255996|FG002|Overall Study|Adverse Event|0|||
125111479|NCT01078623|450032785|FG016|Treatment Period 1|Withdrawal by Subject|0|||
125111480|NCT01078623|450032786|FG017|Treatment Period 1|Withdrawal by Subject|0|||
125111481|NCT01078623|450032787|FG018|Treatment Period 1|Withdrawal by Subject|0|||
125111482|NCT01078623|450032788|FG019|Treatment Period 1|Withdrawal by Subject|0|||
125111483|NCT01078623|450032769|FG000|Treatment Period 1|Protocol Violation|0|||
125111484|NCT01078623|450032770|FG001|Treatment Period 1|Protocol Violation|0|||
125111485|NCT01078623|450032771|FG002|Treatment Period 1|Protocol Violation|0|||
125111486|NCT01078623|450032772|FG003|Treatment Period 1|Protocol Violation|0|||
125111487|NCT01078623|450032773|FG004|Treatment Period 1|Protocol Violation|0|||
125111488|NCT01078623|450032774|FG005|Treatment Period 1|Protocol Violation|1|||
125111489|NCT01078623|450032775|FG006|Treatment Period 1|Protocol Violation|0|||
124899219|NCT00817635|449255997|FG003|Overall Study|Adverse Event|1|||
124899220|NCT00817635|449255998|FG004|Overall Study|Adverse Event|1|||
125111490|NCT01078623|450032776|FG007|Treatment Period 1|Protocol Violation|0|||
125111491|NCT01078623|450032777|FG008|Treatment Period 1|Protocol Violation|0|||
125111492|NCT01078623|450032778|FG009|Treatment Period 1|Protocol Violation|0|||
125019706|NCT01496885|449696394|FG000|Overall Study|Withdrawal by Subject|7|||
125019707|NCT01496885|449696394|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
125019708|NCT01496885|449696394|FG000|Overall Study|Death|1|||
125019709|NCT03446885|449696395|FG000|Overall Study|Lost to Follow-up|1|||
125019710|NCT03446885|449696396|FG001|Overall Study|Lost to Follow-up|0|||
125019711|NCT03446885|449696395|FG000|Overall Study|Did not complete entire visit|1|||
125019712|NCT03446885|449696396|FG001|Overall Study|Did not complete entire visit|0|||
125019713|NCT02728830|449696403|FG000|Overall Study|Exclusionary Surgery|9|||
125019714|NCT02728830|449696403|FG000|Overall Study|Exclusionary Pathology|6|||
125019715|NCT02728830|449696403|FG000|Overall Study|Physician Decision|3|||
125019716|NCT02728830|449696403|FG000|Overall Study|Withdrawal by Subject|2|||
125019717|NCT02728830|449696403|FG000|Overall Study|Lost to Follow-up|1|||
125019718|NCT02728830|449696403|FG000|Overall Study|Exclusionary Lab Values|1|||
125019719|NCT02728830|449696403|FG000|Overall Study|Contraindicated Illness|1|||
125019720|NCT02728830|449696403|FG000|Overall Study|Language Barrier|1|||
125019721|NCT00143455|449696404|FG000|Cohort 1|Adverse Event|8|||
125019722|NCT00143455|449696405|FG001|Cohort 1|Adverse Event|4|||
125019723|NCT00143455|449696406|FG002|Cohort 1|Adverse Event|0|||
125019724|NCT00143455|449696407|FG003|Cohort 1|Adverse Event|0|||
125019725|NCT00143455|449696404|FG000|Cohort 1|Death|5|||
125019726|NCT00143455|449696405|FG001|Cohort 1|Death|2|||
125019727|NCT00143455|449696406|FG002|Cohort 1|Death|0|||
125019728|NCT00143455|449696407|FG003|Cohort 1|Death|0|||
125019729|NCT00143455|449696404|FG000|Cohort 1|Progressive Disease|0|||
125019730|NCT00143455|449696405|FG001|Cohort 1|Progressive Disease|6|||
125019731|NCT00143455|449696406|FG002|Cohort 1|Progressive Disease|0|||
125019732|NCT00143455|449696407|FG003|Cohort 1|Progressive Disease|0|||
125019733|NCT00143455|449696404|FG000|Cohort 1|Withdrawal by Subject|1|||
125019734|NCT00143455|449696405|FG001|Cohort 1|Withdrawal by Subject|4|||
125019735|NCT00143455|449696406|FG002|Cohort 1|Withdrawal by Subject|0|||
125019736|NCT00143455|449696407|FG003|Cohort 1|Withdrawal by Subject|0|||
125019737|NCT00143455|449696404|FG000|Cohort 1|Randomized But Not Treated|0|||
125019738|NCT00143455|449696405|FG001|Cohort 1|Randomized But Not Treated|1|||
125019739|NCT00143455|449696406|FG002|Cohort 1|Randomized But Not Treated|0|||
125019740|NCT00143455|449696407|FG003|Cohort 1|Randomized But Not Treated|0|||
125019741|NCT00143455|449696404|FG000|Cohort 2|Adverse Event|0|||
125019742|NCT00143455|449696405|FG001|Cohort 2|Adverse Event|0|||
125019743|NCT00143455|449696406|FG002|Cohort 2|Adverse Event|42|||
125019744|NCT00143455|449696407|FG003|Cohort 2|Adverse Event|30|||
125019745|NCT00143455|449696404|FG000|Cohort 2|No Longer Required Study Treatment|0|||
125019746|NCT00143455|449696405|FG001|Cohort 2|No Longer Required Study Treatment|0|||
125019747|NCT00143455|449696406|FG002|Cohort 2|No Longer Required Study Treatment|1|||
125019748|NCT00143455|449696407|FG003|Cohort 2|No Longer Required Study Treatment|0|||
125019749|NCT00143455|449696404|FG000|Cohort 2|Protocol Violation|0|||
125019750|NCT00143455|449696405|FG001|Cohort 2|Protocol Violation|0|||
125019751|NCT00143455|449696406|FG002|Cohort 2|Protocol Violation|1|||
125019752|NCT00143455|449696407|FG003|Cohort 2|Protocol Violation|1|||
125019753|NCT00143455|449696404|FG000|Cohort 2|Lost to Follow-up|0|||
125019754|NCT00143455|449696405|FG001|Cohort 2|Lost to Follow-up|0|||
125019755|NCT00143455|449696406|FG002|Cohort 2|Lost to Follow-up|1|||
125019756|NCT00143455|449696407|FG003|Cohort 2|Lost to Follow-up|4|||
125019757|NCT00143455|449696404|FG000|Cohort 2|Death|0|||
125019758|NCT00143455|449696405|FG001|Cohort 2|Death|0|||
125019759|NCT00143455|449696406|FG002|Cohort 2|Death|20|||
125019760|NCT00143455|449696407|FG003|Cohort 2|Death|12|||
125019761|NCT00143455|449696404|FG000|Cohort 2|Progressive Disease|0|||
125019762|NCT00143455|449696405|FG001|Cohort 2|Progressive Disease|0|||
125019763|NCT00143455|449696406|FG002|Cohort 2|Progressive Disease|20|||
125019764|NCT00143455|449696407|FG003|Cohort 2|Progressive Disease|27|||
125019765|NCT00143455|449696404|FG000|Cohort 2|Withdrawal by Subject|0|||
125019766|NCT00143455|449696405|FG001|Cohort 2|Withdrawal by Subject|0|||
125111493|NCT01078623|450032779|FG010|Treatment Period 1|Protocol Violation|0|||
125111494|NCT01078623|450032780|FG011|Treatment Period 1|Protocol Violation|0|||
125019767|NCT00143455|449696406|FG002|Cohort 2|Withdrawal by Subject|13|||
125019768|NCT00143455|449696407|FG003|Cohort 2|Withdrawal by Subject|12|||
125019769|NCT00143455|449696404|FG000|Cohort 2|Other|0|||
125019770|NCT00143455|449696405|FG001|Cohort 2|Other|0|||
125019771|NCT00143455|449696406|FG002|Cohort 2|Other|7|||
125019772|NCT00143455|449696407|FG003|Cohort 2|Other|6|||
125019773|NCT00143455|449696404|FG000|Cohort 2|Randomized But Not Treated|0|||
125019774|NCT00143455|449696405|FG001|Cohort 2|Randomized But Not Treated|0|||
125019775|NCT00143455|449696406|FG002|Cohort 2|Randomized But Not Treated|1|||
125019776|NCT00143455|449696407|FG003|Cohort 2|Randomized But Not Treated|1|||
125019777|NCT01325428|449696408|FG000|Part A|Progressive disease according to RECIST|9|||
125019778|NCT01325428|449696408|FG000|Part A|Clinical signs, symptoms of progression|2|||
125019779|NCT01325428|449696408|FG000|Part A|Other adverse event|1|||
125019780|NCT01325428|449696408|FG000|Part A|Refused continue taking trial medication|2|||
125111495|NCT01078623|450032781|FG012|Treatment Period 1|Protocol Violation|0|||
125111496|NCT01078623|450032782|FG013|Treatment Period 1|Protocol Violation|0|||
125111497|NCT01078623|450032783|FG014|Treatment Period 1|Protocol Violation|0|||
125111498|NCT01078623|450032784|FG015|Treatment Period 1|Protocol Violation|0|||
125111499|NCT01078623|450032785|FG016|Treatment Period 1|Protocol Violation|0|||
125111500|NCT01078623|450032786|FG017|Treatment Period 1|Protocol Violation|0|||
125111501|NCT01078623|450032787|FG018|Treatment Period 1|Protocol Violation|0|||
125111502|NCT01078623|450032788|FG019|Treatment Period 1|Protocol Violation|0|||
125111503|NCT01078623|450032769|FG000|Treatment Period 2|Adverse Event|0|||
125111504|NCT01078623|450032770|FG001|Treatment Period 2|Adverse Event|0|||
125019781|NCT01325428|449696408|FG000|Part A|Other reason not defined above|2|||
125019782|NCT01325428|449696408|FG000|Part B|Refused continue taking trial medication|2|||
125019783|NCT01325428|449696408|FG000|Part B|Other reason not defined above|1|||
125019784|NCT03298022|449696411|FG000|Overall Study|Lack of Efficacy|4|||
125019785|NCT03298022|449696411|FG000|Overall Study|Withdrawal by Subject|7|||
125019786|NCT03298022|449696411|FG000|Overall Study|Adverse Event|1|||
125019787|NCT03298022|449696411|FG000|Overall Study|disease relapse|1|||
125019788|NCT01445769|449696414|FG000|Overall Study|Consent Withdrawn|2|||
125019789|NCT01445769|449696414|FG000|Overall Study|Disease Progression|1|||
125019790|NCT01445769|449696414|FG000|Overall Study|Lost to Follow-up|5|||
125019791|NCT03099707|449696415|FG000|Overall Study|Withdrawal by Subject|0|||
125019792|NCT03099707|449696416|FG001|Overall Study|Withdrawal by Subject|3|||
125019793|NCT03099707|449696415|FG000|Overall Study|Lost to Follow-up|0|||
125019794|NCT03099707|449696416|FG001|Overall Study|Lost to Follow-up|1|||
125019795|NCT00343889|449696427|FG000|Overall Study|Lost to Follow-up|2|||
125019796|NCT00343889|449696428|FG001|Overall Study|Lost to Follow-up|0|||
125019797|NCT00343889|449696427|FG000|Overall Study|Withdrawal by Subject|0|||
125019798|NCT00343889|449696428|FG001|Overall Study|Withdrawal by Subject|1|||
125019799|NCT00343889|449696427|FG000|Overall Study|Protocol Violation|1|||
125019800|NCT00343889|449696428|FG001|Overall Study|Protocol Violation|0|||
125019801|NCT01294579|449696429|FG000|Overall Study|Disease progression|12|||
125019802|NCT01294579|449696429|FG000|Overall Study|Adverse Event|11|||
125019803|NCT01294579|449696429|FG000|Overall Study|Study closed/terminated|3|||
125019804|NCT01294579|449696429|FG000|Overall Study|Lost to Follow-up|1|||
125019805|NCT01294579|449696429|FG000|Overall Study|Physician Decision|3|||
125019806|NCT01294579|449696429|FG000|Overall Study|Withdrawal by Subject|5|||
125019807|NCT00487539|449696430|FG000|Overall Study|Adverse Event|3|||
125019808|NCT00487539|449696431|FG001|Overall Study|Adverse Event|2|||
125019809|NCT00487539|449696432|FG002|Overall Study|Adverse Event|1|||
125019810|NCT00487539|449696433|FG003|Overall Study|Adverse Event|1|||
125019811|NCT00487539|449696430|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125019812|NCT00487539|449696431|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125019813|NCT00487539|449696432|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
125019814|NCT00487539|449696433|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
125019815|NCT00487539|449696430|FG000|Overall Study|Other|3|||
125019816|NCT00487539|449696431|FG001|Overall Study|Other|1|||
125019817|NCT00487539|449696432|FG002|Overall Study|Other|2|||
125019818|NCT00487539|449696433|FG003|Overall Study|Other|2|||
125019819|NCT00879697|449696434|FG000|Overall Study|Physician Decision|2|||
125019820|NCT00879697|449696435|FG001|Overall Study|Physician Decision|2|||
125019821|NCT02751502|449696436|FG000|Overall Study|Lack of funding|4|||
125019822|NCT00088374|449696437|FG000|Overall Study|patient did not receive any 17AAG|1|||
125019823|NCT00088374|449696437|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
125019824|NCT03499028|449696438|FG000|Overall Study|Lost to Follow-up|12|||
125019825|NCT03499028|449696439|FG001|Overall Study|Lost to Follow-up|9|||
125019826|NCT03499028|449696438|FG000|Overall Study|Withdrawal by Subject|5|||
125019827|NCT03499028|449696439|FG001|Overall Study|Withdrawal by Subject|8|||
125019828|NCT03499028|449696438|FG000|Overall Study|Unplanned SNF discharge|5|||
125019829|NCT03499028|449696439|FG001|Overall Study|Unplanned SNF discharge|8|||
125019830|NCT01437397|449696440|FG000|Overall Study|Lost to Follow-up|9|||
125019831|NCT01437397|449696441|FG001|Overall Study|Lost to Follow-up|4|||
125019832|NCT01437397|449696442|FG002|Overall Study|Lost to Follow-up|2|||
125019833|NCT01437397|449696443|FG003|Overall Study|Lost to Follow-up|4|||
125019834|NCT01437397|449696444|FG004|Overall Study|Lost to Follow-up|5|||
125019835|NCT01437397|449696440|FG000|Overall Study|Withdrawal by Subject|11|||
125019836|NCT01437397|449696441|FG001|Overall Study|Withdrawal by Subject|12|||
125019837|NCT01437397|449696442|FG002|Overall Study|Withdrawal by Subject|24|||
125019838|NCT01437397|449696443|FG003|Overall Study|Withdrawal by Subject|11|||
125019839|NCT01437397|449696444|FG004|Overall Study|Withdrawal by Subject|22|||
125019840|NCT01437397|449696440|FG000|Overall Study|Protocol Violation|10|||
125019841|NCT01437397|449696441|FG001|Overall Study|Protocol Violation|12|||
125019842|NCT01437397|449696442|FG002|Overall Study|Protocol Violation|13|||
125019843|NCT01437397|449696443|FG003|Overall Study|Protocol Violation|21|||
125019844|NCT01437397|449696444|FG004|Overall Study|Protocol Violation|19|||
125019845|NCT01437397|449696440|FG000|Overall Study|Lack of Efficacy|5|||
125019846|NCT01437397|449696441|FG001|Overall Study|Lack of Efficacy|4|||
125019847|NCT01437397|449696442|FG002|Overall Study|Lack of Efficacy|8|||
125111505|NCT01078623|450032771|FG002|Treatment Period 2|Adverse Event|0|||
125111506|NCT01078623|450032772|FG003|Treatment Period 2|Adverse Event|0|||
125111507|NCT01078623|450032773|FG004|Treatment Period 2|Adverse Event|0|||
125111508|NCT01078623|450032774|FG005|Treatment Period 2|Adverse Event|0|||
125111509|NCT01078623|450032775|FG006|Treatment Period 2|Adverse Event|1|||
125111510|NCT01078623|450032776|FG007|Treatment Period 2|Adverse Event|0|||
125111511|NCT01078623|450032777|FG008|Treatment Period 2|Adverse Event|0|||
125111512|NCT01078623|450032778|FG009|Treatment Period 2|Adverse Event|0|||
125111513|NCT01078623|450032779|FG010|Treatment Period 2|Adverse Event|0|||
125111514|NCT01078623|450032780|FG011|Treatment Period 2|Adverse Event|0|||
125111515|NCT01078623|450032781|FG012|Treatment Period 2|Adverse Event|0|||
125111516|NCT01078623|450032782|FG013|Treatment Period 2|Adverse Event|0|||
125111517|NCT01078623|450032783|FG014|Treatment Period 2|Adverse Event|0|||
125111518|NCT01078623|450032784|FG015|Treatment Period 2|Adverse Event|0|||
125111519|NCT01078623|450032785|FG016|Treatment Period 2|Adverse Event|0|||
125111520|NCT01078623|450032786|FG017|Treatment Period 2|Adverse Event|0|||
125111521|NCT01078623|450032787|FG018|Treatment Period 2|Adverse Event|1|||
125111522|NCT01078623|450032788|FG019|Treatment Period 2|Adverse Event|0|||
125111523|NCT01078623|450032769|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125111524|NCT01078623|450032770|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125111525|NCT01078623|450032771|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125111526|NCT01078623|450032772|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125111527|NCT01078623|450032773|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125111528|NCT01078623|450032774|FG005|Treatment Period 2|Withdrawal by Subject|1|||
125111529|NCT01078623|450032775|FG006|Treatment Period 2|Withdrawal by Subject|0|||
125111530|NCT01078623|450032776|FG007|Treatment Period 2|Withdrawal by Subject|0|||
125111531|NCT01078623|450032777|FG008|Treatment Period 2|Withdrawal by Subject|0|||
125111532|NCT01078623|450032778|FG009|Treatment Period 2|Withdrawal by Subject|0|||
125111533|NCT01078623|450032779|FG010|Treatment Period 2|Withdrawal by Subject|0|||
125111534|NCT01078623|450032780|FG011|Treatment Period 2|Withdrawal by Subject|0|||
125111535|NCT01078623|450032781|FG012|Treatment Period 2|Withdrawal by Subject|0|||
125111536|NCT01078623|450032782|FG013|Treatment Period 2|Withdrawal by Subject|0|||
125111537|NCT01078623|450032783|FG014|Treatment Period 2|Withdrawal by Subject|0|||
125111538|NCT01078623|450032784|FG015|Treatment Period 2|Withdrawal by Subject|0|||
125111539|NCT01078623|450032785|FG016|Treatment Period 2|Withdrawal by Subject|0|||
125111540|NCT01078623|450032786|FG017|Treatment Period 2|Withdrawal by Subject|0|||
125111541|NCT01078623|450032787|FG018|Treatment Period 2|Withdrawal by Subject|0|||
125111542|NCT01078623|450032788|FG019|Treatment Period 2|Withdrawal by Subject|0|||
125111543|NCT01078623|450032769|FG000|Treatment Period 3|Adverse Event|0|||
125111544|NCT01078623|450032770|FG001|Treatment Period 3|Adverse Event|0|||
125111545|NCT01078623|450032771|FG002|Treatment Period 3|Adverse Event|0|||
125111546|NCT01078623|450032772|FG003|Treatment Period 3|Adverse Event|0|||
125111547|NCT01078623|450032773|FG004|Treatment Period 3|Adverse Event|1|||
125111548|NCT01078623|450032774|FG005|Treatment Period 3|Adverse Event|0|||
125111549|NCT01078623|450032775|FG006|Treatment Period 3|Adverse Event|0|||
125111550|NCT01078623|450032776|FG007|Treatment Period 3|Adverse Event|0|||
125111551|NCT01078623|450032777|FG008|Treatment Period 3|Adverse Event|0|||
125111552|NCT01078623|450032778|FG009|Treatment Period 3|Adverse Event|0|||
125111553|NCT01078623|450032779|FG010|Treatment Period 3|Adverse Event|0|||
125111554|NCT01078623|450032780|FG011|Treatment Period 3|Adverse Event|0|||
125111555|NCT01078623|450032781|FG012|Treatment Period 3|Adverse Event|0|||
125111556|NCT01078623|450032782|FG013|Treatment Period 3|Adverse Event|1|||
125111557|NCT01078623|450032783|FG014|Treatment Period 3|Adverse Event|0|||
125111558|NCT01078623|450032784|FG015|Treatment Period 3|Adverse Event|0|||
125111559|NCT01078623|450032785|FG016|Treatment Period 3|Adverse Event|0|||
125111560|NCT01078623|450032786|FG017|Treatment Period 3|Adverse Event|0|||
125111561|NCT01078623|450032787|FG018|Treatment Period 3|Adverse Event|0|||
125111562|NCT01078623|450032788|FG019|Treatment Period 3|Adverse Event|0|||
125111563|NCT01078623|450032769|FG000|Treatment Period 4|Adverse Event|0|||
125111564|NCT01078623|450032770|FG001|Treatment Period 4|Adverse Event|0|||
125111565|NCT01078623|450032771|FG002|Treatment Period 4|Adverse Event|1|||
125111566|NCT01078623|450032772|FG003|Treatment Period 4|Adverse Event|0|||
125111567|NCT01078623|450032773|FG004|Treatment Period 4|Adverse Event|0|||
125111568|NCT01078623|450032774|FG005|Treatment Period 4|Adverse Event|0|||
125111569|NCT01078623|450032775|FG006|Treatment Period 4|Adverse Event|0|||
125111570|NCT01078623|450032776|FG007|Treatment Period 4|Adverse Event|0|||
125111571|NCT01078623|450032777|FG008|Treatment Period 4|Adverse Event|0|||
125111572|NCT01078623|450032778|FG009|Treatment Period 4|Adverse Event|0|||
125111573|NCT01078623|450032779|FG010|Treatment Period 4|Adverse Event|0|||
125111574|NCT01078623|450032780|FG011|Treatment Period 4|Adverse Event|0|||
125111575|NCT01078623|450032781|FG012|Treatment Period 4|Adverse Event|0|||
125111576|NCT01078623|450032782|FG013|Treatment Period 4|Adverse Event|0|||
125111577|NCT01078623|450032783|FG014|Treatment Period 4|Adverse Event|0|||
125111578|NCT01078623|450032784|FG015|Treatment Period 4|Adverse Event|0|||
125111579|NCT01078623|450032785|FG016|Treatment Period 4|Adverse Event|0|||
125111580|NCT01078623|450032786|FG017|Treatment Period 4|Adverse Event|0|||
125111581|NCT01078623|450032787|FG018|Treatment Period 4|Adverse Event|0|||
125111582|NCT01078623|450032788|FG019|Treatment Period 4|Adverse Event|0|||
125111583|NCT01078623|450032769|FG000|Treatment Period 4|Withdrawal by Subject|0|||
125111584|NCT01078623|450032770|FG001|Treatment Period 4|Withdrawal by Subject|0|||
125111585|NCT01078623|450032771|FG002|Treatment Period 4|Withdrawal by Subject|0|||
125111586|NCT01078623|450032772|FG003|Treatment Period 4|Withdrawal by Subject|0|||
125111587|NCT01078623|450032773|FG004|Treatment Period 4|Withdrawal by Subject|0|||
125019848|NCT01437397|449696443|FG003|Overall Study|Lack of Efficacy|10|||
125019849|NCT01437397|449696444|FG004|Overall Study|Lack of Efficacy|20|||
125019850|NCT01437397|449696440|FG000|Overall Study|Adverse Event|21|||
125019851|NCT01437397|449696441|FG001|Overall Study|Adverse Event|22|||
125019852|NCT01437397|449696442|FG002|Overall Study|Adverse Event|16|||
125019853|NCT01437397|449696443|FG003|Overall Study|Adverse Event|14|||
125019854|NCT01437397|449696444|FG004|Overall Study|Adverse Event|21|||
125019855|NCT01437397|449696440|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
125019856|NCT01437397|449696441|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
125019857|NCT01437397|449696442|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
125019858|NCT01437397|449696443|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
125019859|NCT01437397|449696444|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
125019860|NCT00371865|449696445|FG000|Overall Study|Lack of Efficacy|0|||
125019861|NCT00371865|449696446|FG001|Overall Study|Lack of Efficacy|2|||
125019862|NCT00371865|449696445|FG000|Overall Study|Protocol Violation|3|||
125019863|NCT00371865|449696446|FG001|Overall Study|Protocol Violation|2|||
125019864|NCT00371865|449696445|FG000|Overall Study|Withdrawal by Subject|12|||
125019865|NCT00371865|449696446|FG001|Overall Study|Withdrawal by Subject|10|||
125019866|NCT01328951|449696448|FG000|Overall Study|Disease Progression|17|||
125019867|NCT01328951|449696449|FG001|Overall Study|Disease Progression|14|||
125019868|NCT01328951|449696448|FG000|Overall Study|Adverse Event|2|||
125019869|NCT01328951|449696449|FG001|Overall Study|Adverse Event|0|||
125019870|NCT01328951|449696448|FG000|Overall Study|Death|243|||
125019871|NCT01328951|449696449|FG001|Overall Study|Death|258|||
125019872|NCT01328951|449696448|FG000|Overall Study|Lost to Follow-up|6|||
125019873|NCT01328951|449696449|FG001|Overall Study|Lost to Follow-up|7|||
125019874|NCT01328951|449696448|FG000|Overall Study|Withdrawal by Subject|6|||
125019875|NCT01328951|449696449|FG001|Overall Study|Withdrawal by Subject|6|||
125019876|NCT01328951|449696448|FG000|Overall Study|Study Closed by the Sponsor|36|||
125019877|NCT01328951|449696449|FG001|Overall Study|Study Closed by the Sponsor|31|||
125019878|NCT01328951|449696448|FG000|Overall Study|Other|11|||
125019879|NCT01328951|449696449|FG001|Overall Study|Other|6|||
125019880|NCT04042103|449696450|FG000|Overall Study|Lost to Follow-up|1|||
125019881|NCT04042103|449696450|FG000|Overall Study|Withdrawal by Subject|1|||
125019882|NCT01003210|449696451|FG000|Overall Study|Lost to Follow-up|1|||
125019883|NCT01003210|449696452|FG001|Overall Study|Lost to Follow-up|3|||
125019884|NCT00271817|449696453|FG000|Part 1|Adverse Event|68|||
125019885|NCT00271817|449696454|FG001|Part 1|Adverse Event|25|||
125019886|NCT00271817|449696455|FG002|Part 1|Adverse Event|156|||
125019887|NCT00271817|449696453|FG000|Part 1|Lost to Follow-up|6|||
125019888|NCT00271817|449696454|FG001|Part 1|Lost to Follow-up|8|||
125019889|NCT00271817|449696455|FG002|Part 1|Lost to Follow-up|24|||
125019890|NCT00271817|449696453|FG000|Part 1|Protocol Violation|5|||
125019891|NCT00271817|449696454|FG001|Part 1|Protocol Violation|4|||
125019892|NCT00271817|449696455|FG002|Part 1|Protocol Violation|7|||
125019893|NCT00271817|449696453|FG000|Part 1|Patient Moved|3|||
125019894|NCT00271817|449696454|FG001|Part 1|Patient Moved|1|||
125019895|NCT00271817|449696455|FG002|Part 1|Patient Moved|5|||
125019896|NCT00271817|449696453|FG000|Part 1|Withdrawal by Subject|23|||
125019897|NCT00271817|449696454|FG001|Part 1|Withdrawal by Subject|17|||
125019898|NCT00271817|449696455|FG002|Part 1|Withdrawal by Subject|45|||
125019899|NCT00271817|449696453|FG000|Part 1|LDL < 50 mg/dL|1|||
125019900|NCT00271817|449696454|FG001|Part 1|LDL < 50 mg/dL|4|||
125019901|NCT00271817|449696455|FG002|Part 1|LDL < 50 mg/dL|48|||
125019902|NCT00271817|449696453|FG000|Part 2|Adverse Event|0|||
125019903|NCT00271817|449696454|FG001|Part 2|Adverse Event|17|||
125019904|NCT00271817|449696455|FG002|Part 2|Adverse Event|33|||
125019905|NCT00271817|449696453|FG000|Part 2|Lack of Efficacy|0|||
125019906|NCT00271817|449696454|FG001|Part 2|Lack of Efficacy|1|||
125019907|NCT00271817|449696455|FG002|Part 2|Lack of Efficacy|6|||
125019908|NCT00271817|449696453|FG000|Part 2|Lost to Follow-up|0|||
125019909|NCT00271817|449696454|FG001|Part 2|Lost to Follow-up|6|||
125019910|NCT00271817|449696455|FG002|Part 2|Lost to Follow-up|18|||
125019911|NCT00271817|449696453|FG000|Part 2|Protocol Violation|0|||
125019912|NCT00271817|449696454|FG001|Part 2|Protocol Violation|3|||
125019913|NCT00271817|449696455|FG002|Part 2|Protocol Violation|5|||
125019914|NCT00271817|449696453|FG000|Part 2|Patient Moved|0|||
125019915|NCT00271817|449696454|FG001|Part 2|Patient Moved|0|||
125019916|NCT00271817|449696455|FG002|Part 2|Patient Moved|5|||
125019917|NCT00271817|449696453|FG000|Part 2|Withdrawal by Subject|0|||
125019918|NCT00271817|449696454|FG001|Part 2|Withdrawal by Subject|2|||
125019919|NCT00271817|449696455|FG002|Part 2|Withdrawal by Subject|13|||
125019920|NCT00271817|449696453|FG000|Part 2|LDL < 50 mg/dL|0|||
125019921|NCT00271817|449696454|FG001|Part 2|LDL < 50 mg/dL|3|||
125019922|NCT00271817|449696455|FG002|Part 2|LDL < 50 mg/dL|4|||
125019923|NCT00700271|449696456|FG000|Overall Study|Adverse Event|4|||
125019924|NCT00700271|449696457|FG001|Overall Study|Adverse Event|6|||
125019925|NCT00700271|449696456|FG000|Overall Study|Protocol Violation|1|||
125019926|NCT00700271|449696457|FG001|Overall Study|Protocol Violation|0|||
125019927|NCT00700271|449696456|FG000|Overall Study|Administrative Reasons|1|||
125019928|NCT00700271|449696457|FG001|Overall Study|Administrative Reasons|0|||
125019929|NCT00700271|449696456|FG000|Overall Study|Withdrawal by Subject|6|||
125019930|NCT00700271|449696457|FG001|Overall Study|Withdrawal by Subject|4|||
125019931|NCT00700271|449696456|FG000|Overall Study|Lost to Follow-up|2|||
125019932|NCT00700271|449696457|FG001|Overall Study|Lost to Follow-up|2|||
125019933|NCT00861744|449696458|FG000|Overall Study|Adverse Event|0|||
125019934|NCT00861744|449696459|FG001|Overall Study|Adverse Event|0|||
125019935|NCT00861744|449696460|FG002|Overall Study|Adverse Event|0|||
125019936|NCT00861744|449696461|FG003|Overall Study|Adverse Event|1|||
125019937|NCT00861744|449696458|FG000|Overall Study|Lost to Follow-up|7|||
125019938|NCT00861744|449696459|FG001|Overall Study|Lost to Follow-up|19|||
125019939|NCT00861744|449696460|FG002|Overall Study|Lost to Follow-up|17|||
125019940|NCT00861744|449696461|FG003|Overall Study|Lost to Follow-up|12|||
125019941|NCT00861744|449696458|FG000|Overall Study|Withdrawal by Subject|10|||
125019942|NCT00861744|449696459|FG001|Overall Study|Withdrawal by Subject|6|||
125019943|NCT00861744|449696460|FG002|Overall Study|Withdrawal by Subject|6|||
125019944|NCT00861744|449696461|FG003|Overall Study|Withdrawal by Subject|19|||
125019945|NCT00861744|449696458|FG000|Overall Study|Protocol Violation|0|||
125019946|NCT00861744|449696459|FG001|Overall Study|Protocol Violation|1|||
125019947|NCT00861744|449696460|FG002|Overall Study|Protocol Violation|0|||
125019948|NCT00861744|449696461|FG003|Overall Study|Protocol Violation|0|||
125019949|NCT00861744|449696458|FG000|Overall Study|Migration from study area|0|||
125019950|NCT00861744|449696459|FG001|Overall Study|Migration from study area|3|||
125019951|NCT00861744|449696460|FG002|Overall Study|Migration from study area|1|||
125019952|NCT00861744|449696461|FG003|Overall Study|Migration from study area|0|||
125019953|NCT00861744|449696458|FG000|Overall Study|Blood draws|0|||
125019954|NCT00861744|449696459|FG001|Overall Study|Blood draws|0|||
125019955|NCT00861744|449696460|FG002|Overall Study|Blood draws|0|||
125019956|NCT00861744|449696461|FG003|Overall Study|Blood draws|1|||
125019957|NCT05107765|449696462|FG000|Overall Study|Lost to Follow-up|4|||
125019958|NCT05107765|449696463|FG001|Overall Study|Lost to Follow-up|1|||
125019959|NCT05107765|449696462|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
125019960|NCT05107765|449696463|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
125019961|NCT05107765|449696462|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
125019962|NCT05107765|449696463|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
125019963|NCT03124563|449696466|FG000|Overall Study|Lost to Follow-up|1|||
125019964|NCT03124563|449696467|FG001|Overall Study|Lost to Follow-up|1|||
125019965|NCT03124563|449696466|FG000|Overall Study|Withdrawal by Subject|1|||
125019966|NCT03124563|449696467|FG001|Overall Study|Withdrawal by Subject|1|||
125019967|NCT00925015|449697498|FG000|Overall Study|Adverse Event|1|||
125019968|NCT00925015|449697499|FG001|Overall Study|Adverse Event|2|||
125019969|NCT00925015|449697500|FG002|Overall Study|Adverse Event|1|||
125019970|NCT00925015|449697498|FG000|Overall Study|Physician Decision|0|||
125019971|NCT00925015|449697499|FG001|Overall Study|Physician Decision|1|||
125019972|NCT00925015|449697500|FG002|Overall Study|Physician Decision|0|||
125019973|NCT00925015|449697498|FG000|Overall Study|Progressive Disease|7|||
125019974|NCT00925015|449697499|FG001|Overall Study|Progressive Disease|3|||
125019975|NCT00925015|449697500|FG002|Overall Study|Progressive Disease|4|||
125019976|NCT00925015|449697498|FG000|Overall Study|Withdrawal by Subject|0|||
125019977|NCT00925015|449697499|FG001|Overall Study|Withdrawal by Subject|0|||
125019978|NCT00925015|449697500|FG002|Overall Study|Withdrawal by Subject|1|||
125019979|NCT01368835|449697501|FG000|Overall Study|Inclusion criteria/photography quality|22|||
125019980|NCT01368835|449697501|FG000|Overall Study|Lost to Follow-up|11|||
125019981|NCT02754726|449697502|FG000|Overall Study|Progressive Disease by RECIST|13|||
125111588|NCT01078623|450032774|FG005|Treatment Period 4|Withdrawal by Subject|0|||
125111589|NCT01078623|450032775|FG006|Treatment Period 4|Withdrawal by Subject|0|||
125111590|NCT01078623|450032776|FG007|Treatment Period 4|Withdrawal by Subject|0|||
124899221|NCT00817635|449255994|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
124899222|NCT00817635|449255995|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
124899223|NCT00817635|449255996|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
124899224|NCT00817635|449255997|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
124899225|NCT00817635|449255998|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
124899226|NCT00817635|449255994|FG000|Overall Study|Withdrawal by Subject|2|||
124899227|NCT00817635|449255995|FG001|Overall Study|Withdrawal by Subject|1|||
124899228|NCT00817635|449255996|FG002|Overall Study|Withdrawal by Subject|0|||
124899229|NCT00817635|449255997|FG003|Overall Study|Withdrawal by Subject|1|||
124899230|NCT00817635|449255998|FG004|Overall Study|Withdrawal by Subject|2|||
124899231|NCT00817635|449255994|FG000|Overall Study|Lost to Follow-up|0|||
124899232|NCT00817635|449255995|FG001|Overall Study|Lost to Follow-up|1|||
124899233|NCT00817635|449255996|FG002|Overall Study|Lost to Follow-up|0|||
124899234|NCT00817635|449255997|FG003|Overall Study|Lost to Follow-up|1|||
124899235|NCT00817635|449255998|FG004|Overall Study|Lost to Follow-up|0|||
124899236|NCT00817635|449255994|FG000|Overall Study|Administrative Problems|0|||
124899237|NCT00817635|449255995|FG001|Overall Study|Administrative Problems|0|||
124899238|NCT00817635|449255996|FG002|Overall Study|Administrative Problems|0|||
124899239|NCT00817635|449255997|FG003|Overall Study|Administrative Problems|0|||
124899240|NCT00817635|449255998|FG004|Overall Study|Administrative Problems|1|||
124899241|NCT00817635|449255994|FG000|Overall Study|Protocol Violation|5|||
124899242|NCT00817635|449255995|FG001|Overall Study|Protocol Violation|1|||
124899243|NCT00817635|449255996|FG002|Overall Study|Protocol Violation|3|||
124899244|NCT00817635|449255997|FG003|Overall Study|Protocol Violation|2|||
124899245|NCT00817635|449255998|FG004|Overall Study|Protocol Violation|3|||
124899246|NCT01720446|449255999|FG000|Overall Study|Lost to Follow-up|12|||
124899247|NCT01720446|449256000|FG001|Overall Study|Lost to Follow-up|6|||
124899248|NCT01720446|449256001|FG002|Overall Study|Lost to Follow-up|16|||
124899249|NCT01720446|449256002|FG003|Overall Study|Lost to Follow-up|16|||
124899250|NCT01720446|449255999|FG000|Overall Study|Withdrawal by Subject|2|||
124899251|NCT01720446|449256000|FG001|Overall Study|Withdrawal by Subject|5|||
124899252|NCT01720446|449256001|FG002|Overall Study|Withdrawal by Subject|4|||
124899253|NCT01720446|449256002|FG003|Overall Study|Withdrawal by Subject|4|||
124899254|NCT01072357|449256005|FG000|Overall Study|Lost to Follow-up|0|||
124899255|NCT01072357|449256006|FG001|Overall Study|Lost to Follow-up|1|||
124899256|NCT01876511|449256007|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
124899257|NCT01876511|449256008|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
124899258|NCT01876511|449256009|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
124899259|NCT01876511|449256007|FG000|Overall Study|Death (unrelated)|3|||
124899260|NCT01876511|449256008|FG001|Overall Study|Death (unrelated)|0|||
124899261|NCT01876511|449256009|FG002|Overall Study|Death (unrelated)|2|||
124899262|NCT01876511|449256007|FG000|Overall Study|Drug-related Toxicity|5|||
124899263|NCT01876511|449256008|FG001|Overall Study|Drug-related Toxicity|1|||
124899264|NCT01876511|449256009|FG002|Overall Study|Drug-related Toxicity|6|||
124899265|NCT01876511|449256007|FG000|Overall Study|Patient Decision|3|||
124899266|NCT01876511|449256008|FG001|Overall Study|Patient Decision|0|||
124899267|NCT01876511|449256009|FG002|Overall Study|Patient Decision|6|||
124899268|NCT01876511|449256007|FG000|Overall Study|Physician Decision|1|||
124899269|NCT01876511|449256008|FG001|Overall Study|Physician Decision|0|||
124899270|NCT01876511|449256009|FG002|Overall Study|Physician Decision|1|||
124899271|NCT00606580|449256011|FG000|Overall Study|Lost to Follow-up|1|||
124899272|NCT00606580|449256012|FG001|Overall Study|Lost to Follow-up|1|||
124899273|NCT00606580|449256013|FG002|Overall Study|Lost to Follow-up|4|||
124899274|NCT00606580|449256011|FG000|Overall Study|Clinical failures|1|||
124899275|NCT00606580|449256012|FG001|Overall Study|Clinical failures|0|||
124899276|NCT00606580|449256013|FG002|Overall Study|Clinical failures|12|||
125019982|NCT02754726|449697502|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
125019983|NCT02754726|449697502|FG000|Overall Study|Clinical Disease Progression|5|||
125019984|NCT02754726|449697502|FG000|Overall Study|Adverse Event|3|||
125019985|NCT02754726|449697502|FG000|Overall Study|Withdrawal by Subject|1|||
125019986|NCT02754726|449697502|FG000|Overall Study|Tolerability|1|||
125019987|NCT01885000|449697503|FG000|Overall Study|Adverse Event|1|||
125019988|NCT01885000|449697504|FG001|Overall Study|Adverse Event|0|||
125019989|NCT01885000|449697503|FG000|Overall Study|Withdrawal by Subject|1|||
125019990|NCT01885000|449697504|FG001|Overall Study|Withdrawal by Subject|1|||
125111591|NCT01078623|450032777|FG008|Treatment Period 4|Withdrawal by Subject|0|||
124899277|NCT00606580|449256011|FG000|Overall Study|Withdrawal by investigator|0|||
124899278|NCT00606580|449256012|FG001|Overall Study|Withdrawal by investigator|1|||
124899279|NCT00606580|449256013|FG002|Overall Study|Withdrawal by investigator|6|||
124899280|NCT00606580|449256011|FG000|Overall Study|Withdrawal by Subject|0|||
124899281|NCT00606580|449256012|FG001|Overall Study|Withdrawal by Subject|1|||
124899282|NCT00606580|449256013|FG002|Overall Study|Withdrawal by Subject|0|||
124899283|NCT01250002|449256018|FG000|Overall Study|Change to open surgical procedure|4|||
124899284|NCT01250002|449256019|FG001|Overall Study|Change to open surgical procedure|3|||
124899285|NCT03256344|449256029|FG000|Overall Study|Death|6|||
124899286|NCT03256344|449256030|FG001|Overall Study|Death|22|||
124899287|NCT03256344|449256029|FG000|Overall Study|Withdrawal by Subject|3|||
124899288|NCT03256344|449256030|FG001|Overall Study|Withdrawal by Subject|3|||
124899289|NCT03256344|449256029|FG000|Overall Study|Sponsor Decision|1|||
124899290|NCT03256344|449256030|FG001|Overall Study|Sponsor Decision|0|||
124899291|NCT00843193|449256033|FG000|Overall Study|Adverse Event|2|||
124899292|NCT00843193|449256034|FG001|Overall Study|Adverse Event|4|||
124899293|NCT00843193|449256033|FG000|Overall Study|Lack of Efficacy|1|||
124899294|NCT00843193|449256034|FG001|Overall Study|Lack of Efficacy|1|||
124899295|NCT00843193|449256033|FG000|Overall Study|Protocol Violation|1|||
124899296|NCT00843193|449256034|FG001|Overall Study|Protocol Violation|2|||
124899297|NCT00843193|449256033|FG000|Overall Study|Lost to Follow-up|1|||
124899298|NCT00843193|449256034|FG001|Overall Study|Lost to Follow-up|0|||
124899299|NCT00843193|449256033|FG000|Overall Study|Physician Decision|0|||
124899300|NCT00843193|449256034|FG001|Overall Study|Physician Decision|1|||
124899301|NCT00843193|449256033|FG000|Overall Study|Withdrawal by Subject|3|||
124899302|NCT00843193|449256034|FG001|Overall Study|Withdrawal by Subject|3|||
124899303|NCT00544440|449256035|FG000|Overall Study|Other|1|||
124899304|NCT00544440|449256035|FG000|Overall Study|Adverse Event|1|||
124899305|NCT00544440|449256035|FG000|Overall Study|Withdrawal by Subject|2|||
124899306|NCT00544440|449256035|FG000|Overall Study|Subject Non-compliance|1|||
124899307|NCT00544440|449256035|FG000|Overall Study|Progressive Disease|47|||
124899308|NCT00544440|449256035|FG000|Overall Study|Other|5|||
124899309|NCT03586167|449256036|FG000|Overall Study|Other|1|||
124899310|NCT03586167|449256037|FG001|Overall Study|Other|0|||
124899311|NCT00591838|449256038|FG000|Overall Study|Withdrawal by Subject|0|||
124899312|NCT00591838|449256039|FG001|Overall Study|Withdrawal by Subject|0|||
124899313|NCT00591838|449256040|FG002|Overall Study|Withdrawal by Subject|0|||
124899314|NCT00591838|449256041|FG003|Overall Study|Withdrawal by Subject|1|||
124899315|NCT00591838|449256042|FG004|Overall Study|Withdrawal by Subject|0|||
124899316|NCT02512042|449256043|FG000|Overall Study|Adverse Event|0|||
124899317|NCT02512042|449256044|FG001|Overall Study|Adverse Event|4|||
124899318|NCT02512042|449256043|FG000|Overall Study|Withdrawal by Subject|6|||
124899319|NCT02512042|449256044|FG001|Overall Study|Withdrawal by Subject|6|||
124899320|NCT02512042|449256043|FG000|Overall Study|Non-compliance with study drug|1|||
125019991|NCT01885000|449697503|FG000|Overall Study|Protocol Violation|0|||
125019992|NCT01885000|449697504|FG001|Overall Study|Protocol Violation|1|||
125019993|NCT03124784|449697505|FG000|Overall Study|Adverse Event|1|||
125019994|NCT03124784|449697505|FG000|Overall Study|Computer/Equip Malfunction|1|||
125019995|NCT01777152|449697511|FG000|Overall Study|Withdrawal by Subject|22|||
125019996|NCT01777152|449697512|FG001|Overall Study|Withdrawal by Subject|16|||
125019997|NCT01777152|449697511|FG000|Overall Study|Lost to Follow-up|3|||
125019998|NCT01777152|449697512|FG001|Overall Study|Lost to Follow-up|5|||
125019999|NCT01777152|449697511|FG000|Overall Study|Death|68|||
125020000|NCT01777152|449697512|FG001|Overall Study|Death|89|||
125020001|NCT01777152|449697511|FG000|Overall Study|Not eligible, no study drug received|1|||
125020002|NCT01777152|449697512|FG001|Overall Study|Not eligible, no study drug received|0|||
125020003|NCT01777152|449697511|FG000|Overall Study|Change of diagnosis|1|||
125020004|NCT01777152|449697512|FG001|Overall Study|Change of diagnosis|0|||
125020005|NCT02792842|449697513|FG000|Overall Study|Adverse Event|4|||
125020006|NCT02792842|449697514|FG001|Overall Study|Adverse Event|2|||
125020007|NCT02792842|449697515|FG002|Overall Study|Adverse Event|3|||
125020008|NCT02792842|449697513|FG000|Overall Study|Withdrawal by Subject|0|||
125020009|NCT02792842|449697514|FG001|Overall Study|Withdrawal by Subject|1|||
125020010|NCT02792842|449697515|FG002|Overall Study|Withdrawal by Subject|2|||
125020011|NCT02792842|449697513|FG000|Overall Study|Lost to Follow-up|0|||
125020012|NCT02792842|449697514|FG001|Overall Study|Lost to Follow-up|0|||
125020013|NCT02792842|449697515|FG002|Overall Study|Lost to Follow-up|1|||
125020014|NCT02792842|449697513|FG000|Overall Study|Schedule delay|0|||
125020015|NCT02792842|449697514|FG001|Overall Study|Schedule delay|1|||
125020016|NCT02792842|449697515|FG002|Overall Study|Schedule delay|1|||
125020017|NCT01098071|449697520|FG000|Overall Study|Surgery (adenoidectomy)|2|||
125020018|NCT01098071|449697520|FG000|Overall Study|Lost to Follow-up|13|||
124899321|NCT02512042|449256044|FG001|Overall Study|Non-compliance with study drug|2|||
124899322|NCT02512042|449256043|FG000|Overall Study|Lost to Follow-up|5|||
124899323|NCT02512042|449256044|FG001|Overall Study|Lost to Follow-up|2|||
124899324|NCT02512042|449256043|FG000|Overall Study|Other|11|||
124899325|NCT02512042|449256044|FG001|Overall Study|Other|11|||
124899326|NCT04163458|449256045|FG000|Overall Study|Protocol Deviation|7|||
124899327|NCT04163458|449256046|FG001|Overall Study|Protocol Deviation|13|||
124899328|NCT04163458|449256045|FG000|Overall Study|Adverse Event|5|||
124899329|NCT04163458|449256046|FG001|Overall Study|Adverse Event|8|||
125020019|NCT04372927|449697523|FG000|Overall Study|Death|1|||
125020020|NCT01665807|449697524|FG000|Overall Study|Withdrawal by Subject|2|||
124899330|NCT04163458|449256045|FG000|Overall Study|Due to COVID-19 pandemic|4|||
124899331|NCT04163458|449256046|FG001|Overall Study|Due to COVID-19 pandemic|2|||
124899332|NCT04163458|449256045|FG000|Overall Study|Participant withdrew consent|2|||
124899333|NCT04163458|449256046|FG001|Overall Study|Participant withdrew consent|3|||
124899334|NCT04163458|449256045|FG000|Overall Study|Randomization failure|2|||
124899335|NCT04163458|449256046|FG001|Overall Study|Randomization failure|2|||
124899336|NCT04163458|449256045|FG000|Overall Study|Other|4|||
124899337|NCT04163458|449256046|FG001|Overall Study|Other|2|||
124899338|NCT01467700|449256050|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
124899339|NCT01467700|449256051|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
124899340|NCT01467700|449256052|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
124899341|NCT01467700|449256053|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
124899342|NCT01467700|449256050|FG000|Overall Study|Major Protocol Deviation|3|||
124899343|NCT01467700|449256051|FG001|Overall Study|Major Protocol Deviation|3|||
124899344|NCT01467700|449256052|FG002|Overall Study|Major Protocol Deviation|2|||
124899345|NCT01467700|449256053|FG003|Overall Study|Major Protocol Deviation|3|||
124899346|NCT01467700|449256050|FG000|Overall Study|Lost to Follow-up|6|||
124899347|NCT01467700|449256051|FG001|Overall Study|Lost to Follow-up|5|||
124899348|NCT01467700|449256052|FG002|Overall Study|Lost to Follow-up|2|||
125111592|NCT01078623|450032778|FG009|Treatment Period 4|Withdrawal by Subject|0|||
125111593|NCT01078623|450032779|FG010|Treatment Period 4|Withdrawal by Subject|0|||
125111594|NCT01078623|450032780|FG011|Treatment Period 4|Withdrawal by Subject|0|||
125111595|NCT01078623|450032781|FG012|Treatment Period 4|Withdrawal by Subject|0|||
125111596|NCT01078623|450032782|FG013|Treatment Period 4|Withdrawal by Subject|0|||
125111597|NCT01078623|450032783|FG014|Treatment Period 4|Withdrawal by Subject|0|||
125111598|NCT01078623|450032784|FG015|Treatment Period 4|Withdrawal by Subject|1|||
125111599|NCT01078623|450032785|FG016|Treatment Period 4|Withdrawal by Subject|0|||
125111600|NCT01078623|450032786|FG017|Treatment Period 4|Withdrawal by Subject|0|||
125111601|NCT01078623|450032787|FG018|Treatment Period 4|Withdrawal by Subject|0|||
125111602|NCT01078623|450032788|FG019|Treatment Period 4|Withdrawal by Subject|0|||
125111603|NCT02424565|450032790|FG000|Period 1 (D0)|Protocol Violation|0|||
125111604|NCT02424565|450032791|FG001|Period 1 (D0)|Protocol Violation|1|||
125111605|NCT03650400|450032792|FG000|Overall Study|Study terminated by sponsor|0|||
125111606|NCT03650400|450032793|FG001|Overall Study|Study terminated by sponsor|5|||
125111607|NCT04132232|450032803|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
125111608|NCT04132232|450032804|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
125111609|NCT04132232|450032803|FG000|Overall Study|Lost to Follow-up|6|||
125111610|NCT04132232|450032804|FG001|Overall Study|Lost to Follow-up|7|||
125111611|NCT00368537|450032805|FG000|Randomization|No study drug dosed|13|||
125111612|NCT00368537|450032806|FG001|Randomization|No study drug dosed|6|||
125111613|NCT00368537|450032805|FG000|Baseline Participants|Lost to Follow-up|16|||
125111614|NCT00368537|450032806|FG001|Baseline Participants|Lost to Follow-up|17|||
125111615|NCT00368537|450032805|FG000|Baseline Participants|Withdrawal by Subject|6|||
125111616|NCT00368537|450032806|FG001|Baseline Participants|Withdrawal by Subject|4|||
125111617|NCT00368537|450032805|FG000|Baseline Participants|Death|1|||
125111618|NCT00368537|450032806|FG001|Baseline Participants|Death|2|||
125111619|NCT00368537|450032805|FG000|Baseline Participants|No susceptibility|1|||
125111620|NCT00368537|450032806|FG001|Baseline Participants|No susceptibility|0|||
125111621|NCT00368537|450032805|FG000|Baseline Participants|Patient uncompliant|0|||
125111622|NCT00368537|450032806|FG001|Baseline Participants|Patient uncompliant|1|||
125111623|NCT01368276|450032820|FG000|Overall Study|Death|1|||
125111624|NCT01368276|450032821|FG001|Overall Study|Death|10|||
125111625|NCT01427920|450032822|FG000|Overall Study|Adverse Event|1|||
125111626|NCT01427920|450032823|FG001|Overall Study|Adverse Event|2|||
125111627|NCT01427920|450032822|FG000|Overall Study|Lack of Efficacy|1|||
125111628|NCT01427920|450032823|FG001|Overall Study|Lack of Efficacy|0|||
125111629|NCT01427920|450032822|FG000|Overall Study|Protocol Violation|1|||
125111630|NCT01427920|450032823|FG001|Overall Study|Protocol Violation|3|||
125111631|NCT01427920|450032822|FG000|Overall Study|Withdrawal Criteria|4|||
125111632|NCT01427920|450032823|FG001|Overall Study|Withdrawal Criteria|4|||
125111633|NCT01427920|450032822|FG000|Overall Study|Unclassified|2|||
124899349|NCT01467700|449256053|FG003|Overall Study|Lost to Follow-up|3|||
125111634|NCT01427920|450032823|FG001|Overall Study|Unclassified|8|||
125111635|NCT04228302|450032824|FG000|Overall Study|Adverse Event|0|||
125111636|NCT04228302|450032825|FG001|Overall Study|Adverse Event|0|||
125111637|NCT04228302|450032826|FG002|Overall Study|Adverse Event|0|||
125111638|NCT04228302|450032827|FG003|Overall Study|Adverse Event|0|||
124899350|NCT01467700|449256050|FG000|Overall Study|Voluntary Withdrawal|5|||
124899351|NCT01467700|449256051|FG001|Overall Study|Voluntary Withdrawal|7|||
124899352|NCT01467700|449256052|FG002|Overall Study|Voluntary Withdrawal|6|||
124899353|NCT01467700|449256053|FG003|Overall Study|Voluntary Withdrawal|2|||
125111639|NCT04228302|450032828|FG004|Overall Study|Adverse Event|1|||
125111640|NCT04228302|450032829|FG005|Overall Study|Adverse Event|0|||
125111641|NCT02732561|450032837|FG000|Overall Study|Lost to Follow-up|1|||
125111642|NCT02732561|450032838|FG001|Overall Study|Lost to Follow-up|1|||
125111643|NCT02732561|450032837|FG000|Overall Study|Withdrawal by Subject|1|||
125111644|NCT02732561|450032838|FG001|Overall Study|Withdrawal by Subject|0|||
125111645|NCT00837577|450032845|FG000|Double-blind Period|Clinical Adverse Event|1|||
125111646|NCT00837577|450032846|FG001|Double-blind Period|Clinical Adverse Event|0|||
125111647|NCT00837577|450032845|FG000|Double-blind Period|Withdrawal by Subject|1|||
125111648|NCT00837577|450032846|FG001|Double-blind Period|Withdrawal by Subject|0|||
125111649|NCT00837577|450032845|FG000|Open-label Period|Clinical Adverse Event|2|||
125111650|NCT00837577|450032846|FG001|Open-label Period|Clinical Adverse Event|2|||
125111651|NCT00837577|450032845|FG000|Open-label Period|Laboratory Adverse Event|0|||
125111652|NCT00837577|450032846|FG001|Open-label Period|Laboratory Adverse Event|1|||
125111653|NCT00837577|450032845|FG000|Open-label Period|Lack of Efficacy|4|||
125111654|NCT00837577|450032846|FG001|Open-label Period|Lack of Efficacy|3|||
125111655|NCT00837577|450032845|FG000|Open-label Period|Withdrawal by Subject|1|||
125111656|NCT00837577|450032846|FG001|Open-label Period|Withdrawal by Subject|2|||
125111657|NCT00837577|450032845|FG000|Open-label Period|Other Reason|1|||
125111658|NCT00837577|450032846|FG001|Open-label Period|Other Reason|1|||
125111659|NCT00272961|450032850|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
125111660|NCT00272961|450032851|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
125111661|NCT00272961|450032852|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
125111662|NCT00272961|450032853|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
125111663|NCT00272961|450032854|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
125111664|NCT00272961|450032850|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
125111665|NCT00272961|450032851|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
125111666|NCT00272961|450032852|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
125111667|NCT00272961|450032853|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
125111668|NCT00272961|450032854|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
125111669|NCT00272961|450032850|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
125111670|NCT00272961|450032851|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
125111671|NCT00272961|450032852|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
125111672|NCT00272961|450032853|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
125111673|NCT00272961|450032854|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
125111674|NCT00272961|450032850|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
125111675|NCT00272961|450032851|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
125111676|NCT00272961|450032852|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
125111677|NCT00272961|450032853|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
125111678|NCT00272961|450032854|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
125111679|NCT00272961|450032850|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
125111680|NCT00272961|450032851|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
125111681|NCT00272961|450032852|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
125111682|NCT00272961|450032853|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
125111683|NCT00272961|450032854|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
125111684|NCT00272961|450032850|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
125111685|NCT00272961|450032851|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
125111686|NCT00272961|450032852|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
124899354|NCT01467700|449256050|FG000|Overall Study|Study Termination|6|||
124899355|NCT01467700|449256051|FG001|Overall Study|Study Termination|5|||
124899356|NCT01467700|449256052|FG002|Overall Study|Study Termination|10|||
124899357|NCT01467700|449256053|FG003|Overall Study|Study Termination|7|||
124899358|NCT01467700|449256050|FG000|Overall Study|Pregnancy|0|||
124899359|NCT01467700|449256051|FG001|Overall Study|Pregnancy|1|||
124899360|NCT01467700|449256052|FG002|Overall Study|Pregnancy|1|||
125020021|NCT01665807|449697525|FG001|Overall Study|Withdrawal by Subject|0|||
125020022|NCT01665807|449697526|FG002|Overall Study|Withdrawal by Subject|1|||
125020023|NCT01081795|449697527|FG000|Overall Study|Adverse Event|18|||
125020024|NCT01081795|449697528|FG001|Overall Study|Adverse Event|23|||
125020025|NCT01081795|449697529|FG002|Overall Study|Adverse Event|6|||
125020026|NCT01081795|449697527|FG000|Overall Study|Lack of Efficacy|7|||
125020027|NCT01081795|449697528|FG001|Overall Study|Lack of Efficacy|5|||
125020028|NCT01081795|449697529|FG002|Overall Study|Lack of Efficacy|19|||
125020029|NCT01081795|449697527|FG000|Overall Study|Subject's schedule|1|||
125020030|NCT01081795|449697528|FG001|Overall Study|Subject's schedule|1|||
125020031|NCT01081795|449697529|FG002|Overall Study|Subject's schedule|2|||
125020032|NCT01081795|449697527|FG000|Overall Study|Revocation of informed consent|2|||
125020033|NCT01081795|449697528|FG001|Overall Study|Revocation of informed consent|0|||
125020034|NCT01081795|449697529|FG002|Overall Study|Revocation of informed consent|0|||
125020035|NCT01081795|449697527|FG000|Overall Study|Ineligible for participation|1|||
125020036|NCT01081795|449697528|FG001|Overall Study|Ineligible for participation|0|||
125020037|NCT01081795|449697529|FG002|Overall Study|Ineligible for participation|0|||
125020038|NCT01081795|449697527|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
125020039|NCT01081795|449697528|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
125020040|NCT01081795|449697529|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
125020041|NCT01081795|449697527|FG000|Overall Study|Using drug with restricted days of use|2|||
124899361|NCT01467700|449256053|FG003|Overall Study|Pregnancy|0|||
124899362|NCT01467700|449256050|FG000|Overall Study|Lack of Efficacy|2|||
124899363|NCT01467700|449256051|FG001|Overall Study|Lack of Efficacy|0|||
124899364|NCT01467700|449256052|FG002|Overall Study|Lack of Efficacy|2|||
124899365|NCT01467700|449256053|FG003|Overall Study|Lack of Efficacy|1|||
124899366|NCT01467700|449256050|FG000|Overall Study|Reason not Specified|1|||
124899367|NCT01467700|449256051|FG001|Overall Study|Reason not Specified|3|||
124899368|NCT01467700|449256052|FG002|Overall Study|Reason not Specified|2|||
124899369|NCT01467700|449256053|FG003|Overall Study|Reason not Specified|8|||
124899370|NCT01253226|449256054|FG000|Overall Study|Adverse Event|0|||
124899371|NCT01253226|449256055|FG001|Overall Study|Adverse Event|0|||
124899372|NCT01253226|449256056|FG002|Overall Study|Adverse Event|1|||
124899373|NCT01253226|449256057|FG003|Overall Study|Adverse Event|0|||
124899374|NCT01253226|449256058|FG004|Overall Study|Adverse Event|0|||
124899375|NCT01253226|449256054|FG000|Overall Study|Death|0|||
124899376|NCT01253226|449256055|FG001|Overall Study|Death|1|||
124899377|NCT01253226|449256056|FG002|Overall Study|Death|0|||
124899378|NCT01253226|449256057|FG003|Overall Study|Death|0|||
124899379|NCT01253226|449256058|FG004|Overall Study|Death|0|||
124899380|NCT01253226|449256054|FG000|Overall Study|Physician Decision|0|||
124899381|NCT01253226|449256055|FG001|Overall Study|Physician Decision|0|||
124899382|NCT01253226|449256056|FG002|Overall Study|Physician Decision|0|||
124899383|NCT01253226|449256057|FG003|Overall Study|Physician Decision|0|||
124899384|NCT01253226|449256058|FG004|Overall Study|Physician Decision|2|||
124899385|NCT01253226|449256054|FG000|Overall Study|Withdrawal by Subject|0|||
124899386|NCT01253226|449256055|FG001|Overall Study|Withdrawal by Subject|0|||
124899387|NCT01253226|449256056|FG002|Overall Study|Withdrawal by Subject|0|||
124899388|NCT01253226|449256057|FG003|Overall Study|Withdrawal by Subject|1|||
124899389|NCT01253226|449256058|FG004|Overall Study|Withdrawal by Subject|0|||
124899390|NCT00988637|449256059|FG000|Overall Study|Lost to Follow-up|2|||
124899391|NCT00988637|449256060|FG001|Overall Study|Lost to Follow-up|1|||
124899392|NCT00988637|449256059|FG000|Overall Study|Withdrawal by Subject|1|||
124899393|NCT00988637|449256060|FG001|Overall Study|Withdrawal by Subject|1|||
124899394|NCT00988637|449256059|FG000|Overall Study|non-compliance with study drug|0|||
124899395|NCT00988637|449256060|FG001|Overall Study|non-compliance with study drug|1|||
124899396|NCT03593070|449256062|FG000|Overall Study|administrative withdrawal|1|||
124899397|NCT03593070|449256063|FG001|Overall Study|administrative withdrawal|1|||
124899398|NCT01582945|449256064|FG000|Overall Study|Intolerable side-effects|1|||
124899399|NCT01582945|449256064|FG000|Overall Study|Scheduling conflicts|1|||
124899400|NCT03310983|449256065|FG000|Overall Study|Lost to Follow-up|15|||
124899401|NCT03310983|449256066|FG001|Overall Study|Lost to Follow-up|17|||
124899402|NCT01656304|449256068|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
124899403|NCT00881335|449256076|FG000|Overall Study|Lost to Follow-up|3|||
124899404|NCT00881335|449256077|FG001|Overall Study|Lost to Follow-up|2|||
124899405|NCT00477412|449256078|FG000|Overall Study|Death|0|||
124899406|NCT00477412|449256079|FG001|Overall Study|Death|0|||
124899407|NCT00477412|449256080|FG002|Overall Study|Death|0|||
124899408|NCT00477412|449256081|FG003|Overall Study|Death|4|||
124899409|NCT00477412|449256078|FG000|Overall Study|Lost to Follow-up|0|||
124899410|NCT00477412|449256079|FG001|Overall Study|Lost to Follow-up|0|||
124899411|NCT00477412|449256080|FG002|Overall Study|Lost to Follow-up|0|||
124899412|NCT00477412|449256081|FG003|Overall Study|Lost to Follow-up|1|||
124899413|NCT00477412|449256078|FG000|Overall Study|Withdrawal by Subject|0|||
124899414|NCT00477412|449256079|FG001|Overall Study|Withdrawal by Subject|0|||
124899415|NCT00477412|449256080|FG002|Overall Study|Withdrawal by Subject|0|||
124899416|NCT00477412|449256081|FG003|Overall Study|Withdrawal by Subject|2|||
124899417|NCT00477412|449256078|FG000|Overall Study|Second Malignancy|0|||
124899418|NCT00477412|449256079|FG001|Overall Study|Second Malignancy|0|||
124899419|NCT00477412|449256080|FG002|Overall Study|Second Malignancy|0|||
124899420|NCT00477412|449256081|FG003|Overall Study|Second Malignancy|1|||
124899421|NCT00477412|449256078|FG000|Overall Study|Adverse Event|1|||
124899422|NCT00477412|449256079|FG001|Overall Study|Adverse Event|0|||
124899423|NCT00477412|449256080|FG002|Overall Study|Adverse Event|1|||
124899424|NCT00477412|449256081|FG003|Overall Study|Adverse Event|0|||
124899425|NCT01838200|449256082|FG000|Overall Study|Adverse Event|0|||
124899426|NCT01838200|449256083|FG001|Overall Study|Adverse Event|2|||
124899427|NCT01838200|449256082|FG000|Overall Study|Progressive disease|3|||
124899428|NCT01838200|449256083|FG001|Overall Study|Progressive disease|0|||
124899429|NCT00762463|449257876|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
124899430|NCT00762463|449257877|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
124899431|NCT00762463|449257878|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
124899432|NCT00762463|449257879|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
124899433|NCT00762463|449257876|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
124899434|NCT00762463|449257877|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
124899435|NCT00762463|449257878|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
125020042|NCT01081795|449697528|FG001|Overall Study|Using drug with restricted days of use|3|||
125020043|NCT01081795|449697529|FG002|Overall Study|Using drug with restricted days of use|2|||
125020044|NCT01081795|449697527|FG000|Overall Study|Other|1|||
125020045|NCT01081795|449697528|FG001|Overall Study|Other|2|||
125020046|NCT01081795|449697529|FG002|Overall Study|Other|0|||
125020047|NCT00661271|449697530|FG000|Overall Study|Lost to Follow-up|28|||
125020048|NCT00661271|449697531|FG001|Overall Study|Lost to Follow-up|25|||
125020049|NCT01707693|449697533|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
125020050|NCT01707693|449697534|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
125020051|NCT01707693|449697533|FG000|Overall Study Allocation|Protocol Violation|4|||
125020052|NCT01707693|449697534|FG001|Overall Study Allocation|Protocol Violation|3|||
125020053|NCT01707693|449697533|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
125020054|NCT01707693|449697534|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
125020055|NCT01707693|449697533|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
125020056|NCT01707693|449697534|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
125020057|NCT03847610|449697535|FG000|Overall Study|Withdrawal by Subject|1|||
125020058|NCT01967537|449697541|FG000|Overall Study|Withdrawal by Subject|52|||
125020059|NCT01967537|449697541|FG000|Overall Study|Refuse treatment|2|||
125020060|NCT01967537|449697541|FG000|Overall Study|Lost to Follow-up|6|||
125020061|NCT05130463|449697542|FG000|Overall Study|Unspecified reasons|2|||
125020062|NCT05130463|449697542|FG000|Overall Study|off-label indication dose|435|||
125020063|NCT03461757|449697543|FG000|Overall Study|Adverse Event|1|||
125020064|NCT03461757|449697544|FG001|Overall Study|Adverse Event|0|||
125020065|NCT03461757|449697543|FG000|Overall Study|Lost to Follow-up|13|||
125020066|NCT03461757|449697544|FG001|Overall Study|Lost to Follow-up|7|||
125020067|NCT03461757|449697543|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
125020068|NCT03461757|449697544|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
125020069|NCT03461757|449697543|FG000|Overall Study|Non-compliance with study treatment|0|||
125020070|NCT03461757|449697544|FG001|Overall Study|Non-compliance with study treatment|1|||
125020071|NCT03461757|449697543|FG000|Overall Study|Pregnancy|2|||
125020072|NCT03461757|449697544|FG001|Overall Study|Pregnancy|0|||
125020073|NCT03461757|449697543|FG000|Overall Study|Protocol Violation|1|||
125020074|NCT03461757|449697544|FG001|Overall Study|Protocol Violation|1|||
125020075|NCT03461757|449697543|FG000|Overall Study|Withdrawal by Subject|7|||
125020076|NCT03461757|449697544|FG001|Overall Study|Withdrawal by Subject|7|||
125020077|NCT03461757|449697543|FG000|Overall Study|Other Reasons|1|||
125020078|NCT03461757|449697544|FG001|Overall Study|Other Reasons|4|||
125020079|NCT03652662|449697550|FG000|Overall Study|Withdrawal by Subject|2|||
125020080|NCT03652662|449697551|FG001|Overall Study|Withdrawal by Subject|1|||
125020081|NCT03652662|449697550|FG000|Overall Study|Lost to Follow-up|1|||
125020082|NCT03652662|449697551|FG001|Overall Study|Lost to Follow-up|0|||
125020083|NCT03861559|449697552|FG000|Overall Study|Adverse Event|0|||
125020084|NCT03861559|449697553|FG001|Overall Study|Adverse Event|2|||
125020085|NCT03861559|449697552|FG000|Overall Study|Treatment failure|0|||
125020086|NCT03861559|449697553|FG001|Overall Study|Treatment failure|2|||
125020087|NCT03861559|449697552|FG000|Overall Study|Noncompliance|1|||
125020088|NCT03861559|449697553|FG001|Overall Study|Noncompliance|1|||
125020089|NCT03861559|449697552|FG000|Overall Study|Did not meet eligibility requirements|1|||
125020090|NCT03861559|449697553|FG001|Overall Study|Did not meet eligibility requirements|0|||
125020091|NCT00720109|449697554|FG000|Induction Period|Did not meet eligibility criteria|3|||
125020092|NCT00720109|449697555|FG001|Induction Period|Did not meet eligibility criteria|0|||
125020093|NCT00720109|449697556|FG002|Induction Period|Did not meet eligibility criteria|0|||
125020094|NCT00720109|449697554|FG000|Induction Period|Bone Marrow Transplant|2|||
125020095|NCT00720109|449697555|FG001|Induction Period|Bone Marrow Transplant|0|||
125020096|NCT00720109|449697556|FG002|Induction Period|Bone Marrow Transplant|0|||
125020097|NCT00720109|449697554|FG000|Induction Period|Physician Decision|1|||
125020098|NCT00720109|449697555|FG001|Induction Period|Physician Decision|0|||
125020099|NCT00720109|449697556|FG002|Induction Period|Physician Decision|0|||
125020100|NCT00720109|449697554|FG000|Risk Stratification Period|Adverse Event|0|||
125020101|NCT00720109|449697555|FG001|Risk Stratification Period|Adverse Event|1|||
125020102|NCT00720109|449697556|FG002|Risk Stratification Period|Adverse Event|0|||
125020103|NCT00720109|449697554|FG000|Risk Stratification Period|Physician Decision|0|||
125020104|NCT00720109|449697555|FG001|Risk Stratification Period|Physician Decision|2|||
125020105|NCT00720109|449697556|FG002|Risk Stratification Period|Physician Decision|1|||
125020106|NCT00720109|449697554|FG000|Risk Stratification Period|Bone marrow transplant|0|||
125020107|NCT00720109|449697555|FG001|Risk Stratification Period|Bone marrow transplant|9|||
125020108|NCT00720109|449697556|FG002|Risk Stratification Period|Bone marrow transplant|7|||
125020109|NCT00720109|449697554|FG000|Risk Stratification Period|Disease progression or relapse|0|||
125020110|NCT00720109|449697555|FG001|Risk Stratification Period|Disease progression or relapse|2|||
125020111|NCT00720109|449697556|FG002|Risk Stratification Period|Disease progression or relapse|0|||
125020112|NCT00720109|449697554|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
124899436|NCT00762463|449257879|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
124899437|NCT00762463|449257876|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
124899438|NCT00762463|449257877|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
124899439|NCT00762463|449257878|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
124899440|NCT00762463|449257879|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
124899441|NCT00762463|449257876|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
124899442|NCT00762463|449257877|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
124899443|NCT00762463|449257878|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
124899444|NCT00762463|449257879|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
124899445|NCT00762463|449257876|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
124899446|NCT00762463|449257877|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
124899447|NCT00762463|449257878|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
124899448|NCT00762463|449257879|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
124899449|NCT00762463|449257876|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
124899450|NCT00762463|449257877|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
124899451|NCT00762463|449257878|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
124899452|NCT00762463|449257879|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
124899453|NCT00762463|449257876|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
124899454|NCT00762463|449257877|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
124899455|NCT00762463|449257878|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
124899456|NCT00762463|449257879|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
124899457|NCT00762463|449257876|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
124899458|NCT00762463|449257877|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
124899459|NCT00762463|449257878|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
124899460|NCT00762463|449257879|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
124899461|NCT01306331|449257880|FG000|Overall Study|Adverse Event|28|||
125020113|NCT00720109|449697555|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
125020114|NCT00720109|449697556|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
125020115|NCT03595553|449697557|FG000|Overall Study|Withdrawal by Subject|20|||
125020116|NCT03595553|449697558|FG001|Overall Study|Withdrawal by Subject|8|||
125020117|NCT03595553|449697557|FG000|Overall Study|Physician Decision|3|||
125020118|NCT03595553|449697558|FG001|Overall Study|Physician Decision|2|||
125020119|NCT03595553|449697557|FG000|Overall Study|Adverse Event|2|||
125020120|NCT03595553|449697558|FG001|Overall Study|Adverse Event|5|||
125020121|NCT03595553|449697557|FG000|Overall Study|Death|24|||
125020122|NCT03595553|449697558|FG001|Overall Study|Death|22|||
125020123|NCT03595553|449697557|FG000|Overall Study|Lost to Follow-up|6|||
125020124|NCT03595553|449697558|FG001|Overall Study|Lost to Follow-up|7|||
125020125|NCT03595553|449697557|FG000|Overall Study|Other as indicated in CSR|3|||
125020126|NCT03595553|449697558|FG001|Overall Study|Other as indicated in CSR|3|||
125020127|NCT03595553|449697557|FG000|Overall Study|Sponsor Decision|0|||
125020128|NCT03595553|449697558|FG001|Overall Study|Sponsor Decision|1|||
125020129|NCT00903175|449697559|FG000|Period 1 - First Line|Adverse Event|36|||
125020130|NCT00903175|449697560|FG001|Period 1 - First Line|Adverse Event|50|||
125020131|NCT00903175|449697559|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
125020132|NCT00903175|449697560|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
125020133|NCT00903175|449697559|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
125020134|NCT00903175|449697560|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
125020135|NCT00903175|449697559|FG000|Period 1 - First Line|Protocol Violation|3|||
125020136|NCT00903175|449697560|FG001|Period 1 - First Line|Protocol Violation|3|||
125020137|NCT00903175|449697559|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
125020138|NCT00903175|449697560|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
125020139|NCT00903175|449697559|FG000|Period 1 - First Line|Administrative problems|12|||
125020140|NCT00903175|449697560|FG001|Period 1 - First Line|Administrative problems|13|||
125020141|NCT00903175|449697559|FG000|Period 1 - First Line|Death|17|||
125020142|NCT00903175|449697560|FG001|Period 1 - First Line|Death|10|||
125020143|NCT00903175|449697559|FG000|Period 2 - Second Line|Missing|1|||
125020144|NCT00903175|449697560|FG001|Period 2 - Second Line|Missing|0|||
125020145|NCT00903175|449697559|FG000|Period 2 - Second Line|Adverse Event|16|||
125020146|NCT00903175|449697560|FG001|Period 2 - Second Line|Adverse Event|20|||
125020147|NCT00903175|449697559|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
125020148|NCT00903175|449697560|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
125020149|NCT00903175|449697559|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
125020150|NCT00903175|449697560|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
125020151|NCT00903175|449697559|FG000|Period 2 - Second Line|Administrative problems|19|||
125020152|NCT00903175|449697560|FG001|Period 2 - Second Line|Administrative problems|9|||
125020153|NCT00903175|449697559|FG000|Period 2 - Second Line|Death|5|||
125020154|NCT00903175|449697560|FG001|Period 2 - Second Line|Death|2|||
125020155|NCT01687712|449697563|FG000|Cycle 1|Not Biochemically Pregnant|386|||
125020156|NCT01687712|449697564|FG001|Cycle 1|Not Biochemically Pregnant|348|||
124899462|NCT01306331|449257881|FG001|Overall Study|Adverse Event|25|||
124899463|NCT01306331|449257880|FG000|Overall Study|Lost to Follow-up|321|||
124899464|NCT01306331|449257881|FG001|Overall Study|Lost to Follow-up|323|||
124899465|NCT01306331|449257880|FG000|Overall Study|Physician Decision|26|||
124899466|NCT01306331|449257881|FG001|Overall Study|Physician Decision|22|||
124899467|NCT01306331|449257880|FG000|Overall Study|Pregnancy|136|||
124899468|NCT01306331|449257881|FG001|Overall Study|Pregnancy|151|||
124899469|NCT01306331|449257880|FG000|Overall Study|Protocol Violation|154|||
124899470|NCT01306331|449257881|FG001|Overall Study|Protocol Violation|124|||
124899471|NCT01306331|449257880|FG000|Overall Study|Withdrawal by Subject|163|||
124899472|NCT01306331|449257881|FG001|Overall Study|Withdrawal by Subject|152|||
124899473|NCT01306331|449257880|FG000|Overall Study|Not sexually active|29|||
124899474|NCT01306331|449257881|FG001|Overall Study|Not sexually active|28|||
124899475|NCT01306331|449257880|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
124899476|NCT01306331|449257881|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
124899477|NCT01306331|449257880|FG000|Overall Study|Other|34|||
124899478|NCT01306331|449257881|FG001|Overall Study|Other|32|||
124899479|NCT00172185|449257884|FG000|Overall Study|Adverse Event|0|||
124899480|NCT00172185|449257885|FG001|Overall Study|Adverse Event|1|||
124899481|NCT00172185|449257886|FG002|Overall Study|Adverse Event|3|||
124899482|NCT00172185|449257887|FG003|Overall Study|Adverse Event|4|||
124899483|NCT00172185|449257884|FG000|Overall Study|Physician Decision|0|||
124899484|NCT00172185|449257885|FG001|Overall Study|Physician Decision|0|||
124899485|NCT00172185|449257886|FG002|Overall Study|Physician Decision|1|||
124899486|NCT00172185|449257887|FG003|Overall Study|Physician Decision|0|||
124899487|NCT00172185|449257884|FG000|Overall Study|SPONSOR Decision|0|||
124899488|NCT00172185|449257885|FG001|Overall Study|SPONSOR Decision|1|||
124899489|NCT00172185|449257886|FG002|Overall Study|SPONSOR Decision|0|||
124899490|NCT00172185|449257887|FG003|Overall Study|SPONSOR Decision|0|||
124899491|NCT00172185|449257884|FG000|Overall Study|Withdrawal by Subject|0|||
124899492|NCT00172185|449257885|FG001|Overall Study|Withdrawal by Subject|0|||
124899493|NCT00172185|449257886|FG002|Overall Study|Withdrawal by Subject|1|||
124899494|NCT00172185|449257887|FG003|Overall Study|Withdrawal by Subject|0|||
124899495|NCT04048135|449257888|FG000|Overall Study|Withdrawal by Subject|1|||
124899496|NCT04048135|449257889|FG001|Overall Study|Withdrawal by Subject|1|||
124899497|NCT04048135|449257890|FG002|Overall Study|Withdrawal by Subject|1|||
124899498|NCT04048135|449257891|FG003|Overall Study|Withdrawal by Subject|2|||
124899499|NCT04048135|449257892|FG004|Overall Study|Withdrawal by Subject|0|||
124899500|NCT04048135|449257893|FG005|Overall Study|Withdrawal by Subject|0|||
124899501|NCT04048135|449257894|FG006|Overall Study|Withdrawal by Subject|1|||
124899502|NCT04048135|449257895|FG007|Overall Study|Withdrawal by Subject|1|||
124899503|NCT04048135|449257888|FG000|Overall Study|Adverse Event|0|||
124899504|NCT04048135|449257889|FG001|Overall Study|Adverse Event|0|||
124899505|NCT04048135|449257890|FG002|Overall Study|Adverse Event|0|||
124899506|NCT04048135|449257891|FG003|Overall Study|Adverse Event|1|||
124899507|NCT04048135|449257892|FG004|Overall Study|Adverse Event|1|||
124899508|NCT04048135|449257893|FG005|Overall Study|Adverse Event|0|||
124899509|NCT04048135|449257894|FG006|Overall Study|Adverse Event|0|||
124899510|NCT04048135|449257895|FG007|Overall Study|Adverse Event|0|||
124899511|NCT04048135|449257888|FG000|Overall Study|Protocol Violation|0|||
124899512|NCT04048135|449257889|FG001|Overall Study|Protocol Violation|0|||
124899513|NCT04048135|449257890|FG002|Overall Study|Protocol Violation|0|||
124899514|NCT04048135|449257891|FG003|Overall Study|Protocol Violation|0|||
124899515|NCT04048135|449257892|FG004|Overall Study|Protocol Violation|0|||
124899516|NCT04048135|449257893|FG005|Overall Study|Protocol Violation|1|||
124899517|NCT04048135|449257894|FG006|Overall Study|Protocol Violation|0|||
124899518|NCT04048135|449257895|FG007|Overall Study|Protocol Violation|0|||
124899519|NCT01677936|449257896|FG000|Overall Study|Lost to Follow-up|4|||
124899520|NCT01677936|449257897|FG001|Overall Study|Lost to Follow-up|1|||
124899521|NCT01677936|449257896|FG000|Overall Study|Protocol Violation|3|||
124899522|NCT01677936|449257897|FG001|Overall Study|Protocol Violation|0|||
124899523|NCT01677936|449257896|FG000|Overall Study|Adverse Event|1|||
124899524|NCT01677936|449257897|FG001|Overall Study|Adverse Event|0|||
124899525|NCT01677936|449257896|FG000|Overall Study|Lost to Follow-up|1|||
124899526|NCT01677936|449257897|FG001|Overall Study|Lost to Follow-up|0|||
124899527|NCT01677936|449257896|FG000|Overall Study|Protocol Violation|0|||
124899528|NCT01677936|449257897|FG001|Overall Study|Protocol Violation|4|||
124899529|NCT04358549|449257898|FG000|Overall Study|Adverse Event|0|||
124899530|NCT04358549|449257899|FG001|Overall Study|Adverse Event|1|||
124899531|NCT04358549|449257898|FG000|Overall Study|Death|1|||
124899532|NCT04358549|449257899|FG001|Overall Study|Death|0|||
124899533|NCT04358549|449257898|FG000|Overall Study|Lost to Follow-up|2|||
124899534|NCT04358549|449257899|FG001|Overall Study|Lost to Follow-up|1|||
124899535|NCT04358549|449257898|FG000|Overall Study|Withdrawal by Subject|6|||
124899536|NCT04358549|449257899|FG001|Overall Study|Withdrawal by Subject|6|||
124899537|NCT04358549|449257898|FG000|Overall Study|Start remdesivir|1|||
124899538|NCT04358549|449257899|FG001|Overall Study|Start remdesivir|0|||
124899539|NCT03895034|449257900|FG000|Overall Study|Lost to Follow-up|2|||
124899540|NCT01118377|449257901|FG000|Overall Study|Did Not Receive Study Medication|1|||
124899541|NCT01118377|449257901|FG000|Overall Study|Death|38|||
124899542|NCT01118377|449257901|FG000|Overall Study|Failure to Return|3|||
124899543|NCT01510912|449257906|FG000|Overall Study|Adverse Event|99|||
124899544|NCT01510912|449257906|FG000|Overall Study|Lack of Efficacy|12|||
124899545|NCT01510912|449257906|FG000|Overall Study|Non-compliance with trial drug|23|||
124899546|NCT01510912|449257906|FG000|Overall Study|Withdrawal by Subject|49|||
124899547|NCT01510912|449257906|FG000|Overall Study|Physician Decision|1|||
124899548|NCT01510912|449257906|FG000|Overall Study|Protocol Violation|27|||
124899549|NCT01510912|449257906|FG000|Overall Study|Lost to Follow-up|26|||
124899550|NCT01510912|449257906|FG000|Overall Study|Other, including joint replacement|5|||
124899551|NCT00157014|449257907|FG000|Overall Study|Death|4|||
124899552|NCT00157014|449257908|FG001|Overall Study|Death|2|||
124899553|NCT00157014|449257909|FG002|Overall Study|Death|1|||
124899554|NCT00157014|449257910|FG003|Overall Study|Death|1|||
124899555|NCT00157014|449257907|FG000|Overall Study|Physician Decision|0|||
124899556|NCT00157014|449257908|FG001|Overall Study|Physician Decision|1|||
124899557|NCT00157014|449257909|FG002|Overall Study|Physician Decision|0|||
124899558|NCT00157014|449257910|FG003|Overall Study|Physician Decision|0|||
124899559|NCT00157014|449257907|FG000|Overall Study|Medications withdrawn on family request|0|||
124899560|NCT00157014|449257908|FG001|Overall Study|Medications withdrawn on family request|1|||
124899561|NCT00157014|449257909|FG002|Overall Study|Medications withdrawn on family request|0|||
124899562|NCT00157014|449257910|FG003|Overall Study|Medications withdrawn on family request|0|||
124899563|NCT00157014|449257907|FG000|Overall Study|Patient withdrawn by investigator|1|||
124899564|NCT00157014|449257908|FG001|Overall Study|Patient withdrawn by investigator|0|||
124899565|NCT00157014|449257909|FG002|Overall Study|Patient withdrawn by investigator|0|||
124899566|NCT00157014|449257910|FG003|Overall Study|Patient withdrawn by investigator|0|||
124899567|NCT00157014|449257907|FG000|Overall Study|Patient unable to return in nursing home|1|||
124899568|NCT00157014|449257908|FG001|Overall Study|Patient unable to return in nursing home|0|||
124899569|NCT00157014|449257909|FG002|Overall Study|Patient unable to return in nursing home|0|||
124899570|NCT00157014|449257910|FG003|Overall Study|Patient unable to return in nursing home|0|||
124899571|NCT00157014|449257907|FG000|Overall Study|Patient would not receive transplant|0|||
124899572|NCT00157014|449257908|FG001|Overall Study|Patient would not receive transplant|1|||
124899573|NCT00157014|449257909|FG002|Overall Study|Patient would not receive transplant|0|||
124899574|NCT00157014|449257910|FG003|Overall Study|Patient would not receive transplant|0|||
124899575|NCT00157014|449257907|FG000|Overall Study|Withdrawal by Subject|1|||
124899576|NCT00157014|449257908|FG001|Overall Study|Withdrawal by Subject|0|||
124899577|NCT00157014|449257909|FG002|Overall Study|Withdrawal by Subject|0|||
124899578|NCT00157014|449257910|FG003|Overall Study|Withdrawal by Subject|0|||
124899579|NCT03181958|449257911|FG000|Overall Study|Lost to Follow-up|17|||
124899580|NCT03181958|449257912|FG001|Overall Study|Lost to Follow-up|21|||
124899581|NCT03181958|449257913|FG002|Overall Study|Lost to Follow-up|15|||
124899582|NCT01257503|449257914|FG000|Overall Study|Lost to Follow-up|7|||
124899583|NCT01257503|449257915|FG001|Overall Study|Lost to Follow-up|10|||
124899584|NCT01257503|449257914|FG000|Overall Study|Over 5 years old at enrollment|0|||
124899585|NCT01257503|449257915|FG001|Overall Study|Over 5 years old at enrollment|1|||
124899586|NCT01257503|449257914|FG000|Overall Study|strep culture positive at enrollment|1|||
124899587|NCT01257503|449257915|FG001|Overall Study|strep culture positive at enrollment|0|||
124899588|NCT04867902|449257916|FG000|Overall Study|Lost to Follow-up|1|||
124899589|NCT04867902|449257916|FG000|Overall Study|Withdrawal by Subject|2|||
124899590|NCT04867902|449257916|FG000|Overall Study|Protocol Violation|1|||
124899591|NCT05355116|449257917|FG000|Overall Study|Withdrawal by Subject|2|||
125111687|NCT00272961|450032853|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
124899592|NCT02380742|449257918|FG000|Overall Study|Withdrawal by Subject|1|||
124899593|NCT02380742|449257919|FG001|Overall Study|Withdrawal by Subject|0|||
124899594|NCT00151996|449257920|FG000|Overall Study|Adverse Event|3|||
124899595|NCT00151996|449257921|FG001|Overall Study|Adverse Event|2|||
125020157|NCT01687712|449697563|FG000|Cycle 1|Early Pregnancy Loss|43|||
125020158|NCT01687712|449697564|FG001|Cycle 1|Early Pregnancy Loss|60|||
125020159|NCT01687712|449697563|FG000|Cycle 1|Ectopic Pregnancy|5|||
125020160|NCT01687712|449697564|FG001|Cycle 1|Ectopic Pregnancy|5|||
125020161|NCT01687712|449697563|FG000|Cycle 1|Heterotropic Pregnancy|1|||
125020162|NCT01687712|449697564|FG001|Cycle 1|Heterotropic Pregnancy|0|||
125020163|NCT01687712|449697563|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
125020164|NCT01687712|449697564|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
125020165|NCT01687712|449697563|FG000|Cycle 1|Abortion|3|||
125020166|NCT01687712|449697564|FG001|Cycle 1|Abortion|0|||
125020167|NCT01687712|449697563|FG000|Cycle 1|Intrauterine Fetal Death|0|||
125020168|NCT01687712|449697564|FG001|Cycle 1|Intrauterine Fetal Death|1|||
125020169|NCT01687712|449697563|FG000|Cycle 1|Lost to Follow-up|1|||
125020170|NCT01687712|449697564|FG001|Cycle 1|Lost to Follow-up|1|||
125020171|NCT01687712|449697563|FG000|Cycle 2|Not Biochemically Pregnant|74|||
125020172|NCT01687712|449697564|FG001|Cycle 2|Not Biochemically Pregnant|77|||
125020173|NCT01687712|449697563|FG000|Cycle 2|Early Pregnancy Loss|18|||
125020174|NCT01687712|449697564|FG001|Cycle 2|Early Pregnancy Loss|16|||
125020175|NCT01687712|449697563|FG000|Cycle 2|Ectopic Pregnancy|0|||
125020176|NCT01687712|449697564|FG001|Cycle 2|Ectopic Pregnancy|1|||
125020177|NCT01687712|449697563|FG000|Cycle 2|Still Birth|1|||
124899596|NCT00151996|449257920|FG000|Overall Study|Withdrawal by Subject|1|||
124899597|NCT00151996|449257921|FG001|Overall Study|Withdrawal by Subject|1|||
124899598|NCT00151996|449257920|FG000|Overall Study|Protocol Violation|1|||
124899599|NCT00151996|449257921|FG001|Overall Study|Protocol Violation|2|||
124899600|NCT00151996|449257920|FG000|Overall Study|Sponsor's decision|0|||
124899601|NCT00151996|449257921|FG001|Overall Study|Sponsor's decision|2|||
124899602|NCT03439124|449257922|FG000|Overall Study|Adverse Event|2|||
124899603|NCT03439124|449257923|FG001|Overall Study|Adverse Event|0|||
124899604|NCT03439124|449257922|FG000|Overall Study|Lost to Follow-up|1|||
124899605|NCT03439124|449257923|FG001|Overall Study|Lost to Follow-up|0|||
124899606|NCT03439124|449257922|FG000|Overall Study|Other reasons|1|||
124899607|NCT03439124|449257923|FG001|Overall Study|Other reasons|0|||
124899608|NCT02236559|449257924|FG000|Overall Study|Met Exclusion|3|||
124899609|NCT02236559|449257925|FG001|Overall Study|Met Exclusion|6|||
124899610|NCT02236559|449257924|FG000|Overall Study|Did not Meet Inclusion|3|||
124899611|NCT02236559|449257925|FG001|Overall Study|Did not Meet Inclusion|3|||
124899612|NCT02236559|449257924|FG000|Overall Study|Subject Did Not Consent|4|||
124899613|NCT02236559|449257925|FG001|Overall Study|Subject Did Not Consent|2|||
124899614|NCT02236559|449257924|FG000|Overall Study|Physician Decision|1|||
124899615|NCT02236559|449257925|FG001|Overall Study|Physician Decision|1|||
124899616|NCT02236559|449257924|FG000|Overall Study|Withdrawal by Subject|1|||
124899617|NCT02236559|449257925|FG001|Overall Study|Withdrawal by Subject|0|||
124899618|NCT01117480|449257926|FG000|Overall Study|Protocol Violation|8|||
124899619|NCT01117480|449257926|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
124899620|NCT00943605|449257927|FG000|Overall Study|Study termination|30|||
124899621|NCT00943605|449257928|FG001|Overall Study|Study termination|30|||
124899622|NCT02131324|449257931|FG000|Overall Study|Withdrawal by Subject|1|||
125111688|NCT00272961|450032854|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
125111689|NCT00272961|450032850|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
125111690|NCT00272961|450032851|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
125111691|NCT00272961|450032852|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
125111692|NCT00272961|450032853|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
125111693|NCT00272961|450032854|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
125111694|NCT00272961|450032850|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
125111695|NCT00272961|450032851|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
125111696|NCT00272961|450032852|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
125111697|NCT00272961|450032853|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
125111698|NCT00272961|450032854|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
125111699|NCT02065791|450032855|FG000|Overall Study|Closed Site|1|||
125111700|NCT02065791|450032856|FG001|Overall Study|Closed Site|1|||
125111701|NCT02065791|450032855|FG000|Overall Study|Withdrawal by Subject|11|||
124899623|NCT02131324|449257932|FG001|Overall Study|Withdrawal by Subject|2|||
124899624|NCT02131324|449257931|FG000|Overall Study|Lost to Follow-up|1|||
124899625|NCT02131324|449257932|FG001|Overall Study|Lost to Follow-up|1|||
124899626|NCT00891618|449257933|FG000|Overall Study|Withdrawal by Subject|1|||
124899627|NCT01693614|449257934|FG000|Overall Study|Adverse Event|7|||
125111702|NCT02065791|450032856|FG001|Overall Study|Withdrawal by Subject|5|||
125111703|NCT02065791|450032855|FG000|Overall Study|Lost to Follow-up|13|||
125111704|NCT02065791|450032856|FG001|Overall Study|Lost to Follow-up|9|||
125111705|NCT01890785|450032857|FG000|Third Intervention|Withdrawal by Subject|0|||
125111706|NCT01890785|450032858|FG001|Third Intervention|Withdrawal by Subject|1|||
125111707|NCT01890785|450032859|FG002|Third Intervention|Withdrawal by Subject|0|||
125111708|NCT01890785|450032860|FG003|Third Intervention|Withdrawal by Subject|0|||
125111709|NCT01890785|450032861|FG004|Third Intervention|Withdrawal by Subject|0|||
125111710|NCT01890785|450032862|FG005|Third Intervention|Withdrawal by Subject|0|||
125111711|NCT01964105|450032865|FG000|Overall Study|Lost to Follow-up|2|||
125111712|NCT01964105|450032866|FG001|Overall Study|Lost to Follow-up|13|||
125111713|NCT01964105|450032867|FG002|Overall Study|Lost to Follow-up|0|||
125111714|NCT00575328|450032868|FG000|Overall Study|Adverse Event|1|||
125111715|NCT00575328|450032869|FG001|Overall Study|Adverse Event|1|||
125111716|NCT00575328|450032868|FG000|Overall Study|Lost to Follow-up|2|||
125111717|NCT00575328|450032869|FG001|Overall Study|Lost to Follow-up|1|||
125111718|NCT02124746|450032870|FG000|Overall Study|Adverse Event|2|||
125111719|NCT02124746|450032871|FG001|Overall Study|Adverse Event|1|||
125111720|NCT02124746|450032872|FG002|Overall Study|Adverse Event|2|||
125111721|NCT02124746|450032870|FG000|Overall Study|Death|2|||
125111722|NCT02124746|450032871|FG001|Overall Study|Death|1|||
125111723|NCT02124746|450032872|FG002|Overall Study|Death|3|||
125111724|NCT02124746|450032870|FG000|Overall Study|Lack of Efficacy|3|||
125111725|NCT02124746|450032871|FG001|Overall Study|Lack of Efficacy|2|||
125111726|NCT02124746|450032872|FG002|Overall Study|Lack of Efficacy|2|||
125111727|NCT02124746|450032870|FG000|Overall Study|Physician Decision|6|||
125111728|NCT02124746|450032871|FG001|Overall Study|Physician Decision|4|||
125111729|NCT02124746|450032872|FG002|Overall Study|Physician Decision|5|||
125111730|NCT02124746|450032870|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125111731|NCT02124746|450032871|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125111732|NCT02124746|450032872|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125210783|NCT02134353|450395684|FG000|Overall Study|Lack of Efficacy|2|||
124899628|NCT01693614|449257935|FG001|Overall Study|Adverse Event|11|||
124899629|NCT01693614|449257936|FG002|Overall Study|Adverse Event|5|||
124899630|NCT01693614|449257934|FG000|Overall Study|Disease progression|11|||
124899631|NCT01693614|449257935|FG001|Overall Study|Disease progression|8|||
124899632|NCT01693614|449257936|FG002|Overall Study|Disease progression|7|||
124899633|NCT01693614|449257934|FG000|Overall Study|Protocol Violation|5|||
124899634|NCT01693614|449257935|FG001|Overall Study|Protocol Violation|2|||
124899635|NCT01693614|449257936|FG002|Overall Study|Protocol Violation|1|||
124899636|NCT01693614|449257934|FG000|Overall Study|Death|1|||
124899637|NCT01693614|449257935|FG001|Overall Study|Death|0|||
124899638|NCT01693614|449257936|FG002|Overall Study|Death|0|||
124899639|NCT01693614|449257934|FG000|Overall Study|Physician Decision|1|||
125020178|NCT01687712|449697564|FG001|Cycle 2|Still Birth|0|||
125020179|NCT01687712|449697563|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
125020180|NCT01687712|449697564|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
125020181|NCT01687712|449697563|FG000|Cycle 3|Not Biochemically Pregnant|21|||
125020182|NCT01687712|449697564|FG001|Cycle 3|Not Biochemically Pregnant|22|||
125020183|NCT01687712|449697563|FG000|Cycle 3|Early Pregnancy Loss|1|||
125020184|NCT01687712|449697564|FG001|Cycle 3|Early Pregnancy Loss|2|||
125020185|NCT01687712|449697563|FG000|Cycle 3|Ectopic Pregnancy|1|||
125020186|NCT01687712|449697564|FG001|Cycle 3|Ectopic Pregnancy|0|||
125020187|NCT01687712|449697563|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
125020188|NCT01687712|449697564|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
125020189|NCT03074474|449697567|FG000|Overall Study|Lost to Follow-up|10|||
124899640|NCT01693614|449257935|FG001|Overall Study|Physician Decision|1|||
124899641|NCT01693614|449257936|FG002|Overall Study|Physician Decision|4|||
124899642|NCT01693614|449257934|FG000|Overall Study|Withdrawal by subject/guardian|0|||
124899643|NCT01693614|449257935|FG001|Overall Study|Withdrawal by subject/guardian|0|||
124899644|NCT01693614|449257936|FG002|Overall Study|Withdrawal by subject/guardian|2|||
124899645|NCT01693614|449257934|FG000|Overall Study|Withdrawal by Subject|1|||
124899646|NCT01693614|449257935|FG001|Overall Study|Withdrawal by Subject|0|||
124899647|NCT01693614|449257936|FG002|Overall Study|Withdrawal by Subject|5|||
124899648|NCT01048788|449257937|FG000|Overall Study|Adverse Event|5|||
124899649|NCT01048788|449257938|FG001|Overall Study|Adverse Event|1|||
124899650|NCT01048788|449257939|FG002|Overall Study|Adverse Event|1|||
124899651|NCT01048788|449257937|FG000|Overall Study|Lack of Efficacy|0|||
124899652|NCT01048788|449257938|FG001|Overall Study|Lack of Efficacy|0|||
124899653|NCT01048788|449257939|FG002|Overall Study|Lack of Efficacy|1|||
124899654|NCT01048788|449257937|FG000|Overall Study|Withdrawal by Subject|0|||
124899655|NCT01048788|449257938|FG001|Overall Study|Withdrawal by Subject|1|||
124899656|NCT01048788|449257939|FG002|Overall Study|Withdrawal by Subject|0|||
124899657|NCT00420316|449257942|FG000|Overall Study|Withdrawal by Subject|0|||
124899658|NCT00420316|449257943|FG001|Overall Study|Withdrawal by Subject|1|||
124899659|NCT00420316|449257942|FG000|Overall Study|Lost to Follow-up|12|||
124899660|NCT00420316|449257943|FG001|Overall Study|Lost to Follow-up|8|||
124899661|NCT01196988|449257944|FG000|Overall Study|Adverse Event|1|||
124899662|NCT01196988|449257945|FG001|Overall Study|Adverse Event|2|||
124899663|NCT01196988|449257946|FG002|Overall Study|Adverse Event|0|||
124899664|NCT01196988|449257947|FG003|Overall Study|Adverse Event|0|||
124899665|NCT01196988|449257944|FG000|Overall Study|Withdrawal by Subject|5|||
124899666|NCT01196988|449257945|FG001|Overall Study|Withdrawal by Subject|1|||
124899667|NCT01196988|449257946|FG002|Overall Study|Withdrawal by Subject|4|||
124899668|NCT01196988|449257947|FG003|Overall Study|Withdrawal by Subject|0|||
124899669|NCT01196988|449257944|FG000|Overall Study|Lost to Follow-up|16|||
124899670|NCT01196988|449257945|FG001|Overall Study|Lost to Follow-up|29|||
124899671|NCT01196988|449257946|FG002|Overall Study|Lost to Follow-up|21|||
124899672|NCT01196988|449257947|FG003|Overall Study|Lost to Follow-up|1|||
124899673|NCT01196988|449257944|FG000|Overall Study|Other|2|||
124899674|NCT01196988|449257945|FG001|Overall Study|Other|0|||
125111733|NCT02124746|450032870|FG000|Overall Study|Withdrawal by Subject|3|||
125111734|NCT02124746|450032871|FG001|Overall Study|Withdrawal by Subject|3|||
125111735|NCT02124746|450032872|FG002|Overall Study|Withdrawal by Subject|0|||
125111736|NCT02124746|450032870|FG000|Overall Study|Study Terminated by Sponsor|0|||
125111737|NCT02124746|450032871|FG001|Overall Study|Study Terminated by Sponsor|0|||
125111738|NCT02124746|450032872|FG002|Overall Study|Study Terminated by Sponsor|6|||
125111739|NCT02124746|450032870|FG000|Overall Study|Disease Progression|3|||
125111740|NCT02124746|450032871|FG001|Overall Study|Disease Progression|6|||
125111741|NCT02124746|450032872|FG002|Overall Study|Disease Progression|4|||
124899675|NCT01196988|449257946|FG002|Overall Study|Other|0|||
124899676|NCT01196988|449257947|FG003|Overall Study|Other|0|||
125111742|NCT00124449|450032875|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
125111743|NCT00124449|450032876|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
124899677|NCT05419557|449257948|FG000|Overall Study|Lost to Follow-up|11|||
124899678|NCT05419557|449257949|FG001|Overall Study|Lost to Follow-up|4|||
125111744|NCT00124449|450032875|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
124899679|NCT00868192|449257951|FG000|Overall Study|Ineligible|4|||
125111745|NCT00124449|450032876|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
125111746|NCT00124449|450032875|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
125111747|NCT00124449|450032876|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
125111748|NCT00124449|450032875|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
125111749|NCT00124449|450032876|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
125111750|NCT00124449|450032875|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
125111751|NCT00124449|450032876|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
125111752|NCT00124449|450032875|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
125111753|NCT00124449|450032876|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
125111754|NCT00124449|450032875|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
125111755|NCT00124449|450032876|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
125111756|NCT00124449|450032875|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
125111757|NCT00124449|450032876|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
125111758|NCT00124449|450032875|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
125111759|NCT00124449|450032876|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
124899680|NCT04304534|449257952|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
125111760|NCT00124449|450032875|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
125111761|NCT00124449|450032876|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
125111762|NCT00124449|450032875|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
125111763|NCT00124449|450032876|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
125111764|NCT00124449|450032875|FG000|18-Month Untreated Observation Period|Relocated|1|||
125111765|NCT00124449|450032876|FG001|18-Month Untreated Observation Period|Relocated|0|||
125111766|NCT00571922|450032877|FG000|Overall Study|Completion unknown|36|||
125111767|NCT00571922|450032878|FG001|Overall Study|Completion unknown|36|||
125111768|NCT02191579|450032887|FG000|Treatment 1|Multiple Reasons Specified|27|||
125111769|NCT02191579|450032888|FG001|Treatment 1|Multiple Reasons Specified|58|||
125111770|NCT02191579|450032887|FG000|Treatment 2|Multiple Reasons Specified|0|||
125111771|NCT02191579|450032888|FG001|Treatment 2|Multiple Reasons Specified|25|||
125111772|NCT00964223|450032895|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
125111773|NCT00811070|450032896|FG000|Overall Study|Death|0|||
125111774|NCT00811070|450032897|FG001|Overall Study|Death|0|||
125111775|NCT00811070|450032898|FG002|Overall Study|Death|0|||
125111776|NCT00811070|450032899|FG003|Overall Study|Death|2|||
125111777|NCT00811070|450032900|FG004|Overall Study|Death|5|||
125111778|NCT00811070|450032901|FG005|Overall Study|Death|0|||
125111779|NCT00811070|450032896|FG000|Overall Study|Other|1|||
125111780|NCT00811070|450032897|FG001|Overall Study|Other|0|||
125111781|NCT00811070|450032898|FG002|Overall Study|Other|0|||
125111782|NCT00811070|450032899|FG003|Overall Study|Other|0|||
125111783|NCT00811070|450032900|FG004|Overall Study|Other|0|||
125111784|NCT00811070|450032901|FG005|Overall Study|Other|0|||
125111785|NCT00811070|450032896|FG000|Overall Study|Withdrawal by Subject|0|||
125111786|NCT00811070|450032897|FG001|Overall Study|Withdrawal by Subject|1|||
125111787|NCT00811070|450032898|FG002|Overall Study|Withdrawal by Subject|0|||
125111788|NCT00811070|450032899|FG003|Overall Study|Withdrawal by Subject|0|||
125111789|NCT00811070|450032900|FG004|Overall Study|Withdrawal by Subject|0|||
125111790|NCT00811070|450032901|FG005|Overall Study|Withdrawal by Subject|0|||
125111791|NCT00811070|450032896|FG000|Overall Study|Physician Decision|0|||
125111792|NCT00811070|450032897|FG001|Overall Study|Physician Decision|0|||
125111793|NCT00811070|450032898|FG002|Overall Study|Physician Decision|0|||
125111794|NCT00811070|450032899|FG003|Overall Study|Physician Decision|0|||
125111795|NCT00811070|450032900|FG004|Overall Study|Physician Decision|0|||
125111796|NCT00811070|450032901|FG005|Overall Study|Physician Decision|1|||
125111797|NCT01585831|450032906|FG000|Overall Study|Physician Decision|0|||
125111798|NCT01585831|450032907|FG001|Overall Study|Physician Decision|1|||
125111799|NCT01585831|450032906|FG000|Overall Study|Withdrawal by Subject|2|||
125111800|NCT01585831|450032907|FG001|Overall Study|Withdrawal by Subject|1|||
125111801|NCT02046369|450032908|FG000|Overall Study|Adverse Event|3|||
125111802|NCT02046369|450032909|FG001|Overall Study|Adverse Event|3|||
125111803|NCT02046369|450032908|FG000|Overall Study|Lack of Efficacy|3|||
125111804|NCT02046369|450032909|FG001|Overall Study|Lack of Efficacy|3|||
125111805|NCT02046369|450032908|FG000|Overall Study|Lost to Follow-up|3|||
125111806|NCT02046369|450032909|FG001|Overall Study|Lost to Follow-up|3|||
125111807|NCT02046369|450032908|FG000|Overall Study|Protocol Violation|1|||
125111808|NCT02046369|450032909|FG001|Overall Study|Protocol Violation|2|||
125111809|NCT02046369|450032908|FG000|Overall Study|Withdrawal by Subject|3|||
125111810|NCT02046369|450032909|FG001|Overall Study|Withdrawal by Subject|6|||
125111811|NCT02046369|450032908|FG000|Overall Study|never received study drug|0|||
125111812|NCT02046369|450032909|FG001|Overall Study|never received study drug|1|||
125111813|NCT02046369|450032908|FG000|Overall Study|non compliance|1|||
124899681|NCT04304534|449257953|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
125111814|NCT02046369|450032909|FG001|Overall Study|non compliance|0|||
125111815|NCT03120520|450032910|FG000|Overall Study|Lost to Follow-up|1|||
125111816|NCT03120520|450032911|FG001|Overall Study|Lost to Follow-up|1|||
125111817|NCT03120520|450032912|FG002|Overall Study|Lost to Follow-up|1|||
125111818|NCT03120520|450032913|FG003|Overall Study|Lost to Follow-up|1|||
125111819|NCT03120520|450032910|FG000|Overall Study|Withdrawal by Subject|3|||
125111820|NCT03120520|450032911|FG001|Overall Study|Withdrawal by Subject|2|||
125111821|NCT03120520|450032912|FG002|Overall Study|Withdrawal by Subject|3|||
125111822|NCT03120520|450032913|FG003|Overall Study|Withdrawal by Subject|2|||
125111823|NCT03120520|450032910|FG000|Overall Study|Other|0|||
125111824|NCT03120520|450032911|FG001|Overall Study|Other|1|||
125111825|NCT03120520|450032912|FG002|Overall Study|Other|0|||
125111826|NCT03120520|450032913|FG003|Overall Study|Other|0|||
125111827|NCT01759537|450032915|FG000|Overall Study|Death|1|||
125111828|NCT01759537|450032916|FG001|Overall Study|Death|1|||
125111829|NCT01759537|450032915|FG000|Overall Study|Pregnancy|1|||
124899682|NCT04304534|449257954|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
124899683|NCT04304534|449257955|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
125111830|NCT01759537|450032916|FG001|Overall Study|Pregnancy|1|||
125111831|NCT01759537|450032915|FG000|Overall Study|Lost to Follow-up|9|||
125111832|NCT01759537|450032916|FG001|Overall Study|Lost to Follow-up|9|||
125111833|NCT01759537|450032915|FG000|Overall Study|Accident involving jaw fracture|1|||
125111834|NCT01759537|450032916|FG001|Overall Study|Accident involving jaw fracture|1|||
125111835|NCT01759537|450032915|FG000|Overall Study|Subcrestal implant too coronal|1|||
125111836|NCT01759537|450032916|FG001|Overall Study|Subcrestal implant too coronal|1|||
125111837|NCT00420290|450032917|FG000|Overall Study|Adverse Event|3|||
125111838|NCT00420290|450032918|FG001|Overall Study|Adverse Event|1|||
125111839|NCT00420290|450032917|FG000|Overall Study|Withdrawal by Subject|0|||
125111840|NCT00420290|450032918|FG001|Overall Study|Withdrawal by Subject|2|||
125111841|NCT00420290|450032917|FG000|Overall Study|did not meet inclusion/exclusion|1|||
125111842|NCT00420290|450032918|FG001|Overall Study|did not meet inclusion/exclusion|1|||
125111843|NCT02092961|450034181|FG000|Overall Study|Not reported|1|||
125111844|NCT02092961|450034182|FG001|Overall Study|Not reported|0|||
125111845|NCT02092961|450034183|FG002|Overall Study|Not reported|1|||
125111846|NCT02092961|450034181|FG000|Overall Study|Study stopped|13|||
125111847|NCT02092961|450034182|FG001|Overall Study|Study stopped|9|||
125111848|NCT02092961|450034183|FG002|Overall Study|Study stopped|12|||
125111849|NCT02092961|450034181|FG000|Overall Study|Lack of therapeutic response|2|||
125111850|NCT02092961|450034182|FG001|Overall Study|Lack of therapeutic response|1|||
125111851|NCT02092961|450034183|FG002|Overall Study|Lack of therapeutic response|3|||
125111852|NCT02092961|450034181|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
125111853|NCT02092961|450034182|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
125111854|NCT02092961|450034183|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
125111855|NCT02092961|450034181|FG000|Overall Study|Adverse Event|2|||
125111856|NCT02092961|450034182|FG001|Overall Study|Adverse Event|4|||
125111857|NCT02092961|450034183|FG002|Overall Study|Adverse Event|0|||
125111858|NCT00854620|450034184|FG000|Overall Study|Adverse Event|1|||
125111859|NCT01623830|450034185|FG000|Overall Study|Withdrawal by Subject|6|||
125111860|NCT01623830|450034186|FG001|Overall Study|Withdrawal by Subject|7|||
125111861|NCT01623830|450034185|FG000|Overall Study|Exclusion from Study|1|||
125111862|NCT01623830|450034186|FG001|Overall Study|Exclusion from Study|2|||
125111863|NCT01792284|450034187|FG000|Lead-in Period|Adverse Event|15|||
125111864|NCT01792284|450034188|FG001|Lead-in Period|Adverse Event|0|||
125111865|NCT01792284|450034189|FG002|Lead-in Period|Adverse Event|0|||
125111866|NCT01792284|450034187|FG000|Lead-in Period|Lost to Follow-up|2|||
125111867|NCT01792284|450034188|FG001|Lead-in Period|Lost to Follow-up|0|||
125111868|NCT01792284|450034189|FG002|Lead-in Period|Lost to Follow-up|0|||
125111869|NCT01792284|450034187|FG000|Lead-in Period|Protocol Violation|1|||
125111870|NCT01792284|450034188|FG001|Lead-in Period|Protocol Violation|0|||
125111871|NCT01792284|450034189|FG002|Lead-in Period|Protocol Violation|0|||
125111872|NCT01792284|450034187|FG000|Lead-in Period|Withdrawal by Subject|10|||
125111873|NCT01792284|450034188|FG001|Lead-in Period|Withdrawal by Subject|0|||
125111874|NCT01792284|450034189|FG002|Lead-in Period|Withdrawal by Subject|0|||
125111875|NCT01792284|450034187|FG000|Lead-in Period|Physician Decision|1|||
125111876|NCT01792284|450034188|FG001|Lead-in Period|Physician Decision|0|||
125111877|NCT01792284|450034189|FG002|Lead-in Period|Physician Decision|0|||
125111878|NCT01792284|450034187|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
125111879|NCT01792284|450034188|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
125111880|NCT01792284|450034189|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
125111881|NCT01792284|450034187|FG000|Randomization Period 1|Withdrawal by Subject|0|||
125111882|NCT01792284|450034188|FG001|Randomization Period 1|Withdrawal by Subject|1|||
125111883|NCT01792284|450034189|FG002|Randomization Period 1|Withdrawal by Subject|1|||
125111884|NCT01792284|450034187|FG000|Randomization Period 1|Physician Decision|0|||
125111885|NCT01792284|450034188|FG001|Randomization Period 1|Physician Decision|1|||
125111886|NCT01792284|450034189|FG002|Randomization Period 1|Physician Decision|1|||
125111887|NCT01792284|450034187|FG000|Randomization Period 1|Adverse Event|0|||
125111888|NCT01792284|450034188|FG001|Randomization Period 1|Adverse Event|0|||
125111889|NCT01792284|450034189|FG002|Randomization Period 1|Adverse Event|2|||
125111890|NCT01792284|450034187|FG000|Randomization Period 1|Lost to Follow-up|0|||
125111891|NCT01792284|450034188|FG001|Randomization Period 1|Lost to Follow-up|0|||
125111892|NCT01792284|450034189|FG002|Randomization Period 1|Lost to Follow-up|1|||
125111893|NCT01792284|450034187|FG000|Randomization Period 2|Protocol Violation|0|||
125111894|NCT01792284|450034188|FG001|Randomization Period 2|Protocol Violation|1|||
125111895|NCT01792284|450034189|FG002|Randomization Period 2|Protocol Violation|0|||
125111896|NCT01792284|450034187|FG000|Randomization Period 2|Withdrawal by Subject|0|||
125111897|NCT01792284|450034188|FG001|Randomization Period 2|Withdrawal by Subject|2|||
125111898|NCT01792284|450034189|FG002|Randomization Period 2|Withdrawal by Subject|0|||
125111899|NCT01169649|450034192|FG000|Overall Study|Patient Not Treated|3|||
125111900|NCT01847313|450034198|FG000|Overall Study|Death|0|||
125111901|NCT01847313|450034199|FG001|Overall Study|Death|1|||
125111902|NCT01847313|450034198|FG000|Overall Study|Withdrawal by Subject|0|||
125111903|NCT01847313|450034199|FG001|Overall Study|Withdrawal by Subject|1|||
125111904|NCT00515073|450034203|FG000|Overall Study|Withdrawal by Subject|1|||
125111905|NCT00515073|450034203|FG000|Overall Study|Physician Decision|1|||
125111906|NCT01456052|450034204|FG000|Overall Study|Adverse Event|1|||
125111907|NCT01456052|450034205|FG001|Overall Study|Adverse Event|1|||
125111908|NCT01456052|450034206|FG002|Overall Study|Adverse Event|2|||
125111909|NCT01456052|450034204|FG000|Overall Study|Consent withdrawn|0|||
125111910|NCT01456052|450034205|FG001|Overall Study|Consent withdrawn|2|||
125111911|NCT01456052|450034206|FG002|Overall Study|Consent withdrawn|1|||
125111912|NCT01456052|450034204|FG000|Overall Study|Protocol Violation|0|||
125020190|NCT03074474|449697567|FG000|Overall Study|Withdrawal by Subject|10|||
125020191|NCT03074474|449697567|FG000|Overall Study|Death|4|||
125020192|NCT03074474|449697567|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
125020193|NCT01035905|449697570|FG000|Overall Study|Lack of Efficacy|1|||
125020194|NCT01035905|449697571|FG001|Overall Study|Lack of Efficacy|1|||
125020195|NCT05913232|449697573|FG000|Overall Study|Adverse Event|0|||
125020196|NCT05913232|449697574|FG001|Overall Study|Adverse Event|2|||
125020197|NCT05913232|449697575|FG002|Overall Study|Adverse Event|1|||
125020198|NCT05913232|449697576|FG003|Overall Study|Adverse Event|1|||
125020199|NCT01627899|449697579|FG000|Overall Study|Study terminated early by sponsor.|5|||
125020200|NCT04153188|449697589|FG000|Overall Study|Lost to Follow-up|1|||
125020201|NCT04153188|449697590|FG001|Overall Study|Lost to Follow-up|1|||
125020202|NCT04153188|449697589|FG000|Overall Study|Withdrawal by Subject|2|||
125020203|NCT04153188|449697590|FG001|Overall Study|Withdrawal by Subject|0|||
125020204|NCT04153188|449697589|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
125020205|NCT04153188|449697590|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
125020206|NCT03809611|449697591|FG000|Overall Study|Withdrawal by Subject|1|||
125020207|NCT03809611|449697592|FG001|Overall Study|Withdrawal by Subject|1|||
125020208|NCT02926950|449697593|FG000|Overall Study|Adverse Event|4|||
125020209|NCT02926950|449697594|FG001|Overall Study|Adverse Event|6|||
125020210|NCT02926950|449697593|FG000|Overall Study|At the participant's own request|21|||
125020211|NCT02926950|449697594|FG001|Overall Study|At the participant's own request|25|||
125020212|NCT02926950|449697593|FG000|Overall Study|Reason not Specified|17|||
125020213|NCT02926950|449697594|FG001|Overall Study|Reason not Specified|9|||
125020214|NCT02926950|449697593|FG000|Overall Study|Lost to Follow-up|7|||
125020215|NCT02926950|449697594|FG001|Overall Study|Lost to Follow-up|8|||
125020216|NCT00264004|449699230|FG000|Overall Study|Adverse Event|2|||
125020217|NCT00264004|449699231|FG001|Overall Study|Adverse Event|3|||
125020218|NCT00264004|449699232|FG002|Overall Study|Adverse Event|6|||
125020219|NCT00264004|449699233|FG003|Overall Study|Adverse Event|4|||
125020220|NCT00264004|449699230|FG000|Overall Study|Withdrawal by Subject|0|||
125020221|NCT00264004|449699231|FG001|Overall Study|Withdrawal by Subject|1|||
125020222|NCT00264004|449699232|FG002|Overall Study|Withdrawal by Subject|2|||
125020223|NCT00264004|449699233|FG003|Overall Study|Withdrawal by Subject|2|||
125020224|NCT00264004|449699230|FG000|Overall Study|Other|2|||
125020225|NCT00264004|449699231|FG001|Overall Study|Other|2|||
125020226|NCT00264004|449699232|FG002|Overall Study|Other|0|||
125020227|NCT00264004|449699233|FG003|Overall Study|Other|3|||
125020228|NCT00264004|449699230|FG000|Overall Study|Development study specific disc. crit.|1|||
125020229|NCT00264004|449699231|FG001|Overall Study|Development study specific disc. crit.|0|||
125020230|NCT00264004|449699232|FG002|Overall Study|Development study specific disc. crit.|1|||
125020231|NCT00264004|449699233|FG003|Overall Study|Development study specific disc. crit.|0|||
125020232|NCT00264004|449699230|FG000|Overall Study|Cond. under inv. worsened|9|||
125020233|NCT00264004|449699231|FG001|Overall Study|Cond. under inv. worsened|5|||
125020234|NCT00264004|449699232|FG002|Overall Study|Cond. under inv. worsened|3|||
125020235|NCT00264004|449699233|FG003|Overall Study|Cond. under inv. worsened|4|||
125020236|NCT00264004|449699230|FG000|Overall Study|Not treated|3|||
125020237|NCT00264004|449699231|FG001|Overall Study|Not treated|0|||
125020238|NCT00264004|449699232|FG002|Overall Study|Not treated|2|||
125020239|NCT00264004|449699233|FG003|Overall Study|Not treated|2|||
125020240|NCT01535729|449699234|FG000|Overall Study|Withdrawal by Subject|2|||
125020241|NCT01535729|449699234|FG000|Overall Study|Disease progression|230|||
125020242|NCT01535729|449699234|FG000|Overall Study|Discontinued treatment|25|||
125020243|NCT01535729|449699234|FG000|Overall Study|Lost to Follow-up|8|||
125020244|NCT01535729|449699234|FG000|Overall Study|Death|52|||
124899684|NCT04304534|449257952|FG000|Overall Study|Non-Compliance with study drug|0|||
124899685|NCT04304534|449257953|FG001|Overall Study|Non-Compliance with study drug|1|||
125111913|NCT01456052|450034205|FG001|Overall Study|Protocol Violation|1|||
125111914|NCT01456052|450034206|FG002|Overall Study|Protocol Violation|0|||
125111915|NCT01456052|450034204|FG000|Overall Study|Physician Decision|1|||
125111916|NCT01456052|450034205|FG001|Overall Study|Physician Decision|0|||
125111917|NCT01456052|450034206|FG002|Overall Study|Physician Decision|1|||
125111918|NCT01456052|450034204|FG000|Overall Study|Treatment Failure|0|||
125111919|NCT01456052|450034205|FG001|Overall Study|Treatment Failure|1|||
125111920|NCT01456052|450034206|FG002|Overall Study|Treatment Failure|1|||
125111921|NCT00463866|450034207|FG000|Overall Study|Adverse Event|70|||
125111922|NCT00463866|450034208|FG001|Overall Study|Adverse Event|93|||
125111923|NCT00463866|450034207|FG000|Overall Study|Withdrawal by Subject|81|||
125111924|NCT00463866|450034208|FG001|Overall Study|Withdrawal by Subject|79|||
125111925|NCT00463866|450034207|FG000|Overall Study|Lost to Follow-up|46|||
125111926|NCT00463866|450034208|FG001|Overall Study|Lost to Follow-up|55|||
125111927|NCT00463866|450034207|FG000|Overall Study|Incorrect Enrolment|64|||
125111928|NCT00463866|450034208|FG001|Overall Study|Incorrect Enrolment|66|||
125111929|NCT00463866|450034207|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
125111930|NCT00463866|450034208|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
125111931|NCT00463866|450034207|FG000|Overall Study|Safety Reason|1|||
125111932|NCT00463866|450034208|FG001|Overall Study|Safety Reason|3|||
125111933|NCT00463866|450034207|FG000|Overall Study|Mis-Randomization of subject|0|||
125111934|NCT00463866|450034208|FG001|Overall Study|Mis-Randomization of subject|1|||
125111935|NCT00463866|450034207|FG000|Overall Study|Other|22|||
125111936|NCT00463866|450034208|FG001|Overall Study|Other|22|||
125111937|NCT02265952|450034209|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
125111938|NCT02265952|450034210|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
125111939|NCT02265952|450034209|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
125111940|NCT02265952|450034210|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
125111941|NCT01042977|450034212|FG000|Overall Study|Adverse Event|4|||
125111942|NCT01042977|450034213|FG001|Overall Study|Adverse Event|12|||
125111943|NCT01042977|450034212|FG000|Overall Study|Death|2|||
125111944|NCT01042977|450034213|FG001|Overall Study|Death|1|||
125111945|NCT01042977|450034212|FG000|Overall Study|Withdrawal by Subject|8|||
125111946|NCT01042977|450034213|FG001|Overall Study|Withdrawal by Subject|16|||
125111947|NCT01042977|450034212|FG000|Overall Study|Lost to Follow-up|0|||
125111948|NCT01042977|450034213|FG001|Overall Study|Lost to Follow-up|2|||
125111949|NCT01042977|450034212|FG000|Overall Study|Poor/non-compliance|3|||
125111950|NCT01042977|450034213|FG001|Overall Study|Poor/non-compliance|4|||
125111951|NCT01042977|450034212|FG000|Overall Study|Subject no longer meets study criteria|15|||
125111952|NCT01042977|450034213|FG001|Overall Study|Subject no longer meets study criteria|13|||
125111953|NCT01042977|450034212|FG000|Overall Study|Incorrect enrollment|6|||
125111954|NCT01042977|450034213|FG001|Overall Study|Incorrect enrollment|4|||
125111955|NCT01042977|450034212|FG000|Overall Study|Safety|0|||
125111956|NCT01042977|450034213|FG001|Overall Study|Safety|2|||
125111957|NCT01042977|450034212|FG000|Overall Study|Administrative reason by sponsor|0|||
125111958|NCT01042977|450034213|FG001|Overall Study|Administrative reason by sponsor|1|||
124899686|NCT04304534|449257954|FG002|Overall Study|Non-Compliance with study drug|1|||
124899687|NCT04304534|449257955|FG003|Overall Study|Non-Compliance with study drug|1|||
124899688|NCT04304534|449257952|FG000|Overall Study|Lost to Follow-up|0|||
124899689|NCT04304534|449257953|FG001|Overall Study|Lost to Follow-up|1|||
124899690|NCT04304534|449257954|FG002|Overall Study|Lost to Follow-up|2|||
124899691|NCT04304534|449257955|FG003|Overall Study|Lost to Follow-up|3|||
124899692|NCT04304534|449257952|FG000|Overall Study|Unspecific|4|||
124899693|NCT04304534|449257953|FG001|Overall Study|Unspecific|2|||
124899694|NCT04304534|449257954|FG002|Overall Study|Unspecific|2|||
124899695|NCT04304534|449257955|FG003|Overall Study|Unspecific|2|||
124899696|NCT04304534|449257952|FG000|Overall Study|Technical Problems|2|||
124899697|NCT04304534|449257953|FG001|Overall Study|Technical Problems|2|||
124899698|NCT04304534|449257954|FG002|Overall Study|Technical Problems|3|||
124899699|NCT04304534|449257955|FG003|Overall Study|Technical Problems|4|||
124899700|NCT04304534|449257952|FG000|Overall Study|Death|7|||
124899701|NCT04304534|449257953|FG001|Overall Study|Death|2|||
124899702|NCT04304534|449257954|FG002|Overall Study|Death|4|||
124899703|NCT04304534|449257955|FG003|Overall Study|Death|3|||
124899704|NCT04304534|449257952|FG000|Overall Study|Withdrawal by Subject|7|||
124899705|NCT04304534|449257953|FG001|Overall Study|Withdrawal by Subject|2|||
124899706|NCT04304534|449257954|FG002|Overall Study|Withdrawal by Subject|7|||
124899707|NCT04304534|449257955|FG003|Overall Study|Withdrawal by Subject|4|||
124899708|NCT04304534|449257952|FG000|Overall Study|Physician Decision|4|||
124899709|NCT04304534|449257953|FG001|Overall Study|Physician Decision|9|||
124899710|NCT04304534|449257954|FG002|Overall Study|Physician Decision|9|||
124899711|NCT04304534|449257955|FG003|Overall Study|Physician Decision|5|||
124899712|NCT04304534|449257952|FG000|Overall Study|Subject Decision|34|||
125020245|NCT01535729|449699234|FG000|Overall Study|Other|19|||
125020246|NCT01535729|449699234|FG000|Overall Study|Did not sign informed consent|1|||
125111959|NCT01042977|450034212|FG000|Overall Study|Various|3|||
125111960|NCT01042977|450034213|FG001|Overall Study|Various|0|||
125020247|NCT01535729|449699234|FG000|Overall Study|No previous chemotherapy|33|||
125020248|NCT01535729|449699234|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
125020249|NCT01535729|449699234|FG000|Overall Study|Protocol Violation|11|||
125020250|NCT01535729|449699234|FG000|Overall Study|Screening failure|1|||
125020251|NCT01535729|449699234|FG000|Overall Study|Not treated|9|||
125020252|NCT01535729|449699234|FG000|Overall Study|No participant record available|5|||
125020253|NCT01262365|449699235|FG000|Overall Study|Lack of Efficacy|35|||
125111961|NCT04356573|450034216|FG000|Overall Study|Didn't Qualify|1|||
124899713|NCT04304534|449257953|FG001|Overall Study|Subject Decision|25|||
124899714|NCT04304534|449257954|FG002|Overall Study|Subject Decision|25|||
124899715|NCT04304534|449257955|FG003|Overall Study|Subject Decision|26|||
124899716|NCT04304534|449257952|FG000|Overall Study|Adverse Event|35|||
124899717|NCT04304534|449257953|FG001|Overall Study|Adverse Event|40|||
125020254|NCT01262365|449699236|FG001|Overall Study|Lack of Efficacy|30|||
125020255|NCT01262365|449699237|FG002|Overall Study|Lack of Efficacy|47|||
125111962|NCT04356573|450034217|FG001|Overall Study|Didn't Qualify|0|||
124899718|NCT04304534|449257954|FG002|Overall Study|Adverse Event|39|||
124899719|NCT04304534|449257955|FG003|Overall Study|Adverse Event|44|||
124899720|NCT00464672|449257956|FG000|Overall Study|withdrawal of consent|0|||
124899721|NCT00464672|449257957|FG001|Overall Study|withdrawal of consent|0|||
124899722|NCT00464672|449257958|FG002|Overall Study|withdrawal of consent|0|||
124899723|NCT00464672|449257959|FG003|Overall Study|withdrawal of consent|1|||
124899724|NCT00464672|449257960|FG004|Overall Study|withdrawal of consent|9|||
124899725|NCT00464672|449257961|FG005|Overall Study|withdrawal of consent|4|||
124899726|NCT00464672|449257956|FG000|Overall Study|Lost to Follow-up|25|||
124899727|NCT00464672|449257957|FG001|Overall Study|Lost to Follow-up|10|||
124899728|NCT00464672|449257958|FG002|Overall Study|Lost to Follow-up|0|||
124899729|NCT00464672|449257959|FG003|Overall Study|Lost to Follow-up|0|||
124899730|NCT00464672|449257960|FG004|Overall Study|Lost to Follow-up|1|||
124899731|NCT00464672|449257961|FG005|Overall Study|Lost to Follow-up|0|||
124899732|NCT00957229|449257962|FG000|Study Start|Adverse Event|0|||
124899733|NCT00957229|449257963|FG001|Study Start|Adverse Event|3|||
124899734|NCT00957229|449257962|FG000|Study Start|Disease Progression|1|||
125020256|NCT01262365|449699235|FG000|Overall Study|Protocol Violation|3|||
125020257|NCT01262365|449699236|FG001|Overall Study|Protocol Violation|1|||
125020258|NCT01262365|449699237|FG002|Overall Study|Protocol Violation|1|||
125020259|NCT01262365|449699235|FG000|Overall Study|Lost to Follow-up|3|||
125020260|NCT01262365|449699236|FG001|Overall Study|Lost to Follow-up|7|||
125020261|NCT01262365|449699237|FG002|Overall Study|Lost to Follow-up|6|||
125020262|NCT01262365|449699235|FG000|Overall Study|Withdrawal by Subject|17|||
125020263|NCT01262365|449699236|FG001|Overall Study|Withdrawal by Subject|22|||
125020264|NCT01262365|449699237|FG002|Overall Study|Withdrawal by Subject|22|||
125020265|NCT01262365|449699235|FG000|Overall Study|Death|1|||
125020266|NCT01262365|449699236|FG001|Overall Study|Death|2|||
125020267|NCT01262365|449699237|FG002|Overall Study|Death|1|||
125111963|NCT03568500|450034218|FG000|Overall Study|Lost to Follow-up|1|||
124899735|NCT00957229|449257963|FG001|Study Start|Disease Progression|0|||
124899736|NCT00957229|449257962|FG000|Reallocated to or Continued Vismodegib|Death|1|||
125020268|NCT01262365|449699235|FG000|Overall Study|Adverse Event|26|||
125020269|NCT01262365|449699236|FG001|Overall Study|Adverse Event|16|||
125020270|NCT01262365|449699237|FG002|Overall Study|Adverse Event|11|||
125020271|NCT01262365|449699235|FG000|Overall Study|sponsor decision|1|||
125020272|NCT01262365|449699236|FG001|Overall Study|sponsor decision|1|||
124899737|NCT00957229|449257963|FG001|Reallocated to or Continued Vismodegib|Death|1|||
124899738|NCT00957229|449257962|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
124899739|NCT00957229|449257963|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
124899740|NCT04044664|449257971|FG000|Stage 1|Adverse Event|3|||
124899741|NCT04044664|449257972|FG001|Stage 1|Adverse Event|3|||
124899742|NCT04044664|449257973|FG002|Stage 1|Adverse Event|1|||
124899743|NCT04044664|449257971|FG000|Stage 1|Lost to Follow-up|3|||
124899744|NCT04044664|449257972|FG001|Stage 1|Lost to Follow-up|2|||
124899745|NCT04044664|449257973|FG002|Stage 1|Lost to Follow-up|2|||
124899746|NCT04044664|449257971|FG000|Stage 1|Withdrawal by Subject|9|||
124899747|NCT04044664|449257972|FG001|Stage 1|Withdrawal by Subject|1|||
124899748|NCT04044664|449257973|FG002|Stage 1|Withdrawal by Subject|0|||
124899749|NCT04044664|449257971|FG000|Stage 1|noncompliance, personal reason|2|||
125020273|NCT01262365|449699237|FG002|Overall Study|sponsor decision|0|||
125020274|NCT01262365|449699235|FG000|Overall Study|Randomization error|1|||
125020275|NCT01262365|449699236|FG001|Overall Study|Randomization error|0|||
125020276|NCT01262365|449699237|FG002|Overall Study|Randomization error|2|||
125020277|NCT01262365|449699235|FG000|Overall Study|Non-compliance|1|||
125020278|NCT01262365|449699236|FG001|Overall Study|Non-compliance|0|||
125020279|NCT01262365|449699237|FG002|Overall Study|Non-compliance|2|||
125020280|NCT01262365|449699235|FG000|Overall Study|Suspected pregnancy|1|||
125020281|NCT01262365|449699236|FG001|Overall Study|Suspected pregnancy|0|||
125020282|NCT01262365|449699237|FG002|Overall Study|Suspected pregnancy|0|||
125020283|NCT01262365|449699235|FG000|Overall Study|Patient pregnant|1|||
125020284|NCT01262365|449699236|FG001|Overall Study|Patient pregnant|0|||
125020285|NCT01262365|449699237|FG002|Overall Study|Patient pregnant|1|||
125020286|NCT01262365|449699235|FG000|Overall Study|Toxicity related to study drug|0|||
125020287|NCT01262365|449699236|FG001|Overall Study|Toxicity related to study drug|1|||
125020288|NCT01262365|449699237|FG002|Overall Study|Toxicity related to study drug|0|||
125020289|NCT01262365|449699235|FG000|Overall Study|Cannot tolerate the protocol|0|||
125020290|NCT01262365|449699236|FG001|Overall Study|Cannot tolerate the protocol|1|||
125020291|NCT01262365|449699237|FG002|Overall Study|Cannot tolerate the protocol|0|||
125020292|NCT01262365|449699235|FG000|Overall Study|Patient unavailable|0|||
125020293|NCT01262365|449699236|FG001|Overall Study|Patient unavailable|0|||
125020294|NCT01262365|449699237|FG002|Overall Study|Patient unavailable|1|||
125020295|NCT02787850|449699238|FG000|Overall Study|Withdrawal by Subject|0|||
125020296|NCT02787850|449699239|FG001|Overall Study|Withdrawal by Subject|1|||
125020297|NCT02921971|449699242|FG000|Overall Study|Adverse Event|1|||
125111964|NCT03568500|450034219|FG001|Overall Study|Lost to Follow-up|1|||
124899750|NCT04044664|449257972|FG001|Stage 1|noncompliance, personal reason|0|||
124899751|NCT04044664|449257973|FG002|Stage 1|noncompliance, personal reason|0|||
125020298|NCT02921971|449699243|FG001|Overall Study|Adverse Event|2|||
125020299|NCT02921971|449699242|FG000|Overall Study|Lack of Efficacy|3|||
125020300|NCT02921971|449699243|FG001|Overall Study|Lack of Efficacy|1|||
125020301|NCT02921971|449699242|FG000|Overall Study|Other than specified above|2|||
125020302|NCT02921971|449699243|FG001|Overall Study|Other than specified above|1|||
125020303|NCT02322710|449699244|FG000|Overall Study|No efficacy assessment post-baseline|0|||
125020304|NCT02322710|449699245|FG001|Overall Study|No efficacy assessment post-baseline|1|||
125111965|NCT03568500|450034220|FG002|Overall Study|Lost to Follow-up|2|||
125111966|NCT03568500|450034218|FG000|Overall Study|Adverse Event|1|||
125111967|NCT03568500|450034219|FG001|Overall Study|Adverse Event|1|||
125111968|NCT03568500|450034220|FG002|Overall Study|Adverse Event|2|||
125111969|NCT03568500|450034218|FG000|Overall Study|Physician Decision|1|||
125111970|NCT03568500|450034219|FG001|Overall Study|Physician Decision|0|||
125111971|NCT03568500|450034220|FG002|Overall Study|Physician Decision|0|||
125111972|NCT03568500|450034218|FG000|Overall Study|Withdrawal by Subject|4|||
125111973|NCT03568500|450034219|FG001|Overall Study|Withdrawal by Subject|2|||
125111974|NCT03568500|450034220|FG002|Overall Study|Withdrawal by Subject|0|||
125111975|NCT03568500|450034218|FG000|Overall Study|Technical Problems|2|||
125111976|NCT03568500|450034219|FG001|Overall Study|Technical Problems|1|||
125111977|NCT03568500|450034220|FG002|Overall Study|Technical Problems|0|||
125111978|NCT03568500|450034218|FG000|Overall Study|Participant Noncompliance|1|||
125111979|NCT03568500|450034219|FG001|Overall Study|Participant Noncompliance|1|||
125111980|NCT03568500|450034220|FG002|Overall Study|Participant Noncompliance|0|||
125111981|NCT01886300|450034224|FG000|Overall Study|Trial terminated by sponsor|16|||
125111982|NCT02008721|450034225|FG000|Overall Study|Withdrawal by Subject|5|||
125111983|NCT02008721|450034226|FG001|Overall Study|Withdrawal by Subject|1|||
125111984|NCT02008721|450034225|FG000|Overall Study|Death|4|||
125111985|NCT02008721|450034226|FG001|Overall Study|Death|2|||
125111986|NCT02008721|450034225|FG000|Overall Study|Adverse Event|3|||
125111987|NCT02008721|450034226|FG001|Overall Study|Adverse Event|5|||
125111988|NCT02008721|450034225|FG000|Overall Study|Protocol Violation|3|||
125111989|NCT02008721|450034226|FG001|Overall Study|Protocol Violation|2|||
125111990|NCT00267007|450034229|FG000|Overall Study|Withdrawal by Subject|6|||
125111991|NCT00267007|450034230|FG001|Overall Study|Withdrawal by Subject|0|||
125111992|NCT00267007|450034229|FG000|Overall Study|Lost to Follow-up|1|||
125111993|NCT00267007|450034230|FG001|Overall Study|Lost to Follow-up|0|||
125111994|NCT00267007|450034229|FG000|Overall Study|Non-compliance|0|||
125111995|NCT00267007|450034230|FG001|Overall Study|Non-compliance|1|||
125111996|NCT00267007|450034229|FG000|Overall Study|Adverse Event|1|||
125111997|NCT00267007|450034230|FG001|Overall Study|Adverse Event|0|||
125111998|NCT01825876|450034231|FG000|Period 2|Withdrawal by Subject|0|||
125111999|NCT01825876|450034232|FG001|Period 2|Withdrawal by Subject|1|||
125112000|NCT04133519|450034237|FG000|Overall Study|Withdrawal by Subject|5|||
125112001|NCT04133519|450034238|FG001|Overall Study|Withdrawal by Subject|4|||
125112002|NCT04133519|450034237|FG000|Overall Study|Protocol Violation|0|||
125112003|NCT04133519|450034238|FG001|Overall Study|Protocol Violation|1|||
125112004|NCT04133519|450034237|FG000|Overall Study|Never started treatment|1|||
125112005|NCT04133519|450034238|FG001|Overall Study|Never started treatment|1|||
125112006|NCT00475852|450034239|FG000|Overall Study|Death|444|||
125112007|NCT00475852|450034240|FG001|Overall Study|Death|456|||
125112008|NCT00475852|450034239|FG000|Overall Study|Withdrawal by Subject|19|||
125112009|NCT00475852|450034240|FG001|Overall Study|Withdrawal by Subject|24|||
125112010|NCT00475852|450034239|FG000|Overall Study|Lost to Follow-up|54|||
125112011|NCT00475852|450034240|FG001|Overall Study|Lost to Follow-up|68|||
125112012|NCT00297479|450034241|FG000|Overall Study|Lost to Follow-up|37|||
125112013|NCT00297479|450034242|FG001|Overall Study|Lost to Follow-up|54|||
125112014|NCT00297479|450034243|FG002|Overall Study|Lost to Follow-up|51|||
125112015|NCT01664494|450034244|FG000|Overall Study|Withdrawal by Subject|27|||
125112016|NCT01664494|450034244|FG000|Overall Study|Death|18|||
125112017|NCT01664494|450034244|FG000|Overall Study|Other|49|||
125112018|NCT01664494|450034244|FG000|Overall Study|Lost to Follow-up|99|||
125112019|NCT03196791|450034245|FG000|Overall Study|Protocol Violation|7|||
125112020|NCT03196791|450034246|FG001|Overall Study|Protocol Violation|3|||
125112021|NCT03196791|450034245|FG000|Overall Study|Withdrawal by Subject|3|||
125112022|NCT03196791|450034246|FG001|Overall Study|Withdrawal by Subject|2|||
125112023|NCT00373685|450034251|FG000|Overall Study|Death|2|||
125112024|NCT00373685|450034252|FG001|Overall Study|Death|1|||
125112025|NCT00373685|450034251|FG000|Overall Study|Adverse Event|278|||
125020305|NCT02322710|449699244|FG000|Overall Study|Protocol Violation|20|||
125020306|NCT02322710|449699245|FG001|Overall Study|Protocol Violation|25|||
125020307|NCT04161131|449699246|FG000|Overall Study|Ineligible|2|||
125020308|NCT04161131|449699246|FG000|Overall Study|Lost to Follow-up|4|||
125020309|NCT04316585|449699247|FG000|Overall Study|Adverse Event|2|||
125020310|NCT04316585|449699248|FG001|Overall Study|Adverse Event|1|||
125020311|NCT04316585|449699247|FG000|Overall Study|Lost to Follow-up|1|||
125020312|NCT04316585|449699248|FG001|Overall Study|Lost to Follow-up|0|||
125020313|NCT04316585|449699247|FG000|Overall Study|Withdrawal by Subject|2|||
125020314|NCT04316585|449699248|FG001|Overall Study|Withdrawal by Subject|3|||
125020315|NCT04316585|449699247|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
125020316|NCT04316585|449699248|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
125020317|NCT04316585|449699247|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
125020318|NCT04316585|449699248|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
125020319|NCT00130832|449699249|FG000|Overall Study|Adverse Event|1|||
125020320|NCT00130832|449699250|FG001|Overall Study|Adverse Event|1|||
125020321|NCT00130832|449699249|FG000|Overall Study|Lost to Follow-up|1|||
125020322|NCT00130832|449699250|FG001|Overall Study|Lost to Follow-up|2|||
125020323|NCT00130832|449699249|FG000|Overall Study|Protocol Violation|6|||
125020324|NCT00130832|449699250|FG001|Overall Study|Protocol Violation|8|||
125020325|NCT00130832|449699249|FG000|Overall Study|Withdrawal by Subject|6|||
125020326|NCT00130832|449699250|FG001|Overall Study|Withdrawal by Subject|1|||
125020327|NCT00130832|449699249|FG000|Overall Study|Moved|2|||
125020328|NCT00130832|449699250|FG001|Overall Study|Moved|2|||
125020329|NCT00130832|449699249|FG000|Overall Study|Other|0|||
125020330|NCT00130832|449699250|FG001|Overall Study|Other|3|||
125020331|NCT03905863|449699251|FG000|Overall Study|Adverse Event|2|||
125020332|NCT03905863|449699252|FG001|Overall Study|Adverse Event|4|||
125020333|NCT03905863|449699251|FG000|Overall Study|Withdrawal by Subject|2|||
125020334|NCT03905863|449699252|FG001|Overall Study|Withdrawal by Subject|2|||
125020335|NCT03905863|449699251|FG000|Overall Study|Physician Decision|0|||
125020336|NCT03905863|449699252|FG001|Overall Study|Physician Decision|3|||
125020337|NCT03905863|449699251|FG000|Overall Study|Lost to Follow-up|1|||
125020338|NCT03905863|449699252|FG001|Overall Study|Lost to Follow-up|0|||
125020339|NCT03905863|449699251|FG000|Overall Study|Protocol Violation|0|||
125020340|NCT03905863|449699252|FG001|Overall Study|Protocol Violation|2|||
125020341|NCT03905863|449699251|FG000|Overall Study|Death|0|||
125020342|NCT03905863|449699252|FG001|Overall Study|Death|1|||
125020343|NCT02944448|449699254|FG000|Overall Study|Adverse Event|37|||
125020344|NCT02944448|449699255|FG001|Overall Study|Adverse Event|6|||
125020345|NCT02944448|449699254|FG000|Overall Study|Lack of Efficacy|8|||
125020346|NCT02944448|449699255|FG001|Overall Study|Lack of Efficacy|5|||
125020347|NCT02944448|449699254|FG000|Overall Study|Lost to Follow-up|3|||
125020348|NCT02944448|449699255|FG001|Overall Study|Lost to Follow-up|1|||
125020349|NCT02944448|449699254|FG000|Overall Study|Protocol Violation|25|||
125020350|NCT02944448|449699255|FG001|Overall Study|Protocol Violation|7|||
125020351|NCT02944448|449699254|FG000|Overall Study|Withdrawal by Subject|14|||
125020352|NCT02944448|449699255|FG001|Overall Study|Withdrawal by Subject|4|||
125020353|NCT02944448|449699254|FG000|Overall Study|Sponsor did not supply drug in time|0|||
125020354|NCT02944448|449699255|FG001|Overall Study|Sponsor did not supply drug in time|1|||
125020355|NCT02944448|449699254|FG000|Overall Study|Noncompliant with dosing|1|||
125020356|NCT02944448|449699255|FG001|Overall Study|Noncompliant with dosing|0|||
125020357|NCT02944448|449699254|FG000|Overall Study|Abnormal laboratory values|1|||
125020358|NCT02944448|449699255|FG001|Overall Study|Abnormal laboratory values|0|||
125020359|NCT05499559|449699258|FG000|Overall Study|Lost to Follow-up|467|||
125020360|NCT04681170|449699259|FG000|Stratified Enrolment & run-in|Death|1|||
125020361|NCT04681170|449699260|FG001|Stratified Enrolment & run-in|Death|0|||
125020362|NCT04681170|449699259|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
125020363|NCT04681170|449699260|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
125020364|NCT04681170|449699259|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
125020365|NCT04681170|449699260|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
125112026|NCT00373685|450034252|FG001|Overall Study|Adverse Event|253|||
125112027|NCT00373685|450034251|FG000|Overall Study|Insufficient clinical response|169|||
125112028|NCT00373685|450034252|FG001|Overall Study|Insufficient clinical response|119|||
125112029|NCT00373685|450034251|FG000|Overall Study|Did not meet entrance criteria|167|||
125112030|NCT00373685|450034252|FG001|Overall Study|Did not meet entrance criteria|184|||
125112031|NCT00373685|450034251|FG000|Overall Study|Lost to follow up|83|||
125112032|NCT00373685|450034252|FG001|Overall Study|Lost to follow up|103|||
125112033|NCT00373685|450034251|FG000|Overall Study|No longer willing to participate|337|||
125112034|NCT00373685|450034252|FG001|Overall Study|No longer willing to participate|352|||
125112035|NCT00373685|450034251|FG000|Overall Study|Other|149|||
125112036|NCT00373685|450034252|FG001|Overall Study|Other|146|||
125112037|NCT00373685|450034251|FG000|Overall Study|Protocol Violation|191|||
125112038|NCT00373685|450034252|FG001|Overall Study|Protocol Violation|182|||
125112039|NCT00373685|450034251|FG000|Overall Study|Final Status Unknown|12|||
125112040|NCT00373685|450034252|FG001|Overall Study|Final Status Unknown|4|||
125112041|NCT00373685|450034251|FG000|Overall Study|Randomized, not treated|51|||
125112042|NCT00373685|450034252|FG001|Overall Study|Randomized, not treated|77|||
125112043|NCT01789281|450034253|FG000|Overall Study|Disease progression|15|||
125112044|NCT01789281|450034254|FG001|Overall Study|Disease progression|4|||
125112045|NCT01789281|450034253|FG000|Overall Study|Adverse Event|5|||
125112046|NCT01789281|450034254|FG001|Overall Study|Adverse Event|5|||
125112047|NCT01789281|450034253|FG000|Overall Study|Withdrawal by Subject|1|||
125112048|NCT01789281|450034254|FG001|Overall Study|Withdrawal by Subject|0|||
125112049|NCT01789281|450034253|FG000|Overall Study|Lost to Follow-up|1|||
125112050|NCT01789281|450034254|FG001|Overall Study|Lost to Follow-up|0|||
125112051|NCT01789281|450034253|FG000|Overall Study|Administrative problems|0|||
125112052|NCT01789281|450034254|FG001|Overall Study|Administrative problems|1|||
125112053|NCT02746705|450034255|FG000|Overall Study|Physician Decision|1|||
125112054|NCT02746705|450034256|FG001|Overall Study|Physician Decision|1|||
125112055|NCT02746705|450034255|FG000|Overall Study|Lost to Follow-up|1|||
125112056|NCT02746705|450034256|FG001|Overall Study|Lost to Follow-up|0|||
125112057|NCT02746705|450034255|FG000|Overall Study|outlier scores deemed not valid|0|||
125112058|NCT02746705|450034256|FG001|Overall Study|outlier scores deemed not valid|1|||
125112059|NCT03940586|450034264|FG000|Overall Study|Death|3|||
125112060|NCT03940586|450034265|FG001|Overall Study|Death|2|||
125112061|NCT03940586|450034266|FG002|Overall Study|Death|0|||
125112062|NCT03940586|450034264|FG000|Overall Study|Physician Decision|1|||
125112063|NCT03940586|450034265|FG001|Overall Study|Physician Decision|0|||
125112064|NCT03940586|450034266|FG002|Overall Study|Physician Decision|1|||
125112065|NCT03940586|450034264|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
125112066|NCT03940586|450034265|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
125112067|NCT03940586|450034266|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
125112068|NCT03940586|450034264|FG000|Overall Study|Not Treated|0|||
125112069|NCT03940586|450034265|FG001|Overall Study|Not Treated|2|||
125112070|NCT03940586|450034266|FG002|Overall Study|Not Treated|0|||
125112071|NCT02862535|450034267|FG000|Overall Study|Death|7|||
125112072|NCT02862535|450034268|FG001|Overall Study|Death|3|||
125112073|NCT02862535|450034269|FG002|Overall Study|Death|2|||
125112074|NCT02862535|450034270|FG003|Overall Study|Death|5|||
125112075|NCT02862535|450034267|FG000|Overall Study|Study Terminated by Sponsor|1|||
125112076|NCT02862535|450034268|FG001|Overall Study|Study Terminated by Sponsor|3|||
125112077|NCT02862535|450034269|FG002|Overall Study|Study Terminated by Sponsor|8|||
125112078|NCT02862535|450034270|FG003|Overall Study|Study Terminated by Sponsor|5|||
125112079|NCT02862535|450034267|FG000|Overall Study|Enrolled, not Treated|1|||
125112080|NCT02862535|450034268|FG001|Overall Study|Enrolled, not Treated|0|||
125112081|NCT02862535|450034269|FG002|Overall Study|Enrolled, not Treated|0|||
125112082|NCT02862535|450034270|FG003|Overall Study|Enrolled, not Treated|1|||
125112083|NCT04304950|450034273|FG000|Overall Study|Lost to Follow-up|1|||
125112084|NCT04304950|450034274|FG001|Overall Study|Lost to Follow-up|1|||
125112085|NCT03077828|450034275|FG000|Treatment Cycles|Death|1|||
124899752|NCT04044664|449257971|FG000|Stage 1|randomization error|0|||
125112086|NCT03077828|450034275|FG000|Treatment Cycles|Withdrawal by Subject|1|||
125112087|NCT03077828|450034275|FG000|Treatment Cycles|Screen Fail|2|||
125210784|NCT02134353|450395685|FG001|Overall Study|Lack of Efficacy|1|||
124899753|NCT04044664|449257972|FG001|Stage 1|randomization error|1|||
124899754|NCT04044664|449257973|FG002|Stage 1|randomization error|0|||
124899755|NCT04044664|449257971|FG000|Stage 2|Adverse Event|2|||
124899756|NCT04044664|449257972|FG001|Stage 2|Adverse Event|0|||
124899757|NCT04044664|449257973|FG002|Stage 2|Adverse Event|0|||
124899758|NCT04044664|449257971|FG000|Stage 2|Lost to Follow-up|3|||
124899759|NCT04044664|449257972|FG001|Stage 2|Lost to Follow-up|2|||
124899760|NCT04044664|449257973|FG002|Stage 2|Lost to Follow-up|1|||
124899761|NCT04044664|449257971|FG000|Stage 2|Withdrawal by Subject|3|||
124899762|NCT04044664|449257972|FG001|Stage 2|Withdrawal by Subject|0|||
124899763|NCT04044664|449257973|FG002|Stage 2|Withdrawal by Subject|0|||
124899764|NCT04044664|449257971|FG000|Stage 2|protocol deviation|1|||
124899765|NCT04044664|449257972|FG001|Stage 2|protocol deviation|0|||
124899766|NCT04044664|449257973|FG002|Stage 2|protocol deviation|0|||
124899767|NCT00001575|449257974|FG000|Overall Study|Screening failures-Ph I portion|22|||
124899768|NCT00001575|449257974|FG000|Overall Study|Withdrawn/deaths|23|||
124899769|NCT03736785|449257975|FG000|Overall Study|Adverse Event|1|||
124899770|NCT03736785|449257976|FG001|Overall Study|Adverse Event|1|||
124899771|NCT03736785|449257977|FG002|Overall Study|Adverse Event|1|||
124899772|NCT03736785|449257975|FG000|Overall Study|Death|1|||
124899773|NCT03736785|449257976|FG001|Overall Study|Death|0|||
124899774|NCT03736785|449257977|FG002|Overall Study|Death|1|||
124899775|NCT03736785|449257975|FG000|Overall Study|Lost to Follow-up|0|||
124899776|NCT03736785|449257976|FG001|Overall Study|Lost to Follow-up|2|||
124899777|NCT03736785|449257977|FG002|Overall Study|Lost to Follow-up|3|||
124899778|NCT03736785|449257975|FG000|Overall Study|Non compliance with study drug|1|||
124899779|NCT03736785|449257976|FG001|Overall Study|Non compliance with study drug|1|||
124899780|NCT03736785|449257977|FG002|Overall Study|Non compliance with study drug|0|||
124899781|NCT03736785|449257975|FG000|Overall Study|Physician Decision|0|||
124899782|NCT03736785|449257976|FG001|Overall Study|Physician Decision|1|||
124899783|NCT03736785|449257977|FG002|Overall Study|Physician Decision|1|||
124899784|NCT03736785|449257975|FG000|Overall Study|Protocol Violation|1|||
124899785|NCT03736785|449257976|FG001|Overall Study|Protocol Violation|4|||
124899786|NCT03736785|449257977|FG002|Overall Study|Protocol Violation|3|||
124899787|NCT03736785|449257975|FG000|Overall Study|Sponsor Decision|1|||
124899788|NCT03736785|449257976|FG001|Overall Study|Sponsor Decision|0|||
124899789|NCT03736785|449257977|FG002|Overall Study|Sponsor Decision|0|||
124899790|NCT03736785|449257975|FG000|Overall Study|Unknown/Missing data|3|||
124899791|NCT03736785|449257976|FG001|Overall Study|Unknown/Missing data|2|||
124899792|NCT03736785|449257977|FG002|Overall Study|Unknown/Missing data|1|||
124899793|NCT03736785|449257975|FG000|Overall Study|Withdrawal by Subject|9|||
124899794|NCT03736785|449257976|FG001|Overall Study|Withdrawal by Subject|6|||
124899795|NCT03736785|449257977|FG002|Overall Study|Withdrawal by Subject|4|||
125020366|NCT04681170|449699259|FG000|Open Label Efficacy Phase|Adverse Event|0|||
125020367|NCT04681170|449699260|FG001|Open Label Efficacy Phase|Adverse Event|2|||
125020368|NCT04681170|449699259|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
124899796|NCT01744691|449257987|FG000|Overall Study|Progressive Disease|18|||
124899797|NCT01744691|449257987|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
124899798|NCT01744691|449257987|FG000|Overall Study|Withdrawal of consent for treatment|3|||
124899799|NCT01744691|449257987|FG000|Overall Study|Physician Decision|4|||
124899800|NCT01190150|449257989|FG000|First Treatment|Withdrawal by Subject|1|||
124899801|NCT01190150|449257990|FG001|First Treatment|Withdrawal by Subject|0|||
124899802|NCT01190150|449257989|FG000|Washout|Withdrawal by Subject|0|||
124899803|NCT01190150|449257990|FG001|Washout|Withdrawal by Subject|1|||
124899804|NCT01190150|449257989|FG000|Washout|Difficulty in adherence|0|||
124899805|NCT01190150|449257990|FG001|Washout|Difficulty in adherence|1|||
124899806|NCT04511650|449257993|FG000|Overall Study|Lost to Follow-up|1|||
124899807|NCT04511650|449257994|FG001|Overall Study|Lost to Follow-up|0|||
124899808|NCT04511650|449257995|FG002|Overall Study|Lost to Follow-up|0|||
124899809|NCT04511650|449257993|FG000|Overall Study|Withdrawal by Subject|1|||
124899810|NCT04511650|449257994|FG001|Overall Study|Withdrawal by Subject|0|||
124899811|NCT04511650|449257995|FG002|Overall Study|Withdrawal by Subject|0|||
124899812|NCT04511650|449257993|FG000|Overall Study|reason not provided|0|||
124899813|NCT04511650|449257994|FG001|Overall Study|reason not provided|0|||
124899814|NCT04511650|449257995|FG002|Overall Study|reason not provided|1|||
124899815|NCT04511650|449257993|FG000|Overall Study|Death|1|||
124899816|NCT04511650|449257994|FG001|Overall Study|Death|1|||
124899817|NCT04511650|449257995|FG002|Overall Study|Death|1|||
124899818|NCT01081145|449258006|FG000|Open-Label Phase|Lack of Efficacy|56|||
124899819|NCT01081145|449258007|FG001|Open-Label Phase|Lack of Efficacy|0|||
124899820|NCT01081145|449258006|FG000|Open-Label Phase|Response criteria not met|46|||
124899821|NCT01081145|449258007|FG001|Open-Label Phase|Response criteria not met|0|||
124899822|NCT01081145|449258006|FG000|Open-Label Phase|Adverse Event|42|||
124899823|NCT01081145|449258007|FG001|Open-Label Phase|Adverse Event|0|||
124899824|NCT01081145|449258006|FG000|Open-Label Phase|Withdrawal by Subject|41|||
124899825|NCT01081145|449258007|FG001|Open-Label Phase|Withdrawal by Subject|0|||
124899826|NCT01081145|449258006|FG000|Open-Label Phase|Other|12|||
124899827|NCT01081145|449258007|FG001|Open-Label Phase|Other|0|||
124899828|NCT01081145|449258006|FG000|Open-Label Phase|Lost to Follow-up|11|||
124899829|NCT01081145|449258007|FG001|Open-Label Phase|Lost to Follow-up|0|||
124899830|NCT01081145|449258006|FG000|Open-Label Phase|Protocol Violation|4|||
124899831|NCT01081145|449258007|FG001|Open-Label Phase|Protocol Violation|0|||
124899832|NCT01081145|449258006|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
124899833|NCT01081145|449258007|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
124899834|NCT01081145|449258006|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
124899835|NCT01081145|449258007|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
124899836|NCT01081145|449258006|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
124899837|NCT01081145|449258007|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
124899838|NCT01081145|449258006|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
124899839|NCT01081145|449258007|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
124899840|NCT01081145|449258006|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
124899841|NCT01081145|449258007|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
124899842|NCT01081145|449258006|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
124899843|NCT01081145|449258007|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
124899844|NCT01081145|449258006|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
124899845|NCT01081145|449258007|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
124899846|NCT02197234|449258008|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
124899847|NCT02197234|449258008|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
125020369|NCT04681170|449699260|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
125020370|NCT04681170|449699259|FG000|Open Label Safety Phase|AEs and none compliance|0|||
125020371|NCT04681170|449699260|FG001|Open Label Safety Phase|AEs and none compliance|1|||
125020372|NCT04986202|449699261|FG000|Overall Study|Death|10|||
125020373|NCT04986202|449699262|FG001|Overall Study|Death|3|||
125020374|NCT04986202|449699263|FG002|Overall Study|Death|10|||
125020375|NCT04986202|449699261|FG000|Overall Study|Physician Decision|3|||
125112088|NCT03077828|450034275|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
125112089|NCT03077828|450034275|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
125112090|NCT03077828|450034275|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
125112091|NCT03077828|450034275|FG000|Follow-up|Patients still in follow-up|15|||
125112092|NCT02418910|450034279|FG000|Overall Study|Lost to Follow-up|3|||
125112093|NCT02418910|450034279|FG000|Overall Study|Withdrawal by Subject|4|||
124899848|NCT02197234|449258008|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
124899849|NCT02197234|449258008|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
124899850|NCT02197234|449258008|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
124899851|NCT02197234|449258008|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
125020376|NCT04986202|449699262|FG001|Overall Study|Physician Decision|1|||
125112094|NCT00345683|450034281|FG000|Overall Study|Lost to Follow-up|19|||
125112095|NCT00345683|450034282|FG001|Overall Study|Lost to Follow-up|7|||
124899852|NCT05826431|449258010|FG000|Overall Study|Withdrawal by Subject|1|||
125020377|NCT04986202|449699263|FG002|Overall Study|Physician Decision|2|||
125020378|NCT04986202|449699261|FG000|Overall Study|Withdrawal by Subject|4|||
125020379|NCT04986202|449699262|FG001|Overall Study|Withdrawal by Subject|2|||
124899853|NCT04771273|449258011|FG000|Dose Escalation Period|Not treated with trial medication|0|||
125020380|NCT04986202|449699263|FG002|Overall Study|Withdrawal by Subject|4|||
124899854|NCT04771273|449258012|FG001|Dose Escalation Period|Not treated with trial medication|1|||
124899855|NCT04771273|449258013|FG002|Dose Escalation Period|Not treated with trial medication|1|||
124899856|NCT04771273|449258014|FG003|Dose Escalation Period|Not treated with trial medication|0|||
124899857|NCT04771273|449258011|FG000|Dose Escalation Period|Other reasons than listed|2|||
124899858|NCT04771273|449258012|FG001|Dose Escalation Period|Other reasons than listed|0|||
124899859|NCT04771273|449258013|FG002|Dose Escalation Period|Other reasons than listed|2|||
124899860|NCT04771273|449258014|FG003|Dose Escalation Period|Other reasons than listed|1|||
124899861|NCT04771273|449258011|FG000|Dose Escalation Period|Protocol Violation|0|||
124899862|NCT04771273|449258012|FG001|Dose Escalation Period|Protocol Violation|0|||
124899863|NCT04771273|449258013|FG002|Dose Escalation Period|Protocol Violation|3|||
124899864|NCT04771273|449258014|FG003|Dose Escalation Period|Protocol Violation|1|||
125112096|NCT00345683|450034281|FG000|Overall Study|Other|6|||
125112097|NCT00345683|450034282|FG001|Overall Study|Other|2|||
125112098|NCT04288115|450034283|FG000|Overall Study|Withdrawal by Subject|0|||
125112099|NCT04288115|450034284|FG001|Overall Study|Withdrawal by Subject|1|||
125112100|NCT04288115|450034283|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
125112101|NCT04288115|450034284|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
125112102|NCT03634488|450034285|FG000|Overall Study|Death|1|||
125112103|NCT03634488|450034286|FG001|Overall Study|Death|0|||
125112104|NCT03634488|450034287|FG002|Overall Study|Death|0|||
125112105|NCT03634488|450034285|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
125112106|NCT03634488|450034286|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
125112107|NCT03634488|450034287|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
125112108|NCT00729365|450034288|FG000|Overall Study|Physician Decision|33|||
125112109|NCT00729365|450034289|FG001|Overall Study|Physician Decision|6|||
125112110|NCT00729365|450034290|FG002|Overall Study|Physician Decision|7|||
125112111|NCT01154127|450034292|FG000|Period 1 (21 Days)|Adverse Event|3|||
125112112|NCT01154127|450034293|FG001|Period 1 (21 Days)|Adverse Event|4|||
125112113|NCT01154127|450034292|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
125112114|NCT01154127|450034293|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
125112115|NCT01154127|450034292|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
125112116|NCT01154127|450034293|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
125112117|NCT01154127|450034292|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
125112118|NCT01154127|450034293|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
125112119|NCT01154127|450034292|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
125112120|NCT01154127|450034293|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
125112121|NCT01697449|450034294|FG000|Overall Study|Disease progression|47|||
125112122|NCT01697449|450034294|FG000|Overall Study|Adverse Event|7|||
125112123|NCT01697449|450034294|FG000|Overall Study|Lost to Follow-up|5|||
125112124|NCT01697449|450034294|FG000|Overall Study|Withdrawal by Subject|2|||
125112125|NCT01697449|450034294|FG000|Overall Study|Physician Decision|1|||
125112126|NCT01697449|450034294|FG000|Overall Study|Death|2|||
124899865|NCT04771273|449258011|FG000|Dose Escalation Period|Burden of study procedures|1|||
124899866|NCT04771273|449258012|FG001|Dose Escalation Period|Burden of study procedures|0|||
124899867|NCT04771273|449258013|FG002|Dose Escalation Period|Burden of study procedures|0|||
124899868|NCT04771273|449258014|FG003|Dose Escalation Period|Burden of study procedures|0|||
124899869|NCT04771273|449258011|FG000|Dose Escalation Period|Change of residence|0|||
124899870|NCT04771273|449258012|FG001|Dose Escalation Period|Change of residence|0|||
124899871|NCT04771273|449258013|FG002|Dose Escalation Period|Change of residence|0|||
124899872|NCT04771273|449258014|FG003|Dose Escalation Period|Change of residence|1|||
125020381|NCT02468648|449699264|FG000|Overall Study|Death|1|||
125020382|NCT02118792|449699265|FG000|Overall Study|Withdrawal by Subject|6|||
125020383|NCT02118792|449699266|FG001|Overall Study|Withdrawal by Subject|3|||
125020384|NCT02118792|449699265|FG000|Overall Study|Lost to Follow-up|4|||
125020385|NCT02118792|449699266|FG001|Overall Study|Lost to Follow-up|4|||
125020386|NCT02118792|449699265|FG000|Overall Study|Adverse Event|5|||
125020387|NCT02118792|449699266|FG001|Overall Study|Adverse Event|4|||
125020388|NCT02118792|449699265|FG000|Overall Study|Withdrawal by parent/guardian|14|||
125020389|NCT02118792|449699266|FG001|Overall Study|Withdrawal by parent/guardian|20|||
125020390|NCT02118792|449699265|FG000|Overall Study|Other|1|||
125020391|NCT02118792|449699266|FG001|Overall Study|Other|6|||
125020392|NCT02118792|449699265|FG000|Overall Study|Randomised but not treated|1|||
125020393|NCT02118792|449699266|FG001|Overall Study|Randomised but not treated|0|||
125020394|NCT05131204|449699267|FG000|Overall Study|Sponsor request|2|||
125020395|NCT05131204|449699268|FG001|Overall Study|Sponsor request|1|||
125020396|NCT04656652|449699269|FG000|Overall Study|Lost to Follow-up|2|||
125020397|NCT04656652|449699270|FG001|Overall Study|Lost to Follow-up|2|||
125020398|NCT04656652|449699269|FG000|Overall Study|Death|213|||
125020399|NCT04656652|449699270|FG001|Overall Study|Death|212|||
125020400|NCT04656652|449699269|FG000|Overall Study|Other|1|||
125020401|NCT04656652|449699270|FG001|Overall Study|Other|0|||
125020402|NCT04656652|449699269|FG000|Overall Study|Withdrawal by Subject|15|||
125020403|NCT04656652|449699270|FG001|Overall Study|Withdrawal by Subject|29|||
124899873|NCT04771273|449258011|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
124899874|NCT04771273|449258012|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
124899875|NCT04771273|449258013|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
124899876|NCT04771273|449258014|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
124899877|NCT04771273|449258011|FG000|Dose Escalation Period|Adverse Event|8|||
124899878|NCT04771273|449258012|FG001|Dose Escalation Period|Adverse Event|9|||
124899879|NCT04771273|449258013|FG002|Dose Escalation Period|Adverse Event|12|||
124899880|NCT04771273|449258014|FG003|Dose Escalation Period|Adverse Event|2|||
124899881|NCT04771273|449258011|FG000|Maintenance Period|Other than listed|4|||
124899882|NCT04771273|449258012|FG001|Maintenance Period|Other than listed|2|||
124899883|NCT04771273|449258013|FG002|Maintenance Period|Other than listed|0|||
124899884|NCT04771273|449258014|FG003|Maintenance Period|Other than listed|3|||
124899885|NCT04771273|449258011|FG000|Maintenance Period|Burden of study procedures|1|||
124899886|NCT04771273|449258012|FG001|Maintenance Period|Burden of study procedures|0|||
124899887|NCT04771273|449258013|FG002|Maintenance Period|Burden of study procedures|0|||
124899888|NCT04771273|449258014|FG003|Maintenance Period|Burden of study procedures|0|||
124899889|NCT04771273|449258011|FG000|Maintenance Period|Change of residence|0|||
125112127|NCT01697449|450034294|FG000|Overall Study|Other|1|||
125112128|NCT01697449|450034294|FG000|Overall Study|Missing|25|||
125112129|NCT01169844|450034296|FG000|Overall Study|Adverse Event|0|||
125112130|NCT01169844|450034297|FG001|Overall Study|Adverse Event|1|||
125112131|NCT01169844|450034296|FG000|Overall Study|Patient withdrew consent|4|||
124899890|NCT04771273|449258012|FG001|Maintenance Period|Change of residence|1|||
124899891|NCT04771273|449258013|FG002|Maintenance Period|Change of residence|3|||
125112132|NCT01169844|450034297|FG001|Overall Study|Patient withdrew consent|0|||
125112133|NCT01169844|450034296|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124899892|NCT04771273|449258014|FG003|Maintenance Period|Change of residence|0|||
124899893|NCT04771273|449258011|FG000|Maintenance Period|Perceived lack of efficacy|0|||
124899894|NCT04771273|449258012|FG001|Maintenance Period|Perceived lack of efficacy|0|||
124899895|NCT04771273|449258013|FG002|Maintenance Period|Perceived lack of efficacy|0|||
125020404|NCT02787863|449699271|FG000|Overall Study|Death|1|||
125020405|NCT02787863|449699272|FG001|Overall Study|Death|0|||
124899896|NCT04771273|449258014|FG003|Maintenance Period|Perceived lack of efficacy|1|||
125020406|NCT02787863|449699273|FG002|Overall Study|Death|1|||
125020407|NCT02787863|449699274|FG003|Overall Study|Death|0|||
125020408|NCT02787863|449699275|FG004|Overall Study|Death|0|||
125020409|NCT02787863|449699276|FG005|Overall Study|Death|0|||
125020410|NCT02787863|449699277|FG006|Overall Study|Death|0|||
125020411|NCT02787863|449699278|FG007|Overall Study|Death|0|||
125020412|NCT02787863|449699271|FG000|Overall Study|Withdrawal by Subject|0|||
125020413|NCT02787863|449699272|FG001|Overall Study|Withdrawal by Subject|1|||
125020414|NCT02787863|449699273|FG002|Overall Study|Withdrawal by Subject|1|||
125020415|NCT02787863|449699274|FG003|Overall Study|Withdrawal by Subject|0|||
125020416|NCT02787863|449699275|FG004|Overall Study|Withdrawal by Subject|0|||
125020417|NCT02787863|449699276|FG005|Overall Study|Withdrawal by Subject|0|||
125020418|NCT02787863|449699277|FG006|Overall Study|Withdrawal by Subject|0|||
125020419|NCT02787863|449699278|FG007|Overall Study|Withdrawal by Subject|0|||
125020420|NCT01978093|449699279|FG000|Overall Study|Death|1|||
125020421|NCT01978093|449699280|FG001|Overall Study|Death|0|||
125020422|NCT01978093|449699279|FG000|Overall Study|Adverse Event|0|||
125020423|NCT01978093|449699280|FG001|Overall Study|Adverse Event|5|||
125020424|NCT01978093|449699279|FG000|Overall Study|Protocol Violation|8|||
124899897|NCT04771273|449258011|FG000|Maintenance Period|Adverse Event|4|||
125020425|NCT01978093|449699280|FG001|Overall Study|Protocol Violation|2|||
125020426|NCT01978093|449699279|FG000|Overall Study|Withdrawal by Subject|29|||
125112134|NCT01169844|450034297|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125112135|NCT05037409|450034298|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
125112136|NCT05037409|450034299|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
125112137|NCT05037409|450034300|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
125112138|NCT00529568|450034301|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
125112139|NCT00529568|450034302|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
125112140|NCT00529568|450034303|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
125112141|NCT00529568|450034301|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
125112142|NCT00529568|450034302|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
125112143|NCT00529568|450034303|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
125112144|NCT00529568|450034301|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
125112145|NCT00529568|450034302|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
125112146|NCT00529568|450034303|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
125112147|NCT00529568|450034301|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
125112148|NCT00529568|450034302|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
125112149|NCT00529568|450034303|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
125112150|NCT00529568|450034301|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
125112151|NCT00529568|450034302|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
125020427|NCT01978093|449699280|FG001|Overall Study|Withdrawal by Subject|25|||
125020428|NCT01978093|449699279|FG000|Overall Study|Lost to Follow-up|11|||
125020429|NCT01978093|449699280|FG001|Overall Study|Lost to Follow-up|15|||
125020430|NCT01978093|449699279|FG000|Overall Study|Migrated/moved from study area|11|||
125020431|NCT01978093|449699280|FG001|Overall Study|Migrated/moved from study area|13|||
125020432|NCT01978093|449699279|FG000|Overall Study|Loss of kaiser coverage|4|||
125020433|NCT01978093|449699280|FG001|Overall Study|Loss of kaiser coverage|10|||
125020434|NCT01978093|449699279|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
125020435|NCT01978093|449699280|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
125020436|NCT01978093|449699279|FG000|Overall Study|Mother lost custody of child|0|||
125020437|NCT01978093|449699280|FG001|Overall Study|Mother lost custody of child|1|||
125020438|NCT01978093|449699279|FG000|Overall Study|Child was in care of grandmother|0|||
125020439|NCT01978093|449699280|FG001|Overall Study|Child was in care of grandmother|1|||
125020440|NCT01978093|449699279|FG000|Overall Study|N/A for vaccine administration|0|||
125020441|NCT01978093|449699280|FG001|Overall Study|N/A for vaccine administration|1|||
125020442|NCT02469090|449699281|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
125020443|NCT02469090|449699282|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
125020444|NCT02469090|449699283|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
125020445|NCT02469090|449699281|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
125020446|NCT02469090|449699282|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
125020447|NCT02469090|449699283|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
125020448|NCT02469090|449699281|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
125020449|NCT02469090|449699282|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
125020450|NCT02469090|449699283|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
125020451|NCT02469090|449699281|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
125020452|NCT02469090|449699282|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
125020453|NCT02469090|449699283|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
125020454|NCT02469090|449699281|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
125020455|NCT02469090|449699282|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
125020456|NCT02469090|449699283|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
125020457|NCT02469090|449699281|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
124899898|NCT04771273|449258012|FG001|Maintenance Period|Adverse Event|5|||
124899899|NCT04771273|449258013|FG002|Maintenance Period|Adverse Event|5|||
124899900|NCT04771273|449258014|FG003|Maintenance Period|Adverse Event|0|||
124899901|NCT01543685|449258015|FG000|Overall Study|Lack of Efficacy|1|||
124899902|NCT01543685|449258016|FG001|Overall Study|Lack of Efficacy|2|||
124899903|NCT01543685|449258017|FG002|Overall Study|Lack of Efficacy|2|||
124899904|NCT01543685|449258018|FG003|Overall Study|Lack of Efficacy|0|||
124899905|NCT01543685|449258019|FG004|Overall Study|Lack of Efficacy|2|||
124899906|NCT01543685|449258015|FG000|Overall Study|Adverse Event|2|||
124899907|NCT01543685|449258016|FG001|Overall Study|Adverse Event|1|||
125112152|NCT00529568|450034303|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
124899908|NCT01543685|449258017|FG002|Overall Study|Adverse Event|0|||
124899909|NCT01543685|449258018|FG003|Overall Study|Adverse Event|0|||
124899910|NCT01543685|449258019|FG004|Overall Study|Adverse Event|2|||
124899911|NCT02163915|449258020|FG000|Overall Study|Withdrawal by Subject|2|||
124899912|NCT02163915|449258021|FG001|Overall Study|Withdrawal by Subject|0|||
125020458|NCT02469090|449699282|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
125020459|NCT02469090|449699283|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
125020460|NCT02469090|449699281|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
125020461|NCT02469090|449699282|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
125020462|NCT02469090|449699283|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
125020463|NCT02469090|449699281|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
125020464|NCT02469090|449699282|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
125020465|NCT02469090|449699283|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
125020466|NCT01415752|449699289|FG000|Induction (Step 1)|Ineligible|4|||
125020467|NCT01415752|449699290|FG001|Induction (Step 1)|Ineligible|3|||
125020468|NCT01415752|449699291|FG002|Induction (Step 1)|Ineligible|4|||
125020469|NCT01415752|449699292|FG003|Induction (Step 1)|Ineligible|4|||
125020470|NCT01415752|449699289|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
124899913|NCT02163915|449258022|FG002|Overall Study|Withdrawal by Subject|2|||
124899914|NCT02163915|449258023|FG003|Overall Study|Withdrawal by Subject|2|||
124899915|NCT02163915|449258024|FG004|Overall Study|Withdrawal by Subject|2|||
124899916|NCT02163915|449258020|FG000|Overall Study|Study termination|1|||
124899917|NCT02163915|449258021|FG001|Overall Study|Study termination|0|||
124899918|NCT02163915|449258022|FG002|Overall Study|Study termination|0|||
124899919|NCT02163915|449258023|FG003|Overall Study|Study termination|0|||
124899920|NCT02163915|449258024|FG004|Overall Study|Study termination|2|||
124899921|NCT02163915|449258020|FG000|Overall Study|Physician Decision|0|||
124899922|NCT02163915|449258021|FG001|Overall Study|Physician Decision|0|||
124899923|NCT02163915|449258022|FG002|Overall Study|Physician Decision|0|||
124899924|NCT02163915|449258023|FG003|Overall Study|Physician Decision|1|||
124899925|NCT02163915|449258024|FG004|Overall Study|Physician Decision|0|||
124899926|NCT02013037|449258025|FG000|Overall Study|Death|6|||
124899927|NCT02013037|449258025|FG000|Overall Study|Withdrawal by Subject|1|||
124899928|NCT02013037|449258025|FG000|Overall Study|Awaiting Transplantation|7|||
124899929|NCT02013037|449258025|FG000|Overall Study|Transplanted without DSA|2|||
124899930|NCT02465359|449258026|FG000|Overall Study|Lack of Efficacy|1|||
124899931|NCT02465359|449258026|FG000|Overall Study|Withdrawal by Subject|1|||
124899932|NCT02465359|449258026|FG000|Overall Study|Adverse Event|1|||
124899933|NCT01304147|449258027|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
124899934|NCT01304147|449258028|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
124899935|NCT00708097|449258029|FG000|Period 1|Protocol Violation|0|||
124899936|NCT00708097|449258030|FG001|Period 1|Protocol Violation|1|||
124899937|NCT00708097|449258031|FG002|Period 1|Protocol Violation|0|||
124899938|NCT00708097|449258032|FG003|Period 1|Protocol Violation|2|||
124899939|NCT00708097|449258033|FG004|Period 1|Protocol Violation|0|||
124899940|NCT00708097|449258029|FG000|Period 1|Other Reason|0|||
124899941|NCT00708097|449258030|FG001|Period 1|Other Reason|0|||
124899942|NCT00708097|449258031|FG002|Period 1|Other Reason|0|||
124899943|NCT00708097|449258032|FG003|Period 1|Other Reason|0|||
124899944|NCT00708097|449258033|FG004|Period 1|Other Reason|1|||
124899945|NCT00708097|449258029|FG000|Period 2|Protocol Violation|0|||
124899946|NCT00708097|449258030|FG001|Period 2|Protocol Violation|1|||
124899947|NCT00708097|449258031|FG002|Period 2|Protocol Violation|1|||
124899948|NCT00708097|449258032|FG003|Period 2|Protocol Violation|1|||
124899949|NCT00708097|449258033|FG004|Period 2|Protocol Violation|0|||
124899950|NCT01244828|449258034|FG000|Overall Study|Adverse Event|37|||
124899951|NCT01244828|449258034|FG000|Overall Study|Withdrawal by Subject|31|||
124899952|NCT01244828|449258034|FG000|Overall Study|Lack of Efficacy|7|||
124899953|NCT01244828|449258034|FG000|Overall Study|Lost to Follow-up|2|||
124899954|NCT01244828|449258034|FG000|Overall Study|Other reason (not specified)|1|||
124899955|NCT01278862|449258035|FG000|Overall Study|Lost to Follow-up|1|||
124899956|NCT01278862|449258036|FG001|Overall Study|Lost to Follow-up|1|||
124899957|NCT02952261|449258038|FG000|Overall Study|Withdrawal by Subject|4|||
124899958|NCT02952261|449258039|FG001|Overall Study|Withdrawal by Subject|5|||
124899959|NCT02952261|449258038|FG000|Overall Study|Protocol Violation|1|||
124899960|NCT02952261|449258039|FG001|Overall Study|Protocol Violation|0|||
124899961|NCT00603447|449258040|FG000|Overall Study|Adverse Event|0|||
124899962|NCT00603447|449258041|FG001|Overall Study|Adverse Event|1|||
124899963|NCT00603447|449258042|FG002|Overall Study|Adverse Event|1|||
125020471|NCT01415752|449699290|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
125020472|NCT01415752|449699291|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
125020473|NCT01415752|449699292|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
125020474|NCT01415752|449699289|FG000|Maintenance (Step 2)|Adverse Event|3|||
124899964|NCT00603447|449258043|FG003|Overall Study|Adverse Event|2|||
125020475|NCT01415752|449699290|FG001|Maintenance (Step 2)|Adverse Event|4|||
125020476|NCT01415752|449699291|FG002|Maintenance (Step 2)|Adverse Event|9|||
125020477|NCT01415752|449699292|FG003|Maintenance (Step 2)|Adverse Event|6|||
125020478|NCT01415752|449699289|FG000|Maintenance (Step 2)|Death|1|||
124899965|NCT00603447|449258044|FG004|Overall Study|Adverse Event|1|||
124899966|NCT00603447|449258045|FG005|Overall Study|Adverse Event|2|||
124899967|NCT00603447|449258046|FG006|Overall Study|Adverse Event|10|||
124899968|NCT00603447|449258040|FG000|Overall Study|Other|0|||
124899969|NCT00603447|449258041|FG001|Overall Study|Other|0|||
124899970|NCT00603447|449258042|FG002|Overall Study|Other|1|||
125112153|NCT00529568|450034301|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
125112154|NCT00529568|450034302|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
125112155|NCT00529568|450034303|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
125112156|NCT00529568|450034301|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
125112157|NCT00529568|450034302|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
125112158|NCT00529568|450034303|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
125112159|NCT00529568|450034301|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
125112160|NCT00529568|450034302|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
125112161|NCT00529568|450034303|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
125112162|NCT00529568|450034301|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
125112163|NCT00529568|450034302|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
125112164|NCT00529568|450034303|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
125112165|NCT00529568|450034301|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
125112166|NCT00529568|450034302|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
125112167|NCT00529568|450034303|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
125112168|NCT00529568|450034301|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
125112169|NCT00529568|450034302|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
125112170|NCT00529568|450034303|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
125112171|NCT00931385|450034304|FG000|Overall Study|Adverse Event|2|||
125112172|NCT00931385|450034305|FG001|Overall Study|Adverse Event|1|||
125112173|NCT00931385|450034306|FG002|Overall Study|Adverse Event|0|||
125112174|NCT00931385|450034307|FG003|Overall Study|Adverse Event|3|||
125112175|NCT00931385|450034304|FG000|Overall Study|Protocol Violation|0|||
125112176|NCT00931385|450034305|FG001|Overall Study|Protocol Violation|0|||
125112177|NCT00931385|450034306|FG002|Overall Study|Protocol Violation|1|||
125112178|NCT00931385|450034307|FG003|Overall Study|Protocol Violation|0|||
125112179|NCT00931385|450034304|FG000|Overall Study|Withdrawal by Subject|0|||
125112180|NCT00931385|450034305|FG001|Overall Study|Withdrawal by Subject|1|||
125112181|NCT00931385|450034306|FG002|Overall Study|Withdrawal by Subject|0|||
125112182|NCT00931385|450034307|FG003|Overall Study|Withdrawal by Subject|1|||
125112183|NCT00931385|450034304|FG000|Overall Study|Lost to Follow-up|0|||
124899971|NCT00603447|449258043|FG003|Overall Study|Other|0|||
125112184|NCT00931385|450034305|FG001|Overall Study|Lost to Follow-up|0|||
124899972|NCT00603447|449258044|FG004|Overall Study|Other|3|||
125112185|NCT00931385|450034306|FG002|Overall Study|Lost to Follow-up|0|||
125112186|NCT00931385|450034307|FG003|Overall Study|Lost to Follow-up|1|||
125112187|NCT01201356|450034308|FG000|Overall Study|Adverse Event|170|||
125112188|NCT01201356|450034308|FG000|Overall Study|Abnormal laboratory value(s)|51|||
124899973|NCT00603447|449258045|FG005|Overall Study|Other|0|||
124899974|NCT00603447|449258046|FG006|Overall Study|Other|13|||
124899975|NCT00603447|449258040|FG000|Overall Study|Withdrew Consent|0|||
124899976|NCT00603447|449258041|FG001|Overall Study|Withdrew Consent|2|||
125112189|NCT01201356|450034308|FG000|Overall Study|Abnormal test procedure result(s)|3|||
125112190|NCT01201356|450034308|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
125112191|NCT01201356|450034308|FG000|Overall Study|Condition no longer requires study drug|12|||
125112192|NCT01201356|450034308|FG000|Overall Study|Withdrawal by Subject|144|||
125112193|NCT01201356|450034308|FG000|Overall Study|Lost to Follow-up|50|||
125112194|NCT01201356|450034308|FG000|Overall Study|administrative problems|74|||
125112195|NCT01201356|450034308|FG000|Overall Study|Death|16|||
125112196|NCT01201356|450034308|FG000|Overall Study|Protocol Violation|12|||
125112197|NCT00738920|450034310|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
125112198|NCT00738920|450034311|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
125112199|NCT00738920|450034312|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
125112200|NCT00738920|450034310|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
125112201|NCT00738920|450034311|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
125112202|NCT00738920|450034312|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
125112203|NCT00738920|450034310|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
125112204|NCT00738920|450034311|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
125112205|NCT00738920|450034312|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
125112206|NCT00738920|450034310|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
125112207|NCT00738920|450034311|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
125112208|NCT00738920|450034312|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
125112209|NCT00738920|450034310|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
125112210|NCT00738920|450034311|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
125112211|NCT00738920|450034312|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
125112212|NCT00738920|450034310|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
125112213|NCT00738920|450034311|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
125112214|NCT00738920|450034312|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
125112215|NCT00738920|450034310|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
125112216|NCT00738920|450034311|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
125112217|NCT00738920|450034312|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
125112218|NCT00738920|450034310|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
125112219|NCT00738920|450034311|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
125112220|NCT00738920|450034312|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
125112221|NCT00738920|450034310|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
125112222|NCT00738920|450034311|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
125112223|NCT00738920|450034312|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
125112224|NCT00738920|450034310|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
124899977|NCT00603447|449258042|FG002|Overall Study|Withdrew Consent|0|||
124899978|NCT00603447|449258043|FG003|Overall Study|Withdrew Consent|0|||
124899979|NCT00603447|449258044|FG004|Overall Study|Withdrew Consent|1|||
125112225|NCT00738920|450034311|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
125112226|NCT00738920|450034312|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
125112227|NCT04079842|450034314|FG000|Overall Study|Request of subject|2|||
124899980|NCT00603447|449258045|FG005|Overall Study|Withdrew Consent|0|||
124899981|NCT00603447|449258046|FG006|Overall Study|Withdrew Consent|1|||
125112228|NCT04079842|450034314|FG000|Overall Study|Unable to draw Arterial samples|1|||
125112229|NCT02904200|450034315|FG000|Overall Study|Withdrawal by Subject|1|||
125112230|NCT02904200|450034316|FG001|Overall Study|Withdrawal by Subject|0|||
125112231|NCT04444752|450034317|FG000|Overall Study|Adverse Event|1|||
125112232|NCT04444752|450034318|FG001|Overall Study|Adverse Event|0|||
125112233|NCT04444752|450034319|FG002|Overall Study|Adverse Event|0|||
125112234|NCT04444752|450034320|FG003|Overall Study|Adverse Event|2|||
125112235|NCT04444752|450034317|FG000|Overall Study|Lost to Follow-up|2|||
125112236|NCT04444752|450034318|FG001|Overall Study|Lost to Follow-up|6|||
125112237|NCT04444752|450034319|FG002|Overall Study|Lost to Follow-up|2|||
125112238|NCT04444752|450034320|FG003|Overall Study|Lost to Follow-up|5|||
125112239|NCT04444752|450034317|FG000|Overall Study|Physician Decision|0|||
125112240|NCT04444752|450034318|FG001|Overall Study|Physician Decision|0|||
125112241|NCT04444752|450034319|FG002|Overall Study|Physician Decision|0|||
125112242|NCT04444752|450034320|FG003|Overall Study|Physician Decision|2|||
125112243|NCT04444752|450034317|FG000|Overall Study|Pregnancy|0|||
125112244|NCT04444752|450034318|FG001|Overall Study|Pregnancy|0|||
125112245|NCT04444752|450034319|FG002|Overall Study|Pregnancy|0|||
125112246|NCT04444752|450034320|FG003|Overall Study|Pregnancy|1|||
125112247|NCT04444752|450034317|FG000|Overall Study|Withdrawal by Subject|6|||
125112248|NCT04444752|450034318|FG001|Overall Study|Withdrawal by Subject|5|||
125112249|NCT04444752|450034319|FG002|Overall Study|Withdrawal by Subject|3|||
124899982|NCT05233085|449258047|FG000|Overall Study|Adverse Event|1|||
124899983|NCT05233085|449258048|FG001|Overall Study|Adverse Event|0|||
124899984|NCT05233085|449258049|FG002|Overall Study|Adverse Event|0|||
124899985|NCT05233085|449258050|FG003|Overall Study|Adverse Event|0|||
124899986|NCT00798265|449258051|FG000|Overall Study|Lost to Follow-up|1|||
124899987|NCT00798265|449258052|FG001|Overall Study|Lost to Follow-up|10|||
124899988|NCT00798265|449258051|FG000|Overall Study|Study closing|7|||
124899989|NCT00798265|449258052|FG001|Overall Study|Study closing|6|||
124899990|NCT00798265|449258051|FG000|Overall Study|Withdrawal by Subject|0|||
124899991|NCT00798265|449258052|FG001|Overall Study|Withdrawal by Subject|1|||
124899992|NCT00798265|449258051|FG000|Overall Study|Screen failure|0|||
125112250|NCT04444752|450034320|FG003|Overall Study|Withdrawal by Subject|4|||
125112251|NCT04444752|450034317|FG000|Overall Study|Protocol Violation|1|||
125112252|NCT04444752|450034318|FG001|Overall Study|Protocol Violation|1|||
124899993|NCT00798265|449258052|FG001|Overall Study|Screen failure|1|||
125112253|NCT04444752|450034319|FG002|Overall Study|Protocol Violation|0|||
125112254|NCT04444752|450034320|FG003|Overall Study|Protocol Violation|0|||
125112255|NCT04444752|450034317|FG000|Overall Study|Patient moving out of town|1|||
125112256|NCT04444752|450034318|FG001|Overall Study|Patient moving out of town|0|||
125112257|NCT04444752|450034319|FG002|Overall Study|Patient moving out of town|0|||
125112258|NCT04444752|450034320|FG003|Overall Study|Patient moving out of town|1|||
125112259|NCT04444752|450034317|FG000|Overall Study|Lack of Efficacy|0|||
125112260|NCT04444752|450034318|FG001|Overall Study|Lack of Efficacy|0|||
124899994|NCT00739102|449259489|FG000|Overall Study|Death|5|||
124899995|NCT00739102|449259489|FG000|Overall Study|Withdrawal by Subject|10|||
124899996|NCT03784963|449259490|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
125020479|NCT01415752|449699290|FG001|Maintenance (Step 2)|Death|1|||
125020480|NCT01415752|449699291|FG002|Maintenance (Step 2)|Death|2|||
125020481|NCT01415752|449699292|FG003|Maintenance (Step 2)|Death|0|||
125020482|NCT01415752|449699289|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
125020483|NCT01415752|449699290|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
125020484|NCT01415752|449699291|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
125020485|NCT01415752|449699292|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
125020486|NCT01415752|449699289|FG000|Maintenance (Step 2)|Alternative therapy|0|||
125020487|NCT01415752|449699290|FG001|Maintenance (Step 2)|Alternative therapy|1|||
125020488|NCT01415752|449699291|FG002|Maintenance (Step 2)|Alternative therapy|0|||
125020489|NCT01415752|449699292|FG003|Maintenance (Step 2)|Alternative therapy|0|||
125020490|NCT01415752|449699289|FG000|Maintenance (Step 2)|Other reasons|3|||
125020491|NCT01415752|449699290|FG001|Maintenance (Step 2)|Other reasons|6|||
125020492|NCT01415752|449699291|FG002|Maintenance (Step 2)|Other reasons|4|||
125020493|NCT01415752|449699292|FG003|Maintenance (Step 2)|Other reasons|6|||
125020494|NCT01415752|449699289|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
125020495|NCT01415752|449699290|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
125020496|NCT01415752|449699291|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
125020497|NCT01415752|449699292|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
125020498|NCT01415752|449699289|FG000|Maintenance (Step 2)|ineligible|1|||
125020499|NCT01415752|449699290|FG001|Maintenance (Step 2)|ineligible|1|||
125020500|NCT01415752|449699291|FG002|Maintenance (Step 2)|ineligible|1|||
125020501|NCT01415752|449699292|FG003|Maintenance (Step 2)|ineligible|0|||
125020502|NCT01415752|449699289|FG000|Maintenance (Step 2)|Missing|4|||
125020503|NCT01415752|449699290|FG001|Maintenance (Step 2)|Missing|1|||
125020504|NCT01415752|449699291|FG002|Maintenance (Step 2)|Missing|4|||
125020505|NCT01415752|449699292|FG003|Maintenance (Step 2)|Missing|3|||
125020506|NCT00252057|449699295|FG000|Overall Study|Withdrawal by Subject|2|||
125020507|NCT00252057|449699296|FG001|Overall Study|Withdrawal by Subject|5|||
125020508|NCT00252057|449699295|FG000|Overall Study|Death|1|||
125020509|NCT00252057|449699296|FG001|Overall Study|Death|2|||
125020510|NCT00252057|449699295|FG000|Overall Study|Participant previously enrolled|0|||
125020511|NCT00252057|449699296|FG001|Overall Study|Participant previously enrolled|1|||
125020512|NCT02926209|449699298|FG000|Study Cohort|Poor Bowel Preparation|1|||
125020513|NCT02926209|449699299|FG001|Study Cohort|Poor Bowel Preparation|0|||
125020514|NCT01903837|449699306|FG000|Part A|Withdrawal by Subject|4|||
125020515|NCT01903837|449699307|FG001|Part A|Withdrawal by Subject|9|||
125020516|NCT01903837|449699308|FG002|Part A|Withdrawal by Subject|8|||
125020517|NCT01903837|449699309|FG003|Part A|Withdrawal by Subject|5|||
125020518|NCT01903837|449699306|FG000|Part A|Adverse Event|3|||
125020519|NCT01903837|449699307|FG001|Part A|Adverse Event|6|||
125020520|NCT01903837|449699308|FG002|Part A|Adverse Event|9|||
125020521|NCT01903837|449699309|FG003|Part A|Adverse Event|6|||
125020522|NCT01903837|449699306|FG000|Part A|Lost to Follow-up|9|||
125020523|NCT01903837|449699307|FG001|Part A|Lost to Follow-up|7|||
125020524|NCT01903837|449699308|FG002|Part A|Lost to Follow-up|7|||
125020525|NCT01903837|449699309|FG003|Part A|Lost to Follow-up|2|||
125020526|NCT01903837|449699306|FG000|Part A|Non-compliance with study drug|1|||
125020527|NCT01903837|449699307|FG001|Part A|Non-compliance with study drug|4|||
125020528|NCT01903837|449699308|FG002|Part A|Non-compliance with study drug|4|||
125112261|NCT04444752|450034319|FG002|Overall Study|Lack of Efficacy|0|||
125112262|NCT04444752|450034320|FG003|Overall Study|Lack of Efficacy|1|||
125112263|NCT04444752|450034317|FG000|Overall Study|Death|0|||
125112264|NCT04444752|450034318|FG001|Overall Study|Death|0|||
125112265|NCT04444752|450034319|FG002|Overall Study|Death|1|||
125112266|NCT04444752|450034320|FG003|Overall Study|Death|0|||
125112267|NCT02270983|450036551|FG000|Overall Study|Adverse Event|3|||
125112268|NCT02270983|450036552|FG001|Overall Study|Adverse Event|2|||
125112269|NCT02270983|450036553|FG002|Overall Study|Adverse Event|6|||
125112270|NCT02270983|450036551|FG000|Overall Study|Lack of Efficacy|2|||
125112271|NCT02270983|450036552|FG001|Overall Study|Lack of Efficacy|1|||
125112272|NCT02270983|450036553|FG002|Overall Study|Lack of Efficacy|1|||
125112273|NCT02270983|450036551|FG000|Overall Study|Withdrawal by Subject|1|||
125112274|NCT02270983|450036552|FG001|Overall Study|Withdrawal by Subject|0|||
125112275|NCT02270983|450036553|FG002|Overall Study|Withdrawal by Subject|2|||
125112276|NCT02270983|450036551|FG000|Overall Study|Lost to Follow-up|1|||
125112277|NCT02270983|450036552|FG001|Overall Study|Lost to Follow-up|1|||
125112278|NCT02270983|450036553|FG002|Overall Study|Lost to Follow-up|2|||
125112279|NCT02270983|450036551|FG000|Overall Study|Protocol Violation|1|||
125112280|NCT02270983|450036552|FG001|Overall Study|Protocol Violation|1|||
125112281|NCT02270983|450036553|FG002|Overall Study|Protocol Violation|1|||
125112282|NCT02270983|450036551|FG000|Overall Study|family emergency|0|||
125112283|NCT02270983|450036552|FG001|Overall Study|family emergency|1|||
125112284|NCT02270983|450036553|FG002|Overall Study|family emergency|0|||
125112285|NCT02270983|450036551|FG000|Overall Study|study procedure non-compliance|1|||
125112286|NCT02270983|450036552|FG001|Overall Study|study procedure non-compliance|0|||
125112287|NCT02270983|450036553|FG002|Overall Study|study procedure non-compliance|0|||
125112288|NCT02270983|450036551|FG000|Overall Study|moved away from study site|0|||
125112289|NCT02270983|450036552|FG001|Overall Study|moved away from study site|1|||
125112290|NCT02270983|450036553|FG002|Overall Study|moved away from study site|0|||
125112291|NCT00928252|450036559|FG000|Overall Study|Physician Decision|3|||
125112292|NCT01605461|450036560|FG000|Overall Study|Lost to Follow-up|3|||
125112293|NCT01605461|450036560|FG000|Overall Study|Withdrawal by Subject|1|||
125112294|NCT02024698|450036561|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
125112295|NCT02024698|450036562|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
125112296|NCT00331630|450036563|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
125112297|NCT00331630|450036563|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
125112298|NCT00331630|450036563|FG000|Follow up for 5 Years|Death|5|||
125112299|NCT00331630|450036563|FG000|Follow up for 5 Years|Data collection was stopped|24|||
125112300|NCT02764489|450036564|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
125112301|NCT02764489|450036565|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
125112302|NCT02764489|450036564|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
125112303|NCT02764489|450036565|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
125112304|NCT02764489|450036564|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
125112305|NCT02764489|450036565|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
125112306|NCT02764489|450036564|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
125112307|NCT02764489|450036565|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
125112308|NCT02038634|450036566|FG000|Overall Study|Lost to Follow-up|0|||
125112309|NCT02038634|450036567|FG001|Overall Study|Lost to Follow-up|1|||
125112310|NCT00693784|450036568|FG000|Overall Study|Lost to Follow-up|2|||
125112311|NCT00693784|450036568|FG000|Overall Study|Withdrawal by Subject|2|||
125112312|NCT01664052|450036571|FG000|Phase 1|No device placement|6|||
125112313|NCT01664052|450036572|FG001|Phase 1|No device placement|0|||
125112314|NCT01664052|450036571|FG000|Phase 1|No HSG 1 hr post placement|1|||
125112315|NCT01664052|450036572|FG001|Phase 1|No HSG 1 hr post placement|0|||
125112316|NCT01664052|450036571|FG000|Phase 2|No device placement|0|||
125112317|NCT01664052|450036572|FG001|Phase 2|No device placement|4|||
125112318|NCT00326885|450036573|FG000|Overall Study|Adverse Event|1|||
125112319|NCT00326885|450036573|FG000|Overall Study|Withdrawal by Subject|3|||
125112320|NCT00326885|450036573|FG000|Overall Study|Physician Decision|1|||
125112321|NCT00326885|450036573|FG000|Overall Study|Hospice withdrew consent|2|||
125112322|NCT01706198|450036574|FG000|Overall Study|Adverse Event|12|||
125112323|NCT01706198|450036575|FG001|Overall Study|Adverse Event|15|||
125112324|NCT01706198|450036574|FG000|Overall Study|Protocol Violation|7|||
125112325|NCT01706198|450036575|FG001|Overall Study|Protocol Violation|5|||
125112326|NCT01706198|450036574|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
125112327|NCT01706198|450036575|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
125112328|NCT01706198|450036574|FG000|Overall Study|Lost to Follow-up|97|||
125112329|NCT01706198|450036575|FG001|Overall Study|Lost to Follow-up|93|||
125112330|NCT01706198|450036574|FG000|Overall Study|Physician Decision|23|||
125112331|NCT01706198|450036575|FG001|Overall Study|Physician Decision|37|||
125112332|NCT01706198|450036574|FG000|Overall Study|Withdrawal by Subject|23|||
125112333|NCT01706198|450036575|FG001|Overall Study|Withdrawal by Subject|31|||
125112334|NCT04313283|450036577|FG000|Overall Study|did not complete intervention|4|||
125112335|NCT01473758|450036582|FG000|Cycle 1|Adverse Event|10|||
125112336|NCT01473758|450036583|FG001|Cycle 1|Adverse Event|2|||
125112337|NCT01473758|450036584|FG002|Cycle 1|Adverse Event|0|||
125112338|NCT01473758|450036585|FG003|Cycle 1|Adverse Event|0|||
125112339|NCT01473758|450036582|FG000|Cycle 1|Withdrawal by Subject|1|||
125112340|NCT01473758|450036583|FG001|Cycle 1|Withdrawal by Subject|1|||
125112341|NCT01473758|450036584|FG002|Cycle 1|Withdrawal by Subject|0|||
125112342|NCT01473758|450036585|FG003|Cycle 1|Withdrawal by Subject|0|||
125112343|NCT01473758|450036582|FG000|Cycle 2|Adverse Event|0|||
125112344|NCT01473758|450036583|FG001|Cycle 2|Adverse Event|0|||
125112345|NCT01473758|450036584|FG002|Cycle 2|Adverse Event|5|||
125112346|NCT01473758|450036585|FG003|Cycle 2|Adverse Event|0|||
125112347|NCT01677910|450036586|FG000|Double-Blind Treatment Period|Adverse Event|6|||
125112348|NCT01677910|450036587|FG001|Double-Blind Treatment Period|Adverse Event|2|||
125112349|NCT01677910|450036588|FG002|Double-Blind Treatment Period|Adverse Event|3|||
125112350|NCT01677910|450036589|FG003|Double-Blind Treatment Period|Adverse Event|0|||
125112351|NCT01677910|450036586|FG000|Double-Blind Treatment Period|Physician Decision|0|||
125112352|NCT01677910|450036587|FG001|Double-Blind Treatment Period|Physician Decision|0|||
125112353|NCT01677910|450036588|FG002|Double-Blind Treatment Period|Physician Decision|1|||
125112354|NCT01677910|450036589|FG003|Double-Blind Treatment Period|Physician Decision|0|||
125112355|NCT01677910|450036586|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
125112356|NCT01677910|450036587|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
125112357|NCT01677910|450036588|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
125112358|NCT01677910|450036589|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
125112359|NCT01677910|450036586|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
125112360|NCT01677910|450036587|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
125112361|NCT01677910|450036588|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
125112362|NCT01677910|450036589|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
125112363|NCT01677910|450036586|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
125112364|NCT01677910|450036587|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
125112365|NCT01677910|450036588|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
125112366|NCT01677910|450036589|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
125112367|NCT01677910|450036586|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
125112368|NCT01677910|450036587|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
125112369|NCT01677910|450036588|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
125112370|NCT01677910|450036589|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
125112371|NCT01677910|450036586|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
125112372|NCT01677910|450036587|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
125112373|NCT01677910|450036588|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
125112374|NCT01677910|450036589|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
125112375|NCT01677910|450036586|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
125020529|NCT01903837|449699309|FG003|Part A|Non-compliance with study drug|0|||
125020530|NCT01903837|449699306|FG000|Part A|Physician Decision|1|||
125020531|NCT01903837|449699307|FG001|Part A|Physician Decision|1|||
125020532|NCT01903837|449699308|FG002|Part A|Physician Decision|0|||
125020533|NCT01903837|449699309|FG003|Part A|Physician Decision|0|||
125020534|NCT01903837|449699306|FG000|Part A|Protocol Violation|1|||
125020535|NCT01903837|449699307|FG001|Part A|Protocol Violation|1|||
125020536|NCT01903837|449699308|FG002|Part A|Protocol Violation|0|||
125020537|NCT01903837|449699309|FG003|Part A|Protocol Violation|0|||
125020538|NCT01903837|449699306|FG000|Part B|Lost to Follow-up|0|||
125020539|NCT01903837|449699307|FG001|Part B|Lost to Follow-up|3|||
125020540|NCT01903837|449699308|FG002|Part B|Lost to Follow-up|3|||
125020541|NCT01903837|449699309|FG003|Part B|Lost to Follow-up|4|||
125020542|NCT01903837|449699306|FG000|Part B|Withdrawal by Subject|1|||
125020543|NCT01903837|449699307|FG001|Part B|Withdrawal by Subject|2|||
125020544|NCT01903837|449699308|FG002|Part B|Withdrawal by Subject|0|||
125020545|NCT01903837|449699309|FG003|Part B|Withdrawal by Subject|3|||
125020546|NCT01903837|449699306|FG000|Part B|Adverse Event|3|||
125020547|NCT01903837|449699307|FG001|Part B|Adverse Event|0|||
125020548|NCT01903837|449699308|FG002|Part B|Adverse Event|2|||
125020549|NCT01903837|449699309|FG003|Part B|Adverse Event|0|||
125020550|NCT01903837|449699306|FG000|Part B|Non-compliance with study drug|2|||
125020551|NCT01903837|449699307|FG001|Part B|Non-compliance with study drug|0|||
125020552|NCT01903837|449699308|FG002|Part B|Non-compliance with study drug|0|||
125020553|NCT01903837|449699309|FG003|Part B|Non-compliance with study drug|1|||
125020554|NCT01903837|449699306|FG000|Part B|Incarceration|2|||
125020555|NCT01903837|449699307|FG001|Part B|Incarceration|0|||
125020556|NCT01903837|449699308|FG002|Part B|Incarceration|0|||
125020557|NCT01903837|449699309|FG003|Part B|Incarceration|1|||
125020558|NCT01903837|449699306|FG000|Part B|Physician Decision|1|||
125020559|NCT01903837|449699307|FG001|Part B|Physician Decision|0|||
125020560|NCT01903837|449699308|FG002|Part B|Physician Decision|0|||
125020561|NCT01903837|449699309|FG003|Part B|Physician Decision|2|||
125020562|NCT01903837|449699306|FG000|Part B|Lack of Efficacy|0|||
125020563|NCT01903837|449699307|FG001|Part B|Lack of Efficacy|1|||
125020564|NCT01903837|449699308|FG002|Part B|Lack of Efficacy|0|||
125020565|NCT01903837|449699309|FG003|Part B|Lack of Efficacy|0|||
125020566|NCT00705939|449699310|FG000|Overall Study|Protocol Violation|0|||
125020567|NCT00705939|449699311|FG001|Overall Study|Protocol Violation|0|||
125020568|NCT00705939|449699312|FG002|Overall Study|Protocol Violation|1|||
125020569|NCT00705939|449699310|FG000|Overall Study|Withdrawal by Subject|0|||
125020570|NCT00705939|449699311|FG001|Overall Study|Withdrawal by Subject|1|||
125020571|NCT00705939|449699312|FG002|Overall Study|Withdrawal by Subject|3|||
125020572|NCT00705939|449699310|FG000|Overall Study|Physician Decision|0|||
125020573|NCT00705939|449699311|FG001|Overall Study|Physician Decision|1|||
125020574|NCT00705939|449699312|FG002|Overall Study|Physician Decision|0|||
125020575|NCT05048342|449699313|FG000|Overall Study|Adverse Event|1|||
125020576|NCT05048342|449699313|FG000|Overall Study|Subject decision|2|||
125020577|NCT03345472|449699318|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
125020578|NCT03345472|449699318|FG000|Implant to 3 Months|Physician Decision|1|||
125020579|NCT03345472|449699318|FG000|Implant to 3 Months|Adverse Event|1|||
125020580|NCT03345472|449699318|FG000|3 Months to 12 Months|Physician Decision|3|||
125020581|NCT03345472|449699318|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
125112376|NCT01677910|450036587|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
125112377|NCT01677910|450036588|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
125112378|NCT01677910|450036589|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
125112379|NCT01677910|450036586|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
125112380|NCT01677910|450036587|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
125112381|NCT01677910|450036588|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
125112382|NCT01677910|450036589|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
125112383|NCT01677910|450036586|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
125112384|NCT01677910|450036587|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
125112385|NCT01677910|450036588|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
125112386|NCT01677910|450036589|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
125112387|NCT02763579|450036599|FG000|Global Period|Death|167|||
125112388|NCT02763579|450036600|FG001|Global Period|Death|151|||
125112389|NCT02763579|450036601|FG002|Global Period|Death|0|||
125112390|NCT02763579|450036602|FG003|Global Period|Death|0|||
125112391|NCT02763579|450036599|FG000|Global Period|Lost to Follow-up|2|||
125112392|NCT02763579|450036600|FG001|Global Period|Lost to Follow-up|4|||
125112393|NCT02763579|450036601|FG002|Global Period|Lost to Follow-up|0|||
125112394|NCT02763579|450036602|FG003|Global Period|Lost to Follow-up|0|||
125112395|NCT02763579|450036599|FG000|Global Period|Physician Decision|0|||
124899997|NCT03784963|449259491|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
124899998|NCT03784963|449259492|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
124899999|NCT03784963|449259493|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
124900000|NCT03179787|449259494|FG000|Overall Study|Lost to Follow-up|15|||
124900001|NCT03179787|449259494|FG000|Overall Study|Case report failures|2|||
125112396|NCT02763579|450036600|FG001|Global Period|Physician Decision|2|||
125112397|NCT02763579|450036601|FG002|Global Period|Physician Decision|0|||
125112398|NCT02763579|450036602|FG003|Global Period|Physician Decision|0|||
125112399|NCT02763579|450036599|FG000|Global Period|Study Terminated By Sponsor|21|||
125112400|NCT02763579|450036600|FG001|Global Period|Study Terminated By Sponsor|26|||
124900002|NCT03179787|449259494|FG000|Overall Study|Treatment not administered|1|||
124900003|NCT01090024|449259495|FG000|Period 1|Met exclusion criteria|0|||
124900004|NCT01090024|449259496|FG001|Period 1|Met exclusion criteria|0|||
124900005|NCT01090024|449259497|FG002|Period 1|Met exclusion criteria|0|||
125020582|NCT03345472|449699318|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
125020583|NCT03345472|449699318|FG000|3 Months to 12 Months|Adverse Event|1|||
125020584|NCT03345472|449699318|FG000|3 Months to 12 Months|Death|1|||
125020585|NCT01926782|449699319|FG000|Overall Study|Participant moved|2|||
125020586|NCT01926782|449699320|FG001|Overall Study|Participant moved|0|||
125020587|NCT01926782|449699321|FG002|Overall Study|Participant moved|1|||
125020588|NCT01926782|449699322|FG003|Overall Study|Participant moved|1|||
125020589|NCT01926782|449699323|FG004|Overall Study|Participant moved|0|||
125020590|NCT01926782|449699324|FG005|Overall Study|Participant moved|3|||
125020591|NCT01926782|449699319|FG000|Overall Study|Physician Decision|0|||
125020592|NCT01926782|449699320|FG001|Overall Study|Physician Decision|2|||
125020593|NCT01926782|449699321|FG002|Overall Study|Physician Decision|1|||
125020594|NCT01926782|449699322|FG003|Overall Study|Physician Decision|1|||
125020595|NCT01926782|449699323|FG004|Overall Study|Physician Decision|0|||
125020596|NCT01926782|449699324|FG005|Overall Study|Physician Decision|0|||
125020597|NCT01926782|449699319|FG000|Overall Study|Other than specified|2|||
125020598|NCT01926782|449699320|FG001|Overall Study|Other than specified|3|||
125020599|NCT01926782|449699321|FG002|Overall Study|Other than specified|5|||
125020600|NCT01926782|449699322|FG003|Overall Study|Other than specified|12|||
125020601|NCT01926782|449699323|FG004|Overall Study|Other than specified|4|||
125020602|NCT01926782|449699324|FG005|Overall Study|Other than specified|11|||
125020603|NCT01926782|449699319|FG000|Overall Study|Adverse Event|13|||
125020604|NCT01926782|449699320|FG001|Overall Study|Adverse Event|4|||
125020605|NCT01926782|449699321|FG002|Overall Study|Adverse Event|17|||
125020606|NCT01926782|449699322|FG003|Overall Study|Adverse Event|4|||
125020607|NCT01926782|449699323|FG004|Overall Study|Adverse Event|3|||
125020608|NCT01926782|449699324|FG005|Overall Study|Adverse Event|14|||
125020609|NCT01926782|449699319|FG000|Overall Study|Poor compliance to protocol|5|||
125020610|NCT01926782|449699320|FG001|Overall Study|Poor compliance to protocol|3|||
125020611|NCT01926782|449699321|FG002|Overall Study|Poor compliance to protocol|8|||
125020612|NCT01926782|449699322|FG003|Overall Study|Poor compliance to protocol|0|||
125020613|NCT01926782|449699323|FG004|Overall Study|Poor compliance to protocol|1|||
125020614|NCT01926782|449699324|FG005|Overall Study|Poor compliance to protocol|6|||
125020615|NCT01926782|449699319|FG000|Overall Study|Randomized and not treated|0|||
125020616|NCT01926782|449699320|FG001|Overall Study|Randomized and not treated|0|||
125020617|NCT01926782|449699321|FG002|Overall Study|Randomized and not treated|0|||
125020618|NCT01926782|449699322|FG003|Overall Study|Randomized and not treated|1|||
125020619|NCT01926782|449699323|FG004|Overall Study|Randomized and not treated|0|||
125020620|NCT01926782|449699324|FG005|Overall Study|Randomized and not treated|0|||
125020621|NCT01926782|449699319|FG000|Overall Study|Withdrawal by Subject|6|||
125020622|NCT01926782|449699320|FG001|Overall Study|Withdrawal by Subject|1|||
125020623|NCT01926782|449699321|FG002|Overall Study|Withdrawal by Subject|8|||
125020624|NCT01926782|449699322|FG003|Overall Study|Withdrawal by Subject|1|||
125020625|NCT01926782|449699323|FG004|Overall Study|Withdrawal by Subject|0|||
125020626|NCT01926782|449699324|FG005|Overall Study|Withdrawal by Subject|5|||
125020627|NCT01926782|449699319|FG000|Overall Study|Related to study drug administration|0|||
125020628|NCT01926782|449699320|FG001|Overall Study|Related to study drug administration|0|||
124900006|NCT01090024|449259498|FG003|Period 1|Met exclusion criteria|0|||
124900007|NCT01090024|449259499|FG004|Period 1|Met exclusion criteria|0|||
125020629|NCT01926782|449699321|FG002|Overall Study|Related to study drug administration|0|||
124900008|NCT01090024|449259500|FG005|Period 1|Met exclusion criteria|0|||
124900009|NCT01090024|449259501|FG006|Period 1|Met exclusion criteria|0|||
124900010|NCT01090024|449259502|FG007|Period 1|Met exclusion criteria|0|||
124900011|NCT01090024|449259503|FG008|Period 1|Met exclusion criteria|0|||
124900012|NCT01090024|449259504|FG009|Period 1|Met exclusion criteria|0|||
124900013|NCT01090024|449259505|FG010|Period 1|Met exclusion criteria|0|||
124900014|NCT01090024|449259506|FG011|Period 1|Met exclusion criteria|0|||
124900015|NCT01090024|449259507|FG012|Period 1|Met exclusion criteria|0|||
124900016|NCT01090024|449259508|FG013|Period 1|Met exclusion criteria|0|||
124900017|NCT01090024|449259509|FG014|Period 1|Met exclusion criteria|1|||
124900018|NCT01090024|449259510|FG015|Period 1|Met exclusion criteria|0|||
124900019|NCT01090024|449259511|FG016|Period 1|Met exclusion criteria|0|||
124900020|NCT01090024|449259512|FG017|Period 1|Met exclusion criteria|0|||
124900021|NCT01090024|449259495|FG000|Period 1|Adverse Event|0|||
124900022|NCT01090024|449259496|FG001|Period 1|Adverse Event|0|||
125112401|NCT02763579|450036601|FG002|Global Period|Study Terminated By Sponsor|0|||
125112402|NCT02763579|450036602|FG003|Global Period|Study Terminated By Sponsor|0|||
125112403|NCT02763579|450036599|FG000|Global Period|Withdrawal by Subject|12|||
125112404|NCT02763579|450036600|FG001|Global Period|Withdrawal by Subject|18|||
125112405|NCT02763579|450036601|FG002|Global Period|Withdrawal by Subject|0|||
125112406|NCT02763579|450036602|FG003|Global Period|Withdrawal by Subject|0|||
125112407|NCT02763579|450036599|FG000|China Period|Death|0|||
125112408|NCT02763579|450036600|FG001|China Period|Death|0|||
125112409|NCT02763579|450036601|FG002|China Period|Death|46|||
125112410|NCT02763579|450036602|FG003|China Period|Death|48|||
125112411|NCT02763579|450036599|FG000|China Period|Lost to Follow-up|0|||
125112412|NCT02763579|450036600|FG001|China Period|Lost to Follow-up|0|||
125112413|NCT02763579|450036601|FG002|China Period|Lost to Follow-up|1|||
125112414|NCT02763579|450036602|FG003|China Period|Lost to Follow-up|1|||
125112415|NCT02763579|450036599|FG000|China Period|Physician Decision|0|||
125112416|NCT02763579|450036600|FG001|China Period|Physician Decision|0|||
125112417|NCT02763579|450036601|FG002|China Period|Physician Decision|0|||
125112418|NCT02763579|450036602|FG003|China Period|Physician Decision|1|||
125112419|NCT02763579|450036599|FG000|China Period|Study Terminated By Sponsor|0|||
125112420|NCT02763579|450036600|FG001|China Period|Study Terminated By Sponsor|0|||
125112421|NCT02763579|450036601|FG002|China Period|Study Terminated By Sponsor|3|||
125112422|NCT02763579|450036602|FG003|China Period|Study Terminated By Sponsor|4|||
125112423|NCT02763579|450036599|FG000|China Period|Withdrawal by Subject|0|||
125112424|NCT02763579|450036600|FG001|China Period|Withdrawal by Subject|0|||
125112425|NCT02763579|450036601|FG002|China Period|Withdrawal by Subject|3|||
125112426|NCT02763579|450036602|FG003|China Period|Withdrawal by Subject|3|||
125112427|NCT00606684|450036603|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
125112428|NCT00606684|450036604|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
125112429|NCT00606684|450036605|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
125112430|NCT00606684|450036606|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
125112431|NCT00606684|450036607|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
125112432|NCT00606684|450036608|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
125112433|NCT00606684|450036609|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
125112434|NCT00606684|450036603|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
125112435|NCT00606684|450036604|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
125112436|NCT00606684|450036605|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
125112437|NCT00606684|450036606|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
125112438|NCT00606684|450036607|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
125112439|NCT00606684|450036608|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
125112440|NCT00606684|450036609|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
125112441|NCT00606684|450036603|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
125112442|NCT00606684|450036604|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
125112443|NCT00606684|450036605|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
125112444|NCT00606684|450036606|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
125112445|NCT00606684|450036607|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
125112446|NCT00606684|450036608|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
125112447|NCT00606684|450036609|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
125112448|NCT00606684|450036603|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
125112449|NCT00606684|450036604|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
125112450|NCT00606684|450036605|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
125112451|NCT00606684|450036606|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
125112452|NCT00606684|450036607|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
125112453|NCT00606684|450036608|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
125112454|NCT00606684|450036609|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
125112455|NCT00606684|450036603|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
125112456|NCT00606684|450036604|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
125112457|NCT00606684|450036605|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
125112458|NCT00606684|450036606|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
125112459|NCT00606684|450036607|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
125112460|NCT00606684|450036608|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
125112461|NCT00606684|450036609|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
125112462|NCT00606684|450036603|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
125020630|NCT01926782|449699322|FG003|Overall Study|Related to study drug administration|0|||
125020631|NCT01926782|449699323|FG004|Overall Study|Related to study drug administration|0|||
125020632|NCT01926782|449699324|FG005|Overall Study|Related to study drug administration|2|||
125020633|NCT02462473|449699327|FG000|Overall Study|Death|1|||
125020634|NCT02462473|449699327|FG000|Overall Study|Other|3|||
125020635|NCT01400451|449699328|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
125020636|NCT01400451|449699329|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
125020637|NCT01400451|449699330|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
125020638|NCT01400451|449699328|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
125020639|NCT01400451|449699329|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
125020640|NCT01400451|449699330|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
125020641|NCT01400451|449699328|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
125020642|NCT01400451|449699329|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
125020643|NCT01400451|449699330|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
125020644|NCT01400451|449699328|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
125020645|NCT01400451|449699329|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
125020646|NCT01400451|449699330|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
125020647|NCT01400451|449699328|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
125112463|NCT00606684|450036604|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
125112464|NCT00606684|450036605|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
125112465|NCT00606684|450036606|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
125112466|NCT00606684|450036607|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
125112467|NCT00606684|450036608|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
125020648|NCT01400451|449699329|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
125020649|NCT01400451|449699330|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
125020650|NCT01079182|449699347|FG000|Overall Study|Lost to Follow-up|1634|||
125020651|NCT01079182|449699347|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
125112468|NCT00606684|450036609|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
125112469|NCT00606684|450036603|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
125112470|NCT00606684|450036604|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
125112471|NCT00606684|450036605|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
125112472|NCT00606684|450036606|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
125112473|NCT00606684|450036607|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
125112474|NCT00606684|450036608|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
125112475|NCT00606684|450036609|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
125112476|NCT00606684|450036603|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125112477|NCT00606684|450036604|FG001|Double-Blind Treatment Period|Adverse Event|3|||
125112478|NCT00606684|450036605|FG002|Double-Blind Treatment Period|Adverse Event|2|||
125112479|NCT00606684|450036606|FG003|Double-Blind Treatment Period|Adverse Event|4|||
125112480|NCT00606684|450036607|FG004|Double-Blind Treatment Period|Adverse Event|2|||
125112481|NCT00606684|450036608|FG005|Double-Blind Treatment Period|Adverse Event|0|||
125112482|NCT00606684|450036609|FG006|Double-Blind Treatment Period|Adverse Event|1|||
125112483|NCT00606684|450036603|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
125112484|NCT00606684|450036604|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
125112485|NCT00606684|450036605|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
125112486|NCT00606684|450036606|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
125112487|NCT00606684|450036607|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
125112488|NCT00606684|450036608|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
125112489|NCT00606684|450036609|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
125112490|NCT00606684|450036603|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
125112491|NCT00606684|450036604|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
125112492|NCT00606684|450036605|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
125112493|NCT00606684|450036606|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
125112494|NCT00606684|450036607|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
125112495|NCT00606684|450036608|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
125112496|NCT00606684|450036609|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
125112497|NCT00606684|450036603|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
125112498|NCT00606684|450036604|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
125112499|NCT00606684|450036605|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
125112500|NCT00606684|450036606|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
125112501|NCT00606684|450036607|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
125112502|NCT00606684|450036608|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
125112503|NCT00606684|450036609|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
125112504|NCT00606684|450036603|FG000|Double-Blind Treatment Period|Physician Decision|0|||
125112505|NCT00606684|450036604|FG001|Double-Blind Treatment Period|Physician Decision|5|||
125112506|NCT00606684|450036605|FG002|Double-Blind Treatment Period|Physician Decision|1|||
125112507|NCT00606684|450036606|FG003|Double-Blind Treatment Period|Physician Decision|0|||
125112508|NCT00606684|450036607|FG004|Double-Blind Treatment Period|Physician Decision|3|||
125112509|NCT00606684|450036608|FG005|Double-Blind Treatment Period|Physician Decision|1|||
125112510|NCT00606684|450036609|FG006|Double-Blind Treatment Period|Physician Decision|2|||
125112511|NCT00606684|450036603|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125112512|NCT00606684|450036604|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125112513|NCT00606684|450036605|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125112514|NCT00606684|450036606|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
125112515|NCT00606684|450036607|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125112516|NCT00606684|450036608|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
125112517|NCT00606684|450036609|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125112518|NCT00910858|450036616|FG000|Pharmacokinetic Phase|Adverse Event|1|||
125112519|NCT00910858|450036617|FG001|Pharmacokinetic Phase|Adverse Event|0|||
125112520|NCT00910858|450036618|FG002|Pharmacokinetic Phase|Adverse Event|0|||
125112521|NCT00910858|450036616|FG000|Monotherapy Phase|Adverse Event|3|||
125112522|NCT00910858|450036617|FG001|Monotherapy Phase|Adverse Event|2|||
125112523|NCT00910858|450036618|FG002|Monotherapy Phase|Adverse Event|0|||
125112524|NCT00910858|450036616|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
125112525|NCT00910858|450036617|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
125112526|NCT00910858|450036618|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
125112527|NCT00910858|450036616|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
125112528|NCT00910858|450036617|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
125112529|NCT00910858|450036618|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
125112530|NCT00910858|450036616|FG000|Monotherapy Phase|Protocol Violation|1|||
125112531|NCT00910858|450036617|FG001|Monotherapy Phase|Protocol Violation|0|||
125112532|NCT00910858|450036618|FG002|Monotherapy Phase|Protocol Violation|0|||
125112533|NCT00910858|450036616|FG000|Monotherapy Phase|Other|3|||
125112534|NCT00910858|450036617|FG001|Monotherapy Phase|Other|4|||
125112535|NCT00910858|450036618|FG002|Monotherapy Phase|Other|2|||
125112536|NCT00910858|450036616|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
125112537|NCT00910858|450036617|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
125112538|NCT00910858|450036618|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
125112539|NCT00910858|450036616|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
125112540|NCT00910858|450036617|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
125112541|NCT00910858|450036618|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
125112542|NCT00910858|450036616|FG000|Combined Treatment Phase|Protocol Violation|1|||
125112543|NCT00910858|450036617|FG001|Combined Treatment Phase|Protocol Violation|0|||
125112544|NCT00910858|450036618|FG002|Combined Treatment Phase|Protocol Violation|0|||
124900023|NCT01090024|449259497|FG002|Period 1|Adverse Event|0|||
125112545|NCT00910858|450036616|FG000|Combined Treatment Phase|Other|0|||
125112546|NCT00910858|450036617|FG001|Combined Treatment Phase|Other|2|||
125112547|NCT00910858|450036618|FG002|Combined Treatment Phase|Other|1|||
125112548|NCT01703741|450036625|FG000|Overall Study|Withdrawal by Subject|6|||
125020652|NCT01079182|449699347|FG000|Overall Study|Lack of Efficacy|514|||
125020653|NCT01079182|449699347|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
125020654|NCT01079182|449699347|FG000|Overall Study|Reasons not Evaluated|271|||
125020655|NCT00903929|449699350|FG000|Overall Study|Withdrawal by Subject|0|||
125020656|NCT00903929|449699351|FG001|Overall Study|Withdrawal by Subject|0|||
125020657|NCT00903929|449699352|FG002|Overall Study|Withdrawal by Subject|1|||
125020658|NCT00903929|449699353|FG003|Overall Study|Withdrawal by Subject|2|||
125112549|NCT01703741|450036625|FG000|Overall Study|Adverse Event|2|||
125112550|NCT01703741|450036625|FG000|Overall Study|Physician Decision|2|||
125112551|NCT01703741|450036625|FG000|Overall Study|Protocol Violation|1|||
125112552|NCT01703741|450036625|FG000|Overall Study|Lost to Follow-up|3|||
125112553|NCT01703741|450036625|FG000|Overall Study|Subject did not want to continue|2|||
125112554|NCT01703741|450036625|FG000|Overall Study|Subject cannot comply with study visits|1|||
125112555|NCT01703741|450036625|FG000|Overall Study|Subject started testosterone injections|1|||
125112556|NCT01170364|450036626|FG000|Overall Study|Protocol Violation|4|||
125112557|NCT01170364|450036627|FG001|Overall Study|Protocol Violation|1|||
125112558|NCT01381900|450036628|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
125020659|NCT00903929|449699350|FG000|Overall Study|Adverse Event|0|||
125020660|NCT00903929|449699351|FG001|Overall Study|Adverse Event|0|||
125020661|NCT00903929|449699352|FG002|Overall Study|Adverse Event|0|||
125020662|NCT00903929|449699353|FG003|Overall Study|Adverse Event|1|||
125020663|NCT02158091|449699354|FG000|Overall Study|DLT|2|||
125020664|NCT02158091|449699355|FG001|Overall Study|DLT|1|||
125020665|NCT02158091|449699356|FG002|Overall Study|DLT|0|||
125020666|NCT03977467|449699357|FG000|Overall Study|Disease Progression|1|||
125020667|NCT03977467|449699358|FG001|Overall Study|Disease Progression|1|||
125020668|NCT03977467|449699359|FG002|Overall Study|Disease Progression|30|||
125020669|NCT03977467|449699360|FG003|Overall Study|Disease Progression|0|||
125020670|NCT03977467|449699357|FG000|Overall Study|Adverse Event|0|||
125112559|NCT01381900|450036629|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
125112560|NCT01381900|450036630|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
125020671|NCT03977467|449699358|FG001|Overall Study|Adverse Event|1|||
125020672|NCT03977467|449699359|FG002|Overall Study|Adverse Event|0|||
125020673|NCT03977467|449699360|FG003|Overall Study|Adverse Event|0|||
125020674|NCT03977467|449699357|FG000|Overall Study|Death|0|||
125020675|NCT03977467|449699358|FG001|Overall Study|Death|0|||
125020676|NCT03977467|449699359|FG002|Overall Study|Death|3|||
125020677|NCT03977467|449699360|FG003|Overall Study|Death|0|||
125020678|NCT03977467|449699357|FG000|Overall Study|Lack of Efficacy|0|||
125020679|NCT03977467|449699358|FG001|Overall Study|Lack of Efficacy|0|||
125020680|NCT03977467|449699359|FG002|Overall Study|Lack of Efficacy|1|||
125112561|NCT01381900|450036628|FG000|Overall Study|Adverse Event|4|||
125112562|NCT01381900|450036629|FG001|Overall Study|Adverse Event|6|||
125112563|NCT01381900|450036630|FG002|Overall Study|Adverse Event|7|||
125112564|NCT01381900|450036628|FG000|Overall Study|Noncompliance with study drug|0|||
125112565|NCT01381900|450036629|FG001|Overall Study|Noncompliance with study drug|0|||
125112566|NCT01381900|450036630|FG002|Overall Study|Noncompliance with study drug|1|||
125112567|NCT01381900|450036628|FG000|Overall Study|Physician Decision|0|||
125112568|NCT01381900|450036629|FG001|Overall Study|Physician Decision|1|||
125112569|NCT01381900|450036630|FG002|Overall Study|Physician Decision|1|||
125112570|NCT01381900|450036628|FG000|Overall Study|Protocol Violation|0|||
125112571|NCT01381900|450036629|FG001|Overall Study|Protocol Violation|1|||
125112572|NCT01381900|450036630|FG002|Overall Study|Protocol Violation|1|||
125112573|NCT01381900|450036628|FG000|Overall Study|Withdrawal by Subject|0|||
125020681|NCT03977467|449699360|FG003|Overall Study|Lack of Efficacy|0|||
125020682|NCT03977467|449699357|FG000|Overall Study|Withdrawal by Subject|2|||
125112574|NCT01381900|450036629|FG001|Overall Study|Withdrawal by Subject|0|||
125112575|NCT01381900|450036630|FG002|Overall Study|Withdrawal by Subject|1|||
125112576|NCT01381900|450036628|FG000|Overall Study|Early withdraw|3|||
125112577|NCT01381900|450036629|FG001|Overall Study|Early withdraw|1|||
125112578|NCT01381900|450036630|FG002|Overall Study|Early withdraw|1|||
125112579|NCT03341273|450036632|FG000|Overall Study|Lost to Follow-up|7|||
125112580|NCT03341273|450036633|FG001|Overall Study|Lost to Follow-up|7|||
125112581|NCT03341273|450036632|FG000|Overall Study|Withdrawal by Subject|4|||
125112582|NCT03341273|450036633|FG001|Overall Study|Withdrawal by Subject|2|||
125112583|NCT03341273|450036632|FG000|Overall Study|Physician Decision|1|||
125112584|NCT03341273|450036633|FG001|Overall Study|Physician Decision|0|||
125112585|NCT03341273|450036632|FG000|Overall Study|Protocol Violation|0|||
125112586|NCT03341273|450036633|FG001|Overall Study|Protocol Violation|1|||
125112587|NCT03341273|450036632|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
125112588|NCT03341273|450036633|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
125112589|NCT03341273|450036632|FG000|Overall Study|Became ineligible after enrollment|1|||
125112590|NCT03341273|450036633|FG001|Overall Study|Became ineligible after enrollment|0|||
125112591|NCT03341273|450036632|FG000|Overall Study|Not Eligible at Enrollment|0|||
125112592|NCT03341273|450036633|FG001|Overall Study|Not Eligible at Enrollment|1|||
125112593|NCT03341273|450036632|FG000|Overall Study|Participant incarcerated|1|||
125112594|NCT03341273|450036633|FG001|Overall Study|Participant incarcerated|0|||
125112595|NCT02041494|450036634|FG000|Overall Study|Death|1|||
125112596|NCT02041494|450036635|FG001|Overall Study|Death|3|||
125112597|NCT02041494|450036634|FG000|Overall Study|Lost to Follow-up|2|||
125112598|NCT02041494|450036635|FG001|Overall Study|Lost to Follow-up|6|||
125112599|NCT02041494|450036634|FG000|Overall Study|study terminated|16|||
125112600|NCT02041494|450036635|FG001|Overall Study|study terminated|11|||
125112601|NCT00685919|450036636|FG000|Overall Study|Withdrawal by Subject|0|||
125112602|NCT00685919|450036637|FG001|Overall Study|Withdrawal by Subject|0|||
125112603|NCT00685919|450036638|FG002|Overall Study|Withdrawal by Subject|1|||
125112604|NCT00685919|450036639|FG003|Overall Study|Withdrawal by Subject|0|||
125112605|NCT00685919|450036636|FG000|Overall Study|Physician Decision|1|||
125112606|NCT00685919|450036637|FG001|Overall Study|Physician Decision|0|||
125112607|NCT00685919|450036638|FG002|Overall Study|Physician Decision|0|||
125020683|NCT03977467|449699358|FG001|Overall Study|Withdrawal by Subject|1|||
125020684|NCT03977467|449699359|FG002|Overall Study|Withdrawal by Subject|4|||
125020685|NCT03977467|449699360|FG003|Overall Study|Withdrawal by Subject|0|||
125020686|NCT03977467|449699357|FG000|Overall Study|Study Terminated|1|||
125020687|NCT03977467|449699358|FG001|Overall Study|Study Terminated|0|||
125020688|NCT03977467|449699359|FG002|Overall Study|Study Terminated|0|||
125020689|NCT03977467|449699360|FG003|Overall Study|Study Terminated|1|||
125020690|NCT01358864|449699361|FG000|Overall Study|Adverse Event|0|||
125020691|NCT01358864|449699362|FG001|Overall Study|Adverse Event|6|||
125020692|NCT01358864|449699363|FG002|Overall Study|Adverse Event|9|||
125020693|NCT01358864|449699364|FG003|Overall Study|Adverse Event|0|||
125020694|NCT01358864|449699365|FG004|Overall Study|Adverse Event|4|||
125020695|NCT01358864|449699366|FG005|Overall Study|Adverse Event|8|||
125020696|NCT01358864|449699367|FG006|Overall Study|Adverse Event|12|||
125020697|NCT01358864|449699368|FG007|Overall Study|Adverse Event|7|||
125020698|NCT01358864|449699361|FG000|Overall Study|Lack of Efficacy|26|||
125020699|NCT01358864|449699362|FG001|Overall Study|Lack of Efficacy|3|||
125020700|NCT01358864|449699363|FG002|Overall Study|Lack of Efficacy|4|||
125020701|NCT01358864|449699364|FG003|Overall Study|Lack of Efficacy|19|||
125020702|NCT01358864|449699365|FG004|Overall Study|Lack of Efficacy|7|||
125020703|NCT01358864|449699366|FG005|Overall Study|Lack of Efficacy|4|||
125020704|NCT01358864|449699367|FG006|Overall Study|Lack of Efficacy|49|||
125020705|NCT01358864|449699368|FG007|Overall Study|Lack of Efficacy|44|||
125020706|NCT01358864|449699361|FG000|Overall Study|Lost to Follow-up|0|||
125020707|NCT01358864|449699362|FG001|Overall Study|Lost to Follow-up|0|||
125020708|NCT01358864|449699363|FG002|Overall Study|Lost to Follow-up|1|||
125020709|NCT01358864|449699364|FG003|Overall Study|Lost to Follow-up|0|||
125020710|NCT01358864|449699365|FG004|Overall Study|Lost to Follow-up|0|||
125020711|NCT01358864|449699366|FG005|Overall Study|Lost to Follow-up|0|||
125020712|NCT01358864|449699367|FG006|Overall Study|Lost to Follow-up|0|||
125020713|NCT01358864|449699368|FG007|Overall Study|Lost to Follow-up|1|||
125020714|NCT01358864|449699361|FG000|Overall Study|Withdrawal by Subject|3|||
125020715|NCT01358864|449699362|FG001|Overall Study|Withdrawal by Subject|4|||
125020716|NCT01358864|449699363|FG002|Overall Study|Withdrawal by Subject|2|||
125020717|NCT01358864|449699364|FG003|Overall Study|Withdrawal by Subject|0|||
125020718|NCT01358864|449699365|FG004|Overall Study|Withdrawal by Subject|0|||
125020719|NCT01358864|449699366|FG005|Overall Study|Withdrawal by Subject|1|||
125020720|NCT01358864|449699367|FG006|Overall Study|Withdrawal by Subject|1|||
125020721|NCT01358864|449699368|FG007|Overall Study|Withdrawal by Subject|3|||
125020722|NCT01358864|449699361|FG000|Overall Study|Other reason not defined above|2|||
125020723|NCT01358864|449699362|FG001|Overall Study|Other reason not defined above|0|||
125020724|NCT01358864|449699363|FG002|Overall Study|Other reason not defined above|0|||
125020725|NCT01358864|449699364|FG003|Overall Study|Other reason not defined above|0|||
125020726|NCT01358864|449699365|FG004|Overall Study|Other reason not defined above|0|||
125020727|NCT01358864|449699366|FG005|Overall Study|Other reason not defined above|0|||
125020728|NCT01358864|449699367|FG006|Overall Study|Other reason not defined above|2|||
125020729|NCT01358864|449699368|FG007|Overall Study|Other reason not defined above|0|||
125020730|NCT01358864|449699361|FG000|Overall Study|Not treated|0|||
125020731|NCT01358864|449699362|FG001|Overall Study|Not treated|0|||
125020732|NCT01358864|449699363|FG002|Overall Study|Not treated|0|||
124900024|NCT01090024|449259498|FG003|Period 1|Adverse Event|0|||
124900025|NCT01090024|449259499|FG004|Period 1|Adverse Event|0|||
125020733|NCT01358864|449699364|FG003|Overall Study|Not treated|0|||
125020734|NCT01358864|449699365|FG004|Overall Study|Not treated|0|||
125020735|NCT01358864|449699366|FG005|Overall Study|Not treated|0|||
125020736|NCT01358864|449699367|FG006|Overall Study|Not treated|1|||
125020737|NCT01358864|449699368|FG007|Overall Study|Not treated|0|||
125020738|NCT04158648|449699376|FG000|Overall Study|Ongoing in the Study|69|||
125020739|NCT04158648|449699376|FG000|Overall Study|Withdrawal by Subject|4|||
125020740|NCT04209855|449699377|FG000|Overall Study|Death|161|||
125020741|NCT04209855|449699378|FG001|Overall Study|Death|177|||
125020742|NCT04209855|449699377|FG000|Overall Study|PI Discretion|1|||
125020743|NCT04209855|449699378|FG001|Overall Study|PI Discretion|1|||
125020744|NCT04209855|449699377|FG000|Overall Study|Lost to Follow-up|5|||
125020745|NCT04209855|449699378|FG001|Overall Study|Lost to Follow-up|2|||
125020746|NCT04209855|449699377|FG000|Overall Study|Withdrew consent|10|||
125020747|NCT04209855|449699378|FG001|Overall Study|Withdrew consent|24|||
125020748|NCT04209855|449699377|FG000|Overall Study|Sponsor decision|44|||
125020749|NCT04209855|449699378|FG001|Overall Study|Sponsor decision|18|||
125020750|NCT04209855|449699377|FG000|Overall Study|Other than specified|6|||
125020751|NCT04209855|449699378|FG001|Overall Study|Other than specified|4|||
125020752|NCT01250379|449699381|FG000|Overall Study|Death|141|||
125020753|NCT01250379|449699382|FG001|Overall Study|Death|148|||
125020754|NCT01250379|449699381|FG000|Overall Study|Withdrawal by Subject|32|||
125020755|NCT01250379|449699382|FG001|Overall Study|Withdrawal by Subject|20|||
125020756|NCT01250379|449699381|FG000|Overall Study|Physician Decision|11|||
125020757|NCT01250379|449699382|FG001|Overall Study|Physician Decision|3|||
125020758|NCT01250379|449699381|FG000|Overall Study|Protocol Violation|2|||
125020759|NCT01250379|449699382|FG001|Overall Study|Protocol Violation|8|||
125020760|NCT01250379|449699381|FG000|Overall Study|Lost to Follow-up|9|||
125020761|NCT01250379|449699382|FG001|Overall Study|Lost to Follow-up|6|||
125020762|NCT01250379|449699381|FG000|Overall Study|Adverse Event|5|||
125020763|NCT01250379|449699382|FG001|Overall Study|Adverse Event|4|||
125020764|NCT01250379|449699381|FG000|Overall Study|Other|0|||
125020765|NCT01250379|449699382|FG001|Overall Study|Other|4|||
124900026|NCT01090024|449259500|FG005|Period 1|Adverse Event|0|||
124900027|NCT01090024|449259501|FG006|Period 1|Adverse Event|0|||
124900028|NCT01090024|449259502|FG007|Period 1|Adverse Event|0|||
124900029|NCT01090024|449259503|FG008|Period 1|Adverse Event|0|||
124900030|NCT01090024|449259504|FG009|Period 1|Adverse Event|1|||
124900031|NCT01090024|449259505|FG010|Period 1|Adverse Event|0|||
124900032|NCT01090024|449259506|FG011|Period 1|Adverse Event|1|||
124900033|NCT01090024|449259507|FG012|Period 1|Adverse Event|0|||
124900034|NCT01090024|449259508|FG013|Period 1|Adverse Event|0|||
124900035|NCT01090024|449259509|FG014|Period 1|Adverse Event|0|||
125112608|NCT00685919|450036639|FG003|Overall Study|Physician Decision|0|||
124900036|NCT01090024|449259510|FG015|Period 1|Adverse Event|0|||
124900037|NCT01090024|449259511|FG016|Period 1|Adverse Event|0|||
124900038|NCT01090024|449259512|FG017|Period 1|Adverse Event|1|||
125020766|NCT01250379|449699381|FG000|Overall Study|Participant noncompliance|2|||
125020767|NCT01250379|449699382|FG001|Overall Study|Participant noncompliance|0|||
125020768|NCT05902364|449699383|FG000|Overall Study|Adverse Event|1|||
125020769|NCT05902364|449699384|FG001|Overall Study|Adverse Event|0|||
125020770|NCT03355300|449699385|FG000|Overall Study|Physician Decision|0|||
125020771|NCT03355300|449699386|FG001|Overall Study|Physician Decision|1|||
125020772|NCT03355300|449699385|FG000|Overall Study|Lack of Efficacy|2|||
125020773|NCT03355300|449699386|FG001|Overall Study|Lack of Efficacy|1|||
125020774|NCT03355300|449699385|FG000|Overall Study|Other reason|1|||
125020775|NCT03355300|449699386|FG001|Overall Study|Other reason|0|||
125020776|NCT01489527|449699388|FG000|Overall Study|Pregnancy|9|||
125020777|NCT01489527|449699389|FG001|Overall Study|Pregnancy|14|||
125020778|NCT01489527|449699388|FG000|Overall Study|Participant moved|6|||
125020779|NCT01489527|449699389|FG001|Overall Study|Participant moved|7|||
125020780|NCT01489527|449699388|FG000|Overall Study|Withdrawal by Subject|0|||
125020781|NCT01489527|449699389|FG001|Overall Study|Withdrawal by Subject|4|||
125020782|NCT01489527|449699388|FG000|Overall Study|Lost to Follow-up|5|||
125020783|NCT01489527|449699389|FG001|Overall Study|Lost to Follow-up|1|||
125020784|NCT01489527|449699388|FG000|Overall Study|Procedures|1|||
125020785|NCT01489527|449699389|FG001|Overall Study|Procedures|0|||
125020786|NCT01489527|449699388|FG000|Overall Study|Not compliant|1|||
125020787|NCT01489527|449699389|FG001|Overall Study|Not compliant|0|||
125020788|NCT01984268|449699390|FG000|Overall Study|Study Terminated|15|||
125020789|NCT04899232|449699391|FG000|Screening Period|Physician Decision|1|||
125020790|NCT04899232|449699392|FG001|Screening Period|Physician Decision|0|||
125020791|NCT04899232|449699393|FG002|Screening Period|Physician Decision|0|||
125020792|NCT04899232|449699391|FG000|Screening Period|Withdrawal by Subject|1|||
125020793|NCT04899232|449699392|FG001|Screening Period|Withdrawal by Subject|0|||
125020794|NCT04899232|449699393|FG002|Screening Period|Withdrawal by Subject|0|||
125112609|NCT01717456|450036640|FG000|End of Treatment|Physician Decision|0|||
125020795|NCT04899232|449699391|FG000|Screening Period|Participant discharged before receiving intervention|3|||
125020796|NCT04899232|449699392|FG001|Screening Period|Participant discharged before receiving intervention|0|||
124900039|NCT01090024|449259495|FG000|Period 1|Withdrawal by Subject|0|||
124900040|NCT01090024|449259496|FG001|Period 1|Withdrawal by Subject|0|||
124900041|NCT01090024|449259497|FG002|Period 1|Withdrawal by Subject|0|||
124900042|NCT01090024|449259498|FG003|Period 1|Withdrawal by Subject|1|||
125112610|NCT01717456|450036641|FG001|End of Treatment|Physician Decision|1|||
125112611|NCT01717456|450036640|FG000|End of Treatment|Lost to Follow-up|0|||
125112612|NCT01717456|450036641|FG001|End of Treatment|Lost to Follow-up|1|||
125112613|NCT01717456|450036640|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
125112614|NCT01717456|450036641|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
125112615|NCT03751020|450036644|FG000|Overall Study|Withdrawal by Subject|2|||
125112616|NCT03751020|450036645|FG001|Overall Study|Withdrawal by Subject|0|||
125112617|NCT03751020|450036646|FG002|Overall Study|Withdrawal by Subject|0|||
125112618|NCT03751020|450036644|FG000|Overall Study|Lost to Follow-up|7|||
125112619|NCT03751020|450036645|FG001|Overall Study|Lost to Follow-up|4|||
125112620|NCT03751020|450036646|FG002|Overall Study|Lost to Follow-up|10|||
125112621|NCT00033631|450036647|FG000|Overall Study|Protocol Violation|14|||
125112622|NCT00033631|450036648|FG001|Overall Study|Protocol Violation|11|||
125112623|NCT00033631|450036647|FG000|Overall Study|Withdrawal by Subject|4|||
125112624|NCT00033631|450036648|FG001|Overall Study|Withdrawal by Subject|4|||
124900043|NCT01090024|449259499|FG004|Period 1|Withdrawal by Subject|0|||
124900044|NCT01090024|449259500|FG005|Period 1|Withdrawal by Subject|0|||
124900045|NCT01090024|449259501|FG006|Period 1|Withdrawal by Subject|0|||
124900046|NCT01090024|449259502|FG007|Period 1|Withdrawal by Subject|0|||
124900047|NCT01090024|449259503|FG008|Period 1|Withdrawal by Subject|0|||
124900048|NCT01090024|449259504|FG009|Period 1|Withdrawal by Subject|0|||
124900049|NCT01090024|449259505|FG010|Period 1|Withdrawal by Subject|0|||
124900050|NCT01090024|449259506|FG011|Period 1|Withdrawal by Subject|0|||
124900051|NCT01090024|449259507|FG012|Period 1|Withdrawal by Subject|0|||
124900052|NCT01090024|449259508|FG013|Period 1|Withdrawal by Subject|0|||
124900053|NCT01090024|449259509|FG014|Period 1|Withdrawal by Subject|0|||
124900054|NCT01090024|449259510|FG015|Period 1|Withdrawal by Subject|0|||
124900055|NCT01090024|449259511|FG016|Period 1|Withdrawal by Subject|0|||
124900056|NCT01090024|449259512|FG017|Period 1|Withdrawal by Subject|0|||
124900057|NCT01090024|449259495|FG000|Period 1|Lost to Follow-up|0|||
124900058|NCT01090024|449259496|FG001|Period 1|Lost to Follow-up|1|||
124900059|NCT01090024|449259497|FG002|Period 1|Lost to Follow-up|0|||
124900060|NCT01090024|449259498|FG003|Period 1|Lost to Follow-up|0|||
124900061|NCT01090024|449259499|FG004|Period 1|Lost to Follow-up|0|||
124900062|NCT01090024|449259500|FG005|Period 1|Lost to Follow-up|0|||
124900063|NCT01090024|449259501|FG006|Period 1|Lost to Follow-up|0|||
124900064|NCT01090024|449259502|FG007|Period 1|Lost to Follow-up|0|||
124900065|NCT01090024|449259503|FG008|Period 1|Lost to Follow-up|0|||
124900066|NCT01090024|449259504|FG009|Period 1|Lost to Follow-up|0|||
124900067|NCT01090024|449259505|FG010|Period 1|Lost to Follow-up|0|||
124900068|NCT01090024|449259506|FG011|Period 1|Lost to Follow-up|0|||
124900069|NCT01090024|449259507|FG012|Period 1|Lost to Follow-up|0|||
124900070|NCT01090024|449259508|FG013|Period 1|Lost to Follow-up|0|||
124900071|NCT01090024|449259509|FG014|Period 1|Lost to Follow-up|0|||
124900072|NCT01090024|449259510|FG015|Period 1|Lost to Follow-up|0|||
124900073|NCT01090024|449259511|FG016|Period 1|Lost to Follow-up|0|||
124900074|NCT01090024|449259512|FG017|Period 1|Lost to Follow-up|0|||
124900075|NCT01090024|449259495|FG000|Period 2|Lost to Follow-up|0|||
124900076|NCT01090024|449259496|FG001|Period 2|Lost to Follow-up|0|||
124900077|NCT01090024|449259497|FG002|Period 2|Lost to Follow-up|0|||
124900078|NCT01090024|449259498|FG003|Period 2|Lost to Follow-up|1|||
124900079|NCT01090024|449259499|FG004|Period 2|Lost to Follow-up|0|||
124900080|NCT01090024|449259500|FG005|Period 2|Lost to Follow-up|0|||
124900081|NCT01090024|449259501|FG006|Period 2|Lost to Follow-up|0|||
124900082|NCT01090024|449259502|FG007|Period 2|Lost to Follow-up|0|||
124900083|NCT01090024|449259503|FG008|Period 2|Lost to Follow-up|0|||
124900084|NCT01090024|449259504|FG009|Period 2|Lost to Follow-up|0|||
124900085|NCT01090024|449259505|FG010|Period 2|Lost to Follow-up|0|||
124900086|NCT01090024|449259506|FG011|Period 2|Lost to Follow-up|0|||
124900087|NCT01090024|449259507|FG012|Period 2|Lost to Follow-up|0|||
124900088|NCT01090024|449259508|FG013|Period 2|Lost to Follow-up|0|||
124900089|NCT01090024|449259509|FG014|Period 2|Lost to Follow-up|0|||
124900090|NCT01090024|449259510|FG015|Period 2|Lost to Follow-up|0|||
124900091|NCT01090024|449259511|FG016|Period 2|Lost to Follow-up|0|||
124900092|NCT01090024|449259512|FG017|Period 2|Lost to Follow-up|0|||
124900093|NCT01090024|449259495|FG000|Period 2|Adverse Event|1|||
124900094|NCT01090024|449259496|FG001|Period 2|Adverse Event|0|||
124900095|NCT01090024|449259497|FG002|Period 2|Adverse Event|0|||
124900096|NCT01090024|449259498|FG003|Period 2|Adverse Event|0|||
124900097|NCT01090024|449259499|FG004|Period 2|Adverse Event|0|||
124900098|NCT01090024|449259500|FG005|Period 2|Adverse Event|0|||
124900099|NCT01090024|449259501|FG006|Period 2|Adverse Event|0|||
124900100|NCT01090024|449259502|FG007|Period 2|Adverse Event|0|||
124900101|NCT01090024|449259503|FG008|Period 2|Adverse Event|0|||
124900102|NCT01090024|449259504|FG009|Period 2|Adverse Event|0|||
124900103|NCT01090024|449259505|FG010|Period 2|Adverse Event|0|||
124900104|NCT01090024|449259506|FG011|Period 2|Adverse Event|0|||
124900105|NCT01090024|449259507|FG012|Period 2|Adverse Event|0|||
124900106|NCT01090024|449259508|FG013|Period 2|Adverse Event|0|||
124900107|NCT01090024|449259509|FG014|Period 2|Adverse Event|0|||
124900108|NCT01090024|449259510|FG015|Period 2|Adverse Event|0|||
124900109|NCT01090024|449259511|FG016|Period 2|Adverse Event|0|||
124900110|NCT01090024|449259512|FG017|Period 2|Adverse Event|0|||
124900111|NCT01090024|449259495|FG000|Period 3|Withdrawal by Subject|0|||
124900112|NCT01090024|449259496|FG001|Period 3|Withdrawal by Subject|0|||
124900113|NCT01090024|449259497|FG002|Period 3|Withdrawal by Subject|0|||
124900114|NCT01090024|449259498|FG003|Period 3|Withdrawal by Subject|0|||
124900115|NCT01090024|449259499|FG004|Period 3|Withdrawal by Subject|0|||
124900116|NCT01090024|449259500|FG005|Period 3|Withdrawal by Subject|0|||
124900117|NCT01090024|449259501|FG006|Period 3|Withdrawal by Subject|0|||
124900118|NCT01090024|449259502|FG007|Period 3|Withdrawal by Subject|0|||
124900119|NCT01090024|449259503|FG008|Period 3|Withdrawal by Subject|0|||
124900120|NCT01090024|449259504|FG009|Period 3|Withdrawal by Subject|0|||
124900121|NCT01090024|449259505|FG010|Period 3|Withdrawal by Subject|0|||
124900122|NCT01090024|449259506|FG011|Period 3|Withdrawal by Subject|0|||
124900123|NCT01090024|449259507|FG012|Period 3|Withdrawal by Subject|0|||
124900124|NCT01090024|449259508|FG013|Period 3|Withdrawal by Subject|0|||
124900125|NCT01090024|449259509|FG014|Period 3|Withdrawal by Subject|0|||
124900126|NCT01090024|449259510|FG015|Period 3|Withdrawal by Subject|1|||
124900127|NCT01090024|449259511|FG016|Period 3|Withdrawal by Subject|0|||
124900128|NCT01090024|449259512|FG017|Period 3|Withdrawal by Subject|0|||
124900129|NCT01090024|449259495|FG000|Period 3|Protocol Violation|0|||
124900130|NCT01090024|449259496|FG001|Period 3|Protocol Violation|0|||
124900131|NCT01090024|449259497|FG002|Period 3|Protocol Violation|0|||
124900132|NCT01090024|449259498|FG003|Period 3|Protocol Violation|0|||
124900133|NCT01090024|449259499|FG004|Period 3|Protocol Violation|0|||
124900134|NCT01090024|449259500|FG005|Period 3|Protocol Violation|0|||
124900135|NCT01090024|449259501|FG006|Period 3|Protocol Violation|0|||
124900136|NCT01090024|449259502|FG007|Period 3|Protocol Violation|0|||
124900137|NCT01090024|449259503|FG008|Period 3|Protocol Violation|1|||
124900138|NCT01090024|449259504|FG009|Period 3|Protocol Violation|0|||
124900139|NCT01090024|449259505|FG010|Period 3|Protocol Violation|0|||
124900140|NCT01090024|449259506|FG011|Period 3|Protocol Violation|0|||
124900141|NCT01090024|449259507|FG012|Period 3|Protocol Violation|0|||
124900142|NCT01090024|449259508|FG013|Period 3|Protocol Violation|0|||
124900143|NCT01090024|449259509|FG014|Period 3|Protocol Violation|0|||
124900144|NCT01090024|449259510|FG015|Period 3|Protocol Violation|0|||
124900145|NCT01090024|449259511|FG016|Period 3|Protocol Violation|0|||
124900146|NCT01090024|449259512|FG017|Period 3|Protocol Violation|0|||
124900147|NCT01090024|449259495|FG000|Period 3|Adverse Event|0|||
124900148|NCT01090024|449259496|FG001|Period 3|Adverse Event|0|||
124900149|NCT01090024|449259497|FG002|Period 3|Adverse Event|0|||
124900150|NCT01090024|449259498|FG003|Period 3|Adverse Event|0|||
124900151|NCT01090024|449259499|FG004|Period 3|Adverse Event|0|||
124900152|NCT01090024|449259500|FG005|Period 3|Adverse Event|1|||
124900153|NCT01090024|449259501|FG006|Period 3|Adverse Event|0|||
124900154|NCT01090024|449259502|FG007|Period 3|Adverse Event|0|||
124900155|NCT01090024|449259503|FG008|Period 3|Adverse Event|0|||
124900156|NCT01090024|449259504|FG009|Period 3|Adverse Event|0|||
124900157|NCT01090024|449259505|FG010|Period 3|Adverse Event|0|||
124900158|NCT01090024|449259506|FG011|Period 3|Adverse Event|0|||
124900159|NCT01090024|449259507|FG012|Period 3|Adverse Event|0|||
124900160|NCT01090024|449259508|FG013|Period 3|Adverse Event|0|||
124900161|NCT01090024|449259509|FG014|Period 3|Adverse Event|0|||
124900162|NCT01090024|449259510|FG015|Period 3|Adverse Event|0|||
124900163|NCT01090024|449259511|FG016|Period 3|Adverse Event|0|||
125112625|NCT00528879|450036649|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
125112626|NCT00528879|450036650|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
125112627|NCT00528879|450036651|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
125112628|NCT00528879|450036652|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
125112629|NCT00528879|450036649|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
125112630|NCT00528879|450036650|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
125112631|NCT00528879|450036651|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
125112632|NCT00528879|450036652|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
124900164|NCT01090024|449259512|FG017|Period 3|Adverse Event|0|||
125112633|NCT00528879|450036649|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
125112634|NCT00528879|450036650|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
125112635|NCT00528879|450036651|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
125112636|NCT00528879|450036652|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
125112637|NCT00528879|450036649|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
125112638|NCT00528879|450036650|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
125112639|NCT00528879|450036651|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
125112640|NCT00528879|450036652|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
125112641|NCT00528879|450036649|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
125112642|NCT00528879|450036650|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
125112643|NCT00528879|450036651|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
125112644|NCT00528879|450036652|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
124900165|NCT00777556|449259515|FG000|Overall Study|Inappropriate self-selection|34|||
125112645|NCT00528879|450036649|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
125112646|NCT00528879|450036650|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
124900166|NCT00777556|449259515|FG000|Overall Study|Dispensed but did not use product|12|||
124900167|NCT00777556|449259515|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
124900168|NCT00920686|449259519|FG000|Overall Study|Lost to Follow-up|2|||
124900169|NCT00920686|449259520|FG001|Overall Study|Lost to Follow-up|3|||
124900170|NCT00920686|449259521|FG002|Overall Study|Lost to Follow-up|1|||
124900171|NCT00920686|449259519|FG000|Overall Study|Study drug dosing criteria not met|17|||
124900172|NCT00920686|449259520|FG001|Overall Study|Study drug dosing criteria not met|19|||
124900173|NCT00920686|449259521|FG002|Overall Study|Study drug dosing criteria not met|12|||
124900174|NCT01313182|449259522|FG000|Overall Study|Protocol Violation|66|||
124900175|NCT01313182|449259523|FG001|Overall Study|Protocol Violation|92|||
124900176|NCT01695317|449259524|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
124900177|NCT01695317|449259525|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
125112647|NCT00528879|450036651|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
125112648|NCT00528879|450036652|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
125112649|NCT00528879|450036649|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
125112650|NCT00528879|450036650|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
124900178|NCT01695317|449259524|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
124900179|NCT01695317|449259525|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
124900180|NCT04580303|449259526|FG000|Overall Study|Adverse Event|0|||
124900181|NCT04580303|449259527|FG001|Overall Study|Adverse Event|1|||
124900182|NCT04580303|449259528|FG002|Overall Study|Adverse Event|0|||
124900183|NCT04580303|449259529|FG003|Overall Study|Adverse Event|0|||
124900184|NCT04580303|449259526|FG000|Overall Study|Withdrawal by Subject|0|||
124900185|NCT04580303|449259527|FG001|Overall Study|Withdrawal by Subject|0|||
124900186|NCT04580303|449259528|FG002|Overall Study|Withdrawal by Subject|1|||
124900187|NCT04580303|449259529|FG003|Overall Study|Withdrawal by Subject|0|||
124900188|NCT02299635|449259533|FG000|Overall Study|Adverse Event|2|||
124900189|NCT02299635|449259533|FG000|Overall Study|Death|1|||
124900190|NCT02299635|449259533|FG000|Overall Study|Global deterioration of health status|1|||
124900191|NCT02299635|449259533|FG000|Overall Study|Objective progression or relapse|10|||
124900192|NCT02299635|449259533|FG000|Overall Study|Withdrawal by Subject|2|||
124900193|NCT02299635|449259533|FG000|Overall Study|Other|3|||
124900194|NCT00927823|449259534|FG000|Continuous Dosing Period|Death|0|||
124900195|NCT00927823|449259535|FG001|Continuous Dosing Period|Death|0|||
124900196|NCT00927823|449259536|FG002|Continuous Dosing Period|Death|6|||
124900197|NCT00927823|449259537|FG003|Continuous Dosing Period|Death|0|||
124900198|NCT00927823|449259534|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
124900199|NCT00927823|449259535|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
124900200|NCT00927823|449259536|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
124900201|NCT00927823|449259537|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
124900202|NCT00927823|449259534|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
124900203|NCT00927823|449259535|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
124900204|NCT00927823|449259536|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
124900205|NCT00927823|449259537|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
124900206|NCT00927823|449259534|FG000|Continuous Dosing Period|Other|1|||
124900207|NCT00927823|449259535|FG001|Continuous Dosing Period|Other|2|||
124900208|NCT00927823|449259536|FG002|Continuous Dosing Period|Other|9|||
124900209|NCT00927823|449259537|FG003|Continuous Dosing Period|Other|3|||
124900210|NCT00828672|449259538|FG000|Study Treatment|Lost to Follow-up|1|||
124900211|NCT00828672|449259539|FG001|Study Treatment|Lost to Follow-up|0|||
124900212|NCT00828672|449259538|FG000|Study Treatment|Adverse Event|0|||
124900213|NCT00828672|449259539|FG001|Study Treatment|Adverse Event|1|||
124900214|NCT00828672|449259538|FG000|Study Treatment|Complete response, no surgery|1|||
124900215|NCT00828672|449259539|FG001|Study Treatment|Complete response, no surgery|1|||
124900216|NCT00828672|449259538|FG000|Post-surgery (<30 Days)|No central review materials|0|||
124900217|NCT00828672|449259539|FG001|Post-surgery (<30 Days)|No central review materials|1|||
124900218|NCT00831792|449259540|FG000|Overall Study|Not Eligible|3|||
124900219|NCT00831792|449259540|FG000|Overall Study|Adverse Event|1|||
124900220|NCT00831792|449259540|FG000|Overall Study|Death|1|||
124900221|NCT00831792|449259540|FG000|Overall Study|Lack of Efficacy|1|||
124900222|NCT02701361|449259544|FG000|Overall Study|Lost to Follow-up|5|||
124900223|NCT02701361|449259545|FG001|Overall Study|Lost to Follow-up|2|||
124900224|NCT02701361|449259546|FG002|Overall Study|Lost to Follow-up|1|||
124900225|NCT02701361|449259544|FG000|Overall Study|Withdrawal by Subject|4|||
124900226|NCT02701361|449259545|FG001|Overall Study|Withdrawal by Subject|0|||
124900227|NCT02701361|449259546|FG002|Overall Study|Withdrawal by Subject|0|||
124900228|NCT02701361|449259544|FG000|Overall Study|timed out in rehab center|0|||
124900229|NCT02701361|449259545|FG001|Overall Study|timed out in rehab center|1|||
124900230|NCT02701361|449259546|FG002|Overall Study|timed out in rehab center|0|||
124900231|NCT02701361|449259544|FG000|Overall Study|incarceration|0|||
124900232|NCT02701361|449259545|FG001|Overall Study|incarceration|0|||
124900233|NCT02701361|449259546|FG002|Overall Study|incarceration|1|||
124900234|NCT04588480|449259547|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
124900235|NCT04588480|449259548|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
124900236|NCT04588480|449259549|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
124900237|NCT04588480|449259547|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
124900238|NCT04588480|449259548|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
124900239|NCT04588480|449259549|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
124900240|NCT00246012|449259550|FG000|Overall Study|Adverse Event|0|||
124900241|NCT00246012|449259551|FG001|Overall Study|Adverse Event|0|||
124900242|NCT00246012|449259552|FG002|Overall Study|Adverse Event|0|||
124900243|NCT00246012|449259553|FG003|Overall Study|Adverse Event|0|||
124900244|NCT00246012|449259554|FG004|Overall Study|Adverse Event|0|||
124900245|NCT00246012|449259555|FG005|Overall Study|Adverse Event|1|||
124900246|NCT00246012|449259556|FG006|Overall Study|Adverse Event|0|||
124900247|NCT00246012|449259557|FG007|Overall Study|Adverse Event|0|||
124900248|NCT00246012|449259558|FG008|Overall Study|Adverse Event|2|||
124900249|NCT00246012|449259550|FG000|Overall Study|Withdrawal by Subject|0|||
124900250|NCT00246012|449259551|FG001|Overall Study|Withdrawal by Subject|0|||
124900251|NCT00246012|449259552|FG002|Overall Study|Withdrawal by Subject|0|||
124900252|NCT00246012|449259553|FG003|Overall Study|Withdrawal by Subject|0|||
124900253|NCT00246012|449259554|FG004|Overall Study|Withdrawal by Subject|0|||
124900254|NCT00246012|449259555|FG005|Overall Study|Withdrawal by Subject|1|||
124900255|NCT00246012|449259556|FG006|Overall Study|Withdrawal by Subject|0|||
124900256|NCT00246012|449259557|FG007|Overall Study|Withdrawal by Subject|0|||
124900257|NCT00246012|449259558|FG008|Overall Study|Withdrawal by Subject|0|||
124900258|NCT00246012|449259550|FG000|Overall Study|Disease progression|3|||
124900259|NCT00246012|449259551|FG001|Overall Study|Disease progression|1|||
124900260|NCT00246012|449259552|FG002|Overall Study|Disease progression|2|||
124900261|NCT00246012|449259553|FG003|Overall Study|Disease progression|3|||
124900262|NCT00246012|449259554|FG004|Overall Study|Disease progression|3|||
124900263|NCT00246012|449259555|FG005|Overall Study|Disease progression|25|||
124900264|NCT00246012|449259556|FG006|Overall Study|Disease progression|30|||
124900265|NCT00246012|449259557|FG007|Overall Study|Disease progression|27|||
124900266|NCT00246012|449259558|FG008|Overall Study|Disease progression|26|||
124900267|NCT00246012|449259550|FG000|Overall Study|Other|0|||
124900268|NCT00246012|449259551|FG001|Overall Study|Other|0|||
124900269|NCT00246012|449259552|FG002|Overall Study|Other|0|||
124900270|NCT00246012|449259553|FG003|Overall Study|Other|0|||
124900271|NCT00246012|449259554|FG004|Overall Study|Other|0|||
124900272|NCT00246012|449259555|FG005|Overall Study|Other|0|||
124900273|NCT00246012|449259556|FG006|Overall Study|Other|0|||
124900274|NCT00246012|449259557|FG007|Overall Study|Other|1|||
124900275|NCT00246012|449259558|FG008|Overall Study|Other|0|||
124900276|NCT00246012|449259550|FG000|Overall Study|Randomly assigned but not treated|0|||
124900277|NCT00246012|449259551|FG001|Overall Study|Randomly assigned but not treated|0|||
124900278|NCT00246012|449259552|FG002|Overall Study|Randomly assigned but not treated|0|||
124900279|NCT00246012|449259553|FG003|Overall Study|Randomly assigned but not treated|0|||
124900280|NCT00246012|449259554|FG004|Overall Study|Randomly assigned but not treated|0|||
124900281|NCT00246012|449259555|FG005|Overall Study|Randomly assigned but not treated|1|||
124900282|NCT00246012|449259556|FG006|Overall Study|Randomly assigned but not treated|1|||
124900283|NCT00246012|449259557|FG007|Overall Study|Randomly assigned but not treated|0|||
124900284|NCT00246012|449259558|FG008|Overall Study|Randomly assigned but not treated|0|||
124900285|NCT01242085|449259559|FG000|Overall Study|Withdrawal by Subject|4|||
124900286|NCT01242085|449259560|FG001|Overall Study|Withdrawal by Subject|2|||
124900287|NCT01242085|449259561|FG002|Overall Study|Withdrawal by Subject|0|||
124900288|NCT01242085|449259559|FG000|Overall Study|medically unable to have surgery|4|||
124900289|NCT01242085|449259560|FG001|Overall Study|medically unable to have surgery|5|||
124900290|NCT01242085|449259561|FG002|Overall Study|medically unable to have surgery|0|||
124900291|NCT01178762|449259562|FG000|Overall Study|Lost to Follow-up|15|||
124900292|NCT01651949|449259571|FG000|Overall Study|Unknown status|4|||
124900293|NCT01651949|449259572|FG001|Overall Study|Unknown status|4|||
124900294|NCT01651949|449259573|FG002|Overall Study|Unknown status|0|||
124900295|NCT01651949|449259571|FG000|Overall Study|Lost to Follow-up|30|||
124900296|NCT01651949|449259572|FG001|Overall Study|Lost to Follow-up|56|||
124900297|NCT01651949|449259573|FG002|Overall Study|Lost to Follow-up|20|||
124900298|NCT01651949|449259571|FG000|Overall Study|Protocol Violation|0|||
124900299|NCT01651949|449259572|FG001|Overall Study|Protocol Violation|2|||
124900300|NCT01651949|449259573|FG002|Overall Study|Protocol Violation|1|||
124900301|NCT01651949|449259571|FG000|Overall Study|Physician Decision|0|||
124900302|NCT01651949|449259572|FG001|Overall Study|Physician Decision|2|||
124900303|NCT01651949|449259573|FG002|Overall Study|Physician Decision|0|||
124900304|NCT01651949|449259571|FG000|Overall Study|Adverse Event|0|||
124900305|NCT01651949|449259572|FG001|Overall Study|Adverse Event|2|||
124900306|NCT01651949|449259573|FG002|Overall Study|Adverse Event|1|||
125020797|NCT04899232|449699393|FG002|Screening Period|Participant discharged before receiving intervention|0|||
125020798|NCT00936208|449699394|FG000|Overall Study|Protocol Violation|37|||
125020799|NCT00936208|449699395|FG001|Overall Study|Protocol Violation|22|||
125020800|NCT01344876|449699399|FG000|Overall Study|Adverse Event|0|||
125020801|NCT01344876|449699400|FG001|Overall Study|Adverse Event|0|||
125020802|NCT01344876|449699401|FG002|Overall Study|Adverse Event|0|||
125020803|NCT01344876|449699402|FG003|Overall Study|Adverse Event|0|||
125020804|NCT01344876|449699403|FG004|Overall Study|Adverse Event|1|||
125020805|NCT01344876|449699399|FG000|Overall Study|Withdrawal by Subject|0|||
125020806|NCT01344876|449699400|FG001|Overall Study|Withdrawal by Subject|0|||
125020807|NCT01344876|449699401|FG002|Overall Study|Withdrawal by Subject|1|||
124900307|NCT01651949|449259571|FG000|Overall Study|Screen failure|2|||
124900308|NCT01651949|449259572|FG001|Overall Study|Screen failure|2|||
124900309|NCT01651949|449259573|FG002|Overall Study|Screen failure|0|||
124900310|NCT01651949|449259571|FG000|Overall Study|Withdrawal by Subject|17|||
124900311|NCT01651949|449259572|FG001|Overall Study|Withdrawal by Subject|18|||
124900312|NCT01651949|449259573|FG002|Overall Study|Withdrawal by Subject|9|||
124900313|NCT01806714|449259574|FG000|Overall Study|No functioning phone number|200|||
124900314|NCT01806714|449259575|FG001|Overall Study|No functioning phone number|170|||
124900315|NCT02469064|449259576|FG000|Overall Study|Request not to receive intervention.|1|||
124900316|NCT02469064|449259577|FG001|Overall Study|Request not to receive intervention.|3|||
124900317|NCT00678795|449259578|FG000|Overall Study|Adverse Event|7|||
124900318|NCT00678795|449259579|FG001|Overall Study|Adverse Event|3|||
125020808|NCT01344876|449699402|FG003|Overall Study|Withdrawal by Subject|0|||
124900319|NCT00678795|449259578|FG000|Overall Study|Withdrawal by Subject|3|||
124900320|NCT00678795|449259579|FG001|Overall Study|Withdrawal by Subject|0|||
124900321|NCT00678795|449259578|FG000|Overall Study|Protocol Violation|0|||
124900322|NCT00678795|449259579|FG001|Overall Study|Protocol Violation|1|||
124900323|NCT00678795|449259578|FG000|Overall Study|Lost to Follow-up|0|||
124900324|NCT00678795|449259579|FG001|Overall Study|Lost to Follow-up|1|||
124900325|NCT00678795|449259578|FG000|Overall Study|Lack of Efficacy|1|||
124900326|NCT00678795|449259579|FG001|Overall Study|Lack of Efficacy|1|||
124900327|NCT02750709|449259580|FG000|Treatment Period 1|Adverse Event|0|||
124900328|NCT02750709|449259581|FG001|Treatment Period 1|Adverse Event|0|||
124900329|NCT02750709|449259582|FG002|Treatment Period 1|Adverse Event|0|||
124900330|NCT02750709|449259583|FG003|Treatment Period 1|Adverse Event|0|||
124900331|NCT02750709|449259584|FG004|Treatment Period 1|Adverse Event|0|||
124900332|NCT02750709|449259585|FG005|Treatment Period 1|Adverse Event|1|||
124900333|NCT00404079|449259587|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
124900334|NCT00404079|449259588|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
124900335|NCT01120275|449259589|FG000|Overall Study|Adverse Event|3|||
124900336|NCT01120275|449259589|FG000|Overall Study|Progression|27|||
124900337|NCT01120275|449259589|FG000|Overall Study|Ineligible|3|||
124900338|NCT01120275|449259589|FG000|Overall Study|Withdrawal by Subject|1|||
124900339|NCT01120275|449259589|FG000|Overall Study|Refusal|1|||
124900340|NCT01120275|449259589|FG000|Overall Study|Not specific|1|||
124900341|NCT02595398|449259590|FG000|Overall Study|Non-compliance|1|||
124900342|NCT02595398|449259591|FG001|Overall Study|Non-compliance|0|||
124900343|NCT02595398|449259590|FG000|Overall Study|Withdrawal by Subject|2|||
124900344|NCT02595398|449259591|FG001|Overall Study|Withdrawal by Subject|1|||
124900345|NCT02595398|449259590|FG000|Overall Study|Lost to Follow-up|1|||
124900346|NCT02595398|449259591|FG001|Overall Study|Lost to Follow-up|0|||
124900347|NCT00197015|449259594|FG000|Overall Study|Adverse Event|3|||
124900348|NCT00197015|449259595|FG001|Overall Study|Adverse Event|0|||
124900349|NCT00197015|449259596|FG002|Overall Study|Adverse Event|1|||
124900350|NCT00197015|449259594|FG000|Overall Study|Protocol Violation|0|||
124900351|NCT00197015|449259595|FG001|Overall Study|Protocol Violation|3|||
124900352|NCT00197015|449259596|FG002|Overall Study|Protocol Violation|3|||
124900353|NCT00197015|449259594|FG000|Overall Study|Withdrawal by Subject|17|||
124900354|NCT00197015|449259595|FG001|Overall Study|Withdrawal by Subject|37|||
124900355|NCT00197015|449259596|FG002|Overall Study|Withdrawal by Subject|34|||
124900356|NCT00197015|449259594|FG000|Overall Study|Lost to Follow-up|28|||
124900357|NCT00197015|449259595|FG001|Overall Study|Lost to Follow-up|46|||
124900358|NCT00197015|449259596|FG002|Overall Study|Lost to Follow-up|37|||
124900359|NCT00197015|449259594|FG000|Overall Study|Other|2|||
124900360|NCT00197015|449259595|FG001|Overall Study|Other|3|||
124900361|NCT00197015|449259596|FG002|Overall Study|Other|2|||
124900362|NCT00880906|449259597|FG000|Overall Study|Lost to Follow-up|0|||
124900363|NCT00880906|449259598|FG001|Overall Study|Lost to Follow-up|1|||
124900364|NCT00880906|449259597|FG000|Overall Study|Did not meet criteria following patholog|12|||
124900365|NCT00880906|449259598|FG001|Overall Study|Did not meet criteria following patholog|6|||
124900366|NCT02982213|449259605|FG000|Overall Study|Did not complete follow up questionnaire|5|||
124900367|NCT02982213|449259606|FG001|Overall Study|Did not complete follow up questionnaire|1|||
124900368|NCT01549652|449259607|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
124900369|NCT01549652|449259608|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
124900370|NCT01549652|449259609|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
124900371|NCT01549652|449259610|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
124900372|NCT01549652|449259607|FG000|Overall Study|Study Drug Titration Failure|5|||
124900373|NCT01549652|449259608|FG001|Overall Study|Study Drug Titration Failure|6|||
124900374|NCT01549652|449259609|FG002|Overall Study|Study Drug Titration Failure|0|||
124900375|NCT01549652|449259610|FG003|Overall Study|Study Drug Titration Failure|0|||
124900376|NCT01549652|449259607|FG000|Overall Study|Withdrawal Effect|0|||
124900377|NCT01549652|449259608|FG001|Overall Study|Withdrawal Effect|2|||
124900378|NCT01549652|449259609|FG002|Overall Study|Withdrawal Effect|0|||
124900379|NCT01549652|449259610|FG003|Overall Study|Withdrawal Effect|0|||
124900380|NCT01549652|449259607|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
124900381|NCT01549652|449259608|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
125020809|NCT01344876|449699403|FG004|Overall Study|Withdrawal by Subject|0|||
125020810|NCT01344876|449699399|FG000|Overall Study|Definite progression of primary disease|1|||
125020811|NCT01344876|449699400|FG001|Overall Study|Definite progression of primary disease|0|||
125020812|NCT01344876|449699401|FG002|Overall Study|Definite progression of primary disease|0|||
124900382|NCT01549652|449259609|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
124900383|NCT01549652|449259610|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
124900384|NCT01549652|449259607|FG000|Overall Study|Problem with Infusion|1|||
124900385|NCT01549652|449259608|FG001|Overall Study|Problem with Infusion|0|||
124900386|NCT01549652|449259609|FG002|Overall Study|Problem with Infusion|0|||
124900387|NCT01549652|449259610|FG003|Overall Study|Problem with Infusion|0|||
124900388|NCT01549652|449259607|FG000|Overall Study|Titration Non-Compliance|1|||
124900389|NCT01549652|449259608|FG001|Overall Study|Titration Non-Compliance|3|||
124900390|NCT01549652|449259609|FG002|Overall Study|Titration Non-Compliance|4|||
124900391|NCT01549652|449259610|FG003|Overall Study|Titration Non-Compliance|5|||
124900392|NCT01549652|449259607|FG000|Overall Study|Titration Side Effects|0|||
124900393|NCT01549652|449259608|FG001|Overall Study|Titration Side Effects|0|||
124900394|NCT01549652|449259609|FG002|Overall Study|Titration Side Effects|6|||
124900395|NCT01549652|449259610|FG003|Overall Study|Titration Side Effects|3|||
124900396|NCT01549652|449259607|FG000|Overall Study|Withdrawal by Subject|0|||
124900397|NCT01549652|449259608|FG001|Overall Study|Withdrawal by Subject|0|||
124900398|NCT01549652|449259609|FG002|Overall Study|Withdrawal by Subject|5|||
124900399|NCT01549652|449259610|FG003|Overall Study|Withdrawal by Subject|3|||
124900400|NCT01972152|449259611|FG000|First Treatment Visit|Lost to Follow-up|0|||
124900401|NCT01972152|449259612|FG001|First Treatment Visit|Lost to Follow-up|1|||
124900402|NCT01972152|449259613|FG002|First Treatment Visit|Lost to Follow-up|0|||
124900403|NCT01972152|449259614|FG003|First Treatment Visit|Lost to Follow-up|0|||
124900404|NCT01972152|449259615|FG004|First Treatment Visit|Lost to Follow-up|0|||
124900405|NCT01972152|449259616|FG005|First Treatment Visit|Lost to Follow-up|0|||
124900406|NCT01972152|449259611|FG000|Second Treatment Visit|Protocol Violation|0|||
124900407|NCT01972152|449259612|FG001|Second Treatment Visit|Protocol Violation|1|||
124900408|NCT01972152|449259613|FG002|Second Treatment Visit|Protocol Violation|0|||
124900409|NCT01972152|449259614|FG003|Second Treatment Visit|Protocol Violation|0|||
124900410|NCT01972152|449259615|FG004|Second Treatment Visit|Protocol Violation|0|||
124900411|NCT01972152|449259616|FG005|Second Treatment Visit|Protocol Violation|0|||
124900412|NCT00559949|449259617|FG000|Overall Study|Progressive Disease during cycle 1|1|||
124900413|NCT00559949|449259617|FG000|Overall Study|Adverse Event|1|||
124900414|NCT00559949|449259617|FG000|Overall Study|Withdrawal by Subject|4|||
124900415|NCT00559949|449259617|FG000|Overall Study|No disease evaluation per protocol|1|||
124900416|NCT00414648|449259620|FG000|Overall Study|Adverse Event|5|||
124900417|NCT00414648|449259621|FG001|Overall Study|Adverse Event|5|||
124900418|NCT00414648|449259620|FG000|Overall Study|Death|0|||
124900419|NCT00414648|449259621|FG001|Overall Study|Death|1|||
124900420|NCT00414648|449259620|FG000|Overall Study|Lack of Efficacy|0|||
124900421|NCT00414648|449259621|FG001|Overall Study|Lack of Efficacy|2|||
124900422|NCT00414648|449259620|FG000|Overall Study|Withdrawal by Subject|0|||
124900423|NCT00414648|449259621|FG001|Overall Study|Withdrawal by Subject|1|||
124900424|NCT01194258|449259622|FG000|Titration Period|Withdrawal by Subject|6|||
124900425|NCT01194258|449259623|FG001|Titration Period|Withdrawal by Subject|0|||
124900426|NCT01194258|449259624|FG002|Titration Period|Withdrawal by Subject|0|||
124900427|NCT01194258|449259625|FG003|Titration Period|Withdrawal by Subject|0|||
124900428|NCT01194258|449259626|FG004|Titration Period|Withdrawal by Subject|0|||
124900429|NCT01194258|449259622|FG000|Titration Period|Lost to Follow-up|2|||
124900430|NCT01194258|449259623|FG001|Titration Period|Lost to Follow-up|0|||
124900431|NCT01194258|449259624|FG002|Titration Period|Lost to Follow-up|0|||
124900432|NCT01194258|449259625|FG003|Titration Period|Lost to Follow-up|0|||
124900433|NCT01194258|449259626|FG004|Titration Period|Lost to Follow-up|0|||
124900434|NCT01194258|449259622|FG000|Titration Period|Titration failure|3|||
124900435|NCT01194258|449259623|FG001|Titration Period|Titration failure|0|||
124900436|NCT01194258|449259624|FG002|Titration Period|Titration failure|0|||
124900437|NCT01194258|449259625|FG003|Titration Period|Titration failure|0|||
124900438|NCT01194258|449259626|FG004|Titration Period|Titration failure|0|||
124900439|NCT01194258|449259622|FG000|Period 1 (12 Weeks)|Death|0|||
124900440|NCT01194258|449259623|FG001|Period 1 (12 Weeks)|Death|0|||
124900441|NCT01194258|449259624|FG002|Period 1 (12 Weeks)|Death|0|||
125020813|NCT01344876|449699402|FG003|Overall Study|Definite progression of primary disease|3|||
125020814|NCT01344876|449699403|FG004|Overall Study|Definite progression of primary disease|0|||
125020815|NCT04428424|449699404|FG000|Overall Study|Does not meet entrance criteria|132|||
125020816|NCT04428424|449699404|FG000|Overall Study|Lost to Follow-up|115|||
125020817|NCT04622046|449699408|FG000|Intervention Period|Adverse Event|1|||
125020818|NCT04622046|449699408|FG000|Intervention Period|Withdrawal by Subject|2|||
125020819|NCT04622046|449699408|FG000|Extension Period|Ongoing in the Extension Period|21|||
125020820|NCT04647253|449699409|FG000|Overall Study|Death ≤ 365 Days|16|||
125020821|NCT04647253|449699410|FG001|Overall Study|Death ≤ 365 Days|7|||
125020822|NCT04647253|449699409|FG000|Overall Study|Physician Decision|0|||
125020823|NCT04647253|449699410|FG001|Overall Study|Physician Decision|1|||
125020824|NCT04647253|449699409|FG000|Overall Study|Withdrawal by Subject|7|||
125020825|NCT04647253|449699410|FG001|Overall Study|Withdrawal by Subject|2|||
125020826|NCT04647253|449699409|FG000|Overall Study|Missed 12-Month Visit|9|||
125020827|NCT04647253|449699410|FG001|Overall Study|Missed 12-Month Visit|7|||
125020828|NCT04647253|449699409|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
125020829|NCT04647253|449699410|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
125020830|NCT02396589|449699411|FG000|Intervention|Lost to Follow-up|1|||
125020831|NCT02396589|449699412|FG001|Intervention|Lost to Follow-up|0|||
125020832|NCT02396589|449699411|FG000|6 Month Follow-up|change in health status|0|||
124900442|NCT01194258|449259625|FG003|Period 1 (12 Weeks)|Death|0|||
124900443|NCT01194258|449259626|FG004|Period 1 (12 Weeks)|Death|1|||
124900444|NCT01194258|449259622|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
124900445|NCT01194258|449259623|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
124900446|NCT01194258|449259624|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
124900447|NCT01194258|449259625|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
124900448|NCT01194258|449259626|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
124900449|NCT01194258|449259622|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
124900450|NCT01194258|449259623|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
124900451|NCT01194258|449259624|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
124900452|NCT01194258|449259625|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
124900453|NCT01194258|449259626|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
124900454|NCT01194258|449259622|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124900455|NCT01194258|449259623|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
124900456|NCT01194258|449259624|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
124900457|NCT01194258|449259625|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124900458|NCT01194258|449259626|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124900459|NCT03523962|449259627|FG000|Closed Fractures|Death|86|||
124900460|NCT03523962|449259628|FG001|Closed Fractures|Death|71|||
124900461|NCT03523962|449259629|FG002|Closed Fractures|Death|0|||
124900462|NCT03523962|449259630|FG003|Closed Fractures|Death|0|||
124900463|NCT03523962|449259627|FG000|Closed Fractures|Lost to Follow-up|62|||
124900464|NCT03523962|449259628|FG001|Closed Fractures|Lost to Follow-up|36|||
124900465|NCT03523962|449259629|FG002|Closed Fractures|Lost to Follow-up|0|||
124900466|NCT03523962|449259630|FG003|Closed Fractures|Lost to Follow-up|0|||
124900467|NCT03523962|449259627|FG000|Closed Fractures|Withdrawal by Subject|19|||
124900468|NCT03523962|449259628|FG001|Closed Fractures|Withdrawal by Subject|29|||
124900469|NCT03523962|449259629|FG002|Closed Fractures|Withdrawal by Subject|0|||
124900470|NCT03523962|449259630|FG003|Closed Fractures|Withdrawal by Subject|0|||
124900471|NCT03523962|449259627|FG000|Closed Fractures|Incarceration|1|||
124900472|NCT03523962|449259628|FG001|Closed Fractures|Incarceration|4|||
124900473|NCT03523962|449259629|FG002|Closed Fractures|Incarceration|0|||
124900474|NCT03523962|449259630|FG003|Closed Fractures|Incarceration|0|||
124900475|NCT03523962|449259627|FG000|Open Fractures|Death|0|||
124900476|NCT03523962|449259628|FG001|Open Fractures|Death|0|||
124900477|NCT03523962|449259629|FG002|Open Fractures|Death|11|||
124900478|NCT03523962|449259630|FG003|Open Fractures|Death|6|||
124900479|NCT03523962|449259627|FG000|Open Fractures|Lost to Follow-up|0|||
124900480|NCT03523962|449259628|FG001|Open Fractures|Lost to Follow-up|0|||
124900481|NCT03523962|449259629|FG002|Open Fractures|Lost to Follow-up|15|||
124900482|NCT03523962|449259630|FG003|Open Fractures|Lost to Follow-up|8|||
124900483|NCT03523962|449259627|FG000|Open Fractures|Withdrawal by Subject|0|||
124900484|NCT03523962|449259628|FG001|Open Fractures|Withdrawal by Subject|0|||
124900485|NCT03523962|449259629|FG002|Open Fractures|Withdrawal by Subject|6|||
124900486|NCT03523962|449259630|FG003|Open Fractures|Withdrawal by Subject|2|||
124900487|NCT03523962|449259627|FG000|Open Fractures|Incarceration|0|||
124900488|NCT03523962|449259628|FG001|Open Fractures|Incarceration|0|||
124900489|NCT03523962|449259629|FG002|Open Fractures|Incarceration|1|||
124900490|NCT03523962|449259630|FG003|Open Fractures|Incarceration|0|||
124900491|NCT03098030|449259631|FG000|Overall Study|Death|10|||
124900492|NCT03098030|449259632|FG001|Overall Study|Death|156|||
124900493|NCT03098030|449259633|FG002|Overall Study|Death|156|||
124900494|NCT03098030|449259634|FG003|Overall Study|Death|82|||
124900495|NCT03098030|449259631|FG000|Overall Study|Withdrawal by Subject|0|||
124900496|NCT03098030|449259632|FG001|Overall Study|Withdrawal by Subject|7|||
124900497|NCT03098030|449259633|FG002|Overall Study|Withdrawal by Subject|8|||
124900498|NCT03098030|449259634|FG003|Overall Study|Withdrawal by Subject|2|||
125112651|NCT00528879|450036651|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
125112652|NCT00528879|450036652|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
125112653|NCT00528879|450036649|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
125112654|NCT00528879|450036650|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
124900499|NCT03098030|449259631|FG000|Overall Study|Lost to Follow-up|0|||
124900500|NCT03098030|449259632|FG001|Overall Study|Lost to Follow-up|0|||
124900501|NCT03098030|449259633|FG002|Overall Study|Lost to Follow-up|2|||
124900502|NCT03098030|449259634|FG003|Overall Study|Lost to Follow-up|1|||
124900503|NCT01726023|449259635|FG000|Overall Study|Death|1|||
124900504|NCT01726023|449259636|FG001|Overall Study|Death|1|||
124900505|NCT01726023|449259635|FG000|Overall Study|Lost to Follow-up|5|||
124900506|NCT01726023|449259636|FG001|Overall Study|Lost to Follow-up|10|||
124900507|NCT01726023|449259635|FG000|Overall Study|Other Eligibility criteria|7|||
124900508|NCT01726023|449259636|FG001|Overall Study|Other Eligibility criteria|7|||
124900509|NCT01726023|449259635|FG000|Overall Study|Withdrawal by Subject|16|||
124900510|NCT01726023|449259636|FG001|Overall Study|Withdrawal by Subject|8|||
124900511|NCT03394027|449259639|FG000|Overall Study|Ineligible|3|||
124900512|NCT03394027|449259640|FG001|Overall Study|Ineligible|1|||
124900513|NCT03394027|449259641|FG002|Overall Study|Ineligible|3|||
124900514|NCT03394027|449259639|FG000|Overall Study|Participant declined to participate before treatment started|0|||
124900515|NCT03394027|449259640|FG001|Overall Study|Participant declined to participate before treatment started|0|||
124900516|NCT03394027|449259641|FG002|Overall Study|Participant declined to participate before treatment started|1|||
125112655|NCT00528879|450036651|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
125112656|NCT00528879|450036652|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
125112657|NCT00528879|450036649|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
125112658|NCT00528879|450036650|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
125112659|NCT00528879|450036651|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
125112660|NCT00528879|450036652|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
125112661|NCT00528879|450036649|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
125112662|NCT00528879|450036650|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
125112663|NCT00528879|450036651|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
125112664|NCT00528879|450036652|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
125112665|NCT00528879|450036649|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
125112666|NCT00528879|450036650|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
125112667|NCT00528879|450036651|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
125112668|NCT00528879|450036652|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
125112669|NCT00528879|450036649|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
125112670|NCT00528879|450036650|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
125112671|NCT00528879|450036651|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
125112672|NCT00528879|450036652|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
125112673|NCT00528879|450036649|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
125112674|NCT00528879|450036650|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
125112675|NCT00528879|450036651|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
125112676|NCT00528879|450036652|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
125112677|NCT00528879|450036649|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
125112678|NCT00528879|450036650|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
125112679|NCT00528879|450036651|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
125112680|NCT00528879|450036652|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
125112681|NCT00528879|450036649|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
125112682|NCT00528879|450036650|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
125112683|NCT00528879|450036651|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
125112684|NCT00528879|450036652|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
125112685|NCT00528879|450036649|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
125112686|NCT00528879|450036650|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
125112687|NCT00528879|450036651|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
125112688|NCT00528879|450036652|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
125112689|NCT00078819|450036653|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
125112690|NCT00078819|450036654|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
125112691|NCT00078819|450036655|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
125112692|NCT00078819|450036656|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
125112693|NCT00078819|450036653|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
125112694|NCT00078819|450036654|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
125112695|NCT00078819|450036655|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
125112696|NCT00078819|450036656|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
125112697|NCT00078819|450036653|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
125112698|NCT00078819|450036654|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
125112699|NCT00078819|450036655|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
125112700|NCT00078819|450036656|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
125112701|NCT00078819|450036653|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
125112702|NCT00078819|450036654|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
125112703|NCT00078819|450036655|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
125112704|NCT00078819|450036656|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
125112705|NCT00078819|450036653|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
125112706|NCT00078819|450036654|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
125112707|NCT00078819|450036655|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
125112708|NCT00078819|450036656|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
125112709|NCT00078819|450036653|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
125112710|NCT00078819|450036654|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
125112711|NCT00078819|450036655|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
125112712|NCT00078819|450036656|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
125112713|NCT00078819|450036653|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
125112714|NCT00078819|450036654|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
125112715|NCT00078819|450036655|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
125112716|NCT00078819|450036656|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
124900522|NCT03643211|449259643|FG000|Overall Study|Contract violation/deficiency|12|||
124900523|NCT03643211|449259643|FG000|Overall Study|Invalid registration|3|||
124900524|NCT03643211|449259643|FG000|Overall Study|No treatment information|2|||
124900525|NCT03643211|449259643|FG000|Overall Study|No adverse event information - No revisit|4|||
124900526|NCT04858425|449259644|FG000|Overall Study|Adverse Event|2|||
124900527|NCT04858425|449259645|FG001|Overall Study|Adverse Event|2|||
124900528|NCT04858425|449259644|FG000|Overall Study|Withdrawal by Subject|3|||
124900529|NCT04858425|449259645|FG001|Overall Study|Withdrawal by Subject|1|||
124900530|NCT04858425|449259644|FG000|Overall Study|Lost to Follow-up|4|||
124900531|NCT04858425|449259645|FG001|Overall Study|Lost to Follow-up|2|||
124900532|NCT04858425|449259644|FG000|Overall Study|Lost to Follow-up|1|||
124900533|NCT04858425|449259645|FG001|Overall Study|Lost to Follow-up|0|||
124900534|NCT03368001|449259648|FG000|Allocation|Lost to Pretest|16|||
124900535|NCT03368001|449259649|FG001|Allocation|Lost to Pretest|25|||
124900536|NCT03368001|449259648|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
124900537|NCT03368001|449259649|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
124900538|NCT03368001|449259648|FG000|Posttest|Lost to Posttest|7|||
124900539|NCT03368001|449259649|FG001|Posttest|Lost to Posttest|11|||
124900540|NCT03368001|449259648|FG000|Posttest|Discontinued Intervention|6|||
124900541|NCT03368001|449259649|FG001|Posttest|Discontinued Intervention|19|||
124900542|NCT03368001|449259648|FG000|Follow-up|Lost to Follow-up|6|||
124900543|NCT03368001|449259649|FG001|Follow-up|Lost to Follow-up|3|||
124900544|NCT00604721|449259656|FG000|Overall Study|Physician Decision|1|||
124900545|NCT00604721|449259656|FG000|Overall Study|Withdrawal by Subject|1|||
124900546|NCT04776213|449259657|FG000|Overall Study|Other|1|||
124900547|NCT04776213|449259657|FG000|Overall Study|Withdrawal by Subject|7|||
124900548|NCT04776213|449259657|FG000|Overall Study|Protocol Violation|1|||
124900549|NCT04776213|449259657|FG000|Overall Study|Lost to Follow-up|2|||
124900550|NCT02317016|449259658|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
124900551|NCT02317016|449259658|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
124900552|NCT02317016|449259658|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
124900553|NCT02317016|449259658|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
124900554|NCT02317016|449259658|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
124900555|NCT02317016|449259658|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
124900556|NCT02317016|449259658|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
124900557|NCT00536380|449259659|FG000|Overall Study|Adverse Event|0|||
124900558|NCT00536380|449259660|FG001|Overall Study|Adverse Event|2|||
124900559|NCT00536380|449259661|FG002|Overall Study|Adverse Event|2|||
124900560|NCT00536380|449259659|FG000|Overall Study|Lost to Follow-up|0|||
124900561|NCT00536380|449259660|FG001|Overall Study|Lost to Follow-up|0|||
124900562|NCT00536380|449259661|FG002|Overall Study|Lost to Follow-up|1|||
124900563|NCT00536380|449259659|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
124900564|NCT00536380|449259660|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
124900565|NCT00536380|449259661|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
124900566|NCT00536380|449259659|FG000|Overall Study|Withdrawal related to study drug|7|||
124900567|NCT00536380|449259660|FG001|Overall Study|Withdrawal related to study drug|5|||
124900568|NCT00536380|449259661|FG002|Overall Study|Withdrawal related to study drug|2|||
124900569|NCT00536380|449259659|FG000|Overall Study|Noncompliance with protocol|3|||
125020833|NCT02396589|449699412|FG001|6 Month Follow-up|change in health status|1|||
125020834|NCT02396589|449699411|FG000|9 Month Follow-up|Death|0|||
125020835|NCT02396589|449699412|FG001|9 Month Follow-up|Death|1|||
125020836|NCT02396589|449699411|FG000|12 Month Follow up|Lost to Follow-up|0|||
125020837|NCT02396589|449699412|FG001|12 Month Follow up|Lost to Follow-up|2|||
125020838|NCT04341948|449699413|FG000|Overall Study|Adverse Event|0|||
125020839|NCT04341948|449699414|FG001|Overall Study|Adverse Event|1|||
125020840|NCT04341948|449699413|FG000|Overall Study|Lost to Follow-up|6|||
125020841|NCT04341948|449699414|FG001|Overall Study|Lost to Follow-up|1|||
125020842|NCT04341948|449699413|FG000|Overall Study|Physician Decision|1|||
125020843|NCT04341948|449699414|FG001|Overall Study|Physician Decision|2|||
125020844|NCT04341948|449699413|FG000|Overall Study|Withdrawal by Participant|6|||
125020845|NCT04341948|449699414|FG001|Overall Study|Withdrawal by Participant|3|||
125020846|NCT04341948|449699413|FG000|Overall Study|Lack of compliance by Participant|1|||
125020847|NCT04341948|449699414|FG001|Overall Study|Lack of compliance by Participant|0|||
125020848|NCT01761266|449700821|FG000|Overall Study|Death|415|||
125020849|NCT01761266|449700822|FG001|Overall Study|Death|402|||
125020850|NCT01761266|449700821|FG000|Overall Study|Lost to Follow-up|8|||
125020851|NCT01761266|449700822|FG001|Overall Study|Lost to Follow-up|12|||
125020852|NCT01761266|449700821|FG000|Overall Study|Withdrawal by Subject|14|||
125020853|NCT01761266|449700822|FG001|Overall Study|Withdrawal by Subject|10|||
125020854|NCT01761266|449700821|FG000|Overall Study|Sponsor Decision|41|||
125020855|NCT01761266|449700822|FG001|Overall Study|Sponsor Decision|52|||
125020856|NCT01284114|449700823|FG000|Overall Study|viral infection|1|||
125020857|NCT01284114|449700823|FG000|Overall Study|From the results of ALLTITUDE study|1|||
125020858|NCT01284114|449700823|FG000|Overall Study|Symptomatic hypotension|1|||
124900570|NCT00536380|449259660|FG001|Overall Study|Noncompliance with protocol|2|||
124900571|NCT00536380|449259661|FG002|Overall Study|Noncompliance with protocol|2|||
124900572|NCT00536380|449259659|FG000|Overall Study|Did not meet protocol eligibility|0|||
124900573|NCT00536380|449259660|FG001|Overall Study|Did not meet protocol eligibility|0|||
124900574|NCT00536380|449259661|FG002|Overall Study|Did not meet protocol eligibility|1|||
124900575|NCT00536380|449259659|FG000|Overall Study|Administrative|0|||
124900576|NCT00536380|449259660|FG001|Overall Study|Administrative|0|||
124900577|NCT00536380|449259661|FG002|Overall Study|Administrative|1|||
124900578|NCT02931396|449259665|FG000|Overall Study|Lost to Follow-up|3|||
124900579|NCT02931396|449259666|FG001|Overall Study|Lost to Follow-up|0|||
124900580|NCT02931396|449259665|FG000|Overall Study|Withdrawal by Subject|2|||
124900581|NCT02931396|449259666|FG001|Overall Study|Withdrawal by Subject|0|||
124900582|NCT02132702|449259667|FG000|Overall Study|Protocol Violation|2|||
124900583|NCT02132702|449259667|FG000|Overall Study|Adverse Event|3|||
124900584|NCT02132702|449259667|FG000|Overall Study|Withdrawal by Subject|3|||
124900585|NCT02738840|449261313|FG000|Overall Study|MRI Scan not Performed|5|||
124900586|NCT02738840|449261313|FG000|Overall Study|Lost to Follow-up|1|||
124900587|NCT02738840|449261313|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
124900588|NCT02738840|449261313|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
124900589|NCT01311648|449261316|FG000|Main Study|Protocol Violation|0|||
124900590|NCT01311648|449261317|FG001|Main Study|Protocol Violation|1|||
124900591|NCT01311648|449261316|FG000|Main Study|Adverse Event|0|||
124900592|NCT01311648|449261317|FG001|Main Study|Adverse Event|1|||
124900593|NCT01311648|449261316|FG000|Main Study|Inhibitor management|0|||
124900594|NCT01311648|449261317|FG001|Main Study|Inhibitor management|17|||
124900595|NCT01311648|449261316|FG000|Main Study|Withdrawal by Subject|0|||
124900596|NCT01311648|449261317|FG001|Main Study|Withdrawal by Subject|2|||
124900597|NCT01311648|449261316|FG000|Extension Study|Physician Decision|0|||
124900598|NCT01311648|449261317|FG001|Extension Study|Physician Decision|1|||
124900599|NCT01311648|449261316|FG000|Extension Study|ITI therapy with marketed product|0|||
124900600|NCT01311648|449261317|FG001|Extension Study|ITI therapy with marketed product|1|||
124900601|NCT01311648|449261316|FG000|Extension Study|Incorrect visit planning|0|||
124900602|NCT01311648|449261317|FG001|Extension Study|Incorrect visit planning|1|||
124900603|NCT01311648|449261316|FG000|Extension Study|Family's decision|0|||
124900604|NCT01311648|449261317|FG001|Extension Study|Family's decision|1|||
124900605|NCT01311648|449261316|FG000|Extension Study|Failure of ITI therapy|0|||
125020859|NCT01284114|449700823|FG000|Overall Study|dizziness|1|||
125020860|NCT03445000|449700825|FG000|Overall Study|Disease progression|8|||
125020861|NCT03445000|449700825|FG000|Overall Study|Adverse Event|3|||
125020862|NCT03445000|449700825|FG000|Overall Study|Death|2|||
125020863|NCT03445000|449700825|FG000|Overall Study|Physician Decision|1|||
125020864|NCT03409744|449700826|FG000|Overall Study|Death|2|||
125112717|NCT00078819|450036653|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
125112718|NCT00078819|450036654|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
125112719|NCT00078819|450036655|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
125112720|NCT00078819|450036656|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
125112721|NCT00323609|450036657|FG000|Overall Study|Death|16|||
125112722|NCT00323609|450036658|FG001|Overall Study|Death|21|||
125112723|NCT00323609|450036659|FG002|Overall Study|Death|0|||
125112724|NCT00323609|450036660|FG003|Overall Study|Death|0|||
125112725|NCT00323609|450036657|FG000|Overall Study|Lost to Follow-up|9|||
125112726|NCT00323609|450036658|FG001|Overall Study|Lost to Follow-up|10|||
125112727|NCT00323609|450036659|FG002|Overall Study|Lost to Follow-up|0|||
125112728|NCT00323609|450036660|FG003|Overall Study|Lost to Follow-up|0|||
125112729|NCT00323609|450036657|FG000|Overall Study|Physician Decision|2|||
125112730|NCT00323609|450036658|FG001|Overall Study|Physician Decision|0|||
125112731|NCT00323609|450036659|FG002|Overall Study|Physician Decision|0|||
125112732|NCT00323609|450036660|FG003|Overall Study|Physician Decision|1|||
125112733|NCT00323609|450036657|FG000|Overall Study|Withdrawal by Subject|11|||
125112734|NCT00323609|450036658|FG001|Overall Study|Withdrawal by Subject|23|||
125112735|NCT00323609|450036659|FG002|Overall Study|Withdrawal by Subject|4|||
125112736|NCT00323609|450036660|FG003|Overall Study|Withdrawal by Subject|4|||
125020865|NCT03409744|449700826|FG000|Overall Study|Physician Decision|5|||
124900606|NCT01311648|449261317|FG001|Extension Study|Failure of ITI therapy|3|||
124900607|NCT01311648|449261316|FG000|Extension Study|Long travel|0|||
124900608|NCT01311648|449261317|FG001|Extension Study|Long travel|1|||
125020866|NCT03409744|449700826|FG000|Overall Study|Pregnancy|1|||
125020867|NCT03409744|449700826|FG000|Overall Study|Lost to Follow-up|1|||
124900609|NCT01311648|449261316|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
125020868|NCT03409744|449700826|FG000|Overall Study|Protocol Violation|1|||
124900610|NCT01311648|449261317|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
124900611|NCT01311648|449261316|FG000|Extension Study|Withdrawal by Subject|0|||
124900612|NCT01311648|449261317|FG001|Extension Study|Withdrawal by Subject|1|||
125112737|NCT00323609|450036657|FG000|Overall Study|Other non-VCF-related medical condition|3|||
125112738|NCT00323609|450036658|FG001|Overall Study|Other non-VCF-related medical condition|2|||
125112739|NCT00323609|450036659|FG002|Overall Study|Other non-VCF-related medical condition|0|||
125112740|NCT00323609|450036660|FG003|Overall Study|Other non-VCF-related medical condition|0|||
125112741|NCT00323609|450036657|FG000|Overall Study|Sponsor discontinued trial|29|||
125112742|NCT00323609|450036658|FG001|Overall Study|Sponsor discontinued trial|29|||
125112743|NCT00323609|450036659|FG002|Overall Study|Sponsor discontinued trial|0|||
125112744|NCT00323609|450036660|FG003|Overall Study|Sponsor discontinued trial|0|||
125112745|NCT00323609|450036657|FG000|Overall Study|Unrelenting or severe back pain|1|||
125112746|NCT00323609|450036658|FG001|Overall Study|Unrelenting or severe back pain|1|||
125112747|NCT00323609|450036659|FG002|Overall Study|Unrelenting or severe back pain|0|||
125112748|NCT00323609|450036660|FG003|Overall Study|Unrelenting or severe back pain|0|||
125112749|NCT00323609|450036657|FG000|Overall Study|Logistical withdrawal|9|||
125112750|NCT00323609|450036658|FG001|Overall Study|Logistical withdrawal|5|||
125112751|NCT00323609|450036659|FG002|Overall Study|Logistical withdrawal|0|||
125112752|NCT00323609|450036660|FG003|Overall Study|Logistical withdrawal|1|||
125112753|NCT00323609|450036657|FG000|Overall Study|Other reason|11|||
125112754|NCT00323609|450036658|FG001|Overall Study|Other reason|8|||
125112755|NCT00323609|450036659|FG002|Overall Study|Other reason|4|||
125112756|NCT00323609|450036660|FG003|Overall Study|Other reason|9|||
125112757|NCT02217345|450036661|FG000|Overall Study|Lost to Follow-up|2|||
124900613|NCT01311648|449261316|FG000|Extension Study|Inhibitor management|0|||
124900614|NCT01311648|449261317|FG001|Extension Study|Inhibitor management|2|||
124900615|NCT01645111|449261318|FG000|Overall Study|Did not require Clevidipine|15|||
124900616|NCT04057196|449261319|FG000|Overall Study|Withdrawal by Subject|3|||
124900617|NCT04057196|449261319|FG000|Overall Study|Death|3|||
124900618|NCT01062126|449261320|FG000|Overall Study|Death|209|||
125112758|NCT02217345|450036662|FG001|Overall Study|Lost to Follow-up|1|||
125112759|NCT02217345|450036661|FG000|Overall Study|Withdrawal by Subject|3|||
125112760|NCT02217345|450036662|FG001|Overall Study|Withdrawal by Subject|2|||
125112761|NCT02217345|450036661|FG000|Overall Study|Adverse Event|2|||
125112762|NCT02217345|450036662|FG001|Overall Study|Adverse Event|1|||
125112763|NCT02217345|450036661|FG000|Overall Study|Physician Decision|0|||
125112764|NCT02217345|450036662|FG001|Overall Study|Physician Decision|1|||
125112765|NCT00950599|450036666|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
125112766|NCT00950599|450036667|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
125112767|NCT00950599|450036668|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
125112768|NCT00950599|450036669|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
124900619|NCT01062126|449261320|FG000|Overall Study|All Withdrawals|324|||
124900620|NCT03837028|449261323|FG000|Overall Study|Lost to Follow-up|4|||
124900621|NCT03837028|449261324|FG001|Overall Study|Lost to Follow-up|0|||
125112769|NCT00950599|450036670|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
124900622|NCT03837028|449261325|FG002|Overall Study|Lost to Follow-up|2|||
125112770|NCT00950599|450036671|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
125112771|NCT00950599|450036672|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
125112772|NCT00950599|450036673|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
124900623|NCT03837028|449261326|FG003|Overall Study|Lost to Follow-up|0|||
124900624|NCT03837028|449261323|FG000|Overall Study|Withdrawal by Subject|12|||
124900625|NCT03837028|449261324|FG001|Overall Study|Withdrawal by Subject|11|||
124900626|NCT03837028|449261325|FG002|Overall Study|Withdrawal by Subject|11|||
124900627|NCT03837028|449261326|FG003|Overall Study|Withdrawal by Subject|7|||
124900628|NCT01091454|449261327|FG000|Overall Study|Ineligible|1|||
124900629|NCT00646451|449261328|FG000|Overall Study|Adverse Event|3|||
124900630|NCT00646451|449261329|FG001|Overall Study|Adverse Event|0|||
124900631|NCT00646451|449261328|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
124900632|NCT00646451|449261329|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
124900633|NCT01362491|449261330|FG000|Overall Study|Ineligible|1|||
124900634|NCT01362491|449261331|FG001|Overall Study|Ineligible|0|||
124900635|NCT01362491|449261332|FG002|Overall Study|Ineligible|0|||
124900636|NCT02030028|449261333|FG000|Overall Study|Withdrawal by Subject|4|||
124900637|NCT02030028|449261333|FG000|Overall Study|lack of transportation|1|||
124900638|NCT00567879|449261334|FG000|Overall Study|Adverse Event|2|||
124900639|NCT00567879|449261335|FG001|Overall Study|Adverse Event|0|||
124900640|NCT00567879|449261336|FG002|Overall Study|Adverse Event|1|||
124900641|NCT00567879|449261337|FG003|Overall Study|Adverse Event|0|||
124900642|NCT00567879|449261338|FG004|Overall Study|Adverse Event|1|||
124900643|NCT00567879|449261339|FG005|Overall Study|Adverse Event|0|||
124900644|NCT00567879|449261334|FG000|Overall Study|Abnormal test procedure(s)|0|||
124900645|NCT00567879|449261335|FG001|Overall Study|Abnormal test procedure(s)|0|||
124900646|NCT00567879|449261336|FG002|Overall Study|Abnormal test procedure(s)|1|||
124900647|NCT00567879|449261337|FG003|Overall Study|Abnormal test procedure(s)|0|||
124900648|NCT00567879|449261338|FG004|Overall Study|Abnormal test procedure(s)|0|||
124900649|NCT00567879|449261339|FG005|Overall Study|Abnormal test procedure(s)|0|||
124900650|NCT00567879|449261334|FG000|Overall Study|Withdrawal by Subject|0|||
124900651|NCT00567879|449261335|FG001|Overall Study|Withdrawal by Subject|0|||
124900652|NCT00567879|449261336|FG002|Overall Study|Withdrawal by Subject|3|||
124900653|NCT00567879|449261337|FG003|Overall Study|Withdrawal by Subject|1|||
124900654|NCT00567879|449261338|FG004|Overall Study|Withdrawal by Subject|0|||
124900655|NCT00567879|449261339|FG005|Overall Study|Withdrawal by Subject|0|||
124900656|NCT00567879|449261334|FG000|Overall Study|New cancer therapy|0|||
124900657|NCT00567879|449261335|FG001|Overall Study|New cancer therapy|0|||
124900658|NCT00567879|449261336|FG002|Overall Study|New cancer therapy|1|||
124900659|NCT00567879|449261337|FG003|Overall Study|New cancer therapy|0|||
124900660|NCT00567879|449261338|FG004|Overall Study|New cancer therapy|0|||
124900661|NCT00567879|449261339|FG005|Overall Study|New cancer therapy|0|||
124900662|NCT00567879|449261334|FG000|Overall Study|Disease progression|5|||
124900663|NCT00567879|449261335|FG001|Overall Study|Disease progression|7|||
124900664|NCT00567879|449261336|FG002|Overall Study|Disease progression|15|||
125112773|NCT00950599|450036674|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
125112774|NCT00950599|450036675|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
125112775|NCT00950599|450036666|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125112776|NCT00950599|450036667|FG001|Double-Blind Treatment Period|Adverse Event|1|||
125112777|NCT00950599|450036668|FG002|Double-Blind Treatment Period|Adverse Event|1|||
125112778|NCT00950599|450036669|FG003|Double-Blind Treatment Period|Adverse Event|1|||
125112779|NCT00950599|450036670|FG004|Double-Blind Treatment Period|Adverse Event|1|||
125112780|NCT00950599|450036671|FG005|Double-Blind Treatment Period|Adverse Event|1|||
125112781|NCT00950599|450036672|FG006|Double-Blind Treatment Period|Adverse Event|0|||
125112782|NCT00950599|450036673|FG007|Double-Blind Treatment Period|Adverse Event|0|||
125112783|NCT00950599|450036674|FG008|Double-Blind Treatment Period|Adverse Event|0|||
125112784|NCT00950599|450036675|FG009|Double-Blind Treatment Period|Adverse Event|0|||
125112785|NCT00950599|450036666|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
125112786|NCT00950599|450036667|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
125112787|NCT00950599|450036668|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
125112788|NCT00950599|450036669|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
125112789|NCT00950599|450036670|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
125112790|NCT00950599|450036671|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
125112791|NCT00950599|450036672|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
125112792|NCT00950599|450036673|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
124900665|NCT00567879|449261337|FG003|Overall Study|Disease progression|5|||
124900666|NCT00567879|449261338|FG004|Overall Study|Disease progression|11|||
124900667|NCT00567879|449261339|FG005|Overall Study|Disease progression|3|||
124900668|NCT01249092|449261340|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
124900669|NCT01249092|449261340|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
124900670|NCT02930343|449261344|FG000|Overall Study|Lost to Follow-up|9|||
124900671|NCT02930343|449261345|FG001|Overall Study|Lost to Follow-up|7|||
124900672|NCT00954707|449261346|FG000|Overall Study|Death|34|||
124900673|NCT00954707|449261346|FG000|Overall Study|Withdrawal by Subject|100|||
124900674|NCT00954707|449261346|FG000|Overall Study|Lost to Follow-up|33|||
124900675|NCT02987543|449261349|FG000|Overall Study|Ongoing study at data cut off|49|||
125112793|NCT00950599|450036674|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
125112794|NCT00950599|450036675|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
124900676|NCT02987543|449261350|FG001|Overall Study|Ongoing study at data cut off|21|||
124900677|NCT02987543|449261351|FG002|Overall Study|Ongoing study at data cut off|19|||
124900678|NCT02987543|449261352|FG003|Overall Study|Ongoing study at data cut off|12|||
124900679|NCT02987543|449261349|FG000|Overall Study|Death|88|||
124900680|NCT02987543|449261350|FG001|Overall Study|Death|54|||
124900681|NCT02987543|449261351|FG002|Overall Study|Death|67|||
124900682|NCT02987543|449261352|FG003|Overall Study|Death|28|||
124900683|NCT02987543|449261349|FG000|Overall Study|Lost to Follow-up|3|||
124900684|NCT02987543|449261350|FG001|Overall Study|Lost to Follow-up|0|||
124900685|NCT02987543|449261351|FG002|Overall Study|Lost to Follow-up|1|||
124900686|NCT02987543|449261352|FG003|Overall Study|Lost to Follow-up|0|||
124900687|NCT02987543|449261349|FG000|Overall Study|Screen failure|0|||
124900688|NCT02987543|449261350|FG001|Overall Study|Screen failure|0|||
124900689|NCT02987543|449261351|FG002|Overall Study|Screen failure|0|||
124900690|NCT02987543|449261352|FG003|Overall Study|Screen failure|1|||
124900691|NCT02987543|449261349|FG000|Overall Study|Withdrawal by Subject|21|||
124900692|NCT02987543|449261350|FG001|Overall Study|Withdrawal by Subject|7|||
124900693|NCT02987543|449261351|FG002|Overall Study|Withdrawal by Subject|7|||
124900694|NCT02987543|449261352|FG003|Overall Study|Withdrawal by Subject|6|||
124900695|NCT02987543|449261349|FG000|Overall Study|Study terminated by sponsor|1|||
124900696|NCT02987543|449261350|FG001|Overall Study|Study terminated by sponsor|0|||
124900697|NCT02987543|449261351|FG002|Overall Study|Study terminated by sponsor|0|||
124900698|NCT02987543|449261352|FG003|Overall Study|Study terminated by sponsor|0|||
124900699|NCT02987543|449261349|FG000|Overall Study|Investigator decision|0|||
124900700|NCT02987543|449261350|FG001|Overall Study|Investigator decision|1|||
124900701|NCT02987543|449261351|FG002|Overall Study|Investigator decision|0|||
124900702|NCT02987543|449261352|FG003|Overall Study|Investigator decision|0|||
124900703|NCT02987543|449261349|FG000|Overall Study|Disease progression|0|||
124900704|NCT02987543|449261350|FG001|Overall Study|Disease progression|0|||
124900705|NCT02987543|449261351|FG002|Overall Study|Disease progression|0|||
124900706|NCT02987543|449261352|FG003|Overall Study|Disease progression|1|||
124900707|NCT00309452|449261353|FG000|Overall Study|Withdrawal by Subject|3|||
124900708|NCT00309452|449261354|FG001|Overall Study|Withdrawal by Subject|0|||
124900709|NCT01977612|449261355|FG000|Overall Study|Lost to Follow-up|1|||
124900710|NCT01977612|449261356|FG001|Overall Study|Lost to Follow-up|1|||
124900711|NCT01451814|449261357|FG000|Overall Study|Withdrawal by Subject|1|||
124900712|NCT01451814|449261358|FG001|Overall Study|Withdrawal by Subject|1|||
124900713|NCT01451814|449261357|FG000|Overall Study|Lost to Follow-up|5|||
124900714|NCT01451814|449261358|FG001|Overall Study|Lost to Follow-up|4|||
124900715|NCT01280591|449261360|FG000|Overall Study|Withdrawal by Subject|0|||
124900716|NCT01280591|449261361|FG001|Overall Study|Withdrawal by Subject|0|||
124900717|NCT01280591|449261362|FG002|Overall Study|Withdrawal by Subject|0|||
124900718|NCT01280591|449261363|FG003|Overall Study|Withdrawal by Subject|2|||
124900719|NCT01280591|449261360|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
124900720|NCT01280591|449261361|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
124900721|NCT01280591|449261362|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
125020869|NCT03704194|449700839|FG000|Overall Study|Withdrawal by Subject|0|||
125020870|NCT03704194|449700840|FG001|Overall Study|Withdrawal by Subject|1|||
125020871|NCT03118297|449700845|FG000|Overall Study|Lost to Follow-up|0|||
125020872|NCT03118297|449700846|FG001|Overall Study|Lost to Follow-up|2|||
125020873|NCT02479802|449700847|FG000|Overall Study|Lost to Follow-up|1|||
125020874|NCT02479802|449700847|FG000|Overall Study|Adverse Event|1|||
125020875|NCT03286842|449700853|FG000|Overall Study|Patients rolled over to another study|80|||
124900722|NCT01280591|449261363|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
124900723|NCT01883492|449261364|FG000|Overall Study|Lost to Follow-up|3|||
124900724|NCT01883492|449261365|FG001|Overall Study|Lost to Follow-up|4|||
124900725|NCT01883492|449261364|FG000|Overall Study|Surgery on contra-lateral hip|0|||
124900726|NCT01883492|449261365|FG001|Overall Study|Surgery on contra-lateral hip|1|||
124900727|NCT01883492|449261364|FG000|Overall Study|Poor X-ray quality|7|||
124900728|NCT01883492|449261365|FG001|Overall Study|Poor X-ray quality|4|||
124900729|NCT01883492|449261364|FG000|Overall Study|Withdrawal by Subject|1|||
124900730|NCT01883492|449261365|FG001|Overall Study|Withdrawal by Subject|0|||
124900731|NCT01883492|449261364|FG000|Overall Study|inappropriate implant used|1|||
124900732|NCT01883492|449261365|FG001|Overall Study|inappropriate implant used|1|||
124900733|NCT01883492|449261364|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
124900734|NCT01883492|449261365|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
124900735|NCT03357341|449261366|FG000|Overall Study|Withdrawal by Subject|3|||
124900736|NCT03357341|449261367|FG001|Overall Study|Withdrawal by Subject|6|||
124900737|NCT03357341|449261366|FG000|Overall Study|Lost to Follow-up|4|||
125020876|NCT01391507|449700857|FG000|Overall Study|Death|0|||
124900738|NCT03357341|449261367|FG001|Overall Study|Lost to Follow-up|5|||
124900739|NCT03357341|449261366|FG000|Overall Study|Death|0|||
124900740|NCT03357341|449261367|FG001|Overall Study|Death|1|||
124900741|NCT01259102|449261368|FG000|Overall Study|Adverse Event|1|||
124900742|NCT01259102|449261369|FG001|Overall Study|Adverse Event|0|||
124900743|NCT01259102|449261370|FG002|Overall Study|Adverse Event|1|||
124900744|NCT01259102|449261371|FG003|Overall Study|Adverse Event|1|||
124900745|NCT01259102|449261372|FG004|Overall Study|Adverse Event|0|||
124900746|NCT01259102|449261368|FG000|Overall Study|Other|0|||
124900747|NCT01259102|449261369|FG001|Overall Study|Other|0|||
124900748|NCT01259102|449261370|FG002|Overall Study|Other|1|||
124900749|NCT01259102|449261371|FG003|Overall Study|Other|1|||
125112795|NCT00950599|450036666|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
125112796|NCT00950599|450036667|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
125112797|NCT00950599|450036668|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
125112798|NCT00950599|450036669|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
125112799|NCT00950599|450036670|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
125112800|NCT00950599|450036671|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
125112801|NCT00950599|450036672|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
125112802|NCT00950599|450036673|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
125112803|NCT00950599|450036674|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
125112804|NCT00950599|450036675|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
125112805|NCT00950599|450036666|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
125112806|NCT00950599|450036667|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
125112807|NCT00950599|450036668|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
125112808|NCT00950599|450036669|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
125112809|NCT00950599|450036670|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
125112810|NCT00950599|450036671|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
125112811|NCT00950599|450036672|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
125112812|NCT00950599|450036673|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
125112813|NCT00950599|450036674|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
125112814|NCT00950599|450036675|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
125112815|NCT00950599|450036666|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
125112816|NCT00950599|450036667|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
125112817|NCT00950599|450036668|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
125112818|NCT00950599|450036669|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
125112819|NCT00950599|450036670|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
125112820|NCT00950599|450036671|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
125112821|NCT00950599|450036672|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
125112822|NCT00950599|450036673|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
125112823|NCT00950599|450036674|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
125112824|NCT00950599|450036675|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
125112825|NCT00950599|450036666|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
125112826|NCT00950599|450036667|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
125112827|NCT00950599|450036668|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
125112828|NCT00950599|450036669|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
125112829|NCT00950599|450036670|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
125112830|NCT00950599|450036671|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
125112831|NCT00950599|450036672|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
125112832|NCT00950599|450036673|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
125112833|NCT00950599|450036674|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
125112834|NCT00950599|450036675|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
125112835|NCT00950599|450036666|FG000|Follow-Up Period|Adverse Event|0|||
125112836|NCT00950599|450036667|FG001|Follow-Up Period|Adverse Event|0|||
125112837|NCT00950599|450036668|FG002|Follow-Up Period|Adverse Event|0|||
125112838|NCT00950599|450036669|FG003|Follow-Up Period|Adverse Event|0|||
125112839|NCT00950599|450036670|FG004|Follow-Up Period|Adverse Event|0|||
125112840|NCT00950599|450036671|FG005|Follow-Up Period|Adverse Event|0|||
125112841|NCT00950599|450036672|FG006|Follow-Up Period|Adverse Event|0|||
125112842|NCT00950599|450036673|FG007|Follow-Up Period|Adverse Event|0|||
124900750|NCT01259102|449261372|FG004|Overall Study|Other|1|||
124900751|NCT01956669|449261376|FG000|Overall Study|Disease Progression|12|||
124900752|NCT01956669|449261377|FG001|Overall Study|Disease Progression|7|||
124900753|NCT01956669|449261378|FG002|Overall Study|Disease Progression|7|||
124900754|NCT01956669|449261379|FG003|Overall Study|Disease Progression|8|||
124900755|NCT01956669|449261380|FG004|Overall Study|Disease Progression|4|||
124900756|NCT01956669|449261381|FG005|Overall Study|Disease Progression|3|||
124900757|NCT01956669|449261382|FG006|Overall Study|Disease Progression|5|||
124900758|NCT01956669|449261376|FG000|Overall Study|Adverse Event|0|||
125112843|NCT00950599|450036674|FG008|Follow-Up Period|Adverse Event|1|||
125112844|NCT00950599|450036675|FG009|Follow-Up Period|Adverse Event|0|||
125112845|NCT00950599|450036666|FG000|Follow-Up Period|Lack of Efficacy|0|||
125112846|NCT00950599|450036667|FG001|Follow-Up Period|Lack of Efficacy|0|||
125112847|NCT00950599|450036668|FG002|Follow-Up Period|Lack of Efficacy|0|||
125112848|NCT00950599|450036669|FG003|Follow-Up Period|Lack of Efficacy|0|||
125112849|NCT00950599|450036670|FG004|Follow-Up Period|Lack of Efficacy|0|||
125112850|NCT00950599|450036671|FG005|Follow-Up Period|Lack of Efficacy|0|||
125112851|NCT00950599|450036672|FG006|Follow-Up Period|Lack of Efficacy|0|||
125112852|NCT00950599|450036673|FG007|Follow-Up Period|Lack of Efficacy|0|||
125112853|NCT00950599|450036674|FG008|Follow-Up Period|Lack of Efficacy|3|||
125112854|NCT00950599|450036675|FG009|Follow-Up Period|Lack of Efficacy|0|||
125112855|NCT00950599|450036666|FG000|Follow-Up Period|Lost to Follow-up|0|||
125112856|NCT00950599|450036667|FG001|Follow-Up Period|Lost to Follow-up|0|||
125112857|NCT00950599|450036668|FG002|Follow-Up Period|Lost to Follow-up|0|||
125112858|NCT00950599|450036669|FG003|Follow-Up Period|Lost to Follow-up|0|||
125112859|NCT00950599|450036670|FG004|Follow-Up Period|Lost to Follow-up|0|||
125112860|NCT00950599|450036671|FG005|Follow-Up Period|Lost to Follow-up|0|||
125112861|NCT00950599|450036672|FG006|Follow-Up Period|Lost to Follow-up|0|||
125112862|NCT00950599|450036673|FG007|Follow-Up Period|Lost to Follow-up|0|||
125112863|NCT00950599|450036674|FG008|Follow-Up Period|Lost to Follow-up|5|||
125112864|NCT00950599|450036675|FG009|Follow-Up Period|Lost to Follow-up|1|||
125112865|NCT00950599|450036666|FG000|Follow-Up Period|Physician Decision|0|||
125112866|NCT00950599|450036667|FG001|Follow-Up Period|Physician Decision|0|||
125112867|NCT00950599|450036668|FG002|Follow-Up Period|Physician Decision|0|||
125112868|NCT00950599|450036669|FG003|Follow-Up Period|Physician Decision|0|||
125112869|NCT00950599|450036670|FG004|Follow-Up Period|Physician Decision|0|||
125112870|NCT00950599|450036671|FG005|Follow-Up Period|Physician Decision|0|||
125112871|NCT00950599|450036672|FG006|Follow-Up Period|Physician Decision|0|||
125112872|NCT00950599|450036673|FG007|Follow-Up Period|Physician Decision|0|||
125112873|NCT00950599|450036674|FG008|Follow-Up Period|Physician Decision|1|||
125112874|NCT00950599|450036675|FG009|Follow-Up Period|Physician Decision|0|||
125112875|NCT00950599|450036666|FG000|Follow-Up Period|Poor/Noncompliance|0|||
125112876|NCT00950599|450036667|FG001|Follow-Up Period|Poor/Noncompliance|0|||
125112877|NCT00950599|450036668|FG002|Follow-Up Period|Poor/Noncompliance|0|||
125112878|NCT00950599|450036669|FG003|Follow-Up Period|Poor/Noncompliance|0|||
125112879|NCT00950599|450036670|FG004|Follow-Up Period|Poor/Noncompliance|0|||
125112880|NCT00950599|450036671|FG005|Follow-Up Period|Poor/Noncompliance|0|||
125112881|NCT00950599|450036672|FG006|Follow-Up Period|Poor/Noncompliance|0|||
125112882|NCT00950599|450036673|FG007|Follow-Up Period|Poor/Noncompliance|0|||
125112883|NCT00950599|450036674|FG008|Follow-Up Period|Poor/Noncompliance|1|||
125112884|NCT00950599|450036675|FG009|Follow-Up Period|Poor/Noncompliance|0|||
125112885|NCT00950599|450036666|FG000|Follow-Up Period|Subject withdrew Consent|0|||
125112886|NCT00950599|450036667|FG001|Follow-Up Period|Subject withdrew Consent|0|||
125112887|NCT00950599|450036668|FG002|Follow-Up Period|Subject withdrew Consent|0|||
125112888|NCT00950599|450036669|FG003|Follow-Up Period|Subject withdrew Consent|0|||
125112889|NCT00950599|450036670|FG004|Follow-Up Period|Subject withdrew Consent|0|||
125112890|NCT00950599|450036671|FG005|Follow-Up Period|Subject withdrew Consent|0|||
125112891|NCT00950599|450036672|FG006|Follow-Up Period|Subject withdrew Consent|0|||
125112892|NCT00950599|450036673|FG007|Follow-Up Period|Subject withdrew Consent|0|||
125112893|NCT00950599|450036674|FG008|Follow-Up Period|Subject withdrew Consent|2|||
125112894|NCT00950599|450036675|FG009|Follow-Up Period|Subject withdrew Consent|1|||
125112895|NCT00971204|450036677|FG000|Overall Study|Did not meet all criteria-not treated|14|||
125112896|NCT00971204|450036677|FG000|Overall Study|Lost to Follow-up|10|||
125112897|NCT02436135|450036678|FG000|Overall Study|Progressive Disease|3|||
125112898|NCT02436135|450036679|FG001|Overall Study|Progressive Disease|1|||
125112899|NCT02436135|450036678|FG000|Overall Study|Investigator Discretion|1|||
125112900|NCT02436135|450036679|FG001|Overall Study|Investigator Discretion|2|||
125112901|NCT02436135|450036678|FG000|Overall Study|Adverse Event|1|||
125112902|NCT02436135|450036679|FG001|Overall Study|Adverse Event|0|||
125112903|NCT02436135|450036678|FG000|Overall Study|Withdrawal by Participant|1|||
125112904|NCT02436135|450036679|FG001|Overall Study|Withdrawal by Participant|0|||
125112905|NCT02436135|450036678|FG000|Overall Study|Study Terminated By Sponsor|0|||
125112906|NCT02436135|450036679|FG001|Overall Study|Study Terminated By Sponsor|1|||
125112907|NCT02729194|450036680|FG000|Overall Study|Withdrawal by Subject|3|||
125112908|NCT01401478|450036686|FG000|Overall Study|Study drug not available|6|||
125112909|NCT01401478|450036686|FG000|Overall Study|Adverse Event|5|||
125112910|NCT01401478|450036686|FG000|Overall Study|Hyperphosphatemia|5|||
125112911|NCT01401478|450036686|FG000|Overall Study|Lost to Follow-up|5|||
125112912|NCT01401478|450036686|FG000|Overall Study|Kidney transplantation|3|||
125112913|NCT01401478|450036686|FG000|Overall Study|Withdrawal by Subject|3|||
125112914|NCT01401478|450036686|FG000|Overall Study|Blood samples not available|1|||
125112915|NCT01401478|450036686|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
125112916|NCT01401478|450036686|FG000|Overall Study|Low intact parathyroid hormone|1|||
124900759|NCT01956669|449261377|FG001|Overall Study|Adverse Event|2|||
124900760|NCT01956669|449261378|FG002|Overall Study|Adverse Event|2|||
124900761|NCT01956669|449261379|FG003|Overall Study|Adverse Event|1|||
124900762|NCT01956669|449261380|FG004|Overall Study|Adverse Event|0|||
124900763|NCT01956669|449261381|FG005|Overall Study|Adverse Event|0|||
124900764|NCT01956669|449261382|FG006|Overall Study|Adverse Event|0|||
124900765|NCT01956669|449261376|FG000|Overall Study|Physician Decision|0|||
124900766|NCT01956669|449261377|FG001|Overall Study|Physician Decision|2|||
124900767|NCT01956669|449261378|FG002|Overall Study|Physician Decision|0|||
124900768|NCT01956669|449261379|FG003|Overall Study|Physician Decision|0|||
125112917|NCT01401478|450036686|FG000|Overall Study|Serious adverse event|1|||
125112918|NCT01684722|450036687|FG000|Overall Study|Lost to Follow-up|78|||
125112919|NCT01684722|450036688|FG001|Overall Study|Lost to Follow-up|56|||
125112920|NCT01684722|450036689|FG002|Overall Study|Lost to Follow-up|75|||
125112921|NCT01684722|450036690|FG003|Overall Study|Lost to Follow-up|89|||
125112922|NCT01684722|450036687|FG000|Overall Study|Death|19|||
125112923|NCT01684722|450036688|FG001|Overall Study|Death|21|||
125112924|NCT01684722|450036689|FG002|Overall Study|Death|19|||
125112925|NCT01684722|450036690|FG003|Overall Study|Death|21|||
125112926|NCT00863057|450036695|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
125112927|NCT00863057|450036696|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
125112928|NCT00863057|450036697|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
125112929|NCT00863057|450036698|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
125112930|NCT00863057|450036695|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
125112931|NCT00863057|450036696|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
125112932|NCT00863057|450036697|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
125112933|NCT00863057|450036698|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
125112934|NCT00863057|450036695|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
125112935|NCT00863057|450036696|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
125112936|NCT00863057|450036697|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
125112937|NCT00863057|450036698|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
125112938|NCT00863057|450036695|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
125112939|NCT00863057|450036696|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
125112940|NCT00863057|450036697|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
125112941|NCT00863057|450036698|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
125112942|NCT03063632|450036700|FG000|Overall Study|Death|4|||
125112943|NCT03063632|450036701|FG001|Overall Study|Death|6|||
125112944|NCT03063632|450036700|FG000|Overall Study|Lost to Follow-up|0|||
125112945|NCT03063632|450036701|FG001|Overall Study|Lost to Follow-up|1|||
124900769|NCT01956669|449261380|FG004|Overall Study|Physician Decision|0|||
124900770|NCT01956669|449261381|FG005|Overall Study|Physician Decision|1|||
125020877|NCT01391507|449700858|FG001|Overall Study|Death|0|||
125020878|NCT01391507|449700859|FG002|Overall Study|Death|0|||
125020879|NCT01391507|449700860|FG003|Overall Study|Death|1|||
125020880|NCT01391507|449700857|FG000|Overall Study|Adverse Event|1|||
125020881|NCT01391507|449700858|FG001|Overall Study|Adverse Event|1|||
125020882|NCT01391507|449700859|FG002|Overall Study|Adverse Event|2|||
125020883|NCT01391507|449700860|FG003|Overall Study|Adverse Event|2|||
125020884|NCT01391507|449700857|FG000|Overall Study|Withdrawal by Subject|1|||
125020885|NCT01391507|449700858|FG001|Overall Study|Withdrawal by Subject|2|||
125020886|NCT01391507|449700859|FG002|Overall Study|Withdrawal by Subject|1|||
125020887|NCT01391507|449700860|FG003|Overall Study|Withdrawal by Subject|1|||
125020888|NCT01391507|449700857|FG000|Overall Study|Lack of Efficacy|0|||
125020889|NCT01391507|449700858|FG001|Overall Study|Lack of Efficacy|0|||
125020890|NCT01391507|449700859|FG002|Overall Study|Lack of Efficacy|0|||
125020891|NCT01391507|449700860|FG003|Overall Study|Lack of Efficacy|1|||
125020892|NCT01391507|449700857|FG000|Overall Study|Protocol Violation|2|||
125020893|NCT01391507|449700858|FG001|Overall Study|Protocol Violation|1|||
125020894|NCT01391507|449700859|FG002|Overall Study|Protocol Violation|1|||
125020895|NCT01391507|449700860|FG003|Overall Study|Protocol Violation|2|||
125020896|NCT01453855|449700861|FG000|Overall Study|Adverse Event|3|||
125020897|NCT01453855|449700862|FG001|Overall Study|Adverse Event|4|||
125020898|NCT01453855|449700861|FG000|Overall Study|Lost to Follow-up|2|||
125020899|NCT01453855|449700862|FG001|Overall Study|Lost to Follow-up|1|||
125020900|NCT01453855|449700861|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
125020901|NCT01453855|449700862|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
125020902|NCT01453855|449700861|FG000|Overall Study|Noncompliance|1|||
125112946|NCT03063632|450036700|FG000|Overall Study|Withdrawal by Subject|0|||
125112947|NCT03063632|450036701|FG001|Overall Study|Withdrawal by Subject|2|||
125112948|NCT03063632|450036700|FG000|Overall Study|Physician Decision|2|||
125112949|NCT03063632|450036701|FG001|Overall Study|Physician Decision|0|||
125112950|NCT03063632|450036700|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
125112951|NCT03063632|450036701|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
125112952|NCT02741271|450036704|FG000|Overall Study|Lost to Follow-up|2|||
124900771|NCT01956669|449261382|FG006|Overall Study|Physician Decision|0|||
124900772|NCT01956669|449261376|FG000|Overall Study|Withdrawal by Subject|0|||
125020903|NCT01453855|449700862|FG001|Overall Study|Noncompliance|0|||
125020904|NCT01453855|449700861|FG000|Overall Study|Inadequate Control of IOP|1|||
124900773|NCT01956669|449261377|FG001|Overall Study|Withdrawal by Subject|0|||
124900774|NCT01956669|449261378|FG002|Overall Study|Withdrawal by Subject|1|||
124900775|NCT01956669|449261379|FG003|Overall Study|Withdrawal by Subject|1|||
124900776|NCT01956669|449261380|FG004|Overall Study|Withdrawal by Subject|0|||
124900777|NCT01956669|449261381|FG005|Overall Study|Withdrawal by Subject|0|||
124900778|NCT01956669|449261382|FG006|Overall Study|Withdrawal by Subject|1|||
124900779|NCT01233050|449261383|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
124900780|NCT01233050|449261384|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
124900781|NCT01368406|449261386|FG000|Overall Study|Lost to Follow-up|8|||
124900782|NCT01368406|449261387|FG001|Overall Study|Lost to Follow-up|4|||
124900783|NCT01368406|449261386|FG000|Overall Study|Withdrawal by Subject|8|||
124900784|NCT01368406|449261387|FG001|Overall Study|Withdrawal by Subject|4|||
124900785|NCT01368406|449261386|FG000|Overall Study|relapse of the disease|3|||
124900786|NCT01368406|449261387|FG001|Overall Study|relapse of the disease|2|||
124900787|NCT01368406|449261386|FG000|Overall Study|started working|2|||
124900788|NCT01368406|449261387|FG001|Overall Study|started working|3|||
124900789|NCT01466881|449261388|FG000|Overall Study|Ineligible|5|||
124900790|NCT01466881|449261388|FG000|Overall Study|Adverse Event|6|||
124900791|NCT01466881|449261388|FG000|Overall Study|Progression/relapse|20|||
124900792|NCT01466881|449261388|FG000|Overall Study|Death|4|||
124900793|NCT01466881|449261388|FG000|Overall Study|Other reason not protocol specified|5|||
124900794|NCT01710514|449261398|FG000|Overall Study|Adverse Event|6|||
124900795|NCT01710514|449261399|FG001|Overall Study|Adverse Event|7|||
124900796|NCT01710514|449261398|FG000|Overall Study|Withdrawal by Subject|1|||
124900797|NCT01710514|449261399|FG001|Overall Study|Withdrawal by Subject|0|||
124900798|NCT02155829|449261403|FG000|Overall Study|Adverse Event|1|||
124900799|NCT02155829|449261404|FG001|Overall Study|Adverse Event|0|||
124900800|NCT02155829|449261403|FG000|Overall Study|Withdrawal by Subject|3|||
124900801|NCT02155829|449261404|FG001|Overall Study|Withdrawal by Subject|3|||
124900802|NCT02155829|449261403|FG000|Overall Study|Protocol Violation|2|||
124900803|NCT02155829|449261404|FG001|Overall Study|Protocol Violation|0|||
124900804|NCT00290732|449261408|FG000|Overall Study|Inability to instill drug intraductally.|0|||
124900805|NCT00290732|449261409|FG001|Overall Study|Inability to instill drug intraductally.|1|||
124900806|NCT00290732|449261410|FG002|Overall Study|Inability to instill drug intraductally.|1|||
124900807|NCT00290732|449261411|FG003|Overall Study|Inability to instill drug intraductally.|0|||
124900808|NCT00290732|449261412|FG004|Overall Study|Inability to instill drug intraductally.|0|||
124900809|NCT00542386|449261416|FG000|Overall Study|Adverse Event|1|||
124900810|NCT00542386|449261417|FG001|Overall Study|Adverse Event|7|||
124900811|NCT00542386|449261418|FG002|Overall Study|Adverse Event|7|||
124900812|NCT00542386|449261419|FG003|Overall Study|Adverse Event|8|||
124900813|NCT00542386|449261420|FG004|Overall Study|Adverse Event|13|||
124900814|NCT00542386|449261421|FG005|Overall Study|Adverse Event|4|||
124900815|NCT00542386|449261416|FG000|Overall Study|Death|0|||
124900816|NCT00542386|449261417|FG001|Overall Study|Death|0|||
125020905|NCT01453855|449700862|FG001|Overall Study|Inadequate Control of IOP|5|||
125020906|NCT01453855|449700861|FG000|Overall Study|Other|0|||
125020907|NCT01453855|449700862|FG001|Overall Study|Other|1|||
125020908|NCT01562548|449700871|FG000|Overall Study|Lost to Follow-up|0|||
125020909|NCT01562548|449700872|FG001|Overall Study|Lost to Follow-up|0|||
125020910|NCT01562548|449700873|FG002|Overall Study|Lost to Follow-up|1|||
125020911|NCT01562548|449700874|FG003|Overall Study|Lost to Follow-up|0|||
125020912|NCT01496066|449700875|FG000|Overall Study|Lost to Follow-up|8|||
125020913|NCT01496066|449700876|FG001|Overall Study|Lost to Follow-up|5|||
125020914|NCT01496066|449700875|FG000|Overall Study|Explant|3|||
125020915|NCT01496066|449700876|FG001|Overall Study|Explant|0|||
125020916|NCT01496066|449700875|FG000|Overall Study|Death|1|||
125020917|NCT01496066|449700876|FG001|Overall Study|Death|4|||
125020918|NCT01441063|449700877|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
125020919|NCT01441063|449700877|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
125020920|NCT00516737|449700880|FG000|Overall Study|Lost to Follow-up|2|||
125020921|NCT00516737|449700881|FG001|Overall Study|Lost to Follow-up|0|||
125020922|NCT00516737|449700880|FG000|Overall Study|Physician Decision|0|||
125020923|NCT00516737|449700881|FG001|Overall Study|Physician Decision|1|||
125020924|NCT00516737|449700880|FG000|Overall Study|Withdrawal by Subject|0|||
125020925|NCT00516737|449700881|FG001|Overall Study|Withdrawal by Subject|1|||
125020926|NCT00516737|449700880|FG000|Overall Study|Lack of Qualifying Event|9|||
125020927|NCT00516737|449700881|FG001|Overall Study|Lack of Qualifying Event|6|||
125020928|NCT01844895|449700882|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
125020929|NCT01844895|449700882|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
125020930|NCT01844895|449700882|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
125020931|NCT01844895|449700882|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
125020932|NCT01844895|449700882|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
125020933|NCT01844895|449700882|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
124900817|NCT00542386|449261418|FG002|Overall Study|Death|1|||
124900818|NCT00542386|449261419|FG003|Overall Study|Death|2|||
124900819|NCT00542386|449261420|FG004|Overall Study|Death|1|||
124900820|NCT00542386|449261421|FG005|Overall Study|Death|2|||
124900821|NCT00542386|449261416|FG000|Overall Study|Lack of Efficacy|32|||
124900822|NCT00542386|449261417|FG001|Overall Study|Lack of Efficacy|12|||
124900823|NCT00542386|449261418|FG002|Overall Study|Lack of Efficacy|10|||
124900824|NCT00542386|449261419|FG003|Overall Study|Lack of Efficacy|13|||
124900825|NCT00542386|449261420|FG004|Overall Study|Lack of Efficacy|7|||
124900826|NCT00542386|449261421|FG005|Overall Study|Lack of Efficacy|31|||
124900827|NCT00542386|449261416|FG000|Overall Study|Physician Decision|1|||
124900828|NCT00542386|449261417|FG001|Overall Study|Physician Decision|0|||
124900829|NCT00542386|449261418|FG002|Overall Study|Physician Decision|0|||
124900830|NCT00542386|449261419|FG003|Overall Study|Physician Decision|1|||
124900831|NCT00542386|449261420|FG004|Overall Study|Physician Decision|0|||
124900832|NCT00542386|449261421|FG005|Overall Study|Physician Decision|0|||
124900833|NCT00542386|449261416|FG000|Overall Study|Protocol Violation|0|||
124900834|NCT00542386|449261417|FG001|Overall Study|Protocol Violation|0|||
124900835|NCT00542386|449261418|FG002|Overall Study|Protocol Violation|1|||
124900836|NCT00542386|449261419|FG003|Overall Study|Protocol Violation|0|||
124900837|NCT00542386|449261420|FG004|Overall Study|Protocol Violation|0|||
124900838|NCT00542386|449261421|FG005|Overall Study|Protocol Violation|4|||
124900839|NCT00542386|449261416|FG000|Overall Study|Withdrawal by Subject|5|||
124900840|NCT00542386|449261417|FG001|Overall Study|Withdrawal by Subject|8|||
124900841|NCT00542386|449261418|FG002|Overall Study|Withdrawal by Subject|10|||
124900842|NCT00542386|449261419|FG003|Overall Study|Withdrawal by Subject|11|||
124900843|NCT00542386|449261420|FG004|Overall Study|Withdrawal by Subject|15|||
124900844|NCT00542386|449261421|FG005|Overall Study|Withdrawal by Subject|7|||
124900845|NCT00542386|449261416|FG000|Overall Study|Other Reasons|4|||
124900846|NCT00542386|449261417|FG001|Overall Study|Other Reasons|1|||
124900847|NCT00542386|449261418|FG002|Overall Study|Other Reasons|4|||
124900848|NCT00542386|449261419|FG003|Overall Study|Other Reasons|3|||
124900849|NCT00542386|449261420|FG004|Overall Study|Other Reasons|4|||
124900850|NCT00542386|449261421|FG005|Overall Study|Other Reasons|2|||
124900851|NCT01191788|449261426|FG000|Overall Study|Lost to Follow-up|21|||
124900852|NCT01191788|449261427|FG001|Overall Study|Lost to Follow-up|22|||
124900853|NCT02596035|449261428|FG000|Overall Study|Disease Progression|64|||
124900854|NCT02596035|449261429|FG001|Overall Study|Disease Progression|32|||
124900855|NCT02596035|449261430|FG002|Overall Study|Disease Progression|1|||
124900856|NCT02596035|449261428|FG000|Overall Study|study drug toxicity|12|||
124900857|NCT02596035|449261429|FG001|Overall Study|study drug toxicity|3|||
125020934|NCT01844895|449700882|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
125020935|NCT00512798|449700883|FG000|Overall Study|Death|0|||
125020936|NCT00512798|449700884|FG001|Overall Study|Death|3|||
125020937|NCT00512798|449700883|FG000|Overall Study|Adverse Event|2|||
125020938|NCT00512798|449700884|FG001|Overall Study|Adverse Event|4|||
125020939|NCT00512798|449700883|FG000|Overall Study|Progression of disease|14|||
125020940|NCT00512798|449700884|FG001|Overall Study|Progression of disease|20|||
125020941|NCT00512798|449700883|FG000|Overall Study|Withdrawal by Subject|3|||
125020942|NCT00512798|449700884|FG001|Overall Study|Withdrawal by Subject|0|||
125020943|NCT02508194|449700887|FG000|Overall Study|Death|5|||
125020944|NCT02508194|449700888|FG001|Overall Study|Death|3|||
125020945|NCT02508194|449700887|FG000|Overall Study|Lost to Follow-up|25|||
125020946|NCT02508194|449700888|FG001|Overall Study|Lost to Follow-up|18|||
125020947|NCT02508194|449700887|FG000|Overall Study|Withdrawal by Subject|20|||
125020948|NCT02508194|449700888|FG001|Overall Study|Withdrawal by Subject|18|||
125020949|NCT02508194|449700887|FG000|Overall Study|Error in Randomization|1|||
125020950|NCT02508194|449700888|FG001|Overall Study|Error in Randomization|3|||
125020951|NCT02508194|449700887|FG000|Overall Study|Principal Investigator Decision|1|||
125020952|NCT02508194|449700888|FG001|Overall Study|Principal Investigator Decision|2|||
125020953|NCT00511355|449700892|FG000|Overall Study|Adverse Event|4|||
125020954|NCT00511355|449700893|FG001|Overall Study|Adverse Event|4|||
125020955|NCT00511355|449700892|FG000|Overall Study|Pregnancy Wish|1|||
125020956|NCT00511355|449700893|FG001|Overall Study|Pregnancy Wish|0|||
125020957|NCT00511355|449700892|FG000|Overall Study|Lost to Follow-up|2|||
125020958|NCT00511355|449700893|FG001|Overall Study|Lost to Follow-up|1|||
125020959|NCT00511355|449700892|FG000|Overall Study|Other Reason|0|||
125020960|NCT00511355|449700893|FG001|Overall Study|Other Reason|1|||
125020961|NCT00511355|449700892|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
125020962|NCT00511355|449700893|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
124900858|NCT02596035|449261430|FG002|Overall Study|study drug toxicity|0|||
124900859|NCT02596035|449261428|FG000|Overall Study|AE unrelated to study drug|5|||
124900860|NCT02596035|449261429|FG001|Overall Study|AE unrelated to study drug|2|||
124900861|NCT02596035|449261430|FG002|Overall Study|AE unrelated to study drug|0|||
124900862|NCT02596035|449261428|FG000|Overall Study|participant request to discontinue study treatment|2|||
124900863|NCT02596035|449261429|FG001|Overall Study|participant request to discontinue study treatment|0|||
124900864|NCT02596035|449261430|FG002|Overall Study|participant request to discontinue study treatment|0|||
124900865|NCT02596035|449261428|FG000|Overall Study|participant withdrew consent|2|||
124900866|NCT02596035|449261429|FG001|Overall Study|participant withdrew consent|2|||
124900867|NCT02596035|449261430|FG002|Overall Study|participant withdrew consent|0|||
124900868|NCT02596035|449261428|FG000|Overall Study|Poor/Non Comlpiance|0|||
125112953|NCT02741271|450036705|FG001|Overall Study|Lost to Follow-up|0|||
125112954|NCT02741271|450036704|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125112955|NCT02741271|450036705|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
125112956|NCT01612156|450036706|FG000|Overall Study|Protocol Violation|2|||
125112957|NCT01612156|450036707|FG001|Overall Study|Protocol Violation|0|||
125112958|NCT02570165|450036708|FG000|Overall Study|Adverse Event|1|||
125112959|NCT02570165|450036709|FG001|Overall Study|Adverse Event|0|||
125112960|NCT02570165|450036710|FG002|Overall Study|Adverse Event|2|||
124900869|NCT02596035|449261429|FG001|Overall Study|Poor/Non Comlpiance|1|||
124900870|NCT02596035|449261430|FG002|Overall Study|Poor/Non Comlpiance|0|||
124900871|NCT02596035|449261428|FG000|Overall Study|participant no longer meets study criteria|1|||
124900872|NCT02596035|449261429|FG001|Overall Study|participant no longer meets study criteria|0|||
124900873|NCT02596035|449261430|FG002|Overall Study|participant no longer meets study criteria|0|||
124900874|NCT02596035|449261428|FG000|Overall Study|other reasons|11|||
124900875|NCT02596035|449261429|FG001|Overall Study|other reasons|4|||
124900876|NCT02596035|449261430|FG002|Overall Study|other reasons|0|||
124900877|NCT01235949|449261431|FG000|Primary Phase|Migrated/moved from study area|1|||
124900878|NCT01235949|449261432|FG001|Primary Phase|Migrated/moved from study area|1|||
124900879|NCT01235949|449261433|FG002|Primary Phase|Migrated/moved from study area|0|||
124900880|NCT01235949|449261434|FG003|Primary Phase|Migrated/moved from study area|0|||
125020963|NCT00511355|449700892|FG000|Overall Study|Withdrawal of informed consent|0|||
125020964|NCT00511355|449700893|FG001|Overall Study|Withdrawal of informed consent|1|||
125020965|NCT00511355|449700892|FG000|Overall Study|Other reason pre-treatment|0|||
125020966|NCT00511355|449700893|FG001|Overall Study|Other reason pre-treatment|1|||
125020967|NCT00454805|449700897|FG000|Overall Study|Withdrawal by Subject|9|||
124900881|NCT01235949|449261435|FG004|Primary Phase|Migrated/moved from study area|1|||
124900882|NCT01235949|449261436|FG005|Primary Phase|Migrated/moved from study area|2|||
125020968|NCT00454805|449700898|FG001|Overall Study|Withdrawal by Subject|2|||
125020969|NCT00454805|449700897|FG000|Overall Study|Death|0|||
125020970|NCT00454805|449700898|FG001|Overall Study|Death|2|||
125020971|NCT00454805|449700897|FG000|Overall Study|Disease progression|16|||
125020972|NCT00454805|449700898|FG001|Overall Study|Disease progression|19|||
125020973|NCT00454805|449700897|FG000|Overall Study|In order to begin radiotherapy|1|||
125020974|NCT00454805|449700898|FG001|Overall Study|In order to begin radiotherapy|0|||
125020975|NCT03742037|449700899|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
125020976|NCT03742037|449700900|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
125020977|NCT03742037|449700901|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
125020978|NCT03742037|449700902|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
125020979|NCT03742037|449700903|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
125020980|NCT03742037|449700904|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
125020981|NCT03742037|449700905|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
125020982|NCT03742037|449700899|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
125020983|NCT03742037|449700900|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
125020984|NCT03742037|449700901|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
125020985|NCT03742037|449700902|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
125020986|NCT03742037|449700903|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
125020987|NCT03742037|449700904|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
125020988|NCT03742037|449700905|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
125020989|NCT03742037|449700899|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
125020990|NCT03742037|449700900|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
125020991|NCT03742037|449700901|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
125020992|NCT03742037|449700902|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
125020993|NCT03742037|449700903|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
125020994|NCT03742037|449700904|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
125020995|NCT03742037|449700905|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
125020996|NCT03742037|449700899|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
125020997|NCT03742037|449700900|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
125020998|NCT03742037|449700901|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
125020999|NCT03742037|449700902|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
125021000|NCT03742037|449700903|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
125021001|NCT03742037|449700904|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
124900883|NCT01235949|449261437|FG006|Primary Phase|Migrated/moved from study area|0|||
124900884|NCT01235949|449261438|FG007|Primary Phase|Migrated/moved from study area|0|||
125112961|NCT02570165|450036711|FG003|Overall Study|Adverse Event|0|||
125112962|NCT02570165|450036712|FG004|Overall Study|Adverse Event|0|||
125112963|NCT02570165|450036713|FG005|Overall Study|Adverse Event|0|||
125112964|NCT02570165|450036714|FG006|Overall Study|Adverse Event|0|||
125112965|NCT02570165|450036708|FG000|Overall Study|Lack of Efficacy|0|||
125112966|NCT02570165|450036709|FG001|Overall Study|Lack of Efficacy|1|||
125112967|NCT02570165|450036710|FG002|Overall Study|Lack of Efficacy|0|||
125112968|NCT02570165|450036711|FG003|Overall Study|Lack of Efficacy|0|||
125112969|NCT02570165|450036712|FG004|Overall Study|Lack of Efficacy|4|||
125112970|NCT02570165|450036713|FG005|Overall Study|Lack of Efficacy|0|||
125112971|NCT02570165|450036714|FG006|Overall Study|Lack of Efficacy|0|||
125112972|NCT02570165|450036708|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
125112973|NCT02570165|450036709|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
125112974|NCT02570165|450036710|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
125112975|NCT02570165|450036711|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
125112976|NCT02570165|450036712|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
125112977|NCT02570165|450036713|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
125112978|NCT02570165|450036714|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
125112979|NCT02570165|450036708|FG000|Overall Study|Lost to Follow-up|0|||
125112980|NCT02570165|450036709|FG001|Overall Study|Lost to Follow-up|0|||
125112981|NCT02570165|450036710|FG002|Overall Study|Lost to Follow-up|1|||
125112982|NCT02570165|450036711|FG003|Overall Study|Lost to Follow-up|1|||
125112983|NCT02570165|450036712|FG004|Overall Study|Lost to Follow-up|0|||
125112984|NCT02570165|450036713|FG005|Overall Study|Lost to Follow-up|0|||
125112985|NCT02570165|450036714|FG006|Overall Study|Lost to Follow-up|0|||
125112986|NCT02570165|450036708|FG000|Overall Study|Physician Decision|0|||
125112987|NCT02570165|450036709|FG001|Overall Study|Physician Decision|1|||
125112988|NCT02570165|450036710|FG002|Overall Study|Physician Decision|0|||
125112989|NCT02570165|450036711|FG003|Overall Study|Physician Decision|0|||
125112990|NCT02570165|450036712|FG004|Overall Study|Physician Decision|0|||
125112991|NCT02570165|450036713|FG005|Overall Study|Physician Decision|0|||
125112992|NCT02570165|450036714|FG006|Overall Study|Physician Decision|0|||
125112993|NCT02570165|450036708|FG000|Overall Study|Withdrawal by Subject|0|||
125112994|NCT02570165|450036709|FG001|Overall Study|Withdrawal by Subject|0|||
125112995|NCT02570165|450036710|FG002|Overall Study|Withdrawal by Subject|0|||
125112996|NCT02570165|450036711|FG003|Overall Study|Withdrawal by Subject|2|||
125112997|NCT02570165|450036712|FG004|Overall Study|Withdrawal by Subject|1|||
125112998|NCT02570165|450036713|FG005|Overall Study|Withdrawal by Subject|0|||
125112999|NCT02570165|450036714|FG006|Overall Study|Withdrawal by Subject|0|||
125113000|NCT02570165|450036708|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
125113001|NCT02570165|450036709|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
125113002|NCT02570165|450036710|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
125113003|NCT02570165|450036711|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
125113004|NCT02570165|450036712|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
125113005|NCT02570165|450036713|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
125113006|NCT02570165|450036714|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
125113007|NCT02570165|450036708|FG000|Overall Study|Withdrawal Request by GSK|0|||
125113008|NCT02570165|450036709|FG001|Overall Study|Withdrawal Request by GSK|0|||
125113009|NCT02570165|450036710|FG002|Overall Study|Withdrawal Request by GSK|2|||
125113010|NCT02570165|450036711|FG003|Overall Study|Withdrawal Request by GSK|0|||
125113011|NCT02570165|450036712|FG004|Overall Study|Withdrawal Request by GSK|0|||
125113012|NCT02570165|450036713|FG005|Overall Study|Withdrawal Request by GSK|0|||
125113013|NCT02570165|450036714|FG006|Overall Study|Withdrawal Request by GSK|0|||
125113014|NCT01430104|450036715|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
125113015|NCT05478603|450036716|FG000|Overall Study|Withdrawal by Subject|0|||
125113016|NCT05478603|450036717|FG001|Overall Study|Withdrawal by Subject|1|||
125113017|NCT05478603|450036718|FG002|Overall Study|Withdrawal by Subject|0|||
125113018|NCT05478603|450036719|FG003|Overall Study|Withdrawal by Subject|0|||
125113019|NCT02472977|450036720|FG000|Overall Study|Disease progression|4|||
125113020|NCT02472977|450036721|FG001|Overall Study|Disease progression|25|||
125113021|NCT02472977|450036722|FG002|Overall Study|Disease progression|6|||
125113022|NCT02472977|450036720|FG000|Overall Study|Withdrawal by Subject|0|||
125113023|NCT02472977|450036721|FG001|Overall Study|Withdrawal by Subject|1|||
125113024|NCT02472977|450036722|FG002|Overall Study|Withdrawal by Subject|0|||
125113025|NCT02472977|450036720|FG000|Overall Study|Study drug toxicity|2|||
125113026|NCT02472977|450036721|FG001|Overall Study|Study drug toxicity|0|||
125113027|NCT02472977|450036722|FG002|Overall Study|Study drug toxicity|2|||
125113028|NCT02472977|450036720|FG000|Overall Study|Subject request to discontinue treatment|0|||
125113029|NCT02472977|450036721|FG001|Overall Study|Subject request to discontinue treatment|1|||
125113030|NCT02472977|450036722|FG002|Overall Study|Subject request to discontinue treatment|0|||
125113031|NCT03182686|450036723|FG000|Overall Study|Lost to Follow-up|2|||
125113032|NCT03182686|450036724|FG001|Overall Study|Lost to Follow-up|0|||
125113033|NCT03182686|450036723|FG000|Overall Study|Adverse Event|2|||
125113034|NCT03182686|450036724|FG001|Overall Study|Adverse Event|0|||
125113035|NCT03182686|450036723|FG000|Overall Study|Withdrawal by Subject|3|||
125113036|NCT03182686|450036724|FG001|Overall Study|Withdrawal by Subject|0|||
124900885|NCT01235949|449261439|FG008|Primary Phase|Migrated/moved from study area|0|||
124900886|NCT01235949|449261440|FG009|Primary Phase|Migrated/moved from study area|0|||
124900887|NCT01235949|449261441|FG010|Primary Phase|Migrated/moved from study area|0|||
124900888|NCT01235949|449261442|FG011|Primary Phase|Migrated/moved from study area|0|||
124900889|NCT01235949|449261443|FG012|Primary Phase|Migrated/moved from study area|0|||
124900890|NCT01235949|449261444|FG013|Primary Phase|Migrated/moved from study area|0|||
125021002|NCT03742037|449700905|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
125021003|NCT03742037|449700899|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
125021004|NCT03742037|449700900|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
125021005|NCT03742037|449700901|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
125021006|NCT03742037|449700902|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
125021007|NCT03742037|449700903|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
125021008|NCT03742037|449700904|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
125021009|NCT03742037|449700905|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
125021010|NCT03742037|449700899|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
125021011|NCT03742037|449700900|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
125021012|NCT03742037|449700901|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
125021013|NCT03742037|449700902|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
125021014|NCT03742037|449700903|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
125021015|NCT03742037|449700904|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
125021016|NCT03742037|449700905|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
125021017|NCT03742037|449700899|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
125021018|NCT03742037|449700900|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
125021019|NCT03742037|449700901|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
125021020|NCT03742037|449700902|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
125021021|NCT03742037|449700903|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
125021022|NCT03742037|449700904|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
125021023|NCT03742037|449700905|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
125021024|NCT03742037|449700899|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
125021025|NCT03742037|449700900|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
125021026|NCT03742037|449700901|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
125021027|NCT03742037|449700902|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
125021028|NCT03742037|449700903|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
125021029|NCT03742037|449700904|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
125021030|NCT03742037|449700905|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
125021031|NCT03742037|449700899|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
125021032|NCT03742037|449700900|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
125021033|NCT03742037|449700901|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
125021034|NCT03742037|449700902|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
125021035|NCT03742037|449700903|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
125021036|NCT03742037|449700904|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
125021037|NCT03742037|449700905|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
125021038|NCT03742037|449700899|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
125021039|NCT03742037|449700900|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
125021040|NCT03742037|449700901|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
125021041|NCT03742037|449700902|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
125021042|NCT03742037|449700903|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
125021043|NCT03742037|449700904|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
125021044|NCT03742037|449700905|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
125021045|NCT03742037|449700899|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
125021046|NCT03742037|449700900|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
125021047|NCT03742037|449700901|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
125021048|NCT03742037|449700902|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
125021049|NCT03742037|449700903|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
125021050|NCT03742037|449700904|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
125021051|NCT03742037|449700905|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
125021052|NCT03742037|449700899|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
125021053|NCT03742037|449700900|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
125021054|NCT03742037|449700901|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
125021055|NCT03742037|449700902|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
125021056|NCT03742037|449700903|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
125021057|NCT03742037|449700904|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
125021058|NCT03742037|449700905|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
125113037|NCT01025193|450036727|FG000|Overall Study|Protocol Violation|1|||
125113038|NCT01025193|450036727|FG000|Overall Study|Adverse Event|3|||
125113039|NCT02378506|450036728|FG000|Overall Study|Lack of Efficacy|3|||
125113040|NCT02378506|450036728|FG000|Overall Study|Withdrawal by Subject|4|||
125113041|NCT02378506|450036728|FG000|Overall Study|Protocol Violation|2|||
125113042|NCT02378506|450036728|FG000|Overall Study|Death|1|||
125113043|NCT02378506|450036728|FG000|Overall Study|Adverse Event|14|||
125113044|NCT02378506|450036728|FG000|Overall Study|Randomized But Not Treated|1|||
125113045|NCT00185211|450036729|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
125113046|NCT00185211|450036730|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
125113047|NCT00185211|450036729|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
125113048|NCT00185211|450036730|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
125113049|NCT00185211|450036729|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
125113050|NCT00185211|450036730|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
125113051|NCT00185211|450036729|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
125113052|NCT00185211|450036730|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
125113053|NCT00185211|450036729|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
125113054|NCT00185211|450036730|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
125113055|NCT00185211|450036729|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
125113056|NCT00185211|450036730|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
125113057|NCT00185211|450036729|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
125113058|NCT00185211|450036730|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
125113059|NCT00185211|450036729|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
125113060|NCT00185211|450036730|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
125113061|NCT00185211|450036729|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
125113062|NCT00185211|450036730|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
125113063|NCT00185211|450036729|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
125113064|NCT00185211|450036730|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
125113065|NCT00185211|450036729|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
125113066|NCT00185211|450036730|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
125113067|NCT00185211|450036729|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
125113068|NCT00185211|450036730|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
125113069|NCT01606137|450036731|FG000|Overall Study|Adverse Event|85|||
125113070|NCT01606137|450036731|FG000|Overall Study|Withdrawal by Subject|74|||
125113071|NCT01606137|450036731|FG000|Overall Study|Lack of Efficacy|56|||
125113072|NCT01606137|450036731|FG000|Overall Study|Lost to Follow-up|15|||
125113073|NCT01606137|450036731|FG000|Overall Study|Protocol Violation|1|||
125113074|NCT01606137|450036731|FG000|Overall Study|Patient non-compliance|9|||
125113075|NCT01606137|450036731|FG000|Overall Study|Death|1|||
125113076|NCT01606137|450036731|FG000|Overall Study|Decreased/no pain|4|||
125113077|NCT01606137|450036731|FG000|Overall Study|Issues with driving|4|||
125113078|NCT01606137|450036731|FG000|Overall Study|multiple sclerosis less stable|1|||
125113079|NCT01606137|450036731|FG000|Overall Study|Increased bilirubin|1|||
125113080|NCT01606137|450036731|FG000|Overall Study|Spray causes nausea|1|||
125113081|NCT01606137|450036731|FG000|Overall Study|Not enough improvement|4|||
125113082|NCT01606137|450036731|FG000|Overall Study|Wanted to try another treatment|1|||
125113083|NCT01606137|450036731|FG000|Overall Study|Patient leaving country|1|||
125113084|NCT01606137|450036731|FG000|Overall Study|Personal reasons|1|||
125113085|NCT01606137|450036731|FG000|Overall Study|Unable to tolerate study med. taste|1|||
125113086|NCT01606137|450036731|FG000|Overall Study|Patient moving|1|||
125113087|NCT01606137|450036731|FG000|Overall Study|Unable to collect consistent data|1|||
125113088|NCT02266706|450038484|FG000|Overall Study|Withdrawal by Subject|0|||
125113089|NCT02266706|450038485|FG001|Overall Study|Withdrawal by Subject|1|||
125113090|NCT02266706|450038486|FG002|Overall Study|Withdrawal by Subject|1|||
125113091|NCT02266706|450038487|FG003|Overall Study|Withdrawal by Subject|0|||
125113092|NCT02266706|450038488|FG004|Overall Study|Withdrawal by Subject|0|||
125113093|NCT02266706|450038489|FG005|Overall Study|Withdrawal by Subject|1|||
125113094|NCT02266706|450038490|FG006|Overall Study|Withdrawal by Subject|0|||
125113095|NCT02266706|450038491|FG007|Overall Study|Withdrawal by Subject|0|||
125113096|NCT02266706|450038492|FG008|Overall Study|Withdrawal by Subject|0|||
125113097|NCT02266706|450038484|FG000|Overall Study|Screen failure|0|||
125113098|NCT02266706|450038485|FG001|Overall Study|Screen failure|0|||
125113099|NCT02266706|450038486|FG002|Overall Study|Screen failure|0|||
125113100|NCT02266706|450038487|FG003|Overall Study|Screen failure|0|||
125113101|NCT02266706|450038488|FG004|Overall Study|Screen failure|0|||
125113102|NCT02266706|450038489|FG005|Overall Study|Screen failure|1|||
125113103|NCT02266706|450038490|FG006|Overall Study|Screen failure|1|||
125113104|NCT02266706|450038491|FG007|Overall Study|Screen failure|0|||
125113105|NCT02266706|450038492|FG008|Overall Study|Screen failure|0|||
125113106|NCT02266706|450038484|FG000|Overall Study|Enrollment in another study|0|||
125113107|NCT02266706|450038485|FG001|Overall Study|Enrollment in another study|0|||
125113108|NCT02266706|450038486|FG002|Overall Study|Enrollment in another study|0|||
125113109|NCT02266706|450038487|FG003|Overall Study|Enrollment in another study|1|||
125113110|NCT02266706|450038488|FG004|Overall Study|Enrollment in another study|0|||
125113111|NCT02266706|450038489|FG005|Overall Study|Enrollment in another study|0|||
125113112|NCT02266706|450038490|FG006|Overall Study|Enrollment in another study|0|||
125113113|NCT02266706|450038491|FG007|Overall Study|Enrollment in another study|0|||
125113114|NCT02266706|450038492|FG008|Overall Study|Enrollment in another study|0|||
125113115|NCT02544633|450038493|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
125113116|NCT02544633|450038494|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
125113117|NCT02544633|450038495|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
125113118|NCT02544633|450038496|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
125113119|NCT02544633|450038493|FG000|Treatment Period|Adverse Event|7|||
125113120|NCT02544633|450038494|FG001|Treatment Period|Adverse Event|4|||
125113121|NCT02544633|450038495|FG002|Treatment Period|Adverse Event|0|||
125113122|NCT02544633|450038496|FG003|Treatment Period|Adverse Event|5|||
125113123|NCT02544633|450038493|FG000|Treatment Period|Lack of Efficacy|17|||
125113124|NCT02544633|450038494|FG001|Treatment Period|Lack of Efficacy|11|||
125113125|NCT02544633|450038495|FG002|Treatment Period|Lack of Efficacy|5|||
125113126|NCT02544633|450038496|FG003|Treatment Period|Lack of Efficacy|5|||
125113127|NCT02544633|450038493|FG000|Treatment Period|Global Deterioration of Health|3|||
125113128|NCT02544633|450038494|FG001|Treatment Period|Global Deterioration of Health|3|||
125113129|NCT02544633|450038495|FG002|Treatment Period|Global Deterioration of Health|0|||
125113130|NCT02544633|450038496|FG003|Treatment Period|Global Deterioration of Health|1|||
125113131|NCT02544633|450038493|FG000|Treatment Period|Withdrawal by Subject|1|||
125113132|NCT02544633|450038494|FG001|Treatment Period|Withdrawal by Subject|0|||
125113133|NCT02544633|450038495|FG002|Treatment Period|Withdrawal by Subject|0|||
125113134|NCT02544633|450038496|FG003|Treatment Period|Withdrawal by Subject|0|||
125113135|NCT02544633|450038493|FG000|Treatment Period|Lost to Follow-up|0|||
125113136|NCT02544633|450038494|FG001|Treatment Period|Lost to Follow-up|1|||
125113137|NCT02544633|450038495|FG002|Treatment Period|Lost to Follow-up|0|||
125113138|NCT02544633|450038496|FG003|Treatment Period|Lost to Follow-up|0|||
125113139|NCT02544633|450038493|FG000|Treatment Period|Death|0|||
125113140|NCT02544633|450038494|FG001|Treatment Period|Death|0|||
125113141|NCT02544633|450038495|FG002|Treatment Period|Death|1|||
125113142|NCT02544633|450038496|FG003|Treatment Period|Death|0|||
125113143|NCT02544633|450038493|FG000|Treatment Period|Non-compliance|0|||
125113144|NCT02544633|450038494|FG001|Treatment Period|Non-compliance|0|||
125113145|NCT02544633|450038495|FG002|Treatment Period|Non-compliance|1|||
125113146|NCT02544633|450038496|FG003|Treatment Period|Non-compliance|0|||
125113147|NCT02544633|450038493|FG000|Treatment Period|Clinical Disease Progression|0|||
125113148|NCT02544633|450038494|FG001|Treatment Period|Clinical Disease Progression|0|||
125113149|NCT02544633|450038495|FG002|Treatment Period|Clinical Disease Progression|0|||
125113150|NCT02544633|450038496|FG003|Treatment Period|Clinical Disease Progression|1|||
125113151|NCT02544633|450038493|FG000|Survival Follow-up Period|Death|12|||
125113152|NCT02544633|450038494|FG001|Survival Follow-up Period|Death|14|||
125113153|NCT02544633|450038495|FG002|Survival Follow-up Period|Death|3|||
125113154|NCT02544633|450038496|FG003|Survival Follow-up Period|Death|9|||
125113155|NCT02544633|450038493|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
125113156|NCT02544633|450038494|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
125113157|NCT02544633|450038495|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
125113158|NCT02544633|450038496|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
125113159|NCT02544633|450038493|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
125113160|NCT02544633|450038494|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
125113161|NCT02544633|450038495|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
125113162|NCT02544633|450038496|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
125113163|NCT02544633|450038493|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
125113164|NCT02544633|450038494|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
125113165|NCT02544633|450038495|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
125113166|NCT02544633|450038496|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
125113167|NCT01977352|450038497|FG000|Overall Study|Lost to Follow-up|1|||
125113168|NCT01977352|450038498|FG001|Overall Study|Lost to Follow-up|2|||
125113169|NCT02257632|450038502|FG000|Overall Study|Withdrawal by Subject|0|||
125113170|NCT02257632|450038503|FG001|Overall Study|Withdrawal by Subject|1|||
125113171|NCT02257632|450038502|FG000|Overall Study|Adverse Event|1|||
125113172|NCT02257632|450038503|FG001|Overall Study|Adverse Event|2|||
125113173|NCT01059071|450038504|FG000|Overall Study|Lack of Efficacy|1|||
125113174|NCT01059071|450038505|FG001|Overall Study|Lack of Efficacy|4|||
125113175|NCT01059071|450038506|FG002|Overall Study|Lack of Efficacy|2|||
125113176|NCT01059071|450038507|FG003|Overall Study|Lack of Efficacy|3|||
125113177|NCT01059071|450038504|FG000|Overall Study|Withdrawal by Subject|1|||
125113178|NCT01059071|450038505|FG001|Overall Study|Withdrawal by Subject|0|||
125113179|NCT01059071|450038506|FG002|Overall Study|Withdrawal by Subject|0|||
125113180|NCT01059071|450038507|FG003|Overall Study|Withdrawal by Subject|2|||
125113181|NCT01059071|450038504|FG000|Overall Study|Physician Decision|0|||
125113182|NCT01059071|450038505|FG001|Overall Study|Physician Decision|0|||
125113183|NCT01059071|450038506|FG002|Overall Study|Physician Decision|0|||
125113184|NCT01059071|450038507|FG003|Overall Study|Physician Decision|1|||
125113185|NCT03763331|450038508|FG000|Overall Study|Lost to Follow-up|1|||
125113186|NCT03763331|450038509|FG001|Overall Study|Lost to Follow-up|0|||
125113187|NCT03763331|450038508|FG000|Overall Study|Withdrawal by Subject|1|||
125113188|NCT03763331|450038509|FG001|Overall Study|Withdrawal by Subject|0|||
125113189|NCT03763331|450038508|FG000|Overall Study|Non-compliance|0|||
125113190|NCT03763331|450038509|FG001|Overall Study|Non-compliance|3|||
125113191|NCT00936884|450038510|FG000|Double-blind|Withdrawal by Subject|6|||
125113192|NCT00936884|450038511|FG001|Double-blind|Withdrawal by Subject|4|||
125113193|NCT00936884|450038512|FG002|Double-blind|Withdrawal by Subject|0|||
125113194|NCT00936884|450038510|FG000|Double-blind|Death|2|||
125113195|NCT00936884|450038511|FG001|Double-blind|Death|1|||
125113196|NCT00936884|450038512|FG002|Double-blind|Death|0|||
125113197|NCT00936884|450038510|FG000|Double-blind|Lack of Efficacy|1|||
125113198|NCT00936884|450038511|FG001|Double-blind|Lack of Efficacy|1|||
125113199|NCT00936884|450038512|FG002|Double-blind|Lack of Efficacy|0|||
125113200|NCT00936884|450038510|FG000|Double-blind|Adverse Event|1|||
125113201|NCT00936884|450038511|FG001|Double-blind|Adverse Event|0|||
125113202|NCT00936884|450038512|FG002|Double-blind|Adverse Event|0|||
125113203|NCT00936884|450038510|FG000|Double-blind|Physician Decision|1|||
125113204|NCT00936884|450038511|FG001|Double-blind|Physician Decision|0|||
125113205|NCT00936884|450038512|FG002|Double-blind|Physician Decision|0|||
125113206|NCT00936884|450038510|FG000|Double-blind|No post baseline diary entry|1|||
125113207|NCT00936884|450038511|FG001|Double-blind|No post baseline diary entry|0|||
125113208|NCT00936884|450038512|FG002|Double-blind|No post baseline diary entry|0|||
125113209|NCT00936884|450038510|FG000|Double-blind|Did not receive study drug|0|||
125113210|NCT00936884|450038511|FG001|Double-blind|Did not receive study drug|1|||
125113211|NCT00936884|450038512|FG002|Double-blind|Did not receive study drug|0|||
125113212|NCT04741503|450038513|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
125113213|NCT04741503|450038514|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
125113214|NCT04741503|450038515|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
125113215|NCT04741503|450038513|FG000|Initial Enrollment|Overquotas removed|0|||
125113216|NCT04741503|450038514|FG001|Initial Enrollment|Overquotas removed|0|||
125113217|NCT04741503|450038515|FG002|Initial Enrollment|Overquotas removed|186|||
125113218|NCT04741503|450038513|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
125113219|NCT04741503|450038514|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
125113220|NCT04741503|450038515|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
125113221|NCT02280421|450038516|FG000|Washout (2 Weeks)|Adverse Event|0|||
125113222|NCT02280421|450038517|FG001|Washout (2 Weeks)|Adverse Event|1|||
125113223|NCT02280421|450038516|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
125113224|NCT02280421|450038517|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
125113225|NCT01859390|450038524|FG000|Overall Study|Insufficient Sputum Collected|1|||
125113226|NCT01859390|450038525|FG001|Overall Study|Insufficient Sputum Collected|3|||
125113227|NCT01859390|450038524|FG000|Overall Study|Sample Missing Collection Date|0|||
125113228|NCT01859390|450038525|FG001|Overall Study|Sample Missing Collection Date|1|||
125113229|NCT01859390|450038524|FG000|Overall Study|Tube Cracked|0|||
125113230|NCT01859390|450038525|FG001|Overall Study|Tube Cracked|2|||
125113231|NCT01859390|450038524|FG000|Overall Study|Shipment Error|0|||
125113232|NCT01859390|450038525|FG001|Overall Study|Shipment Error|1|||
125113233|NCT02965820|450038533|FG000|Period 2, Second 30 Days|Adverse Event|1|||
125113234|NCT02965820|450038534|FG001|Period 2, Second 30 Days|Adverse Event|1|||
125113235|NCT01967888|450038535|FG000|Overall Study|Lost to Follow-up|6|||
125113236|NCT01967888|450038536|FG001|Overall Study|Lost to Follow-up|4|||
125113237|NCT01967888|450038535|FG000|Overall Study|Withdrawal by Subject|1|||
125113238|NCT01967888|450038536|FG001|Overall Study|Withdrawal by Subject|1|||
125113239|NCT01967888|450038535|FG000|Overall Study|Did Not Have Transplant|1|||
125113240|NCT01967888|450038536|FG001|Overall Study|Did Not Have Transplant|0|||
125113241|NCT01967888|450038535|FG000|Overall Study|Research visit not done, data recorded|1|||
125113242|NCT01967888|450038536|FG001|Overall Study|Research visit not done, data recorded|0|||
125113243|NCT01967888|450038535|FG000|Overall Study|Subject excluded after randomization|1|||
125113244|NCT01967888|450038536|FG001|Overall Study|Subject excluded after randomization|0|||
125113245|NCT01967888|450038535|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
125113246|NCT01967888|450038536|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
125113247|NCT01967888|450038535|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
125113248|NCT01967888|450038536|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
125113249|NCT00553540|450038539|FG000|Overall Study|discharged after first visit|2|||
125113250|NCT00553540|450038540|FG001|Overall Study|discharged after first visit|5|||
125113251|NCT02622074|450038541|FG000|Overall Study|Death|4|||
125113252|NCT02622074|450038542|FG001|Overall Study|Death|0|||
125113253|NCT02622074|450038543|FG002|Overall Study|Death|0|||
125113254|NCT02622074|450038544|FG003|Overall Study|Death|1|||
125113255|NCT02622074|450038545|FG004|Overall Study|Death|1|||
124900891|NCT01235949|449261445|FG014|Primary Phase|Migrated/moved from study area|0|||
124900892|NCT01235949|449261446|FG015|Primary Phase|Migrated/moved from study area|0|||
124900893|NCT01235949|449261447|FG016|Primary Phase|Migrated/moved from study area|0|||
124900894|NCT01235949|449261448|FG017|Primary Phase|Migrated/moved from study area|0|||
124900895|NCT01235949|449261431|FG000|Primary Phase|Adverse Event|0|||
124900896|NCT01235949|449261432|FG001|Primary Phase|Adverse Event|0|||
125113256|NCT02622074|450038546|FG005|Overall Study|Death|0|||
125113257|NCT02622074|450038541|FG000|Overall Study|Withdrawal by Subject|0|||
124900897|NCT01235949|449261433|FG002|Primary Phase|Adverse Event|0|||
124900898|NCT01235949|449261434|FG003|Primary Phase|Adverse Event|1|||
124900899|NCT01235949|449261435|FG004|Primary Phase|Adverse Event|0|||
124900900|NCT01235949|449261436|FG005|Primary Phase|Adverse Event|0|||
124900901|NCT01235949|449261437|FG006|Primary Phase|Adverse Event|0|||
124900902|NCT01235949|449261438|FG007|Primary Phase|Adverse Event|0|||
124900903|NCT01235949|449261439|FG008|Primary Phase|Adverse Event|0|||
125113258|NCT02622074|450038542|FG001|Overall Study|Withdrawal by Subject|1|||
125113259|NCT02622074|450038543|FG002|Overall Study|Withdrawal by Subject|0|||
125113260|NCT02622074|450038544|FG003|Overall Study|Withdrawal by Subject|0|||
125113261|NCT02622074|450038545|FG004|Overall Study|Withdrawal by Subject|0|||
125113262|NCT02622074|450038546|FG005|Overall Study|Withdrawal by Subject|0|||
125113263|NCT02114931|450038547|FG000|Overall Study|Withdrawal by Subject|15|||
125113264|NCT02114931|450038548|FG001|Overall Study|Withdrawal by Subject|18|||
125113265|NCT02114931|450038547|FG000|Overall Study|Adverse Event|4|||
125113266|NCT02114931|450038548|FG001|Overall Study|Adverse Event|6|||
125113267|NCT02114931|450038547|FG000|Overall Study|Lost to Follow-up|3|||
125113268|NCT02114931|450038548|FG001|Overall Study|Lost to Follow-up|3|||
125113269|NCT02114931|450038547|FG000|Overall Study|Physician Decision|1|||
125113270|NCT02114931|450038548|FG001|Overall Study|Physician Decision|2|||
125113271|NCT02114931|450038547|FG000|Overall Study|Other|2|||
125113272|NCT02114931|450038548|FG001|Overall Study|Other|1|||
125113273|NCT03870997|450038550|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
125113274|NCT03870997|450038551|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
124900904|NCT01235949|449261440|FG009|Primary Phase|Adverse Event|0|||
124900905|NCT01235949|449261441|FG010|Primary Phase|Adverse Event|0|||
124900906|NCT01235949|449261442|FG011|Primary Phase|Adverse Event|0|||
124900907|NCT01235949|449261443|FG012|Primary Phase|Adverse Event|0|||
124900908|NCT01235949|449261444|FG013|Primary Phase|Adverse Event|0|||
124900909|NCT01235949|449261445|FG014|Primary Phase|Adverse Event|0|||
124900910|NCT01235949|449261446|FG015|Primary Phase|Adverse Event|0|||
125113275|NCT03870997|450038552|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
125113276|NCT03870997|450038553|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
125113277|NCT03870997|450038554|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
125113278|NCT03870997|450038555|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
125113279|NCT03565211|450038556|FG000|Overall Study|Withdrawal by Subject|2|||
125113280|NCT03565211|450038556|FG000|Overall Study|Lost to Follow-up|1|||
125113281|NCT03565211|450038556|FG000|Overall Study|Adverse Event|44|||
125113282|NCT03565211|450038556|FG000|Overall Study|Personal issues|1|||
125113283|NCT01894984|450038560|FG000|Overall Study|Other|314|||
125113284|NCT01894984|450038561|FG001|Overall Study|Other|175|||
125113285|NCT03840135|450038563|FG000|Overall Study|Protocol Violation|6|||
125113286|NCT03840135|450038564|FG001|Overall Study|Protocol Violation|1|||
125113287|NCT03840135|450038563|FG000|Overall Study|Withdrawal by Subject|1|||
125113288|NCT03840135|450038564|FG001|Overall Study|Withdrawal by Subject|0|||
124900911|NCT01235949|449261447|FG016|Primary Phase|Adverse Event|0|||
125113289|NCT00667719|450038565|FG000|Overall Study|Adverse Event|39|||
125113290|NCT00667719|450038565|FG000|Overall Study|Abnormal Test Procedure|1|||
125113291|NCT00667719|450038565|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
125113292|NCT00667719|450038565|FG000|Overall Study|Protocol Violation|3|||
125113293|NCT00667719|450038565|FG000|Overall Study|Withdrawal by Subject|17|||
125113294|NCT00667719|450038565|FG000|Overall Study|Lost to Follow-up|8|||
125113295|NCT01827371|450038567|FG000|Overall Study|Adverse Event|0|||
125113296|NCT01827371|450038568|FG001|Overall Study|Adverse Event|0|||
124900912|NCT01235949|449261448|FG017|Primary Phase|Adverse Event|0|||
124900913|NCT01235949|449261431|FG000|Primary Phase|Withdrawal by Subject|3|||
125113297|NCT01827371|450038569|FG002|Overall Study|Adverse Event|4|||
125113298|NCT01827371|450038570|FG003|Overall Study|Adverse Event|2|||
125113299|NCT01827371|450038567|FG000|Overall Study|Lost to Follow-up|0|||
125113300|NCT01827371|450038568|FG001|Overall Study|Lost to Follow-up|2|||
124900914|NCT01235949|449261432|FG001|Primary Phase|Withdrawal by Subject|2|||
124900915|NCT01235949|449261433|FG002|Primary Phase|Withdrawal by Subject|2|||
124900916|NCT01235949|449261434|FG003|Primary Phase|Withdrawal by Subject|0|||
124900917|NCT01235949|449261435|FG004|Primary Phase|Withdrawal by Subject|0|||
125113301|NCT01827371|450038569|FG002|Overall Study|Lost to Follow-up|0|||
125113302|NCT01827371|450038570|FG003|Overall Study|Lost to Follow-up|4|||
124900918|NCT01235949|449261436|FG005|Primary Phase|Withdrawal by Subject|3|||
124900919|NCT01235949|449261437|FG006|Primary Phase|Withdrawal by Subject|0|||
124900920|NCT01235949|449261438|FG007|Primary Phase|Withdrawal by Subject|0|||
124900921|NCT01235949|449261439|FG008|Primary Phase|Withdrawal by Subject|0|||
124900922|NCT01235949|449261440|FG009|Primary Phase|Withdrawal by Subject|0|||
124900923|NCT01235949|449261441|FG010|Primary Phase|Withdrawal by Subject|0|||
124900924|NCT01235949|449261442|FG011|Primary Phase|Withdrawal by Subject|0|||
124900925|NCT01235949|449261443|FG012|Primary Phase|Withdrawal by Subject|0|||
124900926|NCT01235949|449261444|FG013|Primary Phase|Withdrawal by Subject|0|||
124900927|NCT01235949|449261445|FG014|Primary Phase|Withdrawal by Subject|0|||
124900928|NCT01235949|449261446|FG015|Primary Phase|Withdrawal by Subject|0|||
124900929|NCT01235949|449261447|FG016|Primary Phase|Withdrawal by Subject|0|||
124900930|NCT01235949|449261448|FG017|Primary Phase|Withdrawal by Subject|0|||
124900931|NCT01235949|449261431|FG000|Primary Phase|Lost to Follow-up|0|||
124900932|NCT01235949|449261432|FG001|Primary Phase|Lost to Follow-up|0|||
124900933|NCT01235949|449261433|FG002|Primary Phase|Lost to Follow-up|1|||
124900934|NCT01235949|449261434|FG003|Primary Phase|Lost to Follow-up|1|||
124900935|NCT01235949|449261435|FG004|Primary Phase|Lost to Follow-up|0|||
124900936|NCT01235949|449261436|FG005|Primary Phase|Lost to Follow-up|2|||
124900937|NCT01235949|449261437|FG006|Primary Phase|Lost to Follow-up|0|||
124900938|NCT01235949|449261438|FG007|Primary Phase|Lost to Follow-up|0|||
124900939|NCT01235949|449261439|FG008|Primary Phase|Lost to Follow-up|0|||
124900940|NCT01235949|449261440|FG009|Primary Phase|Lost to Follow-up|0|||
124900941|NCT01235949|449261441|FG010|Primary Phase|Lost to Follow-up|0|||
124900942|NCT01235949|449261442|FG011|Primary Phase|Lost to Follow-up|0|||
124900943|NCT01235949|449261443|FG012|Primary Phase|Lost to Follow-up|0|||
124900944|NCT01235949|449261444|FG013|Primary Phase|Lost to Follow-up|0|||
124900945|NCT01235949|449261445|FG014|Primary Phase|Lost to Follow-up|0|||
124900946|NCT01235949|449261446|FG015|Primary Phase|Lost to Follow-up|0|||
124900947|NCT01235949|449261447|FG016|Primary Phase|Lost to Follow-up|0|||
124900948|NCT01235949|449261448|FG017|Primary Phase|Lost to Follow-up|0|||
124900949|NCT01235949|449261431|FG000|Booster Phase|Migrated/moved from study area|0|||
124900950|NCT01235949|449261432|FG001|Booster Phase|Migrated/moved from study area|0|||
124900951|NCT01235949|449261433|FG002|Booster Phase|Migrated/moved from study area|0|||
124900952|NCT01235949|449261434|FG003|Booster Phase|Migrated/moved from study area|0|||
124900953|NCT01235949|449261435|FG004|Booster Phase|Migrated/moved from study area|0|||
124900954|NCT01235949|449261436|FG005|Booster Phase|Migrated/moved from study area|0|||
124900955|NCT01235949|449261437|FG006|Booster Phase|Migrated/moved from study area|0|||
124900956|NCT01235949|449261438|FG007|Booster Phase|Migrated/moved from study area|0|||
124900957|NCT01235949|449261439|FG008|Booster Phase|Migrated/moved from study area|0|||
124900958|NCT01235949|449261440|FG009|Booster Phase|Migrated/moved from study area|0|||
124900959|NCT01235949|449261441|FG010|Booster Phase|Migrated/moved from study area|0|||
124900960|NCT01235949|449261442|FG011|Booster Phase|Migrated/moved from study area|1|||
124900961|NCT01235949|449261443|FG012|Booster Phase|Migrated/moved from study area|1|||
124900962|NCT01235949|449261444|FG013|Booster Phase|Migrated/moved from study area|0|||
124900963|NCT01235949|449261445|FG014|Booster Phase|Migrated/moved from study area|0|||
124900964|NCT01235949|449261446|FG015|Booster Phase|Migrated/moved from study area|0|||
124900965|NCT01235949|449261447|FG016|Booster Phase|Migrated/moved from study area|0|||
124900966|NCT01235949|449261448|FG017|Booster Phase|Migrated/moved from study area|1|||
124900967|NCT01235949|449261431|FG000|Booster Phase|Adverse Event|0|||
124900968|NCT01235949|449261432|FG001|Booster Phase|Adverse Event|0|||
124900969|NCT01235949|449261433|FG002|Booster Phase|Adverse Event|0|||
124900970|NCT01235949|449261434|FG003|Booster Phase|Adverse Event|0|||
124900971|NCT01235949|449261435|FG004|Booster Phase|Adverse Event|0|||
124900972|NCT01235949|449261436|FG005|Booster Phase|Adverse Event|0|||
124900973|NCT01235949|449261437|FG006|Booster Phase|Adverse Event|0|||
124900974|NCT01235949|449261438|FG007|Booster Phase|Adverse Event|0|||
124900975|NCT01235949|449261439|FG008|Booster Phase|Adverse Event|0|||
124900976|NCT01235949|449261440|FG009|Booster Phase|Adverse Event|0|||
124900977|NCT01235949|449261441|FG010|Booster Phase|Adverse Event|0|||
124900978|NCT01235949|449261442|FG011|Booster Phase|Adverse Event|0|||
124900979|NCT01235949|449261443|FG012|Booster Phase|Adverse Event|0|||
124900980|NCT01235949|449261444|FG013|Booster Phase|Adverse Event|0|||
124900981|NCT01235949|449261445|FG014|Booster Phase|Adverse Event|0|||
124900982|NCT01235949|449261446|FG015|Booster Phase|Adverse Event|1|||
124900983|NCT01235949|449261447|FG016|Booster Phase|Adverse Event|0|||
124900984|NCT01235949|449261448|FG017|Booster Phase|Adverse Event|0|||
124900985|NCT01235949|449261431|FG000|Booster Phase|Withdrawal by Subject|0|||
124900986|NCT01235949|449261432|FG001|Booster Phase|Withdrawal by Subject|0|||
124900987|NCT01235949|449261433|FG002|Booster Phase|Withdrawal by Subject|0|||
124900988|NCT01235949|449261434|FG003|Booster Phase|Withdrawal by Subject|0|||
124900989|NCT01235949|449261435|FG004|Booster Phase|Withdrawal by Subject|0|||
124900990|NCT01235949|449261436|FG005|Booster Phase|Withdrawal by Subject|0|||
124900991|NCT01235949|449261437|FG006|Booster Phase|Withdrawal by Subject|0|||
124900992|NCT01235949|449261438|FG007|Booster Phase|Withdrawal by Subject|1|||
124900993|NCT01235949|449261439|FG008|Booster Phase|Withdrawal by Subject|1|||
125113303|NCT01827371|450038567|FG000|Overall Study|Protocol Violation|1|||
124900994|NCT01235949|449261440|FG009|Booster Phase|Withdrawal by Subject|0|||
124900995|NCT01235949|449261441|FG010|Booster Phase|Withdrawal by Subject|1|||
124900996|NCT01235949|449261442|FG011|Booster Phase|Withdrawal by Subject|1|||
124900997|NCT01235949|449261443|FG012|Booster Phase|Withdrawal by Subject|2|||
124900998|NCT01235949|449261444|FG013|Booster Phase|Withdrawal by Subject|0|||
124900999|NCT01235949|449261445|FG014|Booster Phase|Withdrawal by Subject|2|||
124901000|NCT01235949|449261446|FG015|Booster Phase|Withdrawal by Subject|0|||
124901001|NCT01235949|449261447|FG016|Booster Phase|Withdrawal by Subject|0|||
124901002|NCT01235949|449261448|FG017|Booster Phase|Withdrawal by Subject|0|||
124901003|NCT01235949|449261431|FG000|Booster Phase|Lost to Follow-up|0|||
124901004|NCT01235949|449261432|FG001|Booster Phase|Lost to Follow-up|0|||
124901005|NCT01235949|449261433|FG002|Booster Phase|Lost to Follow-up|0|||
124901006|NCT01235949|449261434|FG003|Booster Phase|Lost to Follow-up|0|||
124901007|NCT01235949|449261435|FG004|Booster Phase|Lost to Follow-up|0|||
124901008|NCT01235949|449261436|FG005|Booster Phase|Lost to Follow-up|0|||
124901009|NCT01235949|449261437|FG006|Booster Phase|Lost to Follow-up|0|||
124901010|NCT01235949|449261438|FG007|Booster Phase|Lost to Follow-up|0|||
124901011|NCT01235949|449261439|FG008|Booster Phase|Lost to Follow-up|1|||
124901012|NCT01235949|449261440|FG009|Booster Phase|Lost to Follow-up|1|||
124901013|NCT01235949|449261441|FG010|Booster Phase|Lost to Follow-up|1|||
124901014|NCT01235949|449261442|FG011|Booster Phase|Lost to Follow-up|1|||
124901015|NCT01235949|449261443|FG012|Booster Phase|Lost to Follow-up|0|||
124901016|NCT01235949|449261444|FG013|Booster Phase|Lost to Follow-up|0|||
124901017|NCT01235949|449261445|FG014|Booster Phase|Lost to Follow-up|0|||
124901018|NCT01235949|449261446|FG015|Booster Phase|Lost to Follow-up|0|||
124901019|NCT01235949|449261447|FG016|Booster Phase|Lost to Follow-up|0|||
124901020|NCT01235949|449261448|FG017|Booster Phase|Lost to Follow-up|1|||
124901021|NCT04173572|449261449|FG000|Overall Study|Withdrawal by Subject|1|||
124901022|NCT04173572|449261450|FG001|Overall Study|Withdrawal by Subject|5|||
124901023|NCT04173572|449261449|FG000|Overall Study|Lost to Follow-up|3|||
124901024|NCT04173572|449261450|FG001|Overall Study|Lost to Follow-up|1|||
124901025|NCT01839877|449261451|FG000|Overall Study|Protocol Violation|1|||
124901026|NCT04536077|449261455|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
124901027|NCT04536077|449261456|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
124901028|NCT04536077|449261455|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
124901029|NCT04536077|449261456|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
124901030|NCT05484726|449261457|FG000|Overall Study|Protocol Violation|3|||
124901031|NCT05484726|449261458|FG001|Overall Study|Protocol Violation|3|||
124901032|NCT05484726|449261457|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
124901033|NCT05484726|449261458|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
124901034|NCT05484726|449261457|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
124901035|NCT05484726|449261458|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
124901036|NCT05484726|449261457|FG000|Overall Study|continued need of mechanical ventilation|2|||
124901037|NCT05484726|449261458|FG001|Overall Study|continued need of mechanical ventilation|3|||
124901038|NCT05484726|449261457|FG000|Overall Study|Withdrawal by Subject|2|||
124901039|NCT05484726|449261458|FG001|Overall Study|Withdrawal by Subject|3|||
124901040|NCT05484726|449261457|FG000|Overall Study|IVH (G III & IV)|2|||
124901041|NCT05484726|449261458|FG001|Overall Study|IVH (G III & IV)|1|||
124901042|NCT05484726|449261457|FG000|Overall Study|NEC (stage II & III)|2|||
124901043|NCT05484726|449261458|FG001|Overall Study|NEC (stage II & III)|3|||
124901044|NCT02824432|449261459|FG000|Overall Study|Major Protocol Deviation|1|||
124901045|NCT02824432|449261460|FG001|Overall Study|Major Protocol Deviation|0|||
125021059|NCT03742037|449700899|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
124901046|NCT00554801|449261461|FG000|Overall Study|left area before completion|5|||
124901047|NCT00554801|449261462|FG001|Overall Study|left area before completion|0|||
124901048|NCT00554801|449261461|FG000|Overall Study|Withdrawal by Subject|14|||
124901049|NCT00554801|449261462|FG001|Overall Study|Withdrawal by Subject|0|||
124901050|NCT04436120|449261463|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
124901051|NCT04436120|449261464|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
124901052|NCT04436120|449261465|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
124901053|NCT04436120|449261466|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
124901054|NCT04436120|449261467|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
124901055|NCT04436120|449261468|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
124901056|NCT04436120|449261469|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
124901057|NCT01838551|449261475|FG000|Overall Study|Adverse Event|16|||
124901058|NCT01838551|449261475|FG000|Overall Study|Death|1|||
124901059|NCT01838551|449261475|FG000|Overall Study|Lack of Efficacy|10|||
124901060|NCT01838551|449261475|FG000|Overall Study|Physician Decision|4|||
124901061|NCT01838551|449261475|FG000|Overall Study|Withdrawal by Subject|10|||
124901062|NCT01838551|449261475|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
124901063|NCT01981356|449261476|FG000|Overall Study|Lost to Follow-up|4|||
124901064|NCT01981356|449261477|FG001|Overall Study|Lost to Follow-up|1|||
124901065|NCT01981356|449261476|FG000|Overall Study|Withdrawal by Subject|1|||
124901066|NCT01981356|449261477|FG001|Overall Study|Withdrawal by Subject|1|||
124901067|NCT01981356|449261476|FG000|Overall Study|Protocol Violation|2|||
124901068|NCT01981356|449261477|FG001|Overall Study|Protocol Violation|0|||
124901069|NCT02486588|449261478|FG000|Overall Study|Randomized in error- ineligible|738|||
124901070|NCT02486588|449261479|FG001|Overall Study|Randomized in error- ineligible|750|||
124901071|NCT02486588|449261480|FG002|Overall Study|Randomized in error- ineligible|755|||
124901072|NCT02486588|449261481|FG003|Overall Study|Randomized in error- ineligible|738|||
124901073|NCT02486588|449261482|FG004|Overall Study|Randomized in error- ineligible|746|||
124901074|NCT02486588|449261483|FG005|Overall Study|Randomized in error- ineligible|746|||
124901075|NCT03354390|449261484|FG000|Level 1|Death|2|||
124901076|NCT03354390|449261485|FG001|Level 1|Death|0|||
124901077|NCT03354390|449261486|FG002|Level 1|Death|0|||
124901078|NCT03354390|449261487|FG003|Level 1|Death|0|||
124901079|NCT03354390|449261484|FG000|Level 1|Physician Decision|1|||
124901080|NCT03354390|449261485|FG001|Level 1|Physician Decision|0|||
124901081|NCT03354390|449261486|FG002|Level 1|Physician Decision|0|||
124901082|NCT03354390|449261487|FG003|Level 1|Physician Decision|0|||
124901083|NCT03354390|449261484|FG000|Level 2|Physician Decision|0|||
124901084|NCT03354390|449261485|FG001|Level 2|Physician Decision|2|||
124901085|NCT03354390|449261486|FG002|Level 2|Physician Decision|0|||
124901086|NCT03354390|449261487|FG003|Level 2|Physician Decision|0|||
124901087|NCT03354390|449261484|FG000|Level 2|Lack of Efficacy|0|||
124901088|NCT03354390|449261485|FG001|Level 2|Lack of Efficacy|1|||
124901089|NCT03354390|449261486|FG002|Level 2|Lack of Efficacy|0|||
124901090|NCT03354390|449261487|FG003|Level 2|Lack of Efficacy|0|||
124901091|NCT03354390|449261484|FG000|Level 2|Lost to Follow-up|0|||
124901092|NCT03354390|449261485|FG001|Level 2|Lost to Follow-up|1|||
124901093|NCT03354390|449261486|FG002|Level 2|Lost to Follow-up|0|||
124901094|NCT03354390|449261487|FG003|Level 2|Lost to Follow-up|0|||
124901095|NCT03354390|449261484|FG000|Level 3|Death|0|||
124901096|NCT03354390|449261485|FG001|Level 3|Death|0|||
124901097|NCT03354390|449261486|FG002|Level 3|Death|1|||
124901098|NCT03354390|449261487|FG003|Level 3|Death|0|||
124901099|NCT03354390|449261484|FG000|Level 3|Physician Decision|0|||
124901100|NCT03354390|449261485|FG001|Level 3|Physician Decision|0|||
124901101|NCT03354390|449261486|FG002|Level 3|Physician Decision|2|||
124901102|NCT03354390|449261487|FG003|Level 3|Physician Decision|0|||
124901103|NCT03354390|449261484|FG000|Level 4|Death|0|||
124901104|NCT03354390|449261485|FG001|Level 4|Death|0|||
124901105|NCT03354390|449261486|FG002|Level 4|Death|0|||
124901106|NCT03354390|449261487|FG003|Level 4|Death|3|||
124901107|NCT03227757|449263264|FG000|Overall Study|Death|25|||
124901108|NCT03227757|449263264|FG000|Overall Study|Withdrawal|10|||
124901109|NCT03227757|449263264|FG000|Overall Study|Missed visits|1|||
124901110|NCT03227757|449263264|FG000|Overall Study|Lost to Follow-up|2|||
124901111|NCT01875250|449263266|FG000|Overall Study|Adverse Event|2|||
124901112|NCT01875250|449263267|FG001|Overall Study|Adverse Event|0|||
124901113|NCT03068468|449263270|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
124901114|NCT03068468|449263271|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
124901115|NCT03068468|449263272|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
124901116|NCT03068468|449263273|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
124901117|NCT03068468|449263270|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
124901118|NCT03068468|449263271|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
125021060|NCT03742037|449700900|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
124901119|NCT03068468|449263272|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
124901120|NCT03068468|449263273|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
124901121|NCT03068468|449263270|FG000|Placebo-Controlled Period|Adverse Event|16|||
124901122|NCT03068468|449263271|FG001|Placebo-Controlled Period|Adverse Event|21|||
124901123|NCT03068468|449263272|FG002|Placebo-Controlled Period|Adverse Event|0|||
124901124|NCT03068468|449263273|FG003|Placebo-Controlled Period|Adverse Event|0|||
124901125|NCT03068468|449263270|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
124901126|NCT03068468|449263271|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
124901127|NCT03068468|449263272|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
124901128|NCT03068468|449263273|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
124901129|NCT03068468|449263270|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
124901130|NCT03068468|449263271|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
124901131|NCT03068468|449263272|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
124901132|NCT03068468|449263273|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
124901133|NCT03068468|449263270|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
124901134|NCT03068468|449263271|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
124901135|NCT03068468|449263272|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
124901136|NCT03068468|449263273|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
125021061|NCT03742037|449700901|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
125021062|NCT03742037|449700902|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
125021063|NCT03742037|449700903|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
125021064|NCT03742037|449700904|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
125021065|NCT03742037|449700905|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
125021066|NCT03742037|449700899|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
125021067|NCT03742037|449700900|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
125021068|NCT03742037|449700901|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
125021069|NCT03742037|449700902|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
125021070|NCT03742037|449700903|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
125021071|NCT03742037|449700904|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
125021072|NCT03742037|449700905|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
125021073|NCT03742037|449700899|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
125021074|NCT03742037|449700900|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
125021075|NCT03742037|449700901|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
125021076|NCT03742037|449700902|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
125021077|NCT03742037|449700903|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
125021078|NCT03742037|449700904|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
125021079|NCT03742037|449700905|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
125021080|NCT03208231|449700916|FG000|Overall Study|Death|1|||
125021081|NCT03208231|449700917|FG001|Overall Study|Death|2|||
125021082|NCT03208231|449700916|FG000|Overall Study|Moved and unable to get to clinic|1|||
125021083|NCT03208231|449700917|FG001|Overall Study|Moved and unable to get to clinic|0|||
125021084|NCT03208231|449700916|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
125021085|NCT03208231|449700917|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
125021086|NCT04347239|449700931|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
125021087|NCT04347239|449700932|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
125021088|NCT04347239|449700933|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
125021089|NCT04347239|449700931|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
125021090|NCT04347239|449700932|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
125021091|NCT04347239|449700933|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
125021092|NCT02289950|449700935|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
125021093|NCT02289950|449700936|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
125021094|NCT02289950|449700935|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
125021095|NCT02289950|449700936|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
125021096|NCT02289950|449700935|FG000|Overall Study|Lost to Follow-up|1|||
125021097|NCT02289950|449700936|FG001|Overall Study|Lost to Follow-up|0|||
125021098|NCT02289950|449700935|FG000|Overall Study|Physician Decision|9|||
125021099|NCT02289950|449700936|FG001|Overall Study|Physician Decision|3|||
125021100|NCT02289950|449700935|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
125021101|NCT02289950|449700936|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
125021102|NCT02289950|449700935|FG000|Overall Study|Withdrawal by Subject|1|||
125021103|NCT02289950|449700936|FG001|Overall Study|Withdrawal by Subject|3|||
125113304|NCT01827371|450038568|FG001|Overall Study|Protocol Violation|0|||
124901137|NCT03068468|449263270|FG000|Placebo-Controlled Period|Death|0|||
124901138|NCT03068468|449263271|FG001|Placebo-Controlled Period|Death|1|||
124901139|NCT03068468|449263272|FG002|Placebo-Controlled Period|Death|0|||
124901140|NCT03068468|449263273|FG003|Placebo-Controlled Period|Death|0|||
124901141|NCT03068468|449263270|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
124901142|NCT03068468|449263271|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
124901143|NCT03068468|449263272|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
124901144|NCT03068468|449263273|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
124901145|NCT03068468|449263270|FG000|Open-Label Extension Period|Adverse Event|0|||
124901146|NCT03068468|449263271|FG001|Open-Label Extension Period|Adverse Event|0|||
124901147|NCT03068468|449263272|FG002|Open-Label Extension Period|Adverse Event|13|||
124901148|NCT03068468|449263273|FG003|Open-Label Extension Period|Adverse Event|17|||
124901149|NCT03068468|449263270|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
125113305|NCT01827371|450038569|FG002|Overall Study|Protocol Violation|0|||
125113306|NCT01827371|450038570|FG003|Overall Study|Protocol Violation|0|||
125113307|NCT01827371|450038567|FG000|Overall Study|Withdrawal by Subject|1|||
125113308|NCT01827371|450038568|FG001|Overall Study|Withdrawal by Subject|2|||
125113309|NCT01827371|450038569|FG002|Overall Study|Withdrawal by Subject|2|||
124901150|NCT03068468|449263271|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
124901151|NCT03068468|449263272|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
124901152|NCT03068468|449263273|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
124901153|NCT03068468|449263270|FG000|Open-Label Extension Period|Death|0|||
124901154|NCT03068468|449263271|FG001|Open-Label Extension Period|Death|0|||
124901155|NCT03068468|449263272|FG002|Open-Label Extension Period|Death|0|||
124901156|NCT03068468|449263273|FG003|Open-Label Extension Period|Death|1|||
124901157|NCT03068468|449263270|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
124901158|NCT03068468|449263271|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
124901159|NCT03068468|449263272|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
124901160|NCT03068468|449263273|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
124901161|NCT03068468|449263270|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
124901162|NCT03068468|449263271|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
124901163|NCT03068468|449263272|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
124901164|NCT03068468|449263273|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
124901165|NCT03068468|449263270|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
124901166|NCT03068468|449263271|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
124901167|NCT03068468|449263272|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
124901168|NCT03068468|449263273|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
124901169|NCT03068468|449263270|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
124901170|NCT03068468|449263271|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
124901171|NCT03068468|449263272|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
124901172|NCT03068468|449263273|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
124901173|NCT03068468|449263270|FG000|Open-Label Extension Period|Reason not Specified|0|||
124901174|NCT03068468|449263271|FG001|Open-Label Extension Period|Reason not Specified|0|||
125113310|NCT01827371|450038570|FG003|Overall Study|Withdrawal by Subject|3|||
125113311|NCT01827371|450038567|FG000|Overall Study|Physician Decision|0|||
125113312|NCT01827371|450038568|FG001|Overall Study|Physician Decision|1|||
125113313|NCT01827371|450038569|FG002|Overall Study|Physician Decision|0|||
125113314|NCT01827371|450038570|FG003|Overall Study|Physician Decision|1|||
125113315|NCT01827371|450038567|FG000|Overall Study|Temporary study halt to vaccinations|11|||
125113316|NCT01827371|450038568|FG001|Overall Study|Temporary study halt to vaccinations|2|||
125113317|NCT01827371|450038569|FG002|Overall Study|Temporary study halt to vaccinations|5|||
125113318|NCT01827371|450038570|FG003|Overall Study|Temporary study halt to vaccinations|13|||
125113319|NCT01361607|450038572|FG000|Overall Study|Adverse Event|38|||
125113320|NCT01361607|450038573|FG001|Overall Study|Adverse Event|29|||
125113321|NCT01361607|450038572|FG000|Overall Study|Withdrawal by Subject|19|||
125113322|NCT01361607|450038573|FG001|Overall Study|Withdrawal by Subject|8|||
124901175|NCT03068468|449263272|FG002|Open-Label Extension Period|Reason not Specified|1|||
124901176|NCT03068468|449263273|FG003|Open-Label Extension Period|Reason not Specified|4|||
124901177|NCT02466516|449263275|FG000|Overall Study|Adverse Event|1|||
124901178|NCT02466516|449263276|FG001|Overall Study|Adverse Event|1|||
124901179|NCT02466516|449263277|FG002|Overall Study|Adverse Event|0|||
124901180|NCT02466516|449263278|FG003|Overall Study|Adverse Event|0|||
124901181|NCT02466516|449263279|FG004|Overall Study|Adverse Event|0|||
124901182|NCT02466516|449263275|FG000|Overall Study|Withdrew Consent|1|||
124901183|NCT02466516|449263276|FG001|Overall Study|Withdrew Consent|0|||
125113323|NCT01361607|450038572|FG000|Overall Study|Withdrawal by Investigator|5|||
124901184|NCT02466516|449263277|FG002|Overall Study|Withdrew Consent|0|||
124901185|NCT02466516|449263278|FG003|Overall Study|Withdrew Consent|0|||
124901186|NCT02466516|449263279|FG004|Overall Study|Withdrew Consent|0|||
125113324|NCT01361607|450038573|FG001|Overall Study|Withdrawal by Investigator|3|||
124901187|NCT02466516|449263275|FG000|Overall Study|Lost to Follow-up|2|||
124901188|NCT02466516|449263276|FG001|Overall Study|Lost to Follow-up|0|||
124901189|NCT02466516|449263277|FG002|Overall Study|Lost to Follow-up|1|||
124901190|NCT02466516|449263278|FG003|Overall Study|Lost to Follow-up|0|||
124901191|NCT02466516|449263279|FG004|Overall Study|Lost to Follow-up|0|||
124901192|NCT03712930|449263280|FG000|Overall Study|Death|7|||
124901193|NCT03712930|449263280|FG000|Overall Study|Physician Decision|1|||
124901194|NCT03712930|449263280|FG000|Overall Study|Study Terminated by Sponsor|3|||
124901195|NCT03712930|449263280|FG000|Overall Study|Progressive Disease|2|||
124901196|NCT00486759|449263284|FG000|Treatment|Adverse event/intercurrent illness|86|||
124901197|NCT00486759|449263285|FG001|Treatment|Adverse event/intercurrent illness|39|||
124901198|NCT00486759|449263284|FG000|Treatment|Insufficient therapeutic response|37|||
124901199|NCT00486759|449263285|FG001|Treatment|Insufficient therapeutic response|39|||
124901200|NCT00486759|449263284|FG000|Treatment|Death|17|||
124901201|NCT00486759|449263285|FG001|Treatment|Death|10|||
124901202|NCT00486759|449263284|FG000|Treatment|Withdrew consent|15|||
124901203|NCT00486759|449263285|FG001|Treatment|Withdrew consent|12|||
124901204|NCT00486759|449263284|FG000|Treatment|Administrative/reason not specified|17|||
124901205|NCT00486759|449263285|FG001|Treatment|Administrative/reason not specified|21|||
124901206|NCT00486759|449263284|FG000|Treatment|Refused treatment|10|||
124901207|NCT00486759|449263285|FG001|Treatment|Refused treatment|7|||
124901208|NCT00486759|449263284|FG000|Treatment|Violation of selection criteria at entry|3|||
124901209|NCT00486759|449263285|FG001|Treatment|Violation of selection criteria at entry|3|||
124901210|NCT00486759|449263284|FG000|Treatment|Other protocol violation|1|||
124901211|NCT00486759|449263285|FG001|Treatment|Other protocol violation|5|||
124901212|NCT00486759|449263284|FG000|Treatment|Failure to return|1|||
124901213|NCT00486759|449263285|FG001|Treatment|Failure to return|1|||
124901214|NCT00486759|449263284|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
124901215|NCT00486759|449263285|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
124901216|NCT00486759|449263284|FG000|Safety Follow-up|Death|40|||
124901217|NCT00486759|449263285|FG001|Safety Follow-up|Death|29|||
124901218|NCT00486759|449263284|FG000|Safety Follow-up|Withdrew consent|32|||
124901219|NCT00486759|449263285|FG001|Safety Follow-up|Withdrew consent|23|||
124901220|NCT00486759|449263284|FG000|Safety Follow-up|Failure to return|9|||
124901221|NCT00486759|449263285|FG001|Safety Follow-up|Failure to return|6|||
124901222|NCT00486759|449263284|FG000|Safety Follow-up|Administrative/not specified|8|||
124901223|NCT00486759|449263285|FG001|Safety Follow-up|Administrative/not specified|6|||
124901224|NCT00486759|449263284|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
124901225|NCT00486759|449263285|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
124901226|NCT00486759|449263284|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
124901227|NCT00486759|449263285|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
124901228|NCT02001623|449263288|FG000|Overall Study|Disease Progression|2|||
124901229|NCT02001623|449263289|FG001|Overall Study|Disease Progression|2|||
124901230|NCT02001623|449263290|FG002|Overall Study|Disease Progression|3|||
124901231|NCT02001623|449263291|FG003|Overall Study|Disease Progression|2|||
124901232|NCT02001623|449263292|FG004|Overall Study|Disease Progression|3|||
124901233|NCT02001623|449263293|FG005|Overall Study|Disease Progression|2|||
124901234|NCT02001623|449263294|FG006|Overall Study|Disease Progression|3|||
124901235|NCT02001623|449263295|FG007|Overall Study|Disease Progression|3|||
124901236|NCT02001623|449263296|FG008|Overall Study|Disease Progression|7|||
124901237|NCT02001623|449263297|FG009|Overall Study|Disease Progression|40|||
124901238|NCT02001623|449263298|FG010|Overall Study|Disease Progression|5|||
124901239|NCT02001623|449263299|FG011|Overall Study|Disease Progression|9|||
124901240|NCT02001623|449263300|FG012|Overall Study|Disease Progression|9|||
124901241|NCT02001623|449263301|FG013|Overall Study|Disease Progression|20|||
124901242|NCT02001623|449263302|FG014|Overall Study|Disease Progression|9|||
124901243|NCT02001623|449263288|FG000|Overall Study|Physician Decision|0|||
124901244|NCT02001623|449263289|FG001|Overall Study|Physician Decision|0|||
124901245|NCT02001623|449263290|FG002|Overall Study|Physician Decision|0|||
124901246|NCT02001623|449263291|FG003|Overall Study|Physician Decision|0|||
124901247|NCT02001623|449263292|FG004|Overall Study|Physician Decision|0|||
124901248|NCT02001623|449263293|FG005|Overall Study|Physician Decision|0|||
124901249|NCT02001623|449263294|FG006|Overall Study|Physician Decision|0|||
124901250|NCT02001623|449263295|FG007|Overall Study|Physician Decision|0|||
124901251|NCT02001623|449263296|FG008|Overall Study|Physician Decision|3|||
124901252|NCT02001623|449263297|FG009|Overall Study|Physician Decision|2|||
124901253|NCT02001623|449263298|FG010|Overall Study|Physician Decision|3|||
124901254|NCT02001623|449263299|FG011|Overall Study|Physician Decision|3|||
124901255|NCT02001623|449263300|FG012|Overall Study|Physician Decision|1|||
124901256|NCT02001623|449263301|FG013|Overall Study|Physician Decision|2|||
124901257|NCT02001623|449263302|FG014|Overall Study|Physician Decision|1|||
124901258|NCT02001623|449263288|FG000|Overall Study|Death|0|||
124901259|NCT02001623|449263289|FG001|Overall Study|Death|1|||
124901260|NCT02001623|449263290|FG002|Overall Study|Death|0|||
124901261|NCT02001623|449263291|FG003|Overall Study|Death|0|||
124901262|NCT02001623|449263292|FG004|Overall Study|Death|0|||
124901263|NCT02001623|449263293|FG005|Overall Study|Death|0|||
124901264|NCT02001623|449263294|FG006|Overall Study|Death|0|||
124901265|NCT02001623|449263295|FG007|Overall Study|Death|0|||
124901266|NCT02001623|449263296|FG008|Overall Study|Death|0|||
124901267|NCT02001623|449263297|FG009|Overall Study|Death|0|||
124901268|NCT02001623|449263298|FG010|Overall Study|Death|0|||
124901269|NCT02001623|449263299|FG011|Overall Study|Death|0|||
124901270|NCT02001623|449263300|FG012|Overall Study|Death|0|||
125113325|NCT01361607|450038572|FG000|Overall Study|Lost to Follow-up|1|||
125113326|NCT01361607|450038573|FG001|Overall Study|Lost to Follow-up|0|||
124901271|NCT02001623|449263301|FG013|Overall Study|Death|0|||
124901272|NCT02001623|449263302|FG014|Overall Study|Death|0|||
124901273|NCT02001623|449263288|FG000|Overall Study|Adverse Event|0|||
124901274|NCT02001623|449263289|FG001|Overall Study|Adverse Event|0|||
124901275|NCT02001623|449263290|FG002|Overall Study|Adverse Event|0|||
124901276|NCT02001623|449263291|FG003|Overall Study|Adverse Event|0|||
124901277|NCT02001623|449263292|FG004|Overall Study|Adverse Event|0|||
124901278|NCT02001623|449263293|FG005|Overall Study|Adverse Event|1|||
124901279|NCT02001623|449263294|FG006|Overall Study|Adverse Event|0|||
124901280|NCT02001623|449263295|FG007|Overall Study|Adverse Event|3|||
124901281|NCT02001623|449263296|FG008|Overall Study|Adverse Event|4|||
124901282|NCT02001623|449263297|FG009|Overall Study|Adverse Event|6|||
124901283|NCT02001623|449263298|FG010|Overall Study|Adverse Event|4|||
124901284|NCT02001623|449263299|FG011|Overall Study|Adverse Event|0|||
124901285|NCT02001623|449263300|FG012|Overall Study|Adverse Event|3|||
124901286|NCT02001623|449263301|FG013|Overall Study|Adverse Event|5|||
124901287|NCT02001623|449263302|FG014|Overall Study|Adverse Event|6|||
124901288|NCT02001623|449263288|FG000|Overall Study|Other - Miscellaneous|0|||
124901289|NCT02001623|449263289|FG001|Overall Study|Other - Miscellaneous|0|||
124901290|NCT02001623|449263290|FG002|Overall Study|Other - Miscellaneous|0|||
124901291|NCT02001623|449263291|FG003|Overall Study|Other - Miscellaneous|0|||
124901292|NCT02001623|449263292|FG004|Overall Study|Other - Miscellaneous|0|||
124901293|NCT02001623|449263293|FG005|Overall Study|Other - Miscellaneous|0|||
124901294|NCT02001623|449263294|FG006|Overall Study|Other - Miscellaneous|0|||
124901295|NCT02001623|449263295|FG007|Overall Study|Other - Miscellaneous|0|||
124901296|NCT02001623|449263296|FG008|Overall Study|Other - Miscellaneous|0|||
124901297|NCT02001623|449263297|FG009|Overall Study|Other - Miscellaneous|1|||
124901298|NCT02001623|449263298|FG010|Overall Study|Other - Miscellaneous|0|||
124901299|NCT02001623|449263299|FG011|Overall Study|Other - Miscellaneous|0|||
124901300|NCT02001623|449263300|FG012|Overall Study|Other - Miscellaneous|0|||
124901301|NCT02001623|449263301|FG013|Overall Study|Other - Miscellaneous|1|||
124901302|NCT02001623|449263302|FG014|Overall Study|Other - Miscellaneous|0|||
124901303|NCT02001623|449263288|FG000|Overall Study|Withdrawal by Subject|1|||
124901304|NCT02001623|449263289|FG001|Overall Study|Withdrawal by Subject|0|||
124901305|NCT02001623|449263290|FG002|Overall Study|Withdrawal by Subject|0|||
124901306|NCT02001623|449263291|FG003|Overall Study|Withdrawal by Subject|0|||
124901307|NCT02001623|449263292|FG004|Overall Study|Withdrawal by Subject|0|||
124901308|NCT02001623|449263293|FG005|Overall Study|Withdrawal by Subject|0|||
124901309|NCT02001623|449263294|FG006|Overall Study|Withdrawal by Subject|0|||
124901310|NCT02001623|449263295|FG007|Overall Study|Withdrawal by Subject|0|||
124901311|NCT02001623|449263296|FG008|Overall Study|Withdrawal by Subject|1|||
124901312|NCT02001623|449263297|FG009|Overall Study|Withdrawal by Subject|3|||
125113327|NCT01361607|450038572|FG000|Overall Study|Met Withdrawal Criteria|1|||
125113328|NCT01361607|450038573|FG001|Overall Study|Met Withdrawal Criteria|1|||
125113329|NCT01809314|450038574|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
125113330|NCT01809314|450038574|FG000|Overall Study|Adverse Event|6|||
125113331|NCT01809314|450038574|FG000|Overall Study|Insufficient Therapeutic Response|14|||
125113332|NCT01809314|450038574|FG000|Overall Study|Lost to Follow-up|724|||
125113333|NCT01814137|450038575|FG000|Overall Study|Adverse Event|0|||
124901313|NCT02001623|449263298|FG010|Overall Study|Withdrawal by Subject|2|||
124901314|NCT02001623|449263299|FG011|Overall Study|Withdrawal by Subject|2|||
124901315|NCT02001623|449263300|FG012|Overall Study|Withdrawal by Subject|1|||
124901316|NCT02001623|449263301|FG013|Overall Study|Withdrawal by Subject|5|||
124901317|NCT02001623|449263302|FG014|Overall Study|Withdrawal by Subject|2|||
124901318|NCT02001623|449263288|FG000|Overall Study|Lost to Follow-up|0|||
124901319|NCT02001623|449263289|FG001|Overall Study|Lost to Follow-up|0|||
125113334|NCT01814137|450038576|FG001|Overall Study|Adverse Event|1|||
125113335|NCT01814137|450038575|FG000|Overall Study|Withdrawal by Subject|2|||
125113336|NCT01814137|450038576|FG001|Overall Study|Withdrawal by Subject|2|||
124901320|NCT02001623|449263290|FG002|Overall Study|Lost to Follow-up|0|||
124901321|NCT02001623|449263291|FG003|Overall Study|Lost to Follow-up|0|||
124901322|NCT02001623|449263292|FG004|Overall Study|Lost to Follow-up|0|||
124901323|NCT02001623|449263293|FG005|Overall Study|Lost to Follow-up|0|||
124901324|NCT02001623|449263294|FG006|Overall Study|Lost to Follow-up|0|||
124901325|NCT02001623|449263295|FG007|Overall Study|Lost to Follow-up|0|||
124901326|NCT02001623|449263296|FG008|Overall Study|Lost to Follow-up|0|||
124901327|NCT02001623|449263297|FG009|Overall Study|Lost to Follow-up|1|||
124901328|NCT02001623|449263298|FG010|Overall Study|Lost to Follow-up|0|||
124901329|NCT02001623|449263299|FG011|Overall Study|Lost to Follow-up|0|||
124901330|NCT02001623|449263300|FG012|Overall Study|Lost to Follow-up|0|||
124901331|NCT02001623|449263301|FG013|Overall Study|Lost to Follow-up|0|||
124901332|NCT02001623|449263302|FG014|Overall Study|Lost to Follow-up|0|||
124901333|NCT02001623|449263288|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
124901334|NCT02001623|449263289|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
124901335|NCT02001623|449263290|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
124901336|NCT02001623|449263291|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
124901337|NCT02001623|449263292|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
124901338|NCT02001623|449263293|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
124901339|NCT02001623|449263294|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
124901340|NCT02001623|449263295|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
124901341|NCT02001623|449263296|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
124901342|NCT02001623|449263297|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
124901343|NCT02001623|449263298|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
124901344|NCT02001623|449263299|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
124901345|NCT02001623|449263300|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
124901346|NCT02001623|449263301|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
124901347|NCT02001623|449263302|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
124901348|NCT02001623|449263288|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
124901349|NCT02001623|449263289|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
124901350|NCT02001623|449263290|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
124901351|NCT02001623|449263291|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
124901352|NCT02001623|449263292|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
124901353|NCT02001623|449263293|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
124901354|NCT02001623|449263294|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
124901355|NCT02001623|449263295|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
124901356|NCT02001623|449263296|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
124901357|NCT02001623|449263297|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
124901358|NCT02001623|449263298|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
124901359|NCT02001623|449263299|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
124901360|NCT02001623|449263300|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
124901361|NCT02001623|449263301|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
124901362|NCT02001623|449263302|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
125113337|NCT01814137|450038575|FG000|Overall Study|Physician Decision|1|||
125113338|NCT01814137|450038576|FG001|Overall Study|Physician Decision|1|||
125113339|NCT01814137|450038575|FG000|Overall Study|Unclassified|2|||
125113340|NCT01814137|450038576|FG001|Overall Study|Unclassified|1|||
125113341|NCT00219557|450038577|FG000|Phase 1|Lack of Efficacy|3|||
125113342|NCT00219557|450038578|FG001|Phase 1|Lack of Efficacy|0|||
125113343|NCT00219557|450038579|FG002|Phase 1|Lack of Efficacy|0|||
125113344|NCT00219557|450038577|FG000|Phase 1|Adverse Event|2|||
125113345|NCT00219557|450038578|FG001|Phase 1|Adverse Event|0|||
125113346|NCT00219557|450038579|FG002|Phase 1|Adverse Event|0|||
125113347|NCT00219557|450038577|FG000|Phase 1|Withdrawal by Subject|1|||
125113348|NCT00219557|450038578|FG001|Phase 1|Withdrawal by Subject|0|||
125113349|NCT00219557|450038579|FG002|Phase 1|Withdrawal by Subject|0|||
125113350|NCT00219557|450038577|FG000|Phase 1|Started chemotherapy at other institute|1|||
125113351|NCT00219557|450038578|FG001|Phase 1|Started chemotherapy at other institute|0|||
125113352|NCT00219557|450038579|FG002|Phase 1|Started chemotherapy at other institute|0|||
125113353|NCT00219557|450038577|FG000|Phase 2|Lack of Efficacy|0|||
124901363|NCT00686517|449263303|FG000|Treatment|Serious Adverse Event|1|||
124901364|NCT00686517|449263304|FG001|Treatment|Serious Adverse Event|2|||
124901365|NCT00686517|449263305|FG002|Treatment|Serious Adverse Event|1|||
124901366|NCT00686517|449263303|FG000|Treatment|Adverse Event|2|||
124901367|NCT00686517|449263304|FG001|Treatment|Adverse Event|0|||
124901368|NCT00686517|449263305|FG002|Treatment|Adverse Event|0|||
124901369|NCT00686517|449263303|FG000|Treatment|Poor Protocol Compliance|1|||
124901370|NCT00686517|449263304|FG001|Treatment|Poor Protocol Compliance|0|||
124901371|NCT00686517|449263305|FG002|Treatment|Poor Protocol Compliance|0|||
124901372|NCT00686517|449263303|FG000|Treatment|Protocol Violation|2|||
124901373|NCT00686517|449263304|FG001|Treatment|Protocol Violation|1|||
124901374|NCT00686517|449263305|FG002|Treatment|Protocol Violation|0|||
124901375|NCT02281318|449263306|FG000|Overall Study|Adverse Event|2|||
124901376|NCT02281318|449263307|FG001|Overall Study|Adverse Event|2|||
124901377|NCT02281318|449263306|FG000|Overall Study|Lack of Efficacy|2|||
124901378|NCT02281318|449263307|FG001|Overall Study|Lack of Efficacy|0|||
124901379|NCT02281318|449263306|FG000|Overall Study|Lost to Follow-up|2|||
124901380|NCT02281318|449263307|FG001|Overall Study|Lost to Follow-up|1|||
124901381|NCT02281318|449263306|FG000|Overall Study|Physician Decision|2|||
124901382|NCT02281318|449263307|FG001|Overall Study|Physician Decision|0|||
124901383|NCT02281318|449263306|FG000|Overall Study|Withdrawal by Subject|6|||
124901384|NCT02281318|449263307|FG001|Overall Study|Withdrawal by Subject|2|||
124901385|NCT01064817|449263310|FG000|Study Completion|Physician Decision|1|||
124901386|NCT01064817|449263311|FG001|Study Completion|Physician Decision|0|||
124901387|NCT01064817|449263310|FG000|Study Completion|Withdrawal by Subject|1|||
124901388|NCT01064817|449263311|FG001|Study Completion|Withdrawal by Subject|0|||
124901389|NCT03670602|449263322|FG000|Overall Study|Lost to Follow-up|1|||
124901390|NCT03670602|449263323|FG001|Overall Study|Lost to Follow-up|0|||
124901391|NCT03670602|449263322|FG000|Overall Study|Withdrawal by Subject|0|||
124901392|NCT03670602|449263323|FG001|Overall Study|Withdrawal by Subject|3|||
124901393|NCT01456936|449263324|FG000|Overall Study|Other reason|41|||
124901394|NCT01456936|449263325|FG001|Overall Study|Other reason|30|||
124901395|NCT01456936|449263326|FG002|Overall Study|Other reason|36|||
124901396|NCT01456936|449263327|FG003|Overall Study|Other reason|33|||
124901397|NCT01456936|449263324|FG000|Overall Study|No longer meets eligibility criteria|4|||
124901398|NCT01456936|449263325|FG001|Overall Study|No longer meets eligibility criteria|8|||
124901399|NCT01456936|449263326|FG002|Overall Study|No longer meets eligibility criteria|6|||
124901400|NCT01456936|449263327|FG003|Overall Study|No longer meets eligibility criteria|5|||
124901401|NCT01456936|449263324|FG000|Overall Study|Protocol Violation|4|||
124901402|NCT01456936|449263325|FG001|Overall Study|Protocol Violation|2|||
124901403|NCT01456936|449263326|FG002|Overall Study|Protocol Violation|5|||
124901404|NCT01456936|449263327|FG003|Overall Study|Protocol Violation|5|||
124901405|NCT01456936|449263324|FG000|Overall Study|Pregnancy|1|||
124901406|NCT01456936|449263325|FG001|Overall Study|Pregnancy|0|||
124901407|NCT01456936|449263326|FG002|Overall Study|Pregnancy|0|||
124901408|NCT01456936|449263327|FG003|Overall Study|Pregnancy|1|||
124901409|NCT01456936|449263324|FG000|Overall Study|Insufficient clinical response|4|||
124901410|NCT01456936|449263325|FG001|Overall Study|Insufficient clinical response|4|||
125113354|NCT00219557|450038578|FG001|Phase 2|Lack of Efficacy|21|||
125113355|NCT00219557|450038579|FG002|Phase 2|Lack of Efficacy|15|||
125113356|NCT00219557|450038577|FG000|Phase 2|Adverse Event|0|||
125113357|NCT00219557|450038578|FG001|Phase 2|Adverse Event|22|||
125113358|NCT00219557|450038579|FG002|Phase 2|Adverse Event|2|||
125113359|NCT00219557|450038577|FG000|Phase 2|Death|0|||
124901411|NCT01456936|449263326|FG002|Overall Study|Insufficient clinical response|14|||
124901412|NCT01456936|449263327|FG003|Overall Study|Insufficient clinical response|13|||
124901413|NCT01456936|449263324|FG000|Overall Study|No longer willing to participate|195|||
124901414|NCT01456936|449263325|FG001|Overall Study|No longer willing to participate|218|||
124901415|NCT01456936|449263326|FG002|Overall Study|No longer willing to participate|224|||
124901416|NCT01456936|449263327|FG003|Overall Study|No longer willing to participate|248|||
124901417|NCT01456936|449263324|FG000|Overall Study|Lost to Follow-up|135|||
124901418|NCT01456936|449263325|FG001|Overall Study|Lost to Follow-up|126|||
125113360|NCT00219557|450038578|FG001|Phase 2|Death|8|||
125113361|NCT00219557|450038579|FG002|Phase 2|Death|2|||
125113362|NCT00219557|450038577|FG000|Phase 2|Other|0|||
125113363|NCT00219557|450038578|FG001|Phase 2|Other|8|||
125113364|NCT00219557|450038579|FG002|Phase 2|Other|6|||
125113365|NCT00219557|450038577|FG000|Phase 2|Withdrawal by Subject|0|||
125113366|NCT00219557|450038578|FG001|Phase 2|Withdrawal by Subject|9|||
125113367|NCT00219557|450038579|FG002|Phase 2|Withdrawal by Subject|5|||
125113368|NCT00219557|450038577|FG000|Phase 2|Treatment not received|0|||
125113369|NCT00219557|450038578|FG001|Phase 2|Treatment not received|1|||
125113370|NCT00219557|450038579|FG002|Phase 2|Treatment not received|3|||
125113371|NCT01427803|450038584|FG000|Overall Study|Lost to Follow-up|32|||
125113372|NCT01427803|450038585|FG001|Overall Study|Lost to Follow-up|26|||
125113373|NCT01427803|450038584|FG000|Overall Study|Withdrawal by Subject|20|||
125113374|NCT01427803|450038585|FG001|Overall Study|Withdrawal by Subject|0|||
125113375|NCT01427803|450038584|FG000|Overall Study|Unable to complete full treatment period|6|||
124901419|NCT01456936|449263326|FG002|Overall Study|Lost to Follow-up|144|||
124901420|NCT01456936|449263327|FG003|Overall Study|Lost to Follow-up|127|||
124901421|NCT01456936|449263324|FG000|Overall Study|Medication error|0|||
124901422|NCT01456936|449263325|FG001|Overall Study|Medication error|1|||
124901423|NCT01456936|449263326|FG002|Overall Study|Medication error|0|||
124901424|NCT01456936|449263327|FG003|Overall Study|Medication error|1|||
125113376|NCT01427803|450038585|FG001|Overall Study|Unable to complete full treatment period|0|||
125113377|NCT01427803|450038584|FG000|Overall Study|Protocol Violation|1|||
124901425|NCT01456936|449263324|FG000|Overall Study|Adverse event (study drug)|25|||
125113378|NCT01427803|450038585|FG001|Overall Study|Protocol Violation|0|||
125113379|NCT01427803|450038584|FG000|Overall Study|Physician Decision|3|||
124901426|NCT01456936|449263325|FG001|Overall Study|Adverse event (study drug)|21|||
125113380|NCT01427803|450038585|FG001|Overall Study|Physician Decision|0|||
125113381|NCT01427803|450038584|FG000|Overall Study|did not take product|1|||
124901427|NCT01456936|449263326|FG002|Overall Study|Adverse event (study drug)|26|||
124901428|NCT01456936|449263327|FG003|Overall Study|Adverse event (study drug)|17|||
124901429|NCT01456936|449263324|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
124901430|NCT01456936|449263325|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
124901431|NCT01456936|449263326|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
124901432|NCT01456936|449263327|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
124901433|NCT01456936|449263324|FG000|Overall Study|Death|0|||
124901434|NCT01456936|449263325|FG001|Overall Study|Death|3|||
124901435|NCT01456936|449263326|FG002|Overall Study|Death|1|||
124901436|NCT01456936|449263327|FG003|Overall Study|Death|3|||
124901437|NCT01456936|449263324|FG000|Overall Study|Randomized but not treated|21|||
124901438|NCT01456936|449263325|FG001|Overall Study|Randomized but not treated|28|||
124901439|NCT01456936|449263326|FG002|Overall Study|Randomized but not treated|16|||
124901440|NCT01456936|449263327|FG003|Overall Study|Randomized but not treated|21|||
124901441|NCT00543725|449263328|FG000|Overall Study|Adverse Event|18|||
124901442|NCT00543725|449263329|FG001|Overall Study|Adverse Event|27|||
124901443|NCT00543725|449263328|FG000|Overall Study|Sponsor's Decision|0|||
124901444|NCT00543725|449263329|FG001|Overall Study|Sponsor's Decision|1|||
124901445|NCT00543725|449263328|FG000|Overall Study|Subject Non-Compliant|4|||
124901446|NCT00543725|449263329|FG001|Overall Study|Subject Non-Compliant|4|||
124901447|NCT00543725|449263328|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
124901448|NCT00543725|449263329|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
124901449|NCT00543725|449263328|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
124901450|NCT00543725|449263329|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
124901451|NCT00543725|449263328|FG000|Overall Study|Protocol Violation|0|||
124901452|NCT00543725|449263329|FG001|Overall Study|Protocol Violation|1|||
124901453|NCT00543725|449263328|FG000|Overall Study|Withdrawal by Subject|4|||
124901454|NCT00543725|449263329|FG001|Overall Study|Withdrawal by Subject|13|||
124901455|NCT00543725|449263328|FG000|Overall Study|Lost to Follow-up|15|||
124901456|NCT00543725|449263329|FG001|Overall Study|Lost to Follow-up|11|||
124901457|NCT00543725|449263328|FG000|Overall Study|Other|3|||
124901458|NCT00543725|449263329|FG001|Overall Study|Other|3|||
124901459|NCT00906698|449263330|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
124901460|NCT00906698|449263331|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
124901461|NCT00906698|449263332|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
124901462|NCT00906698|449263333|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
124901463|NCT00906698|449263334|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
124901464|NCT00906698|449263335|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
124901465|NCT00906698|449263330|FG000|Overall Study|Adverse Event|0|||
124901466|NCT00906698|449263331|FG001|Overall Study|Adverse Event|0|||
124901467|NCT00906698|449263332|FG002|Overall Study|Adverse Event|2|||
124901468|NCT00906698|449263333|FG003|Overall Study|Adverse Event|0|||
124901469|NCT00906698|449263334|FG004|Overall Study|Adverse Event|4|||
124901470|NCT00906698|449263335|FG005|Overall Study|Adverse Event|1|||
124901471|NCT00906698|449263330|FG000|Overall Study|Disease progression|3|||
124901472|NCT00906698|449263331|FG001|Overall Study|Disease progression|12|||
124901473|NCT00906698|449263332|FG002|Overall Study|Disease progression|4|||
124901474|NCT00906698|449263333|FG003|Overall Study|Disease progression|4|||
124901475|NCT00906698|449263334|FG004|Overall Study|Disease progression|12|||
124901476|NCT00906698|449263335|FG005|Overall Study|Disease progression|4|||
124901477|NCT00906698|449263330|FG000|Overall Study|Withdrawal by Subject|0|||
124901478|NCT00906698|449263331|FG001|Overall Study|Withdrawal by Subject|0|||
124901479|NCT00906698|449263332|FG002|Overall Study|Withdrawal by Subject|0|||
124901480|NCT00906698|449263333|FG003|Overall Study|Withdrawal by Subject|0|||
124901481|NCT00906698|449263334|FG004|Overall Study|Withdrawal by Subject|1|||
124901482|NCT00906698|449263335|FG005|Overall Study|Withdrawal by Subject|0|||
124901483|NCT00906698|449263330|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
124901484|NCT00906698|449263331|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
124901485|NCT00906698|449263332|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
124901486|NCT00906698|449263333|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
124901487|NCT00906698|449263334|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
124901488|NCT00906698|449263335|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
125021104|NCT02289950|449700935|FG000|Overall Study|Test article held for greater than 28 days|0|||
125021105|NCT02289950|449700936|FG001|Overall Study|Test article held for greater than 28 days|1|||
125021106|NCT02289950|449700935|FG000|Overall Study|Adverse Event|11|||
125021107|NCT02289950|449700936|FG001|Overall Study|Adverse Event|3|||
125021108|NCT02289950|449700935|FG000|Overall Study|Death|1|||
125021109|NCT02289950|449700936|FG001|Overall Study|Death|1|||
125021110|NCT02289950|449700935|FG000|Overall Study|Other|5|||
124901489|NCT02846415|449263337|FG000|Overall Study|Lost to Follow-up|2|||
124901490|NCT02846415|449263338|FG001|Overall Study|Lost to Follow-up|0|||
124901491|NCT02846415|449263337|FG000|Overall Study|Withdrawal by Subject|1|||
124901492|NCT02846415|449263338|FG001|Overall Study|Withdrawal by Subject|1|||
124901493|NCT03383887|449263339|FG000|Overall Study|Lost to Follow-up|0|||
124901494|NCT03383887|449263340|FG001|Overall Study|Lost to Follow-up|1|||
125021111|NCT02289950|449700936|FG001|Overall Study|Other|2|||
124901495|NCT02322216|449263342|FG000|Overall Study|Adverse Event|1|||
124901496|NCT02322216|449263343|FG001|Overall Study|Adverse Event|0|||
124901497|NCT02322216|449263342|FG000|Overall Study|Withdrawal by Subject|1|||
124901498|NCT02322216|449263343|FG001|Overall Study|Withdrawal by Subject|4|||
124901499|NCT01585038|449263344|FG000|Overall Study|Adverse Event|2|||
124901500|NCT01585038|449263345|FG001|Overall Study|Adverse Event|2|||
124901501|NCT00754936|449263350|FG000|Overall Study|Lost to Follow-up|3|||
124901502|NCT00754936|449263350|FG000|Overall Study|Physician Decision|1|||
124901503|NCT00754936|449263350|FG000|Overall Study|Withdrawal by Subject|2|||
124901504|NCT00754936|449263350|FG000|Overall Study|Side Effects|3|||
124901505|NCT00754936|449263350|FG000|Overall Study|Inter-current medical events|3|||
124901506|NCT00835380|449263356|FG000|Overall Study|Withdrawal by Subject|2|||
124901507|NCT03247543|449263357|FG000|Overall Study|Adverse Event|3|||
124901508|NCT03247543|449263358|FG001|Overall Study|Adverse Event|6|||
124901509|NCT03247543|449263359|FG002|Overall Study|Adverse Event|4|||
124901510|NCT03247543|449263357|FG000|Overall Study|Lost to Follow-up|10|||
124901511|NCT03247543|449263358|FG001|Overall Study|Lost to Follow-up|7|||
124901512|NCT03247543|449263359|FG002|Overall Study|Lost to Follow-up|8|||
124901513|NCT03247543|449263357|FG000|Overall Study|Consent withdrawn by caregiver|2|||
124901514|NCT03247543|449263358|FG001|Overall Study|Consent withdrawn by caregiver|2|||
124901515|NCT03247543|449263359|FG002|Overall Study|Consent withdrawn by caregiver|9|||
124901516|NCT03247543|449263357|FG000|Overall Study|Withdrawal by Subject|0|||
124901517|NCT03247543|449263358|FG001|Overall Study|Withdrawal by Subject|0|||
124901518|NCT03247543|449263359|FG002|Overall Study|Withdrawal by Subject|1|||
124901519|NCT03247543|449263357|FG000|Overall Study|Failure to Follow study procedures|1|||
124901520|NCT03247543|449263358|FG001|Overall Study|Failure to Follow study procedures|3|||
124901521|NCT03247543|449263359|FG002|Overall Study|Failure to Follow study procedures|1|||
124901522|NCT03247543|449263357|FG000|Overall Study|Lack of Efficacy|1|||
124901523|NCT03247543|449263358|FG001|Overall Study|Lack of Efficacy|0|||
124901524|NCT03247543|449263359|FG002|Overall Study|Lack of Efficacy|0|||
124901525|NCT03247543|449263357|FG000|Overall Study|Non-compliance with study visits|0|||
124901526|NCT03247543|449263358|FG001|Overall Study|Non-compliance with study visits|1|||
124901527|NCT03247543|449263359|FG002|Overall Study|Non-compliance with study visits|0|||
124901528|NCT02059980|449263362|FG000|Overall Study|Lost to Follow-up|2|||
124901529|NCT02059980|449263363|FG001|Overall Study|Lost to Follow-up|1|||
124901530|NCT01104415|449263364|FG000|Core Phase|Consent withdrawn by subjects|1|||
124901531|NCT01104415|449263365|FG001|Core Phase|Consent withdrawn by subjects|0|||
124901532|NCT01104415|449263364|FG000|Extension Period|Progressive disease|0|||
124901533|NCT01104415|449263365|FG001|Extension Period|Progressive disease|4|||
124901534|NCT01104415|449263364|FG000|Extension Period|Death|0|||
124901535|NCT01104415|449263365|FG001|Extension Period|Death|1|||
124901536|NCT01104415|449263364|FG000|Extension Period|Physician Decision|0|||
124901537|NCT01104415|449263365|FG001|Extension Period|Physician Decision|1|||
124901538|NCT01104415|449263364|FG000|Extension Period|Transition to Study LX1606.302|0|||
124901539|NCT01104415|449263365|FG001|Extension Period|Transition to Study LX1606.302|4|||
124901540|NCT01104415|449263364|FG000|Extension Period|Heart surgery/feeling miserable|0|||
124901541|NCT01104415|449263365|FG001|Extension Period|Heart surgery/feeling miserable|1|||
124901542|NCT02341625|449263370|FG000|Overall Study|Disease Progression|2|||
124901543|NCT02341625|449263371|FG001|Overall Study|Disease Progression|2|||
124901544|NCT02341625|449263372|FG002|Overall Study|Disease Progression|3|||
124901545|NCT02341625|449263373|FG003|Overall Study|Disease Progression|6|||
124901546|NCT02341625|449263374|FG004|Overall Study|Disease Progression|7|||
124901547|NCT02341625|449263375|FG005|Overall Study|Disease Progression|7|||
124901548|NCT02341625|449263376|FG006|Overall Study|Disease Progression|28|||
124901549|NCT02341625|449263377|FG007|Overall Study|Disease Progression|5|||
124901550|NCT02341625|449263378|FG008|Overall Study|Disease Progression|4|||
124901551|NCT02341625|449263379|FG009|Overall Study|Disease Progression|19|||
124901552|NCT02341625|449263370|FG000|Overall Study|Study Drug Toxicity|0|||
124901553|NCT02341625|449263371|FG001|Overall Study|Study Drug Toxicity|0|||
124901554|NCT02341625|449263372|FG002|Overall Study|Study Drug Toxicity|0|||
124901555|NCT02341625|449263373|FG003|Overall Study|Study Drug Toxicity|1|||
124901556|NCT02341625|449263374|FG004|Overall Study|Study Drug Toxicity|0|||
124901557|NCT02341625|449263375|FG005|Overall Study|Study Drug Toxicity|3|||
124901558|NCT02341625|449263376|FG006|Overall Study|Study Drug Toxicity|10|||
125113382|NCT01427803|450038585|FG001|Overall Study|did not take product|0|||
124901559|NCT02341625|449263377|FG007|Overall Study|Study Drug Toxicity|0|||
124901560|NCT02341625|449263378|FG008|Overall Study|Study Drug Toxicity|0|||
124901561|NCT02341625|449263379|FG009|Overall Study|Study Drug Toxicity|3|||
124901562|NCT02341625|449263370|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
124901563|NCT02341625|449263371|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
124901564|NCT02341625|449263372|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
124901565|NCT02341625|449263373|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
124901566|NCT02341625|449263374|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
124901567|NCT02341625|449263375|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
124901568|NCT02341625|449263376|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
124901569|NCT02341625|449263377|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
124901570|NCT02341625|449263378|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
124901571|NCT02341625|449263379|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
124901572|NCT02341625|449263370|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
124901573|NCT02341625|449263371|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
124901574|NCT02341625|449263372|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
124901575|NCT02341625|449263373|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
124901576|NCT02341625|449263374|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
124901577|NCT02341625|449263375|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
124901578|NCT02341625|449263376|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
124901579|NCT02341625|449263377|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
124901580|NCT02341625|449263378|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
124901581|NCT02341625|449263379|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
124901582|NCT02341625|449263370|FG000|Overall Study|Participant Withdrew Consent|0|||
124901583|NCT02341625|449263371|FG001|Overall Study|Participant Withdrew Consent|0|||
124901584|NCT02341625|449263372|FG002|Overall Study|Participant Withdrew Consent|0|||
124901585|NCT02341625|449263373|FG003|Overall Study|Participant Withdrew Consent|1|||
124901586|NCT02341625|449263374|FG004|Overall Study|Participant Withdrew Consent|0|||
124901587|NCT02341625|449263375|FG005|Overall Study|Participant Withdrew Consent|0|||
124901588|NCT02341625|449263376|FG006|Overall Study|Participant Withdrew Consent|0|||
124901589|NCT02341625|449263377|FG007|Overall Study|Participant Withdrew Consent|0|||
124901590|NCT02341625|449263378|FG008|Overall Study|Participant Withdrew Consent|0|||
124901591|NCT02341625|449263379|FG009|Overall Study|Participant Withdrew Consent|0|||
124901592|NCT02341625|449263370|FG000|Overall Study|Completed Treatment as per Protocol|0|||
124901593|NCT02341625|449263371|FG001|Overall Study|Completed Treatment as per Protocol|0|||
124901594|NCT02341625|449263372|FG002|Overall Study|Completed Treatment as per Protocol|0|||
124901595|NCT02341625|449263373|FG003|Overall Study|Completed Treatment as per Protocol|0|||
124901596|NCT02341625|449263374|FG004|Overall Study|Completed Treatment as per Protocol|0|||
124901597|NCT02341625|449263375|FG005|Overall Study|Completed Treatment as per Protocol|0|||
124901598|NCT02341625|449263376|FG006|Overall Study|Completed Treatment as per Protocol|0|||
124901599|NCT02341625|449263377|FG007|Overall Study|Completed Treatment as per Protocol|0|||
124901600|NCT02341625|449263378|FG008|Overall Study|Completed Treatment as per Protocol|0|||
124901601|NCT02341625|449263379|FG009|Overall Study|Completed Treatment as per Protocol|1|||
124901602|NCT02341625|449263370|FG000|Overall Study|Other Reasons|0|||
124901603|NCT02341625|449263371|FG001|Overall Study|Other Reasons|0|||
124901604|NCT02341625|449263372|FG002|Overall Study|Other Reasons|0|||
124901605|NCT02341625|449263373|FG003|Overall Study|Other Reasons|0|||
124901606|NCT02341625|449263374|FG004|Overall Study|Other Reasons|1|||
124901607|NCT02341625|449263375|FG005|Overall Study|Other Reasons|0|||
124901608|NCT02341625|449263376|FG006|Overall Study|Other Reasons|5|||
124901609|NCT02341625|449263377|FG007|Overall Study|Other Reasons|0|||
124901610|NCT02341625|449263378|FG008|Overall Study|Other Reasons|0|||
124901611|NCT02341625|449263379|FG009|Overall Study|Other Reasons|2|||
124901612|NCT02341625|449263370|FG000|Overall Study|Not Reported|0|||
124901613|NCT02341625|449263371|FG001|Overall Study|Not Reported|0|||
124901614|NCT02341625|449263372|FG002|Overall Study|Not Reported|0|||
124901615|NCT02341625|449263373|FG003|Overall Study|Not Reported|0|||
124901616|NCT02341625|449263374|FG004|Overall Study|Not Reported|0|||
124901617|NCT02341625|449263375|FG005|Overall Study|Not Reported|0|||
124901618|NCT02341625|449263376|FG006|Overall Study|Not Reported|0|||
124901619|NCT02341625|449263377|FG007|Overall Study|Not Reported|0|||
124901620|NCT02341625|449263378|FG008|Overall Study|Not Reported|0|||
124901621|NCT02341625|449263379|FG009|Overall Study|Not Reported|3|||
124901622|NCT01227707|449263388|FG000|Overall Study|Adverse Event|10|||
124901623|NCT01227707|449263388|FG000|Overall Study|Progression of disease|3|||
125021112|NCT02289950|449700935|FG000|Overall Study|Not Treated|2|||
125021113|NCT02289950|449700936|FG001|Overall Study|Not Treated|1|||
124901624|NCT01227707|449263388|FG000|Overall Study|Withdrawal by Subject|1|||
124901625|NCT01227707|449263388|FG000|Overall Study|Patient non-compliance|3|||
124901626|NCT01227707|449263388|FG000|Overall Study|Medical decision|6|||
124901627|NCT01227707|449263388|FG000|Overall Study|Death|1|||
124901628|NCT02357784|449263393|FG000|Overall Study|Withdrawal by Subject|1|||
124901629|NCT02698241|449263396|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
124901630|NCT02698241|449263396|FG000|Overall Study|Screening not met|7|||
124901631|NCT02698241|449263396|FG000|Overall Study|Withdrawal by Subject|7|||
124901632|NCT02698241|449263396|FG000|Overall Study|Physician Decision|2|||
124901633|NCT02698241|449263396|FG000|Overall Study|Subject underwent system modification|2|||
124901634|NCT02698241|449263396|FG000|Overall Study|Lost to Follow-up|3|||
124901635|NCT02698241|449263396|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
124901636|NCT02698241|449263396|FG000|Overall Study|geographic and licensing issue|1|||
124901637|NCT02698241|449263396|FG000|Overall Study|Death|2|||
124901638|NCT01837641|449263397|FG000|Overall Study|Sponsor decision|1|||
124901639|NCT01837641|449263398|FG001|Overall Study|Sponsor decision|0|||
124901640|NCT01837641|449263399|FG002|Overall Study|Sponsor decision|0|||
124901641|NCT01837641|449263400|FG003|Overall Study|Sponsor decision|0|||
124901642|NCT01837641|449263401|FG004|Overall Study|Sponsor decision|0|||
124901643|NCT01837641|449263402|FG005|Overall Study|Sponsor decision|1|||
124901644|NCT01837641|449263403|FG006|Overall Study|Sponsor decision|0|||
124901645|NCT01837641|449263404|FG007|Overall Study|Sponsor decision|0|||
124901646|NCT01837641|449263397|FG000|Overall Study|Adverse Event|0|||
124901647|NCT01837641|449263398|FG001|Overall Study|Adverse Event|0|||
124901648|NCT01837641|449263399|FG002|Overall Study|Adverse Event|0|||
124901649|NCT01837641|449263400|FG003|Overall Study|Adverse Event|0|||
124901650|NCT01837641|449263401|FG004|Overall Study|Adverse Event|0|||
124901651|NCT01837641|449263402|FG005|Overall Study|Adverse Event|1|||
124901652|NCT01837641|449263403|FG006|Overall Study|Adverse Event|0|||
124901653|NCT01837641|449263404|FG007|Overall Study|Adverse Event|0|||
124901654|NCT01837641|449263397|FG000|Overall Study|Withdrawal by Subject|0|||
124901655|NCT01837641|449263398|FG001|Overall Study|Withdrawal by Subject|0|||
124901656|NCT01837641|449263399|FG002|Overall Study|Withdrawal by Subject|0|||
124901657|NCT01837641|449263400|FG003|Overall Study|Withdrawal by Subject|0|||
124901658|NCT01837641|449263401|FG004|Overall Study|Withdrawal by Subject|1|||
124901659|NCT01837641|449263402|FG005|Overall Study|Withdrawal by Subject|0|||
124901660|NCT01837641|449263403|FG006|Overall Study|Withdrawal by Subject|1|||
124901661|NCT01837641|449263404|FG007|Overall Study|Withdrawal by Subject|0|||
124901662|NCT00906282|449263407|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
124901663|NCT00906282|449263407|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
124901664|NCT00906282|449263407|FG000|Preoperative Chemotherapy|Progressive disease|6|||
124901665|NCT00906282|449263407|FG000|Preoperative Chemotherapy|Toxicity|1|||
124901666|NCT02540213|449263408|FG000|Overall Study|Death/adverse event|18|||
124901667|NCT02540213|449263408|FG000|Overall Study|Administrative reasons|3|||
124901668|NCT02540213|449263408|FG000|Overall Study|Kidney transplant|3|||
124901669|NCT02540213|449263408|FG000|Overall Study|Lack of Efficacy|6|||
124901670|NCT02540213|449263408|FG000|Overall Study|Consent withdrawn|7|||
124901671|NCT02540213|449263408|FG000|Overall Study|Enrolled but not treated|2|||
124901672|NCT02289560|449263409|FG000|Overall Study|Lost to Follow-up|6|||
124901673|NCT02289560|449263409|FG000|Overall Study|Alternative Treatment|4|||
124901674|NCT02289560|449263409|FG000|Overall Study|Inadequate Treatment|2|||
124901675|NCT02289560|449263409|FG000|Overall Study|Withdrawal by Subject|23|||
124901676|NCT00290706|449263412|FG000|Overall Study|Withdrawal by Subject|2|||
124901677|NCT00290706|449263413|FG001|Overall Study|Withdrawal by Subject|0|||
124901678|NCT00290706|449263414|FG002|Overall Study|Withdrawal by Subject|0|||
124901679|NCT00290706|449263415|FG003|Overall Study|Withdrawal by Subject|0|||
124901680|NCT00290706|449263412|FG000|Overall Study|Progressive Disease|3|||
124901681|NCT00290706|449263413|FG001|Overall Study|Progressive Disease|5|||
124901682|NCT00290706|449263414|FG002|Overall Study|Progressive Disease|4|||
124901683|NCT00290706|449263415|FG003|Overall Study|Progressive Disease|10|||
124901684|NCT00290706|449263412|FG000|Overall Study|Adverse Event|0|||
124901685|NCT00290706|449263413|FG001|Overall Study|Adverse Event|1|||
124901686|NCT00290706|449263414|FG002|Overall Study|Adverse Event|2|||
124901687|NCT00290706|449263415|FG003|Overall Study|Adverse Event|0|||
124901688|NCT00290706|449263412|FG000|Overall Study|Receive auto transplant or radiation|0|||
124901689|NCT00290706|449263413|FG001|Overall Study|Receive auto transplant or radiation|0|||
124901690|NCT00290706|449263414|FG002|Overall Study|Receive auto transplant or radiation|0|||
124901691|NCT00290706|449263415|FG003|Overall Study|Receive auto transplant or radiation|1|||
124901692|NCT00290706|449263412|FG000|Overall Study|Physician Decision|0|||
124901693|NCT00290706|449263413|FG001|Overall Study|Physician Decision|0|||
124901694|NCT00290706|449263414|FG002|Overall Study|Physician Decision|0|||
124901695|NCT00290706|449263415|FG003|Overall Study|Physician Decision|1|||
124901696|NCT00605033|449263418|FG000|Overall Study|Adverse Event|2|||
124901697|NCT00605033|449263419|FG001|Overall Study|Adverse Event|2|||
124901698|NCT00605033|449263418|FG000|Overall Study|Lost to Follow-up|1|||
124901699|NCT00605033|449263419|FG001|Overall Study|Lost to Follow-up|1|||
124901700|NCT00605033|449263418|FG000|Overall Study|Withdrawal by Subject|3|||
124901701|NCT00605033|449263419|FG001|Overall Study|Withdrawal by Subject|4|||
124901702|NCT00605033|449263418|FG000|Overall Study|Protocol Violation|1|||
124901703|NCT00605033|449263419|FG001|Overall Study|Protocol Violation|1|||
124901704|NCT03395353|449263420|FG000|Overall Study|Adverse Event|20|||
124901705|NCT03395353|449263420|FG000|Overall Study|Protocol Violation|1|||
124901706|NCT03395353|449263420|FG000|Overall Study|Lack of Efficacy|3|||
124901707|NCT03395353|449263420|FG000|Overall Study|Withdrawal by Subject|24|||
124901708|NCT03395353|449263420|FG000|Overall Study|Discontinued visit|1|||
124901709|NCT03395353|449263420|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
124901710|NCT03395353|449263420|FG000|Overall Study|Physician Decision|4|||
124901711|NCT03395353|449263420|FG000|Overall Study|Early termination of overall study|33|||
124901712|NCT01196429|449263421|FG000|Overall Study|Ineligible - inadequate pathology|1|||
124901713|NCT01196429|449263422|FG001|Overall Study|Ineligible - inadequate pathology|0|||
124901714|NCT01196429|449263421|FG000|Overall Study|Ineligible - wrong cell type|1|||
124901715|NCT01196429|449263422|FG001|Overall Study|Ineligible - wrong cell type|0|||
124901716|NCT01196429|449263421|FG000|Overall Study|Refused - Never Treated|1|||
124901717|NCT01196429|449263422|FG001|Overall Study|Refused - Never Treated|0|||
124901718|NCT01144468|449265125|FG000|Overall Study|Lost to Follow-up|4|||
124901719|NCT01144468|449265126|FG001|Overall Study|Lost to Follow-up|7|||
124901720|NCT01144468|449265125|FG000|Overall Study|Adverse Event|3|||
124901721|NCT01144468|449265126|FG001|Overall Study|Adverse Event|2|||
124901722|NCT01144468|449265125|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
124901723|NCT01144468|449265126|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
124901724|NCT02960659|449265127|FG000|Overall Study|Withdrawal by Subject|1|||
124901725|NCT02960659|449265128|FG001|Overall Study|Withdrawal by Subject|0|||
124901726|NCT02960659|449265127|FG000|Overall Study|Poor compliance|0|||
124901727|NCT02960659|449265128|FG001|Overall Study|Poor compliance|1|||
124901728|NCT03140176|449265134|FG000|Overall Study|Reason missing|23|||
124901729|NCT03140176|449265134|FG000|Overall Study|Death|33|||
124901730|NCT03140176|449265134|FG000|Overall Study|Disease progression|1|||
124901731|NCT03140176|449265134|FG000|Overall Study|Physician Decision|1|||
124901732|NCT03140176|449265134|FG000|Overall Study|Withdrawal by Subject|1|||
124901733|NCT03140176|449265134|FG000|Overall Study|Lost to Follow-up|15|||
124901734|NCT01331824|449265135|FG000|Overall Study|Adverse Event|2|||
125021114|NCT02270242|449700937|FG000|Overall Study|Withdrawal by Subject|18|||
125021115|NCT02270242|449700938|FG001|Overall Study|Withdrawal by Subject|25|||
125021116|NCT02270242|449700937|FG000|Overall Study|Lost to Follow-up|41|||
124901735|NCT01331824|449265135|FG000|Overall Study|Death|1|||
124901736|NCT01331824|449265135|FG000|Overall Study|Disease Progression|9|||
124901737|NCT01331824|449265135|FG000|Overall Study|Withdrawal by Subject|1|||
124901738|NCT00149630|449265136|FG000|Overall Study|Incarceration|2|||
124901739|NCT00149630|449265137|FG001|Overall Study|Incarceration|0|||
124901740|NCT00149630|449265136|FG000|Overall Study|Treatment Programs|4|||
124901741|NCT00149630|449265137|FG001|Overall Study|Treatment Programs|5|||
125021117|NCT02270242|449700938|FG001|Overall Study|Lost to Follow-up|27|||
125021118|NCT02270242|449700937|FG000|Overall Study|Physician Decision|0|||
124901742|NCT00149630|449265136|FG000|Overall Study|Adverse Event|2|||
124901743|NCT00149630|449265137|FG001|Overall Study|Adverse Event|0|||
124901744|NCT05298111|449265142|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
124901745|NCT05298111|449265143|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
124901746|NCT02689349|449265144|FG000|Overall Study|Not implanted|4|||
124901747|NCT02689349|449265145|FG001|Overall Study|Not implanted|0|||
124901748|NCT02689349|449265144|FG000|Overall Study|Withdrawal by Subject|9|||
124901749|NCT02689349|449265145|FG001|Overall Study|Withdrawal by Subject|0|||
124901750|NCT03518112|449265146|FG000|Overall Study|Withdrawal by Subject|1|||
124901751|NCT01185522|449265147|FG000|Overall Study|Lack of Efficacy|28|||
124901752|NCT01185522|449265147|FG000|Overall Study|Lost to Follow-up|19|||
124901753|NCT01185522|449265147|FG000|Overall Study|Withdrawal by Subject|10|||
124901754|NCT01185522|449265147|FG000|Overall Study|Poor tolerance|39|||
124901755|NCT01185522|449265147|FG000|Overall Study|Other reasons|12|||
124901756|NCT00918957|449265148|FG000|Overall Study|Adverse Event|2|||
124901757|NCT00918957|449265149|FG001|Overall Study|Adverse Event|0|||
125021119|NCT02270242|449700938|FG001|Overall Study|Physician Decision|1|||
124901758|NCT00918957|449265148|FG000|Overall Study|Withdrawal by Subject|1|||
124901759|NCT00918957|449265149|FG001|Overall Study|Withdrawal by Subject|0|||
124901760|NCT01803646|449265150|FG000|Overall Study|Protocol Violation|1|||
124901761|NCT01803646|449265151|FG001|Overall Study|Protocol Violation|0|||
124901762|NCT01803646|449265150|FG000|Overall Study|Adverse Event|1|||
125021120|NCT02321436|449700941|FG000|Overall Study|Withdrawal by Subject|1|||
125021121|NCT02321436|449700942|FG001|Overall Study|Withdrawal by Subject|0|||
125021122|NCT02321436|449700941|FG000|Overall Study|Lost to Follow-up|0|||
124901763|NCT01803646|449265151|FG001|Overall Study|Adverse Event|1|||
125113383|NCT03412019|450038586|FG000|Overall Study|Withdrawal by Subject|1|||
124901764|NCT01803646|449265150|FG000|Overall Study|Withdrawal by Subject|9|||
124901765|NCT01803646|449265151|FG001|Overall Study|Withdrawal by Subject|6|||
124901766|NCT01803646|449265150|FG000|Overall Study|Randomization error|1|||
124901767|NCT01803646|449265151|FG001|Overall Study|Randomization error|2|||
124901768|NCT01803646|449265150|FG000|Overall Study|Lost to Follow-up|5|||
124901769|NCT01803646|449265151|FG001|Overall Study|Lost to Follow-up|1|||
124901770|NCT01131494|449265152|FG000|Overall Study|Withdrawal by Subject|2|||
124901771|NCT02614560|449265153|FG000|Overall Study|Death|6|||
124901772|NCT02614560|449265154|FG001|Overall Study|Death|2|||
124901773|NCT03923491|449265155|FG000|Overall Study|Lost to Follow-up|5|||
124901774|NCT03923491|449265156|FG001|Overall Study|Lost to Follow-up|8|||
124901775|NCT03923491|449265155|FG000|Overall Study|Withdrawal by Subject|4|||
124901776|NCT03923491|449265156|FG001|Overall Study|Withdrawal by Subject|6|||
125113384|NCT03412019|450038587|FG001|Overall Study|Withdrawal by Subject|1|||
125113385|NCT01023269|450038592|FG000|Overall Study|early termination of the study|2|||
125113386|NCT01023269|450038593|FG001|Overall Study|early termination of the study|0|||
125113387|NCT00947011|450038595|FG000|Overall Study|Study was terminated,PI left institution|12|||
125113388|NCT00814658|450038596|FG000|Overall Study|Lost to Follow-up|0|||
125113389|NCT00814658|450038597|FG001|Overall Study|Lost to Follow-up|1|||
125113390|NCT00814658|450038596|FG000|Overall Study|Physician Decision|1|||
125113391|NCT00814658|450038597|FG001|Overall Study|Physician Decision|0|||
125113392|NCT00814658|450038596|FG000|Overall Study|Adverse Event|3|||
124901777|NCT02174562|449265157|FG000|Overall Study|Withdrawal by Subject|7|||
125113393|NCT00814658|450038597|FG001|Overall Study|Adverse Event|3|||
125113394|NCT05266456|450038598|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
125113395|NCT05266456|450038599|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
125113396|NCT05266456|450038600|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
125113397|NCT05266456|450038601|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
125113398|NCT05266456|450038598|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
125113399|NCT05266456|450038599|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
124901778|NCT02174562|449265158|FG001|Overall Study|Withdrawal by Subject|2|||
124901779|NCT02174562|449265157|FG000|Overall Study|Death|2|||
124901780|NCT02174562|449265158|FG001|Overall Study|Death|0|||
124901781|NCT02174562|449265157|FG000|Overall Study|Lost to Follow-up|0|||
124901782|NCT02174562|449265158|FG001|Overall Study|Lost to Follow-up|3|||
124901783|NCT05193318|449265159|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
124901784|NCT05193318|449265159|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
125113400|NCT05266456|450038600|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
125113401|NCT05266456|450038601|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
125113402|NCT05266456|450038598|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
125113403|NCT05266456|450038599|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
125113404|NCT05266456|450038600|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
125113405|NCT05266456|450038601|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
125113406|NCT05266456|450038598|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
125113407|NCT05266456|450038599|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
125113408|NCT05266456|450038600|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
125113409|NCT05266456|450038601|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
125113410|NCT05266456|450038598|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
125113411|NCT05266456|450038599|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
124901785|NCT00798096|449265160|FG000|Overall Study|Ongoing|2|||
124901786|NCT01833065|449265161|FG000|Overall Study|Adverse Event|6|||
124901787|NCT01833065|449265162|FG001|Overall Study|Adverse Event|1|||
124901788|NCT01833065|449265163|FG002|Overall Study|Adverse Event|0|||
124901789|NCT01833065|449265164|FG003|Overall Study|Adverse Event|2|||
124901790|NCT01833065|449265165|FG004|Overall Study|Adverse Event|3|||
124901791|NCT01833065|449265161|FG000|Overall Study|Protocol Violation|1|||
124901792|NCT01833065|449265162|FG001|Overall Study|Protocol Violation|0|||
124901793|NCT01833065|449265163|FG002|Overall Study|Protocol Violation|0|||
124901794|NCT01833065|449265164|FG003|Overall Study|Protocol Violation|0|||
124901795|NCT01833065|449265165|FG004|Overall Study|Protocol Violation|2|||
124901796|NCT01833065|449265161|FG000|Overall Study|Lost to Follow-up|1|||
124901797|NCT01833065|449265162|FG001|Overall Study|Lost to Follow-up|0|||
124901798|NCT01833065|449265163|FG002|Overall Study|Lost to Follow-up|0|||
125113412|NCT05266456|450038600|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
124901799|NCT01833065|449265164|FG003|Overall Study|Lost to Follow-up|0|||
124901800|NCT01833065|449265165|FG004|Overall Study|Lost to Follow-up|3|||
124901801|NCT01833065|449265161|FG000|Overall Study|Withdrawal by Subject|6|||
125113413|NCT05266456|450038601|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
125113414|NCT01141283|450038602|FG000|Overall Study|Adverse Event|56|||
125113415|NCT01141283|450038602|FG000|Overall Study|Lost to Follow-up|4|||
125113416|NCT01141283|450038602|FG000|Overall Study|Withdrawal by Subject|14|||
125113417|NCT01141283|450038602|FG000|Overall Study|Administrative|4|||
125113418|NCT01141283|450038602|FG000|Overall Study|Lack of Efficacy|10|||
125113419|NCT00479401|450038606|FG000|Overall Study|Adverse Event|24|||
125113420|NCT00479401|450038607|FG001|Overall Study|Adverse Event|20|||
124901802|NCT01833065|449265162|FG001|Overall Study|Withdrawal by Subject|2|||
124901803|NCT01833065|449265163|FG002|Overall Study|Withdrawal by Subject|4|||
124901804|NCT01833065|449265164|FG003|Overall Study|Withdrawal by Subject|3|||
124901805|NCT01833065|449265165|FG004|Overall Study|Withdrawal by Subject|11|||
124901806|NCT01833065|449265161|FG000|Overall Study|Subject's substantial non-compliance|0|||
124901807|NCT01833065|449265162|FG001|Overall Study|Subject's substantial non-compliance|1|||
124901808|NCT01833065|449265163|FG002|Overall Study|Subject's substantial non-compliance|0|||
124901809|NCT01833065|449265164|FG003|Overall Study|Subject's substantial non-compliance|0|||
124901810|NCT01833065|449265165|FG004|Overall Study|Subject's substantial non-compliance|0|||
124901811|NCT01833065|449265161|FG000|Overall Study|Trial terminated by sponsor|8|||
124901812|NCT01833065|449265162|FG001|Overall Study|Trial terminated by sponsor|8|||
124901813|NCT01833065|449265163|FG002|Overall Study|Trial terminated by sponsor|7|||
124901814|NCT01833065|449265164|FG003|Overall Study|Trial terminated by sponsor|3|||
124901815|NCT01833065|449265165|FG004|Overall Study|Trial terminated by sponsor|13|||
124901816|NCT01833065|449265161|FG000|Overall Study|Others|2|||
124901817|NCT01833065|449265162|FG001|Overall Study|Others|1|||
124901818|NCT01833065|449265163|FG002|Overall Study|Others|1|||
124901819|NCT01833065|449265164|FG003|Overall Study|Others|1|||
124901820|NCT01833065|449265165|FG004|Overall Study|Others|4|||
124901821|NCT00241644|449265166|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
124901822|NCT00241644|449265167|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
124901823|NCT00241644|449265168|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
124901824|NCT00241644|449265169|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
124901825|NCT00241644|449265166|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
125021123|NCT02321436|449700942|FG001|Overall Study|Lost to Follow-up|1|||
125021124|NCT00644787|449700943|FG000|Period 1: Titration Phase|Adverse Event|11|||
125021125|NCT00644787|449700944|FG001|Period 1: Titration Phase|Adverse Event|0|||
125021126|NCT00644787|449700945|FG002|Period 1: Titration Phase|Adverse Event|0|||
125021127|NCT00644787|449700943|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
125021128|NCT00644787|449700944|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
125021129|NCT00644787|449700945|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
125021130|NCT00644787|449700943|FG000|Period 1: Titration Phase|Physician Decision|1|||
125021131|NCT00644787|449700944|FG001|Period 1: Titration Phase|Physician Decision|0|||
125021132|NCT00644787|449700945|FG002|Period 1: Titration Phase|Physician Decision|0|||
125021133|NCT00644787|449700943|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
125021134|NCT00644787|449700944|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
125021135|NCT00644787|449700945|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
125021136|NCT00644787|449700943|FG000|Period 1: Titration Phase|Worsening of complications|1|||
125021137|NCT00644787|449700944|FG001|Period 1: Titration Phase|Worsening of complications|0|||
125021138|NCT00644787|449700945|FG002|Period 1: Titration Phase|Worsening of complications|0|||
125021139|NCT00644787|449700943|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
125021140|NCT00644787|449700944|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
125021141|NCT00644787|449700945|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
125021142|NCT00644787|449700943|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
125021143|NCT00644787|449700944|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
125021144|NCT00644787|449700945|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
125021145|NCT00644787|449700943|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
125021146|NCT00644787|449700944|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
125021147|NCT00644787|449700945|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
125021148|NCT00644787|449700943|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
125021149|NCT00644787|449700944|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
125021150|NCT00644787|449700945|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
125021151|NCT00644787|449700943|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
125113421|NCT00479401|450038608|FG002|Overall Study|Adverse Event|4|||
125113422|NCT00479401|450038606|FG000|Overall Study|Lack of Efficacy|2|||
124901826|NCT00241644|449265167|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
124901827|NCT00241644|449265168|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
124901828|NCT00241644|449265169|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
125113423|NCT00479401|450038607|FG001|Overall Study|Lack of Efficacy|2|||
125113424|NCT00479401|450038608|FG002|Overall Study|Lack of Efficacy|4|||
125113425|NCT00479401|450038606|FG000|Overall Study|Protocol Violation|2|||
125113426|NCT00479401|450038607|FG001|Overall Study|Protocol Violation|1|||
125113427|NCT00479401|450038608|FG002|Overall Study|Protocol Violation|1|||
125113428|NCT00479401|450038606|FG000|Overall Study|Lost to Follow-up|1|||
125113429|NCT00479401|450038607|FG001|Overall Study|Lost to Follow-up|1|||
125113430|NCT00479401|450038608|FG002|Overall Study|Lost to Follow-up|1|||
125113431|NCT00479401|450038606|FG000|Overall Study|Withdrawal by Subject|16|||
125113432|NCT00479401|450038607|FG001|Overall Study|Withdrawal by Subject|10|||
125113433|NCT00479401|450038608|FG002|Overall Study|Withdrawal by Subject|2|||
125113434|NCT00479401|450038606|FG000|Overall Study|Exclusion criteria, relocation|4|||
125113435|NCT00479401|450038607|FG001|Overall Study|Exclusion criteria, relocation|3|||
125113436|NCT00479401|450038608|FG002|Overall Study|Exclusion criteria, relocation|0|||
125113437|NCT01571635|450038611|FG000|Overall Study|Adverse Event|3|||
125113438|NCT01571635|450038612|FG001|Overall Study|Adverse Event|0|||
125113439|NCT01571635|450038613|FG002|Overall Study|Adverse Event|2|||
125113440|NCT01571635|450038614|FG003|Overall Study|Adverse Event|3|||
125113441|NCT01571635|450038615|FG004|Overall Study|Adverse Event|5|||
125113442|NCT01571635|450038611|FG000|Overall Study|Other reasons|2|||
125113443|NCT01571635|450038612|FG001|Overall Study|Other reasons|1|||
125113444|NCT01571635|450038613|FG002|Overall Study|Other reasons|2|||
125113445|NCT01571635|450038614|FG003|Overall Study|Other reasons|2|||
125113446|NCT01571635|450038615|FG004|Overall Study|Other reasons|1|||
125113447|NCT01571635|450038611|FG000|Overall Study|Study terminated by sponsor|0|||
125113448|NCT01571635|450038612|FG001|Overall Study|Study terminated by sponsor|4|||
125113449|NCT01571635|450038613|FG002|Overall Study|Study terminated by sponsor|1|||
125113450|NCT01571635|450038614|FG003|Overall Study|Study terminated by sponsor|3|||
125113451|NCT01571635|450038615|FG004|Overall Study|Study terminated by sponsor|1|||
125113452|NCT01571635|450038611|FG000|Overall Study|Withdrew consent|1|||
125113453|NCT01571635|450038612|FG001|Overall Study|Withdrew consent|1|||
125113454|NCT01571635|450038613|FG002|Overall Study|Withdrew consent|2|||
125113455|NCT01571635|450038614|FG003|Overall Study|Withdrew consent|3|||
125113456|NCT01571635|450038615|FG004|Overall Study|Withdrew consent|0|||
125113457|NCT01571635|450038611|FG000|Overall Study|Lack of Efficacy|0|||
125113458|NCT01571635|450038612|FG001|Overall Study|Lack of Efficacy|2|||
125113459|NCT01571635|450038613|FG002|Overall Study|Lack of Efficacy|0|||
125113460|NCT01571635|450038614|FG003|Overall Study|Lack of Efficacy|1|||
125113461|NCT01571635|450038615|FG004|Overall Study|Lack of Efficacy|2|||
125113462|NCT02868281|450038616|FG000|Overall Study|Adverse Event|2|||
125113463|NCT02868281|450038617|FG001|Overall Study|Adverse Event|2|||
125113464|NCT02868281|450038616|FG000|Overall Study|Protocol Violation|13|||
125113465|NCT02868281|450038617|FG001|Overall Study|Protocol Violation|10|||
125113466|NCT02868281|450038616|FG000|Overall Study|Lost to Follow-up|3|||
125113467|NCT02868281|450038617|FG001|Overall Study|Lost to Follow-up|6|||
125113468|NCT02868281|450038616|FG000|Overall Study|Withdrawal by Subject|11|||
125113469|NCT02868281|450038617|FG001|Overall Study|Withdrawal by Subject|15|||
125113470|NCT02868281|450038616|FG000|Overall Study|Physician Decision|2|||
125113471|NCT02868281|450038617|FG001|Overall Study|Physician Decision|0|||
125113472|NCT02868281|450038616|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
125113473|NCT02868281|450038617|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
125113474|NCT02868281|450038616|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
125113475|NCT02868281|450038617|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
125113476|NCT02868281|450038616|FG000|Overall Study|Long journey/moving away|1|||
125113477|NCT02868281|450038617|FG001|Overall Study|Long journey/moving away|1|||
125113478|NCT01722266|450038618|FG000|Overall Study|Withdrawal by Subject|1|||
125113479|NCT01722266|450038619|FG001|Overall Study|Withdrawal by Subject|2|||
125113480|NCT01722266|450038620|FG002|Overall Study|Withdrawal by Subject|0|||
125113481|NCT01722266|450038621|FG003|Overall Study|Withdrawal by Subject|0|||
125113482|NCT01722266|450038618|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
125113483|NCT01722266|450038619|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
125113484|NCT01722266|450038620|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
125113485|NCT01722266|450038621|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
125113486|NCT01722266|450038618|FG000|Overall Study|Dropped out due to Nausea|0|||
125113487|NCT01722266|450038619|FG001|Overall Study|Dropped out due to Nausea|0|||
125113488|NCT01722266|450038620|FG002|Overall Study|Dropped out due to Nausea|2|||
125113489|NCT01722266|450038621|FG003|Overall Study|Dropped out due to Nausea|0|||
125113490|NCT03124381|450038627|FG000|Overall Study|Lost to Follow-up|1|||
125113491|NCT03124381|450038628|FG001|Overall Study|Lost to Follow-up|1|||
125113492|NCT03124381|450038627|FG000|Overall Study|Withdrawal by Subject|6|||
125113493|NCT03124381|450038628|FG001|Overall Study|Withdrawal by Subject|3|||
125113494|NCT03124381|450038627|FG000|Overall Study|Protocol Violation|0|||
125113495|NCT03124381|450038628|FG001|Overall Study|Protocol Violation|1|||
125113496|NCT03124381|450038627|FG000|Overall Study|Adverse Event|1|||
124901829|NCT00241644|449265166|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
124901830|NCT00241644|449265167|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
124901831|NCT00241644|449265168|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
124901832|NCT00241644|449265169|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
124901833|NCT00241644|449265166|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
124901834|NCT00241644|449265167|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
124901835|NCT00241644|449265168|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
124901836|NCT00241644|449265169|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
124901837|NCT00241644|449265166|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
124901838|NCT00241644|449265167|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
124901839|NCT00241644|449265168|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
124901840|NCT00241644|449265169|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
124901841|NCT00241644|449265166|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
124901842|NCT00241644|449265167|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
124901843|NCT00241644|449265168|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
124901844|NCT00241644|449265169|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
124901845|NCT00241644|449265166|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
124901846|NCT00241644|449265167|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
124901847|NCT00241644|449265168|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
124901848|NCT00241644|449265169|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
124901849|NCT00241644|449265166|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
124901850|NCT00241644|449265167|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
124901851|NCT00241644|449265168|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
124901852|NCT00241644|449265169|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
124901853|NCT00241644|449265166|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
124901854|NCT00241644|449265167|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
124901855|NCT00241644|449265168|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
124901856|NCT00241644|449265169|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
124901857|NCT00241644|449265166|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
124901858|NCT00241644|449265167|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
124901859|NCT00241644|449265168|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
124901860|NCT00241644|449265169|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
124901861|NCT00241644|449265166|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
124901862|NCT00241644|449265167|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
124901863|NCT00241644|449265168|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
124901864|NCT00241644|449265169|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
124901865|NCT00241644|449265166|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
124901866|NCT00241644|449265167|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
124901867|NCT00241644|449265168|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
124901868|NCT00241644|449265169|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
124901869|NCT00241644|449265166|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
124901870|NCT00241644|449265167|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
124901871|NCT00241644|449265168|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
124901872|NCT00241644|449265169|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
124901873|NCT03095508|449265170|FG000|Overall Study|Adverse Event|0|||
124901874|NCT03095508|449265171|FG001|Overall Study|Adverse Event|1|||
124901875|NCT01027286|449265172|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
124901876|NCT01027286|449265173|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
124901877|NCT01027286|449265172|FG000|Overall Study|Lost to Follow-up|0|||
124901878|NCT01027286|449265173|FG001|Overall Study|Lost to Follow-up|1|||
124901879|NCT03201809|449265174|FG000|Overall Study|Lost to Follow-up|2|||
124901880|NCT03201809|449265175|FG001|Overall Study|Lost to Follow-up|0|||
124901881|NCT00545844|449265176|FG000|Overall Study|Lost to Follow-up|9|||
124901882|NCT00545844|449265176|FG000|Overall Study|Protocol Violation|1|||
124901883|NCT00545844|449265176|FG000|Overall Study|Withdrawal by Subject|2|||
124901884|NCT00975806|449265177|FG000|Overall Study|Adverse Event|2|||
124901885|NCT00975806|449265178|FG001|Overall Study|Adverse Event|1|||
124901886|NCT00975806|449265179|FG002|Overall Study|Adverse Event|2|||
124901887|NCT00975806|449265177|FG000|Overall Study|Disease Progression|1|||
124901888|NCT00975806|449265178|FG001|Overall Study|Disease Progression|5|||
124901889|NCT00975806|449265179|FG002|Overall Study|Disease Progression|1|||
124901890|NCT00975806|449265177|FG000|Overall Study|Withdrawal by Subject|1|||
124901891|NCT00975806|449265178|FG001|Overall Study|Withdrawal by Subject|0|||
124901892|NCT00975806|449265179|FG002|Overall Study|Withdrawal by Subject|0|||
124901893|NCT00975806|449265177|FG000|Overall Study|Death|0|||
124901894|NCT00975806|449265178|FG001|Overall Study|Death|1|||
124901895|NCT00975806|449265179|FG002|Overall Study|Death|0|||
124901896|NCT00975806|449265177|FG000|Overall Study|Physician decision and disease related|1|||
124901897|NCT00975806|449265178|FG001|Overall Study|Physician decision and disease related|0|||
124901898|NCT00975806|449265179|FG002|Overall Study|Physician decision and disease related|1|||
124901899|NCT02377362|449265180|FG000|Part A Second Treatment|Protocol Violation|0|||
124901900|NCT02377362|449265181|FG001|Part A Second Treatment|Protocol Violation|0|||
124901901|NCT02377362|449265182|FG002|Part A Second Treatment|Protocol Violation|0|||
124901902|NCT02377362|449265183|FG003|Part A Second Treatment|Protocol Violation|0|||
124901903|NCT02377362|449265184|FG004|Part A Second Treatment|Protocol Violation|1|||
124901904|NCT02377362|449265185|FG005|Part A Second Treatment|Protocol Violation|0|||
124901905|NCT02377362|449265186|FG006|Part A Second Treatment|Protocol Violation|0|||
124901906|NCT02377362|449265187|FG007|Part A Second Treatment|Protocol Violation|0|||
124901907|NCT02377362|449265188|FG008|Part A Second Treatment|Protocol Violation|0|||
124901908|NCT02377362|449265189|FG009|Part A Second Treatment|Protocol Violation|0|||
124901909|NCT02377362|449265190|FG010|Part A Second Treatment|Protocol Violation|0|||
124901910|NCT02377362|449265191|FG011|Part A Second Treatment|Protocol Violation|0|||
124901911|NCT02377362|449265192|FG012|Part A Second Treatment|Protocol Violation|0|||
124901912|NCT02377362|449265180|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
124901913|NCT02377362|449265181|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
124901914|NCT02377362|449265182|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
124901915|NCT02377362|449265183|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
124901916|NCT02377362|449265184|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
124901917|NCT02377362|449265185|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
124901918|NCT02377362|449265186|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
124901919|NCT02377362|449265187|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
124901920|NCT02377362|449265188|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
124901921|NCT02377362|449265189|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
124901922|NCT02377362|449265190|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
124901923|NCT02377362|449265191|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
124901924|NCT02377362|449265192|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
124901925|NCT02377362|449265180|FG000|Part B Overall|Protocol Violation|0|||
124901926|NCT02377362|449265181|FG001|Part B Overall|Protocol Violation|0|||
124901927|NCT02377362|449265182|FG002|Part B Overall|Protocol Violation|0|||
124901928|NCT02377362|449265183|FG003|Part B Overall|Protocol Violation|0|||
124901929|NCT02377362|449265184|FG004|Part B Overall|Protocol Violation|0|||
124901930|NCT02377362|449265185|FG005|Part B Overall|Protocol Violation|0|||
124901931|NCT02377362|449265186|FG006|Part B Overall|Protocol Violation|0|||
124901932|NCT02377362|449265187|FG007|Part B Overall|Protocol Violation|0|||
124901933|NCT02377362|449265188|FG008|Part B Overall|Protocol Violation|0|||
124901934|NCT02377362|449265189|FG009|Part B Overall|Protocol Violation|1|||
124901935|NCT02377362|449265190|FG010|Part B Overall|Protocol Violation|0|||
124901936|NCT02377362|449265191|FG011|Part B Overall|Protocol Violation|0|||
124901937|NCT02377362|449265192|FG012|Part B Overall|Protocol Violation|0|||
124901938|NCT02377362|449265180|FG000|Part B Overall|Adverse Event|0|||
124901939|NCT02377362|449265181|FG001|Part B Overall|Adverse Event|0|||
124901940|NCT02377362|449265182|FG002|Part B Overall|Adverse Event|0|||
124901941|NCT02377362|449265183|FG003|Part B Overall|Adverse Event|0|||
124901942|NCT02377362|449265184|FG004|Part B Overall|Adverse Event|0|||
124901943|NCT02377362|449265185|FG005|Part B Overall|Adverse Event|0|||
124901944|NCT02377362|449265186|FG006|Part B Overall|Adverse Event|1|||
124901945|NCT02377362|449265187|FG007|Part B Overall|Adverse Event|1|||
124901946|NCT02377362|449265188|FG008|Part B Overall|Adverse Event|0|||
124901947|NCT02377362|449265189|FG009|Part B Overall|Adverse Event|0|||
124901948|NCT02377362|449265190|FG010|Part B Overall|Adverse Event|0|||
124901949|NCT02377362|449265191|FG011|Part B Overall|Adverse Event|0|||
124901950|NCT02377362|449265192|FG012|Part B Overall|Adverse Event|0|||
124901951|NCT02377362|449265180|FG000|Part B Overall|Withdrawal by Subject|0|||
124901952|NCT02377362|449265181|FG001|Part B Overall|Withdrawal by Subject|0|||
124901953|NCT02377362|449265182|FG002|Part B Overall|Withdrawal by Subject|0|||
124901954|NCT02377362|449265183|FG003|Part B Overall|Withdrawal by Subject|0|||
124901955|NCT02377362|449265184|FG004|Part B Overall|Withdrawal by Subject|0|||
124901956|NCT02377362|449265185|FG005|Part B Overall|Withdrawal by Subject|0|||
124901957|NCT02377362|449265186|FG006|Part B Overall|Withdrawal by Subject|1|||
124901958|NCT02377362|449265187|FG007|Part B Overall|Withdrawal by Subject|0|||
124901959|NCT02377362|449265188|FG008|Part B Overall|Withdrawal by Subject|0|||
124901960|NCT02377362|449265189|FG009|Part B Overall|Withdrawal by Subject|0|||
124901961|NCT02377362|449265190|FG010|Part B Overall|Withdrawal by Subject|0|||
124901962|NCT02377362|449265191|FG011|Part B Overall|Withdrawal by Subject|1|||
124901963|NCT02377362|449265192|FG012|Part B Overall|Withdrawal by Subject|0|||
124901964|NCT00094809|449265193|FG000|Overall Study|Protocol deviation|2|||
124901965|NCT00094809|449265194|FG001|Overall Study|Protocol deviation|2|||
124901966|NCT00094809|449265193|FG000|Overall Study|Noncompliance|1|||
124901967|NCT00094809|449265194|FG001|Overall Study|Noncompliance|0|||
124901968|NCT00094809|449265193|FG000|Overall Study|Adverse Event|3|||
124901969|NCT00094809|449265194|FG001|Overall Study|Adverse Event|1|||
124901970|NCT00094809|449265193|FG000|Overall Study|Withdrawal by Subject|8|||
124901971|NCT00094809|449265194|FG001|Overall Study|Withdrawal by Subject|9|||
124901972|NCT00094809|449265193|FG000|Overall Study|Disease progression|3|||
124901973|NCT00094809|449265194|FG001|Overall Study|Disease progression|3|||
124901974|NCT00094809|449265193|FG000|Overall Study|Physician Decision|3|||
124901975|NCT00094809|449265194|FG001|Overall Study|Physician Decision|5|||
124901976|NCT00094809|449265193|FG000|Overall Study|Lost to Follow-up|6|||
124901977|NCT00094809|449265194|FG001|Overall Study|Lost to Follow-up|6|||
124901978|NCT00094809|449265193|FG000|Overall Study|Death|19|||
124901979|NCT00094809|449265194|FG001|Overall Study|Death|25|||
124901980|NCT00094809|449265193|FG000|Overall Study|Protocol-specified criteria|1|||
124901981|NCT00094809|449265194|FG001|Overall Study|Protocol-specified criteria|1|||
124901982|NCT00094809|449265193|FG000|Overall Study|Other|2|||
124901983|NCT00094809|449265194|FG001|Overall Study|Other|4|||
124901984|NCT00094809|449265193|FG000|Overall Study|Informed consent signed after treatment|1|||
124901985|NCT00094809|449265194|FG001|Overall Study|Informed consent signed after treatment|0|||
124901986|NCT00094809|449265193|FG000|Overall Study|Study drug not received|2|||
124901987|NCT00094809|449265194|FG001|Overall Study|Study drug not received|8|||
124901988|NCT00094809|449265193|FG000|Overall Study|Other|1|||
124901989|NCT00094809|449265194|FG001|Overall Study|Other|1|||
124901990|NCT04889664|449265195|FG000|Screen|Lost to Follow-up|1|||
124901991|NCT04889664|449265195|FG000|Screen|Failed to meet screening criteria|1|||
124901992|NCT04889664|449265195|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
124901993|NCT04107805|449265200|FG000|Overall Study|Adverse Event|0|||
124901994|NCT04107805|449265201|FG001|Overall Study|Adverse Event|0|||
124901995|NCT04107805|449265202|FG002|Overall Study|Adverse Event|0|||
124901996|NCT04107805|449265203|FG003|Overall Study|Adverse Event|1|||
125113497|NCT03124381|450038628|FG001|Overall Study|Adverse Event|1|||
124901997|NCT04107805|449265204|FG004|Overall Study|Adverse Event|0|||
124901998|NCT04107805|449265205|FG005|Overall Study|Adverse Event|1|||
124901999|NCT04107805|449265206|FG006|Overall Study|Adverse Event|0|||
124902000|NCT04107805|449265207|FG007|Overall Study|Adverse Event|0|||
124902001|NCT04107805|449265208|FG008|Overall Study|Adverse Event|1|||
125113498|NCT03124381|450038627|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
124902002|NCT01191086|449265220|FG000|Overall Study|Adverse Event|20|||
124902003|NCT01191086|449265220|FG000|Overall Study|Lack of Efficacy|10|||
124902004|NCT01191086|449265220|FG000|Overall Study|Lost to Follow-up|4|||
124902005|NCT01191086|449265220|FG000|Overall Study|Physician Decision|2|||
124902006|NCT01191086|449265220|FG000|Overall Study|Withdrawal by Subject|24|||
124902007|NCT01191086|449265220|FG000|Overall Study|Discontinuation criterion met|1|||
124902008|NCT01191086|449265220|FG000|Overall Study|Other|1|||
124902009|NCT00771849|449265221|FG000|Overall Study|Lost to Follow-up|1|||
124902010|NCT00771849|449265222|FG001|Overall Study|Lost to Follow-up|2|||
124902011|NCT00771849|449265221|FG000|Overall Study|Withdrawal by Subject|1|||
124902012|NCT00771849|449265222|FG001|Overall Study|Withdrawal by Subject|1|||
124902013|NCT00771849|449265221|FG000|Overall Study|Not vaccinated|0|||
124902014|NCT00771849|449265222|FG001|Overall Study|Not vaccinated|1|||
124902015|NCT02046616|449265227|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
124902016|NCT02046616|449265227|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
124902017|NCT02046616|449265227|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
124902018|NCT02046616|449265227|FG000|24-Week Treatment Period|Physician Decision|3|||
124902019|NCT02046616|449265227|FG000|24-Week Treatment Period|Other|1|||
124902020|NCT02046616|449265227|FG000|8-Week FU Period|Lost to Follow-up|1|||
124902021|NCT02736799|449265228|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
124902022|NCT02736799|449265229|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
124902023|NCT02736799|449265230|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
124902024|NCT02736799|449265231|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
124902025|NCT01156116|449265234|FG000|Overall Study|Withdrawal by Subject|3|||
124902026|NCT01156116|449265235|FG001|Overall Study|Withdrawal by Subject|1|||
124902027|NCT01156116|449265234|FG000|Overall Study|CPAP intolerance|2|||
124902028|NCT01156116|449265235|FG001|Overall Study|CPAP intolerance|0|||
125021152|NCT00644787|449700944|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
125021153|NCT00644787|449700945|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
125021154|NCT00644787|449700943|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
125021155|NCT00644787|449700944|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
125021156|NCT00644787|449700945|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
125021157|NCT00644787|449700943|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
125021158|NCT00644787|449700944|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
125021159|NCT00644787|449700945|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
125021160|NCT03048422|449700946|FG000|Overall Study|Death|1|||
125021161|NCT03048422|449700947|FG001|Overall Study|Death|0|||
125021162|NCT03048422|449700948|FG002|Overall Study|Death|0|||
125021163|NCT03048422|449700946|FG000|Overall Study|Lost to Follow-up|5|||
125021164|NCT03048422|449700947|FG001|Overall Study|Lost to Follow-up|0|||
125021165|NCT03048422|449700948|FG002|Overall Study|Lost to Follow-up|1|||
125021166|NCT03048422|449700946|FG000|Overall Study|Withdrawal by Subject|5|||
125021167|NCT03048422|449700947|FG001|Overall Study|Withdrawal by Subject|7|||
125021168|NCT03048422|449700948|FG002|Overall Study|Withdrawal by Subject|4|||
125021169|NCT03048422|449700946|FG000|Overall Study|Moved|3|||
125021170|NCT03048422|449700947|FG001|Overall Study|Moved|2|||
125021171|NCT03048422|449700948|FG002|Overall Study|Moved|2|||
125021172|NCT03048422|449700946|FG000|Overall Study|Noncompliant with Study Requirements|2|||
125021173|NCT03048422|449700947|FG001|Overall Study|Noncompliant with Study Requirements|1|||
125021174|NCT03048422|449700948|FG002|Overall Study|Noncompliant with Study Requirements|2|||
125021175|NCT03048422|449700946|FG000|Overall Study|Not Able to Get to Clinic|1|||
125021176|NCT03048422|449700947|FG001|Overall Study|Not Able to Get to Clinic|0|||
125021177|NCT03048422|449700948|FG002|Overall Study|Not Able to Get to Clinic|0|||
125021178|NCT03110224|449700949|FG000|Overall Study|Death|3|||
125021179|NCT03110224|449700949|FG000|Overall Study|Lost to Follow-up|132|||
125021180|NCT03110224|449700949|FG000|Overall Study|Physician Decision|2|||
125021181|NCT03110224|449700949|FG000|Overall Study|Site Closed by Physician|35|||
125021182|NCT03110224|449700949|FG000|Overall Study|Site Closed by Sponsor|202|||
125021183|NCT03110224|449700949|FG000|Overall Study|Withdrawal by Subject|9|||
125021184|NCT04818593|449700950|FG000|Overall Study|Low Oocyte Yield|8|||
125021185|NCT04818593|449700951|FG001|Overall Study|Low Oocyte Yield|8|||
125021186|NCT04818593|449700950|FG000|Overall Study|Not ICSI Insemination|7|||
125021187|NCT04818593|449700951|FG001|Overall Study|Not ICSI Insemination|7|||
125021188|NCT04818593|449700950|FG000|Overall Study|Poor Sperm Quality|2|||
125021189|NCT04818593|449700951|FG001|Overall Study|Poor Sperm Quality|2|||
125021190|NCT04818593|449700950|FG000|Overall Study|Withdrawal by Subject|2|||
125021191|NCT04818593|449700951|FG001|Overall Study|Withdrawal by Subject|2|||
125021192|NCT04818593|449700950|FG000|Overall Study|Conversion to IUI due to low response|1|||
125021193|NCT04818593|449700951|FG001|Overall Study|Conversion to IUI due to low response|1|||
125021194|NCT01564862|449700952|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
125021195|NCT01564862|449700953|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
125021196|NCT01564862|449700954|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
125021197|NCT01564862|449700952|FG000|Overall Study|Major Protocol Deviation|3|||
124902029|NCT00344019|449265236|FG000|Overall Study|did not meet final inclusion criteria|0|||
125021198|NCT01564862|449700953|FG001|Overall Study|Major Protocol Deviation|3|||
125021199|NCT01564862|449700954|FG002|Overall Study|Major Protocol Deviation|4|||
124902030|NCT00344019|449265237|FG001|Overall Study|did not meet final inclusion criteria|0|||
124902031|NCT00344019|449265238|FG002|Overall Study|did not meet final inclusion criteria|74|||
124902032|NCT02057718|449265239|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
124902033|NCT02057718|449265240|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
124902034|NCT02057718|449265239|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
124902035|NCT02057718|449265240|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
124902036|NCT02057718|449265239|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
124902037|NCT02057718|449265240|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
124902038|NCT02057718|449265239|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
124902039|NCT02057718|449265240|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
124902040|NCT02057718|449265239|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
124902041|NCT02057718|449265240|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
124902042|NCT02057718|449265239|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
124902043|NCT02057718|449265240|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
124902044|NCT02057718|449265239|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
124902045|NCT02057718|449265240|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
124902046|NCT02057718|449265239|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
124902047|NCT02057718|449265240|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
124902048|NCT02057718|449265239|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
124902049|NCT02057718|449265240|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
124902050|NCT02057718|449265239|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
124902051|NCT02057718|449265240|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
124902052|NCT02057718|449265239|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
124902053|NCT02057718|449265240|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
124902054|NCT02503202|449265241|FG000|Base Study: Up to Month 6|Death|1|||
124902055|NCT02503202|449265242|FG001|Base Study: Up to Month 6|Death|1|||
124902056|NCT02503202|449265243|FG002|Base Study: Up to Month 6|Death|0|||
124902057|NCT02503202|449265244|FG003|Base Study: Up to Month 6|Death|0|||
124902058|NCT02503202|449265245|FG004|Base Study: Up to Month 6|Death|0|||
124902059|NCT02503202|449265241|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
124902060|NCT02503202|449265242|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
124902061|NCT02503202|449265243|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
124902062|NCT02503202|449265244|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
124902063|NCT02503202|449265245|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
124902064|NCT02503202|449265241|FG000|Base Study: Up to Month 6|Physician Decision|0|||
124902065|NCT02503202|449265242|FG001|Base Study: Up to Month 6|Physician Decision|0|||
124902066|NCT02503202|449265243|FG002|Base Study: Up to Month 6|Physician Decision|0|||
124902067|NCT02503202|449265244|FG003|Base Study: Up to Month 6|Physician Decision|0|||
124902068|NCT02503202|449265245|FG004|Base Study: Up to Month 6|Physician Decision|1|||
124902069|NCT02503202|449265241|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
124902070|NCT02503202|449265242|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
124902071|NCT02503202|449265243|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
124902072|NCT02503202|449265244|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
124902073|NCT02503202|449265245|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
124902074|NCT02503202|449265241|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
124902075|NCT02503202|449265242|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
124902076|NCT02503202|449265243|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
124902077|NCT02503202|449265244|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
124902078|NCT02503202|449265245|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
124902079|NCT02503202|449265241|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
124902080|NCT02503202|449265242|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
124902081|NCT02503202|449265243|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
124902082|NCT02503202|449265244|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
124902083|NCT02503202|449265245|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
124902084|NCT02503202|449265241|FG000|Extension: Month 6 to 24|Death|1|||
124902085|NCT02503202|449265242|FG001|Extension: Month 6 to 24|Death|0|||
124902086|NCT02503202|449265243|FG002|Extension: Month 6 to 24|Death|0|||
124902087|NCT02503202|449265244|FG003|Extension: Month 6 to 24|Death|0|||
124902088|NCT02503202|449265245|FG004|Extension: Month 6 to 24|Death|0|||
124902089|NCT02503202|449265241|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
124902090|NCT02503202|449265242|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
124902091|NCT02503202|449265243|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
124902092|NCT02503202|449265244|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
124902093|NCT02503202|449265245|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
124902094|NCT02503202|449265241|FG000|Extension: Month 6 to 24|Physician Decision|1|||
124902095|NCT02503202|449265242|FG001|Extension: Month 6 to 24|Physician Decision|0|||
124902096|NCT02503202|449265243|FG002|Extension: Month 6 to 24|Physician Decision|1|||
124902097|NCT02503202|449265244|FG003|Extension: Month 6 to 24|Physician Decision|3|||
124902098|NCT02503202|449265245|FG004|Extension: Month 6 to 24|Physician Decision|0|||
124902099|NCT02503202|449265241|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
124902100|NCT02503202|449265242|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
124902101|NCT02503202|449265243|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
124902102|NCT02503202|449265244|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
124902103|NCT02503202|449265245|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
124902104|NCT01050569|449265249|FG000|Overall Study|Lost to Follow-up|20|||
124902105|NCT01050569|449265250|FG001|Overall Study|Lost to Follow-up|14|||
124902106|NCT01050569|449265251|FG002|Overall Study|Lost to Follow-up|16|||
124902107|NCT01050569|449265249|FG000|Overall Study|Withdrawal by Subject|9|||
124902108|NCT01050569|449265250|FG001|Overall Study|Withdrawal by Subject|3|||
124902109|NCT01050569|449265251|FG002|Overall Study|Withdrawal by Subject|11|||
124902110|NCT01050569|449265249|FG000|Overall Study|Lack of Efficacy|5|||
124902111|NCT01050569|449265250|FG001|Overall Study|Lack of Efficacy|4|||
124902112|NCT01050569|449265251|FG002|Overall Study|Lack of Efficacy|3|||
124902113|NCT01050569|449265249|FG000|Overall Study|Adverse Event|1|||
124902114|NCT01050569|449265250|FG001|Overall Study|Adverse Event|0|||
124902115|NCT01050569|449265251|FG002|Overall Study|Adverse Event|0|||
124902116|NCT01050569|449265249|FG000|Overall Study|Physician Decision|3|||
124902117|NCT01050569|449265250|FG001|Overall Study|Physician Decision|3|||
124902118|NCT01050569|449265251|FG002|Overall Study|Physician Decision|3|||
124902119|NCT03525119|449265253|FG000|Overall Study|Adverse Event|0|||
124902120|NCT03525119|449265254|FG001|Overall Study|Adverse Event|1|||
124902121|NCT03525119|449265255|FG002|Overall Study|Adverse Event|0|||
124902122|NCT03525119|449265253|FG000|Overall Study|Lost to Follow-up|32|||
124902123|NCT03525119|449265254|FG001|Overall Study|Lost to Follow-up|33|||
124902124|NCT03525119|449265255|FG002|Overall Study|Lost to Follow-up|37|||
124902125|NCT03525119|449265253|FG000|Overall Study|Withdrawal by Subject|5|||
124902126|NCT03525119|449265254|FG001|Overall Study|Withdrawal by Subject|4|||
124902127|NCT03525119|449265255|FG002|Overall Study|Withdrawal by Subject|2|||
124902128|NCT03525119|449265253|FG000|Overall Study|Reason not Specified|2|||
124902129|NCT03525119|449265254|FG001|Overall Study|Reason not Specified|1|||
124902130|NCT03525119|449265255|FG002|Overall Study|Reason not Specified|2|||
124902131|NCT03525119|449265253|FG000|Overall Study|Randomized but not Vaccinated|1|||
124902132|NCT03525119|449265254|FG001|Overall Study|Randomized but not Vaccinated|0|||
124902133|NCT03525119|449265255|FG002|Overall Study|Randomized but not Vaccinated|2|||
124902134|NCT01959412|449265256|FG000|Overall Study|Protocol deviation|1|||
124902135|NCT01959412|449265257|FG001|Overall Study|Protocol deviation|1|||
124902136|NCT01959412|449265258|FG002|Overall Study|Protocol deviation|0|||
124902137|NCT01959412|449265259|FG003|Overall Study|Protocol deviation|1|||
124902138|NCT01959412|449265260|FG004|Overall Study|Protocol deviation|3|||
124902139|NCT01959412|449265261|FG005|Overall Study|Protocol deviation|0|||
124902140|NCT01959412|449265256|FG000|Overall Study|Adverse Event|0|||
124902141|NCT01959412|449265257|FG001|Overall Study|Adverse Event|0|||
124902142|NCT01959412|449265258|FG002|Overall Study|Adverse Event|0|||
124902143|NCT01959412|449265259|FG003|Overall Study|Adverse Event|1|||
124902144|NCT01959412|449265260|FG004|Overall Study|Adverse Event|0|||
124902145|NCT01959412|449265261|FG005|Overall Study|Adverse Event|0|||
124902146|NCT00509769|449265262|FG000|Overall Study|Progressive disease|77|||
124902147|NCT00509769|449265262|FG000|Overall Study|Adverse Event|4|||
124902148|NCT00509769|449265262|FG000|Overall Study|Patient's decision|1|||
124902149|NCT00509769|449265262|FG000|Overall Study|Physician Decision|8|||
124902150|NCT00509769|449265262|FG000|Overall Study|Use of prohibited therapies during study|1|||
124902151|NCT04364269|449265263|FG000|Overall Study|Adverse Event|1|||
124902152|NCT04364269|449265264|FG001|Overall Study|Adverse Event|0|||
124902153|NCT04364269|449265265|FG002|Overall Study|Adverse Event|0|||
124902154|NCT04364269|449265263|FG000|Overall Study|Withdrawal by Subject|0|||
124902155|NCT04364269|449265264|FG001|Overall Study|Withdrawal by Subject|1|||
124902156|NCT04364269|449265265|FG002|Overall Study|Withdrawal by Subject|0|||
125021200|NCT01564862|449700952|FG000|Overall Study|Lost to Follow-up|10|||
125021201|NCT01564862|449700953|FG001|Overall Study|Lost to Follow-up|8|||
125021202|NCT01564862|449700954|FG002|Overall Study|Lost to Follow-up|6|||
124902157|NCT00383188|449265266|FG000|Overall Study|Adverse Event|4|||
124902158|NCT00383188|449265267|FG001|Overall Study|Adverse Event|7|||
124902159|NCT00383188|449265268|FG002|Overall Study|Adverse Event|9|||
124902160|NCT00383188|449265269|FG003|Overall Study|Adverse Event|8|||
124902161|NCT00383188|449265270|FG004|Overall Study|Adverse Event|8|||
125021203|NCT01564862|449700952|FG000|Overall Study|Voluntary Withdrawal|9|||
125021204|NCT01564862|449700953|FG001|Overall Study|Voluntary Withdrawal|6|||
124902162|NCT00383188|449265266|FG000|Overall Study|Lack of Efficacy|9|||
124902163|NCT00383188|449265267|FG001|Overall Study|Lack of Efficacy|3|||
124902164|NCT00383188|449265268|FG002|Overall Study|Lack of Efficacy|3|||
124902165|NCT00383188|449265269|FG003|Overall Study|Lack of Efficacy|2|||
124902166|NCT00383188|449265270|FG004|Overall Study|Lack of Efficacy|6|||
124902167|NCT00383188|449265266|FG000|Overall Study|Other|3|||
124902168|NCT00383188|449265267|FG001|Overall Study|Other|1|||
124902169|NCT00383188|449265268|FG002|Overall Study|Other|0|||
124902170|NCT00383188|449265269|FG003|Overall Study|Other|2|||
124902171|NCT00383188|449265270|FG004|Overall Study|Other|6|||
124902172|NCT00383188|449265266|FG000|Overall Study|No longer willing to participate|1|||
125113499|NCT03124381|450038628|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
125113500|NCT02533999|450038629|FG000|Overall Study|Lost to Follow-up|3|||
124902173|NCT00383188|449265267|FG001|Overall Study|No longer willing to participate|0|||
124902174|NCT00383188|449265268|FG002|Overall Study|No longer willing to participate|1|||
124902175|NCT00383188|449265269|FG003|Overall Study|No longer willing to participate|0|||
125113501|NCT02533999|450038630|FG001|Overall Study|Lost to Follow-up|5|||
125113502|NCT02533999|450038629|FG000|Overall Study|Protocol Violation|3|||
125113503|NCT02533999|450038630|FG001|Overall Study|Protocol Violation|0|||
125113504|NCT02533999|450038629|FG000|Overall Study|Adverse Event|0|||
125113505|NCT02533999|450038630|FG001|Overall Study|Adverse Event|1|||
125113506|NCT02533999|450038629|FG000|Overall Study|Randomized but intervention not received|0|||
125113507|NCT02533999|450038630|FG001|Overall Study|Randomized but intervention not received|1|||
125113508|NCT00291330|450038631|FG000|Overall Study|Adverse Event|47|||
125113509|NCT00291330|450038632|FG001|Overall Study|Adverse Event|40|||
125113510|NCT00291330|450038631|FG000|Overall Study|Protocol Violation|13|||
125113511|NCT00291330|450038632|FG001|Overall Study|Protocol Violation|20|||
125113512|NCT00291330|450038631|FG000|Overall Study|Lost to Follow-up|16|||
124902176|NCT00383188|449265270|FG004|Overall Study|No longer willing to participate|2|||
124902177|NCT00383188|449265266|FG000|Overall Study|Lost to Follow-up|0|||
124902178|NCT00383188|449265267|FG001|Overall Study|Lost to Follow-up|0|||
124902179|NCT00383188|449265268|FG002|Overall Study|Lost to Follow-up|0|||
124902180|NCT00383188|449265269|FG003|Overall Study|Lost to Follow-up|0|||
124902181|NCT00383188|449265270|FG004|Overall Study|Lost to Follow-up|1|||
124902182|NCT01093534|449265271|FG000|Overall Study|Adverse Event|2|||
124902183|NCT01093534|449265272|FG001|Overall Study|Adverse Event|5|||
124902184|NCT01093534|449265273|FG002|Overall Study|Adverse Event|2|||
124902185|NCT01093534|449265271|FG000|Overall Study|Lack of Efficacy|2|||
124902186|NCT01093534|449265272|FG001|Overall Study|Lack of Efficacy|1|||
124902187|NCT01093534|449265273|FG002|Overall Study|Lack of Efficacy|1|||
124902188|NCT01093534|449265271|FG000|Overall Study|Withdrawal by Subject|5|||
124902189|NCT01093534|449265272|FG001|Overall Study|Withdrawal by Subject|7|||
124902190|NCT01093534|449265273|FG002|Overall Study|Withdrawal by Subject|2|||
125113513|NCT00291330|450038632|FG001|Overall Study|Lost to Follow-up|11|||
125113514|NCT00291330|450038631|FG000|Overall Study|Withdrawal by Subject|22|||
125113515|NCT00291330|450038632|FG001|Overall Study|Withdrawal by Subject|25|||
125113516|NCT00291330|450038631|FG000|Overall Study|Other|3|||
125113517|NCT00291330|450038632|FG001|Overall Study|Other|1|||
125113518|NCT01829295|450038633|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
125113519|NCT01829295|450038634|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
125113520|NCT01829295|450038635|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
125113521|NCT01829295|450038636|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
125113522|NCT01829295|450038633|FG000|6-12 Months|Adverse Event|0|||
124902191|NCT01093534|449265271|FG000|Overall Study|Other|1|||
124902192|NCT01093534|449265272|FG001|Overall Study|Other|3|||
124902193|NCT01093534|449265273|FG002|Overall Study|Other|4|||
124902194|NCT03418324|449265288|FG000|Overall Study|Death|0|||
124902195|NCT03418324|449265289|FG001|Overall Study|Death|1|||
124902196|NCT03418324|449265288|FG000|Overall Study|Physician Decision|1|||
124902197|NCT03418324|449265289|FG001|Overall Study|Physician Decision|1|||
124902198|NCT01768676|449265290|FG000|Overall Study|Adverse Event|3|||
124902199|NCT01768676|449265291|FG001|Overall Study|Adverse Event|3|||
124902200|NCT01768676|449265290|FG000|Overall Study|Lost to Follow-up|13|||
124902201|NCT01768676|449265291|FG001|Overall Study|Lost to Follow-up|16|||
124902202|NCT01768676|449265290|FG000|Overall Study|Protocol Violation|1|||
124902203|NCT01768676|449265291|FG001|Overall Study|Protocol Violation|1|||
124902204|NCT01768676|449265290|FG000|Overall Study|Physician Decision|4|||
124902205|NCT01768676|449265291|FG001|Overall Study|Physician Decision|1|||
124902206|NCT01768676|449265290|FG000|Overall Study|Withdrawal by Subject|3|||
124902207|NCT01768676|449265291|FG001|Overall Study|Withdrawal by Subject|10|||
124902208|NCT04248829|449265292|FG000|Overall Study|Disease progression|44|||
124902209|NCT04248829|449265293|FG001|Overall Study|Disease progression|109|||
125113523|NCT01829295|450038634|FG001|6-12 Months|Adverse Event|0|||
125113524|NCT01829295|450038635|FG002|6-12 Months|Adverse Event|3|||
124902210|NCT04248829|449265292|FG000|Overall Study|Adverse Event|19|||
124902211|NCT04248829|449265293|FG001|Overall Study|Adverse Event|18|||
124902212|NCT04248829|449265292|FG000|Overall Study|Withdrawal by Subject|11|||
124902213|NCT04248829|449265293|FG001|Overall Study|Withdrawal by Subject|2|||
124902214|NCT04248829|449265292|FG000|Overall Study|Lost to Follow-up|0|||
125113525|NCT01829295|450038636|FG003|6-12 Months|Adverse Event|2|||
124902215|NCT04248829|449265293|FG001|Overall Study|Lost to Follow-up|1|||
124902216|NCT04248829|449265292|FG000|Overall Study|Death|12|||
124902217|NCT04248829|449265293|FG001|Overall Study|Death|14|||
124902218|NCT04248829|449265292|FG000|Overall Study|Physician Decision|2|||
124902219|NCT04248829|449265293|FG001|Overall Study|Physician Decision|4|||
125113526|NCT01829295|450038633|FG000|6-12 Months|Lost to Follow-up|2|||
125113527|NCT01829295|450038634|FG001|6-12 Months|Lost to Follow-up|0|||
125113528|NCT01829295|450038635|FG002|6-12 Months|Lost to Follow-up|0|||
124902220|NCT04248829|449265292|FG000|Overall Study|Any reason not specifically recorded|0|||
124902221|NCT04248829|449265293|FG001|Overall Study|Any reason not specifically recorded|2|||
124902222|NCT02685033|449265294|FG000|Overall Study|Withdrawal of Consent|0|||
124902223|NCT02685033|449265295|FG001|Overall Study|Withdrawal of Consent|1|||
124902224|NCT02685033|449265294|FG000|Overall Study|Lost to Follow-up|2|||
124902225|NCT02685033|449265295|FG001|Overall Study|Lost to Follow-up|1|||
124902226|NCT02685033|449265294|FG000|Overall Study|Adverse Event|1|||
124902227|NCT02685033|449265295|FG001|Overall Study|Adverse Event|0|||
124902228|NCT01066923|449265296|FG000|Overall Study|Withdrawal by Subject|3|||
124902229|NCT01066923|449265297|FG001|Overall Study|Withdrawal by Subject|3|||
124902230|NCT01066923|449265298|FG002|Overall Study|Withdrawal by Subject|8|||
124902231|NCT01066923|449265299|FG003|Overall Study|Withdrawal by Subject|8|||
124902232|NCT01546155|449266577|FG000|Overall Study|could not tolerate long scan duration|3|||
124902233|NCT00771667|449266579|FG000|Induction Phase|Adverse Event|5|||
124902234|NCT00771667|449266580|FG001|Induction Phase|Adverse Event|2|||
124902235|NCT00771667|449266581|FG002|Induction Phase|Adverse Event|4|||
124902236|NCT00771667|449266582|FG003|Induction Phase|Adverse Event|1|||
124902237|NCT00771667|449266583|FG004|Induction Phase|Adverse Event|0|||
124902238|NCT00771667|449266584|FG005|Induction Phase|Adverse Event|0|||
124902239|NCT00771667|449266585|FG006|Induction Phase|Adverse Event|0|||
124902240|NCT00771667|449266586|FG007|Induction Phase|Adverse Event|0|||
124902241|NCT00771667|449266587|FG008|Induction Phase|Adverse Event|0|||
124902242|NCT00771667|449266588|FG009|Induction Phase|Adverse Event|0|||
124902243|NCT00771667|449266579|FG000|Induction Phase|Lack of Efficacy|9|||
124902244|NCT00771667|449266580|FG001|Induction Phase|Lack of Efficacy|2|||
124902245|NCT00771667|449266581|FG002|Induction Phase|Lack of Efficacy|4|||
124902246|NCT00771667|449266582|FG003|Induction Phase|Lack of Efficacy|3|||
124902247|NCT00771667|449266583|FG004|Induction Phase|Lack of Efficacy|0|||
124902248|NCT00771667|449266584|FG005|Induction Phase|Lack of Efficacy|0|||
124902249|NCT00771667|449266585|FG006|Induction Phase|Lack of Efficacy|0|||
124902250|NCT00771667|449266586|FG007|Induction Phase|Lack of Efficacy|0|||
124902251|NCT00771667|449266587|FG008|Induction Phase|Lack of Efficacy|0|||
124902252|NCT00771667|449266588|FG009|Induction Phase|Lack of Efficacy|0|||
124902253|NCT00771667|449266579|FG000|Induction Phase|Lost to Follow-up|1|||
124902254|NCT00771667|449266580|FG001|Induction Phase|Lost to Follow-up|0|||
124902255|NCT00771667|449266581|FG002|Induction Phase|Lost to Follow-up|1|||
124902256|NCT00771667|449266582|FG003|Induction Phase|Lost to Follow-up|0|||
124902257|NCT00771667|449266583|FG004|Induction Phase|Lost to Follow-up|0|||
124902258|NCT00771667|449266584|FG005|Induction Phase|Lost to Follow-up|0|||
124902259|NCT00771667|449266585|FG006|Induction Phase|Lost to Follow-up|0|||
124902260|NCT00771667|449266586|FG007|Induction Phase|Lost to Follow-up|0|||
124902261|NCT00771667|449266587|FG008|Induction Phase|Lost to Follow-up|0|||
124902262|NCT00771667|449266588|FG009|Induction Phase|Lost to Follow-up|0|||
124902263|NCT00771667|449266579|FG000|Induction Phase|Other|4|||
124902264|NCT00771667|449266580|FG001|Induction Phase|Other|6|||
124902265|NCT00771667|449266581|FG002|Induction Phase|Other|3|||
124902266|NCT00771667|449266582|FG003|Induction Phase|Other|4|||
124902267|NCT00771667|449266583|FG004|Induction Phase|Other|0|||
124902268|NCT00771667|449266584|FG005|Induction Phase|Other|0|||
124902269|NCT00771667|449266585|FG006|Induction Phase|Other|0|||
124902270|NCT00771667|449266586|FG007|Induction Phase|Other|0|||
124902271|NCT00771667|449266587|FG008|Induction Phase|Other|0|||
124902272|NCT00771667|449266588|FG009|Induction Phase|Other|0|||
124902273|NCT00771667|449266579|FG000|Maintenance Phase|Adverse Event|0|||
124902274|NCT00771667|449266580|FG001|Maintenance Phase|Adverse Event|0|||
125021205|NCT01564862|449700954|FG002|Overall Study|Voluntary Withdrawal|8|||
125021206|NCT01564862|449700952|FG000|Overall Study|Lack of Efficacy|1|||
125021207|NCT01564862|449700953|FG001|Overall Study|Lack of Efficacy|5|||
125021208|NCT01564862|449700954|FG002|Overall Study|Lack of Efficacy|6|||
125021209|NCT01564862|449700952|FG000|Overall Study|Other reason(s)|1|||
125021210|NCT01564862|449700953|FG001|Overall Study|Other reason(s)|0|||
125021211|NCT01564862|449700954|FG002|Overall Study|Other reason(s)|0|||
125021212|NCT04526665|449700955|FG000|Overall Study|Withdrawal by Subject|6|||
125021213|NCT04526665|449700956|FG001|Overall Study|Withdrawal by Subject|3|||
124902275|NCT00771667|449266581|FG002|Maintenance Phase|Adverse Event|0|||
124902276|NCT00771667|449266582|FG003|Maintenance Phase|Adverse Event|0|||
124902277|NCT00771667|449266583|FG004|Maintenance Phase|Adverse Event|1|||
124902278|NCT00771667|449266584|FG005|Maintenance Phase|Adverse Event|3|||
124902279|NCT00771667|449266585|FG006|Maintenance Phase|Adverse Event|5|||
124902280|NCT00771667|449266586|FG007|Maintenance Phase|Adverse Event|1|||
124902281|NCT00771667|449266587|FG008|Maintenance Phase|Adverse Event|8|||
124902282|NCT00771667|449266588|FG009|Maintenance Phase|Adverse Event|7|||
124902283|NCT00771667|449266579|FG000|Maintenance Phase|Lack of Efficacy|0|||
124902284|NCT00771667|449266580|FG001|Maintenance Phase|Lack of Efficacy|0|||
124902285|NCT00771667|449266581|FG002|Maintenance Phase|Lack of Efficacy|0|||
124902286|NCT00771667|449266582|FG003|Maintenance Phase|Lack of Efficacy|0|||
124902287|NCT00771667|449266583|FG004|Maintenance Phase|Lack of Efficacy|1|||
124902288|NCT00771667|449266584|FG005|Maintenance Phase|Lack of Efficacy|3|||
125021214|NCT04526665|449700955|FG000|Overall Study|Adverse Event|4|||
125021215|NCT04526665|449700956|FG001|Overall Study|Adverse Event|1|||
124902289|NCT00771667|449266585|FG006|Maintenance Phase|Lack of Efficacy|3|||
124902290|NCT00771667|449266586|FG007|Maintenance Phase|Lack of Efficacy|2|||
124902291|NCT00771667|449266587|FG008|Maintenance Phase|Lack of Efficacy|11|||
124902292|NCT00771667|449266588|FG009|Maintenance Phase|Lack of Efficacy|7|||
124902293|NCT00771667|449266579|FG000|Maintenance Phase|Other|0|||
124902294|NCT00771667|449266580|FG001|Maintenance Phase|Other|0|||
124902295|NCT00771667|449266581|FG002|Maintenance Phase|Other|0|||
124902296|NCT00771667|449266582|FG003|Maintenance Phase|Other|0|||
124902297|NCT00771667|449266583|FG004|Maintenance Phase|Other|0|||
124902298|NCT00771667|449266584|FG005|Maintenance Phase|Other|1|||
124902299|NCT00771667|449266585|FG006|Maintenance Phase|Other|2|||
124902300|NCT00771667|449266586|FG007|Maintenance Phase|Other|2|||
124902301|NCT00771667|449266587|FG008|Maintenance Phase|Other|3|||
124902302|NCT00771667|449266588|FG009|Maintenance Phase|Other|3|||
124902303|NCT00109967|449266589|FG000|Overall Study|Cancel Prior to Treatment|2|||
124902304|NCT00109967|449266590|FG001|Overall Study|Cancel Prior to Treatment|0|||
124902305|NCT00109967|449266589|FG000|Overall Study|Adverse Event|12|||
124902306|NCT00109967|449266590|FG001|Overall Study|Adverse Event|1|||
124902307|NCT00109967|449266589|FG000|Overall Study|Withdrawal by Subject|5|||
124902308|NCT00109967|449266590|FG001|Overall Study|Withdrawal by Subject|0|||
124902309|NCT00109967|449266589|FG000|Overall Study|Physician Decision|1|||
124902310|NCT00109967|449266590|FG001|Overall Study|Physician Decision|3|||
125021216|NCT04526665|449700955|FG000|Overall Study|Physician Decision|2|||
125021217|NCT04526665|449700956|FG001|Overall Study|Physician Decision|2|||
125021218|NCT04526665|449700955|FG000|Overall Study|Death|2|||
125021219|NCT04526665|449700956|FG001|Overall Study|Death|0|||
125021220|NCT04526665|449700955|FG000|Overall Study|Other|0|||
125021221|NCT04526665|449700956|FG001|Overall Study|Other|1|||
125021222|NCT01844986|449700957|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
125021223|NCT01844986|449700958|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
125021224|NCT01844986|449700957|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
125021225|NCT01844986|449700958|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
124902311|NCT00109967|449266589|FG000|Overall Study|Death|0|||
124902312|NCT00109967|449266590|FG001|Overall Study|Death|2|||
124902313|NCT00628862|449266597|FG000|Overall Study|Adverse Event|6|||
124902314|NCT00628862|449266598|FG001|Overall Study|Adverse Event|8|||
124902315|NCT00628862|449266599|FG002|Overall Study|Adverse Event|10|||
124902316|NCT00628862|449266597|FG000|Overall Study|Withdrawal by Subject|4|||
124902317|NCT00628862|449266598|FG001|Overall Study|Withdrawal by Subject|6|||
124902318|NCT00628862|449266599|FG002|Overall Study|Withdrawal by Subject|11|||
124902319|NCT00628862|449266597|FG000|Overall Study|Lost to Follow-up|0|||
124902320|NCT00628862|449266598|FG001|Overall Study|Lost to Follow-up|2|||
124902321|NCT00628862|449266599|FG002|Overall Study|Lost to Follow-up|1|||
124902322|NCT00628862|449266597|FG000|Overall Study|Protocol Violation|1|||
124902323|NCT00628862|449266598|FG001|Overall Study|Protocol Violation|0|||
124902324|NCT00628862|449266599|FG002|Overall Study|Protocol Violation|0|||
125021226|NCT01844986|449700957|FG000|Overall Study (Global Cohort)|Death|55|||
125021227|NCT01844986|449700958|FG001|Overall Study (Global Cohort)|Death|26|||
125021228|NCT01844986|449700957|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
125021229|NCT01844986|449700958|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
124902325|NCT00628862|449266597|FG000|Overall Study|COPD Exacerbation|0|||
124902326|NCT00628862|449266598|FG001|Overall Study|COPD Exacerbation|1|||
124902327|NCT00628862|449266599|FG002|Overall Study|COPD Exacerbation|0|||
124902328|NCT01063036|449266600|FG000|Participants Treated With Study Drug|Adverse Event|1|||
124902329|NCT01063036|449266600|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
125021230|NCT01844986|449700957|FG000|Overall Study (China Cohort)|Death|10|||
125021231|NCT01844986|449700958|FG001|Overall Study (China Cohort)|Death|6|||
125021232|NCT02028455|449700959|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
124902330|NCT01063036|449266600|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
125021233|NCT02028455|449700960|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
125021234|NCT02028455|449700961|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
124902331|NCT01063036|449266600|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
124902332|NCT01063036|449266600|FG000|Participants Treated With Study Drug|Pregnancy|1|||
124902333|NCT01063036|449266600|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
124902334|NCT01063036|449266600|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
124902335|NCT01063036|449266600|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
124902336|NCT00703911|449266603|FG000|Overall Study|Death|1|||
124902337|NCT00703911|449266603|FG000|Overall Study|Physician Decision|6|||
124902338|NCT00703911|449266603|FG000|Overall Study|Lost to Follow-up|1|||
124902339|NCT00703911|449266603|FG000|Overall Study|Withdrawal by Subject|2|||
124902340|NCT00853827|449266606|FG000|Single Blind Period (1 Week)|Other|4|||
124902341|NCT00853827|449266607|FG001|Single Blind Period (1 Week)|Other|0|||
124902342|NCT00853827|449266606|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
124902343|NCT00853827|449266607|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
124902344|NCT00853827|449266606|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
124902345|NCT00853827|449266607|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
124902346|NCT00853827|449266606|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
124902347|NCT00853827|449266607|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
124902348|NCT00853827|449266606|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
124902349|NCT00853827|449266607|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
124902350|NCT00853827|449266606|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
124902351|NCT00853827|449266607|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
124902352|NCT00853827|449266606|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
124902353|NCT00853827|449266607|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
124902354|NCT00853827|449266606|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
124902355|NCT00853827|449266607|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
124902356|NCT00853827|449266606|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
124902357|NCT00853827|449266607|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
124902358|NCT00853827|449266606|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
124902359|NCT00853827|449266607|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
124902360|NCT00853827|449266606|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
124902361|NCT00853827|449266607|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
124902362|NCT00853827|449266606|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
124902363|NCT00853827|449266607|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
124902364|NCT00853827|449266606|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
124902365|NCT00853827|449266607|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
124902366|NCT00853827|449266606|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
124902367|NCT00853827|449266607|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
124902368|NCT00853827|449266606|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
124902369|NCT00853827|449266607|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
124902370|NCT00853827|449266606|FG000|Double Blind Period (103 Weeks)|Death|1|||
124902371|NCT00853827|449266607|FG001|Double Blind Period (103 Weeks)|Death|6|||
124902372|NCT00906035|449266609|FG000|Overall Study|Withdrawal by Subject|2|||
124902373|NCT00906035|449266610|FG001|Overall Study|Withdrawal by Subject|3|||
124902374|NCT00906035|449266611|FG002|Overall Study|Withdrawal by Subject|0|||
124902375|NCT03058991|449266614|FG000|Overall Study|Lost to Follow-up|17|||
124902376|NCT03058991|449266615|FG001|Overall Study|Lost to Follow-up|12|||
124902377|NCT03058991|449266616|FG002|Overall Study|Lost to Follow-up|12|||
124902378|NCT03058991|449266614|FG000|Overall Study|Withdrawal by Subject|1|||
124902379|NCT03058991|449266615|FG001|Overall Study|Withdrawal by Subject|0|||
124902380|NCT03058991|449266616|FG002|Overall Study|Withdrawal by Subject|0|||
124902381|NCT00130637|449266617|FG000|Overall Study|Adverse Event|2|||
124902382|NCT00130637|449266617|FG000|Overall Study|Withdrawal by Subject|1|||
124902383|NCT01460342|449266619|FG000|Overall Study|Adverse Event|5|||
124902384|NCT01460342|449266620|FG001|Overall Study|Adverse Event|4|||
124902385|NCT01460342|449266619|FG000|Overall Study|Lost to Follow-up|1|||
124902386|NCT01460342|449266620|FG001|Overall Study|Lost to Follow-up|2|||
124902387|NCT01460342|449266619|FG000|Overall Study|Protocol Violation|0|||
124902388|NCT01460342|449266620|FG001|Overall Study|Protocol Violation|1|||
124902389|NCT01460342|449266619|FG000|Overall Study|Withdrawal by Subject|3|||
124902390|NCT01460342|449266620|FG001|Overall Study|Withdrawal by Subject|4|||
124902391|NCT01460342|449266619|FG000|Overall Study|Physician Decision|1|||
124902392|NCT01460342|449266620|FG001|Overall Study|Physician Decision|3|||
124902393|NCT01460342|449266619|FG000|Overall Study|Lack of Efficacy|1|||
124902394|NCT01460342|449266620|FG001|Overall Study|Lack of Efficacy|0|||
124902395|NCT01689519|449266621|FG000|Intent to Treat|Death|157|||
124902396|NCT01689519|449266622|FG001|Intent to Treat|Death|167|||
124902397|NCT01689519|449266621|FG000|Intent to Treat|Lost to Follow-up|4|||
124902398|NCT01689519|449266622|FG001|Intent to Treat|Lost to Follow-up|8|||
124902399|NCT01689519|449266621|FG000|Intent to Treat|Other|2|||
124902400|NCT01689519|449266622|FG001|Intent to Treat|Other|4|||
124902401|NCT01689519|449266621|FG000|Intent to Treat|Physician Decision|4|||
125021235|NCT02028455|449700962|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
124902402|NCT01689519|449266622|FG001|Intent to Treat|Physician Decision|1|||
124902403|NCT01689519|449266621|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
125021236|NCT02028455|449700963|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
125021237|NCT02028455|449700964|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
124902404|NCT01689519|449266622|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
125021238|NCT02028455|449700965|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
124902405|NCT01689519|449266621|FG000|Intent to Treat|Withdrawal by Subject|21|||
124902406|NCT01689519|449266622|FG001|Intent to Treat|Withdrawal by Subject|20|||
124902407|NCT01689519|449266621|FG000|Safety Population|Death|158|||
124902408|NCT01689519|449266622|FG001|Safety Population|Death|165|||
124902409|NCT01689519|449266621|FG000|Safety Population|Lost to Follow-up|4|||
124902410|NCT01689519|449266622|FG001|Safety Population|Lost to Follow-up|8|||
124902411|NCT01689519|449266621|FG000|Safety Population|Other|2|||
124902412|NCT01689519|449266622|FG001|Safety Population|Other|4|||
124902413|NCT01689519|449266621|FG000|Safety Population|Physician Decision|4|||
124902414|NCT01689519|449266622|FG001|Safety Population|Physician Decision|1|||
124902415|NCT01689519|449266621|FG000|Safety Population|Study Terminated By Sponsor|60|||
124902416|NCT01689519|449266622|FG001|Safety Population|Study Terminated By Sponsor|47|||
124902417|NCT01689519|449266621|FG000|Safety Population|Withdrawal by Subject|20|||
124902418|NCT01689519|449266622|FG001|Safety Population|Withdrawal by Subject|20|||
124902419|NCT01713530|449266623|FG000|Overall Study|Adverse Event|0|||
124902420|NCT01713530|449266624|FG001|Overall Study|Adverse Event|5|||
124902421|NCT01713530|449266623|FG000|Overall Study|Withdrawal criteria|21|||
124902422|NCT01713530|449266624|FG001|Overall Study|Withdrawal criteria|12|||
124902423|NCT01713530|449266623|FG000|Overall Study|Unclassified|4|||
124902424|NCT01713530|449266624|FG001|Overall Study|Unclassified|2|||
124902425|NCT03939819|449266625|FG000|Overall Study|Death|2|||
124902426|NCT03939819|449266626|FG001|Overall Study|Death|0|||
124902427|NCT02613364|449266627|FG000|Overall Study|Other|19|||
124902428|NCT02613364|449266628|FG001|Overall Study|Other|29|||
124902429|NCT02613364|449266629|FG002|Overall Study|Other|17|||
124902430|NCT02613364|449266627|FG000|Overall Study|Too time consuming|21|||
124902431|NCT02613364|449266628|FG001|Overall Study|Too time consuming|26|||
124902432|NCT02613364|449266629|FG002|Overall Study|Too time consuming|26|||
124902433|NCT02613364|449266627|FG000|Overall Study|Withdrawal by Subject|13|||
124902434|NCT02613364|449266628|FG001|Overall Study|Withdrawal by Subject|18|||
124902435|NCT02613364|449266629|FG002|Overall Study|Withdrawal by Subject|17|||
124902436|NCT02613364|449266627|FG000|Overall Study|Medical|12|||
124902437|NCT02613364|449266628|FG001|Overall Study|Medical|13|||
124902438|NCT02613364|449266629|FG002|Overall Study|Medical|9|||
124902439|NCT02613364|449266627|FG000|Overall Study|Disliked Study Procedure|1|||
124902440|NCT02613364|449266628|FG001|Overall Study|Disliked Study Procedure|1|||
124902441|NCT02613364|449266629|FG002|Overall Study|Disliked Study Procedure|4|||
124902442|NCT02613364|449266627|FG000|Overall Study|Disliked Intervention|0|||
124902443|NCT02613364|449266628|FG001|Overall Study|Disliked Intervention|3|||
124902444|NCT02613364|449266629|FG002|Overall Study|Disliked Intervention|3|||
124902445|NCT00436644|449266630|FG000|Overall Study|Adverse Event|2|||
124902446|NCT00436644|449266630|FG000|Overall Study|Death|1|||
124902447|NCT00619645|449266631|FG000|Overall Study|Adverse Event|1|||
124902448|NCT00972504|449266633|FG000|Overall Study|Adverse Event|2|||
124902449|NCT00972504|449266633|FG000|Overall Study|Investigator discretion|1|||
124902450|NCT00597519|449266634|FG000|Overall Study|Death|1|||
124902451|NCT04246762|449266635|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
124902452|NCT00410124|449266636|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
124902453|NCT00410124|449266637|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
124902454|NCT00410124|449266636|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
124902455|NCT00410124|449266637|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
124902456|NCT00410124|449266636|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
124902457|NCT00410124|449266637|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
124902458|NCT00410124|449266636|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
124902459|NCT00410124|449266637|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
124902460|NCT00410124|449266636|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
124902461|NCT00410124|449266637|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
125113529|NCT01829295|450038636|FG003|6-12 Months|Lost to Follow-up|0|||
124902462|NCT00410124|449266636|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
124902463|NCT00410124|449266637|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
124902464|NCT00410124|449266636|FG000|Core Phase Double Blind (15 Months)|Death|7|||
124902465|NCT00410124|449266637|FG001|Core Phase Double Blind (15 Months)|Death|4|||
124902466|NCT00410124|449266636|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
124902467|NCT00410124|449266637|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
124902468|NCT00410124|449266636|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
124902469|NCT00410124|449266637|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
124902470|NCT00410124|449266636|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
124902471|NCT00410124|449266637|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
124902472|NCT00410124|449266636|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
124902473|NCT00410124|449266637|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
124902474|NCT00410124|449266636|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
124902475|NCT00410124|449266637|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
124902476|NCT00410124|449266636|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
124902477|NCT00410124|449266637|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
124902478|NCT00410124|449266636|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
124902479|NCT00410124|449266637|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
124902480|NCT00410124|449266636|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
124902481|NCT00410124|449266637|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
124902482|NCT00410124|449266636|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
124902483|NCT00410124|449266637|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
124902484|NCT00741988|449266641|FG000|Overall Study|Adverse Event|2|||
124902485|NCT00741988|449266642|FG001|Overall Study|Adverse Event|4|||
124902486|NCT00741988|449266641|FG000|Overall Study|Lack of Efficacy|2|||
124902487|NCT00741988|449266642|FG001|Overall Study|Lack of Efficacy|0|||
124902488|NCT00811057|449266643|FG000|Overall Study|Protocol Violation|5|||
124902489|NCT00811057|449266644|FG001|Overall Study|Protocol Violation|10|||
124902490|NCT00811057|449266645|FG002|Overall Study|Protocol Violation|10|||
124902491|NCT00768651|449266650|FG000|Overall Study|Withdrawal by Subject|1|||
124902492|NCT02104765|449266651|FG000|Overall Study|Lost to Follow-up|0|||
124902493|NCT02104765|449266652|FG001|Overall Study|Lost to Follow-up|0|||
124902494|NCT02104765|449266653|FG002|Overall Study|Lost to Follow-up|1|||
124902495|NCT02104765|449266654|FG003|Overall Study|Lost to Follow-up|0|||
124902496|NCT02104765|449266655|FG004|Overall Study|Lost to Follow-up|0|||
124902497|NCT02104765|449266656|FG005|Overall Study|Lost to Follow-up|0|||
124902498|NCT02104765|449266657|FG006|Overall Study|Lost to Follow-up|0|||
124902499|NCT02104765|449266651|FG000|Overall Study|Withdrawal by Subject|0|||
124902500|NCT02104765|449266652|FG001|Overall Study|Withdrawal by Subject|0|||
124902501|NCT02104765|449266653|FG002|Overall Study|Withdrawal by Subject|0|||
124902502|NCT02104765|449266654|FG003|Overall Study|Withdrawal by Subject|1|||
124902503|NCT02104765|449266655|FG004|Overall Study|Withdrawal by Subject|1|||
124902504|NCT02104765|449266656|FG005|Overall Study|Withdrawal by Subject|0|||
124902505|NCT02104765|449266657|FG006|Overall Study|Withdrawal by Subject|1|||
124902506|NCT00995709|449266662|FG000|Overall Study|Adverse Event|4|||
124902507|NCT00995709|449266663|FG001|Overall Study|Adverse Event|2|||
124902508|NCT00995709|449266664|FG002|Overall Study|Adverse Event|0|||
124902509|NCT00995709|449266662|FG000|Overall Study|Lack of Efficacy|0|||
124902510|NCT00995709|449266663|FG001|Overall Study|Lack of Efficacy|1|||
124902511|NCT00995709|449266664|FG002|Overall Study|Lack of Efficacy|4|||
124902512|NCT00995709|449266662|FG000|Overall Study|Withdrawal by Subject|0|||
124902513|NCT00995709|449266663|FG001|Overall Study|Withdrawal by Subject|4|||
124902514|NCT00995709|449266664|FG002|Overall Study|Withdrawal by Subject|1|||
124902515|NCT00995709|449266662|FG000|Overall Study|Lost to Follow-up|1|||
124902516|NCT00995709|449266663|FG001|Overall Study|Lost to Follow-up|0|||
124902517|NCT00995709|449266664|FG002|Overall Study|Lost to Follow-up|0|||
124902518|NCT00995709|449266662|FG000|Overall Study|Death|0|||
124902519|NCT00995709|449266663|FG001|Overall Study|Death|1|||
124902520|NCT00995709|449266664|FG002|Overall Study|Death|0|||
124902521|NCT00995709|449266662|FG000|Overall Study|Protocol Violation|2|||
124902522|NCT00995709|449266663|FG001|Overall Study|Protocol Violation|1|||
124902523|NCT00995709|449266664|FG002|Overall Study|Protocol Violation|0|||
125113530|NCT01829295|450038633|FG000|6-12 Months|Withdrawal by Subject|2|||
125113531|NCT01829295|450038634|FG001|6-12 Months|Withdrawal by Subject|2|||
125113532|NCT01829295|450038635|FG002|6-12 Months|Withdrawal by Subject|0|||
125113533|NCT01829295|450038636|FG003|6-12 Months|Withdrawal by Subject|0|||
125113534|NCT02390219|450038643|FG000|Overall Study|Death|1|||
124902524|NCT01697319|449266665|FG000|Primary Phase|Withdrawal by Subject|1|||
124902525|NCT01697319|449266665|FG000|Extension Phase|Terminated by Sponsor|15|||
124902526|NCT04222959|449266666|FG000|Overall Study|Lost to Follow-up|76|||
124902527|NCT04222959|449266667|FG001|Overall Study|Lost to Follow-up|28|||
124902528|NCT03008915|449266672|FG000|Treatment 1|Withdrawal by Subject|0|||
124902529|NCT03008915|449266673|FG001|Treatment 1|Withdrawal by Subject|1|||
125113535|NCT02390219|450038643|FG000|Overall Study|Physician Decision|1|||
125113536|NCT02390219|450038643|FG000|Overall Study|Adverse Event|6|||
125113537|NCT02390219|450038643|FG000|Overall Study|Withdrawal by Subject|1|||
125113538|NCT02390219|450038643|FG000|Overall Study|Lost to Follow-up|2|||
125113539|NCT02390219|450038643|FG000|Overall Study|Other|2|||
125113540|NCT01360632|450038646|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
125113541|NCT01360632|450038647|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
124902530|NCT00712166|449266676|FG000|Overall Study|Noncompliance|0|||
124902531|NCT00712166|449266677|FG001|Overall Study|Noncompliance|1|||
124902532|NCT01773122|449266678|FG000|Overall Study|Due to amended age eligibility criteria|3|||
124902533|NCT01773122|449266679|FG001|Overall Study|Due to amended age eligibility criteria|1|||
124902534|NCT01773122|449266680|FG002|Overall Study|Due to amended age eligibility criteria|0|||
124902535|NCT01773122|449266681|FG003|Overall Study|Due to amended age eligibility criteria|1|||
124902536|NCT01264718|449266682|FG000|Overall Study|Lost to Follow-up|3|||
124902537|NCT01264718|449266683|FG001|Overall Study|Lost to Follow-up|2|||
124902538|NCT01264718|449266682|FG000|Overall Study|Withdrawal by Subject|9|||
124902539|NCT01264718|449266683|FG001|Overall Study|Withdrawal by Subject|15|||
124902540|NCT01264718|449266682|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
124902541|NCT01264718|449266683|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
124902542|NCT01769391|449266686|FG000|Overall Study|Death|10|||
124902543|NCT01769391|449266687|FG001|Overall Study|Death|1|||
124902544|NCT01769391|449266686|FG000|Overall Study|Adverse Event|0|||
124902545|NCT01769391|449266687|FG001|Overall Study|Adverse Event|3|||
124902546|NCT01769391|449266686|FG000|Overall Study|Progressive Disease|1|||
124902547|NCT01769391|449266687|FG001|Overall Study|Progressive Disease|2|||
124902548|NCT01769391|449266686|FG000|Overall Study|Withdrawal by Subject|4|||
124902549|NCT01769391|449266687|FG001|Overall Study|Withdrawal by Subject|3|||
124902550|NCT01769391|449266686|FG000|Overall Study|Investigator Decision|2|||
124902551|NCT01769391|449266687|FG001|Overall Study|Investigator Decision|0|||
124902552|NCT03386929|449266688|FG000|Overall Study|Death|0|||
124902553|NCT03386929|449266689|FG001|Overall Study|Death|0|||
124902554|NCT03386929|449266690|FG002|Overall Study|Death|1|||
124902555|NCT03386929|449266688|FG000|Overall Study|Withdrawal by Subject|0|||
124902556|NCT03386929|449266689|FG001|Overall Study|Withdrawal by Subject|1|||
124902557|NCT03386929|449266690|FG002|Overall Study|Withdrawal by Subject|0|||
124902558|NCT03386929|449266688|FG000|Overall Study|Physician Decision|0|||
124902559|NCT03386929|449266689|FG001|Overall Study|Physician Decision|0|||
124902560|NCT03386929|449266690|FG002|Overall Study|Physician Decision|1|||
124902561|NCT03386929|449266688|FG000|Overall Study|Progression|4|||
124902562|NCT03386929|449266689|FG001|Overall Study|Progression|4|||
124902563|NCT03386929|449266690|FG002|Overall Study|Progression|0|||
124902564|NCT03386929|449266688|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
124902565|NCT03386929|449266689|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
124902566|NCT03386929|449266690|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
124902567|NCT03386929|449266688|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
124902568|NCT03386929|449266689|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
124902569|NCT03386929|449266690|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
124902570|NCT01144182|449266694|FG000|Overall Study|Death|5|||
124902571|NCT01144182|449266695|FG001|Overall Study|Death|6|||
124902572|NCT01144182|449266694|FG000|Overall Study|Withdrawal by Subject|3|||
124902573|NCT01144182|449266695|FG001|Overall Study|Withdrawal by Subject|6|||
124902574|NCT01144182|449266694|FG000|Overall Study|Lost to Follow-up|9|||
124902575|NCT01144182|449266695|FG001|Overall Study|Lost to Follow-up|9|||
124902576|NCT03264456|449266700|FG000|Overall Study|Withdrawal by Subject|3|||
125113542|NCT01360632|450038648|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
124902577|NCT03264456|449266700|FG000|Overall Study|Lost to Follow-up|1|||
124902578|NCT03538054|449266701|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
125113543|NCT01360632|450038649|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
124902579|NCT03538054|449266701|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
124902580|NCT03538054|449266701|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
124902581|NCT03254394|449266702|FG000|Overall Study|Withdrawal by Subject|0|||
124902582|NCT03254394|449266703|FG001|Overall Study|Withdrawal by Subject|2|||
124902583|NCT02351180|449266706|FG000|Overall Study|Withdrawal by Subject|1|||
124902584|NCT02351180|449266707|FG001|Overall Study|Withdrawal by Subject|0|||
124902585|NCT01751724|449266708|FG000|Overall Study|extubated bef.start assigned treatment|1|||
124902586|NCT01751724|449266709|FG001|Overall Study|extubated bef.start assigned treatment|0|||
124902587|NCT01751724|449266708|FG000|Overall Study|withdrawn by parent|0|||
124902588|NCT01751724|449266709|FG001|Overall Study|withdrawn by parent|2|||
124902589|NCT03121950|449266711|FG000|Overall Study|Withdrawal by Subject|11|||
124902590|NCT03121950|449266712|FG001|Overall Study|Withdrawal by Subject|2|||
124902591|NCT01867580|449266713|FG000|Overall Study|Withdrawal by Subject|2|||
124902592|NCT01867580|449266714|FG001|Overall Study|Withdrawal by Subject|3|||
124902593|NCT01867580|449266713|FG000|Overall Study|Physician Decision|17|||
124902594|NCT01867580|449266714|FG001|Overall Study|Physician Decision|12|||
124902595|NCT01867580|449266713|FG000|Overall Study|Lost to Follow-up|3|||
124902596|NCT01867580|449266714|FG001|Overall Study|Lost to Follow-up|5|||
124902597|NCT01867580|449266713|FG000|Overall Study|Sponsor terminated study|1|||
124902598|NCT01867580|449266714|FG001|Overall Study|Sponsor terminated study|0|||
124902599|NCT01867580|449266713|FG000|Overall Study|Missed follow-up assessment|2|||
124902600|NCT01867580|449266714|FG001|Overall Study|Missed follow-up assessment|1|||
124902601|NCT01867580|449266713|FG000|Overall Study|Interruption to therapy|3|||
124902602|NCT01867580|449266714|FG001|Overall Study|Interruption to therapy|0|||
124902603|NCT01867580|449266713|FG000|Overall Study|Osteomyelitis|0|||
124902604|NCT01867580|449266714|FG001|Overall Study|Osteomyelitis|1|||
124902605|NCT01867580|449266713|FG000|Overall Study|Continuation of therapy|0|||
124902606|NCT01867580|449266714|FG001|Overall Study|Continuation of therapy|1|||
124902607|NCT01867580|449266713|FG000|Overall Study|Wound recurrence|0|||
124902608|NCT01867580|449266714|FG001|Overall Study|Wound recurrence|1|||
124902609|NCT03425643|449266717|FG000|Overall Study|Withdrawal by Subject|10|||
124902610|NCT03425643|449266718|FG001|Overall Study|Withdrawal by Subject|12|||
124902611|NCT03425643|449266717|FG000|Overall Study|Lost to Follow-up|2|||
124902612|NCT03425643|449266718|FG001|Overall Study|Lost to Follow-up|0|||
124902613|NCT03425643|449266717|FG000|Overall Study|Death|109|||
124902614|NCT03425643|449266718|FG001|Overall Study|Death|141|||
124902615|NCT03425643|449266717|FG000|Overall Study|Ongoing in study|276|||
124902616|NCT03425643|449266718|FG001|Overall Study|Ongoing in study|247|||
124902617|NCT03141788|449266719|FG000|Overall Study|Lost to Follow-up|1|||
124902618|NCT03141788|449266719|FG000|Overall Study|Protocol Violation|3|||
124902619|NCT03141788|449266719|FG000|Overall Study|Withdrawal by Subject|4|||
124902620|NCT01025843|449268303|FG000|Washout 4|Withdrawal by Subject|0|||
124902621|NCT01025843|449268304|FG001|Washout 4|Withdrawal by Subject|0|||
124902622|NCT01025843|449268305|FG002|Washout 4|Withdrawal by Subject|1|||
124902623|NCT01025843|449268306|FG003|Washout 4|Withdrawal by Subject|1|||
124902624|NCT01025843|449268307|FG004|Washout 4|Withdrawal by Subject|0|||
124902625|NCT01025843|449268308|FG005|Washout 4|Withdrawal by Subject|0|||
124902626|NCT01025843|449268309|FG006|Washout 4|Withdrawal by Subject|0|||
124902627|NCT01025843|449268310|FG007|Washout 4|Withdrawal by Subject|0|||
124902628|NCT01025843|449268311|FG008|Washout 4|Withdrawal by Subject|0|||
124902629|NCT01025843|449268312|FG009|Washout 4|Withdrawal by Subject|0|||
124902630|NCT00377455|449268315|FG000|Overall Study|Withdrawal by Subject|1|||
124902631|NCT01070888|449268316|FG000|First Intervention (14 Days)|Adverse Event|0|||
124902632|NCT01070888|449268317|FG001|First Intervention (14 Days)|Adverse Event|1|||
124902633|NCT01070888|449268316|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
124902634|NCT01070888|449268317|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
124902635|NCT01070888|449268316|FG000|Washout (14 Days)|Physician Decision|1|||
124902636|NCT01070888|449268317|FG001|Washout (14 Days)|Physician Decision|0|||
124902637|NCT01897233|449268322|FG000|Part B (24 Weeks)|Adverse Event|1|||
124902638|NCT01897233|449268322|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
124902639|NCT01897233|449268322|FG000|Part B (24 Weeks)|Physician Decision|1|||
124902640|NCT02715258|449268323|FG000|Overall Study|Withdrawal by Subject|6|||
124902641|NCT02715258|449268324|FG001|Overall Study|Withdrawal by Subject|1|||
124902642|NCT02715258|449268323|FG000|Overall Study|Lost to Follow-up|7|||
124902643|NCT02715258|449268324|FG001|Overall Study|Lost to Follow-up|1|||
124902644|NCT02715258|449268323|FG000|Overall Study|Terminated by Sponsor|0|||
124902645|NCT02715258|449268324|FG001|Overall Study|Terminated by Sponsor|1|||
124902646|NCT02715258|449268323|FG000|Overall Study|Death|0|||
124902647|NCT02715258|449268324|FG001|Overall Study|Death|1|||
124902648|NCT02715258|449268323|FG000|Overall Study|Subject non-compliant|1|||
124902649|NCT02715258|449268324|FG001|Overall Study|Subject non-compliant|1|||
124902650|NCT02715258|449268323|FG000|Overall Study|GCP violation|2|||
124902651|NCT02715258|449268324|FG001|Overall Study|GCP violation|1|||
124902652|NCT02814643|449268325|FG000|Overall Study|Lost to Follow-up|0|||
124902653|NCT02814643|449268326|FG001|Overall Study|Lost to Follow-up|1|||
124902654|NCT02814643|449268325|FG000|Overall Study|Withdrawal by Subject|1|||
124902655|NCT02814643|449268326|FG001|Overall Study|Withdrawal by Subject|2|||
124902656|NCT02263508|449268327|FG000|Overall Study|Withdrawal by Subject|1|||
124902657|NCT02263508|449268328|FG001|Overall Study|Withdrawal by Subject|23|||
124902658|NCT02263508|449268329|FG002|Overall Study|Withdrawal by Subject|17|||
124902659|NCT02263508|449268327|FG000|Overall Study|Sponsor Decision|12|||
124902660|NCT02263508|449268328|FG001|Overall Study|Sponsor Decision|165|||
124902661|NCT02263508|449268329|FG002|Overall Study|Sponsor Decision|182|||
124902662|NCT02263508|449268327|FG000|Overall Study|Lost to Follow-up|2|||
124902663|NCT02263508|449268328|FG001|Overall Study|Lost to Follow-up|7|||
124902664|NCT02263508|449268329|FG002|Overall Study|Lost to Follow-up|7|||
125113544|NCT01360632|450038650|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
125113545|NCT01360632|450038646|FG000|Phase A (8 Weeks)|Adverse Event|60|||
125113546|NCT01360632|450038647|FG001|Phase A (8 Weeks)|Adverse Event|0|||
125113547|NCT01360632|450038648|FG002|Phase A (8 Weeks)|Adverse Event|0|||
125113548|NCT01360632|450038649|FG003|Phase A (8 Weeks)|Adverse Event|0|||
125113549|NCT01360632|450038650|FG004|Phase A (8 Weeks)|Adverse Event|0|||
125113550|NCT01360632|450038646|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
125113551|NCT01360632|450038647|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
125113552|NCT01360632|450038648|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
125113553|NCT01360632|450038649|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
125113554|NCT01360632|450038650|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
125113555|NCT01360632|450038646|FG000|Phase A (8 Weeks)|Physician Decision|10|||
125113556|NCT01360632|450038647|FG001|Phase A (8 Weeks)|Physician Decision|0|||
125113557|NCT01360632|450038648|FG002|Phase A (8 Weeks)|Physician Decision|0|||
125113558|NCT01360632|450038649|FG003|Phase A (8 Weeks)|Physician Decision|0|||
125113559|NCT01360632|450038650|FG004|Phase A (8 Weeks)|Physician Decision|0|||
125113560|NCT01360632|450038646|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
125113561|NCT01360632|450038647|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
125113562|NCT01360632|450038648|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
125113563|NCT01360632|450038649|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
125113564|NCT01360632|450038650|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
125113565|NCT01360632|450038646|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
125113566|NCT01360632|450038647|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
125113567|NCT01360632|450038648|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
125113568|NCT01360632|450038649|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
125113569|NCT01360632|450038650|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
125113570|NCT01360632|450038646|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
125113571|NCT01360632|450038647|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
125113572|NCT01360632|450038648|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
125113573|NCT01360632|450038649|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
125113574|NCT01360632|450038650|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
125113575|NCT01360632|450038646|FG000|Phase B (6 Weeks)|Adverse Event|0|||
125113576|NCT01360632|450038647|FG001|Phase B (6 Weeks)|Adverse Event|3|||
125113577|NCT01360632|450038648|FG002|Phase B (6 Weeks)|Adverse Event|9|||
125113578|NCT01360632|450038649|FG003|Phase B (6 Weeks)|Adverse Event|3|||
125113579|NCT01360632|450038650|FG004|Phase B (6 Weeks)|Adverse Event|0|||
125113580|NCT01360632|450038646|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
125113581|NCT01360632|450038647|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
125113582|NCT01360632|450038648|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
125113583|NCT01360632|450038649|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
125113584|NCT01360632|450038650|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
125113585|NCT01360632|450038646|FG000|Phase B (6 Weeks)|Physician Decision|0|||
125113586|NCT01360632|450038647|FG001|Phase B (6 Weeks)|Physician Decision|0|||
125113587|NCT01360632|450038648|FG002|Phase B (6 Weeks)|Physician Decision|0|||
125113588|NCT01360632|450038649|FG003|Phase B (6 Weeks)|Physician Decision|1|||
125113589|NCT01360632|450038650|FG004|Phase B (6 Weeks)|Physician Decision|0|||
125113590|NCT01360632|450038646|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
125113591|NCT01360632|450038647|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
125113592|NCT01360632|450038648|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
125113593|NCT01360632|450038649|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
125113594|NCT01360632|450038650|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
125113595|NCT01360632|450038646|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
125113596|NCT01360632|450038647|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
125113597|NCT01360632|450038648|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
125113598|NCT01360632|450038649|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
125113599|NCT01360632|450038650|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
125113600|NCT01360632|450038646|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
125113601|NCT01360632|450038647|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
125113602|NCT01360632|450038648|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
125113603|NCT01360632|450038649|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
125113604|NCT01360632|450038650|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
125113605|NCT01360632|450038646|FG000|Phase A+|Lost to Follow-up|0|||
125113606|NCT01360632|450038647|FG001|Phase A+|Lost to Follow-up|0|||
125113607|NCT01360632|450038648|FG002|Phase A+|Lost to Follow-up|0|||
125113608|NCT01360632|450038649|FG003|Phase A+|Lost to Follow-up|0|||
125113609|NCT01360632|450038650|FG004|Phase A+|Lost to Follow-up|2|||
125113610|NCT01360632|450038646|FG000|Phase A+|Adverse Event|0|||
125113611|NCT01360632|450038647|FG001|Phase A+|Adverse Event|0|||
125113612|NCT01360632|450038648|FG002|Phase A+|Adverse Event|0|||
124902665|NCT02263508|449268327|FG000|Overall Study|Death|6|||
124902666|NCT02263508|449268328|FG001|Overall Study|Death|151|||
124902667|NCT02263508|449268329|FG002|Overall Study|Death|140|||
124902668|NCT03265210|449268332|FG000|Overall Study|Withdrawal by Subject|7|||
124902669|NCT03265210|449268333|FG001|Overall Study|Withdrawal by Subject|9|||
124902670|NCT03265210|449268332|FG000|Overall Study|Lost to Follow-up|2|||
124902671|NCT03265210|449268333|FG001|Overall Study|Lost to Follow-up|0|||
124902672|NCT03265210|449268332|FG000|Overall Study|Physician Decision|2|||
124902673|NCT03265210|449268333|FG001|Overall Study|Physician Decision|0|||
124902674|NCT03265210|449268332|FG000|Overall Study|Adverse Event|1|||
124902675|NCT03265210|449268333|FG001|Overall Study|Adverse Event|0|||
124902676|NCT01281813|449268342|FG000|Overall Study|Adverse Event|0|||
124902677|NCT01281813|449268343|FG001|Overall Study|Adverse Event|0|||
124902678|NCT01281813|449268344|FG002|Overall Study|Adverse Event|10|||
124902679|NCT01281813|449268342|FG000|Overall Study|Lost to Follow-up|0|||
124902680|NCT01281813|449268343|FG001|Overall Study|Lost to Follow-up|0|||
124902681|NCT01281813|449268344|FG002|Overall Study|Lost to Follow-up|31|||
124902682|NCT01281813|449268342|FG000|Overall Study|Withdrawal by Subject|0|||
124902683|NCT01281813|449268343|FG001|Overall Study|Withdrawal by Subject|0|||
124902684|NCT01281813|449268344|FG002|Overall Study|Withdrawal by Subject|13|||
124902685|NCT01281813|449268342|FG000|Overall Study|Subject Non-Compliant|0|||
124902686|NCT01281813|449268343|FG001|Overall Study|Subject Non-Compliant|0|||
124902687|NCT01281813|449268344|FG002|Overall Study|Subject Non-Compliant|6|||
124902688|NCT01281813|449268342|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
124902689|NCT01281813|449268343|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
124902690|NCT01281813|449268344|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
124902691|NCT01281813|449268342|FG000|Overall Study|Sponsor's Decision|4|||
124902692|NCT01281813|449268343|FG001|Overall Study|Sponsor's Decision|3|||
124902693|NCT01281813|449268344|FG002|Overall Study|Sponsor's Decision|7|||
124902694|NCT01281813|449268342|FG000|Overall Study|Switched to Commercially Available Medication|0|||
124902695|NCT01281813|449268343|FG001|Overall Study|Switched to Commercially Available Medication|0|||
124902696|NCT01281813|449268344|FG002|Overall Study|Switched to Commercially Available Medication|26|||
124902697|NCT01281813|449268342|FG000|Overall Study|Other|0|||
124902698|NCT01281813|449268343|FG001|Overall Study|Other|1|||
124902699|NCT01281813|449268344|FG002|Overall Study|Other|39|||
124902700|NCT03546907|449268345|FG000|Overall Study|Lack of Efficacy|1|||
124902701|NCT03546907|449268346|FG001|Overall Study|Lack of Efficacy|1|||
124902702|NCT03546907|449268345|FG000|Overall Study|Withdrawal by Subject|8|||
124902703|NCT03546907|449268346|FG001|Overall Study|Withdrawal by Subject|9|||
124902704|NCT03546907|449268345|FG000|Overall Study|Adverse events (AEs)|7|||
124902705|NCT03546907|449268346|FG001|Overall Study|Adverse events (AEs)|10|||
124902706|NCT03546907|449268345|FG000|Overall Study|Other-unspecified|1|||
124902707|NCT03546907|449268346|FG001|Overall Study|Other-unspecified|1|||
124902708|NCT04033432|449268351|FG000|Overall Study|Progressive Disease|8|||
124902709|NCT04033432|449268351|FG000|Overall Study|Adverse Event|4|||
124902710|NCT04033432|449268351|FG000|Overall Study|Death|1|||
124902711|NCT02192606|449268352|FG000|Overall Study|surgery type was changed|1|||
124902712|NCT02192606|449268353|FG001|Overall Study|surgery type was changed|1|||
124902713|NCT02192606|449268352|FG000|Overall Study|Physician Decision|1|||
124902714|NCT02192606|449268353|FG001|Overall Study|Physician Decision|2|||
124902715|NCT02192606|449268352|FG000|Overall Study|3D equipment rep unable to join|0|||
124902716|NCT02192606|449268353|FG001|Overall Study|3D equipment rep unable to join|1|||
124902717|NCT01458210|449268357|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
124902718|NCT01458210|449268357|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
124902719|NCT01458210|449268357|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
124902720|NCT01458210|449268357|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
124902721|NCT00957658|449268363|FG000|Overall Study|Death|1|||
124902722|NCT00957658|449268363|FG000|Overall Study|Lost to Follow-up|4|||
124902723|NCT00957658|449268363|FG000|Overall Study|Withdrawal by Subject|12|||
124902724|NCT00957658|449268363|FG000|Overall Study|Revision|1|||
125021239|NCT02028455|449700966|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
125021240|NCT02028455|449700959|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
125021241|NCT02028455|449700960|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
125021242|NCT02028455|449700961|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
125021243|NCT02028455|449700962|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
124902725|NCT00957658|449268363|FG000|Overall Study|Incomplete 2 yr data|28|||
124902726|NCT00957658|449268363|FG000|Overall Study|Site termination|10|||
124902727|NCT00957658|449268363|FG000|Overall Study|unwilling/unable to return|2|||
124902728|NCT00957658|449268363|FG000|Overall Study|surgery cancelled|2|||
124902729|NCT00957658|449268363|FG000|Overall Study|Protocol Violation|5|||
124902730|NCT01833832|449268364|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
124902731|NCT01193153|449268365|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
124902732|NCT01193153|449268366|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
124902733|NCT01193153|449268365|FG000|Open-label Lead in Period|Pregnancy|1|||
124902734|NCT01193153|449268366|FG001|Open-label Lead in Period|Pregnancy|0|||
124902735|NCT01193153|449268365|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
124902736|NCT01193153|449268366|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
124902737|NCT01193153|449268365|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
124902738|NCT01193153|449268366|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
124902739|NCT01193153|449268365|FG000|Open-label Lead in Period|Other|14|||
124902740|NCT01193153|449268366|FG001|Open-label Lead in Period|Other|0|||
124902741|NCT01193153|449268365|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
124902742|NCT01193153|449268366|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
124902743|NCT01193153|449268365|FG000|Open-label Lead in Period|Adverse Event|41|||
124902744|NCT01193153|449268366|FG001|Open-label Lead in Period|Adverse Event|0|||
124902745|NCT01193153|449268365|FG000|Open-label Lead in Period|Death|1|||
124902746|NCT01193153|449268366|FG001|Open-label Lead in Period|Death|0|||
124902747|NCT01193153|449268365|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
124902748|NCT01193153|449268366|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
124902749|NCT01193153|449268365|FG000|Open-label Stabilization Period|Adverse Event|9|||
124902750|NCT01193153|449268366|FG001|Open-label Stabilization Period|Adverse Event|0|||
124902751|NCT01193153|449268365|FG000|Open-label Stabilization Period|Death|2|||
124902752|NCT01193153|449268366|FG001|Open-label Stabilization Period|Death|0|||
124902753|NCT01193153|449268365|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
124902754|NCT01193153|449268366|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
124902755|NCT01193153|449268365|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
124902756|NCT01193153|449268366|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
124902757|NCT01193153|449268365|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
124902758|NCT01193153|449268366|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
124902759|NCT01193153|449268365|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
124902760|NCT01193153|449268366|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
124902761|NCT01193153|449268365|FG000|Open-label Stabilization Period|Other|8|||
124902762|NCT01193153|449268366|FG001|Open-label Stabilization Period|Other|0|||
124902763|NCT01193153|449268365|FG000|Double Blind Relapse Prevention Period|Other|2|||
124902764|NCT01193153|449268366|FG001|Double Blind Relapse Prevention Period|Other|3|||
124902765|NCT01193153|449268365|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
124902766|NCT01193153|449268366|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
124902767|NCT01193153|449268365|FG000|Double Blind Relapse Prevention Period|Death|2|||
124902768|NCT01193153|449268366|FG001|Double Blind Relapse Prevention Period|Death|0|||
124902769|NCT01193153|449268365|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
124902770|NCT01193153|449268366|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
124902771|NCT01193153|449268365|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
124902772|NCT01193153|449268366|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
124902773|NCT01193153|449268365|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
124902774|NCT01193153|449268366|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
124902775|NCT01193153|449268365|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
124902776|NCT01193153|449268366|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
124902777|NCT01193153|449268365|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
124902778|NCT01193153|449268366|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
124902779|NCT01988233|449268367|FG000|Overall Study|Lost to Follow-up|64|||
124902780|NCT01988233|449268368|FG001|Overall Study|Lost to Follow-up|51|||
124902781|NCT03621761|449268369|FG000|Overall Study|Lost to Follow-up|1|||
124902782|NCT03621761|449268370|FG001|Overall Study|Lost to Follow-up|1|||
124902783|NCT03621761|449268371|FG002|Overall Study|Lost to Follow-up|2|||
124902784|NCT03621761|449268369|FG000|Overall Study|Withdrawal by Subject|2|||
124902785|NCT03621761|449268370|FG001|Overall Study|Withdrawal by Subject|1|||
124902786|NCT03621761|449268371|FG002|Overall Study|Withdrawal by Subject|1|||
124902787|NCT03621761|449268369|FG000|Overall Study|Became Ineligible|0|||
124902788|NCT03621761|449268370|FG001|Overall Study|Became Ineligible|2|||
124902789|NCT03621761|449268371|FG002|Overall Study|Became Ineligible|0|||
124902790|NCT05046132|449268372|FG000|Overall Study|Adverse Event|4|||
124902791|NCT05046132|449268373|FG001|Overall Study|Adverse Event|0|||
124902792|NCT05046132|449268374|FG002|Overall Study|Adverse Event|0|||
124902793|NCT05046132|449268372|FG000|Overall Study|Withdrawal by Subject|3|||
124902794|NCT05046132|449268373|FG001|Overall Study|Withdrawal by Subject|0|||
124902795|NCT05046132|449268374|FG002|Overall Study|Withdrawal by Subject|0|||
124902796|NCT05046132|449268372|FG000|Overall Study|Positive Covid19 Result.|0|||
124902797|NCT05046132|449268373|FG001|Overall Study|Positive Covid19 Result.|1|||
125021244|NCT02028455|449700963|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
125021245|NCT02028455|449700964|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
125113613|NCT01360632|450038649|FG003|Phase A+|Adverse Event|0|||
125113614|NCT01360632|450038650|FG004|Phase A+|Adverse Event|2|||
125113615|NCT01360632|450038646|FG000|Phase A+|Met Withdrawal Criteria|0|||
125113616|NCT01360632|450038647|FG001|Phase A+|Met Withdrawal Criteria|0|||
125113617|NCT01360632|450038648|FG002|Phase A+|Met Withdrawal Criteria|0|||
125113618|NCT01360632|450038649|FG003|Phase A+|Met Withdrawal Criteria|0|||
125113619|NCT01360632|450038650|FG004|Phase A+|Met Withdrawal Criteria|7|||
125113620|NCT01360632|450038646|FG000|Phase A+|Physician Decision|0|||
125113621|NCT01360632|450038647|FG001|Phase A+|Physician Decision|0|||
125113622|NCT01360632|450038648|FG002|Phase A+|Physician Decision|0|||
125113623|NCT01360632|450038649|FG003|Phase A+|Physician Decision|0|||
125113624|NCT01360632|450038650|FG004|Phase A+|Physician Decision|3|||
125113625|NCT01360632|450038646|FG000|Phase A+|Withdrawal by Subject|0|||
125113626|NCT01360632|450038647|FG001|Phase A+|Withdrawal by Subject|0|||
125113627|NCT01360632|450038648|FG002|Phase A+|Withdrawal by Subject|0|||
125113628|NCT01360632|450038649|FG003|Phase A+|Withdrawal by Subject|0|||
125113629|NCT01360632|450038650|FG004|Phase A+|Withdrawal by Subject|8|||
125113630|NCT01360632|450038646|FG000|Phase A+|Protocol Deviation|0|||
125113631|NCT01360632|450038647|FG001|Phase A+|Protocol Deviation|0|||
125113632|NCT01360632|450038648|FG002|Phase A+|Protocol Deviation|0|||
125113633|NCT01360632|450038649|FG003|Phase A+|Protocol Deviation|0|||
125113634|NCT01360632|450038650|FG004|Phase A+|Protocol Deviation|3|||
125113635|NCT01084005|450040341|FG000|Overall Study|Adverse Event|1|||
125113636|NCT01084005|450040342|FG001|Overall Study|Adverse Event|8|||
125113637|NCT01084005|450040341|FG000|Overall Study|Protocol Violation|3|||
125113638|NCT01084005|450040342|FG001|Overall Study|Protocol Violation|7|||
125113639|NCT01084005|450040341|FG000|Overall Study|Withdrawal by Subject|1|||
125113640|NCT01084005|450040342|FG001|Overall Study|Withdrawal by Subject|1|||
125113641|NCT02480010|450040343|FG000|Overall Study|Adverse Event|3|||
125113642|NCT02480010|450040344|FG001|Overall Study|Adverse Event|1|||
125113643|NCT02480010|450040343|FG000|Overall Study|Death|1|||
125113644|NCT02480010|450040344|FG001|Overall Study|Death|0|||
125113645|NCT02480010|450040343|FG000|Overall Study|Insufficient therapeutic response|31|||
124902798|NCT05046132|449268374|FG002|Overall Study|Positive Covid19 Result.|0|||
124902799|NCT01186848|449268380|FG000|Overall Study|Lost to Follow-up|4|||
124902800|NCT01186848|449268380|FG000|Overall Study|Withdrawal by Subject|2|||
124902801|NCT01186848|449268380|FG000|Overall Study|Adverse Event|2|||
124902802|NCT01183780|449268389|FG000|Overall Study|Withdrawal by Subject|25|||
124902803|NCT01183780|449268390|FG001|Overall Study|Withdrawal by Subject|14|||
124902804|NCT01183780|449268389|FG000|Overall Study|Lost to Follow-up|6|||
124902805|NCT01183780|449268390|FG001|Overall Study|Lost to Follow-up|11|||
124902806|NCT04379713|449268391|FG000|Overall Study|Adverse Event|2|||
124902807|NCT04379713|449268392|FG001|Overall Study|Adverse Event|0|||
124902808|NCT04379713|449268391|FG000|Overall Study|Physician Decision|2|||
124902809|NCT04379713|449268392|FG001|Overall Study|Physician Decision|1|||
124902810|NCT04379713|449268391|FG000|Overall Study|Protocol Violation|11|||
124902811|NCT04379713|449268392|FG001|Overall Study|Protocol Violation|6|||
125113646|NCT02480010|450040344|FG001|Overall Study|Insufficient therapeutic response|29|||
125113647|NCT02480010|450040343|FG000|Overall Study|Refused Treatment|0|||
125113648|NCT02480010|450040344|FG001|Overall Study|Refused Treatment|3|||
125113649|NCT01034137|450040348|FG000|Overall Study|Adverse Event|9|||
125113650|NCT01034137|450040349|FG001|Overall Study|Adverse Event|10|||
125113651|NCT01034137|450040350|FG002|Overall Study|Adverse Event|8|||
125113652|NCT01034137|450040348|FG000|Overall Study|Withdrawal by Subject|4|||
125113653|NCT01034137|450040349|FG001|Overall Study|Withdrawal by Subject|3|||
125113654|NCT01034137|450040350|FG002|Overall Study|Withdrawal by Subject|3|||
125113655|NCT01034137|450040348|FG000|Overall Study|Lack of Efficacy|9|||
125113656|NCT01034137|450040349|FG001|Overall Study|Lack of Efficacy|4|||
125113657|NCT01034137|450040350|FG002|Overall Study|Lack of Efficacy|13|||
125113658|NCT01034137|450040348|FG000|Overall Study|Protocol Violation|2|||
125113659|NCT01034137|450040349|FG001|Overall Study|Protocol Violation|2|||
125113660|NCT01034137|450040350|FG002|Overall Study|Protocol Violation|1|||
124902812|NCT04379713|449268391|FG000|Overall Study|No longer met eligibility criteria|14|||
124902813|NCT04379713|449268392|FG001|Overall Study|No longer met eligibility criteria|11|||
124902814|NCT04379713|449268391|FG000|Overall Study|Withdrawal by parent/guardian|36|||
125113661|NCT01034137|450040348|FG000|Overall Study|Refused treatment or did not cooperate|2|||
125113662|NCT01034137|450040349|FG001|Overall Study|Refused treatment or did not cooperate|0|||
125113663|NCT01034137|450040350|FG002|Overall Study|Refused treatment or did not cooperate|1|||
125113664|NCT01034137|450040348|FG000|Overall Study|Administrative or other|2|||
125113665|NCT01034137|450040349|FG001|Overall Study|Administrative or other|3|||
125113666|NCT01034137|450040350|FG002|Overall Study|Administrative or other|4|||
125113667|NCT01764854|450040354|FG000|Overall Study|Adverse Event|0|||
125113668|NCT01764854|450040355|FG001|Overall Study|Adverse Event|0|||
125113669|NCT01764854|450040356|FG002|Overall Study|Adverse Event|2|||
125113670|NCT01764854|450040357|FG003|Overall Study|Adverse Event|0|||
125113671|NCT01764854|450040354|FG000|Overall Study|Withdrawal by Subject|0|||
125113672|NCT01764854|450040355|FG001|Overall Study|Withdrawal by Subject|0|||
125113673|NCT01764854|450040356|FG002|Overall Study|Withdrawal by Subject|1|||
125113674|NCT01764854|450040357|FG003|Overall Study|Withdrawal by Subject|0|||
124902815|NCT04379713|449268392|FG001|Overall Study|Withdrawal by parent/guardian|15|||
124902816|NCT04379713|449268391|FG000|Overall Study|Lost to Follow-up|31|||
124902817|NCT04379713|449268392|FG001|Overall Study|Lost to Follow-up|21|||
124902818|NCT02148133|449268397|FG000|Overall Study|Investigator discretion|1|||
124902819|NCT02148133|449268397|FG000|Overall Study|Lack of Efficacy|1|||
124902820|NCT02148133|449268397|FG000|Overall Study|Protocol deviation|1|||
124902821|NCT02148133|449268397|FG000|Overall Study|Protocol-defined stopping criteria|2|||
124902822|NCT03808883|449268398|FG000|Overall Study|Withdrawal by Subject|2|||
124902823|NCT03808883|449268399|FG001|Overall Study|Withdrawal by Subject|0|||
124902824|NCT03808883|449268398|FG000|Overall Study|Did not complete pre test or post test survey|4|||
124902825|NCT03808883|449268399|FG001|Overall Study|Did not complete pre test or post test survey|3|||
124902826|NCT04567888|449268400|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
124902827|NCT04567888|449268401|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
124902828|NCT04567888|449268400|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
124902829|NCT04567888|449268401|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
124902830|NCT04567888|449268400|FG000|Overall Study|Reported Unusual Birth Year|2|||
124902831|NCT04567888|449268401|FG001|Overall Study|Reported Unusual Birth Year|3|||
124902832|NCT04567888|449268400|FG000|Overall Study|Duplicate Responses|0|||
124902833|NCT04567888|449268401|FG001|Overall Study|Duplicate Responses|1|||
124902834|NCT00371566|449268404|FG000|Treatment Phase|Withdrawal by Subject|0|||
124902835|NCT00371566|449268405|FG001|Treatment Phase|Withdrawal by Subject|1|||
124902836|NCT00371566|449268404|FG000|Treatment Phase|Adverse Event|0|||
124902837|NCT00371566|449268405|FG001|Treatment Phase|Adverse Event|1|||
124902838|NCT00371566|449268404|FG000|Treatment Phase|Protocol Violation|0|||
124902839|NCT00371566|449268405|FG001|Treatment Phase|Protocol Violation|1|||
124902840|NCT00371566|449268404|FG000|Chemoradiation Phase|Physician Decision|2|||
124902841|NCT00371566|449268405|FG001|Chemoradiation Phase|Physician Decision|0|||
124902842|NCT00371566|449268404|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
124902843|NCT00371566|449268405|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
124902844|NCT00371566|449268404|FG000|Chemoradiation Phase|Non compliant|0|||
124902845|NCT00371566|449268405|FG001|Chemoradiation Phase|Non compliant|1|||
124902846|NCT00371566|449268404|FG000|Chemoradiation Phase|Progressive Disease|1|||
124902847|NCT00371566|449268405|FG001|Chemoradiation Phase|Progressive Disease|1|||
124902848|NCT00371566|449268404|FG000|Chemoradiation Phase|Death|2|||
124902849|NCT00371566|449268405|FG001|Chemoradiation Phase|Death|0|||
124902850|NCT00371566|449268404|FG000|Follow Up Phase|Death|0|||
124902851|NCT00371566|449268405|FG001|Follow Up Phase|Death|5|||
124902852|NCT00371566|449268404|FG000|Follow Up Phase|Disease progression|1|||
124902853|NCT00371566|449268405|FG001|Follow Up Phase|Disease progression|0|||
124902854|NCT00371566|449268404|FG000|Follow Up Phase|Withdrawal by Subject|0|||
124902855|NCT00371566|449268405|FG001|Follow Up Phase|Withdrawal by Subject|1|||
124902856|NCT00371566|449268404|FG000|Follow Up Phase|Physician Decision|1|||
124902857|NCT00371566|449268405|FG001|Follow Up Phase|Physician Decision|1|||
124902858|NCT00371566|449268404|FG000|Follow Up Phase|Lost to Follow-up|1|||
124902859|NCT00371566|449268405|FG001|Follow Up Phase|Lost to Follow-up|0|||
124902860|NCT00878722|449268406|FG000|Overall Study|Progressive disease|3|||
124902861|NCT00878722|449268407|FG001|Overall Study|Progressive disease|3|||
124902862|NCT00878722|449268408|FG002|Overall Study|Progressive disease|3|||
124902863|NCT00878722|449268409|FG003|Overall Study|Progressive disease|7|||
124902864|NCT00878722|449268410|FG004|Overall Study|Progressive disease|7|||
124902865|NCT00878722|449268411|FG005|Overall Study|Progressive disease|1|||
124902866|NCT00878722|449268412|FG006|Overall Study|Progressive disease|4|||
124902867|NCT00878722|449268413|FG007|Overall Study|Progressive disease|3|||
124902868|NCT00878722|449268406|FG000|Overall Study|Death|0|||
124902869|NCT00878722|449268407|FG001|Overall Study|Death|0|||
124902870|NCT00878722|449268408|FG002|Overall Study|Death|0|||
124902871|NCT00878722|449268409|FG003|Overall Study|Death|1|||
124902872|NCT00878722|449268410|FG004|Overall Study|Death|0|||
124902873|NCT00878722|449268411|FG005|Overall Study|Death|1|||
124902874|NCT00878722|449268412|FG006|Overall Study|Death|0|||
124902875|NCT00878722|449268413|FG007|Overall Study|Death|2|||
124902876|NCT00878722|449268406|FG000|Overall Study|Adverse Event|0|||
124902877|NCT00878722|449268407|FG001|Overall Study|Adverse Event|0|||
124902878|NCT00878722|449268408|FG002|Overall Study|Adverse Event|0|||
124902879|NCT00878722|449268409|FG003|Overall Study|Adverse Event|0|||
124902880|NCT00878722|449268410|FG004|Overall Study|Adverse Event|0|||
124902881|NCT00878722|449268411|FG005|Overall Study|Adverse Event|0|||
124902882|NCT00878722|449268412|FG006|Overall Study|Adverse Event|2|||
124902883|NCT00878722|449268413|FG007|Overall Study|Adverse Event|0|||
124902884|NCT00878722|449268406|FG000|Overall Study|Withdrawal by Subject|0|||
124902885|NCT00878722|449268407|FG001|Overall Study|Withdrawal by Subject|0|||
124902886|NCT00878722|449268408|FG002|Overall Study|Withdrawal by Subject|0|||
124902887|NCT00878722|449268409|FG003|Overall Study|Withdrawal by Subject|0|||
124902888|NCT00878722|449268410|FG004|Overall Study|Withdrawal by Subject|0|||
124902889|NCT00878722|449268411|FG005|Overall Study|Withdrawal by Subject|0|||
124902890|NCT00878722|449268412|FG006|Overall Study|Withdrawal by Subject|0|||
124902891|NCT00878722|449268413|FG007|Overall Study|Withdrawal by Subject|2|||
124902892|NCT00878722|449268406|FG000|Overall Study|Relapse|0|||
124902893|NCT00878722|449268407|FG001|Overall Study|Relapse|0|||
124902894|NCT00878722|449268408|FG002|Overall Study|Relapse|0|||
124902895|NCT00878722|449268409|FG003|Overall Study|Relapse|1|||
124902896|NCT00878722|449268410|FG004|Overall Study|Relapse|0|||
124902897|NCT00878722|449268411|FG005|Overall Study|Relapse|0|||
124902898|NCT00878722|449268412|FG006|Overall Study|Relapse|0|||
124902899|NCT00878722|449268413|FG007|Overall Study|Relapse|0|||
124902900|NCT00319436|449268414|FG000|Overall Study|Withdrawal by Subject|6|||
124902901|NCT00319436|449268415|FG001|Overall Study|Withdrawal by Subject|7|||
124902902|NCT01161498|449268416|FG000|Overall Study|Disease Progression|0|||
124902903|NCT01161498|449268417|FG001|Overall Study|Disease Progression|1|||
124902904|NCT02807493|449268420|FG000|Overall Study|Adverse Event|5|||
124902905|NCT02807493|449268421|FG001|Overall Study|Adverse Event|2|||
124902906|NCT02807493|449268420|FG000|Overall Study|Lost to Follow-up|6|||
124902907|NCT02807493|449268421|FG001|Overall Study|Lost to Follow-up|0|||
124902908|NCT02807493|449268420|FG000|Overall Study|Physician Decision|4|||
124902909|NCT02807493|449268421|FG001|Overall Study|Physician Decision|1|||
124902910|NCT02807493|449268420|FG000|Overall Study|Protocol Violation|7|||
124902911|NCT02807493|449268421|FG001|Overall Study|Protocol Violation|0|||
124902912|NCT02807493|449268420|FG000|Overall Study|Withdrawal by Subject|17|||
124902913|NCT02807493|449268421|FG001|Overall Study|Withdrawal by Subject|10|||
124902914|NCT02807493|449268420|FG000|Overall Study|Other withdrawal|17|||
124902915|NCT02807493|449268421|FG001|Overall Study|Other withdrawal|0|||
124902916|NCT02807493|449268420|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
124902917|NCT02807493|449268421|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
124902918|NCT02781584|449268422|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
124902919|NCT02781584|449268423|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
124902920|NCT02781584|449268424|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
124902921|NCT02781584|449268425|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
124902922|NCT02781584|449268426|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
124902923|NCT02781584|449268427|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
124902924|NCT02781584|449268428|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
124902925|NCT02781584|449268429|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
124902926|NCT02781584|449268430|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
124902927|NCT02781584|449268431|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
124902928|NCT02781584|449268432|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
124902929|NCT02781584|449268433|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
124902930|NCT02781584|449268434|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
124902931|NCT02781584|449268422|FG000|Pre-treatment Phase|Adverse Event|0|||
124902932|NCT02781584|449268423|FG001|Pre-treatment Phase|Adverse Event|0|||
124902933|NCT02781584|449268424|FG002|Pre-treatment Phase|Adverse Event|0|||
124902934|NCT02781584|449268425|FG003|Pre-treatment Phase|Adverse Event|0|||
124902935|NCT02781584|449268426|FG004|Pre-treatment Phase|Adverse Event|0|||
124902936|NCT02781584|449268427|FG005|Pre-treatment Phase|Adverse Event|0|||
124902937|NCT02781584|449268428|FG006|Pre-treatment Phase|Adverse Event|0|||
124902938|NCT02781584|449268429|FG007|Pre-treatment Phase|Adverse Event|0|||
124902939|NCT02781584|449268430|FG008|Pre-treatment Phase|Adverse Event|0|||
124902940|NCT02781584|449268431|FG009|Pre-treatment Phase|Adverse Event|0|||
124902941|NCT02781584|449268432|FG010|Pre-treatment Phase|Adverse Event|0|||
124902942|NCT02781584|449268433|FG011|Pre-treatment Phase|Adverse Event|1|||
124902943|NCT02781584|449268434|FG012|Pre-treatment Phase|Adverse Event|0|||
124902944|NCT02781584|449268422|FG000|Treatment Phase|Withdrew Consent|0|||
124902945|NCT02781584|449268423|FG001|Treatment Phase|Withdrew Consent|0|||
124902946|NCT02781584|449268424|FG002|Treatment Phase|Withdrew Consent|0|||
124902947|NCT02781584|449268425|FG003|Treatment Phase|Withdrew Consent|0|||
124902948|NCT02781584|449268426|FG004|Treatment Phase|Withdrew Consent|0|||
124902949|NCT02781584|449268427|FG005|Treatment Phase|Withdrew Consent|1|||
124902950|NCT02781584|449268428|FG006|Treatment Phase|Withdrew Consent|0|||
124902951|NCT02781584|449268429|FG007|Treatment Phase|Withdrew Consent|0|||
124902952|NCT02781584|449268430|FG008|Treatment Phase|Withdrew Consent|0|||
124902953|NCT02781584|449268431|FG009|Treatment Phase|Withdrew Consent|0|||
124902954|NCT02781584|449268432|FG010|Treatment Phase|Withdrew Consent|1|||
124902955|NCT02781584|449268433|FG011|Treatment Phase|Withdrew Consent|2|||
124902956|NCT02781584|449268434|FG012|Treatment Phase|Withdrew Consent|0|||
124902957|NCT02781584|449268422|FG000|Treatment Phase|Adverse Event|0|||
124902958|NCT02781584|449268423|FG001|Treatment Phase|Adverse Event|0|||
124902959|NCT02781584|449268424|FG002|Treatment Phase|Adverse Event|0|||
124902960|NCT02781584|449268425|FG003|Treatment Phase|Adverse Event|0|||
124902961|NCT02781584|449268426|FG004|Treatment Phase|Adverse Event|0|||
124902962|NCT02781584|449268427|FG005|Treatment Phase|Adverse Event|0|||
124902963|NCT02781584|449268428|FG006|Treatment Phase|Adverse Event|0|||
124902964|NCT02781584|449268429|FG007|Treatment Phase|Adverse Event|1|||
124902965|NCT02781584|449268430|FG008|Treatment Phase|Adverse Event|0|||
124902966|NCT02781584|449268431|FG009|Treatment Phase|Adverse Event|0|||
124902967|NCT02781584|449268432|FG010|Treatment Phase|Adverse Event|0|||
124902968|NCT02781584|449268433|FG011|Treatment Phase|Adverse Event|0|||
124902969|NCT02781584|449268434|FG012|Treatment Phase|Adverse Event|0|||
124902970|NCT01123083|449268441|FG000|Overall Study|Investigator recommendation|1|||
124902971|NCT01123083|449268442|FG001|Overall Study|Investigator recommendation|1|||
124902972|NCT01123083|449268441|FG000|Overall Study|Administrative reasons|0|||
124902973|NCT01123083|449268442|FG001|Overall Study|Administrative reasons|4|||
124902974|NCT01123083|449268441|FG000|Overall Study|Lost to Follow-up|2|||
124902975|NCT01123083|449268442|FG001|Overall Study|Lost to Follow-up|6|||
124902976|NCT01123083|449268441|FG000|Overall Study|Adverse Event|1|||
124902977|NCT01123083|449268442|FG001|Overall Study|Adverse Event|0|||
124902978|NCT01123083|449268441|FG000|Overall Study|Withdrew for another reason not covered|0|||
124902979|NCT01123083|449268442|FG001|Overall Study|Withdrew for another reason not covered|1|||
124902980|NCT01123083|449268441|FG000|Overall Study|Participant/legal representative request|7|||
124902981|NCT01123083|449268442|FG001|Overall Study|Participant/legal representative request|3|||
124902982|NCT02385669|449270002|FG000|Overall Study|Adverse Event|2|||
124902983|NCT02810080|449270003|FG000|Overall Study|Adverse Event|3|||
124902984|NCT02810080|449270004|FG001|Overall Study|Adverse Event|0|||
124902985|NCT02810080|449270003|FG000|Overall Study|Death|0|||
124902986|NCT02810080|449270004|FG001|Overall Study|Death|2|||
124902987|NCT02810080|449270003|FG000|Overall Study|Physician Decision|4|||
124902988|NCT02810080|449270004|FG001|Overall Study|Physician Decision|0|||
124902989|NCT02810080|449270003|FG000|Overall Study|Withdrawal by Subject|0|||
124902990|NCT02810080|449270004|FG001|Overall Study|Withdrawal by Subject|2|||
124902991|NCT05257798|449270006|FG000|Follow-up Phase|Lost to Follow-up|1|||
124902992|NCT05257798|449270007|FG001|Follow-up Phase|Lost to Follow-up|0|||
124902993|NCT00419094|449270010|FG000|Overall Study|Adverse Event|3|||
124902994|NCT00419094|449270011|FG001|Overall Study|Adverse Event|7|||
124902995|NCT00419094|449270010|FG000|Overall Study|Lack of Efficacy|1|||
124902996|NCT00419094|449270011|FG001|Overall Study|Lack of Efficacy|0|||
124902997|NCT00419094|449270010|FG000|Overall Study|Lost to Follow-up|0|||
124902998|NCT00419094|449270011|FG001|Overall Study|Lost to Follow-up|2|||
124902999|NCT00419094|449270010|FG000|Overall Study|Protocol Violation|1|||
124903000|NCT00419094|449270011|FG001|Overall Study|Protocol Violation|14|||
124903001|NCT00419094|449270010|FG000|Overall Study|Withdrawal of consent|1|||
124903002|NCT00419094|449270011|FG001|Overall Study|Withdrawal of consent|5|||
124903003|NCT00419094|449270010|FG000|Overall Study|Other: Error determining exit criteria|1|||
124903004|NCT00419094|449270011|FG001|Overall Study|Other: Error determining exit criteria|0|||
124903005|NCT00419094|449270010|FG000|Overall Study|Other: Patient non-compliant|0|||
124903006|NCT00419094|449270011|FG001|Overall Study|Other: Patient non-compliant|1|||
124903007|NCT00419094|449270010|FG000|Overall Study|Other: No contact for extended period|0|||
124903008|NCT00419094|449270011|FG001|Overall Study|Other: No contact for extended period|1|||
124903009|NCT02034916|449270013|FG000|Overall Study|Death|39|||
124903010|NCT02034916|449270014|FG001|Overall Study|Death|28|||
124903011|NCT02034916|449270013|FG000|Overall Study|Withdrawal by Subject|2|||
124903012|NCT02034916|449270014|FG001|Overall Study|Withdrawal by Subject|1|||
124903013|NCT02034916|449270013|FG000|Overall Study|Lost to Follow-up|4|||
124903014|NCT02034916|449270014|FG001|Overall Study|Lost to Follow-up|1|||
124903015|NCT02034916|449270013|FG000|Overall Study|Study terminated by sponsor|4|||
124903016|NCT02034916|449270014|FG001|Overall Study|Study terminated by sponsor|5|||
124903017|NCT01616654|449270019|FG000|Overall Study|Lack of Efficacy|1|||
124903018|NCT01616654|449270020|FG001|Overall Study|Lack of Efficacy|0|||
124903019|NCT01616654|449270021|FG002|Overall Study|Lack of Efficacy|0|||
124903020|NCT01616654|449270022|FG003|Overall Study|Lack of Efficacy|0|||
124903021|NCT01616654|449270023|FG004|Overall Study|Lack of Efficacy|1|||
124903022|NCT01616654|449270019|FG000|Overall Study|Adverse Event|0|||
124903023|NCT01616654|449270020|FG001|Overall Study|Adverse Event|1|||
124903024|NCT01616654|449270021|FG002|Overall Study|Adverse Event|2|||
124903025|NCT01616654|449270022|FG003|Overall Study|Adverse Event|1|||
124903026|NCT01616654|449270023|FG004|Overall Study|Adverse Event|0|||
124903027|NCT01616654|449270019|FG000|Overall Study|Withdrawal by Subject|2|||
124903028|NCT01616654|449270020|FG001|Overall Study|Withdrawal by Subject|2|||
124903029|NCT01616654|449270021|FG002|Overall Study|Withdrawal by Subject|3|||
124903030|NCT01616654|449270022|FG003|Overall Study|Withdrawal by Subject|1|||
124903031|NCT01616654|449270023|FG004|Overall Study|Withdrawal by Subject|5|||
124903032|NCT01616654|449270019|FG000|Overall Study|Protocol Violation|0|||
124903033|NCT01616654|449270020|FG001|Overall Study|Protocol Violation|5|||
124903034|NCT01616654|449270021|FG002|Overall Study|Protocol Violation|2|||
124903035|NCT01616654|449270022|FG003|Overall Study|Protocol Violation|4|||
124903036|NCT01616654|449270023|FG004|Overall Study|Protocol Violation|4|||
124903037|NCT01616654|449270019|FG000|Overall Study|Lost to Follow-up|1|||
124903038|NCT01616654|449270020|FG001|Overall Study|Lost to Follow-up|0|||
124903039|NCT01616654|449270021|FG002|Overall Study|Lost to Follow-up|3|||
124903040|NCT01616654|449270022|FG003|Overall Study|Lost to Follow-up|2|||
124903041|NCT01616654|449270023|FG004|Overall Study|Lost to Follow-up|1|||
124903042|NCT01616654|449270019|FG000|Overall Study|Pregnancy|1|||
124903043|NCT01616654|449270020|FG001|Overall Study|Pregnancy|0|||
124903044|NCT01616654|449270021|FG002|Overall Study|Pregnancy|0|||
124903045|NCT01616654|449270022|FG003|Overall Study|Pregnancy|0|||
124903046|NCT01616654|449270023|FG004|Overall Study|Pregnancy|1|||
124903047|NCT02057692|449270024|FG000|Overall Study|Adverse Event|1|||
124903048|NCT02057692|449270025|FG001|Overall Study|Adverse Event|0|||
124903049|NCT02057692|449270026|FG002|Overall Study|Adverse Event|0|||
124903050|NCT02057692|449270027|FG003|Overall Study|Adverse Event|0|||
124903051|NCT02057692|449270024|FG000|Overall Study|Lost to Follow-up|0|||
124903052|NCT02057692|449270025|FG001|Overall Study|Lost to Follow-up|0|||
124903053|NCT02057692|449270026|FG002|Overall Study|Lost to Follow-up|0|||
124903054|NCT02057692|449270027|FG003|Overall Study|Lost to Follow-up|1|||
124903055|NCT00864682|449270028|FG000|Overall Study|Protocol Violation|2|||
124903056|NCT00864682|449270029|FG001|Overall Study|Protocol Violation|1|||
124903057|NCT00864682|449270030|FG002|Overall Study|Protocol Violation|2|||
124903058|NCT02393716|449270032|FG000|Overall Study|Death|29|||
124903059|NCT02393716|449270032|FG000|Overall Study|Withdrawal by Subject|8|||
124903060|NCT02393716|449270032|FG000|Overall Study|Device Explanted|8|||
124903061|NCT02393716|449270032|FG000|Overall Study|Missed visit|16|||
124903062|NCT04842604|449270035|FG000|Overall Study|Death|1|||
124903063|NCT04842604|449270036|FG001|Overall Study|Death|0|||
124903064|NCT04842604|449270035|FG000|Overall Study|Other|4|||
124903065|NCT04842604|449270036|FG001|Overall Study|Other|4|||
124903066|NCT04842604|449270035|FG000|Overall Study|Randomized but not treated|1|||
124903067|NCT04842604|449270036|FG001|Overall Study|Randomized but not treated|0|||
124903068|NCT01648140|449270037|FG000|Overall Study|Physician Decision|1|||
124903069|NCT01648140|449270038|FG001|Overall Study|Physician Decision|0|||
124903070|NCT01648140|449270039|FG002|Overall Study|Physician Decision|0|||
124903071|NCT01648140|449270040|FG003|Overall Study|Physician Decision|0|||
124903072|NCT01648140|449270037|FG000|Overall Study|Lack of Efficacy|4|||
124903073|NCT01648140|449270038|FG001|Overall Study|Lack of Efficacy|7|||
124903074|NCT01648140|449270039|FG002|Overall Study|Lack of Efficacy|1|||
124903075|NCT01648140|449270040|FG003|Overall Study|Lack of Efficacy|0|||
124903076|NCT01648140|449270037|FG000|Overall Study|Adverse Event|3|||
124903077|NCT01648140|449270038|FG001|Overall Study|Adverse Event|1|||
124903078|NCT01648140|449270039|FG002|Overall Study|Adverse Event|2|||
124903079|NCT01648140|449270040|FG003|Overall Study|Adverse Event|0|||
124903080|NCT01648140|449270037|FG000|Overall Study|Withdrawal by Subject|2|||
124903081|NCT01648140|449270038|FG001|Overall Study|Withdrawal by Subject|3|||
124903082|NCT01648140|449270039|FG002|Overall Study|Withdrawal by Subject|3|||
124903083|NCT01648140|449270040|FG003|Overall Study|Withdrawal by Subject|2|||
124903084|NCT01648140|449270037|FG000|Overall Study|Lost to Follow-up|2|||
124903085|NCT01648140|449270038|FG001|Overall Study|Lost to Follow-up|1|||
124903086|NCT01648140|449270039|FG002|Overall Study|Lost to Follow-up|2|||
124903087|NCT01648140|449270040|FG003|Overall Study|Lost to Follow-up|0|||
124903088|NCT00608907|449270043|FG000|Overall Study|Adverse Event|6|||
124903089|NCT00608907|449270044|FG001|Overall Study|Adverse Event|0|||
124903090|NCT00608907|449270045|FG002|Overall Study|Adverse Event|1|||
124903091|NCT00608907|449270043|FG000|Overall Study|Death|1|||
124903092|NCT00608907|449270044|FG001|Overall Study|Death|0|||
124903093|NCT00608907|449270045|FG002|Overall Study|Death|0|||
124903094|NCT00608907|449270043|FG000|Overall Study|Withdrawal by Subject|4|||
124903095|NCT00608907|449270044|FG001|Overall Study|Withdrawal by Subject|0|||
124903096|NCT00608907|449270045|FG002|Overall Study|Withdrawal by Subject|0|||
124903097|NCT00608907|449270043|FG000|Overall Study|Progressive Disease|1|||
124903098|NCT00608907|449270044|FG001|Overall Study|Progressive Disease|0|||
124903099|NCT00608907|449270045|FG002|Overall Study|Progressive Disease|0|||
124903100|NCT00758602|449270054|FG000|Overall Study|Adverse Event|11|||
124903101|NCT00758602|449270055|FG001|Overall Study|Adverse Event|10|||
124903102|NCT00758602|449270054|FG000|Overall Study|Lost to Follow-up|4|||
124903103|NCT00758602|449270055|FG001|Overall Study|Lost to Follow-up|3|||
124903104|NCT00758602|449270054|FG000|Overall Study|Withdrawal by Subject|1|||
124903105|NCT00758602|449270055|FG001|Overall Study|Withdrawal by Subject|3|||
124903106|NCT00758602|449270054|FG000|Overall Study|Protocol Violation|0|||
124903107|NCT00758602|449270055|FG001|Overall Study|Protocol Violation|2|||
124903108|NCT00758602|449270054|FG000|Overall Study|Death|0|||
124903109|NCT00758602|449270055|FG001|Overall Study|Death|1|||
124903110|NCT00758602|449270054|FG000|Overall Study|Reason not specified|3|||
124903111|NCT00758602|449270055|FG001|Overall Study|Reason not specified|3|||
124903112|NCT00158054|449270057|FG000|Overall Study|Refused to continue|3|||
125021246|NCT02028455|449700965|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
125021247|NCT02028455|449700966|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
124903113|NCT00158054|449270058|FG001|Overall Study|Refused to continue|0|||
125021248|NCT02028455|449700959|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
125021249|NCT02028455|449700960|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
124903114|NCT00158054|449270057|FG000|Overall Study|Unavailable for follow up|7|||
124903115|NCT00158054|449270058|FG001|Overall Study|Unavailable for follow up|3|||
124903116|NCT00079183|449270074|FG000|Overall Study|Withdrawal by Subject|4|||
124903117|NCT00079183|449270074|FG000|Overall Study|Study medication non-compliance|2|||
124903118|NCT00079183|449270074|FG000|Overall Study|Specimen collection non-compliance|1|||
124903119|NCT02371746|449270075|FG000|Overall Study|Consent withdrawn|0|||
124903120|NCT02371746|449270076|FG001|Overall Study|Consent withdrawn|0|||
124903121|NCT02371746|449270077|FG002|Overall Study|Consent withdrawn|0|||
124903122|NCT02371746|449270078|FG003|Overall Study|Consent withdrawn|0|||
124903123|NCT02371746|449270079|FG004|Overall Study|Consent withdrawn|0|||
124903124|NCT02371746|449270080|FG005|Overall Study|Consent withdrawn|0|||
124903125|NCT02371746|449270081|FG006|Overall Study|Consent withdrawn|1|||
124903126|NCT03743246|449270083|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
124903127|NCT03743246|449270084|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
124903128|NCT03743246|449270085|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
124903129|NCT03743246|449270086|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
124903130|NCT03743246|449270083|FG000|Pre-Treatment Period|Death|0|||
124903131|NCT03743246|449270084|FG001|Pre-Treatment Period|Death|1|||
124903132|NCT03743246|449270085|FG002|Pre-Treatment Period|Death|0|||
124903133|NCT03743246|449270086|FG003|Pre-Treatment Period|Death|1|||
124903134|NCT03743246|449270083|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
124903135|NCT03743246|449270084|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
124903136|NCT03743246|449270085|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
124903137|NCT03743246|449270086|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
124903138|NCT03743246|449270083|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
124903139|NCT03743246|449270084|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
124903140|NCT03743246|449270085|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
124903141|NCT03743246|449270086|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
124903142|NCT03743246|449270083|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
124903143|NCT03743246|449270084|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
124903144|NCT03743246|449270085|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
124903145|NCT03743246|449270086|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
124903146|NCT03743246|449270083|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
124903147|NCT03743246|449270084|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
124903148|NCT03743246|449270085|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
124903149|NCT03743246|449270086|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
124903150|NCT03743246|449270083|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
124903151|NCT03743246|449270084|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
124903152|NCT03743246|449270085|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
124903153|NCT03743246|449270086|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
124903154|NCT03743246|449270083|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
124903155|NCT03743246|449270084|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
124903156|NCT03743246|449270085|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
124903157|NCT03743246|449270086|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
124903158|NCT03743246|449270083|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
124903159|NCT03743246|449270084|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
124903160|NCT03743246|449270085|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
124903161|NCT03743246|449270086|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
124903162|NCT01490580|449270087|FG000|Overall Study|Parents withdrew consent|0|||
124903163|NCT01490580|449270088|FG001|Overall Study|Parents withdrew consent|2|||
124903164|NCT00949975|449270089|FG000|Overall Study|Voluntary discontinuation|6|||
124903165|NCT00949975|449270090|FG001|Overall Study|Voluntary discontinuation|5|||
124903166|NCT00949975|449270091|FG002|Overall Study|Voluntary discontinuation|3|||
124903167|NCT00949975|449270092|FG003|Overall Study|Voluntary discontinuation|6|||
124903168|NCT00949975|449270089|FG000|Overall Study|Adverse Event|11|||
124903169|NCT00949975|449270090|FG001|Overall Study|Adverse Event|11|||
124903170|NCT00949975|449270091|FG002|Overall Study|Adverse Event|10|||
124903171|NCT00949975|449270092|FG003|Overall Study|Adverse Event|10|||
124903172|NCT00949975|449270089|FG000|Overall Study|Safety reason|0|||
124903173|NCT00949975|449270090|FG001|Overall Study|Safety reason|1|||
124903174|NCT00949975|449270091|FG002|Overall Study|Safety reason|0|||
124903175|NCT00949975|449270092|FG003|Overall Study|Safety reason|0|||
124903176|NCT00949975|449270089|FG000|Overall Study|Study-specific criteria|0|||
124903177|NCT00949975|449270090|FG001|Overall Study|Study-specific criteria|1|||
124903178|NCT00949975|449270091|FG002|Overall Study|Study-specific criteria|1|||
124903179|NCT00949975|449270092|FG003|Overall Study|Study-specific criteria|0|||
124903180|NCT00949975|449270089|FG000|Overall Study|Incorrect enrolment|5|||
124903181|NCT00949975|449270090|FG001|Overall Study|Incorrect enrolment|10|||
124903182|NCT00949975|449270091|FG002|Overall Study|Incorrect enrolment|4|||
125021250|NCT02028455|449700961|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
125021251|NCT02028455|449700962|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
125021252|NCT02028455|449700963|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
124903183|NCT00949975|449270092|FG003|Overall Study|Incorrect enrolment|7|||
124903184|NCT00949975|449270089|FG000|Overall Study|Severe non-compliance|3|||
124903185|NCT00949975|449270090|FG001|Overall Study|Severe non-compliance|1|||
124903186|NCT00949975|449270091|FG002|Overall Study|Severe non-compliance|0|||
124903187|NCT00949975|449270092|FG003|Overall Study|Severe non-compliance|2|||
124903188|NCT00949975|449270089|FG000|Overall Study|Lost to Follow-up|1|||
124903189|NCT00949975|449270090|FG001|Overall Study|Lost to Follow-up|0|||
124903190|NCT00949975|449270091|FG002|Overall Study|Lost to Follow-up|1|||
124903191|NCT00949975|449270092|FG003|Overall Study|Lost to Follow-up|3|||
124903192|NCT00949975|449270089|FG000|Overall Study|Other|1|||
124903193|NCT00949975|449270090|FG001|Overall Study|Other|0|||
124903194|NCT00949975|449270091|FG002|Overall Study|Other|0|||
124903195|NCT00949975|449270092|FG003|Overall Study|Other|0|||
124903196|NCT02873754|449270093|FG000|Overall Study|Lost to Follow-up|5|||
124903197|NCT02873754|449270093|FG000|Overall Study|Couldn't complete study procedures|1|||
124903198|NCT00082810|449270106|FG000|Overall Study|Adverse Event|3|||
124903199|NCT00082810|449270106|FG000|Overall Study|Progressive disease|24|||
124903200|NCT00082810|449270106|FG000|Overall Study|Withdrawal by Subject|4|||
124903201|NCT02950558|449270107|FG000|Overall Study|Lost to Follow-up|2|||
124903202|NCT02950558|449270108|FG001|Overall Study|Lost to Follow-up|0|||
124903203|NCT01321606|449270111|FG000|Overall Study|Lost to Follow-up|0|||
124903204|NCT01321606|449270112|FG001|Overall Study|Lost to Follow-up|0|||
125113675|NCT01764854|450040354|FG000|Overall Study|relocation|0|||
125113676|NCT01764854|450040355|FG001|Overall Study|relocation|0|||
125113677|NCT01764854|450040356|FG002|Overall Study|relocation|2|||
125113678|NCT01764854|450040357|FG003|Overall Study|relocation|0|||
125113679|NCT01764854|450040354|FG000|Overall Study|Protocol Violation|0|||
125113680|NCT01764854|450040355|FG001|Overall Study|Protocol Violation|0|||
125113681|NCT01764854|450040356|FG002|Overall Study|Protocol Violation|1|||
125113682|NCT01764854|450040357|FG003|Overall Study|Protocol Violation|2|||
125113683|NCT03377556|450040366|FG000|Overall Study|Adverse Event|5|||
125113684|NCT03377556|450040366|FG000|Overall Study|Refusal unrelated to adverse events|1|||
125113685|NCT03377556|450040366|FG000|Overall Study|Progression/relapse|38|||
124903205|NCT01321606|449270113|FG002|Overall Study|Lost to Follow-up|0|||
124903206|NCT01321606|449270114|FG003|Overall Study|Lost to Follow-up|1|||
125113686|NCT03377556|450040366|FG000|Overall Study|Death|3|||
124903207|NCT02914522|449270115|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
125113687|NCT02736227|450040375|FG000|Overall Study|Withdrawal by Subject|0|||
125021253|NCT02028455|449700964|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
125021254|NCT02028455|449700965|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
125021255|NCT02028455|449700966|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
125021256|NCT02028455|449700959|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
125021257|NCT02028455|449700960|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
125021258|NCT02028455|449700961|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
125021259|NCT02028455|449700962|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
125021260|NCT02028455|449700963|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
125021261|NCT02028455|449700964|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
125021262|NCT02028455|449700965|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
125021263|NCT02028455|449700966|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
125021264|NCT01790503|449703182|FG000|Overall Study|Adverse Event|1|||
125021265|NCT01790503|449703183|FG001|Overall Study|Adverse Event|0|||
125021266|NCT01790503|449703184|FG002|Overall Study|Adverse Event|0|||
125021267|NCT01790503|449703185|FG003|Overall Study|Adverse Event|0|||
125021268|NCT01790503|449703186|FG004|Overall Study|Adverse Event|0|||
125021269|NCT01790503|449703187|FG005|Overall Study|Adverse Event|2|||
125021270|NCT01790503|449703188|FG006|Overall Study|Adverse Event|0|||
125021271|NCT01790503|449703189|FG007|Overall Study|Adverse Event|0|||
125021272|NCT01790503|449703190|FG008|Overall Study|Adverse Event|2|||
125021273|NCT01790503|449703191|FG009|Overall Study|Adverse Event|4|||
125021274|NCT01790503|449703192|FG010|Overall Study|Adverse Event|7|||
125021275|NCT01790503|449703182|FG000|Overall Study|Withdrawal by Subject|0|||
125021276|NCT01790503|449703183|FG001|Overall Study|Withdrawal by Subject|0|||
125021277|NCT01790503|449703184|FG002|Overall Study|Withdrawal by Subject|1|||
124903208|NCT02914522|449270116|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
124903209|NCT02914522|449270117|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
124903210|NCT02914522|449270118|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
124903211|NCT02914522|449270119|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
124903212|NCT02914522|449270120|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
124903213|NCT02914522|449270121|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
124903214|NCT02914522|449270122|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
124903215|NCT02914522|449270123|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
124903216|NCT02914522|449270124|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
124903217|NCT02914522|449270125|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
124903218|NCT02914522|449270115|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
124903219|NCT02914522|449270116|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
124903220|NCT02914522|449270117|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
124903221|NCT02914522|449270118|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
124903222|NCT02914522|449270119|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
124903223|NCT02914522|449270120|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
124903224|NCT02914522|449270121|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
124903225|NCT02914522|449270122|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
124903226|NCT02914522|449270123|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
124903227|NCT02914522|449270124|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
124903228|NCT02914522|449270125|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
124903229|NCT02914522|449270115|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
124903230|NCT02914522|449270116|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
124903231|NCT02914522|449270117|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
124903232|NCT02914522|449270118|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
124903233|NCT02914522|449270119|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
124903234|NCT02914522|449270120|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
124903235|NCT02914522|449270121|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
124903236|NCT02914522|449270122|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
124903237|NCT02914522|449270123|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
124903238|NCT02914522|449270124|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
124903239|NCT02914522|449270125|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
125021278|NCT01790503|449703185|FG003|Overall Study|Withdrawal by Subject|1|||
124903240|NCT02914522|449270115|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
124903241|NCT02914522|449270116|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
124903242|NCT02914522|449270117|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
124903243|NCT02914522|449270118|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
125021279|NCT01790503|449703186|FG004|Overall Study|Withdrawal by Subject|1|||
125021280|NCT01790503|449703187|FG005|Overall Study|Withdrawal by Subject|2|||
124903244|NCT02914522|449270119|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
124903245|NCT02914522|449270120|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
124903246|NCT02914522|449270121|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
124903247|NCT02914522|449270122|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
124903248|NCT02914522|449270123|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
124903249|NCT02914522|449270124|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
124903250|NCT02914522|449270125|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
124903251|NCT02914522|449270115|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
124903252|NCT02914522|449270116|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
124903253|NCT02914522|449270117|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
124903254|NCT02914522|449270118|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
124903255|NCT02914522|449270119|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
124903256|NCT02914522|449270120|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
124903257|NCT02914522|449270121|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
124903258|NCT02914522|449270122|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
124903259|NCT02914522|449270123|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
124903260|NCT02914522|449270124|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
124903261|NCT02914522|449270125|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
124903262|NCT02914522|449270115|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
124903263|NCT02914522|449270116|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
124903264|NCT02914522|449270117|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
124903265|NCT02914522|449270118|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
124903266|NCT02914522|449270119|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
124903267|NCT02914522|449270120|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
124903268|NCT02914522|449270121|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
124903269|NCT02914522|449270122|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
124903270|NCT02914522|449270123|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
124903271|NCT02914522|449270124|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
124903272|NCT02914522|449270125|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
124903273|NCT02914522|449270115|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
124903274|NCT02914522|449270116|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
125113688|NCT02736227|450040376|FG001|Overall Study|Withdrawal by Subject|0|||
125113689|NCT02736227|450040377|FG002|Overall Study|Withdrawal by Subject|1|||
125113690|NCT02736227|450040375|FG000|Overall Study|Physician Decision|0|||
125113691|NCT02736227|450040376|FG001|Overall Study|Physician Decision|0|||
125113692|NCT02736227|450040377|FG002|Overall Study|Physician Decision|5|||
124903275|NCT02914522|449270117|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
124903276|NCT02914522|449270118|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
124903277|NCT02914522|449270119|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
124903278|NCT02914522|449270120|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
124903279|NCT02914522|449270121|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
124903280|NCT02914522|449270122|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
124903281|NCT02914522|449270123|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
124903282|NCT02914522|449270124|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
124903283|NCT02914522|449270125|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
124903284|NCT02914522|449270115|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
125113693|NCT02736227|450040375|FG000|Overall Study|Non Compliant|0|||
124903285|NCT02914522|449270116|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
124903286|NCT02914522|449270117|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
124903287|NCT02914522|449270118|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
124903288|NCT02914522|449270119|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
124903289|NCT02914522|449270120|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
124903290|NCT02914522|449270121|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
124903291|NCT02914522|449270122|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
124903292|NCT02914522|449270123|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
124903293|NCT02914522|449270124|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
124903294|NCT02914522|449270125|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
124903295|NCT02914522|449270115|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
124903296|NCT02914522|449270116|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
124903297|NCT02914522|449270117|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
124903298|NCT02914522|449270118|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
124903299|NCT02914522|449270119|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
124903300|NCT02914522|449270120|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
124903301|NCT02914522|449270121|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
124903302|NCT02914522|449270122|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
124903303|NCT02914522|449270123|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
124903304|NCT02914522|449270124|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
124903305|NCT02914522|449270125|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
124903306|NCT02914522|449270115|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
124903307|NCT02914522|449270116|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
124903308|NCT02914522|449270117|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
124903309|NCT02914522|449270118|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
124903310|NCT02914522|449270119|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
124903311|NCT02914522|449270120|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
124903312|NCT02914522|449270121|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
124903313|NCT02914522|449270122|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
124903314|NCT02914522|449270123|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
124903315|NCT02914522|449270124|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
124903316|NCT02914522|449270125|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
124903317|NCT02914522|449270115|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
124903318|NCT02914522|449270116|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
124903319|NCT02914522|449270117|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
124903320|NCT02914522|449270118|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
124903321|NCT02914522|449270119|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
124903322|NCT02914522|449270120|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
124903323|NCT02914522|449270121|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
124903324|NCT02914522|449270122|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
124903325|NCT02914522|449270123|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
124903326|NCT02914522|449270124|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
124903327|NCT02914522|449270125|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
124903328|NCT02914522|449270115|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
124903329|NCT02914522|449270116|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
124903330|NCT02914522|449270117|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
124903331|NCT02914522|449270118|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
124903332|NCT02914522|449270119|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
124903333|NCT02914522|449270120|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
125021281|NCT01790503|449703188|FG006|Overall Study|Withdrawal by Subject|1|||
125021282|NCT01790503|449703189|FG007|Overall Study|Withdrawal by Subject|0|||
125021283|NCT01790503|449703190|FG008|Overall Study|Withdrawal by Subject|0|||
125021284|NCT01790503|449703191|FG009|Overall Study|Withdrawal by Subject|0|||
125021285|NCT01790503|449703192|FG010|Overall Study|Withdrawal by Subject|1|||
125021286|NCT01790503|449703182|FG000|Overall Study|Disease progression|2|||
125021287|NCT01790503|449703183|FG001|Overall Study|Disease progression|1|||
125021288|NCT01790503|449703184|FG002|Overall Study|Disease progression|0|||
125021289|NCT01790503|449703185|FG003|Overall Study|Disease progression|1|||
125021290|NCT01790503|449703186|FG004|Overall Study|Disease progression|2|||
125021291|NCT01790503|449703187|FG005|Overall Study|Disease progression|1|||
125021292|NCT01790503|449703188|FG006|Overall Study|Disease progression|0|||
125021293|NCT01790503|449703189|FG007|Overall Study|Disease progression|1|||
125021294|NCT01790503|449703190|FG008|Overall Study|Disease progression|0|||
125021295|NCT01790503|449703191|FG009|Overall Study|Disease progression|17|||
125021296|NCT01790503|449703192|FG010|Overall Study|Disease progression|7|||
125021297|NCT01790503|449703182|FG000|Overall Study|Protocol Violation|0|||
124903334|NCT02914522|449270121|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
124903335|NCT02914522|449270122|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
124903336|NCT02914522|449270123|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
124903337|NCT02914522|449270124|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
124903338|NCT02914522|449270125|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
124903339|NCT02914522|449270115|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
124903340|NCT02914522|449270116|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
124903341|NCT02914522|449270117|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
124903342|NCT02914522|449270118|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
124903343|NCT02914522|449270119|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
124903344|NCT02914522|449270120|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
124903345|NCT02914522|449270121|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
124903346|NCT02914522|449270122|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
124903347|NCT02914522|449270123|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
124903348|NCT02914522|449270124|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
124903349|NCT02914522|449270125|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
124903350|NCT02914522|449270115|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
124903351|NCT02914522|449270116|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
124903352|NCT02914522|449270117|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
124903353|NCT02914522|449270118|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
124903354|NCT02914522|449270119|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
124903355|NCT02914522|449270120|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
124903356|NCT02914522|449270121|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
124903357|NCT02914522|449270122|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
124903358|NCT02914522|449270123|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
124903359|NCT02914522|449270124|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
124903360|NCT02914522|449270125|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
124903361|NCT02914522|449270115|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
124903362|NCT02914522|449270116|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
124903363|NCT02914522|449270117|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
124903364|NCT02914522|449270118|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
124903365|NCT02914522|449270119|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
124903366|NCT02914522|449270120|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
124903367|NCT02914522|449270121|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
124903368|NCT02914522|449270122|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
124903369|NCT02914522|449270123|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
124903370|NCT02914522|449270124|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
124903371|NCT02914522|449270125|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
124903372|NCT02914522|449270115|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
124903373|NCT02914522|449270116|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
124903374|NCT02914522|449270117|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
124903375|NCT02914522|449270118|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
124903376|NCT02914522|449270119|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
124903377|NCT02914522|449270120|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
124903378|NCT02914522|449270121|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
124903379|NCT02914522|449270122|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
124903380|NCT02914522|449270123|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
124903381|NCT02914522|449270124|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
124903382|NCT02914522|449270125|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
124903383|NCT00756730|449270126|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
124903384|NCT00756730|449270127|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
125113694|NCT02736227|450040376|FG001|Overall Study|Non Compliant|0|||
125113695|NCT02736227|450040377|FG002|Overall Study|Non Compliant|2|||
124903385|NCT00756730|449270126|FG000|Overall Study|persistent low-level viremmia|0|||
124903386|NCT00756730|449270127|FG001|Overall Study|persistent low-level viremmia|1|||
124903387|NCT05382104|449270129|FG000|Period 2 (2 Days)|Adverse Event|0|||
124903388|NCT05382104|449270130|FG001|Period 2 (2 Days)|Adverse Event|1|||
124903389|NCT05382104|449270131|FG002|Period 2 (2 Days)|Adverse Event|0|||
124903390|NCT05382104|449270132|FG003|Period 2 (2 Days)|Adverse Event|0|||
124903391|NCT05382104|449270133|FG004|Period 2 (2 Days)|Adverse Event|0|||
124903392|NCT05382104|449270134|FG005|Period 2 (2 Days)|Adverse Event|0|||
124903393|NCT00639002|449270135|FG000|Overall Study|Death|1|||
124903394|NCT00639002|449270135|FG000|Overall Study|Adverse Event|1|||
124903395|NCT00639002|449270135|FG000|Overall Study|Protocol Violation|1|||
124903396|NCT00639002|449270135|FG000|Overall Study|Disease progression|3|||
124903397|NCT00639002|449270135|FG000|Overall Study|Physician Decision|6|||
124903398|NCT00639002|449270135|FG000|Overall Study|Lack of Efficacy|1|||
125113696|NCT04120194|450040378|FG000|Overall Study|Lost to Follow-up|11|||
124903399|NCT05686421|449270143|FG000|Overall Study|Screen failure|22|||
124903400|NCT05686421|449270144|FG001|Overall Study|Screen failure|0|||
124903401|NCT05686421|449270145|FG002|Overall Study|Screen failure|0|||
124903402|NCT05686421|449270146|FG003|Overall Study|Screen failure|0|||
124903403|NCT00940992|449270147|FG000|Overall Study|Adverse Event|2|||
124903404|NCT00940992|449270148|FG001|Overall Study|Adverse Event|0|||
124903405|NCT00940992|449270149|FG002|Overall Study|Adverse Event|1|||
124903406|NCT00940992|449270147|FG000|Overall Study|subject request|2|||
124903407|NCT00940992|449270148|FG001|Overall Study|subject request|1|||
124903408|NCT00940992|449270149|FG002|Overall Study|subject request|0|||
124903409|NCT00940992|449270147|FG000|Overall Study|Lost to Follow-up|0|||
124903410|NCT00940992|449270148|FG001|Overall Study|Lost to Follow-up|1|||
124903411|NCT00940992|449270149|FG002|Overall Study|Lost to Follow-up|1|||
124903412|NCT00361283|449270154|FG000|Overall Study|Lost to Follow-up|27|||
125113697|NCT04120194|450040379|FG001|Overall Study|Lost to Follow-up|8|||
125113698|NCT04120194|450040378|FG000|Overall Study|Adverse Event|4|||
124903413|NCT00208767|449270155|FG000|Overall Study|Adverse Event|9|||
124903414|NCT00208767|449270156|FG001|Overall Study|Adverse Event|1|||
124903415|NCT00208767|449270155|FG000|Overall Study|Withdrawal by Subject|14|||
124903416|NCT00208767|449270156|FG001|Overall Study|Withdrawal by Subject|3|||
124903417|NCT00208767|449270155|FG000|Overall Study|Death|1|||
124903418|NCT00208767|449270156|FG001|Overall Study|Death|0|||
124903419|NCT00208767|449270155|FG000|Overall Study|Lost to Follow-up|3|||
124903420|NCT00208767|449270156|FG001|Overall Study|Lost to Follow-up|3|||
124903421|NCT05052983|449270158|FG000|Overall Study|Lack of Efficacy|3|||
124903422|NCT05052983|449270159|FG001|Overall Study|Lack of Efficacy|12|||
124903423|NCT05052983|449270158|FG000|Overall Study|Adverse Event|1|||
124903424|NCT05052983|449270159|FG001|Overall Study|Adverse Event|0|||
124903425|NCT04133363|449270160|FG000|Overall Study|Lost to Follow-up|2|||
124903426|NCT04133363|449270161|FG001|Overall Study|Lost to Follow-up|1|||
124903427|NCT04133363|449270162|FG002|Overall Study|Lost to Follow-up|4|||
124903428|NCT00849147|449270166|FG000|Overall Study|Withdrawal by Subject|1|||
124903429|NCT00849147|449270166|FG000|Overall Study|Protocol Violation|2|||
124903430|NCT00849147|449270166|FG000|Overall Study|Disease Relapse/Progression|2|||
124903431|NCT00482729|449272353|FG000|Overall Study|Adverse Event|29|||
124903432|NCT00482729|449272354|FG001|Overall Study|Adverse Event|33|||
124903433|NCT00482729|449272353|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
124903434|NCT00482729|449272354|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
124903435|NCT00482729|449272353|FG000|Overall Study|Hyperglycemia Criteria|7|||
124903436|NCT00482729|449272354|FG001|Overall Study|Hyperglycemia Criteria|5|||
124903437|NCT00482729|449272353|FG000|Overall Study|Lack of Efficacy|4|||
124903438|NCT00482729|449272354|FG001|Overall Study|Lack of Efficacy|16|||
124903439|NCT00482729|449272353|FG000|Overall Study|Lost to Follow-up|86|||
124903440|NCT00482729|449272354|FG001|Overall Study|Lost to Follow-up|66|||
124903441|NCT00482729|449272353|FG000|Overall Study|Physician Decision|10|||
124903442|NCT00482729|449272354|FG001|Overall Study|Physician Decision|7|||
124903443|NCT00482729|449272353|FG000|Overall Study|Pregnancy|4|||
124903444|NCT00482729|449272354|FG001|Overall Study|Pregnancy|2|||
124903445|NCT00482729|449272353|FG000|Overall Study|Protocol Violation|10|||
124903446|NCT00482729|449272354|FG001|Overall Study|Protocol Violation|18|||
124903447|NCT00482729|449272353|FG000|Overall Study|Withdrawal by Subject|67|||
124903448|NCT00482729|449272354|FG001|Overall Study|Withdrawal by Subject|69|||
124903449|NCT02631148|449272358|FG000|Overall Study|8 were ineligible|8|||
124903450|NCT02631148|449272359|FG001|Overall Study|8 were ineligible|0|||
124903451|NCT02631148|449272358|FG000|Overall Study|Withdrawal by Subject|1|||
124903452|NCT02631148|449272359|FG001|Overall Study|Withdrawal by Subject|0|||
124903453|NCT02631148|449272358|FG000|Overall Study|PAH not available to study participant|1|||
124903454|NCT02631148|449272359|FG001|Overall Study|PAH not available to study participant|0|||
124903455|NCT04860258|449272361|FG000|Overall Study|Withdrawal by Subject|0|||
124903456|NCT04860258|449272362|FG001|Overall Study|Withdrawal by Subject|0|||
124903457|NCT04860258|449272363|FG002|Overall Study|Withdrawal by Subject|4|||
124903458|NCT04860258|449272364|FG003|Overall Study|Withdrawal by Subject|1|||
124903459|NCT04860258|449272365|FG004|Overall Study|Withdrawal by Subject|4|||
124903460|NCT04860258|449272366|FG005|Overall Study|Withdrawal by Subject|1|||
124903461|NCT04860258|449272367|FG006|Overall Study|Withdrawal by Subject|0|||
124903462|NCT00028769|449272368|FG000|Overall Study|Adverse Event|2|||
124903463|NCT00028769|449272368|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
124903464|NCT00028769|449272368|FG000|Overall Study|Progression or Death|31|||
124903465|NCT00028769|449272368|FG000|Overall Study|Other - Not Protocol Specified|1|||
125113699|NCT04120194|450040379|FG001|Overall Study|Adverse Event|5|||
125113700|NCT04120194|450040378|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
125113701|NCT04120194|450040379|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
125113702|NCT04120194|450040378|FG000|Overall Study|Miscellaneous|4|||
125113703|NCT04120194|450040379|FG001|Overall Study|Miscellaneous|5|||
125113704|NCT00827359|450040383|FG000|Overall Study|Progressive Diseas|19|||
125113705|NCT00827359|450040383|FG000|Overall Study|Unacceptable Toxicity|5|||
125113706|NCT00827359|450040383|FG000|Overall Study|Ineligible|1|||
125113707|NCT01159769|450040384|FG000|Overall Study|Adverse Event|1|||
124903466|NCT00028769|449272368|FG000|Overall Study|Ineligible|5|||
124903467|NCT00028769|449272368|FG000|Overall Study|Not Analyzable|1|||
124903468|NCT01134562|449272369|FG000|Overall Study|Adverse Event|0|||
124903469|NCT01134562|449272370|FG001|Overall Study|Adverse Event|1|||
124903470|NCT01134562|449272371|FG002|Overall Study|Adverse Event|0|||
124903471|NCT01134562|449272372|FG003|Overall Study|Adverse Event|0|||
124903472|NCT01134562|449272373|FG004|Overall Study|Adverse Event|0|||
124903473|NCT00357396|449272374|FG000|Overall Study|Adverse Event|1|||
124903474|NCT00357396|449272375|FG001|Overall Study|Adverse Event|0|||
124903475|NCT02496702|449272377|FG000|Overall Study|Lost to Follow-up|8|||
125113708|NCT02555618|450040385|FG000|Overall Study|Sponsor's Circumstances|1|||
125113709|NCT02555618|450040386|FG001|Overall Study|Sponsor's Circumstances|0|||
124903476|NCT02496702|449272378|FG001|Overall Study|Lost to Follow-up|6|||
124903477|NCT02496702|449272377|FG000|Overall Study|Only partially tested|0|||
124903478|NCT02496702|449272378|FG001|Overall Study|Only partially tested|2|||
124903479|NCT00487578|449272379|FG000|Overall Study|Adverse Event|1|||
124903480|NCT00487578|449272380|FG001|Overall Study|Adverse Event|2|||
124903481|NCT00487578|449272379|FG000|Overall Study|Lack of Efficacy|0|||
124903482|NCT00487578|449272380|FG001|Overall Study|Lack of Efficacy|1|||
124903483|NCT00487578|449272379|FG000|Overall Study|Lost to Follow-up|0|||
124903484|NCT00487578|449272380|FG001|Overall Study|Lost to Follow-up|1|||
124903485|NCT02525796|449272385|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
124903486|NCT02525796|449272386|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
124903487|NCT02525796|449272387|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
124903488|NCT02525796|449272385|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
124903489|NCT02525796|449272386|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
124903490|NCT02525796|449272387|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
124903491|NCT02525796|449272385|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
124903492|NCT02525796|449272386|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
124903493|NCT02525796|449272387|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
124903494|NCT02525796|449272385|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
124903495|NCT02525796|449272386|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
124903496|NCT02525796|449272387|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
124903497|NCT02525796|449272385|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
124903498|NCT02525796|449272386|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
124903499|NCT02525796|449272387|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
124903500|NCT00726999|449272390|FG000|Overall Study|Physician Decision|0|||
124903501|NCT00726999|449272391|FG001|Overall Study|Physician Decision|1|||
124903502|NCT00726999|449272390|FG000|Overall Study|Withdrawal by Subject|2|||
124903503|NCT00726999|449272391|FG001|Overall Study|Withdrawal by Subject|0|||
124903504|NCT00726999|449272390|FG000|Overall Study|Protocol Violation|1|||
124903505|NCT00726999|449272391|FG001|Overall Study|Protocol Violation|0|||
124903506|NCT00955825|449272392|FG000|Overall Study|Adverse Event|15|||
124903507|NCT00955825|449272393|FG001|Overall Study|Adverse Event|2|||
124903508|NCT00955825|449272392|FG000|Overall Study|Withdrawal by Subject|4|||
124903509|NCT00955825|449272393|FG001|Overall Study|Withdrawal by Subject|6|||
124903510|NCT00955825|449272392|FG000|Overall Study|Any other reason not above-mentioned|7|||
124903511|NCT00955825|449272393|FG001|Overall Study|Any other reason not above-mentioned|9|||
124903512|NCT01499134|449272394|FG000|Overall Study|Withdrawal by Subject|0|||
124903513|NCT01499134|449272395|FG001|Overall Study|Withdrawal by Subject|1|||
124903514|NCT02488980|449272396|FG000|Overall Study|Protocol Violation|2|||
124903515|NCT02488980|449272397|FG001|Overall Study|Protocol Violation|2|||
124903516|NCT02488980|449272398|FG002|Overall Study|Protocol Violation|2|||
124903517|NCT01198275|449272399|FG000|Overall Study|Adverse Event|2|||
124903518|NCT01198275|449272400|FG001|Overall Study|Adverse Event|3|||
124903519|NCT01198275|449272399|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
124903520|NCT01198275|449272400|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
124903521|NCT00391846|449272401|FG000|Overall Study|Adverse Event|4|||
124903522|NCT00391846|449272402|FG001|Overall Study|Adverse Event|1|||
124903523|NCT00391846|449272401|FG000|Overall Study|Did not meet the required elig. crit|2|||
124903524|NCT00391846|449272402|FG001|Overall Study|Did not meet the required elig. crit|2|||
124903525|NCT00391846|449272401|FG000|Overall Study|Withdrawal by Subject|2|||
124903526|NCT00391846|449272402|FG001|Overall Study|Withdrawal by Subject|3|||
124903527|NCT00391846|449272401|FG000|Overall Study|Developed study specific DC criteria|0|||
124903528|NCT00391846|449272402|FG001|Overall Study|Developed study specific DC criteria|1|||
124903529|NCT00150176|449272403|FG000|Overall Study|Adverse Event|16|||
124903530|NCT00150176|449272404|FG001|Overall Study|Adverse Event|53|||
124903531|NCT00150176|449272403|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
124903532|NCT00150176|449272404|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
124903533|NCT00150176|449272403|FG000|Overall Study|Withdrawal by Subject|19|||
124903534|NCT00150176|449272404|FG001|Overall Study|Withdrawal by Subject|12|||
124903535|NCT00150176|449272403|FG000|Overall Study|Lost to Follow-up|3|||
124903536|NCT00150176|449272404|FG001|Overall Study|Lost to Follow-up|3|||
124903537|NCT00150176|449272403|FG000|Overall Study|OTHER|11|||
124903538|NCT00150176|449272404|FG001|Overall Study|OTHER|13|||
124903539|NCT00970307|449272407|FG000|Overall Study|Serious Adverse Event|1|||
124903540|NCT00970307|449272408|FG001|Overall Study|Serious Adverse Event|0|||
124903541|NCT00970307|449272409|FG002|Overall Study|Serious Adverse Event|0|||
124903542|NCT00970307|449272407|FG000|Overall Study|Withdrawal by Subject|2|||
125113710|NCT02063698|450040387|FG000|Overall Study|did not complete booklet for days 2-8|1|||
125113711|NCT02063698|450040388|FG001|Overall Study|did not complete booklet for days 2-8|2|||
125113712|NCT00410410|450040389|FG000|Induction Period (IP)|Death|1|||
125113713|NCT00410410|450040390|FG001|Induction Period (IP)|Death|0|||
125113714|NCT00410410|450040391|FG002|Induction Period (IP)|Death|0|||
125113715|NCT00410410|450040392|FG003|Induction Period (IP)|Death|0|||
125113716|NCT00410410|450040393|FG004|Induction Period (IP)|Death|0|||
125113717|NCT00410410|450040394|FG005|Induction Period (IP)|Death|0|||
125113718|NCT00410410|450040395|FG006|Induction Period (IP)|Death|0|||
125113719|NCT00410410|450040396|FG007|Induction Period (IP)|Death|0|||
125113720|NCT00410410|450040397|FG008|Induction Period (IP)|Death|0|||
125113721|NCT00410410|450040389|FG000|Induction Period (IP)|Adverse Event|3|||
125113722|NCT00410410|450040390|FG001|Induction Period (IP)|Adverse Event|4|||
125113723|NCT00410410|450040391|FG002|Induction Period (IP)|Adverse Event|2|||
125113724|NCT00410410|450040392|FG003|Induction Period (IP)|Adverse Event|4|||
125113725|NCT00410410|450040393|FG004|Induction Period (IP)|Adverse Event|1|||
125113726|NCT00410410|450040394|FG005|Induction Period (IP)|Adverse Event|0|||
125113727|NCT00410410|450040395|FG006|Induction Period (IP)|Adverse Event|0|||
125113728|NCT00410410|450040396|FG007|Induction Period (IP)|Adverse Event|0|||
125113729|NCT00410410|450040397|FG008|Induction Period (IP)|Adverse Event|0|||
125113730|NCT00410410|450040389|FG000|Induction Period (IP)|Lack of Efficacy|26|||
125113731|NCT00410410|450040390|FG001|Induction Period (IP)|Lack of Efficacy|24|||
125113732|NCT00410410|450040391|FG002|Induction Period (IP)|Lack of Efficacy|8|||
125113733|NCT00410410|450040392|FG003|Induction Period (IP)|Lack of Efficacy|8|||
125113734|NCT00410410|450040393|FG004|Induction Period (IP)|Lack of Efficacy|7|||
125113735|NCT00410410|450040394|FG005|Induction Period (IP)|Lack of Efficacy|7|||
125113736|NCT00410410|450040395|FG006|Induction Period (IP)|Lack of Efficacy|0|||
125113737|NCT00410410|450040396|FG007|Induction Period (IP)|Lack of Efficacy|0|||
125113738|NCT00410410|450040397|FG008|Induction Period (IP)|Lack of Efficacy|0|||
125113739|NCT00410410|450040389|FG000|Induction Period (IP)|Lost to Follow-up|2|||
125113740|NCT00410410|450040390|FG001|Induction Period (IP)|Lost to Follow-up|2|||
125113741|NCT00410410|450040391|FG002|Induction Period (IP)|Lost to Follow-up|2|||
125113742|NCT00410410|450040392|FG003|Induction Period (IP)|Lost to Follow-up|3|||
125113743|NCT00410410|450040393|FG004|Induction Period (IP)|Lost to Follow-up|0|||
125113744|NCT00410410|450040394|FG005|Induction Period (IP)|Lost to Follow-up|1|||
125113745|NCT00410410|450040395|FG006|Induction Period (IP)|Lost to Follow-up|0|||
125113746|NCT00410410|450040396|FG007|Induction Period (IP)|Lost to Follow-up|0|||
125113747|NCT00410410|450040397|FG008|Induction Period (IP)|Lost to Follow-up|0|||
125113748|NCT00410410|450040389|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
125113749|NCT00410410|450040390|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
125113750|NCT00410410|450040391|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
125113751|NCT00410410|450040392|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
125113752|NCT00410410|450040393|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
125113753|NCT00410410|450040394|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
125113754|NCT00410410|450040395|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
125113755|NCT00410410|450040396|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
125113756|NCT00410410|450040397|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
125113757|NCT00410410|450040389|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
125113758|NCT00410410|450040390|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
125113759|NCT00410410|450040391|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
125113760|NCT00410410|450040392|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
125113761|NCT00410410|450040393|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
125113762|NCT00410410|450040394|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
125113763|NCT00410410|450040395|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
125113764|NCT00410410|450040396|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
125113765|NCT00410410|450040397|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
125113766|NCT00410410|450040389|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
125113767|NCT00410410|450040390|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
125113768|NCT00410410|450040391|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
125113769|NCT00410410|450040392|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
124903543|NCT00970307|449272408|FG001|Overall Study|Withdrawal by Subject|3|||
125113770|NCT00410410|450040393|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
125113771|NCT00410410|450040394|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
125113772|NCT00410410|450040395|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
125113773|NCT00410410|450040396|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
125113774|NCT00410410|450040397|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
125113775|NCT00410410|450040389|FG000|Induction Period (IP)|Other|0|||
125113776|NCT00410410|450040390|FG001|Induction Period (IP)|Other|0|||
125113777|NCT00410410|450040391|FG002|Induction Period (IP)|Other|1|||
125113778|NCT00410410|450040392|FG003|Induction Period (IP)|Other|0|||
125113779|NCT00410410|450040393|FG004|Induction Period (IP)|Other|0|||
125113780|NCT00410410|450040394|FG005|Induction Period (IP)|Other|0|||
125113781|NCT00410410|450040395|FG006|Induction Period (IP)|Other|0|||
124903544|NCT00970307|449272409|FG002|Overall Study|Withdrawal by Subject|2|||
124903545|NCT00393848|449272416|FG000|Overall Study|Surgical schedule|0|||
124903546|NCT00393848|449272417|FG001|Overall Study|Surgical schedule|0|||
124903547|NCT00393848|449272418|FG002|Overall Study|Surgical schedule|0|||
124903548|NCT00393848|449272419|FG003|Overall Study|Surgical schedule|1|||
124903549|NCT00393848|449272416|FG000|Overall Study|Personal reasons|0|||
124903550|NCT00393848|449272417|FG001|Overall Study|Personal reasons|0|||
124903551|NCT00393848|449272418|FG002|Overall Study|Personal reasons|2|||
124903552|NCT00393848|449272419|FG003|Overall Study|Personal reasons|0|||
124903553|NCT02082158|449272423|FG000|Overall Study|Withdrawal by Subject|0|||
124903554|NCT02082158|449272424|FG001|Overall Study|Withdrawal by Subject|0|||
124903555|NCT02082158|449272425|FG002|Overall Study|Withdrawal by Subject|0|||
124903556|NCT02082158|449272426|FG003|Overall Study|Withdrawal by Subject|0|||
124903557|NCT02082158|449272427|FG004|Overall Study|Withdrawal by Subject|1|||
124903558|NCT02082158|449272428|FG005|Overall Study|Withdrawal by Subject|0|||
124903559|NCT02082158|449272423|FG000|Overall Study|Failed Fit-testing|8|||
124903560|NCT02082158|449272424|FG001|Overall Study|Failed Fit-testing|8|||
124903561|NCT02082158|449272425|FG002|Overall Study|Failed Fit-testing|14|||
124903562|NCT02082158|449272426|FG003|Overall Study|Failed Fit-testing|4|||
124903563|NCT02082158|449272427|FG004|Overall Study|Failed Fit-testing|3|||
124903564|NCT02082158|449272428|FG005|Overall Study|Failed Fit-testing|7|||
124903565|NCT00738699|449272429|FG000|Overall Study|Withdrawal by Subject|5|||
124903566|NCT00738699|449272430|FG001|Overall Study|Withdrawal by Subject|0|||
124903567|NCT00738699|449272429|FG000|Overall Study|Lost to Follow-up|1|||
124903568|NCT00738699|449272430|FG001|Overall Study|Lost to Follow-up|0|||
124903569|NCT00738699|449272429|FG000|Overall Study|Death|144|||
124903570|NCT00738699|449272430|FG001|Overall Study|Death|68|||
124903571|NCT00738699|449272429|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
124903572|NCT00738699|449272430|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
124903573|NCT00738699|449272429|FG000|Overall Study|Other|2|||
124903574|NCT00738699|449272430|FG001|Overall Study|Other|0|||
124903575|NCT00943735|449272441|FG000|Overall Study|Adverse Event|12|||
125113782|NCT00410410|450040396|FG007|Induction Period (IP)|Other|0|||
125113783|NCT00410410|450040397|FG008|Induction Period (IP)|Other|0|||
125113784|NCT00410410|450040389|FG000|Maintenance Period (MP)|Death|0|||
125113785|NCT00410410|450040390|FG001|Maintenance Period (MP)|Death|0|||
125113786|NCT00410410|450040391|FG002|Maintenance Period (MP)|Death|0|||
125113787|NCT00410410|450040392|FG003|Maintenance Period (MP)|Death|0|||
125113788|NCT00410410|450040393|FG004|Maintenance Period (MP)|Death|0|||
125113789|NCT00410410|450040394|FG005|Maintenance Period (MP)|Death|0|||
125113790|NCT00410410|450040395|FG006|Maintenance Period (MP)|Death|1|||
125113791|NCT00410410|450040396|FG007|Maintenance Period (MP)|Death|0|||
125113792|NCT00410410|450040397|FG008|Maintenance Period (MP)|Death|0|||
125113793|NCT00410410|450040389|FG000|Maintenance Period (MP)|Adverse Event|0|||
125113794|NCT00410410|450040390|FG001|Maintenance Period (MP)|Adverse Event|0|||
125113795|NCT00410410|450040391|FG002|Maintenance Period (MP)|Adverse Event|0|||
125113796|NCT00410410|450040392|FG003|Maintenance Period (MP)|Adverse Event|0|||
125113797|NCT00410410|450040393|FG004|Maintenance Period (MP)|Adverse Event|0|||
125113798|NCT00410410|450040394|FG005|Maintenance Period (MP)|Adverse Event|0|||
125113799|NCT00410410|450040395|FG006|Maintenance Period (MP)|Adverse Event|1|||
125113800|NCT00410410|450040396|FG007|Maintenance Period (MP)|Adverse Event|3|||
125113801|NCT00410410|450040397|FG008|Maintenance Period (MP)|Adverse Event|0|||
125113802|NCT00410410|450040389|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
125113803|NCT00410410|450040390|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
125113804|NCT00410410|450040391|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
125113805|NCT00410410|450040392|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
125113806|NCT00410410|450040393|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
125113807|NCT00410410|450040394|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
125113808|NCT00410410|450040395|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
125113809|NCT00410410|450040396|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
125113810|NCT00410410|450040397|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
125113811|NCT00410410|450040389|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
125113812|NCT00410410|450040390|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
125113813|NCT00410410|450040391|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
125113814|NCT00410410|450040392|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
125113815|NCT00410410|450040393|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
125113816|NCT00410410|450040394|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
124903576|NCT00943735|449272441|FG000|Overall Study|Withdrawal by Subject|8|||
124903577|NCT00943735|449272441|FG000|Overall Study|Death|1|||
124903578|NCT00943735|449272441|FG000|Overall Study|Other|8|||
124903579|NCT00943735|449272441|FG000|Overall Study|Other|3|||
124903580|NCT03804918|449272442|FG000|Overall Study|Participant did not use the app|1|||
124903581|NCT01329328|449272443|FG000|Overall Study|Withdrawal by Subject|2|||
125113817|NCT00410410|450040395|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
125113818|NCT00410410|450040396|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
125113819|NCT00410410|450040397|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
125113820|NCT00410410|450040389|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
124903582|NCT01329328|449272444|FG001|Overall Study|Withdrawal by Subject|4|||
124903583|NCT01329328|449272445|FG002|Overall Study|Withdrawal by Subject|3|||
124903584|NCT00964366|449272446|FG000|Overall Study|Did not qualify at Day 1|1|||
124903585|NCT00964366|449272447|FG001|Overall Study|Did not qualify at Day 1|0|||
124903586|NCT00964366|449272446|FG000|Overall Study|Withdrawal by Subject|0|||
124903587|NCT00964366|449272447|FG001|Overall Study|Withdrawal by Subject|1|||
124903588|NCT01370694|449272448|FG000|Overall Study|Switched to rituximab|4|||
124903589|NCT01370694|449272448|FG000|Overall Study|Progressive disease|2|||
124903590|NCT02957539|449272449|FG000|Baseline to Week 16|Lost to Follow-up|8|||
124903591|NCT02957539|449272450|FG001|Baseline to Week 16|Lost to Follow-up|10|||
124903592|NCT02957539|449272451|FG002|Baseline to Week 16|Lost to Follow-up|16|||
124903593|NCT02957539|449272449|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
124903594|NCT02957539|449272450|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
124903595|NCT02957539|449272451|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
124903596|NCT02957539|449272449|FG000|Week 16 to 32|Withdrawal by Subject|3|||
124903597|NCT02957539|449272450|FG001|Week 16 to 32|Withdrawal by Subject|3|||
124903598|NCT02957539|449272451|FG002|Week 16 to 32|Withdrawal by Subject|1|||
124903599|NCT02957539|449272449|FG000|Week 16 to 32|Lost to Follow-up|8|||
124903600|NCT02957539|449272450|FG001|Week 16 to 32|Lost to Follow-up|7|||
124903601|NCT02957539|449272451|FG002|Week 16 to 32|Lost to Follow-up|5|||
124903602|NCT02957539|449272449|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
124903603|NCT02957539|449272450|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
124903604|NCT02957539|449272451|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
124903605|NCT02957539|449272449|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
124903606|NCT02957539|449272450|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
124903607|NCT02957539|449272451|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
124903608|NCT01563354|449272454|FG000|Core Phase|Adverse Event|5|||
124903609|NCT01563354|449272455|FG001|Core Phase|Adverse Event|15|||
124903610|NCT01563354|449272456|FG002|Core Phase|Adverse Event|13|||
124903611|NCT01563354|449272454|FG000|Core Phase|Withdrawal by Subject|1|||
124903612|NCT01563354|449272455|FG001|Core Phase|Withdrawal by Subject|0|||
124903613|NCT01563354|449272456|FG002|Core Phase|Withdrawal by Subject|3|||
124903614|NCT01563354|449272454|FG000|Core Phase|Lost to Follow-up|1|||
124903615|NCT01563354|449272455|FG001|Core Phase|Lost to Follow-up|0|||
124903616|NCT01563354|449272456|FG002|Core Phase|Lost to Follow-up|0|||
124903617|NCT01563354|449272454|FG000|Core Phase|Death|1|||
124903618|NCT01563354|449272455|FG001|Core Phase|Death|5|||
124903619|NCT01563354|449272456|FG002|Core Phase|Death|2|||
124903620|NCT01563354|449272454|FG000|Core Phase|Diseasse progression|18|||
124903621|NCT01563354|449272455|FG001|Core Phase|Diseasse progression|7|||
124903622|NCT01563354|449272456|FG002|Core Phase|Diseasse progression|8|||
124903623|NCT01563354|449272454|FG000|Core Phase|Protocol deviation|2|||
124903624|NCT01563354|449272455|FG001|Core Phase|Protocol deviation|0|||
124903625|NCT01563354|449272456|FG002|Core Phase|Protocol deviation|0|||
124903626|NCT01563354|449272454|FG000|Core Phase|PI decision - did not enter extension|0|||
124903627|NCT01563354|449272455|FG001|Core Phase|PI decision - did not enter extension|1|||
124903628|NCT01563354|449272456|FG002|Core Phase|PI decision - did not enter extension|0|||
124903629|NCT01563354|449272454|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
124903630|NCT01563354|449272455|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
124903631|NCT01563354|449272456|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
124903632|NCT01563354|449272454|FG000|Extension Phase|Adverse Event|0|||
124903633|NCT01563354|449272455|FG001|Extension Phase|Adverse Event|3|||
124903634|NCT01563354|449272456|FG002|Extension Phase|Adverse Event|2|||
124903635|NCT01563354|449272454|FG000|Extension Phase|Withdrawal by Subject|0|||
124903636|NCT01563354|449272455|FG001|Extension Phase|Withdrawal by Subject|1|||
125021298|NCT01790503|449703183|FG001|Overall Study|Protocol Violation|0|||
125021299|NCT01790503|449703184|FG002|Overall Study|Protocol Violation|0|||
125021300|NCT01790503|449703185|FG003|Overall Study|Protocol Violation|0|||
125021301|NCT01790503|449703186|FG004|Overall Study|Protocol Violation|0|||
125021302|NCT01790503|449703187|FG005|Overall Study|Protocol Violation|0|||
125021303|NCT01790503|449703188|FG006|Overall Study|Protocol Violation|0|||
125021304|NCT01790503|449703189|FG007|Overall Study|Protocol Violation|0|||
124903637|NCT01563354|449272456|FG002|Extension Phase|Withdrawal by Subject|0|||
124903638|NCT01563354|449272454|FG000|Extension Phase|Administration problems|3|||
124903639|NCT01563354|449272455|FG001|Extension Phase|Administration problems|2|||
124903640|NCT01563354|449272456|FG002|Extension Phase|Administration problems|3|||
124903641|NCT01563354|449272454|FG000|Extension Phase|Disease progression|9|||
124903642|NCT01563354|449272455|FG001|Extension Phase|Disease progression|8|||
124903643|NCT01563354|449272456|FG002|Extension Phase|Disease progression|10|||
124903644|NCT01565928|449272457|FG000|Overall Study|Adverse Event|3|||
124903645|NCT01565928|449272457|FG000|Overall Study|Other|3|||
124903646|NCT01565928|449272457|FG000|Overall Study|Progressive Disease|13|||
124903647|NCT01565928|449272457|FG000|Overall Study|Withdrawal by Subject|1|||
125021305|NCT01790503|449703190|FG008|Overall Study|Protocol Violation|0|||
124903648|NCT01565928|449272457|FG000|Overall Study|Death|2|||
124903649|NCT01119950|449272458|FG000|Overall Study|Adverse Event|25|||
125021306|NCT01790503|449703191|FG009|Overall Study|Protocol Violation|1|||
125021307|NCT01790503|449703192|FG010|Overall Study|Protocol Violation|0|||
125021308|NCT01790503|449703182|FG000|Overall Study|Physician Decision|0|||
124903650|NCT01119950|449272458|FG000|Overall Study|Withdrawal by Subject|9|||
124903651|NCT01119950|449272458|FG000|Overall Study|Protocol Violation|5|||
124903652|NCT01119950|449272458|FG000|Overall Study|Lost to Follow-up|4|||
124903653|NCT01119950|449272458|FG000|Overall Study|Administrative|2|||
124903654|NCT01119950|449272458|FG000|Overall Study|Abnormal lab value|1|||
124903655|NCT01119950|449272458|FG000|Overall Study|Death|1|||
124903656|NCT01591616|449272461|FG000|Overall Study|Withdrawal by Subject|1|||
124903657|NCT00855465|449272462|FG000|Treatment Period|Adverse Event|4|||
124903658|NCT00855465|449272463|FG001|Treatment Period|Adverse Event|2|||
124903659|NCT00855465|449272462|FG000|Treatment Period|Death|2|||
124903660|NCT00855465|449272463|FG001|Treatment Period|Death|2|||
124903661|NCT00855465|449272462|FG000|Treatment Period|Lack of Efficacy|2|||
124903662|NCT00855465|449272463|FG001|Treatment Period|Lack of Efficacy|1|||
124903663|NCT00855465|449272462|FG000|Treatment Period|Non-compliance|1|||
124903664|NCT00855465|449272463|FG001|Treatment Period|Non-compliance|0|||
124903665|NCT00855465|449272462|FG000|Treatment Period|Protocol Violation|2|||
124903666|NCT00855465|449272463|FG001|Treatment Period|Protocol Violation|0|||
124903667|NCT00855465|449272462|FG000|Treatment Period|Withdrawal by Subject|2|||
124903668|NCT00855465|449272463|FG001|Treatment Period|Withdrawal by Subject|0|||
124903669|NCT00855465|449272462|FG000|Treatment Period|Not treated|1|||
124903670|NCT00855465|449272463|FG001|Treatment Period|Not treated|0|||
124903671|NCT00855465|449272462|FG000|Follow-up Period (FUP)|Adverse Event|0|||
124903672|NCT00855465|449272463|FG001|Follow-up Period (FUP)|Adverse Event|1|||
124903673|NCT00855465|449272462|FG000|Follow-up Period (FUP)|Death|0|||
124903674|NCT00855465|449272463|FG001|Follow-up Period (FUP)|Death|1|||
124903675|NCT00855465|449272462|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
124903676|NCT00855465|449272463|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
124903677|NCT00855465|449272462|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
124903678|NCT00855465|449272463|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
124903679|NCT00855465|449272462|FG000|Follow-up Period (FUP)|Missing|1|||
124903680|NCT00855465|449272463|FG001|Follow-up Period (FUP)|Missing|0|||
124903681|NCT01157182|449272468|FG000|Washout of 28 Days|Adverse Event|2|||
124903682|NCT01157182|449272469|FG001|Washout of 28 Days|Adverse Event|0|||
124903683|NCT00716144|449272470|FG000|Overall Study|Withdrawal by Subject|4|||
124903684|NCT00716144|449272471|FG001|Overall Study|Withdrawal by Subject|2|||
124903685|NCT00716144|449272472|FG002|Overall Study|Withdrawal by Subject|6|||
124903686|NCT00716144|449272473|FG003|Overall Study|Withdrawal by Subject|6|||
124903687|NCT00716144|449272470|FG000|Overall Study|Lost to Follow-up|2|||
124903688|NCT00716144|449272471|FG001|Overall Study|Lost to Follow-up|2|||
124903689|NCT00716144|449272472|FG002|Overall Study|Lost to Follow-up|1|||
124903690|NCT00716144|449272473|FG003|Overall Study|Lost to Follow-up|2|||
124903691|NCT00716144|449272470|FG000|Overall Study|Adverse Event|0|||
124903692|NCT00716144|449272471|FG001|Overall Study|Adverse Event|0|||
124903693|NCT00716144|449272472|FG002|Overall Study|Adverse Event|0|||
124903694|NCT00716144|449272473|FG003|Overall Study|Adverse Event|2|||
124903695|NCT00716144|449272470|FG000|Overall Study|Non-compliance|1|||
124903696|NCT00716144|449272471|FG001|Overall Study|Non-compliance|0|||
124903697|NCT00716144|449272472|FG002|Overall Study|Non-compliance|0|||
124903698|NCT00716144|449272473|FG003|Overall Study|Non-compliance|0|||
124903699|NCT00716144|449272470|FG000|Overall Study|Protocol Violation|2|||
124903700|NCT00716144|449272471|FG001|Overall Study|Protocol Violation|0|||
124903701|NCT00716144|449272472|FG002|Overall Study|Protocol Violation|1|||
124903702|NCT00716144|449272473|FG003|Overall Study|Protocol Violation|0|||
124903703|NCT00716144|449272470|FG000|Overall Study|Physician Decision|0|||
124903704|NCT00716144|449272471|FG001|Overall Study|Physician Decision|1|||
124903705|NCT00716144|449272472|FG002|Overall Study|Physician Decision|2|||
124903706|NCT00716144|449272473|FG003|Overall Study|Physician Decision|2|||
124903707|NCT00716144|449272470|FG000|Overall Study|Intercurrent illness|0|||
124903708|NCT00716144|449272471|FG001|Overall Study|Intercurrent illness|0|||
124903709|NCT00716144|449272472|FG002|Overall Study|Intercurrent illness|1|||
124903710|NCT00716144|449272473|FG003|Overall Study|Intercurrent illness|0|||
124903711|NCT00716144|449272470|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
124903712|NCT00716144|449272471|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
124903713|NCT00716144|449272472|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
124903714|NCT00716144|449272473|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
124903715|NCT00716144|449272470|FG000|Overall Study|Adverse event: left foot pain|0|||
124903716|NCT00716144|449272471|FG001|Overall Study|Adverse event: left foot pain|1|||
124903717|NCT00716144|449272472|FG002|Overall Study|Adverse event: left foot pain|0|||
124903718|NCT00716144|449272473|FG003|Overall Study|Adverse event: left foot pain|0|||
124903719|NCT00716144|449272470|FG000|Overall Study|Clinical Depression|0|||
124903720|NCT00716144|449272471|FG001|Overall Study|Clinical Depression|1|||
124903721|NCT00716144|449272472|FG002|Overall Study|Clinical Depression|0|||
124903722|NCT00716144|449272473|FG003|Overall Study|Clinical Depression|0|||
125021309|NCT01790503|449703183|FG001|Overall Study|Physician Decision|0|||
125021310|NCT01790503|449703184|FG002|Overall Study|Physician Decision|0|||
124903723|NCT00909363|449272474|FG000|Overall Study|Withdrawal by Subject|1|||
124903724|NCT00909363|449272475|FG001|Overall Study|Withdrawal by Subject|0|||
124903725|NCT00909363|449272476|FG002|Overall Study|Withdrawal by Subject|0|||
125113821|NCT00410410|450040390|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
125113822|NCT00410410|450040391|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
125113823|NCT00410410|450040392|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
125113824|NCT00410410|450040393|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
125113825|NCT00410410|450040394|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
125113826|NCT00410410|450040395|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
125113827|NCT00410410|450040396|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
125113828|NCT00410410|450040397|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
125113829|NCT00410410|450040389|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
125113830|NCT00410410|450040390|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
125113831|NCT00410410|450040391|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
125113832|NCT00410410|450040392|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
125113833|NCT00410410|450040393|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
125113834|NCT00410410|450040394|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
125113835|NCT00410410|450040395|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
125113836|NCT00410410|450040396|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
125113837|NCT00410410|450040397|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
125113838|NCT00410410|450040389|FG000|Open-Label Period (OL)|Death|0|||
125113839|NCT00410410|450040390|FG001|Open-Label Period (OL)|Death|0|||
125113840|NCT00410410|450040391|FG002|Open-Label Period (OL)|Death|0|||
125113841|NCT00410410|450040392|FG003|Open-Label Period (OL)|Death|0|||
125113842|NCT00410410|450040393|FG004|Open-Label Period (OL)|Death|0|||
125113843|NCT00410410|450040394|FG005|Open-Label Period (OL)|Death|0|||
125113844|NCT00410410|450040395|FG006|Open-Label Period (OL)|Death|0|||
125113845|NCT00410410|450040396|FG007|Open-Label Period (OL)|Death|0|||
125113846|NCT00410410|450040397|FG008|Open-Label Period (OL)|Death|1|||
125113847|NCT00410410|450040389|FG000|Open-Label Period (OL)|Adverse Event|0|||
125113848|NCT00410410|450040390|FG001|Open-Label Period (OL)|Adverse Event|0|||
125113849|NCT00410410|450040391|FG002|Open-Label Period (OL)|Adverse Event|0|||
125113850|NCT00410410|450040392|FG003|Open-Label Period (OL)|Adverse Event|0|||
125113851|NCT00410410|450040393|FG004|Open-Label Period (OL)|Adverse Event|0|||
125113852|NCT00410410|450040394|FG005|Open-Label Period (OL)|Adverse Event|0|||
125113853|NCT00410410|450040395|FG006|Open-Label Period (OL)|Adverse Event|0|||
125113854|NCT00410410|450040396|FG007|Open-Label Period (OL)|Adverse Event|0|||
125113855|NCT00410410|450040397|FG008|Open-Label Period (OL)|Adverse Event|10|||
125113856|NCT00410410|450040389|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
125113857|NCT00410410|450040390|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
125113858|NCT00410410|450040391|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
125113859|NCT00410410|450040392|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
125113860|NCT00410410|450040393|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
125113861|NCT00410410|450040394|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
125113862|NCT00410410|450040395|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
125113863|NCT00410410|450040396|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
125113864|NCT00410410|450040397|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
125113865|NCT00410410|450040389|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
125113866|NCT00410410|450040390|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
125113867|NCT00410410|450040391|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
125113868|NCT00410410|450040392|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
125113869|NCT00410410|450040393|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
125113870|NCT00410410|450040394|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
125113871|NCT00410410|450040395|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
125113872|NCT00410410|450040396|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
125113873|NCT00410410|450040397|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
125113874|NCT00410410|450040389|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
125113875|NCT00410410|450040390|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
125113876|NCT00410410|450040391|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
125113877|NCT00410410|450040392|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
125113878|NCT00410410|450040393|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
125113879|NCT00410410|450040394|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
125113880|NCT00410410|450040395|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
125113881|NCT00410410|450040396|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
125113882|NCT00410410|450040397|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
125113883|NCT00410410|450040389|FG000|Open-Label Period (OL)|Pregnancy|0|||
125113884|NCT00410410|450040390|FG001|Open-Label Period (OL)|Pregnancy|0|||
124903726|NCT00909363|449272474|FG000|Overall Study|Lack of Efficacy|1|||
124903727|NCT00909363|449272475|FG001|Overall Study|Lack of Efficacy|0|||
124903728|NCT00909363|449272476|FG002|Overall Study|Lack of Efficacy|0|||
124903729|NCT05641311|449272477|FG000|Dosing Period 1|Adverse Event|1|||
124903730|NCT05641311|449272478|FG001|Dosing Period 1|Adverse Event|0|||
124903731|NCT00367055|449272480|FG000|Overall Study|Adverse Event|6|||
124903732|NCT00367055|449272481|FG001|Overall Study|Adverse Event|3|||
124903733|NCT00367055|449272480|FG000|Overall Study|Patient's Willing|3|||
124903734|NCT00367055|449272481|FG001|Overall Study|Patient's Willing|2|||
124903735|NCT00367055|449272480|FG000|Overall Study|Lack of Efficacy|1|||
124903736|NCT00367055|449272481|FG001|Overall Study|Lack of Efficacy|2|||
124903737|NCT00367055|449272480|FG000|Overall Study|Lost to Follow-up|1|||
124903738|NCT00367055|449272481|FG001|Overall Study|Lost to Follow-up|1|||
124903739|NCT00367055|449272480|FG000|Overall Study|Protocol Violation|0|||
124903740|NCT00367055|449272481|FG001|Overall Study|Protocol Violation|1|||
124903741|NCT00367055|449272480|FG000|Overall Study|Stopping Criterion Met|0|||
125021311|NCT01790503|449703185|FG003|Overall Study|Physician Decision|0|||
125021312|NCT01790503|449703186|FG004|Overall Study|Physician Decision|0|||
125021313|NCT01790503|449703187|FG005|Overall Study|Physician Decision|0|||
125021314|NCT01790503|449703188|FG006|Overall Study|Physician Decision|0|||
125021315|NCT01790503|449703189|FG007|Overall Study|Physician Decision|0|||
125021316|NCT01790503|449703190|FG008|Overall Study|Physician Decision|0|||
125021317|NCT01790503|449703191|FG009|Overall Study|Physician Decision|1|||
125021318|NCT01790503|449703192|FG010|Overall Study|Physician Decision|1|||
125021319|NCT01790503|449703182|FG000|Overall Study|Death|0|||
125021320|NCT01790503|449703183|FG001|Overall Study|Death|0|||
125021321|NCT01790503|449703184|FG002|Overall Study|Death|0|||
125021322|NCT01790503|449703185|FG003|Overall Study|Death|0|||
125021323|NCT01790503|449703186|FG004|Overall Study|Death|0|||
125021324|NCT01790503|449703187|FG005|Overall Study|Death|0|||
125021325|NCT01790503|449703188|FG006|Overall Study|Death|0|||
125021326|NCT01790503|449703189|FG007|Overall Study|Death|0|||
125021327|NCT01790503|449703190|FG008|Overall Study|Death|0|||
125021328|NCT01790503|449703191|FG009|Overall Study|Death|1|||
125021329|NCT01790503|449703192|FG010|Overall Study|Death|0|||
125021330|NCT01790503|449703182|FG000|Overall Study|Non Compliance|0|||
125021331|NCT01790503|449703183|FG001|Overall Study|Non Compliance|0|||
125021332|NCT01790503|449703184|FG002|Overall Study|Non Compliance|0|||
125021333|NCT01790503|449703185|FG003|Overall Study|Non Compliance|0|||
125021334|NCT01790503|449703186|FG004|Overall Study|Non Compliance|1|||
125021335|NCT01790503|449703187|FG005|Overall Study|Non Compliance|0|||
125021336|NCT01790503|449703188|FG006|Overall Study|Non Compliance|0|||
125021337|NCT01790503|449703189|FG007|Overall Study|Non Compliance|0|||
125021338|NCT01790503|449703190|FG008|Overall Study|Non Compliance|0|||
125021339|NCT01790503|449703191|FG009|Overall Study|Non Compliance|0|||
125021340|NCT01790503|449703192|FG010|Overall Study|Non Compliance|0|||
125021341|NCT01790503|449703182|FG000|Overall Study|Other|0|||
125021342|NCT01790503|449703183|FG001|Overall Study|Other|0|||
125021343|NCT01790503|449703184|FG002|Overall Study|Other|0|||
125021344|NCT01790503|449703185|FG003|Overall Study|Other|0|||
125021345|NCT01790503|449703186|FG004|Overall Study|Other|1|||
125021346|NCT01790503|449703187|FG005|Overall Study|Other|0|||
125021347|NCT01790503|449703188|FG006|Overall Study|Other|0|||
125021348|NCT01790503|449703189|FG007|Overall Study|Other|0|||
125021349|NCT01790503|449703190|FG008|Overall Study|Other|1|||
125021350|NCT01790503|449703191|FG009|Overall Study|Other|2|||
125021351|NCT01790503|449703192|FG010|Overall Study|Other|0|||
125021352|NCT02740478|449703195|FG000|Overall Study|Withdrawal by Subject|1|||
125021353|NCT03269344|449703196|FG000|Overall Study|Protocol Violation|4|||
125021354|NCT03269344|449703197|FG001|Overall Study|Protocol Violation|3|||
125021355|NCT02597855|449703198|FG000|Overall Study|Lost to Follow-up|2|||
125021356|NCT02597855|449703199|FG001|Overall Study|Lost to Follow-up|1|||
125021357|NCT01449708|449703200|FG000|Overall Study|Protocol Violation|0|||
125021358|NCT01449708|449703201|FG001|Overall Study|Protocol Violation|1|||
125021359|NCT01449708|449703200|FG000|Overall Study|surgical complication|1|||
125021360|NCT01449708|449703201|FG001|Overall Study|surgical complication|2|||
125021361|NCT01449708|449703200|FG000|Overall Study|respiratory failure|1|||
125021362|NCT01449708|449703201|FG001|Overall Study|respiratory failure|0|||
125021363|NCT00559507|449703202|FG000|Overall Study|Not treated, patient ineligible|3|||
125021364|NCT02889796|449703203|FG000|Overall Study|Withdrew Consent|18|||
125021365|NCT02889796|449703204|FG001|Overall Study|Withdrew Consent|29|||
125021366|NCT02889796|449703205|FG002|Overall Study|Withdrew Consent|20|||
125021367|NCT02889796|449703206|FG003|Overall Study|Withdrew Consent|1|||
125021368|NCT02889796|449703207|FG004|Overall Study|Withdrew Consent|2|||
125021369|NCT02889796|449703208|FG005|Overall Study|Withdrew Consent|35|||
124903742|NCT00367055|449272481|FG001|Overall Study|Stopping Criterion Met|1|||
124903743|NCT00367055|449272480|FG000|Overall Study|Participant Living too Far from Hospital|0|||
124903744|NCT00367055|449272481|FG001|Overall Study|Participant Living too Far from Hospital|1|||
124903745|NCT02459899|449272482|FG000|Overall Study|Adverse Event|1|||
124903746|NCT02459899|449272483|FG001|Overall Study|Adverse Event|1|||
124903747|NCT02459899|449272484|FG002|Overall Study|Adverse Event|0|||
124903748|NCT02459899|449272485|FG003|Overall Study|Adverse Event|0|||
124903749|NCT02459899|449272482|FG000|Overall Study|Lost to Follow-up|1|||
124903750|NCT02459899|449272483|FG001|Overall Study|Lost to Follow-up|2|||
124903751|NCT02459899|449272484|FG002|Overall Study|Lost to Follow-up|0|||
124903752|NCT02459899|449272485|FG003|Overall Study|Lost to Follow-up|1|||
124903753|NCT02459899|449272482|FG000|Overall Study|Non-compliance with the treatment|0|||
124903754|NCT02459899|449272483|FG001|Overall Study|Non-compliance with the treatment|0|||
124903755|NCT02459899|449272484|FG002|Overall Study|Non-compliance with the treatment|0|||
124903756|NCT02459899|449272485|FG003|Overall Study|Non-compliance with the treatment|1|||
124903757|NCT02459899|449272482|FG000|Overall Study|Withdrawal by Subject|1|||
124903758|NCT02459899|449272483|FG001|Overall Study|Withdrawal by Subject|3|||
124903759|NCT02459899|449272484|FG002|Overall Study|Withdrawal by Subject|0|||
124903760|NCT02459899|449272485|FG003|Overall Study|Withdrawal by Subject|0|||
124903761|NCT03612804|449272502|FG000|Overall Study|Death|0|||
124903762|NCT03612804|449272503|FG001|Overall Study|Death|7|||
124903763|NCT03612804|449272504|FG002|Overall Study|Death|0|||
124903764|NCT03612804|449272505|FG003|Overall Study|Death|8|||
124903765|NCT03612804|449272502|FG000|Overall Study|Medication copay coverage issues|0|||
124903766|NCT03612804|449272503|FG001|Overall Study|Medication copay coverage issues|0|||
124903767|NCT03612804|449272504|FG002|Overall Study|Medication copay coverage issues|0|||
124903768|NCT03612804|449272505|FG003|Overall Study|Medication copay coverage issues|17|||
125113885|NCT00410410|450040391|FG002|Open-Label Period (OL)|Pregnancy|0|||
125113886|NCT00410410|450040392|FG003|Open-Label Period (OL)|Pregnancy|0|||
125113887|NCT00410410|450040393|FG004|Open-Label Period (OL)|Pregnancy|0|||
125113888|NCT00410410|450040394|FG005|Open-Label Period (OL)|Pregnancy|0|||
125113889|NCT00410410|450040395|FG006|Open-Label Period (OL)|Pregnancy|0|||
125113890|NCT00410410|450040396|FG007|Open-Label Period (OL)|Pregnancy|0|||
125113891|NCT00410410|450040397|FG008|Open-Label Period (OL)|Pregnancy|1|||
125113892|NCT00410410|450040389|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
125113893|NCT00410410|450040390|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
125113894|NCT00410410|450040391|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
125113895|NCT00410410|450040392|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
125113896|NCT00410410|450040393|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
125113897|NCT00410410|450040394|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
125113898|NCT00410410|450040395|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
125113899|NCT00410410|450040396|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
125113900|NCT00410410|450040397|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
125113901|NCT00410410|450040389|FG000|Open-Label Period (OL)|Other|0|||
125113902|NCT00410410|450040390|FG001|Open-Label Period (OL)|Other|0|||
125113903|NCT00410410|450040391|FG002|Open-Label Period (OL)|Other|0|||
125113904|NCT00410410|450040392|FG003|Open-Label Period (OL)|Other|0|||
124903769|NCT03612804|449272502|FG000|Overall Study|Not current smoker at time of screening|0|||
125113905|NCT00410410|450040393|FG004|Open-Label Period (OL)|Other|0|||
125210785|NCT02134353|450395684|FG000|Overall Study|Withdrawal by Subject|12|||
125210786|NCT02134353|450395685|FG001|Overall Study|Withdrawal by Subject|13|||
125210787|NCT02134353|450395684|FG000|Overall Study|Death|0|||
125210788|NCT02134353|450395685|FG001|Overall Study|Death|1|||
125210789|NCT02134353|450395684|FG000|Overall Study|Pregnancy|0|||
125210790|NCT02134353|450395685|FG001|Overall Study|Pregnancy|1|||
125210791|NCT02134353|450395684|FG000|Overall Study|Relocation|1|||
125210792|NCT02134353|450395685|FG001|Overall Study|Relocation|0|||
125210793|NCT02134353|450395684|FG000|Overall Study|Other - Patient's Choice|0|||
125210794|NCT02134353|450395685|FG001|Overall Study|Other - Patient's Choice|1|||
125210795|NCT00477607|450395686|FG000|Overall Study|Lost to Follow-up|7|||
125210796|NCT00477607|450395687|FG001|Overall Study|Lost to Follow-up|7|||
125210797|NCT00474786|450395688|FG000|Overall Study|Not Meeting Study Criteria|0|||
125210798|NCT00474786|450395689|FG001|Overall Study|Not Meeting Study Criteria|1|||
125210799|NCT00474786|450395688|FG000|Overall Study|Investigator Request|2|||
125210800|NCT00474786|450395689|FG001|Overall Study|Investigator Request|1|||
125210801|NCT00474786|450395688|FG000|Overall Study|Death|189|||
125210802|NCT00474786|450395689|FG001|Overall Study|Death|170|||
125210803|NCT00474786|450395688|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
125210804|NCT00474786|450395689|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
125210805|NCT00474786|450395688|FG000|Overall Study|Lost to Follow-up|4|||
125210806|NCT00474786|450395689|FG001|Overall Study|Lost to Follow-up|7|||
125210807|NCT00474786|450395688|FG000|Overall Study|Protocol Violation|2|||
125210808|NCT00474786|450395689|FG001|Overall Study|Protocol Violation|0|||
125210809|NCT00474786|450395688|FG000|Overall Study|Withdrawal by Subject|15|||
125210810|NCT00474786|450395689|FG001|Overall Study|Withdrawal by Subject|15|||
125210811|NCT00474786|450395688|FG000|Overall Study|Other|5|||
125210812|NCT00474786|450395689|FG001|Overall Study|Other|0|||
125210813|NCT00358956|450395690|FG000|Overall Study|Adverse Event|3|||
125210814|NCT00358956|450395690|FG000|Overall Study|condition under investigation worsened|4|||
125210815|NCT00358956|450395690|FG000|Overall Study|Withdrawal by Subject|1|||
125210816|NCT02578940|450396653|FG000|Overall Study|Screening failure|5|||
125210817|NCT02578940|450396653|FG000|Overall Study|Lost to Follow-up|1|||
125210818|NCT04942210|450396659|FG000|Overall Study|Adverse Event|0|||
125210819|NCT04942210|450396660|FG001|Overall Study|Adverse Event|1|||
125210820|NCT04942210|450396659|FG000|Overall Study|Protocol Deviation|4|||
125210821|NCT04942210|450396660|FG001|Overall Study|Protocol Deviation|1|||
125210822|NCT04942210|450396659|FG000|Overall Study|Withdrawal by Subject|5|||
125210823|NCT04942210|450396660|FG001|Overall Study|Withdrawal by Subject|2|||
125210824|NCT04942210|450396659|FG000|Overall Study|Lost to Follow-up|16|||
125210825|NCT04942210|450396660|FG001|Overall Study|Lost to Follow-up|7|||
125210826|NCT04942210|450396659|FG000|Overall Study|Ongoing at the time of DBL date|60|||
125210827|NCT04942210|450396660|FG001|Overall Study|Ongoing at the time of DBL date|25|||
125210828|NCT04942210|450396659|FG000|Overall Study|Randomized but did not receive vaccination|3|||
125210829|NCT04942210|450396660|FG001|Overall Study|Randomized but did not receive vaccination|0|||
125210830|NCT05697627|450396663|FG000|Overall Study|Adverse Event|1|||
125210831|NCT02570750|450396664|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
125210832|NCT02570750|450396665|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
125210833|NCT02570750|450396664|FG000|Overall Study|Protocol deviation|4|||
125210834|NCT02570750|450396665|FG001|Overall Study|Protocol deviation|2|||
125210835|NCT02570750|450396664|FG000|Overall Study|Withdrawal by Subject|5|||
124903770|NCT03612804|449272503|FG001|Overall Study|Not current smoker at time of screening|1|||
125021370|NCT02889796|449703203|FG000|Overall Study|Investigator's Discretion|10|||
124903771|NCT03612804|449272504|FG002|Overall Study|Not current smoker at time of screening|0|||
124903772|NCT03612804|449272505|FG003|Overall Study|Not current smoker at time of screening|3|||
124903773|NCT03612804|449272502|FG000|Overall Study|Non-veteran status|0|||
124903774|NCT03612804|449272503|FG001|Overall Study|Non-veteran status|1|||
124903775|NCT03612804|449272504|FG002|Overall Study|Non-veteran status|0|||
124903776|NCT03612804|449272505|FG003|Overall Study|Non-veteran status|0|||
124903777|NCT03612804|449272502|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
124903778|NCT03612804|449272503|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
124903779|NCT03612804|449272504|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
125021371|NCT02889796|449703204|FG001|Overall Study|Investigator's Discretion|9|||
125210836|NCT02570750|450396665|FG001|Overall Study|Withdrawal by Subject|0|||
125210837|NCT02570750|450396664|FG000|Overall Study|Lost to Follow-up|2|||
125210838|NCT02570750|450396665|FG001|Overall Study|Lost to Follow-up|2|||
125210839|NCT02570750|450396664|FG000|Overall Study|Adverse Event|2|||
125210840|NCT02570750|450396665|FG001|Overall Study|Adverse Event|1|||
125210841|NCT01410240|450396666|FG000|Overall Study|Physician Decision|0|||
125210842|NCT01410240|450396667|FG001|Overall Study|Physician Decision|0|||
125210843|NCT01410240|450396668|FG002|Overall Study|Physician Decision|1|||
125210844|NCT01410240|450396666|FG000|Overall Study|Missed week 6 assessments|1|||
125210845|NCT01410240|450396667|FG001|Overall Study|Missed week 6 assessments|1|||
124903780|NCT03612804|449272505|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
124903781|NCT03612804|449272502|FG000|Overall Study|Provider retired from VA|0|||
124903782|NCT03612804|449272503|FG001|Overall Study|Provider retired from VA|0|||
124903783|NCT03612804|449272504|FG002|Overall Study|Provider retired from VA|2|||
124903784|NCT03612804|449272505|FG003|Overall Study|Provider retired from VA|0|||
124903785|NCT03612804|449272502|FG000|Overall Study|Withdrawal by Subject|0|||
124903786|NCT03612804|449272503|FG001|Overall Study|Withdrawal by Subject|0|||
124903787|NCT03612804|449272504|FG002|Overall Study|Withdrawal by Subject|7|||
124903788|NCT03612804|449272505|FG003|Overall Study|Withdrawal by Subject|0|||
124903789|NCT03612804|449272502|FG000|Overall Study|Provider involved with study activities|1|||
124903790|NCT03612804|449272503|FG001|Overall Study|Provider involved with study activities|0|||
124903791|NCT03612804|449272504|FG002|Overall Study|Provider involved with study activities|0|||
124903792|NCT03612804|449272505|FG003|Overall Study|Provider involved with study activities|0|||
124903793|NCT05019729|449272513|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
124903794|NCT05019729|449272514|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
124903795|NCT05019729|449272515|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
124903796|NCT05019729|449272516|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
124903797|NCT05019729|449272517|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
124903798|NCT05019729|449272518|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
124903799|NCT00038103|449272523|FG000|Overall Study|Adverse Event|5|||
124903800|NCT00038103|449272524|FG001|Overall Study|Adverse Event|6|||
124903801|NCT00038103|449272523|FG000|Overall Study|Lack of Efficacy|48|||
124903802|NCT00038103|449272524|FG001|Overall Study|Lack of Efficacy|41|||
124903803|NCT00038103|449272523|FG000|Overall Study|Withdrawal by Subject|0|||
124903804|NCT00038103|449272524|FG001|Overall Study|Withdrawal by Subject|3|||
124903805|NCT00038103|449272523|FG000|Overall Study|Lost to Follow-up|0|||
124903806|NCT00038103|449272524|FG001|Overall Study|Lost to Follow-up|3|||
124903807|NCT00038103|449272523|FG000|Overall Study|Protocol Violation|0|||
124903808|NCT00038103|449272524|FG001|Overall Study|Protocol Violation|2|||
124903809|NCT00038103|449272523|FG000|Overall Study|Sponsor Decision|0|||
124903810|NCT00038103|449272524|FG001|Overall Study|Sponsor Decision|1|||
124903811|NCT00038103|449272523|FG000|Overall Study|Randomized/never treated|2|||
124903812|NCT00038103|449272524|FG001|Overall Study|Randomized/never treated|0|||
124903813|NCT03545984|449272527|FG000|Overall Study|CSF cases not present during rotation|11|||
124903814|NCT03545984|449272528|FG001|Overall Study|CSF cases not present during rotation|9|||
124903815|NCT00387465|449272529|FG000|Overall Study|Withdrawal by Subject|0|||
124903816|NCT00387465|449272530|FG001|Overall Study|Withdrawal by Subject|1|||
124903817|NCT00387465|449272531|FG002|Overall Study|Withdrawal by Subject|0|||
124903818|NCT01212757|449272537|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
124903819|NCT01212757|449272538|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
124903820|NCT01212757|449272539|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
124903821|NCT01212757|449272540|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124903822|NCT01212757|449272541|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124903823|NCT01212757|449272542|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124903824|NCT01212757|449272543|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124903825|NCT01212757|449272544|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124903826|NCT01212757|449272545|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124903827|NCT01212757|449272537|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
124903828|NCT01212757|449272538|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
124903829|NCT01212757|449272539|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
124903830|NCT01212757|449272540|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124903831|NCT01212757|449272541|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124903832|NCT01212757|449272542|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124903833|NCT01212757|449272543|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124903834|NCT01212757|449272544|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124903835|NCT01212757|449272545|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124903836|NCT01212757|449272537|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
124903837|NCT01212757|449272538|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
124903838|NCT01212757|449272539|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
124903839|NCT01212757|449272540|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124903840|NCT01212757|449272541|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124903841|NCT01212757|449272542|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124903842|NCT01212757|449272543|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124903843|NCT01212757|449272544|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124903844|NCT01212757|449272545|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125113906|NCT00410410|450040394|FG005|Open-Label Period (OL)|Other|0|||
124903845|NCT01212757|449272537|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
124903846|NCT01212757|449272538|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124903847|NCT01212757|449272539|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
124903848|NCT01212757|449272540|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124903849|NCT01212757|449272541|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124903850|NCT01212757|449272542|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124903851|NCT01212757|449272543|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124903852|NCT01212757|449272544|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124903853|NCT01212757|449272545|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124903854|NCT01212757|449272537|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
124903855|NCT01212757|449272538|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
124903856|NCT01212757|449272539|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
125113907|NCT00410410|450040395|FG006|Open-Label Period (OL)|Other|0|||
125113908|NCT00410410|450040396|FG007|Open-Label Period (OL)|Other|0|||
125113909|NCT00410410|450040397|FG008|Open-Label Period (OL)|Other|7|||
125113910|NCT01953783|450040398|FG000|Overall Study|Progressive disease|2|||
125113911|NCT01271933|450040403|FG000|Single-Blind Phase|Lack of Efficacy|37|||
125113912|NCT01271933|450040404|FG001|Single-Blind Phase|Lack of Efficacy|0|||
125113913|NCT01271933|450040405|FG002|Single-Blind Phase|Lack of Efficacy|0|||
125113914|NCT01271933|450040403|FG000|Single-Blind Phase|Lost to Follow-up|10|||
125113915|NCT01271933|450040404|FG001|Single-Blind Phase|Lost to Follow-up|0|||
125113916|NCT01271933|450040405|FG002|Single-Blind Phase|Lost to Follow-up|0|||
125113917|NCT01271933|450040403|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
125113918|NCT01271933|450040404|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
125113919|NCT01271933|450040405|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
125113920|NCT01271933|450040403|FG000|Single-Blind Phase|Protocol Violation|3|||
125113921|NCT01271933|450040404|FG001|Single-Blind Phase|Protocol Violation|0|||
125113922|NCT01271933|450040405|FG002|Single-Blind Phase|Protocol Violation|0|||
125113923|NCT01271933|450040403|FG000|Single-Blind Phase|Adverse Event|52|||
125113924|NCT01271933|450040404|FG001|Single-Blind Phase|Adverse Event|0|||
125113925|NCT01271933|450040405|FG002|Single-Blind Phase|Adverse Event|0|||
125113926|NCT01271933|450040403|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
125113927|NCT01271933|450040404|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
125113928|NCT01271933|450040405|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
125113929|NCT01271933|450040403|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
125113930|NCT01271933|450040404|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
125113931|NCT01271933|450040405|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
125113932|NCT01271933|450040403|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
125113933|NCT01271933|450040404|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
125113934|NCT01271933|450040405|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
125113935|NCT01271933|450040403|FG000|Double-Blind Phase|Randomized but not treated|0|||
125113936|NCT01271933|450040404|FG001|Double-Blind Phase|Randomized but not treated|0|||
125113937|NCT01271933|450040405|FG002|Double-Blind Phase|Randomized but not treated|1|||
125113938|NCT01271933|450040403|FG000|Double-Blind Phase|Lack of Efficacy|0|||
125113939|NCT01271933|450040404|FG001|Double-Blind Phase|Lack of Efficacy|6|||
125113940|NCT01271933|450040405|FG002|Double-Blind Phase|Lack of Efficacy|9|||
125113941|NCT01271933|450040403|FG000|Double-Blind Phase|Lost to Follow-up|0|||
125113942|NCT01271933|450040404|FG001|Double-Blind Phase|Lost to Follow-up|1|||
125113943|NCT01271933|450040405|FG002|Double-Blind Phase|Lost to Follow-up|1|||
125113944|NCT01271933|450040403|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
125113945|NCT01271933|450040404|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
125113946|NCT01271933|450040405|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
125113947|NCT01271933|450040403|FG000|Double-Blind Phase|Adverse Event|0|||
125113948|NCT01271933|450040404|FG001|Double-Blind Phase|Adverse Event|3|||
125113949|NCT01271933|450040405|FG002|Double-Blind Phase|Adverse Event|0|||
125113950|NCT01271933|450040403|FG000|Double-Blind Phase|Participant request-personal reason|0|||
125113951|NCT01271933|450040404|FG001|Double-Blind Phase|Participant request-personal reason|1|||
125113952|NCT01271933|450040405|FG002|Double-Blind Phase|Participant request-personal reason|0|||
125113953|NCT01138150|450040406|FG000|Overall Study|blood unable to be processed|0|||
125113954|NCT01138150|450040407|FG001|Overall Study|blood unable to be processed|1|||
125113955|NCT01138150|450040406|FG000|Overall Study|Physician Decision|1|||
125113956|NCT01138150|450040407|FG001|Overall Study|Physician Decision|0|||
125113957|NCT05085964|450040408|FG000|Overall Study|Premature termination of study|21|||
125113958|NCT05085964|450040409|FG001|Overall Study|Premature termination of study|0|||
125113959|NCT03156270|450040412|FG000|Overall Study|Failed pre-treatment screening|1|||
125113960|NCT03156270|450040412|FG000|Overall Study|Lost to Follow-up|1|||
125113961|NCT00591253|450040413|FG000|Overall Study|Adverse Event|3|||
125113962|NCT00591253|450040414|FG001|Overall Study|Adverse Event|3|||
125113963|NCT00591253|450040415|FG002|Overall Study|Adverse Event|1|||
125113964|NCT00591253|450040413|FG000|Overall Study|Protocol Violation|2|||
125113965|NCT00591253|450040414|FG001|Overall Study|Protocol Violation|2|||
125113966|NCT00591253|450040415|FG002|Overall Study|Protocol Violation|2|||
124903857|NCT01212757|449272540|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124903858|NCT01212757|449272541|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124903859|NCT01212757|449272542|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124903860|NCT01212757|449272543|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124903861|NCT01212757|449272544|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124903862|NCT01212757|449272545|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124903863|NCT01212757|449272537|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124903864|NCT01212757|449272538|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
124903865|NCT01212757|449272539|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
124903866|NCT01212757|449272540|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124903867|NCT01212757|449272541|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124903868|NCT01212757|449272542|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124903869|NCT01212757|449272543|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124903870|NCT01212757|449272544|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124903871|NCT01212757|449272545|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124903872|NCT01212757|449272537|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
124903873|NCT01212757|449272538|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
124903874|NCT01212757|449272539|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
124903875|NCT01212757|449272540|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
124903876|NCT01212757|449272541|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
124903877|NCT01212757|449272542|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
124903878|NCT01212757|449272543|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
124903879|NCT01212757|449272544|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
124903880|NCT01212757|449272545|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
124903881|NCT01212757|449272537|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
124903882|NCT01212757|449272538|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
124903883|NCT01212757|449272539|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
124903884|NCT01212757|449272540|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
124903885|NCT01212757|449272541|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
124903886|NCT01212757|449272542|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
124903887|NCT01212757|449272543|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
124903888|NCT01212757|449272544|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
124903889|NCT01212757|449272545|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
124903890|NCT01212757|449272537|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
124903891|NCT01212757|449272538|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
124903892|NCT01212757|449272539|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
124903893|NCT01212757|449272540|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
124903894|NCT01212757|449272541|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
124903895|NCT01212757|449272542|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
124903896|NCT01212757|449272543|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
124903897|NCT01212757|449272544|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
124903898|NCT01212757|449272545|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
124903899|NCT01212757|449272537|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
124903900|NCT01212757|449272538|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
124903901|NCT01212757|449272539|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
124903902|NCT01212757|449272540|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
124903903|NCT01212757|449272541|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
124903904|NCT01212757|449272542|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
124903905|NCT01212757|449272543|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
124903906|NCT01212757|449272544|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
124903907|NCT01212757|449272545|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
124903908|NCT01212757|449272537|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
124903909|NCT01212757|449272538|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
124903910|NCT01212757|449272539|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
124903911|NCT01212757|449272540|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
124903912|NCT01212757|449272541|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
124903913|NCT01212757|449272542|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
124903914|NCT01212757|449272543|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
124903915|NCT01212757|449272544|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
124903916|NCT01212757|449272545|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
124903917|NCT01212757|449272537|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
124903918|NCT01212757|449272538|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
124903919|NCT01212757|449272539|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
124903920|NCT01212757|449272540|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
125210846|NCT01410240|450396668|FG002|Overall Study|Missed week 6 assessments|1|||
125210847|NCT02722746|450396673|FG000|Overall Study|Withdrawal by Subject|0|||
125210848|NCT02722746|450396674|FG001|Overall Study|Withdrawal by Subject|1|||
125210849|NCT02722746|450396675|FG002|Overall Study|Withdrawal by Subject|0|||
125210850|NCT02722746|450396673|FG000|Overall Study|Protocol Violation|8|||
125210851|NCT02722746|450396674|FG001|Overall Study|Protocol Violation|4|||
125210852|NCT02722746|450396675|FG002|Overall Study|Protocol Violation|6|||
125210853|NCT01134263|450396682|FG000|Overall Study|Serious adverse event|2|||
125210854|NCT01134263|450396683|FG001|Overall Study|Serious adverse event|1|||
125210855|NCT01134263|450396684|FG002|Overall Study|Serious adverse event|1|||
125210856|NCT01134263|450396685|FG003|Overall Study|Serious adverse event|1|||
125210857|NCT01134263|450396686|FG004|Overall Study|Serious adverse event|1|||
125210858|NCT01134263|450396682|FG000|Overall Study|Other adverse event|1|||
125210859|NCT01134263|450396683|FG001|Overall Study|Other adverse event|2|||
125210860|NCT01134263|450396684|FG002|Overall Study|Other adverse event|5|||
125210861|NCT01134263|450396685|FG003|Overall Study|Other adverse event|3|||
125210862|NCT01134263|450396686|FG004|Overall Study|Other adverse event|0|||
125210863|NCT01134263|450396682|FG000|Overall Study|Protocol Violation|8|||
125210864|NCT01134263|450396683|FG001|Overall Study|Protocol Violation|7|||
125210865|NCT01134263|450396684|FG002|Overall Study|Protocol Violation|2|||
125210866|NCT01134263|450396685|FG003|Overall Study|Protocol Violation|4|||
125210867|NCT01134263|450396686|FG004|Overall Study|Protocol Violation|2|||
125210868|NCT01134263|450396682|FG000|Overall Study|Lost to Follow-up|4|||
125210869|NCT01134263|450396683|FG001|Overall Study|Lost to Follow-up|3|||
125210870|NCT01134263|450396684|FG002|Overall Study|Lost to Follow-up|5|||
125210871|NCT01134263|450396685|FG003|Overall Study|Lost to Follow-up|3|||
125210872|NCT01134263|450396686|FG004|Overall Study|Lost to Follow-up|1|||
125210873|NCT01134263|450396682|FG000|Overall Study|Withdrawal by Subject|8|||
125210874|NCT01134263|450396683|FG001|Overall Study|Withdrawal by Subject|6|||
125210875|NCT01134263|450396684|FG002|Overall Study|Withdrawal by Subject|16|||
125210876|NCT01134263|450396685|FG003|Overall Study|Withdrawal by Subject|7|||
125210877|NCT01134263|450396686|FG004|Overall Study|Withdrawal by Subject|5|||
125210878|NCT01134263|450396682|FG000|Overall Study|Enrolled, but not treated|1|||
125210879|NCT01134263|450396683|FG001|Overall Study|Enrolled, but not treated|1|||
125210880|NCT01134263|450396684|FG002|Overall Study|Enrolled, but not treated|0|||
125210881|NCT01134263|450396685|FG003|Overall Study|Enrolled, but not treated|1|||
124903921|NCT01212757|449272541|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
124903922|NCT01212757|449272542|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
124903923|NCT01212757|449272543|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
124903924|NCT01212757|449272544|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
124903925|NCT01212757|449272545|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
124903926|NCT01212757|449272537|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
124903927|NCT01212757|449272538|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
124903928|NCT01212757|449272539|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
124903929|NCT01212757|449272540|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
124903930|NCT01212757|449272541|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
124903931|NCT01212757|449272542|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
124903932|NCT01212757|449272543|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
124903933|NCT01212757|449272544|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
124903934|NCT01212757|449272545|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
124903935|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
124903936|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
124903937|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
124903938|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
124903939|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
124903940|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
124903941|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
124903942|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
124903943|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
124903944|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
124903945|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
124903946|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
124903947|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
124903948|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
124903949|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
125210882|NCT01134263|450396686|FG004|Overall Study|Enrolled, but not treated|0|||
125210883|NCT02305446|450396689|FG000|Overall Study|Adverse Event|1|||
125210884|NCT00957424|450396690|FG000|Overall Study|Lost to Follow-up|19|||
125210885|NCT00957424|450396690|FG000|Overall Study|Protocol Violation|3|||
125210886|NCT00957424|450396690|FG000|Overall Study|Withdrawal by Subject|1|||
125210887|NCT05182606|450396698|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
125210888|NCT01955109|450396701|FG000|Overall Study|Adverse Event|2|||
124903950|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
124903951|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
124903952|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
124903953|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
124903954|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
124903955|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
124903956|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
124903957|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
124903958|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
124903959|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
124903960|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
124903961|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
124903962|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124903963|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
124903964|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
124903965|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124903966|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124903967|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124903968|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124903969|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
124903970|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
124903971|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
124903972|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
124903973|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
124903974|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
124903975|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
124903976|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
124903977|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
124903978|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
124903979|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
124903980|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
124903981|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
124903982|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
124903983|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
124903984|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
124903985|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
124903986|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
124903987|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
124903988|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
124903989|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
124903990|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
124903991|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
124903992|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
124903993|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
124903994|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
124903995|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
124903996|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
124903997|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
124903998|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
124903999|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
124904000|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
124904001|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
124904002|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
124904003|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
124904004|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
124904005|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
124904006|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
124904007|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124904008|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
124904009|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
124904010|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124904011|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124904012|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124904013|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124904014|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
124904015|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
124904016|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
125113967|NCT00591253|450040413|FG000|Overall Study|Lost to Follow-up|2|||
125113968|NCT00591253|450040414|FG001|Overall Study|Lost to Follow-up|4|||
125113969|NCT00591253|450040415|FG002|Overall Study|Lost to Follow-up|0|||
125113970|NCT00591253|450040413|FG000|Overall Study|Withdrawal by Subject|1|||
125113971|NCT00591253|450040414|FG001|Overall Study|Withdrawal by Subject|7|||
125113972|NCT00591253|450040415|FG002|Overall Study|Withdrawal by Subject|6|||
125113973|NCT00591253|450040413|FG000|Overall Study|Lack of Efficacy|1|||
125113974|NCT00591253|450040414|FG001|Overall Study|Lack of Efficacy|0|||
125113975|NCT00591253|450040415|FG002|Overall Study|Lack of Efficacy|3|||
125113976|NCT00591253|450040413|FG000|Overall Study|Other|5|||
125021372|NCT02889796|449703205|FG002|Overall Study|Investigator's Discretion|10|||
125021373|NCT02889796|449703206|FG003|Overall Study|Investigator's Discretion|3|||
125021374|NCT02889796|449703207|FG004|Overall Study|Investigator's Discretion|0|||
125021375|NCT02889796|449703208|FG005|Overall Study|Investigator's Discretion|15|||
125021376|NCT02889796|449703203|FG000|Overall Study|Adverse Event|17|||
125021377|NCT02889796|449703204|FG001|Overall Study|Adverse Event|8|||
125021378|NCT02889796|449703205|FG002|Overall Study|Adverse Event|8|||
125021379|NCT02889796|449703206|FG003|Overall Study|Adverse Event|4|||
125021380|NCT02889796|449703207|FG004|Overall Study|Adverse Event|1|||
125021381|NCT02889796|449703208|FG005|Overall Study|Adverse Event|7|||
125021382|NCT02889796|449703203|FG000|Overall Study|Lost to Follow-up|5|||
125021383|NCT02889796|449703204|FG001|Overall Study|Lost to Follow-up|7|||
125021384|NCT02889796|449703205|FG002|Overall Study|Lost to Follow-up|2|||
125021385|NCT02889796|449703206|FG003|Overall Study|Lost to Follow-up|0|||
125021386|NCT02889796|449703207|FG004|Overall Study|Lost to Follow-up|2|||
125021387|NCT02889796|449703208|FG005|Overall Study|Lost to Follow-up|6|||
125021388|NCT02889796|449703203|FG000|Overall Study|Protocol Violation|0|||
125021389|NCT02889796|449703204|FG001|Overall Study|Protocol Violation|1|||
125021390|NCT02889796|449703205|FG002|Overall Study|Protocol Violation|3|||
125021391|NCT02889796|449703206|FG003|Overall Study|Protocol Violation|0|||
125021392|NCT02889796|449703207|FG004|Overall Study|Protocol Violation|0|||
125021393|NCT02889796|449703208|FG005|Overall Study|Protocol Violation|4|||
125021394|NCT02889796|449703203|FG000|Overall Study|Non-compliance With Study Drug|0|||
125021395|NCT02889796|449703204|FG001|Overall Study|Non-compliance With Study Drug|2|||
125021396|NCT02889796|449703205|FG002|Overall Study|Non-compliance With Study Drug|0|||
125021397|NCT02889796|449703206|FG003|Overall Study|Non-compliance With Study Drug|0|||
125021398|NCT02889796|449703207|FG004|Overall Study|Non-compliance With Study Drug|1|||
125021399|NCT02889796|449703208|FG005|Overall Study|Non-compliance With Study Drug|2|||
125021400|NCT02889796|449703203|FG000|Overall Study|Death|1|||
125021401|NCT02889796|449703204|FG001|Overall Study|Death|1|||
125021402|NCT02889796|449703205|FG002|Overall Study|Death|0|||
125021403|NCT02889796|449703206|FG003|Overall Study|Death|1|||
125021404|NCT02889796|449703207|FG004|Overall Study|Death|0|||
125021405|NCT02889796|449703208|FG005|Overall Study|Death|1|||
125021406|NCT02889796|449703203|FG000|Overall Study|Pregnancy|0|||
125021407|NCT02889796|449703204|FG001|Overall Study|Pregnancy|1|||
125021408|NCT02889796|449703205|FG002|Overall Study|Pregnancy|1|||
125021409|NCT02889796|449703206|FG003|Overall Study|Pregnancy|0|||
125021410|NCT02889796|449703207|FG004|Overall Study|Pregnancy|0|||
125021411|NCT02889796|449703208|FG005|Overall Study|Pregnancy|0|||
125021412|NCT02889796|449703203|FG000|Overall Study|Randomized but not Dosed|2|||
125021413|NCT02889796|449703204|FG001|Overall Study|Randomized but not Dosed|0|||
125021414|NCT02889796|449703205|FG002|Overall Study|Randomized but not Dosed|0|||
125021415|NCT02889796|449703206|FG003|Overall Study|Randomized but not Dosed|0|||
125021416|NCT02889796|449703207|FG004|Overall Study|Randomized but not Dosed|0|||
125021417|NCT02889796|449703208|FG005|Overall Study|Randomized but not Dosed|2|||
125021418|NCT01407926|449703214|FG000|Overall Study|Lost to Follow-up|55|||
125021419|NCT02814565|449703215|FG000|Overall Study|Lack of Efficacy|0|||
125021420|NCT02814565|449703216|FG001|Overall Study|Lack of Efficacy|1|||
125021421|NCT02814565|449703215|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
125021422|NCT02814565|449703216|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
125021423|NCT01414257|449703217|FG000|Overall Study|No Visit After First Day of Treatment|12|||
125021424|NCT01414257|449703217|FG000|Overall Study|Protocol Violation|10|||
125021425|NCT01882907|449703221|FG000|Overall Study|Adverse Event|3|||
125021426|NCT01882907|449703222|FG001|Overall Study|Adverse Event|1|||
125021427|NCT01882907|449703221|FG000|Overall Study|Lack of Efficacy|0|||
125021428|NCT01882907|449703222|FG001|Overall Study|Lack of Efficacy|3|||
124904017|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
124904018|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
124904019|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
124904020|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
124904021|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
124904022|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
124904023|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
124904024|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
124904025|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
124904026|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
124904027|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
124904028|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
124904029|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
124904030|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
124904031|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
124904032|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
124904033|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
124904034|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
124904035|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
124904036|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
124904037|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
124904038|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
124904039|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
124904040|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
124904041|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
124904042|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
124904043|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
124904044|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
124904045|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
124904046|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
124904047|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
124904048|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
124904049|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
124904050|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
124904051|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
124904052|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
124904053|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
124904054|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
124904055|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
124904056|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
124904057|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
124904058|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
124904059|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
124904060|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
124904061|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
124904062|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
124904063|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
124904064|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
124904065|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
124904066|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
124904067|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
124904068|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
124904069|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
124904070|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124904071|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
124904072|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
124904073|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125021429|NCT01882907|449703221|FG000|Overall Study|Lost to Follow-up|1|||
125021430|NCT01882907|449703222|FG001|Overall Study|Lost to Follow-up|4|||
125021431|NCT01882907|449703221|FG000|Overall Study|Protocol Violation|10|||
125021432|NCT01882907|449703222|FG001|Overall Study|Protocol Violation|14|||
125021433|NCT01882907|449703221|FG000|Overall Study|Withdrawal by Subject|0|||
125021434|NCT01882907|449703222|FG001|Overall Study|Withdrawal by Subject|6|||
125113977|NCT00591253|450040414|FG001|Overall Study|Other|5|||
124904074|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124904075|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125021435|NCT01784965|449703223|FG000|Overall Study|Withdrawal by Subject|6|||
125021436|NCT01784965|449703224|FG001|Overall Study|Withdrawal by Subject|3|||
125021437|NCT01784965|449703223|FG000|Overall Study|Adverse Event|0|||
124904076|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124904077|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
124904078|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
124904079|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
124904080|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
124904081|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
124904082|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
124904083|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
124904084|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
124904085|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
124904086|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
124904087|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
124904088|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
124904089|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
124904090|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
124904091|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
124904092|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
124904093|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
124904094|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
124904095|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
124904096|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
124904097|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124904098|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
124904099|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
124904100|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124904101|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124904102|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124904103|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124904104|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
124904105|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
124904106|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
124904107|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
124904108|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
124904109|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
124904110|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
124904111|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
124904112|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
124904113|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
124904114|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
124904115|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
124904116|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
124904117|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
124904118|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
124904119|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
124904120|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
124904121|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
124904122|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
124904123|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
124904124|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
124904125|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
124904126|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
124904127|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
124904128|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
124904129|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
124904130|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
124904131|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
124904132|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
124904133|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
124904134|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
124904135|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
124904136|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
125113978|NCT00591253|450040415|FG002|Overall Study|Other|3|||
124904137|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
124904138|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
124904139|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
124904140|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
124904141|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
124904142|NCT02983617|449274023|FG000|Overall Study|Adverse Event|0|||
124904143|NCT02983617|449274024|FG001|Overall Study|Adverse Event|7|||
124904144|NCT02983617|449274023|FG000|Overall Study|Death|0|||
124904145|NCT02983617|449274024|FG001|Overall Study|Death|1|||
124904146|NCT02983617|449274023|FG000|Overall Study|Investigator's Discretion|0|||
124904147|NCT02983617|449274024|FG001|Overall Study|Investigator's Discretion|1|||
124904148|NCT02698891|449274029|FG000|Overall Study|Withdrawal by Subject|2|||
124904149|NCT02698891|449274029|FG000|Overall Study|deemed ineligible|1|||
124904150|NCT02698891|449274029|FG000|Overall Study|Adverse Event|9|||
124904151|NCT00516386|449274030|FG000|Overall Study|not interested in the study|4|||
124904152|NCT00516386|449274030|FG000|Overall Study|Lost to Follow-up|2|||
124904153|NCT00818454|449274031|FG000|Treatment Period 1|Adverse Event|0|||
124904154|NCT00818454|449274032|FG001|Treatment Period 1|Adverse Event|1|||
124904155|NCT00818454|449274033|FG002|Treatment Period 1|Adverse Event|0|||
124904156|NCT00818454|449274034|FG003|Treatment Period 1|Adverse Event|0|||
124904157|NCT00818454|449274031|FG000|Treatment Period 1|Other|3|||
124904158|NCT00818454|449274032|FG001|Treatment Period 1|Other|0|||
124904159|NCT00818454|449274033|FG002|Treatment Period 1|Other|0|||
124904160|NCT00818454|449274034|FG003|Treatment Period 1|Other|0|||
124904161|NCT00818454|449274031|FG000|Washout Period of 1 Week|Adverse Event|1|||
124904162|NCT00818454|449274032|FG001|Washout Period of 1 Week|Adverse Event|1|||
124904163|NCT00818454|449274033|FG002|Washout Period of 1 Week|Adverse Event|0|||
124904164|NCT00818454|449274034|FG003|Washout Period of 1 Week|Adverse Event|0|||
124904165|NCT00818454|449274031|FG000|Washout Period of 1 Week|Protocol Violation|2|||
124904166|NCT00818454|449274032|FG001|Washout Period of 1 Week|Protocol Violation|0|||
124904167|NCT00818454|449274033|FG002|Washout Period of 1 Week|Protocol Violation|0|||
124904168|NCT00818454|449274034|FG003|Washout Period of 1 Week|Protocol Violation|0|||
124904169|NCT00818454|449274031|FG000|Washout Period of 1 Week|Other|1|||
124904170|NCT00818454|449274032|FG001|Washout Period of 1 Week|Other|2|||
124904171|NCT00818454|449274033|FG002|Washout Period of 1 Week|Other|0|||
124904172|NCT00818454|449274034|FG003|Washout Period of 1 Week|Other|0|||
124904173|NCT00818454|449274031|FG000|Treatment Period 2|Other|2|||
124904174|NCT00818454|449274032|FG001|Treatment Period 2|Other|1|||
124904175|NCT00818454|449274033|FG002|Treatment Period 2|Other|0|||
124904176|NCT00818454|449274034|FG003|Treatment Period 2|Other|0|||
124904177|NCT00818454|449274031|FG000|Treatment Period 3|Adverse Event|0|||
124904178|NCT00818454|449274032|FG001|Treatment Period 3|Adverse Event|0|||
124904179|NCT00818454|449274033|FG002|Treatment Period 3|Adverse Event|0|||
124904180|NCT00818454|449274034|FG003|Treatment Period 3|Adverse Event|1|||
124904181|NCT01171625|449274040|FG000|Overall Study|On-Protocol|67|||
124904182|NCT01171625|449274040|FG000|Overall Study|Death|38|||
124904183|NCT01171625|449274040|FG000|Overall Study|Withdrawal by Subject|31|||
124904184|NCT01171625|449274040|FG000|Overall Study|Explanted|10|||
124904185|NCT01171625|449274040|FG000|Overall Study|Lost to Follow-up|5|||
125021438|NCT01784965|449703224|FG001|Overall Study|Adverse Event|8|||
125021439|NCT03178487|449703227|FG000|Period 1|Adverse Event|1|||
125021440|NCT03178487|449703228|FG001|Period 1|Adverse Event|2|||
125021441|NCT03178487|449703227|FG000|Period 1|Withdrawal by Subject|2|||
124904186|NCT01171625|449274040|FG000|Overall Study|Patient received valve-in-valve|3|||
124904187|NCT01171625|449274040|FG000|Overall Study|Other|1|||
124904188|NCT01171625|449274040|FG000|Overall Study|Consented but did not receive device|25|||
124904189|NCT01376089|449274041|FG000|Overall Study|Patient received no contrast media|3|||
124904190|NCT01376089|449274042|FG001|Overall Study|Patient received no contrast media|4|||
125021442|NCT03178487|449703228|FG001|Period 1|Withdrawal by Subject|1|||
125021443|NCT03178487|449703227|FG000|Period 1|Lost to Follow-up|1|||
125021444|NCT03178487|449703228|FG001|Period 1|Lost to Follow-up|0|||
125021445|NCT03178487|449703227|FG000|Period 1|Other|0|||
125021446|NCT03178487|449703228|FG001|Period 1|Other|1|||
125021447|NCT03178487|449703227|FG000|Period 2|Adverse Event|4|||
125021448|NCT03178487|449703228|FG001|Period 2|Adverse Event|4|||
125021449|NCT03178487|449703227|FG000|Period 2|Withdrawal by Subject|6|||
125210889|NCT01955109|450396702|FG001|Overall Study|Adverse Event|0|||
124904191|NCT00549848|449274043|FG000|Overall Study|Death|1|||
125210890|NCT01955109|450396701|FG000|Overall Study|Participant unwilling to continue|35|||
124904192|NCT00549848|449274044|FG001|Overall Study|Death|4|||
124904193|NCT00549848|449274045|FG002|Overall Study|Death|13|||
124904194|NCT00549848|449274043|FG000|Overall Study|Physician Decision|0|||
124904195|NCT00549848|449274044|FG001|Overall Study|Physician Decision|0|||
125021450|NCT03178487|449703228|FG001|Period 2|Withdrawal by Subject|6|||
125021451|NCT03178487|449703227|FG000|Period 2|Lost to Follow-up|2|||
125021452|NCT03178487|449703228|FG001|Period 2|Lost to Follow-up|2|||
124904196|NCT00549848|449274045|FG002|Overall Study|Physician Decision|4|||
124904197|NCT00549848|449274043|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
125021453|NCT03178487|449703227|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
124904198|NCT00549848|449274044|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
124904199|NCT00549848|449274045|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
124904200|NCT00549848|449274043|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
124904201|NCT00549848|449274044|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
124904202|NCT00549848|449274045|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
124904203|NCT00549848|449274043|FG000|Overall Study|Participant/Family Withdraw|2|||
124904204|NCT00549848|449274044|FG001|Overall Study|Participant/Family Withdraw|3|||
124904205|NCT00549848|449274045|FG002|Overall Study|Participant/Family Withdraw|5|||
124904206|NCT00549848|449274043|FG000|Overall Study|Second Malignancy|1|||
124904207|NCT00549848|449274044|FG001|Overall Study|Second Malignancy|0|||
124904208|NCT00549848|449274045|FG002|Overall Study|Second Malignancy|0|||
124904209|NCT00549848|449274043|FG000|Overall Study|Transplant|3|||
124904210|NCT00549848|449274044|FG001|Overall Study|Transplant|3|||
124904211|NCT00549848|449274045|FG002|Overall Study|Transplant|18|||
124904212|NCT00549848|449274043|FG000|Overall Study|Unacceptable Toxicity|1|||
124904213|NCT00549848|449274044|FG001|Overall Study|Unacceptable Toxicity|6|||
124904214|NCT00549848|449274045|FG002|Overall Study|Unacceptable Toxicity|6|||
124904215|NCT03262935|449274048|FG000|Overall Study|Withdrawal by Subject|6|||
124904216|NCT03262935|449274049|FG001|Overall Study|Withdrawal by Subject|7|||
124904217|NCT03262935|449274048|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
124904218|NCT03262935|449274049|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
124904219|NCT03262935|449274048|FG000|Overall Study|Death|181|||
124904220|NCT03262935|449274049|FG001|Overall Study|Death|94|||
124904221|NCT03262935|449274048|FG000|Overall Study|Lost to Follow-up|9|||
124904222|NCT03262935|449274049|FG001|Overall Study|Lost to Follow-up|4|||
124904223|NCT03262935|449274048|FG000|Overall Study|Other reason|5|||
124904224|NCT03262935|449274049|FG001|Overall Study|Other reason|0|||
124904225|NCT01811706|449274050|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
124904226|NCT01811706|449274051|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
124904227|NCT00753012|449274053|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
124904228|NCT00753012|449274054|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
124904229|NCT00753012|449274053|FG000|Overall Study|Adverse Event|2|||
124904230|NCT00753012|449274054|FG001|Overall Study|Adverse Event|0|||
124904231|NCT00753012|449274053|FG000|Overall Study|Withdrawal by Subject|0|||
124904232|NCT00753012|449274054|FG001|Overall Study|Withdrawal by Subject|1|||
124904233|NCT00753012|449274053|FG000|Overall Study|Lost to Follow-up|4|||
124904234|NCT00753012|449274054|FG001|Overall Study|Lost to Follow-up|0|||
124904235|NCT00753012|449274053|FG000|Overall Study|Confounded endpoint data|1|||
124904236|NCT00753012|449274054|FG001|Overall Study|Confounded endpoint data|0|||
124904237|NCT00217672|449274058|FG000|Allocation|Ineligible|2|||
124904238|NCT00217672|449274059|FG001|Allocation|Ineligible|0|||
124904239|NCT00217672|449274058|FG000|Treatment|disease progression|33|||
124904240|NCT00217672|449274059|FG001|Treatment|disease progression|4|||
124904241|NCT00217672|449274058|FG000|Treatment|Adverse Event|18|||
124904242|NCT00217672|449274059|FG001|Treatment|Adverse Event|2|||
124904243|NCT00217672|449274058|FG000|Treatment|reqd treatment not permitted by protocol|6|||
124904244|NCT00217672|449274059|FG001|Treatment|reqd treatment not permitted by protocol|0|||
124904245|NCT00217672|449274058|FG000|Treatment|Physician Decision|6|||
124904246|NCT00217672|449274059|FG001|Treatment|Physician Decision|0|||
124904247|NCT00217672|449274058|FG000|Treatment|insurance issues|1|||
124904248|NCT00217672|449274059|FG001|Treatment|insurance issues|1|||
124904249|NCT00217672|449274058|FG000|Treatment|Death|2|||
124904250|NCT00217672|449274059|FG001|Treatment|Death|0|||
124904251|NCT00217672|449274058|FG000|Treatment|secondary malignancy|1|||
124904252|NCT00217672|449274059|FG001|Treatment|secondary malignancy|0|||
124904253|NCT00217672|449274058|FG000|Follow-up|Withdrawal by Subject|4|||
124904254|NCT00217672|449274059|FG001|Follow-up|Withdrawal by Subject|0|||
124904255|NCT00217672|449274058|FG000|Follow-up|Lost to Follow-up|1|||
124904256|NCT00217672|449274059|FG001|Follow-up|Lost to Follow-up|0|||
124904257|NCT01596504|449274064|FG000|Overall Study|Participant's Private Reason|0|||
124904258|NCT01596504|449274065|FG001|Overall Study|Participant's Private Reason|1|||
124904259|NCT01596504|449274066|FG002|Overall Study|Participant's Private Reason|0|||
124904260|NCT01596504|449274064|FG000|Overall Study|Adverse Event|1|||
124904261|NCT01596504|449274065|FG001|Overall Study|Adverse Event|2|||
125113979|NCT01841359|450040421|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
125113980|NCT01841359|450040421|FG000|Overall Study|Concommitant medical issues|2|||
124904262|NCT01596504|449274066|FG002|Overall Study|Adverse Event|1|||
124904263|NCT01596504|449274064|FG000|Overall Study|Withdrawal by Subject|1|||
125113981|NCT01841359|450040421|FG000|Overall Study|Adverse Event|3|||
125113982|NCT01841359|450040421|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
125113983|NCT02168270|450040422|FG000|Overall Study|Lack of Efficacy|4|||
125113984|NCT01875445|450040425|FG000|Overall Study|Lost to Follow-up|5|||
125113985|NCT01875445|450040426|FG001|Overall Study|Lost to Follow-up|0|||
124904264|NCT01596504|449274065|FG001|Overall Study|Withdrawal by Subject|0|||
124904265|NCT01596504|449274066|FG002|Overall Study|Withdrawal by Subject|0|||
124904266|NCT01901276|449274067|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
124904267|NCT01901276|449274068|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
124904268|NCT04347954|449274069|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
124904269|NCT04347954|449274070|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
124904270|NCT04347954|449274071|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
124904271|NCT04347954|449274069|FG000|Overall Study|Lost to Follow-up|0|||
124904272|NCT04347954|449274070|FG001|Overall Study|Lost to Follow-up|1|||
124904273|NCT04347954|449274071|FG002|Overall Study|Lost to Follow-up|0|||
124904274|NCT03257813|449274075|FG000|Overall Study|Protocol Violation|6|||
124904275|NCT03257813|449274076|FG001|Overall Study|Protocol Violation|3|||
124904276|NCT02878330|449274077|FG000|Overall Study|Death|3|||
124904277|NCT02878330|449274078|FG001|Overall Study|Death|2|||
124904278|NCT02878330|449274077|FG000|Overall Study|Lost to Follow-up|11|||
124904279|NCT02878330|449274078|FG001|Overall Study|Lost to Follow-up|26|||
124904280|NCT02878330|449274077|FG000|Overall Study|Withdrawal by Subject|11|||
124904281|NCT02878330|449274078|FG001|Overall Study|Withdrawal by Subject|21|||
124904282|NCT02878330|449274077|FG000|Overall Study|Other|4|||
124904283|NCT02878330|449274078|FG001|Overall Study|Other|7|||
124904284|NCT02954848|449274081|FG000|Overall Study|Randomized but Not Treated|0|||
124904285|NCT02954848|449274082|FG001|Overall Study|Randomized but Not Treated|1|||
124904286|NCT02954848|449274081|FG000|Overall Study|Adverse Event|2|||
124904287|NCT02954848|449274082|FG001|Overall Study|Adverse Event|3|||
124904288|NCT02954848|449274081|FG000|Overall Study|Withdrawal by Participant|0|||
124904289|NCT02954848|449274082|FG001|Overall Study|Withdrawal by Participant|1|||
124904290|NCT01069341|449274083|FG000|Overall Study|Lost to Follow-up|1|||
124904291|NCT00922207|449274084|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
124904292|NCT00922207|449274085|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
124904293|NCT00922207|449274086|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
124904294|NCT00922207|449274084|FG000|Overall Study|Insufficient Therapeutic Response|0|||
124904295|NCT00922207|449274085|FG001|Overall Study|Insufficient Therapeutic Response|0|||
124904296|NCT00922207|449274086|FG002|Overall Study|Insufficient Therapeutic Response|1|||
124904297|NCT00922207|449274084|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
124904298|NCT00922207|449274085|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
124904299|NCT00922207|449274086|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
124904300|NCT00922207|449274084|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
124904301|NCT00922207|449274085|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
124904302|NCT00922207|449274086|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
124904303|NCT00922207|449274084|FG000|Overall Study|Withdrew Consent|2|||
124904304|NCT00922207|449274085|FG001|Overall Study|Withdrew Consent|5|||
124904305|NCT00922207|449274086|FG002|Overall Study|Withdrew Consent|2|||
124904306|NCT00922207|449274084|FG000|Overall Study|Abnormality of Laboratory Test|0|||
124904307|NCT00922207|449274085|FG001|Overall Study|Abnormality of Laboratory Test|1|||
124904308|NCT00922207|449274086|FG002|Overall Study|Abnormality of Laboratory Test|1|||
124904309|NCT01802632|449274087|FG000|Overall Study|Death|28|||
124904310|NCT01802632|449274088|FG001|Overall Study|Death|1|||
124904311|NCT01802632|449274089|FG002|Overall Study|Death|38|||
124904312|NCT01802632|449274090|FG003|Overall Study|Death|0|||
124904313|NCT01802632|449274091|FG004|Overall Study|Death|2|||
124904314|NCT01802632|449274092|FG005|Overall Study|Death|0|||
124904315|NCT01802632|449274087|FG000|Overall Study|Withdrawal by Subject|4|||
124904316|NCT01802632|449274088|FG001|Overall Study|Withdrawal by Subject|2|||
124904317|NCT01802632|449274089|FG002|Overall Study|Withdrawal by Subject|7|||
124904318|NCT01802632|449274090|FG003|Overall Study|Withdrawal by Subject|3|||
124904319|NCT01802632|449274091|FG004|Overall Study|Withdrawal by Subject|0|||
124904320|NCT01802632|449274092|FG005|Overall Study|Withdrawal by Subject|1|||
124904321|NCT01802632|449274087|FG000|Overall Study|Objective Disease Progression|1|||
124904322|NCT01802632|449274088|FG001|Overall Study|Objective Disease Progression|12|||
124904323|NCT01802632|449274089|FG002|Overall Study|Objective Disease Progression|104|||
124904324|NCT01802632|449274090|FG003|Overall Study|Objective Disease Progression|6|||
124904325|NCT01802632|449274091|FG004|Overall Study|Objective Disease Progression|4|||
124904326|NCT01802632|449274092|FG005|Overall Study|Objective Disease Progression|4|||
124904327|NCT01802632|449274087|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
124904328|NCT01802632|449274088|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
124904329|NCT01802632|449274089|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
124904330|NCT01802632|449274090|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
125021454|NCT03178487|449703228|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
125021455|NCT03178487|449703227|FG000|Period 2|Other|8|||
124904331|NCT01802632|449274091|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
124904332|NCT01802632|449274092|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
124904333|NCT01802632|449274087|FG000|Overall Study|Other (not specified)|0|||
124904334|NCT01802632|449274088|FG001|Overall Study|Other (not specified)|0|||
124904335|NCT01802632|449274089|FG002|Overall Study|Other (not specified)|7|||
124904336|NCT01802632|449274090|FG003|Overall Study|Other (not specified)|1|||
124904337|NCT01802632|449274091|FG004|Overall Study|Other (not specified)|0|||
124904338|NCT01802632|449274092|FG005|Overall Study|Other (not specified)|1|||
124904339|NCT02880241|449274105|FG000|Overall Study|Lack of Efficacy|1|||
124904340|NCT02880241|449274106|FG001|Overall Study|Lack of Efficacy|0|||
124904341|NCT02880241|449274107|FG002|Overall Study|Lack of Efficacy|0|||
124904342|NCT02880241|449274108|FG003|Overall Study|Lack of Efficacy|0|||
124904343|NCT02880241|449274109|FG004|Overall Study|Lack of Efficacy|0|||
124904344|NCT02880241|449274110|FG005|Overall Study|Lack of Efficacy|0|||
124904345|NCT02705586|449274112|FG000|Overall Study|Health Issues|2|||
124904346|NCT02705586|449274112|FG000|Overall Study|Transportation Difficulties|5|||
124904347|NCT02705586|449274112|FG000|Overall Study|Vacation/Planned Absence|1|||
124904348|NCT02194933|449274116|FG000|Overall Study|Lost to Follow-up|1|||
124904349|NCT02194933|449274117|FG001|Overall Study|Lost to Follow-up|2|||
124904350|NCT02194933|449274116|FG000|Overall Study|Participant met withdrawal criteria|1|||
124904351|NCT02194933|449274117|FG001|Overall Study|Participant met withdrawal criteria|3|||
124904352|NCT02194933|449274116|FG000|Overall Study|Withdrawal by Subject|0|||
124904353|NCT02194933|449274117|FG001|Overall Study|Withdrawal by Subject|2|||
124904354|NCT02194933|449274116|FG000|Overall Study|Lack of Efficacy|1|||
124904355|NCT02194933|449274117|FG001|Overall Study|Lack of Efficacy|2|||
124904356|NCT02045836|449274121|FG000|Overall Study|Adverse Event|4|||
124904357|NCT02045836|449274122|FG001|Overall Study|Adverse Event|4|||
124904358|NCT02045836|449274121|FG000|Overall Study|Withdrawal by Subject|1|||
124904359|NCT02045836|449274122|FG001|Overall Study|Withdrawal by Subject|1|||
124904360|NCT02045836|449274121|FG000|Overall Study|Lost to Follow-up|4|||
124904361|NCT02045836|449274122|FG001|Overall Study|Lost to Follow-up|7|||
124904362|NCT02045836|449274121|FG000|Overall Study|Migrated from study area|0|||
124904363|NCT02045836|449274122|FG001|Overall Study|Migrated from study area|2|||
124904364|NCT03920215|449274126|FG000|Overall Study|Lost to Follow-up|1|||
124904365|NCT03920215|449274127|FG001|Overall Study|Lost to Follow-up|2|||
124904366|NCT03920215|449274128|FG002|Overall Study|Lost to Follow-up|0|||
124904367|NCT03920215|449274129|FG003|Overall Study|Lost to Follow-up|0|||
124904368|NCT03920215|449274126|FG000|Overall Study|Death|0|||
124904369|NCT03920215|449274127|FG001|Overall Study|Death|0|||
124904370|NCT03920215|449274128|FG002|Overall Study|Death|0|||
124904371|NCT03920215|449274129|FG003|Overall Study|Death|1|||
124904372|NCT02000817|449274130|FG000|Overall Study|Withdrawal by Subject|2|||
124904373|NCT02000817|449274131|FG001|Overall Study|Withdrawal by Subject|0|||
124904374|NCT02000817|449274132|FG002|Overall Study|Withdrawal by Subject|0|||
124904375|NCT02000817|449274133|FG003|Overall Study|Withdrawal by Subject|0|||
124904376|NCT02000817|449274130|FG000|Overall Study|Adverse Event|0|||
124904377|NCT02000817|449274131|FG001|Overall Study|Adverse Event|1|||
124904378|NCT02000817|449274132|FG002|Overall Study|Adverse Event|0|||
124904379|NCT02000817|449274133|FG003|Overall Study|Adverse Event|0|||
124904380|NCT02000817|449274130|FG000|Overall Study|Lost to Follow-up|0|||
124904381|NCT02000817|449274131|FG001|Overall Study|Lost to Follow-up|0|||
124904382|NCT02000817|449274132|FG002|Overall Study|Lost to Follow-up|1|||
124904383|NCT02000817|449274133|FG003|Overall Study|Lost to Follow-up|0|||
124904384|NCT00177216|449274136|FG000|Overall Study|Withdrawal by Subject|6|||
124904385|NCT00177216|449274137|FG001|Overall Study|Withdrawal by Subject|3|||
124904386|NCT00177216|449274138|FG002|Overall Study|Withdrawal by Subject|1|||
124904387|NCT03383146|449274143|FG000|Overall Study|Screen Failure|1|||
124904388|NCT03383146|449274144|FG001|Overall Study|Screen Failure|0|||
124904389|NCT03383146|449274143|FG000|Overall Study|Adverse Event|6|||
124904390|NCT03383146|449274144|FG001|Overall Study|Adverse Event|18|||
124904391|NCT03383146|449274143|FG000|Overall Study|Lack of Efficacy|0|||
124904392|NCT03383146|449274144|FG001|Overall Study|Lack of Efficacy|3|||
124904393|NCT03383146|449274143|FG000|Overall Study|Withdrawal by Subject|20|||
124904394|NCT03383146|449274144|FG001|Overall Study|Withdrawal by Subject|36|||
124904395|NCT03383146|449274143|FG000|Overall Study|Lost to Follow-up|5|||
124904396|NCT03383146|449274144|FG001|Overall Study|Lost to Follow-up|15|||
124904397|NCT03383146|449274143|FG000|Overall Study|Death|0|||
124904398|NCT03383146|449274144|FG001|Overall Study|Death|2|||
124904399|NCT03383146|449274143|FG000|Overall Study|Physician Decision|0|||
124904400|NCT03383146|449274144|FG001|Overall Study|Physician Decision|1|||
124904401|NCT03383146|449274143|FG000|Overall Study|Protocol Deviation|1|||
124904402|NCT03383146|449274144|FG001|Overall Study|Protocol Deviation|8|||
124904403|NCT03383146|449274143|FG000|Overall Study|Study Terminated by the Sponsor|48|||
124904404|NCT03383146|449274144|FG001|Overall Study|Study Terminated by the Sponsor|95|||
124904405|NCT03383146|449274143|FG000|Overall Study|Reason not Specified|4|||
124904406|NCT03383146|449274144|FG001|Overall Study|Reason not Specified|6|||
124904407|NCT02739035|449274149|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
124904408|NCT02739035|449274150|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
124904409|NCT02739035|449274149|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
124904410|NCT02739035|449274150|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
124904411|NCT02739035|449274149|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
124904412|NCT02739035|449274150|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
124904413|NCT02739035|449274149|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
124904414|NCT02739035|449274150|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
124904415|NCT03210402|449274151|FG000|Overall Study|Withdrawal by Subject|0|||
124904416|NCT03210402|449274152|FG001|Overall Study|Withdrawal by Subject|1|||
124904417|NCT02517307|449274155|FG000|Overall Study|Withdrawal by Subject|1|||
124904418|NCT02517307|449274156|FG001|Overall Study|Withdrawal by Subject|0|||
125021456|NCT03178487|449703228|FG001|Period 2|Other|7|||
124904419|NCT02517307|449274157|FG002|Overall Study|Withdrawal by Subject|1|||
124904420|NCT02517307|449274158|FG003|Overall Study|Withdrawal by Subject|0|||
124904421|NCT02517307|449274155|FG000|Overall Study|Protocol Violation|0|||
124904422|NCT02517307|449274156|FG001|Overall Study|Protocol Violation|0|||
124904423|NCT02517307|449274157|FG002|Overall Study|Protocol Violation|1|||
124904424|NCT02517307|449274158|FG003|Overall Study|Protocol Violation|1|||
124904425|NCT00823979|449274159|FG000|Overall Study|Lack of Efficacy|13|||
124904426|NCT00823979|449274160|FG001|Overall Study|Lack of Efficacy|16|||
124904427|NCT00823979|449274161|FG002|Overall Study|Lack of Efficacy|9|||
124904428|NCT00823979|449274159|FG000|Overall Study|Lost to Follow-up|2|||
124904429|NCT00823979|449274160|FG001|Overall Study|Lost to Follow-up|1|||
124904430|NCT00823979|449274161|FG002|Overall Study|Lost to Follow-up|0|||
124904431|NCT00823979|449274159|FG000|Overall Study|Withdrawal by Subject|2|||
124904432|NCT00823979|449274160|FG001|Overall Study|Withdrawal by Subject|3|||
124904433|NCT00823979|449274161|FG002|Overall Study|Withdrawal by Subject|2|||
124904434|NCT00823979|449274159|FG000|Overall Study|Protocol Violation|1|||
124904435|NCT00823979|449274160|FG001|Overall Study|Protocol Violation|1|||
124904436|NCT00823979|449274161|FG002|Overall Study|Protocol Violation|0|||
124904437|NCT00823979|449274159|FG000|Overall Study|Pregnancy|0|||
124904438|NCT00823979|449274160|FG001|Overall Study|Pregnancy|1|||
124904439|NCT00823979|449274161|FG002|Overall Study|Pregnancy|0|||
124904440|NCT00823979|449274159|FG000|Overall Study|Adverse Event|0|||
124904441|NCT00823979|449274160|FG001|Overall Study|Adverse Event|2|||
124904442|NCT00823979|449274161|FG002|Overall Study|Adverse Event|4|||
124904443|NCT00823979|449274159|FG000|Overall Study|Other|2|||
124904444|NCT00823979|449274160|FG001|Overall Study|Other|0|||
124904445|NCT00823979|449274161|FG002|Overall Study|Other|1|||
124904446|NCT00823979|449274159|FG000|Overall Study|Randomized but not Treated|4|||
124904447|NCT00823979|449274160|FG001|Overall Study|Randomized but not Treated|3|||
124904448|NCT00823979|449274161|FG002|Overall Study|Randomized but not Treated|1|||
124904449|NCT00823979|449274159|FG000|Overall Study|Study Terminated by Sponsor|5|||
124904450|NCT00823979|449274160|FG001|Overall Study|Study Terminated by Sponsor|5|||
124904451|NCT00823979|449274161|FG002|Overall Study|Study Terminated by Sponsor|7|||
124904452|NCT03586544|449274162|FG000|First Intervention|Adverse Event|0|||
124904453|NCT03586544|449274163|FG001|First Intervention|Adverse Event|1|||
124904454|NCT03586544|449274162|FG000|Second Intervention|Withdrawal by Subject|0|||
124904455|NCT03586544|449274163|FG001|Second Intervention|Withdrawal by Subject|1|||
124904456|NCT03523091|449274164|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
124904457|NCT03523091|449274165|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
124904458|NCT03523091|449274164|FG000|Overall Study|Withdrawal by Subject|0|||
124904459|NCT03523091|449274165|FG001|Overall Study|Withdrawal by Subject|3|||
124904460|NCT03523091|449274164|FG000|Overall Study|Increase Botox dose|0|||
124904461|NCT03523091|449274165|FG001|Overall Study|Increase Botox dose|1|||
124904462|NCT03863834|449274171|FG000|Overall Study|Lost to Follow-up|3|||
124904463|NCT02685488|449274172|FG000|Overall Study|Withdrawal by Subject|0|||
124904464|NCT02685488|449274173|FG001|Overall Study|Withdrawal by Subject|1|||
124904465|NCT00324038|449274174|FG000|Overall Study|Adverse Event|38|||
124904466|NCT00324038|449274175|FG001|Overall Study|Adverse Event|23|||
124904467|NCT00324038|449274174|FG000|Overall Study|Lack of Efficacy|5|||
124904468|NCT00324038|449274175|FG001|Overall Study|Lack of Efficacy|13|||
124904469|NCT00324038|449274174|FG000|Overall Study|Lost to Follow-up|0|||
124904470|NCT00324038|449274175|FG001|Overall Study|Lost to Follow-up|2|||
124904471|NCT00324038|449274174|FG000|Overall Study|Other|6|||
124904472|NCT00324038|449274175|FG001|Overall Study|Other|13|||
124904473|NCT02770248|449274176|FG000|Overall Study|Adverse Event|0|||
124904474|NCT02770248|449274177|FG001|Overall Study|Adverse Event|1|||
124904475|NCT02770248|449274176|FG000|Overall Study|Randomized in error, prior to treatment|0|||
124904476|NCT02770248|449274177|FG001|Overall Study|Randomized in error, prior to treatment|1|||
124904477|NCT03768206|449274180|FG000|Overall Study|Lost to Follow-up|2|||
124904478|NCT03768206|449274181|FG001|Overall Study|Lost to Follow-up|1|||
124904479|NCT03768206|449274180|FG000|Overall Study|Withdrawal by Subject|0|||
124904480|NCT03768206|449274181|FG001|Overall Study|Withdrawal by Subject|1|||
124904481|NCT04493242|449274182|FG000|Overall Study|Death|10|||
124904482|NCT04493242|449274183|FG001|Overall Study|Death|14|||
124904483|NCT04493242|449274184|FG002|Overall Study|Death|16|||
124904484|NCT04493242|449274182|FG000|Overall Study|Lost to Follow-up|1|||
124904485|NCT04493242|449274183|FG001|Overall Study|Lost to Follow-up|1|||
124904486|NCT04493242|449274184|FG002|Overall Study|Lost to Follow-up|0|||
124904487|NCT04493242|449274182|FG000|Overall Study|Withdrawal by Subject|1|||
124904488|NCT04493242|449274183|FG001|Overall Study|Withdrawal by Subject|0|||
124904489|NCT04493242|449274184|FG002|Overall Study|Withdrawal by Subject|0|||
124904490|NCT04493242|449274182|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
125021457|NCT02268058|449703231|FG000|Overall Study|Protocol Violation|1|||
125021458|NCT02268058|449703232|FG001|Overall Study|Protocol Violation|0|||
125021459|NCT02268058|449703233|FG002|Overall Study|Protocol Violation|0|||
125021460|NCT02268058|449703234|FG003|Overall Study|Protocol Violation|0|||
125021461|NCT00493038|449703235|FG000|Treatment|Adverse Event|8|||
125021462|NCT00493038|449703236|FG001|Treatment|Adverse Event|4|||
125021463|NCT00493038|449703235|FG000|Treatment|Lost to Follow-up|5|||
124904491|NCT04493242|449274183|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
124904492|NCT04493242|449274184|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
124904493|NCT04493242|449274182|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
124904494|NCT04493242|449274183|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
124904495|NCT04493242|449274184|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
124904496|NCT02812966|449274187|FG000|Overall Study|Death|1|||
124904497|NCT02812966|449274188|FG001|Overall Study|Death|0|||
124904498|NCT04257058|449276261|FG000|Overall Study|Lost to Follow-up|31|||
124904499|NCT05147233|449276268|FG000|Overall Study|Adverse Event|0|||
124904500|NCT05147233|449276269|FG001|Overall Study|Adverse Event|1|||
124904501|NCT05147233|449276268|FG000|Overall Study|Lost to Follow-up|1|||
124904502|NCT05147233|449276269|FG001|Overall Study|Lost to Follow-up|1|||
124904503|NCT05147233|449276268|FG000|Overall Study|Protocol Violation|0|||
124904504|NCT05147233|449276269|FG001|Overall Study|Protocol Violation|1|||
124904505|NCT05147233|449276268|FG000|Overall Study|Withdrawal by Subject|2|||
124904506|NCT05147233|449276269|FG001|Overall Study|Withdrawal by Subject|1|||
124904507|NCT04517864|449276276|FG000|Placebo-Controlled Phase|Adverse Event|1|||
124904508|NCT04517864|449276277|FG001|Placebo-Controlled Phase|Adverse Event|0|||
124904509|NCT04517864|449276278|FG002|Placebo-Controlled Phase|Adverse Event|0|||
124904510|NCT04517864|449276276|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
124904511|NCT04517864|449276277|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
124904512|NCT04517864|449276278|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
124904513|NCT04517864|449276276|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
124904514|NCT04517864|449276277|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
124904515|NCT04517864|449276278|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
124904516|NCT04517864|449276276|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
124904517|NCT04517864|449276277|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
124904518|NCT04517864|449276278|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
124904519|NCT04517864|449276276|FG000|Active Therapy Extension Phase|Adverse Event|1|||
124904520|NCT04517864|449276277|FG001|Active Therapy Extension Phase|Adverse Event|0|||
124904521|NCT04517864|449276278|FG002|Active Therapy Extension Phase|Adverse Event|0|||
124904522|NCT04517864|449276276|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
124904523|NCT04517864|449276277|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
124904524|NCT04517864|449276278|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
124904525|NCT04517864|449276276|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
124904526|NCT04517864|449276277|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
124904527|NCT04517864|449276278|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
124904528|NCT04517864|449276276|FG000|Active Therapy Extension Phase|Physician Decision|1|||
124904529|NCT04517864|449276277|FG001|Active Therapy Extension Phase|Physician Decision|0|||
124904530|NCT04517864|449276278|FG002|Active Therapy Extension Phase|Physician Decision|0|||
124904531|NCT04517864|449276276|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
124904532|NCT04517864|449276277|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
124904533|NCT04517864|449276278|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
124904534|NCT04517864|449276276|FG000|Extension Phase|Adverse Event|0|||
124904535|NCT04517864|449276277|FG001|Extension Phase|Adverse Event|0|||
124904536|NCT04517864|449276278|FG002|Extension Phase|Adverse Event|1|||
124904537|NCT04517864|449276276|FG000|Extension Phase|Lack of Efficacy|0|||
124904538|NCT04517864|449276277|FG001|Extension Phase|Lack of Efficacy|0|||
124904539|NCT04517864|449276278|FG002|Extension Phase|Lack of Efficacy|2|||
124904540|NCT04517864|449276276|FG000|Extension Phase|Study Terminated By Sponsor|0|||
124904541|NCT04517864|449276277|FG001|Extension Phase|Study Terminated By Sponsor|0|||
124904542|NCT04517864|449276278|FG002|Extension Phase|Study Terminated By Sponsor|32|||
124904543|NCT04517864|449276276|FG000|Extension Phase|Withdrawal by Subject|0|||
124904544|NCT04517864|449276277|FG001|Extension Phase|Withdrawal by Subject|0|||
124904545|NCT04517864|449276278|FG002|Extension Phase|Withdrawal by Subject|3|||
124904546|NCT04517864|449276276|FG000|Extension Phase|Approved Drug Available for Indication|0|||
124904547|NCT04517864|449276277|FG001|Extension Phase|Approved Drug Available for Indication|0|||
124904548|NCT04517864|449276278|FG002|Extension Phase|Approved Drug Available for Indication|7|||
124904549|NCT04199728|449276279|FG000|Overall Study|Adverse Event|1|||
124904550|NCT04199728|449276280|FG001|Overall Study|Adverse Event|0|||
125113986|NCT01875445|450040425|FG000|Overall Study|Withdrawal by Subject|2|||
124904551|NCT04199728|449276279|FG000|Overall Study|Withdrawal by Subject|8|||
124904552|NCT04199728|449276280|FG001|Overall Study|Withdrawal by Subject|3|||
124904553|NCT04199728|449276279|FG000|Overall Study|Screen fail after consent|0|||
124904554|NCT04199728|449276280|FG001|Overall Study|Screen fail after consent|1|||
124904555|NCT04199728|449276279|FG000|Overall Study|Early withdraw criteria met|0|||
124904556|NCT04199728|449276280|FG001|Overall Study|Early withdraw criteria met|1|||
124904557|NCT04199728|449276279|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
124904558|NCT04199728|449276280|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
124904559|NCT04722003|449276281|FG000|Overall Study|Lost to Follow-up|2|||
124904560|NCT04722003|449276282|FG001|Overall Study|Lost to Follow-up|0|||
124904561|NCT04722003|449276281|FG000|Overall Study|Physician Decision|1|||
124904562|NCT04722003|449276282|FG001|Overall Study|Physician Decision|0|||
124904563|NCT01049503|449276283|FG000|Overall Study|Lost to Follow-up|11|||
124904564|NCT01049503|449276284|FG001|Overall Study|Lost to Follow-up|12|||
124904565|NCT01049503|449276285|FG002|Overall Study|Lost to Follow-up|24|||
124904566|NCT01049503|449276286|FG003|Overall Study|Lost to Follow-up|26|||
124904567|NCT01049503|449276287|FG004|Overall Study|Lost to Follow-up|27|||
124904568|NCT01049503|449276288|FG005|Overall Study|Lost to Follow-up|8|||
124904569|NCT00726596|449276289|FG000|Overall Study|Adverse Event|2|||
124904570|NCT00726596|449276290|FG001|Overall Study|Adverse Event|1|||
124904571|NCT00726596|449276289|FG000|Overall Study|Withdrawal by Subject|3|||
124904572|NCT00726596|449276290|FG001|Overall Study|Withdrawal by Subject|3|||
124904573|NCT02974634|449276294|FG000|Overall Study|Advanced disease|12|||
124904574|NCT02974634|449276295|FG001|Overall Study|Advanced disease|3|||
124904575|NCT02974634|449276294|FG000|Overall Study|Noncompliance|3|||
124904576|NCT02974634|449276295|FG001|Overall Study|Noncompliance|7|||
124904577|NCT02974634|449276294|FG000|Overall Study|intervention technology related issues|5|||
124904578|NCT02974634|449276295|FG001|Overall Study|intervention technology related issues|0|||
124904579|NCT02974634|449276294|FG000|Overall Study|Death|8|||
124904580|NCT02974634|449276295|FG001|Overall Study|Death|11|||
124904581|NCT00661778|449276297|FG000|Overall Study|Disease Progression|23|||
124904582|NCT00661778|449276297|FG000|Overall Study|Adverse Event|18|||
124904583|NCT00661778|449276297|FG000|Overall Study|Reason not Specified|6|||
124904584|NCT00661778|449276297|FG000|Overall Study|Protocol Violation|2|||
124904585|NCT00661778|449276297|FG000|Overall Study|Withdrawal of Consent|1|||
124904586|NCT02962674|449276303|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
124904587|NCT00364286|449276304|FG000|Overall Study|Withdrawal by Subject|1|||
124904588|NCT00364286|449276304|FG000|Overall Study|Adverse Event|2|||
124904589|NCT02577523|449276307|FG000|Overall Study|Adverse Event|1|||
124904590|NCT02577523|449276308|FG001|Overall Study|Adverse Event|1|||
124904591|NCT02577523|449276307|FG000|Overall Study|Lack of Efficacy|1|||
124904592|NCT02577523|449276308|FG001|Overall Study|Lack of Efficacy|1|||
124904593|NCT02577523|449276307|FG000|Overall Study|Withdrawal by Subject|1|||
124904594|NCT02577523|449276308|FG001|Overall Study|Withdrawal by Subject|0|||
124904595|NCT01266265|449276311|FG000|Overall Study|Death|95|||
124904596|NCT01266265|449276312|FG001|Overall Study|Death|73|||
124904597|NCT01266265|449276311|FG000|Overall Study|Lost to Follow-up|23|||
124904598|NCT01266265|449276312|FG001|Overall Study|Lost to Follow-up|28|||
124904599|NCT01266265|449276311|FG000|Overall Study|Withdrawal by Subject|13|||
124904600|NCT01266265|449276312|FG001|Overall Study|Withdrawal by Subject|11|||
124904601|NCT01266265|449276311|FG000|Overall Study|Respiratory-related adverse event|2|||
124904602|NCT01266265|449276312|FG001|Overall Study|Respiratory-related adverse event|1|||
124904603|NCT01266265|449276311|FG000|Overall Study|Transferred care to another provider|22|||
124904604|NCT01266265|449276312|FG001|Overall Study|Transferred care to another provider|28|||
124904605|NCT01266265|449276311|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
124904606|NCT01266265|449276312|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
124904607|NCT01266265|449276311|FG000|Overall Study|Enrolled in another clinical study|15|||
124904608|NCT01266265|449276312|FG001|Overall Study|Enrolled in another clinical study|26|||
124904609|NCT01266265|449276311|FG000|Overall Study|Non-compliance|8|||
124904610|NCT01266265|449276312|FG001|Overall Study|Non-compliance|5|||
124904611|NCT01266265|449276311|FG000|Overall Study|Lung transplant|6|||
124904612|NCT01266265|449276312|FG001|Overall Study|Lung transplant|5|||
124904613|NCT01266265|449276311|FG000|Overall Study|Site closed early|4|||
124904614|NCT01266265|449276312|FG001|Overall Study|Site closed early|3|||
124904615|NCT01266265|449276311|FG000|Overall Study|Clinical worsening|1|||
124904616|NCT01266265|449276312|FG001|Overall Study|Clinical worsening|1|||
124904617|NCT01580293|449276313|FG000|Part A_Main Trial|Adverse Event|0|||
124904618|NCT01580293|449276314|FG001|Part A_Main Trial|Adverse Event|2|||
124904619|NCT01580293|449276315|FG002|Part A_Main Trial|Adverse Event|0|||
124904620|NCT01580293|449276313|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
124904621|NCT01580293|449276314|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
125113987|NCT01875445|450040426|FG001|Overall Study|Withdrawal by Subject|0|||
125113988|NCT01102777|450040427|FG000|Overall Study|Death|2|||
125113989|NCT01102777|450040428|FG001|Overall Study|Death|6|||
125113990|NCT01102777|450040427|FG000|Overall Study|Lost to Follow-up|7|||
125113991|NCT01102777|450040428|FG001|Overall Study|Lost to Follow-up|10|||
125113992|NCT00771901|450040429|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
125113993|NCT00771901|450040430|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
125113994|NCT00771901|450040431|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
125113995|NCT01965652|450040434|FG000|Overall Study|Adverse Event|40|||
125113996|NCT01965652|450040435|FG001|Overall Study|Adverse Event|37|||
125113997|NCT01965652|450040434|FG000|Overall Study|Withdrawal by Subject|62|||
125113998|NCT01965652|450040435|FG001|Overall Study|Withdrawal by Subject|69|||
125113999|NCT01965652|450040434|FG000|Overall Study|Lost to Follow-up|53|||
125114000|NCT01965652|450040435|FG001|Overall Study|Lost to Follow-up|40|||
125114001|NCT01965652|450040434|FG000|Overall Study|Protocol Violation|34|||
125114002|NCT01965652|450040435|FG001|Overall Study|Protocol Violation|38|||
124904622|NCT01580293|449276315|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
124904623|NCT01580293|449276313|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
124904624|NCT01580293|449276314|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
124904625|NCT01580293|449276315|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
124904626|NCT01580293|449276313|FG000|Part A_Extension|Adverse Event|0|||
124904627|NCT01580293|449276314|FG001|Part A_Extension|Adverse Event|2|||
124904628|NCT01580293|449276315|FG002|Part A_Extension|Adverse Event|0|||
124904629|NCT01580293|449276313|FG000|Part A_Extension|Withdrawal by Subject|0|||
124904630|NCT01580293|449276314|FG001|Part A_Extension|Withdrawal by Subject|3|||
125114003|NCT01965652|450040434|FG000|Overall Study|Death|3|||
125114004|NCT01965652|450040435|FG001|Overall Study|Death|4|||
124904631|NCT01580293|449276315|FG002|Part A_Extension|Withdrawal by Subject|0|||
124904632|NCT01580293|449276313|FG000|Part A_Extension|Lost to Follow-up|0|||
124904633|NCT01580293|449276314|FG001|Part A_Extension|Lost to Follow-up|1|||
124904634|NCT01580293|449276315|FG002|Part A_Extension|Lost to Follow-up|0|||
124904635|NCT01580293|449276313|FG000|Part A_Extension|Other Reason|0|||
124904636|NCT01580293|449276314|FG001|Part A_Extension|Other Reason|1|||
124904637|NCT01580293|449276315|FG002|Part A_Extension|Other Reason|0|||
124904638|NCT01580293|449276313|FG000|Part A_Extension|Completed Japan only|0|||
124904639|NCT01580293|449276314|FG001|Part A_Extension|Completed Japan only|5|||
124904640|NCT01580293|449276315|FG002|Part A_Extension|Completed Japan only|0|||
124904641|NCT01580293|449276313|FG000|Part B|Withdrawal by Subject|0|||
124904642|NCT01580293|449276314|FG001|Part B|Withdrawal by Subject|0|||
124904643|NCT01580293|449276315|FG002|Part B|Withdrawal by Subject|1|||
124904644|NCT01580293|449276313|FG000|Part B|Other reason|0|||
124904645|NCT01580293|449276314|FG001|Part B|Other reason|0|||
124904646|NCT01580293|449276315|FG002|Part B|Other reason|1|||
124904647|NCT00768664|449276318|FG000|Overall Study|Death|57|||
124904648|NCT00768664|449276318|FG000|Overall Study|Lost to Follow-up|2|||
124904649|NCT00768664|449276318|FG000|Overall Study|Other|9|||
124904650|NCT00768664|449276318|FG000|Overall Study|Participant refused|1|||
125021464|NCT00493038|449703236|FG001|Treatment|Lost to Follow-up|3|||
125021465|NCT00493038|449703235|FG000|Treatment|Withdrawal by Subject|11|||
125021466|NCT00493038|449703236|FG001|Treatment|Withdrawal by Subject|12|||
125021467|NCT00493038|449703235|FG000|Treatment|Other|0|||
125021468|NCT00493038|449703236|FG001|Treatment|Other|1|||
125021469|NCT00493038|449703235|FG000|Follow-up|Lost to Follow-up|1|||
125021470|NCT00493038|449703236|FG001|Follow-up|Lost to Follow-up|0|||
125021471|NCT01847885|449703237|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
125021472|NCT01847885|449703238|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
125021473|NCT01847885|449703239|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
125021474|NCT01847885|449703237|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
125021475|NCT01847885|449703238|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
125021476|NCT01847885|449703239|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
125021477|NCT01847885|449703237|FG000|Initial Enrollment (Consented)|Screen failure|39|||
125021478|NCT01847885|449703238|FG001|Initial Enrollment (Consented)|Screen failure|0|||
125021479|NCT01847885|449703239|FG002|Initial Enrollment (Consented)|Screen failure|0|||
125021480|NCT01847885|449703237|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
125021481|NCT01847885|449703238|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
125021482|NCT01847885|449703239|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
125021483|NCT01847885|449703237|FG000|Randomization|Protocol Violation|0|||
125021484|NCT01847885|449703238|FG001|Randomization|Protocol Violation|1|||
125021485|NCT01847885|449703239|FG002|Randomization|Protocol Violation|0|||
125021486|NCT01847885|449703237|FG000|Randomization|Withdrawal by Subject|0|||
125021487|NCT01847885|449703238|FG001|Randomization|Withdrawal by Subject|0|||
125021488|NCT01847885|449703239|FG002|Randomization|Withdrawal by Subject|2|||
125021489|NCT01847885|449703237|FG000|Randomization|Screen Failure|0|||
125021490|NCT01847885|449703238|FG001|Randomization|Screen Failure|3|||
125021491|NCT01847885|449703239|FG002|Randomization|Screen Failure|0|||
125021492|NCT02574637|449703242|FG000|Double-blind Period|Adverse Event|1|||
125021493|NCT02574637|449703243|FG001|Double-blind Period|Adverse Event|0|||
125021494|NCT02574637|449703244|FG002|Double-blind Period|Adverse Event|0|||
125021495|NCT02574637|449703245|FG003|Double-blind Period|Adverse Event|0|||
125021496|NCT02574637|449703246|FG004|Double-blind Period|Adverse Event|0|||
125021497|NCT02574637|449703247|FG005|Double-blind Period|Adverse Event|0|||
125021498|NCT02574637|449703248|FG006|Double-blind Period|Adverse Event|0|||
125021499|NCT02574637|449703249|FG007|Double-blind Period|Adverse Event|0|||
125021500|NCT02574637|449703250|FG008|Double-blind Period|Adverse Event|0|||
125021501|NCT02574637|449703251|FG009|Double-blind Period|Adverse Event|0|||
125021502|NCT02574637|449703242|FG000|Double-blind Period|Lack of Efficacy|0|||
125021503|NCT02574637|449703243|FG001|Double-blind Period|Lack of Efficacy|0|||
125021504|NCT02574637|449703244|FG002|Double-blind Period|Lack of Efficacy|2|||
125021505|NCT02574637|449703245|FG003|Double-blind Period|Lack of Efficacy|0|||
125021506|NCT02574637|449703246|FG004|Double-blind Period|Lack of Efficacy|0|||
125114005|NCT01965652|450040434|FG000|Overall Study|Other - Miscellaneous|18|||
124904651|NCT00708032|449276321|FG000|Overall Study|Adverse Event|0|||
125021507|NCT02574637|449703247|FG005|Double-blind Period|Lack of Efficacy|0|||
125021508|NCT02574637|449703248|FG006|Double-blind Period|Lack of Efficacy|0|||
125021509|NCT02574637|449703249|FG007|Double-blind Period|Lack of Efficacy|0|||
125021510|NCT02574637|449703250|FG008|Double-blind Period|Lack of Efficacy|0|||
125021511|NCT02574637|449703251|FG009|Double-blind Period|Lack of Efficacy|0|||
124904652|NCT00708032|449276322|FG001|Overall Study|Adverse Event|2|||
124904653|NCT00708032|449276321|FG000|Overall Study|Lost to Follow-up|1|||
124904654|NCT00708032|449276322|FG001|Overall Study|Lost to Follow-up|2|||
124904655|NCT00708032|449276321|FG000|Overall Study|Pregnancy|0|||
124904656|NCT00708032|449276322|FG001|Overall Study|Pregnancy|1|||
125021512|NCT02574637|449703242|FG000|Double-blind Period|Protocol Deviation|1|||
125021513|NCT02574637|449703243|FG001|Double-blind Period|Protocol Deviation|0|||
124904657|NCT00708032|449276321|FG000|Overall Study|Poor vision|0|||
124904658|NCT00708032|449276322|FG001|Overall Study|Poor vision|6|||
124904659|NCT00708032|449276321|FG000|Overall Study|Visit out of range at month 12|4|||
124904660|NCT00708032|449276322|FG001|Overall Study|Visit out of range at month 12|1|||
124904661|NCT00708032|449276321|FG000|Overall Study|Did not meet protocol criteria|1|||
124904662|NCT00708032|449276322|FG001|Overall Study|Did not meet protocol criteria|2|||
124904663|NCT00708032|449276321|FG000|Overall Study|Protocol Violation|4|||
124904664|NCT00708032|449276322|FG001|Overall Study|Protocol Violation|1|||
124904665|NCT00708032|449276321|FG000|Overall Study|Withdrawal by Subject|0|||
124904666|NCT00708032|449276322|FG001|Overall Study|Withdrawal by Subject|1|||
124904667|NCT01400776|449276323|FG000|Overall Study|Adverse Event|7|||
124904668|NCT01400776|449276324|FG001|Overall Study|Adverse Event|2|||
124904669|NCT01400776|449276325|FG002|Overall Study|Adverse Event|9|||
124904670|NCT01400776|449276326|FG003|Overall Study|Adverse Event|2|||
124904671|NCT01400776|449276323|FG000|Overall Study|Lost to Follow-up|1|||
124904672|NCT01400776|449276324|FG001|Overall Study|Lost to Follow-up|0|||
124904673|NCT01400776|449276325|FG002|Overall Study|Lost to Follow-up|4|||
124904674|NCT01400776|449276326|FG003|Overall Study|Lost to Follow-up|1|||
124904675|NCT01400776|449276323|FG000|Overall Study|Withdrew Consent|4|||
124904676|NCT01400776|449276324|FG001|Overall Study|Withdrew Consent|2|||
124904677|NCT01400776|449276325|FG002|Overall Study|Withdrew Consent|6|||
124904678|NCT01400776|449276326|FG003|Overall Study|Withdrew Consent|1|||
124904679|NCT01400776|449276323|FG000|Overall Study|Protocol Deviation|6|||
124904680|NCT01400776|449276324|FG001|Overall Study|Protocol Deviation|1|||
124904681|NCT01400776|449276325|FG002|Overall Study|Protocol Deviation|5|||
124904682|NCT01400776|449276326|FG003|Overall Study|Protocol Deviation|2|||
124904683|NCT01400776|449276323|FG000|Overall Study|Reason not Specified|3|||
124904684|NCT01400776|449276324|FG001|Overall Study|Reason not Specified|0|||
124904685|NCT01400776|449276325|FG002|Overall Study|Reason not Specified|4|||
124904686|NCT01400776|449276326|FG003|Overall Study|Reason not Specified|3|||
124904687|NCT01227278|449276327|FG000|Overall Study|Withdrawal by Subject|4|||
124904688|NCT01227278|449276328|FG001|Overall Study|Withdrawal by Subject|4|||
125114006|NCT01965652|450040435|FG001|Overall Study|Other - Miscellaneous|21|||
125114007|NCT01965652|450040434|FG000|Overall Study|Pregnancy|0|||
125114008|NCT01965652|450040435|FG001|Overall Study|Pregnancy|1|||
125114009|NCT01121900|450040436|FG000|First Intervention Period|Adverse Event|1|||
125114010|NCT01121900|450040437|FG001|First Intervention Period|Adverse Event|1|||
125114011|NCT01121900|450040436|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
125114012|NCT01121900|450040437|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
125114013|NCT01328054|450040438|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
125114014|NCT01328054|450040439|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
125114015|NCT01328054|450040438|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
125114016|NCT01328054|450040439|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
125114017|NCT01328054|450040438|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
125114018|NCT01328054|450040439|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
125114019|NCT03493698|450040440|FG000|Treatment Period C|Adverse Event|1|||
125114020|NCT03493698|450040440|FG000|Treatment Period C|Withdrawal by Subject|1|||
125114021|NCT03760510|450040441|FG000|Overall Study|Not ventilated for 24 hours|105|||
125114022|NCT03760510|450040442|FG001|Overall Study|Not ventilated for 24 hours|97|||
125114023|NCT00566709|450040448|FG000|Overall Study|Protocol Violation|5|||
125114024|NCT00566709|450040449|FG001|Overall Study|Protocol Violation|0|||
124904689|NCT01227278|449276327|FG000|Overall Study|Death|0|||
124904690|NCT01227278|449276328|FG001|Overall Study|Death|2|||
125114025|NCT03443869|450040450|FG000|Overall Study|Death|3|||
125114026|NCT03443869|450040451|FG001|Overall Study|Death|3|||
125114027|NCT03443869|450040450|FG000|Overall Study|Withdrawal by Subject|34|||
125114028|NCT03443869|450040451|FG001|Overall Study|Withdrawal by Subject|22|||
125114029|NCT03443869|450040450|FG000|Overall Study|Lost to Follow-up|1|||
125114030|NCT03443869|450040451|FG001|Overall Study|Lost to Follow-up|2|||
124904691|NCT01227278|449276327|FG000|Overall Study|Other|1|||
124904692|NCT01227278|449276328|FG001|Overall Study|Other|2|||
124904693|NCT00423098|449276329|FG000|Overall Study|Adverse Event|1|||
125114031|NCT03443869|450040450|FG000|Overall Study|Physician Decision|3|||
124904694|NCT00423098|449276330|FG001|Overall Study|Adverse Event|2|||
124904695|NCT00423098|449276329|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124904696|NCT00423098|449276330|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125210891|NCT01955109|450396702|FG001|Overall Study|Participant unwilling to continue|7|||
124904697|NCT00423098|449276329|FG000|Overall Study|Administrative problems|0|||
124904698|NCT00423098|449276330|FG001|Overall Study|Administrative problems|1|||
124904699|NCT00423098|449276329|FG000|Overall Study|Death|2|||
124904700|NCT00423098|449276330|FG001|Overall Study|Death|0|||
124904701|NCT04035668|449276332|FG000|Overall Study|Adverse Event|3|||
125210892|NCT01955109|450396701|FG000|Overall Study|Physician Decision|2|||
125210893|NCT01955109|450396702|FG001|Overall Study|Physician Decision|0|||
125210894|NCT01955109|450396701|FG000|Overall Study|Lost to Follow-up|3|||
125210895|NCT01955109|450396702|FG001|Overall Study|Lost to Follow-up|1|||
125210896|NCT01955109|450396701|FG000|Overall Study|Non-compliance|3|||
125210897|NCT01955109|450396702|FG001|Overall Study|Non-compliance|1|||
125210898|NCT01618916|450396704|FG000|Overall Study|Adverse Event|1|||
125210899|NCT01618916|450396705|FG001|Overall Study|Adverse Event|0|||
125210900|NCT01618916|450396706|FG002|Overall Study|Adverse Event|0|||
125210901|NCT01618916|450396707|FG003|Overall Study|Adverse Event|0|||
125210902|NCT01618916|450396708|FG004|Overall Study|Adverse Event|0|||
125210903|NCT01618916|450396709|FG005|Overall Study|Adverse Event|0|||
125210904|NCT01618916|450396704|FG000|Overall Study|Withdrawal by Subject|0|||
125210905|NCT01618916|450396705|FG001|Overall Study|Withdrawal by Subject|1|||
125210906|NCT01618916|450396706|FG002|Overall Study|Withdrawal by Subject|1|||
125210907|NCT01618916|450396707|FG003|Overall Study|Withdrawal by Subject|0|||
125210908|NCT01618916|450396708|FG004|Overall Study|Withdrawal by Subject|1|||
125210909|NCT01618916|450396709|FG005|Overall Study|Withdrawal by Subject|0|||
124904702|NCT04035668|449276333|FG001|Overall Study|Adverse Event|4|||
124904703|NCT04035668|449276334|FG002|Overall Study|Adverse Event|2|||
124904704|NCT04035668|449276332|FG000|Overall Study|Lost to Follow-up|0|||
124904705|NCT04035668|449276333|FG001|Overall Study|Lost to Follow-up|1|||
124904706|NCT04035668|449276334|FG002|Overall Study|Lost to Follow-up|0|||
124904707|NCT04035668|449276332|FG000|Overall Study|Physician Decision|2|||
124904708|NCT04035668|449276333|FG001|Overall Study|Physician Decision|1|||
124904709|NCT04035668|449276334|FG002|Overall Study|Physician Decision|1|||
124904710|NCT04035668|449276332|FG000|Overall Study|Subject Decision|2|||
124904711|NCT04035668|449276333|FG001|Overall Study|Subject Decision|2|||
124904712|NCT04035668|449276334|FG002|Overall Study|Subject Decision|0|||
124904713|NCT02320123|449276336|FG000|Overall Study|Lost to Follow-up|4|||
125210910|NCT01618916|450396704|FG000|Overall Study|Lost to Follow-up|1|||
125210911|NCT01618916|450396705|FG001|Overall Study|Lost to Follow-up|0|||
125210912|NCT01618916|450396706|FG002|Overall Study|Lost to Follow-up|0|||
124904714|NCT02320123|449276337|FG001|Overall Study|Lost to Follow-up|6|||
124904715|NCT02320123|449276336|FG000|Overall Study|Death|6|||
124904716|NCT02320123|449276337|FG001|Overall Study|Death|5|||
124904717|NCT04480827|449276338|FG000|Overall Study|Adverse Event|0|||
124904718|NCT04480827|449276339|FG001|Overall Study|Adverse Event|0|||
125210913|NCT01618916|450396707|FG003|Overall Study|Lost to Follow-up|2|||
125210914|NCT01618916|450396708|FG004|Overall Study|Lost to Follow-up|0|||
125210915|NCT01618916|450396709|FG005|Overall Study|Lost to Follow-up|0|||
125210916|NCT04521114|450396710|FG000|Overall Study|Lost to Follow-up|1|||
125210917|NCT04521114|450396711|FG001|Overall Study|Lost to Follow-up|2|||
124904719|NCT04480827|449276340|FG002|Overall Study|Adverse Event|0|||
124904720|NCT04480827|449276341|FG003|Overall Study|Adverse Event|0|||
124904721|NCT04480827|449276342|FG004|Overall Study|Adverse Event|0|||
124904722|NCT04480827|449276343|FG005|Overall Study|Adverse Event|1|||
124904723|NCT04480827|449276344|FG006|Overall Study|Adverse Event|0|||
125210918|NCT04521114|450396712|FG002|Overall Study|Lost to Follow-up|0|||
124904724|NCT00465816|449276345|FG000|Overall Study|Lost to Follow-up|0|||
124904725|NCT00465816|449276346|FG001|Overall Study|Lost to Follow-up|0|||
124904726|NCT00465816|449276347|FG002|Overall Study|Lost to Follow-up|2|||
124904727|NCT00941655|449276350|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
124904728|NCT00941655|449276351|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
124904729|NCT00941655|449276350|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
124904730|NCT00941655|449276351|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
124904731|NCT00941655|449276350|FG000|Overall Study|progressed while on chemo|0|||
124904732|NCT00941655|449276351|FG001|Overall Study|progressed while on chemo|2|||
124904733|NCT00941655|449276350|FG000|Overall Study|refused further treatment|0|||
124904734|NCT00941655|449276351|FG001|Overall Study|refused further treatment|1|||
124904735|NCT00941655|449276350|FG000|Overall Study|withdrew consent|0|||
124904736|NCT00941655|449276351|FG001|Overall Study|withdrew consent|1|||
124904737|NCT00941655|449276350|FG000|Overall Study|non-compliant|0|||
124904738|NCT00941655|449276351|FG001|Overall Study|non-compliant|1|||
124904739|NCT02477670|449276352|FG000|Stage 1|Adverse Event|2|||
124904740|NCT02477670|449276353|FG001|Stage 1|Adverse Event|7|||
124904741|NCT02477670|449276354|FG002|Stage 1|Adverse Event|0|||
124904742|NCT02477670|449276355|FG003|Stage 1|Adverse Event|0|||
124904743|NCT02477670|449276356|FG004|Stage 1|Adverse Event|0|||
124904744|NCT02477670|449276357|FG005|Stage 1|Adverse Event|0|||
124904745|NCT02477670|449276358|FG006|Stage 1|Adverse Event|0|||
125021514|NCT02574637|449703244|FG002|Double-blind Period|Protocol Deviation|0|||
125021515|NCT02574637|449703245|FG003|Double-blind Period|Protocol Deviation|0|||
125021516|NCT02574637|449703246|FG004|Double-blind Period|Protocol Deviation|0|||
125021517|NCT02574637|449703247|FG005|Double-blind Period|Protocol Deviation|0|||
125021518|NCT02574637|449703248|FG006|Double-blind Period|Protocol Deviation|0|||
125021519|NCT02574637|449703249|FG007|Double-blind Period|Protocol Deviation|0|||
125021520|NCT02574637|449703250|FG008|Double-blind Period|Protocol Deviation|0|||
125021521|NCT02574637|449703251|FG009|Double-blind Period|Protocol Deviation|0|||
125021522|NCT02574637|449703242|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
125021523|NCT02574637|449703243|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
125021524|NCT02574637|449703244|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
125021525|NCT02574637|449703245|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
125021526|NCT02574637|449703246|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
125021527|NCT02574637|449703247|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
125021528|NCT02574637|449703248|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
125021529|NCT02574637|449703249|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
125021530|NCT02574637|449703250|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
125021531|NCT02574637|449703251|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
125021532|NCT02574637|449703242|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
125021533|NCT02574637|449703243|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
125021534|NCT02574637|449703244|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
125021535|NCT02574637|449703245|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
125021536|NCT02574637|449703246|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
125021537|NCT02574637|449703247|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
125021538|NCT02574637|449703248|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
125021539|NCT02574637|449703249|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
125021540|NCT02574637|449703250|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
125021541|NCT02574637|449703251|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
125021542|NCT02574637|449703242|FG000|Double-blind Period|Reason Not Specified|0|||
125021543|NCT02574637|449703243|FG001|Double-blind Period|Reason Not Specified|0|||
125021544|NCT02574637|449703244|FG002|Double-blind Period|Reason Not Specified|0|||
125021545|NCT02574637|449703245|FG003|Double-blind Period|Reason Not Specified|1|||
125021546|NCT02574637|449703246|FG004|Double-blind Period|Reason Not Specified|0|||
125021547|NCT02574637|449703247|FG005|Double-blind Period|Reason Not Specified|0|||
125021548|NCT02574637|449703248|FG006|Double-blind Period|Reason Not Specified|0|||
125021549|NCT02574637|449703249|FG007|Double-blind Period|Reason Not Specified|0|||
125021550|NCT02574637|449703250|FG008|Double-blind Period|Reason Not Specified|0|||
125210919|NCT04521114|450396710|FG000|Overall Study|Withdrawal by Subject|1|||
124904746|NCT02477670|449276352|FG000|Stage 1|Lost to Follow-up|0|||
124904747|NCT02477670|449276353|FG001|Stage 1|Lost to Follow-up|2|||
124904748|NCT02477670|449276354|FG002|Stage 1|Lost to Follow-up|0|||
124904749|NCT02477670|449276355|FG003|Stage 1|Lost to Follow-up|0|||
124904750|NCT02477670|449276356|FG004|Stage 1|Lost to Follow-up|0|||
125021551|NCT02574637|449703251|FG009|Double-blind Period|Reason Not Specified|0|||
124904751|NCT02477670|449276357|FG005|Stage 1|Lost to Follow-up|0|||
124904752|NCT02477670|449276358|FG006|Stage 1|Lost to Follow-up|0|||
124904753|NCT02477670|449276352|FG000|Stage 1|Withdrawal by Subject|1|||
124904754|NCT02477670|449276353|FG001|Stage 1|Withdrawal by Subject|2|||
124904755|NCT02477670|449276354|FG002|Stage 1|Withdrawal by Subject|0|||
124904756|NCT02477670|449276355|FG003|Stage 1|Withdrawal by Subject|0|||
124904757|NCT02477670|449276356|FG004|Stage 1|Withdrawal by Subject|0|||
124904758|NCT02477670|449276357|FG005|Stage 1|Withdrawal by Subject|0|||
124904759|NCT02477670|449276358|FG006|Stage 1|Withdrawal by Subject|0|||
124904760|NCT02477670|449276352|FG000|Stage 1|Non-compliance with Study Drug|1|||
124904761|NCT02477670|449276353|FG001|Stage 1|Non-compliance with Study Drug|2|||
124904762|NCT02477670|449276354|FG002|Stage 1|Non-compliance with Study Drug|0|||
124904763|NCT02477670|449276355|FG003|Stage 1|Non-compliance with Study Drug|0|||
124904764|NCT02477670|449276356|FG004|Stage 1|Non-compliance with Study Drug|0|||
124904765|NCT02477670|449276357|FG005|Stage 1|Non-compliance with Study Drug|0|||
124904766|NCT02477670|449276358|FG006|Stage 1|Non-compliance with Study Drug|0|||
124904767|NCT02477670|449276352|FG000|Stage 2|Adverse Event|0|||
124904768|NCT02477670|449276353|FG001|Stage 2|Adverse Event|0|||
124904769|NCT02477670|449276354|FG002|Stage 2|Adverse Event|1|||
124904770|NCT02477670|449276355|FG003|Stage 2|Adverse Event|0|||
124904771|NCT02477670|449276356|FG004|Stage 2|Adverse Event|0|||
124904772|NCT02477670|449276357|FG005|Stage 2|Adverse Event|0|||
124904773|NCT02477670|449276358|FG006|Stage 2|Adverse Event|0|||
124904774|NCT02477670|449276352|FG000|Stage 2|Antipsychotic Medication Changed|0|||
124904775|NCT02477670|449276353|FG001|Stage 2|Antipsychotic Medication Changed|0|||
124904776|NCT02477670|449276354|FG002|Stage 2|Antipsychotic Medication Changed|1|||
124904777|NCT02477670|449276355|FG003|Stage 2|Antipsychotic Medication Changed|0|||
124904778|NCT02477670|449276356|FG004|Stage 2|Antipsychotic Medication Changed|0|||
124904779|NCT02477670|449276357|FG005|Stage 2|Antipsychotic Medication Changed|0|||
124904780|NCT02477670|449276358|FG006|Stage 2|Antipsychotic Medication Changed|0|||
124904781|NCT02477670|449276352|FG000|Stage 2|Withdrawal by Subject|0|||
124904782|NCT02477670|449276353|FG001|Stage 2|Withdrawal by Subject|0|||
124904783|NCT02477670|449276354|FG002|Stage 2|Withdrawal by Subject|0|||
124904784|NCT02477670|449276355|FG003|Stage 2|Withdrawal by Subject|1|||
124904785|NCT02477670|449276356|FG004|Stage 2|Withdrawal by Subject|0|||
124904786|NCT02477670|449276357|FG005|Stage 2|Withdrawal by Subject|0|||
124904787|NCT02477670|449276358|FG006|Stage 2|Withdrawal by Subject|0|||
124904788|NCT00446550|449276363|FG000|Overall Study|Adverse Event|1|||
124904789|NCT00446550|449276364|FG001|Overall Study|Adverse Event|0|||
124904790|NCT02937831|449276365|FG000|Overall Study|Protocol Violation|4|||
124904791|NCT03720210|449276370|FG000|Overall Study|Lost to Follow-up|1|||
124904792|NCT00114244|449276371|FG000|Overall Study|Adverse Event|2|||
124904793|NCT00114244|449276372|FG001|Overall Study|Adverse Event|5|||
125114032|NCT03443869|450040451|FG001|Overall Study|Physician Decision|3|||
125114033|NCT03443869|450040450|FG000|Overall Study|Other|4|||
125114034|NCT03443869|450040451|FG001|Overall Study|Other|4|||
125114035|NCT00299728|450040452|FG000|Overall Study|Lost to Follow-up|0|||
125114036|NCT00299728|450040453|FG001|Overall Study|Lost to Follow-up|1|||
125114037|NCT00299728|450040452|FG000|Overall Study|Withdrawal by Subject|0|||
125114038|NCT00299728|450040453|FG001|Overall Study|Withdrawal by Subject|1|||
125114039|NCT00299728|450040452|FG000|Overall Study|Progressive disease|0|||
125114040|NCT00299728|450040453|FG001|Overall Study|Progressive disease|1|||
125114041|NCT02826603|450040454|FG000|Overall Study|Adverse Event|17|||
125114042|NCT02826603|450040455|FG001|Overall Study|Adverse Event|9|||
125114043|NCT02826603|450040454|FG000|Overall Study|Lack of Efficacy|4|||
125114044|NCT02826603|450040455|FG001|Overall Study|Lack of Efficacy|9|||
125114045|NCT02826603|450040454|FG000|Overall Study|Lost to Follow-up|13|||
125114046|NCT02826603|450040455|FG001|Overall Study|Lost to Follow-up|12|||
125114047|NCT02826603|450040454|FG000|Overall Study|Noncompliance with treatment|0|||
125114048|NCT02826603|450040455|FG001|Overall Study|Noncompliance with treatment|2|||
125114049|NCT02826603|450040454|FG000|Overall Study|Physician Decision|1|||
125114050|NCT02826603|450040455|FG001|Overall Study|Physician Decision|7|||
125114051|NCT02826603|450040454|FG000|Overall Study|Pregnancy|1|||
124904794|NCT00114244|449276371|FG000|Overall Study|Withdrawal by Subject|0|||
124904795|NCT00114244|449276372|FG001|Overall Study|Withdrawal by Subject|2|||
124904796|NCT00711958|449276373|FG000|Overall Study|Withdrawal by Subject|6|||
124904797|NCT00711958|449276374|FG001|Overall Study|Withdrawal by Subject|8|||
124904798|NCT00711958|449276373|FG000|Overall Study|Lack of Efficacy|3|||
125114052|NCT02826603|450040455|FG001|Overall Study|Pregnancy|2|||
124904799|NCT00711958|449276374|FG001|Overall Study|Lack of Efficacy|1|||
124904800|NCT00711958|449276373|FG000|Overall Study|Clinical deterioration|1|||
124904801|NCT00711958|449276374|FG001|Overall Study|Clinical deterioration|0|||
124904802|NCT00711958|449276373|FG000|Overall Study|Adverse Event|9|||
124904803|NCT00711958|449276374|FG001|Overall Study|Adverse Event|7|||
124904804|NCT00711958|449276373|FG000|Overall Study|Protocol Violation|1|||
124904805|NCT00711958|449276374|FG001|Overall Study|Protocol Violation|0|||
124904806|NCT00711958|449276373|FG000|Overall Study|Lost to Follow-up|2|||
124904807|NCT00711958|449276374|FG001|Overall Study|Lost to Follow-up|2|||
124904808|NCT00711958|449276373|FG000|Overall Study|Death|10|||
124904809|NCT00711958|449276374|FG001|Overall Study|Death|5|||
124904810|NCT00711958|449276373|FG000|Overall Study|Progression of disease|1|||
124904811|NCT00711958|449276374|FG001|Overall Study|Progression of disease|0|||
124904812|NCT02694978|449276377|FG000|Overall Study|Adverse Event|10|||
124904813|NCT02694978|449276378|FG001|Overall Study|Adverse Event|9|||
124904814|NCT02694978|449276377|FG000|Overall Study|Withdrawal by Subject|22|||
124904815|NCT02694978|449276378|FG001|Overall Study|Withdrawal by Subject|19|||
124904816|NCT02694978|449276377|FG000|Overall Study|Lost to Follow-up|14|||
124904817|NCT02694978|449276378|FG001|Overall Study|Lost to Follow-up|17|||
124904818|NCT02694978|449276377|FG000|Overall Study|Death|4|||
124904819|NCT02694978|449276378|FG001|Overall Study|Death|1|||
124904820|NCT02694978|449276377|FG000|Overall Study|Other-Decision of Participant|6|||
125114053|NCT02826603|450040454|FG000|Overall Study|Protocol Violation|3|||
125114054|NCT02826603|450040455|FG001|Overall Study|Protocol Violation|3|||
125114055|NCT02826603|450040454|FG000|Overall Study|Withdrawal by Subject|20|||
125114056|NCT02826603|450040455|FG001|Overall Study|Withdrawal by Subject|19|||
125114057|NCT02826603|450040454|FG000|Overall Study|Death|2|||
125114058|NCT02826603|450040455|FG001|Overall Study|Death|0|||
125114059|NCT02826603|450040454|FG000|Overall Study|New therapy for study indication|0|||
125114060|NCT02826603|450040455|FG001|Overall Study|New therapy for study indication|1|||
125114061|NCT01337050|450040459|FG000|Overall Study|Death|0|||
125114062|NCT01337050|450040460|FG001|Overall Study|Death|0|||
125114063|NCT01337050|450040461|FG002|Overall Study|Death|4|||
125114064|NCT01337050|450040459|FG000|Overall Study|Other|4|||
125114065|NCT01337050|450040460|FG001|Overall Study|Other|6|||
125114066|NCT01337050|450040461|FG002|Overall Study|Other|8|||
125114067|NCT01337050|450040459|FG000|Overall Study|Participants refused further follow-up|0|||
125114068|NCT01337050|450040460|FG001|Overall Study|Participants refused further follow-up|7|||
125114069|NCT01337050|450040461|FG002|Overall Study|Participants refused further follow-up|7|||
125114070|NCT00003102|450040462|FG000|Overall Study|Physician Decision|1|||
125114071|NCT00003102|450040463|FG001|Overall Study|Physician Decision|1|||
125114072|NCT00003102|450040464|FG002|Overall Study|Physician Decision|0|||
125114073|NCT00003102|450040462|FG000|Overall Study|Progressive Disease|0|||
125114074|NCT00003102|450040463|FG001|Overall Study|Progressive Disease|1|||
125114075|NCT00003102|450040464|FG002|Overall Study|Progressive Disease|0|||
125114076|NCT00003102|450040462|FG000|Overall Study|Adverse Event|0|||
125114077|NCT00003102|450040463|FG001|Overall Study|Adverse Event|1|||
125114078|NCT00003102|450040464|FG002|Overall Study|Adverse Event|1|||
125114079|NCT00003102|450040462|FG000|Overall Study|Death|0|||
125114080|NCT00003102|450040463|FG001|Overall Study|Death|0|||
125114081|NCT00003102|450040464|FG002|Overall Study|Death|1|||
125114082|NCT00583596|450040465|FG000|Overall Study|Lost to Follow-up|110|||
125114083|NCT00583596|450040465|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
125114084|NCT00583596|450040465|FG000|Overall Study|Death|2|||
125114085|NCT00583596|450040465|FG000|Overall Study|Withdrawal by Subject|6|||
125114086|NCT00583596|450040465|FG000|Overall Study|Lost to Follow-up|94|||
125114087|NCT00583596|450040465|FG000|Overall Study|Data not complete|1|||
125114088|NCT00583596|450040465|FG000|Overall Study|Not consented|15|||
125114089|NCT00583596|450040465|FG000|Overall Study|Outside f-up window|26|||
125114090|NCT00656019|450040466|FG000|Overall Study|Not Eligible|10|||
125114091|NCT00656019|450040467|FG001|Overall Study|Not Eligible|0|||
125114092|NCT00656019|450040468|FG002|Overall Study|Not Eligible|0|||
125114093|NCT00656019|450040469|FG003|Overall Study|Not Eligible|0|||
125114094|NCT00656019|450040466|FG000|Overall Study|Withdrawal by Subject|2|||
125114095|NCT00656019|450040467|FG001|Overall Study|Withdrawal by Subject|0|||
124904821|NCT02694978|449276378|FG001|Overall Study|Other-Decision of Participant|1|||
124904822|NCT02694978|449276377|FG000|Overall Study|Other-Investigator's decision|1|||
124904823|NCT02694978|449276378|FG001|Overall Study|Other-Investigator's decision|0|||
124904824|NCT02694978|449276377|FG000|Overall Study|Other-Unable to be reached|0|||
124904825|NCT02694978|449276378|FG001|Overall Study|Other-Unable to be reached|1|||
124904826|NCT02694978|449276377|FG000|Overall Study|Other-Protocol noncompliant|2|||
125114096|NCT00656019|450040468|FG002|Overall Study|Withdrawal by Subject|0|||
125114097|NCT00656019|450040469|FG003|Overall Study|Withdrawal by Subject|0|||
125114098|NCT00656019|450040466|FG000|Overall Study|Lost to Follow-up|2|||
125114099|NCT00656019|450040467|FG001|Overall Study|Lost to Follow-up|1|||
125114100|NCT00656019|450040468|FG002|Overall Study|Lost to Follow-up|0|||
125114101|NCT00656019|450040469|FG003|Overall Study|Lost to Follow-up|0|||
124904827|NCT02694978|449276378|FG001|Overall Study|Other-Protocol noncompliant|1|||
124904828|NCT02694978|449276377|FG000|Overall Study|Other-Personal reasons|3|||
124904829|NCT02694978|449276378|FG001|Overall Study|Other-Personal reasons|3|||
124904830|NCT02694978|449276377|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
124904831|NCT02694978|449276378|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
124904832|NCT01613716|449276379|FG000|Overall Study|screen failures|3|||
124904833|NCT01613716|449276379|FG000|Overall Study|Lost to Follow-up|4|||
124904834|NCT02224924|449276380|FG000|Overall Study|Withdrawal by Subject|7|||
124904835|NCT02224924|449276381|FG001|Overall Study|Withdrawal by Subject|6|||
124904836|NCT02224924|449276380|FG000|Overall Study|Biopsy cancelled|20|||
124904837|NCT02224924|449276381|FG001|Overall Study|Biopsy cancelled|14|||
124904838|NCT02224924|449276380|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
124904839|NCT02224924|449276381|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
124904840|NCT02224924|449276380|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
124904841|NCT02224924|449276381|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
124904842|NCT03020745|449276382|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
124904843|NCT03020745|449276383|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
124904844|NCT03020745|449276384|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
124904845|NCT03020745|449276385|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
124904846|NCT03020745|449276386|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
124904847|NCT03020745|449276387|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
124904848|NCT03020745|449276388|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
124904849|NCT03020745|449276389|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
124904850|NCT03020745|449276390|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
124904851|NCT03020745|449276391|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
124904852|NCT03020745|449276382|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
124904853|NCT03020745|449276383|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
124904854|NCT03020745|449276384|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
124904855|NCT03020745|449276385|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
124904856|NCT03020745|449276386|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
124904857|NCT03020745|449276387|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
124904858|NCT03020745|449276388|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
124904859|NCT03020745|449276389|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
124904860|NCT03020745|449276390|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
124904861|NCT03020745|449276391|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
125021552|NCT02574637|449703242|FG000|Open-label (OL) Period|Adverse Event|0|||
125021553|NCT02574637|449703243|FG001|Open-label (OL) Period|Adverse Event|0|||
125021554|NCT02574637|449703244|FG002|Open-label (OL) Period|Adverse Event|0|||
125021555|NCT02574637|449703245|FG003|Open-label (OL) Period|Adverse Event|0|||
125021556|NCT02574637|449703246|FG004|Open-label (OL) Period|Adverse Event|0|||
125021557|NCT02574637|449703247|FG005|Open-label (OL) Period|Adverse Event|0|||
125021558|NCT02574637|449703248|FG006|Open-label (OL) Period|Adverse Event|0|||
125021559|NCT02574637|449703249|FG007|Open-label (OL) Period|Adverse Event|0|||
125021560|NCT02574637|449703250|FG008|Open-label (OL) Period|Adverse Event|1|||
125021561|NCT02574637|449703251|FG009|Open-label (OL) Period|Adverse Event|0|||
125021562|NCT02574637|449703242|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
125021563|NCT02574637|449703243|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
125021564|NCT02574637|449703244|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
125021565|NCT02574637|449703245|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
125021566|NCT02574637|449703246|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
125021567|NCT02574637|449703247|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
125021568|NCT02574637|449703248|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
125021569|NCT02574637|449703249|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
125021570|NCT02574637|449703250|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
125021571|NCT02574637|449703251|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
125021572|NCT02574637|449703242|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
125021573|NCT02574637|449703243|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
125021574|NCT02574637|449703244|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
125021575|NCT02574637|449703245|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
125021576|NCT02574637|449703246|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
125021577|NCT02574637|449703247|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
125021578|NCT02574637|449703248|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
125021579|NCT02574637|449703249|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
125114102|NCT00096486|450040470|FG000|Overall Study|Withdrawal by Subject|0|||
125114103|NCT00096486|450040471|FG001|Overall Study|Withdrawal by Subject|0|||
124904862|NCT03020745|449276382|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
124904863|NCT03020745|449276383|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
124904864|NCT03020745|449276384|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
125021580|NCT02574637|449703250|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
124904865|NCT03020745|449276385|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
124904866|NCT03020745|449276386|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
124904867|NCT03020745|449276387|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
124904868|NCT03020745|449276388|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
124904869|NCT03020745|449276389|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
124904870|NCT03020745|449276390|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
124904871|NCT03020745|449276391|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
124904872|NCT03020745|449276382|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
124904873|NCT03020745|449276383|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
124904874|NCT03020745|449276384|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
124904875|NCT03020745|449276385|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
124904876|NCT03020745|449276386|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
124904877|NCT03020745|449276387|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
124904878|NCT03020745|449276388|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
124904879|NCT03020745|449276389|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
124904880|NCT03020745|449276390|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
124904881|NCT03020745|449276391|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
124904882|NCT03184558|449276394|FG000|Overall Study|Withdrawal by Subject|2|||
124904883|NCT03184558|449276394|FG000|Overall Study|Death|16|||
124904884|NCT03184558|449276394|FG000|Overall Study|Lost to Follow-up|2|||
124904885|NCT03184558|449276394|FG000|Overall Study|Other|9|||
124904886|NCT02506257|449276395|FG000|Overall Study|Adverse Event|0|||
124904887|NCT02506257|449276396|FG001|Overall Study|Adverse Event|2|||
124904888|NCT02506257|449276397|FG002|Overall Study|Adverse Event|3|||
124904889|NCT02506257|449276398|FG003|Overall Study|Adverse Event|0|||
124904890|NCT02506257|449276395|FG000|Overall Study|Protocol Violation|0|||
124904891|NCT02506257|449276396|FG001|Overall Study|Protocol Violation|0|||
124904892|NCT02506257|449276397|FG002|Overall Study|Protocol Violation|1|||
124904893|NCT02506257|449276398|FG003|Overall Study|Protocol Violation|0|||
124904894|NCT01924767|449276401|FG000|Overall Study|Adverse Event|1|||
124904895|NCT01924767|449276402|FG001|Overall Study|Adverse Event|0|||
124904896|NCT01924767|449276403|FG002|Overall Study|Adverse Event|1|||
124904897|NCT01924767|449276404|FG003|Overall Study|Adverse Event|0|||
124904898|NCT01924767|449276405|FG004|Overall Study|Adverse Event|0|||
124904899|NCT00139737|449276413|FG000|Overall Study|Withdrawal by Subject|190|||
124904900|NCT00139737|449276413|FG000|Overall Study|Adverse Event|58|||
124904901|NCT00139737|449276413|FG000|Overall Study|Lack of Efficacy|40|||
124904902|NCT00139737|449276413|FG000|Overall Study|Lost to Follow-up|8|||
124904903|NCT00139737|449276413|FG000|Overall Study|Death|3|||
124904904|NCT00139737|449276413|FG000|Overall Study|Laboratory Abnormality|2|||
124904905|NCT00139737|449276413|FG000|Overall Study|Protocol Violation|18|||
124904906|NCT00139737|449276413|FG000|Overall Study|Withdrew During Screening Phase|8|||
124904907|NCT00139737|449276413|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
124904908|NCT00139737|449276413|FG000|Overall Study|Screened, Not Treated|13|||
124904909|NCT03781336|449276416|FG000|Overall Study|Withdrawal by Subject|2|||
124904910|NCT03781336|449276417|FG001|Overall Study|Withdrawal by Subject|2|||
124904911|NCT03460756|449276418|FG000|Overall Study|Adverse Event|0|||
124904912|NCT03460756|449276419|FG001|Overall Study|Adverse Event|0|||
124904913|NCT03460756|449276420|FG002|Overall Study|Adverse Event|0|||
124904914|NCT03460756|449276421|FG003|Overall Study|Adverse Event|1|||
124904915|NCT03460756|449276418|FG000|Overall Study|Lack of Efficacy|0|||
125021581|NCT02574637|449703251|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
125021582|NCT00070941|449703256|FG000|Overall Study|Adverse Event|10|||
125021583|NCT00070941|449703257|FG001|Overall Study|Adverse Event|8|||
125021584|NCT00070941|449703258|FG002|Overall Study|Adverse Event|4|||
125021585|NCT00094055|449703259|FG000|Overall Study|Adverse Event|11|||
125021586|NCT00094055|449703259|FG000|Overall Study|Death|4|||
125021587|NCT00094055|449703259|FG000|Overall Study|Lack of Efficacy|17|||
125021588|NCT00094055|449703259|FG000|Overall Study|Lost to Follow-up|2|||
125021589|NCT00094055|449703259|FG000|Overall Study|progressive disease|2|||
125021590|NCT00094055|449703259|FG000|Overall Study|clinical progression|1|||
125021591|NCT00094055|449703259|FG000|Overall Study|roll-over to another study|14|||
125021592|NCT00094055|449703259|FG000|Overall Study|Withdrawal by Subject|9|||
125021593|NCT00411554|449703263|FG000|Overall Study|Adverse Event|2|||
125021594|NCT00411554|449703264|FG001|Overall Study|Adverse Event|4|||
125021595|NCT00411554|449703263|FG000|Overall Study|Lack of Efficacy|2|||
125021596|NCT00411554|449703264|FG001|Overall Study|Lack of Efficacy|5|||
125021597|NCT00411554|449703263|FG000|Overall Study|Withdrawal by Subject|3|||
125021598|NCT00411554|449703264|FG001|Overall Study|Withdrawal by Subject|0|||
125021599|NCT00411554|449703263|FG000|Overall Study|Patient Moved|1|||
125021600|NCT00411554|449703264|FG001|Overall Study|Patient Moved|0|||
124904916|NCT03460756|449276419|FG001|Overall Study|Lack of Efficacy|0|||
124904917|NCT03460756|449276420|FG002|Overall Study|Lack of Efficacy|0|||
124904918|NCT03460756|449276421|FG003|Overall Study|Lack of Efficacy|2|||
124904919|NCT03460756|449276418|FG000|Overall Study|Lost to Follow-up|0|||
124904920|NCT03460756|449276419|FG001|Overall Study|Lost to Follow-up|1|||
125021601|NCT00699907|449703265|FG000|Overall Study|Withdrawal by Subject|2|||
125210920|NCT04521114|450396711|FG001|Overall Study|Withdrawal by Subject|2|||
125210921|NCT04521114|450396712|FG002|Overall Study|Withdrawal by Subject|2|||
125210922|NCT04521114|450396710|FG000|Overall Study|Adverse Event|1|||
125210923|NCT04521114|450396711|FG001|Overall Study|Adverse Event|0|||
125210924|NCT04521114|450396712|FG002|Overall Study|Adverse Event|0|||
125210925|NCT04521114|450396710|FG000|Overall Study|Sponsor Wish|1|||
125210926|NCT04521114|450396711|FG001|Overall Study|Sponsor Wish|0|||
125210927|NCT04521114|450396712|FG002|Overall Study|Sponsor Wish|0|||
125210928|NCT04521114|450396710|FG000|Overall Study|Withdrawal of Consent|2|||
125210929|NCT04521114|450396711|FG001|Overall Study|Withdrawal of Consent|2|||
125210930|NCT04521114|450396712|FG002|Overall Study|Withdrawal of Consent|0|||
125210931|NCT01133288|450396715|FG000|Eligibility Assessment|met exclusion criteria|5|||
125210932|NCT01133288|450396715|FG000|Intervention Allocation|study terminated|2|||
125210933|NCT00438256|450396716|FG000|Overall Study|Ineligible for Resection|2|||
125210934|NCT00438256|450396717|FG001|Overall Study|Ineligible for Resection|1|||
125210935|NCT00438256|450396718|FG002|Overall Study|Ineligible for Resection|1|||
125210936|NCT00438256|450396719|FG003|Overall Study|Ineligible for Resection|7|||
125210937|NCT00438256|450396716|FG000|Overall Study|Excluded final Diagnosis|0|||
125210938|NCT00438256|450396717|FG001|Overall Study|Excluded final Diagnosis|0|||
125210939|NCT00438256|450396718|FG002|Overall Study|Excluded final Diagnosis|0|||
125210940|NCT00438256|450396719|FG003|Overall Study|Excluded final Diagnosis|2|||
125210941|NCT00750919|450396728|FG000|Overall Study|Adverse Event|9|||
125210942|NCT00750919|450396728|FG000|Overall Study|Withdrawal by Subject|1|||
125210943|NCT00750919|450396728|FG000|Overall Study|Lack of Efficacy|8|||
125210944|NCT00750919|450396728|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
125210945|NCT00750919|450396728|FG000|Overall Study|Other|36|||
125210946|NCT01404949|450396734|FG000|Overall Study|Not Treated|1|||
125210947|NCT00380718|450396737|FG000|Overall Study|Adverse Event|1|||
125210948|NCT00380718|450396737|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
125210949|NCT01094782|450396738|FG000|Overall Study|Withdrawal by Subject|5|||
125210950|NCT01094782|450396739|FG001|Overall Study|Withdrawal by Subject|5|||
125210951|NCT01094782|450396740|FG002|Overall Study|Withdrawal by Subject|1|||
125210952|NCT01094782|450396741|FG003|Overall Study|Withdrawal by Subject|5|||
125210953|NCT01094782|450396742|FG004|Overall Study|Withdrawal by Subject|5|||
125210954|NCT01094782|450396743|FG005|Overall Study|Withdrawal by Subject|0|||
125210955|NCT01094782|450396738|FG000|Overall Study|Lost to Follow-up|1|||
125210956|NCT01094782|450396739|FG001|Overall Study|Lost to Follow-up|0|||
125210957|NCT01094782|450396740|FG002|Overall Study|Lost to Follow-up|0|||
125210958|NCT01094782|450396741|FG003|Overall Study|Lost to Follow-up|2|||
125210959|NCT01094782|450396742|FG004|Overall Study|Lost to Follow-up|1|||
125210960|NCT01094782|450396743|FG005|Overall Study|Lost to Follow-up|4|||
125210961|NCT01094782|450396738|FG000|Overall Study|Positive Drug Screen|2|||
125210962|NCT01094782|450396739|FG001|Overall Study|Positive Drug Screen|2|||
125210963|NCT01094782|450396740|FG002|Overall Study|Positive Drug Screen|1|||
125210964|NCT01094782|450396741|FG003|Overall Study|Positive Drug Screen|1|||
125210965|NCT01094782|450396742|FG004|Overall Study|Positive Drug Screen|3|||
125210966|NCT01094782|450396743|FG005|Overall Study|Positive Drug Screen|2|||
125210967|NCT01094782|450396738|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
125210968|NCT01094782|450396739|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
125210969|NCT01094782|450396740|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
125210970|NCT01094782|450396741|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
125210971|NCT01094782|450396742|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
125210972|NCT01094782|450396743|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
125210973|NCT01094782|450396738|FG000|Overall Study|Unable to Complete Questionnaires|0|||
125210974|NCT01094782|450396739|FG001|Overall Study|Unable to Complete Questionnaires|1|||
125210975|NCT01094782|450396740|FG002|Overall Study|Unable to Complete Questionnaires|0|||
125210976|NCT01094782|450396741|FG003|Overall Study|Unable to Complete Questionnaires|0|||
125210977|NCT01094782|450396742|FG004|Overall Study|Unable to Complete Questionnaires|0|||
125210978|NCT01094782|450396743|FG005|Overall Study|Unable to Complete Questionnaires|0|||
125210979|NCT01094782|450396738|FG000|Overall Study|Healthy Subject Had Pain|0|||
125210980|NCT01094782|450396739|FG001|Overall Study|Healthy Subject Had Pain|1|||
125210981|NCT01094782|450396740|FG002|Overall Study|Healthy Subject Had Pain|0|||
125210982|NCT01094782|450396741|FG003|Overall Study|Healthy Subject Had Pain|0|||
125210983|NCT01094782|450396742|FG004|Overall Study|Healthy Subject Had Pain|0|||
125210984|NCT01094782|450396743|FG005|Overall Study|Healthy Subject Had Pain|0|||
125210985|NCT01094782|450396738|FG000|Overall Study|Hypertension|0|||
125210986|NCT01094782|450396739|FG001|Overall Study|Hypertension|0|||
125210987|NCT01094782|450396740|FG002|Overall Study|Hypertension|1|||
125210988|NCT01094782|450396741|FG003|Overall Study|Hypertension|0|||
125210989|NCT01094782|450396742|FG004|Overall Study|Hypertension|0|||
125210990|NCT01094782|450396743|FG005|Overall Study|Hypertension|0|||
125210991|NCT01094782|450396738|FG000|Overall Study|Wrong Pain Condition|0|||
125210992|NCT01094782|450396739|FG001|Overall Study|Wrong Pain Condition|0|||
125210993|NCT01094782|450396740|FG002|Overall Study|Wrong Pain Condition|0|||
125210994|NCT01094782|450396741|FG003|Overall Study|Wrong Pain Condition|2|||
125210995|NCT01094782|450396742|FG004|Overall Study|Wrong Pain Condition|1|||
125210996|NCT01094782|450396743|FG005|Overall Study|Wrong Pain Condition|1|||
125210997|NCT01094782|450396738|FG000|Overall Study|Recent Interventional Injection|0|||
125210998|NCT01094782|450396739|FG001|Overall Study|Recent Interventional Injection|0|||
125210999|NCT01094782|450396740|FG002|Overall Study|Recent Interventional Injection|0|||
125211000|NCT01094782|450396741|FG003|Overall Study|Recent Interventional Injection|0|||
125211001|NCT01094782|450396742|FG004|Overall Study|Recent Interventional Injection|0|||
125211002|NCT01094782|450396743|FG005|Overall Study|Recent Interventional Injection|1|||
125211003|NCT01094782|450396738|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
125211004|NCT01094782|450396739|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
125211005|NCT01094782|450396740|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
125211006|NCT01094782|450396741|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
125211007|NCT01094782|450396742|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
125211008|NCT01094782|450396743|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
125211009|NCT01094782|450396738|FG000|Overall Study|Noncompliance With Study Schedule|0|||
125211010|NCT01094782|450396739|FG001|Overall Study|Noncompliance With Study Schedule|0|||
125211011|NCT01094782|450396740|FG002|Overall Study|Noncompliance With Study Schedule|0|||
125211012|NCT01094782|450396741|FG003|Overall Study|Noncompliance With Study Schedule|1|||
125211013|NCT01094782|450396742|FG004|Overall Study|Noncompliance With Study Schedule|0|||
125211014|NCT01094782|450396743|FG005|Overall Study|Noncompliance With Study Schedule|0|||
125211015|NCT02912455|450396746|FG000|Overall Study|Withdrawal by Subject|0|||
125211016|NCT02912455|450396747|FG001|Overall Study|Withdrawal by Subject|1|||
125211017|NCT02912455|450396746|FG000|Overall Study|Lack of Efficacy|0|||
125211018|NCT02912455|450396747|FG001|Overall Study|Lack of Efficacy|1|||
125211019|NCT02912455|450396746|FG000|Overall Study|Lost to Follow-up|2|||
125211020|NCT02912455|450396747|FG001|Overall Study|Lost to Follow-up|1|||
125211021|NCT00957905|450396752|FG000|Part B|Not Treated|0|||
125211022|NCT00957905|450396753|FG001|Part B|Not Treated|1|||
124904921|NCT03460756|449276420|FG002|Overall Study|Lost to Follow-up|2|||
124904922|NCT03460756|449276421|FG003|Overall Study|Lost to Follow-up|1|||
124904923|NCT03460756|449276418|FG000|Overall Study|Pregnancy|0|||
124904924|NCT03460756|449276419|FG001|Overall Study|Pregnancy|0|||
124904925|NCT03460756|449276420|FG002|Overall Study|Pregnancy|0|||
124904926|NCT03460756|449276421|FG003|Overall Study|Pregnancy|1|||
124904927|NCT03460756|449276418|FG000|Overall Study|Protocol Violation|0|||
124904928|NCT03460756|449276419|FG001|Overall Study|Protocol Violation|0|||
124904929|NCT03460756|449276420|FG002|Overall Study|Protocol Violation|0|||
124904930|NCT03460756|449276421|FG003|Overall Study|Protocol Violation|1|||
124904931|NCT03460756|449276418|FG000|Overall Study|Withdrawal by Subject|0|||
125114104|NCT00096486|450040472|FG002|Overall Study|Withdrawal by Subject|1|||
125114105|NCT00096486|450040473|FG003|Overall Study|Withdrawal by Subject|1|||
125114106|NCT00096486|450040470|FG000|Overall Study|Not Treated|0|||
125114107|NCT00096486|450040471|FG001|Overall Study|Not Treated|0|||
125114108|NCT00096486|450040472|FG002|Overall Study|Not Treated|1|||
125114109|NCT00096486|450040473|FG003|Overall Study|Not Treated|1|||
125114110|NCT03558997|450040474|FG000|Overall Study|Adverse Event|0|||
125114111|NCT03558997|450040475|FG001|Overall Study|Adverse Event|2|||
125114112|NCT03558997|450040476|FG002|Overall Study|Adverse Event|5|||
125114113|NCT03558997|450040477|FG003|Overall Study|Adverse Event|1|||
124904932|NCT03460756|449276419|FG001|Overall Study|Withdrawal by Subject|4|||
124904933|NCT03460756|449276420|FG002|Overall Study|Withdrawal by Subject|7|||
124904934|NCT03460756|449276421|FG003|Overall Study|Withdrawal by Subject|3|||
124904935|NCT03987451|449276422|FG000|Overall Study|Lost to Follow-up|1|||
124904936|NCT03987451|449276423|FG001|Overall Study|Lost to Follow-up|0|||
124904937|NCT03987451|449276422|FG000|Overall Study|Withdrawal by Subject|1|||
124904938|NCT03987451|449276423|FG001|Overall Study|Withdrawal by Subject|1|||
124904939|NCT02441036|449276425|FG000|Overall Study|No tissue resected|0|||
124904940|NCT02441036|449276426|FG001|Overall Study|No tissue resected|1|||
124904941|NCT02441036|449276427|FG002|Overall Study|No tissue resected|0|||
125114114|NCT03558997|450040474|FG000|Overall Study|Physician Decision|0|||
125114115|NCT03558997|450040475|FG001|Overall Study|Physician Decision|0|||
125211023|NCT00957905|450396752|FG000|Part B|Physician Decision|0|||
125211024|NCT00957905|450396753|FG001|Part B|Physician Decision|1|||
124904942|NCT02441036|449276428|FG003|Overall Study|No tissue resected|1|||
125211025|NCT00957905|450396752|FG000|Part B|Death|0|||
125211026|NCT00957905|450396753|FG001|Part B|Death|1|||
125211027|NCT00957905|450396752|FG000|Part B|Protocol Violation|0|||
125211028|NCT00957905|450396753|FG001|Part B|Protocol Violation|1|||
125211029|NCT02073656|450396754|FG000|Primary Study|Lost to Follow-up|6|||
125211030|NCT02073656|450396754|FG000|Primary Study|Death|1|||
125211031|NCT02073656|450396754|FG000|Primary Study|Withdrew Consent|1|||
125211032|NCT01048099|450396760|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
124904943|NCT02441036|449276429|FG004|Overall Study|No tissue resected|0|||
124904944|NCT00004124|449278279|FG000|Overall Study|Received no protocol therapy|12|||
124904945|NCT00004124|449278280|FG001|Overall Study|Received no protocol therapy|20|||
124904946|NCT02296424|449278281|FG000|Part 1|New therapy for study indication|0|||
124904947|NCT02296424|449278282|FG001|Part 1|New therapy for study indication|1|||
125114116|NCT03558997|450040476|FG002|Overall Study|Physician Decision|1|||
125114117|NCT03558997|450040477|FG003|Overall Study|Physician Decision|0|||
125114118|NCT03558997|450040474|FG000|Overall Study|Withdrawal by Subject|1|||
125114119|NCT03558997|450040475|FG001|Overall Study|Withdrawal by Subject|0|||
125114120|NCT03558997|450040476|FG002|Overall Study|Withdrawal by Subject|1|||
125114121|NCT03558997|450040477|FG003|Overall Study|Withdrawal by Subject|1|||
125114122|NCT03558997|450040474|FG000|Overall Study|Lost to Follow-up|0|||
125114123|NCT03558997|450040475|FG001|Overall Study|Lost to Follow-up|0|||
125114124|NCT03558997|450040476|FG002|Overall Study|Lost to Follow-up|1|||
125114125|NCT03558997|450040477|FG003|Overall Study|Lost to Follow-up|0|||
125114126|NCT02230085|450040478|FG000|Overall Study|Physician Decision|1|||
125114127|NCT02230085|450040478|FG000|Overall Study|Withdrawal by Subject|3|||
125114128|NCT02173301|450040482|FG000|Overall Study|Adverse Event|7|||
125114129|NCT02173301|450040483|FG001|Overall Study|Adverse Event|8|||
125114130|NCT02173301|450040484|FG002|Overall Study|Adverse Event|13|||
125114131|NCT02173301|450040485|FG003|Overall Study|Adverse Event|5|||
125114132|NCT02173301|450040482|FG000|Overall Study|Withdrawal by Subject|8|||
125114133|NCT02173301|450040483|FG001|Overall Study|Withdrawal by Subject|10|||
125114134|NCT02173301|450040484|FG002|Overall Study|Withdrawal by Subject|4|||
125114135|NCT02173301|450040485|FG003|Overall Study|Withdrawal by Subject|8|||
125114136|NCT02173301|450040482|FG000|Overall Study|Lost to Follow-up|4|||
125114137|NCT02173301|450040483|FG001|Overall Study|Lost to Follow-up|4|||
125114138|NCT02173301|450040484|FG002|Overall Study|Lost to Follow-up|2|||
125114139|NCT02173301|450040485|FG003|Overall Study|Lost to Follow-up|2|||
125114140|NCT02173301|450040482|FG000|Overall Study|Protocol Violation|0|||
125114141|NCT02173301|450040483|FG001|Overall Study|Protocol Violation|1|||
125114142|NCT02173301|450040484|FG002|Overall Study|Protocol Violation|0|||
125114143|NCT02173301|450040485|FG003|Overall Study|Protocol Violation|0|||
125114144|NCT02173301|450040482|FG000|Overall Study|Physician Decision|0|||
125114145|NCT02173301|450040483|FG001|Overall Study|Physician Decision|0|||
125114146|NCT02173301|450040484|FG002|Overall Study|Physician Decision|1|||
125114147|NCT02173301|450040485|FG003|Overall Study|Physician Decision|0|||
125114148|NCT02173301|450040482|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
125114149|NCT02173301|450040483|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
125114150|NCT02173301|450040484|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
125114151|NCT02173301|450040485|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
125114152|NCT03016078|450040487|FG000|Overall Study|Protocol Violation|1|||
125114153|NCT03016078|450040487|FG000|Overall Study|Protocol Violation|1|||
125114154|NCT02123459|450040490|FG000|Washout Period (1 Day)|Adverse Event|1|||
125114155|NCT02123459|450040491|FG001|Washout Period (1 Day)|Adverse Event|0|||
125114156|NCT00254397|450040492|FG000|Overall Study|Disease Progression|4|||
125114157|NCT00254397|450040493|FG001|Overall Study|Disease Progression|1|||
125114158|NCT00254397|450040494|FG002|Overall Study|Disease Progression|16|||
125114159|NCT00254397|450040495|FG003|Overall Study|Disease Progression|23|||
125114160|NCT00254397|450040492|FG000|Overall Study|Non-Compliant|0|||
125114161|NCT00254397|450040493|FG001|Overall Study|Non-Compliant|0|||
125114162|NCT00254397|450040494|FG002|Overall Study|Non-Compliant|0|||
125114163|NCT00254397|450040495|FG003|Overall Study|Non-Compliant|1|||
124904948|NCT02296424|449278283|FG002|Part 1|New therapy for study indication|0|||
124904949|NCT02296424|449278284|FG003|Part 1|New therapy for study indication|0|||
124904950|NCT02296424|449278281|FG000|Part 1|Protocol Violation|0|||
124904951|NCT02296424|449278282|FG001|Part 1|Protocol Violation|1|||
124904952|NCT02296424|449278283|FG002|Part 1|Protocol Violation|0|||
124904953|NCT02296424|449278284|FG003|Part 1|Protocol Violation|0|||
124904954|NCT02296424|449278281|FG000|Part 1|Withdrawal by Subject|0|||
124904955|NCT02296424|449278282|FG001|Part 1|Withdrawal by Subject|2|||
124904956|NCT02296424|449278283|FG002|Part 1|Withdrawal by Subject|0|||
124904957|NCT02296424|449278284|FG003|Part 1|Withdrawal by Subject|0|||
124904958|NCT02296424|449278281|FG000|Part 1|Study terminated by sponsor|0|||
124904959|NCT02296424|449278282|FG001|Part 1|Study terminated by sponsor|1|||
124904960|NCT02296424|449278283|FG002|Part 1|Study terminated by sponsor|0|||
124904961|NCT02296424|449278284|FG003|Part 1|Study terminated by sponsor|0|||
124904962|NCT02296424|449278281|FG000|Part 1|Adverse Event|2|||
124904963|NCT02296424|449278282|FG001|Part 1|Adverse Event|11|||
124904964|NCT02296424|449278283|FG002|Part 1|Adverse Event|0|||
125114164|NCT00254397|450040492|FG000|Overall Study|Adverse Event|2|||
125114165|NCT00254397|450040493|FG001|Overall Study|Adverse Event|0|||
125114166|NCT00254397|450040494|FG002|Overall Study|Adverse Event|3|||
125114167|NCT00254397|450040495|FG003|Overall Study|Adverse Event|1|||
125114168|NCT00972153|450040508|FG000|Overall Study|Equipment malfunction during case|0|||
125211033|NCT01048099|450396760|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
125211034|NCT00508157|450396761|FG000|Overall Study|Adverse Event|0|||
124904965|NCT02296424|449278284|FG003|Part 1|Adverse Event|0|||
124904966|NCT02296424|449278281|FG000|Part 1|Lack of Efficacy|5|||
124904967|NCT02296424|449278282|FG001|Part 1|Lack of Efficacy|17|||
124904968|NCT02296424|449278283|FG002|Part 1|Lack of Efficacy|0|||
124904969|NCT02296424|449278284|FG003|Part 1|Lack of Efficacy|0|||
124904970|NCT02296424|449278281|FG000|Part 1|16 directly started part II|16|||
124904971|NCT02296424|449278282|FG001|Part 1|16 directly started part II|0|||
124904972|NCT02296424|449278283|FG002|Part 1|16 directly started part II|0|||
124904973|NCT02296424|449278284|FG003|Part 1|16 directly started part II|0|||
124904974|NCT02296424|449278281|FG000|Part 2|Lack of Efficacy|0|||
124904975|NCT02296424|449278282|FG001|Part 2|Lack of Efficacy|0|||
124904976|NCT02296424|449278283|FG002|Part 2|Lack of Efficacy|1|||
124904977|NCT02296424|449278284|FG003|Part 2|Lack of Efficacy|0|||
124904978|NCT02296424|449278281|FG000|Part 2|Adverse Event|0|||
124904979|NCT02296424|449278282|FG001|Part 2|Adverse Event|0|||
124904980|NCT02296424|449278283|FG002|Part 2|Adverse Event|1|||
124904981|NCT02296424|449278284|FG003|Part 2|Adverse Event|0|||
124904982|NCT02296424|449278281|FG000|Part 2|Lost to Follow-up|0|||
124904983|NCT02296424|449278282|FG001|Part 2|Lost to Follow-up|0|||
124904984|NCT02296424|449278283|FG002|Part 2|Lost to Follow-up|1|||
124904985|NCT02296424|449278284|FG003|Part 2|Lost to Follow-up|0|||
124904986|NCT04956575|449278285|FG000|Overall Study|Death|1|||
124904987|NCT04956575|449278286|FG001|Overall Study|Death|0|||
124904988|NCT04956575|449278287|FG002|Overall Study|Death|0|||
124904989|NCT04956575|449278288|FG003|Overall Study|Death|0|||
124904990|NCT04956575|449278289|FG004|Overall Study|Death|0|||
124904991|NCT04956575|449278290|FG005|Overall Study|Death|0|||
124904992|NCT04956575|449278291|FG006|Overall Study|Death|0|||
124904993|NCT04956575|449278292|FG007|Overall Study|Death|1|||
124904994|NCT04956575|449278293|FG008|Overall Study|Death|0|||
124904995|NCT04956575|449278294|FG009|Overall Study|Death|1|||
124904996|NCT04956575|449278295|FG010|Overall Study|Death|0|||
124904997|NCT04956575|449278296|FG011|Overall Study|Death|0|||
124904998|NCT04956575|449278285|FG000|Overall Study|Lost to Follow-up|3|||
124904999|NCT04956575|449278286|FG001|Overall Study|Lost to Follow-up|4|||
124905000|NCT04956575|449278287|FG002|Overall Study|Lost to Follow-up|2|||
124905001|NCT04956575|449278288|FG003|Overall Study|Lost to Follow-up|3|||
124905002|NCT04956575|449278289|FG004|Overall Study|Lost to Follow-up|1|||
124905003|NCT04956575|449278290|FG005|Overall Study|Lost to Follow-up|10|||
124905004|NCT04956575|449278291|FG006|Overall Study|Lost to Follow-up|11|||
124905005|NCT04956575|449278292|FG007|Overall Study|Lost to Follow-up|7|||
124905006|NCT04956575|449278293|FG008|Overall Study|Lost to Follow-up|4|||
124905007|NCT04956575|449278294|FG009|Overall Study|Lost to Follow-up|2|||
124905008|NCT04956575|449278295|FG010|Overall Study|Lost to Follow-up|3|||
124905009|NCT04956575|449278296|FG011|Overall Study|Lost to Follow-up|8|||
124905010|NCT04956575|449278285|FG000|Overall Study|Withdrawal by Subject|1|||
124905011|NCT04956575|449278286|FG001|Overall Study|Withdrawal by Subject|2|||
124905012|NCT04956575|449278287|FG002|Overall Study|Withdrawal by Subject|1|||
124905013|NCT04956575|449278288|FG003|Overall Study|Withdrawal by Subject|4|||
124905014|NCT04956575|449278289|FG004|Overall Study|Withdrawal by Subject|2|||
124905015|NCT04956575|449278290|FG005|Overall Study|Withdrawal by Subject|8|||
124905016|NCT04956575|449278291|FG006|Overall Study|Withdrawal by Subject|5|||
124905017|NCT04956575|449278292|FG007|Overall Study|Withdrawal by Subject|1|||
124905018|NCT04956575|449278293|FG008|Overall Study|Withdrawal by Subject|1|||
124905019|NCT04956575|449278294|FG009|Overall Study|Withdrawal by Subject|0|||
124905020|NCT04956575|449278295|FG010|Overall Study|Withdrawal by Subject|3|||
124905021|NCT04956575|449278296|FG011|Overall Study|Withdrawal by Subject|1|||
124905022|NCT03593876|449278297|FG000|Overall Study|Withdrawal by Subject|1|||
124905023|NCT03593876|449278297|FG000|Overall Study|Discharged home before intervention completion|2|||
124905024|NCT03287622|449278298|FG000|Overall Study|Withdrawal by Subject|1|||
124905025|NCT03287622|449278299|FG001|Overall Study|Withdrawal by Subject|0|||
124905026|NCT03287622|449278298|FG000|Overall Study|Lost to Follow-up|27|||
125021602|NCT00699907|449703266|FG001|Overall Study|Withdrawal by Subject|1|||
125021603|NCT00699907|449703267|FG002|Overall Study|Withdrawal by Subject|0|||
125021604|NCT00699907|449703265|FG000|Overall Study|No usable sample|0|||
125021605|NCT00699907|449703266|FG001|Overall Study|No usable sample|9|||
125021606|NCT00699907|449703267|FG002|Overall Study|No usable sample|8|||
125021607|NCT02161211|449703268|FG000|Overall Study|Lost to Follow-up|21|||
125021608|NCT02161211|449703269|FG001|Overall Study|Lost to Follow-up|27|||
125021609|NCT02161211|449703270|FG002|Overall Study|Lost to Follow-up|21|||
125021610|NCT02161211|449703268|FG000|Overall Study|Dropped|12|||
125021611|NCT02161211|449703269|FG001|Overall Study|Dropped|5|||
125021612|NCT02161211|449703270|FG002|Overall Study|Dropped|9|||
125114169|NCT00972153|450040509|FG001|Overall Study|Equipment malfunction during case|1|||
125211035|NCT00508157|450396762|FG001|Overall Study|Adverse Event|1|||
124905027|NCT03287622|449278299|FG001|Overall Study|Lost to Follow-up|15|||
124905028|NCT03287622|449278298|FG000|Overall Study|No prescripion after surgery|28|||
124905029|NCT03287622|449278299|FG001|Overall Study|No prescripion after surgery|31|||
124905030|NCT03287622|449278298|FG000|Overall Study|prolonged Length of stay|2|||
124905031|NCT03287622|449278299|FG001|Overall Study|prolonged Length of stay|0|||
124905032|NCT03287622|449278298|FG000|Overall Study|surgery related|0|||
124905033|NCT03287622|449278299|FG001|Overall Study|surgery related|2|||
125021613|NCT00430508|449703271|FG000|Overall Study|Adverse Event|2|||
124905034|NCT03823300|449278302|FG000|Overall Study|Withdrawal by Subject|16|||
124905035|NCT03823300|449278303|FG001|Overall Study|Withdrawal by Subject|22|||
124905036|NCT03823300|449278302|FG000|Overall Study|Death|10|||
124905037|NCT03823300|449278303|FG001|Overall Study|Death|14|||
124905038|NCT03823300|449278302|FG000|Overall Study|Adverse Event|3|||
124905039|NCT03823300|449278303|FG001|Overall Study|Adverse Event|5|||
124905040|NCT03823300|449278302|FG000|Overall Study|Physician Decision|1|||
124905041|NCT03823300|449278303|FG001|Overall Study|Physician Decision|7|||
124905042|NCT03823300|449278302|FG000|Overall Study|Lost to Follow-up|1|||
124905043|NCT03823300|449278303|FG001|Overall Study|Lost to Follow-up|3|||
124905044|NCT03823300|449278302|FG000|Overall Study|Protocol Violation|1|||
124905045|NCT03823300|449278303|FG001|Overall Study|Protocol Violation|1|||
124905046|NCT03823300|449278302|FG000|Overall Study|Lack of Efficacy|1|||
124905047|NCT03823300|449278303|FG001|Overall Study|Lack of Efficacy|1|||
124905048|NCT03823300|449278302|FG000|Overall Study|Not Eligible|0|||
124905049|NCT03823300|449278303|FG001|Overall Study|Not Eligible|1|||
124905050|NCT03823300|449278302|FG000|Overall Study|Other|1|||
124905051|NCT03823300|449278303|FG001|Overall Study|Other|0|||
124905052|NCT00507689|449278306|FG000|Pre-Randomization Period|Adverse Event|1|||
124905053|NCT00507689|449278307|FG001|Pre-Randomization Period|Adverse Event|0|||
124905054|NCT00507689|449278306|FG000|Pre-Randomization Period|Physician Decision|1|||
124905055|NCT00507689|449278307|FG001|Pre-Randomization Period|Physician Decision|0|||
124905056|NCT00507689|449278306|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
124905057|NCT00507689|449278307|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
124905058|NCT00507689|449278306|FG000|Randomized Period|Adverse Event|1|||
124905059|NCT00507689|449278307|FG001|Randomized Period|Adverse Event|1|||
124905060|NCT00507689|449278306|FG000|Randomized Period|Withdrawal by Subject|0|||
124905061|NCT00507689|449278307|FG001|Randomized Period|Withdrawal by Subject|1|||
124905062|NCT01786564|449278308|FG000|Overall Study|Lost to Follow-up|47|||
124905063|NCT01786564|449278308|FG000|Overall Study|Ineligible|17|||
124905064|NCT00486330|449278309|FG000|Overall Study|Adverse Event|2|||
124905065|NCT01290224|449278310|FG000|Overall Study|Adverse Event|1|||
124905066|NCT01290224|449278310|FG000|Overall Study|Refused Further Treatment|4|||
124905067|NCT00346333|449278311|FG000|Overall Study|Death|1|||
124905068|NCT00346333|449278312|FG001|Overall Study|Death|0|||
124905069|NCT00346333|449278311|FG000|Overall Study|unwilling or unable to continue|4|||
124905070|NCT00346333|449278312|FG001|Overall Study|unwilling or unable to continue|8|||
124905071|NCT00723450|449278313|FG000|Open-Label Phase|Adverse Event|26|||
124905072|NCT00723450|449278314|FG001|Open-Label Phase|Adverse Event|0|||
124905073|NCT00723450|449278315|FG002|Open-Label Phase|Adverse Event|0|||
124905074|NCT00723450|449278313|FG000|Open-Label Phase|Lack of Efficacy|18|||
124905075|NCT00723450|449278314|FG001|Open-Label Phase|Lack of Efficacy|0|||
124905076|NCT00723450|449278315|FG002|Open-Label Phase|Lack of Efficacy|0|||
124905077|NCT00723450|449278313|FG000|Open-Label Phase|Protocol Violation|35|||
124905078|NCT00723450|449278314|FG001|Open-Label Phase|Protocol Violation|0|||
124905079|NCT00723450|449278315|FG002|Open-Label Phase|Protocol Violation|0|||
124905080|NCT00723450|449278313|FG000|Open-Label Phase|Lost to Follow-up|7|||
124905081|NCT00723450|449278314|FG001|Open-Label Phase|Lost to Follow-up|0|||
124905082|NCT00723450|449278315|FG002|Open-Label Phase|Lost to Follow-up|0|||
124905083|NCT00723450|449278313|FG000|Open-Label Phase|Physician Decision|2|||
124905084|NCT00723450|449278314|FG001|Open-Label Phase|Physician Decision|0|||
125114170|NCT00972153|450040510|FG002|Overall Study|Equipment malfunction during case|0|||
125114171|NCT04136626|450040511|FG000|Treatment Phase|Withdrawal by Subject|1|||
125114172|NCT04136626|450040512|FG001|Treatment Phase|Withdrawal by Subject|9|||
125114173|NCT04136626|450040511|FG000|Treatment Phase|Adverse Event|1|||
125114174|NCT04136626|450040512|FG001|Treatment Phase|Adverse Event|0|||
125114175|NCT04136626|450040511|FG000|Treatment Phase|Lost to Follow-up|1|||
125114176|NCT04136626|450040512|FG001|Treatment Phase|Lost to Follow-up|5|||
125114177|NCT04136626|450040511|FG000|12-month Follow-up|Lost to Follow-up|8|||
125114178|NCT04136626|450040512|FG001|12-month Follow-up|Lost to Follow-up|7|||
125114179|NCT00409188|450042364|FG000|Overall Study|Ongoing at data cut-off|383|||
125114180|NCT00409188|450042365|FG001|Overall Study|Ongoing at data cut-off|175|||
125114181|NCT01393990|450042369|FG000|Overall Study|Adverse Event|0|||
125114182|NCT01393990|450042370|FG001|Overall Study|Adverse Event|0|||
125114183|NCT01393990|450042371|FG002|Overall Study|Adverse Event|0|||
124905085|NCT00723450|449278315|FG002|Open-Label Phase|Physician Decision|0|||
124905086|NCT00723450|449278313|FG000|Open-Label Phase|Withdrawal by Subject|37|||
124905087|NCT00723450|449278314|FG001|Open-Label Phase|Withdrawal by Subject|0|||
125114184|NCT01393990|450042372|FG003|Overall Study|Adverse Event|0|||
125114185|NCT01393990|450042373|FG004|Overall Study|Adverse Event|0|||
124905088|NCT00723450|449278315|FG002|Open-Label Phase|Withdrawal by Subject|0|||
124905089|NCT00723450|449278313|FG000|Randomized Phase|Adverse Event|0|||
124905090|NCT00723450|449278314|FG001|Randomized Phase|Adverse Event|26|||
124905091|NCT00723450|449278315|FG002|Randomized Phase|Adverse Event|17|||
124905092|NCT00723450|449278313|FG000|Randomized Phase|Lack of Efficacy|0|||
125114186|NCT01393990|450042374|FG005|Overall Study|Adverse Event|0|||
124905093|NCT00723450|449278314|FG001|Randomized Phase|Lack of Efficacy|11|||
124905094|NCT00723450|449278315|FG002|Randomized Phase|Lack of Efficacy|11|||
124905095|NCT00723450|449278313|FG000|Randomized Phase|Protocol Violation|0|||
124905096|NCT00723450|449278314|FG001|Randomized Phase|Protocol Violation|9|||
124905097|NCT00723450|449278315|FG002|Randomized Phase|Protocol Violation|13|||
124905098|NCT00723450|449278313|FG000|Randomized Phase|Lost to Follow-up|0|||
124905099|NCT00723450|449278314|FG001|Randomized Phase|Lost to Follow-up|2|||
124905100|NCT00723450|449278315|FG002|Randomized Phase|Lost to Follow-up|3|||
124905101|NCT00723450|449278313|FG000|Randomized Phase|Physician Decision|0|||
125114187|NCT01393990|450042375|FG006|Overall Study|Adverse Event|0|||
125114188|NCT01393990|450042376|FG007|Overall Study|Adverse Event|0|||
125114189|NCT01393990|450042377|FG008|Overall Study|Adverse Event|0|||
124905102|NCT00723450|449278314|FG001|Randomized Phase|Physician Decision|3|||
124905103|NCT00723450|449278315|FG002|Randomized Phase|Physician Decision|1|||
124905104|NCT00723450|449278313|FG000|Randomized Phase|Withdrawal by Subject|0|||
124905105|NCT00723450|449278314|FG001|Randomized Phase|Withdrawal by Subject|14|||
124905106|NCT00723450|449278315|FG002|Randomized Phase|Withdrawal by Subject|22|||
124905107|NCT00612586|449278317|FG000|Overall Study|Adverse Event|6|||
124905108|NCT00612586|449278318|FG001|Overall Study|Adverse Event|2|||
124905109|NCT00612586|449278317|FG000|Overall Study|Death|1|||
125114190|NCT01393990|450042378|FG009|Overall Study|Adverse Event|0|||
125114191|NCT01393990|450042379|FG010|Overall Study|Adverse Event|0|||
125114192|NCT01393990|450042380|FG011|Overall Study|Adverse Event|0|||
125114193|NCT01393990|450042381|FG012|Overall Study|Adverse Event|0|||
125114194|NCT01393990|450042382|FG013|Overall Study|Adverse Event|0|||
125114195|NCT01393990|450042383|FG014|Overall Study|Adverse Event|1|||
125114196|NCT01393990|450042384|FG015|Overall Study|Adverse Event|1|||
125114197|NCT01393990|450042385|FG016|Overall Study|Adverse Event|0|||
125114198|NCT01393990|450042386|FG017|Overall Study|Adverse Event|0|||
125114199|NCT01393990|450042369|FG000|Overall Study|Progressive Disease|1|||
125114200|NCT01393990|450042370|FG001|Overall Study|Progressive Disease|0|||
125114201|NCT01393990|450042371|FG002|Overall Study|Progressive Disease|0|||
125114202|NCT01393990|450042372|FG003|Overall Study|Progressive Disease|1|||
125114203|NCT01393990|450042373|FG004|Overall Study|Progressive Disease|1|||
125114204|NCT01393990|450042374|FG005|Overall Study|Progressive Disease|1|||
125114205|NCT01393990|450042375|FG006|Overall Study|Progressive Disease|1|||
125114206|NCT01393990|450042376|FG007|Overall Study|Progressive Disease|1|||
125114207|NCT01393990|450042377|FG008|Overall Study|Progressive Disease|3|||
125114208|NCT01393990|450042378|FG009|Overall Study|Progressive Disease|1|||
125114209|NCT01393990|450042379|FG010|Overall Study|Progressive Disease|0|||
125114210|NCT01393990|450042380|FG011|Overall Study|Progressive Disease|0|||
125114211|NCT01393990|450042381|FG012|Overall Study|Progressive Disease|0|||
125114212|NCT01393990|450042382|FG013|Overall Study|Progressive Disease|1|||
125114213|NCT01393990|450042383|FG014|Overall Study|Progressive Disease|6|||
125114214|NCT01393990|450042384|FG015|Overall Study|Progressive Disease|1|||
125114215|NCT01393990|450042385|FG016|Overall Study|Progressive Disease|0|||
125114216|NCT01393990|450042386|FG017|Overall Study|Progressive Disease|0|||
125114217|NCT01393990|450042369|FG000|Overall Study|Death|0|||
125114218|NCT01393990|450042370|FG001|Overall Study|Death|0|||
125114219|NCT01393990|450042371|FG002|Overall Study|Death|0|||
125114220|NCT01393990|450042372|FG003|Overall Study|Death|0|||
125114221|NCT01393990|450042373|FG004|Overall Study|Death|1|||
125114222|NCT01393990|450042374|FG005|Overall Study|Death|0|||
125114223|NCT01393990|450042375|FG006|Overall Study|Death|0|||
125114224|NCT01393990|450042376|FG007|Overall Study|Death|0|||
125114225|NCT01393990|450042377|FG008|Overall Study|Death|0|||
125114226|NCT01393990|450042378|FG009|Overall Study|Death|0|||
125114227|NCT01393990|450042379|FG010|Overall Study|Death|0|||
125114228|NCT01393990|450042380|FG011|Overall Study|Death|0|||
125114229|NCT01393990|450042381|FG012|Overall Study|Death|0|||
125114230|NCT01393990|450042382|FG013|Overall Study|Death|1|||
125114231|NCT01393990|450042383|FG014|Overall Study|Death|1|||
124905110|NCT00612586|449278318|FG001|Overall Study|Death|0|||
124905111|NCT00612586|449278317|FG000|Overall Study|Entry Criteria Not Met|0|||
124905112|NCT00612586|449278318|FG001|Overall Study|Entry Criteria Not Met|2|||
124905113|NCT00612586|449278317|FG000|Overall Study|Withdrawal by Subject|7|||
124905114|NCT00612586|449278318|FG001|Overall Study|Withdrawal by Subject|9|||
124905115|NCT00612586|449278317|FG000|Overall Study|Physician Decision|1|||
125114232|NCT01393990|450042384|FG015|Overall Study|Death|0|||
125114233|NCT01393990|450042385|FG016|Overall Study|Death|0|||
125114234|NCT01393990|450042386|FG017|Overall Study|Death|0|||
125114235|NCT01393990|450042369|FG000|Overall Study|Withdrawal by Subject|0|||
125114236|NCT01393990|450042370|FG001|Overall Study|Withdrawal by Subject|0|||
125114237|NCT01393990|450042371|FG002|Overall Study|Withdrawal by Subject|0|||
125114238|NCT01393990|450042372|FG003|Overall Study|Withdrawal by Subject|0|||
124905116|NCT00612586|449278318|FG001|Overall Study|Physician Decision|2|||
124905117|NCT00612586|449278317|FG000|Overall Study|Sponsor Decision|1|||
124905118|NCT00612586|449278318|FG001|Overall Study|Sponsor Decision|1|||
124905119|NCT00612586|449278317|FG000|Overall Study|Progressive Disease|26|||
124905120|NCT00612586|449278318|FG001|Overall Study|Progressive Disease|24|||
124905121|NCT00612586|449278317|FG000|Overall Study|Randomized and Not Treated|1|||
124905122|NCT00612586|449278318|FG001|Overall Study|Randomized and Not Treated|1|||
124905123|NCT03192046|449278319|FG000|Overall Study|Withdrawal by Subject|1|||
124905124|NCT03192046|449278320|FG001|Overall Study|Withdrawal by Subject|1|||
124905125|NCT00762606|449278321|FG000|Overall Study|Lost to Follow-up|18|||
124905126|NCT00762606|449278322|FG001|Overall Study|Lost to Follow-up|13|||
124905127|NCT01194154|449278323|FG000|Overall Study|Adverse Event|12|||
124905128|NCT01194154|449278324|FG001|Overall Study|Adverse Event|7|||
124905129|NCT01194154|449278323|FG000|Overall Study|Lost to Follow-up|2|||
124905130|NCT01194154|449278324|FG001|Overall Study|Lost to Follow-up|3|||
124905131|NCT01194154|449278323|FG000|Overall Study|Protocol Violation|0|||
124905132|NCT01194154|449278324|FG001|Overall Study|Protocol Violation|1|||
124905133|NCT01194154|449278323|FG000|Overall Study|Withdrawal by Subject|5|||
124905134|NCT01194154|449278324|FG001|Overall Study|Withdrawal by Subject|6|||
124905135|NCT01194154|449278323|FG000|Overall Study|Blood pressure increase|5|||
124905136|NCT01194154|449278324|FG001|Overall Study|Blood pressure increase|3|||
124905137|NCT01194154|449278323|FG000|Overall Study|Hemoglobin decrease|0|||
124905138|NCT01194154|449278324|FG001|Overall Study|Hemoglobin decrease|1|||
124905139|NCT01194154|449278323|FG000|Overall Study|Hemoglobin increase|12|||
124905140|NCT01194154|449278324|FG001|Overall Study|Hemoglobin increase|3|||
124905141|NCT01194154|449278323|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
124905142|NCT01194154|449278324|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
124905143|NCT01194154|449278323|FG000|Overall Study|Treatment with prohibited medication|4|||
124905144|NCT01194154|449278324|FG001|Overall Study|Treatment with prohibited medication|5|||
124905145|NCT01194154|449278323|FG000|Overall Study|Other|4|||
124905146|NCT01194154|449278324|FG001|Overall Study|Other|0|||
125114239|NCT01393990|450042373|FG004|Overall Study|Withdrawal by Subject|0|||
125114240|NCT01393990|450042374|FG005|Overall Study|Withdrawal by Subject|0|||
125114241|NCT01393990|450042375|FG006|Overall Study|Withdrawal by Subject|0|||
125114242|NCT01393990|450042376|FG007|Overall Study|Withdrawal by Subject|0|||
125114243|NCT01393990|450042377|FG008|Overall Study|Withdrawal by Subject|0|||
125114244|NCT01393990|450042378|FG009|Overall Study|Withdrawal by Subject|0|||
125114245|NCT01393990|450042379|FG010|Overall Study|Withdrawal by Subject|0|||
125114246|NCT01393990|450042380|FG011|Overall Study|Withdrawal by Subject|0|||
125114247|NCT01393990|450042381|FG012|Overall Study|Withdrawal by Subject|0|||
125114248|NCT01393990|450042382|FG013|Overall Study|Withdrawal by Subject|0|||
125114249|NCT01393990|450042383|FG014|Overall Study|Withdrawal by Subject|1|||
125114250|NCT01393990|450042384|FG015|Overall Study|Withdrawal by Subject|1|||
125114251|NCT01393990|450042385|FG016|Overall Study|Withdrawal by Subject|0|||
125114252|NCT01393990|450042386|FG017|Overall Study|Withdrawal by Subject|0|||
125114253|NCT00275028|450042387|FG000|Overall Study|Withdrew consent before treatment began|1|||
125114254|NCT00275028|450042387|FG000|Overall Study|Withdrawal by Subject|5|||
125114255|NCT00275028|450042387|FG000|Overall Study|Adverse Event|9|||
125114256|NCT00275028|450042387|FG000|Overall Study|Progressive Disease|30|||
125114257|NCT00275028|450042387|FG000|Overall Study|Physician Decision|2|||
125114258|NCT00720798|450042389|FG000|Overall Study|Adverse Event|304|||
125114259|NCT00720798|450042389|FG000|Overall Study|Death|39|||
125114260|NCT00720798|450042389|FG000|Overall Study|Insufficient Therapeutic Response|129|||
124905147|NCT01194154|449278323|FG000|Overall Study|Did not receive study medication|2|||
124905148|NCT01194154|449278324|FG001|Overall Study|Did not receive study medication|4|||
124905149|NCT01909336|449278325|FG000|Overall Study|Lost to Follow-up|4|||
124905150|NCT01909336|449278326|FG001|Overall Study|Lost to Follow-up|2|||
124905151|NCT01909336|449278327|FG002|Overall Study|Lost to Follow-up|2|||
124905152|NCT01909336|449278325|FG000|Overall Study|Physician Decision|0|||
124905153|NCT01909336|449278326|FG001|Overall Study|Physician Decision|1|||
124905154|NCT01909336|449278327|FG002|Overall Study|Physician Decision|1|||
124905155|NCT01505881|449278328|FG000|Overall Study|Adverse Event|0|||
125114261|NCT00720798|450042389|FG000|Overall Study|Protocol Violation|4|||
124905156|NCT01505881|449278329|FG001|Overall Study|Adverse Event|1|||
125114262|NCT00720798|450042389|FG000|Overall Study|Refused Treatment|151|||
125114263|NCT00720798|450042389|FG000|Overall Study|Failure to Return|46|||
125114264|NCT00720798|450042389|FG000|Overall Study|Reason not Specified|83|||
125114265|NCT00433381|450042390|FG000|Overall Study|Ineligible / no protocol treatment|3|||
124905157|NCT01505881|449278328|FG000|Overall Study|Lost to Follow-up|2|||
124905158|NCT01505881|449278329|FG001|Overall Study|Lost to Follow-up|0|||
124905159|NCT01505881|449278328|FG000|Overall Study|Withdrawal by Subject|2|||
125114266|NCT00433381|450042391|FG001|Overall Study|Ineligible / no protocol treatment|3|||
125114267|NCT00549198|450042396|FG000|Overall Study|Adverse Event|28|||
124905160|NCT01505881|449278329|FG001|Overall Study|Withdrawal by Subject|0|||
124905161|NCT00842257|449278330|FG000|Overall Study|Adverse Event|1|||
124905162|NCT00395018|449278331|FG000|On-Treatment|Death|4|||
124905163|NCT00395018|449278331|FG000|On-Treatment|Other Reason|2|||
124905164|NCT00395018|449278331|FG000|On-Treatment|Poor/non-compliance|2|||
124905165|NCT00395018|449278331|FG000|On-Treatment|Subject no longer meets study criteria|2|||
124905166|NCT00395018|449278331|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
124905167|NCT00395018|449278331|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
124905168|NCT00395018|449278331|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
124905169|NCT02314117|449278332|FG000|Overall Study|Lost to Follow-up|9|||
124905170|NCT02314117|449278333|FG001|Overall Study|Lost to Follow-up|14|||
124905171|NCT02314117|449278332|FG000|Overall Study|Withdrawal by Subject|3|||
124905172|NCT02314117|449278333|FG001|Overall Study|Withdrawal by Subject|2|||
124905173|NCT02026258|449278334|FG000|Randomized|Did not start treatment|2|||
124905174|NCT02026258|449278335|FG001|Randomized|Did not start treatment|1|||
124905175|NCT02026258|449278334|FG000|Randomized|Change in treatment plan|1|||
124905176|NCT02026258|449278335|FG001|Randomized|Change in treatment plan|0|||
124905177|NCT02026258|449278334|FG000|Randomized|Presence of periodontal disease|1|||
124905178|NCT02026258|449278335|FG001|Randomized|Presence of periodontal disease|1|||
124905179|NCT02026258|449278334|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
124905180|NCT02026258|449278335|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
124905181|NCT02026258|449278334|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
124905182|NCT02026258|449278335|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
124905183|NCT04439799|449278336|FG000|Overall Study|Lost to Follow-up|6|||
124905184|NCT04439799|449278337|FG001|Overall Study|Lost to Follow-up|6|||
124905185|NCT04439799|449278336|FG000|Overall Study|Withdrawal by Subject|2|||
124905186|NCT04439799|449278337|FG001|Overall Study|Withdrawal by Subject|6|||
124905187|NCT04439799|449278336|FG000|Overall Study|Adverse Event|2|||
124905188|NCT04439799|449278337|FG001|Overall Study|Adverse Event|5|||
124905189|NCT00530842|449278343|FG000|Overall Study|Adverse Event|10|||
124905190|NCT00530842|449278344|FG001|Overall Study|Adverse Event|6|||
124905191|NCT00530842|449278343|FG000|Overall Study|Lack of Efficacy|2|||
124905192|NCT00530842|449278344|FG001|Overall Study|Lack of Efficacy|1|||
124905193|NCT00530842|449278343|FG000|Overall Study|Lost to Follow-up|0|||
124905194|NCT00530842|449278344|FG001|Overall Study|Lost to Follow-up|4|||
124905195|NCT00530842|449278343|FG000|Overall Study|Protocol Violation|3|||
124905196|NCT00530842|449278344|FG001|Overall Study|Protocol Violation|2|||
124905197|NCT00530842|449278343|FG000|Overall Study|Withdrawal by Subject|4|||
124905198|NCT00530842|449278344|FG001|Overall Study|Withdrawal by Subject|5|||
124905199|NCT00530842|449278343|FG000|Overall Study|Individual different reasons|4|||
124905200|NCT00530842|449278344|FG001|Overall Study|Individual different reasons|3|||
124905201|NCT00530842|449278343|FG000|Period 1|Adverse Event|7|||
124905202|NCT00530842|449278344|FG001|Period 1|Adverse Event|3|||
124905203|NCT00530842|449278343|FG000|Period 1|Lack of Efficacy|1|||
124905204|NCT00530842|449278344|FG001|Period 1|Lack of Efficacy|1|||
124905205|NCT00530842|449278343|FG000|Period 1|Protocol Violation|2|||
124905206|NCT00530842|449278344|FG001|Period 1|Protocol Violation|1|||
124905207|NCT00530842|449278343|FG000|Period 1|Withdrawal by Subject|2|||
124905208|NCT00530842|449278344|FG001|Period 1|Withdrawal by Subject|3|||
124905209|NCT00530842|449278343|FG000|Period 1|Individual different reasons|2|||
124905210|NCT00530842|449278344|FG001|Period 1|Individual different reasons|3|||
124905211|NCT00530842|449278343|FG000|Period 2|Adverse Event|3|||
124905212|NCT00530842|449278344|FG001|Period 2|Adverse Event|3|||
124905213|NCT00530842|449278343|FG000|Period 2|Lack of Efficacy|1|||
124905214|NCT00530842|449278344|FG001|Period 2|Lack of Efficacy|0|||
124905215|NCT00530842|449278343|FG000|Period 2|Lost to Follow-up|0|||
124905216|NCT00530842|449278344|FG001|Period 2|Lost to Follow-up|4|||
124905217|NCT00530842|449278343|FG000|Period 2|Protocol Violation|1|||
124905218|NCT00530842|449278344|FG001|Period 2|Protocol Violation|0|||
124905219|NCT00530842|449278343|FG000|Period 2|Withdrawal by Subject|1|||
124905220|NCT00530842|449278344|FG001|Period 2|Withdrawal by Subject|2|||
124905221|NCT00530842|449278343|FG000|Period 2|Individual different reasons|2|||
124905222|NCT00530842|449278344|FG001|Period 2|Individual different reasons|0|||
124905223|NCT02534350|449278345|FG000|Overall Study|Randomized But Not Treated|1|||
124905224|NCT02534350|449278346|FG001|Overall Study|Randomized But Not Treated|0|||
124905225|NCT02534350|449278345|FG000|Overall Study|Protocol Violation|1|||
124905226|NCT02534350|449278346|FG001|Overall Study|Protocol Violation|0|||
125021614|NCT00430508|449703272|FG001|Overall Study|Adverse Event|3|||
125021615|NCT00430508|449703273|FG002|Overall Study|Adverse Event|5|||
124905227|NCT02534350|449278345|FG000|Overall Study|Withdrew Consent|2|||
124905228|NCT02534350|449278346|FG001|Overall Study|Withdrew Consent|0|||
124905229|NCT00880048|449278355|FG000|Overall Study|Adverse Event|2|||
124905230|NCT00880048|449278356|FG001|Overall Study|Adverse Event|3|||
124905231|NCT00880048|449278357|FG002|Overall Study|Adverse Event|5|||
125021616|NCT00430508|449703274|FG003|Overall Study|Adverse Event|3|||
125021617|NCT00430508|449703271|FG000|Overall Study|Withdrawal by Subject|0|||
125021618|NCT00430508|449703272|FG001|Overall Study|Withdrawal by Subject|1|||
124905232|NCT00880048|449278355|FG000|Overall Study|Lack of Efficacy|1|||
124905233|NCT00880048|449278356|FG001|Overall Study|Lack of Efficacy|2|||
124905234|NCT00880048|449278357|FG002|Overall Study|Lack of Efficacy|2|||
124905235|NCT00880048|449278355|FG000|Overall Study|Protocol Violation|4|||
124905236|NCT00880048|449278356|FG001|Overall Study|Protocol Violation|6|||
124905237|NCT00880048|449278357|FG002|Overall Study|Protocol Violation|5|||
124905238|NCT00880048|449278355|FG000|Overall Study|Lost to Follow-up|6|||
124905239|NCT00880048|449278356|FG001|Overall Study|Lost to Follow-up|6|||
124905240|NCT00880048|449278357|FG002|Overall Study|Lost to Follow-up|5|||
124905241|NCT00880048|449278355|FG000|Overall Study|Physician Decision|1|||
124905242|NCT00880048|449278356|FG001|Overall Study|Physician Decision|1|||
124905243|NCT00880048|449278357|FG002|Overall Study|Physician Decision|7|||
124905244|NCT00880048|449278355|FG000|Overall Study|Withdrawal by Subject|5|||
124905245|NCT00880048|449278356|FG001|Overall Study|Withdrawal by Subject|8|||
124905246|NCT00880048|449278357|FG002|Overall Study|Withdrawal by Subject|5|||
124905247|NCT00880048|449278355|FG000|Overall Study|Study closed/terminated|9|||
124905248|NCT00880048|449278356|FG001|Overall Study|Study closed/terminated|7|||
124905249|NCT00880048|449278357|FG002|Overall Study|Study closed/terminated|6|||
124905250|NCT00346151|449278359|FG000|Overall Study|Withdrawal by Subject|3|||
124905251|NCT00790790|449278367|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
124905252|NCT00790790|449278368|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
124905253|NCT00790790|449278369|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
124905254|NCT00790790|449278367|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
124905255|NCT00790790|449278368|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
124905256|NCT00790790|449278369|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
124905257|NCT00790790|449278367|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
124905258|NCT00790790|449278368|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
124905259|NCT00790790|449278369|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
124905260|NCT00790790|449278367|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
124905261|NCT00790790|449278368|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
124905262|NCT00790790|449278369|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
124905263|NCT00790790|449278367|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
124905264|NCT00790790|449278368|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
124905265|NCT00790790|449278369|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
124905266|NCT02570711|449278372|FG000|Overall Study|Death|1|||
124905267|NCT02570711|449278373|FG001|Overall Study|Death|0|||
124905268|NCT02570711|449278372|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
124905269|NCT02570711|449278373|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
124905270|NCT02798835|449278374|FG000|Overall Study|Protocol Violation|0|||
124905271|NCT02798835|449278375|FG001|Overall Study|Protocol Violation|0|||
124905272|NCT02798835|449278376|FG002|Overall Study|Protocol Violation|3|||
124905273|NCT03070483|449278378|FG000|Overall Study|Lost to Follow-up|2|||
124905274|NCT01585558|449278381|FG000|Overall Study|Withdrawal by Subject|4|||
124905275|NCT01585558|449278382|FG001|Overall Study|Withdrawal by Subject|5|||
124905276|NCT01585558|449278383|FG002|Overall Study|Withdrawal by Subject|8|||
124905277|NCT01585558|449278381|FG000|Overall Study|Lost to Follow-up|2|||
124905278|NCT01585558|449278382|FG001|Overall Study|Lost to Follow-up|0|||
124905279|NCT01585558|449278383|FG002|Overall Study|Lost to Follow-up|3|||
124905280|NCT01585558|449278381|FG000|Overall Study|Adverse Event|3|||
124905281|NCT01585558|449278382|FG001|Overall Study|Adverse Event|4|||
124905282|NCT01585558|449278383|FG002|Overall Study|Adverse Event|1|||
124905283|NCT01585558|449278381|FG000|Overall Study|Protocol Violation|4|||
124905284|NCT01585558|449278382|FG001|Overall Study|Protocol Violation|3|||
124905285|NCT01585558|449278383|FG002|Overall Study|Protocol Violation|2|||
124905286|NCT01585558|449278381|FG000|Overall Study|Lack of Efficacy|0|||
124905287|NCT01585558|449278382|FG001|Overall Study|Lack of Efficacy|0|||
124905288|NCT01585558|449278383|FG002|Overall Study|Lack of Efficacy|1|||
124905289|NCT00094575|449278389|FG000|Overall Study|Death|146|||
124905290|NCT00094575|449278390|FG001|Overall Study|Death|146|||
124905291|NCT01390402|449278391|FG000|Overall Study|Death|1|||
124905292|NCT01390402|449278391|FG000|Overall Study|Disease Progression|4|||
124905293|NCT00430300|449278392|FG000|Overall Study|Adverse Event|0|||
124905294|NCT00430300|449278393|FG001|Overall Study|Adverse Event|2|||
124905295|NCT00430300|449278394|FG002|Overall Study|Adverse Event|1|||
125114268|NCT00549198|450042397|FG001|Overall Study|Adverse Event|26|||
125114269|NCT00549198|450042396|FG000|Overall Study|Insufficient Viral Load Response|4|||
125114270|NCT00549198|450042397|FG001|Overall Study|Insufficient Viral Load Response|2|||
125114271|NCT00549198|450042396|FG000|Overall Study|Protocol-defined Virological Failure|7|||
125114272|NCT00549198|450042397|FG001|Overall Study|Protocol-defined Virological Failure|0|||
125114273|NCT00549198|450042396|FG000|Overall Study|Non-compliance|2|||
125114274|NCT00549198|450042397|FG001|Overall Study|Non-compliance|4|||
125114275|NCT00549198|450042396|FG000|Overall Study|Lost to Follow-up|7|||
125114276|NCT00549198|450042397|FG001|Overall Study|Lost to Follow-up|8|||
125114277|NCT00549198|450042396|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
125114278|NCT00549198|450042397|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
124905296|NCT00430300|449278395|FG003|Overall Study|Adverse Event|1|||
124905297|NCT00430300|449278392|FG000|Overall Study|Withdrawal by Subject|1|||
124905298|NCT00430300|449278393|FG001|Overall Study|Withdrawal by Subject|0|||
124905299|NCT00430300|449278394|FG002|Overall Study|Withdrawal by Subject|5|||
124905300|NCT00430300|449278395|FG003|Overall Study|Withdrawal by Subject|0|||
124905301|NCT00430300|449278392|FG000|Overall Study|Laboratory abnormality|1|||
124905302|NCT00430300|449278393|FG001|Overall Study|Laboratory abnormality|0|||
124905303|NCT00430300|449278394|FG002|Overall Study|Laboratory abnormality|0|||
124905304|NCT00430300|449278395|FG003|Overall Study|Laboratory abnormality|0|||
124905305|NCT00430300|449278392|FG000|Overall Study|Other|0|||
124905306|NCT00430300|449278393|FG001|Overall Study|Other|0|||
124905307|NCT00430300|449278394|FG002|Overall Study|Other|0|||
124905308|NCT00430300|449278395|FG003|Overall Study|Other|1|||
124905309|NCT02754479|449278396|FG000|Overall Study|Lost to Follow-up|1|||
124905310|NCT00617201|449278399|FG000|Overall Study|Lost to Follow-up|9|||
124905311|NCT00617201|449278400|FG001|Overall Study|Lost to Follow-up|13|||
124905312|NCT00546871|449278401|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
124905313|NCT00546871|449278402|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
124905314|NCT00546871|449278401|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
124905315|NCT00546871|449278402|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
124905316|NCT00546871|449278401|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
124905317|NCT00546871|449278402|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
124905318|NCT00546871|449278401|FG000|Study Extension Period|Protocol Violation|1|||
124905319|NCT00546871|449278402|FG001|Study Extension Period|Protocol Violation|0|||
124905320|NCT00546871|449278401|FG000|Study Extension Period|Withdrawal by Subject|0|||
124905321|NCT00546871|449278402|FG001|Study Extension Period|Withdrawal by Subject|1|||
124905322|NCT03183518|449278403|FG000|Overall Study|Other (Not specified)|2|||
124905323|NCT03183518|449278403|FG000|Overall Study|Other (Withdrawal of consent)|1|||
124905324|NCT02299336|449278404|FG000|Overall Study|Withdrawal by Subject|11|||
124905325|NCT02299336|449278404|FG000|Overall Study|Adverse Event|1|||
124905326|NCT02299336|449278404|FG000|Overall Study|Death|1|||
124905327|NCT02299336|449278404|FG000|Overall Study|Lost to Follow-up|1|||
124905328|NCT02106442|449278406|FG000|Overall Study|Case Report Forms Uncollected|7|||
124905329|NCT02106442|449278406|FG000|Overall Study|Protocol Deviation|30|||
124905330|NCT04513522|449281041|FG000|Overall Study|Other reasons|1|||
125021619|NCT00430508|449703273|FG002|Overall Study|Withdrawal by Subject|1|||
125021620|NCT00430508|449703274|FG003|Overall Study|Withdrawal by Subject|1|||
125021621|NCT00430508|449703271|FG000|Overall Study|responder at visit 4|0|||
125021622|NCT00430508|449703272|FG001|Overall Study|responder at visit 4|0|||
125021623|NCT00430508|449703273|FG002|Overall Study|responder at visit 4|2|||
125021624|NCT00430508|449703274|FG003|Overall Study|responder at visit 4|0|||
125021625|NCT00430508|449703271|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
125021626|NCT00430508|449703272|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
125021627|NCT00430508|449703273|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
125021628|NCT00430508|449703274|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
125021629|NCT00430508|449703271|FG000|Overall Study|Other|1|||
125021630|NCT00430508|449703272|FG001|Overall Study|Other|1|||
125021631|NCT00430508|449703273|FG002|Overall Study|Other|3|||
125021632|NCT00430508|449703274|FG003|Overall Study|Other|0|||
125021633|NCT03728309|449703278|FG000|Overall Study|Randomized but not Treated|0|||
125021634|NCT03728309|449703279|FG001|Overall Study|Randomized but not Treated|1|||
125021635|NCT03728309|449703278|FG000|Overall Study|Adverse Event|0|||
125021636|NCT03728309|449703279|FG001|Overall Study|Adverse Event|1|||
125021637|NCT03728309|449703278|FG000|Overall Study|Withdrawal by Subject|2|||
125021638|NCT03728309|449703279|FG001|Overall Study|Withdrawal by Subject|8|||
125021639|NCT03728309|449703278|FG000|Overall Study|Lost to Follow-up|9|||
125021640|NCT03728309|449703279|FG001|Overall Study|Lost to Follow-up|10|||
125021641|NCT03728309|449703278|FG000|Overall Study|Protocol Deviation|0|||
125021642|NCT03728309|449703279|FG001|Overall Study|Protocol Deviation|1|||
125021643|NCT03728309|449703278|FG000|Overall Study|Due to COVID|1|||
125021644|NCT03728309|449703279|FG001|Overall Study|Due to COVID|3|||
125021645|NCT00953758|449703280|FG000|Overall Study|Death|2|||
125021646|NCT00953758|449703281|FG001|Overall Study|Death|0|||
125021647|NCT00953758|449703282|FG002|Overall Study|Death|1|||
125021648|NCT00953758|449703283|FG003|Overall Study|Death|1|||
125021649|NCT00953758|449703284|FG004|Overall Study|Death|1|||
125021650|NCT00953758|449703285|FG005|Overall Study|Death|1|||
124905331|NCT04513522|449281041|FG000|Overall Study|Adverse event unrelated to study drug|9|||
124905332|NCT04513522|449281041|FG000|Overall Study|Study drug toxicity|14|||
124905333|NCT04513522|449281041|FG000|Overall Study|Disease progression|39|||
125021651|NCT00953758|449703286|FG006|Overall Study|Death|1|||
125211036|NCT00508157|450396761|FG000|Overall Study|Subject Withdrew Consent|1|||
124905334|NCT04513522|449281041|FG000|Overall Study|Participants withdrew consent|2|||
124905335|NCT00589667|449281044|FG000|Overall Study|Adverse Event|2|||
124905336|NCT00589667|449281044|FG000|Overall Study|Withdrawal by Subject|1|||
124905337|NCT03538041|449281045|FG000|12-Week Treatment Period|Adverse Event|1|||
124905338|NCT03538041|449281046|FG001|12-Week Treatment Period|Adverse Event|1|||
124905339|NCT03538041|449281045|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
124905340|NCT03538041|449281046|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
124905341|NCT03538041|449281045|FG000|Treatment Extension Period|Adverse Event|4|||
124905342|NCT03538041|449281046|FG001|Treatment Extension Period|Adverse Event|1|||
125021652|NCT00953758|449703287|FG007|Overall Study|Death|3|||
125021653|NCT00953758|449703288|FG008|Overall Study|Death|1|||
125021654|NCT00953758|449703289|FG009|Overall Study|Death|0|||
125021655|NCT00953758|449703280|FG000|Overall Study|Participant refused further follow-up|0|||
125021656|NCT00953758|449703281|FG001|Overall Study|Participant refused further follow-up|0|||
125021657|NCT00953758|449703282|FG002|Overall Study|Participant refused further follow-up|1|||
125021658|NCT00953758|449703283|FG003|Overall Study|Participant refused further follow-up|0|||
125021659|NCT00953758|449703284|FG004|Overall Study|Participant refused further follow-up|3|||
125021660|NCT00953758|449703285|FG005|Overall Study|Participant refused further follow-up|0|||
125021661|NCT00953758|449703286|FG006|Overall Study|Participant refused further follow-up|0|||
125021662|NCT00953758|449703287|FG007|Overall Study|Participant refused further follow-up|0|||
125021663|NCT00953758|449703288|FG008|Overall Study|Participant refused further follow-up|1|||
125021664|NCT00953758|449703289|FG009|Overall Study|Participant refused further follow-up|0|||
125021665|NCT00953758|449703280|FG000|Overall Study|Lost to Follow-up|0|||
125021666|NCT00953758|449703281|FG001|Overall Study|Lost to Follow-up|0|||
125021667|NCT00953758|449703282|FG002|Overall Study|Lost to Follow-up|0|||
125021668|NCT00953758|449703283|FG003|Overall Study|Lost to Follow-up|1|||
125021669|NCT00953758|449703284|FG004|Overall Study|Lost to Follow-up|0|||
125021670|NCT00953758|449703285|FG005|Overall Study|Lost to Follow-up|0|||
125021671|NCT00953758|449703286|FG006|Overall Study|Lost to Follow-up|0|||
125021672|NCT00953758|449703287|FG007|Overall Study|Lost to Follow-up|1|||
125021673|NCT00953758|449703288|FG008|Overall Study|Lost to Follow-up|0|||
125021674|NCT00953758|449703289|FG009|Overall Study|Lost to Follow-up|1|||
125021675|NCT00953758|449703280|FG000|Overall Study|Physician Decision|0|||
125021676|NCT00953758|449703281|FG001|Overall Study|Physician Decision|0|||
125021677|NCT00953758|449703282|FG002|Overall Study|Physician Decision|0|||
125021678|NCT00953758|449703283|FG003|Overall Study|Physician Decision|0|||
125021679|NCT00953758|449703284|FG004|Overall Study|Physician Decision|1|||
125021680|NCT00953758|449703285|FG005|Overall Study|Physician Decision|0|||
125021681|NCT00953758|449703286|FG006|Overall Study|Physician Decision|0|||
125021682|NCT00953758|449703287|FG007|Overall Study|Physician Decision|0|||
125021683|NCT00953758|449703288|FG008|Overall Study|Physician Decision|0|||
125021684|NCT00953758|449703289|FG009|Overall Study|Physician Decision|0|||
125021685|NCT00953758|449703280|FG000|Overall Study|Disease progression|0|||
125021686|NCT00953758|449703281|FG001|Overall Study|Disease progression|0|||
125021687|NCT00953758|449703282|FG002|Overall Study|Disease progression|0|||
125021688|NCT00953758|449703283|FG003|Overall Study|Disease progression|0|||
125021689|NCT00953758|449703284|FG004|Overall Study|Disease progression|1|||
125021690|NCT00953758|449703285|FG005|Overall Study|Disease progression|0|||
125021691|NCT00953758|449703286|FG006|Overall Study|Disease progression|0|||
125021692|NCT00953758|449703287|FG007|Overall Study|Disease progression|0|||
125021693|NCT00953758|449703288|FG008|Overall Study|Disease progression|0|||
125021694|NCT00953758|449703289|FG009|Overall Study|Disease progression|0|||
125021695|NCT00953758|449703280|FG000|Overall Study|Participant went for transplant|0|||
125021696|NCT00953758|449703281|FG001|Overall Study|Participant went for transplant|0|||
125021697|NCT00953758|449703282|FG002|Overall Study|Participant went for transplant|0|||
125021698|NCT00953758|449703283|FG003|Overall Study|Participant went for transplant|0|||
125021699|NCT00953758|449703284|FG004|Overall Study|Participant went for transplant|0|||
125021700|NCT00953758|449703285|FG005|Overall Study|Participant went for transplant|0|||
125021701|NCT00953758|449703286|FG006|Overall Study|Participant went for transplant|0|||
125021702|NCT00953758|449703287|FG007|Overall Study|Participant went for transplant|0|||
125021703|NCT00953758|449703288|FG008|Overall Study|Participant went for transplant|1|||
125021704|NCT00953758|449703289|FG009|Overall Study|Participant went for transplant|0|||
125021705|NCT01164722|449703290|FG000|Overall Study|Adverse Event|0|||
125021706|NCT01164722|449703291|FG001|Overall Study|Adverse Event|1|||
125021707|NCT01164722|449703290|FG000|Overall Study|Withdrawal by Subject|3|||
124905343|NCT03538041|449281045|FG000|Treatment Extension Period|Physician Decision|1|||
125021708|NCT01164722|449703291|FG001|Overall Study|Withdrawal by Subject|4|||
125021709|NCT01164722|449703290|FG000|Overall Study|Lost to Follow-up|3|||
125021710|NCT01164722|449703291|FG001|Overall Study|Lost to Follow-up|6|||
124905344|NCT03538041|449281046|FG001|Treatment Extension Period|Physician Decision|1|||
125021711|NCT01164722|449703290|FG000|Overall Study|met protocol criteria for non-treatment|11|||
125021712|NCT01164722|449703291|FG001|Overall Study|met protocol criteria for non-treatment|1|||
125021713|NCT01164722|449703290|FG000|Overall Study|enrolled on other study, concomitant med|1|||
125021714|NCT01164722|449703291|FG001|Overall Study|enrolled on other study, concomitant med|3|||
125021715|NCT00999908|449703292|FG000|Treatment Period 1|Subject withdrew consent|2|||
125211037|NCT00508157|450396762|FG001|Overall Study|Subject Withdrew Consent|0|||
125211038|NCT00508157|450396761|FG000|Overall Study|Lost to Follow-up|1|||
125211039|NCT00508157|450396762|FG001|Overall Study|Lost to Follow-up|0|||
125211040|NCT00508157|450396761|FG000|Overall Study|Subject no longer met study criteria|0|||
125021716|NCT00999908|449703293|FG001|Treatment Period 1|Subject withdrew consent|0|||
125021717|NCT00999908|449703294|FG002|Treatment Period 1|Subject withdrew consent|0|||
125021718|NCT00999908|449703292|FG000|Treatment Period 2|Protocol Violation|1|||
125021719|NCT00999908|449703293|FG001|Treatment Period 2|Protocol Violation|0|||
125021720|NCT00999908|449703294|FG002|Treatment Period 2|Protocol Violation|0|||
125021721|NCT01703858|449703297|FG000|Overall Study|Withdrawal by Subject|0|||
125021722|NCT01703858|449703298|FG001|Overall Study|Withdrawal by Subject|1|||
125021723|NCT01703858|449703299|FG002|Overall Study|Withdrawal by Subject|0|||
125021724|NCT01290692|449703301|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
125021725|NCT02556255|449703302|FG000|Overall Study|Lost to Follow-up|4|||
125021726|NCT00993031|449703306|FG000|Overall Study|Death|0|||
125021727|NCT00993031|449703307|FG001|Overall Study|Death|1|||
125021728|NCT00993031|449703306|FG000|Overall Study|Physician Decision|0|||
125021729|NCT00993031|449703307|FG001|Overall Study|Physician Decision|2|||
125021730|NCT00993031|449703306|FG000|Overall Study|Withdrawal by Subject|3|||
125021731|NCT00993031|449703307|FG001|Overall Study|Withdrawal by Subject|3|||
125021732|NCT00993031|449703306|FG000|Overall Study|Lost to Follow-up|19|||
125021733|NCT00993031|449703307|FG001|Overall Study|Lost to Follow-up|13|||
125021734|NCT03115151|449703308|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
125021735|NCT03115151|449703309|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
125021736|NCT03115151|449703308|FG000|Overall Study|Epidural catheter removal|1|||
125021737|NCT03115151|449703309|FG001|Overall Study|Epidural catheter removal|0|||
125021738|NCT03115151|449703308|FG000|Overall Study|Withdrawal by Subject|0|||
125021739|NCT03115151|449703309|FG001|Overall Study|Withdrawal by Subject|1|||
125021740|NCT03115151|449703308|FG000|Overall Study|Intervention not received according to the protocol.|1|||
125021741|NCT03115151|449703309|FG001|Overall Study|Intervention not received according to the protocol.|1|||
125021742|NCT03115151|449703308|FG000|Overall Study|Physician Decision|1|||
125021743|NCT03115151|449703309|FG001|Overall Study|Physician Decision|0|||
125021744|NCT03115151|449703308|FG000|Overall Study|Randomization not applied|1|||
125021745|NCT03115151|449703309|FG001|Overall Study|Randomization not applied|1|||
125021746|NCT01543087|449703314|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
125021747|NCT01543087|449703315|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
125021748|NCT01543087|449703316|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
125021749|NCT01543087|449703317|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
125021750|NCT01543087|449703318|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
125021751|NCT01543087|449703319|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
125021752|NCT01543087|449703314|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
125021753|NCT01543087|449703315|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
125021754|NCT01543087|449703316|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
125021755|NCT01543087|449703317|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
125021756|NCT01543087|449703318|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
125021757|NCT01543087|449703319|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
125021758|NCT01543087|449703314|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
125021759|NCT01543087|449703315|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
125021760|NCT01543087|449703316|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
125021761|NCT01543087|449703317|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
125021762|NCT01543087|449703318|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
125021763|NCT01543087|449703319|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
125021764|NCT01543087|449703314|FG000|Stage 1 (48 Months)|Other than specified|5|||
125021765|NCT01543087|449703315|FG001|Stage 1 (48 Months)|Other than specified|0|||
125021766|NCT01543087|449703316|FG002|Stage 1 (48 Months)|Other than specified|9|||
125021767|NCT01543087|449703317|FG003|Stage 1 (48 Months)|Other than specified|0|||
125021768|NCT01543087|449703318|FG004|Stage 1 (48 Months)|Other than specified|0|||
125021769|NCT01543087|449703319|FG005|Stage 1 (48 Months)|Other than specified|0|||
125021770|NCT01543087|449703314|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
125021771|NCT01543087|449703315|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
125021772|NCT01543087|449703316|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
125021773|NCT01543087|449703317|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
125021774|NCT01543087|449703318|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
125021775|NCT01543087|449703319|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
125021776|NCT01543087|449703314|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
125021777|NCT01543087|449703315|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
125021778|NCT01543087|449703316|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
125021779|NCT01543087|449703317|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
125021780|NCT01543087|449703318|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
125021781|NCT01543087|449703319|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
125021782|NCT01543087|449703314|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
124905345|NCT03538041|449281045|FG000|Treatment Extension Period|Lack of Efficacy|1|||
124905346|NCT03538041|449281046|FG001|Treatment Extension Period|Lack of Efficacy|4|||
124905347|NCT03538041|449281045|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
124905348|NCT03538041|449281046|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
124905349|NCT03538041|449281045|FG000|Treatment Extension Period|Death|0|||
124905350|NCT03538041|449281046|FG001|Treatment Extension Period|Death|1|||
124905351|NCT00743444|449281049|FG000|First Intervention|Catheter placement problems|0|||
125114279|NCT00549198|450042396|FG000|Overall Study|Protocol Violation|7|||
125114280|NCT00549198|450042397|FG001|Overall Study|Protocol Violation|2|||
125114281|NCT00549198|450042396|FG000|Overall Study|Investigator Decision|4|||
125114282|NCT00549198|450042397|FG001|Overall Study|Investigator Decision|3|||
125114283|NCT00549198|450042396|FG000|Overall Study|Withdrawal by Subject|7|||
125114284|NCT00549198|450042397|FG001|Overall Study|Withdrawal by Subject|7|||
125114285|NCT00549198|450042396|FG000|Overall Study|Disease Progression|1|||
125114286|NCT00549198|450042397|FG001|Overall Study|Disease Progression|0|||
125114287|NCT00549198|450042396|FG000|Overall Study|Participant Moved|2|||
125114288|NCT00549198|450042397|FG001|Overall Study|Participant Moved|0|||
125114289|NCT00549198|450042396|FG000|Overall Study|Participant not able to perform Week 96|1|||
125114290|NCT00549198|450042397|FG001|Overall Study|Participant not able to perform Week 96|0|||
125114291|NCT00549198|450042396|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
125114292|NCT00549198|450042397|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
125114293|NCT00549198|450042396|FG000|Overall Study|Prohibited Medication|1|||
125114294|NCT00549198|450042397|FG001|Overall Study|Prohibited Medication|2|||
125114295|NCT00549198|450042396|FG000|Overall Study|Participant planning pregnancy|1|||
125114296|NCT00549198|450042397|FG001|Overall Study|Participant planning pregnancy|0|||
125114297|NCT00549198|450042396|FG000|Overall Study|Participant overweight, no scan possible|1|||
125114298|NCT00549198|450042397|FG001|Overall Study|Participant overweight, no scan possible|0|||
125114299|NCT00549198|450042396|FG000|Overall Study|No scan facilities|0|||
125114300|NCT00549198|450042397|FG001|Overall Study|No scan facilities|2|||
125114301|NCT00549198|450042396|FG000|Overall Study|Pregnancy|0|||
125114302|NCT00549198|450042397|FG001|Overall Study|Pregnancy|3|||
125114303|NCT00549198|450042396|FG000|Overall Study|Not Exposed to Study Drug|3|||
125114304|NCT00549198|450042397|FG001|Overall Study|Not Exposed to Study Drug|4|||
125114305|NCT00472446|450042398|FG000|Overall Study|Protocol Violation|0|||
125114306|NCT00472446|450042399|FG001|Overall Study|Protocol Violation|0|||
125114307|NCT00472446|450042400|FG002|Overall Study|Protocol Violation|0|||
125114308|NCT00472446|450042401|FG003|Overall Study|Protocol Violation|1|||
125114309|NCT00472446|450042398|FG000|Overall Study|Reintervention|0|||
125114310|NCT00472446|450042399|FG001|Overall Study|Reintervention|0|||
125114311|NCT00472446|450042400|FG002|Overall Study|Reintervention|1|||
125114312|NCT00472446|450042401|FG003|Overall Study|Reintervention|1|||
125114313|NCT00472446|450042398|FG000|Overall Study|Questionnaires not returned|5|||
125114314|NCT00472446|450042399|FG001|Overall Study|Questionnaires not returned|6|||
125114315|NCT00472446|450042400|FG002|Overall Study|Questionnaires not returned|6|||
125114316|NCT00472446|450042401|FG003|Overall Study|Questionnaires not returned|4|||
125114317|NCT01165684|450042402|FG000|Overall Study|Adverse Event|1|||
125114318|NCT01165684|450042403|FG001|Overall Study|Adverse Event|1|||
125114319|NCT01165684|450042402|FG000|Overall Study|Lack of Efficacy|2|||
125114320|NCT01165684|450042403|FG001|Overall Study|Lack of Efficacy|1|||
125114321|NCT01165684|450042402|FG000|Overall Study|Protocol Violation|7|||
125114322|NCT01165684|450042403|FG001|Overall Study|Protocol Violation|15|||
125114323|NCT01165684|450042402|FG000|Overall Study|Withdrawal Criteria|2|||
125114324|NCT01165684|450042403|FG001|Overall Study|Withdrawal Criteria|13|||
125114325|NCT01165684|450042402|FG000|Overall Study|Unclassified|16|||
125114326|NCT01165684|450042403|FG001|Overall Study|Unclassified|22|||
125114327|NCT00671879|450042404|FG000|Overall Study|Withdrawal by Subject|0|||
125114328|NCT00671879|450042405|FG001|Overall Study|Withdrawal by Subject|4|||
125114329|NCT00671879|450042406|FG002|Overall Study|Withdrawal by Subject|6|||
125114330|NCT04633837|450042409|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
125114331|NCT04633837|450042410|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
125114332|NCT00901628|450042411|FG000|Overall Study|disconnection of catheter|4|||
125114333|NCT00901628|450042412|FG001|Overall Study|disconnection of catheter|8|||
125114334|NCT00901628|450042411|FG000|Overall Study|disconnection of drain|0|||
125114335|NCT00901628|450042412|FG001|Overall Study|disconnection of drain|1|||
125114336|NCT00901628|450042411|FG000|Overall Study|peroneal nerve palsy|0|||
125114337|NCT00901628|450042412|FG001|Overall Study|peroneal nerve palsy|1|||
125114338|NCT00608205|450042415|FG000|Overall Study|Adverse Event|3|||
125114339|NCT00608205|450042416|FG001|Overall Study|Adverse Event|2|||
125114340|NCT00608205|450042415|FG000|Overall Study|Patient non-compliant|0|||
125114341|NCT00608205|450042416|FG001|Overall Study|Patient non-compliant|1|||
125114342|NCT01797120|450042417|FG000|Overall Study|Disesae progression|37|||
125114343|NCT01797120|450042418|FG001|Overall Study|Disesae progression|49|||
125114344|NCT01797120|450042417|FG000|Overall Study|Adverse Event|13|||
125114345|NCT01797120|450042418|FG001|Overall Study|Adverse Event|5|||
125114346|NCT01797120|450042417|FG000|Overall Study|Withdrawal by Subject|6|||
124905352|NCT00743444|449281050|FG001|First Intervention|Catheter placement problems|1|||
124905353|NCT00743444|449281049|FG000|Washout Period|Adverse Event|0|||
124905354|NCT00743444|449281050|FG001|Washout Period|Adverse Event|1|||
124905355|NCT00807144|449281053|FG000|Overall Study|Lost to Follow-up|0|||
124905356|NCT00807144|449281054|FG001|Overall Study|Lost to Follow-up|1|||
124905357|NCT01307267|449281055|FG000|Overall Study|Death|4|||
124905358|NCT01307267|449281056|FG001|Overall Study|Death|3|||
125114347|NCT01797120|450042418|FG001|Overall Study|Withdrawal by Subject|6|||
125114348|NCT01797120|450042417|FG000|Overall Study|Symptomatic progression|2|||
125114349|NCT01797120|450042418|FG001|Overall Study|Symptomatic progression|1|||
125114350|NCT01797120|450042417|FG000|Overall Study|Non-compliance|1|||
125114351|NCT01797120|450042418|FG001|Overall Study|Non-compliance|0|||
125114352|NCT01797120|450042417|FG000|Overall Study|Physician Decision|3|||
125114353|NCT01797120|450042418|FG001|Overall Study|Physician Decision|0|||
125114354|NCT01797120|450042417|FG000|Overall Study|still on treatment|2|||
125114355|NCT01797120|450042418|FG001|Overall Study|still on treatment|4|||
125114356|NCT01797120|450042417|FG000|Overall Study|never start protocol therapy|2|||
125114357|NCT01797120|450042418|FG001|Overall Study|never start protocol therapy|0|||
125114358|NCT01909466|450042424|FG000|Overall Study|Lost to Follow-up|5|||
125114359|NCT01909466|450042425|FG001|Overall Study|Lost to Follow-up|7|||
125114360|NCT01909466|450042424|FG000|Overall Study|Adverse Event|3|||
125114361|NCT01909466|450042425|FG001|Overall Study|Adverse Event|4|||
125114362|NCT01909466|450042424|FG000|Overall Study|Met Withdrawal Criteria|0|||
125114363|NCT01909466|450042425|FG001|Overall Study|Met Withdrawal Criteria|3|||
125114364|NCT01909466|450042424|FG000|Overall Study|Physician Decision|2|||
125114365|NCT01909466|450042425|FG001|Overall Study|Physician Decision|0|||
125114366|NCT01909466|450042424|FG000|Overall Study|Withdrawal by Subject|11|||
125114367|NCT01909466|450042425|FG001|Overall Study|Withdrawal by Subject|9|||
125114368|NCT01909466|450042424|FG000|Overall Study|Lack of Efficacy|1|||
125114369|NCT01909466|450042425|FG001|Overall Study|Lack of Efficacy|0|||
125114370|NCT01339910|450042426|FG000|Overall Study|Withdrawal by Subject|1|||
125114371|NCT01339910|450042427|FG001|Overall Study|Withdrawal by Subject|0|||
125114372|NCT01339910|450042426|FG000|Overall Study|Physician Decision|1|||
125114373|NCT01339910|450042427|FG001|Overall Study|Physician Decision|0|||
125114374|NCT01339910|450042426|FG000|Overall Study|Disease relapse|1|||
125114375|NCT01339910|450042427|FG001|Overall Study|Disease relapse|4|||
125114376|NCT01567306|450042429|FG000|Overall Study|Protocol Violation|2|||
125114377|NCT01567306|450042430|FG001|Overall Study|Protocol Violation|2|||
125114378|NCT01567306|450042431|FG002|Overall Study|Protocol Violation|0|||
125114379|NCT01567306|450042432|FG003|Overall Study|Protocol Violation|3|||
125114380|NCT01567306|450042433|FG004|Overall Study|Protocol Violation|1|||
125114381|NCT01567306|450042434|FG005|Overall Study|Protocol Violation|1|||
125114382|NCT01567306|450042429|FG000|Overall Study|Change site living|1|||
125114383|NCT01567306|450042430|FG001|Overall Study|Change site living|0|||
125114384|NCT01567306|450042431|FG002|Overall Study|Change site living|0|||
125114385|NCT01567306|450042432|FG003|Overall Study|Change site living|0|||
125114386|NCT01567306|450042433|FG004|Overall Study|Change site living|0|||
125114387|NCT01567306|450042434|FG005|Overall Study|Change site living|0|||
125114388|NCT01567306|450042429|FG000|Overall Study|Adverse Event|0|||
125114389|NCT01567306|450042430|FG001|Overall Study|Adverse Event|0|||
125114390|NCT01567306|450042431|FG002|Overall Study|Adverse Event|0|||
124905359|NCT01307267|449281057|FG002|Overall Study|Death|5|||
124905360|NCT01307267|449281058|FG003|Overall Study|Death|3|||
124905361|NCT01307267|449281059|FG004|Overall Study|Death|1|||
124905362|NCT01307267|449281060|FG005|Overall Study|Death|26|||
124905363|NCT01307267|449281061|FG006|Overall Study|Death|2|||
124905364|NCT01307267|449281062|FG007|Overall Study|Death|2|||
124905365|NCT01307267|449281063|FG008|Overall Study|Death|21|||
124905366|NCT01307267|449281064|FG009|Overall Study|Death|2|||
124905367|NCT01307267|449281065|FG010|Overall Study|Death|3|||
124905368|NCT01307267|449281066|FG011|Overall Study|Death|9|||
125114391|NCT01567306|450042432|FG003|Overall Study|Adverse Event|2|||
125114392|NCT01567306|450042433|FG004|Overall Study|Adverse Event|4|||
125114393|NCT01567306|450042434|FG005|Overall Study|Adverse Event|1|||
125114394|NCT01567306|450042429|FG000|Overall Study|Lost to Follow-up|0|||
125114395|NCT01567306|450042430|FG001|Overall Study|Lost to Follow-up|0|||
125114396|NCT01567306|450042431|FG002|Overall Study|Lost to Follow-up|0|||
125114397|NCT01567306|450042432|FG003|Overall Study|Lost to Follow-up|0|||
125114398|NCT01567306|450042433|FG004|Overall Study|Lost to Follow-up|2|||
125114399|NCT01567306|450042434|FG005|Overall Study|Lost to Follow-up|0|||
125114400|NCT01567306|450042429|FG000|Overall Study|Withdrawal by Subject|0|||
125114401|NCT01567306|450042430|FG001|Overall Study|Withdrawal by Subject|0|||
125114402|NCT01567306|450042431|FG002|Overall Study|Withdrawal by Subject|0|||
124905369|NCT01307267|449281067|FG012|Overall Study|Death|0|||
124905370|NCT01307267|449281068|FG013|Overall Study|Death|0|||
125114403|NCT01567306|450042432|FG003|Overall Study|Withdrawal by Subject|0|||
125114404|NCT01567306|450042433|FG004|Overall Study|Withdrawal by Subject|0|||
124905371|NCT01307267|449281069|FG014|Overall Study|Death|0|||
124905372|NCT01307267|449281070|FG015|Overall Study|Death|0|||
125114405|NCT01567306|450042434|FG005|Overall Study|Withdrawal by Subject|1|||
124905373|NCT01307267|449281071|FG016|Overall Study|Death|1|||
125114406|NCT00738673|450042435|FG000|Overall Study|Adverse Event|1|||
124905374|NCT01307267|449281072|FG017|Overall Study|Death|1|||
124905375|NCT01307267|449281073|FG018|Overall Study|Death|2|||
124905376|NCT01307267|449281074|FG019|Overall Study|Death|8|||
124905377|NCT01307267|449281075|FG020|Overall Study|Death|1|||
124905378|NCT01307267|449281076|FG021|Overall Study|Death|2|||
124905379|NCT01307267|449281077|FG022|Overall Study|Death|2|||
124905380|NCT01307267|449281055|FG000|Overall Study|Lost to Follow-up|0|||
124905381|NCT01307267|449281056|FG001|Overall Study|Lost to Follow-up|0|||
124905382|NCT01307267|449281057|FG002|Overall Study|Lost to Follow-up|0|||
124905383|NCT01307267|449281058|FG003|Overall Study|Lost to Follow-up|0|||
124905384|NCT01307267|449281059|FG004|Overall Study|Lost to Follow-up|0|||
124905385|NCT01307267|449281060|FG005|Overall Study|Lost to Follow-up|7|||
124905386|NCT01307267|449281061|FG006|Overall Study|Lost to Follow-up|0|||
124905387|NCT01307267|449281062|FG007|Overall Study|Lost to Follow-up|0|||
124905388|NCT01307267|449281063|FG008|Overall Study|Lost to Follow-up|1|||
124905389|NCT01307267|449281064|FG009|Overall Study|Lost to Follow-up|2|||
124905390|NCT01307267|449281065|FG010|Overall Study|Lost to Follow-up|1|||
124905391|NCT01307267|449281066|FG011|Overall Study|Lost to Follow-up|0|||
124905392|NCT01307267|449281067|FG012|Overall Study|Lost to Follow-up|0|||
124905393|NCT01307267|449281068|FG013|Overall Study|Lost to Follow-up|0|||
124905394|NCT01307267|449281069|FG014|Overall Study|Lost to Follow-up|0|||
124905395|NCT01307267|449281070|FG015|Overall Study|Lost to Follow-up|0|||
124905396|NCT01307267|449281071|FG016|Overall Study|Lost to Follow-up|0|||
124905397|NCT01307267|449281072|FG017|Overall Study|Lost to Follow-up|0|||
124905398|NCT01307267|449281073|FG018|Overall Study|Lost to Follow-up|0|||
125114407|NCT00738673|450042436|FG001|Overall Study|Adverse Event|0|||
125114408|NCT00738673|450042435|FG000|Overall Study|Lack of Efficacy|19|||
125114409|NCT00738673|450042436|FG001|Overall Study|Lack of Efficacy|8|||
125114410|NCT00738673|450042435|FG000|Overall Study|Protocol Violation|1|||
125114411|NCT00738673|450042436|FG001|Overall Study|Protocol Violation|2|||
125114412|NCT00738673|450042435|FG000|Overall Study|Withdrawal by Subject|3|||
125114413|NCT00738673|450042436|FG001|Overall Study|Withdrawal by Subject|1|||
125114414|NCT03038113|450042437|FG000|Overall Study|Withdrawal by Subject|0|||
125114415|NCT03038113|450042438|FG001|Overall Study|Withdrawal by Subject|0|||
125114416|NCT03038113|450042439|FG002|Overall Study|Withdrawal by Subject|1|||
125114417|NCT03038113|450042440|FG003|Overall Study|Withdrawal by Subject|0|||
125114418|NCT03038113|450042441|FG004|Overall Study|Withdrawal by Subject|0|||
125114419|NCT03038113|450042442|FG005|Overall Study|Withdrawal by Subject|0|||
125114420|NCT03038113|450042443|FG006|Overall Study|Withdrawal by Subject|0|||
125114421|NCT03038113|450042444|FG007|Overall Study|Withdrawal by Subject|0|||
125114422|NCT03038113|450042445|FG008|Overall Study|Withdrawal by Subject|0|||
125114423|NCT03038113|450042446|FG009|Overall Study|Withdrawal by Subject|0|||
125114424|NCT03038113|450042447|FG010|Overall Study|Withdrawal by Subject|0|||
125114425|NCT03038113|450042448|FG011|Overall Study|Withdrawal by Subject|0|||
125114426|NCT03038113|450042449|FG012|Overall Study|Withdrawal by Subject|0|||
125114427|NCT03038113|450042450|FG013|Overall Study|Withdrawal by Subject|1|||
125114428|NCT03038113|450042437|FG000|Overall Study|Lost to Follow-up|0|||
125114429|NCT03038113|450042438|FG001|Overall Study|Lost to Follow-up|0|||
125114430|NCT03038113|450042439|FG002|Overall Study|Lost to Follow-up|0|||
125114431|NCT03038113|450042440|FG003|Overall Study|Lost to Follow-up|0|||
125114432|NCT03038113|450042441|FG004|Overall Study|Lost to Follow-up|0|||
125114433|NCT03038113|450042442|FG005|Overall Study|Lost to Follow-up|0|||
125114434|NCT03038113|450042443|FG006|Overall Study|Lost to Follow-up|1|||
125114435|NCT03038113|450042444|FG007|Overall Study|Lost to Follow-up|0|||
125114436|NCT03038113|450042445|FG008|Overall Study|Lost to Follow-up|0|||
125114437|NCT03038113|450042446|FG009|Overall Study|Lost to Follow-up|0|||
125211041|NCT00508157|450396762|FG001|Overall Study|Subject no longer met study criteria|1|||
125211042|NCT00508157|450396761|FG000|Overall Study|Other known cause|0|||
124905399|NCT01307267|449281074|FG019|Overall Study|Lost to Follow-up|2|||
125114438|NCT03038113|450042447|FG010|Overall Study|Lost to Follow-up|0|||
125114439|NCT03038113|450042448|FG011|Overall Study|Lost to Follow-up|0|||
125114440|NCT03038113|450042449|FG012|Overall Study|Lost to Follow-up|0|||
125114441|NCT03038113|450042450|FG013|Overall Study|Lost to Follow-up|0|||
125114442|NCT01418352|450042453|FG000|Overall Study|Lost to Follow-up|2|||
125114443|NCT01418352|450042454|FG001|Overall Study|Lost to Follow-up|0|||
125114444|NCT01418352|450042455|FG002|Overall Study|Lost to Follow-up|0|||
125114445|NCT01418352|450042456|FG003|Overall Study|Lost to Follow-up|0|||
124905400|NCT01307267|449281075|FG020|Overall Study|Lost to Follow-up|0|||
124905401|NCT01307267|449281076|FG021|Overall Study|Lost to Follow-up|0|||
124905402|NCT01307267|449281077|FG022|Overall Study|Lost to Follow-up|0|||
124905403|NCT01307267|449281055|FG000|Overall Study|Withdrawal by Subject|0|||
124905404|NCT01307267|449281056|FG001|Overall Study|Withdrawal by Subject|0|||
125114446|NCT01418352|450042453|FG000|Overall Study|Adverse Event|0|||
125114447|NCT01418352|450042454|FG001|Overall Study|Adverse Event|1|||
125114448|NCT01418352|450042455|FG002|Overall Study|Adverse Event|0|||
125114449|NCT01418352|450042456|FG003|Overall Study|Adverse Event|0|||
125211043|NCT00508157|450396762|FG001|Overall Study|Other known cause|1|||
124905405|NCT01307267|449281057|FG002|Overall Study|Withdrawal by Subject|0|||
125114450|NCT01418352|450042453|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
125211044|NCT01625689|450396765|FG000|Overall Study|Migration|2|||
124905406|NCT01307267|449281058|FG003|Overall Study|Withdrawal by Subject|0|||
124905407|NCT01307267|449281059|FG004|Overall Study|Withdrawal by Subject|0|||
124905408|NCT01307267|449281060|FG005|Overall Study|Withdrawal by Subject|1|||
124905409|NCT01307267|449281061|FG006|Overall Study|Withdrawal by Subject|0|||
124905410|NCT01307267|449281062|FG007|Overall Study|Withdrawal by Subject|1|||
124905411|NCT01307267|449281063|FG008|Overall Study|Withdrawal by Subject|5|||
124905412|NCT01307267|449281064|FG009|Overall Study|Withdrawal by Subject|1|||
124905413|NCT01307267|449281065|FG010|Overall Study|Withdrawal by Subject|1|||
124905414|NCT01307267|449281066|FG011|Overall Study|Withdrawal by Subject|1|||
124905415|NCT01307267|449281067|FG012|Overall Study|Withdrawal by Subject|0|||
124905416|NCT01307267|449281068|FG013|Overall Study|Withdrawal by Subject|0|||
124905417|NCT01307267|449281069|FG014|Overall Study|Withdrawal by Subject|0|||
124905418|NCT01307267|449281070|FG015|Overall Study|Withdrawal by Subject|0|||
124905419|NCT01307267|449281071|FG016|Overall Study|Withdrawal by Subject|0|||
124905420|NCT01307267|449281072|FG017|Overall Study|Withdrawal by Subject|0|||
124905421|NCT01307267|449281073|FG018|Overall Study|Withdrawal by Subject|0|||
124905422|NCT01307267|449281074|FG019|Overall Study|Withdrawal by Subject|3|||
125114451|NCT01418352|450042454|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
125114452|NCT01418352|450042455|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
125114453|NCT01418352|450042456|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
125114454|NCT01418352|450042453|FG000|Overall Study|Subject Withdrew Consent|0|||
125114455|NCT01418352|450042454|FG001|Overall Study|Subject Withdrew Consent|1|||
125114456|NCT01418352|450042455|FG002|Overall Study|Subject Withdrew Consent|2|||
125114457|NCT01418352|450042456|FG003|Overall Study|Subject Withdrew Consent|1|||
125114458|NCT01418352|450042453|FG000|Overall Study|Protocol Deviation|0|||
125114459|NCT01418352|450042454|FG001|Overall Study|Protocol Deviation|0|||
125114460|NCT01418352|450042455|FG002|Overall Study|Protocol Deviation|1|||
125114461|NCT01418352|450042456|FG003|Overall Study|Protocol Deviation|0|||
125114462|NCT01418352|450042453|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
125114463|NCT01418352|450042454|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
125114464|NCT01418352|450042455|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
125114465|NCT01418352|450042456|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
125114466|NCT00619619|450042457|FG000|Overall Study|Physician Decision|0|||
125114467|NCT00619619|450042458|FG001|Overall Study|Physician Decision|0|||
125114468|NCT00619619|450042459|FG002|Overall Study|Physician Decision|1|||
125114469|NCT00619619|450042460|FG003|Overall Study|Physician Decision|0|||
125114470|NCT00619619|450042461|FG004|Overall Study|Physician Decision|0|||
125114471|NCT00619619|450042462|FG005|Overall Study|Physician Decision|0|||
125114472|NCT00619619|450042463|FG006|Overall Study|Physician Decision|0|||
125114473|NCT00619619|450042464|FG007|Overall Study|Physician Decision|0|||
125114474|NCT00619619|450042457|FG000|Overall Study|Protocol Violation|0|||
125114475|NCT00619619|450042458|FG001|Overall Study|Protocol Violation|0|||
125114476|NCT00619619|450042459|FG002|Overall Study|Protocol Violation|0|||
125114477|NCT00619619|450042460|FG003|Overall Study|Protocol Violation|1|||
125114478|NCT00619619|450042461|FG004|Overall Study|Protocol Violation|0|||
125114479|NCT00619619|450042462|FG005|Overall Study|Protocol Violation|0|||
125114480|NCT00619619|450042463|FG006|Overall Study|Protocol Violation|1|||
125114481|NCT00619619|450042464|FG007|Overall Study|Protocol Violation|1|||
125114482|NCT00619619|450042457|FG000|Overall Study|Adverse Event|0|||
125114483|NCT00619619|450042458|FG001|Overall Study|Adverse Event|0|||
125114484|NCT00619619|450042459|FG002|Overall Study|Adverse Event|0|||
125114485|NCT00619619|450042460|FG003|Overall Study|Adverse Event|0|||
125114486|NCT00619619|450042461|FG004|Overall Study|Adverse Event|2|||
125114487|NCT00619619|450042462|FG005|Overall Study|Adverse Event|0|||
125114488|NCT00619619|450042463|FG006|Overall Study|Adverse Event|0|||
125114489|NCT00619619|450042464|FG007|Overall Study|Adverse Event|2|||
125114490|NCT01092702|450042465|FG000|Overall Study|Withdrawal by Subject|7|||
125114491|NCT01092702|450042465|FG000|Overall Study|Lost to Follow-up|2|||
125114492|NCT03263819|450042466|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
125114493|NCT03263819|450042467|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
125114494|NCT03652961|450042470|FG000|Overall Study|Lost to Follow-up|3|||
124905423|NCT01307267|449281075|FG020|Overall Study|Withdrawal by Subject|0|||
124905424|NCT01307267|449281076|FG021|Overall Study|Withdrawal by Subject|0|||
125114495|NCT03652961|450042470|FG000|Overall Study|Screen Failure|1|||
125114496|NCT01783496|450042471|FG000|Overall Study|Lost to Follow-up|0|||
125114497|NCT01783496|450042472|FG001|Overall Study|Lost to Follow-up|0|||
125114498|NCT01783496|450042473|FG002|Overall Study|Lost to Follow-up|0|||
125114499|NCT01783496|450042474|FG003|Overall Study|Lost to Follow-up|2|||
125114500|NCT01783496|450042475|FG004|Overall Study|Lost to Follow-up|0|||
125114501|NCT01783496|450042476|FG005|Overall Study|Lost to Follow-up|1|||
125114502|NCT01783496|450042471|FG000|Overall Study|Withdrawal by Subject|1|||
124905425|NCT01307267|449281077|FG022|Overall Study|Withdrawal by Subject|0|||
124905426|NCT01307267|449281055|FG000|Overall Study|Other|0|||
124905427|NCT01307267|449281056|FG001|Overall Study|Other|0|||
125114503|NCT01783496|450042472|FG001|Overall Study|Withdrawal by Subject|0|||
125114504|NCT01783496|450042473|FG002|Overall Study|Withdrawal by Subject|0|||
125211045|NCT01625689|450396766|FG001|Overall Study|Migration|1|||
125211046|NCT03089853|450398539|FG000|Overall Study|Lost to Follow-up|2|||
125211047|NCT03089853|450398540|FG001|Overall Study|Lost to Follow-up|1|||
125211048|NCT04114656|450398541|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
124905428|NCT01307267|449281057|FG002|Overall Study|Other|0|||
124905429|NCT01307267|449281058|FG003|Overall Study|Other|0|||
124905430|NCT01307267|449281059|FG004|Overall Study|Other|0|||
124905431|NCT01307267|449281060|FG005|Overall Study|Other|7|||
124905432|NCT01307267|449281061|FG006|Overall Study|Other|0|||
124905433|NCT01307267|449281062|FG007|Overall Study|Other|1|||
125211049|NCT04114656|450398542|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
125211050|NCT04114656|450398541|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
125211051|NCT04114656|450398542|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
125211052|NCT04114656|450398541|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
125211053|NCT04114656|450398542|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
125211054|NCT04114656|450398541|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
125211055|NCT04114656|450398542|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
125211056|NCT04114656|450398541|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
125211057|NCT04114656|450398542|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
125211058|NCT03326518|450398548|FG000|Overall Study|Protocol Violation|1|||
125211059|NCT03326518|450398549|FG001|Overall Study|Protocol Violation|0|||
125211060|NCT03326518|450398550|FG002|Overall Study|Protocol Violation|0|||
125211061|NCT03326518|450398548|FG000|Overall Study|Withdrawal by Subject|1|||
125211062|NCT03326518|450398549|FG001|Overall Study|Withdrawal by Subject|0|||
125211063|NCT03326518|450398550|FG002|Overall Study|Withdrawal by Subject|0|||
125211064|NCT03326518|450398548|FG000|Overall Study|Lost to Follow-up|1|||
125211065|NCT03326518|450398549|FG001|Overall Study|Lost to Follow-up|0|||
125211066|NCT03326518|450398550|FG002|Overall Study|Lost to Follow-up|1|||
125211067|NCT01375374|450398553|FG000|Overall Study|Adverse Event|1|||
125211068|NCT01908582|450398554|FG000|Period 2|Physician Decision|1|||
125211069|NCT01908582|450398554|FG000|Period 2|Withdrawal by Subject|1|||
125211070|NCT01108237|450398556|FG000|Overall Study|No alignment data|2|||
125211071|NCT01108237|450398557|FG001|Overall Study|No alignment data|15|||
125211072|NCT01108237|450398556|FG000|Overall Study|Did not meet criteria for analysis|7|||
125211073|NCT01108237|450398557|FG001|Overall Study|Did not meet criteria for analysis|0|||
125211074|NCT02065518|450398559|FG000|Overall Study|Lost to Follow-up|3|||
125211075|NCT02065518|450398560|FG001|Overall Study|Lost to Follow-up|4|||
125211076|NCT02065518|450398561|FG002|Overall Study|Lost to Follow-up|0|||
125211077|NCT02065518|450398562|FG003|Overall Study|Lost to Follow-up|3|||
125211078|NCT02065518|450398559|FG000|Overall Study|Withdrawal by Subject|3|||
125211079|NCT02065518|450398560|FG001|Overall Study|Withdrawal by Subject|4|||
125211080|NCT02065518|450398561|FG002|Overall Study|Withdrawal by Subject|9|||
125211081|NCT02065518|450398562|FG003|Overall Study|Withdrawal by Subject|2|||
125211082|NCT03484403|450398565|FG000|Overall Study|Withdrawal by Subject|6|||
125211083|NCT03484403|450398566|FG001|Overall Study|Withdrawal by Subject|4|||
125211084|NCT02173379|450398567|FG000|Overall Study|Lost to Follow-up|89|||
125211085|NCT02173379|450398568|FG001|Overall Study|Lost to Follow-up|81|||
125211086|NCT02173379|450398567|FG000|Overall Study|Withdrawal by Subject|24|||
125211087|NCT02173379|450398568|FG001|Overall Study|Withdrawal by Subject|29|||
125211088|NCT02173379|450398567|FG000|Overall Study|Physician Decision|8|||
124905434|NCT01307267|449281063|FG008|Overall Study|Other|3|||
124905435|NCT01307267|449281064|FG009|Overall Study|Other|0|||
124905436|NCT01307267|449281065|FG010|Overall Study|Other|1|||
124905437|NCT01307267|449281066|FG011|Overall Study|Other|1|||
124905438|NCT01307267|449281067|FG012|Overall Study|Other|1|||
124905439|NCT01307267|449281068|FG013|Overall Study|Other|0|||
125211089|NCT02173379|450398568|FG001|Overall Study|Physician Decision|8|||
125211090|NCT02173379|450398567|FG000|Overall Study|Death|75|||
125211091|NCT02173379|450398568|FG001|Overall Study|Death|72|||
125211092|NCT02173379|450398567|FG000|Overall Study|Other Reason|1|||
124905440|NCT01307267|449281069|FG014|Overall Study|Other|2|||
124905441|NCT01307267|449281070|FG015|Overall Study|Other|1|||
124905442|NCT01307267|449281071|FG016|Overall Study|Other|0|||
125211093|NCT02173379|450398568|FG001|Overall Study|Other Reason|0|||
124905443|NCT01307267|449281072|FG017|Overall Study|Other|0|||
124905444|NCT01307267|449281073|FG018|Overall Study|Other|0|||
124905445|NCT01307267|449281074|FG019|Overall Study|Other|19|||
124905446|NCT01307267|449281075|FG020|Overall Study|Other|2|||
124905447|NCT01307267|449281076|FG021|Overall Study|Other|3|||
125211094|NCT06226649|450398576|FG000|Overall Study|Withdrawal by Subject|4|||
125211095|NCT06226649|450398577|FG001|Overall Study|Withdrawal by Subject|1|||
125211096|NCT04767529|450398578|FG000|Overall Study|Adverse Event|0|||
125211097|NCT04767529|450398579|FG001|Overall Study|Adverse Event|4|||
125211098|NCT04767529|450398580|FG002|Overall Study|Adverse Event|3|||
125211099|NCT04767529|450398578|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
125211100|NCT04767529|450398579|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
124905448|NCT01307267|449281077|FG022|Overall Study|Other|2|||
124905449|NCT05174013|449281080|FG000|Overall Study|Lost to Follow-up|0|||
124905450|NCT05174013|449281081|FG001|Overall Study|Lost to Follow-up|0|||
124905451|NCT05174013|449281082|FG002|Overall Study|Lost to Follow-up|0|||
124905452|NCT05174013|449281083|FG003|Overall Study|Lost to Follow-up|1|||
124905453|NCT05174013|449281084|FG004|Overall Study|Lost to Follow-up|0|||
124905454|NCT05174013|449281085|FG005|Overall Study|Lost to Follow-up|0|||
124905455|NCT05174013|449281080|FG000|Overall Study|Withdrawal by Subject|0|||
124905456|NCT05174013|449281081|FG001|Overall Study|Withdrawal by Subject|0|||
124905457|NCT05174013|449281082|FG002|Overall Study|Withdrawal by Subject|1|||
124905458|NCT05174013|449281083|FG003|Overall Study|Withdrawal by Subject|0|||
124905459|NCT05174013|449281084|FG004|Overall Study|Withdrawal by Subject|0|||
124905460|NCT05174013|449281085|FG005|Overall Study|Withdrawal by Subject|0|||
124905461|NCT00854906|449281089|FG000|Overall Study|One person had no ocular history|1|||
124905462|NCT00814346|449281090|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
124905463|NCT00814346|449281091|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
124905464|NCT00814346|449281090|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
124905465|NCT00814346|449281091|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
124905466|NCT00814346|449281090|FG000|Open Phase (17 Months)|Adverse Event|5|||
124905467|NCT00814346|449281091|FG001|Open Phase (17 Months)|Adverse Event|0|||
124905468|NCT00814346|449281090|FG000|Open Phase (17 Months)|Consent|2|||
124905469|NCT00814346|449281091|FG001|Open Phase (17 Months)|Consent|0|||
124905470|NCT00814346|449281090|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
124905471|NCT00814346|449281091|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
124905472|NCT00814346|449281090|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
124905473|NCT00814346|449281091|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
124905474|NCT05136443|449281094|FG000|Overall Study|Lost to Follow-up|2|||
124905475|NCT05136443|449281094|FG000|Overall Study|Adverse Event|2|||
124905476|NCT02613871|449281095|FG000|Overall Study|Death|2|||
124905477|NCT02613871|449281095|FG000|Overall Study|Withdrew Consent|1|||
124905478|NCT00494442|449281096|FG000|Overall Study|Death|1|||
124905479|NCT00494442|449281097|FG001|Overall Study|Death|1|||
124905480|NCT00494442|449281096|FG000|Overall Study|Lack of Efficacy|16|||
124905481|NCT00494442|449281097|FG001|Overall Study|Lack of Efficacy|10|||
124905482|NCT00494442|449281096|FG000|Overall Study|Adverse Event|0|||
124905483|NCT00494442|449281097|FG001|Overall Study|Adverse Event|2|||
124905484|NCT00494442|449281096|FG000|Overall Study|Physician Decision|0|||
124905485|NCT00494442|449281097|FG001|Overall Study|Physician Decision|1|||
124905486|NCT00494442|449281096|FG000|Overall Study|Non-compliance|0|||
124905487|NCT00494442|449281097|FG001|Overall Study|Non-compliance|1|||
124905488|NCT00494442|449281096|FG000|Overall Study|Intercurrent illness|0|||
124905489|NCT00494442|449281097|FG001|Overall Study|Intercurrent illness|1|||
124905490|NCT00831415|449281100|FG000|Overall Study|Adverse Event|14|||
124905491|NCT00831415|449281100|FG000|Overall Study|Failed to return|3|||
124905492|NCT00831415|449281100|FG000|Overall Study|Physician Decision|6|||
124905493|NCT00831415|449281100|FG000|Overall Study|Lost to Follow-up|9|||
124905494|NCT00831415|449281100|FG000|Overall Study|Protocol Violation|3|||
124905495|NCT00831415|449281100|FG000|Overall Study|Withdrawal by Subject|35|||
124905496|NCT00831415|449281100|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
124905497|NCT00831415|449281100|FG000|Overall Study|Death|1|||
124905498|NCT01241292|449281101|FG000|Overall Study|Administrative Reason by Sponsor|1|||
124905499|NCT01241292|449281102|FG001|Overall Study|Administrative Reason by Sponsor|0|||
124905500|NCT01241292|449281101|FG000|Overall Study|Disease Progression|2|||
124905501|NCT01241292|449281102|FG001|Overall Study|Disease Progression|0|||
124905502|NCT01241292|449281101|FG000|Overall Study|Study Drug Toxicity|0|||
124905503|NCT01241292|449281102|FG001|Overall Study|Study Drug Toxicity|1|||
124905504|NCT01241292|449281101|FG000|Overall Study|Participant Discontinued Treatment|0|||
124905505|NCT01241292|449281102|FG001|Overall Study|Participant Discontinued Treatment|2|||
124905506|NCT03034915|449281105|FG000|Overall Study|Adverse Event|29|||
124905507|NCT03034915|449281106|FG001|Overall Study|Adverse Event|32|||
124905508|NCT03034915|449281107|FG002|Overall Study|Adverse Event|22|||
124905509|NCT03034915|449281105|FG000|Overall Study|Lost to Follow-up|5|||
124905510|NCT03034915|449281106|FG001|Overall Study|Lost to Follow-up|13|||
124905511|NCT03034915|449281107|FG002|Overall Study|Lost to Follow-up|3|||
125021783|NCT01543087|449703315|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
125021784|NCT01543087|449703316|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
125021785|NCT01543087|449703317|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
125021786|NCT01543087|449703318|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
125021787|NCT01543087|449703319|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
124905512|NCT03034915|449281105|FG000|Overall Study|Withdrawal by Subject|29|||
124905513|NCT03034915|449281106|FG001|Overall Study|Withdrawal by Subject|46|||
124905514|NCT03034915|449281107|FG002|Overall Study|Withdrawal by Subject|41|||
124905515|NCT03034915|449281105|FG000|Overall Study|Protocol Deviation|2|||
124905516|NCT03034915|449281106|FG001|Overall Study|Protocol Deviation|14|||
124905517|NCT03034915|449281107|FG002|Overall Study|Protocol Deviation|7|||
124905518|NCT03034915|449281105|FG000|Overall Study|Lack of Efficacy|8|||
124905519|NCT03034915|449281106|FG001|Overall Study|Lack of Efficacy|16|||
124905520|NCT03034915|449281107|FG002|Overall Study|Lack of Efficacy|18|||
124905521|NCT03034915|449281105|FG000|Overall Study|Site closed|2|||
124905522|NCT03034915|449281106|FG001|Overall Study|Site closed|2|||
124905523|NCT03034915|449281107|FG002|Overall Study|Site closed|4|||
124905524|NCT03034915|449281105|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
124905525|NCT03034915|449281106|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
124905526|NCT03034915|449281107|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
124905527|NCT03034915|449281105|FG000|Overall Study|Physician Decision|1|||
124905528|NCT03034915|449281106|FG001|Overall Study|Physician Decision|5|||
124905529|NCT03034915|449281107|FG002|Overall Study|Physician Decision|2|||
124905530|NCT03861767|449281108|FG000|Overall Study|Withdrawal by Subject|2|||
124905531|NCT03861767|449281109|FG001|Overall Study|Withdrawal by Subject|1|||
124905532|NCT03861767|449281110|FG002|Overall Study|Withdrawal by Subject|0|||
124905533|NCT03861767|449281111|FG003|Overall Study|Withdrawal by Subject|5|||
124905534|NCT03861767|449281112|FG004|Overall Study|Withdrawal by Subject|2|||
124905535|NCT03861767|449281113|FG005|Overall Study|Withdrawal by Subject|1|||
124905536|NCT03861767|449281114|FG006|Overall Study|Withdrawal by Subject|3|||
124905537|NCT03861767|449281115|FG007|Overall Study|Withdrawal by Subject|1|||
124905538|NCT03861767|449281116|FG008|Overall Study|Withdrawal by Subject|0|||
124905539|NCT03861767|449281117|FG009|Overall Study|Withdrawal by Subject|5|||
124905540|NCT01087762|449281118|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
124905541|NCT01087762|449281119|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
124905542|NCT01087762|449281120|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
124905543|NCT01087762|449281121|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
124905544|NCT01087762|449281122|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
124905545|NCT01087762|449281118|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
124905546|NCT01087762|449281119|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
124905547|NCT01087762|449281120|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
124905548|NCT01087762|449281121|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
124905549|NCT01087762|449281122|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
124905550|NCT01087762|449281118|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
124905551|NCT01087762|449281119|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
124905552|NCT01087762|449281120|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
124905553|NCT01087762|449281121|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
124905554|NCT01087762|449281122|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
124905555|NCT01087762|449281118|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
124905556|NCT01087762|449281119|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
124905557|NCT01087762|449281120|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
124905558|NCT01087762|449281121|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
124905559|NCT01087762|449281122|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
125114505|NCT01783496|450042474|FG003|Overall Study|Withdrawal by Subject|0|||
125114506|NCT01783496|450042475|FG004|Overall Study|Withdrawal by Subject|0|||
125114507|NCT01783496|450042476|FG005|Overall Study|Withdrawal by Subject|0|||
125114508|NCT00686920|450042482|FG000|Overall Study|Death|45|||
125114509|NCT00686920|450042483|FG001|Overall Study|Death|14|||
125114510|NCT00686920|450042482|FG000|Overall Study|Liver Transplant|23|||
125114511|NCT00686920|450042483|FG001|Overall Study|Liver Transplant|8|||
125114512|NCT00686920|450042482|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
125114513|NCT00686920|450042483|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
125114514|NCT00686920|450042482|FG000|Overall Study|Withdrawal by Subject|23|||
125114515|NCT00686920|450042483|FG001|Overall Study|Withdrawal by Subject|5|||
125114516|NCT00686920|450042482|FG000|Overall Study|Protocol Violation|2|||
125114517|NCT00686920|450042483|FG001|Overall Study|Protocol Violation|1|||
125114518|NCT00686920|450042482|FG000|Overall Study|Adverse Event|10|||
125114519|NCT00686920|450042483|FG001|Overall Study|Adverse Event|2|||
125114520|NCT00686920|450042482|FG000|Overall Study|Personal Reason|0|||
125114521|NCT00686920|450042483|FG001|Overall Study|Personal Reason|1|||
125114522|NCT00686920|450042482|FG000|Overall Study|Lost to Follow-up|15|||
125114523|NCT00686920|450042483|FG001|Overall Study|Lost to Follow-up|3|||
125114524|NCT00686920|450042482|FG000|Overall Study|Moved to Another State|1|||
124905560|NCT01087762|449281118|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
124905561|NCT01087762|449281119|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
124905562|NCT01087762|449281120|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
124905563|NCT01087762|449281121|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
124905564|NCT01087762|449281122|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
125114525|NCT00686920|450042483|FG001|Overall Study|Moved to Another State|0|||
125114526|NCT00686920|450042482|FG000|Overall Study|Transferred to Nursing Home|1|||
124905565|NCT01087762|449281118|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
124905566|NCT01087762|449281119|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
125114527|NCT00686920|450042483|FG001|Overall Study|Transferred to Nursing Home|0|||
125114528|NCT00686920|450042482|FG000|Overall Study|Noncompliance|9|||
124905567|NCT01087762|449281120|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
125114529|NCT00686920|450042483|FG001|Overall Study|Noncompliance|0|||
124905568|NCT01087762|449281121|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
124905569|NCT01087762|449281122|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
124905570|NCT01087762|449281118|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
124905571|NCT01087762|449281119|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
124905572|NCT01087762|449281120|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
124905573|NCT01087762|449281121|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
124905574|NCT01087762|449281122|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
124905575|NCT01087762|449281118|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
124905576|NCT01087762|449281119|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
124905577|NCT01087762|449281120|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
124905578|NCT01087762|449281121|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
124905579|NCT01087762|449281122|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
124905580|NCT01087762|449281118|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
124905581|NCT01087762|449281119|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
124905582|NCT01087762|449281120|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
124905583|NCT01087762|449281121|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
124905584|NCT01087762|449281122|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
124905585|NCT01087762|449281118|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
124905586|NCT01087762|449281119|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
124905587|NCT01087762|449281120|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
124905588|NCT01087762|449281121|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
124905589|NCT01087762|449281122|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
124905590|NCT01087762|449281118|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
124905591|NCT01087762|449281119|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
124905592|NCT01087762|449281120|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
124905593|NCT01087762|449281121|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
124905594|NCT01087762|449281122|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
124905595|NCT01087762|449281118|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
124905596|NCT01087762|449281119|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
124905597|NCT01087762|449281120|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
124905598|NCT01087762|449281121|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
124905599|NCT01087762|449281122|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
124905600|NCT01087762|449281118|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
124905601|NCT01087762|449281119|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
124905602|NCT01087762|449281120|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
124905603|NCT01087762|449281121|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
124905604|NCT01087762|449281122|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
124905605|NCT00813904|449281123|FG000|Overall Study|Death|1|||
124905606|NCT00424762|449281129|FG000|Overall Study|Withdrawal by Subject|18|||
124905607|NCT00424762|449281130|FG001|Overall Study|Withdrawal by Subject|19|||
124905608|NCT00424762|449281129|FG000|Overall Study|Lost to Follow-up|2|||
124905609|NCT00424762|449281130|FG001|Overall Study|Lost to Follow-up|3|||
124905610|NCT01405924|449281133|FG000|Overall Study|Protocol Violation|8|||
124905611|NCT01405924|449281133|FG000|Overall Study|Missing/Incomplete Data|2|||
124905612|NCT00770965|449281137|FG000|Safety Set|Withdrawal by Subject|0|||
124905613|NCT00770965|449281138|FG001|Safety Set|Withdrawal by Subject|0|||
124905614|NCT00770965|449281139|FG002|Safety Set|Withdrawal by Subject|0|||
124905615|NCT00770965|449281140|FG003|Safety Set|Withdrawal by Subject|1|||
124905616|NCT00770965|449281137|FG000|Safety Set|Protocol deviation|0|||
125021788|NCT00706030|449703320|FG000|Overall Study|Disease Progression|4|||
125021789|NCT00706030|449703321|FG001|Overall Study|Disease Progression|6|||
125021790|NCT00706030|449703322|FG002|Overall Study|Disease Progression|46|||
125021791|NCT00706030|449703323|FG003|Overall Study|Disease Progression|12|||
125021792|NCT00706030|449703320|FG000|Overall Study|Adverse Event|1|||
125021793|NCT00706030|449703321|FG001|Overall Study|Adverse Event|0|||
125021794|NCT00706030|449703322|FG002|Overall Study|Adverse Event|4|||
125021795|NCT00706030|449703323|FG003|Overall Study|Adverse Event|2|||
125021796|NCT00706030|449703320|FG000|Overall Study|Withdrawal by Subject|1|||
125021797|NCT00706030|449703321|FG001|Overall Study|Withdrawal by Subject|0|||
125021798|NCT00706030|449703322|FG002|Overall Study|Withdrawal by Subject|2|||
125021799|NCT00706030|449703323|FG003|Overall Study|Withdrawal by Subject|0|||
125021800|NCT00706030|449703320|FG000|Overall Study|Physician Decision|0|||
125021801|NCT00706030|449703321|FG001|Overall Study|Physician Decision|0|||
125021802|NCT00706030|449703322|FG002|Overall Study|Physician Decision|2|||
125021803|NCT00706030|449703323|FG003|Overall Study|Physician Decision|0|||
125021804|NCT00706030|449703320|FG000|Overall Study|Not recorded|0|||
125021805|NCT00706030|449703321|FG001|Overall Study|Not recorded|0|||
125021806|NCT00706030|449703322|FG002|Overall Study|Not recorded|2|||
125021807|NCT00706030|449703323|FG003|Overall Study|Not recorded|0|||
125021808|NCT00706030|449703320|FG000|Overall Study|Protocol Violation|0|||
125021809|NCT00706030|449703321|FG001|Overall Study|Protocol Violation|0|||
125021810|NCT00706030|449703322|FG002|Overall Study|Protocol Violation|1|||
125114530|NCT00686920|450042482|FG000|Overall Study|Principal Investigator Decision|2|||
125114531|NCT00686920|450042483|FG001|Overall Study|Principal Investigator Decision|0|||
125114532|NCT01620983|450042486|FG000|Overall Study|Lost to Follow-up|8|||
125114533|NCT01620983|450042487|FG001|Overall Study|Lost to Follow-up|4|||
125114534|NCT01620983|450042488|FG002|Overall Study|Lost to Follow-up|9|||
125114535|NCT01620983|450042486|FG000|Overall Study|Withdrawal by Subject|6|||
124905617|NCT00770965|449281138|FG001|Safety Set|Protocol deviation|0|||
124905618|NCT00770965|449281139|FG002|Safety Set|Protocol deviation|1|||
124905619|NCT00770965|449281140|FG003|Safety Set|Protocol deviation|0|||
124905620|NCT00770965|449281137|FG000|Excluded Set|Administrative problems|14|||
124905621|NCT00770965|449281138|FG001|Excluded Set|Administrative problems|12|||
124905622|NCT00770965|449281139|FG002|Excluded Set|Administrative problems|12|||
124905623|NCT00770965|449281140|FG003|Excluded Set|Administrative problems|10|||
124905624|NCT00770965|449281137|FG000|Excluded Set|Withdrawal by Subject|1|||
124905625|NCT00770965|449281138|FG001|Excluded Set|Withdrawal by Subject|1|||
124905626|NCT00770965|449281139|FG002|Excluded Set|Withdrawal by Subject|2|||
124905627|NCT00770965|449281140|FG003|Excluded Set|Withdrawal by Subject|3|||
124905628|NCT01391130|449281143|FG000|Overall Study|Withdrawal by Subject|3|||
124905629|NCT01391130|449281144|FG001|Overall Study|Withdrawal by Subject|2|||
124905630|NCT01391130|449281143|FG000|Overall Study|Physician Decision|2|||
124905631|NCT01391130|449281144|FG001|Overall Study|Physician Decision|3|||
124905632|NCT01391130|449281143|FG000|Overall Study|Did not Receive Drug|1|||
124905633|NCT01391130|449281144|FG001|Overall Study|Did not Receive Drug|1|||
124905634|NCT03478696|449281145|FG000|Overall Study|Adverse Event|1|||
124905635|NCT03478696|449281146|FG001|Overall Study|Adverse Event|5|||
124905636|NCT03478696|449281145|FG000|Overall Study|Lost to Follow-up|1|||
124905637|NCT03478696|449281146|FG001|Overall Study|Lost to Follow-up|0|||
124905638|NCT03478696|449281145|FG000|Overall Study|Physician Decision|6|||
124905639|NCT03478696|449281146|FG001|Overall Study|Physician Decision|3|||
124905640|NCT03478696|449281145|FG000|Overall Study|Withdrawal by Subject|9|||
124905641|NCT03478696|449281146|FG001|Overall Study|Withdrawal by Subject|4|||
124905642|NCT03615924|449281147|FG000|Overall Study|Withdrawal by Subject|2|||
124905643|NCT03615924|449281148|FG001|Overall Study|Withdrawal by Subject|5|||
124905644|NCT03615924|449281147|FG000|Overall Study|Death|3|||
124905645|NCT03615924|449281148|FG001|Overall Study|Death|1|||
124905646|NCT03615924|449281147|FG000|Overall Study|Lost to Follow-up|1|||
124905647|NCT03615924|449281148|FG001|Overall Study|Lost to Follow-up|0|||
124905648|NCT03615924|449281147|FG000|Overall Study|Randomized in error|1|||
124905649|NCT03615924|449281148|FG001|Overall Study|Randomized in error|0|||
124905650|NCT03615924|449281147|FG000|Overall Study|Study termination by Sponsor|94|||
124905651|NCT03615924|449281148|FG001|Overall Study|Study termination by Sponsor|86|||
124905652|NCT00367991|449281154|FG000|Overall Study|Withdrawal by Subject|1|||
124905653|NCT00367991|449281155|FG001|Overall Study|Withdrawal by Subject|1|||
124905654|NCT00367991|449281154|FG000|Overall Study|Adverse Event|1|||
124905655|NCT00367991|449281155|FG001|Overall Study|Adverse Event|1|||
124905656|NCT01184508|449281156|FG000|Overall Study|Adverse Event|4|||
124905657|NCT01184508|449281157|FG001|Overall Study|Adverse Event|6|||
124905658|NCT01184508|449281156|FG000|Overall Study|Lack of Efficacy|1|||
124905659|NCT01184508|449281157|FG001|Overall Study|Lack of Efficacy|1|||
124905660|NCT01184508|449281156|FG000|Overall Study|Lost to Follow-up|1|||
124905661|NCT01184508|449281157|FG001|Overall Study|Lost to Follow-up|1|||
124905662|NCT01184508|449281156|FG000|Overall Study|Physician Decision|1|||
124905663|NCT01184508|449281157|FG001|Overall Study|Physician Decision|0|||
124905664|NCT01184508|449281156|FG000|Overall Study|Protocol Violation|3|||
124905665|NCT01184508|449281157|FG001|Overall Study|Protocol Violation|1|||
125114536|NCT01620983|450042487|FG001|Overall Study|Withdrawal by Subject|8|||
125114537|NCT01620983|450042488|FG002|Overall Study|Withdrawal by Subject|1|||
125114538|NCT01620983|450042486|FG000|Overall Study|Death|2|||
124905666|NCT01184508|449281156|FG000|Overall Study|Sponsor Decision|5|||
124905667|NCT01184508|449281157|FG001|Overall Study|Sponsor Decision|2|||
124905668|NCT01184508|449281156|FG000|Overall Study|Withdrawal by Subject|1|||
124905669|NCT01184508|449281157|FG001|Overall Study|Withdrawal by Subject|3|||
124905670|NCT01184508|449281156|FG000|Overall Study|Randomized, Not Treated|0|||
124905671|NCT01184508|449281157|FG001|Overall Study|Randomized, Not Treated|1|||
125114539|NCT01620983|450042487|FG001|Overall Study|Death|0|||
125114540|NCT01620983|450042488|FG002|Overall Study|Death|0|||
124905672|NCT04707313|449281164|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
124905673|NCT04707313|449281165|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
124905674|NCT04707313|449281166|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
124905675|NCT04707313|449281167|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
124905676|NCT04707313|449281168|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
124905677|NCT04707313|449281169|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
124905678|NCT04707313|449281170|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
124905679|NCT04707313|449281171|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
124905680|NCT04707313|449281172|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
124905681|NCT04707313|449281173|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
124905682|NCT04707313|449281174|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
124905683|NCT04707313|449281175|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
124905684|NCT04707313|449281176|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
124905685|NCT04707313|449281164|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
124905686|NCT04707313|449281165|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
124905687|NCT04707313|449281166|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
124905688|NCT04707313|449281167|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
124905689|NCT04707313|449281168|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
124905690|NCT04707313|449281169|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
124905691|NCT04707313|449281170|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
124905692|NCT04707313|449281171|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
124905693|NCT04707313|449281172|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
124905694|NCT04707313|449281173|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
124905695|NCT04707313|449281174|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
124905696|NCT04707313|449281175|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
124905697|NCT04707313|449281176|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
124905698|NCT04707313|449281164|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
124905699|NCT04707313|449281165|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
124905700|NCT04707313|449281166|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
124905701|NCT04707313|449281167|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
124905702|NCT04707313|449281168|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
124905703|NCT04707313|449281169|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
124905704|NCT04707313|449281170|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
124905705|NCT04707313|449281171|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
124905706|NCT04707313|449281172|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
124905707|NCT04707313|449281173|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
124905708|NCT04707313|449281174|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
124905709|NCT04707313|449281175|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
124905710|NCT04707313|449281176|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
124905711|NCT04707313|449281164|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
124905712|NCT04707313|449281165|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
124905713|NCT04707313|449281166|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
124905714|NCT04707313|449281167|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
124905715|NCT04707313|449281168|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
124905716|NCT04707313|449281169|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
124905717|NCT04707313|449281170|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
124905718|NCT04707313|449281171|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
124905719|NCT04707313|449281172|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
124905720|NCT04707313|449281173|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
124905721|NCT04707313|449281174|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
124905722|NCT04707313|449281175|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
124905723|NCT04707313|449281176|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
125114541|NCT01620983|450042486|FG000|Overall Study|Physician Decision|3|||
125114542|NCT01620983|450042487|FG001|Overall Study|Physician Decision|10|||
125114543|NCT01620983|450042488|FG002|Overall Study|Physician Decision|5|||
124905724|NCT04707313|449281164|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
124905725|NCT04707313|449281165|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
124905726|NCT04707313|449281166|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
124905727|NCT04707313|449281167|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
124905728|NCT04707313|449281168|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
124905729|NCT04707313|449281169|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
124905730|NCT04707313|449281170|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
124905731|NCT04707313|449281171|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
124905732|NCT04707313|449281172|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
124905733|NCT04707313|449281173|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
124905734|NCT04707313|449281174|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
124905735|NCT04707313|449281175|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
124905736|NCT04707313|449281176|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
124905737|NCT04707313|449281164|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
124905738|NCT04707313|449281165|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
125114544|NCT00545233|450042490|FG000|Overall Study|Adverse Event|10|||
124905739|NCT04707313|449281166|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
124905740|NCT04707313|449281167|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
125114545|NCT00545233|450042491|FG001|Overall Study|Adverse Event|5|||
125114546|NCT00545233|450042490|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
125021811|NCT00706030|449703323|FG003|Overall Study|Protocol Violation|1|||
125021812|NCT00706030|449703320|FG000|Overall Study|Failed to return|0|||
124905741|NCT04707313|449281168|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
124905742|NCT04707313|449281169|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
124905743|NCT04707313|449281170|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
124905744|NCT04707313|449281171|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
124905745|NCT04707313|449281172|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
124905746|NCT04707313|449281173|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
124905747|NCT04707313|449281174|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
124905748|NCT04707313|449281175|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
124905749|NCT04707313|449281176|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
124905750|NCT04707313|449281164|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
125021813|NCT00706030|449703321|FG001|Overall Study|Failed to return|0|||
125021814|NCT00706030|449703322|FG002|Overall Study|Failed to return|1|||
125021815|NCT00706030|449703323|FG003|Overall Study|Failed to return|0|||
125021816|NCT00706030|449703320|FG000|Overall Study|Symptomatic Deterioration|0|||
125021817|NCT00706030|449703321|FG001|Overall Study|Symptomatic Deterioration|0|||
125021818|NCT00706030|449703322|FG002|Overall Study|Symptomatic Deterioration|1|||
125021819|NCT00706030|449703323|FG003|Overall Study|Symptomatic Deterioration|0|||
125021820|NCT00706030|449703320|FG000|Overall Study|No treatment received|0|||
125021821|NCT00706030|449703321|FG001|Overall Study|No treatment received|0|||
124905751|NCT04707313|449281165|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
124905752|NCT04707313|449281166|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
125021822|NCT00706030|449703322|FG002|Overall Study|No treatment received|0|||
125114547|NCT00545233|450042491|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
125114548|NCT00545233|450042490|FG000|Overall Study|Protocol Violation|2|||
124905753|NCT04707313|449281167|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
125114549|NCT00545233|450042491|FG001|Overall Study|Protocol Violation|0|||
125114550|NCT00545233|450042490|FG000|Overall Study|Refused Treatment|9|||
125114551|NCT00545233|450042491|FG001|Overall Study|Refused Treatment|7|||
124905754|NCT04707313|449281168|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
124905755|NCT04707313|449281169|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
124905756|NCT04707313|449281170|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
124905757|NCT04707313|449281171|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
124905758|NCT04707313|449281172|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
124905759|NCT04707313|449281173|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
124905760|NCT04707313|449281174|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
124905761|NCT04707313|449281175|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
124905762|NCT04707313|449281176|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
125021823|NCT00706030|449703323|FG003|Overall Study|No treatment received|1|||
125021824|NCT00706030|449703320|FG000|Overall Study|Death|0|||
125021825|NCT00706030|449703321|FG001|Overall Study|Death|0|||
125021826|NCT00706030|449703322|FG002|Overall Study|Death|1|||
125021827|NCT00706030|449703323|FG003|Overall Study|Death|0|||
125021828|NCT04673786|449703324|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
125021829|NCT04673786|449703325|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
125021830|NCT04673786|449703326|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
125114552|NCT00545233|450042490|FG000|Overall Study|Failure to Return|4|||
125114553|NCT00545233|450042491|FG001|Overall Study|Failure to Return|6|||
125114554|NCT00545233|450042490|FG000|Overall Study|Insufficient response|14|||
125114555|NCT00545233|450042491|FG001|Overall Study|Insufficient response|15|||
125114556|NCT00545233|450042490|FG000|Overall Study|Physician Decision|2|||
125114557|NCT00545233|450042491|FG001|Overall Study|Physician Decision|1|||
125114558|NCT00446654|450042492|FG000|Overall Study|Withdrawal by Subject|1|||
125114559|NCT00446654|450042493|FG001|Overall Study|Withdrawal by Subject|0|||
125114560|NCT00446654|450042492|FG000|Overall Study|Adverse Event|1|||
125114561|NCT00446654|450042493|FG001|Overall Study|Adverse Event|0|||
125114562|NCT01504867|450042497|FG000|Overall Study|Inclusion criteria not met|2|||
125114563|NCT01504867|450042498|FG001|Overall Study|Inclusion criteria not met|2|||
125114564|NCT01504867|450042497|FG000|Overall Study|Consent revoked|5|||
125114565|NCT01504867|450042498|FG001|Overall Study|Consent revoked|1|||
125114566|NCT01783730|450042499|FG000|Overall Study|Failed to meet inclusion criteria|6|||
125114567|NCT02151461|450042500|FG000|Overall Study|Adverse Event|5|||
125114568|NCT02151461|450042501|FG001|Overall Study|Adverse Event|1|||
125114569|NCT02151461|450042502|FG002|Overall Study|Adverse Event|0|||
125114570|NCT02151461|450042503|FG003|Overall Study|Adverse Event|2|||
125114571|NCT02151461|450042500|FG000|Overall Study|Lost to Follow-up|0|||
125114572|NCT02151461|450042501|FG001|Overall Study|Lost to Follow-up|0|||
125114573|NCT02151461|450042502|FG002|Overall Study|Lost to Follow-up|1|||
125021831|NCT04673786|449703324|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
125114574|NCT02151461|450042503|FG003|Overall Study|Lost to Follow-up|1|||
125114575|NCT02151461|450042500|FG000|Overall Study|Withdrawal by Subject|1|||
125114576|NCT02151461|450042501|FG001|Overall Study|Withdrawal by Subject|0|||
125114577|NCT02151461|450042502|FG002|Overall Study|Withdrawal by Subject|1|||
125021832|NCT04673786|449703325|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
125021833|NCT04673786|449703326|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
125021834|NCT04673786|449703324|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
125021835|NCT04673786|449703325|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
125021836|NCT04673786|449703326|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
125021837|NCT04673786|449703324|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
125021838|NCT04673786|449703325|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
125021839|NCT04673786|449703326|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
125021840|NCT04673786|449703324|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
125021841|NCT04673786|449703325|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
125021842|NCT04673786|449703326|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
125021843|NCT04673786|449703324|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
125021844|NCT04673786|449703325|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
125021845|NCT04673786|449703326|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
125021846|NCT02682901|449703329|FG000|Overall Study|Adverse Event|10|||
125021847|NCT02682901|449703330|FG001|Overall Study|Adverse Event|3|||
125021848|NCT02682901|449703329|FG000|Overall Study|Lack of Efficacy|0|||
125021849|NCT02682901|449703330|FG001|Overall Study|Lack of Efficacy|1|||
125021850|NCT03870555|449703331|FG000|Period 3 (2 Days)|Adverse Event|1|||
125021851|NCT03870555|449703332|FG001|Period 3 (2 Days)|Adverse Event|0|||
125021852|NCT03870555|449703333|FG002|Period 3 (2 Days)|Adverse Event|0|||
125021853|NCT01422239|449703336|FG000|Overall Study|Lost to Follow-up|4|||
125021854|NCT01422239|449703337|FG001|Overall Study|Lost to Follow-up|3|||
125021855|NCT03167073|449703339|FG000|Overall Study|Stillbirth|1|||
125021856|NCT03167073|449703340|FG001|Overall Study|Stillbirth|0|||
125021857|NCT01276236|449703341|FG000|Overall Study|Lack of Efficacy|2|||
125021858|NCT01276236|449703341|FG000|Overall Study|Withdrawal by Subject|4|||
125021859|NCT00044512|449703342|FG000|Follow Up|Lost to Follow-up|2|||
125021860|NCT00357500|449703346|FG000|Overall Study|Adverse Event|3|||
125021861|NCT00357500|449703346|FG000|Overall Study|Withdrawal by Subject|5|||
125021862|NCT00357500|449703346|FG000|Overall Study|Progressive Disease|65|||
125021863|NCT00357500|449703346|FG000|Overall Study|Not Started Protocol Therapy|4|||
125021864|NCT02695628|449703347|FG000|Overall Study|Withdrawal by Subject|1|||
125021865|NCT02573155|449703348|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
125021866|NCT02573155|449703349|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
125021867|NCT02573155|449703348|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
125021868|NCT02573155|449703349|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
125021869|NCT02573155|449703348|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
125021870|NCT02573155|449703349|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
125021871|NCT02573155|449703348|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
125021872|NCT02573155|449703349|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
125021873|NCT02573155|449703348|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
125021874|NCT02573155|449703349|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
125021875|NCT02573155|449703348|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
125021876|NCT02573155|449703349|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
125021877|NCT02573155|449703348|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
125021878|NCT02573155|449703349|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
125021879|NCT02573155|449703348|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
125114578|NCT02151461|450042503|FG003|Overall Study|Withdrawal by Subject|1|||
125114579|NCT02151461|450042500|FG000|Overall Study|Treatment discontinuation|0|||
125114580|NCT02151461|450042501|FG001|Overall Study|Treatment discontinuation|0|||
125114581|NCT02151461|450042502|FG002|Overall Study|Treatment discontinuation|1|||
125114582|NCT02151461|450042503|FG003|Overall Study|Treatment discontinuation|0|||
125114583|NCT00871169|450042505|FG000|Overall Study|Protocol Violation|1|||
125114584|NCT00871169|450042505|FG000|Overall Study|Patient did not receive study treatment|2|||
125114585|NCT03210259|450042509|FG000|12-Week Run-in Period|Adverse Event|1|||
125021880|NCT02573155|449703349|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
125021881|NCT01681433|449703350|FG000|Overall Study|Lack of Efficacy|23|||
125021882|NCT01681433|449703351|FG001|Overall Study|Lack of Efficacy|23|||
125114586|NCT03210259|450042510|FG001|12-Week Run-in Period|Adverse Event|0|||
125114587|NCT03210259|450042511|FG002|12-Week Run-in Period|Adverse Event|0|||
125211101|NCT04767529|450398580|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
125021883|NCT01681433|449703350|FG000|Overall Study|Withdrawal by Subject|5|||
125021884|NCT01681433|449703351|FG001|Overall Study|Withdrawal by Subject|5|||
125021885|NCT01681433|449703350|FG000|Overall Study|Protocol Violation|2|||
125114588|NCT03210259|450042509|FG000|12-Week Run-in Period|Death|1|||
125021886|NCT01681433|449703351|FG001|Overall Study|Protocol Violation|0|||
125021887|NCT01681433|449703350|FG000|Overall Study|Adverse Event|2|||
125021888|NCT01681433|449703351|FG001|Overall Study|Adverse Event|4|||
124905763|NCT04707313|449281164|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905764|NCT04707313|449281165|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905765|NCT04707313|449281166|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
124905766|NCT04707313|449281167|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905767|NCT04707313|449281168|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905768|NCT04707313|449281169|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905769|NCT04707313|449281170|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905770|NCT04707313|449281171|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
124905771|NCT04707313|449281172|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905772|NCT04707313|449281173|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905773|NCT04707313|449281174|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905774|NCT04707313|449281175|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905775|NCT04707313|449281176|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905776|NCT04707313|449281164|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
124905777|NCT04707313|449281165|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
124905778|NCT04707313|449281166|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
124905779|NCT04707313|449281167|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
124905780|NCT04707313|449281168|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
124905781|NCT04707313|449281169|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
124905782|NCT04707313|449281170|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
124905783|NCT04707313|449281171|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
124905784|NCT04707313|449281172|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
124905785|NCT04707313|449281173|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
124905786|NCT04707313|449281174|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
124905787|NCT04707313|449281175|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
124905788|NCT04707313|449281176|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
124905789|NCT04707313|449281164|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
124905790|NCT04707313|449281165|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
124905791|NCT04707313|449281166|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
124905792|NCT04707313|449281167|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
124905793|NCT04707313|449281168|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
124905794|NCT04707313|449281169|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
124905795|NCT04707313|449281170|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
124905796|NCT04707313|449281171|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
124905797|NCT04707313|449281172|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
124905798|NCT04707313|449281173|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
124905799|NCT04707313|449281174|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
124905800|NCT04707313|449281175|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
124905801|NCT04707313|449281176|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
124905802|NCT04707313|449281164|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
124905803|NCT04707313|449281165|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
124905804|NCT04707313|449281166|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
124905805|NCT04707313|449281167|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
124905806|NCT04707313|449281168|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
124905807|NCT04707313|449281169|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
124905808|NCT04707313|449281170|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
124905809|NCT04707313|449281171|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
124905810|NCT04707313|449281172|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
124905811|NCT04707313|449281173|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
124905812|NCT04707313|449281174|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
124905813|NCT04707313|449281175|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
124905814|NCT04707313|449281176|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
124905815|NCT04707313|449281164|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
124905816|NCT04707313|449281165|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
124905817|NCT04707313|449281166|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
124905818|NCT04707313|449281167|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
124905819|NCT04707313|449281168|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
124905820|NCT04707313|449281169|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
124905821|NCT04707313|449281170|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
124905822|NCT04707313|449281171|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
124905823|NCT04707313|449281172|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
124905824|NCT04707313|449281173|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
125114589|NCT03210259|450042510|FG001|12-Week Run-in Period|Death|0|||
125114590|NCT03210259|450042511|FG002|12-Week Run-in Period|Death|0|||
125114591|NCT03210259|450042509|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
124905825|NCT04707313|449281174|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
124905826|NCT04707313|449281175|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
124905827|NCT04707313|449281176|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
125114592|NCT03210259|450042510|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
125114593|NCT03210259|450042511|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
125021889|NCT01681433|449703350|FG000|Overall Study|Lost to Follow-up|0|||
125021890|NCT01681433|449703351|FG001|Overall Study|Lost to Follow-up|1|||
125021891|NCT02301403|449703352|FG000|Overall Study|Withdrawal by Subject|28|||
125021892|NCT02301403|449703353|FG001|Overall Study|Withdrawal by Subject|41|||
125021893|NCT03505021|449703363|FG000|Overall Study|Protocol Violation|1|||
125021894|NCT03505021|449703364|FG001|Overall Study|Protocol Violation|0|||
125021895|NCT03505021|449703363|FG000|Overall Study|Death|9|||
125021896|NCT03505021|449703364|FG001|Overall Study|Death|8|||
125021897|NCT03505021|449703363|FG000|Overall Study|Consent withdrawn by subject|6|||
125021898|NCT03505021|449703364|FG001|Overall Study|Consent withdrawn by subject|1|||
125021899|NCT03505021|449703363|FG000|Overall Study|Lost to Follow-up|5|||
125021900|NCT03505021|449703364|FG001|Overall Study|Lost to Follow-up|3|||
125021901|NCT03505021|449703363|FG000|Overall Study|Adverse Event|26|||
125021902|NCT03505021|449703364|FG001|Overall Study|Adverse Event|9|||
125021903|NCT03505021|449703363|FG000|Overall Study|Disease progression|33|||
125021904|NCT03505021|449703364|FG001|Overall Study|Disease progression|17|||
125021905|NCT03505021|449703363|FG000|Overall Study|Other|11|||
125021906|NCT03505021|449703364|FG001|Overall Study|Other|5|||
125021907|NCT03505021|449703363|FG000|Overall Study|Personal reason|21|||
125021908|NCT03505021|449703364|FG001|Overall Study|Personal reason|12|||
125021909|NCT04705051|449705285|FG000|Overall Study|Enrolled but not treated|1|||
125021910|NCT04705051|449705285|FG000|Overall Study|Study terminated by sponsor|23|||
125021911|NCT00984204|449705296|FG000|Overall Study|Death|1|||
125021912|NCT00984204|449705296|FG000|Overall Study|Lost to Follow-up|4|||
125021913|NCT00984204|449705296|FG000|Overall Study|Lack of Efficacy|10|||
125021914|NCT01268293|449705306|FG000|Overall Study|Disease progression|7|||
125021915|NCT01268293|449705306|FG000|Overall Study|Adverse Event|1|||
125021916|NCT01268293|449705306|FG000|Overall Study|Subject choice|1|||
125021917|NCT00699348|449705307|FG000|Overall Study|Death|6|||
125021918|NCT00699348|449705307|FG000|Overall Study|Adverse Event|15|||
125021919|NCT00699348|449705307|FG000|Overall Study|Withdrawal by Subject|11|||
125021920|NCT00699348|449705307|FG000|Overall Study|Protocol Violation|10|||
125021921|NCT00699348|449705307|FG000|Overall Study|Lack of Efficacy|8|||
125021922|NCT00699348|449705307|FG000|Overall Study|Failure to return|1|||
125021923|NCT00699348|449705307|FG000|Overall Study|Blood transfusion|24|||
125021924|NCT00699348|449705307|FG000|Overall Study|Renal transplantation|10|||
125021925|NCT00699348|449705307|FG000|Overall Study|Other|5|||
125021926|NCT00618748|449705308|FG000|Overall Study|Adverse Event|4|||
125021927|NCT00618748|449705309|FG001|Overall Study|Adverse Event|3|||
125021928|NCT00618748|449705310|FG002|Overall Study|Adverse Event|8|||
125021929|NCT00618748|449705308|FG000|Overall Study|Physician Decision|3|||
125021930|NCT00618748|449705309|FG001|Overall Study|Physician Decision|1|||
125021931|NCT00618748|449705310|FG002|Overall Study|Physician Decision|1|||
125021932|NCT00618748|449705308|FG000|Overall Study|Withdrawal by Subject|4|||
125021933|NCT00618748|449705309|FG001|Overall Study|Withdrawal by Subject|1|||
125021934|NCT00618748|449705310|FG002|Overall Study|Withdrawal by Subject|5|||
125021935|NCT00223496|449705317|FG000|Overall Study|screen failure|9|||
125021936|NCT00223496|449705317|FG000|Overall Study|Lost to Follow-up|4|||
125021937|NCT00223496|449705317|FG000|Overall Study|Lack of Efficacy|6|||
125021938|NCT00223496|449705317|FG000|Overall Study|Withdrawal by Subject|1|||
125114594|NCT03210259|450042509|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
125114595|NCT03210259|450042510|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
125114596|NCT03210259|450042511|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
125021939|NCT00223496|449705317|FG000|Overall Study|Physician Decision|2|||
125021940|NCT05702515|449705318|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
125021941|NCT00424827|449705322|FG000|Overall Study|Adverse Event|1|||
125021942|NCT00159432|449705323|FG000|Overall Study|Adverse Event|1|||
125021943|NCT00159432|449705323|FG000|Overall Study|Death|1|||
125021944|NCT00159432|449705323|FG000|Overall Study|Lack of Efficacy|8|||
125021945|NCT01491178|449705324|FG000|Overall Study|Adverse Event|1016|||
124905828|NCT04707313|449281164|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124905829|NCT04707313|449281165|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124905830|NCT04707313|449281166|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124905831|NCT04707313|449281167|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124905832|NCT04707313|449281168|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124905833|NCT04707313|449281169|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124905834|NCT04707313|449281170|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124905835|NCT04707313|449281171|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124905836|NCT04707313|449281172|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124905837|NCT04707313|449281173|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
124905838|NCT04707313|449281174|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
124905839|NCT04707313|449281175|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124905840|NCT04707313|449281176|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124905841|NCT04707313|449281164|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
124905842|NCT04707313|449281165|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
124905843|NCT04707313|449281166|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
124905844|NCT04707313|449281167|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
124905845|NCT04707313|449281168|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
124905846|NCT04707313|449281169|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
124905847|NCT04707313|449281170|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
124905848|NCT04707313|449281171|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
124905849|NCT04707313|449281172|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
124905850|NCT04707313|449281173|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
124905851|NCT04707313|449281174|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
124905852|NCT04707313|449281175|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
124905853|NCT04707313|449281176|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
124905854|NCT00834834|449281179|FG000|Overall Study|Withdrawal by Subject|4|||
124905855|NCT00834834|449281180|FG001|Overall Study|Withdrawal by Subject|3|||
124905856|NCT00539292|449281181|FG000|Overall Study|Physician Decision|1|||
124905857|NCT00539292|449281182|FG001|Overall Study|Physician Decision|0|||
124905858|NCT02020616|449281183|FG000|Overall Study|Adverse Event|0|||
124905859|NCT02020616|449281184|FG001|Overall Study|Adverse Event|0|||
124905860|NCT02020616|449281185|FG002|Overall Study|Adverse Event|0|||
124905861|NCT02020616|449281186|FG003|Overall Study|Adverse Event|0|||
124905862|NCT02020616|449281187|FG004|Overall Study|Adverse Event|0|||
124905863|NCT02020616|449281188|FG005|Overall Study|Adverse Event|1|||
124905864|NCT02020616|449281189|FG006|Overall Study|Adverse Event|1|||
124905865|NCT02020616|449281183|FG000|Overall Study|Physician Decision|0|||
124905866|NCT02020616|449281184|FG001|Overall Study|Physician Decision|0|||
124905867|NCT02020616|449281185|FG002|Overall Study|Physician Decision|0|||
124905868|NCT02020616|449281186|FG003|Overall Study|Physician Decision|0|||
124905869|NCT02020616|449281187|FG004|Overall Study|Physician Decision|0|||
124905870|NCT02020616|449281188|FG005|Overall Study|Physician Decision|1|||
124905871|NCT02020616|449281189|FG006|Overall Study|Physician Decision|2|||
124905872|NCT02020616|449281183|FG000|Overall Study|Withdrawal by Subject|0|||
124905873|NCT02020616|449281184|FG001|Overall Study|Withdrawal by Subject|0|||
124905874|NCT02020616|449281185|FG002|Overall Study|Withdrawal by Subject|1|||
124905875|NCT02020616|449281186|FG003|Overall Study|Withdrawal by Subject|0|||
124905876|NCT02020616|449281187|FG004|Overall Study|Withdrawal by Subject|0|||
124905877|NCT02020616|449281188|FG005|Overall Study|Withdrawal by Subject|1|||
124905878|NCT02020616|449281189|FG006|Overall Study|Withdrawal by Subject|1|||
124905879|NCT02020616|449281183|FG000|Overall Study|Lost to Follow-up|0|||
124905880|NCT02020616|449281184|FG001|Overall Study|Lost to Follow-up|1|||
124905881|NCT02020616|449281185|FG002|Overall Study|Lost to Follow-up|0|||
125021946|NCT01491178|449705324|FG000|Overall Study|Improvement of NVAF|210|||
125021947|NCT01491178|449705324|FG000|Overall Study|To conduct invasive treatment|59|||
124905882|NCT02020616|449281186|FG003|Overall Study|Lost to Follow-up|1|||
124905883|NCT02020616|449281187|FG004|Overall Study|Lost to Follow-up|1|||
124905884|NCT02020616|449281188|FG005|Overall Study|Lost to Follow-up|1|||
124905885|NCT02020616|449281189|FG006|Overall Study|Lost to Follow-up|0|||
124905886|NCT02020616|449281183|FG000|Overall Study|Early Termination Criteria Met|0|||
124905887|NCT02020616|449281184|FG001|Overall Study|Early Termination Criteria Met|0|||
124905888|NCT02020616|449281185|FG002|Overall Study|Early Termination Criteria Met|1|||
124905889|NCT02020616|449281186|FG003|Overall Study|Early Termination Criteria Met|0|||
124905890|NCT02020616|449281187|FG004|Overall Study|Early Termination Criteria Met|0|||
124905891|NCT02020616|449281188|FG005|Overall Study|Early Termination Criteria Met|1|||
124905892|NCT02020616|449281189|FG006|Overall Study|Early Termination Criteria Met|0|||
124905893|NCT02020616|449281183|FG000|Overall Study|Randomized in Error|0|||
124905894|NCT02020616|449281184|FG001|Overall Study|Randomized in Error|0|||
124905895|NCT02020616|449281185|FG002|Overall Study|Randomized in Error|0|||
124905896|NCT02020616|449281186|FG003|Overall Study|Randomized in Error|1|||
124905897|NCT02020616|449281187|FG004|Overall Study|Randomized in Error|0|||
124905898|NCT02020616|449281188|FG005|Overall Study|Randomized in Error|0|||
124905899|NCT02020616|449281189|FG006|Overall Study|Randomized in Error|0|||
124905900|NCT02020616|449281183|FG000|Overall Study|Lack of Efficacy|0|||
124905901|NCT02020616|449281184|FG001|Overall Study|Lack of Efficacy|0|||
124905902|NCT02020616|449281185|FG002|Overall Study|Lack of Efficacy|0|||
124905903|NCT02020616|449281186|FG003|Overall Study|Lack of Efficacy|0|||
124905904|NCT02020616|449281187|FG004|Overall Study|Lack of Efficacy|1|||
124905905|NCT02020616|449281188|FG005|Overall Study|Lack of Efficacy|0|||
124905906|NCT02020616|449281189|FG006|Overall Study|Lack of Efficacy|0|||
124905907|NCT00305695|449281194|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
124905908|NCT00305695|449281195|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
124905909|NCT00305695|449281194|FG000|Overall Study|Did not have baseline scan|1|||
124905910|NCT00305695|449281195|FG001|Overall Study|Did not have baseline scan|1|||
124905911|NCT02031471|449281198|FG000|24 Week Treatment Period|Adverse Event|6|||
124905912|NCT02031471|449281198|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
124905913|NCT02031471|449281198|FG000|24 Week Treatment Period|Protocol Violation|1|||
124905914|NCT02031471|449281198|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
124905915|NCT02031471|449281198|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
124905916|NCT02031471|449281198|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
124905917|NCT02031471|449281198|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
124905918|NCT00997386|449281199|FG000|Overall Study|Death|7|||
124905919|NCT00961636|449281209|FG000|Overall Study|Adverse Event|35|||
124905920|NCT00961636|449281210|FG001|Overall Study|Adverse Event|54|||
124905921|NCT00961636|449281211|FG002|Overall Study|Adverse Event|13|||
124905922|NCT00961636|449281209|FG000|Overall Study|Flushing Symptoms|29|||
124905923|NCT00961636|449281210|FG001|Overall Study|Flushing Symptoms|46|||
124905924|NCT00961636|449281211|FG002|Overall Study|Flushing Symptoms|3|||
124905925|NCT00961636|449281209|FG000|Overall Study|Lost to Follow-up|2|||
124905926|NCT00961636|449281210|FG001|Overall Study|Lost to Follow-up|3|||
124905927|NCT00961636|449281211|FG002|Overall Study|Lost to Follow-up|1|||
124905928|NCT00961636|449281209|FG000|Overall Study|Physician Decision|3|||
124905929|NCT00961636|449281210|FG001|Overall Study|Physician Decision|1|||
124905930|NCT00961636|449281211|FG002|Overall Study|Physician Decision|1|||
124905931|NCT00961636|449281209|FG000|Overall Study|Protocol Violation|9|||
125114597|NCT03210259|450042509|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
125114598|NCT03210259|450042510|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
125114599|NCT03210259|450042511|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
125114600|NCT03210259|450042509|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
125114601|NCT03210259|450042510|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
125114602|NCT03210259|450042511|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
125114603|NCT03210259|450042509|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
125114604|NCT03210259|450042510|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
125114605|NCT03210259|450042511|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
125114606|NCT03210259|450042509|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
125114607|NCT03210259|450042510|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
125114608|NCT03210259|450042511|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
125114609|NCT03210259|450042509|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
125114610|NCT03210259|450042510|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
125114611|NCT03210259|450042511|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
125114612|NCT03210259|450042509|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
125114613|NCT03210259|450042510|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
125114614|NCT03210259|450042511|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
124905932|NCT00961636|449281210|FG001|Overall Study|Protocol Violation|5|||
124905933|NCT00961636|449281211|FG002|Overall Study|Protocol Violation|1|||
124905934|NCT00961636|449281209|FG000|Overall Study|Withdrawal by Subject|29|||
124905935|NCT00961636|449281210|FG001|Overall Study|Withdrawal by Subject|22|||
124905936|NCT00961636|449281211|FG002|Overall Study|Withdrawal by Subject|13|||
124905937|NCT02551055|449281214|FG000|Overall Study|Death|2|||
124905938|NCT02551055|449281215|FG001|Overall Study|Death|4|||
124905939|NCT02551055|449281216|FG002|Overall Study|Death|2|||
124905940|NCT02551055|449281217|FG003|Overall Study|Death|2|||
124905941|NCT02551055|449281218|FG004|Overall Study|Death|2|||
124905942|NCT02551055|449281219|FG005|Overall Study|Death|1|||
124905943|NCT02551055|449281220|FG006|Overall Study|Death|2|||
124905944|NCT02551055|449281221|FG007|Overall Study|Death|0|||
124905945|NCT02551055|449281214|FG000|Overall Study|Study Terminated by Sponsor|1|||
124905946|NCT02551055|449281215|FG001|Overall Study|Study Terminated by Sponsor|1|||
124905947|NCT02551055|449281216|FG002|Overall Study|Study Terminated by Sponsor|0|||
124905948|NCT02551055|449281217|FG003|Overall Study|Study Terminated by Sponsor|2|||
124905949|NCT02551055|449281218|FG004|Overall Study|Study Terminated by Sponsor|2|||
124905950|NCT02551055|449281219|FG005|Overall Study|Study Terminated by Sponsor|0|||
124905951|NCT02551055|449281220|FG006|Overall Study|Study Terminated by Sponsor|0|||
124905952|NCT02551055|449281221|FG007|Overall Study|Study Terminated by Sponsor|0|||
124905953|NCT02551055|449281214|FG000|Overall Study|Withdrawal by Subject|1|||
124905954|NCT02551055|449281215|FG001|Overall Study|Withdrawal by Subject|1|||
124905955|NCT02551055|449281216|FG002|Overall Study|Withdrawal by Subject|0|||
124905956|NCT02551055|449281217|FG003|Overall Study|Withdrawal by Subject|1|||
124905957|NCT02551055|449281218|FG004|Overall Study|Withdrawal by Subject|2|||
124905958|NCT02551055|449281219|FG005|Overall Study|Withdrawal by Subject|0|||
124905959|NCT02551055|449281220|FG006|Overall Study|Withdrawal by Subject|0|||
124905960|NCT02551055|449281221|FG007|Overall Study|Withdrawal by Subject|0|||
124905961|NCT02551055|449281214|FG000|Overall Study|Reason not specified|0|||
124905962|NCT02551055|449281215|FG001|Overall Study|Reason not specified|0|||
124905963|NCT02551055|449281216|FG002|Overall Study|Reason not specified|0|||
124905964|NCT02551055|449281217|FG003|Overall Study|Reason not specified|0|||
124905965|NCT02551055|449281218|FG004|Overall Study|Reason not specified|1|||
124905966|NCT02551055|449281219|FG005|Overall Study|Reason not specified|0|||
124905967|NCT02551055|449281220|FG006|Overall Study|Reason not specified|1|||
124905968|NCT02551055|449281221|FG007|Overall Study|Reason not specified|0|||
124905969|NCT02041104|449281229|FG000|Overall Study|Lost to Follow-up|1|||
124905970|NCT02041104|449281230|FG001|Overall Study|Lost to Follow-up|4|||
124905971|NCT02041104|449281229|FG000|Overall Study|discomfort during OGTT|0|||
124905972|NCT02041104|449281230|FG001|Overall Study|discomfort during OGTT|3|||
124905973|NCT01063517|449281231|FG000|Overall Study|Consent withdrawal|1|||
124905974|NCT01063517|449281232|FG001|Overall Study|Consent withdrawal|0|||
124905975|NCT01063517|449281231|FG000|Overall Study|Study reached data cut-off|19|||
124905976|NCT01063517|449281232|FG001|Overall Study|Study reached data cut-off|7|||
124905977|NCT01063517|449281231|FG000|Overall Study|Lost to Follow-up|4|||
124905978|NCT01063517|449281232|FG001|Overall Study|Lost to Follow-up|3|||
124905979|NCT01063517|449281231|FG000|Overall Study|Withdrawal by Subject|1|||
124905980|NCT01063517|449281232|FG001|Overall Study|Withdrawal by Subject|2|||
124905981|NCT01063517|449281231|FG000|Overall Study|Death|33|||
124905982|NCT01063517|449281232|FG001|Overall Study|Death|48|||
124905983|NCT01350804|449281233|FG000|Core Study|Withdrawal by Subject|11|||
124905984|NCT01350804|449281234|FG001|Core Study|Withdrawal by Subject|17|||
124905985|NCT01350804|449281235|FG002|Core Study|Withdrawal by Subject|16|||
124905986|NCT01350804|449281236|FG003|Core Study|Withdrawal by Subject|7|||
124905987|NCT01350804|449281233|FG000|Core Study|Study terminated by Sponsor|0|||
124905988|NCT01350804|449281234|FG001|Core Study|Study terminated by Sponsor|0|||
124905989|NCT01350804|449281235|FG002|Core Study|Study terminated by Sponsor|0|||
124905990|NCT01350804|449281236|FG003|Core Study|Study terminated by Sponsor|2|||
124905991|NCT01350804|449281233|FG000|Core Study|Protocol deviation|1|||
124905992|NCT01350804|449281234|FG001|Core Study|Protocol deviation|0|||
125021948|NCT01491178|449705324|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
125021949|NCT01491178|449705324|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
125021950|NCT01491178|449705324|FG000|Overall Study|To take a contraindication|20|||
125021951|NCT01491178|449705324|FG000|Overall Study|Other than specified above|657|||
125021952|NCT05218499|449705325|FG000|Overall Study|Not treated|1|||
125021953|NCT05218499|449705326|FG001|Overall Study|Not treated|1|||
125021954|NCT05218499|449705327|FG002|Overall Study|Not treated|8|||
124905993|NCT01350804|449281235|FG002|Core Study|Protocol deviation|1|||
124905994|NCT01350804|449281236|FG003|Core Study|Protocol deviation|0|||
124905995|NCT01350804|449281233|FG000|Core Study|Physician Decision|1|||
124905996|NCT01350804|449281234|FG001|Core Study|Physician Decision|0|||
124905997|NCT01350804|449281235|FG002|Core Study|Physician Decision|1|||
124905998|NCT01350804|449281236|FG003|Core Study|Physician Decision|3|||
124905999|NCT01350804|449281233|FG000|Core Study|Lost to Follow-up|3|||
124906000|NCT01350804|449281234|FG001|Core Study|Lost to Follow-up|0|||
124906001|NCT01350804|449281235|FG002|Core Study|Lost to Follow-up|2|||
124906002|NCT01350804|449281236|FG003|Core Study|Lost to Follow-up|1|||
124906003|NCT01350804|449281233|FG000|Core Study|Lack of Efficacy|16|||
124906004|NCT01350804|449281234|FG001|Core Study|Lack of Efficacy|19|||
124906005|NCT01350804|449281235|FG002|Core Study|Lack of Efficacy|18|||
124906006|NCT01350804|449281236|FG003|Core Study|Lack of Efficacy|5|||
124906007|NCT01350804|449281233|FG000|Core Study|Death|1|||
124906008|NCT01350804|449281234|FG001|Core Study|Death|1|||
124906009|NCT01350804|449281235|FG002|Core Study|Death|1|||
124906010|NCT01350804|449281236|FG003|Core Study|Death|0|||
124906011|NCT01350804|449281233|FG000|Core Study|Adverse Event|8|||
124906012|NCT01350804|449281234|FG001|Core Study|Adverse Event|10|||
124906013|NCT01350804|449281235|FG002|Core Study|Adverse Event|8|||
124906014|NCT01350804|449281236|FG003|Core Study|Adverse Event|8|||
124906015|NCT01350804|449281233|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
124906016|NCT01350804|449281234|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
125021955|NCT05218499|449705325|FG000|Overall Study|Death|2|||
125021956|NCT05218499|449705326|FG001|Overall Study|Death|0|||
125021957|NCT05218499|449705327|FG002|Overall Study|Death|0|||
125021958|NCT05218499|449705325|FG000|Overall Study|Other than listed|3|||
125021959|NCT05218499|449705326|FG001|Overall Study|Other than listed|7|||
125021960|NCT05218499|449705327|FG002|Overall Study|Other than listed|10|||
125021961|NCT05218499|449705325|FG000|Overall Study|Protocol deviation|5|||
125021962|NCT05218499|449705326|FG001|Overall Study|Protocol deviation|6|||
125021963|NCT05218499|449705327|FG002|Overall Study|Protocol deviation|4|||
125021964|NCT05218499|449705325|FG000|Overall Study|Technical problems|0|||
125021965|NCT05218499|449705326|FG001|Overall Study|Technical problems|1|||
125021966|NCT05218499|449705327|FG002|Overall Study|Technical problems|0|||
125021967|NCT05218499|449705325|FG000|Overall Study|Burden of trial procedures|0|||
125021968|NCT05218499|449705326|FG001|Overall Study|Burden of trial procedures|1|||
125021969|NCT05218499|449705327|FG002|Overall Study|Burden of trial procedures|2|||
125021970|NCT05218499|449705325|FG000|Overall Study|Clinical disease progression|6|||
125021971|NCT05218499|449705326|FG001|Overall Study|Clinical disease progression|6|||
125021972|NCT05218499|449705327|FG002|Overall Study|Clinical disease progression|11|||
125021973|NCT05218499|449705325|FG000|Overall Study|Objective disease progression|44|||
125021974|NCT05218499|449705326|FG001|Overall Study|Objective disease progression|61|||
125021975|NCT05218499|449705327|FG002|Overall Study|Objective disease progression|42|||
125021976|NCT05218499|449705325|FG000|Overall Study|Adverse Event|11|||
125021977|NCT05218499|449705326|FG001|Overall Study|Adverse Event|36|||
125021978|NCT05218499|449705327|FG002|Overall Study|Adverse Event|9|||
125021979|NCT05218499|449705325|FG000|Overall Study|On treatment at time of snapshot|18|||
125114615|NCT03210259|450042509|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
124906017|NCT01350804|449281235|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
124906018|NCT01350804|449281236|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
124906019|NCT01350804|449281233|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
124906020|NCT01350804|449281234|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
124906021|NCT01350804|449281235|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
124906022|NCT01350804|449281236|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
124906023|NCT01350804|449281233|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
124906024|NCT01350804|449281234|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
124906025|NCT01350804|449281235|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
124906026|NCT01350804|449281236|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
124906027|NCT01350804|449281233|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
124906028|NCT01350804|449281234|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
124906029|NCT01350804|449281235|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
124906030|NCT01350804|449281236|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
124906031|NCT01350804|449281233|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
124906032|NCT01350804|449281234|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
124906033|NCT01350804|449281235|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
124906034|NCT01350804|449281236|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
124906035|NCT01350804|449281233|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
124906036|NCT01350804|449281234|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
124906037|NCT01350804|449281235|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
124906038|NCT01350804|449281236|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
124906039|NCT01713946|449281237|FG000|Overall Study|Death|0|||
124906040|NCT01713946|449281238|FG001|Overall Study|Death|2|||
124906041|NCT01713946|449281239|FG002|Overall Study|Death|2|||
124906042|NCT01713946|449281237|FG000|Overall Study|Adverse Event|19|||
124906043|NCT01713946|449281238|FG001|Overall Study|Adverse Event|14|||
124906044|NCT01713946|449281239|FG002|Overall Study|Adverse Event|13|||
124906045|NCT01713946|449281237|FG000|Overall Study|Withdrawal by Subject|12|||
124906046|NCT01713946|449281238|FG001|Overall Study|Withdrawal by Subject|12|||
124906047|NCT01713946|449281239|FG002|Overall Study|Withdrawal by Subject|8|||
124906048|NCT01713946|449281237|FG000|Overall Study|Lack of Efficacy|8|||
124906049|NCT01713946|449281238|FG001|Overall Study|Lack of Efficacy|8|||
124906050|NCT01713946|449281239|FG002|Overall Study|Lack of Efficacy|14|||
124906051|NCT01713946|449281237|FG000|Overall Study|Protocol Violation|2|||
124906052|NCT01713946|449281238|FG001|Overall Study|Protocol Violation|4|||
124906053|NCT01713946|449281239|FG002|Overall Study|Protocol Violation|1|||
124906054|NCT01713946|449281237|FG000|Overall Study|Lost to Follow-up|0|||
124906055|NCT01713946|449281238|FG001|Overall Study|Lost to Follow-up|0|||
124906056|NCT01713946|449281239|FG002|Overall Study|Lost to Follow-up|1|||
124906057|NCT01713946|449281237|FG000|Overall Study|Administrative problems|1|||
124906058|NCT01713946|449281238|FG001|Overall Study|Administrative problems|0|||
124906059|NCT01713946|449281239|FG002|Overall Study|Administrative problems|0|||
124906060|NCT01713946|449281237|FG000|Overall Study|Did not continue in Ext|0|||
124906061|NCT01713946|449281238|FG001|Overall Study|Did not continue in Ext|3|||
124906062|NCT01713946|449281239|FG002|Overall Study|Did not continue in Ext|0|||
124906063|NCT01713946|449281237|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
124906064|NCT01713946|449281238|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
124906065|NCT01713946|449281239|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
124906066|NCT01713946|449281237|FG000|Overall Study|Patients never switched to everolimus|0|||
124906067|NCT01713946|449281238|FG001|Overall Study|Patients never switched to everolimus|0|||
124906068|NCT01713946|449281239|FG002|Overall Study|Patients never switched to everolimus|5|||
124906069|NCT03622580|449282648|FG000|Overall Study|Death|16|||
124906070|NCT03622580|449282649|FG001|Overall Study|Death|21|||
125211102|NCT04767529|450398578|FG000|Overall Study|Required use of a prohibited medication|0|||
125211103|NCT04767529|450398579|FG001|Overall Study|Required use of a prohibited medication|1|||
125211104|NCT04767529|450398580|FG002|Overall Study|Required use of a prohibited medication|0|||
125211105|NCT04767529|450398578|FG000|Overall Study|Withdrawal by Subject|7|||
125211106|NCT04767529|450398579|FG001|Overall Study|Withdrawal by Subject|5|||
125211107|NCT04767529|450398580|FG002|Overall Study|Withdrawal by Subject|4|||
124906071|NCT03622580|449282650|FG002|Overall Study|Death|13|||
124906072|NCT03622580|449282648|FG000|Overall Study|Adverse Event|6|||
124906073|NCT03622580|449282649|FG001|Overall Study|Adverse Event|6|||
124906074|NCT03622580|449282650|FG002|Overall Study|Adverse Event|5|||
124906075|NCT03622580|449282648|FG000|Overall Study|Withdrawal by Subject|12|||
124906076|NCT03622580|449282649|FG001|Overall Study|Withdrawal by Subject|7|||
124906077|NCT03622580|449282650|FG002|Overall Study|Withdrawal by Subject|19|||
124906078|NCT03622580|449282648|FG000|Overall Study|Lost to Follow-up|12|||
124906079|NCT03622580|449282649|FG001|Overall Study|Lost to Follow-up|9|||
124906080|NCT03622580|449282650|FG002|Overall Study|Lost to Follow-up|9|||
124906081|NCT03622580|449282648|FG000|Overall Study|Protocol Violation|1|||
125217428|NCT01348100|450423522|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124906082|NCT03622580|449282649|FG001|Overall Study|Protocol Violation|0|||
124906083|NCT03622580|449282650|FG002|Overall Study|Protocol Violation|1|||
124906084|NCT03622580|449282648|FG000|Overall Study|Physician Decision|3|||
124906085|NCT03622580|449282649|FG001|Overall Study|Physician Decision|0|||
124906086|NCT03622580|449282650|FG002|Overall Study|Physician Decision|1|||
124906087|NCT03622580|449282648|FG000|Overall Study|Pregnancy|0|||
124906088|NCT03622580|449282649|FG001|Overall Study|Pregnancy|1|||
124906089|NCT03622580|449282650|FG002|Overall Study|Pregnancy|0|||
124906090|NCT03622580|449282648|FG000|Overall Study|Lack of Efficacy|0|||
124906091|NCT03622580|449282649|FG001|Overall Study|Lack of Efficacy|0|||
124906092|NCT03622580|449282650|FG002|Overall Study|Lack of Efficacy|1|||
124906093|NCT03622580|449282648|FG000|Overall Study|Other|2|||
124906094|NCT03622580|449282649|FG001|Overall Study|Other|0|||
124906095|NCT03622580|449282650|FG002|Overall Study|Other|3|||
124906096|NCT01930045|449282655|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
124906097|NCT01930045|449282656|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
124906098|NCT01930045|449282657|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
124906099|NCT01930045|449282658|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
124906100|NCT01930045|449282659|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
124906101|NCT01930045|449282660|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
124906102|NCT01930045|449282655|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
124906103|NCT01930045|449282656|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
124906104|NCT01930045|449282657|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
124906105|NCT01930045|449282658|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
124906106|NCT01930045|449282659|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
124906107|NCT01930045|449282660|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
124906108|NCT01147341|449282667|FG000|Double Blind Period|Lack of Efficacy|1|||
124906109|NCT01147341|449282668|FG001|Double Blind Period|Lack of Efficacy|1|||
124906110|NCT01147341|449282667|FG000|Double Blind Period|Withdrawal by Subject|0|||
124906111|NCT01147341|449282668|FG001|Double Blind Period|Withdrawal by Subject|1|||
124906112|NCT01147341|449282667|FG000|Open Label Period|Lack of Efficacy|3|||
124906113|NCT01147341|449282668|FG001|Open Label Period|Lack of Efficacy|0|||
124906114|NCT01147341|449282667|FG000|Open Label Period|Subject moved|1|||
124906115|NCT01147341|449282668|FG001|Open Label Period|Subject moved|0|||
124906116|NCT02808338|449282671|FG000|Screening|Screen Failure|10|||
124906117|NCT02808338|449282671|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
124906118|NCT02808338|449282671|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
124906119|NCT00057837|449282672|FG000|Overall Study|Progression/relapse|12|||
124906120|NCT00057837|449282673|FG001|Overall Study|Progression/relapse|14|||
124906121|NCT00057837|449282672|FG000|Overall Study|Adverse Event|2|||
124906122|NCT00057837|449282673|FG001|Overall Study|Adverse Event|12|||
124906123|NCT00057837|449282672|FG000|Overall Study|Death|5|||
124906124|NCT00057837|449282673|FG001|Overall Study|Death|4|||
124906125|NCT00057837|449282672|FG000|Overall Study|Withdrawal by Subject|5|||
124906126|NCT00057837|449282673|FG001|Overall Study|Withdrawal by Subject|3|||
124906127|NCT00057837|449282672|FG000|Overall Study|Alternative therapy|0|||
124906128|NCT00057837|449282673|FG001|Overall Study|Alternative therapy|1|||
124906129|NCT00057837|449282672|FG000|Overall Study|Other complicating disease|2|||
124906130|NCT00057837|449282673|FG001|Overall Study|Other complicating disease|1|||
124906131|NCT00057837|449282672|FG000|Overall Study|Physician Decision|1|||
124906132|NCT00057837|449282673|FG001|Overall Study|Physician Decision|0|||
124906133|NCT00057837|449282672|FG000|Overall Study|Ineligible|3|||
124906134|NCT00057837|449282673|FG001|Overall Study|Ineligible|3|||
124906135|NCT00057837|449282672|FG000|Overall Study|Never started treatment|1|||
124906136|NCT00057837|449282673|FG001|Overall Study|Never started treatment|1|||
124906137|NCT00463788|449282675|FG000|Overall Study|Progressive Disease|86|||
124906138|NCT00463788|449282676|FG001|Overall Study|Progressive Disease|42|||
124906139|NCT00463788|449282675|FG000|Overall Study|Adverse Event|6|||
124906140|NCT00463788|449282676|FG001|Overall Study|Adverse Event|2|||
124906141|NCT00463788|449282675|FG000|Overall Study|Withdrawal by Subject|6|||
124906142|NCT00463788|449282676|FG001|Overall Study|Withdrawal by Subject|2|||
124906143|NCT00463788|449282675|FG000|Overall Study|Death|4|||
124906144|NCT00463788|449282676|FG001|Overall Study|Death|3|||
124906145|NCT00463788|449282675|FG000|Overall Study|Symptomatic Deterioration|2|||
124906146|NCT00463788|449282676|FG001|Overall Study|Symptomatic Deterioration|3|||
124906147|NCT00463788|449282675|FG000|Overall Study|Lost to Follow-up|1|||
124906148|NCT00463788|449282676|FG001|Overall Study|Lost to Follow-up|0|||
124906149|NCT00463788|449282675|FG000|Overall Study|Protocol Violation|0|||
124906150|NCT00463788|449282676|FG001|Overall Study|Protocol Violation|1|||
124906151|NCT00463788|449282675|FG000|Overall Study|Other|3|||
124906152|NCT00463788|449282676|FG001|Overall Study|Other|0|||
124906153|NCT00463788|449282675|FG000|Overall Study|Randomized but not treated|1|||
124906154|NCT00463788|449282676|FG001|Overall Study|Randomized but not treated|1|||
124906155|NCT00360698|449282677|FG000|Run-In|Physician Decision|0|||
124906156|NCT00360698|449282678|FG001|Run-In|Physician Decision|1|||
124906157|NCT00360698|449282677|FG000|Run-In|Withdrawal by Subject|0|||
124906158|NCT00360698|449282678|FG001|Run-In|Withdrawal by Subject|2|||
124906159|NCT00360698|449282677|FG000|Run-In|Non compliance with treatment procedure|0|||
124906160|NCT00360698|449282678|FG001|Run-In|Non compliance with treatment procedure|1|||
124906161|NCT00360698|449282677|FG000|Run-In|Sponsor request|0|||
124906162|NCT00360698|449282678|FG001|Run-In|Sponsor request|2|||
124906163|NCT00360698|449282677|FG000|Run-In|Patient did not meet inclusion criteria|0|||
124906164|NCT00360698|449282678|FG001|Run-In|Patient did not meet inclusion criteria|1|||
124906165|NCT00360698|449282677|FG000|Run-In|Patient personal reasons|0|||
124906166|NCT00360698|449282678|FG001|Run-In|Patient personal reasons|2|||
124906167|NCT00360698|449282677|FG000|Run-In|Need of insulin with meals|0|||
124906168|NCT00360698|449282678|FG001|Run-In|Need of insulin with meals|1|||
124906169|NCT00360698|449282677|FG000|Treatment Period|Non compliance with treatment procedure|1|||
124906170|NCT00360698|449282678|FG001|Treatment Period|Non compliance with treatment procedure|0|||
124906171|NCT00360698|449282677|FG000|Treatment Period|Early termination by error|0|||
124906172|NCT00360698|449282678|FG001|Treatment Period|Early termination by error|1|||
124906173|NCT03024606|449282683|FG000|Overall Study|Withdrawal by Subject|9|||
124906174|NCT03024606|449282684|FG001|Overall Study|Withdrawal by Subject|10|||
124906175|NCT01692938|449282685|FG000|Overall Study|Protocol Deviation|1|||
124906176|NCT01692938|449282686|FG001|Overall Study|Protocol Deviation|1|||
124906177|NCT01692938|449282685|FG000|Overall Study|Study completed prior to site completion|3|||
124906178|NCT01692938|449282686|FG001|Overall Study|Study completed prior to site completion|3|||
124906179|NCT02547922|449282690|FG000|Overall Study|Withdrawal by Subject|9|||
124906180|NCT02547922|449282691|FG001|Overall Study|Withdrawal by Subject|6|||
124906181|NCT02547922|449282692|FG002|Overall Study|Withdrawal by Subject|10|||
124906182|NCT02547922|449282690|FG000|Overall Study|Adverse Event|3|||
124906183|NCT02547922|449282691|FG001|Overall Study|Adverse Event|1|||
124906184|NCT02547922|449282692|FG002|Overall Study|Adverse Event|2|||
124906185|NCT02547922|449282690|FG000|Overall Study|Lost to Follow-up|1|||
124906186|NCT02547922|449282691|FG001|Overall Study|Lost to Follow-up|0|||
124906187|NCT02547922|449282692|FG002|Overall Study|Lost to Follow-up|0|||
124906188|NCT02547922|449282690|FG000|Overall Study|Lack of Efficacy|5|||
124906189|NCT02547922|449282691|FG001|Overall Study|Lack of Efficacy|7|||
124906190|NCT02547922|449282692|FG002|Overall Study|Lack of Efficacy|4|||
124906191|NCT02547922|449282690|FG000|Overall Study|Death|1|||
124906192|NCT02547922|449282691|FG001|Overall Study|Death|0|||
124906193|NCT02547922|449282692|FG002|Overall Study|Death|0|||
124906194|NCT02547922|449282690|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
124906195|NCT02547922|449282691|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
124906196|NCT02547922|449282692|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
124906197|NCT02547922|449282690|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
124906198|NCT02547922|449282691|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
124906199|NCT02547922|449282692|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
124906200|NCT02547922|449282690|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
124906201|NCT02547922|449282691|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
124906202|NCT02547922|449282692|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
124906203|NCT02547922|449282690|FG000|Overall Study|Physician Decision|2|||
124906204|NCT02547922|449282691|FG001|Overall Study|Physician Decision|1|||
124906205|NCT02547922|449282692|FG002|Overall Study|Physician Decision|2|||
124906206|NCT02547922|449282690|FG000|Overall Study|Patients did not receive IP|1|||
124906207|NCT02547922|449282691|FG001|Overall Study|Patients did not receive IP|1|||
124906208|NCT02547922|449282692|FG002|Overall Study|Patients did not receive IP|0|||
124906209|NCT01317420|449282697|FG000|Overall Study|Progressive disease according to RECIST|2|||
124906210|NCT01317420|449282698|FG001|Overall Study|Progressive disease according to RECIST|3|||
124906211|NCT01317420|449282699|FG002|Overall Study|Progressive disease according to RECIST|3|||
124906212|NCT01317420|449282700|FG003|Overall Study|Progressive disease according to RECIST|3|||
124906213|NCT01317420|449282701|FG004|Overall Study|Progressive disease according to RECIST|3|||
124906214|NCT01317420|449282702|FG005|Overall Study|Progressive disease according to RECIST|3|||
124906215|NCT01317420|449282703|FG006|Overall Study|Progressive disease according to RECIST|3|||
124906216|NCT01317420|449282704|FG007|Overall Study|Progressive disease according to RECIST|3|||
124906217|NCT01317420|449282705|FG008|Overall Study|Progressive disease according to RECIST|3|||
124906218|NCT01317420|449282706|FG009|Overall Study|Progressive disease according to RECIST|2|||
124906219|NCT01317420|449282707|FG010|Overall Study|Progressive disease according to RECIST|3|||
124906220|NCT01317420|449282708|FG011|Overall Study|Progressive disease according to RECIST|11|||
124906221|NCT01317420|449282709|FG012|Overall Study|Progressive disease according to RECIST|16|||
124906222|NCT01317420|449282697|FG000|Overall Study|Other adverse event|1|||
124906223|NCT01317420|449282698|FG001|Overall Study|Other adverse event|0|||
124906224|NCT01317420|449282699|FG002|Overall Study|Other adverse event|0|||
124906225|NCT01317420|449282700|FG003|Overall Study|Other adverse event|0|||
124906226|NCT01317420|449282701|FG004|Overall Study|Other adverse event|0|||
124906227|NCT01317420|449282702|FG005|Overall Study|Other adverse event|0|||
124906228|NCT01317420|449282703|FG006|Overall Study|Other adverse event|0|||
125021980|NCT05218499|449705326|FG001|Overall Study|On treatment at time of snapshot|29|||
125021981|NCT05218499|449705327|FG002|Overall Study|On treatment at time of snapshot|0|||
124906229|NCT01317420|449282704|FG007|Overall Study|Other adverse event|0|||
124906230|NCT01317420|449282705|FG008|Overall Study|Other adverse event|0|||
125021982|NCT05689047|449705328|FG000|Overall Study|Lost to Follow-up|0|||
124906231|NCT01317420|449282706|FG009|Overall Study|Other adverse event|0|||
124906232|NCT01317420|449282707|FG010|Overall Study|Other adverse event|0|||
124906233|NCT01317420|449282708|FG011|Overall Study|Other adverse event|0|||
124906234|NCT01317420|449282709|FG012|Overall Study|Other adverse event|2|||
124906235|NCT01317420|449282697|FG000|Overall Study|Non-compliant with protocol|0|||
124906236|NCT01317420|449282698|FG001|Overall Study|Non-compliant with protocol|0|||
124906237|NCT01317420|449282699|FG002|Overall Study|Non-compliant with protocol|0|||
124906238|NCT01317420|449282700|FG003|Overall Study|Non-compliant with protocol|0|||
124906239|NCT01317420|449282701|FG004|Overall Study|Non-compliant with protocol|0|||
124906240|NCT01317420|449282702|FG005|Overall Study|Non-compliant with protocol|0|||
124906241|NCT01317420|449282703|FG006|Overall Study|Non-compliant with protocol|0|||
124906242|NCT01317420|449282704|FG007|Overall Study|Non-compliant with protocol|0|||
124906243|NCT01317420|449282705|FG008|Overall Study|Non-compliant with protocol|0|||
124906244|NCT01317420|449282706|FG009|Overall Study|Non-compliant with protocol|0|||
124906245|NCT01317420|449282707|FG010|Overall Study|Non-compliant with protocol|0|||
124906246|NCT01317420|449282708|FG011|Overall Study|Non-compliant with protocol|0|||
124906247|NCT01317420|449282709|FG012|Overall Study|Non-compliant with protocol|1|||
124906248|NCT01317420|449282697|FG000|Overall Study|Refused to cont. taking trial medication|0|||
124906249|NCT01317420|449282698|FG001|Overall Study|Refused to cont. taking trial medication|0|||
124906250|NCT01317420|449282699|FG002|Overall Study|Refused to cont. taking trial medication|0|||
124906251|NCT01317420|449282700|FG003|Overall Study|Refused to cont. taking trial medication|0|||
124906252|NCT01317420|449282701|FG004|Overall Study|Refused to cont. taking trial medication|0|||
124906253|NCT01317420|449282702|FG005|Overall Study|Refused to cont. taking trial medication|0|||
124906254|NCT01317420|449282703|FG006|Overall Study|Refused to cont. taking trial medication|0|||
124906255|NCT01317420|449282704|FG007|Overall Study|Refused to cont. taking trial medication|0|||
124906256|NCT01317420|449282705|FG008|Overall Study|Refused to cont. taking trial medication|0|||
124906257|NCT01317420|449282706|FG009|Overall Study|Refused to cont. taking trial medication|0|||
124906258|NCT01317420|449282707|FG010|Overall Study|Refused to cont. taking trial medication|0|||
124906259|NCT01317420|449282708|FG011|Overall Study|Refused to cont. taking trial medication|0|||
124906260|NCT01317420|449282709|FG012|Overall Study|Refused to cont. taking trial medication|1|||
125021983|NCT05689047|449705329|FG001|Overall Study|Lost to Follow-up|1|||
125021984|NCT05689047|449705328|FG000|Overall Study|Protocol Deviation|1|||
124906261|NCT01317420|449282697|FG000|Overall Study|Reason other than those specified|0|||
124906262|NCT01317420|449282698|FG001|Overall Study|Reason other than those specified|0|||
124906263|NCT01317420|449282699|FG002|Overall Study|Reason other than those specified|0|||
124906264|NCT01317420|449282700|FG003|Overall Study|Reason other than those specified|0|||
124906265|NCT01317420|449282701|FG004|Overall Study|Reason other than those specified|0|||
124906266|NCT01317420|449282702|FG005|Overall Study|Reason other than those specified|0|||
124906267|NCT01317420|449282703|FG006|Overall Study|Reason other than those specified|0|||
124906268|NCT01317420|449282704|FG007|Overall Study|Reason other than those specified|0|||
124906269|NCT01317420|449282705|FG008|Overall Study|Reason other than those specified|0|||
124906270|NCT01317420|449282706|FG009|Overall Study|Reason other than those specified|1|||
124906271|NCT01317420|449282707|FG010|Overall Study|Reason other than those specified|0|||
124906272|NCT01317420|449282708|FG011|Overall Study|Reason other than those specified|0|||
124906273|NCT01317420|449282709|FG012|Overall Study|Reason other than those specified|0|||
124906274|NCT03194958|449282710|FG000|Overall Study|Death|0|||
124906275|NCT03194958|449282711|FG001|Overall Study|Death|1|||
124906276|NCT03194958|449282712|FG002|Overall Study|Death|1|||
124906277|NCT03194958|449282713|FG003|Overall Study|Death|1|||
124906278|NCT03194958|449282710|FG000|Overall Study|Withdrawal by Subject|24|||
124906279|NCT03194958|449282711|FG001|Overall Study|Withdrawal by Subject|27|||
124906280|NCT03194958|449282712|FG002|Overall Study|Withdrawal by Subject|7|||
124906281|NCT03194958|449282713|FG003|Overall Study|Withdrawal by Subject|22|||
124906282|NCT03194958|449282710|FG000|Overall Study|Lost to Follow-up|168|||
124906283|NCT03194958|449282711|FG001|Overall Study|Lost to Follow-up|196|||
124906284|NCT03194958|449282712|FG002|Overall Study|Lost to Follow-up|174|||
124906285|NCT03194958|449282713|FG003|Overall Study|Lost to Follow-up|186|||
124906286|NCT01968226|449282715|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
124906287|NCT04975308|449282720|FG000|Overall Study|Withdrawal by Subject|6|||
124906288|NCT04975308|449282721|FG001|Overall Study|Withdrawal by Subject|16|||
124906289|NCT04975308|449282722|FG002|Overall Study|Withdrawal by Subject|6|||
124906290|NCT04975308|449282720|FG000|Overall Study|Physician Decision|0|||
124906291|NCT04975308|449282721|FG001|Overall Study|Physician Decision|3|||
124906292|NCT04975308|449282722|FG002|Overall Study|Physician Decision|1|||
124906293|NCT04975308|449282720|FG000|Overall Study|Adverse Event|10|||
124906294|NCT04975308|449282721|FG001|Overall Study|Adverse Event|1|||
124906295|NCT04975308|449282722|FG002|Overall Study|Adverse Event|12|||
124906296|NCT04975308|449282720|FG000|Overall Study|On study treatment (Ongoing)|65|||
124906297|NCT04975308|449282721|FG001|Overall Study|On study treatment (Ongoing)|43|||
124906298|NCT04975308|449282722|FG002|Overall Study|On study treatment (Ongoing)|75|||
125021985|NCT05689047|449705329|FG001|Overall Study|Protocol Deviation|0|||
125021986|NCT01604512|449705330|FG000|Overall Study|Withdrawal by Subject|3|||
125021987|NCT01604512|449705330|FG000|Overall Study|Not treated|4|||
125021988|NCT03655756|449705331|FG000|Overall Study|Death|1|||
125021989|NCT00253630|449705332|FG000|Overall Study|ineligible|2|||
125021990|NCT03237065|449705333|FG000|Overall Study|Adverse Event|0|||
125021991|NCT03237065|449705334|FG001|Overall Study|Adverse Event|2|||
125021992|NCT03237065|449705333|FG000|Overall Study|Protocol Violation|0|||
125021993|NCT03237065|449705334|FG001|Overall Study|Protocol Violation|1|||
125021994|NCT03237065|449705333|FG000|Overall Study|Withdrawal by Subject|3|||
125021995|NCT03237065|449705334|FG001|Overall Study|Withdrawal by Subject|0|||
125021996|NCT03237065|449705333|FG000|Overall Study|Lost to Follow-up|1|||
125021997|NCT03237065|449705334|FG001|Overall Study|Lost to Follow-up|0|||
125021998|NCT03237065|449705333|FG000|Overall Study|Unable to obtain venous access|0|||
125021999|NCT03237065|449705334|FG001|Overall Study|Unable to obtain venous access|1|||
125022000|NCT00209339|449705335|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
125022001|NCT00209339|449705335|FG000|At 12 Months Follow-up|Death|1|||
125022002|NCT00209339|449705335|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
125022003|NCT00209339|449705335|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
125022004|NCT00209339|449705335|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
125022005|NCT00209339|449705335|FG000|At 24 Months Follow-up|Death|1|||
125022006|NCT00209339|449705335|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
125022007|NCT00209339|449705335|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
125022008|NCT00209339|449705335|FG000|At 4 Years Follow-up|Death|1|||
125022009|NCT00209339|449705335|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
125022010|NCT00209339|449705335|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
125022011|NCT00209339|449705335|FG000|At 5 Years Follow-up|Death|1|||
125022012|NCT00429858|449705336|FG000|Overall Study|Withdrawal by Subject|1|||
125022013|NCT00429858|449705336|FG000|Overall Study|Study Termination|1|||
125022014|NCT01587079|449705337|FG000|Overall Study|Protocol-specified criteria|9|||
125022015|NCT01587079|449705337|FG000|Overall Study|Protocol Violation|5|||
125022016|NCT01587079|449705337|FG000|Overall Study|Lost to Follow-up|2|||
125022017|NCT01587079|449705337|FG000|Overall Study|Physician Decision|2|||
125022018|NCT01587079|449705337|FG000|Overall Study|Withdrawal by Subject|7|||
124906299|NCT04975308|449282720|FG000|Overall Study|Protocol Deviation|4|||
124906300|NCT04975308|449282721|FG001|Overall Study|Protocol Deviation|3|||
124906301|NCT04975308|449282722|FG002|Overall Study|Protocol Deviation|2|||
125114616|NCT03210259|450042510|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
125114617|NCT03210259|450042511|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
125114618|NCT02110706|450042512|FG000|Overall Study|Adverse Event|2|||
125114619|NCT02110706|450042513|FG001|Overall Study|Adverse Event|3|||
125114620|NCT02110706|450042512|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
125114621|NCT02110706|450042513|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
125114622|NCT02087059|450042514|FG000|Overall Study|Disease Progression|1|||
125114623|NCT02087059|450042514|FG000|Overall Study|Adverse Event|5|||
125114624|NCT02087059|450042514|FG000|Overall Study|Lost to Follow-up|1|||
125114625|NCT00252187|450042515|FG000|Overall Study|Adverse Event|3|||
125114626|NCT00252187|450042516|FG001|Overall Study|Adverse Event|1|||
124906302|NCT02709655|449282723|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
124906303|NCT02709655|449282724|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
124906304|NCT02709655|449282725|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
124906305|NCT02709655|449282726|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
124906306|NCT02709655|449282727|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
124906307|NCT02709655|449282723|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
124906308|NCT02709655|449282724|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
124906309|NCT02709655|449282725|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
124906310|NCT02709655|449282726|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
124906311|NCT02709655|449282727|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
124906312|NCT02709655|449282723|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
124906313|NCT02709655|449282724|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
124906314|NCT02709655|449282725|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
124906315|NCT02709655|449282726|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
124906316|NCT02709655|449282727|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
124906317|NCT02709655|449282723|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
124906318|NCT02709655|449282724|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
124906319|NCT02709655|449282725|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
124906320|NCT02709655|449282726|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
124906321|NCT02709655|449282727|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
124906322|NCT02709655|449282723|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
124906323|NCT02709655|449282724|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
124906324|NCT02709655|449282725|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
124906325|NCT02709655|449282726|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
124906326|NCT02709655|449282727|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
124906327|NCT02709655|449282723|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
124906328|NCT02709655|449282724|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
124906329|NCT02709655|449282725|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
124906330|NCT02709655|449282726|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
124906331|NCT02709655|449282727|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
124906332|NCT02709655|449282723|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
124906333|NCT02709655|449282724|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
124906334|NCT02709655|449282725|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
124906335|NCT02709655|449282726|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
124906336|NCT02709655|449282727|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
124906337|NCT02709655|449282723|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
124906338|NCT02709655|449282724|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
124906339|NCT02709655|449282725|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
124906340|NCT02709655|449282726|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
124906341|NCT02709655|449282727|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
124906342|NCT02709655|449282723|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
124906343|NCT02709655|449282724|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
124906344|NCT02709655|449282725|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
124906345|NCT02709655|449282726|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
124906346|NCT02709655|449282727|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
124906347|NCT02709655|449282723|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
124906348|NCT02709655|449282724|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
124906349|NCT02709655|449282725|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
124906350|NCT02709655|449282726|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
125114627|NCT00252187|450042515|FG000|Overall Study|Withdrawal by Subject|1|||
125114628|NCT00252187|450042516|FG001|Overall Study|Withdrawal by Subject|0|||
125114629|NCT05017493|450042519|FG000|Overall Study|Withdrawal by Subject|26|||
125114630|NCT05017493|450042520|FG001|Overall Study|Withdrawal by Subject|0|||
124906351|NCT02709655|449282727|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
124906352|NCT02709655|449282723|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
124906353|NCT02709655|449282724|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
125114631|NCT05017493|450042519|FG000|Overall Study|Physician Decision|15|||
125114632|NCT05017493|450042520|FG001|Overall Study|Physician Decision|0|||
124906354|NCT02709655|449282725|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
124906355|NCT02709655|449282726|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
124906356|NCT02709655|449282727|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
124906357|NCT02709655|449282723|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
124906358|NCT02709655|449282724|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
124906359|NCT02709655|449282725|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
124906360|NCT02709655|449282726|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
124906361|NCT02709655|449282727|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
124906362|NCT02709655|449282723|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
124906363|NCT02709655|449282724|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
124906364|NCT02709655|449282725|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
124906365|NCT02709655|449282726|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
124906366|NCT02709655|449282727|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
124906367|NCT02709655|449282723|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
124906368|NCT02709655|449282724|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
124906369|NCT02709655|449282725|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
124906370|NCT02709655|449282726|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
124906371|NCT02709655|449282727|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
124906372|NCT02709655|449282723|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
124906373|NCT02709655|449282724|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
124906374|NCT02709655|449282725|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
124906375|NCT02709655|449282726|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
124906376|NCT02709655|449282727|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
124906377|NCT02709655|449282723|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
124906378|NCT02709655|449282724|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
124906379|NCT02709655|449282725|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
124906380|NCT02709655|449282726|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
124906381|NCT02709655|449282727|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
124906382|NCT00102063|449282728|FG000|Overall Study|Lack of Efficacy|5|||
124906383|NCT00102063|449282729|FG001|Overall Study|Lack of Efficacy|1|||
124906384|NCT00102063|449282730|FG002|Overall Study|Lack of Efficacy|1|||
124906385|NCT00102063|449282728|FG000|Overall Study|Adverse Event|7|||
124906386|NCT00102063|449282729|FG001|Overall Study|Adverse Event|4|||
124906387|NCT00102063|449282730|FG002|Overall Study|Adverse Event|2|||
124906388|NCT00102063|449282728|FG000|Overall Study|Withdrawal by Subject|4|||
124906389|NCT00102063|449282729|FG001|Overall Study|Withdrawal by Subject|12|||
124906390|NCT00102063|449282730|FG002|Overall Study|Withdrawal by Subject|5|||
124906391|NCT00102063|449282728|FG000|Overall Study|Lost to Follow-up|0|||
124906392|NCT00102063|449282729|FG001|Overall Study|Lost to Follow-up|0|||
124906393|NCT00102063|449282730|FG002|Overall Study|Lost to Follow-up|1|||
124906394|NCT00102063|449282728|FG000|Overall Study|Protocol Violation|0|||
124906395|NCT00102063|449282729|FG001|Overall Study|Protocol Violation|1|||
124906396|NCT00102063|449282730|FG002|Overall Study|Protocol Violation|1|||
124906397|NCT05082025|449282731|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
124906398|NCT04210180|449282732|FG000|Overall Study|Withdrawal by Subject|2|||
124906399|NCT01179334|449282733|FG000|Treatment Period|Adverse Event|1|||
124906400|NCT01179334|449282734|FG001|Treatment Period|Adverse Event|0|||
124906401|NCT01179334|449282733|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
124906402|NCT01179334|449282734|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
124906403|NCT01179334|449282733|FG000|Long-term Extension (LTE) Period|Death|3|||
124906404|NCT01179334|449282734|FG001|Long-term Extension (LTE) Period|Death|0|||
124906405|NCT01179334|449282733|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
124906406|NCT01179334|449282734|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
125114633|NCT05017493|450042519|FG000|Overall Study|Protocol Violation|81|||
125114634|NCT05017493|450042520|FG001|Overall Study|Protocol Violation|0|||
125114635|NCT01261325|450042527|FG000|Overall Study|Lack of Efficacy|1|||
125114636|NCT01261325|450042528|FG001|Overall Study|Lack of Efficacy|1|||
125114637|NCT01261325|450042529|FG002|Overall Study|Lack of Efficacy|0|||
125114638|NCT01261325|450042527|FG000|Overall Study|Withdrawal by Subject|2|||
125114639|NCT01261325|450042528|FG001|Overall Study|Withdrawal by Subject|2|||
125114640|NCT01261325|450042529|FG002|Overall Study|Withdrawal by Subject|4|||
125114641|NCT01261325|450042527|FG000|Overall Study|SAE, non-fatal|1|||
125114642|NCT01261325|450042528|FG001|Overall Study|SAE, non-fatal|5|||
124906407|NCT05190419|449282735|FG000|Overall Study|Lack of Efficacy|8|||
124906408|NCT05190419|449282736|FG001|Overall Study|Lack of Efficacy|0|||
124906409|NCT05190419|449282737|FG002|Overall Study|Lack of Efficacy|1|||
124906410|NCT05190419|449282738|FG003|Overall Study|Lack of Efficacy|0|||
124906411|NCT05190419|449282735|FG000|Overall Study|Withdrawal by Subject|7|||
124906412|NCT05190419|449282736|FG001|Overall Study|Withdrawal by Subject|1|||
124906413|NCT05190419|449282737|FG002|Overall Study|Withdrawal by Subject|2|||
125114643|NCT01261325|450042529|FG002|Overall Study|SAE, non-fatal|1|||
124906414|NCT05190419|449282738|FG003|Overall Study|Withdrawal by Subject|2|||
124906415|NCT05190419|449282735|FG000|Overall Study|Adverse Event|2|||
124906416|NCT05190419|449282736|FG001|Overall Study|Adverse Event|10|||
124906417|NCT05190419|449282737|FG002|Overall Study|Adverse Event|11|||
124906418|NCT05190419|449282738|FG003|Overall Study|Adverse Event|21|||
124906419|NCT05190419|449282735|FG000|Overall Study|Lost to Follow-up|1|||
124906420|NCT05190419|449282736|FG001|Overall Study|Lost to Follow-up|2|||
124906421|NCT05190419|449282737|FG002|Overall Study|Lost to Follow-up|3|||
124906422|NCT05190419|449282738|FG003|Overall Study|Lost to Follow-up|1|||
124906423|NCT05190419|449282735|FG000|Overall Study|Other|1|||
124906424|NCT05190419|449282736|FG001|Overall Study|Other|1|||
124906425|NCT05190419|449282737|FG002|Overall Study|Other|0|||
124906426|NCT05190419|449282738|FG003|Overall Study|Other|3|||
124906427|NCT00919763|449282739|FG000|Overall Study|Adverse Event|7|||
124906428|NCT00919763|449282740|FG001|Overall Study|Adverse Event|1|||
124906429|NCT00919763|449282739|FG000|Overall Study|Lost to Follow-up|1|||
124906430|NCT00919763|449282740|FG001|Overall Study|Lost to Follow-up|0|||
124906431|NCT00919763|449282739|FG000|Overall Study|Protocol Violation|1|||
124906432|NCT00919763|449282740|FG001|Overall Study|Protocol Violation|1|||
124906433|NCT00919763|449282739|FG000|Overall Study|Withdrawal by Subject|3|||
124906434|NCT00919763|449282740|FG001|Overall Study|Withdrawal by Subject|1|||
124906435|NCT00919763|449282739|FG000|Overall Study|Non-compliance|0|||
124906436|NCT00919763|449282740|FG001|Overall Study|Non-compliance|1|||
124906437|NCT00256243|449282744|FG000|Overall Study|Lost to Follow-up|2|||
124906438|NCT00256243|449282744|FG000|Overall Study|Death|7|||
124906439|NCT00256243|449282744|FG000|Overall Study|Not treated|1|||
124906440|NCT05061693|449282745|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
124906441|NCT05061693|449282746|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
124906442|NCT05061693|449282747|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
124906443|NCT05061693|449282748|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
124906444|NCT05061693|449282749|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
124906445|NCT05061693|449282750|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
124906446|NCT05061693|449282751|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
124906447|NCT05061693|449282752|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
124906448|NCT05061693|449282753|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
124906449|NCT05061693|449282754|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
124906450|NCT05061693|449282755|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
124906451|NCT05061693|449282756|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
124906452|NCT05061693|449282745|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
124906453|NCT05061693|449282746|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
124906454|NCT05061693|449282747|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
124906455|NCT05061693|449282748|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
124906456|NCT05061693|449282749|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
124906457|NCT05061693|449282750|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
124906458|NCT05061693|449282751|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
124906459|NCT05061693|449282752|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
124906460|NCT05061693|449282753|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
124906461|NCT05061693|449282754|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
124906462|NCT05061693|449282755|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
124906463|NCT05061693|449282756|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
124906464|NCT05061693|449282745|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
124906465|NCT05061693|449282746|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
124906466|NCT05061693|449282747|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
124906467|NCT05061693|449282748|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
124906468|NCT05061693|449282749|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
124906469|NCT05061693|449282750|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
124906470|NCT05061693|449282751|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
125022019|NCT01587079|449705337|FG000|Overall Study|Adverse Event|14|||
125022020|NCT04781816|449705338|FG000|Overall Study|Adverse Event|0|||
125022021|NCT04781816|449705339|FG001|Overall Study|Adverse Event|1|||
125022022|NCT04781816|449705338|FG000|Overall Study|Withdrawal by Subject|1|||
125022023|NCT04781816|449705339|FG001|Overall Study|Withdrawal by Subject|1|||
125022024|NCT04781816|449705338|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
125022025|NCT04781816|449705339|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
125022026|NCT01121393|449705340|FG000|Overall Study|Progressive disease|201|||
125022027|NCT01121393|449705341|FG001|Overall Study|Progressive disease|20|||
125022028|NCT01121393|449705340|FG000|Overall Study|Other Adverse events|24|||
125022029|NCT01121393|449705341|FG001|Overall Study|Other Adverse events|45|||
125022030|NCT01121393|449705340|FG000|Overall Study|Non-compliant with protocol|0|||
125022031|NCT01121393|449705341|FG001|Overall Study|Non-compliant with protocol|3|||
125022032|NCT01121393|449705340|FG000|Overall Study|Lost to Follow-up|1|||
125022033|NCT01121393|449705341|FG001|Overall Study|Lost to Follow-up|0|||
125022034|NCT01121393|449705340|FG000|Overall Study|Refused cont. medication|7|||
124906471|NCT05061693|449282752|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
124906472|NCT05061693|449282753|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
124906473|NCT05061693|449282754|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
124906474|NCT05061693|449282755|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
124906475|NCT05061693|449282756|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
124906476|NCT05061693|449282745|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906477|NCT05061693|449282746|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906478|NCT05061693|449282747|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
124906479|NCT05061693|449282748|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906480|NCT05061693|449282749|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906481|NCT05061693|449282750|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906482|NCT05061693|449282751|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906483|NCT05061693|449282752|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906484|NCT05061693|449282753|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906485|NCT05061693|449282754|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906486|NCT05061693|449282755|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906487|NCT05061693|449282756|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906488|NCT05061693|449282745|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
124906489|NCT05061693|449282746|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
124906490|NCT05061693|449282747|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
124906491|NCT05061693|449282748|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
124906492|NCT05061693|449282749|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
124906493|NCT05061693|449282750|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
124906494|NCT05061693|449282751|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
125114644|NCT01261325|450042527|FG000|Overall Study|AE, non-serious non-fatal|9|||
125114645|NCT01261325|450042528|FG001|Overall Study|AE, non-serious non-fatal|15|||
125114646|NCT01261325|450042529|FG002|Overall Study|AE, non-serious non-fatal|13|||
125114647|NCT01261325|450042527|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
125114648|NCT01261325|450042528|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
125114649|NCT01261325|450042529|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
125114650|NCT01261325|450042527|FG000|Overall Study|Non Compliance|2|||
125114651|NCT01261325|450042528|FG001|Overall Study|Non Compliance|0|||
125114652|NCT01261325|450042529|FG002|Overall Study|Non Compliance|0|||
125114653|NCT01261325|450042527|FG000|Overall Study|Patient Randomized by Mistake|0|||
125114654|NCT01261325|450042528|FG001|Overall Study|Patient Randomized by Mistake|1|||
125114655|NCT01261325|450042529|FG002|Overall Study|Patient Randomized by Mistake|0|||
125114656|NCT01261325|450042527|FG000|Overall Study|Erroneously Randomized|1|||
125114657|NCT01261325|450042528|FG001|Overall Study|Erroneously Randomized|0|||
125114658|NCT01261325|450042529|FG002|Overall Study|Erroneously Randomized|0|||
125114659|NCT01261325|450042527|FG000|Overall Study|Screen Failure|1|||
125114660|NCT01261325|450042528|FG001|Overall Study|Screen Failure|0|||
125114661|NCT01261325|450042529|FG002|Overall Study|Screen Failure|0|||
125114662|NCT01261325|450042527|FG000|Overall Study|Randomized in Error|0|||
125114663|NCT01261325|450042528|FG001|Overall Study|Randomized in Error|0|||
125114664|NCT01261325|450042529|FG002|Overall Study|Randomized in Error|1|||
125114665|NCT01261325|450042527|FG000|Overall Study|Protocol Violation|0|||
125114666|NCT01261325|450042528|FG001|Overall Study|Protocol Violation|3|||
125114667|NCT01261325|450042529|FG002|Overall Study|Protocol Violation|1|||
125114668|NCT01261325|450042527|FG000|Overall Study|Lost to Follow-up|0|||
125114669|NCT01261325|450042528|FG001|Overall Study|Lost to Follow-up|1|||
125114670|NCT01261325|450042529|FG002|Overall Study|Lost to Follow-up|3|||
125114671|NCT01261325|450042527|FG000|Overall Study|AE, serious fatal|0|||
125114672|NCT01261325|450042528|FG001|Overall Study|AE, serious fatal|0|||
125114673|NCT01261325|450042529|FG002|Overall Study|AE, serious fatal|2|||
124906495|NCT05061693|449282752|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
124906496|NCT05061693|449282753|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
125114674|NCT03469271|450042532|FG000|Overall Study|Withdrawal by Subject|2|||
125114675|NCT03469271|450042533|FG001|Overall Study|Withdrawal by Subject|0|||
124906497|NCT05061693|449282754|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
125114676|NCT03469271|450042534|FG002|Overall Study|Withdrawal by Subject|0|||
125114677|NCT03469271|450042535|FG003|Overall Study|Withdrawal by Subject|1|||
125114678|NCT03404206|450042540|FG000|Overall Study|Withdrawal by Subject|1|||
125114679|NCT03404206|450042541|FG001|Overall Study|Withdrawal by Subject|1|||
125114680|NCT03404206|450042542|FG002|Overall Study|Withdrawal by Subject|0|||
124906498|NCT05061693|449282755|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
124906499|NCT05061693|449282756|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
124906500|NCT05061693|449282745|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
124906501|NCT05061693|449282746|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
124906502|NCT05061693|449282747|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
124906503|NCT05061693|449282748|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
125217429|NCT01348100|450423523|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124906504|NCT05061693|449282749|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
124906505|NCT05061693|449282750|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
124906506|NCT05061693|449282751|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
124906507|NCT05061693|449282752|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
124906508|NCT05061693|449282753|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
124906509|NCT05061693|449282754|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
124906510|NCT05061693|449282755|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
124906511|NCT05061693|449282756|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
124906512|NCT05061693|449282745|FG000|24-week Extension Period|Adverse Event|0|||
124906513|NCT05061693|449282746|FG001|24-week Extension Period|Adverse Event|0|||
124906514|NCT05061693|449282747|FG002|24-week Extension Period|Adverse Event|0|||
124906515|NCT05061693|449282748|FG003|24-week Extension Period|Adverse Event|0|||
124906516|NCT05061693|449282749|FG004|24-week Extension Period|Adverse Event|0|||
124906517|NCT05061693|449282750|FG005|24-week Extension Period|Adverse Event|0|||
124906518|NCT05061693|449282751|FG006|24-week Extension Period|Adverse Event|0|||
124906519|NCT05061693|449282752|FG007|24-week Extension Period|Adverse Event|2|||
124906520|NCT05061693|449282753|FG008|24-week Extension Period|Adverse Event|2|||
124906521|NCT05061693|449282754|FG009|24-week Extension Period|Adverse Event|0|||
124906522|NCT05061693|449282755|FG010|24-week Extension Period|Adverse Event|1|||
124906523|NCT05061693|449282756|FG011|24-week Extension Period|Adverse Event|3|||
124906524|NCT05061693|449282745|FG000|24-week Extension Period|Lack of Efficacy|0|||
124906525|NCT05061693|449282746|FG001|24-week Extension Period|Lack of Efficacy|0|||
124906526|NCT05061693|449282747|FG002|24-week Extension Period|Lack of Efficacy|0|||
124906527|NCT05061693|449282748|FG003|24-week Extension Period|Lack of Efficacy|0|||
124906528|NCT05061693|449282749|FG004|24-week Extension Period|Lack of Efficacy|0|||
124906529|NCT05061693|449282750|FG005|24-week Extension Period|Lack of Efficacy|0|||
124906530|NCT05061693|449282751|FG006|24-week Extension Period|Lack of Efficacy|0|||
124906531|NCT05061693|449282752|FG007|24-week Extension Period|Lack of Efficacy|0|||
124906532|NCT05061693|449282753|FG008|24-week Extension Period|Lack of Efficacy|0|||
124906533|NCT05061693|449282754|FG009|24-week Extension Period|Lack of Efficacy|0|||
124906534|NCT05061693|449282755|FG010|24-week Extension Period|Lack of Efficacy|2|||
124906535|NCT05061693|449282756|FG011|24-week Extension Period|Lack of Efficacy|0|||
124906536|NCT05061693|449282745|FG000|24-week Extension Period|Lost to Follow-up|0|||
124906537|NCT05061693|449282746|FG001|24-week Extension Period|Lost to Follow-up|0|||
124906538|NCT05061693|449282747|FG002|24-week Extension Period|Lost to Follow-up|0|||
124906539|NCT05061693|449282748|FG003|24-week Extension Period|Lost to Follow-up|0|||
124906540|NCT05061693|449282749|FG004|24-week Extension Period|Lost to Follow-up|0|||
124906541|NCT05061693|449282750|FG005|24-week Extension Period|Lost to Follow-up|0|||
124906542|NCT05061693|449282751|FG006|24-week Extension Period|Lost to Follow-up|1|||
124906543|NCT05061693|449282752|FG007|24-week Extension Period|Lost to Follow-up|0|||
124906544|NCT05061693|449282753|FG008|24-week Extension Period|Lost to Follow-up|1|||
124906545|NCT05061693|449282754|FG009|24-week Extension Period|Lost to Follow-up|1|||
124906546|NCT05061693|449282755|FG010|24-week Extension Period|Lost to Follow-up|0|||
124906547|NCT05061693|449282756|FG011|24-week Extension Period|Lost to Follow-up|0|||
124906548|NCT05061693|449282745|FG000|24-week Extension Period|Withdrawal by Subject|0|||
124906549|NCT05061693|449282746|FG001|24-week Extension Period|Withdrawal by Subject|0|||
124906550|NCT05061693|449282747|FG002|24-week Extension Period|Withdrawal by Subject|0|||
124906551|NCT05061693|449282748|FG003|24-week Extension Period|Withdrawal by Subject|0|||
124906552|NCT05061693|449282749|FG004|24-week Extension Period|Withdrawal by Subject|0|||
124906553|NCT05061693|449282750|FG005|24-week Extension Period|Withdrawal by Subject|0|||
124906554|NCT05061693|449282751|FG006|24-week Extension Period|Withdrawal by Subject|0|||
124906555|NCT05061693|449282752|FG007|24-week Extension Period|Withdrawal by Subject|0|||
124906556|NCT05061693|449282753|FG008|24-week Extension Period|Withdrawal by Subject|1|||
124906557|NCT05061693|449282754|FG009|24-week Extension Period|Withdrawal by Subject|2|||
124906558|NCT05061693|449282755|FG010|24-week Extension Period|Withdrawal by Subject|2|||
124906559|NCT05061693|449282756|FG011|24-week Extension Period|Withdrawal by Subject|1|||
124906560|NCT05061693|449282745|FG000|24-week Extension Period|Sponsor Decision|0|||
124906561|NCT05061693|449282746|FG001|24-week Extension Period|Sponsor Decision|0|||
124906562|NCT05061693|449282747|FG002|24-week Extension Period|Sponsor Decision|0|||
124906563|NCT05061693|449282748|FG003|24-week Extension Period|Sponsor Decision|0|||
124906564|NCT05061693|449282749|FG004|24-week Extension Period|Sponsor Decision|0|||
124906565|NCT05061693|449282750|FG005|24-week Extension Period|Sponsor Decision|0|||
124906566|NCT05061693|449282751|FG006|24-week Extension Period|Sponsor Decision|0|||
124906567|NCT05061693|449282752|FG007|24-week Extension Period|Sponsor Decision|1|||
124906568|NCT05061693|449282753|FG008|24-week Extension Period|Sponsor Decision|0|||
124906569|NCT05061693|449282754|FG009|24-week Extension Period|Sponsor Decision|0|||
124906570|NCT05061693|449282755|FG010|24-week Extension Period|Sponsor Decision|0|||
124906571|NCT05061693|449282756|FG011|24-week Extension Period|Sponsor Decision|0|||
124906572|NCT05061693|449282745|FG000|24-week Extension Period|Site Closure|0|||
124906573|NCT05061693|449282746|FG001|24-week Extension Period|Site Closure|0|||
124906574|NCT05061693|449282747|FG002|24-week Extension Period|Site Closure|0|||
124906575|NCT05061693|449282748|FG003|24-week Extension Period|Site Closure|0|||
124906576|NCT05061693|449282749|FG004|24-week Extension Period|Site Closure|0|||
124906577|NCT05061693|449282750|FG005|24-week Extension Period|Site Closure|0|||
124906578|NCT05061693|449282751|FG006|24-week Extension Period|Site Closure|0|||
124906579|NCT05061693|449282752|FG007|24-week Extension Period|Site Closure|0|||
124906580|NCT05061693|449282753|FG008|24-week Extension Period|Site Closure|1|||
124906581|NCT05061693|449282754|FG009|24-week Extension Period|Site Closure|0|||
124906582|NCT05061693|449282755|FG010|24-week Extension Period|Site Closure|0|||
124906583|NCT05061693|449282756|FG011|24-week Extension Period|Site Closure|1|||
124906584|NCT01152190|449282757|FG000|Overall Study|Adverse Event|2|||
124906585|NCT01152190|449282758|FG001|Overall Study|Adverse Event|4|||
124906586|NCT01152190|449282757|FG000|Overall Study|Death|1|||
124906587|NCT01152190|449282758|FG001|Overall Study|Death|0|||
124906588|NCT01152190|449282757|FG000|Overall Study|Protocol Violation|1|||
124906589|NCT01152190|449282758|FG001|Overall Study|Protocol Violation|1|||
124906590|NCT01152190|449282757|FG000|Overall Study|Withdrawal by Subject|1|||
124906591|NCT01152190|449282758|FG001|Overall Study|Withdrawal by Subject|3|||
124906592|NCT03823911|449282759|FG000|Overall Study|Lost to Follow-up|1|||
124906593|NCT03823911|449282760|FG001|Overall Study|Lost to Follow-up|5|||
124906594|NCT03823911|449282761|FG002|Overall Study|Lost to Follow-up|2|||
124906595|NCT03823911|449282759|FG000|Overall Study|Did not meet eligibility criteria|13|||
124906596|NCT03823911|449282760|FG001|Overall Study|Did not meet eligibility criteria|7|||
124906597|NCT03823911|449282761|FG002|Overall Study|Did not meet eligibility criteria|4|||
124906598|NCT03823911|449282759|FG000|Overall Study|Death|0|||
124906599|NCT03823911|449282760|FG001|Overall Study|Death|1|||
124906600|NCT03823911|449282761|FG002|Overall Study|Death|0|||
124906601|NCT00547118|449282762|FG000|Overall Study|Did not qualify prior to starting drug|1|||
124906602|NCT00547118|449282763|FG001|Overall Study|Did not qualify prior to starting drug|1|||
124906603|NCT00547118|449282762|FG000|Overall Study|Study suspended|7|||
124906604|NCT00547118|449282763|FG001|Overall Study|Study suspended|8|||
124906605|NCT00442117|449282766|FG000|Overall Study|Adverse Event|3|||
124906606|NCT00442117|449282767|FG001|Overall Study|Adverse Event|2|||
124906607|NCT00442117|449282766|FG000|Overall Study|Lack of Efficacy|2|||
124906608|NCT00442117|449282767|FG001|Overall Study|Lack of Efficacy|6|||
124906609|NCT00442117|449282766|FG000|Overall Study|Lost to Follow-up|1|||
124906610|NCT00442117|449282767|FG001|Overall Study|Lost to Follow-up|2|||
124906611|NCT00442117|449282766|FG000|Overall Study|Withdrawal by Subject|2|||
124906612|NCT00442117|449282767|FG001|Overall Study|Withdrawal by Subject|2|||
124906613|NCT00442117|449282766|FG000|Overall Study|Major Deviation|25|||
124906614|NCT00442117|449282767|FG001|Overall Study|Major Deviation|20|||
124906615|NCT00442117|449282766|FG000|Overall Study|Non compliance with protocol|3|||
124906616|NCT00442117|449282767|FG001|Overall Study|Non compliance with protocol|5|||
124906617|NCT00442117|449282766|FG000|Overall Study|Met Withdrawal Criteria|2|||
124906618|NCT00442117|449282767|FG001|Overall Study|Met Withdrawal Criteria|1|||
124906619|NCT04009577|449282773|FG000|Core Study|Adverse Event|1|||
124906620|NCT04009577|449282774|FG001|Core Study|Adverse Event|0|||
124906621|NCT04009577|449282775|FG002|Core Study|Adverse Event|2|||
124906622|NCT04009577|449282776|FG003|Core Study|Adverse Event|4|||
124906623|NCT04009577|449282773|FG000|Core Study|Withdrawal by Subject|0|||
124906624|NCT04009577|449282774|FG001|Core Study|Withdrawal by Subject|0|||
124906625|NCT04009577|449282775|FG002|Core Study|Withdrawal by Subject|2|||
124906626|NCT04009577|449282776|FG003|Core Study|Withdrawal by Subject|0|||
124906627|NCT04009577|449282773|FG000|Core Study|Other|0|||
124906628|NCT04009577|449282774|FG001|Core Study|Other|0|||
124906629|NCT04009577|449282775|FG002|Core Study|Other|0|||
124906630|NCT04009577|449282776|FG003|Core Study|Other|1|||
124906631|NCT04009577|449282773|FG000|Extension Phase|Adverse Event|0|||
124906632|NCT04009577|449282774|FG001|Extension Phase|Adverse Event|0|||
124906633|NCT04009577|449282775|FG002|Extension Phase|Adverse Event|0|||
124906634|NCT04009577|449282776|FG003|Extension Phase|Adverse Event|1|||
124906635|NCT04009577|449282773|FG000|Extension Phase|Inadequate therapeutic effect|0|||
124906636|NCT04009577|449282774|FG001|Extension Phase|Inadequate therapeutic effect|0|||
124906637|NCT04009577|449282775|FG002|Extension Phase|Inadequate therapeutic effect|1|||
124906638|NCT04009577|449282776|FG003|Extension Phase|Inadequate therapeutic effect|0|||
125114681|NCT03404206|450042540|FG000|Overall Study|Lost to Follow-up|3|||
124906639|NCT04009577|449282773|FG000|Extension Phase|Withdrawal by Subject|0|||
124906640|NCT04009577|449282774|FG001|Extension Phase|Withdrawal by Subject|0|||
124906641|NCT04009577|449282775|FG002|Extension Phase|Withdrawal by Subject|1|||
124906642|NCT04009577|449282776|FG003|Extension Phase|Withdrawal by Subject|0|||
124906643|NCT04009577|449282773|FG000|Extension Phase|Not Treated|0|||
124906644|NCT04009577|449282774|FG001|Extension Phase|Not Treated|0|||
124906645|NCT04009577|449282775|FG002|Extension Phase|Not Treated|2|||
124906646|NCT04009577|449282776|FG003|Extension Phase|Not Treated|0|||
125114682|NCT03404206|450042541|FG001|Overall Study|Lost to Follow-up|1|||
125114683|NCT03404206|450042542|FG002|Overall Study|Lost to Follow-up|0|||
124906649|NCT00841035|449282782|FG000|Phase 1 Overall Study|Physician Decision|13|||
124906650|NCT02994654|449282784|FG000|Overall Study|Lost to Follow-up|1|||
124906651|NCT05328297|449284123|FG000|Overall Study|Adverse Event|5|||
124906652|NCT05328297|449284124|FG001|Overall Study|Adverse Event|7|||
124906653|NCT05328297|449284123|FG000|Overall Study|Withdrawal by Subject|4|||
124906654|NCT05328297|449284124|FG001|Overall Study|Withdrawal by Subject|3|||
124906655|NCT05328297|449284123|FG000|Overall Study|Lack of Efficacy|1|||
124906656|NCT05328297|449284124|FG001|Overall Study|Lack of Efficacy|0|||
124906657|NCT05328297|449284123|FG000|Overall Study|Lost to Follow-up|1|||
124906658|NCT05328297|449284124|FG001|Overall Study|Lost to Follow-up|0|||
124906659|NCT05328297|449284123|FG000|Overall Study|Protocol Violation|1|||
124906660|NCT05328297|449284124|FG001|Overall Study|Protocol Violation|0|||
124906661|NCT05328297|449284123|FG000|Overall Study|Randomized but not treated|1|||
124906662|NCT05328297|449284124|FG001|Overall Study|Randomized but not treated|1|||
124906663|NCT03544515|449284134|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
124906664|NCT03544515|449284135|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
124906665|NCT03544515|449284134|FG000|Overall Study|Lost to Follow-up|2|||
124906666|NCT03544515|449284135|FG001|Overall Study|Lost to Follow-up|0|||
124906667|NCT03175172|449284136|FG000|Overall Study|Death|3|||
124906668|NCT03175172|449284136|FG000|Overall Study|Withdrawal by Subject|3|||
124906669|NCT03175172|449284136|FG000|Overall Study|Lost to Follow-up|1|||
124906670|NCT03175172|449284136|FG000|Overall Study|Study Terminated by Sponsor|3|||
124906671|NCT03169244|449284137|FG000|Overall Study|Lost to Follow-up|1|||
124906672|NCT03169244|449284138|FG001|Overall Study|Lost to Follow-up|2|||
124906673|NCT03169244|449284137|FG000|Overall Study|Adverse Event|1|||
124906674|NCT03169244|449284138|FG001|Overall Study|Adverse Event|0|||
124906675|NCT03169244|449284137|FG000|Overall Study|Withdrawal by Subject|2|||
124906676|NCT03169244|449284138|FG001|Overall Study|Withdrawal by Subject|2|||
124906677|NCT03169244|449284137|FG000|Overall Study|Physician Decision|1|||
124906678|NCT03169244|449284138|FG001|Overall Study|Physician Decision|0|||
124906679|NCT01662336|449284139|FG000|Overall Study|Adverse Event|1|||
124906680|NCT01662336|449284139|FG000|Overall Study|No longer on LPV/r|30|||
124906681|NCT01662336|449284139|FG000|Overall Study|Other|29|||
124906682|NCT01662336|449284139|FG000|Overall Study|Withdrawal by Subject|6|||
124906683|NCT03622593|449284143|FG000|Overall Study|Withdrawal by Subject|11|||
124906684|NCT03622593|449284144|FG001|Overall Study|Withdrawal by Subject|9|||
124906685|NCT03622593|449284145|FG002|Overall Study|Withdrawal by Subject|13|||
124906686|NCT03622593|449284143|FG000|Overall Study|Death|12|||
124906687|NCT03622593|449284144|FG001|Overall Study|Death|9|||
124906688|NCT03622593|449284145|FG002|Overall Study|Death|10|||
124906689|NCT03622593|449284143|FG000|Overall Study|Lost to Follow-up|11|||
124906690|NCT03622593|449284144|FG001|Overall Study|Lost to Follow-up|5|||
124906691|NCT03622593|449284145|FG002|Overall Study|Lost to Follow-up|8|||
124906692|NCT03622593|449284143|FG000|Overall Study|Adverse Event|4|||
124906693|NCT03622593|449284144|FG001|Overall Study|Adverse Event|5|||
124906694|NCT03622593|449284145|FG002|Overall Study|Adverse Event|6|||
125211108|NCT04767529|450398578|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
125211109|NCT04767529|450398579|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
124906695|NCT03622593|449284143|FG000|Overall Study|Physician Decision|2|||
124906696|NCT03622593|449284144|FG001|Overall Study|Physician Decision|1|||
124906697|NCT03622593|449284145|FG002|Overall Study|Physician Decision|6|||
124906698|NCT03622593|449284143|FG000|Overall Study|Other|2|||
124906699|NCT03622593|449284144|FG001|Overall Study|Other|2|||
124906700|NCT03622593|449284145|FG002|Overall Study|Other|3|||
124906701|NCT03622593|449284143|FG000|Overall Study|Protocol Violation|0|||
124906702|NCT03622593|449284144|FG001|Overall Study|Protocol Violation|0|||
124906703|NCT03622593|449284145|FG002|Overall Study|Protocol Violation|1|||
124906704|NCT03622593|449284143|FG000|Overall Study|Pregnancy|0|||
124906705|NCT03622593|449284144|FG001|Overall Study|Pregnancy|0|||
124906706|NCT03622593|449284145|FG002|Overall Study|Pregnancy|1|||
124906707|NCT03762668|449284146|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
124906708|NCT03762668|449284147|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
124906709|NCT00178399|449284148|FG000|Overall Study|Physician Decision|4|||
124906710|NCT00178399|449284148|FG000|Overall Study|Withdrawal by Subject|8|||
124906711|NCT00178399|449284148|FG000|Overall Study|Lost to Follow-up|1|||
124906712|NCT01393119|449284149|FG000|Overall Study|Adverse Event|1|||
124906713|NCT01393119|449284150|FG001|Overall Study|Adverse Event|1|||
124906714|NCT01393119|449284151|FG002|Overall Study|Adverse Event|0|||
124906715|NCT01393119|449284152|FG003|Overall Study|Adverse Event|1|||
124906716|NCT01393119|449284149|FG000|Overall Study|Withdrawal by Subject|0|||
124906717|NCT01393119|449284150|FG001|Overall Study|Withdrawal by Subject|1|||
124906718|NCT01393119|449284151|FG002|Overall Study|Withdrawal by Subject|1|||
124906719|NCT01393119|449284152|FG003|Overall Study|Withdrawal by Subject|0|||
124906720|NCT01393119|449284149|FG000|Overall Study|Lack of Efficacy|1|||
124906721|NCT01393119|449284150|FG001|Overall Study|Lack of Efficacy|0|||
124906722|NCT01393119|449284151|FG002|Overall Study|Lack of Efficacy|2|||
124906723|NCT01393119|449284152|FG003|Overall Study|Lack of Efficacy|1|||
124906724|NCT01393119|449284149|FG000|Overall Study|Protocol Violation|0|||
124906725|NCT01393119|449284150|FG001|Overall Study|Protocol Violation|0|||
124906726|NCT01393119|449284151|FG002|Overall Study|Protocol Violation|1|||
124906727|NCT01393119|449284152|FG003|Overall Study|Protocol Violation|0|||
124906728|NCT01393119|449284149|FG000|Overall Study|Death|0|||
124906729|NCT01393119|449284150|FG001|Overall Study|Death|0|||
124906730|NCT01393119|449284151|FG002|Overall Study|Death|0|||
124906731|NCT01393119|449284152|FG003|Overall Study|Death|1|||
124906732|NCT01393119|449284149|FG000|Overall Study|Randomized but Not treated|1|||
124906733|NCT01393119|449284150|FG001|Overall Study|Randomized but Not treated|0|||
124906734|NCT01393119|449284151|FG002|Overall Study|Randomized but Not treated|1|||
124906735|NCT01393119|449284152|FG003|Overall Study|Randomized but Not treated|1|||
124906736|NCT01393119|449284149|FG000|Overall Study|Sponsor Termination of Study|11|||
124906737|NCT01393119|449284150|FG001|Overall Study|Sponsor Termination of Study|12|||
124906738|NCT01393119|449284151|FG002|Overall Study|Sponsor Termination of Study|9|||
124906739|NCT01393119|449284152|FG003|Overall Study|Sponsor Termination of Study|12|||
124906740|NCT02544152|449284153|FG000|Overall Study|Adverse Event|0|||
124906741|NCT02544152|449284154|FG001|Overall Study|Adverse Event|4|||
124906742|NCT02544152|449284153|FG000|Overall Study|Withdrawal by Subject|0|||
124906743|NCT02544152|449284154|FG001|Overall Study|Withdrawal by Subject|3|||
124906744|NCT02544152|449284153|FG000|Overall Study|Other|1|||
124906745|NCT02544152|449284154|FG001|Overall Study|Other|0|||
124906746|NCT01759264|449284157|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
124906747|NCT01759264|449284157|FG000|Overall Study|Adverse Event|1|||
124906748|NCT01759264|449284157|FG000|Overall Study|Other|2|||
124906749|NCT01759264|449284157|FG000|Overall Study|Lost to Follow-up|2|||
124906750|NCT01759264|449284157|FG000|Overall Study|Withdrawal by Subject|3|||
124906751|NCT01759264|449284157|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
124906752|NCT00516321|449284158|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
124906753|NCT00516321|449284159|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
124906754|NCT00516321|449284160|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
124906755|NCT00516321|449284158|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
124906756|NCT00516321|449284159|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
124906757|NCT00516321|449284160|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
124906758|NCT00516321|449284158|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
124906759|NCT00516321|449284159|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
124906760|NCT00516321|449284160|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
124906761|NCT00516321|449284158|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
124906762|NCT00516321|449284159|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
124906763|NCT00516321|449284160|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
124906764|NCT00516321|449284158|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
124906765|NCT00516321|449284159|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
124906766|NCT00516321|449284160|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
124906767|NCT00516321|449284158|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
124906768|NCT00516321|449284159|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
124906769|NCT00516321|449284160|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
124906770|NCT00516321|449284158|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
124906771|NCT00516321|449284159|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
124906772|NCT00516321|449284160|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
124906773|NCT00516321|449284158|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
124906774|NCT00516321|449284159|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
124906775|NCT00516321|449284160|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
124906776|NCT00516321|449284158|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
124906777|NCT00516321|449284159|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
124906778|NCT00516321|449284160|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
124906779|NCT00516321|449284158|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
124906780|NCT00516321|449284159|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
124906781|NCT00516321|449284160|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
124906782|NCT00516321|449284158|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
124906783|NCT00516321|449284159|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
124906784|NCT00516321|449284160|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
124906785|NCT02027558|449284162|FG000|Overall Study|Death|0|||
124906786|NCT02027558|449284163|FG001|Overall Study|Death|1|||
124906787|NCT02027558|449284162|FG000|Overall Study|Withdrawal by Subject|2|||
124906788|NCT02027558|449284163|FG001|Overall Study|Withdrawal by Subject|0|||
124906789|NCT02027558|449284162|FG000|Overall Study|Lost to Follow-up|4|||
124906790|NCT02027558|449284163|FG001|Overall Study|Lost to Follow-up|1|||
124906791|NCT02027558|449284162|FG000|Overall Study|Refused assessment|3|||
124906792|NCT02027558|449284163|FG001|Overall Study|Refused assessment|0|||
124906793|NCT02139046|449284164|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
124906794|NCT02139046|449284165|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
124906795|NCT02139046|449284166|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
124906796|NCT02139046|449284167|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
124906797|NCT02139046|449284168|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
124906798|NCT02139046|449284164|FG000|Overall Study|Major Protocol Deviation|9|||
124906799|NCT02139046|449284165|FG001|Overall Study|Major Protocol Deviation|10|||
124906800|NCT02139046|449284166|FG002|Overall Study|Major Protocol Deviation|16|||
124906801|NCT02139046|449284167|FG003|Overall Study|Major Protocol Deviation|12|||
124906802|NCT02139046|449284168|FG004|Overall Study|Major Protocol Deviation|6|||
124906803|NCT02139046|449284164|FG000|Overall Study|Lost to Follow-up|13|||
124906804|NCT02139046|449284165|FG001|Overall Study|Lost to Follow-up|16|||
124906805|NCT02139046|449284166|FG002|Overall Study|Lost to Follow-up|16|||
124906806|NCT02139046|449284167|FG003|Overall Study|Lost to Follow-up|18|||
124906807|NCT02139046|449284168|FG004|Overall Study|Lost to Follow-up|13|||
124906808|NCT02139046|449284164|FG000|Overall Study|Voluntary Withdrawal|20|||
124906809|NCT02139046|449284165|FG001|Overall Study|Voluntary Withdrawal|8|||
124906810|NCT02139046|449284166|FG002|Overall Study|Voluntary Withdrawal|10|||
124906811|NCT02139046|449284167|FG003|Overall Study|Voluntary Withdrawal|15|||
124906812|NCT02139046|449284168|FG004|Overall Study|Voluntary Withdrawal|16|||
124906813|NCT02139046|449284164|FG000|Overall Study|Lack of Efficacy|0|||
124906814|NCT02139046|449284165|FG001|Overall Study|Lack of Efficacy|1|||
124906815|NCT02139046|449284166|FG002|Overall Study|Lack of Efficacy|2|||
124906816|NCT02139046|449284167|FG003|Overall Study|Lack of Efficacy|1|||
124906817|NCT02139046|449284168|FG004|Overall Study|Lack of Efficacy|2|||
124906818|NCT02139046|449284164|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
124906819|NCT02139046|449284165|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
124906820|NCT02139046|449284166|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
124906821|NCT02139046|449284167|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
124906822|NCT02139046|449284168|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
124906823|NCT02139046|449284164|FG000|Overall Study|Other Miscellaneous Reasons|10|||
124906824|NCT02139046|449284165|FG001|Overall Study|Other Miscellaneous Reasons|9|||
124906825|NCT02139046|449284166|FG002|Overall Study|Other Miscellaneous Reasons|4|||
124906826|NCT02139046|449284167|FG003|Overall Study|Other Miscellaneous Reasons|9|||
124906827|NCT02139046|449284168|FG004|Overall Study|Other Miscellaneous Reasons|12|||
124906828|NCT02383472|449284169|FG000|Overall Study|Withdrawal by Subject|1|||
124906829|NCT02383472|449284170|FG001|Overall Study|Withdrawal by Subject|1|||
124906830|NCT01111526|449284171|FG000|Overall Study|GVHD Disease Progression|0|||
124906831|NCT01111526|449284172|FG001|Overall Study|GVHD Disease Progression|1|||
124906832|NCT01111526|449284173|FG002|Overall Study|GVHD Disease Progression|2|||
124906833|NCT02013830|449284174|FG000|Overall Study|Adverse Event|3|||
124906834|NCT02013830|449284174|FG000|Overall Study|Death|1|||
124906835|NCT02013830|449284174|FG000|Overall Study|Insufficient therapeutic response|25|||
124906836|NCT02013830|449284174|FG000|Overall Study|Refused treatment|1|||
124906837|NCT02015546|449284175|FG000|Overall Study|Withdrawal by Subject|1|||
124906838|NCT02015546|449284176|FG001|Overall Study|Withdrawal by Subject|1|||
124906839|NCT02015546|449284177|FG002|Overall Study|Withdrawal by Subject|1|||
124906840|NCT02015546|449284175|FG000|Overall Study|Screem Failure|2|||
124906841|NCT02015546|449284176|FG001|Overall Study|Screem Failure|1|||
124906842|NCT02015546|449284177|FG002|Overall Study|Screem Failure|3|||
124906843|NCT04424641|449284178|FG000|Overall Study|Death|1|||
124906844|NCT04424641|449284179|FG001|Overall Study|Death|2|||
124906845|NCT04424641|449284180|FG002|Overall Study|Death|3|||
124906846|NCT04424641|449284181|FG003|Overall Study|Death|0|||
124906847|NCT04424641|449284182|FG004|Overall Study|Death|3|||
124906848|NCT04424641|449284183|FG005|Overall Study|Death|0|||
124906849|NCT04424641|449284184|FG006|Overall Study|Death|1|||
124906850|NCT04424641|449284185|FG007|Overall Study|Death|2|||
124906851|NCT04424641|449284178|FG000|Overall Study|Sponsor decision|0|||
124906852|NCT04424641|449284179|FG001|Overall Study|Sponsor decision|2|||
124906853|NCT04424641|449284180|FG002|Overall Study|Sponsor decision|3|||
124906854|NCT04424641|449284181|FG003|Overall Study|Sponsor decision|7|||
124906855|NCT04424641|449284182|FG004|Overall Study|Sponsor decision|2|||
124906856|NCT04424641|449284183|FG005|Overall Study|Sponsor decision|2|||
124906857|NCT04424641|449284184|FG006|Overall Study|Sponsor decision|3|||
124906858|NCT04424641|449284185|FG007|Overall Study|Sponsor decision|4|||
124906859|NCT04424641|449284178|FG000|Overall Study|Withdrawal by Subject|0|||
124906860|NCT04424641|449284179|FG001|Overall Study|Withdrawal by Subject|0|||
124906861|NCT04424641|449284180|FG002|Overall Study|Withdrawal by Subject|0|||
124906862|NCT04424641|449284181|FG003|Overall Study|Withdrawal by Subject|0|||
124906863|NCT04424641|449284182|FG004|Overall Study|Withdrawal by Subject|1|||
124906864|NCT04424641|449284183|FG005|Overall Study|Withdrawal by Subject|0|||
124906865|NCT04424641|449284184|FG006|Overall Study|Withdrawal by Subject|0|||
124906866|NCT04424641|449284185|FG007|Overall Study|Withdrawal by Subject|0|||
124906867|NCT04424641|449284178|FG000|Overall Study|Other|0|||
124906868|NCT04424641|449284179|FG001|Overall Study|Other|0|||
124906869|NCT04424641|449284180|FG002|Overall Study|Other|1|||
124906870|NCT04424641|449284181|FG003|Overall Study|Other|0|||
124906871|NCT04424641|449284182|FG004|Overall Study|Other|0|||
124906872|NCT04424641|449284183|FG005|Overall Study|Other|0|||
124906873|NCT04424641|449284184|FG006|Overall Study|Other|0|||
124906874|NCT04424641|449284185|FG007|Overall Study|Other|0|||
124906875|NCT01426269|449284194|FG000|Period 1: 12 Weeks|Adverse Event|5|||
124906876|NCT01426269|449284195|FG001|Period 1: 12 Weeks|Adverse Event|0|||
124906877|NCT01426269|449284196|FG002|Period 1: 12 Weeks|Adverse Event|0|||
124906878|NCT01426269|449284194|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
124906879|NCT01426269|449284195|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
124906880|NCT01426269|449284196|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
124906881|NCT01426269|449284194|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
124906882|NCT01426269|449284195|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
124906883|NCT01426269|449284196|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
124906884|NCT01426269|449284194|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
124906885|NCT01426269|449284195|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
124906886|NCT01426269|449284196|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
124906887|NCT01426269|449284194|FG000|Period 1: 12 Weeks|Pregnancy|1|||
124906888|NCT01426269|449284195|FG001|Period 1: 12 Weeks|Pregnancy|0|||
124906889|NCT01426269|449284196|FG002|Period 1: 12 Weeks|Pregnancy|0|||
124906890|NCT01426269|449284194|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
124906891|NCT01426269|449284195|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
124906892|NCT01426269|449284196|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
124906893|NCT01426269|449284194|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
124906894|NCT01426269|449284195|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
124906895|NCT01426269|449284196|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
124906896|NCT01426269|449284194|FG000|Period 2: 40 Weeks|Adverse Event|0|||
124906897|NCT01426269|449284195|FG001|Period 2: 40 Weeks|Adverse Event|1|||
124906898|NCT01426269|449284196|FG002|Period 2: 40 Weeks|Adverse Event|2|||
124906899|NCT01426269|449284194|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
124906900|NCT01426269|449284195|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
124906901|NCT01426269|449284196|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
124906902|NCT01426269|449284194|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
124906903|NCT01426269|449284195|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
124906904|NCT01426269|449284196|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
124906905|NCT01426269|449284194|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
124906906|NCT01426269|449284195|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
124906907|NCT01426269|449284196|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
124906908|NCT01426269|449284194|FG000|Period 2: 40 Weeks|Site closed|0|||
124906909|NCT01426269|449284195|FG001|Period 2: 40 Weeks|Site closed|6|||
124906910|NCT01426269|449284196|FG002|Period 2: 40 Weeks|Site closed|5|||
124906911|NCT01426269|449284194|FG000|Period 2: 40 Weeks|Relapsed|0|||
125114684|NCT02330081|450042553|FG000|Overall Study|Adverse Event|1|||
125114685|NCT02330081|450042553|FG000|Overall Study|Donation did not meet criteria|1|||
124906912|NCT01426269|449284195|FG001|Period 2: 40 Weeks|Relapsed|9|||
124906913|NCT01426269|449284196|FG002|Period 2: 40 Weeks|Relapsed|18|||
125114686|NCT02330081|450042553|FG000|Overall Study|Protocol Violation|6|||
124906914|NCT00186186|449284198|FG000|Overall Study|Lack of Efficacy|3|||
124906915|NCT00186186|449284198|FG000|Overall Study|Withdrawal by Subject|3|||
124906916|NCT00186186|449284198|FG000|Overall Study|Not reported as to reason|2|||
124906917|NCT01337635|449284199|FG000|Overall Study|Lost to Follow-up|0|||
124906918|NCT01337635|449284200|FG001|Overall Study|Lost to Follow-up|1|||
124906919|NCT03959241|449284204|FG000|Overall Study|Withdrawal by Subject|7|||
124906920|NCT03959241|449284205|FG001|Overall Study|Withdrawal by Subject|8|||
124906921|NCT03959241|449284204|FG000|Overall Study|Lost to Follow-up|1|||
124906922|NCT03959241|449284205|FG001|Overall Study|Lost to Follow-up|0|||
124906923|NCT03959241|449284204|FG000|Overall Study|Move to Hospice Care|1|||
124906924|NCT03959241|449284205|FG001|Overall Study|Move to Hospice Care|0|||
124906925|NCT03959241|449284204|FG000|Overall Study|Screen Failure|1|||
124906926|NCT03959241|449284205|FG001|Overall Study|Screen Failure|0|||
124906927|NCT03959241|449284204|FG000|Overall Study|Disease Relapse|0|||
124906928|NCT03959241|449284205|FG001|Overall Study|Disease Relapse|1|||
124906929|NCT03959241|449284204|FG000|Overall Study|Off Study|1|||
124906930|NCT03959241|449284205|FG001|Overall Study|Off Study|0|||
124906931|NCT01145885|449284206|FG000|Overall Study|Progressive Disease|7|||
124906932|NCT03691428|449284207|FG000|Overall Study|Withdrawal by Subject|6|||
124906933|NCT03691428|449284208|FG001|Overall Study|Withdrawal by Subject|8|||
124906934|NCT02527148|449284209|FG000|Overall Study|Did not receive study intervention|1|||
124906935|NCT02527148|449284210|FG001|Overall Study|Did not receive study intervention|0|||
124906936|NCT01140048|449284211|FG000|Overall Study|Physician Decision|1|||
124906937|NCT01140048|449284211|FG000|Overall Study|Withdrawal by Subject|13|||
124906938|NCT01140048|449284211|FG000|Overall Study|Lost to Follow-up|31|||
124906939|NCT01831791|449284212|FG000|Overall Study|Withdrawal by Subject|10|||
124906940|NCT00494780|449284213|FG000|Overall Study|Adverse Event|1|||
124906941|NCT00494780|449284214|FG001|Overall Study|Adverse Event|0|||
124906942|NCT00494780|449284213|FG000|Overall Study|Withdrew before Dosed|0|||
124906943|NCT00494780|449284214|FG001|Overall Study|Withdrew before Dosed|1|||
124906944|NCT00494780|449284213|FG000|Overall Study|Progression of Study Disease|7|||
124906945|NCT00494780|449284214|FG001|Overall Study|Progression of Study Disease|8|||
124906946|NCT00494780|449284213|FG000|Overall Study|New Treatment|2|||
124906947|NCT00494780|449284214|FG001|Overall Study|New Treatment|2|||
124906948|NCT00494780|449284213|FG000|Overall Study|Non-compliance|1|||
124906949|NCT00494780|449284214|FG001|Overall Study|Non-compliance|0|||
124906950|NCT00494780|449284213|FG000|Overall Study|Residual Tumour Mass|0|||
124906951|NCT00494780|449284214|FG001|Overall Study|Residual Tumour Mass|1|||
124906952|NCT00494780|449284213|FG000|Overall Study|Insurance Issues|0|||
124906953|NCT00494780|449284214|FG001|Overall Study|Insurance Issues|1|||
124906954|NCT04054635|449284223|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
124906955|NCT04054635|449284224|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
124906956|NCT04054635|449284225|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
124906957|NCT04054635|449284223|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
124906958|NCT04054635|449284224|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
124906959|NCT04054635|449284225|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
124906960|NCT00891930|449284226|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
124906961|NCT00891930|449284226|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
124906962|NCT00891930|449284226|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
124906963|NCT00891930|449284226|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
124906964|NCT00891930|449284226|FG000|Part 2 Panitumumab + AMG479|Death|30|||
124906965|NCT02537522|449284233|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
124906966|NCT02537522|449284234|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
124906967|NCT02537522|449284235|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
124906968|NCT02537522|449284236|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
124906969|NCT02537522|449284233|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
124906970|NCT02537522|449284234|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
124906971|NCT02537522|449284235|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
124906972|NCT02537522|449284236|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
124906973|NCT02537522|449284233|FG000|Phase I - Contralateral|incorrect randomization|0|||
124906974|NCT02537522|449284234|FG001|Phase I - Contralateral|incorrect randomization|1|||
124906975|NCT02537522|449284235|FG002|Phase I - Contralateral|incorrect randomization|0|||
124906976|NCT02537522|449284236|FG003|Phase I - Contralateral|incorrect randomization|0|||
124906977|NCT02537522|449284233|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
124906978|NCT02537522|449284234|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
124906979|NCT02537522|449284235|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
124906980|NCT02537522|449284236|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
124906981|NCT02537522|449284233|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
124906982|NCT02537522|449284234|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
124906983|NCT02537522|449284235|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
124906984|NCT02537522|449284236|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
124906985|NCT01493778|449284240|FG000|Overall Study|Withdrawal by Subject|8|||
124906986|NCT00857649|449284241|FG000|Overall Study|Adverse Event|15|||
124906987|NCT00857649|449284242|FG001|Overall Study|Adverse Event|10|||
124906988|NCT00857649|449284241|FG000|Overall Study|Non-compliance|1|||
124906989|NCT00857649|449284242|FG001|Overall Study|Non-compliance|1|||
124906990|NCT00857649|449284241|FG000|Overall Study|Protocol Violation|2|||
124906991|NCT00857649|449284242|FG001|Overall Study|Protocol Violation|2|||
124906992|NCT00857649|449284241|FG000|Overall Study|Withdrawal of Consent|10|||
124906993|NCT00857649|449284242|FG001|Overall Study|Withdrawal of Consent|7|||
124906994|NCT00857649|449284241|FG000|Overall Study|Nursing Home Placement|2|||
124906995|NCT00857649|449284242|FG001|Overall Study|Nursing Home Placement|9|||
124906996|NCT00857649|449284241|FG000|Overall Study|Other Reasons|1|||
124906997|NCT00857649|449284242|FG001|Overall Study|Other Reasons|3|||
124906998|NCT04177394|449284245|FG000|Overall Study|Death|16|||
124906999|NCT04177394|449284245|FG000|Overall Study|Withdrawal by Subject|19|||
124907000|NCT04177394|449284245|FG000|Overall Study|Missed visits|61|||
124907001|NCT04177394|449284245|FG000|Overall Study|Expected Visits|15|||
124907002|NCT00258895|449284246|FG000|Overall Study|Lost to Follow-up|3|||
124907003|NCT00258895|449284247|FG001|Overall Study|Lost to Follow-up|1|||
124907004|NCT00258895|449284246|FG000|Overall Study|Protocol Violation|6|||
124907005|NCT00258895|449284247|FG001|Overall Study|Protocol Violation|2|||
124907006|NCT00258895|449284246|FG000|Overall Study|Withdrawal by Subject|1|||
124907007|NCT00258895|449284247|FG001|Overall Study|Withdrawal by Subject|0|||
124907008|NCT00630786|449284248|FG000|Overall Study|Physician Decision|0|||
124907009|NCT00630786|449284249|FG001|Overall Study|Physician Decision|0|||
124907010|NCT00630786|449284250|FG002|Overall Study|Physician Decision|1|||
124907011|NCT00630786|449284248|FG000|Overall Study|Withdrawal by Subject|0|||
124907012|NCT00630786|449284249|FG001|Overall Study|Withdrawal by Subject|1|||
124907013|NCT00630786|449284250|FG002|Overall Study|Withdrawal by Subject|1|||
124907014|NCT00630786|449284248|FG000|Overall Study|Lost to Follow-up|0|||
124907015|NCT00630786|449284249|FG001|Overall Study|Lost to Follow-up|1|||
124907016|NCT00630786|449284250|FG002|Overall Study|Lost to Follow-up|0|||
124907017|NCT00630786|449284248|FG000|Overall Study|Other|1|||
124907018|NCT00630786|449284249|FG001|Overall Study|Other|0|||
124907019|NCT00630786|449284250|FG002|Overall Study|Other|0|||
124907020|NCT03603717|449284254|FG000|Overall Study|Lost to Follow-up|20|||
124907021|NCT03603717|449284255|FG001|Overall Study|Lost to Follow-up|20|||
124907022|NCT03603717|449284254|FG000|Overall Study|Withdrawal by Subject|16|||
124907023|NCT03603717|449284255|FG001|Overall Study|Withdrawal by Subject|10|||
124907024|NCT04668339|449285708|FG000|Overall Study|Physician Decision|1|||
124907025|NCT04668339|449285709|FG001|Overall Study|Physician Decision|0|||
124907026|NCT04668339|449285710|FG002|Overall Study|Physician Decision|1|||
124907027|NCT04668339|449285711|FG003|Overall Study|Physician Decision|1|||
124907028|NCT04668339|449285708|FG000|Overall Study|Lost to Follow-up|14|||
124907029|NCT04668339|449285709|FG001|Overall Study|Lost to Follow-up|12|||
124907030|NCT04668339|449285710|FG002|Overall Study|Lost to Follow-up|8|||
124907031|NCT04668339|449285711|FG003|Overall Study|Lost to Follow-up|5|||
124907032|NCT04668339|449285708|FG000|Overall Study|Adverse Event|0|||
124907033|NCT04668339|449285709|FG001|Overall Study|Adverse Event|0|||
124907034|NCT04668339|449285710|FG002|Overall Study|Adverse Event|1|||
124907035|NCT04668339|449285711|FG003|Overall Study|Adverse Event|0|||
124907036|NCT04668339|449285708|FG000|Overall Study|Other than specified|3|||
124907037|NCT04668339|449285709|FG001|Overall Study|Other than specified|0|||
124907038|NCT04668339|449285710|FG002|Overall Study|Other than specified|1|||
124907039|NCT04668339|449285711|FG003|Overall Study|Other than specified|0|||
124907040|NCT04668339|449285708|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
124907041|NCT04668339|449285709|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
124907042|NCT04668339|449285710|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
124907043|NCT04668339|449285711|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
124907044|NCT04668339|449285708|FG000|Overall Study|Vaccine not Administered|0|||
124907045|NCT04668339|449285709|FG001|Overall Study|Vaccine not Administered|0|||
124907046|NCT04668339|449285710|FG002|Overall Study|Vaccine not Administered|1|||
124907047|NCT04668339|449285711|FG003|Overall Study|Vaccine not Administered|0|||
124907048|NCT04668339|449285708|FG000|Overall Study|Protocol Violation|18|||
124907049|NCT04668339|449285709|FG001|Overall Study|Protocol Violation|23|||
124907050|NCT04668339|449285710|FG002|Overall Study|Protocol Violation|12|||
124907051|NCT04668339|449285711|FG003|Overall Study|Protocol Violation|20|||
124907052|NCT04668339|449285708|FG000|Overall Study|Withdrawal by Subject|45|||
124907053|NCT04668339|449285709|FG001|Overall Study|Withdrawal by Subject|46|||
124907054|NCT04668339|449285710|FG002|Overall Study|Withdrawal by Subject|46|||
124907055|NCT04668339|449285711|FG003|Overall Study|Withdrawal by Subject|27|||
124907056|NCT04668339|449285708|FG000|Overall Study|Study Terminated by Sponsor|59|||
124907057|NCT04668339|449285709|FG001|Overall Study|Study Terminated by Sponsor|59|||
124907058|NCT04668339|449285710|FG002|Overall Study|Study Terminated by Sponsor|71|||
124907059|NCT04668339|449285711|FG003|Overall Study|Study Terminated by Sponsor|1|||
124907060|NCT00002842|449285719|FG000|Overall Study|ineligible for surgical resection|27|||
124907061|NCT03557008|449285721|FG000|Overall Study|Withdrawal by Subject|2|||
124907062|NCT03557008|449285722|FG001|Overall Study|Withdrawal by Subject|2|||
124907063|NCT03557008|449285721|FG000|Overall Study|Early termination from study|3|||
124907064|NCT03557008|449285722|FG001|Overall Study|Early termination from study|1|||
125114687|NCT00616928|450042561|FG000|Overall Study|Adverse Event|6|||
125114688|NCT00616928|450042562|FG001|Overall Study|Adverse Event|3|||
125114689|NCT00616928|450042563|FG002|Overall Study|Adverse Event|2|||
124907065|NCT01113931|449285725|FG000|Overall Study|Adverse Event|2|||
124907066|NCT01113931|449285726|FG001|Overall Study|Adverse Event|2|||
124907067|NCT01113931|449285725|FG000|Overall Study|Physician Decision|0|||
124907068|NCT01113931|449285726|FG001|Overall Study|Physician Decision|2|||
124907069|NCT01113931|449285725|FG000|Overall Study|Lost to Follow-up|12|||
124907070|NCT01113931|449285726|FG001|Overall Study|Lost to Follow-up|9|||
124907071|NCT01113931|449285725|FG000|Overall Study|Various|2|||
124907072|NCT01113931|449285726|FG001|Overall Study|Various|4|||
124907073|NCT01113931|449285725|FG000|Overall Study|Withdrawal by Subject|3|||
124907074|NCT01113931|449285726|FG001|Overall Study|Withdrawal by Subject|0|||
124907075|NCT02567656|449285727|FG000|Overall Study|Premature discontinuation due to PD|1|||
124907076|NCT02567656|449285728|FG001|Overall Study|Premature discontinuation due to PD|1|||
124907077|NCT02567656|449285729|FG002|Overall Study|Premature discontinuation due to PD|2|||
124907078|NCT02567656|449285730|FG003|Overall Study|Premature discontinuation due to PD|0|||
124907079|NCT02567656|449285731|FG004|Overall Study|Premature discontinuation due to PD|0|||
124907080|NCT02567656|449285732|FG005|Overall Study|Premature discontinuation due to PD|0|||
124907081|NCT01424397|449285733|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907082|NCT01424397|449285734|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907083|NCT01424397|449285735|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
124907084|NCT01424397|449285736|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907085|NCT01424397|449285737|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907086|NCT01424397|449285738|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907087|NCT01424397|449285739|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907088|NCT01424397|449285740|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907089|NCT01424397|449285741|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907090|NCT01424397|449285742|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907091|NCT01424397|449285743|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907092|NCT01424397|449285744|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907093|NCT00980330|449285749|FG000|Overall Study|Adverse Event|0|||
124907094|NCT00980330|449285750|FG001|Overall Study|Adverse Event|0|||
124907095|NCT00980330|449285751|FG002|Overall Study|Adverse Event|0|||
124907096|NCT00980330|449285752|FG003|Overall Study|Adverse Event|1|||
124907097|NCT00980330|449285753|FG004|Overall Study|Adverse Event|0|||
124907098|NCT00980330|449285754|FG005|Overall Study|Adverse Event|0|||
124907099|NCT00980330|449285755|FG006|Overall Study|Adverse Event|0|||
124907100|NCT00980330|449285749|FG000|Overall Study|Lost to Follow-up|1|||
124907101|NCT00980330|449285750|FG001|Overall Study|Lost to Follow-up|1|||
124907102|NCT00980330|449285751|FG002|Overall Study|Lost to Follow-up|4|||
124907103|NCT00980330|449285752|FG003|Overall Study|Lost to Follow-up|2|||
124907104|NCT00980330|449285753|FG004|Overall Study|Lost to Follow-up|1|||
124907105|NCT00980330|449285754|FG005|Overall Study|Lost to Follow-up|1|||
124907106|NCT00980330|449285755|FG006|Overall Study|Lost to Follow-up|2|||
124907107|NCT00980330|449285749|FG000|Overall Study|Withdrawal by Subject|2|||
124907108|NCT00980330|449285750|FG001|Overall Study|Withdrawal by Subject|4|||
124907109|NCT00980330|449285751|FG002|Overall Study|Withdrawal by Subject|4|||
124907110|NCT00980330|449285752|FG003|Overall Study|Withdrawal by Subject|1|||
124907111|NCT00980330|449285753|FG004|Overall Study|Withdrawal by Subject|3|||
124907112|NCT00980330|449285754|FG005|Overall Study|Withdrawal by Subject|2|||
124907113|NCT00980330|449285755|FG006|Overall Study|Withdrawal by Subject|5|||
124907114|NCT00980330|449285749|FG000|Overall Study|(not specified)|2|||
124907115|NCT00980330|449285750|FG001|Overall Study|(not specified)|0|||
124907116|NCT00980330|449285751|FG002|Overall Study|(not specified)|0|||
124907117|NCT00980330|449285752|FG003|Overall Study|(not specified)|1|||
124907118|NCT00980330|449285753|FG004|Overall Study|(not specified)|1|||
124907119|NCT00980330|449285754|FG005|Overall Study|(not specified)|1|||
124907120|NCT00980330|449285755|FG006|Overall Study|(not specified)|0|||
124907121|NCT00666276|449285756|FG000|Overall Study|Protocol Violation|34|||
124907122|NCT03299816|449285757|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
124907123|NCT03299816|449285758|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
124907124|NCT03299816|449285757|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
124907125|NCT03299816|449285758|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
124907126|NCT03299816|449285757|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
124907127|NCT03299816|449285758|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
124907128|NCT03520413|449285759|FG000|Overall Study|Lost to Follow-up|1|||
125114690|NCT00616928|450042564|FG003|Overall Study|Adverse Event|2|||
125114691|NCT00616928|450042561|FG000|Overall Study|Other|51|||
125114692|NCT00616928|450042562|FG001|Overall Study|Other|8|||
125114693|NCT00616928|450042563|FG002|Overall Study|Other|15|||
125114694|NCT00616928|450042564|FG003|Overall Study|Other|5|||
125114695|NCT00616928|450042561|FG000|Overall Study|Lost to Follow-up|5|||
124907129|NCT03520413|449285760|FG001|Overall Study|Lost to Follow-up|1|||
124907130|NCT03520413|449285759|FG000|Overall Study|Withdrawal by Subject|1|||
124907131|NCT03520413|449285760|FG001|Overall Study|Withdrawal by Subject|2|||
124907132|NCT03520413|449285759|FG000|Overall Study|Death|0|||
124907133|NCT03520413|449285760|FG001|Overall Study|Death|1|||
124907134|NCT03520413|449285759|FG000|Overall Study|Physician Decision|3|||
124907135|NCT03520413|449285760|FG001|Overall Study|Physician Decision|3|||
124907136|NCT03520413|449285759|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
124907137|NCT03520413|449285760|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
125114696|NCT00616928|450042562|FG001|Overall Study|Lost to Follow-up|7|||
125114697|NCT00616928|450042563|FG002|Overall Study|Lost to Follow-up|0|||
124907138|NCT05001945|449285766|FG000|Overall Study|Adverse Event|0|||
124907139|NCT05001945|449285767|FG001|Overall Study|Adverse Event|0|||
124907140|NCT05001945|449285768|FG002|Overall Study|Adverse Event|0|||
124907141|NCT05001945|449285769|FG003|Overall Study|Adverse Event|1|||
124907142|NCT05001945|449285770|FG004|Overall Study|Adverse Event|0|||
124907143|NCT05001945|449285771|FG005|Overall Study|Adverse Event|0|||
124907144|NCT05001945|449285772|FG006|Overall Study|Adverse Event|0|||
124907145|NCT05001945|449285773|FG007|Overall Study|Adverse Event|0|||
124907146|NCT05001945|449285766|FG000|Overall Study|Lost to Follow-up|0|||
124907147|NCT05001945|449285767|FG001|Overall Study|Lost to Follow-up|1|||
124907148|NCT05001945|449285768|FG002|Overall Study|Lost to Follow-up|1|||
124907149|NCT05001945|449285769|FG003|Overall Study|Lost to Follow-up|2|||
124907150|NCT05001945|449285770|FG004|Overall Study|Lost to Follow-up|0|||
124907151|NCT05001945|449285771|FG005|Overall Study|Lost to Follow-up|1|||
124907152|NCT05001945|449285772|FG006|Overall Study|Lost to Follow-up|0|||
124907153|NCT05001945|449285773|FG007|Overall Study|Lost to Follow-up|0|||
124907154|NCT05001945|449285766|FG000|Overall Study|Protocol Violation|1|||
124907155|NCT05001945|449285767|FG001|Overall Study|Protocol Violation|0|||
124907156|NCT05001945|449285768|FG002|Overall Study|Protocol Violation|1|||
124907157|NCT05001945|449285769|FG003|Overall Study|Protocol Violation|1|||
124907158|NCT05001945|449285770|FG004|Overall Study|Protocol Violation|0|||
124907159|NCT05001945|449285771|FG005|Overall Study|Protocol Violation|1|||
124907160|NCT05001945|449285772|FG006|Overall Study|Protocol Violation|0|||
124907161|NCT05001945|449285773|FG007|Overall Study|Protocol Violation|0|||
124907162|NCT05001945|449285766|FG000|Overall Study|Withdrawal by Subject|0|||
124907163|NCT05001945|449285767|FG001|Overall Study|Withdrawal by Subject|0|||
124907164|NCT05001945|449285768|FG002|Overall Study|Withdrawal by Subject|0|||
124907165|NCT05001945|449285769|FG003|Overall Study|Withdrawal by Subject|1|||
124907166|NCT05001945|449285770|FG004|Overall Study|Withdrawal by Subject|1|||
124907167|NCT05001945|449285771|FG005|Overall Study|Withdrawal by Subject|1|||
124907168|NCT05001945|449285772|FG006|Overall Study|Withdrawal by Subject|0|||
124907169|NCT05001945|449285773|FG007|Overall Study|Withdrawal by Subject|1|||
124907170|NCT05001945|449285766|FG000|Overall Study|Not specified by Investigator|0|||
124907171|NCT05001945|449285767|FG001|Overall Study|Not specified by Investigator|3|||
124907172|NCT05001945|449285768|FG002|Overall Study|Not specified by Investigator|0|||
124907173|NCT05001945|449285769|FG003|Overall Study|Not specified by Investigator|0|||
124907174|NCT05001945|449285770|FG004|Overall Study|Not specified by Investigator|1|||
124907175|NCT05001945|449285771|FG005|Overall Study|Not specified by Investigator|0|||
124907176|NCT05001945|449285772|FG006|Overall Study|Not specified by Investigator|0|||
124907177|NCT05001945|449285773|FG007|Overall Study|Not specified by Investigator|0|||
125114698|NCT00616928|450042564|FG003|Overall Study|Lost to Follow-up|0|||
125114699|NCT03372083|450044630|FG000|Overall Study|Adverse Event|3|||
125114700|NCT03372083|450044630|FG000|Overall Study|Physician Decision|1|||
125114701|NCT03372083|450044630|FG000|Overall Study|Withdrawal by Subject|1|||
125114702|NCT00598559|450044631|FG000|Overall Study|Adverse Event|11|||
125114703|NCT00598559|450044632|FG001|Overall Study|Adverse Event|7|||
125114704|NCT00598559|450044633|FG002|Overall Study|Adverse Event|0|||
125114705|NCT00598559|450044631|FG000|Overall Study|Withdrawal by Subject|2|||
125114706|NCT00598559|450044632|FG001|Overall Study|Withdrawal by Subject|2|||
125114707|NCT00598559|450044633|FG002|Overall Study|Withdrawal by Subject|0|||
125114708|NCT00598559|450044631|FG000|Overall Study|Protocol Non-compliance|1|||
125114709|NCT00598559|450044632|FG001|Overall Study|Protocol Non-compliance|0|||
125114710|NCT00598559|450044633|FG002|Overall Study|Protocol Non-compliance|0|||
125114711|NCT00598559|450044631|FG000|Overall Study|Early discharge from hospital|9|||
125114712|NCT00598559|450044632|FG001|Overall Study|Early discharge from hospital|12|||
125114713|NCT00598559|450044633|FG002|Overall Study|Early discharge from hospital|3|||
125114714|NCT00598559|450044631|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
125114715|NCT00598559|450044632|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
125114716|NCT00598559|450044633|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
125114717|NCT03381248|450044634|FG000|0-6 Months|Withdrawal by Subject|4|||
124907178|NCT02448446|449285774|FG000|Overall Study|Withdrawal by Subject|1|||
124907179|NCT02448446|449285775|FG001|Overall Study|Withdrawal by Subject|0|||
125114718|NCT03381248|450044635|FG001|0-6 Months|Withdrawal by Subject|1|||
125114719|NCT03381248|450044634|FG000|0-6 Months|Lost to Follow-up|3|||
125114720|NCT03381248|450044635|FG001|0-6 Months|Lost to Follow-up|2|||
125114721|NCT03381248|450044634|FG000|0-6 Months|Lack of Efficacy|1|||
125114722|NCT03381248|450044635|FG001|0-6 Months|Lack of Efficacy|0|||
124907180|NCT02425111|449285776|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
124907181|NCT02425111|449285776|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
124907182|NCT02425111|449285776|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
124907183|NCT02425111|449285776|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
124907184|NCT02425111|449285776|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
124907185|NCT02425111|449285776|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
125114723|NCT03381248|450044634|FG000|0-6 Months|Adverse Event|1|||
124907186|NCT00545077|449285778|FG000|Overall Study|Treatment not received|5|||
125114724|NCT03381248|450044635|FG001|0-6 Months|Adverse Event|0|||
124907187|NCT00545077|449285779|FG001|Overall Study|Treatment not received|1|||
124907188|NCT00545077|449285778|FG000|Overall Study|Disease Progression|131|||
124907189|NCT00545077|449285779|FG001|Overall Study|Disease Progression|98|||
124907190|NCT00545077|449285778|FG000|Overall Study|Withdrawal by Subject|3|||
124907191|NCT00545077|449285779|FG001|Overall Study|Withdrawal by Subject|14|||
124907192|NCT00545077|449285778|FG000|Overall Study|Physician Decision|6|||
124907193|NCT00545077|449285779|FG001|Overall Study|Physician Decision|3|||
124907194|NCT00545077|449285778|FG000|Overall Study|Lost to Follow-up|2|||
124907195|NCT00545077|449285779|FG001|Overall Study|Lost to Follow-up|0|||
124907196|NCT00545077|449285778|FG000|Overall Study|Protocol Violation|1|||
124907197|NCT00545077|449285779|FG001|Overall Study|Protocol Violation|0|||
124907198|NCT00545077|449285778|FG000|Overall Study|Adverse Event|0|||
124907199|NCT00545077|449285779|FG001|Overall Study|Adverse Event|31|||
124907200|NCT00545077|449285778|FG000|Overall Study|Death|0|||
124907201|NCT00545077|449285779|FG001|Overall Study|Death|8|||
124907202|NCT02202499|449285780|FG000|Overall Study|Cancer diagnosis|0|||
124907203|NCT02202499|449285781|FG001|Overall Study|Cancer diagnosis|0|||
124907204|NCT02202499|449285782|FG002|Overall Study|Cancer diagnosis|1|||
124907205|NCT02202499|449285780|FG000|Overall Study|Moved from area|0|||
124907206|NCT02202499|449285781|FG001|Overall Study|Moved from area|0|||
124907207|NCT02202499|449285782|FG002|Overall Study|Moved from area|1|||
124907208|NCT02202499|449285780|FG000|Overall Study|Declined before randomization|1|||
124907209|NCT02202499|449285781|FG001|Overall Study|Declined before randomization|0|||
124907210|NCT02202499|449285782|FG002|Overall Study|Declined before randomization|0|||
124907211|NCT02202499|449285780|FG000|Overall Study|Auto accident|1|||
124907212|NCT02202499|449285781|FG001|Overall Study|Auto accident|0|||
124907213|NCT02202499|449285782|FG002|Overall Study|Auto accident|0|||
124907214|NCT00535145|449285783|FG000|Phase I|Adverse Event|3|||
124907215|NCT00535145|449285783|FG000|Phase I|Lost to Follow-up|7|||
124907216|NCT00535145|449285783|FG000|Phase I|Withdrawal by Subject|6|||
124907217|NCT00535145|449285783|FG000|Phase I|(eligibility)|8|||
124907218|NCT00535145|449285783|FG000|Phase I|(protocol violation)|1|||
124907219|NCT00535145|449285783|FG000|Phase I|(PI decision)|1|||
124907220|NCT00535145|449285783|FG000|Phase I|(diagnosis)|3|||
124907221|NCT00535145|449285783|FG000|Phase II|Adverse Event|2|||
124907222|NCT00535145|449285783|FG000|Phase II|Lack of Efficacy|1|||
124907223|NCT00535145|449285783|FG000|Phase II|Lost to Follow-up|5|||
124907224|NCT00535145|449285783|FG000|Phase II|Withdrawal by Subject|5|||
124907225|NCT00535145|449285783|FG000|Phase II|Subject non-compliance|2|||
124907226|NCT02200770|449285784|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
124907227|NCT02200770|449285785|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
124907228|NCT02200770|449285784|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
124907229|NCT02200770|449285785|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
124907230|NCT02200770|449285784|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
124907231|NCT02200770|449285785|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
124907232|NCT02200770|449285784|FG000|Randomized-controlled Period (RCP)|Other|1|||
124907233|NCT02200770|449285785|FG001|Randomized-controlled Period (RCP)|Other|2|||
124907234|NCT02200770|449285784|FG000|Open-label Period (OLP)|Adverse Event|1|||
124907235|NCT02200770|449285785|FG001|Open-label Period (OLP)|Adverse Event|2|||
124907236|NCT02200770|449285784|FG000|Open-label Period (OLP)|Death|1|||
124907237|NCT02200770|449285785|FG001|Open-label Period (OLP)|Death|2|||
124907238|NCT02200770|449285784|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
124907239|NCT02200770|449285785|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
124907240|NCT02200770|449285784|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
124907241|NCT02200770|449285785|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
124907242|NCT02200770|449285784|FG000|Open-label Period (OLP)|Other|6|||
124907243|NCT02200770|449285785|FG001|Open-label Period (OLP)|Other|15|||
124907244|NCT00712335|449285791|FG000|Overall Study|Withdrawal by Subject|0|||
124907245|NCT00712335|449285792|FG001|Overall Study|Withdrawal by Subject|7|||
124907246|NCT00712335|449285793|FG002|Overall Study|Withdrawal by Subject|2|||
124907247|NCT00712335|449285794|FG003|Overall Study|Withdrawal by Subject|3|||
124907248|NCT00712335|449285795|FG004|Overall Study|Withdrawal by Subject|0|||
124907249|NCT00712335|449285791|FG000|Overall Study|Lost to Follow-up|2|||
124907250|NCT00712335|449285792|FG001|Overall Study|Lost to Follow-up|5|||
124907251|NCT00712335|449285793|FG002|Overall Study|Lost to Follow-up|0|||
124907252|NCT00712335|449285794|FG003|Overall Study|Lost to Follow-up|1|||
124907253|NCT00712335|449285795|FG004|Overall Study|Lost to Follow-up|0|||
124907254|NCT00712335|449285791|FG000|Overall Study|Protocol Violation|1|||
124907255|NCT00712335|449285792|FG001|Overall Study|Protocol Violation|2|||
124907256|NCT00712335|449285793|FG002|Overall Study|Protocol Violation|1|||
124907257|NCT00712335|449285794|FG003|Overall Study|Protocol Violation|0|||
124907258|NCT00712335|449285795|FG004|Overall Study|Protocol Violation|0|||
124907259|NCT00712335|449285791|FG000|Overall Study|Lack of Efficacy|0|||
124907260|NCT00712335|449285792|FG001|Overall Study|Lack of Efficacy|0|||
124907261|NCT00712335|449285793|FG002|Overall Study|Lack of Efficacy|1|||
124907262|NCT00712335|449285794|FG003|Overall Study|Lack of Efficacy|1|||
124907263|NCT00712335|449285795|FG004|Overall Study|Lack of Efficacy|0|||
124907264|NCT00712335|449285791|FG000|Overall Study|Other Reason|0|||
124907265|NCT00712335|449285792|FG001|Overall Study|Other Reason|3|||
124907266|NCT00712335|449285793|FG002|Overall Study|Other Reason|1|||
124907267|NCT00712335|449285794|FG003|Overall Study|Other Reason|0|||
124907268|NCT00712335|449285795|FG004|Overall Study|Other Reason|0|||
124907269|NCT03401112|449285797|FG000|Overall Study|Adverse Event|1|||
124907270|NCT03401112|449285798|FG001|Overall Study|Adverse Event|2|||
124907271|NCT03401112|449285799|FG002|Overall Study|Adverse Event|3|||
124907272|NCT03401112|449285800|FG003|Overall Study|Adverse Event|2|||
124907273|NCT03401112|449285801|FG004|Overall Study|Adverse Event|0|||
124907274|NCT03401112|449285797|FG000|Overall Study|Lost to Follow-up|1|||
124907275|NCT03401112|449285798|FG001|Overall Study|Lost to Follow-up|0|||
124907276|NCT03401112|449285799|FG002|Overall Study|Lost to Follow-up|0|||
124907277|NCT03401112|449285800|FG003|Overall Study|Lost to Follow-up|0|||
124907278|NCT03401112|449285801|FG004|Overall Study|Lost to Follow-up|0|||
124907279|NCT03401112|449285797|FG000|Overall Study|Noncompliance|1|||
124907280|NCT03401112|449285798|FG001|Overall Study|Noncompliance|2|||
124907281|NCT03401112|449285799|FG002|Overall Study|Noncompliance|3|||
124907282|NCT03401112|449285800|FG003|Overall Study|Noncompliance|0|||
124907283|NCT03401112|449285801|FG004|Overall Study|Noncompliance|0|||
124907284|NCT03401112|449285797|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
124907285|NCT03401112|449285798|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
124907286|NCT03401112|449285799|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
124907287|NCT03401112|449285800|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
124907288|NCT03401112|449285801|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
124907289|NCT03401112|449285797|FG000|Overall Study|Withdrawal by Subject|0|||
124907290|NCT03401112|449285798|FG001|Overall Study|Withdrawal by Subject|3|||
124907291|NCT03401112|449285799|FG002|Overall Study|Withdrawal by Subject|2|||
124907292|NCT03401112|449285800|FG003|Overall Study|Withdrawal by Subject|1|||
124907293|NCT03401112|449285801|FG004|Overall Study|Withdrawal by Subject|0|||
124907294|NCT03401112|449285797|FG000|Overall Study|Physician Decision|0|||
124907295|NCT03401112|449285798|FG001|Overall Study|Physician Decision|0|||
124907296|NCT03401112|449285799|FG002|Overall Study|Physician Decision|0|||
124907297|NCT03401112|449285800|FG003|Overall Study|Physician Decision|2|||
124907298|NCT03401112|449285801|FG004|Overall Study|Physician Decision|0|||
124907299|NCT03401112|449285797|FG000|Overall Study|Study was Terminated by Sponsor|0|||
124907300|NCT03401112|449285798|FG001|Overall Study|Study was Terminated by Sponsor|0|||
124907301|NCT03401112|449285799|FG002|Overall Study|Study was Terminated by Sponsor|0|||
124907302|NCT03401112|449285800|FG003|Overall Study|Study was Terminated by Sponsor|1|||
124907303|NCT03401112|449285801|FG004|Overall Study|Study was Terminated by Sponsor|0|||
124907304|NCT03401112|449285797|FG000|Overall Study|Day 1 Assessment not Done|1|||
124907305|NCT03401112|449285798|FG001|Overall Study|Day 1 Assessment not Done|0|||
124907306|NCT03401112|449285799|FG002|Overall Study|Day 1 Assessment not Done|0|||
124907307|NCT03401112|449285800|FG003|Overall Study|Day 1 Assessment not Done|0|||
124907308|NCT03401112|449285801|FG004|Overall Study|Day 1 Assessment not Done|0|||
124907309|NCT03401112|449285797|FG000|Overall Study|Not Dosed|0|||
124907310|NCT03401112|449285798|FG001|Overall Study|Not Dosed|0|||
124907311|NCT03401112|449285799|FG002|Overall Study|Not Dosed|1|||
124907312|NCT03401112|449285800|FG003|Overall Study|Not Dosed|0|||
124907313|NCT03401112|449285801|FG004|Overall Study|Not Dosed|0|||
124907314|NCT03401112|449285797|FG000|Overall Study|Missed Clinical Visit|0|||
124907315|NCT03401112|449285798|FG001|Overall Study|Missed Clinical Visit|0|||
124907316|NCT03401112|449285799|FG002|Overall Study|Missed Clinical Visit|1|||
124907317|NCT03401112|449285800|FG003|Overall Study|Missed Clinical Visit|0|||
124907318|NCT03401112|449285801|FG004|Overall Study|Missed Clinical Visit|0|||
124907319|NCT03401112|449285797|FG000|Overall Study|Missed Doses|0|||
124907320|NCT03401112|449285798|FG001|Overall Study|Missed Doses|0|||
124907321|NCT03401112|449285799|FG002|Overall Study|Missed Doses|1|||
124907322|NCT03401112|449285800|FG003|Overall Study|Missed Doses|0|||
124907323|NCT03401112|449285801|FG004|Overall Study|Missed Doses|0|||
124907324|NCT03475316|449285802|FG000|6 Month Intervention|Adverse Event|2|||
124907325|NCT03475316|449285803|FG001|6 Month Intervention|Adverse Event|1|||
124907326|NCT03475316|449285802|FG000|6 Month Intervention|Withdrawal by Subject|2|||
124907327|NCT03475316|449285803|FG001|6 Month Intervention|Withdrawal by Subject|0|||
124907328|NCT03475316|449285802|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
124907329|NCT03475316|449285803|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
124907330|NCT03475316|449285802|FG000|9 Months|Study stopped due to COVID pandemic|3|||
124907331|NCT03475316|449285803|FG001|9 Months|Study stopped due to COVID pandemic|4|||
124907332|NCT00424645|449285804|FG000|Overall Study|Death|1|||
124907333|NCT00424645|449285805|FG001|Overall Study|Death|0|||
124907334|NCT02555215|449285806|FG000|Overall Study|Other|1|||
124907335|NCT02555215|449285806|FG000|Overall Study|Investigator Decision|2|||
124907336|NCT00529789|449285807|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
124907337|NCT00529789|449285807|FG000|Study Period II/III|Adverse Event|3|||
124907338|NCT00529789|449285807|FG000|Study Period II/III|Lack of Efficacy|2|||
124907339|NCT00529789|449285807|FG000|Study Period II/III|Withdrawal by Subject|1|||
124907340|NCT00529789|449285807|FG000|Study Period II/III|Protocol Violation|3|||
124907341|NCT00529789|449285807|FG000|Study Period II/III|Physician Decision|3|||
124907342|NCT00529789|449285807|FG000|Study Period II/III|Lost to Follow-up|3|||
124907343|NCT00529789|449285807|FG000|Study Period IV|Parent/Caregiver Decision|1|||
124907344|NCT00529789|449285807|FG000|Study Period IV|Adverse Event|1|||
124907345|NCT00529789|449285807|FG000|Study Period IV|Lack of Efficacy|1|||
124907346|NCT00529789|449285807|FG000|Study Period IV|Lost to Follow-up|3|||
124907347|NCT01430611|449285808|FG000|Overall Study|Adverse Event|0|||
124907348|NCT01430611|449285809|FG001|Overall Study|Adverse Event|1|||
124907349|NCT01430611|449285808|FG000|Overall Study|Protocol Violation|1|||
124907350|NCT01430611|449285809|FG001|Overall Study|Protocol Violation|0|||
124907351|NCT01430611|449285808|FG000|Overall Study|Lost to Follow-up|1|||
124907352|NCT01430611|449285809|FG001|Overall Study|Lost to Follow-up|0|||
124907353|NCT01430611|449285808|FG000|Overall Study|Withdrawal by Subject|15|||
124907354|NCT01430611|449285809|FG001|Overall Study|Withdrawal by Subject|14|||
124907355|NCT00959946|449285810|FG000|Overall Study|Adverse Event|0|||
124907356|NCT00959946|449285811|FG001|Overall Study|Adverse Event|0|||
124907357|NCT00959946|449285812|FG002|Overall Study|Adverse Event|2|||
124907358|NCT00959946|449285813|FG003|Overall Study|Adverse Event|1|||
124907359|NCT00959946|449285814|FG004|Overall Study|Adverse Event|0|||
124907360|NCT00959946|449285815|FG005|Overall Study|Adverse Event|1|||
124907361|NCT00959946|449285816|FG006|Overall Study|Adverse Event|0|||
124907362|NCT00959946|449285817|FG007|Overall Study|Adverse Event|0|||
124907363|NCT00959946|449285810|FG000|Overall Study|Death|0|||
124907364|NCT00959946|449285811|FG001|Overall Study|Death|0|||
124907365|NCT00959946|449285812|FG002|Overall Study|Death|0|||
124907366|NCT00959946|449285813|FG003|Overall Study|Death|0|||
124907367|NCT00959946|449285814|FG004|Overall Study|Death|0|||
125114725|NCT03381248|450044634|FG000|0-6 Months|Protocol Violation|2|||
125114726|NCT03381248|450044635|FG001|0-6 Months|Protocol Violation|1|||
125114727|NCT03381248|450044634|FG000|0-6 Months|Physician Decision|1|||
125114728|NCT03381248|450044635|FG001|0-6 Months|Physician Decision|0|||
125114729|NCT03381248|450044634|FG000|0-6 Months|Planning another procedure|1|||
125114730|NCT03381248|450044635|FG001|0-6 Months|Planning another procedure|2|||
125114731|NCT03381248|450044634|FG000|6-12 Months|Withdrawal by Subject|1|||
125114732|NCT03381248|450044635|FG001|6-12 Months|Withdrawal by Subject|3|||
125114733|NCT03381248|450044634|FG000|6-12 Months|Lost to Follow-up|0|||
125114734|NCT03381248|450044635|FG001|6-12 Months|Lost to Follow-up|2|||
125114735|NCT03381248|450044634|FG000|6-12 Months|Protocol Violation|3|||
124907368|NCT00959946|449285815|FG005|Overall Study|Death|1|||
124907369|NCT00959946|449285816|FG006|Overall Study|Death|0|||
124907370|NCT00959946|449285817|FG007|Overall Study|Death|0|||
124907371|NCT00959946|449285810|FG000|Overall Study|Disease Progression|2|||
124907372|NCT00959946|449285811|FG001|Overall Study|Disease Progression|4|||
124907373|NCT00959946|449285812|FG002|Overall Study|Disease Progression|2|||
124907374|NCT00959946|449285813|FG003|Overall Study|Disease Progression|4|||
124907375|NCT00959946|449285814|FG004|Overall Study|Disease Progression|4|||
124907376|NCT00959946|449285815|FG005|Overall Study|Disease Progression|6|||
125114736|NCT03381248|450044635|FG001|6-12 Months|Protocol Violation|2|||
124907377|NCT00959946|449285816|FG006|Overall Study|Disease Progression|2|||
124907378|NCT00959946|449285817|FG007|Overall Study|Disease Progression|2|||
124907379|NCT00959946|449285810|FG000|Overall Study|Withdrawal by Subject|0|||
124907380|NCT00959946|449285811|FG001|Overall Study|Withdrawal by Subject|0|||
124907381|NCT00959946|449285812|FG002|Overall Study|Withdrawal by Subject|0|||
125114737|NCT03381248|450044634|FG000|6-12 Months|Planning another procedure|6|||
124907382|NCT00959946|449285813|FG003|Overall Study|Withdrawal by Subject|0|||
124907383|NCT00959946|449285814|FG004|Overall Study|Withdrawal by Subject|0|||
124907384|NCT00959946|449285815|FG005|Overall Study|Withdrawal by Subject|1|||
124907385|NCT00959946|449285816|FG006|Overall Study|Withdrawal by Subject|0|||
124907386|NCT00959946|449285817|FG007|Overall Study|Withdrawal by Subject|0|||
124907387|NCT01202955|449285820|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
124907388|NCT01202955|449285821|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
124907389|NCT02115139|449285822|FG000|Overall Study|Protocol Violation|1|||
124907390|NCT02115139|449285822|FG000|Overall Study|treatment discontinuation|6|||
124907391|NCT01909778|449285823|FG000|Overall Study|failed screening|1|||
124907392|NCT02471755|449285825|FG000|Overall Study|Withdrawal by Subject|1|||
124907393|NCT02471755|449285826|FG001|Overall Study|Withdrawal by Subject|0|||
124907394|NCT02471755|449285825|FG000|Overall Study|Lost to Follow-up|0|||
124907395|NCT02471755|449285826|FG001|Overall Study|Lost to Follow-up|1|||
124907396|NCT04740164|449285830|FG000|Overall Study|Lack of Efficacy|4|||
124907397|NCT04740164|449285831|FG001|Overall Study|Lack of Efficacy|0|||
124907398|NCT04740164|449285830|FG000|Overall Study|Physician Decision|3|||
124907399|NCT04740164|449285831|FG001|Overall Study|Physician Decision|3|||
124907400|NCT05323734|449285832|FG000|Overall Study|Adverse Event|5|||
124907401|NCT05323734|449285833|FG001|Overall Study|Adverse Event|2|||
124907402|NCT05323734|449285832|FG000|Overall Study|Physician Decision|1|||
124907403|NCT05323734|449285833|FG001|Overall Study|Physician Decision|0|||
124907404|NCT05323734|449285832|FG000|Overall Study|Lack of Efficacy|1|||
124907405|NCT05323734|449285833|FG001|Overall Study|Lack of Efficacy|2|||
124907406|NCT05323734|449285832|FG000|Overall Study|Withdrawal by Subject|2|||
124907407|NCT05323734|449285833|FG001|Overall Study|Withdrawal by Subject|0|||
124907408|NCT05323734|449285832|FG000|Overall Study|Participant Withdrawn Due|0|||
124907409|NCT05323734|449285833|FG001|Overall Study|Participant Withdrawn Due|1|||
124907410|NCT02486718|449285834|FG000|Enrollment Phase|Death|19|||
124907411|NCT02486718|449285835|FG001|Enrollment Phase|Death|0|||
124907412|NCT02486718|449285836|FG002|Enrollment Phase|Death|0|||
124907413|NCT02486718|449285834|FG000|Enrollment Phase|Symptomatic deterioration|1|||
124907414|NCT02486718|449285835|FG001|Enrollment Phase|Symptomatic deterioration|0|||
124907415|NCT02486718|449285836|FG002|Enrollment Phase|Symptomatic deterioration|0|||
124907416|NCT02486718|449285834|FG000|Enrollment Phase|Withdrawal by Subject|86|||
124907417|NCT02486718|449285835|FG001|Enrollment Phase|Withdrawal by Subject|0|||
124907418|NCT02486718|449285836|FG002|Enrollment Phase|Withdrawal by Subject|0|||
124907419|NCT02486718|449285834|FG000|Enrollment Phase|Protocol Violation|18|||
124907420|NCT02486718|449285835|FG001|Enrollment Phase|Protocol Violation|0|||
124907421|NCT02486718|449285836|FG002|Enrollment Phase|Protocol Violation|0|||
124907422|NCT02486718|449285834|FG000|Enrollment Phase|Physician Decision|18|||
124907423|NCT02486718|449285835|FG001|Enrollment Phase|Physician Decision|0|||
124907424|NCT02486718|449285836|FG002|Enrollment Phase|Physician Decision|0|||
124907425|NCT02486718|449285834|FG000|Enrollment Phase|Reason not provided|41|||
124907426|NCT02486718|449285835|FG001|Enrollment Phase|Reason not provided|0|||
124907427|NCT02486718|449285836|FG002|Enrollment Phase|Reason not provided|0|||
124907428|NCT02486718|449285834|FG000|Enrollment Phase|Disease relapse|54|||
124907429|NCT02486718|449285835|FG001|Enrollment Phase|Disease relapse|0|||
124907430|NCT02486718|449285836|FG002|Enrollment Phase|Disease relapse|0|||
124907431|NCT02486718|449285834|FG000|Enrollment Phase|Lost to Follow-up|4|||
125022035|NCT01121393|449705341|FG001|Overall Study|Refused cont. medication|7|||
124907432|NCT02486718|449285835|FG001|Enrollment Phase|Lost to Follow-up|0|||
124907433|NCT02486718|449285836|FG002|Enrollment Phase|Lost to Follow-up|0|||
124907434|NCT02486718|449285834|FG000|Enrollment Phase|Adverse Event|34|||
124907435|NCT02486718|449285835|FG001|Enrollment Phase|Adverse Event|0|||
124907436|NCT02486718|449285836|FG002|Enrollment Phase|Adverse Event|0|||
124907437|NCT02486718|449285834|FG000|Randomized Phase|Withdrawal by Subject|0|||
124907438|NCT02486718|449285835|FG001|Randomized Phase|Withdrawal by Subject|44|||
124907439|NCT02486718|449285836|FG002|Randomized Phase|Withdrawal by Subject|47|||
124907440|NCT02486718|449285834|FG000|Randomized Phase|Protocol Violation|0|||
124907441|NCT02486718|449285835|FG001|Randomized Phase|Protocol Violation|2|||
124907442|NCT02486718|449285836|FG002|Randomized Phase|Protocol Violation|0|||
124907443|NCT02486718|449285834|FG000|Randomized Phase|Physician Decision|0|||
124907444|NCT02486718|449285835|FG001|Randomized Phase|Physician Decision|0|||
124907445|NCT02486718|449285836|FG002|Randomized Phase|Physician Decision|3|||
125022036|NCT01121393|449705340|FG000|Overall Study|Not treated|3|||
124907446|NCT02486718|449285834|FG000|Randomized Phase|Lost to Follow-up|0|||
124907447|NCT02486718|449285835|FG001|Randomized Phase|Lost to Follow-up|5|||
124907448|NCT02486718|449285836|FG002|Randomized Phase|Lost to Follow-up|11|||
124907449|NCT02486718|449285834|FG000|Randomized Phase|Disease Relapse|0|||
124907450|NCT02486718|449285835|FG001|Randomized Phase|Disease Relapse|1|||
124907451|NCT02486718|449285836|FG002|Randomized Phase|Disease Relapse|0|||
124907452|NCT02486718|449285834|FG000|Randomized Phase|Death|0|||
124907453|NCT02486718|449285835|FG001|Randomized Phase|Death|154|||
124907454|NCT02486718|449285836|FG002|Randomized Phase|Death|155|||
124907455|NCT02486718|449285834|FG000|Randomized Phase|Ongoing|0|||
124907456|NCT02486718|449285835|FG001|Randomized Phase|Ongoing|301|||
124907457|NCT02486718|449285836|FG002|Randomized Phase|Ongoing|282|||
124907458|NCT02248480|449285837|FG000|Overall Study|Lack of Efficacy|4|||
124907459|NCT02248480|449285838|FG001|Overall Study|Lack of Efficacy|6|||
124907460|NCT02248480|449285837|FG000|Overall Study|Adverse Event|11|||
124907461|NCT02248480|449285838|FG001|Overall Study|Adverse Event|2|||
124907462|NCT02248480|449285837|FG000|Overall Study|Withdrawal by Subject|2|||
124907463|NCT02248480|449285838|FG001|Overall Study|Withdrawal by Subject|4|||
124907464|NCT02248480|449285837|FG000|Overall Study|Entry Criteria Not Met|0|||
124907465|NCT02248480|449285838|FG001|Overall Study|Entry Criteria Not Met|1|||
124907466|NCT02248480|449285837|FG000|Overall Study|Other:Physician Decision|0|||
124907467|NCT02248480|449285838|FG001|Overall Study|Other:Physician Decision|1|||
124907468|NCT01595321|449285839|FG000|Overall Study|Adverse Event|1|||
124907469|NCT01595321|449285840|FG001|Overall Study|Adverse Event|1|||
124907470|NCT01595321|449285841|FG002|Overall Study|Adverse Event|1|||
124907471|NCT01595321|449285839|FG000|Overall Study|Lack of Efficacy|0|||
124907472|NCT01595321|449285840|FG001|Overall Study|Lack of Efficacy|0|||
124907473|NCT01595321|449285841|FG002|Overall Study|Lack of Efficacy|4|||
124907474|NCT04504916|449285842|FG000|Overall Study|Study terminated|7|||
124907475|NCT04504916|449285843|FG001|Overall Study|Study terminated|8|||
124907476|NCT04504916|449285842|FG000|Overall Study|Death|54|||
124907477|NCT04504916|449285843|FG001|Overall Study|Death|18|||
124907478|NCT04504916|449285842|FG000|Overall Study|Lost to Follow-up|1|||
124907479|NCT04504916|449285843|FG001|Overall Study|Lost to Follow-up|1|||
124907480|NCT04504916|449285842|FG000|Overall Study|Withdrawal by Subject|8|||
124907481|NCT04504916|449285843|FG001|Overall Study|Withdrawal by Subject|4|||
124907482|NCT04504916|449285842|FG000|Overall Study|Did not agree to follow-up|0|||
124907483|NCT04504916|449285843|FG001|Overall Study|Did not agree to follow-up|1|||
124907484|NCT00373529|449285845|FG000|Overall Study|Physician Decision|19|||
124907485|NCT00373529|449285845|FG000|Overall Study|Withdrawal by Subject|7|||
124907486|NCT00373529|449285845|FG000|Overall Study|Adverse Event|7|||
124907487|NCT00373529|449285845|FG000|Overall Study|Treatment failure|36|||
124907488|NCT00373529|449285845|FG000|Overall Study|Disease recurrence|10|||
124907489|NCT00373529|449285845|FG000|Overall Study|Death|16|||
124907490|NCT00373529|449285845|FG000|Overall Study|Need for treatment prohibited by study|1|||
124907491|NCT00373529|449285845|FG000|Overall Study|Other|8|||
124907492|NCT00373529|449285845|FG000|Overall Study|Failed independent confirmation of AML|3|||
124907493|NCT00373529|449285845|FG000|Overall Study|Consent violation|1|||
124907494|NCT01579916|449285847|FG000|Overall Study|Lost to Follow-up|6|||
124907495|NCT01579916|449285848|FG001|Overall Study|Lost to Follow-up|1|||
124907496|NCT01579916|449285847|FG000|Overall Study|Withdrawal by Subject|1|||
124907497|NCT01579916|449285848|FG001|Overall Study|Withdrawal by Subject|1|||
124907498|NCT01579916|449285847|FG000|Overall Study|Death|1|||
124907499|NCT01579916|449285848|FG001|Overall Study|Death|0|||
124907500|NCT00732381|449285854|FG000|Overall Study|Adverse Event|1|||
124907501|NCT00732381|449285855|FG001|Overall Study|Adverse Event|0|||
124907502|NCT00732381|449285854|FG000|Overall Study|Treatment Failure|1|||
125114738|NCT03381248|450044635|FG001|6-12 Months|Planning another procedure|2|||
125114739|NCT03381248|450044634|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
125114740|NCT03381248|450044635|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
125114741|NCT03381248|450044634|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
125114742|NCT03381248|450044635|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
124907503|NCT00732381|449285855|FG001|Overall Study|Treatment Failure|1|||
124907504|NCT00457691|449285857|FG000|Overall Study|Adverse Event|4|||
124907505|NCT00457691|449285858|FG001|Overall Study|Adverse Event|1|||
124907506|NCT00457691|449285857|FG000|Overall Study|Death|163|||
124907507|NCT00457691|449285858|FG001|Overall Study|Death|148|||
124907508|NCT00457691|449285857|FG000|Overall Study|Protocol Violation|1|||
124907509|NCT00457691|449285858|FG001|Overall Study|Protocol Violation|3|||
124907510|NCT00457691|449285857|FG000|Overall Study|Lost to Follow-up|23|||
124907511|NCT00457691|449285858|FG001|Overall Study|Lost to Follow-up|14|||
124907512|NCT00457691|449285857|FG000|Overall Study|Study terminated by Sponsor|1|||
124907513|NCT00457691|449285858|FG001|Overall Study|Study terminated by Sponsor|1|||
124907514|NCT00457691|449285857|FG000|Overall Study|Subject refused (reason other than AE)|14|||
125114743|NCT03381248|450044634|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
125114744|NCT03381248|450044635|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
125114745|NCT01466686|450044642|FG000|Overall Study|Withdrawal by Subject|1|||
125114746|NCT00827827|450044643|FG000|Overall Study|Lost to Follow-up|3|||
125114747|NCT00827827|450044644|FG001|Overall Study|Lost to Follow-up|0|||
125114748|NCT00827827|450044643|FG000|Overall Study|Fall at home- hospitalization|1|||
125114749|NCT00827827|450044644|FG001|Overall Study|Fall at home- hospitalization|0|||
125114750|NCT00827827|450044643|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
125114751|NCT00827827|450044644|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
125114752|NCT00827827|450044643|FG000|Overall Study|Gout|1|||
125114753|NCT00827827|450044644|FG001|Overall Study|Gout|0|||
125114754|NCT00827827|450044643|FG000|Overall Study|Transportation issues|1|||
125114755|NCT00827827|450044644|FG001|Overall Study|Transportation issues|0|||
125114756|NCT00827827|450044643|FG000|Overall Study|Burned with water at home|1|||
125114757|NCT00827827|450044644|FG001|Overall Study|Burned with water at home|0|||
125114758|NCT02884206|450044661|FG000|Valsartan Run-in Period|Death|1|||
125114759|NCT02884206|450044662|FG001|Valsartan Run-in Period|Death|0|||
125114760|NCT02884206|450044663|FG002|Valsartan Run-in Period|Death|0|||
125114761|NCT02884206|450044661|FG000|Valsartan Run-in Period|Adverse Event|31|||
125114762|NCT02884206|450044662|FG001|Valsartan Run-in Period|Adverse Event|0|||
125114763|NCT02884206|450044663|FG002|Valsartan Run-in Period|Adverse Event|0|||
125114764|NCT02884206|450044661|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
125114765|NCT02884206|450044662|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
125114766|NCT02884206|450044663|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
125114767|NCT02884206|450044661|FG000|Valsartan Run-in Period|Protocol deviation|4|||
125114768|NCT02884206|450044662|FG001|Valsartan Run-in Period|Protocol deviation|0|||
125114769|NCT02884206|450044663|FG002|Valsartan Run-in Period|Protocol deviation|0|||
125114770|NCT02884206|450044661|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
125114771|NCT02884206|450044662|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
125114772|NCT02884206|450044663|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
125114773|NCT02884206|450044661|FG000|Valsartan Run-in Period|Physician Decision|1|||
125114774|NCT02884206|450044662|FG001|Valsartan Run-in Period|Physician Decision|0|||
125114775|NCT02884206|450044663|FG002|Valsartan Run-in Period|Physician Decision|0|||
125114776|NCT02884206|450044661|FG000|LCZ696 Run-in Period|Adverse Event|38|||
125114777|NCT02884206|450044662|FG001|LCZ696 Run-in Period|Adverse Event|0|||
125114778|NCT02884206|450044663|FG002|LCZ696 Run-in Period|Adverse Event|0|||
125114779|NCT02884206|450044661|FG000|LCZ696 Run-in Period|Death|2|||
125114780|NCT02884206|450044662|FG001|LCZ696 Run-in Period|Death|0|||
125114781|NCT02884206|450044663|FG002|LCZ696 Run-in Period|Death|0|||
125114782|NCT02884206|450044661|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
125114783|NCT02884206|450044662|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
125114784|NCT02884206|450044663|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
125114785|NCT02884206|450044661|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
125114786|NCT02884206|450044662|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
125114787|NCT02884206|450044663|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
125114788|NCT02884206|450044661|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
125114789|NCT02884206|450044662|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
125114790|NCT02884206|450044663|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
125114791|NCT02884206|450044661|FG000|LCZ696 Run-in Period|Physician Decision|1|||
125114792|NCT02884206|450044662|FG001|LCZ696 Run-in Period|Physician Decision|0|||
125114793|NCT02884206|450044663|FG002|LCZ696 Run-in Period|Physician Decision|0|||
125114794|NCT02884206|450044661|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
125114795|NCT02884206|450044662|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
124907515|NCT00457691|449285858|FG001|Overall Study|Subject refused (reason other than AE)|19|||
124907516|NCT00457691|449285857|FG000|Overall Study|Disease progression, study terminated|180|||
124907517|NCT00457691|449285858|FG001|Overall Study|Disease progression, study terminated|196|||
124907518|NCT01121549|449285863|FG000|Overall Study|Adverse Event|10|||
124907519|NCT01121549|449285863|FG000|Overall Study|Lack of Efficacy|11|||
124907520|NCT01121549|449285863|FG000|Overall Study|Lost to Follow-up|12|||
124907521|NCT01121549|449285863|FG000|Overall Study|Did not meet entrance criteria|9|||
124907522|NCT01121549|449285863|FG000|Overall Study|Study terminated by sponsor|197|||
124907523|NCT01121549|449285863|FG000|Overall Study|Pregnancy|1|||
124907524|NCT01121549|449285863|FG000|Overall Study|Protocol Violation|33|||
124907525|NCT01121549|449285863|FG000|Overall Study|Withdrawal by Subject|16|||
124907526|NCT01121549|449285863|FG000|Overall Study|Other|58|||
125114796|NCT02884206|450044663|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
124907527|NCT00493649|449286735|FG000|Overall Study|Adverse Event|44|||
124907528|NCT00493649|449286735|FG000|Overall Study|Patient Request|21|||
125114797|NCT02884206|450044661|FG000|Double-Blind Period|Death|0|||
125114798|NCT02884206|450044662|FG001|Double-Blind Period|Death|28|||
125114799|NCT02884206|450044663|FG002|Double-Blind Period|Death|39|||
125114800|NCT02884206|450044661|FG000|Double-Blind Period|Patient/guardian decision|0|||
125114801|NCT02884206|450044662|FG001|Double-Blind Period|Patient/guardian decision|10|||
125114802|NCT02884206|450044663|FG002|Double-Blind Period|Patient/guardian decision|13|||
124907529|NCT00493649|449286735|FG000|Overall Study|Investigator Request|2|||
124907530|NCT00493649|449286735|FG000|Overall Study|Disease Progression|1|||
124907531|NCT00493649|449286735|FG000|Overall Study|Lost to Follow-up|1|||
124907532|NCT00493649|449286735|FG000|Overall Study|Other|13|||
124907533|NCT05219253|449286736|FG000|Overall Study|Withdrawal by Subject|1|||
125114803|NCT02884206|450044661|FG000|Double-Blind Period|Lost to Follow-up|0|||
125114804|NCT02884206|450044662|FG001|Double-Blind Period|Lost to Follow-up|4|||
125114805|NCT02884206|450044663|FG002|Double-Blind Period|Lost to Follow-up|4|||
125114806|NCT02884206|450044661|FG000|Double-Blind Period|Physician Decision|0|||
125114807|NCT02884206|450044662|FG001|Double-Blind Period|Physician Decision|2|||
125114808|NCT02884206|450044663|FG002|Double-Blind Period|Physician Decision|0|||
125114809|NCT02884206|450044661|FG000|Double-Blind Period|Adverse Event|0|||
125114810|NCT02884206|450044662|FG001|Double-Blind Period|Adverse Event|0|||
125114811|NCT02884206|450044663|FG002|Double-Blind Period|Adverse Event|3|||
125114812|NCT02884206|450044661|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
125114813|NCT02884206|450044662|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
125114814|NCT02884206|450044663|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
125114815|NCT00112489|450044664|FG000|Overall Study|Refused further treatment|8|||
125114816|NCT00112489|450044664|FG000|Overall Study|Adverse Event|12|||
125114817|NCT00112489|450044664|FG000|Overall Study|Death|2|||
125114818|NCT00112489|450044664|FG000|Overall Study|Other, Not Specified|9|||
125114819|NCT00112489|450044664|FG000|Overall Study|Patient never treated|2|||
124907534|NCT05219253|449286737|FG001|Overall Study|Withdrawal by Subject|2|||
124907535|NCT03086369|449286738|FG000|Overall Study|Lost to Follow-up|1|||
124907536|NCT03086369|449286739|FG001|Overall Study|Lost to Follow-up|0|||
124907537|NCT03086369|449286740|FG002|Overall Study|Lost to Follow-up|0|||
124907538|NCT03086369|449286741|FG003|Overall Study|Lost to Follow-up|2|||
124907539|NCT03086369|449286742|FG004|Overall Study|Lost to Follow-up|1|||
124907540|NCT03086369|449286738|FG000|Overall Study|Physician Decision|0|||
124907541|NCT03086369|449286739|FG001|Overall Study|Physician Decision|0|||
125114820|NCT00112489|450044664|FG000|Overall Study|Ineligible|7|||
125114821|NCT05751629|450044665|FG000|Overall Study|Withdrawal by Subject|6|||
125114822|NCT05751629|450044665|FG000|Overall Study|Death|25|||
125114823|NCT05751629|450044665|FG000|Overall Study|Study Site Closed|9|||
124907542|NCT03086369|449286740|FG002|Overall Study|Physician Decision|0|||
124907543|NCT03086369|449286741|FG003|Overall Study|Physician Decision|1|||
124907544|NCT03086369|449286742|FG004|Overall Study|Physician Decision|2|||
124907545|NCT03086369|449286738|FG000|Overall Study|Withdrawal by Subject|0|||
124907546|NCT03086369|449286739|FG001|Overall Study|Withdrawal by Subject|0|||
124907547|NCT03086369|449286740|FG002|Overall Study|Withdrawal by Subject|0|||
124907548|NCT03086369|449286741|FG003|Overall Study|Withdrawal by Subject|5|||
124907549|NCT03086369|449286742|FG004|Overall Study|Withdrawal by Subject|3|||
124907550|NCT03086369|449286738|FG000|Overall Study|Progressive Disease|0|||
124907551|NCT03086369|449286739|FG001|Overall Study|Progressive Disease|0|||
124907552|NCT03086369|449286740|FG002|Overall Study|Progressive Disease|0|||
124907553|NCT03086369|449286741|FG003|Overall Study|Progressive Disease|1|||
124907554|NCT03086369|449286742|FG004|Overall Study|Progressive Disease|1|||
124907555|NCT04603924|449286745|FG000|Overall Study|Not Dosed|2|||
124907556|NCT04603924|449286746|FG001|Overall Study|Not Dosed|1|||
124907557|NCT04603924|449286745|FG000|Overall Study|Withdrawal by Subject|6|||
124907558|NCT04603924|449286746|FG001|Overall Study|Withdrawal by Subject|6|||
124907559|NCT04603924|449286745|FG000|Overall Study|Adverse Event|2|||
124907560|NCT04603924|449286746|FG001|Overall Study|Adverse Event|2|||
124907561|NCT01765543|449286749|FG000|Overall Study|Death|1|||
124907562|NCT01765543|449286749|FG000|Overall Study|Withdrawal by Subject|2|||
124907563|NCT05876949|449286750|FG000|Overall Study|Withdrawal by Subject|1|||
124907564|NCT05876949|449286751|FG001|Overall Study|Withdrawal by Subject|3|||
124907565|NCT05876949|449286750|FG000|Overall Study|Physician Decision|0|||
124907566|NCT05876949|449286751|FG001|Overall Study|Physician Decision|2|||
124907567|NCT05876949|449286750|FG000|Overall Study|Death|0|||
124907568|NCT05876949|449286751|FG001|Overall Study|Death|1|||
124907569|NCT03644849|449286752|FG000|Overall Study|Lost to Follow-up|1|||
124907570|NCT03644849|449286753|FG001|Overall Study|Lost to Follow-up|3|||
124907571|NCT00071799|449286754|FG000|Overall Study|Adverse Event|19|||
124907572|NCT00071799|449286755|FG001|Overall Study|Adverse Event|10|||
124907573|NCT00071799|449286754|FG000|Overall Study|Protocol Violation|1|||
124907574|NCT00071799|449286755|FG001|Overall Study|Protocol Violation|7|||
124907575|NCT00071799|449286754|FG000|Overall Study|Lost to Follow-up|1|||
124907576|NCT00071799|449286755|FG001|Overall Study|Lost to Follow-up|1|||
124907577|NCT00071799|449286754|FG000|Overall Study|Withdrawal by Subject|15|||
124907578|NCT00071799|449286755|FG001|Overall Study|Withdrawal by Subject|37|||
124907579|NCT00071799|449286754|FG000|Overall Study|Physician Decision|0|||
124907580|NCT00071799|449286755|FG001|Overall Study|Physician Decision|2|||
124907581|NCT00071799|449286754|FG000|Overall Study|Lack of Efficacy|11|||
124907582|NCT00071799|449286755|FG001|Overall Study|Lack of Efficacy|18|||
124907583|NCT00071799|449286754|FG000|Overall Study|Disease Progression|23|||
125114824|NCT05751629|450044665|FG000|Overall Study|Physician Decision|1|||
125114825|NCT02231710|450044667|FG000|Overall Study|Physician Decision|1|||
125114826|NCT00295854|450044669|FG000|Overall Study|Adverse Event|7|||
124907584|NCT00071799|449286755|FG001|Overall Study|Disease Progression|20|||
124907585|NCT00071799|449286754|FG000|Overall Study|Different Central+Local Pathology Review|0|||
124907586|NCT00071799|449286755|FG001|Overall Study|Different Central+Local Pathology Review|1|||
124907587|NCT00071799|449286754|FG000|Overall Study|Not Documented|0|||
124907588|NCT00071799|449286755|FG001|Overall Study|Not Documented|2|||
124907589|NCT00979992|449286756|FG000|Overall Study|Ineligible - inadequate pathology|1|||
124907590|NCT00979992|449286756|FG000|Overall Study|Ineligible - wrong cell type|2|||
124907591|NCT00979992|449286756|FG000|Overall Study|Refused - Never Treated|2|||
124907592|NCT03593213|449286757|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
124907593|NCT03593213|449286758|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
124907594|NCT03593213|449286759|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
124907595|NCT03593213|449286760|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
124907596|NCT03593213|449286757|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
124907597|NCT03593213|449286758|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
124907598|NCT03593213|449286759|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
124907599|NCT03593213|449286760|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
124907600|NCT03593213|449286757|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
124907601|NCT03593213|449286758|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
124907602|NCT03593213|449286759|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
124907603|NCT03593213|449286760|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
124907604|NCT03593213|449286757|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
124907605|NCT03593213|449286758|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
124907606|NCT03593213|449286759|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
124907607|NCT03593213|449286760|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
124907608|NCT03593213|449286757|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
124907609|NCT03593213|449286758|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
124907610|NCT03593213|449286759|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
124907611|NCT03593213|449286760|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
124907612|NCT03593213|449286757|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
124907613|NCT03593213|449286758|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
124907614|NCT03593213|449286759|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
124907615|NCT03593213|449286760|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
124907616|NCT03593213|449286757|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
124907617|NCT03593213|449286758|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
124907618|NCT03593213|449286759|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
125022037|NCT01121393|449705341|FG001|Overall Study|Not treated|9|||
125022038|NCT01121393|449705340|FG000|Overall Study|Other than listed|6|||
125022039|NCT01121393|449705341|FG001|Overall Study|Other than listed|0|||
125022040|NCT01100944|449705342|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
125022041|NCT01100944|449705343|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
125022042|NCT01100944|449705344|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
125022043|NCT01100944|449705342|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
125022044|NCT01100944|449705343|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
125022045|NCT01100944|449705344|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
125022046|NCT01100944|449705342|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
125022047|NCT01100944|449705343|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
125022048|NCT01100944|449705344|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
125022049|NCT01100944|449705342|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
125022050|NCT01100944|449705343|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
125022051|NCT01100944|449705344|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
124907619|NCT03593213|449286760|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
124907620|NCT03593213|449286757|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
124907621|NCT03593213|449286758|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
124907622|NCT03593213|449286759|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
124907623|NCT03593213|449286760|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
124907624|NCT03593213|449286757|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
124907625|NCT03593213|449286758|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
124907626|NCT03593213|449286759|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
124907627|NCT03593213|449286760|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
124907628|NCT03593213|449286757|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
124907629|NCT03593213|449286758|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
124907630|NCT03593213|449286759|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
124907631|NCT03593213|449286760|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
124907632|NCT03593213|449286757|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
124907633|NCT03593213|449286758|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
124907634|NCT03593213|449286759|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
124907635|NCT03593213|449286760|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
124907636|NCT03593213|449286757|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
124907637|NCT03593213|449286758|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
124907638|NCT03593213|449286759|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
124907639|NCT03593213|449286760|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
124907640|NCT03593213|449286757|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
124907641|NCT03593213|449286758|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
124907642|NCT03593213|449286759|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
124907643|NCT03593213|449286760|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
124907644|NCT03593213|449286757|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
124907645|NCT03593213|449286758|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
124907646|NCT03593213|449286759|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
124907647|NCT03593213|449286760|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
124907648|NCT03593213|449286757|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
124907649|NCT03593213|449286758|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
124907650|NCT03593213|449286759|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
124907651|NCT03593213|449286760|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
124907652|NCT03593213|449286757|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
124907653|NCT03593213|449286758|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
124907654|NCT03593213|449286759|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
124907655|NCT03593213|449286760|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
124907656|NCT03593213|449286757|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
124907657|NCT03593213|449286758|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
124907658|NCT03593213|449286759|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
124907659|NCT03593213|449286760|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
125022052|NCT00577993|449705345|FG000|Overall Study|Adverse Event|1|||
125022053|NCT00577993|449705346|FG001|Overall Study|Adverse Event|0|||
125022054|NCT00577993|449705347|FG002|Overall Study|Adverse Event|0|||
125022055|NCT00577993|449705345|FG000|Overall Study|Death|0|||
125022056|NCT00577993|449705346|FG001|Overall Study|Death|1|||
125022057|NCT00577993|449705347|FG002|Overall Study|Death|1|||
125022058|NCT00577993|449705345|FG000|Overall Study|Lack of Efficacy|0|||
125022059|NCT00577993|449705346|FG001|Overall Study|Lack of Efficacy|1|||
124907660|NCT03593213|449286757|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
124907661|NCT03593213|449286758|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
124907662|NCT03593213|449286759|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
124907663|NCT03593213|449286760|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
124907664|NCT03593213|449286757|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
124907665|NCT03593213|449286758|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
124907666|NCT03593213|449286759|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
124907667|NCT03593213|449286760|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
124907668|NCT01254019|449286763|FG000|Overall Study|Adverse Event|0|||
124907669|NCT01254019|449286764|FG001|Overall Study|Adverse Event|2|||
124907670|NCT01254019|449286763|FG000|Overall Study|Protocol Violation|1|||
124907671|NCT01254019|449286764|FG001|Overall Study|Protocol Violation|0|||
124907672|NCT01254019|449286763|FG000|Overall Study|Withdrawal by Subject|0|||
124907673|NCT01254019|449286764|FG001|Overall Study|Withdrawal by Subject|2|||
124907674|NCT00665444|449286769|FG000|Overall Study|Physician Decision|1|||
124907675|NCT00665444|449286769|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
124907676|NCT00638963|449286771|FG000|Overall Study|Withdrawal by Subject|1|||
124907677|NCT00638963|449286772|FG001|Overall Study|Withdrawal by Subject|0|||
124907678|NCT03260140|449286774|FG000|Overall Study|Death|4|||
124907679|NCT03260140|449286775|FG001|Overall Study|Death|1|||
124907680|NCT03260140|449286774|FG000|Overall Study|Withdrawal by Subject|1|||
124907681|NCT03260140|449286775|FG001|Overall Study|Withdrawal by Subject|4|||
124907682|NCT01444417|449286776|FG000|Overall Study|Ineligibility Determined|0|||
124907683|NCT01444417|449286777|FG001|Overall Study|Ineligibility Determined|1|||
124907684|NCT01444417|449286776|FG000|Overall Study|Withdrawal by Subject|2|||
124907685|NCT01444417|449286777|FG001|Overall Study|Withdrawal by Subject|0|||
124907686|NCT02423291|449286778|FG000|Overall Study|Lack of Efficacy|14|||
124907687|NCT02423291|449286778|FG000|Overall Study|Adverse Event|1|||
124907688|NCT05283395|449286782|FG000|Overall Study|Adverse Event|4|||
124907689|NCT05283395|449286783|FG001|Overall Study|Adverse Event|4|||
124907690|NCT05283395|449286784|FG002|Overall Study|Adverse Event|0|||
124907691|NCT05283395|449286782|FG000|Overall Study|Patient Lost to Follow-Up|0|||
124907692|NCT05283395|449286783|FG001|Overall Study|Patient Lost to Follow-Up|0|||
124907693|NCT05283395|449286784|FG002|Overall Study|Patient Lost to Follow-Up|1|||
124907694|NCT05283395|449286782|FG000|Overall Study|Patient Withdrawal|2|||
124907695|NCT05283395|449286783|FG001|Overall Study|Patient Withdrawal|4|||
124907696|NCT05283395|449286784|FG002|Overall Study|Patient Withdrawal|2|||
124907697|NCT05283395|449286782|FG000|Overall Study|Investigator Decision|1|||
124907698|NCT05283395|449286783|FG001|Overall Study|Investigator Decision|0|||
124907699|NCT05283395|449286784|FG002|Overall Study|Investigator Decision|1|||
124907700|NCT05283395|449286782|FG000|Overall Study|Enrolled in error|0|||
124907701|NCT05283395|449286783|FG001|Overall Study|Enrolled in error|0|||
124907702|NCT05283395|449286784|FG002|Overall Study|Enrolled in error|1|||
124907703|NCT03144674|449286787|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
124907704|NCT03144674|449286788|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
124907705|NCT03144674|449286789|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
124907706|NCT03144674|449286790|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
124907707|NCT03144674|449286787|FG000|Overall Study|Death|3|||
124907708|NCT03144674|449286788|FG001|Overall Study|Death|2|||
124907709|NCT03144674|449286789|FG002|Overall Study|Death|6|||
124907710|NCT03144674|449286790|FG003|Overall Study|Death|24|||
124907711|NCT03144674|449286787|FG000|Overall Study|Lost to Follow-up|0|||
124907712|NCT03144674|449286788|FG001|Overall Study|Lost to Follow-up|1|||
124907713|NCT03144674|449286789|FG002|Overall Study|Lost to Follow-up|0|||
124907714|NCT03144674|449286790|FG003|Overall Study|Lost to Follow-up|4|||
124907715|NCT03144674|449286787|FG000|Overall Study|Withdrawal by Participant|0|||
124907716|NCT03144674|449286788|FG001|Overall Study|Withdrawal by Participant|0|||
124907717|NCT03144674|449286789|FG002|Overall Study|Withdrawal by Participant|2|||
124907718|NCT03144674|449286790|FG003|Overall Study|Withdrawal by Participant|6|||
124907719|NCT03144674|449286787|FG000|Overall Study|Discharged from the Trust|0|||
124907720|NCT03144674|449286788|FG001|Overall Study|Discharged from the Trust|0|||
124907721|NCT03144674|449286789|FG002|Overall Study|Discharged from the Trust|1|||
124907722|NCT03144674|449286790|FG003|Overall Study|Discharged from the Trust|0|||
124907723|NCT03144674|449286787|FG000|Overall Study|Exclusion Criteria Met|0|||
124907724|NCT03144674|449286788|FG001|Overall Study|Exclusion Criteria Met|0|||
125211110|NCT04767529|450398580|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
124907725|NCT03144674|449286789|FG002|Overall Study|Exclusion Criteria Met|1|||
124907726|NCT03144674|449286790|FG003|Overall Study|Exclusion Criteria Met|0|||
124907727|NCT03144674|449286787|FG000|Overall Study|Changed Physicians|0|||
124907728|NCT03144674|449286788|FG001|Overall Study|Changed Physicians|0|||
124907729|NCT03144674|449286789|FG002|Overall Study|Changed Physicians|0|||
124907730|NCT03144674|449286790|FG003|Overall Study|Changed Physicians|1|||
124907731|NCT03144674|449286787|FG000|Overall Study|Removed for Safety|0|||
124907732|NCT03144674|449286788|FG001|Overall Study|Removed for Safety|0|||
124907733|NCT03144674|449286789|FG002|Overall Study|Removed for Safety|0|||
124907734|NCT03144674|449286790|FG003|Overall Study|Removed for Safety|1|||
124907735|NCT03144674|449286787|FG000|Overall Study|Site Closed|0|||
124907736|NCT03144674|449286788|FG001|Overall Study|Site Closed|0|||
124907737|NCT03144674|449286789|FG002|Overall Study|Site Closed|0|||
124907738|NCT03144674|449286790|FG003|Overall Study|Site Closed|1|||
124907739|NCT03144674|449286787|FG000|Overall Study|Histological Criteria Not Met|0|||
124907740|NCT03144674|449286788|FG001|Overall Study|Histological Criteria Not Met|0|||
124907741|NCT03144674|449286789|FG002|Overall Study|Histological Criteria Not Met|0|||
124907742|NCT03144674|449286790|FG003|Overall Study|Histological Criteria Not Met|1|||
124907743|NCT03144674|449286787|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
124907744|NCT03144674|449286788|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
124907745|NCT03144674|449286789|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
124907746|NCT03144674|449286790|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
124907747|NCT03144674|449286787|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
124907748|NCT03144674|449286788|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
124907749|NCT03144674|449286789|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
124907750|NCT03144674|449286790|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
124907751|NCT00206375|449286791|FG000|Overall Study|Lost to Follow-up|1|||
124907752|NCT00206375|449286792|FG001|Overall Study|Lost to Follow-up|0|||
124907753|NCT00206375|449286793|FG002|Overall Study|Lost to Follow-up|0|||
124907754|NCT00206375|449286791|FG000|Overall Study|Withdrawal by Subject|2|||
124907755|NCT00206375|449286792|FG001|Overall Study|Withdrawal by Subject|1|||
124907756|NCT00206375|449286793|FG002|Overall Study|Withdrawal by Subject|3|||
124907757|NCT00206375|449286791|FG000|Overall Study|Study terminated due to lack of funds|0|||
124907758|NCT00206375|449286792|FG001|Overall Study|Study terminated due to lack of funds|1|||
124907759|NCT00206375|449286793|FG002|Overall Study|Study terminated due to lack of funds|1|||
124907760|NCT03368664|449286794|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
124907761|NCT03368664|449286794|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
124907762|NCT03368664|449286794|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
124907763|NCT03368664|449286794|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
124907764|NCT00837616|449286795|FG000|Overall Study|Withdrawal by Subject|0|||
124907765|NCT00837616|449286796|FG001|Overall Study|Withdrawal by Subject|1|||
124907766|NCT01810263|449286803|FG000|Overall Study|Lost to Follow-up|8|||
124907767|NCT01810263|449286804|FG001|Overall Study|Lost to Follow-up|7|||
124907768|NCT00688519|449286808|FG000|Overall Study|Adverse Event|2|||
124907769|NCT00688519|449286809|FG001|Overall Study|Adverse Event|3|||
124907770|NCT00688519|449286808|FG000|Overall Study|Lost to Follow-up|3|||
124907771|NCT00688519|449286809|FG001|Overall Study|Lost to Follow-up|3|||
124907772|NCT00688519|449286808|FG000|Overall Study|Lack of Efficacy|3|||
124907773|NCT00688519|449286809|FG001|Overall Study|Lack of Efficacy|1|||
124907774|NCT00688519|449286808|FG000|Overall Study|Withdrawal by Subject|7|||
124907775|NCT00688519|449286809|FG001|Overall Study|Withdrawal by Subject|6|||
124907776|NCT00688519|449286808|FG000|Overall Study|Prohibited medication|1|||
124907777|NCT00688519|449286809|FG001|Overall Study|Prohibited medication|0|||
124907778|NCT00688519|449286808|FG000|Overall Study|Non-compliance|0|||
124907779|NCT00688519|449286809|FG001|Overall Study|Non-compliance|1|||
124907780|NCT00688519|449286808|FG000|Overall Study|Subject moved out of state|1|||
124907781|NCT00688519|449286809|FG001|Overall Study|Subject moved out of state|0|||
124907782|NCT00688519|449286808|FG000|Overall Study|Investigator decision|1|||
124907783|NCT00688519|449286809|FG001|Overall Study|Investigator decision|0|||
124907784|NCT00688519|449286808|FG000|Overall Study|Subject moved out of area|1|||
124907785|NCT00688519|449286809|FG001|Overall Study|Subject moved out of area|0|||
124907786|NCT00688519|449286808|FG000|Overall Study|Pregnancy|0|||
124907787|NCT00688519|449286809|FG001|Overall Study|Pregnancy|1|||
124907788|NCT01685606|449286812|FG000|Overall Study|Withdrawal by Subject|1|||
124907789|NCT01353963|449286813|FG000|Overall Study|Adverse Event|2|||
124907790|NCT04789408|449286814|FG000|Overall Study|Death|4|||
124907791|NCT04789408|449286815|FG001|Overall Study|Death|3|||
124907792|NCT04789408|449286816|FG002|Overall Study|Death|6|||
124907793|NCT04789408|449286814|FG000|Overall Study|Did not meet eligibility criteria|1|||
124907794|NCT04789408|449286815|FG001|Overall Study|Did not meet eligibility criteria|0|||
124907795|NCT04789408|449286816|FG002|Overall Study|Did not meet eligibility criteria|0|||
124907796|NCT04789408|449286814|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
124907797|NCT04789408|449286815|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
124907798|NCT04789408|449286816|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
124907799|NCT02999477|449286819|FG000|Overall Study|found ineligible after first dose|0|||
124907800|NCT02999477|449286820|FG001|Overall Study|found ineligible after first dose|1|||
124907801|NCT02999477|449286819|FG000|Overall Study|Withdrawal by Subject|1|||
124907802|NCT02999477|449286820|FG001|Overall Study|Withdrawal by Subject|1|||
124907803|NCT00573833|449286821|FG000|Overall Study|Not Treated|2|||
124907804|NCT03351075|449288531|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
124907805|NCT03351075|449288532|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
124907806|NCT03351075|449288531|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
124907807|NCT03351075|449288532|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
124907808|NCT03351075|449288531|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
125211111|NCT04767529|450398578|FG000|Overall Study|Lost to Follow-up|0|||
125211112|NCT04767529|450398579|FG001|Overall Study|Lost to Follow-up|2|||
124907809|NCT03351075|449288532|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
124907810|NCT03351075|449288531|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
124907811|NCT03351075|449288532|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
124907812|NCT00925899|449288533|FG000|Part 1|Death|1|||
124907813|NCT00925899|449288534|FG001|Part 1|Death|2|||
124907814|NCT00925899|449288533|FG000|Part 1|Withdrawal by Subject|10|||
124907815|NCT00925899|449288534|FG001|Part 1|Withdrawal by Subject|9|||
124907816|NCT02396316|449288535|FG000|Overall Study|Physician Decision|1|||
124907817|NCT02396316|449288536|FG001|Overall Study|Physician Decision|0|||
124907818|NCT02396316|449288535|FG000|Overall Study|Progressive disease|6|||
124907819|NCT02396316|449288536|FG001|Overall Study|Progressive disease|3|||
124907820|NCT02396316|449288535|FG000|Overall Study|Protocol Violation|0|||
124907821|NCT02396316|449288536|FG001|Overall Study|Protocol Violation|1|||
124907822|NCT02396316|449288535|FG000|Overall Study|Treatment unblinded|0|||
124907823|NCT02396316|449288536|FG001|Overall Study|Treatment unblinded|1|||
124907824|NCT00566735|449288537|FG000|Overall Study|Withdrawal by Subject|0|||
124907825|NCT00566735|449288538|FG001|Overall Study|Withdrawal by Subject|1|||
124907826|NCT00566735|449288537|FG000|Overall Study|Refused neuropsychological testing|2|||
124907827|NCT00566735|449288538|FG001|Overall Study|Refused neuropsychological testing|5|||
124907828|NCT00566735|449288537|FG000|Overall Study|Switched into a manic episode|0|||
124907829|NCT00566735|449288538|FG001|Overall Study|Switched into a manic episode|1|||
124907830|NCT00925587|449288540|FG000|Overall Study|Protocol Specified Criteria|6|||
124907831|NCT00925587|449288541|FG001|Overall Study|Protocol Specified Criteria|6|||
124907832|NCT00925587|449288540|FG000|Overall Study|Physician Decision|4|||
124907833|NCT00925587|449288541|FG001|Overall Study|Physician Decision|1|||
124907834|NCT00925587|449288540|FG000|Overall Study|Protocol Violation|6|||
124907835|NCT00925587|449288541|FG001|Overall Study|Protocol Violation|4|||
124907836|NCT00925587|449288540|FG000|Overall Study|Withdrawal by Subject|9|||
124907837|NCT00925587|449288541|FG001|Overall Study|Withdrawal by Subject|6|||
124907838|NCT00925587|449288540|FG000|Overall Study|Death|5|||
124907839|NCT00925587|449288541|FG001|Overall Study|Death|5|||
124907840|NCT00925587|449288540|FG000|Overall Study|Adverse Event|6|||
124907841|NCT00925587|449288541|FG001|Overall Study|Adverse Event|2|||
124907842|NCT00925587|449288540|FG000|Overall Study|Lost to Follow-up|0|||
124907843|NCT00925587|449288541|FG001|Overall Study|Lost to Follow-up|1|||
124907844|NCT03454529|449288544|FG000|Overall Study|Did not receive treatment|6|||
124907845|NCT03454529|449288544|FG000|Overall Study|Received < 80% doses|1|||
124907846|NCT01582100|449288545|FG000|Overall Study|Adverse Event|1|||
124907847|NCT01582100|449288545|FG000|Overall Study|Withdrawal by Subject|1|||
124907848|NCT01078116|449288546|FG000|Overall Study|Lost to Follow-up|17|||
124907849|NCT01078116|449288546|FG000|Overall Study|Adverse Event|5|||
124907850|NCT01078116|449288546|FG000|Overall Study|Withdrawal by Subject|8|||
124907851|NCT01078116|449288546|FG000|Overall Study|Lack of effectiveness|15|||
124907852|NCT01078116|449288546|FG000|Overall Study|Case report form not completed|3|||
124907853|NCT01177670|449288549|FG000|Overall Study|Study Terminated|115|||
124907854|NCT01177670|449288549|FG000|Overall Study|Physician Decision|50|||
124907855|NCT01177670|449288549|FG000|Overall Study|Withdrawal by Subject|4|||
124907856|NCT04532528|449288553|FG000|Overall Study|Adverse Event|12|||
124907857|NCT04532528|449288554|FG001|Overall Study|Adverse Event|17|||
124907858|NCT04532528|449288553|FG000|Overall Study|Withdrawal of consent|16|||
124907859|NCT04532528|449288554|FG001|Overall Study|Withdrawal of consent|17|||
124907860|NCT04532528|449288553|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
124907861|NCT04532528|449288554|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
124907862|NCT04532528|449288553|FG000|Overall Study|Lost to Follow-up|69|||
124907863|NCT04532528|449288554|FG001|Overall Study|Lost to Follow-up|68|||
124907864|NCT04532528|449288553|FG000|Overall Study|Administrative problems|12|||
124907865|NCT04532528|449288554|FG001|Overall Study|Administrative problems|14|||
124907866|NCT04532528|449288553|FG000|Overall Study|Death|3|||
124907867|NCT04532528|449288554|FG001|Overall Study|Death|3|||
124907868|NCT04532528|449288553|FG000|Overall Study|Other|38|||
124907869|NCT04532528|449288554|FG001|Overall Study|Other|46|||
124907870|NCT03061474|449288559|FG000|Overall Study|Adverse Event|2|||
124907871|NCT03061474|449288560|FG001|Overall Study|Adverse Event|0|||
124907872|NCT03061474|449288559|FG000|Overall Study|Safety Risk|0|||
124907873|NCT03061474|449288560|FG001|Overall Study|Safety Risk|1|||
124907874|NCT03061474|449288559|FG000|Overall Study|Participant unwilling or unable to participate|0|||
124907875|NCT03061474|449288560|FG001|Overall Study|Participant unwilling or unable to participate|2|||
124907876|NCT03061474|449288559|FG000|Overall Study|Lost to Follow-up|0|||
124907877|NCT03061474|449288560|FG001|Overall Study|Lost to Follow-up|1|||
124907878|NCT02888080|449288561|FG000|Overall Study|Subject / Guardian decision|1|||
124907879|NCT02888080|449288562|FG001|Overall Study|Subject / Guardian decision|3|||
124907880|NCT02888080|449288561|FG000|Overall Study|New Therapy for study indication|1|||
124907881|NCT02888080|449288562|FG001|Overall Study|New Therapy for study indication|0|||
124907882|NCT02888080|449288561|FG000|Overall Study|Lack of Efficacy|0|||
124907883|NCT02888080|449288562|FG001|Overall Study|Lack of Efficacy|1|||
124907884|NCT02888080|449288561|FG000|Overall Study|Adverse Event|0|||
124907885|NCT02888080|449288562|FG001|Overall Study|Adverse Event|1|||
124907886|NCT00845832|449288563|FG000|Treatment Period|Adverse Event|0|||
124907887|NCT00845832|449288564|FG001|Treatment Period|Adverse Event|2|||
124907888|NCT00845832|449288565|FG002|Treatment Period|Adverse Event|0|||
124907889|NCT00845832|449288563|FG000|Treatment Period|Protocol Violation|1|||
124907890|NCT00845832|449288564|FG001|Treatment Period|Protocol Violation|1|||
124907891|NCT00845832|449288565|FG002|Treatment Period|Protocol Violation|0|||
124907892|NCT00845832|449288563|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
124907893|NCT00845832|449288564|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
125022060|NCT00577993|449705347|FG002|Overall Study|Lack of Efficacy|0|||
124907894|NCT00845832|449288565|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
124907895|NCT00845832|449288563|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
124907896|NCT00845832|449288564|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
124907897|NCT00845832|449288565|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
124907898|NCT00189202|449288570|FG000|Overall Study|Physician Decision|5|||
124907899|NCT01039688|449288571|FG000|Overall Study|Adverse Event|38|||
124907900|NCT01039688|449288572|FG001|Overall Study|Adverse Event|39|||
124907901|NCT01039688|449288573|FG002|Overall Study|Adverse Event|24|||
124907902|NCT01039688|449288571|FG000|Overall Study|Lack of Efficacy|20|||
124907903|NCT01039688|449288572|FG001|Overall Study|Lack of Efficacy|11|||
124907904|NCT01039688|449288573|FG002|Overall Study|Lack of Efficacy|26|||
124907905|NCT01039688|449288571|FG000|Overall Study|Lost to Follow-up|11|||
124907906|NCT01039688|449288572|FG001|Overall Study|Lost to Follow-up|9|||
124907907|NCT01039688|449288573|FG002|Overall Study|Lost to Follow-up|5|||
124907908|NCT01039688|449288571|FG000|Overall Study|Other|13|||
124907909|NCT01039688|449288572|FG001|Overall Study|Other|25|||
124907910|NCT01039688|449288573|FG002|Overall Study|Other|12|||
124907911|NCT01039688|449288571|FG000|Overall Study|Withdrawal by Subject|23|||
124907912|NCT01039688|449288572|FG001|Overall Study|Withdrawal by Subject|27|||
124907913|NCT01039688|449288573|FG002|Overall Study|Withdrawal by Subject|13|||
124907914|NCT01039688|449288571|FG000|Overall Study|Death|2|||
124907915|NCT01039688|449288572|FG001|Overall Study|Death|0|||
124907916|NCT01039688|449288573|FG002|Overall Study|Death|0|||
124907917|NCT00668863|449288574|FG000|Overall Study|Objective Progression or Relapse|42|||
124907918|NCT00668863|449288574|FG000|Overall Study|Adverse Event|13|||
124907919|NCT00668863|449288574|FG000|Overall Study|Study Terminated by Sponsor|8|||
124907920|NCT00668863|449288574|FG000|Overall Study|Global Deterioration of Health Status|4|||
124907921|NCT00668863|449288574|FG000|Overall Study|Withdrawal by Subject|1|||
124907922|NCT00668863|449288574|FG000|Overall Study|Surgery|1|||
124907923|NCT00668863|449288574|FG000|Overall Study|Subject's work scheduling problem|1|||
124907924|NCT00668863|449288574|FG000|Overall Study|Physician Decision|1|||
124907925|NCT03844269|449288579|FG000|Overall Study|Withdrawal pre-intervention|1|||
124907926|NCT03844269|449288579|FG000|Overall Study|Did not complete the intervention|2|||
124907927|NCT00101010|449288581|FG000|Overall Study|Physician Decision|1|||
124907928|NCT00869323|449288584|FG000|Maintenance Therapy|concurrent illness|1|||
124907929|NCT01135511|449288585|FG000|Overall Study|Adverse Event|0|||
124907930|NCT01135511|449288586|FG001|Overall Study|Adverse Event|1|||
124907931|NCT01135511|449288587|FG002|Overall Study|Adverse Event|2|||
124907932|NCT01135511|449288588|FG003|Overall Study|Adverse Event|0|||
124907933|NCT01135511|449288589|FG004|Overall Study|Adverse Event|0|||
124907934|NCT01135511|449288590|FG005|Overall Study|Adverse Event|1|||
124907935|NCT01135511|449288591|FG006|Overall Study|Adverse Event|0|||
124907936|NCT01135511|449288592|FG007|Overall Study|Adverse Event|1|||
124907937|NCT01135511|449288593|FG008|Overall Study|Adverse Event|0|||
124907938|NCT01135511|449288585|FG000|Overall Study|Lack of Efficacy|0|||
124907939|NCT01135511|449288586|FG001|Overall Study|Lack of Efficacy|1|||
124907940|NCT01135511|449288587|FG002|Overall Study|Lack of Efficacy|1|||
124907941|NCT01135511|449288588|FG003|Overall Study|Lack of Efficacy|2|||
124907942|NCT01135511|449288589|FG004|Overall Study|Lack of Efficacy|0|||
124907943|NCT01135511|449288590|FG005|Overall Study|Lack of Efficacy|0|||
124907944|NCT01135511|449288591|FG006|Overall Study|Lack of Efficacy|0|||
124907945|NCT01135511|449288592|FG007|Overall Study|Lack of Efficacy|0|||
124907946|NCT01135511|449288593|FG008|Overall Study|Lack of Efficacy|0|||
124907947|NCT01135511|449288585|FG000|Overall Study|Protocol Violation|0|||
124907948|NCT01135511|449288586|FG001|Overall Study|Protocol Violation|0|||
124907949|NCT01135511|449288587|FG002|Overall Study|Protocol Violation|3|||
124907950|NCT01135511|449288588|FG003|Overall Study|Protocol Violation|0|||
124907951|NCT01135511|449288589|FG004|Overall Study|Protocol Violation|0|||
124907952|NCT01135511|449288590|FG005|Overall Study|Protocol Violation|0|||
124907953|NCT01135511|449288591|FG006|Overall Study|Protocol Violation|0|||
124907954|NCT01135511|449288592|FG007|Overall Study|Protocol Violation|0|||
124907955|NCT01135511|449288593|FG008|Overall Study|Protocol Violation|0|||
124907956|NCT01135511|449288585|FG000|Overall Study|Pregnancy|0|||
124907957|NCT01135511|449288586|FG001|Overall Study|Pregnancy|0|||
124907958|NCT01135511|449288587|FG002|Overall Study|Pregnancy|0|||
124907959|NCT01135511|449288588|FG003|Overall Study|Pregnancy|1|||
124907960|NCT01135511|449288589|FG004|Overall Study|Pregnancy|0|||
124907961|NCT01135511|449288590|FG005|Overall Study|Pregnancy|0|||
124907962|NCT01135511|449288591|FG006|Overall Study|Pregnancy|0|||
124907963|NCT01135511|449288592|FG007|Overall Study|Pregnancy|0|||
124907964|NCT01135511|449288593|FG008|Overall Study|Pregnancy|0|||
124907965|NCT01135511|449288585|FG000|Overall Study|could not visit the clinic|0|||
124907966|NCT01135511|449288586|FG001|Overall Study|could not visit the clinic|1|||
124907967|NCT01135511|449288587|FG002|Overall Study|could not visit the clinic|2|||
124907968|NCT01135511|449288588|FG003|Overall Study|could not visit the clinic|0|||
124907969|NCT01135511|449288589|FG004|Overall Study|could not visit the clinic|0|||
124907970|NCT01135511|449288590|FG005|Overall Study|could not visit the clinic|0|||
124907971|NCT01135511|449288591|FG006|Overall Study|could not visit the clinic|0|||
124907972|NCT01135511|449288592|FG007|Overall Study|could not visit the clinic|0|||
124907973|NCT01135511|449288593|FG008|Overall Study|could not visit the clinic|0|||
124907974|NCT01135511|449288585|FG000|Overall Study|noncompliance with study drug taken|0|||
124907975|NCT01135511|449288586|FG001|Overall Study|noncompliance with study drug taken|0|||
124907976|NCT01135511|449288587|FG002|Overall Study|noncompliance with study drug taken|0|||
124907977|NCT01135511|449288588|FG003|Overall Study|noncompliance with study drug taken|0|||
124907978|NCT01135511|449288589|FG004|Overall Study|noncompliance with study drug taken|1|||
124907979|NCT01135511|449288590|FG005|Overall Study|noncompliance with study drug taken|0|||
124907980|NCT01135511|449288591|FG006|Overall Study|noncompliance with study drug taken|0|||
124907981|NCT01135511|449288592|FG007|Overall Study|noncompliance with study drug taken|0|||
124907982|NCT01135511|449288593|FG008|Overall Study|noncompliance with study drug taken|0|||
124907983|NCT01135511|449288585|FG000|Overall Study|Withdrawal by Subject|0|||
124907984|NCT01135511|449288586|FG001|Overall Study|Withdrawal by Subject|0|||
124907985|NCT01135511|449288587|FG002|Overall Study|Withdrawal by Subject|0|||
124907986|NCT01135511|449288588|FG003|Overall Study|Withdrawal by Subject|0|||
124907987|NCT01135511|449288589|FG004|Overall Study|Withdrawal by Subject|0|||
124907988|NCT01135511|449288590|FG005|Overall Study|Withdrawal by Subject|0|||
124907989|NCT01135511|449288591|FG006|Overall Study|Withdrawal by Subject|1|||
124907990|NCT01135511|449288592|FG007|Overall Study|Withdrawal by Subject|0|||
124907991|NCT01135511|449288593|FG008|Overall Study|Withdrawal by Subject|1|||
124907992|NCT05082935|449288609|FG000|Overall Study|Lost to Follow-up|549|||
124907993|NCT05082935|449288610|FG001|Overall Study|Lost to Follow-up|631|||
124907994|NCT05082935|449288609|FG000|Overall Study|Withdrawal by Subject|27|||
124907995|NCT05082935|449288610|FG001|Overall Study|Withdrawal by Subject|58|||
124907996|NCT02957136|449288612|FG000|Overall Study|Withdrawal by Subject|2|||
124907997|NCT02957136|449288613|FG001|Overall Study|Withdrawal by Subject|1|||
124907998|NCT01595061|449288614|FG000|Overall Study|Never Treated|3|||
124907999|NCT01595061|449288614|FG000|Overall Study|Inadequate Pathology|1|||
124908000|NCT00960141|449288615|FG000|Overall Study|Adverse Event|4|||
124908001|NCT00960141|449288616|FG001|Overall Study|Adverse Event|8|||
124908002|NCT00960141|449288617|FG002|Overall Study|Adverse Event|2|||
124908003|NCT00960141|449288615|FG000|Overall Study|Lack of Efficacy|3|||
124908004|NCT00960141|449288616|FG001|Overall Study|Lack of Efficacy|4|||
124908005|NCT00960141|449288617|FG002|Overall Study|Lack of Efficacy|2|||
124908006|NCT00960141|449288615|FG000|Overall Study|Lost to Follow-up|1|||
124908007|NCT00960141|449288616|FG001|Overall Study|Lost to Follow-up|0|||
124908008|NCT00960141|449288617|FG002|Overall Study|Lost to Follow-up|0|||
124908009|NCT00960141|449288615|FG000|Overall Study|Protocol Violation|1|||
124908010|NCT00960141|449288616|FG001|Overall Study|Protocol Violation|3|||
124908011|NCT00960141|449288617|FG002|Overall Study|Protocol Violation|2|||
124908012|NCT00960141|449288615|FG000|Overall Study|Withdrawal by Subject|1|||
124908013|NCT00960141|449288616|FG001|Overall Study|Withdrawal by Subject|2|||
124908014|NCT00960141|449288617|FG002|Overall Study|Withdrawal by Subject|1|||
124908015|NCT00566527|449288620|FG000|Overall Study|Reason not provided|3|||
124908016|NCT00566527|449288621|FG001|Overall Study|Reason not provided|11|||
124908017|NCT00566527|449288622|FG002|Overall Study|Reason not provided|10|||
124908018|NCT00566527|449288620|FG000|Overall Study|Adverse Event|2|||
124908019|NCT00566527|449288621|FG001|Overall Study|Adverse Event|0|||
124908020|NCT00566527|449288622|FG002|Overall Study|Adverse Event|1|||
124908021|NCT00566527|449288620|FG000|Overall Study|Physician Decision|3|||
124908022|NCT00566527|449288621|FG001|Overall Study|Physician Decision|8|||
124908023|NCT00566527|449288622|FG002|Overall Study|Physician Decision|20|||
124908024|NCT00566527|449288620|FG000|Overall Study|Lost to Follow-up|3|||
124908025|NCT00566527|449288621|FG001|Overall Study|Lost to Follow-up|4|||
124908026|NCT00566527|449288622|FG002|Overall Study|Lost to Follow-up|4|||
124908027|NCT00566527|449288620|FG000|Overall Study|Withdrawal by Subject|6|||
124908028|NCT00566527|449288621|FG001|Overall Study|Withdrawal by Subject|43|||
124908029|NCT00566527|449288622|FG002|Overall Study|Withdrawal by Subject|43|||
124908030|NCT00457743|449288623|FG000|Overall Study|Adverse Event|0|||
124908031|NCT00457743|449288624|FG001|Overall Study|Adverse Event|4|||
124908032|NCT00457743|449288625|FG002|Overall Study|Adverse Event|0|||
124908033|NCT00457743|449288623|FG000|Overall Study|Lack of Efficacy|3|||
124908034|NCT00457743|449288624|FG001|Overall Study|Lack of Efficacy|23|||
124908035|NCT00457743|449288625|FG002|Overall Study|Lack of Efficacy|3|||
124908036|NCT00356265|449288626|FG000|Overall Study|Withdrawal by Subject|0|||
124908037|NCT00356265|449288627|FG001|Overall Study|Withdrawal by Subject|0|||
124908038|NCT00356265|449288628|FG002|Overall Study|Withdrawal by Subject|1|||
124908039|NCT01837966|449288629|FG000|Overall Study|Withdrawal by Subject|2|||
124908040|NCT01837966|449288630|FG001|Overall Study|Withdrawal by Subject|1|||
124908041|NCT01278394|449288634|FG000|Overall Study|Lost to Follow-up|1|||
124908042|NCT01236560|449288637|FG000|Overall Study|Adverse Event|0|||
124908043|NCT01236560|449288638|FG001|Overall Study|Adverse Event|2|||
124908044|NCT01236560|449288639|FG002|Overall Study|Adverse Event|1|||
125022061|NCT00577993|449705345|FG000|Overall Study|Protocol Violation|2|||
124908045|NCT01236560|449288640|FG003|Overall Study|Adverse Event|3|||
124908046|NCT01236560|449288641|FG004|Overall Study|Adverse Event|0|||
124908047|NCT01236560|449288642|FG005|Overall Study|Adverse Event|0|||
124908048|NCT01236560|449288637|FG000|Overall Study|Death|0|||
124908049|NCT01236560|449288638|FG001|Overall Study|Death|1|||
124908050|NCT01236560|449288639|FG002|Overall Study|Death|0|||
124908051|NCT01236560|449288640|FG003|Overall Study|Death|1|||
124908052|NCT01236560|449288641|FG004|Overall Study|Death|0|||
124908053|NCT01236560|449288642|FG005|Overall Study|Death|0|||
124908054|NCT01236560|449288637|FG000|Overall Study|Lost to Follow-up|0|||
124908055|NCT01236560|449288638|FG001|Overall Study|Lost to Follow-up|1|||
124908056|NCT01236560|449288639|FG002|Overall Study|Lost to Follow-up|1|||
124908057|NCT01236560|449288640|FG003|Overall Study|Lost to Follow-up|0|||
124908058|NCT01236560|449288641|FG004|Overall Study|Lost to Follow-up|0|||
124908059|NCT01236560|449288642|FG005|Overall Study|Lost to Follow-up|0|||
124908060|NCT01236560|449288637|FG000|Overall Study|Physician Decision|0|||
124908061|NCT01236560|449288638|FG001|Overall Study|Physician Decision|1|||
124908062|NCT01236560|449288639|FG002|Overall Study|Physician Decision|8|||
124908063|NCT01236560|449288640|FG003|Overall Study|Physician Decision|0|||
124908064|NCT01236560|449288641|FG004|Overall Study|Physician Decision|0|||
124908065|NCT01236560|449288642|FG005|Overall Study|Physician Decision|0|||
124908066|NCT01236560|449288637|FG000|Overall Study|Withdrawal by Subject|0|||
124908067|NCT01236560|449288638|FG001|Overall Study|Withdrawal by Subject|0|||
124908068|NCT01236560|449288639|FG002|Overall Study|Withdrawal by Subject|1|||
124908069|NCT01236560|449288640|FG003|Overall Study|Withdrawal by Subject|2|||
124908070|NCT01236560|449288641|FG004|Overall Study|Withdrawal by Subject|0|||
124908071|NCT01236560|449288642|FG005|Overall Study|Withdrawal by Subject|0|||
124908072|NCT01236560|449288637|FG000|Overall Study|Progressive disease|5|||
124908073|NCT01236560|449288638|FG001|Overall Study|Progressive disease|19|||
124908074|NCT01236560|449288639|FG002|Overall Study|Progressive disease|9|||
124908075|NCT01236560|449288640|FG003|Overall Study|Progressive disease|16|||
124908076|NCT01236560|449288641|FG004|Overall Study|Progressive disease|0|||
124908077|NCT01236560|449288642|FG005|Overall Study|Progressive disease|0|||
124908078|NCT01792830|449288646|FG000|Overall Study|Withdrawal by Subject|22|||
124908079|NCT01792830|449288647|FG001|Overall Study|Withdrawal by Subject|0|||
124908080|NCT01792830|449288648|FG002|Overall Study|Withdrawal by Subject|0|||
124908081|NCT01792830|449288649|FG003|Overall Study|Withdrawal by Subject|2|||
124908082|NCT01792830|449288650|FG004|Overall Study|Withdrawal by Subject|1|||
124908083|NCT01792830|449288651|FG005|Overall Study|Withdrawal by Subject|1|||
124908084|NCT01792830|449288652|FG006|Overall Study|Withdrawal by Subject|1|||
124908085|NCT01792830|449288653|FG007|Overall Study|Withdrawal by Subject|1|||
124908086|NCT01792830|449288654|FG008|Overall Study|Withdrawal by Subject|7|||
124908087|NCT01792830|449288655|FG009|Overall Study|Withdrawal by Subject|0|||
124908088|NCT01792830|449288656|FG010|Overall Study|Withdrawal by Subject|2|||
124908089|NCT01792830|449288646|FG000|Overall Study|Death|3|||
124908090|NCT01792830|449288647|FG001|Overall Study|Death|0|||
124908091|NCT01792830|449288648|FG002|Overall Study|Death|0|||
124908092|NCT01792830|449288649|FG003|Overall Study|Death|1|||
125114827|NCT00295854|450044670|FG001|Overall Study|Adverse Event|7|||
125114828|NCT00295854|450044671|FG002|Overall Study|Adverse Event|6|||
125114829|NCT00295854|450044669|FG000|Overall Study|Protocol Violation|1|||
125114830|NCT00295854|450044670|FG001|Overall Study|Protocol Violation|1|||
125114831|NCT00295854|450044671|FG002|Overall Study|Protocol Violation|1|||
124908093|NCT01792830|449288650|FG004|Overall Study|Death|0|||
124908094|NCT01792830|449288651|FG005|Overall Study|Death|0|||
124908095|NCT01792830|449288652|FG006|Overall Study|Death|1|||
124908096|NCT01792830|449288653|FG007|Overall Study|Death|0|||
124908097|NCT01792830|449288654|FG008|Overall Study|Death|1|||
125114832|NCT00295854|450044669|FG000|Overall Study|Lost to Follow-up|2|||
125114833|NCT00295854|450044670|FG001|Overall Study|Lost to Follow-up|0|||
125114834|NCT00295854|450044671|FG002|Overall Study|Lost to Follow-up|1|||
125114835|NCT00295854|450044669|FG000|Overall Study|Withdrawal by Subject|3|||
125211113|NCT04767529|450398580|FG002|Overall Study|Lost to Follow-up|3|||
124908098|NCT01792830|449288655|FG009|Overall Study|Death|0|||
124908099|NCT01792830|449288656|FG010|Overall Study|Death|1|||
124908100|NCT01792830|449288646|FG000|Overall Study|Adverse Event|0|||
124908101|NCT01792830|449288647|FG001|Overall Study|Adverse Event|0|||
125211114|NCT04122625|450398585|FG000|Part A (up to 2.92 Years)|Death|2|||
125211115|NCT04122625|450398586|FG001|Part A (up to 2.92 Years)|Death|4|||
124908102|NCT01792830|449288648|FG002|Overall Study|Adverse Event|0|||
124908103|NCT01792830|449288649|FG003|Overall Study|Adverse Event|0|||
124908104|NCT01792830|449288650|FG004|Overall Study|Adverse Event|0|||
124908105|NCT01792830|449288651|FG005|Overall Study|Adverse Event|0|||
124908106|NCT01792830|449288652|FG006|Overall Study|Adverse Event|0|||
124908107|NCT01792830|449288653|FG007|Overall Study|Adverse Event|0|||
124908108|NCT01792830|449288654|FG008|Overall Study|Adverse Event|1|||
125114836|NCT00295854|450044670|FG001|Overall Study|Withdrawal by Subject|7|||
125114837|NCT00295854|450044671|FG002|Overall Study|Withdrawal by Subject|4|||
125114838|NCT00295854|450044669|FG000|Overall Study|did not continue to meet criteria|1|||
125211116|NCT04122625|450398587|FG002|Part A (up to 2.92 Years)|Death|0|||
124908109|NCT01792830|449288655|FG009|Overall Study|Adverse Event|0|||
124908110|NCT01792830|449288656|FG010|Overall Study|Adverse Event|0|||
124908111|NCT01198028|449288657|FG000|Overall Study|Adverse Event|5|||
124908112|NCT01198028|449288657|FG000|Overall Study|Death|3|||
124908113|NCT01198028|449288657|FG000|Overall Study|Physician Decision|2|||
124908114|NCT00658996|449288660|FG000|First Intervention|Positive slit lamp finding|1|||
124908115|NCT00658996|449288661|FG001|First Intervention|Positive slit lamp finding|0|||
124908116|NCT00658996|449288660|FG000|First Intervention|Lack of lenses|0|||
124908117|NCT00658996|449288661|FG001|First Intervention|Lack of lenses|1|||
124908118|NCT00658996|449288660|FG000|Crossover Period|Physician Decision|1|||
124908119|NCT00658996|449288661|FG001|Crossover Period|Physician Decision|0|||
124908120|NCT00658996|449288660|FG000|Crossover Period|Ineligible|1|||
124908121|NCT00658996|449288661|FG001|Crossover Period|Ineligible|1|||
124908122|NCT00658996|449288660|FG000|Second Intervention|Developed a stye on upper lid|1|||
124908123|NCT00658996|449288661|FG001|Second Intervention|Developed a stye on upper lid|0|||
124908124|NCT00658996|449288660|FG000|Second Intervention|Positive slit lamp finding|0|||
124908125|NCT00658996|449288661|FG001|Second Intervention|Positive slit lamp finding|1|||
124908126|NCT02079844|449288662|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
124908127|NCT02079844|449288663|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
124908128|NCT02079844|449288664|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
124908129|NCT02079844|449288662|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
124908130|NCT02079844|449288663|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
124908131|NCT02079844|449288664|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
124908132|NCT01420549|449288665|FG000|Overall Study|Adverse Event|1|||
124908133|NCT01420549|449288666|FG001|Overall Study|Adverse Event|1|||
124908134|NCT01420549|449288665|FG000|Overall Study|Lost to Follow-up|2|||
124908135|NCT01420549|449288666|FG001|Overall Study|Lost to Follow-up|2|||
124908136|NCT01420549|449288665|FG000|Overall Study|Protocol Violation|0|||
124908137|NCT01420549|449288666|FG001|Overall Study|Protocol Violation|1|||
124908138|NCT01420549|449288665|FG000|Overall Study|Non-adherence to medication|4|||
124908139|NCT01420549|449288666|FG001|Overall Study|Non-adherence to medication|1|||
124908140|NCT00683696|449290432|FG000|Overall Study|Withdrawn due to study closure|337|||
124908141|NCT00683696|449290433|FG001|Overall Study|Withdrawn due to study closure|338|||
124908142|NCT00683696|449290432|FG000|Overall Study|Withdrawn prior to study closure|13|||
124908143|NCT00683696|449290433|FG001|Overall Study|Withdrawn prior to study closure|28|||
124908144|NCT00683696|449290432|FG000|Overall Study|Lost to Follow-up|5|||
124908145|NCT00683696|449290433|FG001|Overall Study|Lost to Follow-up|6|||
124908146|NCT00683696|449290432|FG000|Overall Study|Vital status follow-up only|3|||
124908147|NCT00683696|449290433|FG001|Overall Study|Vital status follow-up only|3|||
124908148|NCT00683696|449290432|FG000|Overall Study|Death|46|||
124908149|NCT00683696|449290433|FG001|Overall Study|Death|30|||
124908150|NCT03648762|449290437|FG000|Overall Study|Lost to Follow-up|1|||
124908151|NCT03648762|449290438|FG001|Overall Study|Lost to Follow-up|2|||
124908152|NCT03648762|449290439|FG002|Overall Study|Lost to Follow-up|0|||
124908153|NCT03648762|449290437|FG000|Overall Study|Withdrawal by Subject|5|||
124908154|NCT03648762|449290438|FG001|Overall Study|Withdrawal by Subject|2|||
124908155|NCT03648762|449290439|FG002|Overall Study|Withdrawal by Subject|1|||
124908156|NCT01040689|449290448|FG000|Overall Study|Adverse Event|0|||
124908157|NCT01040689|449290449|FG001|Overall Study|Adverse Event|0|||
124908158|NCT01040689|449290450|FG002|Overall Study|Adverse Event|2|||
124908159|NCT01040689|449290451|FG003|Overall Study|Adverse Event|4|||
124908160|NCT01040689|449290448|FG000|Overall Study|Lack of Efficacy|0|||
124908161|NCT01040689|449290449|FG001|Overall Study|Lack of Efficacy|0|||
124908162|NCT01040689|449290450|FG002|Overall Study|Lack of Efficacy|1|||
125114839|NCT00295854|450044670|FG001|Overall Study|did not continue to meet criteria|1|||
125114840|NCT00295854|450044671|FG002|Overall Study|did not continue to meet criteria|2|||
125114841|NCT00295854|450044669|FG000|Overall Study|required a prohibited medication|1|||
125114842|NCT00295854|450044670|FG001|Overall Study|required a prohibited medication|0|||
125114843|NCT00295854|450044671|FG002|Overall Study|required a prohibited medication|0|||
125114844|NCT00295854|450044669|FG000|Overall Study|Other|3|||
125114845|NCT00295854|450044670|FG001|Overall Study|Other|5|||
125114846|NCT00295854|450044671|FG002|Overall Study|Other|1|||
124908163|NCT01040689|449290451|FG003|Overall Study|Lack of Efficacy|0|||
124908164|NCT01040689|449290448|FG000|Overall Study|Lost to Follow-up|1|||
124908165|NCT01040689|449290449|FG001|Overall Study|Lost to Follow-up|0|||
124908166|NCT01040689|449290450|FG002|Overall Study|Lost to Follow-up|0|||
124908167|NCT01040689|449290451|FG003|Overall Study|Lost to Follow-up|0|||
124908168|NCT01040689|449290448|FG000|Overall Study|Withdrawal by Subject|2|||
124908169|NCT01040689|449290449|FG001|Overall Study|Withdrawal by Subject|1|||
124908170|NCT01040689|449290450|FG002|Overall Study|Withdrawal by Subject|1|||
124908171|NCT01040689|449290451|FG003|Overall Study|Withdrawal by Subject|0|||
124908172|NCT01040689|449290448|FG000|Overall Study|Other reasons not listed above|0|||
124908173|NCT01040689|449290449|FG001|Overall Study|Other reasons not listed above|1|||
125114847|NCT00672620|450044672|FG000|Overall Study|Adverse Event|7|||
125114848|NCT00672620|450044673|FG001|Overall Study|Adverse Event|7|||
125114849|NCT00672620|450044674|FG002|Overall Study|Adverse Event|12|||
125114850|NCT00672620|450044675|FG003|Overall Study|Adverse Event|17|||
125114851|NCT00672620|450044672|FG000|Overall Study|Lack of Efficacy|1|||
125114852|NCT00672620|450044673|FG001|Overall Study|Lack of Efficacy|2|||
124908174|NCT01040689|449290450|FG002|Overall Study|Other reasons not listed above|0|||
124908175|NCT01040689|449290451|FG003|Overall Study|Other reasons not listed above|0|||
124908176|NCT01185561|449290452|FG000|Overall Study|Lost to Follow-up|0|||
124908177|NCT01185561|449290453|FG001|Overall Study|Lost to Follow-up|4|||
124908178|NCT01185561|449290452|FG000|Overall Study|Withdrawal by Subject|2|||
124908179|NCT01185561|449290453|FG001|Overall Study|Withdrawal by Subject|8|||
124908180|NCT02616900|449290454|FG000|Overall Study|Lack of Efficacy|7|||
124908181|NCT02616900|449290454|FG000|Overall Study|Lost to Follow-up|2|||
124908182|NCT02616900|449290454|FG000|Overall Study|Protocol Violation|5|||
124908183|NCT02616900|449290454|FG000|Overall Study|Withdrawal by Subject|3|||
124908184|NCT02616900|449290454|FG000|Overall Study|Incomplete data|6|||
124908185|NCT02499159|449290455|FG000|Randomization|Protocol Violation|1|||
124908186|NCT02499159|449290456|FG001|Randomization|Protocol Violation|1|||
124908187|NCT02499159|449290455|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
124908188|NCT02499159|449290456|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
124908189|NCT02499159|449290455|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
124908190|NCT02499159|449290456|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
124908191|NCT02499159|449290455|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
124908192|NCT02499159|449290456|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
124908193|NCT02499159|449290455|FG000|30-Day Follow-Up Phone Call|Other|1|||
124908194|NCT02499159|449290456|FG001|30-Day Follow-Up Phone Call|Other|0|||
124908195|NCT02601820|449290457|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
124908196|NCT02601820|449290457|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
124908197|NCT02601820|449290457|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
124908198|NCT02601820|449290457|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
124908199|NCT02242487|449290458|FG000|Overall Study|Adverse Event|13|||
124908200|NCT02242487|449290459|FG001|Overall Study|Adverse Event|15|||
124908201|NCT02242487|449290458|FG000|Overall Study|Lack of Efficacy|4|||
124908202|NCT02242487|449290459|FG001|Overall Study|Lack of Efficacy|6|||
124908203|NCT02242487|449290458|FG000|Overall Study|Protocol Violation|2|||
124908204|NCT02242487|449290459|FG001|Overall Study|Protocol Violation|0|||
124908205|NCT02242487|449290458|FG000|Overall Study|Lost to Follow-up|2|||
124908206|NCT02242487|449290459|FG001|Overall Study|Lost to Follow-up|1|||
124908207|NCT02242487|449290458|FG000|Overall Study|Other - Miscellaneous|4|||
124908208|NCT02242487|449290459|FG001|Overall Study|Other - Miscellaneous|6|||
124908209|NCT02242487|449290458|FG000|Overall Study|Withdrawal by Subject|37|||
124908210|NCT02242487|449290459|FG001|Overall Study|Withdrawal by Subject|19|||
124908211|NCT01599793|449290460|FG000|Overall Study|Adverse Event|2|||
124908212|NCT02564744|449290464|FG000|Overall Study|Investigator decision|0|||
124908213|NCT02564744|449290465|FG001|Overall Study|Investigator decision|0|||
124908214|NCT02564744|449290466|FG002|Overall Study|Investigator decision|0|||
124908215|NCT02564744|449290467|FG003|Overall Study|Investigator decision|0|||
124908216|NCT02564744|449290468|FG004|Overall Study|Investigator decision|1|||
124908217|NCT02564744|449290464|FG000|Overall Study|Death|10|||
124908218|NCT02564744|449290465|FG001|Overall Study|Death|5|||
124908219|NCT02564744|449290466|FG002|Overall Study|Death|4|||
124908220|NCT02564744|449290467|FG003|Overall Study|Death|16|||
124908221|NCT02564744|449290468|FG004|Overall Study|Death|16|||
124908222|NCT02564744|449290464|FG000|Overall Study|End of study Page Missing|0|||
124908223|NCT02564744|449290465|FG001|Overall Study|End of study Page Missing|0|||
124908224|NCT02564744|449290466|FG002|Overall Study|End of study Page Missing|3|||
124908225|NCT02564744|449290467|FG003|Overall Study|End of study Page Missing|3|||
124908226|NCT02564744|449290468|FG004|Overall Study|End of study Page Missing|0|||
124908227|NCT02564744|449290464|FG000|Overall Study|Subject Withdrew Consent|1|||
124908228|NCT02564744|449290465|FG001|Overall Study|Subject Withdrew Consent|1|||
124908229|NCT02564744|449290466|FG002|Overall Study|Subject Withdrew Consent|1|||
124908230|NCT02564744|449290467|FG003|Overall Study|Subject Withdrew Consent|0|||
124908231|NCT02564744|449290468|FG004|Overall Study|Subject Withdrew Consent|2|||
124908232|NCT02564744|449290464|FG000|Overall Study|Lost to Follow-up|0|||
124908233|NCT02564744|449290465|FG001|Overall Study|Lost to Follow-up|1|||
124908234|NCT02564744|449290466|FG002|Overall Study|Lost to Follow-up|0|||
124908235|NCT02564744|449290467|FG003|Overall Study|Lost to Follow-up|0|||
125114853|NCT00672620|450044674|FG002|Overall Study|Lack of Efficacy|2|||
125114854|NCT00672620|450044675|FG003|Overall Study|Lack of Efficacy|0|||
124908236|NCT02564744|449290468|FG004|Overall Study|Lost to Follow-up|1|||
124908237|NCT02564744|449290464|FG000|Overall Study|Reason not specified|1|||
125114855|NCT00672620|450044672|FG000|Overall Study|Noncompliance with Study Drug|3|||
124908238|NCT02564744|449290465|FG001|Overall Study|Reason not specified|0|||
124908239|NCT02564744|449290466|FG002|Overall Study|Reason not specified|0|||
124908240|NCT02564744|449290467|FG003|Overall Study|Reason not specified|0|||
124908241|NCT02564744|449290468|FG004|Overall Study|Reason not specified|0|||
125114856|NCT00672620|450044673|FG001|Overall Study|Noncompliance with Study Drug|4|||
124908242|NCT00508924|449290472|FG000|Overall Study|Protocol Violation|0|||
124908243|NCT00508924|449290473|FG001|Overall Study|Protocol Violation|0|||
124908244|NCT00508924|449290474|FG002|Overall Study|Protocol Violation|1|||
124908245|NCT00508924|449290475|FG003|Overall Study|Protocol Violation|1|||
124908246|NCT02755805|449290476|FG000|Overall Study|Lost to Follow-up|1|||
124908247|NCT02755805|449290477|FG001|Overall Study|Lost to Follow-up|2|||
124908248|NCT02755805|449290476|FG000|Overall Study|Refused assessments|1|||
124908249|NCT02755805|449290477|FG001|Overall Study|Refused assessments|0|||
124908250|NCT02755805|449290476|FG000|Overall Study|Withdrawal by Subject|0|||
124908251|NCT02755805|449290477|FG001|Overall Study|Withdrawal by Subject|2|||
124908252|NCT02252042|449290480|FG000|Overall Study|Adverse Event|9|||
124908253|NCT02252042|449290481|FG001|Overall Study|Adverse Event|6|||
124908254|NCT02252042|449290480|FG000|Overall Study|Death|209|||
124908255|NCT02252042|449290481|FG001|Overall Study|Death|217|||
124908256|NCT02252042|449290480|FG000|Overall Study|Physician Decision|0|||
124908257|NCT02252042|449290481|FG001|Overall Study|Physician Decision|2|||
124908258|NCT02252042|449290480|FG000|Overall Study|Transferred to Extension Study|7|||
124908259|NCT02252042|449290481|FG001|Overall Study|Transferred to Extension Study|1|||
124908260|NCT02252042|449290480|FG000|Overall Study|Did Not Continue on Extension Study|7|||
124908261|NCT02252042|449290481|FG001|Overall Study|Did Not Continue on Extension Study|2|||
124908262|NCT02252042|449290480|FG000|Overall Study|Withdrawal by Subject|15|||
124908263|NCT02252042|449290481|FG001|Overall Study|Withdrawal by Subject|20|||
124908264|NCT01460290|449290484|FG000|Overall Study|Adverse Event|3|||
124908265|NCT01460290|449290484|FG000|Overall Study|Elevated liver function|1|||
124908266|NCT01190007|449290489|FG000|Overall Study|Withdrawal by Subject|4|||
124908267|NCT01190007|449290489|FG000|Overall Study|Adverse Event|8|||
124908268|NCT01190007|449290489|FG000|Overall Study|Difficulty of visit for complications|1|||
124908269|NCT01190007|449290489|FG000|Overall Study|Participant was arrested|1|||
124908270|NCT00439569|449290494|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
124908271|NCT00439569|449290494|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
124908272|NCT00439569|449290494|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
124908273|NCT02755116|449290495|FG000|Overall Study|surgery converted to open, pt admitted|3|||
124908274|NCT02755116|449290496|FG001|Overall Study|surgery converted to open, pt admitted|1|||
124908275|NCT01124734|449290497|FG000|Overall Study|Disease progression|13|||
124908276|NCT01124734|449290497|FG000|Overall Study|Adverse Event|1|||
124908277|NCT01124734|449290497|FG000|Overall Study|Withdrawal by Subject|1|||
124908278|NCT01124734|449290497|FG000|Overall Study|Elected for alternative treatment|2|||
124908279|NCT02214160|449290498|FG000|Overall Study|Withdrawal by Subject|1|||
124908280|NCT02214160|449290499|FG001|Overall Study|Withdrawal by Subject|0|||
124908281|NCT02214160|449290500|FG002|Overall Study|Withdrawal by Subject|6|||
124908282|NCT02214160|449290498|FG000|Overall Study|Death|2|||
124908283|NCT02214160|449290499|FG001|Overall Study|Death|2|||
124908284|NCT02214160|449290500|FG002|Overall Study|Death|1|||
124908285|NCT02214160|449290498|FG000|Overall Study|Subject Non-Compliance|0|||
124908286|NCT02214160|449290499|FG001|Overall Study|Subject Non-Compliance|3|||
124908287|NCT02214160|449290500|FG002|Overall Study|Subject Non-Compliance|1|||
124908288|NCT02214160|449290498|FG000|Overall Study|Adverse Event|0|||
125114857|NCT00672620|450044674|FG002|Overall Study|Noncompliance with Study Drug|0|||
125114858|NCT00672620|450044675|FG003|Overall Study|Noncompliance with Study Drug|2|||
125114859|NCT00672620|450044672|FG000|Overall Study|Protocol Deviations|5|||
125114860|NCT00672620|450044673|FG001|Overall Study|Protocol Deviations|7|||
125114861|NCT00672620|450044674|FG002|Overall Study|Protocol Deviations|2|||
125114862|NCT00672620|450044675|FG003|Overall Study|Protocol Deviations|5|||
125114863|NCT00672620|450044672|FG000|Overall Study|Withdrawal of Consent|6|||
125114864|NCT00672620|450044673|FG001|Overall Study|Withdrawal of Consent|12|||
125114865|NCT00672620|450044674|FG002|Overall Study|Withdrawal of Consent|5|||
125114866|NCT00672620|450044675|FG003|Overall Study|Withdrawal of Consent|6|||
125114867|NCT00672620|450044672|FG000|Overall Study|Lost to Follow-up|8|||
125114868|NCT00672620|450044673|FG001|Overall Study|Lost to Follow-up|19|||
125114869|NCT00672620|450044674|FG002|Overall Study|Lost to Follow-up|8|||
125114870|NCT00672620|450044675|FG003|Overall Study|Lost to Follow-up|11|||
125114871|NCT00672620|450044672|FG000|Overall Study|Reason not Specified|3|||
125114872|NCT00672620|450044673|FG001|Overall Study|Reason not Specified|3|||
124908289|NCT02214160|449290499|FG001|Overall Study|Adverse Event|1|||
124908290|NCT02214160|449290500|FG002|Overall Study|Adverse Event|1|||
124908291|NCT02214160|449290498|FG000|Overall Study|Sponsor Decision|0|||
124908292|NCT02214160|449290499|FG001|Overall Study|Sponsor Decision|2|||
124908293|NCT02214160|449290500|FG002|Overall Study|Sponsor Decision|0|||
124908294|NCT02214160|449290498|FG000|Overall Study|Protocol Violation|1|||
124908295|NCT02214160|449290499|FG001|Overall Study|Protocol Violation|0|||
124908296|NCT02214160|449290500|FG002|Overall Study|Protocol Violation|0|||
124908297|NCT02214160|449290498|FG000|Overall Study|Physician Decision|0|||
124908298|NCT02214160|449290499|FG001|Overall Study|Physician Decision|0|||
124908299|NCT02214160|449290500|FG002|Overall Study|Physician Decision|1|||
124908300|NCT02423798|449290501|FG000|Overall Study|Withdrawal by Subject|3|||
124908301|NCT01063972|449290502|FG000|Overall Study|Death|12|||
124908302|NCT01063972|449290503|FG001|Overall Study|Death|11|||
124908303|NCT01063972|449290502|FG000|Overall Study|Incarcerated|2|||
124908304|NCT01063972|449290503|FG001|Overall Study|Incarcerated|1|||
124908305|NCT01510717|449290505|FG000|Overall Study|Adverse Event|1|||
124908306|NCT01510717|449290506|FG001|Overall Study|Adverse Event|2|||
124908307|NCT01510717|449290505|FG000|Overall Study|Death|1|||
124908308|NCT01510717|449290506|FG001|Overall Study|Death|0|||
124908309|NCT01510717|449290505|FG000|Overall Study|Lost to Follow-up|0|||
124908310|NCT01510717|449290506|FG001|Overall Study|Lost to Follow-up|1|||
124908311|NCT01510717|449290505|FG000|Overall Study|Withdrawal by Subject|0|||
124908312|NCT01510717|449290506|FG001|Overall Study|Withdrawal by Subject|2|||
125114873|NCT00672620|450044674|FG002|Overall Study|Reason not Specified|2|||
125114874|NCT00672620|450044675|FG003|Overall Study|Reason not Specified|1|||
125114875|NCT00772577|450044676|FG000|Overall Study|Adverse Event|6|||
125114876|NCT00772577|450044677|FG001|Overall Study|Adverse Event|3|||
125114877|NCT00772577|450044676|FG000|Overall Study|Abnormal laboratory values|0|||
125114878|NCT00772577|450044677|FG001|Overall Study|Abnormal laboratory values|1|||
125114879|NCT00772577|450044676|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125114880|NCT00772577|450044677|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
125114881|NCT00772577|450044676|FG000|Overall Study|Patient withdrew consent|8|||
125114882|NCT00772577|450044677|FG001|Overall Study|Patient withdrew consent|5|||
125114883|NCT00772577|450044676|FG000|Overall Study|Lost to Follow-up|4|||
125114884|NCT00772577|450044677|FG001|Overall Study|Lost to Follow-up|3|||
125114885|NCT00772577|450044676|FG000|Overall Study|Administrative problems|2|||
125114886|NCT00772577|450044677|FG001|Overall Study|Administrative problems|1|||
125114887|NCT00772577|450044676|FG000|Overall Study|Protocol Deviation|3|||
125114888|NCT00772577|450044677|FG001|Overall Study|Protocol Deviation|2|||
125114889|NCT03211156|450044678|FG000|Overall Study|Withdrawal by Subject|0|||
125114890|NCT03211156|450044679|FG001|Overall Study|Withdrawal by Subject|2|||
125114891|NCT03211156|450044678|FG000|Overall Study|Lost to Follow-up|1|||
125114892|NCT03211156|450044679|FG001|Overall Study|Lost to Follow-up|1|||
125114893|NCT03211156|450044678|FG000|Overall Study|Adverse Event|1|||
125114894|NCT03211156|450044679|FG001|Overall Study|Adverse Event|0|||
125114895|NCT03255031|450044680|FG000|Overall Study|Adverse Event|5|||
125114896|NCT03255031|450044681|FG001|Overall Study|Adverse Event|3|||
124908313|NCT01264679|449290507|FG000|Overall Study|Participation in Another Clinical Trial|1|||
124908314|NCT01264679|449290507|FG000|Overall Study|Physician Decision|1|||
124908315|NCT01264679|449290507|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
124908316|NCT01264679|449290507|FG000|Overall Study|Withdrawal by Subject|1|||
124908317|NCT00468052|449290512|FG000|Overall Study|Protocol Violation|7|||
125114897|NCT03255031|450044680|FG000|Overall Study|Physician Decision|2|||
125114898|NCT03255031|450044681|FG001|Overall Study|Physician Decision|1|||
125114899|NCT03255031|450044680|FG000|Overall Study|Withdrawal by Subject|9|||
125114900|NCT03255031|450044681|FG001|Overall Study|Withdrawal by Subject|3|||
125114901|NCT00415532|450044685|FG000|Treatment Period|Adverse Event|2|||
125114902|NCT00415532|450044686|FG001|Treatment Period|Adverse Event|3|||
125114903|NCT00415532|450044685|FG000|Treatment Period|Death|2|||
124908318|NCT00468052|449290513|FG001|Overall Study|Protocol Violation|8|||
124908319|NCT02204982|449290516|FG000|Overall Study|Patient ineligible-medical monitor|1|||
124908320|NCT02204982|449290517|FG001|Overall Study|Patient ineligible-medical monitor|0|||
124908321|NCT02204982|449290516|FG000|Overall Study|Withdrawal by Subject|1|||
124908322|NCT02204982|449290517|FG001|Overall Study|Withdrawal by Subject|0|||
124908323|NCT02204982|449290516|FG000|Overall Study|Adverse Event|1|||
124908324|NCT02204982|449290517|FG001|Overall Study|Adverse Event|0|||
124908325|NCT02204982|449290516|FG000|Overall Study|Adverse Event and Investigator decision|1|||
124908326|NCT02204982|449290517|FG001|Overall Study|Adverse Event and Investigator decision|0|||
124908327|NCT02204982|449290516|FG000|Overall Study|Physician Decision|0|||
124908328|NCT02204982|449290517|FG001|Overall Study|Physician Decision|2|||
124908329|NCT02204982|449290516|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
124908330|NCT02204982|449290517|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
124908331|NCT02204982|449290516|FG000|Overall Study|Termination of Study bySponsor|0|||
124908332|NCT02204982|449290517|FG001|Overall Study|Termination of Study bySponsor|1|||
124908333|NCT00159783|449290518|FG000|Overall Study|Adverse Event|5|||
124908334|NCT00159783|449290519|FG001|Overall Study|Adverse Event|7|||
124908335|NCT00159783|449290520|FG002|Overall Study|Adverse Event|9|||
124908336|NCT00159783|449290518|FG000|Overall Study|Lack of Efficacy|1|||
124908337|NCT00159783|449290519|FG001|Overall Study|Lack of Efficacy|2|||
124908338|NCT00159783|449290520|FG002|Overall Study|Lack of Efficacy|3|||
124908339|NCT00159783|449290518|FG000|Overall Study|Withdrawal by Subject|7|||
124908340|NCT00159783|449290519|FG001|Overall Study|Withdrawal by Subject|11|||
124908341|NCT00159783|449290520|FG002|Overall Study|Withdrawal by Subject|12|||
124908342|NCT00159783|449290518|FG000|Overall Study|Lost to Follow-up|6|||
124908343|NCT00159783|449290519|FG001|Overall Study|Lost to Follow-up|5|||
124908344|NCT00159783|449290520|FG002|Overall Study|Lost to Follow-up|11|||
124908345|NCT00159783|449290518|FG000|Overall Study|Other|0|||
124908346|NCT00159783|449290519|FG001|Overall Study|Other|2|||
124908347|NCT00159783|449290520|FG002|Overall Study|Other|4|||
124908348|NCT02928224|449290521|FG000|Overall Study|Lost to Follow-up|1|||
124908349|NCT02928224|449290522|FG001|Overall Study|Lost to Follow-up|1|||
124908350|NCT02928224|449290523|FG002|Overall Study|Lost to Follow-up|3|||
124908351|NCT02928224|449290524|FG003|Overall Study|Lost to Follow-up|0|||
124908352|NCT02928224|449290521|FG000|Overall Study|Death|30|||
124908353|NCT02928224|449290522|FG001|Overall Study|Death|209|||
124908354|NCT02928224|449290523|FG002|Overall Study|Death|193|||
124908355|NCT02928224|449290524|FG003|Overall Study|Death|198|||
124908356|NCT02928224|449290521|FG000|Overall Study|Withdrawal by Subject|0|||
124908357|NCT02928224|449290522|FG001|Overall Study|Withdrawal by Subject|3|||
124908358|NCT02928224|449290523|FG002|Overall Study|Withdrawal by Subject|7|||
124908359|NCT02928224|449290524|FG003|Overall Study|Withdrawal by Subject|20|||
124908360|NCT02928224|449290521|FG000|Overall Study|Study participation terminated by sponsor|3|||
124908361|NCT02928224|449290522|FG001|Overall Study|Study participation terminated by sponsor|8|||
124908362|NCT02928224|449290523|FG002|Overall Study|Study participation terminated by sponsor|12|||
124908363|NCT02928224|449290524|FG003|Overall Study|Study participation terminated by sponsor|3|||
124908364|NCT02928224|449290521|FG000|Overall Study|Other|3|||
124908365|NCT02928224|449290522|FG001|Overall Study|Other|3|||
124908366|NCT02928224|449290523|FG002|Overall Study|Other|5|||
124908367|NCT02928224|449290524|FG003|Overall Study|Other|0|||
124908368|NCT00468910|449290525|FG000|Overall Study|Lost to Follow-up|2|||
124908369|NCT00468910|449290526|FG001|Overall Study|Lost to Follow-up|1|||
124908370|NCT00468910|449290525|FG000|Overall Study|Withdrawal by Subject|2|||
124908371|NCT00468910|449290526|FG001|Overall Study|Withdrawal by Subject|1|||
125022062|NCT00577993|449705346|FG001|Overall Study|Protocol Violation|3|||
124908372|NCT00468910|449290525|FG000|Overall Study|Medical Contraindication|0|||
124908373|NCT00468910|449290526|FG001|Overall Study|Medical Contraindication|1|||
124908374|NCT01576484|449290527|FG000|Overall Study|Adverse Event|1|||
124908375|NCT01576484|449290528|FG001|Overall Study|Adverse Event|1|||
124908376|NCT01576484|449290527|FG000|Overall Study|Protocol Violation|0|||
124908377|NCT01576484|449290528|FG001|Overall Study|Protocol Violation|2|||
124908378|NCT01576484|449290527|FG000|Overall Study|Sponsor Decision|2|||
124908379|NCT01576484|449290528|FG001|Overall Study|Sponsor Decision|8|||
124908380|NCT01576484|449290527|FG000|Overall Study|Withdrawal by Subject|0|||
124908381|NCT01576484|449290528|FG001|Overall Study|Withdrawal by Subject|3|||
124908382|NCT01576484|449290527|FG000|Overall Study|Other|2|||
124908383|NCT01576484|449290528|FG001|Overall Study|Other|5|||
124908384|NCT01943799|449290545|FG000|Overall Study|Lost to Follow-up|0|||
124908385|NCT01943799|449290546|FG001|Overall Study|Lost to Follow-up|1|||
124908386|NCT01943799|449290547|FG002|Overall Study|Lost to Follow-up|1|||
124908387|NCT01943799|449290548|FG003|Overall Study|Lost to Follow-up|0|||
124908388|NCT01943799|449290545|FG000|Overall Study|Protocol Violation|1|||
124908389|NCT01943799|449290546|FG001|Overall Study|Protocol Violation|0|||
124908390|NCT01943799|449290547|FG002|Overall Study|Protocol Violation|0|||
124908391|NCT01943799|449290548|FG003|Overall Study|Protocol Violation|0|||
124908392|NCT01943799|449290545|FG000|Overall Study|Withdrawal by Subject|4|||
124908393|NCT01943799|449290546|FG001|Overall Study|Withdrawal by Subject|2|||
124908394|NCT01943799|449290547|FG002|Overall Study|Withdrawal by Subject|1|||
124908395|NCT01943799|449290548|FG003|Overall Study|Withdrawal by Subject|0|||
124908396|NCT04594759|449290549|FG000|Overall Study|Lost to Follow-up|3|||
124908397|NCT03811574|449290550|FG000|Overall Study|Withdrawal by Subject|2|||
124908398|NCT03811574|449290551|FG001|Overall Study|Withdrawal by Subject|4|||
124908399|NCT03811574|449290552|FG002|Overall Study|Withdrawal by Subject|0|||
124908400|NCT01832480|449290553|FG000|Overall Study|Lost to Follow-up|33|||
124908401|NCT01832480|449290554|FG001|Overall Study|Lost to Follow-up|30|||
124908402|NCT01832480|449290553|FG000|Overall Study|Withdrawal by Subject|0|||
124908403|NCT01832480|449290554|FG001|Overall Study|Withdrawal by Subject|2|||
124908404|NCT01832480|449290553|FG000|Overall Study|post randomization ineligible|8|||
124908405|NCT01832480|449290554|FG001|Overall Study|post randomization ineligible|10|||
124908406|NCT00958633|449290557|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
124908407|NCT00958633|449290558|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
124908408|NCT00958633|449290559|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
124908409|NCT00958633|449290557|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
124908410|NCT00958633|449290558|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
124908411|NCT00958633|449290559|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
124908412|NCT00958633|449290557|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
124908413|NCT00958633|449290558|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
124908414|NCT00958633|449290559|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
124908415|NCT00958633|449290557|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
124908416|NCT00958633|449290558|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
124908417|NCT00958633|449290559|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
124908418|NCT00958633|449290557|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
124908419|NCT00958633|449290558|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
124908420|NCT00958633|449290559|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
124908421|NCT00958633|449290557|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
124908422|NCT00958633|449290558|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
124908423|NCT00958633|449290559|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
124908424|NCT00958633|449290557|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
124908425|NCT00958633|449290558|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
124908426|NCT00958633|449290559|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
124908427|NCT02674750|449290568|FG000|Overall Study|Death|4|||
124908428|NCT02674750|449290569|FG001|Overall Study|Death|5|||
124908429|NCT02674750|449290570|FG002|Overall Study|Death|8|||
124908430|NCT02674750|449290568|FG000|Overall Study|Lost to Follow-up|0|||
124908431|NCT02674750|449290569|FG001|Overall Study|Lost to Follow-up|8|||
124908432|NCT02674750|449290570|FG002|Overall Study|Lost to Follow-up|0|||
124908433|NCT02674750|449290568|FG000|Overall Study|Lack of Efficacy|1|||
124908434|NCT02674750|449290569|FG001|Overall Study|Lack of Efficacy|17|||
124908435|NCT02674750|449290570|FG002|Overall Study|Lack of Efficacy|3|||
124908436|NCT02674750|449290568|FG000|Overall Study|Withdrawal by Subject|0|||
124908437|NCT02674750|449290569|FG001|Overall Study|Withdrawal by Subject|7|||
124908438|NCT02674750|449290570|FG002|Overall Study|Withdrawal by Subject|1|||
124908439|NCT02674750|449290568|FG000|Overall Study|Other|0|||
124908440|NCT02674750|449290569|FG001|Overall Study|Other|8|||
124908441|NCT02674750|449290570|FG002|Overall Study|Other|0|||
124908442|NCT01597258|449290571|FG000|Overall Study|No Drug Administration|1|||
124908443|NCT01415349|449290572|FG000|Treatment Period 1|Adverse Event|0|||
124908444|NCT01415349|449290573|FG001|Treatment Period 1|Adverse Event|1|||
124908445|NCT01415349|449290572|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124908446|NCT01415349|449290573|FG001|Treatment Period 1|Withdrawal by Subject|1|||
124908447|NCT01616459|449290574|FG000|Overall Study|Adverse Event|1|||
124908448|NCT01616459|449290575|FG001|Overall Study|Adverse Event|1|||
124908449|NCT01616459|449290576|FG002|Overall Study|Adverse Event|2|||
124908450|NCT01616459|449290577|FG003|Overall Study|Adverse Event|0|||
124908451|NCT01616459|449290574|FG000|Overall Study|Lost to Follow-up|1|||
124908452|NCT01616459|449290575|FG001|Overall Study|Lost to Follow-up|11|||
124908453|NCT01616459|449290576|FG002|Overall Study|Lost to Follow-up|3|||
124908454|NCT01616459|449290577|FG003|Overall Study|Lost to Follow-up|2|||
124908455|NCT01616459|449290574|FG000|Overall Study|Protocol Violation|0|||
124908456|NCT01616459|449290575|FG001|Overall Study|Protocol Violation|0|||
124908457|NCT01616459|449290576|FG002|Overall Study|Protocol Violation|0|||
124908458|NCT01616459|449290577|FG003|Overall Study|Protocol Violation|2|||
124908459|NCT01616459|449290574|FG000|Overall Study|Withdrawal by Subject|2|||
125114904|NCT00415532|450044686|FG001|Treatment Period|Death|1|||
125114905|NCT00415532|450044685|FG000|Treatment Period|Lost to Follow-up|1|||
125114906|NCT00415532|450044686|FG001|Treatment Period|Lost to Follow-up|1|||
125114907|NCT00415532|450044685|FG000|Treatment Period|Protocol Violation|1|||
125114908|NCT00415532|450044686|FG001|Treatment Period|Protocol Violation|0|||
125114909|NCT00415532|450044685|FG000|Treatment Period|Withdrawal by Subject|6|||
125114910|NCT00415532|450044686|FG001|Treatment Period|Withdrawal by Subject|6|||
125114911|NCT00415532|450044685|FG000|Treatment Period|Other|2|||
125114912|NCT00415532|450044686|FG001|Treatment Period|Other|2|||
125114913|NCT00415532|450044685|FG000|Treatment Period|Ineligibility determined|1|||
125114914|NCT00415532|450044686|FG001|Treatment Period|Ineligibility determined|1|||
125114915|NCT00415532|450044685|FG000|Treatment Period|Noncompliance|1|||
125114916|NCT00415532|450044686|FG001|Treatment Period|Noncompliance|1|||
125114917|NCT00415532|450044685|FG000|Treatment Period|Requirement for alternative therapy|1|||
125114918|NCT00415532|450044686|FG001|Treatment Period|Requirement for alternative therapy|0|||
125114919|NCT00415532|450044685|FG000|Safety Follow Up Period|Adverse Event|1|||
125114920|NCT00415532|450044686|FG001|Safety Follow Up Period|Adverse Event|3|||
125114921|NCT00415532|450044685|FG000|Safety Follow Up Period|Death|3|||
125114922|NCT00415532|450044686|FG001|Safety Follow Up Period|Death|0|||
125114923|NCT00415532|450044685|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
125114924|NCT00415532|450044686|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
125114925|NCT00415532|450044685|FG000|Safety Follow Up Period|Other|1|||
125114926|NCT00415532|450044686|FG001|Safety Follow Up Period|Other|4|||
125114927|NCT00415532|450044685|FG000|Safety Follow Up Period|Ineligibility determined|1|||
125114928|NCT00415532|450044686|FG001|Safety Follow Up Period|Ineligibility determined|1|||
125114929|NCT00415532|450044685|FG000|Safety Follow Up Period|Noncompliance|1|||
125114930|NCT00415532|450044686|FG001|Safety Follow Up Period|Noncompliance|0|||
125114931|NCT00415532|450044685|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
125114932|NCT00415532|450044686|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
125114933|NCT01698320|450044687|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
125114934|NCT01698320|450044688|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
125114935|NCT01698320|450044689|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
125114936|NCT01698320|450044687|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
125114937|NCT01698320|450044688|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
125114938|NCT01698320|450044689|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
125114939|NCT01698320|450044687|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
125114940|NCT01698320|450044688|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
125114941|NCT01698320|450044689|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
125114942|NCT01698320|450044687|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
125114943|NCT01698320|450044688|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
125114944|NCT01698320|450044689|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
125114945|NCT01698320|450044687|FG000|12-Week Double-Blind Period|Adverse Event|0|||
125114946|NCT01698320|450044688|FG001|12-Week Double-Blind Period|Adverse Event|1|||
125114947|NCT01698320|450044689|FG002|12-Week Double-Blind Period|Adverse Event|1|||
125114948|NCT01698320|450044687|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
125114949|NCT01698320|450044688|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
125114950|NCT01698320|450044689|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
125114951|NCT01698320|450044687|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
125114952|NCT01698320|450044688|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
125114953|NCT01698320|450044689|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
125114954|NCT01698320|450044687|FG000|12-Week Double-Blind Period|Pregnancy|0|||
125114955|NCT01698320|450044688|FG001|12-Week Double-Blind Period|Pregnancy|1|||
125114956|NCT01698320|450044689|FG002|12-Week Double-Blind Period|Pregnancy|1|||
125114957|NCT01698320|450044687|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
125114958|NCT01698320|450044688|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
125114959|NCT01698320|450044689|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
124908460|NCT01616459|449290575|FG001|Overall Study|Withdrawal by Subject|4|||
124908461|NCT01616459|449290576|FG002|Overall Study|Withdrawal by Subject|4|||
124908462|NCT01616459|449290577|FG003|Overall Study|Withdrawal by Subject|4|||
124908463|NCT01616459|449290574|FG000|Overall Study|Other reason|0|||
124908464|NCT01616459|449290575|FG001|Overall Study|Other reason|1|||
124908465|NCT01616459|449290576|FG002|Overall Study|Other reason|1|||
124908466|NCT01616459|449290577|FG003|Overall Study|Other reason|0|||
124908467|NCT04980755|449290578|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
124908468|NCT04980755|449290578|FG000|Body Reprogramming Courses|Work commitment|2|||
124908469|NCT04980755|449290578|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
124908470|NCT04980755|449290578|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
124908471|NCT00304031|449292011|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
124908472|NCT00304031|449292012|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
124908473|NCT00304031|449292013|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
124908474|NCT00304031|449292011|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
124908475|NCT00304031|449292012|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
125022063|NCT00577993|449705347|FG002|Overall Study|Protocol Violation|0|||
124908476|NCT00304031|449292013|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
124908477|NCT00304031|449292011|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
124908478|NCT00304031|449292012|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
124908479|NCT00304031|449292013|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
124908480|NCT00304031|449292011|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
124908481|NCT00304031|449292012|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
124908482|NCT00304031|449292013|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
124908483|NCT00304031|449292011|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
124908484|NCT00304031|449292012|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
124908485|NCT00304031|449292013|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
124908486|NCT00304031|449292011|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
124908487|NCT00304031|449292012|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
124908488|NCT00304031|449292013|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
124908489|NCT00304031|449292011|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
124908490|NCT00304031|449292012|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
124908491|NCT00304031|449292013|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
124908492|NCT00304031|449292011|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
124908493|NCT00304031|449292012|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
124908494|NCT00304031|449292013|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
124908495|NCT00304031|449292011|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
124908496|NCT00304031|449292012|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
124908497|NCT00304031|449292013|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
124908498|NCT01188655|449292014|FG000|Overall Study|Lack of Efficacy|1|||
124908499|NCT01188655|449292014|FG000|Overall Study|Lost to Follow-up|1|||
124908500|NCT01188655|449292014|FG000|Overall Study|Other|11|||
124908501|NCT01875848|449292024|FG000|Overall Study|Withdrawal by Subject|2|||
124908502|NCT01875848|449292025|FG001|Overall Study|Withdrawal by Subject|0|||
124908503|NCT02189252|449292026|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
124908504|NCT02189252|449292027|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
124908505|NCT02189252|449292028|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
124908506|NCT02189252|449292029|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
124908507|NCT02189252|449292026|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
124908508|NCT02189252|449292027|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
124908509|NCT02189252|449292028|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
124908510|NCT02189252|449292029|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
124908511|NCT00840177|449292030|FG000|Overall Study|Adverse Event|5|||
124908512|NCT00840177|449292031|FG001|Overall Study|Adverse Event|1|||
124908513|NCT00840177|449292032|FG002|Overall Study|Adverse Event|1|||
124908514|NCT00840177|449292030|FG000|Overall Study|Refusal unrelated to adverse events|1|||
124908515|NCT00840177|449292031|FG001|Overall Study|Refusal unrelated to adverse events|0|||
124908516|NCT00840177|449292032|FG002|Overall Study|Refusal unrelated to adverse events|1|||
124908517|NCT00840177|449292030|FG000|Overall Study|Progression/relapse|2|||
124908518|NCT00840177|449292031|FG001|Overall Study|Progression/relapse|0|||
124908519|NCT00840177|449292032|FG002|Overall Study|Progression/relapse|0|||
124908520|NCT00840177|449292030|FG000|Overall Study|Death|4|||
124908521|NCT00840177|449292031|FG001|Overall Study|Death|5|||
124908522|NCT00840177|449292032|FG002|Overall Study|Death|5|||
124908523|NCT00840177|449292030|FG000|Overall Study|not protocol specified|6|||
124908524|NCT00840177|449292031|FG001|Overall Study|not protocol specified|3|||
124908525|NCT00840177|449292032|FG002|Overall Study|not protocol specified|0|||
124908526|NCT00840177|449292030|FG000|Overall Study|Ineligible|0|||
124908527|NCT00840177|449292031|FG001|Overall Study|Ineligible|0|||
124908528|NCT00840177|449292032|FG002|Overall Study|Ineligible|3|||
124908529|NCT00840177|449292030|FG000|Overall Study|Did not start treatment|0|||
124908530|NCT00840177|449292031|FG001|Overall Study|Did not start treatment|0|||
124908531|NCT00840177|449292032|FG002|Overall Study|Did not start treatment|1|||
124908532|NCT01391832|449292033|FG000|Overall Study|Withdrawal by Subject|21|||
124908533|NCT01391832|449292034|FG001|Overall Study|Withdrawal by Subject|22|||
124908534|NCT01391832|449292033|FG000|Overall Study|Lost to Follow-up|0|||
124908535|NCT01391832|449292034|FG001|Overall Study|Lost to Follow-up|1|||
124908536|NCT03345901|449292038|FG000|Overall Study|The study was terminated|18|||
124908537|NCT00722046|449292039|FG000|Overall Study|Adverse Event|0|||
124908538|NCT00722046|449292040|FG001|Overall Study|Adverse Event|1|||
124908539|NCT00722046|449292041|FG002|Overall Study|Adverse Event|2|||
125022064|NCT00577993|449705345|FG000|Overall Study|Withdrawal by Subject|1|||
125022065|NCT00577993|449705346|FG001|Overall Study|Withdrawal by Subject|0|||
125022066|NCT00577993|449705347|FG002|Overall Study|Withdrawal by Subject|2|||
125022067|NCT00577993|449705345|FG000|Overall Study|Conversion|2|||
125022068|NCT00577993|449705346|FG001|Overall Study|Conversion|5|||
125022069|NCT00577993|449705347|FG002|Overall Study|Conversion|0|||
125022070|NCT00577993|449705345|FG000|Overall Study|Uninsured|1|||
125022071|NCT00577993|449705346|FG001|Overall Study|Uninsured|0|||
125022072|NCT00577993|449705347|FG002|Overall Study|Uninsured|0|||
125211117|NCT04122625|450398588|FG003|Part A (up to 2.92 Years)|Death|0|||
125211118|NCT04122625|450398589|FG004|Part A (up to 2.92 Years)|Death|0|||
125211119|NCT04122625|450398590|FG005|Part A (up to 2.92 Years)|Death|0|||
125211120|NCT04122625|450398585|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
125211121|NCT04122625|450398586|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
125211122|NCT04122625|450398587|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
125211123|NCT04122625|450398588|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
125211124|NCT04122625|450398589|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
125211125|NCT04122625|450398590|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
125211126|NCT04122625|450398585|FG000|Part B (up to 2.33 Years)|Death|0|||
125211127|NCT04122625|450398586|FG001|Part B (up to 2.33 Years)|Death|0|||
125211128|NCT04122625|450398587|FG002|Part B (up to 2.33 Years)|Death|5|||
125211129|NCT04122625|450398588|FG003|Part B (up to 2.33 Years)|Death|7|||
125211130|NCT04122625|450398589|FG004|Part B (up to 2.33 Years)|Death|6|||
125211131|NCT04122625|450398590|FG005|Part B (up to 2.33 Years)|Death|7|||
125211132|NCT04348500|450398591|FG000|Overall Study|Death|2|||
125211133|NCT04348500|450398592|FG001|Overall Study|Death|2|||
125211134|NCT04348500|450398591|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
125211135|NCT04348500|450398592|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
125211136|NCT02776670|450398593|FG000|Overall Study|Adverse Event|0|||
125211137|NCT02776670|450398594|FG001|Overall Study|Adverse Event|2|||
125211138|NCT02776670|450398593|FG000|Overall Study|Protocol Violation|0|||
125211139|NCT02776670|450398594|FG001|Overall Study|Protocol Violation|2|||
125211140|NCT02776670|450398593|FG000|Overall Study|Withdrawal by Subject|0|||
125211141|NCT02776670|450398594|FG001|Overall Study|Withdrawal by Subject|1|||
125211142|NCT02776670|450398593|FG000|Overall Study|Other - Reason not given|0|||
125211143|NCT02776670|450398594|FG001|Overall Study|Other - Reason not given|1|||
125211144|NCT01937884|450398595|FG000|Overall Study|Withdrawal by Subject|1|||
125211145|NCT01937884|450398596|FG001|Overall Study|Withdrawal by Subject|0|||
125211146|NCT00004088|450398597|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
125211147|NCT00004088|450398597|FG000|Overall Study|Withdrawal by Subject|1|||
125211148|NCT00004088|450398597|FG000|Overall Study|Protocol Violation|3|||
125211149|NCT00004088|450398597|FG000|Overall Study|Physician Decision|1|||
125211150|NCT00981058|450398598|FG000|Overall Study|Progressive Disease|38|||
125211151|NCT00981058|450398599|FG001|Overall Study|Progressive Disease|31|||
125211152|NCT00981058|450398598|FG000|Overall Study|Lost to Follow-up|3|||
125211153|NCT00981058|450398599|FG001|Overall Study|Lost to Follow-up|2|||
125211154|NCT00981058|450398598|FG000|Overall Study|Physician Decision|4|||
125211155|NCT00981058|450398599|FG001|Overall Study|Physician Decision|5|||
125211156|NCT00981058|450398598|FG000|Overall Study|Randomization Error|0|||
125211157|NCT00981058|450398599|FG001|Overall Study|Randomization Error|1|||
125211158|NCT00981058|450398598|FG000|Overall Study|Withdrawal by Subject|24|||
125211159|NCT00981058|450398599|FG001|Overall Study|Withdrawal by Subject|22|||
125211160|NCT02667587|450398600|FG000|Pre-Treatment|Not reported|1|||
125211161|NCT02667587|450398601|FG001|Pre-Treatment|Not reported|0|||
125211162|NCT02667587|450398600|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
125211163|NCT02667587|450398601|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
125211164|NCT02667587|450398600|FG000|Pre-Treatment|Participant withdrew consent|0|||
125211165|NCT02667587|450398601|FG001|Pre-Treatment|Participant withdrew consent|1|||
125211166|NCT02667587|450398600|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
125211167|NCT02667587|450398601|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
125211168|NCT02667587|450398600|FG000|End of Treatment|Disease Progression|193|||
125211169|NCT02667587|450398601|FG001|End of Treatment|Disease Progression|226|||
125211170|NCT02667587|450398600|FG000|End of Treatment|Study Drug Toxicity|75|||
125211171|NCT02667587|450398601|FG001|End of Treatment|Study Drug Toxicity|19|||
125211172|NCT02667587|450398600|FG000|End of Treatment|Death|2|||
125211173|NCT02667587|450398601|FG001|End of Treatment|Death|1|||
125211174|NCT02667587|450398600|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
125211175|NCT02667587|450398601|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
125211176|NCT02667587|450398600|FG000|End of Treatment|participant request to discontinue treatment|33|||
124908540|NCT00722046|449292042|FG003|Overall Study|Adverse Event|1|||
124908541|NCT00722046|449292043|FG004|Overall Study|Adverse Event|2|||
125211177|NCT02667587|450398601|FG001|End of Treatment|participant request to discontinue treatment|35|||
125211178|NCT02667587|450398600|FG000|End of Treatment|participant withdrew consent|5|||
125211179|NCT02667587|450398601|FG001|End of Treatment|participant withdrew consent|6|||
125211180|NCT02667587|450398600|FG000|End of Treatment|Lost to Follow-up|1|||
125211181|NCT02667587|450398601|FG001|End of Treatment|Lost to Follow-up|2|||
124908542|NCT00722046|449292044|FG005|Overall Study|Adverse Event|1|||
124908543|NCT00722046|449292045|FG006|Overall Study|Adverse Event|0|||
125211182|NCT02667587|450398600|FG000|End of Treatment|maximum clinical benefit|4|||
125211183|NCT02667587|450398601|FG001|End of Treatment|maximum clinical benefit|4|||
124908544|NCT00722046|449292039|FG000|Overall Study|Death|0|||
125211184|NCT02667587|450398600|FG000|End of Treatment|poor or non compliant|0|||
125211185|NCT02667587|450398601|FG001|End of Treatment|poor or non compliant|1|||
125211186|NCT02667587|450398600|FG000|End of Treatment|participant no longer meets study criteria|1|||
124908545|NCT00722046|449292040|FG001|Overall Study|Death|1|||
124908546|NCT00722046|449292041|FG002|Overall Study|Death|0|||
124908547|NCT00722046|449292042|FG003|Overall Study|Death|0|||
124908548|NCT00722046|449292043|FG004|Overall Study|Death|0|||
124908549|NCT00722046|449292044|FG005|Overall Study|Death|0|||
124908550|NCT00722046|449292045|FG006|Overall Study|Death|2|||
125211187|NCT02667587|450398601|FG001|End of Treatment|participant no longer meets study criteria|1|||
125211188|NCT02667587|450398600|FG000|End of Treatment|administrative reason by sponsor|1|||
125211189|NCT02667587|450398601|FG001|End of Treatment|administrative reason by sponsor|29|||
125211190|NCT02667587|450398600|FG000|End of Treatment|other reasonse|21|||
125211191|NCT02667587|450398601|FG001|End of Treatment|other reasonse|10|||
125211192|NCT04165135|450398602|FG000|Overall Study|Protocol Violation|10|||
125211193|NCT04165135|450398602|FG000|Overall Study|Participants withdrawal of consent|5|||
125211194|NCT02886884|450398608|FG000|Follow-up|Withdrawal by Subject|0|||
125211195|NCT02886884|450398609|FG001|Follow-up|Withdrawal by Subject|0|||
125211196|NCT02886884|450398610|FG002|Follow-up|Withdrawal by Subject|0|||
125211197|NCT02886884|450398611|FG003|Follow-up|Withdrawal by Subject|1|||
125211198|NCT00575510|450398614|FG000|Overall Study|Lost to Follow-up|4|||
125211199|NCT00575510|450398615|FG001|Overall Study|Lost to Follow-up|6|||
125211200|NCT00575510|450398616|FG002|Overall Study|Lost to Follow-up|9|||
125211201|NCT00575510|450398614|FG000|Overall Study|Withdrawal by Subject|1|||
125211202|NCT00575510|450398615|FG001|Overall Study|Withdrawal by Subject|0|||
125211203|NCT00575510|450398616|FG002|Overall Study|Withdrawal by Subject|0|||
125211204|NCT00575510|450398614|FG000|Overall Study|Clinic Called Patient|7|||
125211205|NCT00575510|450398615|FG001|Overall Study|Clinic Called Patient|7|||
125211206|NCT00575510|450398616|FG002|Overall Study|Clinic Called Patient|7|||
125211207|NCT00575510|450398614|FG000|Overall Study|Pregnancy|0|||
125211208|NCT00575510|450398615|FG001|Overall Study|Pregnancy|0|||
125211209|NCT00575510|450398616|FG002|Overall Study|Pregnancy|1|||
125211210|NCT00106639|450398620|FG000|Overall Study|Adverse Event|3|||
125211211|NCT00106639|450398621|FG001|Overall Study|Adverse Event|4|||
125211212|NCT00106639|450398622|FG002|Overall Study|Adverse Event|1|||
125211213|NCT00106639|450398620|FG000|Overall Study|Protocol Violation|0|||
125211214|NCT00106639|450398621|FG001|Overall Study|Protocol Violation|1|||
125211215|NCT00106639|450398622|FG002|Overall Study|Protocol Violation|0|||
125211216|NCT00106639|450398620|FG000|Overall Study|Withdrawal by Subject|0|||
125211217|NCT00106639|450398621|FG001|Overall Study|Withdrawal by Subject|1|||
125211218|NCT00106639|450398622|FG002|Overall Study|Withdrawal by Subject|0|||
125211219|NCT00106639|450398620|FG000|Overall Study|Participant defaulted|0|||
125211220|NCT00106639|450398621|FG001|Overall Study|Participant defaulted|1|||
125211221|NCT00106639|450398622|FG002|Overall Study|Participant defaulted|1|||
125211222|NCT00594386|450398624|FG000|Overall Study|Major protocol violation|2|||
125211223|NCT00594386|450398624|FG000|Overall Study|Lack of Efficacy|12|||
125211224|NCT00594386|450398624|FG000|Overall Study|Adverse Event|68|||
125211225|NCT00594386|450398624|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
125211226|NCT00594386|450398624|FG000|Overall Study|Subject withdrew consent|35|||
125211227|NCT00594386|450398624|FG000|Overall Study|Study ended per sponsor|115|||
125211228|NCT00594386|450398624|FG000|Overall Study|Lost to Follow-up|6|||
125211229|NCT00594386|450398624|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
125211230|NCT00594386|450398624|FG000|Overall Study|Other: Subject moved to Seattle|1|||
125211231|NCT00594386|450398624|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
125211232|NCT00594386|450398624|FG000|Overall Study|Other: Study terminated per investigator|2|||
125211233|NCT00594386|450398624|FG000|Overall Study|Other: Sponsor closure of study|1|||
124908551|NCT00722046|449292039|FG000|Overall Study|Protocol Violation|1|||
124908552|NCT00722046|449292040|FG001|Overall Study|Protocol Violation|0|||
124908553|NCT00722046|449292041|FG002|Overall Study|Protocol Violation|0|||
125211234|NCT00594386|450398624|FG000|Overall Study|Other: Site terminated participation|1|||
125211235|NCT00594386|450398624|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
125211236|NCT00594386|450398624|FG000|Overall Study|Other: Loss of drivers license|1|||
125211237|NCT01210144|450398625|FG000|Overall Study|Lack of ovarian response|1|||
125211238|NCT01210144|450398626|FG001|Overall Study|Lack of ovarian response|0|||
125211239|NCT01210144|450398625|FG000|Overall Study|No fertilization|1|||
125211240|NCT01210144|450398626|FG001|Overall Study|No fertilization|0|||
124908554|NCT00722046|449292042|FG003|Overall Study|Protocol Violation|0|||
124908555|NCT00722046|449292043|FG004|Overall Study|Protocol Violation|0|||
124908556|NCT00722046|449292044|FG005|Overall Study|Protocol Violation|1|||
124908557|NCT00722046|449292045|FG006|Overall Study|Protocol Violation|0|||
124908558|NCT00722046|449292039|FG000|Overall Study|Withdrawal by Subject|3|||
124908559|NCT00722046|449292040|FG001|Overall Study|Withdrawal by Subject|3|||
124908560|NCT00722046|449292041|FG002|Overall Study|Withdrawal by Subject|4|||
124908561|NCT00722046|449292042|FG003|Overall Study|Withdrawal by Subject|4|||
124908562|NCT00722046|449292043|FG004|Overall Study|Withdrawal by Subject|4|||
124908563|NCT00722046|449292044|FG005|Overall Study|Withdrawal by Subject|7|||
124908564|NCT00722046|449292045|FG006|Overall Study|Withdrawal by Subject|3|||
124908565|NCT00722046|449292039|FG000|Overall Study|Randomized, but not treated|1|||
124908566|NCT00722046|449292040|FG001|Overall Study|Randomized, but not treated|1|||
124908567|NCT00722046|449292041|FG002|Overall Study|Randomized, but not treated|0|||
124908568|NCT00722046|449292042|FG003|Overall Study|Randomized, but not treated|2|||
124908569|NCT00722046|449292043|FG004|Overall Study|Randomized, but not treated|0|||
124908570|NCT00722046|449292044|FG005|Overall Study|Randomized, but not treated|0|||
124908571|NCT00722046|449292045|FG006|Overall Study|Randomized, but not treated|0|||
124908572|NCT00722046|449292039|FG000|Overall Study|Other|0|||
124908573|NCT00722046|449292040|FG001|Overall Study|Other|0|||
124908574|NCT00722046|449292041|FG002|Overall Study|Other|1|||
124908575|NCT00722046|449292042|FG003|Overall Study|Other|1|||
124908576|NCT00722046|449292043|FG004|Overall Study|Other|3|||
124908577|NCT00722046|449292044|FG005|Overall Study|Other|2|||
124908578|NCT00722046|449292045|FG006|Overall Study|Other|1|||
124908579|NCT00686855|449292049|FG000|Overall Study|Lost to Follow-up|1|||
124908580|NCT00686855|449292050|FG001|Overall Study|Lost to Follow-up|0|||
124908581|NCT00686855|449292049|FG000|Overall Study|Progressive GVHD|0|||
124908582|NCT00686855|449292050|FG001|Overall Study|Progressive GVHD|1|||
124908583|NCT02731755|449292056|FG000|First Intervention|Withdrawal by Subject|0|||
124908584|NCT02731755|449292057|FG001|First Intervention|Withdrawal by Subject|2|||
124908585|NCT00414544|449292060|FG000|Overall Study|Lost to Follow-up|14|||
124908586|NCT00799396|449292062|FG000|Clopidogrel Treatment|Adverse Event|6|||
124908587|NCT00799396|449292062|FG000|Clopidogrel Treatment|Physician Decision|5|||
124908588|NCT00799396|449292062|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
124908589|NCT00799396|449292062|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
124908590|NCT00799396|449292062|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
124908591|NCT01318382|449292065|FG000|Overall Study|Physician Decision|2|||
124908592|NCT01318382|449292065|FG000|Overall Study|Device Malfunction|10|||
124908593|NCT01318382|449292065|FG000|Overall Study|Protocol Violation|1|||
124908594|NCT01867216|449292066|FG000|Overall Study|Withdrawal by Subject|2|||
124908595|NCT01867216|449292067|FG001|Overall Study|Withdrawal by Subject|0|||
124908596|NCT01867216|449292068|FG002|Overall Study|Withdrawal by Subject|0|||
124908597|NCT01867216|449292069|FG003|Overall Study|Withdrawal by Subject|0|||
124908598|NCT01867216|449292070|FG004|Overall Study|Withdrawal by Subject|1|||
124908599|NCT01867216|449292071|FG005|Overall Study|Withdrawal by Subject|0|||
124908600|NCT01867216|449292072|FG006|Overall Study|Withdrawal by Subject|1|||
124908601|NCT01867216|449292066|FG000|Overall Study|Physician Decision|1|||
124908602|NCT01867216|449292067|FG001|Overall Study|Physician Decision|0|||
124908603|NCT01867216|449292068|FG002|Overall Study|Physician Decision|0|||
124908604|NCT01867216|449292069|FG003|Overall Study|Physician Decision|0|||
124908605|NCT01867216|449292070|FG004|Overall Study|Physician Decision|0|||
124908606|NCT01867216|449292071|FG005|Overall Study|Physician Decision|0|||
124908607|NCT01867216|449292072|FG006|Overall Study|Physician Decision|0|||
124908608|NCT01867216|449292066|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
124908609|NCT01867216|449292067|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
124908610|NCT01867216|449292068|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
124908611|NCT01867216|449292069|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
124908612|NCT01867216|449292070|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
124908613|NCT01867216|449292071|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
124908614|NCT01867216|449292072|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
124908615|NCT01599104|449292073|FG000|Overall Study|Withdrawal by Subject|1|||
124908616|NCT01599104|449292074|FG001|Overall Study|Withdrawal by Subject|1|||
124908617|NCT01599104|449292075|FG002|Overall Study|Withdrawal by Subject|2|||
124908618|NCT01599104|449292073|FG000|Overall Study|Technical Problems|1|||
124908619|NCT01599104|449292074|FG001|Overall Study|Technical Problems|0|||
124908620|NCT01599104|449292075|FG002|Overall Study|Technical Problems|0|||
124908621|NCT01599104|449292073|FG000|Overall Study|Physician Decision|3|||
124908622|NCT01599104|449292074|FG001|Overall Study|Physician Decision|2|||
124908623|NCT01599104|449292075|FG002|Overall Study|Physician Decision|2|||
124908624|NCT01599104|449292073|FG000|Overall Study|Non-compliance with study treatment|0|||
124908625|NCT01599104|449292074|FG001|Overall Study|Non-compliance with study treatment|1|||
124908626|NCT01599104|449292075|FG002|Overall Study|Non-compliance with study treatment|0|||
124908627|NCT01599104|449292073|FG000|Overall Study|Lack of Efficacy|4|||
124908628|NCT01599104|449292074|FG001|Overall Study|Lack of Efficacy|4|||
124908629|NCT01599104|449292075|FG002|Overall Study|Lack of Efficacy|10|||
124908630|NCT01599104|449292073|FG000|Overall Study|Adverse Event|7|||
124908631|NCT01599104|449292074|FG001|Overall Study|Adverse Event|6|||
124908632|NCT01599104|449292075|FG002|Overall Study|Adverse Event|12|||
124908633|NCT00714714|449292078|FG000|Overall Study|Adverse Event|1|||
124908634|NCT01308567|449292087|FG000|Overall Study|Lost to Follow-up|2|||
124908635|NCT01308567|449292088|FG001|Overall Study|Lost to Follow-up|4|||
124908636|NCT01308567|449292089|FG002|Overall Study|Lost to Follow-up|4|||
124908637|NCT01149369|449292102|FG000|Overall Study|Adverse Event|6|||
124908638|NCT01149369|449292103|FG001|Overall Study|Adverse Event|3|||
124908639|NCT02593149|449292104|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
124908640|NCT02593149|449292105|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
124908641|NCT02593149|449292104|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
124908642|NCT02593149|449292105|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
124908643|NCT01636687|449292107|FG000|Induction Period|Withdrawal by Subject|1|||
124908644|NCT01636687|449292108|FG001|Induction Period|Withdrawal by Subject|0|||
124908645|NCT01636687|449292109|FG002|Induction Period|Withdrawal by Subject|0|||
124908646|NCT01636687|449292110|FG003|Induction Period|Withdrawal by Subject|0|||
124908647|NCT01636687|449292111|FG004|Induction Period|Withdrawal by Subject|0|||
124908648|NCT01636687|449292107|FG000|Induction Period|Adverse Event|1|||
124908649|NCT01636687|449292108|FG001|Induction Period|Adverse Event|0|||
124908650|NCT01636687|449292109|FG002|Induction Period|Adverse Event|0|||
124908651|NCT01636687|449292110|FG003|Induction Period|Adverse Event|0|||
124908652|NCT01636687|449292111|FG004|Induction Period|Adverse Event|1|||
124908653|NCT01636687|449292107|FG000|Induction Period|Lack of Efficacy|0|||
124908654|NCT01636687|449292108|FG001|Induction Period|Lack of Efficacy|0|||
124908655|NCT01636687|449292109|FG002|Induction Period|Lack of Efficacy|0|||
124908656|NCT01636687|449292110|FG003|Induction Period|Lack of Efficacy|0|||
124908657|NCT01636687|449292111|FG004|Induction Period|Lack of Efficacy|1|||
124908658|NCT01636687|449292107|FG000|Induction Period|Physician Decision|1|||
124908659|NCT01636687|449292108|FG001|Induction Period|Physician Decision|0|||
124908660|NCT01636687|449292109|FG002|Induction Period|Physician Decision|0|||
124908661|NCT01636687|449292110|FG003|Induction Period|Physician Decision|0|||
124908662|NCT01636687|449292111|FG004|Induction Period|Physician Decision|0|||
124908663|NCT01636687|449292107|FG000|Maintenance Period|Withdrawal by Subject|2|||
124908664|NCT01636687|449292108|FG001|Maintenance Period|Withdrawal by Subject|0|||
124908665|NCT01636687|449292109|FG002|Maintenance Period|Withdrawal by Subject|2|||
124908666|NCT01636687|449292110|FG003|Maintenance Period|Withdrawal by Subject|0|||
124908667|NCT01636687|449292111|FG004|Maintenance Period|Withdrawal by Subject|0|||
124908668|NCT01636687|449292107|FG000|Maintenance Period|Adverse Event|1|||
124908669|NCT01636687|449292108|FG001|Maintenance Period|Adverse Event|0|||
124908670|NCT01636687|449292109|FG002|Maintenance Period|Adverse Event|0|||
124908671|NCT01636687|449292110|FG003|Maintenance Period|Adverse Event|0|||
124908672|NCT01636687|449292111|FG004|Maintenance Period|Adverse Event|0|||
124908673|NCT01636687|449292107|FG000|Maintenance Period|Lack of Efficacy|4|||
124908674|NCT01636687|449292108|FG001|Maintenance Period|Lack of Efficacy|1|||
124908675|NCT01636687|449292109|FG002|Maintenance Period|Lack of Efficacy|0|||
124908676|NCT01636687|449292110|FG003|Maintenance Period|Lack of Efficacy|0|||
124908677|NCT01636687|449292111|FG004|Maintenance Period|Lack of Efficacy|0|||
124908678|NCT01636687|449292107|FG000|Maintenance Period|Lost to Follow-up|1|||
124908679|NCT01636687|449292108|FG001|Maintenance Period|Lost to Follow-up|1|||
124908680|NCT01636687|449292109|FG002|Maintenance Period|Lost to Follow-up|0|||
124908681|NCT01636687|449292110|FG003|Maintenance Period|Lost to Follow-up|0|||
124908682|NCT01636687|449292111|FG004|Maintenance Period|Lost to Follow-up|1|||
124908683|NCT01636687|449292107|FG000|Maintenance Period|Physician Decision|0|||
124908684|NCT01636687|449292108|FG001|Maintenance Period|Physician Decision|0|||
124908685|NCT01636687|449292109|FG002|Maintenance Period|Physician Decision|0|||
124908686|NCT01636687|449292110|FG003|Maintenance Period|Physician Decision|0|||
124908687|NCT01636687|449292111|FG004|Maintenance Period|Physician Decision|1|||
125114960|NCT01698320|450044687|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
125114961|NCT01698320|450044688|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
125114962|NCT01698320|450044689|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
124908688|NCT01636687|449292107|FG000|Extension Period|technical problems|0|||
124908689|NCT01636687|449292108|FG001|Extension Period|technical problems|1|||
124908690|NCT01636687|449292109|FG002|Extension Period|technical problems|2|||
124908691|NCT01636687|449292110|FG003|Extension Period|technical problems|1|||
124908692|NCT01636687|449292111|FG004|Extension Period|technical problems|0|||
124908693|NCT01636687|449292107|FG000|Extension Period|Adverse Event|4|||
125114963|NCT01698320|450044687|FG000|40-Week Open-Label Period|Adverse Event|0|||
124908694|NCT01636687|449292108|FG001|Extension Period|Adverse Event|3|||
125211241|NCT01210144|450398625|FG000|Overall Study|No transfer|1|||
125211242|NCT01210144|450398626|FG001|Overall Study|No transfer|0|||
125211243|NCT00094536|450398633|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
125211244|NCT00094536|450398633|FG000|Treatment and Follow-up|Adverse Event|4|||
125211245|NCT00094536|450398633|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
125211246|NCT00094536|450398633|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
125211247|NCT00094536|450398633|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
125211248|NCT00094536|450398633|FG000|Treatment and Follow-up|Subject non-compliance|9|||
125211249|NCT00094536|450398633|FG000|Treatment and Follow-up|Unable to attend visits|1|||
125211250|NCT00494221|450398634|FG000|Overall Study|Death|15|||
125211251|NCT00494221|450398635|FG001|Overall Study|Death|9|||
125211252|NCT00494221|450398636|FG002|Overall Study|Death|14|||
125211253|NCT00494221|450398634|FG000|Overall Study|Withdrawal by Subject|1|||
125211254|NCT00494221|450398635|FG001|Overall Study|Withdrawal by Subject|2|||
125211255|NCT00494221|450398636|FG002|Overall Study|Withdrawal by Subject|0|||
125211256|NCT01900431|450398641|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
125211257|NCT01900431|450398642|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
125211258|NCT01900431|450398643|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
125211259|NCT01900431|450398641|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
125211260|NCT01900431|450398642|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
125211261|NCT01900431|450398643|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
125211262|NCT01900431|450398641|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
125211263|NCT01900431|450398642|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
125211264|NCT01900431|450398643|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
125211265|NCT01900431|450398641|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
125211266|NCT01900431|450398642|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
125211267|NCT01900431|450398643|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
125211268|NCT01900431|450398641|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
125211269|NCT01900431|450398642|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
124908695|NCT01636687|449292109|FG002|Extension Period|Adverse Event|2|||
124908696|NCT01636687|449292110|FG003|Extension Period|Adverse Event|1|||
124908697|NCT01636687|449292111|FG004|Extension Period|Adverse Event|0|||
124908698|NCT01636687|449292107|FG000|Extension Period|Lack of Efficacy|7|||
124908699|NCT01636687|449292108|FG001|Extension Period|Lack of Efficacy|0|||
124908700|NCT01636687|449292109|FG002|Extension Period|Lack of Efficacy|2|||
124908701|NCT01636687|449292110|FG003|Extension Period|Lack of Efficacy|1|||
124908702|NCT01636687|449292111|FG004|Extension Period|Lack of Efficacy|0|||
124908703|NCT01636687|449292107|FG000|Extension Period|Lost to Follow-up|1|||
124908704|NCT01636687|449292108|FG001|Extension Period|Lost to Follow-up|0|||
124908705|NCT01636687|449292109|FG002|Extension Period|Lost to Follow-up|1|||
124908706|NCT01636687|449292110|FG003|Extension Period|Lost to Follow-up|0|||
124908707|NCT01636687|449292111|FG004|Extension Period|Lost to Follow-up|0|||
124908708|NCT01636687|449292107|FG000|Extension Period|Physician Decision|1|||
124908709|NCT01636687|449292108|FG001|Extension Period|Physician Decision|0|||
124908710|NCT01636687|449292109|FG002|Extension Period|Physician Decision|0|||
124908711|NCT01636687|449292110|FG003|Extension Period|Physician Decision|1|||
124908712|NCT01636687|449292111|FG004|Extension Period|Physician Decision|0|||
124908713|NCT01636687|449292107|FG000|Extension Period|study terminated by sponsor|33|||
124908714|NCT01636687|449292108|FG001|Extension Period|study terminated by sponsor|50|||
124908715|NCT01636687|449292109|FG002|Extension Period|study terminated by sponsor|17|||
124908716|NCT01636687|449292110|FG003|Extension Period|study terminated by sponsor|23|||
124908717|NCT01636687|449292111|FG004|Extension Period|study terminated by sponsor|0|||
124908718|NCT01636687|449292107|FG000|Extension Period|Withdrawal by Subject|1|||
124908719|NCT01636687|449292108|FG001|Extension Period|Withdrawal by Subject|0|||
124908720|NCT01636687|449292109|FG002|Extension Period|Withdrawal by Subject|1|||
124908721|NCT01636687|449292110|FG003|Extension Period|Withdrawal by Subject|1|||
124908722|NCT01636687|449292111|FG004|Extension Period|Withdrawal by Subject|0|||
124908723|NCT01636687|449292107|FG000|Follow-up Period|Withdrawal by Subject|1|||
124908724|NCT01636687|449292108|FG001|Follow-up Period|Withdrawal by Subject|0|||
124908725|NCT01636687|449292109|FG002|Follow-up Period|Withdrawal by Subject|0|||
124908726|NCT01636687|449292110|FG003|Follow-up Period|Withdrawal by Subject|0|||
124908727|NCT01636687|449292111|FG004|Follow-up Period|Withdrawal by Subject|1|||
124908728|NCT01254188|449292117|FG000|Overall Study|Disease Progression|6|||
124908729|NCT01254188|449292117|FG000|Overall Study|Protocol Violation|6|||
124908730|NCT01254188|449292117|FG000|Overall Study|Pregnancy|2|||
125211270|NCT01900431|450398643|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
125211271|NCT01900431|450398641|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
125211272|NCT01900431|450398642|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
125211273|NCT01900431|450398643|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
125211274|NCT01900431|450398641|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
124908731|NCT01254188|449292117|FG000|Overall Study|Death|4|||
124908732|NCT01254188|449292117|FG000|Overall Study|Lost to Follow-up|5|||
124908733|NCT01254188|449292117|FG000|Overall Study|Withdrawal by Subject|7|||
124908734|NCT01254188|449292117|FG000|Overall Study|Adverse Event|43|||
124908735|NCT01254188|449292117|FG000|Overall Study|per investigator discretion|20|||
124908736|NCT03482011|449292118|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
124908737|NCT03482011|449292119|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
124908738|NCT03482011|449292120|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
124908739|NCT03482011|449292121|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
124908740|NCT03482011|449292122|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
124908741|NCT03482011|449292123|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
124908742|NCT03482011|449292124|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
124908743|NCT03482011|449292125|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
124908744|NCT03482011|449292118|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
124908745|NCT03482011|449292119|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
124908746|NCT03482011|449292120|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124908747|NCT03482011|449292121|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124908748|NCT03482011|449292122|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124908749|NCT03482011|449292123|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124908750|NCT03482011|449292124|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124908751|NCT03482011|449292125|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124908752|NCT03482011|449292118|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
124908753|NCT03482011|449292119|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
124908754|NCT03482011|449292120|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
124908755|NCT03482011|449292121|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
124908756|NCT03482011|449292122|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
124908757|NCT03482011|449292123|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
124908758|NCT03482011|449292124|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
124908759|NCT03482011|449292125|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
124908760|NCT03482011|449292118|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
124908761|NCT03482011|449292119|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
124908762|NCT03482011|449292120|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
124908763|NCT03482011|449292121|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
124908764|NCT03482011|449292122|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
124908765|NCT03482011|449292123|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
124908766|NCT03482011|449292124|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
124908767|NCT03482011|449292125|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
124908768|NCT03482011|449292118|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
124908769|NCT03482011|449292119|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
124908770|NCT03482011|449292120|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124908771|NCT03482011|449292121|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124908772|NCT03482011|449292122|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124908773|NCT03482011|449292123|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124908774|NCT03482011|449292124|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124908775|NCT03482011|449292125|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124908776|NCT03482011|449292118|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
124908777|NCT03482011|449292119|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
124908778|NCT03482011|449292120|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
124908779|NCT03482011|449292121|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
124908780|NCT03482011|449292122|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
124908781|NCT03482011|449292123|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
124908782|NCT03482011|449292124|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
124908783|NCT03482011|449292125|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
124908784|NCT03482011|449292118|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
124908785|NCT03482011|449292119|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
124908786|NCT03482011|449292120|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
124908787|NCT03482011|449292121|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
124908788|NCT03482011|449292122|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
124908789|NCT03482011|449292123|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
124908790|NCT03482011|449292124|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
124908791|NCT03482011|449292125|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
124908792|NCT03482011|449292118|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124908793|NCT03482011|449292119|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124908794|NCT03482011|449292120|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124908795|NCT03482011|449292121|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124908796|NCT03482011|449292122|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
124908797|NCT03482011|449292123|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124908798|NCT03482011|449292124|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124908799|NCT03482011|449292125|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
124908800|NCT03482011|449292118|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
124908801|NCT03482011|449292119|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
124908802|NCT03482011|449292120|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
124908803|NCT03482011|449292121|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
124908804|NCT03482011|449292122|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
124908805|NCT03482011|449292123|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
124908806|NCT03482011|449292124|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
124908807|NCT03482011|449292125|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
124908808|NCT03482011|449292118|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124908809|NCT03482011|449292119|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124908810|NCT03482011|449292120|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124908811|NCT03482011|449292121|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
124908812|NCT03482011|449292122|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
124908813|NCT03482011|449292123|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
124908814|NCT03482011|449292124|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
124908815|NCT03482011|449292125|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
124908816|NCT03482011|449292118|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
125114964|NCT01698320|450044688|FG001|40-Week Open-Label Period|Adverse Event|3|||
125114965|NCT01698320|450044689|FG002|40-Week Open-Label Period|Adverse Event|2|||
125114966|NCT01698320|450044687|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
125114967|NCT01698320|450044688|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
125114968|NCT01698320|450044689|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
125114969|NCT01698320|450044687|FG000|40-Week Open-Label Period|Pregnancy|0|||
125114970|NCT01698320|450044688|FG001|40-Week Open-Label Period|Pregnancy|2|||
124908817|NCT03482011|449292119|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
124908818|NCT03482011|449292120|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
124908819|NCT03482011|449292121|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
125114971|NCT01698320|450044689|FG002|40-Week Open-Label Period|Pregnancy|1|||
125114972|NCT01698320|450044687|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
125114973|NCT01698320|450044688|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
125114974|NCT01698320|450044689|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
125114975|NCT01698320|450044687|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
125114976|NCT01698320|450044688|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
125114977|NCT01698320|450044689|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
125211275|NCT01900431|450398642|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
124908820|NCT03482011|449292122|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
124908821|NCT03482011|449292123|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
124908822|NCT03482011|449292124|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
124908823|NCT03482011|449292125|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
124908824|NCT03482011|449292118|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
124908825|NCT03482011|449292119|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
124908826|NCT03482011|449292120|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
124908827|NCT03482011|449292121|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
124908828|NCT03482011|449292122|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
124908829|NCT03482011|449292123|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
124908830|NCT03482011|449292124|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
124908831|NCT03482011|449292125|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
124908832|NCT03482011|449292118|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
124908833|NCT03482011|449292119|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
124908834|NCT03482011|449292120|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
124908835|NCT03482011|449292121|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
124908836|NCT03482011|449292122|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
124908837|NCT03482011|449292123|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
124908838|NCT03482011|449292124|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
124908839|NCT03482011|449292125|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
124908840|NCT03482011|449292118|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
124908841|NCT03482011|449292119|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
124908842|NCT03482011|449292120|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
124908843|NCT03482011|449292121|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
124908844|NCT03482011|449292122|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
124908845|NCT03482011|449292123|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
124908846|NCT03482011|449292124|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
124908847|NCT03482011|449292125|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
124908848|NCT03482011|449292118|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
124908849|NCT03482011|449292119|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
124908850|NCT03482011|449292120|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
124908851|NCT03482011|449292121|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
124908852|NCT03482011|449292122|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
124908853|NCT03482011|449292123|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
124908854|NCT03482011|449292124|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
124908855|NCT03482011|449292125|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
124908856|NCT05609032|449292135|FG000|Overall Study|Lost to Follow-up|3|||
124908857|NCT05609032|449292136|FG001|Overall Study|Lost to Follow-up|1|||
124908858|NCT05609032|449292135|FG000|Overall Study|Withdrawal by Subject|1|||
124908859|NCT05609032|449292136|FG001|Overall Study|Withdrawal by Subject|0|||
124908860|NCT02261467|449292137|FG000|Overall Study|Enrolled in Error|1|||
124908861|NCT02261467|449292138|FG001|Overall Study|Enrolled in Error|0|||
124908862|NCT02261467|449292137|FG000|Overall Study|Protocol Violation|0|||
124908863|NCT02261467|449292138|FG001|Overall Study|Protocol Violation|1|||
124908864|NCT02261467|449292137|FG000|Overall Study|Personal Reasons|17|||
124908865|NCT02261467|449292138|FG001|Overall Study|Personal Reasons|22|||
124908866|NCT02261467|449292137|FG000|Overall Study|Lost to Follow-up|2|||
125211276|NCT01900431|450398643|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
125211277|NCT01900431|450398641|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
124908867|NCT02261467|449292138|FG001|Overall Study|Lost to Follow-up|13|||
124908868|NCT02261467|449292137|FG000|Overall Study|Adverse Event|1|||
124908869|NCT02261467|449292138|FG001|Overall Study|Adverse Event|1|||
124908870|NCT00433199|449292142|FG000|Double-Blind Period|Adverse Event|0|||
124908871|NCT00433199|449292143|FG001|Double-Blind Period|Adverse Event|25|||
124908872|NCT00433199|449292142|FG000|Double-Blind Period|Lack of Efficacy|0|||
124908873|NCT00433199|449292143|FG001|Double-Blind Period|Lack of Efficacy|2|||
124908874|NCT00433199|449292142|FG000|Double-Blind Period|Lost to Follow-up|2|||
124908875|NCT00433199|449292143|FG001|Double-Blind Period|Lost to Follow-up|5|||
124908876|NCT00433199|449292142|FG000|Double-Blind Period|Withdrawal by Subject|8|||
125022073|NCT02217566|449705348|FG000|Overall Study|Lost to Follow-up|2|||
125022074|NCT02217566|449705348|FG000|Overall Study|Death|3|||
125022075|NCT02217566|449705348|FG000|Overall Study|Early study termination|6|||
125022076|NCT02296242|449705349|FG000|Overall Study|Death|1|||
125022077|NCT02296242|449705350|FG001|Overall Study|Death|1|||
125022078|NCT02296242|449705351|FG002|Overall Study|Death|1|||
125022079|NCT02296242|449705352|FG003|Overall Study|Death|1|||
125022080|NCT02296242|449705353|FG004|Overall Study|Death|1|||
125022081|NCT02296242|449705349|FG000|Overall Study|Withdrawal by Subject|0|||
125022082|NCT02296242|449705350|FG001|Overall Study|Withdrawal by Subject|0|||
125022083|NCT02296242|449705351|FG002|Overall Study|Withdrawal by Subject|1|||
125022084|NCT02296242|449705352|FG003|Overall Study|Withdrawal by Subject|1|||
125022085|NCT02296242|449705353|FG004|Overall Study|Withdrawal by Subject|3|||
125022086|NCT02296242|449705349|FG000|Overall Study|Disease Progression|1|||
124908877|NCT00433199|449292143|FG001|Double-Blind Period|Withdrawal by Subject|19|||
124908878|NCT00433199|449292142|FG000|Double-Blind Period|Protocol Violation|1|||
124908879|NCT00433199|449292143|FG001|Double-Blind Period|Protocol Violation|10|||
124908880|NCT00433199|449292142|FG000|Double-Blind Period|Administrative|1|||
124908881|NCT00433199|449292143|FG001|Double-Blind Period|Administrative|5|||
124908882|NCT00433199|449292142|FG000|Open-Label Period|Adverse Event|0|||
124908883|NCT00433199|449292143|FG001|Open-Label Period|Adverse Event|19|||
124908884|NCT00433199|449292142|FG000|Open-Label Period|Lack of Efficacy|0|||
124908885|NCT00433199|449292143|FG001|Open-Label Period|Lack of Efficacy|2|||
124908886|NCT00433199|449292142|FG000|Open-Label Period|Lost to Follow-up|0|||
124908887|NCT00433199|449292143|FG001|Open-Label Period|Lost to Follow-up|3|||
124908888|NCT00433199|449292142|FG000|Open-Label Period|Withdrawal by Subject|0|||
124908889|NCT00433199|449292143|FG001|Open-Label Period|Withdrawal by Subject|7|||
124908890|NCT00433199|449292142|FG000|Open-Label Period|Protocol Violation|0|||
124908891|NCT00433199|449292143|FG001|Open-Label Period|Protocol Violation|2|||
124908892|NCT00433199|449292142|FG000|Open-Label Period|Administrative|0|||
124908893|NCT00433199|449292143|FG001|Open-Label Period|Administrative|1|||
125114978|NCT01208402|450044694|FG000|Overall Study|Withdrawal by Subject|1|||
125114979|NCT01208402|450044695|FG001|Overall Study|Withdrawal by Subject|0|||
125114980|NCT03811249|450044696|FG000|Overall Study|Withdrawal by Subject|44|||
125114981|NCT03811249|450044696|FG000|Overall Study|Missed Visit|24|||
125114982|NCT00706706|450044697|FG000|Overall Study|Death|53|||
125114983|NCT00706706|450044697|FG000|Overall Study|Lost to Follow-up|7|||
124908900|NCT01170962|449292147|FG000|Treatment Period|Lack of Efficacy|96|||
124908901|NCT01170962|449292148|FG001|Treatment Period|Lack of Efficacy|91|||
124908902|NCT01170962|449292149|FG002|Treatment Period|Lack of Efficacy|7|||
124908903|NCT01170962|449292147|FG000|Treatment Period|Adverse Event|11|||
124908904|NCT01170962|449292148|FG001|Treatment Period|Adverse Event|12|||
124908905|NCT01170962|449292149|FG002|Treatment Period|Adverse Event|3|||
124908906|NCT01170962|449292147|FG000|Treatment Period|Withdrawal by Subject|2|||
124908907|NCT01170962|449292148|FG001|Treatment Period|Withdrawal by Subject|1|||
124908908|NCT01170962|449292149|FG002|Treatment Period|Withdrawal by Subject|0|||
124908909|NCT01170962|449292147|FG000|Treatment Period|Lost to Follow-up|1|||
124908910|NCT01170962|449292148|FG001|Treatment Period|Lost to Follow-up|1|||
124908911|NCT01170962|449292149|FG002|Treatment Period|Lost to Follow-up|1|||
124908912|NCT01170962|449292147|FG000|Treatment Period|Participant no longer meets criteria|0|||
124908913|NCT01170962|449292148|FG001|Treatment Period|Participant no longer meets criteria|1|||
124908914|NCT01170962|449292149|FG002|Treatment Period|Participant no longer meets criteria|0|||
124908915|NCT01170962|449292147|FG000|Treatment Period|Request to discontinue treatment|7|||
124908916|NCT01170962|449292148|FG001|Treatment Period|Request to discontinue treatment|3|||
124908917|NCT01170962|449292149|FG002|Treatment Period|Request to discontinue treatment|1|||
124908918|NCT01170962|449292147|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
124908919|NCT01170962|449292148|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
124908920|NCT01170962|449292149|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
124908921|NCT01170962|449292147|FG000|Follow up Period|Withdrawal by Subject|14|||
124908922|NCT01170962|449292148|FG001|Follow up Period|Withdrawal by Subject|10|||
124908923|NCT01170962|449292149|FG002|Follow up Period|Withdrawal by Subject|2|||
124908924|NCT01170962|449292147|FG000|Follow up Period|Lost to Follow-up|13|||
124908925|NCT01170962|449292148|FG001|Follow up Period|Lost to Follow-up|8|||
124908926|NCT01170962|449292149|FG002|Follow up Period|Lost to Follow-up|1|||
124908927|NCT01170962|449292147|FG000|Follow up Period|Death|2|||
124908928|NCT01170962|449292148|FG001|Follow up Period|Death|2|||
124908929|NCT01170962|449292149|FG002|Follow up Period|Death|0|||
125022087|NCT02296242|449705350|FG001|Overall Study|Disease Progression|3|||
125114984|NCT00706706|450044697|FG000|Overall Study|Study endpoint had reached|45|||
125114985|NCT02175966|450044702|FG000|Follow-up Period|Lack of Efficacy|10|||
125114986|NCT02175966|450044703|FG001|Follow-up Period|Lack of Efficacy|6|||
125114987|NCT01154153|450044704|FG000|Overall Study|Poor compliance to protocol|2|||
125114988|NCT01154153|450044705|FG001|Overall Study|Poor compliance to protocol|0|||
125114989|NCT01154153|450044704|FG000|Overall Study|Unable to use labs|2|||
125114990|NCT01154153|450044705|FG001|Overall Study|Unable to use labs|3|||
125114991|NCT01154153|450044704|FG000|Overall Study|Withdrew consent|1|||
125114992|NCT01154153|450044705|FG001|Overall Study|Withdrew consent|0|||
125114993|NCT00210626|450044706|FG000|Overall Study|Adverse Event|1|||
125114994|NCT00210626|450044707|FG001|Overall Study|Adverse Event|2|||
125114995|NCT00210626|450044706|FG000|Overall Study|Protocol Violation|1|||
125114996|NCT00210626|450044707|FG001|Overall Study|Protocol Violation|5|||
125114997|NCT00210626|450044706|FG000|Overall Study|Lost to Follow-up|11|||
125114998|NCT00210626|450044707|FG001|Overall Study|Lost to Follow-up|11|||
125114999|NCT00210626|450044706|FG000|Overall Study|Death|1|||
125115000|NCT00210626|450044707|FG001|Overall Study|Death|0|||
125115001|NCT00210626|450044706|FG000|Overall Study|Withdrawal by Subject|29|||
125115002|NCT00210626|450044707|FG001|Overall Study|Withdrawal by Subject|20|||
125115003|NCT00210626|450044706|FG000|Overall Study|Physician Decision|0|||
125115004|NCT00210626|450044707|FG001|Overall Study|Physician Decision|2|||
125115005|NCT00210626|450044706|FG000|Overall Study|Sponser Request|1|||
125115006|NCT00210626|450044707|FG001|Overall Study|Sponser Request|0|||
125115007|NCT00210626|450044706|FG000|Overall Study|Other|4|||
125115008|NCT00210626|450044707|FG001|Overall Study|Other|5|||
125115009|NCT01227668|450044708|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
125115010|NCT01227668|450044709|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
125115011|NCT01227668|450044708|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
125115012|NCT01227668|450044709|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
125115013|NCT01227668|450044708|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
125115014|NCT01227668|450044709|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
125115015|NCT01227668|450044708|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
124908930|NCT01170962|449292147|FG000|Follow up Period|Others|10|||
124908931|NCT01170962|449292148|FG001|Follow up Period|Others|7|||
124908932|NCT01170962|449292149|FG002|Follow up Period|Others|3|||
125022088|NCT02296242|449705351|FG002|Overall Study|Disease Progression|2|||
125022089|NCT02296242|449705352|FG003|Overall Study|Disease Progression|8|||
125022090|NCT02296242|449705353|FG004|Overall Study|Disease Progression|11|||
125022091|NCT02296242|449705349|FG000|Overall Study|Unacceptable Toxicity|0|||
125022092|NCT02296242|449705350|FG001|Overall Study|Unacceptable Toxicity|0|||
125022093|NCT02296242|449705351|FG002|Overall Study|Unacceptable Toxicity|0|||
125022094|NCT02296242|449705352|FG003|Overall Study|Unacceptable Toxicity|0|||
125022095|NCT02296242|449705353|FG004|Overall Study|Unacceptable Toxicity|1|||
125022096|NCT02296242|449705349|FG000|Overall Study|Patient Condition Changed|0|||
125022097|NCT02296242|449705350|FG001|Overall Study|Patient Condition Changed|0|||
124908933|NCT02407249|449293536|FG000|Overall Study|Did not complete 12-month follow-up|13|||
124908934|NCT02407249|449293536|FG000|Overall Study|Not treated|13|||
124908935|NCT01460446|449293539|FG000|Overall Study|Non-compliance|2|||
124908936|NCT01460446|449293540|FG001|Overall Study|Non-compliance|9|||
124908937|NCT01460446|449293539|FG000|Overall Study|Consent Withdrawn|0|||
124908938|NCT01460446|449293540|FG001|Overall Study|Consent Withdrawn|4|||
124908939|NCT01460446|449293539|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
124908940|NCT01460446|449293540|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
124908941|NCT01460446|449293539|FG000|Overall Study|Surgery/Illness|1|||
124908942|NCT01460446|449293540|FG001|Overall Study|Surgery/Illness|1|||
124908943|NCT01460446|449293539|FG000|Overall Study|Pregnancy|1|||
124908944|NCT01460446|449293540|FG001|Overall Study|Pregnancy|0|||
124908945|NCT01460446|449293539|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
124908946|NCT01460446|449293540|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
124908947|NCT00542789|449293541|FG000|Overall Study|Adverse Event|18|||
124908948|NCT00542789|449293542|FG001|Overall Study|Adverse Event|17|||
124908949|NCT00542789|449293541|FG000|Overall Study|Withdrawal by Subject|7|||
124908950|NCT00542789|449293542|FG001|Overall Study|Withdrawal by Subject|3|||
124908951|NCT00542789|449293541|FG000|Overall Study|Protocol Violation|8|||
124908952|NCT00542789|449293542|FG001|Overall Study|Protocol Violation|1|||
124908953|NCT00542789|449293541|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
124908954|NCT00542789|449293542|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
124908955|NCT00636207|449293545|FG000|Overall Study|Adverse Event|1|||
124908956|NCT00636207|449293546|FG001|Overall Study|Adverse Event|0|||
124908957|NCT00636207|449293547|FG002|Overall Study|Adverse Event|0|||
124908958|NCT00636207|449293548|FG003|Overall Study|Adverse Event|0|||
124908959|NCT00636207|449293549|FG004|Overall Study|Adverse Event|0|||
124908960|NCT00636207|449293550|FG005|Overall Study|Adverse Event|0|||
124908961|NCT00636207|449293551|FG006|Overall Study|Adverse Event|0|||
124908962|NCT00636207|449293545|FG000|Overall Study|Withdrawal by Subject|0|||
124908963|NCT00636207|449293546|FG001|Overall Study|Withdrawal by Subject|1|||
124908964|NCT00636207|449293547|FG002|Overall Study|Withdrawal by Subject|0|||
124908965|NCT00636207|449293548|FG003|Overall Study|Withdrawal by Subject|0|||
124908966|NCT00636207|449293549|FG004|Overall Study|Withdrawal by Subject|1|||
124908967|NCT00636207|449293550|FG005|Overall Study|Withdrawal by Subject|0|||
125022098|NCT02296242|449705351|FG002|Overall Study|Patient Condition Changed|2|||
125022099|NCT02296242|449705352|FG003|Overall Study|Patient Condition Changed|0|||
125022100|NCT02296242|449705353|FG004|Overall Study|Patient Condition Changed|1|||
125022101|NCT02296242|449705349|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
125022102|NCT02296242|449705350|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
125022103|NCT02296242|449705351|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
125022104|NCT02296242|449705352|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
125022105|NCT02296242|449705353|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
125022106|NCT02296242|449705349|FG000|Overall Study|Lost to Follow-up|1|||
125022107|NCT02296242|449705350|FG001|Overall Study|Lost to Follow-up|0|||
125022108|NCT02296242|449705351|FG002|Overall Study|Lost to Follow-up|0|||
125022109|NCT02296242|449705352|FG003|Overall Study|Lost to Follow-up|0|||
125022110|NCT02296242|449705353|FG004|Overall Study|Lost to Follow-up|0|||
125022111|NCT02296242|449705349|FG000|Overall Study|Need for Hydroxyurea|2|||
125022112|NCT02296242|449705350|FG001|Overall Study|Need for Hydroxyurea|0|||
125022113|NCT02296242|449705351|FG002|Overall Study|Need for Hydroxyurea|0|||
125022114|NCT02296242|449705352|FG003|Overall Study|Need for Hydroxyurea|0|||
125022115|NCT02296242|449705353|FG004|Overall Study|Need for Hydroxyurea|0|||
125022116|NCT02296242|449705349|FG000|Overall Study|Screened for Other Protocol|0|||
125022117|NCT02296242|449705350|FG001|Overall Study|Screened for Other Protocol|1|||
125022118|NCT02296242|449705351|FG002|Overall Study|Screened for Other Protocol|0|||
125022119|NCT02296242|449705352|FG003|Overall Study|Screened for Other Protocol|0|||
125022120|NCT02296242|449705353|FG004|Overall Study|Screened for Other Protocol|0|||
125022121|NCT02296242|449705349|FG000|Overall Study|Physician Decision|0|||
125022122|NCT02296242|449705350|FG001|Overall Study|Physician Decision|1|||
125022123|NCT02296242|449705351|FG002|Overall Study|Physician Decision|0|||
125022124|NCT02296242|449705352|FG003|Overall Study|Physician Decision|1|||
125022125|NCT02296242|449705353|FG004|Overall Study|Physician Decision|0|||
125022126|NCT02296242|449705349|FG000|Overall Study|Alternative Treatment|0|||
125022127|NCT02296242|449705350|FG001|Overall Study|Alternative Treatment|0|||
125022128|NCT02296242|449705351|FG002|Overall Study|Alternative Treatment|0|||
125022129|NCT02296242|449705352|FG003|Overall Study|Alternative Treatment|1|||
125022130|NCT02296242|449705353|FG004|Overall Study|Alternative Treatment|0|||
125022131|NCT02296242|449705349|FG000|Overall Study|Adverse Event|0|||
125022132|NCT02296242|449705350|FG001|Overall Study|Adverse Event|0|||
125022133|NCT02296242|449705351|FG002|Overall Study|Adverse Event|0|||
125022134|NCT02296242|449705352|FG003|Overall Study|Adverse Event|1|||
125022135|NCT02296242|449705353|FG004|Overall Study|Adverse Event|0|||
125022136|NCT02296242|449705349|FG000|Overall Study|Lack of Efficacy|0|||
125022137|NCT02296242|449705350|FG001|Overall Study|Lack of Efficacy|0|||
125022138|NCT02296242|449705351|FG002|Overall Study|Lack of Efficacy|0|||
125022139|NCT02296242|449705352|FG003|Overall Study|Lack of Efficacy|0|||
124908968|NCT00636207|449293551|FG006|Overall Study|Withdrawal by Subject|0|||
124908969|NCT01641198|449293554|FG000|After 12 Months of Function|Lost to Follow-up|3|||
124908970|NCT01641198|449293555|FG001|After 12 Months of Function|Lost to Follow-up|2|||
124908971|NCT01641198|449293556|FG002|After 12 Months of Function|Lost to Follow-up|2|||
124908972|NCT01641198|449293554|FG000|After 12 Months of Function|Protocol Violation|1|||
124908973|NCT01641198|449293555|FG001|After 12 Months of Function|Protocol Violation|0|||
124908974|NCT01641198|449293556|FG002|After 12 Months of Function|Protocol Violation|0|||
124908975|NCT01641198|449293554|FG000|After 12 Months of Function|Adverse Event|0|||
124908976|NCT01641198|449293555|FG001|After 12 Months of Function|Adverse Event|1|||
124908977|NCT01641198|449293556|FG002|After 12 Months of Function|Adverse Event|0|||
124908978|NCT01641198|449293554|FG000|After 24 Months of Function|Lost to Follow-up|4|||
124908979|NCT01641198|449293555|FG001|After 24 Months of Function|Lost to Follow-up|9|||
124908980|NCT01641198|449293556|FG002|After 24 Months of Function|Lost to Follow-up|6|||
124908981|NCT01641198|449293554|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
124908982|NCT01641198|449293555|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
124908983|NCT01641198|449293556|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
124908984|NCT01641198|449293554|FG000|At 15-20 Years of Function|Death|1|||
124908985|NCT01641198|449293555|FG001|At 15-20 Years of Function|Death|0|||
124908986|NCT01641198|449293556|FG002|At 15-20 Years of Function|Death|1|||
124908987|NCT02594735|449293558|FG000|Overall Study|Adverse Event|1|||
124908988|NCT02529995|449293559|FG000|Part A|Ongoing Study at Data Cut-off|14|||
124908989|NCT02529995|449293560|FG001|Part A|Ongoing Study at Data Cut-off|16|||
124908990|NCT02529995|449293559|FG000|Part A|Discontinued Study|1|||
124908991|NCT02529995|449293560|FG001|Part A|Discontinued Study|0|||
124908992|NCT02529995|449293559|FG000|Part B|Ongoing Study at Data Cut-off|0|||
124908993|NCT02529995|449293560|FG001|Part B|Ongoing Study at Data Cut-off|7|||
124908994|NCT02529995|449293559|FG000|Part B|Discontinued Study|6|||
124908995|NCT02529995|449293560|FG001|Part B|Discontinued Study|5|||
124908996|NCT01075217|449293564|FG000|Overall Study|Adverse Event|1|||
124908997|NCT01075217|449293565|FG001|Overall Study|Adverse Event|1|||
125211278|NCT01900431|450398642|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
125211279|NCT01900431|450398643|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
125211280|NCT01900431|450398641|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
124908998|NCT01075217|449293564|FG000|Overall Study|Physician Decision|1|||
124908999|NCT01075217|449293565|FG001|Overall Study|Physician Decision|0|||
124909000|NCT02969863|449293566|FG000|Overall Study|Physician Decision|1|||
124909001|NCT02969863|449293567|FG001|Overall Study|Physician Decision|0|||
124909002|NCT02969863|449293568|FG002|Overall Study|Physician Decision|0|||
124909003|NCT02969863|449293569|FG003|Overall Study|Physician Decision|0|||
124909004|NCT02969863|449293570|FG004|Overall Study|Physician Decision|0|||
124909005|NCT02969863|449293571|FG005|Overall Study|Physician Decision|0|||
124909006|NCT03737240|449293572|FG000|Overall Study|Lost to Follow-up|16|||
124909007|NCT03737240|449293573|FG001|Overall Study|Lost to Follow-up|15|||
124909008|NCT01068743|449293574|FG000|Period 3|Adverse Event|0|||
124909009|NCT01068743|449293575|FG001|Period 3|Adverse Event|1|||
124909010|NCT01068743|449293576|FG002|Period 3|Adverse Event|0|||
124909011|NCT01068743|449293577|FG003|Period 3|Adverse Event|0|||
124909012|NCT00364013|449293578|FG000|Overall Study|Ineligibility determined|4|||
124909013|NCT00364013|449293579|FG001|Overall Study|Ineligibility determined|2|||
124909014|NCT00364013|449293578|FG000|Overall Study|Adverse Event|4|||
124909015|NCT00364013|449293579|FG001|Overall Study|Adverse Event|3|||
124909016|NCT00364013|449293578|FG000|Overall Study|Withdrawal by Subject|13|||
124909017|NCT00364013|449293579|FG001|Overall Study|Withdrawal by Subject|18|||
124909018|NCT00364013|449293578|FG000|Overall Study|Physician Decision|3|||
124909019|NCT00364013|449293579|FG001|Overall Study|Physician Decision|3|||
124909020|NCT00364013|449293578|FG000|Overall Study|Lost to Follow-up|10|||
124909021|NCT00364013|449293579|FG001|Overall Study|Lost to Follow-up|3|||
124909022|NCT00364013|449293578|FG000|Overall Study|Protocol-specified criteria|6|||
124909023|NCT00364013|449293579|FG001|Overall Study|Protocol-specified criteria|6|||
125022140|NCT02296242|449705353|FG004|Overall Study|Lack of Efficacy|3|||
125022141|NCT04029519|449705358|FG000|Overall Study|Protocol Violation|1|||
125022142|NCT04029519|449705358|FG000|Overall Study|Withdrawal by Subject|3|||
124909024|NCT00364013|449293578|FG000|Overall Study|Other|41|||
124909025|NCT00364013|449293579|FG001|Overall Study|Other|47|||
125022143|NCT04029519|449705358|FG000|Overall Study|Lost to Follow-up|1|||
125022144|NCT02706730|449705359|FG000|Overall Study|Adverse Event|3|||
125022145|NCT02706730|449705359|FG000|Overall Study|Lack of Efficacy|5|||
125022146|NCT02706730|449705359|FG000|Overall Study|Withdrawal by Subject|11|||
124909026|NCT00364013|449293578|FG000|Overall Study|Ongoing|20|||
124909027|NCT00364013|449293579|FG001|Overall Study|Ongoing|13|||
125022147|NCT02706730|449705359|FG000|Overall Study|Study Terminated by Sponsor|11|||
125022148|NCT02706730|449705359|FG000|Overall Study|Subject chose not to receive injection|3|||
124909028|NCT00585533|449293581|FG000|Overall Study|objective or symptomatic progression|9|||
125022149|NCT02064387|449705360|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
125022150|NCT02064387|449705361|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
125022151|NCT02064387|449705362|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
124909029|NCT01369498|449293583|FG000|Overall Study|Lack of Efficacy|9|||
124909030|NCT01369498|449293584|FG001|Overall Study|Lack of Efficacy|9|||
124909031|NCT01369498|449293585|FG002|Overall Study|Lack of Efficacy|1|||
124909032|NCT01369498|449293586|FG003|Overall Study|Lack of Efficacy|3|||
124909033|NCT01369498|449293583|FG000|Overall Study|Adverse Event|1|||
124909034|NCT01369498|449293584|FG001|Overall Study|Adverse Event|2|||
124909035|NCT01369498|449293585|FG002|Overall Study|Adverse Event|0|||
124909036|NCT01369498|449293586|FG003|Overall Study|Adverse Event|1|||
124909037|NCT01369498|449293583|FG000|Overall Study|Withdrawal of Consent|0|||
124909038|NCT01369498|449293584|FG001|Overall Study|Withdrawal of Consent|1|||
124909039|NCT01369498|449293585|FG002|Overall Study|Withdrawal of Consent|1|||
124909040|NCT01369498|449293586|FG003|Overall Study|Withdrawal of Consent|1|||
124909041|NCT01369498|449293583|FG000|Overall Study|Death|0|||
124909042|NCT01369498|449293584|FG001|Overall Study|Death|0|||
124909043|NCT01369498|449293585|FG002|Overall Study|Death|1|||
124909044|NCT01369498|449293586|FG003|Overall Study|Death|0|||
124909045|NCT01369498|449293583|FG000|Overall Study|Investigator's Discretion|1|||
124909046|NCT01369498|449293584|FG001|Overall Study|Investigator's Discretion|0|||
124909047|NCT01369498|449293585|FG002|Overall Study|Investigator's Discretion|1|||
124909048|NCT01369498|449293586|FG003|Overall Study|Investigator's Discretion|3|||
124909049|NCT01369498|449293583|FG000|Overall Study|Unknown Reason|1|||
124909050|NCT01369498|449293584|FG001|Overall Study|Unknown Reason|0|||
124909051|NCT01369498|449293585|FG002|Overall Study|Unknown Reason|11|||
124909052|NCT01369498|449293586|FG003|Overall Study|Unknown Reason|6|||
124909053|NCT01369498|449293583|FG000|Overall Study|Disease Progression|0|||
124909054|NCT01369498|449293584|FG001|Overall Study|Disease Progression|0|||
124909055|NCT01369498|449293585|FG002|Overall Study|Disease Progression|0|||
124909056|NCT01369498|449293586|FG003|Overall Study|Disease Progression|1|||
124909057|NCT01236001|449293589|FG000|Overall Study|Adverse Event|5|||
124909058|NCT01236001|449293590|FG001|Overall Study|Adverse Event|14|||
124909059|NCT01236001|449293589|FG000|Overall Study|Lack of Efficacy|6|||
124909060|NCT01236001|449293590|FG001|Overall Study|Lack of Efficacy|6|||
124909061|NCT01236001|449293589|FG000|Overall Study|Lost to Follow-up|6|||
124909062|NCT01236001|449293590|FG001|Overall Study|Lost to Follow-up|1|||
124909063|NCT01236001|449293589|FG000|Overall Study|Incompliance|1|||
124909064|NCT01236001|449293590|FG001|Overall Study|Incompliance|0|||
124909065|NCT01236001|449293589|FG000|Overall Study|Planned Visit After End of Study|0|||
124909066|NCT01236001|449293590|FG001|Overall Study|Planned Visit After End of Study|1|||
124909067|NCT02538107|449293592|FG000|Overall Study|Did not receive any Mircera dose|11|||
124909068|NCT02538107|449293592|FG000|Overall Study|Missing|5|||
124909069|NCT02538107|449293592|FG000|Overall Study|Necessity of dialysis|20|||
124909070|NCT02538107|449293592|FG000|Overall Study|Administration of other ESA|11|||
124909071|NCT02538107|449293592|FG000|Overall Study|No further treatment necessary|18|||
124909072|NCT02538107|449293592|FG000|Overall Study|Withdrawal by Subject|17|||
124909073|NCT02538107|449293592|FG000|Overall Study|Death|4|||
124909074|NCT02538107|449293592|FG000|Overall Study|Administrative reason|5|||
124909075|NCT02538107|449293592|FG000|Overall Study|Adverse Event|4|||
124909076|NCT02538107|449293592|FG000|Overall Study|Surgery|1|||
124909077|NCT02538107|449293592|FG000|Overall Study|Other|7|||
124909078|NCT02538107|449293592|FG000|Overall Study|Not recorded|7|||
125115016|NCT01227668|450044709|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
124909079|NCT01943916|449293593|FG000|Overall Study|Technically invalid images|10|||
125115017|NCT01227668|450044708|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
125115018|NCT01227668|450044709|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
125115019|NCT01227668|450044708|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
125115020|NCT01227668|450044709|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
125115021|NCT01227668|450044708|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
125115022|NCT01227668|450044709|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
125115023|NCT01227668|450044708|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
125115024|NCT01227668|450044709|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
124909080|NCT01943916|449293593|FG000|Overall Study|Enrollment Failure|23|||
124909081|NCT01943916|449293593|FG000|Overall Study|Pilot Phase exclusion|100|||
125115025|NCT01227668|450044708|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
125115026|NCT01227668|450044709|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
125115027|NCT01227668|450044708|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
125115028|NCT01227668|450044709|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
125115029|NCT01227668|450044708|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
124909082|NCT01943916|449293593|FG000|Overall Study|Quality Assurance Reader Fail|130|||
124909083|NCT01943916|449293593|FG000|Overall Study|Technical Failure|39|||
124909084|NCT01943916|449293593|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
124909085|NCT01943916|449293593|FG000|Overall Study|No Truth Panel Review|38|||
124909086|NCT01943916|449293593|FG000|Overall Study|Protocol Deviation|1|||
124909087|NCT05782231|449293594|FG000|Overall Study|Withdrawal by Subject|1|||
124909088|NCT05274217|449293595|FG000|Overall Study|Study terminated.|11|||
124909089|NCT05274217|449293596|FG001|Overall Study|Study terminated.|0|||
124909090|NCT01373346|449293601|FG000|Overall Study|Death|1|||
124909091|NCT01395758|449293602|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
124909092|NCT01395758|449293603|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
124909093|NCT01395758|449293604|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
124909094|NCT00357097|449293605|FG000|Overall Study|Did not meet inclusion criteria|5|||
124909095|NCT00357097|449293606|FG001|Overall Study|Did not meet inclusion criteria|3|||
124909096|NCT00357097|449293605|FG000|Overall Study|Adverse Event|34|||
124909097|NCT00357097|449293606|FG001|Overall Study|Adverse Event|6|||
124909098|NCT00357097|449293605|FG000|Overall Study|Withdrawal by Subject|8|||
124909099|NCT00357097|449293606|FG001|Overall Study|Withdrawal by Subject|7|||
124909100|NCT00357097|449293605|FG000|Overall Study|Non-compliance|1|||
124909101|NCT00357097|449293606|FG001|Overall Study|Non-compliance|2|||
124909102|NCT00357097|449293605|FG000|Overall Study|Lack of Efficacy|2|||
124909103|NCT00357097|449293606|FG001|Overall Study|Lack of Efficacy|8|||
124909104|NCT00357097|449293605|FG000|Overall Study|Met Exclusion Criteria|3|||
124909105|NCT00357097|449293606|FG001|Overall Study|Met Exclusion Criteria|1|||
124909106|NCT00357097|449293605|FG000|Overall Study|Other|1|||
124909107|NCT00357097|449293606|FG001|Overall Study|Other|1|||
124909108|NCT00357097|449293605|FG000|Overall Study|Increase of RLS Symptoms|0|||
124909109|NCT00357097|449293606|FG001|Overall Study|Increase of RLS Symptoms|1|||
124909110|NCT00794118|449293607|FG000|Overall Study|Lost to Follow-up|16|||
124909111|NCT00794118|449293607|FG000|Overall Study|Withdrawal by Subject|9|||
124909112|NCT00794118|449293607|FG000|Overall Study|Changed hospital center|2|||
124909113|NCT04305405|449293608|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124909114|NCT04305405|449293609|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124909115|NCT02528188|449293610|FG000|Overall Study|Adverse Event|23|||
124909116|NCT02528188|449293611|FG001|Overall Study|Adverse Event|22|||
124909117|NCT02528188|449293612|FG002|Overall Study|Adverse Event|8|||
124909118|NCT02528188|449293610|FG000|Overall Study|Protocol Violation|4|||
124909119|NCT02528188|449293611|FG001|Overall Study|Protocol Violation|6|||
124909120|NCT02528188|449293612|FG002|Overall Study|Protocol Violation|4|||
124909121|NCT02528188|449293610|FG000|Overall Study|Lack of Efficacy|19|||
124909122|NCT02528188|449293611|FG001|Overall Study|Lack of Efficacy|21|||
124909123|NCT02528188|449293612|FG002|Overall Study|Lack of Efficacy|22|||
124909124|NCT02528188|449293610|FG000|Overall Study|Withdrawal by Subject|97|||
124909125|NCT02528188|449293611|FG001|Overall Study|Withdrawal by Subject|104|||
124909126|NCT02528188|449293612|FG002|Overall Study|Withdrawal by Subject|100|||
124909127|NCT02528188|449293610|FG000|Overall Study|Lost to Follow-up|25|||
124909128|NCT02528188|449293611|FG001|Overall Study|Lost to Follow-up|21|||
124909129|NCT02528188|449293612|FG002|Overall Study|Lost to Follow-up|31|||
124909130|NCT02528188|449293610|FG000|Overall Study|Death|4|||
124909131|NCT02528188|449293611|FG001|Overall Study|Death|4|||
124909132|NCT02528188|449293612|FG002|Overall Study|Death|0|||
124909133|NCT02528188|449293610|FG000|Overall Study|Other|89|||
124909134|NCT02528188|449293611|FG001|Overall Study|Other|91|||
124909135|NCT02528188|449293612|FG002|Overall Study|Other|74|||
124909136|NCT02528188|449293610|FG000|Overall Study|Randomized but not treated|6|||
124909137|NCT02528188|449293611|FG001|Overall Study|Randomized but not treated|7|||
124909138|NCT02528188|449293612|FG002|Overall Study|Randomized but not treated|12|||
124909139|NCT00529659|449293613|FG000|Overall Study|Adverse Event|8|||
124909140|NCT00529659|449293614|FG001|Overall Study|Adverse Event|7|||
124909141|NCT00529659|449293613|FG000|Overall Study|Lost to Follow-up|0|||
124909142|NCT00529659|449293614|FG001|Overall Study|Lost to Follow-up|2|||
124909143|NCT00529659|449293613|FG000|Overall Study|Physician Decision|0|||
124909144|NCT00529659|449293614|FG001|Overall Study|Physician Decision|2|||
124909145|NCT00529659|449293613|FG000|Overall Study|Protocol Violation|2|||
124909146|NCT00529659|449293614|FG001|Overall Study|Protocol Violation|6|||
124909147|NCT00529659|449293613|FG000|Overall Study|Withdrawal by Subject|1|||
124909148|NCT00529659|449293614|FG001|Overall Study|Withdrawal by Subject|6|||
124909149|NCT03887650|449293615|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
124909150|NCT03887650|449293616|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
124909151|NCT03887650|449293615|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
124909152|NCT03887650|449293616|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
125115030|NCT01227668|450044709|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
125115031|NCT01227668|450044708|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
124909153|NCT03887650|449293615|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
124909154|NCT03887650|449293616|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
125115032|NCT01227668|450044709|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
125115033|NCT02473510|450044710|FG000|Overall Study|Lost to Follow-up|1|||
124909155|NCT03512756|449293621|FG000|Part 1|Death|23|||
124909156|NCT03512756|449293622|FG001|Part 1|Death|18|||
124909157|NCT03512756|449293623|FG002|Part 1|Death|0|||
125115034|NCT02473510|450044711|FG001|Overall Study|Lost to Follow-up|2|||
124909158|NCT03512756|449293624|FG003|Part 1|Death|0|||
124909159|NCT03512756|449293621|FG000|Part 1|Lost to Follow-up|0|||
124909160|NCT03512756|449293622|FG001|Part 1|Lost to Follow-up|3|||
124909161|NCT03512756|449293623|FG002|Part 1|Lost to Follow-up|0|||
124909162|NCT03512756|449293624|FG003|Part 1|Lost to Follow-up|0|||
124909163|NCT03512756|449293621|FG000|Part 1|Physician Decision|0|||
124909164|NCT03512756|449293622|FG001|Part 1|Physician Decision|1|||
124909165|NCT03512756|449293623|FG002|Part 1|Physician Decision|0|||
124909166|NCT03512756|449293624|FG003|Part 1|Physician Decision|0|||
124909167|NCT03512756|449293621|FG000|Part 1|Withdrawal by Subject|2|||
124909168|NCT03512756|449293622|FG001|Part 1|Withdrawal by Subject|2|||
124909169|NCT03512756|449293623|FG002|Part 1|Withdrawal by Subject|0|||
124909170|NCT03512756|449293624|FG003|Part 1|Withdrawal by Subject|0|||
124909171|NCT03512756|449293621|FG000|Part 2|Death|0|||
124909172|NCT03512756|449293622|FG001|Part 2|Death|0|||
124909173|NCT03512756|449293623|FG002|Part 2|Death|32|||
124909174|NCT03512756|449293624|FG003|Part 2|Death|21|||
124909175|NCT03512756|449293621|FG000|Part 2|Lost to Follow-up|0|||
124909176|NCT03512756|449293622|FG001|Part 2|Lost to Follow-up|0|||
124909177|NCT03512756|449293623|FG002|Part 2|Lost to Follow-up|1|||
124909178|NCT03512756|449293624|FG003|Part 2|Lost to Follow-up|0|||
124909179|NCT03512756|449293621|FG000|Part 2|Physician Decision|0|||
124909180|NCT03512756|449293622|FG001|Part 2|Physician Decision|0|||
124909181|NCT03512756|449293623|FG002|Part 2|Physician Decision|2|||
124909182|NCT03512756|449293624|FG003|Part 2|Physician Decision|4|||
124909183|NCT03512756|449293621|FG000|Part 2|Study Terminated by Sponsor|0|||
124909184|NCT03512756|449293622|FG001|Part 2|Study Terminated by Sponsor|0|||
124909185|NCT03512756|449293623|FG002|Part 2|Study Terminated by Sponsor|2|||
124909186|NCT03512756|449293624|FG003|Part 2|Study Terminated by Sponsor|6|||
124909187|NCT03512756|449293621|FG000|Part 2|Protocol Violation|0|||
124909188|NCT03512756|449293622|FG001|Part 2|Protocol Violation|0|||
124909189|NCT03512756|449293623|FG002|Part 2|Protocol Violation|1|||
124909190|NCT03512756|449293624|FG003|Part 2|Protocol Violation|0|||
124909191|NCT03512756|449293621|FG000|Part 2|Withdrawal by Subject|0|||
124909192|NCT03512756|449293622|FG001|Part 2|Withdrawal by Subject|0|||
124909193|NCT03512756|449293623|FG002|Part 2|Withdrawal by Subject|3|||
124909194|NCT03512756|449293624|FG003|Part 2|Withdrawal by Subject|9|||
124909195|NCT00736853|449293625|FG000|Open-Label Period|Physician Decision|2|||
124909196|NCT00736853|449293626|FG001|Open-Label Period|Physician Decision|0|||
124909197|NCT00736853|449293627|FG002|Open-Label Period|Physician Decision|0|||
124909198|NCT00736853|449293625|FG000|Open-Label Period|Adverse Event|31|||
124909199|NCT00736853|449293626|FG001|Open-Label Period|Adverse Event|0|||
124909200|NCT00736853|449293627|FG002|Open-Label Period|Adverse Event|0|||
124909201|NCT00736853|449293625|FG000|Open-Label Period|Withdrawal by Subject|16|||
124909202|NCT00736853|449293626|FG001|Open-Label Period|Withdrawal by Subject|0|||
124909203|NCT00736853|449293627|FG002|Open-Label Period|Withdrawal by Subject|0|||
124909204|NCT00736853|449293625|FG000|Open-Label Period|Started but not treated|42|||
124909205|NCT00736853|449293626|FG001|Open-Label Period|Started but not treated|0|||
124909206|NCT00736853|449293627|FG002|Open-Label Period|Started but not treated|0|||
124909207|NCT00736853|449293625|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
124909208|NCT00736853|449293626|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
124909209|NCT00736853|449293627|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
125022152|NCT02064387|449705363|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
125022153|NCT02064387|449705364|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
125022154|NCT02064387|449705365|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
125022155|NCT02064387|449705366|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
125022156|NCT02064387|449705367|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
125022157|NCT02064387|449705368|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
125115035|NCT01306253|450044712|FG000|Overall Study|Lost to Follow-up|1|||
125115036|NCT01306253|450044713|FG001|Overall Study|Lost to Follow-up|1|||
125115037|NCT02280356|450044717|FG000|Overall Study|Not Treated|2|||
125115038|NCT02280356|450044717|FG000|Overall Study|Withdrawal by Subject|1|||
125115039|NCT02280356|450044717|FG000|Overall Study|Not evaluable|2|||
125115040|NCT01086215|450044718|FG000|Overall Study|Death|14|||
125115041|NCT01086215|450044719|FG001|Overall Study|Death|8|||
125115042|NCT01086215|450044720|FG002|Overall Study|Death|8|||
125115043|NCT01086215|450044721|FG003|Overall Study|Death|1|||
125115044|NCT01086215|450044718|FG000|Overall Study|Lost to Follow-up|22|||
125115045|NCT01086215|450044719|FG001|Overall Study|Lost to Follow-up|39|||
125022158|NCT02064387|449705369|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
125022159|NCT02064387|449705370|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
125022160|NCT02064387|449705371|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
125022161|NCT02064387|449705360|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125022162|NCT02064387|449705361|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125115046|NCT01086215|450044720|FG002|Overall Study|Lost to Follow-up|18|||
125115047|NCT01086215|450044721|FG003|Overall Study|Lost to Follow-up|2|||
125115048|NCT03361956|450044724|FG000|Overall Study|Adverse Event|1|||
124909210|NCT00736853|449293625|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
124909211|NCT00736853|449293626|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
124909212|NCT00736853|449293627|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
124909213|NCT00736853|449293625|FG000|Double-Blind Period|Lack of Efficacy|0|||
124909214|NCT00736853|449293626|FG001|Double-Blind Period|Lack of Efficacy|19|||
124909215|NCT00736853|449293627|FG002|Double-Blind Period|Lack of Efficacy|42|||
124909216|NCT00736853|449293625|FG000|Double-Blind Period|Adverse Event|0|||
124909217|NCT00736853|449293626|FG001|Double-Blind Period|Adverse Event|3|||
124909218|NCT00736853|449293627|FG002|Double-Blind Period|Adverse Event|2|||
124909219|NCT00736853|449293625|FG000|Double-Blind Period|Withdrawal by Subject|0|||
124909220|NCT00736853|449293626|FG001|Double-Blind Period|Withdrawal by Subject|1|||
125022163|NCT02064387|449705362|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125115049|NCT03361956|450044725|FG001|Overall Study|Adverse Event|0|||
124909221|NCT00736853|449293627|FG002|Double-Blind Period|Withdrawal by Subject|4|||
124909222|NCT00736853|449293625|FG000|Double-Blind Period|Ineligible to participate the study|0|||
124909223|NCT00736853|449293626|FG001|Double-Blind Period|Ineligible to participate the study|1|||
124909224|NCT00736853|449293627|FG002|Double-Blind Period|Ineligible to participate the study|0|||
124909225|NCT01199705|449293628|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
124909226|NCT01764464|449293633|FG000|First Intervention|Withdrawal by Subject|1|||
124909227|NCT01764464|449293634|FG001|First Intervention|Withdrawal by Subject|0|||
124909228|NCT01764464|449293633|FG000|First Intervention|Lost to Follow-up|1|||
124909229|NCT01764464|449293634|FG001|First Intervention|Lost to Follow-up|0|||
124909230|NCT01764464|449293633|FG000|First Intervention|Adverse Event|0|||
124909231|NCT01764464|449293634|FG001|First Intervention|Adverse Event|2|||
124909232|NCT01764464|449293633|FG000|First Intervention|did not receive study drug|0|||
124909233|NCT01764464|449293634|FG001|First Intervention|did not receive study drug|1|||
124909234|NCT01764464|449293633|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
124909235|NCT01764464|449293634|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
124909236|NCT03215927|449295530|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
124909237|NCT03215927|449295531|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
124909238|NCT03215927|449295530|FG000|Open Label Extension|Adverse Event|1|||
124909239|NCT03215927|449295531|FG001|Open Label Extension|Adverse Event|0|||
124909240|NCT03215927|449295530|FG000|Open Label Extension|Lack of Efficacy|1|||
124909241|NCT03215927|449295531|FG001|Open Label Extension|Lack of Efficacy|0|||
124909242|NCT03215927|449295530|FG000|Open Label Extension|Death|0|||
124909243|NCT03215927|449295531|FG001|Open Label Extension|Death|1|||
124909244|NCT03889925|449295534|FG000|Overall Study|Lost to Follow-up|11|||
124909245|NCT03889925|449295535|FG001|Overall Study|Lost to Follow-up|10|||
124909246|NCT03073941|449295536|FG000|Overall Study|Received non-study device intraoperatively|0|||
124909247|NCT03073941|449295537|FG001|Overall Study|Received non-study device intraoperatively|2|||
124909248|NCT03073941|449295536|FG000|Overall Study|Death|1|||
124909249|NCT03073941|449295537|FG001|Overall Study|Death|0|||
124909250|NCT03073941|449295536|FG000|Overall Study|Withdrawal by Subject|1|||
124909251|NCT03073941|449295537|FG001|Overall Study|Withdrawal by Subject|3|||
124909252|NCT03073941|449295536|FG000|Overall Study|Lost to Follow-up|5|||
124909253|NCT03073941|449295537|FG001|Overall Study|Lost to Follow-up|4|||
124909254|NCT03073941|449295536|FG000|Overall Study|Adverse Event|4|||
124909255|NCT03073941|449295537|FG001|Overall Study|Adverse Event|2|||
124909256|NCT03073941|449295536|FG000|Overall Study|Met an exclusion criterion|0|||
124909257|NCT03073941|449295537|FG001|Overall Study|Met an exclusion criterion|1|||
124909258|NCT04250883|449295538|FG000|Overall Study|Lost to Follow-up|1|||
124909259|NCT04250883|449295539|FG001|Overall Study|Lost to Follow-up|0|||
124909260|NCT01823536|449295546|FG000|Overall Study|Lost to Follow-up|1|||
124909261|NCT01823536|449295547|FG001|Overall Study|Lost to Follow-up|0|||
124909262|NCT01823536|449295548|FG002|Overall Study|Lost to Follow-up|0|||
124909263|NCT01823536|449295549|FG003|Overall Study|Lost to Follow-up|1|||
124909264|NCT01823536|449295550|FG004|Overall Study|Lost to Follow-up|1|||
124909265|NCT01823536|449295551|FG005|Overall Study|Lost to Follow-up|0|||
124909266|NCT01823536|449295546|FG000|Overall Study|Protocol Violation|0|||
124909267|NCT01823536|449295547|FG001|Overall Study|Protocol Violation|1|||
124909268|NCT01823536|449295548|FG002|Overall Study|Protocol Violation|0|||
124909269|NCT01823536|449295549|FG003|Overall Study|Protocol Violation|0|||
124909270|NCT01823536|449295550|FG004|Overall Study|Protocol Violation|0|||
124909271|NCT01823536|449295551|FG005|Overall Study|Protocol Violation|0|||
124909272|NCT01823536|449295546|FG000|Overall Study|Withdrawal by Subject|1|||
124909273|NCT01823536|449295547|FG001|Overall Study|Withdrawal by Subject|1|||
124909274|NCT01823536|449295548|FG002|Overall Study|Withdrawal by Subject|0|||
124909275|NCT01823536|449295549|FG003|Overall Study|Withdrawal by Subject|0|||
124909276|NCT01823536|449295550|FG004|Overall Study|Withdrawal by Subject|0|||
124909277|NCT01823536|449295551|FG005|Overall Study|Withdrawal by Subject|0|||
124909278|NCT01823536|449295546|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
125115050|NCT03361956|450044726|FG002|Overall Study|Adverse Event|1|||
124909279|NCT01823536|449295547|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
124909280|NCT01823536|449295548|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
124909281|NCT01823536|449295549|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
124909282|NCT01823536|449295550|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
124909283|NCT01823536|449295551|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
124909284|NCT01823536|449295546|FG000|Overall Study|Met exclusion criterion No 6|0|||
124909285|NCT01823536|449295547|FG001|Overall Study|Met exclusion criterion No 6|0|||
124909286|NCT01823536|449295548|FG002|Overall Study|Met exclusion criterion No 6|0|||
124909287|NCT01823536|449295549|FG003|Overall Study|Met exclusion criterion No 6|1|||
124909288|NCT01823536|449295550|FG004|Overall Study|Met exclusion criterion No 6|0|||
124909289|NCT01823536|449295551|FG005|Overall Study|Met exclusion criterion No 6|0|||
124909290|NCT01823536|449295546|FG000|Overall Study|Subject moved out of the state|0|||
124909291|NCT01823536|449295547|FG001|Overall Study|Subject moved out of the state|0|||
124909292|NCT01823536|449295548|FG002|Overall Study|Subject moved out of the state|0|||
124909293|NCT01823536|449295549|FG003|Overall Study|Subject moved out of the state|0|||
124909294|NCT01823536|449295550|FG004|Overall Study|Subject moved out of the state|1|||
124909295|NCT01823536|449295551|FG005|Overall Study|Subject moved out of the state|0|||
124909296|NCT04425629|449295552|FG000|Overall Study|Adverse Event|0|||
124909297|NCT04425629|449295553|FG001|Overall Study|Adverse Event|0|||
124909298|NCT04425629|449295554|FG002|Overall Study|Adverse Event|0|||
124909299|NCT04425629|449295555|FG003|Overall Study|Adverse Event|0|||
124909300|NCT04425629|449295556|FG004|Overall Study|Adverse Event|1|||
124909301|NCT04425629|449295557|FG005|Overall Study|Adverse Event|0|||
124909302|NCT04425629|449295558|FG006|Overall Study|Adverse Event|0|||
124909303|NCT04425629|449295559|FG007|Overall Study|Adverse Event|0|||
124909304|NCT04425629|449295560|FG008|Overall Study|Adverse Event|0|||
124909305|NCT04425629|449295561|FG009|Overall Study|Adverse Event|3|||
124909306|NCT04425629|449295562|FG010|Overall Study|Adverse Event|2|||
124909307|NCT04425629|449295563|FG011|Overall Study|Adverse Event|1|||
124909308|NCT04425629|449295564|FG012|Overall Study|Adverse Event|1|||
124909309|NCT04425629|449295565|FG013|Overall Study|Adverse Event|0|||
124909310|NCT04425629|449295566|FG014|Overall Study|Adverse Event|0|||
124909311|NCT04425629|449295567|FG015|Overall Study|Adverse Event|0|||
124909312|NCT04425629|449295568|FG016|Overall Study|Adverse Event|0|||
124909313|NCT04425629|449295569|FG017|Overall Study|Adverse Event|0|||
124909314|NCT04425629|449295570|FG018|Overall Study|Adverse Event|0|||
124909315|NCT04425629|449295552|FG000|Overall Study|Lost to Follow-up|1|||
124909316|NCT04425629|449295553|FG001|Overall Study|Lost to Follow-up|3|||
124909317|NCT04425629|449295554|FG002|Overall Study|Lost to Follow-up|1|||
124909318|NCT04425629|449295555|FG003|Overall Study|Lost to Follow-up|7|||
124909319|NCT04425629|449295556|FG004|Overall Study|Lost to Follow-up|1|||
124909320|NCT04425629|449295557|FG005|Overall Study|Lost to Follow-up|2|||
124909321|NCT04425629|449295558|FG006|Overall Study|Lost to Follow-up|1|||
124909322|NCT04425629|449295559|FG007|Overall Study|Lost to Follow-up|0|||
124909323|NCT04425629|449295560|FG008|Overall Study|Lost to Follow-up|1|||
124909324|NCT04425629|449295561|FG009|Overall Study|Lost to Follow-up|64|||
124909325|NCT04425629|449295562|FG010|Overall Study|Lost to Follow-up|70|||
124909326|NCT04425629|449295563|FG011|Overall Study|Lost to Follow-up|98|||
124909327|NCT04425629|449295564|FG012|Overall Study|Lost to Follow-up|30|||
124909328|NCT04425629|449295565|FG013|Overall Study|Lost to Follow-up|0|||
124909329|NCT04425629|449295566|FG014|Overall Study|Lost to Follow-up|5|||
124909330|NCT04425629|449295567|FG015|Overall Study|Lost to Follow-up|4|||
124909331|NCT04425629|449295568|FG016|Overall Study|Lost to Follow-up|0|||
124909332|NCT04425629|449295569|FG017|Overall Study|Lost to Follow-up|3|||
124909333|NCT04425629|449295570|FG018|Overall Study|Lost to Follow-up|1|||
124909334|NCT04425629|449295552|FG000|Overall Study|Subject Decision|0|||
124909335|NCT04425629|449295553|FG001|Overall Study|Subject Decision|2|||
124909336|NCT04425629|449295554|FG002|Overall Study|Subject Decision|1|||
124909337|NCT04425629|449295555|FG003|Overall Study|Subject Decision|3|||
124909338|NCT04425629|449295556|FG004|Overall Study|Subject Decision|6|||
124909339|NCT04425629|449295557|FG005|Overall Study|Subject Decision|6|||
124909340|NCT04425629|449295558|FG006|Overall Study|Subject Decision|3|||
124909341|NCT04425629|449295559|FG007|Overall Study|Subject Decision|3|||
124909342|NCT04425629|449295560|FG008|Overall Study|Subject Decision|1|||
124909343|NCT04425629|449295561|FG009|Overall Study|Subject Decision|70|||
124909344|NCT04425629|449295562|FG010|Overall Study|Subject Decision|95|||
124909345|NCT04425629|449295563|FG011|Overall Study|Subject Decision|124|||
124909346|NCT04425629|449295564|FG012|Overall Study|Subject Decision|25|||
124909347|NCT04425629|449295565|FG013|Overall Study|Subject Decision|0|||
124909348|NCT04425629|449295566|FG014|Overall Study|Subject Decision|1|||
124909349|NCT04425629|449295567|FG015|Overall Study|Subject Decision|4|||
124909350|NCT04425629|449295568|FG016|Overall Study|Subject Decision|1|||
124909351|NCT04425629|449295569|FG017|Overall Study|Subject Decision|0|||
124909352|NCT04425629|449295570|FG018|Overall Study|Subject Decision|2|||
124909353|NCT04425629|449295552|FG000|Overall Study|Death|0|||
124909354|NCT04425629|449295553|FG001|Overall Study|Death|0|||
124909355|NCT04425629|449295554|FG002|Overall Study|Death|0|||
124909356|NCT04425629|449295555|FG003|Overall Study|Death|0|||
124909357|NCT04425629|449295556|FG004|Overall Study|Death|0|||
124909358|NCT04425629|449295557|FG005|Overall Study|Death|0|||
124909359|NCT04425629|449295558|FG006|Overall Study|Death|0|||
124909360|NCT04425629|449295559|FG007|Overall Study|Death|0|||
124909361|NCT04425629|449295560|FG008|Overall Study|Death|0|||
124909362|NCT04425629|449295561|FG009|Overall Study|Death|11|||
124909363|NCT04425629|449295562|FG010|Overall Study|Death|2|||
124909364|NCT04425629|449295563|FG011|Overall Study|Death|4|||
124909365|NCT04425629|449295564|FG012|Overall Study|Death|0|||
124909366|NCT04425629|449295565|FG013|Overall Study|Death|0|||
124909367|NCT04425629|449295566|FG014|Overall Study|Death|0|||
124909368|NCT04425629|449295567|FG015|Overall Study|Death|0|||
124909369|NCT04425629|449295568|FG016|Overall Study|Death|0|||
124909370|NCT04425629|449295569|FG017|Overall Study|Death|0|||
124909371|NCT04425629|449295570|FG018|Overall Study|Death|0|||
124909372|NCT04425629|449295552|FG000|Overall Study|Sponsor Request|0|||
124909373|NCT04425629|449295553|FG001|Overall Study|Sponsor Request|0|||
124909374|NCT04425629|449295554|FG002|Overall Study|Sponsor Request|0|||
124909375|NCT04425629|449295555|FG003|Overall Study|Sponsor Request|2|||
124909376|NCT04425629|449295556|FG004|Overall Study|Sponsor Request|2|||
124909377|NCT04425629|449295557|FG005|Overall Study|Sponsor Request|2|||
124909378|NCT04425629|449295558|FG006|Overall Study|Sponsor Request|1|||
124909379|NCT04425629|449295559|FG007|Overall Study|Sponsor Request|0|||
124909380|NCT04425629|449295560|FG008|Overall Study|Sponsor Request|0|||
124909381|NCT04425629|449295561|FG009|Overall Study|Sponsor Request|9|||
124909382|NCT04425629|449295562|FG010|Overall Study|Sponsor Request|9|||
124909383|NCT04425629|449295563|FG011|Overall Study|Sponsor Request|10|||
124909384|NCT04425629|449295564|FG012|Overall Study|Sponsor Request|8|||
124909385|NCT04425629|449295565|FG013|Overall Study|Sponsor Request|0|||
124909386|NCT04425629|449295566|FG014|Overall Study|Sponsor Request|0|||
124909387|NCT04425629|449295567|FG015|Overall Study|Sponsor Request|1|||
124909388|NCT04425629|449295568|FG016|Overall Study|Sponsor Request|0|||
124909389|NCT04425629|449295569|FG017|Overall Study|Sponsor Request|0|||
124909390|NCT04425629|449295570|FG018|Overall Study|Sponsor Request|0|||
124909391|NCT04425629|449295552|FG000|Overall Study|Physician Decision|0|||
124909392|NCT04425629|449295553|FG001|Overall Study|Physician Decision|0|||
125211281|NCT01900431|450398642|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
125211282|NCT01900431|450398643|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
125211283|NCT03172364|450398644|FG000|Overall Study|Adverse Event|1|||
125211284|NCT03172364|450398645|FG001|Overall Study|Adverse Event|1|||
125211285|NCT03172364|450398644|FG000|Overall Study|Protocol Violation|1|||
125211286|NCT03172364|450398645|FG001|Overall Study|Protocol Violation|0|||
125211287|NCT03755518|450398646|FG000|Overall Study|Lack of Efficacy|10|||
125211288|NCT03755518|450398646|FG000|Overall Study|Adverse Event|7|||
125211289|NCT03755518|450398646|FG000|Overall Study|Study Terminated by Sponsor|5|||
125211290|NCT03755518|450398646|FG000|Overall Study|Death|1|||
125211291|NCT03755518|450398646|FG000|Overall Study|Withdrawal by Subject|3|||
125211292|NCT03755518|450398646|FG000|Overall Study|Progressive Disease|4|||
125211293|NCT03755518|450398646|FG000|Overall Study|Bone Marrow Transplant|4|||
125211294|NCT03755518|450398646|FG000|Overall Study|Physicians Decision|1|||
125211295|NCT03755518|450398646|FG000|Overall Study|Relapse|1|||
125211296|NCT03755518|450398646|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
124909393|NCT04425629|449295554|FG002|Overall Study|Physician Decision|0|||
124909394|NCT04425629|449295555|FG003|Overall Study|Physician Decision|0|||
124909395|NCT04425629|449295556|FG004|Overall Study|Physician Decision|0|||
124909396|NCT04425629|449295557|FG005|Overall Study|Physician Decision|0|||
124909397|NCT04425629|449295558|FG006|Overall Study|Physician Decision|0|||
124909398|NCT04425629|449295559|FG007|Overall Study|Physician Decision|0|||
124909399|NCT04425629|449295560|FG008|Overall Study|Physician Decision|0|||
124909400|NCT04425629|449295561|FG009|Overall Study|Physician Decision|4|||
125211297|NCT03755518|450398646|FG000|Overall Study|Withdrawal by PI|1|||
125211298|NCT01714609|450398647|FG000|Overall Study|Protocol Violation|1|||
125211299|NCT01714609|450398648|FG001|Overall Study|Protocol Violation|0|||
125211300|NCT00630747|450398649|FG000|Overall Study|Death|1|||
125211301|NCT00630747|450398649|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
124909401|NCT04425629|449295562|FG010|Overall Study|Physician Decision|3|||
125115051|NCT03361956|450044727|FG003|Overall Study|Adverse Event|1|||
125115052|NCT03361956|450044728|FG004|Overall Study|Adverse Event|0|||
125115053|NCT03361956|450044724|FG000|Overall Study|Other|0|||
125115054|NCT03361956|450044725|FG001|Overall Study|Other|0|||
125115055|NCT03361956|450044726|FG002|Overall Study|Other|0|||
125115056|NCT03361956|450044727|FG003|Overall Study|Other|1|||
125115057|NCT03361956|450044728|FG004|Overall Study|Other|0|||
125115058|NCT03361956|450044724|FG000|Overall Study|Withdrawal by Subject|2|||
125115059|NCT03361956|450044725|FG001|Overall Study|Withdrawal by Subject|2|||
125115060|NCT03361956|450044726|FG002|Overall Study|Withdrawal by Subject|2|||
125115061|NCT03361956|450044727|FG003|Overall Study|Withdrawal by Subject|0|||
125115062|NCT03361956|450044728|FG004|Overall Study|Withdrawal by Subject|3|||
125115063|NCT03361956|450044724|FG000|Overall Study|Disease Relapse|0|||
125115064|NCT03361956|450044725|FG001|Overall Study|Disease Relapse|0|||
125115065|NCT03361956|450044726|FG002|Overall Study|Disease Relapse|1|||
125115066|NCT03361956|450044727|FG003|Overall Study|Disease Relapse|0|||
125115067|NCT03361956|450044728|FG004|Overall Study|Disease Relapse|0|||
125115068|NCT03361956|450044724|FG000|Overall Study|Physician Decision|0|||
125115069|NCT03361956|450044725|FG001|Overall Study|Physician Decision|2|||
125115070|NCT03361956|450044726|FG002|Overall Study|Physician Decision|0|||
125115071|NCT03361956|450044727|FG003|Overall Study|Physician Decision|1|||
125115072|NCT03361956|450044728|FG004|Overall Study|Physician Decision|0|||
125115073|NCT03361956|450044724|FG000|Overall Study|Lost to Follow-up|0|||
125115074|NCT03361956|450044725|FG001|Overall Study|Lost to Follow-up|0|||
125115075|NCT03361956|450044726|FG002|Overall Study|Lost to Follow-up|1|||
125115076|NCT03361956|450044727|FG003|Overall Study|Lost to Follow-up|1|||
125115077|NCT03361956|450044728|FG004|Overall Study|Lost to Follow-up|2|||
125115078|NCT00408876|450044729|FG000|Overall Study|Adverse Event|9|||
125115079|NCT00408876|450044730|FG001|Overall Study|Adverse Event|17|||
125115080|NCT00408876|450044731|FG002|Overall Study|Adverse Event|27|||
125115081|NCT00408876|450044732|FG003|Overall Study|Adverse Event|10|||
125115082|NCT00408876|450044729|FG000|Overall Study|Withdrawal by Subject|3|||
125115083|NCT00408876|450044730|FG001|Overall Study|Withdrawal by Subject|6|||
125115084|NCT00408876|450044731|FG002|Overall Study|Withdrawal by Subject|6|||
125115085|NCT00408876|450044732|FG003|Overall Study|Withdrawal by Subject|14|||
125115086|NCT00408876|450044729|FG000|Overall Study|Lack of Efficacy|2|||
125115087|NCT00408876|450044730|FG001|Overall Study|Lack of Efficacy|4|||
125115088|NCT00408876|450044731|FG002|Overall Study|Lack of Efficacy|5|||
125115089|NCT00408876|450044732|FG003|Overall Study|Lack of Efficacy|6|||
125115090|NCT00408876|450044729|FG000|Overall Study|Lost to Follow-up|1|||
125115091|NCT00408876|450044730|FG001|Overall Study|Lost to Follow-up|6|||
125115092|NCT00408876|450044731|FG002|Overall Study|Lost to Follow-up|5|||
125115093|NCT00408876|450044732|FG003|Overall Study|Lost to Follow-up|2|||
125115094|NCT00408876|450044729|FG000|Overall Study|Protocol Violation|0|||
125115095|NCT00408876|450044730|FG001|Overall Study|Protocol Violation|3|||
125115096|NCT00408876|450044731|FG002|Overall Study|Protocol Violation|4|||
125115097|NCT00408876|450044732|FG003|Overall Study|Protocol Violation|3|||
124909402|NCT04425629|449295563|FG011|Overall Study|Physician Decision|5|||
125115098|NCT00408876|450044729|FG000|Overall Study|Physician Decision|1|||
125115099|NCT00408876|450044730|FG001|Overall Study|Physician Decision|0|||
125115100|NCT00408876|450044731|FG002|Overall Study|Physician Decision|3|||
125115101|NCT00408876|450044732|FG003|Overall Study|Physician Decision|0|||
124909403|NCT04425629|449295564|FG012|Overall Study|Physician Decision|1|||
125211302|NCT00630747|450398649|FG000|Overall Study|Returned to country of origin|1|||
124909404|NCT04425629|449295565|FG013|Overall Study|Physician Decision|0|||
125115102|NCT02006147|450044733|FG000|Overall Study|Protocol Violation|1|||
125115103|NCT02006147|450044734|FG001|Overall Study|Protocol Violation|1|||
125115104|NCT02006147|450044735|FG002|Overall Study|Protocol Violation|0|||
125115105|NCT02006147|450044736|FG003|Overall Study|Protocol Violation|0|||
125115106|NCT02006147|450044733|FG000|Overall Study|Withdrawal by Subject|0|||
125115107|NCT02006147|450044734|FG001|Overall Study|Withdrawal by Subject|1|||
125115108|NCT02006147|450044735|FG002|Overall Study|Withdrawal by Subject|0|||
125211303|NCT02306694|450398652|FG000|Overall Study|Withdrawal by Subject|3|||
124909405|NCT04425629|449295566|FG014|Overall Study|Physician Decision|0|||
124909406|NCT04425629|449295567|FG015|Overall Study|Physician Decision|1|||
124909407|NCT04425629|449295568|FG016|Overall Study|Physician Decision|0|||
124909408|NCT04425629|449295569|FG017|Overall Study|Physician Decision|0|||
124909409|NCT04425629|449295570|FG018|Overall Study|Physician Decision|0|||
124909410|NCT04425629|449295552|FG000|Overall Study|Lack of Efficacy|0|||
124909411|NCT04425629|449295553|FG001|Overall Study|Lack of Efficacy|0|||
124909412|NCT04425629|449295554|FG002|Overall Study|Lack of Efficacy|0|||
124909413|NCT04425629|449295555|FG003|Overall Study|Lack of Efficacy|0|||
124909414|NCT04425629|449295556|FG004|Overall Study|Lack of Efficacy|0|||
124909415|NCT04425629|449295557|FG005|Overall Study|Lack of Efficacy|0|||
124909416|NCT04425629|449295558|FG006|Overall Study|Lack of Efficacy|0|||
124909417|NCT04425629|449295559|FG007|Overall Study|Lack of Efficacy|0|||
124909418|NCT04425629|449295560|FG008|Overall Study|Lack of Efficacy|0|||
124909419|NCT04425629|449295561|FG009|Overall Study|Lack of Efficacy|0|||
124909420|NCT04425629|449295562|FG010|Overall Study|Lack of Efficacy|1|||
124909421|NCT04425629|449295563|FG011|Overall Study|Lack of Efficacy|0|||
124909422|NCT04425629|449295564|FG012|Overall Study|Lack of Efficacy|0|||
124909423|NCT04425629|449295565|FG013|Overall Study|Lack of Efficacy|0|||
124909424|NCT04425629|449295566|FG014|Overall Study|Lack of Efficacy|0|||
124909425|NCT04425629|449295567|FG015|Overall Study|Lack of Efficacy|0|||
124909426|NCT04425629|449295568|FG016|Overall Study|Lack of Efficacy|0|||
124909427|NCT04425629|449295569|FG017|Overall Study|Lack of Efficacy|0|||
124909428|NCT04425629|449295570|FG018|Overall Study|Lack of Efficacy|0|||
124909429|NCT04218110|449295571|FG000|Overall Study|Withdrawal by Subject|0|||
124909430|NCT04218110|449295572|FG001|Overall Study|Withdrawal by Subject|0|||
124909431|NCT04218110|449295573|FG002|Overall Study|Withdrawal by Subject|0|||
124909432|NCT04218110|449295574|FG003|Overall Study|Withdrawal by Subject|1|||
125115109|NCT02006147|450044736|FG003|Overall Study|Withdrawal by Subject|0|||
125115110|NCT02006147|450044733|FG000|Overall Study|Withdrawal by Sponsor|1|||
125115111|NCT02006147|450044734|FG001|Overall Study|Withdrawal by Sponsor|0|||
125115112|NCT02006147|450044735|FG002|Overall Study|Withdrawal by Sponsor|0|||
125115113|NCT02006147|450044736|FG003|Overall Study|Withdrawal by Sponsor|0|||
125115114|NCT00871728|450044742|FG000|Overall Study|Adverse Event|1|||
125115115|NCT00871728|450044742|FG000|Overall Study|Protocol Violation|7|||
125115116|NCT00871728|450044742|FG000|Overall Study|Lost to Follow-up|2|||
125115117|NCT00871728|450044742|FG000|Overall Study|Failed to Visit Hospital|4|||
125115118|NCT00871728|450044742|FG000|Overall Study|Participant Non-compliance|1|||
125115119|NCT00871728|450044742|FG000|Overall Study|Withdrawal of Informed Consent|5|||
124909433|NCT02271854|449295575|FG000|Overall Study|Withdrawal by Subject|2|||
124909434|NCT02271854|449295575|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
124909435|NCT02271854|449295575|FG000|Overall Study|Lost to Follow-up|1|||
124909436|NCT00446459|449295577|FG000|8 Months|Protocol Violation|12|||
124909437|NCT00446459|449295577|FG000|12 Months|Protocol Violation|4|||
124909438|NCT00446459|449295577|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
124909439|NCT02918279|449295578|FG000|Overall Study|Lost to Follow-up|3|||
124909440|NCT02918279|449295579|FG001|Overall Study|Lost to Follow-up|6|||
124909441|NCT02918279|449295578|FG000|Overall Study|Withdrawal by Subject|5|||
124909442|NCT02918279|449295579|FG001|Overall Study|Withdrawal by Subject|15|||
124909443|NCT02918279|449295578|FG000|Overall Study|Withdrawal by parent/guardian|2|||
125115120|NCT04147715|450044743|FG000|Overall Study|Adverse Event|0|||
124909444|NCT02918279|449295579|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124909445|NCT02918279|449295578|FG000|Overall Study|Other|3|||
124909446|NCT02918279|449295579|FG001|Overall Study|Other|1|||
124909447|NCT00309907|449295580|FG000|Overall Study|Death|4|||
124909448|NCT00309907|449295580|FG000|Overall Study|Physician Decision|1|||
124909449|NCT00309907|449295580|FG000|Overall Study|Ineligible|11|||
124909450|NCT00309907|449295580|FG000|Overall Study|Major infectious event|4|||
124909451|NCT00244855|449295581|FG000|Overall Study|Withdrawal by Subject|0|||
124909452|NCT00244855|449295582|FG001|Overall Study|Withdrawal by Subject|1|||
124909453|NCT00869258|449295583|FG000|Overall Study|Physician Decision|1|||
124909454|NCT02706717|449295584|FG000|Overall Study|Withdrawal by Subject|1|||
124909455|NCT02706717|449295585|FG001|Overall Study|Withdrawal by Subject|8|||
124909456|NCT02706717|449295584|FG000|Overall Study|Lost to Follow-up|0|||
124909457|NCT02706717|449295585|FG001|Overall Study|Lost to Follow-up|1|||
124909458|NCT02706717|449295584|FG000|Overall Study|Physician Decision|0|||
124909459|NCT02706717|449295585|FG001|Overall Study|Physician Decision|1|||
124909460|NCT02706717|449295584|FG000|Overall Study|Death|0|||
124909461|NCT02706717|449295585|FG001|Overall Study|Death|1|||
124909462|NCT02512965|449295588|FG000|Overall Study|Withdrawal by Subject|0|||
124909463|NCT02512965|449295589|FG001|Overall Study|Withdrawal by Subject|4|||
124909464|NCT00835770|449295593|FG000|Overall Study|MS Relapse|17|||
124909465|NCT00835770|449295594|FG001|Overall Study|MS Relapse|23|||
124909466|NCT00835770|449295593|FG000|Overall Study|MS Progression|14|||
124909467|NCT00835770|449295594|FG001|Overall Study|MS Progression|9|||
124909468|NCT00835770|449295593|FG000|Overall Study|Adverse Event|113|||
124909469|NCT00835770|449295594|FG001|Overall Study|Adverse Event|124|||
124909470|NCT00835770|449295593|FG000|Overall Study|Lost to Follow-up|22|||
124909471|NCT00835770|449295594|FG001|Overall Study|Lost to Follow-up|19|||
124909472|NCT00835770|449295593|FG000|Overall Study|Consent Withdrawn|144|||
124909473|NCT00835770|449295594|FG001|Overall Study|Consent Withdrawn|156|||
124909474|NCT00835770|449295593|FG000|Overall Study|Investigator Decision|42|||
124909475|NCT00835770|449295594|FG001|Overall Study|Investigator Decision|42|||
124909476|NCT00835770|449295593|FG000|Overall Study|Participant Non-Compliance|11|||
124909477|NCT00835770|449295594|FG001|Overall Study|Participant Non-Compliance|9|||
124909478|NCT00835770|449295593|FG000|Overall Study|Death|4|||
124909479|NCT00835770|449295594|FG001|Overall Study|Death|6|||
124909480|NCT00835770|449295593|FG000|Overall Study|Other|115|||
124909481|NCT00835770|449295594|FG001|Overall Study|Other|104|||
124909482|NCT00835770|449295593|FG000|Overall Study|Other|2|||
124909483|NCT00835770|449295594|FG001|Overall Study|Other|1|||
124909484|NCT01185782|449295595|FG000|Overall Study|Adverse Event|0|||
124909485|NCT01185782|449295596|FG001|Overall Study|Adverse Event|1|||
124909486|NCT01185782|449295595|FG000|Overall Study|Protocol Violation|1|||
124909487|NCT01185782|449295596|FG001|Overall Study|Protocol Violation|0|||
124909488|NCT01185782|449295595|FG000|Overall Study|Poor Response to Treatment|3|||
124909489|NCT01185782|449295596|FG001|Overall Study|Poor Response to Treatment|1|||
124909490|NCT01185782|449295595|FG000|Overall Study|Other|2|||
124909491|NCT01185782|449295596|FG001|Overall Study|Other|5|||
124909492|NCT01185782|449295595|FG000|Overall Study|Randomized but not treated|0|||
124909493|NCT01185782|449295596|FG001|Overall Study|Randomized but not treated|4|||
124909494|NCT02507752|449295597|FG000|Overall Study|Adverse Event|1|||
124909495|NCT02507752|449295597|FG000|Overall Study|Protocol Violation|6|||
124909496|NCT02507752|449295597|FG000|Overall Study|Lost to Follow-up|7|||
124909497|NCT02507752|449295597|FG000|Overall Study|Infusion reaction at first infusion|1|||
124909498|NCT02507752|449295597|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
124909499|NCT02507752|449295597|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
124909500|NCT01061151|449295602|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
124909501|NCT01061151|449295603|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
124909502|NCT01061151|449295604|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
124909503|NCT01061151|449295605|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
124909504|NCT01061151|449295602|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
124909505|NCT01061151|449295603|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
124909506|NCT01061151|449295604|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
124909507|NCT01061151|449295605|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
124909508|NCT01061151|449295602|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
124909509|NCT01061151|449295603|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
124909510|NCT01061151|449295604|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
124909511|NCT01061151|449295605|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
124909512|NCT01061151|449295602|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
124909513|NCT01061151|449295603|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
124909514|NCT01061151|449295604|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
124909515|NCT01061151|449295605|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
124909516|NCT01061151|449295602|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
124909517|NCT01061151|449295603|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
124909518|NCT01061151|449295604|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
124909519|NCT01061151|449295605|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
124909520|NCT01061151|449295602|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
124909521|NCT01061151|449295603|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
125115121|NCT04147715|450044744|FG001|Overall Study|Adverse Event|0|||
124909522|NCT01061151|449295604|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
124909523|NCT01061151|449295605|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
124909524|NCT01061151|449295602|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
124909525|NCT01061151|449295603|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
124909526|NCT01061151|449295604|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
124909527|NCT01061151|449295605|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
124909528|NCT01061151|449295602|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
124909529|NCT01061151|449295603|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
124909530|NCT01061151|449295604|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
124909531|NCT01061151|449295605|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
124909532|NCT01061151|449295602|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
124909533|NCT01061151|449295603|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
125115122|NCT04147715|450044745|FG002|Overall Study|Adverse Event|0|||
124909534|NCT01061151|449295604|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
124909535|NCT01061151|449295605|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
124909536|NCT01061151|449295602|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
124909537|NCT01061151|449295603|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
124909538|NCT01061151|449295604|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
124909539|NCT01061151|449295605|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
124909540|NCT01061151|449295602|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
124909541|NCT01061151|449295603|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
124909542|NCT01061151|449295604|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
124909543|NCT01061151|449295605|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
124909544|NCT01061151|449295602|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
124909545|NCT01061151|449295603|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
124909546|NCT01061151|449295604|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
124909547|NCT01061151|449295605|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
124909548|NCT01061151|449295602|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
124909549|NCT01061151|449295603|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
124909550|NCT01061151|449295604|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
124909551|NCT01061151|449295605|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
124909552|NCT01061151|449295602|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
124909553|NCT01061151|449295603|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
124909554|NCT01061151|449295604|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
124909555|NCT01061151|449295605|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
124909556|NCT01061151|449295602|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
124909557|NCT01061151|449295603|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
124909558|NCT01061151|449295604|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
124909559|NCT01061151|449295605|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
124909560|NCT03740009|449295606|FG000|Overall Study|Physician Decision|9|||
124909561|NCT03740009|449295606|FG000|Overall Study|Lost to Follow-up|1|||
124909562|NCT01692730|449295622|FG000|Overall Study|Lost to Follow-up|225|||
124909563|NCT01692730|449295623|FG001|Overall Study|Lost to Follow-up|227|||
124909564|NCT00933400|449295624|FG000|Overall Study|Withdrawal by Subject|21|||
124909565|NCT00933400|449295625|FG001|Overall Study|Withdrawal by Subject|1|||
124909566|NCT01041417|449295628|FG000|Overall Study|Adverse Event|5|||
124909567|NCT01041417|449295629|FG001|Overall Study|Adverse Event|2|||
124909568|NCT01041417|449295628|FG000|Overall Study|Lost to Follow-up|1|||
124909569|NCT01041417|449295629|FG001|Overall Study|Lost to Follow-up|1|||
124909570|NCT01041417|449295628|FG000|Overall Study|Death|1|||
124909571|NCT01041417|449295629|FG001|Overall Study|Death|0|||
124909572|NCT02299375|449295630|FG000|Overall Study|Adverse Event, serious fatal|1|||
124909573|NCT02299375|449295631|FG001|Overall Study|Adverse Event, serious fatal|3|||
124909574|NCT02299375|449295630|FG000|Overall Study|Adverse Event, non-fatal|8|||
124909575|NCT02299375|449295631|FG001|Overall Study|Adverse Event, non-fatal|9|||
124909576|NCT02299375|449295630|FG000|Overall Study|Lack of Efficacy|1|||
124909577|NCT02299375|449295631|FG001|Overall Study|Lack of Efficacy|3|||
124909578|NCT02299375|449295630|FG000|Overall Study|Protocol Violation|1|||
124909579|NCT02299375|449295631|FG001|Overall Study|Protocol Violation|3|||
124909580|NCT02299375|449295630|FG000|Overall Study|Other: Met stopping criteria|1|||
124909581|NCT02299375|449295631|FG001|Overall Study|Other: Met stopping criteria|0|||
124909582|NCT02299375|449295630|FG000|Overall Study|Other: Study closed/terminated|66|||
124909583|NCT02299375|449295631|FG001|Overall Study|Other: Study closed/terminated|55|||
124909584|NCT02299375|449295630|FG000|Overall Study|Lost to Follow-up|0|||
124909585|NCT02299375|449295631|FG001|Overall Study|Lost to Follow-up|2|||
124909586|NCT02299375|449295630|FG000|Overall Study|Physician Decision|1|||
124909587|NCT02299375|449295631|FG001|Overall Study|Physician Decision|1|||
124909588|NCT02299375|449295630|FG000|Overall Study|Withdrawal by Subject|1|||
124909589|NCT02299375|449295631|FG001|Overall Study|Withdrawal by Subject|4|||
124909590|NCT00704184|449295632|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
124909591|NCT00704184|449295633|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
124909592|NCT00704184|449295634|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
124909593|NCT00704184|449295635|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
124909594|NCT00704184|449295636|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
124909595|NCT00704184|449295632|FG000|Open-Label Treatment|Adverse Event|0|||
124909596|NCT00704184|449295633|FG001|Open-Label Treatment|Adverse Event|0|||
124909597|NCT00704184|449295634|FG002|Open-Label Treatment|Adverse Event|2|||
124909598|NCT00704184|449295635|FG003|Open-Label Treatment|Adverse Event|0|||
124909599|NCT00704184|449295636|FG004|Open-Label Treatment|Adverse Event|1|||
124909600|NCT00704184|449295632|FG000|Open-Label Treatment|Lack of Efficacy|0|||
124909601|NCT00704184|449295633|FG001|Open-Label Treatment|Lack of Efficacy|2|||
124909602|NCT00704184|449295634|FG002|Open-Label Treatment|Lack of Efficacy|2|||
124909603|NCT00704184|449295635|FG003|Open-Label Treatment|Lack of Efficacy|2|||
124909604|NCT00704184|449295636|FG004|Open-Label Treatment|Lack of Efficacy|1|||
124909605|NCT00704184|449295632|FG000|Open-Label Treatment|Physician Decision|0|||
124909606|NCT00704184|449295633|FG001|Open-Label Treatment|Physician Decision|0|||
124909607|NCT00704184|449295634|FG002|Open-Label Treatment|Physician Decision|0|||
124909608|NCT00704184|449295635|FG003|Open-Label Treatment|Physician Decision|0|||
124909609|NCT00704184|449295636|FG004|Open-Label Treatment|Physician Decision|1|||
124909610|NCT00704184|449295632|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
124909611|NCT00704184|449295633|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
124909612|NCT00704184|449295634|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
124909613|NCT00704184|449295635|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
124909614|NCT00704184|449295636|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
124909615|NCT03473340|449295646|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
124909616|NCT03473340|449295647|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
124909617|NCT03473340|449295646|FG000|Overall Study|Withdrawal by Subject|1|||
124909618|NCT03473340|449295647|FG001|Overall Study|Withdrawal by Subject|0|||
124909619|NCT03473340|449295646|FG000|Overall Study|Lost to Follow-up|1|||
124909620|NCT03473340|449295647|FG001|Overall Study|Lost to Follow-up|2|||
124909621|NCT03394885|449295648|FG000|Overall Study|Adverse Event|4|||
124909622|NCT03394885|449295648|FG000|Overall Study|Lack of Efficacy|1|||
124909623|NCT03394885|449295648|FG000|Overall Study|Physician Decision|1|||
124909624|NCT03394885|449295648|FG000|Overall Study|Withdrawal by Subject|8|||
124909625|NCT03394885|449295648|FG000|Overall Study|Alternative Therapy|1|||
124909626|NCT01212991|449295649|FG000|Double-blind|Lost to Follow-up|8|||
124909627|NCT01212991|449295650|FG001|Double-blind|Lost to Follow-up|4|||
124909628|NCT01212991|449295651|FG002|Double-blind|Lost to Follow-up|0|||
124909629|NCT01212991|449295649|FG000|Double-blind|Death|699|||
124909630|NCT01212991|449295650|FG001|Double-blind|Death|550|||
124909631|NCT01212991|449295651|FG002|Double-blind|Death|0|||
124909632|NCT01212991|449295649|FG000|Double-blind|Withdrawal by Subject|16|||
124909633|NCT01212991|449295650|FG001|Double-blind|Withdrawal by Subject|19|||
124909634|NCT01212991|449295651|FG002|Double-blind|Withdrawal by Subject|0|||
124909635|NCT01212991|449295649|FG000|Double-blind|Other|7|||
124909636|NCT01212991|449295650|FG001|Double-blind|Other|0|||
124909637|NCT01212991|449295651|FG002|Double-blind|Other|0|||
124909638|NCT01212991|449295649|FG000|Double-blind|Sponsor decision|142|||
124909639|NCT01212991|449295650|FG001|Double-blind|Sponsor decision|38|||
124909640|NCT01212991|449295651|FG002|Double-blind|Sponsor decision|0|||
124909641|NCT01212991|449295649|FG000|Open-label|Death|0|||
124909642|NCT01212991|449295650|FG001|Open-label|Death|0|||
124909643|NCT01212991|449295651|FG002|Open-label|Death|166|||
124909644|NCT01212991|449295649|FG000|Open-label|Lost to Follow-up|0|||
124909645|NCT01212991|449295650|FG001|Open-label|Lost to Follow-up|0|||
124909646|NCT01212991|449295651|FG002|Open-label|Lost to Follow-up|5|||
124909647|NCT01212991|449295649|FG000|Open-label|Withdrawal by Subject|0|||
124909648|NCT01212991|449295650|FG001|Open-label|Withdrawal by Subject|0|||
124909649|NCT01212991|449295651|FG002|Open-label|Withdrawal by Subject|7|||
124909650|NCT01212991|449295649|FG000|Open-label|Sponsor decision|0|||
124909651|NCT01212991|449295650|FG001|Open-label|Sponsor decision|0|||
124909652|NCT01212991|449295651|FG002|Open-label|Sponsor decision|53|||
124909653|NCT01212991|449295649|FG000|Open-label|Other|0|||
124909654|NCT01212991|449295650|FG001|Open-label|Other|0|||
124909655|NCT01212991|449295651|FG002|Open-label|Other|3|||
124909656|NCT00801983|449295658|FG000|Period 1|Lost to Follow-up|2|||
124909657|NCT00801983|449295659|FG001|Period 1|Lost to Follow-up|0|||
124909658|NCT00801983|449295658|FG000|Period 1|Withdrawal by Subject|2|||
124909659|NCT00801983|449295659|FG001|Period 1|Withdrawal by Subject|8|||
124909660|NCT00801983|449295658|FG000|Period 2|Withdrawal by Subject|2|||
124909661|NCT00801983|449295659|FG001|Period 2|Withdrawal by Subject|1|||
124909662|NCT01251354|449295660|FG000|Overall Study|Adverse Event|1|||
124909663|NCT01251354|449295660|FG000|Overall Study|Investigator's Decision|1|||
124909664|NCT01251354|449295660|FG000|Overall Study|Disease Progression|4|||
124909665|NCT03807778|449295668|FG000|Overall Study|Adverse Event|0|||
124909666|NCT03807778|449295669|FG001|Overall Study|Adverse Event|0|||
124909667|NCT03807778|449295670|FG002|Overall Study|Adverse Event|3|||
124909668|NCT03807778|449295671|FG003|Overall Study|Adverse Event|5|||
124909669|NCT03807778|449295668|FG000|Overall Study|Progressive Disease|4|||
124909670|NCT03807778|449295669|FG001|Overall Study|Progressive Disease|2|||
124909671|NCT03807778|449295670|FG002|Overall Study|Progressive Disease|8|||
124909672|NCT03807778|449295671|FG003|Overall Study|Progressive Disease|15|||
124909673|NCT03807778|449295668|FG000|Overall Study|Symptomatic Deterioration|0|||
124909674|NCT03807778|449295669|FG001|Overall Study|Symptomatic Deterioration|1|||
124909675|NCT03807778|449295670|FG002|Overall Study|Symptomatic Deterioration|0|||
124909676|NCT03807778|449295671|FG003|Overall Study|Symptomatic Deterioration|1|||
124909677|NCT03807778|449295668|FG000|Overall Study|Withdrawal by Subject|0|||
124909678|NCT03807778|449295669|FG001|Overall Study|Withdrawal by Subject|1|||
124909679|NCT03807778|449295670|FG002|Overall Study|Withdrawal by Subject|0|||
124909680|NCT03807778|449295671|FG003|Overall Study|Withdrawal by Subject|1|||
124909681|NCT03807778|449295668|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
124909682|NCT03807778|449295669|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
124909683|NCT03807778|449295670|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
124909684|NCT03807778|449295671|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
124909685|NCT05135000|449295672|FG000|Overall Study|Adverse Event|2|||
124909686|NCT05135000|449295673|FG001|Overall Study|Adverse Event|0|||
124909687|NCT05135000|449295672|FG000|Overall Study|Lost to Follow-up|1|||
124909688|NCT05135000|449295673|FG001|Overall Study|Lost to Follow-up|0|||
124909689|NCT05135000|449295672|FG000|Overall Study|Study Terminated by Sponsor|6|||
124909690|NCT05135000|449295673|FG001|Overall Study|Study Terminated by Sponsor|3|||
124909691|NCT05094141|449295681|FG000|Overall Study|Death|0|||
124909692|NCT05094141|449295682|FG001|Overall Study|Death|0|||
124909693|NCT05094141|449295683|FG002|Overall Study|Death|1|||
124909694|NCT05094141|449295681|FG000|Overall Study|Withdrawal by Subject|0|||
124909695|NCT05094141|449295682|FG001|Overall Study|Withdrawal by Subject|0|||
124909696|NCT05094141|449295683|FG002|Overall Study|Withdrawal by Subject|1|||
124909697|NCT05094141|449295681|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
124909698|NCT05094141|449295682|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
124909699|NCT05094141|449295683|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
124909700|NCT05094141|449295681|FG000|Overall Study|Did not participate in randomization|0|||
124909701|NCT05094141|449295682|FG001|Overall Study|Did not participate in randomization|0|||
124909702|NCT05094141|449295683|FG002|Overall Study|Did not participate in randomization|33|||
124909703|NCT01170026|449297348|FG000|Overall Study|Lost to Follow-up|4|||
124909704|NCT01170026|449297349|FG001|Overall Study|Lost to Follow-up|2|||
124909705|NCT04411056|449297350|FG000|Overall Study|surgery cancelled|1|||
124909706|NCT04411056|449297351|FG001|Overall Study|surgery cancelled|0|||
124909707|NCT04411056|449297350|FG000|Overall Study|Equipment problem during intubation|0|||
124909708|NCT04411056|449297351|FG001|Overall Study|Equipment problem during intubation|1|||
124909709|NCT03785782|449297361|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
124909710|NCT03785782|449297362|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
124909711|NCT03785782|449297361|FG000|Overall Study|Withdrawal by Subject|1|||
124909712|NCT03785782|449297362|FG001|Overall Study|Withdrawal by Subject|1|||
124909713|NCT03785782|449297361|FG000|Overall Study|insufficient image quality.|3|||
124909714|NCT03785782|449297362|FG001|Overall Study|insufficient image quality.|0|||
124909715|NCT05777785|449297363|FG000|Overall Study|Withdrawal by Subject|5|||
124909716|NCT05777785|449297363|FG000|Overall Study|Lost to Follow-up|1|||
124909717|NCT02763319|449297365|FG000|Overall Study|Adverse Event|12|||
124909718|NCT02763319|449297366|FG001|Overall Study|Adverse Event|3|||
124909719|NCT02763319|449297365|FG000|Overall Study|Death|123|||
124909720|NCT02763319|449297366|FG001|Overall Study|Death|123|||
124909721|NCT02763319|449297365|FG000|Overall Study|Lost to Follow-up|6|||
124909722|NCT02763319|449297366|FG001|Overall Study|Lost to Follow-up|7|||
124909723|NCT02763319|449297365|FG000|Overall Study|Noncompliance with Study Drug|2|||
125022164|NCT02064387|449705363|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125022165|NCT02064387|449705364|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125022166|NCT02064387|449705365|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125022167|NCT02064387|449705366|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125022168|NCT02064387|449705367|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
125022169|NCT02064387|449705368|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125022170|NCT02064387|449705369|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125022171|NCT02064387|449705370|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125022172|NCT02064387|449705371|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125022173|NCT02064387|449705360|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125022174|NCT02064387|449705361|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125022175|NCT02064387|449705362|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125022176|NCT02064387|449705363|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125022177|NCT02064387|449705364|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125022178|NCT02064387|449705365|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125022179|NCT02064387|449705366|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125022180|NCT02064387|449705367|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125022181|NCT02064387|449705368|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
125022182|NCT02064387|449705369|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125022183|NCT02064387|449705370|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125022184|NCT02064387|449705371|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125022185|NCT02064387|449705360|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
125115123|NCT04147715|450044746|FG003|Overall Study|Adverse Event|0|||
125115124|NCT04147715|450044747|FG004|Overall Study|Adverse Event|0|||
124909724|NCT02763319|449297366|FG001|Overall Study|Noncompliance with Study Drug|0|||
124909725|NCT02763319|449297365|FG000|Overall Study|"Captured as Other in Database"|29|||
124909726|NCT02763319|449297366|FG001|Overall Study|"Captured as Other in Database"|34|||
124909727|NCT02763319|449297365|FG000|Overall Study|Physician Decision|1|||
124909728|NCT02763319|449297366|FG001|Overall Study|Physician Decision|7|||
124909729|NCT02763319|449297365|FG000|Overall Study|Progressive Disease|24|||
124909730|NCT02763319|449297366|FG001|Overall Study|Progressive Disease|27|||
124909731|NCT02763319|449297365|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
124909732|NCT02763319|449297366|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
124909733|NCT02763319|449297365|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
124909734|NCT02763319|449297366|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
124909735|NCT02763319|449297365|FG000|Overall Study|Withdrawal by Subject|26|||
124909736|NCT02763319|449297366|FG001|Overall Study|Withdrawal by Subject|25|||
124909737|NCT00089544|449297367|FG000|Overall Study|Ineligible|1|||
124909738|NCT00089544|449297368|FG001|Overall Study|Ineligible|0|||
124909739|NCT01622868|449297371|FG000|Overall Study|Protocol Violation|7|||
124909740|NCT01622868|449297372|FG001|Overall Study|Protocol Violation|0|||
124909741|NCT00610649|449297374|FG000|Overall Study|Adverse Event|1|||
124909742|NCT00610649|449297375|FG001|Overall Study|Adverse Event|0|||
124909743|NCT00610649|449297376|FG002|Overall Study|Adverse Event|0|||
124909744|NCT00610649|449297377|FG003|Overall Study|Adverse Event|0|||
124909745|NCT00610649|449297378|FG004|Overall Study|Adverse Event|0|||
124909746|NCT00610649|449297379|FG005|Overall Study|Adverse Event|0|||
124909747|NCT00610649|449297380|FG006|Overall Study|Adverse Event|0|||
124909748|NCT00610649|449297381|FG007|Overall Study|Adverse Event|0|||
124909749|NCT00610649|449297382|FG008|Overall Study|Adverse Event|0|||
124909750|NCT00610649|449297383|FG009|Overall Study|Adverse Event|0|||
124909751|NCT00610649|449297384|FG010|Overall Study|Adverse Event|1|||
124909752|NCT00610649|449297374|FG000|Overall Study|Family Emergency|0|||
124909753|NCT00610649|449297375|FG001|Overall Study|Family Emergency|1|||
124909754|NCT00610649|449297376|FG002|Overall Study|Family Emergency|0|||
124909755|NCT00610649|449297377|FG003|Overall Study|Family Emergency|0|||
124909756|NCT00610649|449297378|FG004|Overall Study|Family Emergency|0|||
124909757|NCT00610649|449297379|FG005|Overall Study|Family Emergency|0|||
124909758|NCT00610649|449297380|FG006|Overall Study|Family Emergency|0|||
124909759|NCT00610649|449297381|FG007|Overall Study|Family Emergency|0|||
124909760|NCT00610649|449297382|FG008|Overall Study|Family Emergency|0|||
124909761|NCT00610649|449297383|FG009|Overall Study|Family Emergency|0|||
124909762|NCT00610649|449297384|FG010|Overall Study|Family Emergency|0|||
124909763|NCT00610649|449297374|FG000|Overall Study|Withdrawal by Subject|0|||
124909764|NCT00610649|449297375|FG001|Overall Study|Withdrawal by Subject|0|||
124909765|NCT00610649|449297376|FG002|Overall Study|Withdrawal by Subject|0|||
124909766|NCT00610649|449297377|FG003|Overall Study|Withdrawal by Subject|0|||
124909767|NCT00610649|449297378|FG004|Overall Study|Withdrawal by Subject|0|||
124909768|NCT00610649|449297379|FG005|Overall Study|Withdrawal by Subject|0|||
124909769|NCT00610649|449297380|FG006|Overall Study|Withdrawal by Subject|0|||
124909770|NCT00610649|449297381|FG007|Overall Study|Withdrawal by Subject|0|||
124909771|NCT00610649|449297382|FG008|Overall Study|Withdrawal by Subject|0|||
124909772|NCT00610649|449297383|FG009|Overall Study|Withdrawal by Subject|1|||
124909773|NCT00610649|449297384|FG010|Overall Study|Withdrawal by Subject|0|||
124909774|NCT04252586|449297385|FG000|Overall Study|Withdrawal by parent/guardian|3|||
124909775|NCT04252586|449297385|FG000|Overall Study|Adverse Event|1|||
124909776|NCT04252586|449297385|FG000|Overall Study|Death|2|||
124909777|NCT04252586|449297385|FG000|Overall Study|Study terminated by sponsor|4|||
124909778|NCT04252586|449297385|FG000|Overall Study|Sponsor request|10|||
124909779|NCT04252586|449297385|FG000|Overall Study|Did not complete treatment period|1|||
124909780|NCT00232180|449297386|FG000|Double-blind (DB) Phase|Death|186|||
124909781|NCT00232180|449297387|FG001|Double-blind (DB) Phase|Death|222|||
124909782|NCT00232180|449297388|FG002|Double-blind (DB) Phase|Death|0|||
124909783|NCT00232180|449297386|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
124909784|NCT00232180|449297387|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
124909785|NCT00232180|449297388|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
124909786|NCT00232180|449297386|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
124909787|NCT00232180|449297387|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
124909788|NCT00232180|449297388|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
124909789|NCT00232180|449297386|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
124909790|NCT00232180|449297387|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
124909791|NCT00232180|449297388|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
124909792|NCT00232180|449297386|FG000|Double-blind (DB) Phase|Adverse Event|83|||
124909793|NCT00232180|449297387|FG001|Double-blind (DB) Phase|Adverse Event|100|||
124909794|NCT00232180|449297388|FG002|Double-blind (DB) Phase|Adverse Event|0|||
124909795|NCT00232180|449297386|FG000|Double-blind (DB) Phase|Other|70|||
124909796|NCT00232180|449297387|FG001|Double-blind (DB) Phase|Other|75|||
124909797|NCT00232180|449297388|FG002|Double-blind (DB) Phase|Other|0|||
124909798|NCT00232180|449297386|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
124909799|NCT00232180|449297387|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
124909800|NCT00232180|449297388|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
124909801|NCT00232180|449297386|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
124909802|NCT00232180|449297387|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
124909803|NCT00232180|449297388|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
124909804|NCT00232180|449297386|FG000|Open Label Phase|Death|0|||
124909805|NCT00232180|449297387|FG001|Open Label Phase|Death|0|||
124909806|NCT00232180|449297388|FG002|Open Label Phase|Death|48|||
124909807|NCT00232180|449297386|FG000|Open Label Phase|Lost to Follow-up|0|||
124909808|NCT00232180|449297387|FG001|Open Label Phase|Lost to Follow-up|0|||
124909809|NCT00232180|449297388|FG002|Open Label Phase|Lost to Follow-up|5|||
124909810|NCT00232180|449297386|FG000|Open Label Phase|Protocol Violation|0|||
124909811|NCT00232180|449297387|FG001|Open Label Phase|Protocol Violation|0|||
124909812|NCT00232180|449297388|FG002|Open Label Phase|Protocol Violation|3|||
124909813|NCT00232180|449297386|FG000|Open Label Phase|Study terminated by sponsor|0|||
124909814|NCT00232180|449297387|FG001|Open Label Phase|Study terminated by sponsor|0|||
124909815|NCT00232180|449297388|FG002|Open Label Phase|Study terminated by sponsor|3|||
124909816|NCT00232180|449297386|FG000|Open Label Phase|Withdrawal by Subject|0|||
124909817|NCT00232180|449297387|FG001|Open Label Phase|Withdrawal by Subject|0|||
124909818|NCT00232180|449297388|FG002|Open Label Phase|Withdrawal by Subject|37|||
124909819|NCT00232180|449297386|FG000|Open Label Phase|Other|0|||
124909820|NCT00232180|449297387|FG001|Open Label Phase|Other|0|||
124909821|NCT00232180|449297388|FG002|Open Label Phase|Other|16|||
124909822|NCT00232180|449297386|FG000|Open Label Phase|Adverse Event|0|||
124909823|NCT00232180|449297387|FG001|Open Label Phase|Adverse Event|0|||
124909824|NCT00232180|449297388|FG002|Open Label Phase|Adverse Event|25|||
124909825|NCT00232180|449297386|FG000|Open Label Phase|Laboratory abnormality|0|||
124909826|NCT00232180|449297387|FG001|Open Label Phase|Laboratory abnormality|0|||
124909827|NCT00232180|449297388|FG002|Open Label Phase|Laboratory abnormality|10|||
124909828|NCT00232180|449297386|FG000|Open Label Phase|Randomized but not treated|0|||
124909829|NCT00232180|449297387|FG001|Open Label Phase|Randomized but not treated|0|||
124909830|NCT00232180|449297388|FG002|Open Label Phase|Randomized but not treated|1|||
124909831|NCT03452189|449297389|FG000|First Intervention (3 Months)|Adverse Event|1|||
124909832|NCT03452189|449297390|FG001|First Intervention (3 Months)|Adverse Event|0|||
124909833|NCT03452189|449297389|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
124909834|NCT03452189|449297390|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
124909835|NCT01571596|449297399|FG000|Overall Study|Adverse Event|2|||
124909836|NCT01571596|449297400|FG001|Overall Study|Adverse Event|0|||
125115125|NCT04147715|450044748|FG005|Overall Study|Adverse Event|0|||
125115126|NCT04147715|450044749|FG006|Overall Study|Adverse Event|0|||
125115127|NCT04147715|450044750|FG007|Overall Study|Adverse Event|2|||
124909837|NCT01571596|449297401|FG002|Overall Study|Adverse Event|0|||
124909838|NCT01571596|449297399|FG000|Overall Study|Study Terminated by the Sponsor|0|||
124909839|NCT01571596|449297400|FG001|Overall Study|Study Terminated by the Sponsor|1|||
124909840|NCT01571596|449297401|FG002|Overall Study|Study Terminated by the Sponsor|1|||
124909841|NCT02767765|449297405|FG000|Overall Study|Adverse Event|4|||
124909842|NCT02767765|449297405|FG000|Overall Study|Death|1|||
124909843|NCT02767765|449297405|FG000|Overall Study|Insufficient response|1|||
124909844|NCT02767765|449297405|FG000|Overall Study|Lost to Follow-up|2|||
124909845|NCT02767765|449297405|FG000|Overall Study|Investigator decision|1|||
124909846|NCT02767765|449297405|FG000|Overall Study|Non-Compliance|1|||
124909847|NCT02767765|449297405|FG000|Overall Study|Withdrawal by Subject|1|||
124909848|NCT01951170|449297406|FG000|Overall Study|Investigator decision|1|||
124909849|NCT04512482|449297412|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
124909850|NCT04512482|449297413|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
124909851|NCT00774397|449297416|FG000|Overall Study|Adverse Event|1|||
124909852|NCT00774397|449297417|FG001|Overall Study|Adverse Event|3|||
124909853|NCT00774397|449297418|FG002|Overall Study|Adverse Event|16|||
124909854|NCT00774397|449297419|FG003|Overall Study|Adverse Event|8|||
124909855|NCT00774397|449297420|FG004|Overall Study|Adverse Event|8|||
124909856|NCT00774397|449297421|FG005|Overall Study|Adverse Event|3|||
124909857|NCT00774397|449297422|FG006|Overall Study|Adverse Event|16|||
124909858|NCT00774397|449297416|FG000|Overall Study|Lack of Efficacy|11|||
124909859|NCT00774397|449297417|FG001|Overall Study|Lack of Efficacy|4|||
124909860|NCT00774397|449297418|FG002|Overall Study|Lack of Efficacy|5|||
124909861|NCT00774397|449297419|FG003|Overall Study|Lack of Efficacy|3|||
124909862|NCT00774397|449297420|FG004|Overall Study|Lack of Efficacy|27|||
124909863|NCT00774397|449297421|FG005|Overall Study|Lack of Efficacy|15|||
124909864|NCT00774397|449297422|FG006|Overall Study|Lack of Efficacy|9|||
124909865|NCT00774397|449297416|FG000|Overall Study|Protocol Violation|0|||
124909866|NCT00774397|449297417|FG001|Overall Study|Protocol Violation|1|||
124909867|NCT00774397|449297418|FG002|Overall Study|Protocol Violation|3|||
124909868|NCT00774397|449297419|FG003|Overall Study|Protocol Violation|1|||
124909869|NCT00774397|449297420|FG004|Overall Study|Protocol Violation|2|||
124909870|NCT00774397|449297421|FG005|Overall Study|Protocol Violation|1|||
124909871|NCT00774397|449297422|FG006|Overall Study|Protocol Violation|0|||
124909872|NCT00774397|449297416|FG000|Overall Study|Lost to Follow-up|0|||
124909873|NCT00774397|449297417|FG001|Overall Study|Lost to Follow-up|1|||
124909874|NCT00774397|449297418|FG002|Overall Study|Lost to Follow-up|1|||
124909875|NCT00774397|449297419|FG003|Overall Study|Lost to Follow-up|1|||
124909876|NCT00774397|449297420|FG004|Overall Study|Lost to Follow-up|0|||
124909877|NCT00774397|449297421|FG005|Overall Study|Lost to Follow-up|1|||
124909878|NCT00774397|449297422|FG006|Overall Study|Lost to Follow-up|0|||
124909879|NCT00774397|449297416|FG000|Overall Study|Refused to continue trial medication|1|||
124909880|NCT00774397|449297417|FG001|Overall Study|Refused to continue trial medication|3|||
124909881|NCT00774397|449297418|FG002|Overall Study|Refused to continue trial medication|2|||
124909882|NCT00774397|449297419|FG003|Overall Study|Refused to continue trial medication|2|||
124909883|NCT00774397|449297420|FG004|Overall Study|Refused to continue trial medication|6|||
124909884|NCT00774397|449297421|FG005|Overall Study|Refused to continue trial medication|2|||
124909885|NCT00774397|449297422|FG006|Overall Study|Refused to continue trial medication|3|||
124909886|NCT00774397|449297416|FG000|Overall Study|Not treated|0|||
124909887|NCT00774397|449297417|FG001|Overall Study|Not treated|0|||
124909888|NCT00774397|449297418|FG002|Overall Study|Not treated|0|||
124909889|NCT00774397|449297419|FG003|Overall Study|Not treated|0|||
124909890|NCT00774397|449297420|FG004|Overall Study|Not treated|1|||
124909891|NCT00774397|449297421|FG005|Overall Study|Not treated|0|||
124909892|NCT00774397|449297422|FG006|Overall Study|Not treated|1|||
124909893|NCT00774397|449297416|FG000|Overall Study|Other than those stated above|1|||
124909894|NCT00774397|449297417|FG001|Overall Study|Other than those stated above|1|||
124909895|NCT00774397|449297418|FG002|Overall Study|Other than those stated above|3|||
124909896|NCT00774397|449297419|FG003|Overall Study|Other than those stated above|2|||
124909897|NCT00774397|449297420|FG004|Overall Study|Other than those stated above|2|||
124909898|NCT00774397|449297421|FG005|Overall Study|Other than those stated above|0|||
124909899|NCT00774397|449297422|FG006|Overall Study|Other than those stated above|1|||
124909900|NCT00077675|449297423|FG000|Overall Study|Adverse Event|1|||
124909901|NCT00077675|449297424|FG001|Overall Study|Adverse Event|2|||
124909902|NCT00077675|449297423|FG000|Overall Study|Lost to Follow-up|6|||
124909903|NCT00077675|449297424|FG001|Overall Study|Lost to Follow-up|3|||
124909904|NCT00077675|449297423|FG000|Overall Study|Withdrawal by Subject|1|||
124909905|NCT00077675|449297424|FG001|Overall Study|Withdrawal by Subject|0|||
124909906|NCT00077675|449297423|FG000|Overall Study|Other|0|||
124909907|NCT00077675|449297424|FG001|Overall Study|Other|1|||
124909908|NCT00077675|449297423|FG000|Overall Study|Never received study treatment|3|||
124909909|NCT00077675|449297424|FG001|Overall Study|Never received study treatment|3|||
124909910|NCT00391898|449297437|FG000|Overall Study|Adverse Event|3|||
124909911|NCT00391898|449297438|FG001|Overall Study|Adverse Event|0|||
124909912|NCT00391898|449297437|FG000|Overall Study|Other|8|||
124909913|NCT00391898|449297438|FG001|Overall Study|Other|10|||
124909914|NCT00293293|449297441|FG000|Overall Study|Withdrawal by Subject|1|||
124909915|NCT00293293|449297442|FG001|Overall Study|Withdrawal by Subject|1|||
124909916|NCT00293293|449297441|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
124909917|NCT00293293|449297442|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
124909918|NCT00293293|449297441|FG000|Overall Study|Patient discontinued chemotherapy|0|||
124909919|NCT00293293|449297442|FG001|Overall Study|Patient discontinued chemotherapy|1|||
124909920|NCT02988817|449297444|FG000|Overall Study|Withdrawal by Subject|1|||
124909921|NCT02988817|449297445|FG001|Overall Study|Withdrawal by Subject|0|||
124909922|NCT02988817|449297446|FG002|Overall Study|Withdrawal by Subject|0|||
124909923|NCT02988817|449297447|FG003|Overall Study|Withdrawal by Subject|1|||
124909924|NCT02988817|449297448|FG004|Overall Study|Withdrawal by Subject|3|||
124909925|NCT02988817|449297449|FG005|Overall Study|Withdrawal by Subject|1|||
124909926|NCT02988817|449297450|FG006|Overall Study|Withdrawal by Subject|2|||
124909927|NCT02988817|449297451|FG007|Overall Study|Withdrawal by Subject|1|||
124909928|NCT02988817|449297452|FG008|Overall Study|Withdrawal by Subject|1|||
124909929|NCT02988817|449297453|FG009|Overall Study|Withdrawal by Subject|1|||
124909930|NCT02988817|449297454|FG010|Overall Study|Withdrawal by Subject|1|||
124909931|NCT02988817|449297455|FG011|Overall Study|Withdrawal by Subject|12|||
124909932|NCT02988817|449297456|FG012|Overall Study|Withdrawal by Subject|6|||
124909933|NCT02988817|449297457|FG013|Overall Study|Withdrawal by Subject|6|||
124909934|NCT02988817|449297458|FG014|Overall Study|Withdrawal by Subject|4|||
124909935|NCT02988817|449297459|FG015|Overall Study|Withdrawal by Subject|5|||
124909936|NCT02988817|449297460|FG016|Overall Study|Withdrawal by Subject|4|||
124909937|NCT02988817|449297461|FG017|Overall Study|Withdrawal by Subject|11|||
124909938|NCT02988817|449297462|FG018|Overall Study|Withdrawal by Subject|4|||
124909939|NCT02988817|449297463|FG019|Overall Study|Withdrawal by Subject|2|||
124909940|NCT02988817|449297444|FG000|Overall Study|Death|0|||
124909941|NCT02988817|449297445|FG001|Overall Study|Death|1|||
124909942|NCT02988817|449297446|FG002|Overall Study|Death|3|||
124909943|NCT02988817|449297447|FG003|Overall Study|Death|1|||
124909944|NCT02988817|449297448|FG004|Overall Study|Death|6|||
124909945|NCT02988817|449297449|FG005|Overall Study|Death|10|||
124909946|NCT02988817|449297450|FG006|Overall Study|Death|1|||
124909947|NCT02988817|449297451|FG007|Overall Study|Death|2|||
124909948|NCT02988817|449297452|FG008|Overall Study|Death|1|||
124909949|NCT02988817|449297453|FG009|Overall Study|Death|5|||
124909950|NCT02988817|449297454|FG010|Overall Study|Death|1|||
124909951|NCT02988817|449297455|FG011|Overall Study|Death|8|||
124909952|NCT02988817|449297456|FG012|Overall Study|Death|9|||
124909953|NCT02988817|449297457|FG013|Overall Study|Death|17|||
124909954|NCT02988817|449297458|FG014|Overall Study|Death|18|||
124909955|NCT02988817|449297459|FG015|Overall Study|Death|30|||
124909956|NCT02988817|449297460|FG016|Overall Study|Death|17|||
124909957|NCT02988817|449297461|FG017|Overall Study|Death|38|||
124909958|NCT02988817|449297462|FG018|Overall Study|Death|14|||
124909959|NCT02988817|449297463|FG019|Overall Study|Death|16|||
124909960|NCT02988817|449297444|FG000|Overall Study|Other|0|||
124909961|NCT02988817|449297445|FG001|Overall Study|Other|0|||
124909962|NCT02988817|449297446|FG002|Overall Study|Other|0|||
124909963|NCT02988817|449297447|FG003|Overall Study|Other|1|||
124909964|NCT02988817|449297448|FG004|Overall Study|Other|1|||
124909965|NCT02988817|449297449|FG005|Overall Study|Other|0|||
124909966|NCT02988817|449297450|FG006|Overall Study|Other|0|||
124909967|NCT02988817|449297451|FG007|Overall Study|Other|0|||
124909968|NCT02988817|449297452|FG008|Overall Study|Other|0|||
124909969|NCT02988817|449297453|FG009|Overall Study|Other|0|||
124909970|NCT02988817|449297454|FG010|Overall Study|Other|0|||
124909971|NCT02988817|449297455|FG011|Overall Study|Other|0|||
124909972|NCT02988817|449297456|FG012|Overall Study|Other|0|||
124909973|NCT02988817|449297457|FG013|Overall Study|Other|0|||
124909974|NCT02988817|449297458|FG014|Overall Study|Other|0|||
124909975|NCT02988817|449297459|FG015|Overall Study|Other|1|||
124909976|NCT02988817|449297460|FG016|Overall Study|Other|0|||
124909977|NCT02988817|449297461|FG017|Overall Study|Other|0|||
124909978|NCT02988817|449297462|FG018|Overall Study|Other|0|||
124909979|NCT02988817|449297463|FG019|Overall Study|Other|0|||
124909980|NCT02988817|449297444|FG000|Overall Study|Lost to Follow-up|0|||
124909981|NCT02988817|449297445|FG001|Overall Study|Lost to Follow-up|0|||
124909982|NCT02988817|449297446|FG002|Overall Study|Lost to Follow-up|0|||
124909983|NCT02988817|449297447|FG003|Overall Study|Lost to Follow-up|0|||
124909984|NCT02988817|449297448|FG004|Overall Study|Lost to Follow-up|0|||
124909985|NCT02988817|449297449|FG005|Overall Study|Lost to Follow-up|0|||
124909986|NCT02988817|449297450|FG006|Overall Study|Lost to Follow-up|0|||
124909987|NCT02988817|449297451|FG007|Overall Study|Lost to Follow-up|0|||
124909988|NCT02988817|449297452|FG008|Overall Study|Lost to Follow-up|1|||
124909989|NCT02988817|449297453|FG009|Overall Study|Lost to Follow-up|0|||
124909990|NCT02988817|449297454|FG010|Overall Study|Lost to Follow-up|1|||
124909991|NCT02988817|449297455|FG011|Overall Study|Lost to Follow-up|1|||
124909992|NCT02988817|449297456|FG012|Overall Study|Lost to Follow-up|0|||
124909993|NCT02988817|449297457|FG013|Overall Study|Lost to Follow-up|0|||
124909994|NCT02988817|449297458|FG014|Overall Study|Lost to Follow-up|1|||
124909995|NCT02988817|449297459|FG015|Overall Study|Lost to Follow-up|1|||
124909996|NCT02988817|449297460|FG016|Overall Study|Lost to Follow-up|2|||
124909997|NCT02988817|449297461|FG017|Overall Study|Lost to Follow-up|3|||
124909998|NCT02988817|449297462|FG018|Overall Study|Lost to Follow-up|0|||
124909999|NCT02988817|449297463|FG019|Overall Study|Lost to Follow-up|0|||
124910000|NCT02988817|449297444|FG000|Overall Study|Sponsor decision|0|||
124910001|NCT02988817|449297445|FG001|Overall Study|Sponsor decision|0|||
124910002|NCT02988817|449297446|FG002|Overall Study|Sponsor decision|0|||
124910003|NCT02988817|449297447|FG003|Overall Study|Sponsor decision|0|||
124910004|NCT02988817|449297448|FG004|Overall Study|Sponsor decision|0|||
124910005|NCT02988817|449297449|FG005|Overall Study|Sponsor decision|0|||
124910006|NCT02988817|449297450|FG006|Overall Study|Sponsor decision|0|||
124910007|NCT02988817|449297451|FG007|Overall Study|Sponsor decision|0|||
124910008|NCT02988817|449297452|FG008|Overall Study|Sponsor decision|0|||
124910009|NCT02988817|449297453|FG009|Overall Study|Sponsor decision|0|||
124910010|NCT02988817|449297454|FG010|Overall Study|Sponsor decision|0|||
124910011|NCT02988817|449297455|FG011|Overall Study|Sponsor decision|1|||
124910012|NCT02988817|449297456|FG012|Overall Study|Sponsor decision|1|||
124910013|NCT02988817|449297457|FG013|Overall Study|Sponsor decision|2|||
124910014|NCT02988817|449297458|FG014|Overall Study|Sponsor decision|2|||
124910015|NCT02988817|449297459|FG015|Overall Study|Sponsor decision|6|||
124910016|NCT02988817|449297460|FG016|Overall Study|Sponsor decision|2|||
124910017|NCT02988817|449297461|FG017|Overall Study|Sponsor decision|3|||
124910018|NCT02988817|449297462|FG018|Overall Study|Sponsor decision|2|||
124910019|NCT02988817|449297463|FG019|Overall Study|Sponsor decision|7|||
124910020|NCT02988817|449297444|FG000|Overall Study|Physician Decision|0|||
124910021|NCT02988817|449297445|FG001|Overall Study|Physician Decision|0|||
124910022|NCT02988817|449297446|FG002|Overall Study|Physician Decision|0|||
124910023|NCT02988817|449297447|FG003|Overall Study|Physician Decision|0|||
124910024|NCT02988817|449297448|FG004|Overall Study|Physician Decision|0|||
124910025|NCT02988817|449297449|FG005|Overall Study|Physician Decision|0|||
124910026|NCT02988817|449297450|FG006|Overall Study|Physician Decision|0|||
124910027|NCT02988817|449297451|FG007|Overall Study|Physician Decision|0|||
124910028|NCT02988817|449297452|FG008|Overall Study|Physician Decision|0|||
124910029|NCT02988817|449297453|FG009|Overall Study|Physician Decision|0|||
124910030|NCT02988817|449297454|FG010|Overall Study|Physician Decision|0|||
124910031|NCT02988817|449297455|FG011|Overall Study|Physician Decision|0|||
124910032|NCT02988817|449297456|FG012|Overall Study|Physician Decision|0|||
124910033|NCT02988817|449297457|FG013|Overall Study|Physician Decision|0|||
124910034|NCT02988817|449297458|FG014|Overall Study|Physician Decision|0|||
124910035|NCT02988817|449297459|FG015|Overall Study|Physician Decision|1|||
124910036|NCT02988817|449297460|FG016|Overall Study|Physician Decision|0|||
124910037|NCT02988817|449297461|FG017|Overall Study|Physician Decision|0|||
124910038|NCT02988817|449297462|FG018|Overall Study|Physician Decision|1|||
124910039|NCT02988817|449297463|FG019|Overall Study|Physician Decision|1|||
124910040|NCT04530747|449297465|FG000|Overall Study|Withdrawal by Subject|1|||
124910041|NCT04530747|449297466|FG001|Overall Study|Withdrawal by Subject|0|||
124910042|NCT03292913|449297467|FG000|Overall Study|Death|9|||
124910043|NCT03292913|449297468|FG001|Overall Study|Death|3|||
124910044|NCT03292913|449297467|FG000|Overall Study|Lost to Follow-up|49|||
124910045|NCT03292913|449297468|FG001|Overall Study|Lost to Follow-up|49|||
124910046|NCT03292913|449297467|FG000|Overall Study|Withdrawal by Subject|2|||
124910047|NCT03292913|449297468|FG001|Overall Study|Withdrawal by Subject|0|||
124910048|NCT03292913|449297467|FG000|Overall Study|Clinic closed due to COVID|22|||
124910049|NCT03292913|449297468|FG001|Overall Study|Clinic closed due to COVID|36|||
124910050|NCT03950622|449297469|FG000|Overall Study|Withdrawal by Subject|1|||
124910051|NCT03950622|449297470|FG001|Overall Study|Withdrawal by Subject|0|||
124910052|NCT03950622|449297469|FG000|Overall Study|Protocol Deviation|0|||
124910053|NCT03950622|449297470|FG001|Overall Study|Protocol Deviation|1|||
124910054|NCT03950622|449297469|FG000|Overall Study|Physician Decision|1|||
124910055|NCT03950622|449297470|FG001|Overall Study|Physician Decision|0|||
124910056|NCT03950622|449297469|FG000|Overall Study|Lost to Follow-up|5|||
124910057|NCT03950622|449297470|FG001|Overall Study|Lost to Follow-up|5|||
124910058|NCT03950622|449297469|FG000|Overall Study|Death|1|||
124910059|NCT03950622|449297470|FG001|Overall Study|Death|1|||
124910060|NCT03752151|449297471|FG000|Overall Study|Withdrawal by Subject|1|||
124910061|NCT03752151|449297471|FG000|Overall Study|Protocol Violation|1|||
124910062|NCT00529516|449297472|FG000|Overall Study|Adverse Event|2|||
124910063|NCT00529516|449297473|FG001|Overall Study|Adverse Event|1|||
124910064|NCT00529516|449297474|FG002|Overall Study|Adverse Event|0|||
124910065|NCT00529516|449297472|FG000|Overall Study|Withdrawal by Subject|1|||
124910066|NCT00529516|449297473|FG001|Overall Study|Withdrawal by Subject|1|||
124910067|NCT00529516|449297474|FG002|Overall Study|Withdrawal by Subject|0|||
124910068|NCT00529516|449297472|FG000|Overall Study|Lost to Follow-up|0|||
124910069|NCT00529516|449297473|FG001|Overall Study|Lost to Follow-up|0|||
124910070|NCT00529516|449297474|FG002|Overall Study|Lost to Follow-up|1|||
124910071|NCT00939510|449297479|FG000|Overall Study|Withdrawal by Subject|1|||
124910072|NCT03942042|449297492|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
124910073|NCT03942042|449297493|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
124910074|NCT03942042|449297492|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
124910075|NCT03942042|449297493|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
124910076|NCT01787760|449297494|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
124910077|NCT01787760|449297495|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
124910078|NCT01787760|449297496|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
124910079|NCT01787760|449297494|FG000|Overall Study|Decompensated on left exotropia|0|||
124910080|NCT01787760|449297495|FG001|Overall Study|Decompensated on left exotropia|0|||
124910081|NCT01787760|449297496|FG002|Overall Study|Decompensated on left exotropia|1|||
124910082|NCT01787760|449297494|FG000|Overall Study|Dryness|0|||
124910083|NCT01787760|449297495|FG001|Overall Study|Dryness|1|||
124910084|NCT01787760|449297496|FG002|Overall Study|Dryness|0|||
124910085|NCT01787760|449297494|FG000|Overall Study|Relocation|1|||
124910086|NCT01787760|449297495|FG001|Overall Study|Relocation|1|||
124910087|NCT01787760|449297496|FG002|Overall Study|Relocation|0|||
124910088|NCT01787760|449297494|FG000|Overall Study|Lens discomfort|3|||
124910089|NCT01787760|449297495|FG001|Overall Study|Lens discomfort|0|||
124910090|NCT01787760|449297496|FG002|Overall Study|Lens discomfort|0|||
124910091|NCT01787760|449297494|FG000|Overall Study|Lens handling difficulty|1|||
124910092|NCT01787760|449297495|FG001|Overall Study|Lens handling difficulty|2|||
124910093|NCT01787760|449297496|FG002|Overall Study|Lens handling difficulty|0|||
124910094|NCT01787760|449297494|FG000|Overall Study|Protocol Violation|6|||
124910095|NCT01787760|449297495|FG001|Overall Study|Protocol Violation|0|||
124910096|NCT01787760|449297496|FG002|Overall Study|Protocol Violation|1|||
124910097|NCT01787760|449297494|FG000|Overall Study|Withdrawal by Subject|5|||
124910098|NCT01787760|449297495|FG001|Overall Study|Withdrawal by Subject|1|||
124910099|NCT01787760|449297496|FG002|Overall Study|Withdrawal by Subject|2|||
124910100|NCT01787760|449297494|FG000|Overall Study|Lost to Follow-up|1|||
124910101|NCT01787760|449297495|FG001|Overall Study|Lost to Follow-up|0|||
124910102|NCT01787760|449297496|FG002|Overall Study|Lost to Follow-up|1|||
124910103|NCT01787760|449297494|FG000|Overall Study|Stroke|1|||
124910104|NCT01787760|449297495|FG001|Overall Study|Stroke|0|||
124910105|NCT01787760|449297496|FG002|Overall Study|Stroke|0|||
124910106|NCT01787760|449297494|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
124910107|NCT01787760|449297495|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
124910108|NCT01787760|449297496|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
124910109|NCT01787760|449297494|FG000|Overall Study|Unsatisfactory physiological response|2|||
124910110|NCT01787760|449297495|FG001|Overall Study|Unsatisfactory physiological response|4|||
124910111|NCT01787760|449297496|FG002|Overall Study|Unsatisfactory physiological response|0|||
124910112|NCT01787760|449297494|FG000|Overall Study|Unsatisfactory visual response|1|||
124910113|NCT01787760|449297495|FG001|Overall Study|Unsatisfactory visual response|1|||
124910114|NCT01787760|449297496|FG002|Overall Study|Unsatisfactory visual response|0|||
124910115|NCT01787760|449297494|FG000|Overall Study|Near vision blur|1|||
124910116|NCT01787760|449297495|FG001|Overall Study|Near vision blur|0|||
124910117|NCT01787760|449297496|FG002|Overall Study|Near vision blur|0|||
124910118|NCT01849055|449297497|FG000|Overall Study|Withdrawal by Subject|0|||
124910119|NCT01849055|449297498|FG001|Overall Study|Withdrawal by Subject|0|||
124910120|NCT01849055|449297499|FG002|Overall Study|Withdrawal by Subject|1|||
124910121|NCT01849055|449297500|FG003|Overall Study|Withdrawal by Subject|0|||
124910122|NCT01849055|449297501|FG004|Overall Study|Withdrawal by Subject|0|||
124910123|NCT01849055|449297502|FG005|Overall Study|Withdrawal by Subject|0|||
124910124|NCT01239316|449297503|FG000|Overall Study|Progression/Relapse|11|||
124910125|NCT01239316|449297503|FG000|Overall Study|Adverse Event|1|||
124910126|NCT04623008|449298558|FG000|Baseline to T2|Withdrawal by Subject|4|||
124910127|NCT04623008|449298559|FG001|Baseline to T2|Withdrawal by Subject|2|||
124910128|NCT04623008|449298558|FG000|Baseline to T3|Withdrawal by Subject|4|||
124910129|NCT04623008|449298559|FG001|Baseline to T3|Withdrawal by Subject|2|||
124910130|NCT03122886|449298560|FG000|Overall Study|Withdrawal by Subject|1|||
124910131|NCT03122886|449298561|FG001|Overall Study|Withdrawal by Subject|2|||
124910132|NCT03779048|449298562|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
124910133|NCT03779048|449298563|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
124910134|NCT03779048|449298564|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
124910135|NCT03779048|449298562|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
124910136|NCT03779048|449298563|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
124910137|NCT03779048|449298564|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
124910138|NCT03779048|449298562|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
124910139|NCT03779048|449298563|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
124910140|NCT03779048|449298564|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
124910141|NCT03422276|449298565|FG000|Overall Study|Withdrawal by Subject|21|||
124910142|NCT03422276|449298566|FG001|Overall Study|Withdrawal by Subject|25|||
124910143|NCT03422276|449298567|FG002|Overall Study|Withdrawal by Subject|14|||
124910144|NCT03422276|449298568|FG003|Overall Study|Withdrawal by Subject|16|||
124910145|NCT03422276|449298565|FG000|Overall Study|Death|14|||
124910146|NCT03422276|449298566|FG001|Overall Study|Death|21|||
124910147|NCT03422276|449298567|FG002|Overall Study|Death|3|||
124910148|NCT03422276|449298568|FG003|Overall Study|Death|1|||
124910149|NCT03422276|449298565|FG000|Overall Study|Discontinued, ineligible|4|||
124910150|NCT03422276|449298566|FG001|Overall Study|Discontinued, ineligible|3|||
124910151|NCT03422276|449298567|FG002|Overall Study|Discontinued, ineligible|0|||
124910152|NCT03422276|449298568|FG003|Overall Study|Discontinued, ineligible|0|||
124910153|NCT03422276|449298565|FG000|Overall Study|Lost to Follow-up|15|||
124910154|NCT03422276|449298566|FG001|Overall Study|Lost to Follow-up|8|||
124910155|NCT03422276|449298567|FG002|Overall Study|Lost to Follow-up|13|||
124910156|NCT03422276|449298568|FG003|Overall Study|Lost to Follow-up|4|||
124910157|NCT03422276|449298565|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
124910158|NCT03422276|449298566|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
124910159|NCT03422276|449298567|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
124910160|NCT03422276|449298568|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
124910161|NCT03422276|449298565|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
124910162|NCT03422276|449298566|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
124910163|NCT03422276|449298567|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
124910164|NCT03422276|449298568|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
124910165|NCT03422276|449298565|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
124910166|NCT03422276|449298566|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
124910167|NCT03422276|449298567|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
124910168|NCT03422276|449298568|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
124910169|NCT03422276|449298565|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
124910170|NCT03422276|449298566|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
124910171|NCT03422276|449298567|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
124910172|NCT03422276|449298568|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
124910173|NCT03422276|449298565|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
124910174|NCT03422276|449298566|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
124910175|NCT03422276|449298567|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
124910176|NCT03422276|449298568|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
124910177|NCT05985044|449298569|FG000|Overall Study|Death|6|||
124910178|NCT05985044|449298569|FG000|Overall Study|Lost to Follow-up|4|||
124910179|NCT05985044|449298569|FG000|Overall Study|Incapacitation|3|||
124910180|NCT05985044|449298569|FG000|Overall Study|Withdrawal by Subject|2|||
124910181|NCT04588259|449298570|FG000|Run-in Period|Run-in failure|0|||
124910182|NCT04588259|449298571|FG001|Run-in Period|Run-in failure|23|||
124910183|NCT04588259|449298570|FG000|Run-in Period|Withdrawn before randomisation|0|||
124910184|NCT04588259|449298571|FG001|Run-in Period|Withdrawn before randomisation|8|||
124910185|NCT04588259|449298570|FG000|Treatment Period|Withdrawal by Subject|6|||
124910186|NCT04588259|449298571|FG001|Treatment Period|Withdrawal by Subject|6|||
124910187|NCT03051165|449298579|FG000|Overall Study|Withdrawal by Subject|1|||
124910188|NCT03051165|449298579|FG000|Overall Study|Early termination of study|12|||
124910189|NCT02092116|449298580|FG000|Overall Study|Withdrawal by Subject|0|||
124910190|NCT02092116|449298581|FG001|Overall Study|Withdrawal by Subject|3|||
124910191|NCT02092116|449298580|FG000|Overall Study|Adverse Event|0|||
124910192|NCT02092116|449298581|FG001|Overall Study|Adverse Event|1|||
124910193|NCT03074331|449298582|FG000|Overall Study|Enrolled but Not Treated|1|||
124910194|NCT03074331|449298582|FG000|Overall Study|Lost to Follow-up|5|||
124910195|NCT03074331|449298582|FG000|Overall Study|Withdrew Consent|1|||
124910196|NCT01546753|449298583|FG000|Overall Study|anxiety|1|||
124910197|NCT01546753|449298584|FG001|Overall Study|anxiety|1|||
124910198|NCT01546753|449298583|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
124910199|NCT01546753|449298584|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
124910200|NCT00546754|449298587|FG000|Overall Study|Serious Adverse Event|1|||
124910201|NCT00546754|449298588|FG001|Overall Study|Serious Adverse Event|1|||
124910202|NCT00546754|449298587|FG000|Overall Study|Adverse Event|11|||
124910203|NCT00546754|449298588|FG001|Overall Study|Adverse Event|16|||
124910204|NCT00546754|449298587|FG000|Overall Study|Lack of Efficacy|1|||
124910205|NCT00546754|449298588|FG001|Overall Study|Lack of Efficacy|1|||
124910206|NCT00546754|449298587|FG000|Overall Study|Lost to Follow-up|9|||
125115128|NCT04147715|450044751|FG008|Overall Study|Adverse Event|1|||
124910207|NCT00546754|449298588|FG001|Overall Study|Lost to Follow-up|15|||
124910208|NCT00546754|449298587|FG000|Overall Study|Protocol Violation|3|||
124910209|NCT00546754|449298588|FG001|Overall Study|Protocol Violation|0|||
124910210|NCT00546754|449298587|FG000|Overall Study|Withdrawal by Subject|6|||
124910211|NCT00546754|449298588|FG001|Overall Study|Withdrawal by Subject|7|||
124910212|NCT00546754|449298587|FG000|Overall Study|Dyspnea|1|||
125115129|NCT04147715|450044752|FG009|Overall Study|Adverse Event|0|||
125115130|NCT04147715|450044753|FG010|Overall Study|Adverse Event|0|||
124910213|NCT00546754|449298588|FG001|Overall Study|Dyspnea|0|||
124910214|NCT00546754|449298587|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
124910215|NCT00546754|449298588|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
124910216|NCT00546754|449298587|FG000|Overall Study|Hip Replacement|1|||
124910217|NCT00546754|449298588|FG001|Overall Study|Hip Replacement|0|||
124910218|NCT00546754|449298587|FG000|Overall Study|Suicide|1|||
124910219|NCT00546754|449298588|FG001|Overall Study|Suicide|0|||
124910220|NCT00546754|449298587|FG000|Overall Study|Missing Cooperation|1|||
124910221|NCT00546754|449298588|FG001|Overall Study|Missing Cooperation|0|||
124910222|NCT00546754|449298587|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
124910223|NCT00546754|449298588|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
124910224|NCT00546754|449298587|FG000|Overall Study|Patient's Decision|0|||
124910225|NCT00546754|449298588|FG001|Overall Study|Patient's Decision|1|||
124910226|NCT00546754|449298587|FG000|Overall Study|Missing|14|||
124910227|NCT00546754|449298588|FG001|Overall Study|Missing|7|||
124910228|NCT00311363|449298591|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
124910229|NCT00311363|449298592|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
124910230|NCT00311363|449298593|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
124910231|NCT00311363|449298591|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
124910232|NCT00311363|449298592|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
124910233|NCT00311363|449298593|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
124910234|NCT00311363|449298591|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
124910235|NCT00311363|449298592|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
124910236|NCT00311363|449298593|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
124910237|NCT00311363|449298591|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
124910238|NCT00311363|449298592|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
124910239|NCT00311363|449298593|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
124910240|NCT00311363|449298591|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
124910241|NCT00311363|449298592|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
124910242|NCT00311363|449298593|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
124910243|NCT00311363|449298591|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
124910244|NCT00311363|449298592|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
124910245|NCT00311363|449298593|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
124910246|NCT00311363|449298591|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
124910247|NCT00311363|449298592|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
124910248|NCT00311363|449298593|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
124910249|NCT00311363|449298591|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
124910250|NCT00311363|449298592|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
124910251|NCT00311363|449298593|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
124910252|NCT00311363|449298591|FG000|24-Week Single-Blind Treatment Period|Death|1|||
124910253|NCT00311363|449298592|FG001|24-Week Single-Blind Treatment Period|Death|0|||
124910254|NCT00311363|449298593|FG002|24-Week Single-Blind Treatment Period|Death|0|||
124910255|NCT00311363|449298591|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
124910256|NCT00311363|449298592|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
124910257|NCT00311363|449298593|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
124910258|NCT00311363|449298591|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
124910259|NCT00311363|449298592|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
124910260|NCT00311363|449298593|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
124910261|NCT00311363|449298591|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
124910262|NCT00311363|449298592|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
124910263|NCT00311363|449298593|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
124910264|NCT00311363|449298591|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
124910265|NCT00311363|449298592|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
124910266|NCT00311363|449298593|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
124910267|NCT00311363|449298591|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
124910268|NCT00311363|449298592|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
124910269|NCT00311363|449298593|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
124910270|NCT00311363|449298591|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
124910271|NCT00311363|449298592|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
124910272|NCT00311363|449298593|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
124910273|NCT03830866|449298594|FG000|Overall Study|Death|90|||
124910274|NCT03830866|449298595|FG001|Overall Study|Death|111|||
124910275|NCT03830866|449298594|FG000|Overall Study|Lost to Follow-up|7|||
124910276|NCT03830866|449298595|FG001|Overall Study|Lost to Follow-up|7|||
124910277|NCT03830866|449298594|FG000|Overall Study|Withdrawal by Subject|19|||
124910278|NCT03830866|449298595|FG001|Overall Study|Withdrawal by Subject|16|||
124910279|NCT03830866|449298594|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
124910280|NCT03830866|449298595|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
124910281|NCT03830866|449298594|FG000|Overall Study|Other|1|||
124910282|NCT03830866|449298595|FG001|Overall Study|Other|1|||
124910283|NCT01759771|449298596|FG000|Overall Study|Withdrawal by Subject|1|||
124910284|NCT01759771|449298597|FG001|Overall Study|Withdrawal by Subject|1|||
124910285|NCT02139943|449298600|FG000|Overall Study|Adverse Event|0|||
124910286|NCT02139943|449298601|FG001|Overall Study|Adverse Event|1|||
124910287|NCT02139943|449298602|FG002|Overall Study|Adverse Event|2|||
124910288|NCT02139943|449298600|FG000|Overall Study|Lost to Follow-up|3|||
124910289|NCT02139943|449298601|FG001|Overall Study|Lost to Follow-up|2|||
124910290|NCT02139943|449298602|FG002|Overall Study|Lost to Follow-up|2|||
124910291|NCT02139943|449298600|FG000|Overall Study|Withdrawal by Subject|4|||
124910292|NCT02139943|449298601|FG001|Overall Study|Withdrawal by Subject|3|||
124910293|NCT02139943|449298602|FG002|Overall Study|Withdrawal by Subject|0|||
124910294|NCT02139943|449298600|FG000|Overall Study|Other|0|||
124910295|NCT02139943|449298601|FG001|Overall Study|Other|0|||
124910296|NCT02139943|449298602|FG002|Overall Study|Other|1|||
124910297|NCT02139943|449298600|FG000|Overall Study|Participant wishes to discontinue|2|||
124910298|NCT02139943|449298601|FG001|Overall Study|Participant wishes to discontinue|0|||
124910299|NCT02139943|449298602|FG002|Overall Study|Participant wishes to discontinue|0|||
124910300|NCT02139943|449298600|FG000|Overall Study|Participant in Poor Compliance|1|||
124910301|NCT02139943|449298601|FG001|Overall Study|Participant in Poor Compliance|0|||
124910302|NCT02139943|449298602|FG002|Overall Study|Participant in Poor Compliance|1|||
124910303|NCT02139943|449298600|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
124910304|NCT02139943|449298601|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
124910305|NCT02139943|449298602|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
124910306|NCT00716859|449298605|FG000|Overall Study|Adverse Event|4|||
124910307|NCT00716859|449298606|FG001|Overall Study|Adverse Event|1|||
124910308|NCT00716859|449298605|FG000|Overall Study|Lack of Efficacy|3|||
124910309|NCT00716859|449298606|FG001|Overall Study|Lack of Efficacy|0|||
124910310|NCT00716859|449298605|FG000|Overall Study|Withdrawal by Subject|1|||
124910311|NCT00716859|449298606|FG001|Overall Study|Withdrawal by Subject|3|||
124910312|NCT00716859|449298605|FG000|Overall Study|Not treated|1|||
124910313|NCT00716859|449298606|FG001|Overall Study|Not treated|1|||
124910314|NCT03750968|449298608|FG000|Overall Study|Adverse Event|2|||
124910315|NCT03750968|449298609|FG001|Overall Study|Adverse Event|0|||
124910316|NCT03750968|449298608|FG000|Overall Study|Lost to Follow-up|1|||
124910317|NCT03750968|449298609|FG001|Overall Study|Lost to Follow-up|3|||
124910318|NCT00088413|449298611|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
124910319|NCT00088413|449298612|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
124910320|NCT00088413|449298613|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
124910321|NCT00088413|449298614|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
124910322|NCT00088413|449298611|FG000|Overall Study|Adverse Events/Side Effects|0|||
124910323|NCT00088413|449298612|FG001|Overall Study|Adverse Events/Side Effects|1|||
124910324|NCT00088413|449298613|FG002|Overall Study|Adverse Events/Side Effects|1|||
124910325|NCT00088413|449298614|FG003|Overall Study|Adverse Events/Side Effects|0|||
124910326|NCT00088413|449298611|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
124910327|NCT00088413|449298612|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
124910328|NCT00088413|449298613|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
124910329|NCT00088413|449298614|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
124910330|NCT00088413|449298611|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
124910331|NCT00088413|449298612|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
124910332|NCT00088413|449298613|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
124910333|NCT00088413|449298614|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
124910334|NCT00088413|449298611|FG000|Overall Study|Death|0|||
124910335|NCT00088413|449298612|FG001|Overall Study|Death|1|||
124910336|NCT00088413|449298613|FG002|Overall Study|Death|0|||
124910337|NCT00088413|449298614|FG003|Overall Study|Death|0|||
124910338|NCT00088413|449298611|FG000|Overall Study|Progressive disease|9|||
124910339|NCT00088413|449298612|FG001|Overall Study|Progressive disease|11|||
124910340|NCT00088413|449298613|FG002|Overall Study|Progressive disease|8|||
124910341|NCT00088413|449298614|FG003|Overall Study|Progressive disease|14|||
124910342|NCT00088413|449298611|FG000|Overall Study|Other|0|||
124910343|NCT00088413|449298612|FG001|Overall Study|Other|1|||
124910344|NCT00088413|449298613|FG002|Overall Study|Other|0|||
124910345|NCT00088413|449298614|FG003|Overall Study|Other|0|||
124910346|NCT00088413|449298611|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
124910347|NCT00088413|449298612|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
124910348|NCT00088413|449298613|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
124910349|NCT00088413|449298614|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
124910350|NCT01551355|449298617|FG000|Overall Study|Lost to Follow-up|51|||
124910351|NCT01551355|449298618|FG001|Overall Study|Lost to Follow-up|49|||
124910352|NCT01551355|449298619|FG002|Overall Study|Lost to Follow-up|34|||
124910353|NCT01551355|449298620|FG003|Overall Study|Lost to Follow-up|24|||
124910354|NCT01551355|449298621|FG004|Overall Study|Lost to Follow-up|9|||
124910355|NCT01551355|449298622|FG005|Overall Study|Lost to Follow-up|6|||
124910356|NCT00411216|449298623|FG000|Overall Study|Ten participants were entered into the c|0|||
124910357|NCT00411216|449298624|FG001|Overall Study|Ten participants were entered into the c|2|||
124910358|NCT02918071|449298625|FG000|Overall Study|Withdrawal by Subject|2|||
124910359|NCT02918071|449298625|FG000|Overall Study|Lost to Follow-up|1|||
124910360|NCT00203411|449298628|FG000|Follow-up|Progressive Disease|4|||
124910361|NCT00632424|449298631|FG000|Overall Study|Disease Progression|17|||
124910362|NCT00632424|449298631|FG000|Overall Study|Study Drug Toxicity|1|||
124910363|NCT02531113|449298632|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
124910364|NCT02531113|449298632|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
124910365|NCT02531113|449298632|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
124910366|NCT02531113|449298632|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
124910367|NCT02531113|449298632|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
124910368|NCT02531113|449298632|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
124910369|NCT02531113|449298632|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
124910370|NCT02531113|449298632|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
124910371|NCT00774852|449298634|FG000|Overall Study|Adverse Event|9|||
124910372|NCT00774852|449298635|FG001|Overall Study|Adverse Event|6|||
124910373|NCT00774852|449298634|FG000|Overall Study|Death|2|||
124910374|NCT00774852|449298635|FG001|Overall Study|Death|1|||
124910375|NCT00774852|449298634|FG000|Overall Study|Lack of Efficacy|3|||
124910376|NCT00774852|449298635|FG001|Overall Study|Lack of Efficacy|7|||
124910377|NCT00774852|449298634|FG000|Overall Study|Lost to Follow-up|9|||
124910378|NCT00774852|449298635|FG001|Overall Study|Lost to Follow-up|5|||
124910379|NCT00774852|449298634|FG000|Overall Study|Physician Decision|2|||
124910380|NCT00774852|449298635|FG001|Overall Study|Physician Decision|6|||
124910381|NCT00774852|449298634|FG000|Overall Study|Pregnancy|1|||
124910382|NCT00774852|449298635|FG001|Overall Study|Pregnancy|2|||
124910383|NCT00774852|449298634|FG000|Overall Study|Withdrawal by Subject|2|||
124910384|NCT00774852|449298635|FG001|Overall Study|Withdrawal by Subject|2|||
124910385|NCT00774852|449298634|FG000|Overall Study|Non-responder|15|||
124910386|NCT00774852|449298635|FG001|Overall Study|Non-responder|11|||
124910387|NCT00774852|449298634|FG000|Overall Study|Subject non-compliance|0|||
124910388|NCT00774852|449298635|FG001|Overall Study|Subject non-compliance|1|||
124910389|NCT00774852|449298634|FG000|Overall Study|Protocol Violation|1|||
124910390|NCT00774852|449298635|FG001|Overall Study|Protocol Violation|0|||
124910391|NCT00774852|449298634|FG000|Overall Study|Subject received prohibited medication|1|||
124910392|NCT00774852|449298635|FG001|Overall Study|Subject received prohibited medication|0|||
124910393|NCT03997916|449298636|FG000|Overall Study|Protocol Violation|35|||
124910394|NCT03482635|449298640|FG000|Overall Study|Lack of Efficacy|0|||
124910395|NCT03482635|449298641|FG001|Overall Study|Lack of Efficacy|0|||
124910396|NCT03482635|449298642|FG002|Overall Study|Lack of Efficacy|1|||
124910397|NCT03482635|449298643|FG003|Overall Study|Lack of Efficacy|3|||
124910398|NCT03482635|449298640|FG000|Overall Study|Adverse Event|2|||
124910399|NCT03482635|449298641|FG001|Overall Study|Adverse Event|2|||
124910400|NCT03482635|449298642|FG002|Overall Study|Adverse Event|0|||
124910401|NCT03482635|449298643|FG003|Overall Study|Adverse Event|3|||
124910402|NCT03482635|449298640|FG000|Overall Study|Withdrawal by Subject|2|||
124910403|NCT03482635|449298641|FG001|Overall Study|Withdrawal by Subject|1|||
124910404|NCT03482635|449298642|FG002|Overall Study|Withdrawal by Subject|0|||
124910405|NCT03482635|449298643|FG003|Overall Study|Withdrawal by Subject|1|||
124910406|NCT03482635|449298640|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
124910407|NCT03482635|449298641|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
124910408|NCT03482635|449298642|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
124910409|NCT03482635|449298643|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
124910410|NCT03482635|449298640|FG000|Overall Study|Not treated|0|||
124910411|NCT03482635|449298641|FG001|Overall Study|Not treated|0|||
124910412|NCT03482635|449298642|FG002|Overall Study|Not treated|0|||
124910413|NCT03482635|449298643|FG003|Overall Study|Not treated|1|||
124910414|NCT02279095|449299757|FG000|Overall Study|Non-Compliance|1|||
124910415|NCT02279095|449299757|FG000|Overall Study|Withdrawal by Subject|8|||
124910416|NCT02279095|449299757|FG000|Overall Study|Adverse Event|2|||
124910417|NCT02279095|449299757|FG000|Overall Study|Other|7|||
124910418|NCT02279095|449299757|FG000|Overall Study|Lost to Follow-up|1|||
124910419|NCT05644444|449299758|FG000|Tolerance Phase|Adverse Event|0|||
124910420|NCT05644444|449299759|FG001|Tolerance Phase|Adverse Event|2|||
124910421|NCT05644444|449299758|FG000|Treatment Phase|Adverse Event|0|||
124910422|NCT05644444|449299759|FG001|Treatment Phase|Adverse Event|2|||
124910423|NCT03936660|449299760|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
124910424|NCT03936660|449299761|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
124910425|NCT02724592|449299764|FG000|Overall Study|Lost to Follow-up|4|||
124910426|NCT02724592|449299765|FG001|Overall Study|Lost to Follow-up|1|||
124910427|NCT02584829|449299766|FG000|Overall Study|Physician Decision|1|||
124910428|NCT02584829|449299767|FG001|Overall Study|Physician Decision|0|||
124910429|NCT02584829|449299766|FG000|Overall Study|Withdrawal by Subject|0|||
124910430|NCT02584829|449299767|FG001|Overall Study|Withdrawal by Subject|1|||
124910431|NCT02584829|449299766|FG000|Overall Study|Progressive Disease|0|||
124910432|NCT02584829|449299767|FG001|Overall Study|Progressive Disease|3|||
124910433|NCT04723394|449299768|FG000|Overall Study|Adverse Event|0|||
124910434|NCT04723394|449299769|FG001|Overall Study|Adverse Event|3|||
124910435|NCT04723394|449299768|FG000|Overall Study|Death|8|||
124910436|NCT04723394|449299769|FG001|Overall Study|Death|8|||
124910437|NCT04723394|449299768|FG000|Overall Study|Lost to Follow-up|20|||
124910438|NCT04723394|449299769|FG001|Overall Study|Lost to Follow-up|17|||
124910439|NCT04723394|449299768|FG000|Overall Study|Physician Decision|1|||
124910440|NCT04723394|449299769|FG001|Overall Study|Physician Decision|0|||
124910441|NCT04723394|449299768|FG000|Overall Study|Withdrawal by Subject|20|||
124910442|NCT04723394|449299769|FG001|Overall Study|Withdrawal by Subject|34|||
124910443|NCT04723394|449299768|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
125115131|NCT04147715|450044754|FG011|Overall Study|Adverse Event|0|||
125115132|NCT01626859|450044755|FG000|Overall Study|Adverse Event|1|||
125115133|NCT01626859|450044756|FG001|Overall Study|Adverse Event|3|||
125115134|NCT01626859|450044757|FG002|Overall Study|Adverse Event|2|||
125115135|NCT01626859|450044755|FG000|Overall Study|Physician Decision|0|||
125115136|NCT01626859|450044756|FG001|Overall Study|Physician Decision|1|||
125115137|NCT01626859|450044757|FG002|Overall Study|Physician Decision|0|||
125115138|NCT01626859|450044755|FG000|Overall Study|Withdrawal by Subject|1|||
125115139|NCT01626859|450044756|FG001|Overall Study|Withdrawal by Subject|4|||
125115140|NCT01626859|450044757|FG002|Overall Study|Withdrawal by Subject|2|||
125115141|NCT02629965|450044758|FG000|Period 1|Adverse Event|1|||
125115142|NCT02629965|450044759|FG001|Period 1|Adverse Event|0|||
125115143|NCT02629965|450044758|FG000|Period 1|Unexpected worsening of disease|2|||
125115144|NCT02629965|450044759|FG001|Period 1|Unexpected worsening of disease|0|||
125115145|NCT02629965|450044758|FG000|Period 1|Other than listed above|1|||
125115146|NCT02629965|450044759|FG001|Period 1|Other than listed above|2|||
125115147|NCT02629965|450044758|FG000|Period 2|Adverse Event|1|||
125115148|NCT02629965|450044759|FG001|Period 2|Adverse Event|0|||
125115149|NCT00905489|450044760|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
125115150|NCT00905489|450044760|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
125115151|NCT00905489|450044760|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
125115152|NCT00895583|450044765|FG000|Overall Study|Adverse Event|28|||
125115153|NCT00895583|450044766|FG001|Overall Study|Adverse Event|4|||
125115154|NCT00895583|450044765|FG000|Overall Study|Death|2|||
125115155|NCT00895583|450044766|FG001|Overall Study|Death|1|||
125115156|NCT00895583|450044765|FG000|Overall Study|Physician Decision|3|||
125115157|NCT00895583|450044766|FG001|Overall Study|Physician Decision|1|||
125115158|NCT00895583|450044765|FG000|Overall Study|Lost to Follow-up|1|||
125115159|NCT00895583|450044766|FG001|Overall Study|Lost to Follow-up|3|||
125115160|NCT00895583|450044765|FG000|Overall Study|Protocol Violation|1|||
125115161|NCT00895583|450044766|FG001|Overall Study|Protocol Violation|0|||
125115162|NCT00895583|450044765|FG000|Overall Study|Withdrawal by Subject|4|||
124910444|NCT04723394|449299769|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
124910445|NCT02765100|449299775|FG000|Overall Study|subject found ineligible after baseline|1|||
124910446|NCT02765100|449299776|FG001|Overall Study|subject found ineligible after baseline|1|||
124910447|NCT02765100|449299775|FG000|Overall Study|Lost to Follow-up|0|||
124910448|NCT02765100|449299776|FG001|Overall Study|Lost to Follow-up|1|||
124910449|NCT02675244|449299777|FG000|Overall Study|Death|9|||
124910450|NCT02675244|449299778|FG001|Overall Study|Death|6|||
124910451|NCT02675244|449299777|FG000|Overall Study|Withdrawal by Subject|3|||
124910452|NCT02675244|449299778|FG001|Overall Study|Withdrawal by Subject|6|||
124910453|NCT02675244|449299777|FG000|Overall Study|Lost to Follow-up|1|||
124910454|NCT02675244|449299778|FG001|Overall Study|Lost to Follow-up|1|||
124910455|NCT02675244|449299777|FG000|Overall Study|Ongoing at 2 Years|190|||
124910456|NCT02675244|449299778|FG001|Overall Study|Ongoing at 2 Years|185|||
124910457|NCT02652442|449299782|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
124910458|NCT00914589|449299789|FG000|Overall Study|Adverse Event|1|||
124910459|NCT00914589|449299790|FG001|Overall Study|Adverse Event|0|||
124910460|NCT00914589|449299791|FG002|Overall Study|Adverse Event|1|||
124910461|NCT00914589|449299789|FG000|Overall Study|Protocol Violation|8|||
124910462|NCT00914589|449299790|FG001|Overall Study|Protocol Violation|6|||
124910463|NCT00914589|449299791|FG002|Overall Study|Protocol Violation|3|||
124910464|NCT00914589|449299789|FG000|Overall Study|unclassified|16|||
124910465|NCT00914589|449299790|FG001|Overall Study|unclassified|9|||
124910466|NCT00914589|449299791|FG002|Overall Study|unclassified|7|||
124910467|NCT00914589|449299789|FG000|Overall Study|Death|0|||
124910468|NCT00914589|449299790|FG001|Overall Study|Death|1|||
124910469|NCT00914589|449299791|FG002|Overall Study|Death|1|||
125115163|NCT00895583|450044766|FG001|Overall Study|Withdrawal by Subject|2|||
125115164|NCT00895583|450044765|FG000|Overall Study|Lack of Efficacy|5|||
125115165|NCT00895583|450044766|FG001|Overall Study|Lack of Efficacy|0|||
125115166|NCT00895583|450044765|FG000|Overall Study|Other|0|||
125115167|NCT00895583|450044766|FG001|Overall Study|Other|1|||
125115168|NCT04535583|450044767|FG000|Overall Study|Lost to Follow-up|1|||
125115169|NCT04535583|450044767|FG000|Overall Study|Physician Decision|1|||
125115170|NCT04535583|450044767|FG000|Overall Study|Withdrawal by Subject|1|||
125115171|NCT04049552|450044769|FG000|Overall Study|Lost to Follow-up|1|||
125115172|NCT02196506|450044774|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
125115173|NCT02196506|450044775|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
125115174|NCT02196506|450044776|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
125115175|NCT02196506|450044777|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
125115176|NCT02196506|450044774|FG000|Phase A|Withdrawal by Subject|34|||
125115177|NCT02196506|450044775|FG001|Phase A|Withdrawal by Subject|0|||
125115178|NCT02196506|450044776|FG002|Phase A|Withdrawal by Subject|0|||
125115179|NCT02196506|450044777|FG003|Phase A|Withdrawal by Subject|0|||
125115180|NCT02196506|450044774|FG000|Phase A|Adverse Event|22|||
125115181|NCT02196506|450044775|FG001|Phase A|Adverse Event|0|||
125115182|NCT02196506|450044776|FG002|Phase A|Adverse Event|0|||
125115183|NCT02196506|450044777|FG003|Phase A|Adverse Event|0|||
125115184|NCT02196506|450044774|FG000|Phase A|Lost to Follow-up|9|||
125115185|NCT02196506|450044775|FG001|Phase A|Lost to Follow-up|0|||
125115186|NCT02196506|450044776|FG002|Phase A|Lost to Follow-up|0|||
125115187|NCT02196506|450044777|FG003|Phase A|Lost to Follow-up|0|||
125115188|NCT02196506|450044774|FG000|Phase A|Protocol deviation|12|||
125115189|NCT02196506|450044775|FG001|Phase A|Protocol deviation|0|||
125115190|NCT02196506|450044776|FG002|Phase A|Protocol deviation|0|||
125115191|NCT02196506|450044777|FG003|Phase A|Protocol deviation|0|||
125115192|NCT02196506|450044774|FG000|Phase A|Participant withdrawn by investigator|10|||
125115193|NCT02196506|450044775|FG001|Phase A|Participant withdrawn by investigator|0|||
125115194|NCT02196506|450044776|FG002|Phase A|Participant withdrawn by investigator|0|||
125115195|NCT02196506|450044777|FG003|Phase A|Participant withdrawn by investigator|0|||
125115196|NCT02196506|450044774|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
125115197|NCT02196506|450044775|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
125115198|NCT02196506|450044776|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
125115199|NCT02196506|450044777|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
125115200|NCT02196506|450044774|FG000|Phase B|Lack of Efficacy|0|||
125115201|NCT02196506|450044775|FG001|Phase B|Lack of Efficacy|1|||
125115202|NCT02196506|450044776|FG002|Phase B|Lack of Efficacy|2|||
125115203|NCT02196506|450044777|FG003|Phase B|Lack of Efficacy|0|||
124910470|NCT01290341|449299792|FG000|Overall Study|Protocol Violation|7|||
124910471|NCT01290341|449299793|FG001|Overall Study|Protocol Violation|3|||
124910472|NCT01290341|449299792|FG000|Overall Study|Adverse Event|1|||
125115204|NCT02196506|450044774|FG000|Phase B|Withdrawal by Participant|0|||
125115205|NCT02196506|450044775|FG001|Phase B|Withdrawal by Participant|8|||
125115206|NCT02196506|450044776|FG002|Phase B|Withdrawal by Participant|1|||
125115207|NCT02196506|450044777|FG003|Phase B|Withdrawal by Participant|0|||
125115208|NCT02196506|450044774|FG000|Phase B|Adverse Event|0|||
125115209|NCT02196506|450044775|FG001|Phase B|Adverse Event|4|||
125115210|NCT02196506|450044776|FG002|Phase B|Adverse Event|1|||
125115211|NCT02196506|450044777|FG003|Phase B|Adverse Event|0|||
124910473|NCT01290341|449299793|FG001|Overall Study|Adverse Event|0|||
124910474|NCT01290341|449299792|FG000|Overall Study|Lost to Follow-up|21|||
124910475|NCT01290341|449299793|FG001|Overall Study|Lost to Follow-up|10|||
124910476|NCT01290341|449299792|FG000|Overall Study|Withdrawal by Subject|19|||
125115212|NCT02196506|450044774|FG000|Phase B|Lost to Follow-up|0|||
125115213|NCT02196506|450044775|FG001|Phase B|Lost to Follow-up|2|||
125115214|NCT02196506|450044776|FG002|Phase B|Lost to Follow-up|1|||
125115215|NCT02196506|450044777|FG003|Phase B|Lost to Follow-up|0|||
125115216|NCT02196506|450044774|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
125115217|NCT02196506|450044775|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
124910477|NCT01290341|449299793|FG001|Overall Study|Withdrawal by Subject|5|||
124910478|NCT01290341|449299792|FG000|Overall Study|Negative baseline culture and others|44|||
124910479|NCT01290341|449299793|FG001|Overall Study|Negative baseline culture and others|11|||
124910480|NCT03036813|449299798|FG000|Overall Study|Adverse Event|6|||
124910481|NCT03036813|449299799|FG001|Overall Study|Adverse Event|11|||
124910482|NCT03036813|449299800|FG002|Overall Study|Adverse Event|6|||
124910483|NCT03036813|449299798|FG000|Overall Study|Withdrawal by Subject|12|||
124910484|NCT03036813|449299799|FG001|Overall Study|Withdrawal by Subject|6|||
124910485|NCT03036813|449299800|FG002|Overall Study|Withdrawal by Subject|10|||
124910486|NCT03036813|449299798|FG000|Overall Study|Lost to Follow-up|1|||
124910487|NCT03036813|449299799|FG001|Overall Study|Lost to Follow-up|1|||
124910488|NCT03036813|449299800|FG002|Overall Study|Lost to Follow-up|0|||
124910489|NCT03036813|449299798|FG000|Overall Study|Physician Decision|2|||
124910490|NCT03036813|449299799|FG001|Overall Study|Physician Decision|1|||
124910491|NCT03036813|449299800|FG002|Overall Study|Physician Decision|1|||
124910492|NCT03036813|449299798|FG000|Overall Study|Non-Compliance|1|||
124910493|NCT03036813|449299799|FG001|Overall Study|Non-Compliance|5|||
124910494|NCT03036813|449299800|FG002|Overall Study|Non-Compliance|3|||
124910495|NCT03036813|449299798|FG000|Overall Study|Pregnancy|0|||
124910496|NCT03036813|449299799|FG001|Overall Study|Pregnancy|0|||
125115218|NCT02196506|450044776|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
124910497|NCT03036813|449299800|FG002|Overall Study|Pregnancy|1|||
124910498|NCT03036813|449299798|FG000|Overall Study|Other|0|||
124910499|NCT03036813|449299799|FG001|Overall Study|Other|3|||
124910500|NCT03036813|449299800|FG002|Overall Study|Other|5|||
125211304|NCT02306694|450398652|FG000|Overall Study|Lost to Follow-up|1|||
124910501|NCT01102231|449299801|FG000|Overall Study|Protocol Violation|3|||
124910502|NCT01102231|449299801|FG000|Overall Study|Lack of Efficacy|2|||
124910503|NCT01102231|449299801|FG000|Overall Study|Death|2|||
124910504|NCT01102231|449299801|FG000|Overall Study|Adverse Event|3|||
124910505|NCT01102231|449299801|FG000|Overall Study|Withdrawal by Subject|1|||
124910506|NCT01102231|449299801|FG000|Overall Study|Did not received the treatment|4|||
124910507|NCT03903822|449299802|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
124910508|NCT03903822|449299803|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
124910509|NCT03903822|449299804|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
124910510|NCT03903822|449299805|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
124910511|NCT03903822|449299806|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
124910512|NCT03903822|449299807|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
124910513|NCT03903822|449299808|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
124910514|NCT03903822|449299809|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
124910515|NCT03903822|449299802|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
124910516|NCT03903822|449299803|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
124910517|NCT03903822|449299804|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
124910518|NCT03903822|449299805|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
124910519|NCT03903822|449299806|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
124910520|NCT03903822|449299807|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
124910521|NCT03903822|449299808|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
124910522|NCT03903822|449299809|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
124910523|NCT03903822|449299802|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
124910524|NCT03903822|449299803|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
124910525|NCT03903822|449299804|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
124910526|NCT03903822|449299805|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
124910527|NCT03903822|449299806|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
124910528|NCT03903822|449299807|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
124910529|NCT03903822|449299808|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
124910530|NCT03903822|449299809|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
124910531|NCT03903822|449299802|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
124910532|NCT03903822|449299803|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
124910533|NCT03903822|449299804|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
124910534|NCT03903822|449299805|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
124910535|NCT03903822|449299806|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
124910536|NCT03903822|449299807|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
124910537|NCT03903822|449299808|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
124910538|NCT03903822|449299809|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
124910539|NCT03903822|449299802|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
124910540|NCT03903822|449299803|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
125211305|NCT00603382|450398653|FG000|Overall Study|Adverse Event|0|||
124910541|NCT03903822|449299804|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
124910542|NCT03903822|449299805|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
124910543|NCT03903822|449299806|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
124910544|NCT03903822|449299807|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
124910545|NCT03903822|449299808|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
124910546|NCT03903822|449299809|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
124910547|NCT03903822|449299802|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
124910548|NCT03903822|449299803|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
124910549|NCT03903822|449299804|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
124910550|NCT03903822|449299805|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
124910551|NCT03903822|449299806|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
124910552|NCT03903822|449299807|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
124910553|NCT03903822|449299808|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
124910554|NCT03903822|449299809|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
124910555|NCT03903822|449299802|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
124910556|NCT03903822|449299803|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
124910557|NCT03903822|449299804|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
124910558|NCT03903822|449299805|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
124910559|NCT03903822|449299806|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
124910560|NCT03903822|449299807|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
124910561|NCT03903822|449299808|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
124910562|NCT03903822|449299809|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
124910563|NCT03903822|449299802|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
124910564|NCT03903822|449299803|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
124910565|NCT03903822|449299804|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
124910566|NCT03903822|449299805|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
124910567|NCT03903822|449299806|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
124910568|NCT03903822|449299807|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
124910569|NCT03903822|449299808|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
124910570|NCT03903822|449299809|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
124910571|NCT03903822|449299802|FG000|Treatment Phase (6 Weeks)|Other|2|||
124910572|NCT03903822|449299803|FG001|Treatment Phase (6 Weeks)|Other|1|||
124910573|NCT03903822|449299804|FG002|Treatment Phase (6 Weeks)|Other|0|||
124910574|NCT03903822|449299805|FG003|Treatment Phase (6 Weeks)|Other|0|||
124910575|NCT03903822|449299806|FG004|Treatment Phase (6 Weeks)|Other|1|||
124910576|NCT03903822|449299807|FG005|Treatment Phase (6 Weeks)|Other|1|||
124910577|NCT03903822|449299808|FG006|Treatment Phase (6 Weeks)|Other|0|||
124910578|NCT03903822|449299809|FG007|Treatment Phase (6 Weeks)|Other|0|||
124910579|NCT03903822|449299802|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
124910580|NCT03903822|449299803|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
124910581|NCT03903822|449299804|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
124910582|NCT03903822|449299805|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
124910583|NCT03903822|449299806|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
124910584|NCT03903822|449299807|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
124910585|NCT03903822|449299808|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
124910586|NCT03903822|449299809|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
124910587|NCT03903822|449299802|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
124910588|NCT03903822|449299803|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
124910589|NCT03903822|449299804|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
124910590|NCT03903822|449299805|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
124910591|NCT03903822|449299806|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
124910592|NCT03903822|449299807|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
124910593|NCT03903822|449299808|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
124910594|NCT03903822|449299809|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
124910595|NCT03903822|449299802|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
124910596|NCT03903822|449299803|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
124910597|NCT03903822|449299804|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
124910598|NCT03903822|449299805|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
124910599|NCT03903822|449299806|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
124910600|NCT03903822|449299807|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
124910601|NCT03903822|449299808|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
124910602|NCT03903822|449299809|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
124910603|NCT03903822|449299802|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
124910604|NCT03903822|449299803|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
124910605|NCT03903822|449299804|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
124910606|NCT03903822|449299805|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
124910607|NCT03903822|449299806|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
124910608|NCT03903822|449299807|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
124910609|NCT03903822|449299808|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
124910610|NCT03903822|449299809|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
124910611|NCT03903822|449299802|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
124910612|NCT03903822|449299803|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
124910613|NCT03903822|449299804|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
124910614|NCT03903822|449299805|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
124910615|NCT03903822|449299806|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
124910616|NCT03903822|449299807|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
124910617|NCT03903822|449299808|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
124910618|NCT03903822|449299809|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
124910619|NCT03903822|449299802|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
124910620|NCT03903822|449299803|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
124910621|NCT03903822|449299804|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
124910622|NCT03903822|449299805|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
124910623|NCT03903822|449299806|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
124910624|NCT03903822|449299807|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
124910625|NCT03903822|449299808|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
124910626|NCT03903822|449299809|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
124910627|NCT03903822|449299802|FG000|Follow up Phase (4 Weeks)|Other|1|||
124910628|NCT03903822|449299803|FG001|Follow up Phase (4 Weeks)|Other|1|||
124910629|NCT03903822|449299804|FG002|Follow up Phase (4 Weeks)|Other|0|||
125115219|NCT02196506|450044777|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
125115220|NCT02196506|450044774|FG000|Phase A+|Withdrawal by Participant|0|||
125115221|NCT02196506|450044775|FG001|Phase A+|Withdrawal by Participant|0|||
125115222|NCT02196506|450044776|FG002|Phase A+|Withdrawal by Participant|0|||
125115223|NCT02196506|450044777|FG003|Phase A+|Withdrawal by Participant|5|||
125115224|NCT02196506|450044774|FG000|Phase A+|Adverse Event|0|||
125115225|NCT02196506|450044775|FG001|Phase A+|Adverse Event|0|||
125115226|NCT02196506|450044776|FG002|Phase A+|Adverse Event|0|||
124910630|NCT03903822|449299805|FG003|Follow up Phase (4 Weeks)|Other|0|||
124910631|NCT03903822|449299806|FG004|Follow up Phase (4 Weeks)|Other|0|||
124910632|NCT03903822|449299807|FG005|Follow up Phase (4 Weeks)|Other|0|||
124910633|NCT03903822|449299808|FG006|Follow up Phase (4 Weeks)|Other|0|||
124910634|NCT03903822|449299809|FG007|Follow up Phase (4 Weeks)|Other|0|||
124910635|NCT00785512|449299810|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
125115227|NCT02196506|450044777|FG003|Phase A+|Adverse Event|1|||
125115228|NCT02196506|450044774|FG000|Phase A+|Lost to Follow-up|0|||
125115229|NCT02196506|450044775|FG001|Phase A+|Lost to Follow-up|0|||
125115230|NCT02196506|450044776|FG002|Phase A+|Lost to Follow-up|0|||
125115231|NCT02196506|450044777|FG003|Phase A+|Lost to Follow-up|6|||
125115232|NCT02196506|450044774|FG000|Phase A+|Participant withdrawn by investigator|0|||
125115233|NCT02196506|450044775|FG001|Phase A+|Participant withdrawn by investigator|0|||
125115234|NCT02196506|450044776|FG002|Phase A+|Participant withdrawn by investigator|0|||
125115235|NCT02196506|450044777|FG003|Phase A+|Participant withdrawn by investigator|1|||
125115236|NCT01715415|450044778|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
125115237|NCT01715415|450044779|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
125115238|NCT01715415|450044778|FG000|Double-blind Treatment|Adverse Event|3|||
125115239|NCT01715415|450044779|FG001|Double-blind Treatment|Adverse Event|0|||
125115240|NCT01715415|450044778|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
125115241|NCT01715415|450044779|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
124910636|NCT00785512|449299811|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
124910637|NCT00785512|449299810|FG000|Overall Study|Adverse Event|0|||
124910638|NCT00785512|449299811|FG001|Overall Study|Adverse Event|0|||
124910639|NCT00785512|449299810|FG000|Overall Study|Lack of Efficacy|0|||
124910640|NCT00785512|449299811|FG001|Overall Study|Lack of Efficacy|2|||
124910641|NCT00785512|449299810|FG000|Overall Study|Withdrawal by Subject|0|||
124910642|NCT00785512|449299811|FG001|Overall Study|Withdrawal by Subject|1|||
124910643|NCT00785512|449299810|FG000|Overall Study|Lost to Follow-up|3|||
124910644|NCT00785512|449299811|FG001|Overall Study|Lost to Follow-up|0|||
124910645|NCT00785512|449299810|FG000|Overall Study|Precedure Refused|0|||
124910646|NCT00785512|449299811|FG001|Overall Study|Precedure Refused|0|||
124910647|NCT00785512|449299810|FG000|Overall Study|IVRS Programing Error|0|||
124910648|NCT00785512|449299811|FG001|Overall Study|IVRS Programing Error|0|||
124910649|NCT00785512|449299810|FG000|Overall Study|Physician Decision|0|||
124910650|NCT00785512|449299811|FG001|Overall Study|Physician Decision|0|||
124910651|NCT00785512|449299810|FG000|Overall Study|Lack of compliance|0|||
124910652|NCT00785512|449299811|FG001|Overall Study|Lack of compliance|1|||
124910653|NCT00529100|449299815|FG000|Overall Study|Adverse Event|0|||
124910654|NCT00529100|449299816|FG001|Overall Study|Adverse Event|5|||
124910655|NCT00529100|449299815|FG000|Overall Study|Protocol Violation|0|||
124910656|NCT00529100|449299816|FG001|Overall Study|Protocol Violation|1|||
124910657|NCT00529100|449299815|FG000|Overall Study|Progressive Disease|0|||
124910658|NCT00529100|449299816|FG001|Overall Study|Progressive Disease|1|||
124910659|NCT00529100|449299815|FG000|Overall Study|Withdrawal by Subject|0|||
124910660|NCT00529100|449299816|FG001|Overall Study|Withdrawal by Subject|1|||
125211306|NCT00603382|450398654|FG001|Overall Study|Adverse Event|1|||
125211307|NCT00603382|450398655|FG002|Overall Study|Adverse Event|1|||
124910661|NCT00529100|449299815|FG000|Overall Study|Participant Ineligibility|0|||
124910662|NCT00529100|449299816|FG001|Overall Study|Participant Ineligibility|1|||
124910663|NCT03733119|449299817|FG000|Overall Study|Physician Decision|2|||
124910664|NCT03733119|449299818|FG001|Overall Study|Physician Decision|1|||
124910665|NCT03733119|449299817|FG000|Overall Study|ineligible to treat per protocol|0|||
124910666|NCT03733119|449299818|FG001|Overall Study|ineligible to treat per protocol|1|||
124910667|NCT00807937|449299825|FG000|Overall Study|Adverse Event|12|||
124910668|NCT00807937|449299826|FG001|Overall Study|Adverse Event|12|||
125211308|NCT00603382|450398656|FG003|Overall Study|Adverse Event|2|||
124910669|NCT00807937|449299827|FG002|Overall Study|Adverse Event|5|||
124910670|NCT00807937|449299828|FG003|Overall Study|Adverse Event|4|||
124910671|NCT00807937|449299825|FG000|Overall Study|Protocol Violation|4|||
124910672|NCT00807937|449299826|FG001|Overall Study|Protocol Violation|5|||
124910673|NCT00807937|449299827|FG002|Overall Study|Protocol Violation|3|||
124910674|NCT00807937|449299828|FG003|Overall Study|Protocol Violation|3|||
124910675|NCT00807937|449299825|FG000|Overall Study|Withdrawal by Subject|5|||
124910676|NCT00807937|449299826|FG001|Overall Study|Withdrawal by Subject|4|||
124910677|NCT00807937|449299827|FG002|Overall Study|Withdrawal by Subject|1|||
124910678|NCT00807937|449299828|FG003|Overall Study|Withdrawal by Subject|4|||
124910679|NCT00807937|449299825|FG000|Overall Study|Lost to Follow-up|4|||
124910680|NCT00807937|449299826|FG001|Overall Study|Lost to Follow-up|0|||
124910681|NCT00807937|449299827|FG002|Overall Study|Lost to Follow-up|2|||
124910682|NCT00807937|449299828|FG003|Overall Study|Lost to Follow-up|1|||
124910683|NCT00807937|449299825|FG000|Overall Study|Lack of Efficacy|0|||
124910684|NCT00807937|449299826|FG001|Overall Study|Lack of Efficacy|0|||
124910685|NCT00807937|449299827|FG002|Overall Study|Lack of Efficacy|1|||
124910686|NCT00807937|449299828|FG003|Overall Study|Lack of Efficacy|2|||
124910687|NCT00807937|449299825|FG000|Overall Study|Intake of prohibited medicine|0|||
124910688|NCT00807937|449299826|FG001|Overall Study|Intake of prohibited medicine|0|||
124910689|NCT00807937|449299827|FG002|Overall Study|Intake of prohibited medicine|2|||
124910690|NCT00807937|449299828|FG003|Overall Study|Intake of prohibited medicine|0|||
124910691|NCT00807937|449299825|FG000|Overall Study|All other reasons (not provided)|2|||
124910692|NCT00807937|449299826|FG001|Overall Study|All other reasons (not provided)|4|||
124910693|NCT00807937|449299827|FG002|Overall Study|All other reasons (not provided)|0|||
124910694|NCT00807937|449299828|FG003|Overall Study|All other reasons (not provided)|1|||
124910695|NCT02708108|449299831|FG000|Overall Study|Death|1|||
124910696|NCT02708108|449299832|FG001|Overall Study|Death|2|||
124910697|NCT02708108|449299831|FG000|Overall Study|Regimen change|1|||
125115242|NCT01715415|450044778|FG000|Double-blind Treatment|Other|1|||
125115243|NCT01715415|450044779|FG001|Double-blind Treatment|Other|0|||
125115244|NCT01715415|450044778|FG000|Open-label Treatment|Adverse Event|0|||
125115245|NCT01715415|450044779|FG001|Open-label Treatment|Adverse Event|1|||
125115246|NCT01715415|450044778|FG000|Open-label Treatment|Subject Noncompliant|0|||
125115247|NCT01715415|450044779|FG001|Open-label Treatment|Subject Noncompliant|1|||
124910698|NCT02708108|449299832|FG001|Overall Study|Regimen change|0|||
124910699|NCT02708108|449299831|FG000|Overall Study|No MRD and no imaging available|0|||
124910700|NCT02708108|449299832|FG001|Overall Study|No MRD and no imaging available|1|||
124910701|NCT00510887|449299833|FG000|Overall Study|Lost to Follow-up|1|||
124910702|NCT03485950|449299845|FG000|Overall Study|Adverse Event|1|||
124910703|NCT03485950|449299846|FG001|Overall Study|Adverse Event|0|||
124910704|NCT03485950|449299845|FG000|Overall Study|Death|3|||
124910705|NCT03485950|449299846|FG001|Overall Study|Death|2|||
124910706|NCT03485950|449299845|FG000|Overall Study|Withdrawal by Subject|3|||
124910707|NCT03485950|449299846|FG001|Overall Study|Withdrawal by Subject|0|||
124910708|NCT00988858|449299848|FG000|Overall Study|Adverse Event|7|||
125115248|NCT01015612|450044780|FG000|Overall Study|Death|113|||
125115249|NCT01015612|450044780|FG000|Overall Study|Withdrawal by Subject|40|||
125211309|NCT00603382|450398657|FG004|Overall Study|Adverse Event|1|||
125211310|NCT00603382|450398658|FG005|Overall Study|Adverse Event|2|||
125211311|NCT00603382|450398653|FG000|Overall Study|Lack of Efficacy|14|||
125211312|NCT00603382|450398654|FG001|Overall Study|Lack of Efficacy|9|||
125211313|NCT00603382|450398655|FG002|Overall Study|Lack of Efficacy|3|||
125211314|NCT00603382|450398656|FG003|Overall Study|Lack of Efficacy|6|||
125211315|NCT00603382|450398657|FG004|Overall Study|Lack of Efficacy|6|||
125211316|NCT00603382|450398658|FG005|Overall Study|Lack of Efficacy|11|||
125211317|NCT00603382|450398653|FG000|Overall Study|Protocol Violation|1|||
125211318|NCT00603382|450398654|FG001|Overall Study|Protocol Violation|0|||
125211319|NCT00603382|450398655|FG002|Overall Study|Protocol Violation|1|||
125211320|NCT00603382|450398656|FG003|Overall Study|Protocol Violation|2|||
125211321|NCT00603382|450398657|FG004|Overall Study|Protocol Violation|1|||
125211322|NCT00603382|450398658|FG005|Overall Study|Protocol Violation|0|||
125211323|NCT00603382|450398653|FG000|Overall Study|Lost to Follow-up|0|||
125211324|NCT00603382|450398654|FG001|Overall Study|Lost to Follow-up|1|||
125211325|NCT00603382|450398655|FG002|Overall Study|Lost to Follow-up|1|||
125211326|NCT00603382|450398656|FG003|Overall Study|Lost to Follow-up|1|||
125211327|NCT00603382|450398657|FG004|Overall Study|Lost to Follow-up|0|||
125211328|NCT00603382|450398658|FG005|Overall Study|Lost to Follow-up|1|||
125211329|NCT00603382|450398653|FG000|Overall Study|Physician Decision|0|||
125211330|NCT00603382|450398654|FG001|Overall Study|Physician Decision|0|||
125211331|NCT00603382|450398655|FG002|Overall Study|Physician Decision|2|||
125211332|NCT00603382|450398656|FG003|Overall Study|Physician Decision|0|||
125211333|NCT00603382|450398657|FG004|Overall Study|Physician Decision|1|||
125211334|NCT00603382|450398658|FG005|Overall Study|Physician Decision|3|||
125211335|NCT00603382|450398653|FG000|Overall Study|Withdrawal by Subject|3|||
125211336|NCT00603382|450398654|FG001|Overall Study|Withdrawal by Subject|3|||
125211337|NCT00603382|450398655|FG002|Overall Study|Withdrawal by Subject|1|||
125211338|NCT00603382|450398656|FG003|Overall Study|Withdrawal by Subject|1|||
125211339|NCT00603382|450398657|FG004|Overall Study|Withdrawal by Subject|0|||
125211340|NCT00603382|450398658|FG005|Overall Study|Withdrawal by Subject|1|||
125211341|NCT00395642|450398659|FG000|Overall Study|Death|4|||
125211342|NCT00395642|450398659|FG000|Overall Study|Lost to Follow-up|1|||
125211343|NCT00395642|450398659|FG000|Overall Study|Physician Decision|7|||
125211344|NCT00395642|450398659|FG000|Overall Study|Withdrawal by Subject|1|||
125211345|NCT02012959|450398660|FG000|Treatment Phase A|Adverse Event|2|||
125211346|NCT02012959|450398661|FG001|Treatment Phase A|Adverse Event|0|||
125211347|NCT02012959|450398662|FG002|Treatment Phase A|Adverse Event|0|||
125211348|NCT02012959|450398663|FG003|Treatment Phase A|Adverse Event|0|||
125211349|NCT02012959|450398664|FG004|Treatment Phase A|Adverse Event|0|||
125211350|NCT02333383|450398667|FG000|Overall Study|Adalimumab discontinuation|21|||
125211351|NCT02333383|450398667|FG000|Overall Study|Lost to Follow-up|15|||
125211352|NCT02333383|450398667|FG000|Overall Study|Withdrawal by Subject|3|||
125211353|NCT02333383|450398667|FG000|Overall Study|Transfer to another hospital|2|||
125211354|NCT01905592|450398680|FG000|Overall Study|Disease Progression|51|||
125211355|NCT01905592|450398681|FG001|Overall Study|Disease Progression|110|||
125211356|NCT01905592|450398680|FG000|Overall Study|Toxicity|1|||
125211357|NCT01905592|450398681|FG001|Overall Study|Toxicity|16|||
125211358|NCT01905592|450398680|FG000|Overall Study|Physician Decision|0|||
125211359|NCT01905592|450398681|FG001|Overall Study|Physician Decision|2|||
125211360|NCT01905592|450398680|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
125211361|NCT01905592|450398681|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
125211362|NCT01905592|450398680|FG000|Overall Study|Protocol Violation|0|||
125211363|NCT01905592|450398681|FG001|Overall Study|Protocol Violation|1|||
125211364|NCT01905592|450398680|FG000|Overall Study|Sponsor's decision|1|||
125211365|NCT01905592|450398681|FG001|Overall Study|Sponsor's decision|1|||
124910709|NCT00988858|449299848|FG000|Overall Study|Death|1|||
124910710|NCT00988858|449299848|FG000|Overall Study|Physician Decision|1|||
124910711|NCT00988858|449299848|FG000|Overall Study|Sponsor Decision|1|||
124910712|NCT03764475|449299849|FG000|Overall Study|Adverse Event|11|||
125211366|NCT01905592|450398680|FG000|Overall Study|Not treated|7|||
124910713|NCT03764475|449299850|FG001|Overall Study|Adverse Event|2|||
124910714|NCT03764475|449299849|FG000|Overall Study|Lost to Follow-up|24|||
124910715|NCT03764475|449299850|FG001|Overall Study|Lost to Follow-up|10|||
124910716|NCT03764475|449299849|FG000|Overall Study|Withdrawal by Subject|26|||
125211367|NCT01905592|450398681|FG001|Overall Study|Not treated|3|||
125211368|NCT01905592|450398680|FG000|Overall Study|Withdrawal by Subject|10|||
125211369|NCT01905592|450398681|FG001|Overall Study|Withdrawal by Subject|2|||
125211370|NCT01687283|450399674|FG000|Overall Study|Adverse Event|11|||
125211371|NCT01687283|450399675|FG001|Overall Study|Adverse Event|4|||
125211372|NCT01687283|450399674|FG000|Overall Study|Lack of Efficacy|3|||
125211373|NCT01687283|450399675|FG001|Overall Study|Lack of Efficacy|1|||
125211374|NCT01687283|450399674|FG000|Overall Study|Protocol Violation|1|||
125211375|NCT01687283|450399675|FG001|Overall Study|Protocol Violation|3|||
125211376|NCT01687283|450399674|FG000|Overall Study|protocol defined stopping criteria|8|||
125211377|NCT01687283|450399675|FG001|Overall Study|protocol defined stopping criteria|10|||
125211378|NCT01687283|450399674|FG000|Overall Study|Lost to Follow-up|1|||
124910717|NCT03764475|449299850|FG001|Overall Study|Withdrawal by Subject|10|||
124910718|NCT03764475|449299849|FG000|Overall Study|Lack of Efficacy|3|||
124910719|NCT03764475|449299850|FG001|Overall Study|Lack of Efficacy|0|||
124910720|NCT03764475|449299849|FG000|Overall Study|COVID-19 Disruption|2|||
124910721|NCT03764475|449299850|FG001|Overall Study|COVID-19 Disruption|0|||
124910722|NCT05510245|449299854|FG000|Overall Study|Withdrawal by Subject|1|||
124910723|NCT05510245|449299855|FG001|Overall Study|Withdrawal by Subject|0|||
124910724|NCT05510245|449299856|FG002|Overall Study|Withdrawal by Subject|0|||
124910725|NCT00390299|449299857|FG000|Overall Study|Cancellation|1|||
124910726|NCT00390299|449299858|FG001|Overall Study|Cancellation|0|||
124910727|NCT00390299|449299859|FG002|Overall Study|Cancellation|0|||
124910728|NCT00390299|449299860|FG003|Overall Study|Cancellation|0|||
124910729|NCT00390299|449299861|FG004|Overall Study|Cancellation|0|||
124910730|NCT00970359|449299865|FG000|Overall Study|Not Treated|4|||
124910731|NCT00068601|449299866|FG000|Overall Study|Ineligible|11|||
124910732|NCT00068601|449299867|FG001|Overall Study|Ineligible|13|||
124910733|NCT00068601|449299866|FG000|Overall Study|Not evaluable: withdrew consent|5|||
124910734|NCT00068601|449299867|FG001|Overall Study|Not evaluable: withdrew consent|4|||
124910735|NCT00068601|449299866|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
124910736|NCT00068601|449299867|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
124910737|NCT00068601|449299866|FG000|Overall Study|Death|11|||
124910738|NCT00068601|449299867|FG001|Overall Study|Death|3|||
124910739|NCT00068601|449299866|FG000|Overall Study|Lost to Follow-up|3|||
124910740|NCT00068601|449299867|FG001|Overall Study|Lost to Follow-up|2|||
124910741|NCT00068601|449299866|FG000|Overall Study|Missing primary outcome data|30|||
124910742|NCT00068601|449299867|FG001|Overall Study|Missing primary outcome data|34|||
124910743|NCT01061671|449299868|FG000|Overall Study|Withdrawal by Subject|16|||
124910744|NCT01061671|449299869|FG001|Overall Study|Withdrawal by Subject|20|||
124910745|NCT01061671|449299868|FG000|Overall Study|Lost to Follow-up|3|||
124910746|NCT01061671|449299869|FG001|Overall Study|Lost to Follow-up|5|||
124910747|NCT01061671|449299868|FG000|Overall Study|Death|28|||
124910748|NCT01061671|449299869|FG001|Overall Study|Death|30|||
124910749|NCT05368831|449299870|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
124910750|NCT00223795|449299875|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
124910751|NCT00223795|449299876|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
124910752|NCT00223795|449299875|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
124910753|NCT00223795|449299876|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
124910754|NCT04732338|449299882|FG000|Overall Study|Lost to Follow-up|3|||
124910755|NCT04732338|449299883|FG001|Overall Study|Lost to Follow-up|3|||
124910756|NCT01803555|449299887|FG000|Overall Study|Adverse Event|3|||
124910757|NCT01803555|449299888|FG001|Overall Study|Adverse Event|2|||
124910758|NCT01803555|449299887|FG000|Overall Study|Withdrawal by Subject|3|||
124910759|NCT01803555|449299888|FG001|Overall Study|Withdrawal by Subject|3|||
124910760|NCT01803555|449299887|FG000|Overall Study|Non-compliance|1|||
124910761|NCT01803555|449299888|FG001|Overall Study|Non-compliance|1|||
124910762|NCT01803555|449299887|FG000|Overall Study|Protocol Violation|3|||
124910763|NCT01803555|449299888|FG001|Overall Study|Protocol Violation|5|||
124910764|NCT01803555|449299887|FG000|Overall Study|Lost to Follow-up|0|||
124910765|NCT01803555|449299888|FG001|Overall Study|Lost to Follow-up|2|||
124910766|NCT01803555|449299887|FG000|Overall Study|Other than specified|3|||
124910767|NCT01803555|449299888|FG001|Overall Study|Other than specified|5|||
124910768|NCT05938413|449301500|FG000|Overall Study|Lost to Follow-up|1|||
124910769|NCT05938413|449301501|FG001|Overall Study|Lost to Follow-up|7|||
124910770|NCT05938413|449301500|FG000|Overall Study|Withdrawal by Subject|1|||
124910771|NCT05938413|449301501|FG001|Overall Study|Withdrawal by Subject|1|||
124910772|NCT04817670|449301506|FG000|Overall Study|Withdrawal by Subject|1|||
124910773|NCT04817670|449301507|FG001|Overall Study|Withdrawal by Subject|0|||
124910774|NCT04817670|449301508|FG002|Overall Study|Withdrawal by Subject|0|||
124910775|NCT04817670|449301509|FG003|Overall Study|Withdrawal by Subject|0|||
124910776|NCT04817670|449301510|FG004|Overall Study|Withdrawal by Subject|0|||
124910777|NCT04817670|449301506|FG000|Overall Study|Lost to Follow-up|0|||
124910778|NCT04817670|449301507|FG001|Overall Study|Lost to Follow-up|0|||
124910779|NCT04817670|449301508|FG002|Overall Study|Lost to Follow-up|1|||
124910780|NCT04817670|449301509|FG003|Overall Study|Lost to Follow-up|0|||
124910781|NCT04817670|449301510|FG004|Overall Study|Lost to Follow-up|0|||
124910782|NCT03312907|449301511|FG000|Overall Study|Adverse Event|1|||
124910783|NCT03312907|449301512|FG001|Overall Study|Adverse Event|6|||
124910784|NCT03312907|449301513|FG002|Overall Study|Adverse Event|1|||
124910785|NCT03312907|449301511|FG000|Overall Study|Protocol Violation|2|||
124910786|NCT03312907|449301512|FG001|Overall Study|Protocol Violation|3|||
124910787|NCT03312907|449301513|FG002|Overall Study|Protocol Violation|4|||
124910788|NCT03312907|449301511|FG000|Overall Study|Lost to Follow-up|2|||
124910789|NCT03312907|449301512|FG001|Overall Study|Lost to Follow-up|3|||
124910790|NCT03312907|449301513|FG002|Overall Study|Lost to Follow-up|2|||
124910791|NCT03312907|449301511|FG000|Overall Study|Physician Decision|3|||
124910792|NCT03312907|449301512|FG001|Overall Study|Physician Decision|4|||
124910793|NCT03312907|449301513|FG002|Overall Study|Physician Decision|2|||
124910794|NCT03312907|449301511|FG000|Overall Study|Withdrawal by Subject|9|||
124910795|NCT03312907|449301512|FG001|Overall Study|Withdrawal by Subject|14|||
124910796|NCT03312907|449301513|FG002|Overall Study|Withdrawal by Subject|10|||
124910797|NCT02980276|449301517|FG000|Overall Study|Withdrawal by Subject|4|||
124910798|NCT02980276|449301518|FG001|Overall Study|Withdrawal by Subject|4|||
124910799|NCT02980276|449301517|FG000|Overall Study|Physician Decision|0|||
124910800|NCT02980276|449301518|FG001|Overall Study|Physician Decision|1|||
124910801|NCT02980276|449301517|FG000|Overall Study|Lost to Follow-up|18|||
124910802|NCT02980276|449301518|FG001|Overall Study|Lost to Follow-up|18|||
124910803|NCT02980276|449301517|FG000|Overall Study|Death|1|||
124910804|NCT02980276|449301518|FG001|Overall Study|Death|0|||
124910805|NCT02980276|449301517|FG000|Overall Study|Miscellaneous other|10|||
124910806|NCT02980276|449301518|FG001|Overall Study|Miscellaneous other|4|||
124910807|NCT01780298|449301520|FG000|Overall Study|Physician Decision|1|||
124910808|NCT01780298|449301521|FG001|Overall Study|Physician Decision|5|||
124910809|NCT01780298|449301522|FG002|Overall Study|Physician Decision|1|||
124910810|NCT01780298|449301523|FG003|Overall Study|Physician Decision|1|||
124910811|NCT01780298|449301520|FG000|Overall Study|Subject not matched|1|||
124910812|NCT01780298|449301521|FG001|Overall Study|Subject not matched|0|||
124910813|NCT01780298|449301522|FG002|Overall Study|Subject not matched|1|||
124910814|NCT01780298|449301523|FG003|Overall Study|Subject not matched|0|||
124910815|NCT01780298|449301520|FG000|Overall Study|Adverse Event|0|||
124910816|NCT01780298|449301521|FG001|Overall Study|Adverse Event|0|||
124910817|NCT01780298|449301522|FG002|Overall Study|Adverse Event|2|||
124910818|NCT01780298|449301523|FG003|Overall Study|Adverse Event|0|||
124910819|NCT04139668|449301524|FG000|Overall Study|Withdrawal by Subject|1|||
124910820|NCT03025789|449301529|FG000|Overall Study|Lack of Efficacy|6|||
124910821|NCT03025789|449301530|FG001|Overall Study|Lack of Efficacy|1|||
124910822|NCT03025789|449301529|FG000|Overall Study|Death|1|||
124910823|NCT03025789|449301530|FG001|Overall Study|Death|0|||
124910824|NCT03025789|449301529|FG000|Overall Study|Withdrawal by Subject|0|||
124910825|NCT03025789|449301530|FG001|Overall Study|Withdrawal by Subject|2|||
124910826|NCT04907474|449301532|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
124910827|NCT04907474|449301533|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
124910828|NCT02411084|449301535|FG000|Overall Study|Lack of Efficacy|6|||
124910829|NCT02411084|449301536|FG001|Overall Study|Lack of Efficacy|3|||
124910830|NCT02411084|449301535|FG000|Overall Study|Death|5|||
124910831|NCT02411084|449301536|FG001|Overall Study|Death|4|||
124910832|NCT02411084|449301535|FG000|Overall Study|Adverse Event|2|||
124910833|NCT02411084|449301536|FG001|Overall Study|Adverse Event|1|||
124910834|NCT02411084|449301535|FG000|Overall Study|Other reasons|0|||
124910835|NCT02411084|449301536|FG001|Overall Study|Other reasons|5|||
124910836|NCT04259450|449301537|FG000|Overall Study|Adverse event/ Toxicity|0|||
124910837|NCT04259450|449301538|FG001|Overall Study|Adverse event/ Toxicity|3|||
124910838|NCT04259450|449301539|FG002|Overall Study|Adverse event/ Toxicity|0|||
124910839|NCT04259450|449301540|FG003|Overall Study|Adverse event/ Toxicity|1|||
124910840|NCT04259450|449301541|FG004|Overall Study|Adverse event/ Toxicity|0|||
124910841|NCT04259450|449301542|FG005|Overall Study|Adverse event/ Toxicity|0|||
124910842|NCT04259450|449301543|FG006|Overall Study|Adverse event/ Toxicity|0|||
124910843|NCT04259450|449301544|FG007|Overall Study|Adverse event/ Toxicity|1|||
124910844|NCT04259450|449301545|FG008|Overall Study|Adverse event/ Toxicity|0|||
124910845|NCT04259450|449301546|FG009|Overall Study|Adverse event/ Toxicity|3|||
124910846|NCT04259450|449301537|FG000|Overall Study|Disease progression|2|||
124910847|NCT04259450|449301538|FG001|Overall Study|Disease progression|3|||
124910848|NCT04259450|449301539|FG002|Overall Study|Disease progression|4|||
124910849|NCT04259450|449301540|FG003|Overall Study|Disease progression|4|||
124910850|NCT04259450|449301541|FG004|Overall Study|Disease progression|6|||
124910851|NCT04259450|449301542|FG005|Overall Study|Disease progression|6|||
124910852|NCT04259450|449301543|FG006|Overall Study|Disease progression|6|||
124910853|NCT04259450|449301544|FG007|Overall Study|Disease progression|15|||
124910854|NCT04259450|449301545|FG008|Overall Study|Disease progression|6|||
124910855|NCT04259450|449301546|FG009|Overall Study|Disease progression|18|||
124910856|NCT04259450|449301537|FG000|Overall Study|Death|0|||
124910857|NCT04259450|449301538|FG001|Overall Study|Death|0|||
124910858|NCT04259450|449301539|FG002|Overall Study|Death|0|||
124910859|NCT04259450|449301540|FG003|Overall Study|Death|0|||
124910860|NCT04259450|449301541|FG004|Overall Study|Death|0|||
124910861|NCT04259450|449301542|FG005|Overall Study|Death|0|||
124910862|NCT04259450|449301543|FG006|Overall Study|Death|0|||
124910863|NCT04259450|449301544|FG007|Overall Study|Death|1|||
124910864|NCT04259450|449301545|FG008|Overall Study|Death|1|||
124910865|NCT04259450|449301546|FG009|Overall Study|Death|0|||
124910866|NCT04259450|449301537|FG000|Overall Study|Withdrawal by Subject|0|||
124910867|NCT04259450|449301538|FG001|Overall Study|Withdrawal by Subject|0|||
124910868|NCT04259450|449301539|FG002|Overall Study|Withdrawal by Subject|0|||
125211379|NCT01687283|450399675|FG001|Overall Study|Lost to Follow-up|1|||
125211380|NCT01687283|450399674|FG000|Overall Study|Investigator discretion|2|||
125211381|NCT01687283|450399675|FG001|Overall Study|Investigator discretion|0|||
125211382|NCT01687283|450399674|FG000|Overall Study|Withdrawal by Subject|9|||
125211383|NCT01687283|450399675|FG001|Overall Study|Withdrawal by Subject|8|||
124910869|NCT04259450|449301540|FG003|Overall Study|Withdrawal by Subject|0|||
125211384|NCT00642954|450399676|FG000|Overall Study|Progressive Disease|3|||
124910870|NCT04259450|449301541|FG004|Overall Study|Withdrawal by Subject|0|||
124910871|NCT04259450|449301542|FG005|Overall Study|Withdrawal by Subject|0|||
124910872|NCT04259450|449301543|FG006|Overall Study|Withdrawal by Subject|0|||
124910873|NCT04259450|449301544|FG007|Overall Study|Withdrawal by Subject|1|||
124910874|NCT04259450|449301545|FG008|Overall Study|Withdrawal by Subject|0|||
124910875|NCT04259450|449301546|FG009|Overall Study|Withdrawal by Subject|0|||
124910876|NCT04259450|449301537|FG000|Overall Study|Other than listed|0|||
124910877|NCT04259450|449301538|FG001|Overall Study|Other than listed|0|||
124910878|NCT04259450|449301539|FG002|Overall Study|Other than listed|0|||
124910879|NCT04259450|449301540|FG003|Overall Study|Other than listed|0|||
125211385|NCT00642954|450399677|FG001|Overall Study|Progressive Disease|3|||
125211386|NCT00642954|450399678|FG002|Overall Study|Progressive Disease|3|||
125211387|NCT00642954|450399679|FG003|Overall Study|Progressive Disease|3|||
125211388|NCT00642954|450399680|FG004|Overall Study|Progressive Disease|9|||
125211389|NCT00642954|450399676|FG000|Overall Study|Withdrawal by Subject|0|||
125211390|NCT00642954|450399677|FG001|Overall Study|Withdrawal by Subject|0|||
125211391|NCT00642954|450399678|FG002|Overall Study|Withdrawal by Subject|0|||
125211392|NCT00642954|450399679|FG003|Overall Study|Withdrawal by Subject|0|||
125211393|NCT00642954|450399680|FG004|Overall Study|Withdrawal by Subject|1|||
125211394|NCT00642954|450399676|FG000|Overall Study|Adverse Event|1|||
125211395|NCT00642954|450399677|FG001|Overall Study|Adverse Event|1|||
125211396|NCT00642954|450399678|FG002|Overall Study|Adverse Event|0|||
125211397|NCT00642954|450399679|FG003|Overall Study|Adverse Event|0|||
125211398|NCT00642954|450399680|FG004|Overall Study|Adverse Event|6|||
125211399|NCT01663857|450399681|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
125211400|NCT01663857|450399682|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
125211401|NCT01663857|450399683|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
125211402|NCT01663857|450399684|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
125211403|NCT01663857|450399681|FG000|Overall Study|Lost to Follow-up|0|||
125211404|NCT01663857|450399682|FG001|Overall Study|Lost to Follow-up|0|||
125211405|NCT01663857|450399683|FG002|Overall Study|Lost to Follow-up|3|||
125211406|NCT01663857|450399684|FG003|Overall Study|Lost to Follow-up|1|||
125211407|NCT03041467|450399685|FG000|Overall Study|Death|46|||
124910880|NCT04259450|449301541|FG004|Overall Study|Other than listed|0|||
124910881|NCT04259450|449301542|FG005|Overall Study|Other than listed|0|||
124910882|NCT04259450|449301543|FG006|Overall Study|Other than listed|0|||
124910883|NCT04259450|449301544|FG007|Overall Study|Other than listed|1|||
124910884|NCT04259450|449301545|FG008|Overall Study|Other than listed|1|||
124910885|NCT04259450|449301546|FG009|Overall Study|Other than listed|2|||
124910886|NCT01534494|449301547|FG000|Overall Study|Withdrawal by Subject|1|||
124910887|NCT00434304|449301549|FG000|Overall Study|Adverse Event|14|||
124910888|NCT00434304|449301549|FG000|Overall Study|Lack of Efficacy|2|||
125211408|NCT03041467|450399686|FG001|Overall Study|Death|39|||
125211409|NCT03041467|450399685|FG000|Overall Study|Withdrawal by Subject|36|||
124910889|NCT00434304|449301549|FG000|Overall Study|Withdrawal by Subject|4|||
124910890|NCT01939899|449301558|FG000|Lead-in Dose Finding Phase|Death|0|||
125211410|NCT03041467|450399686|FG001|Overall Study|Withdrawal by Subject|37|||
125211411|NCT03041467|450399685|FG000|Overall Study|Lost to Follow-up|6|||
125211412|NCT03041467|450399686|FG001|Overall Study|Lost to Follow-up|8|||
125211413|NCT03041467|450399685|FG000|Overall Study|Declined consent for study extension|21|||
125211414|NCT03041467|450399686|FG001|Overall Study|Declined consent for study extension|33|||
124910891|NCT01939899|449301559|FG001|Lead-in Dose Finding Phase|Death|3|||
124910892|NCT01939899|449301560|FG002|Lead-in Dose Finding Phase|Death|1|||
124910893|NCT01939899|449301561|FG003|Lead-in Dose Finding Phase|Death|0|||
124910894|NCT01939899|449301562|FG004|Lead-in Dose Finding Phase|Death|0|||
124910895|NCT01939899|449301558|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
125211415|NCT03041467|450399685|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
125211416|NCT03041467|450399686|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
125211417|NCT02732015|450399687|FG000|Overall Study|Lost to Follow-up|0|||
125211418|NCT02732015|450399688|FG001|Overall Study|Lost to Follow-up|1|||
125211419|NCT03052920|450399689|FG000|Overall Study|Withdrawal by Subject|1|||
124910896|NCT01939899|449301559|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
124910897|NCT01939899|449301560|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
124910898|NCT01939899|449301561|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
124910899|NCT01939899|449301562|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
124910900|NCT01939899|449301558|FG000|Lead-in Dose Finding Phase|Other|0|||
124910901|NCT01939899|449301559|FG001|Lead-in Dose Finding Phase|Other|0|||
124910902|NCT01939899|449301560|FG002|Lead-in Dose Finding Phase|Other|1|||
124910903|NCT01939899|449301561|FG003|Lead-in Dose Finding Phase|Other|0|||
124910904|NCT01939899|449301562|FG004|Lead-in Dose Finding Phase|Other|0|||
124910905|NCT01939899|449301558|FG000|Phase 2|Withdrawal by Subject|0|||
124910906|NCT01939899|449301559|FG001|Phase 2|Withdrawal by Subject|0|||
124910907|NCT01939899|449301560|FG002|Phase 2|Withdrawal by Subject|0|||
124910908|NCT01939899|449301561|FG003|Phase 2|Withdrawal by Subject|2|||
124910909|NCT01939899|449301562|FG004|Phase 2|Withdrawal by Subject|0|||
124910910|NCT01939899|449301558|FG000|Phase 2|Disease Progression|0|||
124910911|NCT01939899|449301559|FG001|Phase 2|Disease Progression|0|||
124910912|NCT01939899|449301560|FG002|Phase 2|Disease Progression|0|||
124910913|NCT01939899|449301561|FG003|Phase 2|Disease Progression|9|||
124910914|NCT01939899|449301562|FG004|Phase 2|Disease Progression|1|||
124910915|NCT00585052|449301563|FG000|Overall Study|Withdrawal by Subject|1|||
124910916|NCT00858117|449301564|FG000|Treatment on Study|Adverse Event|2|||
124910917|NCT00858117|449301564|FG000|Follow up for 5 Years|Death|4|||
124910918|NCT00858117|449301564|FG000|Follow up for 5 Years|No further data collected for study|9|||
124910919|NCT00371787|449301565|FG000|Overall Study|Withdrawal by Subject|3|||
124910920|NCT00371787|449301566|FG001|Overall Study|Withdrawal by Subject|1|||
124910921|NCT04425863|449301567|FG000|Overall Study|Death|0|||
124910922|NCT04425863|449301568|FG001|Overall Study|Death|0|||
124910923|NCT04425863|449301569|FG002|Overall Study|Death|1|||
124910924|NCT01854385|449301573|FG000|Pre-Treatment|Withdrawal by Subject|4|||
124910925|NCT01854385|449301573|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
124910926|NCT01854385|449301573|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
124910927|NCT01854385|449301573|FG000|Pre-Treatment|Unable to come for study visits|1|||
124910928|NCT01854385|449301573|FG000|Treatment|Lost to Follow-up|1|||
124910929|NCT00277355|449301575|FG000|Overall Study|Withdrawal by Subject|3|||
124910930|NCT00277355|449301576|FG001|Overall Study|Withdrawal by Subject|3|||
124910931|NCT00277355|449301575|FG000|Overall Study|Lost to Follow-up|2|||
124910932|NCT00277355|449301576|FG001|Overall Study|Lost to Follow-up|2|||
124910933|NCT00277355|449301575|FG000|Overall Study|Adverse Event|5|||
124910934|NCT00277355|449301576|FG001|Overall Study|Adverse Event|0|||
124910935|NCT00277355|449301575|FG000|Overall Study|Death|3|||
124910936|NCT00277355|449301576|FG001|Overall Study|Death|0|||
124910937|NCT00277355|449301575|FG000|Overall Study|Physician Decision|1|||
124910938|NCT00277355|449301576|FG001|Overall Study|Physician Decision|0|||
124910939|NCT02597920|449301579|FG000|Overall Study|Worsening of other pre-existing disease|0|||
124910940|NCT02597920|449301580|FG001|Overall Study|Worsening of other pre-existing disease|1|||
124910941|NCT02597920|449301581|FG002|Overall Study|Worsening of other pre-existing disease|0|||
124910942|NCT02597920|449301579|FG000|Overall Study|Other adverse event|20|||
124910943|NCT02597920|449301580|FG001|Overall Study|Other adverse event|30|||
124910944|NCT02597920|449301581|FG002|Overall Study|Other adverse event|0|||
124910945|NCT02597920|449301579|FG000|Overall Study|Lost to Follow-up|7|||
124910946|NCT02597920|449301580|FG001|Overall Study|Lost to Follow-up|9|||
124910947|NCT02597920|449301581|FG002|Overall Study|Lost to Follow-up|0|||
124910948|NCT02597920|449301579|FG000|Overall Study|Refuse to continue in the study|3|||
124910949|NCT02597920|449301580|FG001|Overall Study|Refuse to continue in the study|13|||
124910950|NCT02597920|449301581|FG002|Overall Study|Refuse to continue in the study|1|||
124910951|NCT02597920|449301579|FG000|Overall Study|Other than specified|10|||
124910952|NCT02597920|449301580|FG001|Overall Study|Other than specified|31|||
124910953|NCT02597920|449301581|FG002|Overall Study|Other than specified|5|||
124910954|NCT02597920|449301579|FG000|Overall Study|Other|1|||
124910955|NCT02597920|449301580|FG001|Overall Study|Other|0|||
124910956|NCT02597920|449301581|FG002|Overall Study|Other|0|||
124910957|NCT00642850|449301582|FG000|Overall Study|Death|7|||
124910958|NCT00642850|449301582|FG000|Overall Study|Adverse Event|2|||
124910959|NCT00642850|449301582|FG000|Overall Study|Lack of Efficacy|1|||
124910960|NCT00642850|449301582|FG000|Overall Study|Protocol Violation|2|||
124910961|NCT00642850|449301582|FG000|Overall Study|Kidney transplantation|8|||
124910962|NCT00642850|449301582|FG000|Overall Study|Blood transfusion|6|||
124910963|NCT00642850|449301582|FG000|Overall Study|Other reasons|7|||
124910964|NCT05489484|449301585|FG000|Overall Study|withdrawn|1|||
124910965|NCT00444600|449301588|FG000|Overall Study|Death|7|||
124910966|NCT00444600|449301589|FG001|Overall Study|Death|5|||
124910967|NCT00444600|449301590|FG002|Overall Study|Death|3|||
124910968|NCT00444600|449301591|FG003|Overall Study|Death|2|||
124910969|NCT00444600|449301588|FG000|Overall Study|Dropped|11|||
124910970|NCT00444600|449301589|FG001|Overall Study|Dropped|11|||
124910971|NCT00444600|449301590|FG002|Overall Study|Dropped|7|||
124910972|NCT00444600|449301591|FG003|Overall Study|Dropped|7|||
124910973|NCT00444600|449301588|FG000|Overall Study|Missed visit|1|||
124910974|NCT00444600|449301589|FG001|Overall Study|Missed visit|0|||
124910975|NCT00444600|449301590|FG002|Overall Study|Missed visit|0|||
124910976|NCT00444600|449301591|FG003|Overall Study|Missed visit|1|||
124910977|NCT05132478|449301592|FG000|Overall Study|did not complete survey after consent|1|||
124910978|NCT05132478|449301593|FG001|Overall Study|did not complete survey after consent|1|||
124910979|NCT05132478|449301592|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
124910980|NCT05132478|449301593|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
124910981|NCT01414738|449301596|FG000|Overall Study|Death|26|||
124910982|NCT01414738|449301596|FG000|Overall Study|Refused testing|5|||
124910983|NCT01414738|449301596|FG000|Overall Study|Lost to Follow-up|2|||
124910984|NCT01414738|449301596|FG000|Overall Study|Refused, disease progression|8|||
124910985|NCT01414738|449301596|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
124910986|NCT01839331|449301597|FG000|Overall Study|Early Termination|3|||
124910987|NCT01839331|449301598|FG001|Overall Study|Early Termination|0|||
124910988|NCT01839331|449301599|FG002|Overall Study|Early Termination|1|||
124910989|NCT01839331|449301600|FG003|Overall Study|Early Termination|2|||
124910990|NCT01839331|449301597|FG000|Overall Study|Protocol Violation|1|||
124910991|NCT01839331|449301598|FG001|Overall Study|Protocol Violation|6|||
124910992|NCT01839331|449301599|FG002|Overall Study|Protocol Violation|4|||
124910993|NCT01839331|449301600|FG003|Overall Study|Protocol Violation|3|||
124910994|NCT04056624|449301601|FG000|Overall Study|Withdrawal by Subject|0|||
124910995|NCT04056624|449301602|FG001|Overall Study|Withdrawal by Subject|0|||
124910996|NCT04056624|449301603|FG002|Overall Study|Withdrawal by Subject|1|||
124910997|NCT04056624|449301601|FG000|Overall Study|Protocol Violation|1|||
124910998|NCT04056624|449301602|FG001|Overall Study|Protocol Violation|2|||
124910999|NCT04056624|449301603|FG002|Overall Study|Protocol Violation|0|||
125115250|NCT00066807|450044781|FG000|Overall Study|Study was terminated early|14|||
124911000|NCT00703820|449301606|FG000|Overall Study|Adverse Event|12|||
124911001|NCT00703820|449301607|FG001|Overall Study|Adverse Event|17|||
124911002|NCT00703820|449301606|FG000|Overall Study|Death|5|||
124911003|NCT00703820|449301607|FG001|Overall Study|Death|0|||
124911004|NCT00703820|449301606|FG000|Overall Study|Lack of Efficacy|11|||
124911005|NCT00703820|449301607|FG001|Overall Study|Lack of Efficacy|11|||
124911006|NCT00703820|449301606|FG000|Overall Study|Received non-protocol therapy|1|||
124911007|NCT00703820|449301607|FG001|Overall Study|Received non-protocol therapy|0|||
124911008|NCT00703820|449301606|FG000|Overall Study|Physician Decision|4|||
124911009|NCT00703820|449301607|FG001|Overall Study|Physician Decision|5|||
124911010|NCT00703820|449301606|FG000|Overall Study|Withdrawal by Subject|2|||
124911011|NCT00703820|449301607|FG001|Overall Study|Withdrawal by Subject|1|||
124911012|NCT03531840|449301610|FG000|Overall Study|Death on study|3|||
124911013|NCT03531840|449301611|FG001|Overall Study|Death on study|2|||
124911014|NCT03531840|449301612|FG002|Overall Study|Death on study|1|||
124911015|NCT03531840|449301613|FG003|Overall Study|Death on study|2|||
124911016|NCT03531840|449301610|FG000|Overall Study|Death during follow up|2|||
124911017|NCT03531840|449301611|FG001|Overall Study|Death during follow up|3|||
124911018|NCT03531840|449301612|FG002|Overall Study|Death during follow up|4|||
124911019|NCT03531840|449301613|FG003|Overall Study|Death during follow up|1|||
124911020|NCT00761605|449301615|FG000|Overall Study|Adverse Event|26|||
124911021|NCT00761605|449301615|FG000|Overall Study|Death|2|||
124911022|NCT00761605|449301615|FG000|Overall Study|Lack of Efficacy|26|||
124911023|NCT00761605|449301615|FG000|Overall Study|Lost to Follow-up|29|||
124911024|NCT00761605|449301615|FG000|Overall Study|Withdrawal by Subject|37|||
124911025|NCT00761605|449301615|FG000|Overall Study|Other|21|||
124911026|NCT02267824|449301616|FG000|Overall Study|Pregnancy|1|||
125115251|NCT00066807|450044782|FG001|Overall Study|Study was terminated early|15|||
125115252|NCT05028751|450044783|FG000|Overall Study|Study Terminated by Sponsor|3|||
124911027|NCT02267824|449301617|FG001|Overall Study|Pregnancy|1|||
124911028|NCT02267824|449301616|FG000|Overall Study|Lost to Follow-up|4|||
124911029|NCT02267824|449301617|FG001|Overall Study|Lost to Follow-up|0|||
124911030|NCT02267824|449301616|FG000|Overall Study|Protocol Violation|3|||
124911031|NCT02267824|449301617|FG001|Overall Study|Protocol Violation|0|||
124911032|NCT02267824|449301616|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
125115253|NCT05028751|450044784|FG001|Overall Study|Study Terminated by Sponsor|0|||
124911033|NCT02267824|449301617|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
125115254|NCT05028751|450044785|FG002|Overall Study|Study Terminated by Sponsor|0|||
125115255|NCT05028751|450044786|FG003|Overall Study|Study Terminated by Sponsor|0|||
125115256|NCT05028751|450044783|FG000|Overall Study|Death|9|||
124911034|NCT03451721|449301618|FG000|Overall Study|Death|1|||
124911035|NCT00350792|449301619|FG000|Overall Study|Adverse Event|11|||
124911036|NCT00350792|449301619|FG000|Overall Study|Death from Study Disease|1|||
124911037|NCT00350792|449301619|FG000|Overall Study|Death from Study Drug Toxicity|1|||
124911038|NCT00350792|449301619|FG000|Overall Study|Death Not Study Drug Related|2|||
124911039|NCT00350792|449301619|FG000|Overall Study|Protocol Violation|1|||
124911040|NCT00350792|449301619|FG000|Overall Study|Withdrawal by Subject|4|||
125115257|NCT05028751|450044784|FG001|Overall Study|Death|3|||
124911041|NCT00350792|449301619|FG000|Overall Study|Physician Decision|2|||
124911042|NCT00350792|449301619|FG000|Overall Study|Lack of Efficacy|11|||
124911043|NCT01985334|449301620|FG000|Overall Study|Administrative problems|1|||
124911044|NCT01985334|449301621|FG001|Overall Study|Administrative problems|1|||
124911045|NCT01985334|449301622|FG002|Overall Study|Administrative problems|0|||
124911046|NCT01985334|449301623|FG003|Overall Study|Administrative problems|2|||
124911047|NCT01985334|449301624|FG004|Overall Study|Administrative problems|0|||
124911048|NCT01985334|449301625|FG005|Overall Study|Administrative problems|1|||
124911049|NCT01985334|449301626|FG006|Overall Study|Administrative problems|1|||
124911050|NCT01985334|449301627|FG007|Overall Study|Administrative problems|3|||
124911051|NCT01985334|449301620|FG000|Overall Study|Death|1|||
124911052|NCT01985334|449301621|FG001|Overall Study|Death|0|||
124911053|NCT01985334|449301622|FG002|Overall Study|Death|0|||
124911054|NCT01985334|449301623|FG003|Overall Study|Death|3|||
124911055|NCT01985334|449301624|FG004|Overall Study|Death|0|||
124911056|NCT01985334|449301625|FG005|Overall Study|Death|0|||
124911057|NCT01985334|449301626|FG006|Overall Study|Death|1|||
124911058|NCT01985334|449301627|FG007|Overall Study|Death|2|||
124911059|NCT01985334|449301620|FG000|Overall Study|Worsening of disease|0|||
124911060|NCT01985334|449301621|FG001|Overall Study|Worsening of disease|0|||
124911061|NCT01985334|449301622|FG002|Overall Study|Worsening of disease|0|||
124911062|NCT01985334|449301623|FG003|Overall Study|Worsening of disease|1|||
124911063|NCT01985334|449301624|FG004|Overall Study|Worsening of disease|0|||
124911064|NCT01985334|449301625|FG005|Overall Study|Worsening of disease|3|||
124911065|NCT01985334|449301626|FG006|Overall Study|Worsening of disease|0|||
124911066|NCT01985334|449301627|FG007|Overall Study|Worsening of disease|1|||
124911067|NCT01985334|449301620|FG000|Overall Study|Other|2|||
124911068|NCT01985334|449301621|FG001|Overall Study|Other|9|||
124911069|NCT01985334|449301622|FG002|Overall Study|Other|7|||
124911070|NCT01985334|449301623|FG003|Overall Study|Other|17|||
124911071|NCT01985334|449301624|FG004|Overall Study|Other|4|||
124911072|NCT01985334|449301625|FG005|Overall Study|Other|8|||
124911073|NCT01985334|449301626|FG006|Overall Study|Other|4|||
124911074|NCT01985334|449301627|FG007|Overall Study|Other|7|||
124911075|NCT01985334|449301620|FG000|Overall Study|Protocol deviation|6|||
124911076|NCT01985334|449301621|FG001|Overall Study|Protocol deviation|31|||
124911077|NCT01985334|449301622|FG002|Overall Study|Protocol deviation|25|||
124911078|NCT01985334|449301623|FG003|Overall Study|Protocol deviation|84|||
124911079|NCT01985334|449301624|FG004|Overall Study|Protocol deviation|17|||
124911080|NCT01985334|449301625|FG005|Overall Study|Protocol deviation|47|||
124911081|NCT01985334|449301626|FG006|Overall Study|Protocol deviation|15|||
124911082|NCT01985334|449301627|FG007|Overall Study|Protocol deviation|42|||
124911083|NCT01985334|449301620|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
124911084|NCT01985334|449301621|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
124911085|NCT01985334|449301622|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
124911086|NCT01985334|449301623|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
124911087|NCT01985334|449301624|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
124911088|NCT01985334|449301625|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
124911089|NCT01985334|449301626|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
124911090|NCT01985334|449301627|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
124911091|NCT01985334|449301620|FG000|Overall Study|Subject withdrawal of consent|3|||
124911092|NCT01985334|449301621|FG001|Overall Study|Subject withdrawal of consent|6|||
124911093|NCT01985334|449301622|FG002|Overall Study|Subject withdrawal of consent|2|||
124911094|NCT01985334|449301623|FG003|Overall Study|Subject withdrawal of consent|28|||
124911095|NCT01985334|449301624|FG004|Overall Study|Subject withdrawal of consent|4|||
124911096|NCT01985334|449301625|FG005|Overall Study|Subject withdrawal of consent|19|||
124911097|NCT01985334|449301626|FG006|Overall Study|Subject withdrawal of consent|0|||
124911098|NCT01985334|449301627|FG007|Overall Study|Subject withdrawal of consent|20|||
124911099|NCT01985334|449301620|FG000|Overall Study|Adverse Event|0|||
124911100|NCT01985334|449301621|FG001|Overall Study|Adverse Event|8|||
124911101|NCT01985334|449301622|FG002|Overall Study|Adverse Event|2|||
124911102|NCT01985334|449301623|FG003|Overall Study|Adverse Event|26|||
124911103|NCT01985334|449301624|FG004|Overall Study|Adverse Event|3|||
124911104|NCT01985334|449301625|FG005|Overall Study|Adverse Event|18|||
124911105|NCT01985334|449301626|FG006|Overall Study|Adverse Event|3|||
124911106|NCT01985334|449301627|FG007|Overall Study|Adverse Event|15|||
124911107|NCT01985334|449301620|FG000|Overall Study|Other|4|||
124911108|NCT01985334|449301621|FG001|Overall Study|Other|2|||
124911109|NCT01985334|449301622|FG002|Overall Study|Other|3|||
124911110|NCT01985334|449301623|FG003|Overall Study|Other|10|||
124911111|NCT01985334|449301624|FG004|Overall Study|Other|1|||
124911112|NCT01985334|449301625|FG005|Overall Study|Other|6|||
124911113|NCT01985334|449301626|FG006|Overall Study|Other|2|||
124911114|NCT01985334|449301627|FG007|Overall Study|Other|2|||
124911115|NCT01985334|449301620|FG000|Overall Study|Medication non-compliance|0|||
124911116|NCT01985334|449301621|FG001|Overall Study|Medication non-compliance|4|||
124911117|NCT01985334|449301622|FG002|Overall Study|Medication non-compliance|1|||
124911118|NCT01985334|449301623|FG003|Overall Study|Medication non-compliance|6|||
124911119|NCT01985334|449301624|FG004|Overall Study|Medication non-compliance|2|||
124911120|NCT01985334|449301625|FG005|Overall Study|Medication non-compliance|3|||
124911121|NCT01985334|449301626|FG006|Overall Study|Medication non-compliance|1|||
124911122|NCT01985334|449301627|FG007|Overall Study|Medication non-compliance|3|||
124911123|NCT01985334|449301620|FG000|Overall Study|Use of prohibited treatment|1|||
124911124|NCT01985334|449301621|FG001|Overall Study|Use of prohibited treatment|4|||
124911125|NCT01985334|449301622|FG002|Overall Study|Use of prohibited treatment|1|||
124911126|NCT01985334|449301623|FG003|Overall Study|Use of prohibited treatment|2|||
124911127|NCT01985334|449301624|FG004|Overall Study|Use of prohibited treatment|1|||
124911128|NCT01985334|449301625|FG005|Overall Study|Use of prohibited treatment|6|||
124911129|NCT01985334|449301626|FG006|Overall Study|Use of prohibited treatment|2|||
124911130|NCT01985334|449301627|FG007|Overall Study|Use of prohibited treatment|0|||
124911131|NCT01985334|449301620|FG000|Overall Study|Investigator decision|0|||
124911132|NCT01985334|449301621|FG001|Overall Study|Investigator decision|3|||
124911133|NCT01985334|449301622|FG002|Overall Study|Investigator decision|0|||
124911134|NCT01985334|449301623|FG003|Overall Study|Investigator decision|7|||
124911135|NCT01985334|449301624|FG004|Overall Study|Investigator decision|1|||
124911136|NCT01985334|449301625|FG005|Overall Study|Investigator decision|1|||
125115258|NCT05028751|450044785|FG002|Overall Study|Death|2|||
124911137|NCT01985334|449301626|FG006|Overall Study|Investigator decision|0|||
124911138|NCT01985334|449301627|FG007|Overall Study|Investigator decision|4|||
124911139|NCT01985334|449301620|FG000|Overall Study|Lost to Follow-up|0|||
124911140|NCT01985334|449301621|FG001|Overall Study|Lost to Follow-up|2|||
125115259|NCT05028751|450044786|FG003|Overall Study|Death|4|||
124911141|NCT01985334|449301622|FG002|Overall Study|Lost to Follow-up|0|||
124911142|NCT01985334|449301623|FG003|Overall Study|Lost to Follow-up|3|||
124911143|NCT01985334|449301624|FG004|Overall Study|Lost to Follow-up|1|||
124911144|NCT01985334|449301625|FG005|Overall Study|Lost to Follow-up|4|||
124911145|NCT01985334|449301626|FG006|Overall Study|Lost to Follow-up|0|||
124911146|NCT01985334|449301627|FG007|Overall Study|Lost to Follow-up|3|||
124911147|NCT00396084|449301630|FG000|Overall Study|Adverse Event|0|||
124911148|NCT00396084|449301631|FG001|Overall Study|Adverse Event|0|||
124911149|NCT00396084|449301632|FG002|Overall Study|Adverse Event|0|||
124911150|NCT00396084|449301633|FG003|Overall Study|Adverse Event|0|||
124911151|NCT00396084|449301634|FG004|Overall Study|Adverse Event|1|||
124911152|NCT00396084|449301635|FG005|Overall Study|Adverse Event|2|||
124911153|NCT00396084|449301630|FG000|Overall Study|Withdrawal by Subject|0|||
124911154|NCT00396084|449301631|FG001|Overall Study|Withdrawal by Subject|0|||
124911155|NCT00396084|449301632|FG002|Overall Study|Withdrawal by Subject|0|||
124911156|NCT00396084|449301633|FG003|Overall Study|Withdrawal by Subject|1|||
124911157|NCT00396084|449301634|FG004|Overall Study|Withdrawal by Subject|0|||
124911158|NCT00396084|449301635|FG005|Overall Study|Withdrawal by Subject|0|||
124911159|NCT01565148|449301641|FG000|Overall Study|Withdrawal by Subject|1|||
124911160|NCT01565148|449301642|FG001|Overall Study|Withdrawal by Subject|1|||
124911161|NCT01565148|449301643|FG002|Overall Study|Withdrawal by Subject|1|||
124911162|NCT01565148|449301644|FG003|Overall Study|Withdrawal by Subject|2|||
124911163|NCT01565148|449301641|FG000|Overall Study|Lost to Follow-up|4|||
124911164|NCT01565148|449301642|FG001|Overall Study|Lost to Follow-up|4|||
124911165|NCT01565148|449301643|FG002|Overall Study|Lost to Follow-up|0|||
124911166|NCT01565148|449301644|FG003|Overall Study|Lost to Follow-up|3|||
124911167|NCT01565148|449301641|FG000|Overall Study|Rescue Therapy|8|||
124911168|NCT01565148|449301642|FG001|Overall Study|Rescue Therapy|5|||
124911169|NCT01565148|449301643|FG002|Overall Study|Rescue Therapy|5|||
124911170|NCT01565148|449301644|FG003|Overall Study|Rescue Therapy|8|||
124911171|NCT01565148|449301641|FG000|Overall Study|Death|0|||
124911172|NCT01565148|449301642|FG001|Overall Study|Death|0|||
124911173|NCT01565148|449301643|FG002|Overall Study|Death|1|||
124911174|NCT01565148|449301644|FG003|Overall Study|Death|0|||
125115260|NCT05028751|450044783|FG000|Overall Study|Withdrawal by Subject|0|||
125115261|NCT05028751|450044784|FG001|Overall Study|Withdrawal by Subject|0|||
125115262|NCT05028751|450044785|FG002|Overall Study|Withdrawal by Subject|1|||
125115263|NCT05028751|450044786|FG003|Overall Study|Withdrawal by Subject|0|||
125115264|NCT05028751|450044783|FG000|Overall Study|Miscellaneous|2|||
125115265|NCT05028751|450044784|FG001|Overall Study|Miscellaneous|0|||
125115266|NCT05028751|450044785|FG002|Overall Study|Miscellaneous|0|||
124911175|NCT01565148|449301641|FG000|Overall Study|Physician Decision|2|||
124911176|NCT01565148|449301642|FG001|Overall Study|Physician Decision|5|||
124911177|NCT01565148|449301643|FG002|Overall Study|Physician Decision|0|||
124911178|NCT01565148|449301644|FG003|Overall Study|Physician Decision|0|||
124911179|NCT01199575|449301647|FG000|Overall Study|Withdrawal by Subject|5|||
124911180|NCT02409667|449301650|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
124911181|NCT02409667|449301651|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
124911182|NCT02409667|449301652|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
124911183|NCT02409667|449301653|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
124911184|NCT02409667|449301654|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
124911185|NCT02409667|449301650|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
124911186|NCT02409667|449301651|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
125115267|NCT05028751|450044786|FG003|Overall Study|Miscellaneous|0|||
125115268|NCT03586830|450044787|FG000|Overall Study|Site terminated by Sponsor|1|||
124911187|NCT02409667|449301652|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
124911188|NCT02409667|449301653|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
124911189|NCT02409667|449301654|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
124911190|NCT02409667|449301650|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
124911191|NCT02409667|449301651|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
124911192|NCT02409667|449301652|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
124911193|NCT02409667|449301653|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
124911194|NCT02409667|449301654|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
124911195|NCT02409667|449301650|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
124911196|NCT02409667|449301651|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
125115269|NCT03586830|450044788|FG001|Overall Study|Site terminated by Sponsor|4|||
125115270|NCT03586830|450044789|FG002|Overall Study|Site terminated by Sponsor|3|||
124911197|NCT02409667|449301652|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
124911198|NCT02409667|449301653|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
124911199|NCT02409667|449301654|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
124911200|NCT02409667|449301650|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
124911201|NCT02409667|449301651|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
125115271|NCT03586830|450044790|FG003|Overall Study|Site terminated by Sponsor|3|||
124911202|NCT02409667|449301652|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
124911203|NCT02409667|449301653|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
124911204|NCT02409667|449301654|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
124911205|NCT02409667|449301650|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
124911206|NCT02409667|449301651|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
124911207|NCT02409667|449301652|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
124911208|NCT02409667|449301653|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
124911209|NCT02409667|449301654|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
124911210|NCT02409667|449301650|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
124911211|NCT02409667|449301651|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
124911212|NCT02409667|449301652|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
124911213|NCT02409667|449301653|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
124911214|NCT02409667|449301654|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
124911215|NCT02409667|449301650|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
124911216|NCT02409667|449301651|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
124911217|NCT02409667|449301652|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
124911218|NCT02409667|449301653|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
124911219|NCT02409667|449301654|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
124911220|NCT02409667|449301650|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
124911221|NCT02409667|449301651|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
124911222|NCT02409667|449301652|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
124911223|NCT02409667|449301653|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
124911224|NCT02409667|449301654|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
124911225|NCT02409667|449301650|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
124911226|NCT02409667|449301651|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
124911227|NCT02409667|449301652|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
124911228|NCT02409667|449301653|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
124911229|NCT02409667|449301654|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
124911230|NCT02409667|449301650|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
124911231|NCT02409667|449301651|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
124911232|NCT02409667|449301652|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
124911233|NCT02409667|449301653|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
124911234|NCT02409667|449301654|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
124911235|NCT02409667|449301650|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
124911236|NCT02409667|449301651|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
124911237|NCT02409667|449301652|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
124911238|NCT02409667|449301653|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
124911239|NCT02409667|449301654|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
124911240|NCT02409667|449301650|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
124911241|NCT02409667|449301651|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
124911242|NCT02409667|449301652|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
124911243|NCT02409667|449301653|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
124911244|NCT02409667|449301654|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
124911245|NCT02409667|449301650|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
124911246|NCT02409667|449301651|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
124911247|NCT02409667|449301652|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
124911248|NCT02409667|449301653|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
124911249|NCT02409667|449301654|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
124911250|NCT02409667|449301650|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
124911251|NCT02409667|449301651|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
124911252|NCT02409667|449301652|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
124911253|NCT02409667|449301653|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
124911254|NCT02409667|449301654|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
124911255|NCT02409667|449301650|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
124911256|NCT02409667|449301651|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
124911257|NCT02409667|449301652|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
124911258|NCT02409667|449301653|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
124911259|NCT02409667|449301654|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
124911260|NCT01925339|449301655|FG000|Overall Study|Adverse Event|2|||
124911261|NCT01925339|449301656|FG001|Overall Study|Adverse Event|0|||
124911262|NCT03960463|449302793|FG000|Overall Study|Withdrawal by Subject|2|||
124911263|NCT03960463|449302794|FG001|Overall Study|Withdrawal by Subject|0|||
124911264|NCT04999085|449302798|FG000|Overall Study|Death|1|||
125115272|NCT03586830|450044787|FG000|Overall Study|Lost to Follow-up|0|||
125115273|NCT03586830|450044788|FG001|Overall Study|Lost to Follow-up|2|||
124911265|NCT02581215|449302799|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
124911266|NCT02581215|449302800|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
124911267|NCT02581215|449302799|FG000|Overall Study|Eligibility Criteria Not Met|0|||
124911268|NCT02581215|449302800|FG001|Overall Study|Eligibility Criteria Not Met|1|||
124911269|NCT03613740|449302801|FG000|Overall Study|Lost to Follow-up|1|||
124911270|NCT03613740|449302802|FG001|Overall Study|Lost to Follow-up|1|||
124911271|NCT04188379|449302803|FG000|Overall Study|Withdrawal by Subject|10|||
124911272|NCT04188379|449302804|FG001|Overall Study|Withdrawal by Subject|3|||
124911273|NCT04188379|449302803|FG000|Overall Study|Physician Decision|0|||
124911274|NCT04188379|449302804|FG001|Overall Study|Physician Decision|1|||
124911275|NCT04188379|449302803|FG000|Overall Study|Adverse Event|3|||
124911276|NCT04188379|449302804|FG001|Overall Study|Adverse Event|1|||
124911277|NCT04188379|449302803|FG000|Overall Study|Pregnancy|1|||
124911278|NCT04188379|449302804|FG001|Overall Study|Pregnancy|0|||
124911279|NCT04188379|449302803|FG000|Overall Study|Lack of Efficacy|8|||
124911280|NCT04188379|449302804|FG001|Overall Study|Lack of Efficacy|5|||
124911281|NCT04188379|449302803|FG000|Overall Study|Other|0|||
124911282|NCT04188379|449302804|FG001|Overall Study|Other|3|||
124911283|NCT02566902|449302807|FG000|Overall Study|Protocol Violation|2|||
124911284|NCT02566902|449302808|FG001|Overall Study|Protocol Violation|1|||
124911285|NCT03112174|449302811|FG000|Overall Study|Withdrawal by Subject|3|||
124911286|NCT03112174|449302812|FG001|Overall Study|Withdrawal by Subject|0|||
124911287|NCT03112174|449302813|FG002|Overall Study|Withdrawal by Subject|11|||
124911288|NCT03112174|449302814|FG003|Overall Study|Withdrawal by Subject|9|||
124911289|NCT03112174|449302815|FG004|Overall Study|Withdrawal by Subject|7|||
124911290|NCT03112174|449302811|FG000|Overall Study|Lost to Follow-up|1|||
124911291|NCT03112174|449302812|FG001|Overall Study|Lost to Follow-up|1|||
124911292|NCT03112174|449302813|FG002|Overall Study|Lost to Follow-up|2|||
124911293|NCT03112174|449302814|FG003|Overall Study|Lost to Follow-up|3|||
124911294|NCT03112174|449302815|FG004|Overall Study|Lost to Follow-up|2|||
124911295|NCT03112174|449302811|FG000|Overall Study|Death|8|||
124911296|NCT03112174|449302812|FG001|Overall Study|Death|3|||
124911297|NCT03112174|449302813|FG002|Overall Study|Death|67|||
124911298|NCT03112174|449302814|FG003|Overall Study|Death|73|||
124911299|NCT03112174|449302815|FG004|Overall Study|Death|18|||
124911300|NCT03112174|449302811|FG000|Overall Study|Other, Not Specified|1|||
124911301|NCT03112174|449302812|FG001|Overall Study|Other, Not Specified|0|||
124911302|NCT03112174|449302813|FG002|Overall Study|Other, Not Specified|1|||
124911303|NCT03112174|449302814|FG003|Overall Study|Other, Not Specified|2|||
124911304|NCT03112174|449302815|FG004|Overall Study|Other, Not Specified|0|||
124911305|NCT02748317|449302818|FG000|Overall Study|Withdrawal by Subject|14|||
124911306|NCT02748317|449302818|FG000|Overall Study|Lost to Follow-up|8|||
124911307|NCT02748317|449302818|FG000|Overall Study|Death|1|||
124911308|NCT00332241|449302821|FG000|Overall Study|Lack of Efficacy|6|||
124911309|NCT00332241|449302822|FG001|Overall Study|Lack of Efficacy|1|||
124911310|NCT00332241|449302821|FG000|Overall Study|Adverse Event|3|||
124911311|NCT00332241|449302822|FG001|Overall Study|Adverse Event|5|||
124911312|NCT00332241|449302821|FG000|Overall Study|Withdrawal by Subject|2|||
124911313|NCT00332241|449302822|FG001|Overall Study|Withdrawal by Subject|1|||
124911314|NCT00332241|449302821|FG000|Overall Study|Lost to Follow-up|4|||
124911315|NCT00332241|449302822|FG001|Overall Study|Lost to Follow-up|1|||
124911316|NCT00802464|449302824|FG000|Month 0 - Month 8|Adverse Event|0|||
124911317|NCT00802464|449302825|FG001|Month 0 - Month 8|Adverse Event|1|||
124911318|NCT00802464|449302826|FG002|Month 0 - Month 8|Adverse Event|1|||
124911319|NCT00802464|449302827|FG003|Month 0 - Month 8|Adverse Event|2|||
124911320|NCT00802464|449302824|FG000|Month 0 - Month 8|Protocol Violation|0|||
124911321|NCT00802464|449302825|FG001|Month 0 - Month 8|Protocol Violation|0|||
124911322|NCT00802464|449302826|FG002|Month 0 - Month 8|Protocol Violation|1|||
124911323|NCT00802464|449302827|FG003|Month 0 - Month 8|Protocol Violation|0|||
124911324|NCT00802464|449302824|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
124911325|NCT00802464|449302825|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
124911326|NCT00802464|449302826|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
124911327|NCT00802464|449302827|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
124911328|NCT00802464|449302824|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
124911329|NCT00802464|449302825|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
124911330|NCT00802464|449302826|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
124911331|NCT00802464|449302827|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
124911332|NCT00802464|449302824|FG000|Month 0 - Month 8|Other|0|||
124911333|NCT00802464|449302825|FG001|Month 0 - Month 8|Other|0|||
124911334|NCT00802464|449302826|FG002|Month 0 - Month 8|Other|1|||
124911335|NCT00802464|449302827|FG003|Month 0 - Month 8|Other|0|||
124911336|NCT00802464|449302824|FG000|Month 8 - Month 14|Adverse Event|0|||
124911337|NCT00802464|449302825|FG001|Month 8 - Month 14|Adverse Event|1|||
124911338|NCT00802464|449302826|FG002|Month 8 - Month 14|Adverse Event|0|||
124911339|NCT00802464|449302827|FG003|Month 8 - Month 14|Adverse Event|0|||
124911340|NCT00802464|449302824|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
124911341|NCT00802464|449302825|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
125115274|NCT03586830|450044789|FG002|Overall Study|Lost to Follow-up|2|||
124911342|NCT00802464|449302826|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
124911343|NCT00802464|449302827|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
124911344|NCT00802464|449302824|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
124911345|NCT00802464|449302825|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
124911346|NCT00802464|449302826|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
124911347|NCT00802464|449302827|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
124911348|NCT00402246|449302828|FG000|Overall Study|Death|62|||
124911349|NCT00402246|449302829|FG001|Overall Study|Death|58|||
124911350|NCT00402246|449302828|FG000|Overall Study|Lost to Follow-up|20|||
124911351|NCT00402246|449302829|FG001|Overall Study|Lost to Follow-up|28|||
124911352|NCT00402246|449302828|FG000|Overall Study|Withdrawal by Subject|72|||
124911353|NCT00402246|449302829|FG001|Overall Study|Withdrawal by Subject|87|||
124911354|NCT00402246|449302828|FG000|Overall Study|Physician Decision|24|||
124911355|NCT00402246|449302829|FG001|Overall Study|Physician Decision|26|||
124911356|NCT00402246|449302828|FG000|Overall Study|Protocol Violation|25|||
124911357|NCT00402246|449302829|FG001|Overall Study|Protocol Violation|24|||
124911358|NCT00402246|449302828|FG000|Overall Study|Missed Final Visit|1|||
124911359|NCT00402246|449302829|FG001|Overall Study|Missed Final Visit|2|||
124911360|NCT00402246|449302828|FG000|Overall Study|Insurance Issues|2|||
124911361|NCT00402246|449302829|FG001|Overall Study|Insurance Issues|1|||
124911362|NCT00402246|449302828|FG000|Overall Study|Heart Transplant|0|||
124911363|NCT00402246|449302829|FG001|Overall Study|Heart Transplant|1|||
124911364|NCT00402246|449302828|FG000|Overall Study|Patient's device explanted|6|||
124911365|NCT00402246|449302829|FG001|Overall Study|Patient's device explanted|2|||
124911366|NCT00402246|449302828|FG000|Overall Study|Center Closure|5|||
124911367|NCT00402246|449302829|FG001|Overall Study|Center Closure|3|||
124911368|NCT00402246|449302828|FG000|Overall Study|Deterioriating Condition|3|||
124911369|NCT00402246|449302829|FG001|Overall Study|Deterioriating Condition|2|||
124911370|NCT05262738|449302834|FG000|Overall Study|Withdrawal by Subject|1|||
124911371|NCT05262738|449302835|FG001|Overall Study|Withdrawal by Subject|0|||
124911372|NCT01471691|449302838|FG000|Overall Study|Lack of Efficacy|0|||
124911373|NCT01471691|449302839|FG001|Overall Study|Lack of Efficacy|1|||
124911374|NCT01808339|449302840|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
124911375|NCT01808339|449302841|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
124911376|NCT01808339|449302842|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
124911377|NCT01808339|449302843|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
124911378|NCT01808339|449302844|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
124911379|NCT01808339|449302845|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
124911380|NCT01808339|449302840|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124911381|NCT01808339|449302841|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
124911382|NCT01808339|449302842|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124911383|NCT01808339|449302843|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
124911384|NCT01808339|449302844|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124911385|NCT01808339|449302845|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124911386|NCT01808339|449302840|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
124911387|NCT01808339|449302841|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
124911388|NCT01808339|449302842|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
124911389|NCT01808339|449302843|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
124911390|NCT01808339|449302844|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
124911391|NCT01808339|449302845|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
124911392|NCT02622568|449302846|FG000|Overall Study|Lost to Follow-up|5|||
124911393|NCT02622568|449302847|FG001|Overall Study|Lost to Follow-up|5|||
124911394|NCT00106080|449302849|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
124911395|NCT00106080|449302850|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
124911396|NCT02549170|449302851|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
124911397|NCT02549170|449302852|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
124911398|NCT02549170|449302853|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
124911399|NCT02549170|449302854|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
124911400|NCT02549170|449302855|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
124911401|NCT02549170|449302851|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
124911402|NCT02549170|449302852|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
125115275|NCT03586830|450044790|FG003|Overall Study|Lost to Follow-up|1|||
125115276|NCT03586830|450044787|FG000|Overall Study|Withdrawal by Subject|1|||
125115277|NCT03586830|450044788|FG001|Overall Study|Withdrawal by Subject|0|||
125115278|NCT03586830|450044789|FG002|Overall Study|Withdrawal by Subject|3|||
125115279|NCT03586830|450044790|FG003|Overall Study|Withdrawal by Subject|1|||
125115280|NCT04578548|450044791|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
125115281|NCT04578548|450044792|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
125115282|NCT04578548|450044791|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
124911403|NCT02549170|449302853|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
124911404|NCT02549170|449302854|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
124911405|NCT02549170|449302855|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
124911406|NCT02549170|449302851|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
124911407|NCT02549170|449302852|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
124911408|NCT02549170|449302853|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
124911409|NCT02549170|449302854|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
124911410|NCT02549170|449302855|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
124911411|NCT02379819|449302856|FG000|Overall Study|Withdrawal by Subject|10|||
124911412|NCT02379819|449302856|FG000|Overall Study|Death|2|||
124911413|NCT02379819|449302856|FG000|Overall Study|Lack of Efficacy|1|||
124911414|NCT02379819|449302856|FG000|Overall Study|Lost to Follow-up|1|||
124911415|NCT03988023|449302862|FG000|Overall Study|Non-compliance|3|||
124911416|NCT03988023|449302863|FG001|Overall Study|Non-compliance|0|||
124911417|NCT03988023|449302862|FG000|Overall Study|Withdrawal by Subject|39|||
124911418|NCT03988023|449302863|FG001|Overall Study|Withdrawal by Subject|37|||
124911419|NCT03988023|449302862|FG000|Overall Study|Adverse Event|0|||
124911420|NCT03988023|449302863|FG001|Overall Study|Adverse Event|2|||
124911421|NCT03988023|449302862|FG000|Overall Study|Physician Decision|0|||
124911422|NCT03988023|449302863|FG001|Overall Study|Physician Decision|1|||
124911423|NCT03988023|449302862|FG000|Overall Study|Lost to Follow-up|5|||
124911424|NCT03988023|449302863|FG001|Overall Study|Lost to Follow-up|8|||
124911425|NCT03988023|449302862|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
124911426|NCT03988023|449302863|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
124911427|NCT03988023|449302862|FG000|Overall Study|Lack of Efficacy|3|||
124911428|NCT03988023|449302863|FG001|Overall Study|Lack of Efficacy|1|||
124911429|NCT03988023|449302862|FG000|Overall Study|COVID-19 pandemic|225|||
124911430|NCT03988023|449302863|FG001|Overall Study|COVID-19 pandemic|227|||
124911431|NCT03703336|449302864|FG000|Overall Study|Parent withdrew consent|29|||
124911432|NCT03703336|449302865|FG001|Overall Study|Parent withdrew consent|8|||
124911433|NCT03703336|449302864|FG000|Overall Study|Migration|3|||
124911434|NCT03703336|449302865|FG001|Overall Study|Migration|3|||
124911435|NCT03703336|449302864|FG000|Overall Study|Protocol Violation|3|||
124911436|NCT03703336|449302865|FG001|Overall Study|Protocol Violation|1|||
124911437|NCT03703336|449302864|FG000|Overall Study|Physician Decision|2|||
124911438|NCT03703336|449302865|FG001|Overall Study|Physician Decision|0|||
124911439|NCT03703336|449302864|FG000|Overall Study|Adverse Event|0|||
124911440|NCT03703336|449302865|FG001|Overall Study|Adverse Event|2|||
124911441|NCT03703336|449302864|FG000|Overall Study|Lost to Follow-up|1|||
124911442|NCT03703336|449302865|FG001|Overall Study|Lost to Follow-up|0|||
124911443|NCT02088853|449302868|FG000|Overall Study|Pregnancy|1|||
124911444|NCT02088853|449302869|FG001|Overall Study|Pregnancy|0|||
124911445|NCT02568683|449302870|FG000|Overall Study|Death|0|||
124911446|NCT02568683|449302871|FG001|Overall Study|Death|2|||
124911447|NCT02568683|449302870|FG000|Overall Study|Withdrew Consent|1|||
124911448|NCT02568683|449302871|FG001|Overall Study|Withdrew Consent|0|||
124911449|NCT02568683|449302870|FG000|Overall Study|Study Terminated By Sponsor|5|||
124911450|NCT02568683|449302871|FG001|Overall Study|Study Terminated By Sponsor|2|||
124911451|NCT01736215|449302872|FG000|Overall Study|Early termination of erythropoietin use|1|||
124911452|NCT01736215|449302872|FG000|Overall Study|Adverse Event|4|||
124911453|NCT01736215|449302872|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
124911454|NCT01736215|449302872|FG000|Overall Study|Insufficient data to perform analysis|8|||
124911455|NCT01248936|449302878|FG000|Overall Study|Sponsor Decision|259|||
124911456|NCT01248936|449302878|FG000|Overall Study|Progression of Disease|50|||
124911457|NCT01248936|449302878|FG000|Overall Study|Death|26|||
124911458|NCT01248936|449302878|FG000|Overall Study|Withdrawal of Consent|20|||
124911459|NCT01248936|449302878|FG000|Overall Study|Adverse Event|8|||
124911460|NCT01248936|449302878|FG000|Overall Study|Lost to Follow-up|7|||
124911461|NCT01248936|449302878|FG000|Overall Study|Refused Treatment|1|||
124911462|NCT01248936|449302878|FG000|Overall Study|Other reason|3|||
124911463|NCT03930420|449302879|FG000|Overall Study|Withdrawal by Subject|7|||
124911464|NCT03930420|449302880|FG001|Overall Study|Withdrawal by Subject|9|||
124911465|NCT04556981|449302881|FG000|Overall Study|Death|0|||
124911466|NCT04556981|449302882|FG001|Overall Study|Death|1|||
124911467|NCT04556981|449302881|FG000|Overall Study|Lost to Follow-up|2|||
124911468|NCT04556981|449302882|FG001|Overall Study|Lost to Follow-up|11|||
124911469|NCT04556981|449302881|FG000|Overall Study|Moved from the study area|1|||
124911470|NCT04556981|449302882|FG001|Overall Study|Moved from the study area|4|||
124911471|NCT04556981|449302881|FG000|Overall Study|Withdrawal by Subject|2|||
124911472|NCT04556981|449302882|FG001|Overall Study|Withdrawal by Subject|2|||
124911473|NCT04556981|449302881|FG000|Overall Study|Other|2|||
124911474|NCT04556981|449302882|FG001|Overall Study|Other|1|||
124911475|NCT00609336|449302883|FG000|Overall Study|Protocol Violation|3|||
124911476|NCT00609336|449302883|FG000|Overall Study|Death|1|||
124911477|NCT00609336|449302883|FG000|Overall Study|LA or Met at Surgery|9|||
124911478|NCT02238483|449302884|FG000|Overall Study|Withdrawal by Subject|2|||
124911479|NCT02238483|449302885|FG001|Overall Study|Withdrawal by Subject|7|||
124911480|NCT02238483|449302884|FG000|Overall Study|Lost to Follow-up|1|||
124911481|NCT02238483|449302885|FG001|Overall Study|Lost to Follow-up|1|||
124911482|NCT02238483|449302884|FG000|Overall Study|Protocol Violation|1|||
124911483|NCT02238483|449302885|FG001|Overall Study|Protocol Violation|2|||
124911484|NCT02238483|449302884|FG000|Overall Study|Death|1|||
124911485|NCT02238483|449302885|FG001|Overall Study|Death|0|||
124911486|NCT02238483|449302884|FG000|Overall Study|Adverse Event|7|||
124911487|NCT02238483|449302885|FG001|Overall Study|Adverse Event|3|||
124911488|NCT02238483|449302884|FG000|Overall Study|Withdrawn due to physician decision|1|||
124911489|NCT02238483|449302885|FG001|Overall Study|Withdrawn due to physician decision|0|||
124911490|NCT02238483|449302884|FG000|Overall Study|Completion status not recorded|1|||
124911491|NCT02238483|449302885|FG001|Overall Study|Completion status not recorded|1|||
124911492|NCT02238483|449302884|FG000|Overall Study|Illness in family member|1|||
124911493|NCT02238483|449302885|FG001|Overall Study|Illness in family member|0|||
124911494|NCT01388361|449302886|FG000|Overall Study|Adverse Event|0|||
124911495|NCT01388361|449302887|FG001|Overall Study|Adverse Event|5|||
124911496|NCT01388361|449302888|FG002|Overall Study|Adverse Event|1|||
124911497|NCT01388361|449302886|FG000|Overall Study|Protocol Violation|0|||
124911498|NCT01388361|449302887|FG001|Overall Study|Protocol Violation|0|||
124911499|NCT01388361|449302888|FG002|Overall Study|Protocol Violation|2|||
124911500|NCT01388361|449302886|FG000|Overall Study|Withdrawal criteria|12|||
124911501|NCT01388361|449302887|FG001|Overall Study|Withdrawal criteria|7|||
124911502|NCT01388361|449302888|FG002|Overall Study|Withdrawal criteria|10|||
124911503|NCT01388361|449302886|FG000|Overall Study|Unclassified|0|||
124911504|NCT01388361|449302887|FG001|Overall Study|Unclassified|0|||
124911505|NCT01388361|449302888|FG002|Overall Study|Unclassified|1|||
124911506|NCT00539734|449302889|FG000|Overall Study|Protocol Violation|1|||
124911507|NCT01070069|449302891|FG000|Overall Study|Death|1|||
124911508|NCT01070069|449302892|FG001|Overall Study|Death|0|||
124911509|NCT01070069|449302893|FG002|Overall Study|Death|2|||
124911510|NCT01070069|449302894|FG003|Overall Study|Death|0|||
124911511|NCT01070069|449302895|FG004|Overall Study|Death|1|||
124911512|NCT01070069|449302891|FG000|Overall Study|Withdrawal by Subject|1|||
124911513|NCT01070069|449302892|FG001|Overall Study|Withdrawal by Subject|1|||
124911514|NCT01070069|449302893|FG002|Overall Study|Withdrawal by Subject|4|||
124911515|NCT01070069|449302894|FG003|Overall Study|Withdrawal by Subject|0|||
124911516|NCT01070069|449302895|FG004|Overall Study|Withdrawal by Subject|0|||
124911517|NCT01070069|449302891|FG000|Overall Study|Lost to Follow-up|4|||
124911518|NCT01070069|449302892|FG001|Overall Study|Lost to Follow-up|1|||
124911519|NCT01070069|449302893|FG002|Overall Study|Lost to Follow-up|0|||
124911520|NCT01070069|449302894|FG003|Overall Study|Lost to Follow-up|0|||
124911521|NCT01070069|449302895|FG004|Overall Study|Lost to Follow-up|3|||
124911522|NCT00440011|449302908|FG000|Overall Study|Adverse Event|2|||
124911523|NCT00440011|449302909|FG001|Overall Study|Adverse Event|0|||
124911524|NCT00440011|449302908|FG000|Overall Study|Lost to Follow-up|0|||
124911525|NCT00440011|449302909|FG001|Overall Study|Lost to Follow-up|2|||
124911526|NCT00440011|449302908|FG000|Overall Study|Protocol Violation|1|||
124911527|NCT00440011|449302909|FG001|Overall Study|Protocol Violation|1|||
124911528|NCT00440011|449302908|FG000|Overall Study|Withdrawal by Subject|1|||
124911529|NCT00440011|449302909|FG001|Overall Study|Withdrawal by Subject|0|||
124911530|NCT00419341|449302910|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
124911531|NCT00419341|449302910|FG000|Wash in/Wash Out Period|Adverse Event|2|||
124911532|NCT00419341|449302910|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
124911533|NCT00419341|449302910|FG000|Efficacy Period|Withdrawal by Subject|6|||
124911534|NCT00419341|449302910|FG000|Efficacy Period|Protocol Violation|1|||
124911535|NCT00419341|449302910|FG000|Efficacy Period|Lost to Follow-up|1|||
124911536|NCT00419341|449302910|FG000|Efficacy Period|Non-compliance|1|||
124911537|NCT00419341|449302910|FG000|Efficacy Period|Termination of study site|1|||
124911538|NCT04200365|449302911|FG000|Overall Study|Adverse Event|2|||
124911539|NCT04200365|449302911|FG000|Overall Study|Progressive Disease|4|||
124911540|NCT04200365|449302911|FG000|Overall Study|Lack of Efficacy|1|||
124911541|NCT04200365|449302911|FG000|Overall Study|Study Closure|4|||
124911542|NCT01538719|449302917|FG000|Overall Study|Lost to Follow-up|2|||
124911543|NCT01538719|449302918|FG001|Overall Study|Lost to Follow-up|0|||
124911544|NCT03664960|449302919|FG000|Overall Study|Adverse Event|0|||
124911545|NCT03664960|449302920|FG001|Overall Study|Adverse Event|3|||
124911546|NCT03664960|449302919|FG000|Overall Study|Lost to Follow-up|3|||
124911547|NCT03664960|449302920|FG001|Overall Study|Lost to Follow-up|2|||
124911548|NCT03664960|449302919|FG000|Overall Study|Physician Decision|1|||
124911549|NCT03664960|449302920|FG001|Overall Study|Physician Decision|0|||
124911550|NCT03664960|449302919|FG000|Overall Study|Withdrawal by Subject|3|||
124911551|NCT03664960|449302920|FG001|Overall Study|Withdrawal by Subject|14|||
124911552|NCT03664960|449302919|FG000|Overall Study|Sponsor Decision|1|||
124911553|NCT03664960|449302920|FG001|Overall Study|Sponsor Decision|1|||
124911554|NCT03664960|449302919|FG000|Overall Study|Other|1|||
124911555|NCT03664960|449302920|FG001|Overall Study|Other|2|||
124911556|NCT03783026|449304749|FG000|Treatment Phase|Adverse Event|15|||
124911557|NCT03783026|449304749|FG000|Treatment Phase|Lack of Efficacy|11|||
124911558|NCT03783026|449304749|FG000|Treatment Phase|Withdrawal by Subject|6|||
124911559|NCT03783026|449304749|FG000|Treatment Phase|Lost to Follow-up|2|||
124911560|NCT03783026|449304749|FG000|Treatment Phase|Protocol Deviation|8|||
124911561|NCT03783026|449304749|FG000|Treatment Phase|Did Not Receive Treatment|1|||
124911562|NCT03783026|449304749|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
124911563|NCT05568615|449304768|FG000|Overall Study|Death|1|||
124911564|NCT05568615|449304768|FG000|Overall Study|Physician Decision|1|||
125211420|NCT01980628|450399690|FG000|Overall Study|Adverse Event|12|||
125211421|NCT01980628|450399690|FG000|Overall Study|Physician Decision|5|||
125211422|NCT01980628|450399690|FG000|Overall Study|Withdrawal by Subject|4|||
125211423|NCT01980628|450399690|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
124911565|NCT03529110|449304769|FG000|Overall Study|Progressive Disease|66|||
124911566|NCT03529110|449304770|FG001|Overall Study|Progressive Disease|158|||
124911567|NCT03529110|449304769|FG000|Overall Study|Clinical Progression|4|||
124911568|NCT03529110|449304770|FG001|Overall Study|Clinical Progression|12|||
124911569|NCT03529110|449304769|FG000|Overall Study|Adverse Event|35|||
124911570|NCT03529110|449304770|FG001|Overall Study|Adverse Event|17|||
124911571|NCT03529110|449304769|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
124911572|NCT03529110|449304770|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
125115283|NCT04578548|450044792|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
125115284|NCT04578548|450044791|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
125115285|NCT04578548|450044792|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
125115286|NCT04578548|450044791|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
125115287|NCT04578548|450044792|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
125115288|NCT04578548|450044791|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
125115289|NCT04578548|450044792|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
125115290|NCT04578548|450044791|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
125115291|NCT04578548|450044792|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
125115292|NCT00395083|450044795|FG000|Overall Study|Withdrawal by Subject|6|||
125115293|NCT00395083|450044796|FG001|Overall Study|Withdrawal by Subject|5|||
125115294|NCT00395083|450044795|FG000|Overall Study|Developed another disease|4|||
125115295|NCT00395083|450044796|FG001|Overall Study|Developed another disease|3|||
125115296|NCT00628745|450044797|FG000|Overall Study|Withdrawal by Subject|63|||
125115297|NCT00628745|450044798|FG001|Overall Study|Withdrawal by Subject|3|||
125115298|NCT00628745|450044799|FG002|Overall Study|Withdrawal by Subject|9|||
125115299|NCT00628745|450044800|FG003|Overall Study|Withdrawal by Subject|2|||
125115300|NCT00628745|450044801|FG004|Overall Study|Withdrawal by Subject|69|||
125115301|NCT00628745|450044797|FG000|Overall Study|Does not meet inclusion criteria|0|||
125115302|NCT00628745|450044798|FG001|Overall Study|Does not meet inclusion criteria|12|||
125115303|NCT00628745|450044799|FG002|Overall Study|Does not meet inclusion criteria|0|||
125115304|NCT00628745|450044800|FG003|Overall Study|Does not meet inclusion criteria|0|||
125115305|NCT00628745|450044801|FG004|Overall Study|Does not meet inclusion criteria|18|||
125115306|NCT00628745|450044797|FG000|Overall Study|Participation in an interventional clinical trial|81|||
125115307|NCT00628745|450044798|FG001|Overall Study|Participation in an interventional clinical trial|4|||
125115308|NCT00628745|450044799|FG002|Overall Study|Participation in an interventional clinical trial|7|||
125115309|NCT00628745|450044800|FG003|Overall Study|Participation in an interventional clinical trial|0|||
125115310|NCT00628745|450044801|FG004|Overall Study|Participation in an interventional clinical trial|63|||
125115311|NCT00628745|450044797|FG000|Overall Study|Physician Decision|8|||
125115312|NCT00628745|450044798|FG001|Overall Study|Physician Decision|4|||
125115313|NCT00628745|450044799|FG002|Overall Study|Physician Decision|3|||
125115314|NCT00628745|450044800|FG003|Overall Study|Physician Decision|0|||
125115315|NCT00628745|450044801|FG004|Overall Study|Physician Decision|30|||
125115316|NCT00628745|450044797|FG000|Overall Study|Lost to Follow-up|109|||
125211424|NCT00564278|450399691|FG000|Overall Study|Lost to Follow-up|35|||
125211425|NCT00564278|450399692|FG001|Overall Study|Lost to Follow-up|33|||
125211426|NCT00564278|450399691|FG000|Overall Study|Physician Decision|1|||
125211427|NCT00564278|450399692|FG001|Overall Study|Physician Decision|2|||
125211428|NCT00564278|450399691|FG000|Overall Study|Withdrawal by Subject|11|||
125211429|NCT00564278|450399692|FG001|Overall Study|Withdrawal by Subject|7|||
124911573|NCT03529110|449304769|FG000|Overall Study|Lack of Efficacy|3|||
124911574|NCT03529110|449304770|FG001|Overall Study|Lack of Efficacy|3|||
124911575|NCT03529110|449304769|FG000|Overall Study|Physician Decision|2|||
124911576|NCT03529110|449304770|FG001|Overall Study|Physician Decision|8|||
124911577|NCT03529110|449304769|FG000|Overall Study|Miscellaneous|2|||
124911578|NCT03529110|449304770|FG001|Overall Study|Miscellaneous|5|||
124911579|NCT03237481|449304771|FG000|Overall Study|Lost to Follow-up|1|||
125211430|NCT06439095|450399693|FG000|Overall Study|Lost to Follow-up|2|||
124911580|NCT03237481|449304772|FG001|Overall Study|Lost to Follow-up|0|||
124911581|NCT03237481|449304773|FG002|Overall Study|Lost to Follow-up|0|||
124911582|NCT03237481|449304771|FG000|Overall Study|Protocol Violation|1|||
124911583|NCT03237481|449304772|FG001|Overall Study|Protocol Violation|0|||
124911584|NCT03237481|449304773|FG002|Overall Study|Protocol Violation|0|||
124911585|NCT03237481|449304771|FG000|Overall Study|Withdrawal by Subject|3|||
124911586|NCT03237481|449304772|FG001|Overall Study|Withdrawal by Subject|2|||
124911587|NCT03237481|449304773|FG002|Overall Study|Withdrawal by Subject|1|||
124911588|NCT03873779|449304778|FG000|Overall Study|Withdrawal by Subject|1|||
124911589|NCT04279574|449304781|FG000|Overall Study|Death|1|||
124911590|NCT04279574|449304782|FG001|Overall Study|Death|0|||
124911591|NCT04279574|449304781|FG000|Overall Study|lost restoration, tooth fracture|1|||
124911592|NCT04279574|449304782|FG001|Overall Study|lost restoration, tooth fracture|0|||
124911593|NCT04279574|449304781|FG000|Overall Study|Lost to Follow-up|0|||
124911594|NCT04279574|449304782|FG001|Overall Study|Lost to Follow-up|1|||
124911595|NCT05773313|449304784|FG000|Overall Study|Lost to Follow-up|3|||
124911596|NCT02374463|449304786|FG000|Overall Study|Withdrawal by Subject|3|||
124911597|NCT02374463|449304787|FG001|Overall Study|Withdrawal by Subject|3|||
124911598|NCT01266122|449304789|FG000|Overall Study|Lost to Follow-up|6|||
124911599|NCT01266122|449304790|FG001|Overall Study|Lost to Follow-up|6|||
124911600|NCT00421889|449304791|FG000|Overall Study|Adverse Event|1|||
124911601|NCT00421889|449304792|FG001|Overall Study|Adverse Event|0|||
124911602|NCT00421889|449304793|FG002|Overall Study|Adverse Event|1|||
124911603|NCT00421889|449304794|FG003|Overall Study|Adverse Event|1|||
124911604|NCT00421889|449304795|FG004|Overall Study|Adverse Event|1|||
124911605|NCT00421889|449304796|FG005|Overall Study|Adverse Event|4|||
125115317|NCT00628745|450044798|FG001|Overall Study|Lost to Follow-up|7|||
124911606|NCT00421889|449304797|FG006|Overall Study|Adverse Event|1|||
125211431|NCT03341936|450399694|FG000|Overall Study|Ineligible|1|||
125211432|NCT03341936|450399694|FG000|Overall Study|Disease Progression|2|||
125211433|NCT03341936|450399694|FG000|Overall Study|Withdrew Consent|4|||
125211434|NCT03341936|450399694|FG000|Overall Study|Non-Compliance|1|||
125211435|NCT03341936|450399694|FG000|Overall Study|Physician Decision|1|||
125211436|NCT03341936|450399694|FG000|Overall Study|Withdrawal by Subject|1|||
125211437|NCT03341936|450399694|FG000|Overall Study|Other|1|||
125211438|NCT02368886|450399695|FG000|Overall Study|Cancel|1|||
125211439|NCT02368886|450399696|FG001|Overall Study|Cancel|1|||
125211440|NCT02368886|450399697|FG002|Overall Study|Cancel|1|||
125211441|NCT02368886|450399698|FG003|Overall Study|Cancel|3|||
125211442|NCT02368886|450399695|FG000|Overall Study|Ineligible|0|||
125211443|NCT02368886|450399696|FG001|Overall Study|Ineligible|0|||
125211444|NCT02368886|450399697|FG002|Overall Study|Ineligible|0|||
125211445|NCT02368886|450399698|FG003|Overall Study|Ineligible|1|||
125211446|NCT04849416|450399700|FG000|Overall Study|Ongoing Treatment|12|||
125211447|NCT04849416|450399701|FG001|Overall Study|Ongoing Treatment|5|||
125211448|NCT04849416|450399702|FG002|Overall Study|Ongoing Treatment|3|||
125211449|NCT04849416|450399700|FG000|Overall Study|On Post-Treatment Follow-up|8|||
125211450|NCT04849416|450399701|FG001|Overall Study|On Post-Treatment Follow-up|9|||
125211451|NCT04849416|450399702|FG002|Overall Study|On Post-Treatment Follow-up|10|||
125211452|NCT04849416|450399700|FG000|Overall Study|Withdrawal by Subject|0|||
125211453|NCT04849416|450399701|FG001|Overall Study|Withdrawal by Subject|0|||
125211454|NCT04849416|450399702|FG002|Overall Study|Withdrawal by Subject|1|||
124911607|NCT00421889|449304798|FG007|Overall Study|Adverse Event|0|||
124911608|NCT00421889|449304799|FG008|Overall Study|Adverse Event|2|||
124911609|NCT00421889|449304791|FG000|Overall Study|Withdrawal by Subject|1|||
124911610|NCT00421889|449304792|FG001|Overall Study|Withdrawal by Subject|3|||
124911611|NCT00421889|449304793|FG002|Overall Study|Withdrawal by Subject|0|||
124911612|NCT00421889|449304794|FG003|Overall Study|Withdrawal by Subject|0|||
124911613|NCT00421889|449304795|FG004|Overall Study|Withdrawal by Subject|2|||
124911614|NCT00421889|449304796|FG005|Overall Study|Withdrawal by Subject|0|||
124911615|NCT00421889|449304797|FG006|Overall Study|Withdrawal by Subject|0|||
124911616|NCT00421889|449304798|FG007|Overall Study|Withdrawal by Subject|0|||
124911617|NCT00421889|449304799|FG008|Overall Study|Withdrawal by Subject|0|||
124911618|NCT00421889|449304791|FG000|Overall Study|Death|0|||
124911619|NCT00421889|449304792|FG001|Overall Study|Death|0|||
124911620|NCT00421889|449304793|FG002|Overall Study|Death|0|||
124911621|NCT00421889|449304794|FG003|Overall Study|Death|0|||
124911622|NCT00421889|449304795|FG004|Overall Study|Death|1|||
124911623|NCT00421889|449304796|FG005|Overall Study|Death|1|||
124911624|NCT00421889|449304797|FG006|Overall Study|Death|0|||
124911625|NCT00421889|449304798|FG007|Overall Study|Death|0|||
124911626|NCT00421889|449304799|FG008|Overall Study|Death|0|||
124911627|NCT00421889|449304791|FG000|Overall Study|Progressive disease|3|||
124911628|NCT00421889|449304792|FG001|Overall Study|Progressive disease|2|||
124911629|NCT00421889|449304793|FG002|Overall Study|Progressive disease|2|||
124911630|NCT00421889|449304794|FG003|Overall Study|Progressive disease|3|||
124911631|NCT00421889|449304795|FG004|Overall Study|Progressive disease|2|||
124911632|NCT00421889|449304796|FG005|Overall Study|Progressive disease|21|||
124911633|NCT00421889|449304797|FG006|Overall Study|Progressive disease|3|||
124911634|NCT00421889|449304798|FG007|Overall Study|Progressive disease|1|||
124911635|NCT00421889|449304799|FG008|Overall Study|Progressive disease|5|||
124911636|NCT00421889|449304791|FG000|Overall Study|Patient/Investigator request|0|||
124911637|NCT00421889|449304792|FG001|Overall Study|Patient/Investigator request|0|||
124911638|NCT00421889|449304793|FG002|Overall Study|Patient/Investigator request|0|||
124911639|NCT00421889|449304794|FG003|Overall Study|Patient/Investigator request|0|||
125022186|NCT02064387|449705361|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
125211455|NCT04849416|450399700|FG000|Overall Study|Lost to Follow-up|1|||
125211456|NCT04849416|450399701|FG001|Overall Study|Lost to Follow-up|0|||
125211457|NCT04849416|450399702|FG002|Overall Study|Lost to Follow-up|0|||
125211458|NCT02131636|450399707|FG000|Overall Study|Personal Reasons|4|||
125211459|NCT02131636|450399708|FG001|Overall Study|Personal Reasons|4|||
125211460|NCT02131636|450399707|FG000|Overall Study|Lost to Follow-up|4|||
125211461|NCT02131636|450399708|FG001|Overall Study|Lost to Follow-up|0|||
125211462|NCT02131636|450399707|FG000|Overall Study|Adverse Event|4|||
125211463|NCT02131636|450399708|FG001|Overall Study|Adverse Event|1|||
125211464|NCT04847232|450399711|FG000|Overall Study|Death|123|||
125211465|NCT04847232|450399712|FG001|Overall Study|Death|115|||
124911640|NCT00421889|449304795|FG004|Overall Study|Patient/Investigator request|0|||
124911641|NCT00421889|449304796|FG005|Overall Study|Patient/Investigator request|9|||
124911642|NCT00421889|449304797|FG006|Overall Study|Patient/Investigator request|0|||
124911643|NCT00421889|449304798|FG007|Overall Study|Patient/Investigator request|1|||
124911644|NCT00421889|449304799|FG008|Overall Study|Patient/Investigator request|3|||
125211466|NCT04847232|450399711|FG000|Overall Study|Lost to Follow-up|3|||
125211467|NCT04847232|450399712|FG001|Overall Study|Lost to Follow-up|10|||
125115318|NCT00628745|450044799|FG002|Overall Study|Lost to Follow-up|7|||
125115319|NCT00628745|450044800|FG003|Overall Study|Lost to Follow-up|0|||
125115320|NCT00628745|450044801|FG004|Overall Study|Lost to Follow-up|498|||
125115321|NCT00628745|450044797|FG000|Overall Study|Death|197|||
125115322|NCT00628745|450044798|FG001|Overall Study|Death|81|||
125115323|NCT00628745|450044799|FG002|Overall Study|Death|12|||
125115324|NCT00628745|450044800|FG003|Overall Study|Death|4|||
124911645|NCT00421889|449304791|FG000|Overall Study|Lost to Follow-up|0|||
124911646|NCT00421889|449304792|FG001|Overall Study|Lost to Follow-up|0|||
124911647|NCT00421889|449304793|FG002|Overall Study|Lost to Follow-up|0|||
124911648|NCT00421889|449304794|FG003|Overall Study|Lost to Follow-up|0|||
124911649|NCT00421889|449304795|FG004|Overall Study|Lost to Follow-up|0|||
124911650|NCT00421889|449304796|FG005|Overall Study|Lost to Follow-up|0|||
124911651|NCT00421889|449304797|FG006|Overall Study|Lost to Follow-up|0|||
124911652|NCT00421889|449304798|FG007|Overall Study|Lost to Follow-up|0|||
124911653|NCT00421889|449304799|FG008|Overall Study|Lost to Follow-up|1|||
124911654|NCT03756571|449304800|FG000|Overall Study|Lost to Follow-up|1|||
124911655|NCT03756571|449304801|FG001|Overall Study|Lost to Follow-up|1|||
124911656|NCT00978042|449304802|FG000|Initial Treatment Period|Treated in Error|0|||
124911657|NCT00978042|449304803|FG001|Initial Treatment Period|Treated in Error|3|||
124911658|NCT00978042|449304802|FG000|Initial Treatment Period|Ineligibility|1|||
125115325|NCT00628745|450044801|FG004|Overall Study|Death|939|||
125115326|NCT00628745|450044797|FG000|Overall Study|Participant transferred to another THAOS site|6|||
125115327|NCT00628745|450044798|FG001|Overall Study|Participant transferred to another THAOS site|0|||
125115328|NCT00628745|450044799|FG002|Overall Study|Participant transferred to another THAOS site|0|||
125115329|NCT00628745|450044800|FG003|Overall Study|Participant transferred to another THAOS site|0|||
125115330|NCT00628745|450044801|FG004|Overall Study|Participant transferred to another THAOS site|7|||
125115331|NCT00628745|450044797|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
125115332|NCT00628745|450044798|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
125115333|NCT00628745|450044799|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
125115334|NCT00628745|450044800|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
125115335|NCT00628745|450044801|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
125115336|NCT00628745|450044797|FG000|Overall Study|Site closure|152|||
125115337|NCT00628745|450044798|FG001|Overall Study|Site closure|146|||
125115338|NCT00628745|450044799|FG002|Overall Study|Site closure|6|||
125115339|NCT00628745|450044800|FG003|Overall Study|Site closure|8|||
125115340|NCT00628745|450044801|FG004|Overall Study|Site closure|691|||
125115341|NCT00628745|450044797|FG000|Overall Study|Duplicate participant|0|||
125115342|NCT00628745|450044798|FG001|Overall Study|Duplicate participant|0|||
125115343|NCT00628745|450044799|FG002|Overall Study|Duplicate participant|0|||
125115344|NCT00628745|450044800|FG003|Overall Study|Duplicate participant|0|||
125115345|NCT00628745|450044801|FG004|Overall Study|Duplicate participant|1|||
125115346|NCT00628745|450044797|FG000|Overall Study|Missing|4|||
125115347|NCT00628745|450044798|FG001|Overall Study|Missing|3|||
125115348|NCT00628745|450044799|FG002|Overall Study|Missing|0|||
125115349|NCT00628745|450044800|FG003|Overall Study|Missing|0|||
125115350|NCT00628745|450044801|FG004|Overall Study|Missing|10|||
125115351|NCT00628745|450044797|FG000|Overall Study|Othe reasons|987|||
125115352|NCT00628745|450044798|FG001|Overall Study|Othe reasons|373|||
125115353|NCT00628745|450044799|FG002|Overall Study|Othe reasons|105|||
125115354|NCT00628745|450044800|FG003|Overall Study|Othe reasons|1|||
125115355|NCT00628745|450044801|FG004|Overall Study|Othe reasons|1772|||
125115356|NCT03322462|450046221|FG000|Overall Study|Technical difficulties|2|||
124911659|NCT00978042|449304803|FG001|Initial Treatment Period|Ineligibility|0|||
125115357|NCT03322462|450046221|FG000|Overall Study|Other|1|||
125115358|NCT01133821|450046226|FG000|Overall Study|Lost to Follow-up|8|||
125115359|NCT01133821|450046227|FG001|Overall Study|Lost to Follow-up|11|||
125115360|NCT01133821|450046226|FG000|Overall Study|Withdrawal by Subject|8|||
125115361|NCT01133821|450046227|FG001|Overall Study|Withdrawal by Subject|3|||
125115362|NCT01133821|450046226|FG000|Overall Study|preferred other treatment|1|||
125115363|NCT01133821|450046227|FG001|Overall Study|preferred other treatment|1|||
124911660|NCT00978042|449304802|FG000|Initial Treatment Period|Lost to Follow-up|21|||
124911661|NCT00978042|449304803|FG001|Initial Treatment Period|Lost to Follow-up|3|||
124911662|NCT00978042|449304802|FG000|Initial Treatment Period|Adverse Event|2|||
124911663|NCT00978042|449304803|FG001|Initial Treatment Period|Adverse Event|0|||
124911664|NCT00978042|449304802|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
124911665|NCT00978042|449304803|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
124911666|NCT00978042|449304802|FG000|Initial Treatment Period|Consent withdrawn|22|||
124911667|NCT00978042|449304803|FG001|Initial Treatment Period|Consent withdrawn|9|||
124911668|NCT00978042|449304802|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
124911669|NCT00978042|449304803|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
124911670|NCT00520546|449304804|FG000|Overall Study|Withdrawal by Subject|1|||
124911671|NCT00520546|449304804|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
124911672|NCT02101281|449304805|FG000|Overall Study|Adverse Event|0|||
124911673|NCT02101281|449304806|FG001|Overall Study|Adverse Event|1|||
124911674|NCT04452318|449304807|FG000|Overall Study|Physician Decision|1|||
124911675|NCT04452318|449304808|FG001|Overall Study|Physician Decision|2|||
124911676|NCT04452318|449304809|FG002|Overall Study|Physician Decision|0|||
124911677|NCT04452318|449304810|FG003|Overall Study|Physician Decision|2|||
125115364|NCT01133821|450046226|FG000|Overall Study|Protocol Violation|0|||
125115365|NCT01133821|450046227|FG001|Overall Study|Protocol Violation|1|||
125115366|NCT01133821|450046226|FG000|Overall Study|Refused participation|1|||
125115367|NCT01133821|450046227|FG001|Overall Study|Refused participation|3|||
125115368|NCT03572933|450046231|FG000|Overall Study|Adverse Event|4|||
125115369|NCT03572933|450046232|FG001|Overall Study|Adverse Event|1|||
125115370|NCT03572933|450046231|FG000|Overall Study|Withdrawal by Subject|0|||
125211468|NCT04847232|450399711|FG000|Overall Study|Withdrawal by Subject|73|||
125211469|NCT04847232|450399712|FG001|Overall Study|Withdrawal by Subject|101|||
125115371|NCT03572933|450046232|FG001|Overall Study|Withdrawal by Subject|1|||
125115372|NCT00633152|450046237|FG000|Overall Study|Adverse Event|1|||
125115373|NCT00633152|450046238|FG001|Overall Study|Adverse Event|0|||
125211470|NCT04847232|450399711|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
125211471|NCT04847232|450399712|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
125211472|NCT02290925|450399718|FG000|First Period of Three Months|Lost to Follow-up|2|||
125211473|NCT02290925|450399719|FG001|First Period of Three Months|Lost to Follow-up|1|||
125211474|NCT02290925|450399718|FG000|First Period of Three Months|Death|1|||
125211475|NCT02290925|450399719|FG001|First Period of Three Months|Death|0|||
125211476|NCT02290925|450399718|FG000|First Period of Three Months|Insulin Started|1|||
125211477|NCT02290925|450399719|FG001|First Period of Three Months|Insulin Started|1|||
125211478|NCT02290925|450399718|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
125211479|NCT02290925|450399719|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
125211480|NCT02290925|450399718|FG000|Second Period of 3 Months|insulin started|0|||
125211481|NCT02290925|450399719|FG001|Second Period of 3 Months|insulin started|1|||
125211482|NCT01716520|450399720|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
125211483|NCT01716520|450399721|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
125211484|NCT01716520|450399722|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
125211485|NCT01716520|450399723|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
125211486|NCT01716520|450399724|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
125211487|NCT01716520|450399725|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
125211488|NCT01716520|450399720|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
125211489|NCT01716520|450399721|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
124911678|NCT04452318|449304811|FG004|Overall Study|Physician Decision|0|||
125022187|NCT02064387|449705362|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
125022188|NCT02064387|449705363|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
125022189|NCT02064387|449705364|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
125022190|NCT02064387|449705365|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
125022191|NCT02064387|449705366|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
125022192|NCT02064387|449705367|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
125022193|NCT02064387|449705368|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
125022194|NCT02064387|449705369|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
125022195|NCT02064387|449705370|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
125022196|NCT02064387|449705371|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
125022197|NCT02064387|449705360|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125022198|NCT02064387|449705361|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125022199|NCT02064387|449705362|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125022200|NCT02064387|449705363|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125022201|NCT02064387|449705364|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125022202|NCT02064387|449705365|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125022203|NCT02064387|449705366|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125022204|NCT02064387|449705367|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125115374|NCT00633152|450046237|FG000|Overall Study|Randomized, did not receive study drug|5|||
125115375|NCT00633152|450046238|FG001|Overall Study|Randomized, did not receive study drug|2|||
125115376|NCT00633152|450046237|FG000|Overall Study|Withdrawal by Subject|1|||
125115377|NCT00633152|450046238|FG001|Overall Study|Withdrawal by Subject|1|||
125115378|NCT00633152|450046237|FG000|Overall Study|Lost to Follow-up|4|||
125115379|NCT00633152|450046238|FG001|Overall Study|Lost to Follow-up|1|||
125115380|NCT00633152|450046237|FG000|Overall Study|Miscellaneous Other|3|||
125115381|NCT00633152|450046238|FG001|Overall Study|Miscellaneous Other|2|||
125115382|NCT01907087|450046239|FG000|Overall Study|Withdrawal by Subject|1|||
125115383|NCT02049359|450046240|FG000|Overall Study|Lost to Follow-up|26|||
125211490|NCT01716520|450399722|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
125211491|NCT01716520|450399723|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
125211492|NCT01716520|450399724|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
125211493|NCT01716520|450399725|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
125115384|NCT02049359|450046241|FG001|Overall Study|Lost to Follow-up|19|||
125115385|NCT03273387|450046242|FG000|Overall Study|Death|2|||
125115386|NCT03273387|450046243|FG001|Overall Study|Death|2|||
125115387|NCT03273387|450046242|FG000|Overall Study|Withdrawal by Subject|1|||
125022205|NCT02064387|449705368|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
124911679|NCT04452318|449304812|FG005|Overall Study|Physician Decision|2|||
124911680|NCT04452318|449304813|FG006|Overall Study|Physician Decision|5|||
124911681|NCT04452318|449304807|FG000|Overall Study|Death|2|||
124911682|NCT04452318|449304808|FG001|Overall Study|Death|3|||
124911683|NCT04452318|449304809|FG002|Overall Study|Death|0|||
124911684|NCT04452318|449304810|FG003|Overall Study|Death|0|||
124911685|NCT04452318|449304811|FG004|Overall Study|Death|0|||
124911686|NCT04452318|449304812|FG005|Overall Study|Death|0|||
125022206|NCT02064387|449705369|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125022207|NCT02064387|449705370|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
125022208|NCT02064387|449705371|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125022209|NCT02499029|449705372|FG000|Overall Study|Lost to Follow-up|2|||
125022210|NCT02499029|449705373|FG001|Overall Study|Lost to Follow-up|2|||
125022211|NCT02499029|449705372|FG000|Overall Study|Physician Decision|2|||
125022212|NCT02499029|449705373|FG001|Overall Study|Physician Decision|1|||
125022213|NCT02499029|449705372|FG000|Overall Study|Death|1|||
125022214|NCT02499029|449705373|FG001|Overall Study|Death|0|||
125022215|NCT01536860|449705376|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
125022216|NCT01536860|449705377|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
125022217|NCT01536860|449705378|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
125022218|NCT03889639|449705379|FG000|Overall Study|Withdrawal by Subject|0|||
125022219|NCT03889639|449705380|FG001|Overall Study|Withdrawal by Subject|0|||
125022220|NCT03889639|449705381|FG002|Overall Study|Withdrawal by Subject|0|||
125022221|NCT03889639|449705382|FG003|Overall Study|Withdrawal by Subject|0|||
125022222|NCT03889639|449705383|FG004|Overall Study|Withdrawal by Subject|0|||
125022223|NCT03889639|449705384|FG005|Overall Study|Withdrawal by Subject|0|||
125022224|NCT03889639|449705385|FG006|Overall Study|Withdrawal by Subject|0|||
125022225|NCT03889639|449705386|FG007|Overall Study|Withdrawal by Subject|1|||
125022226|NCT00927095|449705387|FG000|Overall Study|Adverse Event|3|||
125022227|NCT00927095|449705388|FG001|Overall Study|Adverse Event|1|||
125022228|NCT00927095|449705389|FG002|Overall Study|Adverse Event|0|||
125022229|NCT00927095|449705387|FG000|Overall Study|Withdrawal by Subject|2|||
125022230|NCT00927095|449705388|FG001|Overall Study|Withdrawal by Subject|1|||
125022231|NCT00927095|449705389|FG002|Overall Study|Withdrawal by Subject|1|||
125022232|NCT00927095|449705387|FG000|Overall Study|Physician Decision|1|||
125022233|NCT00927095|449705388|FG001|Overall Study|Physician Decision|2|||
125022234|NCT00927095|449705389|FG002|Overall Study|Physician Decision|1|||
125022235|NCT02340663|449705394|FG000|Overall Study|Lost to Follow-up|1|||
125022236|NCT02340663|449705395|FG001|Overall Study|Lost to Follow-up|0|||
125022237|NCT02340663|449705394|FG000|Overall Study|Protocol Violation|1|||
125022238|NCT02340663|449705395|FG001|Overall Study|Protocol Violation|0|||
125022239|NCT02340663|449705394|FG000|Overall Study|Withdrawal by Subject|3|||
125022240|NCT02340663|449705395|FG001|Overall Study|Withdrawal by Subject|1|||
125022241|NCT01656434|449705396|FG000|Overall Study|Adverse Event|199|||
125022242|NCT01656434|449705397|FG001|Overall Study|Adverse Event|63|||
125022243|NCT01656434|449705396|FG000|Overall Study|Enrollment terminated at trial site|2|||
125022244|NCT01656434|449705397|FG001|Overall Study|Enrollment terminated at trial site|0|||
125022245|NCT01656434|449705396|FG000|Overall Study|Lost to Follow-up|309|||
125022246|NCT01656434|449705397|FG001|Overall Study|Lost to Follow-up|76|||
125022247|NCT01656434|449705396|FG000|Overall Study|Site discontinued study participation|24|||
125022248|NCT01656434|449705397|FG001|Overall Study|Site discontinued study participation|9|||
125022249|NCT01656434|449705396|FG000|Overall Study|Screen failure|2|||
125022250|NCT01656434|449705397|FG001|Overall Study|Screen failure|0|||
125022251|NCT01656434|449705396|FG000|Overall Study|Protocol Violation|7|||
125022252|NCT01656434|449705397|FG001|Overall Study|Protocol Violation|0|||
125022253|NCT01656434|449705396|FG000|Overall Study|Pregnancy wish|18|||
125022254|NCT01656434|449705397|FG001|Overall Study|Pregnancy wish|6|||
125022255|NCT01656434|449705396|FG000|Overall Study|Pregnancy|45|||
125022256|NCT01656434|449705397|FG001|Overall Study|Pregnancy|10|||
125022257|NCT01656434|449705396|FG000|Overall Study|Physician Decision|7|||
125022258|NCT01656434|449705397|FG001|Overall Study|Physician Decision|2|||
125022259|NCT01656434|449705396|FG000|Overall Study|Non-compliance with study drug|48|||
125022260|NCT01656434|449705397|FG001|Overall Study|Non-compliance with study drug|9|||
125022261|NCT01656434|449705396|FG000|Overall Study|Study terminated by sponsor|1501|||
125022262|NCT01656434|449705397|FG001|Overall Study|Study terminated by sponsor|348|||
125022263|NCT01656434|449705396|FG000|Overall Study|Participant discontinued; drug related|13|||
124911687|NCT04452318|449304813|FG006|Overall Study|Death|0|||
125022264|NCT01656434|449705397|FG001|Overall Study|Participant discontinued; drug related|4|||
125022265|NCT01656434|449705396|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
125022266|NCT01656434|449705397|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
125022267|NCT01656434|449705396|FG000|Overall Study|Non-compliance with protocol|39|||
125022268|NCT01656434|449705397|FG001|Overall Study|Non-compliance with protocol|15|||
125022269|NCT01656434|449705396|FG000|Overall Study|Participant moved|40|||
125022270|NCT01656434|449705397|FG001|Overall Study|Participant moved|12|||
125022271|NCT01656434|449705396|FG000|Overall Study|Participant withdrew consent|28|||
124911688|NCT04452318|449304807|FG000|Overall Study|Lost to Follow-up|38|||
124911689|NCT04452318|449304808|FG001|Overall Study|Lost to Follow-up|28|||
124911690|NCT04452318|449304809|FG002|Overall Study|Lost to Follow-up|0|||
124911691|NCT04452318|449304810|FG003|Overall Study|Lost to Follow-up|3|||
124911692|NCT04452318|449304811|FG004|Overall Study|Lost to Follow-up|3|||
124911693|NCT04452318|449304812|FG005|Overall Study|Lost to Follow-up|2|||
124911694|NCT04452318|449304813|FG006|Overall Study|Lost to Follow-up|1|||
124911695|NCT04452318|449304807|FG000|Overall Study|Withdrawal by Subject|46|||
124911696|NCT04452318|449304808|FG001|Overall Study|Withdrawal by Subject|40|||
124911697|NCT04452318|449304809|FG002|Overall Study|Withdrawal by Subject|0|||
124911698|NCT04452318|449304810|FG003|Overall Study|Withdrawal by Subject|18|||
124911699|NCT04452318|449304811|FG004|Overall Study|Withdrawal by Subject|6|||
124911700|NCT04452318|449304812|FG005|Overall Study|Withdrawal by Subject|8|||
124911701|NCT04452318|449304813|FG006|Overall Study|Withdrawal by Subject|6|||
124911702|NCT03951805|449304815|FG000|Overall Study|Adverse Event|1|||
124911703|NCT03951805|449304816|FG001|Overall Study|Adverse Event|0|||
124911704|NCT03951805|449304817|FG002|Overall Study|Adverse Event|0|||
124911705|NCT03951805|449304818|FG003|Overall Study|Adverse Event|0|||
124911706|NCT00604669|449304819|FG000|Overall Study|lack of information in chart|7|||
124911707|NCT01695954|449304820|FG000|Overall Study|Withdrawal by Subject|4|||
124911708|NCT01695954|449304821|FG001|Overall Study|Withdrawal by Subject|0|||
124911709|NCT01695954|449304820|FG000|Overall Study|Adverse Event|0|||
124911710|NCT01695954|449304821|FG001|Overall Study|Adverse Event|2|||
124911711|NCT04328727|449304823|FG000|Overall Study|Guardian Decision|1|||
124911712|NCT04328727|449304823|FG000|Overall Study|Participant decision|4|||
124911713|NCT04328727|449304823|FG000|Overall Study|Death|3|||
124911714|NCT03684044|449304824|FG000|Overall Study|Adverse Event|3|||
124911715|NCT03684044|449304825|FG001|Overall Study|Adverse Event|0|||
124911716|NCT03684044|449304824|FG000|Overall Study|Death|4|||
124911717|NCT03684044|449304825|FG001|Overall Study|Death|7|||
124911718|NCT03684044|449304824|FG000|Overall Study|Lost to Follow-up|3|||
124911719|NCT03684044|449304825|FG001|Overall Study|Lost to Follow-up|2|||
124911720|NCT03684044|449304824|FG000|Overall Study|Patient Not Available|0|||
124911721|NCT03684044|449304825|FG001|Overall Study|Patient Not Available|2|||
124911722|NCT03684044|449304824|FG000|Overall Study|Physician Decision|1|||
124911723|NCT03684044|449304825|FG001|Overall Study|Physician Decision|0|||
124911724|NCT03684044|449304824|FG000|Overall Study|Withdrawal by Subject|11|||
124911725|NCT03684044|449304825|FG001|Overall Study|Withdrawal by Subject|9|||
124911726|NCT00595413|449304826|FG000|Overall Study|Adverse Event|0|||
124911727|NCT00595413|449304827|FG001|Overall Study|Adverse Event|2|||
124911728|NCT00595413|449304828|FG002|Overall Study|Adverse Event|1|||
124911729|NCT00595413|449304829|FG003|Overall Study|Adverse Event|1|||
124911730|NCT00595413|449304826|FG000|Overall Study|Lost to Follow-up|2|||
124911731|NCT00595413|449304827|FG001|Overall Study|Lost to Follow-up|2|||
124911732|NCT00595413|449304828|FG002|Overall Study|Lost to Follow-up|1|||
125115388|NCT03273387|450046243|FG001|Overall Study|Withdrawal by Subject|1|||
125115389|NCT05216978|450046244|FG000|Overall Study|Withdrawal by Subject|3|||
124911733|NCT00595413|449304829|FG003|Overall Study|Lost to Follow-up|3|||
124911734|NCT00595413|449304826|FG000|Overall Study|Death|0|||
124911735|NCT00595413|449304827|FG001|Overall Study|Death|0|||
124911736|NCT00595413|449304828|FG002|Overall Study|Death|1|||
124911737|NCT00595413|449304829|FG003|Overall Study|Death|0|||
124911738|NCT00595413|449304826|FG000|Overall Study|Other|5|||
124911739|NCT00595413|449304827|FG001|Overall Study|Other|1|||
124911740|NCT00595413|449304828|FG002|Overall Study|Other|5|||
124911741|NCT00595413|449304829|FG003|Overall Study|Other|0|||
124911742|NCT04149002|449304830|FG000|Overall Study|Lost to Follow-up|1|||
124911743|NCT04149002|449304831|FG001|Overall Study|Lost to Follow-up|0|||
124911744|NCT04149002|449304830|FG000|Overall Study|Withdrawal by Subject|1|||
124911745|NCT04149002|449304831|FG001|Overall Study|Withdrawal by Subject|0|||
124911746|NCT04629950|449304832|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
124911747|NCT04629950|449304833|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
124911748|NCT04629950|449304834|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
124911749|NCT04629950|449304835|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
124911750|NCT04629950|449304832|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
124911751|NCT04629950|449304833|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
124911752|NCT04629950|449304834|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
124911753|NCT04629950|449304835|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
125115390|NCT05216978|450046244|FG000|Overall Study|Lost to Follow-up|5|||
124911754|NCT04629950|449304832|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
124911755|NCT04629950|449304833|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
124911756|NCT04629950|449304834|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
124911757|NCT04629950|449304835|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
124911758|NCT04629950|449304832|FG000|Extension Study|Withdrawal by Subject|0|||
124911759|NCT04629950|449304833|FG001|Extension Study|Withdrawal by Subject|0|||
124911760|NCT04629950|449304834|FG002|Extension Study|Withdrawal by Subject|1|||
124911761|NCT04629950|449304835|FG003|Extension Study|Withdrawal by Subject|0|||
124911762|NCT04629950|449304832|FG000|Extension Study|Adverse Event|0|||
124911763|NCT04629950|449304833|FG001|Extension Study|Adverse Event|0|||
124911764|NCT04629950|449304834|FG002|Extension Study|Adverse Event|0|||
124911765|NCT04629950|449304835|FG003|Extension Study|Adverse Event|1|||
124911766|NCT03233633|449304836|FG000|Overall Study|Adverse Event|2|||
124911767|NCT03233633|449304836|FG000|Overall Study|Less Than 3 Days of Data|6|||
124911768|NCT01198145|449304838|FG000|Overall Study|Withdrawal by Subject|1|||
124911769|NCT01198145|449304839|FG001|Overall Study|Withdrawal by Subject|1|||
124911770|NCT01697969|449304842|FG000|Overall Study|Did not meet inc/exc criteria|3|||
124911771|NCT01561989|449304843|FG000|Overall Study|accural target not met.|5|||
124911772|NCT01561989|449304844|FG001|Overall Study|accural target not met.|6|||
124911773|NCT03447249|449304848|FG000|Overall Study|Adverse Event|1|||
124911774|NCT03447249|449304849|FG001|Overall Study|Adverse Event|0|||
124911775|NCT03447249|449304848|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
124911776|NCT03447249|449304849|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
124911777|NCT03447249|449304848|FG000|Overall Study|Other|3|||
124911778|NCT03447249|449304849|FG001|Overall Study|Other|0|||
124911779|NCT02574455|449304851|FG000|Overall Study|Death|197|||
125115391|NCT02180061|450046245|FG000|Overall Study|Adverse Event|4|||
125115392|NCT02180061|450046246|FG001|Overall Study|Adverse Event|2|||
125115393|NCT02180061|450046245|FG000|Overall Study|Clinical Progression|5|||
125115394|NCT02180061|450046246|FG001|Overall Study|Clinical Progression|1|||
125115395|NCT02180061|450046245|FG000|Overall Study|Progressive Disease|15|||
125115396|NCT02180061|450046246|FG001|Overall Study|Progressive Disease|5|||
125115397|NCT02180061|450046245|FG000|Overall Study|Physician Decision|1|||
125115398|NCT02180061|450046246|FG001|Overall Study|Physician Decision|0|||
125115399|NCT01405950|450046247|FG000|Overall Study|Withdrawal by Subject|1|||
125115400|NCT01405950|450046248|FG001|Overall Study|Withdrawal by Subject|0|||
125115401|NCT01405950|450046249|FG002|Overall Study|Withdrawal by Subject|0|||
125115402|NCT01405950|450046250|FG003|Overall Study|Withdrawal by Subject|0|||
125115403|NCT02410252|450046251|FG000|Overall Study|Withdrawal by Subject|4|||
125115404|NCT02410252|450046251|FG000|Overall Study|Physician Decision|2|||
124911780|NCT02574455|449304852|FG001|Overall Study|Death|210|||
124911781|NCT02574455|449304851|FG000|Overall Study|Withdrawal of Consent|11|||
124911782|NCT02574455|449304852|FG001|Overall Study|Withdrawal of Consent|28|||
124911783|NCT02574455|449304851|FG000|Overall Study|Lost to Follow-up|4|||
125115405|NCT01772368|450046256|FG000|Overall Study|Adverse Event|1|||
125115406|NCT01772368|450046256|FG000|Overall Study|Withdrawal by Subject|3|||
125115407|NCT01772368|450046256|FG000|Overall Study|Protocol Violation|2|||
125115408|NCT01772368|450046256|FG000|Overall Study|Other|1|||
125115409|NCT01452529|450046257|FG000|Run-in Period|Adverse Event|96|||
125115410|NCT01452529|450046258|FG001|Run-in Period|Adverse Event|0|||
125115411|NCT01452529|450046259|FG002|Run-in Period|Adverse Event|0|||
125115412|NCT01452529|450046257|FG000|Run-in Period|Withdrawal by Subject|49|||
125115413|NCT01452529|450046258|FG001|Run-in Period|Withdrawal by Subject|0|||
125115414|NCT01452529|450046259|FG002|Run-in Period|Withdrawal by Subject|0|||
125115415|NCT01452529|450046257|FG000|Run-in Period|Lost to Follow-up|19|||
125115416|NCT01452529|450046258|FG001|Run-in Period|Lost to Follow-up|0|||
125115417|NCT01452529|450046259|FG002|Run-in Period|Lost to Follow-up|0|||
125115418|NCT01452529|450046257|FG000|Run-in Period|Lack of Efficacy|46|||
125115419|NCT01452529|450046258|FG001|Run-in Period|Lack of Efficacy|0|||
125115420|NCT01452529|450046259|FG002|Run-in Period|Lack of Efficacy|0|||
125115421|NCT01452529|450046257|FG000|Run-in Period|Confirmed or suspected diversion|23|||
125115422|NCT01452529|450046258|FG001|Run-in Period|Confirmed or suspected diversion|0|||
125115423|NCT01452529|450046259|FG002|Run-in Period|Confirmed or suspected diversion|0|||
125115424|NCT01452529|450046257|FG000|Run-in Period|Administrative|21|||
125115425|NCT01452529|450046258|FG001|Run-in Period|Administrative|0|||
125115426|NCT01452529|450046259|FG002|Run-in Period|Administrative|0|||
125115427|NCT01452529|450046257|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
125115428|NCT01452529|450046258|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
125115429|NCT01452529|450046259|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
125115430|NCT01452529|450046257|FG000|Double-blind (DB) Period|Adverse Event|0|||
125115431|NCT01452529|450046258|FG001|Double-blind (DB) Period|Adverse Event|18|||
125115432|NCT01452529|450046259|FG002|Double-blind (DB) Period|Adverse Event|11|||
125115433|NCT01452529|450046257|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
125115434|NCT01452529|450046258|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
125115435|NCT01452529|450046259|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
125115436|NCT01452529|450046257|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
125115437|NCT01452529|450046258|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
125115438|NCT01452529|450046259|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
125115439|NCT01452529|450046257|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
125115440|NCT01452529|450046258|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
125115441|NCT01452529|450046259|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
125115442|NCT01452529|450046257|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
125115443|NCT01452529|450046258|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
125115444|NCT01452529|450046259|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
125115445|NCT01452529|450046257|FG000|Double-blind (DB) Period|Administrative|0|||
125115446|NCT01452529|450046258|FG001|Double-blind (DB) Period|Administrative|11|||
125115447|NCT01452529|450046259|FG002|Double-blind (DB) Period|Administrative|7|||
125115448|NCT03551730|450046260|FG000|Overall Study|Adverse Event|1|||
125115449|NCT03551730|450046261|FG001|Overall Study|Adverse Event|0|||
125115450|NCT03551730|450046262|FG002|Overall Study|Adverse Event|0|||
125115451|NCT03551730|450046263|FG003|Overall Study|Adverse Event|0|||
125115452|NCT03347695|450046267|FG000|Overall Study|Death|0|||
125115453|NCT03347695|450046268|FG001|Overall Study|Death|4|||
125115454|NCT03347695|450046267|FG000|Overall Study|Lost to Follow-up|0|||
125115455|NCT03347695|450046268|FG001|Overall Study|Lost to Follow-up|1|||
125115456|NCT01003886|450046273|FG000|Overall Study|Lack of Efficacy|5|||
125115457|NCT01003886|450046273|FG000|Overall Study|Lost to Follow-up|169|||
125115458|NCT01003886|450046273|FG000|Overall Study|Withdrawal by Subject|39|||
125115459|NCT01003886|450046273|FG000|Overall Study|Other|14|||
125115460|NCT01003886|450046273|FG000|Overall Study|Adverse Event|3|||
125115461|NCT03907280|450046274|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
125115462|NCT03907280|450046275|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
124911784|NCT02574455|449304852|FG001|Overall Study|Lost to Follow-up|4|||
125115463|NCT03907280|450046276|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
125115464|NCT00673361|450046281|FG000|Overall Study|Screen Failure|2|||
125115465|NCT00829413|450046282|FG000|Overall Study|No study drug admimnistered|13|||
125115466|NCT00829413|450046282|FG000|Overall Study|Training Patients|67|||
125115467|NCT00829413|450046282|FG000|Overall Study|No truth standard procedure available|9|||
125115468|NCT00829413|450046282|FG000|Overall Study|Technically inadequate truth standard|2|||
125115469|NCT00829413|450046282|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
125115470|NCT01464827|450046283|FG000|Overall Study|Adverse Event|0|||
125115471|NCT01464827|450046284|FG001|Overall Study|Adverse Event|0|||
125115472|NCT01464827|450046285|FG002|Overall Study|Adverse Event|0|||
124911785|NCT02574455|449304851|FG000|Overall Study|Sponsor's Decision|55|||
124911786|NCT02574455|449304852|FG001|Overall Study|Sponsor's Decision|20|||
124911787|NCT02677896|449304853|FG000|Double Blind Period (up to 35 Months)|Death|117|||
124911788|NCT02677896|449304854|FG001|Double Blind Period (up to 35 Months)|Death|197|||
124911789|NCT02677896|449304853|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
124911790|NCT02677896|449304854|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
124911791|NCT02677896|449304853|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
124911792|NCT02677896|449304854|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
124911793|NCT02677896|449304853|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
124911794|NCT02677896|449304854|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
124911795|NCT02677896|449304853|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
124911796|NCT02677896|449304854|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
124911797|NCT02677896|449304853|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
124911798|NCT02677896|449304854|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
124911799|NCT02677896|449304853|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
124911800|NCT02677896|449304854|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
124911801|NCT02677896|449304853|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
124911802|NCT02677896|449304854|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
124911803|NCT02677896|449304853|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
124911804|NCT02677896|449304854|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
124911805|NCT02677896|449304853|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
124911806|NCT02677896|449304854|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
124911807|NCT02677896|449304853|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
124911808|NCT02677896|449304854|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
124911809|NCT02677896|449304853|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
124911810|NCT02677896|449304854|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
124911811|NCT02677896|449304853|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
124911812|NCT02677896|449304854|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
124911813|NCT02677896|449304853|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
124911814|NCT02677896|449304854|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
124911815|NCT03565315|449304860|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
124911816|NCT03565315|449304861|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
124911817|NCT03565315|449304862|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
124911818|NCT03565315|449304863|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
124911819|NCT01499199|449304864|FG000|Overall Study|Adverse Event|1|||
124911820|NCT01499199|449304864|FG000|Overall Study|Lack of Efficacy|1|||
124911821|NCT02692417|449304865|FG000|Overall Study|Withdrawal by Subject|5|||
124911822|NCT02692417|449304866|FG001|Overall Study|Withdrawal by Subject|1|||
125211494|NCT01716520|450399720|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125211495|NCT01716520|450399721|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
125211496|NCT01716520|450399722|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125211497|NCT01716520|450399723|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125211498|NCT01716520|450399724|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125211499|NCT01716520|450399725|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125211500|NCT01716520|450399720|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
125211501|NCT01716520|450399721|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
125211502|NCT01716520|450399722|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
125211503|NCT01716520|450399723|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
125211504|NCT01716520|450399724|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
125211505|NCT01716520|450399725|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
125211506|NCT01716520|450399720|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
125211507|NCT01716520|450399721|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
124911823|NCT02692417|449304865|FG000|Overall Study|Adverse Event|1|||
124911824|NCT02692417|449304866|FG001|Overall Study|Adverse Event|0|||
124911825|NCT02372253|449304875|FG000|Overall Study|Non Compliance|2|||
124911826|NCT02372253|449304876|FG001|Overall Study|Non Compliance|0|||
124911827|NCT00393484|449304879|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
124911828|NCT00393484|449304880|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
124911829|NCT00393484|449304879|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
124911830|NCT00393484|449304880|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
124911831|NCT00393484|449304879|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
124911832|NCT00393484|449304880|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
124911833|NCT00393484|449304879|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
124911834|NCT00393484|449304880|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
124911835|NCT00393484|449304879|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
124911836|NCT00393484|449304880|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
124911837|NCT00393484|449304879|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
124911838|NCT00393484|449304880|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
124911839|NCT00393484|449304879|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
125115473|NCT01464827|450046286|FG003|Overall Study|Adverse Event|0|||
125115474|NCT01464827|450046287|FG004|Overall Study|Adverse Event|0|||
125115475|NCT01464827|450046288|FG005|Overall Study|Adverse Event|0|||
125115476|NCT01464827|450046289|FG006|Overall Study|Adverse Event|0|||
125115477|NCT01464827|450046290|FG007|Overall Study|Adverse Event|0|||
125115478|NCT01464827|450046291|FG008|Overall Study|Adverse Event|0|||
125115479|NCT01464827|450046292|FG009|Overall Study|Adverse Event|0|||
125115480|NCT01464827|450046293|FG010|Overall Study|Adverse Event|0|||
125115481|NCT01464827|450046294|FG011|Overall Study|Adverse Event|0|||
125115482|NCT01464827|450046295|FG012|Overall Study|Adverse Event|1|||
125115483|NCT01464827|450046296|FG013|Overall Study|Adverse Event|0|||
125115484|NCT01464827|450046283|FG000|Overall Study|Withdrawal by Subject|1|||
125115485|NCT01464827|450046284|FG001|Overall Study|Withdrawal by Subject|0|||
125115486|NCT01464827|450046285|FG002|Overall Study|Withdrawal by Subject|0|||
125115487|NCT01464827|450046286|FG003|Overall Study|Withdrawal by Subject|0|||
125115488|NCT01464827|450046287|FG004|Overall Study|Withdrawal by Subject|1|||
125115489|NCT01464827|450046288|FG005|Overall Study|Withdrawal by Subject|0|||
125115490|NCT01464827|450046289|FG006|Overall Study|Withdrawal by Subject|0|||
125115491|NCT01464827|450046290|FG007|Overall Study|Withdrawal by Subject|1|||
125115492|NCT01464827|450046291|FG008|Overall Study|Withdrawal by Subject|0|||
125115493|NCT01464827|450046292|FG009|Overall Study|Withdrawal by Subject|0|||
125115494|NCT01464827|450046293|FG010|Overall Study|Withdrawal by Subject|0|||
125115495|NCT01464827|450046294|FG011|Overall Study|Withdrawal by Subject|0|||
125115496|NCT01464827|450046295|FG012|Overall Study|Withdrawal by Subject|0|||
125115497|NCT01464827|450046296|FG013|Overall Study|Withdrawal by Subject|0|||
125115498|NCT01464827|450046283|FG000|Overall Study|Lost to Follow-up|0|||
125115499|NCT01464827|450046284|FG001|Overall Study|Lost to Follow-up|2|||
125115500|NCT01464827|450046285|FG002|Overall Study|Lost to Follow-up|0|||
125115501|NCT01464827|450046286|FG003|Overall Study|Lost to Follow-up|2|||
125115502|NCT01464827|450046287|FG004|Overall Study|Lost to Follow-up|3|||
125115503|NCT01464827|450046288|FG005|Overall Study|Lost to Follow-up|1|||
125115504|NCT01464827|450046289|FG006|Overall Study|Lost to Follow-up|2|||
125115505|NCT01464827|450046290|FG007|Overall Study|Lost to Follow-up|2|||
125115506|NCT01464827|450046291|FG008|Overall Study|Lost to Follow-up|0|||
125115507|NCT01464827|450046292|FG009|Overall Study|Lost to Follow-up|0|||
125115508|NCT01464827|450046293|FG010|Overall Study|Lost to Follow-up|0|||
125115509|NCT01464827|450046294|FG011|Overall Study|Lost to Follow-up|1|||
125115510|NCT01464827|450046295|FG012|Overall Study|Lost to Follow-up|0|||
125115511|NCT01464827|450046296|FG013|Overall Study|Lost to Follow-up|1|||
125115512|NCT01464827|450046283|FG000|Overall Study|Other|2|||
125115513|NCT01464827|450046284|FG001|Overall Study|Other|3|||
125115514|NCT01464827|450046285|FG002|Overall Study|Other|0|||
125115515|NCT01464827|450046286|FG003|Overall Study|Other|2|||
125115516|NCT01464827|450046287|FG004|Overall Study|Other|3|||
125115517|NCT01464827|450046288|FG005|Overall Study|Other|0|||
125115518|NCT01464827|450046289|FG006|Overall Study|Other|1|||
125115519|NCT01464827|450046290|FG007|Overall Study|Other|0|||
125115520|NCT01464827|450046291|FG008|Overall Study|Other|3|||
125115521|NCT01464827|450046292|FG009|Overall Study|Other|1|||
125115522|NCT01464827|450046293|FG010|Overall Study|Other|2|||
125115523|NCT01464827|450046294|FG011|Overall Study|Other|0|||
125115524|NCT01464827|450046295|FG012|Overall Study|Other|1|||
125115525|NCT01464827|450046296|FG013|Overall Study|Other|0|||
125115526|NCT01464827|450046283|FG000|Overall Study|Not Treated|0|||
125115527|NCT01464827|450046284|FG001|Overall Study|Not Treated|2|||
125115528|NCT01464827|450046285|FG002|Overall Study|Not Treated|0|||
125115529|NCT01464827|450046286|FG003|Overall Study|Not Treated|0|||
125115530|NCT01464827|450046287|FG004|Overall Study|Not Treated|1|||
125115531|NCT01464827|450046288|FG005|Overall Study|Not Treated|0|||
125115532|NCT01464827|450046289|FG006|Overall Study|Not Treated|1|||
125115533|NCT01464827|450046290|FG007|Overall Study|Not Treated|0|||
125115534|NCT01464827|450046291|FG008|Overall Study|Not Treated|0|||
125115535|NCT01464827|450046292|FG009|Overall Study|Not Treated|2|||
125115536|NCT01464827|450046293|FG010|Overall Study|Not Treated|0|||
125115537|NCT01464827|450046294|FG011|Overall Study|Not Treated|1|||
125115538|NCT01464827|450046295|FG012|Overall Study|Not Treated|0|||
125115539|NCT01464827|450046296|FG013|Overall Study|Not Treated|2|||
125115540|NCT03487796|450046298|FG000|Overall Study|Lost to Follow-up|18|||
125115541|NCT03487796|450046299|FG001|Overall Study|Lost to Follow-up|6|||
125115542|NCT04272775|450046300|FG000|Overall Study|Study Terminated by Sponsor|1|||
125115543|NCT04272775|450046301|FG001|Overall Study|Study Terminated by Sponsor|0|||
125115544|NCT04272775|450046300|FG000|Overall Study|Protocol Violation|0|||
125115545|NCT04272775|450046301|FG001|Overall Study|Protocol Violation|1|||
125115546|NCT04272775|450046300|FG000|Overall Study|Symptomatic Deterioration|1|||
125115547|NCT04272775|450046301|FG001|Overall Study|Symptomatic Deterioration|1|||
125115548|NCT04272775|450046300|FG000|Overall Study|Withdrawal by Subject|1|||
125115549|NCT04272775|450046301|FG001|Overall Study|Withdrawal by Subject|2|||
125115550|NCT04272775|450046300|FG000|Overall Study|Adverse Event|1|||
125115551|NCT04272775|450046301|FG001|Overall Study|Adverse Event|2|||
125115552|NCT04272775|450046300|FG000|Overall Study|Progressive Disease|3|||
125115553|NCT04272775|450046301|FG001|Overall Study|Progressive Disease|1|||
125115554|NCT00124020|450046302|FG000|Overall Study|Death|67|||
125115555|NCT00124020|450046303|FG001|Overall Study|Death|71|||
125115556|NCT00124020|450046302|FG000|Overall Study|Withdrawal by Subject|13|||
125115557|NCT00124020|450046303|FG001|Overall Study|Withdrawal by Subject|11|||
125115558|NCT00124020|450046302|FG000|Overall Study|Lost to Follow-up|5|||
125115559|NCT00124020|450046303|FG001|Overall Study|Lost to Follow-up|8|||
125115560|NCT00124020|450046302|FG000|Overall Study|Other|1|||
125115561|NCT00124020|450046303|FG001|Overall Study|Other|1|||
125115562|NCT00124020|450046302|FG000|Overall Study|Transfer to another hospital|2|||
125115563|NCT00124020|450046303|FG001|Overall Study|Transfer to another hospital|0|||
125115564|NCT02043366|450046304|FG000|Overall Study|Lost to Follow-up|2|||
125115565|NCT02043366|450046305|FG001|Overall Study|Lost to Follow-up|2|||
125115566|NCT02043366|450046306|FG002|Overall Study|Lost to Follow-up|2|||
125115567|NCT02043366|450046307|FG003|Overall Study|Lost to Follow-up|2|||
125115568|NCT02043366|450046308|FG004|Overall Study|Lost to Follow-up|2|||
125115569|NCT02043366|450046309|FG005|Overall Study|Lost to Follow-up|2|||
125115570|NCT01489956|450046312|FG000|Overall Study|Lost to Follow-up|1|||
125115571|NCT01489956|450046313|FG001|Overall Study|Lost to Follow-up|0|||
125115572|NCT01489956|450046314|FG002|Overall Study|Lost to Follow-up|0|||
125115573|NCT01489956|450046312|FG000|Overall Study|Withdrawal by Subject|0|||
125115574|NCT01489956|450046313|FG001|Overall Study|Withdrawal by Subject|0|||
125115575|NCT01489956|450046314|FG002|Overall Study|Withdrawal by Subject|1|||
125115576|NCT00891774|450046315|FG000|Overall Study|Lost to Follow-up|5|||
125115577|NCT00891774|450046315|FG000|Overall Study|Illness (Self/Mother)|3|||
125115578|NCT00891774|450046315|FG000|Overall Study|Withdrawal by Subject|2|||
125115579|NCT00891774|450046315|FG000|Overall Study|Protocol Violation|4|||
125115580|NCT01977092|450046317|FG000|Overall Study|Death|3|||
125115581|NCT01977092|450046318|FG001|Overall Study|Death|4|||
125115582|NCT01977092|450046317|FG000|Overall Study|Lost to Follow-up|23|||
125115583|NCT01977092|450046318|FG001|Overall Study|Lost to Follow-up|14|||
125115584|NCT01977092|450046317|FG000|Overall Study|Withdrawal by Subject|2|||
125115585|NCT01977092|450046318|FG001|Overall Study|Withdrawal by Subject|1|||
125115586|NCT01977092|450046317|FG000|Overall Study|In prison|3|||
125115587|NCT01977092|450046318|FG001|Overall Study|In prison|11|||
125115588|NCT02927847|450046319|FG000|Overall Study|Lost to Follow-up|1|||
125115589|NCT02927847|450046320|FG001|Overall Study|Lost to Follow-up|0|||
125115590|NCT02927847|450046319|FG000|Overall Study|Withdrawal by Subject|4|||
125115591|NCT02927847|450046320|FG001|Overall Study|Withdrawal by Subject|2|||
124911840|NCT00393484|449304880|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
124911841|NCT00393484|449304879|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
124911842|NCT00393484|449304880|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
124911843|NCT00393484|449304879|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
124911844|NCT00393484|449304880|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
124911845|NCT00393484|449304879|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
124911846|NCT00393484|449304880|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
124911847|NCT03201562|449304881|FG000|Overall Study|Physician Decision|0|||
124911848|NCT03201562|449304882|FG001|Overall Study|Physician Decision|0|||
124911849|NCT03201562|449304883|FG002|Overall Study|Physician Decision|1|||
124911850|NCT03201562|449304881|FG000|Overall Study|Adverse Event|0|||
124911851|NCT03201562|449304882|FG001|Overall Study|Adverse Event|0|||
124911852|NCT03201562|449304883|FG002|Overall Study|Adverse Event|1|||
124911853|NCT03201562|449304881|FG000|Overall Study|Lost to Follow-up|0|||
124911854|NCT03201562|449304882|FG001|Overall Study|Lost to Follow-up|1|||
124911855|NCT03201562|449304883|FG002|Overall Study|Lost to Follow-up|2|||
124911856|NCT00001277|449304884|FG000|Overall Study|Adverse Event|0|||
124911857|NCT00001277|449304885|FG001|Overall Study|Adverse Event|0|||
124911858|NCT00001277|449304886|FG002|Overall Study|Adverse Event|1|||
124911859|NCT00001277|449304884|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
124911860|NCT00001277|449304885|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
124911861|NCT00001277|449304886|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
124911862|NCT02539225|449304894|FG000|Part A|Adverse Event|13|||
125115592|NCT02927847|450046319|FG000|Overall Study|PI withdrawn due to missed visits|1|||
125115593|NCT02927847|450046320|FG001|Overall Study|PI withdrawn due to missed visits|1|||
125115594|NCT00723554|450046321|FG000|Overall Study|Adverse Event|12|||
125115595|NCT00723554|450046321|FG000|Overall Study|Investigator's judgement|5|||
125115596|NCT00723554|450046321|FG000|Overall Study|Inhaled medication other than iloprost|4|||
125115597|NCT00723554|450046321|FG000|Overall Study|Withdrawal of consent|3|||
125115598|NCT00723554|450046321|FG000|Overall Study|Other|3|||
125115599|NCT00723554|450046321|FG000|Overall Study|Lost to Follow-up|1|||
125115600|NCT00723554|450046321|FG000|Overall Study|Non-compliance|1|||
125115601|NCT01405820|450046322|FG000|Randomized Treatment Period|Adverse Event|3|||
125115602|NCT01405820|450046323|FG001|Randomized Treatment Period|Adverse Event|3|||
125115603|NCT01405820|450046324|FG002|Randomized Treatment Period|Adverse Event|3|||
125115604|NCT01405820|450046325|FG003|Randomized Treatment Period|Adverse Event|0|||
125115605|NCT01405820|450046326|FG004|Randomized Treatment Period|Adverse Event|2|||
125115606|NCT01405820|450046327|FG005|Randomized Treatment Period|Adverse Event|1|||
125115607|NCT01405820|450046322|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
125115608|NCT01405820|450046323|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
125115609|NCT01405820|450046324|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
125115610|NCT01405820|450046325|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
125115611|NCT01405820|450046326|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
125115612|NCT01405820|450046327|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
125115613|NCT01405820|450046322|FG000|Randomized Treatment Period|Other|2|||
125115614|NCT01405820|450046323|FG001|Randomized Treatment Period|Other|2|||
125115615|NCT01405820|450046324|FG002|Randomized Treatment Period|Other|1|||
125115616|NCT01405820|450046325|FG003|Randomized Treatment Period|Other|1|||
125211508|NCT01716520|450399722|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
125211509|NCT01716520|450399723|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
125211510|NCT01716520|450399724|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
125211511|NCT01716520|450399725|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
125211512|NCT01716520|450399720|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
125211513|NCT01716520|450399721|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
125211514|NCT01716520|450399722|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
125211515|NCT01716520|450399723|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
125211516|NCT01716520|450399724|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
125211517|NCT01716520|450399725|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
125211518|NCT01716520|450399720|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
125211519|NCT01716520|450399721|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
125211520|NCT01716520|450399722|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
125211521|NCT01716520|450399723|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
125211522|NCT01716520|450399724|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
125211523|NCT01716520|450399725|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
125211524|NCT01716520|450399720|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125211525|NCT01716520|450399721|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125211526|NCT01716520|450399722|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125211527|NCT01716520|450399723|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125211528|NCT01716520|450399724|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
125211529|NCT01716520|450399725|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125211530|NCT01716520|450399720|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
125211531|NCT01716520|450399721|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
125211532|NCT01716520|450399722|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
125211533|NCT01716520|450399723|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
125211534|NCT01716520|450399724|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
125211535|NCT01716520|450399725|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
125211536|NCT01716520|450399720|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
125211537|NCT01716520|450399721|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
125211538|NCT01716520|450399722|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
125211539|NCT01716520|450399723|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
125211540|NCT01716520|450399724|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
125211541|NCT01716520|450399725|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
125211542|NCT01716520|450399720|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
125211543|NCT01716520|450399721|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
125211544|NCT01716520|450399722|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
125211545|NCT01716520|450399723|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
125211546|NCT01716520|450399724|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
125211547|NCT01716520|450399725|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
125211548|NCT01716520|450399720|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
125211549|NCT01716520|450399721|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
125211550|NCT01716520|450399722|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
125211551|NCT01716520|450399723|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
125211552|NCT01716520|450399724|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
125211553|NCT01716520|450399725|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
125211554|NCT01716520|450399720|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
125211555|NCT01716520|450399721|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
125211556|NCT01716520|450399722|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
125211557|NCT01716520|450399723|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
125211558|NCT01716520|450399724|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
125211559|NCT01716520|450399725|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
125211560|NCT01716520|450399720|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125211561|NCT01716520|450399721|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125211562|NCT01716520|450399722|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125211563|NCT01716520|450399723|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125211564|NCT01716520|450399724|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125211565|NCT01716520|450399725|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
125211566|NCT01716520|450399720|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
125211567|NCT01716520|450399721|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
125211568|NCT01716520|450399722|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
125211569|NCT01716520|450399723|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
124911863|NCT02539225|449304895|FG001|Part A|Adverse Event|4|||
124911864|NCT02539225|449304894|FG000|Part A|Withdrawal by Subject|2|||
124911865|NCT02539225|449304895|FG001|Part A|Withdrawal by Subject|4|||
124911866|NCT02539225|449304894|FG000|Part A|Physician Decision|4|||
124911867|NCT02539225|449304895|FG001|Part A|Physician Decision|7|||
124911868|NCT02539225|449304894|FG000|Part A|Did Not Receive study Drug|1|||
124911869|NCT02539225|449304895|FG001|Part A|Did Not Receive study Drug|1|||
124911870|NCT02539225|449304894|FG000|Pre Treatment for Part B|Progressive disease|1|||
124911871|NCT02539225|449304895|FG001|Pre Treatment for Part B|Progressive disease|1|||
124911872|NCT02539225|449304894|FG000|Pre Treatment for Part B|Adverse Event|1|||
124911873|NCT02539225|449304895|FG001|Pre Treatment for Part B|Adverse Event|1|||
124911874|NCT02539225|449304894|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
124911875|NCT02539225|449304895|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
124911876|NCT02539225|449304894|FG000|Pre Treatment for Part B|Physician Decision|2|||
124911877|NCT02539225|449304895|FG001|Pre Treatment for Part B|Physician Decision|0|||
124911878|NCT02539225|449304894|FG000|Part B|Adverse Event|4|||
124911879|NCT02539225|449304895|FG001|Part B|Adverse Event|4|||
124911880|NCT02539225|449304894|FG000|Part B|Withdrawal by Subject|0|||
124911881|NCT02539225|449304895|FG001|Part B|Withdrawal by Subject|3|||
124911882|NCT02539225|449304894|FG000|Part B|Physician Decision|0|||
124911883|NCT02539225|449304895|FG001|Part B|Physician Decision|9|||
124911884|NCT03101371|449304896|FG000|Overall Study|Physician Decision|0|||
124911885|NCT03101371|449304897|FG001|Overall Study|Physician Decision|1|||
124911886|NCT03101371|449304896|FG000|Overall Study|Lost to Follow-up|1|||
124911887|NCT03101371|449304897|FG001|Overall Study|Lost to Follow-up|4|||
124911888|NCT03101371|449304896|FG000|Overall Study|Did not meet eligibility criteria|2|||
124911889|NCT03101371|449304897|FG001|Overall Study|Did not meet eligibility criteria|1|||
124911890|NCT02318134|449304898|FG000|Overall Study|Withdrawal by Subject|2|||
124911891|NCT02318134|449304899|FG001|Overall Study|Withdrawal by Subject|1|||
124911892|NCT04766034|449304900|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
124911893|NCT04766034|449304901|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
124911894|NCT04766034|449304902|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
124911895|NCT04766034|449304903|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
124911896|NCT04766034|449304904|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
124911897|NCT04766034|449304900|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
124911898|NCT04766034|449304901|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
124911899|NCT04766034|449304902|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
124911900|NCT04766034|449304903|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
124911901|NCT04766034|449304904|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
124911902|NCT04766034|449304900|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
124911903|NCT04766034|449304901|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
124911904|NCT04766034|449304902|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
124911905|NCT04766034|449304903|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
124911906|NCT04766034|449304904|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
124911907|NCT04766034|449304900|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
124911908|NCT04766034|449304901|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
124911909|NCT04766034|449304902|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
125022272|NCT01656434|449705397|FG001|Overall Study|Participant withdrew consent|9|||
124911910|NCT04766034|449304903|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
125211570|NCT01716520|450399724|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
124911911|NCT04766034|449304904|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
124911912|NCT01976312|449304905|FG000|Overall Study|Pregnancy|0|||
124911913|NCT01976312|449304906|FG001|Overall Study|Pregnancy|1|||
124911914|NCT01976312|449304905|FG000|Overall Study|Lost to Follow-up|2|||
124911915|NCT01976312|449304906|FG001|Overall Study|Lost to Follow-up|0|||
124911916|NCT01976312|449304905|FG000|Overall Study|Withdrawal by Subject|7|||
124911917|NCT01976312|449304906|FG001|Overall Study|Withdrawal by Subject|2|||
124911918|NCT01976312|449304905|FG000|Overall Study|Adverse Event|6|||
124911919|NCT01976312|449304906|FG001|Overall Study|Adverse Event|6|||
124911920|NCT01976312|449304905|FG000|Overall Study|Protocol Violation|2|||
124911921|NCT01976312|449304906|FG001|Overall Study|Protocol Violation|0|||
124911922|NCT04048382|449304911|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
124911923|NCT04048382|449304912|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
124911924|NCT04048382|449304911|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
124911925|NCT04048382|449304912|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
124911926|NCT04048382|449304911|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
124911927|NCT04048382|449304912|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
124911928|NCT02556138|449304913|FG000|Overall Study|Withdrawal by Subject|1|||
124911929|NCT01205048|449304918|FG000|Overall Study|Withdrawal by Subject|14|||
124911930|NCT01205048|449304918|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
124911931|NCT01205048|449304918|FG000|Overall Study|Lost to Follow-up|4|||
124911932|NCT01205048|449304918|FG000|Overall Study|Other|2|||
124911933|NCT01255670|449304919|FG000|Overall Study|Adverse Event|10|||
124911934|NCT01255670|449304920|FG001|Overall Study|Adverse Event|10|||
124911935|NCT01255670|449304919|FG000|Overall Study|Lost to Follow-up|16|||
124911936|NCT01255670|449304920|FG001|Overall Study|Lost to Follow-up|10|||
124911937|NCT02269475|449304921|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
124911938|NCT02269475|449304922|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
124911939|NCT02269475|449304921|FG000|Overall Study|Withdrawal by Subject|0|||
125115617|NCT01405820|450046326|FG004|Randomized Treatment Period|Other|0|||
125115618|NCT01405820|450046327|FG005|Randomized Treatment Period|Other|0|||
124911940|NCT02269475|449304922|FG001|Overall Study|Withdrawal by Subject|1|||
124911941|NCT01037985|449304923|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
124911942|NCT01037985|449304924|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
124911943|NCT01037985|449304923|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
124911944|NCT01037985|449304924|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
124911945|NCT01037985|449304923|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
124911946|NCT01037985|449304924|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
124911947|NCT01037985|449304923|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
124911948|NCT01037985|449304924|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
124911949|NCT02730871|449304925|FG000|Overall Study|Adverse Event|6|||
125022273|NCT01656434|449705396|FG000|Overall Study|Withdrawal by Subject|64|||
125022274|NCT01656434|449705397|FG001|Overall Study|Withdrawal by Subject|7|||
125022275|NCT03694925|449705399|FG000|Overall Study|Inadequate laboratory testing|0|||
125022276|NCT03694925|449705400|FG001|Overall Study|Inadequate laboratory testing|3|||
125115619|NCT01405820|450046322|FG000|Randomized Treatment Period|Physician Decision|0|||
125022277|NCT03694925|449705401|FG002|Overall Study|Inadequate laboratory testing|0|||
125022278|NCT02799069|449705404|FG000|Overall Study|Adverse Event|0|||
125022279|NCT02799069|449705405|FG001|Overall Study|Adverse Event|2|||
125022280|NCT02799069|449705406|FG002|Overall Study|Adverse Event|2|||
125115620|NCT01405820|450046323|FG001|Randomized Treatment Period|Physician Decision|2|||
125115621|NCT01405820|450046324|FG002|Randomized Treatment Period|Physician Decision|1|||
125115622|NCT01405820|450046325|FG003|Randomized Treatment Period|Physician Decision|0|||
125115623|NCT01405820|450046326|FG004|Randomized Treatment Period|Physician Decision|0|||
125115624|NCT01405820|450046327|FG005|Randomized Treatment Period|Physician Decision|0|||
125115625|NCT01405820|450046322|FG000|Randomized Treatment Period|Rescue|0|||
125115626|NCT01405820|450046323|FG001|Randomized Treatment Period|Rescue|1|||
125115627|NCT01405820|450046324|FG002|Randomized Treatment Period|Rescue|13|||
125115628|NCT01405820|450046325|FG003|Randomized Treatment Period|Rescue|10|||
125115629|NCT01405820|450046326|FG004|Randomized Treatment Period|Rescue|8|||
125115630|NCT01405820|450046327|FG005|Randomized Treatment Period|Rescue|8|||
125115631|NCT01405820|450046322|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
125115632|NCT01405820|450046323|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
125115633|NCT01405820|450046324|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
125115634|NCT01405820|450046325|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
125115635|NCT01405820|450046326|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
125115636|NCT01405820|450046327|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
124911950|NCT02730871|449304926|FG001|Overall Study|Adverse Event|0|||
124911951|NCT00823472|449304927|FG000|Overall Study|Physician Decision|24|||
125022281|NCT02799069|449705404|FG000|Overall Study|Lack of Efficacy|2|||
125022282|NCT02799069|449705405|FG001|Overall Study|Lack of Efficacy|0|||
124911952|NCT00823472|449304928|FG001|Overall Study|Physician Decision|28|||
124911953|NCT04019444|449304929|FG000|Overall Study|Withdrawal by Subject|0|||
124911954|NCT04019444|449304930|FG001|Overall Study|Withdrawal by Subject|1|||
124911955|NCT04019444|449304931|FG002|Overall Study|Withdrawal by Subject|0|||
124911956|NCT04019444|449304932|FG003|Overall Study|Withdrawal by Subject|1|||
124911957|NCT04019444|449304929|FG000|Overall Study|Solicited Event|0|||
124911958|NCT04019444|449304930|FG001|Overall Study|Solicited Event|0|||
124911959|NCT04019444|449304931|FG002|Overall Study|Solicited Event|2|||
124911960|NCT04019444|449304932|FG003|Overall Study|Solicited Event|0|||
125115637|NCT01405820|450046322|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
125115638|NCT01405820|450046323|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
125115639|NCT01405820|450046324|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
125115640|NCT01405820|450046325|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
125115641|NCT01405820|450046326|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
125115642|NCT01405820|450046327|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
125115643|NCT01405820|450046322|FG000|Randomized Treatment Period|Death|0|||
124911961|NCT01609218|449304933|FG000|Period 1|Adverse Event|3|||
124911962|NCT01609218|449304934|FG001|Period 1|Adverse Event|5|||
124911963|NCT01609218|449304933|FG000|Period 1|Sponsor Decision|0|||
124911964|NCT01609218|449304934|FG001|Period 1|Sponsor Decision|1|||
124911965|NCT01609218|449304933|FG000|Period 2|Adverse Event|1|||
124911966|NCT01609218|449304934|FG001|Period 2|Adverse Event|0|||
124911967|NCT04428112|449304940|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
124911968|NCT04428112|449304941|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
124911969|NCT04428112|449304940|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
124911970|NCT04428112|449304941|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
124911971|NCT04428112|449304940|FG000|Overall Study|Withdrawal by Subject|9|||
124911972|NCT04428112|449304941|FG001|Overall Study|Withdrawal by Subject|4|||
124911973|NCT04428112|449304940|FG000|Overall Study|Lost to Follow-up|27|||
124911974|NCT04428112|449304941|FG001|Overall Study|Lost to Follow-up|7|||
124911975|NCT01207492|449304942|FG000|Overall Study|Still on study|1|||
124911976|NCT01207492|449304942|FG000|Overall Study|Withdrawal by Subject|9|||
124911977|NCT01207492|449304942|FG000|Overall Study|Physician Decision|1|||
124911978|NCT01207492|449304942|FG000|Overall Study|Progressive disease|3|||
124911979|NCT01207492|449304942|FG000|Overall Study|Toxicity|1|||
124911980|NCT02769858|449304943|FG000|Overall Study|Withdrawal by Subject|2|||
124911981|NCT02807779|449304944|FG000|Overall Study|Lost to Follow-up|1|||
124911982|NCT02807779|449304945|FG001|Overall Study|Lost to Follow-up|0|||
124911983|NCT02807779|449304946|FG002|Overall Study|Lost to Follow-up|0|||
124911984|NCT02807779|449304944|FG000|Overall Study|Physician Decision|2|||
124911985|NCT02807779|449304945|FG001|Overall Study|Physician Decision|0|||
124911986|NCT02807779|449304946|FG002|Overall Study|Physician Decision|1|||
124911987|NCT02807779|449304944|FG000|Overall Study|Death|1|||
124911988|NCT02807779|449304945|FG001|Overall Study|Death|1|||
124911989|NCT02807779|449304946|FG002|Overall Study|Death|0|||
124911990|NCT04814186|449306952|FG000|Treatment Phase|Adverse Event|1|||
124911991|NCT04814186|449306952|FG000|Treatment Phase|Death|6|||
124911992|NCT04814186|449306952|FG000|Treatment Phase|Withdrawal by Subject|2|||
124911993|NCT04814186|449306952|FG000|Treatment Phase|Other|1|||
124911994|NCT04814186|449306952|FG000|Follow-Up Phase|Adverse Event|1|||
124911995|NCT04814186|449306952|FG000|Follow-Up Phase|Death|6|||
124911996|NCT04814186|449306952|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
124911997|NCT04814186|449306952|FG000|Follow-Up Phase|Other|1|||
124911998|NCT01853748|449306958|FG000|Allocation|Withdrawal by Subject|1|||
124911999|NCT01853748|449306959|FG001|Allocation|Withdrawal by Subject|13|||
124912000|NCT01853748|449306958|FG000|Allocation|not sufficient to receive intervention|0|||
124912001|NCT01853748|449306959|FG001|Allocation|not sufficient to receive intervention|1|||
124912002|NCT01853748|449306958|FG000|Follow-Up|Withdrawal by Subject|7|||
125115644|NCT01405820|450046323|FG001|Randomized Treatment Period|Death|0|||
125115645|NCT01405820|450046324|FG002|Randomized Treatment Period|Death|0|||
125115646|NCT01405820|450046325|FG003|Randomized Treatment Period|Death|1|||
125115647|NCT01405820|450046326|FG004|Randomized Treatment Period|Death|0|||
125115648|NCT01405820|450046327|FG005|Randomized Treatment Period|Death|0|||
125115649|NCT01405820|450046322|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
125115650|NCT01405820|450046323|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
125115651|NCT01405820|450046324|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
125115652|NCT01405820|450046325|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
124912003|NCT01853748|449306959|FG001|Follow-Up|Withdrawal by Subject|6|||
124912004|NCT01853748|449306958|FG000|Follow-Up|Adverse Event|67|||
124912005|NCT01853748|449306959|FG001|Follow-Up|Adverse Event|7|||
125115653|NCT01405820|450046326|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
124912006|NCT01853748|449306958|FG000|Follow-Up|not available for data collection|16|||
124912007|NCT01853748|449306959|FG001|Follow-Up|not available for data collection|4|||
124912008|NCT04043455|449306973|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
124912009|NCT04043455|449306974|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
124912010|NCT04043455|449306975|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
124912011|NCT04043455|449306976|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
124912012|NCT04043455|449306977|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
124912013|NCT04043455|449306978|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
124912014|NCT04043455|449306973|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
124912015|NCT04043455|449306974|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
125115654|NCT01405820|450046327|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
125115655|NCT01405820|450046322|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
125115656|NCT01405820|450046323|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
125115657|NCT01405820|450046324|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
125115658|NCT01405820|450046325|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
125115659|NCT01405820|450046326|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
124912016|NCT04043455|449306975|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
124912017|NCT04043455|449306976|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
124912018|NCT04043455|449306977|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
124912019|NCT04043455|449306978|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
124912020|NCT04043455|449306973|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
124912021|NCT04043455|449306974|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
124912022|NCT04043455|449306975|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
124912023|NCT04043455|449306976|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
124912024|NCT04043455|449306977|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
124912025|NCT04043455|449306978|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
124912026|NCT04043455|449306973|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
124912027|NCT04043455|449306974|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
124912028|NCT04043455|449306975|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
124912029|NCT04043455|449306976|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
124912030|NCT04043455|449306977|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
124912031|NCT04043455|449306978|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
124912032|NCT04043455|449306973|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
124912033|NCT04043455|449306974|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
124912034|NCT04043455|449306975|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
124912035|NCT04043455|449306976|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
124912036|NCT04043455|449306977|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
124912037|NCT04043455|449306978|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
124912038|NCT04043455|449306973|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
124912039|NCT04043455|449306974|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
124912040|NCT04043455|449306975|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
124912041|NCT04043455|449306976|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
124912042|NCT04043455|449306977|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
124912043|NCT04043455|449306978|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
124912044|NCT04043455|449306973|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
124912045|NCT04043455|449306974|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
125115660|NCT01405820|450046327|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
125115661|NCT01405820|450046322|FG000|Open-Label Treatment Period|Other|1|||
125115662|NCT01405820|450046323|FG001|Open-Label Treatment Period|Other|1|||
125115663|NCT01405820|450046324|FG002|Open-Label Treatment Period|Other|1|||
125115664|NCT01405820|450046325|FG003|Open-Label Treatment Period|Other|1|||
125115665|NCT01405820|450046326|FG004|Open-Label Treatment Period|Other|1|||
125115666|NCT01405820|450046327|FG005|Open-Label Treatment Period|Other|1|||
125115667|NCT01405820|450046322|FG000|Open-Label Treatment Period|Physician Decision|0|||
125115668|NCT01405820|450046323|FG001|Open-Label Treatment Period|Physician Decision|0|||
125115669|NCT01405820|450046324|FG002|Open-Label Treatment Period|Physician Decision|1|||
125115670|NCT01405820|450046325|FG003|Open-Label Treatment Period|Physician Decision|2|||
125115671|NCT01405820|450046326|FG004|Open-Label Treatment Period|Physician Decision|1|||
125115672|NCT01405820|450046327|FG005|Open-Label Treatment Period|Physician Decision|0|||
125115673|NCT01405820|450046322|FG000|Open-Label Treatment Period|Adverse Event|0|||
125115674|NCT01405820|450046323|FG001|Open-Label Treatment Period|Adverse Event|0|||
125115675|NCT01405820|450046324|FG002|Open-Label Treatment Period|Adverse Event|0|||
125115676|NCT01405820|450046325|FG003|Open-Label Treatment Period|Adverse Event|1|||
125115677|NCT01405820|450046326|FG004|Open-Label Treatment Period|Adverse Event|0|||
125115678|NCT01405820|450046327|FG005|Open-Label Treatment Period|Adverse Event|0|||
125115679|NCT01689974|450046334|FG000|Overall Study|Termination of Study|5|||
125115680|NCT01689974|450046335|FG001|Overall Study|Termination of Study|5|||
125115681|NCT01952574|450046336|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
124912046|NCT04043455|449306975|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
124912047|NCT04043455|449306976|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
124912048|NCT04043455|449306977|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
124912049|NCT04043455|449306978|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
124912050|NCT04043455|449306973|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
124912051|NCT04043455|449306974|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
124912052|NCT04043455|449306975|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
124912053|NCT04043455|449306976|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
124912054|NCT04043455|449306977|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
124912055|NCT04043455|449306978|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
124912056|NCT04043455|449306973|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
124912057|NCT04043455|449306974|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
125022283|NCT02799069|449705406|FG002|Overall Study|Lack of Efficacy|0|||
125022284|NCT02799069|449705404|FG000|Overall Study|Lost to Follow-up|1|||
125022285|NCT02799069|449705405|FG001|Overall Study|Lost to Follow-up|1|||
125022286|NCT02799069|449705406|FG002|Overall Study|Lost to Follow-up|0|||
125022287|NCT02799069|449705404|FG000|Overall Study|Withdrawal by Subject|4|||
124912058|NCT04043455|449306975|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
124912059|NCT04043455|449306976|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
124912060|NCT04043455|449306977|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
124912061|NCT04043455|449306978|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
124912062|NCT04043455|449306973|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
124912063|NCT04043455|449306974|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
124912064|NCT04043455|449306975|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
124912065|NCT04043455|449306976|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
124912066|NCT04043455|449306977|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
124912067|NCT04043455|449306978|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
124912068|NCT04043455|449306973|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
124912069|NCT04043455|449306974|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
124912070|NCT04043455|449306975|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
124912071|NCT04043455|449306976|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
124912072|NCT04043455|449306977|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
124912073|NCT04043455|449306978|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
124912074|NCT05194917|449306979|FG000|Overall Study|Lost to Follow-up|7|||
124912075|NCT05194917|449306980|FG001|Overall Study|Lost to Follow-up|5|||
124912076|NCT05194917|449306981|FG002|Overall Study|Lost to Follow-up|6|||
124912077|NCT05194917|449306982|FG003|Overall Study|Lost to Follow-up|5|||
124912078|NCT04922021|449306987|FG000|Overall Study|Withdrawal by Subject|4|||
124912079|NCT04922021|449306988|FG001|Overall Study|Withdrawal by Subject|10|||
124912080|NCT04922021|449306987|FG000|Overall Study|Adverse Event|2|||
124912081|NCT04922021|449306988|FG001|Overall Study|Adverse Event|2|||
124912082|NCT04922021|449306987|FG000|Overall Study|Lack of Efficacy|0|||
124912083|NCT04922021|449306988|FG001|Overall Study|Lack of Efficacy|1|||
124912084|NCT04922021|449306987|FG000|Overall Study|Multiple reasons|1|||
124912085|NCT04922021|449306988|FG001|Overall Study|Multiple reasons|0|||
124912086|NCT02544074|449307000|FG000|Overall Study|Withdrawal by Subject|0|||
124912087|NCT02544074|449307001|FG001|Overall Study|Withdrawal by Subject|1|||
124912088|NCT02544074|449307002|FG002|Overall Study|Withdrawal by Subject|0|||
124912089|NCT02544074|449307003|FG003|Overall Study|Withdrawal by Subject|0|||
124912090|NCT02544074|449307004|FG004|Overall Study|Withdrawal by Subject|0|||
124912091|NCT02544074|449307005|FG005|Overall Study|Withdrawal by Subject|0|||
124912092|NCT02544074|449307006|FG006|Overall Study|Withdrawal by Subject|0|||
124912093|NCT02544074|449307007|FG007|Overall Study|Withdrawal by Subject|0|||
124912094|NCT02544074|449307008|FG008|Overall Study|Withdrawal by Subject|0|||
124912095|NCT02544074|449307009|FG009|Overall Study|Withdrawal by Subject|0|||
124912096|NCT02544074|449307010|FG010|Overall Study|Withdrawal by Subject|0|||
124912097|NCT02544074|449307011|FG011|Overall Study|Withdrawal by Subject|0|||
124912098|NCT02544074|449307012|FG012|Overall Study|Withdrawal by Subject|0|||
124912099|NCT02544074|449307013|FG013|Overall Study|Withdrawal by Subject|0|||
125022288|NCT02799069|449705405|FG001|Overall Study|Withdrawal by Subject|4|||
125022289|NCT02799069|449705406|FG002|Overall Study|Withdrawal by Subject|3|||
125022290|NCT02799069|449705404|FG000|Overall Study|Protocol Violation|1|||
125022291|NCT02799069|449705405|FG001|Overall Study|Protocol Violation|0|||
125022292|NCT02799069|449705406|FG002|Overall Study|Protocol Violation|2|||
125022293|NCT03033875|449705407|FG000|Overall Study|Withdrawal by Subject|5|||
125022294|NCT03033875|449705408|FG001|Overall Study|Withdrawal by Subject|9|||
124912100|NCT02544074|449307014|FG014|Overall Study|Withdrawal by Subject|0|||
124912101|NCT02544074|449307015|FG015|Overall Study|Withdrawal by Subject|0|||
124912102|NCT02544074|449307016|FG016|Overall Study|Withdrawal by Subject|0|||
124912103|NCT02544074|449307017|FG017|Overall Study|Withdrawal by Subject|0|||
124912104|NCT02544074|449307018|FG018|Overall Study|Withdrawal by Subject|0|||
124912105|NCT02544074|449307019|FG019|Overall Study|Withdrawal by Subject|0|||
124912106|NCT02544074|449307020|FG020|Overall Study|Withdrawal by Subject|0|||
124912107|NCT02544074|449307000|FG000|Overall Study|Tablet error|0|||
125211571|NCT01716520|450399725|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
124912108|NCT02544074|449307001|FG001|Overall Study|Tablet error|0|||
124912109|NCT02544074|449307002|FG002|Overall Study|Tablet error|0|||
124912110|NCT02544074|449307003|FG003|Overall Study|Tablet error|0|||
124912111|NCT02544074|449307004|FG004|Overall Study|Tablet error|0|||
124912112|NCT02544074|449307005|FG005|Overall Study|Tablet error|1|||
124912113|NCT02544074|449307006|FG006|Overall Study|Tablet error|0|||
124912114|NCT02544074|449307007|FG007|Overall Study|Tablet error|0|||
124912115|NCT02544074|449307008|FG008|Overall Study|Tablet error|0|||
124912116|NCT02544074|449307009|FG009|Overall Study|Tablet error|1|||
124912117|NCT02544074|449307010|FG010|Overall Study|Tablet error|0|||
124912118|NCT02544074|449307011|FG011|Overall Study|Tablet error|0|||
124912119|NCT02544074|449307012|FG012|Overall Study|Tablet error|0|||
124912120|NCT02544074|449307013|FG013|Overall Study|Tablet error|0|||
124912121|NCT02544074|449307014|FG014|Overall Study|Tablet error|0|||
124912122|NCT02544074|449307015|FG015|Overall Study|Tablet error|0|||
124912123|NCT02544074|449307016|FG016|Overall Study|Tablet error|0|||
124912124|NCT02544074|449307017|FG017|Overall Study|Tablet error|0|||
124912125|NCT02544074|449307018|FG018|Overall Study|Tablet error|0|||
124912126|NCT02544074|449307019|FG019|Overall Study|Tablet error|0|||
124912127|NCT02544074|449307020|FG020|Overall Study|Tablet error|0|||
124912128|NCT03189524|449307021|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
124912129|NCT03189524|449307022|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
124912130|NCT03189524|449307023|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
124912131|NCT03189524|449307021|FG000|Overall Study|Death|2|||
124912132|NCT03189524|449307022|FG001|Overall Study|Death|2|||
124912133|NCT03189524|449307023|FG002|Overall Study|Death|1|||
124912134|NCT03189524|449307021|FG000|Overall Study|Lost to Follow-up|1|||
124912135|NCT03189524|449307022|FG001|Overall Study|Lost to Follow-up|0|||
124912136|NCT03189524|449307023|FG002|Overall Study|Lost to Follow-up|8|||
124912137|NCT03189524|449307021|FG000|Overall Study|Withdrawal by Subject|1|||
124912138|NCT03189524|449307022|FG001|Overall Study|Withdrawal by Subject|1|||
124912139|NCT03189524|449307023|FG002|Overall Study|Withdrawal by Subject|3|||
124912140|NCT03189524|449307021|FG000|Overall Study|Progressive Disease|0|||
124912141|NCT03189524|449307022|FG001|Overall Study|Progressive Disease|2|||
124912142|NCT03189524|449307023|FG002|Overall Study|Progressive Disease|0|||
124912143|NCT02723955|449307024|FG000|Escalation Phase|Death|1|||
124912144|NCT02723955|449307025|FG001|Escalation Phase|Death|1|||
124912145|NCT02723955|449307026|FG002|Escalation Phase|Death|2|||
124912146|NCT02723955|449307027|FG003|Escalation Phase|Death|7|||
124912147|NCT02723955|449307028|FG004|Escalation Phase|Death|18|||
124912148|NCT02723955|449307029|FG005|Escalation Phase|Death|17|||
124912149|NCT02723955|449307030|FG006|Escalation Phase|Death|11|||
124912150|NCT02723955|449307031|FG007|Escalation Phase|Death|21|||
124912151|NCT02723955|449307032|FG008|Escalation Phase|Death|3|||
124912152|NCT02723955|449307033|FG009|Escalation Phase|Death|0|||
124912153|NCT02723955|449307034|FG010|Escalation Phase|Death|0|||
124912154|NCT02723955|449307035|FG011|Escalation Phase|Death|0|||
124912155|NCT02723955|449307036|FG012|Escalation Phase|Death|2|||
124912156|NCT02723955|449307037|FG013|Escalation Phase|Death|4|||
124912157|NCT02723955|449307038|FG014|Escalation Phase|Death|5|||
124912158|NCT02723955|449307039|FG015|Escalation Phase|Death|6|||
124912159|NCT02723955|449307040|FG016|Escalation Phase|Death|6|||
124912160|NCT02723955|449307041|FG017|Escalation Phase|Death|7|||
124912161|NCT02723955|449307042|FG018|Escalation Phase|Death|1|||
124912162|NCT02723955|449307043|FG019|Escalation Phase|Death|3|||
124912163|NCT02723955|449307044|FG020|Escalation Phase|Death|13|||
124912164|NCT02723955|449307045|FG021|Escalation Phase|Death|3|||
124912165|NCT02723955|449307046|FG022|Escalation Phase|Death|2|||
124912166|NCT02723955|449307047|FG023|Escalation Phase|Death|4|||
124912167|NCT02723955|449307048|FG024|Escalation Phase|Death|31|||
125115682|NCT01952574|450046337|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
125115683|NCT01952574|450046338|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
125115684|NCT01952574|450046339|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
125115685|NCT01952574|450046340|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125115686|NCT01952574|450046341|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125115687|NCT01952574|450046342|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125115688|NCT01952574|450046336|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
125115689|NCT01952574|450046337|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
125115690|NCT01952574|450046338|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
125211572|NCT03699540|450399726|FG000|Overall Study|Lost to Follow-up|1|||
124912168|NCT02723955|449307049|FG025|Escalation Phase|Death|7|||
124912169|NCT02723955|449307050|FG026|Escalation Phase|Death|13|||
124912170|NCT02723955|449307051|FG027|Escalation Phase|Death|0|||
124912171|NCT02723955|449307052|FG028|Escalation Phase|Death|1|||
124912172|NCT02723955|449307053|FG029|Escalation Phase|Death|0|||
124912173|NCT02723955|449307054|FG030|Escalation Phase|Death|0|||
124912174|NCT02723955|449307055|FG031|Escalation Phase|Death|0|||
124912175|NCT02723955|449307056|FG032|Escalation Phase|Death|0|||
124912176|NCT02723955|449307057|FG033|Escalation Phase|Death|0|||
125115691|NCT01952574|450046339|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
125115692|NCT01952574|450046340|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
125115693|NCT01952574|450046341|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
125115694|NCT01952574|450046342|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
125115695|NCT01952574|450046336|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
125115696|NCT01952574|450046337|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
125115697|NCT01952574|450046338|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
125115698|NCT01952574|450046339|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
125115699|NCT01952574|450046340|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
125115700|NCT01952574|450046341|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
125115701|NCT01952574|450046342|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
125115702|NCT01952574|450046336|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
124912177|NCT02723955|449307058|FG034|Escalation Phase|Death|0|||
124912178|NCT02723955|449307059|FG035|Escalation Phase|Death|0|||
124912179|NCT02723955|449307060|FG036|Escalation Phase|Death|0|||
124912180|NCT02723955|449307061|FG037|Escalation Phase|Death|0|||
124912181|NCT02723955|449307062|FG038|Escalation Phase|Death|0|||
124912182|NCT02723955|449307063|FG039|Escalation Phase|Death|0|||
124912183|NCT02723955|449307064|FG040|Escalation Phase|Death|0|||
124912184|NCT02723955|449307065|FG041|Escalation Phase|Death|0|||
124912185|NCT02723955|449307066|FG042|Escalation Phase|Death|0|||
125115703|NCT01952574|450046337|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
125115704|NCT01952574|450046338|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
125115705|NCT01952574|450046339|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
125115706|NCT01952574|450046340|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
125115707|NCT01952574|450046341|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
125115708|NCT01952574|450046342|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
125115709|NCT01952574|450046336|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
125115710|NCT01952574|450046337|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
125115711|NCT01952574|450046338|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
125115712|NCT01952574|450046339|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
125115713|NCT01952574|450046340|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
125211573|NCT02697591|450399731|FG000|Overall Study|Lost to Follow-up|0|||
125211574|NCT02697591|450399732|FG001|Overall Study|Lost to Follow-up|0|||
125211575|NCT02697591|450399733|FG002|Overall Study|Lost to Follow-up|0|||
125211576|NCT02697591|450399734|FG003|Overall Study|Lost to Follow-up|0|||
125211577|NCT02697591|450399735|FG004|Overall Study|Lost to Follow-up|0|||
125211578|NCT02697591|450399736|FG005|Overall Study|Lost to Follow-up|1|||
125211579|NCT02697591|450399737|FG006|Overall Study|Lost to Follow-up|1|||
125211580|NCT02697591|450399738|FG007|Overall Study|Lost to Follow-up|0|||
125211581|NCT02697591|450399739|FG008|Overall Study|Lost to Follow-up|0|||
125211582|NCT02697591|450399740|FG009|Overall Study|Lost to Follow-up|1|||
125211583|NCT02697591|450399731|FG000|Overall Study|Withdrawal by Subject|1|||
125211584|NCT02697591|450399732|FG001|Overall Study|Withdrawal by Subject|1|||
125211585|NCT02697591|450399733|FG002|Overall Study|Withdrawal by Subject|2|||
125211586|NCT02697591|450399734|FG003|Overall Study|Withdrawal by Subject|1|||
125211587|NCT02697591|450399735|FG004|Overall Study|Withdrawal by Subject|7|||
125211588|NCT02697591|450399736|FG005|Overall Study|Withdrawal by Subject|6|||
125211589|NCT02697591|450399737|FG006|Overall Study|Withdrawal by Subject|9|||
124912186|NCT02723955|449307024|FG000|Escalation Phase|Lost to Follow-up|0|||
124912187|NCT02723955|449307025|FG001|Escalation Phase|Lost to Follow-up|0|||
124912188|NCT02723955|449307026|FG002|Escalation Phase|Lost to Follow-up|0|||
124912189|NCT02723955|449307027|FG003|Escalation Phase|Lost to Follow-up|0|||
124912190|NCT02723955|449307028|FG004|Escalation Phase|Lost to Follow-up|0|||
124912191|NCT02723955|449307029|FG005|Escalation Phase|Lost to Follow-up|2|||
125115714|NCT01952574|450046341|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
125115715|NCT01952574|450046342|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
125115716|NCT01952574|450046336|FG000|Open-label Treatment Phase|Missing|0|||
124912192|NCT02723955|449307030|FG006|Escalation Phase|Lost to Follow-up|1|||
125211590|NCT02697591|450399738|FG007|Overall Study|Withdrawal by Subject|1|||
125211591|NCT02697591|450399739|FG008|Overall Study|Withdrawal by Subject|6|||
125211592|NCT02697591|450399740|FG009|Overall Study|Withdrawal by Subject|10|||
125211593|NCT02697591|450399731|FG000|Overall Study|Physician Decision|1|||
125211594|NCT02697591|450399732|FG001|Overall Study|Physician Decision|0|||
125211595|NCT02697591|450399733|FG002|Overall Study|Physician Decision|0|||
124912193|NCT02723955|449307031|FG007|Escalation Phase|Lost to Follow-up|1|||
124912194|NCT02723955|449307032|FG008|Escalation Phase|Lost to Follow-up|1|||
125115717|NCT01952574|450046337|FG001|Open-label Treatment Phase|Missing|0|||
125115718|NCT01952574|450046338|FG002|Open-label Treatment Phase|Missing|0|||
125115719|NCT01952574|450046339|FG003|Open-label Treatment Phase|Missing|0|||
125115720|NCT01952574|450046340|FG004|Open-label Treatment Phase|Missing|4|||
125115721|NCT01952574|450046341|FG005|Open-label Treatment Phase|Missing|0|||
125115722|NCT01952574|450046342|FG006|Open-label Treatment Phase|Missing|0|||
125115723|NCT01952574|450046336|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
125115724|NCT01952574|450046337|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
125115725|NCT01952574|450046338|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
125115726|NCT01952574|450046339|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
125115727|NCT01952574|450046340|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
125115728|NCT01952574|450046341|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
125115729|NCT01952574|450046342|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
125115730|NCT01952574|450046336|FG000|Open-label Treatment Phase|Death|0|||
125115731|NCT01952574|450046337|FG001|Open-label Treatment Phase|Death|0|||
125115732|NCT01952574|450046338|FG002|Open-label Treatment Phase|Death|0|||
125115733|NCT01952574|450046339|FG003|Open-label Treatment Phase|Death|0|||
125115734|NCT01952574|450046340|FG004|Open-label Treatment Phase|Death|1|||
125115735|NCT01952574|450046341|FG005|Open-label Treatment Phase|Death|0|||
125115736|NCT01952574|450046342|FG006|Open-label Treatment Phase|Death|0|||
125115737|NCT01952574|450046336|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
125115738|NCT01952574|450046337|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
124912195|NCT02723955|449307033|FG009|Escalation Phase|Lost to Follow-up|0|||
124912196|NCT02723955|449307034|FG010|Escalation Phase|Lost to Follow-up|0|||
124912197|NCT02723955|449307035|FG011|Escalation Phase|Lost to Follow-up|0|||
124912198|NCT02723955|449307036|FG012|Escalation Phase|Lost to Follow-up|1|||
124912199|NCT02723955|449307037|FG013|Escalation Phase|Lost to Follow-up|0|||
124912200|NCT02723955|449307038|FG014|Escalation Phase|Lost to Follow-up|0|||
124912201|NCT02723955|449307039|FG015|Escalation Phase|Lost to Follow-up|0|||
124912202|NCT02723955|449307040|FG016|Escalation Phase|Lost to Follow-up|1|||
124912203|NCT02723955|449307041|FG017|Escalation Phase|Lost to Follow-up|2|||
124912204|NCT02723955|449307042|FG018|Escalation Phase|Lost to Follow-up|0|||
124912205|NCT02723955|449307043|FG019|Escalation Phase|Lost to Follow-up|1|||
124912206|NCT02723955|449307044|FG020|Escalation Phase|Lost to Follow-up|2|||
124912207|NCT02723955|449307045|FG021|Escalation Phase|Lost to Follow-up|1|||
124912208|NCT02723955|449307046|FG022|Escalation Phase|Lost to Follow-up|0|||
124912209|NCT02723955|449307047|FG023|Escalation Phase|Lost to Follow-up|0|||
125115739|NCT01952574|450046338|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
125115740|NCT01952574|450046339|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
124912210|NCT02723955|449307048|FG024|Escalation Phase|Lost to Follow-up|1|||
124912211|NCT02723955|449307049|FG025|Escalation Phase|Lost to Follow-up|1|||
124912212|NCT02723955|449307050|FG026|Escalation Phase|Lost to Follow-up|3|||
124912213|NCT02723955|449307051|FG027|Escalation Phase|Lost to Follow-up|0|||
124912214|NCT02723955|449307052|FG028|Escalation Phase|Lost to Follow-up|1|||
124912215|NCT02723955|449307053|FG029|Escalation Phase|Lost to Follow-up|0|||
124912216|NCT02723955|449307054|FG030|Escalation Phase|Lost to Follow-up|0|||
124912217|NCT02723955|449307055|FG031|Escalation Phase|Lost to Follow-up|0|||
124912218|NCT02723955|449307056|FG032|Escalation Phase|Lost to Follow-up|0|||
124912219|NCT02723955|449307057|FG033|Escalation Phase|Lost to Follow-up|0|||
124912220|NCT02723955|449307058|FG034|Escalation Phase|Lost to Follow-up|0|||
124912221|NCT02723955|449307059|FG035|Escalation Phase|Lost to Follow-up|0|||
125115741|NCT01952574|450046340|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
125115742|NCT01952574|450046341|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
125115743|NCT01952574|450046342|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
125211596|NCT02697591|450399734|FG003|Overall Study|Physician Decision|0|||
124912222|NCT02723955|449307060|FG036|Escalation Phase|Lost to Follow-up|0|||
124912223|NCT02723955|449307061|FG037|Escalation Phase|Lost to Follow-up|0|||
124912224|NCT02723955|449307062|FG038|Escalation Phase|Lost to Follow-up|0|||
124912225|NCT02723955|449307063|FG039|Escalation Phase|Lost to Follow-up|0|||
124912226|NCT02723955|449307064|FG040|Escalation Phase|Lost to Follow-up|0|||
124912227|NCT02723955|449307065|FG041|Escalation Phase|Lost to Follow-up|0|||
124912228|NCT02723955|449307066|FG042|Escalation Phase|Lost to Follow-up|0|||
124912229|NCT02723955|449307024|FG000|Escalation Phase|Physician Decision|0|||
124912230|NCT02723955|449307025|FG001|Escalation Phase|Physician Decision|0|||
124912231|NCT02723955|449307026|FG002|Escalation Phase|Physician Decision|0|||
124912232|NCT02723955|449307027|FG003|Escalation Phase|Physician Decision|0|||
124912233|NCT02723955|449307028|FG004|Escalation Phase|Physician Decision|0|||
124912234|NCT02723955|449307029|FG005|Escalation Phase|Physician Decision|2|||
124912235|NCT02723955|449307030|FG006|Escalation Phase|Physician Decision|0|||
124912236|NCT02723955|449307031|FG007|Escalation Phase|Physician Decision|0|||
124912237|NCT02723955|449307032|FG008|Escalation Phase|Physician Decision|0|||
124912238|NCT02723955|449307033|FG009|Escalation Phase|Physician Decision|0|||
124912239|NCT02723955|449307034|FG010|Escalation Phase|Physician Decision|0|||
124912240|NCT02723955|449307035|FG011|Escalation Phase|Physician Decision|0|||
124912241|NCT02723955|449307036|FG012|Escalation Phase|Physician Decision|0|||
124912242|NCT02723955|449307037|FG013|Escalation Phase|Physician Decision|0|||
124912243|NCT02723955|449307038|FG014|Escalation Phase|Physician Decision|0|||
124912244|NCT02723955|449307039|FG015|Escalation Phase|Physician Decision|0|||
124912245|NCT02723955|449307040|FG016|Escalation Phase|Physician Decision|0|||
124912246|NCT02723955|449307041|FG017|Escalation Phase|Physician Decision|0|||
124912247|NCT02723955|449307042|FG018|Escalation Phase|Physician Decision|0|||
124912248|NCT02723955|449307043|FG019|Escalation Phase|Physician Decision|0|||
124912249|NCT02723955|449307044|FG020|Escalation Phase|Physician Decision|0|||
124912250|NCT02723955|449307045|FG021|Escalation Phase|Physician Decision|0|||
124912251|NCT02723955|449307046|FG022|Escalation Phase|Physician Decision|0|||
124912252|NCT02723955|449307047|FG023|Escalation Phase|Physician Decision|0|||
124912253|NCT02723955|449307048|FG024|Escalation Phase|Physician Decision|0|||
124912254|NCT02723955|449307049|FG025|Escalation Phase|Physician Decision|0|||
124912255|NCT02723955|449307050|FG026|Escalation Phase|Physician Decision|2|||
124912256|NCT02723955|449307051|FG027|Escalation Phase|Physician Decision|0|||
124912257|NCT02723955|449307052|FG028|Escalation Phase|Physician Decision|0|||
124912258|NCT02723955|449307053|FG029|Escalation Phase|Physician Decision|0|||
124912259|NCT02723955|449307054|FG030|Escalation Phase|Physician Decision|0|||
124912260|NCT02723955|449307055|FG031|Escalation Phase|Physician Decision|0|||
124912261|NCT02723955|449307056|FG032|Escalation Phase|Physician Decision|0|||
124912262|NCT02723955|449307057|FG033|Escalation Phase|Physician Decision|0|||
124912263|NCT02723955|449307058|FG034|Escalation Phase|Physician Decision|0|||
124912264|NCT02723955|449307059|FG035|Escalation Phase|Physician Decision|0|||
124912265|NCT02723955|449307060|FG036|Escalation Phase|Physician Decision|0|||
124912266|NCT02723955|449307061|FG037|Escalation Phase|Physician Decision|0|||
124912267|NCT02723955|449307062|FG038|Escalation Phase|Physician Decision|0|||
124912268|NCT02723955|449307063|FG039|Escalation Phase|Physician Decision|0|||
124912269|NCT02723955|449307064|FG040|Escalation Phase|Physician Decision|0|||
124912270|NCT02723955|449307065|FG041|Escalation Phase|Physician Decision|0|||
124912271|NCT02723955|449307066|FG042|Escalation Phase|Physician Decision|0|||
124912272|NCT02723955|449307024|FG000|Escalation Phase|Withdrawal by Subject|0|||
124912273|NCT02723955|449307025|FG001|Escalation Phase|Withdrawal by Subject|0|||
124912274|NCT02723955|449307026|FG002|Escalation Phase|Withdrawal by Subject|0|||
125022295|NCT03033875|449705409|FG002|Overall Study|Withdrawal by Subject|4|||
125022296|NCT03033875|449705407|FG000|Overall Study|Other|14|||
125022297|NCT03033875|449705408|FG001|Overall Study|Other|15|||
125022298|NCT03033875|449705409|FG002|Overall Study|Other|8|||
125022299|NCT00730639|449705411|FG000|Overall Study|Adverse Event|3|||
124912275|NCT02723955|449307027|FG003|Escalation Phase|Withdrawal by Subject|0|||
124912276|NCT02723955|449307028|FG004|Escalation Phase|Withdrawal by Subject|1|||
124912277|NCT02723955|449307029|FG005|Escalation Phase|Withdrawal by Subject|1|||
124912278|NCT02723955|449307030|FG006|Escalation Phase|Withdrawal by Subject|1|||
124912279|NCT02723955|449307031|FG007|Escalation Phase|Withdrawal by Subject|1|||
124912280|NCT02723955|449307032|FG008|Escalation Phase|Withdrawal by Subject|0|||
124912281|NCT02723955|449307033|FG009|Escalation Phase|Withdrawal by Subject|0|||
124912282|NCT02723955|449307034|FG010|Escalation Phase|Withdrawal by Subject|0|||
124912283|NCT02723955|449307035|FG011|Escalation Phase|Withdrawal by Subject|0|||
124912284|NCT02723955|449307036|FG012|Escalation Phase|Withdrawal by Subject|1|||
124912285|NCT02723955|449307037|FG013|Escalation Phase|Withdrawal by Subject|0|||
124912286|NCT02723955|449307038|FG014|Escalation Phase|Withdrawal by Subject|0|||
124912287|NCT02723955|449307039|FG015|Escalation Phase|Withdrawal by Subject|0|||
124912288|NCT02723955|449307040|FG016|Escalation Phase|Withdrawal by Subject|1|||
124912289|NCT02723955|449307041|FG017|Escalation Phase|Withdrawal by Subject|0|||
124912290|NCT02723955|449307042|FG018|Escalation Phase|Withdrawal by Subject|0|||
124912291|NCT02723955|449307043|FG019|Escalation Phase|Withdrawal by Subject|0|||
124912292|NCT02723955|449307044|FG020|Escalation Phase|Withdrawal by Subject|0|||
124912293|NCT02723955|449307045|FG021|Escalation Phase|Withdrawal by Subject|0|||
124912294|NCT02723955|449307046|FG022|Escalation Phase|Withdrawal by Subject|0|||
124912295|NCT02723955|449307047|FG023|Escalation Phase|Withdrawal by Subject|2|||
124912296|NCT02723955|449307048|FG024|Escalation Phase|Withdrawal by Subject|0|||
124912297|NCT02723955|449307049|FG025|Escalation Phase|Withdrawal by Subject|1|||
124912298|NCT02723955|449307050|FG026|Escalation Phase|Withdrawal by Subject|0|||
124912299|NCT02723955|449307051|FG027|Escalation Phase|Withdrawal by Subject|0|||
124912300|NCT02723955|449307052|FG028|Escalation Phase|Withdrawal by Subject|1|||
124912301|NCT02723955|449307053|FG029|Escalation Phase|Withdrawal by Subject|0|||
124912302|NCT02723955|449307054|FG030|Escalation Phase|Withdrawal by Subject|0|||
125022300|NCT00730639|449705412|FG001|Overall Study|Adverse Event|0|||
125022301|NCT00730639|449705413|FG002|Overall Study|Adverse Event|9|||
125022302|NCT00730639|449705414|FG003|Overall Study|Adverse Event|8|||
125022303|NCT00730639|449705415|FG004|Overall Study|Adverse Event|23|||
125022304|NCT00730639|449705411|FG000|Overall Study|Complete Response|0|||
125022305|NCT00730639|449705412|FG001|Overall Study|Complete Response|0|||
125022306|NCT00730639|449705413|FG002|Overall Study|Complete Response|2|||
125115744|NCT01952574|450046336|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
125115745|NCT01952574|450046337|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
125115746|NCT01952574|450046338|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
125115747|NCT01952574|450046339|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
125115748|NCT01952574|450046340|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
125115749|NCT01952574|450046341|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
125115750|NCT01952574|450046342|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
125115751|NCT02974114|450046344|FG000|Overall Study|Other (Not specified)|0|||
125115752|NCT02974114|450046345|FG001|Overall Study|Other (Not specified)|1|||
125115753|NCT02974114|450046346|FG002|Overall Study|Other (Not specified)|2|||
125115754|NCT01580020|450046347|FG000|Overall Study|Lack of Efficacy|0|||
125115755|NCT01580020|450046348|FG001|Overall Study|Lack of Efficacy|5|||
125115756|NCT01580020|450046349|FG002|Overall Study|Lack of Efficacy|0|||
125115757|NCT01580020|450046350|FG003|Overall Study|Lack of Efficacy|1|||
125115758|NCT01580020|450046347|FG000|Overall Study|Withdrawal by Subject|0|||
125115759|NCT01580020|450046348|FG001|Overall Study|Withdrawal by Subject|1|||
125115760|NCT01580020|450046349|FG002|Overall Study|Withdrawal by Subject|1|||
125115761|NCT01580020|450046350|FG003|Overall Study|Withdrawal by Subject|0|||
125115762|NCT01580020|450046347|FG000|Overall Study|Adverse Event|1|||
125115763|NCT01580020|450046348|FG001|Overall Study|Adverse Event|1|||
125115764|NCT01580020|450046349|FG002|Overall Study|Adverse Event|1|||
125115765|NCT01580020|450046350|FG003|Overall Study|Adverse Event|1|||
125115766|NCT01580020|450046347|FG000|Overall Study|Administrative Problems|0|||
125115767|NCT01580020|450046348|FG001|Overall Study|Administrative Problems|0|||
125115768|NCT01580020|450046349|FG002|Overall Study|Administrative Problems|1|||
125115769|NCT01580020|450046350|FG003|Overall Study|Administrative Problems|0|||
125115770|NCT01580020|450046347|FG000|Overall Study|Lost to Follow-up|0|||
125115771|NCT01580020|450046348|FG001|Overall Study|Lost to Follow-up|0|||
125115772|NCT01580020|450046349|FG002|Overall Study|Lost to Follow-up|1|||
125115773|NCT01580020|450046350|FG003|Overall Study|Lost to Follow-up|0|||
125211597|NCT02697591|450399735|FG004|Overall Study|Physician Decision|1|||
124912303|NCT02723955|449307055|FG031|Escalation Phase|Withdrawal by Subject|0|||
124912304|NCT02723955|449307056|FG032|Escalation Phase|Withdrawal by Subject|0|||
124912305|NCT02723955|449307057|FG033|Escalation Phase|Withdrawal by Subject|0|||
124912306|NCT02723955|449307058|FG034|Escalation Phase|Withdrawal by Subject|0|||
124912307|NCT02723955|449307059|FG035|Escalation Phase|Withdrawal by Subject|0|||
124912308|NCT02723955|449307060|FG036|Escalation Phase|Withdrawal by Subject|0|||
124912309|NCT02723955|449307061|FG037|Escalation Phase|Withdrawal by Subject|0|||
125022307|NCT00730639|449705414|FG003|Overall Study|Complete Response|2|||
124912310|NCT02723955|449307062|FG038|Escalation Phase|Withdrawal by Subject|0|||
124912311|NCT02723955|449307063|FG039|Escalation Phase|Withdrawal by Subject|0|||
124912312|NCT02723955|449307064|FG040|Escalation Phase|Withdrawal by Subject|0|||
124912313|NCT02723955|449307065|FG041|Escalation Phase|Withdrawal by Subject|0|||
124912314|NCT02723955|449307066|FG042|Escalation Phase|Withdrawal by Subject|0|||
124912315|NCT02723955|449307024|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912316|NCT02723955|449307025|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912317|NCT02723955|449307026|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912318|NCT02723955|449307027|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912319|NCT02723955|449307028|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
124912320|NCT02723955|449307029|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
124912321|NCT02723955|449307030|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
124912322|NCT02723955|449307031|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
124912323|NCT02723955|449307032|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
124912324|NCT02723955|449307033|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912325|NCT02723955|449307034|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912326|NCT02723955|449307035|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912327|NCT02723955|449307036|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912328|NCT02723955|449307037|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912329|NCT02723955|449307038|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912330|NCT02723955|449307039|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912331|NCT02723955|449307040|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912332|NCT02723955|449307041|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912333|NCT02723955|449307042|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912334|NCT02723955|449307043|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912335|NCT02723955|449307044|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912336|NCT02723955|449307045|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912337|NCT02723955|449307046|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912338|NCT02723955|449307047|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912339|NCT02723955|449307048|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912340|NCT02723955|449307049|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912341|NCT02723955|449307050|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912342|NCT02723955|449307051|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912343|NCT02723955|449307052|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912344|NCT02723955|449307053|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912345|NCT02723955|449307054|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912346|NCT02723955|449307055|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912347|NCT02723955|449307056|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912348|NCT02723955|449307057|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912349|NCT02723955|449307058|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912350|NCT02723955|449307059|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912351|NCT02723955|449307060|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912352|NCT02723955|449307061|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125022308|NCT00730639|449705415|FG004|Overall Study|Complete Response|1|||
125115774|NCT01724359|450046351|FG000|Overall Study|Adverse Event|10|||
125211598|NCT02697591|450399736|FG005|Overall Study|Physician Decision|2|||
125211599|NCT02697591|450399737|FG006|Overall Study|Physician Decision|0|||
125211600|NCT02697591|450399738|FG007|Overall Study|Physician Decision|0|||
125211601|NCT02697591|450399739|FG008|Overall Study|Physician Decision|1|||
124912353|NCT02723955|449307062|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912354|NCT02723955|449307063|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912355|NCT02723955|449307064|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125211602|NCT02697591|450399740|FG009|Overall Study|Physician Decision|1|||
125211603|NCT02697591|450399731|FG000|Overall Study|Death|2|||
125211604|NCT02697591|450399732|FG001|Overall Study|Death|3|||
125211605|NCT02697591|450399733|FG002|Overall Study|Death|1|||
125211606|NCT02697591|450399734|FG003|Overall Study|Death|1|||
125211607|NCT02697591|450399735|FG004|Overall Study|Death|4|||
125211608|NCT02697591|450399736|FG005|Overall Study|Death|5|||
125211609|NCT02697591|450399737|FG006|Overall Study|Death|3|||
125211610|NCT02697591|450399738|FG007|Overall Study|Death|1|||
125211611|NCT02697591|450399739|FG008|Overall Study|Death|1|||
125211612|NCT02697591|450399740|FG009|Overall Study|Death|5|||
125211613|NCT02697591|450399731|FG000|Overall Study|Reason not Specified|0|||
125211614|NCT02697591|450399732|FG001|Overall Study|Reason not Specified|0|||
125211615|NCT02697591|450399733|FG002|Overall Study|Reason not Specified|0|||
125211616|NCT02697591|450399734|FG003|Overall Study|Reason not Specified|1|||
125211617|NCT02697591|450399735|FG004|Overall Study|Reason not Specified|1|||
125211618|NCT02697591|450399736|FG005|Overall Study|Reason not Specified|2|||
124912356|NCT02723955|449307065|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125211619|NCT02697591|450399737|FG006|Overall Study|Reason not Specified|3|||
125211620|NCT02697591|450399738|FG007|Overall Study|Reason not Specified|1|||
125211621|NCT02697591|450399739|FG008|Overall Study|Reason not Specified|1|||
125211622|NCT02697591|450399740|FG009|Overall Study|Reason not Specified|3|||
125211623|NCT00624832|450399741|FG000|Overall Study|Adverse Event|0|||
125211624|NCT00624832|450399742|FG001|Overall Study|Adverse Event|1|||
125211625|NCT00624832|450399743|FG002|Overall Study|Adverse Event|0|||
124912357|NCT02723955|449307066|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912358|NCT02723955|449307024|FG000|Escalation Phase|Site Closed|0|||
124912359|NCT02723955|449307025|FG001|Escalation Phase|Site Closed|0|||
124912360|NCT02723955|449307026|FG002|Escalation Phase|Site Closed|0|||
124912361|NCT02723955|449307027|FG003|Escalation Phase|Site Closed|0|||
124912362|NCT02723955|449307028|FG004|Escalation Phase|Site Closed|0|||
124912363|NCT02723955|449307029|FG005|Escalation Phase|Site Closed|0|||
124912364|NCT02723955|449307030|FG006|Escalation Phase|Site Closed|0|||
125022309|NCT00730639|449705411|FG000|Overall Study|Completed Maximum Cycles|0|||
125211626|NCT00624832|450399744|FG003|Overall Study|Adverse Event|1|||
125211627|NCT00624832|450399741|FG000|Overall Study|Abnormal Laboratory Value|2|||
125211628|NCT00624832|450399742|FG001|Overall Study|Abnormal Laboratory Value|0|||
125211629|NCT00624832|450399743|FG002|Overall Study|Abnormal Laboratory Value|0|||
125211630|NCT00624832|450399744|FG003|Overall Study|Abnormal Laboratory Value|0|||
124912365|NCT02723955|449307031|FG007|Escalation Phase|Site Closed|0|||
124912366|NCT02723955|449307032|FG008|Escalation Phase|Site Closed|0|||
124912367|NCT02723955|449307033|FG009|Escalation Phase|Site Closed|0|||
124912368|NCT02723955|449307034|FG010|Escalation Phase|Site Closed|0|||
124912369|NCT02723955|449307035|FG011|Escalation Phase|Site Closed|0|||
124912370|NCT02723955|449307036|FG012|Escalation Phase|Site Closed|0|||
124912371|NCT02723955|449307037|FG013|Escalation Phase|Site Closed|0|||
124912372|NCT02723955|449307038|FG014|Escalation Phase|Site Closed|0|||
124912373|NCT02723955|449307039|FG015|Escalation Phase|Site Closed|1|||
124912374|NCT02723955|449307040|FG016|Escalation Phase|Site Closed|0|||
124912375|NCT02723955|449307041|FG017|Escalation Phase|Site Closed|2|||
124912376|NCT02723955|449307042|FG018|Escalation Phase|Site Closed|0|||
124912377|NCT02723955|449307043|FG019|Escalation Phase|Site Closed|0|||
124912378|NCT02723955|449307044|FG020|Escalation Phase|Site Closed|1|||
124912379|NCT02723955|449307045|FG021|Escalation Phase|Site Closed|0|||
124912380|NCT02723955|449307046|FG022|Escalation Phase|Site Closed|0|||
124912381|NCT02723955|449307047|FG023|Escalation Phase|Site Closed|0|||
124912382|NCT02723955|449307048|FG024|Escalation Phase|Site Closed|3|||
124912383|NCT02723955|449307049|FG025|Escalation Phase|Site Closed|1|||
124912384|NCT02723955|449307050|FG026|Escalation Phase|Site Closed|3|||
124912385|NCT02723955|449307051|FG027|Escalation Phase|Site Closed|1|||
125211631|NCT04379700|450399745|FG000|Overall Study|Withdrawal by Subject|10|||
125211632|NCT04379700|450399745|FG000|Overall Study|Screen Fail|4|||
125211633|NCT04379700|450399745|FG000|Overall Study|Lost to Follow-up|3|||
125211634|NCT00592592|450399746|FG000|Overall Study|Patient found ineligible upon chart review|1|||
124912386|NCT02723955|449307052|FG028|Escalation Phase|Site Closed|1|||
124912387|NCT02723955|449307053|FG029|Escalation Phase|Site Closed|0|||
124912388|NCT02723955|449307054|FG030|Escalation Phase|Site Closed|0|||
124912389|NCT02723955|449307055|FG031|Escalation Phase|Site Closed|0|||
124912390|NCT02723955|449307056|FG032|Escalation Phase|Site Closed|0|||
124912391|NCT02723955|449307057|FG033|Escalation Phase|Site Closed|0|||
124912392|NCT02723955|449307058|FG034|Escalation Phase|Site Closed|0|||
124912393|NCT02723955|449307059|FG035|Escalation Phase|Site Closed|0|||
124912394|NCT02723955|449307060|FG036|Escalation Phase|Site Closed|0|||
124912395|NCT02723955|449307061|FG037|Escalation Phase|Site Closed|0|||
124912396|NCT02723955|449307062|FG038|Escalation Phase|Site Closed|0|||
124912397|NCT02723955|449307063|FG039|Escalation Phase|Site Closed|0|||
124912398|NCT02723955|449307064|FG040|Escalation Phase|Site Closed|0|||
124912399|NCT02723955|449307065|FG041|Escalation Phase|Site Closed|0|||
124912400|NCT02723955|449307066|FG042|Escalation Phase|Site Closed|0|||
124912401|NCT02723955|449307024|FG000|Expansion Phase|Death|0|||
124912402|NCT02723955|449307025|FG001|Expansion Phase|Death|0|||
124912403|NCT02723955|449307026|FG002|Expansion Phase|Death|0|||
124912404|NCT02723955|449307027|FG003|Expansion Phase|Death|0|||
124912405|NCT02723955|449307028|FG004|Expansion Phase|Death|0|||
124912406|NCT02723955|449307029|FG005|Expansion Phase|Death|0|||
124912407|NCT02723955|449307030|FG006|Expansion Phase|Death|0|||
124912408|NCT02723955|449307031|FG007|Expansion Phase|Death|0|||
124912409|NCT02723955|449307032|FG008|Expansion Phase|Death|0|||
124912410|NCT02723955|449307033|FG009|Expansion Phase|Death|25|||
124912411|NCT02723955|449307034|FG010|Expansion Phase|Death|69|||
124912412|NCT02723955|449307035|FG011|Expansion Phase|Death|48|||
124912413|NCT02723955|449307036|FG012|Expansion Phase|Death|0|||
124912414|NCT02723955|449307037|FG013|Expansion Phase|Death|0|||
124912415|NCT02723955|449307038|FG014|Expansion Phase|Death|0|||
124912416|NCT02723955|449307039|FG015|Expansion Phase|Death|0|||
124912417|NCT02723955|449307040|FG016|Expansion Phase|Death|0|||
124912418|NCT02723955|449307041|FG017|Expansion Phase|Death|0|||
124912419|NCT02723955|449307042|FG018|Expansion Phase|Death|0|||
125211635|NCT01038752|450399748|FG000|Overall Study|Tumor Progression|2|||
124912420|NCT02723955|449307043|FG019|Expansion Phase|Death|0|||
124912421|NCT02723955|449307044|FG020|Expansion Phase|Death|0|||
124912422|NCT02723955|449307045|FG021|Expansion Phase|Death|0|||
124912423|NCT02723955|449307046|FG022|Expansion Phase|Death|0|||
124912424|NCT02723955|449307047|FG023|Expansion Phase|Death|0|||
124912425|NCT02723955|449307048|FG024|Expansion Phase|Death|0|||
124912426|NCT02723955|449307049|FG025|Expansion Phase|Death|0|||
124912427|NCT02723955|449307050|FG026|Expansion Phase|Death|0|||
124912428|NCT02723955|449307051|FG027|Expansion Phase|Death|0|||
124912429|NCT02723955|449307052|FG028|Expansion Phase|Death|0|||
124912430|NCT02723955|449307053|FG029|Expansion Phase|Death|12|||
124912431|NCT02723955|449307054|FG030|Expansion Phase|Death|202|||
124912432|NCT02723955|449307055|FG031|Expansion Phase|Death|31|||
124912433|NCT02723955|449307056|FG032|Expansion Phase|Death|17|||
124912434|NCT02723955|449307057|FG033|Expansion Phase|Death|2|||
125115775|NCT01724359|450046351|FG000|Overall Study|Death|1|||
124912435|NCT02723955|449307058|FG034|Expansion Phase|Death|3|||
124912436|NCT02723955|449307059|FG035|Expansion Phase|Death|3|||
124912437|NCT02723955|449307060|FG036|Expansion Phase|Death|1|||
124912438|NCT02723955|449307061|FG037|Expansion Phase|Death|0|||
124912439|NCT02723955|449307062|FG038|Expansion Phase|Death|0|||
124912440|NCT02723955|449307063|FG039|Expansion Phase|Death|0|||
124912441|NCT02723955|449307064|FG040|Expansion Phase|Death|0|||
124912442|NCT02723955|449307065|FG041|Expansion Phase|Death|0|||
124912443|NCT02723955|449307066|FG042|Expansion Phase|Death|0|||
124912444|NCT02723955|449307024|FG000|Expansion Phase|Lost to Follow-up|0|||
124912445|NCT02723955|449307025|FG001|Expansion Phase|Lost to Follow-up|0|||
124912446|NCT02723955|449307026|FG002|Expansion Phase|Lost to Follow-up|0|||
124912447|NCT02723955|449307027|FG003|Expansion Phase|Lost to Follow-up|0|||
124912448|NCT02723955|449307028|FG004|Expansion Phase|Lost to Follow-up|0|||
124912449|NCT02723955|449307029|FG005|Expansion Phase|Lost to Follow-up|0|||
124912450|NCT02723955|449307030|FG006|Expansion Phase|Lost to Follow-up|0|||
124912451|NCT02723955|449307031|FG007|Expansion Phase|Lost to Follow-up|0|||
124912452|NCT02723955|449307032|FG008|Expansion Phase|Lost to Follow-up|0|||
125022310|NCT00730639|449705412|FG001|Overall Study|Completed Maximum Cycles|0|||
125022311|NCT00730639|449705413|FG002|Overall Study|Completed Maximum Cycles|11|||
124912453|NCT02723955|449307033|FG009|Expansion Phase|Lost to Follow-up|0|||
124912454|NCT02723955|449307034|FG010|Expansion Phase|Lost to Follow-up|4|||
124912455|NCT02723955|449307035|FG011|Expansion Phase|Lost to Follow-up|1|||
125022312|NCT00730639|449705414|FG003|Overall Study|Completed Maximum Cycles|3|||
125022313|NCT00730639|449705415|FG004|Overall Study|Completed Maximum Cycles|6|||
125022314|NCT00730639|449705411|FG000|Overall Study|Death|0|||
125022315|NCT00730639|449705412|FG001|Overall Study|Death|0|||
125022316|NCT00730639|449705413|FG002|Overall Study|Death|0|||
125022317|NCT00730639|449705414|FG003|Overall Study|Death|0|||
125022318|NCT00730639|449705415|FG004|Overall Study|Death|2|||
125022319|NCT00730639|449705411|FG000|Overall Study|Disease Progression|12|||
125022320|NCT00730639|449705412|FG001|Overall Study|Disease Progression|13|||
125022321|NCT00730639|449705413|FG002|Overall Study|Disease Progression|48|||
125022322|NCT00730639|449705414|FG003|Overall Study|Disease Progression|32|||
125022323|NCT00730639|449705415|FG004|Overall Study|Disease Progression|88|||
125022324|NCT00730639|449705411|FG000|Overall Study|non-specified|0|||
125022325|NCT00730639|449705412|FG001|Overall Study|non-specified|0|||
125022326|NCT00730639|449705413|FG002|Overall Study|non-specified|4|||
125022327|NCT00730639|449705414|FG003|Overall Study|non-specified|2|||
125022328|NCT00730639|449705415|FG004|Overall Study|non-specified|3|||
125022329|NCT00730639|449705411|FG000|Overall Study|Protocol Violation|0|||
125022330|NCT00730639|449705412|FG001|Overall Study|Protocol Violation|0|||
125022331|NCT00730639|449705413|FG002|Overall Study|Protocol Violation|1|||
125022332|NCT00730639|449705414|FG003|Overall Study|Protocol Violation|0|||
125022333|NCT00730639|449705415|FG004|Overall Study|Protocol Violation|0|||
124912456|NCT02723955|449307036|FG012|Expansion Phase|Lost to Follow-up|0|||
124912457|NCT02723955|449307037|FG013|Expansion Phase|Lost to Follow-up|0|||
124912458|NCT02723955|449307038|FG014|Expansion Phase|Lost to Follow-up|0|||
125022334|NCT00730639|449705411|FG000|Overall Study|Withdrawal by Subject|0|||
125022335|NCT00730639|449705412|FG001|Overall Study|Withdrawal by Subject|0|||
125115776|NCT01724359|450046351|FG000|Overall Study|Other|20|||
124912459|NCT02723955|449307039|FG015|Expansion Phase|Lost to Follow-up|0|||
124912460|NCT02723955|449307040|FG016|Expansion Phase|Lost to Follow-up|0|||
124912461|NCT02723955|449307041|FG017|Expansion Phase|Lost to Follow-up|0|||
124912462|NCT02723955|449307042|FG018|Expansion Phase|Lost to Follow-up|0|||
124912463|NCT02723955|449307043|FG019|Expansion Phase|Lost to Follow-up|0|||
124912464|NCT02723955|449307044|FG020|Expansion Phase|Lost to Follow-up|0|||
124912465|NCT02723955|449307045|FG021|Expansion Phase|Lost to Follow-up|0|||
124912466|NCT02723955|449307046|FG022|Expansion Phase|Lost to Follow-up|0|||
124912467|NCT02723955|449307047|FG023|Expansion Phase|Lost to Follow-up|0|||
124912468|NCT02723955|449307048|FG024|Expansion Phase|Lost to Follow-up|0|||
124912469|NCT02723955|449307049|FG025|Expansion Phase|Lost to Follow-up|0|||
124912470|NCT02723955|449307050|FG026|Expansion Phase|Lost to Follow-up|0|||
124912471|NCT02723955|449307051|FG027|Expansion Phase|Lost to Follow-up|0|||
124912472|NCT02723955|449307052|FG028|Expansion Phase|Lost to Follow-up|0|||
124912473|NCT02723955|449307053|FG029|Expansion Phase|Lost to Follow-up|1|||
124912474|NCT02723955|449307054|FG030|Expansion Phase|Lost to Follow-up|19|||
124912475|NCT02723955|449307055|FG031|Expansion Phase|Lost to Follow-up|2|||
124912476|NCT02723955|449307056|FG032|Expansion Phase|Lost to Follow-up|1|||
124912477|NCT02723955|449307057|FG033|Expansion Phase|Lost to Follow-up|0|||
124912478|NCT02723955|449307058|FG034|Expansion Phase|Lost to Follow-up|0|||
124912479|NCT02723955|449307059|FG035|Expansion Phase|Lost to Follow-up|0|||
124912480|NCT02723955|449307060|FG036|Expansion Phase|Lost to Follow-up|0|||
124912481|NCT02723955|449307061|FG037|Expansion Phase|Lost to Follow-up|0|||
124912482|NCT02723955|449307062|FG038|Expansion Phase|Lost to Follow-up|0|||
124912483|NCT02723955|449307063|FG039|Expansion Phase|Lost to Follow-up|0|||
124912484|NCT02723955|449307064|FG040|Expansion Phase|Lost to Follow-up|0|||
124912485|NCT02723955|449307065|FG041|Expansion Phase|Lost to Follow-up|0|||
124912486|NCT02723955|449307066|FG042|Expansion Phase|Lost to Follow-up|0|||
124912487|NCT02723955|449307024|FG000|Expansion Phase|Physician Decision|0|||
124912488|NCT02723955|449307025|FG001|Expansion Phase|Physician Decision|0|||
124912489|NCT02723955|449307026|FG002|Expansion Phase|Physician Decision|0|||
124912490|NCT02723955|449307027|FG003|Expansion Phase|Physician Decision|0|||
124912491|NCT02723955|449307028|FG004|Expansion Phase|Physician Decision|0|||
124912492|NCT02723955|449307029|FG005|Expansion Phase|Physician Decision|0|||
124912493|NCT02723955|449307030|FG006|Expansion Phase|Physician Decision|0|||
124912494|NCT02723955|449307031|FG007|Expansion Phase|Physician Decision|0|||
124912495|NCT02723955|449307032|FG008|Expansion Phase|Physician Decision|0|||
124912496|NCT02723955|449307033|FG009|Expansion Phase|Physician Decision|0|||
124912497|NCT02723955|449307034|FG010|Expansion Phase|Physician Decision|0|||
124912498|NCT02723955|449307035|FG011|Expansion Phase|Physician Decision|0|||
124912499|NCT02723955|449307036|FG012|Expansion Phase|Physician Decision|0|||
124912500|NCT02723955|449307037|FG013|Expansion Phase|Physician Decision|0|||
124912501|NCT02723955|449307038|FG014|Expansion Phase|Physician Decision|0|||
124912502|NCT02723955|449307039|FG015|Expansion Phase|Physician Decision|0|||
124912503|NCT02723955|449307040|FG016|Expansion Phase|Physician Decision|0|||
124912504|NCT02723955|449307041|FG017|Expansion Phase|Physician Decision|0|||
124912505|NCT02723955|449307042|FG018|Expansion Phase|Physician Decision|0|||
124912506|NCT02723955|449307043|FG019|Expansion Phase|Physician Decision|0|||
125022336|NCT00730639|449705413|FG002|Overall Study|Withdrawal by Subject|6|||
124912507|NCT02723955|449307044|FG020|Expansion Phase|Physician Decision|0|||
124912508|NCT02723955|449307045|FG021|Expansion Phase|Physician Decision|0|||
124912509|NCT02723955|449307046|FG022|Expansion Phase|Physician Decision|0|||
124912510|NCT02723955|449307047|FG023|Expansion Phase|Physician Decision|0|||
124912511|NCT02723955|449307048|FG024|Expansion Phase|Physician Decision|0|||
124912512|NCT02723955|449307049|FG025|Expansion Phase|Physician Decision|0|||
124912513|NCT02723955|449307050|FG026|Expansion Phase|Physician Decision|0|||
125022337|NCT00730639|449705414|FG003|Overall Study|Withdrawal by Subject|3|||
125211636|NCT01038752|450399749|FG001|Overall Study|Tumor Progression|2|||
125022338|NCT00730639|449705415|FG004|Overall Study|Withdrawal by Subject|4|||
125022339|NCT00730639|449705411|FG000|Overall Study|Treatment on-going|2|||
125022340|NCT00730639|449705412|FG001|Overall Study|Treatment on-going|5|||
125022341|NCT00730639|449705413|FG002|Overall Study|Treatment on-going|5|||
125022342|NCT00730639|449705414|FG003|Overall Study|Treatment on-going|4|||
125022343|NCT00730639|449705415|FG004|Overall Study|Treatment on-going|4|||
125022344|NCT02665286|449705416|FG000|Overall Study|Lost to Follow-up|3|||
125022345|NCT02665286|449705417|FG001|Overall Study|Lost to Follow-up|2|||
124912514|NCT02723955|449307051|FG027|Expansion Phase|Physician Decision|0|||
124912515|NCT02723955|449307052|FG028|Expansion Phase|Physician Decision|0|||
124912516|NCT02723955|449307053|FG029|Expansion Phase|Physician Decision|0|||
124912517|NCT02723955|449307054|FG030|Expansion Phase|Physician Decision|1|||
124912518|NCT02723955|449307055|FG031|Expansion Phase|Physician Decision|1|||
124912519|NCT02723955|449307056|FG032|Expansion Phase|Physician Decision|0|||
124912520|NCT02723955|449307057|FG033|Expansion Phase|Physician Decision|0|||
124912521|NCT02723955|449307058|FG034|Expansion Phase|Physician Decision|0|||
124912522|NCT02723955|449307059|FG035|Expansion Phase|Physician Decision|0|||
124912523|NCT02723955|449307060|FG036|Expansion Phase|Physician Decision|0|||
124912524|NCT02723955|449307061|FG037|Expansion Phase|Physician Decision|0|||
124912525|NCT02723955|449307062|FG038|Expansion Phase|Physician Decision|0|||
124912526|NCT02723955|449307063|FG039|Expansion Phase|Physician Decision|0|||
124912527|NCT02723955|449307064|FG040|Expansion Phase|Physician Decision|0|||
124912528|NCT02723955|449307065|FG041|Expansion Phase|Physician Decision|0|||
124912529|NCT02723955|449307066|FG042|Expansion Phase|Physician Decision|0|||
124912530|NCT02723955|449307024|FG000|Expansion Phase|Withdrawal by Subject|0|||
124912531|NCT02723955|449307025|FG001|Expansion Phase|Withdrawal by Subject|0|||
124912532|NCT02723955|449307026|FG002|Expansion Phase|Withdrawal by Subject|0|||
124912533|NCT02723955|449307027|FG003|Expansion Phase|Withdrawal by Subject|0|||
124912534|NCT02723955|449307028|FG004|Expansion Phase|Withdrawal by Subject|0|||
124912535|NCT02723955|449307029|FG005|Expansion Phase|Withdrawal by Subject|0|||
124912536|NCT02723955|449307030|FG006|Expansion Phase|Withdrawal by Subject|0|||
124912537|NCT02723955|449307031|FG007|Expansion Phase|Withdrawal by Subject|0|||
125211637|NCT01038752|450399748|FG000|Overall Study|Lost to Follow-up|3|||
125211638|NCT01038752|450399749|FG001|Overall Study|Lost to Follow-up|3|||
125211639|NCT00530790|450399750|FG000|Overall Study|Adverse Event|2|||
125211640|NCT00530790|450399750|FG000|Overall Study|Withdrawal by Subject|2|||
125211641|NCT00530790|450399750|FG000|Overall Study|Physician Decision|1|||
125211642|NCT02005627|450399753|FG000|Overall Study|Lost to Follow-up|1|||
125211643|NCT02005627|450399754|FG001|Overall Study|Lost to Follow-up|2|||
125211644|NCT02005627|450399753|FG000|Overall Study|Withdrawal by Subject|1|||
125211645|NCT02005627|450399754|FG001|Overall Study|Withdrawal by Subject|2|||
125211646|NCT01693185|450399757|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
125211647|NCT01693185|450399758|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
125211648|NCT01084538|450399759|FG000|Overall Study|Drug not available|30|||
125211649|NCT01084538|450399759|FG000|Overall Study|Adverse Event|9|||
125211650|NCT01084538|450399759|FG000|Overall Study|Kidney transplant|6|||
125211651|NCT01084538|450399759|FG000|Overall Study|Serious Adverse Event|3|||
125211652|NCT01084538|450399759|FG000|Overall Study|Lack of effectiveness|2|||
125211653|NCT01084538|450399759|FG000|Overall Study|Patient noncompliance|2|||
125211654|NCT01084538|450399759|FG000|Overall Study|Hyperphosphatemia|2|||
125211655|NCT01084538|450399759|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
125211656|NCT01084538|450399759|FG000|Overall Study|Change of residence|2|||
125211657|NCT01084538|450399759|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
125211658|NCT01084538|450399759|FG000|Overall Study|Reason unknown|8|||
125211659|NCT02279745|450399760|FG000|Overall Study|Adverse Event|7|||
125211660|NCT02279745|450399760|FG000|Overall Study|Death|6|||
125211661|NCT02279745|450399760|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
125211662|NCT02279745|450399760|FG000|Overall Study|Withdrawal by Subject|2|||
125211663|NCT02279745|450399760|FG000|Overall Study|Pregnancy|1|||
124912538|NCT02723955|449307032|FG008|Expansion Phase|Withdrawal by Subject|0|||
124912539|NCT02723955|449307033|FG009|Expansion Phase|Withdrawal by Subject|2|||
124912540|NCT02723955|449307034|FG010|Expansion Phase|Withdrawal by Subject|1|||
125022346|NCT02665286|449705418|FG002|Overall Study|Lost to Follow-up|1|||
125211664|NCT02279745|450399760|FG000|Overall Study|Study Non-compliance|1|||
125211665|NCT02279745|450399760|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
125211666|NCT01606748|450399765|FG000|Overall Study|Adverse Event|1|||
125211667|NCT01606748|450399766|FG001|Overall Study|Adverse Event|0|||
124912541|NCT02723955|449307035|FG011|Expansion Phase|Withdrawal by Subject|0|||
124912542|NCT02723955|449307036|FG012|Expansion Phase|Withdrawal by Subject|0|||
124912543|NCT02723955|449307037|FG013|Expansion Phase|Withdrawal by Subject|0|||
124912544|NCT02723955|449307038|FG014|Expansion Phase|Withdrawal by Subject|0|||
124912545|NCT02723955|449307039|FG015|Expansion Phase|Withdrawal by Subject|0|||
124912546|NCT02723955|449307040|FG016|Expansion Phase|Withdrawal by Subject|0|||
124912547|NCT02723955|449307041|FG017|Expansion Phase|Withdrawal by Subject|0|||
125211668|NCT01606748|450399765|FG000|Overall Study|Progressive Disease|1|||
125211669|NCT01606748|450399766|FG001|Overall Study|Progressive Disease|0|||
124912548|NCT02723955|449307042|FG018|Expansion Phase|Withdrawal by Subject|0|||
124912549|NCT02723955|449307043|FG019|Expansion Phase|Withdrawal by Subject|0|||
124912550|NCT02723955|449307044|FG020|Expansion Phase|Withdrawal by Subject|0|||
124912551|NCT02723955|449307045|FG021|Expansion Phase|Withdrawal by Subject|0|||
124912552|NCT02723955|449307046|FG022|Expansion Phase|Withdrawal by Subject|0|||
124912553|NCT02723955|449307047|FG023|Expansion Phase|Withdrawal by Subject|0|||
124912554|NCT02723955|449307048|FG024|Expansion Phase|Withdrawal by Subject|0|||
124912555|NCT02723955|449307049|FG025|Expansion Phase|Withdrawal by Subject|0|||
124912556|NCT02723955|449307050|FG026|Expansion Phase|Withdrawal by Subject|0|||
124912557|NCT02723955|449307051|FG027|Expansion Phase|Withdrawal by Subject|0|||
124912558|NCT02723955|449307052|FG028|Expansion Phase|Withdrawal by Subject|0|||
124912559|NCT02723955|449307053|FG029|Expansion Phase|Withdrawal by Subject|0|||
124912560|NCT02723955|449307054|FG030|Expansion Phase|Withdrawal by Subject|8|||
124912561|NCT02723955|449307055|FG031|Expansion Phase|Withdrawal by Subject|4|||
124912562|NCT02723955|449307056|FG032|Expansion Phase|Withdrawal by Subject|0|||
124912563|NCT02723955|449307057|FG033|Expansion Phase|Withdrawal by Subject|0|||
124912564|NCT02723955|449307058|FG034|Expansion Phase|Withdrawal by Subject|0|||
124912565|NCT02723955|449307059|FG035|Expansion Phase|Withdrawal by Subject|1|||
124912566|NCT02723955|449307060|FG036|Expansion Phase|Withdrawal by Subject|0|||
124912567|NCT02723955|449307061|FG037|Expansion Phase|Withdrawal by Subject|0|||
124912568|NCT02723955|449307062|FG038|Expansion Phase|Withdrawal by Subject|0|||
124912569|NCT02723955|449307063|FG039|Expansion Phase|Withdrawal by Subject|0|||
124912570|NCT02723955|449307064|FG040|Expansion Phase|Withdrawal by Subject|0|||
124912571|NCT02723955|449307065|FG041|Expansion Phase|Withdrawal by Subject|0|||
124912572|NCT02723955|449307066|FG042|Expansion Phase|Withdrawal by Subject|0|||
124912573|NCT02723955|449307024|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912574|NCT02723955|449307025|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912575|NCT02723955|449307026|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912576|NCT02723955|449307027|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912577|NCT02723955|449307028|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912578|NCT02723955|449307029|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912579|NCT02723955|449307030|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912580|NCT02723955|449307031|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912581|NCT02723955|449307032|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912582|NCT02723955|449307033|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
124912583|NCT02723955|449307034|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
124912584|NCT02723955|449307035|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
124912585|NCT02723955|449307036|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912586|NCT02723955|449307037|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912587|NCT02723955|449307038|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912588|NCT02723955|449307039|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912589|NCT02723955|449307040|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912590|NCT02723955|449307041|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912591|NCT02723955|449307042|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912592|NCT02723955|449307043|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912593|NCT02723955|449307044|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912594|NCT02723955|449307045|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912595|NCT02723955|449307046|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912596|NCT02723955|449307047|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912597|NCT02723955|449307048|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912598|NCT02723955|449307049|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912599|NCT02723955|449307050|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912600|NCT02723955|449307051|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912601|NCT02723955|449307052|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912602|NCT02723955|449307053|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912603|NCT02723955|449307054|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
124912604|NCT02723955|449307055|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912605|NCT02723955|449307056|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912606|NCT02723955|449307057|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912607|NCT02723955|449307058|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125211670|NCT01606748|450399765|FG000|Overall Study|Withdrawal by Subject|1|||
125211671|NCT01606748|450399766|FG001|Overall Study|Withdrawal by Subject|0|||
125211672|NCT03084315|450399768|FG000|Overall Study|Lost to Follow-up|8|||
125211673|NCT03084315|450399769|FG001|Overall Study|Lost to Follow-up|7|||
125211674|NCT03084315|450399768|FG000|Overall Study|Withdrawal by Subject|2|||
124912608|NCT02723955|449307059|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912609|NCT02723955|449307060|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912610|NCT02723955|449307061|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912611|NCT02723955|449307062|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912612|NCT02723955|449307063|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912613|NCT02723955|449307064|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912614|NCT02723955|449307065|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912615|NCT02723955|449307066|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912616|NCT02723955|449307024|FG000|Expansion Phase|Site Closed|0|||
124912617|NCT02723955|449307025|FG001|Expansion Phase|Site Closed|0|||
124912618|NCT02723955|449307026|FG002|Expansion Phase|Site Closed|0|||
124912619|NCT02723955|449307027|FG003|Expansion Phase|Site Closed|0|||
124912620|NCT02723955|449307028|FG004|Expansion Phase|Site Closed|0|||
124912621|NCT02723955|449307029|FG005|Expansion Phase|Site Closed|0|||
124912622|NCT02723955|449307030|FG006|Expansion Phase|Site Closed|0|||
124912623|NCT02723955|449307031|FG007|Expansion Phase|Site Closed|0|||
124912624|NCT02723955|449307032|FG008|Expansion Phase|Site Closed|0|||
124912625|NCT02723955|449307033|FG009|Expansion Phase|Site Closed|1|||
124912626|NCT02723955|449307034|FG010|Expansion Phase|Site Closed|2|||
124912627|NCT02723955|449307035|FG011|Expansion Phase|Site Closed|6|||
125211675|NCT03084315|450399769|FG001|Overall Study|Withdrawal by Subject|2|||
124912628|NCT02723955|449307036|FG012|Expansion Phase|Site Closed|0|||
124912629|NCT02723955|449307037|FG013|Expansion Phase|Site Closed|0|||
124912630|NCT02723955|449307038|FG014|Expansion Phase|Site Closed|0|||
125211676|NCT01952080|450399770|FG000|Overall Study|Withdrawal by Subject|0|||
125211677|NCT01952080|450399771|FG001|Overall Study|Withdrawal by Subject|0|||
125211678|NCT01952080|450399772|FG002|Overall Study|Withdrawal by Subject|0|||
125211679|NCT01952080|450399773|FG003|Overall Study|Withdrawal by Subject|1|||
124912631|NCT02723955|449307039|FG015|Expansion Phase|Site Closed|0|||
124912632|NCT02723955|449307040|FG016|Expansion Phase|Site Closed|0|||
124912633|NCT02723955|449307041|FG017|Expansion Phase|Site Closed|0|||
124912634|NCT02723955|449307042|FG018|Expansion Phase|Site Closed|0|||
124912635|NCT02723955|449307043|FG019|Expansion Phase|Site Closed|0|||
124912636|NCT02723955|449307044|FG020|Expansion Phase|Site Closed|0|||
124912637|NCT02723955|449307045|FG021|Expansion Phase|Site Closed|0|||
124912638|NCT02723955|449307046|FG022|Expansion Phase|Site Closed|0|||
124912639|NCT02723955|449307047|FG023|Expansion Phase|Site Closed|0|||
124912640|NCT02723955|449307048|FG024|Expansion Phase|Site Closed|0|||
124912641|NCT02723955|449307049|FG025|Expansion Phase|Site Closed|0|||
124912642|NCT02723955|449307050|FG026|Expansion Phase|Site Closed|0|||
124912643|NCT02723955|449307051|FG027|Expansion Phase|Site Closed|0|||
124912644|NCT02723955|449307052|FG028|Expansion Phase|Site Closed|0|||
124912645|NCT02723955|449307053|FG029|Expansion Phase|Site Closed|0|||
124912646|NCT02723955|449307054|FG030|Expansion Phase|Site Closed|8|||
124912647|NCT02723955|449307055|FG031|Expansion Phase|Site Closed|4|||
124912648|NCT02723955|449307056|FG032|Expansion Phase|Site Closed|2|||
124912649|NCT02723955|449307057|FG033|Expansion Phase|Site Closed|2|||
124912650|NCT02723955|449307058|FG034|Expansion Phase|Site Closed|0|||
125022347|NCT03064841|449705424|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
124912651|NCT02723955|449307059|FG035|Expansion Phase|Site Closed|0|||
124912652|NCT02723955|449307060|FG036|Expansion Phase|Site Closed|0|||
124912653|NCT02723955|449307061|FG037|Expansion Phase|Site Closed|0|||
124912654|NCT02723955|449307062|FG038|Expansion Phase|Site Closed|0|||
124912655|NCT02723955|449307063|FG039|Expansion Phase|Site Closed|0|||
124912656|NCT02723955|449307064|FG040|Expansion Phase|Site Closed|0|||
124912657|NCT02723955|449307065|FG041|Expansion Phase|Site Closed|0|||
124912658|NCT02723955|449307066|FG042|Expansion Phase|Site Closed|0|||
124912659|NCT02723955|449307024|FG000|Crossover/ Re-treatment Phase|Death|0|||
124912660|NCT02723955|449307025|FG001|Crossover/ Re-treatment Phase|Death|0|||
124912661|NCT02723955|449307026|FG002|Crossover/ Re-treatment Phase|Death|0|||
124912662|NCT02723955|449307027|FG003|Crossover/ Re-treatment Phase|Death|0|||
124912663|NCT02723955|449307028|FG004|Crossover/ Re-treatment Phase|Death|0|||
124912664|NCT02723955|449307029|FG005|Crossover/ Re-treatment Phase|Death|0|||
124912665|NCT02723955|449307030|FG006|Crossover/ Re-treatment Phase|Death|0|||
124912666|NCT02723955|449307031|FG007|Crossover/ Re-treatment Phase|Death|0|||
124912667|NCT02723955|449307032|FG008|Crossover/ Re-treatment Phase|Death|0|||
124912668|NCT02723955|449307033|FG009|Crossover/ Re-treatment Phase|Death|0|||
124912669|NCT02723955|449307034|FG010|Crossover/ Re-treatment Phase|Death|0|||
124912670|NCT02723955|449307035|FG011|Crossover/ Re-treatment Phase|Death|0|||
124912671|NCT02723955|449307036|FG012|Crossover/ Re-treatment Phase|Death|0|||
124912672|NCT02723955|449307037|FG013|Crossover/ Re-treatment Phase|Death|0|||
124912673|NCT02723955|449307038|FG014|Crossover/ Re-treatment Phase|Death|0|||
124912674|NCT02723955|449307039|FG015|Crossover/ Re-treatment Phase|Death|0|||
125022348|NCT03064841|449705424|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
125022349|NCT03064841|449705424|FG000|Overall Study|Screen failure|2|||
124912675|NCT02723955|449307040|FG016|Crossover/ Re-treatment Phase|Death|0|||
124912676|NCT02723955|449307041|FG017|Crossover/ Re-treatment Phase|Death|0|||
124912677|NCT02723955|449307042|FG018|Crossover/ Re-treatment Phase|Death|0|||
124912678|NCT02723955|449307043|FG019|Crossover/ Re-treatment Phase|Death|0|||
124912679|NCT02723955|449307044|FG020|Crossover/ Re-treatment Phase|Death|0|||
124912680|NCT02723955|449307045|FG021|Crossover/ Re-treatment Phase|Death|0|||
124912681|NCT02723955|449307046|FG022|Crossover/ Re-treatment Phase|Death|0|||
124912682|NCT02723955|449307047|FG023|Crossover/ Re-treatment Phase|Death|0|||
124912683|NCT02723955|449307048|FG024|Crossover/ Re-treatment Phase|Death|0|||
124912684|NCT02723955|449307049|FG025|Crossover/ Re-treatment Phase|Death|0|||
124912685|NCT02723955|449307050|FG026|Crossover/ Re-treatment Phase|Death|0|||
124912686|NCT02723955|449307051|FG027|Crossover/ Re-treatment Phase|Death|0|||
124912687|NCT02723955|449307052|FG028|Crossover/ Re-treatment Phase|Death|0|||
124912688|NCT02723955|449307053|FG029|Crossover/ Re-treatment Phase|Death|0|||
124912689|NCT02723955|449307054|FG030|Crossover/ Re-treatment Phase|Death|0|||
124912690|NCT02723955|449307055|FG031|Crossover/ Re-treatment Phase|Death|0|||
124912691|NCT02723955|449307056|FG032|Crossover/ Re-treatment Phase|Death|0|||
124912692|NCT02723955|449307057|FG033|Crossover/ Re-treatment Phase|Death|0|||
124912693|NCT02723955|449307058|FG034|Crossover/ Re-treatment Phase|Death|0|||
124912694|NCT02723955|449307059|FG035|Crossover/ Re-treatment Phase|Death|0|||
124912695|NCT02723955|449307060|FG036|Crossover/ Re-treatment Phase|Death|0|||
124912696|NCT02723955|449307061|FG037|Crossover/ Re-treatment Phase|Death|1|||
124912697|NCT02723955|449307062|FG038|Crossover/ Re-treatment Phase|Death|14|||
124912698|NCT02723955|449307063|FG039|Crossover/ Re-treatment Phase|Death|32|||
124912699|NCT02723955|449307064|FG040|Crossover/ Re-treatment Phase|Death|2|||
124912700|NCT02723955|449307065|FG041|Crossover/ Re-treatment Phase|Death|1|||
124912701|NCT02723955|449307066|FG042|Crossover/ Re-treatment Phase|Death|0|||
124912702|NCT02723955|449307024|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912703|NCT02723955|449307025|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912704|NCT02723955|449307026|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912705|NCT02723955|449307027|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912706|NCT02723955|449307028|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912707|NCT02723955|449307029|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912708|NCT02723955|449307030|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912709|NCT02723955|449307031|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912710|NCT02723955|449307032|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912711|NCT02723955|449307033|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912712|NCT02723955|449307034|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912713|NCT02723955|449307035|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912714|NCT02723955|449307036|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912715|NCT02723955|449307037|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912716|NCT02723955|449307038|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912717|NCT02723955|449307039|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912718|NCT02723955|449307040|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912719|NCT02723955|449307041|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912720|NCT02723955|449307042|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912721|NCT02723955|449307043|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912722|NCT02723955|449307044|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912723|NCT02723955|449307045|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912724|NCT02723955|449307046|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912725|NCT02723955|449307047|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912726|NCT02723955|449307048|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912727|NCT02723955|449307049|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912728|NCT02723955|449307050|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912729|NCT02723955|449307051|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912730|NCT02723955|449307052|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912731|NCT02723955|449307053|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125022350|NCT03434977|449705425|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
124912732|NCT02723955|449307054|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912733|NCT02723955|449307055|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912734|NCT02723955|449307056|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912735|NCT02723955|449307057|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912736|NCT02723955|449307058|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912737|NCT02723955|449307059|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912738|NCT02723955|449307060|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912739|NCT02723955|449307061|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912740|NCT02723955|449307062|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912741|NCT02723955|449307063|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
124912742|NCT02723955|449307064|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912743|NCT02723955|449307065|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912744|NCT02723955|449307066|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912745|NCT02723955|449307024|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912746|NCT02723955|449307025|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912747|NCT02723955|449307026|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912748|NCT02723955|449307027|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912749|NCT02723955|449307028|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912750|NCT02723955|449307029|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912751|NCT02723955|449307030|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912752|NCT02723955|449307031|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912753|NCT02723955|449307032|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912754|NCT02723955|449307033|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912755|NCT02723955|449307034|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912756|NCT02723955|449307035|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912757|NCT02723955|449307036|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912758|NCT02723955|449307037|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912759|NCT02723955|449307038|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912760|NCT02723955|449307039|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912761|NCT02723955|449307040|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912762|NCT02723955|449307041|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912763|NCT02723955|449307042|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912764|NCT02723955|449307043|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912765|NCT02723955|449307044|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912766|NCT02723955|449307045|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912767|NCT02723955|449307046|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912768|NCT02723955|449307047|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912769|NCT02723955|449307048|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912770|NCT02723955|449307049|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912771|NCT02723955|449307050|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912772|NCT02723955|449307051|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912773|NCT02723955|449307052|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912774|NCT02723955|449307053|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912775|NCT02723955|449307054|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912776|NCT02723955|449307055|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912777|NCT02723955|449307056|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912778|NCT02723955|449307057|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912779|NCT02723955|449307058|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912780|NCT02723955|449307059|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912781|NCT02723955|449307060|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912782|NCT02723955|449307061|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912783|NCT02723955|449307062|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
124912784|NCT02723955|449307063|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
124912785|NCT02723955|449307064|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912786|NCT02723955|449307065|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912787|NCT02723955|449307066|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
124912788|NCT02723955|449307024|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
124912789|NCT02723955|449307025|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
124912790|NCT02723955|449307026|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
124912791|NCT02723955|449307027|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
124912792|NCT02723955|449307028|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
124912793|NCT02723955|449307029|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
124912794|NCT02723955|449307030|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
124912795|NCT02723955|449307031|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
124912796|NCT02723955|449307032|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
124912797|NCT02723955|449307033|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
124912798|NCT02723955|449307034|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
124912799|NCT02723955|449307035|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
124912800|NCT02723955|449307036|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
124912801|NCT02723955|449307037|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
124912802|NCT02723955|449307038|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
124912803|NCT02723955|449307039|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
124912804|NCT02723955|449307040|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
124912805|NCT02723955|449307041|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
124912806|NCT02723955|449307042|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
124912807|NCT02723955|449307043|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
124912808|NCT02723955|449307044|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
124912809|NCT02723955|449307045|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
124912810|NCT02723955|449307046|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
124912811|NCT02723955|449307047|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
124912812|NCT02723955|449307048|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
124912813|NCT02723955|449307049|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
124912814|NCT02723955|449307050|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
124912815|NCT02723955|449307051|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
124912816|NCT02723955|449307052|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
124912817|NCT02723955|449307053|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
124912818|NCT02723955|449307054|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
124912819|NCT02723955|449307055|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
124912820|NCT02723955|449307056|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
124912821|NCT02723955|449307057|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
124912822|NCT02723955|449307058|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
124912823|NCT02723955|449307059|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
124912824|NCT02723955|449307060|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
124912825|NCT02723955|449307061|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
124912826|NCT02723955|449307062|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
124912827|NCT02723955|449307063|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
124912828|NCT02723955|449307064|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
124912829|NCT02723955|449307065|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
124912830|NCT02723955|449307066|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
124912831|NCT04300647|449307067|FG000|Pre-Crossover|Death|19|||
124912832|NCT04300647|449307068|FG001|Pre-Crossover|Death|58|||
124912833|NCT04300647|449307069|FG002|Pre-Crossover|Death|0|||
124912834|NCT04300647|449307067|FG000|Pre-Crossover|Lost to Follow-up|0|||
124912835|NCT04300647|449307068|FG001|Pre-Crossover|Lost to Follow-up|3|||
124912836|NCT04300647|449307069|FG002|Pre-Crossover|Lost to Follow-up|0|||
124912837|NCT04300647|449307067|FG000|Pre-Crossover|Withdrawal by Subject|2|||
124912838|NCT04300647|449307068|FG001|Pre-Crossover|Withdrawal by Subject|4|||
124912839|NCT04300647|449307069|FG002|Pre-Crossover|Withdrawal by Subject|0|||
124912840|NCT04300647|449307067|FG000|Pre-Crossover|On-going in Study|24|||
124912841|NCT04300647|449307068|FG001|Pre-Crossover|On-going in Study|61|||
124912842|NCT04300647|449307069|FG002|Pre-Crossover|On-going in Study|0|||
125211680|NCT01952080|450399770|FG000|Overall Study|Protocol Non-compliance|0|||
124912843|NCT04300647|449307067|FG000|Post-Crossover|Death|0|||
124912844|NCT04300647|449307068|FG001|Post-Crossover|Death|0|||
124912845|NCT04300647|449307069|FG002|Post-Crossover|Death|3|||
124912846|NCT04300647|449307067|FG000|Post-Crossover|Lost to Follow-up|0|||
124912847|NCT04300647|449307068|FG001|Post-Crossover|Lost to Follow-up|0|||
124912848|NCT04300647|449307069|FG002|Post-Crossover|Lost to Follow-up|1|||
124912849|NCT04300647|449307067|FG000|Post-Crossover|Withdrawal by Subject|0|||
124912850|NCT04300647|449307068|FG001|Post-Crossover|Withdrawal by Subject|0|||
124912851|NCT04300647|449307069|FG002|Post-Crossover|Withdrawal by Subject|1|||
124912852|NCT04300647|449307067|FG000|Post-Crossover|On-going in Study|0|||
124912853|NCT04300647|449307068|FG001|Post-Crossover|On-going in Study|0|||
124912854|NCT04300647|449307069|FG002|Post-Crossover|On-going in Study|8|||
124912855|NCT02824029|449307072|FG000|Overall Study|Didn't receive treatment|2|||
124912856|NCT02824029|449307072|FG000|Overall Study|Patient decision to discontinue treatment|3|||
124912857|NCT02824029|449307072|FG000|Overall Study|Non-compliant|5|||
124912858|NCT02824029|449307072|FG000|Overall Study|Progression of disease|15|||
124912859|NCT02824029|449307072|FG000|Overall Study|Inadequate response to therapy|2|||
124912860|NCT02824029|449307072|FG000|Overall Study|Possible progression per treating physician|1|||
124912861|NCT01693120|449307077|FG000|Enrollment|Lost to Follow-up|1|||
124912862|NCT01693120|449307077|FG000|Enrollment|Withdrawal by Subject|10|||
124912863|NCT01693120|449307077|FG000|Enrollment|Protocol Violation|46|||
124912864|NCT01693120|449307077|FG000|Enrollment|Physician Decision|3|||
124912865|NCT01693120|449307077|FG000|Enrollment|Adverse Event|1|||
124912866|NCT01693120|449307077|FG000|Enrollment|Study closed|8|||
124912867|NCT01693120|449307077|FG000|Enrollment|Other|1|||
124912868|NCT01693120|449307077|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
124912869|NCT01693120|449307077|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
124912870|NCT01693120|449307077|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
124912871|NCT01693120|449307077|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
124912872|NCT01693120|449307077|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
124912873|NCT04153565|449307078|FG000|Overall Study|Death|13|||
124912874|NCT03990649|449307092|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
124912875|NCT03990649|449307093|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
124912876|NCT03990649|449307094|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
124912877|NCT03990649|449307092|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
124912878|NCT03990649|449307093|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
124912879|NCT03990649|449307094|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
124912880|NCT03990649|449307092|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
124912881|NCT03990649|449307093|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
124912882|NCT03990649|449307094|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
124912883|NCT03990649|449307092|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
124912884|NCT03990649|449307093|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
124912885|NCT03990649|449307094|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
124912886|NCT03990649|449307092|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
124912887|NCT03990649|449307093|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
124912888|NCT03990649|449307094|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
124912889|NCT03990649|449307092|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
124912890|NCT03990649|449307093|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
124912891|NCT03990649|449307094|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
125022351|NCT03434977|449705426|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
125022352|NCT00217087|449705427|FG000|Overall Study|decided to have esophagectomy|1|||
125022353|NCT00217087|449705428|FG001|Overall Study|decided to have esophagectomy|2|||
125022354|NCT00217087|449705427|FG000|Overall Study|completed less than 12 months return|10|||
125022355|NCT00217087|449705428|FG001|Overall Study|completed less than 12 months return|18|||
125022356|NCT03920670|449705429|FG000|Overall Study|Protocol Violation|2|||
125022357|NCT03920670|449705430|FG001|Overall Study|Protocol Violation|2|||
125022358|NCT03920670|449705429|FG000|Overall Study|Adverse Event|1|||
125022359|NCT03920670|449705430|FG001|Overall Study|Adverse Event|0|||
125022360|NCT05574062|449705431|FG000|Pre Run-In|Screening failure|3|||
125022361|NCT05574062|449705432|FG001|Pre Run-In|Screening failure|0|||
125022362|NCT05574062|449705433|FG002|Pre Run-In|Screening failure|0|||
125022363|NCT05574062|449705434|FG003|Pre Run-In|Screening failure|0|||
125022364|NCT05574062|449705435|FG004|Pre Run-In|Screening failure|0|||
125022365|NCT05574062|449705431|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
125022366|NCT05574062|449705432|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
125022367|NCT05574062|449705433|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
125022368|NCT05574062|449705434|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
125022369|NCT05574062|449705435|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
125022370|NCT05574062|449705431|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
125022371|NCT05574062|449705432|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
125022372|NCT05574062|449705433|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
125022373|NCT05574062|449705434|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
124912892|NCT03990649|449307092|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
124912893|NCT03990649|449307093|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
124912894|NCT03990649|449307094|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
124912895|NCT00505934|449307095|FG000|Overall Study|Adverse Event|1|||
124912896|NCT00505934|449307095|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
124912897|NCT00505934|449307095|FG000|Overall Study|Other: IV dose needed to be changed|1|||
124912898|NCT03050814|449307098|FG000|Overall Study|Screen failures|0|||
124912899|NCT03050814|449307099|FG001|Overall Study|Screen failures|0|||
124912900|NCT03050814|449307100|FG002|Overall Study|Screen failures|4|||
124912901|NCT01443845|449307101|FG000|Overall Study|Protocol Violation|43|||
124912902|NCT01443845|449307102|FG001|Overall Study|Protocol Violation|45|||
124912903|NCT01443845|449307101|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
124912904|NCT01443845|449307102|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
124912905|NCT01443845|449307101|FG000|Overall Study|Deterioration in pulmonary function|1|||
124912906|NCT01443845|449307102|FG001|Overall Study|Deterioration in pulmonary function|4|||
124912907|NCT01443845|449307101|FG000|Overall Study|Lack of Efficacy|10|||
124912908|NCT01443845|449307102|FG001|Overall Study|Lack of Efficacy|5|||
124912909|NCT01443845|449307101|FG000|Overall Study|Adverse Event|64|||
124912910|NCT01443845|449307102|FG001|Overall Study|Adverse Event|138|||
124912911|NCT01443845|449307101|FG000|Overall Study|Withdrawal by Subject|63|||
124912912|NCT01443845|449307102|FG001|Overall Study|Withdrawal by Subject|67|||
124912913|NCT01443845|449307101|FG000|Overall Study|Military Conflict - Site Terminated|20|||
124912914|NCT01443845|449307102|FG001|Overall Study|Military Conflict - Site Terminated|21|||
124912915|NCT01443845|449307101|FG000|Overall Study|Lost to Follow-up|9|||
124912916|NCT01443845|449307102|FG001|Overall Study|Lost to Follow-up|13|||
124912917|NCT05137236|449307106|FG000|Part A|Other than Specified|1|||
124912918|NCT05137236|449307107|FG001|Part A|Other than Specified|0|||
124912919|NCT05137236|449307108|FG002|Part A|Other than Specified|0|||
125022374|NCT05574062|449705435|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
124912920|NCT05137236|449307109|FG003|Part A|Other than Specified|0|||
124912921|NCT05137236|449307110|FG004|Part A|Other than Specified|0|||
125022375|NCT05574062|449705431|FG000|Continuation Phase Period 1|Physician Decision|1|||
125022376|NCT05574062|449705432|FG001|Continuation Phase Period 1|Physician Decision|0|||
125022377|NCT05574062|449705433|FG002|Continuation Phase Period 1|Physician Decision|0|||
125022378|NCT05574062|449705434|FG003|Continuation Phase Period 1|Physician Decision|0|||
125022379|NCT05574062|449705435|FG004|Continuation Phase Period 1|Physician Decision|0|||
125022380|NCT05574062|449705431|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
125022381|NCT05574062|449705432|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
125022382|NCT05574062|449705433|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
125022383|NCT05574062|449705434|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
125022384|NCT05574062|449705435|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
125022385|NCT05574062|449705431|FG000|Continuation Phase Period 1|Adverse Event|1|||
125022386|NCT05574062|449705432|FG001|Continuation Phase Period 1|Adverse Event|0|||
125022387|NCT05574062|449705433|FG002|Continuation Phase Period 1|Adverse Event|0|||
125022388|NCT05574062|449705434|FG003|Continuation Phase Period 1|Adverse Event|0|||
125022389|NCT05574062|449705435|FG004|Continuation Phase Period 1|Adverse Event|0|||
125022390|NCT05574062|449705431|FG000|Continuation Phase Period 1|Death|1|||
125022391|NCT05574062|449705432|FG001|Continuation Phase Period 1|Death|0|||
125022392|NCT05574062|449705433|FG002|Continuation Phase Period 1|Death|0|||
125022393|NCT05574062|449705434|FG003|Continuation Phase Period 1|Death|0|||
125022394|NCT05574062|449705435|FG004|Continuation Phase Period 1|Death|0|||
125022395|NCT05574062|449705431|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
125022396|NCT05574062|449705432|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
125022397|NCT05574062|449705433|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
125022398|NCT05574062|449705434|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
125022399|NCT05574062|449705435|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
125022400|NCT03864653|449705436|FG000|Overall Study|Withdrawal by Subject|1|||
125022401|NCT00546052|449705437|FG000|Overall Study|Adverse Event|47|||
125022402|NCT00546052|449705437|FG000|Overall Study|Lost to Follow-up|144|||
125022403|NCT00546052|449705437|FG000|Overall Study|Protocol Violation|9|||
125022404|NCT00546052|449705437|FG000|Overall Study|Withdrawal by Subject|20|||
125022405|NCT00546052|449705437|FG000|Overall Study|Non Compliance|7|||
125022406|NCT02482129|449705438|FG000|Overall Study|Adverse Event-prior to treatment|0|||
125022407|NCT02482129|449705439|FG001|Overall Study|Adverse Event-prior to treatment|1|||
125022408|NCT02482129|449705438|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
125022409|NCT02482129|449705439|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
125022410|NCT02482129|449705438|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
124912922|NCT05137236|449307111|FG005|Part A|Other than Specified|0|||
124912923|NCT05137236|449307112|FG006|Part A|Other than Specified|0|||
124912924|NCT05137236|449307113|FG007|Part A|Other than Specified|0|||
124912925|NCT05137236|449307106|FG000|Part A|Withdrawal by Subject|0|||
124912926|NCT05137236|449307107|FG001|Part A|Withdrawal by Subject|4|||
124912927|NCT05137236|449307108|FG002|Part A|Withdrawal by Subject|1|||
124912928|NCT05137236|449307109|FG003|Part A|Withdrawal by Subject|1|||
124912929|NCT05137236|449307110|FG004|Part A|Withdrawal by Subject|3|||
124912930|NCT05137236|449307111|FG005|Part A|Withdrawal by Subject|2|||
124912931|NCT05137236|449307112|FG006|Part A|Withdrawal by Subject|0|||
124912932|NCT05137236|449307113|FG007|Part A|Withdrawal by Subject|0|||
124912933|NCT05137236|449307106|FG000|Part A|Lost to Follow-up|5|||
124912934|NCT05137236|449307107|FG001|Part A|Lost to Follow-up|7|||
124912935|NCT05137236|449307108|FG002|Part A|Lost to Follow-up|1|||
124912936|NCT05137236|449307109|FG003|Part A|Lost to Follow-up|3|||
124912937|NCT05137236|449307110|FG004|Part A|Lost to Follow-up|3|||
124912938|NCT05137236|449307111|FG005|Part A|Lost to Follow-up|8|||
124912939|NCT05137236|449307112|FG006|Part A|Lost to Follow-up|0|||
124912940|NCT05137236|449307113|FG007|Part A|Lost to Follow-up|0|||
124912941|NCT05137236|449307106|FG000|Part B|Withdrawal by Subject|0|||
124912942|NCT05137236|449307107|FG001|Part B|Withdrawal by Subject|0|||
124912943|NCT05137236|449307108|FG002|Part B|Withdrawal by Subject|0|||
124912944|NCT05137236|449307109|FG003|Part B|Withdrawal by Subject|0|||
124912945|NCT05137236|449307110|FG004|Part B|Withdrawal by Subject|0|||
124912946|NCT05137236|449307111|FG005|Part B|Withdrawal by Subject|0|||
124912947|NCT05137236|449307112|FG006|Part B|Withdrawal by Subject|0|||
124912948|NCT05137236|449307113|FG007|Part B|Withdrawal by Subject|2|||
124912949|NCT05137236|449307106|FG000|Part B|Lost to Follow-up|0|||
124912950|NCT05137236|449307107|FG001|Part B|Lost to Follow-up|0|||
125115777|NCT01335464|450046358|FG000|Overall Study|Adverse Event|15|||
125115778|NCT01335464|450046359|FG001|Overall Study|Adverse Event|25|||
125115779|NCT01335464|450046358|FG000|Overall Study|Non compliant with protocol|2|||
125115780|NCT01335464|450046359|FG001|Overall Study|Non compliant with protocol|0|||
125115781|NCT01335464|450046358|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
125115782|NCT01335464|450046359|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
125115783|NCT01335464|450046358|FG000|Overall Study|Not treated|2|||
125115784|NCT01335464|450046359|FG001|Overall Study|Not treated|0|||
125115785|NCT01335464|450046358|FG000|Overall Study|Reason other than those stated above|1|||
124912951|NCT05137236|449307108|FG002|Part B|Lost to Follow-up|0|||
124912952|NCT05137236|449307109|FG003|Part B|Lost to Follow-up|0|||
125115786|NCT01335464|450046359|FG001|Overall Study|Reason other than those stated above|1|||
125115787|NCT00593333|450046363|FG000|Overall Study|Lost to Follow-up|10|||
125115788|NCT00593333|450046364|FG001|Overall Study|Lost to Follow-up|11|||
125115789|NCT01752920|450046365|FG000|Overall Study|Adverse Event|1|||
125115790|NCT01752920|450046366|FG001|Overall Study|Adverse Event|0|||
125115791|NCT01752920|450046367|FG002|Overall Study|Adverse Event|5|||
125115792|NCT01752920|450046368|FG003|Overall Study|Adverse Event|10|||
125115793|NCT01752920|450046365|FG000|Overall Study|Clinical Disease Progression|6|||
125115794|NCT01752920|450046366|FG001|Overall Study|Clinical Disease Progression|4|||
125115795|NCT01752920|450046367|FG002|Overall Study|Clinical Disease Progression|1|||
125115796|NCT01752920|450046368|FG003|Overall Study|Clinical Disease Progression|13|||
125115797|NCT01752920|450046365|FG000|Overall Study|Physician Decision|1|||
125115798|NCT01752920|450046366|FG001|Overall Study|Physician Decision|0|||
125115799|NCT01752920|450046367|FG002|Overall Study|Physician Decision|0|||
125115800|NCT01752920|450046368|FG003|Overall Study|Physician Decision|3|||
125115801|NCT01752920|450046365|FG000|Overall Study|Radiographic Disease Progression|20|||
125115802|NCT01752920|450046366|FG001|Overall Study|Radiographic Disease Progression|7|||
125115803|NCT01752920|450046367|FG002|Overall Study|Radiographic Disease Progression|12|||
125115804|NCT01752920|450046368|FG003|Overall Study|Radiographic Disease Progression|29|||
125115805|NCT01752920|450046365|FG000|Overall Study|Study Terminated by Sponsor|0|||
125115806|NCT01752920|450046366|FG001|Overall Study|Study Terminated by Sponsor|0|||
125115807|NCT01752920|450046367|FG002|Overall Study|Study Terminated by Sponsor|0|||
125115808|NCT01752920|450046368|FG003|Overall Study|Study Terminated by Sponsor|1|||
124912953|NCT05137236|449307110|FG004|Part B|Lost to Follow-up|0|||
124912954|NCT05137236|449307111|FG005|Part B|Lost to Follow-up|0|||
124912955|NCT05137236|449307112|FG006|Part B|Lost to Follow-up|5|||
124912956|NCT05137236|449307113|FG007|Part B|Lost to Follow-up|5|||
124912957|NCT05137236|449307106|FG000|Part B|Death|0|||
125115809|NCT01752920|450046365|FG000|Overall Study|Withdrawal by Subject|0|||
125115810|NCT01752920|450046366|FG001|Overall Study|Withdrawal by Subject|1|||
125115811|NCT01752920|450046367|FG002|Overall Study|Withdrawal by Subject|0|||
124912958|NCT05137236|449307107|FG001|Part B|Death|0|||
124912959|NCT05137236|449307108|FG002|Part B|Death|0|||
124912960|NCT05137236|449307109|FG003|Part B|Death|0|||
124912961|NCT05137236|449307110|FG004|Part B|Death|0|||
125115812|NCT01752920|450046368|FG003|Overall Study|Withdrawal by Subject|1|||
124912962|NCT05137236|449307111|FG005|Part B|Death|0|||
124912963|NCT05137236|449307112|FG006|Part B|Death|0|||
124912964|NCT05137236|449307113|FG007|Part B|Death|2|||
124912965|NCT02724956|449307114|FG000|Overall Study|Physician Decision|1|||
124912966|NCT02724956|449307115|FG001|Overall Study|Physician Decision|0|||
124912967|NCT02724956|449307114|FG000|Overall Study|Lack of Efficacy|0|||
124912968|NCT02724956|449307115|FG001|Overall Study|Lack of Efficacy|1|||
124912969|NCT02724956|449307114|FG000|Overall Study|Withdrawal by Subject|0|||
124912970|NCT02724956|449307115|FG001|Overall Study|Withdrawal by Subject|1|||
124912971|NCT00431834|449307118|FG000|Overall Study|Withdrawal by Subject|7|||
124912972|NCT00431834|449307118|FG000|Overall Study|Death|3|||
124912973|NCT00431834|449307118|FG000|Overall Study|Missed Endpoint Visit|2|||
124912974|NCT00431834|449307118|FG000|Overall Study|Lost to Follow-up|1|||
124912975|NCT02461628|449307124|FG000|Overall Study|Refused to complete survey|4|||
124912976|NCT02461628|449307125|FG001|Overall Study|Refused to complete survey|7|||
124912977|NCT02647905|449307128|FG000|Overall Study|Lost to Follow-up|1|||
124912978|NCT02647905|449307128|FG000|Overall Study|Withdrawal by Subject|2|||
124912979|NCT02015520|449307129|FG000|Overall Study|Lack of Efficacy|1|||
124912980|NCT02015520|449307130|FG001|Overall Study|Lack of Efficacy|0|||
124912981|NCT02015520|449307131|FG002|Overall Study|Lack of Efficacy|3|||
124912982|NCT02015520|449307132|FG003|Overall Study|Lack of Efficacy|2|||
124912983|NCT02015520|449307129|FG000|Overall Study|Adverse Event|0|||
124912984|NCT02015520|449307130|FG001|Overall Study|Adverse Event|0|||
124912985|NCT02015520|449307131|FG002|Overall Study|Adverse Event|0|||
124912986|NCT02015520|449307132|FG003|Overall Study|Adverse Event|1|||
124912987|NCT02015520|449307129|FG000|Overall Study|Withdrawal by Subject|2|||
124912988|NCT02015520|449307130|FG001|Overall Study|Withdrawal by Subject|2|||
124912989|NCT02015520|449307131|FG002|Overall Study|Withdrawal by Subject|1|||
124912990|NCT02015520|449307132|FG003|Overall Study|Withdrawal by Subject|0|||
124912991|NCT02015520|449307129|FG000|Overall Study|Death|1|||
124912992|NCT02015520|449307130|FG001|Overall Study|Death|0|||
124912993|NCT02015520|449307131|FG002|Overall Study|Death|0|||
125115813|NCT01752920|450046365|FG000|Overall Study|Lack of clinical benefit|1|||
125115814|NCT01752920|450046366|FG001|Overall Study|Lack of clinical benefit|1|||
125115815|NCT01752920|450046367|FG002|Overall Study|Lack of clinical benefit|1|||
125115816|NCT01752920|450046368|FG003|Overall Study|Lack of clinical benefit|1|||
125115817|NCT01738581|450046369|FG000|Overall Study|Lost to Follow-up|1|||
125115818|NCT01738581|450046370|FG001|Overall Study|Lost to Follow-up|0|||
125115819|NCT00696709|450046371|FG000|Overall Study|Withdrawal by Subject|1|||
125115820|NCT00696709|450046372|FG001|Overall Study|Withdrawal by Subject|2|||
125115821|NCT00696709|450046373|FG002|Overall Study|Withdrawal by Subject|1|||
125115822|NCT00696709|450046374|FG003|Overall Study|Withdrawal by Subject|4|||
125115823|NCT00696709|450046375|FG004|Overall Study|Withdrawal by Subject|3|||
125115824|NCT00696709|450046371|FG000|Overall Study|Protocol Violation|1|||
125115825|NCT00696709|450046372|FG001|Overall Study|Protocol Violation|0|||
125211681|NCT01952080|450399771|FG001|Overall Study|Protocol Non-compliance|1|||
125211682|NCT01952080|450399772|FG002|Overall Study|Protocol Non-compliance|0|||
125211683|NCT01952080|450399773|FG003|Overall Study|Protocol Non-compliance|0|||
125211684|NCT02732327|450399774|FG000|Overall Study|Protocol Violation|0|||
125211685|NCT02732327|450399775|FG001|Overall Study|Protocol Violation|1|||
125211686|NCT04503668|450399776|FG000|Overall Study|Incomplete data|4|||
125211687|NCT04503668|450399777|FG001|Overall Study|Incomplete data|3|||
125211688|NCT04503668|450399776|FG000|Overall Study|Withdrawal by Subject|1|||
125211689|NCT04503668|450399777|FG001|Overall Study|Withdrawal by Subject|1|||
125211690|NCT04503668|450399776|FG000|Overall Study|Adverse Event|2|||
125211691|NCT04503668|450399777|FG001|Overall Study|Adverse Event|0|||
125211692|NCT03782974|450399778|FG000|Overall Study|Withdrawal by Subject|7|||
125211693|NCT03782974|450399779|FG001|Overall Study|Withdrawal by Subject|7|||
125211694|NCT03782974|450399778|FG000|Overall Study|Pregnancy|1|||
125211695|NCT03782974|450399779|FG001|Overall Study|Pregnancy|0|||
125211696|NCT01783821|450399780|FG000|Overall Study|Screen Failure|1|||
125211697|NCT01783821|450399781|FG001|Overall Study|Screen Failure|1|||
125211698|NCT01907217|450399782|FG000|Overall Study|Withdrawal by Subject|0|||
125211699|NCT01907217|450399783|FG001|Overall Study|Withdrawal by Subject|2|||
125211700|NCT00659776|450399784|FG000|Overall Study|Withdrawal by Subject|12|||
125211701|NCT00659776|450399785|FG001|Overall Study|Withdrawal by Subject|2|||
125211702|NCT00659776|450399786|FG002|Overall Study|Withdrawal by Subject|0|||
125211703|NCT01180049|450399787|FG000|Overall Study|Other|9|||
125211704|NCT01180049|450399788|FG001|Overall Study|Other|7|||
125211705|NCT01180049|450399787|FG000|Overall Study|Lost to Follow-up|8|||
125211706|NCT01180049|450399788|FG001|Overall Study|Lost to Follow-up|6|||
125211707|NCT01180049|450399787|FG000|Overall Study|Death|36|||
125211708|NCT01180049|450399788|FG001|Overall Study|Death|35|||
125211709|NCT00350779|450399790|FG000|Overall Study|Adverse Event|4|||
125211710|NCT00350779|450399791|FG001|Overall Study|Adverse Event|2|||
125211711|NCT00350779|450399790|FG000|Overall Study|Lack of Efficacy|0|||
125211712|NCT00350779|450399791|FG001|Overall Study|Lack of Efficacy|4|||
125211713|NCT00350779|450399790|FG000|Overall Study|Lost to Follow-up|2|||
125211714|NCT00350779|450399791|FG001|Overall Study|Lost to Follow-up|0|||
125211715|NCT00350779|450399790|FG000|Overall Study|Physician Decision|2|||
125211716|NCT00350779|450399791|FG001|Overall Study|Physician Decision|4|||
125211717|NCT00350779|450399790|FG000|Overall Study|Protocol Violation|3|||
125211718|NCT00350779|450399791|FG001|Overall Study|Protocol Violation|1|||
125211719|NCT00350779|450399790|FG000|Overall Study|Withdrawal by Subject|9|||
125211720|NCT00350779|450399791|FG001|Overall Study|Withdrawal by Subject|8|||
125211721|NCT00350779|450399790|FG000|Overall Study|Patient Moved|2|||
125211722|NCT00350779|450399791|FG001|Overall Study|Patient Moved|1|||
125211723|NCT00350779|450399790|FG000|Overall Study|Non-compliance with study procedures|0|||
125211724|NCT00350779|450399791|FG001|Overall Study|Non-compliance with study procedures|1|||
125211725|NCT03015194|450401308|FG000|Overall Study|Death|10|||
125211726|NCT03015194|450401308|FG000|Overall Study|Withdrawal by Subject|2|||
125211727|NCT02469168|450401311|FG000|Overall Study|Trial closed|1|||
125211728|NCT02469168|450401312|FG001|Overall Study|Trial closed|0|||
125211729|NCT00433017|450401313|FG000|Overall Study|Adverse Event|5|||
125211730|NCT00433017|450401314|FG001|Overall Study|Adverse Event|3|||
125211731|NCT00433017|450401313|FG000|Overall Study|Withdrawal by Subject|4|||
125211732|NCT00433017|450401314|FG001|Overall Study|Withdrawal by Subject|5|||
125211733|NCT00433017|450401313|FG000|Overall Study|Lost to Follow-up|3|||
125211734|NCT00433017|450401314|FG001|Overall Study|Lost to Follow-up|4|||
125211735|NCT00433017|450401313|FG000|Overall Study|Administrative problems|80|||
125211736|NCT00433017|450401314|FG001|Overall Study|Administrative problems|86|||
125211737|NCT00433017|450401313|FG000|Overall Study|Protocol Violation|1|||
125211738|NCT00433017|450401314|FG001|Overall Study|Protocol Violation|0|||
125211739|NCT00433017|450401313|FG000|Overall Study|Death|2|||
125211740|NCT00433017|450401314|FG001|Overall Study|Death|2|||
125211741|NCT00433017|450401313|FG000|Overall Study|Subject no longer requires study drug|1|||
125211742|NCT00433017|450401314|FG001|Overall Study|Subject no longer requires study drug|1|||
125211743|NCT00255840|450401317|FG000|Overall Study|Lost to Follow-up|10|||
125211744|NCT00255840|450401318|FG001|Overall Study|Lost to Follow-up|14|||
125211745|NCT00255840|450401317|FG000|Overall Study|Discontinued intervention|53|||
125211746|NCT00255840|450401318|FG001|Overall Study|Discontinued intervention|56|||
125211747|NCT00715520|450401319|FG000|Overall Study|Screen failure|8|||
125211748|NCT00715520|450401320|FG001|Overall Study|Screen failure|1|||
125211749|NCT00715520|450401321|FG002|Overall Study|Screen failure|1|||
125211750|NCT00715520|450401319|FG000|Overall Study|Withdrawal by Subject|2|||
125211751|NCT00715520|450401320|FG001|Overall Study|Withdrawal by Subject|0|||
125211752|NCT00715520|450401321|FG002|Overall Study|Withdrawal by Subject|1|||
125211753|NCT03332095|450401322|FG000|Overall Study|Lost to Follow-up|1|||
125211754|NCT03332095|450401323|FG001|Overall Study|Lost to Follow-up|0|||
125211755|NCT03332095|450401322|FG000|Overall Study|Pregnancy|0|||
125211756|NCT03332095|450401323|FG001|Overall Study|Pregnancy|1|||
125115826|NCT00696709|450046373|FG002|Overall Study|Protocol Violation|0|||
125115827|NCT00696709|450046374|FG003|Overall Study|Protocol Violation|0|||
125115828|NCT00696709|450046375|FG004|Overall Study|Protocol Violation|0|||
125115829|NCT00696709|450046371|FG000|Overall Study|Lost to Follow-up|1|||
125115830|NCT00696709|450046372|FG001|Overall Study|Lost to Follow-up|1|||
125115831|NCT00696709|450046373|FG002|Overall Study|Lost to Follow-up|0|||
125115832|NCT00696709|450046374|FG003|Overall Study|Lost to Follow-up|0|||
125115833|NCT00696709|450046375|FG004|Overall Study|Lost to Follow-up|0|||
125115834|NCT00696709|450046371|FG000|Overall Study|Adverse Event|0|||
125115835|NCT00696709|450046372|FG001|Overall Study|Adverse Event|0|||
125115836|NCT00696709|450046373|FG002|Overall Study|Adverse Event|0|||
124912994|NCT02015520|449307132|FG003|Overall Study|Death|0|||
124912995|NCT02015520|449307129|FG000|Overall Study|Lost to Follow-up|0|||
124912996|NCT02015520|449307130|FG001|Overall Study|Lost to Follow-up|0|||
124912997|NCT02015520|449307131|FG002|Overall Study|Lost to Follow-up|1|||
124912998|NCT02015520|449307132|FG003|Overall Study|Lost to Follow-up|0|||
124912999|NCT02015520|449307129|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
124913000|NCT02015520|449307130|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
125115837|NCT00696709|450046374|FG003|Overall Study|Adverse Event|1|||
125115838|NCT00696709|450046375|FG004|Overall Study|Adverse Event|0|||
125115839|NCT01186978|450046376|FG000|Overall Study|Withdrawal by Subject|1|||
125115840|NCT03264066|450046382|FG000|Overall Study|Adverse Event|1|||
125115841|NCT03264066|450046383|FG001|Overall Study|Adverse Event|1|||
125115842|NCT03264066|450046384|FG002|Overall Study|Adverse Event|0|||
125115843|NCT03264066|450046385|FG003|Overall Study|Adverse Event|0|||
125115844|NCT03264066|450046386|FG004|Overall Study|Adverse Event|0|||
125115845|NCT03264066|450046387|FG005|Overall Study|Adverse Event|0|||
125115846|NCT03264066|450046382|FG000|Overall Study|Death|12|||
125115847|NCT03264066|450046383|FG001|Overall Study|Death|12|||
125115848|NCT03264066|450046384|FG002|Overall Study|Death|8|||
125115849|NCT03264066|450046385|FG003|Overall Study|Death|10|||
125115850|NCT03264066|450046386|FG004|Overall Study|Death|6|||
125115851|NCT03264066|450046387|FG005|Overall Study|Death|1|||
125115852|NCT03264066|450046382|FG000|Overall Study|Lost to Follow-up|1|||
125115853|NCT03264066|450046383|FG001|Overall Study|Lost to Follow-up|0|||
125115854|NCT03264066|450046384|FG002|Overall Study|Lost to Follow-up|0|||
125115855|NCT03264066|450046385|FG003|Overall Study|Lost to Follow-up|0|||
125115856|NCT03264066|450046386|FG004|Overall Study|Lost to Follow-up|0|||
125115857|NCT03264066|450046387|FG005|Overall Study|Lost to Follow-up|0|||
125115858|NCT03264066|450046382|FG000|Overall Study|Progressive Disease|0|||
125115859|NCT03264066|450046383|FG001|Overall Study|Progressive Disease|2|||
125115860|NCT03264066|450046384|FG002|Overall Study|Progressive Disease|1|||
125115861|NCT03264066|450046385|FG003|Overall Study|Progressive Disease|0|||
125115862|NCT03264066|450046386|FG004|Overall Study|Progressive Disease|0|||
125115863|NCT03264066|450046387|FG005|Overall Study|Progressive Disease|0|||
125115864|NCT03264066|450046382|FG000|Overall Study|Study Terminated by Sponsor|5|||
125115865|NCT03264066|450046383|FG001|Overall Study|Study Terminated by Sponsor|5|||
125115866|NCT03264066|450046384|FG002|Overall Study|Study Terminated by Sponsor|8|||
125115867|NCT03264066|450046385|FG003|Overall Study|Study Terminated by Sponsor|5|||
125115868|NCT03264066|450046386|FG004|Overall Study|Study Terminated by Sponsor|1|||
125115869|NCT03264066|450046387|FG005|Overall Study|Study Terminated by Sponsor|2|||
125115870|NCT03264066|450046382|FG000|Overall Study|Withdrawal by Subject|1|||
125115871|NCT03264066|450046383|FG001|Overall Study|Withdrawal by Subject|0|||
125115872|NCT03264066|450046384|FG002|Overall Study|Withdrawal by Subject|0|||
125115873|NCT03264066|450046385|FG003|Overall Study|Withdrawal by Subject|5|||
125115874|NCT03264066|450046386|FG004|Overall Study|Withdrawal by Subject|0|||
125115875|NCT03264066|450046387|FG005|Overall Study|Withdrawal by Subject|0|||
125115876|NCT00926289|450046388|FG000|Overall Study|Adverse Event|9|||
125115877|NCT00926289|450046389|FG001|Overall Study|Adverse Event|11|||
125115878|NCT00926289|450046388|FG000|Overall Study|Protocol Violation|8|||
125115879|NCT00926289|450046389|FG001|Overall Study|Protocol Violation|12|||
124913001|NCT02015520|449307131|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
124913002|NCT02015520|449307132|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
124913003|NCT02015520|449307129|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
124913004|NCT02015520|449307130|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
125115880|NCT00926289|450046388|FG000|Overall Study|Lost to Follow-up|3|||
125115881|NCT00926289|450046389|FG001|Overall Study|Lost to Follow-up|6|||
125115882|NCT00926289|450046388|FG000|Overall Study|Withdrawal by Subject|4|||
125115883|NCT00926289|450046389|FG001|Overall Study|Withdrawal by Subject|4|||
125115884|NCT00926289|450046388|FG000|Overall Study|Other|1|||
125115885|NCT00926289|450046389|FG001|Overall Study|Other|3|||
125115886|NCT02115256|450046393|FG000|Overall Study|Withdrawal by Subject|0|||
125115887|NCT02115256|450046394|FG001|Overall Study|Withdrawal by Subject|1|||
125115888|NCT02668302|450046396|FG000|Overall Study|Withdrawal by Subject|1|||
125115889|NCT02668302|450046397|FG001|Overall Study|Withdrawal by Subject|0|||
124913005|NCT02015520|449307131|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
124913006|NCT02015520|449307132|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
124913007|NCT05119855|449307133|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
124913008|NCT05119855|449307134|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
124913009|NCT05119855|449307133|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
124913010|NCT05119855|449307134|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
124913011|NCT05119855|449307133|FG000|Overall Study|Lost to Follow-up|6|||
124913012|NCT05119855|449307134|FG001|Overall Study|Lost to Follow-up|8|||
124913013|NCT02932579|449307135|FG000|Overall Study|Withdrawal by Subject|4|||
124913014|NCT02932579|449307136|FG001|Overall Study|Withdrawal by Subject|1|||
124913015|NCT01972724|449307137|FG000|Double-Blind|Rescue Criteria Met|1|||
125211757|NCT05053035|450401328|FG000|Overall Study|Withdrawal by Subject|1|||
125211758|NCT05053035|450401329|FG001|Overall Study|Withdrawal by Subject|0|||
125211759|NCT03003000|450401336|FG000|Overall Study|Adverse Event|1|||
125211760|NCT03003000|450401337|FG001|Overall Study|Adverse Event|2|||
125211761|NCT03003000|450401338|FG002|Overall Study|Adverse Event|3|||
125211762|NCT03003000|450401336|FG000|Overall Study|Lack of Efficacy|1|||
125211763|NCT03003000|450401337|FG001|Overall Study|Lack of Efficacy|0|||
125211764|NCT03003000|450401338|FG002|Overall Study|Lack of Efficacy|0|||
125211765|NCT03003000|450401336|FG000|Overall Study|Non-compliant with protocol|0|||
125211766|NCT03003000|450401337|FG001|Overall Study|Non-compliant with protocol|1|||
125211767|NCT03003000|450401338|FG002|Overall Study|Non-compliant with protocol|1|||
125211768|NCT03003000|450401336|FG000|Overall Study|Refused to continue medication|2|||
125211769|NCT03003000|450401337|FG001|Overall Study|Refused to continue medication|0|||
125211770|NCT03003000|450401338|FG002|Overall Study|Refused to continue medication|0|||
125211771|NCT03003000|450401336|FG000|Overall Study|Other than listed|1|||
125211772|NCT03003000|450401337|FG001|Overall Study|Other than listed|1|||
125211773|NCT03003000|450401338|FG002|Overall Study|Other than listed|1|||
125211774|NCT04933617|450401341|FG000|Dose Escalation|Early closure of study|0|||
125211775|NCT04933617|450401342|FG001|Dose Escalation|Early closure of study|3|||
125211776|NCT04933617|450401343|FG002|Dose Escalation|Early closure of study|0|||
125211777|NCT04933617|450401344|FG003|Dose Escalation|Early closure of study|0|||
125211778|NCT04933617|450401345|FG004|Dose Escalation|Early closure of study|0|||
125211779|NCT02191046|450401348|FG000|Overall Study|low compliance|5|||
125211780|NCT02191046|450401349|FG001|Overall Study|low compliance|1|||
125211781|NCT03760458|450401350|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
125211782|NCT03760458|450401351|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
125211783|NCT03760458|450401352|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
125211784|NCT03760458|450401353|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
125211785|NCT03760458|450401354|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
125211786|NCT00048997|450401359|FG000|Overall Study|Protocol Violation|7|||
125211787|NCT00048997|450401360|FG001|Overall Study|Protocol Violation|2|||
124913016|NCT01972724|449307138|FG001|Double-Blind|Rescue Criteria Met|0|||
125211788|NCT00048997|450401359|FG000|Overall Study|Withdrawal by Subject|6|||
124913017|NCT01972724|449307139|FG002|Double-Blind|Rescue Criteria Met|0|||
124913018|NCT01972724|449307137|FG000|Double-Blind|Adverse Event|1|||
124913019|NCT01972724|449307138|FG001|Double-Blind|Adverse Event|0|||
125211789|NCT00048997|450401360|FG001|Overall Study|Withdrawal by Subject|1|||
125211790|NCT02819440|450401361|FG000|Overall Study|Adverse Event|3|||
125211791|NCT02819440|450401362|FG001|Overall Study|Adverse Event|1|||
125211792|NCT02819440|450401361|FG000|Overall Study|Lost to Follow-up|1|||
124913020|NCT01972724|449307139|FG002|Double-Blind|Adverse Event|0|||
124913021|NCT01972724|449307137|FG000|Double-Blind|Withdrawal of Consent|2|||
125211793|NCT02819440|450401362|FG001|Overall Study|Lost to Follow-up|3|||
124913022|NCT01972724|449307138|FG001|Double-Blind|Withdrawal of Consent|1|||
125115890|NCT01078090|450046398|FG000|Overall Study|Lost to Follow-up|2363|||
125115891|NCT01078090|450046398|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
125115892|NCT01078090|450046398|FG000|Overall Study|Lack of Efficacy|1193|||
125115893|NCT01078090|450046398|FG000|Overall Study|ADR and lack of efficacy|61|||
125115894|NCT01078090|450046398|FG000|Overall Study|Other|523|||
125115895|NCT00526890|450046399|FG000|Overall Study|Adverse Event|2|||
125115896|NCT03529955|450046400|FG000|Overall Study|Adverse Event|1|||
125115897|NCT03529955|450046400|FG000|Overall Study|Lack of Efficacy|1|||
125115898|NCT00580983|450046401|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
125115899|NCT03740100|450046402|FG000|Overall Study|Adverse Event|1|||
125115900|NCT03740100|450046402|FG000|Overall Study|Death|1|||
125115901|NCT03387059|450046404|FG000|Overall Study|Study termination|5|||
125115902|NCT03387059|450046405|FG001|Overall Study|Study termination|4|||
125115903|NCT01859702|450046406|FG000|Overall Study|Protocol deviation|3|||
125115904|NCT01859702|450046406|FG000|Overall Study|Adverse Event|2|||
125115905|NCT02468557|450048039|FG000|Overall Study|Adverse Event|1|||
125115906|NCT02468557|450048039|FG000|Overall Study|Death|1|||
124913023|NCT01972724|449307139|FG002|Double-Blind|Withdrawal of Consent|0|||
124913024|NCT01972724|449307137|FG000|Double-Blind|Significant Protocol Deviation|5|||
124913025|NCT01972724|449307138|FG001|Double-Blind|Significant Protocol Deviation|8|||
124913026|NCT01972724|449307139|FG002|Double-Blind|Significant Protocol Deviation|0|||
124913027|NCT01972724|449307137|FG000|Open-Label|Withdrew Consent|0|||
124913028|NCT01972724|449307138|FG001|Open-Label|Withdrew Consent|0|||
124913029|NCT01972724|449307139|FG002|Open-Label|Withdrew Consent|3|||
124913030|NCT01972724|449307137|FG000|Open-Label|Significant Protocol Deviation|0|||
124913031|NCT01972724|449307138|FG001|Open-Label|Significant Protocol Deviation|0|||
124913032|NCT01972724|449307139|FG002|Open-Label|Significant Protocol Deviation|2|||
124913033|NCT00111813|449307144|FG000|Overall Study|Adverse Event|1|||
124913034|NCT00111813|449307145|FG001|Overall Study|Adverse Event|2|||
124913035|NCT00111813|449307146|FG002|Overall Study|Adverse Event|4|||
124913036|NCT00111813|449307147|FG003|Overall Study|Adverse Event|2|||
124913037|NCT00111813|449307148|FG004|Overall Study|Adverse Event|2|||
124913038|NCT00111813|449307149|FG005|Overall Study|Adverse Event|2|||
124913039|NCT00111813|449307144|FG000|Overall Study|Progressive disease|2|||
124913040|NCT00111813|449307145|FG001|Overall Study|Progressive disease|1|||
124913041|NCT00111813|449307146|FG002|Overall Study|Progressive disease|5|||
124913042|NCT00111813|449307147|FG003|Overall Study|Progressive disease|3|||
124913043|NCT00111813|449307148|FG004|Overall Study|Progressive disease|4|||
124913044|NCT00111813|449307149|FG005|Overall Study|Progressive disease|3|||
124913045|NCT00111813|449307144|FG000|Overall Study|Lack of Efficacy|0|||
124913046|NCT00111813|449307145|FG001|Overall Study|Lack of Efficacy|0|||
124913047|NCT00111813|449307146|FG002|Overall Study|Lack of Efficacy|0|||
124913048|NCT00111813|449307147|FG003|Overall Study|Lack of Efficacy|0|||
124913049|NCT00111813|449307148|FG004|Overall Study|Lack of Efficacy|0|||
124913050|NCT00111813|449307149|FG005|Overall Study|Lack of Efficacy|1|||
124913051|NCT00111813|449307144|FG000|Overall Study|Other|0|||
124913052|NCT00111813|449307145|FG001|Overall Study|Other|0|||
124913053|NCT00111813|449307146|FG002|Overall Study|Other|1|||
124913054|NCT00111813|449307147|FG003|Overall Study|Other|0|||
124913055|NCT00111813|449307148|FG004|Overall Study|Other|0|||
124913056|NCT00111813|449307149|FG005|Overall Study|Other|0|||
124913057|NCT01000480|449307152|FG000|Induction Phase|Adverse Event|2|||
124913058|NCT01000480|449307152|FG000|Induction Phase|Lost to Follow-up|1|||
124913059|NCT01000480|449307152|FG000|Induction Phase|Physician Decision|1|||
124913060|NCT01000480|449307152|FG000|Induction Phase|Entry Criteria Not Met|3|||
124913061|NCT01000480|449307152|FG000|Concurrent Therapy Phase|Adverse Event|4|||
124913062|NCT01000480|449307152|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
124913063|NCT01000480|449307152|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
124913064|NCT01000480|449307152|FG000|Concurrent Therapy Phase|Physician Decision|1|||
124913065|NCT00174382|449307154|FG000|Overall Study|Death|2|||
124913066|NCT00174382|449307154|FG000|Overall Study|Adverse Event|19|||
124913067|NCT00174382|449307154|FG000|Overall Study|Withdrawal by Subject|6|||
124913068|NCT00174382|449307154|FG000|Overall Study|Protocol Violation|3|||
125115907|NCT02468557|450048039|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
125115908|NCT02468557|450048039|FG000|Overall Study|All Enrolled but Never Dosed|4|||
125115909|NCT00982410|450048040|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
125115910|NCT00982410|450048041|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
125115911|NCT00982410|450048040|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
124913069|NCT00174382|449307154|FG000|Overall Study|Arrived early for last visit in error|1|||
124913070|NCT00174382|449307154|FG000|Overall Study|Subject felt pill not effective enough|1|||
124913071|NCT00174382|449307154|FG000|Overall Study|Lost to Follow-up|1|||
124913072|NCT00296036|449307155|FG000|Overall Study|Withdrawal by Subject|1|||
124913073|NCT00296036|449307156|FG001|Overall Study|Withdrawal by Subject|0|||
124913074|NCT00296036|449307157|FG002|Overall Study|Withdrawal by Subject|2|||
124913075|NCT00296036|449307158|FG003|Overall Study|Withdrawal by Subject|1|||
124913076|NCT00296036|449307159|FG004|Overall Study|Withdrawal by Subject|2|||
124913077|NCT00296036|449307160|FG005|Overall Study|Withdrawal by Subject|1|||
124913078|NCT00296036|449307155|FG000|Overall Study|Protocol Violation|0|||
124913079|NCT00296036|449307156|FG001|Overall Study|Protocol Violation|0|||
124913080|NCT00296036|449307157|FG002|Overall Study|Protocol Violation|0|||
124913081|NCT00296036|449307158|FG003|Overall Study|Protocol Violation|0|||
124913082|NCT00296036|449307159|FG004|Overall Study|Protocol Violation|0|||
124913083|NCT00296036|449307160|FG005|Overall Study|Protocol Violation|3|||
124913084|NCT02576509|449308688|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
124913085|NCT02576509|449308689|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
124913086|NCT02576509|449308688|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
124913087|NCT02576509|449308689|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
124913088|NCT02576509|449308688|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
124913089|NCT02576509|449308689|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
124913090|NCT02576509|449308688|FG000|Treatment Period|Disease progression|263|||
124913091|NCT02576509|449308689|FG001|Treatment Period|Disease progression|244|||
124913092|NCT02576509|449308688|FG000|Treatment Period|Study drug toxicity|37|||
124913093|NCT02576509|449308689|FG001|Treatment Period|Study drug toxicity|41|||
125115912|NCT00982410|450048041|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
125115913|NCT00982410|450048040|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
125115914|NCT00982410|450048041|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
125115915|NCT00982410|450048040|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
125115916|NCT00982410|450048041|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
125115917|NCT00982410|450048040|FG000|6-month Follow-up Assessment|participant no transportation|1|||
125115918|NCT00982410|450048041|FG001|6-month Follow-up Assessment|participant no transportation|0|||
125115919|NCT00982410|450048040|FG000|6-month Follow-up Assessment|incarceration|0|||
125115920|NCT00982410|450048041|FG001|6-month Follow-up Assessment|incarceration|2|||
125115921|NCT00982410|450048040|FG000|6-month Follow-up Assessment|patent surgery|0|||
125115922|NCT00982410|450048041|FG001|6-month Follow-up Assessment|patent surgery|1|||
125115923|NCT00982410|450048040|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
125115924|NCT00982410|450048041|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
125115925|NCT00982410|450048040|FG000|12-month Follow-up Assessment|Death|0|||
125115926|NCT00982410|450048041|FG001|12-month Follow-up Assessment|Death|2|||
125115927|NCT00982410|450048040|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
125115928|NCT00982410|450048041|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
125115929|NCT00982410|450048040|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
125115930|NCT00982410|450048041|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
125115931|NCT00982410|450048040|FG000|12-month Follow-up Assessment|incarceration|2|||
125115932|NCT00982410|450048041|FG001|12-month Follow-up Assessment|incarceration|1|||
125115933|NCT00982410|450048040|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
125115934|NCT00982410|450048041|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
125115935|NCT04014959|450048045|FG000|Baseline MRI and Assessments|Physician Decision|2|||
125115936|NCT04014959|450048045|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
125115937|NCT04014959|450048045|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
125115938|NCT02034799|450048049|FG000|Overall Study|Withdrawal by Subject|0|||
125115939|NCT02034799|450048050|FG001|Overall Study|Withdrawal by Subject|2|||
125115940|NCT02034799|450048049|FG000|Overall Study|Lost to Follow-up|0|||
125115941|NCT02034799|450048050|FG001|Overall Study|Lost to Follow-up|1|||
125115942|NCT02034799|450048049|FG000|Overall Study|Death|2|||
125115943|NCT02034799|450048050|FG001|Overall Study|Death|1|||
125115944|NCT02806232|450048059|FG000|Overall Study|Lost to Follow-up|1|||
125115945|NCT02806232|450048060|FG001|Overall Study|Lost to Follow-up|2|||
125115946|NCT02806232|450048061|FG002|Overall Study|Lost to Follow-up|1|||
125115947|NCT02806232|450048062|FG003|Overall Study|Lost to Follow-up|0|||
125115948|NCT02806232|450048063|FG004|Overall Study|Lost to Follow-up|0|||
125115949|NCT02806232|450048064|FG005|Overall Study|Lost to Follow-up|1|||
125115950|NCT02806232|450048065|FG006|Overall Study|Lost to Follow-up|0|||
125115951|NCT02806232|450048066|FG007|Overall Study|Lost to Follow-up|0|||
125115952|NCT02806232|450048067|FG008|Overall Study|Lost to Follow-up|0|||
125115953|NCT02806232|450048059|FG000|Overall Study|Withdrawal by Subject|0|||
124913094|NCT02576509|449308688|FG000|Treatment Period|Death|1|||
124913095|NCT02576509|449308689|FG001|Treatment Period|Death|1|||
124913096|NCT02576509|449308688|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
125115954|NCT02806232|450048060|FG001|Overall Study|Withdrawal by Subject|2|||
125115955|NCT02806232|450048061|FG002|Overall Study|Withdrawal by Subject|0|||
125115956|NCT02806232|450048062|FG003|Overall Study|Withdrawal by Subject|0|||
125115957|NCT02806232|450048063|FG004|Overall Study|Withdrawal by Subject|2|||
125115958|NCT02806232|450048064|FG005|Overall Study|Withdrawal by Subject|1|||
124913097|NCT02576509|449308689|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
125022411|NCT02482129|449705439|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
125022412|NCT02482129|449705438|FG000|Overall Study|Criteria not met-prior to treatment|1|||
125022413|NCT02482129|449705439|FG001|Overall Study|Criteria not met-prior to treatment|0|||
125022414|NCT02482129|449705438|FG000|Overall Study|Adverse Event|1|||
125022415|NCT02482129|449705439|FG001|Overall Study|Adverse Event|0|||
125022416|NCT02482129|449705438|FG000|Overall Study|Withdrawal by Subject|2|||
125022417|NCT02482129|449705439|FG001|Overall Study|Withdrawal by Subject|0|||
125022418|NCT02482129|449705438|FG000|Overall Study|Criteria not met|1|||
125022419|NCT02482129|449705439|FG001|Overall Study|Criteria not met|0|||
125022420|NCT01928381|449705440|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
125022421|NCT01928381|449705441|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
125022422|NCT01928381|449705442|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
125022423|NCT01928381|449705443|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
125022424|NCT01928381|449705444|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
125022425|NCT01928381|449705445|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
125022426|NCT01928381|449705446|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
125022427|NCT01928381|449705440|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
125022428|NCT01928381|449705441|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
125022429|NCT01928381|449705442|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
125022430|NCT01928381|449705443|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
125022431|NCT01928381|449705444|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
125022432|NCT01928381|449705445|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
125022433|NCT01928381|449705446|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
125022434|NCT01928381|449705440|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
125022435|NCT01928381|449705441|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
125022436|NCT01928381|449705442|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
125022437|NCT01928381|449705443|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
125022438|NCT01928381|449705444|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
125022439|NCT01928381|449705445|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
125022440|NCT01928381|449705446|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
125022441|NCT01928381|449705440|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
125022442|NCT01928381|449705441|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
125022443|NCT01928381|449705442|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
125022444|NCT01928381|449705443|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
125022445|NCT01928381|449705444|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
125022446|NCT01928381|449705445|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
125022447|NCT01928381|449705446|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
125022448|NCT01928381|449705440|FG000|Part 1 - Pain Training|Protocol Violation|1|||
125022449|NCT01928381|449705441|FG001|Part 1 - Pain Training|Protocol Violation|0|||
125022450|NCT01928381|449705442|FG002|Part 1 - Pain Training|Protocol Violation|0|||
125022451|NCT01928381|449705443|FG003|Part 1 - Pain Training|Protocol Violation|0|||
125022452|NCT01928381|449705444|FG004|Part 1 - Pain Training|Protocol Violation|0|||
125022453|NCT01928381|449705445|FG005|Part 1 - Pain Training|Protocol Violation|0|||
125022454|NCT01928381|449705446|FG006|Part 1 - Pain Training|Protocol Violation|0|||
125022455|NCT01928381|449705440|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
125022456|NCT01928381|449705441|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
125022457|NCT01928381|449705442|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
125022458|NCT01928381|449705443|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
125022459|NCT01928381|449705444|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
125022460|NCT01928381|449705445|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
125022461|NCT01928381|449705446|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
125022462|NCT01928381|449705440|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
124913098|NCT02576509|449308688|FG000|Treatment Period|Participant request to stop treatment|8|||
124913099|NCT02576509|449308689|FG001|Treatment Period|Participant request to stop treatment|18|||
124913100|NCT02576509|449308688|FG000|Treatment Period|Participant withdrew consent|3|||
124913101|NCT02576509|449308689|FG001|Treatment Period|Participant withdrew consent|7|||
124913102|NCT02576509|449308688|FG000|Treatment Period|Lost to Follow-up|0|||
124913103|NCT02576509|449308689|FG001|Treatment Period|Lost to Follow-up|1|||
124913104|NCT02576509|449308688|FG000|Treatment Period|Maximum clinical benefit|1|||
124913105|NCT02576509|449308689|FG001|Treatment Period|Maximum clinical benefit|0|||
124913106|NCT02576509|449308688|FG000|Treatment Period|Poor/non-compliance|1|||
124913107|NCT02576509|449308689|FG001|Treatment Period|Poor/non-compliance|1|||
124913108|NCT02576509|449308688|FG000|Treatment Period|Participant no longer meets criteria|1|||
124913109|NCT02576509|449308689|FG001|Treatment Period|Participant no longer meets criteria|0|||
124913110|NCT02576509|449308688|FG000|Treatment Period|Other reason|12|||
124913111|NCT02576509|449308689|FG001|Treatment Period|Other reason|8|||
124913112|NCT02576509|449308688|FG000|Treatment Period|NOT REPORTED|1|||
124913113|NCT02576509|449308689|FG001|Treatment Period|NOT REPORTED|0|||
124913114|NCT02576509|449308688|FG000|Treatment Period|Administrative reason by sponsor|0|||
124913115|NCT02576509|449308689|FG001|Treatment Period|Administrative reason by sponsor|1|||
124913116|NCT04688450|449308690|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
124913117|NCT04688450|449308690|FG000|Overall Study|Withdrawal by Subject|1|||
124913118|NCT01353313|449308693|FG000|Overall Study|Lost to Follow-up|22|||
124913119|NCT01353313|449308694|FG001|Overall Study|Lost to Follow-up|23|||
124913120|NCT01353313|449308693|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
124913121|NCT01353313|449308694|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
124913122|NCT04755660|449308695|FG000|Overall Study|Lost to Follow-up|1|||
124913123|NCT04755660|449308696|FG001|Overall Study|Lost to Follow-up|1|||
124913124|NCT04755660|449308697|FG002|Overall Study|Lost to Follow-up|0|||
124913125|NCT04755660|449308695|FG000|Overall Study|Withdrawal by Subject|0|||
124913126|NCT04755660|449308696|FG001|Overall Study|Withdrawal by Subject|1|||
124913127|NCT04755660|449308697|FG002|Overall Study|Withdrawal by Subject|1|||
124913128|NCT04755660|449308695|FG000|Overall Study|Physician Decision|0|||
124913129|NCT04755660|449308696|FG001|Overall Study|Physician Decision|0|||
124913130|NCT04755660|449308697|FG002|Overall Study|Physician Decision|1|||
124913131|NCT00670046|449308706|FG000|Overall Study|Lost to Follow-up|1|||
124913132|NCT00670046|449308707|FG001|Overall Study|Lost to Follow-up|1|||
124913133|NCT00670046|449308706|FG000|Overall Study|Withdrawal by Subject|0|||
124913134|NCT00670046|449308707|FG001|Overall Study|Withdrawal by Subject|1|||
124913135|NCT02121002|449308710|FG000|Overall Study|Physician Decision|2|||
125022463|NCT01928381|449705441|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
125022464|NCT01928381|449705442|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
125022465|NCT01928381|449705443|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
125022466|NCT01928381|449705444|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
125022467|NCT01928381|449705445|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
125022468|NCT01928381|449705446|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
125022469|NCT01928381|449705440|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
125022470|NCT01928381|449705441|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
125022471|NCT01928381|449705442|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
125022472|NCT01928381|449705443|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
125022473|NCT01928381|449705444|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
125022474|NCT01928381|449705445|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
124913136|NCT02121002|449308711|FG001|Overall Study|Physician Decision|0|||
125022475|NCT01928381|449705446|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
125022476|NCT01928381|449705440|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
125022477|NCT01928381|449705441|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
125022478|NCT01928381|449705442|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
125022479|NCT01928381|449705443|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
124913137|NCT02121002|449308712|FG002|Overall Study|Physician Decision|0|||
124913138|NCT02121002|449308710|FG000|Overall Study|Withdrawal by Subject|3|||
124913139|NCT02121002|449308711|FG001|Overall Study|Withdrawal by Subject|1|||
124913140|NCT02121002|449308712|FG002|Overall Study|Withdrawal by Subject|4|||
124913141|NCT02121002|449308710|FG000|Overall Study|Protocol Violation|1|||
124913142|NCT02121002|449308711|FG001|Overall Study|Protocol Violation|2|||
124913143|NCT02121002|449308712|FG002|Overall Study|Protocol Violation|4|||
124913144|NCT02121002|449308710|FG000|Overall Study|Concomitant therapy|0|||
124913145|NCT02121002|449308711|FG001|Overall Study|Concomitant therapy|1|||
124913146|NCT02121002|449308712|FG002|Overall Study|Concomitant therapy|1|||
124913147|NCT02121002|449308710|FG000|Overall Study|Others|1|||
124913148|NCT02121002|449308711|FG001|Overall Study|Others|0|||
124913149|NCT02121002|449308712|FG002|Overall Study|Others|1|||
124913150|NCT03403413|449308713|FG000|Overall Study|Lack of Efficacy|2|||
124913151|NCT03655262|449308714|FG000|Overall Study|Withdrawal by Subject|0|||
124913152|NCT03655262|449308715|FG001|Overall Study|Withdrawal by Subject|0|||
124913153|NCT03655262|449308716|FG002|Overall Study|Withdrawal by Subject|1|||
124913154|NCT04583423|449308719|FG000|Overall Study|Lost to Follow-up|0|||
124913155|NCT04583423|449308720|FG001|Overall Study|Lost to Follow-up|1|||
124913156|NCT04583423|449308721|FG002|Overall Study|Lost to Follow-up|0|||
124913157|NCT04583423|449308722|FG003|Overall Study|Lost to Follow-up|2|||
124913158|NCT04583423|449308719|FG000|Overall Study|Study Terminated by Sponsor|32|||
124913159|NCT04583423|449308720|FG001|Overall Study|Study Terminated by Sponsor|35|||
124913160|NCT04583423|449308721|FG002|Overall Study|Study Terminated by Sponsor|36|||
124913161|NCT04583423|449308722|FG003|Overall Study|Study Terminated by Sponsor|33|||
124913162|NCT04583423|449308719|FG000|Overall Study|Withdrawal by Subject|3|||
124913163|NCT04583423|449308720|FG001|Overall Study|Withdrawal by Subject|1|||
124913164|NCT04583423|449308721|FG002|Overall Study|Withdrawal by Subject|2|||
124913165|NCT04583423|449308722|FG003|Overall Study|Withdrawal by Subject|1|||
124913166|NCT04704284|449308728|FG000|Overall Study|Withdrawal by Subject|1|||
124913167|NCT00603954|449308732|FG000|Overall Study|Protocol Violation|1|||
124913168|NCT00603954|449308733|FG001|Overall Study|Protocol Violation|2|||
124913169|NCT00580866|449308736|FG000|Overall Study|Lost to Follow-up|2|||
124913170|NCT00580866|449308737|FG001|Overall Study|Lost to Follow-up|2|||
124913171|NCT02477605|449308738|FG000|Overall Study|Discontinued prior to treatment|1|||
124913172|NCT02477605|449308739|FG001|Overall Study|Discontinued prior to treatment|0|||
124913173|NCT02477605|449308738|FG000|Overall Study|Lost to Follow-up|0|||
124913174|NCT02477605|449308739|FG001|Overall Study|Lost to Follow-up|2|||
124913175|NCT02477605|449308738|FG000|Overall Study|Withdrawal by Subject|0|||
124913176|NCT02477605|449308739|FG001|Overall Study|Withdrawal by Subject|1|||
124913177|NCT02477605|449308738|FG000|Overall Study|Administered gas during surgery|0|||
124913178|NCT02477605|449308739|FG001|Overall Study|Administered gas during surgery|1|||
124913179|NCT00567489|449308740|FG000|Overall Study|Adverse Event|6|||
124913180|NCT00567489|449308741|FG001|Overall Study|Adverse Event|14|||
124913181|NCT00567489|449308740|FG000|Overall Study|Physician Decision|0|||
124913182|NCT00567489|449308741|FG001|Overall Study|Physician Decision|4|||
124913183|NCT00567489|449308740|FG000|Overall Study|Withdrawal by Subject|0|||
125115959|NCT02806232|450048065|FG006|Overall Study|Withdrawal by Subject|0|||
125115960|NCT02806232|450048066|FG007|Overall Study|Withdrawal by Subject|0|||
125115961|NCT02806232|450048067|FG008|Overall Study|Withdrawal by Subject|0|||
125115962|NCT00434161|450048068|FG000|Overall Study|Adverse Event|5|||
125115963|NCT00434161|450048069|FG001|Overall Study|Adverse Event|1|||
125115964|NCT00434161|450048070|FG002|Overall Study|Adverse Event|4|||
125115965|NCT00434161|450048068|FG000|Overall Study|Lost to Follow-up|0|||
125115966|NCT00434161|450048069|FG001|Overall Study|Lost to Follow-up|1|||
125115967|NCT00434161|450048070|FG002|Overall Study|Lost to Follow-up|0|||
125115968|NCT00434161|450048068|FG000|Overall Study|Death|1|||
125115969|NCT00434161|450048069|FG001|Overall Study|Death|0|||
125115970|NCT00434161|450048070|FG002|Overall Study|Death|1|||
125115971|NCT00434161|450048068|FG000|Overall Study|Non-Compliance|1|||
125115972|NCT00434161|450048069|FG001|Overall Study|Non-Compliance|1|||
125115973|NCT00434161|450048070|FG002|Overall Study|Non-Compliance|0|||
125211794|NCT02819440|450401361|FG000|Overall Study|Withdrawal by Subject|9|||
125211795|NCT02819440|450401362|FG001|Overall Study|Withdrawal by Subject|8|||
124913184|NCT00567489|449308741|FG001|Overall Study|Withdrawal by Subject|2|||
124913185|NCT00567489|449308740|FG000|Overall Study|Renal Transplantation|0|||
124913186|NCT00567489|449308741|FG001|Overall Study|Renal Transplantation|3|||
124913187|NCT00567489|449308740|FG000|Overall Study|Other|1|||
124913188|NCT00567489|449308741|FG001|Overall Study|Other|0|||
124913189|NCT03101930|449308746|FG000|Overall Study|Withdrawal by Subject|2|||
124913190|NCT03101930|449308747|FG001|Overall Study|Withdrawal by Subject|1|||
124913191|NCT03101930|449308748|FG002|Overall Study|Withdrawal by Subject|2|||
124913192|NCT01083316|449308749|FG000|Overall Study|Adverse Event|2|||
124913193|NCT01083316|449308749|FG000|Overall Study|Withdrawal by Subject|1|||
124913194|NCT00331136|449308750|FG000|Overall Study|Adverse Event|3|||
124913195|NCT00331136|449308751|FG001|Overall Study|Adverse Event|5|||
124913196|NCT00331136|449308752|FG002|Overall Study|Adverse Event|0|||
124913197|NCT00331136|449308753|FG003|Overall Study|Adverse Event|1|||
124913198|NCT00331136|449308750|FG000|Overall Study|Withdrawal by Subject|0|||
124913199|NCT00331136|449308751|FG001|Overall Study|Withdrawal by Subject|1|||
124913200|NCT00331136|449308752|FG002|Overall Study|Withdrawal by Subject|0|||
124913201|NCT00331136|449308753|FG003|Overall Study|Withdrawal by Subject|0|||
124913202|NCT00331136|449308750|FG000|Overall Study|Lost to Follow-up|0|||
124913203|NCT00331136|449308751|FG001|Overall Study|Lost to Follow-up|1|||
124913204|NCT00331136|449308752|FG002|Overall Study|Lost to Follow-up|0|||
124913205|NCT00331136|449308753|FG003|Overall Study|Lost to Follow-up|0|||
124913206|NCT00331136|449308750|FG000|Overall Study|Protocol Violation|1|||
124913207|NCT00331136|449308751|FG001|Overall Study|Protocol Violation|0|||
124913208|NCT00331136|449308752|FG002|Overall Study|Protocol Violation|0|||
124913209|NCT00331136|449308753|FG003|Overall Study|Protocol Violation|0|||
124913210|NCT00331136|449308750|FG000|Overall Study|Not treated|1|||
124913211|NCT00331136|449308751|FG001|Overall Study|Not treated|0|||
124913212|NCT00331136|449308752|FG002|Overall Study|Not treated|0|||
124913213|NCT00331136|449308753|FG003|Overall Study|Not treated|0|||
124913214|NCT00065260|449308758|FG000|Overall Study|Death|0|||
124913215|NCT00065260|449308759|FG001|Overall Study|Death|1|||
124913216|NCT02178098|449308762|FG000|Overall Study|Withdrawal by Subject|0|||
124913217|NCT02178098|449308763|FG001|Overall Study|Withdrawal by Subject|6|||
124913218|NCT02178098|449308762|FG000|Overall Study|Adverse Event|1|||
124913219|NCT02178098|449308763|FG001|Overall Study|Adverse Event|2|||
124913220|NCT02178098|449308762|FG000|Overall Study|Protocol Violation|1|||
124913221|NCT02178098|449308763|FG001|Overall Study|Protocol Violation|1|||
124913222|NCT02178098|449308762|FG000|Overall Study|Lost to Follow-up|0|||
124913223|NCT02178098|449308763|FG001|Overall Study|Lost to Follow-up|1|||
124913224|NCT02178098|449308762|FG000|Overall Study|Sponsor Request|1|||
124913225|NCT02178098|449308763|FG001|Overall Study|Sponsor Request|0|||
124913226|NCT02178098|449308762|FG000|Overall Study|Other|2|||
124913227|NCT02178098|449308763|FG001|Overall Study|Other|2|||
124913228|NCT03432858|449308765|FG000|Overall Study|Protocol Violation|2|||
124913229|NCT03432858|449308766|FG001|Overall Study|Protocol Violation|1|||
124913230|NCT03432858|449308767|FG002|Overall Study|Protocol Violation|9|||
125115974|NCT00434161|450048068|FG000|Overall Study|Withdrawal by Subject|2|||
125115975|NCT00434161|450048069|FG001|Overall Study|Withdrawal by Subject|0|||
124913231|NCT03432858|449308765|FG000|Overall Study|Withdrawal by Subject|0|||
124913232|NCT03432858|449308766|FG001|Overall Study|Withdrawal by Subject|1|||
125115976|NCT00434161|450048070|FG002|Overall Study|Withdrawal by Subject|3|||
125022480|NCT01928381|449705444|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
125022481|NCT01928381|449705445|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
124913233|NCT03432858|449308767|FG002|Overall Study|Withdrawal by Subject|1|||
124913234|NCT03432858|449308765|FG000|Overall Study|Procedure canceled/rescheduled|0|||
124913235|NCT03432858|449308766|FG001|Overall Study|Procedure canceled/rescheduled|9|||
124913236|NCT03432858|449308767|FG002|Overall Study|Procedure canceled/rescheduled|6|||
124913237|NCT03432858|449308765|FG000|Overall Study|Required postop mobilization with splinting|0|||
124913238|NCT03432858|449308766|FG001|Overall Study|Required postop mobilization with splinting|0|||
124913239|NCT03432858|449308767|FG002|Overall Study|Required postop mobilization with splinting|1|||
124913240|NCT01044303|449308772|FG000|Overall Study|Lost to Follow-up|2|||
124913241|NCT01109524|449308773|FG000|Overall Study|Disease Progression|29|||
124913242|NCT01109524|449308773|FG000|Overall Study|Study Drug toxicity|6|||
124913243|NCT01109524|449308773|FG000|Overall Study|Adverse Event|4|||
124913244|NCT01109524|449308773|FG000|Overall Study|Withdrawal by Subject|2|||
124913245|NCT01109524|449308773|FG000|Overall Study|Maximum clinical benefit|3|||
124913246|NCT01109524|449308773|FG000|Overall Study|Death|2|||
124913247|NCT01109524|449308773|FG000|Overall Study|No longer meets criteria|2|||
124913248|NCT01109524|449308773|FG000|Overall Study|Participant requested to end treatment|4|||
124913249|NCT01109524|449308773|FG000|Overall Study|Other|5|||
124913250|NCT00031694|449308785|FG000|Overall Study|Adverse Event|12|||
124913251|NCT00031694|449308785|FG000|Overall Study|Death|2|||
124913252|NCT00031694|449308785|FG000|Overall Study|Withdrawal by Subject|5|||
124913253|NCT01303445|449308801|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
124913254|NCT01303445|449308802|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
124913255|NCT01303445|449308801|FG000|Second Intervention (7 Days)|Adverse Event|0|||
124913256|NCT01303445|449308802|FG001|Second Intervention (7 Days)|Adverse Event|2|||
124913257|NCT01303445|449308801|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
124913258|NCT01303445|449308802|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
124913259|NCT01303445|449308801|FG000|Washout (14 Days)|Protocol Violation|1|||
124913260|NCT01303445|449308802|FG001|Washout (14 Days)|Protocol Violation|0|||
124913261|NCT01303445|449308801|FG000|Washout (14 Days)|Lost to Follow-up|0|||
124913262|NCT01303445|449308802|FG001|Washout (14 Days)|Lost to Follow-up|2|||
124913263|NCT01303445|449308801|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
124913264|NCT01303445|449308802|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
124913265|NCT01303445|449308801|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
125022482|NCT01928381|449705446|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
125022483|NCT01928381|449705440|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
125022484|NCT01928381|449705441|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
125022485|NCT01928381|449705442|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
125022486|NCT01928381|449705443|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
125022487|NCT01928381|449705444|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
125022488|NCT01928381|449705445|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
125022489|NCT01928381|449705446|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
125022490|NCT01928381|449705440|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
125022491|NCT01928381|449705441|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
125022492|NCT01928381|449705442|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
124913266|NCT01303445|449308802|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
124913267|NCT04939246|449308803|FG000|After Treatment|Death|4|||
124913268|NCT04939246|449308803|FG000|After Treatment|Lost to Follow-up|1|||
124913269|NCT04939246|449308803|FG000|After Treatment|Discharged to hospice|2|||
124913270|NCT04994509|449308804|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
124913271|NCT04994509|449308805|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
124913272|NCT04994509|449308806|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
125115977|NCT00434161|450048068|FG000|Overall Study|Logistical error study assessments|1|||
125115978|NCT00434161|450048069|FG001|Overall Study|Logistical error study assessments|0|||
125115979|NCT00434161|450048070|FG002|Overall Study|Logistical error study assessments|3|||
125115980|NCT01387282|450048071|FG000|Overall Study|Death|47|||
125115981|NCT01387282|450048072|FG001|Overall Study|Death|16|||
125115982|NCT01387282|450048071|FG000|Overall Study|Other|5|||
125115983|NCT01387282|450048072|FG001|Overall Study|Other|1|||
125115984|NCT01387282|450048071|FG000|Overall Study|Unrelated AE|6|||
125115985|NCT01387282|450048072|FG001|Overall Study|Unrelated AE|4|||
125115986|NCT01387282|450048071|FG000|Overall Study|Withdrawal by patient|33|||
125115987|NCT01387282|450048072|FG001|Overall Study|Withdrawal by patient|23|||
125115988|NCT01387282|450048071|FG000|Overall Study|Study drug-related AE|2|||
125115989|NCT01387282|450048072|FG001|Overall Study|Study drug-related AE|2|||
125115990|NCT01387282|450048071|FG000|Overall Study|Lost to Follow-up|4|||
125115991|NCT01387282|450048072|FG001|Overall Study|Lost to Follow-up|1|||
125115992|NCT01267266|450048073|FG000|Enrollment Phase|Withdrawal by Subject|2|||
125115993|NCT01267266|450048074|FG001|Enrollment Phase|Withdrawal by Subject|0|||
125115994|NCT01267266|450048073|FG000|Lead-in Phase|Lack of Efficacy|20|||
125115995|NCT01267266|450048074|FG001|Lead-in Phase|Lack of Efficacy|0|||
125115996|NCT01267266|450048073|FG000|Lead-in Phase|Adverse Event|2|||
125115997|NCT01267266|450048074|FG001|Lead-in Phase|Adverse Event|0|||
125115998|NCT01267266|450048073|FG000|Lead-in Phase|Withdrawal by Subject|1|||
125115999|NCT01267266|450048074|FG001|Lead-in Phase|Withdrawal by Subject|0|||
125116000|NCT02497391|450048075|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
125116001|NCT02497391|450048076|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
125116002|NCT02497391|450048077|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
125116003|NCT02497391|450048078|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
125116004|NCT02497391|450048079|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
125116005|NCT02497391|450048080|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
125116006|NCT02497391|450048075|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
125116007|NCT02497391|450048076|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
125116008|NCT02497391|450048077|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
125116009|NCT02497391|450048078|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
125116010|NCT02497391|450048079|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
125116011|NCT02497391|450048080|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
125116012|NCT02497391|450048075|FG000|Period 3 (14 Days)|Adverse Event|0|||
125116013|NCT02497391|450048076|FG001|Period 3 (14 Days)|Adverse Event|1|||
124913273|NCT04994509|449308804|FG000|Overall Study|Withdrew Consent|73|||
124913274|NCT04994509|449308805|FG001|Overall Study|Withdrew Consent|72|||
125116014|NCT02497391|450048077|FG002|Period 3 (14 Days)|Adverse Event|0|||
125116015|NCT02497391|450048078|FG003|Period 3 (14 Days)|Adverse Event|0|||
125116016|NCT02497391|450048079|FG004|Period 3 (14 Days)|Adverse Event|0|||
125116017|NCT02497391|450048080|FG005|Period 3 (14 Days)|Adverse Event|0|||
125116018|NCT02497391|450048075|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
125116019|NCT02497391|450048076|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
125116020|NCT02497391|450048077|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
125116021|NCT02497391|450048078|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
125116022|NCT02497391|450048079|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
125116023|NCT02497391|450048080|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
124913275|NCT04994509|449308806|FG002|Overall Study|Withdrew Consent|46|||
124913276|NCT04994509|449308804|FG000|Overall Study|Lost to Follow-up|39|||
124913277|NCT04994509|449308805|FG001|Overall Study|Lost to Follow-up|36|||
124913278|NCT04994509|449308806|FG002|Overall Study|Lost to Follow-up|26|||
124913279|NCT04994509|449308804|FG000|Overall Study|HIV-1 Infection|4|||
124913280|NCT04994509|449308805|FG001|Overall Study|HIV-1 Infection|20|||
124913281|NCT04994509|449308806|FG002|Overall Study|HIV-1 Infection|12|||
124913282|NCT04994509|449308804|FG000|Overall Study|Investigator's Discretion|9|||
124913283|NCT04994509|449308805|FG001|Overall Study|Investigator's Discretion|8|||
124913284|NCT04994509|449308806|FG002|Overall Study|Investigator's Discretion|11|||
125116024|NCT02497391|450048075|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
125116025|NCT02497391|450048076|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
125116026|NCT02497391|450048077|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
125116027|NCT02497391|450048078|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
125116028|NCT02497391|450048079|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
125116029|NCT02497391|450048080|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
125116030|NCT00658320|450048090|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
125116031|NCT00658320|450048091|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
125116032|NCT00658320|450048090|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
124913285|NCT04994509|449308804|FG000|Overall Study|Randomized but Never Treated|10|||
124913286|NCT04994509|449308805|FG001|Overall Study|Randomized but Never Treated|10|||
124913287|NCT04994509|449308806|FG002|Overall Study|Randomized but Never Treated|3|||
124913288|NCT04994509|449308804|FG000|Overall Study|Pregnancy|5|||
124913289|NCT04994509|449308805|FG001|Overall Study|Pregnancy|5|||
124913290|NCT04994509|449308806|FG002|Overall Study|Pregnancy|0|||
124913291|NCT04994509|449308804|FG000|Overall Study|Death|0|||
124913292|NCT04994509|449308805|FG001|Overall Study|Death|5|||
124913293|NCT04994509|449308806|FG002|Overall Study|Death|0|||
124913294|NCT04994509|449308804|FG000|Overall Study|Adverse Event|2|||
125022493|NCT01928381|449705443|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
125022494|NCT01928381|449705444|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
125022495|NCT01928381|449705445|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
124913295|NCT04994509|449308805|FG001|Overall Study|Adverse Event|1|||
124913296|NCT04994509|449308806|FG002|Overall Study|Adverse Event|0|||
124913297|NCT04994509|449308804|FG000|Overall Study|Non-compliance With Study Drug|1|||
124913298|NCT04994509|449308805|FG001|Overall Study|Non-compliance With Study Drug|1|||
124913299|NCT04994509|449308806|FG002|Overall Study|Non-compliance With Study Drug|1|||
124913300|NCT04994509|449308804|FG000|Overall Study|Withdrew Assent|3|||
124913301|NCT04994509|449308805|FG001|Overall Study|Withdrew Assent|0|||
124913302|NCT04994509|449308806|FG002|Overall Study|Withdrew Assent|0|||
124913303|NCT04994509|449308804|FG000|Overall Study|Protocol Violation|1|||
124913304|NCT04994509|449308805|FG001|Overall Study|Protocol Violation|0|||
124913305|NCT04994509|449308806|FG002|Overall Study|Protocol Violation|0|||
124913306|NCT04278586|449310139|FG000|Overall Study|Withdrawal by Subject|13|||
124913307|NCT04278586|449310140|FG001|Overall Study|Withdrawal by Subject|6|||
124913308|NCT04278586|449310139|FG000|Overall Study|Lost to Follow-up|37|||
124913309|NCT04278586|449310140|FG001|Overall Study|Lost to Follow-up|24|||
124913310|NCT05386238|449310144|FG000|Overall Study|Lost to Follow-up|3|||
124913311|NCT05386238|449310145|FG001|Overall Study|Lost to Follow-up|2|||
124913312|NCT05386238|449310144|FG000|Overall Study|Withdrawal by Subject|0|||
124913313|NCT05386238|449310145|FG001|Overall Study|Withdrawal by Subject|1|||
124913314|NCT04714320|449310146|FG000|Overall Study|Voluntary Withdrawal|4|||
124913315|NCT04714320|449310147|FG001|Overall Study|Voluntary Withdrawal|1|||
124913316|NCT04714320|449310148|FG002|Overall Study|Voluntary Withdrawal|2|||
124913317|NCT04714320|449310146|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
124913318|NCT04714320|449310147|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
124913319|NCT04714320|449310148|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
124913320|NCT04714320|449310146|FG000|Overall Study|Reason Not Specified|1|||
124913321|NCT04714320|449310147|FG001|Overall Study|Reason Not Specified|3|||
124913322|NCT04714320|449310148|FG002|Overall Study|Reason Not Specified|3|||
124913323|NCT05057897|449310149|FG000|Overall Study|Site closure|2|||
124913324|NCT05057897|449310150|FG001|Overall Study|Site closure|2|||
124913325|NCT05057897|449310149|FG000|Overall Study|Death|1|||
124913326|NCT05057897|449310150|FG001|Overall Study|Death|0|||
124913327|NCT03346538|449310151|FG000|Overall Study|Physician Decision|0|||
124913328|NCT03346538|449310152|FG001|Overall Study|Physician Decision|1|||
124913329|NCT03346538|449310153|FG002|Overall Study|Physician Decision|0|||
124913330|NCT03346538|449310151|FG000|Overall Study|Withdrawal by Subject|3|||
124913331|NCT03346538|449310152|FG001|Overall Study|Withdrawal by Subject|2|||
124913332|NCT03346538|449310153|FG002|Overall Study|Withdrawal by Subject|0|||
124913333|NCT03346538|449310151|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
124913334|NCT03346538|449310152|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
124913335|NCT03346538|449310153|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
124913336|NCT05672667|449310154|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
124913337|NCT04524390|449310155|FG000|Double Blind|Consent Withdrawal by subject|2|||
124913338|NCT04524390|449310156|FG001|Double Blind|Consent Withdrawal by subject|1|||
124913339|NCT04524390|449310157|FG002|Double Blind|Consent Withdrawal by subject|0|||
124913340|NCT04524390|449310155|FG000|Double Blind|Adverse Event|5|||
124913341|NCT04524390|449310156|FG001|Double Blind|Adverse Event|3|||
124913342|NCT04524390|449310157|FG002|Double Blind|Adverse Event|0|||
124913343|NCT04524390|449310155|FG000|Double Blind|Liver Transplant|5|||
124913344|NCT04524390|449310156|FG001|Double Blind|Liver Transplant|6|||
125022496|NCT01928381|449705446|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
125022497|NCT01928381|449705440|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
125022498|NCT01928381|449705441|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
125022499|NCT01928381|449705442|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
125116033|NCT00658320|450048091|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
124913345|NCT04524390|449310157|FG002|Double Blind|Liver Transplant|0|||
124913346|NCT04524390|449310155|FG000|Double Blind|Disease Progression|0|||
124913347|NCT04524390|449310156|FG001|Double Blind|Disease Progression|1|||
124913348|NCT04524390|449310157|FG002|Double Blind|Disease Progression|0|||
124913349|NCT04524390|449310155|FG000|Open-Label|Drug interruption criteria|0|||
124913350|NCT04524390|449310156|FG001|Open-Label|Drug interruption criteria|0|||
124913351|NCT04524390|449310157|FG002|Open-Label|Drug interruption criteria|1|||
124913352|NCT04524390|449310155|FG000|Open-Label|Liver Transplant|0|||
124913353|NCT04524390|449310156|FG001|Open-Label|Liver Transplant|0|||
124913354|NCT04524390|449310157|FG002|Open-Label|Liver Transplant|1|||
124913355|NCT04524390|449310155|FG000|Open-Label|Disease Progression|0|||
124913356|NCT04524390|449310156|FG001|Open-Label|Disease Progression|0|||
124913357|NCT04524390|449310157|FG002|Open-Label|Disease Progression|1|||
124913358|NCT04524390|449310155|FG000|Open-Label|Adverse Event|0|||
124913359|NCT04524390|449310156|FG001|Open-Label|Adverse Event|0|||
124913360|NCT04524390|449310157|FG002|Open-Label|Adverse Event|3|||
124913361|NCT04524390|449310155|FG000|Open-Label|Study Termination by sponsor|0|||
124913362|NCT04524390|449310156|FG001|Open-Label|Study Termination by sponsor|0|||
124913363|NCT04524390|449310157|FG002|Open-Label|Study Termination by sponsor|45|||
124913364|NCT04540913|449310163|FG000|Overall Study|Withdrawal by Subject|14|||
124913365|NCT04540913|449310164|FG001|Overall Study|Withdrawal by Subject|3|||
124913366|NCT03438188|449310165|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
124913367|NCT03438188|449310166|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
124913368|NCT03438188|449310167|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
124913369|NCT03438188|449310165|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
124913370|NCT03438188|449310166|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
124913371|NCT03438188|449310167|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
124913372|NCT03438188|449310165|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
124913373|NCT03438188|449310166|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
124913374|NCT03438188|449310167|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
124913375|NCT03438188|449310165|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
124913376|NCT03438188|449310166|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
124913377|NCT03438188|449310167|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
125022500|NCT01928381|449705443|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
125022501|NCT01928381|449705444|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
125022502|NCT01928381|449705445|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
125022503|NCT01928381|449705446|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
125022504|NCT01928381|449705440|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
125022505|NCT01928381|449705441|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
125022506|NCT01928381|449705442|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
125022507|NCT01928381|449705443|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
125022508|NCT01928381|449705444|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
125022509|NCT01928381|449705445|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
125022510|NCT01928381|449705446|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
125131363|NCT01854047|450108127|FG000|Overall Study|Poor compliance to protocol|3|||
124913378|NCT03438188|449310165|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
125116034|NCT00658320|450048090|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
125116035|NCT00658320|450048091|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
125116036|NCT00658320|450048090|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
125116037|NCT00658320|450048091|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
125116038|NCT00387712|450048107|FG000|Overall Study|Physician Decision|6|||
124913379|NCT03438188|449310166|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
124913380|NCT03438188|449310167|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
125116039|NCT00387712|450048108|FG001|Overall Study|Physician Decision|4|||
125116040|NCT00387712|450048107|FG000|Overall Study|Lost to Follow-up|17|||
125116041|NCT00387712|450048108|FG001|Overall Study|Lost to Follow-up|20|||
125116042|NCT00387712|450048107|FG000|Overall Study|Withdrawal by Subject|6|||
125116043|NCT00387712|450048108|FG001|Overall Study|Withdrawal by Subject|12|||
125116044|NCT01907737|450048113|FG000|Overall Study|Withdrawal by Subject|1|||
125116045|NCT02668783|450048117|FG000|Overall Study|Pregnancy|0|||
125116046|NCT02668783|450048118|FG001|Overall Study|Pregnancy|1|||
125116047|NCT02668783|450048117|FG000|Overall Study|Protocol Violation|2|||
125116048|NCT02668783|450048118|FG001|Overall Study|Protocol Violation|1|||
125116049|NCT02668783|450048117|FG000|Overall Study|Study terminated by sponsor|9|||
125116050|NCT02668783|450048118|FG001|Overall Study|Study terminated by sponsor|10|||
125116051|NCT02668783|450048117|FG000|Overall Study|Subject moved|1|||
124913381|NCT02991807|449310168|FG000|Overall Study|Withdrawal by Subject|2|||
124913382|NCT02991807|449310169|FG001|Overall Study|Withdrawal by Subject|1|||
124913383|NCT02991807|449310168|FG000|Overall Study|Physician Decision|0|||
124913384|NCT02991807|449310169|FG001|Overall Study|Physician Decision|1|||
124913385|NCT02991807|449310168|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
124913386|NCT02991807|449310169|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
124913387|NCT02300298|449310170|FG000|Disposition for Nintedanib|Progressive disease|10|||
124913388|NCT02300298|449310171|FG001|Disposition for Nintedanib|Progressive disease|0|||
124913389|NCT02300298|449310170|FG000|Disposition for Docetaxel|Progressive disease|0|||
124913390|NCT02300298|449310171|FG001|Disposition for Docetaxel|Progressive disease|6|||
124913391|NCT02300298|449310170|FG000|Disposition for Docetaxel|other adverse event|0|||
124913392|NCT02300298|449310171|FG001|Disposition for Docetaxel|other adverse event|4|||
124913393|NCT00792636|449310172|FG000|Overall Study|Protocol Violation|17|||
124913394|NCT00792636|449310173|FG001|Overall Study|Protocol Violation|23|||
124913395|NCT00792636|449310174|FG002|Overall Study|Protocol Violation|20|||
124913396|NCT00792636|449310172|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
124913397|NCT00792636|449310173|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
124913398|NCT00792636|449310174|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
124913399|NCT00792636|449310172|FG000|Overall Study|Lost to Follow-up|13|||
124913400|NCT00792636|449310173|FG001|Overall Study|Lost to Follow-up|19|||
124913401|NCT00792636|449310174|FG002|Overall Study|Lost to Follow-up|14|||
124913402|NCT00792636|449310172|FG000|Overall Study|Withdrew Consent|10|||
124913403|NCT00792636|449310173|FG001|Overall Study|Withdrew Consent|13|||
124913404|NCT00792636|449310174|FG002|Overall Study|Withdrew Consent|9|||
124913405|NCT00792636|449310172|FG000|Overall Study|Lack of Efficacy|3|||
124913406|NCT00792636|449310173|FG001|Overall Study|Lack of Efficacy|4|||
124913407|NCT00792636|449310174|FG002|Overall Study|Lack of Efficacy|13|||
124913408|NCT00792636|449310172|FG000|Overall Study|Adverse Event|4|||
124913409|NCT00792636|449310173|FG001|Overall Study|Adverse Event|2|||
124913410|NCT00792636|449310174|FG002|Overall Study|Adverse Event|3|||
124913411|NCT00792636|449310172|FG000|Overall Study|Investigator Discretion|2|||
124913412|NCT00792636|449310173|FG001|Overall Study|Investigator Discretion|0|||
124913413|NCT00792636|449310174|FG002|Overall Study|Investigator Discretion|2|||
124913414|NCT01610297|449310175|FG000|Overall Study|Lost to Follow-up|1|||
124913415|NCT01007396|449310179|FG000|Overall Study|Lost to Follow-up|47|||
124913416|NCT02590432|449310180|FG000|Open-label Treatment Period|Adverse Event|97|||
124913417|NCT02590432|449310181|FG001|Open-label Treatment Period|Adverse Event|79|||
124913418|NCT02590432|449310182|FG002|Open-label Treatment Period|Adverse Event|0|||
124913419|NCT02590432|449310183|FG003|Open-label Treatment Period|Adverse Event|0|||
124913420|NCT02590432|449310184|FG004|Open-label Treatment Period|Adverse Event|0|||
124913421|NCT02590432|449310185|FG005|Open-label Treatment Period|Adverse Event|0|||
125116052|NCT02668783|450048118|FG001|Overall Study|Subject moved|0|||
125116053|NCT02668783|450048117|FG000|Overall Study|Withdrawal by Subject|1|||
125211796|NCT02007278|450401372|FG000|Overall Study|Failure to comply with an eligibility|0|||
124913422|NCT02590432|449310186|FG006|Open-label Treatment Period|Adverse Event|0|||
124913423|NCT02590432|449310187|FG007|Open-label Treatment Period|Adverse Event|0|||
124913424|NCT02590432|449310188|FG008|Open-label Treatment Period|Adverse Event|0|||
124913425|NCT02590432|449310180|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
124913426|NCT02590432|449310181|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
124913427|NCT02590432|449310182|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
124913428|NCT02590432|449310183|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
124913429|NCT02590432|449310184|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
124913430|NCT02590432|449310185|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
124913431|NCT02590432|449310186|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
124913432|NCT02590432|449310187|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
124913433|NCT02590432|449310188|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
124913434|NCT02590432|449310180|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
124913435|NCT02590432|449310181|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
124913436|NCT02590432|449310182|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
124913437|NCT02590432|449310183|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
124913438|NCT02590432|449310184|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
124913439|NCT02590432|449310185|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
124913440|NCT02590432|449310186|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
124913441|NCT02590432|449310187|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
124913442|NCT02590432|449310188|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
125022511|NCT01928381|449705440|FG000|Washout First Intervention|Protocol Violation|0|||
125022512|NCT01928381|449705441|FG001|Washout First Intervention|Protocol Violation|0|||
124913443|NCT02590432|449310180|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
124913444|NCT02590432|449310181|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
124913445|NCT02590432|449310182|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
124913446|NCT02590432|449310183|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
125211797|NCT02007278|450401373|FG001|Overall Study|Failure to comply with an eligibility|1|||
124913447|NCT02590432|449310184|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
124913448|NCT02590432|449310185|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
124913449|NCT02590432|449310186|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
124913450|NCT02590432|449310187|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
124913451|NCT02590432|449310188|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
124913452|NCT02590432|449310180|FG000|Open-label Treatment Period|Protocol Violation|10|||
124913453|NCT02590432|449310181|FG001|Open-label Treatment Period|Protocol Violation|4|||
124913454|NCT02590432|449310182|FG002|Open-label Treatment Period|Protocol Violation|0|||
124913455|NCT02590432|449310183|FG003|Open-label Treatment Period|Protocol Violation|0|||
124913456|NCT02590432|449310184|FG004|Open-label Treatment Period|Protocol Violation|0|||
124913457|NCT02590432|449310185|FG005|Open-label Treatment Period|Protocol Violation|0|||
124913458|NCT02590432|449310186|FG006|Open-label Treatment Period|Protocol Violation|0|||
124913459|NCT02590432|449310187|FG007|Open-label Treatment Period|Protocol Violation|0|||
124913460|NCT02590432|449310188|FG008|Open-label Treatment Period|Protocol Violation|0|||
124913461|NCT02590432|449310180|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
124913462|NCT02590432|449310181|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
124913463|NCT02590432|449310182|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
124913464|NCT02590432|449310183|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
124913465|NCT02590432|449310184|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
124913466|NCT02590432|449310185|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
124913467|NCT02590432|449310186|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
124913468|NCT02590432|449310187|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
124913469|NCT02590432|449310188|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
124913470|NCT02590432|449310180|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
124913471|NCT02590432|449310181|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
124913472|NCT02590432|449310182|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
124913473|NCT02590432|449310183|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
124913474|NCT02590432|449310184|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
124913475|NCT02590432|449310185|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
124913476|NCT02590432|449310186|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
124913477|NCT02590432|449310187|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
125116054|NCT02668783|450048118|FG001|Overall Study|Withdrawal by Subject|0|||
125116055|NCT04467697|450048121|FG000|Overall Study|Adverse Event|2|||
125116056|NCT04467697|450048121|FG000|Overall Study|Lost to Follow-up|6|||
125116057|NCT04467697|450048121|FG000|Overall Study|Withdrawal by Subject|9|||
125116058|NCT04467697|450048121|FG000|Overall Study|Protocol Violation|3|||
125116059|NCT00909727|450048124|FG000|Overall Study|Adverse Event|1|||
125116060|NCT00909727|450048125|FG001|Overall Study|Adverse Event|0|||
125116061|NCT00909727|450048124|FG000|Overall Study|Wrong Genotype|1|||
125116062|NCT00909727|450048125|FG001|Overall Study|Wrong Genotype|0|||
125116063|NCT00909727|450048124|FG000|Overall Study|Withdrawal of Consent|1|||
125116064|NCT00909727|450048125|FG001|Overall Study|Withdrawal of Consent|0|||
125116065|NCT00909727|450048124|FG000|Overall Study|Prohibited Medication|1|||
124913478|NCT02590432|449310188|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
124913479|NCT02590432|449310180|FG000|Double-blind Treatment Period|Adverse Event|0|||
124913480|NCT02590432|449310181|FG001|Double-blind Treatment Period|Adverse Event|0|||
124913481|NCT02590432|449310182|FG002|Double-blind Treatment Period|Adverse Event|14|||
124913482|NCT02590432|449310183|FG003|Double-blind Treatment Period|Adverse Event|12|||
124913483|NCT02590432|449310184|FG004|Double-blind Treatment Period|Adverse Event|6|||
124913484|NCT02590432|449310185|FG005|Double-blind Treatment Period|Adverse Event|22|||
124913485|NCT02590432|449310186|FG006|Double-blind Treatment Period|Adverse Event|20|||
124913486|NCT02590432|449310187|FG007|Double-blind Treatment Period|Adverse Event|0|||
124913487|NCT02590432|449310188|FG008|Double-blind Treatment Period|Adverse Event|0|||
124913488|NCT02590432|449310180|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
124913489|NCT02590432|449310181|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
124913490|NCT02590432|449310182|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
124913491|NCT02590432|449310183|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
124913492|NCT02590432|449310184|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
124913493|NCT02590432|449310185|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
124913494|NCT02590432|449310186|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
124913495|NCT02590432|449310187|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
124913496|NCT02590432|449310188|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
124913497|NCT02590432|449310180|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
124913498|NCT02590432|449310181|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
124913499|NCT02590432|449310182|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
124913500|NCT02590432|449310183|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
124913501|NCT02590432|449310184|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
124913502|NCT02590432|449310185|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
124913503|NCT02590432|449310186|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
124913504|NCT02590432|449310187|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
124913505|NCT02590432|449310188|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
124913506|NCT02590432|449310180|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
124913507|NCT02590432|449310181|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
124913508|NCT02590432|449310182|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
124913509|NCT02590432|449310183|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
124913510|NCT02590432|449310184|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
124913511|NCT02590432|449310185|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
124913512|NCT02590432|449310186|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
124913513|NCT02590432|449310187|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
124913514|NCT02590432|449310188|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
124913515|NCT02590432|449310180|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
124913516|NCT02590432|449310181|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
124913517|NCT02590432|449310182|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
124913518|NCT02590432|449310183|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
124913519|NCT02590432|449310184|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
124913520|NCT02590432|449310185|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
124913521|NCT02590432|449310186|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
124913522|NCT02590432|449310187|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
124913523|NCT02590432|449310188|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
124913524|NCT02590432|449310180|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
124913525|NCT02590432|449310181|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
124913526|NCT02590432|449310182|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
124913527|NCT02590432|449310183|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
124913528|NCT02590432|449310184|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
124913529|NCT02590432|449310185|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
124913530|NCT02590432|449310186|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
124913531|NCT02590432|449310187|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
124913532|NCT02590432|449310188|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
124913533|NCT02590432|449310180|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
124913534|NCT02590432|449310181|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
124913535|NCT02590432|449310182|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
124913536|NCT02590432|449310183|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
124913537|NCT02590432|449310184|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
124913538|NCT02590432|449310185|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
124913539|NCT02590432|449310186|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
124913540|NCT02590432|449310187|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
124913541|NCT02590432|449310188|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
124913542|NCT02590432|449310180|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
124913543|NCT02590432|449310181|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
124913544|NCT02590432|449310182|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
124913545|NCT02590432|449310183|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
124913546|NCT02590432|449310184|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
124913547|NCT02590432|449310185|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
124913548|NCT02590432|449310186|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
124913549|NCT02590432|449310187|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
124913550|NCT02590432|449310188|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
124913551|NCT02590432|449310180|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
124913552|NCT02590432|449310181|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
124913553|NCT02590432|449310182|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
124913554|NCT02590432|449310183|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
124913555|NCT02590432|449310184|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
124913556|NCT02590432|449310185|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
124913557|NCT02590432|449310186|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
124913558|NCT02590432|449310187|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
124913559|NCT02590432|449310188|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
124913560|NCT02590432|449310180|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
124913561|NCT02590432|449310181|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
124913562|NCT02590432|449310182|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
124913563|NCT02590432|449310183|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
124913564|NCT02590432|449310184|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
124913565|NCT02590432|449310185|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
124913566|NCT02590432|449310186|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
124913567|NCT02590432|449310187|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
124913568|NCT02590432|449310188|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
124913569|NCT02590432|449310180|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
124913570|NCT02590432|449310181|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
124913571|NCT02590432|449310182|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
124913572|NCT02590432|449310183|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
124913573|NCT02590432|449310184|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
124913574|NCT02590432|449310185|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
124913575|NCT02590432|449310186|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
124913576|NCT02590432|449310187|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
124913577|NCT02590432|449310188|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
124913578|NCT02590432|449310180|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
124913579|NCT02590432|449310181|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
124913580|NCT02590432|449310182|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
124913581|NCT02590432|449310183|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
124913582|NCT02590432|449310184|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
124913583|NCT02590432|449310185|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
124913584|NCT02590432|449310186|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
124913585|NCT02590432|449310187|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
124913586|NCT02590432|449310188|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
124913587|NCT02740231|449310193|FG000|Overall Study|Withdrawal by Subject|1|||
124913588|NCT02740231|449310194|FG001|Overall Study|Withdrawal by Subject|1|||
124913589|NCT02740231|449310195|FG002|Overall Study|Withdrawal by Subject|1|||
124913590|NCT02740231|449310196|FG003|Overall Study|Withdrawal by Subject|0|||
124913591|NCT02740231|449310193|FG000|Overall Study|Lack of Efficacy|0|||
124913592|NCT02740231|449310194|FG001|Overall Study|Lack of Efficacy|1|||
124913593|NCT02740231|449310195|FG002|Overall Study|Lack of Efficacy|0|||
124913594|NCT02740231|449310196|FG003|Overall Study|Lack of Efficacy|4|||
124913595|NCT02740231|449310193|FG000|Overall Study|Lost to Follow-up|1|||
125116066|NCT00909727|450048125|FG001|Overall Study|Prohibited Medication|0|||
125116067|NCT04081337|450048126|FG000|Overall Study|Adverse Event|0|||
125116068|NCT04081337|450048127|FG001|Overall Study|Adverse Event|1|||
125116069|NCT04081337|450048126|FG000|Overall Study|Withdrawal by Subject|2|||
125116070|NCT04081337|450048127|FG001|Overall Study|Withdrawal by Subject|0|||
125116071|NCT04081337|450048126|FG000|Overall Study|Physician Decision|1|||
125116072|NCT04081337|450048127|FG001|Overall Study|Physician Decision|2|||
125116073|NCT04081337|450048126|FG000|Overall Study|Lost to Follow-up|1|||
125116074|NCT04081337|450048127|FG001|Overall Study|Lost to Follow-up|0|||
125116075|NCT01799590|450048132|FG000|Overall Study|Adverse Event|13|||
125116076|NCT01799590|450048133|FG001|Overall Study|Adverse Event|7|||
125116077|NCT01799590|450048134|FG002|Overall Study|Adverse Event|5|||
125116078|NCT01799590|450048132|FG000|Overall Study|Pregnancy|2|||
125116079|NCT01799590|450048133|FG001|Overall Study|Pregnancy|0|||
125116080|NCT01799590|450048134|FG002|Overall Study|Pregnancy|0|||
125116081|NCT01799590|450048132|FG000|Overall Study|Lack of Efficacy|3|||
125116082|NCT01799590|450048133|FG001|Overall Study|Lack of Efficacy|1|||
125116083|NCT01799590|450048134|FG002|Overall Study|Lack of Efficacy|3|||
125116084|NCT01799590|450048132|FG000|Overall Study|Participants convenience|4|||
125116085|NCT01799590|450048133|FG001|Overall Study|Participants convenience|4|||
125116086|NCT01799590|450048134|FG002|Overall Study|Participants convenience|2|||
125116087|NCT01799590|450048132|FG000|Overall Study|Aggravation of complications|0|||
124913596|NCT02740231|449310194|FG001|Overall Study|Lost to Follow-up|3|||
124913597|NCT02740231|449310195|FG002|Overall Study|Lost to Follow-up|0|||
124913598|NCT02740231|449310196|FG003|Overall Study|Lost to Follow-up|3|||
124913599|NCT02740231|449310193|FG000|Overall Study|Adverse Event|0|||
125116088|NCT01799590|450048133|FG001|Overall Study|Aggravation of complications|1|||
125116089|NCT01799590|450048134|FG002|Overall Study|Aggravation of complications|1|||
125116090|NCT01799590|450048132|FG000|Overall Study|Using drugs with restricted days of use|0|||
125116091|NCT01799590|450048133|FG001|Overall Study|Using drugs with restricted days of use|3|||
125116092|NCT01799590|450048134|FG002|Overall Study|Using drugs with restricted days of use|2|||
125116093|NCT01799590|450048132|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
125211798|NCT02007278|450401372|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
125211799|NCT02007278|450401373|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
124913600|NCT02740231|449310194|FG001|Overall Study|Adverse Event|1|||
124913601|NCT02740231|449310195|FG002|Overall Study|Adverse Event|0|||
124913602|NCT02740231|449310196|FG003|Overall Study|Adverse Event|1|||
124913603|NCT00243503|449310199|FG000|Overall Study|Adverse Event|11|||
124913604|NCT00243503|449310199|FG000|Overall Study|Withdrawal by Subject|1|||
124913605|NCT00243503|449310199|FG000|Overall Study|Lack of Efficacy|44|||
124913606|NCT00243503|449310199|FG000|Overall Study|Death|1|||
124913607|NCT00243503|449310199|FG000|Overall Study|Other|1|||
124913608|NCT03076515|449310202|FG000|Overall Study|DMC decision based on interim analysis|25|||
124913609|NCT03076515|449310203|FG001|Overall Study|DMC decision based on interim analysis|29|||
124913610|NCT02374307|449310204|FG000|3-months Follow-up|Lost to Follow-up|1|||
124913611|NCT02374307|449310205|FG001|3-months Follow-up|Lost to Follow-up|2|||
124913612|NCT02374307|449310204|FG000|3-months Follow-up|Withdrawal by Subject|1|||
124913613|NCT02374307|449310205|FG001|3-months Follow-up|Withdrawal by Subject|4|||
124913614|NCT02374307|449310204|FG000|3-months Follow-up|Death|1|||
124913615|NCT02374307|449310205|FG001|3-months Follow-up|Death|2|||
124913616|NCT02374307|449310204|FG000|3-months Follow-up|Missed first follow-up|5|||
124913617|NCT02374307|449310205|FG001|3-months Follow-up|Missed first follow-up|1|||
124913618|NCT02374307|449310204|FG000|6-months Follow-up|Lost to Follow-up|1|||
124913619|NCT02374307|449310205|FG001|6-months Follow-up|Lost to Follow-up|2|||
124913620|NCT02374307|449310204|FG000|6-months Follow-up|Death|2|||
124913621|NCT02374307|449310205|FG001|6-months Follow-up|Death|1|||
124913622|NCT02374307|449310204|FG000|6-months Follow-up|Withdrawal by Subject|0|||
124913623|NCT02374307|449310205|FG001|6-months Follow-up|Withdrawal by Subject|3|||
124913624|NCT00999167|449310206|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
124913625|NCT00999167|449310207|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
124913626|NCT00999167|449310208|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
124913627|NCT00999167|449310206|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
124913628|NCT00999167|449310207|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
124913629|NCT00999167|449310208|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
124913630|NCT00999167|449310206|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
124913631|NCT00999167|449310207|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
124913632|NCT00999167|449310208|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
124913633|NCT00999167|449310206|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
124913634|NCT00999167|449310207|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
124913635|NCT00999167|449310208|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
124913636|NCT00999167|449310206|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
124913637|NCT00999167|449310207|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
124913638|NCT00999167|449310208|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
124913639|NCT00999167|449310206|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
124913640|NCT00999167|449310207|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
124913641|NCT00999167|449310208|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
124913642|NCT00999167|449310206|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
124913643|NCT00999167|449310207|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
124913644|NCT00999167|449310208|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
124913645|NCT00999167|449310206|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
124913646|NCT00999167|449310207|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
124913647|NCT00999167|449310208|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
124913648|NCT02554786|449310209|FG000|Overall Study|Subject/guardian decision|29|||
124913649|NCT02554786|449310210|FG001|Overall Study|Subject/guardian decision|17|||
124913650|NCT02554786|449310211|FG002|Overall Study|Subject/guardian decision|18|||
124913651|NCT02554786|449310212|FG003|Overall Study|Subject/guardian decision|30|||
124913652|NCT02554786|449310213|FG004|Overall Study|Subject/guardian decision|20|||
124913653|NCT02554786|449310209|FG000|Overall Study|Lost to Follow-up|4|||
124913654|NCT02554786|449310210|FG001|Overall Study|Lost to Follow-up|3|||
124913655|NCT02554786|449310211|FG002|Overall Study|Lost to Follow-up|4|||
124913656|NCT02554786|449310212|FG003|Overall Study|Lost to Follow-up|2|||
124913657|NCT02554786|449310213|FG004|Overall Study|Lost to Follow-up|2|||
124913658|NCT02554786|449310209|FG000|Overall Study|Protocol deviation|1|||
124913659|NCT02554786|449310210|FG001|Overall Study|Protocol deviation|3|||
124913660|NCT02554786|449310211|FG002|Overall Study|Protocol deviation|3|||
124913661|NCT02554786|449310212|FG003|Overall Study|Protocol deviation|4|||
124913662|NCT02554786|449310213|FG004|Overall Study|Protocol deviation|2|||
124913663|NCT02554786|449310209|FG000|Overall Study|Technical problems|1|||
124913664|NCT02554786|449310210|FG001|Overall Study|Technical problems|1|||
124913665|NCT02554786|449310211|FG002|Overall Study|Technical problems|0|||
124913666|NCT02554786|449310212|FG003|Overall Study|Technical problems|2|||
124913667|NCT02554786|449310213|FG004|Overall Study|Technical problems|1|||
124913668|NCT02554786|449310209|FG000|Overall Study|Adverse Event|0|||
124913669|NCT02554786|449310210|FG001|Overall Study|Adverse Event|0|||
124913670|NCT02554786|449310211|FG002|Overall Study|Adverse Event|0|||
124913671|NCT02554786|449310212|FG003|Overall Study|Adverse Event|0|||
124913672|NCT02554786|449310213|FG004|Overall Study|Adverse Event|2|||
124913673|NCT02554786|449310209|FG000|Overall Study|Death|0|||
124913674|NCT02554786|449310210|FG001|Overall Study|Death|0|||
124913675|NCT02554786|449310211|FG002|Overall Study|Death|0|||
124913676|NCT02554786|449310212|FG003|Overall Study|Death|1|||
124913677|NCT02554786|449310213|FG004|Overall Study|Death|0|||
124913678|NCT02554786|449310209|FG000|Overall Study|Non-compliance with study treatment|0|||
124913679|NCT02554786|449310210|FG001|Overall Study|Non-compliance with study treatment|1|||
124913680|NCT02554786|449310211|FG002|Overall Study|Non-compliance with study treatment|1|||
124913681|NCT02554786|449310212|FG003|Overall Study|Non-compliance with study treatment|0|||
124913682|NCT02554786|449310213|FG004|Overall Study|Non-compliance with study treatment|1|||
124913683|NCT02554786|449310209|FG000|Overall Study|Physician Decision|0|||
124913684|NCT02554786|449310210|FG001|Overall Study|Physician Decision|1|||
124913685|NCT02554786|449310211|FG002|Overall Study|Physician Decision|4|||
124913686|NCT02554786|449310212|FG003|Overall Study|Physician Decision|1|||
124913687|NCT02554786|449310213|FG004|Overall Study|Physician Decision|1|||
124913688|NCT02554786|449310209|FG000|Overall Study|Pregnancy|0|||
124913689|NCT02554786|449310210|FG001|Overall Study|Pregnancy|0|||
125116094|NCT01799590|450048133|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
125116095|NCT01799590|450048134|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
125116096|NCT01799590|450048132|FG000|Overall Study|Other|3|||
125116097|NCT01799590|450048133|FG001|Overall Study|Other|0|||
125116098|NCT01799590|450048134|FG002|Overall Study|Other|1|||
125116099|NCT03175120|450048137|FG000|Overall Study|Adverse Event|2|||
125116100|NCT03175120|450048138|FG001|Overall Study|Adverse Event|2|||
125116101|NCT03175120|450048137|FG000|Overall Study|Protocol Violation|5|||
125116102|NCT03175120|450048138|FG001|Overall Study|Protocol Violation|2|||
125116103|NCT03175120|450048137|FG000|Overall Study|Lost to Follow-up|1|||
125116104|NCT03175120|450048138|FG001|Overall Study|Lost to Follow-up|0|||
125116105|NCT03175120|450048137|FG000|Overall Study|Withdrawal by Subject|2|||
125116106|NCT03175120|450048138|FG001|Overall Study|Withdrawal by Subject|5|||
125116107|NCT03175120|450048137|FG000|Overall Study|Other|2|||
125116108|NCT03175120|450048138|FG001|Overall Study|Other|3|||
124913690|NCT02554786|449310211|FG002|Overall Study|Pregnancy|0|||
124913691|NCT02554786|449310212|FG003|Overall Study|Pregnancy|1|||
124913692|NCT02554786|449310213|FG004|Overall Study|Pregnancy|1|||
124913693|NCT05052996|449310214|FG000|Overall Study|Still on study|0|||
124913694|NCT05052996|449310215|FG001|Overall Study|Still on study|0|||
124913695|NCT05052996|449310216|FG002|Overall Study|Still on study|47|||
124913696|NCT05052996|449310217|FG003|Overall Study|Still on study|44|||
124913697|NCT05052996|449310214|FG000|Overall Study|Cohort terminated by sponsor|21|||
124913698|NCT05052996|449310215|FG001|Overall Study|Cohort terminated by sponsor|12|||
124913699|NCT05052996|449310216|FG002|Overall Study|Cohort terminated by sponsor|0|||
124913700|NCT05052996|449310217|FG003|Overall Study|Cohort terminated by sponsor|0|||
124913701|NCT05052996|449310214|FG000|Overall Study|Withdrew consent|1|||
124913702|NCT05052996|449310215|FG001|Overall Study|Withdrew consent|0|||
124913703|NCT05052996|449310216|FG002|Overall Study|Withdrew consent|1|||
124913704|NCT05052996|449310217|FG003|Overall Study|Withdrew consent|2|||
124913705|NCT05052996|449310214|FG000|Overall Study|Lost to Follow-up|1|||
124913706|NCT05052996|449310215|FG001|Overall Study|Lost to Follow-up|0|||
124913707|NCT05052996|449310216|FG002|Overall Study|Lost to Follow-up|0|||
124913708|NCT05052996|449310217|FG003|Overall Study|Lost to Follow-up|2|||
124913709|NCT05052996|449310214|FG000|Overall Study|Adverse Event|0|||
124913710|NCT05052996|449310215|FG001|Overall Study|Adverse Event|0|||
124913711|NCT05052996|449310216|FG002|Overall Study|Adverse Event|2|||
124913712|NCT05052996|449310217|FG003|Overall Study|Adverse Event|0|||
124913713|NCT05052996|449310214|FG000|Overall Study|Randomized but never treated|0|||
124913714|NCT05052996|449310215|FG001|Overall Study|Randomized but never treated|0|||
124913715|NCT05052996|449310216|FG002|Overall Study|Randomized but never treated|1|||
125116109|NCT00678392|450048139|FG000|Overall Study|Adverse Event|0|||
125116110|NCT00678392|450048140|FG001|Overall Study|Adverse Event|6|||
124913716|NCT05052996|449310217|FG003|Overall Study|Randomized but never treated|1|||
124913717|NCT05052996|449310214|FG000|Overall Study|Protocol Violation|1|||
124913718|NCT05052996|449310215|FG001|Overall Study|Protocol Violation|0|||
124913719|NCT05052996|449310216|FG002|Overall Study|Protocol Violation|0|||
124913720|NCT05052996|449310217|FG003|Overall Study|Protocol Violation|0|||
124913721|NCT00522951|449310218|FG000|Period 1|body motion|0|||
124913722|NCT00522951|449310219|FG001|Period 1|body motion|1|||
124913723|NCT00522951|449310218|FG000|Washout Period|Adverse Event|0|||
124913724|NCT00522951|449310219|FG001|Washout Period|Adverse Event|1|||
124913725|NCT00522951|449310218|FG000|Washout Period|Death|0|||
124913726|NCT00522951|449310219|FG001|Washout Period|Death|1|||
124913727|NCT00522951|449310218|FG000|Period 2|Withdrawal by Subject|1|||
124913728|NCT00522951|449310219|FG001|Period 2|Withdrawal by Subject|0|||
124913729|NCT00522951|449310218|FG000|Period 2|residual contrast medium|1|||
124913730|NCT00522951|449310219|FG001|Period 2|residual contrast medium|1|||
124913731|NCT02794480|449310220|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
124913732|NCT02794480|449310221|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
124913733|NCT02794480|449310222|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
124913734|NCT02794480|449310223|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
124913735|NCT02794480|449310220|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
124913736|NCT02794480|449310221|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
124913737|NCT02794480|449310222|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
124913738|NCT02794480|449310223|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
124913739|NCT02794480|449310220|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124913740|NCT02794480|449310221|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124913741|NCT02794480|449310222|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124913742|NCT02794480|449310223|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
124913743|NCT02794480|449310220|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124913744|NCT02794480|449310221|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
124913745|NCT02794480|449310222|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124913746|NCT02794480|449310223|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
124913747|NCT02794480|449310220|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
124913748|NCT02794480|449310221|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124913749|NCT02794480|449310222|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124913750|NCT02794480|449310223|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
124913751|NCT01017146|449310224|FG000|Overall Study|Adverse Event|11|||
124913752|NCT01017146|449310225|FG001|Overall Study|Adverse Event|1|||
124913753|NCT01017146|449310224|FG000|Overall Study|Lost to Follow-up|14|||
124913754|NCT01017146|449310225|FG001|Overall Study|Lost to Follow-up|14|||
124913755|NCT01017146|449310224|FG000|Overall Study|Noncompliance with Study Product|1|||
124913756|NCT01017146|449310225|FG001|Overall Study|Noncompliance with Study Product|1|||
124913757|NCT01017146|449310224|FG000|Overall Study|Withdrawal by Subject|32|||
124913758|NCT01017146|449310225|FG001|Overall Study|Withdrawal by Subject|16|||
124913759|NCT01017146|449310224|FG000|Overall Study|Relocation|0|||
124913760|NCT01017146|449310225|FG001|Overall Study|Relocation|4|||
124913761|NCT01017146|449310224|FG000|Overall Study|Pregnancy|2|||
124913762|NCT01017146|449310225|FG001|Overall Study|Pregnancy|1|||
124913763|NCT01017146|449310224|FG000|Overall Study|Protocol Violation|2|||
124913764|NCT01017146|449310225|FG001|Overall Study|Protocol Violation|0|||
124913765|NCT01017146|449310224|FG000|Overall Study|Took Excluded Medication|2|||
124913766|NCT01017146|449310225|FG001|Overall Study|Took Excluded Medication|0|||
124913767|NCT01017146|449310224|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
124913768|NCT01017146|449310225|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
124913769|NCT01017146|449310224|FG000|Overall Study|Change in Work Situation|1|||
124913770|NCT01017146|449310225|FG001|Overall Study|Change in Work Situation|0|||
124913771|NCT01771731|449310226|FG000|Overall Study|Physician Decision|1|||
124913772|NCT01771731|449310227|FG001|Overall Study|Physician Decision|0|||
124913773|NCT01771731|449310226|FG000|Overall Study|Protocol Violation|0|||
124913774|NCT01771731|449310227|FG001|Overall Study|Protocol Violation|1|||
124913775|NCT01771731|449310226|FG000|Overall Study|Adverse event: Pain Crisis|1|||
124913776|NCT01771731|449310227|FG001|Overall Study|Adverse event: Pain Crisis|1|||
124913777|NCT01747486|449310228|FG000|Stage 1|Physician Decision|3|||
124913778|NCT01747486|449310229|FG001|Stage 1|Physician Decision|0|||
124913779|NCT01747486|449310228|FG000|Stage 1|Withdrawal by Subject|4|||
124913780|NCT01747486|449310229|FG001|Stage 1|Withdrawal by Subject|3|||
124913781|NCT01747486|449310228|FG000|Stage 1|Disease progression|4|||
124913782|NCT01747486|449310229|FG001|Stage 1|Disease progression|9|||
124913783|NCT01747486|449310228|FG000|Stage 1|Death|1|||
124913784|NCT01747486|449310229|FG001|Stage 1|Death|1|||
124913785|NCT01747486|449310228|FG000|Stage 2|Physician Decision|2|||
124913786|NCT01747486|449310229|FG001|Stage 2|Physician Decision|0|||
124913787|NCT01747486|449310228|FG000|Stage 2|Withdrawal by Subject|1|||
124913788|NCT01747486|449310229|FG001|Stage 2|Withdrawal by Subject|0|||
124913789|NCT01747486|449310228|FG000|Stage 2|New Cancer Therapy|3|||
124913790|NCT01747486|449310229|FG001|Stage 2|New Cancer Therapy|0|||
124913791|NCT01747486|449310228|FG000|Stage 2|Disease Progression|3|||
124913792|NCT01747486|449310229|FG001|Stage 2|Disease Progression|0|||
124913793|NCT00087139|449310230|FG000|Overall Study|Adverse Event|18|||
124913794|NCT00087139|449310231|FG001|Overall Study|Adverse Event|17|||
124913795|NCT00087139|449310232|FG002|Overall Study|Adverse Event|13|||
124913796|NCT00087139|449310230|FG000|Overall Study|Death|2|||
124913797|NCT00087139|449310231|FG001|Overall Study|Death|1|||
124913798|NCT00087139|449310232|FG002|Overall Study|Death|0|||
124913799|NCT00087139|449310230|FG000|Overall Study|Withdrawal by Subject|3|||
124913800|NCT00087139|449310231|FG001|Overall Study|Withdrawal by Subject|2|||
124913801|NCT00087139|449310232|FG002|Overall Study|Withdrawal by Subject|2|||
124913802|NCT00087139|449310230|FG000|Overall Study|Physician Decision|1|||
124913803|NCT00087139|449310231|FG001|Overall Study|Physician Decision|1|||
124913804|NCT00087139|449310232|FG002|Overall Study|Physician Decision|1|||
124913805|NCT00087139|449310230|FG000|Overall Study|Disease progression|9|||
124913806|NCT00087139|449310231|FG001|Overall Study|Disease progression|19|||
124913807|NCT00087139|449310232|FG002|Overall Study|Disease progression|12|||
124913808|NCT00087139|449310230|FG000|Overall Study|Ineligible|4|||
124913809|NCT00087139|449310231|FG001|Overall Study|Ineligible|7|||
124913810|NCT00087139|449310232|FG002|Overall Study|Ineligible|4|||
124913811|NCT00087139|449310230|FG000|Overall Study|Symptomatic deterioration|1|||
124913812|NCT00087139|449310231|FG001|Overall Study|Symptomatic deterioration|1|||
124913813|NCT00087139|449310232|FG002|Overall Study|Symptomatic deterioration|3|||
124913814|NCT00087139|449310230|FG000|Overall Study|Use of coumadin|1|||
124913815|NCT00087139|449310231|FG001|Overall Study|Use of coumadin|0|||
124913816|NCT00087139|449310232|FG002|Overall Study|Use of coumadin|0|||
124913817|NCT00087139|449310230|FG000|Overall Study|Response achieved|0|||
124913818|NCT00087139|449310231|FG001|Overall Study|Response achieved|1|||
124913819|NCT00087139|449310232|FG002|Overall Study|Response achieved|0|||
124913820|NCT00087139|449310230|FG000|Overall Study|Extradural disease|0|||
124913821|NCT00087139|449310231|FG001|Overall Study|Extradural disease|0|||
124913822|NCT00087139|449310232|FG002|Overall Study|Extradural disease|1|||
124913823|NCT00976495|449310233|FG000|Overall Study|Withdrawal by Subject|0|||
124913824|NCT00976495|449310234|FG001|Overall Study|Withdrawal by Subject|1|||
124913825|NCT00976495|449310235|FG002|Overall Study|Withdrawal by Subject|0|||
124913826|NCT02321514|449310236|FG000|Overall Study|Death|15|||
124913827|NCT02321514|449310236|FG000|Overall Study|Missed Visit|7|||
124913828|NCT02321514|449310236|FG000|Overall Study|Study Exit|3|||
124913829|NCT04128319|449310237|FG000|Overall Study|Death|3|||
124913830|NCT04484935|449310238|FG000|Overall Study|Other|0|||
124913831|NCT04484935|449310239|FG001|Overall Study|Other|1|||
124913832|NCT04484935|449310238|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124913833|NCT04484935|449310239|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124913834|NCT04484935|449310238|FG000|Overall Study|Lost to Follow-up|1|||
124913835|NCT04484935|449310239|FG001|Overall Study|Lost to Follow-up|0|||
124913836|NCT04484935|449310238|FG000|Overall Study|Death|2|||
124913837|NCT04484935|449310239|FG001|Overall Study|Death|1|||
124913838|NCT01094184|449310242|FG000|Overall Study|Death|35|||
124913839|NCT01094184|449310243|FG001|Overall Study|Death|11|||
124913840|NCT03892564|449310247|FG000|Overall Study|Withdrawal by Subject|2|||
124913841|NCT04992390|449310248|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
124913842|NCT04992390|449310249|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
124913843|NCT04992390|449310250|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
124913844|NCT04992390|449310248|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
124913845|NCT04992390|449310249|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
124913846|NCT04992390|449310250|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
124913847|NCT04992390|449310248|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
124913848|NCT04992390|449310249|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
124913849|NCT04992390|449310250|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
124913850|NCT04992390|449310248|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
124913851|NCT04992390|449310249|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
124913852|NCT04992390|449310250|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
124913853|NCT04992390|449310248|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
124913854|NCT04992390|449310249|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
124913855|NCT04992390|449310250|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
124913856|NCT04992390|449310248|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
124913857|NCT04992390|449310249|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
124913858|NCT04992390|449310250|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
124913859|NCT04992390|449310248|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
124913860|NCT04992390|449310249|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
124913861|NCT04992390|449310250|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
124913862|NCT04992390|449310248|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
124913863|NCT04992390|449310249|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
124913864|NCT04992390|449310250|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
124913865|NCT04992390|449310248|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
124913866|NCT04992390|449310249|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
124913867|NCT04992390|449310250|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
124913868|NCT04992390|449310248|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
124913869|NCT04992390|449310249|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
124913870|NCT04992390|449310250|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
124913871|NCT04992390|449310248|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
124913872|NCT04992390|449310249|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
124913873|NCT04992390|449310250|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
124913874|NCT04992390|449310248|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
124913875|NCT04992390|449310249|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
124913876|NCT04992390|449310250|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
124913877|NCT04992390|449310248|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
124913878|NCT04992390|449310249|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
124913879|NCT04992390|449310250|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
124913880|NCT04992390|449310248|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
124913881|NCT04992390|449310249|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
124913882|NCT04992390|449310250|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
124913883|NCT04992390|449310248|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
124913884|NCT04992390|449310249|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
124913885|NCT04992390|449310250|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
124913886|NCT04992390|449310248|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
124913887|NCT04992390|449310249|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
124913888|NCT04992390|449310250|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
124913889|NCT01216176|449312362|FG000|Overall Study|Adverse Event|0|||
124913890|NCT01216176|449312363|FG001|Overall Study|Adverse Event|8|||
124913891|NCT01216176|449312364|FG002|Overall Study|Adverse Event|0|||
124913892|NCT01216176|449312362|FG000|Overall Study|Physician Decision|0|||
124913893|NCT01216176|449312363|FG001|Overall Study|Physician Decision|0|||
124913894|NCT01216176|449312364|FG002|Overall Study|Physician Decision|1|||
124913895|NCT03725722|449312367|FG000|Overall Study|Lack of Efficacy|2|||
124913896|NCT03725722|449312368|FG001|Overall Study|Lack of Efficacy|1|||
124913897|NCT03725722|449312369|FG002|Overall Study|Lack of Efficacy|2|||
124913898|NCT03725722|449312370|FG003|Overall Study|Lack of Efficacy|0|||
124913899|NCT03725722|449312371|FG004|Overall Study|Lack of Efficacy|2|||
124913900|NCT03725722|449312367|FG000|Overall Study|Adverse Event|2|||
124913901|NCT03725722|449312368|FG001|Overall Study|Adverse Event|2|||
124913902|NCT03725722|449312369|FG002|Overall Study|Adverse Event|1|||
124913903|NCT03725722|449312370|FG003|Overall Study|Adverse Event|0|||
124913904|NCT03725722|449312371|FG004|Overall Study|Adverse Event|6|||
124913905|NCT03725722|449312367|FG000|Overall Study|Withdrawal by Subject|4|||
124913906|NCT03725722|449312368|FG001|Overall Study|Withdrawal by Subject|1|||
124913907|NCT03725722|449312369|FG002|Overall Study|Withdrawal by Subject|0|||
124913908|NCT03725722|449312370|FG003|Overall Study|Withdrawal by Subject|4|||
124913909|NCT03725722|449312371|FG004|Overall Study|Withdrawal by Subject|4|||
124913910|NCT03725722|449312367|FG000|Overall Study|Lost to Follow-up|3|||
124913911|NCT03725722|449312368|FG001|Overall Study|Lost to Follow-up|1|||
124913912|NCT03725722|449312369|FG002|Overall Study|Lost to Follow-up|2|||
124913913|NCT03725722|449312370|FG003|Overall Study|Lost to Follow-up|2|||
124913914|NCT03725722|449312371|FG004|Overall Study|Lost to Follow-up|1|||
124913915|NCT03725722|449312367|FG000|Overall Study|Personal reasons|0|||
124913916|NCT03725722|449312368|FG001|Overall Study|Personal reasons|0|||
124913917|NCT03725722|449312369|FG002|Overall Study|Personal reasons|1|||
124913918|NCT03725722|449312370|FG003|Overall Study|Personal reasons|0|||
124913919|NCT03725722|449312371|FG004|Overall Study|Personal reasons|1|||
124913920|NCT03725722|449312367|FG000|Overall Study|COVID-19 situation|0|||
124913921|NCT03725722|449312368|FG001|Overall Study|COVID-19 situation|1|||
124913922|NCT03725722|449312369|FG002|Overall Study|COVID-19 situation|0|||
124913923|NCT03725722|449312370|FG003|Overall Study|COVID-19 situation|0|||
124913924|NCT03725722|449312371|FG004|Overall Study|COVID-19 situation|0|||
124913925|NCT05505045|449312372|FG000|Overall Study|Withdrawal by Subject|2|||
124913926|NCT05505045|449312373|FG001|Overall Study|Withdrawal by Subject|1|||
124913927|NCT01643070|449312374|FG000|Overall Study|Withdrawal by Subject|3|||
124913928|NCT01643070|449312375|FG001|Overall Study|Withdrawal by Subject|1|||
124913929|NCT01643070|449312374|FG000|Overall Study|Death|1|||
124913930|NCT01643070|449312375|FG001|Overall Study|Death|0|||
124913931|NCT01643070|449312374|FG000|Overall Study|Pregressive disease|0|||
124913932|NCT01643070|449312375|FG001|Overall Study|Pregressive disease|2|||
124913933|NCT01600014|449312376|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
124913934|NCT01600014|449312377|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
124913935|NCT01600014|449312376|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
124913936|NCT01600014|449312377|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
124913937|NCT01600014|449312376|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
124913938|NCT01600014|449312377|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
124913939|NCT01600014|449312376|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
124913940|NCT01600014|449312377|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
124913941|NCT01600014|449312376|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
124913942|NCT01600014|449312377|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
124913943|NCT01600014|449312376|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
124913944|NCT01600014|449312377|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
124913945|NCT01600014|449312376|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
124913946|NCT01600014|449312377|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
124913947|NCT01600014|449312376|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
124913948|NCT01600014|449312377|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
124913949|NCT01600014|449312376|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
124913950|NCT01600014|449312377|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
124913951|NCT01600014|449312376|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
124913952|NCT01600014|449312377|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
124913953|NCT01600014|449312376|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
124913954|NCT01600014|449312377|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
124913955|NCT01600014|449312376|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
124913956|NCT01600014|449312377|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
124913957|NCT01600014|449312376|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
124913958|NCT01600014|449312377|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
124913959|NCT01600014|449312376|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
124913960|NCT01600014|449312377|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
124913961|NCT01600014|449312376|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
124913962|NCT01600014|449312377|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
124913963|NCT01600014|449312376|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
124913964|NCT01600014|449312377|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
124913965|NCT01600014|449312376|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
124913966|NCT01600014|449312377|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
124913967|NCT01259401|449312380|FG000|4-month Follow-up|Death|0|||
124913968|NCT01259401|449312381|FG001|4-month Follow-up|Death|1|||
124913969|NCT01259401|449312380|FG000|4-month Follow-up|Lost to Follow-up|0|||
124913970|NCT01259401|449312381|FG001|4-month Follow-up|Lost to Follow-up|1|||
124913971|NCT03481777|449312386|FG000|Overall Study|Withdrawal by Subject|36|||
124913972|NCT03481777|449312387|FG001|Overall Study|Withdrawal by Subject|31|||
124913973|NCT03481777|449312386|FG000|Overall Study|Non stroke = non target population|277|||
124913974|NCT03481777|449312387|FG001|Overall Study|Non stroke = non target population|254|||
124913975|NCT05696080|449312388|FG000|Overall Study|Lost to Follow-up|2|||
124913976|NCT05696080|449312389|FG001|Overall Study|Lost to Follow-up|1|||
124913977|NCT05696080|449312388|FG000|Overall Study|Physician Decision|1|||
125116111|NCT00678392|450048139|FG000|Overall Study|Death|280|||
125116112|NCT00678392|450048140|FG001|Overall Study|Death|269|||
125116113|NCT00678392|450048139|FG000|Overall Study|Lost to Follow-up|15|||
125116114|NCT00678392|450048140|FG001|Overall Study|Lost to Follow-up|13|||
124913978|NCT05696080|449312389|FG001|Overall Study|Physician Decision|0|||
125116115|NCT00678392|450048139|FG000|Overall Study|Objective Progression or Relapse|3|||
125116116|NCT00678392|450048140|FG001|Overall Study|Objective Progression or Relapse|8|||
124913979|NCT05696080|449312388|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124913980|NCT05696080|449312389|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
124913981|NCT05696080|449312388|FG000|Overall Study|Withdrawal by Subject|12|||
124913982|NCT05696080|449312389|FG001|Overall Study|Withdrawal by Subject|0|||
124913983|NCT03954184|449312396|FG000|Overall Study|Lost to Follow-up|500|||
124913984|NCT03954184|449312397|FG001|Overall Study|Lost to Follow-up|0|||
124913985|NCT03398200|449312398|FG000|Overall Study|Withdrawal by Subject|0|||
124913986|NCT03398200|449312399|FG001|Overall Study|Withdrawal by Subject|1|||
124913987|NCT01649271|449312400|FG000|Overall Study|Progressive disease|4|||
124913988|NCT01649271|449312401|FG001|Overall Study|Progressive disease|5|||
124913989|NCT01649271|449312400|FG000|Overall Study|Other Adverse Event|0|||
124913990|NCT01649271|449312401|FG001|Overall Study|Other Adverse Event|2|||
124913991|NCT01649271|449312400|FG000|Overall Study|Withdrawal by Subject|1|||
124913992|NCT01649271|449312401|FG001|Overall Study|Withdrawal by Subject|0|||
124913993|NCT01649271|449312400|FG000|Overall Study|Other than stated above|1|||
124913994|NCT01649271|449312401|FG001|Overall Study|Other than stated above|0|||
124913995|NCT05756075|449312404|FG000|Overall Study|Withdrawal by Subject|16|||
124913996|NCT05756075|449312405|FG001|Overall Study|Withdrawal by Subject|9|||
124913997|NCT04038957|449312409|FG000|Overall Study|Withdrawal by Subject|1|||
124913998|NCT04038957|449312409|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
124913999|NCT03821844|449312410|FG000|Overall Study|Death|37|||
124914000|NCT03821844|449312411|FG001|Overall Study|Death|31|||
124914001|NCT03821844|449312410|FG000|Overall Study|Discharged|10|||
124914002|NCT03821844|449312411|FG001|Overall Study|Discharged|14|||
124914003|NCT03821844|449312410|FG000|Overall Study|Not present in facility at followup|2|||
124914004|NCT03821844|449312411|FG001|Overall Study|Not present in facility at followup|3|||
124914005|NCT01998984|449312416|FG000|Overall Study|Adverse Event|0|||
124914006|NCT01998984|449312417|FG001|Overall Study|Adverse Event|0|||
124914007|NCT01998984|449312418|FG002|Overall Study|Adverse Event|0|||
124914008|NCT01998984|449312419|FG003|Overall Study|Adverse Event|1|||
124914009|NCT01998984|449312416|FG000|Overall Study|Lost to Follow-up|0|||
124914010|NCT01998984|449312417|FG001|Overall Study|Lost to Follow-up|1|||
124914011|NCT01998984|449312418|FG002|Overall Study|Lost to Follow-up|0|||
124914012|NCT01998984|449312419|FG003|Overall Study|Lost to Follow-up|1|||
124914013|NCT01998984|449312416|FG000|Overall Study|Withdrawal by Subject|0|||
124914014|NCT01998984|449312417|FG001|Overall Study|Withdrawal by Subject|0|||
124914015|NCT01998984|449312418|FG002|Overall Study|Withdrawal by Subject|1|||
124914016|NCT01998984|449312419|FG003|Overall Study|Withdrawal by Subject|0|||
124914017|NCT01998984|449312416|FG000|Overall Study|Other|0|||
124914018|NCT01998984|449312417|FG001|Overall Study|Other|0|||
124914019|NCT01998984|449312418|FG002|Overall Study|Other|0|||
124914020|NCT01998984|449312419|FG003|Overall Study|Other|1|||
124914021|NCT01843374|449312421|FG000|Overall Study|Death|155|||
124914022|NCT01843374|449312422|FG001|Overall Study|Death|313|||
124914023|NCT01843374|449312421|FG000|Overall Study|Withdrawal by Subject|14|||
124914024|NCT01843374|449312422|FG001|Overall Study|Withdrawal by Subject|20|||
124914025|NCT01843374|449312421|FG000|Overall Study|Withdrawing due to Other reason|20|||
124914026|NCT01843374|449312422|FG001|Overall Study|Withdrawing due to Other reason|46|||
124914027|NCT03397108|449312423|FG000|Overall Study|Lost to Follow-up|15|||
124914028|NCT03397108|449312424|FG001|Overall Study|Lost to Follow-up|0|||
124914029|NCT03397108|449312423|FG000|Overall Study|Insufficient milk production|3|||
124914030|NCT03397108|449312424|FG001|Overall Study|Insufficient milk production|2|||
124914031|NCT03397108|449312423|FG000|Overall Study|Withdrawal by Subject|2|||
124914032|NCT03397108|449312424|FG001|Overall Study|Withdrawal by Subject|0|||
124914033|NCT03554265|449312425|FG000|Overall Study|Withdrawal by Subject|2|||
124914034|NCT03554265|449312426|FG001|Overall Study|Withdrawal by Subject|2|||
124914035|NCT03554265|449312427|FG002|Overall Study|Withdrawal by Subject|3|||
124914036|NCT03554265|449312425|FG000|Overall Study|Physician Decision|0|||
124914037|NCT03554265|449312426|FG001|Overall Study|Physician Decision|0|||
124914038|NCT03554265|449312427|FG002|Overall Study|Physician Decision|1|||
124914039|NCT02605837|449312428|FG000|Overall Study|Adverse Event|3|||
124914040|NCT02605837|449312429|FG001|Overall Study|Adverse Event|1|||
124914041|NCT02605837|449312428|FG000|Overall Study|Non-Compliance with Study Drug|0|||
124914042|NCT02605837|449312429|FG001|Overall Study|Non-Compliance with Study Drug|1|||
124914043|NCT02605837|449312428|FG000|Overall Study|Withdrawal by Subject|8|||
124914044|NCT02605837|449312429|FG001|Overall Study|Withdrawal by Subject|8|||
124914045|NCT02605837|449312428|FG000|Overall Study|Physician Decision|0|||
124914046|NCT02605837|449312429|FG001|Overall Study|Physician Decision|1|||
124914047|NCT02652260|449312430|FG000|Base Study|Pregnancy|0|||
124914048|NCT02652260|449312431|FG001|Base Study|Pregnancy|1|||
124914049|NCT02652260|449312430|FG000|Base Study|Withdrawal by Subject|0|||
124914050|NCT02652260|449312431|FG001|Base Study|Withdrawal by Subject|1|||
124914051|NCT02652260|449312430|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
125022513|NCT01928381|449705442|FG002|Washout First Intervention|Protocol Violation|0|||
124914052|NCT02652260|449312431|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
125022514|NCT01928381|449705443|FG003|Washout First Intervention|Protocol Violation|0|||
124914053|NCT02652260|449312430|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
124914054|NCT02652260|449312431|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
124914055|NCT02652260|449312430|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
124914056|NCT02652260|449312431|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
124914057|NCT02652260|449312430|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
124914058|NCT02652260|449312431|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
124914059|NCT02652260|449312430|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
124914060|NCT02652260|449312431|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
124914061|NCT02652260|449312430|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
124914062|NCT02652260|449312431|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
124914063|NCT02652260|449312430|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
124914064|NCT02652260|449312431|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
124914065|NCT02652260|449312430|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
124914066|NCT02652260|449312431|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
124914067|NCT02652260|449312430|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
124914068|NCT02652260|449312431|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
124914069|NCT02652260|449312430|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
124914070|NCT02652260|449312431|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
124914071|NCT02652260|449312430|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
124914072|NCT02652260|449312431|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
124914073|NCT02652260|449312430|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
124914074|NCT02652260|449312431|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
124914075|NCT05056246|449312432|FG000|Overall Study|Adverse Event|0|||
124914076|NCT05056246|449312433|FG001|Overall Study|Adverse Event|0|||
124914077|NCT05056246|449312434|FG002|Overall Study|Adverse Event|0|||
124914078|NCT05056246|449312435|FG003|Overall Study|Adverse Event|0|||
124914079|NCT05056246|449312436|FG004|Overall Study|Adverse Event|1|||
124914080|NCT05056246|449312432|FG000|Overall Study|Lost to Follow-up|0|||
124914081|NCT05056246|449312433|FG001|Overall Study|Lost to Follow-up|0|||
124914082|NCT05056246|449312434|FG002|Overall Study|Lost to Follow-up|0|||
124914083|NCT05056246|449312435|FG003|Overall Study|Lost to Follow-up|2|||
124914084|NCT05056246|449312436|FG004|Overall Study|Lost to Follow-up|0|||
124914085|NCT05056246|449312432|FG000|Overall Study|Withdrawal by Subject|0|||
124914086|NCT05056246|449312433|FG001|Overall Study|Withdrawal by Subject|1|||
124914087|NCT05056246|449312434|FG002|Overall Study|Withdrawal by Subject|0|||
124914088|NCT05056246|449312435|FG003|Overall Study|Withdrawal by Subject|0|||
124914089|NCT05056246|449312436|FG004|Overall Study|Withdrawal by Subject|0|||
124914090|NCT03899961|449312447|FG000|Overall Study|-delivery prior to|2|||
124914091|NCT03899961|449312448|FG001|Overall Study|-delivery prior to|7|||
124914092|NCT03899961|449312447|FG000|Overall Study|req general anesth|1|||
124914093|NCT03899961|449312448|FG001|Overall Study|req general anesth|2|||
124914094|NCT03899961|449312447|FG000|Overall Study|capacity|5|||
124914095|NCT03899961|449312448|FG001|Overall Study|capacity|6|||
124914096|NCT03899961|449312447|FG000|Overall Study|Withdrawal by Subject|1|||
124914097|NCT03899961|449312448|FG001|Overall Study|Withdrawal by Subject|1|||
124914098|NCT05656911|449312449|FG000|Treatment Phase|Physician Decision|2|||
124914099|NCT05656911|449312450|FG001|Treatment Phase|Physician Decision|0|||
124914100|NCT05656911|449312449|FG000|Treatment Phase|Lack of Efficacy|6|||
124914101|NCT05656911|449312450|FG001|Treatment Phase|Lack of Efficacy|3|||
124914102|NCT05656911|449312449|FG000|Treatment Phase|Subject Decision|4|||
124914103|NCT05656911|449312450|FG001|Treatment Phase|Subject Decision|2|||
124914104|NCT05656911|449312449|FG000|Treatment Phase|Other Reasons|1|||
124914105|NCT05656911|449312450|FG001|Treatment Phase|Other Reasons|0|||
124914106|NCT05656911|449312449|FG000|Treatment Phase|Adverse Event|3|||
124914107|NCT05656911|449312450|FG001|Treatment Phase|Adverse Event|1|||
124914108|NCT05656911|449312449|FG000|Follow-up Phase|Subject Decision|0|||
124914109|NCT05656911|449312450|FG001|Follow-up Phase|Subject Decision|1|||
124914110|NCT05656911|449312449|FG000|Follow-up Phase|Missing|1|||
124914111|NCT05656911|449312450|FG001|Follow-up Phase|Missing|0|||
124914112|NCT02837510|449312451|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
124914113|NCT02837510|449312452|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
124914114|NCT02837510|449312451|FG000|Washout (2 Weeks)|Adverse Event|0|||
124914115|NCT02837510|449312452|FG001|Washout (2 Weeks)|Adverse Event|1|||
124914116|NCT02837510|449312451|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
124914117|NCT02837510|449312452|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
124914118|NCT02837510|449312451|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
124914119|NCT02837510|449312452|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
124914120|NCT02837510|449312451|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
124914121|NCT02837510|449312452|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
124914122|NCT02837510|449312451|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
124914123|NCT02837510|449312452|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
124914124|NCT03088813|449312453|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
124914125|NCT03088813|449312454|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
124914126|NCT03088813|449312455|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
124914127|NCT03088813|449312456|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
124914128|NCT03088813|449312453|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
124914129|NCT03088813|449312454|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
124914130|NCT03088813|449312455|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
124914131|NCT03088813|449312456|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
124914132|NCT03088813|449312453|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
124914133|NCT03088813|449312454|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
124914134|NCT03088813|449312455|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
124914135|NCT03088813|449312456|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
124914136|NCT03088813|449312453|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
124914137|NCT03088813|449312454|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
124914138|NCT03088813|449312455|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
124914139|NCT03088813|449312456|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
124914140|NCT03088813|449312453|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
124914141|NCT03088813|449312454|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
124914142|NCT03088813|449312455|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
124914143|NCT03088813|449312456|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
124914144|NCT03088813|449312453|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
124914145|NCT03088813|449312454|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
124914146|NCT03088813|449312455|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
124914147|NCT03088813|449312456|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
124914148|NCT03088813|449312453|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
124914149|NCT03088813|449312454|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
124914150|NCT03088813|449312455|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
124914151|NCT03088813|449312456|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
124914152|NCT02780388|449312457|FG000|Overall Study|Lost to Follow-up|0|||
124914153|NCT02780388|449312458|FG001|Overall Study|Lost to Follow-up|1|||
124914154|NCT02780388|449312459|FG002|Overall Study|Lost to Follow-up|0|||
124914155|NCT02780388|449312460|FG003|Overall Study|Lost to Follow-up|0|||
124914156|NCT02780388|449312461|FG004|Overall Study|Lost to Follow-up|0|||
124914157|NCT02780388|449312457|FG000|Overall Study|Withdrawal by Subject|1|||
124914158|NCT02780388|449312458|FG001|Overall Study|Withdrawal by Subject|1|||
124914159|NCT02780388|449312459|FG002|Overall Study|Withdrawal by Subject|0|||
124914160|NCT02780388|449312460|FG003|Overall Study|Withdrawal by Subject|0|||
124914161|NCT02780388|449312461|FG004|Overall Study|Withdrawal by Subject|0|||
124914162|NCT04527146|449312462|FG000|Overall Study|Withdrawal by Subject|12|||
124914163|NCT04527146|449312463|FG001|Overall Study|Withdrawal by Subject|15|||
124914164|NCT04527146|449312464|FG002|Overall Study|Withdrawal by Subject|7|||
124914165|NCT04527146|449312465|FG003|Overall Study|Withdrawal by Subject|16|||
124914166|NCT04527146|449312462|FG000|Overall Study|Lost to Follow-up|13|||
124914167|NCT04527146|449312463|FG001|Overall Study|Lost to Follow-up|9|||
124914168|NCT04527146|449312464|FG002|Overall Study|Lost to Follow-up|16|||
124914169|NCT04527146|449312465|FG003|Overall Study|Lost to Follow-up|13|||
124914170|NCT04527146|449312462|FG000|Overall Study|Death|0|||
124914171|NCT04527146|449312463|FG001|Overall Study|Death|1|||
124914172|NCT04527146|449312464|FG002|Overall Study|Death|1|||
124914173|NCT04527146|449312465|FG003|Overall Study|Death|0|||
124914174|NCT04527146|449312462|FG000|Overall Study|Adverse Event|0|||
124914175|NCT04527146|449312463|FG001|Overall Study|Adverse Event|0|||
124914176|NCT04527146|449312464|FG002|Overall Study|Adverse Event|1|||
124914177|NCT04527146|449312465|FG003|Overall Study|Adverse Event|0|||
124914178|NCT04527146|449312462|FG000|Overall Study|Ineligible after randomization|2|||
124914179|NCT04527146|449312463|FG001|Overall Study|Ineligible after randomization|0|||
124914180|NCT04527146|449312464|FG002|Overall Study|Ineligible after randomization|2|||
124914181|NCT04527146|449312465|FG003|Overall Study|Ineligible after randomization|2|||
124914182|NCT04527146|449312462|FG000|Overall Study|Moved to a different group|6|||
124914183|NCT04527146|449312463|FG001|Overall Study|Moved to a different group|3|||
124914184|NCT04527146|449312464|FG002|Overall Study|Moved to a different group|0|||
124914185|NCT04527146|449312465|FG003|Overall Study|Moved to a different group|2|||
124914186|NCT05107401|449312466|FG000|Overall Study|Lost to Follow-up|13|||
124914187|NCT05107401|449312467|FG001|Overall Study|Lost to Follow-up|12|||
124914188|NCT01903811|449312479|FG000|Overall Study|No measurable disease|1|||
124914189|NCT01903811|449312480|FG001|Overall Study|No measurable disease|1|||
125022515|NCT01928381|449705444|FG004|Washout First Intervention|Protocol Violation|1|||
124914190|NCT01903811|449312479|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
124914191|NCT01903811|449312480|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
124914192|NCT01903811|449312479|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
124914193|NCT01903811|449312480|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
124914194|NCT01903811|449312479|FG000|Overall Study|Withdrawal by Subject|0|||
124914195|NCT01903811|449312480|FG001|Overall Study|Withdrawal by Subject|1|||
124914196|NCT04468776|449312483|FG000|Overall Study|Lost to Follow-up|4|||
124914197|NCT04468776|449312484|FG001|Overall Study|Lost to Follow-up|3|||
124914198|NCT04468776|449312485|FG002|Overall Study|Lost to Follow-up|4|||
124914199|NCT04468776|449312483|FG000|Overall Study|Withdrawal by Subject|1|||
124914200|NCT04468776|449312484|FG001|Overall Study|Withdrawal by Subject|10|||
124914201|NCT04468776|449312485|FG002|Overall Study|Withdrawal by Subject|4|||
124914202|NCT04468776|449312483|FG000|Overall Study|Physician Decision|0|||
124914203|NCT04468776|449312484|FG001|Overall Study|Physician Decision|1|||
124914204|NCT04468776|449312485|FG002|Overall Study|Physician Decision|1|||
124914205|NCT04440176|449312488|FG000|Overall Study|Withdrawal by Subject|5|||
124914206|NCT04440176|449312489|FG001|Overall Study|Withdrawal by Subject|3|||
124914207|NCT04440176|449312488|FG000|Overall Study|Withdrawal by parent/guardian|4|||
124914208|NCT04440176|449312489|FG001|Overall Study|Withdrawal by parent/guardian|5|||
124914209|NCT04440176|449312488|FG000|Overall Study|Adverse Event|2|||
124914210|NCT04440176|449312489|FG001|Overall Study|Adverse Event|6|||
124914211|NCT04440176|449312488|FG000|Overall Study|Lost to Follow-up|22|||
124914212|NCT04440176|449312489|FG001|Overall Study|Lost to Follow-up|23|||
124914213|NCT04440176|449312488|FG000|Overall Study|Medication error without associated adverse event|0|||
124914214|NCT04440176|449312489|FG001|Overall Study|Medication error without associated adverse event|1|||
124914215|NCT04440176|449312488|FG000|Overall Study|No longer met eligibility criteria|7|||
124914216|NCT04440176|449312489|FG001|Overall Study|No longer met eligibility criteria|1|||
124914217|NCT04440176|449312488|FG000|Overall Study|Other|1|||
124914218|NCT04440176|449312489|FG001|Overall Study|Other|2|||
124914219|NCT04440176|449312488|FG000|Overall Study|Protocol deviation|6|||
124914220|NCT04440176|449312489|FG001|Overall Study|Protocol deviation|8|||
124914221|NCT04440176|449312488|FG000|Overall Study|Randomized but not vaccinated|6|||
124914222|NCT04440176|449312489|FG001|Overall Study|Randomized but not vaccinated|3|||
124914223|NCT01704079|449312493|FG000|Overall Study|Withdrawal by Subject|5|||
124914224|NCT01704079|449312494|FG001|Overall Study|Withdrawal by Subject|7|||
124914225|NCT01704079|449312493|FG000|Overall Study|Lost to Follow-up|2|||
124914226|NCT01704079|449312494|FG001|Overall Study|Lost to Follow-up|5|||
124914227|NCT01704079|449312493|FG000|Overall Study|Adverse Event|4|||
124914228|NCT01704079|449312494|FG001|Overall Study|Adverse Event|7|||
124914229|NCT01704079|449312493|FG000|Overall Study|Protocol Violation|1|||
124914230|NCT01704079|449312494|FG001|Overall Study|Protocol Violation|0|||
124914231|NCT01704079|449312493|FG000|Overall Study|Subject noncompliance|2|||
124914232|NCT01704079|449312494|FG001|Overall Study|Subject noncompliance|3|||
124914233|NCT01704079|449312493|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
124914234|NCT01704079|449312494|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
124914235|NCT03285763|449312497|FG000|Overall Study|Death|470|||
124914236|NCT03285763|449312497|FG000|Overall Study|Lost to Follow-up|18|||
124914237|NCT03285763|449312497|FG000|Overall Study|Physician Decision|2|||
124914238|NCT03285763|449312497|FG000|Overall Study|Study Terminated By Sponsor|79|||
124914239|NCT03285763|449312497|FG000|Overall Study|Withdrawal by Subject|33|||
124914240|NCT03624972|449312498|FG000|Overall Study|Lost to Follow-up|2|||
124914241|NCT03624972|449312499|FG001|Overall Study|Lost to Follow-up|0|||
124914242|NCT03624972|449312500|FG002|Overall Study|Lost to Follow-up|0|||
124914243|NCT03624972|449312498|FG000|Overall Study|Withdrawal by Subject|0|||
124914244|NCT03624972|449312499|FG001|Overall Study|Withdrawal by Subject|2|||
124914245|NCT03624972|449312500|FG002|Overall Study|Withdrawal by Subject|0|||
125022516|NCT01928381|449705445|FG005|Washout First Intervention|Protocol Violation|0|||
125022517|NCT01928381|449705446|FG006|Washout First Intervention|Protocol Violation|0|||
125022518|NCT01928381|449705440|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
125022519|NCT01928381|449705441|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
125022520|NCT01928381|449705442|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
125022521|NCT01928381|449705443|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
125022522|NCT01928381|449705444|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
125022523|NCT01928381|449705445|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
125022524|NCT01928381|449705446|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
125022525|NCT01928381|449705440|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
124914246|NCT03456076|449312501|FG000|Overall Study|Withdrawal by Subject|5|||
124914247|NCT03456076|449312502|FG001|Overall Study|Withdrawal by Subject|9|||
124914248|NCT03456076|449312501|FG000|Overall Study|Protocol deviation|0|||
124914249|NCT03456076|449312502|FG001|Overall Study|Protocol deviation|1|||
124914250|NCT03456076|449312501|FG000|Overall Study|Lost to Follow-up|0|||
124914251|NCT03456076|449312502|FG001|Overall Study|Lost to Follow-up|1|||
124914252|NCT03456076|449312501|FG000|Overall Study|Death|2|||
124914253|NCT03456076|449312502|FG001|Overall Study|Death|5|||
124914254|NCT03456076|449312501|FG000|Overall Study|Study ongoing|123|||
124914255|NCT03456076|449312502|FG001|Overall Study|Study ongoing|111|||
124914256|NCT04579250|449312506|FG000|Overall Study|Withdrawal by Subject|1|||
124914257|NCT04579250|449312507|FG001|Overall Study|Withdrawal by Subject|1|||
124914258|NCT04579250|449312508|FG002|Overall Study|Withdrawal by Subject|0|||
124914259|NCT04579250|449312506|FG000|Overall Study|Lost to Follow-up|1|||
124914260|NCT04579250|449312507|FG001|Overall Study|Lost to Follow-up|1|||
124914261|NCT04579250|449312508|FG002|Overall Study|Lost to Follow-up|0|||
124914262|NCT04579250|449312506|FG000|Overall Study|Moved from area|0|||
124914263|NCT04579250|449312507|FG001|Overall Study|Moved from area|1|||
124914264|NCT04579250|449312508|FG002|Overall Study|Moved from area|2|||
124914265|NCT04711135|449312513|FG000|Overall Study|Physician Decision|0|||
124914266|NCT04711135|449312514|FG001|Overall Study|Physician Decision|1|||
124914267|NCT04711135|449312513|FG000|Overall Study|Ongoing treatment|0|||
124914268|NCT04711135|449312514|FG001|Overall Study|Ongoing treatment|1|||
124914269|NCT00998881|449312515|FG000|Overall Study|Adverse Event|2|||
124914270|NCT00998881|449312516|FG001|Overall Study|Adverse Event|2|||
124914271|NCT00998881|449312515|FG000|Overall Study|Lack of Efficacy|1|||
124914272|NCT00998881|449312516|FG001|Overall Study|Lack of Efficacy|0|||
124914273|NCT00998881|449312515|FG000|Overall Study|Physician Decision|3|||
124914274|NCT00998881|449312516|FG001|Overall Study|Physician Decision|0|||
124914275|NCT00998881|449312515|FG000|Overall Study|Withdrawal by Subject|1|||
124914276|NCT00998881|449312516|FG001|Overall Study|Withdrawal by Subject|0|||
124914277|NCT00998881|449312515|FG000|Overall Study|Personal matter|1|||
124914278|NCT00998881|449312516|FG001|Overall Study|Personal matter|0|||
124914279|NCT00818246|449312518|FG000|Overall Study|Impossible to match pictures|5|||
124914280|NCT02006758|449312522|FG000|Overall Study|Protocol Violation|1|||
124914281|NCT02006758|449312522|FG000|Overall Study|Death|1|||
124914282|NCT02006758|449312522|FG000|Overall Study|Lost to Follow-up|4|||
124914283|NCT02006758|449312522|FG000|Overall Study|Withdrawal by Subject|4|||
124914284|NCT02006758|449312522|FG000|Overall Study|Procedurally excluded|1|||
124914285|NCT02006758|449312522|FG000|Overall Study|Other|2|||
124914286|NCT04788641|449312524|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
124914287|NCT04788641|449312525|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
124914288|NCT04788641|449312526|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
124914289|NCT04788641|449312527|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
124914290|NCT04788641|449312524|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
124914291|NCT04788641|449312525|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
124914292|NCT04788641|449312526|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
124914293|NCT04788641|449312527|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
124914294|NCT04788641|449312524|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
124914295|NCT04788641|449312525|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
124914296|NCT04788641|449312526|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
124914297|NCT04788641|449312527|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
124914298|NCT03283371|449312528|FG000|Placebo-controlled|Adverse Event|1|||
124914299|NCT03283371|449312529|FG001|Placebo-controlled|Adverse Event|1|||
124914300|NCT03283371|449312530|FG002|Placebo-controlled|Adverse Event|0|||
124914301|NCT03283371|449312531|FG003|Placebo-controlled|Adverse Event|0|||
124914302|NCT03283371|449312528|FG000|Placebo-controlled|Lack of Efficacy|1|||
124914303|NCT03283371|449312529|FG001|Placebo-controlled|Lack of Efficacy|0|||
124914304|NCT03283371|449312530|FG002|Placebo-controlled|Lack of Efficacy|0|||
124914305|NCT03283371|449312531|FG003|Placebo-controlled|Lack of Efficacy|0|||
124914306|NCT03283371|449312528|FG000|Placebo-controlled|Withdrawal by Subject|1|||
124914307|NCT03283371|449312529|FG001|Placebo-controlled|Withdrawal by Subject|1|||
124914308|NCT03283371|449312530|FG002|Placebo-controlled|Withdrawal by Subject|0|||
124914309|NCT03283371|449312531|FG003|Placebo-controlled|Withdrawal by Subject|0|||
124914310|NCT03283371|449312528|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
124914311|NCT03283371|449312529|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
124914312|NCT03283371|449312530|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
124914313|NCT03283371|449312531|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
124914314|NCT03283371|449312528|FG000|Open-label Phase|Adverse Event|0|||
124914315|NCT03283371|449312529|FG001|Open-label Phase|Adverse Event|0|||
124914316|NCT03283371|449312530|FG002|Open-label Phase|Adverse Event|2|||
124914317|NCT03283371|449312531|FG003|Open-label Phase|Adverse Event|0|||
124914318|NCT03283371|449312528|FG000|Open-label Phase|Withdrawal by Subject|0|||
124914319|NCT03283371|449312529|FG001|Open-label Phase|Withdrawal by Subject|0|||
124914320|NCT03283371|449312530|FG002|Open-label Phase|Withdrawal by Subject|1|||
124914321|NCT03283371|449312531|FG003|Open-label Phase|Withdrawal by Subject|0|||
124914322|NCT03283371|449312528|FG000|Open-label Phase|Other|0|||
124914323|NCT03283371|449312529|FG001|Open-label Phase|Other|0|||
124914324|NCT03283371|449312530|FG002|Open-label Phase|Other|1|||
124914325|NCT03283371|449312531|FG003|Open-label Phase|Other|1|||
124914326|NCT02462759|449312532|FG000|Part 1: Double Blind|Death|1|||
124914327|NCT02462759|449312533|FG001|Part 1: Double Blind|Death|0|||
124914328|NCT02462759|449312534|FG002|Part 1: Double Blind|Death|0|||
124914329|NCT00093015|449312535|FG000|Overall Study|Withdrawal by Subject|194|||
124914330|NCT00093015|449312536|FG001|Overall Study|Withdrawal by Subject|171|||
124914331|NCT00093015|449312535|FG000|Overall Study|Lost to Follow-up|96|||
124914332|NCT00093015|449312536|FG001|Overall Study|Lost to Follow-up|108|||
124914333|NCT00093015|449312535|FG000|Overall Study|Death|375|||
124914334|NCT00093015|449312536|FG001|Overall Study|Death|385|||
124914335|NCT04600752|449312539|FG000|Overall Study|Physician Decision|0|||
124914336|NCT04600752|449312540|FG001|Overall Study|Physician Decision|0|||
124914337|NCT04600752|449312541|FG002|Overall Study|Physician Decision|1|||
124914338|NCT04600752|449312539|FG000|Overall Study|Adverse Event|0|||
124914339|NCT04600752|449312540|FG001|Overall Study|Adverse Event|1|||
124914340|NCT04600752|449312541|FG002|Overall Study|Adverse Event|0|||
124914341|NCT04600752|449312539|FG000|Overall Study|Withdrawal by Subject|2|||
124914342|NCT04600752|449312540|FG001|Overall Study|Withdrawal by Subject|1|||
124914343|NCT04600752|449312541|FG002|Overall Study|Withdrawal by Subject|0|||
124914344|NCT04600752|449312539|FG000|Overall Study|Lack of Efficacy|1|||
124914345|NCT04600752|449312540|FG001|Overall Study|Lack of Efficacy|0|||
124914346|NCT04600752|449312541|FG002|Overall Study|Lack of Efficacy|0|||
124914347|NCT03398148|449314606|FG000|Substudy 1 Period 1|Adverse Event|5|||
124914348|NCT03398148|449314607|FG001|Substudy 1 Period 1|Adverse Event|2|||
124914349|NCT03398148|449314608|FG002|Substudy 1 Period 1|Adverse Event|2|||
124914350|NCT03398148|449314609|FG003|Substudy 1 Period 1|Adverse Event|0|||
124914351|NCT03398148|449314610|FG004|Substudy 1 Period 1|Adverse Event|8|||
124914352|NCT03398148|449314611|FG005|Substudy 1 Period 1|Adverse Event|0|||
124914353|NCT03398148|449314612|FG006|Substudy 1 Period 1|Adverse Event|0|||
124914354|NCT03398148|449314613|FG007|Substudy 1 Period 1|Adverse Event|0|||
124914355|NCT03398148|449314614|FG008|Substudy 1 Period 1|Adverse Event|0|||
124914356|NCT03398148|449314615|FG009|Substudy 1 Period 1|Adverse Event|0|||
124914357|NCT03398148|449314616|FG010|Substudy 1 Period 1|Adverse Event|0|||
124914358|NCT03398148|449314617|FG011|Substudy 1 Period 1|Adverse Event|0|||
124914359|NCT03398148|449314618|FG012|Substudy 1 Period 1|Adverse Event|0|||
124914360|NCT03398148|449314619|FG013|Substudy 1 Period 1|Adverse Event|0|||
124914361|NCT03398148|449314620|FG014|Substudy 1 Period 1|Adverse Event|0|||
124914362|NCT03398148|449314606|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
124914363|NCT03398148|449314607|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
124914364|NCT03398148|449314608|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914365|NCT03398148|449314609|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
124914366|NCT03398148|449314610|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
124914367|NCT03398148|449314611|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914368|NCT03398148|449314612|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914369|NCT03398148|449314613|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914370|NCT03398148|449314614|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914371|NCT03398148|449314615|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914372|NCT03398148|449314616|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914373|NCT03398148|449314617|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914374|NCT03398148|449314618|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914375|NCT03398148|449314619|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914376|NCT03398148|449314620|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914377|NCT03398148|449314606|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
124914378|NCT03398148|449314607|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
124914379|NCT03398148|449314608|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
124914380|NCT03398148|449314609|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
124914381|NCT03398148|449314610|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
124914382|NCT03398148|449314611|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
124914383|NCT03398148|449314612|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
124914384|NCT03398148|449314613|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
124914385|NCT03398148|449314614|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
124914386|NCT03398148|449314615|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
124914387|NCT03398148|449314616|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
124914388|NCT03398148|449314617|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
124914389|NCT03398148|449314618|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
124914390|NCT03398148|449314619|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
124914391|NCT03398148|449314620|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
124914392|NCT03398148|449314606|FG000|Substudy 1 Period 1|Other|0|||
124914393|NCT03398148|449314607|FG001|Substudy 1 Period 1|Other|1|||
124914394|NCT03398148|449314608|FG002|Substudy 1 Period 1|Other|0|||
124914395|NCT03398148|449314609|FG003|Substudy 1 Period 1|Other|0|||
124914396|NCT03398148|449314610|FG004|Substudy 1 Period 1|Other|3|||
124914397|NCT03398148|449314611|FG005|Substudy 1 Period 1|Other|0|||
124914398|NCT03398148|449314612|FG006|Substudy 1 Period 1|Other|0|||
124914399|NCT03398148|449314613|FG007|Substudy 1 Period 1|Other|0|||
124914400|NCT03398148|449314614|FG008|Substudy 1 Period 1|Other|0|||
124914401|NCT03398148|449314615|FG009|Substudy 1 Period 1|Other|0|||
124914402|NCT03398148|449314616|FG010|Substudy 1 Period 1|Other|0|||
124914403|NCT03398148|449314617|FG011|Substudy 1 Period 1|Other|0|||
124914404|NCT03398148|449314618|FG012|Substudy 1 Period 1|Other|0|||
124914405|NCT03398148|449314619|FG013|Substudy 1 Period 1|Other|0|||
124914406|NCT03398148|449314620|FG014|Substudy 1 Period 1|Other|0|||
124914407|NCT03398148|449314606|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914408|NCT03398148|449314607|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
125116117|NCT00678392|450048139|FG000|Overall Study|Sponsor's Decision|1|||
124914409|NCT03398148|449314608|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
125116118|NCT00678392|450048140|FG001|Overall Study|Sponsor's Decision|2|||
125116119|NCT00678392|450048139|FG000|Overall Study|Withdrawal by Subject|4|||
125116120|NCT00678392|450048140|FG001|Overall Study|Withdrawal by Subject|4|||
125116121|NCT00678392|450048139|FG000|Overall Study|Randomized But Not Treated|2|||
124914410|NCT03398148|449314609|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914411|NCT03398148|449314610|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
124914412|NCT03398148|449314611|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914413|NCT03398148|449314612|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914414|NCT03398148|449314613|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914415|NCT03398148|449314614|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914416|NCT03398148|449314615|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914417|NCT03398148|449314616|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914418|NCT03398148|449314617|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914419|NCT03398148|449314618|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914420|NCT03398148|449314619|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914421|NCT03398148|449314620|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914422|NCT03398148|449314606|FG000|Substudy 1 Period 2|Adverse Event|0|||
124914423|NCT03398148|449314607|FG001|Substudy 1 Period 2|Adverse Event|0|||
124914424|NCT03398148|449314608|FG002|Substudy 1 Period 2|Adverse Event|0|||
124914425|NCT03398148|449314609|FG003|Substudy 1 Period 2|Adverse Event|0|||
125116122|NCT00678392|450048140|FG001|Overall Study|Randomized But Not Treated|7|||
125116123|NCT00678392|450048139|FG000|Overall Study|Other|56|||
125116124|NCT00678392|450048140|FG001|Overall Study|Other|53|||
125116125|NCT03341507|450048142|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
125116126|NCT03882047|450048143|FG000|Overall Study|Adverse Event|0|||
125116127|NCT03882047|450048144|FG001|Overall Study|Adverse Event|2|||
125116128|NCT03882047|450048145|FG002|Overall Study|Adverse Event|2|||
125116129|NCT03882047|450048143|FG000|Overall Study|Treatment Failure|3|||
125116130|NCT03882047|450048144|FG001|Overall Study|Treatment Failure|3|||
125116131|NCT03882047|450048145|FG002|Overall Study|Treatment Failure|12|||
125116132|NCT03882047|450048143|FG000|Overall Study|Lost to Follow-up|0|||
125116133|NCT03882047|450048144|FG001|Overall Study|Lost to Follow-up|1|||
125116134|NCT03882047|450048145|FG002|Overall Study|Lost to Follow-up|0|||
125116135|NCT03882047|450048143|FG000|Overall Study|Did Not Wish to Continue|1|||
125116136|NCT03882047|450048144|FG001|Overall Study|Did Not Wish to Continue|4|||
125116137|NCT03882047|450048145|FG002|Overall Study|Did Not Wish to Continue|1|||
125116138|NCT03882047|450048143|FG000|Overall Study|Noncompliance With Protocol|2|||
124914426|NCT03398148|449314610|FG004|Substudy 1 Period 2|Adverse Event|0|||
124914427|NCT03398148|449314611|FG005|Substudy 1 Period 2|Adverse Event|2|||
124914428|NCT03398148|449314612|FG006|Substudy 1 Period 2|Adverse Event|4|||
124914429|NCT03398148|449314613|FG007|Substudy 1 Period 2|Adverse Event|0|||
124914430|NCT03398148|449314614|FG008|Substudy 1 Period 2|Adverse Event|0|||
124914431|NCT03398148|449314615|FG009|Substudy 1 Period 2|Adverse Event|0|||
124914432|NCT03398148|449314616|FG010|Substudy 1 Period 2|Adverse Event|0|||
124914433|NCT03398148|449314617|FG011|Substudy 1 Period 2|Adverse Event|0|||
124914434|NCT03398148|449314618|FG012|Substudy 1 Period 2|Adverse Event|0|||
124914435|NCT03398148|449314619|FG013|Substudy 1 Period 2|Adverse Event|0|||
124914436|NCT03398148|449314620|FG014|Substudy 1 Period 2|Adverse Event|0|||
124914437|NCT03398148|449314606|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914438|NCT03398148|449314607|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914439|NCT03398148|449314608|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914440|NCT03398148|449314609|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914441|NCT03398148|449314610|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914442|NCT03398148|449314611|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914443|NCT03398148|449314612|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
124914444|NCT03398148|449314613|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
124914445|NCT03398148|449314614|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914446|NCT03398148|449314615|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
125116139|NCT03882047|450048144|FG001|Overall Study|Noncompliance With Protocol|0|||
124914447|NCT03398148|449314616|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914448|NCT03398148|449314617|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914449|NCT03398148|449314618|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914450|NCT03398148|449314619|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914451|NCT03398148|449314620|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914452|NCT03398148|449314606|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
124914453|NCT03398148|449314607|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
124914454|NCT03398148|449314608|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
125116140|NCT03882047|450048145|FG002|Overall Study|Noncompliance With Protocol|0|||
125116141|NCT03882047|450048143|FG000|Overall Study|Did Not Meet Eligibility|0|||
124914455|NCT03398148|449314609|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
124914456|NCT03398148|449314610|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
124914457|NCT03398148|449314611|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
124914458|NCT03398148|449314612|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
124914459|NCT03398148|449314613|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
124914460|NCT03398148|449314614|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
124914461|NCT03398148|449314615|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
124914462|NCT03398148|449314616|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
124914463|NCT03398148|449314617|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
124914464|NCT03398148|449314618|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
124914465|NCT03398148|449314619|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
124914466|NCT03398148|449314620|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
124914467|NCT03398148|449314606|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914468|NCT03398148|449314607|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914469|NCT03398148|449314608|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914470|NCT03398148|449314609|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914471|NCT03398148|449314610|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914472|NCT03398148|449314611|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914473|NCT03398148|449314612|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
124914474|NCT03398148|449314613|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125116142|NCT03882047|450048144|FG001|Overall Study|Did Not Meet Eligibility|0|||
125116143|NCT03882047|450048145|FG002|Overall Study|Did Not Meet Eligibility|1|||
125116144|NCT00441584|450048148|FG000|Overall Study|Lack of Efficacy|79|||
125116145|NCT00441584|450048148|FG000|Overall Study|Withdrawal by Subject|8|||
125116146|NCT00441584|450048148|FG000|Overall Study|Adverse Event|6|||
125116147|NCT00441584|450048148|FG000|Overall Study|Protocol Violation|5|||
125116148|NCT00441584|450048148|FG000|Overall Study|Lost to Follow-up|4|||
125116149|NCT00441584|450048148|FG000|Overall Study|Failure to meet eligibility criteria|3|||
125116150|NCT00770991|450048153|FG000|Overall Study|Physician Decision|2|||
125116151|NCT00770991|450048154|FG001|Overall Study|Physician Decision|0|||
125116152|NCT00770991|450048153|FG000|Overall Study|Withdrawal by Subject|1|||
125116153|NCT00770991|450048154|FG001|Overall Study|Withdrawal by Subject|0|||
125116154|NCT00770991|450048153|FG000|Overall Study|Adverse Event|1|||
125116155|NCT00770991|450048154|FG001|Overall Study|Adverse Event|5|||
125116156|NCT00770991|450048153|FG000|Overall Study|Pregnancy|1|||
125116157|NCT00770991|450048154|FG001|Overall Study|Pregnancy|0|||
125116158|NCT03465891|450048155|FG000|Overall Study|Withdrawal by Subject|0|||
125116159|NCT03465891|450048156|FG001|Overall Study|Withdrawal by Subject|1|||
125116160|NCT03465891|450048155|FG000|Overall Study|Disease progression|1|||
125116161|NCT03465891|450048156|FG001|Overall Study|Disease progression|0|||
125116162|NCT01001169|450048157|FG000|Overall Study|Withdrawal by Subject|2|||
125116163|NCT01001169|450048158|FG001|Overall Study|Withdrawal by Subject|1|||
125116164|NCT02040766|450048161|FG000|Overall Study|Adverse Event|1|||
125116165|NCT02040766|450048162|FG001|Overall Study|Adverse Event|1|||
125116166|NCT02040766|450048163|FG002|Overall Study|Adverse Event|1|||
125116167|NCT02040766|450048164|FG003|Overall Study|Adverse Event|0|||
125116168|NCT02040766|450048165|FG004|Overall Study|Adverse Event|2|||
125116169|NCT02040766|450048161|FG000|Overall Study|Withdrawal by Subject|4|||
125116170|NCT02040766|450048162|FG001|Overall Study|Withdrawal by Subject|3|||
125116171|NCT02040766|450048163|FG002|Overall Study|Withdrawal by Subject|2|||
125116172|NCT02040766|450048164|FG003|Overall Study|Withdrawal by Subject|3|||
125116173|NCT02040766|450048165|FG004|Overall Study|Withdrawal by Subject|2|||
125116174|NCT02040766|450048161|FG000|Overall Study|Non-compliance|0|||
125116175|NCT02040766|450048162|FG001|Overall Study|Non-compliance|1|||
125116176|NCT02040766|450048163|FG002|Overall Study|Non-compliance|0|||
124914475|NCT03398148|449314614|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914476|NCT03398148|449314615|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914477|NCT03398148|449314616|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125116177|NCT02040766|450048164|FG003|Overall Study|Non-compliance|0|||
125116178|NCT02040766|450048165|FG004|Overall Study|Non-compliance|0|||
124914478|NCT03398148|449314617|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914479|NCT03398148|449314618|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914480|NCT03398148|449314619|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914481|NCT03398148|449314620|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125116179|NCT02040766|450048161|FG000|Overall Study|Protocol Violation|2|||
125116180|NCT02040766|450048162|FG001|Overall Study|Protocol Violation|1|||
125116181|NCT02040766|450048163|FG002|Overall Study|Protocol Violation|2|||
124914482|NCT03398148|449314606|FG000|Substudy 1 Period 2|Other|0|||
124914483|NCT03398148|449314607|FG001|Substudy 1 Period 2|Other|0|||
124914484|NCT03398148|449314608|FG002|Substudy 1 Period 2|Other|0|||
125116182|NCT02040766|450048164|FG003|Overall Study|Protocol Violation|3|||
124914485|NCT03398148|449314609|FG003|Substudy 1 Period 2|Other|0|||
124914486|NCT03398148|449314610|FG004|Substudy 1 Period 2|Other|0|||
124914487|NCT03398148|449314611|FG005|Substudy 1 Period 2|Other|0|||
124914488|NCT03398148|449314612|FG006|Substudy 1 Period 2|Other|1|||
124914489|NCT03398148|449314613|FG007|Substudy 1 Period 2|Other|0|||
124914490|NCT03398148|449314614|FG008|Substudy 1 Period 2|Other|0|||
124914491|NCT03398148|449314615|FG009|Substudy 1 Period 2|Other|0|||
124914492|NCT03398148|449314616|FG010|Substudy 1 Period 2|Other|0|||
125116183|NCT02040766|450048165|FG004|Overall Study|Protocol Violation|0|||
125116184|NCT02040766|450048161|FG000|Overall Study|Lost to Follow-up|4|||
125116185|NCT02040766|450048162|FG001|Overall Study|Lost to Follow-up|1|||
125116186|NCT02040766|450048163|FG002|Overall Study|Lost to Follow-up|3|||
125116187|NCT02040766|450048164|FG003|Overall Study|Lost to Follow-up|1|||
125116188|NCT02040766|450048165|FG004|Overall Study|Lost to Follow-up|4|||
125116189|NCT02040766|450048161|FG000|Overall Study|Not reported|1|||
125116190|NCT02040766|450048162|FG001|Overall Study|Not reported|0|||
124914493|NCT03398148|449314617|FG011|Substudy 1 Period 2|Other|0|||
124914494|NCT03398148|449314618|FG012|Substudy 1 Period 2|Other|0|||
124914495|NCT03398148|449314619|FG013|Substudy 1 Period 2|Other|0|||
125116191|NCT02040766|450048163|FG002|Overall Study|Not reported|0|||
125116192|NCT02040766|450048164|FG003|Overall Study|Not reported|0|||
124914496|NCT03398148|449314620|FG014|Substudy 1 Period 2|Other|0|||
124914497|NCT03398148|449314606|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914498|NCT03398148|449314607|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914499|NCT03398148|449314608|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914500|NCT03398148|449314609|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914501|NCT03398148|449314610|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914502|NCT03398148|449314611|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914503|NCT03398148|449314612|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
124914504|NCT03398148|449314613|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914505|NCT03398148|449314614|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914506|NCT03398148|449314615|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914507|NCT03398148|449314616|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914508|NCT03398148|449314617|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914509|NCT03398148|449314618|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914510|NCT03398148|449314619|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914511|NCT03398148|449314620|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914512|NCT03398148|449314606|FG000|Substudy 2 Period 1|Adverse Event|0|||
124914513|NCT03398148|449314607|FG001|Substudy 2 Period 1|Adverse Event|0|||
124914514|NCT03398148|449314608|FG002|Substudy 2 Period 1|Adverse Event|0|||
124914515|NCT03398148|449314609|FG003|Substudy 2 Period 1|Adverse Event|0|||
124914516|NCT03398148|449314610|FG004|Substudy 2 Period 1|Adverse Event|0|||
124914517|NCT03398148|449314611|FG005|Substudy 2 Period 1|Adverse Event|0|||
124914518|NCT03398148|449314612|FG006|Substudy 2 Period 1|Adverse Event|0|||
124914519|NCT03398148|449314613|FG007|Substudy 2 Period 1|Adverse Event|0|||
124914520|NCT03398148|449314614|FG008|Substudy 2 Period 1|Adverse Event|0|||
124914521|NCT03398148|449314615|FG009|Substudy 2 Period 1|Adverse Event|12|||
124914522|NCT03398148|449314616|FG010|Substudy 2 Period 1|Adverse Event|2|||
124914523|NCT03398148|449314617|FG011|Substudy 2 Period 1|Adverse Event|0|||
124914524|NCT03398148|449314618|FG012|Substudy 2 Period 1|Adverse Event|0|||
124914525|NCT03398148|449314619|FG013|Substudy 2 Period 1|Adverse Event|0|||
124914526|NCT03398148|449314620|FG014|Substudy 2 Period 1|Adverse Event|0|||
124914527|NCT03398148|449314606|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914528|NCT03398148|449314607|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914529|NCT03398148|449314608|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914530|NCT03398148|449314609|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914531|NCT03398148|449314610|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914532|NCT03398148|449314611|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914533|NCT03398148|449314612|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914534|NCT03398148|449314613|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914535|NCT03398148|449314614|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914536|NCT03398148|449314615|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
124914537|NCT03398148|449314616|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
124914538|NCT03398148|449314617|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914539|NCT03398148|449314618|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914540|NCT03398148|449314619|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914541|NCT03398148|449314620|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914542|NCT03398148|449314606|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
124914543|NCT03398148|449314607|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
125116193|NCT02040766|450048165|FG004|Overall Study|Not reported|0|||
124914544|NCT03398148|449314608|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
124914545|NCT03398148|449314609|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
124914546|NCT03398148|449314610|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
124914547|NCT03398148|449314611|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
124914548|NCT03398148|449314612|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
124914549|NCT03398148|449314613|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
124914550|NCT03398148|449314614|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
124914551|NCT03398148|449314615|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
124914552|NCT03398148|449314616|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
124914553|NCT03398148|449314617|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
124914554|NCT03398148|449314618|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
124914555|NCT03398148|449314619|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
124914556|NCT03398148|449314620|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
124914557|NCT03398148|449314606|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914558|NCT03398148|449314607|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914559|NCT03398148|449314608|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914560|NCT03398148|449314609|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914561|NCT03398148|449314610|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914562|NCT03398148|449314611|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914563|NCT03398148|449314612|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914564|NCT03398148|449314613|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914565|NCT03398148|449314614|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914566|NCT03398148|449314615|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914567|NCT03398148|449314616|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
124914568|NCT03398148|449314617|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914569|NCT03398148|449314618|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914570|NCT03398148|449314619|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914571|NCT03398148|449314620|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914572|NCT03398148|449314606|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914573|NCT03398148|449314607|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914574|NCT03398148|449314608|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914575|NCT03398148|449314609|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914576|NCT03398148|449314610|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914577|NCT03398148|449314611|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125116194|NCT02040766|450048161|FG000|Overall Study|Lack of Efficacy|6|||
124914578|NCT03398148|449314612|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914579|NCT03398148|449314613|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914580|NCT03398148|449314614|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914581|NCT03398148|449314615|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914582|NCT03398148|449314616|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
124914583|NCT03398148|449314617|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914584|NCT03398148|449314618|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914585|NCT03398148|449314619|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914586|NCT03398148|449314620|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914587|NCT03398148|449314606|FG000|Substudy 2 Period 1|Other|0|||
125022526|NCT01928381|449705441|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
125022527|NCT01928381|449705442|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
125022528|NCT01928381|449705443|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
125022529|NCT01928381|449705444|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
125022530|NCT01928381|449705445|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
125022531|NCT01928381|449705446|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
125022532|NCT05036083|449705447|FG000|Overall Study|Physician Decision|1|||
125022533|NCT05036083|449705447|FG000|Overall Study|Withdrawal by Subject|1|||
125022534|NCT05036083|449705447|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
125022535|NCT05036083|449705447|FG000|Overall Study|IV not sustainable|1|||
125022536|NCT03087955|449707766|FG000|Overall Study|Death|4|||
125022537|NCT03087955|449707767|FG001|Overall Study|Death|0|||
125022538|NCT03087955|449707766|FG000|Overall Study|Lack of Efficacy|2|||
125022539|NCT03087955|449707767|FG001|Overall Study|Lack of Efficacy|0|||
125022540|NCT03087955|449707766|FG000|Overall Study|Lost to Follow-up|1|||
125022541|NCT03087955|449707767|FG001|Overall Study|Lost to Follow-up|0|||
125022542|NCT02392429|449707768|FG000|Screening|Screen failure|15|||
125022543|NCT02392429|449707768|FG000|Enrolled Participants|Ineligible due to disease|3|||
125022544|NCT02392429|449707768|FG000|Enrolled Participants|Withdrawal by Subject|4|||
125022545|NCT02392429|449707768|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
125022546|NCT02392429|449707768|FG000|Evaluable|Death|5|||
124914588|NCT03398148|449314607|FG001|Substudy 2 Period 1|Other|0|||
124914589|NCT03398148|449314608|FG002|Substudy 2 Period 1|Other|0|||
124914590|NCT03398148|449314609|FG003|Substudy 2 Period 1|Other|0|||
124914591|NCT03398148|449314610|FG004|Substudy 2 Period 1|Other|0|||
124914592|NCT03398148|449314611|FG005|Substudy 2 Period 1|Other|0|||
124914593|NCT03398148|449314612|FG006|Substudy 2 Period 1|Other|0|||
124914594|NCT03398148|449314613|FG007|Substudy 2 Period 1|Other|0|||
124914595|NCT03398148|449314614|FG008|Substudy 2 Period 1|Other|0|||
124914596|NCT03398148|449314615|FG009|Substudy 2 Period 1|Other|4|||
124914597|NCT03398148|449314616|FG010|Substudy 2 Period 1|Other|4|||
124914598|NCT03398148|449314617|FG011|Substudy 2 Period 1|Other|0|||
124914599|NCT03398148|449314618|FG012|Substudy 2 Period 1|Other|0|||
124914600|NCT03398148|449314619|FG013|Substudy 2 Period 1|Other|0|||
124914601|NCT03398148|449314620|FG014|Substudy 2 Period 1|Other|0|||
124914602|NCT03398148|449314606|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914603|NCT03398148|449314607|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
125022547|NCT02392429|449707768|FG000|Evaluable|Withdrawal by Subject|1|||
125022548|NCT02392429|449707768|FG000|Evaluable|Adverse Event|1|||
125022549|NCT02392429|449707768|FG000|Evaluable|remission bone marrow biopsy|3|||
125022550|NCT03656562|449707769|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
125022551|NCT03656562|449707770|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
125022552|NCT03656562|449707771|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
125022553|NCT03656562|449707772|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
125022554|NCT03656562|449707769|FG000|Overall Study|Physician Decision|1|||
125022555|NCT03656562|449707770|FG001|Overall Study|Physician Decision|2|||
125022556|NCT03656562|449707771|FG002|Overall Study|Physician Decision|0|||
125022557|NCT03656562|449707772|FG003|Overall Study|Physician Decision|0|||
125022558|NCT03656562|449707769|FG000|Overall Study|Subject Decision|3|||
125022559|NCT03656562|449707770|FG001|Overall Study|Subject Decision|5|||
125022560|NCT03656562|449707771|FG002|Overall Study|Subject Decision|0|||
125022561|NCT03656562|449707772|FG003|Overall Study|Subject Decision|2|||
125022562|NCT00482014|449707773|FG000|Overall Study|Withdrawal by Subject|1|||
125022563|NCT00482014|449707774|FG001|Overall Study|Withdrawal by Subject|2|||
125022564|NCT00482014|449707775|FG002|Overall Study|Withdrawal by Subject|3|||
125022565|NCT00482014|449707776|FG003|Overall Study|Withdrawal by Subject|4|||
125022566|NCT00482014|449707773|FG000|Overall Study|Adverse Event|3|||
125022567|NCT00482014|449707774|FG001|Overall Study|Adverse Event|0|||
125022568|NCT00482014|449707775|FG002|Overall Study|Adverse Event|2|||
125022569|NCT00482014|449707776|FG003|Overall Study|Adverse Event|8|||
125022570|NCT00482014|449707773|FG000|Overall Study|Death|1|||
125022571|NCT00482014|449707774|FG001|Overall Study|Death|2|||
125022572|NCT00482014|449707775|FG002|Overall Study|Death|1|||
125022573|NCT00482014|449707776|FG003|Overall Study|Death|4|||
125022574|NCT00482014|449707773|FG000|Overall Study|Lack of Efficacy|1|||
125022575|NCT00482014|449707774|FG001|Overall Study|Lack of Efficacy|0|||
125022576|NCT00482014|449707775|FG002|Overall Study|Lack of Efficacy|4|||
125022577|NCT00482014|449707776|FG003|Overall Study|Lack of Efficacy|6|||
125022578|NCT00482014|449707773|FG000|Overall Study|Sponsor Decision|1|||
125022579|NCT00482014|449707774|FG001|Overall Study|Sponsor Decision|2|||
125022580|NCT00482014|449707775|FG002|Overall Study|Sponsor Decision|1|||
125022581|NCT00482014|449707776|FG003|Overall Study|Sponsor Decision|1|||
125022582|NCT01178138|449707777|FG000|Overall Study|Lost to Follow-up|8|||
125022583|NCT01178138|449707777|FG000|Overall Study|Withdrawal by Subject|7|||
125022584|NCT01178138|449707777|FG000|Overall Study|Physician Decision|8|||
125022585|NCT01241708|449707778|FG000|Overall Study|Withdrawal by Subject|6|||
125022586|NCT01241708|449707778|FG000|Overall Study|Screen Failure|6|||
125022587|NCT01241708|449707778|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
125022588|NCT01241708|449707778|FG000|Overall Study|Lost to Follow-up|5|||
125022589|NCT02968810|449707779|FG000|Overall Study|Lost to Follow-up|1|||
125022590|NCT02968810|449707780|FG001|Overall Study|Lost to Follow-up|0|||
125022591|NCT02968810|449707779|FG000|Overall Study|Physician Decision|1|||
125022592|NCT02968810|449707780|FG001|Overall Study|Physician Decision|0|||
125022593|NCT02968810|449707779|FG000|Overall Study|Withdrawal by Subject|1|||
125022594|NCT02968810|449707780|FG001|Overall Study|Withdrawal by Subject|3|||
125022595|NCT02968810|449707779|FG000|Overall Study|Disease Progression|0|||
125022596|NCT02968810|449707780|FG001|Overall Study|Disease Progression|1|||
125022597|NCT04137887|449707781|FG000|Overall Study|Death|102|||
125022598|NCT04137887|449707782|FG001|Overall Study|Death|92|||
125022599|NCT04137887|449707781|FG000|Overall Study|Withdrawal by Subject|2|||
124914604|NCT03398148|449314608|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
125022600|NCT04137887|449707782|FG001|Overall Study|Withdrawal by Subject|3|||
125116195|NCT02040766|450048162|FG001|Overall Study|Lack of Efficacy|3|||
124914605|NCT03398148|449314609|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914606|NCT03398148|449314610|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914607|NCT03398148|449314611|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914608|NCT03398148|449314612|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914609|NCT03398148|449314613|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914610|NCT03398148|449314614|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914611|NCT03398148|449314615|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914612|NCT03398148|449314616|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
124914613|NCT03398148|449314617|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914614|NCT03398148|449314618|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914615|NCT03398148|449314619|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914616|NCT03398148|449314620|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914617|NCT03398148|449314606|FG000|Substudy 2 Period 2|Adverse Event|0|||
124914618|NCT03398148|449314607|FG001|Substudy 2 Period 2|Adverse Event|0|||
124914619|NCT03398148|449314608|FG002|Substudy 2 Period 2|Adverse Event|0|||
124914620|NCT03398148|449314609|FG003|Substudy 2 Period 2|Adverse Event|0|||
124914621|NCT03398148|449314610|FG004|Substudy 2 Period 2|Adverse Event|0|||
124914622|NCT03398148|449314611|FG005|Substudy 2 Period 2|Adverse Event|0|||
124914623|NCT03398148|449314612|FG006|Substudy 2 Period 2|Adverse Event|0|||
124914624|NCT03398148|449314613|FG007|Substudy 2 Period 2|Adverse Event|0|||
124914625|NCT03398148|449314614|FG008|Substudy 2 Period 2|Adverse Event|0|||
124914626|NCT03398148|449314615|FG009|Substudy 2 Period 2|Adverse Event|0|||
124914627|NCT03398148|449314616|FG010|Substudy 2 Period 2|Adverse Event|0|||
124914628|NCT03398148|449314617|FG011|Substudy 2 Period 2|Adverse Event|0|||
124914629|NCT03398148|449314618|FG012|Substudy 2 Period 2|Adverse Event|0|||
124914630|NCT03398148|449314619|FG013|Substudy 2 Period 2|Adverse Event|1|||
124914631|NCT03398148|449314620|FG014|Substudy 2 Period 2|Adverse Event|3|||
124914632|NCT03398148|449314606|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
124914633|NCT03398148|449314607|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
124914634|NCT03398148|449314608|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
124914635|NCT03398148|449314609|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
124914636|NCT03398148|449314610|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
124914637|NCT03398148|449314611|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
124914638|NCT03398148|449314612|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
124914639|NCT03398148|449314613|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
124914640|NCT03398148|449314614|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
124914641|NCT03398148|449314615|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
124914642|NCT03398148|449314616|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
124914643|NCT03398148|449314617|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
124914644|NCT03398148|449314618|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
124914645|NCT03398148|449314619|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
124914646|NCT03398148|449314620|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
124914647|NCT03398148|449314606|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914648|NCT03398148|449314607|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914649|NCT03398148|449314608|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914650|NCT03398148|449314609|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914651|NCT03398148|449314610|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914652|NCT03398148|449314611|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914653|NCT03398148|449314612|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914654|NCT03398148|449314613|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914655|NCT03398148|449314614|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914656|NCT03398148|449314615|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914657|NCT03398148|449314616|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914658|NCT03398148|449314617|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
124914659|NCT03398148|449314618|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914660|NCT03398148|449314619|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
124914661|NCT03398148|449314620|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
124914662|NCT03398148|449314606|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
124914663|NCT03398148|449314607|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
124914664|NCT03398148|449314608|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
124914665|NCT03398148|449314609|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
124914666|NCT03398148|449314610|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
124914667|NCT03398148|449314611|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
125116196|NCT02040766|450048163|FG002|Overall Study|Lack of Efficacy|4|||
125116197|NCT02040766|450048164|FG003|Overall Study|Lack of Efficacy|6|||
124914668|NCT03398148|449314612|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
124914669|NCT03398148|449314613|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
124914670|NCT03398148|449314614|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
124914671|NCT03398148|449314615|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
124914672|NCT03398148|449314616|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
124914673|NCT03398148|449314617|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
124914674|NCT03398148|449314618|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
124914675|NCT03398148|449314619|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
124914676|NCT03398148|449314620|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
124914677|NCT03398148|449314606|FG000|Substudy 2 Period 2|Other|0|||
124914678|NCT03398148|449314607|FG001|Substudy 2 Period 2|Other|0|||
124914679|NCT03398148|449314608|FG002|Substudy 2 Period 2|Other|0|||
124914680|NCT03398148|449314609|FG003|Substudy 2 Period 2|Other|0|||
124914681|NCT03398148|449314610|FG004|Substudy 2 Period 2|Other|0|||
124914682|NCT03398148|449314611|FG005|Substudy 2 Period 2|Other|0|||
124914683|NCT03398148|449314612|FG006|Substudy 2 Period 2|Other|0|||
124914684|NCT03398148|449314613|FG007|Substudy 2 Period 2|Other|0|||
124914685|NCT03398148|449314614|FG008|Substudy 2 Period 2|Other|0|||
124914686|NCT03398148|449314615|FG009|Substudy 2 Period 2|Other|0|||
124914687|NCT03398148|449314616|FG010|Substudy 2 Period 2|Other|0|||
124914688|NCT03398148|449314617|FG011|Substudy 2 Period 2|Other|0|||
124914689|NCT03398148|449314618|FG012|Substudy 2 Period 2|Other|0|||
124914690|NCT03398148|449314619|FG013|Substudy 2 Period 2|Other|1|||
124914691|NCT03398148|449314620|FG014|Substudy 2 Period 2|Other|1|||
124914692|NCT03398148|449314606|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914693|NCT03398148|449314607|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914694|NCT03398148|449314608|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914695|NCT03398148|449314609|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914696|NCT03398148|449314610|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914697|NCT03398148|449314611|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914698|NCT03398148|449314612|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914699|NCT03398148|449314613|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914700|NCT03398148|449314614|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914701|NCT03398148|449314615|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914702|NCT03398148|449314616|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914703|NCT03398148|449314617|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914704|NCT03398148|449314618|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
124914705|NCT03398148|449314619|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914706|NCT03398148|449314620|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
125116198|NCT02040766|450048165|FG004|Overall Study|Lack of Efficacy|5|||
125116199|NCT00481247|450048175|FG000|Overall Study|Death|0|||
125116200|NCT00481247|450048176|FG001|Overall Study|Death|1|||
125116201|NCT00481247|450048175|FG000|Overall Study|Disease progression|18|||
125116202|NCT00481247|450048176|FG001|Overall Study|Disease progression|22|||
125116203|NCT00481247|450048175|FG000|Overall Study|Intolerance|42|||
125116204|NCT00481247|450048176|FG001|Overall Study|Intolerance|17|||
125116205|NCT00481247|450048175|FG000|Overall Study|Treatment failure|10|||
125116206|NCT00481247|450048176|FG001|Overall Study|Treatment failure|14|||
125116207|NCT00481247|450048175|FG000|Overall Study|AE unrelated to study drug|13|||
125116208|NCT00481247|450048176|FG001|Overall Study|AE unrelated to study drug|4|||
125116209|NCT00481247|450048175|FG000|Overall Study|Withdrawal by Subject|8|||
125116210|NCT00481247|450048176|FG001|Overall Study|Withdrawal by Subject|13|||
125116211|NCT00481247|450048175|FG000|Overall Study|Pregnancy|2|||
125116212|NCT00481247|450048176|FG001|Overall Study|Pregnancy|1|||
125116213|NCT00481247|450048175|FG000|Overall Study|Lost to Follow-up|1|||
125116214|NCT00481247|450048176|FG001|Overall Study|Lost to Follow-up|2|||
125116215|NCT00481247|450048175|FG000|Overall Study|Poor compliance/noncompliance|1|||
125116216|NCT00481247|450048176|FG001|Overall Study|Poor compliance/noncompliance|7|||
125116217|NCT00481247|450048175|FG000|Overall Study|Administrative reason by sponsor|157|||
125116218|NCT00481247|450048176|FG001|Overall Study|Administrative reason by sponsor|162|||
125116219|NCT00481247|450048175|FG000|Overall Study|Varied|6|||
125116220|NCT00481247|450048176|FG001|Overall Study|Varied|15|||
125116221|NCT00481247|450048175|FG000|Overall Study|Did not receive treatment|1|||
125116222|NCT00481247|450048176|FG001|Overall Study|Did not receive treatment|2|||
125116223|NCT02535000|450048177|FG000|Overall Study|Cancellation of surgery.|1|||
125116224|NCT02535000|450048178|FG001|Overall Study|Cancellation of surgery.|2|||
125116225|NCT04317781|450048179|FG000|Overall Study|Adverse Event|1|||
125116226|NCT04317781|450048179|FG000|Overall Study|Disease relapse|1|||
125116227|NCT04317781|450048179|FG000|Overall Study|Withdrawal by Subject|1|||
125116228|NCT01620489|450048180|FG000|Overall Study|Adverse Event|17|||
125116229|NCT01620489|450048181|FG001|Overall Study|Adverse Event|4|||
125116230|NCT01620489|450048180|FG000|Overall Study|Protocol Violation|0|||
125116231|NCT01620489|450048181|FG001|Overall Study|Protocol Violation|3|||
125116232|NCT01620489|450048180|FG000|Overall Study|Withdrawal Criteria|17|||
125116233|NCT01620489|450048181|FG001|Overall Study|Withdrawal Criteria|25|||
125116234|NCT01620489|450048180|FG000|Overall Study|Unclassified|1|||
125116235|NCT01620489|450048181|FG001|Overall Study|Unclassified|2|||
125116236|NCT00947856|450048182|FG000|Treatment Period|Progressive Disease|33|||
125116237|NCT00947856|450048183|FG001|Treatment Period|Progressive Disease|12|||
125116238|NCT00947856|450048182|FG000|Treatment Period|Adverse Event|15|||
124914707|NCT02791230|449314621|FG000|Overall Study|Adverse Event|10|||
124914708|NCT02791230|449314622|FG001|Overall Study|Adverse Event|9|||
124914709|NCT02791230|449314623|FG002|Overall Study|Adverse Event|66|||
124914710|NCT02791230|449314621|FG000|Overall Study|Death|38|||
124914711|NCT02791230|449314622|FG001|Overall Study|Death|25|||
124914712|NCT02791230|449314623|FG002|Overall Study|Death|184|||
125116239|NCT00947856|450048183|FG001|Treatment Period|Adverse Event|9|||
125116240|NCT00947856|450048182|FG000|Treatment Period|Physician Decision|14|||
125116241|NCT00947856|450048183|FG001|Treatment Period|Physician Decision|6|||
124914713|NCT02791230|449314621|FG000|Overall Study|Lack of Efficacy|1|||
124914714|NCT02791230|449314622|FG001|Overall Study|Lack of Efficacy|0|||
124914715|NCT02791230|449314623|FG002|Overall Study|Lack of Efficacy|3|||
124914716|NCT02791230|449314621|FG000|Overall Study|Lost to Follow-up|0|||
124914717|NCT02791230|449314622|FG001|Overall Study|Lost to Follow-up|0|||
124914718|NCT02791230|449314623|FG002|Overall Study|Lost to Follow-up|10|||
124914719|NCT02791230|449314621|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
124914720|NCT02791230|449314622|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
124914721|NCT02791230|449314623|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
124914722|NCT02791230|449314621|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
124914723|NCT02791230|449314622|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
124914724|NCT02791230|449314623|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
124914725|NCT02791230|449314621|FG000|Overall Study|Study sites terminated by sponsor|1|||
124914726|NCT02791230|449314622|FG001|Overall Study|Study sites terminated by sponsor|0|||
124914727|NCT02791230|449314623|FG002|Overall Study|Study sites terminated by sponsor|5|||
124914728|NCT02791230|449314621|FG000|Overall Study|Other|9|||
124914729|NCT02791230|449314622|FG001|Overall Study|Other|1|||
124914730|NCT02791230|449314623|FG002|Overall Study|Other|28|||
124914731|NCT02791230|449314621|FG000|Overall Study|Protocol Violation|0|||
124914732|NCT02791230|449314622|FG001|Overall Study|Protocol Violation|0|||
124914733|NCT02791230|449314623|FG002|Overall Study|Protocol Violation|4|||
124914734|NCT02791230|449314621|FG000|Overall Study|Withdrawal by Subject|24|||
124914735|NCT02791230|449314622|FG001|Overall Study|Withdrawal by Subject|13|||
124914736|NCT02791230|449314623|FG002|Overall Study|Withdrawal by Subject|172|||
124914737|NCT02791230|449314621|FG000|Overall Study|Enrolled but not treated|0|||
124914738|NCT02791230|449314622|FG001|Overall Study|Enrolled but not treated|0|||
124914739|NCT02791230|449314623|FG002|Overall Study|Enrolled but not treated|5|||
124914740|NCT04201834|449314631|FG000|Overall Study|Screen fail|1|||
124914741|NCT00212355|449314632|FG000|Overall Study|Adverse Event|1|||
124914742|NCT00212355|449314632|FG000|Overall Study|Withdrawal by Subject|1|||
124914743|NCT00212355|449314632|FG000|Overall Study|A change of address|1|||
124914744|NCT04310735|449314634|FG000|Overall Study|Withdrawal by Subject|1|||
124914745|NCT04310735|449314635|FG001|Overall Study|Withdrawal by Subject|3|||
124914746|NCT04310735|449314636|FG002|Overall Study|Withdrawal by Subject|8|||
124914747|NCT04310735|449314634|FG000|Overall Study|Equipment malfunction|0|||
124914748|NCT04310735|449314635|FG001|Overall Study|Equipment malfunction|1|||
124914749|NCT04310735|449314636|FG002|Overall Study|Equipment malfunction|0|||
124914750|NCT04104321|449314637|FG000|Overall Study|didn't take the study drug|3|||
124914751|NCT04608045|449314638|FG000|Overall Study|Physician Decision|1|||
124914752|NCT03517553|449314639|FG000|Overall Study|Withdrawal by Subject|2|||
124914753|NCT03271151|449314640|FG000|Overall Study|Lost to Follow-up|1|||
124914754|NCT03271151|449314641|FG001|Overall Study|Lost to Follow-up|3|||
124914755|NCT03271151|449314640|FG000|Overall Study|Withdrawal by Subject|1|||
124914756|NCT03271151|449314641|FG001|Overall Study|Withdrawal by Subject|0|||
124914757|NCT03575052|449314642|FG000|Overall Study|Adverse Event|6|||
124914758|NCT03575052|449314643|FG001|Overall Study|Adverse Event|10|||
124914759|NCT03575052|449314642|FG000|Overall Study|Not further specified|5|||
124914760|NCT03575052|449314643|FG001|Overall Study|Not further specified|7|||
124914761|NCT03575052|449314642|FG000|Overall Study|Withdrawal by Subject|5|||
124914762|NCT03575052|449314643|FG001|Overall Study|Withdrawal by Subject|6|||
124914763|NCT03575052|449314642|FG000|Overall Study|Lost to Follow-up|3|||
124914764|NCT03575052|449314643|FG001|Overall Study|Lost to Follow-up|0|||
124914765|NCT03575052|449314642|FG000|Overall Study|Death|2|||
124914766|NCT03575052|449314643|FG001|Overall Study|Death|1|||
124914767|NCT03575052|449314642|FG000|Overall Study|Lack of Efficacy|2|||
124914768|NCT03575052|449314643|FG001|Overall Study|Lack of Efficacy|1|||
124914769|NCT03575052|449314642|FG000|Overall Study|Study drug noncompliance|1|||
124914770|NCT03575052|449314643|FG001|Overall Study|Study drug noncompliance|2|||
124914771|NCT03575052|449314642|FG000|Overall Study|Protocol Violation|0|||
124914772|NCT03575052|449314643|FG001|Overall Study|Protocol Violation|2|||
124914773|NCT03575052|449314642|FG000|Overall Study|Physician Decision|1|||
124914774|NCT03575052|449314643|FG001|Overall Study|Physician Decision|0|||
124914775|NCT03103321|449314644|FG000|Overall Study|Protocol Violation|1|||
124914776|NCT03103321|449314645|FG001|Overall Study|Protocol Violation|1|||
124914777|NCT03103321|449314646|FG002|Overall Study|Protocol Violation|1|||
124914778|NCT03103321|449314647|FG003|Overall Study|Protocol Violation|0|||
124914779|NCT04247542|449314648|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
124914780|NCT04247542|449314649|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
124914781|NCT04247542|449314650|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
124914782|NCT04247542|449314648|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
124914783|NCT04247542|449314649|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
124914784|NCT04247542|449314650|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
124914785|NCT04118452|449314651|FG000|Overall Study|Lost to Follow-up|5|||
124914786|NCT04118452|449314652|FG001|Overall Study|Lost to Follow-up|5|||
124914787|NCT04118452|449314651|FG000|Overall Study|Withdrawal by Subject|17|||
124914788|NCT04118452|449314652|FG001|Overall Study|Withdrawal by Subject|17|||
124914789|NCT05086744|449314653|FG000|Part A|Adverse Event|0|||
124914790|NCT05086744|449314654|FG001|Part A|Adverse Event|1|||
124914791|NCT05086744|449314653|FG000|Part A|Lack of Efficacy|3|||
124914792|NCT05086744|449314654|FG001|Part A|Lack of Efficacy|0|||
124914793|NCT05086744|449314653|FG000|Part A|Protocol deviation|1|||
124914794|NCT05086744|449314654|FG001|Part A|Protocol deviation|0|||
124914795|NCT05086744|449314653|FG000|Part A|Subject decision|1|||
124914796|NCT05086744|449314654|FG001|Part A|Subject decision|0|||
124914797|NCT05086744|449314653|FG000|Part B|Adverse Event|0|||
124914798|NCT05086744|449314654|FG001|Part B|Adverse Event|1|||
124914799|NCT05086744|449314653|FG000|Part B|Lack of Efficacy|0|||
124914800|NCT05086744|449314654|FG001|Part B|Lack of Efficacy|1|||
124914801|NCT05086744|449314653|FG000|Part B|Study terminated by sponsor|1|||
124914802|NCT05086744|449314654|FG001|Part B|Study terminated by sponsor|6|||
124914803|NCT04300231|449314655|FG000|Overall Study|Protocol Violation|4|||
124914804|NCT04300231|449314656|FG001|Overall Study|Protocol Violation|3|||
124914805|NCT04300231|449314657|FG002|Overall Study|Protocol Violation|0|||
124914806|NCT04300231|449314658|FG003|Overall Study|Protocol Violation|2|||
124914807|NCT05986565|449314664|FG000|Overall Study|Lost to Follow-up|8|||
124914808|NCT05986565|449314665|FG001|Overall Study|Lost to Follow-up|3|||
124914809|NCT05986565|449314664|FG000|Overall Study|Withdrawal by Subject|0|||
124914810|NCT05986565|449314665|FG001|Overall Study|Withdrawal by Subject|1|||
124914811|NCT02058108|449314669|FG000|Overall Study|Abnormal Laboratory Values|0|||
124914812|NCT02058108|449314670|FG001|Overall Study|Abnormal Laboratory Values|1|||
124914813|NCT02058108|449314669|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
124914814|NCT02058108|449314670|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
124914815|NCT02058108|449314669|FG000|Overall Study|No longer requires study drug|0|||
124914816|NCT02058108|449314670|FG001|Overall Study|No longer requires study drug|1|||
124914817|NCT02058108|449314669|FG000|Overall Study|Withdrawal by Subject|1|||
124914818|NCT02058108|449314670|FG001|Overall Study|Withdrawal by Subject|0|||
124914819|NCT02058108|449314669|FG000|Overall Study|Administrative problems|3|||
124914820|NCT02058108|449314670|FG001|Overall Study|Administrative problems|3|||
124914821|NCT02058108|449314669|FG000|Overall Study|Protocol Violation|0|||
124914822|NCT02058108|449314670|FG001|Overall Study|Protocol Violation|1|||
124914823|NCT00411151|449314674|FG000|Overall Study|Death|38|||
125116242|NCT00947856|450048182|FG000|Treatment Period|Study Stopped by Sponsor|4|||
125116243|NCT00947856|450048183|FG001|Treatment Period|Study Stopped by Sponsor|4|||
125116244|NCT00947856|450048182|FG000|Treatment Period|Withdrawal by Subject|12|||
125116245|NCT00947856|450048183|FG001|Treatment Period|Withdrawal by Subject|1|||
125116246|NCT00947856|450048182|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
125116247|NCT00947856|450048183|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
125116248|NCT00947856|450048182|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
125116249|NCT00947856|450048183|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
125116250|NCT00947856|450048182|FG000|Follow-up Period|Lost to Follow-up|7|||
125116251|NCT00947856|450048183|FG001|Follow-up Period|Lost to Follow-up|0|||
125116252|NCT00947856|450048182|FG000|Follow-up Period|Patient unavailable for site visits|1|||
124914824|NCT00411151|449314674|FG000|Overall Study|Withdrawal by Subject|2|||
125116253|NCT00947856|450048183|FG001|Follow-up Period|Patient unavailable for site visits|0|||
125116254|NCT00947856|450048182|FG000|Follow-up Period|Withdrawal by Subject|1|||
125116255|NCT00947856|450048183|FG001|Follow-up Period|Withdrawal by Subject|0|||
125116256|NCT01709383|450048188|FG000|Overall Study|Lost to Follow-up|1|||
125116257|NCT01709383|450048189|FG001|Overall Study|Lost to Follow-up|0|||
125116258|NCT01193517|450048190|FG000|Overall Study|Early Progression|1|||
125116259|NCT01193517|450048191|FG001|Overall Study|Early Progression|0|||
125116260|NCT01193517|450048192|FG002|Overall Study|Early Progression|0|||
125116261|NCT01512979|450048201|FG000|Overall Study|Adverse Event|2|||
125116262|NCT01512979|450048202|FG001|Overall Study|Adverse Event|2|||
125116263|NCT01512979|450048201|FG000|Overall Study|Protocol Violation|1|||
125116264|NCT01512979|450048202|FG001|Overall Study|Protocol Violation|4|||
125116265|NCT01512979|450048201|FG000|Overall Study|Lost to Follow-up|2|||
125116266|NCT01512979|450048202|FG001|Overall Study|Lost to Follow-up|5|||
125116267|NCT01512979|450048201|FG000|Overall Study|Withdrawal by Subject|1|||
125116268|NCT01512979|450048202|FG001|Overall Study|Withdrawal by Subject|2|||
125116269|NCT01512979|450048201|FG000|Overall Study|Reason other than stated above|13|||
125116270|NCT01512979|450048202|FG001|Overall Study|Reason other than stated above|9|||
125116271|NCT00874757|450048209|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
125131364|NCT01854047|450108128|FG001|Overall Study|Poor compliance to protocol|0|||
125131365|NCT01854047|450108129|FG002|Overall Study|Poor compliance to protocol|2|||
125131366|NCT01854047|450108130|FG003|Overall Study|Poor compliance to protocol|0|||
125131367|NCT01854047|450108131|FG004|Overall Study|Poor compliance to protocol|0|||
125131368|NCT01854047|450108127|FG000|Overall Study|Adverse Event|5|||
125131369|NCT01854047|450108128|FG001|Overall Study|Adverse Event|4|||
125131370|NCT01854047|450108129|FG002|Overall Study|Adverse Event|6|||
125131371|NCT01854047|450108130|FG003|Overall Study|Adverse Event|10|||
125131372|NCT01854047|450108131|FG004|Overall Study|Adverse Event|7|||
125131373|NCT01854047|450108127|FG000|Overall Study|Randomized but not treated|0|||
125131374|NCT01854047|450108128|FG001|Overall Study|Randomized but not treated|1|||
125131375|NCT01854047|450108129|FG002|Overall Study|Randomized but not treated|2|||
125131376|NCT01854047|450108130|FG003|Overall Study|Randomized but not treated|0|||
125131377|NCT01854047|450108131|FG004|Overall Study|Randomized but not treated|4|||
125131378|NCT01854047|450108127|FG000|Overall Study|Other than specified above|3|||
125131379|NCT01854047|450108128|FG001|Overall Study|Other than specified above|3|||
125131380|NCT01854047|450108129|FG002|Overall Study|Other than specified above|3|||
125131381|NCT01854047|450108130|FG003|Overall Study|Other than specified above|5|||
125131382|NCT01854047|450108131|FG004|Overall Study|Other than specified above|8|||
124914825|NCT00411151|449314674|FG000|Overall Study|Lost to Follow-up|2|||
124914826|NCT00411151|449314674|FG000|Overall Study|Protocol Violation|1|||
124914827|NCT00411151|449314674|FG000|Overall Study|Trial prematurely closed|4|||
124914828|NCT01121991|449314677|FG000|Overall Study|Lack of Ovarian Response|2|||
124914829|NCT01121991|449314677|FG000|Overall Study|No Oocytes Retrieved|3|||
124914830|NCT01121991|449314677|FG000|Overall Study|No Fertilization|1|||
124914831|NCT00409838|449314678|FG000|Short-term Period|Adverse Event|0|||
124914832|NCT00409838|449314679|FG001|Short-term Period|Adverse Event|1|||
124914833|NCT00409838|449314678|FG000|Short-term Period|Lost to Follow-up|0|||
124914834|NCT00409838|449314679|FG001|Short-term Period|Lost to Follow-up|1|||
124914835|NCT00409838|449314678|FG000|Short-term Period|Withdrawal by Subject|2|||
125131383|NCT02847650|450109958|FG000|Overall Study|Adverse Event|2|||
125131384|NCT02847650|450109959|FG001|Overall Study|Adverse Event|4|||
125131385|NCT02847650|450109958|FG000|Overall Study|Lost to Follow-up|1|||
125131386|NCT02847650|450109959|FG001|Overall Study|Lost to Follow-up|0|||
125131387|NCT02847650|450109958|FG000|Overall Study|Protocol Violation|0|||
124914836|NCT00409838|449314679|FG001|Short-term Period|Withdrawal by Subject|3|||
124914837|NCT00409838|449314678|FG000|Short-term Period|Never Treated|1|||
124914838|NCT00409838|449314679|FG001|Short-term Period|Never Treated|0|||
124914839|NCT00409838|449314678|FG000|Long-term Extension Period|Adverse Event|10|||
124914840|NCT00409838|449314679|FG001|Long-term Extension Period|Adverse Event|0|||
124914841|NCT00409838|449314678|FG000|Long-term Extension Period|Death|1|||
124914842|NCT00409838|449314679|FG001|Long-term Extension Period|Death|0|||
125131388|NCT02847650|450109959|FG001|Overall Study|Protocol Violation|1|||
125131389|NCT02847650|450109958|FG000|Overall Study|Withdrawal by Subject|1|||
125131390|NCT02847650|450109959|FG001|Overall Study|Withdrawal by Subject|1|||
125131391|NCT03818581|450109960|FG000|Overall Study|Adverse Event|1|||
124914843|NCT00409838|449314678|FG000|Long-term Extension Period|Lack of Efficacy|2|||
124914844|NCT00409838|449314679|FG001|Long-term Extension Period|Lack of Efficacy|0|||
124914845|NCT00409838|449314678|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
124914846|NCT00409838|449314679|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
124914847|NCT00409838|449314678|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
124914848|NCT00409838|449314679|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
124914849|NCT00409838|449314678|FG000|Long-term Extension Period|Pregnancy|1|||
124914850|NCT00409838|449314679|FG001|Long-term Extension Period|Pregnancy|0|||
124914851|NCT01619410|449314680|FG000|Overall Study|Lost to Follow-up|7|||
124914852|NCT01619410|449314681|FG001|Overall Study|Lost to Follow-up|4|||
125116272|NCT00759148|450049765|FG000|Overall Study|Adverse Event|1|||
125116273|NCT00759148|450049766|FG001|Overall Study|Adverse Event|6|||
125116274|NCT00759148|450049765|FG000|Overall Study|Withdrawal by Subject|3|||
125116275|NCT00759148|450049766|FG001|Overall Study|Withdrawal by Subject|7|||
125116276|NCT00759148|450049765|FG000|Overall Study|Lost to Follow-up|3|||
125116277|NCT00759148|450049766|FG001|Overall Study|Lost to Follow-up|9|||
125116278|NCT00759148|450049765|FG000|Overall Study|Treatment Failure|6|||
125116279|NCT00759148|450049766|FG001|Overall Study|Treatment Failure|10|||
125116280|NCT00759148|450049765|FG000|Overall Study|Reason not given|1|||
125116281|NCT00759148|450049766|FG001|Overall Study|Reason not given|0|||
125116282|NCT03433001|450049778|FG000|Overall Study|Lack of Efficacy|109|||
125116283|NCT03433001|450049778|FG000|Overall Study|Adverse Event|69|||
125116284|NCT03433001|450049778|FG000|Overall Study|Withdrawal by Subject|10|||
125116285|NCT03433001|450049778|FG000|Overall Study|Death|12|||
125116286|NCT03433001|450049778|FG000|Overall Study|Lost to Follow-up|4|||
125116287|NCT03433001|450049778|FG000|Overall Study|Other|25|||
125116288|NCT01165996|450049793|FG000|Overall Study|Death|1|||
125116289|NCT01165996|450049793|FG000|Overall Study|Physician Decision|1|||
125116290|NCT01399723|450049794|FG000|Overall Study|Lost to Follow-up|0|||
125116291|NCT01399723|450049795|FG001|Overall Study|Lost to Follow-up|1|||
125116292|NCT00268346|450049799|FG000|Overall Study|Adverse Event|0|||
125116293|NCT00268346|450049800|FG001|Overall Study|Adverse Event|1|||
125116294|NCT00268346|450049799|FG000|Overall Study|Death|0|||
125116295|NCT00268346|450049800|FG001|Overall Study|Death|1|||
125116296|NCT00268346|450049799|FG000|Overall Study|Withdrawal by Subject|0|||
125116297|NCT00268346|450049800|FG001|Overall Study|Withdrawal by Subject|1|||
125116298|NCT05487456|450049801|FG000|Overall Study|Withdrawal by Subject|0|||
125116299|NCT05487456|450049802|FG001|Overall Study|Withdrawal by Subject|0|||
125116300|NCT05487456|450049803|FG002|Overall Study|Withdrawal by Subject|1|||
125116301|NCT05487456|450049804|FG003|Overall Study|Withdrawal by Subject|0|||
125116302|NCT00294723|450049807|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
125116303|NCT00294723|450049808|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
125116304|NCT00294723|450049809|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
125116305|NCT00294723|450049807|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
125116306|NCT00294723|450049808|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
125116307|NCT00294723|450049809|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
125116308|NCT00294723|450049807|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
125116309|NCT00294723|450049808|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
125116310|NCT00294723|450049809|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
125116311|NCT00294723|450049807|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
125116312|NCT00294723|450049808|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
125116313|NCT00294723|450049809|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
125116314|NCT00294723|450049807|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
125116315|NCT00294723|450049808|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
125116316|NCT00294723|450049809|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
125116317|NCT00294723|450049807|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
125116318|NCT00294723|450049808|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
125116319|NCT00294723|450049809|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
125116320|NCT00294723|450049807|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
125116321|NCT00294723|450049808|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
125116322|NCT00294723|450049809|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
125116323|NCT00294723|450049807|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
124914853|NCT01250769|449314682|FG000|Overall Study|Withdrawal by Subject|0|||
125116324|NCT00294723|450049808|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
125116325|NCT00294723|450049809|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
124914854|NCT01250769|449314683|FG001|Overall Study|Withdrawal by Subject|1|||
124914855|NCT01250769|449314684|FG002|Overall Study|Withdrawal by Subject|1|||
124914856|NCT01250769|449314685|FG003|Overall Study|Withdrawal by Subject|0|||
125131392|NCT03818581|450109961|FG001|Overall Study|Adverse Event|0|||
124914857|NCT01250769|449314682|FG000|Overall Study|Adverse Event|0|||
124914858|NCT01250769|449314683|FG001|Overall Study|Adverse Event|0|||
124914859|NCT01250769|449314684|FG002|Overall Study|Adverse Event|1|||
124914860|NCT01250769|449314685|FG003|Overall Study|Adverse Event|0|||
124914861|NCT02538900|449314686|FG000|Overall Study|Death|2|||
124914862|NCT02538900|449314687|FG001|Overall Study|Death|2|||
124914863|NCT02538900|449314688|FG002|Overall Study|Death|2|||
124914864|NCT02538900|449314686|FG000|Overall Study|Withdrawal by Subject|18|||
124914865|NCT02538900|449314687|FG001|Overall Study|Withdrawal by Subject|16|||
124914866|NCT02538900|449314688|FG002|Overall Study|Withdrawal by Subject|15|||
124914867|NCT04110054|449314689|FG000|Overall Study|COVID-19 reason other than AE|0|||
124914868|NCT04110054|449314690|FG001|Overall Study|COVID-19 reason other than AE|0|||
124914869|NCT04110054|449314691|FG002|Overall Study|COVID-19 reason other than AE|2|||
124914870|NCT04110054|449314692|FG003|Overall Study|COVID-19 reason other than AE|0|||
124914871|NCT04110054|449314689|FG000|Overall Study|Withdrawal by Subject|0|||
124914872|NCT04110054|449314690|FG001|Overall Study|Withdrawal by Subject|3|||
124914873|NCT04110054|449314691|FG002|Overall Study|Withdrawal by Subject|2|||
124914874|NCT04110054|449314692|FG003|Overall Study|Withdrawal by Subject|0|||
124914875|NCT04110054|449314689|FG000|Overall Study|Adverse Event|1|||
124914876|NCT04110054|449314690|FG001|Overall Study|Adverse Event|1|||
124914877|NCT04110054|449314691|FG002|Overall Study|Adverse Event|4|||
124914878|NCT04110054|449314692|FG003|Overall Study|Adverse Event|3|||
124914879|NCT02874534|449314693|FG000|Overall Study|Withdrawal by Subject|5|||
124914880|NCT02874534|449314694|FG001|Overall Study|Withdrawal by Subject|8|||
124914881|NCT02874534|449314693|FG000|Overall Study|Lost to Follow-up|2|||
124914882|NCT02874534|449314694|FG001|Overall Study|Lost to Follow-up|2|||
124914883|NCT02874534|449314693|FG000|Overall Study|Ongoing in study|1|||
124914884|NCT02874534|449314694|FG001|Overall Study|Ongoing in study|1|||
124914885|NCT02923180|449314696|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
124914886|NCT02923180|449314696|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
124914887|NCT04287985|449314706|FG000|Overall Study|Adverse Event|1|||
124914888|NCT04287985|449314707|FG001|Overall Study|Adverse Event|0|||
124914889|NCT04287985|449314708|FG002|Overall Study|Adverse Event|0|||
124914890|NCT04287985|449314709|FG003|Overall Study|Adverse Event|0|||
124914891|NCT04287985|449314706|FG000|Overall Study|Protocol Violation|0|||
124914892|NCT04287985|449314707|FG001|Overall Study|Protocol Violation|1|||
124914893|NCT04287985|449314708|FG002|Overall Study|Protocol Violation|0|||
124914894|NCT04287985|449314709|FG003|Overall Study|Protocol Violation|0|||
124914895|NCT04287985|449314706|FG000|Overall Study|Physician Decision|0|||
124914896|NCT04287985|449314707|FG001|Overall Study|Physician Decision|0|||
124914897|NCT04287985|449314708|FG002|Overall Study|Physician Decision|0|||
124914898|NCT04287985|449314709|FG003|Overall Study|Physician Decision|1|||
124914899|NCT04287985|449314706|FG000|Overall Study|Withdrawal by Subject|2|||
124914900|NCT04287985|449314707|FG001|Overall Study|Withdrawal by Subject|1|||
124914901|NCT04287985|449314708|FG002|Overall Study|Withdrawal by Subject|1|||
124914902|NCT04287985|449314709|FG003|Overall Study|Withdrawal by Subject|2|||
124914903|NCT01340066|449314714|FG000|Placebo Run in Period|Screen Failures|27|||
124914904|NCT01340066|449314715|FG001|Placebo Run in Period|Screen Failures|0|||
124914905|NCT01340066|449314716|FG002|Placebo Run in Period|Screen Failures|0|||
124914906|NCT01340066|449314714|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
124914907|NCT01340066|449314715|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
124914908|NCT01340066|449314716|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
124914909|NCT01340066|449314714|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
124914910|NCT01340066|449314715|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
124914911|NCT01340066|449314716|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
124914912|NCT01340066|449314714|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
124914913|NCT01340066|449314715|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
124914914|NCT01340066|449314716|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
125116326|NCT00294723|450049807|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
125116327|NCT00294723|450049808|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
124914915|NCT02789020|449314717|FG000|Overall Study|Withdrawal by Subject|6|||
124914916|NCT02789020|449314718|FG001|Overall Study|Withdrawal by Subject|5|||
124914917|NCT03771352|449314729|FG000|Overall Study|Screen failure|2|||
124914918|NCT03771352|449314729|FG000|Overall Study|Withdrawal by Subject|2|||
124914919|NCT03380390|449314730|FG000|Overall Study|Adverse Event|3|||
124914920|NCT05171777|449314733|FG000|Treatment Crossover Period|Adverse Event|9|||
124914921|NCT05171777|449314734|FG001|Treatment Crossover Period|Adverse Event|6|||
124914922|NCT05171777|449314735|FG002|Treatment Crossover Period|Adverse Event|0|||
124914923|NCT05171777|449314736|FG003|Treatment Crossover Period|Adverse Event|0|||
124914924|NCT05171777|449314733|FG000|Treatment Crossover Period|Death|5|||
124914925|NCT05171777|449314734|FG001|Treatment Crossover Period|Death|5|||
124914926|NCT05171777|449314735|FG002|Treatment Crossover Period|Death|0|||
124914927|NCT05171777|449314736|FG003|Treatment Crossover Period|Death|0|||
124914928|NCT05171777|449314733|FG000|Treatment Crossover Period|Disease Relapse|0|||
124914929|NCT05171777|449314734|FG001|Treatment Crossover Period|Disease Relapse|1|||
124914930|NCT05171777|449314735|FG002|Treatment Crossover Period|Disease Relapse|0|||
124914931|NCT05171777|449314736|FG003|Treatment Crossover Period|Disease Relapse|0|||
124914932|NCT05171777|449314733|FG000|Treatment Crossover Period|Reason not Specified|2|||
124914933|NCT05171777|449314734|FG001|Treatment Crossover Period|Reason not Specified|1|||
124914934|NCT05171777|449314735|FG002|Treatment Crossover Period|Reason not Specified|0|||
124914935|NCT05171777|449314736|FG003|Treatment Crossover Period|Reason not Specified|0|||
124914936|NCT05171777|449314733|FG000|Treatment Crossover Period|Physician Decision|0|||
124914937|NCT05171777|449314734|FG001|Treatment Crossover Period|Physician Decision|1|||
124914938|NCT05171777|449314735|FG002|Treatment Crossover Period|Physician Decision|0|||
124914939|NCT05171777|449314736|FG003|Treatment Crossover Period|Physician Decision|0|||
124914940|NCT05171777|449314733|FG000|Treatment Crossover Period|Progressive Disease|13|||
124914941|NCT05171777|449314734|FG001|Treatment Crossover Period|Progressive Disease|9|||
124914942|NCT05171777|449314735|FG002|Treatment Crossover Period|Progressive Disease|0|||
124914943|NCT05171777|449314736|FG003|Treatment Crossover Period|Progressive Disease|0|||
124914944|NCT05171777|449314733|FG000|Treatment Crossover Period|Protocol Violation|0|||
124914945|NCT05171777|449314734|FG001|Treatment Crossover Period|Protocol Violation|2|||
124914946|NCT05171777|449314735|FG002|Treatment Crossover Period|Protocol Violation|0|||
124914947|NCT05171777|449314736|FG003|Treatment Crossover Period|Protocol Violation|0|||
124914948|NCT05171777|449314733|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
124914949|NCT05171777|449314734|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
124914950|NCT05171777|449314735|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
124914951|NCT05171777|449314736|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
124914952|NCT05171777|449314733|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
124914953|NCT05171777|449314734|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
124914954|NCT05171777|449314735|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
124914955|NCT05171777|449314736|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
125116328|NCT00294723|450049809|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
125116329|NCT00294723|450049807|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
125116330|NCT00294723|450049808|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
125116331|NCT00294723|450049809|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
124914956|NCT05171777|449314733|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
124914957|NCT05171777|449314734|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
124914958|NCT05171777|449314735|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
124914959|NCT05171777|449314736|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
124914960|NCT05171777|449314733|FG000|Treatment Continuation Period|Death|0|||
124914961|NCT05171777|449314734|FG001|Treatment Continuation Period|Death|0|||
124914962|NCT05171777|449314735|FG002|Treatment Continuation Period|Death|1|||
124914963|NCT05171777|449314736|FG003|Treatment Continuation Period|Death|6|||
124914964|NCT05171777|449314733|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
124914965|NCT05171777|449314734|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
124914966|NCT05171777|449314735|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
124914967|NCT05171777|449314736|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
124914968|NCT02538341|449314737|FG000|Overall Study|Lost to Follow-up|51|||
124914969|NCT02538341|449314738|FG001|Overall Study|Lost to Follow-up|46|||
124914970|NCT02538341|449314737|FG000|Overall Study|Withdrawal by Subject|3|||
124914971|NCT02538341|449314738|FG001|Overall Study|Withdrawal by Subject|1|||
124914972|NCT02538341|449314737|FG000|Overall Study|Death|2|||
124914973|NCT02538341|449314738|FG001|Overall Study|Death|0|||
124914974|NCT00632749|449314739|FG000|Overall Study|Progressive disease|3|||
124914975|NCT00632749|449314740|FG001|Overall Study|Progressive disease|2|||
124914976|NCT00632749|449314741|FG002|Overall Study|Progressive disease|2|||
124914977|NCT00632749|449314742|FG003|Overall Study|Progressive disease|2|||
124914978|NCT00632749|449314743|FG004|Overall Study|Progressive disease|4|||
124914979|NCT00632749|449314744|FG005|Overall Study|Progressive disease|4|||
124914980|NCT00632749|449314745|FG006|Overall Study|Progressive disease|3|||
124914981|NCT00632749|449314746|FG007|Overall Study|Progressive disease|2|||
124914982|NCT00632749|449314747|FG008|Overall Study|Progressive disease|3|||
124914983|NCT00632749|449314748|FG009|Overall Study|Progressive disease|2|||
124914984|NCT00632749|449314749|FG010|Overall Study|Progressive disease|4|||
124914985|NCT00632749|449314750|FG011|Overall Study|Progressive disease|3|||
124914986|NCT00632749|449314751|FG012|Overall Study|Progressive disease|2|||
124914987|NCT00632749|449314752|FG013|Overall Study|Progressive disease|4|||
124914988|NCT00632749|449314739|FG000|Overall Study|Other Adverse event|1|||
124914989|NCT00632749|449314740|FG001|Overall Study|Other Adverse event|1|||
124914990|NCT00632749|449314741|FG002|Overall Study|Other Adverse event|1|||
124914991|NCT00632749|449314742|FG003|Overall Study|Other Adverse event|1|||
124914992|NCT00632749|449314743|FG004|Overall Study|Other Adverse event|2|||
124914993|NCT00632749|449314744|FG005|Overall Study|Other Adverse event|4|||
124914994|NCT00632749|449314745|FG006|Overall Study|Other Adverse event|1|||
124914995|NCT00632749|449314746|FG007|Overall Study|Other Adverse event|2|||
124914996|NCT00632749|449314747|FG008|Overall Study|Other Adverse event|2|||
124914997|NCT00632749|449314748|FG009|Overall Study|Other Adverse event|0|||
124914998|NCT00632749|449314749|FG010|Overall Study|Other Adverse event|1|||
124914999|NCT00632749|449314750|FG011|Overall Study|Other Adverse event|0|||
124915000|NCT00632749|449314751|FG012|Overall Study|Other Adverse event|1|||
124915001|NCT00632749|449314752|FG013|Overall Study|Other Adverse event|0|||
124915002|NCT00632749|449314739|FG000|Overall Study|Refuse to continue medication|0|||
124915003|NCT00632749|449314740|FG001|Overall Study|Refuse to continue medication|0|||
124915004|NCT00632749|449314741|FG002|Overall Study|Refuse to continue medication|0|||
124915005|NCT00632749|449314742|FG003|Overall Study|Refuse to continue medication|1|||
124915006|NCT00632749|449314743|FG004|Overall Study|Refuse to continue medication|0|||
125116332|NCT00294723|450049807|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
125116333|NCT00294723|450049808|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
124915007|NCT00632749|449314744|FG005|Overall Study|Refuse to continue medication|0|||
124915008|NCT00632749|449314745|FG006|Overall Study|Refuse to continue medication|0|||
124915009|NCT00632749|449314746|FG007|Overall Study|Refuse to continue medication|0|||
124915010|NCT00632749|449314747|FG008|Overall Study|Refuse to continue medication|0|||
124915011|NCT00632749|449314748|FG009|Overall Study|Refuse to continue medication|1|||
124915012|NCT00632749|449314749|FG010|Overall Study|Refuse to continue medication|0|||
124915013|NCT00632749|449314750|FG011|Overall Study|Refuse to continue medication|0|||
124915014|NCT00632749|449314751|FG012|Overall Study|Refuse to continue medication|0|||
124915015|NCT00632749|449314752|FG013|Overall Study|Refuse to continue medication|0|||
124915016|NCT00632749|449314739|FG000|Overall Study|Reason other than those specified above|0|||
124915017|NCT00632749|449314740|FG001|Overall Study|Reason other than those specified above|2|||
124915018|NCT00632749|449314741|FG002|Overall Study|Reason other than those specified above|0|||
124915019|NCT00632749|449314742|FG003|Overall Study|Reason other than those specified above|0|||
124915020|NCT00632749|449314743|FG004|Overall Study|Reason other than those specified above|1|||
124915021|NCT00632749|449314744|FG005|Overall Study|Reason other than those specified above|0|||
124915022|NCT00632749|449314745|FG006|Overall Study|Reason other than those specified above|1|||
124915023|NCT00632749|449314746|FG007|Overall Study|Reason other than those specified above|0|||
124915024|NCT00632749|449314747|FG008|Overall Study|Reason other than those specified above|0|||
124915025|NCT00632749|449314748|FG009|Overall Study|Reason other than those specified above|0|||
124915026|NCT00632749|449314749|FG010|Overall Study|Reason other than those specified above|2|||
124915027|NCT00632749|449314750|FG011|Overall Study|Reason other than those specified above|1|||
124915028|NCT00632749|449314751|FG012|Overall Study|Reason other than those specified above|0|||
124915029|NCT00632749|449314752|FG013|Overall Study|Reason other than those specified above|2|||
124915030|NCT03988842|449314755|FG000|Overall Study|Death|1|||
124915031|NCT01227265|449314757|FG000|Overall Study|Did Not Receive Treatment|1|||
124915032|NCT01227265|449314758|FG001|Overall Study|Did Not Receive Treatment|2|||
124915033|NCT01227265|449314759|FG002|Overall Study|Did Not Receive Treatment|0|||
124915034|NCT01227265|449314757|FG000|Overall Study|Administrative|1|||
124915035|NCT01227265|449314758|FG001|Overall Study|Administrative|0|||
124915036|NCT01227265|449314759|FG002|Overall Study|Administrative|2|||
124915037|NCT01227265|449314757|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
124915038|NCT01227265|449314758|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
124915039|NCT01227265|449314759|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
124915040|NCT01227265|449314757|FG000|Overall Study|Protocol Violation|2|||
124915041|NCT01227265|449314758|FG001|Overall Study|Protocol Violation|1|||
124915042|NCT01227265|449314759|FG002|Overall Study|Protocol Violation|0|||
124915043|NCT01227265|449314757|FG000|Overall Study|Withdrawal by Subject|7|||
124915044|NCT01227265|449314758|FG001|Overall Study|Withdrawal by Subject|7|||
124915045|NCT01227265|449314759|FG002|Overall Study|Withdrawal by Subject|3|||
124915046|NCT01227265|449314757|FG000|Overall Study|Lost to Follow-up|2|||
124915047|NCT01227265|449314758|FG001|Overall Study|Lost to Follow-up|0|||
124915048|NCT01227265|449314759|FG002|Overall Study|Lost to Follow-up|3|||
124915049|NCT01227265|449314757|FG000|Overall Study|Adverse Event|6|||
124915050|NCT01227265|449314758|FG001|Overall Study|Adverse Event|10|||
124915051|NCT01227265|449314759|FG002|Overall Study|Adverse Event|5|||
124915052|NCT03690206|449314761|FG000|Overall Study|Withdrawal by Subject|2|||
124915053|NCT03690206|449314762|FG001|Overall Study|Withdrawal by Subject|0|||
124915054|NCT03690206|449314763|FG002|Overall Study|Withdrawal by Subject|0|||
124915055|NCT03690206|449314761|FG000|Overall Study|ICF withdrawal|2|||
124915056|NCT03690206|449314762|FG001|Overall Study|ICF withdrawal|0|||
124915057|NCT03690206|449314763|FG002|Overall Study|ICF withdrawal|0|||
124915058|NCT05028582|449314764|FG000|Overall Study|Lost to Follow-up|11|||
124915059|NCT05028582|449314765|FG001|Overall Study|Lost to Follow-up|9|||
124915060|NCT05028582|449314764|FG000|Overall Study|Withdrawal by Subject|9|||
124915061|NCT05028582|449314765|FG001|Overall Study|Withdrawal by Subject|10|||
124915062|NCT05028582|449314764|FG000|Overall Study|Adverse Event|5|||
124915063|NCT05028582|449314765|FG001|Overall Study|Adverse Event|2|||
124915064|NCT05028582|449314764|FG000|Overall Study|Miscellaneous|3|||
124915065|NCT05028582|449314765|FG001|Overall Study|Miscellaneous|2|||
124915066|NCT05028582|449314764|FG000|Overall Study|Lack of Efficacy|3|||
124915067|NCT05028582|449314765|FG001|Overall Study|Lack of Efficacy|1|||
124915068|NCT05028582|449314764|FG000|Overall Study|Physician Decision|0|||
124915069|NCT05028582|449314765|FG001|Overall Study|Physician Decision|1|||
124915070|NCT01959698|449314766|FG000|Overall Study|Adverse Event|0|||
124915071|NCT01959698|449314767|FG001|Overall Study|Adverse Event|0|||
124915072|NCT01959698|449314768|FG002|Overall Study|Adverse Event|0|||
124915073|NCT01959698|449314769|FG003|Overall Study|Adverse Event|0|||
124915074|NCT01959698|449314770|FG004|Overall Study|Adverse Event|0|||
124915075|NCT01959698|449314771|FG005|Overall Study|Adverse Event|0|||
124915076|NCT01959698|449314772|FG006|Overall Study|Adverse Event|1|||
124915077|NCT01959698|449314766|FG000|Overall Study|Physician Decision|1|||
124915078|NCT01959698|449314767|FG001|Overall Study|Physician Decision|0|||
124915079|NCT01959698|449314768|FG002|Overall Study|Physician Decision|1|||
124915080|NCT01959698|449314769|FG003|Overall Study|Physician Decision|2|||
124915081|NCT01959698|449314770|FG004|Overall Study|Physician Decision|0|||
124915082|NCT01959698|449314771|FG005|Overall Study|Physician Decision|3|||
124915083|NCT01959698|449314772|FG006|Overall Study|Physician Decision|3|||
124915084|NCT04402294|449314773|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
124915085|NCT04402294|449314774|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
124915086|NCT04402294|449314773|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
124915087|NCT04402294|449314774|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
124915088|NCT00186992|449316398|FG000|Overall Study|Withdrawal by Subject|5|||
124915089|NCT00186992|449316398|FG000|Overall Study|Physician's discretion|13|||
124915090|NCT00186992|449316398|FG000|Overall Study|PI Discretion|4|||
124915091|NCT00186992|449316398|FG000|Overall Study|Ineligible|2|||
124915092|NCT00186992|449316398|FG000|Overall Study|Lost to Follow-up|2|||
124915093|NCT00186992|449316398|FG000|Overall Study|Still on Study|9|||
124915094|NCT03769168|449316399|FG000|Overall Study|Adverse Event|0|||
124915095|NCT03769168|449316400|FG001|Overall Study|Adverse Event|1|||
124915096|NCT03769168|449316399|FG000|Overall Study|Lack of Efficacy|2|||
124915097|NCT03769168|449316400|FG001|Overall Study|Lack of Efficacy|4|||
124915098|NCT03769168|449316399|FG000|Overall Study|Post study access to treatment|3|||
124915099|NCT03769168|449316400|FG001|Overall Study|Post study access to treatment|11|||
124915100|NCT03769168|449316399|FG000|Overall Study|Physician Decision|1|||
124915101|NCT03769168|449316400|FG001|Overall Study|Physician Decision|4|||
124915102|NCT03769168|449316399|FG000|Overall Study|Subject Decision|2|||
124915103|NCT03769168|449316400|FG001|Overall Study|Subject Decision|4|||
124915104|NCT03769168|449316399|FG000|Overall Study|Guardian decision|1|||
125116334|NCT00294723|450049809|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
125116335|NCT00294723|450049807|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
125116336|NCT00294723|450049808|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
125116337|NCT00294723|450049809|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
124915105|NCT03769168|449316400|FG001|Overall Study|Guardian decision|0|||
124915106|NCT05478525|449316401|FG000|Overall Study|Withdrawal by Subject|0|||
124915107|NCT05478525|449316402|FG001|Overall Study|Withdrawal by Subject|1|||
124915108|NCT05478525|449316403|FG002|Overall Study|Withdrawal by Subject|2|||
124915109|NCT05478525|449316404|FG003|Overall Study|Withdrawal by Subject|0|||
124915110|NCT05478525|449316401|FG000|Overall Study|COVID-19 Infection|2|||
124915111|NCT05478525|449316402|FG001|Overall Study|COVID-19 Infection|0|||
124915112|NCT05478525|449316403|FG002|Overall Study|COVID-19 Infection|1|||
124915113|NCT05478525|449316404|FG003|Overall Study|COVID-19 Infection|1|||
124915114|NCT05644002|449316407|FG000|Overall Study|Lost to Follow-up|1|||
124915115|NCT05644002|449316408|FG001|Overall Study|Lost to Follow-up|2|||
124915116|NCT05644002|449316407|FG000|Overall Study|Withdrawal by Subject|0|||
124915117|NCT05644002|449316408|FG001|Overall Study|Withdrawal by Subject|1|||
124915118|NCT04842500|449316409|FG000|Overall Study|Withdrawal by Subject|4|||
124915119|NCT04842500|449316410|FG001|Overall Study|Withdrawal by Subject|1|||
124915120|NCT04842500|449316411|FG002|Overall Study|Withdrawal by Subject|2|||
124915121|NCT04842500|449316412|FG003|Overall Study|Withdrawal by Subject|3|||
124915122|NCT04842500|449316409|FG000|Overall Study|Protocol Violation|1|||
124915123|NCT04842500|449316410|FG001|Overall Study|Protocol Violation|0|||
124915124|NCT04842500|449316411|FG002|Overall Study|Protocol Violation|0|||
124915125|NCT04842500|449316412|FG003|Overall Study|Protocol Violation|1|||
124915126|NCT05104697|449316414|FG000|Overall Study|Withdrawal by Subject|0|||
124915127|NCT05104697|449316415|FG001|Overall Study|Withdrawal by Subject|1|||
124915128|NCT03845465|449316416|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
124915129|NCT03845465|449316417|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
124915130|NCT03845465|449316416|FG000|6-month Data Collection|Withdrawal by Subject|0|||
124915131|NCT03845465|449316417|FG001|6-month Data Collection|Withdrawal by Subject|2|||
124915132|NCT03845465|449316416|FG000|12-month Data Collection|Withdrawal by Subject|0|||
124915133|NCT03845465|449316417|FG001|12-month Data Collection|Withdrawal by Subject|2|||
124915134|NCT03547908|449316418|FG000|Blinded Phase|Lost to Follow-up|3|||
124915135|NCT03547908|449316419|FG001|Blinded Phase|Lost to Follow-up|3|||
124915136|NCT03547908|449316420|FG002|Blinded Phase|Lost to Follow-up|0|||
124915137|NCT03547908|449316421|FG003|Blinded Phase|Lost to Follow-up|0|||
124915138|NCT03547908|449316418|FG000|Blinded Phase|Withdrew Consent|2|||
124915139|NCT03547908|449316419|FG001|Blinded Phase|Withdrew Consent|3|||
124915140|NCT03547908|449316420|FG002|Blinded Phase|Withdrew Consent|0|||
124915141|NCT03547908|449316421|FG003|Blinded Phase|Withdrew Consent|0|||
124915142|NCT03547908|449316418|FG000|Blinded Phase|Investigator's Discretion|2|||
124915143|NCT03547908|449316419|FG001|Blinded Phase|Investigator's Discretion|1|||
124915144|NCT03547908|449316420|FG002|Blinded Phase|Investigator's Discretion|0|||
124915145|NCT03547908|449316421|FG003|Blinded Phase|Investigator's Discretion|0|||
124915146|NCT03547908|449316418|FG000|Blinded Phase|Death|2|||
124915147|NCT03547908|449316419|FG001|Blinded Phase|Death|0|||
124915148|NCT03547908|449316420|FG002|Blinded Phase|Death|0|||
124915149|NCT03547908|449316421|FG003|Blinded Phase|Death|0|||
124915150|NCT03547908|449316418|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
124915151|NCT03547908|449316419|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
124915152|NCT03547908|449316420|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
124915153|NCT03547908|449316421|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
124915154|NCT03547908|449316418|FG000|Blinded Phase|Adverse Event|1|||
124915155|NCT03547908|449316419|FG001|Blinded Phase|Adverse Event|0|||
124915156|NCT03547908|449316420|FG002|Blinded Phase|Adverse Event|0|||
124915157|NCT03547908|449316421|FG003|Blinded Phase|Adverse Event|0|||
124915158|NCT03547908|449316418|FG000|Blinded Phase|Randomized But Never Treated|1|||
125211800|NCT02007278|450401372|FG000|Overall Study|Incorrect medication administration|1|||
124915159|NCT03547908|449316419|FG001|Blinded Phase|Randomized But Never Treated|0|||
124915160|NCT03547908|449316420|FG002|Blinded Phase|Randomized But Never Treated|0|||
124915161|NCT03547908|449316421|FG003|Blinded Phase|Randomized But Never Treated|0|||
124915162|NCT03547908|449316418|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
124915163|NCT03547908|449316419|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
124915164|NCT03547908|449316420|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
124915165|NCT03547908|449316421|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
124915166|NCT03547908|449316418|FG000|Open-label Extension Phase|Death|0|||
124915167|NCT03547908|449316419|FG001|Open-label Extension Phase|Death|0|||
124915168|NCT03547908|449316420|FG002|Open-label Extension Phase|Death|1|||
125116338|NCT00752791|450049810|FG000|Overall Study|Adverse Event|7|||
125116339|NCT00752791|450049810|FG000|Overall Study|Withdrawal by Subject|1|||
125116340|NCT00752791|450049810|FG000|Overall Study|Physician Decision|1|||
125116341|NCT00752791|450049810|FG000|Overall Study|Death|1|||
125116342|NCT00752791|450049810|FG000|Overall Study|Renal transplant|3|||
124915169|NCT03547908|449316421|FG003|Open-label Extension Phase|Death|0|||
124915170|NCT03416023|449316424|FG000|Overall Study|Exclusion criteria failure|1|||
124915171|NCT03416023|449316424|FG000|Overall Study|Withdrawal by Subject|6|||
124915172|NCT03416023|449316424|FG000|Overall Study|Explanted|7|||
124915173|NCT03416023|449316424|FG000|Overall Study|Physician Decision|1|||
124915174|NCT03416023|449316424|FG000|Overall Study|Lost to Follow-up|1|||
124915175|NCT03416023|449316424|FG000|Overall Study|Death|1|||
124915176|NCT05419505|449316425|FG000|Overall Study|Adverse Event|0|||
124915177|NCT05419505|449316426|FG001|Overall Study|Adverse Event|0|||
124915178|NCT05419505|449316427|FG002|Overall Study|Adverse Event|0|||
124915179|NCT05419505|449316428|FG003|Overall Study|Adverse Event|1|||
124915180|NCT05419505|449316429|FG004|Overall Study|Adverse Event|0|||
124915181|NCT05419505|449316430|FG005|Overall Study|Adverse Event|0|||
124915182|NCT05419505|449316431|FG006|Overall Study|Adverse Event|0|||
124915183|NCT05419505|449316432|FG007|Overall Study|Adverse Event|0|||
124915184|NCT05419505|449316425|FG000|Overall Study|Withdrawal by Subject|1|||
124915185|NCT05419505|449316426|FG001|Overall Study|Withdrawal by Subject|2|||
124915186|NCT05419505|449316427|FG002|Overall Study|Withdrawal by Subject|0|||
124915187|NCT05419505|449316428|FG003|Overall Study|Withdrawal by Subject|0|||
124915188|NCT05419505|449316429|FG004|Overall Study|Withdrawal by Subject|0|||
124915189|NCT05419505|449316430|FG005|Overall Study|Withdrawal by Subject|0|||
124915190|NCT05419505|449316431|FG006|Overall Study|Withdrawal by Subject|1|||
124915191|NCT05419505|449316432|FG007|Overall Study|Withdrawal by Subject|0|||
124915192|NCT05419505|449316425|FG000|Overall Study|Lost to Follow-up|2|||
124915193|NCT05419505|449316426|FG001|Overall Study|Lost to Follow-up|1|||
124915194|NCT05419505|449316427|FG002|Overall Study|Lost to Follow-up|0|||
124915195|NCT05419505|449316428|FG003|Overall Study|Lost to Follow-up|0|||
124915196|NCT05419505|449316429|FG004|Overall Study|Lost to Follow-up|1|||
125116343|NCT00752791|450049810|FG000|Overall Study|Switched to hemodialysis|2|||
124915197|NCT05419505|449316430|FG005|Overall Study|Lost to Follow-up|2|||
124915198|NCT05419505|449316431|FG006|Overall Study|Lost to Follow-up|0|||
124915199|NCT05419505|449316432|FG007|Overall Study|Lost to Follow-up|1|||
124915200|NCT03358875|449316433|FG000|Overall Study|Death|409|||
124915201|NCT03358875|449316434|FG001|Overall Study|Death|223|||
124915202|NCT03358875|449316433|FG000|Overall Study|Study Closed by Sponsor|66|||
124915203|NCT03358875|449316434|FG001|Overall Study|Study Closed by Sponsor|29|||
124915204|NCT03358875|449316433|FG000|Overall Study|Withdrawal by Subject|13|||
124915205|NCT03358875|449316434|FG001|Overall Study|Withdrawal by Subject|16|||
124915206|NCT03358875|449316433|FG000|Overall Study|Lost to Follow-up|13|||
124915207|NCT03358875|449316434|FG001|Overall Study|Lost to Follow-up|2|||
124915208|NCT03358875|449316433|FG000|Overall Study|Miscellaneous|33|||
124915209|NCT03358875|449316434|FG001|Overall Study|Miscellaneous|0|||
124915210|NCT03358875|449316433|FG000|Overall Study|Remained on Study|1|||
124915211|NCT03358875|449316434|FG001|Overall Study|Remained on Study|0|||
124915212|NCT01064440|449316439|FG000|Overall Study|Lost to Follow-up|1|||
124915213|NCT01064440|449316440|FG001|Overall Study|Lost to Follow-up|1|||
124915214|NCT01064440|449316441|FG002|Overall Study|Lost to Follow-up|1|||
124915215|NCT01064440|449316439|FG000|Overall Study|Non-compliance|0|||
124915216|NCT01064440|449316440|FG001|Overall Study|Non-compliance|1|||
124915217|NCT01064440|449316441|FG002|Overall Study|Non-compliance|0|||
124915218|NCT01064440|449316439|FG000|Overall Study|Death|1|||
124915219|NCT01064440|449316440|FG001|Overall Study|Death|0|||
124915220|NCT01064440|449316441|FG002|Overall Study|Death|1|||
124915221|NCT01064440|449316439|FG000|Overall Study|Withdrawal by Subject|0|||
124915222|NCT01064440|449316440|FG001|Overall Study|Withdrawal by Subject|1|||
124915223|NCT01064440|449316441|FG002|Overall Study|Withdrawal by Subject|1|||
124915224|NCT01064440|449316439|FG000|Overall Study|Other: amputation|1|||
124915225|NCT01064440|449316440|FG001|Overall Study|Other: amputation|0|||
124915226|NCT01064440|449316441|FG002|Overall Study|Other: amputation|0|||
124915227|NCT06194214|449316443|FG000|Overall Study|Adverse Event|1|||
124915228|NCT01631214|449316453|FG000|Overall Study|Withdrawal by Subject|276|||
124915229|NCT01631214|449316454|FG001|Overall Study|Withdrawal by Subject|290|||
124915230|NCT01631214|449316453|FG000|Overall Study|Death|113|||
124915231|NCT01631214|449316454|FG001|Overall Study|Death|106|||
124915232|NCT01631214|449316453|FG000|Overall Study|Lost to Follow-up|54|||
124915233|NCT01631214|449316454|FG001|Overall Study|Lost to Follow-up|40|||
124915234|NCT01631214|449316453|FG000|Overall Study|Adverse Event|45|||
124915235|NCT01631214|449316454|FG001|Overall Study|Adverse Event|45|||
124915236|NCT01631214|449316453|FG000|Overall Study|Other|22|||
124915237|NCT01631214|449316454|FG001|Overall Study|Other|19|||
124915238|NCT01631214|449316453|FG000|Overall Study|Noncompliance|16|||
124915239|NCT01631214|449316454|FG001|Overall Study|Noncompliance|15|||
124915240|NCT01631214|449316453|FG000|Overall Study|Requirement for Alternative Therapy|8|||
124915241|NCT01631214|449316454|FG001|Overall Study|Requirement for Alternative Therapy|3|||
124915242|NCT01631214|449316453|FG000|Overall Study|Protocol Deviation|4|||
124915243|NCT01631214|449316454|FG001|Overall Study|Protocol Deviation|3|||
124915244|NCT01631214|449316453|FG000|Overall Study|Ineligibility determined|5|||
124915245|NCT01631214|449316454|FG001|Overall Study|Ineligibility determined|2|||
124915246|NCT01631214|449316453|FG000|Overall Study|Administrative Decision|1|||
124915247|NCT01631214|449316454|FG001|Overall Study|Administrative Decision|0|||
124915248|NCT04093362|449316462|FG000|Overall Study|Study Termination|1|||
124915249|NCT04093362|449316463|FG001|Overall Study|Study Termination|1|||
124915250|NCT04093362|449316462|FG000|Overall Study|Withdrawal of Consent|1|||
124915251|NCT04093362|449316463|FG001|Overall Study|Withdrawal of Consent|0|||
124915252|NCT04093362|449316462|FG000|Overall Study|Death|1|||
124915253|NCT04093362|449316463|FG001|Overall Study|Death|3|||
124915254|NCT04093362|449316462|FG000|Overall Study|Reason not Specified|1|||
124915255|NCT04093362|449316463|FG001|Overall Study|Reason not Specified|2|||
124915256|NCT05288283|449316476|FG000|Overall Study|Study Terminated Early|1|||
124915257|NCT05288283|449316477|FG001|Overall Study|Study Terminated Early|1|||
124915258|NCT01046136|449316481|FG000|Overall Study|Withdrawal by Subject|0|||
124915259|NCT01046136|449316482|FG001|Overall Study|Withdrawal by Subject|4|||
124915260|NCT01046136|449316481|FG000|Overall Study|Physician Decision|1|||
124915261|NCT01046136|449316482|FG001|Overall Study|Physician Decision|1|||
124915262|NCT01046136|449316481|FG000|Overall Study|Lost to Follow-up|3|||
124915263|NCT01046136|449316482|FG001|Overall Study|Lost to Follow-up|3|||
124915264|NCT04759833|449316483|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
124915265|NCT04759833|449316484|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
124915266|NCT04759833|449316485|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
124915267|NCT04759833|449316486|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
124915268|NCT04759833|449316487|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
124915269|NCT04759833|449316483|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
124915270|NCT04759833|449316484|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
124915271|NCT04759833|449316485|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
124915272|NCT04759833|449316486|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
124915273|NCT04759833|449316487|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
125116344|NCT00752791|450049810|FG000|Overall Study|Protocol deviation|1|||
124915274|NCT04759833|449316483|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
124915275|NCT04759833|449316484|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
124915276|NCT04759833|449316485|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
124915277|NCT04759833|449316486|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
124915278|NCT04759833|449316487|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
124915279|NCT04759833|449316483|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
125116345|NCT01958281|450049811|FG000|Overall Study|Lack of Efficacy|5|||
125116346|NCT01958281|450049812|FG001|Overall Study|Lack of Efficacy|2|||
125116347|NCT01958281|450049813|FG002|Overall Study|Lack of Efficacy|0|||
125116348|NCT01958281|450049811|FG000|Overall Study|Adverse Event|0|||
125116349|NCT01958281|450049812|FG001|Overall Study|Adverse Event|2|||
125116350|NCT01958281|450049813|FG002|Overall Study|Adverse Event|0|||
125116351|NCT01958281|450049811|FG000|Overall Study|Withdrew Consent|1|||
125116352|NCT01958281|450049812|FG001|Overall Study|Withdrew Consent|0|||
125116353|NCT01958281|450049813|FG002|Overall Study|Withdrew Consent|0|||
125116354|NCT02784106|450049814|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
125116355|NCT02784106|450049815|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
125116356|NCT02784106|450049816|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
125116357|NCT02784106|450049817|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
125116358|NCT02784106|450049814|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
125116359|NCT02784106|450049815|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
125116360|NCT02784106|450049816|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
125116361|NCT02784106|450049817|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
125116362|NCT02784106|450049814|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
125116363|NCT02784106|450049815|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
125116364|NCT02784106|450049816|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
125116365|NCT02784106|450049817|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
125116366|NCT02784106|450049814|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
125116367|NCT02784106|450049815|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
125116368|NCT02784106|450049816|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
125116369|NCT02784106|450049817|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
125116370|NCT02784106|450049814|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
125116371|NCT02784106|450049815|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
125116372|NCT02784106|450049816|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
125116373|NCT02784106|450049817|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
125116374|NCT02784106|450049814|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
125116375|NCT02784106|450049815|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
125116376|NCT02784106|450049816|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
125116377|NCT02784106|450049817|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
124915280|NCT04759833|449316484|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
124915281|NCT04759833|449316485|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
124915282|NCT04759833|449316486|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
124915283|NCT04759833|449316487|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
124915284|NCT04759833|449316483|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
124915285|NCT04759833|449316484|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
124915286|NCT04759833|449316485|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
124915287|NCT04759833|449316486|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
124915288|NCT04759833|449316487|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
124915289|NCT04759833|449316483|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
124915290|NCT04759833|449316484|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
124969515|NCT03520075|449517409|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124915291|NCT04759833|449316485|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
124915292|NCT04759833|449316486|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
124915293|NCT04759833|449316487|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
124915294|NCT04759833|449316483|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
124915295|NCT04759833|449316484|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
124915296|NCT04759833|449316485|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
124915297|NCT04759833|449316486|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
125116378|NCT03222141|450049818|FG000|Overall Study|Death|15|||
125116379|NCT03222141|450049818|FG000|Overall Study|Lost to Follow-up|3|||
125116380|NCT02536378|450049819|FG000|Overall Study|Physician Decision|0|||
125116381|NCT02536378|450049820|FG001|Overall Study|Physician Decision|2|||
125116382|NCT02536378|450049819|FG000|Overall Study|Withdrawal by Subject|0|||
125116383|NCT02536378|450049820|FG001|Overall Study|Withdrawal by Subject|1|||
125116384|NCT02536378|450049819|FG000|Overall Study|Death|1|||
125116385|NCT02536378|450049820|FG001|Overall Study|Death|2|||
125116386|NCT02536378|450049819|FG000|Overall Study|Patient refused further follow up|6|||
125116387|NCT02536378|450049820|FG001|Overall Study|Patient refused further follow up|2|||
125116388|NCT00798889|450049821|FG000|Overall Study|Adverse Event|53|||
125116389|NCT00798889|450049821|FG000|Overall Study|Protocol Violation|2|||
125116390|NCT00798889|450049821|FG000|Overall Study|Withdrawal by Subject|31|||
125116391|NCT00798889|450049821|FG000|Overall Study|Lost to Follow-up|1|||
125116392|NCT00798889|450049821|FG000|Overall Study|Lack of Efficacy|213|||
125116393|NCT00798889|450049821|FG000|Overall Study|Decision of Sponsor|11|||
125116394|NCT00798889|450049821|FG000|Overall Study|Enrolled, Not treated|3|||
125116395|NCT00617461|450049822|FG000|First Treatment Intervention Period|Adverse Event|2|||
125116396|NCT00617461|450049823|FG001|First Treatment Intervention Period|Adverse Event|0|||
125116397|NCT00617461|450049822|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
125116398|NCT00617461|450049823|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
125116399|NCT00617461|450049822|FG000|First Treatment Intervention Period|Protocol Violation|2|||
125116400|NCT00617461|450049823|FG001|First Treatment Intervention Period|Protocol Violation|1|||
125116401|NCT00617461|450049822|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
125116402|NCT00617461|450049823|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
125116403|NCT00617461|450049822|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
125116404|NCT00617461|450049823|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
125116405|NCT00617461|450049822|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
125116406|NCT00617461|450049823|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
124915298|NCT04759833|449316487|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
124915299|NCT04759833|449316483|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
124915300|NCT04759833|449316484|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
124915301|NCT04759833|449316485|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
124915302|NCT04759833|449316486|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
124915303|NCT04759833|449316487|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
124915304|NCT04759833|449316483|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
124915305|NCT04759833|449316484|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
124915306|NCT04759833|449316485|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
124915307|NCT04759833|449316486|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
124915308|NCT04759833|449316487|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
124915309|NCT04759833|449316483|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
124915310|NCT04759833|449316484|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
124915311|NCT04759833|449316485|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
124915312|NCT04759833|449316486|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
124915313|NCT04759833|449316487|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
124915314|NCT04759833|449316483|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
124915315|NCT04759833|449316484|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
124915316|NCT04759833|449316485|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
124915317|NCT04759833|449316486|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
124915318|NCT04759833|449316487|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
124915319|NCT04759833|449316483|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
124915320|NCT04759833|449316484|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
124915321|NCT04759833|449316485|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
124915322|NCT04759833|449316486|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
124915323|NCT04759833|449316487|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
124915324|NCT04759833|449316483|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
124915325|NCT04759833|449316484|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
124915326|NCT04759833|449316485|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
124915327|NCT04759833|449316486|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
124915328|NCT04759833|449316487|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
124915329|NCT03446157|449316488|FG000|Overall Study|Death|11|||
124915330|NCT03446157|449316489|FG001|Overall Study|Death|9|||
124915331|NCT03446157|449316488|FG000|Overall Study|Lost to Follow-up|0|||
124915332|NCT03446157|449316489|FG001|Overall Study|Lost to Follow-up|1|||
124915333|NCT03446157|449316488|FG000|Overall Study|Withdrawal by Subject|2|||
124915334|NCT03446157|449316489|FG001|Overall Study|Withdrawal by Subject|1|||
124915335|NCT01989455|449316492|FG000|Overall Study|Adverse Event|0|||
124915336|NCT01989455|449316493|FG001|Overall Study|Adverse Event|1|||
124915337|NCT01989455|449316494|FG002|Overall Study|Adverse Event|0|||
124915338|NCT01989455|449316495|FG003|Overall Study|Adverse Event|0|||
124915339|NCT01989455|449316496|FG004|Overall Study|Adverse Event|0|||
124915340|NCT01989455|449316492|FG000|Overall Study|Withdrawal by Subject|0|||
124915341|NCT01989455|449316493|FG001|Overall Study|Withdrawal by Subject|1|||
124915342|NCT01989455|449316494|FG002|Overall Study|Withdrawal by Subject|0|||
124915343|NCT01989455|449316495|FG003|Overall Study|Withdrawal by Subject|0|||
124915344|NCT01989455|449316496|FG004|Overall Study|Withdrawal by Subject|0|||
124915345|NCT01989455|449316492|FG000|Overall Study|Technical problems with infusion|0|||
124915346|NCT01989455|449316493|FG001|Overall Study|Technical problems with infusion|0|||
124915347|NCT01989455|449316494|FG002|Overall Study|Technical problems with infusion|1|||
124915348|NCT01989455|449316495|FG003|Overall Study|Technical problems with infusion|0|||
124915349|NCT01989455|449316496|FG004|Overall Study|Technical problems with infusion|1|||
125116407|NCT00617461|450049822|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
124915350|NCT00632203|449316497|FG000|Overall Study|Did not start study treatment|1|||
124915351|NCT00632203|449316498|FG001|Overall Study|Did not start study treatment|0|||
124915352|NCT04238247|449316501|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
124915353|NCT04238247|449316502|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
124915354|NCT04238247|449316503|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
124915355|NCT04238247|449316504|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
124915356|NCT04238247|449316501|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
124915357|NCT04238247|449316502|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
124915358|NCT04238247|449316503|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
124915359|NCT04238247|449316504|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
124915360|NCT04238247|449316501|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
124915361|NCT04238247|449316502|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
124915362|NCT04238247|449316503|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
125116408|NCT00617461|450049823|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
125116409|NCT00617461|450049822|FG000|Second Treatment Intervention Period|Adverse Event|0|||
125116410|NCT00617461|450049823|FG001|Second Treatment Intervention Period|Adverse Event|1|||
125116411|NCT00617461|450049822|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
125116412|NCT00617461|450049823|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
125116413|NCT00617461|450049822|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
124915363|NCT04238247|449316504|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
124915364|NCT04238247|449316501|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
125116414|NCT00617461|450049823|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
124915365|NCT04238247|449316502|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
124915366|NCT04238247|449316503|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
124915367|NCT04238247|449316504|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
124915368|NCT05064735|449316505|FG000|Overall Study|Withdrawal by Subject|7|||
124915369|NCT05064735|449316506|FG001|Overall Study|Withdrawal by Subject|8|||
124915370|NCT05064735|449316505|FG000|Overall Study|Lost to Follow-up|7|||
124915371|NCT05064735|449316506|FG001|Overall Study|Lost to Follow-up|2|||
124915372|NCT05064735|449316505|FG000|Overall Study|Physician Decision|2|||
124915373|NCT05064735|449316506|FG001|Overall Study|Physician Decision|1|||
124915374|NCT05064735|449316505|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
124915375|NCT05064735|449316506|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
124915376|NCT05064735|449316505|FG000|Overall Study|Site Closure|7|||
124915377|NCT05064735|449316506|FG001|Overall Study|Site Closure|2|||
124915378|NCT02886286|449316507|FG000|Overall Study|pump motor stall|0|||
124915379|NCT02886286|449316508|FG001|Overall Study|pump motor stall|1|||
124915380|NCT02376790|449316509|FG000|Overall Study|Withdrawal by Subject|43|||
124915381|NCT02376790|449316510|FG001|Overall Study|Withdrawal by Subject|36|||
124915382|NCT02376790|449316511|FG002|Overall Study|Withdrawal by Subject|37|||
124915383|NCT02376790|449316509|FG000|Overall Study|Decision by Sponsor|2|||
124915384|NCT02376790|449316510|FG001|Overall Study|Decision by Sponsor|1|||
124915385|NCT02376790|449316511|FG002|Overall Study|Decision by Sponsor|4|||
124915386|NCT02376790|449316509|FG000|Overall Study|Lost to Follow-up|15|||
124915387|NCT02376790|449316510|FG001|Overall Study|Lost to Follow-up|10|||
124915388|NCT02376790|449316511|FG002|Overall Study|Lost to Follow-up|12|||
124915389|NCT03014453|449316512|FG000|Overall Study|Lost to Follow-up|12|||
124915390|NCT03014453|449316512|FG000|Overall Study|Discontinued GER|3|||
124915391|NCT03014453|449316512|FG000|Overall Study|Excluded|19|||
124915392|NCT03014453|449316512|FG000|Overall Study|Refused to take part in|37|||
124915393|NCT00901901|449316513|FG000|Treatment Period|Adverse Event|120|||
124915394|NCT00901901|449316514|FG001|Treatment Period|Adverse Event|128|||
124915395|NCT00901901|449316513|FG000|Treatment Period|Withdrawal by Subject|26|||
124915396|NCT00901901|449316514|FG001|Treatment Period|Withdrawal by Subject|24|||
124915397|NCT00901901|449316513|FG000|Treatment Period|Physician Decision|2|||
124915398|NCT00901901|449316514|FG001|Treatment Period|Physician Decision|2|||
124915399|NCT00901901|449316513|FG000|Treatment Period|Lost to Follow-up|3|||
124915400|NCT00901901|449316514|FG001|Treatment Period|Lost to Follow-up|5|||
124915401|NCT00901901|449316513|FG000|Treatment Period|Noncompliance with study medication|4|||
124915402|NCT00901901|449316514|FG001|Treatment Period|Noncompliance with study medication|1|||
124915403|NCT00901901|449316513|FG000|Treatment Period|Missing|1|||
124915404|NCT00901901|449316514|FG001|Treatment Period|Missing|0|||
124915405|NCT00901901|449316513|FG000|Treatment Period|Never treated|0|||
124915406|NCT00901901|449316514|FG001|Treatment Period|Never treated|3|||
125116415|NCT00617461|450049822|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
125131393|NCT03818581|450109962|FG002|Overall Study|Adverse Event|0|||
124915407|NCT00901901|449316513|FG000|Treatment Period|Protocol driven decision point|0|||
124915408|NCT00901901|449316514|FG001|Treatment Period|Protocol driven decision point|2|||
124915409|NCT00901901|449316513|FG000|Treatment Period|Study terminated by sponsor|2|||
124915410|NCT00901901|449316514|FG001|Treatment Period|Study terminated by sponsor|0|||
124915411|NCT00901901|449316513|FG000|Treatment Period|Protocol Violation|5|||
124915412|NCT00901901|449316514|FG001|Treatment Period|Protocol Violation|9|||
124915413|NCT00901901|449316513|FG000|Treatment Period|Switch to commercial drug|1|||
124915414|NCT00901901|449316514|FG001|Treatment Period|Switch to commercial drug|1|||
124915415|NCT00901901|449316513|FG000|Treatment Period|Transfer to treatment continuation study|5|||
124915416|NCT00901901|449316514|FG001|Treatment Period|Transfer to treatment continuation study|2|||
124915417|NCT00901901|449316513|FG000|Follow-up Period|Death|181|||
124915418|NCT00901901|449316514|FG001|Follow-up Period|Death|208|||
124915419|NCT00901901|449316513|FG000|Follow-up Period|Protocol driven decision point|47|||
124915420|NCT00901901|449316514|FG001|Follow-up Period|Protocol driven decision point|36|||
124915421|NCT00901901|449316513|FG000|Follow-up Period|Withdrawal by Subject|6|||
124915422|NCT00901901|449316514|FG001|Follow-up Period|Withdrawal by Subject|9|||
124915423|NCT00901901|449316513|FG000|Follow-up Period|Lost to Follow-up|12|||
124915424|NCT00901901|449316514|FG001|Follow-up Period|Lost to Follow-up|8|||
124915425|NCT00901901|449316513|FG000|Follow-up Period|Missing|94|||
124915426|NCT00901901|449316514|FG001|Follow-up Period|Missing|80|||
124915427|NCT02272816|449316515|FG000|Overall Study|Adverse Event|1|||
124915428|NCT01136876|449316516|FG000|Overall Study|Lost to Follow-up|0|||
124915429|NCT01136876|449316517|FG001|Overall Study|Lost to Follow-up|1|||
124915430|NCT01136876|449316516|FG000|Overall Study|Physician Decision|3|||
124915431|NCT01136876|449316517|FG001|Overall Study|Physician Decision|5|||
124915432|NCT01136876|449316516|FG000|Overall Study|Missing NGAL measurement|2|||
124915433|NCT01136876|449316517|FG001|Overall Study|Missing NGAL measurement|5|||
124915434|NCT00976937|449316520|FG000|Overall Study|Adverse Event|4|||
124915435|NCT00976937|449316521|FG001|Overall Study|Adverse Event|5|||
124915436|NCT00976937|449316520|FG000|Overall Study|Lost to Follow-up|2|||
124915437|NCT00976937|449316521|FG001|Overall Study|Lost to Follow-up|1|||
124915438|NCT00976937|449316520|FG000|Overall Study|Withdrawal by Subject|5|||
124915439|NCT00976937|449316521|FG001|Overall Study|Withdrawal by Subject|3|||
124915440|NCT00976937|449316520|FG000|Overall Study|Poor compliance to protocol|3|||
124915441|NCT00976937|449316521|FG001|Overall Study|Poor compliance to protocol|0|||
124915442|NCT00976937|449316520|FG000|Overall Study|Personal and Familial Reason|2|||
124915443|NCT00976937|449316521|FG001|Overall Study|Personal and Familial Reason|2|||
124915444|NCT01011946|449316522|FG000|Overall Study|Transferred to another hospital|2|||
124915445|NCT01011946|449316522|FG000|Overall Study|No pathological lab value|1|||
124915446|NCT04820686|449316523|FG000|Overall Study|Withdrawal by Subject|5|||
124915447|NCT04820686|449316524|FG001|Overall Study|Withdrawal by Subject|2|||
124915448|NCT04820686|449316525|FG002|Overall Study|Withdrawal by Subject|3|||
124915449|NCT04820686|449316523|FG000|Overall Study|Study Termination|25|||
124915450|NCT04820686|449316524|FG001|Overall Study|Study Termination|13|||
124915451|NCT04820686|449316525|FG002|Overall Study|Study Termination|14|||
124915452|NCT04820686|449316523|FG000|Overall Study|Adverse Event|0|||
124915453|NCT04820686|449316524|FG001|Overall Study|Adverse Event|1|||
124915454|NCT04820686|449316525|FG002|Overall Study|Adverse Event|0|||
124915455|NCT01424670|449316526|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
124915456|NCT01424670|449316527|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
124915457|NCT01424670|449316526|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
124915458|NCT01424670|449316527|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
124915459|NCT01424670|449316526|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
124915460|NCT01424670|449316527|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
124915461|NCT01424670|449316526|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
124915462|NCT01424670|449316527|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
124915463|NCT01424670|449316526|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
124915464|NCT01424670|449316527|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
124915465|NCT01424670|449316526|FG000|Continuation Period|Adverse Event|13|||
124915466|NCT01424670|449316527|FG001|Continuation Period|Adverse Event|5|||
124915467|NCT01424670|449316526|FG000|Continuation Period|Lost to Follow-up|2|||
124915468|NCT01424670|449316527|FG001|Continuation Period|Lost to Follow-up|0|||
124915469|NCT01424670|449316526|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
124915470|NCT01424670|449316527|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
124915471|NCT01424670|449316526|FG000|Continuation Period|Physician Decision|5|||
124915472|NCT01424670|449316527|FG001|Continuation Period|Physician Decision|4|||
124915473|NCT01424670|449316526|FG000|Continuation Period|Withdrawal by Subject|13|||
124915474|NCT01424670|449316527|FG001|Continuation Period|Withdrawal by Subject|4|||
124915475|NCT02891915|449316530|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
124915476|NCT02891915|449316531|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
124915477|NCT02891915|449316530|FG000|Overall Study|Withdrawal by Subject|3|||
124915478|NCT02891915|449316531|FG001|Overall Study|Withdrawal by Subject|3|||
124915479|NCT02891915|449316530|FG000|Overall Study|Became Ineligible After Enrollment|2|||
124915480|NCT02891915|449316531|FG001|Overall Study|Became Ineligible After Enrollment|1|||
124915481|NCT02891915|449316530|FG000|Overall Study|Lost to Follow-up|1|||
124915482|NCT02891915|449316531|FG001|Overall Study|Lost to Follow-up|4|||
124915483|NCT02891915|449316530|FG000|Overall Study|Physician Decision|1|||
124915484|NCT02891915|449316531|FG001|Overall Study|Physician Decision|0|||
124915485|NCT00709098|449316532|FG000|Double-blind Period|Withdrawal of consent|3|||
124915486|NCT00709098|449316533|FG001|Double-blind Period|Withdrawal of consent|3|||
124915487|NCT00709098|449316534|FG002|Double-blind Period|Withdrawal of consent|0|||
124915488|NCT00709098|449316532|FG000|Double-blind Period|Administrative reason|1|||
124915489|NCT00709098|449316533|FG001|Double-blind Period|Administrative reason|3|||
124915490|NCT00709098|449316534|FG002|Double-blind Period|Administrative reason|0|||
124915491|NCT00709098|449316532|FG000|Double-blind Period|Death|1|||
124915492|NCT00709098|449316533|FG001|Double-blind Period|Death|1|||
124915493|NCT00709098|449316534|FG002|Double-blind Period|Death|0|||
124915494|NCT00709098|449316532|FG000|Double-blind Period|Lost to Follow-up|1|||
124915495|NCT00709098|449316533|FG001|Double-blind Period|Lost to Follow-up|1|||
124915496|NCT00709098|449316534|FG002|Double-blind Period|Lost to Follow-up|0|||
124915497|NCT00709098|449316532|FG000|Open-label Period|Withdrawal of consent|0|||
125116416|NCT00617461|450049823|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
125116417|NCT00358826|450049824|FG000|Core Study|Adverse Event|1|||
125116418|NCT00358826|450049825|FG001|Core Study|Adverse Event|3|||
125116419|NCT00358826|450049826|FG002|Core Study|Adverse Event|1|||
125116420|NCT00358826|450049827|FG003|Core Study|Adverse Event|1|||
125116421|NCT00358826|450049828|FG004|Core Study|Adverse Event|0|||
125116422|NCT00358826|450049829|FG005|Core Study|Adverse Event|0|||
125116423|NCT00358826|450049830|FG006|Core Study|Adverse Event|0|||
125116424|NCT00358826|450049831|FG007|Core Study|Adverse Event|0|||
125116425|NCT00358826|450049824|FG000|Core Study|Withdrawal by Subject|2|||
125116426|NCT00358826|450049825|FG001|Core Study|Withdrawal by Subject|2|||
125116427|NCT00358826|450049826|FG002|Core Study|Withdrawal by Subject|0|||
124915498|NCT00709098|449316533|FG001|Open-label Period|Withdrawal of consent|0|||
124915499|NCT00709098|449316534|FG002|Open-label Period|Withdrawal of consent|7|||
124915500|NCT00709098|449316532|FG000|Open-label Period|Administrative reason|0|||
124915501|NCT00709098|449316533|FG001|Open-label Period|Administrative reason|0|||
124915502|NCT00709098|449316534|FG002|Open-label Period|Administrative reason|5|||
124915503|NCT00709098|449316532|FG000|Open-label Period|Death|0|||
125116428|NCT00358826|450049827|FG003|Core Study|Withdrawal by Subject|0|||
125116429|NCT00358826|450049828|FG004|Core Study|Withdrawal by Subject|0|||
125116430|NCT00358826|450049829|FG005|Core Study|Withdrawal by Subject|0|||
125116431|NCT00358826|450049830|FG006|Core Study|Withdrawal by Subject|0|||
125116432|NCT00358826|450049831|FG007|Core Study|Withdrawal by Subject|0|||
124915504|NCT00709098|449316533|FG001|Open-label Period|Death|0|||
124915505|NCT00709098|449316534|FG002|Open-label Period|Death|1|||
124915506|NCT00709098|449316532|FG000|Open-label Period|Lost to Follow-up|0|||
124915507|NCT00709098|449316533|FG001|Open-label Period|Lost to Follow-up|0|||
125116433|NCT00358826|450049824|FG000|Core Study|Lost to Follow-up|0|||
125116434|NCT00358826|450049825|FG001|Core Study|Lost to Follow-up|0|||
125116435|NCT00358826|450049826|FG002|Core Study|Lost to Follow-up|0|||
124915508|NCT00709098|449316534|FG002|Open-label Period|Lost to Follow-up|1|||
124915509|NCT03481816|449316536|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
124915510|NCT03481816|449316537|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
125116436|NCT00358826|450049827|FG003|Core Study|Lost to Follow-up|1|||
124915511|NCT03481816|449316536|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
124915512|NCT03481816|449316537|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
124915513|NCT03481816|449316536|FG000|Dose Expansion|Withdrawal by Subject|0|||
124915514|NCT03481816|449316537|FG001|Dose Expansion|Withdrawal by Subject|2|||
125116437|NCT00358826|450049828|FG004|Core Study|Lost to Follow-up|0|||
125116438|NCT00358826|450049829|FG005|Core Study|Lost to Follow-up|0|||
125116439|NCT00358826|450049830|FG006|Core Study|Lost to Follow-up|0|||
125116440|NCT00358826|450049831|FG007|Core Study|Lost to Follow-up|0|||
125116441|NCT00358826|450049824|FG000|Core Study|Physician Decision|0|||
125116442|NCT00358826|450049825|FG001|Core Study|Physician Decision|0|||
125116443|NCT00358826|450049826|FG002|Core Study|Physician Decision|1|||
125116444|NCT00358826|450049827|FG003|Core Study|Physician Decision|0|||
125116445|NCT00358826|450049828|FG004|Core Study|Physician Decision|0|||
125116446|NCT00358826|450049829|FG005|Core Study|Physician Decision|0|||
125116447|NCT00358826|450049830|FG006|Core Study|Physician Decision|0|||
125116448|NCT00358826|450049831|FG007|Core Study|Physician Decision|0|||
125116449|NCT00358826|450049824|FG000|MDCT Substudy|Adverse Event|0|||
125116450|NCT00358826|450049825|FG001|MDCT Substudy|Adverse Event|0|||
125116451|NCT00358826|450049826|FG002|MDCT Substudy|Adverse Event|0|||
125116452|NCT00358826|450049827|FG003|MDCT Substudy|Adverse Event|0|||
125116453|NCT00358826|450049828|FG004|MDCT Substudy|Adverse Event|1|||
125116454|NCT00358826|450049829|FG005|MDCT Substudy|Adverse Event|0|||
125116455|NCT00358826|450049830|FG006|MDCT Substudy|Adverse Event|0|||
125116456|NCT00358826|450049831|FG007|MDCT Substudy|Adverse Event|0|||
125116457|NCT00358826|450049824|FG000|MDCT Substudy|Lost to Follow-up|0|||
125116458|NCT00358826|450049825|FG001|MDCT Substudy|Lost to Follow-up|0|||
124915515|NCT03481816|449316536|FG000|Dose Expansion|Physician Decision|0|||
125116459|NCT00358826|450049826|FG002|MDCT Substudy|Lost to Follow-up|0|||
125116460|NCT00358826|450049827|FG003|MDCT Substudy|Lost to Follow-up|0|||
125116461|NCT00358826|450049828|FG004|MDCT Substudy|Lost to Follow-up|0|||
125116462|NCT00358826|450049829|FG005|MDCT Substudy|Lost to Follow-up|1|||
125116463|NCT00358826|450049830|FG006|MDCT Substudy|Lost to Follow-up|0|||
125116464|NCT00358826|450049831|FG007|MDCT Substudy|Lost to Follow-up|0|||
125116465|NCT00358826|450049824|FG000|MDCT Substudy|Withdrawal by Subject|0|||
125116466|NCT00358826|450049825|FG001|MDCT Substudy|Withdrawal by Subject|0|||
125116467|NCT00358826|450049826|FG002|MDCT Substudy|Withdrawal by Subject|0|||
124915516|NCT03481816|449316537|FG001|Dose Expansion|Physician Decision|5|||
124915517|NCT01091168|449316540|FG000|Overall Study|Progressive disease|250|||
124915518|NCT01091168|449316541|FG001|Overall Study|Progressive disease|234|||
124915519|NCT01091168|449316540|FG000|Overall Study|Adverse Event|21|||
124915520|NCT01091168|449316541|FG001|Overall Study|Adverse Event|24|||
124915521|NCT01091168|449316540|FG000|Overall Study|Lost to Follow-up|0|||
124915522|NCT01091168|449316541|FG001|Overall Study|Lost to Follow-up|1|||
124915523|NCT01091168|449316540|FG000|Overall Study|Physician, patient's decision, other|27|||
124915524|NCT01091168|449316541|FG001|Overall Study|Physician, patient's decision, other|37|||
124915525|NCT03582722|449316544|FG000|Overall Study|Lost to Follow-up|1|||
124915526|NCT03582722|449316545|FG001|Overall Study|Lost to Follow-up|4|||
124915527|NCT03582722|449316544|FG000|Overall Study|Withdrawal by Subject|3|||
124915528|NCT03582722|449316545|FG001|Overall Study|Withdrawal by Subject|3|||
124915529|NCT06024174|449316546|FG000|Overall Study|Other Reasons|1|||
124915530|NCT06024174|449316546|FG000|Overall Study|Study terminated by Sponsor|4|||
124915531|NCT04567615|449316547|FG000|Randomization|Participant withdrew consent|1|||
124915532|NCT04567615|449316548|FG001|Randomization|Participant withdrew consent|0|||
124915533|NCT04567615|449316549|FG002|Randomization|Participant withdrew consent|0|||
124915534|NCT04567615|449316547|FG000|Randomization|Adverse event unrelated to study drug|0|||
124915535|NCT04567615|449316548|FG001|Randomization|Adverse event unrelated to study drug|1|||
124915536|NCT04567615|449316549|FG002|Randomization|Adverse event unrelated to study drug|0|||
124915537|NCT04567615|449316547|FG000|Treatment Period|Participant Withdrew Consent|2|||
124915538|NCT04567615|449316548|FG001|Treatment Period|Participant Withdrew Consent|5|||
124915539|NCT04567615|449316549|FG002|Treatment Period|Participant Withdrew Consent|1|||
124915540|NCT04567615|449316547|FG000|Treatment Period|Death|1|||
124915541|NCT04567615|449316548|FG001|Treatment Period|Death|2|||
124915542|NCT04567615|449316549|FG002|Treatment Period|Death|0|||
124915543|NCT04567615|449316547|FG000|Treatment Period|Lost to Follow-up|0|||
124915544|NCT04567615|449316548|FG001|Treatment Period|Lost to Follow-up|1|||
124915545|NCT04567615|449316549|FG002|Treatment Period|Lost to Follow-up|0|||
124915546|NCT04567615|449316547|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
124915547|NCT04567615|449316548|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
124915548|NCT04567615|449316549|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
124915549|NCT04567615|449316547|FG000|Treatment Period|Disease Progression|85|||
124915550|NCT04567615|449316548|FG001|Treatment Period|Disease Progression|63|||
124915551|NCT04567615|449316549|FG002|Treatment Period|Disease Progression|16|||
124915552|NCT04567615|449316547|FG000|Treatment Period|Study Drug Toxicity|3|||
124915553|NCT04567615|449316548|FG001|Treatment Period|Study Drug Toxicity|10|||
124915554|NCT04567615|449316549|FG002|Treatment Period|Study Drug Toxicity|4|||
124915555|NCT04567615|449316547|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
124915556|NCT04567615|449316548|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
124915557|NCT04567615|449316549|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
124915558|NCT04567615|449316547|FG000|Treatment Period|Other Reasons|1|||
124915559|NCT04567615|449316548|FG001|Treatment Period|Other Reasons|2|||
124915560|NCT04567615|449316549|FG002|Treatment Period|Other Reasons|0|||
124915561|NCT04567615|449316547|FG000|Treatment Period|Still On-going Treatment|21|||
124915562|NCT04567615|449316548|FG001|Treatment Period|Still On-going Treatment|22|||
124915563|NCT04567615|449316549|FG002|Treatment Period|Still On-going Treatment|2|||
124915564|NCT03481660|449318572|FG000|Overall Study|Adverse Event|5|||
124915565|NCT03481660|449318573|FG001|Overall Study|Adverse Event|4|||
124915566|NCT03481660|449318572|FG000|Overall Study|Death|13|||
124915567|NCT03481660|449318573|FG001|Overall Study|Death|9|||
124915568|NCT03481660|449318572|FG000|Overall Study|Lost to Follow-up|2|||
124915569|NCT03481660|449318573|FG001|Overall Study|Lost to Follow-up|2|||
124915570|NCT03481660|449318572|FG000|Overall Study|Physician Decision|2|||
124915571|NCT03481660|449318573|FG001|Overall Study|Physician Decision|3|||
124915572|NCT03481660|449318572|FG000|Overall Study|Withdrawal by Subject|14|||
124915573|NCT03481660|449318573|FG001|Overall Study|Withdrawal by Subject|7|||
124915574|NCT03012841|449318574|FG000|Overall Study|Protocol Violation|0|||
124915575|NCT03012841|449318575|FG001|Overall Study|Protocol Violation|10|||
124915576|NCT03012841|449318574|FG000|Overall Study|Lost to Follow-up|6|||
124915577|NCT03012841|449318575|FG001|Overall Study|Lost to Follow-up|1|||
124915578|NCT03012841|449318574|FG000|Overall Study|Withdrawal by Subject|6|||
124915579|NCT03012841|449318575|FG001|Overall Study|Withdrawal by Subject|0|||
124915580|NCT03012841|449318574|FG000|Overall Study|Unable to complete 12 month visit|6|||
124915581|NCT03012841|449318575|FG001|Overall Study|Unable to complete 12 month visit|0|||
124915582|NCT03012841|449318574|FG000|Overall Study|Subject relocation|1|||
124915583|NCT03012841|449318575|FG001|Overall Study|Subject relocation|0|||
124915584|NCT03012841|449318574|FG000|Overall Study|Seasonal winter travel|1|||
124915585|NCT03012841|449318575|FG001|Overall Study|Seasonal winter travel|0|||
124915586|NCT03012841|449318574|FG000|Overall Study|Physician Decision|0|||
124915587|NCT03012841|449318575|FG001|Overall Study|Physician Decision|2|||
124915588|NCT03012841|449318574|FG000|Overall Study|No ablation performed|0|||
124915589|NCT03012841|449318575|FG001|Overall Study|No ablation performed|2|||
124915590|NCT03012841|449318574|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
124915591|NCT03012841|449318575|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
124915592|NCT03012841|449318574|FG000|Overall Study|Insurance change|0|||
124915593|NCT03012841|449318575|FG001|Overall Study|Insurance change|1|||
124915594|NCT03683069|449318576|FG000|Overall Study|see limitations|12|||
124915595|NCT03683069|449318577|FG001|Overall Study|see limitations|13|||
124915596|NCT04941287|449318578|FG000|Overall Study|Rapid decline before starting treatment|3|||
124915597|NCT04941287|449318579|FG001|Overall Study|Rapid decline before starting treatment|1|||
124915598|NCT04065048|449318580|FG000|Overall Study|Withdrawal by Subject|1|||
124915599|NCT04065048|449318581|FG001|Overall Study|Withdrawal by Subject|2|||
124915600|NCT04065048|449318582|FG002|Overall Study|Withdrawal by Subject|1|||
124915601|NCT04065048|449318583|FG003|Overall Study|Withdrawal by Subject|1|||
124915602|NCT04065048|449318580|FG000|Overall Study|Adverse Event|1|||
124915603|NCT04065048|449318581|FG001|Overall Study|Adverse Event|0|||
124915604|NCT04065048|449318582|FG002|Overall Study|Adverse Event|1|||
124915605|NCT04065048|449318583|FG003|Overall Study|Adverse Event|0|||
124915609|NCT05096819|449318593|FG000|Overall Study|Withdrawal by Subject|3|||
124915610|NCT05096819|449318594|FG001|Overall Study|Withdrawal by Subject|0|||
124915611|NCT05307978|449318595|FG000|Overall Study|Lost to Follow-up|0|||
124915612|NCT05307978|449318596|FG001|Overall Study|Lost to Follow-up|1|||
124915613|NCT05307978|449318597|FG002|Overall Study|Lost to Follow-up|0|||
124915614|NCT05307978|449318598|FG003|Overall Study|Lost to Follow-up|4|||
124915615|NCT05307978|449318599|FG004|Overall Study|Lost to Follow-up|0|||
124915616|NCT05307978|449318600|FG005|Overall Study|Lost to Follow-up|0|||
124915617|NCT05307978|449318601|FG006|Overall Study|Lost to Follow-up|1|||
124915618|NCT03324984|449318602|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
124915619|NCT03324984|449318603|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
124915620|NCT04607044|449318608|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
124915621|NCT04607044|449318608|FG000|Overall Study|Adverse Event|1|||
124915622|NCT04607044|449318608|FG000|Overall Study|Did not receive study device|3|||
124915623|NCT04607044|449318608|FG000|Overall Study|Death|1|||
124915624|NCT05075408|449318609|FG000|Overall Study|Withdrawal by Subject|5|||
124915625|NCT05075408|449318610|FG001|Overall Study|Withdrawal by Subject|3|||
124915626|NCT05075408|449318611|FG002|Overall Study|Withdrawal by Subject|4|||
124915627|NCT05075408|449318609|FG000|Overall Study|Adverse Event|5|||
124915628|NCT05075408|449318610|FG001|Overall Study|Adverse Event|7|||
124915629|NCT05075408|449318611|FG002|Overall Study|Adverse Event|8|||
124915630|NCT05075408|449318609|FG000|Overall Study|Protocol Violation|0|||
124915631|NCT05075408|449318610|FG001|Overall Study|Protocol Violation|1|||
124915632|NCT05075408|449318611|FG002|Overall Study|Protocol Violation|0|||
124915633|NCT05075408|449318609|FG000|Overall Study|Lost to Follow-up|2|||
124915634|NCT05075408|449318610|FG001|Overall Study|Lost to Follow-up|1|||
124915635|NCT05075408|449318611|FG002|Overall Study|Lost to Follow-up|1|||
124915636|NCT05075408|449318609|FG000|Overall Study|Physician Decision|1|||
124915637|NCT05075408|449318610|FG001|Overall Study|Physician Decision|0|||
124915638|NCT05075408|449318611|FG002|Overall Study|Physician Decision|0|||
124915639|NCT05075408|449318609|FG000|Overall Study|Other-unspecified|3|||
124915640|NCT05075408|449318610|FG001|Overall Study|Other-unspecified|2|||
124915641|NCT05075408|449318611|FG002|Overall Study|Other-unspecified|0|||
124915642|NCT04878354|449318615|FG000|Overall Study|Adverse Event|4|||
124915643|NCT04878354|449318616|FG001|Overall Study|Adverse Event|13|||
124915644|NCT04878354|449318615|FG000|Overall Study|Withdrawal by Subject|14|||
124915645|NCT04878354|449318616|FG001|Overall Study|Withdrawal by Subject|12|||
124915646|NCT04878354|449318615|FG000|Overall Study|Lost to Follow-up|4|||
124915647|NCT04878354|449318616|FG001|Overall Study|Lost to Follow-up|1|||
124915648|NCT04878354|449318615|FG000|Overall Study|Lack of Efficacy|1|||
124915649|NCT04878354|449318616|FG001|Overall Study|Lack of Efficacy|0|||
124915650|NCT04878354|449318615|FG000|Overall Study|Protocol Violation|0|||
124915651|NCT04878354|449318616|FG001|Overall Study|Protocol Violation|1|||
124915652|NCT04878354|449318615|FG000|Overall Study|"Reason stated as other in CRF"|2|||
124915653|NCT04878354|449318616|FG001|Overall Study|"Reason stated as other in CRF"|3|||
124915654|NCT04847999|449318617|FG000|Overall Study|Lost to Follow-up|0|||
124915655|NCT04847999|449318618|FG001|Overall Study|Lost to Follow-up|1|||
124915656|NCT02879448|449318619|FG000|Overall Study|Death|251|||
124915657|NCT02879448|449318620|FG001|Overall Study|Death|263|||
124915658|NCT02879448|449318619|FG000|Overall Study|Lost to Follow-up|23|||
124915659|NCT02879448|449318620|FG001|Overall Study|Lost to Follow-up|28|||
124915660|NCT02879448|449318619|FG000|Overall Study|Withdrawal by Subject|42|||
124915661|NCT02879448|449318620|FG001|Overall Study|Withdrawal by Subject|79|||
124915662|NCT02879448|449318619|FG000|Overall Study|Other Reasons|8|||
124915663|NCT02879448|449318620|FG001|Overall Study|Other Reasons|12|||
124915664|NCT03433339|449318621|FG000|Overall Study|Lost to Follow-up|2|||
124915665|NCT03433339|449318622|FG001|Overall Study|Lost to Follow-up|0|||
124915666|NCT03433339|449318621|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
124915667|NCT03433339|449318622|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
124915668|NCT03433339|449318621|FG000|Overall Study|Withdrawal by Subject|0|||
124915669|NCT03433339|449318622|FG001|Overall Study|Withdrawal by Subject|2|||
124915670|NCT05952076|449318623|FG000|Overall Study|Death|1|||
124915671|NCT05952076|449318624|FG001|Overall Study|Death|1|||
124915672|NCT05952076|449318623|FG000|Overall Study|Lost to Follow-up|0|||
124915673|NCT05952076|449318624|FG001|Overall Study|Lost to Follow-up|1|||
124915674|NCT04143061|449318626|FG000|Overall Study|Protocol Deviation|0|||
124915675|NCT04143061|449318627|FG001|Overall Study|Protocol Deviation|0|||
124915676|NCT04143061|449318628|FG002|Overall Study|Protocol Deviation|0|||
124915677|NCT04143061|449318629|FG003|Overall Study|Protocol Deviation|0|||
124915678|NCT04143061|449318630|FG004|Overall Study|Protocol Deviation|0|||
124915679|NCT04143061|449318631|FG005|Overall Study|Protocol Deviation|0|||
124915680|NCT04143061|449318632|FG006|Overall Study|Protocol Deviation|5|||
124915681|NCT04143061|449318633|FG007|Overall Study|Protocol Deviation|5|||
124915682|NCT04143061|449318626|FG000|Overall Study|Withdrawal by Subject|2|||
124915683|NCT04143061|449318627|FG001|Overall Study|Withdrawal by Subject|0|||
124915684|NCT04143061|449318628|FG002|Overall Study|Withdrawal by Subject|0|||
124915685|NCT04143061|449318629|FG003|Overall Study|Withdrawal by Subject|0|||
124915686|NCT04143061|449318630|FG004|Overall Study|Withdrawal by Subject|0|||
124915687|NCT04143061|449318631|FG005|Overall Study|Withdrawal by Subject|1|||
124915688|NCT04143061|449318632|FG006|Overall Study|Withdrawal by Subject|0|||
124915689|NCT04143061|449318633|FG007|Overall Study|Withdrawal by Subject|0|||
124915690|NCT04143061|449318626|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125131394|NCT03818581|450109963|FG003|Overall Study|Adverse Event|0|||
124915691|NCT04143061|449318627|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124915692|NCT04143061|449318628|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
124915693|NCT04143061|449318629|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
124915694|NCT04143061|449318630|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
124915695|NCT04143061|449318631|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
124915696|NCT04143061|449318632|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
124915697|NCT04143061|449318633|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
124915698|NCT01718743|449318634|FG000|Overall Study|Physician Decision|7|||
124915699|NCT01718743|449318634|FG000|Overall Study|Withdrawal by Subject|14|||
124915700|NCT01718743|449318634|FG000|Overall Study|Progressive Disease|22|||
124915701|NCT01718743|449318634|FG000|Overall Study|Toxicity|1|||
124915702|NCT01718743|449318634|FG000|Overall Study|Malignancy|1|||
124915703|NCT03739996|449318637|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
124915704|NCT03739996|449318637|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
124915705|NCT03739996|449318637|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
124915706|NCT03739996|449318637|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
124915707|NCT03739996|449318637|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
124915708|NCT03739996|449318637|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
124915709|NCT03739996|449318637|FG000|Step 3 (SOC ART)|Death|1|||
124915710|NCT03739996|449318637|FG000|Step 3 (SOC ART)|Participant moved|1|||
124915711|NCT01673984|449318638|FG000|Overall Study|Adverse Event|1|||
124915712|NCT01673984|449318639|FG001|Overall Study|Adverse Event|0|||
124915713|NCT01673984|449318638|FG000|Overall Study|Study termination|9|||
124915714|NCT01673984|449318639|FG001|Overall Study|Study termination|6|||
124915715|NCT02553642|449318640|FG000|Overall Study|Withdrawal by Subject|0|||
124915716|NCT02553642|449318641|FG001|Overall Study|Withdrawal by Subject|3|||
124915717|NCT02553642|449318640|FG000|Overall Study|Physician Decision|0|||
124915718|NCT02553642|449318641|FG001|Overall Study|Physician Decision|1|||
124915719|NCT02553642|449318640|FG000|Overall Study|Additional cancer dx|0|||
124915720|NCT02553642|449318641|FG001|Overall Study|Additional cancer dx|1|||
124915721|NCT02553642|449318640|FG000|Overall Study|Never started treatment|0|||
124915722|NCT02553642|449318641|FG001|Overall Study|Never started treatment|1|||
124915723|NCT04437433|449318642|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
124915724|NCT04437433|449318643|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
125116468|NCT00358826|450049827|FG003|MDCT Substudy|Withdrawal by Subject|0|||
125116469|NCT00358826|450049828|FG004|MDCT Substudy|Withdrawal by Subject|0|||
125116470|NCT00358826|450049829|FG005|MDCT Substudy|Withdrawal by Subject|1|||
125116471|NCT00358826|450049830|FG006|MDCT Substudy|Withdrawal by Subject|0|||
125116472|NCT00358826|450049831|FG007|MDCT Substudy|Withdrawal by Subject|0|||
125116473|NCT00903383|450049832|FG000|Overall Study|Adverse Event|1|||
125116474|NCT00903383|450049833|FG001|Overall Study|Adverse Event|2|||
125116475|NCT00903383|450049834|FG002|Overall Study|Adverse Event|3|||
125116476|NCT00903383|450049835|FG003|Overall Study|Adverse Event|1|||
125116477|NCT00903383|450049832|FG000|Overall Study|Physician Decision|1|||
125116478|NCT00903383|450049833|FG001|Overall Study|Physician Decision|2|||
125116479|NCT00903383|450049834|FG002|Overall Study|Physician Decision|0|||
125116480|NCT00903383|450049835|FG003|Overall Study|Physician Decision|0|||
125116481|NCT00903383|450049832|FG000|Overall Study|Lost to Follow-up|0|||
125116482|NCT00903383|450049833|FG001|Overall Study|Lost to Follow-up|0|||
124915725|NCT04437433|449318642|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
124915726|NCT04437433|449318643|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
124915727|NCT04437433|449318642|FG000|Overall Study|Adverse Event|9|||
124915728|NCT04437433|449318643|FG001|Overall Study|Adverse Event|0|||
124915729|NCT04437433|449318642|FG000|Overall Study|Lack of Efficacy|4|||
124915730|NCT04437433|449318643|FG001|Overall Study|Lack of Efficacy|0|||
124915731|NCT04437433|449318642|FG000|Overall Study|Withdrawal by Subject|4|||
124915732|NCT04437433|449318643|FG001|Overall Study|Withdrawal by Subject|1|||
124915733|NCT04437433|449318642|FG000|Overall Study|Protocol Deviation|0|||
124915734|NCT04437433|449318643|FG001|Overall Study|Protocol Deviation|1|||
124915735|NCT04437433|449318642|FG000|Overall Study|Other, not specified|0|||
124915736|NCT04437433|449318643|FG001|Overall Study|Other, not specified|1|||
124915737|NCT00894543|449318646|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
124915738|NCT00894543|449318647|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
124915739|NCT00894543|449318646|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
124915740|NCT00894543|449318647|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
125116483|NCT00903383|450049834|FG002|Overall Study|Lost to Follow-up|0|||
125116484|NCT00903383|450049835|FG003|Overall Study|Lost to Follow-up|1|||
125116485|NCT00903383|450049832|FG000|Overall Study|Decision of Sponsor|1|||
125116486|NCT00903383|450049833|FG001|Overall Study|Decision of Sponsor|0|||
125116487|NCT00903383|450049834|FG002|Overall Study|Decision of Sponsor|0|||
124915741|NCT04048681|449318648|FG000|Overall Study|family emergency|0|||
124915742|NCT04048681|449318649|FG001|Overall Study|family emergency|0|||
124915743|NCT04048681|449318650|FG002|Overall Study|family emergency|0|||
124915744|NCT04048681|449318651|FG003|Overall Study|family emergency|1|||
124915745|NCT04048681|449318652|FG004|Overall Study|family emergency|0|||
124915746|NCT01532388|449318653|FG000|3-month Follow-up|Lost to Follow-up|68|||
124915747|NCT01532388|449318654|FG001|3-month Follow-up|Lost to Follow-up|68|||
124915748|NCT01532388|449318653|FG000|6-month Follow-up|Lost to Follow-up|74|||
124915749|NCT01532388|449318654|FG001|6-month Follow-up|Lost to Follow-up|66|||
124915750|NCT01532388|449318653|FG000|12-month Follow-up|Lost to Follow-up|69|||
124915751|NCT01532388|449318654|FG001|12-month Follow-up|Lost to Follow-up|67|||
124915752|NCT02919449|449318655|FG000|Overall Study|Withdrawal by Subject|1|||
124915753|NCT02919449|449318655|FG000|Overall Study|Investigator decision|1|||
124915754|NCT00727909|449318656|FG000|Overall Study|Withdrawal by Subject|5|||
124915755|NCT00727909|449318657|FG001|Overall Study|Withdrawal by Subject|11|||
124915756|NCT00727909|449318658|FG002|Overall Study|Withdrawal by Subject|8|||
124915757|NCT00727909|449318659|FG003|Overall Study|Withdrawal by Subject|5|||
124915758|NCT00727909|449318656|FG000|Overall Study|Death|0|||
124915759|NCT00727909|449318657|FG001|Overall Study|Death|0|||
124915760|NCT00727909|449318658|FG002|Overall Study|Death|1|||
124915761|NCT00727909|449318659|FG003|Overall Study|Death|0|||
124915762|NCT03578536|449318662|FG000|Overall Study|Lost to Follow-up|1|||
124915763|NCT05198310|449318663|FG000|Overall Study|Lost to Follow-up|0|||
125116488|NCT00903383|450049835|FG003|Overall Study|Decision of Sponsor|0|||
125116489|NCT00903383|450049832|FG000|Overall Study|Withdrawal by Subject|4|||
125116490|NCT00903383|450049833|FG001|Overall Study|Withdrawal by Subject|1|||
125116491|NCT00903383|450049834|FG002|Overall Study|Withdrawal by Subject|0|||
125116492|NCT00903383|450049835|FG003|Overall Study|Withdrawal by Subject|2|||
125116493|NCT00903383|450049832|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
125116494|NCT00903383|450049833|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
125116495|NCT00903383|450049834|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
125116496|NCT00903383|450049835|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
125116497|NCT00903383|450049832|FG000|Overall Study|Patient Decision|0|||
125116498|NCT00903383|450049833|FG001|Overall Study|Patient Decision|0|||
125116499|NCT00903383|450049834|FG002|Overall Study|Patient Decision|0|||
125116500|NCT00903383|450049835|FG003|Overall Study|Patient Decision|1|||
125116501|NCT01821625|450049838|FG000|Overall Study|Withdrawal by Subject|2|||
125116502|NCT01821625|450049838|FG000|Overall Study|Lack of Efficacy|2|||
125116503|NCT01821625|450049838|FG000|Overall Study|Adverse Event|1|||
125116504|NCT01821625|450049838|FG000|Overall Study|Medical contraindication|1|||
125116505|NCT00320593|450049841|FG000|Overall Study|Lost to Follow-up|3|||
125116506|NCT00320593|450049842|FG001|Overall Study|Lost to Follow-up|0|||
125116507|NCT00320593|450049841|FG000|Overall Study|Moved to another state|1|||
125116508|NCT00320593|450049842|FG001|Overall Study|Moved to another state|0|||
125116509|NCT00320593|450049841|FG000|Overall Study|Withdrawal by Subject|2|||
125116510|NCT00320593|450049842|FG001|Overall Study|Withdrawal by Subject|1|||
125116511|NCT00320593|450049841|FG000|Overall Study|Withdrawal by clinical center|1|||
125116512|NCT00320593|450049842|FG001|Overall Study|Withdrawal by clinical center|0|||
125116513|NCT00457665|450049843|FG000|12 Months|Drug allergy|1|||
125116514|NCT00457665|450049844|FG001|12 Months|Drug allergy|1|||
125116515|NCT00457665|450049843|FG000|12 Months|High HIV viral load|5|||
125116516|NCT00457665|450049844|FG001|12 Months|High HIV viral load|1|||
125116517|NCT00457665|450049843|FG000|12 Months|Lipodystrophy|2|||
125116518|NCT00457665|450049844|FG001|12 Months|Lipodystrophy|0|||
125116519|NCT00457665|450049843|FG000|12 Months|Withdrawal by Subject|0|||
125116520|NCT00457665|450049844|FG001|12 Months|Withdrawal by Subject|2|||
125116521|NCT00457665|450049843|FG000|12 Months|Abnormal Liver function tests|0|||
125116522|NCT00457665|450049844|FG001|12 Months|Abnormal Liver function tests|5|||
125116523|NCT00457665|450049843|FG000|24 Months|Withdrawal by Subject|3|||
125116524|NCT00457665|450049844|FG001|24 Months|Withdrawal by Subject|2|||
125116525|NCT00457665|450049843|FG000|24 Months|Lipodystrophy|1|||
125116526|NCT00457665|450049844|FG001|24 Months|Lipodystrophy|1|||
125116527|NCT00457665|450049843|FG000|24 Months|Abnormal liver function tests|1|||
125116528|NCT00457665|450049844|FG001|24 Months|Abnormal liver function tests|5|||
125211801|NCT02007278|450401373|FG001|Overall Study|Incorrect medication administration|0|||
124915764|NCT05198310|449318664|FG001|Overall Study|Lost to Follow-up|1|||
124915765|NCT05198310|449318665|FG002|Overall Study|Lost to Follow-up|0|||
124915766|NCT05198310|449318666|FG003|Overall Study|Lost to Follow-up|0|||
125116529|NCT01716754|450049845|FG000|Overall Study|Death|0|||
125116530|NCT01716754|450049846|FG001|Overall Study|Death|0|||
125116531|NCT01716754|450049847|FG002|Overall Study|Death|0|||
125116532|NCT01716754|450049848|FG003|Overall Study|Death|1|||
125116533|NCT01716754|450049845|FG000|Overall Study|Protocol deviation|0|||
125116534|NCT01716754|450049846|FG001|Overall Study|Protocol deviation|2|||
125116535|NCT01716754|450049847|FG002|Overall Study|Protocol deviation|7|||
125116536|NCT01716754|450049848|FG003|Overall Study|Protocol deviation|2|||
125211802|NCT02007278|450401372|FG000|Overall Study|Mis-randomization|1|||
125211803|NCT02007278|450401373|FG001|Overall Study|Mis-randomization|1|||
124915767|NCT05198310|449318667|FG004|Overall Study|Lost to Follow-up|0|||
124915768|NCT05198310|449318668|FG005|Overall Study|Lost to Follow-up|0|||
124915769|NCT05198310|449318669|FG006|Overall Study|Lost to Follow-up|0|||
124915770|NCT05198310|449318670|FG007|Overall Study|Lost to Follow-up|0|||
125116537|NCT01716754|450049845|FG000|Overall Study|Non-compliance with study treatment|0|||
124915771|NCT05198310|449318663|FG000|Overall Study|Withdrawal by Subject|0|||
124915772|NCT05198310|449318664|FG001|Overall Study|Withdrawal by Subject|0|||
124915773|NCT05198310|449318665|FG002|Overall Study|Withdrawal by Subject|0|||
124915774|NCT05198310|449318666|FG003|Overall Study|Withdrawal by Subject|2|||
124915775|NCT05198310|449318667|FG004|Overall Study|Withdrawal by Subject|0|||
124915776|NCT05198310|449318668|FG005|Overall Study|Withdrawal by Subject|2|||
124915777|NCT05198310|449318669|FG006|Overall Study|Withdrawal by Subject|1|||
124915778|NCT05198310|449318670|FG007|Overall Study|Withdrawal by Subject|3|||
124915779|NCT04436107|449318671|FG000|Overall Study|Sponsor Ended Study|2|||
124915780|NCT04436107|449318672|FG001|Overall Study|Sponsor Ended Study|4|||
124915781|NCT04436107|449318673|FG002|Overall Study|Sponsor Ended Study|8|||
124915782|NCT04436107|449318674|FG003|Overall Study|Sponsor Ended Study|20|||
124915783|NCT04436107|449318671|FG000|Overall Study|Death|3|||
124915784|NCT04436107|449318672|FG001|Overall Study|Death|5|||
124915785|NCT04436107|449318673|FG002|Overall Study|Death|3|||
124915786|NCT04436107|449318674|FG003|Overall Study|Death|18|||
124915787|NCT04436107|449318671|FG000|Overall Study|Withdrawal by Subject|1|||
124915788|NCT04436107|449318672|FG001|Overall Study|Withdrawal by Subject|1|||
124915789|NCT04436107|449318673|FG002|Overall Study|Withdrawal by Subject|0|||
124915790|NCT04436107|449318674|FG003|Overall Study|Withdrawal by Subject|1|||
124915791|NCT00448669|449318677|FG000|Overall Study|Lost to Follow-up|52|||
124915792|NCT00448669|449318678|FG001|Overall Study|Lost to Follow-up|63|||
124915793|NCT00448669|449318677|FG000|Overall Study|Withdrawal by Subject|90|||
124915794|NCT00448669|449318678|FG001|Overall Study|Withdrawal by Subject|74|||
124915795|NCT00448669|449318677|FG000|Overall Study|Relocated|49|||
124915796|NCT00448669|449318678|FG001|Overall Study|Relocated|36|||
124915797|NCT00448669|449318677|FG000|Overall Study|Were withdrawn by investigator|10|||
124915798|NCT00448669|449318678|FG001|Overall Study|Were withdrawn by investigator|6|||
124915799|NCT00448669|449318677|FG000|Overall Study|Death|2|||
124915800|NCT00448669|449318678|FG001|Overall Study|Death|4|||
124915801|NCT00448669|449318677|FG000|Overall Study|Had other reasons|5|||
124915802|NCT00448669|449318678|FG001|Overall Study|Had other reasons|6|||
124915803|NCT00448669|449318677|FG000|Overall Study|HIV-infected at enrollment|1|||
124915804|NCT00448669|449318678|FG001|Overall Study|HIV-infected at enrollment|2|||
124915805|NCT00448669|449318677|FG000|Overall Study|Never started drug|9|||
124915806|NCT00448669|449318678|FG001|Overall Study|Never started drug|7|||
124915807|NCT02638337|449318679|FG000|Overall Study|Adverse Event|6|||
124915808|NCT02638337|449318680|FG001|Overall Study|Adverse Event|10|||
124915809|NCT02638337|449318679|FG000|Overall Study|Protocol Violation|3|||
124915810|NCT02638337|449318680|FG001|Overall Study|Protocol Violation|0|||
124915811|NCT02638337|449318679|FG000|Overall Study|Withdrawal by Subject|13|||
124915812|NCT02638337|449318680|FG001|Overall Study|Withdrawal by Subject|16|||
124915813|NCT02638337|449318679|FG000|Overall Study|Lost to Follow-up|7|||
124915814|NCT02638337|449318680|FG001|Overall Study|Lost to Follow-up|7|||
124915815|NCT02638337|449318679|FG000|Overall Study|Other - Miscellaneous|4|||
124915816|NCT02638337|449318680|FG001|Overall Study|Other - Miscellaneous|3|||
124915817|NCT03338816|449318694|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
124915818|NCT03338816|449318695|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
124915819|NCT03338816|449318696|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
124915820|NCT03338816|449318697|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
124915821|NCT03338816|449318694|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
124915822|NCT03338816|449318695|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
124915823|NCT03338816|449318696|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
124915824|NCT03338816|449318697|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
124915825|NCT03338816|449318694|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
124915826|NCT03338816|449318695|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
124915827|NCT03338816|449318696|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
124915828|NCT03338816|449318697|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
124915829|NCT03338816|449318694|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
124915830|NCT03338816|449318695|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
124915831|NCT03338816|449318696|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
124915832|NCT03338816|449318697|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
124915833|NCT03338816|449318694|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
124915834|NCT03338816|449318695|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
124915835|NCT03338816|449318696|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
124915836|NCT03338816|449318697|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
124915837|NCT03338816|449318694|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
124915838|NCT03338816|449318695|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
124915839|NCT03338816|449318696|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
124915840|NCT03338816|449318697|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
124915841|NCT03338816|449318694|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
124915842|NCT03338816|449318695|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
124915843|NCT03338816|449318696|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
124915844|NCT03338816|449318697|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
124915845|NCT03092726|449318698|FG000|Overall Study|Adverse Event|3|||
124915846|NCT03092726|449318699|FG001|Overall Study|Adverse Event|10|||
124915847|NCT03092726|449318698|FG000|Overall Study|Lack of Efficacy|0|||
124915848|NCT03092726|449318699|FG001|Overall Study|Lack of Efficacy|1|||
124915849|NCT03092726|449318698|FG000|Overall Study|Lost to Follow-up|1|||
124915850|NCT03092726|449318699|FG001|Overall Study|Lost to Follow-up|0|||
124915851|NCT03092726|449318698|FG000|Overall Study|Withdrawal by Subject|5|||
124915852|NCT03092726|449318699|FG001|Overall Study|Withdrawal by Subject|3|||
124915853|NCT04950127|449318700|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
124915854|NCT04950127|449318701|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
124915855|NCT04950127|449318702|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
124915856|NCT04950127|449318703|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
124915857|NCT04950127|449318704|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
124915858|NCT04950127|449318705|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
124915859|NCT04950127|449318700|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
124915860|NCT04950127|449318701|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
124915861|NCT04950127|449318702|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
124915862|NCT04950127|449318703|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
124915863|NCT04950127|449318704|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
124915864|NCT04950127|449318705|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
124915865|NCT04950127|449318700|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
124915866|NCT04950127|449318701|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
124915867|NCT04950127|449318702|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
124915868|NCT04950127|449318703|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
124915869|NCT04950127|449318704|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
124915870|NCT04950127|449318705|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
124915871|NCT04950127|449318700|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
124915872|NCT04950127|449318701|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
124915873|NCT04950127|449318702|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
124915874|NCT04950127|449318703|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
124915875|NCT04950127|449318704|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
124915876|NCT04950127|449318705|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
124915877|NCT04950127|449318700|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
124915878|NCT04950127|449318701|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
124915879|NCT04950127|449318702|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
124915880|NCT04950127|449318703|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
124915881|NCT04950127|449318704|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
124915882|NCT04950127|449318705|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
124915883|NCT03833167|449318710|FG000|Overall Study|Withdrawal by Subject|4|||
124915884|NCT03833167|449318711|FG001|Overall Study|Withdrawal by Subject|6|||
124915885|NCT03833167|449318710|FG000|Overall Study|Ongoing|186|||
124915886|NCT03833167|449318711|FG001|Overall Study|Ongoing|194|||
124915887|NCT03833167|449318710|FG000|Overall Study|Lost to Follow-up|1|||
124915888|NCT03833167|449318711|FG001|Overall Study|Lost to Follow-up|1|||
124915889|NCT03833167|449318710|FG000|Overall Study|Physician Decision|0|||
124915890|NCT03833167|449318711|FG001|Overall Study|Physician Decision|2|||
124915891|NCT03833167|449318710|FG000|Overall Study|Death|34|||
124915892|NCT03833167|449318711|FG001|Overall Study|Death|22|||
124915893|NCT01948661|449318713|FG000|Overall Study|Withdrawal by Subject|2|||
124915894|NCT01948661|449318714|FG001|Overall Study|Withdrawal by Subject|4|||
124915895|NCT03271489|449318715|FG000|Double-Blind (DB) Period|Adverse Event|4|||
124915896|NCT03271489|449318716|FG001|Double-Blind (DB) Period|Adverse Event|1|||
124915897|NCT03271489|449318715|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
124915898|NCT03271489|449318716|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
124915899|NCT03271489|449318715|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
124915900|NCT03271489|449318716|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
124915901|NCT03271489|449318715|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
124915902|NCT03271489|449318716|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
124915903|NCT03271489|449318715|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
124915904|NCT03271489|449318716|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
124915905|NCT03271489|449318715|FG000|Double-Blind (DB) Period|Other|6|||
124915906|NCT03271489|449318716|FG001|Double-Blind (DB) Period|Other|1|||
124915907|NCT03271489|449318715|FG000|Double-Blind (DB) Period|Missing|1|||
124915908|NCT03271489|449318716|FG001|Double-Blind (DB) Period|Missing|0|||
124915909|NCT03271489|449318715|FG000|Open-Label (OL) Period|Adverse Event|2|||
124915910|NCT03271489|449318716|FG001|Open-Label (OL) Period|Adverse Event|0|||
124915911|NCT03271489|449318715|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
124915912|NCT03271489|449318716|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
124915913|NCT03271489|449318715|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
124915914|NCT03271489|449318716|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
124915915|NCT03271489|449318715|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
124915916|NCT03271489|449318716|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
124915917|NCT03271489|449318715|FG000|Open-Label (OL) Period|No Specified|2|||
124915918|NCT03271489|449318716|FG001|Open-Label (OL) Period|No Specified|2|||
124915919|NCT03271489|449318715|FG000|Open-Label (OL) Period|Missing|2|||
124915920|NCT03271489|449318716|FG001|Open-Label (OL) Period|Missing|0|||
124915921|NCT03271489|449318715|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
124915922|NCT03271489|449318716|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
124915923|NCT03271489|449318715|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
124915924|NCT03271489|449318716|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
124915925|NCT03271489|449318715|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
124915926|NCT03271489|449318716|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
124915927|NCT03271489|449318715|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
124915928|NCT03271489|449318716|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
124915929|NCT03271489|449318715|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
124915930|NCT03271489|449318716|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
124915931|NCT03271489|449318715|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
124915932|NCT03271489|449318716|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
124915933|NCT03271489|449318715|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
124915934|NCT03271489|449318716|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
124915935|NCT03271489|449318715|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
124915936|NCT03271489|449318716|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
124915937|NCT02860130|449318717|FG000|Overall Study|Adverse Event|2|||
124915938|NCT02860130|449318718|FG001|Overall Study|Adverse Event|3|||
124915939|NCT02860130|449318717|FG000|Overall Study|Protocol Violation|1|||
124915940|NCT02860130|449318718|FG001|Overall Study|Protocol Violation|1|||
124915941|NCT02860130|449318717|FG000|Overall Study|Withdrawal by Subject|0|||
124915942|NCT02860130|449318718|FG001|Overall Study|Withdrawal by Subject|2|||
124915943|NCT02860130|449318717|FG000|Overall Study|Physician Decision|2|||
124915944|NCT02860130|449318718|FG001|Overall Study|Physician Decision|2|||
124915945|NCT02860130|449318717|FG000|Overall Study|Other|2|||
124915946|NCT02860130|449318718|FG001|Overall Study|Other|1|||
124915947|NCT03330795|449318719|FG000|Overall Study|Death|3|||
124915948|NCT03330795|449318719|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
124915949|NCT05575076|449318721|FG000|Overall Study|Adverse Event|24|||
124915950|NCT05575076|449318721|FG000|Overall Study|Death|7|||
124915951|NCT05575076|449318721|FG000|Overall Study|Lost to Follow-up|16|||
124915952|NCT05575076|449318721|FG000|Overall Study|Non-Compliance|3|||
124915953|NCT05575076|449318721|FG000|Overall Study|Physician Decision|6|||
124915954|NCT05575076|449318721|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
124915955|NCT05575076|449318721|FG000|Overall Study|Withdrawal by Subject|71|||
124915956|NCT05575076|449318721|FG000|Overall Study|Study Terminated by Sponsor|630|||
124915957|NCT05575076|449318721|FG000|Overall Study|Other|17|||
124915958|NCT01127373|449318722|FG000|Overall Study|Not Treated|3|||
124915959|NCT01127373|449318722|FG000|Overall Study|Lost to Follow-up|7|||
124915960|NCT01127373|449318722|FG000|Overall Study|Withdrawal by Subject|1|||
124915961|NCT01127373|449318722|FG000|Overall Study|Disease progression|1|||
124915962|NCT01426412|449318729|FG000|Overall Study|Withdrawal by Subject|1|||
124915963|NCT01426412|449318730|FG001|Overall Study|Withdrawal by Subject|0|||
124915964|NCT01426412|449318731|FG002|Overall Study|Withdrawal by Subject|0|||
124915965|NCT01426412|449318732|FG003|Overall Study|Withdrawal by Subject|0|||
124915966|NCT01426412|449318733|FG004|Overall Study|Withdrawal by Subject|1|||
124915967|NCT01426412|449318734|FG005|Overall Study|Withdrawal by Subject|0|||
124915968|NCT01426412|449318735|FG006|Overall Study|Withdrawal by Subject|0|||
124915969|NCT01426412|449318736|FG007|Overall Study|Withdrawal by Subject|3|||
124915970|NCT01426412|449318737|FG008|Overall Study|Withdrawal by Subject|1|||
124915971|NCT05450458|449318738|FG000|Overall Study|Lost to Follow-up|4|||
124915972|NCT04157348|449318740|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
124915973|NCT04157348|449318741|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
124915974|NCT04157348|449318740|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
124915975|NCT04157348|449318741|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
124915976|NCT04157348|449318740|FG000|Double-blind Treatment Period|Adverse Event|0|||
124915977|NCT04157348|449318741|FG001|Double-blind Treatment Period|Adverse Event|1|||
124915978|NCT04157348|449318740|FG000|Open-label Extension Period|Adverse Event|1|||
124915979|NCT04157348|449318741|FG001|Open-label Extension Period|Adverse Event|1|||
124915980|NCT04157348|449318740|FG000|Open-label Extension Period|Death|0|||
124915981|NCT04157348|449318741|FG001|Open-label Extension Period|Death|1|||
124915982|NCT04157348|449318740|FG000|Open-label Extension Period|Lack of Efficacy|2|||
124915983|NCT04157348|449318741|FG001|Open-label Extension Period|Lack of Efficacy|2|||
124915984|NCT04157348|449318740|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
124915985|NCT04157348|449318741|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
124915986|NCT04157348|449318740|FG000|Open-label Extension Period|Ongoing|60|||
124915987|NCT04157348|449318741|FG001|Open-label Extension Period|Ongoing|57|||
124915988|NCT04157348|449318740|FG000|Open-label Extension Period|other reasons|1|||
124915989|NCT04157348|449318741|FG001|Open-label Extension Period|other reasons|1|||
124915990|NCT02965846|449318742|FG000|Overall Study|Lost to Follow-up|1|||
124915991|NCT02965846|449318743|FG001|Overall Study|Lost to Follow-up|0|||
124915992|NCT02965846|449318744|FG002|Overall Study|Lost to Follow-up|0|||
124915993|NCT02965846|449318742|FG000|Overall Study|Withdrawal by Subject|0|||
124915994|NCT02965846|449318743|FG001|Overall Study|Withdrawal by Subject|1|||
124915995|NCT02965846|449318744|FG002|Overall Study|Withdrawal by Subject|0|||
124915996|NCT02965846|449318742|FG000|Overall Study|Study Terminated By Sponsor|4|||
124915997|NCT02965846|449318743|FG001|Overall Study|Study Terminated By Sponsor|4|||
124915998|NCT02965846|449318744|FG002|Overall Study|Study Terminated By Sponsor|0|||
124915999|NCT02965846|449318742|FG000|Overall Study|Participants not randomized|0|||
124916000|NCT02965846|449318743|FG001|Overall Study|Participants not randomized|0|||
124916001|NCT02965846|449318744|FG002|Overall Study|Participants not randomized|33|||
124916002|NCT00262301|449318745|FG000|Double-blind Phase|Lost to Follow-up|1|||
124916003|NCT00262301|449318746|FG001|Double-blind Phase|Lost to Follow-up|0|||
125211804|NCT00435188|450401375|FG000|Overall Study|Death|1|||
124916004|NCT00262301|449318747|FG002|Double-blind Phase|Lost to Follow-up|0|||
124916005|NCT00262301|449318745|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
124916006|NCT00262301|449318746|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
124916007|NCT00262301|449318747|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
124916008|NCT01084707|449318748|FG000|Overall Study|Withdrawal by Subject|6|||
124916009|NCT02412748|449318752|FG000|Overall Study|Lost to Follow-up|38|||
124916010|NCT02412748|449318753|FG001|Overall Study|Lost to Follow-up|39|||
124916011|NCT03069313|449318754|FG000|Overall Study|Adverse Event|5|||
124916012|NCT01872078|449318756|FG000|Overall Study|Adverse Event|0|||
124916013|NCT01872078|449318757|FG001|Overall Study|Adverse Event|0|||
124916014|NCT01872078|449318758|FG002|Overall Study|Adverse Event|1|||
124916015|NCT01872078|449318759|FG003|Overall Study|Adverse Event|0|||
124916016|NCT01872078|449318756|FG000|Overall Study|Dose administration non-compliance|0|||
125211805|NCT00435188|450401376|FG001|Overall Study|Death|6|||
125211806|NCT00435188|450401375|FG000|Overall Study|Withdrawal by Subject|16|||
124916017|NCT01872078|449318757|FG001|Overall Study|Dose administration non-compliance|0|||
124916018|NCT01872078|449318758|FG002|Overall Study|Dose administration non-compliance|0|||
124916019|NCT01872078|449318759|FG003|Overall Study|Dose administration non-compliance|1|||
124916020|NCT01872078|449318756|FG000|Overall Study|Protocol Violation|0|||
124916021|NCT01872078|449318757|FG001|Overall Study|Protocol Violation|0|||
124916022|NCT01872078|449318758|FG002|Overall Study|Protocol Violation|1|||
124916023|NCT01872078|449318759|FG003|Overall Study|Protocol Violation|0|||
124916024|NCT01872078|449318756|FG000|Overall Study|Withdrawal by Subject|0|||
124916025|NCT01872078|449318757|FG001|Overall Study|Withdrawal by Subject|0|||
124916026|NCT01872078|449318758|FG002|Overall Study|Withdrawal by Subject|1|||
124916027|NCT01872078|449318759|FG003|Overall Study|Withdrawal by Subject|0|||
124916028|NCT01872078|449318756|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
124916029|NCT01872078|449318757|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
124916030|NCT01872078|449318758|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
124916031|NCT01872078|449318759|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
124916032|NCT01494922|449318760|FG000|Overall Study|Adverse Event|1|||
124916033|NCT02152137|449320232|FG000|Overall Study|Withdrawal by Subject|1|||
124916034|NCT02152137|449320232|FG000|Overall Study|Originally assigned to Arm B|3|||
124916035|NCT05510232|449320233|FG000|Overall Study|Withdrawal by Subject|2|||
124916036|NCT05510232|449320234|FG001|Overall Study|Withdrawal by Subject|7|||
124916037|NCT05510232|449320235|FG002|Overall Study|Withdrawal by Subject|6|||
124916038|NCT04337372|449320242|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
124916039|NCT04337372|449320243|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
124916040|NCT04337372|449320244|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
124916041|NCT04337372|449320245|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
124916042|NCT04337372|449320242|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
124916043|NCT04337372|449320243|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
124916044|NCT04337372|449320244|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
124916045|NCT04337372|449320245|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
124916046|NCT04337372|449320242|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
124916047|NCT04337372|449320243|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
124916048|NCT04337372|449320244|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
124916049|NCT04337372|449320245|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
124916050|NCT04337372|449320242|FG000|Day 2: EEG Measures|Protocol Violation|6|||
124916051|NCT04337372|449320243|FG001|Day 2: EEG Measures|Protocol Violation|6|||
124916052|NCT04337372|449320244|FG002|Day 2: EEG Measures|Protocol Violation|5|||
124916053|NCT04337372|449320245|FG003|Day 2: EEG Measures|Protocol Violation|17|||
124916054|NCT05307783|449320246|FG000|Overall Study|Death|7|||
124916055|NCT05307783|449320246|FG000|Overall Study|Lost to Follow-up|4|||
124916056|NCT04883645|449320247|FG000|Overall Study|Death|1|||
124916057|NCT00979576|449320248|FG000|Combination Treatment Phase|Progressive disease|3|||
124916058|NCT00979576|449320249|FG001|Combination Treatment Phase|Progressive disease|1|||
124916059|NCT00979576|449320250|FG002|Combination Treatment Phase|Progressive disease|5|||
124916060|NCT00979576|449320248|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
124916061|NCT00979576|449320249|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
124916062|NCT00979576|449320250|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
124916063|NCT00979576|449320248|FG000|Combination Treatment Phase|Adverse Event|0|||
125131395|NCT03818581|450109964|FG004|Overall Study|Adverse Event|0|||
124916064|NCT00979576|449320249|FG001|Combination Treatment Phase|Adverse Event|2|||
124916065|NCT00979576|449320250|FG002|Combination Treatment Phase|Adverse Event|2|||
124916066|NCT00979576|449320248|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
124916067|NCT00979576|449320249|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
124916068|NCT00979576|449320250|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
124916069|NCT05687903|449320251|FG000|Overall Study|Protocol Deviation|1|||
124916070|NCT05687903|449320252|FG001|Overall Study|Protocol Deviation|1|||
124916071|NCT05687903|449320253|FG002|Overall Study|Protocol Deviation|0|||
124916072|NCT05687903|449320254|FG003|Overall Study|Protocol Deviation|1|||
124916073|NCT05687903|449320255|FG004|Overall Study|Protocol Deviation|0|||
124916074|NCT04855760|449320256|FG000|Overall Study|Adverse Event|21|||
124916075|NCT04855760|449320256|FG000|Overall Study|Withdrawal by Subject|116|||
124916076|NCT04855760|449320256|FG000|Overall Study|Lack of Efficacy|21|||
124916077|NCT04855760|449320256|FG000|Overall Study|Lost to Follow-up|49|||
125116538|NCT01716754|450049846|FG001|Overall Study|Non-compliance with study treatment|0|||
124916078|NCT04855760|449320256|FG000|Overall Study|Protocol Violation|2|||
125022601|NCT04137887|449707781|FG000|Overall Study|Randomized but not treated|0|||
125022602|NCT04137887|449707782|FG001|Overall Study|Randomized but not treated|1|||
125022603|NCT04183335|449707786|FG000|Overall Study|Adverse Event|1|||
125022604|NCT04183335|449707787|FG001|Overall Study|Adverse Event|0|||
125022605|NCT04183335|449707786|FG000|Overall Study|Withdrawal by Subject|12|||
125022606|NCT04183335|449707787|FG001|Overall Study|Withdrawal by Subject|3|||
125022607|NCT03718143|449707788|FG000|Overall Study|Death|1|||
124916079|NCT04855760|449320256|FG000|Overall Study|Physician Decision|5|||
124916080|NCT04855760|449320256|FG000|Overall Study|Pregnancy|1|||
124916081|NCT04855760|449320256|FG000|Overall Study|Non-Compliance with Study Drug|11|||
124916082|NCT04855760|449320256|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
124916083|NCT04855760|449320256|FG000|Overall Study|Study Completed by Sponsor|202|||
124916084|NCT04855760|449320256|FG000|Overall Study|Other|13|||
124916085|NCT05613205|449320257|FG000|Overall Study|Lost to Follow-up|0|||
124916086|NCT05613205|449320258|FG001|Overall Study|Lost to Follow-up|0|||
124916087|NCT05613205|449320259|FG002|Overall Study|Lost to Follow-up|1|||
124916088|NCT05613205|449320260|FG003|Overall Study|Lost to Follow-up|1|||
124916089|NCT05613205|449320261|FG004|Overall Study|Lost to Follow-up|0|||
124916090|NCT05613205|449320257|FG000|Overall Study|Withdrawal by Subject|0|||
124916091|NCT05613205|449320258|FG001|Overall Study|Withdrawal by Subject|0|||
124916092|NCT05613205|449320259|FG002|Overall Study|Withdrawal by Subject|1|||
124916093|NCT05613205|449320260|FG003|Overall Study|Withdrawal by Subject|1|||
124916094|NCT05613205|449320261|FG004|Overall Study|Withdrawal by Subject|0|||
124916095|NCT04869982|449320264|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
124916096|NCT04869982|449320265|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
124916097|NCT04869982|449320264|FG000|Overall Study|Migrated / moved from the study area|1|||
124916098|NCT04869982|449320265|FG001|Overall Study|Migrated / moved from the study area|1|||
124916099|NCT04869982|449320264|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
124916100|NCT04869982|449320265|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
124916101|NCT04869982|449320264|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
124916102|NCT04869982|449320265|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
124916103|NCT04869982|449320264|FG000|Overall Study|Solicited adverse event|2|||
124916104|NCT04869982|449320265|FG001|Overall Study|Solicited adverse event|1|||
124916105|NCT04112316|449320267|FG000|First Period (8 Weeks)|Protocol Violation|1|||
124916106|NCT04112316|449320268|FG001|First Period (8 Weeks)|Protocol Violation|0|||
124916107|NCT04112316|449320267|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
124916108|NCT04112316|449320268|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
124916109|NCT03857620|449320269|FG000|Overall Study|Death|4|||
124916110|NCT03857620|449320270|FG001|Overall Study|Death|5|||
124916111|NCT03857620|449320271|FG002|Overall Study|Death|7|||
124916112|NCT03857620|449320269|FG000|Overall Study|Lost to Follow-up|2|||
124916113|NCT03857620|449320270|FG001|Overall Study|Lost to Follow-up|5|||
124916114|NCT03857620|449320271|FG002|Overall Study|Lost to Follow-up|3|||
124916115|NCT03857620|449320269|FG000|Overall Study|Disease progression or relapse after study registration|1|||
124916116|NCT03857620|449320270|FG001|Overall Study|Disease progression or relapse after study registration|5|||
124916117|NCT03857620|449320271|FG002|Overall Study|Disease progression or relapse after study registration|1|||
124916118|NCT03857620|449320269|FG000|Overall Study|Ineligible|5|||
124916119|NCT03857620|449320270|FG001|Overall Study|Ineligible|0|||
124916120|NCT03857620|449320271|FG002|Overall Study|Ineligible|2|||
124916121|NCT03857620|449320269|FG000|Overall Study|No malignancy|1|||
124916122|NCT03857620|449320270|FG001|Overall Study|No malignancy|0|||
124916123|NCT03857620|449320271|FG002|Overall Study|No malignancy|1|||
124916124|NCT03857620|449320269|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
124916125|NCT03857620|449320270|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
124916126|NCT03857620|449320271|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
124916127|NCT03857620|449320269|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
124916128|NCT03857620|449320270|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
124916129|NCT03857620|449320271|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
124916130|NCT03857620|449320269|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
124916131|NCT03857620|449320270|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
124916132|NCT03857620|449320271|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
124916133|NCT03857620|449320269|FG000|Overall Study|Surgery not performed, patient decision|0|||
124916134|NCT03857620|449320270|FG001|Overall Study|Surgery not performed, patient decision|3|||
124916135|NCT03857620|449320271|FG002|Overall Study|Surgery not performed, patient decision|1|||
124916136|NCT03857620|449320269|FG000|Overall Study|Surgery not performed, other reason|3|||
124916137|NCT03857620|449320270|FG001|Overall Study|Surgery not performed, other reason|1|||
124916138|NCT03857620|449320271|FG002|Overall Study|Surgery not performed, other reason|4|||
124916139|NCT03857620|449320269|FG000|Overall Study|Worsening performance status after surgery performed|0|||
124916140|NCT03857620|449320270|FG001|Overall Study|Worsening performance status after surgery performed|1|||
124916141|NCT03857620|449320271|FG002|Overall Study|Worsening performance status after surgery performed|1|||
124916142|NCT02473250|449320272|FG000|Overall Study|Lost to Follow-up|10|||
124916143|NCT02473250|449320272|FG000|Overall Study|Physician Decision|5|||
124916144|NCT02473250|449320272|FG000|Overall Study|Did not tolerate medication washout|3|||
124916145|NCT02473250|449320272|FG000|Overall Study|Antidepressant effect of divalproex|2|||
124916146|NCT00567398|449320273|FG000|Overall Study|Adverse Event|6|||
124916147|NCT00567398|449320274|FG001|Overall Study|Adverse Event|14|||
124916148|NCT00567398|449320273|FG000|Overall Study|Physician Decision|0|||
124916149|NCT00567398|449320274|FG001|Overall Study|Physician Decision|4|||
124916150|NCT00567398|449320273|FG000|Overall Study|Withdrawal by Subject|0|||
124916151|NCT00567398|449320274|FG001|Overall Study|Withdrawal by Subject|2|||
124916152|NCT00567398|449320273|FG000|Overall Study|Renal Transplantation|0|||
124916153|NCT00567398|449320274|FG001|Overall Study|Renal Transplantation|3|||
124916154|NCT00567398|449320273|FG000|Overall Study|Other|1|||
125022608|NCT03718143|449707789|FG001|Overall Study|Death|0|||
124916155|NCT00567398|449320274|FG001|Overall Study|Other|0|||
124916156|NCT03602014|449320280|FG000|Overall Study|Lost to Follow-up|2|||
124916157|NCT03602014|449320281|FG001|Overall Study|Lost to Follow-up|0|||
124916158|NCT03602014|449320282|FG002|Overall Study|Lost to Follow-up|0|||
124916159|NCT01898494|449320283|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
124916160|NCT01898494|449320284|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
124916161|NCT01898494|449320285|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
124916162|NCT01898494|449320286|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
124916163|NCT01898494|449320287|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
124916164|NCT01898494|449320283|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
124916165|NCT01898494|449320284|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
124916166|NCT01898494|449320285|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
124916167|NCT01898494|449320286|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
124916168|NCT01898494|449320287|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
124916169|NCT01898494|449320283|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
124916170|NCT01898494|449320284|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
124916171|NCT01898494|449320285|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
124916172|NCT01898494|449320286|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
124916173|NCT01898494|449320287|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
124916174|NCT01898494|449320283|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
124916175|NCT01898494|449320284|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
124916176|NCT01898494|449320285|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
124916177|NCT01898494|449320286|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
124916178|NCT01898494|449320287|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
124916179|NCT01898494|449320283|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
124916180|NCT01898494|449320284|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
124916181|NCT01898494|449320285|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
124916182|NCT01898494|449320286|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
124916183|NCT01898494|449320287|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
124916184|NCT01898494|449320283|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
124916185|NCT01898494|449320284|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
124916186|NCT01898494|449320285|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
124916187|NCT01898494|449320286|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
124916188|NCT01898494|449320287|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
124916189|NCT01898494|449320283|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
124916190|NCT01898494|449320284|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
124916191|NCT01898494|449320285|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
124916192|NCT01898494|449320286|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
124916193|NCT01898494|449320287|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
124916194|NCT01898494|449320283|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
124916195|NCT01898494|449320284|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
124916196|NCT01898494|449320285|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
124916197|NCT01898494|449320286|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
125022609|NCT03718143|449707790|FG002|Overall Study|Death|0|||
124916198|NCT01898494|449320287|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
124916199|NCT01898494|449320283|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
124916200|NCT01898494|449320284|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
124916201|NCT01898494|449320285|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
124916202|NCT01898494|449320286|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
124916203|NCT01898494|449320287|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
124916204|NCT01898494|449320283|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
124916205|NCT01898494|449320284|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
124916206|NCT01898494|449320285|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
124916207|NCT01898494|449320286|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
124916208|NCT01898494|449320287|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
124916209|NCT01898494|449320283|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
124916210|NCT01898494|449320284|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
124916211|NCT01898494|449320285|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
124916212|NCT01898494|449320286|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
124916213|NCT01898494|449320287|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
124916214|NCT01898494|449320283|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
124916215|NCT01898494|449320284|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
124916216|NCT01898494|449320285|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
124916217|NCT01898494|449320286|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
124916218|NCT01898494|449320287|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
125022610|NCT03718143|449707788|FG000|Overall Study|Progression of Disease|1|||
125022611|NCT03718143|449707789|FG001|Overall Study|Progression of Disease|0|||
125022612|NCT03718143|449707790|FG002|Overall Study|Progression of Disease|0|||
125022613|NCT03718143|449707788|FG000|Overall Study|Withdrawal of Informed Consent|1|||
125116539|NCT01716754|450049847|FG002|Overall Study|Non-compliance with study treatment|1|||
125116540|NCT01716754|450049848|FG003|Overall Study|Non-compliance with study treatment|0|||
125116541|NCT01716754|450049845|FG000|Overall Study|Physician Decision|1|||
125116542|NCT01716754|450049846|FG001|Overall Study|Physician Decision|0|||
125116543|NCT01716754|450049847|FG002|Overall Study|Physician Decision|0|||
125116544|NCT01716754|450049848|FG003|Overall Study|Physician Decision|0|||
125116545|NCT01716754|450049845|FG000|Overall Study|Lost to Follow-up|1|||
125116546|NCT01716754|450049846|FG001|Overall Study|Lost to Follow-up|0|||
125022614|NCT03718143|449707789|FG001|Overall Study|Withdrawal of Informed Consent|2|||
125022615|NCT03718143|449707790|FG002|Overall Study|Withdrawal of Informed Consent|1|||
125022616|NCT05064059|449707791|FG000|Overall Study|Death|199|||
125022617|NCT05064059|449707792|FG001|Overall Study|Death|196|||
125022618|NCT05064059|449707791|FG000|Overall Study|Physician Decision|4|||
125022619|NCT05064059|449707792|FG001|Overall Study|Physician Decision|2|||
125022620|NCT05064059|449707791|FG000|Overall Study|Sponsor Decision|14|||
125022621|NCT05064059|449707792|FG001|Overall Study|Sponsor Decision|11|||
125022622|NCT05064059|449707791|FG000|Overall Study|Withdrawal by Subject|4|||
125022623|NCT05064059|449707792|FG001|Overall Study|Withdrawal by Subject|11|||
125022624|NCT02605642|449707793|FG000|Overall Study|Other|11|||
125022625|NCT02605642|449707794|FG001|Overall Study|Other|1|||
125022626|NCT02605642|449707793|FG000|Overall Study|Participant non-compliance|2|||
125022627|NCT02605642|449707794|FG001|Overall Study|Participant non-compliance|4|||
125022628|NCT02605642|449707793|FG000|Overall Study|Physician Decision|10|||
125022629|NCT02605642|449707794|FG001|Overall Study|Physician Decision|0|||
125022630|NCT02605642|449707793|FG000|Overall Study|Lost to Follow-up|12|||
125022631|NCT02605642|449707794|FG001|Overall Study|Lost to Follow-up|1|||
125022632|NCT02605642|449707793|FG000|Overall Study|Adverse Event|14|||
125022633|NCT02605642|449707794|FG001|Overall Study|Adverse Event|2|||
125022634|NCT02605642|449707793|FG000|Overall Study|Withdrawal by Subject|23|||
125022635|NCT02605642|449707794|FG001|Overall Study|Withdrawal by Subject|2|||
125022636|NCT02605642|449707793|FG000|Overall Study|Lack of response|24|||
125022637|NCT02605642|449707794|FG001|Overall Study|Lack of response|11|||
125022638|NCT04294459|449707795|FG000|Overall Study|Adverse Event|0|||
125022639|NCT04294459|449707796|FG001|Overall Study|Adverse Event|1|||
125022640|NCT01396005|449707797|FG000|Overall Study|Withdrawal by Subject|0|||
125022641|NCT01396005|449707798|FG001|Overall Study|Withdrawal by Subject|1|||
125022642|NCT01396005|449707797|FG000|Overall Study|Non-compliance with protocol|0|||
125022643|NCT01396005|449707798|FG001|Overall Study|Non-compliance with protocol|1|||
125022644|NCT03757988|449707799|FG000|Overall Study|Withdrawal by Subject|1|||
125022645|NCT03806127|449707800|FG000|Overall Study|Withdrawal by Subject|4|||
125022646|NCT03806127|449707801|FG001|Overall Study|Withdrawal by Subject|5|||
125022647|NCT03806127|449707800|FG000|Overall Study|Protocol Violation|3|||
125211807|NCT00435188|450401376|FG001|Overall Study|Withdrawal by Subject|11|||
125022648|NCT03806127|449707801|FG001|Overall Study|Protocol Violation|1|||
125022649|NCT03806127|449707800|FG000|Overall Study|Adverse Event|3|||
125116547|NCT01716754|450049847|FG002|Overall Study|Lost to Follow-up|0|||
125022650|NCT03806127|449707801|FG001|Overall Study|Adverse Event|0|||
125022651|NCT03806127|449707800|FG000|Overall Study|Unable to Complete Procedures|0|||
125022652|NCT03806127|449707801|FG001|Overall Study|Unable to Complete Procedures|1|||
125022653|NCT03806127|449707800|FG000|Overall Study|Pregnancy|0|||
125022654|NCT03806127|449707801|FG001|Overall Study|Pregnancy|1|||
125022655|NCT03806127|449707800|FG000|Overall Study|Lost to Follow-up|5|||
125022656|NCT03806127|449707801|FG001|Overall Study|Lost to Follow-up|1|||
125022657|NCT03806127|449707800|FG000|Overall Study|Physician Decision|1|||
125022658|NCT03806127|449707801|FG001|Overall Study|Physician Decision|1|||
125022659|NCT03806127|449707800|FG000|Overall Study|Could Not Come Due to Covid|1|||
125022660|NCT03806127|449707801|FG001|Overall Study|Could Not Come Due to Covid|0|||
125022661|NCT03806127|449707800|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
125022662|NCT03806127|449707801|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
125022663|NCT03806127|449707800|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
125022664|NCT03806127|449707801|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
125211808|NCT00435188|450401375|FG000|Overall Study|Lost to Follow-up|5|||
125022665|NCT03806127|449707800|FG000|Overall Study|Covid 19 Restrictions|2|||
125022666|NCT03806127|449707801|FG001|Overall Study|Covid 19 Restrictions|0|||
125022667|NCT03806127|449707800|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
125022668|NCT03806127|449707801|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
125022669|NCT03806127|449707800|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
125022670|NCT03806127|449707801|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
125022671|NCT01467492|449707802|FG000|Overall Study|Withdrawal by Subject|6|||
125022672|NCT01467492|449707803|FG001|Overall Study|Withdrawal by Subject|4|||
125022673|NCT01467492|449707802|FG000|Overall Study|Study Terminated by Sponsor|6|||
125022674|NCT01467492|449707803|FG001|Overall Study|Study Terminated by Sponsor|4|||
125022675|NCT01467492|449707802|FG000|Overall Study|Adverse Event|4|||
125022676|NCT01467492|449707803|FG001|Overall Study|Adverse Event|3|||
125022677|NCT01467492|449707802|FG000|Overall Study|Lost to Follow-up|3|||
125022678|NCT01467492|449707803|FG001|Overall Study|Lost to Follow-up|2|||
125022679|NCT01467492|449707802|FG000|Overall Study|Undefined|2|||
125022680|NCT01467492|449707803|FG001|Overall Study|Undefined|0|||
125022681|NCT01467492|449707802|FG000|Overall Study|Enrolled But Not Treated|1|||
125022682|NCT01467492|449707803|FG001|Overall Study|Enrolled But Not Treated|0|||
125022683|NCT03946670|449707810|FG000|Overall Study|Progressive Disease|26|||
125022684|NCT03946670|449707811|FG001|Overall Study|Progressive Disease|23|||
125022685|NCT03946670|449707810|FG000|Overall Study|Adverse Event|7|||
125022686|NCT03946670|449707811|FG001|Overall Study|Adverse Event|9|||
125022687|NCT03946670|449707810|FG000|Overall Study|Death|5|||
125022688|NCT03946670|449707811|FG001|Overall Study|Death|6|||
125022689|NCT03946670|449707810|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
125022690|NCT03946670|449707811|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
125022691|NCT03946670|449707810|FG000|Overall Study|Subject Decision|4|||
125022692|NCT03946670|449707811|FG001|Overall Study|Subject Decision|4|||
125022693|NCT03946670|449707810|FG000|Overall Study|Physician Decision|3|||
125022694|NCT03946670|449707811|FG001|Overall Study|Physician Decision|3|||
125022695|NCT03946670|449707810|FG000|Overall Study|New Therapy for Study Indication|1|||
125022696|NCT03946670|449707811|FG001|Overall Study|New Therapy for Study Indication|0|||
125022697|NCT03946670|449707810|FG000|Overall Study|Not treated|1|||
125022698|NCT03946670|449707811|FG001|Overall Study|Not treated|1|||
125022699|NCT03132636|449707812|FG000|Overall Study|Adverse Event|1|||
125022700|NCT03132636|449707813|FG001|Overall Study|Adverse Event|2|||
125022701|NCT03132636|449707812|FG000|Overall Study|Death|4|||
125022702|NCT03132636|449707813|FG001|Overall Study|Death|7|||
125022703|NCT03132636|449707812|FG000|Overall Study|Lost to Follow-up|3|||
125022704|NCT03132636|449707813|FG001|Overall Study|Lost to Follow-up|2|||
125022705|NCT03132636|449707812|FG000|Overall Study|Non compliance with protocol by participant|1|||
125022706|NCT03132636|449707813|FG001|Overall Study|Non compliance with protocol by participant|1|||
125022707|NCT03132636|449707812|FG000|Overall Study|Subject decision|1|||
125022708|NCT03132636|449707813|FG001|Overall Study|Subject decision|9|||
125022709|NCT03132636|449707812|FG000|Overall Study|Sponsor decision|0|||
125022710|NCT03132636|449707813|FG001|Overall Study|Sponsor decision|1|||
125022711|NCT03132636|449707812|FG000|Overall Study|Physician Decision|1|||
125022712|NCT03132636|449707813|FG001|Overall Study|Physician Decision|0|||
125022713|NCT03132636|449707812|FG000|Overall Study|Progressive disease|33|||
125022714|NCT03132636|449707813|FG001|Overall Study|Progressive disease|36|||
125022715|NCT03132636|449707812|FG000|Overall Study|Withdrawal of consent|2|||
125116548|NCT01716754|450049848|FG003|Overall Study|Lost to Follow-up|1|||
125022716|NCT03132636|449707813|FG001|Overall Study|Withdrawal of consent|5|||
124916219|NCT01898494|449320283|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
124916220|NCT01898494|449320284|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
124916221|NCT01898494|449320285|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
124916222|NCT01898494|449320286|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
124916223|NCT01898494|449320287|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
124916224|NCT01898494|449320283|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
124916225|NCT01898494|449320284|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
124916226|NCT01898494|449320285|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
124916227|NCT01898494|449320286|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
124916228|NCT01898494|449320287|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
124916229|NCT03289039|449320288|FG000|Overall Study|Withdrawal by Subject|0|||
124916230|NCT03289039|449320289|FG001|Overall Study|Withdrawal by Subject|1|||
124916231|NCT03289039|449320288|FG000|Overall Study|Became ineligible prior to treatment start|0|||
124916232|NCT03289039|449320289|FG001|Overall Study|Became ineligible prior to treatment start|1|||
124916233|NCT03289039|449320288|FG000|Overall Study|progressed before treatment start|1|||
124916234|NCT03289039|449320289|FG001|Overall Study|progressed before treatment start|0|||
124916235|NCT04732494|449320292|FG000|Overall Study|Death|39|||
124916236|NCT04732494|449320293|FG001|Overall Study|Death|36|||
124916237|NCT04732494|449320292|FG000|Overall Study|Study Closed by Sponsor|20|||
124916238|NCT04732494|449320293|FG001|Overall Study|Study Closed by Sponsor|15|||
124916239|NCT04732494|449320292|FG000|Overall Study|Withdrawal by Subject|2|||
124916240|NCT04732494|449320293|FG001|Overall Study|Withdrawal by Subject|7|||
124916241|NCT04732494|449320292|FG000|Overall Study|Lost to Follow-up|1|||
124916242|NCT04732494|449320293|FG001|Overall Study|Lost to Follow-up|5|||
124916243|NCT03897686|449320294|FG000|Overall Study|Protocol Violation|1|||
124916244|NCT03897686|449320295|FG001|Overall Study|Protocol Violation|1|||
124916245|NCT03897686|449320294|FG000|Overall Study|Withdrawal by Subject|1|||
124916246|NCT03897686|449320295|FG001|Overall Study|Withdrawal by Subject|1|||
124916247|NCT04905407|449320296|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
124916248|NCT04905407|449320297|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
124916249|NCT04905407|449320298|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
124916250|NCT04905407|449320299|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
124916251|NCT04905407|449320296|FG000|Part 1 and Part 2|Death|7|||
124916252|NCT04905407|449320297|FG001|Part 1 and Part 2|Death|7|||
124916253|NCT04905407|449320298|FG002|Part 1 and Part 2|Death|7|||
124916254|NCT04905407|449320299|FG003|Part 1 and Part 2|Death|0|||
124916255|NCT04905407|449320296|FG000|Part 1 and Part 2|Other than specified|0|||
124916256|NCT04905407|449320297|FG001|Part 1 and Part 2|Other than specified|0|||
124916257|NCT04905407|449320298|FG002|Part 1 and Part 2|Other than specified|1|||
124916258|NCT04905407|449320299|FG003|Part 1 and Part 2|Other than specified|0|||
124916259|NCT04905407|449320296|FG000|Part 3|Death|0|||
124916260|NCT04905407|449320297|FG001|Part 3|Death|0|||
124916261|NCT04905407|449320298|FG002|Part 3|Death|0|||
124916262|NCT04905407|449320299|FG003|Part 3|Death|2|||
124916263|NCT03263026|449320302|FG000|Overall Study|Withdrawal by Subject|1|||
124916264|NCT03263026|449320303|FG001|Overall Study|Withdrawal by Subject|0|||
124916265|NCT03263026|449320302|FG000|Overall Study|Death|1|||
124916266|NCT03263026|449320303|FG001|Overall Study|Death|0|||
124916267|NCT03263026|449320302|FG000|Overall Study|Other/ Various|41|||
124916268|NCT03263026|449320303|FG001|Overall Study|Other/ Various|29|||
124916269|NCT02697136|449320305|FG000|Overall Study|Adverse Event|3|||
124916270|NCT02697136|449320306|FG001|Overall Study|Adverse Event|0|||
125022717|NCT03132636|449707812|FG000|Overall Study|Did not re-consent|1|||
124916271|NCT01095796|449320307|FG000|Overall Study|Randomized but Not Treated|5|||
124916272|NCT01095796|449320308|FG001|Overall Study|Randomized but Not Treated|2|||
124916273|NCT01095796|449320307|FG000|Overall Study|Adverse Event|9|||
124916274|NCT01095796|449320308|FG001|Overall Study|Adverse Event|19|||
124916275|NCT01095796|449320307|FG000|Overall Study|Death|3|||
124916276|NCT01095796|449320308|FG001|Overall Study|Death|2|||
124916277|NCT01095796|449320307|FG000|Overall Study|Pregnancy|2|||
124916278|NCT01095796|449320308|FG001|Overall Study|Pregnancy|0|||
124916279|NCT01095796|449320307|FG000|Overall Study|Lack of Efficacy|5|||
124916280|NCT01095796|449320308|FG001|Overall Study|Lack of Efficacy|3|||
125022718|NCT03132636|449707813|FG001|Overall Study|Did not re-consent|0|||
124916281|NCT01095796|449320307|FG000|Overall Study|Investigator's Discretion|7|||
124916282|NCT01095796|449320308|FG001|Overall Study|Investigator's Discretion|2|||
124916283|NCT01095796|449320307|FG000|Overall Study|Withdrew Consent|16|||
125116549|NCT01716754|450049845|FG000|Overall Study|Adverse Event|4|||
125116550|NCT01716754|450049846|FG001|Overall Study|Adverse Event|2|||
125116551|NCT01716754|450049847|FG002|Overall Study|Adverse Event|2|||
125116552|NCT01716754|450049848|FG003|Overall Study|Adverse Event|1|||
125116553|NCT01716754|450049845|FG000|Overall Study|Withdrawal by Subject|5|||
125116554|NCT01716754|450049846|FG001|Overall Study|Withdrawal by Subject|0|||
125116555|NCT01716754|450049847|FG002|Overall Study|Withdrawal by Subject|4|||
125116556|NCT01716754|450049848|FG003|Overall Study|Withdrawal by Subject|3|||
125116557|NCT00638157|450049870|FG000|Overall Study|Adverse Event|0|||
125116558|NCT00638157|450049871|FG001|Overall Study|Adverse Event|1|||
125116559|NCT00638157|450049870|FG000|Overall Study|Clinical (symptomatic) failure|1|||
125116560|NCT00638157|450049871|FG001|Overall Study|Clinical (symptomatic) failure|1|||
124916284|NCT01095796|449320308|FG001|Overall Study|Withdrew Consent|22|||
124916285|NCT01095796|449320307|FG000|Overall Study|Lost to Follow-up|27|||
124916286|NCT01095796|449320308|FG001|Overall Study|Lost to Follow-up|29|||
124916287|NCT01095796|449320307|FG000|Overall Study|Participant Noncompliance|5|||
124916288|NCT01095796|449320308|FG001|Overall Study|Participant Noncompliance|10|||
124916289|NCT01095796|449320307|FG000|Overall Study|Protocol Violation|1|||
124916290|NCT01095796|449320308|FG001|Overall Study|Protocol Violation|0|||
124916291|NCT01095796|449320307|FG000|Overall Study|Participant Transferred to Another Study|215|||
124916292|NCT01095796|449320308|FG001|Overall Study|Participant Transferred to Another Study|200|||
124916293|NCT04116736|449320311|FG000|Overall Study|Withdrew consent during study|3|||
124916294|NCT04116736|449320312|FG001|Overall Study|Withdrew consent during study|1|||
124916295|NCT04116736|449320311|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
124916296|NCT04116736|449320312|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
124916297|NCT04116736|449320311|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
124916298|NCT04116736|449320312|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
124916299|NCT04116736|449320311|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
124916300|NCT04116736|449320312|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
124916301|NCT04116736|449320311|FG000|Overall Study|Subject was enrolled in error|2|||
124916302|NCT04116736|449320312|FG001|Overall Study|Subject was enrolled in error|0|||
124916303|NCT04116736|449320311|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
124916304|NCT04116736|449320312|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
124916305|NCT04116736|449320311|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
124916306|NCT04116736|449320312|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
124916307|NCT04116736|449320311|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
124916308|NCT04116736|449320312|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
124916309|NCT05512962|449320316|FG000|Overall Study|Withdrawal by Subject|1|||
124916310|NCT05512962|449320317|FG001|Overall Study|Withdrawal by Subject|0|||
124916311|NCT00879333|449320318|FG000|Overall Study|Adverse Event|94|||
124916312|NCT00879333|449320319|FG001|Overall Study|Adverse Event|34|||
124916313|NCT00879333|449320318|FG000|Overall Study|Abnormal Laboratory Value|1|||
124916314|NCT00879333|449320319|FG001|Overall Study|Abnormal Laboratory Value|0|||
124916315|NCT00879333|449320318|FG000|Overall Study|Withdrawal by Subject|20|||
124916316|NCT00879333|449320319|FG001|Overall Study|Withdrawal by Subject|7|||
124916317|NCT00879333|449320318|FG000|Overall Study|Lost to Follow-up|2|||
124916318|NCT00879333|449320319|FG001|Overall Study|Lost to Follow-up|1|||
124916319|NCT00879333|449320318|FG000|Overall Study|Administrative Problems|2|||
124916320|NCT00879333|449320319|FG001|Overall Study|Administrative Problems|0|||
124916321|NCT00879333|449320318|FG000|Overall Study|Death|16|||
124916322|NCT00879333|449320319|FG001|Overall Study|Death|5|||
124916323|NCT00879333|449320318|FG000|Overall Study|Disease Progression|292|||
124916324|NCT00879333|449320319|FG001|Overall Study|Disease Progression|169|||
124916325|NCT00879333|449320318|FG000|Overall Study|Protocol Violation|1|||
124916326|NCT00879333|449320319|FG001|Overall Study|Protocol Violation|1|||
124916327|NCT02671435|449320321|FG000|Overall Study|Death|1|||
124916328|NCT02671435|449320322|FG001|Overall Study|Death|3|||
124916329|NCT02671435|449320323|FG002|Overall Study|Death|0|||
124916330|NCT02671435|449320324|FG003|Overall Study|Death|16|||
124916331|NCT02671435|449320325|FG004|Overall Study|Death|14|||
124916332|NCT02671435|449320326|FG005|Overall Study|Death|29|||
124916333|NCT02671435|449320327|FG006|Overall Study|Death|34|||
124916334|NCT02671435|449320328|FG007|Overall Study|Death|28|||
124916335|NCT02671435|449320329|FG008|Overall Study|Death|19|||
125116561|NCT00638157|450049870|FG000|Overall Study|Microbiological failure|1|||
125116562|NCT00638157|450049871|FG001|Overall Study|Microbiological failure|0|||
125116563|NCT00638157|450049870|FG000|Overall Study|Lost to Follow-up|1|||
125116564|NCT00638157|450049871|FG001|Overall Study|Lost to Follow-up|0|||
125211809|NCT00435188|450401376|FG001|Overall Study|Lost to Follow-up|6|||
124916336|NCT02671435|449320330|FG009|Overall Study|Death|10|||
124916337|NCT02671435|449320331|FG010|Overall Study|Death|8|||
124916338|NCT02671435|449320332|FG011|Overall Study|Death|29|||
125022719|NCT03132636|449707812|FG000|Overall Study|Lost insurance coverage|1|||
125022720|NCT03132636|449707813|FG001|Overall Study|Lost insurance coverage|0|||
125022721|NCT03132636|449707812|FG000|Overall Study|Related to radiological outcomes|0|||
125022722|NCT03132636|449707813|FG001|Overall Study|Related to radiological outcomes|1|||
125022723|NCT03132636|449707812|FG000|Overall Study|Unable to come to site for continued visits|0|||
125022724|NCT03132636|449707813|FG001|Overall Study|Unable to come to site for continued visits|1|||
125022725|NCT04537208|449707818|FG000|Overall Study|Adverse Event|0|||
125022726|NCT04537208|449707819|FG001|Overall Study|Adverse Event|0|||
125022727|NCT04537208|449707820|FG002|Overall Study|Adverse Event|0|||
125022728|NCT04537208|449707821|FG003|Overall Study|Adverse Event|0|||
125022729|NCT04537208|449707822|FG004|Overall Study|Adverse Event|0|||
125022730|NCT04537208|449707823|FG005|Overall Study|Adverse Event|0|||
125022731|NCT04537208|449707824|FG006|Overall Study|Adverse Event|0|||
125022732|NCT04537208|449707825|FG007|Overall Study|Adverse Event|0|||
125022733|NCT04537208|449707826|FG008|Overall Study|Adverse Event|1|||
125022734|NCT04537208|449707827|FG009|Overall Study|Adverse Event|0|||
125022735|NCT04537208|449707828|FG010|Overall Study|Adverse Event|0|||
125022736|NCT04537208|449707818|FG000|Overall Study|Protocol deviation|0|||
125022737|NCT04537208|449707819|FG001|Overall Study|Protocol deviation|0|||
125022738|NCT04537208|449707820|FG002|Overall Study|Protocol deviation|2|||
125022739|NCT04537208|449707821|FG003|Overall Study|Protocol deviation|0|||
125022740|NCT04537208|449707822|FG004|Overall Study|Protocol deviation|0|||
125022741|NCT04537208|449707823|FG005|Overall Study|Protocol deviation|2|||
125022742|NCT04537208|449707824|FG006|Overall Study|Protocol deviation|4|||
125022743|NCT04537208|449707825|FG007|Overall Study|Protocol deviation|0|||
125022744|NCT04537208|449707826|FG008|Overall Study|Protocol deviation|1|||
125022745|NCT04537208|449707827|FG009|Overall Study|Protocol deviation|0|||
125022746|NCT04537208|449707828|FG010|Overall Study|Protocol deviation|2|||
125022747|NCT04537208|449707818|FG000|Overall Study|Withdrawal by Subject|4|||
125022748|NCT04537208|449707819|FG001|Overall Study|Withdrawal by Subject|2|||
125022749|NCT04537208|449707820|FG002|Overall Study|Withdrawal by Subject|1|||
125022750|NCT04537208|449707821|FG003|Overall Study|Withdrawal by Subject|3|||
125022751|NCT04537208|449707822|FG004|Overall Study|Withdrawal by Subject|5|||
125022752|NCT04537208|449707823|FG005|Overall Study|Withdrawal by Subject|1|||
125022753|NCT04537208|449707824|FG006|Overall Study|Withdrawal by Subject|6|||
125022754|NCT04537208|449707825|FG007|Overall Study|Withdrawal by Subject|1|||
125022755|NCT04537208|449707826|FG008|Overall Study|Withdrawal by Subject|7|||
125022756|NCT04537208|449707827|FG009|Overall Study|Withdrawal by Subject|2|||
125022757|NCT04537208|449707828|FG010|Overall Study|Withdrawal by Subject|4|||
125022758|NCT04537208|449707818|FG000|Overall Study|Lost to Follow-up|4|||
125022759|NCT04537208|449707819|FG001|Overall Study|Lost to Follow-up|1|||
125022760|NCT04537208|449707820|FG002|Overall Study|Lost to Follow-up|3|||
125022761|NCT04537208|449707821|FG003|Overall Study|Lost to Follow-up|4|||
125022762|NCT04537208|449707822|FG004|Overall Study|Lost to Follow-up|3|||
125022763|NCT04537208|449707823|FG005|Overall Study|Lost to Follow-up|2|||
125022764|NCT04537208|449707824|FG006|Overall Study|Lost to Follow-up|3|||
125116565|NCT00638157|450049870|FG000|Overall Study|Physician Decision|1|||
124916339|NCT02671435|449320333|FG012|Overall Study|Death|29|||
124916340|NCT02671435|449320334|FG013|Overall Study|Death|29|||
124916341|NCT02671435|449320335|FG014|Overall Study|Death|27|||
124916342|NCT02671435|449320321|FG000|Overall Study|Lost to Follow-up|0|||
124916343|NCT02671435|449320322|FG001|Overall Study|Lost to Follow-up|0|||
124916344|NCT02671435|449320323|FG002|Overall Study|Lost to Follow-up|1|||
124916345|NCT02671435|449320324|FG003|Overall Study|Lost to Follow-up|0|||
124916346|NCT02671435|449320325|FG004|Overall Study|Lost to Follow-up|1|||
124916347|NCT02671435|449320326|FG005|Overall Study|Lost to Follow-up|1|||
124916348|NCT02671435|449320327|FG006|Overall Study|Lost to Follow-up|2|||
124916349|NCT02671435|449320328|FG007|Overall Study|Lost to Follow-up|2|||
124916350|NCT02671435|449320329|FG008|Overall Study|Lost to Follow-up|0|||
124916351|NCT02671435|449320330|FG009|Overall Study|Lost to Follow-up|2|||
124916352|NCT02671435|449320331|FG010|Overall Study|Lost to Follow-up|0|||
124916353|NCT02671435|449320332|FG011|Overall Study|Lost to Follow-up|3|||
124916354|NCT02671435|449320333|FG012|Overall Study|Lost to Follow-up|3|||
124916355|NCT02671435|449320334|FG013|Overall Study|Lost to Follow-up|2|||
124916356|NCT02671435|449320335|FG014|Overall Study|Lost to Follow-up|0|||
124916357|NCT02671435|449320321|FG000|Overall Study|Withdrawal by Subject|2|||
124916358|NCT02671435|449320322|FG001|Overall Study|Withdrawal by Subject|0|||
124916359|NCT02671435|449320323|FG002|Overall Study|Withdrawal by Subject|2|||
124916360|NCT02671435|449320324|FG003|Overall Study|Withdrawal by Subject|2|||
124916361|NCT02671435|449320325|FG004|Overall Study|Withdrawal by Subject|2|||
124916362|NCT02671435|449320326|FG005|Overall Study|Withdrawal by Subject|7|||
124916363|NCT02671435|449320327|FG006|Overall Study|Withdrawal by Subject|2|||
124916364|NCT02671435|449320328|FG007|Overall Study|Withdrawal by Subject|7|||
124916365|NCT02671435|449320329|FG008|Overall Study|Withdrawal by Subject|1|||
124916366|NCT02671435|449320330|FG009|Overall Study|Withdrawal by Subject|1|||
124916367|NCT02671435|449320331|FG010|Overall Study|Withdrawal by Subject|2|||
124916368|NCT02671435|449320332|FG011|Overall Study|Withdrawal by Subject|4|||
124916369|NCT02671435|449320333|FG012|Overall Study|Withdrawal by Subject|4|||
124916370|NCT02671435|449320334|FG013|Overall Study|Withdrawal by Subject|4|||
124916371|NCT02671435|449320335|FG014|Overall Study|Withdrawal by Subject|2|||
124916372|NCT02671435|449320321|FG000|Overall Study|Un-specified|0|||
124916373|NCT02671435|449320322|FG001|Overall Study|Un-specified|0|||
124916374|NCT02671435|449320323|FG002|Overall Study|Un-specified|0|||
124916375|NCT02671435|449320324|FG003|Overall Study|Un-specified|0|||
124916376|NCT02671435|449320325|FG004|Overall Study|Un-specified|1|||
124916377|NCT02671435|449320326|FG005|Overall Study|Un-specified|3|||
124916378|NCT02671435|449320327|FG006|Overall Study|Un-specified|2|||
124916379|NCT02671435|449320328|FG007|Overall Study|Un-specified|3|||
124916380|NCT02671435|449320329|FG008|Overall Study|Un-specified|0|||
124916381|NCT02671435|449320330|FG009|Overall Study|Un-specified|5|||
124916382|NCT02671435|449320331|FG010|Overall Study|Un-specified|8|||
124916383|NCT02671435|449320332|FG011|Overall Study|Un-specified|4|||
124916384|NCT02671435|449320333|FG012|Overall Study|Un-specified|5|||
124916385|NCT02671435|449320334|FG013|Overall Study|Un-specified|9|||
124916386|NCT02671435|449320335|FG014|Overall Study|Un-specified|8|||
124916387|NCT00761189|449320340|FG000|Overall Study|Adverse Event|42|||
124916388|NCT00761189|449320340|FG000|Overall Study|Lack of Efficacy|45|||
124916389|NCT00761189|449320340|FG000|Overall Study|Lost to Follow-up|36|||
124916390|NCT00761189|449320340|FG000|Overall Study|Withdrawal by Subject|49|||
124916391|NCT00761189|449320340|FG000|Overall Study|Other|13|||
124916392|NCT02759016|449320341|FG000|Overall Study|Not treated with BI 836826|1|||
124916393|NCT02759016|449320342|FG001|Overall Study|Not treated with BI 836826|0|||
124916394|NCT02759016|449320341|FG000|Overall Study|Progressive disease|1|||
124916395|NCT02759016|449320342|FG001|Overall Study|Progressive disease|0|||
124916396|NCT02759016|449320341|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
124916397|NCT02759016|449320342|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
124916398|NCT02759016|449320341|FG000|Overall Study|Other not defined above|2|||
124916399|NCT02759016|449320342|FG001|Overall Study|Other not defined above|1|||
124916400|NCT03939312|449320343|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
124916401|NCT03939312|449320343|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
124916402|NCT03939312|449320343|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
124916403|NCT03939312|449320343|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
124916404|NCT03939312|449320343|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
124916405|NCT03939312|449320343|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
124916406|NCT03939312|449320343|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
124916407|NCT03939312|449320343|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
124916408|NCT03939312|449320343|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
124916409|NCT03939312|449320343|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
124916410|NCT03939312|449320343|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
124916411|NCT03939312|449320343|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
124916412|NCT02119650|449320344|FG000|Overall Study|Adverse Event|3|||
124916413|NCT02119650|449320345|FG001|Overall Study|Adverse Event|4|||
124916414|NCT02119650|449320344|FG000|Overall Study|Subject decision|2|||
124916415|NCT02119650|449320345|FG001|Overall Study|Subject decision|3|||
124916416|NCT02119650|449320344|FG000|Overall Study|Disease progression|11|||
124916417|NCT02119650|449320345|FG001|Overall Study|Disease progression|14|||
124916418|NCT02119650|449320344|FG000|Overall Study|Death|5|||
124916419|NCT02119650|449320345|FG001|Overall Study|Death|1|||
124916420|NCT02119650|449320344|FG000|Overall Study|Noncompliance with study treatment|1|||
124916421|NCT02119650|449320345|FG001|Overall Study|Noncompliance with study treatment|1|||
124916422|NCT02119650|449320344|FG000|Overall Study|Study terminated by the sponsor|1|||
124916423|NCT02119650|449320345|FG001|Overall Study|Study terminated by the sponsor|0|||
124916424|NCT02119650|449320344|FG000|Overall Study|Physician Decision|0|||
124916425|NCT02119650|449320345|FG001|Overall Study|Physician Decision|2|||
124916426|NCT02119650|449320344|FG000|Overall Study|Multiple reasons for termination|2|||
124916427|NCT02119650|449320345|FG001|Overall Study|Multiple reasons for termination|1|||
124916428|NCT01721291|449320346|FG000|Overall Study|Withdrawal by Subject|1|||
124916429|NCT01721291|449320347|FG001|Overall Study|Withdrawal by Subject|0|||
124916430|NCT01721291|449320346|FG000|Overall Study|did not like the treatment|1|||
124916431|NCT01721291|449320347|FG001|Overall Study|did not like the treatment|0|||
124916432|NCT03744312|449321518|FG000|Overall Study|Withdrawal by Subject|0|||
124916433|NCT03744312|449321519|FG001|Overall Study|Withdrawal by Subject|1|||
124916434|NCT03744312|449321518|FG000|Overall Study|Screen fail|0|||
124916435|NCT03744312|449321519|FG001|Overall Study|Screen fail|1|||
124916436|NCT05134337|449321520|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
124916437|NCT05134337|449321521|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
124916438|NCT03152786|449321525|FG000|Overall Study|Withdrawal by Subject|2|||
124916439|NCT03152786|449321526|FG001|Overall Study|Withdrawal by Subject|1|||
124916440|NCT04924062|449321527|FG000|Overall Study|Death|49|||
124916441|NCT04924062|449321528|FG001|Overall Study|Death|63|||
124916442|NCT04924062|449321527|FG000|Overall Study|Participant On-going|26|||
124916443|NCT04924062|449321528|FG001|Overall Study|Participant On-going|20|||
124916444|NCT04059354|449321535|FG000|Overall Study|COVID-19 pandemic|3|||
124916445|NCT05403801|449321536|FG000|Overall Study|Withdrawal by Subject|2|||
124916446|NCT03651895|449321538|FG000|First Drug Assignment|Adverse Event|4|||
124916447|NCT03651895|449321539|FG001|First Drug Assignment|Adverse Event|5|||
124916448|NCT03651895|449321538|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
124916449|NCT03651895|449321539|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
124916450|NCT02525692|449321540|FG000|Overall Study|Withdrawal by Subject|1|||
124916451|NCT02525692|449321541|FG001|Overall Study|Withdrawal by Subject|1|||
124916452|NCT02525692|449321542|FG002|Overall Study|Withdrawal by Subject|0|||
124916453|NCT02525692|449321543|FG003|Overall Study|Withdrawal by Subject|5|||
124916454|NCT02525692|449321544|FG004|Overall Study|Withdrawal by Subject|0|||
124916455|NCT02525692|449321545|FG005|Overall Study|Withdrawal by Subject|1|||
124916456|NCT02525692|449321540|FG000|Overall Study|Death|16|||
124916457|NCT02525692|449321541|FG001|Overall Study|Death|18|||
124916458|NCT02525692|449321542|FG002|Overall Study|Death|7|||
124916459|NCT02525692|449321543|FG003|Overall Study|Death|20|||
124916460|NCT02525692|449321544|FG004|Overall Study|Death|3|||
124916461|NCT02525692|449321545|FG005|Overall Study|Death|6|||
124916462|NCT02525692|449321540|FG000|Overall Study|Lost to Follow-up|0|||
124916463|NCT02525692|449321541|FG001|Overall Study|Lost to Follow-up|0|||
124916464|NCT02525692|449321542|FG002|Overall Study|Lost to Follow-up|1|||
124916465|NCT02525692|449321543|FG003|Overall Study|Lost to Follow-up|5|||
124916466|NCT02525692|449321544|FG004|Overall Study|Lost to Follow-up|0|||
124916467|NCT02525692|449321545|FG005|Overall Study|Lost to Follow-up|0|||
124916468|NCT02396199|449321546|FG000|Overall Study|Lost to Follow-up|1|||
124916469|NCT02396199|449321546|FG000|Overall Study|Death|4|||
124916470|NCT02349412|449321550|FG000|Overall Study|Withdrawal by Subject|7|||
124916471|NCT02349412|449321551|FG001|Overall Study|Withdrawal by Subject|7|||
124916472|NCT03460236|449321552|FG000|Overall Study|failed radiographic screening|16|||
124916473|NCT03460236|449321552|FG000|Overall Study|Withdrawal by Subject|11|||
124916474|NCT04840199|449321555|FG000|Overall Study|Study Terminated by Sponsor|8|||
124916475|NCT04840199|449321556|FG001|Overall Study|Study Terminated by Sponsor|9|||
124916476|NCT04840199|449321555|FG000|Overall Study|Lost to Follow-up|0|||
124916477|NCT04840199|449321556|FG001|Overall Study|Lost to Follow-up|2|||
124916478|NCT04840199|449321555|FG000|Overall Study|Withdrawal by Subject|2|||
124916479|NCT04840199|449321556|FG001|Overall Study|Withdrawal by Subject|0|||
124916480|NCT04840199|449321555|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
124916481|NCT04840199|449321556|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
124916482|NCT00753090|449321557|FG000|Overall Study|Withdrawal by Subject|10|||
124916483|NCT00753090|449321558|FG001|Overall Study|Withdrawal by Subject|10|||
124916484|NCT00753090|449321557|FG000|Overall Study|Death|17|||
124916485|NCT00753090|449321558|FG001|Overall Study|Death|6|||
124916486|NCT00753090|449321557|FG000|Overall Study|Study Prosthesis Removed|12|||
124916487|NCT00753090|449321558|FG001|Overall Study|Study Prosthesis Removed|3|||
124916488|NCT00753090|449321557|FG000|Overall Study|Lost to Follow-up|2|||
124916489|NCT00753090|449321558|FG001|Overall Study|Lost to Follow-up|2|||
124916490|NCT00753090|449321557|FG000|Overall Study|Other|127|||
124916491|NCT00753090|449321558|FG001|Overall Study|Other|75|||
124916492|NCT02201108|449321559|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
124916493|NCT02201108|449321560|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
124916494|NCT02201108|449321561|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
124916495|NCT02201108|449321559|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
124916496|NCT02201108|449321560|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
124916497|NCT02201108|449321561|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
124916498|NCT02201108|449321559|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
124916499|NCT02201108|449321560|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
124916500|NCT02201108|449321561|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
124916501|NCT02201108|449321559|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
124916502|NCT02201108|449321560|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
124916503|NCT02201108|449321561|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
124916504|NCT02201108|449321559|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
124916505|NCT02201108|449321560|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
124916506|NCT02201108|449321561|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
124916507|NCT02201108|449321559|FG000|Open Label Period (up to Week 192)|Other reason|4|||
124916508|NCT02201108|449321560|FG001|Open Label Period (up to Week 192)|Other reason|7|||
124916509|NCT02201108|449321561|FG002|Open Label Period (up to Week 192)|Other reason|0|||
124916510|NCT02201108|449321559|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
124916511|NCT02201108|449321560|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
124916512|NCT02201108|449321561|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
124916513|NCT02201108|449321559|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
124916514|NCT02201108|449321560|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
124916515|NCT02201108|449321561|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
124916516|NCT02201108|449321559|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
124916517|NCT02201108|449321560|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
124916518|NCT02201108|449321561|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
124916519|NCT03055377|449321571|FG000|Treatment Phase|Lost to Follow-up|28|||
124916520|NCT03055377|449321572|FG001|Treatment Phase|Lost to Follow-up|24|||
124916521|NCT03055377|449321571|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
124916522|NCT03055377|449321572|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
124916527|NCT05215847|449321575|FG000|Overall Study|Lost to Follow-up|1|||
124916528|NCT03157167|449321576|FG000|Overall Study|Withdrawal by Subject|1|||
124916529|NCT03157167|449321577|FG001|Overall Study|Withdrawal by Subject|0|||
124916530|NCT03157167|449321578|FG002|Overall Study|Withdrawal by Subject|0|||
124916531|NCT06023082|449321581|FG000|Overall Study|Withdrawal by Subject|2|||
124916532|NCT06023082|449321581|FG000|Overall Study|Lost to Follow-up|15|||
124916533|NCT06023082|449321581|FG000|Overall Study|Side effects|5|||
124916534|NCT04823611|449321582|FG000|Overall Study|Adverse Event|2|||
124916535|NCT04823611|449321583|FG001|Overall Study|Adverse Event|0|||
124916536|NCT04823611|449321584|FG002|Overall Study|Adverse Event|1|||
124916537|NCT04823611|449321585|FG003|Overall Study|Adverse Event|0|||
124916538|NCT04823611|449321586|FG004|Overall Study|Adverse Event|0|||
124916539|NCT04823611|449321587|FG005|Overall Study|Adverse Event|0|||
124916540|NCT04823611|449321588|FG006|Overall Study|Adverse Event|0|||
125116566|NCT00638157|450049871|FG001|Overall Study|Physician Decision|0|||
124916541|NCT05444192|449321589|FG000|Overall Study|Lost to Follow-up|1|||
124916542|NCT05444192|449321590|FG001|Overall Study|Lost to Follow-up|0|||
124916543|NCT05623345|449321592|FG000|Overall Study|Withdrawal by Subject|14|||
124916544|NCT05623345|449321593|FG001|Overall Study|Withdrawal by Subject|0|||
124916545|NCT05623345|449321594|FG002|Overall Study|Withdrawal by Subject|9|||
124916546|NCT05623345|449321595|FG003|Overall Study|Withdrawal by Subject|20|||
124916547|NCT05623345|449321592|FG000|Overall Study|Lost to Follow-up|3|||
124916548|NCT05623345|449321593|FG001|Overall Study|Lost to Follow-up|0|||
124916549|NCT05623345|449321594|FG002|Overall Study|Lost to Follow-up|7|||
124916550|NCT05623345|449321595|FG003|Overall Study|Lost to Follow-up|2|||
124916551|NCT05623345|449321592|FG000|Overall Study|Termination of Study By Sponsor|37|||
124916552|NCT05623345|449321593|FG001|Overall Study|Termination of Study By Sponsor|4|||
124916553|NCT05623345|449321594|FG002|Overall Study|Termination of Study By Sponsor|40|||
124916554|NCT05623345|449321595|FG003|Overall Study|Termination of Study By Sponsor|38|||
124916555|NCT01385176|449321596|FG000|Randomization Phase|Death|1|||
124916556|NCT01385176|449321597|FG001|Randomization Phase|Death|2|||
124916557|NCT01385176|449321596|FG000|6-18 Month All VNS Active|Death|1|||
124916558|NCT01385176|449321597|FG001|6-18 Month All VNS Active|Death|2|||
124916559|NCT01385176|449321596|FG000|6-18 Month All VNS Active|Physician Decision|0|||
124916560|NCT01385176|449321597|FG001|6-18 Month All VNS Active|Physician Decision|1|||
124916561|NCT01385176|449321596|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
124916562|NCT01385176|449321597|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
124916563|NCT01385176|449321596|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
124916564|NCT01385176|449321597|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
124916565|NCT05384730|449321598|FG000|Overall Study|Adverse Event|1|||
124916566|NCT05384730|449321599|FG001|Overall Study|Adverse Event|0|||
124916567|NCT05384730|449321598|FG000|Overall Study|Lack of social support|2|||
124916568|NCT05384730|449321599|FG001|Overall Study|Lack of social support|0|||
124916569|NCT05384730|449321598|FG000|Overall Study|Hospital readmission|2|||
124916570|NCT05384730|449321599|FG001|Overall Study|Hospital readmission|0|||
124916571|NCT05384730|449321598|FG000|Overall Study|Disease progression|5|||
124916572|NCT05384730|449321599|FG001|Overall Study|Disease progression|0|||
124916573|NCT05384730|449321598|FG000|Overall Study|Overwhelmed with College commitments|0|||
124916574|NCT05384730|449321599|FG001|Overall Study|Overwhelmed with College commitments|2|||
124916575|NCT01772472|449321600|FG000|Overall Study|Death|126|||
124916576|NCT01772472|449321601|FG001|Overall Study|Death|94|||
124916577|NCT01772472|449321600|FG000|Overall Study|Lost to Follow-up|51|||
124916578|NCT01772472|449321601|FG001|Overall Study|Lost to Follow-up|50|||
124916579|NCT01772472|449321600|FG000|Overall Study|Other|9|||
124916580|NCT01772472|449321601|FG001|Overall Study|Other|7|||
124916581|NCT01772472|449321600|FG000|Overall Study|Physician Decision|1|||
124916582|NCT01772472|449321601|FG001|Overall Study|Physician Decision|7|||
124916583|NCT01772472|449321600|FG000|Overall Study|Withdrawal by Subject|115|||
124916584|NCT01772472|449321601|FG001|Overall Study|Withdrawal by Subject|90|||
124916585|NCT01772472|449321600|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
124916586|NCT01772472|449321601|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
124916587|NCT04431726|449321610|FG000|Overall Study|Ongoing in the Study|55|||
124916588|NCT04093752|449321612|FG000|Overall Study|Adverse Event|7|||
124916589|NCT04093752|449321613|FG001|Overall Study|Adverse Event|19|||
124916590|NCT04093752|449321614|FG002|Overall Study|Adverse Event|18|||
124916591|NCT04093752|449321615|FG003|Overall Study|Adverse Event|4|||
124916592|NCT04093752|449321612|FG000|Overall Study|Withdrawal by Subject|6|||
124916593|NCT04093752|449321613|FG001|Overall Study|Withdrawal by Subject|6|||
124916594|NCT04093752|449321614|FG002|Overall Study|Withdrawal by Subject|8|||
124916595|NCT04093752|449321615|FG003|Overall Study|Withdrawal by Subject|20|||
124916596|NCT04093752|449321612|FG000|Overall Study|Lost to Follow-up|2|||
124916597|NCT04093752|449321613|FG001|Overall Study|Lost to Follow-up|1|||
124916598|NCT04093752|449321614|FG002|Overall Study|Lost to Follow-up|1|||
124916599|NCT04093752|449321615|FG003|Overall Study|Lost to Follow-up|1|||
124916600|NCT04093752|449321612|FG000|Overall Study|Death|0|||
124916601|NCT04093752|449321613|FG001|Overall Study|Death|0|||
124916602|NCT04093752|449321614|FG002|Overall Study|Death|1|||
124916603|NCT04093752|449321615|FG003|Overall Study|Death|2|||
124916604|NCT04093752|449321612|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
124916605|NCT04093752|449321613|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
124916606|NCT04093752|449321614|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
124916607|NCT04093752|449321615|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
124916608|NCT04093752|449321612|FG000|Overall Study|Covid 19|0|||
124916609|NCT04093752|449321613|FG001|Overall Study|Covid 19|0|||
124916610|NCT04093752|449321614|FG002|Overall Study|Covid 19|0|||
124916611|NCT04093752|449321615|FG003|Overall Study|Covid 19|1|||
124916612|NCT04093752|449321612|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
124916613|NCT04093752|449321613|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
124916614|NCT04093752|449321614|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
124916615|NCT04093752|449321615|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
124916616|NCT04093752|449321612|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
124916617|NCT04093752|449321613|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
124916618|NCT04093752|449321614|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
124916619|NCT04093752|449321615|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
124916620|NCT04093752|449321612|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
124916621|NCT04093752|449321613|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
124916622|NCT04093752|449321614|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
124916623|NCT04093752|449321615|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
124916624|NCT01101451|449321616|FG000|Overall Study|Eligible and never treated|0|||
124916625|NCT01101451|449321617|FG001|Overall Study|Eligible and never treated|5|||
124916626|NCT01101451|449321616|FG000|Overall Study|Ineligible and treated|12|||
124916627|NCT01101451|449321617|FG001|Overall Study|Ineligible and treated|8|||
124916628|NCT01101451|449321616|FG000|Overall Study|Ineligible and never treated|2|||
124916629|NCT01101451|449321617|FG001|Overall Study|Ineligible and never treated|2|||
124916630|NCT04854096|449321618|FG000|Overall Study|Adverse Event|1|||
124916631|NCT04854096|449321619|FG001|Overall Study|Adverse Event|0|||
124916632|NCT04854096|449321618|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
124916633|NCT04854096|449321619|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
124916634|NCT04854096|449321618|FG000|Overall Study|Withdrawal by Subject|1|||
124916635|NCT04854096|449321619|FG001|Overall Study|Withdrawal by Subject|0|||
124916636|NCT04854096|449321618|FG000|Overall Study|Other reasons|1|||
124916637|NCT04854096|449321619|FG001|Overall Study|Other reasons|0|||
124916638|NCT04757610|449321620|FG000|Overall Study|Adverse Event|13|||
124916639|NCT04757610|449321621|FG001|Overall Study|Adverse Event|10|||
124916640|NCT04757610|449321622|FG002|Overall Study|Adverse Event|5|||
124916641|NCT04757610|449321620|FG000|Overall Study|Death|5|||
125211810|NCT00055497|450401381|FG000|Overall Study|Adverse Event|1|||
124916642|NCT04757610|449321621|FG001|Overall Study|Death|13|||
124916643|NCT04757610|449321622|FG002|Overall Study|Death|8|||
124916644|NCT04757610|449321620|FG000|Overall Study|Lack of Efficacy|1|||
124916645|NCT04757610|449321621|FG001|Overall Study|Lack of Efficacy|2|||
124916646|NCT04757610|449321622|FG002|Overall Study|Lack of Efficacy|3|||
124916647|NCT04757610|449321620|FG000|Overall Study|Lost to Follow-up|7|||
124916648|NCT04757610|449321621|FG001|Overall Study|Lost to Follow-up|2|||
124916649|NCT04757610|449321622|FG002|Overall Study|Lost to Follow-up|7|||
124916650|NCT04757610|449321620|FG000|Overall Study|Physician Decision|4|||
124916651|NCT04757610|449321621|FG001|Overall Study|Physician Decision|1|||
124916652|NCT04757610|449321622|FG002|Overall Study|Physician Decision|2|||
124916653|NCT04757610|449321620|FG000|Overall Study|Withdrawal by Subject|26|||
124916654|NCT04757610|449321621|FG001|Overall Study|Withdrawal by Subject|25|||
124916655|NCT04757610|449321622|FG002|Overall Study|Withdrawal by Subject|25|||
124916656|NCT04757610|449321620|FG000|Overall Study|Study Terminated by Sponsor|105|||
124916657|NCT04757610|449321621|FG001|Overall Study|Study Terminated by Sponsor|105|||
124916658|NCT04757610|449321622|FG002|Overall Study|Study Terminated by Sponsor|110|||
124916659|NCT04757610|449321620|FG000|Overall Study|Randomized in Error|1|||
124916660|NCT04757610|449321621|FG001|Overall Study|Randomized in Error|0|||
124916661|NCT04757610|449321622|FG002|Overall Study|Randomized in Error|0|||
124916662|NCT00073749|449321623|FG000|Overall Study|Disease Progression|2|||
124916663|NCT00073749|449321624|FG001|Overall Study|Disease Progression|0|||
124916664|NCT00073749|449321625|FG002|Overall Study|Disease Progression|3|||
124916665|NCT00073749|449321626|FG003|Overall Study|Disease Progression|2|||
124916666|NCT00073749|449321627|FG004|Overall Study|Disease Progression|3|||
124916667|NCT00073749|449321628|FG005|Overall Study|Disease Progression|1|||
124916668|NCT00073749|449321629|FG006|Overall Study|Disease Progression|3|||
124916669|NCT00073749|449321623|FG000|Overall Study|Death|0|||
124916670|NCT00073749|449321624|FG001|Overall Study|Death|1|||
124916671|NCT00073749|449321625|FG002|Overall Study|Death|1|||
124916672|NCT00073749|449321626|FG003|Overall Study|Death|0|||
124916673|NCT00073749|449321627|FG004|Overall Study|Death|0|||
124916674|NCT00073749|449321628|FG005|Overall Study|Death|0|||
124916675|NCT00073749|449321629|FG006|Overall Study|Death|29|||
124916676|NCT00073749|449321623|FG000|Overall Study|Adverse Event|0|||
124916677|NCT00073749|449321624|FG001|Overall Study|Adverse Event|3|||
124916678|NCT00073749|449321625|FG002|Overall Study|Adverse Event|6|||
124916679|NCT00073749|449321626|FG003|Overall Study|Adverse Event|4|||
124916680|NCT00073749|449321627|FG004|Overall Study|Adverse Event|2|||
124916681|NCT00073749|449321628|FG005|Overall Study|Adverse Event|1|||
124916682|NCT00073749|449321629|FG006|Overall Study|Adverse Event|0|||
124916683|NCT00073749|449321623|FG000|Overall Study|Physician Decision|0|||
124916684|NCT00073749|449321624|FG001|Overall Study|Physician Decision|0|||
124916685|NCT00073749|449321625|FG002|Overall Study|Physician Decision|1|||
124916686|NCT00073749|449321626|FG003|Overall Study|Physician Decision|0|||
124916687|NCT00073749|449321627|FG004|Overall Study|Physician Decision|0|||
124916688|NCT00073749|449321628|FG005|Overall Study|Physician Decision|2|||
124916689|NCT00073749|449321629|FG006|Overall Study|Physician Decision|0|||
124916690|NCT00073749|449321623|FG000|Overall Study|Withdrawal by Subject|0|||
124916691|NCT00073749|449321624|FG001|Overall Study|Withdrawal by Subject|1|||
124916692|NCT00073749|449321625|FG002|Overall Study|Withdrawal by Subject|0|||
124916693|NCT00073749|449321626|FG003|Overall Study|Withdrawal by Subject|0|||
124916694|NCT00073749|449321627|FG004|Overall Study|Withdrawal by Subject|1|||
124916695|NCT00073749|449321628|FG005|Overall Study|Withdrawal by Subject|0|||
124916696|NCT00073749|449321629|FG006|Overall Study|Withdrawal by Subject|2|||
124916697|NCT00073749|449321623|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
124916698|NCT00073749|449321624|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
124916699|NCT00073749|449321625|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
124916700|NCT00073749|449321626|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
124916701|NCT00073749|449321627|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
124916702|NCT00073749|449321628|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
124916703|NCT00073749|449321629|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
124916704|NCT00073749|449321623|FG000|Overall Study|Lost to Follow-up|0|||
124916705|NCT00073749|449321624|FG001|Overall Study|Lost to Follow-up|0|||
124916706|NCT00073749|449321625|FG002|Overall Study|Lost to Follow-up|0|||
124916707|NCT00073749|449321626|FG003|Overall Study|Lost to Follow-up|0|||
124916708|NCT00073749|449321627|FG004|Overall Study|Lost to Follow-up|0|||
124916709|NCT00073749|449321628|FG005|Overall Study|Lost to Follow-up|0|||
124916710|NCT00073749|449321629|FG006|Overall Study|Lost to Follow-up|2|||
124916711|NCT00073749|449321623|FG000|Overall Study|Other|0|||
124916712|NCT00073749|449321624|FG001|Overall Study|Other|0|||
124916713|NCT00073749|449321625|FG002|Overall Study|Other|0|||
124916714|NCT00073749|449321626|FG003|Overall Study|Other|0|||
124916715|NCT00073749|449321627|FG004|Overall Study|Other|0|||
125211811|NCT00055497|450401382|FG001|Overall Study|Adverse Event|1|||
124916716|NCT00073749|449321628|FG005|Overall Study|Other|2|||
124916717|NCT00073749|449321629|FG006|Overall Study|Other|0|||
124916718|NCT04154384|449321630|FG000|Overall Study|Lost to Follow-up|24|||
124916719|NCT04154384|449321631|FG001|Overall Study|Lost to Follow-up|33|||
124916720|NCT04154384|449321632|FG002|Overall Study|Lost to Follow-up|0|||
124916721|NCT04154384|449321630|FG000|Overall Study|Withdrawal by Subject|7|||
124916722|NCT04154384|449321631|FG001|Overall Study|Withdrawal by Subject|18|||
124916723|NCT04154384|449321632|FG002|Overall Study|Withdrawal by Subject|0|||
124916724|NCT04154384|449321630|FG000|Overall Study|Missing outcome data|1|||
124916725|NCT04154384|449321631|FG001|Overall Study|Missing outcome data|0|||
124916726|NCT04154384|449321632|FG002|Overall Study|Missing outcome data|0|||
124916727|NCT05048186|449321633|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
124916728|NCT05048186|449321634|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
124916729|NCT05048186|449321633|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
124916730|NCT05048186|449321634|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
124916731|NCT00951379|449321635|FG000|Overall Study|Adverse Event|4|||
124916732|NCT00951379|449321636|FG001|Overall Study|Adverse Event|1|||
124916733|NCT00951379|449321635|FG000|Overall Study|Withdrawal by Subject|1|||
124916734|NCT00951379|449321636|FG001|Overall Study|Withdrawal by Subject|0|||
124916735|NCT00951379|449321635|FG000|Overall Study|Noncompliance|1|||
124916736|NCT00951379|449321636|FG001|Overall Study|Noncompliance|0|||
124916737|NCT00951379|449321635|FG000|Overall Study|Disease Progression|0|||
124916738|NCT00951379|449321636|FG001|Overall Study|Disease Progression|1|||
124916739|NCT04218266|449321638|FG000|Overall Study|Death|1|||
124916740|NCT04218266|449321639|FG001|Overall Study|Death|2|||
124916741|NCT04218266|449321640|FG002|Overall Study|Death|3|||
124916742|NCT04218266|449321638|FG000|Overall Study|Adverse Event|13|||
124916743|NCT04218266|449321639|FG001|Overall Study|Adverse Event|14|||
124916744|NCT04218266|449321640|FG002|Overall Study|Adverse Event|11|||
124916745|NCT04218266|449321638|FG000|Overall Study|Other|7|||
124916746|NCT04218266|449321639|FG001|Overall Study|Other|5|||
124916747|NCT04218266|449321640|FG002|Overall Study|Other|14|||
124916748|NCT04218266|449321638|FG000|Overall Study|Physician Decision|1|||
124916749|NCT04218266|449321639|FG001|Overall Study|Physician Decision|3|||
124916750|NCT04218266|449321640|FG002|Overall Study|Physician Decision|2|||
124916751|NCT04218266|449321638|FG000|Overall Study|Non-compliance with study drug|0|||
124916752|NCT04218266|449321639|FG001|Overall Study|Non-compliance with study drug|0|||
124916753|NCT04218266|449321640|FG002|Overall Study|Non-compliance with study drug|1|||
124916754|NCT04218266|449321638|FG000|Overall Study|Withdrawal by Subject|1|||
124916755|NCT04218266|449321639|FG001|Overall Study|Withdrawal by Subject|3|||
124916756|NCT04218266|449321640|FG002|Overall Study|Withdrawal by Subject|1|||
124916757|NCT04218266|449321638|FG000|Overall Study|Study drug never administered|2|||
124916758|NCT04218266|449321639|FG001|Overall Study|Study drug never administered|0|||
124916759|NCT04218266|449321640|FG002|Overall Study|Study drug never administered|0|||
124916760|NCT02742519|449321641|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
124916761|NCT02742519|449321642|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
124916762|NCT02742519|449321643|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
124916763|NCT02742519|449321641|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
124916764|NCT02742519|449321642|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
124916765|NCT02742519|449321643|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
124916766|NCT02742519|449321641|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
124916767|NCT02742519|449321642|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
124916768|NCT02742519|449321643|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
124916769|NCT04377308|449321644|FG000|Overall Study|Withdrawal by Subject|0|||
124916770|NCT04377308|449321645|FG001|Overall Study|Withdrawal by Subject|1|||
124916771|NCT03580369|449321646|FG000|Overall Study|No treatment due to mis-randomization|1|||
124916772|NCT03580369|449321647|FG001|Overall Study|No treatment due to mis-randomization|0|||
124916773|NCT03580369|449321648|FG002|Overall Study|No treatment due to mis-randomization|0|||
124916774|NCT03580369|449321649|FG003|Overall Study|No treatment due to mis-randomization|0|||
124916775|NCT03580369|449321650|FG004|Overall Study|No treatment due to mis-randomization|3|||
124916776|NCT03580369|449321651|FG005|Overall Study|No treatment due to mis-randomization|0|||
124916777|NCT03580369|449321652|FG006|Overall Study|No treatment due to mis-randomization|0|||
124916778|NCT03580369|449321653|FG007|Overall Study|No treatment due to mis-randomization|0|||
124916779|NCT03580369|449321646|FG000|Overall Study|Reason unknown|0|||
124916780|NCT03580369|449321647|FG001|Overall Study|Reason unknown|0|||
124916781|NCT03580369|449321648|FG002|Overall Study|Reason unknown|1|||
124916782|NCT03580369|449321649|FG003|Overall Study|Reason unknown|0|||
124916783|NCT03580369|449321650|FG004|Overall Study|Reason unknown|0|||
124916784|NCT03580369|449321651|FG005|Overall Study|Reason unknown|0|||
124916785|NCT03580369|449321652|FG006|Overall Study|Reason unknown|0|||
124916786|NCT03580369|449321653|FG007|Overall Study|Reason unknown|0|||
124916787|NCT03580369|449321646|FG000|Overall Study|Technical problems|0|||
124916788|NCT03580369|449321647|FG001|Overall Study|Technical problems|0|||
124916789|NCT03580369|449321648|FG002|Overall Study|Technical problems|0|||
124916790|NCT03580369|449321649|FG003|Overall Study|Technical problems|0|||
124916791|NCT03580369|449321650|FG004|Overall Study|Technical problems|1|||
124916792|NCT03580369|449321651|FG005|Overall Study|Technical problems|0|||
124916793|NCT03580369|449321652|FG006|Overall Study|Technical problems|2|||
124916794|NCT03580369|449321653|FG007|Overall Study|Technical problems|0|||
124916795|NCT03580369|449321646|FG000|Overall Study|Pregnancy|2|||
124916796|NCT03580369|449321647|FG001|Overall Study|Pregnancy|0|||
124916797|NCT03580369|449321648|FG002|Overall Study|Pregnancy|3|||
124916798|NCT03580369|449321649|FG003|Overall Study|Pregnancy|0|||
124916799|NCT03580369|449321650|FG004|Overall Study|Pregnancy|2|||
124916800|NCT03580369|449321651|FG005|Overall Study|Pregnancy|0|||
124916801|NCT03580369|449321652|FG006|Overall Study|Pregnancy|0|||
124916802|NCT03580369|449321653|FG007|Overall Study|Pregnancy|0|||
124916803|NCT03580369|449321646|FG000|Overall Study|Lost to Follow-up|2|||
124916804|NCT03580369|449321647|FG001|Overall Study|Lost to Follow-up|0|||
124916805|NCT03580369|449321648|FG002|Overall Study|Lost to Follow-up|2|||
124916806|NCT03580369|449321649|FG003|Overall Study|Lost to Follow-up|0|||
124916807|NCT03580369|449321650|FG004|Overall Study|Lost to Follow-up|3|||
124916808|NCT03580369|449321651|FG005|Overall Study|Lost to Follow-up|0|||
124916809|NCT03580369|449321652|FG006|Overall Study|Lost to Follow-up|1|||
124916810|NCT03580369|449321653|FG007|Overall Study|Lost to Follow-up|0|||
124916811|NCT03580369|449321646|FG000|Overall Study|Physician Decision|4|||
124916812|NCT03580369|449321647|FG001|Overall Study|Physician Decision|0|||
124916813|NCT03580369|449321648|FG002|Overall Study|Physician Decision|4|||
124916814|NCT03580369|449321649|FG003|Overall Study|Physician Decision|1|||
124916815|NCT03580369|449321650|FG004|Overall Study|Physician Decision|1|||
124916816|NCT03580369|449321651|FG005|Overall Study|Physician Decision|0|||
124916817|NCT03580369|449321652|FG006|Overall Study|Physician Decision|0|||
124916818|NCT03580369|449321653|FG007|Overall Study|Physician Decision|0|||
124916819|NCT03580369|449321646|FG000|Overall Study|Lack of Efficacy|3|||
124916820|NCT03580369|449321647|FG001|Overall Study|Lack of Efficacy|0|||
124916821|NCT03580369|449321648|FG002|Overall Study|Lack of Efficacy|7|||
124916822|NCT03580369|449321649|FG003|Overall Study|Lack of Efficacy|0|||
124916823|NCT03580369|449321650|FG004|Overall Study|Lack of Efficacy|2|||
124916824|NCT03580369|449321651|FG005|Overall Study|Lack of Efficacy|0|||
124916825|NCT03580369|449321652|FG006|Overall Study|Lack of Efficacy|3|||
124916826|NCT03580369|449321653|FG007|Overall Study|Lack of Efficacy|0|||
124916827|NCT03580369|449321646|FG000|Overall Study|Protocol Violation|6|||
124916828|NCT03580369|449321647|FG001|Overall Study|Protocol Violation|0|||
124916829|NCT03580369|449321648|FG002|Overall Study|Protocol Violation|6|||
124916830|NCT03580369|449321649|FG003|Overall Study|Protocol Violation|1|||
124916831|NCT03580369|449321650|FG004|Overall Study|Protocol Violation|8|||
124916832|NCT03580369|449321651|FG005|Overall Study|Protocol Violation|2|||
124916833|NCT03580369|449321652|FG006|Overall Study|Protocol Violation|1|||
124916834|NCT03580369|449321653|FG007|Overall Study|Protocol Violation|0|||
124916835|NCT03580369|449321646|FG000|Overall Study|Adverse Event|7|||
124916836|NCT03580369|449321647|FG001|Overall Study|Adverse Event|0|||
124916837|NCT03580369|449321648|FG002|Overall Study|Adverse Event|14|||
124916838|NCT03580369|449321649|FG003|Overall Study|Adverse Event|1|||
124916839|NCT03580369|449321650|FG004|Overall Study|Adverse Event|6|||
124916840|NCT03580369|449321651|FG005|Overall Study|Adverse Event|0|||
124916841|NCT03580369|449321652|FG006|Overall Study|Adverse Event|1|||
124916842|NCT03580369|449321653|FG007|Overall Study|Adverse Event|0|||
124916843|NCT03580369|449321646|FG000|Overall Study|Withdrawal by Subject|19|||
124916844|NCT03580369|449321647|FG001|Overall Study|Withdrawal by Subject|0|||
124916845|NCT03580369|449321648|FG002|Overall Study|Withdrawal by Subject|17|||
124916846|NCT03580369|449321649|FG003|Overall Study|Withdrawal by Subject|0|||
124916847|NCT03580369|449321650|FG004|Overall Study|Withdrawal by Subject|16|||
124916848|NCT03580369|449321651|FG005|Overall Study|Withdrawal by Subject|1|||
124916849|NCT03580369|449321652|FG006|Overall Study|Withdrawal by Subject|7|||
124916850|NCT03580369|449321653|FG007|Overall Study|Withdrawal by Subject|0|||
124916851|NCT04774237|449321657|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
124916852|NCT04774237|449321658|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
124916853|NCT04774237|449321659|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
124916854|NCT04774237|449321660|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
124916855|NCT04774237|449321661|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
124916856|NCT04774237|449321662|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
124916857|NCT04923347|449323504|FG000|Overall Study|Withdrawal by Subject|14|||
124916858|NCT06066541|449323511|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
124916859|NCT06066541|449323512|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
124916860|NCT06066541|449323513|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
125022765|NCT04537208|449707825|FG007|Overall Study|Lost to Follow-up|2|||
125022766|NCT04537208|449707826|FG008|Overall Study|Lost to Follow-up|7|||
125022767|NCT04537208|449707827|FG009|Overall Study|Lost to Follow-up|2|||
125022768|NCT04537208|449707828|FG010|Overall Study|Lost to Follow-up|2|||
124916861|NCT06066541|449323514|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
124916862|NCT06066541|449323515|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
124916863|NCT06066541|449323516|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
124916864|NCT06066541|449323517|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
124916865|NCT06066541|449323511|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
124916866|NCT06066541|449323512|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
124916867|NCT06066541|449323513|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
124916868|NCT06066541|449323514|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
124916869|NCT06066541|449323515|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
124916870|NCT06066541|449323516|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
124916871|NCT06066541|449323517|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
124916872|NCT02819843|449323518|FG000|Overall Study|Disease progression before RT|0|||
124916873|NCT02819843|449323519|FG001|Overall Study|Disease progression before RT|1|||
124916874|NCT03055858|449323521|FG000|Overall Study|Death|9|||
125211812|NCT00055497|450401383|FG002|Overall Study|Adverse Event|1|||
125211813|NCT00055497|450401384|FG003|Overall Study|Adverse Event|28|||
125211814|NCT00055497|450401381|FG000|Overall Study|Withdrawal by Subject|3|||
124916875|NCT03055858|449323521|FG000|Overall Study|Withdrawal by Subject|11|||
124916876|NCT03055858|449323521|FG000|Overall Study|Lost to Follow-up|6|||
124916877|NCT03055858|449323521|FG000|Overall Study|Missed Follow-Up Visits|18|||
124916878|NCT04586920|449323522|FG000|Overall Study|Lost to Follow-up|0|||
124916879|NCT04586920|449323523|FG001|Overall Study|Lost to Follow-up|0|||
124916880|NCT04586920|449323524|FG002|Overall Study|Lost to Follow-up|0|||
124916881|NCT04586920|449323525|FG003|Overall Study|Lost to Follow-up|0|||
124916882|NCT04586920|449323526|FG004|Overall Study|Lost to Follow-up|0|||
124916883|NCT04586920|449323527|FG005|Overall Study|Lost to Follow-up|0|||
124916884|NCT04586920|449323528|FG006|Overall Study|Lost to Follow-up|1|||
124916885|NCT04586920|449323529|FG007|Overall Study|Lost to Follow-up|1|||
124916886|NCT04586920|449323530|FG008|Overall Study|Lost to Follow-up|0|||
124916887|NCT04586920|449323531|FG009|Overall Study|Lost to Follow-up|1|||
124916888|NCT04586920|449323532|FG010|Overall Study|Lost to Follow-up|0|||
124916889|NCT04586920|449323533|FG011|Overall Study|Lost to Follow-up|0|||
124916890|NCT04586920|449323534|FG012|Overall Study|Lost to Follow-up|0|||
124916891|NCT04586920|449323535|FG013|Overall Study|Lost to Follow-up|1|||
124916892|NCT04586920|449323536|FG014|Overall Study|Lost to Follow-up|0|||
124916893|NCT04586920|449323537|FG015|Overall Study|Lost to Follow-up|0|||
124916894|NCT04586920|449323538|FG016|Overall Study|Lost to Follow-up|0|||
124916895|NCT04586920|449323539|FG017|Overall Study|Lost to Follow-up|0|||
124916896|NCT04586920|449323522|FG000|Overall Study|Withdrawal by Subject|0|||
124916897|NCT04586920|449323523|FG001|Overall Study|Withdrawal by Subject|0|||
124916898|NCT04586920|449323524|FG002|Overall Study|Withdrawal by Subject|0|||
124916899|NCT04586920|449323525|FG003|Overall Study|Withdrawal by Subject|0|||
124916900|NCT04586920|449323526|FG004|Overall Study|Withdrawal by Subject|0|||
124916901|NCT04586920|449323527|FG005|Overall Study|Withdrawal by Subject|0|||
124916902|NCT04586920|449323528|FG006|Overall Study|Withdrawal by Subject|0|||
124916903|NCT04586920|449323529|FG007|Overall Study|Withdrawal by Subject|1|||
124916904|NCT04586920|449323530|FG008|Overall Study|Withdrawal by Subject|0|||
124916905|NCT04586920|449323531|FG009|Overall Study|Withdrawal by Subject|1|||
124916906|NCT04586920|449323532|FG010|Overall Study|Withdrawal by Subject|0|||
124916907|NCT04586920|449323533|FG011|Overall Study|Withdrawal by Subject|1|||
124916908|NCT04586920|449323534|FG012|Overall Study|Withdrawal by Subject|0|||
124916909|NCT04586920|449323535|FG013|Overall Study|Withdrawal by Subject|0|||
124916910|NCT04586920|449323536|FG014|Overall Study|Withdrawal by Subject|0|||
124916911|NCT04586920|449323537|FG015|Overall Study|Withdrawal by Subject|0|||
124916912|NCT04586920|449323538|FG016|Overall Study|Withdrawal by Subject|0|||
124916913|NCT04586920|449323539|FG017|Overall Study|Withdrawal by Subject|0|||
124916914|NCT04052516|449323544|FG000|Overall Study|Withdrawal by Subject|4|||
124916915|NCT04052516|449323545|FG001|Overall Study|Withdrawal by Subject|5|||
124916916|NCT04052516|449323546|FG002|Overall Study|Withdrawal by Subject|6|||
124916917|NCT04052516|449323544|FG000|Overall Study|Adverse Event|3|||
124916918|NCT04052516|449323545|FG001|Overall Study|Adverse Event|2|||
124916919|NCT04052516|449323546|FG002|Overall Study|Adverse Event|8|||
124916920|NCT04052516|449323544|FG000|Overall Study|Lost to Follow-up|2|||
124916921|NCT04052516|449323545|FG001|Overall Study|Lost to Follow-up|5|||
124916922|NCT04052516|449323546|FG002|Overall Study|Lost to Follow-up|3|||
124916923|NCT04052516|449323544|FG000|Overall Study|Protocol Violation|1|||
124916924|NCT04052516|449323545|FG001|Overall Study|Protocol Violation|1|||
124916925|NCT04052516|449323546|FG002|Overall Study|Protocol Violation|0|||
124916926|NCT04052516|449323544|FG000|Overall Study|Death|1|||
124916927|NCT04052516|449323545|FG001|Overall Study|Death|0|||
124916928|NCT04052516|449323546|FG002|Overall Study|Death|0|||
124916929|NCT04052516|449323544|FG000|Overall Study|Physician Decision|0|||
124916930|NCT04052516|449323545|FG001|Overall Study|Physician Decision|1|||
124916931|NCT04052516|449323546|FG002|Overall Study|Physician Decision|0|||
124916932|NCT04052516|449323544|FG000|Overall Study|Pregnancy|1|||
124916933|NCT04052516|449323545|FG001|Overall Study|Pregnancy|0|||
124916934|NCT04052516|449323546|FG002|Overall Study|Pregnancy|0|||
124916935|NCT04052516|449323544|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
124916936|NCT04052516|449323545|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
124916937|NCT04052516|449323546|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
124916938|NCT04052516|449323544|FG000|Overall Study|Reason not recorded|0|||
124916939|NCT04052516|449323545|FG001|Overall Study|Reason not recorded|1|||
124916940|NCT04052516|449323546|FG002|Overall Study|Reason not recorded|0|||
124916941|NCT03948763|449323550|FG000|Overall Study|Sponsor's decision|0|||
124916942|NCT03948763|449323551|FG001|Overall Study|Sponsor's decision|2|||
124916943|NCT03948763|449323552|FG002|Overall Study|Sponsor's decision|6|||
124916944|NCT03948763|449323553|FG003|Overall Study|Sponsor's decision|4|||
124916945|NCT03948763|449323554|FG004|Overall Study|Sponsor's decision|0|||
124916946|NCT03948763|449323550|FG000|Overall Study|Physician Decision|0|||
124916947|NCT03948763|449323551|FG001|Overall Study|Physician Decision|0|||
124916948|NCT03948763|449323552|FG002|Overall Study|Physician Decision|1|||
124916949|NCT03948763|449323553|FG003|Overall Study|Physician Decision|0|||
124916950|NCT03948763|449323554|FG004|Overall Study|Physician Decision|0|||
124916951|NCT03948763|449323550|FG000|Overall Study|Lost to Follow-up|0|||
124916952|NCT03948763|449323551|FG001|Overall Study|Lost to Follow-up|0|||
124916953|NCT03948763|449323552|FG002|Overall Study|Lost to Follow-up|0|||
124916954|NCT03948763|449323553|FG003|Overall Study|Lost to Follow-up|0|||
124916955|NCT03948763|449323554|FG004|Overall Study|Lost to Follow-up|1|||
124916956|NCT03948763|449323550|FG000|Overall Study|Death|2|||
124916957|NCT03948763|449323551|FG001|Overall Study|Death|12|||
124916958|NCT03948763|449323552|FG002|Overall Study|Death|13|||
124916959|NCT03948763|449323553|FG003|Overall Study|Death|10|||
124916960|NCT03948763|449323554|FG004|Overall Study|Death|11|||
124916961|NCT03948763|449323550|FG000|Overall Study|Withdrawal by Subject|1|||
124916962|NCT03948763|449323551|FG001|Overall Study|Withdrawal by Subject|1|||
124916963|NCT03948763|449323552|FG002|Overall Study|Withdrawal by Subject|0|||
124916964|NCT03948763|449323553|FG003|Overall Study|Withdrawal by Subject|2|||
124916965|NCT03948763|449323554|FG004|Overall Study|Withdrawal by Subject|4|||
124916966|NCT05415436|449323555|FG000|Overall Study|Surgeon cancelled procedure|1|||
124916967|NCT05415436|449323556|FG001|Overall Study|Surgeon cancelled procedure|0|||
124916968|NCT05415436|449323555|FG000|Overall Study|Death|1|||
124916969|NCT05415436|449323556|FG001|Overall Study|Death|0|||
124916970|NCT02597946|449323570|FG000|Overall Study|Withdrawal by Subject|1|||
124916971|NCT02597946|449323570|FG000|Overall Study|Progressive disease|16|||
124916972|NCT02597946|449323570|FG000|Overall Study|Other than above|1|||
124916973|NCT05058391|449323577|FG000|Overall Study|Adverse Event|1|||
124916974|NCT05136404|449323578|FG000|Period 1|Adverse Event|0|||
124916975|NCT05136404|449323579|FG001|Period 1|Adverse Event|1|||
124916976|NCT05136404|449323580|FG002|Period 1|Adverse Event|1|||
124916977|NCT05136404|449323578|FG000|Period 2|Inappropriate Behavior|0|||
124916978|NCT05136404|449323579|FG001|Period 2|Inappropriate Behavior|0|||
124916979|NCT05136404|449323580|FG002|Period 2|Inappropriate Behavior|1|||
124916980|NCT05136404|449323578|FG000|Period 3|Adverse Event|0|||
124916981|NCT05136404|449323579|FG001|Period 3|Adverse Event|0|||
124916982|NCT05136404|449323580|FG002|Period 3|Adverse Event|1|||
124916983|NCT03584516|449323581|FG000|Part 1|Death|2|||
124916984|NCT03584516|449323582|FG001|Part 1|Death|3|||
124916985|NCT03584516|449323583|FG002|Part 1|Death|0|||
124916986|NCT03584516|449323584|FG003|Part 1|Death|0|||
124916987|NCT03584516|449323585|FG004|Part 1|Death|0|||
124916988|NCT03584516|449323586|FG005|Part 1|Death|0|||
124916989|NCT03584516|449323581|FG000|Part 1|Withdrawal by Subject|2|||
124916990|NCT03584516|449323582|FG001|Part 1|Withdrawal by Subject|0|||
124916991|NCT03584516|449323583|FG002|Part 1|Withdrawal by Subject|0|||
124916992|NCT03584516|449323584|FG003|Part 1|Withdrawal by Subject|0|||
124916993|NCT03584516|449323585|FG004|Part 1|Withdrawal by Subject|0|||
124916994|NCT03584516|449323586|FG005|Part 1|Withdrawal by Subject|0|||
124916995|NCT03584516|449323581|FG000|Part 1|Lost to Follow-up|1|||
124916996|NCT03584516|449323582|FG001|Part 1|Lost to Follow-up|0|||
124916997|NCT03584516|449323583|FG002|Part 1|Lost to Follow-up|0|||
124916998|NCT03584516|449323584|FG003|Part 1|Lost to Follow-up|0|||
124916999|NCT03584516|449323585|FG004|Part 1|Lost to Follow-up|0|||
124917000|NCT03584516|449323586|FG005|Part 1|Lost to Follow-up|0|||
124917001|NCT03584516|449323581|FG000|Part 1|Study Terminated by Sponsor|0|||
124917002|NCT03584516|449323582|FG001|Part 1|Study Terminated by Sponsor|2|||
124917003|NCT03584516|449323583|FG002|Part 1|Study Terminated by Sponsor|0|||
124917004|NCT03584516|449323584|FG003|Part 1|Study Terminated by Sponsor|0|||
124917005|NCT03584516|449323585|FG004|Part 1|Study Terminated by Sponsor|0|||
124917006|NCT03584516|449323586|FG005|Part 1|Study Terminated by Sponsor|0|||
124917007|NCT03584516|449323581|FG000|Part 1 Expansion|Death|0|||
124917008|NCT03584516|449323582|FG001|Part 1 Expansion|Death|0|||
124917009|NCT03584516|449323583|FG002|Part 1 Expansion|Death|9|||
124917010|NCT03584516|449323584|FG003|Part 1 Expansion|Death|8|||
124917011|NCT03584516|449323585|FG004|Part 1 Expansion|Death|4|||
124917012|NCT03584516|449323586|FG005|Part 1 Expansion|Death|5|||
124917013|NCT03584516|449323581|FG000|Part 1 Expansion|Lost to Follow-up|0|||
124917014|NCT03584516|449323582|FG001|Part 1 Expansion|Lost to Follow-up|0|||
124917015|NCT03584516|449323583|FG002|Part 1 Expansion|Lost to Follow-up|0|||
124917016|NCT03584516|449323584|FG003|Part 1 Expansion|Lost to Follow-up|1|||
124917017|NCT03584516|449323585|FG004|Part 1 Expansion|Lost to Follow-up|0|||
124917018|NCT03584516|449323586|FG005|Part 1 Expansion|Lost to Follow-up|0|||
124917019|NCT03584516|449323581|FG000|Part 1 Expansion|Physician Decision|0|||
124917020|NCT03584516|449323582|FG001|Part 1 Expansion|Physician Decision|0|||
124917021|NCT03584516|449323583|FG002|Part 1 Expansion|Physician Decision|4|||
124917022|NCT03584516|449323584|FG003|Part 1 Expansion|Physician Decision|3|||
124917023|NCT03584516|449323585|FG004|Part 1 Expansion|Physician Decision|2|||
124917024|NCT03584516|449323586|FG005|Part 1 Expansion|Physician Decision|3|||
124917025|NCT03584516|449323581|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
124917026|NCT03584516|449323582|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
124917027|NCT03584516|449323583|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
124917028|NCT03584516|449323584|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
124917029|NCT03584516|449323585|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
124917030|NCT03584516|449323586|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
124917031|NCT03584516|449323581|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
124917032|NCT03584516|449323582|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
124917033|NCT03584516|449323583|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
124917034|NCT03584516|449323584|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
124917035|NCT03584516|449323585|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
124917036|NCT03584516|449323586|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
124917037|NCT03584516|449323581|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
124917038|NCT03584516|449323582|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
124917039|NCT03584516|449323583|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
124917040|NCT03584516|449323584|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
124917041|NCT03584516|449323585|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
124917042|NCT03584516|449323586|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
124917043|NCT03584516|449323581|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
124917044|NCT03584516|449323582|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
124917045|NCT03584516|449323583|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
124917046|NCT03584516|449323584|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
124917047|NCT03584516|449323585|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
124917048|NCT03584516|449323586|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
124917049|NCT04868110|449323588|FG000|Overall Study|Withdrawal by Subject|3|||
124917050|NCT04868110|449323589|FG001|Overall Study|Withdrawal by Subject|4|||
124917051|NCT04511702|449323598|FG000|Overall Study|Lost to Follow-up|3|||
124917052|NCT04511702|449323599|FG001|Overall Study|Lost to Follow-up|0|||
124917053|NCT04511702|449323600|FG002|Overall Study|Lost to Follow-up|4|||
124917054|NCT04511702|449323598|FG000|Overall Study|Withdrawal by Subject|17|||
124917055|NCT04511702|449323599|FG001|Overall Study|Withdrawal by Subject|1|||
124917056|NCT04511702|449323600|FG002|Overall Study|Withdrawal by Subject|8|||
124917057|NCT01894061|449323601|FG000|Overall Study|Screen failure|1|||
124917058|NCT01894061|449323601|FG000|Overall Study|Withdrawal by Subject|1|||
124917059|NCT02840474|449323604|FG000|Overall Study|Lost to Follow-up|1|||
124917060|NCT02840474|449323605|FG001|Overall Study|Lost to Follow-up|0|||
124917061|NCT03192891|449323606|FG000|Overall Study|Lost to Follow-up|55|||
124917062|NCT05141903|449323607|FG000|Overall Study|Withdrawal by Subject|0|||
124917063|NCT05141903|449323608|FG001|Overall Study|Withdrawal by Subject|1|||
124917064|NCT05141903|449323609|FG002|Overall Study|Withdrawal by Subject|1|||
124917065|NCT05141903|449323610|FG003|Overall Study|Withdrawal by Subject|0|||
124917066|NCT05141903|449323611|FG004|Overall Study|Withdrawal by Subject|0|||
124917067|NCT05141903|449323607|FG000|Overall Study|Other|1|||
124917068|NCT05141903|449323608|FG001|Overall Study|Other|1|||
124917069|NCT05141903|449323609|FG002|Overall Study|Other|0|||
124917070|NCT05141903|449323610|FG003|Overall Study|Other|0|||
124917071|NCT05141903|449323611|FG004|Overall Study|Other|0|||
124917072|NCT03089398|449323614|FG000|Overall Study|Death|4|||
124917073|NCT03089398|449323615|FG001|Overall Study|Death|9|||
124917074|NCT03089398|449323614|FG000|Overall Study|Lost to Follow-up|21|||
124917075|NCT03089398|449323615|FG001|Overall Study|Lost to Follow-up|30|||
124917076|NCT03089398|449323614|FG000|Overall Study|Withdrawal by Subject|2|||
124917077|NCT03089398|449323615|FG001|Overall Study|Withdrawal by Subject|2|||
124917078|NCT05062265|449323616|FG000|Overall Study|Withdrawal by Subject|1|||
124917079|NCT05062265|449323617|FG001|Overall Study|Withdrawal by Subject|0|||
124917080|NCT05439603|449323618|FG000|Overall Study|met withdrawal criteria|2|||
124917081|NCT02682316|449323621|FG000|Overall Study|Benign Final Pathology|27|||
124917082|NCT02682316|449323622|FG001|Overall Study|Benign Final Pathology|26|||
124917083|NCT02682316|449323621|FG000|Overall Study|Reoperation before 30 days|7|||
124917084|NCT02682316|449323622|FG001|Overall Study|Reoperation before 30 days|6|||
124917085|NCT02682316|449323621|FG000|Overall Study|Ineligible|1|||
124917086|NCT02682316|449323622|FG001|Overall Study|Ineligible|0|||
124917087|NCT02682316|449323621|FG000|Overall Study|Death|1|||
124917088|NCT02682316|449323622|FG001|Overall Study|Death|0|||
124917089|NCT02682316|449323621|FG000|Overall Study|Lost to Follow-up|7|||
124917090|NCT02682316|449323622|FG001|Overall Study|Lost to Follow-up|3|||
124917091|NCT05927753|449323624|FG000|Overall Study|Withdrawal by Subject|0|||
124917092|NCT05927753|449323625|FG001|Overall Study|Withdrawal by Subject|2|||
124917093|NCT05927753|449323624|FG000|Overall Study|Physician Decision|0|||
124917094|NCT05927753|449323625|FG001|Overall Study|Physician Decision|1|||
124917095|NCT00150813|449323626|FG000|Overall Study|Adverse Event|1|||
124917096|NCT00150813|449323626|FG000|Overall Study|Lack of Efficacy|1|||
124917097|NCT00150813|449323626|FG000|Overall Study|Lost to Follow-up|5|||
124917098|NCT00150813|449323626|FG000|Overall Study|Withdrawal by Subject|5|||
124917099|NCT00150813|449323626|FG000|Overall Study|Remission|3|||
124917100|NCT00150813|449323626|FG000|Overall Study|Planned pregancy|1|||
124917101|NCT00150813|449323626|FG000|Overall Study|Switch to commercially available LEV|2|||
124917102|NCT03052608|449323628|FG000|Treatment Phase|Adverse Event|10|||
124917103|NCT03052608|449323629|FG001|Treatment Phase|Adverse Event|12|||
124917104|NCT03052608|449323628|FG000|Treatment Phase|Death|6|||
124917105|NCT03052608|449323629|FG001|Treatment Phase|Death|4|||
124917106|NCT03052608|449323628|FG000|Treatment Phase|Withdrawal by Subject|4|||
124917107|NCT03052608|449323629|FG001|Treatment Phase|Withdrawal by Subject|12|||
124917108|NCT03052608|449323628|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
124917109|NCT03052608|449323629|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
124917110|NCT03052608|449323628|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
124917111|NCT03052608|449323629|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
124917112|NCT03052608|449323628|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
124917113|NCT03052608|449323629|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
124917114|NCT03052608|449323628|FG000|Treatment Phase|Ongoing|103|||
124917115|NCT03052608|449323629|FG001|Treatment Phase|Ongoing|31|||
124917116|NCT03052608|449323628|FG000|Long-Term Follow-up Phase|Death|23|||
124917117|NCT03052608|449323629|FG001|Long-Term Follow-up Phase|Death|28|||
124917118|NCT03052608|449323628|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
124917119|NCT03052608|449323629|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
124917120|NCT03052608|449323628|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
124917121|NCT03052608|449323629|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
124917122|NCT03052608|449323628|FG000|Long-Term Follow-up Phase|Ongoing|122|||
124917123|NCT03052608|449323629|FG001|Long-Term Follow-up Phase|Ongoing|99|||
124917124|NCT03113500|449323630|FG000|Overall Study|Withdrawal by Subject|1|||
124917125|NCT04820855|449323634|FG000|Overall Study|Lost to Follow-up|6|||
124917126|NCT04820855|449323635|FG001|Overall Study|Lost to Follow-up|9|||
124917127|NCT00650104|449323645|FG000|Overall Study|Adverse Event|17|||
124917128|NCT00650104|449323645|FG000|Overall Study|Death|2|||
124917129|NCT00650104|449323645|FG000|Overall Study|Withdrawal by Subject|11|||
124917130|NCT00650104|449323645|FG000|Overall Study|Physician Decision|7|||
124917131|NCT00650104|449323645|FG000|Overall Study|Lost to Follow-up|1|||
124917132|NCT00650104|449323645|FG000|Overall Study|Non-compliance|2|||
124917133|NCT00650104|449323645|FG000|Overall Study|Sponsor Terminated Dosing|1|||
124917134|NCT00931710|449323646|FG000|Overall Study|Adverse Event|16|||
124917135|NCT00931710|449323647|FG001|Overall Study|Adverse Event|10|||
124917136|NCT00931710|449323646|FG000|Overall Study|Abnormal test procedure results|2|||
124917137|NCT00931710|449323647|FG001|Overall Study|Abnormal test procedure results|0|||
124917138|NCT00931710|449323646|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
124917139|NCT00931710|449323647|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
124917140|NCT00931710|449323646|FG000|Overall Study|Patient withdrew consent|4|||
124917141|NCT00931710|449323647|FG001|Overall Study|Patient withdrew consent|9|||
124917142|NCT00931710|449323646|FG000|Overall Study|Lost to Follow-up|6|||
124917143|NCT00931710|449323647|FG001|Overall Study|Lost to Follow-up|5|||
124917144|NCT00931710|449323646|FG000|Overall Study|Protocol deviation|1|||
124917145|NCT00931710|449323647|FG001|Overall Study|Protocol deviation|2|||
124917146|NCT01376700|449323648|FG000|Overall Study|Sponsor terminated study early|8|||
124917147|NCT01376700|449323648|FG000|Overall Study|Low or high titer inhibitor|8|||
124917148|NCT00601900|449323660|FG000|Overall Study|Withdrawal by Subject|0|||
124917149|NCT00601900|449323661|FG001|Overall Study|Withdrawal by Subject|3|||
124917150|NCT02140645|449323667|FG000|Overall Study|Not linked|5489|||
124917151|NCT02140645|449323668|FG001|Overall Study|Not linked|61654|||
124917152|NCT02140645|449323669|FG002|Overall Study|Not linked|4236|||
124917153|NCT02140645|449323670|FG003|Overall Study|Not linked|13833|||
124917154|NCT02140645|449323671|FG004|Overall Study|Not linked|3286|||
124917155|NCT02140645|449323672|FG005|Overall Study|Not linked|70896|||
124917156|NCT00593489|449323676|FG000|Allocation|did not attend workshop; allocation not|2|||
124917157|NCT00593489|449323677|FG001|Allocation|did not attend workshop; allocation not|1|||
124917158|NCT00611559|449323678|FG000|Overall Study|Lost to Follow-up|0|||
124917159|NCT00611559|449323679|FG001|Overall Study|Lost to Follow-up|1|||
124917160|NCT00611559|449323680|FG002|Overall Study|Lost to Follow-up|0|||
124917161|NCT00611559|449323678|FG000|Overall Study|Protocol Violation|1|||
124917162|NCT00611559|449323679|FG001|Overall Study|Protocol Violation|0|||
124917163|NCT00611559|449323680|FG002|Overall Study|Protocol Violation|1|||
124917164|NCT04442126|449323681|FG000|Overall Study|Withdrawal by Subject|0|||
124917165|NCT04442126|449323682|FG001|Overall Study|Withdrawal by Subject|0|||
124917166|NCT04442126|449323683|FG002|Overall Study|Withdrawal by Subject|0|||
124917167|NCT04442126|449323684|FG003|Overall Study|Withdrawal by Subject|2|||
124917168|NCT04442126|449323685|FG004|Overall Study|Withdrawal by Subject|1|||
124917169|NCT04442126|449323686|FG005|Overall Study|Withdrawal by Subject|0|||
124917170|NCT04442126|449323687|FG006|Overall Study|Withdrawal by Subject|1|||
124917171|NCT04442126|449323688|FG007|Overall Study|Withdrawal by Subject|1|||
124917172|NCT04442126|449323689|FG008|Overall Study|Withdrawal by Subject|3|||
124917173|NCT04442126|449323681|FG000|Overall Study|Death|1|||
124917174|NCT04442126|449323682|FG001|Overall Study|Death|0|||
124917175|NCT04442126|449323683|FG002|Overall Study|Death|0|||
124917176|NCT04442126|449323684|FG003|Overall Study|Death|1|||
124917177|NCT04442126|449323685|FG004|Overall Study|Death|2|||
124917178|NCT04442126|449323686|FG005|Overall Study|Death|2|||
124917179|NCT04442126|449323687|FG006|Overall Study|Death|4|||
124917180|NCT04442126|449323688|FG007|Overall Study|Death|1|||
124917181|NCT04442126|449323689|FG008|Overall Study|Death|5|||
124917182|NCT04442126|449323681|FG000|Overall Study|Study Terminated by Sponsor|0|||
124917183|NCT04442126|449323682|FG001|Overall Study|Study Terminated by Sponsor|0|||
124917184|NCT04442126|449323683|FG002|Overall Study|Study Terminated by Sponsor|0|||
124917185|NCT04442126|449323684|FG003|Overall Study|Study Terminated by Sponsor|0|||
124917186|NCT04442126|449323685|FG004|Overall Study|Study Terminated by Sponsor|0|||
124917187|NCT04442126|449323686|FG005|Overall Study|Study Terminated by Sponsor|1|||
125022769|NCT03042468|449707830|FG000|Overall Study|Death|0|||
124917188|NCT04442126|449323687|FG006|Overall Study|Study Terminated by Sponsor|4|||
124917189|NCT04442126|449323688|FG007|Overall Study|Study Terminated by Sponsor|2|||
124917190|NCT04442126|449323689|FG008|Overall Study|Study Terminated by Sponsor|10|||
124917191|NCT04442126|449323681|FG000|Overall Study|Lost to Follow-up|0|||
124917192|NCT04442126|449323682|FG001|Overall Study|Lost to Follow-up|0|||
124917193|NCT04442126|449323683|FG002|Overall Study|Lost to Follow-up|0|||
124917194|NCT04442126|449323684|FG003|Overall Study|Lost to Follow-up|0|||
124917195|NCT04442126|449323685|FG004|Overall Study|Lost to Follow-up|0|||
124917196|NCT04442126|449323686|FG005|Overall Study|Lost to Follow-up|0|||
124917197|NCT04442126|449323687|FG006|Overall Study|Lost to Follow-up|0|||
124917198|NCT04442126|449323688|FG007|Overall Study|Lost to Follow-up|1|||
124917199|NCT04442126|449323689|FG008|Overall Study|Lost to Follow-up|2|||
124917200|NCT04442126|449323681|FG000|Overall Study|Progressive Disease|0|||
124917201|NCT04442126|449323682|FG001|Overall Study|Progressive Disease|1|||
124917202|NCT04442126|449323683|FG002|Overall Study|Progressive Disease|3|||
124917203|NCT04442126|449323684|FG003|Overall Study|Progressive Disease|0|||
124917204|NCT04442126|449323685|FG004|Overall Study|Progressive Disease|3|||
124917205|NCT04442126|449323686|FG005|Overall Study|Progressive Disease|0|||
124917206|NCT04442126|449323687|FG006|Overall Study|Progressive Disease|0|||
124917207|NCT04442126|449323688|FG007|Overall Study|Progressive Disease|0|||
124917208|NCT04442126|449323689|FG008|Overall Study|Progressive Disease|0|||
124917209|NCT04442126|449323681|FG000|Overall Study|Other|0|||
124917210|NCT04442126|449323682|FG001|Overall Study|Other|0|||
124917211|NCT04442126|449323683|FG002|Overall Study|Other|0|||
124917212|NCT04442126|449323684|FG003|Overall Study|Other|0|||
124917213|NCT04442126|449323685|FG004|Overall Study|Other|0|||
124917214|NCT04442126|449323686|FG005|Overall Study|Other|0|||
124917215|NCT04442126|449323687|FG006|Overall Study|Other|0|||
124917216|NCT04442126|449323688|FG007|Overall Study|Other|0|||
124917217|NCT04442126|449323689|FG008|Overall Study|Other|1|||
124917218|NCT06450405|449323690|FG000|Overall Study|Study funding terminated.|0|||
124917219|NCT06450405|449323691|FG001|Overall Study|Study funding terminated.|2|||
124917220|NCT03424811|449325169|FG000|Overall Study|Lost to Follow-up|9|||
124917221|NCT03424811|449325170|FG001|Overall Study|Lost to Follow-up|0|||
124917222|NCT02728557|449325182|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
124917223|NCT02728557|449325183|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
124917224|NCT02728557|449325182|FG000|Overall Study|Dissatisfaction with research tasks|0|||
124917225|NCT02728557|449325183|FG001|Overall Study|Dissatisfaction with research tasks|1|||
124917226|NCT02728557|449325182|FG000|Overall Study|Scheduling or change in availability|1|||
124917227|NCT02728557|449325183|FG001|Overall Study|Scheduling or change in availability|1|||
124917228|NCT03416010|449325184|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
124917229|NCT03416010|449325185|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
124917230|NCT03416010|449325184|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
124917231|NCT03416010|449325185|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
124917232|NCT03416010|449325184|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
124917233|NCT03416010|449325185|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
124917234|NCT03416010|449325184|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
124917235|NCT03416010|449325185|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
124917236|NCT03416010|449325184|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
124917237|NCT03416010|449325185|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
124917238|NCT03416010|449325184|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
124917239|NCT03416010|449325185|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
124917240|NCT03416010|449325184|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
124917241|NCT03416010|449325185|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
124917242|NCT03819686|449325190|FG000|Overall Study|Lost to Follow-up|2|||
124917243|NCT03819686|449325191|FG001|Overall Study|Lost to Follow-up|3|||
124917244|NCT01938547|449325203|FG000|Overall Study|Physician Decision|1|||
124917245|NCT05038566|449325204|FG000|Overall Study|Technical Difficulties with the Device|0|||
124917246|NCT05038566|449325205|FG001|Overall Study|Technical Difficulties with the Device|1|||
124917247|NCT04842643|449325206|FG000|Overall Study|Physician Decision|1|||
124917248|NCT04842643|449325206|FG000|Overall Study|Other|1|||
124917249|NCT00739648|449325209|FG000|Overall Study|Adverse Event|3|||
124917250|NCT00739648|449325210|FG001|Overall Study|Adverse Event|15|||
124917251|NCT00739648|449325209|FG000|Overall Study|Withdrawal by Subject|13|||
124917252|NCT00739648|449325210|FG001|Overall Study|Withdrawal by Subject|25|||
124917253|NCT00739648|449325209|FG000|Overall Study|Lost to Follow-up|4|||
124917254|NCT00739648|449325210|FG001|Overall Study|Lost to Follow-up|7|||
124917255|NCT00739648|449325209|FG000|Overall Study|Death|2|||
124917256|NCT00739648|449325210|FG001|Overall Study|Death|0|||
124917257|NCT00739648|449325209|FG000|Overall Study|Do not know|4|||
124917258|NCT00739648|449325210|FG001|Overall Study|Do not know|6|||
124917259|NCT01757665|449325211|FG000|Overall Study|Still on Study - Visit Completed|240|||
124917260|NCT01757665|449325212|FG001|Overall Study|Still on Study - Visit Completed|30|||
124917261|NCT01757665|449325211|FG000|Overall Study|Still on Study - Visit Pending|398|||
124917262|NCT01757665|449325212|FG001|Overall Study|Still on Study - Visit Pending|40|||
124917263|NCT01757665|449325211|FG000|Overall Study|Still on Study - Missed Visit|14|||
124917264|NCT01757665|449325212|FG001|Overall Study|Still on Study - Missed Visit|1|||
124917265|NCT01757665|449325211|FG000|Overall Study|Death|25|||
124917266|NCT01757665|449325212|FG001|Overall Study|Death|8|||
124917267|NCT01757665|449325211|FG000|Overall Study|Explant|1|||
124917268|NCT01757665|449325212|FG001|Overall Study|Explant|2|||
124917269|NCT01757665|449325211|FG000|Overall Study|Withdrawal by Subject|10|||
124917270|NCT01757665|449325212|FG001|Overall Study|Withdrawal by Subject|0|||
124917271|NCT01757665|449325211|FG000|Overall Study|Lost to Follow-up|1|||
124917272|NCT01757665|449325212|FG001|Overall Study|Lost to Follow-up|1|||
124917273|NCT01757665|449325211|FG000|Overall Study|Not Implanted with Device|5|||
124917274|NCT01757665|449325212|FG001|Overall Study|Not Implanted with Device|1|||
124917275|NCT05387447|449325214|FG000|Overall Study|Participants changed their minds about study participation.|3|||
124917276|NCT05387447|449325215|FG001|Overall Study|Participants changed their minds about study participation.|5|||
124917277|NCT03391466|449325218|FG000|Overall Study|Death|82|||
124917278|NCT03391466|449325219|FG001|Overall Study|Death|85|||
124917279|NCT03391466|449325218|FG000|Overall Study|Still on study|93|||
124917280|NCT03391466|449325219|FG001|Overall Study|Still on study|74|||
124917281|NCT03391466|449325218|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
124917282|NCT03391466|449325219|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
124917283|NCT03391466|449325218|FG000|Overall Study|Lost to Follow-up|5|||
124917284|NCT03391466|449325219|FG001|Overall Study|Lost to Follow-up|5|||
125022770|NCT03042468|449707831|FG001|Overall Study|Death|1|||
124917285|NCT03391466|449325218|FG000|Overall Study|Investigator decision|0|||
124917286|NCT03391466|449325219|FG001|Overall Study|Investigator decision|1|||
124917287|NCT03391466|449325218|FG000|Overall Study|Other|0|||
124917288|NCT03391466|449325219|FG001|Overall Study|Other|1|||
124917289|NCT03655132|449325220|FG000|Overall Study|Lost to Follow-up|2|||
124917290|NCT03655132|449325221|FG001|Overall Study|Lost to Follow-up|1|||
124917291|NCT03655132|449325220|FG000|Overall Study|Withdrawal by Subject|0|||
124917292|NCT03655132|449325221|FG001|Overall Study|Withdrawal by Subject|1|||
124917293|NCT03655132|449325220|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
124917294|NCT03655132|449325221|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
124917295|NCT05919082|449325225|FG000|Overall Study|Adverse Event|3|||
124917296|NCT05919082|449325226|FG001|Overall Study|Adverse Event|0|||
124917297|NCT05919082|449325225|FG000|Overall Study|Lost to Follow-up|0|||
124917298|NCT05919082|449325226|FG001|Overall Study|Lost to Follow-up|1|||
124917299|NCT05919082|449325225|FG000|Overall Study|Withdrawal by Subject|8|||
124917300|NCT05919082|449325226|FG001|Overall Study|Withdrawal by Subject|9|||
124917301|NCT05919082|449325225|FG000|Overall Study|Lack of Efficacy|0|||
124917302|NCT05919082|449325226|FG001|Overall Study|Lack of Efficacy|1|||
124917303|NCT05919082|449325225|FG000|Overall Study|Investigator Decision|1|||
124917304|NCT05919082|449325226|FG001|Overall Study|Investigator Decision|0|||
124917305|NCT04703322|449325232|FG000|Overall Study|Ongoing|8|||
124917306|NCT04703322|449325232|FG000|Overall Study|Withdrawal by Subject|1|||
124917307|NCT06311084|449325233|FG000|Overall Study|Lost to Follow-up|14|||
124917308|NCT05249439|449325239|FG000|Overall Study|Withdrawal by Subject|2|||
124917309|NCT05249439|449325240|FG001|Overall Study|Withdrawal by Subject|5|||
124917310|NCT05249439|449325239|FG000|Overall Study|Physician Decision|3|||
124917311|NCT05249439|449325240|FG001|Overall Study|Physician Decision|1|||
124917312|NCT01707030|449325241|FG000|Overall Study|Death|1|||
124917313|NCT01707030|449325242|FG001|Overall Study|Death|1|||
124917314|NCT01707030|449325241|FG000|Overall Study|Withdrawal by Subject|2|||
124917315|NCT01707030|449325242|FG001|Overall Study|Withdrawal by Subject|3|||
124917316|NCT01707030|449325241|FG000|Overall Study|Lost to Follow-up|8|||
124917317|NCT01707030|449325242|FG001|Overall Study|Lost to Follow-up|13|||
124917318|NCT03526861|449325243|FG000|Initial Treatment Period|Not dosed|1|||
124917319|NCT03526861|449325244|FG001|Initial Treatment Period|Not dosed|1|||
124917320|NCT03526861|449325245|FG002|Initial Treatment Period|Not dosed|1|||
124917321|NCT03526861|449325246|FG003|Initial Treatment Period|Not dosed|0|||
124917322|NCT03526861|449325247|FG004|Initial Treatment Period|Not dosed|0|||
124917323|NCT03526861|449325248|FG005|Initial Treatment Period|Not dosed|0|||
124917324|NCT03526861|449325249|FG006|Initial Treatment Period|Not dosed|0|||
124917325|NCT03526861|449325250|FG007|Initial Treatment Period|Not dosed|0|||
124917326|NCT03526861|449325251|FG008|Initial Treatment Period|Not dosed|0|||
124917327|NCT03526861|449325243|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
124917328|NCT03526861|449325244|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
124917329|NCT03526861|449325245|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
124917330|NCT03526861|449325246|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917331|NCT03526861|449325247|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917332|NCT03526861|449325248|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917333|NCT03526861|449325249|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917334|NCT03526861|449325250|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917335|NCT03526861|449325251|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917336|NCT03526861|449325243|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
124917337|NCT03526861|449325244|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
124917338|NCT03526861|449325245|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
124917339|NCT03526861|449325246|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
124917340|NCT03526861|449325247|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
124917341|NCT03526861|449325248|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
124917342|NCT03526861|449325249|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
124917343|NCT03526861|449325250|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
124917344|NCT03526861|449325251|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
124917345|NCT03526861|449325243|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917346|NCT03526861|449325244|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917347|NCT03526861|449325245|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917348|NCT03526861|449325246|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
124917349|NCT03526861|449325247|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
124917350|NCT03526861|449325248|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917351|NCT03526861|449325249|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
124917352|NCT03526861|449325250|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917353|NCT03526861|449325251|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917354|NCT03526861|449325243|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
124917355|NCT03526861|449325244|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
124917356|NCT03526861|449325245|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
124917357|NCT03526861|449325246|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
124917358|NCT03526861|449325247|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
124917359|NCT03526861|449325248|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
124917360|NCT03526861|449325249|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
124917361|NCT03526861|449325250|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
124917362|NCT03526861|449325251|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
124917363|NCT03526861|449325243|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917364|NCT03526861|449325244|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917365|NCT03526861|449325245|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917366|NCT03526861|449325246|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
124917367|NCT03526861|449325247|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917368|NCT03526861|449325248|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917369|NCT03526861|449325249|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917370|NCT03526861|449325250|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917371|NCT03526861|449325251|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917372|NCT03526861|449325243|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917373|NCT03526861|449325244|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917374|NCT03526861|449325245|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917375|NCT03526861|449325246|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917376|NCT03526861|449325247|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917377|NCT03526861|449325248|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917378|NCT03526861|449325249|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917379|NCT03526861|449325250|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917380|NCT03526861|449325251|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
124917381|NCT03526861|449325243|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
124917382|NCT03526861|449325244|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
124917383|NCT03526861|449325245|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
124917384|NCT03526861|449325246|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
124917385|NCT03526861|449325247|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
124969516|NCT03520075|449517410|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
124917386|NCT03526861|449325248|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
124917387|NCT03526861|449325249|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
124917388|NCT03526861|449325250|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
124917389|NCT03526861|449325251|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
124917390|NCT03526861|449325243|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917391|NCT03526861|449325244|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917392|NCT03526861|449325245|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917393|NCT03526861|449325246|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917394|NCT03526861|449325247|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917395|NCT03526861|449325248|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917396|NCT03526861|449325249|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917397|NCT03526861|449325250|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917398|NCT03526861|449325251|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
124917399|NCT05862870|449325252|FG000|Overall Study|Lost to Follow-up|3|||
124917400|NCT00274469|449325254|FG000|Overall Study|Death|63|||
124917401|NCT00274469|449325255|FG001|Overall Study|Death|74|||
124917402|NCT00274469|449325254|FG000|Overall Study|Did not consent to OS follow-up|16|||
124917403|NCT00274469|449325255|FG001|Overall Study|Did not consent to OS follow-up|19|||
124917404|NCT04095104|449325261|FG000|Overall Study|Withdrawal by Subject|0|||
124917405|NCT04095104|449325262|FG001|Overall Study|Withdrawal by Subject|1|||
124917406|NCT03912831|449325265|FG000|Overall Study|Death|1|||
124917407|NCT03912831|449325266|FG001|Overall Study|Death|1|||
124917408|NCT03912831|449325267|FG002|Overall Study|Death|1|||
124917409|NCT03912831|449325268|FG003|Overall Study|Death|1|||
124917410|NCT03912831|449325269|FG004|Overall Study|Death|1|||
124917411|NCT03912831|449325270|FG005|Overall Study|Death|1|||
124917412|NCT03912831|449325265|FG000|Overall Study|Reason not Specified|0|||
124917413|NCT03912831|449325266|FG001|Overall Study|Reason not Specified|0|||
124917414|NCT03912831|449325267|FG002|Overall Study|Reason not Specified|0|||
124917415|NCT03912831|449325268|FG003|Overall Study|Reason not Specified|0|||
124917416|NCT03912831|449325269|FG004|Overall Study|Reason not Specified|1|||
124917417|NCT03912831|449325270|FG005|Overall Study|Reason not Specified|0|||
124917418|NCT03912831|449325265|FG000|Overall Study|Withdrawal by Participant|0|||
124917419|NCT03912831|449325266|FG001|Overall Study|Withdrawal by Participant|0|||
124917420|NCT03912831|449325267|FG002|Overall Study|Withdrawal by Participant|0|||
124917421|NCT03912831|449325268|FG003|Overall Study|Withdrawal by Participant|0|||
124917422|NCT03912831|449325269|FG004|Overall Study|Withdrawal by Participant|1|||
124917423|NCT03912831|449325270|FG005|Overall Study|Withdrawal by Participant|0|||
124917424|NCT03527160|449325271|FG000|Overall Study|No urine collected|13|||
124917425|NCT03527160|449325271|FG000|Overall Study|No clinical serum creatinine collected|6|||
124917426|NCT03527160|449325271|FG000|Overall Study|Did not meet inclusion|2|||
124917427|NCT02910713|449325274|FG000|Overall Study|Protocol Violation|2|||
124917428|NCT02910713|449325274|FG000|Overall Study|Subject Choice|4|||
124917429|NCT02910713|449325274|FG000|Overall Study|Received One Application|10|||
124917430|NCT02910713|449325274|FG000|Overall Study|Received Neither Application|18|||
124917431|NCT02910713|449325274|FG000|Overall Study|Enrollment cap|7|||
124917432|NCT02910713|449325274|FG000|Overall Study|Investigator Discretion|1|||
124917433|NCT03767517|449325276|FG000|Overall Study|Lost to Follow-up|16|||
124917434|NCT03767517|449325277|FG001|Overall Study|Lost to Follow-up|10|||
124917435|NCT03767517|449325276|FG000|Overall Study|Death|2|||
124917436|NCT03767517|449325277|FG001|Overall Study|Death|3|||
124917437|NCT05792423|449325278|FG000|Overall Study|Withdrawal by Subject|2|||
124917438|NCT05338086|449326070|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
124917439|NCT05338086|449326071|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
124917440|NCT05338086|449326072|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
124917441|NCT05338086|449326073|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
124917442|NCT05338086|449326074|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
124917443|NCT05338086|449326070|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
124917444|NCT05338086|449326071|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
124917445|NCT05338086|449326072|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
124917446|NCT05338086|449326073|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
124917447|NCT05338086|449326074|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
124917448|NCT05338086|449326070|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
125022771|NCT03042468|449707832|FG002|Overall Study|Death|1|||
125022772|NCT03042468|449707833|FG003|Overall Study|Death|0|||
124917449|NCT05338086|449326071|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
124917450|NCT05338086|449326072|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
124917451|NCT05338086|449326073|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
124917452|NCT05338086|449326074|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
124917453|NCT05338086|449326070|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
124917454|NCT05338086|449326071|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
124917455|NCT05338086|449326072|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
124917456|NCT05338086|449326073|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
124917457|NCT05338086|449326074|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
124917458|NCT05338086|449326070|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
124917459|NCT05338086|449326071|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
124917460|NCT05338086|449326072|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
124917461|NCT05338086|449326073|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
124917462|NCT05338086|449326074|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
124917463|NCT05338086|449326070|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
124917464|NCT05338086|449326071|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
124917465|NCT05338086|449326072|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
124917466|NCT05338086|449326073|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
124917467|NCT05338086|449326074|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
124917468|NCT05338086|449326070|FG000|Transition Period (M12 to M18)|Death|0|||
124917469|NCT05338086|449326071|FG001|Transition Period (M12 to M18)|Death|0|||
124917470|NCT05338086|449326072|FG002|Transition Period (M12 to M18)|Death|1|||
124917471|NCT05338086|449326073|FG003|Transition Period (M12 to M18)|Death|0|||
124917472|NCT05338086|449326074|FG004|Transition Period (M12 to M18)|Death|0|||
124917473|NCT05338086|449326070|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
124917474|NCT05338086|449326071|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
124917475|NCT05338086|449326072|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
124917476|NCT05338086|449326073|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
124917477|NCT05338086|449326074|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
124917478|NCT05338086|449326070|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
124917479|NCT05338086|449326071|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
124917480|NCT05338086|449326072|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
124917481|NCT05338086|449326073|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
124917482|NCT05338086|449326074|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
124917483|NCT05338086|449326070|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
124917484|NCT05338086|449326071|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
124917485|NCT05338086|449326072|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
124917486|NCT05338086|449326073|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
124917487|NCT05338086|449326074|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
124917488|NCT04533022|449326075|FG000|Overall Study|Withdrawal by Subject|15|||
124917489|NCT04533022|449326075|FG000|Overall Study|Adverse Event|6|||
124917490|NCT04533022|449326075|FG000|Overall Study|Death|1|||
124917491|NCT04533022|449326075|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
124917492|NCT04533022|449326075|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
124917493|NCT02163447|449326076|FG000|Overall Study|Withdrawal by Subject|2|||
124917494|NCT02163447|449326077|FG001|Overall Study|Withdrawal by Subject|0|||
125116567|NCT00638157|450049870|FG000|Overall Study|Other|1|||
125116568|NCT00638157|450049871|FG001|Overall Study|Other|2|||
124917495|NCT02163447|449326078|FG002|Overall Study|Withdrawal by Subject|1|||
124917496|NCT02163447|449326076|FG000|Overall Study|Lost to Follow-up|1|||
124917497|NCT02163447|449326077|FG001|Overall Study|Lost to Follow-up|3|||
124917498|NCT02163447|449326078|FG002|Overall Study|Lost to Follow-up|0|||
124917499|NCT02163447|449326076|FG000|Overall Study|Moved out of study area|2|||
124917500|NCT02163447|449326077|FG001|Overall Study|Moved out of study area|3|||
124917501|NCT02163447|449326078|FG002|Overall Study|Moved out of study area|2|||
124917502|NCT02163447|449326076|FG000|Overall Study|Became HIV infected at time of delivery|1|||
124917503|NCT02163447|449326077|FG001|Overall Study|Became HIV infected at time of delivery|0|||
124917504|NCT02163447|449326078|FG002|Overall Study|Became HIV infected at time of delivery|0|||
124917505|NCT05113966|449326080|FG000|Overall Study|Death|21|||
124917506|NCT05113966|449326080|FG000|Overall Study|Study Terminated by Sponsor|9|||
124917507|NCT05386355|449326081|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
124917508|NCT05386355|449326082|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
124917509|NCT05386355|449326083|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
124917510|NCT05386355|449326084|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
124917511|NCT06143670|449326085|FG000|Overall Study|Lost to Follow-up|0|||
124917512|NCT06143670|449326086|FG001|Overall Study|Lost to Follow-up|1|||
124917513|NCT06143670|449326085|FG000|Overall Study|Withdrawal by Subject|3|||
124917514|NCT06143670|449326086|FG001|Overall Study|Withdrawal by Subject|0|||
124917515|NCT03747484|449326087|FG000|Overall Study|Lack of Efficacy|0|||
124917516|NCT03747484|449326088|FG001|Overall Study|Lack of Efficacy|1|||
124917517|NCT03747484|449326089|FG002|Overall Study|Lack of Efficacy|1|||
124917518|NCT03747484|449326090|FG003|Overall Study|Lack of Efficacy|2|||
124917519|NCT03747484|449326091|FG004|Overall Study|Lack of Efficacy|2|||
124917520|NCT03833245|449326092|FG000|Overall Study|Death|0|||
124917521|NCT03833245|449326093|FG001|Overall Study|Death|1|||
124917522|NCT03775109|449326094|FG000|Overall Study|Adverse Event|1|||
124917523|NCT03775109|449326095|FG001|Overall Study|Adverse Event|0|||
124917524|NCT03775109|449326094|FG000|Overall Study|COVID-19 outbreak|2|||
124917525|NCT03775109|449326095|FG001|Overall Study|COVID-19 outbreak|0|||
124917526|NCT03775109|449326094|FG000|Overall Study|Lost to Follow-up|0|||
124917527|NCT03775109|449326095|FG001|Overall Study|Lost to Follow-up|2|||
124917528|NCT03775109|449326094|FG000|Overall Study|Withdrawal by Subject|1|||
124917529|NCT03775109|449326095|FG001|Overall Study|Withdrawal by Subject|1|||
124917530|NCT03775109|449326094|FG000|Overall Study|Death|0|||
124917531|NCT03775109|449326095|FG001|Overall Study|Death|1|||
124917532|NCT03775109|449326094|FG000|Overall Study|Lack of Efficacy|1|||
124917533|NCT03775109|449326095|FG001|Overall Study|Lack of Efficacy|0|||
124917534|NCT03347383|449326096|FG000|Overall Study|Death|39|||
124917535|NCT03347383|449326096|FG000|Overall Study|Withdrawal by Subject|3|||
124917536|NCT03347383|449326096|FG000|Overall Study|Lost to Follow-up|9|||
124917537|NCT05691452|449326098|FG000|Overall Study|Withdrawal by Subject|1|||
124917538|NCT05691452|449326099|FG001|Overall Study|Withdrawal by Subject|1|||
124917539|NCT05691452|449326100|FG002|Overall Study|Withdrawal by Subject|0|||
124917540|NCT05691452|449326098|FG000|Overall Study|Physician Decision|1|||
124917541|NCT05691452|449326099|FG001|Overall Study|Physician Decision|0|||
124917542|NCT05691452|449326100|FG002|Overall Study|Physician Decision|0|||
124917543|NCT05691452|449326098|FG000|Overall Study|Lost to Follow-up|0|||
124917544|NCT05691452|449326099|FG001|Overall Study|Lost to Follow-up|0|||
124917545|NCT05691452|449326100|FG002|Overall Study|Lost to Follow-up|1|||
124917546|NCT05691452|449326098|FG000|Overall Study|Adverse Event|0|||
124917547|NCT05691452|449326099|FG001|Overall Study|Adverse Event|0|||
124917548|NCT05691452|449326100|FG002|Overall Study|Adverse Event|1|||
124917549|NCT05110495|449326103|FG000|Overall Study|Lost to Follow-up|1|||
124917550|NCT05110495|449326103|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
124917551|NCT04716634|449326106|FG000|Overall Study|Death|24|||
124917552|NCT04716634|449326107|FG001|Overall Study|Death|24|||
124917553|NCT04716634|449326108|FG002|Overall Study|Death|8|||
124917554|NCT04716634|449326106|FG000|Overall Study|Closed by Sponsor|4|||
124917555|NCT04716634|449326107|FG001|Overall Study|Closed by Sponsor|4|||
124917556|NCT04716634|449326108|FG002|Overall Study|Closed by Sponsor|5|||
124917557|NCT04716634|449326106|FG000|Overall Study|Lost to Follow-up|1|||
124917558|NCT04716634|449326107|FG001|Overall Study|Lost to Follow-up|0|||
124917559|NCT04716634|449326108|FG002|Overall Study|Lost to Follow-up|1|||
125116569|NCT00638157|450049870|FG000|Overall Study|Randomized, not treated|2|||
125116570|NCT00638157|450049871|FG001|Overall Study|Randomized, not treated|0|||
124917560|NCT04716634|449326106|FG000|Overall Study|Withdrawal by Subject|0|||
124917561|NCT04716634|449326107|FG001|Overall Study|Withdrawal by Subject|0|||
124917562|NCT04716634|449326108|FG002|Overall Study|Withdrawal by Subject|1|||
124917563|NCT04593472|449326112|FG000|Overall Study|Death|31|||
124917564|NCT04593472|449326113|FG001|Overall Study|Death|27|||
124917565|NCT04593472|449326112|FG000|Overall Study|Withdrawal by Subject|12|||
124917566|NCT04593472|449326113|FG001|Overall Study|Withdrawal by Subject|12|||
124917567|NCT04593472|449326112|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
125131396|NCT03818581|450109960|FG000|Overall Study|Covid-19|2|||
124917568|NCT04593472|449326113|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
124917569|NCT04593472|449326112|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
124917570|NCT04593472|449326113|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
124917571|NCT04593472|449326112|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
124917572|NCT04593472|449326113|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
124917573|NCT04593472|449326112|FG000|Overall Study|Lost to Follow-up|0|||
124917574|NCT04593472|449326113|FG001|Overall Study|Lost to Follow-up|2|||
124917575|NCT04593472|449326112|FG000|Overall Study|Still collecting 24-month assessment|17|||
124917576|NCT04593472|449326113|FG001|Overall Study|Still collecting 24-month assessment|10|||
124917577|NCT04538417|449326115|FG000|Overall Study|Withdrawal by Subject|2|||
124917578|NCT04549168|449326119|FG000|Randomization Phase|Adverse Event|0|||
124917579|NCT04549168|449326120|FG001|Randomization Phase|Adverse Event|0|||
124917580|NCT04549168|449326121|FG002|Randomization Phase|Adverse Event|1|||
124917581|NCT04549168|449326119|FG000|Randomization Phase|Other|0|||
124917582|NCT04549168|449326120|FG001|Randomization Phase|Other|2|||
124917583|NCT04549168|449326121|FG002|Randomization Phase|Other|0|||
124917584|NCT04549168|449326119|FG000|Randomization Phase|Withdrawal by Subject|0|||
124917585|NCT04549168|449326120|FG001|Randomization Phase|Withdrawal by Subject|2|||
124917586|NCT04549168|449326121|FG002|Randomization Phase|Withdrawal by Subject|1|||
124917587|NCT03988634|449326125|FG000|Double-Blind|Adverse Event|4|||
124917588|NCT03988634|449326126|FG001|Double-Blind|Adverse Event|0|||
124917589|NCT03988634|449326127|FG002|Double-Blind|Adverse Event|0|||
124917590|NCT03988634|449326125|FG000|Double-Blind|Death|18|||
124917591|NCT03988634|449326126|FG001|Double-Blind|Death|26|||
124917592|NCT03988634|449326127|FG002|Double-Blind|Death|0|||
124917593|NCT03988634|449326125|FG000|Double-Blind|Lost to Follow-up|6|||
124917594|NCT03988634|449326126|FG001|Double-Blind|Lost to Follow-up|7|||
124917595|NCT03988634|449326127|FG002|Double-Blind|Lost to Follow-up|0|||
124917596|NCT03988634|449326125|FG000|Double-Blind|Physician Decision|9|||
124917597|NCT03988634|449326126|FG001|Double-Blind|Physician Decision|5|||
124917598|NCT03988634|449326127|FG002|Double-Blind|Physician Decision|0|||
124917599|NCT03988634|449326125|FG000|Double-Blind|Subject decision|24|||
124917600|NCT03988634|449326126|FG001|Double-Blind|Subject decision|13|||
124917601|NCT03988634|449326127|FG002|Double-Blind|Subject decision|0|||
124917602|NCT03988634|449326125|FG000|Open-Label|Adverse Event|0|||
124917603|NCT03988634|449326126|FG001|Open-Label|Adverse Event|0|||
124917604|NCT03988634|449326127|FG002|Open-Label|Adverse Event|7|||
124917605|NCT03988634|449326125|FG000|Open-Label|Physician Decision|0|||
124917606|NCT03988634|449326126|FG001|Open-Label|Physician Decision|0|||
124917607|NCT03988634|449326127|FG002|Open-Label|Physician Decision|1|||
124917608|NCT03988634|449326125|FG000|Open-Label|Technical problems|0|||
124917609|NCT03988634|449326126|FG001|Open-Label|Technical problems|0|||
124917610|NCT03988634|449326127|FG002|Open-Label|Technical problems|1|||
124917611|NCT04725240|449326128|FG000|Overall Study|Adverse Event|2|||
124917612|NCT02249949|449326129|FG000|Overall Study|Cancelled prior to treatment|2|||
124917613|NCT02867384|449326132|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
124917614|NCT02867384|449326133|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
124917615|NCT02867384|449326134|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
124917616|NCT02867384|449326132|FG000|Overall Study|Progression/ Relapse|15|||
124917617|NCT02867384|449326133|FG001|Overall Study|Progression/ Relapse|19|||
124917618|NCT02867384|449326134|FG002|Overall Study|Progression/ Relapse|0|||
124917619|NCT02867384|449326132|FG000|Overall Study|Adverse Event|13|||
124917620|NCT02867384|449326133|FG001|Overall Study|Adverse Event|1|||
124917621|NCT02867384|449326134|FG002|Overall Study|Adverse Event|0|||
124917622|NCT02867384|449326132|FG000|Overall Study|Withdrawal by Subject|6|||
124917623|NCT02867384|449326133|FG001|Overall Study|Withdrawal by Subject|5|||
124917624|NCT02867384|449326134|FG002|Overall Study|Withdrawal by Subject|0|||
124917625|NCT02867384|449326132|FG000|Overall Study|Physician Decision|1|||
124917626|NCT02867384|449326133|FG001|Overall Study|Physician Decision|2|||
124917627|NCT02867384|449326134|FG002|Overall Study|Physician Decision|0|||
124917628|NCT02867384|449326132|FG000|Overall Study|Patient compliance|1|||
124917629|NCT02867384|449326133|FG001|Overall Study|Patient compliance|0|||
124917630|NCT02867384|449326134|FG002|Overall Study|Patient compliance|0|||
124917631|NCT02867384|449326132|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
124917632|NCT02867384|449326133|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
124917633|NCT02867384|449326134|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
125116571|NCT01851590|450049874|FG000|Overall Study|Withdrawal by Subject|0|||
125116572|NCT01851590|450049875|FG001|Overall Study|Withdrawal by Subject|0|||
125131397|NCT03818581|450109961|FG001|Overall Study|Covid-19|0|||
124917634|NCT02867384|449326132|FG000|Overall Study|Never start treatment|0|||
124917635|NCT02867384|449326133|FG001|Overall Study|Never start treatment|0|||
124917636|NCT02867384|449326134|FG002|Overall Study|Never start treatment|3|||
124917637|NCT05633407|449326142|FG000|Overall Study|Physician Decision|2|||
124917638|NCT05633407|449326143|FG001|Overall Study|Physician Decision|0|||
124917639|NCT05633407|449326142|FG000|Overall Study|Adverse Event|1|||
124917640|NCT05633407|449326143|FG001|Overall Study|Adverse Event|0|||
124917641|NCT05633407|449326142|FG000|Overall Study|Withdrawal by Subject|1|||
124917642|NCT05633407|449326143|FG001|Overall Study|Withdrawal by Subject|0|||
124917643|NCT05633407|449326142|FG000|Overall Study|Other|1|||
124917644|NCT05633407|449326143|FG001|Overall Study|Other|1|||
124917645|NCT02500758|449326144|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
124917646|NCT02500758|449326145|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
124917647|NCT02500758|449326144|FG000|Washout (1 Week)|Lost to Follow-up|2|||
124917648|NCT02500758|449326145|FG001|Washout (1 Week)|Lost to Follow-up|2|||
124917649|NCT02500758|449326144|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
124917650|NCT02500758|449326145|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
124917651|NCT02500758|449326144|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
124917652|NCT02500758|449326145|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
124917653|NCT02500758|449326144|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
124917654|NCT02500758|449326145|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
124917655|NCT04999592|449326148|FG000|Overall Study|Withdrawal by Subject|1|||
124917656|NCT04999592|449326149|FG001|Overall Study|Withdrawal by Subject|0|||
124917657|NCT05179395|449326150|FG000|Overall Study|Lack of Efficacy|1|||
124917658|NCT02471638|449326154|FG000|Overall Study|Early Term Withdrawal|10|||
124917659|NCT03940703|449327119|FG000|Overall Study|Still under treatment|31|||
124917660|NCT03940703|449327120|FG001|Overall Study|Still under treatment|0|||
124917661|NCT04521478|449327121|FG000|Overall Study|Protocol Violation|2|||
124917662|NCT04521478|449327122|FG001|Overall Study|Protocol Violation|0|||
124917663|NCT04521478|449327123|FG002|Overall Study|Protocol Violation|1|||
124917664|NCT04521478|449327124|FG003|Overall Study|Protocol Violation|0|||
124917665|NCT04521478|449327125|FG004|Overall Study|Protocol Violation|0|||
124917666|NCT04521478|449327126|FG005|Overall Study|Protocol Violation|0|||
124917667|NCT04521478|449327121|FG000|Overall Study|Technical Problems|0|||
124917668|NCT04521478|449327122|FG001|Overall Study|Technical Problems|0|||
124917669|NCT04521478|449327123|FG002|Overall Study|Technical Problems|0|||
124917670|NCT04521478|449327124|FG003|Overall Study|Technical Problems|1|||
124917671|NCT04521478|449327125|FG004|Overall Study|Technical Problems|0|||
124917672|NCT04521478|449327126|FG005|Overall Study|Technical Problems|0|||
124917673|NCT04521478|449327121|FG000|Overall Study|Burden of Study Procedures|1|||
125022773|NCT03042468|449707834|FG004|Overall Study|Death|0|||
125022774|NCT03042468|449707835|FG005|Overall Study|Death|0|||
125022775|NCT03042468|449707830|FG000|Overall Study|Withdrawal by Subject|0|||
125022776|NCT03042468|449707831|FG001|Overall Study|Withdrawal by Subject|0|||
125211815|NCT00055497|450401382|FG001|Overall Study|Withdrawal by Subject|1|||
124917674|NCT04521478|449327122|FG001|Overall Study|Burden of Study Procedures|0|||
125211816|NCT00055497|450401383|FG002|Overall Study|Withdrawal by Subject|1|||
125211817|NCT00055497|450401384|FG003|Overall Study|Withdrawal by Subject|15|||
124917675|NCT04521478|449327123|FG002|Overall Study|Burden of Study Procedures|0|||
124917676|NCT04521478|449327124|FG003|Overall Study|Burden of Study Procedures|1|||
124917677|NCT04521478|449327125|FG004|Overall Study|Burden of Study Procedures|0|||
124917678|NCT04521478|449327126|FG005|Overall Study|Burden of Study Procedures|1|||
124917679|NCT04521478|449327121|FG000|Overall Study|Lack of Efficacy|0|||
124917680|NCT04521478|449327122|FG001|Overall Study|Lack of Efficacy|0|||
124917681|NCT04521478|449327123|FG002|Overall Study|Lack of Efficacy|0|||
124917682|NCT04521478|449327124|FG003|Overall Study|Lack of Efficacy|0|||
124917683|NCT04521478|449327125|FG004|Overall Study|Lack of Efficacy|1|||
124917684|NCT04521478|449327126|FG005|Overall Study|Lack of Efficacy|1|||
124917685|NCT04521478|449327121|FG000|Overall Study|Adverse Event|7|||
124917686|NCT04521478|449327122|FG001|Overall Study|Adverse Event|0|||
124917687|NCT04521478|449327123|FG002|Overall Study|Adverse Event|2|||
124917688|NCT04521478|449327124|FG003|Overall Study|Adverse Event|1|||
124917689|NCT04521478|449327125|FG004|Overall Study|Adverse Event|2|||
124917690|NCT04521478|449327126|FG005|Overall Study|Adverse Event|7|||
124917691|NCT04521478|449327121|FG000|Overall Study|No Reason Available|0|||
124917692|NCT04521478|449327122|FG001|Overall Study|No Reason Available|2|||
124917693|NCT04521478|449327123|FG002|Overall Study|No Reason Available|0|||
124917694|NCT04521478|449327124|FG003|Overall Study|No Reason Available|0|||
124917695|NCT04521478|449327125|FG004|Overall Study|No Reason Available|1|||
124917696|NCT04521478|449327126|FG005|Overall Study|No Reason Available|0|||
125211818|NCT00055497|450401381|FG000|Overall Study|Lost to Follow-up|0|||
125211819|NCT00055497|450401382|FG001|Overall Study|Lost to Follow-up|1|||
125211820|NCT00055497|450401383|FG002|Overall Study|Lost to Follow-up|0|||
125211821|NCT00055497|450401384|FG003|Overall Study|Lost to Follow-up|5|||
125211822|NCT00055497|450401381|FG000|Overall Study|Protocol Violation|0|||
125211823|NCT00055497|450401382|FG001|Overall Study|Protocol Violation|0|||
125211824|NCT00055497|450401383|FG002|Overall Study|Protocol Violation|0|||
125211825|NCT00055497|450401384|FG003|Overall Study|Protocol Violation|3|||
125211826|NCT00055497|450401381|FG000|Overall Study|Lack of Efficacy|1|||
125211827|NCT00055497|450401382|FG001|Overall Study|Lack of Efficacy|0|||
125211828|NCT00055497|450401383|FG002|Overall Study|Lack of Efficacy|0|||
125211829|NCT00055497|450401384|FG003|Overall Study|Lack of Efficacy|27|||
125211830|NCT00055497|450401381|FG000|Overall Study|Administrative Reasons|0|||
125211831|NCT00055497|450401382|FG001|Overall Study|Administrative Reasons|0|||
125211832|NCT00055497|450401383|FG002|Overall Study|Administrative Reasons|0|||
124917697|NCT04521478|449327121|FG000|Overall Study|Other than listed|3|||
124917698|NCT04521478|449327122|FG001|Overall Study|Other than listed|3|||
125022777|NCT03042468|449707832|FG002|Overall Study|Withdrawal by Subject|0|||
125022778|NCT03042468|449707833|FG003|Overall Study|Withdrawal by Subject|0|||
125211833|NCT00055497|450401384|FG003|Overall Study|Administrative Reasons|1|||
124917699|NCT04521478|449327123|FG002|Overall Study|Other than listed|3|||
125211834|NCT00055497|450401381|FG000|Overall Study|Other|0|||
124917700|NCT04521478|449327124|FG003|Overall Study|Other than listed|2|||
124917701|NCT04521478|449327125|FG004|Overall Study|Other than listed|3|||
124917702|NCT04521478|449327126|FG005|Overall Study|Other than listed|3|||
124917703|NCT04521478|449327121|FG000|Overall Study|Not treated|0|||
124917704|NCT04521478|449327122|FG001|Overall Study|Not treated|0|||
124917705|NCT04521478|449327123|FG002|Overall Study|Not treated|0|||
124917706|NCT04521478|449327124|FG003|Overall Study|Not treated|0|||
124917707|NCT04521478|449327125|FG004|Overall Study|Not treated|0|||
124917708|NCT04521478|449327126|FG005|Overall Study|Not treated|1|||
124917709|NCT05320432|449327134|FG000|Overall Study|Withdrawal by Subject|0|||
124917710|NCT05320432|449327135|FG001|Overall Study|Withdrawal by Subject|2|||
124917711|NCT04173663|449327142|FG000|Overall Study|Withdrawal by Subject|1|||
124917712|NCT04173663|449327143|FG001|Overall Study|Withdrawal by Subject|6|||
124917713|NCT04173663|449327142|FG000|Overall Study|Lost to Follow-up|17|||
124917714|NCT04173663|449327143|FG001|Overall Study|Lost to Follow-up|24|||
124917715|NCT04850807|449327145|FG000|Overall Study|Death|50|||
124917716|NCT04850807|449327146|FG001|Overall Study|Death|55|||
124917717|NCT04850807|449327145|FG000|Overall Study|Discharged|17|||
124917718|NCT04850807|449327146|FG001|Overall Study|Discharged|13|||
124917719|NCT04850807|449327145|FG000|Overall Study|Incomplete baseline data|3|||
124917720|NCT04850807|449327146|FG001|Overall Study|Incomplete baseline data|2|||
124917721|NCT02187003|449327150|FG000|Overall Study|Adverse Event|2|||
124917722|NCT02187003|449327151|FG001|Overall Study|Adverse Event|0|||
124917723|NCT02187003|449327150|FG000|Overall Study|Lost to Follow-up|14|||
124917724|NCT02187003|449327151|FG001|Overall Study|Lost to Follow-up|10|||
124917725|NCT02187003|449327150|FG000|Overall Study|Withdrawal by Subject|3|||
124917726|NCT02187003|449327151|FG001|Overall Study|Withdrawal by Subject|7|||
124917727|NCT02187003|449327150|FG000|Overall Study|Protocol Violation|2|||
124917728|NCT02187003|449327151|FG001|Overall Study|Protocol Violation|4|||
124917729|NCT02187003|449327150|FG000|Overall Study|Other|5|||
124917730|NCT02187003|449327151|FG001|Overall Study|Other|5|||
124917731|NCT02187003|449327150|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
124917732|NCT02187003|449327151|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
124917733|NCT05816551|449327152|FG000|Overall Study|Withdrawal by Subject|0|||
124917734|NCT05816551|449327153|FG001|Overall Study|Withdrawal by Subject|1|||
124917735|NCT05816551|449327152|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
124917736|NCT05816551|449327153|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
124917737|NCT02630823|449327160|FG000|Overall Study|Withdrawal by Subject|1|||
124917738|NCT02630823|449327160|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
124917739|NCT04178733|449327161|FG000|Overall Study|Investigator Decision|0|||
124917740|NCT04178733|449327162|FG001|Overall Study|Investigator Decision|0|||
124917741|NCT04178733|449327163|FG002|Overall Study|Investigator Decision|0|||
124917742|NCT04178733|449327164|FG003|Overall Study|Investigator Decision|1|||
124917743|NCT04178733|449327165|FG004|Overall Study|Investigator Decision|2|||
124917744|NCT04833777|449327173|FG000|Overall Study|Lost to Follow-up|1|||
124917745|NCT04833777|449327174|FG001|Overall Study|Lost to Follow-up|0|||
124917746|NCT05461131|449327185|FG000|Overall Study|Lost to Follow-up|0|||
124917747|NCT05461131|449327186|FG001|Overall Study|Lost to Follow-up|2|||
124917748|NCT03896516|449327187|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
124917749|NCT03896516|449327188|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
124917750|NCT03896516|449327187|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
124917751|NCT03896516|449327188|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
124917752|NCT03896516|449327187|FG000|Washout Period|Physician Decision|3|||
124917753|NCT03896516|449327188|FG001|Washout Period|Physician Decision|1|||
124917754|NCT03896516|449327187|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
124917755|NCT03896516|449327188|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
124917756|NCT03648840|449327193|FG000|First IV Infusion Session|Adverse Event|0|||
124917757|NCT03648840|449327194|FG001|First IV Infusion Session|Adverse Event|2|||
124917758|NCT03648840|449327193|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
124917759|NCT03648840|449327194|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
124917760|NCT03648840|449327193|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
124917761|NCT03648840|449327194|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
124917762|NCT03648840|449327193|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
124917763|NCT03648840|449327194|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
124917764|NCT05382936|449327197|FG000|Overall Study|Progressive Disease|3|||
124917765|NCT05382936|449327198|FG001|Overall Study|Progressive Disease|5|||
124917766|NCT05382936|449327199|FG002|Overall Study|Progressive Disease|2|||
124917767|NCT05382936|449327200|FG003|Overall Study|Progressive Disease|5|||
124917768|NCT05382936|449327197|FG000|Overall Study|Adverse Event|0|||
124917769|NCT05382936|449327198|FG001|Overall Study|Adverse Event|1|||
124917770|NCT05382936|449327199|FG002|Overall Study|Adverse Event|1|||
124917771|NCT05382936|449327200|FG003|Overall Study|Adverse Event|0|||
124917772|NCT05382936|449327197|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
124917773|NCT05382936|449327198|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
124917774|NCT05382936|449327199|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
125022779|NCT03042468|449707834|FG004|Overall Study|Withdrawal by Subject|0|||
124917775|NCT05382936|449327200|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
124917776|NCT05382936|449327197|FG000|Overall Study|Withdrawal by Subject|0|||
124917777|NCT05382936|449327198|FG001|Overall Study|Withdrawal by Subject|0|||
124917778|NCT05382936|449327199|FG002|Overall Study|Withdrawal by Subject|1|||
124917779|NCT05382936|449327200|FG003|Overall Study|Withdrawal by Subject|1|||
124917780|NCT03101904|449327204|FG000|Wash Out (10 Days)|Adverse Event|1|||
124917781|NCT03101904|449327205|FG001|Wash Out (10 Days)|Adverse Event|0|||
124917782|NCT03101904|449327204|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
124917783|NCT03101904|449327205|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
124917784|NCT05054374|449327206|FG000|Overall Study|Withdrawal by Subject|1|||
124917785|NCT05054374|449327207|FG001|Overall Study|Withdrawal by Subject|0|||
124917786|NCT05054374|449327208|FG002|Overall Study|Withdrawal by Subject|0|||
124917787|NCT05054374|449327209|FG003|Overall Study|Withdrawal by Subject|0|||
124917788|NCT05054374|449327206|FG000|Overall Study|Progressive Disease|5|||
124917789|NCT05054374|449327207|FG001|Overall Study|Progressive Disease|0|||
124917790|NCT05054374|449327208|FG002|Overall Study|Progressive Disease|0|||
124917791|NCT05054374|449327209|FG003|Overall Study|Progressive Disease|0|||
124917792|NCT03453619|449327210|FG000|Core Study (Part A)|Physician Decision|0|||
124917793|NCT03453619|449327211|FG001|Core Study (Part A)|Physician Decision|0|||
124917794|NCT03453619|449327212|FG002|Core Study (Part A)|Physician Decision|2|||
124917795|NCT03453619|449327213|FG003|Core Study (Part A)|Physician Decision|0|||
124917796|NCT03453619|449327210|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
124917797|NCT03453619|449327211|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
124917798|NCT03453619|449327212|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
124917799|NCT03453619|449327213|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
124917800|NCT03453619|449327210|FG000|Core Study (Part A)|Other|0|||
124917801|NCT03453619|449327211|FG001|Core Study (Part A)|Other|1|||
124917802|NCT03453619|449327212|FG002|Core Study (Part A)|Other|0|||
124917803|NCT03453619|449327213|FG003|Core Study (Part A)|Other|0|||
124917804|NCT03453619|449327210|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
124917805|NCT03453619|449327211|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
124917806|NCT03453619|449327212|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
124917807|NCT03453619|449327213|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
124917808|NCT03453619|449327210|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
124917809|NCT03453619|449327211|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
124917810|NCT03453619|449327212|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
124917811|NCT03453619|449327213|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
124917812|NCT03453619|449327210|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
125116573|NCT01851590|450049876|FG002|Overall Study|Withdrawal by Subject|1|||
125116574|NCT01851590|450049874|FG000|Overall Study|Adverse Event|0|||
125116575|NCT01851590|450049875|FG001|Overall Study|Adverse Event|0|||
124917813|NCT03453619|449327211|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
124917814|NCT03453619|449327212|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
124917815|NCT03453619|449327213|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
124917816|NCT03453619|449327210|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
124917817|NCT03453619|449327211|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
124917818|NCT03453619|449327212|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
124917819|NCT03453619|449327213|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
124917820|NCT03625882|449328527|FG000|Overall Study|Protocol Violation|3|||
124917821|NCT03484702|449328535|FG000|Treatment Period|Death|3|||
124917822|NCT03484702|449328536|FG001|Treatment Period|Death|1|||
124917823|NCT03484702|449328537|FG002|Treatment Period|Death|0|||
124917824|NCT03484702|449328538|FG003|Treatment Period|Death|0|||
124917825|NCT03484702|449328539|FG004|Treatment Period|Death|0|||
124917826|NCT03484702|449328540|FG005|Treatment Period|Death|0|||
124917827|NCT03484702|449328535|FG000|Treatment Period|Adverse Event|1|||
124917828|NCT03484702|449328536|FG001|Treatment Period|Adverse Event|0|||
124917829|NCT03484702|449328537|FG002|Treatment Period|Adverse Event|0|||
124917830|NCT03484702|449328538|FG003|Treatment Period|Adverse Event|0|||
124917831|NCT03484702|449328539|FG004|Treatment Period|Adverse Event|0|||
124917832|NCT03484702|449328540|FG005|Treatment Period|Adverse Event|0|||
124917833|NCT03484702|449328535|FG000|Treatment Period|Participant Withdrew from Study|0|||
124917834|NCT03484702|449328536|FG001|Treatment Period|Participant Withdrew from Study|1|||
124917835|NCT03484702|449328537|FG002|Treatment Period|Participant Withdrew from Study|0|||
124917836|NCT03484702|449328538|FG003|Treatment Period|Participant Withdrew from Study|0|||
124917837|NCT03484702|449328539|FG004|Treatment Period|Participant Withdrew from Study|0|||
124917838|NCT03484702|449328540|FG005|Treatment Period|Participant Withdrew from Study|0|||
124917839|NCT03484702|449328535|FG000|Treatment Period|Physician Decision|0|||
124917840|NCT03484702|449328536|FG001|Treatment Period|Physician Decision|1|||
124917841|NCT03484702|449328537|FG002|Treatment Period|Physician Decision|0|||
124917842|NCT03484702|449328538|FG003|Treatment Period|Physician Decision|0|||
124917843|NCT03484702|449328539|FG004|Treatment Period|Physician Decision|0|||
124917844|NCT03484702|449328540|FG005|Treatment Period|Physician Decision|1|||
124917845|NCT02651324|449328543|FG000|Overall Study|drug not administered, due dispensing issue|1|||
124917846|NCT02651324|449328544|FG001|Overall Study|drug not administered, due dispensing issue|0|||
124917847|NCT01195831|449328547|FG000|Overall Study|Lost to Follow-up|2|||
124917848|NCT01195831|449328548|FG001|Overall Study|Lost to Follow-up|4|||
124917849|NCT01195831|449328547|FG000|Overall Study|Withdrawal by Subject|2|||
124917850|NCT01195831|449328548|FG001|Overall Study|Withdrawal by Subject|2|||
124917851|NCT01195831|449328547|FG000|Overall Study|Adverse Event|4|||
124917852|NCT01195831|449328548|FG001|Overall Study|Adverse Event|2|||
124917853|NCT01195831|449328547|FG000|Overall Study|Protocol Violation|0|||
124917854|NCT01195831|449328548|FG001|Overall Study|Protocol Violation|2|||
124917855|NCT01857934|449328549|FG000|Overall Study|Relapse or progression|2|||
124917856|NCT01857934|449328549|FG000|Overall Study|Unacceptable toxicity|3|||
124917857|NCT01857934|449328549|FG000|Overall Study|Unwillingness or inability to comply|2|||
124917858|NCT01857934|449328549|FG000|Overall Study|Physician Decision|3|||
124917859|NCT03713086|449328552|FG000|Overall Study|Withdrawal by Subject|0|||
124917860|NCT03713086|449328553|FG001|Overall Study|Withdrawal by Subject|2|||
124917861|NCT03713086|449328554|FG002|Overall Study|Withdrawal by Subject|1|||
124917862|NCT03713086|449328555|FG003|Overall Study|Withdrawal by Subject|0|||
124917863|NCT03713086|449328552|FG000|Overall Study|Lost to Follow-up|0|||
124917864|NCT03713086|449328553|FG001|Overall Study|Lost to Follow-up|1|||
124917865|NCT03713086|449328554|FG002|Overall Study|Lost to Follow-up|0|||
124917866|NCT03713086|449328555|FG003|Overall Study|Lost to Follow-up|1|||
124917867|NCT02662062|449328560|FG000|Overall Study|Withdrawal by Subject|1|||
124917868|NCT05406921|449328565|FG000|Overall Study|Withdrawal by Subject|25|||
124917869|NCT05406921|449328566|FG001|Overall Study|Withdrawal by Subject|0|||
124917870|NCT05406921|449328567|FG002|Overall Study|Withdrawal by Subject|25|||
124917871|NCT05406921|449328565|FG000|Overall Study|Protocol Violation|0|||
124917872|NCT05406921|449328566|FG001|Overall Study|Protocol Violation|12|||
124917873|NCT05406921|449328567|FG002|Overall Study|Protocol Violation|0|||
124917874|NCT00676715|449328571|FG000|Treatment Period (TP)|Adverse Event|0|||
124917875|NCT00676715|449328572|FG001|Treatment Period (TP)|Adverse Event|3|||
124917876|NCT00676715|449328573|FG002|Treatment Period (TP)|Adverse Event|2|||
124917877|NCT00676715|449328574|FG003|Treatment Period (TP)|Adverse Event|2|||
124917878|NCT00676715|449328571|FG000|Treatment Period (TP)|Death|0|||
124917879|NCT00676715|449328572|FG001|Treatment Period (TP)|Death|0|||
124917880|NCT00676715|449328573|FG002|Treatment Period (TP)|Death|1|||
124917881|NCT00676715|449328574|FG003|Treatment Period (TP)|Death|0|||
124917882|NCT00676715|449328571|FG000|Treatment Period (TP)|Failure to return|1|||
124917883|NCT00676715|449328572|FG001|Treatment Period (TP)|Failure to return|0|||
124917884|NCT00676715|449328573|FG002|Treatment Period (TP)|Failure to return|0|||
124917885|NCT00676715|449328574|FG003|Treatment Period (TP)|Failure to return|0|||
124917886|NCT00676715|449328571|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
124917887|NCT00676715|449328572|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
125116576|NCT01851590|450049876|FG002|Overall Study|Adverse Event|2|||
124917888|NCT00676715|449328573|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
124917889|NCT00676715|449328574|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
124917890|NCT00676715|449328571|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
124917891|NCT00676715|449328572|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
124917892|NCT00676715|449328573|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
124917893|NCT00676715|449328574|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
124917894|NCT00676715|449328571|FG000|Treatment Period (TP)|Withdrew consent|3|||
124917895|NCT00676715|449328572|FG001|Treatment Period (TP)|Withdrew consent|3|||
124917896|NCT00676715|449328573|FG002|Treatment Period (TP)|Withdrew consent|3|||
124917897|NCT00676715|449328574|FG003|Treatment Period (TP)|Withdrew consent|3|||
124917898|NCT00676715|449328571|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
124917899|NCT00676715|449328572|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
124917900|NCT00676715|449328573|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
124917901|NCT00676715|449328574|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
124917902|NCT00676715|449328571|FG000|Treatment Period (TP)|Administrative|0|||
124917903|NCT00676715|449328572|FG001|Treatment Period (TP)|Administrative|0|||
124917904|NCT00676715|449328573|FG002|Treatment Period (TP)|Administrative|0|||
124917905|NCT00676715|449328574|FG003|Treatment Period (TP)|Administrative|1|||
124917906|NCT00676715|449328571|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
124917907|NCT00676715|449328572|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
124917908|NCT00676715|449328573|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
124917909|NCT00676715|449328574|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
124917910|NCT00676715|449328571|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
124917911|NCT00676715|449328572|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
124917912|NCT00676715|449328573|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
124917913|NCT00676715|449328574|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
124917914|NCT00676715|449328571|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
124917915|NCT00676715|449328572|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
124917916|NCT00676715|449328573|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
124917917|NCT00676715|449328574|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
124917918|NCT00676715|449328571|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
124917919|NCT00676715|449328572|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
124917920|NCT00676715|449328573|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
124917921|NCT00676715|449328574|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
124917922|NCT00676715|449328571|FG000|Treatment-free Period (TFP)|Death|1|||
124917923|NCT00676715|449328572|FG001|Treatment-free Period (TFP)|Death|1|||
124917924|NCT00676715|449328573|FG002|Treatment-free Period (TFP)|Death|1|||
124917925|NCT00676715|449328574|FG003|Treatment-free Period (TFP)|Death|0|||
124917926|NCT00676715|449328571|FG000|Open Label Extension (OLE)|Reason not provided|3|||
124917927|NCT00676715|449328572|FG001|Open Label Extension (OLE)|Reason not provided|4|||
124917928|NCT00676715|449328573|FG002|Open Label Extension (OLE)|Reason not provided|1|||
124917929|NCT00676715|449328574|FG003|Open Label Extension (OLE)|Reason not provided|4|||
124917930|NCT00676715|449328571|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
124917931|NCT00676715|449328572|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
124917932|NCT00676715|449328573|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
124917933|NCT00676715|449328574|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
124917934|NCT00676715|449328571|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
124917935|NCT00676715|449328572|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
124917936|NCT00676715|449328573|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
124917937|NCT00676715|449328574|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
124917938|NCT00676715|449328571|FG000|Open Label Extension (OLE)|Adverse Event|0|||
124917939|NCT00676715|449328572|FG001|Open Label Extension (OLE)|Adverse Event|3|||
124917940|NCT00676715|449328573|FG002|Open Label Extension (OLE)|Adverse Event|1|||
124917941|NCT00676715|449328574|FG003|Open Label Extension (OLE)|Adverse Event|0|||
124917942|NCT00676715|449328571|FG000|Open Label Extension (OLE)|Death|2|||
124917943|NCT00676715|449328572|FG001|Open Label Extension (OLE)|Death|0|||
124917944|NCT00676715|449328573|FG002|Open Label Extension (OLE)|Death|2|||
124917945|NCT00676715|449328574|FG003|Open Label Extension (OLE)|Death|2|||
124917946|NCT01820260|449328575|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917947|NCT01820260|449328576|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917948|NCT01820260|449328577|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917949|NCT01820260|449328578|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917950|NCT01820260|449328579|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917951|NCT01820260|449328580|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917952|NCT01820260|449328581|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
124917953|NCT01820260|449328582|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917954|NCT01820260|449328583|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124969517|NCT03520075|449517411|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969518|NCT03520075|449517412|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
124917955|NCT01820260|449328584|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917956|NCT01820260|449328585|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917957|NCT01820260|449328586|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917958|NCT01820260|449328587|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917959|NCT01820260|449328588|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917960|NCT01820260|449328575|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917961|NCT01820260|449328576|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917962|NCT01820260|449328577|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917963|NCT01820260|449328578|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917964|NCT01820260|449328579|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917965|NCT01820260|449328580|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917966|NCT01820260|449328581|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917967|NCT01820260|449328582|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917968|NCT01820260|449328583|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917969|NCT01820260|449328584|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
124917970|NCT01820260|449328585|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917971|NCT01820260|449328586|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917972|NCT01820260|449328587|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917973|NCT01820260|449328588|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917974|NCT04831281|449328590|FG000|Overall Study|Adverse Event|1|||
124917975|NCT04831281|449328591|FG001|Overall Study|Adverse Event|0|||
124917976|NCT04831281|449328592|FG002|Overall Study|Adverse Event|3|||
124917977|NCT04831281|449328590|FG000|Overall Study|Withdrawal by Subject|0|||
124917978|NCT04831281|449328591|FG001|Overall Study|Withdrawal by Subject|1|||
124917979|NCT04831281|449328592|FG002|Overall Study|Withdrawal by Subject|2|||
124917980|NCT04831281|449328590|FG000|Overall Study|Undetermined|1|||
124917981|NCT04831281|449328591|FG001|Overall Study|Undetermined|1|||
124917982|NCT04831281|449328592|FG002|Overall Study|Undetermined|0|||
124917983|NCT02097420|449328593|FG000|Overall Study|Death|6|||
124917984|NCT02097420|449328593|FG000|Overall Study|Valve explanted|13|||
124917985|NCT02097420|449328593|FG000|Overall Study|Other Reason|1|||
124917986|NCT03161379|449328607|FG000|Overall Study|Withdrawal by Subject|4|||
124917987|NCT03161379|449328607|FG000|Overall Study|disease progression during chemotherapy|5|||
124917988|NCT03161379|449328607|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
124917989|NCT03161379|449328607|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
124917990|NCT02728076|449328608|FG000|Overall Study|Physician Decision|4|||
124917991|NCT04089371|449328614|FG000|Overall Study|Withdrawal by Subject|0|||
124917992|NCT04089371|449328615|FG001|Overall Study|Withdrawal by Subject|1|||
124917993|NCT04089371|449328614|FG000|Overall Study|Study terminated early|0|||
124917994|NCT04089371|449328615|FG001|Overall Study|Study terminated early|9|||
124917995|NCT04936035|449328619|FG000|Overall Study|Adverse Event|0|||
124917996|NCT04936035|449328620|FG001|Overall Study|Adverse Event|1|||
124917997|NCT04936035|449328621|FG002|Overall Study|Adverse Event|0|||
124917998|NCT04936035|449328622|FG003|Overall Study|Adverse Event|0|||
124917999|NCT04936035|449328623|FG004|Overall Study|Adverse Event|0|||
124918000|NCT04936035|449328619|FG000|Overall Study|Death|0|||
124918001|NCT04936035|449328620|FG001|Overall Study|Death|0|||
124918002|NCT04936035|449328621|FG002|Overall Study|Death|0|||
124918003|NCT04936035|449328622|FG003|Overall Study|Death|1|||
124918004|NCT04936035|449328623|FG004|Overall Study|Death|0|||
124918005|NCT04936035|449328619|FG000|Overall Study|Lost to Follow-up|0|||
124918006|NCT04936035|449328620|FG001|Overall Study|Lost to Follow-up|1|||
124918007|NCT04936035|449328621|FG002|Overall Study|Lost to Follow-up|1|||
124918008|NCT04936035|449328622|FG003|Overall Study|Lost to Follow-up|2|||
124918009|NCT04936035|449328623|FG004|Overall Study|Lost to Follow-up|1|||
124918010|NCT04936035|449328619|FG000|Overall Study|Physician Decision|0|||
124918011|NCT04936035|449328620|FG001|Overall Study|Physician Decision|1|||
124918012|NCT04936035|449328621|FG002|Overall Study|Physician Decision|0|||
124918013|NCT04936035|449328622|FG003|Overall Study|Physician Decision|0|||
124918014|NCT04936035|449328623|FG004|Overall Study|Physician Decision|0|||
124918015|NCT04936035|449328619|FG000|Overall Study|Protocol Deviation|0|||
124918016|NCT04936035|449328620|FG001|Overall Study|Protocol Deviation|0|||
124918017|NCT04936035|449328621|FG002|Overall Study|Protocol Deviation|1|||
124918018|NCT04936035|449328622|FG003|Overall Study|Protocol Deviation|0|||
124918019|NCT04936035|449328623|FG004|Overall Study|Protocol Deviation|0|||
125116577|NCT01851590|450049874|FG000|Overall Study|Lack of Efficacy|0|||
125116578|NCT01851590|450049875|FG001|Overall Study|Lack of Efficacy|1|||
125116579|NCT01851590|450049876|FG002|Overall Study|Lack of Efficacy|0|||
125116580|NCT02611752|450049880|FG000|Overall Study|Adverse Event|0|||
125116581|NCT02611752|450049881|FG001|Overall Study|Adverse Event|1|||
125116582|NCT00310856|450049882|FG000|Overall Study|Withdrawal by Subject|2|||
125116583|NCT00310856|450049883|FG001|Overall Study|Withdrawal by Subject|2|||
125116584|NCT00310856|450049884|FG002|Overall Study|Withdrawal by Subject|2|||
125116585|NCT00310856|450049882|FG000|Overall Study|Lost to Follow-up|1|||
125116586|NCT00310856|450049883|FG001|Overall Study|Lost to Follow-up|2|||
124918020|NCT04936035|449328619|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
124918021|NCT04936035|449328620|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
124918022|NCT04936035|449328621|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
124918023|NCT04936035|449328622|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
124918024|NCT04936035|449328623|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
124918025|NCT04936035|449328619|FG000|Overall Study|Reason Unknown|0|||
124918026|NCT04936035|449328620|FG001|Overall Study|Reason Unknown|0|||
124918027|NCT04936035|449328621|FG002|Overall Study|Reason Unknown|0|||
124918028|NCT04936035|449328622|FG003|Overall Study|Reason Unknown|0|||
124918029|NCT04936035|449328623|FG004|Overall Study|Reason Unknown|1|||
125022780|NCT03042468|449707835|FG005|Overall Study|Withdrawal by Subject|1|||
125022781|NCT03042468|449707830|FG000|Overall Study|Lost to Follow-up|0|||
125022782|NCT03042468|449707831|FG001|Overall Study|Lost to Follow-up|0|||
125022783|NCT03042468|449707832|FG002|Overall Study|Lost to Follow-up|0|||
124918030|NCT04936035|449328619|FG000|Overall Study|Withdrawal by Subject|1|||
124918031|NCT04936035|449328620|FG001|Overall Study|Withdrawal by Subject|0|||
124918032|NCT04936035|449328621|FG002|Overall Study|Withdrawal by Subject|0|||
124918033|NCT04936035|449328622|FG003|Overall Study|Withdrawal by Subject|0|||
124918034|NCT04936035|449328623|FG004|Overall Study|Withdrawal by Subject|0|||
124918035|NCT04936035|449328619|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
124918036|NCT04936035|449328620|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
124918037|NCT04936035|449328621|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
124918038|NCT04936035|449328622|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
124918039|NCT04936035|449328623|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
124918040|NCT04936035|449328619|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
124918041|NCT04936035|449328620|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
124918042|NCT04936035|449328621|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
124918043|NCT04936035|449328622|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
124918044|NCT04936035|449328623|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
124918045|NCT04936035|449328619|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
124918046|NCT04936035|449328620|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
124918047|NCT04936035|449328621|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
124918048|NCT04936035|449328622|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
124918049|NCT04936035|449328623|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
124918050|NCT03978871|449328632|FG000|Overall Study|Lost to Follow-up|11|||
124918051|NCT03978871|449328633|FG001|Overall Study|Lost to Follow-up|12|||
124918052|NCT04450342|449328634|FG000|Overall Study|Adverse Event|1|||
124918053|NCT04450342|449328635|FG001|Overall Study|Adverse Event|1|||
124918054|NCT04450342|449328636|FG002|Overall Study|Adverse Event|0|||
124918055|NCT04450342|449328634|FG000|Overall Study|Device not used|1|||
124918056|NCT04450342|449328635|FG001|Overall Study|Device not used|0|||
124918057|NCT04450342|449328636|FG002|Overall Study|Device not used|0|||
124918058|NCT04450342|449328634|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
124918059|NCT04450342|449328635|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
124918060|NCT04450342|449328636|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
124918061|NCT04450342|449328634|FG000|Overall Study|Physician Decision|1|||
124918062|NCT04450342|449328635|FG001|Overall Study|Physician Decision|0|||
124918063|NCT04450342|449328636|FG002|Overall Study|Physician Decision|1|||
124918064|NCT04450342|449328634|FG000|Overall Study|Protocol Deviation|0|||
124918065|NCT04450342|449328635|FG001|Overall Study|Protocol Deviation|1|||
124918066|NCT04450342|449328636|FG002|Overall Study|Protocol Deviation|0|||
124918067|NCT04450342|449328634|FG000|Overall Study|Reoperation|1|||
125022784|NCT03042468|449707833|FG003|Overall Study|Lost to Follow-up|0|||
125022785|NCT03042468|449707834|FG004|Overall Study|Lost to Follow-up|1|||
125022786|NCT03042468|449707835|FG005|Overall Study|Lost to Follow-up|1|||
125022787|NCT04161495|449707836|FG000|Overall Study|Withdrawal by Subject|3|||
125022788|NCT04161495|449707837|FG001|Overall Study|Withdrawal by Subject|0|||
124918068|NCT04450342|449328635|FG001|Overall Study|Reoperation|1|||
124918069|NCT04450342|449328636|FG002|Overall Study|Reoperation|0|||
124918070|NCT04450342|449328634|FG000|Overall Study|Screen Failures|0|||
124918071|NCT04450342|449328635|FG001|Overall Study|Screen Failures|0|||
124918072|NCT04450342|449328636|FG002|Overall Study|Screen Failures|2|||
124918073|NCT04450342|449328634|FG000|Overall Study|Site Terminated by Sponsor|1|||
125022789|NCT04161495|449707836|FG000|Overall Study|Protocol Violation|1|||
125022790|NCT04161495|449707837|FG001|Overall Study|Protocol Violation|0|||
125022791|NCT04161495|449707836|FG000|Overall Study|Prohibited concomitant medication|3|||
125022792|NCT04161495|449707837|FG001|Overall Study|Prohibited concomitant medication|0|||
125022793|NCT04161495|449707836|FG000|Overall Study|Adverse Event|1|||
125022794|NCT04161495|449707837|FG001|Overall Study|Adverse Event|0|||
124918074|NCT04450342|449328635|FG001|Overall Study|Site Terminated by Sponsor|1|||
124918075|NCT04450342|449328636|FG002|Overall Study|Site Terminated by Sponsor|1|||
124918076|NCT04450342|449328634|FG000|Overall Study|Study Terminated by Sponsor|31|||
124918077|NCT04450342|449328635|FG001|Overall Study|Study Terminated by Sponsor|29|||
124918078|NCT04450342|449328636|FG002|Overall Study|Study Terminated by Sponsor|6|||
124918079|NCT04450342|449328634|FG000|Overall Study|Withdrawal by Subject|0|||
124918080|NCT04450342|449328635|FG001|Overall Study|Withdrawal by Subject|1|||
124918081|NCT04450342|449328636|FG002|Overall Study|Withdrawal by Subject|2|||
124918082|NCT00220740|449328637|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
124918083|NCT00220740|449328638|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
124918084|NCT00220740|449328637|FG000|Efficacy Period|Adverse Event|1|||
124918085|NCT00220740|449328638|FG001|Efficacy Period|Adverse Event|1|||
124918086|NCT00220740|449328637|FG000|Efficacy Period|Withdrawal by Subject|1|||
124918087|NCT00220740|449328638|FG001|Efficacy Period|Withdrawal by Subject|0|||
124918088|NCT00220740|449328637|FG000|Efficacy Period|Protocol Violation|1|||
124918089|NCT00220740|449328638|FG001|Efficacy Period|Protocol Violation|0|||
124918090|NCT00220740|449328637|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
124918091|NCT00220740|449328638|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
124918092|NCT04314895|449328641|FG000|Overall Study|Lost to Follow-up|1|||
124918093|NCT04314895|449328641|FG000|Overall Study|Death|10|||
124918094|NCT04314895|449328641|FG000|Overall Study|Physician Decision|2|||
124918095|NCT03941860|449328642|FG000|Overall Study|Withdrawal by Subject|0|||
124918096|NCT03941860|449328643|FG001|Overall Study|Withdrawal by Subject|1|||
124918097|NCT03396588|449328647|FG000|Overall Study|Physician Decision|2|||
124918098|NCT03396588|449328648|FG001|Overall Study|Physician Decision|3|||
124918099|NCT00812461|449328649|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
124918100|NCT00812461|449328650|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
124918101|NCT00812461|449328649|FG000|All Treated Patients|Adverse Event|8|||
124918102|NCT00812461|449328650|FG001|All Treated Patients|Adverse Event|15|||
124918103|NCT00812461|449328649|FG000|All Treated Patients|Lack of Efficacy|13|||
124918104|NCT00812461|449328650|FG001|All Treated Patients|Lack of Efficacy|7|||
124918105|NCT00812461|449328649|FG000|All Treated Patients|Non-compliance|6|||
124918106|NCT00812461|449328650|FG001|All Treated Patients|Non-compliance|9|||
124918107|NCT00812461|449328649|FG000|All Treated Patients|Protocol Violation|36|||
124918108|NCT00812461|449328650|FG001|All Treated Patients|Protocol Violation|27|||
124918109|NCT00812461|449328649|FG000|All Treated Patients|Withdrawal by Subject|45|||
124918110|NCT00812461|449328650|FG001|All Treated Patients|Withdrawal by Subject|54|||
124918111|NCT00812461|449328649|FG000|All Treated Patients|Lost to Follow-up|11|||
124918112|NCT00812461|449328650|FG001|All Treated Patients|Lost to Follow-up|14|||
124918113|NCT00812461|449328649|FG000|All Treated Patients|Other Reason|13|||
124918114|NCT00812461|449328650|FG001|All Treated Patients|Other Reason|21|||
124918115|NCT04402489|449330322|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
124918116|NCT04402489|449330323|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
124918117|NCT04402489|449330324|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
124918118|NCT04402489|449330325|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
124918119|NCT04402489|449330326|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
124918120|NCT04402489|449330322|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
124918121|NCT04402489|449330323|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
124918122|NCT04402489|449330324|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
124918123|NCT04402489|449330325|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
124918124|NCT04402489|449330326|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
124918125|NCT04402489|449330322|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
124918126|NCT04402489|449330323|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
125022795|NCT04161495|449707836|FG000|Overall Study|Other - Unspecified|1|||
124918127|NCT04402489|449330324|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
124918128|NCT04402489|449330325|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
124918129|NCT04402489|449330326|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
124918130|NCT04402489|449330322|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
124918131|NCT04402489|449330323|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
124918132|NCT04402489|449330324|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
124918133|NCT04402489|449330325|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
124918134|NCT04402489|449330326|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
125022796|NCT04161495|449707837|FG001|Overall Study|Other - Unspecified|0|||
124918135|NCT04402489|449330322|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
124918136|NCT04402489|449330323|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
124918137|NCT04402489|449330324|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
124918138|NCT04402489|449330325|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
124918139|NCT04402489|449330326|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
124918140|NCT04402489|449330322|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
124918141|NCT04402489|449330323|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
124918142|NCT04402489|449330324|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
124918143|NCT04402489|449330325|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
124918144|NCT04402489|449330326|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
124918145|NCT02287311|449330333|FG000|Cohort 1: Dose Level 1|Death|2|||
124918146|NCT02287311|449330334|FG001|Cohort 1: Dose Level 1|Death|0|||
124918147|NCT02287311|449330335|FG002|Cohort 1: Dose Level 1|Death|0|||
124918148|NCT02287311|449330336|FG003|Cohort 1: Dose Level 1|Death|3|||
124918149|NCT02287311|449330337|FG004|Cohort 1: Dose Level 1|Death|0|||
124918150|NCT02287311|449330338|FG005|Cohort 1: Dose Level 1|Death|0|||
124918151|NCT02287311|449330339|FG006|Cohort 1: Dose Level 1|Death|1|||
124918152|NCT02287311|449330340|FG007|Cohort 1: Dose Level 1|Death|0|||
124918153|NCT02287311|449330341|FG008|Cohort 1: Dose Level 1|Death|0|||
124918154|NCT02287311|449330333|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
124918155|NCT02287311|449330334|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
124918156|NCT02287311|449330335|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
124918157|NCT02287311|449330336|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
124918158|NCT02287311|449330337|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
124918159|NCT02287311|449330338|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
124918160|NCT02287311|449330339|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
125022797|NCT04161495|449707836|FG000|Overall Study|Death|0|||
124918161|NCT02287311|449330340|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
124918162|NCT02287311|449330341|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
124918163|NCT02287311|449330333|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
124918164|NCT02287311|449330334|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
124918165|NCT02287311|449330335|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
124918166|NCT02287311|449330336|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
124918167|NCT02287311|449330337|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
124918168|NCT02287311|449330338|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
124918169|NCT02287311|449330339|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
124918170|NCT02287311|449330340|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
124918171|NCT02287311|449330341|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
125022798|NCT04161495|449707837|FG001|Overall Study|Death|1|||
124918172|NCT02287311|449330333|FG000|Cohort 2: Dose Level 2|Death|0|||
124918173|NCT02287311|449330334|FG001|Cohort 2: Dose Level 2|Death|2|||
124918174|NCT02287311|449330335|FG002|Cohort 2: Dose Level 2|Death|0|||
125022799|NCT01239160|449707839|FG000|Overall Study|Lost to Follow-up|3|||
125022800|NCT01239160|449707840|FG001|Overall Study|Lost to Follow-up|5|||
124918175|NCT02287311|449330336|FG003|Cohort 2: Dose Level 2|Death|0|||
124918176|NCT02287311|449330337|FG004|Cohort 2: Dose Level 2|Death|2|||
124918177|NCT02287311|449330338|FG005|Cohort 2: Dose Level 2|Death|0|||
124918178|NCT02287311|449330339|FG006|Cohort 2: Dose Level 2|Death|0|||
124918179|NCT02287311|449330340|FG007|Cohort 2: Dose Level 2|Death|2|||
124918180|NCT02287311|449330341|FG008|Cohort 2: Dose Level 2|Death|0|||
124918181|NCT02287311|449330333|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
124918182|NCT02287311|449330334|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
124918183|NCT02287311|449330335|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
124918184|NCT02287311|449330336|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
124918185|NCT02287311|449330337|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
124918186|NCT02287311|449330338|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
124918187|NCT02287311|449330339|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
124918188|NCT02287311|449330340|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
124918189|NCT02287311|449330341|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
124918190|NCT02287311|449330333|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
124918191|NCT02287311|449330334|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
124918192|NCT02287311|449330335|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
124918193|NCT02287311|449330336|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
124918194|NCT02287311|449330337|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
124918195|NCT02287311|449330338|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
124918196|NCT02287311|449330339|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
124918197|NCT02287311|449330340|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
124918198|NCT02287311|449330341|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
124918199|NCT02287311|449330333|FG000|Cohort 3: Dose Level 3|Death|0|||
124918200|NCT02287311|449330334|FG001|Cohort 3: Dose Level 3|Death|0|||
124918201|NCT02287311|449330335|FG002|Cohort 3: Dose Level 3|Death|4|||
124918202|NCT02287311|449330336|FG003|Cohort 3: Dose Level 3|Death|0|||
124918203|NCT02287311|449330337|FG004|Cohort 3: Dose Level 3|Death|0|||
124918204|NCT02287311|449330338|FG005|Cohort 3: Dose Level 3|Death|4|||
124918205|NCT02287311|449330339|FG006|Cohort 3: Dose Level 3|Death|0|||
124918206|NCT02287311|449330340|FG007|Cohort 3: Dose Level 3|Death|0|||
124918207|NCT02287311|449330341|FG008|Cohort 3: Dose Level 3|Death|2|||
124918208|NCT02287311|449330333|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
124918209|NCT02287311|449330334|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
124918210|NCT02287311|449330335|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
124918211|NCT02287311|449330336|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
124918212|NCT02287311|449330337|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
124918213|NCT02287311|449330338|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
124918214|NCT02287311|449330339|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
124918215|NCT02287311|449330340|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
124918216|NCT02287311|449330341|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
124918217|NCT02287311|449330333|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
124918218|NCT02287311|449330334|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
124918219|NCT02287311|449330335|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
124918220|NCT02287311|449330336|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
124918221|NCT02287311|449330337|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
124918222|NCT02287311|449330338|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
124918223|NCT02287311|449330339|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
124918224|NCT02287311|449330340|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
124918225|NCT02287311|449330341|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
124918226|NCT05418296|449330344|FG000|Overall Study|Withdrawal by Subject|4|||
124918227|NCT05418296|449330345|FG001|Overall Study|Withdrawal by Subject|1|||
124918228|NCT00616967|449330349|FG000|Overall Study|Withdrawal by Subject|0|||
124918229|NCT00616967|449330350|FG001|Overall Study|Withdrawal by Subject|0|||
124918230|NCT00616967|449330351|FG002|Overall Study|Withdrawal by Subject|1|||
124918231|NCT05059262|449330352|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
124918232|NCT05059262|449330353|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
124918233|NCT05059262|449330352|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
124918234|NCT05059262|449330353|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
124918235|NCT05059262|449330352|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
124918236|NCT05059262|449330353|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
124918237|NCT05059262|449330352|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
124918238|NCT05059262|449330353|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
124918239|NCT05059262|449330352|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
124918240|NCT05059262|449330353|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
124918241|NCT05059262|449330352|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
124918242|NCT05059262|449330353|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
124918243|NCT05059262|449330352|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
124918244|NCT05059262|449330353|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
124918245|NCT05059262|449330352|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
124918246|NCT05059262|449330353|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
124918247|NCT05059262|449330352|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
124918248|NCT05059262|449330353|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
124918249|NCT02312960|449330361|FG000|Overall Study|Death|24|||
124918250|NCT02312960|449330362|FG001|Overall Study|Death|32|||
124918251|NCT02312960|449330363|FG002|Overall Study|Death|25|||
124918252|NCT02312960|449330364|FG003|Overall Study|Death|11|||
124918253|NCT02312960|449330365|FG004|Overall Study|Death|5|||
124918254|NCT02312960|449330366|FG005|Overall Study|Death|5|||
124918255|NCT02312960|449330367|FG006|Overall Study|Death|8|||
124918256|NCT02312960|449330368|FG007|Overall Study|Death|5|||
124918257|NCT02312960|449330369|FG008|Overall Study|Death|7|||
124918258|NCT02312960|449330370|FG009|Overall Study|Death|3|||
124918259|NCT02312960|449330371|FG010|Overall Study|Death|3|||
124918260|NCT02312960|449330372|FG011|Overall Study|Death|1|||
124918261|NCT02312960|449330373|FG012|Overall Study|Death|25|||
124918262|NCT02312960|449330374|FG013|Overall Study|Death|19|||
124918263|NCT02312960|449330361|FG000|Overall Study|Missing|0|||
124918264|NCT02312960|449330362|FG001|Overall Study|Missing|0|||
124918265|NCT02312960|449330363|FG002|Overall Study|Missing|2|||
124918266|NCT02312960|449330364|FG003|Overall Study|Missing|0|||
124918267|NCT02312960|449330365|FG004|Overall Study|Missing|0|||
124918268|NCT02312960|449330366|FG005|Overall Study|Missing|0|||
124918269|NCT02312960|449330367|FG006|Overall Study|Missing|0|||
124918270|NCT02312960|449330368|FG007|Overall Study|Missing|0|||
124918271|NCT02312960|449330369|FG008|Overall Study|Missing|0|||
124918272|NCT02312960|449330370|FG009|Overall Study|Missing|0|||
124918273|NCT02312960|449330371|FG010|Overall Study|Missing|0|||
124918274|NCT02312960|449330372|FG011|Overall Study|Missing|0|||
124918275|NCT02312960|449330373|FG012|Overall Study|Missing|0|||
124918276|NCT02312960|449330374|FG013|Overall Study|Missing|0|||
124918277|NCT02312960|449330361|FG000|Overall Study|Lost to Follow-up|0|||
124918278|NCT02312960|449330362|FG001|Overall Study|Lost to Follow-up|0|||
124918279|NCT02312960|449330363|FG002|Overall Study|Lost to Follow-up|1|||
124918280|NCT02312960|449330364|FG003|Overall Study|Lost to Follow-up|0|||
124918281|NCT02312960|449330365|FG004|Overall Study|Lost to Follow-up|0|||
124918282|NCT02312960|449330366|FG005|Overall Study|Lost to Follow-up|0|||
124918283|NCT02312960|449330367|FG006|Overall Study|Lost to Follow-up|1|||
124918284|NCT02312960|449330368|FG007|Overall Study|Lost to Follow-up|1|||
124918285|NCT02312960|449330369|FG008|Overall Study|Lost to Follow-up|0|||
124918286|NCT02312960|449330370|FG009|Overall Study|Lost to Follow-up|1|||
124918287|NCT02312960|449330371|FG010|Overall Study|Lost to Follow-up|0|||
124918288|NCT02312960|449330372|FG011|Overall Study|Lost to Follow-up|0|||
125116587|NCT00310856|450049884|FG002|Overall Study|Lost to Follow-up|6|||
124918289|NCT02312960|449330373|FG012|Overall Study|Lost to Follow-up|1|||
124918290|NCT02312960|449330374|FG013|Overall Study|Lost to Follow-up|0|||
124918291|NCT02312960|449330361|FG000|Overall Study|Withdrawal by Subject|1|||
124918292|NCT02312960|449330362|FG001|Overall Study|Withdrawal by Subject|2|||
124918293|NCT02312960|449330363|FG002|Overall Study|Withdrawal by Subject|0|||
124918294|NCT02312960|449330364|FG003|Overall Study|Withdrawal by Subject|0|||
124918295|NCT02312960|449330365|FG004|Overall Study|Withdrawal by Subject|1|||
124918296|NCT02312960|449330366|FG005|Overall Study|Withdrawal by Subject|0|||
124918297|NCT02312960|449330367|FG006|Overall Study|Withdrawal by Subject|1|||
124918298|NCT02312960|449330368|FG007|Overall Study|Withdrawal by Subject|2|||
124918299|NCT02312960|449330369|FG008|Overall Study|Withdrawal by Subject|2|||
124918300|NCT02312960|449330370|FG009|Overall Study|Withdrawal by Subject|3|||
124918301|NCT02312960|449330371|FG010|Overall Study|Withdrawal by Subject|0|||
124918302|NCT02312960|449330372|FG011|Overall Study|Withdrawal by Subject|0|||
124918303|NCT02312960|449330373|FG012|Overall Study|Withdrawal by Subject|2|||
124918304|NCT02312960|449330374|FG013|Overall Study|Withdrawal by Subject|0|||
124918305|NCT03281291|449330377|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
124918306|NCT03281291|449330378|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
124918307|NCT03281291|449330379|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
124918308|NCT03281291|449330380|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
124918309|NCT03281291|449330381|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
124918310|NCT03281291|449330377|FG000|Overall Study|Protocol Deviation|2|||
124918311|NCT03281291|449330378|FG001|Overall Study|Protocol Deviation|0|||
124918312|NCT03281291|449330379|FG002|Overall Study|Protocol Deviation|1|||
124918313|NCT03281291|449330380|FG003|Overall Study|Protocol Deviation|2|||
124918314|NCT03281291|449330381|FG004|Overall Study|Protocol Deviation|1|||
124918315|NCT03281291|449330377|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
124918316|NCT03281291|449330378|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
124918317|NCT03281291|449330379|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
124918318|NCT03281291|449330380|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
124918319|NCT03281291|449330381|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
124918320|NCT03281291|449330377|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
124918321|NCT03281291|449330378|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
124918322|NCT03281291|449330379|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
124918323|NCT03281291|449330380|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
124918324|NCT03281291|449330381|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
124918325|NCT03281291|449330377|FG000|Overall Study|Lost to Follow-up|10|||
124918326|NCT03281291|449330378|FG001|Overall Study|Lost to Follow-up|10|||
124918327|NCT03281291|449330379|FG002|Overall Study|Lost to Follow-up|4|||
124918328|NCT03281291|449330380|FG003|Overall Study|Lost to Follow-up|6|||
124918329|NCT03281291|449330381|FG004|Overall Study|Lost to Follow-up|10|||
124918330|NCT03281291|449330377|FG000|Overall Study|Other|0|||
124918331|NCT03281291|449330378|FG001|Overall Study|Other|2|||
124918332|NCT03281291|449330379|FG002|Overall Study|Other|0|||
124918333|NCT03281291|449330380|FG003|Overall Study|Other|2|||
124918334|NCT03281291|449330381|FG004|Overall Study|Other|1|||
124918335|NCT04382898|449330382|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
124918336|NCT04382898|449330383|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
124918337|NCT04382898|449330384|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
124918338|NCT04382898|449330385|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
124918339|NCT04382898|449330386|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
124918340|NCT04382898|449330382|FG000|Part 1: Dose Titration|Death|6|||
124918341|NCT04382898|449330383|FG001|Part 1: Dose Titration|Death|0|||
124918342|NCT04382898|449330384|FG002|Part 1: Dose Titration|Death|0|||
124918343|NCT04382898|449330385|FG003|Part 1: Dose Titration|Death|0|||
124918344|NCT04382898|449330386|FG004|Part 1: Dose Titration|Death|0|||
124918345|NCT04382898|449330382|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124918346|NCT04382898|449330383|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124918347|NCT04382898|449330384|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
124918348|NCT04382898|449330385|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124918349|NCT04382898|449330386|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124918350|NCT04382898|449330382|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
124918351|NCT04382898|449330383|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
124918352|NCT04382898|449330384|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
124918353|NCT04382898|449330385|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
124918354|NCT04382898|449330386|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
124918355|NCT04382898|449330382|FG000|Part 2: Dose Expansion|Death|0|||
124918356|NCT04382898|449330383|FG001|Part 2: Dose Expansion|Death|17|||
124918357|NCT04382898|449330384|FG002|Part 2: Dose Expansion|Death|13|||
124918358|NCT04382898|449330385|FG003|Part 2: Dose Expansion|Death|1|||
124918359|NCT04382898|449330386|FG004|Part 2: Dose Expansion|Death|0|||
124918360|NCT04382898|449330382|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
124918361|NCT04382898|449330383|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
124918362|NCT04382898|449330384|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
124918363|NCT04382898|449330385|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
124918364|NCT04382898|449330386|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
124918365|NCT04382898|449330382|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
124918366|NCT04382898|449330383|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
124918367|NCT04382898|449330384|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
125022801|NCT01239160|449707841|FG002|Overall Study|Lost to Follow-up|0|||
124918368|NCT04382898|449330385|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
124918369|NCT04382898|449330386|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
124918370|NCT04382898|449330382|FG000|Part 2: Dose Expansion|Other|0|||
124918371|NCT04382898|449330383|FG001|Part 2: Dose Expansion|Other|0|||
124918372|NCT04382898|449330384|FG002|Part 2: Dose Expansion|Other|1|||
124918373|NCT04382898|449330385|FG003|Part 2: Dose Expansion|Other|0|||
124918374|NCT04382898|449330386|FG004|Part 2: Dose Expansion|Other|0|||
124918375|NCT05229120|449330387|FG000|Overall Study|Withdrawal by Subject|8|||
124918376|NCT02900924|449330388|FG000|Overall Study|Death|52|||
124918377|NCT02900924|449330388|FG000|Overall Study|Lost to Follow-up|4|||
124918378|NCT02900924|449330388|FG000|Overall Study|Withdrawal by Subject|20|||
124918379|NCT02900924|449330388|FG000|Overall Study|Missed Visit|33|||
124918380|NCT02365766|449330408|FG000|Overall Study|Withdrawal by Subject|0|||
124918381|NCT02365766|449330409|FG001|Overall Study|Withdrawal by Subject|0|||
124918382|NCT02365766|449330410|FG002|Overall Study|Withdrawal by Subject|1|||
124918383|NCT02365766|449330408|FG000|Overall Study|Eligibility Criteria Not Met|0|||
124918384|NCT02365766|449330409|FG001|Overall Study|Eligibility Criteria Not Met|0|||
124918385|NCT02365766|449330410|FG002|Overall Study|Eligibility Criteria Not Met|1|||
124918386|NCT01566695|449330411|FG000|Overall Study|Lack of Efficacy|1|||
124918387|NCT01566695|449330412|FG001|Overall Study|Lack of Efficacy|0|||
124918388|NCT01566695|449330411|FG000|Overall Study|Adverse Event|3|||
124918389|NCT01566695|449330412|FG001|Overall Study|Adverse Event|0|||
124918390|NCT01566695|449330411|FG000|Overall Study|Death|79|||
124918391|NCT01566695|449330412|FG001|Overall Study|Death|86|||
124918392|NCT01566695|449330411|FG000|Overall Study|Withdrawal by Subject|13|||
124918393|NCT01566695|449330412|FG001|Overall Study|Withdrawal by Subject|12|||
124918394|NCT01566695|449330411|FG000|Overall Study|Lost to Follow-up|0|||
124918395|NCT01566695|449330412|FG001|Overall Study|Lost to Follow-up|3|||
124918396|NCT01566695|449330411|FG000|Overall Study|Other reasons|11|||
124918397|NCT01566695|449330412|FG001|Overall Study|Other reasons|8|||
124918398|NCT03763708|449330413|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
124918399|NCT03763708|449330414|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
124918400|NCT03763708|449330415|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
124918401|NCT03763708|449330416|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
124918402|NCT03763708|449330417|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
124918403|NCT03763708|449330418|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
124918404|NCT03763708|449330419|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
124918405|NCT03763708|449330420|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
124918406|NCT03763708|449330421|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
124918407|NCT03763708|449330413|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
124918408|NCT03763708|449330414|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
124918409|NCT03763708|449330415|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
124918410|NCT03763708|449330416|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
124918411|NCT03763708|449330417|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
124918412|NCT03763708|449330418|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
124918413|NCT03763708|449330419|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
124918414|NCT03763708|449330420|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
124918415|NCT03763708|449330421|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
124918416|NCT03763708|449330413|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
124918417|NCT03763708|449330414|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
124918418|NCT03763708|449330415|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
124918419|NCT03763708|449330416|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
124918420|NCT03763708|449330417|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
124918421|NCT03763708|449330418|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
124918422|NCT03763708|449330419|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
124918423|NCT03763708|449330420|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
124918424|NCT03763708|449330421|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
124918425|NCT03763708|449330413|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
124918426|NCT03763708|449330414|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
124918427|NCT03763708|449330415|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
124918428|NCT03763708|449330416|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
124918429|NCT03763708|449330417|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
124918430|NCT03763708|449330418|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
124918431|NCT03763708|449330419|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
124918432|NCT03763708|449330420|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
124918433|NCT03763708|449330421|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
124918434|NCT03763708|449330413|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
125211835|NCT00055497|450401382|FG001|Overall Study|Other|0|||
125211836|NCT00055497|450401383|FG002|Overall Study|Other|0|||
125211837|NCT00055497|450401384|FG003|Overall Study|Other|11|||
124918435|NCT03763708|449330414|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
124918436|NCT03763708|449330415|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
124918437|NCT03763708|449330416|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
124918438|NCT03763708|449330417|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
124918439|NCT03763708|449330418|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
124918440|NCT03763708|449330419|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
124918441|NCT03763708|449330420|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
124918442|NCT03763708|449330421|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
124918443|NCT03763708|449330413|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
124918444|NCT03763708|449330414|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
124918445|NCT03763708|449330415|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
124918446|NCT03763708|449330416|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
124918447|NCT03763708|449330417|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
124918448|NCT03763708|449330418|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
124918449|NCT03763708|449330419|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
124918450|NCT03763708|449330420|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
124918451|NCT03763708|449330421|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
124918452|NCT03763708|449330413|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
124918453|NCT03763708|449330414|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
124918454|NCT03763708|449330415|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
124918455|NCT03763708|449330416|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
124918456|NCT03763708|449330417|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
124918457|NCT03763708|449330418|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
124918458|NCT03763708|449330419|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
124918459|NCT03763708|449330420|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
124918460|NCT03763708|449330421|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
124918461|NCT03763708|449330413|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
124918462|NCT03763708|449330414|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
124918463|NCT03763708|449330415|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
124918464|NCT03763708|449330416|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
124918465|NCT03763708|449330417|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
124918466|NCT03763708|449330418|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
124918467|NCT03763708|449330419|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
124918468|NCT03763708|449330420|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
124918469|NCT03763708|449330421|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
124918470|NCT03763708|449330413|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
124918471|NCT03763708|449330414|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
124918472|NCT03763708|449330415|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
124918473|NCT03763708|449330416|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
124918474|NCT03763708|449330417|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
124918475|NCT03763708|449330418|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
124918476|NCT03763708|449330419|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
124918477|NCT03763708|449330420|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
124918478|NCT03763708|449330421|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
124918479|NCT05470400|449330424|FG000|Overall Study|Lost to Follow-up|0|||
124918480|NCT05470400|449330425|FG001|Overall Study|Lost to Follow-up|0|||
124918481|NCT05470400|449330426|FG002|Overall Study|Lost to Follow-up|0|||
124918482|NCT05470400|449330427|FG003|Overall Study|Lost to Follow-up|0|||
124918483|NCT05470400|449330428|FG004|Overall Study|Lost to Follow-up|0|||
124918484|NCT05470400|449330429|FG005|Overall Study|Lost to Follow-up|0|||
124918485|NCT05470400|449330430|FG006|Overall Study|Lost to Follow-up|0|||
124918486|NCT05470400|449330431|FG007|Overall Study|Lost to Follow-up|1|||
124918487|NCT05470400|449330424|FG000|Overall Study|Withdrawal by Subject|1|||
124918488|NCT05470400|449330425|FG001|Overall Study|Withdrawal by Subject|0|||
124918489|NCT05470400|449330426|FG002|Overall Study|Withdrawal by Subject|0|||
124918490|NCT05470400|449330427|FG003|Overall Study|Withdrawal by Subject|0|||
124918491|NCT05470400|449330428|FG004|Overall Study|Withdrawal by Subject|0|||
124918492|NCT05470400|449330429|FG005|Overall Study|Withdrawal by Subject|1|||
124918493|NCT05470400|449330430|FG006|Overall Study|Withdrawal by Subject|0|||
124918494|NCT05470400|449330431|FG007|Overall Study|Withdrawal by Subject|2|||
124918495|NCT05956002|449330433|FG000|Treatment Period 3|Adverse Event|0|||
124918496|NCT05956002|449330434|FG001|Treatment Period 3|Adverse Event|0|||
124918497|NCT05956002|449330435|FG002|Treatment Period 3|Adverse Event|1|||
124918498|NCT05956002|449330436|FG003|Treatment Period 3|Adverse Event|0|||
124918499|NCT02307565|449330439|FG000|Overall Study|Adverse Event|3|||
124918500|NCT02307565|449330440|FG001|Overall Study|Adverse Event|2|||
124918501|NCT02307565|449330439|FG000|Overall Study|Withdrawal by Subject|2|||
124918502|NCT02307565|449330440|FG001|Overall Study|Withdrawal by Subject|2|||
124918503|NCT04401800|449330443|FG000|Overall Study|Death|17|||
124918504|NCT04401800|449330443|FG000|Overall Study|Lost to Follow-up|5|||
124918505|NCT04401800|449330443|FG000|Overall Study|Withdrawal by Subject|4|||
124918506|NCT03385629|449330444|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
125022802|NCT01239160|449707839|FG000|Overall Study|Withdrawal by Subject|17|||
125022803|NCT01239160|449707840|FG001|Overall Study|Withdrawal by Subject|6|||
125022804|NCT01239160|449707841|FG002|Overall Study|Withdrawal by Subject|2|||
125022805|NCT01239160|449707839|FG000|Overall Study|Physician Decision|5|||
125022806|NCT01239160|449707840|FG001|Overall Study|Physician Decision|7|||
125022807|NCT01239160|449707841|FG002|Overall Study|Physician Decision|2|||
125022808|NCT01239160|449707839|FG000|Overall Study|Early Termination Due to Study Closure|0|||
125022809|NCT01239160|449707840|FG001|Overall Study|Early Termination Due to Study Closure|1|||
125022810|NCT01239160|449707841|FG002|Overall Study|Early Termination Due to Study Closure|6|||
125022811|NCT01764633|449707842|FG000|Overall Study|Withdrawal by Subject|105|||
125022812|NCT01764633|449707843|FG001|Overall Study|Withdrawal by Subject|88|||
125022813|NCT01764633|449707842|FG000|Overall Study|Lost to Follow-up|13|||
124918507|NCT03385629|449330445|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
124918508|NCT03385629|449330444|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
124918509|NCT03385629|449330445|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
124918510|NCT03385629|449330444|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
124918511|NCT03385629|449330445|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
124918512|NCT02281955|449330454|FG000|Overall Study|Death|1|||
125022814|NCT01764633|449707843|FG001|Overall Study|Lost to Follow-up|5|||
125022815|NCT00704964|449707845|FG000|Overall Study|Not completed on time|328|||
125022816|NCT04418765|449707846|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
125022817|NCT04418765|449707847|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
125022818|NCT04418765|449707848|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
124918513|NCT02913872|449330455|FG000|Overall Study|Withdrawal by Subject|1|||
125022819|NCT04418765|449707846|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
125022820|NCT04418765|449707847|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
125022821|NCT04418765|449707848|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
124918514|NCT04072822|449330456|FG000|Treatment|Adverse Event|9|||
124918515|NCT04072822|449330457|FG001|Treatment|Adverse Event|5|||
124918516|NCT04072822|449330456|FG000|Treatment|Met Stopping Criteria|13|||
124918517|NCT04072822|449330457|FG001|Treatment|Met Stopping Criteria|24|||
124918518|NCT04072822|449330456|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
124918519|NCT04072822|449330457|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
124918520|NCT04072822|449330456|FG000|Treatment|Withdrawal by Subject|0|||
124918521|NCT04072822|449330457|FG001|Treatment|Withdrawal by Subject|2|||
124918522|NCT04072822|449330456|FG000|Treatment|Death|0|||
124918523|NCT04072822|449330457|FG001|Treatment|Death|2|||
124918524|NCT04072822|449330456|FG000|Treatment|Lost to Follow-up|11|||
124918525|NCT04072822|449330457|FG001|Treatment|Lost to Follow-up|3|||
124918526|NCT04072822|449330456|FG000|Treatment|Physician Decision|1|||
124918527|NCT04072822|449330457|FG001|Treatment|Physician Decision|0|||
125022822|NCT04418765|449707846|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
125116588|NCT00310856|450049882|FG000|Overall Study|Inappropriate enrollment|1|||
124918528|NCT04072822|449330456|FG000|Treatment|Other|7|||
125116589|NCT00310856|450049883|FG001|Overall Study|Inappropriate enrollment|1|||
125022823|NCT04418765|449707847|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
124918529|NCT04072822|449330457|FG001|Treatment|Other|9|||
124918530|NCT04072822|449330456|FG000|Follow-up|Withdrawal by Subject|1|||
124918531|NCT04072822|449330457|FG001|Follow-up|Withdrawal by Subject|0|||
124918532|NCT04072822|449330456|FG000|Follow-up|Lost to Follow-up|5|||
124918533|NCT04072822|449330457|FG001|Follow-up|Lost to Follow-up|4|||
124918534|NCT04391894|449330459|FG000|Overall Study|Adverse Event|1|||
124918535|NCT04391894|449330460|FG001|Overall Study|Adverse Event|1|||
124918536|NCT04391894|449330461|FG002|Overall Study|Adverse Event|1|||
124918537|NCT04391894|449330462|FG003|Overall Study|Adverse Event|1|||
124918538|NCT04391894|449330463|FG004|Overall Study|Adverse Event|1|||
124918539|NCT04391894|449330459|FG000|Overall Study|Lost to Follow-up|1|||
124918540|NCT04391894|449330460|FG001|Overall Study|Lost to Follow-up|0|||
124918541|NCT04391894|449330461|FG002|Overall Study|Lost to Follow-up|0|||
124918542|NCT04391894|449330462|FG003|Overall Study|Lost to Follow-up|0|||
124918543|NCT04391894|449330463|FG004|Overall Study|Lost to Follow-up|0|||
124918544|NCT04391894|449330459|FG000|Overall Study|Protocol Violation|0|||
124918545|NCT04391894|449330460|FG001|Overall Study|Protocol Violation|0|||
124918546|NCT04391894|449330461|FG002|Overall Study|Protocol Violation|0|||
124918547|NCT04391894|449330462|FG003|Overall Study|Protocol Violation|1|||
124918548|NCT04391894|449330463|FG004|Overall Study|Protocol Violation|0|||
124918549|NCT04391894|449330459|FG000|Overall Study|Withdrawal by Subject|2|||
124918550|NCT04391894|449330460|FG001|Overall Study|Withdrawal by Subject|0|||
124918551|NCT04391894|449330461|FG002|Overall Study|Withdrawal by Subject|3|||
124918552|NCT04391894|449330462|FG003|Overall Study|Withdrawal by Subject|0|||
124918553|NCT04391894|449330463|FG004|Overall Study|Withdrawal by Subject|1|||
124918554|NCT04391894|449330459|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
124918555|NCT04391894|449330460|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
124918556|NCT04391894|449330461|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
124918557|NCT04391894|449330462|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
124918558|NCT04391894|449330463|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
124918559|NCT02323321|449330467|FG000|Overall Study|Re-Transplant|1|||
124918560|NCT02323321|449330467|FG000|Overall Study|Death|12|||
124918561|NCT00446225|449330468|FG000|Overall Study|Protocol Violation|1|||
124918562|NCT00446225|449330469|FG001|Overall Study|Protocol Violation|0|||
124918563|NCT01057433|449330470|FG000|Overall Study|Adverse Event|1|||
124918564|NCT02811679|449330471|FG000|Overall Study|Adverse Event|1|||
124918565|NCT02811679|449330471|FG000|Overall Study|Lack of Efficacy|6|||
124918566|NCT02811679|449330471|FG000|Overall Study|Early study closure due to slow accrual|3|||
124918567|NCT03361748|449330477|FG000|Overall Study|Death|77|||
124918568|NCT03361748|449330477|FG000|Overall Study|Lost to Follow-up|4|||
124918569|NCT03361748|449330477|FG000|Overall Study|Withdrawal by Subject|20|||
124918570|NCT02814838|449330483|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
124918571|NCT02814838|449330484|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
124918572|NCT02814838|449330483|FG000|Overall Study|Consent withdrawal|1|||
124918573|NCT02814838|449330484|FG001|Overall Study|Consent withdrawal|1|||
124918574|NCT01361711|449330486|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
124918575|NCT01361711|449330486|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
124918576|NCT01361711|449330486|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
124918577|NCT01361711|449330486|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
124918578|NCT01361711|449330486|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
124918579|NCT01361711|449330486|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
124918580|NCT01361711|449330486|FG000|Completed Week 18 of Treatment|Other|9|||
124918581|NCT01361711|449330486|FG000|10 Year Follow-up|Still in follow-up|22|||
124918582|NCT01361711|449330486|FG000|10 Year Follow-up|Death|7|||
124918583|NCT01361711|449330486|FG000|10 Year Follow-up|Developed new cancer|1|||
124918584|NCT01361711|449330486|FG000|10 Year Follow-up|Lost to Follow-up|2|||
124918585|NCT01361711|449330486|FG000|10 Year Follow-up|New treatment started|6|||
124918586|NCT01361711|449330486|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
124918587|NCT01361711|449330486|FG000|10 Year Follow-up|Progressive Disease|1|||
124918588|NCT02596126|449330487|FG000|Overall Study|Lost to Follow-up|12|||
124918589|NCT02596126|449330488|FG001|Overall Study|Lost to Follow-up|21|||
124918590|NCT02596126|449330487|FG000|Overall Study|Protocol Violation|7|||
125211838|NCT00048165|450401385|FG000|Completed 6 Months Study|Administration/Other|8|||
124918591|NCT02596126|449330488|FG001|Overall Study|Protocol Violation|9|||
124918592|NCT05063994|449332334|FG000|Cortef Run-In|Withdrawal of Consent|1|||
124918593|NCT05063994|449332335|FG001|Cortef Run-In|Withdrawal of Consent|0|||
124918594|NCT05063994|449332336|FG002|Cortef Run-In|Withdrawal of Consent|0|||
124918595|NCT05063994|449332334|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
124918596|NCT05063994|449332335|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
124918597|NCT05063994|449332336|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
124918598|NCT05063994|449332334|FG000|Treatment|Physician Decision|0|||
124918599|NCT05063994|449332335|FG001|Treatment|Physician Decision|0|||
124918600|NCT05063994|449332336|FG002|Treatment|Physician Decision|1|||
124918601|NCT05063994|449332334|FG000|Treatment|Withdrawal by Subject|0|||
124918602|NCT05063994|449332335|FG001|Treatment|Withdrawal by Subject|0|||
124918603|NCT05063994|449332336|FG002|Treatment|Withdrawal by Subject|1|||
124918604|NCT05063994|449332334|FG000|Treatment|Withdrawal of Consent|0|||
124918605|NCT05063994|449332335|FG001|Treatment|Withdrawal of Consent|0|||
124918606|NCT05063994|449332336|FG002|Treatment|Withdrawal of Consent|1|||
124918607|NCT04630262|449332337|FG000|Overall Study|Intraoperative Screen Failure|5|||
124918608|NCT04630262|449332337|FG000|Overall Study|Study terminated prematurely|71|||
124918609|NCT04630262|449332337|FG000|Overall Study|Withdrawal by Subject|2|||
124918610|NCT04630262|449332337|FG000|Overall Study|Physician Decision|2|||
124918611|NCT04638998|449332343|FG000|Overall Study|Withdrawal by Subject|1|||
124918612|NCT04638998|449332344|FG001|Overall Study|Withdrawal by Subject|3|||
124918613|NCT03692676|449332345|FG000|Overall Study|exclude patients with prior use|4424|||
124918614|NCT03692676|449332346|FG001|Overall Study|exclude patients with prior use|24726|||
124918615|NCT03692676|449332347|FG002|Overall Study|exclude patients with prior use|0|||
124918616|NCT03692676|449332348|FG003|Overall Study|exclude patients with prior use|0|||
124918617|NCT03692676|449332345|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
124918618|NCT03692676|449332346|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
124918619|NCT03692676|449332347|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
124918620|NCT03692676|449332348|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
124918621|NCT03692676|449332345|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
124918622|NCT03692676|449332346|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
124918623|NCT03692676|449332347|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
124918624|NCT03692676|449332348|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
124918625|NCT03692676|449332345|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
124918626|NCT03692676|449332346|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
124918627|NCT03692676|449332347|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
124918628|NCT03692676|449332348|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
124918629|NCT03692676|449332345|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
124918630|NCT03692676|449332346|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
124918631|NCT03692676|449332347|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
124918632|NCT03692676|449332348|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
124918633|NCT03692676|449332345|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
124918634|NCT03692676|449332346|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
124918635|NCT03692676|449332347|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
124918636|NCT03692676|449332348|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
124918637|NCT03692676|449332345|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
124918638|NCT03692676|449332346|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
124918639|NCT03692676|449332347|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
124918640|NCT03692676|449332348|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
124918641|NCT03692676|449332345|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
124918642|NCT03692676|449332346|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
124918643|NCT03692676|449332347|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
124918644|NCT03692676|449332348|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
124918645|NCT03692676|449332345|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
124918646|NCT03692676|449332346|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
124918647|NCT03692676|449332347|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
124918648|NCT03692676|449332348|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
124918649|NCT03692676|449332345|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
124918650|NCT03692676|449332346|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
124918651|NCT03692676|449332347|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
125022824|NCT04418765|449707848|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
125022825|NCT04418765|449707846|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
125022826|NCT04418765|449707847|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
125211839|NCT00048165|450401386|FG001|Completed 6 Months Study|Administration/Other|8|||
125211840|NCT00048165|450401385|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
125022827|NCT04418765|449707848|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
125022828|NCT04418765|449707846|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
125022829|NCT04418765|449707847|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
125022830|NCT04418765|449707848|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
124918652|NCT03692676|449332348|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
124918653|NCT03692676|449332345|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
124918654|NCT03692676|449332346|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
124918655|NCT03692676|449332347|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
124918656|NCT03692676|449332348|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
124918657|NCT03692676|449332345|FG000|Overall Study|Other|0|||
124918658|NCT03692676|449332346|FG001|Overall Study|Other|805|||
124918659|NCT03692676|449332347|FG002|Overall Study|Other|758|||
124918660|NCT03692676|449332348|FG003|Overall Study|Other|277|||
124918661|NCT03692676|449332345|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
124918662|NCT03692676|449332346|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
124918663|NCT03692676|449332347|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
125022831|NCT04418765|449707846|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
125022832|NCT04418765|449707847|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
125022833|NCT04418765|449707848|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
124918664|NCT03692676|449332348|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
124918665|NCT01180634|449332350|FG000|Overall Study|Adverse Event|4|||
124918666|NCT01180634|449332351|FG001|Overall Study|Adverse Event|1|||
124918667|NCT01180634|449332350|FG000|Overall Study|Miscellaneous|2|||
124918668|NCT01180634|449332351|FG001|Overall Study|Miscellaneous|0|||
124918669|NCT01180634|449332350|FG000|Overall Study|Withdrawal by Subject|4|||
124918670|NCT01180634|449332351|FG001|Overall Study|Withdrawal by Subject|0|||
124918671|NCT03692611|449332352|FG000|Overall Study|Found to be ineligible postrandomization|3|||
124918672|NCT03692611|449332353|FG001|Overall Study|Found to be ineligible postrandomization|0|||
124918673|NCT04419168|449332354|FG000|Overall Study|Protocol Violation|1|||
124918674|NCT04419168|449332355|FG001|Overall Study|Protocol Violation|1|||
125022834|NCT04418765|449707846|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
125022835|NCT04418765|449707847|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
124918675|NCT04419168|449332354|FG000|Overall Study|Lost to Follow-up|7|||
124918676|NCT04419168|449332355|FG001|Overall Study|Lost to Follow-up|7|||
124918677|NCT04419168|449332354|FG000|Overall Study|Missed 6-month Visit|48|||
124918678|NCT04419168|449332355|FG001|Overall Study|Missed 6-month Visit|45|||
124918679|NCT04490915|449332356|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
124918680|NCT04490915|449332357|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
124918681|NCT04490915|449332356|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
124918682|NCT04490915|449332357|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
124918683|NCT04490915|449332356|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
124918684|NCT04490915|449332357|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
124918685|NCT04490915|449332356|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
124918686|NCT04490915|449332357|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
124918687|NCT04490915|449332356|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
124918688|NCT04490915|449332357|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
124918689|NCT04490915|449332356|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
124918690|NCT04490915|449332357|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
124918691|NCT04490915|449332356|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
124918692|NCT04490915|449332357|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
124918693|NCT05009251|449332358|FG000|Overall Study|Protocol Violation|100|||
124918694|NCT05009251|449332359|FG001|Overall Study|Protocol Violation|105|||
124918695|NCT05009251|449332360|FG002|Overall Study|Protocol Violation|119|||
124918696|NCT05009251|449332361|FG003|Overall Study|Protocol Violation|120|||
124918697|NCT05009251|449332362|FG004|Overall Study|Protocol Violation|119|||
124918698|NCT05009251|449332358|FG000|Overall Study|Death|25|||
124918699|NCT05009251|449332359|FG001|Overall Study|Death|22|||
124918700|NCT05009251|449332360|FG002|Overall Study|Death|24|||
124918701|NCT05009251|449332361|FG003|Overall Study|Death|19|||
124918702|NCT05009251|449332362|FG004|Overall Study|Death|15|||
124918703|NCT05374837|449332363|FG000|Overall Study|Lost to Follow-up|17|||
124918704|NCT05374837|449332364|FG001|Overall Study|Lost to Follow-up|18|||
124918705|NCT03786783|449332368|FG000|Overall Study|Death|1|||
124918706|NCT03786783|449332368|FG000|Overall Study|Physician Decision|6|||
124918707|NCT03786783|449332368|FG000|Overall Study|Withdrawal by Subject|2|||
124918708|NCT03786783|449332368|FG000|Overall Study|Disease Progression|7|||
124918709|NCT03786783|449332368|FG000|Overall Study|Patient/Parent Refusal|4|||
124918710|NCT02910583|449332369|FG000|Overall Study|Death|7|||
124918711|NCT02910583|449332370|FG001|Overall Study|Death|3|||
124918712|NCT02910583|449332369|FG000|Overall Study|Lost to Follow-up|1|||
124918713|NCT02910583|449332370|FG001|Overall Study|Lost to Follow-up|0|||
124918714|NCT02910583|449332369|FG000|Overall Study|Withdrawal by Subject|12|||
124918715|NCT02910583|449332370|FG001|Overall Study|Withdrawal by Subject|8|||
124918716|NCT02910583|449332369|FG000|Overall Study|Other, Not Specified|6|||
124918717|NCT02910583|449332370|FG001|Overall Study|Other, Not Specified|3|||
124918718|NCT01331005|449332372|FG000|Overall Study|Lost to Follow-up|2|||
124918719|NCT01331005|449332373|FG001|Overall Study|Lost to Follow-up|1|||
124918720|NCT01331005|449332372|FG000|Overall Study|Withdrawal by Subject|2|||
124918721|NCT01331005|449332373|FG001|Overall Study|Withdrawal by Subject|3|||
124918722|NCT02029443|449332376|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
124918723|NCT02029443|449332377|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
124918724|NCT02029443|449332378|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
124918725|NCT02029443|449332379|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
124918726|NCT02029443|449332380|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
124918727|NCT02029443|449332376|FG000|Overall Study|Death|13|||
124918728|NCT02029443|449332377|FG001|Overall Study|Death|2|||
124918729|NCT02029443|449332378|FG002|Overall Study|Death|2|||
124918730|NCT02029443|449332379|FG003|Overall Study|Death|11|||
124918731|NCT02029443|449332380|FG004|Overall Study|Death|2|||
124918732|NCT02029443|449332376|FG000|Overall Study|Lost to Follow-up|1|||
124918733|NCT02029443|449332377|FG001|Overall Study|Lost to Follow-up|0|||
124918734|NCT02029443|449332378|FG002|Overall Study|Lost to Follow-up|1|||
124918735|NCT02029443|449332379|FG003|Overall Study|Lost to Follow-up|1|||
124918736|NCT02029443|449332380|FG004|Overall Study|Lost to Follow-up|0|||
124918737|NCT02029443|449332376|FG000|Overall Study|Started other anti-cancer therapy|17|||
124918738|NCT02029443|449332377|FG001|Overall Study|Started other anti-cancer therapy|4|||
124918739|NCT02029443|449332378|FG002|Overall Study|Started other anti-cancer therapy|7|||
124918740|NCT02029443|449332379|FG003|Overall Study|Started other anti-cancer therapy|9|||
124918741|NCT02029443|449332380|FG004|Overall Study|Started other anti-cancer therapy|3|||
124918742|NCT02029443|449332376|FG000|Overall Study|Withdrawal by Subject|3|||
124918743|NCT02029443|449332377|FG001|Overall Study|Withdrawal by Subject|1|||
124918744|NCT02029443|449332378|FG002|Overall Study|Withdrawal by Subject|1|||
124918745|NCT02029443|449332379|FG003|Overall Study|Withdrawal by Subject|1|||
124918746|NCT02029443|449332380|FG004|Overall Study|Withdrawal by Subject|0|||
124918747|NCT02029443|449332376|FG000|Overall Study|Other|6|||
124918748|NCT02029443|449332377|FG001|Overall Study|Other|6|||
124918749|NCT02029443|449332378|FG002|Overall Study|Other|4|||
124918750|NCT02029443|449332379|FG003|Overall Study|Other|2|||
124918751|NCT02029443|449332380|FG004|Overall Study|Other|0|||
124918752|NCT03393975|449332383|FG000|Urgent Treatment Period|Physician Decision|0|||
124918753|NCT03393975|449332384|FG001|Urgent Treatment Period|Physician Decision|0|||
124918754|NCT03393975|449332385|FG002|Urgent Treatment Period|Physician Decision|0|||
124918755|NCT03393975|449332386|FG003|Urgent Treatment Period|Physician Decision|1|||
124918756|NCT03393975|449332383|FG000|Prophylaxis Period 1|Reason not Specified|0|||
124918757|NCT03393975|449332384|FG001|Prophylaxis Period 1|Reason not Specified|1|||
124918758|NCT03393975|449332385|FG002|Prophylaxis Period 1|Reason not Specified|0|||
124918759|NCT03393975|449332386|FG003|Prophylaxis Period 1|Reason not Specified|0|||
124918760|NCT03393975|449332383|FG000|Prophylaxis Period 2|Reason not Specified|0|||
124918761|NCT03393975|449332384|FG001|Prophylaxis Period 2|Reason not Specified|1|||
124918762|NCT03393975|449332385|FG002|Prophylaxis Period 2|Reason not Specified|0|||
124918763|NCT03393975|449332386|FG003|Prophylaxis Period 2|Reason not Specified|0|||
124918764|NCT04083235|449332387|FG000|Overall Study|Death|252|||
124918765|NCT04083235|449332388|FG001|Overall Study|Death|277|||
124918766|NCT04083235|449332387|FG000|Overall Study|Withdrawal by Subject|13|||
124918767|NCT04083235|449332388|FG001|Overall Study|Withdrawal by Subject|17|||
124918768|NCT04083235|449332387|FG000|Overall Study|Lost to Follow-up|1|||
124918769|NCT04083235|449332388|FG001|Overall Study|Lost to Follow-up|1|||
124918770|NCT04083235|449332387|FG000|Overall Study|Does not meet entry criteria|1|||
124918771|NCT04083235|449332388|FG001|Overall Study|Does not meet entry criteria|0|||
125022836|NCT04418765|449707848|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
124918772|NCT04083235|449332387|FG000|Overall Study|Did not receive treatment|13|||
124918773|NCT04083235|449332388|FG001|Overall Study|Did not receive treatment|8|||
124918774|NCT04083235|449332387|FG000|Overall Study|Ongoing at the time of DCO|44|||
124918775|NCT04083235|449332388|FG001|Overall Study|Ongoing at the time of DCO|7|||
124918776|NCT02549339|449332391|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
124918777|NCT02549339|449332392|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
124918778|NCT02549339|449332391|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
124918779|NCT02549339|449332392|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
124918780|NCT02549339|449332391|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
124918781|NCT02549339|449332392|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
124918782|NCT02549339|449332391|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
124918783|NCT02549339|449332392|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
124918784|NCT02549339|449332391|FG000|12-month Follow-up|Lack of Efficacy|0|||
124918785|NCT02549339|449332392|FG001|12-month Follow-up|Lack of Efficacy|2|||
124918786|NCT02549339|449332391|FG000|12-month Follow-up|Withdrawal by Subject|8|||
124918787|NCT02549339|449332392|FG001|12-month Follow-up|Withdrawal by Subject|3|||
124918788|NCT02549339|449332391|FG000|12-month Follow-up|Lost to Follow-up|1|||
124918789|NCT02549339|449332392|FG001|12-month Follow-up|Lost to Follow-up|3|||
124918790|NCT02549339|449332391|FG000|12-month Follow-up|Other|0|||
124918791|NCT02549339|449332392|FG001|12-month Follow-up|Other|3|||
124918792|NCT03016169|449332393|FG000|Overall Study|Lost to Follow-up|4|||
124918793|NCT03016169|449332393|FG000|Overall Study|Death|54|||
124918794|NCT03016169|449332393|FG000|Overall Study|Device Explant|11|||
124918795|NCT03016169|449332393|FG000|Overall Study|Withdrawal by Subject|19|||
124918796|NCT03016169|449332393|FG000|Overall Study|Other Reasons|1|||
124918797|NCT05458011|449332395|FG000|DB Period (12 Weeks)|Adverse Event|2|||
124918798|NCT05458011|449332396|FG001|DB Period (12 Weeks)|Adverse Event|1|||
124918799|NCT05458011|449332397|FG002|DB Period (12 Weeks)|Adverse Event|1|||
124918800|NCT05458011|449332395|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
124918801|NCT05458011|449332396|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
124918802|NCT05458011|449332397|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
124918803|NCT05458011|449332395|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
124918804|NCT05458011|449332396|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
124918805|NCT05458011|449332397|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
124918806|NCT05458011|449332395|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
124918807|NCT05458011|449332396|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
124918808|NCT05458011|449332397|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
124918809|NCT05458011|449332395|FG000|OL Period (12 Weeks)|Adverse Event|1|||
124918810|NCT05458011|449332396|FG001|OL Period (12 Weeks)|Adverse Event|2|||
124918811|NCT05458011|449332397|FG002|OL Period (12 Weeks)|Adverse Event|1|||
124918812|NCT05458011|449332395|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
124918813|NCT05458011|449332396|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
124918814|NCT05458011|449332397|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
124918815|NCT02724878|449332414|FG000|Overall Study|Still on Active Therapy|15|||
124918816|NCT02724878|449332414|FG000|Overall Study|Disease Progression|31|||
124918817|NCT02724878|449332414|FG000|Overall Study|Toxicity|5|||
124918818|NCT02724878|449332414|FG000|Overall Study|Death|1|||
124918819|NCT02724878|449332414|FG000|Overall Study|Withdrawal by Subject|4|||
124918820|NCT02724878|449332414|FG000|Overall Study|Lost to Follow-up|2|||
124918821|NCT02724878|449332414|FG000|Overall Study|Protocol Violation|1|||
124918822|NCT02724878|449332414|FG000|Overall Study|Ineligible for Study Drug|5|||
124918823|NCT02724878|449332414|FG000|Overall Study|not started|1|||
124918824|NCT04838262|449332415|FG000|Overall Study|Withdrawal by Subject|9|||
124918825|NCT04838262|449332416|FG001|Overall Study|Withdrawal by Subject|4|||
124918826|NCT05082909|449332419|FG000|Overall Study|Protocol Violation|0|||
124918827|NCT05082909|449332420|FG001|Overall Study|Protocol Violation|0|||
124918828|NCT05082909|449332421|FG002|Overall Study|Protocol Violation|1|||
124918829|NCT05082909|449332422|FG003|Overall Study|Protocol Violation|0|||
124918830|NCT05082909|449332423|FG004|Overall Study|Protocol Violation|0|||
124918831|NCT05082909|449332424|FG005|Overall Study|Protocol Violation|0|||
124918832|NCT03175029|449332427|FG000|Overall Study|Withdrawal by Subject|2|||
124918833|NCT03175029|449332428|FG001|Overall Study|Withdrawal by Subject|1|||
124918834|NCT03175029|449332427|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
124918835|NCT03175029|449332428|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
124918836|NCT05227209|449332433|FG000|Overall Study|Adverse Event|11|||
124918837|NCT05227209|449332433|FG000|Overall Study|Lost to Follow-up|1|||
124918838|NCT05227209|449332433|FG000|Overall Study|Withdrawal by Subject|7|||
124918839|NCT05227209|449332433|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
124918840|NCT04950660|449332434|FG000|Overall Study|Protocol Violation|4|||
124918841|NCT04950660|449332435|FG001|Overall Study|Protocol Violation|2|||
124918842|NCT04950660|449332434|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
124918843|NCT04950660|449332435|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
124918844|NCT04950660|449332434|FG000|Overall Study|Withdrawal by Subject|0|||
124918845|NCT04950660|449332435|FG001|Overall Study|Withdrawal by Subject|1|||
124918846|NCT04950660|449332434|FG000|Overall Study|Hypotension|1|||
124918847|NCT04950660|449332435|FG001|Overall Study|Hypotension|0|||
124918848|NCT05524233|449332438|FG000|Overall Study|Lost to Follow-up|2|||
124918849|NCT05524233|449332438|FG000|Overall Study|Adverse Event|2|||
124918850|NCT05524233|449332438|FG000|Overall Study|Withdrawal by Subject|1|||
124918851|NCT02530671|449332441|FG000|Overall Study|Lost to Follow-up|2|||
124918852|NCT02530671|449332442|FG001|Overall Study|Lost to Follow-up|0|||
124918853|NCT02530671|449332441|FG000|Overall Study|Withdrawal by Subject|1|||
124918854|NCT02530671|449332442|FG001|Overall Study|Withdrawal by Subject|0|||
124918855|NCT02736409|449332443|FG000|Overall Study|Withdrawal by Subject|4|||
124918856|NCT02736409|449332444|FG001|Overall Study|Withdrawal by Subject|2|||
124918857|NCT02736409|449332445|FG002|Overall Study|Withdrawal by Subject|17|||
124918858|NCT02736409|449332446|FG003|Overall Study|Withdrawal by Subject|3|||
124918859|NCT02736409|449332443|FG000|Overall Study|Non-Compliance with Study Drug|0|||
124918860|NCT02736409|449332444|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124918861|NCT02736409|449332445|FG002|Overall Study|Non-Compliance with Study Drug|0|||
124918862|NCT02736409|449332446|FG003|Overall Study|Non-Compliance with Study Drug|1|||
124918863|NCT02736409|449332443|FG000|Overall Study|Adverse Event|0|||
124918864|NCT02736409|449332444|FG001|Overall Study|Adverse Event|1|||
124918865|NCT02736409|449332445|FG002|Overall Study|Adverse Event|5|||
124918866|NCT02736409|449332446|FG003|Overall Study|Adverse Event|4|||
124918867|NCT02736409|449332443|FG000|Overall Study|Other|0|||
124918868|NCT02736409|449332444|FG001|Overall Study|Other|0|||
124918869|NCT02736409|449332445|FG002|Overall Study|Other|1|||
124918870|NCT02736409|449332446|FG003|Overall Study|Other|1|||
124918871|NCT02736409|449332443|FG000|Overall Study|Pregnancy|0|||
124918872|NCT02736409|449332444|FG001|Overall Study|Pregnancy|0|||
124918873|NCT02736409|449332445|FG002|Overall Study|Pregnancy|1|||
124918874|NCT02736409|449332446|FG003|Overall Study|Pregnancy|0|||
124918875|NCT02736409|449332443|FG000|Overall Study|Lost to Follow-up|0|||
124918876|NCT02736409|449332444|FG001|Overall Study|Lost to Follow-up|0|||
124918877|NCT02736409|449332445|FG002|Overall Study|Lost to Follow-up|2|||
124918878|NCT02736409|449332446|FG003|Overall Study|Lost to Follow-up|1|||
124918879|NCT02736409|449332443|FG000|Overall Study|Physician Decision|0|||
124918880|NCT02736409|449332444|FG001|Overall Study|Physician Decision|0|||
124918881|NCT02736409|449332445|FG002|Overall Study|Physician Decision|0|||
124918882|NCT02736409|449332446|FG003|Overall Study|Physician Decision|2|||
124918883|NCT04390048|449332447|FG000|Overall Study|Withdrawal by Subject|1|||
124918884|NCT04390048|449332448|FG001|Overall Study|Withdrawal by Subject|3|||
124918885|NCT03126019|449332450|FG000|Overall Study|Death|5|||
124918886|NCT03126019|449332451|FG001|Overall Study|Death|27|||
124918887|NCT03126019|449332450|FG000|Overall Study|Lost to Follow-up|2|||
124918888|NCT03126019|449332451|FG001|Overall Study|Lost to Follow-up|4|||
124918889|NCT03126019|449332450|FG000|Overall Study|Withdrawal by Subject|1|||
124918890|NCT03126019|449332451|FG001|Overall Study|Withdrawal by Subject|9|||
124918891|NCT03126019|449332450|FG000|Overall Study|Physician Decision|1|||
124918892|NCT03126019|449332451|FG001|Overall Study|Physician Decision|0|||
124918893|NCT03126019|449332450|FG000|Overall Study|Transitioned to Rollover Study|0|||
124918894|NCT03126019|449332451|FG001|Overall Study|Transitioned to Rollover Study|11|||
124918895|NCT03126019|449332450|FG000|Overall Study|Did Not Return to Site for Care|0|||
124918896|NCT03126019|449332451|FG001|Overall Study|Did Not Return to Site for Care|1|||
124918897|NCT03126019|449332450|FG000|Overall Study|Site Closed|0|||
124918898|NCT03126019|449332451|FG001|Overall Study|Site Closed|1|||
124918899|NCT01809691|449332457|FG000|Overall Study|Currently on Treatment|192|||
124918900|NCT01809691|449332458|FG001|Overall Study|Currently on Treatment|100|||
124918901|NCT01809691|449332457|FG000|Overall Study|No Protocol Treatment|10|||
124918902|NCT01809691|449332458|FG001|Overall Study|No Protocol Treatment|11|||
124918903|NCT01809691|449332457|FG000|Overall Study|Adverse Event|80|||
124918904|NCT01809691|449332458|FG001|Overall Study|Adverse Event|21|||
125116590|NCT00310856|450049884|FG002|Overall Study|Inappropriate enrollment|0|||
124918905|NCT01809691|449332457|FG000|Overall Study|Disease Progression|226|||
124918906|NCT01809691|449332458|FG001|Overall Study|Disease Progression|372|||
124918907|NCT01809691|449332457|FG000|Overall Study|Death|26|||
124918908|NCT01809691|449332458|FG001|Overall Study|Death|13|||
124918909|NCT01809691|449332457|FG000|Overall Study|Participant Refusal|70|||
124918910|NCT01809691|449332458|FG001|Overall Study|Participant Refusal|72|||
124918911|NCT01809691|449332457|FG000|Overall Study|Other, Not Specified|34|||
124918912|NCT01809691|449332458|FG001|Overall Study|Other, Not Specified|52|||
124918913|NCT04533347|449332462|FG000|Overall Study|Adverse Event|1|||
124918914|NCT04533347|449332463|FG001|Overall Study|Adverse Event|2|||
124918915|NCT04533347|449332462|FG000|Overall Study|Lost to Follow-up|2|||
124918916|NCT04533347|449332463|FG001|Overall Study|Lost to Follow-up|0|||
124918917|NCT04533347|449332462|FG000|Overall Study|Withdrawal by Subject|1|||
124918918|NCT04533347|449332463|FG001|Overall Study|Withdrawal by Subject|0|||
124918919|NCT04831216|449332467|FG000|Overall Study|Lost to Follow-up|32|||
124918920|NCT05268302|449332472|FG000|Overall Study|Death|0|||
124918921|NCT05268302|449332473|FG001|Overall Study|Death|1|||
124918922|NCT04285567|449332474|FG000|Overall Study|Death|3|||
124918923|NCT04285567|449332475|FG001|Overall Study|Death|3|||
124918924|NCT04285567|449332474|FG000|Overall Study|Lost to Follow-up|1|||
124918925|NCT04285567|449332475|FG001|Overall Study|Lost to Follow-up|1|||
124918926|NCT04285567|449332474|FG000|Overall Study|Reason Not Specified|1|||
124918927|NCT04285567|449332475|FG001|Overall Study|Reason Not Specified|1|||
124918928|NCT04285567|449332474|FG000|Overall Study|Physician Decision|2|||
124918929|NCT04285567|449332475|FG001|Overall Study|Physician Decision|1|||
124918930|NCT04285567|449332474|FG000|Overall Study|Withdrawal by Subject|2|||
124918931|NCT04285567|449332475|FG001|Overall Study|Withdrawal by Subject|6|||
124918932|NCT04285567|449332474|FG000|Overall Study|Adverse Event|1|||
124918933|NCT04285567|449332475|FG001|Overall Study|Adverse Event|0|||
124918934|NCT04285567|449332474|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
124918935|NCT04285567|449332475|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
124918936|NCT05319860|449332476|FG000|Overall Study|Death|1|||
124918937|NCT05319860|449332477|FG001|Overall Study|Death|1|||
124918938|NCT05319860|449332476|FG000|Overall Study|Lost to Follow-up|3|||
124918939|NCT05319860|449332477|FG001|Overall Study|Lost to Follow-up|1|||
124918940|NCT05319860|449332476|FG000|Overall Study|Withdrawal by Subject|1|||
124918941|NCT05319860|449332477|FG001|Overall Study|Withdrawal by Subject|7|||
124918942|NCT04263311|449334173|FG000|Overall Study|Lost to Follow-up|1|||
124918943|NCT04263311|449334174|FG001|Overall Study|Lost to Follow-up|2|||
124918944|NCT04263311|449334175|FG002|Overall Study|Lost to Follow-up|0|||
124918945|NCT04263311|449334173|FG000|Overall Study|Health Issues|1|||
124918946|NCT04263311|449334174|FG001|Overall Study|Health Issues|0|||
124918947|NCT04263311|449334175|FG002|Overall Study|Health Issues|0|||
124918948|NCT04263311|449334173|FG000|Overall Study|Left the country|1|||
124918949|NCT04263311|449334174|FG001|Overall Study|Left the country|0|||
124918950|NCT04263311|449334175|FG002|Overall Study|Left the country|0|||
124918951|NCT04263311|449334173|FG000|Overall Study|Unable to maintain time commitment|1|||
124918952|NCT04263311|449334174|FG001|Overall Study|Unable to maintain time commitment|0|||
124918953|NCT04263311|449334175|FG002|Overall Study|Unable to maintain time commitment|0|||
124918954|NCT04263311|449334173|FG000|Overall Study|No longer interested|1|||
124918955|NCT04263311|449334174|FG001|Overall Study|No longer interested|0|||
124918956|NCT04263311|449334175|FG002|Overall Study|No longer interested|0|||
124918957|NCT04263311|449334173|FG000|Overall Study|Ineligible post consent|0|||
124918958|NCT04263311|449334174|FG001|Overall Study|Ineligible post consent|0|||
124918959|NCT04263311|449334175|FG002|Overall Study|Ineligible post consent|5|||
124918960|NCT02954341|449334176|FG000|Overall Study|Attempted Implant unsuccessful|5|||
124918961|NCT02954341|449334176|FG000|Overall Study|Death|90|||
124918962|NCT02954341|449334176|FG000|Overall Study|Withdrawal by Subject|4|||
124918963|NCT02954341|449334176|FG000|Overall Study|Physician Decision|13|||
124918964|NCT02954341|449334176|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
124918965|NCT02954341|449334176|FG000|Overall Study|Not implanted due to physician's decision|1|||
124918966|NCT02954341|449334176|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
124918967|NCT06074523|449334180|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
124918968|NCT06074523|449334180|FG000|Overall Study|Withdrawal by Subject|1|||
124918969|NCT01426425|449334181|FG000|Overall Study|Exited prior to EP study|22|||
124918970|NCT01426425|449334181|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
124918971|NCT01426425|449334181|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
124918972|NCT00512070|449334189|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
124918973|NCT00512070|449334190|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
124918974|NCT00512070|449334191|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
124918975|NCT00512070|449334189|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
124918976|NCT00512070|449334190|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
124918977|NCT00512070|449334191|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
124918978|NCT02506959|449334192|FG000|Overall Study|Physician Decision|2|||
124918979|NCT02506959|449334193|FG001|Overall Study|Physician Decision|1|||
124918980|NCT03932682|449334195|FG000|Overall Study|Death|1|||
124918981|NCT03932682|449334196|FG001|Overall Study|Death|2|||
124918982|NCT03932682|449334195|FG000|Overall Study|Withdrawal by Subject|37|||
124918983|NCT03932682|449334196|FG001|Overall Study|Withdrawal by Subject|45|||
124918984|NCT03932682|449334195|FG000|Overall Study|Lost to Follow-up|19|||
124918985|NCT03932682|449334196|FG001|Overall Study|Lost to Follow-up|25|||
124918986|NCT03932682|449334195|FG000|Overall Study|Protocol Violation|0|||
124918987|NCT03932682|449334196|FG001|Overall Study|Protocol Violation|2|||
124918988|NCT03932682|449334195|FG000|Overall Study|Other|9|||
124918989|NCT03932682|449334196|FG001|Overall Study|Other|23|||
124918990|NCT04806594|449334199|FG000|Overall Study|Withdrawal by Subject|2|||
124918991|NCT04806594|449334199|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
124918992|NCT02543281|449334200|FG000|Overall Study|Lost to Follow-up|0|||
124918993|NCT02543281|449334201|FG001|Overall Study|Lost to Follow-up|0|||
124918994|NCT02543281|449334202|FG002|Overall Study|Lost to Follow-up|1|||
124918995|NCT03143153|449334203|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
124918996|NCT03143153|449334204|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
124918997|NCT03143153|449334205|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
124918998|NCT03143153|449334203|FG000|Pre-Treatment|Participant withdrew consent|0|||
124918999|NCT03143153|449334204|FG001|Pre-Treatment|Participant withdrew consent|1|||
125022837|NCT04418765|449707846|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
124919000|NCT03143153|449334205|FG002|Pre-Treatment|Participant withdrew consent|12|||
124919001|NCT03143153|449334203|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
124919002|NCT03143153|449334204|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
124919003|NCT03143153|449334205|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
124919004|NCT03143153|449334203|FG000|Pre-Treatment|Other Reasons|1|||
124919005|NCT03143153|449334204|FG001|Pre-Treatment|Other Reasons|2|||
124919006|NCT03143153|449334205|FG002|Pre-Treatment|Other Reasons|1|||
124919007|NCT03143153|449334203|FG000|Pre-Treatment|Disease Progression|1|||
124919008|NCT03143153|449334204|FG001|Pre-Treatment|Disease Progression|1|||
124919009|NCT03143153|449334205|FG002|Pre-Treatment|Disease Progression|2|||
124919010|NCT03143153|449334203|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
124919011|NCT03143153|449334204|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
124919012|NCT03143153|449334205|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
124919013|NCT03143153|449334203|FG000|Treatment|Disease progression|174|||
124919014|NCT03143153|449334204|FG001|Treatment|Disease progression|184|||
124919015|NCT03143153|449334205|FG002|Treatment|Disease progression|193|||
124919016|NCT03143153|449334203|FG000|Treatment|Study drug toxicity|59|||
124919017|NCT03143153|449334204|FG001|Treatment|Study drug toxicity|33|||
124919018|NCT03143153|449334205|FG002|Treatment|Study drug toxicity|40|||
124919019|NCT03143153|449334203|FG000|Treatment|Death|5|||
124919020|NCT03143153|449334204|FG001|Treatment|Death|3|||
124919021|NCT03143153|449334205|FG002|Treatment|Death|4|||
124919022|NCT03143153|449334203|FG000|Treatment|Adverse event unrelated to study drug|19|||
124919023|NCT03143153|449334204|FG001|Treatment|Adverse event unrelated to study drug|28|||
124919024|NCT03143153|449334205|FG002|Treatment|Adverse event unrelated to study drug|12|||
124919025|NCT03143153|449334203|FG000|Treatment|Participant request to discontinue study treatment|13|||
124919026|NCT03143153|449334204|FG001|Treatment|Participant request to discontinue study treatment|15|||
124919027|NCT03143153|449334205|FG002|Treatment|Participant request to discontinue study treatment|20|||
124919028|NCT03143153|449334203|FG000|Treatment|Participant withdrew consent|3|||
124919029|NCT03143153|449334204|FG001|Treatment|Participant withdrew consent|4|||
124919030|NCT03143153|449334205|FG002|Treatment|Participant withdrew consent|12|||
124919031|NCT03143153|449334203|FG000|Treatment|Pregnancy|1|||
124919032|NCT03143153|449334204|FG001|Treatment|Pregnancy|0|||
124919033|NCT03143153|449334205|FG002|Treatment|Pregnancy|0|||
124919034|NCT03143153|449334203|FG000|Treatment|Maximum clinical benefit|1|||
124919035|NCT03143153|449334204|FG001|Treatment|Maximum clinical benefit|3|||
124919036|NCT03143153|449334205|FG002|Treatment|Maximum clinical benefit|4|||
124919037|NCT03143153|449334203|FG000|Treatment|Completed treatment as per Protocol|13|||
124919038|NCT03143153|449334204|FG001|Treatment|Completed treatment as per Protocol|8|||
124919039|NCT03143153|449334205|FG002|Treatment|Completed treatment as per Protocol|0|||
124919040|NCT03143153|449334203|FG000|Treatment|Other reasons|12|||
124919041|NCT03143153|449334204|FG001|Treatment|Other reasons|7|||
125022838|NCT04418765|449707847|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
124919042|NCT03143153|449334205|FG002|Treatment|Other reasons|15|||
124919043|NCT03143153|449334203|FG000|Treatment|Not reported|1|||
124919044|NCT03143153|449334204|FG001|Treatment|Not reported|0|||
124919045|NCT03143153|449334205|FG002|Treatment|Not reported|0|||
124919046|NCT02312557|449334206|FG000|Overall Study|Survival follow-up|4|||
124919047|NCT04237298|449334207|FG000|Overall Study|Lost to Follow-up|4|||
124919048|NCT04237298|449334208|FG001|Overall Study|Lost to Follow-up|5|||
124919049|NCT01415154|449334214|FG000|Overall Study|Lack of Efficacy|4|||
124919050|NCT01415154|449334215|FG001|Overall Study|Lack of Efficacy|5|||
124919051|NCT01415154|449334214|FG000|Overall Study|Withdrawal by Subject|7|||
124919052|NCT01415154|449334215|FG001|Overall Study|Withdrawal by Subject|8|||
124919053|NCT01415154|449334214|FG000|Overall Study|Lost to Follow-up|1|||
124919054|NCT01415154|449334215|FG001|Overall Study|Lost to Follow-up|4|||
124919055|NCT01415154|449334214|FG000|Overall Study|Protocol Violation|0|||
124919056|NCT01415154|449334215|FG001|Overall Study|Protocol Violation|1|||
124919057|NCT01415154|449334214|FG000|Overall Study|Satisfactory Response|0|||
125022839|NCT04418765|449707848|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
125022840|NCT04418765|449707846|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
124919058|NCT01415154|449334215|FG001|Overall Study|Satisfactory Response|1|||
124919059|NCT01415154|449334214|FG000|Overall Study|Adverse Event|1|||
124919060|NCT01415154|449334215|FG001|Overall Study|Adverse Event|1|||
125022841|NCT04418765|449707847|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
124919061|NCT00170573|449334220|FG000|Overall Study|Violation of inclusion criteria|13|||
124919062|NCT04556656|449334222|FG000|Overall Study|Withdrawal by Subject|14|||
124919063|NCT04556656|449334223|FG001|Overall Study|Withdrawal by Subject|12|||
124919064|NCT04556656|449334222|FG000|Overall Study|Physician Decision|1|||
124919065|NCT04556656|449334223|FG001|Overall Study|Physician Decision|0|||
124919066|NCT04556656|449334222|FG000|Overall Study|Adverse Event|4|||
124919067|NCT04556656|449334223|FG001|Overall Study|Adverse Event|7|||
124919068|NCT04556656|449334222|FG000|Overall Study|Death|4|||
124919069|NCT04556656|449334223|FG001|Overall Study|Death|0|||
124919070|NCT04556656|449334222|FG000|Overall Study|Lost to Follow-up|3|||
124919071|NCT04556656|449334223|FG001|Overall Study|Lost to Follow-up|2|||
124919072|NCT04556656|449334222|FG000|Overall Study|Not further specified|2|||
124919073|NCT04556656|449334223|FG001|Overall Study|Not further specified|1|||
124919074|NCT05323084|449334245|FG000|Period 2 - Washout|Lost to Follow-up|0|||
124919075|NCT05323084|449334246|FG001|Period 2 - Washout|Lost to Follow-up|1|||
124919076|NCT04382404|449334247|FG000|Overall Study|Adverse Event|1|||
124919077|NCT04382404|449334247|FG000|Overall Study|Lost to Follow-up|2|||
124919078|NCT02960893|449334249|FG000|Randomization Phase (8-week)|Adverse Event|5|||
124919079|NCT02960893|449334250|FG001|Randomization Phase (8-week)|Adverse Event|0|||
124919080|NCT02960893|449334249|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
124919081|NCT02960893|449334250|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
124919082|NCT02960893|449334249|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
124919083|NCT02960893|449334250|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
124919084|NCT02960893|449334249|FG000|Extension Phase (48-week)|Adverse Event|2|||
124919085|NCT02960893|449334250|FG001|Extension Phase (48-week)|Adverse Event|3|||
124919086|NCT02960893|449334249|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
124919087|NCT02960893|449334250|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
124919088|NCT02960893|449334249|FG000|Extension Phase (48-week)|Other Reason|2|||
124919089|NCT02960893|449334250|FG001|Extension Phase (48-week)|Other Reason|1|||
124919090|NCT02960893|449334249|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
124919091|NCT02960893|449334250|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
124919092|NCT02960893|449334249|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
124919093|NCT02960893|449334250|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
124919094|NCT05687916|449334252|FG000|Overall Study|Adverse Event|1|||
124919095|NCT05687916|449334253|FG001|Overall Study|Adverse Event|2|||
124919096|NCT05687916|449334254|FG002|Overall Study|Adverse Event|0|||
124919097|NCT05687916|449334252|FG000|Overall Study|Withdrawal by Subject|1|||
124919098|NCT05687916|449334253|FG001|Overall Study|Withdrawal by Subject|0|||
124919099|NCT05687916|449334254|FG002|Overall Study|Withdrawal by Subject|1|||
124919100|NCT05687916|449334252|FG000|Overall Study|Protocol Violation|0|||
124919101|NCT05687916|449334253|FG001|Overall Study|Protocol Violation|2|||
124919102|NCT05687916|449334254|FG002|Overall Study|Protocol Violation|1|||
124919103|NCT05687916|449334252|FG000|Overall Study|Reason not Specified|1|||
124919104|NCT05687916|449334253|FG001|Overall Study|Reason not Specified|0|||
124919105|NCT05687916|449334254|FG002|Overall Study|Reason not Specified|0|||
124919106|NCT03792555|449334264|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
124919107|NCT03792555|449334265|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
124919108|NCT03792555|449334266|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
124919109|NCT03792555|449334264|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
124919110|NCT03792555|449334265|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
124919111|NCT03792555|449334266|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
124919112|NCT03792555|449334264|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
124919113|NCT03792555|449334265|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
124919114|NCT03792555|449334266|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
124919115|NCT04485039|449334267|FG000|TPOXX Only|Adverse Event|2|||
124919116|NCT04485039|449334267|FG000|TPOXX Only|Physician Decision|1|||
124919117|NCT04485039|449334267|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
124919118|NCT04485039|449334267|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
124919119|NCT04005716|449334268|FG000|Overall Study|Death|175|||
124919120|NCT04005716|449334269|FG001|Overall Study|Death|196|||
124919121|NCT04005716|449334268|FG000|Overall Study|Withdrawal by Subject|1|||
124919122|NCT04005716|449334269|FG001|Overall Study|Withdrawal by Subject|6|||
124919123|NCT04005716|449334268|FG000|Overall Study|Lost to Follow-up|2|||
124919124|NCT04005716|449334269|FG001|Overall Study|Lost to Follow-up|2|||
124919125|NCT04021602|449334272|FG000|Overall Study|Lost to Follow-up|3|||
124919126|NCT04021602|449334273|FG001|Overall Study|Lost to Follow-up|3|||
125022842|NCT04418765|449707848|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
125022843|NCT04418765|449707846|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
125022844|NCT04418765|449707847|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
124919127|NCT04021602|449334274|FG002|Overall Study|Lost to Follow-up|1|||
125022845|NCT04418765|449707848|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
125022846|NCT04418765|449707846|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
124919128|NCT04021602|449334272|FG000|Overall Study|Adverse Event|1|||
124919129|NCT04021602|449334273|FG001|Overall Study|Adverse Event|0|||
124919130|NCT04021602|449334274|FG002|Overall Study|Adverse Event|1|||
124919131|NCT02783300|449334275|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919132|NCT02783300|449334276|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919133|NCT02783300|449334277|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919134|NCT02783300|449334278|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919135|NCT02783300|449334279|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919136|NCT02783300|449334280|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919137|NCT02783300|449334281|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
124919138|NCT02783300|449334282|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919139|NCT02783300|449334283|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919140|NCT02783300|449334284|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919141|NCT02783300|449334285|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919142|NCT02783300|449334286|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919143|NCT02783300|449334287|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919144|NCT02783300|449334288|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919145|NCT02783300|449334289|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919146|NCT02783300|449334290|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919147|NCT02783300|449334291|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919148|NCT02783300|449334292|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919149|NCT02783300|449334293|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125022847|NCT04418765|449707847|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
125022848|NCT04418765|449707848|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
124919150|NCT02783300|449334294|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919151|NCT02783300|449334295|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919152|NCT02783300|449334296|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919153|NCT02783300|449334297|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919154|NCT02783300|449334298|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919155|NCT02783300|449334299|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919156|NCT02783300|449334300|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919157|NCT02783300|449334301|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919158|NCT02783300|449334275|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919159|NCT02783300|449334276|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919160|NCT02783300|449334277|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125022849|NCT04418765|449707846|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
125022850|NCT04418765|449707847|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
125022851|NCT04418765|449707848|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
125022852|NCT04418765|449707846|FG000|Extension Period (48 Weeks)|Other than specified|0|||
125022853|NCT04418765|449707847|FG001|Extension Period (48 Weeks)|Other than specified|5|||
125022854|NCT04418765|449707848|FG002|Extension Period (48 Weeks)|Other than specified|2|||
125022855|NCT01789970|449707849|FG000|Open-label Titration Period|Adverse Event|68|||
125022856|NCT01789970|449707850|FG001|Open-label Titration Period|Adverse Event|0|||
125022857|NCT01789970|449707851|FG002|Open-label Titration Period|Adverse Event|0|||
125022858|NCT01789970|449707849|FG000|Open-label Titration Period|Lack of Efficacy|31|||
125022859|NCT01789970|449707850|FG001|Open-label Titration Period|Lack of Efficacy|0|||
125022860|NCT01789970|449707851|FG002|Open-label Titration Period|Lack of Efficacy|0|||
125022861|NCT01789970|449707849|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
125022862|NCT01789970|449707850|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
125022863|NCT01789970|449707851|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
125022864|NCT01789970|449707849|FG000|Open-label Titration Period|Protocol Violation|18|||
125022865|NCT01789970|449707850|FG001|Open-label Titration Period|Protocol Violation|0|||
125022866|NCT01789970|449707851|FG002|Open-label Titration Period|Protocol Violation|0|||
125022867|NCT01789970|449707849|FG000|Open-label Titration Period|Lost to Follow-up|5|||
125022868|NCT01789970|449707850|FG001|Open-label Titration Period|Lost to Follow-up|0|||
125022869|NCT01789970|449707851|FG002|Open-label Titration Period|Lost to Follow-up|0|||
125022870|NCT01789970|449707849|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
125022871|NCT01789970|449707850|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
125022872|NCT01789970|449707851|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
125022873|NCT01789970|449707849|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
125022874|NCT01789970|449707850|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
125022875|NCT01789970|449707851|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
125022876|NCT01789970|449707849|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
125022877|NCT01789970|449707850|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
125022878|NCT01789970|449707851|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
124919161|NCT02783300|449334278|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
124919162|NCT02783300|449334279|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919163|NCT02783300|449334280|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919164|NCT02783300|449334281|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919165|NCT02783300|449334282|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919166|NCT02783300|449334283|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919167|NCT02783300|449334284|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919168|NCT02783300|449334285|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919169|NCT02783300|449334286|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919170|NCT02783300|449334287|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919171|NCT02783300|449334288|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919172|NCT02783300|449334289|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919173|NCT02783300|449334290|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919174|NCT02783300|449334291|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919175|NCT02783300|449334292|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919176|NCT02783300|449334293|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919177|NCT02783300|449334294|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919178|NCT02783300|449334295|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919179|NCT02783300|449334296|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919180|NCT02783300|449334297|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919181|NCT02783300|449334298|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919182|NCT02783300|449334299|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919183|NCT02783300|449334300|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919184|NCT02783300|449334301|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919185|NCT02783300|449334275|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
124919186|NCT02783300|449334276|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
125022879|NCT01789970|449707849|FG000|Open-label Titration Period|Pregnancy|2|||
125022880|NCT01789970|449707850|FG001|Open-label Titration Period|Pregnancy|0|||
125022881|NCT01789970|449707851|FG002|Open-label Titration Period|Pregnancy|0|||
124919187|NCT02783300|449334277|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
124919188|NCT02783300|449334278|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
124919189|NCT02783300|449334279|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
124919190|NCT02783300|449334280|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
124919191|NCT02783300|449334281|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
124919192|NCT02783300|449334282|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
125022882|NCT01789970|449707849|FG000|Open-label Titration Period|Other|76|||
125022883|NCT01789970|449707850|FG001|Open-label Titration Period|Other|0|||
125022884|NCT01789970|449707851|FG002|Open-label Titration Period|Other|0|||
125022885|NCT01789970|449707849|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
124919193|NCT02783300|449334283|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
124919194|NCT02783300|449334284|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
124919195|NCT02783300|449334285|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
124919196|NCT02783300|449334286|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
124919197|NCT02783300|449334287|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
124919198|NCT02783300|449334288|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
124919199|NCT02783300|449334289|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
124919200|NCT02783300|449334290|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
124919201|NCT02783300|449334291|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
124919202|NCT02783300|449334292|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
124919203|NCT02783300|449334293|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
124919204|NCT02783300|449334294|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
124919205|NCT02783300|449334295|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
124919206|NCT02783300|449334296|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
124919207|NCT02783300|449334297|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
124919208|NCT02783300|449334298|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
124919209|NCT02783300|449334299|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
124919210|NCT02783300|449334300|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
124919211|NCT02783300|449334301|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
124919212|NCT02783300|449334275|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919213|NCT02783300|449334276|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919214|NCT02783300|449334277|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919215|NCT02783300|449334278|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919216|NCT02783300|449334279|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919217|NCT02783300|449334280|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919218|NCT02783300|449334281|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
124919219|NCT02783300|449334282|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919220|NCT02783300|449334283|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919221|NCT02783300|449334284|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919222|NCT02783300|449334285|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919223|NCT02783300|449334286|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919224|NCT02783300|449334287|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
124919225|NCT02783300|449334288|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919226|NCT02783300|449334289|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919227|NCT02783300|449334290|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919228|NCT02783300|449334291|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919229|NCT02783300|449334292|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919230|NCT02783300|449334293|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919231|NCT02783300|449334294|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919232|NCT02783300|449334295|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919233|NCT02783300|449334296|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919234|NCT02783300|449334297|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919235|NCT02783300|449334298|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919236|NCT02783300|449334299|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919237|NCT02783300|449334300|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919238|NCT02783300|449334301|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919239|NCT02783300|449334275|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919240|NCT02783300|449334276|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919241|NCT02783300|449334277|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919242|NCT02783300|449334278|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919243|NCT02783300|449334279|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
125022886|NCT01789970|449707850|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
125022887|NCT01789970|449707851|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
125022888|NCT01789970|449707849|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
125022889|NCT01789970|449707850|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
125022890|NCT01789970|449707851|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
124919244|NCT02783300|449334280|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125022891|NCT01789970|449707849|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
124919245|NCT02783300|449334281|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
124919246|NCT02783300|449334282|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919247|NCT02783300|449334283|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919248|NCT02783300|449334284|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
124919249|NCT02783300|449334285|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919250|NCT02783300|449334286|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919251|NCT02783300|449334287|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
124919252|NCT02783300|449334288|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919253|NCT02783300|449334289|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919254|NCT02783300|449334290|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919255|NCT02783300|449334291|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919256|NCT02783300|449334292|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919257|NCT02783300|449334293|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919258|NCT02783300|449334294|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919259|NCT02783300|449334295|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919260|NCT02783300|449334296|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919261|NCT02783300|449334297|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919262|NCT02783300|449334298|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919263|NCT02783300|449334299|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919264|NCT02783300|449334300|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919265|NCT02783300|449334301|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919266|NCT02783300|449334275|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919267|NCT02783300|449334276|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919268|NCT02783300|449334277|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919269|NCT02783300|449334278|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919270|NCT02783300|449334279|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919271|NCT02783300|449334280|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919272|NCT02783300|449334281|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919273|NCT02783300|449334282|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919274|NCT02783300|449334283|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919275|NCT02783300|449334284|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919276|NCT02783300|449334285|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919277|NCT02783300|449334286|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919278|NCT02783300|449334287|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919279|NCT02783300|449334288|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919280|NCT02783300|449334289|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919281|NCT02783300|449334290|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
124919282|NCT02783300|449334291|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919283|NCT02783300|449334292|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
124919284|NCT02783300|449334293|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
124919285|NCT02783300|449334294|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
124919286|NCT02783300|449334295|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919287|NCT02783300|449334296|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919288|NCT02783300|449334297|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919289|NCT02783300|449334298|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919290|NCT02783300|449334299|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
124919291|NCT02783300|449334300|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919292|NCT02783300|449334301|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919293|NCT02783300|449334275|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919294|NCT02783300|449334276|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919295|NCT02783300|449334277|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919296|NCT02783300|449334278|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919297|NCT02783300|449334279|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919298|NCT02783300|449334280|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919299|NCT02783300|449334281|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919300|NCT02783300|449334282|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919301|NCT02783300|449334283|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919302|NCT02783300|449334284|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919303|NCT02783300|449334285|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125211841|NCT00048165|450401386|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
125211842|NCT00048165|450401385|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
125211843|NCT00048165|450401386|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
124919304|NCT02783300|449334286|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919305|NCT02783300|449334287|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919306|NCT02783300|449334288|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919307|NCT02783300|449334289|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919308|NCT02783300|449334290|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919309|NCT02783300|449334291|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
124919310|NCT02783300|449334292|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919311|NCT02783300|449334293|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
124919312|NCT02783300|449334294|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
124919313|NCT02783300|449334295|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919314|NCT02783300|449334296|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919315|NCT02783300|449334297|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919316|NCT02783300|449334298|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919317|NCT02783300|449334299|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919318|NCT02783300|449334300|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919319|NCT02783300|449334301|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919320|NCT02783300|449334275|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919321|NCT02783300|449334276|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919322|NCT02783300|449334277|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919323|NCT02783300|449334278|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919324|NCT02783300|449334279|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919325|NCT02783300|449334280|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919326|NCT02783300|449334281|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919327|NCT02783300|449334282|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919328|NCT02783300|449334283|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919329|NCT02783300|449334284|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919330|NCT02783300|449334285|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919331|NCT02783300|449334286|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919332|NCT02783300|449334287|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919333|NCT02783300|449334288|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919334|NCT02783300|449334289|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919335|NCT02783300|449334290|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919336|NCT02783300|449334291|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
124919337|NCT02783300|449334292|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919338|NCT02783300|449334293|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
124919339|NCT02783300|449334294|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
124919340|NCT02783300|449334295|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
124919341|NCT02783300|449334296|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919342|NCT02783300|449334297|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919343|NCT02783300|449334298|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919344|NCT02783300|449334299|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919345|NCT02783300|449334300|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919346|NCT02783300|449334301|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919347|NCT02783300|449334275|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919348|NCT02783300|449334276|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919349|NCT02783300|449334277|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919350|NCT02783300|449334278|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919351|NCT02783300|449334279|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919352|NCT02783300|449334280|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919353|NCT02783300|449334281|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919354|NCT02783300|449334282|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919355|NCT02783300|449334283|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919356|NCT02783300|449334284|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919357|NCT02783300|449334285|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919358|NCT02783300|449334286|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919359|NCT02783300|449334287|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919360|NCT02783300|449334288|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919361|NCT02783300|449334289|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919362|NCT02783300|449334290|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
124919363|NCT02783300|449334291|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919364|NCT02783300|449334292|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919365|NCT02783300|449334293|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919366|NCT02783300|449334294|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919367|NCT02783300|449334295|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919368|NCT02783300|449334296|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919369|NCT02783300|449334297|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
124919370|NCT02783300|449334298|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919371|NCT02783300|449334299|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919372|NCT02783300|449334300|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919373|NCT02783300|449334301|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919374|NCT02783300|449334275|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919375|NCT02783300|449334276|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919376|NCT02783300|449334277|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919377|NCT02783300|449334278|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919378|NCT02783300|449334279|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919379|NCT02783300|449334280|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919380|NCT02783300|449334281|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919381|NCT02783300|449334282|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919382|NCT02783300|449334283|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919383|NCT02783300|449334284|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919384|NCT02783300|449334285|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919385|NCT02783300|449334286|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919386|NCT02783300|449334287|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919387|NCT02783300|449334288|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
124919388|NCT02783300|449334289|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
124919389|NCT02783300|449334290|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
124919390|NCT02783300|449334291|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
124919391|NCT02783300|449334292|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919392|NCT02783300|449334293|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
124919393|NCT02783300|449334294|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
124919394|NCT02783300|449334295|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919395|NCT02783300|449334296|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919396|NCT02783300|449334297|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919397|NCT02783300|449334298|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919398|NCT02783300|449334299|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919399|NCT02783300|449334300|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919400|NCT02783300|449334301|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919401|NCT02783300|449334275|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919402|NCT02783300|449334276|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919403|NCT02783300|449334277|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919404|NCT02783300|449334278|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919405|NCT02783300|449334279|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919406|NCT02783300|449334280|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919407|NCT02783300|449334281|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919408|NCT02783300|449334282|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919409|NCT02783300|449334283|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919410|NCT02783300|449334284|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919411|NCT02783300|449334285|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919412|NCT02783300|449334286|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919413|NCT02783300|449334287|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919414|NCT02783300|449334288|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
124919415|NCT02783300|449334289|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
124919416|NCT02783300|449334290|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
124919417|NCT02783300|449334291|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
124919418|NCT02783300|449334292|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
124919419|NCT02783300|449334293|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
124919420|NCT02783300|449334294|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
124919421|NCT02783300|449334295|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
124919422|NCT02783300|449334296|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
124919423|NCT02783300|449334297|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
124919424|NCT02783300|449334298|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
124919425|NCT02783300|449334299|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
124919426|NCT02783300|449334300|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
124919427|NCT02783300|449334301|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919428|NCT02783300|449334275|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919429|NCT02783300|449334276|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919430|NCT02783300|449334277|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919431|NCT02783300|449334278|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919432|NCT02783300|449334279|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919433|NCT02783300|449334280|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919434|NCT02783300|449334281|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919435|NCT02783300|449334282|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919436|NCT02783300|449334283|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919437|NCT02783300|449334284|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919438|NCT02783300|449334285|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919439|NCT02783300|449334286|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919440|NCT02783300|449334287|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919441|NCT02783300|449334288|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919442|NCT02783300|449334289|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919443|NCT02783300|449334290|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919444|NCT02783300|449334291|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919445|NCT02783300|449334292|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919446|NCT02783300|449334293|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919447|NCT02783300|449334294|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919448|NCT02783300|449334295|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919449|NCT02783300|449334296|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919450|NCT02783300|449334297|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919451|NCT02783300|449334298|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919452|NCT02783300|449334299|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919453|NCT02783300|449334300|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919454|NCT02783300|449334301|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
124919455|NCT02783300|449334275|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919456|NCT02783300|449334276|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919457|NCT02783300|449334277|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919458|NCT02783300|449334278|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919459|NCT02783300|449334279|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919460|NCT02783300|449334280|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919461|NCT02783300|449334281|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919462|NCT02783300|449334282|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919463|NCT02783300|449334283|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919464|NCT02783300|449334284|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919465|NCT02783300|449334285|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919466|NCT02783300|449334286|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919467|NCT02783300|449334287|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919468|NCT02783300|449334288|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919469|NCT02783300|449334289|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919470|NCT02783300|449334290|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919471|NCT02783300|449334291|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919472|NCT02783300|449334292|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919473|NCT02783300|449334293|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919474|NCT02783300|449334294|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919475|NCT02783300|449334295|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919476|NCT02783300|449334296|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919477|NCT02783300|449334297|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919478|NCT02783300|449334298|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919479|NCT02783300|449334299|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919480|NCT02783300|449334300|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919481|NCT02783300|449334301|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
124919482|NCT03535272|449334302|FG000|Overall Study|Lost to Follow-up|71|||
124919483|NCT03535272|449334303|FG001|Overall Study|Lost to Follow-up|73|||
124919484|NCT03892616|449334306|FG000|Washout Period 2|Met discontinuation criterion|0|||
124919485|NCT03892616|449334307|FG001|Washout Period 2|Met discontinuation criterion|0|||
125116591|NCT00310856|450049882|FG000|Overall Study|Unable to classify|1|||
124919486|NCT03892616|449334308|FG002|Washout Period 2|Met discontinuation criterion|0|||
124919487|NCT03892616|449334309|FG003|Washout Period 2|Met discontinuation criterion|0|||
124919488|NCT03892616|449334310|FG004|Washout Period 2|Met discontinuation criterion|0|||
124919489|NCT03892616|449334311|FG005|Washout Period 2|Met discontinuation criterion|0|||
124919490|NCT03892616|449334312|FG006|Washout Period 2|Met discontinuation criterion|0|||
124919491|NCT03892616|449334313|FG007|Washout Period 2|Met discontinuation criterion|0|||
124919492|NCT03892616|449334314|FG008|Washout Period 2|Met discontinuation criterion|1|||
124919493|NCT03892616|449334315|FG009|Washout Period 2|Met discontinuation criterion|0|||
124919494|NCT03892616|449334316|FG010|Washout Period 2|Met discontinuation criterion|0|||
124919495|NCT03892616|449334317|FG011|Washout Period 2|Met discontinuation criterion|0|||
124919496|NCT00378105|449334318|FG000|Overall Study|Adverse Event|3|||
124919497|NCT00378105|449334319|FG001|Overall Study|Adverse Event|1|||
124919498|NCT00378105|449334318|FG000|Overall Study|Withdrawal by Subject|3|||
124919499|NCT00378105|449334319|FG001|Overall Study|Withdrawal by Subject|3|||
124919500|NCT00378105|449334318|FG000|Overall Study|Death|1|||
124919501|NCT00378105|449334319|FG001|Overall Study|Death|0|||
124919502|NCT00378105|449334318|FG000|Overall Study|Going to transplant|7|||
124919503|NCT00378105|449334319|FG001|Overall Study|Going to transplant|8|||
124919504|NCT00378105|449334318|FG000|Overall Study|Progressive disease|3|||
124919505|NCT00378105|449334319|FG001|Overall Study|Progressive disease|3|||
124919506|NCT00378105|449334318|FG000|Overall Study|remain on study|3|||
124919507|NCT00378105|449334319|FG001|Overall Study|remain on study|11|||
124919508|NCT00378105|449334318|FG000|Overall Study|Physician Decision|0|||
124919509|NCT00378105|449334319|FG001|Overall Study|Physician Decision|2|||
124919510|NCT00378105|449334318|FG000|Overall Study|Going non-protocol therapy|0|||
124919511|NCT00378105|449334319|FG001|Overall Study|Going non-protocol therapy|1|||
124919512|NCT00378105|449334318|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
124919513|NCT00378105|449334319|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
124919514|NCT05192200|449334320|FG000|Treatment Period|Other|1|||
124919515|NCT05192200|449334320|FG000|Treatment Period|Lack of Efficacy|1|||
124919516|NCT05192200|449334320|FG000|Treatment Period|Withdrawal by Subject|1|||
124919517|NCT05192200|449334320|FG000|Follow-up|Withdrawal by Subject|1|||
124919518|NCT03907397|449334321|FG000|Overall Study|Lost to Follow-up|0|||
124919519|NCT03907397|449334322|FG001|Overall Study|Lost to Follow-up|1|||
124919520|NCT03907397|449334321|FG000|Overall Study|Physician Decision|2|||
124919521|NCT03907397|449334322|FG001|Overall Study|Physician Decision|1|||
124919522|NCT03907397|449334321|FG000|Overall Study|Withdrawal by Subject|5|||
124919523|NCT03907397|449334322|FG001|Overall Study|Withdrawal by Subject|4|||
124919524|NCT03907397|449334321|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
124919525|NCT03907397|449334322|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
124919526|NCT03930342|449334334|FG000|Overall Study|Lost to Follow-up|70|||
124919527|NCT03930342|449334335|FG001|Overall Study|Lost to Follow-up|77|||
124919528|NCT05021640|449336101|FG000|Overall Study|Lost to Follow-up|0|||
124919529|NCT05021640|449336102|FG001|Overall Study|Lost to Follow-up|0|||
124919530|NCT05021640|449336103|FG002|Overall Study|Lost to Follow-up|0|||
124919531|NCT05021640|449336104|FG003|Overall Study|Lost to Follow-up|0|||
124919532|NCT05021640|449336105|FG004|Overall Study|Lost to Follow-up|1|||
124919533|NCT04737772|449336106|FG000|Phase 2 Study|Lost to Follow-up|15|||
124919534|NCT04737772|449336107|FG001|Phase 2 Study|Lost to Follow-up|15|||
124919535|NCT04737772|449336106|FG000|Phase 2 Study|Withdrawal by Subject|0|||
124919536|NCT04737772|449336107|FG001|Phase 2 Study|Withdrawal by Subject|1|||
124919537|NCT04737772|449336106|FG000|Phase 2 Study|Did not take any coaching calls|4|||
124919538|NCT04737772|449336107|FG001|Phase 2 Study|Did not take any coaching calls|0|||
124919539|NCT04737772|449336106|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
124919540|NCT04737772|449336107|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
124919541|NCT04737772|449336106|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
124919542|NCT04737772|449336107|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
124919543|NCT05691309|449336108|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
124919544|NCT05691309|449336108|FG000|Overall Study|vancomycin levels not evaluable|2|||
124919545|NCT03376321|449336110|FG000|Overall Study|Other|5|||
124919546|NCT03376321|449336111|FG001|Overall Study|Other|1|||
124919547|NCT03376321|449336110|FG000|Overall Study|Withdrawal by Subject|8|||
124919548|NCT03376321|449336111|FG001|Overall Study|Withdrawal by Subject|14|||
124919549|NCT03376321|449336110|FG000|Overall Study|Lost to Follow-up|1|||
124919550|NCT03376321|449336111|FG001|Overall Study|Lost to Follow-up|7|||
124919551|NCT03376321|449336110|FG000|Overall Study|Death|4|||
124919552|NCT03376321|449336111|FG001|Overall Study|Death|0|||
124919553|NCT03376321|449336110|FG000|Overall Study|Randomized, not treated|5|||
124919554|NCT03376321|449336111|FG001|Overall Study|Randomized, not treated|3|||
124919555|NCT02992925|449336116|FG000|Cohort 2|Physician Decision|0|||
125022892|NCT01789970|449707850|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
125022893|NCT01789970|449707851|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
125211844|NCT00048165|450401385|FG000|Completed 6 Months Study|Death|12|||
125211845|NCT00048165|450401386|FG001|Completed 6 Months Study|Death|6|||
124919556|NCT02992925|449336117|FG001|Cohort 2|Physician Decision|0|||
124919557|NCT02992925|449336118|FG002|Cohort 2|Physician Decision|1|||
124919558|NCT02992925|449336119|FG003|Cohort 2|Physician Decision|0|||
124919559|NCT02992925|449336116|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
124919560|NCT02992925|449336117|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
124919561|NCT02992925|449336118|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
124919562|NCT02992925|449336119|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
124919563|NCT01804816|449336120|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
124919564|NCT01804816|449336120|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
124919565|NCT04421378|449336126|FG000|Overall Study|Adverse Event|2|||
124919566|NCT04421378|449336127|FG001|Overall Study|Adverse Event|7|||
124919567|NCT04421378|449336128|FG002|Overall Study|Adverse Event|0|||
124919568|NCT04421378|449336129|FG003|Overall Study|Adverse Event|1|||
124919569|NCT04421378|449336130|FG004|Overall Study|Adverse Event|0|||
124919570|NCT04421378|449336126|FG000|Overall Study|Physician Decision|1|||
124919571|NCT04421378|449336127|FG001|Overall Study|Physician Decision|2|||
124919572|NCT04421378|449336128|FG002|Overall Study|Physician Decision|0|||
124919573|NCT04421378|449336129|FG003|Overall Study|Physician Decision|0|||
124919574|NCT04421378|449336130|FG004|Overall Study|Physician Decision|0|||
124919575|NCT04421378|449336126|FG000|Overall Study|Progressive Disease|16|||
124919576|NCT04421378|449336127|FG001|Overall Study|Progressive Disease|4|||
124919577|NCT04421378|449336128|FG002|Overall Study|Progressive Disease|18|||
124919578|NCT04421378|449336129|FG003|Overall Study|Progressive Disease|11|||
124919579|NCT04421378|449336130|FG004|Overall Study|Progressive Disease|3|||
124919580|NCT04421378|449336126|FG000|Overall Study|Study Terminated by Sponsor|0|||
124919581|NCT04421378|449336127|FG001|Overall Study|Study Terminated by Sponsor|1|||
124919582|NCT04421378|449336128|FG002|Overall Study|Study Terminated by Sponsor|1|||
124919583|NCT04421378|449336129|FG003|Overall Study|Study Terminated by Sponsor|0|||
124919584|NCT04421378|449336130|FG004|Overall Study|Study Terminated by Sponsor|0|||
124919585|NCT04421378|449336126|FG000|Overall Study|Withdrawal by Subject|3|||
124919586|NCT04421378|449336127|FG001|Overall Study|Withdrawal by Subject|1|||
124919587|NCT04421378|449336128|FG002|Overall Study|Withdrawal by Subject|0|||
124919588|NCT04421378|449336129|FG003|Overall Study|Withdrawal by Subject|2|||
124919589|NCT04421378|449336130|FG004|Overall Study|Withdrawal by Subject|0|||
124919590|NCT04421378|449336126|FG000|Overall Study|Other|1|||
124919591|NCT04421378|449336127|FG001|Overall Study|Other|0|||
124919592|NCT04421378|449336128|FG002|Overall Study|Other|0|||
124919593|NCT04421378|449336129|FG003|Overall Study|Other|0|||
124919594|NCT04421378|449336130|FG004|Overall Study|Other|0|||
124919595|NCT04150718|449336131|FG000|Overall Study|Withdrawal by Subject|2|||
124919596|NCT04150718|449336132|FG001|Overall Study|Withdrawal by Subject|7|||
124919597|NCT04150718|449336133|FG002|Overall Study|Withdrawal by Subject|1|||
124919598|NCT04150718|449336131|FG000|Overall Study|Lost to Follow-up|1|||
124919599|NCT04150718|449336132|FG001|Overall Study|Lost to Follow-up|2|||
124919600|NCT04150718|449336133|FG002|Overall Study|Lost to Follow-up|0|||
124919601|NCT04150718|449336131|FG000|Overall Study|Ineligible|1|||
124919602|NCT04150718|449336132|FG001|Overall Study|Ineligible|0|||
124919603|NCT04150718|449336133|FG002|Overall Study|Ineligible|10|||
124919604|NCT02592330|449336134|FG000|Overall Study|Withdrawal by Subject|1|||
124919605|NCT02592330|449336135|FG001|Overall Study|Withdrawal by Subject|0|||
124919606|NCT02592330|449336134|FG000|Overall Study|Failed Biopsy|1|||
124919607|NCT02592330|449336135|FG001|Overall Study|Failed Biopsy|0|||
124919608|NCT03090152|449336136|FG000|Overall Study|Withdrawal by Subject|0|||
124919609|NCT03090152|449336137|FG001|Overall Study|Withdrawal by Subject|2|||
124919610|NCT03090152|449336138|FG002|Overall Study|Withdrawal by Subject|1|||
124919611|NCT03090152|449336136|FG000|Overall Study|Surgery Canceled|1|||
124919612|NCT03090152|449336137|FG001|Overall Study|Surgery Canceled|0|||
124919613|NCT03090152|449336138|FG002|Overall Study|Surgery Canceled|0|||
124919614|NCT03090152|449336136|FG000|Overall Study|Epidural catheter could not be placed|0|||
124919615|NCT03090152|449336137|FG001|Overall Study|Epidural catheter could not be placed|2|||
124919616|NCT03090152|449336138|FG002|Overall Study|Epidural catheter could not be placed|0|||
124919617|NCT03958955|449336139|FG000|Overall Study|Adverse Event|1|||
124919618|NCT04673929|449336140|FG000|Overall Study|Death|73|||
124919619|NCT04673929|449336140|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
124919620|NCT02927769|449336142|FG000|Induction Phase|Study drug toxicity|1|||
124919621|NCT02927769|449336143|FG001|Induction Phase|Study drug toxicity|1|||
124919622|NCT02927769|449336142|FG000|Induction Phase|Disease progression|0|||
124919623|NCT02927769|449336143|FG001|Induction Phase|Disease progression|1|||
124919624|NCT02927769|449336142|FG000|Intensification Phase|Study drug toxicity|1|||
124919625|NCT02927769|449336143|FG001|Intensification Phase|Study drug toxicity|0|||
124919626|NCT02807636|449336144|FG000|Overall Study|Lost to Follow-up|10|||
124919627|NCT02807636|449336145|FG001|Overall Study|Lost to Follow-up|13|||
124919628|NCT02807636|449336146|FG002|Overall Study|Lost to Follow-up|6|||
124919629|NCT02807636|449336144|FG000|Overall Study|Protocol Deviation|1|||
124919630|NCT02807636|449336145|FG001|Overall Study|Protocol Deviation|0|||
124919631|NCT02807636|449336146|FG002|Overall Study|Protocol Deviation|0|||
124919632|NCT02807636|449336144|FG000|Overall Study|Symptomatic Deterioration|0|||
124919633|NCT02807636|449336145|FG001|Overall Study|Symptomatic Deterioration|1|||
124919634|NCT02807636|449336146|FG002|Overall Study|Symptomatic Deterioration|0|||
124919635|NCT02807636|449336144|FG000|Overall Study|Withdrawal by Subject|39|||
124919636|NCT02807636|449336145|FG001|Overall Study|Withdrawal by Subject|28|||
124919637|NCT02807636|449336146|FG002|Overall Study|Withdrawal by Subject|24|||
124919638|NCT02807636|449336144|FG000|Overall Study|Death|303|||
124919639|NCT02807636|449336145|FG001|Overall Study|Death|332|||
124919640|NCT02807636|449336146|FG002|Overall Study|Death|272|||
125022894|NCT01789970|449707849|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
125022895|NCT01789970|449707850|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
125022896|NCT01789970|449707851|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
124919641|NCT02807636|449336144|FG000|Overall Study|Study Terminated By Sponsor|47|||
124919642|NCT02807636|449336145|FG001|Overall Study|Study Terminated By Sponsor|76|||
124919643|NCT02807636|449336146|FG002|Overall Study|Study Terminated By Sponsor|60|||
124919644|NCT02807636|449336144|FG000|Overall Study|Physician Decision|0|||
124919645|NCT02807636|449336145|FG001|Overall Study|Physician Decision|1|||
125022897|NCT01789970|449707849|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
125022898|NCT01789970|449707850|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
125022899|NCT01789970|449707851|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
125022900|NCT01789970|449707849|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
125022901|NCT01789970|449707850|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
125022902|NCT01789970|449707851|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
125022903|NCT01789970|449707849|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
125116592|NCT00310856|450049883|FG001|Overall Study|Unable to classify|0|||
124919646|NCT02807636|449336146|FG002|Overall Study|Physician Decision|0|||
124919647|NCT04088630|449336147|FG000|Overall Study|Lost to Follow-up|3|||
124919648|NCT04088630|449336148|FG001|Overall Study|Lost to Follow-up|2|||
124919649|NCT04088630|449336149|FG002|Overall Study|Lost to Follow-up|6|||
124919650|NCT04088630|449336147|FG000|Overall Study|Death|3|||
124919651|NCT04088630|449336148|FG001|Overall Study|Death|1|||
124919652|NCT04088630|449336149|FG002|Overall Study|Death|1|||
124919653|NCT04088630|449336147|FG000|Overall Study|Physician Decision|0|||
124919654|NCT04088630|449336148|FG001|Overall Study|Physician Decision|1|||
124919655|NCT04088630|449336149|FG002|Overall Study|Physician Decision|1|||
124919656|NCT03315754|449336150|FG000|Overall Study|COVID-19 complications leading to death|1|||
124919657|NCT03315754|449336150|FG000|Overall Study|insurance coverage issue|1|||
124919658|NCT04024813|449336151|FG000|Overall Study|Study terminated by Sponsor|1|||
124919659|NCT05034952|449336152|FG000|Overall Study|Adverse Event|1|||
124919660|NCT05034952|449336153|FG001|Overall Study|Adverse Event|0|||
124919661|NCT05034952|449336154|FG002|Overall Study|Adverse Event|0|||
124919662|NCT05034952|449336155|FG003|Overall Study|Adverse Event|0|||
124919663|NCT05034952|449336152|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
124919664|NCT05034952|449336153|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
124919665|NCT05034952|449336154|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
124919666|NCT05034952|449336155|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
124919667|NCT05034952|449336152|FG000|Overall Study|Lost to Follow-up|1|||
124919668|NCT05034952|449336153|FG001|Overall Study|Lost to Follow-up|4|||
124919669|NCT05034952|449336154|FG002|Overall Study|Lost to Follow-up|3|||
124919670|NCT05034952|449336155|FG003|Overall Study|Lost to Follow-up|3|||
124919671|NCT05034952|449336152|FG000|Overall Study|Other|0|||
124919672|NCT05034952|449336153|FG001|Overall Study|Other|0|||
124919673|NCT05034952|449336154|FG002|Overall Study|Other|0|||
124919674|NCT05034952|449336155|FG003|Overall Study|Other|1|||
124919675|NCT04783935|449336172|FG000|Overall Study|Withdrawal by Subject|6|||
124919676|NCT04783935|449336172|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
124919677|NCT04783935|449336172|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
124919678|NCT04783935|449336172|FG000|Overall Study|Lost to Follow-up|3|||
124919679|NCT04783935|449336172|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
124919680|NCT02437318|449336174|FG000|Overall Study|Progressive disease|207|||
124919681|NCT02437318|449336175|FG001|Overall Study|Progressive disease|240|||
124919682|NCT02437318|449336174|FG000|Overall Study|Subject/guardian decision|24|||
124919683|NCT02437318|449336175|FG001|Overall Study|Subject/guardian decision|11|||
124919684|NCT02437318|449336174|FG000|Overall Study|Physician Decision|29|||
124919685|NCT02437318|449336175|FG001|Overall Study|Physician Decision|22|||
124919686|NCT02437318|449336174|FG000|Overall Study|Adverse Event|14|||
124919687|NCT02437318|449336175|FG001|Overall Study|Adverse Event|4|||
124919688|NCT02437318|449336174|FG000|Overall Study|Death|4|||
124919689|NCT02437318|449336175|FG001|Overall Study|Death|4|||
124919690|NCT02437318|449336174|FG000|Overall Study|Protocol deviation|5|||
124919691|NCT02437318|449336175|FG001|Overall Study|Protocol deviation|7|||
124919692|NCT02437318|449336174|FG000|Overall Study|Sponsor decision|1|||
124919693|NCT02437318|449336175|FG001|Overall Study|Sponsor decision|0|||
124919694|NCT00920621|449336178|FG000|Overall Study|Lost to Follow-up|16|||
124919695|NCT00920621|449336179|FG001|Overall Study|Lost to Follow-up|17|||
124919696|NCT00920621|449336180|FG002|Overall Study|Lost to Follow-up|19|||
124919697|NCT00920621|449336181|FG003|Overall Study|Lost to Follow-up|21|||
124919698|NCT00920621|449336178|FG000|Overall Study|Fetal/neonatal deaths|16|||
124919699|NCT00920621|449336179|FG001|Overall Study|Fetal/neonatal deaths|14|||
124919700|NCT00920621|449336180|FG002|Overall Study|Fetal/neonatal deaths|16|||
124919701|NCT00920621|449336181|FG003|Overall Study|Fetal/neonatal deaths|14|||
124919702|NCT00920621|449336178|FG000|Overall Study|Blood sample not collected|22|||
124919703|NCT00920621|449336179|FG001|Overall Study|Blood sample not collected|14|||
124919704|NCT00920621|449336180|FG002|Overall Study|Blood sample not collected|0|||
124919705|NCT00920621|449336181|FG003|Overall Study|Blood sample not collected|0|||
124919706|NCT04245501|449336182|FG000|Overall Study|Adverse Event|2|||
124919707|NCT04245501|449336183|FG001|Overall Study|Adverse Event|0|||
124919708|NCT04245501|449336182|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
124919709|NCT04245501|449336183|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
124919710|NCT00961571|449336184|FG000|Overall Study|Physician Decision|39|||
124919711|NCT05337748|449336191|FG000|Overall Study|Withdrawal by Subject|1|||
124919712|NCT05337748|449336192|FG001|Overall Study|Withdrawal by Subject|0|||
124919713|NCT05337748|449336191|FG000|Overall Study|Death|1|||
124919714|NCT05337748|449336192|FG001|Overall Study|Death|0|||
124919715|NCT04321031|449336195|FG000|Overall Study|Adverse Event|0|||
124919716|NCT04321031|449336196|FG001|Overall Study|Adverse Event|2|||
124919717|NCT04321031|449336197|FG002|Overall Study|Adverse Event|2|||
124919718|NCT04321031|449336198|FG003|Overall Study|Adverse Event|2|||
124919719|NCT04321031|449336199|FG004|Overall Study|Adverse Event|2|||
124919720|NCT04321031|449336200|FG005|Overall Study|Adverse Event|2|||
124919721|NCT04321031|449336201|FG006|Overall Study|Adverse Event|0|||
124919722|NCT04321031|449336195|FG000|Overall Study|Lost to Follow-up|0|||
124919723|NCT04321031|449336196|FG001|Overall Study|Lost to Follow-up|0|||
124919724|NCT04321031|449336197|FG002|Overall Study|Lost to Follow-up|0|||
124919725|NCT04321031|449336198|FG003|Overall Study|Lost to Follow-up|1|||
124919726|NCT04321031|449336199|FG004|Overall Study|Lost to Follow-up|0|||
124919727|NCT04321031|449336200|FG005|Overall Study|Lost to Follow-up|2|||
124919728|NCT04321031|449336201|FG006|Overall Study|Lost to Follow-up|1|||
124919729|NCT04321031|449336195|FG000|Overall Study|Withdrawal by Subject|2|||
124919730|NCT04321031|449336196|FG001|Overall Study|Withdrawal by Subject|2|||
124919731|NCT04321031|449336197|FG002|Overall Study|Withdrawal by Subject|1|||
124919732|NCT04321031|449336198|FG003|Overall Study|Withdrawal by Subject|3|||
124919733|NCT04321031|449336199|FG004|Overall Study|Withdrawal by Subject|1|||
124919734|NCT04321031|449336200|FG005|Overall Study|Withdrawal by Subject|0|||
124919735|NCT04321031|449336201|FG006|Overall Study|Withdrawal by Subject|1|||
124919736|NCT04321031|449336195|FG000|Overall Study|Non-compliance with study drug|0|||
124919737|NCT04321031|449336196|FG001|Overall Study|Non-compliance with study drug|0|||
124919738|NCT04321031|449336197|FG002|Overall Study|Non-compliance with study drug|0|||
124919739|NCT04321031|449336198|FG003|Overall Study|Non-compliance with study drug|0|||
124919740|NCT04321031|449336199|FG004|Overall Study|Non-compliance with study drug|0|||
124919741|NCT04321031|449336200|FG005|Overall Study|Non-compliance with study drug|1|||
124919742|NCT04321031|449336201|FG006|Overall Study|Non-compliance with study drug|0|||
124919743|NCT04321031|449336195|FG000|Overall Study|Other|0|||
124919744|NCT04321031|449336196|FG001|Overall Study|Other|0|||
124919745|NCT04321031|449336197|FG002|Overall Study|Other|0|||
124919746|NCT04321031|449336198|FG003|Overall Study|Other|1|||
124919747|NCT04321031|449336199|FG004|Overall Study|Other|0|||
124919748|NCT04321031|449336200|FG005|Overall Study|Other|0|||
124919749|NCT04321031|449336201|FG006|Overall Study|Other|0|||
124919750|NCT05536440|449336202|FG000|Overall Study|Adverse Event|0|||
124919751|NCT05536440|449336203|FG001|Overall Study|Adverse Event|0|||
124919752|NCT05536440|449336204|FG002|Overall Study|Adverse Event|0|||
124919753|NCT05536440|449336205|FG003|Overall Study|Adverse Event|0|||
124919754|NCT05536440|449336206|FG004|Overall Study|Adverse Event|0|||
124919755|NCT05536440|449336207|FG005|Overall Study|Adverse Event|0|||
124919756|NCT05536440|449336208|FG006|Overall Study|Adverse Event|0|||
124919757|NCT05536440|449336209|FG007|Overall Study|Adverse Event|0|||
124919758|NCT05536440|449336210|FG008|Overall Study|Adverse Event|1|||
124919759|NCT06283173|449336211|FG000|Overall Study|Did not show for first visit|10|||
124919760|NCT06283173|449336211|FG000|Overall Study|Lost to Follow-up|12|||
124919761|NCT06283173|449336211|FG000|Overall Study|Physician Decision|7|||
124919762|NCT04784559|449336213|FG000|Overall Study|Withdrawal by Subject|3|||
124919763|NCT04784559|449336214|FG001|Overall Study|Withdrawal by Subject|2|||
124919764|NCT04784559|449336215|FG002|Overall Study|Withdrawal by Subject|1|||
124919765|NCT04784559|449336213|FG000|Overall Study|Death|2|||
124919766|NCT04784559|449336214|FG001|Overall Study|Death|1|||
124919767|NCT04784559|449336215|FG002|Overall Study|Death|2|||
124919768|NCT04784559|449336213|FG000|Overall Study|Lost to Follow-up|0|||
124919769|NCT04784559|449336214|FG001|Overall Study|Lost to Follow-up|0|||
124919770|NCT04784559|449336215|FG002|Overall Study|Lost to Follow-up|2|||
124919771|NCT04784559|449336213|FG000|Overall Study|Participant worsened, PI decision|1|||
124919772|NCT04784559|449336214|FG001|Overall Study|Participant worsened, PI decision|0|||
124919773|NCT04784559|449336215|FG002|Overall Study|Participant worsened, PI decision|0|||
124919774|NCT04784559|449336213|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
124919775|NCT04784559|449336214|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
124919776|NCT04784559|449336215|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
124919777|NCT04784559|449336213|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
124919778|NCT04784559|449336214|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
124919779|NCT04784559|449336215|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
124919780|NCT04784559|449336213|FG000|Overall Study|Did not meet all inclusion criteria|0|||
124919781|NCT04784559|449336214|FG001|Overall Study|Did not meet all inclusion criteria|1|||
124919782|NCT04784559|449336215|FG002|Overall Study|Did not meet all inclusion criteria|0|||
124919783|NCT04784559|449336213|FG000|Overall Study|The participant was transferred to IRCU|0|||
124919784|NCT04784559|449336214|FG001|Overall Study|The participant was transferred to IRCU|1|||
124919785|NCT04784559|449336215|FG002|Overall Study|The participant was transferred to IRCU|0|||
124919786|NCT04784559|449336213|FG000|Overall Study|SAE|0|||
124919787|NCT04784559|449336214|FG001|Overall Study|SAE|1|||
124919788|NCT04784559|449336215|FG002|Overall Study|SAE|0|||
124919789|NCT04784559|449336213|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
124919790|NCT04784559|449336214|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
124919791|NCT04784559|449336215|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
124919792|NCT03138512|449336216|FG000|Randomization|Participants withdrew consent|0|||
124919793|NCT03138512|449336217|FG001|Randomization|Participants withdrew consent|1|||
124919794|NCT03138512|449336218|FG002|Randomization|Participants withdrew consent|1|||
124919795|NCT03138512|449336219|FG003|Randomization|Participants withdrew consent|0|||
124919796|NCT03138512|449336220|FG004|Randomization|Participants withdrew consent|0|||
124919797|NCT03138512|449336216|FG000|Randomization|Participant no longer meets study criteria|0|||
124919798|NCT03138512|449336217|FG001|Randomization|Participant no longer meets study criteria|3|||
124919799|NCT03138512|449336218|FG002|Randomization|Participant no longer meets study criteria|1|||
124919800|NCT03138512|449336219|FG003|Randomization|Participant no longer meets study criteria|1|||
124919801|NCT03138512|449336220|FG004|Randomization|Participant no longer meets study criteria|3|||
124919802|NCT03138512|449336216|FG000|Randomization|Other reasons|1|||
124919803|NCT03138512|449336217|FG001|Randomization|Other reasons|0|||
125022904|NCT01789970|449707850|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
125022905|NCT01789970|449707851|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
125022906|NCT01789970|449707849|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
124919804|NCT03138512|449336218|FG002|Randomization|Other reasons|0|||
124919805|NCT03138512|449336219|FG003|Randomization|Other reasons|0|||
124919806|NCT03138512|449336220|FG004|Randomization|Other reasons|0|||
124919807|NCT03138512|449336216|FG000|Treatment Part A|Disease recurrence|10|||
124919808|NCT03138512|449336217|FG001|Treatment Part A|Disease recurrence|20|||
124919809|NCT03138512|449336218|FG002|Treatment Part A|Disease recurrence|0|||
124919810|NCT03138512|449336219|FG003|Treatment Part A|Disease recurrence|0|||
124919811|NCT03138512|449336220|FG004|Treatment Part A|Disease recurrence|0|||
124919812|NCT03138512|449336216|FG000|Treatment Part A|Study Drug Toxicity|132|||
124919813|NCT03138512|449336217|FG001|Treatment Part A|Study Drug Toxicity|5|||
124919814|NCT03138512|449336218|FG002|Treatment Part A|Study Drug Toxicity|0|||
124919815|NCT03138512|449336219|FG003|Treatment Part A|Study Drug Toxicity|0|||
124919816|NCT03138512|449336220|FG004|Treatment Part A|Study Drug Toxicity|0|||
124919817|NCT03138512|449336216|FG000|Treatment Part A|Death|1|||
124919818|NCT03138512|449336217|FG001|Treatment Part A|Death|0|||
124919819|NCT03138512|449336218|FG002|Treatment Part A|Death|0|||
124919820|NCT03138512|449336219|FG003|Treatment Part A|Death|0|||
124919821|NCT03138512|449336220|FG004|Treatment Part A|Death|0|||
124919822|NCT03138512|449336216|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
124919823|NCT03138512|449336217|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
124919824|NCT03138512|449336218|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
124919825|NCT03138512|449336219|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
124919826|NCT03138512|449336220|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
124919827|NCT03138512|449336216|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
124919828|NCT03138512|449336217|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
124919829|NCT03138512|449336218|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
124919830|NCT03138512|449336219|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
124919831|NCT03138512|449336220|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
124919832|NCT03138512|449336216|FG000|Treatment Part A|Participant withdrew consent|2|||
124919833|NCT03138512|449336217|FG001|Treatment Part A|Participant withdrew consent|4|||
124919834|NCT03138512|449336218|FG002|Treatment Part A|Participant withdrew consent|0|||
124919835|NCT03138512|449336219|FG003|Treatment Part A|Participant withdrew consent|0|||
124919836|NCT03138512|449336220|FG004|Treatment Part A|Participant withdrew consent|0|||
124919837|NCT03138512|449336216|FG000|Treatment Part A|Lost to Follow-up|0|||
124919838|NCT03138512|449336217|FG001|Treatment Part A|Lost to Follow-up|1|||
124919839|NCT03138512|449336218|FG002|Treatment Part A|Lost to Follow-up|0|||
124919840|NCT03138512|449336219|FG003|Treatment Part A|Lost to Follow-up|0|||
124919841|NCT03138512|449336220|FG004|Treatment Part A|Lost to Follow-up|0|||
124919842|NCT03138512|449336216|FG000|Treatment Part A|Poor/non-compliance|1|||
124919843|NCT03138512|449336217|FG001|Treatment Part A|Poor/non-compliance|0|||
124919844|NCT03138512|449336218|FG002|Treatment Part A|Poor/non-compliance|0|||
124919845|NCT03138512|449336219|FG003|Treatment Part A|Poor/non-compliance|0|||
124919846|NCT03138512|449336220|FG004|Treatment Part A|Poor/non-compliance|0|||
124919847|NCT03138512|449336216|FG000|Treatment Part A|Pregnancy|0|||
124919848|NCT03138512|449336217|FG001|Treatment Part A|Pregnancy|1|||
124919849|NCT03138512|449336218|FG002|Treatment Part A|Pregnancy|0|||
124919850|NCT03138512|449336219|FG003|Treatment Part A|Pregnancy|0|||
124919851|NCT03138512|449336220|FG004|Treatment Part A|Pregnancy|0|||
125022907|NCT01789970|449707850|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
124919852|NCT03138512|449336216|FG000|Treatment Part A|Other reasons|11|||
124919853|NCT03138512|449336217|FG001|Treatment Part A|Other reasons|8|||
124919854|NCT03138512|449336218|FG002|Treatment Part A|Other reasons|0|||
124919855|NCT03138512|449336219|FG003|Treatment Part A|Other reasons|0|||
124919856|NCT03138512|449336220|FG004|Treatment Part A|Other reasons|0|||
124919857|NCT03138512|449336216|FG000|Treatment Part B|Disease recurrence|0|||
124919858|NCT03138512|449336217|FG001|Treatment Part B|Disease recurrence|0|||
124919859|NCT03138512|449336218|FG002|Treatment Part B|Disease recurrence|6|||
124919860|NCT03138512|449336219|FG003|Treatment Part B|Disease recurrence|12|||
124919861|NCT03138512|449336220|FG004|Treatment Part B|Disease recurrence|10|||
124919862|NCT03138512|449336216|FG000|Treatment Part B|Study drug toxicity|0|||
124919863|NCT03138512|449336217|FG001|Treatment Part B|Study drug toxicity|0|||
124919864|NCT03138512|449336218|FG002|Treatment Part B|Study drug toxicity|63|||
124919865|NCT03138512|449336219|FG003|Treatment Part B|Study drug toxicity|3|||
124919866|NCT03138512|449336220|FG004|Treatment Part B|Study drug toxicity|45|||
124919867|NCT03138512|449336216|FG000|Treatment Part B|Death|0|||
124919868|NCT03138512|449336217|FG001|Treatment Part B|Death|0|||
124919869|NCT03138512|449336218|FG002|Treatment Part B|Death|1|||
124919870|NCT03138512|449336219|FG003|Treatment Part B|Death|0|||
124919871|NCT03138512|449336220|FG004|Treatment Part B|Death|0|||
124919872|NCT03138512|449336216|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
124919873|NCT03138512|449336217|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
124919874|NCT03138512|449336218|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
124919875|NCT03138512|449336219|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
124919876|NCT03138512|449336220|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
124919877|NCT03138512|449336216|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
124919878|NCT03138512|449336217|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
124919879|NCT03138512|449336218|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
124919880|NCT03138512|449336219|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
124919881|NCT03138512|449336220|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
124919882|NCT03138512|449336216|FG000|Treatment Part B|Participant withdrew consent|0|||
124919883|NCT03138512|449336217|FG001|Treatment Part B|Participant withdrew consent|0|||
124919884|NCT03138512|449336218|FG002|Treatment Part B|Participant withdrew consent|1|||
124919885|NCT03138512|449336219|FG003|Treatment Part B|Participant withdrew consent|1|||
124919886|NCT03138512|449336220|FG004|Treatment Part B|Participant withdrew consent|2|||
124919887|NCT03138512|449336216|FG000|Treatment Part B|Lost to Follow-up|0|||
124919888|NCT03138512|449336217|FG001|Treatment Part B|Lost to Follow-up|0|||
124919889|NCT03138512|449336218|FG002|Treatment Part B|Lost to Follow-up|0|||
124919890|NCT03138512|449336219|FG003|Treatment Part B|Lost to Follow-up|1|||
124919891|NCT03138512|449336220|FG004|Treatment Part B|Lost to Follow-up|0|||
124919892|NCT03138512|449336216|FG000|Treatment Part B|Poor/non-compliance|0|||
124919893|NCT03138512|449336217|FG001|Treatment Part B|Poor/non-compliance|0|||
124919894|NCT03138512|449336218|FG002|Treatment Part B|Poor/non-compliance|1|||
124919895|NCT03138512|449336219|FG003|Treatment Part B|Poor/non-compliance|1|||
124919896|NCT03138512|449336220|FG004|Treatment Part B|Poor/non-compliance|1|||
124919897|NCT03138512|449336216|FG000|Treatment Part B|Other reasons|0|||
124919898|NCT03138512|449336217|FG001|Treatment Part B|Other reasons|0|||
124919899|NCT03138512|449336218|FG002|Treatment Part B|Other reasons|3|||
124919900|NCT03138512|449336219|FG003|Treatment Part B|Other reasons|1|||
124919901|NCT03138512|449336220|FG004|Treatment Part B|Other reasons|5|||
124919902|NCT03332017|449336221|FG000|Overall Study|Lost to Follow-up|1|||
124919903|NCT03332017|449336222|FG001|Overall Study|Lost to Follow-up|2|||
124919904|NCT03332017|449336221|FG000|Overall Study|Death|17|||
124919905|NCT03332017|449336222|FG001|Overall Study|Death|16|||
124919906|NCT03332017|449336221|FG000|Overall Study|Withdrawal by Subject|6|||
124919907|NCT03332017|449336222|FG001|Overall Study|Withdrawal by Subject|14|||
124919908|NCT03332017|449336221|FG000|Overall Study|Other|1|||
124919909|NCT03332017|449336222|FG001|Overall Study|Other|3|||
124919910|NCT03332017|449336221|FG000|Overall Study|Remained in Study (Ongoing)|47|||
124919911|NCT03332017|449336222|FG001|Overall Study|Remained in Study (Ongoing)|110|||
124919912|NCT01261312|449336223|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
124919913|NCT01261312|449336224|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
124919914|NCT01261312|449336225|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
124919915|NCT01261312|449336226|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
124919916|NCT01261312|449336227|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
124919917|NCT01261312|449336228|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
124919918|NCT01261312|449336229|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
124919919|NCT01261312|449336230|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
124919920|NCT01261312|449336231|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
124919921|NCT01261312|449336232|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
124919922|NCT01261312|449336233|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
124919923|NCT01261312|449336234|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
124919924|NCT01261312|449336235|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
124919925|NCT01261312|449336223|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
124919926|NCT01261312|449336224|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
124919927|NCT01261312|449336225|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919928|NCT01261312|449336226|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919929|NCT01261312|449336227|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919930|NCT01261312|449336228|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919931|NCT01261312|449336229|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919932|NCT01261312|449336230|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919933|NCT01261312|449336231|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919934|NCT01261312|449336232|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919935|NCT01261312|449336233|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919936|NCT01261312|449336234|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919937|NCT01261312|449336235|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919938|NCT01261312|449336223|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
124919939|NCT01261312|449336224|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
124919940|NCT01261312|449336225|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
124919941|NCT01261312|449336226|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
124919942|NCT01261312|449336227|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
125116593|NCT00310856|450049884|FG002|Overall Study|Unable to classify|0|||
125116594|NCT00321711|450049888|FG000|Part A|Adverse Event|3|||
125116595|NCT00321711|450049889|FG001|Part A|Adverse Event|3|||
125116596|NCT00321711|450049890|FG002|Part A|Adverse Event|2|||
125116597|NCT00321711|450049891|FG003|Part A|Adverse Event|0|||
125116598|NCT00321711|450049892|FG004|Part A|Adverse Event|0|||
125116599|NCT00321711|450049888|FG000|Part A|Withdrawal by Subject|1|||
125116600|NCT00321711|450049889|FG001|Part A|Withdrawal by Subject|1|||
125116601|NCT00321711|450049890|FG002|Part A|Withdrawal by Subject|1|||
125116602|NCT00321711|450049891|FG003|Part A|Withdrawal by Subject|0|||
125116603|NCT00321711|450049892|FG004|Part A|Withdrawal by Subject|0|||
125116604|NCT00321711|450049888|FG000|Part A|Disease progression|0|||
125116605|NCT00321711|450049889|FG001|Part A|Disease progression|1|||
125116606|NCT00321711|450049890|FG002|Part A|Disease progression|0|||
125116607|NCT00321711|450049891|FG003|Part A|Disease progression|0|||
124919943|NCT01261312|449336228|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
124919944|NCT01261312|449336229|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
125116608|NCT00321711|450049892|FG004|Part A|Disease progression|0|||
124919945|NCT01261312|449336230|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
124919946|NCT01261312|449336231|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
124919947|NCT01261312|449336232|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
124919948|NCT01261312|449336233|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
124919949|NCT01261312|449336234|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
124919950|NCT01261312|449336235|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
124919951|NCT01261312|449336223|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
124919952|NCT01261312|449336224|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
124919953|NCT01261312|449336225|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919954|NCT01261312|449336226|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919955|NCT01261312|449336227|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919956|NCT01261312|449336228|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919957|NCT01261312|449336229|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919958|NCT01261312|449336230|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919959|NCT01261312|449336231|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919960|NCT01261312|449336232|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919961|NCT01261312|449336233|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919962|NCT01261312|449336234|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919963|NCT01261312|449336235|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919964|NCT01261312|449336223|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
124919965|NCT01261312|449336224|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
124919966|NCT01261312|449336225|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
124919967|NCT01261312|449336226|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
124919968|NCT01261312|449336227|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
124919969|NCT01261312|449336228|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
124919970|NCT01261312|449336229|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
124919971|NCT01261312|449336230|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
124919972|NCT01261312|449336231|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
124919973|NCT01261312|449336232|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
124919974|NCT01261312|449336233|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
124919975|NCT01261312|449336234|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
124919976|NCT01261312|449336235|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
124919977|NCT01261312|449336223|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
124919978|NCT01261312|449336224|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
124919979|NCT01261312|449336225|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
124919980|NCT01261312|449336226|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
124919981|NCT01261312|449336227|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
124919982|NCT01261312|449336228|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
124919983|NCT01261312|449336229|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
124919984|NCT01261312|449336230|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
124919985|NCT01261312|449336231|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
124919986|NCT01261312|449336232|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
124919987|NCT01261312|449336233|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
124919988|NCT01261312|449336234|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
124919989|NCT01261312|449336235|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
124919990|NCT01261312|449336223|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
124919991|NCT01261312|449336224|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124919992|NCT01261312|449336225|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
124919993|NCT01261312|449336226|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124919994|NCT01261312|449336227|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124919995|NCT01261312|449336228|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124919996|NCT01261312|449336229|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124919997|NCT01261312|449336230|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124919998|NCT01261312|449336231|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124919999|NCT01261312|449336232|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124920000|NCT01261312|449336233|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124920001|NCT01261312|449336234|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124920002|NCT01261312|449336235|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124920003|NCT01261312|449336223|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
124920004|NCT01261312|449336224|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
124920005|NCT01261312|449336225|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
124920006|NCT01261312|449336226|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
124920007|NCT01261312|449336227|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
124920008|NCT01261312|449336228|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
124920009|NCT01261312|449336229|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
124920010|NCT01261312|449336230|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
124920011|NCT01261312|449336231|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
124920012|NCT01261312|449336232|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
124920013|NCT01261312|449336233|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
124920014|NCT01261312|449336234|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
124920015|NCT01261312|449336235|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
124920016|NCT01261312|449336223|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920017|NCT01261312|449336224|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920018|NCT01261312|449336225|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920019|NCT01261312|449336226|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920020|NCT01261312|449336227|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
124920021|NCT01261312|449336228|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
124920022|NCT01261312|449336229|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920023|NCT01261312|449336230|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920024|NCT01261312|449336231|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920025|NCT01261312|449336232|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920026|NCT01261312|449336233|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920027|NCT01261312|449336234|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920028|NCT01261312|449336235|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920029|NCT01261312|449336223|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920030|NCT01261312|449336224|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920031|NCT01261312|449336225|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920032|NCT01261312|449336226|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920033|NCT01261312|449336227|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
124920034|NCT01261312|449336228|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
124920035|NCT01261312|449336229|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920036|NCT01261312|449336230|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920037|NCT01261312|449336231|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920038|NCT01261312|449336232|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920039|NCT01261312|449336233|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920040|NCT01261312|449336234|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920041|NCT01261312|449336235|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920042|NCT01261312|449336223|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
124920043|NCT01261312|449336224|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
124920044|NCT01261312|449336225|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
124920045|NCT01261312|449336226|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
124920046|NCT01261312|449336227|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
124920047|NCT01261312|449336228|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
124920048|NCT01261312|449336229|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
124920049|NCT01261312|449336230|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
124920050|NCT01261312|449336231|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
124920051|NCT01261312|449336232|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
124920052|NCT01261312|449336233|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
124920053|NCT01261312|449336234|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
124920054|NCT01261312|449336235|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
124920055|NCT01261312|449336223|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124920056|NCT01261312|449336224|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124920057|NCT01261312|449336225|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124920058|NCT01261312|449336226|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124920059|NCT01261312|449336227|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124920060|NCT01261312|449336228|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
124920061|NCT01261312|449336229|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124920062|NCT01261312|449336230|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124920063|NCT01261312|449336231|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124920064|NCT01261312|449336232|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
125116609|NCT00321711|450049888|FG000|Part A|Requirement for alternative therapy|0|||
124920065|NCT01261312|449336233|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124920066|NCT01261312|449336234|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124920067|NCT01261312|449336235|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124920068|NCT01261312|449336223|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
124920069|NCT01261312|449336224|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
124920070|NCT01261312|449336225|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
124920071|NCT01261312|449336226|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
124920072|NCT01261312|449336227|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
124920073|NCT01261312|449336228|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
124920074|NCT01261312|449336229|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
124920075|NCT01261312|449336230|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
124920076|NCT01261312|449336231|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
124920077|NCT01261312|449336232|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
124920078|NCT01261312|449336233|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
124920079|NCT01261312|449336234|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
124920080|NCT01261312|449336235|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
124920081|NCT01261312|449336223|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
124920082|NCT01261312|449336224|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
124920083|NCT01261312|449336225|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
124920084|NCT01261312|449336226|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
124920085|NCT01261312|449336227|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
124920086|NCT01261312|449336228|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
124920087|NCT01261312|449336229|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
124920088|NCT01261312|449336230|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
124920089|NCT01261312|449336231|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
124920090|NCT01261312|449336232|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
124920091|NCT01261312|449336233|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
124920092|NCT01261312|449336234|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
124920093|NCT01261312|449336235|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
124920094|NCT01261312|449336223|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
124920095|NCT01261312|449336224|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
124920096|NCT01261312|449336225|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
124920097|NCT01261312|449336226|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
124920098|NCT01261312|449336227|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
124920099|NCT01261312|449336228|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
124920100|NCT01261312|449336229|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
124920101|NCT01261312|449336230|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
124920102|NCT01261312|449336231|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
124920103|NCT01261312|449336232|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
124920104|NCT01261312|449336233|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
124920105|NCT01261312|449336234|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
124920106|NCT01261312|449336235|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
124920107|NCT01261312|449336223|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920108|NCT01261312|449336224|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920109|NCT01261312|449336225|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920110|NCT01261312|449336226|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920111|NCT01261312|449336227|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920112|NCT01261312|449336228|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920113|NCT01261312|449336229|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920114|NCT01261312|449336230|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
124920115|NCT01261312|449336231|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
124920116|NCT01261312|449336232|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920117|NCT01261312|449336233|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920118|NCT01261312|449336234|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920119|NCT01261312|449336235|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920120|NCT01261312|449336223|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
124920121|NCT01261312|449336224|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
124920122|NCT01261312|449336225|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
124920123|NCT01261312|449336226|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
124920124|NCT01261312|449336227|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
124920125|NCT01261312|449336228|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
124920126|NCT01261312|449336229|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
124920127|NCT01261312|449336230|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
124920128|NCT01261312|449336231|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
124920129|NCT01261312|449336232|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
124920130|NCT01261312|449336233|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
124920131|NCT01261312|449336234|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
124920132|NCT01261312|449336235|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
124920133|NCT01261312|449336223|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
124920134|NCT01261312|449336224|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
124920135|NCT01261312|449336225|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
124920136|NCT01261312|449336226|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
124920137|NCT01261312|449336227|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
124920138|NCT01261312|449336228|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
124920139|NCT01261312|449336229|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
124920140|NCT01261312|449336230|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
124920141|NCT01261312|449336231|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
124920142|NCT01261312|449336232|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
124920143|NCT01261312|449336233|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
124920144|NCT01261312|449336234|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
124920145|NCT01261312|449336235|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
124920146|NCT01261312|449336223|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
124920147|NCT01261312|449336224|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
124920148|NCT01261312|449336225|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
124920149|NCT01261312|449336226|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
124920150|NCT01261312|449336227|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
124920151|NCT01261312|449336228|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
124920152|NCT01261312|449336229|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
124920153|NCT01261312|449336230|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
124920154|NCT01261312|449336231|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
124920155|NCT01261312|449336232|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
124920156|NCT01261312|449336233|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
124920157|NCT01261312|449336234|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
124920158|NCT01261312|449336235|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
124920159|NCT01261312|449336223|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
124920160|NCT01261312|449336224|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
124920161|NCT01261312|449336225|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
124920162|NCT01261312|449336226|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
124920163|NCT01261312|449336227|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
124920164|NCT01261312|449336228|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
124920165|NCT01261312|449336229|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
124920166|NCT01261312|449336230|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
124920167|NCT01261312|449336231|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
124920168|NCT01261312|449336232|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
124920169|NCT01261312|449336233|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
124920170|NCT01261312|449336234|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
124920171|NCT01261312|449336235|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
124920172|NCT01261312|449336223|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
124920173|NCT01261312|449336224|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
124920174|NCT01261312|449336225|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
124920175|NCT01261312|449336226|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
124920176|NCT01261312|449336227|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
124920177|NCT01261312|449336228|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
124920178|NCT01261312|449336229|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
124920179|NCT01261312|449336230|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
124920180|NCT01261312|449336231|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
124920181|NCT01261312|449336232|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
124920182|NCT01261312|449336233|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
124920183|NCT01261312|449336234|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
124920184|NCT01261312|449336235|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
124920185|NCT01261312|449336223|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
124920186|NCT01261312|449336224|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
124920187|NCT01261312|449336225|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
124920188|NCT01261312|449336226|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
124920189|NCT01261312|449336227|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
124920190|NCT01261312|449336228|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
124920191|NCT01261312|449336229|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
124920192|NCT01261312|449336230|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
124920193|NCT01261312|449336231|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
124920194|NCT01261312|449336232|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
124920195|NCT01261312|449336233|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
124920196|NCT01261312|449336234|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
124920197|NCT01261312|449336235|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
124920198|NCT01261312|449336223|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
124920199|NCT01261312|449336224|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
124920200|NCT01261312|449336225|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
124920201|NCT01261312|449336226|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
124920202|NCT01261312|449336227|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
124920203|NCT01261312|449336228|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
124920204|NCT01261312|449336229|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
124920205|NCT01261312|449336230|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
124920206|NCT01261312|449336231|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
124920207|NCT01261312|449336232|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
124920208|NCT01261312|449336233|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
124920209|NCT01261312|449336234|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
124920210|NCT01261312|449336235|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
124920211|NCT01261312|449336223|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
124920212|NCT01261312|449336224|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
124920213|NCT01261312|449336225|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
124920214|NCT01261312|449336226|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
124920215|NCT01261312|449336227|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
124920216|NCT01261312|449336228|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
124920217|NCT01261312|449336229|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
124920218|NCT01261312|449336230|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
124920219|NCT01261312|449336231|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
124920220|NCT01261312|449336232|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
124920221|NCT01261312|449336233|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
124920222|NCT01261312|449336234|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
124920223|NCT01261312|449336235|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
125116610|NCT00321711|450049889|FG001|Part A|Requirement for alternative therapy|2|||
125116611|NCT00321711|450049890|FG002|Part A|Requirement for alternative therapy|1|||
125116612|NCT00321711|450049891|FG003|Part A|Requirement for alternative therapy|0|||
125116613|NCT00321711|450049892|FG004|Part A|Requirement for alternative therapy|0|||
125116614|NCT00321711|450049888|FG000|Part A|Physician Decision|0|||
124920224|NCT01261312|449336223|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
124920225|NCT01261312|449336224|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
124920226|NCT01261312|449336225|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
124920227|NCT01261312|449336226|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
124920228|NCT01261312|449336227|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
124920229|NCT01261312|449336228|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
124920230|NCT01261312|449336229|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
124920231|NCT01261312|449336230|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
124920232|NCT01261312|449336231|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
124920233|NCT01261312|449336232|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
124920234|NCT01261312|449336233|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
124920235|NCT01261312|449336234|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
124920236|NCT01261312|449336235|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
124920237|NCT01261312|449336223|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
124920238|NCT01261312|449336224|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
124920239|NCT01261312|449336225|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
124920240|NCT01261312|449336226|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
124920241|NCT01261312|449336227|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
124920242|NCT01261312|449336228|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
124920243|NCT01261312|449336229|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
124920244|NCT01261312|449336230|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
124920245|NCT01261312|449336231|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
124920246|NCT01261312|449336232|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
124920247|NCT01261312|449336233|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
124920248|NCT01261312|449336234|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
124920249|NCT01261312|449336235|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
124920250|NCT01261312|449336223|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
124920251|NCT01261312|449336224|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
124920252|NCT01261312|449336225|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
124920253|NCT01261312|449336226|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
124920254|NCT01261312|449336227|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
124920255|NCT01261312|449336228|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
124920256|NCT01261312|449336229|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
124920257|NCT01261312|449336230|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
124920258|NCT01261312|449336231|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
124920259|NCT01261312|449336232|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
124920260|NCT01261312|449336233|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
124920261|NCT01261312|449336234|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
124920262|NCT01261312|449336235|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
124920263|NCT01261312|449336223|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
124920264|NCT01261312|449336224|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
124920265|NCT01261312|449336225|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
124920266|NCT01261312|449336226|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
124920267|NCT01261312|449336227|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
124920268|NCT01261312|449336228|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
124920269|NCT01261312|449336229|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
124920270|NCT01261312|449336230|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
124920271|NCT01261312|449336231|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
124920272|NCT01261312|449336232|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
124920273|NCT01261312|449336233|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
124920274|NCT01261312|449336234|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
124920275|NCT01261312|449336235|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
124920276|NCT03436745|449336242|FG000|Overall Study|Ineligible|0|||
124920277|NCT03436745|449336243|FG001|Overall Study|Ineligible|0|||
124920278|NCT03436745|449336244|FG002|Overall Study|Ineligible|1|||
124920279|NCT03406871|449336248|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
124920280|NCT03406871|449336249|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
124920281|NCT03406871|449336250|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
124920282|NCT03406871|449336248|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
124920283|NCT03406871|449336249|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
124920284|NCT03406871|449336250|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
125116615|NCT00321711|450049889|FG001|Part A|Physician Decision|1|||
124920285|NCT03406871|449336248|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
124920286|NCT03406871|449336249|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
124920287|NCT03406871|449336250|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
124920288|NCT03406871|449336248|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
124920289|NCT03406871|449336249|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
124920290|NCT03406871|449336250|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
124920291|NCT03406871|449336248|FG000|Expansion Cohort(Final Analysis)|Death|0|||
124920292|NCT03406871|449336249|FG001|Expansion Cohort(Final Analysis)|Death|1|||
124920293|NCT03406871|449336250|FG002|Expansion Cohort(Final Analysis)|Death|0|||
124920294|NCT03406871|449336248|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
124920295|NCT03406871|449336249|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
124920296|NCT03406871|449336250|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
124920297|NCT04588298|449336251|FG000|Overall Study|Adverse Event|0|||
124920298|NCT04588298|449336252|FG001|Overall Study|Adverse Event|0|||
124920299|NCT04588298|449336253|FG002|Overall Study|Adverse Event|1|||
124920300|NCT04588298|449336254|FG003|Overall Study|Adverse Event|0|||
124920301|NCT04588298|449336255|FG004|Overall Study|Adverse Event|2|||
124920302|NCT04588298|449336251|FG000|Overall Study|Withdrawal by Subject|1|||
124920303|NCT04588298|449336252|FG001|Overall Study|Withdrawal by Subject|0|||
124920304|NCT04588298|449336253|FG002|Overall Study|Withdrawal by Subject|0|||
124920305|NCT04588298|449336254|FG003|Overall Study|Withdrawal by Subject|1|||
124920306|NCT04588298|449336255|FG004|Overall Study|Withdrawal by Subject|0|||
124920307|NCT02120456|449336262|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
124920308|NCT02120456|449336263|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
124920309|NCT02120456|449336264|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
124920310|NCT02120456|449336265|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
124920311|NCT02120456|449336266|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
124920312|NCT02120456|449336267|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
124920313|NCT02120456|449336268|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
124920314|NCT02120456|449336269|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
124920315|NCT02120456|449336270|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
124920316|NCT02120456|449336262|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
124920317|NCT02120456|449336263|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
124920318|NCT02120456|449336264|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
124920319|NCT02120456|449336265|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
124920320|NCT02120456|449336266|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
124920321|NCT02120456|449336267|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
124920322|NCT02120456|449336268|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
124920323|NCT02120456|449336269|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
124920324|NCT02120456|449336270|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
124920325|NCT02120456|449336262|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
124920326|NCT02120456|449336263|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
124920327|NCT02120456|449336264|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
124920328|NCT02120456|449336265|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
124920329|NCT02120456|449336266|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
124920330|NCT02120456|449336267|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
124920331|NCT02120456|449336268|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
124920332|NCT02120456|449336269|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
124920333|NCT02120456|449336270|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
124920334|NCT05520190|449336271|FG000|Overall Study|Lost to Follow-up|7|||
124920335|NCT05520190|449336271|FG000|Overall Study|Withdrawal by Subject|2|||
124920336|NCT03476187|449336273|FG000|Overall Study|Protocol Violation|7|||
124920337|NCT03476187|449336273|FG000|Overall Study|Physician Decision|5|||
124920338|NCT04060355|449337967|FG000|Overall Study|Lost to Follow-up|41|||
124920339|NCT04956861|449337973|FG000|Overall Study|Withdrawal by Subject|4|||
124920340|NCT04956861|449337974|FG001|Overall Study|Withdrawal by Subject|4|||
124920341|NCT04956861|449337975|FG002|Overall Study|Withdrawal by Subject|2|||
124920342|NCT04956861|449337973|FG000|Overall Study|Physician Decision|4|||
125116616|NCT00321711|450049890|FG002|Part A|Physician Decision|3|||
125116617|NCT00321711|450049891|FG003|Part A|Physician Decision|0|||
125116618|NCT00321711|450049892|FG004|Part A|Physician Decision|0|||
125116619|NCT00321711|450049888|FG000|Part A|Other|1|||
125116620|NCT00321711|450049889|FG001|Part A|Other|2|||
125116621|NCT00321711|450049890|FG002|Part A|Other|3|||
125116622|NCT00321711|450049891|FG003|Part A|Other|0|||
125116623|NCT00321711|450049892|FG004|Part A|Other|0|||
125116624|NCT00321711|450049888|FG000|Part A|Protocol deviation|0|||
124920343|NCT04956861|449337974|FG001|Overall Study|Physician Decision|5|||
124920344|NCT04956861|449337975|FG002|Overall Study|Physician Decision|1|||
124920345|NCT05215314|449337976|FG000|Overall Study|Lost to Follow-up|2|||
124920346|NCT05215314|449337977|FG001|Overall Study|Lost to Follow-up|2|||
124920347|NCT05215314|449337976|FG000|Overall Study|Withdrawal by Subject|2|||
125116625|NCT00321711|450049889|FG001|Part A|Protocol deviation|0|||
125116626|NCT00321711|450049890|FG002|Part A|Protocol deviation|1|||
124920348|NCT05215314|449337977|FG001|Overall Study|Withdrawal by Subject|0|||
124920349|NCT05215314|449337976|FG000|Overall Study|Physician Decision|1|||
124920350|NCT05215314|449337977|FG001|Overall Study|Physician Decision|0|||
124920351|NCT04294225|449337978|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
124920352|NCT04294225|449337978|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
124920353|NCT04294225|449337978|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
124920354|NCT04294225|449337978|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
124920355|NCT04294225|449337978|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
124920356|NCT01580488|449337980|FG000|Overall Study|Withdrawal by Subject|1|||
124920357|NCT03738228|449337981|FG000|Overall Study|Never received study treatment|2|||
124920358|NCT03738228|449337982|FG001|Overall Study|Never received study treatment|2|||
124920359|NCT03338790|449337990|FG000|Overall Study|Disease Progression|65|||
124920360|NCT03338790|449337991|FG001|Overall Study|Disease Progression|43|||
124920361|NCT03338790|449337992|FG002|Overall Study|Disease Progression|50|||
124920362|NCT03338790|449337993|FG003|Overall Study|Disease Progression|37|||
124920363|NCT03338790|449337990|FG000|Overall Study|Study Drug Toxicity|9|||
124920364|NCT03338790|449337991|FG001|Overall Study|Study Drug Toxicity|8|||
124920365|NCT03338790|449337992|FG002|Overall Study|Study Drug Toxicity|15|||
124920366|NCT03338790|449337993|FG003|Overall Study|Study Drug Toxicity|0|||
124920367|NCT03338790|449337990|FG000|Overall Study|Death|1|||
124920368|NCT03338790|449337991|FG001|Overall Study|Death|1|||
124920369|NCT03338790|449337992|FG002|Overall Study|Death|1|||
124920370|NCT03338790|449337993|FG003|Overall Study|Death|0|||
124920371|NCT03338790|449337990|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
124920372|NCT03338790|449337991|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
124920373|NCT03338790|449337992|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
124920374|NCT03338790|449337993|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
124920375|NCT03338790|449337990|FG000|Overall Study|Participant request to discontinue study treatment|3|||
124920376|NCT03338790|449337991|FG001|Overall Study|Participant request to discontinue study treatment|3|||
124920377|NCT03338790|449337992|FG002|Overall Study|Participant request to discontinue study treatment|2|||
124920378|NCT03338790|449337993|FG003|Overall Study|Participant request to discontinue study treatment|1|||
124920379|NCT03338790|449337990|FG000|Overall Study|Poor/non-compliance|0|||
124920380|NCT03338790|449337991|FG001|Overall Study|Poor/non-compliance|1|||
124920381|NCT03338790|449337992|FG002|Overall Study|Poor/non-compliance|0|||
124920382|NCT03338790|449337993|FG003|Overall Study|Poor/non-compliance|0|||
124920383|NCT03338790|449337990|FG000|Overall Study|Participant withdrew consent|1|||
124920384|NCT03338790|449337991|FG001|Overall Study|Participant withdrew consent|0|||
124920385|NCT03338790|449337992|FG002|Overall Study|Participant withdrew consent|1|||
124920386|NCT03338790|449337993|FG003|Overall Study|Participant withdrew consent|1|||
124920387|NCT03338790|449337990|FG000|Overall Study|Other reasons|0|||
124920388|NCT03338790|449337991|FG001|Overall Study|Other reasons|5|||
124920389|NCT03338790|449337992|FG002|Overall Study|Other reasons|0|||
124920390|NCT03338790|449337993|FG003|Overall Study|Other reasons|2|||
124920391|NCT03338790|449337990|FG000|Overall Study|Not reported|0|||
124920392|NCT03338790|449337991|FG001|Overall Study|Not reported|0|||
124920393|NCT03338790|449337992|FG002|Overall Study|Not reported|1|||
124920394|NCT03338790|449337993|FG003|Overall Study|Not reported|0|||
124920395|NCT03338790|449337990|FG000|Overall Study|Completed treatment period|1|||
124920396|NCT03338790|449337991|FG001|Overall Study|Completed treatment period|2|||
124920397|NCT03338790|449337992|FG002|Overall Study|Completed treatment period|0|||
124920398|NCT03338790|449337993|FG003|Overall Study|Completed treatment period|0|||
124920399|NCT03366649|449337995|FG000|Overall Study|Failed preoperative screening|4|||
124920400|NCT03366649|449337996|FG001|Overall Study|Failed preoperative screening|0|||
124920401|NCT03366649|449337997|FG002|Overall Study|Failed preoperative screening|0|||
124920402|NCT03366649|449337995|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
124920403|NCT03366649|449337996|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
124920404|NCT03366649|449337997|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
124920405|NCT03673111|449337998|FG000|Overall Study|Protocol Violation|0|||
124920406|NCT03673111|449337999|FG001|Overall Study|Protocol Violation|0|||
124920407|NCT03673111|449338000|FG002|Overall Study|Protocol Violation|0|||
124920408|NCT03673111|449338001|FG003|Overall Study|Protocol Violation|0|||
124920409|NCT03673111|449338002|FG004|Overall Study|Protocol Violation|0|||
124920410|NCT03673111|449338003|FG005|Overall Study|Protocol Violation|0|||
124920411|NCT03673111|449338004|FG006|Overall Study|Protocol Violation|0|||
124920412|NCT03673111|449338005|FG007|Overall Study|Protocol Violation|0|||
124920413|NCT03673111|449338006|FG008|Overall Study|Protocol Violation|0|||
124920414|NCT03673111|449338007|FG009|Overall Study|Protocol Violation|0|||
124920415|NCT03673111|449338008|FG010|Overall Study|Protocol Violation|1|||
124920416|NCT03673111|449338009|FG011|Overall Study|Protocol Violation|0|||
124920417|NCT03673111|449338010|FG012|Overall Study|Protocol Violation|0|||
124920418|NCT03673111|449338011|FG013|Overall Study|Protocol Violation|0|||
124920419|NCT03673111|449337998|FG000|Overall Study|Adverse Event|1|||
124920420|NCT03673111|449337999|FG001|Overall Study|Adverse Event|0|||
124920421|NCT03673111|449338000|FG002|Overall Study|Adverse Event|0|||
124920422|NCT03673111|449338001|FG003|Overall Study|Adverse Event|0|||
125022908|NCT01789970|449707851|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
125022909|NCT01789970|449707849|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
124920423|NCT03673111|449338002|FG004|Overall Study|Adverse Event|0|||
124920424|NCT03673111|449338003|FG005|Overall Study|Adverse Event|0|||
124920425|NCT03673111|449338004|FG006|Overall Study|Adverse Event|0|||
125022910|NCT01789970|449707850|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
125022911|NCT01789970|449707851|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
125022912|NCT01789970|449707849|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
125022913|NCT01789970|449707850|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
125022914|NCT01789970|449707851|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
125022915|NCT01789970|449707849|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
125022916|NCT01789970|449707850|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
125022917|NCT01789970|449707851|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
125022918|NCT02161562|449707852|FG000|Overall Study|Withdrawal by Subject|5|||
125022919|NCT02161562|449707853|FG001|Overall Study|Withdrawal by Subject|8|||
125022920|NCT02161562|449707852|FG000|Overall Study|Protocol Violation|9|||
125022921|NCT02161562|449707853|FG001|Overall Study|Protocol Violation|4|||
125022922|NCT02161562|449707852|FG000|Overall Study|Pregnancy|1|||
125022923|NCT02161562|449707853|FG001|Overall Study|Pregnancy|2|||
125022924|NCT02161562|449707852|FG000|Overall Study|Lost to Follow-up|3|||
125022925|NCT02161562|449707853|FG001|Overall Study|Lost to Follow-up|1|||
125022926|NCT02161562|449707852|FG000|Overall Study|Lack of Efficacy|4|||
125022927|NCT02161562|449707853|FG001|Overall Study|Lack of Efficacy|1|||
125022928|NCT02161562|449707852|FG000|Overall Study|Adverse Event|1|||
125022929|NCT02161562|449707853|FG001|Overall Study|Adverse Event|1|||
125022930|NCT02161562|449707852|FG000|Overall Study|Participant moved back to home country|1|||
125022931|NCT02161562|449707853|FG001|Overall Study|Participant moved back to home country|0|||
125022932|NCT02161562|449707852|FG000|Overall Study|Withdrew due to being out of the country|1|||
125022933|NCT02161562|449707853|FG001|Overall Study|Withdrew due to being out of the country|0|||
125022934|NCT02161562|449707852|FG000|Overall Study|Participant moved out of province|1|||
125022935|NCT02161562|449707853|FG001|Overall Study|Participant moved out of province|0|||
125022936|NCT01639833|449707860|FG000|Overall Study|Death|4|||
125022937|NCT01639833|449707861|FG001|Overall Study|Death|2|||
125022938|NCT01639833|449707860|FG000|Overall Study|Withdrawal by Subject|2|||
125022939|NCT01639833|449707861|FG001|Overall Study|Withdrawal by Subject|2|||
125022940|NCT02450578|449707863|FG000|Overall Study|ECG abnormality so not treated|1|||
125022941|NCT02450578|449707864|FG001|Overall Study|ECG abnormality so not treated|0|||
124920426|NCT03673111|449338005|FG007|Overall Study|Adverse Event|0|||
124920427|NCT03673111|449338006|FG008|Overall Study|Adverse Event|0|||
124920428|NCT03673111|449338007|FG009|Overall Study|Adverse Event|0|||
124920429|NCT03673111|449338008|FG010|Overall Study|Adverse Event|0|||
124920430|NCT03673111|449338009|FG011|Overall Study|Adverse Event|0|||
124920431|NCT03673111|449338010|FG012|Overall Study|Adverse Event|0|||
124920432|NCT03673111|449338011|FG013|Overall Study|Adverse Event|0|||
124920433|NCT03846505|449338012|FG000|Treatment Phase|Withdrawal by Subject|9|||
124920434|NCT03846505|449338013|FG001|Treatment Phase|Withdrawal by Subject|11|||
124920435|NCT03846505|449338012|FG000|Treatment Phase|Lost to Follow-up|6|||
124920436|NCT03846505|449338013|FG001|Treatment Phase|Lost to Follow-up|2|||
124920437|NCT03846505|449338012|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
124920438|NCT03846505|449338013|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
124920439|NCT03846505|449338012|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
125022942|NCT02450578|449707865|FG002|Overall Study|ECG abnormality so not treated|0|||
125022943|NCT02450578|449707866|FG003|Overall Study|ECG abnormality so not treated|0|||
125022944|NCT04016311|449707867|FG000|Overall Study|Withdrawal by Subject|1|||
125022945|NCT04016311|449707868|FG001|Overall Study|Withdrawal by Subject|0|||
125022946|NCT01999582|449707873|FG000|Overall Study|Withdrawal by Subject|0|||
125022947|NCT01999582|449707874|FG001|Overall Study|Withdrawal by Subject|0|||
125022948|NCT01999582|449707875|FG002|Overall Study|Withdrawal by Subject|0|||
125022949|NCT01999582|449707876|FG003|Overall Study|Withdrawal by Subject|1|||
125022950|NCT01999582|449707877|FG004|Overall Study|Withdrawal by Subject|0|||
125116627|NCT00321711|450049891|FG003|Part A|Protocol deviation|0|||
124920440|NCT03846505|449338013|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
124920441|NCT01744782|449338017|FG000|Overall Study|Death|1|||
124920442|NCT04649359|449338018|FG000|Overall Study|Withdrawal by Subject|7|||
125022951|NCT01999582|449707878|FG005|Overall Study|Withdrawal by Subject|0|||
125022952|NCT01999582|449707873|FG000|Overall Study|Adverse Event|0|||
125022953|NCT01999582|449707874|FG001|Overall Study|Adverse Event|0|||
125022954|NCT01999582|449707875|FG002|Overall Study|Adverse Event|3|||
125022955|NCT01999582|449707876|FG003|Overall Study|Adverse Event|0|||
125022956|NCT01999582|449707877|FG004|Overall Study|Adverse Event|1|||
125022957|NCT01999582|449707878|FG005|Overall Study|Adverse Event|0|||
125022958|NCT01999582|449707873|FG000|Overall Study|Other Reasons|1|||
125022959|NCT01999582|449707874|FG001|Overall Study|Other Reasons|0|||
125022960|NCT01999582|449707875|FG002|Overall Study|Other Reasons|3|||
125022961|NCT01999582|449707876|FG003|Overall Study|Other Reasons|1|||
125022962|NCT01999582|449707877|FG004|Overall Study|Other Reasons|1|||
125022963|NCT01999582|449707878|FG005|Overall Study|Other Reasons|2|||
125022964|NCT01999582|449707873|FG000|Overall Study|Protocol Violation|1|||
125022965|NCT01999582|449707874|FG001|Overall Study|Protocol Violation|0|||
125022966|NCT01999582|449707875|FG002|Overall Study|Protocol Violation|0|||
125022967|NCT01999582|449707876|FG003|Overall Study|Protocol Violation|0|||
125022968|NCT01999582|449707877|FG004|Overall Study|Protocol Violation|0|||
125022969|NCT01999582|449707878|FG005|Overall Study|Protocol Violation|1|||
125022970|NCT01999582|449707873|FG000|Overall Study|Lack of Efficacy|1|||
125022971|NCT01999582|449707874|FG001|Overall Study|Lack of Efficacy|3|||
125022972|NCT01999582|449707875|FG002|Overall Study|Lack of Efficacy|0|||
125022973|NCT01999582|449707876|FG003|Overall Study|Lack of Efficacy|1|||
125022974|NCT01999582|449707877|FG004|Overall Study|Lack of Efficacy|0|||
125022975|NCT01999582|449707878|FG005|Overall Study|Lack of Efficacy|0|||
125022976|NCT02436876|449707885|FG000|Overall Study|Lost to Follow-up|0|||
125022977|NCT02436876|449707886|FG001|Overall Study|Lost to Follow-up|1|||
125022978|NCT02436876|449707887|FG002|Overall Study|Lost to Follow-up|1|||
125022979|NCT02436876|449707888|FG003|Overall Study|Lost to Follow-up|1|||
125022980|NCT02436876|449707885|FG000|Overall Study|Withdrawal by Subject|1|||
125022981|NCT02436876|449707886|FG001|Overall Study|Withdrawal by Subject|0|||
125022982|NCT02436876|449707887|FG002|Overall Study|Withdrawal by Subject|0|||
125022983|NCT02436876|449707888|FG003|Overall Study|Withdrawal by Subject|1|||
125022984|NCT02436876|449707885|FG000|Overall Study|Physician Decision|0|||
125022985|NCT02436876|449707886|FG001|Overall Study|Physician Decision|2|||
125022986|NCT02436876|449707887|FG002|Overall Study|Physician Decision|1|||
125022987|NCT02436876|449707888|FG003|Overall Study|Physician Decision|0|||
125022988|NCT02436876|449707885|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
125022989|NCT02436876|449707886|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
125022990|NCT02436876|449707887|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
125022991|NCT02436876|449707888|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
125022992|NCT02809833|449707889|FG000|Overall Study|Death|3|||
125022993|NCT02809833|449707889|FG000|Overall Study|Intolerance|54|||
125022994|NCT02809833|449707889|FG000|Overall Study|Lack of Efficacy|89|||
125022995|NCT02809833|449707889|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
125022996|NCT02809833|449707889|FG000|Overall Study|Noncompliance|1|||
125022997|NCT02809833|449707889|FG000|Overall Study|Withdrawal by Subject|34|||
125022998|NCT02809833|449707889|FG000|Overall Study|Lost to Follow-up|35|||
125022999|NCT02809833|449707889|FG000|Overall Study|Adverse Event (AE)|24|||
125023000|NCT02809833|449707889|FG000|Overall Study|Other|5|||
125023001|NCT02809833|449707889|FG000|Overall Study|Missing Information|52|||
125023002|NCT05779072|449707893|FG000|Overall Study|Lost to Follow-up|0|||
125023003|NCT05779072|449707894|FG001|Overall Study|Lost to Follow-up|1|||
125023004|NCT05779072|449707893|FG000|Overall Study|Withdrawal by Subject|1|||
125023005|NCT05779072|449707894|FG001|Overall Study|Withdrawal by Subject|5|||
125023006|NCT02387580|449707896|FG000|Overall Study|Withdrawal by Subject|0|||
125023007|NCT02387580|449707897|FG001|Overall Study|Withdrawal by Subject|0|||
125023008|NCT02387580|449707898|FG002|Overall Study|Withdrawal by Subject|0|||
125023009|NCT02387580|449707899|FG003|Overall Study|Withdrawal by Subject|1|||
125023010|NCT02387580|449707900|FG004|Overall Study|Withdrawal by Subject|0|||
125023011|NCT02387580|449707901|FG005|Overall Study|Withdrawal by Subject|0|||
125023012|NCT00725075|449707902|FG000|Overall Study|Use of Excluded Medication|0|||
125023013|NCT00725075|449707903|FG001|Overall Study|Use of Excluded Medication|1|||
125023014|NCT00725075|449707904|FG002|Overall Study|Use of Excluded Medication|0|||
125023015|NCT00725075|449707902|FG000|Overall Study|Protocol Violation|0|||
125211846|NCT00048165|450401385|FG000|Completed 6 Months Study|Insufficient therapy|1|||
125023016|NCT00725075|449707903|FG001|Overall Study|Protocol Violation|0|||
125023017|NCT00725075|449707904|FG002|Overall Study|Protocol Violation|1|||
125023018|NCT00725075|449707902|FG000|Overall Study|Lost to Follow-up|1|||
125023019|NCT00725075|449707903|FG001|Overall Study|Lost to Follow-up|0|||
125023020|NCT00725075|449707904|FG002|Overall Study|Lost to Follow-up|0|||
125023021|NCT00725075|449707902|FG000|Overall Study|Withdrawal by Subject|4|||
125023022|NCT00725075|449707903|FG001|Overall Study|Withdrawal by Subject|5|||
125023023|NCT00725075|449707904|FG002|Overall Study|Withdrawal by Subject|4|||
125023024|NCT00725075|449707902|FG000|Overall Study|Adverse Event|2|||
125023025|NCT00725075|449707903|FG001|Overall Study|Adverse Event|1|||
124920443|NCT04649359|449338019|FG001|Overall Study|Withdrawal by Subject|7|||
124920444|NCT04649359|449338018|FG000|Overall Study|Death|41|||
124920445|NCT04649359|449338019|FG001|Overall Study|Death|26|||
124920446|NCT04649359|449338018|FG000|Overall Study|Ongoing in the study|75|||
124920447|NCT04649359|449338019|FG001|Overall Study|Ongoing in the study|31|||
124920448|NCT02243709|449338020|FG000|Phase 1|Lost to Follow-up|0|||
124920449|NCT02243709|449338021|FG001|Phase 1|Lost to Follow-up|1|||
124920450|NCT02243709|449338020|FG000|Phase 1|Withdrawal by Subject|1|||
124920451|NCT02243709|449338021|FG001|Phase 1|Withdrawal by Subject|0|||
124920452|NCT02243709|449338020|FG000|Phase 1|Protocol Violation|0|||
124920453|NCT02243709|449338021|FG001|Phase 1|Protocol Violation|1|||
124920454|NCT02243709|449338020|FG000|Phase 1|Adverse Event|0|||
124920455|NCT02243709|449338021|FG001|Phase 1|Adverse Event|1|||
124920456|NCT03443323|449338024|FG000|Overall Study|Lost to Follow-up|2|||
124920457|NCT03443323|449338025|FG001|Overall Study|Lost to Follow-up|2|||
124920458|NCT03443323|449338024|FG000|Overall Study|PI withdrawal|1|||
124920459|NCT03443323|449338025|FG001|Overall Study|PI withdrawal|0|||
124920460|NCT04610892|449338026|FG000|Overall Study|Adverse Event|1|||
124920461|NCT04610892|449338027|FG001|Overall Study|Adverse Event|0|||
124920462|NCT04610892|449338028|FG002|Overall Study|Adverse Event|0|||
124920463|NCT04610892|449338029|FG003|Overall Study|Adverse Event|1|||
124920464|NCT04610892|449338030|FG004|Overall Study|Adverse Event|3|||
124920465|NCT04610892|449338026|FG000|Overall Study|Death|0|||
124920466|NCT04610892|449338027|FG001|Overall Study|Death|1|||
124920467|NCT04610892|449338028|FG002|Overall Study|Death|0|||
124920468|NCT04610892|449338029|FG003|Overall Study|Death|1|||
124920469|NCT04610892|449338030|FG004|Overall Study|Death|0|||
124920470|NCT04610892|449338026|FG000|Overall Study|Withdrawal by Subject|3|||
124920471|NCT04610892|449338027|FG001|Overall Study|Withdrawal by Subject|2|||
124920472|NCT04610892|449338028|FG002|Overall Study|Withdrawal by Subject|0|||
124920473|NCT04610892|449338029|FG003|Overall Study|Withdrawal by Subject|6|||
124920474|NCT04610892|449338030|FG004|Overall Study|Withdrawal by Subject|6|||
124920475|NCT04610892|449338026|FG000|Overall Study|Subjects who did not receive treatment|1|||
124920476|NCT04610892|449338027|FG001|Overall Study|Subjects who did not receive treatment|0|||
124920477|NCT04610892|449338028|FG002|Overall Study|Subjects who did not receive treatment|0|||
124920478|NCT04610892|449338029|FG003|Overall Study|Subjects who did not receive treatment|0|||
124920479|NCT04610892|449338030|FG004|Overall Study|Subjects who did not receive treatment|2|||
124920480|NCT03683719|449338031|FG000|Overall Study|Lack of Efficacy|1|||
124920481|NCT03683719|449338032|FG001|Overall Study|Lack of Efficacy|3|||
124920482|NCT03683719|449338033|FG002|Overall Study|Lack of Efficacy|4|||
124920483|NCT03683719|449338034|FG003|Overall Study|Lack of Efficacy|0|||
124920484|NCT03683719|449338035|FG004|Overall Study|Lack of Efficacy|4|||
124920485|NCT03683719|449338031|FG000|Overall Study|Adverse Event|6|||
124920486|NCT03683719|449338032|FG001|Overall Study|Adverse Event|6|||
124920487|NCT03683719|449338033|FG002|Overall Study|Adverse Event|0|||
124920488|NCT03683719|449338034|FG003|Overall Study|Adverse Event|1|||
124920489|NCT03683719|449338035|FG004|Overall Study|Adverse Event|3|||
124920490|NCT03683719|449338031|FG000|Overall Study|Withdrawal by Subject|4|||
124920491|NCT03683719|449338032|FG001|Overall Study|Withdrawal by Subject|4|||
124920492|NCT03683719|449338033|FG002|Overall Study|Withdrawal by Subject|3|||
124920493|NCT03683719|449338034|FG003|Overall Study|Withdrawal by Subject|5|||
124920494|NCT03683719|449338035|FG004|Overall Study|Withdrawal by Subject|5|||
124920495|NCT03683719|449338031|FG000|Overall Study|Lost to Follow-up|1|||
124920496|NCT03683719|449338032|FG001|Overall Study|Lost to Follow-up|0|||
124920497|NCT03683719|449338033|FG002|Overall Study|Lost to Follow-up|0|||
124920498|NCT03683719|449338034|FG003|Overall Study|Lost to Follow-up|1|||
124920499|NCT03683719|449338035|FG004|Overall Study|Lost to Follow-up|1|||
124920500|NCT03683719|449338031|FG000|Overall Study|Other personal reasons|0|||
124920501|NCT03683719|449338032|FG001|Overall Study|Other personal reasons|0|||
124920502|NCT03683719|449338033|FG002|Overall Study|Other personal reasons|1|||
124920503|NCT03683719|449338034|FG003|Overall Study|Other personal reasons|0|||
124920504|NCT03683719|449338035|FG004|Overall Study|Other personal reasons|1|||
124920505|NCT04896476|449338041|FG000|Overall Study|Withdrawal by Subject|1|||
124920506|NCT04896476|449338041|FG000|Overall Study|Lost to Follow-up|2|||
124920507|NCT03135548|449338042|FG000|Overall Study|Lost to Follow-up|3|||
124920508|NCT03135548|449338043|FG001|Overall Study|Lost to Follow-up|0|||
124920509|NCT03135548|449338044|FG002|Overall Study|Lost to Follow-up|0|||
124920510|NCT03135548|449338042|FG000|Overall Study|Withdrawal by Subject|2|||
125023026|NCT00725075|449707904|FG002|Overall Study|Adverse Event|1|||
124920511|NCT03135548|449338043|FG001|Overall Study|Withdrawal by Subject|2|||
124920512|NCT03135548|449338044|FG002|Overall Study|Withdrawal by Subject|1|||
124920513|NCT03135548|449338042|FG000|Overall Study|Other than listed|0|||
124920514|NCT03135548|449338043|FG001|Overall Study|Other than listed|2|||
124920515|NCT03135548|449338044|FG002|Overall Study|Other than listed|2|||
124920516|NCT03924986|449338045|FG000|Overall Study|Death|57|||
124920517|NCT03924986|449338046|FG001|Overall Study|Death|66|||
124920518|NCT03924986|449338045|FG000|Overall Study|Study Concluded by Sponsor|51|||
124920519|NCT03924986|449338046|FG001|Overall Study|Study Concluded by Sponsor|41|||
124920520|NCT03924986|449338045|FG000|Overall Study|Withdrawal by Subject|15|||
124920521|NCT03924986|449338046|FG001|Overall Study|Withdrawal by Subject|20|||
124920522|NCT03924986|449338045|FG000|Overall Study|Lost to Follow-up|7|||
124920523|NCT03924986|449338046|FG001|Overall Study|Lost to Follow-up|5|||
124920524|NCT03924986|449338045|FG000|Overall Study|Miscellaneous|1|||
124920525|NCT03924986|449338046|FG001|Overall Study|Miscellaneous|0|||
124920526|NCT03445988|449338049|FG000|Overall Study|Lost to Follow-up|14|||
124920527|NCT03445988|449338050|FG001|Overall Study|Lost to Follow-up|26|||
124920528|NCT03445988|449338051|FG002|Overall Study|Lost to Follow-up|27|||
124920529|NCT03445988|449338052|FG003|Overall Study|Lost to Follow-up|66|||
124920530|NCT03445988|449338049|FG000|Overall Study|Withdrawal by Subject|7|||
124920531|NCT03445988|449338050|FG001|Overall Study|Withdrawal by Subject|4|||
124920532|NCT03445988|449338051|FG002|Overall Study|Withdrawal by Subject|3|||
124920533|NCT03445988|449338052|FG003|Overall Study|Withdrawal by Subject|5|||
124920534|NCT03445988|449338049|FG000|Overall Study|Death (unrelated to study)|5|||
124920535|NCT03445988|449338050|FG001|Overall Study|Death (unrelated to study)|1|||
124920536|NCT03445988|449338051|FG002|Overall Study|Death (unrelated to study)|2|||
124920537|NCT03445988|449338052|FG003|Overall Study|Death (unrelated to study)|4|||
124920538|NCT03988608|449338053|FG000|Overall Study|Adverse Event|1|||
124920539|NCT03988608|449338053|FG000|Overall Study|Lost to Follow-up|1|||
124920540|NCT03988608|449338053|FG000|Overall Study|Withdrawal by Subject|3|||
124920541|NCT03988608|449338053|FG000|Overall Study|Death|1|||
124920542|NCT02689284|449338060|FG000|Overall Study|Adverse Event|1|||
124920543|NCT02689284|449338061|FG001|Overall Study|Adverse Event|8|||
124920544|NCT02689284|449338060|FG000|Overall Study|Death|0|||
124920545|NCT02689284|449338061|FG001|Overall Study|Death|1|||
124920546|NCT02689284|449338060|FG000|Overall Study|Physician Decision|1|||
124920547|NCT02689284|449338061|FG001|Overall Study|Physician Decision|2|||
124920548|NCT02689284|449338060|FG000|Overall Study|Withdrawal by Subject|0|||
124920549|NCT02689284|449338061|FG001|Overall Study|Withdrawal by Subject|1|||
124920550|NCT02689284|449338060|FG000|Overall Study|progression of cancer|1|||
124920551|NCT02689284|449338061|FG001|Overall Study|progression of cancer|72|||
124920552|NCT02689284|449338060|FG000|Overall Study|decreased heart function|0|||
124920553|NCT02689284|449338061|FG001|Overall Study|decreased heart function|1|||
124920554|NCT02689284|449338060|FG000|Overall Study|concern for anemia|0|||
124920555|NCT02689284|449338061|FG001|Overall Study|concern for anemia|1|||
124920556|NCT02689284|449338060|FG000|Overall Study|no measurable cancer for evaluation|0|||
124920557|NCT02689284|449338061|FG001|Overall Study|no measurable cancer for evaluation|1|||
124920558|NCT05592418|449338062|FG000|Overall Study|Adverse Event|1|||
124920559|NCT05592418|449338063|FG001|Overall Study|Adverse Event|0|||
124920560|NCT05592418|449338062|FG000|Overall Study|Lost to Follow-up|1|||
124920561|NCT05592418|449338063|FG001|Overall Study|Lost to Follow-up|3|||
124920562|NCT05592418|449338062|FG000|Overall Study|Withdrawal by Subject|2|||
124920563|NCT05592418|449338063|FG001|Overall Study|Withdrawal by Subject|7|||
124920564|NCT05569252|449338066|FG000|Overall Study|Adverse event (central vision loss)|1|||
124920565|NCT05569252|449338067|FG001|Overall Study|Adverse event (central vision loss)|0|||
124920566|NCT05569252|449338068|FG002|Overall Study|Adverse event (central vision loss)|0|||
124920567|NCT05569252|449338069|FG003|Overall Study|Adverse event (central vision loss)|0|||
124920568|NCT03665597|449338070|FG000|Period 1|Adverse Event|1|||
124920569|NCT03665597|449338071|FG001|Period 1|Adverse Event|0|||
124920570|NCT03665597|449338072|FG002|Period 1|Adverse Event|0|||
124920571|NCT03665597|449338073|FG003|Period 1|Adverse Event|1|||
124920572|NCT03665597|449338074|FG004|Period 1|Adverse Event|0|||
124920573|NCT03665597|449338075|FG005|Period 1|Adverse Event|0|||
124920574|NCT03665597|449338076|FG006|Period 1|Adverse Event|0|||
124920575|NCT03665597|449338070|FG000|Period 1|Screen Failure|0|||
124920576|NCT03665597|449338071|FG001|Period 1|Screen Failure|0|||
124920577|NCT03665597|449338072|FG002|Period 1|Screen Failure|0|||
124920578|NCT03665597|449338073|FG003|Period 1|Screen Failure|1|||
124920579|NCT03665597|449338074|FG004|Period 1|Screen Failure|0|||
124920580|NCT03665597|449338075|FG005|Period 1|Screen Failure|0|||
124920581|NCT03665597|449338076|FG006|Period 1|Screen Failure|0|||
124920582|NCT03665597|449338070|FG000|Period 1|Death|0|||
124920583|NCT03665597|449338071|FG001|Period 1|Death|0|||
125023027|NCT00725075|449707902|FG000|Overall Study|Worsening of Disease|2|||
124920584|NCT03665597|449338072|FG002|Period 1|Death|0|||
124920585|NCT03665597|449338073|FG003|Period 1|Death|0|||
124920586|NCT03665597|449338074|FG004|Period 1|Death|0|||
124920587|NCT03665597|449338075|FG005|Period 1|Death|0|||
124920588|NCT03665597|449338076|FG006|Period 1|Death|45|||
124920589|NCT03665597|449338070|FG000|Period 1|Withdrawal by Subject|0|||
124920590|NCT03665597|449338071|FG001|Period 1|Withdrawal by Subject|0|||
124920591|NCT03665597|449338072|FG002|Period 1|Withdrawal by Subject|0|||
124920592|NCT03665597|449338073|FG003|Period 1|Withdrawal by Subject|0|||
124920593|NCT03665597|449338074|FG004|Period 1|Withdrawal by Subject|0|||
124920594|NCT03665597|449338075|FG005|Period 1|Withdrawal by Subject|0|||
124920595|NCT03665597|449338076|FG006|Period 1|Withdrawal by Subject|5|||
124920596|NCT03665597|449338070|FG000|Period 2|Adverse Event|0|||
124920597|NCT03665597|449338071|FG001|Period 2|Adverse Event|0|||
124920598|NCT03665597|449338072|FG002|Period 2|Adverse Event|0|||
124920599|NCT03665597|449338073|FG003|Period 2|Adverse Event|0|||
124920600|NCT03665597|449338074|FG004|Period 2|Adverse Event|0|||
124920601|NCT03665597|449338075|FG005|Period 2|Adverse Event|1|||
124920602|NCT03665597|449338076|FG006|Period 2|Adverse Event|0|||
124920603|NCT03665597|449338070|FG000|Period 3|Adverse Event|0|||
124920604|NCT03665597|449338071|FG001|Period 3|Adverse Event|1|||
124920605|NCT03665597|449338072|FG002|Period 3|Adverse Event|0|||
124920606|NCT03665597|449338073|FG003|Period 3|Adverse Event|0|||
124920607|NCT03665597|449338074|FG004|Period 3|Adverse Event|0|||
124920608|NCT03665597|449338075|FG005|Period 3|Adverse Event|0|||
124920609|NCT03665597|449338076|FG006|Period 3|Adverse Event|0|||
124920610|NCT03665597|449338070|FG000|Period 3|Death|0|||
124920611|NCT03665597|449338071|FG001|Period 3|Death|0|||
124920612|NCT03665597|449338072|FG002|Period 3|Death|0|||
124920613|NCT03665597|449338073|FG003|Period 3|Death|0|||
124920614|NCT03665597|449338074|FG004|Period 3|Death|1|||
124920615|NCT03665597|449338075|FG005|Period 3|Death|0|||
124920616|NCT03665597|449338076|FG006|Period 3|Death|0|||
124920617|NCT03665597|449338070|FG000|Period 4|Adverse Event|2|||
124920618|NCT03665597|449338071|FG001|Period 4|Adverse Event|2|||
124920619|NCT03665597|449338072|FG002|Period 4|Adverse Event|2|||
124920620|NCT03665597|449338073|FG003|Period 4|Adverse Event|2|||
124920621|NCT03665597|449338074|FG004|Period 4|Adverse Event|1|||
124920622|NCT03665597|449338075|FG005|Period 4|Adverse Event|0|||
124920623|NCT03665597|449338076|FG006|Period 4|Adverse Event|0|||
124920624|NCT03665597|449338070|FG000|Period 4|Death|0|||
124920625|NCT03665597|449338071|FG001|Period 4|Death|0|||
124920626|NCT03665597|449338072|FG002|Period 4|Death|2|||
124920627|NCT03665597|449338073|FG003|Period 4|Death|0|||
124920628|NCT03665597|449338074|FG004|Period 4|Death|0|||
124920629|NCT03665597|449338075|FG005|Period 4|Death|0|||
124920630|NCT03665597|449338076|FG006|Period 4|Death|0|||
124920631|NCT03665597|449338070|FG000|Period 4|Physician Decision|1|||
124920632|NCT03665597|449338071|FG001|Period 4|Physician Decision|2|||
124920633|NCT03665597|449338072|FG002|Period 4|Physician Decision|0|||
124920634|NCT03665597|449338073|FG003|Period 4|Physician Decision|0|||
124920635|NCT03665597|449338074|FG004|Period 4|Physician Decision|0|||
124920636|NCT03665597|449338075|FG005|Period 4|Physician Decision|0|||
124920637|NCT03665597|449338076|FG006|Period 4|Physician Decision|0|||
124920638|NCT04739956|449338080|FG000|Overall Study|Withdrawal by Subject|1|||
124920639|NCT04739956|449338081|FG001|Overall Study|Withdrawal by Subject|1|||
124920640|NCT03519581|449338084|FG000|Overall Study|Lost to Follow-up|3|||
124920641|NCT03519581|449338085|FG001|Overall Study|Lost to Follow-up|2|||
124920642|NCT03519581|449338084|FG000|Overall Study|Adverse Event|5|||
124920643|NCT03519581|449338085|FG001|Overall Study|Adverse Event|2|||
124920644|NCT03519581|449338084|FG000|Overall Study|Withdrawal by Subject|2|||
124920645|NCT03519581|449338085|FG001|Overall Study|Withdrawal by Subject|0|||
124920646|NCT03519581|449338084|FG000|Overall Study|Change to insurance|2|||
124920647|NCT03519581|449338085|FG001|Overall Study|Change to insurance|1|||
124920648|NCT03519581|449338084|FG000|Overall Study|Other|2|||
124920649|NCT03519581|449338085|FG001|Overall Study|Other|4|||
124920650|NCT03396926|449338086|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
124920651|NCT03396926|449338087|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
124920652|NCT03110315|449338088|FG000|Overall Study|Withdrawal by Subject|1|||
124920653|NCT03110315|449338089|FG001|Overall Study|Withdrawal by Subject|0|||
124920654|NCT00450658|449338093|FG000|Overall Study|Adverse Event|24|||
124920655|NCT00450658|449338094|FG001|Overall Study|Adverse Event|15|||
124920656|NCT00450658|449338093|FG000|Overall Study|Withdrawal by Subject|43|||
124920657|NCT00450658|449338094|FG001|Overall Study|Withdrawal by Subject|26|||
124920658|NCT00450658|449338093|FG000|Overall Study|Lost to Follow-up|22|||
124920659|NCT00450658|449338094|FG001|Overall Study|Lost to Follow-up|5|||
124920660|NCT00450658|449338093|FG000|Overall Study|UGI ulcer|33|||
124920661|NCT00450658|449338094|FG001|Overall Study|UGI ulcer|34|||
124920662|NCT00450658|449338093|FG000|Overall Study|misc|21|||
124920663|NCT00450658|449338094|FG001|Overall Study|misc|10|||
124920664|NCT04727554|449338097|FG000|Overall Study|Lost to Follow-up|0|||
124920665|NCT04727554|449338098|FG001|Overall Study|Lost to Follow-up|1|||
124920666|NCT04727554|449338097|FG000|Overall Study|Death|2|||
124920667|NCT04727554|449338098|FG001|Overall Study|Death|6|||
124920668|NCT04727554|449338097|FG000|Overall Study|Withdrawal by Subject|1|||
124920669|NCT04727554|449338098|FG001|Overall Study|Withdrawal by Subject|0|||
124920670|NCT05763823|449338099|FG000|Overall Study|Death|6|||
124920671|NCT05763823|449338099|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
124920672|NCT05763823|449338099|FG000|Overall Study|Withdrawal by Subject|6|||
124920673|NCT05371652|449338103|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
124920674|NCT05371652|449338103|FG000|Overall Study|Withdrawal by Subject|12|||
124920675|NCT05371652|449338103|FG000|Overall Study|Adverse Event|1|||
124920676|NCT05371652|449338103|FG000|Overall Study|Other|11|||
124920677|NCT05134233|449338108|FG000|Overall Study|Pregnancy|1|||
124920678|NCT05134233|449338108|FG000|Overall Study|MEP value too low|2|||
124920679|NCT05134233|449338108|FG000|Overall Study|Lost to Follow-up|1|||
124920680|NCT01573442|449338109|FG000|Overall Study|Cancels|9|||
124920681|NCT01573442|449338110|FG001|Overall Study|Cancels|10|||
124920682|NCT02724631|449338113|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
124920683|NCT04763265|449338114|FG000|Overall Study|Adverse Event|1|||
124920684|NCT04763265|449338115|FG001|Overall Study|Adverse Event|0|||
124920685|NCT04763265|449338114|FG000|Overall Study|Lost to Follow-up|2|||
124920686|NCT04763265|449338115|FG001|Overall Study|Lost to Follow-up|4|||
124920687|NCT04763265|449338114|FG000|Overall Study|Withdrawal by Subject|0|||
124920688|NCT04763265|449338115|FG001|Overall Study|Withdrawal by Subject|1|||
124920689|NCT05609760|449338131|FG000|Overall Study|Lost to Follow-up|0|||
124920690|NCT05609760|449338132|FG001|Overall Study|Lost to Follow-up|1|||
124920691|NCT05609760|449338131|FG000|Overall Study|Withdrawal by Subject|1|||
124920692|NCT05609760|449338132|FG001|Overall Study|Withdrawal by Subject|0|||
124920693|NCT04049643|449338133|FG000|Overall Study|Lack of Efficacy|1|||
124920694|NCT04049643|449338134|FG001|Overall Study|Lack of Efficacy|1|||
124920695|NCT04049643|449338135|FG002|Overall Study|Lack of Efficacy|0|||
124920696|NCT04049643|449338133|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
124920697|NCT04049643|449338134|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
124920698|NCT04049643|449338135|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
124920699|NCT05089734|449338136|FG000|Overall Study|Still on study|122|||
124920700|NCT05089734|449338137|FG001|Overall Study|Still on study|101|||
124920701|NCT05089734|449338136|FG000|Overall Study|Death|161|||
124920702|NCT05089734|449338137|FG001|Overall Study|Death|179|||
124920703|NCT05089734|449338136|FG000|Overall Study|Withdrew consent|11|||
124920704|NCT05089734|449338137|FG001|Overall Study|Withdrew consent|24|||
124920705|NCT05089734|449338136|FG000|Overall Study|Lost to Follow-up|5|||
124920706|NCT05089734|449338137|FG001|Overall Study|Lost to Follow-up|0|||
124920707|NCT05302596|449338138|FG000|Overall Study|Withdrawal by Subject|1|||
124920708|NCT05302596|449338139|FG001|Overall Study|Withdrawal by Subject|1|||
124920709|NCT04353661|449339939|FG000|Overall Study|Protocol Violation|0|||
124920710|NCT04353661|449339940|FG001|Overall Study|Protocol Violation|0|||
124920711|NCT04353661|449339941|FG002|Overall Study|Protocol Violation|1|||
124920712|NCT04353661|449339939|FG000|Overall Study|Study termination by the Sponsor|1|||
124920713|NCT04353661|449339940|FG001|Overall Study|Study termination by the Sponsor|1|||
124920714|NCT04353661|449339941|FG002|Overall Study|Study termination by the Sponsor|1|||
124920715|NCT00667251|449339942|FG000|Overall Study|Disease progression|232|||
124920716|NCT00667251|449339943|FG001|Overall Study|Disease progression|203|||
124920717|NCT00667251|449339942|FG000|Overall Study|Toxicity|44|||
124920718|NCT00667251|449339943|FG001|Overall Study|Toxicity|23|||
124920719|NCT00667251|449339942|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
124920720|NCT00667251|449339943|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
124920721|NCT00667251|449339942|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
124920722|NCT00667251|449339943|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
124920723|NCT00667251|449339942|FG000|Overall Study|Symptomatic progression|8|||
124920724|NCT00667251|449339943|FG001|Overall Study|Symptomatic progression|4|||
124920725|NCT00667251|449339942|FG000|Overall Study|Death|6|||
124920726|NCT00667251|449339943|FG001|Overall Study|Death|11|||
124920727|NCT00667251|449339942|FG000|Overall Study|Intercurrent illness|5|||
124920728|NCT00667251|449339943|FG001|Overall Study|Intercurrent illness|6|||
124920729|NCT00667251|449339942|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
124920730|NCT00667251|449339943|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
124920731|NCT00667251|449339942|FG000|Overall Study|Randomized not Treated|4|||
124920732|NCT00667251|449339943|FG001|Overall Study|Randomized not Treated|1|||
124920733|NCT01140880|449339945|FG000|Overall Study|Death|0|||
124920734|NCT01140880|449339946|FG001|Overall Study|Death|1|||
124920735|NCT01140880|449339945|FG000|Overall Study|Withdrawal by Subject|6|||
124920736|NCT01140880|449339946|FG001|Overall Study|Withdrawal by Subject|3|||
124920737|NCT01140880|449339945|FG000|Overall Study|Lost to Follow-up|8|||
125023028|NCT00725075|449707903|FG001|Overall Study|Worsening of Disease|1|||
125023029|NCT00725075|449707904|FG002|Overall Study|Worsening of Disease|2|||
124920738|NCT01140880|449339946|FG001|Overall Study|Lost to Follow-up|10|||
124920739|NCT01140880|449339945|FG000|Overall Study|Protocol Violation|0|||
125023030|NCT00725075|449707902|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
125023031|NCT00725075|449707903|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
125023032|NCT00725075|449707904|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
125023033|NCT00725075|449707902|FG000|Overall Study|Other|1|||
124920740|NCT01140880|449339946|FG001|Overall Study|Protocol Violation|30|||
124920741|NCT03131648|449339948|FG000|Initial Treatment Period|Not dosed|2|||
124920742|NCT03131648|449339949|FG001|Initial Treatment Period|Not dosed|2|||
125023034|NCT00725075|449707903|FG001|Overall Study|Other|0|||
124920743|NCT03131648|449339950|FG002|Initial Treatment Period|Not dosed|0|||
124920744|NCT03131648|449339951|FG003|Initial Treatment Period|Not dosed|0|||
124920745|NCT03131648|449339952|FG004|Initial Treatment Period|Not dosed|0|||
124920746|NCT03131648|449339953|FG005|Initial Treatment Period|Not dosed|0|||
124920747|NCT03131648|449339954|FG006|Initial Treatment Period|Not dosed|0|||
124920748|NCT03131648|449339955|FG007|Initial Treatment Period|Not dosed|0|||
125023035|NCT00725075|449707904|FG002|Overall Study|Other|0|||
125023036|NCT03984305|449707906|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
125023037|NCT03984305|449707907|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
125023038|NCT03984305|449707906|FG000|Overall Study|Withdrawal by Subject|3|||
125023039|NCT03984305|449707907|FG001|Overall Study|Withdrawal by Subject|3|||
125023040|NCT03984305|449707906|FG000|Overall Study|Lost to Follow-up|1|||
125023041|NCT03984305|449707907|FG001|Overall Study|Lost to Follow-up|0|||
125023042|NCT02979431|449707908|FG000|Overall Study|Parent/guardian withdrew consent|2|||
125023043|NCT02979431|449707909|FG001|Overall Study|Parent/guardian withdrew consent|1|||
125023044|NCT02979431|449707910|FG002|Overall Study|Parent/guardian withdrew consent|1|||
125023045|NCT02979431|449707911|FG003|Overall Study|Parent/guardian withdrew consent|1|||
125023046|NCT02979431|449707908|FG000|Overall Study|Randomized but received no study drug|1|||
125023047|NCT02979431|449707909|FG001|Overall Study|Randomized but received no study drug|1|||
125023048|NCT02979431|449707910|FG002|Overall Study|Randomized but received no study drug|0|||
125023049|NCT02979431|449707911|FG003|Overall Study|Randomized but received no study drug|0|||
125023050|NCT02979431|449707908|FG000|Overall Study|Adverse Event|0|||
125023051|NCT02979431|449707909|FG001|Overall Study|Adverse Event|0|||
125023052|NCT02979431|449707910|FG002|Overall Study|Adverse Event|1|||
125023053|NCT02979431|449707911|FG003|Overall Study|Adverse Event|0|||
125023054|NCT02979431|449707908|FG000|Overall Study|Subject left country after Day14|1|||
125023055|NCT02979431|449707909|FG001|Overall Study|Subject left country after Day14|0|||
125023056|NCT02979431|449707910|FG002|Overall Study|Subject left country after Day14|0|||
125023057|NCT02979431|449707911|FG003|Overall Study|Subject left country after Day14|0|||
125023058|NCT02004873|449707912|FG000|Overall Study|Implant unsuccessful|6|||
125023059|NCT02004873|449707912|FG000|Overall Study|Awaiting 6-month visit|390|||
125023060|NCT02004873|449707912|FG000|Overall Study|Missed 6-month visit|4|||
124920749|NCT03131648|449339948|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
124920750|NCT03131648|449339949|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
124920751|NCT03131648|449339950|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124920752|NCT03131648|449339951|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124920753|NCT03131648|449339952|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124920754|NCT03131648|449339953|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124920755|NCT03131648|449339954|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124920756|NCT03131648|449339955|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124920757|NCT03131648|449339948|FG000|Open-label Treatment|Discontinued IMP|0|||
124920758|NCT03131648|449339949|FG001|Open-label Treatment|Discontinued IMP|0|||
124920759|NCT03131648|449339950|FG002|Open-label Treatment|Discontinued IMP|0|||
124920760|NCT03131648|449339951|FG003|Open-label Treatment|Discontinued IMP|0|||
124920761|NCT03131648|449339952|FG004|Open-label Treatment|Discontinued IMP|0|||
124920762|NCT03131648|449339953|FG005|Open-label Treatment|Discontinued IMP|0|||
124920763|NCT03131648|449339954|FG006|Open-label Treatment|Discontinued IMP|112|||
124920764|NCT03131648|449339955|FG007|Open-label Treatment|Discontinued IMP|0|||
124920765|NCT03131648|449339948|FG000|Open-label Treatment|Completed Week 50|0|||
124920766|NCT03131648|449339949|FG001|Open-label Treatment|Completed Week 50|0|||
124920767|NCT03131648|449339950|FG002|Open-label Treatment|Completed Week 50|0|||
124920768|NCT03131648|449339951|FG003|Open-label Treatment|Completed Week 50|0|||
124920769|NCT03131648|449339952|FG004|Open-label Treatment|Completed Week 50|0|||
124920770|NCT03131648|449339953|FG005|Open-label Treatment|Completed Week 50|0|||
124920771|NCT03131648|449339954|FG006|Open-label Treatment|Completed Week 50|6|||
124920772|NCT03131648|449339955|FG007|Open-label Treatment|Completed Week 50|0|||
124920773|NCT03131648|449339948|FG000|Maintenance Treatment Period|Not dosed|0|||
124920774|NCT03131648|449339949|FG001|Maintenance Treatment Period|Not dosed|0|||
124920775|NCT03131648|449339950|FG002|Maintenance Treatment Period|Not dosed|3|||
124920776|NCT03131648|449339951|FG003|Maintenance Treatment Period|Not dosed|2|||
124920777|NCT03131648|449339952|FG004|Maintenance Treatment Period|Not dosed|1|||
124920778|NCT03131648|449339953|FG005|Maintenance Treatment Period|Not dosed|0|||
124920779|NCT03131648|449339954|FG006|Maintenance Treatment Period|Not dosed|0|||
124920780|NCT03131648|449339955|FG007|Maintenance Treatment Period|Not dosed|0|||
124920781|NCT03131648|449339948|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
124920782|NCT03131648|449339949|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
124920783|NCT03131648|449339950|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
124920784|NCT03131648|449339951|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
124920785|NCT03131648|449339952|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
124920786|NCT03131648|449339953|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
125023061|NCT02004873|449707912|FG000|Overall Study|Death|23|||
125023062|NCT02004873|449707912|FG000|Overall Study|Withdrawal by Subject|1|||
125023063|NCT00866307|449707916|FG000|Induction|Adverse Event|5|||
125023064|NCT00866307|449707917|FG001|Induction|Adverse Event|0|||
125023065|NCT00866307|449707918|FG002|Induction|Adverse Event|0|||
124920787|NCT03131648|449339954|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
124920788|NCT03131648|449339955|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
124920789|NCT03131648|449339948|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
124920790|NCT03131648|449339949|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
124920791|NCT03131648|449339950|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
124920792|NCT03131648|449339951|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
124920793|NCT03131648|449339952|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
124920794|NCT03131648|449339953|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
124920795|NCT03131648|449339954|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
124920796|NCT03131648|449339955|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
124920797|NCT03131648|449339948|FG000|Maintenance Treatment Period|Completed Week 50|0|||
124920798|NCT03131648|449339949|FG001|Maintenance Treatment Period|Completed Week 50|0|||
124920799|NCT03131648|449339950|FG002|Maintenance Treatment Period|Completed Week 50|0|||
124920800|NCT03131648|449339951|FG003|Maintenance Treatment Period|Completed Week 50|0|||
124920801|NCT03131648|449339952|FG004|Maintenance Treatment Period|Completed Week 50|1|||
124920802|NCT03131648|449339953|FG005|Maintenance Treatment Period|Completed Week 50|0|||
124920803|NCT03131648|449339954|FG006|Maintenance Treatment Period|Completed Week 50|0|||
124920804|NCT03131648|449339955|FG007|Maintenance Treatment Period|Completed Week 50|0|||
124920805|NCT03131648|449339948|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
124920806|NCT03131648|449339949|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
124920807|NCT03131648|449339950|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
124920808|NCT03131648|449339951|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
124920809|NCT03131648|449339952|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
124920810|NCT03131648|449339953|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
124920811|NCT03131648|449339954|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
124920812|NCT03131648|449339955|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
124920813|NCT02671903|449339956|FG000|Period 0 (Run-In)|Death|0|||
124920814|NCT02671903|449339957|FG001|Period 0 (Run-In)|Death|0|||
124920815|NCT02671903|449339958|FG002|Period 0 (Run-In)|Death|3|||
124920816|NCT02671903|449339956|FG000|Period 0 (Run-In)|Physician Decision|0|||
124920817|NCT02671903|449339957|FG001|Period 0 (Run-In)|Physician Decision|0|||
124920818|NCT02671903|449339958|FG002|Period 0 (Run-In)|Physician Decision|4|||
124920819|NCT02671903|449339956|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
124920820|NCT02671903|449339957|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
124920821|NCT02671903|449339958|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
124920822|NCT02671903|449339956|FG000|Period 0 (Run-In)|Protocol Violation|0|||
124920823|NCT02671903|449339957|FG001|Period 0 (Run-In)|Protocol Violation|0|||
124920824|NCT02671903|449339958|FG002|Period 0 (Run-In)|Protocol Violation|1|||
124920825|NCT02671903|449339956|FG000|Period 0 (Run-In)|Adverse Event|0|||
124920826|NCT02671903|449339957|FG001|Period 0 (Run-In)|Adverse Event|0|||
124920827|NCT02671903|449339958|FG002|Period 0 (Run-In)|Adverse Event|1|||
124920828|NCT02671903|449339956|FG000|Period 0 (Run-In)|Implantation Failure|0|||
124920829|NCT02671903|449339957|FG001|Period 0 (Run-In)|Implantation Failure|0|||
124920830|NCT02671903|449339958|FG002|Period 0 (Run-In)|Implantation Failure|2|||
124920831|NCT02671903|449339956|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
124920832|NCT02671903|449339957|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
124920833|NCT02671903|449339958|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
124920834|NCT04258709|449339959|FG000|Overall Study|Lost to Follow-up|10|||
124920835|NCT04258709|449339960|FG001|Overall Study|Lost to Follow-up|4|||
124920836|NCT04258709|449339959|FG000|Overall Study|Withdrawal by Subject|1|||
124920837|NCT04258709|449339960|FG001|Overall Study|Withdrawal by Subject|0|||
124920838|NCT04258709|449339959|FG000|Overall Study|Fetal demise|0|||
124920839|NCT04258709|449339960|FG001|Overall Study|Fetal demise|1|||
124920840|NCT04258709|449339959|FG000|Overall Study|Protocol Violation|1|||
124920841|NCT04258709|449339960|FG001|Overall Study|Protocol Violation|1|||
124920842|NCT05633953|449339961|FG000|Overall Study|Adverse Event|7|||
124920843|NCT05633953|449339961|FG000|Overall Study|Death|30|||
124920844|NCT05633953|449339961|FG000|Overall Study|Lost to Follow-up|1|||
124920845|NCT05633953|449339961|FG000|Overall Study|Osilodrostat discontinued|4|||
124920846|NCT05633953|449339961|FG000|Overall Study|Physician Decision|1|||
124920847|NCT05633953|449339961|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
124920848|NCT05633953|449339961|FG000|Overall Study|Progressive disease|2|||
124920849|NCT03047928|449339962|FG000|Overall Study|Adverse Event|0|||
124920850|NCT03047928|449339963|FG001|Overall Study|Adverse Event|2|||
124920851|NCT03047928|449339964|FG002|Overall Study|Adverse Event|0|||
124920852|NCT03047928|449339962|FG000|Overall Study|Protocol Violation|0|||
124920853|NCT03047928|449339963|FG001|Overall Study|Protocol Violation|1|||
124920854|NCT03047928|449339964|FG002|Overall Study|Protocol Violation|0|||
124920855|NCT03047928|449339962|FG000|Overall Study|included in another protocol|0|||
124920856|NCT03047928|449339963|FG001|Overall Study|included in another protocol|1|||
124920857|NCT03047928|449339964|FG002|Overall Study|included in another protocol|0|||
124920858|NCT02729311|449339965|FG000|Overall Study|Withdrawal by Subject|8|||
124920859|NCT02729311|449339966|FG001|Overall Study|Withdrawal by Subject|2|||
124920860|NCT05324124|449339967|FG000|Period 1|Withdrawal by Subject|1|||
124920861|NCT05324124|449339968|FG001|Period 1|Withdrawal by Subject|0|||
124920862|NCT05324124|449339967|FG000|Period 1|Physician Decision|0|||
124920863|NCT05324124|449339968|FG001|Period 1|Physician Decision|1|||
124920864|NCT04034251|449339969|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
124920865|NCT04034251|449339970|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
124920866|NCT04034251|449339971|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
124920867|NCT02287610|449339972|FG000|Overall Study|Lost to Follow-up|3|||
124920868|NCT02287610|449339972|FG000|Overall Study|Withdrawal by Subject|8|||
124920869|NCT02287610|449339972|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
124920870|NCT05273749|449339974|FG000|Overall Study|Adverse Event|14|||
124920871|NCT05273749|449339975|FG001|Overall Study|Adverse Event|8|||
124920872|NCT05273749|449339974|FG000|Overall Study|Lack of Efficacy|2|||
124920873|NCT05273749|449339975|FG001|Overall Study|Lack of Efficacy|8|||
124920874|NCT05273749|449339974|FG000|Overall Study|Physician Decision|0|||
124920875|NCT05273749|449339975|FG001|Overall Study|Physician Decision|2|||
124920876|NCT05273749|449339974|FG000|Overall Study|Withdrawal by Subject|14|||
124920877|NCT05273749|449339975|FG001|Overall Study|Withdrawal by Subject|16|||
124920878|NCT05273749|449339974|FG000|Overall Study|Lost to Follow-up|10|||
124920879|NCT05273749|449339975|FG001|Overall Study|Lost to Follow-up|10|||
124920880|NCT05273749|449339974|FG000|Overall Study|Pregnancy|1|||
124920881|NCT05273749|449339975|FG001|Overall Study|Pregnancy|0|||
124920882|NCT05273749|449339974|FG000|Overall Study|Non-Compliance|3|||
124920883|NCT05273749|449339975|FG001|Overall Study|Non-Compliance|2|||
124920884|NCT05273749|449339974|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
124920885|NCT05273749|449339975|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
124920886|NCT05247489|449339978|FG000|Overall Study|Lost to Follow-up|5|||
124920887|NCT05247489|449339979|FG001|Overall Study|Lost to Follow-up|1|||
124920888|NCT05247489|449339978|FG000|Overall Study|Withdrawal by Subject|6|||
124920889|NCT05247489|449339979|FG001|Overall Study|Withdrawal by Subject|7|||
124920890|NCT05247489|449339978|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
124920891|NCT05247489|449339979|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
124920892|NCT05247489|449339978|FG000|Overall Study|Left Country|1|||
124920893|NCT05247489|449339979|FG001|Overall Study|Left Country|0|||
124920894|NCT05247489|449339978|FG000|Overall Study|Noncompliance with Investigational Product|1|||
124920895|NCT05247489|449339979|FG001|Overall Study|Noncompliance with Investigational Product|0|||
124920896|NCT05247489|449339978|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
124920897|NCT05247489|449339979|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
124920898|NCT03771898|449339980|FG000|Overall Study|Adverse Event|1|||
124920899|NCT03771898|449339981|FG001|Overall Study|Adverse Event|0|||
124920900|NCT03771898|449339982|FG002|Overall Study|Adverse Event|0|||
124920901|NCT03771898|449339983|FG003|Overall Study|Adverse Event|0|||
124920902|NCT03771898|449339984|FG004|Overall Study|Adverse Event|0|||
124920903|NCT03771898|449339980|FG000|Overall Study|Lost to Follow-up|1|||
124920904|NCT03771898|449339981|FG001|Overall Study|Lost to Follow-up|1|||
124920905|NCT03771898|449339982|FG002|Overall Study|Lost to Follow-up|1|||
124920906|NCT03771898|449339983|FG003|Overall Study|Lost to Follow-up|0|||
124920907|NCT03771898|449339984|FG004|Overall Study|Lost to Follow-up|0|||
124920908|NCT03771898|449339980|FG000|Overall Study|Withdrawal by parent/guardian|1|||
124920909|NCT03771898|449339981|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124920910|NCT03771898|449339982|FG002|Overall Study|Withdrawal by parent/guardian|0|||
124920911|NCT03771898|449339983|FG003|Overall Study|Withdrawal by parent/guardian|0|||
124920912|NCT03771898|449339984|FG004|Overall Study|Withdrawal by parent/guardian|0|||
124920913|NCT03771898|449339980|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
124920914|NCT03771898|449339981|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
124920915|NCT03771898|449339982|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
124920916|NCT03771898|449339983|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
124920917|NCT03771898|449339984|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
124920918|NCT04541706|449339985|FG000|Overall Study|Withdrawal by Subject|3|||
124920919|NCT04541706|449339985|FG000|Overall Study|Progressive disease|33|||
124920920|NCT04541706|449339985|FG000|Overall Study|Physician Decision|1|||
124920921|NCT04541706|449339985|FG000|Overall Study|Lost to Follow-up|2|||
124920922|NCT04541706|449339985|FG000|Overall Study|Death|5|||
124920923|NCT04541706|449339985|FG000|Overall Study|Adverse Event|1|||
124920924|NCT05563246|449339986|FG000|Overall Study|Withdrawal by Subject|1|||
124920925|NCT05563246|449339987|FG001|Overall Study|Withdrawal by Subject|2|||
124920926|NCT05563246|449339988|FG002|Overall Study|Withdrawal by Subject|0|||
124920927|NCT05563246|449339989|FG003|Overall Study|Withdrawal by Subject|0|||
124920928|NCT05563246|449339986|FG000|Overall Study|Protocol Deviation|0|||
124920929|NCT05563246|449339987|FG001|Overall Study|Protocol Deviation|1|||
124920930|NCT05563246|449339988|FG002|Overall Study|Protocol Deviation|0|||
124920931|NCT05563246|449339989|FG003|Overall Study|Protocol Deviation|0|||
124920932|NCT05563246|449339986|FG000|Overall Study|Physician Decision|0|||
124920933|NCT05563246|449339987|FG001|Overall Study|Physician Decision|1|||
124920934|NCT05563246|449339988|FG002|Overall Study|Physician Decision|0|||
124920935|NCT05563246|449339989|FG003|Overall Study|Physician Decision|0|||
124920936|NCT05563246|449339986|FG000|Overall Study|Adverse Event|0|||
124920937|NCT05563246|449339987|FG001|Overall Study|Adverse Event|0|||
124920938|NCT05563246|449339988|FG002|Overall Study|Adverse Event|2|||
124920939|NCT05563246|449339989|FG003|Overall Study|Adverse Event|0|||
124920940|NCT05563246|449339986|FG000|Overall Study|Lost to Follow-up|0|||
124920941|NCT05563246|449339987|FG001|Overall Study|Lost to Follow-up|0|||
124920942|NCT05563246|449339988|FG002|Overall Study|Lost to Follow-up|1|||
124920943|NCT05563246|449339989|FG003|Overall Study|Lost to Follow-up|0|||
124920944|NCT01416831|449339992|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
124920945|NCT01416831|449339993|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
124920946|NCT04179500|449339994|FG000|Treatment|Withdrawal by Subject|1|||
124920947|NCT04179500|449339994|FG000|Treatment|Adverse Event|2|||
124920948|NCT04179500|449339994|FG000|Treatment|pyrazinamide resistance|1|||
124920949|NCT04812535|449339999|FG000|Overall Study|Withdrawal by Subject|0|||
124920950|NCT04812535|449340000|FG001|Overall Study|Withdrawal by Subject|0|||
124920951|NCT04812535|449340001|FG002|Overall Study|Withdrawal by Subject|0|||
124920952|NCT04812535|449340002|FG003|Overall Study|Withdrawal by Subject|1|||
124920953|NCT04812535|449339999|FG000|Overall Study|Death|7|||
124920954|NCT04812535|449340000|FG001|Overall Study|Death|2|||
124920955|NCT04812535|449340001|FG002|Overall Study|Death|4|||
124920956|NCT04812535|449340002|FG003|Overall Study|Death|1|||
124920957|NCT04812535|449339999|FG000|Overall Study|Due to premature study termination by sponsor|2|||
124920958|NCT04812535|449340000|FG001|Overall Study|Due to premature study termination by sponsor|0|||
124920959|NCT04812535|449340001|FG002|Overall Study|Due to premature study termination by sponsor|1|||
124920960|NCT04812535|449340002|FG003|Overall Study|Due to premature study termination by sponsor|3|||
124920961|NCT03336333|449340003|FG000|Overall Study|Remained on study at time of data cut-off|202|||
124920962|NCT03336333|449340004|FG001|Overall Study|Remained on study at time of data cut-off|219|||
124920963|NCT03336333|449340005|FG002|Overall Study|Remained on study at time of data cut-off|102|||
124920964|NCT03336333|449340003|FG000|Overall Study|Death|14|||
124920965|NCT03336333|449340004|FG001|Overall Study|Death|16|||
124920966|NCT03336333|449340005|FG002|Overall Study|Death|8|||
124920967|NCT03336333|449340003|FG000|Overall Study|Withdrawal by Subject|16|||
124920968|NCT03336333|449340004|FG001|Overall Study|Withdrawal by Subject|5|||
124920969|NCT03336333|449340005|FG002|Overall Study|Withdrawal by Subject|1|||
124920970|NCT03336333|449340003|FG000|Overall Study|Physician Decision|5|||
124920971|NCT03336333|449340004|FG001|Overall Study|Physician Decision|1|||
124920972|NCT03336333|449340005|FG002|Overall Study|Physician Decision|0|||
124920973|NCT03336333|449340003|FG000|Overall Study|Lost to Follow-up|1|||
124920974|NCT03336333|449340004|FG001|Overall Study|Lost to Follow-up|0|||
124920975|NCT03336333|449340005|FG002|Overall Study|Lost to Follow-up|0|||
124920976|NCT03623321|449340012|FG000|Overall Study|Adverse Event|32|||
124920977|NCT03623321|449340012|FG000|Overall Study|Death|9|||
124920978|NCT03623321|449340012|FG000|Overall Study|Lack of Efficacy|9|||
124920979|NCT03623321|449340012|FG000|Overall Study|Lost to Follow-up|6|||
124920980|NCT03623321|449340012|FG000|Overall Study|Noncompliance with study drug|6|||
124920981|NCT03623321|449340012|FG000|Overall Study|Use of prohibited medication|3|||
124920982|NCT03623321|449340012|FG000|Overall Study|Physician Decision|5|||
124920983|NCT03623321|449340012|FG000|Overall Study|Protocol Violation|1|||
124920984|NCT03623321|449340012|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
124920985|NCT03623321|449340012|FG000|Overall Study|Not further specified|43|||
124920986|NCT01785719|449340014|FG000|4-week Baseline Evaluation|Physician Decision|1|||
124920987|NCT01785719|449340015|FG001|4-week Baseline Evaluation|Physician Decision|0|||
124920988|NCT01785719|449340014|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
124920989|NCT01785719|449340015|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
124920990|NCT01785719|449340014|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
124920991|NCT01785719|449340015|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
124920992|NCT01785719|449340014|FG000|4-week Baseline Evaluation|Pregnancy|0|||
124920993|NCT01785719|449340015|FG001|4-week Baseline Evaluation|Pregnancy|2|||
124920994|NCT01785719|449340014|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
124920995|NCT01785719|449340015|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
124920996|NCT01785719|449340014|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
124920997|NCT01785719|449340015|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
124920998|NCT01785719|449340014|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
124920999|NCT01785719|449340015|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
124921000|NCT01785719|449340014|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
124921001|NCT01785719|449340015|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
124921002|NCT01785719|449340014|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
124921003|NCT01785719|449340015|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
124921004|NCT01785719|449340014|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
124921005|NCT01785719|449340015|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
124921006|NCT01785719|449340014|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
124921007|NCT01785719|449340015|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
124921008|NCT01785719|449340014|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
124921009|NCT01785719|449340015|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
124921010|NCT01785719|449340014|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
124921011|NCT01785719|449340015|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
124921012|NCT01785719|449340014|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
124921013|NCT01785719|449340015|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
124921014|NCT01785719|449340014|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
124921015|NCT01785719|449340015|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
124921016|NCT03699709|449340027|FG000|Overall Study|Death|1|||
124921017|NCT03699709|449340028|FG001|Overall Study|Death|2|||
124921018|NCT03699709|449340027|FG000|Overall Study|Lost to Follow-up|10|||
124921019|NCT03699709|449340028|FG001|Overall Study|Lost to Follow-up|3|||
124921020|NCT03699709|449340027|FG000|Overall Study|Withdrawal by Subject|5|||
124921021|NCT03699709|449340028|FG001|Overall Study|Withdrawal by Subject|0|||
124921022|NCT03699709|449340027|FG000|Overall Study|incarcerated|1|||
124921023|NCT03699709|449340028|FG001|Overall Study|incarcerated|0|||
124921024|NCT03699709|449340027|FG000|Overall Study|scheduled, but no show|0|||
124921025|NCT03699709|449340028|FG001|Overall Study|scheduled, but no show|1|||
124921026|NCT04562649|449340029|FG000|Overall Study|Withdrawal by Subject|11|||
124921027|NCT04562649|449340030|FG001|Overall Study|Withdrawal by Subject|8|||
124921028|NCT04562649|449340029|FG000|Overall Study|Lost to Follow-up|26|||
124921029|NCT04562649|449340030|FG001|Overall Study|Lost to Follow-up|20|||
125116628|NCT00321711|450049892|FG004|Part A|Protocol deviation|0|||
125116629|NCT00321711|450049888|FG000|Part B|Noncompliance|0|||
125116630|NCT00321711|450049889|FG001|Part B|Noncompliance|0|||
125116631|NCT00321711|450049890|FG002|Part B|Noncompliance|0|||
125116632|NCT00321711|450049891|FG003|Part B|Noncompliance|0|||
125116633|NCT00321711|450049892|FG004|Part B|Noncompliance|1|||
124921036|NCT05368103|449340032|FG000|Overall Study|Withdrawal by Subject|4|||
124921037|NCT05368103|449340032|FG000|Overall Study|Lost to Follow-up|1|||
124921038|NCT05368103|449340032|FG000|Overall Study|Lack of Efficacy|3|||
124921039|NCT03039023|449340041|FG000|Overall Study|Withdrawal by Subject|1|||
124921040|NCT03039023|449340042|FG001|Overall Study|Withdrawal by Subject|0|||
124921041|NCT03039023|449340043|FG002|Overall Study|Withdrawal by Subject|1|||
124921042|NCT03039023|449340044|FG003|Overall Study|Withdrawal by Subject|1|||
124921043|NCT03039023|449340045|FG004|Overall Study|Withdrawal by Subject|0|||
124921044|NCT03039023|449340041|FG000|Overall Study|Physician Decision|0|||
124921045|NCT03039023|449340042|FG001|Overall Study|Physician Decision|0|||
124921046|NCT03039023|449340043|FG002|Overall Study|Physician Decision|0|||
124921047|NCT03039023|449340044|FG003|Overall Study|Physician Decision|1|||
124921048|NCT03039023|449340045|FG004|Overall Study|Physician Decision|0|||
124921049|NCT04130438|449340046|FG000|Overall Study|Lost to Follow-up|0|||
124921050|NCT04130438|449340047|FG001|Overall Study|Lost to Follow-up|0|||
124921051|NCT04130438|449340048|FG002|Overall Study|Lost to Follow-up|1|||
124921052|NCT05268393|449340049|FG000|Overall Study|Withdrawal by Subject|2|||
124921053|NCT05268393|449340050|FG001|Overall Study|Withdrawal by Subject|1|||
124921054|NCT05256706|449340052|FG000|Overall Study|Lost to Follow-up|9|||
124921055|NCT05256706|449340053|FG001|Overall Study|Lost to Follow-up|3|||
124921056|NCT05256706|449340052|FG000|Overall Study|Withdrawal by Subject|7|||
124921057|NCT05256706|449340053|FG001|Overall Study|Withdrawal by Subject|11|||
124921058|NCT05256706|449340052|FG000|Overall Study|Screen Failures|3|||
124921059|NCT05256706|449340053|FG001|Overall Study|Screen Failures|0|||
124921060|NCT04410042|449340054|FG000|Overall Study|Not Eligible|1|||
124921061|NCT04410042|449340055|FG001|Overall Study|Not Eligible|1|||
124921062|NCT03850678|449340058|FG000|Overall Study|Withdrawal by Subject|3|||
124921063|NCT03850678|449340059|FG001|Overall Study|Withdrawal by Subject|0|||
124921064|NCT03850678|449340058|FG000|Overall Study|Experimenter Error|1|||
124921065|NCT03850678|449340059|FG001|Overall Study|Experimenter Error|1|||
124921066|NCT03850678|449340058|FG000|Overall Study|Did Not Condition To Experiment|7|||
124921067|NCT03850678|449340059|FG001|Overall Study|Did Not Condition To Experiment|2|||
124921068|NCT03720795|449340060|FG000|Phase 1|Lost to Follow-up|4|||
124921069|NCT03720795|449340060|FG000|Phase 1|Withdrawal by Subject|6|||
124921070|NCT03720795|449340060|FG000|Phase 1|Protocol Violation|1|||
124921071|NCT03720795|449340060|FG000|Phase 1|Other|1|||
124921072|NCT03720795|449340060|FG000|Phase 2|Lost to Follow-up|5|||
124921073|NCT03720795|449340060|FG000|Phase 2|Withdrawal by Subject|10|||
124921074|NCT03720795|449340060|FG000|Phase 2|Protocol Violation|2|||
124921075|NCT03720795|449340060|FG000|3 Month Follow Up|Lost to Follow-up|2|||
124921076|NCT03891667|449340061|FG000|Overall Study|Physician Decision|1|||
124921077|NCT03891667|449340062|FG001|Overall Study|Physician Decision|1|||
125116634|NCT00321711|450049888|FG000|Part B|Adverse Event|0|||
125023066|NCT00866307|449707916|FG000|Induction|Death|2|||
125023067|NCT00866307|449707917|FG001|Induction|Death|0|||
125023068|NCT00866307|449707918|FG002|Induction|Death|0|||
125023069|NCT00866307|449707916|FG000|Induction|Physician Decision|5|||
125023070|NCT00866307|449707917|FG001|Induction|Physician Decision|0|||
125023071|NCT00866307|449707918|FG002|Induction|Physician Decision|0|||
125023072|NCT00866307|449707916|FG000|Induction|Progressive Disease|1|||
125023073|NCT00866307|449707917|FG001|Induction|Progressive Disease|0|||
125023074|NCT00866307|449707918|FG002|Induction|Progressive Disease|0|||
125023075|NCT00866307|449707916|FG000|Induction|Identification of Patients with Day 29 M|3|||
125023076|NCT00866307|449707917|FG001|Induction|Identification of Patients with Day 29 M|0|||
125023077|NCT00866307|449707918|FG002|Induction|Identification of Patients with Day 29 M|0|||
125023078|NCT00866307|449707916|FG000|Induction|Inadequate cytognetic samples th|1|||
125023079|NCT00866307|449707917|FG001|Induction|Inadequate cytognetic samples th|0|||
125023080|NCT00866307|449707918|FG002|Induction|Inadequate cytognetic samples th|0|||
125023081|NCT00866307|449707916|FG000|Induction|Improper post-induction consent|2|||
125023082|NCT00866307|449707917|FG001|Induction|Improper post-induction consent|0|||
125023083|NCT00866307|449707918|FG002|Induction|Improper post-induction consent|0|||
125023084|NCT00866307|449707916|FG000|Induction|Study was closed at the time|1|||
125023085|NCT00866307|449707917|FG001|Induction|Study was closed at the time|0|||
125023086|NCT00866307|449707918|FG002|Induction|Study was closed at the time|0|||
125023087|NCT00866307|449707916|FG000|Consolidation/Maintenance|Adverse Event|0|||
125023088|NCT00866307|449707917|FG001|Consolidation/Maintenance|Adverse Event|0|||
125023089|NCT00866307|449707918|FG002|Consolidation/Maintenance|Adverse Event|8|||
125023090|NCT00866307|449707916|FG000|Consolidation/Maintenance|Death|0|||
125023091|NCT00866307|449707917|FG001|Consolidation/Maintenance|Death|0|||
125023092|NCT00866307|449707918|FG002|Consolidation/Maintenance|Death|1|||
125023093|NCT00866307|449707916|FG000|Consolidation/Maintenance|Physician Decision|0|||
125023094|NCT00866307|449707917|FG001|Consolidation/Maintenance|Physician Decision|3|||
125023095|NCT00866307|449707918|FG002|Consolidation/Maintenance|Physician Decision|2|||
125023096|NCT00866307|449707916|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
124921078|NCT03891667|449340061|FG000|Overall Study|COVID related pause|1|||
124921079|NCT03891667|449340062|FG001|Overall Study|COVID related pause|0|||
124921080|NCT03891667|449340061|FG000|Overall Study|Withdrawal by Subject|0|||
124921081|NCT03891667|449340062|FG001|Overall Study|Withdrawal by Subject|1|||
124921082|NCT03891667|449340061|FG000|Overall Study|Adverse Event|0|||
124921083|NCT03891667|449340062|FG001|Overall Study|Adverse Event|1|||
124921084|NCT03302494|449340063|FG000|Overall Study|Other|7|||
124921085|NCT03302494|449340064|FG001|Overall Study|Other|4|||
124921086|NCT03302494|449340065|FG002|Overall Study|Other|6|||
124921087|NCT03302494|449340063|FG000|Overall Study|Withdrawal by Subject|10|||
124921088|NCT03302494|449340064|FG001|Overall Study|Withdrawal by Subject|2|||
124921089|NCT03302494|449340065|FG002|Overall Study|Withdrawal by Subject|9|||
124921090|NCT03302494|449340063|FG000|Overall Study|Study Terminated by Sponsor|32|||
124921091|NCT03302494|449340064|FG001|Overall Study|Study Terminated by Sponsor|29|||
124921092|NCT03302494|449340065|FG002|Overall Study|Study Terminated by Sponsor|30|||
124921093|NCT03302494|449340063|FG000|Overall Study|Physician Decision|1|||
124921094|NCT03302494|449340064|FG001|Overall Study|Physician Decision|0|||
124921095|NCT03302494|449340065|FG002|Overall Study|Physician Decision|1|||
124921096|NCT03302494|449340063|FG000|Overall Study|Lost to Follow-up|1|||
124921097|NCT03302494|449340064|FG001|Overall Study|Lost to Follow-up|3|||
124921098|NCT03302494|449340065|FG002|Overall Study|Lost to Follow-up|3|||
124921099|NCT03302494|449340063|FG000|Overall Study|Death|13|||
124921100|NCT03302494|449340064|FG001|Overall Study|Death|11|||
124921101|NCT03302494|449340065|FG002|Overall Study|Death|4|||
124921102|NCT03302494|449340063|FG000|Overall Study|Adverse Event|1|||
124921103|NCT03302494|449340064|FG001|Overall Study|Adverse Event|2|||
125023097|NCT00866307|449707917|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
125023098|NCT00866307|449707918|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
125023099|NCT00866307|449707916|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
125023100|NCT00866307|449707917|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
125023101|NCT00866307|449707918|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
125023102|NCT00866307|449707916|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
125116635|NCT00321711|450049889|FG001|Part B|Adverse Event|0|||
124921104|NCT03302494|449340065|FG002|Overall Study|Adverse Event|0|||
124921105|NCT03302494|449340063|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
124921106|NCT03302494|449340064|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
124921107|NCT03302494|449340065|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
125116636|NCT00321711|450049890|FG002|Part B|Adverse Event|0|||
125116637|NCT00321711|450049891|FG003|Part B|Adverse Event|2|||
125116638|NCT00321711|450049892|FG004|Part B|Adverse Event|1|||
125116639|NCT00321711|450049888|FG000|Part B|Disease progression|0|||
125116640|NCT00321711|450049889|FG001|Part B|Disease progression|0|||
125116641|NCT00321711|450049890|FG002|Part B|Disease progression|0|||
125116642|NCT00321711|450049891|FG003|Part B|Disease progression|1|||
125116643|NCT00321711|450049892|FG004|Part B|Disease progression|0|||
125211847|NCT00048165|450401386|FG001|Completed 6 Months Study|Insufficient therapy|4|||
125211848|NCT00048165|450401385|FG000|Completed 6 Months Study|Other violation|4|||
125211849|NCT00048165|450401386|FG001|Completed 6 Months Study|Other violation|6|||
125211850|NCT00048165|450401385|FG000|Completed 6 Months Study|Refused treatment|5|||
125211851|NCT00048165|450401386|FG001|Completed 6 Months Study|Refused treatment|5|||
125211852|NCT00048165|450401385|FG000|Completed 6 Months Study|Violation criteria|0|||
125211853|NCT00048165|450401386|FG001|Completed 6 Months Study|Violation criteria|2|||
125211854|NCT00048165|450401385|FG000|Completed 6 Months Study|Did not receive study drug|6|||
125211855|NCT00048165|450401386|FG001|Completed 6 Months Study|Did not receive study drug|6|||
125211856|NCT00048165|450401385|FG000|Completed 12 Months Study|Administration/Other|0|||
125211857|NCT00048165|450401386|FG001|Completed 12 Months Study|Administration/Other|2|||
125211858|NCT00048165|450401385|FG000|Completed 12 Months Study|Death|2|||
124921108|NCT05076708|449340071|FG000|Overall Study|Withdrawal by Subject|4|||
124921109|NCT05076708|449340071|FG000|Overall Study|Lost to study during switch phase|8|||
124921110|NCT03269136|449340075|FG000|Part 1: Dose Escalation|Other|0|||
124921111|NCT03269136|449340076|FG001|Part 1: Dose Escalation|Other|0|||
124921112|NCT03269136|449340077|FG002|Part 1: Dose Escalation|Other|0|||
124921113|NCT03269136|449340078|FG003|Part 1: Dose Escalation|Other|0|||
124921114|NCT03269136|449340079|FG004|Part 1: Dose Escalation|Other|0|||
124921115|NCT03269136|449340080|FG005|Part 1: Dose Escalation|Other|0|||
124921116|NCT03269136|449340081|FG006|Part 1: Dose Escalation|Other|0|||
124921117|NCT03269136|449340082|FG007|Part 1: Dose Escalation|Other|0|||
124921118|NCT03269136|449340083|FG008|Part 1: Dose Escalation|Other|0|||
124921119|NCT03269136|449340084|FG009|Part 1: Dose Escalation|Other|0|||
124921120|NCT03269136|449340085|FG010|Part 1: Dose Escalation|Other|1|||
124921121|NCT03269136|449340086|FG011|Part 1: Dose Escalation|Other|1|||
124921122|NCT03269136|449340087|FG012|Part 1: Dose Escalation|Other|1|||
124921123|NCT03269136|449340088|FG013|Part 1: Dose Escalation|Other|0|||
124921124|NCT03269136|449340089|FG014|Part 1: Dose Escalation|Other|3|||
124921125|NCT03269136|449340090|FG015|Part 1: Dose Escalation|Other|1|||
124921126|NCT03269136|449340091|FG016|Part 1: Dose Escalation|Other|1|||
124921127|NCT03269136|449340092|FG017|Part 1: Dose Escalation|Other|0|||
124921128|NCT03269136|449340075|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921129|NCT03269136|449340076|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921130|NCT03269136|449340077|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921131|NCT03269136|449340078|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921132|NCT03269136|449340079|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921133|NCT03269136|449340080|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921134|NCT03269136|449340081|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
124921135|NCT03269136|449340082|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921136|NCT03269136|449340083|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
124921137|NCT03269136|449340084|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921138|NCT03269136|449340085|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921139|NCT03269136|449340086|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921140|NCT03269136|449340087|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
124921141|NCT03269136|449340088|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921142|NCT03269136|449340089|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921143|NCT03269136|449340090|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921144|NCT03269136|449340091|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921145|NCT03269136|449340092|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921146|NCT03269136|449340075|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921147|NCT03269136|449340076|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921148|NCT03269136|449340077|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921149|NCT03269136|449340078|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921150|NCT03269136|449340079|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921151|NCT03269136|449340080|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921152|NCT03269136|449340081|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921153|NCT03269136|449340082|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
124921154|NCT03269136|449340083|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921155|NCT03269136|449340084|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921156|NCT03269136|449340085|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921157|NCT03269136|449340086|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
125211859|NCT00048165|450401386|FG001|Completed 12 Months Study|Death|1|||
125211860|NCT00048165|450401385|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
124921158|NCT03269136|449340087|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921159|NCT03269136|449340088|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921160|NCT03269136|449340089|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
125211861|NCT00048165|450401386|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
125211862|NCT00731731|450401387|FG000|Overall Study|Protocol Violation|0|||
125211863|NCT00731731|450401388|FG001|Overall Study|Protocol Violation|0|||
124921161|NCT03269136|449340090|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921162|NCT03269136|449340091|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921163|NCT03269136|449340092|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921164|NCT03269136|449340075|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921165|NCT03269136|449340076|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921166|NCT03269136|449340077|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921167|NCT03269136|449340078|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921168|NCT03269136|449340079|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921169|NCT03269136|449340080|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921170|NCT03269136|449340081|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921171|NCT03269136|449340082|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921172|NCT03269136|449340083|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921173|NCT03269136|449340084|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
124921174|NCT03269136|449340085|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921175|NCT03269136|449340086|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921176|NCT03269136|449340087|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921177|NCT03269136|449340088|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921178|NCT03269136|449340089|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921179|NCT03269136|449340090|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921180|NCT03269136|449340091|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921181|NCT03269136|449340092|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921182|NCT03269136|449340075|FG000|Part 1: Dose Escalation|Death|0|||
124921183|NCT03269136|449340076|FG001|Part 1: Dose Escalation|Death|0|||
124921184|NCT03269136|449340077|FG002|Part 1: Dose Escalation|Death|0|||
124921185|NCT03269136|449340078|FG003|Part 1: Dose Escalation|Death|0|||
124921186|NCT03269136|449340079|FG004|Part 1: Dose Escalation|Death|0|||
124921187|NCT03269136|449340080|FG005|Part 1: Dose Escalation|Death|0|||
124921188|NCT03269136|449340081|FG006|Part 1: Dose Escalation|Death|0|||
124921189|NCT03269136|449340082|FG007|Part 1: Dose Escalation|Death|0|||
124921190|NCT03269136|449340083|FG008|Part 1: Dose Escalation|Death|0|||
124921191|NCT03269136|449340084|FG009|Part 1: Dose Escalation|Death|1|||
124921192|NCT03269136|449340085|FG010|Part 1: Dose Escalation|Death|0|||
124921193|NCT03269136|449340086|FG011|Part 1: Dose Escalation|Death|1|||
124921194|NCT03269136|449340087|FG012|Part 1: Dose Escalation|Death|0|||
124921195|NCT03269136|449340088|FG013|Part 1: Dose Escalation|Death|1|||
124921196|NCT03269136|449340089|FG014|Part 1: Dose Escalation|Death|0|||
124921197|NCT03269136|449340090|FG015|Part 1: Dose Escalation|Death|0|||
124921198|NCT03269136|449340091|FG016|Part 1: Dose Escalation|Death|2|||
124921199|NCT03269136|449340092|FG017|Part 1: Dose Escalation|Death|0|||
124921200|NCT03269136|449340075|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
124921201|NCT03269136|449340076|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
124921202|NCT03269136|449340077|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
124921203|NCT03269136|449340078|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
124921204|NCT03269136|449340079|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
124921205|NCT03269136|449340080|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
124921206|NCT03269136|449340081|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
124921207|NCT03269136|449340082|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
124921208|NCT03269136|449340083|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
124921209|NCT03269136|449340084|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
124921210|NCT03269136|449340085|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
124921211|NCT03269136|449340086|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
124921212|NCT03269136|449340087|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
124921213|NCT03269136|449340088|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
124921214|NCT03269136|449340089|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
124921215|NCT03269136|449340090|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
124921216|NCT03269136|449340091|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
124921217|NCT03269136|449340092|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
124921218|NCT03269136|449340075|FG000|Part 1: Dose Escalation|Adverse Event|0|||
124921219|NCT03269136|449340076|FG001|Part 1: Dose Escalation|Adverse Event|0|||
124921220|NCT03269136|449340077|FG002|Part 1: Dose Escalation|Adverse Event|0|||
124921221|NCT03269136|449340078|FG003|Part 1: Dose Escalation|Adverse Event|0|||
124921222|NCT03269136|449340079|FG004|Part 1: Dose Escalation|Adverse Event|0|||
124921223|NCT03269136|449340080|FG005|Part 1: Dose Escalation|Adverse Event|0|||
124921224|NCT03269136|449340081|FG006|Part 1: Dose Escalation|Adverse Event|2|||
124921225|NCT03269136|449340082|FG007|Part 1: Dose Escalation|Adverse Event|0|||
125116644|NCT00321711|450049888|FG000|Part B|Physician Decision|0|||
125116645|NCT00321711|450049889|FG001|Part B|Physician Decision|0|||
124921226|NCT03269136|449340083|FG008|Part 1: Dose Escalation|Adverse Event|0|||
124921227|NCT03269136|449340084|FG009|Part 1: Dose Escalation|Adverse Event|0|||
124921228|NCT03269136|449340085|FG010|Part 1: Dose Escalation|Adverse Event|1|||
124921229|NCT03269136|449340086|FG011|Part 1: Dose Escalation|Adverse Event|2|||
124921230|NCT03269136|449340087|FG012|Part 1: Dose Escalation|Adverse Event|0|||
124921231|NCT03269136|449340088|FG013|Part 1: Dose Escalation|Adverse Event|1|||
124921232|NCT03269136|449340089|FG014|Part 1: Dose Escalation|Adverse Event|0|||
124921233|NCT03269136|449340090|FG015|Part 1: Dose Escalation|Adverse Event|0|||
124921234|NCT03269136|449340091|FG016|Part 1: Dose Escalation|Adverse Event|1|||
124921235|NCT03269136|449340092|FG017|Part 1: Dose Escalation|Adverse Event|0|||
124921236|NCT03269136|449340075|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
124921237|NCT03269136|449340076|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
124921238|NCT03269136|449340077|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
124921239|NCT03269136|449340078|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
124921240|NCT03269136|449340079|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
124921241|NCT03269136|449340080|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
124921242|NCT03269136|449340081|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
124921243|NCT03269136|449340082|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
124921244|NCT03269136|449340083|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
124921245|NCT03269136|449340084|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
124921246|NCT03269136|449340085|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
124921247|NCT03269136|449340086|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
124921248|NCT03269136|449340087|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
124921249|NCT03269136|449340088|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
124921250|NCT03269136|449340089|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
124921251|NCT03269136|449340090|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
124921252|NCT03269136|449340091|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
124921253|NCT03269136|449340092|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
124921254|NCT03269136|449340075|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921255|NCT03269136|449340076|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921256|NCT03269136|449340077|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921257|NCT03269136|449340078|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921258|NCT03269136|449340079|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921259|NCT03269136|449340080|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921260|NCT03269136|449340081|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921261|NCT03269136|449340082|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921262|NCT03269136|449340083|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921263|NCT03269136|449340084|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921264|NCT03269136|449340085|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921265|NCT03269136|449340086|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921266|NCT03269136|449340087|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
124921267|NCT03269136|449340088|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
124921268|NCT03269136|449340089|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
124921269|NCT03269136|449340090|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921270|NCT03269136|449340091|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
124921271|NCT03269136|449340092|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921272|NCT03269136|449340075|FG000|Part 2A: Dose Expansion|Other|0|||
124921273|NCT03269136|449340076|FG001|Part 2A: Dose Expansion|Other|0|||
124921274|NCT03269136|449340077|FG002|Part 2A: Dose Expansion|Other|0|||
124921275|NCT03269136|449340078|FG003|Part 2A: Dose Expansion|Other|0|||
124921276|NCT03269136|449340079|FG004|Part 2A: Dose Expansion|Other|0|||
124921277|NCT03269136|449340080|FG005|Part 2A: Dose Expansion|Other|0|||
124921278|NCT03269136|449340081|FG006|Part 2A: Dose Expansion|Other|0|||
124921279|NCT03269136|449340082|FG007|Part 2A: Dose Expansion|Other|0|||
124921280|NCT03269136|449340083|FG008|Part 2A: Dose Expansion|Other|0|||
124921281|NCT03269136|449340084|FG009|Part 2A: Dose Expansion|Other|0|||
124921282|NCT03269136|449340085|FG010|Part 2A: Dose Expansion|Other|0|||
125116646|NCT00321711|450049890|FG002|Part B|Physician Decision|0|||
125116647|NCT00321711|450049891|FG003|Part B|Physician Decision|1|||
125116648|NCT00321711|450049892|FG004|Part B|Physician Decision|2|||
125116649|NCT00321711|450049888|FG000|Part B|Death|0|||
125116650|NCT00321711|450049889|FG001|Part B|Death|0|||
124921283|NCT03269136|449340086|FG011|Part 2A: Dose Expansion|Other|0|||
124921284|NCT03269136|449340087|FG012|Part 2A: Dose Expansion|Other|0|||
124921285|NCT03269136|449340088|FG013|Part 2A: Dose Expansion|Other|0|||
124921286|NCT03269136|449340089|FG014|Part 2A: Dose Expansion|Other|0|||
124921287|NCT03269136|449340090|FG015|Part 2A: Dose Expansion|Other|0|||
124921288|NCT03269136|449340091|FG016|Part 2A: Dose Expansion|Other|0|||
124921289|NCT03269136|449340092|FG017|Part 2A: Dose Expansion|Other|1|||
125116651|NCT00321711|450049890|FG002|Part B|Death|0|||
125116652|NCT00321711|450049891|FG003|Part B|Death|2|||
124921290|NCT03269136|449340075|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921291|NCT03269136|449340076|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
125116653|NCT00321711|450049892|FG004|Part B|Death|1|||
124921292|NCT03269136|449340077|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921293|NCT03269136|449340078|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921294|NCT03269136|449340079|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921295|NCT03269136|449340080|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921296|NCT03269136|449340081|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921297|NCT03269136|449340082|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921298|NCT03269136|449340083|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921299|NCT03269136|449340084|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921300|NCT03269136|449340085|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921301|NCT03269136|449340086|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921302|NCT03269136|449340087|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921303|NCT03269136|449340088|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921304|NCT03269136|449340089|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921305|NCT03269136|449340090|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921306|NCT03269136|449340091|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921307|NCT03269136|449340092|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
124921308|NCT03269136|449340075|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
124921309|NCT03269136|449340076|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
124921310|NCT03269136|449340077|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
124921311|NCT03269136|449340078|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
124921312|NCT03269136|449340079|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
124921313|NCT03269136|449340080|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
124921314|NCT03269136|449340081|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
124921315|NCT03269136|449340082|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
124921316|NCT03269136|449340083|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
124921317|NCT03269136|449340084|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
124921318|NCT03269136|449340085|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
124921319|NCT03269136|449340086|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
124921320|NCT03269136|449340087|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
124921321|NCT03269136|449340088|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
124921322|NCT03269136|449340089|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
124921323|NCT03269136|449340090|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
124921324|NCT03269136|449340091|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
124921325|NCT03269136|449340092|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
124921326|NCT03269136|449340075|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
124921327|NCT03269136|449340076|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
124921328|NCT03269136|449340077|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
124921329|NCT03269136|449340078|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
124921330|NCT03269136|449340079|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
124921331|NCT03269136|449340080|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
124921332|NCT03269136|449340081|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
124921333|NCT03269136|449340082|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
124921334|NCT03269136|449340083|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
124921335|NCT03269136|449340084|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
124921336|NCT03269136|449340085|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
124921337|NCT03269136|449340086|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
124921338|NCT03269136|449340087|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
124921339|NCT03269136|449340088|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
124921340|NCT03269136|449340089|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
124921341|NCT03269136|449340090|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
124921342|NCT03269136|449340091|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
124921343|NCT03269136|449340092|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
124921344|NCT03269136|449340075|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
124921345|NCT03269136|449340076|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
124921346|NCT03269136|449340077|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
124921347|NCT03269136|449340078|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
124921348|NCT03269136|449340079|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
124921349|NCT03269136|449340080|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
124921350|NCT03269136|449340081|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
124921351|NCT03269136|449340082|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
124921352|NCT03269136|449340083|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
124921353|NCT03269136|449340084|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
124921354|NCT03269136|449340085|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
124921355|NCT03269136|449340086|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
124921356|NCT03269136|449340087|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
124921357|NCT03269136|449340088|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
124921358|NCT03269136|449340089|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
124921359|NCT03269136|449340090|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
124921360|NCT03269136|449340091|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
124921361|NCT03269136|449340092|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
124921362|NCT04456517|449340093|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
124921363|NCT04456517|449340094|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
124921364|NCT04055090|449340095|FG000|Overall Study|screen failure|1|||
124921365|NCT04055090|449340096|FG001|Overall Study|screen failure|0|||
124921366|NCT04055090|449340095|FG000|Overall Study|Withdrawal by Subject|1|||
124921367|NCT04055090|449340096|FG001|Overall Study|Withdrawal by Subject|0|||
124921368|NCT05282173|449340099|FG000|Overall Study|Missed|3|||
124921369|NCT05282173|449340100|FG001|Overall Study|Missed|2|||
124921370|NCT05282173|449340101|FG002|Overall Study|Missed|4|||
124921371|NCT05093829|449340102|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
124921372|NCT05093829|449340103|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
124921373|NCT05093829|449340104|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
124921374|NCT05093829|449340105|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
124921375|NCT05093829|449340106|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
124921376|NCT02727699|449341977|FG000|Overall Study|Adverse Event|2|||
124921377|NCT02727699|449341978|FG001|Overall Study|Adverse Event|0|||
124921378|NCT02727699|449341977|FG000|Overall Study|Withdrawal by Subject|5|||
124921379|NCT02727699|449341978|FG001|Overall Study|Withdrawal by Subject|3|||
124921380|NCT02727699|449341977|FG000|Overall Study|Protocol Violation|0|||
124921381|NCT02727699|449341978|FG001|Overall Study|Protocol Violation|1|||
124921382|NCT02727699|449341977|FG000|Overall Study|Physician Decision|0|||
124921383|NCT02727699|449341978|FG001|Overall Study|Physician Decision|1|||
124921384|NCT02727699|449341977|FG000|Overall Study|Lost to Follow-up|1|||
124921385|NCT02727699|449341978|FG001|Overall Study|Lost to Follow-up|0|||
124921386|NCT02727699|449341977|FG000|Overall Study|Sponsor Decision|1|||
124921387|NCT02727699|449341978|FG001|Overall Study|Sponsor Decision|0|||
124921388|NCT02995434|449341983|FG000|Overall Study|Adverse Event|1|||
124921389|NCT02995434|449341984|FG001|Overall Study|Adverse Event|0|||
124921390|NCT02995434|449341983|FG000|Overall Study|Withdrawal by Subject|6|||
124921391|NCT02995434|449341984|FG001|Overall Study|Withdrawal by Subject|3|||
124921392|NCT03779204|449341985|FG000|Overall Study|Lost to Follow-up|2|||
124921393|NCT03779204|449341986|FG001|Overall Study|Lost to Follow-up|0|||
124921394|NCT04318548|449341996|FG000|Overall Study|Adverse Event|0|||
124921395|NCT04318548|449341997|FG001|Overall Study|Adverse Event|0|||
124921396|NCT04318548|449341998|FG002|Overall Study|Adverse Event|1|||
124921397|NCT04318548|449341996|FG000|Overall Study|Lost to Follow-up|6|||
124921398|NCT04318548|449341997|FG001|Overall Study|Lost to Follow-up|13|||
124921399|NCT04318548|449341998|FG002|Overall Study|Lost to Follow-up|9|||
124921400|NCT04318548|449341996|FG000|Overall Study|Protocol Violation|1|||
124921401|NCT04318548|449341997|FG001|Overall Study|Protocol Violation|0|||
124921402|NCT04318548|449341998|FG002|Overall Study|Protocol Violation|2|||
124921403|NCT04318548|449341996|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
124921404|NCT04318548|449341997|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
124921405|NCT04318548|449341998|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
124921406|NCT04318548|449341996|FG000|Overall Study|Migrated / moved from the study area|0|||
124921407|NCT04318548|449341997|FG001|Overall Study|Migrated / moved from the study area|0|||
124921408|NCT04318548|449341998|FG002|Overall Study|Migrated / moved from the study area|1|||
124921409|NCT04318548|449341996|FG000|Overall Study|Other|1|||
124921410|NCT04318548|449341997|FG001|Overall Study|Other|2|||
124921411|NCT04318548|449341998|FG002|Overall Study|Other|3|||
124921412|NCT04927065|449341999|FG000|First Booster|Adverse Event|1|||
124921413|NCT04927065|449342000|FG001|First Booster|Adverse Event|0|||
125211864|NCT00731731|450401389|FG002|Overall Study|Protocol Violation|1|||
124921414|NCT04927065|449342001|FG002|First Booster|Adverse Event|0|||
124921415|NCT04927065|449342002|FG003|First Booster|Adverse Event|0|||
124921416|NCT04927065|449342003|FG004|First Booster|Adverse Event|0|||
124921417|NCT04927065|449342004|FG005|First Booster|Adverse Event|0|||
124921418|NCT04927065|449342005|FG006|First Booster|Adverse Event|0|||
124921419|NCT04927065|449342006|FG007|First Booster|Adverse Event|1|||
124921420|NCT04927065|449342007|FG008|First Booster|Adverse Event|0|||
124921421|NCT04927065|449342008|FG009|First Booster|Adverse Event|0|||
124921422|NCT04927065|449342009|FG010|First Booster|Adverse Event|0|||
124921423|NCT04927065|449342010|FG011|First Booster|Adverse Event|0|||
124921424|NCT04927065|449342011|FG012|First Booster|Adverse Event|0|||
124921425|NCT04927065|449342012|FG013|First Booster|Adverse Event|0|||
124921426|NCT04927065|449342013|FG014|First Booster|Adverse Event|0|||
124921427|NCT04927065|449342014|FG015|First Booster|Adverse Event|0|||
124921428|NCT04927065|449341999|FG000|First Booster|Death|1|||
124921429|NCT04927065|449342000|FG001|First Booster|Death|0|||
124921430|NCT04927065|449342001|FG002|First Booster|Death|0|||
124921431|NCT04927065|449342002|FG003|First Booster|Death|1|||
124921432|NCT04927065|449342003|FG004|First Booster|Death|0|||
124921433|NCT04927065|449342004|FG005|First Booster|Death|1|||
124921434|NCT04927065|449342005|FG006|First Booster|Death|0|||
124921435|NCT04927065|449342006|FG007|First Booster|Death|0|||
124921436|NCT04927065|449342007|FG008|First Booster|Death|0|||
124921437|NCT04927065|449342008|FG009|First Booster|Death|0|||
124921438|NCT04927065|449342009|FG010|First Booster|Death|0|||
124921439|NCT04927065|449342010|FG011|First Booster|Death|0|||
124921440|NCT04927065|449342011|FG012|First Booster|Death|0|||
124921441|NCT04927065|449342012|FG013|First Booster|Death|0|||
124921442|NCT04927065|449342013|FG014|First Booster|Death|0|||
124921443|NCT04927065|449342014|FG015|First Booster|Death|0|||
124921444|NCT04927065|449341999|FG000|First Booster|Lost to Follow-up|8|||
124921445|NCT04927065|449342000|FG001|First Booster|Lost to Follow-up|20|||
124921446|NCT04927065|449342001|FG002|First Booster|Lost to Follow-up|0|||
124921447|NCT04927065|449342002|FG003|First Booster|Lost to Follow-up|11|||
124921448|NCT04927065|449342003|FG004|First Booster|Lost to Follow-up|43|||
124921449|NCT04927065|449342004|FG005|First Booster|Lost to Follow-up|30|||
124921450|NCT04927065|449342005|FG006|First Booster|Lost to Follow-up|28|||
124921451|NCT04927065|449342006|FG007|First Booster|Lost to Follow-up|23|||
124921452|NCT04927065|449342007|FG008|First Booster|Lost to Follow-up|4|||
124921453|NCT04927065|449342008|FG009|First Booster|Lost to Follow-up|15|||
124921454|NCT04927065|449342009|FG010|First Booster|Lost to Follow-up|0|||
124921455|NCT04927065|449342010|FG011|First Booster|Lost to Follow-up|0|||
124921456|NCT04927065|449342011|FG012|First Booster|Lost to Follow-up|0|||
124921457|NCT04927065|449342012|FG013|First Booster|Lost to Follow-up|0|||
124921458|NCT04927065|449342013|FG014|First Booster|Lost to Follow-up|0|||
124921459|NCT04927065|449342014|FG015|First Booster|Lost to Follow-up|0|||
124921460|NCT04927065|449341999|FG000|First Booster|Physician Decision|1|||
124921461|NCT04927065|449342000|FG001|First Booster|Physician Decision|0|||
124921462|NCT04927065|449342001|FG002|First Booster|Physician Decision|0|||
124921463|NCT04927065|449342002|FG003|First Booster|Physician Decision|3|||
124921464|NCT04927065|449342003|FG004|First Booster|Physician Decision|1|||
124921465|NCT04927065|449342004|FG005|First Booster|Physician Decision|1|||
124921466|NCT04927065|449342005|FG006|First Booster|Physician Decision|0|||
124921467|NCT04927065|449342006|FG007|First Booster|Physician Decision|3|||
124921468|NCT04927065|449342007|FG008|First Booster|Physician Decision|0|||
124921469|NCT04927065|449342008|FG009|First Booster|Physician Decision|0|||
124921470|NCT04927065|449342009|FG010|First Booster|Physician Decision|0|||
124921471|NCT04927065|449342010|FG011|First Booster|Physician Decision|0|||
124921472|NCT04927065|449342011|FG012|First Booster|Physician Decision|0|||
124921473|NCT04927065|449342012|FG013|First Booster|Physician Decision|0|||
124921474|NCT04927065|449342013|FG014|First Booster|Physician Decision|0|||
124921475|NCT04927065|449342014|FG015|First Booster|Physician Decision|0|||
124921476|NCT04927065|449341999|FG000|First Booster|Protocol Violation|4|||
124921477|NCT04927065|449342000|FG001|First Booster|Protocol Violation|4|||
124921478|NCT04927065|449342001|FG002|First Booster|Protocol Violation|0|||
124921479|NCT04927065|449342002|FG003|First Booster|Protocol Violation|3|||
124921480|NCT04927065|449342003|FG004|First Booster|Protocol Violation|0|||
124921481|NCT04927065|449342004|FG005|First Booster|Protocol Violation|0|||
124921482|NCT04927065|449342005|FG006|First Booster|Protocol Violation|0|||
124921483|NCT04927065|449342006|FG007|First Booster|Protocol Violation|2|||
124921484|NCT04927065|449342007|FG008|First Booster|Protocol Violation|0|||
124921485|NCT04927065|449342008|FG009|First Booster|Protocol Violation|0|||
124921486|NCT04927065|449342009|FG010|First Booster|Protocol Violation|0|||
124921487|NCT04927065|449342010|FG011|First Booster|Protocol Violation|0|||
124921488|NCT04927065|449342011|FG012|First Booster|Protocol Violation|0|||
124921489|NCT04927065|449342012|FG013|First Booster|Protocol Violation|0|||
124921490|NCT04927065|449342013|FG014|First Booster|Protocol Violation|0|||
124921491|NCT04927065|449342014|FG015|First Booster|Protocol Violation|0|||
124921492|NCT04927065|449341999|FG000|First Booster|Withdrawal by Subject|8|||
124921493|NCT04927065|449342000|FG001|First Booster|Withdrawal by Subject|23|||
124921494|NCT04927065|449342001|FG002|First Booster|Withdrawal by Subject|0|||
124921495|NCT04927065|449342002|FG003|First Booster|Withdrawal by Subject|19|||
124921496|NCT04927065|449342003|FG004|First Booster|Withdrawal by Subject|20|||
124921497|NCT04927065|449342004|FG005|First Booster|Withdrawal by Subject|15|||
124921498|NCT04927065|449342005|FG006|First Booster|Withdrawal by Subject|6|||
124921499|NCT04927065|449342006|FG007|First Booster|Withdrawal by Subject|24|||
124921500|NCT04927065|449342007|FG008|First Booster|Withdrawal by Subject|0|||
124921501|NCT04927065|449342008|FG009|First Booster|Withdrawal by Subject|4|||
124921502|NCT04927065|449342009|FG010|First Booster|Withdrawal by Subject|0|||
124921503|NCT04927065|449342010|FG011|First Booster|Withdrawal by Subject|0|||
124921504|NCT04927065|449342011|FG012|First Booster|Withdrawal by Subject|0|||
124921505|NCT04927065|449342012|FG013|First Booster|Withdrawal by Subject|0|||
124921506|NCT04927065|449342013|FG014|First Booster|Withdrawal by Subject|0|||
124921507|NCT04927065|449342014|FG015|First Booster|Withdrawal by Subject|0|||
124921508|NCT04927065|449341999|FG000|First Booster|Other Than Specified|1|||
124921509|NCT04927065|449342000|FG001|First Booster|Other Than Specified|1|||
124921510|NCT04927065|449342001|FG002|First Booster|Other Than Specified|0|||
124921511|NCT04927065|449342002|FG003|First Booster|Other Than Specified|1|||
124921512|NCT04927065|449342003|FG004|First Booster|Other Than Specified|2|||
124921513|NCT04927065|449342004|FG005|First Booster|Other Than Specified|3|||
124921514|NCT04927065|449342005|FG006|First Booster|Other Than Specified|2|||
124921515|NCT04927065|449342006|FG007|First Booster|Other Than Specified|6|||
124921516|NCT04927065|449342007|FG008|First Booster|Other Than Specified|0|||
124921517|NCT04927065|449342008|FG009|First Booster|Other Than Specified|4|||
124921518|NCT04927065|449342009|FG010|First Booster|Other Than Specified|0|||
124921519|NCT04927065|449342010|FG011|First Booster|Other Than Specified|0|||
124921520|NCT04927065|449342011|FG012|First Booster|Other Than Specified|0|||
124921521|NCT04927065|449342012|FG013|First Booster|Other Than Specified|0|||
124921522|NCT04927065|449342013|FG014|First Booster|Other Than Specified|0|||
124921523|NCT04927065|449342014|FG015|First Booster|Other Than Specified|0|||
125211865|NCT00731731|450401387|FG000|Overall Study|Cancel prior to treatment|0|||
124921524|NCT04927065|449341999|FG000|Second Booster|Death|0|||
124921525|NCT04927065|449342000|FG001|Second Booster|Death|0|||
125023103|NCT00866307|449707917|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
125023104|NCT00866307|449707918|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
125023105|NCT00866307|449707916|FG000|Consolidation/Maintenance|Therapy error|0|||
125023106|NCT00866307|449707917|FG001|Consolidation/Maintenance|Therapy error|1|||
125023107|NCT00866307|449707918|FG002|Consolidation/Maintenance|Therapy error|0|||
125023108|NCT00866307|449707916|FG000|Consolidation/Maintenance|Non-compliance|0|||
125023109|NCT00866307|449707917|FG001|Consolidation/Maintenance|Non-compliance|0|||
125023110|NCT00866307|449707918|FG002|Consolidation/Maintenance|Non-compliance|1|||
125023111|NCT00866307|449707916|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
125023112|NCT00866307|449707917|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
125023113|NCT00866307|449707918|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
125023114|NCT01060059|449707921|FG000|Overall Study|Adverse Event|1|||
125023115|NCT01060059|449707922|FG001|Overall Study|Adverse Event|1|||
125023116|NCT01060059|449707921|FG000|Overall Study|Death|2|||
125023117|NCT01060059|449707922|FG001|Overall Study|Death|3|||
125023118|NCT01060059|449707921|FG000|Overall Study|Lost to Follow-up|18|||
125023119|NCT01060059|449707922|FG001|Overall Study|Lost to Follow-up|34|||
125023120|NCT01060059|449707921|FG000|Overall Study|entry criteria not met|4|||
125023121|NCT01060059|449707922|FG001|Overall Study|entry criteria not met|3|||
125023122|NCT01060059|449707921|FG000|Overall Study|Withdrawal by Subject|35|||
125023123|NCT01060059|449707922|FG001|Overall Study|Withdrawal by Subject|23|||
125023124|NCT01060059|449707921|FG000|Overall Study|lack of glycemic control|2|||
125023125|NCT01060059|449707922|FG001|Overall Study|lack of glycemic control|1|||
125023126|NCT01060059|449707921|FG000|Overall Study|lack of compliance|5|||
125023127|NCT01060059|449707922|FG001|Overall Study|lack of compliance|2|||
125023128|NCT01614093|449707923|FG000|Overall Study|Withdrawal by Subject|1|||
125023129|NCT00848354|449707924|FG000|Phase 1|Adverse Event|5|||
125023130|NCT00848354|449707925|FG001|Phase 1|Adverse Event|4|||
125023131|NCT00848354|449707924|FG000|Phase 1|Discontinuation of study by sponsor|2|||
125023132|NCT00848354|449707925|FG001|Phase 1|Discontinuation of study by sponsor|1|||
125023133|NCT00848354|449707924|FG000|Phase 1|Failed to return|0|||
125023134|NCT00848354|449707925|FG001|Phase 1|Failed to return|1|||
125023135|NCT00848354|449707924|FG000|Phase 1|Lost to Follow-up|1|||
125023136|NCT00848354|449707925|FG001|Phase 1|Lost to Follow-up|1|||
125023137|NCT00848354|449707924|FG000|Phase 1|Unspecified Reason|1|||
125023138|NCT00848354|449707925|FG001|Phase 1|Unspecified Reason|1|||
125023139|NCT00848354|449707924|FG000|Phase 1|Protocol Violation|1|||
125023140|NCT00848354|449707925|FG001|Phase 1|Protocol Violation|1|||
125023141|NCT00848354|449707924|FG000|Phase 1|Withdrawal by Subject|2|||
125023142|NCT00848354|449707925|FG001|Phase 1|Withdrawal by Subject|4|||
125023143|NCT00848354|449707924|FG000|Phase 1|Lack of Efficacy|0|||
125023144|NCT00848354|449707925|FG001|Phase 1|Lack of Efficacy|1|||
125023145|NCT00848354|449707924|FG000|Phase 2 Year 1|Adverse Event|7|||
125023146|NCT00848354|449707925|FG001|Phase 2 Year 1|Adverse Event|2|||
125023147|NCT00848354|449707924|FG000|Phase 2 Year 1|Death|1|||
125023148|NCT00848354|449707925|FG001|Phase 2 Year 1|Death|0|||
125023149|NCT00848354|449707924|FG000|Phase 2 Year 1|Failed to Return|1|||
125023150|NCT00848354|449707925|FG001|Phase 2 Year 1|Failed to Return|1|||
125023151|NCT00848354|449707924|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
125023152|NCT00848354|449707925|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
125023153|NCT00848354|449707924|FG000|Phase 2 Year 1|Unspecified Reason|3|||
125023154|NCT00848354|449707925|FG001|Phase 2 Year 1|Unspecified Reason|0|||
125023155|NCT00848354|449707924|FG000|Phase 2 Year 1|Protocol Violation|4|||
125023156|NCT00848354|449707925|FG001|Phase 2 Year 1|Protocol Violation|1|||
125023157|NCT00848354|449707924|FG000|Phase 2 Year 1|Subject Request|1|||
125211866|NCT00731731|450401388|FG001|Overall Study|Cancel prior to treatment|0|||
124921526|NCT04927065|449342001|FG002|Second Booster|Death|0|||
124921527|NCT04927065|449342002|FG003|Second Booster|Death|0|||
124921528|NCT04927065|449342003|FG004|Second Booster|Death|0|||
124921529|NCT04927065|449342004|FG005|Second Booster|Death|0|||
124921530|NCT04927065|449342005|FG006|Second Booster|Death|0|||
124921531|NCT04927065|449342006|FG007|Second Booster|Death|0|||
124921532|NCT04927065|449342007|FG008|Second Booster|Death|0|||
124921533|NCT04927065|449342008|FG009|Second Booster|Death|0|||
124921534|NCT04927065|449342009|FG010|Second Booster|Death|2|||
124921535|NCT04927065|449342010|FG011|Second Booster|Death|0|||
124921536|NCT04927065|449342011|FG012|Second Booster|Death|2|||
124921537|NCT04927065|449342012|FG013|Second Booster|Death|2|||
124921538|NCT04927065|449342013|FG014|Second Booster|Death|0|||
124921539|NCT04927065|449342014|FG015|Second Booster|Death|0|||
124921540|NCT04927065|449341999|FG000|Second Booster|Lost to Follow-up|0|||
124921541|NCT04927065|449342000|FG001|Second Booster|Lost to Follow-up|0|||
124921542|NCT04927065|449342001|FG002|Second Booster|Lost to Follow-up|3|||
124921543|NCT04927065|449342002|FG003|Second Booster|Lost to Follow-up|0|||
124921544|NCT04927065|449342003|FG004|Second Booster|Lost to Follow-up|0|||
124921545|NCT04927065|449342004|FG005|Second Booster|Lost to Follow-up|0|||
124921546|NCT04927065|449342005|FG006|Second Booster|Lost to Follow-up|0|||
124921547|NCT04927065|449342006|FG007|Second Booster|Lost to Follow-up|0|||
125116654|NCT02843074|450049893|FG000|Overall Study|Withdrawal by Subject|5|||
125116655|NCT02843074|450049893|FG000|Overall Study|Progressive disease|1|||
125116656|NCT02843074|450049893|FG000|Overall Study|Physician Decision|1|||
125116657|NCT02843074|450049893|FG000|Overall Study|Lost to Follow-up|1|||
125116658|NCT02843074|450049893|FG000|Overall Study|Death|9|||
125116659|NCT01211769|450049896|FG000|Overall Study|Lost to Follow-up|7|||
125116660|NCT01211769|450049897|FG001|Overall Study|Lost to Follow-up|9|||
125116661|NCT01211769|450049898|FG002|Overall Study|Lost to Follow-up|5|||
125116662|NCT01211769|450049899|FG003|Overall Study|Lost to Follow-up|9|||
125116663|NCT01211769|450049896|FG000|Overall Study|Physician Decision|2|||
125116664|NCT01211769|450049897|FG001|Overall Study|Physician Decision|0|||
124921548|NCT04927065|449342007|FG008|Second Booster|Lost to Follow-up|0|||
124921549|NCT04927065|449342008|FG009|Second Booster|Lost to Follow-up|0|||
124921550|NCT04927065|449342009|FG010|Second Booster|Lost to Follow-up|14|||
124921551|NCT04927065|449342010|FG011|Second Booster|Lost to Follow-up|10|||
124921552|NCT04927065|449342011|FG012|Second Booster|Lost to Follow-up|13|||
124921553|NCT04927065|449342012|FG013|Second Booster|Lost to Follow-up|16|||
124921554|NCT04927065|449342013|FG014|Second Booster|Lost to Follow-up|0|||
125116665|NCT01211769|450049898|FG002|Overall Study|Physician Decision|2|||
125116666|NCT01211769|450049899|FG003|Overall Study|Physician Decision|1|||
125116667|NCT01211769|450049896|FG000|Overall Study|Adverse Event|0|||
125116668|NCT01211769|450049897|FG001|Overall Study|Adverse Event|1|||
125116669|NCT01211769|450049898|FG002|Overall Study|Adverse Event|1|||
125116670|NCT01211769|450049899|FG003|Overall Study|Adverse Event|1|||
125116671|NCT01214330|450049900|FG000|Overall Study|Withdrawal by Subject|2|||
125116672|NCT01214330|450049900|FG000|Overall Study|Withdrawal by Subject|2|||
125116673|NCT01348542|450049901|FG000|Overall Study|Withdrawal by Subject|3|||
125116674|NCT01348542|450049902|FG001|Overall Study|Withdrawal by Subject|0|||
125116675|NCT03402893|450049903|FG000|Overall Study|Withdrawal by Subject|1|||
125116676|NCT01484028|450049904|FG000|Period 1|Lost to Follow-up|0|||
125116677|NCT01484028|450049905|FG001|Period 1|Lost to Follow-up|1|||
125116678|NCT01484028|450049906|FG002|Period 1|Lost to Follow-up|0|||
125116679|NCT01484028|450049907|FG003|Period 1|Lost to Follow-up|0|||
125116680|NCT01484028|450049904|FG000|Period 1|Non-Compliance to Protocol|0|||
125116681|NCT01484028|450049905|FG001|Period 1|Non-Compliance to Protocol|1|||
125116682|NCT01484028|450049906|FG002|Period 1|Non-Compliance to Protocol|0|||
125116683|NCT01484028|450049907|FG003|Period 1|Non-Compliance to Protocol|1|||
125116684|NCT01484028|450049904|FG000|Period 1|Lens Discomfort|0|||
125116685|NCT01484028|450049905|FG001|Period 1|Lens Discomfort|1|||
125116686|NCT01484028|450049906|FG002|Period 1|Lens Discomfort|0|||
125116687|NCT01484028|450049907|FG003|Period 1|Lens Discomfort|0|||
125116688|NCT01199601|450049911|FG000|Overall Study|Lost to Follow-up|47|||
124921555|NCT04927065|449342014|FG015|Second Booster|Lost to Follow-up|0|||
124921556|NCT04927065|449341999|FG000|Second Booster|Physician Decision|0|||
125116689|NCT01199601|450049912|FG001|Overall Study|Lost to Follow-up|66|||
125116690|NCT01199601|450049911|FG000|Overall Study|Withdrawal by Subject|15|||
125116691|NCT01199601|450049912|FG001|Overall Study|Withdrawal by Subject|3|||
125116692|NCT01199601|450049911|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
125116693|NCT01199601|450049912|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
125116694|NCT00146770|450049913|FG000|Overall Study|Adverse Event|2|||
124921557|NCT04927065|449342000|FG001|Second Booster|Physician Decision|0|||
124921558|NCT04927065|449342001|FG002|Second Booster|Physician Decision|0|||
124921559|NCT04927065|449342002|FG003|Second Booster|Physician Decision|0|||
124921560|NCT04927065|449342003|FG004|Second Booster|Physician Decision|0|||
124921561|NCT04927065|449342004|FG005|Second Booster|Physician Decision|0|||
125116695|NCT00146770|450049914|FG001|Overall Study|Adverse Event|0|||
124921562|NCT04927065|449342005|FG006|Second Booster|Physician Decision|0|||
124921563|NCT04927065|449342006|FG007|Second Booster|Physician Decision|0|||
124921564|NCT04927065|449342007|FG008|Second Booster|Physician Decision|0|||
125116696|NCT00146770|450049913|FG000|Overall Study|Pregnancy|1|||
125116697|NCT00146770|450049914|FG001|Overall Study|Pregnancy|0|||
125116698|NCT00146770|450049913|FG000|Overall Study|Withdrawal by Subject|2|||
125116699|NCT00146770|450049914|FG001|Overall Study|Withdrawal by Subject|0|||
125116700|NCT03775681|450049919|FG000|Overall Study|Physician Decision|3|||
125116701|NCT01855126|450049920|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
125116702|NCT01855126|450049921|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
125116703|NCT01855126|450049920|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
125116704|NCT01855126|450049921|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
125116705|NCT01748890|450049931|FG000|Overall Study|Insufficient recruitment for analysis|4|||
125116706|NCT02669264|450049932|FG000|Overall Study|Death|5|||
125116707|NCT02669264|450049933|FG001|Overall Study|Death|5|||
125116708|NCT02669264|450049934|FG002|Overall Study|Death|3|||
125116709|NCT02669264|450049935|FG003|Overall Study|Death|3|||
125116710|NCT02669264|450049936|FG004|Overall Study|Death|3|||
125116711|NCT02669264|450049937|FG005|Overall Study|Death|6|||
125116712|NCT02669264|450049938|FG006|Overall Study|Death|3|||
125116713|NCT02669264|450049932|FG000|Overall Study|Withdrawal by Subject|0|||
125116714|NCT02669264|450049933|FG001|Overall Study|Withdrawal by Subject|1|||
125116715|NCT02669264|450049934|FG002|Overall Study|Withdrawal by Subject|0|||
125116716|NCT02669264|450049935|FG003|Overall Study|Withdrawal by Subject|0|||
125116717|NCT02669264|450049936|FG004|Overall Study|Withdrawal by Subject|1|||
125116718|NCT02669264|450049937|FG005|Overall Study|Withdrawal by Subject|0|||
125116719|NCT02669264|450049938|FG006|Overall Study|Withdrawal by Subject|0|||
125116720|NCT02669264|450049932|FG000|Overall Study|Lost to Follow-up|0|||
125116721|NCT02669264|450049933|FG001|Overall Study|Lost to Follow-up|0|||
125116722|NCT02669264|450049934|FG002|Overall Study|Lost to Follow-up|0|||
125116723|NCT02669264|450049935|FG003|Overall Study|Lost to Follow-up|0|||
125116724|NCT02669264|450049936|FG004|Overall Study|Lost to Follow-up|1|||
125116725|NCT02669264|450049937|FG005|Overall Study|Lost to Follow-up|0|||
125116726|NCT02669264|450049938|FG006|Overall Study|Lost to Follow-up|0|||
125116727|NCT02669264|450049932|FG000|Overall Study|Miscellaneous|0|||
125116728|NCT02669264|450049933|FG001|Overall Study|Miscellaneous|0|||
125116729|NCT02669264|450049934|FG002|Overall Study|Miscellaneous|0|||
125116730|NCT02669264|450049935|FG003|Overall Study|Miscellaneous|0|||
125116731|NCT02669264|450049936|FG004|Overall Study|Miscellaneous|0|||
125116732|NCT02669264|450049937|FG005|Overall Study|Miscellaneous|0|||
125116733|NCT02669264|450049938|FG006|Overall Study|Miscellaneous|2|||
125116734|NCT01688037|450049939|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
125116735|NCT01688037|450049940|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
125116736|NCT01688037|450049941|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
125116737|NCT01688037|450049939|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
125116738|NCT01688037|450049940|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
125116739|NCT01688037|450049941|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
125116740|NCT01688037|450049939|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
125116741|NCT01688037|450049940|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
125116742|NCT01688037|450049941|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
125116743|NCT01688037|450049939|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
125116744|NCT01688037|450049940|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
125116745|NCT01688037|450049941|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
125116746|NCT01688037|450049939|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
125116747|NCT01688037|450049940|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
125116748|NCT01688037|450049941|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
125116749|NCT01688037|450049939|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
125116750|NCT01688037|450049940|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
125116751|NCT01688037|450049941|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
124921565|NCT04927065|449342008|FG009|Second Booster|Physician Decision|0|||
124921566|NCT04927065|449342009|FG010|Second Booster|Physician Decision|0|||
124921567|NCT04927065|449342010|FG011|Second Booster|Physician Decision|3|||
124921568|NCT04927065|449342011|FG012|Second Booster|Physician Decision|0|||
124921569|NCT04927065|449342012|FG013|Second Booster|Physician Decision|1|||
124921570|NCT04927065|449342013|FG014|Second Booster|Physician Decision|0|||
124921571|NCT04927065|449342014|FG015|Second Booster|Physician Decision|0|||
124921572|NCT04927065|449341999|FG000|Second Booster|Withdrawal by Subject|0|||
124921573|NCT04927065|449342000|FG001|Second Booster|Withdrawal by Subject|0|||
124921574|NCT04927065|449342001|FG002|Second Booster|Withdrawal by Subject|4|||
124921575|NCT04927065|449342002|FG003|Second Booster|Withdrawal by Subject|0|||
124921576|NCT04927065|449342003|FG004|Second Booster|Withdrawal by Subject|0|||
125116752|NCT01688037|450049939|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
125116753|NCT01688037|450049940|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
124921577|NCT04927065|449342004|FG005|Second Booster|Withdrawal by Subject|0|||
125116754|NCT01688037|450049941|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
125116755|NCT01688037|450049939|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
125116756|NCT01688037|450049940|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
125116757|NCT01688037|450049941|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
125116758|NCT01688037|450049939|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
125116759|NCT01688037|450049940|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
125116760|NCT01688037|450049941|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
125116761|NCT01688037|450049939|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
124921578|NCT04927065|449342005|FG006|Second Booster|Withdrawal by Subject|0|||
124921579|NCT04927065|449342006|FG007|Second Booster|Withdrawal by Subject|0|||
124921580|NCT04927065|449342007|FG008|Second Booster|Withdrawal by Subject|0|||
124921581|NCT04927065|449342008|FG009|Second Booster|Withdrawal by Subject|0|||
124921582|NCT04927065|449342009|FG010|Second Booster|Withdrawal by Subject|3|||
124921583|NCT04927065|449342010|FG011|Second Booster|Withdrawal by Subject|16|||
124921584|NCT04927065|449342011|FG012|Second Booster|Withdrawal by Subject|13|||
124921585|NCT04927065|449342012|FG013|Second Booster|Withdrawal by Subject|9|||
124921586|NCT04927065|449342013|FG014|Second Booster|Withdrawal by Subject|0|||
124921587|NCT04927065|449342014|FG015|Second Booster|Withdrawal by Subject|0|||
124921588|NCT04927065|449341999|FG000|Second Booster|Other Than Specified|0|||
124921589|NCT04927065|449342000|FG001|Second Booster|Other Than Specified|0|||
124921590|NCT04927065|449342001|FG002|Second Booster|Other Than Specified|0|||
124921591|NCT04927065|449342002|FG003|Second Booster|Other Than Specified|0|||
124921592|NCT04927065|449342003|FG004|Second Booster|Other Than Specified|0|||
124921593|NCT04927065|449342004|FG005|Second Booster|Other Than Specified|0|||
124921594|NCT04927065|449342005|FG006|Second Booster|Other Than Specified|0|||
124921595|NCT04927065|449342006|FG007|Second Booster|Other Than Specified|0|||
124921596|NCT04927065|449342007|FG008|Second Booster|Other Than Specified|0|||
124921597|NCT04927065|449342008|FG009|Second Booster|Other Than Specified|0|||
124921598|NCT04927065|449342009|FG010|Second Booster|Other Than Specified|1|||
124921599|NCT04927065|449342010|FG011|Second Booster|Other Than Specified|1|||
124921600|NCT04927065|449342011|FG012|Second Booster|Other Than Specified|4|||
124921601|NCT04927065|449342012|FG013|Second Booster|Other Than Specified|0|||
124921602|NCT04927065|449342013|FG014|Second Booster|Other Than Specified|0|||
124921603|NCT04927065|449342014|FG015|Second Booster|Other Than Specified|0|||
124921604|NCT04927065|449341999|FG000|Third Booster|Lost to Follow-up|0|||
124921605|NCT04927065|449342000|FG001|Third Booster|Lost to Follow-up|0|||
124921606|NCT04927065|449342001|FG002|Third Booster|Lost to Follow-up|0|||
124921607|NCT04927065|449342002|FG003|Third Booster|Lost to Follow-up|0|||
124921608|NCT04927065|449342003|FG004|Third Booster|Lost to Follow-up|0|||
124921609|NCT04927065|449342004|FG005|Third Booster|Lost to Follow-up|0|||
124921610|NCT04927065|449342005|FG006|Third Booster|Lost to Follow-up|0|||
125116762|NCT01688037|450049940|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
124921611|NCT04927065|449342006|FG007|Third Booster|Lost to Follow-up|0|||
124921612|NCT04927065|449342007|FG008|Third Booster|Lost to Follow-up|0|||
124921613|NCT04927065|449342008|FG009|Third Booster|Lost to Follow-up|0|||
124921614|NCT04927065|449342009|FG010|Third Booster|Lost to Follow-up|0|||
124921615|NCT04927065|449342010|FG011|Third Booster|Lost to Follow-up|0|||
124921616|NCT04927065|449342011|FG012|Third Booster|Lost to Follow-up|0|||
124921617|NCT04927065|449342012|FG013|Third Booster|Lost to Follow-up|0|||
124921618|NCT04927065|449342013|FG014|Third Booster|Lost to Follow-up|0|||
124921619|NCT04927065|449342014|FG015|Third Booster|Lost to Follow-up|1|||
124921620|NCT04927065|449341999|FG000|Third Booster|Withdrawal by Subject|0|||
124921621|NCT04927065|449342000|FG001|Third Booster|Withdrawal by Subject|0|||
124921622|NCT04927065|449342001|FG002|Third Booster|Withdrawal by Subject|0|||
124921623|NCT04927065|449342002|FG003|Third Booster|Withdrawal by Subject|0|||
124921624|NCT04927065|449342003|FG004|Third Booster|Withdrawal by Subject|0|||
124921625|NCT04927065|449342004|FG005|Third Booster|Withdrawal by Subject|0|||
124921626|NCT04927065|449342005|FG006|Third Booster|Withdrawal by Subject|0|||
124921627|NCT04927065|449342006|FG007|Third Booster|Withdrawal by Subject|0|||
124921628|NCT04927065|449342007|FG008|Third Booster|Withdrawal by Subject|0|||
124921629|NCT04927065|449342008|FG009|Third Booster|Withdrawal by Subject|0|||
124921630|NCT04927065|449342009|FG010|Third Booster|Withdrawal by Subject|0|||
124921631|NCT04927065|449342010|FG011|Third Booster|Withdrawal by Subject|0|||
124921632|NCT04927065|449342011|FG012|Third Booster|Withdrawal by Subject|0|||
124921633|NCT04927065|449342012|FG013|Third Booster|Withdrawal by Subject|0|||
124921634|NCT04927065|449342013|FG014|Third Booster|Withdrawal by Subject|0|||
124921635|NCT04927065|449342014|FG015|Third Booster|Withdrawal by Subject|1|||
124921636|NCT04241068|449342017|FG000|Core Treatment Period|Adverse Event|91|||
124921637|NCT04241068|449342017|FG000|Core Treatment Period|Change of Treatment|4|||
124921638|NCT04241068|449342017|FG000|Core Treatment Period|Consent Withdrawn|143|||
124921639|NCT04241068|449342017|FG000|Core Treatment Period|Death|26|||
124921640|NCT04241068|449342017|FG000|Core Treatment Period|Disease Progression|67|||
124921641|NCT04241068|449342017|FG000|Core Treatment Period|Investigator Decision|40|||
124921642|NCT04241068|449342017|FG000|Core Treatment Period|Loss of Capacity|9|||
124921643|NCT04241068|449342017|FG000|Core Treatment Period|Lost to Follow-up|11|||
125116763|NCT01688037|450049941|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
125116764|NCT03280537|450049944|FG000|Overall Study|Withdrawal by Subject|2|||
125116765|NCT03280537|450049945|FG001|Overall Study|Withdrawal by Subject|4|||
125116766|NCT03083132|450049946|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
125116767|NCT03083132|450049947|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
125116768|NCT03083132|450049946|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
125116769|NCT03083132|450049947|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
125116770|NCT03083132|450049946|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
125131398|NCT03818581|450109962|FG002|Overall Study|Covid-19|0|||
124921644|NCT04241068|449342017|FG000|Core Treatment Period|Relocation|4|||
124921645|NCT04241068|449342017|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
124921646|NCT04241068|449342017|FG000|Core Treatment Period|Study Visit Burden|40|||
124921647|NCT04241068|449342017|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
124921648|NCT04241068|449342017|FG000|Core Treatment Period|Missing|2|||
124921649|NCT04241068|449342017|FG000|Core Treatment Period|Reason Not Specified|41|||
124921650|NCT04241068|449342017|FG000|LTE Period|Adverse Event|19|||
124921651|NCT04241068|449342017|FG000|LTE Period|Change of Treatment|1|||
124921652|NCT04241068|449342017|FG000|LTE Period|Consent Withdrawn|71|||
124921653|NCT04241068|449342017|FG000|LTE Period|Death|8|||
124921654|NCT04241068|449342017|FG000|LTE Period|Disease Progression|11|||
124921655|NCT04241068|449342017|FG000|LTE Period|Investigator Decision|12|||
124921656|NCT04241068|449342017|FG000|LTE Period|Loss of Capacity|2|||
124921657|NCT04241068|449342017|FG000|LTE Period|Lost to Follow-up|7|||
124921658|NCT04241068|449342017|FG000|LTE Period|Relocation|6|||
124921659|NCT04241068|449342017|FG000|LTE Period|Site Terminated by Sponsor|26|||
124921660|NCT04241068|449342017|FG000|LTE Period|Study Terminated by Sponsor|276|||
124921661|NCT04241068|449342017|FG000|LTE Period|Study Visit Burden|10|||
124921662|NCT04241068|449342017|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
124921663|NCT04241068|449342017|FG000|LTE Period|Reason Not Specified|65|||
124921664|NCT04492007|449342018|FG000|Overall Study|Lost to Follow-up|1|||
124921665|NCT04492007|449342019|FG001|Overall Study|Lost to Follow-up|1|||
124921666|NCT04492007|449342020|FG002|Overall Study|Lost to Follow-up|2|||
124921667|NCT04492007|449342021|FG003|Overall Study|Lost to Follow-up|2|||
124921668|NCT04492007|449342018|FG000|Overall Study|Protocol Violation|1|||
124921669|NCT04492007|449342019|FG001|Overall Study|Protocol Violation|1|||
124921670|NCT04492007|449342020|FG002|Overall Study|Protocol Violation|1|||
124921671|NCT04492007|449342021|FG003|Overall Study|Protocol Violation|1|||
124921672|NCT04492007|449342018|FG000|Overall Study|Withdrawal by Subject|0|||
124921673|NCT04492007|449342019|FG001|Overall Study|Withdrawal by Subject|0|||
124921674|NCT04492007|449342020|FG002|Overall Study|Withdrawal by Subject|1|||
124921675|NCT04492007|449342021|FG003|Overall Study|Withdrawal by Subject|1|||
124921676|NCT04347161|449342022|FG000|Overall Study|Death|0|||
124921677|NCT04347161|449342023|FG001|Overall Study|Death|2|||
124921678|NCT04347161|449342022|FG000|Overall Study|Withdrawal by Subject|1|||
125116771|NCT03083132|450049947|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
125116772|NCT01588106|450049948|FG000|Overall Study|Withdrawal by Subject|5|||
125116773|NCT01588106|450049949|FG001|Overall Study|Withdrawal by Subject|4|||
125116774|NCT02995837|450049950|FG000|Overall Study|Lost to Follow-up|9|||
125116775|NCT02995837|450049951|FG001|Overall Study|Lost to Follow-up|8|||
125116776|NCT02004847|450051641|FG000|Overall Study|Protocol Violation|1|||
125116777|NCT02004847|450051642|FG001|Overall Study|Protocol Violation|1|||
125116778|NCT03342898|450051643|FG000|Overall Study|Adverse Event|3|||
125116779|NCT03342898|450051644|FG001|Overall Study|Adverse Event|1|||
125116780|NCT03342898|450051645|FG002|Overall Study|Adverse Event|0|||
125116781|NCT03342898|450051643|FG000|Overall Study|Lost to Follow-up|44|||
125116782|NCT03342898|450051644|FG001|Overall Study|Lost to Follow-up|40|||
125116783|NCT03342898|450051645|FG002|Overall Study|Lost to Follow-up|42|||
125116784|NCT03342898|450051643|FG000|Overall Study|Withdrawal of Consent|5|||
125116785|NCT03342898|450051644|FG001|Overall Study|Withdrawal of Consent|9|||
125116786|NCT03342898|450051645|FG002|Overall Study|Withdrawal of Consent|11|||
125116787|NCT03342898|450051643|FG000|Overall Study|Death|0|||
125116788|NCT03342898|450051644|FG001|Overall Study|Death|1|||
125116789|NCT03342898|450051645|FG002|Overall Study|Death|1|||
125116790|NCT03342898|450051643|FG000|Overall Study|Reason not Specified|2|||
125116791|NCT03342898|450051644|FG001|Overall Study|Reason not Specified|2|||
125116792|NCT03342898|450051645|FG002|Overall Study|Reason not Specified|0|||
125116793|NCT03997448|450051646|FG000|Study Treatment|Disease Progression|1|||
125116794|NCT03997448|450051646|FG000|Study Treatment|Symptomatic Deterioration|1|||
125116795|NCT03997448|450051646|FG000|Follow up|Death|2|||
125116796|NCT03997448|450051646|FG000|Follow up|study terminated|1|||
125116797|NCT02482805|450051655|FG000|Overall Study|Lost to Follow-up|4|||
124921679|NCT04347161|449342023|FG001|Overall Study|Withdrawal by Subject|0|||
124921680|NCT04347161|449342022|FG000|Overall Study|Lost to Follow-up|0|||
124921681|NCT04347161|449342023|FG001|Overall Study|Lost to Follow-up|1|||
124921682|NCT04347161|449342022|FG000|Overall Study|No longer on study medication|1|||
124921683|NCT04347161|449342023|FG001|Overall Study|No longer on study medication|1|||
124921684|NCT04169373|449342024|FG000|Week 1 to Week 14|Adverse Event|1|||
124921685|NCT04169373|449342025|FG001|Week 1 to Week 14|Adverse Event|0|||
124921686|NCT04169373|449342026|FG002|Week 1 to Week 14|Adverse Event|1|||
124921687|NCT04169373|449342027|FG003|Week 1 to Week 14|Adverse Event|2|||
124921688|NCT04169373|449342024|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
125116798|NCT02482805|450051656|FG001|Overall Study|Lost to Follow-up|4|||
125116799|NCT02482805|450051657|FG002|Overall Study|Lost to Follow-up|0|||
125116800|NCT01144663|450051658|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
125116801|NCT01144663|450051659|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
125131399|NCT03818581|450109963|FG003|Overall Study|Covid-19|0|||
124921689|NCT04169373|449342025|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
124921690|NCT04169373|449342026|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
124921691|NCT04169373|449342027|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
124921692|NCT04169373|449342024|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
124921693|NCT04169373|449342025|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
124921694|NCT04169373|449342026|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
124921695|NCT04169373|449342027|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
124921696|NCT04169373|449342024|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
124921697|NCT04169373|449342025|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
124921698|NCT04169373|449342026|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
124921699|NCT04169373|449342027|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
124921700|NCT04169373|449342024|FG000|Week 1 to Week 14|Other|1|||
124921701|NCT04169373|449342025|FG001|Week 1 to Week 14|Other|3|||
124921702|NCT04169373|449342026|FG002|Week 1 to Week 14|Other|3|||
124921703|NCT04169373|449342027|FG003|Week 1 to Week 14|Other|5|||
124921704|NCT04169373|449342024|FG000|Week 14 to Week 52|Adverse Event|1|||
124921705|NCT04169373|449342025|FG001|Week 14 to Week 52|Adverse Event|0|||
124921706|NCT04169373|449342026|FG002|Week 14 to Week 52|Adverse Event|0|||
124921707|NCT04169373|449342027|FG003|Week 14 to Week 52|Adverse Event|1|||
124921708|NCT04169373|449342024|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
124921709|NCT04169373|449342025|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
124921710|NCT04169373|449342026|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
124921711|NCT04169373|449342027|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
124921712|NCT04169373|449342024|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
124921713|NCT04169373|449342025|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
124921714|NCT04169373|449342026|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
124921715|NCT04169373|449342027|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
124921716|NCT04169373|449342024|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
124921717|NCT04169373|449342025|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
124921718|NCT04169373|449342026|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
124921719|NCT04169373|449342027|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
124921720|NCT04169373|449342024|FG000|Week 14 to Week 52|Other|4|||
124921721|NCT04169373|449342025|FG001|Week 14 to Week 52|Other|5|||
124921722|NCT04169373|449342026|FG002|Week 14 to Week 52|Other|4|||
125116802|NCT01144663|450051660|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
125116803|NCT01144663|450051661|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
125116804|NCT01144663|450051658|FG000|Primary Vaccination Phase|Adverse Event|1|||
125116805|NCT01144663|450051659|FG001|Primary Vaccination Phase|Adverse Event|0|||
125116806|NCT01144663|450051660|FG002|Primary Vaccination Phase|Adverse Event|0|||
125116807|NCT01144663|450051661|FG003|Primary Vaccination Phase|Adverse Event|1|||
125116808|NCT01144663|450051658|FG000|Primary Vaccination Phase|Protocol Violation|2|||
125116809|NCT01144663|450051659|FG001|Primary Vaccination Phase|Protocol Violation|0|||
125116810|NCT01144663|450051660|FG002|Primary Vaccination Phase|Protocol Violation|1|||
125116811|NCT01144663|450051661|FG003|Primary Vaccination Phase|Protocol Violation|0|||
125116812|NCT01144663|450051658|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
125116813|NCT01144663|450051659|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
125116814|NCT01144663|450051660|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
125116815|NCT01144663|450051661|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
125116816|NCT01144663|450051658|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
125116817|NCT01144663|450051659|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
125116818|NCT01144663|450051660|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
125116819|NCT01144663|450051661|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
125116820|NCT01144663|450051658|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
125116821|NCT01144663|450051659|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
125116822|NCT01144663|450051660|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
125116823|NCT01144663|450051661|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
125116824|NCT01144663|450051658|FG000|Primary Vaccination Phase|Other|0|||
125116825|NCT01144663|450051659|FG001|Primary Vaccination Phase|Other|1|||
125116826|NCT01144663|450051660|FG002|Primary Vaccination Phase|Other|0|||
125116827|NCT01144663|450051661|FG003|Primary Vaccination Phase|Other|2|||
125116828|NCT01144663|450051658|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
125116829|NCT01144663|450051659|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
125116830|NCT01144663|450051660|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
124921723|NCT04169373|449342027|FG003|Week 14 to Week 52|Other|5|||
124921724|NCT04169373|449342024|FG000|Week 14 to Week 52|Ongoing|0|||
124921725|NCT04169373|449342025|FG001|Week 14 to Week 52|Ongoing|1|||
124921726|NCT04169373|449342026|FG002|Week 14 to Week 52|Ongoing|0|||
124921727|NCT04169373|449342027|FG003|Week 14 to Week 52|Ongoing|0|||
124921728|NCT01999075|449342030|FG000|Overall Study|Lost to Follow-up|0|||
124921729|NCT01999075|449342031|FG001|Overall Study|Lost to Follow-up|2|||
124921730|NCT01999075|449342030|FG000|Overall Study|Withdrawal by Subject|2|||
124921731|NCT01999075|449342031|FG001|Overall Study|Withdrawal by Subject|7|||
125116831|NCT01144663|450051661|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
124921732|NCT01999075|449342030|FG000|Overall Study|Enrolled in drug trial|3|||
124921733|NCT01999075|449342031|FG001|Overall Study|Enrolled in drug trial|1|||
124921734|NCT01999075|449342030|FG000|Overall Study|Became ineligible|0|||
124921735|NCT01999075|449342031|FG001|Overall Study|Became ineligible|2|||
124921736|NCT01413100|449342033|FG000|Overall Study|Withdrawal by Subject|1|||
124921737|NCT05369403|449342034|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
124921738|NCT05369403|449342035|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
124921739|NCT05369403|449342036|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
124921740|NCT05369403|449342034|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
124921741|NCT05369403|449342035|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
124921742|NCT05369403|449342036|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
124921743|NCT05369403|449342034|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
124921744|NCT05369403|449342035|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
124921745|NCT05369403|449342036|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
125211867|NCT00731731|450401389|FG002|Overall Study|Cancel prior to treatment|2|||
124921746|NCT05369403|449342034|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
124921747|NCT05369403|449342035|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
124921748|NCT05369403|449342036|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
124921749|NCT05369403|449342034|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
124921750|NCT05369403|449342035|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
124921751|NCT05369403|449342036|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
124921752|NCT05369403|449342034|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
124921753|NCT05369403|449342035|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
124921754|NCT05369403|449342036|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
124921755|NCT05369403|449342034|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
124921756|NCT05369403|449342035|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
124921757|NCT05369403|449342036|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
124921758|NCT05369403|449342034|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
124921759|NCT05369403|449342035|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
124921760|NCT05369403|449342036|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
124921761|NCT05369403|449342034|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
124921762|NCT05369403|449342035|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
124921763|NCT05369403|449342036|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
124921764|NCT05369403|449342034|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
124921765|NCT05369403|449342035|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
124921766|NCT05369403|449342036|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
124921767|NCT05369403|449342034|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
124921768|NCT05369403|449342035|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
124921769|NCT05369403|449342036|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
124921770|NCT05948670|449342039|FG000|Overall Study|Protocol Violation|6|||
124921771|NCT05948670|449342040|FG001|Overall Study|Protocol Violation|8|||
124921772|NCT05948670|449342039|FG000|Overall Study|Withdrawal by Subject|0|||
124921773|NCT05948670|449342040|FG001|Overall Study|Withdrawal by Subject|1|||
124921774|NCT02907099|449342041|FG000|Overall Study|Adverse Event|1|||
124921775|NCT02907099|449342041|FG000|Overall Study|Withdrawal by Subject|2|||
124921776|NCT02907099|449342041|FG000|Overall Study|Screen Fail|2|||
124921777|NCT03675282|449342043|FG000|Overall Study|Lost to Follow-up|4|||
124921778|NCT03675282|449342044|FG001|Overall Study|Lost to Follow-up|8|||
124921779|NCT03675282|449342045|FG002|Overall Study|Lost to Follow-up|1|||
124921780|NCT03675282|449342046|FG003|Overall Study|Lost to Follow-up|0|||
124921781|NCT03675282|449342047|FG004|Overall Study|Lost to Follow-up|2|||
124921782|NCT03675282|449342048|FG005|Overall Study|Lost to Follow-up|7|||
124921783|NCT03675282|449342043|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
124921784|NCT03675282|449342044|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
124921785|NCT03675282|449342045|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
124921786|NCT03675282|449342046|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
124921787|NCT03675282|449342047|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
124921788|NCT03675282|449342048|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
124921789|NCT03675282|449342043|FG000|Overall Study|Physician Decision|1|||
124921790|NCT03675282|449342044|FG001|Overall Study|Physician Decision|0|||
124921791|NCT03675282|449342045|FG002|Overall Study|Physician Decision|0|||
124921792|NCT03675282|449342046|FG003|Overall Study|Physician Decision|0|||
124921793|NCT03675282|449342047|FG004|Overall Study|Physician Decision|0|||
124921794|NCT03675282|449342048|FG005|Overall Study|Physician Decision|0|||
124921795|NCT03056040|449342052|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
124921796|NCT03056040|449342053|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
124921797|NCT03056040|449342052|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
124921798|NCT03056040|449342053|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
124921799|NCT03056040|449342052|FG000|Primary Evaluation Period|Pregnancy|0|||
124921800|NCT03056040|449342053|FG001|Primary Evaluation Period|Pregnancy|1|||
124921801|NCT03056040|449342052|FG000|Primary Evaluation Period|Randomized, not treated|1|||
124921802|NCT03056040|449342053|FG001|Primary Evaluation Period|Randomized, not treated|1|||
124921803|NCT03056040|449342052|FG000|Extension Period|Physician Decision|3|||
124921804|NCT03056040|449342053|FG001|Extension Period|Physician Decision|3|||
124921805|NCT03056040|449342052|FG000|Extension Period|Lost to Follow-up|0|||
124921806|NCT03056040|449342053|FG001|Extension Period|Lost to Follow-up|1|||
124921807|NCT03056040|449342052|FG000|Extension Period|Death|0|||
124921808|NCT03056040|449342053|FG001|Extension Period|Death|3|||
124921809|NCT03056040|449342052|FG000|Extension Period|Withdrawal by Subject|1|||
124921810|NCT03056040|449342053|FG001|Extension Period|Withdrawal by Subject|0|||
124921811|NCT04977947|449342054|FG000|Overall Study|Lost to Follow-up|1|||
124921812|NCT04977947|449342055|FG001|Overall Study|Lost to Follow-up|1|||
124921813|NCT04029688|449342056|FG000|Overall Study|Death|8|||
124921814|NCT04029688|449342057|FG001|Overall Study|Death|3|||
124921815|NCT04029688|449342058|FG002|Overall Study|Death|6|||
124921816|NCT04029688|449342059|FG003|Overall Study|Death|2|||
124921817|NCT04029688|449342060|FG004|Overall Study|Death|5|||
124921818|NCT04029688|449342061|FG005|Overall Study|Death|0|||
124921819|NCT04029688|449342062|FG006|Overall Study|Death|2|||
124921820|NCT04029688|449342063|FG007|Overall Study|Death|3|||
124921821|NCT04029688|449342056|FG000|Overall Study|Study Terminated by Sponsor|0|||
124921822|NCT04029688|449342057|FG001|Overall Study|Study Terminated by Sponsor|0|||
124921823|NCT04029688|449342058|FG002|Overall Study|Study Terminated by Sponsor|0|||
124921824|NCT04029688|449342059|FG003|Overall Study|Study Terminated by Sponsor|0|||
124921825|NCT04029688|449342060|FG004|Overall Study|Study Terminated by Sponsor|1|||
124921826|NCT04029688|449342061|FG005|Overall Study|Study Terminated by Sponsor|3|||
124921827|NCT04029688|449342062|FG006|Overall Study|Study Terminated by Sponsor|1|||
124921828|NCT04029688|449342063|FG007|Overall Study|Study Terminated by Sponsor|3|||
124921829|NCT04029688|449342056|FG000|Overall Study|Withdrawal by Subject|0|||
124921830|NCT04029688|449342057|FG001|Overall Study|Withdrawal by Subject|0|||
124921831|NCT04029688|449342058|FG002|Overall Study|Withdrawal by Subject|0|||
124921832|NCT04029688|449342059|FG003|Overall Study|Withdrawal by Subject|1|||
124921833|NCT04029688|449342060|FG004|Overall Study|Withdrawal by Subject|0|||
124921834|NCT04029688|449342061|FG005|Overall Study|Withdrawal by Subject|0|||
124921835|NCT04029688|449342062|FG006|Overall Study|Withdrawal by Subject|0|||
124921836|NCT04029688|449342063|FG007|Overall Study|Withdrawal by Subject|0|||
124921837|NCT05875142|449342064|FG000|Overall Study|Lost to Follow-up|0|||
124921838|NCT05875142|449342065|FG001|Overall Study|Lost to Follow-up|1|||
124921839|NCT05875142|449342066|FG002|Overall Study|Lost to Follow-up|1|||
124921840|NCT05784662|449342067|FG000|Overall Study|Lost to Follow-up|21|||
124921841|NCT05784662|449342068|FG001|Overall Study|Lost to Follow-up|17|||
124921842|NCT04274764|449342069|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
124921843|NCT04274764|449342070|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
124921844|NCT02677298|449342071|FG000|Double Blind Phase|Adverse Event|2|||
124921845|NCT02677298|449342072|FG001|Double Blind Phase|Adverse Event|1|||
124921846|NCT02677298|449342073|FG002|Double Blind Phase|Adverse Event|0|||
124921847|NCT02677298|449342071|FG000|Double Blind Phase|Physician Decision|5|||
124921848|NCT02677298|449342072|FG001|Double Blind Phase|Physician Decision|0|||
124921849|NCT02677298|449342073|FG002|Double Blind Phase|Physician Decision|0|||
124921850|NCT02677298|449342071|FG000|Double Blind Phase|Lost to Follow-up|11|||
124921851|NCT02677298|449342072|FG001|Double Blind Phase|Lost to Follow-up|7|||
124921852|NCT02677298|449342073|FG002|Double Blind Phase|Lost to Follow-up|0|||
124921853|NCT02677298|449342071|FG000|Double Blind Phase|Withdrawal by Subject|11|||
124921854|NCT02677298|449342072|FG001|Double Blind Phase|Withdrawal by Subject|8|||
124921855|NCT02677298|449342073|FG002|Double Blind Phase|Withdrawal by Subject|0|||
124921856|NCT02677298|449342071|FG000|Double Blind Phase|No study drug available at site|0|||
124921857|NCT02677298|449342072|FG001|Double Blind Phase|No study drug available at site|1|||
124921858|NCT02677298|449342073|FG002|Double Blind Phase|No study drug available at site|0|||
125023158|NCT00848354|449707925|FG001|Phase 2 Year 1|Subject Request|2|||
125023159|NCT00848354|449707924|FG000|Phase 2 Year 2|Adverse Event|12|||
124921859|NCT02677298|449342071|FG000|Open Label Phase|Adverse Event|0|||
124921860|NCT02677298|449342072|FG001|Open Label Phase|Adverse Event|0|||
124921861|NCT02677298|449342073|FG002|Open Label Phase|Adverse Event|4|||
124921862|NCT02677298|449342071|FG000|Open Label Phase|Physician Decision|0|||
124921863|NCT02677298|449342072|FG001|Open Label Phase|Physician Decision|0|||
124921864|NCT02677298|449342073|FG002|Open Label Phase|Physician Decision|1|||
124921865|NCT02677298|449342071|FG000|Open Label Phase|Lost to Follow-up|0|||
124921866|NCT02677298|449342072|FG001|Open Label Phase|Lost to Follow-up|0|||
124921867|NCT02677298|449342073|FG002|Open Label Phase|Lost to Follow-up|17|||
124921868|NCT02677298|449342071|FG000|Open Label Phase|Withdrawal by Subject|0|||
124921869|NCT02677298|449342072|FG001|Open Label Phase|Withdrawal by Subject|0|||
125023160|NCT00848354|449707925|FG001|Phase 2 Year 2|Adverse Event|2|||
125023161|NCT00848354|449707924|FG000|Phase 2 Year 2|Death|2|||
125023162|NCT00848354|449707925|FG001|Phase 2 Year 2|Death|0|||
125023163|NCT00848354|449707924|FG000|Phase 2 Year 2|Failed to return|3|||
125023164|NCT00848354|449707925|FG001|Phase 2 Year 2|Failed to return|0|||
125023165|NCT00848354|449707924|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
125023166|NCT00848354|449707925|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
125023167|NCT00848354|449707924|FG000|Phase 2 Year 2|Unspecified Reason|1|||
125023168|NCT00848354|449707925|FG001|Phase 2 Year 2|Unspecified Reason|0|||
125023169|NCT00848354|449707924|FG000|Phase 2 Year 2|Protocol Violation|1|||
125023170|NCT00848354|449707925|FG001|Phase 2 Year 2|Protocol Violation|1|||
125023171|NCT00848354|449707924|FG000|Phase 2 Year 2|Subject Request|1|||
125023172|NCT00848354|449707925|FG001|Phase 2 Year 2|Subject Request|1|||
125023173|NCT00848354|449707924|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
125023174|NCT00848354|449707925|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
125023175|NCT01972074|449707928|FG000|Overall Study|Adverse Event|4|||
125023176|NCT01972074|449707929|FG001|Overall Study|Adverse Event|1|||
125023177|NCT01972074|449707930|FG002|Overall Study|Adverse Event|0|||
125116832|NCT01144663|450051658|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
125116833|NCT01144663|450051659|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
125116834|NCT01144663|450051660|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
125116835|NCT01144663|450051661|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
125116836|NCT01144663|450051658|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
125116837|NCT01144663|450051659|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
125116838|NCT01144663|450051660|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
125116839|NCT01144663|450051661|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
125116840|NCT01144663|450051658|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
125116841|NCT01144663|450051659|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
125116842|NCT01144663|450051660|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
125116843|NCT01144663|450051661|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
125116844|NCT01144663|450051658|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
125116845|NCT01144663|450051659|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
125116846|NCT01144663|450051660|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
125116847|NCT01144663|450051661|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
125116848|NCT01144663|450051658|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
125116849|NCT01144663|450051659|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
125116850|NCT01144663|450051660|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
125116851|NCT01144663|450051661|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
125116852|NCT01335477|450051663|FG000|Overall Study|Adverse Event|30|||
125116853|NCT01335477|450051664|FG001|Overall Study|Adverse Event|42|||
125116854|NCT01335477|450051663|FG000|Overall Study|Non compliant with protocol|0|||
125116855|NCT01335477|450051664|FG001|Overall Study|Non compliant with protocol|2|||
125211868|NCT03970200|450401390|FG000|Overall Study|Death|2|||
124921870|NCT02677298|449342073|FG002|Open Label Phase|Withdrawal by Subject|38|||
124921871|NCT03611621|449342074|FG000|Overall Study|Graft loss|3|||
124921872|NCT03611621|449342074|FG000|Overall Study|Death|3|||
124921873|NCT03611621|449342074|FG000|Overall Study|Lost to Follow-up|1|||
124921874|NCT03920111|449342089|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
124921875|NCT03920111|449342090|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
124921876|NCT03920111|449342091|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
124921877|NCT04764448|449342092|FG000|Overall Study|Study terminated by sponsor|2|||
124921878|NCT04764448|449342093|FG001|Overall Study|Study terminated by sponsor|2|||
124921879|NCT04764448|449342094|FG002|Overall Study|Study terminated by sponsor|5|||
124921880|NCT04764448|449342092|FG000|Overall Study|Withdrawal by Subject|3|||
124921881|NCT04764448|449342093|FG001|Overall Study|Withdrawal by Subject|3|||
124921882|NCT04764448|449342094|FG002|Overall Study|Withdrawal by Subject|1|||
124921883|NCT01997840|449342095|FG000|Overall Study|Lost to Follow-up|0|||
124921884|NCT01997840|449342096|FG001|Overall Study|Lost to Follow-up|0|||
124921885|NCT01997840|449342097|FG002|Overall Study|Lost to Follow-up|1|||
124921886|NCT01997840|449342098|FG003|Overall Study|Lost to Follow-up|0|||
124921887|NCT01997840|449342095|FG000|Overall Study|Withdrawal by participant|0|||
124921888|NCT01997840|449342096|FG001|Overall Study|Withdrawal by participant|0|||
124921889|NCT01997840|449342097|FG002|Overall Study|Withdrawal by participant|8|||
124921890|NCT01997840|449342098|FG003|Overall Study|Withdrawal by participant|1|||
125023178|NCT01972074|449707928|FG000|Overall Study|Lack of Efficacy|1|||
125023179|NCT01972074|449707929|FG001|Overall Study|Lack of Efficacy|1|||
125023180|NCT01972074|449707930|FG002|Overall Study|Lack of Efficacy|0|||
125116856|NCT01335477|450051663|FG000|Overall Study|Lost to Follow-up|1|||
125211869|NCT03970200|450401391|FG001|Overall Study|Death|2|||
125211870|NCT03970200|450401392|FG002|Overall Study|Death|1|||
124921891|NCT01997840|449342095|FG000|Overall Study|Physician Decision|0|||
124921892|NCT01997840|449342096|FG001|Overall Study|Physician Decision|0|||
124921893|NCT01997840|449342097|FG002|Overall Study|Physician Decision|3|||
124921894|NCT01997840|449342098|FG003|Overall Study|Physician Decision|0|||
125023181|NCT01972074|449707928|FG000|Overall Study|Lost to Follow-up|0|||
124921895|NCT01997840|449342095|FG000|Overall Study|Progressive disease|3|||
124921896|NCT01997840|449342096|FG001|Overall Study|Progressive disease|4|||
124921897|NCT01997840|449342097|FG002|Overall Study|Progressive disease|57|||
124921898|NCT01997840|449342098|FG003|Overall Study|Progressive disease|8|||
124921899|NCT01997840|449342095|FG000|Overall Study|Other reasons|0|||
124921900|NCT01997840|449342096|FG001|Overall Study|Other reasons|0|||
124921901|NCT01997840|449342097|FG002|Overall Study|Other reasons|1|||
124921902|NCT01997840|449342098|FG003|Overall Study|Other reasons|0|||
124921903|NCT01997840|449342095|FG000|Overall Study|Adverse Event|0|||
124921904|NCT01997840|449342096|FG001|Overall Study|Adverse Event|0|||
124921905|NCT01997840|449342097|FG002|Overall Study|Adverse Event|15|||
124921906|NCT01997840|449342098|FG003|Overall Study|Adverse Event|2|||
124921907|NCT01494662|449342106|FG000|Overall Study|Withdrawal by Subject|0|||
124921908|NCT01494662|449342107|FG001|Overall Study|Withdrawal by Subject|0|||
124921909|NCT01494662|449342108|FG002|Overall Study|Withdrawal by Subject|1|||
124921910|NCT01494662|449342109|FG003|Overall Study|Withdrawal by Subject|0|||
124921911|NCT01494662|449342110|FG004|Overall Study|Withdrawal by Subject|0|||
124921912|NCT01494662|449342111|FG005|Overall Study|Withdrawal by Subject|0|||
124921913|NCT01494662|449342112|FG006|Overall Study|Withdrawal by Subject|0|||
124921914|NCT01494662|449342106|FG000|Overall Study|Physician Decision|0|||
124921915|NCT01494662|449342107|FG001|Overall Study|Physician Decision|0|||
124921916|NCT01494662|449342108|FG002|Overall Study|Physician Decision|1|||
124921917|NCT01494662|449342109|FG003|Overall Study|Physician Decision|0|||
124921918|NCT01494662|449342110|FG004|Overall Study|Physician Decision|0|||
124921919|NCT01494662|449342111|FG005|Overall Study|Physician Decision|0|||
124921920|NCT01494662|449342112|FG006|Overall Study|Physician Decision|0|||
124921921|NCT05311384|449342113|FG000|Overall Study|Uncontrolled health conditions|2|||
124921922|NCT05311384|449342113|FG000|Overall Study|Withdrawal by Subject|1|||
124921923|NCT04322643|449342114|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
124921924|NCT05710107|449342124|FG000|Overall Study|Withdrawal by Subject|1|||
124921925|NCT05710107|449342125|FG001|Overall Study|Withdrawal by Subject|1|||
124921926|NCT05710107|449342124|FG000|Overall Study|Lost to Follow-up|8|||
124921927|NCT05710107|449342125|FG001|Overall Study|Lost to Follow-up|9|||
124921928|NCT05710107|449342124|FG000|Overall Study|Unable to place assigned block|2|||
124921929|NCT05710107|449342125|FG001|Overall Study|Unable to place assigned block|0|||
124921930|NCT05710107|449342124|FG000|Overall Study|Withdrawn by study team|0|||
124921931|NCT05710107|449342125|FG001|Overall Study|Withdrawn by study team|1|||
124921932|NCT04717492|449342126|FG000|Overall Study|Withdrawal by Subject|2|||
124921933|NCT04717492|449342127|FG001|Overall Study|Withdrawal by Subject|13|||
124921934|NCT04717492|449342126|FG000|Overall Study|Lost to Follow-up|2|||
124921935|NCT04717492|449342127|FG001|Overall Study|Lost to Follow-up|9|||
124921936|NCT05071807|449342128|FG000|Overall Study|Withdrawal by Subject|4|||
124921937|NCT05071807|449342129|FG001|Overall Study|Withdrawal by Subject|0|||
124921938|NCT05071807|449342128|FG000|Overall Study|Unrelated medical issues|3|||
124921939|NCT05071807|449342129|FG001|Overall Study|Unrelated medical issues|0|||
124921940|NCT05071807|449342128|FG000|Overall Study|Relocated|0|||
124921941|NCT05071807|449342129|FG001|Overall Study|Relocated|1|||
124921942|NCT04072380|449342131|FG000|Overall Study|Adverse Event|4|||
124921943|NCT04072380|449342132|FG001|Overall Study|Adverse Event|6|||
124921944|NCT04072380|449342133|FG002|Overall Study|Adverse Event|0|||
124921945|NCT04072380|449342131|FG000|Overall Study|Withdrawal by Subject|3|||
125023182|NCT01972074|449707929|FG001|Overall Study|Lost to Follow-up|1|||
125023183|NCT01972074|449707930|FG002|Overall Study|Lost to Follow-up|1|||
125023184|NCT01972074|449707928|FG000|Overall Study|Withdrawal by Subject|1|||
125023185|NCT01972074|449707929|FG001|Overall Study|Withdrawal by Subject|1|||
125023186|NCT01972074|449707930|FG002|Overall Study|Withdrawal by Subject|1|||
125023187|NCT01972074|449707928|FG000|Overall Study|Scanner Unavailable|0|||
125023188|NCT01972074|449707929|FG001|Overall Study|Scanner Unavailable|0|||
125023189|NCT01972074|449707930|FG002|Overall Study|Scanner Unavailable|1|||
125023190|NCT04770779|449707933|FG000|Overall Study|Randomized, never treated|0|||
125023191|NCT04770779|449707934|FG001|Overall Study|Randomized, never treated|1|||
125023192|NCT04770779|449707933|FG000|Overall Study|Adverse Event|9|||
125023193|NCT04770779|449707934|FG001|Overall Study|Adverse Event|1|||
125023194|NCT04770779|449707933|FG000|Overall Study|Withdrawal by Subject|7|||
125023195|NCT04770779|449707934|FG001|Overall Study|Withdrawal by Subject|1|||
125023196|NCT04770779|449707933|FG000|Overall Study|Pregnancy|0|||
125023197|NCT04770779|449707934|FG001|Overall Study|Pregnancy|1|||
125023198|NCT04820309|449707935|FG000|Overall Study|Adverse Event|96|||
125023199|NCT04820309|449707935|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
125023200|NCT04820309|449707935|FG000|Overall Study|Consent Withdrawn|93|||
125023201|NCT04820309|449707935|FG000|Overall Study|failure to adhere to protocol|32|||
125023202|NCT04820309|449707935|FG000|Overall Study|alcohol or drug use|6|||
125023203|NCT04820309|449707935|FG000|Overall Study|Lost to Follow-up|46|||
125023204|NCT04820309|449707935|FG000|Overall Study|Death|2|||
125023205|NCT04820309|449707935|FG000|Overall Study|Pregnancy|1|||
125023206|NCT04820309|449707935|FG000|Overall Study|Other reasons|12|||
124921946|NCT04072380|449342132|FG001|Overall Study|Withdrawal by Subject|1|||
125023207|NCT03692052|449707936|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
125023208|NCT03692052|449707936|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
125023209|NCT03692052|449707936|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
125023210|NCT03692052|449707936|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
125023211|NCT05600309|449707939|FG000|Overall Study|Death|41|||
125023212|NCT05600309|449707940|FG001|Overall Study|Death|38|||
125023213|NCT05600309|449707939|FG000|Overall Study|Sponsor Decision|9|||
125023214|NCT05600309|449707940|FG001|Overall Study|Sponsor Decision|6|||
125023215|NCT00980538|449707947|FG000|Overall Study|Lost to Follow-up|20|||
125023216|NCT00980538|449707947|FG000|Overall Study|Sponsor's Decision|4|||
125023217|NCT00980538|449707947|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
125023218|NCT00980538|449707947|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
125023219|NCT00980538|449707947|FG000|Overall Study|Switch to Commercially Available Medication|25|||
125023220|NCT00980538|449707947|FG000|Overall Study|Participant Non-Compliant|9|||
125023221|NCT00980538|449707947|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
125023222|NCT00980538|449707947|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
125023223|NCT00980538|449707947|FG000|Overall Study|Other|60|||
125023224|NCT00980538|449707947|FG000|Overall Study|Other|1|||
125023225|NCT04441905|449709437|FG000|Overall Study|Lost to Follow-up|1|||
125023226|NCT04441905|449709438|FG001|Overall Study|Lost to Follow-up|0|||
125023227|NCT04441905|449709439|FG002|Overall Study|Lost to Follow-up|0|||
125023228|NCT04441905|449709440|FG003|Overall Study|Lost to Follow-up|0|||
125023229|NCT04441905|449709441|FG004|Overall Study|Lost to Follow-up|0|||
125023230|NCT04441905|449709442|FG005|Overall Study|Lost to Follow-up|0|||
125023231|NCT04441905|449709437|FG000|Overall Study|Enrolled but treatment not administered|0|||
125023232|NCT04441905|449709438|FG001|Overall Study|Enrolled but treatment not administered|1|||
125023233|NCT04441905|449709439|FG002|Overall Study|Enrolled but treatment not administered|0|||
125023234|NCT04441905|449709440|FG003|Overall Study|Enrolled but treatment not administered|0|||
125023235|NCT04441905|449709441|FG004|Overall Study|Enrolled but treatment not administered|0|||
125023236|NCT04441905|449709442|FG005|Overall Study|Enrolled but treatment not administered|0|||
125023237|NCT04441905|449709437|FG000|Overall Study|Became ineligible after enrollment|0|||
125023238|NCT04441905|449709438|FG001|Overall Study|Became ineligible after enrollment|0|||
125023239|NCT04441905|449709439|FG002|Overall Study|Became ineligible after enrollment|0|||
125023240|NCT04441905|449709440|FG003|Overall Study|Became ineligible after enrollment|0|||
125116857|NCT01335477|450051664|FG001|Overall Study|Lost to Follow-up|2|||
125116858|NCT01335477|450051663|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
125116859|NCT01335477|450051664|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
125116860|NCT01335477|450051663|FG000|Overall Study|Not treated|1|||
125116861|NCT01335477|450051664|FG001|Overall Study|Not treated|2|||
125116862|NCT01335477|450051663|FG000|Overall Study|Reason other than those stated above|2|||
125116863|NCT01335477|450051664|FG001|Overall Study|Reason other than those stated above|2|||
125116864|NCT01007916|450051665|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
125116865|NCT01007916|450051666|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
125116866|NCT01007916|450051665|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
125116867|NCT01007916|450051666|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
125116868|NCT02040428|450051670|FG000|Overall Study|Death|4|||
125116869|NCT02040428|450051671|FG001|Overall Study|Death|3|||
125116870|NCT02040428|450051670|FG000|Overall Study|Withdrawal by Subject|1|||
125116871|NCT02040428|450051671|FG001|Overall Study|Withdrawal by Subject|1|||
125116872|NCT01927757|450051691|FG000|Overall Study|Withdrawal by Subject|14|||
125116873|NCT01927757|450051691|FG000|Overall Study|Lost to Follow-up|2|||
125116874|NCT01927757|450051691|FG000|Overall Study|Decision by Sponsor|2|||
125116875|NCT01927757|450051691|FG000|Overall Study|Other|1|||
125116876|NCT01927757|450051691|FG000|Overall Study|Ethical Reasons|4|||
125116877|NCT00449072|450051693|FG000|Overall Study|Adverse Event|3|||
125116878|NCT00449072|450051694|FG001|Overall Study|Adverse Event|1|||
125116879|NCT00449072|450051693|FG000|Overall Study|Protocol Violation|14|||
125116880|NCT00449072|450051694|FG001|Overall Study|Protocol Violation|12|||
125116881|NCT00449072|450051693|FG000|Overall Study|Lost to Follow-up|5|||
125116882|NCT00449072|450051694|FG001|Overall Study|Lost to Follow-up|7|||
125023241|NCT04441905|449709441|FG004|Overall Study|Became ineligible after enrollment|1|||
125023242|NCT04441905|449709442|FG005|Overall Study|Became ineligible after enrollment|0|||
125023243|NCT04770753|449709443|FG000|Overall Study|Randomized, never treated|1|||
125023244|NCT04770753|449709444|FG001|Overall Study|Randomized, never treated|1|||
125023245|NCT04770753|449709443|FG000|Overall Study|Withdrawal by Subject|3|||
125023246|NCT04770753|449709444|FG001|Overall Study|Withdrawal by Subject|1|||
125023247|NCT04770753|449709443|FG000|Overall Study|Adverse Event|2|||
125023248|NCT04770753|449709444|FG001|Overall Study|Adverse Event|0|||
125116883|NCT00449072|450051693|FG000|Overall Study|Withdrawal by Subject|11|||
125116884|NCT00449072|450051694|FG001|Overall Study|Withdrawal by Subject|8|||
125116885|NCT00449072|450051693|FG000|Overall Study|Lack of Efficacy|1|||
125116886|NCT00449072|450051694|FG001|Overall Study|Lack of Efficacy|1|||
125116887|NCT00449072|450051693|FG000|Overall Study|Physician Decision|1|||
125116888|NCT00449072|450051694|FG001|Overall Study|Physician Decision|0|||
125116889|NCT00449072|450051693|FG000|Overall Study|Not treated|0|||
124921947|NCT04072380|449342133|FG002|Overall Study|Withdrawal by Subject|1|||
124921948|NCT04072380|449342131|FG000|Overall Study|Physician Decision|2|||
124921949|NCT04072380|449342132|FG001|Overall Study|Physician Decision|0|||
124921950|NCT04072380|449342133|FG002|Overall Study|Physician Decision|0|||
124921951|NCT04072380|449342131|FG000|Overall Study|Protocol Violation|0|||
124921952|NCT04072380|449342132|FG001|Overall Study|Protocol Violation|2|||
124921953|NCT04072380|449342133|FG002|Overall Study|Protocol Violation|3|||
124921954|NCT04072380|449342131|FG000|Overall Study|Intercurrent Illness and Others|3|||
124921955|NCT04072380|449342132|FG001|Overall Study|Intercurrent Illness and Others|5|||
125116890|NCT00449072|450051694|FG001|Overall Study|Not treated|1|||
124921956|NCT04072380|449342133|FG002|Overall Study|Intercurrent Illness and Others|6|||
125116891|NCT00449072|450051693|FG000|Overall Study|Excluded medication|0|||
125116892|NCT00449072|450051694|FG001|Overall Study|Excluded medication|2|||
125116893|NCT00449072|450051693|FG000|Overall Study|Non-compliance|2|||
125116894|NCT00449072|450051694|FG001|Overall Study|Non-compliance|5|||
125116895|NCT00449072|450051693|FG000|Overall Study|Sponsor decision|1|||
125116896|NCT00449072|450051694|FG001|Overall Study|Sponsor decision|3|||
125116897|NCT00449072|450051693|FG000|Overall Study|Relocation|3|||
125116898|NCT00449072|450051694|FG001|Overall Study|Relocation|2|||
125116899|NCT02022007|450051697|FG000|Overall Study|Withdrawal by Subject|1|||
125116900|NCT02022007|450051698|FG001|Overall Study|Withdrawal by Subject|1|||
125116901|NCT02022007|450051699|FG002|Overall Study|Withdrawal by Subject|1|||
125116902|NCT02022007|450051697|FG000|Overall Study|Noncompliant|0|||
125116903|NCT02022007|450051698|FG001|Overall Study|Noncompliant|0|||
125116904|NCT02022007|450051699|FG002|Overall Study|Noncompliant|1|||
125116905|NCT02087046|450051700|FG000|Overall Study|Adverse Event|4|||
125116906|NCT02087046|450051700|FG000|Overall Study|Death|1|||
125116907|NCT02087046|450051700|FG000|Overall Study|Lost to Follow-up|3|||
125116908|NCT02087046|450051700|FG000|Overall Study|Withdrawal by Subject|2|||
125116909|NCT02087046|450051700|FG000|Overall Study|Physician Decision|1|||
125116910|NCT01107535|450051701|FG000|Overall Study|Death|5|||
125116911|NCT01507896|450051702|FG000|Overall Study|Withdrawal by Subject|1|||
125116912|NCT01507896|450051702|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
125116913|NCT00192296|450051709|FG000|Overall Study|Withdrawal by Subject|0|||
125116914|NCT00192296|450051710|FG001|Overall Study|Withdrawal by Subject|1|||
125116915|NCT00192296|450051711|FG002|Overall Study|Withdrawal by Subject|0|||
125116916|NCT00192296|450051712|FG003|Overall Study|Withdrawal by Subject|0|||
125116917|NCT00818623|450051713|FG000|Overall Study|Adverse Event|1|||
125116918|NCT00818623|450051714|FG001|Overall Study|Adverse Event|0|||
125116919|NCT00818623|450051715|FG002|Overall Study|Adverse Event|1|||
125116920|NCT00818623|450051716|FG003|Overall Study|Adverse Event|0|||
125116921|NCT00818623|450051717|FG004|Overall Study|Adverse Event|0|||
125116922|NCT00818623|450051718|FG005|Overall Study|Adverse Event|1|||
125116923|NCT00818623|450051719|FG006|Overall Study|Adverse Event|0|||
125116924|NCT00818623|450051720|FG007|Overall Study|Adverse Event|0|||
125116925|NCT00818623|450051713|FG000|Overall Study|Bad prostate specific antigen response|0|||
125116926|NCT00818623|450051714|FG001|Overall Study|Bad prostate specific antigen response|3|||
125116927|NCT00818623|450051715|FG002|Overall Study|Bad prostate specific antigen response|2|||
125116928|NCT00818623|450051716|FG003|Overall Study|Bad prostate specific antigen response|5|||
125116929|NCT00818623|450051717|FG004|Overall Study|Bad prostate specific antigen response|0|||
125116930|NCT00818623|450051718|FG005|Overall Study|Bad prostate specific antigen response|1|||
125116931|NCT00818623|450051719|FG006|Overall Study|Bad prostate specific antigen response|0|||
125116932|NCT00818623|450051720|FG007|Overall Study|Bad prostate specific antigen response|0|||
125116933|NCT00818623|450051713|FG000|Overall Study|Withdrawal by Subject|0|||
125116934|NCT00818623|450051714|FG001|Overall Study|Withdrawal by Subject|1|||
125116935|NCT00818623|450051715|FG002|Overall Study|Withdrawal by Subject|1|||
125116936|NCT00818623|450051716|FG003|Overall Study|Withdrawal by Subject|0|||
125116937|NCT00818623|450051717|FG004|Overall Study|Withdrawal by Subject|0|||
125116938|NCT00818623|450051718|FG005|Overall Study|Withdrawal by Subject|1|||
125116939|NCT00818623|450051719|FG006|Overall Study|Withdrawal by Subject|1|||
125116940|NCT00818623|450051720|FG007|Overall Study|Withdrawal by Subject|1|||
125116941|NCT00818623|450051713|FG000|Overall Study|Protocol Violation|1|||
125116942|NCT00818623|450051714|FG001|Overall Study|Protocol Violation|0|||
124921957|NCT05551637|449342134|FG000|Overall Study|Lack of Efficacy|0|||
124921958|NCT05551637|449342135|FG001|Overall Study|Lack of Efficacy|6|||
124921959|NCT05551637|449342134|FG000|Overall Study|Lost to Follow-up|1|||
124921960|NCT05551637|449342135|FG001|Overall Study|Lost to Follow-up|1|||
124921961|NCT05351554|449342137|FG000|Overall Study|Study terminated by sponsor|1|||
124921962|NCT03774082|449342138|FG000|Overall Study|Death|6|||
124921963|NCT03774082|449342139|FG001|Overall Study|Death|3|||
124921964|NCT03774082|449342140|FG002|Overall Study|Death|2|||
125116943|NCT00818623|450051715|FG002|Overall Study|Protocol Violation|0|||
125116944|NCT00818623|450051716|FG003|Overall Study|Protocol Violation|0|||
125116945|NCT00818623|450051717|FG004|Overall Study|Protocol Violation|1|||
125116946|NCT00818623|450051718|FG005|Overall Study|Protocol Violation|0|||
125116947|NCT00818623|450051719|FG006|Overall Study|Protocol Violation|1|||
125116948|NCT00818623|450051720|FG007|Overall Study|Protocol Violation|0|||
125116949|NCT00818623|450051713|FG000|Overall Study|Need of additional treatment|0|||
125116950|NCT00818623|450051714|FG001|Overall Study|Need of additional treatment|0|||
125116951|NCT00818623|450051715|FG002|Overall Study|Need of additional treatment|0|||
125116952|NCT00818623|450051716|FG003|Overall Study|Need of additional treatment|0|||
125116953|NCT00818623|450051717|FG004|Overall Study|Need of additional treatment|1|||
125116954|NCT00818623|450051718|FG005|Overall Study|Need of additional treatment|0|||
125116955|NCT00818623|450051719|FG006|Overall Study|Need of additional treatment|0|||
124921965|NCT03774082|449342138|FG000|Overall Study|Subject decision|0|||
124921966|NCT03774082|449342139|FG001|Overall Study|Subject decision|3|||
124921967|NCT03774082|449342140|FG002|Overall Study|Subject decision|0|||
124921968|NCT03774082|449342138|FG000|Overall Study|Lost to Follow-up|2|||
124921969|NCT03774082|449342139|FG001|Overall Study|Lost to Follow-up|0|||
124921970|NCT03774082|449342140|FG002|Overall Study|Lost to Follow-up|0|||
124921971|NCT03774082|449342138|FG000|Overall Study|Guardian decision|0|||
124921972|NCT03774082|449342139|FG001|Overall Study|Guardian decision|0|||
124921973|NCT03774082|449342140|FG002|Overall Study|Guardian decision|1|||
124921974|NCT03774082|449342138|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
124921975|NCT03774082|449342139|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
124921976|NCT03774082|449342140|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
124921977|NCT03792256|449343733|FG000|Overall Study|Death|0|||
124921978|NCT03792256|449343734|FG001|Overall Study|Death|1|||
124921979|NCT03792256|449343733|FG000|Overall Study|Lack of Efficacy|0|||
124921980|NCT03792256|449343734|FG001|Overall Study|Lack of Efficacy|1|||
124921981|NCT03792256|449343733|FG000|Overall Study|Withdrawal by Subject|0|||
124921982|NCT03792256|449343734|FG001|Overall Study|Withdrawal by Subject|1|||
124921983|NCT04760678|449343735|FG000|Overall Study|Death|13|||
124921984|NCT04760678|449343735|FG000|Overall Study|Lost to Follow-up|48|||
124921985|NCT04760678|449343735|FG000|Overall Study|Withdrawal by Subject|1|||
124921986|NCT01748448|449343738|FG000|Treatment Period|Consent withdrawn by subject|1|||
124921987|NCT01748448|449343739|FG001|Treatment Period|Consent withdrawn by subject|0|||
124921988|NCT01748448|449343738|FG000|Treatment Period|Adverse Event|1|||
124921989|NCT01748448|449343739|FG001|Treatment Period|Adverse Event|0|||
124921990|NCT01748448|449343738|FG000|Treatment Period|Personal|0|||
124921991|NCT01748448|449343739|FG001|Treatment Period|Personal|1|||
124921992|NCT03232138|449343755|FG000|Overall Study|Physician Decision|1|||
124921993|NCT03232138|449343756|FG001|Overall Study|Physician Decision|0|||
124921994|NCT03232138|449343755|FG000|Overall Study|Adverse Event|2|||
124921995|NCT03232138|449343756|FG001|Overall Study|Adverse Event|0|||
124921996|NCT03232138|449343755|FG000|Overall Study|Withdrawal by Subject|1|||
125023249|NCT04770753|449709443|FG000|Overall Study|Pregnancy|1|||
125023250|NCT04770753|449709444|FG001|Overall Study|Pregnancy|0|||
125023251|NCT04770753|449709443|FG000|Overall Study|Other un-specified|1|||
125023252|NCT04770753|449709444|FG001|Overall Study|Other un-specified|0|||
125023253|NCT02775851|449709445|FG000|Overall Study|Adverse Event|1|||
125023254|NCT02775851|449709446|FG001|Overall Study|Adverse Event|10|||
125023255|NCT02775851|449709445|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
125023256|NCT02775851|449709446|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
125023257|NCT02775851|449709445|FG000|Overall Study|Progression/Relapse|0|||
125023258|NCT02775851|449709446|FG001|Overall Study|Progression/Relapse|4|||
125023259|NCT02775851|449709445|FG000|Overall Study|Other - Not Protocol Specified|0|||
125023260|NCT02775851|449709446|FG001|Overall Study|Other - Not Protocol Specified|7|||
125023261|NCT02775851|449709445|FG000|Overall Study|Withdrawal by Subject|1|||
125023262|NCT02775851|449709446|FG001|Overall Study|Withdrawal by Subject|0|||
125023263|NCT03266016|449709450|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
125023264|NCT03266016|449709451|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
125023265|NCT03266016|449709452|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
125023266|NCT03266016|449709453|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
125023267|NCT03266016|449709450|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
125023268|NCT03266016|449709451|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
125023269|NCT03266016|449709452|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
125023270|NCT03266016|449709453|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
125023271|NCT03686397|449709454|FG000|Overall Study|Lack of Efficacy|3|||
125023272|NCT03686397|449709455|FG001|Overall Study|Lack of Efficacy|5|||
125023273|NCT03686397|449709454|FG000|Overall Study|Adverse Event|0|||
125023274|NCT03686397|449709455|FG001|Overall Study|Adverse Event|1|||
125023275|NCT03686397|449709454|FG000|Overall Study|Protocol Violation|0|||
125023276|NCT03686397|449709455|FG001|Overall Study|Protocol Violation|1|||
125023277|NCT03686397|449709454|FG000|Overall Study|Withdrawal by Subject|0|||
125023278|NCT03686397|449709455|FG001|Overall Study|Withdrawal by Subject|1|||
125023279|NCT03686397|449709454|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
125023280|NCT03686397|449709455|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
125023281|NCT01934140|449709461|FG000|Persistence Phase (Year 6-10)|Other|24|||
125023282|NCT01934140|449709462|FG001|Persistence Phase (Year 6-10)|Other|6|||
125023283|NCT01934140|449709461|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
125023284|NCT01934140|449709462|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
124921997|NCT03232138|449343756|FG001|Overall Study|Withdrawal by Subject|2|||
124921998|NCT04142788|449343757|FG000|Overall Study|Trial terminated prematurely|2|||
125023285|NCT01934140|449709461|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
124921999|NCT04142788|449343758|FG001|Overall Study|Trial terminated prematurely|2|||
125116956|NCT00818623|450051720|FG007|Overall Study|Need of additional treatment|0|||
125116957|NCT00818623|450051713|FG000|Overall Study|Lack of trial drug at site|0|||
125116958|NCT00818623|450051714|FG001|Overall Study|Lack of trial drug at site|0|||
125116959|NCT00818623|450051715|FG002|Overall Study|Lack of trial drug at site|0|||
125116960|NCT00818623|450051716|FG003|Overall Study|Lack of trial drug at site|0|||
125116961|NCT00818623|450051717|FG004|Overall Study|Lack of trial drug at site|2|||
125116962|NCT00818623|450051718|FG005|Overall Study|Lack of trial drug at site|0|||
125116963|NCT00818623|450051719|FG006|Overall Study|Lack of trial drug at site|1|||
125116964|NCT00818623|450051720|FG007|Overall Study|Lack of trial drug at site|0|||
125116965|NCT00818623|450051713|FG000|Overall Study|Disease progression|0|||
125116966|NCT00818623|450051714|FG001|Overall Study|Disease progression|0|||
125116967|NCT00818623|450051715|FG002|Overall Study|Disease progression|0|||
125116968|NCT00818623|450051716|FG003|Overall Study|Disease progression|0|||
125116969|NCT00818623|450051717|FG004|Overall Study|Disease progression|0|||
125116970|NCT00818623|450051718|FG005|Overall Study|Disease progression|0|||
125116971|NCT00818623|450051719|FG006|Overall Study|Disease progression|1|||
125116972|NCT00818623|450051720|FG007|Overall Study|Disease progression|0|||
125116973|NCT02649231|450051724|FG000|Overall Study|Adverse Event|0|||
125116974|NCT02649231|450051725|FG001|Overall Study|Adverse Event|0|||
125116975|NCT02649231|450051726|FG002|Overall Study|Adverse Event|0|||
125116976|NCT02649231|450051727|FG003|Overall Study|Adverse Event|1|||
125116977|NCT02649231|450051724|FG000|Overall Study|Lost to Follow-up|2|||
125116978|NCT02649231|450051725|FG001|Overall Study|Lost to Follow-up|1|||
125116979|NCT02649231|450051726|FG002|Overall Study|Lost to Follow-up|1|||
125116980|NCT02649231|450051727|FG003|Overall Study|Lost to Follow-up|0|||
125116981|NCT02649231|450051724|FG000|Overall Study|Withdrawal by Subject|0|||
125116982|NCT02649231|450051725|FG001|Overall Study|Withdrawal by Subject|1|||
125116983|NCT02649231|450051726|FG002|Overall Study|Withdrawal by Subject|0|||
125116984|NCT02649231|450051727|FG003|Overall Study|Withdrawal by Subject|1|||
125116985|NCT02649231|450051724|FG000|Overall Study|Protocol Violation|2|||
125116986|NCT02649231|450051725|FG001|Overall Study|Protocol Violation|1|||
125116987|NCT02649231|450051726|FG002|Overall Study|Protocol Violation|1|||
125116988|NCT02649231|450051727|FG003|Overall Study|Protocol Violation|0|||
125116989|NCT00543439|450051729|FG000|Period 1|Adverse Event|0|||
125116990|NCT00543439|450051730|FG001|Period 1|Adverse Event|2|||
125116991|NCT00543439|450051731|FG002|Period 1|Adverse Event|1|||
125116992|NCT00543439|450051729|FG000|Period 1|Withdrawal by Subject|1|||
125116993|NCT00543439|450051730|FG001|Period 1|Withdrawal by Subject|1|||
125116994|NCT00543439|450051731|FG002|Period 1|Withdrawal by Subject|0|||
125116995|NCT00543439|450051729|FG000|Period 1|Physician Decision|0|||
125116996|NCT00543439|450051730|FG001|Period 1|Physician Decision|0|||
125116997|NCT00543439|450051731|FG002|Period 1|Physician Decision|1|||
125116998|NCT00543439|450051729|FG000|Period 2|Protocol Violation|1|||
125116999|NCT00543439|450051730|FG001|Period 2|Protocol Violation|0|||
125117000|NCT00543439|450051731|FG002|Period 2|Protocol Violation|1|||
125117001|NCT00543439|450051729|FG000|Period 2|Adverse Event|0|||
125117002|NCT00543439|450051730|FG001|Period 2|Adverse Event|1|||
125117003|NCT00543439|450051731|FG002|Period 2|Adverse Event|1|||
125117004|NCT00686036|450051733|FG000|Overall Study|Adverse Event|3|||
124922000|NCT05516147|449343759|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
124922001|NCT03338933|449343761|FG000|Screening Visit|Lost to Follow-up|1|||
124922002|NCT03338933|449343762|FG001|Screening Visit|Lost to Follow-up|3|||
124922003|NCT03338933|449343763|FG002|Screening Visit|Lost to Follow-up|1|||
124922004|NCT03338933|449343764|FG003|Screening Visit|Lost to Follow-up|4|||
124922005|NCT03338933|449343761|FG000|Screening Visit|Screen fail after consent|2|||
124922006|NCT03338933|449343762|FG001|Screening Visit|Screen fail after consent|7|||
124922007|NCT03338933|449343763|FG002|Screening Visit|Screen fail after consent|1|||
124922008|NCT03338933|449343764|FG003|Screening Visit|Screen fail after consent|4|||
124922009|NCT03338933|449343761|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
124922010|NCT03338933|449343762|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
124922011|NCT03338933|449343763|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
124922012|NCT03338933|449343764|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
124922013|NCT03338933|449343761|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
125117005|NCT00686036|450051734|FG001|Overall Study|Adverse Event|0|||
125117006|NCT00686036|450051733|FG000|Overall Study|Withdrawal by Subject|3|||
125117007|NCT00686036|450051734|FG001|Overall Study|Withdrawal by Subject|1|||
125117008|NCT00686036|450051733|FG000|Overall Study|Study terminated by AstraZeneca|2|||
125117009|NCT00686036|450051734|FG001|Overall Study|Study terminated by AstraZeneca|1|||
125117010|NCT00686036|450051733|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
124969519|NCT03520075|449517413|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
125117011|NCT00686036|450051734|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
125117012|NCT00686036|450051733|FG000|Overall Study|Other reasons not identified|0|||
125117013|NCT00686036|450051734|FG001|Overall Study|Other reasons not identified|4|||
125023286|NCT01934140|449709462|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
125023287|NCT01934140|449709461|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
125023288|NCT01934140|449709462|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
125023289|NCT01934140|449709461|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
125023290|NCT01934140|449709462|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
125023291|NCT01934140|449709461|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
125023292|NCT01934140|449709462|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
125023293|NCT01934140|449709461|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
125023294|NCT01934140|449709462|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
125023295|NCT01934140|449709461|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
125023296|NCT01934140|449709462|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
125023297|NCT00805740|449709463|FG000|Overall Study|Death|7|||
125023298|NCT00805740|449709464|FG001|Overall Study|Death|4|||
125023299|NCT00805740|449709463|FG000|Overall Study|Withdrawal by Subject|1|||
125023300|NCT00805740|449709464|FG001|Overall Study|Withdrawal by Subject|0|||
125023301|NCT00805740|449709463|FG000|Overall Study|Lost to Follow-up|1|||
125023302|NCT00805740|449709464|FG001|Overall Study|Lost to Follow-up|0|||
125023303|NCT00805740|449709463|FG000|Overall Study|Randomized, but not treated|2|||
125023304|NCT00805740|449709464|FG001|Overall Study|Randomized, but not treated|0|||
125023305|NCT00200850|449709465|FG000|Overall Study|relocation|1|||
125023306|NCT00200850|449709466|FG001|Overall Study|relocation|0|||
125023307|NCT00200850|449709467|FG002|Overall Study|relocation|1|||
125023308|NCT00200850|449709465|FG000|Overall Study|too busy|1|||
125023309|NCT00200850|449709466|FG001|Overall Study|too busy|0|||
125023310|NCT00200850|449709467|FG002|Overall Study|too busy|0|||
125023311|NCT00200850|449709465|FG000|Overall Study|Pregnancy|0|||
125023312|NCT00200850|449709466|FG001|Overall Study|Pregnancy|0|||
125023313|NCT00200850|449709467|FG002|Overall Study|Pregnancy|1|||
125023314|NCT00200850|449709465|FG000|Overall Study|Poor adherence|0|||
125023315|NCT00200850|449709466|FG001|Overall Study|Poor adherence|0|||
125023316|NCT00200850|449709467|FG002|Overall Study|Poor adherence|1|||
125023317|NCT00200850|449709465|FG000|Overall Study|optic neuritis|0|||
125023318|NCT00200850|449709466|FG001|Overall Study|optic neuritis|0|||
125023319|NCT00200850|449709467|FG002|Overall Study|optic neuritis|1|||
125023320|NCT00200850|449709465|FG000|Overall Study|Adverse Event|1|||
125023321|NCT00200850|449709466|FG001|Overall Study|Adverse Event|1|||
125023322|NCT00200850|449709467|FG002|Overall Study|Adverse Event|2|||
125023323|NCT02595879|449709468|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
125023324|NCT02595879|449709469|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
125023325|NCT05227690|449709475|FG000|Overall Study|Adverse Event|5|||
125023326|NCT05227690|449709476|FG001|Overall Study|Adverse Event|6|||
125023327|NCT05227690|449709477|FG002|Overall Study|Adverse Event|10|||
125023328|NCT05227690|449709475|FG000|Overall Study|Lack of Efficacy|2|||
125023329|NCT05227690|449709476|FG001|Overall Study|Lack of Efficacy|4|||
125023330|NCT05227690|449709477|FG002|Overall Study|Lack of Efficacy|1|||
125117014|NCT01185288|450051737|FG000|Overall Study|Adverse Event|7|||
125117015|NCT01185288|450051738|FG001|Overall Study|Adverse Event|6|||
125117016|NCT01185288|450051737|FG000|Overall Study|Withdrawal by Subject|6|||
125117017|NCT01185288|450051738|FG001|Overall Study|Withdrawal by Subject|4|||
125117018|NCT01185288|450051737|FG000|Overall Study|Lost to Follow-up|2|||
125117019|NCT01185288|450051738|FG001|Overall Study|Lost to Follow-up|5|||
125117020|NCT01185288|450051737|FG000|Overall Study|Lack of Efficacy|2|||
125117021|NCT01185288|450051738|FG001|Overall Study|Lack of Efficacy|0|||
125117022|NCT01185288|450051737|FG000|Overall Study|Investigator discretion|1|||
125117023|NCT01185288|450051738|FG001|Overall Study|Investigator discretion|0|||
125117024|NCT01185288|450051737|FG000|Overall Study|Did not meet inclusion criteria|1|||
125117025|NCT01185288|450051738|FG001|Overall Study|Did not meet inclusion criteria|0|||
125117026|NCT01185288|450051737|FG000|Overall Study|Noncompliance|0|||
125023331|NCT05227690|449709475|FG000|Overall Study|Physician Decision|6|||
125023332|NCT05227690|449709476|FG001|Overall Study|Physician Decision|0|||
125023333|NCT05227690|449709477|FG002|Overall Study|Physician Decision|4|||
125023334|NCT05227690|449709475|FG000|Overall Study|Withdrawal of consent|28|||
125117027|NCT01185288|450051738|FG001|Overall Study|Noncompliance|1|||
125117028|NCT01200394|450051739|FG000|Overall Study|Adverse Event|0|||
125117029|NCT01200394|450051740|FG001|Overall Study|Adverse Event|14|||
125117030|NCT01200394|450051739|FG000|Overall Study|Death|1|||
125117031|NCT01200394|450051740|FG001|Overall Study|Death|0|||
125117032|NCT01200394|450051739|FG000|Overall Study|Lost to Follow-up|0|||
125023335|NCT05227690|449709476|FG001|Overall Study|Withdrawal of consent|27|||
125023336|NCT05227690|449709477|FG002|Overall Study|Withdrawal of consent|21|||
125023337|NCT05227690|449709475|FG000|Overall Study|Other, not specified|2|||
125117033|NCT01200394|450051740|FG001|Overall Study|Lost to Follow-up|1|||
125131400|NCT03818581|450109964|FG004|Overall Study|Covid-19|1|||
124922014|NCT03338933|449343762|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
124922015|NCT03338933|449343763|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
124922016|NCT03338933|449343764|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
124922017|NCT03338933|449343761|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
124922018|NCT03338933|449343762|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
124922019|NCT03338933|449343763|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
124922020|NCT03338933|449343764|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
124922021|NCT03853746|449343767|FG000|Overall Study|Withdrawal by Subject|1|||
125117034|NCT01200394|450051739|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
125117035|NCT01200394|450051740|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
125117036|NCT01200394|450051739|FG000|Overall Study|Protocol Violation|0|||
125117037|NCT01200394|450051740|FG001|Overall Study|Protocol Violation|3|||
125117038|NCT01200394|450051739|FG000|Overall Study|Withdrawal by Subject|0|||
125117039|NCT01200394|450051740|FG001|Overall Study|Withdrawal by Subject|5|||
125117040|NCT01200394|450051739|FG000|Overall Study|Other|0|||
125117041|NCT01200394|450051740|FG001|Overall Study|Other|1|||
125117042|NCT02666430|450051741|FG000|Period 1|Lost to Follow-up|1|||
125117043|NCT02666430|450051742|FG001|Period 1|Lost to Follow-up|0|||
125117044|NCT02666430|450051741|FG000|Period 1|Adverse Event|0|||
125117045|NCT02666430|450051742|FG001|Period 1|Adverse Event|1|||
125117046|NCT02666430|450051741|FG000|Period 2|Withdrawal by Subject|1|||
125117047|NCT02666430|450051742|FG001|Period 2|Withdrawal by Subject|4|||
125117048|NCT02666430|450051741|FG000|Period 3|Lost to Follow-up|1|||
125117049|NCT02666430|450051742|FG001|Period 3|Lost to Follow-up|0|||
125117050|NCT03828461|450051743|FG000|Overall Study|Lost to Follow-up|1|||
125117051|NCT03828461|450051743|FG000|Overall Study|Withdrawal by Subject|3|||
125117052|NCT02100956|450051744|FG000|At Least One Week Between Injections|Adverse Event|0|||
125117053|NCT02100956|450051745|FG001|At Least One Week Between Injections|Adverse Event|1|||
125117054|NCT03035227|450051746|FG000|Overall Study|study stopped due to PI leaving institut|1|||
125117055|NCT03035227|450051747|FG001|Overall Study|study stopped due to PI leaving institut|1|||
125117056|NCT00576199|450051748|FG000|Overall Study|Adverse Event|12|||
125117057|NCT00576199|450051748|FG000|Overall Study|Insufficient Therapeutic Response|14|||
125117058|NCT00576199|450051748|FG000|Overall Study|Refused Treatment|2|||
125117059|NCT00576199|450051748|FG000|Overall Study|Reason Unspecified|2|||
125117060|NCT00859469|450051750|FG000|Overall Study|Adverse Event|2|||
125117061|NCT00859469|450051750|FG000|Overall Study|Lack of Efficacy|9|||
125117062|NCT00859469|450051750|FG000|Overall Study|Withdrawal by Subject|1|||
125117063|NCT00859469|450051750|FG000|Overall Study|Death|16|||
125117064|NCT02220907|450051751|FG000|Overall Study|Adverse Event|7|||
125117065|NCT02220907|450051751|FG000|Overall Study|Physician Decision|1|||
125117066|NCT02220907|450051751|FG000|Overall Study|Withdrawal by Subject|2|||
125117067|NCT02220907|450051751|FG000|Overall Study|Conflict with the stopping criteria|1|||
125117068|NCT03111147|450051752|FG000|Overall Study|Lost to Follow-up|2|||
125117069|NCT03111147|450051753|FG001|Overall Study|Lost to Follow-up|5|||
125117070|NCT03111147|450051752|FG000|Overall Study|Withdrawal by Subject|4|||
125117071|NCT03111147|450051753|FG001|Overall Study|Withdrawal by Subject|3|||
125117072|NCT03111147|450051752|FG000|Overall Study|Protocol Violation|2|||
125117073|NCT03111147|450051753|FG001|Overall Study|Protocol Violation|1|||
125117074|NCT03111147|450051752|FG000|Overall Study|Death|1|||
125117075|NCT03111147|450051753|FG001|Overall Study|Death|1|||
125117076|NCT00095199|450051756|FG000|Overall Study|Adverse Event|40|||
125117077|NCT00095199|450051757|FG001|Overall Study|Adverse Event|22|||
125117078|NCT00095199|450051758|FG002|Overall Study|Adverse Event|26|||
125117079|NCT00095199|450051759|FG003|Overall Study|Adverse Event|11|||
125117080|NCT00095199|450051756|FG000|Overall Study|Progressive disease|213|||
125117081|NCT00095199|450051757|FG001|Overall Study|Progressive disease|179|||
125117082|NCT00095199|450051758|FG002|Overall Study|Progressive disease|105|||
125117083|NCT00095199|450051759|FG003|Overall Study|Progressive disease|98|||
125117084|NCT00095199|450051756|FG000|Overall Study|Death|10|||
125117085|NCT00095199|450051757|FG001|Overall Study|Death|6|||
125117086|NCT00095199|450051758|FG002|Overall Study|Death|11|||
125117087|NCT00095199|450051759|FG003|Overall Study|Death|9|||
125117088|NCT00095199|450051756|FG000|Overall Study|Withdrawal by Subject|21|||
125117089|NCT00095199|450051757|FG001|Overall Study|Withdrawal by Subject|16|||
125117090|NCT00095199|450051758|FG002|Overall Study|Withdrawal by Subject|13|||
125117091|NCT00095199|450051759|FG003|Overall Study|Withdrawal by Subject|22|||
125117092|NCT00095199|450051756|FG000|Overall Study|Protocol Violation|4|||
125117093|NCT00095199|450051757|FG001|Overall Study|Protocol Violation|4|||
125117094|NCT00095199|450051758|FG002|Overall Study|Protocol Violation|2|||
125117095|NCT00095199|450051759|FG003|Overall Study|Protocol Violation|0|||
125117096|NCT00095199|450051756|FG000|Overall Study|Liver function test results elevated|0|||
125117097|NCT00095199|450051757|FG001|Overall Study|Liver function test results elevated|0|||
125211871|NCT03970200|450401390|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
125211872|NCT03970200|450401391|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
125211873|NCT03970200|450401392|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
125211874|NCT02112877|450401393|FG000|Overall Study|Withdrawal by Subject|1|||
125211875|NCT02112877|450401394|FG001|Overall Study|Withdrawal by Subject|7|||
125211876|NCT02112877|450401393|FG000|Overall Study|Visit Missed|1|||
125211877|NCT02112877|450401394|FG001|Overall Study|Visit Missed|6|||
125211878|NCT03742258|450401395|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
125211879|NCT03742258|450401396|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
125211880|NCT03742258|450401397|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
125211881|NCT03742258|450401395|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
125211882|NCT03742258|450401396|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
125211883|NCT03742258|450401397|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
125211884|NCT03742258|450401395|FG000|Survival Follow-Up|Still in Follow-up|0|||
125211885|NCT03742258|450401396|FG001|Survival Follow-Up|Still in Follow-up|0|||
125211886|NCT03742258|450401397|FG002|Survival Follow-Up|Still in Follow-up|2|||
125211887|NCT02083653|450401400|FG000|Overall Study|Randomized but not Treated|0|||
125211888|NCT02083653|450401401|FG001|Overall Study|Randomized but not Treated|2|||
125211889|NCT02083653|450401402|FG002|Overall Study|Randomized but not Treated|7|||
125211890|NCT02083653|450401400|FG000|Overall Study|Adverse Event|12|||
125211891|NCT02083653|450401401|FG001|Overall Study|Adverse Event|5|||
125211892|NCT02083653|450401402|FG002|Overall Study|Adverse Event|4|||
125211893|NCT02083653|450401400|FG000|Overall Study|Lost to Follow-up|1|||
125211894|NCT02083653|450401401|FG001|Overall Study|Lost to Follow-up|0|||
125211895|NCT02083653|450401402|FG002|Overall Study|Lost to Follow-up|0|||
125211896|NCT02083653|450401400|FG000|Overall Study|Death|2|||
125211897|NCT02083653|450401401|FG001|Overall Study|Death|2|||
125211898|NCT02083653|450401402|FG002|Overall Study|Death|2|||
125211899|NCT02083653|450401400|FG000|Overall Study|Progressive Disease|65|||
125211900|NCT02083653|450401401|FG001|Overall Study|Progressive Disease|73|||
125211901|NCT02083653|450401402|FG002|Overall Study|Progressive Disease|63|||
125211902|NCT02083653|450401400|FG000|Overall Study|Withdrawal by Subject|2|||
125211903|NCT02083653|450401401|FG001|Overall Study|Withdrawal by Subject|1|||
125211904|NCT02083653|450401402|FG002|Overall Study|Withdrawal by Subject|2|||
125211905|NCT02083653|450401400|FG000|Overall Study|Other Events|0|||
125211906|NCT02083653|450401401|FG001|Overall Study|Other Events|2|||
125211907|NCT02083653|450401402|FG002|Overall Study|Other Events|2|||
125211908|NCT02083653|450401400|FG000|Overall Study|Reason Missing|0|||
125211909|NCT02083653|450401401|FG001|Overall Study|Reason Missing|0|||
125211910|NCT02083653|450401402|FG002|Overall Study|Reason Missing|4|||
125211911|NCT00621517|450401403|FG000|Overall Study|Lost to Follow-up|3|||
125211912|NCT00621517|450401404|FG001|Overall Study|Lost to Follow-up|3|||
125211913|NCT00621517|450401403|FG000|Overall Study|Withdrawal by Subject|3|||
125211914|NCT00621517|450401404|FG001|Overall Study|Withdrawal by Subject|4|||
124922022|NCT00999804|449343768|FG000|Overall Study|Lack of Efficacy|9|||
124922023|NCT00999804|449343769|FG001|Overall Study|Lack of Efficacy|2|||
124922024|NCT00999804|449343768|FG000|Overall Study|Adverse Event|4|||
124922025|NCT00999804|449343769|FG001|Overall Study|Adverse Event|3|||
124922026|NCT00999804|449343768|FG000|Overall Study|Withdrawal by Subject|4|||
124922027|NCT00999804|449343769|FG001|Overall Study|Withdrawal by Subject|0|||
124922028|NCT00999804|449343768|FG000|Overall Study|Death|1|||
124922029|NCT00999804|449343769|FG001|Overall Study|Death|0|||
124922030|NCT00999804|449343768|FG000|Overall Study|Ineligible|3|||
124922031|NCT00999804|449343769|FG001|Overall Study|Ineligible|0|||
124922032|NCT04166773|449343775|FG000|Overall Study|Adverse Event|2|||
124922033|NCT04166773|449343776|FG001|Overall Study|Adverse Event|0|||
124922034|NCT04166773|449343777|FG002|Overall Study|Adverse Event|2|||
124922035|NCT04166773|449343778|FG003|Overall Study|Adverse Event|1|||
124922036|NCT04166773|449343775|FG000|Overall Study|Lost to Follow-up|4|||
124922037|NCT04166773|449343776|FG001|Overall Study|Lost to Follow-up|2|||
124922038|NCT04166773|449343777|FG002|Overall Study|Lost to Follow-up|1|||
124922039|NCT04166773|449343778|FG003|Overall Study|Lost to Follow-up|3|||
125211915|NCT00621517|450401403|FG000|Overall Study|Adverse Event|1|||
125211916|NCT00621517|450401404|FG001|Overall Study|Adverse Event|0|||
124922040|NCT04166773|449343775|FG000|Overall Study|Physician Decision|0|||
124922041|NCT04166773|449343776|FG001|Overall Study|Physician Decision|0|||
125211917|NCT02155322|450401406|FG000|Overall Study|Adverse Event|1|||
125211918|NCT02155322|450401406|FG000|Overall Study|Physician Decision|1|||
124922042|NCT04166773|449343777|FG002|Overall Study|Physician Decision|0|||
124922043|NCT04166773|449343778|FG003|Overall Study|Physician Decision|1|||
124922044|NCT04166773|449343775|FG000|Overall Study|Withdrawal by Subject|1|||
124922045|NCT04166773|449343776|FG001|Overall Study|Withdrawal by Subject|1|||
124922046|NCT04166773|449343777|FG002|Overall Study|Withdrawal by Subject|2|||
125211919|NCT02155322|450401406|FG000|Overall Study|Relapse/Recurrence|8|||
125211920|NCT02155322|450401406|FG000|Overall Study|Withdrawal by Subject|4|||
125211921|NCT00073008|450401407|FG000|Overall Study|Missing|6|||
125211922|NCT00073008|450401408|FG001|Overall Study|Missing|6|||
125211923|NCT00073008|450401407|FG000|Overall Study|Withdrawal by Subject|2|||
125023338|NCT05227690|449709476|FG001|Overall Study|Other, not specified|2|||
125023339|NCT05227690|449709477|FG002|Overall Study|Other, not specified|1|||
125023340|NCT04033367|449709478|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
125023341|NCT04033367|449709479|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
125023342|NCT04033367|449709478|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
125023343|NCT04033367|449709479|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
125023344|NCT04033367|449709478|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
125023345|NCT04033367|449709479|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
125023346|NCT04033367|449709478|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
125023347|NCT04033367|449709479|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
125023348|NCT02908880|449709480|FG000|Overall Study|Lost to Follow-up|4|||
125023349|NCT02908880|449709480|FG000|Overall Study|Explantation of the device|1|||
125023350|NCT02908880|449709480|FG000|Overall Study|Withdrawal by Subject|17|||
125023351|NCT02908880|449709480|FG000|Overall Study|Death|5|||
125023352|NCT03823391|449709487|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
125023353|NCT03823391|449709488|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
125023354|NCT03823391|449709487|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
125023355|NCT03823391|449709488|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
125023356|NCT02450487|449709489|FG000|Overall Study|Lost to Follow-up|3|||
125023357|NCT01790048|449709490|FG000|Overall Study|Incorrect Age|9|||
125023358|NCT01790048|449709491|FG001|Overall Study|Incorrect Age|14|||
125023359|NCT01790048|449709490|FG000|Overall Study|data entry error|0|||
125023360|NCT01790048|449709491|FG001|Overall Study|data entry error|1|||
125023361|NCT01790048|449709490|FG000|Overall Study|Other|0|||
125023362|NCT01790048|449709491|FG001|Overall Study|Other|2|||
125023363|NCT01790048|449709490|FG000|Overall Study|SAM at Enrollment|2|||
125023364|NCT01790048|449709491|FG001|Overall Study|SAM at Enrollment|0|||
125023365|NCT01790048|449709490|FG000|Overall Study|Measurement error|1|||
125023366|NCT01790048|449709491|FG001|Overall Study|Measurement error|0|||
125023367|NCT05030311|449709492|FG000|Overall Study|Technical problems|0|||
125023368|NCT05030311|449709493|FG001|Overall Study|Technical problems|1|||
125023369|NCT05030311|449709492|FG000|Overall Study|Withdrawal by Subject|31|||
125023370|NCT05030311|449709493|FG001|Overall Study|Withdrawal by Subject|17|||
125023371|NCT05030311|449709492|FG000|Overall Study|Adverse Event|13|||
125023372|NCT05030311|449709493|FG001|Overall Study|Adverse Event|5|||
125023373|NCT05030311|449709492|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
125023374|NCT05030311|449709493|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
125023375|NCT05030311|449709492|FG000|Overall Study|Physician Decision|5|||
125023376|NCT05030311|449709493|FG001|Overall Study|Physician Decision|2|||
125117098|NCT00095199|450051758|FG002|Overall Study|Liver function test results elevated|1|||
125117099|NCT00095199|450051759|FG003|Overall Study|Liver function test results elevated|1|||
125117100|NCT00095199|450051756|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
125117101|NCT00095199|450051757|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
125117102|NCT00095199|450051758|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
125117103|NCT00095199|450051759|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
125117104|NCT00095199|450051756|FG000|Overall Study|Physician Decision|5|||
125117105|NCT00095199|450051757|FG001|Overall Study|Physician Decision|6|||
125117106|NCT00095199|450051758|FG002|Overall Study|Physician Decision|1|||
125117107|NCT00095199|450051759|FG003|Overall Study|Physician Decision|1|||
125117108|NCT00095199|450051756|FG000|Overall Study|Not eligible|1|||
125117109|NCT00095199|450051757|FG001|Overall Study|Not eligible|7|||
125117110|NCT00095199|450051758|FG002|Overall Study|Not eligible|0|||
125117111|NCT00095199|450051759|FG003|Overall Study|Not eligible|1|||
125117112|NCT00095199|450051756|FG000|Overall Study|Started Palliative Radiotherapy|1|||
125023377|NCT05030311|449709492|FG000|Overall Study|Lost to Follow-up|5|||
125023378|NCT05030311|449709493|FG001|Overall Study|Lost to Follow-up|1|||
125023379|NCT05030311|449709492|FG000|Overall Study|Protocol Violation|4|||
125023380|NCT05030311|449709493|FG001|Overall Study|Protocol Violation|4|||
125023381|NCT03083886|449709494|FG000|Overall Study|Withdrawal by Subject|51|||
125023382|NCT03083886|449709495|FG001|Overall Study|Withdrawal by Subject|73|||
125023383|NCT03083886|449709496|FG002|Overall Study|Withdrawal by Subject|104|||
125117113|NCT00095199|450051757|FG001|Overall Study|Started Palliative Radiotherapy|0|||
125117114|NCT00095199|450051758|FG002|Overall Study|Started Palliative Radiotherapy|0|||
125023384|NCT03083886|449709494|FG000|Overall Study|Missing Baseline data|43|||
125023385|NCT03083886|449709495|FG001|Overall Study|Missing Baseline data|42|||
125023386|NCT03083886|449709496|FG002|Overall Study|Missing Baseline data|31|||
125023387|NCT03083886|449709494|FG000|Overall Study|Investigator terminated|1|||
125023388|NCT03083886|449709495|FG001|Overall Study|Investigator terminated|6|||
125023389|NCT03083886|449709496|FG002|Overall Study|Investigator terminated|3|||
125023390|NCT02062658|449709497|FG000|Overall Study|Withdrawal by Subject|1|||
124922047|NCT04166773|449343778|FG003|Overall Study|Withdrawal by Subject|5|||
124922048|NCT04952909|449343790|FG000|Overall Study|Death|3|||
124922049|NCT03575897|449343791|FG000|Overall Study|Lost to Follow-up|12|||
124922050|NCT03575897|449343792|FG001|Overall Study|Lost to Follow-up|13|||
124922051|NCT03150810|449343799|FG000|Overall Study|Death|4|||
124922052|NCT03150810|449343800|FG001|Overall Study|Death|8|||
124922053|NCT03150810|449343801|FG002|Overall Study|Death|7|||
124922054|NCT03150810|449343802|FG003|Overall Study|Death|2|||
124922055|NCT03150810|449343803|FG004|Overall Study|Death|2|||
124922056|NCT03150810|449343804|FG005|Overall Study|Death|10|||
124922057|NCT03150810|449343805|FG006|Overall Study|Death|8|||
124922058|NCT03150810|449343806|FG007|Overall Study|Death|6|||
124922059|NCT03150810|449343807|FG008|Overall Study|Death|18|||
124922060|NCT03150810|449343808|FG009|Overall Study|Death|3|||
124922061|NCT03150810|449343809|FG010|Overall Study|Death|19|||
124922062|NCT03150810|449343810|FG011|Overall Study|Death|1|||
124922063|NCT03150810|449343811|FG012|Overall Study|Death|19|||
124922064|NCT03150810|449343799|FG000|Overall Study|Withdrawal by Subject|0|||
124922065|NCT03150810|449343800|FG001|Overall Study|Withdrawal by Subject|1|||
124922066|NCT03150810|449343801|FG002|Overall Study|Withdrawal by Subject|1|||
125117115|NCT00095199|450051759|FG003|Overall Study|Started Palliative Radiotherapy|0|||
125117116|NCT00095199|450051756|FG000|Overall Study|Started radiotherapy regimen|0|||
125117117|NCT00095199|450051757|FG001|Overall Study|Started radiotherapy regimen|1|||
125117118|NCT00095199|450051758|FG002|Overall Study|Started radiotherapy regimen|0|||
125117119|NCT00095199|450051759|FG003|Overall Study|Started radiotherapy regimen|0|||
125117120|NCT00095199|450051756|FG000|Overall Study|Primary tumor removed in other surgery|0|||
125117121|NCT00095199|450051757|FG001|Overall Study|Primary tumor removed in other surgery|1|||
125117122|NCT00095199|450051758|FG002|Overall Study|Primary tumor removed in other surgery|0|||
125117123|NCT00095199|450051759|FG003|Overall Study|Primary tumor removed in other surgery|0|||
125117124|NCT00095199|450051756|FG000|Overall Study|Data inadvertently lost by site|1|||
125117125|NCT00095199|450051757|FG001|Overall Study|Data inadvertently lost by site|0|||
125117126|NCT00095199|450051758|FG002|Overall Study|Data inadvertently lost by site|0|||
125117127|NCT00095199|450051759|FG003|Overall Study|Data inadvertently lost by site|0|||
125117128|NCT01896297|450051760|FG000|Overall Study|Died in post treatment phase|1|||
125117129|NCT01098240|450051761|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
125117130|NCT01098240|450051762|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
125117131|NCT01098240|450051763|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
125117132|NCT01098240|450051761|FG000|Open-Label Phase|Protocol Violation|4|||
125117133|NCT01098240|450051762|FG001|Open-Label Phase|Protocol Violation|0|||
125117134|NCT01098240|450051763|FG002|Open-Label Phase|Protocol Violation|0|||
125117135|NCT01098240|450051761|FG000|Open-Label Phase|Lost to Follow-up|13|||
125117136|NCT01098240|450051762|FG001|Open-Label Phase|Lost to Follow-up|0|||
125117137|NCT01098240|450051763|FG002|Open-Label Phase|Lost to Follow-up|0|||
125117138|NCT01098240|450051761|FG000|Open-Label Phase|Other|19|||
125117139|NCT01098240|450051762|FG001|Open-Label Phase|Other|0|||
125117140|NCT01098240|450051763|FG002|Open-Label Phase|Other|0|||
125117141|NCT01098240|450051761|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
125117142|NCT01098240|450051762|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
125117143|NCT01098240|450051763|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
125117144|NCT01098240|450051761|FG000|Open-Label Phase|Pregnancy|1|||
125117145|NCT01098240|450051762|FG001|Open-Label Phase|Pregnancy|0|||
125117146|NCT01098240|450051763|FG002|Open-Label Phase|Pregnancy|0|||
125117147|NCT01098240|450051761|FG000|Open-Label Phase|Withdrawal by Subject|9|||
125117148|NCT01098240|450051762|FG001|Open-Label Phase|Withdrawal by Subject|0|||
125117149|NCT01098240|450051763|FG002|Open-Label Phase|Withdrawal by Subject|0|||
125117150|NCT01098240|450051761|FG000|Open-Label Phase|Adverse Event|12|||
125117151|NCT01098240|450051762|FG001|Open-Label Phase|Adverse Event|0|||
124922067|NCT03150810|449343802|FG003|Overall Study|Withdrawal by Subject|1|||
124922068|NCT03150810|449343803|FG004|Overall Study|Withdrawal by Subject|0|||
124922069|NCT03150810|449343804|FG005|Overall Study|Withdrawal by Subject|0|||
124922070|NCT03150810|449343805|FG006|Overall Study|Withdrawal by Subject|2|||
124922071|NCT03150810|449343806|FG007|Overall Study|Withdrawal by Subject|0|||
125117152|NCT01098240|450051763|FG002|Open-Label Phase|Adverse Event|0|||
125117153|NCT01098240|450051761|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
125117154|NCT01098240|450051762|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
125117155|NCT01098240|450051763|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
125117156|NCT01098240|450051761|FG000|Double-Blind Phase|Protocol Violation|0|||
125117157|NCT01098240|450051762|FG001|Double-Blind Phase|Protocol Violation|2|||
124922072|NCT03150810|449343807|FG008|Overall Study|Withdrawal by Subject|2|||
124922073|NCT03150810|449343808|FG009|Overall Study|Withdrawal by Subject|0|||
124922074|NCT03150810|449343809|FG010|Overall Study|Withdrawal by Subject|1|||
124922075|NCT03150810|449343810|FG011|Overall Study|Withdrawal by Subject|0|||
124922076|NCT03150810|449343811|FG012|Overall Study|Withdrawal by Subject|1|||
124922077|NCT03150810|449343799|FG000|Overall Study|Sponsor Decision|0|||
124922078|NCT03150810|449343800|FG001|Overall Study|Sponsor Decision|2|||
124922079|NCT03150810|449343801|FG002|Overall Study|Sponsor Decision|0|||
125211924|NCT00073008|450401408|FG001|Overall Study|Withdrawal by Subject|2|||
125211925|NCT00073008|450401407|FG000|Overall Study|Lost to Follow-up|1|||
125211926|NCT00073008|450401408|FG001|Overall Study|Lost to Follow-up|3|||
125211927|NCT00073008|450401407|FG000|Overall Study|Death|46|||
125211928|NCT00073008|450401408|FG001|Overall Study|Death|47|||
125211929|NCT00073008|450401407|FG000|Overall Study|"Other selected on Case Report Form"|7|||
125211930|NCT00073008|450401408|FG001|Overall Study|"Other selected on Case Report Form"|5|||
125211931|NCT00913770|450401409|FG000|Overall Study|Unable to contact|24|||
125211932|NCT00913770|450401410|FG001|Overall Study|Unable to contact|19|||
125211933|NCT00913770|450401411|FG002|Overall Study|Unable to contact|13|||
125211934|NCT00913770|450401409|FG000|Overall Study|Refused|11|||
125211935|NCT00913770|450401410|FG001|Overall Study|Refused|10|||
125211936|NCT00913770|450401411|FG002|Overall Study|Refused|8|||
125211937|NCT03337048|450401412|FG000|Overall Study|Withdrawal by Subject|2|||
125211938|NCT03337048|450401413|FG001|Overall Study|Withdrawal by Subject|0|||
125211939|NCT03337048|450401414|FG002|Overall Study|Withdrawal by Subject|0|||
125211940|NCT02791438|450401417|FG000|Treatment Period|Adverse Event|1|||
125211941|NCT02791438|450401418|FG001|Treatment Period|Adverse Event|0|||
125211942|NCT02791438|450401417|FG000|Treatment Period|Withdrawal by Subject|0|||
125211943|NCT02791438|450401418|FG001|Treatment Period|Withdrawal by Subject|1|||
125211944|NCT02791438|450401417|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
125211945|NCT02791438|450401418|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
125211946|NCT00564395|450401420|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
124922080|NCT03150810|449343802|FG003|Overall Study|Sponsor Decision|0|||
124922081|NCT03150810|449343803|FG004|Overall Study|Sponsor Decision|1|||
124922082|NCT03150810|449343804|FG005|Overall Study|Sponsor Decision|1|||
124922083|NCT03150810|449343805|FG006|Overall Study|Sponsor Decision|0|||
124922084|NCT03150810|449343806|FG007|Overall Study|Sponsor Decision|0|||
124922085|NCT03150810|449343807|FG008|Overall Study|Sponsor Decision|1|||
124922086|NCT03150810|449343808|FG009|Overall Study|Sponsor Decision|0|||
124922087|NCT03150810|449343809|FG010|Overall Study|Sponsor Decision|0|||
124922088|NCT03150810|449343810|FG011|Overall Study|Sponsor Decision|0|||
124922089|NCT03150810|449343811|FG012|Overall Study|Sponsor Decision|5|||
124922090|NCT03150810|449343799|FG000|Overall Study|Lost to Follow-up|0|||
124922091|NCT03150810|449343800|FG001|Overall Study|Lost to Follow-up|1|||
124922092|NCT03150810|449343801|FG002|Overall Study|Lost to Follow-up|1|||
124922093|NCT03150810|449343802|FG003|Overall Study|Lost to Follow-up|0|||
124922094|NCT03150810|449343803|FG004|Overall Study|Lost to Follow-up|0|||
124922095|NCT03150810|449343804|FG005|Overall Study|Lost to Follow-up|0|||
124922096|NCT03150810|449343805|FG006|Overall Study|Lost to Follow-up|1|||
124922097|NCT03150810|449343806|FG007|Overall Study|Lost to Follow-up|0|||
124922098|NCT03150810|449343807|FG008|Overall Study|Lost to Follow-up|0|||
124922099|NCT03150810|449343808|FG009|Overall Study|Lost to Follow-up|0|||
124922100|NCT03150810|449343809|FG010|Overall Study|Lost to Follow-up|1|||
124922101|NCT03150810|449343810|FG011|Overall Study|Lost to Follow-up|0|||
124922102|NCT03150810|449343811|FG012|Overall Study|Lost to Follow-up|0|||
124922103|NCT03150810|449343799|FG000|Overall Study|Physician Decision|0|||
124922104|NCT03150810|449343800|FG001|Overall Study|Physician Decision|0|||
124922105|NCT03150810|449343801|FG002|Overall Study|Physician Decision|0|||
124922106|NCT03150810|449343802|FG003|Overall Study|Physician Decision|0|||
124922107|NCT03150810|449343803|FG004|Overall Study|Physician Decision|0|||
124922108|NCT03150810|449343804|FG005|Overall Study|Physician Decision|1|||
124922109|NCT03150810|449343805|FG006|Overall Study|Physician Decision|1|||
124922110|NCT03150810|449343806|FG007|Overall Study|Physician Decision|0|||
124922111|NCT03150810|449343807|FG008|Overall Study|Physician Decision|0|||
124922112|NCT03150810|449343808|FG009|Overall Study|Physician Decision|0|||
124922113|NCT03150810|449343809|FG010|Overall Study|Physician Decision|0|||
124922114|NCT03150810|449343810|FG011|Overall Study|Physician Decision|0|||
124922115|NCT03150810|449343811|FG012|Overall Study|Physician Decision|0|||
125211947|NCT00564395|450401421|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
125211948|NCT00564395|450401420|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
125211949|NCT00564395|450401421|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
125211950|NCT01428115|450401422|FG000|Overall Study|Lack of Efficacy|3|||
125211951|NCT01428115|450401422|FG000|Overall Study|Lost to Follow-up|10|||
124922116|NCT03150810|449343799|FG000|Overall Study|Site withdrawal from study|0|||
124922117|NCT03150810|449343800|FG001|Overall Study|Site withdrawal from study|1|||
124922118|NCT03150810|449343801|FG002|Overall Study|Site withdrawal from study|0|||
124922119|NCT03150810|449343802|FG003|Overall Study|Site withdrawal from study|0|||
124922120|NCT03150810|449343803|FG004|Overall Study|Site withdrawal from study|0|||
124922121|NCT03150810|449343804|FG005|Overall Study|Site withdrawal from study|0|||
124922122|NCT03150810|449343805|FG006|Overall Study|Site withdrawal from study|0|||
124922123|NCT03150810|449343806|FG007|Overall Study|Site withdrawal from study|0|||
124922124|NCT03150810|449343807|FG008|Overall Study|Site withdrawal from study|0|||
124922125|NCT03150810|449343808|FG009|Overall Study|Site withdrawal from study|1|||
124922126|NCT03150810|449343809|FG010|Overall Study|Site withdrawal from study|1|||
124922127|NCT03150810|449343810|FG011|Overall Study|Site withdrawal from study|0|||
124922128|NCT03150810|449343811|FG012|Overall Study|Site withdrawal from study|0|||
124922129|NCT03150810|449343799|FG000|Overall Study|Hospice|0|||
125023391|NCT02062658|449709497|FG000|Overall Study|Lack of Efficacy|1|||
125023392|NCT00608985|449709498|FG000|Overall Study|Adverse Event|2|||
125023393|NCT00608985|449709499|FG001|Overall Study|Adverse Event|7|||
125023394|NCT00608985|449709500|FG002|Overall Study|Adverse Event|4|||
125023395|NCT00608985|449709501|FG003|Overall Study|Adverse Event|6|||
125023396|NCT00608985|449709498|FG000|Overall Study|Administrative/Other|7|||
125023397|NCT00608985|449709499|FG001|Overall Study|Administrative/Other|4|||
125023398|NCT00608985|449709500|FG002|Overall Study|Administrative/Other|1|||
125023399|NCT00608985|449709501|FG003|Overall Study|Administrative/Other|2|||
125023400|NCT00608985|449709498|FG000|Overall Study|Withdrawal of Consent|5|||
125023401|NCT00608985|449709499|FG001|Overall Study|Withdrawal of Consent|1|||
125023402|NCT00608985|449709500|FG002|Overall Study|Withdrawal of Consent|1|||
125023403|NCT00608985|449709501|FG003|Overall Study|Withdrawal of Consent|1|||
125023404|NCT00608985|449709498|FG000|Overall Study|Lost to Follow-up|2|||
125023405|NCT00608985|449709499|FG001|Overall Study|Lost to Follow-up|1|||
125023406|NCT00608985|449709500|FG002|Overall Study|Lost to Follow-up|0|||
125023407|NCT00608985|449709501|FG003|Overall Study|Lost to Follow-up|0|||
125023408|NCT03033745|449709502|FG000|Overall Study|Protocol Violation|0|||
125023409|NCT03033745|449709503|FG001|Overall Study|Protocol Violation|0|||
125023410|NCT03033745|449709504|FG002|Overall Study|Protocol Violation|1|||
125023411|NCT03033745|449709502|FG000|Overall Study|Adverse Event|1|||
125023412|NCT03033745|449709503|FG001|Overall Study|Adverse Event|0|||
125023413|NCT03033745|449709504|FG002|Overall Study|Adverse Event|1|||
125023414|NCT03033745|449709502|FG000|Overall Study|Withdrawal by Subject|0|||
125023415|NCT03033745|449709503|FG001|Overall Study|Withdrawal by Subject|1|||
125023416|NCT03033745|449709504|FG002|Overall Study|Withdrawal by Subject|0|||
125023417|NCT00323557|449709505|FG000|Overall Study|Physician Decision|1|||
125023418|NCT00323557|449709506|FG001|Overall Study|Physician Decision|0|||
125023419|NCT00662792|449709508|FG000|Period 1|Personal Reasons|0|||
125117158|NCT01098240|450051763|FG002|Double-Blind Phase|Protocol Violation|4|||
125117159|NCT01098240|450051761|FG000|Double-Blind Phase|Lost to Follow-up|0|||
125117160|NCT01098240|450051762|FG001|Double-Blind Phase|Lost to Follow-up|2|||
125117161|NCT01098240|450051763|FG002|Double-Blind Phase|Lost to Follow-up|0|||
125117162|NCT01098240|450051761|FG000|Double-Blind Phase|Other|0|||
125117163|NCT01098240|450051762|FG001|Double-Blind Phase|Other|2|||
125117164|NCT01098240|450051763|FG002|Double-Blind Phase|Other|2|||
125117165|NCT01098240|450051761|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
125117166|NCT01098240|450051762|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
125117167|NCT01098240|450051763|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
125117168|NCT01098240|450051761|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
125117169|NCT01098240|450051762|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
125117170|NCT01098240|450051763|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
125117171|NCT01098240|450051761|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
125117172|NCT01098240|450051762|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
125117173|NCT01098240|450051763|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
125117174|NCT01098240|450051761|FG000|Double-Blind Phase|Adverse Event|0|||
125117175|NCT01098240|450051762|FG001|Double-Blind Phase|Adverse Event|3|||
125117176|NCT01098240|450051763|FG002|Double-Blind Phase|Adverse Event|3|||
125117177|NCT01070394|450051764|FG000|Overall Study|Adverse Event|6|||
125117178|NCT01070394|450051764|FG000|Overall Study|Withdrawal by Subject|1|||
125117179|NCT03118739|450051766|FG000|Overall Study|Physician Decision|0|||
125117180|NCT03118739|450051767|FG001|Overall Study|Physician Decision|1|||
125117181|NCT03118739|450051766|FG000|Overall Study|Withdrawal by Subject|5|||
125117182|NCT03118739|450051767|FG001|Overall Study|Withdrawal by Subject|3|||
125117183|NCT03118739|450051766|FG000|Overall Study|Lost to Follow-up|2|||
125117184|NCT03118739|450051767|FG001|Overall Study|Lost to Follow-up|0|||
125117185|NCT00669955|450051768|FG000|Overall Study|Adverse Event|3|||
125117186|NCT00669955|450051769|FG001|Overall Study|Adverse Event|5|||
125117187|NCT00669955|450051768|FG000|Overall Study|Death|0|||
125117188|NCT00669955|450051769|FG001|Overall Study|Death|1|||
125117189|NCT00669955|450051768|FG000|Overall Study|Withdrawal by Subject|2|||
125117190|NCT00669955|450051769|FG001|Overall Study|Withdrawal by Subject|3|||
125117191|NCT00669955|450051768|FG000|Overall Study|Lost to Follow-up|5|||
125117192|NCT00669955|450051769|FG001|Overall Study|Lost to Follow-up|7|||
125117193|NCT00669955|450051768|FG000|Overall Study|Protocol Violation|2|||
125117194|NCT00669955|450051769|FG001|Overall Study|Protocol Violation|7|||
125117195|NCT00669955|450051768|FG000|Overall Study|Investigator Sponsor Judgement|0|||
125117196|NCT00669955|450051769|FG001|Overall Study|Investigator Sponsor Judgement|1|||
125117197|NCT00669955|450051768|FG000|Overall Study|not compliant with study drug/visit|2|||
125117198|NCT00669955|450051769|FG001|Overall Study|not compliant with study drug/visit|3|||
125117199|NCT04317053|450051774|FG000|Overall Study|Withdrawn (screen failure)|4|||
125117200|NCT04317053|450051775|FG001|Overall Study|Withdrawn (screen failure)|2|||
125117201|NCT01077713|450051776|FG000|Overall Study|Withdrawal by Subject|1|||
125023420|NCT00662792|449709509|FG001|Period 1|Personal Reasons|0|||
125023421|NCT00662792|449709510|FG002|Period 1|Personal Reasons|1|||
125023422|NCT00662792|449709511|FG003|Period 1|Personal Reasons|0|||
125023423|NCT00662792|449709508|FG000|Period 1|Refused continuing medication|0|||
125023424|NCT00662792|449709509|FG001|Period 1|Refused continuing medication|1|||
125117202|NCT01077713|450051777|FG001|Overall Study|Withdrawal by Subject|2|||
125117203|NCT01077713|450051776|FG000|Overall Study|Progressive Disease (PD)|0|||
125117204|NCT01077713|450051777|FG001|Overall Study|Progressive Disease (PD)|1|||
125117205|NCT01077713|450051776|FG000|Overall Study|Death|28|||
125117206|NCT01077713|450051777|FG001|Overall Study|Death|29|||
125211952|NCT01428115|450401422|FG000|Overall Study|Pregnancy|1|||
125211953|NCT01428115|450401422|FG000|Overall Study|Protocol Violation|3|||
125211954|NCT01428115|450401422|FG000|Overall Study|Withdrawal by Subject|4|||
125211955|NCT02620384|450401427|FG000|Overall Study|Adverse Event|2|||
125211956|NCT02620384|450401428|FG001|Overall Study|Adverse Event|1|||
125211957|NCT02620384|450401427|FG000|Overall Study|Discharged prior to 2nd dose|2|||
125211958|NCT02620384|450401428|FG001|Overall Study|Discharged prior to 2nd dose|5|||
125211959|NCT02620384|450401427|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
125211960|NCT02620384|450401428|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
125211961|NCT02071082|450401429|FG000|Overall Study|Enrolled and Never Treated|1|||
125211962|NCT02071082|450401430|FG001|Overall Study|Enrolled and Never Treated|1|||
125211963|NCT02071082|450401429|FG000|Overall Study|Adverse Event|0|||
125211964|NCT02071082|450401430|FG001|Overall Study|Adverse Event|1|||
125211965|NCT02071082|450401429|FG000|Overall Study|Withdrew Consent|0|||
125211966|NCT02071082|450401430|FG001|Overall Study|Withdrew Consent|4|||
125211967|NCT02071082|450401429|FG000|Overall Study|Lost to Follow-up|1|||
125211968|NCT02071082|450401430|FG001|Overall Study|Lost to Follow-up|1|||
125211969|NCT02101359|450401431|FG000|Overall Study|Not included|23|||
125211970|NCT02101359|450401432|FG001|Overall Study|Not included|13|||
125211971|NCT02101359|450401431|FG000|Overall Study|Withdrawal by Subject|5|||
125211972|NCT02101359|450401432|FG001|Overall Study|Withdrawal by Subject|4|||
125211973|NCT02101359|450401431|FG000|Overall Study|Lost to Follow-up|1|||
125211974|NCT02101359|450401432|FG001|Overall Study|Lost to Follow-up|0|||
125211975|NCT02101359|450401431|FG000|Overall Study|Protocol Violation|0|||
125211976|NCT02101359|450401432|FG001|Overall Study|Protocol Violation|2|||
125211977|NCT02494401|450401437|FG000|Overall Study|Lost to Follow-up|22|||
125211978|NCT02494401|450401438|FG001|Overall Study|Lost to Follow-up|25|||
125211979|NCT02494401|450401437|FG000|Overall Study|Withdrawal by Subject|3|||
125211980|NCT02494401|450401438|FG001|Overall Study|Withdrawal by Subject|2|||
125211981|NCT00966355|450401439|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
125211982|NCT00966355|450401440|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
125211983|NCT00966355|450401441|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
125211984|NCT00966355|450401439|FG000|Overall Study|newly diagnosed advanced HCC|11|||
125211985|NCT00966355|450401440|FG001|Overall Study|newly diagnosed advanced HCC|12|||
125211986|NCT00966355|450401441|FG002|Overall Study|newly diagnosed advanced HCC|10|||
124922130|NCT03150810|449343800|FG001|Overall Study|Hospice|0|||
124922131|NCT03150810|449343801|FG002|Overall Study|Hospice|0|||
124922132|NCT03150810|449343802|FG003|Overall Study|Hospice|0|||
125117207|NCT01077713|450051776|FG000|Overall Study|Lost to Follow-up|1|||
125117208|NCT01077713|450051777|FG001|Overall Study|Lost to Follow-up|1|||
125117209|NCT01077713|450051776|FG000|Overall Study|Adverse Event|2|||
125117210|NCT01077713|450051777|FG001|Overall Study|Adverse Event|1|||
125117211|NCT01077713|450051776|FG000|Overall Study|Other|4|||
125117212|NCT01077713|450051777|FG001|Overall Study|Other|2|||
125117213|NCT03507439|450051778|FG000|Overall Study|Other|2|||
125117214|NCT03507439|450051779|FG001|Overall Study|Other|1|||
125117215|NCT03507439|450051778|FG000|Overall Study|Withdrawal by Subject|1|||
125117216|NCT03507439|450051779|FG001|Overall Study|Withdrawal by Subject|0|||
125117217|NCT03507439|450051778|FG000|Overall Study|Death|1|||
125117218|NCT03507439|450051779|FG001|Overall Study|Death|1|||
125117219|NCT00289458|450051780|FG000|Overall Study|Death|1|||
125117220|NCT00289458|450051781|FG001|Overall Study|Death|0|||
125117221|NCT00289458|450051782|FG002|Overall Study|Death|0|||
124922133|NCT03150810|449343803|FG004|Overall Study|Hospice|0|||
124922134|NCT03150810|449343804|FG005|Overall Study|Hospice|1|||
124922135|NCT03150810|449343805|FG006|Overall Study|Hospice|0|||
124922136|NCT03150810|449343806|FG007|Overall Study|Hospice|0|||
124922137|NCT03150810|449343807|FG008|Overall Study|Hospice|0|||
124922138|NCT03150810|449343808|FG009|Overall Study|Hospice|0|||
124922139|NCT03150810|449343809|FG010|Overall Study|Hospice|0|||
124922140|NCT03150810|449343810|FG011|Overall Study|Hospice|0|||
125117222|NCT00289458|450051780|FG000|Overall Study|Physician Decision|3|||
125211987|NCT00966355|450401439|FG000|Overall Study|Lost to Follow-up|5|||
125211988|NCT00966355|450401440|FG001|Overall Study|Lost to Follow-up|4|||
125211989|NCT00966355|450401441|FG002|Overall Study|Lost to Follow-up|3|||
125211990|NCT00958412|450401442|FG000|Overall Study|Study prematurely terminated|18|||
125211991|NCT02227368|450403233|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
125211992|NCT02227368|450403234|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
125211993|NCT02227368|450403233|FG000|Overall Study|Lost to Follow-up|1|||
124922141|NCT03150810|449343811|FG012|Overall Study|Hospice|0|||
125117223|NCT00289458|450051781|FG001|Overall Study|Physician Decision|4|||
125211994|NCT02227368|450403234|FG001|Overall Study|Lost to Follow-up|0|||
124922142|NCT03150810|449343799|FG000|Overall Study|Participant relocated abroad.|0|||
125117224|NCT00289458|450051782|FG002|Overall Study|Physician Decision|2|||
125117225|NCT00289458|450051780|FG000|Overall Study|Withdrawal by Subject|2|||
125211995|NCT02227368|450403233|FG000|Overall Study|Adverse Event|1|||
125211996|NCT02227368|450403234|FG001|Overall Study|Adverse Event|0|||
125211997|NCT04494425|450403236|FG000|Overall Study|Death|160|||
125211998|NCT04494425|450403237|FG001|Overall Study|Death|166|||
125211999|NCT04494425|450403236|FG000|Overall Study|Withdrawal by Subject|10|||
125212000|NCT04494425|450403237|FG001|Overall Study|Withdrawal by Subject|40|||
125212001|NCT04494425|450403236|FG000|Overall Study|Other|1|||
125212002|NCT04494425|450403237|FG001|Overall Study|Other|1|||
125212003|NCT04494425|450403236|FG000|Overall Study|Ongoing at the time of PCD|265|||
125212004|NCT04494425|450403237|FG001|Overall Study|Ongoing at the time of PCD|223|||
124922143|NCT03150810|449343800|FG001|Overall Study|Participant relocated abroad.|0|||
124922144|NCT03150810|449343801|FG002|Overall Study|Participant relocated abroad.|0|||
124922145|NCT03150810|449343802|FG003|Overall Study|Participant relocated abroad.|0|||
124922146|NCT03150810|449343803|FG004|Overall Study|Participant relocated abroad.|0|||
124922147|NCT03150810|449343804|FG005|Overall Study|Participant relocated abroad.|1|||
125117226|NCT00289458|450051781|FG001|Overall Study|Withdrawal by Subject|2|||
125117227|NCT00289458|450051782|FG002|Overall Study|Withdrawal by Subject|4|||
125117228|NCT04274192|450051783|FG000|Overall Study|Protocol Violation|1|||
125117229|NCT04274192|450051784|FG001|Overall Study|Protocol Violation|0|||
125117230|NCT01621490|450053427|FG000|Overall Study|Subject no longer meets study criteria|0|||
125117231|NCT01621490|450053428|FG001|Overall Study|Subject no longer meets study criteria|0|||
125117232|NCT01621490|450053429|FG002|Overall Study|Subject no longer meets study criteria|0|||
125117233|NCT01621490|450053430|FG003|Overall Study|Subject no longer meets study criteria|0|||
125117234|NCT01621490|450053431|FG004|Overall Study|Subject no longer meets study criteria|1|||
125117235|NCT01621490|450053432|FG005|Overall Study|Subject no longer meets study criteria|0|||
125117236|NCT01621490|450053433|FG006|Overall Study|Subject no longer meets study criteria|0|||
125117237|NCT01621490|450053434|FG007|Overall Study|Subject no longer meets study criteria|0|||
125117238|NCT01621490|450053435|FG008|Overall Study|Subject no longer meets study criteria|0|||
125117239|NCT01621490|450053436|FG009|Overall Study|Subject no longer meets study criteria|0|||
125117240|NCT01621490|450053437|FG010|Overall Study|Subject no longer meets study criteria|0|||
125117241|NCT01621490|450053427|FG000|Overall Study|Maximum clinical benefit|3|||
125117242|NCT01621490|450053428|FG001|Overall Study|Maximum clinical benefit|2|||
125212005|NCT01744483|450403239|FG000|Overall Study|Death|9|||
125212006|NCT01744483|450403240|FG001|Overall Study|Death|4|||
125212007|NCT01744483|450403241|FG002|Overall Study|Death|11|||
125212008|NCT01744483|450403239|FG000|Overall Study|Lost to Follow-up|8|||
125212009|NCT01744483|450403240|FG001|Overall Study|Lost to Follow-up|9|||
125212010|NCT01744483|450403241|FG002|Overall Study|Lost to Follow-up|11|||
125212011|NCT01744483|450403239|FG000|Overall Study|Protocol Violation|1|||
125212012|NCT01744483|450403240|FG001|Overall Study|Protocol Violation|2|||
125212013|NCT01744483|450403241|FG002|Overall Study|Protocol Violation|1|||
125212014|NCT01744483|450403239|FG000|Overall Study|Withdrawal by Subject|4|||
125212015|NCT01744483|450403240|FG001|Overall Study|Withdrawal by Subject|6|||
125212016|NCT01744483|450403241|FG002|Overall Study|Withdrawal by Subject|2|||
125212017|NCT01744483|450403239|FG000|Overall Study|No ICU Admit|5|||
125212018|NCT01744483|450403240|FG001|Overall Study|No ICU Admit|1|||
125117243|NCT01621490|450053429|FG002|Overall Study|Maximum clinical benefit|0|||
125117244|NCT01621490|450053430|FG003|Overall Study|Maximum clinical benefit|0|||
125117245|NCT01621490|450053431|FG004|Overall Study|Maximum clinical benefit|0|||
125117246|NCT01621490|450053432|FG005|Overall Study|Maximum clinical benefit|0|||
125117247|NCT01621490|450053433|FG006|Overall Study|Maximum clinical benefit|1|||
125117248|NCT01621490|450053434|FG007|Overall Study|Maximum clinical benefit|2|||
125117249|NCT01621490|450053435|FG008|Overall Study|Maximum clinical benefit|2|||
125117250|NCT01621490|450053436|FG009|Overall Study|Maximum clinical benefit|0|||
125117251|NCT01621490|450053437|FG010|Overall Study|Maximum clinical benefit|0|||
125117252|NCT01621490|450053427|FG000|Overall Study|Withdrawal by Subject|1|||
125117253|NCT01621490|450053428|FG001|Overall Study|Withdrawal by Subject|0|||
125212019|NCT01744483|450403241|FG002|Overall Study|No ICU Admit|2|||
125212020|NCT01744483|450403239|FG000|Overall Study|Routed to OSH|2|||
125212021|NCT01744483|450403240|FG001|Overall Study|Routed to OSH|0|||
124922148|NCT03150810|449343805|FG006|Overall Study|Participant relocated abroad.|0|||
125212022|NCT01744483|450403241|FG002|Overall Study|Routed to OSH|1|||
125212023|NCT01754766|450403242|FG000|Overall Study|Personal reasons|1|||
125212024|NCT01754766|450403243|FG001|Overall Study|Personal reasons|1|||
125023425|NCT00662792|449709510|FG002|Period 1|Refused continuing medication|1|||
125023426|NCT00662792|449709511|FG003|Period 1|Refused continuing medication|0|||
125023427|NCT00662792|449709508|FG000|Period 1|Lost to Follow-up|1|||
125023428|NCT00662792|449709509|FG001|Period 1|Lost to Follow-up|0|||
125023429|NCT00662792|449709510|FG002|Period 1|Lost to Follow-up|0|||
125023430|NCT00662792|449709511|FG003|Period 1|Lost to Follow-up|0|||
125023431|NCT00662792|449709508|FG000|Period 1|Other adverse event (AE)|0|||
125023432|NCT00662792|449709509|FG001|Period 1|Other adverse event (AE)|2|||
125023433|NCT00662792|449709510|FG002|Period 1|Other adverse event (AE)|0|||
125023434|NCT00662792|449709511|FG003|Period 1|Other adverse event (AE)|0|||
125023435|NCT00662792|449709508|FG000|Period 1|Worsening of disease under study (AE)|1|||
125023436|NCT00662792|449709509|FG001|Period 1|Worsening of disease under study (AE)|3|||
125023437|NCT00662792|449709510|FG002|Period 1|Worsening of disease under study (AE)|2|||
125023438|NCT00662792|449709511|FG003|Period 1|Worsening of disease under study (AE)|0|||
125023439|NCT00662792|449709508|FG000|Period 1|Not treated|0|||
125023440|NCT00662792|449709509|FG001|Period 1|Not treated|1|||
125023441|NCT00662792|449709510|FG002|Period 1|Not treated|0|||
125023442|NCT00662792|449709511|FG003|Period 1|Not treated|0|||
125023443|NCT00662792|449709508|FG000|Period 2|Worsening of disease under study|1|||
125023444|NCT00662792|449709509|FG001|Period 2|Worsening of disease under study|0|||
125023445|NCT00662792|449709510|FG002|Period 2|Worsening of disease under study|0|||
125023446|NCT00662792|449709511|FG003|Period 2|Worsening of disease under study|3|||
125023447|NCT00662792|449709508|FG000|Period 3|Refused continuing medication|1|||
125023448|NCT00662792|449709509|FG001|Period 3|Refused continuing medication|0|||
125023449|NCT00662792|449709510|FG002|Period 3|Refused continuing medication|1|||
125023450|NCT00662792|449709511|FG003|Period 3|Refused continuing medication|0|||
125023451|NCT00662792|449709508|FG000|Period 3|Other adverse event (AE)|0|||
125023452|NCT00662792|449709509|FG001|Period 3|Other adverse event (AE)|0|||
125023453|NCT00662792|449709510|FG002|Period 3|Other adverse event (AE)|1|||
125023454|NCT00662792|449709511|FG003|Period 3|Other adverse event (AE)|1|||
125023455|NCT00662792|449709508|FG000|Period 4|Refused continuing medication|0|||
125023456|NCT00662792|449709509|FG001|Period 4|Refused continuing medication|1|||
125023457|NCT00662792|449709510|FG002|Period 4|Refused continuing medication|0|||
125023458|NCT00662792|449709511|FG003|Period 4|Refused continuing medication|0|||
125023459|NCT00662792|449709508|FG000|Period 4|Other adverse event (AE)|1|||
125023460|NCT00662792|449709509|FG001|Period 4|Other adverse event (AE)|0|||
125023461|NCT00662792|449709510|FG002|Period 4|Other adverse event (AE)|0|||
125023462|NCT00662792|449709511|FG003|Period 4|Other adverse event (AE)|0|||
125023463|NCT00662792|449709508|FG000|Period 4|Worsening of disease under study (AE)|0|||
125023464|NCT00662792|449709509|FG001|Period 4|Worsening of disease under study (AE)|0|||
125023465|NCT00662792|449709510|FG002|Period 4|Worsening of disease under study (AE)|0|||
125023466|NCT00662792|449709511|FG003|Period 4|Worsening of disease under study (AE)|1|||
125023467|NCT00090545|449709512|FG000|Overall Study|Disease progression on study|21|||
125023468|NCT00090545|449709513|FG001|Overall Study|Disease progression on study|17|||
125023469|NCT00090545|449709512|FG000|Overall Study|Refused further treatment|1|||
125023470|NCT00090545|449709513|FG001|Overall Study|Refused further treatment|4|||
125023471|NCT00090545|449709512|FG000|Overall Study|Death|0|||
125023472|NCT00090545|449709513|FG001|Overall Study|Death|1|||
125023473|NCT00090545|449709512|FG000|Overall Study|Adverse Event|0|||
125023474|NCT00090545|449709513|FG001|Overall Study|Adverse Event|2|||
125023475|NCT02347176|449709514|FG000|Overall Study|Lost to Follow-up|2|||
125023476|NCT02347176|449709515|FG001|Overall Study|Lost to Follow-up|3|||
125023477|NCT02347176|449709516|FG002|Overall Study|Lost to Follow-up|1|||
125023478|NCT02347176|449709517|FG003|Overall Study|Lost to Follow-up|1|||
125023479|NCT02347176|449709514|FG000|Overall Study|Withdrawal by Subject|9|||
125023480|NCT02347176|449709515|FG001|Overall Study|Withdrawal by Subject|5|||
125023481|NCT02347176|449709516|FG002|Overall Study|Withdrawal by Subject|5|||
125023482|NCT02347176|449709517|FG003|Overall Study|Withdrawal by Subject|3|||
125023483|NCT02347176|449709514|FG000|Overall Study|Other|1|||
125023484|NCT02347176|449709515|FG001|Overall Study|Other|2|||
125023485|NCT02347176|449709516|FG002|Overall Study|Other|2|||
125023486|NCT02347176|449709517|FG003|Overall Study|Other|0|||
125023487|NCT03403205|449709520|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
125023488|NCT03403205|449709521|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
125023489|NCT03403205|449709522|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
125023490|NCT03403205|449709523|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
125023491|NCT03403205|449709524|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
125023492|NCT03403205|449709525|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
125023493|NCT03403205|449709520|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
125023494|NCT03403205|449709521|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
125023495|NCT03403205|449709522|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
125023496|NCT03403205|449709523|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
125023497|NCT03403205|449709524|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
125023498|NCT03403205|449709525|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
125023499|NCT03403205|449709520|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
124922149|NCT03150810|449343806|FG007|Overall Study|Participant relocated abroad.|0|||
124922150|NCT03150810|449343807|FG008|Overall Study|Participant relocated abroad.|0|||
124922151|NCT03150810|449343808|FG009|Overall Study|Participant relocated abroad.|0|||
124922152|NCT03150810|449343809|FG010|Overall Study|Participant relocated abroad.|0|||
124922153|NCT03150810|449343810|FG011|Overall Study|Participant relocated abroad.|0|||
124922154|NCT03150810|449343811|FG012|Overall Study|Participant relocated abroad.|0|||
124922155|NCT03150810|449343799|FG000|Overall Study|Transferred care to oncologist|0|||
124922156|NCT03150810|449343800|FG001|Overall Study|Transferred care to oncologist|0|||
124922157|NCT03150810|449343801|FG002|Overall Study|Transferred care to oncologist|0|||
124922158|NCT03150810|449343802|FG003|Overall Study|Transferred care to oncologist|0|||
124922159|NCT03150810|449343803|FG004|Overall Study|Transferred care to oncologist|0|||
124922160|NCT03150810|449343804|FG005|Overall Study|Transferred care to oncologist|0|||
124922161|NCT03150810|449343805|FG006|Overall Study|Transferred care to oncologist|2|||
124922162|NCT03150810|449343806|FG007|Overall Study|Transferred care to oncologist|0|||
124922163|NCT03150810|449343807|FG008|Overall Study|Transferred care to oncologist|0|||
124922164|NCT03150810|449343808|FG009|Overall Study|Transferred care to oncologist|0|||
124922165|NCT03150810|449343809|FG010|Overall Study|Transferred care to oncologist|0|||
124922166|NCT03150810|449343810|FG011|Overall Study|Transferred care to oncologist|0|||
124922167|NCT03150810|449343811|FG012|Overall Study|Transferred care to oncologist|0|||
124922168|NCT05116787|449343812|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
124922169|NCT05116787|449343813|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
124922170|NCT05116787|449343812|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
124922171|NCT05116787|449343813|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
124922172|NCT05116787|449343812|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
124922173|NCT05116787|449343813|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
124922174|NCT05116787|449343812|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
124922175|NCT05116787|449343813|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
124922176|NCT03557697|449343815|FG000|Overall Study|Withdrawal by Subject|2|||
125023500|NCT03403205|449709521|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
125023501|NCT03403205|449709522|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
125023502|NCT03403205|449709523|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
125023503|NCT03403205|449709524|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
125023504|NCT03403205|449709525|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
125023505|NCT03403205|449709520|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
125023506|NCT03403205|449709521|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
124922177|NCT03557697|449343816|FG001|Overall Study|Withdrawal by Subject|4|||
124922178|NCT03611491|449343817|FG000|Overall Study|Lost to Follow-up|1|||
124922179|NCT05478499|449343823|FG000|Overall Study|Adverse Event|4|||
124922180|NCT05478499|449343824|FG001|Overall Study|Adverse Event|2|||
124922181|NCT05478499|449343823|FG000|Overall Study|Withdrawal by Subject|3|||
124922182|NCT05478499|449343824|FG001|Overall Study|Withdrawal by Subject|2|||
124922183|NCT05478499|449343823|FG000|Overall Study|Lack of Efficacy|1|||
125023507|NCT03403205|449709522|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
125023508|NCT03403205|449709523|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
125023509|NCT03403205|449709524|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
125023510|NCT03403205|449709525|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
125023511|NCT03403205|449709520|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
125023512|NCT03403205|449709521|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
125023513|NCT03403205|449709522|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
125023514|NCT03403205|449709523|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
125023515|NCT03403205|449709524|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
125023516|NCT03403205|449709525|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
125023517|NCT03403205|449709520|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
125023518|NCT03403205|449709521|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
125023519|NCT03403205|449709522|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
125023520|NCT03403205|449709523|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
125023521|NCT03403205|449709524|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
125023522|NCT03403205|449709525|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
125023523|NCT03403205|449709520|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
125023524|NCT03403205|449709521|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
125023525|NCT03403205|449709522|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
125023526|NCT03403205|449709523|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
125023527|NCT03403205|449709524|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
125023528|NCT03403205|449709525|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
125023529|NCT03403205|449709520|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
125023530|NCT03403205|449709521|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
125023531|NCT03403205|449709522|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
125023532|NCT03403205|449709523|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
125212025|NCT01754766|450403244|FG002|Overall Study|Personal reasons|0|||
125117254|NCT01621490|450053429|FG002|Overall Study|Withdrawal by Subject|0|||
125117255|NCT01621490|450053430|FG003|Overall Study|Withdrawal by Subject|0|||
125117256|NCT01621490|450053431|FG004|Overall Study|Withdrawal by Subject|0|||
125117257|NCT01621490|450053432|FG005|Overall Study|Withdrawal by Subject|1|||
125117258|NCT01621490|450053433|FG006|Overall Study|Withdrawal by Subject|0|||
125117259|NCT01621490|450053434|FG007|Overall Study|Withdrawal by Subject|0|||
125117260|NCT01621490|450053435|FG008|Overall Study|Withdrawal by Subject|0|||
125117261|NCT01621490|450053436|FG009|Overall Study|Withdrawal by Subject|0|||
125117262|NCT01621490|450053437|FG010|Overall Study|Withdrawal by Subject|0|||
125117263|NCT01621490|450053427|FG000|Overall Study|Subject request to discontinue study|1|||
125117264|NCT01621490|450053428|FG001|Overall Study|Subject request to discontinue study|3|||
125117265|NCT01621490|450053429|FG002|Overall Study|Subject request to discontinue study|1|||
125117266|NCT01621490|450053430|FG003|Overall Study|Subject request to discontinue study|1|||
125117267|NCT01621490|450053431|FG004|Overall Study|Subject request to discontinue study|0|||
125117268|NCT01621490|450053432|FG005|Overall Study|Subject request to discontinue study|2|||
125117269|NCT01621490|450053433|FG006|Overall Study|Subject request to discontinue study|1|||
125117270|NCT01621490|450053434|FG007|Overall Study|Subject request to discontinue study|0|||
125117271|NCT01621490|450053435|FG008|Overall Study|Subject request to discontinue study|1|||
125117272|NCT01621490|450053436|FG009|Overall Study|Subject request to discontinue study|0|||
125117273|NCT01621490|450053437|FG010|Overall Study|Subject request to discontinue study|0|||
125117274|NCT01621490|450053427|FG000|Overall Study|Adverse event unrelated to study drug|1|||
125117275|NCT01621490|450053428|FG001|Overall Study|Adverse event unrelated to study drug|1|||
125117276|NCT01621490|450053429|FG002|Overall Study|Adverse event unrelated to study drug|0|||
125117277|NCT01621490|450053430|FG003|Overall Study|Adverse event unrelated to study drug|0|||
125117278|NCT01621490|450053431|FG004|Overall Study|Adverse event unrelated to study drug|0|||
125117279|NCT01621490|450053432|FG005|Overall Study|Adverse event unrelated to study drug|0|||
125117280|NCT01621490|450053433|FG006|Overall Study|Adverse event unrelated to study drug|0|||
125117281|NCT01621490|450053434|FG007|Overall Study|Adverse event unrelated to study drug|2|||
125117282|NCT01621490|450053435|FG008|Overall Study|Adverse event unrelated to study drug|0|||
125117283|NCT01621490|450053436|FG009|Overall Study|Adverse event unrelated to study drug|0|||
125117284|NCT01621490|450053437|FG010|Overall Study|Adverse event unrelated to study drug|0|||
125117285|NCT01621490|450053427|FG000|Overall Study|Disease progression|27|||
125117286|NCT01621490|450053428|FG001|Overall Study|Disease progression|28|||
125117287|NCT01621490|450053429|FG002|Overall Study|Disease progression|1|||
125117288|NCT01621490|450053430|FG003|Overall Study|Disease progression|5|||
125117289|NCT01621490|450053431|FG004|Overall Study|Disease progression|3|||
125117290|NCT01621490|450053432|FG005|Overall Study|Disease progression|8|||
125117291|NCT01621490|450053433|FG006|Overall Study|Disease progression|7|||
125117292|NCT01621490|450053434|FG007|Overall Study|Disease progression|1|||
125117293|NCT01621490|450053435|FG008|Overall Study|Disease progression|4|||
125117294|NCT01621490|450053436|FG009|Overall Study|Disease progression|1|||
125117295|NCT01621490|450053437|FG010|Overall Study|Disease progression|1|||
125117296|NCT01621490|450053427|FG000|Overall Study|Study drug toxicity|1|||
125117297|NCT01621490|450053428|FG001|Overall Study|Study drug toxicity|4|||
125117298|NCT01621490|450053429|FG002|Overall Study|Study drug toxicity|5|||
125117299|NCT01621490|450053430|FG003|Overall Study|Study drug toxicity|3|||
125117300|NCT01621490|450053431|FG004|Overall Study|Study drug toxicity|1|||
125117301|NCT01621490|450053432|FG005|Overall Study|Study drug toxicity|10|||
125117302|NCT01621490|450053433|FG006|Overall Study|Study drug toxicity|1|||
125117303|NCT01621490|450053434|FG007|Overall Study|Study drug toxicity|4|||
125117304|NCT01621490|450053435|FG008|Overall Study|Study drug toxicity|1|||
125117305|NCT01621490|450053436|FG009|Overall Study|Study drug toxicity|0|||
125117306|NCT01621490|450053437|FG010|Overall Study|Study drug toxicity|0|||
125117307|NCT01621490|450053427|FG000|Overall Study|Death|0|||
125117308|NCT01621490|450053428|FG001|Overall Study|Death|0|||
125117309|NCT01621490|450053429|FG002|Overall Study|Death|0|||
125117310|NCT01621490|450053430|FG003|Overall Study|Death|0|||
125117311|NCT01621490|450053431|FG004|Overall Study|Death|0|||
125117312|NCT01621490|450053432|FG005|Overall Study|Death|0|||
125117313|NCT01621490|450053433|FG006|Overall Study|Death|0|||
125117314|NCT01621490|450053434|FG007|Overall Study|Death|0|||
125117315|NCT01621490|450053435|FG008|Overall Study|Death|1|||
125117316|NCT01621490|450053436|FG009|Overall Study|Death|0|||
125117317|NCT01621490|450053437|FG010|Overall Study|Death|0|||
125117318|NCT01621490|450053427|FG000|Overall Study|Other reasons|7|||
125117319|NCT01621490|450053428|FG001|Overall Study|Other reasons|6|||
125117320|NCT01621490|450053429|FG002|Overall Study|Other reasons|4|||
125117321|NCT01621490|450053430|FG003|Overall Study|Other reasons|1|||
125212026|NCT01709409|450403245|FG000|Overall Study|Protocol Violation|1|||
125117322|NCT01621490|450053431|FG004|Overall Study|Other reasons|1|||
125023533|NCT03403205|449709524|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
125023534|NCT03403205|449709525|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
125023535|NCT03403205|449709520|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
125023536|NCT03403205|449709521|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
125023537|NCT03403205|449709522|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
125023538|NCT03403205|449709523|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
125023539|NCT03403205|449709524|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
125023540|NCT03403205|449709525|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
125023541|NCT03403205|449709520|FG000|Extension Period (Up to 60 Months)|Death|1|||
125023542|NCT03403205|449709521|FG001|Extension Period (Up to 60 Months)|Death|0|||
125023543|NCT03403205|449709522|FG002|Extension Period (Up to 60 Months)|Death|0|||
125023544|NCT03403205|449709523|FG003|Extension Period (Up to 60 Months)|Death|0|||
125023545|NCT03403205|449709524|FG004|Extension Period (Up to 60 Months)|Death|0|||
125023546|NCT03403205|449709525|FG005|Extension Period (Up to 60 Months)|Death|0|||
125023547|NCT03403205|449709520|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
125023548|NCT03403205|449709521|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
125023549|NCT03403205|449709522|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
125117323|NCT01621490|450053432|FG005|Overall Study|Other reasons|3|||
125117324|NCT01621490|450053433|FG006|Overall Study|Other reasons|1|||
125117325|NCT01621490|450053434|FG007|Overall Study|Other reasons|1|||
125117326|NCT01621490|450053435|FG008|Overall Study|Other reasons|1|||
125117327|NCT01621490|450053436|FG009|Overall Study|Other reasons|0|||
125117328|NCT01621490|450053437|FG010|Overall Study|Other reasons|0|||
125117329|NCT00461500|450053438|FG000|Overall Study|Adverse Event|1|||
125117330|NCT00461500|450053439|FG001|Overall Study|Adverse Event|0|||
125117331|NCT00461500|450053438|FG000|Overall Study|Lack of Efficacy|0|||
125117332|NCT00461500|450053439|FG001|Overall Study|Lack of Efficacy|1|||
125117333|NCT00461500|450053438|FG000|Overall Study|Expired Drug Treatment|1|||
125117334|NCT00461500|450053439|FG001|Overall Study|Expired Drug Treatment|1|||
125117335|NCT00461500|450053438|FG000|Overall Study|Study Stopped|1|||
125117336|NCT00461500|450053439|FG001|Overall Study|Study Stopped|2|||
125117337|NCT00461500|450053438|FG000|Overall Study|Drug Treatment Misuse|1|||
125117338|NCT00461500|450053439|FG001|Overall Study|Drug Treatment Misuse|0|||
125117339|NCT00461500|450053438|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
125117340|NCT00461500|450053439|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
125117341|NCT00461500|450053438|FG000|Overall Study|Lost to Follow-up|2|||
125117342|NCT00461500|450053439|FG001|Overall Study|Lost to Follow-up|2|||
125117343|NCT01806597|450053440|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
125117344|NCT01806597|450053441|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
125117345|NCT01806597|450053442|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
125117346|NCT01806597|450053443|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
125117347|NCT01806597|450053444|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
125117348|NCT01806597|450053445|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
125117349|NCT01806597|450053440|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
125117350|NCT01806597|450053441|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
125117351|NCT01806597|450053442|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
125117352|NCT01806597|450053443|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
125117353|NCT01806597|450053444|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
125117354|NCT01806597|450053445|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
125117355|NCT01806597|450053440|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
125117356|NCT01806597|450053441|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
125117357|NCT01806597|450053442|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
125117358|NCT01806597|450053443|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
125117359|NCT01806597|450053444|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
125117360|NCT01806597|450053445|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
125117361|NCT01806597|450053440|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
125117362|NCT01806597|450053441|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
125117363|NCT01806597|450053442|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
125117364|NCT01806597|450053443|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
125117365|NCT01806597|450053444|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
125117366|NCT01806597|450053445|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
125117367|NCT01806597|450053440|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
125117368|NCT01806597|450053441|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
125117369|NCT01806597|450053442|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
125117370|NCT01806597|450053443|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
125117371|NCT01806597|450053444|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
125117372|NCT01806597|450053445|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
125117373|NCT01806597|450053440|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
125117374|NCT01806597|450053441|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
125117375|NCT01806597|450053442|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
125117376|NCT01806597|450053443|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
125117377|NCT01806597|450053444|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
125117378|NCT01806597|450053445|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
125117379|NCT01806597|450053440|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
125117380|NCT01806597|450053441|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
125117381|NCT01806597|450053442|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
125117382|NCT01806597|450053443|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
125117383|NCT01806597|450053444|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
125117384|NCT01806597|450053445|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
125117385|NCT01806597|450053440|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
125117386|NCT01806597|450053441|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
125117387|NCT01806597|450053442|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
125117388|NCT01806597|450053443|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
125117389|NCT01806597|450053444|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
125117390|NCT01806597|450053445|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
125117391|NCT01806597|450053440|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
125117392|NCT01806597|450053441|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
124922184|NCT05478499|449343824|FG001|Overall Study|Lack of Efficacy|0|||
124922185|NCT05478499|449343823|FG000|Overall Study|Lost to Follow-up|1|||
124922186|NCT05478499|449343824|FG001|Overall Study|Lost to Follow-up|0|||
124922187|NCT05478499|449343823|FG000|Overall Study|Other reasons|0|||
124922188|NCT05478499|449343824|FG001|Overall Study|Other reasons|1|||
124922189|NCT02962895|449343825|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
125117393|NCT01806597|450053442|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
125117394|NCT01806597|450053443|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
125117395|NCT01806597|450053444|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
124922190|NCT02962895|449343826|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
124922191|NCT02962895|449343827|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
124922192|NCT02962895|449343828|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
124922193|NCT02962895|449343829|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
124922194|NCT02962895|449343830|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
124922195|NCT02962895|449343831|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
124922196|NCT02962895|449343825|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
124922197|NCT02962895|449343826|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
124922198|NCT02962895|449343827|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
124922199|NCT02962895|449343828|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
124922200|NCT02962895|449343829|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
124922201|NCT02962895|449343830|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
124922202|NCT02962895|449343831|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
124922203|NCT02962895|449343825|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
124922204|NCT02962895|449343826|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
124922205|NCT02962895|449343827|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
124922206|NCT02962895|449343828|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
125117396|NCT01806597|450053445|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
125117397|NCT01806597|450053440|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
125117398|NCT01806597|450053441|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
125117399|NCT01806597|450053442|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
125117400|NCT01806597|450053443|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
125117401|NCT01806597|450053444|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
125117402|NCT01806597|450053445|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
125117403|NCT01806597|450053440|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
125117404|NCT01806597|450053441|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
125117405|NCT01806597|450053442|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
125117406|NCT01806597|450053443|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
125117407|NCT01806597|450053444|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
125117408|NCT01806597|450053445|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
125117409|NCT01806597|450053440|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
125117410|NCT01806597|450053441|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
125117411|NCT01806597|450053442|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
125117412|NCT01806597|450053443|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
125117413|NCT01806597|450053444|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
125117414|NCT01806597|450053445|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
125117415|NCT01806597|450053440|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
125117416|NCT01806597|450053441|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
125117417|NCT01806597|450053442|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
125117418|NCT01806597|450053443|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
125117419|NCT01806597|450053444|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
125117420|NCT01806597|450053445|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
125117421|NCT01806597|450053440|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
125117422|NCT01806597|450053441|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
125117423|NCT01806597|450053442|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
125117424|NCT01806597|450053443|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
125117425|NCT01806597|450053444|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
125117426|NCT01806597|450053445|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
125117427|NCT01806597|450053440|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
125117428|NCT01806597|450053441|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
125117429|NCT01806597|450053442|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
125117430|NCT01806597|450053443|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
125117431|NCT01806597|450053444|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
125117432|NCT01806597|450053445|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
125117433|NCT01806597|450053440|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
125117434|NCT01806597|450053441|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
125117435|NCT01806597|450053442|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
125117436|NCT01806597|450053443|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
125212027|NCT01709409|450403246|FG001|Overall Study|Protocol Violation|0|||
125212028|NCT02412878|450403247|FG000|Overall Study|Withdrawal by Subject|19|||
125212029|NCT02412878|450403248|FG001|Overall Study|Withdrawal by Subject|10|||
125212030|NCT02412878|450403247|FG000|Overall Study|Lost to Follow-up|2|||
125212031|NCT02412878|450403248|FG001|Overall Study|Lost to Follow-up|3|||
125212032|NCT02190721|450403249|FG000|Overall Study|Patient was out of the city|0|||
125212033|NCT02190721|450403250|FG001|Overall Study|Patient was out of the city|1|||
125212034|NCT02190721|450403251|FG002|Overall Study|Patient was out of the city|0|||
125212035|NCT05025332|450403252|FG000|Screening|Screen failure|12|||
125212036|NCT05025332|450403252|FG000|Treatment & Follow Up|Protocol Violation|1|||
125212037|NCT05025332|450403252|FG000|Treatment & Follow Up|Adverse Event|4|||
125212038|NCT01306214|450403253|FG000|Overall Study|Death|0|||
125212039|NCT01306214|450403254|FG001|Overall Study|Death|0|||
125212040|NCT01306214|450403255|FG002|Overall Study|Death|1|||
124922207|NCT02962895|449343829|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
124922208|NCT02962895|449343830|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
124922209|NCT02962895|449343831|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
124922210|NCT02962895|449343825|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
124922211|NCT02962895|449343826|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
124922212|NCT02962895|449343827|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
124922213|NCT02962895|449343828|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
124922214|NCT02962895|449343829|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
124922215|NCT02962895|449343830|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
124922216|NCT02962895|449343831|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
124922217|NCT02962895|449343825|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
124922218|NCT02962895|449343826|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
124922219|NCT02962895|449343827|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
124922220|NCT02962895|449343828|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
124922221|NCT02962895|449343829|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
124922222|NCT02962895|449343830|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
124922223|NCT02962895|449343831|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
124922224|NCT02962895|449343825|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
124922225|NCT02962895|449343826|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
124922226|NCT02962895|449343827|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
124922227|NCT02962895|449343828|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
124922228|NCT02962895|449343829|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
124922229|NCT02962895|449343830|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
124922230|NCT02962895|449343831|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
124922231|NCT02962895|449343825|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
124922232|NCT02962895|449343826|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
124922233|NCT02962895|449343827|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
124922234|NCT02962895|449343828|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
124922235|NCT02962895|449343829|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
124922236|NCT02962895|449343830|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
124922237|NCT02962895|449343831|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
124922238|NCT02962895|449343825|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
125212041|NCT01306214|450403253|FG000|Overall Study|Lost to Follow-up|3|||
125212042|NCT01306214|450403254|FG001|Overall Study|Lost to Follow-up|5|||
125212043|NCT01306214|450403255|FG002|Overall Study|Lost to Follow-up|4|||
125212044|NCT01306214|450403253|FG000|Overall Study|Withdrawal by Subject|24|||
125212045|NCT01306214|450403254|FG001|Overall Study|Withdrawal by Subject|22|||
125212046|NCT01306214|450403255|FG002|Overall Study|Withdrawal by Subject|16|||
125212047|NCT01306214|450403253|FG000|Overall Study|Not treated|1|||
125212048|NCT01306214|450403254|FG001|Overall Study|Not treated|1|||
124922239|NCT02962895|449343826|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
124922240|NCT02962895|449343827|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
124922241|NCT02962895|449343828|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
124922242|NCT02962895|449343829|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
124922243|NCT02962895|449343830|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
124922244|NCT02962895|449343831|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
124922245|NCT02962895|449343825|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
124922246|NCT02962895|449343826|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
124922247|NCT02962895|449343827|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
124922248|NCT02962895|449343828|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
124922249|NCT02962895|449343829|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
124922250|NCT02962895|449343830|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
124922251|NCT02962895|449343831|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
124922252|NCT02962895|449343825|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
124922253|NCT02962895|449343826|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
124922254|NCT02962895|449343827|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
124922255|NCT02962895|449343828|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
124922256|NCT02962895|449343829|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
124922257|NCT02962895|449343830|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
124922258|NCT02962895|449343831|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
124922259|NCT02962895|449343825|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
124922260|NCT02962895|449343826|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
124922261|NCT02962895|449343827|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
124922262|NCT02962895|449343828|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
124922263|NCT02962895|449343829|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
124922264|NCT02962895|449343830|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
124922265|NCT02962895|449343831|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
124922266|NCT02962895|449343825|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
124922267|NCT02962895|449343826|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
124922268|NCT02962895|449343827|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
124922269|NCT02962895|449343828|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
124922270|NCT02962895|449343829|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
124922271|NCT02962895|449343830|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
124922272|NCT02962895|449343831|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
125117437|NCT01806597|450053444|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
125117438|NCT01806597|450053445|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
124922273|NCT02962895|449343825|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
124922274|NCT02962895|449343826|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
124922275|NCT02962895|449343827|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
125117439|NCT01806597|450053440|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
125117440|NCT01806597|450053441|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
125117441|NCT01806597|450053442|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
125117442|NCT01806597|450053443|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
125117443|NCT01806597|450053444|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
125117444|NCT01806597|450053445|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
125117445|NCT01806597|450053440|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
125117446|NCT01806597|450053441|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
125117447|NCT01806597|450053442|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
125117448|NCT01806597|450053443|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
125117449|NCT01806597|450053444|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
125117450|NCT01806597|450053445|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
125117451|NCT01806597|450053440|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
125117452|NCT01806597|450053441|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
125117453|NCT01806597|450053442|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
125117454|NCT01806597|450053443|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
125117455|NCT01806597|450053444|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
125117456|NCT01806597|450053445|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
125117457|NCT02247479|450053447|FG000|Overall Study|Adverse Event|8|||
125117458|NCT02247479|450053448|FG001|Overall Study|Adverse Event|9|||
125117459|NCT02247479|450053449|FG002|Overall Study|Adverse Event|8|||
125117460|NCT02247479|450053447|FG000|Overall Study|Death|5|||
125117461|NCT02247479|450053448|FG001|Overall Study|Death|4|||
125117462|NCT02247479|450053449|FG002|Overall Study|Death|6|||
125117463|NCT02247479|450053447|FG000|Overall Study|Lost to Follow-up|3|||
124922276|NCT02962895|449343828|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
124922277|NCT02962895|449343829|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
125212049|NCT01306214|450403255|FG002|Overall Study|Not treated|1|||
125212050|NCT01928199|450403258|FG000|Overall Study|Lost to Follow-up|2|||
125212051|NCT01928199|450403259|FG001|Overall Study|Lost to Follow-up|1|||
125212052|NCT01928199|450403258|FG000|Overall Study|Withdrawal by Subject|3|||
125212053|NCT01928199|450403259|FG001|Overall Study|Withdrawal by Subject|5|||
125212054|NCT03959488|450403260|FG000|Season 1|Other|6|||
125212055|NCT03959488|450403261|FG001|Season 1|Other|7|||
125212056|NCT03959488|450403262|FG002|Season 1|Other|0|||
125212057|NCT03959488|450403263|FG003|Season 1|Other|0|||
125212058|NCT03959488|450403264|FG004|Season 1|Other|0|||
125212059|NCT03959488|450403260|FG000|Season 1|Withdrawal by parent/guardian|43|||
125212060|NCT03959488|450403261|FG001|Season 1|Withdrawal by parent/guardian|28|||
125212061|NCT03959488|450403262|FG002|Season 1|Withdrawal by parent/guardian|0|||
125212062|NCT03959488|450403263|FG003|Season 1|Withdrawal by parent/guardian|0|||
125212063|NCT03959488|450403264|FG004|Season 1|Withdrawal by parent/guardian|0|||
125212064|NCT03959488|450403260|FG000|Season 1|Due to COVID-19 pandemic|2|||
125212065|NCT03959488|450403261|FG001|Season 1|Due to COVID-19 pandemic|3|||
125212066|NCT03959488|450403262|FG002|Season 1|Due to COVID-19 pandemic|0|||
125212067|NCT03959488|450403263|FG003|Season 1|Due to COVID-19 pandemic|0|||
125212068|NCT03959488|450403264|FG004|Season 1|Due to COVID-19 pandemic|0|||
125212069|NCT03959488|450403260|FG000|Season 1|Lost to Follow-up|17|||
125212070|NCT03959488|450403261|FG001|Season 1|Lost to Follow-up|7|||
125212071|NCT03959488|450403262|FG002|Season 1|Lost to Follow-up|0|||
125212072|NCT03959488|450403263|FG003|Season 1|Lost to Follow-up|0|||
125212073|NCT03959488|450403264|FG004|Season 1|Lost to Follow-up|0|||
124922278|NCT02962895|449343830|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
124922279|NCT02962895|449343831|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
124922280|NCT02962895|449343825|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
124922281|NCT02962895|449343826|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
124922282|NCT02962895|449343827|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
124922283|NCT02962895|449343828|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
124922284|NCT02962895|449343829|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
124922285|NCT02962895|449343830|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
124922286|NCT02962895|449343831|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
125023550|NCT03403205|449709523|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
125023551|NCT03403205|449709524|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
125023552|NCT03403205|449709525|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
125023553|NCT03403205|449709520|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
125023554|NCT03403205|449709521|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
125023555|NCT03403205|449709522|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
125023556|NCT03403205|449709523|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
125023557|NCT03403205|449709524|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
125023558|NCT03403205|449709525|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
125023559|NCT03403205|449709520|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
125023560|NCT03403205|449709521|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
125023561|NCT03403205|449709522|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
125023562|NCT03403205|449709523|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
125023563|NCT03403205|449709524|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
125023564|NCT03403205|449709525|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
125023565|NCT03403205|449709520|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
125023566|NCT03403205|449709521|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
125023567|NCT03403205|449709522|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
125023568|NCT03403205|449709523|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
125023569|NCT03403205|449709524|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
125023570|NCT03403205|449709525|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
125023571|NCT03403205|449709520|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
125023572|NCT03403205|449709521|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
125023573|NCT03403205|449709522|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
125023574|NCT03403205|449709523|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
125023575|NCT03403205|449709524|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
125023576|NCT03403205|449709525|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
125212074|NCT03959488|450403260|FG000|Season 1|Death|5|||
125023577|NCT03403205|449709520|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
125212075|NCT03959488|450403261|FG001|Season 1|Death|1|||
125212076|NCT03959488|450403262|FG002|Season 1|Death|0|||
125212077|NCT03959488|450403263|FG003|Season 1|Death|0|||
125212078|NCT03959488|450403264|FG004|Season 1|Death|0|||
125212079|NCT03959488|450403260|FG000|Season 2|Other|0|||
125212080|NCT03959488|450403261|FG001|Season 2|Other|0|||
125212081|NCT03959488|450403262|FG002|Season 2|Other|2|||
125212082|NCT03959488|450403263|FG003|Season 2|Other|0|||
125023578|NCT03403205|449709521|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
125023579|NCT03403205|449709522|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
125023580|NCT03403205|449709523|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
125023581|NCT03403205|449709524|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
125023582|NCT03403205|449709525|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
125023583|NCT01834729|449709526|FG000|Overall Study|Did not return bowel diaries|0|||
125023584|NCT01834729|449709527|FG001|Overall Study|Did not return bowel diaries|0|||
125023585|NCT01834729|449709528|FG002|Overall Study|Did not return bowel diaries|3|||
125023586|NCT01834729|449709529|FG003|Overall Study|Did not return bowel diaries|0|||
125023587|NCT01834729|449709526|FG000|Overall Study|Withdrawal by Subject|1|||
125023588|NCT01834729|449709527|FG001|Overall Study|Withdrawal by Subject|1|||
125023589|NCT01834729|449709528|FG002|Overall Study|Withdrawal by Subject|0|||
125023590|NCT01834729|449709529|FG003|Overall Study|Withdrawal by Subject|0|||
125023591|NCT01834729|449709526|FG000|Overall Study|Adverse Event|0|||
125023592|NCT01834729|449709527|FG001|Overall Study|Adverse Event|0|||
125023593|NCT01834729|449709528|FG002|Overall Study|Adverse Event|0|||
125023594|NCT01834729|449709529|FG003|Overall Study|Adverse Event|2|||
125023595|NCT02971670|449709530|FG000|Overall Study|Withdrawal by Subject|4|||
125023596|NCT02971670|449709531|FG001|Overall Study|Withdrawal by Subject|1|||
125023597|NCT02971670|449709532|FG002|Overall Study|Withdrawal by Subject|1|||
125023598|NCT02971670|449709533|FG003|Overall Study|Withdrawal by Subject|2|||
125023599|NCT00288080|449709534|FG000|Overall Study|Withdrawal by Subject|1|||
125023600|NCT00288080|449709535|FG001|Overall Study|Withdrawal by Subject|3|||
125023601|NCT00288080|449709534|FG000|Overall Study|Protocol Violation|25|||
125023602|NCT00288080|449709535|FG001|Overall Study|Protocol Violation|20|||
125023603|NCT01235962|449709536|FG000|Overall Study|Withdrawal by Subject|20|||
125023604|NCT01235962|449709537|FG001|Overall Study|Withdrawal by Subject|19|||
125023605|NCT01235962|449709538|FG002|Overall Study|Withdrawal by Subject|62|||
125023606|NCT01235962|449709539|FG003|Overall Study|Withdrawal by Subject|49|||
125023607|NCT01235962|449709536|FG000|Overall Study|Lost to Follow-up|21|||
125023608|NCT01235962|449709537|FG001|Overall Study|Lost to Follow-up|16|||
125023609|NCT01235962|449709538|FG002|Overall Study|Lost to Follow-up|47|||
125023610|NCT01235962|449709539|FG003|Overall Study|Lost to Follow-up|32|||
125023611|NCT01235962|449709536|FG000|Overall Study|Physician Decision|5|||
125023612|NCT01235962|449709537|FG001|Overall Study|Physician Decision|0|||
125023613|NCT01235962|449709538|FG002|Overall Study|Physician Decision|9|||
125023614|NCT01235962|449709539|FG003|Overall Study|Physician Decision|5|||
125023615|NCT00087646|449709540|FG000|Overall Study|Adverse Event|37|||
125023616|NCT00087646|449709541|FG001|Overall Study|Adverse Event|6|||
125023617|NCT00087646|449709542|FG002|Overall Study|Adverse Event|18|||
125023618|NCT00087646|449709543|FG003|Overall Study|Adverse Event|20|||
125023619|NCT00087646|449709540|FG000|Overall Study|Death|0|||
125023620|NCT00087646|449709541|FG001|Overall Study|Death|1|||
125023621|NCT00087646|449709542|FG002|Overall Study|Death|0|||
125023622|NCT00087646|449709543|FG003|Overall Study|Death|0|||
125023623|NCT00087646|449709540|FG000|Overall Study|Withdrawal by Subject|6|||
125023624|NCT00087646|449709541|FG001|Overall Study|Withdrawal by Subject|1|||
125023625|NCT00087646|449709542|FG002|Overall Study|Withdrawal by Subject|2|||
125023626|NCT00087646|449709543|FG003|Overall Study|Withdrawal by Subject|2|||
125023627|NCT00087646|449709540|FG000|Overall Study|Insufficient therapeutic response|64|||
125023628|NCT00087646|449709541|FG001|Overall Study|Insufficient therapeutic response|24|||
125023629|NCT00087646|449709542|FG002|Overall Study|Insufficient therapeutic response|38|||
125023630|NCT00087646|449709543|FG003|Overall Study|Insufficient therapeutic response|51|||
125023631|NCT00087646|449709540|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
125023632|NCT00087646|449709541|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
125023633|NCT00087646|449709542|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
125023634|NCT00087646|449709543|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
125023635|NCT00087646|449709540|FG000|Overall Study|Failure to Return|5|||
125117464|NCT02247479|450053448|FG001|Overall Study|Lost to Follow-up|3|||
125117465|NCT02247479|450053449|FG002|Overall Study|Lost to Follow-up|1|||
125117466|NCT02247479|450053447|FG000|Overall Study|Non-compliance|0|||
125117467|NCT02247479|450053448|FG001|Overall Study|Non-compliance|0|||
125023636|NCT00087646|449709541|FG001|Overall Study|Failure to Return|2|||
125117468|NCT02247479|450053449|FG002|Overall Study|Non-compliance|1|||
125117469|NCT02247479|450053447|FG000|Overall Study|Withdrawal by Subject|25|||
125023637|NCT00087646|449709542|FG002|Overall Study|Failure to Return|2|||
125023638|NCT00087646|449709543|FG003|Overall Study|Failure to Return|3|||
125023639|NCT00087646|449709540|FG000|Overall Study|Administrative/Other|6|||
125023640|NCT00087646|449709541|FG001|Overall Study|Administrative/Other|1|||
125023641|NCT00087646|449709542|FG002|Overall Study|Administrative/Other|1|||
125023642|NCT00087646|449709543|FG003|Overall Study|Administrative/Other|2|||
125023643|NCT00087646|449709540|FG000|Overall Study|Other Protocol Violation|3|||
125023644|NCT00087646|449709541|FG001|Overall Study|Other Protocol Violation|1|||
125023645|NCT00087646|449709542|FG002|Overall Study|Other Protocol Violation|0|||
125023646|NCT00087646|449709543|FG003|Overall Study|Other Protocol Violation|0|||
125117470|NCT02247479|450053448|FG001|Overall Study|Withdrawal by Subject|29|||
125023647|NCT00087646|449709540|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
125023648|NCT00087646|449709541|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
125023649|NCT00087646|449709542|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
125023650|NCT00087646|449709543|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
125023651|NCT01580397|449709546|FG000|Overall Study|Lack of Efficacy|14|||
125023652|NCT06098729|449709554|FG000|Overall Study|Withdrawal by Subject|1|||
125023653|NCT04925752|449709563|FG000|Overall Study|Still on Study|1826|||
125023654|NCT04925752|449709564|FG001|Overall Study|Still on Study|926|||
125023655|NCT04925752|449709563|FG000|Overall Study|Withdrew Consent|128|||
125023656|NCT04925752|449709564|FG001|Overall Study|Withdrew Consent|59|||
125023657|NCT04925752|449709563|FG000|Overall Study|Lost to Follow-up|73|||
125023658|NCT04925752|449709564|FG001|Overall Study|Lost to Follow-up|47|||
125023659|NCT04925752|449709563|FG000|Overall Study|Randomized but Never Treated|12|||
125023660|NCT04925752|449709564|FG001|Overall Study|Randomized but Never Treated|9|||
125023661|NCT04925752|449709563|FG000|Overall Study|Hiv-1 Infection|6|||
125023662|NCT04925752|449709564|FG001|Overall Study|Hiv-1 Infection|7|||
125023663|NCT04925752|449709563|FG000|Overall Study|Investigator's discretion|8|||
125023664|NCT04925752|449709564|FG001|Overall Study|Investigator's discretion|5|||
125023665|NCT04925752|449709563|FG000|Overall Study|Non-compliance with Study Drug|8|||
125023666|NCT04925752|449709564|FG001|Overall Study|Non-compliance with Study Drug|5|||
125023667|NCT04925752|449709563|FG000|Overall Study|Adverse Event|5|||
125023668|NCT04925752|449709564|FG001|Overall Study|Adverse Event|2|||
125023669|NCT04925752|449709563|FG000|Overall Study|Death|4|||
125023670|NCT04925752|449709564|FG001|Overall Study|Death|2|||
125023671|NCT04925752|449709563|FG000|Overall Study|Protocol Violation|1|||
125023672|NCT04925752|449709564|FG001|Overall Study|Protocol Violation|3|||
125023673|NCT04925752|449709563|FG000|Overall Study|Withdrew Assent|1|||
125023674|NCT04925752|449709564|FG001|Overall Study|Withdrew Assent|0|||
125023675|NCT03467958|449709565|FG000|Overall Study|Adverse Event|20|||
125117471|NCT02247479|450053449|FG002|Overall Study|Withdrawal by Subject|24|||
125117472|NCT02247479|450053447|FG000|Overall Study|Study Terminated by Sponsor|98|||
125117473|NCT02247479|450053448|FG001|Overall Study|Study Terminated by Sponsor|88|||
125023676|NCT03467958|449709566|FG001|Overall Study|Adverse Event|32|||
125023677|NCT03467958|449709567|FG002|Overall Study|Adverse Event|5|||
125023678|NCT03467958|449709568|FG003|Overall Study|Adverse Event|3|||
125023679|NCT03467958|449709569|FG004|Overall Study|Adverse Event|3|||
125023680|NCT03467958|449709570|FG005|Overall Study|Adverse Event|3|||
125023681|NCT03467958|449709571|FG006|Overall Study|Adverse Event|6|||
125212083|NCT03959488|450403264|FG004|Season 2|Other|0|||
125023682|NCT03467958|449709572|FG007|Overall Study|Adverse Event|5|||
124922287|NCT05894577|449343832|FG000|Overall Study|No receipt of study drug|14|||
124922288|NCT05894577|449343833|FG001|Overall Study|No receipt of study drug|13|||
124922289|NCT05894577|449343832|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
124922290|NCT05894577|449343833|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
124922291|NCT05894577|449343832|FG000|Overall Study|Screen Fail|2|||
124922292|NCT05894577|449343833|FG001|Overall Study|Screen Fail|0|||
124922293|NCT05894577|449343832|FG000|Overall Study|Study drug recall|86|||
124922294|NCT05894577|449343833|FG001|Overall Study|Study drug recall|63|||
124922295|NCT05481320|449343834|FG000|Overall Study|Withdrawal by Subject|1|||
124922296|NCT05481320|449343835|FG001|Overall Study|Withdrawal by Subject|1|||
124922297|NCT05481320|449343834|FG000|Overall Study|Care recipent passed away|0|||
124922298|NCT05481320|449343835|FG001|Overall Study|Care recipent passed away|1|||
124922299|NCT05481320|449343834|FG000|Overall Study|Out-of-window assessment|0|||
124922300|NCT05481320|449343835|FG001|Overall Study|Out-of-window assessment|1|||
124922301|NCT05481320|449343834|FG000|Overall Study|No longer a primary caregiver|3|||
124922302|NCT05481320|449343835|FG001|Overall Study|No longer a primary caregiver|0|||
124922303|NCT05481320|449343834|FG000|Overall Study|Unable to contact|1|||
124922304|NCT05481320|449343835|FG001|Overall Study|Unable to contact|0|||
124922305|NCT04509674|449343837|FG000|Overall Study|Not treated|33|||
124922306|NCT04509674|449343838|FG001|Overall Study|Not treated|26|||
124922307|NCT04509674|449343837|FG000|Overall Study|Protocol Violation|9|||
124922308|NCT04509674|449343838|FG001|Overall Study|Protocol Violation|10|||
124922309|NCT04509674|449343837|FG000|Overall Study|Lost to Follow-up|31|||
124922310|NCT04509674|449343838|FG001|Overall Study|Lost to Follow-up|39|||
124922311|NCT04509674|449343837|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
124922312|NCT04509674|449343838|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
124922313|NCT04509674|449343837|FG000|Overall Study|Adverse event, serious fatal event|11|||
124922314|NCT04509674|449343838|FG001|Overall Study|Adverse event, serious fatal event|4|||
124922315|NCT04509674|449343837|FG000|Overall Study|Adverse event, non-fatal event|107|||
124922316|NCT04509674|449343838|FG001|Overall Study|Adverse event, non-fatal event|118|||
124922317|NCT04509674|449343837|FG000|Overall Study|Other reason than listed|106|||
124922318|NCT04509674|449343838|FG001|Overall Study|Other reason than listed|95|||
124922319|NCT03476460|449343843|FG000|Overall Study|Withdrawal by Subject|3|||
124922320|NCT03476460|449343844|FG001|Overall Study|Withdrawal by Subject|2|||
124922321|NCT03476460|449343843|FG000|Overall Study|Non-compliance with treatment|3|||
124922322|NCT03476460|449343844|FG001|Overall Study|Non-compliance with treatment|0|||
124922323|NCT03476460|449343843|FG000|Overall Study|Missing laboratory tests|5|||
125117474|NCT02247479|450053449|FG002|Overall Study|Study Terminated by Sponsor|94|||
125117475|NCT02247479|450053447|FG000|Overall Study|Physician Decision|1|||
125117476|NCT02247479|450053448|FG001|Overall Study|Physician Decision|0|||
125117477|NCT02247479|450053449|FG002|Overall Study|Physician Decision|2|||
125117478|NCT02247479|450053447|FG000|Overall Study|Unspecified Reason|2|||
125117479|NCT02247479|450053448|FG001|Overall Study|Unspecified Reason|5|||
125117480|NCT02247479|450053449|FG002|Overall Study|Unspecified Reason|2|||
125117481|NCT01073020|450053450|FG000|Overall Study|Withdrawal by Subject|6|||
124922324|NCT03476460|449343844|FG001|Overall Study|Missing laboratory tests|5|||
124922325|NCT03476460|449343843|FG000|Overall Study|Adverse Event|0|||
124922326|NCT03476460|449343844|FG001|Overall Study|Adverse Event|1|||
124922327|NCT01606215|449343852|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
124922328|NCT01606215|449343853|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
124922329|NCT04592549|449343854|FG000|Overall Study|Withdrawal by Subject|0|||
124922330|NCT04592549|449343855|FG001|Overall Study|Withdrawal by Subject|1|||
124922331|NCT04592549|449343856|FG002|Overall Study|Withdrawal by Subject|0|||
124922332|NCT04592549|449343857|FG003|Overall Study|Withdrawal by Subject|1|||
124922333|NCT04592549|449343858|FG004|Overall Study|Withdrawal by Subject|1|||
124922334|NCT04592549|449343859|FG005|Overall Study|Withdrawal by Subject|0|||
124922335|NCT04592549|449343854|FG000|Overall Study|Lost to Follow-up|2|||
125117482|NCT01073020|450053451|FG001|Overall Study|Withdrawal by Subject|4|||
124922336|NCT04592549|449343855|FG001|Overall Study|Lost to Follow-up|0|||
124922337|NCT04592549|449343856|FG002|Overall Study|Lost to Follow-up|0|||
124922338|NCT04592549|449343857|FG003|Overall Study|Lost to Follow-up|1|||
124922339|NCT04592549|449343858|FG004|Overall Study|Lost to Follow-up|1|||
124922340|NCT04592549|449343859|FG005|Overall Study|Lost to Follow-up|1|||
125117483|NCT01073020|450053452|FG002|Overall Study|Withdrawal by Subject|1|||
125117484|NCT01073020|450053453|FG003|Overall Study|Withdrawal by Subject|2|||
124922341|NCT05184192|449343860|FG000|Overall Study|Lost to Follow-up|4|||
124922342|NCT05184192|449343861|FG001|Overall Study|Lost to Follow-up|7|||
124922343|NCT05184192|449343860|FG000|Overall Study|Adverse Event|1|||
124922344|NCT05184192|449343861|FG001|Overall Study|Adverse Event|4|||
124922345|NCT05184192|449343860|FG000|Overall Study|PI withdrawal|1|||
124922346|NCT05184192|449343861|FG001|Overall Study|PI withdrawal|2|||
124922347|NCT05184192|449343860|FG000|Overall Study|Withdrew due to adverse effect|1|||
124922348|NCT05184192|449343861|FG001|Overall Study|Withdrew due to adverse effect|0|||
124922349|NCT05184192|449343860|FG000|Overall Study|Medication schedule|1|||
124922350|NCT05184192|449343861|FG001|Overall Study|Medication schedule|0|||
124922351|NCT05184192|449343860|FG000|Overall Study|Concern for adverse effects|0|||
124922352|NCT05184192|449343861|FG001|Overall Study|Concern for adverse effects|4|||
124922353|NCT03640312|449343870|FG000|Overall Study|Lost to Follow-up|3|||
124922354|NCT03640312|449343871|FG001|Overall Study|Lost to Follow-up|6|||
124922355|NCT04948697|449343872|FG000|Overall Study|Progressive disease|27|||
124922356|NCT04948697|449343873|FG001|Overall Study|Progressive disease|18|||
124922357|NCT04948697|449343872|FG000|Overall Study|Adverse Event|14|||
124922358|NCT04948697|449343873|FG001|Overall Study|Adverse Event|4|||
124922359|NCT04948697|449343872|FG000|Overall Study|Participant moved to long term extension study|7|||
124922360|NCT04948697|449343873|FG001|Overall Study|Participant moved to long term extension study|4|||
124922361|NCT04948697|449343872|FG000|Overall Study|Withdrawal by Subject|10|||
124922362|NCT04948697|449343873|FG001|Overall Study|Withdrawal by Subject|0|||
124922363|NCT04948697|449343872|FG000|Overall Study|Closed by Sponsor|3|||
124922364|NCT04948697|449343873|FG001|Overall Study|Closed by Sponsor|2|||
124922365|NCT04948697|449343872|FG000|Overall Study|Physician Decision|0|||
124922366|NCT04948697|449343873|FG001|Overall Study|Physician Decision|2|||
124922367|NCT04948697|449343872|FG000|Overall Study|Lost to Follow-up|0|||
124922368|NCT04948697|449343873|FG001|Overall Study|Lost to Follow-up|1|||
124922369|NCT04948697|449343872|FG000|Overall Study|Other-Miscellaneous|1|||
124922370|NCT04948697|449343873|FG001|Overall Study|Other-Miscellaneous|0|||
124922371|NCT04948697|449343872|FG000|Overall Study|Randomized but not treated|0|||
124922372|NCT04948697|449343873|FG001|Overall Study|Randomized but not treated|1|||
124969520|NCT03520075|449517414|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969521|NCT03520075|449517415|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969522|NCT03520075|449517416|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969523|NCT03520075|449517417|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969524|NCT03520075|449517418|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969525|NCT03520075|449517419|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
124969526|NCT03520075|449517420|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969527|NCT03520075|449517421|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
124969528|NCT03520075|449517422|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969529|NCT03520075|449517423|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969530|NCT03520075|449517424|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969531|NCT03520075|449517425|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969532|NCT03520075|449517426|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969533|NCT03520075|449517427|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969534|NCT03520075|449517409|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969535|NCT03520075|449517410|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969536|NCT03520075|449517411|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969537|NCT03520075|449517412|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969538|NCT03520075|449517413|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969539|NCT03520075|449517414|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969540|NCT03520075|449517415|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969541|NCT03520075|449517416|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969542|NCT03520075|449517417|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969543|NCT03520075|449517418|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
124969544|NCT03520075|449517419|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969545|NCT03520075|449517420|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969546|NCT03520075|449517421|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
124969547|NCT03520075|449517422|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969548|NCT03520075|449517423|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969549|NCT03520075|449517424|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969550|NCT03520075|449517425|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969551|NCT03520075|449517426|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969552|NCT03520075|449517427|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969553|NCT03520075|449517409|FG000|Phase 2 (Dose Expansion)|Death|0|||
124969554|NCT03520075|449517410|FG001|Phase 2 (Dose Expansion)|Death|0|||
124969555|NCT03520075|449517411|FG002|Phase 2 (Dose Expansion)|Death|0|||
124969556|NCT03520075|449517412|FG003|Phase 2 (Dose Expansion)|Death|0|||
124922373|NCT04177823|449345355|FG000|Overall Study|Physician Decision|1|||
124922374|NCT04177823|449345355|FG000|Overall Study|Withdrawal by Subject|1|||
124922375|NCT04229992|449345356|FG000|Overall Study|Withdrawal by Subject|0|||
124922376|NCT04229992|449345357|FG001|Overall Study|Withdrawal by Subject|2|||
124922377|NCT04229992|449345358|FG002|Overall Study|Withdrawal by Subject|1|||
124922378|NCT04229992|449345359|FG003|Overall Study|Withdrawal by Subject|1|||
124922379|NCT04229992|449345356|FG000|Overall Study|Adverse Event|1|||
124922380|NCT04229992|449345357|FG001|Overall Study|Adverse Event|1|||
124922381|NCT04229992|449345358|FG002|Overall Study|Adverse Event|3|||
124922382|NCT04229992|449345359|FG003|Overall Study|Adverse Event|1|||
124922383|NCT04229992|449345356|FG000|Overall Study|Lost to Follow-up|0|||
125023683|NCT03467958|449709573|FG008|Overall Study|Adverse Event|0|||
125117485|NCT01073020|450053450|FG000|Overall Study|Physician Decision|1|||
125117486|NCT01073020|450053451|FG001|Overall Study|Physician Decision|0|||
125117487|NCT01073020|450053452|FG002|Overall Study|Physician Decision|2|||
125117488|NCT01073020|450053453|FG003|Overall Study|Physician Decision|0|||
125117489|NCT01073020|450053450|FG000|Overall Study|Death|0|||
125117490|NCT01073020|450053451|FG001|Overall Study|Death|1|||
125117491|NCT01073020|450053452|FG002|Overall Study|Death|0|||
125117492|NCT01073020|450053453|FG003|Overall Study|Death|0|||
125117493|NCT03031899|450053460|FG000|Overall Study|Protocol Violation|1|||
125117494|NCT03031899|450053460|FG000|Overall Study|lesion disappeared after stopping habit|1|||
125117495|NCT03740698|450053462|FG000|Overall Study|Physician Decision|0|||
125117496|NCT03740698|450053463|FG001|Overall Study|Physician Decision|1|||
125117497|NCT03740698|450053464|FG002|Overall Study|Physician Decision|1|||
125117498|NCT01469364|450053466|FG000|Overall Study|Adverse Event|1|||
125117499|NCT01469364|450053466|FG000|Overall Study|Withdrawal by Subject|1|||
125117500|NCT01162499|450053469|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
125117501|NCT01162499|450053470|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
125117502|NCT01590433|450053471|FG000|Overall Study|Lost to Follow-up|20|||
125117503|NCT01590433|450053472|FG001|Overall Study|Lost to Follow-up|8|||
125117504|NCT01590433|450053471|FG000|Overall Study|Withdrawal by Subject|21|||
125117505|NCT01590433|450053472|FG001|Overall Study|Withdrawal by Subject|11|||
125117506|NCT01590433|450053471|FG000|Overall Study|Adverse Event|11|||
125117507|NCT01590433|450053472|FG001|Overall Study|Adverse Event|3|||
125117508|NCT00555009|450053473|FG000|Overall Study|Withdrawal by Subject|0|||
125117509|NCT00555009|450053474|FG001|Overall Study|Withdrawal by Subject|1|||
125117510|NCT00555009|450053473|FG000|Overall Study|Terminated by Sponsor|2|||
125117511|NCT00555009|450053474|FG001|Overall Study|Terminated by Sponsor|5|||
125117512|NCT00989261|450053475|FG000|Overall Study|Still in follow up|12|||
125117513|NCT00989261|450053476|FG001|Overall Study|Still in follow up|21|||
125117514|NCT00989261|450053475|FG000|Overall Study|Withdrawal by Subject|0|||
125117515|NCT00989261|450053476|FG001|Overall Study|Withdrawal by Subject|1|||
125117516|NCT00989261|450053475|FG000|Overall Study|Lost to Follow-up|3|||
125117517|NCT00989261|450053476|FG001|Overall Study|Lost to Follow-up|0|||
125117518|NCT00718159|450053477|FG000|Overall Study|Progressive Disease|3|||
125023684|NCT03467958|449709565|FG000|Overall Study|Lack of Efficacy|59|||
125023685|NCT03467958|449709566|FG001|Overall Study|Lack of Efficacy|120|||
125023686|NCT03467958|449709567|FG002|Overall Study|Lack of Efficacy|6|||
125023687|NCT03467958|449709568|FG003|Overall Study|Lack of Efficacy|9|||
125023688|NCT03467958|449709569|FG004|Overall Study|Lack of Efficacy|8|||
125023689|NCT03467958|449709570|FG005|Overall Study|Lack of Efficacy|9|||
125023690|NCT03467958|449709571|FG006|Overall Study|Lack of Efficacy|11|||
125023691|NCT03467958|449709572|FG007|Overall Study|Lack of Efficacy|9|||
125023692|NCT03467958|449709573|FG008|Overall Study|Lack of Efficacy|3|||
125023693|NCT03467958|449709565|FG000|Overall Study|Lost to Follow-up|1|||
125023694|NCT03467958|449709566|FG001|Overall Study|Lost to Follow-up|2|||
125023695|NCT03467958|449709567|FG002|Overall Study|Lost to Follow-up|1|||
125023696|NCT03467958|449709568|FG003|Overall Study|Lost to Follow-up|0|||
125023697|NCT03467958|449709569|FG004|Overall Study|Lost to Follow-up|4|||
125023698|NCT03467958|449709570|FG005|Overall Study|Lost to Follow-up|0|||
125023699|NCT03467958|449709571|FG006|Overall Study|Lost to Follow-up|0|||
125023700|NCT03467958|449709572|FG007|Overall Study|Lost to Follow-up|0|||
125023701|NCT03467958|449709573|FG008|Overall Study|Lost to Follow-up|0|||
125117519|NCT00718159|450053478|FG001|Overall Study|Progressive Disease|3|||
125117520|NCT00718159|450053479|FG002|Overall Study|Progressive Disease|2|||
125117521|NCT00718159|450053480|FG003|Overall Study|Progressive Disease|0|||
124922384|NCT04229992|449345357|FG001|Overall Study|Lost to Follow-up|0|||
124922385|NCT04229992|449345358|FG002|Overall Study|Lost to Follow-up|0|||
125023702|NCT03467958|449709565|FG000|Overall Study|Other reasons|8|||
125023703|NCT03467958|449709566|FG001|Overall Study|Other reasons|14|||
125023704|NCT03467958|449709567|FG002|Overall Study|Other reasons|2|||
125023705|NCT03467958|449709568|FG003|Overall Study|Other reasons|1|||
125023706|NCT03467958|449709569|FG004|Overall Study|Other reasons|4|||
125023707|NCT03467958|449709570|FG005|Overall Study|Other reasons|0|||
125117522|NCT00718159|450053481|FG004|Overall Study|Progressive Disease|6|||
125117523|NCT00718159|450053482|FG005|Overall Study|Progressive Disease|0|||
125117524|NCT00718159|450053483|FG006|Overall Study|Progressive Disease|0|||
124922386|NCT04229992|449345359|FG003|Overall Study|Lost to Follow-up|1|||
125117525|NCT00718159|450053477|FG000|Overall Study|Death due to Adverse Event|0|||
125117526|NCT00718159|450053478|FG001|Overall Study|Death due to Adverse Event|0|||
125117527|NCT00718159|450053479|FG002|Overall Study|Death due to Adverse Event|0|||
125117528|NCT00718159|450053480|FG003|Overall Study|Death due to Adverse Event|2|||
125117529|NCT00718159|450053481|FG004|Overall Study|Death due to Adverse Event|2|||
125117530|NCT00718159|450053482|FG005|Overall Study|Death due to Adverse Event|0|||
125117531|NCT00718159|450053483|FG006|Overall Study|Death due to Adverse Event|0|||
125117532|NCT00718159|450053477|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
125117533|NCT00718159|450053478|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
125117534|NCT00718159|450053479|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
125117535|NCT00718159|450053480|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
125117536|NCT00718159|450053481|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
125117537|NCT00718159|450053482|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
125117538|NCT00718159|450053483|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
125117539|NCT00718159|450053477|FG000|Overall Study|Investigator Decision|0|||
125117540|NCT00718159|450053478|FG001|Overall Study|Investigator Decision|0|||
125117541|NCT00718159|450053479|FG002|Overall Study|Investigator Decision|0|||
125117542|NCT00718159|450053480|FG003|Overall Study|Investigator Decision|0|||
125117543|NCT00718159|450053481|FG004|Overall Study|Investigator Decision|0|||
125117544|NCT00718159|450053482|FG005|Overall Study|Investigator Decision|1|||
125117545|NCT00718159|450053483|FG006|Overall Study|Investigator Decision|1|||
125117546|NCT03532009|450053486|FG000|Overall Study|Other|1|||
125117547|NCT03532009|450053487|FG001|Overall Study|Other|1|||
125117548|NCT03532009|450053486|FG000|Overall Study|Death|1|||
125117549|NCT03532009|450053487|FG001|Overall Study|Death|1|||
125117550|NCT03532009|450053486|FG000|Overall Study|Withdrawal by Patient|0|||
125117551|NCT03532009|450053487|FG001|Overall Study|Withdrawal by Patient|2|||
125117552|NCT00681863|450053490|FG000|Overall Study|Adverse Event|1|||
125117553|NCT00681863|450053490|FG000|Overall Study|Lost to Follow-up|2|||
125117554|NCT00681863|450053490|FG000|Overall Study|Lack of Efficacy|2|||
125117555|NCT00681863|450053490|FG000|Overall Study|Other|18|||
124922387|NCT05178316|449345360|FG000|Overall Study|Adverse Event|5|||
125117556|NCT01333033|450053491|FG000|Overall Study|Ineligible|0|||
125117557|NCT01333033|450053492|FG001|Overall Study|Ineligible|0|||
125117558|NCT01333033|450053493|FG002|Overall Study|Ineligible|0|||
125117559|NCT01333033|450053494|FG003|Overall Study|Ineligible|0|||
125117560|NCT01333033|450053495|FG004|Overall Study|Ineligible|6|||
125117561|NCT01333033|450053496|FG005|Overall Study|Ineligible|8|||
125117562|NCT01333033|450053491|FG000|Overall Study|Withdrawal by Subject|0|||
125117563|NCT01333033|450053492|FG001|Overall Study|Withdrawal by Subject|0|||
125117564|NCT01333033|450053493|FG002|Overall Study|Withdrawal by Subject|0|||
125117565|NCT01333033|450053494|FG003|Overall Study|Withdrawal by Subject|0|||
125117566|NCT01333033|450053495|FG004|Overall Study|Withdrawal by Subject|4|||
125117567|NCT01333033|450053496|FG005|Overall Study|Withdrawal by Subject|2|||
125117568|NCT01333033|450053491|FG000|Overall Study|PET inevaluable|0|||
125117569|NCT01333033|450053492|FG001|Overall Study|PET inevaluable|0|||
125117570|NCT01333033|450053493|FG002|Overall Study|PET inevaluable|0|||
125117571|NCT01333033|450053494|FG003|Overall Study|PET inevaluable|0|||
125117572|NCT01333033|450053495|FG004|Overall Study|PET inevaluable|2|||
125117573|NCT01333033|450053496|FG005|Overall Study|PET inevaluable|4|||
125117574|NCT01333033|450053491|FG000|Overall Study|Adverse Event|0|||
125117575|NCT01333033|450053492|FG001|Overall Study|Adverse Event|0|||
125117576|NCT01333033|450053493|FG002|Overall Study|Adverse Event|0|||
125117577|NCT01333033|450053494|FG003|Overall Study|Adverse Event|0|||
125117578|NCT01333033|450053495|FG004|Overall Study|Adverse Event|2|||
124922388|NCT05178316|449345361|FG001|Overall Study|Adverse Event|4|||
124922389|NCT05178316|449345362|FG002|Overall Study|Adverse Event|9|||
124922390|NCT05178316|449345360|FG000|Overall Study|Enrolled in Error|1|||
124922391|NCT05178316|449345361|FG001|Overall Study|Enrolled in Error|2|||
124922392|NCT05178316|449345362|FG002|Overall Study|Enrolled in Error|1|||
124922393|NCT05178316|449345360|FG000|Overall Study|Lost to Follow-up|3|||
124922394|NCT05178316|449345361|FG001|Overall Study|Lost to Follow-up|15|||
124922395|NCT05178316|449345362|FG002|Overall Study|Lost to Follow-up|11|||
124922396|NCT05178316|449345360|FG000|Overall Study|Noncompliance|1|||
124922397|NCT05178316|449345361|FG001|Overall Study|Noncompliance|3|||
125117579|NCT01333033|450053496|FG005|Overall Study|Adverse Event|1|||
125117580|NCT01333033|450053491|FG000|Overall Study|Progression|0|||
125117581|NCT01333033|450053492|FG001|Overall Study|Progression|0|||
124922398|NCT05178316|449345362|FG002|Overall Study|Noncompliance|1|||
124922399|NCT05178316|449345360|FG000|Overall Study|Other|0|||
125117582|NCT01333033|450053493|FG002|Overall Study|Progression|0|||
124922400|NCT05178316|449345361|FG001|Overall Study|Other|1|||
124922401|NCT05178316|449345362|FG002|Overall Study|Other|0|||
124922402|NCT05178316|449345360|FG000|Overall Study|Physician Decision|0|||
124922403|NCT05178316|449345361|FG001|Overall Study|Physician Decision|3|||
124922404|NCT05178316|449345362|FG002|Overall Study|Physician Decision|2|||
124922405|NCT05178316|449345360|FG000|Overall Study|Protocol deviation|1|||
124922406|NCT05178316|449345361|FG001|Overall Study|Protocol deviation|0|||
124922407|NCT05178316|449345362|FG002|Overall Study|Protocol deviation|1|||
124922408|NCT05178316|449345360|FG000|Overall Study|Sponsor decision|1|||
124922409|NCT05178316|449345361|FG001|Overall Study|Sponsor decision|0|||
124922410|NCT05178316|449345362|FG002|Overall Study|Sponsor decision|1|||
125117583|NCT01333033|450053494|FG003|Overall Study|Progression|0|||
125117584|NCT01333033|450053495|FG004|Overall Study|Progression|0|||
125117585|NCT01333033|450053496|FG005|Overall Study|Progression|1|||
125117586|NCT01333033|450053491|FG000|Overall Study|MD Decision|0|||
125117587|NCT01333033|450053492|FG001|Overall Study|MD Decision|0|||
125117588|NCT01333033|450053493|FG002|Overall Study|MD Decision|0|||
125117589|NCT01333033|450053494|FG003|Overall Study|MD Decision|0|||
125117590|NCT01333033|450053495|FG004|Overall Study|MD Decision|0|||
125117591|NCT01333033|450053496|FG005|Overall Study|MD Decision|2|||
125117592|NCT03687125|450053497|FG000|Overall Study|Progressive Disease|2|||
125117593|NCT03687125|450053498|FG001|Overall Study|Progressive Disease|1|||
125117594|NCT03687125|450053497|FG000|Overall Study|Protocol Violation|1|||
125117595|NCT03687125|450053498|FG001|Overall Study|Protocol Violation|0|||
125117596|NCT01992107|450053499|FG000|Overall Study|Administrative reasons|2|||
125117597|NCT01992107|450053500|FG001|Overall Study|Administrative reasons|0|||
125117598|NCT01992107|450053501|FG002|Overall Study|Administrative reasons|0|||
125117599|NCT01992107|450053499|FG000|Overall Study|Adverse Event|0|||
125117600|NCT01992107|450053500|FG001|Overall Study|Adverse Event|1|||
125117601|NCT01992107|450053501|FG002|Overall Study|Adverse Event|0|||
125117602|NCT01992107|450053499|FG000|Overall Study|Lost to Follow-up|46|||
125117603|NCT01992107|450053500|FG001|Overall Study|Lost to Follow-up|22|||
125117604|NCT01992107|450053501|FG002|Overall Study|Lost to Follow-up|26|||
125117605|NCT01992107|450053499|FG000|Overall Study|noncompliance and were unavailable|7|||
125117606|NCT01992107|450053500|FG001|Overall Study|noncompliance and were unavailable|3|||
125117607|NCT01992107|450053501|FG002|Overall Study|noncompliance and were unavailable|2|||
125117608|NCT01992107|450053499|FG000|Overall Study|Withdrawal by Subject|13|||
125117609|NCT01992107|450053500|FG001|Overall Study|Withdrawal by Subject|7|||
125117610|NCT01992107|450053501|FG002|Overall Study|Withdrawal by Subject|8|||
125117611|NCT02035137|450053504|FG000|Overall Study|Physician Decision|0|||
125117612|NCT02035137|450053505|FG001|Overall Study|Physician Decision|0|||
125117613|NCT02035137|450053506|FG002|Overall Study|Physician Decision|1|||
125117614|NCT02035137|450053504|FG000|Overall Study|Withdrawal by Subject|0|||
125117615|NCT02035137|450053505|FG001|Overall Study|Withdrawal by Subject|1|||
125117616|NCT02035137|450053506|FG002|Overall Study|Withdrawal by Subject|2|||
125117617|NCT02035137|450053504|FG000|Overall Study|Ineligible|0|||
125117618|NCT02035137|450053505|FG001|Overall Study|Ineligible|1|||
125117619|NCT02035137|450053506|FG002|Overall Study|Ineligible|2|||
125117620|NCT02035137|450053504|FG000|Overall Study|Disease progression prior to treatment start|2|||
125117621|NCT02035137|450053505|FG001|Overall Study|Disease progression prior to treatment start|0|||
125117622|NCT02035137|450053506|FG002|Overall Study|Disease progression prior to treatment start|0|||
125117623|NCT01214603|450053522|FG000|Overall Study|Adverse Event|0|||
125117624|NCT01214603|450053523|FG001|Overall Study|Adverse Event|0|||
125117625|NCT01214603|450053524|FG002|Overall Study|Adverse Event|1|||
125117626|NCT01214603|450053522|FG000|Overall Study|Death|1|||
125117627|NCT01214603|450053523|FG001|Overall Study|Death|0|||
125117628|NCT01214603|450053524|FG002|Overall Study|Death|0|||
125117629|NCT01214603|450053522|FG000|Overall Study|Progressive Disease|4|||
125117630|NCT01214603|450053523|FG001|Overall Study|Progressive Disease|1|||
124922411|NCT05178316|449345360|FG000|Overall Study|Withdrawal by Subject|5|||
124922412|NCT05178316|449345361|FG001|Overall Study|Withdrawal by Subject|11|||
125117631|NCT01214603|450053524|FG002|Overall Study|Progressive Disease|3|||
125117632|NCT02444533|450053525|FG000|Overall Study|Not able to complete forms|0|||
125117633|NCT02444533|450053526|FG001|Overall Study|Not able to complete forms|2|||
125117634|NCT02444533|450053525|FG000|Overall Study|Only gave post-procedure complications|2|||
124922413|NCT05178316|449345362|FG002|Overall Study|Withdrawal by Subject|5|||
124922414|NCT03457142|449345365|FG000|Overall Study|Death|1|||
125117635|NCT02444533|450053526|FG001|Overall Study|Only gave post-procedure complications|2|||
125117636|NCT01388647|450053527|FG000|Overall Study|Adverse Event|1|||
125117637|NCT01388647|450053528|FG001|Overall Study|Adverse Event|2|||
125117638|NCT03567057|450053530|FG000|Overall Study|Adverse Event|56|||
125117639|NCT03567057|450053531|FG001|Overall Study|Adverse Event|53|||
125117640|NCT03567057|450053532|FG002|Overall Study|Adverse Event|28|||
124922415|NCT03770273|449345366|FG000|Overall Study|Adverse Event|2|||
125117641|NCT03567057|450053530|FG000|Overall Study|Withdrawal by Subject|22|||
125117642|NCT03567057|450053531|FG001|Overall Study|Withdrawal by Subject|24|||
125117643|NCT03567057|450053532|FG002|Overall Study|Withdrawal by Subject|13|||
125117644|NCT03567057|450053530|FG000|Overall Study|Lost to Follow-up|3|||
125117645|NCT03567057|450053531|FG001|Overall Study|Lost to Follow-up|5|||
124922416|NCT03770273|449345367|FG001|Overall Study|Adverse Event|0|||
124922417|NCT03770273|449345366|FG000|Overall Study|Lost to Follow-up|1|||
124922418|NCT03770273|449345367|FG001|Overall Study|Lost to Follow-up|1|||
124922419|NCT00418886|449345368|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
124922420|NCT00418886|449345369|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
124922421|NCT00418886|449345368|FG000|Randomized Period|Death|122|||
124922422|NCT00418886|449345369|FG001|Randomized Period|Death|147|||
124922423|NCT00418886|449345368|FG000|Randomized Period|Withdrawal by Subject|9|||
125117646|NCT03567057|450053532|FG002|Overall Study|Lost to Follow-up|2|||
125117647|NCT03567057|450053530|FG000|Overall Study|COVID-19 pandemic|4|||
125117648|NCT03567057|450053531|FG001|Overall Study|COVID-19 pandemic|3|||
125117649|NCT03567057|450053532|FG002|Overall Study|COVID-19 pandemic|0|||
125117650|NCT03567057|450053530|FG000|Overall Study|Non-compliance with study drug|4|||
125117651|NCT03567057|450053531|FG001|Overall Study|Non-compliance with study drug|2|||
125117652|NCT03567057|450053532|FG002|Overall Study|Non-compliance with study drug|0|||
125117653|NCT03567057|450053530|FG000|Overall Study|Lack of Efficacy|3|||
125117654|NCT03567057|450053531|FG001|Overall Study|Lack of Efficacy|0|||
125117655|NCT03567057|450053532|FG002|Overall Study|Lack of Efficacy|1|||
125117656|NCT03567057|450053530|FG000|Overall Study|Death|1|||
125117657|NCT03567057|450053531|FG001|Overall Study|Death|0|||
125117658|NCT03567057|450053532|FG002|Overall Study|Death|0|||
125117659|NCT03567057|450053530|FG000|Overall Study|Physician Decision|1|||
125117660|NCT03567057|450053531|FG001|Overall Study|Physician Decision|0|||
125117661|NCT03567057|450053532|FG002|Overall Study|Physician Decision|0|||
125117662|NCT03567057|450053530|FG000|Overall Study|Unstable medical condition|1|||
125117663|NCT03567057|450053531|FG001|Overall Study|Unstable medical condition|0|||
125117664|NCT03567057|450053532|FG002|Overall Study|Unstable medical condition|0|||
125117665|NCT03567057|450053530|FG000|Overall Study|Medical history event|0|||
125117666|NCT03567057|450053531|FG001|Overall Study|Medical history event|0|||
125117667|NCT03567057|450053532|FG002|Overall Study|Medical history event|1|||
125117668|NCT03567057|450053530|FG000|Overall Study|Other|0|||
125117669|NCT03567057|450053531|FG001|Overall Study|Other|0|||
125117670|NCT03567057|450053532|FG002|Overall Study|Other|1|||
125117671|NCT01006707|450053533|FG000|Study Session 1|Lost to Follow-up|2|||
125117672|NCT01006707|450053534|FG001|Study Session 1|Lost to Follow-up|0|||
125117673|NCT01006707|450053535|FG002|Study Session 1|Lost to Follow-up|0|||
125117674|NCT01006707|450053533|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
125117675|NCT01006707|450053534|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
125117676|NCT01006707|450053535|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
125117677|NCT00490061|450053536|FG000|Overall Study|Physician Decision|1|||
125117678|NCT01155583|450053537|FG000|Phase I|Screen failure - did not start treatment|0|||
125117679|NCT01155583|450053538|FG001|Phase I|Screen failure - did not start treatment|0|||
125117680|NCT01155583|450053539|FG002|Phase I|Screen failure - did not start treatment|0|||
125117681|NCT01155583|450053540|FG003|Phase I|Screen failure - did not start treatment|0|||
125117682|NCT01155583|450053541|FG004|Phase I|Screen failure - did not start treatment|1|||
125117683|NCT01155583|450053542|FG005|Phase I|Screen failure - did not start treatment|0|||
125117684|NCT01155583|450053543|FG006|Phase I|Screen failure - did not start treatment|0|||
125117685|NCT01155583|450053544|FG007|Phase I|Screen failure - did not start treatment|2|||
125117686|NCT01155583|450053545|FG008|Phase I|Screen failure - did not start treatment|0|||
125117687|NCT01155583|450053537|FG000|Phase I|Withdrawal by Subject|0|||
125117688|NCT01155583|450053538|FG001|Phase I|Withdrawal by Subject|0|||
125117689|NCT01155583|450053539|FG002|Phase I|Withdrawal by Subject|0|||
124922424|NCT00418886|449345369|FG001|Randomized Period|Withdrawal by Subject|10|||
124922425|NCT00418886|449345368|FG000|Randomized Period|Lost to Follow-up|4|||
124922426|NCT00418886|449345369|FG001|Randomized Period|Lost to Follow-up|6|||
124922427|NCT00418886|449345368|FG000|Randomized Period|withdrawn due to other reason|1|||
124922428|NCT00418886|449345369|FG001|Randomized Period|withdrawn due to other reason|0|||
124922429|NCT00418886|449345368|FG000|Randomized Period|randomised but no treatment received|0|||
124922430|NCT00418886|449345369|FG001|Randomized Period|randomised but no treatment received|1|||
124922431|NCT04060654|449345370|FG000|Overall Study|Withdrawal by Subject|1|||
124922432|NCT04060654|449345370|FG000|Overall Study|Lost to Follow-up|5|||
124922433|NCT03707951|449345371|FG000|Overall Study|Lost to Follow-up|8|||
124922434|NCT03707951|449345372|FG001|Overall Study|Lost to Follow-up|17|||
124922435|NCT03707951|449345371|FG000|Overall Study|Withdrawal by Subject|6|||
124922436|NCT03707951|449345372|FG001|Overall Study|Withdrawal by Subject|6|||
124922437|NCT04887129|449345373|FG000|Overall Study|Lost to Follow-up|0|||
124922438|NCT04887129|449345374|FG001|Overall Study|Lost to Follow-up|24|||
124922439|NCT04887129|449345373|FG000|Overall Study|Withdrawal by Subject|9|||
124922440|NCT04887129|449345374|FG001|Overall Study|Withdrawal by Subject|57|||
124922441|NCT04887129|449345373|FG000|Overall Study|Other|2|||
124922442|NCT04887129|449345374|FG001|Overall Study|Other|9|||
124922443|NCT02921230|449345381|FG000|Overall Study|Withdrawal by Subject|20|||
124922444|NCT02921230|449345382|FG001|Overall Study|Withdrawal by Subject|8|||
124922445|NCT02921230|449345381|FG000|Overall Study|Death|12|||
124922446|NCT02921230|449345382|FG001|Overall Study|Death|3|||
124922447|NCT02921230|449345381|FG000|Overall Study|Protocol Violation|17|||
124922448|NCT02921230|449345382|FG001|Overall Study|Protocol Violation|6|||
124922449|NCT02921230|449345381|FG000|Overall Study|Early completion|5|||
124922450|NCT02921230|449345382|FG001|Overall Study|Early completion|1|||
124922451|NCT02921230|449345381|FG000|Overall Study|Pending data entry|1|||
124922452|NCT02921230|449345382|FG001|Overall Study|Pending data entry|0|||
124922453|NCT03436290|449345383|FG000|Overall Study|Post-randomization Exclusion|1|||
124922454|NCT03436290|449345384|FG001|Overall Study|Post-randomization Exclusion|0|||
124922455|NCT03436290|449345383|FG000|Overall Study|Death|6|||
124922456|NCT03436290|449345384|FG001|Overall Study|Death|0|||
124922457|NCT03436290|449345383|FG000|Overall Study|Withdrawal by Subject|4|||
124922458|NCT03436290|449345384|FG001|Overall Study|Withdrawal by Subject|0|||
124922459|NCT03436290|449345383|FG000|Overall Study|Protocol Violation|30|||
124922460|NCT03436290|449345384|FG001|Overall Study|Protocol Violation|0|||
124922461|NCT01084876|449345387|FG000|Main Study Treatment Period|Adverse Event|12|||
124922462|NCT01084876|449345388|FG001|Main Study Treatment Period|Adverse Event|7|||
124922463|NCT01084876|449345387|FG000|Main Study Treatment Period|Disease Progression|41|||
124922464|NCT01084876|449345388|FG001|Main Study Treatment Period|Disease Progression|24|||
124922465|NCT01084876|449345387|FG000|Main Study Treatment Period|Physician Decision|2|||
124922466|NCT01084876|449345388|FG001|Main Study Treatment Period|Physician Decision|0|||
124922467|NCT01084876|449345387|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
124922468|NCT01084876|449345388|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
124922469|NCT01084876|449345387|FG000|Main Study Treatment Period|Other Reason|0|||
124922470|NCT01084876|449345388|FG001|Main Study Treatment Period|Other Reason|1|||
124922471|NCT01084876|449345387|FG000|Main Study Treatment Period|Other|0|||
124922472|NCT01084876|449345388|FG001|Main Study Treatment Period|Other|1|||
124922473|NCT01084876|449345387|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
124922474|NCT01084876|449345388|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
124922475|NCT01084876|449345387|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
124922476|NCT01084876|449345388|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
124922477|NCT01084876|449345387|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
124922478|NCT01084876|449345388|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
124922479|NCT01084876|449345387|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
124922480|NCT01084876|449345388|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
124922481|NCT01084876|449345387|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
124922482|NCT01084876|449345388|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
124922483|NCT01084876|449345387|FG000|Treatment Period Beyond Cycle 8|Other|6|||
124922484|NCT01084876|449345388|FG001|Treatment Period Beyond Cycle 8|Other|9|||
124922485|NCT04971395|449345389|FG000|Overall Study|Withdrawal by Subject|0|||
124922486|NCT04971395|449345390|FG001|Overall Study|Withdrawal by Subject|1|||
124922487|NCT04971395|449345391|FG002|Overall Study|Withdrawal by Subject|0|||
124922488|NCT02924272|449345392|FG000|Overall Study|Site Terminated by Sponsor|4|||
124922489|NCT02924272|449345393|FG001|Overall Study|Site Terminated by Sponsor|1|||
124922490|NCT02924272|449345392|FG000|Overall Study|Withdrawal by Subject|2|||
124922491|NCT02924272|449345393|FG001|Overall Study|Withdrawal by Subject|0|||
124922492|NCT02924272|449345392|FG000|Overall Study|Adverse Event|3|||
124922493|NCT02924272|449345393|FG001|Overall Study|Adverse Event|0|||
124922494|NCT02924272|449345392|FG000|Overall Study|Progressive Disease|11|||
124922495|NCT02924272|449345393|FG001|Overall Study|Progressive Disease|8|||
124922496|NCT02924272|449345392|FG000|Overall Study|Clinical Deterioration|1|||
124922497|NCT02924272|449345393|FG001|Overall Study|Clinical Deterioration|0|||
124922498|NCT02924272|449345392|FG000|Overall Study|Death|1|||
124922499|NCT02924272|449345393|FG001|Overall Study|Death|0|||
124922500|NCT02924272|449345392|FG000|Overall Study|Reason Not Specified|1|||
124922501|NCT02924272|449345393|FG001|Overall Study|Reason Not Specified|0|||
124922502|NCT02100813|449345396|FG000|Overall Study|Adverse Event|0|||
124922503|NCT02100813|449345397|FG001|Overall Study|Adverse Event|0|||
124922504|NCT02100813|449345398|FG002|Overall Study|Adverse Event|0|||
124922505|NCT02100813|449345399|FG003|Overall Study|Adverse Event|0|||
124922506|NCT02100813|449345400|FG004|Overall Study|Adverse Event|0|||
124922507|NCT02100813|449345401|FG005|Overall Study|Adverse Event|0|||
124922508|NCT02100813|449345402|FG006|Overall Study|Adverse Event|0|||
124922509|NCT02100813|449345403|FG007|Overall Study|Adverse Event|1|||
124922510|NCT04359108|449345405|FG000|Overall Study|Withdrawal by Subject|1|||
124922511|NCT04359108|449345406|FG001|Overall Study|Withdrawal by Subject|0|||
124922512|NCT04359108|449345405|FG000|Overall Study|Unable or too feeble to walk independently|0|||
124922513|NCT04359108|449345406|FG001|Overall Study|Unable or too feeble to walk independently|2|||
124922514|NCT04359108|449345405|FG000|Overall Study|Argus II system stopped functioning|0|||
124922515|NCT04359108|449345406|FG001|Overall Study|Argus II system stopped functioning|1|||
124922516|NCT04359108|449345405|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
124922517|NCT04359108|449345406|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
124922518|NCT06393088|449345407|FG000|Overall Study|Withdrawal by Subject|0|||
124922519|NCT06393088|449345408|FG001|Overall Study|Withdrawal by Subject|2|||
124922520|NCT02515773|449345409|FG000|Overall Study|Withdrawal by Subject|12|||
124922521|NCT02515773|449345410|FG001|Overall Study|Withdrawal by Subject|2|||
124922522|NCT02515773|449345409|FG000|Overall Study|Lost to Follow-up|119|||
124922523|NCT02515773|449345410|FG001|Overall Study|Lost to Follow-up|126|||
124922524|NCT02515773|449345409|FG000|Overall Study|Discharged from Clinic Services|53|||
124922525|NCT02515773|449345410|FG001|Overall Study|Discharged from Clinic Services|84|||
124922526|NCT02515773|449345409|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
124922527|NCT02515773|449345410|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
124922528|NCT02515773|449345409|FG000|Overall Study|Follow-up at non-study site|8|||
124922529|NCT02515773|449345410|FG001|Overall Study|Follow-up at non-study site|16|||
124922530|NCT02515773|449345409|FG000|Overall Study|Moved from area|9|||
124922531|NCT02515773|449345410|FG001|Overall Study|Moved from area|14|||
124922532|NCT04176965|449345411|FG000|Overall Study|Death|1|||
124922533|NCT04176965|449345412|FG001|Overall Study|Death|2|||
124922534|NCT04176965|449345411|FG000|Overall Study|Lost to Follow-up|10|||
124922535|NCT04176965|449345412|FG001|Overall Study|Lost to Follow-up|2|||
124922536|NCT04176965|449345411|FG000|Overall Study|Withdrawal by Subject|6|||
124922537|NCT04176965|449345412|FG001|Overall Study|Withdrawal by Subject|1|||
124922538|NCT03903146|449345413|FG000|Overall Study|Lost to Follow-up|6|||
124922539|NCT03903146|449345414|FG001|Overall Study|Lost to Follow-up|4|||
124922540|NCT03903146|449345413|FG000|Overall Study|Withdrawal by Subject|0|||
124922541|NCT03903146|449345414|FG001|Overall Study|Withdrawal by Subject|1|||
124922542|NCT02919683|449345415|FG000|Post-Surgery Follow-Up|Death|2|||
124922543|NCT02919683|449345416|FG001|Post-Surgery Follow-Up|Death|2|||
124922544|NCT02919683|449345415|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
124922545|NCT02919683|449345416|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
124922546|NCT03652688|449345417|FG000|Baseline|Withdrawal by Subject|0|||
124922547|NCT03652688|449345418|FG001|Baseline|Withdrawal by Subject|3|||
124922548|NCT03652688|449345417|FG000|Follow-up|Lost to Follow-up|56|||
124922549|NCT03652688|449345418|FG001|Follow-up|Lost to Follow-up|54|||
124922550|NCT03468218|449345419|FG000|Overall Study|Adverse Event|5|||
125023708|NCT03467958|449709571|FG006|Overall Study|Other reasons|1|||
125023709|NCT03467958|449709572|FG007|Overall Study|Other reasons|0|||
125023710|NCT03467958|449709573|FG008|Overall Study|Other reasons|1|||
125023711|NCT03467958|449709565|FG000|Overall Study|Pregnancy|1|||
125023712|NCT03467958|449709566|FG001|Overall Study|Pregnancy|0|||
125023713|NCT03467958|449709567|FG002|Overall Study|Pregnancy|0|||
125023714|NCT03467958|449709568|FG003|Overall Study|Pregnancy|0|||
125023715|NCT03467958|449709569|FG004|Overall Study|Pregnancy|0|||
125023716|NCT03467958|449709570|FG005|Overall Study|Pregnancy|1|||
125023717|NCT03467958|449709571|FG006|Overall Study|Pregnancy|0|||
125023718|NCT03467958|449709572|FG007|Overall Study|Pregnancy|0|||
125023719|NCT03467958|449709573|FG008|Overall Study|Pregnancy|0|||
124922551|NCT03468218|449345419|FG000|Overall Study|Progressive Disease|16|||
124922552|NCT03468218|449345419|FG000|Overall Study|Death|1|||
124922553|NCT03468218|449345419|FG000|Overall Study|Alternate therapy|1|||
124922554|NCT03468218|449345419|FG000|Overall Study|Withdrawal by Subject|2|||
124922555|NCT03829410|449345421|FG000|Overall Study|Adverse Event|1|||
124922556|NCT03829410|449345422|FG001|Overall Study|Adverse Event|0|||
124922557|NCT03829410|449345423|FG002|Overall Study|Adverse Event|1|||
124922558|NCT03829410|449345424|FG003|Overall Study|Adverse Event|4|||
124922559|NCT03829410|449345421|FG000|Overall Study|Physician Decision|0|||
125023720|NCT03467958|449709565|FG000|Overall Study|Study terminated by sponsor|65|||
125023721|NCT03467958|449709566|FG001|Overall Study|Study terminated by sponsor|117|||
125023722|NCT03467958|449709567|FG002|Overall Study|Study terminated by sponsor|45|||
125117690|NCT01155583|450053540|FG003|Phase I|Withdrawal by Subject|0|||
124922560|NCT03829410|449345422|FG001|Overall Study|Physician Decision|0|||
124922561|NCT03829410|449345423|FG002|Overall Study|Physician Decision|0|||
124922562|NCT03829410|449345424|FG003|Overall Study|Physician Decision|2|||
124922563|NCT03829410|449345421|FG000|Overall Study|Disease Progressing|3|||
124922564|NCT03829410|449345422|FG001|Overall Study|Disease Progressing|4|||
124922565|NCT03829410|449345423|FG002|Overall Study|Disease Progressing|2|||
124922566|NCT03829410|449345424|FG003|Overall Study|Disease Progressing|31|||
124922567|NCT03829410|449345421|FG000|Overall Study|Miscellaneous|2|||
124922568|NCT03829410|449345422|FG001|Overall Study|Miscellaneous|4|||
124922569|NCT03829410|449345423|FG002|Overall Study|Miscellaneous|3|||
124922570|NCT03829410|449345424|FG003|Overall Study|Miscellaneous|10|||
124922571|NCT03033576|449345425|FG000|Overall Study|Ineligible|1|||
124922572|NCT03033576|449345426|FG001|Overall Study|Ineligible|1|||
124922573|NCT03033576|449345425|FG000|Overall Study|Adverse Event|4|||
124922574|NCT03033576|449345426|FG001|Overall Study|Adverse Event|20|||
124922575|NCT03033576|449345425|FG000|Overall Study|Progression/relapse|9|||
124922576|NCT03033576|449345426|FG001|Overall Study|Progression/relapse|36|||
125117691|NCT01155583|450053541|FG004|Phase I|Withdrawal by Subject|0|||
125117692|NCT01155583|450053542|FG005|Phase I|Withdrawal by Subject|0|||
125117693|NCT01155583|450053543|FG006|Phase I|Withdrawal by Subject|0|||
125117694|NCT01155583|450053544|FG007|Phase I|Withdrawal by Subject|1|||
125117695|NCT01155583|450053545|FG008|Phase I|Withdrawal by Subject|0|||
125117696|NCT00952484|450053550|FG000|Overall Study|Withdrawal by Subject|0|||
125117697|NCT00952484|450053551|FG001|Overall Study|Withdrawal by Subject|1|||
125117698|NCT00952484|450053552|FG002|Overall Study|Withdrawal by Subject|0|||
125117699|NCT00886483|450053554|FG000|Overall Study|Lost to Follow-up|0|||
125117700|NCT00886483|450053555|FG001|Overall Study|Lost to Follow-up|1|||
125117701|NCT00886483|450053554|FG000|Overall Study|Pursue medications|1|||
125117702|NCT00886483|450053555|FG001|Overall Study|Pursue medications|2|||
125117703|NCT00886483|450053554|FG000|Overall Study|Distance to center, poor grades|1|||
125117704|NCT00886483|450053555|FG001|Overall Study|Distance to center, poor grades|0|||
125117705|NCT00585351|450053558|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
125117706|NCT00585351|450053559|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
124922577|NCT03033576|449345425|FG000|Overall Study|Death|1|||
124922578|NCT03033576|449345426|FG001|Overall Study|Death|1|||
124922579|NCT03033576|449345425|FG000|Overall Study|Patient refusal|1|||
124922580|NCT03033576|449345426|FG001|Overall Study|Patient refusal|6|||
124922581|NCT03033576|449345425|FG000|Overall Study|Other, unspecified reasons|0|||
124922582|NCT03033576|449345426|FG001|Overall Study|Other, unspecified reasons|4|||
124922583|NCT03033576|449345425|FG000|Overall Study|Currently on protocol therapy|0|||
124922584|NCT03033576|449345426|FG001|Overall Study|Currently on protocol therapy|2|||
124922585|NCT05179837|449345427|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
124922586|NCT05179837|449345427|FG000|Overall Study|Device malfunctioned|1|||
124922587|NCT05179837|449345427|FG000|Overall Study|Image quality too low|2|||
124922588|NCT03719443|449345428|FG000|Overall Study|Lost to Follow-up|0|||
124922589|NCT03719443|449345429|FG001|Overall Study|Lost to Follow-up|0|||
124922590|NCT03719443|449345430|FG002|Overall Study|Lost to Follow-up|1|||
124922591|NCT03719443|449345431|FG003|Overall Study|Lost to Follow-up|0|||
124922592|NCT03719443|449345432|FG004|Overall Study|Lost to Follow-up|1|||
124922593|NCT03719443|449345433|FG005|Overall Study|Lost to Follow-up|0|||
124922594|NCT03719443|449345434|FG006|Overall Study|Lost to Follow-up|1|||
124922595|NCT03719443|449345428|FG000|Overall Study|Withdrawal by Subject|0|||
124922596|NCT03719443|449345429|FG001|Overall Study|Withdrawal by Subject|0|||
124922597|NCT03719443|449345430|FG002|Overall Study|Withdrawal by Subject|1|||
124922598|NCT03719443|449345431|FG003|Overall Study|Withdrawal by Subject|0|||
124922599|NCT03719443|449345432|FG004|Overall Study|Withdrawal by Subject|0|||
124922600|NCT03719443|449345433|FG005|Overall Study|Withdrawal by Subject|0|||
124922601|NCT03719443|449345434|FG006|Overall Study|Withdrawal by Subject|0|||
124922602|NCT05051124|449345435|FG000|Overall Study|Lost to Follow-up|2|||
124922603|NCT05051124|449345435|FG000|Overall Study|Withdrawal by Subject|1|||
124922604|NCT05051124|449345435|FG000|Overall Study|Residential relocation|2|||
124922605|NCT05051124|449345435|FG000|Overall Study|Death|1|||
124922606|NCT04782973|449345436|FG000|Overall Study|Withdrawal by Subject|5|||
124922607|NCT04782973|449345436|FG000|Overall Study|Protocol Violation|6|||
125117707|NCT00585351|450053560|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
125117708|NCT00585351|450053561|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
124922608|NCT04782973|449345436|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
124922609|NCT04924660|449345437|FG000|United States|Death|29|||
124922610|NCT04924660|449345438|FG001|United States|Death|32|||
124922611|NCT04924660|449345439|FG002|United States|Death|34|||
124922612|NCT04924660|449345440|FG003|United States|Death|25|||
124922613|NCT04924660|449345441|FG004|United States|Death|26|||
124922614|NCT04924660|449345442|FG005|United States|Death|23|||
125117709|NCT00585351|450053562|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
124922615|NCT04924660|449345437|FG000|United States|Lost to Follow-up|15|||
124922616|NCT04924660|449345438|FG001|United States|Lost to Follow-up|10|||
124922617|NCT04924660|449345439|FG002|United States|Lost to Follow-up|13|||
124922618|NCT04924660|449345440|FG003|United States|Lost to Follow-up|5|||
124922619|NCT04924660|449345441|FG004|United States|Lost to Follow-up|19|||
124922620|NCT04924660|449345442|FG005|United States|Lost to Follow-up|20|||
124922621|NCT04924660|449345437|FG000|United States|Withdrawal by Subject|8|||
124922622|NCT04924660|449345438|FG001|United States|Withdrawal by Subject|3|||
124922623|NCT04924660|449345439|FG002|United States|Withdrawal by Subject|3|||
124922624|NCT04924660|449345440|FG003|United States|Withdrawal by Subject|3|||
124922625|NCT04924660|449345441|FG004|United States|Withdrawal by Subject|8|||
124922626|NCT04924660|449345442|FG005|United States|Withdrawal by Subject|4|||
124922627|NCT04924660|449345437|FG000|Spain|Death|0|||
124922628|NCT04924660|449345438|FG001|Spain|Death|0|||
124922629|NCT04924660|449345439|FG002|Spain|Death|0|||
124922630|NCT04924660|449345440|FG003|Spain|Death|0|||
124922631|NCT04924660|449345441|FG004|Spain|Death|0|||
124922632|NCT04924660|449345442|FG005|Spain|Death|2|||
124922633|NCT04924660|449345437|FG000|Spain|Lost to Follow-up|0|||
124922634|NCT04924660|449345438|FG001|Spain|Lost to Follow-up|0|||
124922635|NCT04924660|449345439|FG002|Spain|Lost to Follow-up|0|||
124922636|NCT04924660|449345440|FG003|Spain|Lost to Follow-up|0|||
124922637|NCT04924660|449345441|FG004|Spain|Lost to Follow-up|1|||
124922638|NCT04924660|449345442|FG005|Spain|Lost to Follow-up|0|||
124922639|NCT04924660|449345437|FG000|Brazil|Death|0|||
124922640|NCT04924660|449345438|FG001|Brazil|Death|0|||
124922641|NCT04924660|449345439|FG002|Brazil|Death|0|||
124922642|NCT04924660|449345440|FG003|Brazil|Death|0|||
124922643|NCT04924660|449345441|FG004|Brazil|Death|1|||
124922644|NCT04924660|449345442|FG005|Brazil|Death|0|||
124922645|NCT04924660|449345437|FG000|Italy|Lost to Follow-up|0|||
124922646|NCT04924660|449345438|FG001|Italy|Lost to Follow-up|0|||
124922647|NCT04924660|449345439|FG002|Italy|Lost to Follow-up|0|||
124922648|NCT04924660|449345440|FG003|Italy|Lost to Follow-up|0|||
124922649|NCT04924660|449345441|FG004|Italy|Lost to Follow-up|0|||
124922650|NCT04924660|449345442|FG005|Italy|Lost to Follow-up|1|||
124922651|NCT04924660|449345437|FG000|South Africa|Death|0|||
124922652|NCT04924660|449345438|FG001|South Africa|Death|0|||
124922653|NCT04924660|449345439|FG002|South Africa|Death|0|||
124922654|NCT04924660|449345440|FG003|South Africa|Death|0|||
124922655|NCT04924660|449345441|FG004|South Africa|Death|0|||
124922656|NCT04924660|449345442|FG005|South Africa|Death|1|||
124922657|NCT04924660|449345437|FG000|South Africa|Lost to Follow-up|0|||
124922658|NCT04924660|449345438|FG001|South Africa|Lost to Follow-up|0|||
124922659|NCT04924660|449345439|FG002|South Africa|Lost to Follow-up|0|||
124922660|NCT04924660|449345440|FG003|South Africa|Lost to Follow-up|0|||
124922661|NCT04924660|449345441|FG004|South Africa|Lost to Follow-up|0|||
124922662|NCT04924660|449345442|FG005|South Africa|Lost to Follow-up|1|||
124922663|NCT06205407|449345443|FG000|Period 2|Withdrawal by Subject|0|||
124922664|NCT06205407|449345444|FG001|Period 2|Withdrawal by Subject|1|||
124922665|NCT06205407|449345443|FG000|Period 2|Adverse Event|2|||
124922666|NCT06205407|449345444|FG001|Period 2|Adverse Event|1|||
124922667|NCT06491433|449345445|FG000|Overall Study|Protocol Violation|51|||
124922668|NCT06491433|449345445|FG000|Overall Study|consent withdrawal|2|||
124922669|NCT06491433|449345445|FG000|Overall Study|screen failure|1|||
124922670|NCT04749615|449345447|FG000|Overall Study|Lost to Follow-up|6|||
124922671|NCT04749615|449345448|FG001|Overall Study|Lost to Follow-up|10|||
124922681|NCT04676022|449345452|FG000|Overall Study|Screen Failure/|1|||
124922682|NCT04676022|449345453|FG001|Overall Study|Screen Failure/|1|||
124922683|NCT04676022|449345454|FG002|Overall Study|Screen Failure/|85|||
124922684|NCT04676022|449345452|FG000|Overall Study|Lost to Follow-up|1|||
125117710|NCT00585351|450053563|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
124922685|NCT04676022|449345453|FG001|Overall Study|Lost to Follow-up|1|||
124922686|NCT04676022|449345454|FG002|Overall Study|Lost to Follow-up|0|||
124922687|NCT04676022|449345452|FG000|Overall Study|Adverse Event|2|||
124922688|NCT04676022|449345453|FG001|Overall Study|Adverse Event|0|||
124922689|NCT04676022|449345454|FG002|Overall Study|Adverse Event|1|||
124922690|NCT04676022|449345452|FG000|Overall Study|Physician Decision|2|||
124922691|NCT04676022|449345453|FG001|Overall Study|Physician Decision|0|||
124922692|NCT04676022|449345454|FG002|Overall Study|Physician Decision|1|||
124922693|NCT04676022|449345452|FG000|Overall Study|Withdrawal by Subject|3|||
125117711|NCT00585351|450053564|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
125117712|NCT00585351|450053565|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
125117713|NCT00585351|450053558|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
125117714|NCT00585351|450053559|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
125117715|NCT00585351|450053560|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
125117716|NCT00585351|450053561|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
125117717|NCT00585351|450053562|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
125117718|NCT00585351|450053563|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
125117719|NCT00585351|450053564|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
125117720|NCT00585351|450053565|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
125117721|NCT00585351|450053558|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
125117722|NCT00585351|450053559|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
125117723|NCT00585351|450053560|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
125117724|NCT00585351|450053561|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
125117725|NCT00585351|450053562|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
125117726|NCT00585351|450053563|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
125117727|NCT00585351|450053564|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
125117728|NCT00585351|450053565|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
125117729|NCT00585351|450053558|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
125117730|NCT00585351|450053559|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
124922694|NCT04676022|449345453|FG001|Overall Study|Withdrawal by Subject|1|||
124922695|NCT04676022|449345454|FG002|Overall Study|Withdrawal by Subject|6|||
124922696|NCT04676022|449345452|FG000|Overall Study|Will not move forward with permanent implant|6|||
124922697|NCT04676022|449345453|FG001|Overall Study|Will not move forward with permanent implant|0|||
124922698|NCT04676022|449345454|FG002|Overall Study|Will not move forward with permanent implant|0|||
124922699|NCT04676022|449345452|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
124922700|NCT04676022|449345453|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
124922701|NCT04676022|449345454|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
124922702|NCT03194217|449345469|FG000|Overall Study|Adverse Event|0|||
124922703|NCT03194217|449345470|FG001|Overall Study|Adverse Event|2|||
124922704|NCT03194217|449345471|FG002|Overall Study|Adverse Event|3|||
124922705|NCT03194217|449345472|FG003|Overall Study|Adverse Event|3|||
124922706|NCT03194217|449345469|FG000|Overall Study|Failure to meet randomisation criteria|0|||
124922707|NCT03194217|449345470|FG001|Overall Study|Failure to meet randomisation criteria|0|||
124922708|NCT03194217|449345471|FG002|Overall Study|Failure to meet randomisation criteria|0|||
124922709|NCT03194217|449345472|FG003|Overall Study|Failure to meet randomisation criteria|1|||
124922710|NCT03194217|449345469|FG000|Overall Study|Other|0|||
124922711|NCT03194217|449345470|FG001|Overall Study|Other|1|||
124922712|NCT03194217|449345471|FG002|Overall Study|Other|1|||
125117731|NCT00585351|450053560|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
125117732|NCT00585351|450053561|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
125117733|NCT00585351|450053562|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
125117734|NCT00585351|450053563|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
125117735|NCT00585351|450053564|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
125117736|NCT00585351|450053565|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
125117737|NCT00585351|450053558|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
125117738|NCT00585351|450053559|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
125117739|NCT00585351|450053560|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
125117740|NCT00585351|450053561|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
125117741|NCT00585351|450053562|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
125117742|NCT00585351|450053563|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
125117743|NCT00585351|450053564|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
125117744|NCT00585351|450053565|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
125117745|NCT00585351|450053558|FG000|Enrollment Period (Intervention)|Death|0|||
125117746|NCT00585351|450053559|FG001|Enrollment Period (Intervention)|Death|0|||
125117747|NCT00585351|450053560|FG002|Enrollment Period (Intervention)|Death|0|||
125117748|NCT00585351|450053561|FG003|Enrollment Period (Intervention)|Death|0|||
125117749|NCT00585351|450053562|FG004|Enrollment Period (Intervention)|Death|1|||
125117750|NCT00585351|450053563|FG005|Enrollment Period (Intervention)|Death|0|||
125117751|NCT00585351|450053564|FG006|Enrollment Period (Intervention)|Death|1|||
125117752|NCT00585351|450053565|FG007|Enrollment Period (Intervention)|Death|0|||
125117753|NCT00585351|450053558|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
125117754|NCT00585351|450053559|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
125117755|NCT00585351|450053560|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
125117756|NCT00585351|450053561|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
125117757|NCT00585351|450053562|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
125117758|NCT00585351|450053563|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
125117759|NCT00585351|450053564|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
125117760|NCT00585351|450053565|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
125117761|NCT01842958|450053567|FG000|Overall Study|Lost to Follow-up|1|||
125117762|NCT01842958|450053568|FG001|Overall Study|Lost to Follow-up|1|||
125117763|NCT01829477|450053569|FG000|Overall Study|Study Terminated by Sponsor|15|||
125117764|NCT01829477|450053570|FG001|Overall Study|Study Terminated by Sponsor|15|||
125117765|NCT01829477|450053569|FG000|Overall Study|Withdrawal by Subject|1|||
125023723|NCT03467958|449709568|FG003|Overall Study|Study terminated by sponsor|64|||
125023724|NCT03467958|449709569|FG004|Overall Study|Study terminated by sponsor|66|||
125023725|NCT03467958|449709570|FG005|Overall Study|Study terminated by sponsor|17|||
125023726|NCT03467958|449709571|FG006|Overall Study|Study terminated by sponsor|11|||
125023727|NCT03467958|449709572|FG007|Overall Study|Study terminated by sponsor|5|||
125023728|NCT03467958|449709573|FG008|Overall Study|Study terminated by sponsor|5|||
125023729|NCT03467958|449709565|FG000|Overall Study|Withdrawal by Subject|25|||
125023730|NCT03467958|449709566|FG001|Overall Study|Withdrawal by Subject|44|||
125023731|NCT03467958|449709567|FG002|Overall Study|Withdrawal by Subject|7|||
125023732|NCT03467958|449709568|FG003|Overall Study|Withdrawal by Subject|8|||
125023733|NCT03467958|449709569|FG004|Overall Study|Withdrawal by Subject|6|||
125023734|NCT03467958|449709570|FG005|Overall Study|Withdrawal by Subject|8|||
125023735|NCT03467958|449709571|FG006|Overall Study|Withdrawal by Subject|4|||
125023736|NCT03467958|449709572|FG007|Overall Study|Withdrawal by Subject|1|||
125023737|NCT03467958|449709573|FG008|Overall Study|Withdrawal by Subject|4|||
125023738|NCT02925156|449709575|FG000|Overall Study|Lost to Follow-up|27|||
125023739|NCT02925156|449709576|FG001|Overall Study|Lost to Follow-up|53|||
125023740|NCT02925156|449709577|FG002|Overall Study|Lost to Follow-up|51|||
125023741|NCT02925156|449709578|FG003|Overall Study|Lost to Follow-up|59|||
125023742|NCT02925156|449709579|FG004|Overall Study|Lost to Follow-up|89|||
125023743|NCT02925156|449709580|FG005|Overall Study|Lost to Follow-up|107|||
125023744|NCT02925156|449709581|FG006|Overall Study|Lost to Follow-up|34|||
125023745|NCT02925156|449709582|FG007|Overall Study|Lost to Follow-up|36|||
125023746|NCT02925156|449709583|FG008|Overall Study|Lost to Follow-up|73|||
125023747|NCT02925156|449709584|FG009|Overall Study|Lost to Follow-up|34|||
125023748|NCT04202679|449709585|FG000|Overall Study|Adverse Event|2|||
125023749|NCT04202679|449709586|FG001|Overall Study|Adverse Event|0|||
125023750|NCT04202679|449709585|FG000|Overall Study|Poor compliance to protocol|1|||
125023751|NCT04202679|449709586|FG001|Overall Study|Poor compliance to protocol|0|||
125023752|NCT04202679|449709585|FG000|Overall Study|Withdrawal by Subject|23|||
124922713|NCT03194217|449345472|FG003|Overall Study|Other|0|||
124922714|NCT03197662|449345473|FG000|Overall Study|Withdrawn by family|0|||
125117766|NCT01829477|450053570|FG001|Overall Study|Withdrawal by Subject|0|||
125117767|NCT01336894|450053573|FG000|Follow-up|Study terminated prematurely|2|||
125117768|NCT01336894|450053574|FG001|Follow-up|Study terminated prematurely|7|||
125117769|NCT05034731|450053575|FG000|Overall Study|Screen fail|1|||
125117770|NCT05034731|450053576|FG001|Overall Study|Screen fail|1|||
125117771|NCT01325207|450053579|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
125117772|NCT01325207|450053580|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
125117773|NCT01325207|450053581|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
125117774|NCT01325207|450053582|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
125117775|NCT01325207|450053583|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
125117776|NCT01325207|450053584|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
125117777|NCT01325207|450053579|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
125117778|NCT01325207|450053580|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
125117779|NCT01325207|450053581|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
125117780|NCT01325207|450053582|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
125117781|NCT01325207|450053583|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
125117782|NCT01325207|450053584|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
125117783|NCT01325207|450053579|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
125117784|NCT01325207|450053580|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
125117785|NCT01325207|450053581|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
125117786|NCT01325207|450053582|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
125117787|NCT01325207|450053583|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
125117788|NCT01325207|450053584|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
125117789|NCT01325207|450053579|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
125117790|NCT01325207|450053580|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
125117791|NCT01325207|450053581|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
125117792|NCT01325207|450053582|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
125117793|NCT01325207|450053583|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
125117794|NCT01325207|450053584|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
125117795|NCT01325207|450053579|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
125117796|NCT01325207|450053580|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
125117797|NCT01325207|450053581|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
125117798|NCT01325207|450053582|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
125117799|NCT01325207|450053583|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
125117800|NCT01325207|450053584|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
125117801|NCT01325207|450053579|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
125117802|NCT01325207|450053580|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
125117803|NCT01325207|450053581|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
125117804|NCT01325207|450053582|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
125117805|NCT01325207|450053583|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
125117806|NCT01325207|450053584|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
125117807|NCT01325207|450053579|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
125117808|NCT01325207|450053580|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
125117809|NCT01325207|450053581|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
125117810|NCT01325207|450053582|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
125117811|NCT01325207|450053583|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
125117812|NCT01325207|450053584|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
125117813|NCT00602030|450053585|FG000|Lead-in Phase|Disease Progression|2|||
125117814|NCT00602030|450053586|FG001|Lead-in Phase|Disease Progression|3|||
125117815|NCT00602030|450053587|FG002|Lead-in Phase|Disease Progression|0|||
125117816|NCT00602030|450053588|FG003|Lead-in Phase|Disease Progression|0|||
125117817|NCT00602030|450053589|FG004|Lead-in Phase|Disease Progression|0|||
125117818|NCT00602030|450053585|FG000|Lead-in Phase|Adverse Event|0|||
125117819|NCT00602030|450053586|FG001|Lead-in Phase|Adverse Event|2|||
125117820|NCT00602030|450053587|FG002|Lead-in Phase|Adverse Event|0|||
125117821|NCT00602030|450053588|FG003|Lead-in Phase|Adverse Event|0|||
125117822|NCT00602030|450053589|FG004|Lead-in Phase|Adverse Event|0|||
124922715|NCT03197662|449345474|FG001|Overall Study|Withdrawn by family|2|||
124922716|NCT04495894|449345484|FG000|Overall Study|Withdrawal by Subject|2|||
125117823|NCT00602030|450053585|FG000|Double-blind Phase|Disease progression|0|||
125117824|NCT00602030|450053586|FG001|Double-blind Phase|Disease progression|0|||
125212084|NCT03959488|450403260|FG000|Season 2|Withdrawal by parent/guardian|0|||
125212085|NCT03959488|450403261|FG001|Season 2|Withdrawal by parent/guardian|0|||
125212086|NCT03959488|450403262|FG002|Season 2|Withdrawal by parent/guardian|3|||
125212087|NCT03959488|450403263|FG003|Season 2|Withdrawal by parent/guardian|1|||
125212088|NCT03959488|450403264|FG004|Season 2|Withdrawal by parent/guardian|1|||
125212089|NCT03959488|450403260|FG000|Season 2|Lost to Follow-up|0|||
125212090|NCT03959488|450403261|FG001|Season 2|Lost to Follow-up|0|||
125212091|NCT03959488|450403262|FG002|Season 2|Lost to Follow-up|1|||
125212092|NCT03959488|450403263|FG003|Season 2|Lost to Follow-up|0|||
125212093|NCT03959488|450403264|FG004|Season 2|Lost to Follow-up|1|||
125212094|NCT01760447|450403265|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
125212095|NCT01760447|450403266|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
125212096|NCT01760447|450403267|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
125212097|NCT01760447|450403268|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
125212098|NCT01760447|450403265|FG000|Weeks 0-20|Withdrawal by Subject|2|||
125212099|NCT01760447|450403266|FG001|Weeks 0-20|Withdrawal by Subject|0|||
125117825|NCT00602030|450053587|FG002|Double-blind Phase|Disease progression|33|||
125117826|NCT00602030|450053588|FG003|Double-blind Phase|Disease progression|30|||
125117827|NCT00602030|450053589|FG004|Double-blind Phase|Disease progression|0|||
125117828|NCT00602030|450053585|FG000|Double-blind Phase|Adverse Event|0|||
125117829|NCT00602030|450053586|FG001|Double-blind Phase|Adverse Event|0|||
125117830|NCT00602030|450053587|FG002|Double-blind Phase|Adverse Event|9|||
125117831|NCT00602030|450053588|FG003|Double-blind Phase|Adverse Event|18|||
125117832|NCT00602030|450053589|FG004|Double-blind Phase|Adverse Event|0|||
124922717|NCT04495894|449345485|FG001|Overall Study|Withdrawal by Subject|0|||
125212100|NCT01760447|450403267|FG002|Weeks 0-20|Withdrawal by Subject|1|||
125212101|NCT01760447|450403268|FG003|Weeks 0-20|Withdrawal by Subject|0|||
125212102|NCT01760447|450403265|FG000|Weeks 0-20|Lost to Follow-up|1|||
125117833|NCT00602030|450053585|FG000|Double-blind Phase|Consent withdrawal|0|||
125117834|NCT00602030|450053586|FG001|Double-blind Phase|Consent withdrawal|0|||
125117835|NCT00602030|450053587|FG002|Double-blind Phase|Consent withdrawal|4|||
125117836|NCT00602030|450053588|FG003|Double-blind Phase|Consent withdrawal|3|||
125117837|NCT00602030|450053589|FG004|Double-blind Phase|Consent withdrawal|0|||
125117838|NCT00602030|450053585|FG000|Double-blind Phase|Death|0|||
124922718|NCT04495894|449345486|FG002|Overall Study|Withdrawal by Subject|2|||
125117839|NCT00602030|450053586|FG001|Double-blind Phase|Death|0|||
125117840|NCT00602030|450053587|FG002|Double-blind Phase|Death|3|||
125117841|NCT00602030|450053588|FG003|Double-blind Phase|Death|3|||
125117842|NCT00602030|450053589|FG004|Double-blind Phase|Death|0|||
125117843|NCT00602030|450053585|FG000|Double-blind Phase|Administrative decision|0|||
125117844|NCT00602030|450053586|FG001|Double-blind Phase|Administrative decision|0|||
125117845|NCT00602030|450053587|FG002|Double-blind Phase|Administrative decision|0|||
125212103|NCT01760447|450403266|FG001|Weeks 0-20|Lost to Follow-up|0|||
124922719|NCT04495894|449345487|FG003|Overall Study|Withdrawal by Subject|3|||
124922720|NCT04495894|449345484|FG000|Overall Study|Early termination|0|||
124922721|NCT04495894|449345485|FG001|Overall Study|Early termination|0|||
124922722|NCT04495894|449345486|FG002|Overall Study|Early termination|3|||
124922723|NCT04495894|449345487|FG003|Overall Study|Early termination|0|||
124922724|NCT05579899|449345489|FG000|Overall Study|Lost to Follow-up|3|||
124922725|NCT05579899|449345490|FG001|Overall Study|Lost to Follow-up|1|||
124922726|NCT05579899|449345489|FG000|Overall Study|Adverse Event|0|||
124922727|NCT05579899|449345490|FG001|Overall Study|Adverse Event|3|||
124922728|NCT05579899|449345489|FG000|Overall Study|Pregnancy|0|||
124922729|NCT05579899|449345490|FG001|Overall Study|Pregnancy|1|||
124922730|NCT05579899|449345489|FG000|Overall Study|Withdrawal by Subject|0|||
124922731|NCT05579899|449345490|FG001|Overall Study|Withdrawal by Subject|3|||
124922732|NCT03364647|449345491|FG000|Overall Study|Withdrawal by Subject|3|||
124922733|NCT03364647|449345492|FG001|Overall Study|Withdrawal by Subject|1|||
124922734|NCT04064164|449345495|FG000|Overall Study|Withdrawal by Subject|8|||
124922735|NCT04064164|449345496|FG001|Overall Study|Withdrawal by Subject|8|||
124922736|NCT01000961|449345498|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
124922737|NCT01000961|449345499|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
124922738|NCT01000961|449345498|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
124922739|NCT01000961|449345499|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
124922740|NCT05030233|449345507|FG000|Overall Study|withdrawn for transfer|1|||
124922741|NCT05030233|449345508|FG001|Overall Study|withdrawn for transfer|0|||
124922742|NCT03365882|449345509|FG000|Randomization|Still Receiving Protocol Treatment|2|||
124922743|NCT03365882|449345510|FG001|Randomization|Still Receiving Protocol Treatment|0|||
124922744|NCT03365882|449345509|FG000|Randomization|Adverse Event|1|||
124922745|NCT03365882|449345510|FG001|Randomization|Adverse Event|2|||
124922746|NCT03365882|449345509|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
124922747|NCT03365882|449345510|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
124922748|NCT03365882|449345509|FG000|Randomization|Progression/Relapse|21|||
125212104|NCT01760447|450403267|FG002|Weeks 0-20|Lost to Follow-up|1|||
125212105|NCT01760447|450403268|FG003|Weeks 0-20|Lost to Follow-up|1|||
125212106|NCT01760447|450403265|FG000|Weeks 0-20|Randomized but not treated|0|||
124922749|NCT03365882|449345510|FG001|Randomization|Progression/Relapse|3|||
124922750|NCT03365882|449345509|FG000|Randomization|Death|1|||
124922751|NCT03365882|449345510|FG001|Randomization|Death|0|||
124922752|NCT03365882|449345509|FG000|Randomization|Other - Not Protocol Specified|1|||
124922753|NCT03365882|449345510|FG001|Randomization|Other - Not Protocol Specified|1|||
125212107|NCT01760447|450403266|FG001|Weeks 0-20|Randomized but not treated|0|||
125212108|NCT01760447|450403267|FG002|Weeks 0-20|Randomized but not treated|2|||
125117846|NCT00602030|450053588|FG003|Double-blind Phase|Administrative decision|2|||
125117847|NCT00602030|450053589|FG004|Double-blind Phase|Administrative decision|0|||
125212109|NCT01760447|450403268|FG003|Weeks 0-20|Randomized but not treated|0|||
124922754|NCT03365882|449345509|FG000|Randomization|Major Protocol Deviation|0|||
124922755|NCT03365882|449345510|FG001|Randomization|Major Protocol Deviation|1|||
124922756|NCT03365882|449345509|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
124922757|NCT03365882|449345510|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
124922758|NCT03365882|449345509|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
124922759|NCT03365882|449345510|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
124922760|NCT03365882|449345509|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
124922761|NCT03365882|449345510|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
124922762|NCT03365882|449345509|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
125117848|NCT00602030|450053585|FG000|Double-blind Phase|Ineligibility|0|||
125117849|NCT00602030|450053586|FG001|Double-blind Phase|Ineligibility|0|||
125117850|NCT00602030|450053587|FG002|Double-blind Phase|Ineligibility|0|||
125117851|NCT00602030|450053588|FG003|Double-blind Phase|Ineligibility|1|||
125117852|NCT00602030|450053589|FG004|Double-blind Phase|Ineligibility|0|||
125117853|NCT00602030|450053585|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
125117854|NCT00602030|450053586|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
125117855|NCT00602030|450053587|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
125117856|NCT00602030|450053588|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
125117857|NCT00602030|450053589|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
125117858|NCT00602030|450053585|FG000|Double-blind Phase|Reason not specified|0|||
125117859|NCT00602030|450053586|FG001|Double-blind Phase|Reason not specified|0|||
125117860|NCT00602030|450053587|FG002|Double-blind Phase|Reason not specified|4|||
125117861|NCT00602030|450053588|FG003|Double-blind Phase|Reason not specified|2|||
125117862|NCT00602030|450053589|FG004|Double-blind Phase|Reason not specified|0|||
125117863|NCT00602030|450053585|FG000|Crossover Phase|Disease Progression|0|||
125117864|NCT00602030|450053586|FG001|Crossover Phase|Disease Progression|0|||
125117865|NCT00602030|450053587|FG002|Crossover Phase|Disease Progression|0|||
125117866|NCT00602030|450053588|FG003|Crossover Phase|Disease Progression|0|||
125117867|NCT00602030|450053589|FG004|Crossover Phase|Disease Progression|11|||
125117868|NCT00602030|450053585|FG000|Crossover Phase|Adverse Event|0|||
125117869|NCT00602030|450053586|FG001|Crossover Phase|Adverse Event|0|||
125117870|NCT00602030|450053587|FG002|Crossover Phase|Adverse Event|0|||
125117871|NCT00602030|450053588|FG003|Crossover Phase|Adverse Event|0|||
125117872|NCT00602030|450053589|FG004|Crossover Phase|Adverse Event|3|||
125117873|NCT00602030|450053585|FG000|Crossover Phase|Consent withdrawal|0|||
125117874|NCT00602030|450053586|FG001|Crossover Phase|Consent withdrawal|0|||
125117875|NCT00602030|450053587|FG002|Crossover Phase|Consent withdrawal|0|||
125117876|NCT00602030|450053588|FG003|Crossover Phase|Consent withdrawal|0|||
125117877|NCT00602030|450053589|FG004|Crossover Phase|Consent withdrawal|2|||
125117878|NCT00283686|450053590|FG000|Overall Study|Death|1|||
125117879|NCT00283686|450053591|FG001|Overall Study|Death|1|||
125117880|NCT00283686|450053592|FG002|Overall Study|Death|1|||
125117881|NCT00283686|450053593|FG003|Overall Study|Death|0|||
125117882|NCT00283686|450053590|FG000|Overall Study|Lost to Follow-up|21|||
125117883|NCT00283686|450053591|FG001|Overall Study|Lost to Follow-up|31|||
125117884|NCT00283686|450053592|FG002|Overall Study|Lost to Follow-up|26|||
125117885|NCT00283686|450053593|FG003|Overall Study|Lost to Follow-up|20|||
125117886|NCT00283686|450053590|FG000|Overall Study|Less than full participation|7|||
125117887|NCT00283686|450053591|FG001|Overall Study|Less than full participation|9|||
125117888|NCT00283686|450053592|FG002|Overall Study|Less than full participation|6|||
125117889|NCT00283686|450053593|FG003|Overall Study|Less than full participation|12|||
125117890|NCT00876733|450053596|FG000|Overall Study|Adverse Event|34|||
125117891|NCT00876733|450053597|FG001|Overall Study|Adverse Event|20|||
125117892|NCT00876733|450053598|FG002|Overall Study|Adverse Event|10|||
125117893|NCT00876733|450053599|FG003|Overall Study|Adverse Event|3|||
125117894|NCT00876733|450053596|FG000|Overall Study|Lack of Efficacy|17|||
125117895|NCT00876733|450053597|FG001|Overall Study|Lack of Efficacy|9|||
125117896|NCT00876733|450053598|FG002|Overall Study|Lack of Efficacy|10|||
125117897|NCT00876733|450053599|FG003|Overall Study|Lack of Efficacy|1|||
125117898|NCT00876733|450053596|FG000|Overall Study|Lost to Follow-up|26|||
125117899|NCT00876733|450053597|FG001|Overall Study|Lost to Follow-up|10|||
125117900|NCT00876733|450053598|FG002|Overall Study|Lost to Follow-up|3|||
125117901|NCT00876733|450053599|FG003|Overall Study|Lost to Follow-up|2|||
125117902|NCT00876733|450053596|FG000|Overall Study|Data not available|14|||
125117903|NCT00876733|450053597|FG001|Overall Study|Data not available|3|||
125117904|NCT00876733|450053598|FG002|Overall Study|Data not available|7|||
124922763|NCT03365882|449345510|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
125117905|NCT00876733|450053599|FG003|Overall Study|Data not available|1|||
125117906|NCT05476679|450053600|FG000|Overall Study|Withdrawal by Subject|0|||
125117907|NCT05476679|450053601|FG001|Overall Study|Withdrawal by Subject|0|||
125117908|NCT05476679|450053602|FG002|Overall Study|Withdrawal by Subject|0|||
125117909|NCT05476679|450053603|FG003|Overall Study|Withdrawal by Subject|1|||
125117910|NCT05476679|450053604|FG004|Overall Study|Withdrawal by Subject|0|||
125117911|NCT05476679|450053600|FG000|Overall Study|Lost to Follow-up|0|||
125117912|NCT05476679|450053601|FG001|Overall Study|Lost to Follow-up|0|||
124922764|NCT05177848|449348179|FG000|Overall Study|Lost to Follow-up|1|||
125117913|NCT05476679|450053602|FG002|Overall Study|Lost to Follow-up|0|||
125117914|NCT05476679|450053603|FG003|Overall Study|Lost to Follow-up|1|||
125117915|NCT05476679|450053604|FG004|Overall Study|Lost to Follow-up|0|||
125117916|NCT00467584|450053609|FG000|Overall Study|Withdrawal by Subject|4|||
124922765|NCT05177848|449348180|FG001|Overall Study|Lost to Follow-up|4|||
124922766|NCT05177848|449348179|FG000|Overall Study|Discontinued|2|||
124922767|NCT05177848|449348180|FG001|Overall Study|Discontinued|1|||
124922768|NCT03771417|449348181|FG000|Overall Study|Withdrawal by Subject|1|||
124922769|NCT03771417|449348182|FG001|Overall Study|Withdrawal by Subject|0|||
124922770|NCT03771417|449348183|FG002|Overall Study|Withdrawal by Subject|0|||
124922771|NCT03771417|449348181|FG000|Overall Study|Covid-19 Shutdown|0|||
124922772|NCT03771417|449348182|FG001|Overall Study|Covid-19 Shutdown|1|||
125023753|NCT04202679|449709586|FG001|Overall Study|Withdrawal by Subject|6|||
125023754|NCT03406897|449709589|FG000|Overall Study|Lost to Follow-up|1|||
125023755|NCT03406897|449709590|FG001|Overall Study|Lost to Follow-up|2|||
125023756|NCT03406897|449709589|FG000|Overall Study|Withdrawal by Subject|4|||
125023757|NCT03406897|449709590|FG001|Overall Study|Withdrawal by Subject|4|||
125023758|NCT03406897|449709589|FG000|Overall Study|Physician Decision|0|||
125023759|NCT03406897|449709590|FG001|Overall Study|Physician Decision|1|||
125023760|NCT00598975|449711309|FG000|Overall Study|Adverse Event|1|||
125023761|NCT00598975|449711310|FG001|Overall Study|Adverse Event|1|||
125023762|NCT00598975|449711309|FG000|Overall Study|Brain metastases|1|||
125023763|NCT00598975|449711310|FG001|Overall Study|Brain metastases|0|||
125023764|NCT00598975|449711309|FG000|Overall Study|Withdrawal by Subject|1|||
125023765|NCT00598975|449711310|FG001|Overall Study|Withdrawal by Subject|1|||
125023766|NCT00598975|449711309|FG000|Overall Study|Withdrawal of consent|0|||
125023767|NCT00598975|449711310|FG001|Overall Study|Withdrawal of consent|1|||
125023768|NCT00598975|449711309|FG000|Overall Study|Disease progression|8|||
125023769|NCT00598975|449711310|FG001|Overall Study|Disease progression|3|||
125023770|NCT00598975|449711309|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
125023771|NCT00598975|449711310|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
125023772|NCT02723201|449711315|FG000|Second Intervention Period|Protocol Violation|1|||
125023773|NCT02723201|449711316|FG001|Second Intervention Period|Protocol Violation|0|||
125023774|NCT02723201|449711317|FG002|Second Intervention Period|Protocol Violation|0|||
125023775|NCT02723201|449711315|FG000|Second Intervention Period|Adverse Event|1|||
125023776|NCT02723201|449711316|FG001|Second Intervention Period|Adverse Event|0|||
125023777|NCT02723201|449711317|FG002|Second Intervention Period|Adverse Event|0|||
125023778|NCT03472560|449711318|FG000|Overall Study|Subject transfer to continuation protocol|0|||
125023779|NCT03472560|449711319|FG001|Overall Study|Subject transfer to continuation protocol|1|||
125023780|NCT03472560|449711318|FG000|Overall Study|Withdrawal by Subject|4|||
125023781|NCT03472560|449711319|FG001|Overall Study|Withdrawal by Subject|0|||
125023782|NCT03472560|449711318|FG000|Overall Study|Progressive disease|24|||
125023783|NCT03472560|449711319|FG001|Overall Study|Progressive disease|8|||
125023784|NCT03472560|449711318|FG000|Overall Study|Physician Decision|1|||
125023785|NCT03472560|449711319|FG001|Overall Study|Physician Decision|0|||
124922773|NCT03771417|449348183|FG002|Overall Study|Covid-19 Shutdown|0|||
125117917|NCT00467584|450053610|FG001|Overall Study|Withdrawal by Subject|5|||
124922774|NCT04342494|449348185|FG000|Overall Study|Questionnaire partially completed|1|||
124922775|NCT04342494|449348186|FG001|Overall Study|Questionnaire partially completed|0|||
124922776|NCT04342494|449348187|FG002|Overall Study|Questionnaire partially completed|2|||
124922777|NCT04342494|449348188|FG003|Overall Study|Questionnaire partially completed|0|||
124922778|NCT04342494|449348189|FG004|Overall Study|Questionnaire partially completed|1|||
124922779|NCT04342494|449348185|FG000|Overall Study|Lost to Follow-up|49|||
124922780|NCT04342494|449348186|FG001|Overall Study|Lost to Follow-up|38|||
124922781|NCT04342494|449348187|FG002|Overall Study|Lost to Follow-up|34|||
124922782|NCT04342494|449348188|FG003|Overall Study|Lost to Follow-up|34|||
124922783|NCT04342494|449348189|FG004|Overall Study|Lost to Follow-up|35|||
124922784|NCT01214616|449348192|FG000|Overall Study|Progressive disease|2|||
124922785|NCT01214616|449348193|FG001|Overall Study|Progressive disease|2|||
124922786|NCT01214616|449348194|FG002|Overall Study|Progressive disease|2|||
124922787|NCT01214616|449348195|FG003|Overall Study|Progressive disease|4|||
124922788|NCT01214616|449348192|FG000|Overall Study|Dose limiting toxicity|0|||
124922789|NCT01214616|449348193|FG001|Overall Study|Dose limiting toxicity|2|||
124922790|NCT01214616|449348194|FG002|Overall Study|Dose limiting toxicity|0|||
124922791|NCT01214616|449348195|FG003|Overall Study|Dose limiting toxicity|0|||
124922792|NCT01214616|449348192|FG000|Overall Study|Other adverse events|0|||
124922793|NCT01214616|449348193|FG001|Overall Study|Other adverse events|1|||
124922794|NCT01214616|449348194|FG002|Overall Study|Other adverse events|1|||
124922795|NCT01214616|449348195|FG003|Overall Study|Other adverse events|1|||
124922796|NCT01214616|449348192|FG000|Overall Study|Withdrawal by Subject|1|||
124922797|NCT01214616|449348193|FG001|Overall Study|Withdrawal by Subject|0|||
124922798|NCT01214616|449348194|FG002|Overall Study|Withdrawal by Subject|0|||
124922799|NCT01214616|449348195|FG003|Overall Study|Withdrawal by Subject|1|||
124922800|NCT03721952|449348196|FG000|Overall Study|Lost to Follow-up|0|||
124922801|NCT03721952|449348197|FG001|Overall Study|Lost to Follow-up|0|||
124922802|NCT03721952|449348198|FG002|Overall Study|Lost to Follow-up|2|||
124922803|NCT03721952|449348199|FG003|Overall Study|Lost to Follow-up|0|||
124922804|NCT03721952|449348200|FG004|Overall Study|Lost to Follow-up|0|||
124922805|NCT03721952|449348196|FG000|Overall Study|Protocol Violation|0|||
124922806|NCT03721952|449348197|FG001|Overall Study|Protocol Violation|1|||
124922807|NCT03721952|449348198|FG002|Overall Study|Protocol Violation|0|||
124922808|NCT03721952|449348199|FG003|Overall Study|Protocol Violation|0|||
124922809|NCT03721952|449348200|FG004|Overall Study|Protocol Violation|0|||
124922810|NCT03721952|449348196|FG000|Overall Study|Withdrawal by Subject|1|||
124922811|NCT03721952|449348197|FG001|Overall Study|Withdrawal by Subject|0|||
124922812|NCT03721952|449348198|FG002|Overall Study|Withdrawal by Subject|40|||
124922813|NCT03721952|449348199|FG003|Overall Study|Withdrawal by Subject|28|||
124922814|NCT03721952|449348200|FG004|Overall Study|Withdrawal by Subject|0|||
124922815|NCT05292365|449348201|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
124922816|NCT05292365|449348202|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
124922817|NCT05292365|449348203|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
124922818|NCT05292365|449348204|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
124922819|NCT04633122|449348205|FG000|Overall Study|Remained on treatment|19|||
124922820|NCT04633122|449348206|FG001|Overall Study|Remained on treatment|14|||
124922821|NCT04633122|449348205|FG000|Overall Study|Survival follow-up stopped|22|||
124922822|NCT04633122|449348206|FG001|Overall Study|Survival follow-up stopped|25|||
124922823|NCT04185298|449348207|FG000|Overall Study|Lost to Follow-up|1|||
125117918|NCT00467584|450053611|FG002|Overall Study|Withdrawal by Subject|1|||
124922824|NCT04185298|449348208|FG001|Overall Study|Lost to Follow-up|3|||
124922825|NCT04185298|449348207|FG000|Overall Study|Withdrawal by Subject|0|||
124922826|NCT04185298|449348208|FG001|Overall Study|Withdrawal by Subject|3|||
124922827|NCT01798498|449348209|FG000|Overall Study|Lost to Follow-up|1|||
124922828|NCT03896789|449348210|FG000|Baseline|Lost to Follow-up|1|||
124922829|NCT03896789|449348211|FG001|Baseline|Lost to Follow-up|2|||
124922830|NCT03896789|449348210|FG000|Baseline|Death|3|||
124922831|NCT03896789|449348211|FG001|Baseline|Death|6|||
124922832|NCT03896789|449348210|FG000|Post-Randomization|Lost to Follow-up|12|||
124922833|NCT03896789|449348211|FG001|Post-Randomization|Lost to Follow-up|11|||
124922834|NCT03896789|449348210|FG000|Post-Randomization|Death|12|||
124922835|NCT03896789|449348211|FG001|Post-Randomization|Death|13|||
124922836|NCT00227344|449348217|FG000|Overall Study|study terminated early|12|||
125117919|NCT00319956|450053612|FG000|Overall Study|Death|20|||
125117920|NCT00319956|450053613|FG001|Overall Study|Death|24|||
124922837|NCT00227344|449348218|FG001|Overall Study|study terminated early|5|||
124922838|NCT01987895|449348219|FG000|Overall Study|Withdrawal by Subject|12|||
124922839|NCT01987895|449348220|FG001|Overall Study|Withdrawal by Subject|7|||
124922840|NCT01987895|449348219|FG000|Overall Study|Physician Decision|8|||
124922841|NCT01987895|449348220|FG001|Overall Study|Physician Decision|10|||
124922842|NCT01987895|449348219|FG000|Overall Study|Death|7|||
124922843|NCT01987895|449348220|FG001|Overall Study|Death|7|||
124922844|NCT01987895|449348219|FG000|Overall Study|Lost to Follow-up|3|||
125212110|NCT01760447|450403265|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
125212111|NCT01760447|450403266|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
125212112|NCT01760447|450403267|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
125212113|NCT01760447|450403268|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
124922845|NCT01987895|449348220|FG001|Overall Study|Lost to Follow-up|5|||
124922846|NCT01987895|449348219|FG000|Overall Study|randomized before giving IC|0|||
124922847|NCT01987895|449348220|FG001|Overall Study|randomized before giving IC|1|||
124922848|NCT05364671|449348221|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
124922849|NCT05364671|449348222|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
124922850|NCT05364671|449348221|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
124922851|NCT05364671|449348222|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
124922852|NCT05364671|449348221|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
124922853|NCT05364671|449348222|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
124922854|NCT05364671|449348221|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
124922855|NCT05364671|449348222|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
124922856|NCT05364671|449348221|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
124922857|NCT05364671|449348222|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
124922858|NCT02359890|449348223|FG000|Overall Study|Not meeting eligibility|4|||
124922859|NCT02359890|449348223|FG000|Overall Study|Never treated with study catheter|6|||
124922860|NCT05256017|449348224|FG000|Treatment Period|Withdrawal by Subject|1|||
124922861|NCT05256017|449348225|FG001|Treatment Period|Withdrawal by Subject|1|||
124922862|NCT05256017|449348224|FG000|Follow-up|Lost to Follow-up|7|||
124922863|NCT05256017|449348225|FG001|Follow-up|Lost to Follow-up|1|||
124922864|NCT05256017|449348224|FG000|Follow-up|Withdrawal by Subject|1|||
124922865|NCT05256017|449348225|FG001|Follow-up|Withdrawal by Subject|0|||
124922866|NCT05256017|449348224|FG000|Follow-up|Death|0|||
124922867|NCT05256017|449348225|FG001|Follow-up|Death|1|||
124922868|NCT05780437|449348228|FG000|Overall Study|Withdrawal by Subject|22|||
124922869|NCT05780437|449348229|FG001|Overall Study|Withdrawal by Subject|16|||
124922870|NCT04015167|449348230|FG000|Overall Study|Lost to Follow-up|40|||
124922871|NCT04015167|449348230|FG000|Overall Study|Adverse Event|5|||
124922872|NCT04015167|449348230|FG000|Overall Study|Withdrawal by Subject|2|||
124922873|NCT04015167|449348230|FG000|Overall Study|Subject went to jail|1|||
124922874|NCT03536754|449348231|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
124922875|NCT03536754|449348232|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
124922876|NCT03536754|449348233|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
124922877|NCT03536754|449348234|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
124922878|NCT03536754|449348235|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
124922879|NCT03536754|449348231|FG000|Open Label Extension|Other|0|||
124922880|NCT03536754|449348232|FG001|Open Label Extension|Other|0|||
124922881|NCT03536754|449348233|FG002|Open Label Extension|Other|0|||
124922882|NCT03536754|449348234|FG003|Open Label Extension|Other|0|||
124922883|NCT03536754|449348235|FG004|Open Label Extension|Other|1|||
125212114|NCT01760447|450403265|FG000|Weeks 20-54|Withdrawal by Subject|2|||
125212115|NCT01760447|450403266|FG001|Weeks 20-54|Withdrawal by Subject|1|||
124922884|NCT03452579|449348236|FG000|Overall Study|Death|0|||
124922885|NCT03452579|449348237|FG001|Overall Study|Death|1|||
124922886|NCT03452579|449348236|FG000|Overall Study|Withdrawal by Subject|2|||
124922887|NCT03452579|449348237|FG001|Overall Study|Withdrawal by Subject|0|||
124922888|NCT03452579|449348236|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
124922889|NCT03452579|449348237|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
125212116|NCT01760447|450403267|FG002|Weeks 20-54|Withdrawal by Subject|1|||
124922890|NCT03452579|449348236|FG000|Overall Study|Physician Decision|1|||
124922891|NCT03452579|449348237|FG001|Overall Study|Physician Decision|1|||
124922892|NCT03452579|449348236|FG000|Overall Study|Adverse Event|1|||
124922893|NCT03452579|449348237|FG001|Overall Study|Adverse Event|4|||
124922894|NCT03382652|449348241|FG000|Overall Study|Lost to Follow-up|6|||
124922895|NCT03382652|449348241|FG000|Overall Study|Death|4|||
124922896|NCT03382652|449348241|FG000|Overall Study|Revision|5|||
124922897|NCT03382652|449348241|FG000|Overall Study|Patient withdrew|3|||
124922898|NCT03382652|449348241|FG000|Overall Study|Other reasons|21|||
124922899|NCT04858321|449348242|FG000|Overall Study|Withdrawal by Subject|3|||
124922900|NCT04810650|449348243|FG000|Overall Study|Disenrolled in error|0|||
124922901|NCT04810650|449348244|FG001|Overall Study|Disenrolled in error|0|||
124922902|NCT04810650|449348245|FG002|Overall Study|Disenrolled in error|0|||
124922903|NCT04810650|449348246|FG003|Overall Study|Disenrolled in error|0|||
124922904|NCT04810650|449348247|FG004|Overall Study|Disenrolled in error|0|||
124922905|NCT04810650|449348248|FG005|Overall Study|Disenrolled in error|0|||
124922906|NCT04810650|449348249|FG006|Overall Study|Disenrolled in error|0|||
124922907|NCT04810650|449348250|FG007|Overall Study|Disenrolled in error|0|||
124922908|NCT04810650|449348251|FG008|Overall Study|Disenrolled in error|1|||
124922909|NCT04810650|449348252|FG009|Overall Study|Disenrolled in error|0|||
124922910|NCT04810650|449348253|FG010|Overall Study|Disenrolled in error|0|||
124922911|NCT04810650|449348254|FG011|Overall Study|Disenrolled in error|0|||
124922912|NCT04810650|449348255|FG012|Overall Study|Disenrolled in error|0|||
124922913|NCT04810650|449348256|FG013|Overall Study|Disenrolled in error|0|||
124922914|NCT04810650|449348243|FG000|Overall Study|Death|0|||
124922915|NCT04810650|449348244|FG001|Overall Study|Death|0|||
124922916|NCT04810650|449348245|FG002|Overall Study|Death|0|||
124922917|NCT04810650|449348246|FG003|Overall Study|Death|0|||
124922918|NCT04810650|449348247|FG004|Overall Study|Death|0|||
124922919|NCT04810650|449348248|FG005|Overall Study|Death|0|||
124922920|NCT04810650|449348249|FG006|Overall Study|Death|2|||
124922921|NCT04810650|449348250|FG007|Overall Study|Death|2|||
124922922|NCT04810650|449348251|FG008|Overall Study|Death|0|||
124922923|NCT04810650|449348252|FG009|Overall Study|Death|1|||
124922924|NCT04810650|449348253|FG010|Overall Study|Death|0|||
124922925|NCT04810650|449348254|FG011|Overall Study|Death|0|||
124922926|NCT04810650|449348255|FG012|Overall Study|Death|2|||
124922927|NCT04810650|449348256|FG013|Overall Study|Death|1|||
124922928|NCT04810650|449348243|FG000|Overall Study|Moved/transferred care|0|||
124922929|NCT04810650|449348244|FG001|Overall Study|Moved/transferred care|0|||
124922930|NCT04810650|449348245|FG002|Overall Study|Moved/transferred care|0|||
124922931|NCT04810650|449348246|FG003|Overall Study|Moved/transferred care|0|||
124922932|NCT04810650|449348247|FG004|Overall Study|Moved/transferred care|0|||
124922933|NCT04810650|449348248|FG005|Overall Study|Moved/transferred care|0|||
124922934|NCT04810650|449348249|FG006|Overall Study|Moved/transferred care|0|||
124922935|NCT04810650|449348250|FG007|Overall Study|Moved/transferred care|1|||
124922936|NCT04810650|449348251|FG008|Overall Study|Moved/transferred care|12|||
124922937|NCT04810650|449348252|FG009|Overall Study|Moved/transferred care|10|||
124922938|NCT04810650|449348253|FG010|Overall Study|Moved/transferred care|0|||
124922939|NCT04810650|449348254|FG011|Overall Study|Moved/transferred care|0|||
124922940|NCT04810650|449348255|FG012|Overall Study|Moved/transferred care|0|||
124922941|NCT04810650|449348256|FG013|Overall Study|Moved/transferred care|0|||
124922942|NCT04810650|449348243|FG000|Overall Study|Lost to Follow-up|15|||
124922943|NCT04810650|449348244|FG001|Overall Study|Lost to Follow-up|12|||
124922944|NCT04810650|449348245|FG002|Overall Study|Lost to Follow-up|7|||
124922945|NCT04810650|449348246|FG003|Overall Study|Lost to Follow-up|9|||
124922946|NCT04810650|449348247|FG004|Overall Study|Lost to Follow-up|10|||
124922947|NCT04810650|449348248|FG005|Overall Study|Lost to Follow-up|6|||
124922948|NCT04810650|449348249|FG006|Overall Study|Lost to Follow-up|0|||
124922949|NCT04810650|449348250|FG007|Overall Study|Lost to Follow-up|0|||
124922950|NCT04810650|449348251|FG008|Overall Study|Lost to Follow-up|0|||
124922951|NCT04810650|449348252|FG009|Overall Study|Lost to Follow-up|0|||
124922952|NCT04810650|449348253|FG010|Overall Study|Lost to Follow-up|1|||
124922953|NCT04810650|449348254|FG011|Overall Study|Lost to Follow-up|0|||
124922954|NCT04810650|449348255|FG012|Overall Study|Lost to Follow-up|3|||
125023786|NCT03472560|449711318|FG000|Overall Study|Death|7|||
125023787|NCT03472560|449711319|FG001|Overall Study|Death|4|||
125023788|NCT03472560|449711318|FG000|Overall Study|Adverse Event|5|||
124922955|NCT04810650|449348256|FG013|Overall Study|Lost to Follow-up|9|||
124922956|NCT04810650|449348243|FG000|Overall Study|Participant declined|0|||
124922957|NCT04810650|449348244|FG001|Overall Study|Participant declined|0|||
124922958|NCT04810650|449348245|FG002|Overall Study|Participant declined|0|||
124922959|NCT04810650|449348246|FG003|Overall Study|Participant declined|0|||
124922960|NCT04810650|449348247|FG004|Overall Study|Participant declined|0|||
125117921|NCT02607800|450053615|FG000|Overall Study|Lost to Follow-up|7|||
125117922|NCT02607800|450053616|FG001|Overall Study|Lost to Follow-up|10|||
125117923|NCT02607800|450053615|FG000|Overall Study|Withdrew Consent|2|||
125117924|NCT02607800|450053616|FG001|Overall Study|Withdrew Consent|0|||
125212117|NCT01760447|450403268|FG003|Weeks 20-54|Withdrawal by Subject|2|||
125212118|NCT01760447|450403265|FG000|Weeks 20-54|Lost to Follow-up|0|||
125212119|NCT01760447|450403266|FG001|Weeks 20-54|Lost to Follow-up|0|||
125212120|NCT01760447|450403267|FG002|Weeks 20-54|Lost to Follow-up|1|||
125212121|NCT01760447|450403268|FG003|Weeks 20-54|Lost to Follow-up|2|||
125212122|NCT01641471|450403269|FG000|Overall Study|Withdrawal by Subject|19|||
125212123|NCT01641471|450403270|FG001|Overall Study|Withdrawal by Subject|19|||
125212124|NCT01641471|450403269|FG000|Overall Study|Lost to Follow-up|2|||
125212125|NCT01641471|450403270|FG001|Overall Study|Lost to Follow-up|4|||
125212126|NCT01641471|450403269|FG000|Overall Study|Protocol Violation|2|||
125212127|NCT01641471|450403270|FG001|Overall Study|Protocol Violation|4|||
125212128|NCT04575584|450403271|FG000|Overall Study|Death|6|||
125212129|NCT04575584|450403272|FG001|Overall Study|Death|4|||
125212130|NCT04575584|450403273|FG002|Overall Study|Death|6|||
125212131|NCT04575584|450403274|FG003|Overall Study|Death|2|||
125212132|NCT04575584|450403275|FG004|Overall Study|Death|0|||
125212133|NCT04575584|450403276|FG005|Overall Study|Death|0|||
125212134|NCT04575584|450403271|FG000|Overall Study|Lost to Follow-up|1|||
125212135|NCT04575584|450403272|FG001|Overall Study|Lost to Follow-up|1|||
125212136|NCT04575584|450403273|FG002|Overall Study|Lost to Follow-up|1|||
125212137|NCT04575584|450403274|FG003|Overall Study|Lost to Follow-up|1|||
125212138|NCT04575584|450403275|FG004|Overall Study|Lost to Follow-up|0|||
125117925|NCT02607800|450053615|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
125117926|NCT02607800|450053616|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
125117927|NCT00753714|450053617|FG000|Overall Study|Lack of Efficacy|21|||
125117928|NCT00753714|450053618|FG001|Overall Study|Lack of Efficacy|34|||
125117929|NCT00753714|450053617|FG000|Overall Study|Adverse Event|26|||
125117930|NCT00753714|450053618|FG001|Overall Study|Adverse Event|18|||
125117931|NCT00753714|450053617|FG000|Overall Study|Protocol Violation|1|||
125117932|NCT00753714|450053618|FG001|Overall Study|Protocol Violation|0|||
125117933|NCT00753714|450053617|FG000|Overall Study|Lost to Follow-up|0|||
125117934|NCT00753714|450053618|FG001|Overall Study|Lost to Follow-up|1|||
125117935|NCT00753714|450053617|FG000|Overall Study|Withdrawal by Subject|2|||
125117936|NCT00753714|450053618|FG001|Overall Study|Withdrawal by Subject|1|||
125117937|NCT00753714|450053617|FG000|Overall Study|Death|3|||
125117938|NCT00753714|450053618|FG001|Overall Study|Death|3|||
125117939|NCT00753714|450053617|FG000|Overall Study|Other|7|||
125117940|NCT00753714|450053618|FG001|Overall Study|Other|5|||
125117941|NCT02486796|450053619|FG000|Overall Study|Withdrawal by Subject|1|||
125117942|NCT02486796|450053620|FG001|Overall Study|Withdrawal by Subject|1|||
125117943|NCT02486796|450053619|FG000|Overall Study|Physician Decision|1|||
125117944|NCT02486796|450053620|FG001|Overall Study|Physician Decision|0|||
125212139|NCT04575584|450403276|FG005|Overall Study|Lost to Follow-up|0|||
125212140|NCT04575584|450403271|FG000|Overall Study|Physician Decision|0|||
125117945|NCT02789111|450053623|FG000|Overall Study|Withdrawal by Subject|1|||
125117946|NCT02789111|450053624|FG001|Overall Study|Withdrawal by Subject|4|||
125117947|NCT01626885|450053625|FG000|Overall Study|Adverse Event|8|||
125117948|NCT01626885|450053625|FG000|Overall Study|Withdrawal by Subject|4|||
125212141|NCT04575584|450403272|FG001|Overall Study|Physician Decision|1|||
125117949|NCT00673790|450053626|FG000|Overall Study|Adverse Event|23|||
125212142|NCT04575584|450403273|FG002|Overall Study|Physician Decision|1|||
125212143|NCT04575584|450403274|FG003|Overall Study|Physician Decision|1|||
125212144|NCT04575584|450403275|FG004|Overall Study|Physician Decision|0|||
124922961|NCT04810650|449348248|FG005|Overall Study|Participant declined|0|||
124922962|NCT04810650|449348249|FG006|Overall Study|Participant declined|0|||
124922963|NCT04810650|449348250|FG007|Overall Study|Participant declined|0|||
124922964|NCT04810650|449348251|FG008|Overall Study|Participant declined|0|||
124922965|NCT04810650|449348252|FG009|Overall Study|Participant declined|0|||
124922966|NCT04810650|449348253|FG010|Overall Study|Participant declined|2|||
124922967|NCT04810650|449348254|FG011|Overall Study|Participant declined|0|||
124922968|NCT04810650|449348255|FG012|Overall Study|Participant declined|0|||
124922969|NCT04810650|449348256|FG013|Overall Study|Participant declined|0|||
124922970|NCT05794243|449348257|FG000|Overall Study|Withdrawal by Subject|1|||
124922971|NCT05794243|449348258|FG001|Overall Study|Withdrawal by Subject|0|||
124922972|NCT05794243|449348259|FG002|Overall Study|Withdrawal by Subject|1|||
124922973|NCT05794243|449348257|FG000|Overall Study|Physician Decision|0|||
124922974|NCT05794243|449348258|FG001|Overall Study|Physician Decision|3|||
124922975|NCT05794243|449348259|FG002|Overall Study|Physician Decision|1|||
124922976|NCT05057247|449348263|FG000|Overall Study|Death|4|||
124922977|NCT05057247|449348263|FG000|Overall Study|Physician Decision|3|||
124922978|NCT05057247|449348263|FG000|Overall Study|Progressive Disease|7|||
124922979|NCT05057247|449348263|FG000|Overall Study|Withdrawal by Subject|3|||
124922980|NCT05057247|449348263|FG000|Overall Study|Adverse Event|6|||
124922981|NCT05057247|449348263|FG000|Overall Study|Subject Non-Compliance|1|||
124922982|NCT05057247|449348263|FG000|Overall Study|On treatment|2|||
124922983|NCT02761057|449348276|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
124922984|NCT02761057|449348277|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
124922985|NCT02761057|449348278|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
125117950|NCT00673790|450053627|FG001|Overall Study|Adverse Event|14|||
125117951|NCT00673790|450053628|FG002|Overall Study|Adverse Event|2|||
125117952|NCT00673790|450053626|FG000|Overall Study|Lack of Efficacy|2|||
125117953|NCT00673790|450053627|FG001|Overall Study|Lack of Efficacy|2|||
125117954|NCT00673790|450053628|FG002|Overall Study|Lack of Efficacy|2|||
125117955|NCT00673790|450053626|FG000|Overall Study|Protocol Violation|6|||
125117956|NCT00673790|450053627|FG001|Overall Study|Protocol Violation|9|||
125117957|NCT00673790|450053628|FG002|Overall Study|Protocol Violation|1|||
125117958|NCT00673790|450053626|FG000|Overall Study|Withdrawal by Subject|7|||
125117959|NCT00673790|450053627|FG001|Overall Study|Withdrawal by Subject|4|||
125117960|NCT00673790|450053628|FG002|Overall Study|Withdrawal by Subject|1|||
125117961|NCT00673790|450053626|FG000|Overall Study|Lost to Follow-up|6|||
125117962|NCT00673790|450053627|FG001|Overall Study|Lost to Follow-up|6|||
125117963|NCT00673790|450053628|FG002|Overall Study|Lost to Follow-up|5|||
125117964|NCT00673790|450053626|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
125117965|NCT00673790|450053627|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
125117966|NCT00673790|450053628|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
125117967|NCT00673790|450053626|FG000|Overall Study|Poor compliance|1|||
125117968|NCT00673790|450053627|FG001|Overall Study|Poor compliance|0|||
125117969|NCT00673790|450053628|FG002|Overall Study|Poor compliance|0|||
125117970|NCT00673790|450053626|FG000|Overall Study|Participated in two Nebivolol studies|0|||
125117971|NCT00673790|450053627|FG001|Overall Study|Participated in two Nebivolol studies|0|||
125117972|NCT00673790|450053628|FG002|Overall Study|Participated in two Nebivolol studies|1|||
125117973|NCT00673790|450053626|FG000|Overall Study|Unconfirmed pregnancy|0|||
125117974|NCT00673790|450053627|FG001|Overall Study|Unconfirmed pregnancy|1|||
125117975|NCT00673790|450053628|FG002|Overall Study|Unconfirmed pregnancy|0|||
125117976|NCT00673790|450053626|FG000|Overall Study|Randomization criteria not met|0|||
125117977|NCT00673790|450053627|FG001|Overall Study|Randomization criteria not met|1|||
125117978|NCT00673790|450053628|FG002|Overall Study|Randomization criteria not met|0|||
125117979|NCT01533428|450053631|FG000|Overall Study|Adverse Event|0|||
125117980|NCT01533428|450053632|FG001|Overall Study|Adverse Event|1|||
125117981|NCT01533428|450053631|FG000|Overall Study|Lost to Follow-up|2|||
125117982|NCT01533428|450053632|FG001|Overall Study|Lost to Follow-up|1|||
124922986|NCT02761057|449348279|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
124922987|NCT02761057|449348276|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
124922988|NCT02761057|449348277|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
124922989|NCT02761057|449348278|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
125117983|NCT01533428|450053631|FG000|Overall Study|Withdrawal by Subject|7|||
124922990|NCT02761057|449348279|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
124922991|NCT02761057|449348276|FG000|Overall Study|Currently On Study Treatment|0|||
125117984|NCT01533428|450053632|FG001|Overall Study|Withdrawal by Subject|6|||
125117985|NCT01364870|450053635|FG000|Overall Study|Withdrawal by Subject|13|||
125117986|NCT01364870|450053636|FG001|Overall Study|Withdrawal by Subject|24|||
125117987|NCT01364870|450053637|FG002|Overall Study|Withdrawal by Subject|10|||
125117988|NCT01364870|450053635|FG000|Overall Study|Adverse Event|8|||
125117989|NCT01364870|450053636|FG001|Overall Study|Adverse Event|6|||
125117990|NCT01364870|450053637|FG002|Overall Study|Adverse Event|4|||
124922992|NCT02761057|449348277|FG001|Overall Study|Currently On Study Treatment|3|||
124922993|NCT02761057|449348278|FG002|Overall Study|Currently On Study Treatment|0|||
124922994|NCT02761057|449348279|FG003|Overall Study|Currently On Study Treatment|0|||
124922995|NCT02761057|449348276|FG000|Overall Study|Adverse Event|11|||
124922996|NCT02761057|449348277|FG001|Overall Study|Adverse Event|9|||
124922997|NCT02761057|449348278|FG002|Overall Study|Adverse Event|5|||
124922998|NCT02761057|449348279|FG003|Overall Study|Adverse Event|3|||
124922999|NCT02761057|449348276|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
124923000|NCT02761057|449348277|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
124923001|NCT02761057|449348278|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
124923002|NCT02761057|449348279|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
124923003|NCT02761057|449348276|FG000|Overall Study|Progression/Relapse|29|||
124923004|NCT02761057|449348277|FG001|Overall Study|Progression/Relapse|27|||
124923005|NCT02761057|449348278|FG002|Overall Study|Progression/Relapse|20|||
124923006|NCT02761057|449348279|FG003|Overall Study|Progression/Relapse|23|||
124923007|NCT02761057|449348276|FG000|Overall Study|Death|2|||
124923008|NCT02761057|449348277|FG001|Overall Study|Death|2|||
124923009|NCT02761057|449348278|FG002|Overall Study|Death|1|||
124923010|NCT02761057|449348279|FG003|Overall Study|Death|1|||
124923011|NCT02761057|449348276|FG000|Overall Study|Other - Not Protocol Specified|2|||
124923012|NCT02761057|449348277|FG001|Overall Study|Other - Not Protocol Specified|1|||
124923013|NCT02761057|449348278|FG002|Overall Study|Other - Not Protocol Specified|2|||
124923014|NCT02761057|449348279|FG003|Overall Study|Other - Not Protocol Specified|0|||
124923015|NCT04788511|449348280|FG000|Overall Study|Withdrawal by Subject|2|||
124923016|NCT04788511|449348281|FG001|Overall Study|Withdrawal by Subject|1|||
124923017|NCT04788511|449348280|FG000|Overall Study|Lost to Follow-up|2|||
124923018|NCT04788511|449348281|FG001|Overall Study|Lost to Follow-up|7|||
124923019|NCT04788511|449348280|FG000|Overall Study|Death|3|||
124923020|NCT04788511|449348281|FG001|Overall Study|Death|4|||
124923021|NCT04652700|449348284|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
124923022|NCT04652700|449348285|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
124923023|NCT04652700|449348284|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
124923024|NCT04652700|449348285|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
124923025|NCT04652700|449348284|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
124923026|NCT04652700|449348285|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
124923027|NCT04652700|449348284|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
124923028|NCT04652700|449348285|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
124923029|NCT04652700|449348284|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
124923030|NCT04652700|449348285|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
124923031|NCT04652700|449348284|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
124923032|NCT04652700|449348285|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
124923033|NCT04652700|449348284|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
124923034|NCT04652700|449348285|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
124923035|NCT04652700|449348284|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
124923036|NCT04652700|449348285|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
124923037|NCT04652700|449348284|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
124923038|NCT04652700|449348285|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
124923039|NCT06037369|449348288|FG000|Overall Study|Lost to Follow-up|0|||
124923040|NCT06037369|449348289|FG001|Overall Study|Lost to Follow-up|1|||
124923041|NCT04209465|449348290|FG000|Overall Study|Adverse Event|0|||
124923042|NCT04209465|449348291|FG001|Overall Study|Adverse Event|0|||
124923043|NCT04209465|449348292|FG002|Overall Study|Adverse Event|0|||
124923044|NCT04209465|449348293|FG003|Overall Study|Adverse Event|0|||
124923045|NCT04209465|449348294|FG004|Overall Study|Adverse Event|0|||
124923046|NCT04209465|449348295|FG005|Overall Study|Adverse Event|1|||
124923047|NCT04209465|449348296|FG006|Overall Study|Adverse Event|0|||
124923048|NCT04209465|449348297|FG007|Overall Study|Adverse Event|0|||
124923049|NCT04209465|449348298|FG008|Overall Study|Adverse Event|1|||
124923050|NCT04209465|449348299|FG009|Overall Study|Adverse Event|0|||
124923051|NCT04209465|449348300|FG010|Overall Study|Adverse Event|2|||
124923052|NCT04209465|449348301|FG011|Overall Study|Adverse Event|1|||
124923053|NCT04209465|449348302|FG012|Overall Study|Adverse Event|1|||
124923054|NCT04209465|449348290|FG000|Overall Study|Death|1|||
124923055|NCT04209465|449348291|FG001|Overall Study|Death|0|||
124923056|NCT04209465|449348292|FG002|Overall Study|Death|0|||
124923057|NCT04209465|449348293|FG003|Overall Study|Death|0|||
124923058|NCT04209465|449348294|FG004|Overall Study|Death|2|||
124923059|NCT04209465|449348295|FG005|Overall Study|Death|7|||
125023789|NCT03472560|449711319|FG001|Overall Study|Adverse Event|3|||
125023790|NCT03472560|449711318|FG000|Overall Study|Global deterioration of health status|0|||
125023791|NCT03472560|449711319|FG001|Overall Study|Global deterioration of health status|4|||
125023792|NCT01534676|449711320|FG000|Overall Study|Study closed due to poor enrollment|2|||
125023793|NCT01534676|449711321|FG001|Overall Study|Study closed due to poor enrollment|1|||
125023794|NCT00491179|449711323|FG000|Overall Study|Adverse Event|5|||
125023795|NCT00491179|449711324|FG001|Overall Study|Adverse Event|1|||
125023796|NCT00491179|449711323|FG000|Overall Study|Withdrawal by Subject|2|||
125023797|NCT00491179|449711324|FG001|Overall Study|Withdrawal by Subject|1|||
125117991|NCT01364870|450053635|FG000|Overall Study|Protocol Violation|1|||
125117992|NCT01364870|450053636|FG001|Overall Study|Protocol Violation|0|||
125117993|NCT01364870|450053637|FG002|Overall Study|Protocol Violation|0|||
125117994|NCT01890707|450053638|FG000|Overall Study|Lost to Follow-up|1|||
124923060|NCT04209465|449348296|FG006|Overall Study|Death|2|||
124923061|NCT04209465|449348297|FG007|Overall Study|Death|2|||
124923062|NCT04209465|449348298|FG008|Overall Study|Death|1|||
124923063|NCT04209465|449348299|FG009|Overall Study|Death|1|||
124923064|NCT04209465|449348300|FG010|Overall Study|Death|1|||
124923065|NCT04209465|449348301|FG011|Overall Study|Death|0|||
124923066|NCT04209465|449348302|FG012|Overall Study|Death|10|||
124923067|NCT04209465|449348290|FG000|Overall Study|Physician Decision|0|||
124923068|NCT04209465|449348291|FG001|Overall Study|Physician Decision|1|||
124923069|NCT04209465|449348292|FG002|Overall Study|Physician Decision|0|||
124923070|NCT04209465|449348293|FG003|Overall Study|Physician Decision|0|||
124923071|NCT04209465|449348294|FG004|Overall Study|Physician Decision|0|||
124923072|NCT04209465|449348295|FG005|Overall Study|Physician Decision|0|||
124923073|NCT04209465|449348296|FG006|Overall Study|Physician Decision|0|||
124923074|NCT04209465|449348297|FG007|Overall Study|Physician Decision|0|||
124923075|NCT04209465|449348298|FG008|Overall Study|Physician Decision|0|||
124923076|NCT04209465|449348299|FG009|Overall Study|Physician Decision|0|||
124923077|NCT04209465|449348300|FG010|Overall Study|Physician Decision|0|||
124923078|NCT04209465|449348301|FG011|Overall Study|Physician Decision|0|||
124923079|NCT04209465|449348302|FG012|Overall Study|Physician Decision|0|||
124923080|NCT04209465|449348290|FG000|Overall Study|Progressive Disease|0|||
124923081|NCT04209465|449348291|FG001|Overall Study|Progressive Disease|0|||
124923082|NCT04209465|449348292|FG002|Overall Study|Progressive Disease|1|||
125023798|NCT04269395|449711325|FG000|Overall Study|Lost to Follow-up|1|||
125023799|NCT04269395|449711326|FG001|Overall Study|Lost to Follow-up|0|||
124923083|NCT04209465|449348293|FG003|Overall Study|Progressive Disease|2|||
124923084|NCT04209465|449348294|FG004|Overall Study|Progressive Disease|8|||
124923085|NCT04209465|449348295|FG005|Overall Study|Progressive Disease|5|||
124923086|NCT04209465|449348296|FG006|Overall Study|Progressive Disease|3|||
125117995|NCT01890707|450053639|FG001|Overall Study|Lost to Follow-up|1|||
125117996|NCT00506753|450055183|FG000|Overall Study|Lost to Follow-up|21|||
125117997|NCT00506753|450055184|FG001|Overall Study|Lost to Follow-up|15|||
125023800|NCT04269395|449711325|FG000|Overall Study|Study terminated by Sponsor|13|||
125023801|NCT04269395|449711326|FG001|Overall Study|Study terminated by Sponsor|10|||
125023802|NCT00584233|449711327|FG000|Overall Study|Withdrawal by Subject|5|||
125023803|NCT00584233|449711327|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
125023804|NCT02222714|449711328|FG000|Overall Study|Death|0|||
125023805|NCT02222714|449711329|FG001|Overall Study|Death|2|||
125023806|NCT02222714|449711330|FG002|Overall Study|Death|3|||
125023807|NCT02222714|449711331|FG003|Overall Study|Death|4|||
125023808|NCT02222714|449711332|FG004|Overall Study|Death|6|||
125023809|NCT02222714|449711328|FG000|Overall Study|Withdrawal by Subject|0|||
125023810|NCT02222714|449711329|FG001|Overall Study|Withdrawal by Subject|0|||
125023811|NCT02222714|449711330|FG002|Overall Study|Withdrawal by Subject|1|||
125023812|NCT02222714|449711331|FG003|Overall Study|Withdrawal by Subject|0|||
124923087|NCT04209465|449348297|FG007|Overall Study|Progressive Disease|4|||
124923088|NCT04209465|449348298|FG008|Overall Study|Progressive Disease|1|||
124923089|NCT04209465|449348299|FG009|Overall Study|Progressive Disease|3|||
124923090|NCT04209465|449348300|FG010|Overall Study|Progressive Disease|2|||
124923091|NCT04209465|449348301|FG011|Overall Study|Progressive Disease|1|||
124923092|NCT04209465|449348302|FG012|Overall Study|Progressive Disease|0|||
124923093|NCT04209465|449348290|FG000|Overall Study|Withdrawal by Subject|0|||
124923094|NCT04209465|449348291|FG001|Overall Study|Withdrawal by Subject|0|||
124923095|NCT04209465|449348292|FG002|Overall Study|Withdrawal by Subject|0|||
124923096|NCT04209465|449348293|FG003|Overall Study|Withdrawal by Subject|0|||
124923097|NCT04209465|449348294|FG004|Overall Study|Withdrawal by Subject|0|||
124923098|NCT04209465|449348295|FG005|Overall Study|Withdrawal by Subject|1|||
124923099|NCT04209465|449348296|FG006|Overall Study|Withdrawal by Subject|2|||
124923100|NCT04209465|449348297|FG007|Overall Study|Withdrawal by Subject|0|||
124923101|NCT04209465|449348298|FG008|Overall Study|Withdrawal by Subject|1|||
124923102|NCT04209465|449348299|FG009|Overall Study|Withdrawal by Subject|0|||
124923103|NCT04209465|449348300|FG010|Overall Study|Withdrawal by Subject|0|||
124923104|NCT04209465|449348301|FG011|Overall Study|Withdrawal by Subject|2|||
124923105|NCT04209465|449348302|FG012|Overall Study|Withdrawal by Subject|2|||
124923106|NCT04209465|449348290|FG000|Overall Study|Lost to Follow-up|0|||
124923107|NCT04209465|449348291|FG001|Overall Study|Lost to Follow-up|0|||
124923108|NCT04209465|449348292|FG002|Overall Study|Lost to Follow-up|0|||
124923109|NCT04209465|449348293|FG003|Overall Study|Lost to Follow-up|0|||
124923110|NCT04209465|449348294|FG004|Overall Study|Lost to Follow-up|0|||
124923111|NCT04209465|449348295|FG005|Overall Study|Lost to Follow-up|1|||
124923112|NCT04209465|449348296|FG006|Overall Study|Lost to Follow-up|0|||
124923113|NCT04209465|449348297|FG007|Overall Study|Lost to Follow-up|0|||
124923114|NCT04209465|449348298|FG008|Overall Study|Lost to Follow-up|1|||
124923115|NCT04209465|449348299|FG009|Overall Study|Lost to Follow-up|0|||
124923116|NCT04209465|449348300|FG010|Overall Study|Lost to Follow-up|0|||
124923117|NCT04209465|449348301|FG011|Overall Study|Lost to Follow-up|1|||
124923118|NCT04209465|449348302|FG012|Overall Study|Lost to Follow-up|0|||
124923119|NCT04209465|449348290|FG000|Overall Study|Started new therapy|0|||
124923120|NCT04209465|449348291|FG001|Overall Study|Started new therapy|0|||
124923121|NCT04209465|449348292|FG002|Overall Study|Started new therapy|0|||
124923122|NCT04209465|449348293|FG003|Overall Study|Started new therapy|0|||
124923123|NCT04209465|449348294|FG004|Overall Study|Started new therapy|0|||
124923124|NCT04209465|449348295|FG005|Overall Study|Started new therapy|1|||
124923125|NCT04209465|449348296|FG006|Overall Study|Started new therapy|0|||
124923126|NCT04209465|449348297|FG007|Overall Study|Started new therapy|0|||
124923127|NCT04209465|449348298|FG008|Overall Study|Started new therapy|0|||
124923128|NCT04209465|449348299|FG009|Overall Study|Started new therapy|0|||
124923129|NCT04209465|449348300|FG010|Overall Study|Started new therapy|0|||
124923130|NCT04209465|449348301|FG011|Overall Study|Started new therapy|0|||
124923131|NCT04209465|449348302|FG012|Overall Study|Started new therapy|0|||
124923132|NCT04209465|449348290|FG000|Overall Study|Study terminated early by sponsor|0|||
124923133|NCT04209465|449348291|FG001|Overall Study|Study terminated early by sponsor|0|||
124923134|NCT04209465|449348292|FG002|Overall Study|Study terminated early by sponsor|0|||
124923135|NCT04209465|449348293|FG003|Overall Study|Study terminated early by sponsor|0|||
124923136|NCT04209465|449348294|FG004|Overall Study|Study terminated early by sponsor|0|||
124923137|NCT04209465|449348295|FG005|Overall Study|Study terminated early by sponsor|0|||
124923138|NCT04209465|449348296|FG006|Overall Study|Study terminated early by sponsor|3|||
124923139|NCT04209465|449348297|FG007|Overall Study|Study terminated early by sponsor|0|||
124923140|NCT04209465|449348298|FG008|Overall Study|Study terminated early by sponsor|0|||
124923141|NCT04209465|449348299|FG009|Overall Study|Study terminated early by sponsor|0|||
125117998|NCT00125359|450055185|FG000|Overall Study|Death|4|||
125117999|NCT00125359|450055185|FG000|Overall Study|Adverse Event|5|||
125118000|NCT00125359|450055185|FG000|Overall Study|Physician Decision|14|||
124923142|NCT04209465|449348300|FG010|Overall Study|Study terminated early by sponsor|0|||
124923143|NCT04209465|449348301|FG011|Overall Study|Study terminated early by sponsor|0|||
124923144|NCT04209465|449348302|FG012|Overall Study|Study terminated early by sponsor|3|||
124923145|NCT04209465|449348290|FG000|Overall Study|Other|0|||
124923146|NCT04209465|449348291|FG001|Overall Study|Other|0|||
124923147|NCT04209465|449348292|FG002|Overall Study|Other|0|||
124923148|NCT04209465|449348293|FG003|Overall Study|Other|0|||
124923149|NCT04209465|449348294|FG004|Overall Study|Other|0|||
124923150|NCT04209465|449348295|FG005|Overall Study|Other|0|||
124923151|NCT04209465|449348296|FG006|Overall Study|Other|0|||
124923152|NCT04209465|449348297|FG007|Overall Study|Other|0|||
124923153|NCT04209465|449348298|FG008|Overall Study|Other|1|||
124923154|NCT04209465|449348299|FG009|Overall Study|Other|0|||
124923155|NCT04209465|449348300|FG010|Overall Study|Other|0|||
124923156|NCT04209465|449348301|FG011|Overall Study|Other|0|||
124923157|NCT04209465|449348302|FG012|Overall Study|Other|0|||
124923158|NCT05008835|449348304|FG000|Overall Study|Adverse Event|5|||
124923159|NCT05008835|449348305|FG001|Overall Study|Adverse Event|2|||
124923160|NCT05008835|449348306|FG002|Overall Study|Adverse Event|1|||
124923161|NCT05008835|449348304|FG000|Overall Study|Lack of Efficacy|0|||
125118001|NCT02451670|450055186|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
124923162|NCT05008835|449348305|FG001|Overall Study|Lack of Efficacy|0|||
124923163|NCT05008835|449348306|FG002|Overall Study|Lack of Efficacy|1|||
124923164|NCT05008835|449348304|FG000|Overall Study|Study terminated by sponsor|0|||
124923165|NCT05008835|449348305|FG001|Overall Study|Study terminated by sponsor|0|||
124923166|NCT05008835|449348306|FG002|Overall Study|Study terminated by sponsor|1|||
124923167|NCT05008835|449348304|FG000|Overall Study|Not further specified|3|||
124923168|NCT05008835|449348305|FG001|Overall Study|Not further specified|2|||
124923169|NCT05008835|449348306|FG002|Overall Study|Not further specified|1|||
124923170|NCT04171999|449348307|FG000|Overall Study|deemed ineligible after randomization|2|||
124923171|NCT04171999|449348308|FG001|Overall Study|deemed ineligible after randomization|1|||
124923172|NCT04505904|449348313|FG000|Overall Study|Withdrawal by Subject|1|||
124923173|NCT04505904|449348314|FG001|Overall Study|Withdrawal by Subject|2|||
124923174|NCT04505904|449348315|FG002|Overall Study|Withdrawal by Subject|0|||
124923175|NCT04505904|449348316|FG003|Overall Study|Withdrawal by Subject|0|||
124923176|NCT04505904|449348313|FG000|Overall Study|Physician Decision|1|||
124923177|NCT04505904|449348314|FG001|Overall Study|Physician Decision|0|||
124923178|NCT04505904|449348315|FG002|Overall Study|Physician Decision|0|||
124923179|NCT04505904|449348316|FG003|Overall Study|Physician Decision|0|||
124923180|NCT04505904|449348313|FG000|Overall Study|Adverse Event|0|||
124923181|NCT04505904|449348314|FG001|Overall Study|Adverse Event|1|||
124923182|NCT04505904|449348315|FG002|Overall Study|Adverse Event|0|||
124923183|NCT04505904|449348316|FG003|Overall Study|Adverse Event|0|||
124923184|NCT04277442|449348319|FG000|Overall Study|Death|1|||
124923185|NCT03544281|449348320|FG000|Main Study Phase|Death|3|||
124923186|NCT03544281|449348321|FG001|Main Study Phase|Death|2|||
124923187|NCT03544281|449348322|FG002|Main Study Phase|Death|6|||
124923188|NCT03544281|449348323|FG003|Main Study Phase|Death|8|||
124923189|NCT03544281|449348324|FG004|Main Study Phase|Death|4|||
124923190|NCT03544281|449348325|FG005|Main Study Phase|Death|2|||
124923191|NCT03544281|449348326|FG006|Main Study Phase|Death|4|||
124923192|NCT03544281|449348327|FG007|Main Study Phase|Death|5|||
124923193|NCT03544281|449348328|FG008|Main Study Phase|Death|5|||
124923194|NCT03544281|449348329|FG009|Main Study Phase|Death|8|||
124923195|NCT03544281|449348330|FG010|Main Study Phase|Death|6|||
124923196|NCT03544281|449348331|FG011|Main Study Phase|Death|4|||
124923197|NCT03544281|449348332|FG012|Main Study Phase|Death|0|||
124923198|NCT03544281|449348333|FG013|Main Study Phase|Death|0|||
124923199|NCT03544281|449348334|FG014|Main Study Phase|Death|0|||
124923200|NCT03544281|449348335|FG015|Main Study Phase|Death|0|||
124923201|NCT03544281|449348336|FG016|Main Study Phase|Death|0|||
124923202|NCT03544281|449348337|FG017|Main Study Phase|Death|0|||
124923203|NCT03544281|449348338|FG018|Main Study Phase|Death|0|||
124923204|NCT03544281|449348339|FG019|Main Study Phase|Death|0|||
124923205|NCT03544281|449348340|FG020|Main Study Phase|Death|0|||
124923206|NCT03544281|449348341|FG021|Main Study Phase|Death|0|||
124923207|NCT03544281|449348320|FG000|Main Study Phase|Lost to Follow-up|0|||
124923208|NCT03544281|449348321|FG001|Main Study Phase|Lost to Follow-up|0|||
124923209|NCT03544281|449348322|FG002|Main Study Phase|Lost to Follow-up|0|||
124923210|NCT03544281|449348323|FG003|Main Study Phase|Lost to Follow-up|0|||
124923211|NCT03544281|449348324|FG004|Main Study Phase|Lost to Follow-up|0|||
124923212|NCT03544281|449348325|FG005|Main Study Phase|Lost to Follow-up|0|||
124923213|NCT03544281|449348326|FG006|Main Study Phase|Lost to Follow-up|0|||
124923214|NCT03544281|449348327|FG007|Main Study Phase|Lost to Follow-up|0|||
124923215|NCT03544281|449348328|FG008|Main Study Phase|Lost to Follow-up|0|||
124923216|NCT03544281|449348329|FG009|Main Study Phase|Lost to Follow-up|0|||
124923217|NCT03544281|449348330|FG010|Main Study Phase|Lost to Follow-up|1|||
124923218|NCT03544281|449348331|FG011|Main Study Phase|Lost to Follow-up|0|||
124923219|NCT03544281|449348332|FG012|Main Study Phase|Lost to Follow-up|0|||
124923220|NCT03544281|449348333|FG013|Main Study Phase|Lost to Follow-up|0|||
124923221|NCT03544281|449348334|FG014|Main Study Phase|Lost to Follow-up|0|||
124923222|NCT03544281|449348335|FG015|Main Study Phase|Lost to Follow-up|0|||
124923223|NCT03544281|449348336|FG016|Main Study Phase|Lost to Follow-up|0|||
125023813|NCT02222714|449711332|FG004|Overall Study|Withdrawal by Subject|1|||
124923224|NCT03544281|449348337|FG017|Main Study Phase|Lost to Follow-up|0|||
124923225|NCT03544281|449348338|FG018|Main Study Phase|Lost to Follow-up|0|||
124923226|NCT03544281|449348339|FG019|Main Study Phase|Lost to Follow-up|0|||
124923227|NCT03544281|449348340|FG020|Main Study Phase|Lost to Follow-up|0|||
124923228|NCT03544281|449348341|FG021|Main Study Phase|Lost to Follow-up|0|||
124923229|NCT03544281|449348320|FG000|Main Study Phase|Physician Decision|0|||
124923230|NCT03544281|449348321|FG001|Main Study Phase|Physician Decision|0|||
124923231|NCT03544281|449348322|FG002|Main Study Phase|Physician Decision|0|||
124923232|NCT03544281|449348323|FG003|Main Study Phase|Physician Decision|0|||
124923233|NCT03544281|449348324|FG004|Main Study Phase|Physician Decision|0|||
124923234|NCT03544281|449348325|FG005|Main Study Phase|Physician Decision|0|||
124923235|NCT03544281|449348326|FG006|Main Study Phase|Physician Decision|0|||
124923236|NCT03544281|449348327|FG007|Main Study Phase|Physician Decision|1|||
124923237|NCT03544281|449348328|FG008|Main Study Phase|Physician Decision|0|||
124923238|NCT03544281|449348329|FG009|Main Study Phase|Physician Decision|0|||
124923239|NCT03544281|449348330|FG010|Main Study Phase|Physician Decision|0|||
124923240|NCT03544281|449348331|FG011|Main Study Phase|Physician Decision|0|||
124923241|NCT03544281|449348332|FG012|Main Study Phase|Physician Decision|0|||
124923242|NCT03544281|449348333|FG013|Main Study Phase|Physician Decision|0|||
124923243|NCT03544281|449348334|FG014|Main Study Phase|Physician Decision|0|||
124923244|NCT03544281|449348335|FG015|Main Study Phase|Physician Decision|0|||
124923245|NCT03544281|449348336|FG016|Main Study Phase|Physician Decision|0|||
124923246|NCT03544281|449348337|FG017|Main Study Phase|Physician Decision|0|||
124923247|NCT03544281|449348338|FG018|Main Study Phase|Physician Decision|0|||
124923248|NCT03544281|449348339|FG019|Main Study Phase|Physician Decision|0|||
124923249|NCT03544281|449348340|FG020|Main Study Phase|Physician Decision|0|||
124923250|NCT03544281|449348341|FG021|Main Study Phase|Physician Decision|0|||
124923251|NCT03544281|449348320|FG000|Main Study Phase|Withdrawal by Subject|2|||
124923252|NCT03544281|449348321|FG001|Main Study Phase|Withdrawal by Subject|0|||
124923253|NCT03544281|449348322|FG002|Main Study Phase|Withdrawal by Subject|1|||
124923254|NCT03544281|449348323|FG003|Main Study Phase|Withdrawal by Subject|2|||
124923255|NCT03544281|449348324|FG004|Main Study Phase|Withdrawal by Subject|0|||
124923256|NCT03544281|449348325|FG005|Main Study Phase|Withdrawal by Subject|0|||
124923257|NCT03544281|449348326|FG006|Main Study Phase|Withdrawal by Subject|0|||
124923258|NCT03544281|449348327|FG007|Main Study Phase|Withdrawal by Subject|0|||
124923259|NCT03544281|449348328|FG008|Main Study Phase|Withdrawal by Subject|2|||
124923260|NCT03544281|449348329|FG009|Main Study Phase|Withdrawal by Subject|3|||
124923261|NCT03544281|449348330|FG010|Main Study Phase|Withdrawal by Subject|0|||
124923262|NCT03544281|449348331|FG011|Main Study Phase|Withdrawal by Subject|4|||
124923263|NCT03544281|449348332|FG012|Main Study Phase|Withdrawal by Subject|0|||
124923264|NCT03544281|449348333|FG013|Main Study Phase|Withdrawal by Subject|0|||
124923265|NCT03544281|449348334|FG014|Main Study Phase|Withdrawal by Subject|0|||
124923266|NCT03544281|449348335|FG015|Main Study Phase|Withdrawal by Subject|0|||
124923267|NCT03544281|449348336|FG016|Main Study Phase|Withdrawal by Subject|0|||
124923268|NCT03544281|449348337|FG017|Main Study Phase|Withdrawal by Subject|0|||
124923269|NCT03544281|449348338|FG018|Main Study Phase|Withdrawal by Subject|0|||
124923270|NCT03544281|449348339|FG019|Main Study Phase|Withdrawal by Subject|0|||
124923271|NCT03544281|449348340|FG020|Main Study Phase|Withdrawal by Subject|0|||
124923272|NCT03544281|449348341|FG021|Main Study Phase|Withdrawal by Subject|0|||
124923273|NCT03544281|449348320|FG000|Main Study Phase|Ongoing|3|||
124923274|NCT03544281|449348321|FG001|Main Study Phase|Ongoing|1|||
124923275|NCT03544281|449348322|FG002|Main Study Phase|Ongoing|2|||
124923276|NCT03544281|449348323|FG003|Main Study Phase|Ongoing|4|||
124923277|NCT03544281|449348324|FG004|Main Study Phase|Ongoing|2|||
124923278|NCT03544281|449348325|FG005|Main Study Phase|Ongoing|4|||
124923279|NCT03544281|449348326|FG006|Main Study Phase|Ongoing|4|||
124923280|NCT03544281|449348327|FG007|Main Study Phase|Ongoing|0|||
124923281|NCT03544281|449348328|FG008|Main Study Phase|Ongoing|2|||
124923282|NCT03544281|449348329|FG009|Main Study Phase|Ongoing|2|||
124923283|NCT03544281|449348330|FG010|Main Study Phase|Ongoing|1|||
124923284|NCT03544281|449348331|FG011|Main Study Phase|Ongoing|0|||
124923285|NCT03544281|449348332|FG012|Main Study Phase|Ongoing|0|||
124923286|NCT03544281|449348333|FG013|Main Study Phase|Ongoing|0|||
124923287|NCT03544281|449348334|FG014|Main Study Phase|Ongoing|0|||
124923288|NCT03544281|449348335|FG015|Main Study Phase|Ongoing|0|||
124923289|NCT03544281|449348336|FG016|Main Study Phase|Ongoing|0|||
124923290|NCT03544281|449348337|FG017|Main Study Phase|Ongoing|0|||
124923291|NCT03544281|449348338|FG018|Main Study Phase|Ongoing|0|||
124923292|NCT03544281|449348339|FG019|Main Study Phase|Ongoing|0|||
124923293|NCT03544281|449348340|FG020|Main Study Phase|Ongoing|0|||
124923294|NCT03544281|449348341|FG021|Main Study Phase|Ongoing|0|||
124923295|NCT03544281|449348320|FG000|Main Study Phase|Investigator Site Closed|0|||
124923296|NCT03544281|449348321|FG001|Main Study Phase|Investigator Site Closed|0|||
124923297|NCT03544281|449348322|FG002|Main Study Phase|Investigator Site Closed|0|||
124923298|NCT03544281|449348323|FG003|Main Study Phase|Investigator Site Closed|0|||
124923299|NCT03544281|449348324|FG004|Main Study Phase|Investigator Site Closed|0|||
124923300|NCT03544281|449348325|FG005|Main Study Phase|Investigator Site Closed|0|||
124923301|NCT03544281|449348326|FG006|Main Study Phase|Investigator Site Closed|0|||
124923302|NCT03544281|449348327|FG007|Main Study Phase|Investigator Site Closed|0|||
124923303|NCT03544281|449348328|FG008|Main Study Phase|Investigator Site Closed|0|||
125023814|NCT03529773|449711333|FG000|Overall Study|Adverse Event|0|||
124923304|NCT03544281|449348329|FG009|Main Study Phase|Investigator Site Closed|1|||
124923305|NCT03544281|449348330|FG010|Main Study Phase|Investigator Site Closed|0|||
124923306|NCT03544281|449348331|FG011|Main Study Phase|Investigator Site Closed|0|||
124923307|NCT03544281|449348332|FG012|Main Study Phase|Investigator Site Closed|0|||
124923308|NCT03544281|449348333|FG013|Main Study Phase|Investigator Site Closed|0|||
124923309|NCT03544281|449348334|FG014|Main Study Phase|Investigator Site Closed|0|||
124923310|NCT03544281|449348335|FG015|Main Study Phase|Investigator Site Closed|0|||
124923311|NCT03544281|449348336|FG016|Main Study Phase|Investigator Site Closed|0|||
124923312|NCT03544281|449348337|FG017|Main Study Phase|Investigator Site Closed|0|||
125023815|NCT03529773|449711334|FG001|Overall Study|Adverse Event|0|||
124923313|NCT03544281|449348338|FG018|Main Study Phase|Investigator Site Closed|0|||
124923314|NCT03544281|449348339|FG019|Main Study Phase|Investigator Site Closed|0|||
124923315|NCT03544281|449348340|FG020|Main Study Phase|Investigator Site Closed|0|||
124923316|NCT03544281|449348341|FG021|Main Study Phase|Investigator Site Closed|0|||
124923317|NCT03544281|449348320|FG000|Main Study Phase|Did not receive study treatment|0|||
124923318|NCT03544281|449348321|FG001|Main Study Phase|Did not receive study treatment|0|||
124923319|NCT03544281|449348322|FG002|Main Study Phase|Did not receive study treatment|0|||
124923320|NCT03544281|449348323|FG003|Main Study Phase|Did not receive study treatment|0|||
124923321|NCT03544281|449348324|FG004|Main Study Phase|Did not receive study treatment|0|||
125118002|NCT02451670|450055187|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
125118003|NCT01513551|450055188|FG000|Overall Study|Death|0|||
125118004|NCT01513551|450055189|FG001|Overall Study|Death|1|||
125118005|NCT01513551|450055190|FG002|Overall Study|Death|0|||
125118006|NCT01513551|450055188|FG000|Overall Study|Lost to Follow-up|3|||
125118007|NCT01513551|450055189|FG001|Overall Study|Lost to Follow-up|5|||
125118008|NCT01513551|450055190|FG002|Overall Study|Lost to Follow-up|2|||
125118009|NCT01513551|450055188|FG000|Overall Study|Withdrawal by Subject|1|||
125118010|NCT01513551|450055189|FG001|Overall Study|Withdrawal by Subject|0|||
125118011|NCT01513551|450055190|FG002|Overall Study|Withdrawal by Subject|2|||
125118012|NCT01513551|450055188|FG000|Overall Study|Randomized but not vaccinated|0|||
125118013|NCT01513551|450055189|FG001|Overall Study|Randomized but not vaccinated|0|||
125118014|NCT01513551|450055190|FG002|Overall Study|Randomized but not vaccinated|1|||
125118015|NCT00094302|450055192|FG000|Overall Study|Lost to Follow-up|43|||
125118016|NCT00094302|450055193|FG001|Overall Study|Lost to Follow-up|41|||
125118017|NCT00094302|450055192|FG000|Overall Study|Physician Decision|5|||
125118018|NCT00094302|450055193|FG001|Overall Study|Physician Decision|8|||
125118019|NCT00094302|450055192|FG000|Overall Study|Withdrawal by Subject|103|||
125118020|NCT00094302|450055193|FG001|Overall Study|Withdrawal by Subject|111|||
125118021|NCT00094302|450055192|FG000|Overall Study|Death|266|||
125118022|NCT00094302|450055193|FG001|Overall Study|Death|246|||
125118023|NCT03705351|450055194|FG000|Overall Study|Study termination|3|||
125118024|NCT03705351|450055194|FG000|Overall Study|Death|1|||
125118025|NCT03705351|450055194|FG000|Overall Study|Lack of Efficacy|2|||
125118026|NCT03705351|450055194|FG000|Overall Study|Withdrawal by Subject|1|||
125118027|NCT00322556|450055204|FG000|Overall Study|Adverse Event|1|||
125118028|NCT00322556|450055204|FG000|Overall Study|Withdrawal by Subject|1|||
125118029|NCT00322556|450055204|FG000|Overall Study|Lost to Follow-up|3|||
125118030|NCT00322556|450055204|FG000|Overall Study|Other Reason|7|||
125118031|NCT02058628|450055205|FG000|Overall Study|Adverse Event|1|||
125118032|NCT02058628|450055206|FG001|Overall Study|Adverse Event|0|||
125118033|NCT02058628|450055205|FG000|Overall Study|Withdrawal by Subject|2|||
125118034|NCT02058628|450055206|FG001|Overall Study|Withdrawal by Subject|2|||
125118035|NCT02058628|450055205|FG000|Overall Study|Lost to Follow-up|2|||
125118036|NCT02058628|450055206|FG001|Overall Study|Lost to Follow-up|4|||
125118037|NCT02058628|450055205|FG000|Overall Study|Not in time schedule|0|||
125118038|NCT02058628|450055206|FG001|Overall Study|Not in time schedule|1|||
125118039|NCT02058628|450055205|FG000|Overall Study|The visit date was not in timeline|0|||
125118040|NCT02058628|450055206|FG001|Overall Study|The visit date was not in timeline|1|||
125118041|NCT02058628|450055205|FG000|Overall Study|A lot of time for study for participant|1|||
125118042|NCT02058628|450055206|FG001|Overall Study|A lot of time for study for participant|0|||
125118043|NCT02058628|450055205|FG000|Overall Study|Non compliance|1|||
125118044|NCT02058628|450055206|FG001|Overall Study|Non compliance|0|||
125118045|NCT01767597|450055207|FG000|Overall Study|Incomplete intervention|3|||
125118046|NCT01767597|450055208|FG001|Overall Study|Incomplete intervention|1|||
125118047|NCT01767597|450055207|FG000|Overall Study|Withdrawal by Subject|1|||
125118048|NCT01767597|450055208|FG001|Overall Study|Withdrawal by Subject|0|||
125118049|NCT02961920|450055209|FG000|Overall Study|did not achive stydy protocol schedule|1|||
125118050|NCT02961920|450055210|FG001|Overall Study|did not achive stydy protocol schedule|1|||
125118051|NCT04527471|450055213|FG000|Overall Study|Adverse Event|1|||
125118052|NCT04527471|450055214|FG001|Overall Study|Adverse Event|0|||
125118053|NCT04527471|450055213|FG000|Overall Study|Lost to Follow-up|1|||
125118054|NCT04527471|450055214|FG001|Overall Study|Lost to Follow-up|0|||
125118055|NCT00096265|450055216|FG000|Overall Study|Ineligible|1|||
125118056|NCT00096265|450055217|FG001|Overall Study|Ineligible|0|||
124923322|NCT03544281|449348325|FG005|Main Study Phase|Did not receive study treatment|0|||
125118057|NCT00096265|450055218|FG002|Overall Study|Ineligible|0|||
125118058|NCT01506323|450055219|FG000|Overall Study|Lost to Follow-up|5|||
125118059|NCT01506323|450055220|FG001|Overall Study|Lost to Follow-up|4|||
125118060|NCT01506323|450055219|FG000|Overall Study|Withdrawal by Subject|4|||
125118061|NCT01506323|450055220|FG001|Overall Study|Withdrawal by Subject|4|||
125118062|NCT01506323|450055219|FG000|Overall Study|Lack of Efficacy|1|||
125118063|NCT01506323|450055220|FG001|Overall Study|Lack of Efficacy|3|||
125118064|NCT01506323|450055219|FG000|Overall Study|Moved out of area|5|||
125118065|NCT01506323|450055220|FG001|Overall Study|Moved out of area|2|||
125118066|NCT01506323|450055219|FG000|Overall Study|Schedule or Transportation conflict|8|||
125118067|NCT01506323|450055220|FG001|Overall Study|Schedule or Transportation conflict|0|||
125118068|NCT01506323|450055219|FG000|Overall Study|Started another treatment|1|||
124923323|NCT03544281|449348326|FG006|Main Study Phase|Did not receive study treatment|1|||
124923324|NCT03544281|449348327|FG007|Main Study Phase|Did not receive study treatment|0|||
124923325|NCT03544281|449348328|FG008|Main Study Phase|Did not receive study treatment|0|||
124923326|NCT03544281|449348329|FG009|Main Study Phase|Did not receive study treatment|0|||
124923327|NCT03544281|449348330|FG010|Main Study Phase|Did not receive study treatment|0|||
124923328|NCT03544281|449348331|FG011|Main Study Phase|Did not receive study treatment|0|||
124923329|NCT03544281|449348332|FG012|Main Study Phase|Did not receive study treatment|0|||
124923330|NCT03544281|449348333|FG013|Main Study Phase|Did not receive study treatment|0|||
124923331|NCT03544281|449348334|FG014|Main Study Phase|Did not receive study treatment|0|||
124923332|NCT03544281|449348335|FG015|Main Study Phase|Did not receive study treatment|0|||
124923333|NCT03544281|449348336|FG016|Main Study Phase|Did not receive study treatment|0|||
124923334|NCT03544281|449348337|FG017|Main Study Phase|Did not receive study treatment|0|||
124923335|NCT03544281|449348338|FG018|Main Study Phase|Did not receive study treatment|0|||
124923336|NCT03544281|449348339|FG019|Main Study Phase|Did not receive study treatment|0|||
125212145|NCT04575584|450403276|FG005|Overall Study|Physician Decision|0|||
125212146|NCT04575584|450403271|FG000|Overall Study|Withdrawal by Subject|7|||
125212147|NCT04575584|450403272|FG001|Overall Study|Withdrawal by Subject|9|||
125212148|NCT04575584|450403273|FG002|Overall Study|Withdrawal by Subject|5|||
125212149|NCT04575584|450403274|FG003|Overall Study|Withdrawal by Subject|3|||
125212150|NCT04575584|450403275|FG004|Overall Study|Withdrawal by Subject|0|||
125212151|NCT04575584|450403276|FG005|Overall Study|Withdrawal by Subject|0|||
125212152|NCT04575584|450403271|FG000|Overall Study|Not recorded|0|||
125212153|NCT04575584|450403272|FG001|Overall Study|Not recorded|0|||
125212154|NCT04575584|450403273|FG002|Overall Study|Not recorded|0|||
125212155|NCT04575584|450403274|FG003|Overall Study|Not recorded|1|||
125212156|NCT04575584|450403275|FG004|Overall Study|Not recorded|0|||
125212157|NCT04575584|450403276|FG005|Overall Study|Not recorded|0|||
125212158|NCT03488563|450403277|FG000|Overall Study|Lost to Follow-up|7|||
125212159|NCT03488563|450403278|FG001|Overall Study|Lost to Follow-up|6|||
125212160|NCT03488563|450403279|FG002|Overall Study|Lost to Follow-up|7|||
125212161|NCT03488563|450403277|FG000|Overall Study|Withdrawal by Subject|8|||
125212162|NCT03488563|450403278|FG001|Overall Study|Withdrawal by Subject|7|||
125212163|NCT03488563|450403279|FG002|Overall Study|Withdrawal by Subject|7|||
125212164|NCT03488563|450403277|FG000|Overall Study|Physician Decision|0|||
125212165|NCT03488563|450403278|FG001|Overall Study|Physician Decision|0|||
125212166|NCT03488563|450403279|FG002|Overall Study|Physician Decision|1|||
125212167|NCT03488563|450403277|FG000|Overall Study|Protocol Violation|3|||
125212168|NCT03488563|450403278|FG001|Overall Study|Protocol Violation|2|||
125212169|NCT03488563|450403279|FG002|Overall Study|Protocol Violation|6|||
125212170|NCT03488563|450403277|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
125212171|NCT03488563|450403278|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
125212172|NCT03488563|450403279|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
125212173|NCT03488563|450403277|FG000|Overall Study|Use of prohibited medication|2|||
125212174|NCT03488563|450403278|FG001|Overall Study|Use of prohibited medication|0|||
125212175|NCT03488563|450403279|FG002|Overall Study|Use of prohibited medication|0|||
125212176|NCT03488563|450403277|FG000|Overall Study|Adverse Event|1|||
125212177|NCT03488563|450403278|FG001|Overall Study|Adverse Event|0|||
124923337|NCT03544281|449348340|FG020|Main Study Phase|Did not receive study treatment|0|||
124923338|NCT03544281|449348341|FG021|Main Study Phase|Did not receive study treatment|0|||
124923339|NCT03544281|449348320|FG000|PACT Phase|Adverse Event|0|||
124923340|NCT03544281|449348321|FG001|PACT Phase|Adverse Event|0|||
124923341|NCT03544281|449348322|FG002|PACT Phase|Adverse Event|0|||
124923342|NCT03544281|449348323|FG003|PACT Phase|Adverse Event|0|||
124923343|NCT03544281|449348324|FG004|PACT Phase|Adverse Event|0|||
124923344|NCT03544281|449348325|FG005|PACT Phase|Adverse Event|0|||
124923345|NCT03544281|449348326|FG006|PACT Phase|Adverse Event|0|||
124923346|NCT03544281|449348327|FG007|PACT Phase|Adverse Event|0|||
124923347|NCT03544281|449348328|FG008|PACT Phase|Adverse Event|0|||
124923348|NCT03544281|449348329|FG009|PACT Phase|Adverse Event|0|||
124923349|NCT03544281|449348330|FG010|PACT Phase|Adverse Event|0|||
124923350|NCT03544281|449348331|FG011|PACT Phase|Adverse Event|0|||
124923351|NCT03544281|449348332|FG012|PACT Phase|Adverse Event|1|||
124923352|NCT03544281|449348333|FG013|PACT Phase|Adverse Event|0|||
124923353|NCT03544281|449348334|FG014|PACT Phase|Adverse Event|0|||
124923354|NCT03544281|449348335|FG015|PACT Phase|Adverse Event|0|||
124923355|NCT03544281|449348336|FG016|PACT Phase|Adverse Event|0|||
124923356|NCT03544281|449348337|FG017|PACT Phase|Adverse Event|1|||
124923357|NCT03544281|449348338|FG018|PACT Phase|Adverse Event|1|||
124923358|NCT03544281|449348339|FG019|PACT Phase|Adverse Event|0|||
124923359|NCT03544281|449348340|FG020|PACT Phase|Adverse Event|0|||
124923360|NCT03544281|449348341|FG021|PACT Phase|Adverse Event|0|||
124923361|NCT04876118|449348343|FG000|Overall Study|Pregnancy|1|||
124923362|NCT04876118|449348343|FG000|Overall Study|Withdrawal by Subject|14|||
124923363|NCT03092518|449348344|FG000|Overall Study|Ineligible|2|||
124923364|NCT02547987|449348347|FG000|Overall Study|Withdrawal by Subject|1|||
124923365|NCT02547987|449348347|FG000|Overall Study|Adverse Event|2|||
124923366|NCT04282148|449348348|FG000|Overall Study|Death|7|||
124923367|NCT04282148|449348348|FG000|Overall Study|Withdrawal by Subject|1|||
124923368|NCT04282148|449348348|FG000|Overall Study|Physician Decision|1|||
124923369|NCT04925986|449348349|FG000|Overall Study|Death|0|||
124923370|NCT04925986|449348350|FG001|Overall Study|Death|0|||
124923371|NCT04925986|449348351|FG002|Overall Study|Death|2|||
124923372|NCT04925986|449348352|FG003|Overall Study|Death|0|||
124923373|NCT04925986|449348349|FG000|Overall Study|Lack of Efficacy|1|||
124923374|NCT04925986|449348350|FG001|Overall Study|Lack of Efficacy|2|||
124923375|NCT04925986|449348351|FG002|Overall Study|Lack of Efficacy|0|||
124923376|NCT04925986|449348352|FG003|Overall Study|Lack of Efficacy|1|||
124923377|NCT04925986|449348349|FG000|Overall Study|Withdrawal by Subject|0|||
124923378|NCT04925986|449348350|FG001|Overall Study|Withdrawal by Subject|0|||
124923379|NCT04925986|449348351|FG002|Overall Study|Withdrawal by Subject|1|||
124923380|NCT04925986|449348352|FG003|Overall Study|Withdrawal by Subject|2|||
124923381|NCT06181760|449348353|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
124923382|NCT06181760|449348354|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
125023816|NCT03529773|449711335|FG002|Overall Study|Adverse Event|0|||
125023817|NCT03529773|449711336|FG003|Overall Study|Adverse Event|0|||
125023818|NCT03529773|449711337|FG004|Overall Study|Adverse Event|0|||
125023819|NCT03529773|449711338|FG005|Overall Study|Adverse Event|0|||
124923383|NCT06181760|449348355|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
124923384|NCT06181760|449348356|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
124923385|NCT04770532|449348357|FG000|Overall Study|Withdrawal by Subject|0|||
124923386|NCT04770532|449348358|FG001|Overall Study|Withdrawal by Subject|3|||
124923387|NCT04770532|449348357|FG000|Overall Study|Physician Decision|1|||
124923388|NCT04770532|449348358|FG001|Overall Study|Physician Decision|0|||
124923389|NCT04770532|449348357|FG000|Overall Study|Death|2|||
124923390|NCT04770532|449348358|FG001|Overall Study|Death|2|||
124923391|NCT04938492|449348359|FG000|Overall Study|Lost to Follow-up|17|||
124923392|NCT04938492|449348360|FG001|Overall Study|Lost to Follow-up|18|||
124923393|NCT04025554|449348361|FG000|Overall Study|Adverse Event|3|||
124923394|NCT04338061|449348364|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
125118069|NCT01506323|450055220|FG001|Overall Study|Started another treatment|0|||
125118070|NCT02192905|450055221|FG000|Overall Study|Lost to Follow-up|1|||
125118071|NCT04604184|450055233|FG000|Overall Study|Adverse Event|5|||
125118072|NCT04604184|450055234|FG001|Overall Study|Adverse Event|5|||
125118073|NCT04604184|450055233|FG000|Overall Study|Death|2|||
124923395|NCT04338061|449348365|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
124923396|NCT04338061|449348364|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
124969557|NCT03520075|449517413|FG004|Phase 2 (Dose Expansion)|Death|0|||
125118074|NCT04604184|450055234|FG001|Overall Study|Death|1|||
125118075|NCT04604184|450055233|FG000|Overall Study|Withdrawal by Subject|1|||
125118076|NCT04604184|450055234|FG001|Overall Study|Withdrawal by Subject|3|||
125118077|NCT04604184|450055233|FG000|Overall Study|Not treated|2|||
125118078|NCT04604184|450055234|FG001|Overall Study|Not treated|2|||
125118079|NCT04604184|450055233|FG000|Overall Study|Due to sponsor decision|9|||
125118080|NCT04604184|450055234|FG001|Overall Study|Due to sponsor decision|7|||
125118081|NCT04604184|450055233|FG000|Overall Study|Physician Decision|0|||
125118082|NCT04604184|450055234|FG001|Overall Study|Physician Decision|1|||
125118083|NCT04604184|450055233|FG000|Overall Study|Transfer to healthcare|1|||
125118084|NCT04604184|450055234|FG001|Overall Study|Transfer to healthcare|0|||
125118085|NCT03294538|450055237|FG000|Overall Study|Adverse Event|0|||
125118086|NCT03294538|450055238|FG001|Overall Study|Adverse Event|1|||
125118087|NCT03294538|450055239|FG002|Overall Study|Adverse Event|1|||
125118088|NCT03294538|450055237|FG000|Overall Study|Lost to Follow-up|1|||
125118089|NCT03294538|450055238|FG001|Overall Study|Lost to Follow-up|0|||
125118090|NCT03294538|450055239|FG002|Overall Study|Lost to Follow-up|0|||
125118091|NCT03294538|450055237|FG000|Overall Study|Outside of Visit Window|4|||
125118092|NCT03294538|450055238|FG001|Overall Study|Outside of Visit Window|4|||
125118093|NCT03294538|450055239|FG002|Overall Study|Outside of Visit Window|1|||
125118094|NCT01787825|450055241|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
125118095|NCT01787825|450055242|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
125118096|NCT01787825|450055241|FG000|Overall Study|Data Not Analyzable|5|||
125118097|NCT01787825|450055242|FG001|Overall Study|Data Not Analyzable|1|||
125118098|NCT01338636|450055251|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
125118099|NCT02385526|450055252|FG000|Overall Study|Withdrawal by Subject|0|||
125118100|NCT02385526|450055253|FG001|Overall Study|Withdrawal by Subject|2|||
125118101|NCT02385526|450055254|FG002|Overall Study|Withdrawal by Subject|0|||
125118102|NCT02385526|450055252|FG000|Overall Study|Lost to Follow-up|0|||
125118103|NCT02385526|450055253|FG001|Overall Study|Lost to Follow-up|1|||
125118104|NCT02385526|450055254|FG002|Overall Study|Lost to Follow-up|0|||
125118105|NCT02385526|450055252|FG000|Overall Study|Physician Decision|1|||
125118106|NCT02385526|450055253|FG001|Overall Study|Physician Decision|0|||
125118107|NCT02385526|450055254|FG002|Overall Study|Physician Decision|0|||
125118108|NCT02385526|450055252|FG000|Overall Study|Protocol Violation|1|||
125118109|NCT02385526|450055253|FG001|Overall Study|Protocol Violation|0|||
125118110|NCT02385526|450055254|FG002|Overall Study|Protocol Violation|0|||
125118111|NCT01798485|450055259|FG000|Overall Study|Adverse Event|32|||
125118112|NCT01798485|450055260|FG001|Overall Study|Adverse Event|40|||
125118113|NCT01798485|450055259|FG000|Overall Study|Withdrawal by Subject|27|||
125118114|NCT01798485|450055260|FG001|Overall Study|Withdrawal by Subject|31|||
125118115|NCT01798485|450055259|FG000|Overall Study|Lost to Follow-up|0|||
125118116|NCT01798485|450055260|FG001|Overall Study|Lost to Follow-up|3|||
125118117|NCT01798485|450055259|FG000|Overall Study|Physician Decision|14|||
125118118|NCT01798485|450055260|FG001|Overall Study|Physician Decision|10|||
125118119|NCT01798485|450055259|FG000|Overall Study|Objective Disease Progression|152|||
125118120|NCT01798485|450055260|FG001|Overall Study|Objective Disease Progression|106|||
125118121|NCT01798485|450055259|FG000|Overall Study|Death|25|||
125118122|NCT01798485|450055260|FG001|Overall Study|Death|22|||
125118123|NCT01798485|450055259|FG000|Overall Study|Sponsor Decision|61|||
125118124|NCT01798485|450055260|FG001|Overall Study|Sponsor Decision|54|||
125118125|NCT01798485|450055259|FG000|Overall Study|Clinical Progression|35|||
125118126|NCT01798485|450055260|FG001|Overall Study|Clinical Progression|24|||
125118127|NCT03361423|450055261|FG000|Overall Study|Withdrawal by Subject|4|||
125118128|NCT03361423|450055262|FG001|Overall Study|Withdrawal by Subject|3|||
125118129|NCT03361423|450055261|FG000|Overall Study|Did not treat|19|||
125118130|NCT03361423|450055262|FG001|Overall Study|Did not treat|18|||
125118131|NCT03361423|450055261|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
125118132|NCT03361423|450055262|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
125118133|NCT03361423|450055261|FG000|Overall Study|Missing data|4|||
125118134|NCT03361423|450055262|FG001|Overall Study|Missing data|1|||
125118135|NCT01254409|450055263|FG000|Overall Study|Adverse Event|0|||
125118136|NCT01254409|450055264|FG001|Overall Study|Adverse Event|1|||
125118137|NCT01254409|450055265|FG002|Overall Study|Adverse Event|0|||
125118138|NCT01254409|450055266|FG003|Overall Study|Adverse Event|0|||
125118139|NCT01076166|450055268|FG000|Overall Study|Adverse Event|3|||
125118140|NCT01076166|450055268|FG000|Overall Study|Symptoms improved/resolved|6|||
125118141|NCT02970669|450055271|FG000|Double-blind Period|Adverse Event|4|||
125118142|NCT02970669|450055272|FG001|Double-blind Period|Adverse Event|0|||
125118143|NCT02970669|450055271|FG000|Double-blind Period|Death|1|||
125118144|NCT02970669|450055272|FG001|Double-blind Period|Death|0|||
125118145|NCT02970669|450055271|FG000|Double-blind Period|Study terminated by sponsor|1|||
125118146|NCT02970669|450055272|FG001|Double-blind Period|Study terminated by sponsor|2|||
125118147|NCT02970669|450055271|FG000|Double-blind Period|Physician Decision|0|||
125118148|NCT02970669|450055272|FG001|Double-blind Period|Physician Decision|2|||
125118149|NCT02970669|450055271|FG000|Double-blind Period|Withdrawal by Subject|2|||
125118150|NCT02970669|450055272|FG001|Double-blind Period|Withdrawal by Subject|2|||
125118151|NCT02970669|450055271|FG000|Open-label Period|Withdrawal by Subject|2|||
125118152|NCT02970669|450055272|FG001|Open-label Period|Withdrawal by Subject|2|||
124923397|NCT04338061|449348365|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
124923398|NCT04338061|449348364|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
124923399|NCT04338061|449348365|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
124923400|NCT04338061|449348364|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
124923401|NCT04338061|449348365|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
124923402|NCT04338061|449348364|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
124923403|NCT04338061|449348365|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
124923404|NCT04338061|449348364|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
124923405|NCT04338061|449348365|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
124923406|NCT04338061|449348364|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
124923407|NCT04338061|449348365|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
124923408|NCT04338061|449348364|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
124923409|NCT04338061|449348365|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
124923410|NCT04338061|449348364|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
124923411|NCT04338061|449348365|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
124923412|NCT04338061|449348364|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
124923413|NCT04338061|449348365|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
124923414|NCT04338061|449348364|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
124923415|NCT04338061|449348365|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
124923416|NCT04338061|449348364|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
124923417|NCT04338061|449348365|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
124923418|NCT03631784|449348367|FG000|Overall Study|Participants Ongoing|1|||
124923419|NCT03631784|449348368|FG001|Overall Study|Participants Ongoing|0|||
124923420|NCT03631784|449348367|FG000|Overall Study|Withdrawal by Subject|3|||
124923421|NCT03631784|449348368|FG001|Overall Study|Withdrawal by Subject|3|||
125118153|NCT02970669|450055271|FG000|Open-label Period|Adverse Event|1|||
125118154|NCT02970669|450055272|FG001|Open-label Period|Adverse Event|0|||
125118155|NCT02970669|450055271|FG000|Open-label Period|Physician Decision|1|||
125118156|NCT02970669|450055272|FG001|Open-label Period|Physician Decision|0|||
125118157|NCT03521999|450055273|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
125118158|NCT03521999|450055274|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
125118159|NCT03521999|450055273|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
125118160|NCT03521999|450055274|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
125118161|NCT03521999|450055273|FG000|Completed 3 Month Follow up|Death|0|||
125118162|NCT03521999|450055274|FG001|Completed 3 Month Follow up|Death|1|||
125118163|NCT03521999|450055273|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
125118164|NCT03521999|450055274|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
125118165|NCT01564758|450055275|FG000|Overall Study|Death|8|||
125118166|NCT01564758|450055275|FG000|Overall Study|Adverse Event|3|||
125118167|NCT01564758|450055275|FG000|Overall Study|Other|3|||
125118168|NCT00249821|450055276|FG000|Overall Study|Technical problem|0|||
125118169|NCT00249821|450055277|FG001|Overall Study|Technical problem|1|||
125118170|NCT01498484|450055283|FG000|Overall Study|Death|6|||
125118171|NCT01498484|450055284|FG001|Overall Study|Death|3|||
125118172|NCT01498484|450055285|FG002|Overall Study|Death|1|||
125118173|NCT01498484|450055286|FG003|Overall Study|Death|1|||
125118174|NCT01498484|450055287|FG004|Overall Study|Death|0|||
125118175|NCT01498484|450055288|FG005|Overall Study|Death|0|||
125118176|NCT01498484|450055289|FG006|Overall Study|Death|10|||
125118177|NCT01498484|450055290|FG007|Overall Study|Death|1|||
125118178|NCT01498484|450055291|FG008|Overall Study|Death|0|||
125118179|NCT01498484|450055283|FG000|Overall Study|Physician Decision|3|||
125118180|NCT01498484|450055284|FG001|Overall Study|Physician Decision|2|||
125118181|NCT01498484|450055285|FG002|Overall Study|Physician Decision|1|||
125118182|NCT01498484|450055286|FG003|Overall Study|Physician Decision|1|||
125118183|NCT01498484|450055287|FG004|Overall Study|Physician Decision|0|||
124923422|NCT03631784|449348367|FG000|Overall Study|Sponsor's Decision|36|||
124923423|NCT03631784|449348368|FG001|Overall Study|Sponsor's Decision|52|||
124923424|NCT03631784|449348367|FG000|Overall Study|Lost to Follow-up|1|||
124923425|NCT03631784|449348368|FG001|Overall Study|Lost to Follow-up|0|||
124923426|NCT03631784|449348367|FG000|Overall Study|Death|71|||
124923427|NCT03631784|449348368|FG001|Overall Study|Death|49|||
124923428|NCT04437615|449348372|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
124923429|NCT02035787|449350413|FG000|Overall Study- 12 Months|Adverse Event|3|||
125118184|NCT01498484|450055288|FG005|Overall Study|Physician Decision|0|||
125118185|NCT01498484|450055289|FG006|Overall Study|Physician Decision|8|||
125118186|NCT01498484|450055290|FG007|Overall Study|Physician Decision|13|||
125118187|NCT01498484|450055291|FG008|Overall Study|Physician Decision|1|||
125118188|NCT01498484|450055283|FG000|Overall Study|Adverse Event|0|||
125118189|NCT01498484|450055284|FG001|Overall Study|Adverse Event|0|||
125118190|NCT01498484|450055285|FG002|Overall Study|Adverse Event|0|||
125118191|NCT01498484|450055286|FG003|Overall Study|Adverse Event|0|||
125118192|NCT01498484|450055287|FG004|Overall Study|Adverse Event|0|||
125118193|NCT01498484|450055288|FG005|Overall Study|Adverse Event|1|||
125118194|NCT01498484|450055289|FG006|Overall Study|Adverse Event|0|||
124923430|NCT02035787|449350414|FG001|Overall Study- 12 Months|Adverse Event|0|||
124923431|NCT02035787|449350413|FG000|Overall Study- 12 Months|Complete response|4|||
124923432|NCT02035787|449350414|FG001|Overall Study- 12 Months|Complete response|1|||
124923433|NCT02035787|449350413|FG000|Overall Study- 12 Months|Protocol Violation|1|||
124923434|NCT02035787|449350414|FG001|Overall Study- 12 Months|Protocol Violation|1|||
124923435|NCT06414213|449350415|FG000|Overall Study|Lost to Follow-up|1|||
124923436|NCT06414213|449350416|FG001|Overall Study|Lost to Follow-up|1|||
125023820|NCT03529773|449711339|FG006|Overall Study|Adverse Event|0|||
125023821|NCT03529773|449711340|FG007|Overall Study|Adverse Event|0|||
125212178|NCT03488563|450403279|FG002|Overall Study|Adverse Event|1|||
125212179|NCT03488563|450403277|FG000|Overall Study|Subject returned for ET visit|0|||
125212180|NCT03488563|450403278|FG001|Overall Study|Subject returned for ET visit|1|||
125212181|NCT03488563|450403279|FG002|Overall Study|Subject returned for ET visit|0|||
125212182|NCT03488563|450403277|FG000|Overall Study|Sponsor's decision|0|||
125212183|NCT03488563|450403278|FG001|Overall Study|Sponsor's decision|0|||
125212184|NCT03488563|450403279|FG002|Overall Study|Sponsor's decision|1|||
125212185|NCT02815267|450403287|FG000|Double-Blind Phase|Adverse Event|0|||
125212186|NCT02815267|450403288|FG001|Double-Blind Phase|Adverse Event|3|||
125212187|NCT02815267|450403287|FG000|Double-Blind Phase|Lost to Follow-up|17|||
124923437|NCT06414213|449350417|FG002|Overall Study|Lost to Follow-up|3|||
125023822|NCT03529773|449711341|FG008|Overall Study|Adverse Event|0|||
125023823|NCT03529773|449711342|FG009|Overall Study|Adverse Event|0|||
125023824|NCT03529773|449711343|FG010|Overall Study|Adverse Event|0|||
125023825|NCT03529773|449711344|FG011|Overall Study|Adverse Event|0|||
125023826|NCT03529773|449711345|FG012|Overall Study|Adverse Event|0|||
125023827|NCT03529773|449711346|FG013|Overall Study|Adverse Event|0|||
125023828|NCT03529773|449711347|FG014|Overall Study|Adverse Event|0|||
125023829|NCT03529773|449711348|FG015|Overall Study|Adverse Event|0|||
125023830|NCT03529773|449711349|FG016|Overall Study|Adverse Event|0|||
125023831|NCT03529773|449711350|FG017|Overall Study|Adverse Event|0|||
125023832|NCT03529773|449711351|FG018|Overall Study|Adverse Event|0|||
125023833|NCT03529773|449711352|FG019|Overall Study|Adverse Event|0|||
125023834|NCT03529773|449711353|FG020|Overall Study|Adverse Event|0|||
125023835|NCT03529773|449711354|FG021|Overall Study|Adverse Event|0|||
125023836|NCT03529773|449711355|FG022|Overall Study|Adverse Event|0|||
125023837|NCT03529773|449711356|FG023|Overall Study|Adverse Event|0|||
125023838|NCT03529773|449711357|FG024|Overall Study|Adverse Event|0|||
125212188|NCT02815267|450403288|FG001|Double-Blind Phase|Lost to Follow-up|9|||
125212189|NCT02815267|450403287|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
124923438|NCT01396278|449350418|FG000|Overall Study|Adverse Event|0|||
124923439|NCT01396278|449350419|FG001|Overall Study|Adverse Event|0|||
124923440|NCT01396278|449350420|FG002|Overall Study|Adverse Event|0|||
124923441|NCT01396278|449350421|FG003|Overall Study|Adverse Event|2|||
124923442|NCT01396278|449350422|FG004|Overall Study|Adverse Event|0|||
124923443|NCT01396278|449350418|FG000|Overall Study|Withdraw due to trial termination|2|||
124923444|NCT01396278|449350419|FG001|Overall Study|Withdraw due to trial termination|1|||
124923445|NCT01396278|449350420|FG002|Overall Study|Withdraw due to trial termination|1|||
124923446|NCT01396278|449350421|FG003|Overall Study|Withdraw due to trial termination|0|||
124923447|NCT01396278|449350422|FG004|Overall Study|Withdraw due to trial termination|2|||
124923448|NCT04515576|449350425|FG000|Overall Study|Withdrawal by Subject|0|||
124923449|NCT04515576|449350426|FG001|Overall Study|Withdrawal by Subject|0|||
124923450|NCT04515576|449350427|FG002|Overall Study|Withdrawal by Subject|0|||
124923451|NCT04515576|449350428|FG003|Overall Study|Withdrawal by Subject|0|||
124923452|NCT04515576|449350429|FG004|Overall Study|Withdrawal by Subject|0|||
124923453|NCT04515576|449350430|FG005|Overall Study|Withdrawal by Subject|1|||
124923454|NCT05028634|449350431|FG000|Overall Study|Withdrawal by Subject|0|||
124923455|NCT05028634|449350432|FG001|Overall Study|Withdrawal by Subject|1|||
124923456|NCT04728347|449350433|FG000|Overall Study|Sponsor decision|0|||
124923457|NCT04728347|449350434|FG001|Overall Study|Sponsor decision|0|||
124923458|NCT04728347|449350435|FG002|Overall Study|Sponsor decision|1|||
124923459|NCT04728347|449350436|FG003|Overall Study|Sponsor decision|0|||
124923460|NCT03953508|449350437|FG000|Baseline|Lost to Follow-up|3|||
124923461|NCT03953508|449350438|FG001|Baseline|Lost to Follow-up|2|||
124923462|NCT03953508|449350437|FG000|6-month Follow-up|Lost to Follow-up|62|||
124923463|NCT03953508|449350438|FG001|6-month Follow-up|Lost to Follow-up|70|||
124923464|NCT05308004|449350443|FG000|Overall Study|Not seen by Palliative Care NP|0|||
124923465|NCT05308004|449350444|FG001|Overall Study|Not seen by Palliative Care NP|1|||
124923466|NCT01160211|449350447|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
124923467|NCT01160211|449350448|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
124923468|NCT01160211|449350449|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
124923469|NCT01160211|449350447|FG000|Overall Study|Lost to Follow-up|4|||
124923470|NCT01160211|449350448|FG001|Overall Study|Lost to Follow-up|8|||
124923471|NCT01160211|449350449|FG002|Overall Study|Lost to Follow-up|4|||
124923472|NCT01160211|449350447|FG000|Overall Study|Physician Decision|1|||
125118195|NCT01498484|450055290|FG007|Overall Study|Adverse Event|0|||
125118196|NCT01498484|450055291|FG008|Overall Study|Adverse Event|0|||
125118197|NCT01498484|450055283|FG000|Overall Study|Withdrawal by Subject|0|||
125118198|NCT01498484|450055284|FG001|Overall Study|Withdrawal by Subject|0|||
125118199|NCT01498484|450055285|FG002|Overall Study|Withdrawal by Subject|0|||
125118200|NCT01498484|450055286|FG003|Overall Study|Withdrawal by Subject|1|||
125118201|NCT01498484|450055287|FG004|Overall Study|Withdrawal by Subject|0|||
125118202|NCT01498484|450055288|FG005|Overall Study|Withdrawal by Subject|0|||
125118203|NCT01498484|450055289|FG006|Overall Study|Withdrawal by Subject|1|||
125118204|NCT01498484|450055290|FG007|Overall Study|Withdrawal by Subject|0|||
125118205|NCT01498484|450055291|FG008|Overall Study|Withdrawal by Subject|0|||
125118206|NCT01498484|450055283|FG000|Overall Study|Other|5|||
125118207|NCT01498484|450055284|FG001|Overall Study|Other|2|||
125118208|NCT01498484|450055285|FG002|Overall Study|Other|0|||
125118209|NCT01498484|450055286|FG003|Overall Study|Other|0|||
125118210|NCT01498484|450055287|FG004|Overall Study|Other|1|||
125118211|NCT01498484|450055288|FG005|Overall Study|Other|0|||
125118212|NCT01498484|450055289|FG006|Overall Study|Other|3|||
125118213|NCT01498484|450055290|FG007|Overall Study|Other|0|||
125118214|NCT01498484|450055291|FG008|Overall Study|Other|1|||
125118215|NCT00278512|450055292|FG000|Overall Study|Death|1|||
125118216|NCT00278512|450055293|FG001|Overall Study|Death|0|||
125118217|NCT01202747|450055294|FG000|Overall Study|Withdrawal by Subject|1|||
125118218|NCT01620177|450055295|FG000|Overall Study|Failure at Screening Visit|43|||
125118219|NCT01620177|450055295|FG000|Overall Study|Withdrawal by Subject|26|||
125118220|NCT01620177|450055295|FG000|Overall Study|Lost to Follow-up|7|||
125118221|NCT01620177|450055295|FG000|Overall Study|Physician Decision|2|||
125118222|NCT01620177|450055295|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
125118223|NCT02292238|450055299|FG000|Overall Study|Protocol Violation|1|||
125118224|NCT02292238|450055300|FG001|Overall Study|Protocol Violation|2|||
125118225|NCT02292238|450055299|FG000|Overall Study|Withdrawal by Subject|2|||
125118226|NCT02292238|450055300|FG001|Overall Study|Withdrawal by Subject|1|||
125118227|NCT02292238|450055299|FG000|Overall Study|Lost to Follow-up|1|||
125118228|NCT02292238|450055300|FG001|Overall Study|Lost to Follow-up|0|||
125118229|NCT02292238|450055299|FG000|Overall Study|Physician Decision|0|||
125118230|NCT02292238|450055300|FG001|Overall Study|Physician Decision|1|||
125118231|NCT01789320|450055301|FG000|Overall Study|Re-enrolled into study|1|||
125118232|NCT01789320|450055301|FG000|Overall Study|Lost to Follow-up|1|||
125118233|NCT00601484|450055307|FG000|Overall Study|Adverse Event|0|||
125118234|NCT00601484|450055308|FG001|Overall Study|Adverse Event|1|||
125118235|NCT00601484|450055307|FG000|Overall Study|Lost to Follow-up|4|||
125118236|NCT00601484|450055308|FG001|Overall Study|Lost to Follow-up|3|||
125118237|NCT00601484|450055307|FG000|Overall Study|Lack of Efficacy|0|||
125118238|NCT00601484|450055308|FG001|Overall Study|Lack of Efficacy|2|||
125118239|NCT00601484|450055307|FG000|Overall Study|Withdrawal by Subject|1|||
125118240|NCT00601484|450055308|FG001|Overall Study|Withdrawal by Subject|1|||
125118241|NCT00601484|450055307|FG000|Overall Study|Randomized, but not treated|0|||
125118242|NCT00601484|450055308|FG001|Overall Study|Randomized, but not treated|1|||
125118243|NCT01463683|450055313|FG000|Overall Study|Adverse Event|2|||
125118244|NCT01463683|450055314|FG001|Overall Study|Adverse Event|0|||
125118245|NCT01463683|450055315|FG002|Overall Study|Adverse Event|0|||
125118246|NCT01463683|450055313|FG000|Overall Study|Lost to Follow-up|10|||
125118247|NCT01463683|450055314|FG001|Overall Study|Lost to Follow-up|9|||
124923473|NCT01160211|449350448|FG001|Overall Study|Physician Decision|0|||
124923474|NCT01160211|449350449|FG002|Overall Study|Physician Decision|0|||
124923475|NCT01160211|449350447|FG000|Overall Study|Withdrawal by Subject|4|||
124923476|NCT01160211|449350448|FG001|Overall Study|Withdrawal by Subject|2|||
124923477|NCT01160211|449350449|FG002|Overall Study|Withdrawal by Subject|2|||
124923478|NCT01160211|449350447|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
124923479|NCT01160211|449350448|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
124923480|NCT01160211|449350449|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
124923481|NCT02577835|449350450|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
124923482|NCT05409183|449350451|FG000|Complete Study|Adverse Event|1|||
124923483|NCT05409183|449350452|FG001|Complete Study|Adverse Event|2|||
124923484|NCT05409183|449350451|FG000|Complete Study|Withdrawal by Subject|3|||
124923485|NCT05409183|449350452|FG001|Complete Study|Withdrawal by Subject|0|||
125118248|NCT01463683|450055315|FG002|Overall Study|Lost to Follow-up|7|||
125118249|NCT01463683|450055313|FG000|Overall Study|Physician Decision|0|||
125118250|NCT01463683|450055314|FG001|Overall Study|Physician Decision|3|||
125118251|NCT01463683|450055315|FG002|Overall Study|Physician Decision|1|||
125118252|NCT01463683|450055313|FG000|Overall Study|Pregnancy|2|||
125118253|NCT01463683|450055314|FG001|Overall Study|Pregnancy|2|||
125118254|NCT01463683|450055315|FG002|Overall Study|Pregnancy|1|||
125118255|NCT01463683|450055313|FG000|Overall Study|Withdrawal by Subject|5|||
125118256|NCT01463683|450055314|FG001|Overall Study|Withdrawal by Subject|17|||
125118257|NCT01463683|450055315|FG002|Overall Study|Withdrawal by Subject|2|||
125118258|NCT01618305|450055317|FG000|Overall Study|Death|0|||
125118259|NCT01618305|450055318|FG001|Overall Study|Death|1|||
125118260|NCT01618305|450055317|FG000|Overall Study|Lost to Follow-up|11|||
125118261|NCT01618305|450055318|FG001|Overall Study|Lost to Follow-up|7|||
125118262|NCT01618305|450055317|FG000|Overall Study|Protocol Violation|1|||
125118263|NCT01618305|450055318|FG001|Overall Study|Protocol Violation|0|||
125118264|NCT01618305|450055317|FG000|Overall Study|Withdrawal by Subject|3|||
125118265|NCT01618305|450055318|FG001|Overall Study|Withdrawal by Subject|2|||
125118266|NCT02708277|450055319|FG000|Overall Study|Lost to Follow-up|7|||
125118267|NCT02708277|450055320|FG001|Overall Study|Lost to Follow-up|4|||
125118268|NCT01960816|450055321|FG000|Overall Study|Lost to Follow-up|1|||
125118269|NCT01118728|450055325|FG000|Overall Study|Adverse Event|17|||
125118270|NCT01118728|450055325|FG000|Overall Study|Lack of Efficacy|27|||
125118271|NCT01118728|450055325|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
125118272|NCT01118728|450055325|FG000|Overall Study|Withdrawal by Subject|3|||
125118273|NCT01118728|450055325|FG000|Overall Study|Lost to Follow-up|4|||
125118274|NCT04345471|450055326|FG000|Overall Study|Adverse Event|8|||
125118275|NCT04345471|450055327|FG001|Overall Study|Adverse Event|5|||
125118276|NCT04345471|450055328|FG002|Overall Study|Adverse Event|6|||
125118277|NCT04345471|450055326|FG000|Overall Study|Lack of Efficacy|1|||
125118278|NCT04345471|450055327|FG001|Overall Study|Lack of Efficacy|1|||
124923486|NCT02274662|449350453|FG000|Overall Study|Death|1|||
124923487|NCT02274662|449350453|FG000|Overall Study|Lost to Follow-up|3|||
124923488|NCT04806451|449350454|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
124923489|NCT04806451|449350455|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
124923490|NCT04806451|449350454|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
124923491|NCT04806451|449350455|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
124923492|NCT04806451|449350454|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
124923493|NCT04806451|449350455|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
124923494|NCT05835336|449350456|FG000|Overall Study|Withdrawal by Subject|5|||
124923495|NCT05835336|449350456|FG000|Overall Study|Did not complete the personalization process|3|||
124923496|NCT02936752|449350457|FG000|Overall Study|Death|2|||
124923497|NCT02936752|449350458|FG001|Overall Study|Death|1|||
124923498|NCT02936752|449350457|FG000|Overall Study|Physician Decision|4|||
124923499|NCT02936752|449350458|FG001|Overall Study|Physician Decision|0|||
124923500|NCT02936752|449350457|FG000|Overall Study|Withdrawal by Subject|0|||
124923501|NCT02936752|449350458|FG001|Overall Study|Withdrawal by Subject|2|||
124923502|NCT04489771|449350461|FG000|Overall Study|Death|27|||
124923503|NCT04489771|449350462|FG001|Overall Study|Death|25|||
124923504|NCT04489771|449350461|FG000|Overall Study|Withdrawal by Subject|1|||
124923505|NCT04489771|449350462|FG001|Overall Study|Withdrawal by Subject|0|||
124923506|NCT04489771|449350461|FG000|Overall Study|Participants Ongoing in Study|50|||
124923507|NCT04489771|449350462|FG001|Overall Study|Participants Ongoing in Study|51|||
124923508|NCT02979522|449350467|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
124923509|NCT02979522|449350468|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
124923510|NCT02979522|449350467|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
124923511|NCT02979522|449350468|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
124923512|NCT04059484|449350472|FG000|Overall Study|Adverse Event|2|||
124923513|NCT04059484|449350473|FG001|Overall Study|Adverse Event|5|||
124923514|NCT04059484|449350472|FG000|Overall Study|Withdrawal by Subject|5|||
124923515|NCT04059484|449350473|FG001|Overall Study|Withdrawal by Subject|3|||
124923516|NCT04059484|449350472|FG000|Overall Study|Progressive disease|112|||
124923517|NCT04059484|449350473|FG001|Overall Study|Progressive disease|112|||
124923518|NCT04059484|449350472|FG000|Overall Study|Other|8|||
124923519|NCT04059484|449350473|FG001|Overall Study|Other|3|||
124923520|NCT04059484|449350472|FG000|Overall Study|Ongoing|20|||
124923521|NCT04059484|449350473|FG001|Overall Study|Ongoing|20|||
124923522|NCT02949362|449350474|FG000|Retrospective Period|Inform consent not signed by participant|4|||
124923523|NCT02949362|449350475|FG001|Retrospective Period|Inform consent not signed by participant|1|||
124923524|NCT02949362|449350476|FG002|Retrospective Period|Inform consent not signed by participant|0|||
124923525|NCT02949362|449350477|FG003|Retrospective Period|Inform consent not signed by participant|0|||
125118279|NCT04345471|450055328|FG002|Overall Study|Lack of Efficacy|0|||
124923526|NCT02949362|449350474|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
124923527|NCT02949362|449350475|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
124923528|NCT02949362|449350476|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
124923529|NCT02949362|449350477|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
124923530|NCT02949362|449350474|FG000|Prospective Period|Other|0|||
124923531|NCT02949362|449350475|FG001|Prospective Period|Other|0|||
124923532|NCT02949362|449350476|FG002|Prospective Period|Other|0|||
124923533|NCT02949362|449350477|FG003|Prospective Period|Other|4|||
124923534|NCT03199469|449350481|FG000|Overall Study|Randomized, not treated|0|||
124923535|NCT03199469|449350482|FG001|Overall Study|Randomized, not treated|3|||
125118280|NCT04345471|450055326|FG000|Overall Study|Protocol Violation|0|||
125118281|NCT04345471|450055327|FG001|Overall Study|Protocol Violation|1|||
125118282|NCT04345471|450055328|FG002|Overall Study|Protocol Violation|2|||
125118283|NCT04345471|450055326|FG000|Overall Study|Withdrawal by Subject|10|||
125023839|NCT03529773|449711358|FG025|Overall Study|Adverse Event|0|||
125023840|NCT03529773|449711359|FG026|Overall Study|Adverse Event|0|||
125023841|NCT03529773|449711360|FG027|Overall Study|Adverse Event|0|||
125023842|NCT03529773|449711361|FG028|Overall Study|Adverse Event|0|||
125023843|NCT03529773|449711362|FG029|Overall Study|Adverse Event|0|||
125023844|NCT03529773|449711363|FG030|Overall Study|Adverse Event|1|||
125023845|NCT03529773|449711364|FG031|Overall Study|Adverse Event|0|||
125023846|NCT03529773|449711365|FG032|Overall Study|Adverse Event|0|||
125023847|NCT03529773|449711366|FG033|Overall Study|Adverse Event|0|||
125023848|NCT03529773|449711367|FG034|Overall Study|Adverse Event|0|||
125023849|NCT03529773|449711368|FG035|Overall Study|Adverse Event|1|||
125023850|NCT03529773|449711369|FG036|Overall Study|Adverse Event|0|||
125023851|NCT03529773|449711370|FG037|Overall Study|Adverse Event|0|||
125023852|NCT03529773|449711371|FG038|Overall Study|Adverse Event|1|||
125023853|NCT03529773|449711372|FG039|Overall Study|Adverse Event|1|||
125023854|NCT03529773|449711333|FG000|Overall Study|Death|0|||
125023855|NCT03529773|449711334|FG001|Overall Study|Death|0|||
125023856|NCT03529773|449711335|FG002|Overall Study|Death|0|||
125023857|NCT03529773|449711336|FG003|Overall Study|Death|0|||
125023858|NCT03529773|449711337|FG004|Overall Study|Death|0|||
125023859|NCT03529773|449711338|FG005|Overall Study|Death|0|||
125023860|NCT03529773|449711339|FG006|Overall Study|Death|0|||
125023861|NCT03529773|449711340|FG007|Overall Study|Death|0|||
125023862|NCT03529773|449711341|FG008|Overall Study|Death|0|||
125023863|NCT03529773|449711342|FG009|Overall Study|Death|0|||
125023864|NCT03529773|449711343|FG010|Overall Study|Death|0|||
125023865|NCT03529773|449711344|FG011|Overall Study|Death|0|||
125023866|NCT03529773|449711345|FG012|Overall Study|Death|1|||
125023867|NCT03529773|449711346|FG013|Overall Study|Death|0|||
125023868|NCT03529773|449711347|FG014|Overall Study|Death|0|||
125023869|NCT03529773|449711348|FG015|Overall Study|Death|0|||
125023870|NCT03529773|449711349|FG016|Overall Study|Death|0|||
125023871|NCT03529773|449711350|FG017|Overall Study|Death|0|||
125118284|NCT04345471|450055327|FG001|Overall Study|Withdrawal by Subject|5|||
125118285|NCT04345471|450055328|FG002|Overall Study|Withdrawal by Subject|10|||
125118286|NCT03896490|450055363|FG000|Overall Study|Withdrawal by Subject|1|||
125118287|NCT03896490|450055364|FG001|Overall Study|Withdrawal by Subject|1|||
125118288|NCT00003782|450055365|FG000|Overall Study|No follow up data|30|||
125118289|NCT00003782|450055366|FG001|Overall Study|No follow up data|31|||
125118290|NCT00003782|450055367|FG002|Overall Study|No follow up data|26|||
125118291|NCT00385541|450055368|FG000|Overall Study|severe pain, clinician requested unblind|0|||
125118292|NCT00385541|450055369|FG001|Overall Study|severe pain, clinician requested unblind|1|||
125118293|NCT01326026|450055370|FG000|Overall Study|Adverse Event|4|||
125118294|NCT01326026|450055371|FG001|Overall Study|Adverse Event|3|||
125118295|NCT01326026|450055370|FG000|Overall Study|Withdrawal Criteria|5|||
125118296|NCT01326026|450055371|FG001|Overall Study|Withdrawal Criteria|7|||
125118297|NCT01326026|450055370|FG000|Overall Study|Other|3|||
125118298|NCT01326026|450055371|FG001|Overall Study|Other|3|||
125118299|NCT05188521|450057391|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
125118300|NCT05188521|450057392|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
125118301|NCT04582266|450057393|FG000|Overall Study|Lost to Follow-up|7|||
125118302|NCT04582266|450057394|FG001|Overall Study|Lost to Follow-up|5|||
125118303|NCT04582266|450057393|FG000|Overall Study|Withdrawal by Subject|1|||
125118304|NCT04582266|450057394|FG001|Overall Study|Withdrawal by Subject|0|||
125118305|NCT04582266|450057393|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
125118306|NCT04582266|450057394|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
125118307|NCT01341639|450057395|FG000|Infant Series|Protocol Violation|1|||
125118308|NCT01341639|450057396|FG001|Infant Series|Protocol Violation|0|||
125118309|NCT01341639|450057395|FG000|Infant Series|Not Vaccinated|0|||
125212190|NCT02815267|450403288|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
125023872|NCT03529773|449711351|FG018|Overall Study|Death|0|||
125023873|NCT03529773|449711352|FG019|Overall Study|Death|1|||
125118310|NCT01341639|450057396|FG001|Infant Series|Not Vaccinated|1|||
125118311|NCT01341639|450057395|FG000|Infant Series|Adverse Event|0|||
125023874|NCT03529773|449711353|FG020|Overall Study|Death|0|||
125023875|NCT03529773|449711354|FG021|Overall Study|Death|0|||
125118312|NCT01341639|450057396|FG001|Infant Series|Adverse Event|5|||
125118313|NCT01341639|450057395|FG000|Infant Series|Withdrawal by Subject|11|||
125118314|NCT01341639|450057396|FG001|Infant Series|Withdrawal by Subject|8|||
125118315|NCT01341639|450057395|FG000|Infant Series|Lost to Follow-up|0|||
125023876|NCT03529773|449711355|FG022|Overall Study|Death|1|||
125023877|NCT03529773|449711356|FG023|Overall Study|Death|0|||
125023878|NCT03529773|449711357|FG024|Overall Study|Death|0|||
125023879|NCT03529773|449711358|FG025|Overall Study|Death|0|||
125023880|NCT03529773|449711359|FG026|Overall Study|Death|0|||
125023881|NCT03529773|449711360|FG027|Overall Study|Death|0|||
125023882|NCT03529773|449711361|FG028|Overall Study|Death|0|||
125118316|NCT01341639|450057396|FG001|Infant Series|Lost to Follow-up|2|||
125118317|NCT01341639|450057395|FG000|Infant Series|Site 0048 Participants|17|||
125118318|NCT01341639|450057396|FG001|Infant Series|Site 0048 Participants|16|||
125118319|NCT01341639|450057395|FG000|Interim Period|Withdrawal by Subject|6|||
125118320|NCT01341639|450057396|FG001|Interim Period|Withdrawal by Subject|7|||
125118321|NCT01341639|450057395|FG000|Interim Period|Lost to Follow-up|2|||
125118322|NCT01341639|450057396|FG001|Interim Period|Lost to Follow-up|0|||
125118323|NCT01341639|450057395|FG000|Interim Period|Physician Decision|0|||
125118324|NCT01341639|450057396|FG001|Interim Period|Physician Decision|1|||
125118325|NCT01341639|450057395|FG000|Interim Period|Protocol Violation|0|||
125118326|NCT01341639|450057396|FG001|Interim Period|Protocol Violation|1|||
125118327|NCT01341639|450057395|FG000|Post-Treatment|Withdrawal by Subject|0|||
125118328|NCT01341639|450057396|FG001|Post-Treatment|Withdrawal by Subject|1|||
125118329|NCT01341639|450057395|FG000|Post-Treatment|Adverse Event|0|||
125118330|NCT01341639|450057396|FG001|Post-Treatment|Adverse Event|2|||
125118331|NCT01132118|450057397|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
125118332|NCT01132118|450057398|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
125118333|NCT01132118|450057397|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
125118334|NCT01132118|450057398|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
125118335|NCT01132118|450057397|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
125118336|NCT01132118|450057398|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
125118337|NCT02742090|450057403|FG000|Overall Study|Adverse Event|10|||
125118338|NCT02742090|450057403|FG000|Overall Study|Death|3|||
125118339|NCT02742090|450057403|FG000|Overall Study|Disease Progression|25|||
125118340|NCT02742090|450057403|FG000|Overall Study|Investigator's Decision|1|||
125118341|NCT02742090|450057403|FG000|Overall Study|Lost to Follow-up|1|||
125118342|NCT02742090|450057403|FG000|Overall Study|Non-compliance with Study|1|||
125118343|NCT02742090|450057403|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
125118344|NCT02742090|450057403|FG000|Overall Study|Withdrawal by Subject|4|||
125118345|NCT02742090|450057403|FG000|Overall Study|Reason Not Specified|1|||
125118346|NCT01299038|450057404|FG000|Overall Study|Withdrawal by Subject|1|||
125118347|NCT01299038|450057405|FG001|Overall Study|Withdrawal by Subject|0|||
125118348|NCT00832078|450057406|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
125118349|NCT00832078|450057407|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
125118350|NCT00832078|450057406|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
125118351|NCT00832078|450057407|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
125118352|NCT03355742|450057408|FG000|Overall Study|Lost to Follow-up|4|||
125118353|NCT03355742|450057408|FG000|Overall Study|Withdrawal by Subject|29|||
125118354|NCT03355742|450057408|FG000|Overall Study|Physician Decision|6|||
125118355|NCT03355742|450057408|FG000|Overall Study|Death|55|||
125118356|NCT03355742|450057408|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
125118357|NCT02891200|450057418|FG000|Overall Study|Lost to Follow-up|31|||
125118358|NCT02891200|450057419|FG001|Overall Study|Lost to Follow-up|36|||
125118359|NCT02891200|450057418|FG000|Overall Study|Death|10|||
125118360|NCT02891200|450057419|FG001|Overall Study|Death|9|||
125118361|NCT02891200|450057418|FG000|Overall Study|Withdrawal by Subject|1|||
125118362|NCT02891200|450057419|FG001|Overall Study|Withdrawal by Subject|4|||
125118363|NCT04480463|450057422|FG000|Overall Study|Death|0|||
125118364|NCT04480463|450057423|FG001|Overall Study|Death|1|||
125118365|NCT04480463|450057422|FG000|Overall Study|Adverse Event|6|||
125118366|NCT04480463|450057423|FG001|Overall Study|Adverse Event|8|||
125118367|NCT04480463|450057422|FG000|Overall Study|Lost to Follow-up|3|||
125118368|NCT04480463|450057423|FG001|Overall Study|Lost to Follow-up|2|||
125118369|NCT04480463|450057422|FG000|Overall Study|Physician Decision|2|||
125118370|NCT04480463|450057423|FG001|Overall Study|Physician Decision|5|||
125118371|NCT04480463|450057422|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
125118372|NCT04480463|450057423|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
125118373|NCT04480463|450057422|FG000|Overall Study|Protocol Violation|2|||
125118374|NCT04480463|450057423|FG001|Overall Study|Protocol Violation|1|||
125118375|NCT04480463|450057422|FG000|Overall Study|Withdrawal by Subject|6|||
125118376|NCT04480463|450057423|FG001|Overall Study|Withdrawal by Subject|7|||
125118377|NCT04480463|450057422|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
125118378|NCT04480463|450057423|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
125118379|NCT04480463|450057422|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
125118380|NCT04480463|450057423|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
125118381|NCT04480463|450057422|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
125118382|NCT04480463|450057423|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
125118383|NCT04480463|450057422|FG000|Overall Study|Other|6|||
125118384|NCT04480463|450057423|FG001|Overall Study|Other|4|||
125118385|NCT00444795|450057425|FG000|Overall Study|Not Treated|1|||
125118386|NCT00444795|450057425|FG000|Overall Study|Treated Prior to the Contract Date|2|||
125118387|NCT00988169|450057426|FG000|Overall Study|Withdrawal by Subject|1|||
125212191|NCT02815267|450403287|FG000|Double-Blind Phase|Protocol Violation|3|||
124923536|NCT03199469|449350481|FG000|Overall Study|Withdrawal by Subject|1|||
124923537|NCT03199469|449350482|FG001|Overall Study|Withdrawal by Subject|0|||
124923538|NCT03199469|449350481|FG000|Overall Study|Death|1|||
124923539|NCT03199469|449350482|FG001|Overall Study|Death|3|||
124923540|NCT03199469|449350481|FG000|Overall Study|Ongoing|5|||
124923541|NCT03199469|449350482|FG001|Overall Study|Ongoing|14|||
124923542|NCT05453773|449350486|FG000|Overall Study|Withdrawal by Subject|3|||
124923543|NCT05453773|449350486|FG000|Overall Study|Lost to Follow-up|3|||
124923544|NCT05453773|449350486|FG000|Overall Study|Difficult Blood Draw|3|||
124923545|NCT02023866|449350487|FG000|Overall Study|Non-compliance|2|||
124923546|NCT02023866|449350487|FG000|Overall Study|Adverse Event|3|||
124923547|NCT02023866|449350487|FG000|Overall Study|Withdrawal by Subject|1|||
124923548|NCT02485938|449350488|FG000|Overall Study|Withdrawal of consent|2|||
124923549|NCT02485938|449350489|FG001|Overall Study|Withdrawal of consent|0|||
124923550|NCT03307343|449350490|FG000|Overall Study|Withdrawal by Subject|1|||
124923551|NCT03307343|449350491|FG001|Overall Study|Withdrawal by Subject|2|||
124923552|NCT03307343|449350490|FG000|Overall Study|Pregnancy|0|||
124923553|NCT03307343|449350491|FG001|Overall Study|Pregnancy|2|||
124923554|NCT03307343|449350490|FG000|Overall Study|Physician Decision|1|||
124923555|NCT03307343|449350491|FG001|Overall Study|Physician Decision|0|||
124923556|NCT03307343|449350490|FG000|Overall Study|Lost to Follow-up|0|||
124923557|NCT03307343|449350491|FG001|Overall Study|Lost to Follow-up|2|||
124923558|NCT04683744|449350492|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
124923559|NCT04683744|449350493|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
124923560|NCT04683744|449350494|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
124923561|NCT03447470|449350497|FG000|Overall Study|Death|0|||
124923562|NCT03447470|449350498|FG001|Overall Study|Death|1|||
124923563|NCT03447470|449350499|FG002|Overall Study|Death|3|||
124923564|NCT03447470|449350500|FG003|Overall Study|Death|0|||
124923565|NCT03447470|449350501|FG004|Overall Study|Death|1|||
124923566|NCT03447470|449350502|FG005|Overall Study|Death|0|||
124923567|NCT03447470|449350503|FG006|Overall Study|Death|3|||
124923568|NCT03447470|449350504|FG007|Overall Study|Death|3|||
124923569|NCT03447470|449350505|FG008|Overall Study|Death|1|||
124923570|NCT03447470|449350497|FG000|Overall Study|Withdrawal by Subject|1|||
124923571|NCT03447470|449350498|FG001|Overall Study|Withdrawal by Subject|0|||
124923572|NCT03447470|449350499|FG002|Overall Study|Withdrawal by Subject|0|||
124923573|NCT03447470|449350500|FG003|Overall Study|Withdrawal by Subject|0|||
124923574|NCT03447470|449350501|FG004|Overall Study|Withdrawal by Subject|1|||
124923575|NCT03447470|449350502|FG005|Overall Study|Withdrawal by Subject|0|||
124923576|NCT03447470|449350503|FG006|Overall Study|Withdrawal by Subject|1|||
124923577|NCT03447470|449350504|FG007|Overall Study|Withdrawal by Subject|1|||
124923578|NCT03447470|449350505|FG008|Overall Study|Withdrawal by Subject|3|||
124923579|NCT03447470|449350497|FG000|Overall Study|Treatment discontinued|3|||
124923580|NCT03447470|449350498|FG001|Overall Study|Treatment discontinued|2|||
124923581|NCT03447470|449350499|FG002|Overall Study|Treatment discontinued|4|||
124923582|NCT03447470|449350500|FG003|Overall Study|Treatment discontinued|6|||
124923583|NCT03447470|449350501|FG004|Overall Study|Treatment discontinued|2|||
124923584|NCT03447470|449350502|FG005|Overall Study|Treatment discontinued|1|||
124923585|NCT03447470|449350503|FG006|Overall Study|Treatment discontinued|2|||
124923586|NCT03447470|449350504|FG007|Overall Study|Treatment discontinued|4|||
124923587|NCT03447470|449350505|FG008|Overall Study|Treatment discontinued|3|||
124923588|NCT04624633|449350507|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
124923589|NCT04624633|449350508|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
124923590|NCT04624633|449350507|FG000|Overall Study|Death|1|||
124923591|NCT04624633|449350508|FG001|Overall Study|Death|0|||
124923592|NCT04316871|449350509|FG000|Overall Study|Protocol Violation|2|||
124923593|NCT04316871|449350510|FG001|Overall Study|Protocol Violation|2|||
124923594|NCT04316871|449350511|FG002|Overall Study|Protocol Violation|2|||
124923595|NCT04316871|449350512|FG003|Overall Study|Protocol Violation|2|||
124923596|NCT05087992|449350513|FG000|Overall Study|Adverse Event|0|||
124923597|NCT05087992|449350514|FG001|Overall Study|Adverse Event|1|||
124923598|NCT05087992|449350515|FG002|Overall Study|Adverse Event|0|||
124923599|NCT05087992|449350513|FG000|Overall Study|Withdrawal by Subject|2|||
124923600|NCT05087992|449350514|FG001|Overall Study|Withdrawal by Subject|0|||
124923601|NCT05087992|449350515|FG002|Overall Study|Withdrawal by Subject|0|||
124923602|NCT05087992|449350513|FG000|Overall Study|clinical disease progression|3|||
124923603|NCT05087992|449350514|FG001|Overall Study|clinical disease progression|1|||
124923604|NCT05087992|449350515|FG002|Overall Study|clinical disease progression|0|||
124923605|NCT05087992|449350513|FG000|Overall Study|objective disease progression|4|||
124923606|NCT05087992|449350514|FG001|Overall Study|objective disease progression|1|||
124923607|NCT05087992|449350515|FG002|Overall Study|objective disease progression|0|||
124923608|NCT04091750|449350516|FG000|Overall Study|Adverse Event|4|||
124923609|NCT04091750|449350516|FG000|Overall Study|Withdrawal by Subject|1|||
124923610|NCT01842542|449350517|FG000|Overall Study|Withdrawal by Subject|2|||
124923611|NCT01842542|449350517|FG000|Overall Study|Lack of Efficacy|1|||
124923612|NCT01842542|449350517|FG000|Overall Study|Protocol Non-compliance|2|||
125023883|NCT03529773|449711362|FG029|Overall Study|Death|0|||
125023884|NCT03529773|449711363|FG030|Overall Study|Death|0|||
125023885|NCT03529773|449711364|FG031|Overall Study|Death|0|||
125023886|NCT03529773|449711365|FG032|Overall Study|Death|0|||
125023887|NCT03529773|449711366|FG033|Overall Study|Death|1|||
125023888|NCT03529773|449711367|FG034|Overall Study|Death|1|||
125023889|NCT03529773|449711368|FG035|Overall Study|Death|0|||
125023890|NCT03529773|449711369|FG036|Overall Study|Death|1|||
125023891|NCT03529773|449711370|FG037|Overall Study|Death|0|||
125023892|NCT03529773|449711371|FG038|Overall Study|Death|0|||
125023893|NCT03529773|449711372|FG039|Overall Study|Death|0|||
125023894|NCT03529773|449711333|FG000|Overall Study|Lost to Follow-up|0|||
125023895|NCT03529773|449711334|FG001|Overall Study|Lost to Follow-up|0|||
125023896|NCT03529773|449711335|FG002|Overall Study|Lost to Follow-up|1|||
125023897|NCT03529773|449711336|FG003|Overall Study|Lost to Follow-up|0|||
125023898|NCT03529773|449711337|FG004|Overall Study|Lost to Follow-up|1|||
125023899|NCT03529773|449711338|FG005|Overall Study|Lost to Follow-up|1|||
125023900|NCT03529773|449711339|FG006|Overall Study|Lost to Follow-up|0|||
125023901|NCT03529773|449711340|FG007|Overall Study|Lost to Follow-up|0|||
125023902|NCT03529773|449711341|FG008|Overall Study|Lost to Follow-up|0|||
125023903|NCT03529773|449711342|FG009|Overall Study|Lost to Follow-up|0|||
125023904|NCT03529773|449711343|FG010|Overall Study|Lost to Follow-up|0|||
125118388|NCT00704418|450057427|FG000|Overall Study|Withdrawal by Subject|2|||
125118389|NCT00704418|450057428|FG001|Overall Study|Withdrawal by Subject|0|||
125118390|NCT00704418|450057427|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
125118391|NCT00704418|450057428|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
125118392|NCT02322879|450057430|FG000|First Intervention|Physician Decision|1|||
125118393|NCT02322879|450057431|FG001|First Intervention|Physician Decision|0|||
125118394|NCT02637076|450057432|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
125118395|NCT02637076|450057433|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
125118396|NCT02637076|450057432|FG000|Overall Study|Withdrawal by Subject|0|||
125118397|NCT02637076|450057433|FG001|Overall Study|Withdrawal by Subject|4|||
125118398|NCT02710071|450057435|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
125118399|NCT02710071|450057436|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
125118400|NCT02710071|450057435|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
125118401|NCT02710071|450057436|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
125118402|NCT02637557|450057440|FG000|Overall Study|Adverse Event|3|||
125118403|NCT02637557|450057441|FG001|Overall Study|Adverse Event|1|||
125118404|NCT02637557|450057442|FG002|Overall Study|Adverse Event|3|||
125118405|NCT02637557|450057443|FG003|Overall Study|Adverse Event|3|||
125118406|NCT02637557|450057440|FG000|Overall Study|Lost to Follow-up|1|||
125118407|NCT02637557|450057441|FG001|Overall Study|Lost to Follow-up|1|||
125118408|NCT02637557|450057442|FG002|Overall Study|Lost to Follow-up|0|||
125118409|NCT02637557|450057443|FG003|Overall Study|Lost to Follow-up|1|||
125118410|NCT02637557|450057440|FG000|Overall Study|Physician Decision|1|||
125118411|NCT02637557|450057441|FG001|Overall Study|Physician Decision|0|||
125118412|NCT02637557|450057442|FG002|Overall Study|Physician Decision|0|||
125118413|NCT02637557|450057443|FG003|Overall Study|Physician Decision|0|||
125118414|NCT02637557|450057440|FG000|Overall Study|Protocol Violation|2|||
125118415|NCT02637557|450057441|FG001|Overall Study|Protocol Violation|0|||
125118416|NCT02637557|450057442|FG002|Overall Study|Protocol Violation|2|||
125118417|NCT02637557|450057443|FG003|Overall Study|Protocol Violation|1|||
125118418|NCT02637557|450057440|FG000|Overall Study|Withdrawal by Subject|1|||
125118419|NCT02637557|450057441|FG001|Overall Study|Withdrawal by Subject|3|||
125118420|NCT02637557|450057442|FG002|Overall Study|Withdrawal by Subject|4|||
125118421|NCT02637557|450057443|FG003|Overall Study|Withdrawal by Subject|2|||
125118422|NCT00613574|450057444|FG000|Overall Study|Adverse Event|3|||
125118423|NCT00613574|450057444|FG000|Overall Study|Lost to Follow-up|2|||
125118424|NCT00613574|450057444|FG000|Overall Study|Other|1|||
125118425|NCT01751412|450057446|FG000|Overall Study|Disease Progression Before Treatment|1|||
125118426|NCT03734237|450057449|FG000|Overall Study|Lost to Follow-up|1|||
125118427|NCT03734237|450057450|FG001|Overall Study|Lost to Follow-up|3|||
125118428|NCT03734237|450057451|FG002|Overall Study|Lost to Follow-up|0|||
125118429|NCT03734237|450057449|FG000|Overall Study|Withdrawal by Subject|7|||
125118430|NCT03734237|450057450|FG001|Overall Study|Withdrawal by Subject|9|||
125118431|NCT03734237|450057451|FG002|Overall Study|Withdrawal by Subject|10|||
125118432|NCT02711956|450057452|FG000|Overall Study|Adverse Event|0|||
125023905|NCT03529773|449711344|FG011|Overall Study|Lost to Follow-up|0|||
125023906|NCT03529773|449711345|FG012|Overall Study|Lost to Follow-up|0|||
125023907|NCT03529773|449711346|FG013|Overall Study|Lost to Follow-up|1|||
125023908|NCT03529773|449711347|FG014|Overall Study|Lost to Follow-up|4|||
125023909|NCT03529773|449711348|FG015|Overall Study|Lost to Follow-up|1|||
125023910|NCT03529773|449711349|FG016|Overall Study|Lost to Follow-up|1|||
125023911|NCT03529773|449711350|FG017|Overall Study|Lost to Follow-up|0|||
125023912|NCT03529773|449711351|FG018|Overall Study|Lost to Follow-up|1|||
125023913|NCT03529773|449711352|FG019|Overall Study|Lost to Follow-up|1|||
125023914|NCT03529773|449711353|FG020|Overall Study|Lost to Follow-up|2|||
125023915|NCT03529773|449711354|FG021|Overall Study|Lost to Follow-up|4|||
125023916|NCT03529773|449711355|FG022|Overall Study|Lost to Follow-up|3|||
125023917|NCT03529773|449711356|FG023|Overall Study|Lost to Follow-up|4|||
125023918|NCT03529773|449711357|FG024|Overall Study|Lost to Follow-up|3|||
125023919|NCT03529773|449711358|FG025|Overall Study|Lost to Follow-up|5|||
125023920|NCT03529773|449711359|FG026|Overall Study|Lost to Follow-up|5|||
125023921|NCT03529773|449711360|FG027|Overall Study|Lost to Follow-up|0|||
125023922|NCT03529773|449711361|FG028|Overall Study|Lost to Follow-up|0|||
125023923|NCT03529773|449711362|FG029|Overall Study|Lost to Follow-up|0|||
125023924|NCT03529773|449711363|FG030|Overall Study|Lost to Follow-up|1|||
125023925|NCT03529773|449711364|FG031|Overall Study|Lost to Follow-up|0|||
125023926|NCT03529773|449711365|FG032|Overall Study|Lost to Follow-up|0|||
125023927|NCT03529773|449711366|FG033|Overall Study|Lost to Follow-up|1|||
125023928|NCT03529773|449711367|FG034|Overall Study|Lost to Follow-up|1|||
125023929|NCT03529773|449711368|FG035|Overall Study|Lost to Follow-up|0|||
125118433|NCT02711956|450057453|FG001|Overall Study|Adverse Event|0|||
125118434|NCT02711956|450057454|FG002|Overall Study|Adverse Event|0|||
125118435|NCT02711956|450057455|FG003|Overall Study|Adverse Event|1|||
125118436|NCT02711956|450057456|FG004|Overall Study|Adverse Event|2|||
125118437|NCT02711956|450057457|FG005|Overall Study|Adverse Event|0|||
125118438|NCT02711956|450057458|FG006|Overall Study|Adverse Event|0|||
125118439|NCT02711956|450057459|FG007|Overall Study|Adverse Event|1|||
125118440|NCT02711956|450057460|FG008|Overall Study|Adverse Event|1|||
125118441|NCT02711956|450057461|FG009|Overall Study|Adverse Event|1|||
125118442|NCT02711956|450057462|FG010|Overall Study|Adverse Event|1|||
125118443|NCT02711956|450057463|FG011|Overall Study|Adverse Event|0|||
125118444|NCT02711956|450057464|FG012|Overall Study|Adverse Event|0|||
125118445|NCT02711956|450057465|FG013|Overall Study|Adverse Event|0|||
125118446|NCT02711956|450057466|FG014|Overall Study|Adverse Event|2|||
125118447|NCT02711956|450057452|FG000|Overall Study|Physician Decision|0|||
125118448|NCT02711956|450057453|FG001|Overall Study|Physician Decision|0|||
125118449|NCT02711956|450057454|FG002|Overall Study|Physician Decision|0|||
125118450|NCT02711956|450057455|FG003|Overall Study|Physician Decision|2|||
125118451|NCT02711956|450057456|FG004|Overall Study|Physician Decision|0|||
125118452|NCT02711956|450057457|FG005|Overall Study|Physician Decision|0|||
125118453|NCT02711956|450057458|FG006|Overall Study|Physician Decision|0|||
125118454|NCT02711956|450057459|FG007|Overall Study|Physician Decision|0|||
125118455|NCT02711956|450057460|FG008|Overall Study|Physician Decision|0|||
125118456|NCT02711956|450057461|FG009|Overall Study|Physician Decision|0|||
125118457|NCT02711956|450057462|FG010|Overall Study|Physician Decision|0|||
125118458|NCT02711956|450057463|FG011|Overall Study|Physician Decision|0|||
125118459|NCT02711956|450057464|FG012|Overall Study|Physician Decision|0|||
125118460|NCT02711956|450057465|FG013|Overall Study|Physician Decision|0|||
125118461|NCT02711956|450057466|FG014|Overall Study|Physician Decision|0|||
125118462|NCT02711956|450057452|FG000|Overall Study|Withdrawal by Subject|0|||
125118463|NCT02711956|450057453|FG001|Overall Study|Withdrawal by Subject|0|||
125118464|NCT02711956|450057454|FG002|Overall Study|Withdrawal by Subject|0|||
125118465|NCT02711956|450057455|FG003|Overall Study|Withdrawal by Subject|0|||
125118466|NCT02711956|450057456|FG004|Overall Study|Withdrawal by Subject|0|||
125118467|NCT02711956|450057457|FG005|Overall Study|Withdrawal by Subject|0|||
125118468|NCT02711956|450057458|FG006|Overall Study|Withdrawal by Subject|1|||
125118469|NCT02711956|450057459|FG007|Overall Study|Withdrawal by Subject|0|||
125118470|NCT02711956|450057460|FG008|Overall Study|Withdrawal by Subject|0|||
125118471|NCT02711956|450057461|FG009|Overall Study|Withdrawal by Subject|0|||
125118472|NCT02711956|450057462|FG010|Overall Study|Withdrawal by Subject|0|||
125118473|NCT02711956|450057463|FG011|Overall Study|Withdrawal by Subject|1|||
125118474|NCT02711956|450057464|FG012|Overall Study|Withdrawal by Subject|6|||
125118475|NCT02711956|450057465|FG013|Overall Study|Withdrawal by Subject|0|||
125118476|NCT02711956|450057466|FG014|Overall Study|Withdrawal by Subject|1|||
125118477|NCT02711956|450057452|FG000|Overall Study|Clinical progression|1|||
125118478|NCT02711956|450057453|FG001|Overall Study|Clinical progression|0|||
125118479|NCT02711956|450057454|FG002|Overall Study|Clinical progression|0|||
125118480|NCT02711956|450057455|FG003|Overall Study|Clinical progression|0|||
125118481|NCT02711956|450057456|FG004|Overall Study|Clinical progression|0|||
125118482|NCT02711956|450057457|FG005|Overall Study|Clinical progression|0|||
125118483|NCT02711956|450057458|FG006|Overall Study|Clinical progression|1|||
125118484|NCT02711956|450057459|FG007|Overall Study|Clinical progression|0|||
125118485|NCT02711956|450057460|FG008|Overall Study|Clinical progression|1|||
125118486|NCT02711956|450057461|FG009|Overall Study|Clinical progression|0|||
125118487|NCT02711956|450057462|FG010|Overall Study|Clinical progression|0|||
125118488|NCT02711956|450057463|FG011|Overall Study|Clinical progression|2|||
125023930|NCT03529773|449711369|FG036|Overall Study|Lost to Follow-up|0|||
125023931|NCT03529773|449711370|FG037|Overall Study|Lost to Follow-up|3|||
125023932|NCT03529773|449711371|FG038|Overall Study|Lost to Follow-up|1|||
125023933|NCT03529773|449711372|FG039|Overall Study|Lost to Follow-up|1|||
125118489|NCT02711956|450057464|FG012|Overall Study|Clinical progression|4|||
125118490|NCT02711956|450057465|FG013|Overall Study|Clinical progression|1|||
124923613|NCT01842542|449350517|FG000|Overall Study|Lost to Follow-up|1|||
124923614|NCT04473222|449350518|FG000|Overall Study|Lost to Follow-up|13|||
124923615|NCT04473222|449350519|FG001|Overall Study|Lost to Follow-up|13|||
124923616|NCT04473222|449350518|FG000|Overall Study|Withdrawal by Subject|0|||
124923617|NCT04473222|449350519|FG001|Overall Study|Withdrawal by Subject|1|||
124923618|NCT04473222|449350518|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
124923619|NCT04473222|449350519|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
124923620|NCT01369355|449350526|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
124923621|NCT01369355|449350527|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
124923622|NCT01369355|449350528|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
124923623|NCT01369355|449350529|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
124923624|NCT01369355|449350530|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
124923625|NCT01369355|449350531|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
124923626|NCT01369355|449350532|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
124923627|NCT01369355|449350533|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
124923628|NCT01369355|449350534|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
124923629|NCT01369355|449350526|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
124923630|NCT01369355|449350527|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
124923631|NCT01369355|449350528|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
124923632|NCT01369355|449350529|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
124923633|NCT01369355|449350530|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
124923634|NCT01369355|449350531|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
124923635|NCT01369355|449350532|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
124923636|NCT01369355|449350533|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
124923637|NCT01369355|449350534|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
124923638|NCT01369355|449350526|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
124923639|NCT01369355|449350527|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
124923640|NCT01369355|449350528|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
124923641|NCT01369355|449350529|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
124923642|NCT01369355|449350530|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
124923643|NCT01369355|449350531|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
124923644|NCT01369355|449350532|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
124923645|NCT01369355|449350533|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
124923646|NCT01369355|449350534|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
124923647|NCT01369355|449350526|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
124923648|NCT01369355|449350527|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
124923649|NCT01369355|449350528|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
124923650|NCT01369355|449350529|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
124923651|NCT01369355|449350530|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
124923652|NCT01369355|449350531|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
124923653|NCT01369355|449350532|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
124923654|NCT01369355|449350533|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
124923655|NCT01369355|449350534|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
124923656|NCT01369355|449350526|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
124923657|NCT01369355|449350527|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
124923658|NCT01369355|449350528|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
124923659|NCT01369355|449350529|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
124923660|NCT01369355|449350530|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
124923661|NCT01369355|449350531|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
124923662|NCT01369355|449350532|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
124923663|NCT01369355|449350533|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
124923664|NCT01369355|449350534|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
124923665|NCT01369355|449350526|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
124923666|NCT01369355|449350527|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
124923667|NCT01369355|449350528|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
124923668|NCT01369355|449350529|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
124923669|NCT01369355|449350530|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
124923670|NCT01369355|449350531|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
124923671|NCT01369355|449350532|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
124923672|NCT01369355|449350533|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
124923673|NCT01369355|449350534|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
124923674|NCT01369355|449350526|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
124923675|NCT01369355|449350527|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
124923676|NCT01369355|449350528|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
125212192|NCT02815267|450403288|FG001|Double-Blind Phase|Protocol Violation|2|||
125212193|NCT02815267|450403287|FG000|Double-Blind Phase|Site withdrawal|1|||
125212194|NCT02815267|450403288|FG001|Double-Blind Phase|Site withdrawal|6|||
125212195|NCT02815267|450403287|FG000|Double-Blind Phase|Received a disallowed medication|1|||
125212196|NCT02815267|450403288|FG001|Double-Blind Phase|Received a disallowed medication|1|||
125212197|NCT02815267|450403287|FG000|Open-Label Phase|Adverse Event|1|||
124923677|NCT01369355|449350529|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
124923678|NCT01369355|449350530|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
124923679|NCT01369355|449350531|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
124923680|NCT01369355|449350532|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
124923681|NCT01369355|449350533|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
124923682|NCT01369355|449350534|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
124923683|NCT01369355|449350526|FG000|Long-term Extension (Week 44-272)|Death|0|||
124923684|NCT01369355|449350527|FG001|Long-term Extension (Week 44-272)|Death|0|||
125118491|NCT02711956|450057466|FG014|Overall Study|Clinical progression|1|||
125118492|NCT02711956|450057452|FG000|Overall Study|Radiographic progression|1|||
125118493|NCT02711956|450057453|FG001|Overall Study|Radiographic progression|1|||
125118494|NCT02711956|450057454|FG002|Overall Study|Radiographic progression|2|||
125118495|NCT02711956|450057455|FG003|Overall Study|Radiographic progression|0|||
125118496|NCT02711956|450057456|FG004|Overall Study|Radiographic progression|1|||
125118497|NCT02711956|450057457|FG005|Overall Study|Radiographic progression|0|||
125118498|NCT02711956|450057458|FG006|Overall Study|Radiographic progression|0|||
125118499|NCT02711956|450057459|FG007|Overall Study|Radiographic progression|0|||
125118500|NCT02711956|450057460|FG008|Overall Study|Radiographic progression|2|||
125118501|NCT02711956|450057461|FG009|Overall Study|Radiographic progression|1|||
125118502|NCT02711956|450057462|FG010|Overall Study|Radiographic progression|0|||
125118503|NCT02711956|450057463|FG011|Overall Study|Radiographic progression|5|||
125118504|NCT02711956|450057464|FG012|Overall Study|Radiographic progression|3|||
125118505|NCT02711956|450057465|FG013|Overall Study|Radiographic progression|0|||
125118506|NCT02711956|450057466|FG014|Overall Study|Radiographic progression|1|||
125118507|NCT02711956|450057452|FG000|Overall Study|PSA progression with clinical progression|0|||
125118508|NCT02711956|450057453|FG001|Overall Study|PSA progression with clinical progression|0|||
125118509|NCT02711956|450057454|FG002|Overall Study|PSA progression with clinical progression|0|||
125118510|NCT02711956|450057455|FG003|Overall Study|PSA progression with clinical progression|0|||
125118511|NCT02711956|450057456|FG004|Overall Study|PSA progression with clinical progression|1|||
125118512|NCT02711956|450057457|FG005|Overall Study|PSA progression with clinical progression|0|||
125118513|NCT02711956|450057458|FG006|Overall Study|PSA progression with clinical progression|0|||
125118514|NCT02711956|450057459|FG007|Overall Study|PSA progression with clinical progression|0|||
125118515|NCT02711956|450057460|FG008|Overall Study|PSA progression with clinical progression|0|||
125118516|NCT02711956|450057461|FG009|Overall Study|PSA progression with clinical progression|0|||
125118517|NCT02711956|450057462|FG010|Overall Study|PSA progression with clinical progression|0|||
125118518|NCT02711956|450057463|FG011|Overall Study|PSA progression with clinical progression|0|||
125118519|NCT02711956|450057464|FG012|Overall Study|PSA progression with clinical progression|1|||
125118520|NCT02711956|450057465|FG013|Overall Study|PSA progression with clinical progression|1|||
125118521|NCT02711956|450057466|FG014|Overall Study|PSA progression with clinical progression|0|||
125118522|NCT02711956|450057452|FG000|Overall Study|PSA progression with radiographic progression|0|||
125118523|NCT02711956|450057453|FG001|Overall Study|PSA progression with radiographic progression|1|||
125118524|NCT02711956|450057454|FG002|Overall Study|PSA progression with radiographic progression|0|||
125118525|NCT02711956|450057455|FG003|Overall Study|PSA progression with radiographic progression|0|||
125118526|NCT02711956|450057456|FG004|Overall Study|PSA progression with radiographic progression|0|||
125118527|NCT02711956|450057457|FG005|Overall Study|PSA progression with radiographic progression|2|||
125118528|NCT02711956|450057458|FG006|Overall Study|PSA progression with radiographic progression|2|||
125118529|NCT02711956|450057459|FG007|Overall Study|PSA progression with radiographic progression|1|||
125118530|NCT02711956|450057460|FG008|Overall Study|PSA progression with radiographic progression|0|||
125118531|NCT02711956|450057461|FG009|Overall Study|PSA progression with radiographic progression|1|||
125118532|NCT02711956|450057462|FG010|Overall Study|PSA progression with radiographic progression|0|||
125118533|NCT02711956|450057463|FG011|Overall Study|PSA progression with radiographic progression|1|||
125118534|NCT02711956|450057464|FG012|Overall Study|PSA progression with radiographic progression|2|||
125118535|NCT02711956|450057465|FG013|Overall Study|PSA progression with radiographic progression|3|||
125118536|NCT02711956|450057466|FG014|Overall Study|PSA progression with radiographic progression|3|||
125118537|NCT01844583|450057467|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
125118538|NCT01844583|450057468|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
125118539|NCT01625377|450057469|FG000|Overall Study|Death|1|||
125118540|NCT01625377|450057470|FG001|Overall Study|Death|1|||
125118541|NCT01625377|450057469|FG000|Overall Study|Administrative Problem|1|||
125118542|NCT01625377|450057470|FG001|Overall Study|Administrative Problem|1|||
125118543|NCT01625377|450057469|FG000|Overall Study|Protocol Violation|0|||
124923685|NCT01369355|449350528|FG002|Long-term Extension (Week 44-272)|Death|0|||
125212198|NCT02815267|450403288|FG001|Open-Label Phase|Adverse Event|1|||
124923686|NCT01369355|449350529|FG003|Long-term Extension (Week 44-272)|Death|0|||
125212199|NCT02815267|450403287|FG000|Open-Label Phase|Lost to Follow-up|23|||
125212200|NCT02815267|450403288|FG001|Open-Label Phase|Lost to Follow-up|9|||
124923687|NCT01369355|449350530|FG004|Long-term Extension (Week 44-272)|Death|0|||
124923688|NCT01369355|449350531|FG005|Long-term Extension (Week 44-272)|Death|0|||
124923689|NCT01369355|449350532|FG006|Long-term Extension (Week 44-272)|Death|0|||
124923690|NCT01369355|449350533|FG007|Long-term Extension (Week 44-272)|Death|1|||
124923691|NCT01369355|449350534|FG008|Long-term Extension (Week 44-272)|Death|3|||
124923692|NCT01369355|449350526|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
124923693|NCT01369355|449350527|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
124923694|NCT01369355|449350528|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
124923695|NCT01369355|449350529|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
124923696|NCT01369355|449350530|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
124923697|NCT01369355|449350531|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
124923698|NCT01369355|449350532|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
124923699|NCT01369355|449350533|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
124923700|NCT01369355|449350534|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
124923701|NCT01369355|449350526|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
124923702|NCT01369355|449350527|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
124923703|NCT01369355|449350528|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
124923704|NCT01369355|449350529|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
124923705|NCT01369355|449350530|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
124923706|NCT01369355|449350531|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
124923707|NCT01369355|449350532|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
124923708|NCT01369355|449350533|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
124923709|NCT01369355|449350534|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
124923710|NCT01369355|449350526|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
124923711|NCT01369355|449350527|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
124923712|NCT01369355|449350528|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
124923713|NCT01369355|449350529|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
124923714|NCT01369355|449350530|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
124923715|NCT01369355|449350531|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
124923716|NCT01369355|449350532|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
124923717|NCT01369355|449350533|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
124923718|NCT01369355|449350534|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
124923719|NCT01369355|449350526|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
124923720|NCT01369355|449350527|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
124923721|NCT01369355|449350528|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
124923722|NCT01369355|449350529|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
124923723|NCT01369355|449350530|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
124923724|NCT01369355|449350531|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
124923725|NCT01369355|449350532|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
124923726|NCT01369355|449350533|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
124923727|NCT01369355|449350534|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
124923728|NCT01369355|449350526|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
124923729|NCT01369355|449350527|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
124923730|NCT01369355|449350528|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
124923731|NCT01369355|449350529|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
124923732|NCT01369355|449350530|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
124923733|NCT01369355|449350531|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
124923734|NCT01369355|449350532|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
124923735|NCT01369355|449350533|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
124923736|NCT01369355|449350534|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
124923737|NCT01369355|449350526|FG000|Long-term Extension (Week 44-272)|Other|0|||
124923738|NCT01369355|449350527|FG001|Long-term Extension (Week 44-272)|Other|0|||
124923739|NCT01369355|449350528|FG002|Long-term Extension (Week 44-272)|Other|0|||
124923740|NCT01369355|449350529|FG003|Long-term Extension (Week 44-272)|Other|0|||
124923741|NCT01369355|449350530|FG004|Long-term Extension (Week 44-272)|Other|0|||
124923742|NCT01369355|449350531|FG005|Long-term Extension (Week 44-272)|Other|0|||
124923743|NCT01369355|449350532|FG006|Long-term Extension (Week 44-272)|Other|110|||
124923744|NCT01369355|449350533|FG007|Long-term Extension (Week 44-272)|Other|9|||
124923745|NCT01369355|449350534|FG008|Long-term Extension (Week 44-272)|Other|17|||
124923746|NCT06424236|449350539|FG000|Overall Study|Adverse Event|0|||
124923747|NCT06424236|449350540|FG001|Overall Study|Adverse Event|1|||
124923748|NCT06424236|449350541|FG002|Overall Study|Adverse Event|0|||
124923749|NCT06424236|449350539|FG000|Overall Study|Withdrawal by Subject|3|||
124923750|NCT06424236|449350540|FG001|Overall Study|Withdrawal by Subject|1|||
124923751|NCT06424236|449350541|FG002|Overall Study|Withdrawal by Subject|2|||
125023934|NCT03529773|449711333|FG000|Overall Study|No longer meets eligibility criteria|0|||
125023935|NCT03529773|449711334|FG001|Overall Study|No longer meets eligibility criteria|0|||
125023936|NCT03529773|449711335|FG002|Overall Study|No longer meets eligibility criteria|0|||
125023937|NCT03529773|449711336|FG003|Overall Study|No longer meets eligibility criteria|0|||
125023938|NCT03529773|449711337|FG004|Overall Study|No longer meets eligibility criteria|0|||
124923752|NCT06424236|449350539|FG000|Overall Study|Physician Decision|0|||
124923753|NCT06424236|449350540|FG001|Overall Study|Physician Decision|1|||
124923754|NCT06424236|449350541|FG002|Overall Study|Physician Decision|0|||
124923755|NCT06424236|449350539|FG000|Overall Study|Study Terminated by Sponsor|11|||
124923756|NCT06424236|449350540|FG001|Overall Study|Study Terminated by Sponsor|20|||
124923757|NCT06424236|449350541|FG002|Overall Study|Study Terminated by Sponsor|16|||
124923758|NCT06424236|449350539|FG000|Overall Study|Lost to Follow-up|0|||
124923759|NCT06424236|449350540|FG001|Overall Study|Lost to Follow-up|1|||
124923760|NCT06424236|449350541|FG002|Overall Study|Lost to Follow-up|0|||
124923761|NCT06424236|449350539|FG000|Overall Study|Disease Progression|0|||
124923762|NCT06424236|449350540|FG001|Overall Study|Disease Progression|1|||
124923763|NCT06424236|449350541|FG002|Overall Study|Disease Progression|2|||
124923764|NCT06424236|449350539|FG000|Overall Study|Other|0|||
124923765|NCT06424236|449350540|FG001|Overall Study|Other|0|||
124923766|NCT06424236|449350541|FG002|Overall Study|Other|1|||
124923767|NCT02817776|449350542|FG000|Overall Study|Excluded|33|||
124923768|NCT02817776|449350542|FG000|Overall Study|Lost to Follow-up|20|||
124923769|NCT02817776|449350542|FG000|Overall Study|Withdrawal by Subject|33|||
124923770|NCT02817776|449350542|FG000|Overall Study|Death|2|||
124923771|NCT01824394|449350543|FG000|Overall Study|Early Termination|1|||
124923772|NCT01824394|449350544|FG001|Overall Study|Early Termination|1|||
124923773|NCT01824394|449350545|FG002|Overall Study|Early Termination|3|||
124923774|NCT01824394|449350543|FG000|Overall Study|Withdrawn due to Study Termination|91|||
124923775|NCT01824394|449350544|FG001|Overall Study|Withdrawn due to Study Termination|83|||
124923776|NCT01824394|449350545|FG002|Overall Study|Withdrawn due to Study Termination|41|||
124923777|NCT01824394|449350543|FG000|Overall Study|Lost to Follow-up|0|||
124923778|NCT01824394|449350544|FG001|Overall Study|Lost to Follow-up|9|||
124923779|NCT01824394|449350545|FG002|Overall Study|Lost to Follow-up|3|||
124923780|NCT01824394|449350543|FG000|Overall Study|Death|3|||
124923781|NCT01824394|449350544|FG001|Overall Study|Death|2|||
124923782|NCT01824394|449350545|FG002|Overall Study|Death|4|||
124923783|NCT01824394|449350543|FG000|Overall Study|Discontinued Subjects|1|||
124923784|NCT01824394|449350544|FG001|Overall Study|Discontinued Subjects|1|||
124923785|NCT01824394|449350545|FG002|Overall Study|Discontinued Subjects|2|||
124923786|NCT01824394|449350543|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
124923787|NCT01824394|449350544|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
124923788|NCT01824394|449350545|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
124923789|NCT05603143|449350546|FG000|Overall Study|Withdrew consent|6|||
124923790|NCT05603143|449350547|FG001|Overall Study|Withdrew consent|2|||
124923791|NCT05603143|449350546|FG000|Overall Study|Randomized but never treated|0|||
124923792|NCT05603143|449350547|FG001|Overall Study|Randomized but never treated|3|||
124923793|NCT05603143|449350546|FG000|Overall Study|Adverse Event|2|||
124923794|NCT05603143|449350547|FG001|Overall Study|Adverse Event|0|||
124923795|NCT05603143|449350546|FG000|Overall Study|Death|0|||
124923796|NCT05603143|449350547|FG001|Overall Study|Death|1|||
124923797|NCT05603143|449350546|FG000|Overall Study|Investigator's discretion|1|||
124923798|NCT05603143|449350547|FG001|Overall Study|Investigator's discretion|0|||
124923799|NCT05603143|449350546|FG000|Overall Study|Lost to Follow-up|0|||
124923800|NCT05603143|449350547|FG001|Overall Study|Lost to Follow-up|1|||
124923801|NCT05603143|449350546|FG000|Overall Study|Protocol Violation|0|||
124923802|NCT05603143|449350547|FG001|Overall Study|Protocol Violation|1|||
124923803|NCT05783102|449350548|FG000|Overall Study|Lost to Follow-up|1|||
124923804|NCT05783102|449350548|FG000|Overall Study|Withdrawal by Subject|2|||
124923805|NCT05647304|449350549|FG000|Overall Study|Withdrawal by Subject|1|||
124923806|NCT05647304|449350550|FG001|Overall Study|Withdrawal by Subject|0|||
124923807|NCT02683447|449350556|FG000|Overall Study|Lost to Follow-up|2|||
124923808|NCT03448107|449350557|FG000|Overall Study|Lost to Follow-up|229|||
124923809|NCT03448107|449350558|FG001|Overall Study|Lost to Follow-up|258|||
124923810|NCT03115476|449350559|FG000|LP0084-1369|Death|1|||
124923811|NCT03115476|449350560|FG001|LP0084-1369|Death|0|||
124923812|NCT03115476|449350561|FG002|LP0084-1369|Death|2|||
124923813|NCT03115476|449350559|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
124923814|NCT03115476|449350560|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
124923815|NCT03115476|449350561|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
124923816|NCT02489903|449350562|FG000|Screening|Screen Failure|24|||
124923817|NCT02489903|449350563|FG001|Screening|Screen Failure|0|||
124923818|NCT02489903|449350564|FG002|Screening|Screen Failure|0|||
124923819|NCT02489903|449350565|FG003|Screening|Screen Failure|8|||
124923820|NCT02489903|449350562|FG000|Randomized and Received Treatment|Protocol Violation|0|||
124923821|NCT02489903|449350563|FG001|Randomized and Received Treatment|Protocol Violation|1|||
124923822|NCT02489903|449350564|FG002|Randomized and Received Treatment|Protocol Violation|0|||
124923823|NCT02489903|449350565|FG003|Randomized and Received Treatment|Protocol Violation|0|||
124923824|NCT02489903|449350562|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
124923825|NCT02489903|449350563|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
124923826|NCT02489903|449350564|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
124923827|NCT02489903|449350565|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
124923828|NCT02489903|449350562|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
124923829|NCT02489903|449350563|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
125118544|NCT01625377|450057470|FG001|Overall Study|Protocol Violation|3|||
125118545|NCT01625377|450057469|FG000|Overall Study|Adverse Event|3|||
125118546|NCT01625377|450057470|FG001|Overall Study|Adverse Event|16|||
125118547|NCT01625377|450057469|FG000|Overall Study|Graft loss|1|||
125118548|NCT01625377|450057470|FG001|Overall Study|Graft loss|0|||
125118549|NCT01625377|450057469|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125118550|NCT01625377|450057470|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125118551|NCT01625377|450057469|FG000|Overall Study|Abnormal laboratory values|1|||
125118552|NCT01625377|450057470|FG001|Overall Study|Abnormal laboratory values|0|||
125118553|NCT02207621|450057475|FG000|Overall Study|Adverse Event|71|||
125118554|NCT02207621|450057476|FG001|Overall Study|Adverse Event|15|||
125118555|NCT02207621|450057477|FG002|Overall Study|Adverse Event|132|||
125212201|NCT02815267|450403287|FG000|Open-Label Phase|Withdrawal by Subject|24|||
125212202|NCT02815267|450403288|FG001|Open-Label Phase|Withdrawal by Subject|13|||
124923830|NCT02489903|449350564|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
124923831|NCT02489903|449350565|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
124923832|NCT02489903|449350562|FG000|Randomized and Received Treatment|Death|10|||
124923833|NCT02489903|449350563|FG001|Randomized and Received Treatment|Death|1|||
124923834|NCT02489903|449350564|FG002|Randomized and Received Treatment|Death|0|||
124923835|NCT02489903|449350565|FG003|Randomized and Received Treatment|Death|0|||
124923836|NCT05257486|449350569|FG000|Overall Study|Protocol Violation|3|||
124923837|NCT04542317|449350570|FG000|Overall Study|Care recipients passed away|18|||
124923838|NCT04542317|449350571|FG001|Overall Study|Care recipients passed away|13|||
124923839|NCT04542317|449350570|FG000|Overall Study|No longer a primary caregiver|5|||
124923840|NCT04542317|449350571|FG001|Overall Study|No longer a primary caregiver|1|||
124923841|NCT04542317|449350570|FG000|Overall Study|Withdrawal by Subject|4|||
124923842|NCT04542317|449350571|FG001|Overall Study|Withdrawal by Subject|2|||
124923843|NCT04542317|449350570|FG000|Overall Study|Caregivers passed away|0|||
124923844|NCT04542317|449350571|FG001|Overall Study|Caregivers passed away|2|||
124923845|NCT04700163|449350572|FG000|Overall Study|Lost to Follow-up|0|||
124923846|NCT04700163|449350573|FG001|Overall Study|Lost to Follow-up|0|||
124923847|NCT04700163|449350574|FG002|Overall Study|Lost to Follow-up|0|||
124923848|NCT04700163|449350575|FG003|Overall Study|Lost to Follow-up|0|||
124923849|NCT04700163|449350576|FG004|Overall Study|Lost to Follow-up|0|||
124923850|NCT04700163|449350577|FG005|Overall Study|Lost to Follow-up|1|||
124923851|NCT03976362|449350580|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
124923852|NCT03976362|449350581|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
124923853|NCT03976362|449350582|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
124923854|NCT03976362|449350580|FG000|Induction Phase|Death|62|||
124923855|NCT03976362|449350581|FG001|Induction Phase|Death|0|||
124923856|NCT03976362|449350582|FG002|Induction Phase|Death|0|||
124923857|NCT03976362|449350580|FG000|Maintenance Phase|Participants Ongoing|0|||
124923858|NCT03976362|449350581|FG001|Maintenance Phase|Participants Ongoing|106|||
124923859|NCT03976362|449350582|FG002|Maintenance Phase|Participants Ongoing|103|||
124923860|NCT03976362|449350580|FG000|Maintenance Phase|Withdrawal by Subject|0|||
124923861|NCT03976362|449350581|FG001|Maintenance Phase|Withdrawal by Subject|4|||
124923862|NCT03976362|449350582|FG002|Maintenance Phase|Withdrawal by Subject|4|||
124923863|NCT03976362|449350580|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
124923864|NCT03976362|449350581|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
124923865|NCT03976362|449350582|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
124923866|NCT03976362|449350580|FG000|Maintenance Phase|Death|0|||
124923867|NCT03976362|449350581|FG001|Maintenance Phase|Death|186|||
124923868|NCT03976362|449350582|FG002|Maintenance Phase|Death|187|||
124923869|NCT00613106|449350583|FG000|Overall Study|Adverse Event|3|||
124923870|NCT00613106|449350584|FG001|Overall Study|Adverse Event|1|||
124923871|NCT00613106|449350583|FG000|Overall Study|Withdrawal by Subject|6|||
124923872|NCT00613106|449350584|FG001|Overall Study|Withdrawal by Subject|3|||
124923873|NCT00613106|449350583|FG000|Overall Study|Lost to Follow-up|7|||
124923874|NCT00613106|449350584|FG001|Overall Study|Lost to Follow-up|2|||
124923875|NCT00613106|449350583|FG000|Overall Study|misc|4|||
124923876|NCT00613106|449350584|FG001|Overall Study|misc|3|||
124923877|NCT05126433|449350589|FG000|Overall Study|Withdrawal by Subject|3|||
124923878|NCT05126433|449350590|FG001|Overall Study|Withdrawal by Subject|0|||
125118556|NCT02207621|450057475|FG000|Overall Study|Withdrawal by Subject|9|||
125212203|NCT02815267|450403287|FG000|Open-Label Phase|Protocol Violation|0|||
124923879|NCT05126433|449350591|FG002|Overall Study|Withdrawal by Subject|4|||
124923880|NCT05126433|449350589|FG000|Overall Study|Death|9|||
124923881|NCT05126433|449350590|FG001|Overall Study|Death|3|||
124923882|NCT05126433|449350591|FG002|Overall Study|Death|5|||
124923883|NCT05126433|449350589|FG000|Overall Study|Study Terminated by sponsor|0|||
124923884|NCT05126433|449350590|FG001|Overall Study|Study Terminated by sponsor|1|||
124923885|NCT05126433|449350591|FG002|Overall Study|Study Terminated by sponsor|2|||
124923886|NCT05126433|449350589|FG000|Overall Study|Progressive Disease|1|||
125118557|NCT02207621|450057476|FG001|Overall Study|Withdrawal by Subject|9|||
125118558|NCT02207621|450057477|FG002|Overall Study|Withdrawal by Subject|13|||
125118559|NCT02207621|450057475|FG000|Overall Study|Non-Compliant|3|||
125118560|NCT02207621|450057476|FG001|Overall Study|Non-Compliant|3|||
125118561|NCT02207621|450057477|FG002|Overall Study|Non-Compliant|1|||
125118562|NCT02207621|450057475|FG000|Overall Study|Lost to Follow-up|1|||
125118563|NCT02207621|450057476|FG001|Overall Study|Lost to Follow-up|0|||
125118564|NCT02207621|450057477|FG002|Overall Study|Lost to Follow-up|3|||
125118565|NCT02207621|450057475|FG000|Overall Study|Lack of Efficacy|10|||
125118566|NCT02207621|450057476|FG001|Overall Study|Lack of Efficacy|2|||
125118567|NCT02207621|450057477|FG002|Overall Study|Lack of Efficacy|4|||
125118568|NCT02207621|450057475|FG000|Overall Study|Disallowed Concurrent Medication|2|||
125118569|NCT02207621|450057476|FG001|Overall Study|Disallowed Concurrent Medication|5|||
125118570|NCT02207621|450057477|FG002|Overall Study|Disallowed Concurrent Medication|2|||
125118571|NCT02207621|450057475|FG000|Overall Study|Physician Decision|1|||
125118572|NCT02207621|450057476|FG001|Overall Study|Physician Decision|2|||
125118573|NCT02207621|450057477|FG002|Overall Study|Physician Decision|2|||
125118574|NCT02207621|450057475|FG000|Overall Study|Protocol Violation|4|||
125118575|NCT02207621|450057476|FG001|Overall Study|Protocol Violation|10|||
125118576|NCT02207621|450057477|FG002|Overall Study|Protocol Violation|6|||
125118577|NCT02207621|450057475|FG000|Overall Study|Death|2|||
125118578|NCT02207621|450057476|FG001|Overall Study|Death|0|||
125118579|NCT02207621|450057477|FG002|Overall Study|Death|0|||
125118580|NCT02207621|450057475|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
125118581|NCT02207621|450057476|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
125118582|NCT02207621|450057477|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
125118583|NCT01769378|450057480|FG000|Overall Study|Adverse Event|10|||
125118584|NCT01769378|450057481|FG001|Overall Study|Adverse Event|0|||
125118585|NCT01769378|450057480|FG000|Overall Study|Entry criteria not met|1|||
125118586|NCT01769378|450057481|FG001|Overall Study|Entry criteria not met|0|||
125118587|NCT01769378|450057480|FG000|Overall Study|Protocol Violation|1|||
125118588|NCT01769378|450057481|FG001|Overall Study|Protocol Violation|1|||
125118589|NCT01769378|450057480|FG000|Overall Study|Withdrawal by Subject|10|||
125118590|NCT01769378|450057481|FG001|Overall Study|Withdrawal by Subject|3|||
125118591|NCT01769378|450057480|FG000|Overall Study|Sponsor Decision|1|||
125118592|NCT01769378|450057481|FG001|Overall Study|Sponsor Decision|0|||
125118593|NCT01769378|450057480|FG000|Overall Study|Lost to Follow-up|2|||
125118594|NCT01769378|450057481|FG001|Overall Study|Lost to Follow-up|0|||
125118595|NCT01238848|450057486|FG000|Overall Study|Physician Decision|13|||
125118596|NCT01238848|450057487|FG001|Overall Study|Physician Decision|5|||
125118597|NCT00576901|450057488|FG000|Overall Study|Withdrawal by Subject|1|||
125118598|NCT00576901|450057488|FG000|Overall Study|Disease course|1|||
125118599|NCT00576901|450057488|FG000|Overall Study|Protocol Violation|1|||
125118600|NCT01755858|450057491|FG000|Overall Study|Adverse Event|1|||
125118601|NCT01755858|450057492|FG001|Overall Study|Adverse Event|1|||
125118602|NCT01259869|450057493|FG000|Overall Study|Duplicated registration|1|||
125118603|NCT00175019|450057494|FG000|Overall Study|Adverse Event|54|||
125118604|NCT00175019|450057495|FG001|Overall Study|Adverse Event|22|||
125118605|NCT00175019|450057496|FG002|Overall Study|Adverse Event|2|||
125212204|NCT02815267|450403288|FG001|Open-Label Phase|Protocol Violation|1|||
124923887|NCT05126433|449350590|FG001|Overall Study|Progressive Disease|4|||
124923888|NCT05126433|449350591|FG002|Overall Study|Progressive Disease|3|||
124923889|NCT05126433|449350589|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
124923890|NCT05126433|449350590|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
124923891|NCT05126433|449350591|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
124923892|NCT05084508|449350597|FG000|Overall Study|Lost to Follow-up|6|||
124923893|NCT05084508|449350598|FG001|Overall Study|Lost to Follow-up|3|||
124923894|NCT05084508|449350599|FG002|Overall Study|Lost to Follow-up|7|||
124923895|NCT05084508|449350600|FG003|Overall Study|Lost to Follow-up|3|||
124923896|NCT05084508|449350597|FG000|Overall Study|Withdrawal by Subject|0|||
124923897|NCT05084508|449350598|FG001|Overall Study|Withdrawal by Subject|2|||
124923898|NCT05084508|449350599|FG002|Overall Study|Withdrawal by Subject|3|||
124923899|NCT05084508|449350600|FG003|Overall Study|Withdrawal by Subject|1|||
124923900|NCT05084508|449350597|FG000|Overall Study|Other|0|||
124923901|NCT05084508|449350598|FG001|Overall Study|Other|0|||
124923902|NCT05084508|449350599|FG002|Overall Study|Other|0|||
124923903|NCT05084508|449350600|FG003|Overall Study|Other|1|||
125118606|NCT00175019|450057494|FG000|Overall Study|Protocol Violation|6|||
125118607|NCT00175019|450057495|FG001|Overall Study|Protocol Violation|3|||
125118608|NCT00175019|450057496|FG002|Overall Study|Protocol Violation|3|||
125118609|NCT00175019|450057494|FG000|Overall Study|Lost to Follow-up|42|||
125118610|NCT00175019|450057495|FG001|Overall Study|Lost to Follow-up|39|||
125118611|NCT00175019|450057496|FG002|Overall Study|Lost to Follow-up|9|||
124923904|NCT05296525|449350601|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
124923905|NCT05296525|449350602|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
124923906|NCT05296525|449350603|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
124923907|NCT05296525|449350604|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
124923908|NCT04065841|449350609|FG000|Overall Study|Adverse Event|4|||
124923909|NCT04065841|449350610|FG001|Overall Study|Adverse Event|2|||
124923910|NCT04065841|449350611|FG002|Overall Study|Adverse Event|10|||
124923911|NCT04065841|449350612|FG003|Overall Study|Adverse Event|1|||
124923912|NCT04065841|449350609|FG000|Overall Study|Lost to Follow-up|1|||
124923913|NCT04065841|449350610|FG001|Overall Study|Lost to Follow-up|2|||
124923914|NCT04065841|449350611|FG002|Overall Study|Lost to Follow-up|2|||
124923915|NCT04065841|449350612|FG003|Overall Study|Lost to Follow-up|2|||
124923916|NCT04065841|449350609|FG000|Overall Study|Physician Decision|1|||
124923917|NCT04065841|449350610|FG001|Overall Study|Physician Decision|0|||
124923918|NCT04065841|449350611|FG002|Overall Study|Physician Decision|0|||
124923919|NCT04065841|449350612|FG003|Overall Study|Physician Decision|0|||
124923920|NCT04065841|449350609|FG000|Overall Study|Protocol Violation|0|||
124923921|NCT04065841|449350610|FG001|Overall Study|Protocol Violation|1|||
124923922|NCT04065841|449350611|FG002|Overall Study|Protocol Violation|0|||
124923923|NCT04065841|449350612|FG003|Overall Study|Protocol Violation|0|||
124923924|NCT04065841|449350609|FG000|Overall Study|Study terminated by Sponsor|22|||
124923925|NCT04065841|449350610|FG001|Overall Study|Study terminated by Sponsor|16|||
124923926|NCT04065841|449350611|FG002|Overall Study|Study terminated by Sponsor|28|||
124923927|NCT04065841|449350612|FG003|Overall Study|Study terminated by Sponsor|17|||
124923928|NCT04065841|449350609|FG000|Overall Study|Withdrawal by Subject|1|||
124923929|NCT04065841|449350610|FG001|Overall Study|Withdrawal by Subject|1|||
125118612|NCT00175019|450057494|FG000|Overall Study|Did not continue under Amendment 4|1|||
125118613|NCT00175019|450057495|FG001|Overall Study|Did not continue under Amendment 4|1|||
125118614|NCT00175019|450057496|FG002|Overall Study|Did not continue under Amendment 4|2|||
125118615|NCT00175019|450057494|FG000|Overall Study|Personal Reason(s)|39|||
125118616|NCT00175019|450057495|FG001|Overall Study|Personal Reason(s)|31|||
125118617|NCT00175019|450057496|FG002|Overall Study|Personal Reason(s)|8|||
125118618|NCT00175019|450057494|FG000|Overall Study|Therapeutic Failure|10|||
125118619|NCT00175019|450057495|FG001|Overall Study|Therapeutic Failure|38|||
125118620|NCT00175019|450057496|FG002|Overall Study|Therapeutic Failure|22|||
125118621|NCT00175019|450057494|FG000|Overall Study|Gout Flare|2|||
125118622|NCT00175019|450057495|FG001|Overall Study|Gout Flare|3|||
125118623|NCT00175019|450057496|FG002|Overall Study|Gout Flare|0|||
125118624|NCT00175019|450057494|FG000|Overall Study|Reason Not Specified|40|||
125118625|NCT00175019|450057495|FG001|Overall Study|Reason Not Specified|34|||
125118626|NCT00175019|450057496|FG002|Overall Study|Reason Not Specified|11|||
125118627|NCT03209570|450057497|FG000|Overall Study|Death|1|||
125118628|NCT03209570|450057498|FG001|Overall Study|Death|0|||
125118629|NCT03209570|450057497|FG000|Overall Study|Incomplete Data|8|||
125118630|NCT03209570|450057498|FG001|Overall Study|Incomplete Data|10|||
125118631|NCT03209570|450057497|FG000|Overall Study|Protocol Violation|1|||
125118632|NCT03209570|450057498|FG001|Overall Study|Protocol Violation|0|||
125118633|NCT03209570|450057497|FG000|Overall Study|Withdrawal by Subject|0|||
125118634|NCT03209570|450057498|FG001|Overall Study|Withdrawal by Subject|3|||
125118635|NCT00220701|450057509|FG000|Overall Study|Lost to Follow-up|5|||
125118636|NCT00220701|450057510|FG001|Overall Study|Lost to Follow-up|4|||
125118637|NCT00755326|450057511|FG000|Overall Study|Lost to Follow-up|2|||
125118638|NCT00755326|450057512|FG001|Overall Study|Lost to Follow-up|3|||
125118639|NCT04041570|450057515|FG000|Overall Study|Moved from Area|0|||
125118640|NCT04041570|450057516|FG001|Overall Study|Moved from Area|2|||
125118641|NCT00384033|450057520|FG000|Overall Study|Adverse Event|10|||
125118642|NCT00384033|450057521|FG001|Overall Study|Adverse Event|8|||
125118643|NCT00384033|450057522|FG002|Overall Study|Adverse Event|11|||
125118644|NCT00384033|450057523|FG003|Overall Study|Adverse Event|20|||
125118645|NCT00384033|450057520|FG000|Overall Study|Failed to return|1|||
125118646|NCT00384033|450057521|FG001|Overall Study|Failed to return|3|||
125118647|NCT00384033|450057522|FG002|Overall Study|Failed to return|2|||
125118648|NCT00384033|450057523|FG003|Overall Study|Failed to return|2|||
125212205|NCT02815267|450403287|FG000|Open-Label Phase|Administrative|21|||
124923930|NCT04065841|449350611|FG002|Overall Study|Withdrawal by Subject|2|||
124923931|NCT04065841|449350612|FG003|Overall Study|Withdrawal by Subject|0|||
124923932|NCT01420237|449350613|FG000|Overall Study|Death|13|||
124923933|NCT01420237|449350613|FG000|Overall Study|Withdrawal by Subject|41|||
124923934|NCT01420237|449350613|FG000|Overall Study|Lost to Follow-up|32|||
124923935|NCT01420237|449350613|FG000|Overall Study|Adverse Event|10|||
124923936|NCT01420237|449350613|FG000|Overall Study|Investigative Site Termination|43|||
125118649|NCT00384033|450057520|FG000|Overall Study|Physician Decision|1|||
125118650|NCT00384033|450057521|FG001|Overall Study|Physician Decision|0|||
125118651|NCT00384033|450057522|FG002|Overall Study|Physician Decision|0|||
125118652|NCT00384033|450057523|FG003|Overall Study|Physician Decision|0|||
125118653|NCT00384033|450057520|FG000|Overall Study|Lost to Follow-up|6|||
125118654|NCT00384033|450057521|FG001|Overall Study|Lost to Follow-up|12|||
125118655|NCT00384033|450057522|FG002|Overall Study|Lost to Follow-up|7|||
125118656|NCT00384033|450057523|FG003|Overall Study|Lost to Follow-up|7|||
125118657|NCT00384033|450057520|FG000|Overall Study|Other|2|||
125118658|NCT00384033|450057521|FG001|Overall Study|Other|0|||
125118659|NCT00384033|450057522|FG002|Overall Study|Other|0|||
125118660|NCT00384033|450057523|FG003|Overall Study|Other|0|||
125118661|NCT00384033|450057520|FG000|Overall Study|Protocol Violation|5|||
125118662|NCT00384033|450057521|FG001|Overall Study|Protocol Violation|0|||
125118663|NCT00384033|450057522|FG002|Overall Study|Protocol Violation|5|||
125118664|NCT00384033|450057523|FG003|Overall Study|Protocol Violation|6|||
125118665|NCT00384033|450057520|FG000|Overall Study|Withdrawal by Subject|6|||
125118666|NCT00384033|450057521|FG001|Overall Study|Withdrawal by Subject|2|||
125118667|NCT00384033|450057522|FG002|Overall Study|Withdrawal by Subject|5|||
125118668|NCT00384033|450057523|FG003|Overall Study|Withdrawal by Subject|2|||
125118669|NCT00384033|450057520|FG000|Overall Study|Lack of Efficacy|7|||
125118670|NCT00384033|450057521|FG001|Overall Study|Lack of Efficacy|3|||
125118671|NCT00384033|450057522|FG002|Overall Study|Lack of Efficacy|3|||
125118672|NCT00384033|450057523|FG003|Overall Study|Lack of Efficacy|1|||
125118673|NCT00384033|450057520|FG000|Overall Study|Randomized but not treated|3|||
125118674|NCT00384033|450057521|FG001|Overall Study|Randomized but not treated|7|||
125118675|NCT00384033|450057522|FG002|Overall Study|Randomized but not treated|10|||
125118676|NCT00384033|450057523|FG003|Overall Study|Randomized but not treated|2|||
125118677|NCT00290745|450057524|FG000|Overall Study|Withdrawal by Subject|4|||
125118678|NCT00290745|450057524|FG000|Overall Study|Physician Decision|2|||
125118679|NCT00290745|450057524|FG000|Overall Study|Surgery after 3 months for progression|3|||
125118680|NCT00290745|450057524|FG000|Overall Study|Baseline MRI not available|3|||
125118681|NCT02750306|450057525|FG000|Overall Study|Withdrawal by Subject|5|||
125118682|NCT02750306|450057526|FG001|Overall Study|Withdrawal by Subject|2|||
125118683|NCT02750306|450057525|FG000|Overall Study|Protocol Violation|1|||
125118684|NCT02750306|450057526|FG001|Overall Study|Protocol Violation|0|||
125118685|NCT02737306|450057527|FG000|Overall Study|Adverse Event|3|||
125118686|NCT02737306|450057528|FG001|Overall Study|Adverse Event|0|||
125118687|NCT02737306|450057527|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
125118688|NCT02737306|450057528|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
125118689|NCT01915732|450057531|FG000|Overall Study|Withdrawal by Subject|18|||
125118690|NCT01915732|450057532|FG001|Overall Study|Withdrawal by Subject|18|||
125118691|NCT01915732|450057531|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
125118692|NCT01915732|450057532|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
125118693|NCT01915732|450057531|FG000|Overall Study|Adverse Event|12|||
125118694|NCT01915732|450057532|FG001|Overall Study|Adverse Event|4|||
125118695|NCT01915732|450057531|FG000|Overall Study|Protocol Violation|5|||
125118696|NCT01915732|450057532|FG001|Overall Study|Protocol Violation|5|||
125118697|NCT01915732|450057531|FG000|Overall Study|Lack of Efficacy|6|||
125118698|NCT01915732|450057532|FG001|Overall Study|Lack of Efficacy|11|||
125118699|NCT01915732|450057531|FG000|Overall Study|Lost to Follow-up|22|||
125118700|NCT01915732|450057532|FG001|Overall Study|Lost to Follow-up|26|||
125118701|NCT01915732|450057531|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
125118702|NCT01915732|450057532|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
125118703|NCT01915732|450057531|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
125118704|NCT01915732|450057532|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
125118705|NCT01915732|450057531|FG000|Overall Study|Drug Release Error|1|||
125118706|NCT01915732|450057532|FG001|Overall Study|Drug Release Error|0|||
125118707|NCT01915732|450057531|FG000|Overall Study|Recovered|1|||
125118708|NCT01915732|450057532|FG001|Overall Study|Recovered|0|||
125118709|NCT01915732|450057531|FG000|Overall Study|Pregnancy|1|||
125118710|NCT01915732|450057532|FG001|Overall Study|Pregnancy|0|||
125118711|NCT01915732|450057531|FG000|Overall Study|Poor Perceived Efficacy|1|||
125118712|NCT01915732|450057532|FG001|Overall Study|Poor Perceived Efficacy|0|||
125118713|NCT01915732|450057531|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
124923937|NCT01420237|449350613|FG000|Overall Study|Censored because study device not implanted|21|||
124923938|NCT01420237|449350613|FG000|Overall Study|Censored because surgery not performed|2|||
124923939|NCT01420237|449350613|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
124923940|NCT01420237|449350613|FG000|Overall Study|Sponsor terminated study early|127|||
124923941|NCT05653427|449352374|FG000|Overall Study|Study Terminated by Sponsor|13|||
124923942|NCT04256941|449352382|FG000|Overall Study|Withdrawal by Subject|0|||
124923943|NCT04256941|449352383|FG001|Overall Study|Withdrawal by Subject|1|||
125118714|NCT01915732|450057532|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
125118715|NCT01915732|450057531|FG000|Overall Study|Got Well|0|||
125118716|NCT01915732|450057532|FG001|Overall Study|Got Well|1|||
125118717|NCT01915732|450057531|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
125118718|NCT01915732|450057532|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
125118719|NCT01915732|450057531|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
125118720|NCT01915732|450057532|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
125118721|NCT01915732|450057531|FG000|Overall Study|Job Transfer|0|||
125118722|NCT01915732|450057532|FG001|Overall Study|Job Transfer|1|||
125118723|NCT01915732|450057531|FG000|Overall Study|Improper Facial Procedure|0|||
125118724|NCT01915732|450057532|FG001|Overall Study|Improper Facial Procedure|1|||
125118725|NCT01915732|450057531|FG000|Overall Study|Poor Conscious Effect|0|||
125118726|NCT01915732|450057532|FG001|Overall Study|Poor Conscious Effect|1|||
125118727|NCT02015793|450057534|FG000|Overall Study|Adverse Event|3|||
125118728|NCT02015793|450057535|FG001|Overall Study|Adverse Event|3|||
125118729|NCT02015793|450057534|FG000|Overall Study|Withdrawal by Subject|1|||
125118730|NCT02015793|450057535|FG001|Overall Study|Withdrawal by Subject|1|||
125118731|NCT01862328|450057536|FG000|Overall Study|Progressive Disease|3|||
125118732|NCT01862328|450057537|FG001|Overall Study|Progressive Disease|11|||
125118733|NCT01862328|450057538|FG002|Overall Study|Progressive Disease|5|||
125118734|NCT01862328|450057539|FG003|Overall Study|Progressive Disease|6|||
125118735|NCT01862328|450057540|FG004|Overall Study|Progressive Disease|7|||
125118736|NCT01862328|450057541|FG005|Overall Study|Progressive Disease|4|||
125118737|NCT01862328|450057542|FG006|Overall Study|Progressive Disease|3|||
125118738|NCT01862328|450057536|FG000|Overall Study|Adverse Event|0|||
125118739|NCT01862328|450057537|FG001|Overall Study|Adverse Event|4|||
125118740|NCT01862328|450057538|FG002|Overall Study|Adverse Event|0|||
125118741|NCT01862328|450057539|FG003|Overall Study|Adverse Event|1|||
125118742|NCT01862328|450057540|FG004|Overall Study|Adverse Event|0|||
125118743|NCT01862328|450057541|FG005|Overall Study|Adverse Event|2|||
125118744|NCT01862328|450057542|FG006|Overall Study|Adverse Event|4|||
125118745|NCT01862328|450057536|FG000|Overall Study|Other|0|||
125118746|NCT01862328|450057537|FG001|Overall Study|Other|2|||
125118747|NCT01862328|450057538|FG002|Overall Study|Other|1|||
125118748|NCT01862328|450057539|FG003|Overall Study|Other|0|||
125118749|NCT01862328|450057540|FG004|Overall Study|Other|4|||
125118750|NCT01862328|450057541|FG005|Overall Study|Other|0|||
125118751|NCT01862328|450057542|FG006|Overall Study|Other|1|||
125118752|NCT01862328|450057536|FG000|Overall Study|Withdrawal by Subject|1|||
125118753|NCT01862328|450057537|FG001|Overall Study|Withdrawal by Subject|1|||
125118754|NCT01862328|450057538|FG002|Overall Study|Withdrawal by Subject|0|||
125118755|NCT01862328|450057539|FG003|Overall Study|Withdrawal by Subject|0|||
125118756|NCT01862328|450057540|FG004|Overall Study|Withdrawal by Subject|1|||
125118757|NCT01862328|450057541|FG005|Overall Study|Withdrawal by Subject|1|||
125118758|NCT01862328|450057542|FG006|Overall Study|Withdrawal by Subject|1|||
125118759|NCT01862328|450057536|FG000|Overall Study|Symptomatic Deterioration|0|||
125118760|NCT01862328|450057537|FG001|Overall Study|Symptomatic Deterioration|0|||
125118761|NCT01862328|450057538|FG002|Overall Study|Symptomatic Deterioration|0|||
125118762|NCT01862328|450057539|FG003|Overall Study|Symptomatic Deterioration|0|||
125118763|NCT01862328|450057540|FG004|Overall Study|Symptomatic Deterioration|0|||
125118764|NCT01862328|450057541|FG005|Overall Study|Symptomatic Deterioration|0|||
125118765|NCT01862328|450057542|FG006|Overall Study|Symptomatic Deterioration|1|||
125118766|NCT02482571|450057543|FG000|Overall Study|Adverse Event|1|||
125118767|NCT02482571|450057543|FG000|Overall Study|Scanner or Respiract failure|3|||
125118768|NCT02482571|450057543|FG000|Overall Study|Withdrawal by Subject|4|||
125118769|NCT01446913|450057544|FG000|Overall Study|Significant illness|1|||
125118770|NCT01446913|450057545|FG001|Overall Study|Significant illness|1|||
125118771|NCT01446913|450057546|FG002|Overall Study|Significant illness|1|||
125118772|NCT01446913|450057544|FG000|Overall Study|Withdrawal by Subject|5|||
125118773|NCT01446913|450057545|FG001|Overall Study|Withdrawal by Subject|3|||
125118774|NCT01446913|450057546|FG002|Overall Study|Withdrawal by Subject|5|||
125118775|NCT01446913|450057544|FG000|Overall Study|Physician Decision|0|||
125118776|NCT01446913|450057545|FG001|Overall Study|Physician Decision|0|||
125118777|NCT01446913|450057546|FG002|Overall Study|Physician Decision|2|||
125118778|NCT01446913|450057544|FG000|Overall Study|Lost to Follow-up|3|||
125118779|NCT01446913|450057545|FG001|Overall Study|Lost to Follow-up|5|||
125118780|NCT01446913|450057546|FG002|Overall Study|Lost to Follow-up|3|||
125118781|NCT02521948|450057547|FG000|Overall Study|Adverse Event|2|||
125118782|NCT02521948|450057547|FG000|Overall Study|Death|4|||
125118783|NCT02521948|450057547|FG000|Overall Study|Lost to Follow-up|1|||
125118784|NCT02521948|450057547|FG000|Overall Study|Did not attend one or both follow-ups|6|||
125118785|NCT02427607|450057548|FG000|Overall Study|Withdrawal by Subject|1|||
125212206|NCT02815267|450403288|FG001|Open-Label Phase|Administrative|12|||
125212207|NCT02815267|450403287|FG000|Open-Label Phase|Other|2|||
125212208|NCT02815267|450403288|FG001|Open-Label Phase|Other|5|||
125212209|NCT03594955|450403289|FG000|Overall Study|Adverse Event|1|||
125212210|NCT03594955|450403289|FG000|Overall Study|Progressive disease|5|||
125118786|NCT04000009|450057549|FG000|Overall Study|Adverse Event|13|||
125118787|NCT04000009|450057549|FG000|Overall Study|Lack of Efficacy|7|||
125118788|NCT04000009|450057549|FG000|Overall Study|Lost to Follow-up|8|||
125118789|NCT04000009|450057549|FG000|Overall Study|Noncompliance with study drug|4|||
125118790|NCT04000009|450057549|FG000|Overall Study|Physician Decision|1|||
125118791|NCT04000009|450057549|FG000|Overall Study|Use of prohibited medication|3|||
125118792|NCT04000009|450057549|FG000|Overall Study|Pregnancy|1|||
125118793|NCT04000009|450057549|FG000|Overall Study|Withdrawal by Subject|22|||
125118794|NCT04000009|450057549|FG000|Overall Study|Study terminated by sponsor|98|||
125118795|NCT04000009|450057549|FG000|Overall Study|Not further specified|8|||
125118796|NCT00679783|450057550|FG000|Overall Study|Adverse Event|0|||
125118797|NCT00679783|450057551|FG001|Overall Study|Adverse Event|0|||
125118798|NCT00679783|450057552|FG002|Overall Study|Adverse Event|0|||
125118799|NCT00679783|450057553|FG003|Overall Study|Adverse Event|3|||
125118800|NCT00679783|450057554|FG004|Overall Study|Adverse Event|0|||
125118801|NCT00679783|450057555|FG005|Overall Study|Adverse Event|0|||
125118802|NCT00679783|450057556|FG006|Overall Study|Adverse Event|1|||
125118803|NCT00679783|450057550|FG000|Overall Study|Lack of Efficacy|0|||
125118804|NCT00679783|450057551|FG001|Overall Study|Lack of Efficacy|1|||
125118805|NCT00679783|450057552|FG002|Overall Study|Lack of Efficacy|0|||
125118806|NCT00679783|450057553|FG003|Overall Study|Lack of Efficacy|2|||
125118807|NCT00679783|450057554|FG004|Overall Study|Lack of Efficacy|0|||
125118808|NCT00679783|450057555|FG005|Overall Study|Lack of Efficacy|0|||
125118809|NCT00679783|450057556|FG006|Overall Study|Lack of Efficacy|0|||
125118810|NCT00679783|450057550|FG000|Overall Study|Withdrawal by Subject|0|||
125118811|NCT00679783|450057551|FG001|Overall Study|Withdrawal by Subject|0|||
125118812|NCT00679783|450057552|FG002|Overall Study|Withdrawal by Subject|1|||
125118813|NCT00679783|450057553|FG003|Overall Study|Withdrawal by Subject|1|||
125118814|NCT00679783|450057554|FG004|Overall Study|Withdrawal by Subject|0|||
125118815|NCT00679783|450057555|FG005|Overall Study|Withdrawal by Subject|0|||
125118816|NCT00679783|450057556|FG006|Overall Study|Withdrawal by Subject|0|||
125118817|NCT00679783|450057550|FG000|Overall Study|Not Captured|0|||
125118818|NCT00679783|450057551|FG001|Overall Study|Not Captured|0|||
125118819|NCT00679783|450057552|FG002|Overall Study|Not Captured|0|||
125118820|NCT00679783|450057553|FG003|Overall Study|Not Captured|5|||
125118821|NCT00679783|450057554|FG004|Overall Study|Not Captured|0|||
125118822|NCT00679783|450057555|FG005|Overall Study|Not Captured|0|||
124923944|NCT04256941|449352382|FG000|Overall Study|Death|1|||
124923945|NCT04256941|449352383|FG001|Overall Study|Death|0|||
124923946|NCT04256941|449352382|FG000|Overall Study|Disease Progession|0|||
125118823|NCT00679783|450057556|FG006|Overall Study|Not Captured|0|||
125118824|NCT00679783|450057550|FG000|Overall Study|Ongoing at data cut-off|2|||
125118825|NCT00679783|450057551|FG001|Overall Study|Ongoing at data cut-off|2|||
125118826|NCT00679783|450057552|FG002|Overall Study|Ongoing at data cut-off|0|||
125118827|NCT00679783|450057553|FG003|Overall Study|Ongoing at data cut-off|9|||
125118828|NCT00679783|450057554|FG004|Overall Study|Ongoing at data cut-off|1|||
124923947|NCT04256941|449352383|FG001|Overall Study|Disease Progession|2|||
124923948|NCT02908477|449352390|FG000|Overall Study|Withdrawal by Subject|8|||
124923949|NCT02908477|449352391|FG001|Overall Study|Withdrawal by Subject|28|||
125118829|NCT00679783|450057555|FG005|Overall Study|Ongoing at data cut-off|0|||
125118830|NCT00679783|450057556|FG006|Overall Study|Ongoing at data cut-off|0|||
125118831|NCT01754259|450057561|FG000|Overall Study|Withdrawal by Subject|2|||
125118832|NCT01754259|450057562|FG001|Overall Study|Withdrawal by Subject|4|||
125118833|NCT01754259|450057561|FG000|Overall Study|Adverse Event|3|||
125118834|NCT01754259|450057562|FG001|Overall Study|Adverse Event|1|||
125118835|NCT01754259|450057561|FG000|Overall Study|Lost to Follow-up|0|||
125118836|NCT01754259|450057562|FG001|Overall Study|Lost to Follow-up|1|||
125118837|NCT00814320|450057563|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
125118838|NCT00814320|450057564|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
125118839|NCT00814320|450057563|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
125118840|NCT00814320|450057564|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
125118841|NCT00814320|450057563|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
125118842|NCT00814320|450057564|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
125118843|NCT00814320|450057563|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
125118844|NCT00814320|450057564|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
125118845|NCT00814320|450057563|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
125118846|NCT00814320|450057564|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
125118847|NCT00814320|450057563|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
125118848|NCT00814320|450057564|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
125118849|NCT00814320|450057563|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
124923950|NCT02140554|449352392|FG000|Overall Study|Withdrawal of consent|1|||
125118850|NCT00814320|450057564|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
124923951|NCT02140554|449352393|FG001|Overall Study|Withdrawal of consent|0|||
124923952|NCT02140554|449352394|FG002|Overall Study|Withdrawal of consent|4|||
124923953|NCT02140554|449352392|FG000|Overall Study|Physician Decision|1|||
124923954|NCT02140554|449352393|FG001|Overall Study|Physician Decision|0|||
125118851|NCT00814320|450057563|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
124923955|NCT02140554|449352394|FG002|Overall Study|Physician Decision|2|||
125118852|NCT00814320|450057564|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
125118853|NCT00814320|450057563|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
125118854|NCT00814320|450057564|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
125118855|NCT00814320|450057563|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
125118856|NCT00814320|450057564|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
125118857|NCT00491504|450057565|FG000|Overall Study|Adverse Event|0|||
125118858|NCT00491504|450057566|FG001|Overall Study|Adverse Event|1|||
125118859|NCT00491504|450057567|FG002|Overall Study|Adverse Event|0|||
125118860|NCT00491504|450057568|FG003|Overall Study|Adverse Event|0|||
125118861|NCT00491504|450057565|FG000|Overall Study|Withdrawal by Subject|0|||
125118862|NCT00491504|450057566|FG001|Overall Study|Withdrawal by Subject|0|||
125118863|NCT00491504|450057567|FG002|Overall Study|Withdrawal by Subject|1|||
125118864|NCT00491504|450057568|FG003|Overall Study|Withdrawal by Subject|2|||
124923956|NCT02140554|449352392|FG000|Overall Study|Death|0|||
124923957|NCT02140554|449352393|FG001|Overall Study|Death|0|||
125118865|NCT00491504|450057565|FG000|Overall Study|Protocol Violation|0|||
125118866|NCT00491504|450057566|FG001|Overall Study|Protocol Violation|0|||
125118867|NCT00491504|450057567|FG002|Overall Study|Protocol Violation|3|||
125118868|NCT00491504|450057568|FG003|Overall Study|Protocol Violation|2|||
125118869|NCT00306384|450057569|FG000|Overall Study|Adverse Event|103|||
125118870|NCT00306384|450057570|FG001|Overall Study|Adverse Event|87|||
125118871|NCT00306384|450057571|FG002|Overall Study|Adverse Event|40|||
125118872|NCT00306384|450057569|FG000|Overall Study|Major protocol deviation|43|||
125118873|NCT00306384|450057570|FG001|Overall Study|Major protocol deviation|51|||
125118874|NCT00306384|450057571|FG002|Overall Study|Major protocol deviation|18|||
125118875|NCT00306384|450057569|FG000|Overall Study|Lost to Follow-up|57|||
125118876|NCT00306384|450057570|FG001|Overall Study|Lost to Follow-up|41|||
125118877|NCT00306384|450057571|FG002|Overall Study|Lost to Follow-up|35|||
125118878|NCT00306384|450057569|FG000|Overall Study|Voluntary withdrawal|199|||
125118879|NCT00306384|450057570|FG001|Overall Study|Voluntary withdrawal|187|||
125118880|NCT00306384|450057571|FG002|Overall Study|Voluntary withdrawal|91|||
125118881|NCT00306384|450057569|FG000|Overall Study|Study termination|1|||
125118882|NCT00306384|450057570|FG001|Overall Study|Study termination|0|||
125118883|NCT00306384|450057571|FG002|Overall Study|Study termination|1|||
125118884|NCT00306384|450057569|FG000|Overall Study|Pregnancy|3|||
125118885|NCT00306384|450057570|FG001|Overall Study|Pregnancy|1|||
125118886|NCT00306384|450057571|FG002|Overall Study|Pregnancy|1|||
125118887|NCT00306384|450057569|FG000|Overall Study|Lack of Efficacy|26|||
125118888|NCT00306384|450057570|FG001|Overall Study|Lack of Efficacy|40|||
125118889|NCT00306384|450057571|FG002|Overall Study|Lack of Efficacy|38|||
125118890|NCT00306384|450057569|FG000|Overall Study|Investigator discretion|28|||
125118891|NCT00306384|450057570|FG001|Overall Study|Investigator discretion|31|||
125118892|NCT00306384|450057571|FG002|Overall Study|Investigator discretion|21|||
125118893|NCT00306384|450057569|FG000|Overall Study|Other|80|||
125118894|NCT00306384|450057570|FG001|Overall Study|Other|70|||
125118895|NCT00306384|450057571|FG002|Overall Study|Other|32|||
125118896|NCT00306384|450057569|FG000|Overall Study|Site closure|2|||
125118897|NCT00306384|450057570|FG001|Overall Study|Site closure|0|||
125118898|NCT00306384|450057571|FG002|Overall Study|Site closure|0|||
125118899|NCT00745251|450057572|FG000|Overall Study|Adverse Event|1|||
125118900|NCT00745251|450057573|FG001|Overall Study|Adverse Event|2|||
125118901|NCT00745251|450057572|FG000|Overall Study|Withdrawal by Subject|1|||
125118902|NCT00745251|450057573|FG001|Overall Study|Withdrawal by Subject|1|||
125118903|NCT00929708|450057575|FG000|Overall Study|Protocol Violation|2|||
125118904|NCT00929708|450057576|FG001|Overall Study|Protocol Violation|1|||
125118905|NCT00929708|450057577|FG002|Overall Study|Protocol Violation|1|||
125118906|NCT00929708|450057578|FG003|Overall Study|Protocol Violation|1|||
125118907|NCT00929708|450057579|FG004|Overall Study|Protocol Violation|1|||
125118908|NCT00929708|450057575|FG000|Overall Study|Withdrawal by Subject|2|||
125118909|NCT00929708|450057576|FG001|Overall Study|Withdrawal by Subject|0|||
125118910|NCT00929708|450057577|FG002|Overall Study|Withdrawal by Subject|0|||
125118911|NCT00929708|450057578|FG003|Overall Study|Withdrawal by Subject|2|||
125118912|NCT00929708|450057579|FG004|Overall Study|Withdrawal by Subject|1|||
125118913|NCT00929708|450057575|FG000|Overall Study|Adverse Event|0|||
124923958|NCT02140554|449352394|FG002|Overall Study|Death|1|||
124923959|NCT02140554|449352392|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
124923960|NCT02140554|449352393|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
124923961|NCT02140554|449352394|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
124923962|NCT05590403|449352395|FG000|Overall Study|Lost to Follow-up|13|||
125118914|NCT00929708|450057576|FG001|Overall Study|Adverse Event|0|||
125118915|NCT00929708|450057577|FG002|Overall Study|Adverse Event|0|||
125118916|NCT00929708|450057578|FG003|Overall Study|Adverse Event|0|||
124923963|NCT05590403|449352396|FG001|Overall Study|Lost to Follow-up|1|||
124923964|NCT05590403|449352397|FG002|Overall Study|Lost to Follow-up|7|||
125118917|NCT00929708|450057579|FG004|Overall Study|Adverse Event|3|||
125118918|NCT00929708|450057575|FG000|Overall Study|Physician Decision|0|||
125118919|NCT00929708|450057576|FG001|Overall Study|Physician Decision|2|||
125118920|NCT00929708|450057577|FG002|Overall Study|Physician Decision|2|||
125118921|NCT00929708|450057578|FG003|Overall Study|Physician Decision|2|||
125118922|NCT00929708|450057579|FG004|Overall Study|Physician Decision|1|||
125118923|NCT00929708|450057575|FG000|Overall Study|Lost to Follow-up|0|||
125118924|NCT00929708|450057576|FG001|Overall Study|Lost to Follow-up|0|||
125118925|NCT00929708|450057577|FG002|Overall Study|Lost to Follow-up|0|||
125118926|NCT00929708|450057578|FG003|Overall Study|Lost to Follow-up|1|||
125118927|NCT00929708|450057579|FG004|Overall Study|Lost to Follow-up|0|||
125118928|NCT01893138|450057580|FG000|Double-Blind Period|Withdrawal by Subject|1|||
125118929|NCT01893138|450057581|FG001|Double-Blind Period|Withdrawal by Subject|1|||
125212211|NCT03594955|450403289|FG000|Overall Study|Sponsor's decision|1|||
125118930|NCT01893138|450057580|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
125118931|NCT01893138|450057581|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
125118932|NCT01893138|450057580|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
125118933|NCT01893138|450057581|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
125118934|NCT01893138|450057580|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
125118935|NCT01893138|450057581|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
125118936|NCT01893138|450057580|FG000|Open Label - Unblinded Period|Adverse Event|1|||
125118937|NCT01893138|450057581|FG001|Open Label - Unblinded Period|Adverse Event|0|||
125118938|NCT02154529|450057582|FG000|Overall Study|Death|1|||
125118939|NCT02154529|450057583|FG001|Overall Study|Death|1|||
125118940|NCT02154529|450057584|FG002|Overall Study|Death|5|||
125118941|NCT02154529|450057585|FG003|Overall Study|Death|1|||
125118942|NCT02154529|450057582|FG000|Overall Study|Termination of study by sponsor|2|||
125118943|NCT02154529|450057583|FG001|Overall Study|Termination of study by sponsor|2|||
125118944|NCT02154529|450057584|FG002|Overall Study|Termination of study by sponsor|3|||
125118945|NCT02154529|450057585|FG003|Overall Study|Termination of study by sponsor|1|||
125118946|NCT02154529|450057582|FG000|Overall Study|Lost to Follow-up|1|||
125118947|NCT02154529|450057583|FG001|Overall Study|Lost to Follow-up|0|||
125118948|NCT02154529|450057584|FG002|Overall Study|Lost to Follow-up|0|||
125118949|NCT02154529|450057585|FG003|Overall Study|Lost to Follow-up|0|||
125118950|NCT01628120|450059337|FG000|Overall Study|Withdrawal by Subject|7|||
125118951|NCT01628120|450059337|FG000|Overall Study|Adverse Event|12|||
125118952|NCT01628120|450059337|FG000|Overall Study|Lost to Follow-up|1|||
125118953|NCT01628120|450059337|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
125118954|NCT01628120|450059337|FG000|Overall Study|Non-compliant with Study Procedures|1|||
125118955|NCT01628120|450059337|FG000|Overall Study|Not Treated|3|||
125118956|NCT01628120|450059337|FG000|Overall Study|Sponsor Decision|5|||
125118957|NCT01628120|450059337|FG000|Overall Study|Switched Dialysis Method|2|||
125118958|NCT01628120|450059337|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
125118959|NCT01628120|450059337|FG000|Overall Study|Moved or Relocated|5|||
125118960|NCT01628120|450059337|FG000|Overall Study|Kidney Transplant|2|||
125118961|NCT01628120|450059337|FG000|Overall Study|Use of Standard of Care|1|||
125118962|NCT02232074|450059338|FG000|Overall Study|Withdrawal by Subject|5|||
125118963|NCT02232074|450059339|FG001|Overall Study|Withdrawal by Subject|3|||
125118964|NCT02232074|450059338|FG000|Overall Study|No legal concerns at baseline|36|||
125118965|NCT02232074|450059339|FG001|Overall Study|No legal concerns at baseline|41|||
125118966|NCT02232074|450059338|FG000|Overall Study|deemed ineligible|0|||
125118967|NCT02232074|450059339|FG001|Overall Study|deemed ineligible|1|||
124923965|NCT05590403|449352398|FG003|Overall Study|Lost to Follow-up|3|||
125212212|NCT04278924|450403294|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
125212213|NCT04278924|450403295|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
125212214|NCT04278924|450403296|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
125212215|NCT04278924|450403297|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
125212216|NCT04278924|450403298|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
124923966|NCT05590403|449352399|FG004|Overall Study|Lost to Follow-up|4|||
124923967|NCT05590403|449352395|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
124923968|NCT05590403|449352396|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
124923969|NCT05590403|449352397|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
124923970|NCT05590403|449352398|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
125118968|NCT01296932|450059342|FG000|Overall Study|Dose limiting toxicity|0|||
125118969|NCT01296932|450059343|FG001|Overall Study|Dose limiting toxicity|0|||
125118970|NCT01296932|450059344|FG002|Overall Study|Dose limiting toxicity|0|||
125118971|NCT01296932|450059345|FG003|Overall Study|Dose limiting toxicity|0|||
125212217|NCT04278924|450403299|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
125212218|NCT04278924|450403300|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
124923971|NCT05590403|449352399|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
124923972|NCT05590403|449352395|FG000|Overall Study|Other|2|||
124923973|NCT05590403|449352396|FG001|Overall Study|Other|0|||
125118972|NCT01296932|450059346|FG004|Overall Study|Dose limiting toxicity|0|||
125118973|NCT01296932|450059347|FG005|Overall Study|Dose limiting toxicity|0|||
125118974|NCT01296932|450059348|FG006|Overall Study|Dose limiting toxicity|1|||
125118975|NCT01296932|450059349|FG007|Overall Study|Dose limiting toxicity|0|||
125118976|NCT01296932|450059350|FG008|Overall Study|Dose limiting toxicity|1|||
125118977|NCT01296932|450059342|FG000|Overall Study|Progressive disease|2|||
125118978|NCT01296932|450059343|FG001|Overall Study|Progressive disease|0|||
125118979|NCT01296932|450059344|FG002|Overall Study|Progressive disease|1|||
125118980|NCT01296932|450059345|FG003|Overall Study|Progressive disease|1|||
125118981|NCT01296932|450059346|FG004|Overall Study|Progressive disease|2|||
125118982|NCT01296932|450059347|FG005|Overall Study|Progressive disease|3|||
125118983|NCT01296932|450059348|FG006|Overall Study|Progressive disease|1|||
125118984|NCT01296932|450059349|FG007|Overall Study|Progressive disease|0|||
125118985|NCT01296932|450059350|FG008|Overall Study|Progressive disease|0|||
125118986|NCT01296932|450059342|FG000|Overall Study|Withdrawal by Subject|0|||
125118987|NCT01296932|450059343|FG001|Overall Study|Withdrawal by Subject|0|||
125118988|NCT01296932|450059344|FG002|Overall Study|Withdrawal by Subject|1|||
125118989|NCT01296932|450059345|FG003|Overall Study|Withdrawal by Subject|1|||
125118990|NCT01296932|450059346|FG004|Overall Study|Withdrawal by Subject|0|||
125118991|NCT01296932|450059347|FG005|Overall Study|Withdrawal by Subject|0|||
125118992|NCT01296932|450059348|FG006|Overall Study|Withdrawal by Subject|3|||
125118993|NCT01296932|450059349|FG007|Overall Study|Withdrawal by Subject|0|||
125118994|NCT01296932|450059350|FG008|Overall Study|Withdrawal by Subject|0|||
125118995|NCT01296932|450059342|FG000|Overall Study|Adverse Event|1|||
125118996|NCT01296932|450059343|FG001|Overall Study|Adverse Event|1|||
125118997|NCT01296932|450059344|FG002|Overall Study|Adverse Event|1|||
125118998|NCT01296932|450059345|FG003|Overall Study|Adverse Event|2|||
125118999|NCT01296932|450059346|FG004|Overall Study|Adverse Event|1|||
125119000|NCT01296932|450059347|FG005|Overall Study|Adverse Event|0|||
125119001|NCT01296932|450059348|FG006|Overall Study|Adverse Event|0|||
125119002|NCT01296932|450059349|FG007|Overall Study|Adverse Event|0|||
125119003|NCT01296932|450059350|FG008|Overall Study|Adverse Event|1|||
125119004|NCT01296932|450059342|FG000|Overall Study|Investigator decision|0|||
125119005|NCT01296932|450059343|FG001|Overall Study|Investigator decision|1|||
125119006|NCT01296932|450059344|FG002|Overall Study|Investigator decision|0|||
125119007|NCT01296932|450059345|FG003|Overall Study|Investigator decision|1|||
125119008|NCT01296932|450059346|FG004|Overall Study|Investigator decision|0|||
125119009|NCT01296932|450059347|FG005|Overall Study|Investigator decision|0|||
125119010|NCT01296932|450059348|FG006|Overall Study|Investigator decision|1|||
125119011|NCT01296932|450059349|FG007|Overall Study|Investigator decision|0|||
125119012|NCT01296932|450059350|FG008|Overall Study|Investigator decision|1|||
125119013|NCT01296932|450059342|FG000|Overall Study|No clinical benefit anymore|0|||
125119014|NCT01296932|450059343|FG001|Overall Study|No clinical benefit anymore|1|||
125119015|NCT01296932|450059344|FG002|Overall Study|No clinical benefit anymore|0|||
125119016|NCT01296932|450059345|FG003|Overall Study|No clinical benefit anymore|0|||
125119017|NCT01296932|450059346|FG004|Overall Study|No clinical benefit anymore|0|||
125119018|NCT01296932|450059347|FG005|Overall Study|No clinical benefit anymore|0|||
125119019|NCT01296932|450059348|FG006|Overall Study|No clinical benefit anymore|0|||
124923974|NCT05590403|449352397|FG002|Overall Study|Other|2|||
124923975|NCT05590403|449352398|FG003|Overall Study|Other|2|||
124923976|NCT05590403|449352399|FG004|Overall Study|Other|0|||
124923977|NCT05590403|449352395|FG000|Overall Study|Migrated / moved from the study area|1|||
124923978|NCT05590403|449352396|FG001|Overall Study|Migrated / moved from the study area|1|||
124923979|NCT05590403|449352397|FG002|Overall Study|Migrated / moved from the study area|0|||
124923980|NCT05590403|449352398|FG003|Overall Study|Migrated / moved from the study area|3|||
124923981|NCT05590403|449352399|FG004|Overall Study|Migrated / moved from the study area|1|||
124923982|NCT05590403|449352395|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
124923983|NCT05590403|449352396|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
124923984|NCT05590403|449352397|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
124923985|NCT05590403|449352398|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
124923986|NCT05590403|449352399|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
124923987|NCT05659537|449352400|FG000|Overall Study|Adverse Event|5|||
124923988|NCT05659537|449352400|FG000|Overall Study|Lost to Follow-up|4|||
124923989|NCT05659537|449352400|FG000|Overall Study|Withdrawal by Subject|13|||
124923990|NCT05659537|449352400|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
124923991|NCT05659537|449352400|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
124923992|NCT05659537|449352400|FG000|Overall Study|Participant was suffering from anaemia|1|||
125119020|NCT01296932|450059349|FG007|Overall Study|No clinical benefit anymore|0|||
125119021|NCT01296932|450059350|FG008|Overall Study|No clinical benefit anymore|0|||
125119022|NCT01296932|450059342|FG000|Overall Study|Physician Decision|0|||
125119023|NCT01296932|450059343|FG001|Overall Study|Physician Decision|0|||
125119024|NCT01296932|450059344|FG002|Overall Study|Physician Decision|1|||
125119025|NCT01296932|450059345|FG003|Overall Study|Physician Decision|0|||
125212219|NCT04278924|450403294|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
125119026|NCT01296932|450059346|FG004|Overall Study|Physician Decision|0|||
125119027|NCT01296932|450059347|FG005|Overall Study|Physician Decision|0|||
125119028|NCT01296932|450059348|FG006|Overall Study|Physician Decision|0|||
125119029|NCT01296932|450059349|FG007|Overall Study|Physician Decision|0|||
125119030|NCT01296932|450059350|FG008|Overall Study|Physician Decision|0|||
125119031|NCT01296932|450059342|FG000|Overall Study|IV problems, administration not possible|0|||
125119032|NCT01296932|450059343|FG001|Overall Study|IV problems, administration not possible|0|||
125119033|NCT01296932|450059344|FG002|Overall Study|IV problems, administration not possible|1|||
125119034|NCT01296932|450059345|FG003|Overall Study|IV problems, administration not possible|0|||
125119035|NCT01296932|450059346|FG004|Overall Study|IV problems, administration not possible|0|||
125119036|NCT01296932|450059347|FG005|Overall Study|IV problems, administration not possible|0|||
125119037|NCT01296932|450059348|FG006|Overall Study|IV problems, administration not possible|0|||
125119038|NCT01296932|450059349|FG007|Overall Study|IV problems, administration not possible|0|||
124923993|NCT04856163|449352402|FG000|Overall Study|Lost to Follow-up|97|||
124923994|NCT04856163|449352403|FG001|Overall Study|Lost to Follow-up|100|||
124923995|NCT04526704|449352412|FG000|Overall Study|Adverse Event|1|||
124923996|NCT04526704|449352413|FG001|Overall Study|Adverse Event|0|||
125119039|NCT01296932|450059350|FG008|Overall Study|IV problems, administration not possible|0|||
124923997|NCT04526704|449352412|FG000|Overall Study|Physician Decision|1|||
125119040|NCT01296932|450059342|FG000|Overall Study|per protocol|0|||
125119041|NCT01296932|450059343|FG001|Overall Study|per protocol|0|||
124923998|NCT04526704|449352413|FG001|Overall Study|Physician Decision|0|||
124923999|NCT04526704|449352412|FG000|Overall Study|Withdrawal by Subject|2|||
124924000|NCT04526704|449352413|FG001|Overall Study|Withdrawal by Subject|0|||
124924001|NCT00881621|449352414|FG000|Overall Study|Physician Decision|34|||
124924002|NCT03936322|449352419|FG000|Overall Study|Lost to Follow-up|1|||
124924003|NCT03936322|449352419|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
124924004|NCT05434078|449352421|FG000|Overall Study|Lost to Follow-up|2|||
124924005|NCT05434078|449352422|FG001|Overall Study|Lost to Follow-up|1|||
124924006|NCT05434078|449352421|FG000|Overall Study|Withdrawal by Subject|1|||
124924007|NCT05434078|449352422|FG001|Overall Study|Withdrawal by Subject|0|||
124924008|NCT02734290|449352426|FG000|Overall Study|Adverse Event|1|||
124924009|NCT02734290|449352427|FG001|Overall Study|Adverse Event|0|||
124924010|NCT02734290|449352426|FG000|Overall Study|Death|1|||
124924011|NCT02734290|449352427|FG001|Overall Study|Death|0|||
124924012|NCT03158129|449352428|FG000|Overall Study|Adverse Event|0|||
124924013|NCT03158129|449352429|FG001|Overall Study|Adverse Event|1|||
124924014|NCT03158129|449352430|FG002|Overall Study|Adverse Event|0|||
124924015|NCT03158129|449352431|FG003|Overall Study|Adverse Event|0|||
124924016|NCT03158129|449352428|FG000|Overall Study|Death|0|||
124924017|NCT03158129|449352429|FG001|Overall Study|Death|0|||
124924018|NCT03158129|449352430|FG002|Overall Study|Death|0|||
124924019|NCT03158129|449352431|FG003|Overall Study|Death|1|||
124924020|NCT03158129|449352428|FG000|Overall Study|High surgical risk|1|||
124924021|NCT03158129|449352429|FG001|Overall Study|High surgical risk|1|||
124924022|NCT03158129|449352430|FG002|Overall Study|High surgical risk|0|||
124924023|NCT03158129|449352431|FG003|Overall Study|High surgical risk|0|||
124924024|NCT03158129|449352428|FG000|Overall Study|Progression|1|||
124924025|NCT03158129|449352429|FG001|Overall Study|Progression|1|||
124924026|NCT03158129|449352430|FG002|Overall Study|Progression|0|||
124924027|NCT03158129|449352431|FG003|Overall Study|Progression|0|||
124924028|NCT03158129|449352428|FG000|Overall Study|Lack of resectability|0|||
124924029|NCT03158129|449352429|FG001|Overall Study|Lack of resectability|1|||
124924030|NCT03158129|449352430|FG002|Overall Study|Lack of resectability|0|||
124924031|NCT03158129|449352431|FG003|Overall Study|Lack of resectability|0|||
124924032|NCT03158129|449352428|FG000|Overall Study|Declined surgery|0|||
124924033|NCT03158129|449352429|FG001|Overall Study|Declined surgery|1|||
124924034|NCT03158129|449352430|FG002|Overall Study|Declined surgery|0|||
124924035|NCT03158129|449352431|FG003|Overall Study|Declined surgery|0|||
124924036|NCT03158129|449352428|FG000|Overall Study|No longer surgical candidate|0|||
124924037|NCT03158129|449352429|FG001|Overall Study|No longer surgical candidate|0|||
124924038|NCT03158129|449352430|FG002|Overall Study|No longer surgical candidate|0|||
124924039|NCT03158129|449352431|FG003|Overall Study|No longer surgical candidate|1|||
124924040|NCT03867500|449352436|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
124924041|NCT00554788|449352437|FG000|Overall Study|Adverse Event|0|||
124924042|NCT00554788|449352438|FG001|Overall Study|Adverse Event|1|||
124924043|NCT00554788|449352439|FG002|Overall Study|Adverse Event|2|||
124924044|NCT00554788|449352437|FG000|Overall Study|Lost to Follow-up|4|||
124924045|NCT00554788|449352438|FG001|Overall Study|Lost to Follow-up|3|||
124924046|NCT00554788|449352439|FG002|Overall Study|Lost to Follow-up|3|||
124924047|NCT00554788|449352437|FG000|Overall Study|Physician Decision|1|||
124924048|NCT00554788|449352438|FG001|Overall Study|Physician Decision|1|||
124924049|NCT00554788|449352439|FG002|Overall Study|Physician Decision|3|||
124924050|NCT00554788|449352437|FG000|Overall Study|Withdrawal by Subject|0|||
124924051|NCT00554788|449352438|FG001|Overall Study|Withdrawal by Subject|0|||
124924052|NCT00554788|449352439|FG002|Overall Study|Withdrawal by Subject|1|||
124924053|NCT00554788|449352437|FG000|Overall Study|Refusal of further protocol therapy|0|||
124924054|NCT00554788|449352438|FG001|Overall Study|Refusal of further protocol therapy|1|||
124924055|NCT00554788|449352439|FG002|Overall Study|Refusal of further protocol therapy|1|||
124924056|NCT00554788|449352437|FG000|Overall Study|Progressive disease|0|||
124924057|NCT00554788|449352438|FG001|Overall Study|Progressive disease|0|||
124924058|NCT00554788|449352439|FG002|Overall Study|Progressive disease|3|||
124924059|NCT00554788|449352437|FG000|Overall Study|Ineligible|2|||
124924060|NCT00554788|449352438|FG001|Overall Study|Ineligible|0|||
124924061|NCT00554788|449352439|FG002|Overall Study|Ineligible|1|||
125119042|NCT01296932|450059344|FG002|Overall Study|per protocol|1|||
125119043|NCT01296932|450059345|FG003|Overall Study|per protocol|1|||
125119044|NCT01296932|450059346|FG004|Overall Study|per protocol|0|||
124924062|NCT03897465|449352441|FG000|Overall Study|Lost to Follow-up|2|||
124924063|NCT03897465|449352442|FG001|Overall Study|Lost to Follow-up|1|||
124924064|NCT03897465|449352441|FG000|Overall Study|Adverse Event|2|||
124924065|NCT03897465|449352442|FG001|Overall Study|Adverse Event|0|||
124924066|NCT03897465|449352441|FG000|Overall Study|complete healing by V2|1|||
124924067|NCT03897465|449352442|FG001|Overall Study|complete healing by V2|0|||
124924068|NCT03897465|449352441|FG000|Overall Study|occurence of exclusion criterion|1|||
124924069|NCT03897465|449352442|FG001|Overall Study|occurence of exclusion criterion|1|||
124924070|NCT03897465|449352441|FG000|Overall Study|Other|1|||
124924071|NCT03897465|449352442|FG001|Overall Study|Other|0|||
124924072|NCT05119023|449352443|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
124924073|NCT05119023|449352443|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
125119045|NCT01296932|450059347|FG005|Overall Study|per protocol|0|||
125119046|NCT01296932|450059348|FG006|Overall Study|per protocol|0|||
124924074|NCT05119023|449352443|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
124924075|NCT04719390|449352459|FG000|Overall Study|Withdrawal by Subject|1|||
125119047|NCT01296932|450059349|FG007|Overall Study|per protocol|0|||
125119048|NCT01296932|450059350|FG008|Overall Study|per protocol|0|||
125119049|NCT01296932|450059342|FG000|Overall Study|Low benefit and too many side effects|0|||
125119050|NCT01296932|450059343|FG001|Overall Study|Low benefit and too many side effects|0|||
125119051|NCT01296932|450059344|FG002|Overall Study|Low benefit and too many side effects|0|||
125119052|NCT01296932|450059345|FG003|Overall Study|Low benefit and too many side effects|0|||
125119053|NCT01296932|450059346|FG004|Overall Study|Low benefit and too many side effects|0|||
125119054|NCT01296932|450059347|FG005|Overall Study|Low benefit and too many side effects|0|||
125119055|NCT01296932|450059348|FG006|Overall Study|Low benefit and too many side effects|0|||
125119056|NCT01296932|450059349|FG007|Overall Study|Low benefit and too many side effects|1|||
125119057|NCT01296932|450059350|FG008|Overall Study|Low benefit and too many side effects|0|||
125119058|NCT01296932|450059342|FG000|Overall Study|No adequate treatment response|0|||
125119059|NCT01296932|450059343|FG001|Overall Study|No adequate treatment response|0|||
125119060|NCT01296932|450059344|FG002|Overall Study|No adequate treatment response|0|||
125119061|NCT01296932|450059345|FG003|Overall Study|No adequate treatment response|0|||
124924076|NCT04292223|449352460|FG000|Overall Study|Adverse Event|1|||
124924077|NCT04292223|449352460|FG000|Overall Study|Lost to Follow-up|1|||
124924078|NCT04292223|449352460|FG000|Overall Study|Noncompliance with study drug|2|||
124924079|NCT04292223|449352460|FG000|Overall Study|Patient moved out of the state|1|||
124924080|NCT04963270|449352464|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
124924081|NCT04963270|449352465|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
124924082|NCT04963270|449352466|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
124924083|NCT04963270|449352467|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
124924084|NCT04963270|449352464|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
124924085|NCT04963270|449352465|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
124924086|NCT04963270|449352466|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
124924087|NCT04963270|449352467|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
124924088|NCT04963270|449352464|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
124924089|NCT04963270|449352465|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
124924090|NCT04963270|449352466|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
124924091|NCT04963270|449352467|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
124924092|NCT04963270|449352464|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
124924093|NCT04963270|449352465|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
124924094|NCT04963270|449352466|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
124924095|NCT04963270|449352467|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
124924096|NCT04963270|449352464|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
124924097|NCT04963270|449352465|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
124924098|NCT04963270|449352466|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
124924099|NCT04963270|449352467|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
124924100|NCT04963270|449352464|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
124924101|NCT04963270|449352465|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
124924102|NCT04963270|449352466|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
124924103|NCT04963270|449352467|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
124924104|NCT04963270|449352464|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
124924105|NCT04963270|449352465|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
124924106|NCT04963270|449352466|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
124924107|NCT04963270|449352467|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
125119062|NCT01296932|450059346|FG004|Overall Study|No adequate treatment response|0|||
125119063|NCT01296932|450059347|FG005|Overall Study|No adequate treatment response|0|||
125119064|NCT01296932|450059348|FG006|Overall Study|No adequate treatment response|0|||
125119065|NCT01296932|450059349|FG007|Overall Study|No adequate treatment response|1|||
125119066|NCT01296932|450059350|FG008|Overall Study|No adequate treatment response|0|||
125119067|NCT01296932|450059342|FG000|Overall Study|Dosage already reduced, AE still present|0|||
125119068|NCT01296932|450059343|FG001|Overall Study|Dosage already reduced, AE still present|0|||
125119069|NCT01296932|450059344|FG002|Overall Study|Dosage already reduced, AE still present|0|||
125119070|NCT01296932|450059345|FG003|Overall Study|Dosage already reduced, AE still present|0|||
124924108|NCT04963270|449352464|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
125119071|NCT01296932|450059346|FG004|Overall Study|Dosage already reduced, AE still present|0|||
124924109|NCT04963270|449352465|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
124924110|NCT04963270|449352466|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
124969558|NCT03520075|449517414|FG005|Phase 2 (Dose Expansion)|Death|0|||
125119072|NCT01296932|450059347|FG005|Overall Study|Dosage already reduced, AE still present|0|||
125119073|NCT01296932|450059348|FG006|Overall Study|Dosage already reduced, AE still present|0|||
125119074|NCT01296932|450059349|FG007|Overall Study|Dosage already reduced, AE still present|0|||
125212220|NCT04278924|450403295|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
125212221|NCT04278924|450403296|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
125212222|NCT04278924|450403297|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
125212223|NCT04278924|450403298|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
125212224|NCT04278924|450403299|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
125212225|NCT04278924|450403300|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
125212226|NCT05600036|450403301|FG000|Overall Study|Adverse Event|0|||
125212227|NCT05600036|450403302|FG001|Overall Study|Adverse Event|2|||
125212228|NCT05600036|450403303|FG002|Overall Study|Adverse Event|1|||
125212229|NCT05600036|450403304|FG003|Overall Study|Adverse Event|0|||
125212230|NCT05600036|450403305|FG004|Overall Study|Adverse Event|1|||
125212231|NCT05600036|450403306|FG005|Overall Study|Adverse Event|0|||
125212232|NCT05600036|450403301|FG000|Overall Study|Lost to Follow-up|0|||
125212233|NCT05600036|450403302|FG001|Overall Study|Lost to Follow-up|2|||
125212234|NCT05600036|450403303|FG002|Overall Study|Lost to Follow-up|1|||
125212235|NCT05600036|450403304|FG003|Overall Study|Lost to Follow-up|1|||
125212236|NCT05600036|450403305|FG004|Overall Study|Lost to Follow-up|0|||
125212237|NCT05600036|450403306|FG005|Overall Study|Lost to Follow-up|0|||
125212238|NCT05600036|450403301|FG000|Overall Study|Protocol Violation|0|||
125212239|NCT05600036|450403302|FG001|Overall Study|Protocol Violation|0|||
125212240|NCT05600036|450403303|FG002|Overall Study|Protocol Violation|2|||
125212241|NCT05600036|450403304|FG003|Overall Study|Protocol Violation|0|||
125212242|NCT05600036|450403305|FG004|Overall Study|Protocol Violation|0|||
125212243|NCT05600036|450403306|FG005|Overall Study|Protocol Violation|0|||
125212244|NCT05600036|450403301|FG000|Overall Study|Withdrawal by Subject|0|||
125212245|NCT05600036|450403302|FG001|Overall Study|Withdrawal by Subject|1|||
125212246|NCT05600036|450403303|FG002|Overall Study|Withdrawal by Subject|2|||
125212247|NCT05600036|450403304|FG003|Overall Study|Withdrawal by Subject|0|||
125212248|NCT05600036|450403305|FG004|Overall Study|Withdrawal by Subject|3|||
125212249|NCT05600036|450403306|FG005|Overall Study|Withdrawal by Subject|5|||
125212250|NCT05600036|450403301|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
125212251|NCT05600036|450403302|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
125212252|NCT05600036|450403303|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
125212253|NCT05600036|450403304|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
125212254|NCT05600036|450403305|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
125212255|NCT05600036|450403306|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
125212256|NCT05600036|450403301|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
125119075|NCT01296932|450059350|FG008|Overall Study|Dosage already reduced, AE still present|1|||
125119076|NCT01579474|450059353|FG000|Overall Study|Adverse Event|1|||
124924111|NCT04963270|449352467|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
124924112|NCT04963270|449352464|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
124924113|NCT04963270|449352465|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
124924114|NCT04963270|449352466|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
124924115|NCT04963270|449352467|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
124924116|NCT04963270|449352464|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
124924117|NCT04963270|449352465|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
124924118|NCT04963270|449352466|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
124924119|NCT04963270|449352467|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
124924120|NCT04963270|449352464|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
124924121|NCT04963270|449352465|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
124924122|NCT04963270|449352466|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
124924123|NCT04963270|449352467|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
124924124|NCT04963270|449352464|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
124924125|NCT04963270|449352465|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
124924126|NCT04963270|449352466|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
124924127|NCT04963270|449352467|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
124924128|NCT04963270|449352464|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
124924129|NCT04963270|449352465|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
124924130|NCT04963270|449352466|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
124924131|NCT04963270|449352467|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
124924132|NCT04963270|449352464|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
124924133|NCT04963270|449352465|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
124924134|NCT04963270|449352466|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
124924135|NCT04963270|449352467|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
124924136|NCT04927364|449352471|FG000|Overall Study|Withdrawal by Subject|3|||
124924137|NCT04927364|449352471|FG000|Overall Study|Unable to complete preassessment MRI|1|||
124924138|NCT02919306|449352474|FG000|Overall Study|Withdrawal by Subject|1|||
124924139|NCT02919306|449352475|FG001|Overall Study|Withdrawal by Subject|0|||
124924140|NCT02919306|449352474|FG000|Overall Study|Protocol Violation|1|||
124924141|NCT02919306|449352475|FG001|Overall Study|Protocol Violation|0|||
124924142|NCT03560609|449352476|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
124924143|NCT03560609|449352477|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
124924144|NCT04293055|449352478|FG000|Overall Study|Lost to Follow-up|1|||
124924145|NCT04293055|449352479|FG001|Overall Study|Lost to Follow-up|1|||
124924146|NCT04293055|449352478|FG000|Overall Study|Did not trigger randomization|6|||
125119077|NCT01579474|450059354|FG001|Overall Study|Adverse Event|13|||
125119078|NCT01579474|450059355|FG002|Overall Study|Adverse Event|2|||
125119079|NCT01579474|450059356|FG003|Overall Study|Adverse Event|0|||
125119080|NCT01579474|450059357|FG004|Overall Study|Adverse Event|0|||
125119081|NCT01579474|450059358|FG005|Overall Study|Adverse Event|1|||
125119082|NCT01579474|450059353|FG000|Overall Study|Lack of Efficacy|1|||
125119083|NCT01579474|450059354|FG001|Overall Study|Lack of Efficacy|0|||
125119084|NCT01579474|450059355|FG002|Overall Study|Lack of Efficacy|0|||
125119085|NCT01579474|450059356|FG003|Overall Study|Lack of Efficacy|0|||
125119086|NCT01579474|450059357|FG004|Overall Study|Lack of Efficacy|1|||
125212257|NCT05600036|450403302|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
124924147|NCT04293055|449352479|FG001|Overall Study|Did not trigger randomization|5|||
124924148|NCT04195698|449352488|FG000|Overall Study|Adverse Event|4|||
124924149|NCT04195698|449352489|FG001|Overall Study|Adverse Event|11|||
124924150|NCT04195698|449352488|FG000|Overall Study|Withdrawal by Subject|9|||
124924151|NCT04195698|449352489|FG001|Overall Study|Withdrawal by Subject|10|||
124924152|NCT04195698|449352488|FG000|Overall Study|Lost to Follow-up|5|||
125119087|NCT01579474|450059358|FG005|Overall Study|Lack of Efficacy|0|||
125119088|NCT01579474|450059353|FG000|Overall Study|Withdrawal by Subject|1|||
124924153|NCT04195698|449352489|FG001|Overall Study|Lost to Follow-up|4|||
124924154|NCT04195698|449352488|FG000|Overall Study|Lack of Efficacy|2|||
124924155|NCT04195698|449352489|FG001|Overall Study|Lack of Efficacy|10|||
124924156|NCT04195698|449352488|FG000|Overall Study|Other|5|||
124924157|NCT04195698|449352489|FG001|Overall Study|Other|4|||
124924158|NCT05459688|449352490|FG000|Overall Study|Lost to Follow-up|6|||
124924159|NCT05459688|449352490|FG000|Overall Study|Physician Decision|1|||
124924160|NCT05459688|449352490|FG000|Overall Study|Withdrawal by Subject|19|||
124924161|NCT05459688|449352490|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
124924162|NCT01959425|449352491|FG000|Overall Study|Withdrawal by Subject|5|||
124924163|NCT01959425|449352492|FG001|Overall Study|Withdrawal by Subject|4|||
124924164|NCT01959425|449352491|FG000|Overall Study|Lost to Follow-up|1|||
124924165|NCT01959425|449352492|FG001|Overall Study|Lost to Follow-up|0|||
124924166|NCT01959425|449352491|FG000|Overall Study|Discontinued Subjects|6|||
124924167|NCT01959425|449352492|FG001|Overall Study|Discontinued Subjects|4|||
124924168|NCT04625283|449352493|FG000|Overall Study|post randomization exclusion|28|||
124924169|NCT04625283|449352494|FG001|Overall Study|post randomization exclusion|20|||
124924170|NCT04632992|449352498|FG000|Overall Study|Adverse Event|0|||
124924171|NCT04632992|449352499|FG001|Overall Study|Adverse Event|0|||
124924172|NCT04632992|449352500|FG002|Overall Study|Adverse Event|0|||
124924173|NCT04632992|449352501|FG003|Overall Study|Adverse Event|0|||
125212258|NCT05600036|450403303|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
124924174|NCT04632992|449352502|FG004|Overall Study|Adverse Event|0|||
124924175|NCT04632992|449352503|FG005|Overall Study|Adverse Event|0|||
124924176|NCT04632992|449352504|FG006|Overall Study|Adverse Event|0|||
124924177|NCT04632992|449352505|FG007|Overall Study|Adverse Event|0|||
124924178|NCT04632992|449352506|FG008|Overall Study|Adverse Event|0|||
124924179|NCT04632992|449352507|FG009|Overall Study|Adverse Event|0|||
124924180|NCT04632992|449352508|FG010|Overall Study|Adverse Event|0|||
124924181|NCT04632992|449352509|FG011|Overall Study|Adverse Event|0|||
125119089|NCT01579474|450059354|FG001|Overall Study|Withdrawal by Subject|0|||
125119090|NCT01579474|450059355|FG002|Overall Study|Withdrawal by Subject|0|||
125119091|NCT01579474|450059356|FG003|Overall Study|Withdrawal by Subject|0|||
125119092|NCT01579474|450059357|FG004|Overall Study|Withdrawal by Subject|0|||
125119093|NCT01579474|450059358|FG005|Overall Study|Withdrawal by Subject|0|||
125119094|NCT00130520|450059359|FG000|Overall Study|Adverse Event|11|||
125119095|NCT00130520|450059359|FG000|Overall Study|Death|1|||
125119096|NCT00130520|450059359|FG000|Overall Study|Physician Decision|1|||
125119097|NCT00130520|450059359|FG000|Overall Study|Withdrawal by Subject|1|||
125119098|NCT00130520|450059359|FG000|Overall Study|Disease Progression|23|||
125119099|NCT00130520|450059359|FG000|Overall Study|Protocol non-compliance|1|||
125119100|NCT00130520|450059359|FG000|Overall Study|Did not meet re-treatment criteria|1|||
125119101|NCT02688400|450059361|FG000|Overall Study|Protocol Violation|2|||
125119102|NCT02688400|450059362|FG001|Overall Study|Protocol Violation|5|||
125119103|NCT02688400|450059361|FG000|Overall Study|Lack of Efficacy|7|||
125119104|NCT02688400|450059362|FG001|Overall Study|Lack of Efficacy|7|||
125119105|NCT02688400|450059361|FG000|Overall Study|Adverse Event|21|||
125119106|NCT02688400|450059362|FG001|Overall Study|Adverse Event|12|||
125119107|NCT02688400|450059361|FG000|Overall Study|Withdrawal by Subject|15|||
124924182|NCT04632992|449352510|FG012|Overall Study|Adverse Event|1|||
124924183|NCT04632992|449352511|FG013|Overall Study|Adverse Event|0|||
124924184|NCT04632992|449352498|FG000|Overall Study|Death|17|||
124924185|NCT04632992|449352499|FG001|Overall Study|Death|1|||
124924186|NCT04632992|449352500|FG002|Overall Study|Death|14|||
124924187|NCT04632992|449352501|FG003|Overall Study|Death|14|||
124924188|NCT04632992|449352502|FG004|Overall Study|Death|13|||
124924189|NCT04632992|449352503|FG005|Overall Study|Death|6|||
124924190|NCT04632992|449352504|FG006|Overall Study|Death|7|||
124924191|NCT04632992|449352505|FG007|Overall Study|Death|12|||
124924192|NCT04632992|449352506|FG008|Overall Study|Death|15|||
124924193|NCT04632992|449352507|FG009|Overall Study|Death|20|||
124924194|NCT04632992|449352508|FG010|Overall Study|Death|8|||
124924195|NCT04632992|449352509|FG011|Overall Study|Death|2|||
124924196|NCT04632992|449352510|FG012|Overall Study|Death|10|||
124924197|NCT04632992|449352511|FG013|Overall Study|Death|1|||
124924198|NCT04632992|449352498|FG000|Overall Study|Lost to Follow-up|1|||
124924199|NCT04632992|449352499|FG001|Overall Study|Lost to Follow-up|0|||
124924200|NCT04632992|449352500|FG002|Overall Study|Lost to Follow-up|1|||
124924201|NCT04632992|449352501|FG003|Overall Study|Lost to Follow-up|0|||
124924202|NCT04632992|449352502|FG004|Overall Study|Lost to Follow-up|2|||
124924203|NCT04632992|449352503|FG005|Overall Study|Lost to Follow-up|0|||
124924204|NCT04632992|449352504|FG006|Overall Study|Lost to Follow-up|1|||
124924205|NCT04632992|449352505|FG007|Overall Study|Lost to Follow-up|1|||
124924206|NCT04632992|449352506|FG008|Overall Study|Lost to Follow-up|1|||
124924207|NCT04632992|449352507|FG009|Overall Study|Lost to Follow-up|1|||
124924208|NCT04632992|449352508|FG010|Overall Study|Lost to Follow-up|2|||
124924209|NCT04632992|449352509|FG011|Overall Study|Lost to Follow-up|0|||
124924210|NCT04632992|449352510|FG012|Overall Study|Lost to Follow-up|0|||
124924211|NCT04632992|449352511|FG013|Overall Study|Lost to Follow-up|0|||
124924212|NCT04632992|449352498|FG000|Overall Study|Reason not Specified|2|||
124924213|NCT04632992|449352499|FG001|Overall Study|Reason not Specified|0|||
124924214|NCT04632992|449352500|FG002|Overall Study|Reason not Specified|1|||
124924215|NCT04632992|449352501|FG003|Overall Study|Reason not Specified|1|||
124924216|NCT04632992|449352502|FG004|Overall Study|Reason not Specified|0|||
124924217|NCT04632992|449352503|FG005|Overall Study|Reason not Specified|0|||
124924218|NCT04632992|449352504|FG006|Overall Study|Reason not Specified|0|||
124924219|NCT04632992|449352505|FG007|Overall Study|Reason not Specified|0|||
124924220|NCT04632992|449352506|FG008|Overall Study|Reason not Specified|0|||
125119108|NCT02688400|450059362|FG001|Overall Study|Withdrawal by Subject|13|||
124924221|NCT04632992|449352507|FG009|Overall Study|Reason not Specified|0|||
125119109|NCT02688400|450059361|FG000|Overall Study|No study medication intake|1|||
125119110|NCT02688400|450059362|FG001|Overall Study|No study medication intake|4|||
124924222|NCT04632992|449352508|FG010|Overall Study|Reason not Specified|1|||
124924223|NCT04632992|449352509|FG011|Overall Study|Reason not Specified|0|||
124924224|NCT04632992|449352510|FG012|Overall Study|Reason not Specified|0|||
124924225|NCT04632992|449352511|FG013|Overall Study|Reason not Specified|0|||
124924226|NCT04632992|449352498|FG000|Overall Study|Physician Decision|0|||
125119111|NCT02688400|450059361|FG000|Overall Study|Lost to Follow-up|0|||
125119112|NCT02688400|450059362|FG001|Overall Study|Lost to Follow-up|3|||
125119113|NCT02295774|450059364|FG000|Overall Study|Physician Decision|1|||
124924227|NCT04632992|449352499|FG001|Overall Study|Physician Decision|0|||
124924228|NCT04632992|449352500|FG002|Overall Study|Physician Decision|0|||
124924229|NCT04632992|449352501|FG003|Overall Study|Physician Decision|2|||
124924230|NCT04632992|449352502|FG004|Overall Study|Physician Decision|1|||
125119114|NCT02295774|450059364|FG000|Overall Study|Withdrawal by Subject|2|||
124924231|NCT04632992|449352503|FG005|Overall Study|Physician Decision|0|||
124924232|NCT04632992|449352504|FG006|Overall Study|Physician Decision|0|||
124924233|NCT04632992|449352505|FG007|Overall Study|Physician Decision|0|||
125119115|NCT01075763|450059365|FG000|Overall Study|Lost to Follow-up|2|||
125119116|NCT01075763|450059366|FG001|Overall Study|Lost to Follow-up|1|||
125119117|NCT01075763|450059365|FG000|Overall Study|Lack of Efficacy|0|||
125119118|NCT01075763|450059366|FG001|Overall Study|Lack of Efficacy|1|||
125119119|NCT01075763|450059365|FG000|Overall Study|Withdrawal by Subject|2|||
125119120|NCT01075763|450059366|FG001|Overall Study|Withdrawal by Subject|2|||
125119121|NCT00586521|450059367|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
125119122|NCT03083483|450059377|FG000|Overall Study|Adverse Event|1|||
125119123|NCT03083483|450059378|FG001|Overall Study|Adverse Event|1|||
125119124|NCT03083483|450059379|FG002|Overall Study|Adverse Event|1|||
125119125|NCT03083483|450059377|FG000|Overall Study|Lost to Follow-up|2|||
125119126|NCT03083483|450059378|FG001|Overall Study|Lost to Follow-up|1|||
125119127|NCT03083483|450059379|FG002|Overall Study|Lost to Follow-up|1|||
125119128|NCT03083483|450059377|FG000|Overall Study|technological issues|1|||
125119129|NCT03083483|450059378|FG001|Overall Study|technological issues|0|||
125119130|NCT03083483|450059379|FG002|Overall Study|technological issues|1|||
125119131|NCT03731182|450059382|FG000|Overall Study|Lost to Follow-up|2|||
125119132|NCT03731182|450059383|FG001|Overall Study|Lost to Follow-up|0|||
125119133|NCT03731182|450059382|FG000|Overall Study|Physician Decision|1|||
125212259|NCT05600036|450403304|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
125212260|NCT05600036|450403305|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
125212261|NCT05600036|450403306|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
125212262|NCT05600036|450403301|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
125212263|NCT05600036|450403302|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
125212264|NCT05600036|450403303|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
125212265|NCT05600036|450403304|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
125212266|NCT05600036|450403305|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
125212267|NCT05600036|450403306|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
124924234|NCT04632992|449352506|FG008|Overall Study|Physician Decision|0|||
124924235|NCT04632992|449352507|FG009|Overall Study|Physician Decision|0|||
124924236|NCT04632992|449352508|FG010|Overall Study|Physician Decision|0|||
124924237|NCT04632992|449352509|FG011|Overall Study|Physician Decision|0|||
124924238|NCT04632992|449352510|FG012|Overall Study|Physician Decision|3|||
124924239|NCT04632992|449352511|FG013|Overall Study|Physician Decision|0|||
124924240|NCT04632992|449352498|FG000|Overall Study|Progressive Disease|0|||
124924241|NCT04632992|449352499|FG001|Overall Study|Progressive Disease|0|||
124924242|NCT04632992|449352500|FG002|Overall Study|Progressive Disease|0|||
124924243|NCT04632992|449352501|FG003|Overall Study|Progressive Disease|0|||
124924244|NCT04632992|449352502|FG004|Overall Study|Progressive Disease|1|||
124924245|NCT04632992|449352503|FG005|Overall Study|Progressive Disease|0|||
124924246|NCT04632992|449352504|FG006|Overall Study|Progressive Disease|0|||
124924247|NCT04632992|449352505|FG007|Overall Study|Progressive Disease|0|||
124924248|NCT04632992|449352506|FG008|Overall Study|Progressive Disease|0|||
124924249|NCT04632992|449352507|FG009|Overall Study|Progressive Disease|1|||
124924250|NCT04632992|449352508|FG010|Overall Study|Progressive Disease|1|||
124924251|NCT04632992|449352509|FG011|Overall Study|Progressive Disease|0|||
124924252|NCT04632992|449352510|FG012|Overall Study|Progressive Disease|2|||
124924253|NCT04632992|449352511|FG013|Overall Study|Progressive Disease|0|||
124924254|NCT04632992|449352498|FG000|Overall Study|Withdrawal by Subject|4|||
124924255|NCT04632992|449352499|FG001|Overall Study|Withdrawal by Subject|1|||
125212268|NCT01006590|450403308|FG000|Overall Study|Adverse Event|2|||
124924256|NCT04632992|449352500|FG002|Overall Study|Withdrawal by Subject|5|||
125119134|NCT03731182|450059383|FG001|Overall Study|Physician Decision|0|||
125119135|NCT03731182|450059382|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
125119136|NCT03731182|450059383|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
125119137|NCT02006706|450059384|FG000|Overall Study|Lost to Follow-up|1|||
124924257|NCT04632992|449352501|FG003|Overall Study|Withdrawal by Subject|4|||
124924258|NCT04632992|449352502|FG004|Overall Study|Withdrawal by Subject|3|||
124924259|NCT04632992|449352503|FG005|Overall Study|Withdrawal by Subject|3|||
124924260|NCT04632992|449352504|FG006|Overall Study|Withdrawal by Subject|0|||
124924261|NCT04632992|449352505|FG007|Overall Study|Withdrawal by Subject|5|||
124924262|NCT04632992|449352506|FG008|Overall Study|Withdrawal by Subject|0|||
124924263|NCT04632992|449352507|FG009|Overall Study|Withdrawal by Subject|2|||
124924264|NCT04632992|449352508|FG010|Overall Study|Withdrawal by Subject|8|||
124924265|NCT04632992|449352509|FG011|Overall Study|Withdrawal by Subject|0|||
124924266|NCT04632992|449352510|FG012|Overall Study|Withdrawal by Subject|1|||
124924267|NCT04632992|449352511|FG013|Overall Study|Withdrawal by Subject|1|||
124924268|NCT04187833|449352512|FG000|Overall Study|Withdrawal by Subject|1|||
124924269|NCT03097549|449352513|FG000|Overall Study|Withdrawal by Subject|1|||
124924270|NCT03097549|449352514|FG001|Overall Study|Withdrawal by Subject|0|||
124924271|NCT03097549|449352513|FG000|Overall Study|Lost to Follow-up|1|||
124924272|NCT03097549|449352514|FG001|Overall Study|Lost to Follow-up|0|||
124924273|NCT02547233|449352515|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
124924274|NCT02547233|449352516|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
124924275|NCT02547233|449352515|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
125119138|NCT00582036|450059385|FG000|Overall Study|Withdrawal by Subject|0|||
125119139|NCT00582036|450059386|FG001|Overall Study|Withdrawal by Subject|1|||
124924276|NCT02547233|449352516|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
124924277|NCT02547233|449352515|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
124924278|NCT02547233|449352516|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
124924279|NCT02547233|449352515|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
124924280|NCT02547233|449352516|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
124924281|NCT02547233|449352515|FG000|12-month Follow-up|Withdrawal by Subject|10|||
124924282|NCT02547233|449352516|FG001|12-month Follow-up|Withdrawal by Subject|10|||
124924283|NCT02547233|449352515|FG000|12-month Follow-up|Lost to Follow-up|3|||
125119140|NCT01673009|450059387|FG000|Overall Study|Physician Decision|5|||
125119141|NCT01673009|450059387|FG000|Overall Study|Withdrawal by Subject|8|||
125119142|NCT04161144|450059388|FG000|Overall Study|Withdrawal by Subject|0|||
125119143|NCT04161144|450059389|FG001|Overall Study|Withdrawal by Subject|1|||
124924284|NCT02547233|449352516|FG001|12-month Follow-up|Lost to Follow-up|3|||
124924285|NCT02547233|449352515|FG000|12-month Follow-up|Lack of Efficacy|1|||
124924286|NCT02547233|449352516|FG001|12-month Follow-up|Lack of Efficacy|2|||
124924287|NCT02547233|449352515|FG000|12-month Follow-up|Protocol Violation|0|||
124924288|NCT02547233|449352516|FG001|12-month Follow-up|Protocol Violation|1|||
124924289|NCT02547233|449352515|FG000|12-month Follow-up|Other|0|||
124924290|NCT02547233|449352516|FG001|12-month Follow-up|Other|1|||
124924291|NCT02146378|449352517|FG000|Overall Study|No information of administration|2|||
124924292|NCT03603600|449352518|FG000|Overall Study|Withdrawal by Subject|5|||
124924293|NCT03603600|449352519|FG001|Overall Study|Withdrawal by Subject|7|||
124924294|NCT03603600|449352518|FG000|Overall Study|Lost to Follow-up|2|||
124924295|NCT03603600|449352519|FG001|Overall Study|Lost to Follow-up|3|||
124924296|NCT03603600|449352518|FG000|Overall Study|Death|3|||
124924297|NCT03603600|449352519|FG001|Overall Study|Death|1|||
124924298|NCT03603600|449352518|FG000|Overall Study|Physician Decision|2|||
124924299|NCT03603600|449352519|FG001|Overall Study|Physician Decision|1|||
124924300|NCT03603600|449352518|FG000|Overall Study|Other reason|1|||
124924301|NCT03603600|449352519|FG001|Overall Study|Other reason|0|||
124924302|NCT05170009|449352520|FG000|Overall Study|Physician Decision|0|||
124924303|NCT05170009|449352521|FG001|Overall Study|Physician Decision|1|||
124924304|NCT03524612|449352522|FG000|Overall Study|Lack of Efficacy|10|||
124924305|NCT03524612|449352522|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
124924306|NCT03524612|449352522|FG000|Overall Study|Adverse Event|10|||
124924307|NCT03524612|449352522|FG000|Overall Study|Withdrawal by Subject|7|||
124924308|NCT03524612|449352522|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
124924309|NCT03524612|449352522|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
124924310|NCT03524612|449352522|FG000|Overall Study|New therapy for study indication|6|||
124924311|NCT03524612|449352522|FG000|Overall Study|Death|3|||
124924312|NCT03524612|449352522|FG000|Overall Study|Lost to Follow-up|2|||
124924313|NCT03524612|449352522|FG000|Overall Study|Protocol Violation|1|||
124924314|NCT05457647|449352523|FG000|Overall Study|Lost to Follow-up|3|||
124924315|NCT04137289|449352526|FG000|Overall Study|Death|0|||
124924316|NCT04137289|449352527|FG001|Overall Study|Death|0|||
124924317|NCT04137289|449352528|FG002|Overall Study|Death|0|||
124924318|NCT04137289|449352529|FG003|Overall Study|Death|0|||
124924319|NCT04137289|449352530|FG004|Overall Study|Death|0|||
124924320|NCT04137289|449352531|FG005|Overall Study|Death|0|||
124924321|NCT04137289|449352532|FG006|Overall Study|Death|1|||
124924322|NCT04137289|449352533|FG007|Overall Study|Death|0|||
124924323|NCT04137289|449352534|FG008|Overall Study|Death|0|||
124924324|NCT04137289|449352526|FG000|Overall Study|Clinical disease progression|0|||
124924325|NCT04137289|449352527|FG001|Overall Study|Clinical disease progression|0|||
124924326|NCT04137289|449352528|FG002|Overall Study|Clinical disease progression|0|||
124924327|NCT04137289|449352529|FG003|Overall Study|Clinical disease progression|4|||
124924328|NCT04137289|449352530|FG004|Overall Study|Clinical disease progression|4|||
124924329|NCT04137289|449352531|FG005|Overall Study|Clinical disease progression|2|||
124924330|NCT04137289|449352532|FG006|Overall Study|Clinical disease progression|5|||
124924331|NCT04137289|449352533|FG007|Overall Study|Clinical disease progression|1|||
124924332|NCT04137289|449352534|FG008|Overall Study|Clinical disease progression|0|||
125119144|NCT04161144|450059388|FG000|Overall Study|Protocol Violation|1|||
125119145|NCT04161144|450059389|FG001|Overall Study|Protocol Violation|0|||
124924333|NCT04137289|449352526|FG000|Overall Study|Lost to Follow-up|0|||
124924334|NCT04137289|449352527|FG001|Overall Study|Lost to Follow-up|0|||
124924335|NCT04137289|449352528|FG002|Overall Study|Lost to Follow-up|0|||
124924336|NCT04137289|449352529|FG003|Overall Study|Lost to Follow-up|1|||
124924337|NCT04137289|449352530|FG004|Overall Study|Lost to Follow-up|0|||
124924338|NCT04137289|449352531|FG005|Overall Study|Lost to Follow-up|0|||
124924339|NCT04137289|449352532|FG006|Overall Study|Lost to Follow-up|0|||
124924340|NCT04137289|449352533|FG007|Overall Study|Lost to Follow-up|0|||
124924341|NCT04137289|449352534|FG008|Overall Study|Lost to Follow-up|0|||
124924342|NCT04137289|449352526|FG000|Overall Study|Adverse Event|0|||
124924343|NCT04137289|449352527|FG001|Overall Study|Adverse Event|0|||
124924344|NCT04137289|449352528|FG002|Overall Study|Adverse Event|1|||
124924345|NCT04137289|449352529|FG003|Overall Study|Adverse Event|0|||
124924346|NCT04137289|449352530|FG004|Overall Study|Adverse Event|0|||
124924347|NCT04137289|449352531|FG005|Overall Study|Adverse Event|1|||
124924348|NCT04137289|449352532|FG006|Overall Study|Adverse Event|0|||
124924349|NCT04137289|449352533|FG007|Overall Study|Adverse Event|0|||
124924350|NCT04137289|449352534|FG008|Overall Study|Adverse Event|0|||
124924351|NCT04137289|449352526|FG000|Overall Study|Lack of clinical benefit|0|||
124924352|NCT04137289|449352527|FG001|Overall Study|Lack of clinical benefit|0|||
124924353|NCT04137289|449352528|FG002|Overall Study|Lack of clinical benefit|0|||
124924354|NCT04137289|449352529|FG003|Overall Study|Lack of clinical benefit|0|||
124924355|NCT04137289|449352530|FG004|Overall Study|Lack of clinical benefit|0|||
124924356|NCT04137289|449352531|FG005|Overall Study|Lack of clinical benefit|0|||
124924357|NCT04137289|449352532|FG006|Overall Study|Lack of clinical benefit|0|||
124924358|NCT04137289|449352533|FG007|Overall Study|Lack of clinical benefit|0|||
124924359|NCT04137289|449352534|FG008|Overall Study|Lack of clinical benefit|1|||
124924360|NCT04137289|449352526|FG000|Overall Study|Objective disease progression|1|||
124924361|NCT04137289|449352527|FG001|Overall Study|Objective disease progression|1|||
124924362|NCT04137289|449352528|FG002|Overall Study|Objective disease progression|6|||
124924363|NCT04137289|449352529|FG003|Overall Study|Objective disease progression|18|||
124924364|NCT04137289|449352530|FG004|Overall Study|Objective disease progression|12|||
124924365|NCT04137289|449352531|FG005|Overall Study|Objective disease progression|20|||
124924366|NCT04137289|449352532|FG006|Overall Study|Objective disease progression|18|||
124924367|NCT04137289|449352533|FG007|Overall Study|Objective disease progression|7|||
124924368|NCT04137289|449352534|FG008|Overall Study|Objective disease progression|6|||
124924369|NCT04492722|449352535|FG000|Overall Study|Adverse Event|7|||
124924370|NCT04492722|449352536|FG001|Overall Study|Adverse Event|2|||
124924371|NCT04492722|449352537|FG002|Overall Study|Adverse Event|3|||
124924372|NCT04492722|449352538|FG003|Overall Study|Adverse Event|0|||
124924373|NCT04492722|449352535|FG000|Overall Study|Death|0|||
124924374|NCT04492722|449352536|FG001|Overall Study|Death|0|||
124924375|NCT04492722|449352537|FG002|Overall Study|Death|0|||
124924376|NCT04492722|449352538|FG003|Overall Study|Death|1|||
124924377|NCT04492722|449352535|FG000|Overall Study|Lost to Follow-up|0|||
124924378|NCT04492722|449352536|FG001|Overall Study|Lost to Follow-up|1|||
124924379|NCT04492722|449352537|FG002|Overall Study|Lost to Follow-up|0|||
124924380|NCT04492722|449352538|FG003|Overall Study|Lost to Follow-up|1|||
124924381|NCT04492722|449352535|FG000|Overall Study|Physician Decision|0|||
124924382|NCT04492722|449352536|FG001|Overall Study|Physician Decision|3|||
124924383|NCT04492722|449352537|FG002|Overall Study|Physician Decision|1|||
124924384|NCT04492722|449352538|FG003|Overall Study|Physician Decision|1|||
124924385|NCT04492722|449352535|FG000|Overall Study|Withdrawal by Subject|6|||
124924386|NCT04492722|449352536|FG001|Overall Study|Withdrawal by Subject|6|||
124924387|NCT04492722|449352537|FG002|Overall Study|Withdrawal by Subject|0|||
124924388|NCT04492722|449352538|FG003|Overall Study|Withdrawal by Subject|3|||
124924389|NCT04492722|449352535|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
124924390|NCT04492722|449352536|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
124924391|NCT04492722|449352537|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
124924392|NCT04492722|449352538|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
124924393|NCT04492722|449352535|FG000|Overall Study|Due to Covid-19 pandemic|7|||
124924394|NCT04492722|449352536|FG001|Overall Study|Due to Covid-19 pandemic|3|||
124924395|NCT04492722|449352537|FG002|Overall Study|Due to Covid-19 pandemic|7|||
124924396|NCT04492722|449352538|FG003|Overall Study|Due to Covid-19 pandemic|6|||
124924397|NCT04492722|449352535|FG000|Overall Study|Failure to meet randomisation criteria|2|||
124924398|NCT04492722|449352536|FG001|Overall Study|Failure to meet randomisation criteria|3|||
124924399|NCT04492722|449352537|FG002|Overall Study|Failure to meet randomisation criteria|4|||
124924400|NCT04492722|449352538|FG003|Overall Study|Failure to meet randomisation criteria|2|||
124924401|NCT04492722|449352535|FG000|Overall Study|Early termination from the study|54|||
124924402|NCT04492722|449352536|FG001|Overall Study|Early termination from the study|51|||
124924403|NCT04492722|449352537|FG002|Overall Study|Early termination from the study|50|||
124924404|NCT04492722|449352538|FG003|Overall Study|Early termination from the study|50|||
124924405|NCT04492722|449352535|FG000|Overall Study|Missing|3|||
124924406|NCT04492722|449352536|FG001|Overall Study|Missing|0|||
124924407|NCT04492722|449352537|FG002|Overall Study|Missing|0|||
124924408|NCT04492722|449352538|FG003|Overall Study|Missing|5|||
124924409|NCT04492722|449352535|FG000|Overall Study|Participants who did not receive treatment|0|||
124924410|NCT04492722|449352536|FG001|Overall Study|Participants who did not receive treatment|1|||
124924411|NCT04492722|449352537|FG002|Overall Study|Participants who did not receive treatment|4|||
124924412|NCT04492722|449352538|FG003|Overall Study|Participants who did not receive treatment|0|||
124924413|NCT05329220|449352539|FG000|Active Trial Period|Adverse Event|0|||
124924414|NCT05329220|449352540|FG001|Active Trial Period|Adverse Event|0|||
124924415|NCT05329220|449352541|FG002|Active Trial Period|Adverse Event|0|||
124924416|NCT05329220|449352542|FG003|Active Trial Period|Adverse Event|0|||
124924417|NCT05329220|449352543|FG004|Active Trial Period|Adverse Event|1|||
124924418|NCT05329220|449352544|FG005|Active Trial Period|Adverse Event|0|||
124924419|NCT05329220|449352539|FG000|Active Trial Period|Lost to Follow-up|0|||
124924420|NCT05329220|449352540|FG001|Active Trial Period|Lost to Follow-up|0|||
124924421|NCT05329220|449352541|FG002|Active Trial Period|Lost to Follow-up|0|||
124924422|NCT05329220|449352542|FG003|Active Trial Period|Lost to Follow-up|0|||
124924423|NCT05329220|449352543|FG004|Active Trial Period|Lost to Follow-up|32|||
124924424|NCT05329220|449352544|FG005|Active Trial Period|Lost to Follow-up|28|||
124924425|NCT05329220|449352539|FG000|Active Trial Period|Physician Decision|0|||
124924426|NCT05329220|449352540|FG001|Active Trial Period|Physician Decision|0|||
124924427|NCT05329220|449352541|FG002|Active Trial Period|Physician Decision|0|||
124924428|NCT05329220|449352542|FG003|Active Trial Period|Physician Decision|0|||
124924429|NCT05329220|449352543|FG004|Active Trial Period|Physician Decision|2|||
124924430|NCT05329220|449352544|FG005|Active Trial Period|Physician Decision|0|||
124924431|NCT05329220|449352539|FG000|Active Trial Period|Protocol Violation|0|||
124924432|NCT05329220|449352540|FG001|Active Trial Period|Protocol Violation|0|||
124924433|NCT05329220|449352541|FG002|Active Trial Period|Protocol Violation|0|||
124924434|NCT05329220|449352542|FG003|Active Trial Period|Protocol Violation|0|||
124924435|NCT05329220|449352543|FG004|Active Trial Period|Protocol Violation|1|||
124924436|NCT05329220|449352544|FG005|Active Trial Period|Protocol Violation|3|||
124924437|NCT05329220|449352539|FG000|Active Trial Period|Withdrawal by Subject|0|||
124924438|NCT05329220|449352540|FG001|Active Trial Period|Withdrawal by Subject|0|||
124924439|NCT05329220|449352541|FG002|Active Trial Period|Withdrawal by Subject|0|||
124924440|NCT05329220|449352542|FG003|Active Trial Period|Withdrawal by Subject|1|||
124924441|NCT05329220|449352543|FG004|Active Trial Period|Withdrawal by Subject|12|||
124924442|NCT05329220|449352544|FG005|Active Trial Period|Withdrawal by Subject|13|||
124924443|NCT05329220|449352539|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
124924444|NCT05329220|449352540|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
124924445|NCT05329220|449352541|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
124924446|NCT05329220|449352542|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
124924447|NCT05329220|449352543|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
124924448|NCT05329220|449352544|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
124924449|NCT05329220|449352539|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
124924450|NCT05329220|449352540|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
124924451|NCT05329220|449352541|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
124924452|NCT05329220|449352542|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
124924453|NCT05329220|449352543|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
124924454|NCT05329220|449352544|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
124924455|NCT05329220|449352539|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
124924456|NCT05329220|449352540|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
124924457|NCT05329220|449352541|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
124924458|NCT05329220|449352542|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
124924459|NCT05329220|449352543|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
124924460|NCT05329220|449352544|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
124924461|NCT05329220|449352539|FG000|Follow-up Period|Adverse Event|0|||
124924462|NCT05329220|449352540|FG001|Follow-up Period|Adverse Event|0|||
124924463|NCT05329220|449352541|FG002|Follow-up Period|Adverse Event|0|||
124924464|NCT05329220|449352542|FG003|Follow-up Period|Adverse Event|0|||
124924465|NCT05329220|449352543|FG004|Follow-up Period|Adverse Event|2|||
124924466|NCT05329220|449352544|FG005|Follow-up Period|Adverse Event|1|||
124924467|NCT05329220|449352539|FG000|Follow-up Period|Death|0|||
124924468|NCT05329220|449352540|FG001|Follow-up Period|Death|0|||
124924469|NCT05329220|449352541|FG002|Follow-up Period|Death|1|||
124924470|NCT05329220|449352542|FG003|Follow-up Period|Death|1|||
124924471|NCT05329220|449352543|FG004|Follow-up Period|Death|0|||
124924472|NCT05329220|449352544|FG005|Follow-up Period|Death|1|||
124924473|NCT05329220|449352539|FG000|Follow-up Period|Lost to Follow-up|0|||
124924474|NCT05329220|449352540|FG001|Follow-up Period|Lost to Follow-up|1|||
124924475|NCT05329220|449352541|FG002|Follow-up Period|Lost to Follow-up|2|||
124924476|NCT05329220|449352542|FG003|Follow-up Period|Lost to Follow-up|2|||
124924477|NCT05329220|449352543|FG004|Follow-up Period|Lost to Follow-up|113|||
124924478|NCT05329220|449352544|FG005|Follow-up Period|Lost to Follow-up|89|||
124924479|NCT05329220|449352539|FG000|Follow-up Period|Physician Decision|0|||
124924480|NCT05329220|449352540|FG001|Follow-up Period|Physician Decision|0|||
124924481|NCT05329220|449352541|FG002|Follow-up Period|Physician Decision|0|||
124924482|NCT05329220|449352542|FG003|Follow-up Period|Physician Decision|0|||
124924483|NCT05329220|449352543|FG004|Follow-up Period|Physician Decision|2|||
124924484|NCT05329220|449352544|FG005|Follow-up Period|Physician Decision|2|||
124924485|NCT05329220|449352539|FG000|Follow-up Period|Protocol Violation|0|||
124924486|NCT05329220|449352540|FG001|Follow-up Period|Protocol Violation|0|||
124924487|NCT05329220|449352541|FG002|Follow-up Period|Protocol Violation|0|||
124924488|NCT05329220|449352542|FG003|Follow-up Period|Protocol Violation|0|||
124924489|NCT05329220|449352543|FG004|Follow-up Period|Protocol Violation|0|||
124924490|NCT05329220|449352544|FG005|Follow-up Period|Protocol Violation|1|||
124924491|NCT05329220|449352539|FG000|Follow-up Period|Withdrawal by Subject|0|||
124924492|NCT05329220|449352540|FG001|Follow-up Period|Withdrawal by Subject|0|||
124924493|NCT05329220|449352541|FG002|Follow-up Period|Withdrawal by Subject|1|||
124924494|NCT05329220|449352542|FG003|Follow-up Period|Withdrawal by Subject|1|||
124924495|NCT05329220|449352543|FG004|Follow-up Period|Withdrawal by Subject|34|||
124924496|NCT05329220|449352544|FG005|Follow-up Period|Withdrawal by Subject|35|||
124924497|NCT05329220|449352539|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
124924498|NCT05329220|449352540|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
124924499|NCT05329220|449352541|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
124924500|NCT05329220|449352542|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
124924501|NCT05329220|449352543|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
124924502|NCT05329220|449352544|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
124924503|NCT05329220|449352539|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
124924504|NCT05329220|449352540|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
124924505|NCT05329220|449352541|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
124924506|NCT05329220|449352542|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
124924507|NCT05329220|449352543|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
124924508|NCT05329220|449352544|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
124924509|NCT05329220|449352539|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
124924510|NCT05329220|449352540|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
124924511|NCT05329220|449352541|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
124924512|NCT05329220|449352542|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
124924513|NCT05329220|449352543|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
124924514|NCT05329220|449352544|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
124924515|NCT05329220|449352539|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
124924516|NCT05329220|449352540|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
124924517|NCT05329220|449352541|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
124924518|NCT05329220|449352542|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
124924519|NCT05329220|449352543|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
124924520|NCT05329220|449352544|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
124924521|NCT05329220|449352539|FG000|Follow-up Period|EARLY TERMINATION|0|||
124924522|NCT05329220|449352540|FG001|Follow-up Period|EARLY TERMINATION|0|||
124924523|NCT05329220|449352541|FG002|Follow-up Period|EARLY TERMINATION|0|||
124924524|NCT05329220|449352542|FG003|Follow-up Period|EARLY TERMINATION|0|||
124924525|NCT05329220|449352543|FG004|Follow-up Period|EARLY TERMINATION|0|||
124924526|NCT05329220|449352544|FG005|Follow-up Period|EARLY TERMINATION|1|||
124924527|NCT05329220|449352539|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
124924528|NCT05329220|449352540|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
124924529|NCT05329220|449352541|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
124924530|NCT05329220|449352542|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
124924531|NCT05329220|449352543|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
124924532|NCT05329220|449352544|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
125212269|NCT01006590|450403309|FG001|Overall Study|Adverse Event|3|||
124924533|NCT05329220|449352539|FG000|Follow-up Period|DROPPED|0|||
124924534|NCT05329220|449352540|FG001|Follow-up Period|DROPPED|0|||
124924535|NCT05329220|449352541|FG002|Follow-up Period|DROPPED|0|||
124924536|NCT05329220|449352542|FG003|Follow-up Period|DROPPED|0|||
124924537|NCT05329220|449352543|FG004|Follow-up Period|DROPPED|0|||
124924538|NCT05329220|449352544|FG005|Follow-up Period|DROPPED|1|||
124924539|NCT05329220|449352539|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
124924540|NCT05329220|449352540|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
124924541|NCT05329220|449352541|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
124924542|NCT05329220|449352542|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
124924543|NCT05329220|449352543|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
124924544|NCT05329220|449352544|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
124924545|NCT02601313|449352545|FG000|Overall Study|Death|2|||
124924546|NCT02601313|449352546|FG001|Overall Study|Death|41|||
124924547|NCT02601313|449352547|FG002|Overall Study|Death|6|||
124924548|NCT02601313|449352545|FG000|Overall Study|Enrolled but never treated|0|||
124924549|NCT02601313|449352546|FG001|Overall Study|Enrolled but never treated|6|||
124924550|NCT02601313|449352547|FG002|Overall Study|Enrolled but never treated|3|||
124924551|NCT02601313|449352545|FG000|Overall Study|Enrolled, did not initiate AC|4|||
124924552|NCT02601313|449352546|FG001|Overall Study|Enrolled, did not initiate AC|0|||
124924553|NCT02601313|449352547|FG002|Overall Study|Enrolled, did not initiate AC|0|||
124924554|NCT02601313|449352545|FG000|Overall Study|Full consent withdrawal|0|||
124924555|NCT02601313|449352546|FG001|Overall Study|Full consent withdrawal|3|||
124924556|NCT02601313|449352547|FG002|Overall Study|Full consent withdrawal|2|||
124924557|NCT02601313|449352545|FG000|Overall Study|Lost to Follow-up|0|||
124924558|NCT02601313|449352546|FG001|Overall Study|Lost to Follow-up|1|||
124924559|NCT02601313|449352547|FG002|Overall Study|Lost to Follow-up|1|||
124924560|NCT03766009|449354511|FG000|Usual Care|Death|0|||
124924561|NCT03766009|449354512|FG001|Usual Care|Death|0|||
124924562|NCT03766009|449354513|FG002|Usual Care|Death|0|||
124924563|NCT03766009|449354514|FG003|Usual Care|Death|1|||
124924564|NCT03766009|449354515|FG004|Usual Care|Death|0|||
124924565|NCT03766009|449354516|FG005|Usual Care|Death|0|||
124924566|NCT03766009|449354511|FG000|Usual Care|Lost to Follow-up|0|||
124924567|NCT03766009|449354512|FG001|Usual Care|Lost to Follow-up|0|||
124924568|NCT03766009|449354513|FG002|Usual Care|Lost to Follow-up|0|||
125119146|NCT00958256|450059391|FG000|Overall Study|Adverse Event|3|||
125119147|NCT01000337|450059398|FG000|Overall Study|Lost to Follow-up|4|||
125119148|NCT01000337|450059399|FG001|Overall Study|Lost to Follow-up|3|||
124924569|NCT03766009|449354514|FG003|Usual Care|Lost to Follow-up|1|||
124924570|NCT03766009|449354515|FG004|Usual Care|Lost to Follow-up|0|||
124924571|NCT03766009|449354516|FG005|Usual Care|Lost to Follow-up|0|||
124924572|NCT03766009|449354511|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
124924573|NCT03766009|449354512|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
124924574|NCT03766009|449354513|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
124924575|NCT03766009|449354514|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
124924576|NCT03766009|449354515|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
124924577|NCT03766009|449354516|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
124924578|NCT03766009|449354511|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
124924579|NCT03766009|449354512|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
124924580|NCT03766009|449354513|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
124924581|NCT03766009|449354514|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
124924582|NCT03766009|449354515|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
124924583|NCT03766009|449354516|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
124924584|NCT03766009|449354511|FG000|Usual Care|No treatment or declined surgery|0|||
124924585|NCT03766009|449354512|FG001|Usual Care|No treatment or declined surgery|0|||
124924586|NCT03766009|449354513|FG002|Usual Care|No treatment or declined surgery|0|||
124924587|NCT03766009|449354514|FG003|Usual Care|No treatment or declined surgery|2|||
125119149|NCT01612000|450059400|FG000|Overall Study|Lost to Follow-up|6|||
125119150|NCT01612000|450059401|FG001|Overall Study|Lost to Follow-up|4|||
125119151|NCT01612000|450059402|FG002|Overall Study|Lost to Follow-up|4|||
125119152|NCT01612000|450059403|FG003|Overall Study|Lost to Follow-up|8|||
125119153|NCT01612000|450059400|FG000|Overall Study|Physician Decision|0|||
125119154|NCT01612000|450059401|FG001|Overall Study|Physician Decision|0|||
125119155|NCT01612000|450059402|FG002|Overall Study|Physician Decision|1|||
125119156|NCT01612000|450059403|FG003|Overall Study|Physician Decision|0|||
125119157|NCT01612000|450059400|FG000|Overall Study|Withdrawal by Subject|3|||
125119158|NCT01612000|450059401|FG001|Overall Study|Withdrawal by Subject|1|||
125119159|NCT01612000|450059402|FG002|Overall Study|Withdrawal by Subject|2|||
125119160|NCT01612000|450059403|FG003|Overall Study|Withdrawal by Subject|2|||
125119161|NCT02173704|450059404|FG000|Overall Study|Adverse Event|1|||
125119162|NCT02173704|450059405|FG001|Overall Study|Adverse Event|0|||
125119163|NCT02173704|450059404|FG000|Overall Study|Lost to Follow-up|1|||
125119164|NCT02173704|450059405|FG001|Overall Study|Lost to Follow-up|0|||
124924588|NCT03766009|449354515|FG004|Usual Care|No treatment or declined surgery|0|||
124924589|NCT03766009|449354516|FG005|Usual Care|No treatment or declined surgery|0|||
124924590|NCT03766009|449354511|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
124924591|NCT03766009|449354512|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
124924592|NCT03766009|449354513|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
124924593|NCT03766009|449354514|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
124924594|NCT03766009|449354515|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
124924595|NCT03766009|449354516|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
124924596|NCT03766009|449354511|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
124924597|NCT03766009|449354512|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
124924598|NCT03766009|449354513|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
124924599|NCT03766009|449354514|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
124924600|NCT03766009|449354515|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
124924601|NCT03766009|449354516|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
124924602|NCT03766009|449354511|FG000|Usual Care|Ineligible|0|||
124924603|NCT03766009|449354512|FG001|Usual Care|Ineligible|1|||
124924604|NCT03766009|449354513|FG002|Usual Care|Ineligible|0|||
124924605|NCT03766009|449354514|FG003|Usual Care|Ineligible|0|||
124924606|NCT03766009|449354515|FG004|Usual Care|Ineligible|0|||
124924607|NCT03766009|449354516|FG005|Usual Care|Ineligible|0|||
124924608|NCT03766009|449354511|FG000|Usual Care|Other: Staff turnover|0|||
124924609|NCT03766009|449354512|FG001|Usual Care|Other: Staff turnover|0|||
124924610|NCT03766009|449354513|FG002|Usual Care|Other: Staff turnover|0|||
124924611|NCT03766009|449354514|FG003|Usual Care|Other: Staff turnover|0|||
124924612|NCT03766009|449354515|FG004|Usual Care|Other: Staff turnover|0|||
125119165|NCT02173704|450059404|FG000|Overall Study|Other|1|||
125119166|NCT02173704|450059405|FG001|Overall Study|Other|0|||
125119167|NCT02173704|450059404|FG000|Overall Study|Protocol Violation|1|||
125119168|NCT02173704|450059405|FG001|Overall Study|Protocol Violation|0|||
125119169|NCT02173704|450059404|FG000|Overall Study|Withdrawal by Subject|9|||
124924613|NCT03766009|449354516|FG005|Usual Care|Other: Staff turnover|2|||
124924614|NCT04552223|449354517|FG000|Overall Study|Withdrawal by Subject|1|||
124924615|NCT03869866|449354518|FG000|Overall Study|Protocol Violation|1|||
124924616|NCT03869866|449354518|FG000|Overall Study|Withdrawal by Subject|3|||
124924617|NCT00506519|449354520|FG000|Overall Study|Death|4|||
124924618|NCT00506519|449354521|FG001|Overall Study|Death|6|||
124924619|NCT00506519|449354522|FG002|Overall Study|Death|0|||
124924620|NCT00506519|449354520|FG000|Overall Study|Adverse Event|1|||
124924621|NCT00506519|449354521|FG001|Overall Study|Adverse Event|0|||
124924622|NCT00506519|449354522|FG002|Overall Study|Adverse Event|0|||
125119170|NCT02173704|450059405|FG001|Overall Study|Withdrawal by Subject|4|||
125119171|NCT00419926|450059407|FG000|Overall Study|Withdrawal by Subject|7|||
125119172|NCT00419926|450059408|FG001|Overall Study|Withdrawal by Subject|3|||
125119173|NCT00419926|450059407|FG000|Overall Study|Administrative Problem|4|||
125119174|NCT00419926|450059408|FG001|Overall Study|Administrative Problem|4|||
125119175|NCT00419926|450059407|FG000|Overall Study|Lost to Follow-up|1|||
125119176|NCT00419926|450059408|FG001|Overall Study|Lost to Follow-up|2|||
125119177|NCT00419926|450059407|FG000|Overall Study|Death|2|||
125119178|NCT00419926|450059408|FG001|Overall Study|Death|1|||
125119179|NCT01180244|450059415|FG000|Overall Study|Lack of Efficacy|0|||
124924623|NCT01186367|449354523|FG000|Overall Study|Lost to Follow-up|7|||
124924624|NCT01186367|449354524|FG001|Overall Study|Lost to Follow-up|4|||
124924625|NCT01186367|449354525|FG002|Overall Study|Lost to Follow-up|7|||
124924626|NCT01186367|449354523|FG000|Overall Study|Did not receive study treatment|0|||
124924627|NCT01186367|449354524|FG001|Overall Study|Did not receive study treatment|1|||
124924628|NCT01186367|449354525|FG002|Overall Study|Did not receive study treatment|0|||
124924629|NCT02975882|449354526|FG000|Overall Study|Adverse Event|1|||
124924630|NCT02975882|449354527|FG001|Overall Study|Adverse Event|2|||
124924631|NCT02975882|449354528|FG002|Overall Study|Adverse Event|1|||
124924632|NCT02975882|449354529|FG003|Overall Study|Adverse Event|1|||
124924633|NCT02975882|449354526|FG000|Overall Study|Death|0|||
124924634|NCT02975882|449354527|FG001|Overall Study|Death|1|||
124924635|NCT02975882|449354528|FG002|Overall Study|Death|0|||
124924636|NCT02975882|449354529|FG003|Overall Study|Death|0|||
124924637|NCT02975882|449354526|FG000|Overall Study|Lack of Efficacy|3|||
124924638|NCT02975882|449354527|FG001|Overall Study|Lack of Efficacy|7|||
124924639|NCT02975882|449354528|FG002|Overall Study|Lack of Efficacy|4|||
124924640|NCT02975882|449354529|FG003|Overall Study|Lack of Efficacy|3|||
124924641|NCT02975882|449354526|FG000|Overall Study|Physician Decision|0|||
124924642|NCT02975882|449354527|FG001|Overall Study|Physician Decision|2|||
124924643|NCT02975882|449354528|FG002|Overall Study|Physician Decision|4|||
124924644|NCT02975882|449354529|FG003|Overall Study|Physician Decision|2|||
124924645|NCT02975882|449354526|FG000|Overall Study|Ineligible|0|||
125119180|NCT01180244|450059416|FG001|Overall Study|Lack of Efficacy|7|||
125119181|NCT01180244|450059415|FG000|Overall Study|Physician Decision|3|||
125119182|NCT01180244|450059416|FG001|Overall Study|Physician Decision|0|||
125119183|NCT01180244|450059415|FG000|Overall Study|Adverse Event|1|||
125119184|NCT01180244|450059416|FG001|Overall Study|Adverse Event|0|||
125119185|NCT01180244|450059415|FG000|Overall Study|Withdrawal by Subject|0|||
125119186|NCT01180244|450059416|FG001|Overall Study|Withdrawal by Subject|1|||
125119187|NCT01180244|450059415|FG000|Overall Study|Protocol Violation|1|||
125119188|NCT01180244|450059416|FG001|Overall Study|Protocol Violation|0|||
125119189|NCT01180244|450059415|FG000|Overall Study|Lost to Follow-up|1|||
125119190|NCT01180244|450059416|FG001|Overall Study|Lost to Follow-up|0|||
125119191|NCT00729859|450059417|FG000|Overall Study|Adverse Event|0|||
125119192|NCT00729859|450059418|FG001|Overall Study|Adverse Event|1|||
125119193|NCT00729859|450059419|FG002|Overall Study|Adverse Event|0|||
125119194|NCT00729859|450059417|FG000|Overall Study|Withdrawal by Subject|0|||
125119195|NCT00729859|450059418|FG001|Overall Study|Withdrawal by Subject|1|||
125119196|NCT00729859|450059419|FG002|Overall Study|Withdrawal by Subject|0|||
124924646|NCT02975882|449354527|FG001|Overall Study|Ineligible|1|||
125119197|NCT02623829|450059420|FG000|Overall Study|Lost to Follow-up|1|||
125119198|NCT02623829|450059421|FG001|Overall Study|Lost to Follow-up|1|||
124924647|NCT02975882|449354528|FG002|Overall Study|Ineligible|0|||
124924648|NCT02975882|449354529|FG003|Overall Study|Ineligible|0|||
125119199|NCT03349333|450059422|FG000|Overall Study|Progression of Disease|36|||
124924649|NCT02737436|449354530|FG000|Washout Period|Lost to Follow-up|5|||
124924650|NCT02737436|449354531|FG001|Washout Period|Lost to Follow-up|11|||
124924651|NCT02737436|449354530|FG000|Data Analysis|Scanning data problems|5|||
124924652|NCT02737436|449354531|FG001|Data Analysis|Scanning data problems|8|||
124924653|NCT02105766|449354532|FG000|Overall Study|Physician Decision|1|||
124924654|NCT02105766|449354533|FG001|Overall Study|Physician Decision|1|||
125119200|NCT03349333|450059422|FG000|Overall Study|Adverse Event|11|||
125119201|NCT03349333|450059422|FG000|Overall Study|Other|6|||
124924655|NCT02105766|449354534|FG002|Overall Study|Physician Decision|0|||
124924656|NCT02105766|449354532|FG000|Overall Study|Lost to Follow-up|2|||
124924657|NCT02105766|449354533|FG001|Overall Study|Lost to Follow-up|0|||
124924658|NCT02105766|449354534|FG002|Overall Study|Lost to Follow-up|0|||
125212270|NCT01006590|450403308|FG000|Overall Study|Death|1|||
124924659|NCT02105766|449354532|FG000|Overall Study|Death|1|||
124924660|NCT02105766|449354533|FG001|Overall Study|Death|1|||
124924661|NCT02105766|449354534|FG002|Overall Study|Death|0|||
124924662|NCT03701399|449354535|FG000|Overall Study|Adverse Event|3|||
124924663|NCT03701399|449354536|FG001|Overall Study|Adverse Event|5|||
124924664|NCT03701399|449354535|FG000|Overall Study|Withdrawal by Subject|6|||
124924665|NCT03701399|449354536|FG001|Overall Study|Withdrawal by Subject|3|||
124924666|NCT03701399|449354535|FG000|Overall Study|Investigators decision|1|||
124924667|NCT03701399|449354536|FG001|Overall Study|Investigators decision|2|||
124924668|NCT03701399|449354535|FG000|Overall Study|Lost to Follow-up|1|||
124924669|NCT03701399|449354536|FG001|Overall Study|Lost to Follow-up|2|||
124924670|NCT03701399|449354535|FG000|Overall Study|Death|1|||
124924671|NCT03701399|449354536|FG001|Overall Study|Death|1|||
124924672|NCT03701399|449354535|FG000|Overall Study|Randomized but not treated|1|||
124924673|NCT03701399|449354536|FG001|Overall Study|Randomized but not treated|0|||
124924674|NCT03134196|449354544|FG000|Overall Study|Death|2|||
124924675|NCT03134196|449354545|FG001|Overall Study|Death|1|||
124924676|NCT03134196|449354544|FG000|Overall Study|Lost to Follow-up|13|||
124924677|NCT03134196|449354545|FG001|Overall Study|Lost to Follow-up|15|||
124924678|NCT03134196|449354544|FG000|Overall Study|Physician Decision|0|||
124924679|NCT03134196|449354545|FG001|Overall Study|Physician Decision|1|||
124924680|NCT03134196|449354544|FG000|Overall Study|Withdrawal by Subject|19|||
124924681|NCT03134196|449354545|FG001|Overall Study|Withdrawal by Subject|12|||
124924682|NCT03134196|449354544|FG000|Overall Study|Site Unable to Contact Participant|2|||
124924683|NCT03134196|449354545|FG001|Overall Study|Site Unable to Contact Participant|0|||
124924684|NCT03134196|449354544|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
124924685|NCT03134196|449354545|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
124924686|NCT03134196|449354544|FG000|Overall Study|Scheduling Conflict|1|||
124924687|NCT03134196|449354545|FG001|Overall Study|Scheduling Conflict|0|||
124924688|NCT06516705|449354550|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
124924689|NCT06516705|449354551|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
124924690|NCT06516705|449354550|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
124924691|NCT06516705|449354551|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
124924692|NCT06516705|449354550|FG000|T3 ( 3 Month After Education)|covid-19|1|||
124924693|NCT06516705|449354551|FG001|T3 ( 3 Month After Education)|covid-19|2|||
124924694|NCT06516705|449354550|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
124924695|NCT06516705|449354551|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
124924696|NCT06516705|449354550|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
124924697|NCT06516705|449354551|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
124924698|NCT06516705|449354550|FG000|T4 ( 6 Month After Education)|covid-19|3|||
124924699|NCT06516705|449354551|FG001|T4 ( 6 Month After Education)|covid-19|2|||
124924700|NCT06516705|449354550|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
124924701|NCT06516705|449354551|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
124924702|NCT00753545|449354552|FG000|Overall Study|Death|98|||
124924703|NCT00753545|449354553|FG001|Overall Study|Death|112|||
124924704|NCT00753545|449354552|FG000|Overall Study|Lost to Follow-up|2|||
124924705|NCT00753545|449354553|FG001|Overall Study|Lost to Follow-up|3|||
124924706|NCT00753545|449354552|FG000|Overall Study|Protocol Violation|1|||
124924707|NCT00753545|449354553|FG001|Overall Study|Protocol Violation|0|||
124924708|NCT00753545|449354552|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
124924709|NCT00753545|449354553|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
124924710|NCT06190691|449354554|FG000|Overall Study|Adverse Event|2|||
124924711|NCT06190691|449354555|FG001|Overall Study|Adverse Event|0|||
124924712|NCT06190691|449354556|FG002|Overall Study|Adverse Event|0|||
124924713|NCT06190691|449354557|FG003|Overall Study|Adverse Event|0|||
124924714|NCT05746455|449354558|FG000|Overall Study|Discharged from Clinical Service|1|||
124924715|NCT05746455|449354558|FG000|Overall Study|Lost to Follow-up|1|||
124924716|NCT03016754|449354562|FG000|Overall Study|Death|5|||
124924717|NCT03016754|449354563|FG001|Overall Study|Death|4|||
124924718|NCT03016754|449354564|FG002|Overall Study|Death|5|||
124924719|NCT03016754|449354565|FG003|Overall Study|Death|1|||
124924720|NCT03016754|449354562|FG000|Overall Study|Lost to Follow-up|23|||
124924721|NCT03016754|449354563|FG001|Overall Study|Lost to Follow-up|17|||
124924722|NCT03016754|449354564|FG002|Overall Study|Lost to Follow-up|4|||
124924723|NCT03016754|449354565|FG003|Overall Study|Lost to Follow-up|2|||
124924724|NCT03016754|449354562|FG000|Overall Study|Withdrawal by Subject|6|||
124924725|NCT03016754|449354563|FG001|Overall Study|Withdrawal by Subject|6|||
124924726|NCT03016754|449354564|FG002|Overall Study|Withdrawal by Subject|2|||
124924727|NCT03016754|449354565|FG003|Overall Study|Withdrawal by Subject|2|||
124924728|NCT03016754|449354562|FG000|Overall Study|Other/Unknown|2|||
124924729|NCT03016754|449354563|FG001|Overall Study|Other/Unknown|4|||
124924730|NCT03016754|449354564|FG002|Overall Study|Other/Unknown|2|||
124924731|NCT03016754|449354565|FG003|Overall Study|Other/Unknown|1|||
124924732|NCT03016754|449354562|FG000|Overall Study|Protocol Violation|0|||
124924733|NCT03016754|449354563|FG001|Overall Study|Protocol Violation|0|||
124924734|NCT03016754|449354564|FG002|Overall Study|Protocol Violation|0|||
124924735|NCT03016754|449354565|FG003|Overall Study|Protocol Violation|4|||
124924736|NCT03839940|449354566|FG000|Overall Study|Withdrawal by Subject|3|||
124969559|NCT03520075|449517415|FG006|Phase 2 (Dose Expansion)|Death|0|||
124969560|NCT03520075|449517416|FG007|Phase 2 (Dose Expansion)|Death|0|||
124969561|NCT03520075|449517417|FG008|Phase 2 (Dose Expansion)|Death|0|||
124969562|NCT03520075|449517418|FG009|Phase 2 (Dose Expansion)|Death|0|||
124969563|NCT03520075|449517419|FG010|Phase 2 (Dose Expansion)|Death|0|||
124969564|NCT03520075|449517420|FG011|Phase 2 (Dose Expansion)|Death|0|||
124969565|NCT03520075|449517421|FG012|Phase 2 (Dose Expansion)|Death|0|||
124969566|NCT03520075|449517422|FG013|Phase 2 (Dose Expansion)|Death|20|||
124924737|NCT03839940|449354567|FG001|Overall Study|Withdrawal by Subject|0|||
124924738|NCT03839940|449354566|FG000|Overall Study|Protocol Violation|0|||
124924739|NCT03839940|449354567|FG001|Overall Study|Protocol Violation|1|||
124924740|NCT03839940|449354566|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
124924741|NCT03839940|449354567|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
124924742|NCT03241745|449354568|FG000|Overall Study|Adverse Event|7|||
124924743|NCT03241745|449354568|FG000|Overall Study|Death|1|||
124924744|NCT03241745|449354568|FG000|Overall Study|Withdrawal by Subject|5|||
124924745|NCT03241745|449354568|FG000|Overall Study|Treatment delay >28 days|2|||
124924746|NCT03241745|449354568|FG000|Overall Study|Lack of Efficacy|14|||
124924747|NCT03023410|449354569|FG000|Overall Study|study termination|0|||
124924748|NCT03023410|449354570|FG001|Overall Study|study termination|1|||
124924749|NCT04799899|449354572|FG000|Overall Study|Lost to Follow-up|2|||
124924750|NCT04799899|449354573|FG001|Overall Study|Lost to Follow-up|4|||
124924751|NCT00470704|449354574|FG000|Overall Study|Withdrawal by Subject|4|||
124924752|NCT00470704|449354575|FG001|Overall Study|Withdrawal by Subject|3|||
124924753|NCT00470704|449354574|FG000|Overall Study|Relapse/Progression|37|||
124924754|NCT00470704|449354575|FG001|Overall Study|Relapse/Progression|42|||
124924755|NCT00470704|449354574|FG000|Overall Study|toxicity|0|||
124924756|NCT00470704|449354575|FG001|Overall Study|toxicity|1|||
124924757|NCT04019873|449354576|FG000|Overall Study|Discontinued from the treatment|1|||
124924758|NCT04019873|449354577|FG001|Overall Study|Discontinued from the treatment|39|||
124924759|NCT04019873|449354578|FG002|Overall Study|Discontinued from the treatment|2|||
124924760|NCT04908722|449354587|FG000|Overall Study|Protocol deviation|1|||
124924761|NCT04908722|449354588|FG001|Overall Study|Protocol deviation|0|||
124924762|NCT04908722|449354589|FG002|Overall Study|Protocol deviation|0|||
124924763|NCT04908722|449354590|FG003|Overall Study|Protocol deviation|0|||
124924764|NCT04908722|449354591|FG004|Overall Study|Protocol deviation|0|||
124924765|NCT04908722|449354592|FG005|Overall Study|Protocol deviation|1|||
124924766|NCT04908722|449354587|FG000|Overall Study|Lost to Follow-up|33|||
124924767|NCT04908722|449354588|FG001|Overall Study|Lost to Follow-up|33|||
124924768|NCT04908722|449354589|FG002|Overall Study|Lost to Follow-up|36|||
124924769|NCT04908722|449354590|FG003|Overall Study|Lost to Follow-up|30|||
124924770|NCT04908722|449354591|FG004|Overall Study|Lost to Follow-up|32|||
124924771|NCT04908722|449354592|FG005|Overall Study|Lost to Follow-up|34|||
124924772|NCT04908722|449354587|FG000|Overall Study|Physician Decision|1|||
124924773|NCT04908722|449354588|FG001|Overall Study|Physician Decision|1|||
124924774|NCT04908722|449354589|FG002|Overall Study|Physician Decision|1|||
124924775|NCT04908722|449354590|FG003|Overall Study|Physician Decision|2|||
124924776|NCT04908722|449354591|FG004|Overall Study|Physician Decision|0|||
124924777|NCT04908722|449354592|FG005|Overall Study|Physician Decision|0|||
124924778|NCT04908722|449354587|FG000|Overall Study|Death|1|||
124924779|NCT04908722|449354588|FG001|Overall Study|Death|0|||
124924780|NCT04908722|449354589|FG002|Overall Study|Death|0|||
124924781|NCT04908722|449354590|FG003|Overall Study|Death|0|||
124924782|NCT04908722|449354591|FG004|Overall Study|Death|0|||
124924783|NCT04908722|449354592|FG005|Overall Study|Death|1|||
124924784|NCT04908722|449354587|FG000|Overall Study|Withdrawal by Subject|12|||
124924785|NCT04908722|449354588|FG001|Overall Study|Withdrawal by Subject|8|||
124924786|NCT04908722|449354589|FG002|Overall Study|Withdrawal by Subject|7|||
124924787|NCT04908722|449354590|FG003|Overall Study|Withdrawal by Subject|6|||
124924788|NCT04908722|449354591|FG004|Overall Study|Withdrawal by Subject|12|||
124924789|NCT04908722|449354592|FG005|Overall Study|Withdrawal by Subject|14|||
124924790|NCT04908722|449354587|FG000|Overall Study|Other|3|||
124924791|NCT04908722|449354588|FG001|Overall Study|Other|1|||
124924792|NCT04908722|449354589|FG002|Overall Study|Other|3|||
124924793|NCT04908722|449354590|FG003|Overall Study|Other|2|||
124924794|NCT04908722|449354591|FG004|Overall Study|Other|4|||
124924795|NCT04908722|449354592|FG005|Overall Study|Other|1|||
124924796|NCT04908722|449354587|FG000|Overall Study|Initiated prohibited medication|0|||
124924797|NCT04908722|449354588|FG001|Overall Study|Initiated prohibited medication|0|||
124924798|NCT04908722|449354589|FG002|Overall Study|Initiated prohibited medication|0|||
125119202|NCT03349333|450059422|FG000|Overall Study|Withdrawal by Subject|5|||
124924799|NCT04908722|449354590|FG003|Overall Study|Initiated prohibited medication|1|||
124924800|NCT04908722|449354591|FG004|Overall Study|Initiated prohibited medication|0|||
124924801|NCT04908722|449354592|FG005|Overall Study|Initiated prohibited medication|1|||
124924802|NCT04908722|449354587|FG000|Overall Study|Randomized but not vaccinated|3|||
124924803|NCT04908722|449354588|FG001|Overall Study|Randomized but not vaccinated|1|||
124924804|NCT04908722|449354589|FG002|Overall Study|Randomized but not vaccinated|2|||
124924805|NCT04908722|449354590|FG003|Overall Study|Randomized but not vaccinated|2|||
124924806|NCT04908722|449354591|FG004|Overall Study|Randomized but not vaccinated|3|||
124924807|NCT04908722|449354592|FG005|Overall Study|Randomized but not vaccinated|4|||
124924808|NCT02319759|449354593|FG000|Week 0 - 16|Lack of Efficacy|1|||
125119203|NCT03349333|450059422|FG000|Overall Study|Conditions interfere with participation|2|||
124924809|NCT02319759|449354594|FG001|Week 0 - 16|Lack of Efficacy|0|||
124924810|NCT02319759|449354595|FG002|Week 0 - 16|Lack of Efficacy|0|||
124924811|NCT02319759|449354596|FG003|Week 0 - 16|Lack of Efficacy|0|||
124924812|NCT02319759|449354597|FG004|Week 0 - 16|Lack of Efficacy|0|||
124924813|NCT02319759|449354593|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
124924814|NCT02319759|449354594|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
124924815|NCT02319759|449354595|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
124924816|NCT02319759|449354596|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
124924817|NCT02319759|449354597|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
124924818|NCT02319759|449354593|FG000|Week 16 - 24|Lack of Efficacy|1|||
124924819|NCT02319759|449354594|FG001|Week 16 - 24|Lack of Efficacy|0|||
124924820|NCT02319759|449354595|FG002|Week 16 - 24|Lack of Efficacy|1|||
124924821|NCT02319759|449354596|FG003|Week 16 - 24|Lack of Efficacy|0|||
124924822|NCT02319759|449354597|FG004|Week 16 - 24|Lack of Efficacy|0|||
124924823|NCT02319759|449354593|FG000|Week 16 - 24|Lost to Follow-up|1|||
124924824|NCT02319759|449354594|FG001|Week 16 - 24|Lost to Follow-up|0|||
125119204|NCT03349333|450059422|FG000|Overall Study|Physician Decision|2|||
125119205|NCT03349333|450059422|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
125119206|NCT03349333|450059422|FG000|Overall Study|Patients in treatment less than 24 month|8|||
125119207|NCT03267264|450059424|FG000|Overall Study|Withdrawal by Subject|1|||
125119208|NCT03267264|450059425|FG001|Overall Study|Withdrawal by Subject|0|||
125119209|NCT03267264|450059426|FG002|Overall Study|Withdrawal by Subject|2|||
125119210|NCT03267264|450059427|FG003|Overall Study|Withdrawal by Subject|4|||
125119211|NCT00622908|450059428|FG000|Overall Study|Protocol Violation|1|||
125119212|NCT00622908|450059429|FG001|Overall Study|Protocol Violation|0|||
125119213|NCT00622908|450059428|FG000|Overall Study|Adverse Event|0|||
125119214|NCT00622908|450059429|FG001|Overall Study|Adverse Event|1|||
124924825|NCT02319759|449354595|FG002|Week 16 - 24|Lost to Follow-up|0|||
124924826|NCT02319759|449354596|FG003|Week 16 - 24|Lost to Follow-up|0|||
124924827|NCT02319759|449354597|FG004|Week 16 - 24|Lost to Follow-up|0|||
124924828|NCT02319759|449354593|FG000|Week 16 - 24|Withdrawal by Subject|0|||
124924829|NCT02319759|449354594|FG001|Week 16 - 24|Withdrawal by Subject|0|||
124924830|NCT02319759|449354595|FG002|Week 16 - 24|Withdrawal by Subject|2|||
124924831|NCT02319759|449354596|FG003|Week 16 - 24|Withdrawal by Subject|0|||
124924832|NCT02319759|449354597|FG004|Week 16 - 24|Withdrawal by Subject|0|||
124924833|NCT02319759|449354593|FG000|Week 24 - 56|Adverse Event|0|||
124924834|NCT02319759|449354594|FG001|Week 24 - 56|Adverse Event|0|||
124924835|NCT02319759|449354595|FG002|Week 24 - 56|Adverse Event|2|||
124924836|NCT02319759|449354596|FG003|Week 24 - 56|Adverse Event|0|||
124924837|NCT02319759|449354597|FG004|Week 24 - 56|Adverse Event|0|||
124924838|NCT02319759|449354593|FG000|Week 24 - 56|Lack of Efficacy|0|||
124924839|NCT02319759|449354594|FG001|Week 24 - 56|Lack of Efficacy|0|||
124924840|NCT02319759|449354595|FG002|Week 24 - 56|Lack of Efficacy|0|||
124924841|NCT02319759|449354596|FG003|Week 24 - 56|Lack of Efficacy|2|||
124924842|NCT02319759|449354597|FG004|Week 24 - 56|Lack of Efficacy|1|||
124924843|NCT02319759|449354593|FG000|Week 24 - 56|Withdrawal by Subject|0|||
124924844|NCT02319759|449354594|FG001|Week 24 - 56|Withdrawal by Subject|1|||
124924845|NCT02319759|449354595|FG002|Week 24 - 56|Withdrawal by Subject|0|||
125119215|NCT00622908|450059428|FG000|Overall Study|Lack of Efficacy|1|||
125119216|NCT00622908|450059429|FG001|Overall Study|Lack of Efficacy|7|||
125119217|NCT00622908|450059428|FG000|Overall Study|Lost to Follow-up|1|||
125119218|NCT00622908|450059429|FG001|Overall Study|Lost to Follow-up|0|||
124924846|NCT02319759|449354596|FG003|Week 24 - 56|Withdrawal by Subject|0|||
124924847|NCT02319759|449354597|FG004|Week 24 - 56|Withdrawal by Subject|0|||
124924848|NCT02319759|449354593|FG000|Week 24 - 56|Lost to Follow-up|0|||
124924849|NCT02319759|449354594|FG001|Week 24 - 56|Lost to Follow-up|0|||
124924850|NCT02319759|449354595|FG002|Week 24 - 56|Lost to Follow-up|0|||
124924851|NCT02319759|449354596|FG003|Week 24 - 56|Lost to Follow-up|0|||
124924852|NCT02319759|449354597|FG004|Week 24 - 56|Lost to Follow-up|1|||
125119219|NCT00622908|450059428|FG000|Overall Study|Refusal|0|||
125119220|NCT00622908|450059429|FG001|Overall Study|Refusal|1|||
125119221|NCT00622908|450059428|FG000|Overall Study|Termination by study sponser|0|||
125119222|NCT00622908|450059429|FG001|Overall Study|Termination by study sponser|1|||
124924853|NCT03339713|449354599|FG000|Overall Study|Lost to Follow-up|2|||
124924854|NCT03339713|449354600|FG001|Overall Study|Lost to Follow-up|1|||
124924855|NCT03339713|449354599|FG000|Overall Study|Protocol Violation|1|||
124924856|NCT03339713|449354600|FG001|Overall Study|Protocol Violation|0|||
124924857|NCT03339713|449354599|FG000|Overall Study|Withdrawal by Subject|1|||
124924858|NCT03339713|449354600|FG001|Overall Study|Withdrawal by Subject|1|||
124924859|NCT01902173|449354601|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
124924860|NCT01902173|449354602|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
124924861|NCT01902173|449354603|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
124924862|NCT01902173|449354604|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
124924863|NCT01902173|449354605|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
124924864|NCT01902173|449354606|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
124924865|NCT01902173|449354601|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
124924866|NCT01902173|449354602|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
124924867|NCT01902173|449354603|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
124924868|NCT01902173|449354604|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
124924869|NCT01902173|449354605|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
124924870|NCT01902173|449354606|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
124924871|NCT01902173|449354601|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
124924872|NCT01902173|449354602|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
124924873|NCT01902173|449354603|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
124924874|NCT01902173|449354604|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
124924875|NCT01902173|449354605|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
124924876|NCT01902173|449354606|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
124924877|NCT01902173|449354601|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
124924878|NCT01902173|449354602|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
124924879|NCT01902173|449354603|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
124924880|NCT01902173|449354604|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
124924881|NCT01902173|449354605|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
124924882|NCT01902173|449354606|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
124924883|NCT01902173|449354601|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
124924884|NCT01902173|449354602|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
124924885|NCT01902173|449354603|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
124924886|NCT01902173|449354604|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
124924887|NCT01902173|449354605|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
124924888|NCT01902173|449354606|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
124924889|NCT01902173|449354601|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
124924890|NCT01902173|449354602|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
124924891|NCT01902173|449354603|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
124924892|NCT01902173|449354604|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
124924893|NCT01902173|449354605|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
124924894|NCT01902173|449354606|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
124924895|NCT01902173|449354601|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
124924896|NCT01902173|449354602|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
124924897|NCT01902173|449354603|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
125119223|NCT03937466|450059430|FG000|Overall Study|not eligbile after the 2-week diary|9|||
125119224|NCT03937466|450059430|FG000|Overall Study|never returned their diary|6|||
125119225|NCT03937466|450059430|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
125119226|NCT03937466|450059430|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
125119227|NCT00113490|450059431|FG000|Overall Study|Withdrawal by Subject|1|||
125119228|NCT00113490|450059432|FG001|Overall Study|Withdrawal by Subject|3|||
125119229|NCT00113490|450059431|FG000|Overall Study|Lost to Follow-up|1|||
125119230|NCT00113490|450059432|FG001|Overall Study|Lost to Follow-up|0|||
125119231|NCT02162758|450059433|FG000|Overall Study|Study termination|0|||
125119232|NCT02162758|450059434|FG001|Overall Study|Study termination|1|||
125119233|NCT04471935|450059435|FG000|Overall Study|Withdrawal by Subject|1|||
125119234|NCT04471935|450059435|FG000|Overall Study|Deemed ineligible to participate|1|||
125119235|NCT03019965|450059436|FG000|Overall Study|Withdrawal by Subject|1|||
125119236|NCT03019965|450059437|FG001|Overall Study|Withdrawal by Subject|0|||
125119237|NCT03019965|450059436|FG000|Overall Study|Protocol Violation|1|||
125119238|NCT03019965|450059437|FG001|Overall Study|Protocol Violation|3|||
125119239|NCT03019965|450059436|FG000|Overall Study|viral or fungal infection|3|||
124924898|NCT01902173|449354604|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
124924899|NCT01902173|449354605|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
125119240|NCT03019965|450059437|FG001|Overall Study|viral or fungal infection|4|||
125119241|NCT03019965|450059436|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
125212271|NCT01006590|450403309|FG001|Overall Study|Death|1|||
124924900|NCT01902173|449354606|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
124924901|NCT01902173|449354601|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
125119242|NCT03019965|450059437|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
125119243|NCT03019965|450059436|FG000|Overall Study|Physician Decision|1|||
125119244|NCT03019965|450059437|FG001|Overall Study|Physician Decision|1|||
125119245|NCT01659567|450059438|FG000|Overall Study|Lack of Efficacy|22|||
125119246|NCT01659567|450059438|FG000|Overall Study|Switched to Pegferon|6|||
125119247|NCT01659567|450059438|FG000|Overall Study|Adverse Event|12|||
125119248|NCT01659567|450059438|FG000|Overall Study|Good result at early stage of treatment|5|||
125119249|NCT01659567|450059438|FG000|Overall Study|Withdrawal by Subject|64|||
125119250|NCT01659567|450059438|FG000|Overall Study|Progression of the main disease|1|||
125119251|NCT01659567|450059438|FG000|Overall Study|Other|13|||
125119252|NCT03213210|450059439|FG000|Overall Study|Lost to Follow-up|2|||
125119253|NCT03213210|450059439|FG000|Overall Study|Study termination|3|||
125119254|NCT00708422|450059447|FG000|Overall Study|Adverse Event|3|||
125119255|NCT00708422|450059448|FG001|Overall Study|Adverse Event|1|||
125119256|NCT00708422|450059447|FG000|Overall Study|Withdrawal by Subject|1|||
125119257|NCT00708422|450059448|FG001|Overall Study|Withdrawal by Subject|0|||
125119258|NCT00299156|450059451|FG000|Period 2 (Randomized)|Screen Failure|0|||
125119259|NCT00299156|450059452|FG001|Period 2 (Randomized)|Screen Failure|1|||
125119260|NCT00299156|450059453|FG002|Period 2 (Randomized)|Screen Failure|0|||
125119261|NCT01166568|450059467|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
125119262|NCT01166568|450059468|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
125119263|NCT01166568|450059469|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
125119264|NCT01166568|450059467|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
125119265|NCT01166568|450059468|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
125119266|NCT01166568|450059469|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
125119267|NCT01166568|450059467|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
125119268|NCT01166568|450059468|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
125119269|NCT01166568|450059469|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
125119270|NCT01654380|450059470|FG000|Part B, Period 1|Physician Decision|0|||
124924902|NCT01902173|449354602|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
124924903|NCT01902173|449354603|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
124924904|NCT01902173|449354604|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
124924905|NCT01902173|449354605|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
124924906|NCT01902173|449354606|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
124924907|NCT01902173|449354601|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
124924908|NCT01902173|449354602|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
124924909|NCT01902173|449354603|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
124924910|NCT01902173|449354604|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
124924911|NCT01902173|449354605|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
124924912|NCT01902173|449354606|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
124924913|NCT01902173|449354601|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
124924914|NCT01902173|449354602|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
124924915|NCT01902173|449354603|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
124924916|NCT01902173|449354604|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
124924917|NCT01902173|449354605|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
124924918|NCT01902173|449354606|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
124924919|NCT01902173|449354601|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
124924920|NCT01902173|449354602|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
124924921|NCT01902173|449354603|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
124924922|NCT01902173|449354604|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
124924923|NCT01902173|449354605|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
124924924|NCT01902173|449354606|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
124924925|NCT01902173|449354601|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
124924926|NCT01902173|449354602|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
124924927|NCT01902173|449354603|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
124924928|NCT01902173|449354604|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
124924929|NCT01902173|449354605|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
125119271|NCT01654380|450059471|FG001|Part B, Period 1|Physician Decision|0|||
125119272|NCT01654380|450059472|FG002|Part B, Period 1|Physician Decision|1|||
125119273|NCT01654380|450059473|FG003|Part B, Period 1|Physician Decision|0|||
124924930|NCT01902173|449354606|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
124924931|NCT01902173|449354601|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
124924932|NCT01902173|449354602|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
125023939|NCT03529773|449711338|FG005|Overall Study|No longer meets eligibility criteria|0|||
125023940|NCT03529773|449711339|FG006|Overall Study|No longer meets eligibility criteria|0|||
125023941|NCT03529773|449711340|FG007|Overall Study|No longer meets eligibility criteria|0|||
125023942|NCT03529773|449711341|FG008|Overall Study|No longer meets eligibility criteria|0|||
125023943|NCT03529773|449711342|FG009|Overall Study|No longer meets eligibility criteria|0|||
125023944|NCT03529773|449711343|FG010|Overall Study|No longer meets eligibility criteria|0|||
125023945|NCT03529773|449711344|FG011|Overall Study|No longer meets eligibility criteria|0|||
125023946|NCT03529773|449711345|FG012|Overall Study|No longer meets eligibility criteria|0|||
125023947|NCT03529773|449711346|FG013|Overall Study|No longer meets eligibility criteria|0|||
125023948|NCT03529773|449711347|FG014|Overall Study|No longer meets eligibility criteria|0|||
125023949|NCT03529773|449711348|FG015|Overall Study|No longer meets eligibility criteria|0|||
125023950|NCT03529773|449711349|FG016|Overall Study|No longer meets eligibility criteria|0|||
125023951|NCT03529773|449711350|FG017|Overall Study|No longer meets eligibility criteria|0|||
125023952|NCT03529773|449711351|FG018|Overall Study|No longer meets eligibility criteria|0|||
125023953|NCT03529773|449711352|FG019|Overall Study|No longer meets eligibility criteria|0|||
125023954|NCT03529773|449711353|FG020|Overall Study|No longer meets eligibility criteria|0|||
125023955|NCT03529773|449711354|FG021|Overall Study|No longer meets eligibility criteria|0|||
125023956|NCT03529773|449711355|FG022|Overall Study|No longer meets eligibility criteria|1|||
125023957|NCT03529773|449711356|FG023|Overall Study|No longer meets eligibility criteria|0|||
125023958|NCT03529773|449711357|FG024|Overall Study|No longer meets eligibility criteria|0|||
125023959|NCT03529773|449711358|FG025|Overall Study|No longer meets eligibility criteria|0|||
125023960|NCT03529773|449711359|FG026|Overall Study|No longer meets eligibility criteria|0|||
125023961|NCT03529773|449711360|FG027|Overall Study|No longer meets eligibility criteria|0|||
125023962|NCT03529773|449711361|FG028|Overall Study|No longer meets eligibility criteria|0|||
125023963|NCT03529773|449711362|FG029|Overall Study|No longer meets eligibility criteria|0|||
125023964|NCT03529773|449711363|FG030|Overall Study|No longer meets eligibility criteria|0|||
125023965|NCT03529773|449711364|FG031|Overall Study|No longer meets eligibility criteria|0|||
125023966|NCT03529773|449711365|FG032|Overall Study|No longer meets eligibility criteria|0|||
125023967|NCT03529773|449711366|FG033|Overall Study|No longer meets eligibility criteria|0|||
125023968|NCT03529773|449711367|FG034|Overall Study|No longer meets eligibility criteria|0|||
125023969|NCT03529773|449711368|FG035|Overall Study|No longer meets eligibility criteria|0|||
125023970|NCT03529773|449711369|FG036|Overall Study|No longer meets eligibility criteria|0|||
125023971|NCT03529773|449711370|FG037|Overall Study|No longer meets eligibility criteria|0|||
125023972|NCT03529773|449711371|FG038|Overall Study|No longer meets eligibility criteria|1|||
125023973|NCT03529773|449711372|FG039|Overall Study|No longer meets eligibility criteria|0|||
125023974|NCT03529773|449711333|FG000|Overall Study|Other|0|||
125023975|NCT03529773|449711334|FG001|Overall Study|Other|0|||
125023976|NCT03529773|449711335|FG002|Overall Study|Other|0|||
125023977|NCT03529773|449711336|FG003|Overall Study|Other|0|||
125023978|NCT03529773|449711337|FG004|Overall Study|Other|0|||
125023979|NCT03529773|449711338|FG005|Overall Study|Other|0|||
125023980|NCT03529773|449711339|FG006|Overall Study|Other|0|||
125023981|NCT03529773|449711340|FG007|Overall Study|Other|0|||
125023982|NCT03529773|449711341|FG008|Overall Study|Other|0|||
125023983|NCT03529773|449711342|FG009|Overall Study|Other|0|||
125023984|NCT03529773|449711343|FG010|Overall Study|Other|0|||
125023985|NCT03529773|449711344|FG011|Overall Study|Other|0|||
125023986|NCT03529773|449711345|FG012|Overall Study|Other|1|||
125023987|NCT03529773|449711346|FG013|Overall Study|Other|0|||
125023988|NCT03529773|449711347|FG014|Overall Study|Other|2|||
125023989|NCT03529773|449711348|FG015|Overall Study|Other|0|||
125023990|NCT03529773|449711349|FG016|Overall Study|Other|0|||
125023991|NCT03529773|449711350|FG017|Overall Study|Other|3|||
125023992|NCT03529773|449711351|FG018|Overall Study|Other|0|||
125023993|NCT03529773|449711352|FG019|Overall Study|Other|0|||
125119274|NCT00684671|450059474|FG000|Overall Study|Adverse Event|1|||
125119275|NCT00684671|450059475|FG001|Overall Study|Adverse Event|0|||
125023994|NCT03529773|449711353|FG020|Overall Study|Other|1|||
125023995|NCT03529773|449711354|FG021|Overall Study|Other|0|||
125023996|NCT03529773|449711355|FG022|Overall Study|Other|1|||
125023997|NCT03529773|449711356|FG023|Overall Study|Other|0|||
125023998|NCT03529773|449711357|FG024|Overall Study|Other|3|||
125023999|NCT03529773|449711358|FG025|Overall Study|Other|2|||
125024000|NCT03529773|449711359|FG026|Overall Study|Other|2|||
125024001|NCT03529773|449711360|FG027|Overall Study|Other|0|||
125024002|NCT03529773|449711361|FG028|Overall Study|Other|0|||
125119276|NCT00684671|450059476|FG002|Overall Study|Adverse Event|0|||
125119277|NCT00684671|450059474|FG000|Overall Study|Lost to Follow-up|1|||
125119278|NCT00684671|450059475|FG001|Overall Study|Lost to Follow-up|0|||
125119279|NCT00684671|450059476|FG002|Overall Study|Lost to Follow-up|0|||
125119280|NCT00684671|450059474|FG000|Overall Study|Alcoholic dependance|1|||
125119281|NCT00684671|450059475|FG001|Overall Study|Alcoholic dependance|0|||
125119282|NCT00684671|450059476|FG002|Overall Study|Alcoholic dependance|0|||
125119283|NCT03335371|450059477|FG000|Overall Study|Lost to Follow-up|0|||
125119284|NCT03335371|450059478|FG001|Overall Study|Lost to Follow-up|0|||
125119285|NCT03335371|450059479|FG002|Overall Study|Lost to Follow-up|0|||
125119286|NCT03335371|450059480|FG003|Overall Study|Lost to Follow-up|0|||
125119287|NCT03335371|450059481|FG004|Overall Study|Lost to Follow-up|1|||
125119288|NCT03335371|450059477|FG000|Overall Study|Withdrawal by Subject|0|||
125119289|NCT03335371|450059478|FG001|Overall Study|Withdrawal by Subject|0|||
125119290|NCT03335371|450059479|FG002|Overall Study|Withdrawal by Subject|0|||
125119291|NCT03335371|450059480|FG003|Overall Study|Withdrawal by Subject|0|||
125119292|NCT03335371|450059481|FG004|Overall Study|Withdrawal by Subject|1|||
125119293|NCT03335371|450059477|FG000|Overall Study|Randomization Error|0|||
125119294|NCT03335371|450059478|FG001|Overall Study|Randomization Error|0|||
125119295|NCT03335371|450059479|FG002|Overall Study|Randomization Error|1|||
125119296|NCT03335371|450059480|FG003|Overall Study|Randomization Error|0|||
125119297|NCT03335371|450059481|FG004|Overall Study|Randomization Error|0|||
125119298|NCT01725451|450059483|FG000|Period 1|Withdrawal by Subject|1|||
125024003|NCT03529773|449711362|FG029|Overall Study|Other|0|||
125024004|NCT03529773|449711363|FG030|Overall Study|Other|0|||
125024005|NCT03529773|449711364|FG031|Overall Study|Other|0|||
125024006|NCT03529773|449711365|FG032|Overall Study|Other|0|||
125024007|NCT03529773|449711366|FG033|Overall Study|Other|0|||
125024008|NCT03529773|449711367|FG034|Overall Study|Other|1|||
125024009|NCT03529773|449711368|FG035|Overall Study|Other|1|||
125024010|NCT03529773|449711369|FG036|Overall Study|Other|0|||
125119299|NCT01725451|450059484|FG001|Period 1|Withdrawal by Subject|0|||
125119300|NCT01725451|450059485|FG002|Period 1|Withdrawal by Subject|0|||
125119301|NCT01725451|450059486|FG003|Period 1|Withdrawal by Subject|0|||
125024011|NCT03529773|449711370|FG037|Overall Study|Other|0|||
125024012|NCT03529773|449711371|FG038|Overall Study|Other|0|||
125024013|NCT03529773|449711372|FG039|Overall Study|Other|0|||
125024014|NCT03529773|449711333|FG000|Overall Study|Physician Decision|0|||
125024015|NCT03529773|449711334|FG001|Overall Study|Physician Decision|0|||
125024016|NCT03529773|449711335|FG002|Overall Study|Physician Decision|0|||
125024017|NCT03529773|449711336|FG003|Overall Study|Physician Decision|0|||
125024018|NCT03529773|449711337|FG004|Overall Study|Physician Decision|0|||
125119302|NCT01725451|450059483|FG000|Washout From Period 3|Protocol Violation|0|||
125119303|NCT01725451|450059484|FG001|Washout From Period 3|Protocol Violation|0|||
125119304|NCT01725451|450059485|FG002|Washout From Period 3|Protocol Violation|1|||
125024019|NCT03529773|449711338|FG005|Overall Study|Physician Decision|0|||
125024020|NCT03529773|449711339|FG006|Overall Study|Physician Decision|0|||
125024021|NCT03529773|449711340|FG007|Overall Study|Physician Decision|0|||
125024022|NCT03529773|449711341|FG008|Overall Study|Physician Decision|0|||
124924933|NCT01902173|449354603|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
124924934|NCT01902173|449354604|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
124924935|NCT01902173|449354605|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
124924936|NCT01902173|449354606|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
124924937|NCT01902173|449354601|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
124924938|NCT01902173|449354602|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
124924939|NCT01902173|449354603|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
125212272|NCT01006590|450403308|FG000|Overall Study|Lost to Follow-up|1|||
125212273|NCT01006590|450403309|FG001|Overall Study|Lost to Follow-up|1|||
125212274|NCT01006590|450403308|FG000|Overall Study|Protocol Violation|1|||
124924940|NCT01902173|449354604|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
124924941|NCT01902173|449354605|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
124924942|NCT01902173|449354606|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
124924943|NCT02262728|449354608|FG000|Follow-up Phase (3 Years)|Death|0|||
124924944|NCT02262728|449354609|FG001|Follow-up Phase (3 Years)|Death|1|||
124924945|NCT02262728|449354608|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
124924946|NCT02262728|449354609|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
124924947|NCT02262728|449354608|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
124924948|NCT02262728|449354609|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
124924949|NCT05540665|449354610|FG000|Overall Study|Study terminated by sponsor|6|||
124924950|NCT05540665|449354611|FG001|Overall Study|Study terminated by sponsor|6|||
124924951|NCT05540665|449354612|FG002|Overall Study|Study terminated by sponsor|7|||
124924952|NCT02619838|449354613|FG000|Overall Study|Lost to Follow-up|9|||
124924953|NCT02619838|449354613|FG000|Overall Study|Withdrawal by Subject|15|||
124924954|NCT04066244|449354616|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
124924955|NCT04066244|449354617|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
124924956|NCT04066244|449354618|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
124924957|NCT04066244|449354619|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
124924958|NCT04066244|449354620|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
124924959|NCT04066244|449354621|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
124924960|NCT04066244|449354616|FG000|Part 2 (Cohort 5)|Death|0|||
124924961|NCT04066244|449354617|FG001|Part 2 (Cohort 5)|Death|0|||
124924962|NCT04066244|449354618|FG002|Part 2 (Cohort 5)|Death|0|||
124924963|NCT04066244|449354619|FG003|Part 2 (Cohort 5)|Death|0|||
124924964|NCT04066244|449354620|FG004|Part 2 (Cohort 5)|Death|0|||
124924965|NCT04066244|449354621|FG005|Part 2 (Cohort 5)|Death|2|||
124924966|NCT04066244|449354616|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
124924967|NCT04066244|449354617|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
124924968|NCT04066244|449354618|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
124924969|NCT04066244|449354619|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
124924970|NCT04066244|449354620|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
124924971|NCT04066244|449354621|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
124924972|NCT04066244|449354616|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
124924973|NCT04066244|449354617|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
124924974|NCT04066244|449354618|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
124924975|NCT04066244|449354619|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
124924976|NCT04066244|449354620|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
124924977|NCT04066244|449354621|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
124924978|NCT01073566|449354622|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
124924979|NCT01073566|449354623|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
124924980|NCT05006872|449354645|FG000|Overall Study|Lost to Follow-up|37|||
124924981|NCT05006872|449354646|FG001|Overall Study|Lost to Follow-up|31|||
124924982|NCT04149704|449354648|FG000|Three Month Follow-up|Death|2|||
124924983|NCT04149704|449354649|FG001|Three Month Follow-up|Death|0|||
124924984|NCT04149704|449354650|FG002|Three Month Follow-up|Death|0|||
124924985|NCT04149704|449354651|FG003|Three Month Follow-up|Death|0|||
124924986|NCT04149704|449354648|FG000|Three Month Follow-up|Lost to Follow-up|1|||
124924987|NCT04149704|449354649|FG001|Three Month Follow-up|Lost to Follow-up|4|||
124924988|NCT04149704|449354650|FG002|Three Month Follow-up|Lost to Follow-up|5|||
124924989|NCT04149704|449354651|FG003|Three Month Follow-up|Lost to Follow-up|5|||
124924990|NCT04149704|449354648|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
124924991|NCT04149704|449354649|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
124924992|NCT04149704|449354650|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
124924993|NCT04149704|449354651|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
124924994|NCT04149704|449354648|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
124924995|NCT04149704|449354649|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
124924996|NCT04149704|449354650|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
124924997|NCT04149704|449354651|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
124924998|NCT02268253|449354654|FG000|Stage 1|Withdrawal by Subject|1|||
124924999|NCT02268253|449354655|FG001|Stage 1|Withdrawal by Subject|0|||
124925000|NCT02268253|449354656|FG002|Stage 1|Withdrawal by Subject|0|||
124925001|NCT02268253|449354657|FG003|Stage 1|Withdrawal by Subject|0|||
124925002|NCT02268253|449354658|FG004|Stage 1|Withdrawal by Subject|0|||
124925003|NCT02268253|449354659|FG005|Stage 1|Withdrawal by Subject|0|||
124925004|NCT02268253|449354660|FG006|Stage 1|Withdrawal by Subject|0|||
124925005|NCT02268253|449354654|FG000|Stage 1|Death|0|||
124925006|NCT02268253|449354655|FG001|Stage 1|Death|2|||
124925007|NCT02268253|449354656|FG002|Stage 1|Death|2|||
124925008|NCT02268253|449354657|FG003|Stage 1|Death|2|||
124925009|NCT02268253|449354658|FG004|Stage 1|Death|1|||
124925010|NCT02268253|449354659|FG005|Stage 1|Death|1|||
124925011|NCT02268253|449354660|FG006|Stage 1|Death|0|||
124925012|NCT02268253|449354654|FG000|Stage 2|Disease Recurrence/ Progression|0|||
124925013|NCT02268253|449354655|FG001|Stage 2|Disease Recurrence/ Progression|0|||
124925014|NCT02268253|449354656|FG002|Stage 2|Disease Recurrence/ Progression|1|||
124925015|NCT02268253|449354657|FG003|Stage 2|Disease Recurrence/ Progression|0|||
124925016|NCT02268253|449354658|FG004|Stage 2|Disease Recurrence/ Progression|0|||
124925017|NCT02268253|449354659|FG005|Stage 2|Disease Recurrence/ Progression|0|||
124925018|NCT02268253|449354660|FG006|Stage 2|Disease Recurrence/ Progression|0|||
124925019|NCT02268253|449354654|FG000|Stage 2|Withdrawal by Subject|0|||
124925020|NCT02268253|449354655|FG001|Stage 2|Withdrawal by Subject|0|||
124925021|NCT02268253|449354656|FG002|Stage 2|Withdrawal by Subject|2|||
124925022|NCT02268253|449354657|FG003|Stage 2|Withdrawal by Subject|0|||
124925023|NCT02268253|449354658|FG004|Stage 2|Withdrawal by Subject|0|||
124925024|NCT02268253|449354659|FG005|Stage 2|Withdrawal by Subject|2|||
124925025|NCT02268253|449354660|FG006|Stage 2|Withdrawal by Subject|0|||
124925026|NCT02268253|449354654|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
124925027|NCT02268253|449354655|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
124925028|NCT02268253|449354656|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
124925029|NCT02268253|449354657|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
124925030|NCT02268253|449354658|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
124925031|NCT02268253|449354659|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
124925032|NCT02268253|449354660|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
124925033|NCT02268253|449354654|FG000|Stage 2|Death|0|||
124925034|NCT02268253|449354655|FG001|Stage 2|Death|0|||
124925035|NCT02268253|449354656|FG002|Stage 2|Death|19|||
124925036|NCT02268253|449354657|FG003|Stage 2|Death|0|||
124925037|NCT02268253|449354658|FG004|Stage 2|Death|0|||
124925038|NCT02268253|449354659|FG005|Stage 2|Death|20|||
124925039|NCT02268253|449354660|FG006|Stage 2|Death|1|||
124925040|NCT02268253|449354654|FG000|Stage 2|Lost to Follow-up|0|||
124925041|NCT02268253|449354655|FG001|Stage 2|Lost to Follow-up|0|||
124925042|NCT02268253|449354656|FG002|Stage 2|Lost to Follow-up|0|||
124925043|NCT02268253|449354657|FG003|Stage 2|Lost to Follow-up|0|||
124925044|NCT02268253|449354658|FG004|Stage 2|Lost to Follow-up|0|||
124925045|NCT02268253|449354659|FG005|Stage 2|Lost to Follow-up|4|||
124925046|NCT02268253|449354660|FG006|Stage 2|Lost to Follow-up|0|||
124925047|NCT02268253|449354654|FG000|Stage 2|Transferred to Hospice|0|||
124925048|NCT02268253|449354655|FG001|Stage 2|Transferred to Hospice|0|||
124925049|NCT02268253|449354656|FG002|Stage 2|Transferred to Hospice|0|||
124925050|NCT02268253|449354657|FG003|Stage 2|Transferred to Hospice|0|||
124925051|NCT02268253|449354658|FG004|Stage 2|Transferred to Hospice|0|||
124925052|NCT02268253|449354659|FG005|Stage 2|Transferred to Hospice|2|||
124925053|NCT02268253|449354660|FG006|Stage 2|Transferred to Hospice|0|||
124925054|NCT02268253|449354654|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
124925055|NCT02268253|449354655|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
124925056|NCT02268253|449354656|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
124925057|NCT02268253|449354657|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
124925058|NCT02268253|449354658|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
124925059|NCT02268253|449354659|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
124925060|NCT02268253|449354660|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
124925061|NCT02268253|449354654|FG000|Stage 3A|Withdrawal by Subject|0|||
124925062|NCT02268253|449354655|FG001|Stage 3A|Withdrawal by Subject|0|||
124925063|NCT02268253|449354656|FG002|Stage 3A|Withdrawal by Subject|2|||
124925064|NCT02268253|449354657|FG003|Stage 3A|Withdrawal by Subject|0|||
124925065|NCT02268253|449354658|FG004|Stage 3A|Withdrawal by Subject|0|||
124925066|NCT02268253|449354659|FG005|Stage 3A|Withdrawal by Subject|0|||
124925067|NCT02268253|449354660|FG006|Stage 3A|Withdrawal by Subject|0|||
124925068|NCT02268253|449354654|FG000|Stage 3A|Physician Decision|0|||
124925069|NCT02268253|449354655|FG001|Stage 3A|Physician Decision|0|||
124925070|NCT02268253|449354656|FG002|Stage 3A|Physician Decision|2|||
124925071|NCT02268253|449354657|FG003|Stage 3A|Physician Decision|0|||
124925072|NCT02268253|449354658|FG004|Stage 3A|Physician Decision|0|||
124925073|NCT02268253|449354659|FG005|Stage 3A|Physician Decision|0|||
124925074|NCT02268253|449354660|FG006|Stage 3A|Physician Decision|0|||
124925075|NCT02268253|449354654|FG000|Stage 3A|Study Terminated by Sponsor|0|||
124925076|NCT02268253|449354655|FG001|Stage 3A|Study Terminated by Sponsor|0|||
124925077|NCT02268253|449354656|FG002|Stage 3A|Study Terminated by Sponsor|2|||
124925078|NCT02268253|449354657|FG003|Stage 3A|Study Terminated by Sponsor|0|||
124925079|NCT02268253|449354658|FG004|Stage 3A|Study Terminated by Sponsor|0|||
124925080|NCT02268253|449354659|FG005|Stage 3A|Study Terminated by Sponsor|0|||
124925081|NCT02268253|449354660|FG006|Stage 3A|Study Terminated by Sponsor|0|||
124925082|NCT02268253|449354654|FG000|Stage 3A|Lost to Follow-up|0|||
124925083|NCT02268253|449354655|FG001|Stage 3A|Lost to Follow-up|0|||
125119305|NCT01725451|450059486|FG003|Washout From Period 3|Protocol Violation|0|||
125119306|NCT01725451|450059483|FG000|Washout From Period 3|Adverse Event|0|||
125119307|NCT01725451|450059484|FG001|Washout From Period 3|Adverse Event|1|||
125119308|NCT01725451|450059485|FG002|Washout From Period 3|Adverse Event|0|||
125119309|NCT01725451|450059486|FG003|Washout From Period 3|Adverse Event|0|||
125119310|NCT01725451|450059483|FG000|Period 4|Adverse Event|0|||
125119311|NCT01725451|450059484|FG001|Period 4|Adverse Event|0|||
125119312|NCT01725451|450059485|FG002|Period 4|Adverse Event|1|||
125119313|NCT01725451|450059486|FG003|Period 4|Adverse Event|0|||
125119314|NCT00437281|450059487|FG000|Overall Study|Adverse Event|0|||
124925084|NCT02268253|449354656|FG002|Stage 3A|Lost to Follow-up|1|||
124925085|NCT02268253|449354657|FG003|Stage 3A|Lost to Follow-up|0|||
124925086|NCT02268253|449354658|FG004|Stage 3A|Lost to Follow-up|0|||
124925087|NCT02268253|449354659|FG005|Stage 3A|Lost to Follow-up|0|||
124925088|NCT02268253|449354660|FG006|Stage 3A|Lost to Follow-up|0|||
124925089|NCT02268253|449354654|FG000|Stage 3A|Death|0|||
124925090|NCT02268253|449354655|FG001|Stage 3A|Death|0|||
124925091|NCT02268253|449354656|FG002|Stage 3A|Death|5|||
125119315|NCT00437281|450059488|FG001|Overall Study|Adverse Event|0|||
125119316|NCT00437281|450059489|FG002|Overall Study|Adverse Event|0|||
125119317|NCT00437281|450059490|FG003|Overall Study|Adverse Event|1|||
125119318|NCT00437281|450059491|FG004|Overall Study|Adverse Event|0|||
125119319|NCT00437281|450059492|FG005|Overall Study|Adverse Event|1|||
125119320|NCT00437281|450059493|FG006|Overall Study|Adverse Event|0|||
125119321|NCT00437281|450059494|FG007|Overall Study|Adverse Event|0|||
125119322|NCT00437281|450059495|FG008|Overall Study|Adverse Event|0|||
125119323|NCT00437281|450059496|FG009|Overall Study|Adverse Event|1|||
125119324|NCT00437281|450059497|FG010|Overall Study|Adverse Event|0|||
125119325|NCT00437281|450059498|FG011|Overall Study|Adverse Event|0|||
125119326|NCT00437281|450059499|FG012|Overall Study|Adverse Event|0|||
125119327|NCT00437281|450059500|FG013|Overall Study|Adverse Event|1|||
125119328|NCT00437281|450059501|FG014|Overall Study|Adverse Event|1|||
125119329|NCT00437281|450059502|FG015|Overall Study|Adverse Event|0|||
125119330|NCT00437281|450059503|FG016|Overall Study|Adverse Event|0|||
125119331|NCT00437281|450059504|FG017|Overall Study|Adverse Event|0|||
125119332|NCT00437281|450059505|FG018|Overall Study|Adverse Event|1|||
125119333|NCT00437281|450059506|FG019|Overall Study|Adverse Event|0|||
125119334|NCT00437281|450059487|FG000|Overall Study|Lost to Follow-up|0|||
125119335|NCT00437281|450059488|FG001|Overall Study|Lost to Follow-up|0|||
125119336|NCT00437281|450059489|FG002|Overall Study|Lost to Follow-up|0|||
125119337|NCT00437281|450059490|FG003|Overall Study|Lost to Follow-up|0|||
125119338|NCT00437281|450059491|FG004|Overall Study|Lost to Follow-up|0|||
125119339|NCT00437281|450059492|FG005|Overall Study|Lost to Follow-up|0|||
125119340|NCT00437281|450059493|FG006|Overall Study|Lost to Follow-up|0|||
125119341|NCT00437281|450059494|FG007|Overall Study|Lost to Follow-up|0|||
125119342|NCT00437281|450059495|FG008|Overall Study|Lost to Follow-up|0|||
125119343|NCT00437281|450059496|FG009|Overall Study|Lost to Follow-up|0|||
125119344|NCT00437281|450059497|FG010|Overall Study|Lost to Follow-up|0|||
125119345|NCT00437281|450059498|FG011|Overall Study|Lost to Follow-up|0|||
125119346|NCT00437281|450059499|FG012|Overall Study|Lost to Follow-up|0|||
125119347|NCT00437281|450059500|FG013|Overall Study|Lost to Follow-up|0|||
125119348|NCT00437281|450059501|FG014|Overall Study|Lost to Follow-up|0|||
125119349|NCT00437281|450059502|FG015|Overall Study|Lost to Follow-up|0|||
125119350|NCT00437281|450059503|FG016|Overall Study|Lost to Follow-up|0|||
125119351|NCT00437281|450059504|FG017|Overall Study|Lost to Follow-up|0|||
125119352|NCT00437281|450059505|FG018|Overall Study|Lost to Follow-up|0|||
124925092|NCT02268253|449354657|FG003|Stage 3A|Death|0|||
124925093|NCT02268253|449354658|FG004|Stage 3A|Death|0|||
124925094|NCT02268253|449354659|FG005|Stage 3A|Death|0|||
124925095|NCT02268253|449354660|FG006|Stage 3A|Death|0|||
124925096|NCT05362487|449354663|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
124925097|NCT06215521|449354672|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
124925098|NCT06215521|449354673|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
124925099|NCT06215521|449354674|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
124925100|NCT06215521|449354675|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
124925101|NCT06215521|449354676|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
124925102|NCT06215521|449354677|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
124925103|NCT04096040|449354678|FG000|Overall Study|Protocol Violation|12|||
124925104|NCT04096040|449354678|FG000|Overall Study|Non-compliant site|4|||
124925105|NCT04973254|449354681|FG000|Overall Study|Not adherent|0|||
124925106|NCT04973254|449354682|FG001|Overall Study|Not adherent|1|||
124925107|NCT04973254|449354683|FG002|Overall Study|Not adherent|0|||
124925108|NCT03808818|449354691|FG000|Overall Study|Death|6|||
124925109|NCT03808818|449354692|FG001|Overall Study|Death|6|||
124925110|NCT03808818|449354691|FG000|Overall Study|Withdrawal by Subject|7|||
124925111|NCT03808818|449354692|FG001|Overall Study|Withdrawal by Subject|18|||
124925112|NCT03808818|449354691|FG000|Overall Study|Lost to Follow-up|31|||
124925113|NCT03808818|449354692|FG001|Overall Study|Lost to Follow-up|33|||
124925114|NCT05415722|449354694|FG000|Overall Study|Lost to Follow-up|0|||
124925115|NCT05415722|449354695|FG001|Overall Study|Lost to Follow-up|2|||
124925116|NCT05415722|449354696|FG002|Overall Study|Lost to Follow-up|0|||
124925117|NCT05415722|449354697|FG003|Overall Study|Lost to Follow-up|1|||
124925118|NCT05415722|449354698|FG004|Overall Study|Lost to Follow-up|0|||
124925119|NCT05415722|449354699|FG005|Overall Study|Lost to Follow-up|0|||
124925120|NCT05415722|449354700|FG006|Overall Study|Lost to Follow-up|1|||
124925121|NCT05415722|449354694|FG000|Overall Study|Physician Decision|0|||
124925122|NCT05415722|449354695|FG001|Overall Study|Physician Decision|0|||
124925123|NCT05415722|449354696|FG002|Overall Study|Physician Decision|0|||
124925124|NCT05415722|449354697|FG003|Overall Study|Physician Decision|1|||
124925125|NCT05415722|449354698|FG004|Overall Study|Physician Decision|0|||
124925126|NCT05415722|449354699|FG005|Overall Study|Physician Decision|0|||
124925127|NCT05415722|449354700|FG006|Overall Study|Physician Decision|1|||
124925128|NCT05415722|449354694|FG000|Overall Study|Protocol Violation|0|||
124925129|NCT05415722|449354695|FG001|Overall Study|Protocol Violation|0|||
124925130|NCT05415722|449354696|FG002|Overall Study|Protocol Violation|0|||
124925131|NCT05415722|449354697|FG003|Overall Study|Protocol Violation|1|||
124925132|NCT05415722|449354698|FG004|Overall Study|Protocol Violation|0|||
124925133|NCT05415722|449354699|FG005|Overall Study|Protocol Violation|0|||
124925134|NCT05415722|449354700|FG006|Overall Study|Protocol Violation|0|||
124925135|NCT05415722|449354694|FG000|Overall Study|Sponsor Discretion|0|||
124925136|NCT05415722|449354695|FG001|Overall Study|Sponsor Discretion|0|||
124925137|NCT05415722|449354696|FG002|Overall Study|Sponsor Discretion|0|||
125119353|NCT00437281|450059506|FG019|Overall Study|Lost to Follow-up|1|||
125119354|NCT00601354|450059507|FG000|Overall Study|Lost to Follow-up|4|||
124925138|NCT05415722|449354697|FG003|Overall Study|Sponsor Discretion|0|||
124925139|NCT05415722|449354698|FG004|Overall Study|Sponsor Discretion|1|||
124925140|NCT05415722|449354699|FG005|Overall Study|Sponsor Discretion|1|||
124925141|NCT05415722|449354700|FG006|Overall Study|Sponsor Discretion|0|||
124925142|NCT05415722|449354694|FG000|Overall Study|Withdrawal by Subject|0|||
125119355|NCT00601354|450059508|FG001|Overall Study|Lost to Follow-up|5|||
124925143|NCT05415722|449354695|FG001|Overall Study|Withdrawal by Subject|1|||
124925144|NCT05415722|449354696|FG002|Overall Study|Withdrawal by Subject|0|||
124925145|NCT05415722|449354697|FG003|Overall Study|Withdrawal by Subject|1|||
124925146|NCT05415722|449354698|FG004|Overall Study|Withdrawal by Subject|1|||
124925147|NCT05415722|449354699|FG005|Overall Study|Withdrawal by Subject|0|||
124925148|NCT05415722|449354700|FG006|Overall Study|Withdrawal by Subject|1|||
124925149|NCT04629716|449354701|FG000|Overall Study|Lost to Follow-up|7|||
124925150|NCT04629716|449354702|FG001|Overall Study|Lost to Follow-up|3|||
124925151|NCT04537715|449354703|FG000|Overall Study|Death|3|||
124925152|NCT04537715|449354704|FG001|Overall Study|Death|1|||
124925153|NCT04537715|449354703|FG000|Overall Study|Withdrawal by Subject|3|||
124925154|NCT04537715|449354704|FG001|Overall Study|Withdrawal by Subject|1|||
124925155|NCT04537715|449354703|FG000|Overall Study|Other|4|||
124925156|NCT04537715|449354704|FG001|Overall Study|Other|3|||
124925157|NCT04537715|449354703|FG000|Overall Study|Progressive disease|1|||
124925158|NCT04537715|449354704|FG001|Overall Study|Progressive disease|0|||
124925159|NCT03031470|449354705|FG000|Overall Study|Adverse Event|3|||
124925160|NCT03031470|449354706|FG001|Overall Study|Adverse Event|0|||
124925161|NCT03031470|449354705|FG000|Overall Study|Death|3|||
124925162|NCT03031470|449354706|FG001|Overall Study|Death|1|||
124925163|NCT03031470|449354705|FG000|Overall Study|Lost to Follow-up|1|||
124925164|NCT03031470|449354706|FG001|Overall Study|Lost to Follow-up|1|||
124925165|NCT03031470|449354705|FG000|Overall Study|Withdrawal by Subject|1|||
124925166|NCT03031470|449354706|FG001|Overall Study|Withdrawal by Subject|0|||
124925167|NCT03031470|449354705|FG000|Overall Study|Protocol entry criteria not met|0|||
124925168|NCT03031470|449354706|FG001|Overall Study|Protocol entry criteria not met|1|||
124925169|NCT03031470|449354705|FG000|Overall Study|Cancel the operation|0|||
124925170|NCT03031470|449354706|FG001|Overall Study|Cancel the operation|1|||
124925171|NCT03461276|449354707|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
124925172|NCT03461276|449354708|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
124925173|NCT03461276|449354707|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
124925174|NCT03461276|449354708|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
124925175|NCT03461276|449354707|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
124925176|NCT03461276|449354708|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
124925177|NCT03461276|449354707|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
124925178|NCT03461276|449354708|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
124925179|NCT03461276|449354707|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
124925180|NCT03461276|449354708|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
124925181|NCT03461276|449354707|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
124925182|NCT03461276|449354708|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
124925183|NCT03461276|449354707|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
124925184|NCT03461276|449354708|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
124925185|NCT03461276|449354707|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
124925186|NCT03461276|449354708|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
124925187|NCT03461276|449354707|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
124925188|NCT03461276|449354708|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
124925189|NCT03461276|449354707|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
124925190|NCT03461276|449354708|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
124925191|NCT02310646|449354710|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
124925192|NCT02310646|449354711|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
124925193|NCT02310646|449354710|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
124925194|NCT02310646|449354711|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
124925195|NCT03865498|449354712|FG000|Overall Study|Lack of Efficacy|12|||
124925196|NCT03865498|449354713|FG001|Overall Study|Lack of Efficacy|11|||
124925197|NCT03865498|449354712|FG000|Overall Study|Lost to Follow-up|125|||
124925198|NCT03865498|449354713|FG001|Overall Study|Lost to Follow-up|133|||
124925199|NCT03865498|449354712|FG000|Overall Study|Withdrawal by Subject|2|||
124925200|NCT03865498|449354713|FG001|Overall Study|Withdrawal by Subject|4|||
124925201|NCT05869383|449354716|FG000|Overall Study|Withdrawal by Subject|2|||
124925202|NCT05869383|449354717|FG001|Overall Study|Withdrawal by Subject|0|||
124925203|NCT03270501|449354720|FG000|Overall Study|Screen failure|6|||
124925204|NCT03270501|449354720|FG000|Overall Study|Lost to Follow-up|2|||
124925205|NCT03270501|449354720|FG000|Overall Study|Adverse Event|1|||
124925206|NCT03812679|449356713|FG000|Overall Study|Adverse Event|2|||
124925207|NCT03812679|449356713|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
124925208|NCT03812679|449356713|FG000|Overall Study|Renal transplant|1|||
124925209|NCT03812679|449356713|FG000|Overall Study|Withdrawal by Subject|1|||
124925210|NCT03812679|449356713|FG000|Overall Study|Termination of study|2|||
124925211|NCT03812679|449356713|FG000|Overall Study|Water device replacement|1|||
124925212|NCT05486078|449356714|FG000|Overall Study|4 drop out and one withdrawn|5|||
124925213|NCT02985957|449356715|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124925214|NCT02985957|449356716|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124925215|NCT02985957|449356717|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124925216|NCT02985957|449356718|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124925217|NCT02985957|449356719|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
124925218|NCT02985957|449356720|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124925219|NCT02985957|449356721|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124925220|NCT02985957|449356715|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
124925221|NCT02985957|449356716|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
124925222|NCT02985957|449356717|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
124925223|NCT02985957|449356718|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
124925224|NCT02985957|449356719|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
124925225|NCT02985957|449356720|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
124925226|NCT02985957|449356721|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
124925227|NCT02985957|449356715|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
124925228|NCT02985957|449356716|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
124925229|NCT02985957|449356717|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
124925230|NCT02985957|449356718|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
124925231|NCT02985957|449356719|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
124925232|NCT02985957|449356720|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
124925233|NCT02985957|449356721|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
124925234|NCT02985957|449356715|FG000|Treatment Period|Death|0|||
124925235|NCT02985957|449356716|FG001|Treatment Period|Death|0|||
124925236|NCT02985957|449356717|FG002|Treatment Period|Death|0|||
124925237|NCT02985957|449356718|FG003|Treatment Period|Death|0|||
124925238|NCT02985957|449356719|FG004|Treatment Period|Death|1|||
124925239|NCT02985957|449356720|FG005|Treatment Period|Death|0|||
124925240|NCT02985957|449356721|FG006|Treatment Period|Death|0|||
124925241|NCT02985957|449356715|FG000|Treatment Period|Participant withdrew consent|0|||
124925242|NCT02985957|449356716|FG001|Treatment Period|Participant withdrew consent|0|||
124925243|NCT02985957|449356717|FG002|Treatment Period|Participant withdrew consent|0|||
124925244|NCT02985957|449356718|FG003|Treatment Period|Participant withdrew consent|1|||
124925245|NCT02985957|449356719|FG004|Treatment Period|Participant withdrew consent|3|||
124925246|NCT02985957|449356720|FG005|Treatment Period|Participant withdrew consent|0|||
124925247|NCT02985957|449356721|FG006|Treatment Period|Participant withdrew consent|1|||
124925248|NCT02985957|449356715|FG000|Treatment Period|Lost to Follow-up|0|||
124925249|NCT02985957|449356716|FG001|Treatment Period|Lost to Follow-up|0|||
124925250|NCT02985957|449356717|FG002|Treatment Period|Lost to Follow-up|0|||
124925251|NCT02985957|449356718|FG003|Treatment Period|Lost to Follow-up|0|||
124925252|NCT02985957|449356719|FG004|Treatment Period|Lost to Follow-up|1|||
124925253|NCT02985957|449356720|FG005|Treatment Period|Lost to Follow-up|0|||
124925254|NCT02985957|449356721|FG006|Treatment Period|Lost to Follow-up|0|||
124925255|NCT02985957|449356715|FG000|Treatment Period|Other reasons|0|||
124925256|NCT02985957|449356716|FG001|Treatment Period|Other reasons|0|||
124925257|NCT02985957|449356717|FG002|Treatment Period|Other reasons|1|||
124925258|NCT02985957|449356718|FG003|Treatment Period|Other reasons|3|||
124925259|NCT02985957|449356719|FG004|Treatment Period|Other reasons|6|||
124925260|NCT02985957|449356720|FG005|Treatment Period|Other reasons|0|||
124925261|NCT02985957|449356721|FG006|Treatment Period|Other reasons|1|||
124925262|NCT02985957|449356715|FG000|Treatment Period|Not reported|0|||
124925263|NCT02985957|449356716|FG001|Treatment Period|Not reported|1|||
125119356|NCT01656889|450059510|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
125119357|NCT01656889|450059511|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
125119358|NCT01656889|450059510|FG000|Treatment Period, 12 Weeks|Death|0|||
125119359|NCT01656889|450059511|FG001|Treatment Period, 12 Weeks|Death|1|||
125119360|NCT01656889|450059510|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
125119361|NCT01656889|450059511|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
125119362|NCT01656889|450059510|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
125119363|NCT01656889|450059511|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
125119364|NCT01656889|450059510|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
125119365|NCT01656889|450059511|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
125119366|NCT01656889|450059510|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
125119367|NCT01656889|450059511|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
125119368|NCT01656889|450059510|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
125119369|NCT01656889|450059511|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
125119370|NCT01656889|450059510|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
125119371|NCT01656889|450059511|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
125119372|NCT01656889|450059510|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
124925264|NCT02985957|449356717|FG002|Treatment Period|Not reported|2|||
124925265|NCT02985957|449356718|FG003|Treatment Period|Not reported|5|||
124925266|NCT02985957|449356719|FG004|Treatment Period|Not reported|0|||
124925267|NCT02985957|449356720|FG005|Treatment Period|Not reported|0|||
124925268|NCT02985957|449356721|FG006|Treatment Period|Not reported|0|||
124925269|NCT02985957|449356715|FG000|Treatment Period|Maximum clinical benefit|0|||
124925270|NCT02985957|449356716|FG001|Treatment Period|Maximum clinical benefit|0|||
124925271|NCT02985957|449356717|FG002|Treatment Period|Maximum clinical benefit|1|||
124925272|NCT02985957|449356718|FG003|Treatment Period|Maximum clinical benefit|1|||
124925273|NCT02985957|449356719|FG004|Treatment Period|Maximum clinical benefit|0|||
124925274|NCT02985957|449356720|FG005|Treatment Period|Maximum clinical benefit|0|||
124925275|NCT02985957|449356721|FG006|Treatment Period|Maximum clinical benefit|2|||
124969567|NCT03520075|449517423|FG014|Phase 2 (Dose Expansion)|Death|13|||
124925276|NCT02985957|449356715|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
124925277|NCT02985957|449356716|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
124925278|NCT02985957|449356717|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
124925279|NCT02985957|449356718|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
124925280|NCT02985957|449356719|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
124925281|NCT02985957|449356720|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
124925282|NCT02985957|449356721|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
124925283|NCT02985957|449356715|FG000|Treatment Period|Study drug toxicity|1|||
124925284|NCT02985957|449356716|FG001|Treatment Period|Study drug toxicity|23|||
124925285|NCT02985957|449356717|FG002|Treatment Period|Study drug toxicity|20|||
124925286|NCT02985957|449356718|FG003|Treatment Period|Study drug toxicity|11|||
124925287|NCT02985957|449356719|FG004|Treatment Period|Study drug toxicity|19|||
124925288|NCT02985957|449356720|FG005|Treatment Period|Study drug toxicity|3|||
124925289|NCT02985957|449356721|FG006|Treatment Period|Study drug toxicity|5|||
124925290|NCT02985957|449356715|FG000|Treatment Period|Disease progression|0|||
124925291|NCT02985957|449356716|FG001|Treatment Period|Disease progression|16|||
124925292|NCT02985957|449356717|FG002|Treatment Period|Disease progression|20|||
124925293|NCT02985957|449356718|FG003|Treatment Period|Disease progression|39|||
124925294|NCT02985957|449356719|FG004|Treatment Period|Disease progression|29|||
124925295|NCT02985957|449356720|FG005|Treatment Period|Disease progression|11|||
124925296|NCT02985957|449356721|FG006|Treatment Period|Disease progression|28|||
124925297|NCT02985957|449356715|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
124925298|NCT02985957|449356716|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
124925299|NCT02985957|449356717|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
124925300|NCT02985957|449356718|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
124925301|NCT02985957|449356719|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
124925302|NCT02985957|449356720|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
124925303|NCT02985957|449356721|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
124925304|NCT02985957|449356715|FG000|Treatment Period|Poor/Non-Compliance|0|||
124925305|NCT02985957|449356716|FG001|Treatment Period|Poor/Non-Compliance|0|||
124925306|NCT02985957|449356717|FG002|Treatment Period|Poor/Non-Compliance|0|||
124925307|NCT02985957|449356718|FG003|Treatment Period|Poor/Non-Compliance|0|||
124925308|NCT02985957|449356719|FG004|Treatment Period|Poor/Non-Compliance|1|||
124925309|NCT02985957|449356720|FG005|Treatment Period|Poor/Non-Compliance|1|||
125119373|NCT01656889|450059511|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
125119374|NCT01656889|450059510|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
125119375|NCT01656889|450059511|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
125119376|NCT00423800|450059512|FG000|Overall Study|Protocol Violation|0|||
125119377|NCT00423800|450059513|FG001|Overall Study|Protocol Violation|1|||
125119378|NCT00458302|450061184|FG000|Overall Study|Adverse Event|4|||
125119379|NCT00458302|450061185|FG001|Overall Study|Adverse Event|14|||
124925310|NCT02985957|449356721|FG006|Treatment Period|Poor/Non-Compliance|0|||
124925311|NCT02985957|449356715|FG000|Treatment Period|Continuing in Treatment Period|0|||
124925312|NCT02985957|449356716|FG001|Treatment Period|Continuing in Treatment Period|1|||
125119380|NCT00458302|450061184|FG000|Overall Study|Pregnancy|2|||
124969568|NCT03520075|449517424|FG015|Phase 2 (Dose Expansion)|Death|9|||
124969569|NCT03520075|449517425|FG016|Phase 2 (Dose Expansion)|Death|5|||
125212275|NCT01006590|450403309|FG001|Overall Study|Protocol Violation|0|||
125212276|NCT01006590|450403308|FG000|Overall Study|Withdrawal by Subject|4|||
124925313|NCT02985957|449356717|FG002|Treatment Period|Continuing in Treatment Period|0|||
124925314|NCT02985957|449356718|FG003|Treatment Period|Continuing in Treatment Period|4|||
124925315|NCT02985957|449356719|FG004|Treatment Period|Continuing in Treatment Period|4|||
124925316|NCT02985957|449356720|FG005|Treatment Period|Continuing in Treatment Period|0|||
124925317|NCT02985957|449356721|FG006|Treatment Period|Continuing in Treatment Period|0|||
124925318|NCT04802967|449356728|FG000|Part B|Withdrawal by Subject|0|||
124925319|NCT04802967|449356729|FG001|Part B|Withdrawal by Subject|0|||
125024023|NCT03529773|449711342|FG009|Overall Study|Physician Decision|0|||
124925320|NCT04802967|449356730|FG002|Part B|Withdrawal by Subject|0|||
124925321|NCT04802967|449356731|FG003|Part B|Withdrawal by Subject|0|||
124925322|NCT04802967|449356732|FG004|Part B|Withdrawal by Subject|0|||
124925323|NCT04802967|449356733|FG005|Part B|Withdrawal by Subject|1|||
124925324|NCT04802967|449356734|FG006|Part B|Withdrawal by Subject|0|||
124925325|NCT04802967|449356735|FG007|Part B|Withdrawal by Subject|0|||
124925326|NCT04802967|449356736|FG008|Part B|Withdrawal by Subject|0|||
124925327|NCT04802967|449356737|FG009|Part B|Withdrawal by Subject|0|||
124925328|NCT03945292|449356740|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
124925329|NCT03945292|449356741|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
124925330|NCT03945292|449356742|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
124925331|NCT03945292|449356743|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
124925332|NCT03945292|449356744|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
124925333|NCT03945292|449356745|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
124925334|NCT03945292|449356746|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
124925335|NCT03945292|449356747|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
124925336|NCT03945292|449356740|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
124925337|NCT03945292|449356741|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
124925338|NCT03945292|449356742|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
124925339|NCT03945292|449356743|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
124925340|NCT03945292|449356744|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
124925341|NCT03945292|449356745|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
124925342|NCT03945292|449356746|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
124925343|NCT03945292|449356747|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
124925344|NCT03945292|449356740|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
124925345|NCT03945292|449356741|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
124925346|NCT03945292|449356742|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
124925347|NCT03945292|449356743|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
124925348|NCT03945292|449356744|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
124925349|NCT03945292|449356745|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
124925350|NCT03945292|449356746|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
124925351|NCT03945292|449356747|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
124925352|NCT04295798|449356751|FG000|Overall Study|Lost to Follow-up|1|||
124925353|NCT03524118|449356756|FG000|Overall Study|Lost to Follow-up|0|||
124925354|NCT03524118|449356757|FG001|Overall Study|Lost to Follow-up|0|||
124925355|NCT03524118|449356758|FG002|Overall Study|Lost to Follow-up|0|||
124925356|NCT03524118|449356759|FG003|Overall Study|Lost to Follow-up|0|||
124925357|NCT03524118|449356760|FG004|Overall Study|Lost to Follow-up|1|||
124925358|NCT03524118|449356761|FG005|Overall Study|Lost to Follow-up|0|||
124925359|NCT03524118|449356756|FG000|Overall Study|Other|0|||
124925360|NCT03524118|449356757|FG001|Overall Study|Other|1|||
124925361|NCT03524118|449356758|FG002|Overall Study|Other|0|||
124925362|NCT03524118|449356759|FG003|Overall Study|Other|0|||
124925363|NCT03524118|449356760|FG004|Overall Study|Other|1|||
124925364|NCT03524118|449356761|FG005|Overall Study|Other|1|||
124925365|NCT03524118|449356756|FG000|Overall Study|Physician Decision|0|||
124925366|NCT03524118|449356757|FG001|Overall Study|Physician Decision|0|||
124925367|NCT03524118|449356758|FG002|Overall Study|Physician Decision|0|||
125024024|NCT03529773|449711343|FG010|Overall Study|Physician Decision|0|||
125024025|NCT03529773|449711344|FG011|Overall Study|Physician Decision|0|||
125024026|NCT03529773|449711345|FG012|Overall Study|Physician Decision|0|||
125024027|NCT03529773|449711346|FG013|Overall Study|Physician Decision|0|||
125024028|NCT03529773|449711347|FG014|Overall Study|Physician Decision|0|||
125024029|NCT03529773|449711348|FG015|Overall Study|Physician Decision|0|||
125024030|NCT03529773|449711349|FG016|Overall Study|Physician Decision|0|||
125024031|NCT03529773|449711350|FG017|Overall Study|Physician Decision|0|||
125024032|NCT03529773|449711351|FG018|Overall Study|Physician Decision|0|||
125024033|NCT03529773|449711352|FG019|Overall Study|Physician Decision|1|||
125024034|NCT03529773|449711353|FG020|Overall Study|Physician Decision|1|||
125024035|NCT03529773|449711354|FG021|Overall Study|Physician Decision|0|||
125024036|NCT03529773|449711355|FG022|Overall Study|Physician Decision|0|||
125024037|NCT03529773|449711356|FG023|Overall Study|Physician Decision|0|||
125024038|NCT03529773|449711357|FG024|Overall Study|Physician Decision|0|||
124925368|NCT03524118|449356759|FG003|Overall Study|Physician Decision|0|||
124925369|NCT03524118|449356760|FG004|Overall Study|Physician Decision|1|||
124925370|NCT03524118|449356761|FG005|Overall Study|Physician Decision|0|||
124925371|NCT03524118|449356756|FG000|Overall Study|Protocol Violation|0|||
124925372|NCT03524118|449356757|FG001|Overall Study|Protocol Violation|0|||
124925373|NCT03524118|449356758|FG002|Overall Study|Protocol Violation|1|||
124925374|NCT03524118|449356759|FG003|Overall Study|Protocol Violation|0|||
124925375|NCT03524118|449356760|FG004|Overall Study|Protocol Violation|1|||
124925376|NCT03524118|449356761|FG005|Overall Study|Protocol Violation|0|||
124925377|NCT03524118|449356756|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124925378|NCT03524118|449356757|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
124925379|NCT03524118|449356758|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
124925380|NCT03524118|449356759|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
124925381|NCT03524118|449356760|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
124925382|NCT03524118|449356761|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
124925383|NCT04650269|449356767|FG000|Overall Study|Death|3|||
124925384|NCT04650269|449356767|FG000|Overall Study|Lost to Follow-up|6|||
124925385|NCT04987320|449356768|FG000|Overall Study|Withdrawal by Subject|0|||
124925386|NCT04987320|449356769|FG001|Overall Study|Withdrawal by Subject|1|||
124925387|NCT01437709|449356770|FG000|Overall Study|Adverse Event|0|||
124925388|NCT01437709|449356771|FG001|Overall Study|Adverse Event|1|||
124925389|NCT01437709|449356772|FG002|Overall Study|Adverse Event|0|||
124925390|NCT01437709|449356770|FG000|Overall Study|Pt trasnferred care|0|||
124925391|NCT01437709|449356771|FG001|Overall Study|Pt trasnferred care|1|||
124925392|NCT01437709|449356772|FG002|Overall Study|Pt trasnferred care|0|||
124925393|NCT00085735|449356773|FG000|Overall Study|Adverse Event|1|||
124925394|NCT00085735|449356774|FG001|Overall Study|Adverse Event|0|||
124925395|NCT00085735|449356775|FG002|Overall Study|Adverse Event|0|||
124925396|NCT00085735|449356776|FG003|Overall Study|Adverse Event|0|||
124925397|NCT00085735|449356777|FG004|Overall Study|Adverse Event|0|||
124925398|NCT00085735|449356778|FG005|Overall Study|Adverse Event|0|||
124925399|NCT00085735|449356773|FG000|Overall Study|Lack of Efficacy|2|||
124925400|NCT00085735|449356774|FG001|Overall Study|Lack of Efficacy|4|||
124925401|NCT00085735|449356775|FG002|Overall Study|Lack of Efficacy|6|||
124925402|NCT00085735|449356776|FG003|Overall Study|Lack of Efficacy|3|||
124925403|NCT00085735|449356777|FG004|Overall Study|Lack of Efficacy|4|||
124925404|NCT00085735|449356778|FG005|Overall Study|Lack of Efficacy|3|||
124925405|NCT00085735|449356773|FG000|Overall Study|Lost to Follow-up|0|||
124925406|NCT00085735|449356774|FG001|Overall Study|Lost to Follow-up|1|||
124925407|NCT00085735|449356775|FG002|Overall Study|Lost to Follow-up|0|||
124925408|NCT00085735|449356776|FG003|Overall Study|Lost to Follow-up|0|||
124925409|NCT00085735|449356777|FG004|Overall Study|Lost to Follow-up|1|||
124925410|NCT00085735|449356778|FG005|Overall Study|Lost to Follow-up|0|||
124925411|NCT00085735|449356773|FG000|Overall Study|Physician Decision|2|||
124925412|NCT00085735|449356774|FG001|Overall Study|Physician Decision|3|||
124925413|NCT00085735|449356775|FG002|Overall Study|Physician Decision|2|||
124925414|NCT00085735|449356776|FG003|Overall Study|Physician Decision|3|||
124925415|NCT00085735|449356777|FG004|Overall Study|Physician Decision|11|||
124925416|NCT00085735|449356778|FG005|Overall Study|Physician Decision|8|||
124925417|NCT00085735|449356773|FG000|Overall Study|Protocol Violation|1|||
124925418|NCT00085735|449356774|FG001|Overall Study|Protocol Violation|0|||
124925419|NCT00085735|449356775|FG002|Overall Study|Protocol Violation|0|||
124925420|NCT00085735|449356776|FG003|Overall Study|Protocol Violation|0|||
124925421|NCT00085735|449356777|FG004|Overall Study|Protocol Violation|0|||
124925422|NCT00085735|449356778|FG005|Overall Study|Protocol Violation|0|||
124925423|NCT00085735|449356773|FG000|Overall Study|Withdrawal by Subject|1|||
124925424|NCT00085735|449356774|FG001|Overall Study|Withdrawal by Subject|0|||
124925425|NCT00085735|449356775|FG002|Overall Study|Withdrawal by Subject|4|||
124925426|NCT00085735|449356776|FG003|Overall Study|Withdrawal by Subject|5|||
124925427|NCT00085735|449356777|FG004|Overall Study|Withdrawal by Subject|7|||
125024039|NCT03529773|449711358|FG025|Overall Study|Physician Decision|0|||
124925428|NCT00085735|449356778|FG005|Overall Study|Withdrawal by Subject|8|||
124925429|NCT00085735|449356773|FG000|Overall Study|Patient ineligible|1|||
124925430|NCT00085735|449356774|FG001|Overall Study|Patient ineligible|0|||
124925431|NCT00085735|449356775|FG002|Overall Study|Patient ineligible|3|||
124925432|NCT00085735|449356776|FG003|Overall Study|Patient ineligible|7|||
124925433|NCT00085735|449356777|FG004|Overall Study|Patient ineligible|17|||
124925434|NCT00085735|449356778|FG005|Overall Study|Patient ineligible|8|||
124925435|NCT00085735|449356773|FG000|Overall Study|Excess residual disease|2|||
124925436|NCT00085735|449356774|FG001|Overall Study|Excess residual disease|2|||
124925437|NCT00085735|449356775|FG002|Overall Study|Excess residual disease|1|||
124925438|NCT00085735|449356776|FG003|Overall Study|Excess residual disease|1|||
124925439|NCT00085735|449356777|FG004|Overall Study|Excess residual disease|1|||
124925440|NCT00085735|449356778|FG005|Overall Study|Excess residual disease|4|||
124925441|NCT00085735|449356773|FG000|Overall Study|Reason not documented|1|||
124925442|NCT00085735|449356774|FG001|Overall Study|Reason not documented|0|||
124925443|NCT00085735|449356775|FG002|Overall Study|Reason not documented|1|||
124925444|NCT00085735|449356776|FG003|Overall Study|Reason not documented|0|||
124925445|NCT00085735|449356777|FG004|Overall Study|Reason not documented|1|||
124925446|NCT00085735|449356778|FG005|Overall Study|Reason not documented|0|||
124925447|NCT00085735|449356773|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
124925448|NCT00085735|449356774|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
124925449|NCT00085735|449356775|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
124925450|NCT00085735|449356776|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
124925451|NCT00085735|449356777|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
124925452|NCT00085735|449356778|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
124925453|NCT01824875|449356779|FG000|Overall Study|Disease progression|22|||
124925454|NCT01824875|449356780|FG001|Overall Study|Disease progression|15|||
124925455|NCT01824875|449356779|FG000|Overall Study|Withdrawal by Subject|5|||
124925456|NCT01824875|449356780|FG001|Overall Study|Withdrawal by Subject|4|||
124925457|NCT01824875|449356779|FG000|Overall Study|Adverse Event|4|||
124925458|NCT01824875|449356780|FG001|Overall Study|Adverse Event|10|||
124925459|NCT01824875|449356779|FG000|Overall Study|Alternative therapy|3|||
124925460|NCT01824875|449356780|FG001|Overall Study|Alternative therapy|0|||
124925461|NCT01824875|449356779|FG000|Overall Study|Complicating disease|1|||
124925462|NCT01824875|449356780|FG001|Overall Study|Complicating disease|0|||
124925463|NCT01824875|449356779|FG000|Overall Study|Physician Decision|0|||
124925464|NCT01824875|449356780|FG001|Overall Study|Physician Decision|1|||
124925465|NCT01824875|449356779|FG000|Overall Study|Non-compliance|1|||
124925466|NCT01824875|449356780|FG001|Overall Study|Non-compliance|1|||
124925467|NCT01824875|449356779|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
124925468|NCT01824875|449356780|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
124925469|NCT01824875|449356779|FG000|Overall Study|Administrative issues|0|||
124925470|NCT01824875|449356780|FG001|Overall Study|Administrative issues|2|||
124925471|NCT01824875|449356779|FG000|Overall Study|Ineligible or never started treatment|9|||
124925472|NCT01824875|449356780|FG001|Overall Study|Ineligible or never started treatment|5|||
124925473|NCT01824875|449356779|FG000|Overall Study|Other|0|||
124925474|NCT01824875|449356780|FG001|Overall Study|Other|2|||
124925475|NCT00433329|449356783|FG000|Overall Study|Adverse Event|9|||
124925476|NCT00433329|449356783|FG000|Overall Study|Death|4|||
124925477|NCT00433329|449356783|FG000|Overall Study|Withdrew consent|3|||
124925478|NCT00433329|449356783|FG000|Overall Study|Discontinued sildenafil|2|||
124925479|NCT00433329|449356783|FG000|Overall Study|Moved out of state|1|||
124925480|NCT00433329|449356783|FG000|Overall Study|Lost to Follow-up|1|||
124925481|NCT00433329|449356783|FG000|Overall Study|Physician Decision|1|||
124925482|NCT01098812|449356784|FG000|Overall Study|Death|2|||
124925483|NCT01098812|449356785|FG001|Overall Study|Death|0|||
124925484|NCT01098812|449356786|FG002|Overall Study|Death|1|||
124925485|NCT01098812|449356784|FG000|Overall Study|Lost to Follow-up|0|||
124925486|NCT01098812|449356785|FG001|Overall Study|Lost to Follow-up|1|||
124925487|NCT01098812|449356786|FG002|Overall Study|Lost to Follow-up|0|||
124925488|NCT01129102|449356787|FG000|Overall Study|No study drug treatment|2|||
124925489|NCT01129102|449356788|FG001|Overall Study|No study drug treatment|3|||
124925490|NCT01129102|449356789|FG002|Overall Study|No study drug treatment|1|||
124925491|NCT01129102|449356787|FG000|Overall Study|Withdrawal by Subject|2|||
124925492|NCT01129102|449356788|FG001|Overall Study|Withdrawal by Subject|0|||
124925493|NCT01129102|449356789|FG002|Overall Study|Withdrawal by Subject|3|||
124925494|NCT01129102|449356787|FG000|Overall Study|Protocol Violation|0|||
124925495|NCT01129102|449356788|FG001|Overall Study|Protocol Violation|1|||
124925496|NCT01129102|449356789|FG002|Overall Study|Protocol Violation|1|||
124925497|NCT01129102|449356787|FG000|Overall Study|Pregnancy|0|||
124925498|NCT01129102|449356788|FG001|Overall Study|Pregnancy|0|||
124925499|NCT01129102|449356789|FG002|Overall Study|Pregnancy|1|||
124925500|NCT01129102|449356787|FG000|Overall Study|Adverse Event|2|||
124925501|NCT01129102|449356788|FG001|Overall Study|Adverse Event|2|||
124925502|NCT01129102|449356789|FG002|Overall Study|Adverse Event|1|||
125024040|NCT03529773|449711359|FG026|Overall Study|Physician Decision|0|||
124925503|NCT01129102|449356787|FG000|Overall Study|Lost to Follow-up|2|||
124925504|NCT01129102|449356788|FG001|Overall Study|Lost to Follow-up|0|||
124925505|NCT01129102|449356789|FG002|Overall Study|Lost to Follow-up|0|||
124925506|NCT01715285|449356790|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
124925507|NCT01715285|449356791|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
124925508|NCT01715285|449356792|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
124925509|NCT01715285|449356790|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
124925510|NCT01715285|449356791|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
124925511|NCT01715285|449356792|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
124925512|NCT01715285|449356790|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
125024041|NCT03529773|449711360|FG027|Overall Study|Physician Decision|0|||
124925513|NCT01715285|449356791|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
124925514|NCT01715285|449356792|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
124925515|NCT01715285|449356790|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
124925516|NCT01715285|449356791|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
124925517|NCT01715285|449356792|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
124925518|NCT01715285|449356790|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
124925519|NCT01715285|449356791|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
124925520|NCT01715285|449356792|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
124925521|NCT01715285|449356790|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
124925522|NCT01715285|449356791|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
124925523|NCT01715285|449356792|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
124925524|NCT01715285|449356790|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
124925525|NCT01715285|449356791|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
124925526|NCT01715285|449356792|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
124925527|NCT01715285|449356790|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
124925528|NCT01715285|449356791|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
124925529|NCT01715285|449356792|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
124925530|NCT01715285|449356790|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
124925531|NCT01715285|449356791|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
124925532|NCT01715285|449356792|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
124925533|NCT01715285|449356790|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
124925534|NCT01715285|449356791|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
124925535|NCT01715285|449356792|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
124925536|NCT01715285|449356790|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
124925537|NCT01715285|449356791|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
124925538|NCT01715285|449356792|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
124925539|NCT01715285|449356790|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
124925540|NCT01715285|449356791|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
124925541|NCT01715285|449356792|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
124925542|NCT01715285|449356790|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
124925543|NCT01715285|449356791|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
124925544|NCT01715285|449356792|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
124925545|NCT01715285|449356790|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
124925546|NCT01715285|449356791|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
124925547|NCT01715285|449356792|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
124925548|NCT02598388|449356793|FG000|Overall Study|Lost to Follow-up|1|||
124925549|NCT02598388|449356794|FG001|Overall Study|Lost to Follow-up|0|||
124925550|NCT02598388|449356795|FG002|Overall Study|Lost to Follow-up|1|||
124925551|NCT02598388|449356796|FG003|Overall Study|Lost to Follow-up|0|||
124925552|NCT02598388|449356797|FG004|Overall Study|Lost to Follow-up|5|||
124925553|NCT02598388|449356798|FG005|Overall Study|Lost to Follow-up|1|||
124925554|NCT02598388|449356799|FG006|Overall Study|Lost to Follow-up|2|||
124925555|NCT02598388|449356800|FG007|Overall Study|Lost to Follow-up|1|||
124925556|NCT02598388|449356801|FG008|Overall Study|Lost to Follow-up|0|||
124925557|NCT02598388|449356802|FG009|Overall Study|Lost to Follow-up|0|||
124925558|NCT02598388|449356803|FG010|Overall Study|Lost to Follow-up|1|||
124925559|NCT02598388|449356804|FG011|Overall Study|Lost to Follow-up|0|||
124925560|NCT02598388|449356793|FG000|Overall Study|Withdrawal by Subject|0|||
124925561|NCT02598388|449356794|FG001|Overall Study|Withdrawal by Subject|0|||
124925562|NCT02598388|449356795|FG002|Overall Study|Withdrawal by Subject|0|||
124925563|NCT02598388|449356796|FG003|Overall Study|Withdrawal by Subject|0|||
124925564|NCT02598388|449356797|FG004|Overall Study|Withdrawal by Subject|2|||
124925565|NCT02598388|449356798|FG005|Overall Study|Withdrawal by Subject|0|||
124925566|NCT02598388|449356799|FG006|Overall Study|Withdrawal by Subject|2|||
124925567|NCT02598388|449356800|FG007|Overall Study|Withdrawal by Subject|0|||
124925568|NCT02598388|449356801|FG008|Overall Study|Withdrawal by Subject|0|||
124925569|NCT02598388|449356802|FG009|Overall Study|Withdrawal by Subject|1|||
124925570|NCT02598388|449356803|FG010|Overall Study|Withdrawal by Subject|0|||
125119381|NCT00458302|450061185|FG001|Overall Study|Pregnancy|1|||
124925571|NCT02598388|449356804|FG011|Overall Study|Withdrawal by Subject|0|||
124925572|NCT02598388|449356793|FG000|Overall Study|Other|0|||
124925573|NCT02598388|449356794|FG001|Overall Study|Other|0|||
124925574|NCT02598388|449356795|FG002|Overall Study|Other|1|||
124925575|NCT02598388|449356796|FG003|Overall Study|Other|0|||
124925576|NCT02598388|449356797|FG004|Overall Study|Other|3|||
124925577|NCT02598388|449356798|FG005|Overall Study|Other|0|||
124925578|NCT02598388|449356799|FG006|Overall Study|Other|1|||
124925579|NCT02598388|449356800|FG007|Overall Study|Other|0|||
124925580|NCT02598388|449356801|FG008|Overall Study|Other|0|||
125119382|NCT00458302|450061184|FG000|Overall Study|Protocol Violation|0|||
125119383|NCT00458302|450061185|FG001|Overall Study|Protocol Violation|2|||
125119384|NCT00458302|450061184|FG000|Overall Study|Withdrawal by Subject|6|||
124925581|NCT02598388|449356802|FG009|Overall Study|Other|0|||
124925582|NCT02598388|449356803|FG010|Overall Study|Other|0|||
124925583|NCT02598388|449356804|FG011|Overall Study|Other|0|||
124925584|NCT05020249|449356805|FG000|Overall Study|Protocol Violation|1|||
124925585|NCT05020249|449356806|FG001|Overall Study|Protocol Violation|0|||
124925586|NCT03628924|449356808|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
124925587|NCT03628924|449356809|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
125119385|NCT00458302|450061185|FG001|Overall Study|Withdrawal by Subject|4|||
124925588|NCT03628924|449356810|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
124925589|NCT03628924|449356811|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
124925590|NCT03628924|449356812|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
124925591|NCT03628924|449356813|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
124925592|NCT03628924|449356814|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
124925593|NCT03628924|449356808|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
124925594|NCT03628924|449356809|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
124925595|NCT03628924|449356810|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
124925596|NCT03628924|449356811|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
124925597|NCT03628924|449356812|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
124925598|NCT03628924|449356813|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
124925599|NCT03628924|449356814|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
124925600|NCT03628924|449356808|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
124925601|NCT03628924|449356809|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
124925602|NCT03628924|449356810|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
124925603|NCT03628924|449356811|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
124925604|NCT03628924|449356812|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
124925605|NCT03628924|449356813|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
125024042|NCT03529773|449711361|FG028|Overall Study|Physician Decision|0|||
125024043|NCT03529773|449711362|FG029|Overall Study|Physician Decision|0|||
125024044|NCT03529773|449711363|FG030|Overall Study|Physician Decision|0|||
125024045|NCT03529773|449711364|FG031|Overall Study|Physician Decision|0|||
125024046|NCT03529773|449711365|FG032|Overall Study|Physician Decision|0|||
125024047|NCT03529773|449711366|FG033|Overall Study|Physician Decision|0|||
125024048|NCT03529773|449711367|FG034|Overall Study|Physician Decision|0|||
125024049|NCT03529773|449711368|FG035|Overall Study|Physician Decision|0|||
125024050|NCT03529773|449711369|FG036|Overall Study|Physician Decision|0|||
125024051|NCT03529773|449711370|FG037|Overall Study|Physician Decision|0|||
125024052|NCT03529773|449711371|FG038|Overall Study|Physician Decision|0|||
125024053|NCT03529773|449711372|FG039|Overall Study|Physician Decision|0|||
125024054|NCT03529773|449711333|FG000|Overall Study|Protocol Violation|0|||
125024055|NCT03529773|449711334|FG001|Overall Study|Protocol Violation|0|||
125024056|NCT03529773|449711335|FG002|Overall Study|Protocol Violation|0|||
125024057|NCT03529773|449711336|FG003|Overall Study|Protocol Violation|0|||
125024058|NCT03529773|449711337|FG004|Overall Study|Protocol Violation|0|||
125024059|NCT03529773|449711338|FG005|Overall Study|Protocol Violation|0|||
125024060|NCT03529773|449711339|FG006|Overall Study|Protocol Violation|0|||
125024061|NCT03529773|449711340|FG007|Overall Study|Protocol Violation|0|||
124925606|NCT03628924|449356814|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
124925607|NCT03628924|449356808|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
124925608|NCT03628924|449356809|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
124925609|NCT03628924|449356810|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
124925610|NCT03628924|449356811|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
124925611|NCT03628924|449356812|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
124925612|NCT03628924|449356813|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
124925613|NCT03628924|449356814|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
124925614|NCT03628924|449356808|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
124925615|NCT03628924|449356809|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
124925616|NCT03628924|449356810|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
124925617|NCT03628924|449356811|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
124925618|NCT03628924|449356812|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
124925619|NCT03628924|449356813|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
124925620|NCT03628924|449356814|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
124925621|NCT03628924|449356808|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
124925622|NCT03628924|449356809|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
124925623|NCT03628924|449356810|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
124925624|NCT03628924|449356811|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
124925625|NCT03628924|449356812|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
124925626|NCT03628924|449356813|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
124925627|NCT03628924|449356814|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
124925628|NCT03628924|449356808|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
124925629|NCT03628924|449356809|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
124925630|NCT03628924|449356810|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
124925631|NCT03628924|449356811|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
124925632|NCT03628924|449356812|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
124925633|NCT03628924|449356813|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
124925634|NCT03628924|449356814|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
124925635|NCT03628924|449356808|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
124925636|NCT03628924|449356809|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
124925637|NCT03628924|449356810|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
124925638|NCT03628924|449356811|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
124925639|NCT03628924|449356812|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
124925640|NCT03628924|449356813|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
124925641|NCT03628924|449356814|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
124925642|NCT03628924|449356808|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
124925643|NCT03628924|449356809|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
124925644|NCT03628924|449356810|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
124925645|NCT03628924|449356811|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
124925646|NCT03628924|449356812|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
124925647|NCT03628924|449356813|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
124925648|NCT03628924|449356814|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
124925649|NCT03628924|449356808|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
124925650|NCT03628924|449356809|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
124925651|NCT03628924|449356810|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
124925652|NCT03628924|449356811|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
124925653|NCT03628924|449356812|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
124925654|NCT03628924|449356813|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
124925655|NCT03628924|449356814|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
124925656|NCT03474679|449356821|FG000|Overall Study|Death|7|||
124925657|NCT03474679|449356821|FG000|Overall Study|Withdrawal by Subject|1|||
124925658|NCT04971681|449356830|FG000|Followup|Lost to Follow-up|1|||
124925659|NCT04971681|449356831|FG001|Followup|Lost to Follow-up|0|||
124925660|NCT00686335|449356832|FG000|Run-in Period|Adverse Event|1|||
124925661|NCT00686335|449356832|FG000|Run-in Period|asthma exacerbation|1|||
124925662|NCT00686335|449356832|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
124925663|NCT04332926|449356833|FG000|Overall Study|Withdrawal by Subject|6|||
124925664|NCT04332926|449356833|FG000|Overall Study|Physician Decision|6|||
124925665|NCT04350463|449356840|FG000|Overall Study|Other reason|0|||
124925666|NCT04350463|449356841|FG001|Overall Study|Other reason|0|||
124925667|NCT04350463|449356842|FG002|Overall Study|Other reason|0|||
124925668|NCT04350463|449356843|FG003|Overall Study|Other reason|1|||
124925669|NCT04350463|449356840|FG000|Overall Study|Lost to Follow-up|0|||
124925670|NCT04350463|449356841|FG001|Overall Study|Lost to Follow-up|0|||
124925671|NCT04350463|449356842|FG002|Overall Study|Lost to Follow-up|0|||
124925672|NCT04350463|449356843|FG003|Overall Study|Lost to Follow-up|2|||
124925673|NCT04350463|449356840|FG000|Overall Study|Withdrawal by Subject|4|||
124925674|NCT04350463|449356841|FG001|Overall Study|Withdrawal by Subject|0|||
124925675|NCT04350463|449356842|FG002|Overall Study|Withdrawal by Subject|1|||
124925676|NCT04350463|449356843|FG003|Overall Study|Withdrawal by Subject|4|||
124925677|NCT04350463|449356840|FG000|Overall Study|Adverse Event|0|||
124925678|NCT04350463|449356841|FG001|Overall Study|Adverse Event|0|||
124925679|NCT04350463|449356842|FG002|Overall Study|Adverse Event|0|||
124925680|NCT04350463|449356843|FG003|Overall Study|Adverse Event|2|||
124925681|NCT04350463|449356840|FG000|Overall Study|Death|27|||
124925682|NCT04350463|449356841|FG001|Overall Study|Death|2|||
124925683|NCT04350463|449356842|FG002|Overall Study|Death|13|||
124925684|NCT04350463|449356843|FG003|Overall Study|Death|26|||
124925685|NCT04111536|449356844|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
124925686|NCT04111536|449356845|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
124925687|NCT04111536|449356844|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
124925688|NCT04111536|449356845|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
124925689|NCT04111536|449356844|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
124925690|NCT04111536|449356845|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
124925691|NCT04111536|449356844|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
124925692|NCT04111536|449356845|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
124925693|NCT05672069|449356847|FG000|Overall Study|Implant removal|1|||
124925694|NCT05672069|449356847|FG000|Overall Study|Lost to Follow-up|2|||
124925695|NCT06019559|449356848|FG000|Overall Study|Withdrawal by Subject|7|||
124925696|NCT06019559|449356849|FG001|Overall Study|Withdrawal by Subject|6|||
124925697|NCT06019559|449356850|FG002|Overall Study|Withdrawal by Subject|5|||
124925698|NCT06019559|449356848|FG000|Overall Study|Lost to Follow-up|2|||
124925699|NCT06019559|449356849|FG001|Overall Study|Lost to Follow-up|0|||
124925700|NCT06019559|449356850|FG002|Overall Study|Lost to Follow-up|3|||
124925701|NCT05949788|449356851|FG000|Overall Study|severe birth deformity|2|||
124925702|NCT05949788|449356852|FG001|Overall Study|severe birth deformity|7|||
124925703|NCT05949788|449356851|FG000|Overall Study|twin-twin transfusion syndrome|2|||
124925704|NCT05949788|449356852|FG001|Overall Study|twin-twin transfusion syndrome|7|||
124925705|NCT05949788|449356851|FG000|Overall Study|neonatal hemolytic disease|3|||
124925706|NCT05949788|449356852|FG001|Overall Study|neonatal hemolytic disease|8|||
124925707|NCT05949788|449356851|FG000|Overall Study|death within 14 days after birth|2|||
124925708|NCT05949788|449356852|FG001|Overall Study|death within 14 days after birth|6|||
124925709|NCT05949788|449356851|FG000|Overall Study|transfer to another hospital|2|||
124925710|NCT05949788|449356852|FG001|Overall Study|transfer to another hospital|6|||
124925711|NCT05213390|449356853|FG000|Overall Study|Withdrawal by Subject|2|||
124925712|NCT05213390|449356853|FG000|Overall Study|Lost to Follow-up|12|||
124925713|NCT05213390|449356853|FG000|Overall Study|Protocol Violation|9|||
124925714|NCT01824537|449356854|FG000|Overall Study|Lost to Follow-up|78|||
124925715|NCT01824537|449356855|FG001|Overall Study|Lost to Follow-up|87|||
124925716|NCT03858634|449356856|FG000|Overall Study|Withdrawal by Subject|1|||
124925717|NCT03858634|449356857|FG001|Overall Study|Withdrawal by Subject|0|||
124925718|NCT03858634|449356856|FG000|Overall Study|Adverse Event|1|||
124925719|NCT03858634|449356857|FG001|Overall Study|Adverse Event|0|||
124925720|NCT03858634|449356856|FG000|Overall Study|Lost to Follow-up|0|||
124925721|NCT03858634|449356857|FG001|Overall Study|Lost to Follow-up|1|||
124925722|NCT03858634|449356856|FG000|Overall Study|Other, Not Specified|1|||
124925723|NCT03858634|449356857|FG001|Overall Study|Other, Not Specified|1|||
124925724|NCT04676763|449356858|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
124925725|NCT04676763|449356859|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
124925726|NCT04676763|449356860|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
124925727|NCT04676763|449356858|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
124925728|NCT04676763|449356859|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
124925729|NCT04676763|449356860|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
124925730|NCT04676763|449356858|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
124925731|NCT04676763|449356859|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
124925732|NCT04676763|449356860|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
124925733|NCT04623671|449356864|FG000|Overall Study|Adverse Event|0|||
124925734|NCT04623671|449356865|FG001|Overall Study|Adverse Event|1|||
124925735|NCT04623671|449356864|FG000|Overall Study|Lost to Follow-up|2|||
124925736|NCT04623671|449356865|FG001|Overall Study|Lost to Follow-up|1|||
124925737|NCT04623671|449356864|FG000|Overall Study|Death|5|||
124925738|NCT04623671|449356865|FG001|Overall Study|Death|5|||
124925739|NCT04663737|449356866|FG000|Overall Study|Withdrawal by Subject|2|||
124925740|NCT04663737|449356867|FG001|Overall Study|Withdrawal by Subject|0|||
124925741|NCT01943409|449356871|FG000|Overall Study|resumed oral/entral|24|||
124925742|NCT01943409|449356872|FG001|Overall Study|resumed oral/entral|20|||
124925743|NCT01943409|449356871|FG000|Overall Study|Protocol Violation|14|||
124925744|NCT01943409|449356872|FG001|Overall Study|Protocol Violation|24|||
124925745|NCT01943409|449356871|FG000|Overall Study|Death|3|||
124925746|NCT01943409|449356872|FG001|Overall Study|Death|1|||
124925747|NCT01943409|449356871|FG000|Overall Study|Withdrawal by Subject|4|||
124925748|NCT01943409|449356872|FG001|Overall Study|Withdrawal by Subject|3|||
124925749|NCT03848065|449356873|FG000|Overall Study|Death|0|||
124925750|NCT03848065|449356874|FG001|Overall Study|Death|1|||
124925751|NCT03848065|449356875|FG002|Overall Study|Death|0|||
124925752|NCT03848065|449356873|FG000|Overall Study|Lost to Follow-up|0|||
124925753|NCT03848065|449356874|FG001|Overall Study|Lost to Follow-up|0|||
124925754|NCT03848065|449356875|FG002|Overall Study|Lost to Follow-up|1|||
124925755|NCT03848065|449356873|FG000|Overall Study|Physician Decision|0|||
124925756|NCT03848065|449356874|FG001|Overall Study|Physician Decision|0|||
124925757|NCT03848065|449356875|FG002|Overall Study|Physician Decision|1|||
124925758|NCT03496168|449356882|FG000|Overall Study|Other Reasons|1|||
124925759|NCT03496168|449356882|FG000|Overall Study|Adverse Event|1|||
124925760|NCT04137367|449356883|FG000|Overall Study|Lost to Follow-up|8|||
124925761|NCT04137367|449356884|FG001|Overall Study|Lost to Follow-up|6|||
124925762|NCT04137367|449356885|FG002|Overall Study|Lost to Follow-up|4|||
124925763|NCT03907878|449356886|FG000|Treatment Period|Withdrawal by Subject|5|||
124925764|NCT03907878|449356886|FG000|Treatment Period|Adverse Event|4|||
124925765|NCT03907878|449356886|FG000|Treatment Period|Lack of Efficacy|1|||
124925766|NCT03907878|449356886|FG000|Treatment Period|Protocol Violation|1|||
124925767|NCT03907878|449356886|FG000|Follow-up Period|Adverse Event|3|||
124925768|NCT03907878|449356886|FG000|Follow-up Period|Withdrawal by Subject|3|||
124925769|NCT05144009|449356887|FG000|Overall Study|Lost to Follow-up|0|||
124925770|NCT05144009|449356888|FG001|Overall Study|Lost to Follow-up|1|||
124925771|NCT05144009|449356887|FG000|Overall Study|Study Termination by the Sponsor|11|||
124925772|NCT05144009|449356888|FG001|Overall Study|Study Termination by the Sponsor|11|||
125119386|NCT00458302|450061184|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
125119387|NCT00458302|450061185|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
125119388|NCT00458302|450061184|FG000|Overall Study|Study Termination By Sponsor|1|||
125119389|NCT00458302|450061185|FG001|Overall Study|Study Termination By Sponsor|0|||
125119390|NCT00458302|450061184|FG000|Overall Study|Lost to Follow-up|2|||
125119391|NCT00458302|450061185|FG001|Overall Study|Lost to Follow-up|0|||
124925773|NCT05144009|449356887|FG000|Overall Study|Disease Progression|1|||
124925774|NCT05144009|449356888|FG001|Overall Study|Disease Progression|0|||
124925775|NCT05144009|449356887|FG000|Overall Study|Participant Decision|0|||
124925776|NCT05144009|449356888|FG001|Overall Study|Participant Decision|2|||
124925777|NCT05144009|449356887|FG000|Overall Study|Death|5|||
124925778|NCT05144009|449356888|FG001|Overall Study|Death|10|||
124925779|NCT04499924|449356889|FG000|Overall Study|Study termination by sponsor|4|||
124925780|NCT04499924|449356890|FG001|Overall Study|Study termination by sponsor|6|||
124925781|NCT04499924|449356889|FG000|Overall Study|Withdrawal by Subject|1|||
124925782|NCT04499924|449356890|FG001|Overall Study|Withdrawal by Subject|3|||
124925783|NCT01648023|449356891|FG000|Overall Study|Screen Fail Post Randomization|1|||
124925784|NCT01648023|449356892|FG001|Overall Study|Screen Fail Post Randomization|2|||
124925785|NCT03379675|449358950|FG000|Overall Study|Lost to Follow-up|0|||
124925786|NCT03379675|449358951|FG001|Overall Study|Lost to Follow-up|1|||
124925787|NCT03379675|449358952|FG002|Overall Study|Lost to Follow-up|0|||
124925788|NCT03379675|449358950|FG000|Overall Study|Adverse Event|2|||
124925789|NCT03379675|449358951|FG001|Overall Study|Adverse Event|0|||
124925790|NCT03379675|449358952|FG002|Overall Study|Adverse Event|0|||
124925791|NCT03379675|449358950|FG000|Overall Study|Withdrawal by Subject|2|||
124925792|NCT03379675|449358951|FG001|Overall Study|Withdrawal by Subject|1|||
124925793|NCT03379675|449358952|FG002|Overall Study|Withdrawal by Subject|2|||
124925794|NCT03462030|449358955|FG000|Overall Study|Withdrawal by Subject|1|||
125119392|NCT00458302|450061184|FG000|Overall Study|Other|4|||
125119393|NCT00458302|450061185|FG001|Overall Study|Other|2|||
125119394|NCT02178709|450061186|FG000|Overall Study|Adverse Event|5|||
125119395|NCT02178709|450061186|FG000|Overall Study|Death|2|||
125119396|NCT02178709|450061186|FG000|Overall Study|Withdrawal by Subject|2|||
125119397|NCT02178709|450061186|FG000|Overall Study|Physician Decision|2|||
125119398|NCT02178709|450061186|FG000|Overall Study|Disease Progression|5|||
125119399|NCT01241461|450061187|FG000|Overall Study|Progressive Disease|3|||
125119400|NCT01241461|450061188|FG001|Overall Study|Progressive Disease|6|||
125119401|NCT01379781|450061192|FG000|Overall Study|Lost to Follow-up|11|||
125119402|NCT01379781|450061193|FG001|Overall Study|Lost to Follow-up|8|||
125119403|NCT03329027|450061196|FG000|Overall Study|Lost to Follow-up|1|||
125119404|NCT03329027|450061197|FG001|Overall Study|Lost to Follow-up|0|||
125119405|NCT03329027|450061198|FG002|Overall Study|Lost to Follow-up|1|||
125119406|NCT03329027|450061196|FG000|Overall Study|Protocol Violation|9|||
125119407|NCT03329027|450061197|FG001|Overall Study|Protocol Violation|5|||
125119408|NCT03329027|450061198|FG002|Overall Study|Protocol Violation|7|||
125119409|NCT04849988|450061201|FG000|Overall Study|Lack of Efficacy|3|||
125119410|NCT04849988|450061202|FG001|Overall Study|Lack of Efficacy|4|||
125119411|NCT04849988|450061203|FG002|Overall Study|Lack of Efficacy|1|||
125119412|NCT04849988|450061204|FG003|Overall Study|Lack of Efficacy|4|||
125212277|NCT01006590|450403309|FG001|Overall Study|Withdrawal by Subject|2|||
124925795|NCT03462030|449358956|FG001|Overall Study|Withdrawal by Subject|1|||
124925796|NCT03381196|449358957|FG000|Overall Study|Withdrawal by Subject|7|||
124925797|NCT03381196|449358958|FG001|Overall Study|Withdrawal by Subject|7|||
124925798|NCT03381196|449358957|FG000|Overall Study|Other|0|||
124925799|NCT03381196|449358958|FG001|Overall Study|Other|1|||
124925800|NCT03381196|449358957|FG000|Overall Study|Lost to Follow-up|5|||
124925801|NCT03381196|449358958|FG001|Overall Study|Lost to Follow-up|4|||
124925802|NCT03381196|449358957|FG000|Overall Study|Death|0|||
124925803|NCT03381196|449358958|FG001|Overall Study|Death|1|||
124925804|NCT03381196|449358957|FG000|Overall Study|Adverse Event|1|||
124925805|NCT03381196|449358958|FG001|Overall Study|Adverse Event|0|||
124925806|NCT03381196|449358957|FG000|Overall Study|Randomized, not treated|3|||
124925807|NCT03381196|449358958|FG001|Overall Study|Randomized, not treated|6|||
124925808|NCT02675751|449358959|FG000|Overall Study|Lost to Follow-up|16|||
124925809|NCT03371381|449358960|FG000|Overall Study|Death|5|||
124925810|NCT03371381|449358960|FG000|Overall Study|Study terminated by sponsor|3|||
124925811|NCT03371381|449358960|FG000|Overall Study|Other|4|||
124925812|NCT02979327|449358961|FG000|First Intervention|Protocol Violation|1|||
124925813|NCT02979327|449358962|FG001|First Intervention|Protocol Violation|0|||
124925814|NCT01539083|449358970|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
124925815|NCT01539083|449358971|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
124925816|NCT01539083|449358972|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
124925817|NCT01539083|449358970|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
124925818|NCT01539083|449358971|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
124925819|NCT01539083|449358972|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
124925820|NCT01539083|449358970|FG000|Before Randomization (VCD Induction)|Death|6|||
124925821|NCT01539083|449358971|FG001|Before Randomization (VCD Induction)|Death|0|||
124925822|NCT01539083|449358972|FG002|Before Randomization (VCD Induction)|Death|0|||
124925823|NCT01539083|449358970|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
124925824|NCT01539083|449358971|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
124925825|NCT01539083|449358972|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
124925826|NCT01539083|449358970|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
124925827|NCT01539083|449358971|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
124925828|NCT01539083|449358972|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
124925829|NCT01539083|449358970|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
124925830|NCT01539083|449358971|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
124925831|NCT01539083|449358972|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
124925832|NCT01539083|449358970|FG000|Before Randomization (VCD Induction)|Other|5|||
124925833|NCT01539083|449358971|FG001|Before Randomization (VCD Induction)|Other|0|||
124925834|NCT01539083|449358972|FG002|Before Randomization (VCD Induction)|Other|0|||
124925835|NCT01539083|449358970|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
124925836|NCT01539083|449358971|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
124925837|NCT01539083|449358972|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
124925838|NCT01539083|449358970|FG000|After Randomization (TP and VTP)|Other|0|||
124925839|NCT01539083|449358971|FG001|After Randomization (TP and VTP)|Other|1|||
124925840|NCT01539083|449358972|FG002|After Randomization (TP and VTP)|Other|1|||
124925841|NCT01539083|449358970|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
124925842|NCT01539083|449358971|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
124925843|NCT01539083|449358972|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
124925844|NCT01539083|449358970|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
124925845|NCT01539083|449358971|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
124925846|NCT01539083|449358972|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
124925847|NCT01539083|449358970|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
125212278|NCT01006590|450403308|FG000|Overall Study|Study specific discontinuation criteria|16|||
124925848|NCT01539083|449358971|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
124925849|NCT01539083|449358972|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
124925850|NCT01539083|449358970|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
124969570|NCT03520075|449517426|FG017|Phase 2 (Dose Expansion)|Death|14|||
124969571|NCT03520075|449517427|FG018|Phase 2 (Dose Expansion)|Death|12|||
124969572|NCT03520075|449517409|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969573|NCT03520075|449517410|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969574|NCT03520075|449517411|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969575|NCT03520075|449517412|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969576|NCT03520075|449517413|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969577|NCT03520075|449517414|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969578|NCT03520075|449517415|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969579|NCT03520075|449517416|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969580|NCT03520075|449517417|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
125024062|NCT03529773|449711341|FG008|Overall Study|Protocol Violation|0|||
125024063|NCT03529773|449711342|FG009|Overall Study|Protocol Violation|0|||
125024064|NCT03529773|449711343|FG010|Overall Study|Protocol Violation|0|||
125024065|NCT03529773|449711344|FG011|Overall Study|Protocol Violation|0|||
125024066|NCT03529773|449711345|FG012|Overall Study|Protocol Violation|0|||
125024067|NCT03529773|449711346|FG013|Overall Study|Protocol Violation|0|||
125024068|NCT03529773|449711347|FG014|Overall Study|Protocol Violation|0|||
125024069|NCT03529773|449711348|FG015|Overall Study|Protocol Violation|0|||
125024070|NCT03529773|449711349|FG016|Overall Study|Protocol Violation|0|||
125024071|NCT03529773|449711350|FG017|Overall Study|Protocol Violation|0|||
125024072|NCT03529773|449711351|FG018|Overall Study|Protocol Violation|0|||
125024073|NCT03529773|449711352|FG019|Overall Study|Protocol Violation|0|||
125024074|NCT03529773|449711353|FG020|Overall Study|Protocol Violation|0|||
125024075|NCT03529773|449711354|FG021|Overall Study|Protocol Violation|0|||
124925851|NCT01539083|449358971|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
124925852|NCT01539083|449358972|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
124925853|NCT01539083|449358970|FG000|After Randomization (TP and VTP)|Death|0|||
124925854|NCT01539083|449358971|FG001|After Randomization (TP and VTP)|Death|6|||
124925855|NCT01539083|449358972|FG002|After Randomization (TP and VTP)|Death|11|||
124925856|NCT05499377|449358973|FG000|Overall Study|Withdrawal by Subject|2|||
124925857|NCT05499377|449358974|FG001|Overall Study|Withdrawal by Subject|0|||
124925858|NCT05499377|449358973|FG000|Overall Study|Physician Decision|1|||
124925859|NCT05499377|449358974|FG001|Overall Study|Physician Decision|0|||
124925860|NCT02573493|449358975|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
124925861|NCT02573493|449358976|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
124925862|NCT02573493|449358977|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
124925863|NCT02573493|449358978|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
124925864|NCT02677805|449358984|FG000|Double Blind Phase|Lost to Follow-up|8|||
124925865|NCT02677805|449358985|FG001|Double Blind Phase|Lost to Follow-up|3|||
124925866|NCT02677805|449358986|FG002|Double Blind Phase|Lost to Follow-up|0|||
124925867|NCT02677805|449358984|FG000|Double Blind Phase|Withdrawal by Subject|5|||
124925868|NCT02677805|449358985|FG001|Double Blind Phase|Withdrawal by Subject|2|||
124925869|NCT02677805|449358986|FG002|Double Blind Phase|Withdrawal by Subject|0|||
124925870|NCT02677805|449358984|FG000|Open Label Phase|Lost to Follow-up|0|||
124925871|NCT02677805|449358985|FG001|Open Label Phase|Lost to Follow-up|0|||
124925872|NCT02677805|449358986|FG002|Open Label Phase|Lost to Follow-up|10|||
124925873|NCT02677805|449358984|FG000|Open Label Phase|Withdrawal by Subject|0|||
124925874|NCT02677805|449358985|FG001|Open Label Phase|Withdrawal by Subject|0|||
124925875|NCT02677805|449358986|FG002|Open Label Phase|Withdrawal by Subject|6|||
124925876|NCT05714761|449358987|FG000|Overall Study|Lost to Follow-up|3|||
124925877|NCT05714761|449358987|FG000|Overall Study|Withdrawal by Subject|3|||
124925878|NCT05714761|449358987|FG000|Overall Study|unblinding of sensor data|1|||
124925879|NCT05714761|449358987|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
124925880|NCT05714761|449358987|FG000|Overall Study|did not return second CGM sensor|4|||
124925881|NCT03150173|449358988|FG000|Overall Study|Lost to Follow-up|13|||
124925882|NCT03150173|449358989|FG001|Overall Study|Lost to Follow-up|5|||
124925883|NCT02191618|449358996|FG000|Overall Study|Withdrawal by Subject|3|||
124925884|NCT02191618|449358996|FG000|Overall Study|Missed Visit|4|||
124925885|NCT01802788|449358999|FG000|Overall Study|Withdrawal by Subject|102|||
124925886|NCT01802788|449359000|FG001|Overall Study|Withdrawal by Subject|5|||
124925887|NCT01802788|449358999|FG000|Overall Study|Death|382|||
124925888|NCT01802788|449359000|FG001|Overall Study|Death|18|||
124925889|NCT01802788|449358999|FG000|Overall Study|Lost to Follow-up|31|||
124925890|NCT01802788|449359000|FG001|Overall Study|Lost to Follow-up|2|||
124925891|NCT01802788|449358999|FG000|Overall Study|Physician Decision|3|||
124925892|NCT01802788|449359000|FG001|Overall Study|Physician Decision|0|||
124925893|NCT01802788|449358999|FG000|Overall Study|Patient Non-Compliance|1|||
124925894|NCT01802788|449359000|FG001|Overall Study|Patient Non-Compliance|0|||
124925895|NCT01802788|449358999|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
124925896|NCT01802788|449359000|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
125024076|NCT03529773|449711355|FG022|Overall Study|Protocol Violation|0|||
125024077|NCT03529773|449711356|FG023|Overall Study|Protocol Violation|0|||
125024078|NCT03529773|449711357|FG024|Overall Study|Protocol Violation|0|||
124925897|NCT01802788|449358999|FG000|Overall Study|Other Reasons|19|||
124925898|NCT01802788|449359000|FG001|Overall Study|Other Reasons|0|||
124925899|NCT03011333|449359007|FG000|Overall Study|Lost to Follow-up|0|||
124925900|NCT03011333|449359008|FG001|Overall Study|Lost to Follow-up|1|||
124925901|NCT03011333|449359009|FG002|Overall Study|Lost to Follow-up|0|||
124925902|NCT03011333|449359010|FG003|Overall Study|Lost to Follow-up|1|||
124925903|NCT03011333|449359011|FG004|Overall Study|Lost to Follow-up|4|||
124925904|NCT03011333|449359012|FG005|Overall Study|Lost to Follow-up|4|||
124925905|NCT03011333|449359013|FG006|Overall Study|Lost to Follow-up|5|||
124925906|NCT05269667|449359018|FG000|Overall Study|Study Terminated by Sponsor|4|||
124925907|NCT04599062|449359024|FG000|Overall Study|Physician Decision|1|||
124925908|NCT04599062|449359025|FG001|Overall Study|Physician Decision|0|||
125024079|NCT03529773|449711358|FG025|Overall Study|Protocol Violation|0|||
125024080|NCT03529773|449711359|FG026|Overall Study|Protocol Violation|0|||
125024081|NCT03529773|449711360|FG027|Overall Study|Protocol Violation|0|||
125024082|NCT03529773|449711361|FG028|Overall Study|Protocol Violation|0|||
124925909|NCT04074759|449359027|FG000|Overall Study|Withdrawal by Subject|0|||
124925910|NCT04074759|449359028|FG001|Overall Study|Withdrawal by Subject|0|||
124925911|NCT04074759|449359029|FG002|Overall Study|Withdrawal by Subject|0|||
124925912|NCT04074759|449359030|FG003|Overall Study|Withdrawal by Subject|0|||
124925913|NCT04074759|449359031|FG004|Overall Study|Withdrawal by Subject|0|||
124925914|NCT04074759|449359032|FG005|Overall Study|Withdrawal by Subject|2|||
125119413|NCT04849988|450061201|FG000|Overall Study|Other reasons|1|||
125119414|NCT04849988|450061202|FG001|Overall Study|Other reasons|2|||
125119415|NCT04849988|450061203|FG002|Overall Study|Other reasons|2|||
125119416|NCT04849988|450061204|FG003|Overall Study|Other reasons|1|||
125119417|NCT01052116|450061216|FG000|Overall Study|Lost to Follow-up|11|||
125119418|NCT01052116|450061217|FG001|Overall Study|Lost to Follow-up|17|||
125119419|NCT01052116|450061216|FG000|Overall Study|Withdrawal by Subject|3|||
125119420|NCT01052116|450061217|FG001|Overall Study|Withdrawal by Subject|6|||
125119421|NCT01052116|450061216|FG000|Overall Study|Spirometry not performed|0|||
124925915|NCT04074759|449359033|FG006|Overall Study|Withdrawal by Subject|0|||
124925916|NCT04074759|449359034|FG007|Overall Study|Withdrawal by Subject|2|||
124925917|NCT04074759|449359035|FG008|Overall Study|Withdrawal by Subject|1|||
124925918|NCT04074759|449359036|FG009|Overall Study|Withdrawal by Subject|2|||
124925919|NCT04074759|449359037|FG010|Overall Study|Withdrawal by Subject|9|||
124925920|NCT04074759|449359038|FG011|Overall Study|Withdrawal by Subject|2|||
124925921|NCT04074759|449359039|FG012|Overall Study|Withdrawal by Subject|1|||
124925922|NCT04074759|449359040|FG013|Overall Study|Withdrawal by Subject|3|||
124925923|NCT04074759|449359041|FG014|Overall Study|Withdrawal by Subject|2|||
124925924|NCT04074759|449359042|FG015|Overall Study|Withdrawal by Subject|0|||
124925925|NCT04074759|449359043|FG016|Overall Study|Withdrawal by Subject|0|||
124925926|NCT04074759|449359044|FG017|Overall Study|Withdrawal by Subject|3|||
124925927|NCT04074759|449359045|FG018|Overall Study|Withdrawal by Subject|1|||
124925928|NCT04074759|449359027|FG000|Overall Study|Death|1|||
124925929|NCT04074759|449359028|FG001|Overall Study|Death|0|||
124925930|NCT04074759|449359029|FG002|Overall Study|Death|1|||
124925931|NCT04074759|449359030|FG003|Overall Study|Death|1|||
124925932|NCT04074759|449359031|FG004|Overall Study|Death|2|||
124925933|NCT04074759|449359032|FG005|Overall Study|Death|0|||
125024083|NCT03529773|449711362|FG029|Overall Study|Protocol Violation|0|||
125024084|NCT03529773|449711363|FG030|Overall Study|Protocol Violation|1|||
125024085|NCT03529773|449711364|FG031|Overall Study|Protocol Violation|0|||
125024086|NCT03529773|449711365|FG032|Overall Study|Protocol Violation|0|||
125024087|NCT03529773|449711366|FG033|Overall Study|Protocol Violation|0|||
125024088|NCT03529773|449711367|FG034|Overall Study|Protocol Violation|0|||
125024089|NCT03529773|449711368|FG035|Overall Study|Protocol Violation|0|||
125024090|NCT03529773|449711369|FG036|Overall Study|Protocol Violation|0|||
125024091|NCT03529773|449711370|FG037|Overall Study|Protocol Violation|0|||
125024092|NCT03529773|449711371|FG038|Overall Study|Protocol Violation|0|||
125024093|NCT03529773|449711372|FG039|Overall Study|Protocol Violation|0|||
125024094|NCT03529773|449711333|FG000|Overall Study|Withdrawal by Subject|0|||
125024095|NCT03529773|449711334|FG001|Overall Study|Withdrawal by Subject|0|||
125024096|NCT03529773|449711335|FG002|Overall Study|Withdrawal by Subject|0|||
125024097|NCT03529773|449711336|FG003|Overall Study|Withdrawal by Subject|0|||
125024098|NCT03529773|449711337|FG004|Overall Study|Withdrawal by Subject|0|||
125024099|NCT03529773|449711338|FG005|Overall Study|Withdrawal by Subject|0|||
125024100|NCT03529773|449711339|FG006|Overall Study|Withdrawal by Subject|0|||
125024101|NCT03529773|449711340|FG007|Overall Study|Withdrawal by Subject|1|||
125024102|NCT03529773|449711341|FG008|Overall Study|Withdrawal by Subject|0|||
125024103|NCT03529773|449711342|FG009|Overall Study|Withdrawal by Subject|1|||
125024104|NCT03529773|449711343|FG010|Overall Study|Withdrawal by Subject|1|||
125024105|NCT03529773|449711344|FG011|Overall Study|Withdrawal by Subject|0|||
125024106|NCT03529773|449711345|FG012|Overall Study|Withdrawal by Subject|0|||
125024107|NCT03529773|449711346|FG013|Overall Study|Withdrawal by Subject|0|||
125024108|NCT03529773|449711347|FG014|Overall Study|Withdrawal by Subject|0|||
125024109|NCT03529773|449711348|FG015|Overall Study|Withdrawal by Subject|3|||
125024110|NCT03529773|449711349|FG016|Overall Study|Withdrawal by Subject|0|||
125024111|NCT03529773|449711350|FG017|Overall Study|Withdrawal by Subject|2|||
125024112|NCT03529773|449711351|FG018|Overall Study|Withdrawal by Subject|3|||
125024113|NCT03529773|449711352|FG019|Overall Study|Withdrawal by Subject|1|||
125024114|NCT03529773|449711353|FG020|Overall Study|Withdrawal by Subject|3|||
125024115|NCT03529773|449711354|FG021|Overall Study|Withdrawal by Subject|1|||
125024116|NCT03529773|449711355|FG022|Overall Study|Withdrawal by Subject|1|||
124925934|NCT04074759|449359033|FG006|Overall Study|Death|1|||
124925935|NCT04074759|449359034|FG007|Overall Study|Death|0|||
124925936|NCT04074759|449359035|FG008|Overall Study|Death|3|||
125024117|NCT03529773|449711356|FG023|Overall Study|Withdrawal by Subject|2|||
125024118|NCT03529773|449711357|FG024|Overall Study|Withdrawal by Subject|2|||
125024119|NCT03529773|449711358|FG025|Overall Study|Withdrawal by Subject|4|||
125024120|NCT03529773|449711359|FG026|Overall Study|Withdrawal by Subject|2|||
125024121|NCT03529773|449711360|FG027|Overall Study|Withdrawal by Subject|1|||
125119422|NCT01052116|450061217|FG001|Overall Study|Spirometry not performed|4|||
125119423|NCT00836927|450061222|FG000|Overall Study|Progressive disease|2|||
124925937|NCT04074759|449359036|FG009|Overall Study|Death|2|||
124925938|NCT04074759|449359037|FG010|Overall Study|Death|4|||
124925939|NCT04074759|449359038|FG011|Overall Study|Death|1|||
124925940|NCT04074759|449359039|FG012|Overall Study|Death|0|||
124925941|NCT04074759|449359040|FG013|Overall Study|Death|2|||
124925942|NCT04074759|449359041|FG014|Overall Study|Death|1|||
124925943|NCT04074759|449359042|FG015|Overall Study|Death|0|||
124925944|NCT04074759|449359043|FG016|Overall Study|Death|1|||
124925945|NCT04074759|449359044|FG017|Overall Study|Death|0|||
124925946|NCT04074759|449359045|FG018|Overall Study|Death|1|||
124925947|NCT04074759|449359027|FG000|Overall Study|Lost to Follow-up|0|||
124925948|NCT04074759|449359028|FG001|Overall Study|Lost to Follow-up|0|||
124925949|NCT04074759|449359029|FG002|Overall Study|Lost to Follow-up|0|||
124925950|NCT04074759|449359030|FG003|Overall Study|Lost to Follow-up|0|||
124925951|NCT04074759|449359031|FG004|Overall Study|Lost to Follow-up|0|||
124925952|NCT04074759|449359032|FG005|Overall Study|Lost to Follow-up|0|||
124925953|NCT04074759|449359033|FG006|Overall Study|Lost to Follow-up|0|||
124925954|NCT04074759|449359034|FG007|Overall Study|Lost to Follow-up|0|||
124925955|NCT04074759|449359035|FG008|Overall Study|Lost to Follow-up|0|||
124925956|NCT04074759|449359036|FG009|Overall Study|Lost to Follow-up|0|||
124925957|NCT04074759|449359037|FG010|Overall Study|Lost to Follow-up|1|||
124925958|NCT04074759|449359038|FG011|Overall Study|Lost to Follow-up|0|||
124925959|NCT04074759|449359039|FG012|Overall Study|Lost to Follow-up|0|||
124925960|NCT04074759|449359040|FG013|Overall Study|Lost to Follow-up|0|||
124925961|NCT04074759|449359041|FG014|Overall Study|Lost to Follow-up|0|||
124925962|NCT04074759|449359042|FG015|Overall Study|Lost to Follow-up|0|||
124925963|NCT04074759|449359043|FG016|Overall Study|Lost to Follow-up|1|||
124925964|NCT04074759|449359044|FG017|Overall Study|Lost to Follow-up|0|||
124925965|NCT04074759|449359045|FG018|Overall Study|Lost to Follow-up|1|||
124925966|NCT04074759|449359027|FG000|Overall Study|Other|0|||
124925967|NCT04074759|449359028|FG001|Overall Study|Other|1|||
124925968|NCT04074759|449359029|FG002|Overall Study|Other|1|||
124925969|NCT04074759|449359030|FG003|Overall Study|Other|0|||
124925970|NCT04074759|449359031|FG004|Overall Study|Other|2|||
124925971|NCT04074759|449359032|FG005|Overall Study|Other|1|||
124925972|NCT04074759|449359033|FG006|Overall Study|Other|2|||
124925973|NCT04074759|449359034|FG007|Overall Study|Other|1|||
124925974|NCT04074759|449359035|FG008|Overall Study|Other|1|||
124925975|NCT04074759|449359036|FG009|Overall Study|Other|4|||
124925976|NCT04074759|449359037|FG010|Overall Study|Other|4|||
124925977|NCT04074759|449359038|FG011|Overall Study|Other|2|||
124925978|NCT04074759|449359039|FG012|Overall Study|Other|0|||
124925979|NCT04074759|449359040|FG013|Overall Study|Other|0|||
124925980|NCT04074759|449359041|FG014|Overall Study|Other|0|||
124925981|NCT04074759|449359042|FG015|Overall Study|Other|1|||
124925982|NCT04074759|449359043|FG016|Overall Study|Other|0|||
124925983|NCT04074759|449359044|FG017|Overall Study|Other|0|||
124925984|NCT04074759|449359045|FG018|Overall Study|Other|0|||
124925985|NCT04074759|449359027|FG000|Overall Study|Missing end of study status|0|||
124925986|NCT04074759|449359028|FG001|Overall Study|Missing end of study status|0|||
125119424|NCT00836927|450061223|FG001|Overall Study|Progressive disease|0|||
125119425|NCT00836927|450061224|FG002|Overall Study|Progressive disease|0|||
125119426|NCT00836927|450061225|FG003|Overall Study|Progressive disease|1|||
125119427|NCT00836927|450061226|FG004|Overall Study|Progressive disease|1|||
125119428|NCT00836927|450061222|FG000|Overall Study|Withdrawal by Subject|1|||
125119429|NCT00836927|450061223|FG001|Overall Study|Withdrawal by Subject|0|||
125119430|NCT00836927|450061224|FG002|Overall Study|Withdrawal by Subject|0|||
125119431|NCT00836927|450061225|FG003|Overall Study|Withdrawal by Subject|0|||
125119432|NCT00836927|450061226|FG004|Overall Study|Withdrawal by Subject|0|||
125119433|NCT00614055|450061230|FG000|Overall Study|Adverse Event|1|||
125119434|NCT00614055|450061231|FG001|Overall Study|Adverse Event|0|||
124925987|NCT04074759|449359029|FG002|Overall Study|Missing end of study status|0|||
124925988|NCT04074759|449359030|FG003|Overall Study|Missing end of study status|0|||
124925989|NCT04074759|449359031|FG004|Overall Study|Missing end of study status|0|||
124925990|NCT04074759|449359032|FG005|Overall Study|Missing end of study status|0|||
124925991|NCT04074759|449359033|FG006|Overall Study|Missing end of study status|0|||
124925992|NCT04074759|449359034|FG007|Overall Study|Missing end of study status|0|||
124925993|NCT04074759|449359035|FG008|Overall Study|Missing end of study status|0|||
124925994|NCT04074759|449359036|FG009|Overall Study|Missing end of study status|0|||
124925995|NCT04074759|449359037|FG010|Overall Study|Missing end of study status|2|||
124925996|NCT04074759|449359038|FG011|Overall Study|Missing end of study status|0|||
124925997|NCT04074759|449359039|FG012|Overall Study|Missing end of study status|0|||
124925998|NCT04074759|449359040|FG013|Overall Study|Missing end of study status|0|||
124925999|NCT04074759|449359041|FG014|Overall Study|Missing end of study status|0|||
124926000|NCT04074759|449359042|FG015|Overall Study|Missing end of study status|0|||
124926001|NCT04074759|449359043|FG016|Overall Study|Missing end of study status|1|||
124926002|NCT04074759|449359044|FG017|Overall Study|Missing end of study status|0|||
124926003|NCT04074759|449359045|FG018|Overall Study|Missing end of study status|0|||
124926004|NCT05399459|449359054|FG000|Overall Study|Randomized but not treated|29|||
124926005|NCT05399459|449359055|FG001|Overall Study|Randomized but not treated|30|||
124926006|NCT05399459|449359056|FG002|Overall Study|Randomized but not treated|38|||
124926007|NCT05399459|449359054|FG000|Overall Study|Lost to Follow-up|1|||
124926008|NCT05399459|449359055|FG001|Overall Study|Lost to Follow-up|0|||
124926009|NCT05399459|449359056|FG002|Overall Study|Lost to Follow-up|0|||
124926010|NCT02231164|449359057|FG000|Overall Study|Adverse Event|1|||
124926011|NCT02231164|449359058|FG001|Overall Study|Adverse Event|1|||
124926012|NCT02231164|449359057|FG000|Overall Study|Lack of Efficacy|4|||
124926013|NCT02231164|449359058|FG001|Overall Study|Lack of Efficacy|3|||
124926014|NCT02231164|449359057|FG000|Overall Study|Withdrawal by Subject|1|||
124926015|NCT02231164|449359058|FG001|Overall Study|Withdrawal by Subject|2|||
124926016|NCT01210807|449359059|FG000|Overall Study|Lost to Follow-up|1|||
124926017|NCT01210807|449359060|FG001|Overall Study|Lost to Follow-up|2|||
124926018|NCT01210807|449359059|FG000|Overall Study|Not implanted bilaterally|2|||
124926019|NCT01210807|449359060|FG001|Overall Study|Not implanted bilaterally|1|||
124926020|NCT04436276|449359061|FG000|Overall Study|Adverse Event|0|||
124926021|NCT04436276|449359062|FG001|Overall Study|Adverse Event|0|||
124926022|NCT04436276|449359063|FG002|Overall Study|Adverse Event|0|||
124926023|NCT04436276|449359064|FG003|Overall Study|Adverse Event|0|||
124926024|NCT04436276|449359065|FG004|Overall Study|Adverse Event|0|||
124926025|NCT04436276|449359066|FG005|Overall Study|Adverse Event|0|||
124926026|NCT04436276|449359067|FG006|Overall Study|Adverse Event|0|||
124926027|NCT04436276|449359068|FG007|Overall Study|Adverse Event|0|||
124926028|NCT04436276|449359069|FG008|Overall Study|Adverse Event|0|||
124926029|NCT04436276|449359070|FG009|Overall Study|Adverse Event|0|||
124926030|NCT04436276|449359071|FG010|Overall Study|Adverse Event|0|||
124926031|NCT04436276|449359072|FG011|Overall Study|Adverse Event|0|||
124926032|NCT04436276|449359073|FG012|Overall Study|Adverse Event|0|||
124926033|NCT04436276|449359074|FG013|Overall Study|Adverse Event|0|||
124926034|NCT04436276|449359075|FG014|Overall Study|Adverse Event|0|||
124926035|NCT04436276|449359076|FG015|Overall Study|Adverse Event|0|||
124926036|NCT04436276|449359077|FG016|Overall Study|Adverse Event|1|||
124926037|NCT04436276|449359078|FG017|Overall Study|Adverse Event|0|||
124926038|NCT04436276|449359079|FG018|Overall Study|Adverse Event|0|||
124926039|NCT04436276|449359080|FG019|Overall Study|Adverse Event|0|||
125119435|NCT00614055|450061232|FG002|Overall Study|Adverse Event|0|||
124926040|NCT04436276|449359081|FG020|Overall Study|Adverse Event|0|||
124926041|NCT04436276|449359082|FG021|Overall Study|Adverse Event|0|||
124926042|NCT04436276|449359083|FG022|Overall Study|Adverse Event|0|||
124926043|NCT04436276|449359061|FG000|Overall Study|Death|0|||
124926044|NCT04436276|449359062|FG001|Overall Study|Death|0|||
124926045|NCT04436276|449359063|FG002|Overall Study|Death|0|||
124926046|NCT04436276|449359064|FG003|Overall Study|Death|0|||
124926047|NCT04436276|449359065|FG004|Overall Study|Death|0|||
124926048|NCT04436276|449359066|FG005|Overall Study|Death|0|||
124926049|NCT04436276|449359067|FG006|Overall Study|Death|0|||
124926050|NCT04436276|449359068|FG007|Overall Study|Death|0|||
125119436|NCT00614055|450061230|FG000|Overall Study|Protocol Violation|2|||
125119437|NCT00614055|450061231|FG001|Overall Study|Protocol Violation|2|||
125024122|NCT03529773|449711361|FG028|Overall Study|Withdrawal by Subject|1|||
125024123|NCT03529773|449711362|FG029|Overall Study|Withdrawal by Subject|0|||
125024124|NCT03529773|449711363|FG030|Overall Study|Withdrawal by Subject|0|||
125024125|NCT03529773|449711364|FG031|Overall Study|Withdrawal by Subject|0|||
125024126|NCT03529773|449711365|FG032|Overall Study|Withdrawal by Subject|0|||
125024127|NCT03529773|449711366|FG033|Overall Study|Withdrawal by Subject|0|||
125024128|NCT03529773|449711367|FG034|Overall Study|Withdrawal by Subject|1|||
125024129|NCT03529773|449711368|FG035|Overall Study|Withdrawal by Subject|2|||
125212279|NCT01006590|450403309|FG001|Overall Study|Study specific discontinuation criteria|23|||
125212280|NCT01006590|450403308|FG000|Overall Study|Other|3|||
125212281|NCT01006590|450403309|FG001|Overall Study|Other|2|||
125212282|NCT00329745|450403310|FG000|Overall Study|Protocol Violation|1|||
125212283|NCT00329745|450403311|FG001|Overall Study|Protocol Violation|0|||
125212284|NCT00329745|450403310|FG000|Overall Study|Withdrawal by Subject|0|||
125212285|NCT00329745|450403311|FG001|Overall Study|Withdrawal by Subject|1|||
125212286|NCT00329745|450403310|FG000|Overall Study|Lost to Follow-up|86|||
125212287|NCT00329745|450403311|FG001|Overall Study|Lost to Follow-up|101|||
125212288|NCT02700698|450403315|FG000|Overall Study|Withdrawal by Subject|1|||
125212289|NCT02700698|450403316|FG001|Overall Study|Withdrawal by Subject|0|||
125212290|NCT00703118|450403317|FG000|Overall Study|Adverse Event|1|||
125212291|NCT00703118|450403318|FG001|Overall Study|Adverse Event|2|||
125212292|NCT00703118|450403319|FG002|Overall Study|Adverse Event|2|||
125212293|NCT00703118|450403317|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
125212294|NCT00703118|450403318|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
125119438|NCT00614055|450061232|FG002|Overall Study|Protocol Violation|1|||
125119439|NCT00614055|450061230|FG000|Overall Study|Lack of Efficacy|0|||
125119440|NCT00614055|450061231|FG001|Overall Study|Lack of Efficacy|0|||
125119441|NCT00614055|450061232|FG002|Overall Study|Lack of Efficacy|2|||
125119442|NCT00614055|450061230|FG000|Overall Study|Unclassified|1|||
125119443|NCT00614055|450061231|FG001|Overall Study|Unclassified|4|||
125212295|NCT00703118|450403319|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
124926051|NCT04436276|449359069|FG008|Overall Study|Death|0|||
124926052|NCT04436276|449359070|FG009|Overall Study|Death|0|||
124926053|NCT04436276|449359071|FG010|Overall Study|Death|0|||
124926054|NCT04436276|449359072|FG011|Overall Study|Death|0|||
124926055|NCT04436276|449359073|FG012|Overall Study|Death|1|||
124926056|NCT04436276|449359074|FG013|Overall Study|Death|0|||
124926057|NCT04436276|449359075|FG014|Overall Study|Death|1|||
124926058|NCT04436276|449359076|FG015|Overall Study|Death|0|||
124926059|NCT04436276|449359077|FG016|Overall Study|Death|0|||
124926060|NCT04436276|449359078|FG017|Overall Study|Death|0|||
124926061|NCT04436276|449359079|FG018|Overall Study|Death|0|||
124926062|NCT04436276|449359080|FG019|Overall Study|Death|2|||
124926063|NCT04436276|449359081|FG020|Overall Study|Death|0|||
124926064|NCT04436276|449359082|FG021|Overall Study|Death|1|||
124926065|NCT04436276|449359083|FG022|Overall Study|Death|0|||
124926066|NCT04436276|449359061|FG000|Overall Study|Lost to Follow-up|0|||
124926067|NCT04436276|449359062|FG001|Overall Study|Lost to Follow-up|2|||
124926068|NCT04436276|449359063|FG002|Overall Study|Lost to Follow-up|2|||
124926069|NCT04436276|449359064|FG003|Overall Study|Lost to Follow-up|1|||
124926070|NCT04436276|449359065|FG004|Overall Study|Lost to Follow-up|4|||
124926071|NCT04436276|449359066|FG005|Overall Study|Lost to Follow-up|1|||
124926072|NCT04436276|449359067|FG006|Overall Study|Lost to Follow-up|0|||
124926073|NCT04436276|449359068|FG007|Overall Study|Lost to Follow-up|0|||
124926074|NCT04436276|449359069|FG008|Overall Study|Lost to Follow-up|1|||
124926075|NCT04436276|449359070|FG009|Overall Study|Lost to Follow-up|0|||
124926076|NCT04436276|449359071|FG010|Overall Study|Lost to Follow-up|5|||
124926077|NCT04436276|449359072|FG011|Overall Study|Lost to Follow-up|5|||
124926078|NCT04436276|449359073|FG012|Overall Study|Lost to Follow-up|4|||
124926079|NCT04436276|449359074|FG013|Overall Study|Lost to Follow-up|1|||
124926080|NCT04436276|449359075|FG014|Overall Study|Lost to Follow-up|7|||
124926081|NCT04436276|449359076|FG015|Overall Study|Lost to Follow-up|7|||
124926082|NCT04436276|449359077|FG016|Overall Study|Lost to Follow-up|1|||
124926083|NCT04436276|449359078|FG017|Overall Study|Lost to Follow-up|0|||
124926084|NCT04436276|449359079|FG018|Overall Study|Lost to Follow-up|1|||
124926085|NCT04436276|449359080|FG019|Overall Study|Lost to Follow-up|1|||
124926086|NCT04436276|449359081|FG020|Overall Study|Lost to Follow-up|2|||
124926087|NCT04436276|449359082|FG021|Overall Study|Lost to Follow-up|1|||
124926088|NCT04436276|449359083|FG022|Overall Study|Lost to Follow-up|1|||
124926089|NCT04436276|449359061|FG000|Overall Study|Physician Decision|1|||
124926090|NCT04436276|449359062|FG001|Overall Study|Physician Decision|0|||
124926091|NCT04436276|449359063|FG002|Overall Study|Physician Decision|2|||
124926092|NCT04436276|449359064|FG003|Overall Study|Physician Decision|1|||
124926093|NCT04436276|449359065|FG004|Overall Study|Physician Decision|0|||
125212296|NCT00703118|450403317|FG000|Overall Study|Lost to Follow-up|6|||
125212297|NCT00703118|450403318|FG001|Overall Study|Lost to Follow-up|4|||
124926094|NCT04436276|449359066|FG005|Overall Study|Physician Decision|0|||
125212298|NCT00703118|450403319|FG002|Overall Study|Lost to Follow-up|4|||
125212299|NCT00703118|450403317|FG000|Overall Study|Withdrawal by Subject|8|||
124926095|NCT04436276|449359067|FG006|Overall Study|Physician Decision|0|||
124926096|NCT04436276|449359068|FG007|Overall Study|Physician Decision|0|||
124926097|NCT04436276|449359069|FG008|Overall Study|Physician Decision|0|||
124926098|NCT04436276|449359070|FG009|Overall Study|Physician Decision|0|||
124926099|NCT04436276|449359071|FG010|Overall Study|Physician Decision|0|||
124926100|NCT04436276|449359072|FG011|Overall Study|Physician Decision|1|||
125119444|NCT00614055|450061232|FG002|Overall Study|Unclassified|2|||
125119445|NCT03036579|450061241|FG000|2 Years|Lost to Follow-up|1|||
125119446|NCT03036579|450061242|FG001|2 Years|Lost to Follow-up|0|||
125212300|NCT00703118|450403318|FG001|Overall Study|Withdrawal by Subject|7|||
124926101|NCT04436276|449359073|FG012|Overall Study|Physician Decision|2|||
124926102|NCT04436276|449359074|FG013|Overall Study|Physician Decision|0|||
124926103|NCT04436276|449359075|FG014|Overall Study|Physician Decision|0|||
124926104|NCT04436276|449359076|FG015|Overall Study|Physician Decision|0|||
124926105|NCT04436276|449359077|FG016|Overall Study|Physician Decision|0|||
124926106|NCT04436276|449359078|FG017|Overall Study|Physician Decision|0|||
124926107|NCT04436276|449359079|FG018|Overall Study|Physician Decision|0|||
124926108|NCT04436276|449359080|FG019|Overall Study|Physician Decision|0|||
124926109|NCT04436276|449359081|FG020|Overall Study|Physician Decision|1|||
124926110|NCT04436276|449359082|FG021|Overall Study|Physician Decision|2|||
124926111|NCT04436276|449359083|FG022|Overall Study|Physician Decision|0|||
124926112|NCT04436276|449359061|FG000|Overall Study|Protocol Violation|0|||
124926113|NCT04436276|449359062|FG001|Overall Study|Protocol Violation|0|||
124926114|NCT04436276|449359063|FG002|Overall Study|Protocol Violation|0|||
124926115|NCT04436276|449359064|FG003|Overall Study|Protocol Violation|0|||
124926116|NCT04436276|449359065|FG004|Overall Study|Protocol Violation|0|||
124926117|NCT04436276|449359066|FG005|Overall Study|Protocol Violation|0|||
124926118|NCT04436276|449359067|FG006|Overall Study|Protocol Violation|0|||
124926119|NCT04436276|449359068|FG007|Overall Study|Protocol Violation|0|||
124926120|NCT04436276|449359069|FG008|Overall Study|Protocol Violation|0|||
124926121|NCT04436276|449359070|FG009|Overall Study|Protocol Violation|0|||
124926122|NCT04436276|449359071|FG010|Overall Study|Protocol Violation|0|||
124926123|NCT04436276|449359072|FG011|Overall Study|Protocol Violation|0|||
124926124|NCT04436276|449359073|FG012|Overall Study|Protocol Violation|0|||
124926125|NCT04436276|449359074|FG013|Overall Study|Protocol Violation|1|||
124926126|NCT04436276|449359075|FG014|Overall Study|Protocol Violation|0|||
124926127|NCT04436276|449359076|FG015|Overall Study|Protocol Violation|1|||
124926128|NCT04436276|449359077|FG016|Overall Study|Protocol Violation|0|||
124926129|NCT04436276|449359078|FG017|Overall Study|Protocol Violation|0|||
124926130|NCT04436276|449359079|FG018|Overall Study|Protocol Violation|0|||
124926131|NCT04436276|449359080|FG019|Overall Study|Protocol Violation|0|||
124926132|NCT04436276|449359081|FG020|Overall Study|Protocol Violation|0|||
124926133|NCT04436276|449359082|FG021|Overall Study|Protocol Violation|0|||
124926134|NCT04436276|449359083|FG022|Overall Study|Protocol Violation|0|||
124926135|NCT04436276|449359061|FG000|Overall Study|Withdrawal by Subject|25|||
124926136|NCT04436276|449359062|FG001|Overall Study|Withdrawal by Subject|22|||
124926137|NCT04436276|449359063|FG002|Overall Study|Withdrawal by Subject|24|||
124926138|NCT04436276|449359064|FG003|Overall Study|Withdrawal by Subject|23|||
124926139|NCT04436276|449359065|FG004|Overall Study|Withdrawal by Subject|14|||
124926140|NCT04436276|449359066|FG005|Overall Study|Withdrawal by Subject|0|||
124926141|NCT04436276|449359067|FG006|Overall Study|Withdrawal by Subject|0|||
124926142|NCT04436276|449359068|FG007|Overall Study|Withdrawal by Subject|1|||
124926143|NCT04436276|449359069|FG008|Overall Study|Withdrawal by Subject|0|||
124926144|NCT04436276|449359070|FG009|Overall Study|Withdrawal by Subject|1|||
124926145|NCT04436276|449359071|FG010|Overall Study|Withdrawal by Subject|17|||
124926146|NCT04436276|449359072|FG011|Overall Study|Withdrawal by Subject|7|||
124926147|NCT04436276|449359073|FG012|Overall Study|Withdrawal by Subject|10|||
124926148|NCT04436276|449359074|FG013|Overall Study|Withdrawal by Subject|6|||
124926149|NCT04436276|449359075|FG014|Overall Study|Withdrawal by Subject|20|||
124926150|NCT04436276|449359076|FG015|Overall Study|Withdrawal by Subject|6|||
124926151|NCT04436276|449359077|FG016|Overall Study|Withdrawal by Subject|11|||
124926152|NCT04436276|449359078|FG017|Overall Study|Withdrawal by Subject|4|||
124926153|NCT04436276|449359079|FG018|Overall Study|Withdrawal by Subject|14|||
124926154|NCT04436276|449359080|FG019|Overall Study|Withdrawal by Subject|24|||
124926155|NCT04436276|449359081|FG020|Overall Study|Withdrawal by Subject|24|||
124926156|NCT04436276|449359082|FG021|Overall Study|Withdrawal by Subject|16|||
124926157|NCT04436276|449359083|FG022|Overall Study|Withdrawal by Subject|14|||
124926158|NCT04436276|449359061|FG000|Overall Study|Other|3|||
125212301|NCT00703118|450403319|FG002|Overall Study|Withdrawal by Subject|13|||
125212302|NCT00703118|450403317|FG000|Overall Study|Other|0|||
125212303|NCT00703118|450403318|FG001|Overall Study|Other|0|||
125212304|NCT00703118|450403319|FG002|Overall Study|Other|1|||
124926159|NCT04436276|449359062|FG001|Overall Study|Other|2|||
124926160|NCT04436276|449359063|FG002|Overall Study|Other|5|||
124926161|NCT04436276|449359064|FG003|Overall Study|Other|9|||
124926162|NCT04436276|449359065|FG004|Overall Study|Other|23|||
124926163|NCT04436276|449359066|FG005|Overall Study|Other|1|||
124926164|NCT04436276|449359067|FG006|Overall Study|Other|0|||
124926165|NCT04436276|449359068|FG007|Overall Study|Other|0|||
124926166|NCT04436276|449359069|FG008|Overall Study|Other|0|||
125212305|NCT01204918|450403324|FG000|Overall Study|Withdrawal by Subject|4|||
124926167|NCT04436276|449359070|FG009|Overall Study|Other|0|||
124926168|NCT04436276|449359071|FG010|Overall Study|Other|3|||
124926169|NCT04436276|449359072|FG011|Overall Study|Other|1|||
124926170|NCT04436276|449359073|FG012|Overall Study|Other|1|||
124926171|NCT04436276|449359074|FG013|Overall Study|Other|2|||
124926172|NCT04436276|449359075|FG014|Overall Study|Other|3|||
124926173|NCT04436276|449359076|FG015|Overall Study|Other|0|||
124926174|NCT04436276|449359077|FG016|Overall Study|Other|0|||
124926175|NCT04436276|449359078|FG017|Overall Study|Other|6|||
125212306|NCT01204918|450403325|FG001|Overall Study|Withdrawal by Subject|10|||
124926176|NCT04436276|449359079|FG018|Overall Study|Other|1|||
124926177|NCT04436276|449359080|FG019|Overall Study|Other|0|||
124926178|NCT04436276|449359081|FG020|Overall Study|Other|2|||
124926179|NCT04436276|449359082|FG021|Overall Study|Other|2|||
124926180|NCT04436276|449359083|FG022|Overall Study|Other|60|||
124926181|NCT00324805|449359084|FG000|Overall Study|Adverse Event|62|||
124926182|NCT00324805|449359085|FG001|Overall Study|Adverse Event|203|||
124926183|NCT00324805|449359084|FG000|Overall Study|Progression|7|||
124926184|NCT00324805|449359085|FG001|Overall Study|Progression|35|||
124926185|NCT00324805|449359084|FG000|Overall Study|Withdrawal by Subject|51|||
124926186|NCT00324805|449359085|FG001|Overall Study|Withdrawal by Subject|174|||
124926187|NCT00324805|449359084|FG000|Overall Study|Death|6|||
124926188|NCT00324805|449359085|FG001|Overall Study|Death|9|||
124926189|NCT00324805|449359084|FG000|Overall Study|Alternative therapy|4|||
124926190|NCT00324805|449359085|FG001|Overall Study|Alternative therapy|8|||
124926191|NCT00324805|449359084|FG000|Overall Study|Other complicating disease|1|||
124926192|NCT00324805|449359085|FG001|Overall Study|Other complicating disease|9|||
124926193|NCT00324805|449359084|FG000|Overall Study|Other reasons|7|||
124926194|NCT00324805|449359085|FG001|Overall Study|Other reasons|26|||
124926195|NCT00324805|449359084|FG000|Overall Study|Other|0|||
124926196|NCT00324805|449359085|FG001|Overall Study|Other|2|||
124926197|NCT00324805|449359084|FG000|Overall Study|Did not start therapy|12|||
124926198|NCT00324805|449359085|FG001|Overall Study|Did not start therapy|17|||
124926199|NCT03931174|449359086|FG000|Providers|Staff left organization|26|||
124926200|NCT03931174|449359087|FG001|Providers|Staff left organization|25|||
125119447|NCT03036579|450061241|FG000|3 Years|Lost to Follow-up|0|||
125119448|NCT03036579|450061242|FG001|3 Years|Lost to Follow-up|1|||
125119449|NCT02848599|450061243|FG000|Overall Study|Protocol Violation|7|||
125119450|NCT02848599|450061244|FG001|Overall Study|Protocol Violation|9|||
125119451|NCT02352337|450061245|FG000|Overall Study|Patients never treated|4|||
125119452|NCT02352337|450061246|FG001|Overall Study|Patients never treated|1|||
124926201|NCT03931174|449359086|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
124926202|NCT03931174|449359087|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
124926203|NCT03931174|449359086|FG000|Providers|Lost to Follow-up|4|||
124926204|NCT03931174|449359087|FG001|Providers|Lost to Follow-up|4|||
124926205|NCT03931174|449359086|FG000|Patients|Post-consent screening failure|1|||
124926206|NCT03931174|449359087|FG001|Patients|Post-consent screening failure|1|||
124926207|NCT03931174|449359086|FG000|Patients|Death|1|||
124926208|NCT03931174|449359087|FG001|Patients|Death|1|||
124926209|NCT03931174|449359086|FG000|Patients|Lost to Follow-up|60|||
124926210|NCT03931174|449359087|FG001|Patients|Lost to Follow-up|89|||
124926211|NCT03322267|449359088|FG000|Overall Study|Lack of Efficacy|11|||
124926212|NCT03322267|449359088|FG000|Overall Study|Adverse Event|1|||
124926213|NCT03322267|449359088|FG000|Overall Study|Withdrawal by Subject|2|||
124926214|NCT03852472|449359098|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
124926215|NCT03852472|449359099|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
124926216|NCT03852472|449359100|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
124926217|NCT03852472|449359101|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
124926218|NCT03852472|449359102|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
124926219|NCT03852472|449359098|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
124926220|NCT03852472|449359099|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
124926221|NCT03852472|449359100|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
124926222|NCT03852472|449359101|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
124926223|NCT03852472|449359102|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
124926224|NCT03852472|449359098|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
124926225|NCT03852472|449359099|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
124926226|NCT03852472|449359100|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
124926227|NCT03852472|449359101|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
124926228|NCT03852472|449359102|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
124926229|NCT03852472|449359098|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
124926230|NCT03852472|449359099|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
124926231|NCT03852472|449359100|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
124926232|NCT03852472|449359101|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
124926233|NCT03852472|449359102|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
124926234|NCT03852472|449359098|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
124926235|NCT03852472|449359099|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
124926236|NCT03852472|449359100|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
124926237|NCT03852472|449359101|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
124969581|NCT03520075|449517418|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
125119453|NCT02352337|450061247|FG002|Overall Study|Patients never treated|2|||
125119454|NCT00992407|450061250|FG000|Overall Study|Protocol Violation|2|||
125119455|NCT00992407|450061251|FG001|Overall Study|Protocol Violation|1|||
125119456|NCT00992407|450061250|FG000|Overall Study|Lost to Follow-up|3|||
125119457|NCT00992407|450061251|FG001|Overall Study|Lost to Follow-up|3|||
124926238|NCT03852472|449359102|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
124926239|NCT03852472|449359098|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
124926240|NCT03852472|449359099|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
124926241|NCT03852472|449359100|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
124926242|NCT03852472|449359101|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
124926243|NCT03852472|449359102|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
124926244|NCT03852472|449359098|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
124926245|NCT03852472|449359099|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
124926246|NCT03852472|449359100|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
124926247|NCT03852472|449359101|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
124926248|NCT03852472|449359102|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
124926249|NCT03852472|449359098|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
124926250|NCT03852472|449359099|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
124926251|NCT03852472|449359100|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
124926252|NCT03852472|449359101|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
124926253|NCT03852472|449359102|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
124926254|NCT03852472|449359098|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
124926255|NCT03852472|449359099|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
124926256|NCT03852472|449359100|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
124926257|NCT03852472|449359101|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
124926258|NCT03852472|449359102|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
124926259|NCT03852472|449359098|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
124926260|NCT03852472|449359099|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
124926261|NCT03852472|449359100|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
124926262|NCT03852472|449359101|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
124926263|NCT03852472|449359102|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
124926264|NCT03852472|449359098|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
124926265|NCT03852472|449359099|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
124926266|NCT03852472|449359100|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
124926267|NCT03852472|449359101|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
124926268|NCT03852472|449359102|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
124926269|NCT03852472|449359098|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
124926270|NCT03852472|449359099|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
124926271|NCT03852472|449359100|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
124926272|NCT03852472|449359101|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
124926273|NCT03852472|449359102|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
124926274|NCT03852472|449359098|FG000|Period 2 - Week 44|Adverse Event|0|||
124926275|NCT03852472|449359099|FG001|Period 2 - Week 44|Adverse Event|3|||
124926276|NCT03852472|449359100|FG002|Period 2 - Week 44|Adverse Event|1|||
124926277|NCT03852472|449359101|FG003|Period 2 - Week 44|Adverse Event|2|||
124926278|NCT03852472|449359102|FG004|Period 2 - Week 44|Adverse Event|2|||
124926279|NCT03852472|449359098|FG000|Period 2 - Week 44|COVID-19 Related|0|||
124926280|NCT03852472|449359099|FG001|Period 2 - Week 44|COVID-19 Related|0|||
124926281|NCT03852472|449359100|FG002|Period 2 - Week 44|COVID-19 Related|0|||
124926282|NCT03852472|449359101|FG003|Period 2 - Week 44|COVID-19 Related|1|||
124926283|NCT03852472|449359102|FG004|Period 2 - Week 44|COVID-19 Related|0|||
124926284|NCT03852472|449359098|FG000|Period 2 - Week 44|Reason not stated|0|||
124926285|NCT03852472|449359099|FG001|Period 2 - Week 44|Reason not stated|0|||
124926286|NCT03852472|449359100|FG002|Period 2 - Week 44|Reason not stated|0|||
124926287|NCT03852472|449359101|FG003|Period 2 - Week 44|Reason not stated|0|||
124926288|NCT03852472|449359102|FG004|Period 2 - Week 44|Reason not stated|1|||
124926289|NCT01919554|449359103|FG000|Overall Study|Withdrawal by Subject|0|||
124926290|NCT01919554|449359104|FG001|Overall Study|Withdrawal by Subject|0|||
124926291|NCT01919554|449359105|FG002|Overall Study|Withdrawal by Subject|1|||
124926292|NCT01919554|449359106|FG003|Overall Study|Withdrawal by Subject|1|||
124926293|NCT05977530|449359107|FG000|Overall Study|Withdrawal by Subject|1|||
124926294|NCT05977530|449359107|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
124926295|NCT06457802|449359108|FG000|Overall Study|Early termination of study prior to participant completion|2|||
124926296|NCT06457802|449359109|FG001|Overall Study|Early termination of study prior to participant completion|2|||
124926297|NCT01467427|449359110|FG000|Overall Study|Withdrawal by Subject|1|||
124926298|NCT01467427|449359111|FG001|Overall Study|Withdrawal by Subject|0|||
124926299|NCT01467427|449359110|FG000|Overall Study|Not continuing in extension phase|0|||
124926300|NCT01467427|449359111|FG001|Overall Study|Not continuing in extension phase|2|||
124926301|NCT01467427|449359110|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
124926302|NCT01467427|449359111|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
125024130|NCT03529773|449711369|FG036|Overall Study|Withdrawal by Subject|0|||
125024131|NCT03529773|449711370|FG037|Overall Study|Withdrawal by Subject|2|||
125024132|NCT03529773|449711371|FG038|Overall Study|Withdrawal by Subject|1|||
124926303|NCT01467427|449359110|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
125212307|NCT01204918|450403326|FG002|Overall Study|Withdrawal by Subject|5|||
125212308|NCT01853696|450403329|FG000|Overall Study|Withdrawal by Subject|1|||
125024133|NCT03529773|449711372|FG039|Overall Study|Withdrawal by Subject|1|||
125024134|NCT03529773|449711333|FG000|Overall Study|Screen Failure|0|||
125024135|NCT03529773|449711334|FG001|Overall Study|Screen Failure|0|||
125024136|NCT03529773|449711335|FG002|Overall Study|Screen Failure|0|||
125024137|NCT03529773|449711336|FG003|Overall Study|Screen Failure|0|||
125024138|NCT03529773|449711337|FG004|Overall Study|Screen Failure|0|||
125024139|NCT03529773|449711338|FG005|Overall Study|Screen Failure|0|||
125024140|NCT03529773|449711339|FG006|Overall Study|Screen Failure|0|||
125024141|NCT03529773|449711340|FG007|Overall Study|Screen Failure|0|||
125024142|NCT03529773|449711341|FG008|Overall Study|Screen Failure|0|||
125024143|NCT03529773|449711342|FG009|Overall Study|Screen Failure|0|||
125024144|NCT03529773|449711343|FG010|Overall Study|Screen Failure|0|||
125024145|NCT03529773|449711344|FG011|Overall Study|Screen Failure|0|||
125024146|NCT03529773|449711345|FG012|Overall Study|Screen Failure|0|||
125024147|NCT03529773|449711346|FG013|Overall Study|Screen Failure|0|||
125024148|NCT03529773|449711347|FG014|Overall Study|Screen Failure|0|||
125024149|NCT03529773|449711348|FG015|Overall Study|Screen Failure|0|||
125024150|NCT03529773|449711349|FG016|Overall Study|Screen Failure|0|||
125119458|NCT00992407|450061250|FG000|Overall Study|Adverse Event|3|||
125119459|NCT00992407|450061251|FG001|Overall Study|Adverse Event|2|||
125024151|NCT03529773|449711350|FG017|Overall Study|Screen Failure|0|||
125024152|NCT03529773|449711351|FG018|Overall Study|Screen Failure|0|||
125024153|NCT03529773|449711352|FG019|Overall Study|Screen Failure|0|||
125024154|NCT03529773|449711353|FG020|Overall Study|Screen Failure|0|||
125119460|NCT00992407|450061250|FG000|Overall Study|protocol Violation & Adverse events|2|||
125119461|NCT00992407|450061251|FG001|Overall Study|protocol Violation & Adverse events|4|||
125119462|NCT00992407|450061250|FG000|Overall Study|Other|2|||
125119463|NCT00992407|450061251|FG001|Overall Study|Other|0|||
125119464|NCT00992407|450061250|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
125119465|NCT00992407|450061251|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
125119466|NCT00992407|450061250|FG000|Overall Study|Study medication not administered|17|||
125119467|NCT00992407|450061251|FG001|Overall Study|Study medication not administered|13|||
125119468|NCT02398188|450061252|FG000|Overall Study|Adverse Event|2|||
125119469|NCT02398188|450061253|FG001|Overall Study|Adverse Event|3|||
125212309|NCT01853696|450403330|FG001|Overall Study|Withdrawal by Subject|1|||
124926304|NCT01467427|449359111|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
124926305|NCT01467427|449359110|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
124926306|NCT01467427|449359111|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
124926307|NCT01467427|449359110|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
124926308|NCT01467427|449359111|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
124926309|NCT03161028|449359112|FG000|Overall Study|Withdrawal by Subject|6|||
124926310|NCT03161028|449359113|FG001|Overall Study|Withdrawal by Subject|4|||
124926311|NCT03161028|449359112|FG000|Overall Study|Adverse Event|5|||
124926312|NCT03161028|449359113|FG001|Overall Study|Adverse Event|1|||
124926313|NCT03161028|449359112|FG000|Overall Study|Study drug side effects|2|||
124926314|NCT03161028|449359113|FG001|Overall Study|Study drug side effects|2|||
124926315|NCT03161028|449359112|FG000|Overall Study|Administrative PD/UP|4|||
124926316|NCT03161028|449359113|FG001|Overall Study|Administrative PD/UP|2|||
124926317|NCT03161028|449359112|FG000|Overall Study|Lost to Follow-up|2|||
124926318|NCT03161028|449359113|FG001|Overall Study|Lost to Follow-up|0|||
124926319|NCT03161028|449359112|FG000|Overall Study|Unable to comply with procedures|1|||
124926320|NCT03161028|449359113|FG001|Overall Study|Unable to comply with procedures|1|||
124926321|NCT00736723|449359114|FG000|Overall Study|Withdrawal by Subject|4|||
124926322|NCT00736723|449359115|FG001|Overall Study|Withdrawal by Subject|3|||
124926323|NCT03492216|449359116|FG000|Overall Study|Death|1|||
124926324|NCT03492216|449359117|FG001|Overall Study|Death|0|||
124926325|NCT03492216|449359118|FG002|Overall Study|Death|4|||
124926326|NCT03492216|449359119|FG003|Overall Study|Death|0|||
124926327|NCT03492216|449359116|FG000|Overall Study|Withdrawal by Subject|5|||
124926328|NCT03492216|449359117|FG001|Overall Study|Withdrawal by Subject|3|||
124926329|NCT03492216|449359118|FG002|Overall Study|Withdrawal by Subject|1|||
124926330|NCT03492216|449359119|FG003|Overall Study|Withdrawal by Subject|1|||
124926331|NCT03492216|449359116|FG000|Overall Study|Lost to Follow-up|9|||
124926332|NCT03492216|449359117|FG001|Overall Study|Lost to Follow-up|2|||
124926333|NCT03492216|449359118|FG002|Overall Study|Lost to Follow-up|7|||
124926334|NCT03492216|449359119|FG003|Overall Study|Lost to Follow-up|8|||
124926335|NCT03492216|449359116|FG000|Overall Study|Moved|5|||
124926336|NCT03492216|449359117|FG001|Overall Study|Moved|3|||
124926337|NCT03492216|449359118|FG002|Overall Study|Moved|3|||
124926338|NCT03492216|449359119|FG003|Overall Study|Moved|5|||
124926339|NCT03492216|449359116|FG000|Overall Study|Too ill|0|||
124926340|NCT03492216|449359117|FG001|Overall Study|Too ill|1|||
124926341|NCT03492216|449359118|FG002|Overall Study|Too ill|0|||
124926342|NCT03492216|449359119|FG003|Overall Study|Too ill|0|||
124926343|NCT03492216|449359116|FG000|Overall Study|Incarcerated|0|||
124926344|NCT03492216|449359117|FG001|Overall Study|Incarcerated|0|||
124926345|NCT03492216|449359118|FG002|Overall Study|Incarcerated|2|||
124926346|NCT03492216|449359119|FG003|Overall Study|Incarcerated|0|||
124926347|NCT04016662|449360791|FG000|Run-In Phase|Death|1|||
124926348|NCT04016662|449360791|FG000|Run-In Phase|Withdrawal by Subject|11|||
124926349|NCT04016662|449360791|FG000|Run-In Phase|Not meeting screening eligibility|9|||
124926350|NCT04016662|449360791|FG000|Run-In Phase|Physician Decision|3|||
125024155|NCT03529773|449711354|FG021|Overall Study|Screen Failure|0|||
125024156|NCT03529773|449711355|FG022|Overall Study|Screen Failure|0|||
125024157|NCT03529773|449711356|FG023|Overall Study|Screen Failure|0|||
125024158|NCT03529773|449711357|FG024|Overall Study|Screen Failure|0|||
125024159|NCT03529773|449711358|FG025|Overall Study|Screen Failure|0|||
125024160|NCT03529773|449711359|FG026|Overall Study|Screen Failure|0|||
125024161|NCT03529773|449711360|FG027|Overall Study|Screen Failure|0|||
125024162|NCT03529773|449711361|FG028|Overall Study|Screen Failure|0|||
125024163|NCT03529773|449711362|FG029|Overall Study|Screen Failure|0|||
125024164|NCT03529773|449711363|FG030|Overall Study|Screen Failure|0|||
125024165|NCT03529773|449711364|FG031|Overall Study|Screen Failure|0|||
125024166|NCT03529773|449711365|FG032|Overall Study|Screen Failure|0|||
125024167|NCT03529773|449711366|FG033|Overall Study|Screen Failure|0|||
124926351|NCT04016662|449360791|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
124926352|NCT04016662|449360791|FG000|PLGS (12 Weeks)|Death|1|||
124926353|NCT04016662|449360791|FG000|SAP (12 Weeks)|Death|1|||
124926354|NCT03021096|449360792|FG000|Overall Study|Lost to Follow-up|4|||
124926355|NCT03021096|449360792|FG000|Overall Study|Protocol Violation|2|||
124926356|NCT00764751|449360802|FG000|Overall Study|Adverse Event|1|||
124926357|NCT00764751|449360803|FG001|Overall Study|Adverse Event|1|||
124926358|NCT00764751|449360802|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
124926359|NCT00764751|449360803|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
124926360|NCT02998268|449360809|FG000|Overall Study|Adverse Event|0|||
124926361|NCT02998268|449360810|FG001|Overall Study|Adverse Event|2|||
124926362|NCT02998268|449360809|FG000|Overall Study|Withdrawal by Subject|0|||
124926363|NCT02998268|449360810|FG001|Overall Study|Withdrawal by Subject|1|||
124926364|NCT01175356|449360811|FG000|Overall Study|Death|1|||
124926365|NCT01175356|449360811|FG000|Overall Study|Lack of Efficacy|12|||
124926366|NCT01175356|449360811|FG000|Overall Study|Lost to Follow-up|1|||
124926367|NCT01175356|449360811|FG000|Overall Study|Physician Decision|23|||
124926368|NCT01175356|449360811|FG000|Overall Study|Ineligible|1|||
124926369|NCT01175356|449360811|FG000|Overall Study|Treatment Slot Not Available|18|||
124926370|NCT01175356|449360811|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
124926371|NCT01175356|449360811|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
124926372|NCT01175356|449360811|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
124926373|NCT01175356|449360811|FG000|Overall Study|Inadequate stem cell for transplant|1|||
124926374|NCT01175356|449360811|FG000|Overall Study|Initiation other tx prior to completion|9|||
124926375|NCT03020199|449360816|FG000|Treatment Period|Adverse Event|0|||
124926376|NCT03020199|449360817|FG001|Treatment Period|Adverse Event|2|||
124926377|NCT03020199|449360816|FG000|Treatment Period|Lack of Efficacy|1|||
124926378|NCT03020199|449360817|FG001|Treatment Period|Lack of Efficacy|6|||
124926379|NCT03020199|449360816|FG000|Treatment Period|Lost to Follow-up|1|||
124926380|NCT03020199|449360817|FG001|Treatment Period|Lost to Follow-up|6|||
124926381|NCT03020199|449360816|FG000|Treatment Period|Physician Decision|0|||
124926382|NCT03020199|449360817|FG001|Treatment Period|Physician Decision|1|||
124926383|NCT03020199|449360816|FG000|Treatment Period|Subject/guardian decision|8|||
124926384|NCT03020199|449360817|FG001|Treatment Period|Subject/guardian decision|15|||
124926385|NCT03020199|449360816|FG000|Treatment Period|Subjects not treated|3|||
124926386|NCT03020199|449360817|FG001|Treatment Period|Subjects not treated|4|||
124926387|NCT03020199|449360816|FG000|Follow-up Period|Disease relapse|32|||
124926388|NCT03020199|449360817|FG001|Follow-up Period|Disease relapse|7|||
124926389|NCT03020199|449360816|FG000|Follow-up Period|Lack of Efficacy|1|||
124926390|NCT03020199|449360817|FG001|Follow-up Period|Lack of Efficacy|2|||
124926391|NCT03020199|449360816|FG000|Follow-up Period|Lost to Follow-up|4|||
124926392|NCT03020199|449360817|FG001|Follow-up Period|Lost to Follow-up|6|||
124926393|NCT03020199|449360816|FG000|Follow-up Period|Physician Decision|2|||
124926394|NCT03020199|449360817|FG001|Follow-up Period|Physician Decision|2|||
124926395|NCT03020199|449360816|FG000|Follow-up Period|Protocol Violation|1|||
124926396|NCT03020199|449360817|FG001|Follow-up Period|Protocol Violation|2|||
124926397|NCT03020199|449360816|FG000|Follow-up Period|Study terminated by Sponsor|6|||
124926398|NCT03020199|449360817|FG001|Follow-up Period|Study terminated by Sponsor|3|||
124926399|NCT03020199|449360816|FG000|Follow-up Period|Subject/guardian decision|14|||
124926400|NCT03020199|449360817|FG001|Follow-up Period|Subject/guardian decision|9|||
124926401|NCT05583578|449360818|FG000|Overall Study|Withdrawal by Subject|2|||
124926402|NCT05583578|449360819|FG001|Overall Study|Withdrawal by Subject|0|||
124926403|NCT04005794|449360822|FG000|Overall Study|Lost to Follow-up|0|||
124926404|NCT04005794|449360823|FG001|Overall Study|Lost to Follow-up|4|||
124926405|NCT04005794|449360824|FG002|Overall Study|Lost to Follow-up|0|||
124926406|NCT04313972|449360825|FG000|Overall Study|Withdrawal by Subject|0|||
124926407|NCT04313972|449360826|FG001|Overall Study|Withdrawal by Subject|1|||
124926408|NCT02547363|449360827|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
124926409|NCT02547363|449360828|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
124926410|NCT02547363|449360827|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
124926411|NCT02547363|449360828|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
124926412|NCT02547363|449360827|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
124926413|NCT02547363|449360828|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
124926414|NCT02547363|449360827|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
124926415|NCT02547363|449360828|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
124926416|NCT02547363|449360827|FG000|12-month Follow-up|Withdrawal by Subject|4|||
124926417|NCT02547363|449360828|FG001|12-month Follow-up|Withdrawal by Subject|3|||
124926418|NCT02547363|449360827|FG000|12-month Follow-up|Lost to Follow-up|4|||
124926419|NCT02547363|449360828|FG001|12-month Follow-up|Lost to Follow-up|1|||
124926420|NCT02547363|449360827|FG000|12-month Follow-up|Lack of Efficacy|1|||
124926421|NCT02547363|449360828|FG001|12-month Follow-up|Lack of Efficacy|1|||
124926422|NCT02547363|449360827|FG000|12-month Follow-up|Other|1|||
124926423|NCT02547363|449360828|FG001|12-month Follow-up|Other|0|||
124926424|NCT05201079|449360841|FG000|Overall Study|Adverse Event|7|||
124926425|NCT05201079|449360842|FG001|Overall Study|Adverse Event|11|||
124926426|NCT05201079|449360841|FG000|Overall Study|Death|1|||
124926427|NCT05201079|449360842|FG001|Overall Study|Death|1|||
124926428|NCT05201079|449360841|FG000|Overall Study|Lack of Efficacy|0|||
124926429|NCT05201079|449360842|FG001|Overall Study|Lack of Efficacy|2|||
124926430|NCT05201079|449360841|FG000|Overall Study|Lost to Follow-up|0|||
124926431|NCT05201079|449360842|FG001|Overall Study|Lost to Follow-up|1|||
124926432|NCT05201079|449360841|FG000|Overall Study|Physician Decision|1|||
124926433|NCT05201079|449360842|FG001|Overall Study|Physician Decision|1|||
124926434|NCT05201079|449360841|FG000|Overall Study|Protocol Violation|1|||
124926435|NCT05201079|449360842|FG001|Overall Study|Protocol Violation|0|||
124926436|NCT05201079|449360841|FG000|Overall Study|Withdrawal by Subject|1|||
124926437|NCT05201079|449360842|FG001|Overall Study|Withdrawal by Subject|0|||
124926438|NCT05201079|449360841|FG000|Overall Study|Forbidden medication|9|||
124926439|NCT05201079|449360842|FG001|Overall Study|Forbidden medication|5|||
124926440|NCT05201079|449360841|FG000|Overall Study|Transfer to another hospital|0|||
124926441|NCT05201079|449360842|FG001|Overall Study|Transfer to another hospital|1|||
124926442|NCT05201079|449360841|FG000|Overall Study|Clinical condition|1|||
124926443|NCT05201079|449360842|FG001|Overall Study|Clinical condition|0|||
124926444|NCT05201079|449360841|FG000|Overall Study|SAE and sepsis|1|||
124926445|NCT05201079|449360842|FG001|Overall Study|SAE and sepsis|0|||
124926446|NCT05808257|449360845|FG000|Overall Study|Lost to Follow-up|8|||
124926447|NCT05808257|449360846|FG001|Overall Study|Lost to Follow-up|8|||
125119470|NCT02398188|450061252|FG000|Overall Study|Lost to Follow-up|5|||
125119471|NCT02398188|450061253|FG001|Overall Study|Lost to Follow-up|0|||
125119472|NCT02398188|450061252|FG000|Overall Study|Non-compliance|4|||
125119473|NCT02398188|450061253|FG001|Overall Study|Non-compliance|4|||
125119474|NCT02398188|450061252|FG000|Overall Study|Protocol Violation|6|||
125119475|NCT02398188|450061253|FG001|Overall Study|Protocol Violation|10|||
125119476|NCT02398188|450061252|FG000|Overall Study|Sponsor Decision|2|||
125119477|NCT02398188|450061253|FG001|Overall Study|Sponsor Decision|1|||
125119478|NCT02398188|450061252|FG000|Overall Study|Pregnancy|1|||
125119479|NCT02398188|450061253|FG001|Overall Study|Pregnancy|0|||
125119480|NCT02398188|450061252|FG000|Overall Study|Withdrawal by Subject|7|||
125119481|NCT02398188|450061253|FG001|Overall Study|Withdrawal by Subject|16|||
125119482|NCT00782509|450061254|FG000|Overall Study|Adverse Event|20|||
125119483|NCT00782509|450061255|FG001|Overall Study|Adverse Event|10|||
125119484|NCT00782509|450061256|FG002|Overall Study|Adverse Event|20|||
125119485|NCT00782509|450061254|FG000|Overall Study|Lost to Follow-up|1|||
125119486|NCT00782509|450061255|FG001|Overall Study|Lost to Follow-up|2|||
125119487|NCT00782509|450061256|FG002|Overall Study|Lost to Follow-up|3|||
125119488|NCT00782509|450061254|FG000|Overall Study|Withdrawal by Subject|3|||
125119489|NCT00782509|450061255|FG001|Overall Study|Withdrawal by Subject|5|||
125119490|NCT00782509|450061256|FG002|Overall Study|Withdrawal by Subject|8|||
125119491|NCT00782509|450061254|FG000|Overall Study|Non compliance with protocol|2|||
125119492|NCT00782509|450061255|FG001|Overall Study|Non compliance with protocol|0|||
125119493|NCT00782509|450061256|FG002|Overall Study|Non compliance with protocol|0|||
125119494|NCT00782509|450061254|FG000|Overall Study|Other reasons not stated above|5|||
125119495|NCT00782509|450061255|FG001|Overall Study|Other reasons not stated above|2|||
125119496|NCT00782509|450061256|FG002|Overall Study|Other reasons not stated above|3|||
125119497|NCT00782509|450061254|FG000|Overall Study|Lack of Efficacy|10|||
125119498|NCT00782509|450061255|FG001|Overall Study|Lack of Efficacy|5|||
125119499|NCT00782509|450061256|FG002|Overall Study|Lack of Efficacy|2|||
125119500|NCT02918162|450061258|FG000|Overall Study|Withdrawal by Subject|1|||
125119501|NCT02918162|450061258|FG000|Overall Study|Omental Disease|1|||
125119502|NCT00395226|450061259|FG000|Overall Study|Adverse Event|4|||
125119503|NCT00395226|450061260|FG001|Overall Study|Adverse Event|3|||
125119504|NCT00395226|450061259|FG000|Overall Study|Withdrawal by Subject|0|||
125119505|NCT00395226|450061260|FG001|Overall Study|Withdrawal by Subject|1|||
125119506|NCT00395226|450061259|FG000|Overall Study|Lost to Follow-up|0|||
125212310|NCT01853696|450403329|FG000|Overall Study|Lost to Follow-up|5|||
125212311|NCT01853696|450403330|FG001|Overall Study|Lost to Follow-up|4|||
125212312|NCT00431067|450403333|FG000|Overall Study|Other Adverse Event|9|||
125212313|NCT00431067|450403333|FG000|Overall Study|Progressive disease|30|||
125212314|NCT00431067|450403333|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
125212315|NCT00849290|450403334|FG000|Overall Study|Adverse Event|3|||
125212316|NCT00849290|450403334|FG000|Overall Study|Death|14|||
125212317|NCT00849290|450403334|FG000|Overall Study|Withdrawal by Subject|11|||
125212318|NCT00849290|450403334|FG000|Overall Study|Lost to Follow-up|2|||
125212319|NCT00849290|450403334|FG000|Overall Study|Protocol Violation|5|||
125212320|NCT00849290|450403334|FG000|Overall Study|Disease Progression|20|||
125212321|NCT00548249|450403335|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
125212322|NCT00548249|450403336|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
125212323|NCT00548249|450403337|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
125212324|NCT00548249|450403338|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
125212325|NCT00548249|450403339|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
125212326|NCT00548249|450403335|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
125212327|NCT00548249|450403336|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
125212328|NCT00548249|450403337|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
125212329|NCT00548249|450403338|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
125212330|NCT00548249|450403339|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
125212331|NCT00548249|450403335|FG000|Overall Study|Protocol Violation|1|||
125212332|NCT00548249|450403336|FG001|Overall Study|Protocol Violation|1|||
125212333|NCT00548249|450403337|FG002|Overall Study|Protocol Violation|4|||
125212334|NCT00548249|450403338|FG003|Overall Study|Protocol Violation|0|||
125212335|NCT00548249|450403339|FG004|Overall Study|Protocol Violation|3|||
125212336|NCT00548249|450403335|FG000|Overall Study|Miscellaneous|2|||
125212337|NCT00548249|450403336|FG001|Overall Study|Miscellaneous|3|||
125212338|NCT00548249|450403337|FG002|Overall Study|Miscellaneous|2|||
125212339|NCT00548249|450403338|FG003|Overall Study|Miscellaneous|0|||
125212340|NCT00548249|450403339|FG004|Overall Study|Miscellaneous|2|||
125212341|NCT00548249|450403335|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
125212342|NCT00548249|450403336|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
125212343|NCT00548249|450403337|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
125212344|NCT00548249|450403338|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
125212345|NCT00548249|450403339|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
125212346|NCT00548249|450403335|FG000|Overall Study|Adverse Event|2|||
124926448|NCT04568486|449360847|FG000|Overall Study|Withdrawal by Subject|26|||
124926449|NCT04568486|449360847|FG000|Overall Study|Lost to Follow-up|7|||
124926450|NCT04042233|449360848|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
124926451|NCT04042233|449360849|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
124926452|NCT04042233|449360848|FG000|Overall Study|Protocol Violation|0|||
124926453|NCT04042233|449360849|FG001|Overall Study|Protocol Violation|2|||
124926454|NCT04907851|449360852|FG000|Overall Study|Consent withdrawn|1|||
124926455|NCT04907851|449360853|FG001|Overall Study|Consent withdrawn|2|||
124926456|NCT04907851|449360854|FG002|Overall Study|Consent withdrawn|0|||
124926457|NCT04907851|449360852|FG000|Overall Study|Death|5|||
124926458|NCT04907851|449360853|FG001|Overall Study|Death|15|||
124926459|NCT04907851|449360854|FG002|Overall Study|Death|10|||
124926460|NCT05281562|449360862|FG000|Overall Study|Ineligible patient|1|||
124926461|NCT05281562|449360863|FG001|Overall Study|Ineligible patient|0|||
124926462|NCT05477186|449360867|FG000|Overall Study|Vaccine not administered|0|||
124926463|NCT05477186|449360868|FG001|Overall Study|Vaccine not administered|2|||
124926464|NCT05477186|449360869|FG002|Overall Study|Vaccine not administered|1|||
124926465|NCT05477186|449360870|FG003|Overall Study|Vaccine not administered|0|||
125024168|NCT03529773|449711367|FG034|Overall Study|Screen Failure|0|||
124926466|NCT05477186|449360871|FG004|Overall Study|Vaccine not administered|1|||
125212347|NCT00548249|450403336|FG001|Overall Study|Adverse Event|2|||
125212348|NCT00548249|450403337|FG002|Overall Study|Adverse Event|0|||
125212349|NCT00548249|450403338|FG003|Overall Study|Adverse Event|1|||
124926467|NCT05477186|449360872|FG005|Overall Study|Vaccine not administered|0|||
124926468|NCT05477186|449360873|FG006|Overall Study|Vaccine not administered|0|||
124926469|NCT05477186|449360867|FG000|Overall Study|Withdrawal by Subject|1|||
125212350|NCT00548249|450403339|FG004|Overall Study|Adverse Event|1|||
125212351|NCT00548249|450403335|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
124926470|NCT05477186|449360868|FG001|Overall Study|Withdrawal by Subject|0|||
124926471|NCT05477186|449360869|FG002|Overall Study|Withdrawal by Subject|0|||
124926472|NCT05477186|449360870|FG003|Overall Study|Withdrawal by Subject|0|||
124926473|NCT05477186|449360871|FG004|Overall Study|Withdrawal by Subject|0|||
124926474|NCT05477186|449360872|FG005|Overall Study|Withdrawal by Subject|1|||
124926475|NCT05477186|449360873|FG006|Overall Study|Withdrawal by Subject|0|||
124926476|NCT05477186|449360867|FG000|Overall Study|Lost to Follow-up|1|||
124926477|NCT05477186|449360868|FG001|Overall Study|Lost to Follow-up|0|||
124926478|NCT05477186|449360869|FG002|Overall Study|Lost to Follow-up|2|||
124926479|NCT05477186|449360870|FG003|Overall Study|Lost to Follow-up|1|||
124926480|NCT05477186|449360871|FG004|Overall Study|Lost to Follow-up|1|||
124926481|NCT05477186|449360872|FG005|Overall Study|Lost to Follow-up|0|||
124926482|NCT05477186|449360873|FG006|Overall Study|Lost to Follow-up|2|||
124926483|NCT05792085|449360876|FG000|Overall Study|Death|0|||
124926484|NCT05792085|449360877|FG001|Overall Study|Death|0|||
124926485|NCT05792085|449360878|FG002|Overall Study|Death|0|||
124926486|NCT05792085|449360879|FG003|Overall Study|Death|0|||
124926487|NCT05792085|449360880|FG004|Overall Study|Death|1|||
124926488|NCT04719832|449360885|FG000|Overall Study|Adverse Event|2|||
124926489|NCT04719832|449360886|FG001|Overall Study|Adverse Event|0|||
124926490|NCT04719832|449360885|FG000|Overall Study|Lack of Efficacy|2|||
124926491|NCT04719832|449360886|FG001|Overall Study|Lack of Efficacy|4|||
124926492|NCT04719832|449360885|FG000|Overall Study|Lost to Follow-up|0|||
124926493|NCT04719832|449360886|FG001|Overall Study|Lost to Follow-up|2|||
124926494|NCT04719832|449360885|FG000|Overall Study|Physician Decision|0|||
124926495|NCT04719832|449360886|FG001|Overall Study|Physician Decision|1|||
124926496|NCT04719832|449360885|FG000|Overall Study|Pregnancy|1|||
124926497|NCT04719832|449360886|FG001|Overall Study|Pregnancy|1|||
124926498|NCT04719832|449360885|FG000|Overall Study|Withdrawal by Subject|5|||
124926499|NCT04719832|449360886|FG001|Overall Study|Withdrawal by Subject|5|||
124926500|NCT04719832|449360885|FG000|Overall Study|Randomized, not treated|0|||
124926501|NCT04719832|449360886|FG001|Overall Study|Randomized, not treated|2|||
124926502|NCT04719832|449360885|FG000|Overall Study|GCP violations|4|||
124926503|NCT04719832|449360886|FG001|Overall Study|GCP violations|7|||
124926504|NCT04880863|449360889|FG000|Overall Study|Adverse Event|1|||
124926505|NCT04880863|449360889|FG000|Overall Study|Patient decision|2|||
124926506|NCT04880863|449360889|FG000|Overall Study|Confirmed Disease Progression|15|||
124926507|NCT04880863|449360889|FG000|Overall Study|Death|3|||
124926508|NCT04880863|449360889|FG000|Overall Study|Physician Decision|4|||
124926509|NCT04880863|449360889|FG000|Overall Study|Unconfirmed Disease Progression|4|||
124926510|NCT04880863|449360889|FG000|Overall Study|Withdrawal by Subject|2|||
124926511|NCT04880863|449360889|FG000|Overall Study|Study discontinuation by the sponsor|4|||
124926512|NCT04880863|449360889|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
124926513|NCT04880863|449360889|FG000|Overall Study|Not received study drug NAP|2|||
124926514|NCT04898673|449360892|FG000|Overall Study|Screenfail|1|||
124926515|NCT04898673|449360893|FG001|Overall Study|Screenfail|0|||
124926516|NCT03899259|449360894|FG000|Overall Study|Adverse Event|5|||
124926517|NCT03899259|449360895|FG001|Overall Study|Adverse Event|4|||
124926518|NCT03899259|449360896|FG002|Overall Study|Adverse Event|6|||
124926519|NCT03899259|449360894|FG000|Overall Study|Lack of Efficacy|5|||
124926520|NCT03899259|449360895|FG001|Overall Study|Lack of Efficacy|0|||
124926521|NCT03899259|449360896|FG002|Overall Study|Lack of Efficacy|2|||
124926522|NCT03899259|449360894|FG000|Overall Study|Pregnancy|3|||
124926523|NCT03899259|449360895|FG001|Overall Study|Pregnancy|0|||
124926524|NCT03899259|449360896|FG002|Overall Study|Pregnancy|1|||
124926525|NCT03899259|449360894|FG000|Overall Study|Physician Decision|0|||
124926526|NCT03899259|449360895|FG001|Overall Study|Physician Decision|1|||
124926527|NCT03899259|449360896|FG002|Overall Study|Physician Decision|0|||
124926528|NCT03899259|449360894|FG000|Overall Study|Protocol Deviation|1|||
124926529|NCT03899259|449360895|FG001|Overall Study|Protocol Deviation|1|||
124926530|NCT03899259|449360896|FG002|Overall Study|Protocol Deviation|1|||
124926531|NCT03899259|449360894|FG000|Overall Study|Withdrawal by Subject|8|||
124926532|NCT03899259|449360895|FG001|Overall Study|Withdrawal by Subject|10|||
124926533|NCT03899259|449360896|FG002|Overall Study|Withdrawal by Subject|12|||
124926534|NCT03899259|449360894|FG000|Overall Study|Lost to Follow-up|5|||
124926535|NCT03899259|449360895|FG001|Overall Study|Lost to Follow-up|6|||
124926536|NCT03899259|449360896|FG002|Overall Study|Lost to Follow-up|2|||
124926537|NCT03899259|449360894|FG000|Overall Study|Lack of Adherence|1|||
124926538|NCT03899259|449360895|FG001|Overall Study|Lack of Adherence|0|||
124926539|NCT03899259|449360896|FG002|Overall Study|Lack of Adherence|0|||
124926540|NCT03899259|449360894|FG000|Overall Study|Screen Failure|1|||
124926541|NCT03899259|449360895|FG001|Overall Study|Screen Failure|0|||
124926542|NCT03899259|449360896|FG002|Overall Study|Screen Failure|0|||
124926543|NCT03899259|449360894|FG000|Overall Study|Ongoing Study Participation|127|||
125212352|NCT00548249|450403336|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
125212353|NCT00548249|450403337|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
125212354|NCT00548249|450403338|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
125212355|NCT00548249|450403339|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
125212356|NCT00548249|450403335|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
125212357|NCT00548249|450403336|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
125212358|NCT00548249|450403337|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
125212359|NCT00548249|450403338|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
124926544|NCT03899259|449360895|FG001|Overall Study|Ongoing Study Participation|134|||
124926545|NCT03899259|449360896|FG002|Overall Study|Ongoing Study Participation|210|||
124926546|NCT04797897|449360897|FG000|Overall Study|Study Termination by Sponsor|1|||
124926547|NCT04797897|449360898|FG001|Overall Study|Study Termination by Sponsor|1|||
124926548|NCT05670587|449360899|FG000|Overall Study|Withdrawal by Subject|3|||
124926549|NCT01197378|449360900|FG000|Overall Study|Adverse Event|3|||
124926550|NCT01197378|449360900|FG000|Overall Study|Withdrawal by Subject|1|||
124926551|NCT01197378|449360900|FG000|Overall Study|Physician Decision|1|||
124926552|NCT01197378|449360900|FG000|Overall Study|Other|2|||
124926553|NCT01544114|449360904|FG000|Overall Study|Withdrawal by Subject|0|||
124926554|NCT01544114|449360905|FG001|Overall Study|Withdrawal by Subject|0|||
124926555|NCT01544114|449360906|FG002|Overall Study|Withdrawal by Subject|3|||
124926556|NCT01544114|449360904|FG000|Overall Study|Lost to Follow-up|0|||
124926557|NCT01544114|449360905|FG001|Overall Study|Lost to Follow-up|2|||
124926558|NCT01544114|449360906|FG002|Overall Study|Lost to Follow-up|0|||
124926559|NCT01544114|449360904|FG000|Overall Study|Adverse Event|1|||
124926560|NCT01544114|449360905|FG001|Overall Study|Adverse Event|1|||
124926561|NCT01544114|449360906|FG002|Overall Study|Adverse Event|2|||
124926562|NCT01544114|449360904|FG000|Overall Study|Protocol Violation|0|||
124926563|NCT01544114|449360905|FG001|Overall Study|Protocol Violation|1|||
124926564|NCT01544114|449360906|FG002|Overall Study|Protocol Violation|0|||
124926565|NCT03024437|449360921|FG000|Overall Study|Adverse Event|0|||
124926566|NCT03024437|449360922|FG001|Overall Study|Adverse Event|1|||
124926567|NCT03024437|449360923|FG002|Overall Study|Adverse Event|3|||
124926568|NCT03024437|449360924|FG003|Overall Study|Adverse Event|5|||
124926569|NCT03024437|449360925|FG004|Overall Study|Adverse Event|0|||
124926570|NCT03024437|449360921|FG000|Overall Study|Physician Decision|1|||
124926571|NCT03024437|449360922|FG001|Overall Study|Physician Decision|0|||
124926572|NCT03024437|449360923|FG002|Overall Study|Physician Decision|0|||
124926573|NCT03024437|449360924|FG003|Overall Study|Physician Decision|1|||
124926574|NCT03024437|449360925|FG004|Overall Study|Physician Decision|0|||
124926575|NCT03024437|449360921|FG000|Overall Study|Disease progression, relapse|1|||
124926576|NCT03024437|449360922|FG001|Overall Study|Disease progression, relapse|0|||
124926577|NCT03024437|449360923|FG002|Overall Study|Disease progression, relapse|0|||
124926578|NCT03024437|449360924|FG003|Overall Study|Disease progression, relapse|3|||
124926579|NCT03024437|449360925|FG004|Overall Study|Disease progression, relapse|0|||
124926580|NCT03024437|449360921|FG000|Overall Study|Disease progression, refractory disease|4|||
124926581|NCT03024437|449360922|FG001|Overall Study|Disease progression, refractory disease|4|||
124926582|NCT03024437|449360923|FG002|Overall Study|Disease progression, refractory disease|2|||
124926583|NCT03024437|449360924|FG003|Overall Study|Disease progression, refractory disease|2|||
124926584|NCT03024437|449360925|FG004|Overall Study|Disease progression, refractory disease|1|||
124926585|NCT03024437|449360921|FG000|Overall Study|Newly diagnosed cancer|0|||
124926586|NCT03024437|449360922|FG001|Overall Study|Newly diagnosed cancer|0|||
124926587|NCT03024437|449360923|FG002|Overall Study|Newly diagnosed cancer|0|||
124926588|NCT03024437|449360924|FG003|Overall Study|Newly diagnosed cancer|1|||
124926589|NCT03024437|449360925|FG004|Overall Study|Newly diagnosed cancer|0|||
124926590|NCT03024437|449360921|FG000|Overall Study|Moved out of state|0|||
124926591|NCT03024437|449360922|FG001|Overall Study|Moved out of state|1|||
124926592|NCT03024437|449360923|FG002|Overall Study|Moved out of state|0|||
124926593|NCT03024437|449360924|FG003|Overall Study|Moved out of state|0|||
124926594|NCT03024437|449360925|FG004|Overall Study|Moved out of state|0|||
124926595|NCT03024437|449360921|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
124926596|NCT03024437|449360922|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
124926597|NCT03024437|449360923|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
124926598|NCT03024437|449360924|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
124926599|NCT03024437|449360925|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
124926600|NCT04625465|449360926|FG000|Overall Study|Lost to Follow-up|2|||
124926601|NCT04625465|449360927|FG001|Overall Study|Lost to Follow-up|2|||
124926602|NCT04625465|449360928|FG002|Overall Study|Lost to Follow-up|1|||
124926603|NCT04625465|449360929|FG003|Overall Study|Lost to Follow-up|0|||
124926604|NCT04625465|449360930|FG004|Overall Study|Lost to Follow-up|0|||
124926605|NCT04625465|449360931|FG005|Overall Study|Lost to Follow-up|2|||
124926606|NCT04625465|449360932|FG006|Overall Study|Lost to Follow-up|0|||
124926607|NCT04625465|449360933|FG007|Overall Study|Lost to Follow-up|0|||
124926608|NCT04625465|449360926|FG000|Overall Study|Death|1|||
124926609|NCT04625465|449360927|FG001|Overall Study|Death|0|||
124926610|NCT04625465|449360928|FG002|Overall Study|Death|0|||
124926611|NCT04625465|449360929|FG003|Overall Study|Death|0|||
124926612|NCT04625465|449360930|FG004|Overall Study|Death|0|||
124926613|NCT04625465|449360931|FG005|Overall Study|Death|0|||
124926614|NCT04625465|449360932|FG006|Overall Study|Death|0|||
125024169|NCT03529773|449711368|FG035|Overall Study|Screen Failure|0|||
124926615|NCT04625465|449360933|FG007|Overall Study|Death|0|||
124926616|NCT04625465|449360926|FG000|Overall Study|Withdrawal by Subject|1|||
124926617|NCT04625465|449360927|FG001|Overall Study|Withdrawal by Subject|0|||
124926618|NCT04625465|449360928|FG002|Overall Study|Withdrawal by Subject|4|||
124926619|NCT04625465|449360929|FG003|Overall Study|Withdrawal by Subject|4|||
124926620|NCT04625465|449360930|FG004|Overall Study|Withdrawal by Subject|4|||
124926621|NCT04625465|449360931|FG005|Overall Study|Withdrawal by Subject|0|||
125024170|NCT03529773|449711369|FG036|Overall Study|Screen Failure|1|||
125119507|NCT00395226|450061260|FG001|Overall Study|Lost to Follow-up|1|||
125119508|NCT02374918|450061261|FG000|Overall Study|Protocol Violation|2|||
125119509|NCT02374918|450061262|FG001|Overall Study|Protocol Violation|0|||
125119510|NCT02374918|450061263|FG002|Overall Study|Protocol Violation|2|||
125119511|NCT02374918|450061264|FG003|Overall Study|Protocol Violation|1|||
125119512|NCT02374918|450061261|FG000|Overall Study|Withdrawal by Subject|1|||
125119513|NCT02374918|450061262|FG001|Overall Study|Withdrawal by Subject|1|||
125119514|NCT02374918|450061263|FG002|Overall Study|Withdrawal by Subject|1|||
125119515|NCT02374918|450061264|FG003|Overall Study|Withdrawal by Subject|0|||
125119516|NCT02374918|450061261|FG000|Overall Study|Lack of Efficacy|0|||
125119517|NCT02374918|450061262|FG001|Overall Study|Lack of Efficacy|0|||
125119518|NCT02374918|450061263|FG002|Overall Study|Lack of Efficacy|1|||
125119519|NCT02374918|450061264|FG003|Overall Study|Lack of Efficacy|1|||
125119520|NCT00760383|450061265|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
125119521|NCT00760383|450061266|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
125119522|NCT00282256|450061267|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
125119523|NCT00282256|450061267|FG000|Extension Treatment Period|Adverse Event|2|||
124926622|NCT04625465|449360932|FG006|Overall Study|Withdrawal by Subject|0|||
124926623|NCT04625465|449360933|FG007|Overall Study|Withdrawal by Subject|0|||
124926624|NCT04501614|449360934|FG000|Overall Study|Study Terminated by Sponsor|6|||
124926625|NCT04501614|449360935|FG001|Overall Study|Study Terminated by Sponsor|3|||
124926626|NCT04501614|449360934|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
124926627|NCT04501614|449360935|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
124926628|NCT05566639|449360936|FG000|Overall Study|Adverse Event|1|||
124926629|NCT05566639|449360937|FG001|Overall Study|Adverse Event|1|||
124926630|NCT05566639|449360936|FG000|Overall Study|Serious Adverse Event|1|||
124926631|NCT05566639|449360937|FG001|Overall Study|Serious Adverse Event|3|||
124926632|NCT05566639|449360936|FG000|Overall Study|Death|44|||
124926633|NCT05566639|449360937|FG001|Overall Study|Death|45|||
124926634|NCT05566639|449360936|FG000|Overall Study|Lost to Follow-up|467|||
124926635|NCT05566639|449360937|FG001|Overall Study|Lost to Follow-up|461|||
124926636|NCT05566639|449360936|FG000|Overall Study|Physician Decision|45|||
124926637|NCT05566639|449360937|FG001|Overall Study|Physician Decision|44|||
124926638|NCT05566639|449360936|FG000|Overall Study|Protocol Deviation|4|||
124926639|NCT05566639|449360937|FG001|Overall Study|Protocol Deviation|4|||
124926640|NCT05566639|449360936|FG000|Overall Study|Withdrawal by Subject|277|||
124926641|NCT05566639|449360937|FG001|Overall Study|Withdrawal by Subject|271|||
124926642|NCT05566639|449360936|FG000|Overall Study|Other Than Specified|52|||
124926643|NCT05566639|449360937|FG001|Overall Study|Other Than Specified|64|||
124926644|NCT05239455|449360939|FG000|Overall Study|Adverse Event|1|||
124926645|NCT05239455|449360939|FG000|Overall Study|Sponsor Decision|5|||
124926646|NCT05239455|449360939|FG000|Overall Study|Incomplete Blood Collection|1|||
124926647|NCT02589522|449360940|FG000|Overall Study|Physician Decision|1|||
124926648|NCT02589522|449360941|FG001|Overall Study|Physician Decision|2|||
125119524|NCT01513148|450061275|FG000|Overall Study|Protocol Violation|2|||
124926649|NCT02589522|449360942|FG002|Overall Study|Physician Decision|0|||
125119525|NCT01513148|450061276|FG001|Overall Study|Protocol Violation|2|||
125119526|NCT04652453|450061277|FG000|Overall Study|Death|8|||
125119527|NCT04652453|450061278|FG001|Overall Study|Death|2|||
125119528|NCT04652453|450061279|FG002|Overall Study|Death|0|||
125119529|NCT04652453|450061277|FG000|Overall Study|Hospice|5|||
125119530|NCT04652453|450061278|FG001|Overall Study|Hospice|5|||
125119531|NCT04652453|450061279|FG002|Overall Study|Hospice|0|||
124926650|NCT02589522|449360940|FG000|Overall Study|Did not start treatment|1|||
124926651|NCT02589522|449360941|FG001|Overall Study|Did not start treatment|0|||
125119532|NCT04652453|450061277|FG000|Overall Study|Withdrawal by Subject|2|||
124926652|NCT02589522|449360942|FG002|Overall Study|Did not start treatment|0|||
124926653|NCT03800654|449360943|FG000|Overall Study|Time constraints|3|||
124926654|NCT03800654|449360944|FG001|Overall Study|Time constraints|3|||
124926655|NCT03800654|449360945|FG002|Overall Study|Time constraints|3|||
124926656|NCT03800654|449360943|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
124926657|NCT03800654|449360944|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
124926658|NCT03800654|449360945|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
124926659|NCT03800654|449360943|FG000|Overall Study|Lost to Follow-up|2|||
124926660|NCT03800654|449360944|FG001|Overall Study|Lost to Follow-up|1|||
124926661|NCT03800654|449360945|FG002|Overall Study|Lost to Follow-up|6|||
124926662|NCT03800654|449360943|FG000|Overall Study|Medical Health Issue|0|||
124926663|NCT03800654|449360944|FG001|Overall Study|Medical Health Issue|0|||
124926664|NCT03800654|449360945|FG002|Overall Study|Medical Health Issue|1|||
124926665|NCT03800654|449360943|FG000|Overall Study|Personal Issues|0|||
124926666|NCT03800654|449360944|FG001|Overall Study|Personal Issues|2|||
124926667|NCT03800654|449360945|FG002|Overall Study|Personal Issues|0|||
124926668|NCT03800654|449360943|FG000|Overall Study|Protocol Violation|0|||
124926669|NCT03800654|449360944|FG001|Overall Study|Protocol Violation|1|||
124926670|NCT03800654|449360945|FG002|Overall Study|Protocol Violation|0|||
124926671|NCT04159415|449360946|FG000|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
124926672|NCT04159415|449360947|FG001|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
124926673|NCT04159415|449360948|FG002|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
124926674|NCT04159415|449360949|FG003|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
124926675|NCT04159415|449360950|FG004|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
124926676|NCT04159415|449360951|FG005|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
124926677|NCT04159415|449360952|FG006|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
124926678|NCT04159415|449360953|FG007|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
124926679|NCT01799265|449360954|FG000|Overall Study|Lost to Follow-up|1|||
124926680|NCT01799265|449360955|FG001|Overall Study|Lost to Follow-up|0|||
124926681|NCT01799265|449360954|FG000|Overall Study|Protocol Violation|2|||
124926682|NCT01799265|449360955|FG001|Overall Study|Protocol Violation|1|||
124926683|NCT01799265|449360954|FG000|Overall Study|inadequate sleep study|0|||
124926684|NCT01799265|449360955|FG001|Overall Study|inadequate sleep study|2|||
124926685|NCT03459729|449360956|FG000|Overall Study|Physician Decision|2|||
124926686|NCT06182033|449360957|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
124926687|NCT06182033|449360958|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
124926688|NCT06182033|449360957|FG000|Overall Study|Target child relocation|1|||
124926689|NCT06182033|449360958|FG001|Overall Study|Target child relocation|1|||
124926690|NCT06182033|449360957|FG000|Overall Study|Withdrawal by Subject|1|||
124926691|NCT06182033|449360958|FG001|Overall Study|Withdrawal by Subject|0|||
124926692|NCT02364557|449360959|FG000|Overall Study|Protocol Violation|3|||
124926693|NCT02364557|449360960|FG001|Overall Study|Protocol Violation|1|||
124926694|NCT04200456|449360965|FG000|Overall Study|Physician Decision|0|||
124926695|NCT04200456|449360966|FG001|Overall Study|Physician Decision|1|||
124926696|NCT04200456|449360965|FG000|Overall Study|Withdrawal by Subject|2|||
124926697|NCT04200456|449360966|FG001|Overall Study|Withdrawal by Subject|2|||
124926698|NCT04200456|449360965|FG000|Overall Study|Lack of Efficacy|1|||
124926699|NCT04200456|449360966|FG001|Overall Study|Lack of Efficacy|1|||
124926700|NCT04200456|449360965|FG000|Overall Study|Adverse event, non-fatal|0|||
124926701|NCT04200456|449360966|FG001|Overall Study|Adverse event, non-fatal|1|||
124926702|NCT04200456|449360965|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
124926703|NCT04200456|449360966|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
124926704|NCT04828005|449360967|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
124926705|NCT04828005|449360968|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
124926706|NCT04828005|449360969|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
124926707|NCT04828005|449360970|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
124926708|NCT04828005|449360967|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
124926709|NCT04828005|449360968|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
124926710|NCT04828005|449360969|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
124926711|NCT04828005|449360970|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
124926712|NCT04828005|449360967|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
124926713|NCT04828005|449360968|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
124926714|NCT04828005|449360969|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
124926715|NCT04828005|449360970|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
124926716|NCT04828005|449360967|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
124926717|NCT04828005|449360968|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
124926718|NCT04828005|449360969|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
124926719|NCT04828005|449360970|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
125024171|NCT03529773|449711370|FG037|Overall Study|Screen Failure|1|||
125024172|NCT03529773|449711371|FG038|Overall Study|Screen Failure|0|||
125024173|NCT03529773|449711372|FG039|Overall Study|Screen Failure|1|||
125024174|NCT03529773|449711333|FG000|Overall Study|Randomized but not vaccinated|0|||
125024175|NCT03529773|449711334|FG001|Overall Study|Randomized but not vaccinated|0|||
125024176|NCT03529773|449711335|FG002|Overall Study|Randomized but not vaccinated|0|||
125024177|NCT03529773|449711336|FG003|Overall Study|Randomized but not vaccinated|0|||
125119533|NCT04652453|450061278|FG001|Overall Study|Withdrawal by Subject|0|||
125119534|NCT04652453|450061279|FG002|Overall Study|Withdrawal by Subject|0|||
125119535|NCT00936975|450061283|FG000|Overall Study|Withdrawal by Subject|1|||
125119536|NCT00936975|450061283|FG000|Overall Study|Disease progression|3|||
125119537|NCT00936975|450061283|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
125119538|NCT00619385|450061284|FG000|Overall Study|Adverse Event|0|||
125119539|NCT00619385|450061285|FG001|Overall Study|Adverse Event|0|||
125119540|NCT00619385|450061286|FG002|Overall Study|Adverse Event|3|||
125119541|NCT00619385|450061284|FG000|Overall Study|Other|1|||
125119542|NCT00619385|450061285|FG001|Overall Study|Other|2|||
125119543|NCT00619385|450061286|FG002|Overall Study|Other|1|||
125119544|NCT02041702|450061289|FG000|Overall Study|Lost to Follow-up|1|||
125212360|NCT00548249|450403339|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
125119545|NCT02041702|450061290|FG001|Overall Study|Lost to Follow-up|6|||
125119546|NCT02041702|450061289|FG000|Overall Study|Death|4|||
125119547|NCT02041702|450061290|FG001|Overall Study|Death|0|||
124926720|NCT04828005|449360967|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
124926721|NCT04828005|449360968|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
124926722|NCT04828005|449360969|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
124926723|NCT04828005|449360970|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
124926724|NCT04828005|449360967|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
124926725|NCT04828005|449360968|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
124926726|NCT04828005|449360969|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
124926727|NCT04828005|449360970|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
124926728|NCT04828005|449360967|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
124926729|NCT04828005|449360968|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
124926730|NCT04828005|449360969|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
124926731|NCT04828005|449360970|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
124926732|NCT04828005|449360967|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
124926733|NCT04828005|449360968|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
124926734|NCT04828005|449360969|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
124926735|NCT04828005|449360970|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
124926736|NCT04828005|449360967|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
124926737|NCT04828005|449360968|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
124926738|NCT04828005|449360969|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
124926739|NCT04828005|449360970|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
124926740|NCT02043678|449362644|FG000|Overall Study|Never treated|11|||
124926741|NCT02043678|449362645|FG001|Overall Study|Never treated|9|||
124926742|NCT02043678|449362644|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
124926743|NCT02043678|449362645|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
124926744|NCT02043678|449362644|FG000|Overall Study|AE without clinical PD|54|||
124926745|NCT02043678|449362645|FG001|Overall Study|AE without clinical PD|36|||
124926746|NCT02043678|449362644|FG000|Overall Study|Lost to Follow-up|1|||
124926747|NCT02043678|449362645|FG001|Overall Study|Lost to Follow-up|1|||
124926748|NCT02043678|449362644|FG000|Overall Study|Other|10|||
124926749|NCT02043678|449362645|FG001|Overall Study|Other|14|||
124926750|NCT02043678|449362644|FG000|Overall Study|Clinical PD|114|||
124926751|NCT02043678|449362645|FG001|Overall Study|Clinical PD|148|||
124926752|NCT02043678|449362644|FG000|Overall Study|Radiological PD|100|||
124926753|NCT02043678|449362645|FG001|Overall Study|Radiological PD|90|||
124926754|NCT02043678|449362644|FG000|Overall Study|Protocol-driven decision point|59|||
124926755|NCT02043678|449362645|FG001|Overall Study|Protocol-driven decision point|58|||
124926756|NCT02043678|449362644|FG000|Overall Study|Withdrawal by Subject|16|||
124926757|NCT02043678|449362645|FG001|Overall Study|Withdrawal by Subject|20|||
124926758|NCT02043678|449362644|FG000|Overall Study|Protocol Violation|1|||
124926759|NCT02043678|449362645|FG001|Overall Study|Protocol Violation|0|||
124926760|NCT02043678|449362644|FG000|Overall Study|Deterioration of general conditions|1|||
124926761|NCT02043678|449362645|FG001|Overall Study|Deterioration of general conditions|1|||
124926762|NCT02043678|449362644|FG000|Overall Study|Logistical difficulties|2|||
124926763|NCT02043678|449362645|FG001|Overall Study|Logistical difficulties|0|||
124926764|NCT02043678|449362644|FG000|Overall Study|Non-compliance with study drug|3|||
124926765|NCT02043678|449362645|FG001|Overall Study|Non-compliance with study drug|1|||
124926766|NCT02043678|449362644|FG000|Overall Study|Physician Decision|4|||
124926767|NCT02043678|449362645|FG001|Overall Study|Physician Decision|3|||
124926768|NCT02043678|449362644|FG000|Overall Study|Subject decision|0|||
124926769|NCT02043678|449362645|FG001|Overall Study|Subject decision|1|||
124926770|NCT02043678|449362644|FG000|Overall Study|Switching to other therapy|3|||
124926771|NCT02043678|449362645|FG001|Overall Study|Switching to other therapy|2|||
124926772|NCT02043678|449362644|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
124926773|NCT02043678|449362645|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
124926774|NCT02043678|449362644|FG000|Overall Study|Missing|1|||
124926775|NCT02043678|449362645|FG001|Overall Study|Missing|0|||
124926776|NCT02043678|449362644|FG000|Overall Study|Adverse Event|0|||
125024178|NCT03529773|449711337|FG004|Overall Study|Randomized but not vaccinated|0|||
124926777|NCT02043678|449362645|FG001|Overall Study|Adverse Event|1|||
125024179|NCT03529773|449711338|FG005|Overall Study|Randomized but not vaccinated|0|||
125024180|NCT03529773|449711339|FG006|Overall Study|Randomized but not vaccinated|0|||
125024181|NCT03529773|449711340|FG007|Overall Study|Randomized but not vaccinated|0|||
125024182|NCT03529773|449711341|FG008|Overall Study|Randomized but not vaccinated|0|||
124926778|NCT05543629|449362646|FG000|Overall Study|Death|1|||
124926779|NCT05543629|449362647|FG001|Overall Study|Death|0|||
124926780|NCT05543629|449362648|FG002|Overall Study|Death|1|||
124926781|NCT05543629|449362649|FG003|Overall Study|Death|0|||
124926782|NCT05543629|449362650|FG004|Overall Study|Death|0|||
124926783|NCT05543629|449362651|FG005|Overall Study|Death|1|||
124926784|NCT05543629|449362652|FG006|Overall Study|Death|2|||
124926785|NCT05543629|449362653|FG007|Overall Study|Death|2|||
124926786|NCT05543629|449362646|FG000|Overall Study|Other Reasons|0|||
124926787|NCT05543629|449362647|FG001|Overall Study|Other Reasons|0|||
124926788|NCT05543629|449362648|FG002|Overall Study|Other Reasons|0|||
125024183|NCT03529773|449711342|FG009|Overall Study|Randomized but not vaccinated|0|||
125024184|NCT03529773|449711343|FG010|Overall Study|Randomized but not vaccinated|0|||
125024185|NCT03529773|449711344|FG011|Overall Study|Randomized but not vaccinated|0|||
125024186|NCT03529773|449711345|FG012|Overall Study|Randomized but not vaccinated|0|||
125024187|NCT03529773|449711346|FG013|Overall Study|Randomized but not vaccinated|0|||
125024188|NCT03529773|449711347|FG014|Overall Study|Randomized but not vaccinated|0|||
125024189|NCT03529773|449711348|FG015|Overall Study|Randomized but not vaccinated|0|||
125024190|NCT03529773|449711349|FG016|Overall Study|Randomized but not vaccinated|0|||
125024191|NCT03529773|449711350|FG017|Overall Study|Randomized but not vaccinated|1|||
125024192|NCT03529773|449711351|FG018|Overall Study|Randomized but not vaccinated|0|||
125119548|NCT02041702|450061289|FG000|Overall Study|Withdrawal by Subject|4|||
125119549|NCT02041702|450061290|FG001|Overall Study|Withdrawal by Subject|3|||
125119550|NCT02041702|450061289|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
125119551|NCT02041702|450061290|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
125119552|NCT02041702|450061289|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
125119553|NCT02041702|450061290|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
125119554|NCT00203307|450061291|FG000|First Intervention|Adverse Event|2|||
125119555|NCT00203307|450061292|FG001|First Intervention|Adverse Event|0|||
125119556|NCT03730103|450061293|FG000|Overall Study|Did not meet inclusion criteria|0|||
125119557|NCT03730103|450061294|FG001|Overall Study|Did not meet inclusion criteria|5|||
125119558|NCT01488578|450061295|FG000|Overall Study|Protocol Violation|1836|||
125119559|NCT02308111|450061296|FG000|Overall Study|Adverse Event|31|||
125119560|NCT02308111|450061297|FG001|Overall Study|Adverse Event|19|||
125119561|NCT02308111|450061296|FG000|Overall Study|Death|9|||
125119562|NCT02308111|450061297|FG001|Overall Study|Death|6|||
125119563|NCT02308111|450061296|FG000|Overall Study|Lost to Follow-up|2|||
125119564|NCT02308111|450061297|FG001|Overall Study|Lost to Follow-up|7|||
125119565|NCT02308111|450061296|FG000|Overall Study|Physician Decision|6|||
125119566|NCT02308111|450061297|FG001|Overall Study|Physician Decision|17|||
125119567|NCT02308111|450061296|FG000|Overall Study|Protocol Violation|0|||
125119568|NCT02308111|450061297|FG001|Overall Study|Protocol Violation|1|||
125119569|NCT02308111|450061296|FG000|Overall Study|Withdrawal by Subject|28|||
125119570|NCT02308111|450061297|FG001|Overall Study|Withdrawal by Subject|38|||
125119571|NCT02308111|450061296|FG000|Overall Study|Study Terminated by Sponsor|72|||
125119572|NCT02308111|450061297|FG001|Overall Study|Study Terminated by Sponsor|61|||
125119573|NCT02308111|450061296|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
125119574|NCT02308111|450061297|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
125119575|NCT02308111|450061296|FG000|Overall Study|Site Closure|3|||
125024193|NCT03529773|449711352|FG019|Overall Study|Randomized but not vaccinated|0|||
125024194|NCT03529773|449711353|FG020|Overall Study|Randomized but not vaccinated|0|||
125119576|NCT02308111|450061297|FG001|Overall Study|Site Closure|3|||
125119577|NCT02308111|450061296|FG000|Overall Study|Non-compliance with Study Drug|3|||
124926789|NCT05543629|449362649|FG003|Overall Study|Other Reasons|0|||
124926790|NCT05543629|449362650|FG004|Overall Study|Other Reasons|1|||
124926791|NCT05543629|449362651|FG005|Overall Study|Other Reasons|0|||
124926792|NCT05543629|449362652|FG006|Overall Study|Other Reasons|0|||
124926793|NCT05543629|449362653|FG007|Overall Study|Other Reasons|0|||
124926794|NCT05543629|449362646|FG000|Overall Study|Physician Decision|0|||
124926795|NCT05543629|449362647|FG001|Overall Study|Physician Decision|0|||
124926796|NCT05543629|449362648|FG002|Overall Study|Physician Decision|3|||
124926797|NCT05543629|449362649|FG003|Overall Study|Physician Decision|0|||
124926798|NCT05543629|449362650|FG004|Overall Study|Physician Decision|0|||
124926799|NCT05543629|449362651|FG005|Overall Study|Physician Decision|0|||
124926800|NCT05543629|449362652|FG006|Overall Study|Physician Decision|1|||
125119578|NCT02308111|450061297|FG001|Overall Study|Non-compliance with Study Drug|1|||
125119579|NCT02308111|450061296|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
125119580|NCT02308111|450061297|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
125119581|NCT02308111|450061296|FG000|Overall Study|Liver Transplant|3|||
125119582|NCT02308111|450061297|FG001|Overall Study|Liver Transplant|3|||
125119583|NCT02308111|450061296|FG000|Overall Study|Liver Transplant Waitlist|2|||
125119584|NCT02308111|450061297|FG001|Overall Study|Liver Transplant Waitlist|2|||
125119585|NCT02308111|450061296|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
125119586|NCT02308111|450061297|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
125119587|NCT03271528|450061299|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
125119588|NCT03271528|450061300|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
125119589|NCT03271528|450061299|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
125119590|NCT03271528|450061300|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
125119591|NCT03271528|450061299|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
125119592|NCT03271528|450061300|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
125119593|NCT03271528|450061299|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
125119594|NCT03271528|450061300|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
125119595|NCT03271528|450061299|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
125119596|NCT03271528|450061300|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
125119597|NCT03271528|450061299|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
125119598|NCT03271528|450061300|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
125119599|NCT03271528|450061299|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
125119600|NCT03271528|450061300|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
125119601|NCT00717756|450061303|FG000|Overall Study|Withdrawal by Subject|1|||
125119602|NCT01873859|450061306|FG000|Overall Study|Withdrawal by Subject|0|||
125119603|NCT01873859|450061307|FG001|Overall Study|Withdrawal by Subject|4|||
125119604|NCT03977584|450061308|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
125119605|NCT03977584|450061309|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
125119606|NCT03977584|450061310|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
124926801|NCT05543629|449362653|FG007|Overall Study|Physician Decision|0|||
124926802|NCT05543629|449362646|FG000|Overall Study|Study terminated by Sponsor|1|||
124926803|NCT05543629|449362647|FG001|Overall Study|Study terminated by Sponsor|0|||
125119607|NCT01066052|450061314|FG000|Overall Study|Enrolled But Not Treated|3|||
124926804|NCT05543629|449362648|FG002|Overall Study|Study terminated by Sponsor|0|||
124926805|NCT05543629|449362649|FG003|Overall Study|Study terminated by Sponsor|1|||
124926806|NCT05543629|449362650|FG004|Overall Study|Study terminated by Sponsor|0|||
124926807|NCT05543629|449362651|FG005|Overall Study|Study terminated by Sponsor|4|||
124926808|NCT05543629|449362652|FG006|Overall Study|Study terminated by Sponsor|1|||
124926809|NCT05543629|449362653|FG007|Overall Study|Study terminated by Sponsor|0|||
124926810|NCT05543629|449362646|FG000|Overall Study|Withdrawal by Subject|1|||
124926811|NCT05543629|449362647|FG001|Overall Study|Withdrawal by Subject|1|||
124926812|NCT05543629|449362648|FG002|Overall Study|Withdrawal by Subject|0|||
124926813|NCT05543629|449362649|FG003|Overall Study|Withdrawal by Subject|2|||
124926814|NCT05543629|449362650|FG004|Overall Study|Withdrawal by Subject|1|||
124926815|NCT05543629|449362651|FG005|Overall Study|Withdrawal by Subject|1|||
124926816|NCT05543629|449362652|FG006|Overall Study|Withdrawal by Subject|1|||
124926817|NCT05543629|449362653|FG007|Overall Study|Withdrawal by Subject|1|||
124926818|NCT05543629|449362646|FG000|Overall Study|Not Reported|2|||
124926819|NCT05543629|449362647|FG001|Overall Study|Not Reported|2|||
124926820|NCT05543629|449362648|FG002|Overall Study|Not Reported|0|||
124926821|NCT05543629|449362649|FG003|Overall Study|Not Reported|0|||
124926822|NCT05543629|449362650|FG004|Overall Study|Not Reported|1|||
124926823|NCT05543629|449362651|FG005|Overall Study|Not Reported|1|||
124926824|NCT05543629|449362652|FG006|Overall Study|Not Reported|3|||
124926825|NCT05543629|449362653|FG007|Overall Study|Not Reported|0|||
124926826|NCT04568603|449362654|FG000|Overall Study|Physician Decision|1|||
124926827|NCT03313076|449362657|FG000|Overall Study|Withdrawal by Subject|2|||
125024195|NCT03529773|449711354|FG021|Overall Study|Randomized but not vaccinated|0|||
125024196|NCT03529773|449711355|FG022|Overall Study|Randomized but not vaccinated|0|||
125024197|NCT03529773|449711356|FG023|Overall Study|Randomized but not vaccinated|0|||
125024198|NCT03529773|449711357|FG024|Overall Study|Randomized but not vaccinated|0|||
125024199|NCT03529773|449711358|FG025|Overall Study|Randomized but not vaccinated|0|||
125024200|NCT03529773|449711359|FG026|Overall Study|Randomized but not vaccinated|0|||
125024201|NCT03529773|449711360|FG027|Overall Study|Randomized but not vaccinated|1|||
125024202|NCT03529773|449711361|FG028|Overall Study|Randomized but not vaccinated|0|||
125024203|NCT03529773|449711362|FG029|Overall Study|Randomized but not vaccinated|0|||
125024204|NCT03529773|449711363|FG030|Overall Study|Randomized but not vaccinated|0|||
125024205|NCT03529773|449711364|FG031|Overall Study|Randomized but not vaccinated|0|||
125024206|NCT03529773|449711365|FG032|Overall Study|Randomized but not vaccinated|0|||
125024207|NCT03529773|449711366|FG033|Overall Study|Randomized but not vaccinated|0|||
125024208|NCT03529773|449711367|FG034|Overall Study|Randomized but not vaccinated|0|||
125024209|NCT03529773|449711368|FG035|Overall Study|Randomized but not vaccinated|0|||
125024210|NCT03529773|449711369|FG036|Overall Study|Randomized but not vaccinated|0|||
125024211|NCT03529773|449711370|FG037|Overall Study|Randomized but not vaccinated|0|||
125024212|NCT03529773|449711371|FG038|Overall Study|Randomized but not vaccinated|0|||
125024213|NCT03529773|449711372|FG039|Overall Study|Randomized but not vaccinated|0|||
125024214|NCT01340209|449711373|FG000|Overall Study|Adverse Event|1|||
125024215|NCT01340209|449711374|FG001|Overall Study|Adverse Event|1|||
125024216|NCT01340209|449711375|FG002|Overall Study|Adverse Event|2|||
125024217|NCT01340209|449711373|FG000|Overall Study|Protocol Violation|1|||
125024218|NCT01340209|449711374|FG001|Overall Study|Protocol Violation|2|||
125024219|NCT01340209|449711375|FG002|Overall Study|Protocol Violation|1|||
125024220|NCT01340209|449711373|FG000|Overall Study|Withdrawal by Subject|0|||
125024221|NCT01340209|449711374|FG001|Overall Study|Withdrawal by Subject|0|||
125024222|NCT01340209|449711375|FG002|Overall Study|Withdrawal by Subject|1|||
125024223|NCT01340209|449711373|FG000|Overall Study|Other reason not defined above|3|||
125024224|NCT01340209|449711374|FG001|Overall Study|Other reason not defined above|5|||
125024225|NCT01340209|449711375|FG002|Overall Study|Other reason not defined above|4|||
125024226|NCT01537211|449711380|FG000|Overall Study|Lost to Follow-up|0|||
125024227|NCT01537211|449711381|FG001|Overall Study|Lost to Follow-up|1|||
125024228|NCT02475655|449711384|FG000|Overall Study|Lost to Follow-up|0|||
125024229|NCT02475655|449711385|FG001|Overall Study|Lost to Follow-up|1|||
125024230|NCT00257010|449711407|FG000|Overall Study|Lack of Efficacy|11|||
125024231|NCT00257010|449711407|FG000|Overall Study|Lost to Follow-up|53|||
125024232|NCT00257010|449711407|FG000|Overall Study|Withdrawal by Subject|34|||
125119608|NCT01066052|450061315|FG001|Overall Study|Enrolled But Not Treated|0|||
125119609|NCT01835145|450061318|FG000|Overall Study|Ineligible prior to treatment|1|||
125119610|NCT01835145|450061319|FG001|Overall Study|Ineligible prior to treatment|0|||
125119611|NCT02729896|450061320|FG000|Overall Study|Death|0|||
124926828|NCT03313076|449362658|FG001|Overall Study|Withdrawal by Subject|0|||
124926829|NCT03313076|449362659|FG002|Overall Study|Withdrawal by Subject|0|||
124926830|NCT03313076|449362660|FG003|Overall Study|Withdrawal by Subject|0|||
124926831|NCT03313076|449362657|FG000|Overall Study|Lost to Follow-up|0|||
125212361|NCT00548249|450403335|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
124926832|NCT03313076|449362658|FG001|Overall Study|Lost to Follow-up|2|||
124926833|NCT03313076|449362659|FG002|Overall Study|Lost to Follow-up|2|||
124926834|NCT03313076|449362660|FG003|Overall Study|Lost to Follow-up|2|||
124926835|NCT04119843|449362661|FG000|Overall Study|Adverse Event|3|||
124926836|NCT04119843|449362661|FG000|Overall Study|Death|1|||
124926837|NCT03904147|449362662|FG000|Overall Study|Death|15|||
124926838|NCT03904147|449362663|FG001|Overall Study|Death|13|||
124926839|NCT03904147|449362664|FG002|Overall Study|Death|15|||
124926840|NCT03904147|449362662|FG000|Overall Study|Withdrawal by Subject|7|||
124926841|NCT03904147|449362663|FG001|Overall Study|Withdrawal by Subject|12|||
124926842|NCT03904147|449362664|FG002|Overall Study|Withdrawal by Subject|1|||
124926843|NCT03904147|449362662|FG000|Overall Study|1Y visit completed after 365 days|1|||
124926844|NCT03904147|449362663|FG001|Overall Study|1Y visit completed after 365 days|1|||
124926845|NCT03904147|449362664|FG002|Overall Study|1Y visit completed after 365 days|0|||
124926846|NCT04233216|449362673|FG000|Overall Study|Lost to Follow-up|1|||
124926847|NCT04233216|449362674|FG001|Overall Study|Lost to Follow-up|0|||
124926848|NCT04233216|449362675|FG002|Overall Study|Lost to Follow-up|2|||
124926849|NCT04233216|449362676|FG003|Overall Study|Lost to Follow-up|0|||
124926850|NCT04233216|449362673|FG000|Overall Study|Physician Decision|0|||
124926851|NCT04233216|449362674|FG001|Overall Study|Physician Decision|3|||
124926852|NCT04233216|449362675|FG002|Overall Study|Physician Decision|0|||
124926853|NCT04233216|449362676|FG003|Overall Study|Physician Decision|2|||
124926854|NCT04233216|449362673|FG000|Overall Study|Withdrawal by Subject|0|||
124926855|NCT04233216|449362674|FG001|Overall Study|Withdrawal by Subject|2|||
124926856|NCT04233216|449362675|FG002|Overall Study|Withdrawal by Subject|1|||
124926857|NCT04233216|449362676|FG003|Overall Study|Withdrawal by Subject|0|||
124926858|NCT04307355|449362677|FG000|Overall Study|Non-Compliance|3|||
124926859|NCT04307355|449362678|FG001|Overall Study|Non-Compliance|3|||
124926860|NCT04307355|449362679|FG002|Overall Study|Non-Compliance|0|||
124926861|NCT04225273|449362681|FG000|Overall Study|Lost to Follow-up|3|||
124926862|NCT03652389|449362682|FG000|Overall Study|Lost to Follow-up|1|||
124926863|NCT03652389|449362683|FG001|Overall Study|Lost to Follow-up|5|||
124926864|NCT03652389|449362682|FG000|Overall Study|Withdrawal by Subject|5|||
124926865|NCT03652389|449362683|FG001|Overall Study|Withdrawal by Subject|1|||
124926866|NCT03652389|449362682|FG000|Overall Study|New diagnosis|2|||
124926867|NCT03652389|449362683|FG001|Overall Study|New diagnosis|0|||
124926868|NCT04413708|449362685|FG000|Overall Study|Lost to Follow-up|1|||
124926869|NCT04413708|449362686|FG001|Overall Study|Lost to Follow-up|2|||
124926870|NCT03768505|449362687|FG000|Overall Study|sponsor decision|76|||
124926871|NCT03768505|449362687|FG000|Overall Study|Death|35|||
124926872|NCT03768505|449362687|FG000|Overall Study|Other -Various|30|||
124926873|NCT03768505|449362687|FG000|Overall Study|Withdrawal by Subject|22|||
124926874|NCT03768505|449362687|FG000|Overall Study|Lost to Follow-up|6|||
124926875|NCT04032704|449362688|FG000|Part A|Withdrawal by Subject|0|||
124926876|NCT04032704|449362689|FG001|Part A|Withdrawal by Subject|0|||
125024233|NCT00257010|449711407|FG000|Overall Study|Adverse Event|10|||
125024234|NCT00257010|449711407|FG000|Overall Study|various|11|||
125024235|NCT00257010|449711407|FG000|Overall Study|no headache reported|9|||
125024236|NCT01699087|449711412|FG000|Overall Study|Lost to Follow-up|7|||
125024237|NCT01699087|449711412|FG000|Overall Study|Screen failure (prior to treatment)|15|||
125024238|NCT01699087|449711412|FG000|Overall Study|Unable to make future visits|2|||
125024239|NCT03021642|449711415|FG000|Washout Period (21 Days)|Adverse Event|1|||
125024240|NCT03021642|449711416|FG001|Washout Period (21 Days)|Adverse Event|1|||
125024241|NCT00441545|449711417|FG000|First Intervention|Adverse Event|6|||
125024242|NCT00441545|449711418|FG001|First Intervention|Adverse Event|5|||
125024243|NCT00441545|449711417|FG000|First Intervention|Protocol Violation|2|||
125024244|NCT00441545|449711418|FG001|First Intervention|Protocol Violation|2|||
125024245|NCT00441545|449711417|FG000|First Intervention|Withdrawal by Subject|3|||
125212362|NCT00548249|450403336|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
125024246|NCT00441545|449711418|FG001|First Intervention|Withdrawal by Subject|3|||
124926877|NCT04032704|449362690|FG002|Part A|Withdrawal by Subject|3|||
124926878|NCT04032704|449362691|FG003|Part A|Withdrawal by Subject|0|||
124926879|NCT04032704|449362692|FG004|Part A|Withdrawal by Subject|1|||
124926880|NCT04032704|449362693|FG005|Part A|Withdrawal by Subject|7|||
124926881|NCT04032704|449362694|FG006|Part A|Withdrawal by Subject|0|||
124926882|NCT04032704|449362695|FG007|Part A|Withdrawal by Subject|0|||
124926883|NCT04032704|449362696|FG008|Part A|Withdrawal by Subject|0|||
124926884|NCT04032704|449362697|FG009|Part A|Withdrawal by Subject|0|||
124926885|NCT04032704|449362698|FG010|Part A|Withdrawal by Subject|0|||
124926886|NCT04032704|449362699|FG011|Part A|Withdrawal by Subject|0|||
124926887|NCT04032704|449362700|FG012|Part A|Withdrawal by Subject|0|||
124926888|NCT04032704|449362701|FG013|Part A|Withdrawal by Subject|0|||
124926889|NCT04032704|449362702|FG014|Part A|Withdrawal by Subject|0|||
124926890|NCT04032704|449362703|FG015|Part A|Withdrawal by Subject|0|||
124926891|NCT04032704|449362704|FG016|Part A|Withdrawal by Subject|0|||
124926892|NCT04032704|449362705|FG017|Part A|Withdrawal by Subject|0|||
124926893|NCT04032704|449362688|FG000|Part A|Lost to Follow-up|1|||
124926894|NCT04032704|449362689|FG001|Part A|Lost to Follow-up|0|||
124926895|NCT04032704|449362690|FG002|Part A|Lost to Follow-up|0|||
124926896|NCT04032704|449362691|FG003|Part A|Lost to Follow-up|0|||
124926897|NCT04032704|449362692|FG004|Part A|Lost to Follow-up|0|||
124926898|NCT04032704|449362693|FG005|Part A|Lost to Follow-up|0|||
124926899|NCT04032704|449362694|FG006|Part A|Lost to Follow-up|0|||
124926900|NCT04032704|449362695|FG007|Part A|Lost to Follow-up|0|||
124926901|NCT04032704|449362696|FG008|Part A|Lost to Follow-up|0|||
124926902|NCT04032704|449362697|FG009|Part A|Lost to Follow-up|0|||
124926903|NCT04032704|449362698|FG010|Part A|Lost to Follow-up|0|||
124926904|NCT04032704|449362699|FG011|Part A|Lost to Follow-up|0|||
124926905|NCT04032704|449362700|FG012|Part A|Lost to Follow-up|0|||
124926906|NCT04032704|449362701|FG013|Part A|Lost to Follow-up|0|||
124926907|NCT04032704|449362702|FG014|Part A|Lost to Follow-up|0|||
124926908|NCT04032704|449362703|FG015|Part A|Lost to Follow-up|0|||
124926909|NCT04032704|449362704|FG016|Part A|Lost to Follow-up|0|||
124926910|NCT04032704|449362705|FG017|Part A|Lost to Follow-up|0|||
124926911|NCT04032704|449362688|FG000|Part A|Death|9|||
124926912|NCT04032704|449362689|FG001|Part A|Death|2|||
124926913|NCT04032704|449362690|FG002|Part A|Death|10|||
124926914|NCT04032704|449362691|FG003|Part A|Death|7|||
124926915|NCT04032704|449362692|FG004|Part A|Death|4|||
124926916|NCT04032704|449362693|FG005|Part A|Death|5|||
124926917|NCT04032704|449362694|FG006|Part A|Death|0|||
124926918|NCT04032704|449362695|FG007|Part A|Death|0|||
124926919|NCT04032704|449362696|FG008|Part A|Death|0|||
124926920|NCT04032704|449362697|FG009|Part A|Death|0|||
124926921|NCT04032704|449362698|FG010|Part A|Death|0|||
124926922|NCT04032704|449362699|FG011|Part A|Death|0|||
124926923|NCT04032704|449362700|FG012|Part A|Death|0|||
124926924|NCT04032704|449362701|FG013|Part A|Death|0|||
124926925|NCT04032704|449362702|FG014|Part A|Death|0|||
124926926|NCT04032704|449362703|FG015|Part A|Death|0|||
124926927|NCT04032704|449362704|FG016|Part A|Death|0|||
124926928|NCT04032704|449362705|FG017|Part A|Death|0|||
124926929|NCT04032704|449362688|FG000|Part B|Other|0|||
124926930|NCT04032704|449362689|FG001|Part B|Other|0|||
124926931|NCT04032704|449362690|FG002|Part B|Other|0|||
124926932|NCT04032704|449362691|FG003|Part B|Other|0|||
124926933|NCT04032704|449362692|FG004|Part B|Other|0|||
124926934|NCT04032704|449362693|FG005|Part B|Other|0|||
124926935|NCT04032704|449362694|FG006|Part B|Other|0|||
124926936|NCT04032704|449362695|FG007|Part B|Other|1|||
124926937|NCT04032704|449362696|FG008|Part B|Other|2|||
124926938|NCT04032704|449362697|FG009|Part B|Other|1|||
124926939|NCT04032704|449362698|FG010|Part B|Other|1|||
124926940|NCT04032704|449362699|FG011|Part B|Other|1|||
124926941|NCT04032704|449362700|FG012|Part B|Other|5|||
124926942|NCT04032704|449362701|FG013|Part B|Other|13|||
124926943|NCT04032704|449362702|FG014|Part B|Other|0|||
124926944|NCT04032704|449362703|FG015|Part B|Other|0|||
124926945|NCT04032704|449362704|FG016|Part B|Other|0|||
124926946|NCT04032704|449362705|FG017|Part B|Other|0|||
124926947|NCT04032704|449362688|FG000|Part B|Study termination by Sponsor|0|||
124926948|NCT04032704|449362689|FG001|Part B|Study termination by Sponsor|0|||
124926949|NCT04032704|449362690|FG002|Part B|Study termination by Sponsor|0|||
124926950|NCT04032704|449362691|FG003|Part B|Study termination by Sponsor|0|||
124926951|NCT04032704|449362692|FG004|Part B|Study termination by Sponsor|0|||
124926952|NCT04032704|449362693|FG005|Part B|Study termination by Sponsor|0|||
124926953|NCT04032704|449362694|FG006|Part B|Study termination by Sponsor|0|||
124926954|NCT04032704|449362695|FG007|Part B|Study termination by Sponsor|0|||
124926955|NCT04032704|449362696|FG008|Part B|Study termination by Sponsor|1|||
124926956|NCT04032704|449362697|FG009|Part B|Study termination by Sponsor|0|||
124926957|NCT04032704|449362698|FG010|Part B|Study termination by Sponsor|0|||
124926958|NCT04032704|449362699|FG011|Part B|Study termination by Sponsor|0|||
124926959|NCT04032704|449362700|FG012|Part B|Study termination by Sponsor|0|||
124926960|NCT04032704|449362701|FG013|Part B|Study termination by Sponsor|0|||
124926961|NCT04032704|449362702|FG014|Part B|Study termination by Sponsor|0|||
124926962|NCT04032704|449362703|FG015|Part B|Study termination by Sponsor|0|||
124926963|NCT04032704|449362704|FG016|Part B|Study termination by Sponsor|0|||
124926964|NCT04032704|449362705|FG017|Part B|Study termination by Sponsor|0|||
124926965|NCT04032704|449362688|FG000|Part B|Withdrawal by Subject|0|||
124926966|NCT04032704|449362689|FG001|Part B|Withdrawal by Subject|0|||
124926967|NCT04032704|449362690|FG002|Part B|Withdrawal by Subject|0|||
124926968|NCT04032704|449362691|FG003|Part B|Withdrawal by Subject|0|||
124926969|NCT04032704|449362692|FG004|Part B|Withdrawal by Subject|0|||
124926970|NCT04032704|449362693|FG005|Part B|Withdrawal by Subject|0|||
124926971|NCT04032704|449362694|FG006|Part B|Withdrawal by Subject|3|||
124926972|NCT04032704|449362695|FG007|Part B|Withdrawal by Subject|2|||
124926973|NCT04032704|449362696|FG008|Part B|Withdrawal by Subject|2|||
124926974|NCT04032704|449362697|FG009|Part B|Withdrawal by Subject|1|||
124926975|NCT04032704|449362698|FG010|Part B|Withdrawal by Subject|4|||
124926976|NCT04032704|449362699|FG011|Part B|Withdrawal by Subject|6|||
124926977|NCT04032704|449362700|FG012|Part B|Withdrawal by Subject|2|||
124926978|NCT04032704|449362701|FG013|Part B|Withdrawal by Subject|1|||
124926979|NCT04032704|449362702|FG014|Part B|Withdrawal by Subject|0|||
124926980|NCT04032704|449362703|FG015|Part B|Withdrawal by Subject|1|||
124926981|NCT04032704|449362704|FG016|Part B|Withdrawal by Subject|0|||
124926982|NCT04032704|449362705|FG017|Part B|Withdrawal by Subject|0|||
124926983|NCT04032704|449362688|FG000|Part B|Lost to Follow-up|0|||
124926984|NCT04032704|449362689|FG001|Part B|Lost to Follow-up|0|||
124926985|NCT04032704|449362690|FG002|Part B|Lost to Follow-up|0|||
124926986|NCT04032704|449362691|FG003|Part B|Lost to Follow-up|0|||
124926987|NCT04032704|449362692|FG004|Part B|Lost to Follow-up|0|||
124926988|NCT04032704|449362693|FG005|Part B|Lost to Follow-up|0|||
125212363|NCT00548249|450403337|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
125212364|NCT00548249|450403338|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
125212365|NCT00548249|450403339|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
124926989|NCT04032704|449362694|FG006|Part B|Lost to Follow-up|0|||
124926990|NCT04032704|449362695|FG007|Part B|Lost to Follow-up|0|||
124926991|NCT04032704|449362696|FG008|Part B|Lost to Follow-up|0|||
124926992|NCT04032704|449362697|FG009|Part B|Lost to Follow-up|0|||
124926993|NCT04032704|449362698|FG010|Part B|Lost to Follow-up|0|||
124926994|NCT04032704|449362699|FG011|Part B|Lost to Follow-up|1|||
124926995|NCT04032704|449362700|FG012|Part B|Lost to Follow-up|0|||
124926996|NCT04032704|449362701|FG013|Part B|Lost to Follow-up|0|||
124926997|NCT04032704|449362702|FG014|Part B|Lost to Follow-up|0|||
124926998|NCT04032704|449362703|FG015|Part B|Lost to Follow-up|0|||
124926999|NCT04032704|449362704|FG016|Part B|Lost to Follow-up|0|||
124927000|NCT04032704|449362705|FG017|Part B|Lost to Follow-up|0|||
124927001|NCT04032704|449362688|FG000|Part B|Death|0|||
124927002|NCT04032704|449362689|FG001|Part B|Death|0|||
124927003|NCT04032704|449362690|FG002|Part B|Death|0|||
124927004|NCT04032704|449362691|FG003|Part B|Death|0|||
124927005|NCT04032704|449362692|FG004|Part B|Death|0|||
124927006|NCT04032704|449362693|FG005|Part B|Death|0|||
124927007|NCT04032704|449362694|FG006|Part B|Death|13|||
124927008|NCT04032704|449362695|FG007|Part B|Death|13|||
124927009|NCT04032704|449362696|FG008|Part B|Death|14|||
124927010|NCT04032704|449362697|FG009|Part B|Death|12|||
125212366|NCT00548249|450403335|FG000|Overall Study|Prolonged hospitalization|0|||
124927011|NCT04032704|449362698|FG010|Part B|Death|12|||
124927012|NCT04032704|449362699|FG011|Part B|Death|13|||
124927013|NCT04032704|449362700|FG012|Part B|Death|7|||
124927014|NCT04032704|449362701|FG013|Part B|Death|17|||
124927015|NCT04032704|449362702|FG014|Part B|Death|2|||
124927016|NCT04032704|449362703|FG015|Part B|Death|1|||
124927017|NCT04032704|449362704|FG016|Part B|Death|2|||
124927018|NCT04032704|449362705|FG017|Part B|Death|2|||
124927019|NCT02861300|449362706|FG000|Overall Study|Death|0|||
124927020|NCT02861300|449362707|FG001|Overall Study|Death|0|||
124927021|NCT02861300|449362708|FG002|Overall Study|Death|0|||
124927022|NCT02861300|449362709|FG003|Overall Study|Death|0|||
124927023|NCT02861300|449362710|FG004|Overall Study|Death|0|||
124927024|NCT02861300|449362711|FG005|Overall Study|Death|0|||
124927025|NCT02861300|449362712|FG006|Overall Study|Death|24|||
124927026|NCT02861300|449362706|FG000|Overall Study|Delay in treatment|0|||
124927027|NCT02861300|449362707|FG001|Overall Study|Delay in treatment|0|||
124927028|NCT02861300|449362708|FG002|Overall Study|Delay in treatment|0|||
124927029|NCT02861300|449362709|FG003|Overall Study|Delay in treatment|0|||
124927030|NCT02861300|449362710|FG004|Overall Study|Delay in treatment|0|||
124927031|NCT02861300|449362711|FG005|Overall Study|Delay in treatment|1|||
124927032|NCT02861300|449362712|FG006|Overall Study|Delay in treatment|0|||
124927033|NCT02861300|449362706|FG000|Overall Study|Disease Progression|0|||
124927034|NCT02861300|449362707|FG001|Overall Study|Disease Progression|1|||
124927035|NCT02861300|449362708|FG002|Overall Study|Disease Progression|0|||
124927036|NCT02861300|449362709|FG003|Overall Study|Disease Progression|0|||
124927037|NCT02861300|449362710|FG004|Overall Study|Disease Progression|0|||
124927038|NCT02861300|449362711|FG005|Overall Study|Disease Progression|0|||
124927039|NCT02861300|449362712|FG006|Overall Study|Disease Progression|2|||
124927040|NCT02861300|449362706|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
124927041|NCT02861300|449362707|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
124927042|NCT02861300|449362708|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
124927043|NCT02861300|449362709|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
124927044|NCT02861300|449362710|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
124927045|NCT02861300|449362711|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
124927046|NCT02861300|449362712|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
124927047|NCT02861300|449362706|FG000|Overall Study|Clinical Complications|0|||
124927048|NCT02861300|449362707|FG001|Overall Study|Clinical Complications|0|||
124927049|NCT02861300|449362708|FG002|Overall Study|Clinical Complications|0|||
124927050|NCT02861300|449362709|FG003|Overall Study|Clinical Complications|0|||
124927051|NCT02861300|449362710|FG004|Overall Study|Clinical Complications|0|||
124927052|NCT02861300|449362711|FG005|Overall Study|Clinical Complications|0|||
124927053|NCT02861300|449362712|FG006|Overall Study|Clinical Complications|1|||
124927054|NCT03133546|449362713|FG000|Overall Study|Death|46|||
124927055|NCT03133546|449362714|FG001|Overall Study|Death|43|||
124927056|NCT03133546|449362713|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
124927057|NCT03133546|449362714|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
124927058|NCT06103188|449362716|FG000|Overall Study|Lost to Follow-up|1|||
124927059|NCT06103188|449362717|FG001|Overall Study|Lost to Follow-up|6|||
124927060|NCT06103188|449362718|FG002|Overall Study|Lost to Follow-up|4|||
124927061|NCT05386030|449362723|FG000|Overall Study|Death|1|||
124927062|NCT05386030|449362724|FG001|Overall Study|Death|0|||
124927063|NCT05386030|449362723|FG000|Overall Study|Physician Decision|2|||
124927064|NCT05386030|449362724|FG001|Overall Study|Physician Decision|1|||
124927065|NCT05386030|449362723|FG000|Overall Study|Lost to Follow-up|19|||
124927066|NCT05386030|449362724|FG001|Overall Study|Lost to Follow-up|7|||
124927067|NCT05386030|449362723|FG000|Overall Study|Withdrawal by Subject|20|||
124927068|NCT05386030|449362724|FG001|Overall Study|Withdrawal by Subject|10|||
124927069|NCT05386030|449362723|FG000|Overall Study|Eligibility criteria violation|1|||
124927070|NCT05386030|449362724|FG001|Overall Study|Eligibility criteria violation|1|||
124927071|NCT05386030|449362723|FG000|Overall Study|Personal Reasons|1|||
124927072|NCT05386030|449362724|FG001|Overall Study|Personal Reasons|0|||
124927073|NCT01733316|449362729|FG000|RP103 Phase|Non-compliance|1|||
124927074|NCT01733316|449362729|FG000|Long Term Extension Phase|Adverse Event|1|||
124927075|NCT01733316|449362729|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
124927076|NCT01733316|449362729|FG000|Long Term Extension Phase|Sponsor Decision|2|||
124927077|NCT03058289|449362730|FG000|Overall Study|Radiographic Deterioration|0|||
124927078|NCT03058289|449362731|FG001|Overall Study|Radiographic Deterioration|3|||
124927079|NCT03058289|449362732|FG002|Overall Study|Radiographic Deterioration|1|||
124927080|NCT03058289|449362733|FG003|Overall Study|Radiographic Deterioration|2|||
124927081|NCT03058289|449362734|FG004|Overall Study|Radiographic Deterioration|6|||
124927082|NCT03058289|449362735|FG005|Overall Study|Radiographic Deterioration|3|||
124927083|NCT03058289|449362736|FG006|Overall Study|Radiographic Deterioration|0|||
124927084|NCT03058289|449362737|FG007|Overall Study|Radiographic Deterioration|4|||
124927085|NCT03058289|449362738|FG008|Overall Study|Radiographic Deterioration|2|||
124927086|NCT03058289|449362730|FG000|Overall Study|Adverse Event|2|||
124927087|NCT03058289|449362731|FG001|Overall Study|Adverse Event|0|||
124927088|NCT03058289|449362732|FG002|Overall Study|Adverse Event|1|||
124927089|NCT03058289|449362733|FG003|Overall Study|Adverse Event|3|||
124927090|NCT03058289|449362734|FG004|Overall Study|Adverse Event|1|||
124927091|NCT03058289|449362735|FG005|Overall Study|Adverse Event|0|||
124927092|NCT03058289|449362736|FG006|Overall Study|Adverse Event|1|||
124927093|NCT03058289|449362737|FG007|Overall Study|Adverse Event|3|||
124927094|NCT03058289|449362738|FG008|Overall Study|Adverse Event|0|||
124927095|NCT03058289|449362730|FG000|Overall Study|Withdrawal by Subject|0|||
124927096|NCT03058289|449362731|FG001|Overall Study|Withdrawal by Subject|0|||
124927097|NCT03058289|449362732|FG002|Overall Study|Withdrawal by Subject|0|||
124927098|NCT03058289|449362733|FG003|Overall Study|Withdrawal by Subject|2|||
124927099|NCT03058289|449362734|FG004|Overall Study|Withdrawal by Subject|0|||
124927100|NCT03058289|449362735|FG005|Overall Study|Withdrawal by Subject|2|||
124927101|NCT03058289|449362736|FG006|Overall Study|Withdrawal by Subject|0|||
124927102|NCT03058289|449362737|FG007|Overall Study|Withdrawal by Subject|4|||
124927103|NCT03058289|449362738|FG008|Overall Study|Withdrawal by Subject|1|||
124927104|NCT03058289|449362730|FG000|Overall Study|Physician Decision|1|||
124927105|NCT03058289|449362731|FG001|Overall Study|Physician Decision|0|||
124927106|NCT03058289|449362732|FG002|Overall Study|Physician Decision|0|||
124927107|NCT03058289|449362733|FG003|Overall Study|Physician Decision|2|||
124927108|NCT03058289|449362734|FG004|Overall Study|Physician Decision|1|||
124927109|NCT03058289|449362735|FG005|Overall Study|Physician Decision|0|||
124927110|NCT03058289|449362736|FG006|Overall Study|Physician Decision|2|||
124927111|NCT03058289|449362737|FG007|Overall Study|Physician Decision|3|||
124927112|NCT03058289|449362738|FG008|Overall Study|Physician Decision|0|||
125119612|NCT02729896|450061321|FG001|Overall Study|Death|2|||
124927113|NCT03058289|449362730|FG000|Overall Study|Clinical Deterioration|2|||
124927114|NCT03058289|449362731|FG001|Overall Study|Clinical Deterioration|0|||
124927115|NCT03058289|449362732|FG002|Overall Study|Clinical Deterioration|0|||
124927116|NCT03058289|449362733|FG003|Overall Study|Clinical Deterioration|2|||
124927117|NCT03058289|449362734|FG004|Overall Study|Clinical Deterioration|1|||
124927118|NCT03058289|449362735|FG005|Overall Study|Clinical Deterioration|1|||
124927119|NCT03058289|449362736|FG006|Overall Study|Clinical Deterioration|0|||
124927120|NCT03058289|449362737|FG007|Overall Study|Clinical Deterioration|3|||
124927121|NCT03058289|449362738|FG008|Overall Study|Clinical Deterioration|2|||
124927122|NCT03058289|449362730|FG000|Overall Study|Lost to Follow-up|0|||
124927123|NCT03058289|449362731|FG001|Overall Study|Lost to Follow-up|0|||
124927124|NCT03058289|449362732|FG002|Overall Study|Lost to Follow-up|0|||
124927125|NCT03058289|449362733|FG003|Overall Study|Lost to Follow-up|0|||
125119613|NCT02729896|450061322|FG002|Overall Study|Death|13|||
125119614|NCT02729896|450061320|FG000|Overall Study|Lost to Follow-up|0|||
124927126|NCT03058289|449362734|FG004|Overall Study|Lost to Follow-up|1|||
124927127|NCT03058289|449362735|FG005|Overall Study|Lost to Follow-up|0|||
124927128|NCT03058289|449362736|FG006|Overall Study|Lost to Follow-up|0|||
124927129|NCT03058289|449362737|FG007|Overall Study|Lost to Follow-up|0|||
124927130|NCT03058289|449362738|FG008|Overall Study|Lost to Follow-up|0|||
124927131|NCT03058289|449362730|FG000|Overall Study|Refused Further Treatment|0|||
124927132|NCT03058289|449362731|FG001|Overall Study|Refused Further Treatment|0|||
124927133|NCT03058289|449362732|FG002|Overall Study|Refused Further Treatment|1|||
124927134|NCT03058289|449362733|FG003|Overall Study|Refused Further Treatment|0|||
124927135|NCT03058289|449362734|FG004|Overall Study|Refused Further Treatment|1|||
124927136|NCT03058289|449362735|FG005|Overall Study|Refused Further Treatment|0|||
124927137|NCT03058289|449362736|FG006|Overall Study|Refused Further Treatment|0|||
124927138|NCT03058289|449362737|FG007|Overall Study|Refused Further Treatment|0|||
124927139|NCT03058289|449362738|FG008|Overall Study|Refused Further Treatment|0|||
124927140|NCT03058289|449362730|FG000|Overall Study|Rapid Progression of Disease|0|||
124927141|NCT03058289|449362731|FG001|Overall Study|Rapid Progression of Disease|0|||
124927142|NCT03058289|449362732|FG002|Overall Study|Rapid Progression of Disease|0|||
124927143|NCT03058289|449362733|FG003|Overall Study|Rapid Progression of Disease|1|||
124927144|NCT03058289|449362734|FG004|Overall Study|Rapid Progression of Disease|0|||
124927145|NCT03058289|449362735|FG005|Overall Study|Rapid Progression of Disease|0|||
124927146|NCT03058289|449362736|FG006|Overall Study|Rapid Progression of Disease|0|||
124927147|NCT03058289|449362737|FG007|Overall Study|Rapid Progression of Disease|0|||
124927148|NCT03058289|449362738|FG008|Overall Study|Rapid Progression of Disease|0|||
124927149|NCT05546411|449362741|FG000|Overall Study|Progressive Disease|1|||
124927150|NCT05546411|449362742|FG001|Overall Study|Progressive Disease|0|||
124927151|NCT05546411|449362741|FG000|Overall Study|Adverse Event|0|||
124927152|NCT05546411|449362742|FG001|Overall Study|Adverse Event|1|||
124927153|NCT05546411|449362741|FG000|Overall Study|Metastatic disease|1|||
124927154|NCT05546411|449362742|FG001|Overall Study|Metastatic disease|0|||
124927155|NCT02606422|449362743|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
124927156|NCT02606422|449362744|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
124927157|NCT02606422|449362743|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
124927158|NCT02606422|449362744|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
124927159|NCT02606422|449362743|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
124927160|NCT02606422|449362744|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
124927161|NCT02606422|449362743|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
124927162|NCT02606422|449362744|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
124927163|NCT02151981|449362748|FG000|Overall Study|Death|184|||
124927164|NCT02151981|449362749|FG001|Overall Study|Death|88|||
124927165|NCT02151981|449362748|FG000|Overall Study|Lost to Follow-up|7|||
124927166|NCT02151981|449362749|FG001|Overall Study|Lost to Follow-up|1|||
124927167|NCT02151981|449362748|FG000|Overall Study|Withdrawal by Subject|27|||
124927168|NCT02151981|449362749|FG001|Overall Study|Withdrawal by Subject|21|||
124927169|NCT02151981|449362748|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124927170|NCT02151981|449362749|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
124927171|NCT02151981|449362748|FG000|Overall Study|Other reasons|1|||
124927172|NCT02151981|449362749|FG001|Overall Study|Other reasons|2|||
124927173|NCT01946789|449362753|FG000|Overall Study|Death|0|||
124927174|NCT01946789|449362754|FG001|Overall Study|Death|2|||
124927175|NCT01946789|449362755|FG002|Overall Study|Death|1|||
124927176|NCT01946789|449362756|FG003|Overall Study|Death|1|||
124927177|NCT01946789|449362757|FG004|Overall Study|Death|1|||
124927178|NCT01946789|449362758|FG005|Overall Study|Death|1|||
124927179|NCT01946789|449362759|FG006|Overall Study|Death|3|||
124927180|NCT01946789|449362760|FG007|Overall Study|Death|1|||
124927181|NCT01946789|449362761|FG008|Overall Study|Death|2|||
124927182|NCT01946789|449362753|FG000|Overall Study|Progressive Disease|0|||
124927183|NCT01946789|449362754|FG001|Overall Study|Progressive Disease|0|||
124927184|NCT01946789|449362755|FG002|Overall Study|Progressive Disease|1|||
124927185|NCT01946789|449362756|FG003|Overall Study|Progressive Disease|0|||
124927186|NCT01946789|449362757|FG004|Overall Study|Progressive Disease|0|||
124927187|NCT01946789|449362758|FG005|Overall Study|Progressive Disease|2|||
124927188|NCT01946789|449362759|FG006|Overall Study|Progressive Disease|0|||
124927189|NCT01946789|449362760|FG007|Overall Study|Progressive Disease|0|||
124927190|NCT01946789|449362761|FG008|Overall Study|Progressive Disease|0|||
125119615|NCT02729896|450061321|FG001|Overall Study|Lost to Follow-up|2|||
124927191|NCT01946789|449362753|FG000|Overall Study|Withdrawal by Subject|0|||
124927192|NCT01946789|449362754|FG001|Overall Study|Withdrawal by Subject|0|||
125119616|NCT02729896|450061322|FG002|Overall Study|Lost to Follow-up|3|||
124927193|NCT01946789|449362755|FG002|Overall Study|Withdrawal by Subject|0|||
124927194|NCT01946789|449362756|FG003|Overall Study|Withdrawal by Subject|2|||
124927195|NCT01946789|449362757|FG004|Overall Study|Withdrawal by Subject|1|||
124927196|NCT01946789|449362758|FG005|Overall Study|Withdrawal by Subject|0|||
124927197|NCT01946789|449362759|FG006|Overall Study|Withdrawal by Subject|1|||
125119617|NCT02729896|450061320|FG000|Overall Study|Other|0|||
124927198|NCT01946789|449362760|FG007|Overall Study|Withdrawal by Subject|0|||
124927199|NCT01946789|449362761|FG008|Overall Study|Withdrawal by Subject|0|||
124927200|NCT05374798|449362762|FG000|Overall Study|Lost to Follow-up|2|||
124927201|NCT05374798|449362762|FG000|Overall Study|Withdrawal by Subject|2|||
124927202|NCT05374798|449362762|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
124927203|NCT05576155|449362763|FG000|Overall Study|Withdrawal by Subject|1|||
124927204|NCT05576155|449362764|FG001|Overall Study|Withdrawal by Subject|1|||
124927205|NCT01275677|449362768|FG000|Overall Study|Not at risk for recurrence.|1|||
124927206|NCT01275677|449362769|FG001|Overall Study|Not at risk for recurrence.|1|||
124927207|NCT01275677|449362768|FG000|Overall Study|No follow-up|26|||
124927208|NCT01275677|449362769|FG001|Overall Study|No follow-up|37|||
124927209|NCT01275677|449362768|FG000|Overall Study|No clinical follow up.|1|||
124927210|NCT01275677|449362769|FG001|Overall Study|No clinical follow up.|4|||
124927211|NCT04409353|449362775|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
124927212|NCT04409353|449362776|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
124927213|NCT04409353|449362777|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
124927214|NCT04409353|449362775|FG000|Overall Study|Lost to Follow-up|6|||
124927215|NCT04409353|449362776|FG001|Overall Study|Lost to Follow-up|8|||
124927216|NCT04409353|449362777|FG002|Overall Study|Lost to Follow-up|7|||
124927217|NCT04409353|449362775|FG000|Overall Study|Major surgery during participation window|4|||
124927218|NCT04409353|449362776|FG001|Overall Study|Major surgery during participation window|3|||
124927219|NCT04409353|449362777|FG002|Overall Study|Major surgery during participation window|3|||
124927220|NCT04409353|449362775|FG000|Overall Study|Life event occurred during participation window|3|||
124927221|NCT04409353|449362776|FG001|Overall Study|Life event occurred during participation window|2|||
124927222|NCT04409353|449362777|FG002|Overall Study|Life event occurred during participation window|4|||
124927223|NCT04409353|449362775|FG000|Overall Study|Lack of Efficacy|4|||
124927224|NCT04409353|449362776|FG001|Overall Study|Lack of Efficacy|1|||
124927225|NCT04409353|449362777|FG002|Overall Study|Lack of Efficacy|3|||
124927226|NCT04409353|449362775|FG000|Overall Study|Adverse Event|2|||
124927227|NCT04409353|449362776|FG001|Overall Study|Adverse Event|1|||
124927228|NCT04409353|449362777|FG002|Overall Study|Adverse Event|1|||
124927229|NCT04409353|449362775|FG000|Overall Study|Disease burden - unable to participate|0|||
124927230|NCT04409353|449362776|FG001|Overall Study|Disease burden - unable to participate|1|||
124927231|NCT04409353|449362777|FG002|Overall Study|Disease burden - unable to participate|1|||
124927232|NCT04409353|449362775|FG000|Overall Study|Intervention too complicated|1|||
124927233|NCT04409353|449362776|FG001|Overall Study|Intervention too complicated|0|||
124927234|NCT04409353|449362777|FG002|Overall Study|Intervention too complicated|1|||
124927235|NCT04081103|449362778|FG000|Overall Study|Adverse Event|1|||
124927236|NCT04081103|449362779|FG001|Overall Study|Adverse Event|1|||
124927237|NCT04081103|449362780|FG002|Overall Study|Adverse Event|1|||
124927238|NCT04081103|449362778|FG000|Overall Study|Physician Decision|0|||
124927239|NCT04081103|449362779|FG001|Overall Study|Physician Decision|0|||
124927240|NCT04081103|449362780|FG002|Overall Study|Physician Decision|1|||
124927241|NCT05309291|449362781|FG000|Overall Study|Adverse Event|0|||
124927242|NCT05309291|449362782|FG001|Overall Study|Adverse Event|1|||
124927243|NCT05209152|449362785|FG000|Overall Study|Sponsor decision|1|||
124927244|NCT05209152|449362786|FG001|Overall Study|Sponsor decision|2|||
124927245|NCT05209152|449362785|FG000|Overall Study|Death|3|||
124927246|NCT05209152|449362786|FG001|Overall Study|Death|1|||
124927247|NCT03287817|449364526|FG000|Overall Study|Progressive disease|4|||
124927248|NCT03287817|449364527|FG001|Overall Study|Progressive disease|2|||
124927249|NCT03287817|449364528|FG002|Overall Study|Progressive disease|3|||
124927250|NCT03287817|449364529|FG003|Overall Study|Progressive disease|10|||
124927251|NCT03287817|449364530|FG004|Overall Study|Progressive disease|8|||
124927252|NCT03287817|449364526|FG000|Overall Study|Death|0|||
124927253|NCT03287817|449364527|FG001|Overall Study|Death|0|||
124927254|NCT03287817|449364528|FG002|Overall Study|Death|2|||
124927255|NCT03287817|449364529|FG003|Overall Study|Death|3|||
124927256|NCT03287817|449364530|FG004|Overall Study|Death|4|||
124927257|NCT03287817|449364526|FG000|Overall Study|Physician Decision|0|||
124927258|NCT03287817|449364527|FG001|Overall Study|Physician Decision|0|||
124927259|NCT03287817|449364528|FG002|Overall Study|Physician Decision|0|||
124927260|NCT03287817|449364529|FG003|Overall Study|Physician Decision|1|||
124927261|NCT03287817|449364530|FG004|Overall Study|Physician Decision|0|||
124927262|NCT03287817|449364526|FG000|Overall Study|Withdrawal by Subject|0|||
124927263|NCT03287817|449364527|FG001|Overall Study|Withdrawal by Subject|0|||
124927264|NCT03287817|449364528|FG002|Overall Study|Withdrawal by Subject|0|||
124927265|NCT03287817|449364529|FG003|Overall Study|Withdrawal by Subject|0|||
124927266|NCT03287817|449364530|FG004|Overall Study|Withdrawal by Subject|4|||
124927267|NCT06181227|449364531|FG000|Overall Study|Study terminated by sponsor|7|||
124927268|NCT06181227|449364532|FG001|Overall Study|Study terminated by sponsor|9|||
124927269|NCT03854227|449364536|FG000|Overall Study|Adverse Event|0|||
124927270|NCT03854227|449364537|FG001|Overall Study|Adverse Event|0|||
124927271|NCT03854227|449364538|FG002|Overall Study|Adverse Event|0|||
124927272|NCT03854227|449364539|FG003|Overall Study|Adverse Event|1|||
124927273|NCT03854227|449364540|FG004|Overall Study|Adverse Event|0|||
124927274|NCT03854227|449364541|FG005|Overall Study|Adverse Event|0|||
124927275|NCT03854227|449364542|FG006|Overall Study|Adverse Event|1|||
124927276|NCT03854227|449364543|FG007|Overall Study|Adverse Event|0|||
124927277|NCT03854227|449364544|FG008|Overall Study|Adverse Event|0|||
124927278|NCT03854227|449364545|FG009|Overall Study|Adverse Event|3|||
124927279|NCT03854227|449364546|FG010|Overall Study|Adverse Event|0|||
124927280|NCT03854227|449364547|FG011|Overall Study|Adverse Event|1|||
124927281|NCT03854227|449364536|FG000|Overall Study|Death|0|||
124927282|NCT03854227|449364537|FG001|Overall Study|Death|0|||
124927283|NCT03854227|449364538|FG002|Overall Study|Death|0|||
124927284|NCT03854227|449364539|FG003|Overall Study|Death|0|||
124927285|NCT03854227|449364540|FG004|Overall Study|Death|0|||
124927286|NCT03854227|449364541|FG005|Overall Study|Death|1|||
124927287|NCT03854227|449364542|FG006|Overall Study|Death|0|||
124927288|NCT03854227|449364543|FG007|Overall Study|Death|0|||
124927289|NCT03854227|449364544|FG008|Overall Study|Death|0|||
124927290|NCT03854227|449364545|FG009|Overall Study|Death|1|||
124927291|NCT03854227|449364546|FG010|Overall Study|Death|0|||
124927292|NCT03854227|449364547|FG011|Overall Study|Death|1|||
124927293|NCT03854227|449364536|FG000|Overall Study|Physician Decision|0|||
124927294|NCT03854227|449364537|FG001|Overall Study|Physician Decision|0|||
124927295|NCT03854227|449364538|FG002|Overall Study|Physician Decision|0|||
124927296|NCT03854227|449364539|FG003|Overall Study|Physician Decision|0|||
124927297|NCT03854227|449364540|FG004|Overall Study|Physician Decision|0|||
124927298|NCT03854227|449364541|FG005|Overall Study|Physician Decision|1|||
124927299|NCT03854227|449364542|FG006|Overall Study|Physician Decision|0|||
124927300|NCT03854227|449364543|FG007|Overall Study|Physician Decision|0|||
124927301|NCT03854227|449364544|FG008|Overall Study|Physician Decision|1|||
124927302|NCT03854227|449364545|FG009|Overall Study|Physician Decision|1|||
124927303|NCT03854227|449364546|FG010|Overall Study|Physician Decision|0|||
124927304|NCT03854227|449364547|FG011|Overall Study|Physician Decision|1|||
124927305|NCT03854227|449364536|FG000|Overall Study|Progressive disease|1|||
124927306|NCT03854227|449364537|FG001|Overall Study|Progressive disease|1|||
124927307|NCT03854227|449364538|FG002|Overall Study|Progressive disease|1|||
124927308|NCT03854227|449364539|FG003|Overall Study|Progressive disease|2|||
124927309|NCT03854227|449364540|FG004|Overall Study|Progressive disease|3|||
124927310|NCT03854227|449364541|FG005|Overall Study|Progressive disease|1|||
124927311|NCT03854227|449364542|FG006|Overall Study|Progressive disease|2|||
124927312|NCT03854227|449364543|FG007|Overall Study|Progressive disease|5|||
124927313|NCT03854227|449364544|FG008|Overall Study|Progressive disease|2|||
124927314|NCT03854227|449364545|FG009|Overall Study|Progressive disease|5|||
124927315|NCT03854227|449364546|FG010|Overall Study|Progressive disease|1|||
124927316|NCT03854227|449364547|FG011|Overall Study|Progressive disease|6|||
124927317|NCT03854227|449364536|FG000|Overall Study|Study terminated by sponsor|0|||
124927318|NCT03854227|449364537|FG001|Overall Study|Study terminated by sponsor|0|||
124927319|NCT03854227|449364538|FG002|Overall Study|Study terminated by sponsor|0|||
124927320|NCT03854227|449364539|FG003|Overall Study|Study terminated by sponsor|0|||
125119618|NCT02729896|450061321|FG001|Overall Study|Other|2|||
125119619|NCT02729896|450061322|FG002|Overall Study|Other|0|||
125119620|NCT02729896|450061320|FG000|Overall Study|Physician Decision|1|||
125119621|NCT02729896|450061321|FG001|Overall Study|Physician Decision|2|||
124927321|NCT03854227|449364540|FG004|Overall Study|Study terminated by sponsor|0|||
124927322|NCT03854227|449364541|FG005|Overall Study|Study terminated by sponsor|0|||
124927323|NCT03854227|449364542|FG006|Overall Study|Study terminated by sponsor|0|||
124927324|NCT03854227|449364543|FG007|Overall Study|Study terminated by sponsor|0|||
124927325|NCT03854227|449364544|FG008|Overall Study|Study terminated by sponsor|0|||
124927326|NCT03854227|449364545|FG009|Overall Study|Study terminated by sponsor|1|||
124927327|NCT03854227|449364546|FG010|Overall Study|Study terminated by sponsor|0|||
124927328|NCT03854227|449364547|FG011|Overall Study|Study terminated by sponsor|0|||
124927329|NCT03854227|449364536|FG000|Overall Study|Withdrawal by Subject|0|||
124927330|NCT03854227|449364537|FG001|Overall Study|Withdrawal by Subject|0|||
124927331|NCT03854227|449364538|FG002|Overall Study|Withdrawal by Subject|1|||
124927332|NCT03854227|449364539|FG003|Overall Study|Withdrawal by Subject|0|||
124927333|NCT03854227|449364540|FG004|Overall Study|Withdrawal by Subject|0|||
124927334|NCT03854227|449364541|FG005|Overall Study|Withdrawal by Subject|0|||
124927335|NCT03854227|449364542|FG006|Overall Study|Withdrawal by Subject|0|||
124927336|NCT03854227|449364543|FG007|Overall Study|Withdrawal by Subject|0|||
125119622|NCT02729896|450061322|FG002|Overall Study|Physician Decision|3|||
125119623|NCT02729896|450061320|FG000|Overall Study|Progressive Disease|0|||
125119624|NCT02729896|450061321|FG001|Overall Study|Progressive Disease|1|||
124927337|NCT03854227|449364544|FG008|Overall Study|Withdrawal by Subject|0|||
124927338|NCT03854227|449364545|FG009|Overall Study|Withdrawal by Subject|1|||
124927339|NCT03854227|449364546|FG010|Overall Study|Withdrawal by Subject|1|||
124927340|NCT03854227|449364547|FG011|Overall Study|Withdrawal by Subject|0|||
124927341|NCT03854227|449364536|FG000|Overall Study|Disease relapse|0|||
124927342|NCT03854227|449364537|FG001|Overall Study|Disease relapse|0|||
124927343|NCT03854227|449364538|FG002|Overall Study|Disease relapse|0|||
124927344|NCT03854227|449364539|FG003|Overall Study|Disease relapse|0|||
125119625|NCT02729896|450061322|FG002|Overall Study|Progressive Disease|0|||
124927345|NCT03854227|449364540|FG004|Overall Study|Disease relapse|0|||
124927346|NCT03854227|449364541|FG005|Overall Study|Disease relapse|0|||
124927347|NCT03854227|449364542|FG006|Overall Study|Disease relapse|0|||
124927348|NCT03854227|449364543|FG007|Overall Study|Disease relapse|0|||
124927349|NCT03854227|449364544|FG008|Overall Study|Disease relapse|1|||
124927350|NCT03854227|449364545|FG009|Overall Study|Disease relapse|0|||
124927351|NCT03854227|449364546|FG010|Overall Study|Disease relapse|0|||
124927352|NCT03854227|449364547|FG011|Overall Study|Disease relapse|0|||
124927353|NCT03854227|449364536|FG000|Overall Study|Global deterioration of health status|0|||
124927354|NCT03854227|449364537|FG001|Overall Study|Global deterioration of health status|0|||
124927355|NCT03854227|449364538|FG002|Overall Study|Global deterioration of health status|0|||
124927356|NCT03854227|449364539|FG003|Overall Study|Global deterioration of health status|0|||
124927357|NCT03854227|449364540|FG004|Overall Study|Global deterioration of health status|0|||
124927358|NCT03854227|449364541|FG005|Overall Study|Global deterioration of health status|1|||
124927359|NCT03854227|449364542|FG006|Overall Study|Global deterioration of health status|0|||
124927360|NCT03854227|449364543|FG007|Overall Study|Global deterioration of health status|1|||
124927361|NCT03854227|449364544|FG008|Overall Study|Global deterioration of health status|0|||
124927362|NCT03854227|449364545|FG009|Overall Study|Global deterioration of health status|0|||
124927363|NCT03854227|449364546|FG010|Overall Study|Global deterioration of health status|0|||
124927364|NCT03854227|449364547|FG011|Overall Study|Global deterioration of health status|0|||
124927365|NCT03854227|449364536|FG000|Overall Study|Refused further treatment|0|||
124927366|NCT03854227|449364537|FG001|Overall Study|Refused further treatment|0|||
124927367|NCT03854227|449364538|FG002|Overall Study|Refused further treatment|0|||
124927368|NCT03854227|449364539|FG003|Overall Study|Refused further treatment|0|||
124927369|NCT03854227|449364540|FG004|Overall Study|Refused further treatment|0|||
124927370|NCT03854227|449364541|FG005|Overall Study|Refused further treatment|0|||
124927371|NCT03854227|449364542|FG006|Overall Study|Refused further treatment|0|||
124927372|NCT03854227|449364543|FG007|Overall Study|Refused further treatment|0|||
124927373|NCT03854227|449364544|FG008|Overall Study|Refused further treatment|0|||
124927374|NCT03854227|449364545|FG009|Overall Study|Refused further treatment|1|||
124927375|NCT03854227|449364546|FG010|Overall Study|Refused further treatment|0|||
124927376|NCT03854227|449364547|FG011|Overall Study|Refused further treatment|1|||
124927377|NCT03854227|449364536|FG000|Overall Study|Other|0|||
124927378|NCT03854227|449364537|FG001|Overall Study|Other|0|||
124927379|NCT03854227|449364538|FG002|Overall Study|Other|0|||
124927380|NCT03854227|449364539|FG003|Overall Study|Other|0|||
124927381|NCT03854227|449364540|FG004|Overall Study|Other|0|||
124927382|NCT03854227|449364541|FG005|Overall Study|Other|0|||
124927383|NCT03854227|449364542|FG006|Overall Study|Other|0|||
124927384|NCT03854227|449364543|FG007|Overall Study|Other|0|||
124927385|NCT03854227|449364544|FG008|Overall Study|Other|1|||
124927386|NCT03854227|449364545|FG009|Overall Study|Other|1|||
124927387|NCT03854227|449364546|FG010|Overall Study|Other|0|||
124927388|NCT03854227|449364547|FG011|Overall Study|Other|0|||
124927389|NCT03668236|449364548|FG000|90-day Follow-up|Withdrawal by Subject|3|||
124927390|NCT03668236|449364549|FG001|90-day Follow-up|Withdrawal by Subject|2|||
124927391|NCT03668236|449364548|FG000|90-day Follow-up|Lost to Follow-up|3|||
124927392|NCT03668236|449364549|FG001|90-day Follow-up|Lost to Follow-up|1|||
124927393|NCT03668236|449364548|FG000|Baseline Characteristics|Lost to Follow-up|9|||
124927394|NCT03668236|449364549|FG001|Baseline Characteristics|Lost to Follow-up|5|||
124927395|NCT03668236|449364548|FG000|1-year Follow-up|Withdrawal by Subject|17|||
124927396|NCT03668236|449364549|FG001|1-year Follow-up|Withdrawal by Subject|15|||
124927397|NCT06132282|449364555|FG000|Overall Study|Lost to Follow-up|31|||
124927398|NCT04376502|449364561|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
124927399|NCT03748953|449364562|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
124927400|NCT03748953|449364563|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
124927401|NCT03748953|449364562|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
124927402|NCT03748953|449364563|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
124927403|NCT03748953|449364562|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
124927404|NCT03748953|449364563|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
124927405|NCT03748953|449364562|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
124927406|NCT03748953|449364563|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
124927407|NCT03748953|449364562|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
124927408|NCT03748953|449364563|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
124927409|NCT04044768|449364565|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
124927410|NCT04044768|449364566|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
124927411|NCT01574274|449364567|FG000|Overall Study|Ineligible|0|||
124927412|NCT01574274|449364568|FG001|Overall Study|Ineligible|1|||
124927413|NCT01574274|449364567|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
124927414|NCT01574274|449364568|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
124927415|NCT01574274|449364567|FG000|Overall Study|Ph+ B-ALL|3|||
124927416|NCT01574274|449364568|FG001|Overall Study|Ph+ B-ALL|4|||
124927417|NCT01574274|449364567|FG000|Overall Study|Induction Death|2|||
124927418|NCT01574274|449364568|FG001|Overall Study|Induction Death|0|||
124927419|NCT01574274|449364567|FG000|Overall Study|Induction Failure|4|||
124927420|NCT01574274|449364568|FG001|Overall Study|Induction Failure|1|||
124927421|NCT01574274|449364567|FG000|Overall Study|Adverse Event|16|||
124927422|NCT01574274|449364568|FG001|Overall Study|Adverse Event|13|||
124927423|NCT01574274|449364567|FG000|Overall Study|Remission Death|1|||
124927424|NCT01574274|449364568|FG001|Overall Study|Remission Death|0|||
124927425|NCT01574274|449364567|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
124927426|NCT01574274|449364568|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
124927427|NCT01574274|449364567|FG000|Overall Study|Other, unknown|3|||
124927428|NCT01574274|449364568|FG001|Overall Study|Other, unknown|2|||
124927429|NCT05089019|449364569|FG000|Period 1|Withdrawal by Subject|0|||
124927430|NCT05089019|449364570|FG001|Period 1|Withdrawal by Subject|1|||
124927431|NCT05089019|449364569|FG000|Washout Period|Adverse Event|3|||
124927432|NCT05089019|449364570|FG001|Washout Period|Adverse Event|4|||
124927433|NCT05089019|449364569|FG000|Washout Period|Lost to Follow-up|1|||
124927434|NCT05089019|449364570|FG001|Washout Period|Lost to Follow-up|0|||
124927435|NCT05089019|449364569|FG000|Washout Period|Physician Decision|2|||
124927436|NCT05089019|449364570|FG001|Washout Period|Physician Decision|0|||
124927437|NCT05089019|449364569|FG000|Washout Period|Withdrawal by Subject|6|||
124927438|NCT05089019|449364570|FG001|Washout Period|Withdrawal by Subject|3|||
124927439|NCT05089019|449364569|FG000|Period 2|Adverse Event|4|||
124927440|NCT05089019|449364570|FG001|Period 2|Adverse Event|2|||
124927441|NCT05089019|449364569|FG000|Period 2|Lost to Follow-up|1|||
124927442|NCT05089019|449364570|FG001|Period 2|Lost to Follow-up|0|||
124927443|NCT05089019|449364569|FG000|Period 2|Withdrawal by Subject|0|||
124927444|NCT05089019|449364570|FG001|Period 2|Withdrawal by Subject|1|||
124927445|NCT01593917|449364575|FG000|Overall Study|Death|67|||
124927446|NCT01593917|449364575|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
124927447|NCT01593917|449364575|FG000|Overall Study|Withdrawal by Subject|23|||
124927448|NCT01593917|449364575|FG000|Overall Study|Lost to Follow-up|12|||
124927449|NCT01593917|449364575|FG000|Overall Study|Protocol Violation|5|||
124927450|NCT01593917|449364575|FG000|Overall Study|Physician Decision|3|||
124927451|NCT03216057|449364576|FG000|Overall Study|Lost to Follow-up|2|||
124927452|NCT03216057|449364577|FG001|Overall Study|Lost to Follow-up|2|||
124927453|NCT04564742|449364578|FG000|Overall Study|Lost to Follow-up|1|||
124927454|NCT04564742|449364579|FG001|Overall Study|Lost to Follow-up|0|||
124927455|NCT04564742|449364578|FG000|Overall Study|Consent Withdrawal|4|||
124927456|NCT04564742|449364579|FG001|Overall Study|Consent Withdrawal|4|||
124927457|NCT02841579|449364581|FG000|Overall Study|Death|1|||
124927458|NCT02841579|449364581|FG000|Overall Study|Adverse Event|1|||
124927459|NCT02841579|449364581|FG000|Overall Study|Lack of Efficacy|9|||
124927460|NCT05270408|449364582|FG000|Started Treatment|Withdrawal by Subject|0|||
124927461|NCT05270408|449364583|FG001|Started Treatment|Withdrawal by Subject|0|||
124927462|NCT05270408|449364584|FG002|Started Treatment|Withdrawal by Subject|3|||
124927463|NCT05270408|449364582|FG000|Started Treatment|Adverse Event|0|||
124927464|NCT05270408|449364583|FG001|Started Treatment|Adverse Event|0|||
124927465|NCT05270408|449364584|FG002|Started Treatment|Adverse Event|1|||
124927466|NCT05270408|449364582|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
124927467|NCT05270408|449364583|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
124927468|NCT05270408|449364584|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
124927469|NCT02465268|449364589|FG000|Overall Study|Withdrawal by Subject|4|||
124927470|NCT02465268|449364590|FG001|Overall Study|Withdrawal by Subject|3|||
124927471|NCT02465268|449364591|FG002|Overall Study|Withdrawal by Subject|1|||
124927472|NCT02465268|449364589|FG000|Overall Study|Not evaluable per protocol criteria|3|||
124927473|NCT02465268|449364590|FG001|Overall Study|Not evaluable per protocol criteria|2|||
124927474|NCT02465268|449364591|FG002|Overall Study|Not evaluable per protocol criteria|1|||
124927475|NCT02465268|449364589|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
124927476|NCT02465268|449364590|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
124927477|NCT02465268|449364591|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
124927478|NCT02465268|449364589|FG000|Overall Study|Study drug did not pass QA/QC|1|||
124927479|NCT02465268|449364590|FG001|Overall Study|Study drug did not pass QA/QC|0|||
124927480|NCT02465268|449364591|FG002|Overall Study|Study drug did not pass QA/QC|0|||
124927481|NCT02465268|449364589|FG000|Overall Study|Adverse Event|0|||
124927482|NCT02465268|449364590|FG001|Overall Study|Adverse Event|1|||
124927483|NCT02465268|449364591|FG002|Overall Study|Adverse Event|0|||
124927484|NCT02465268|449364589|FG000|Overall Study|Physician Decision|0|||
124927485|NCT02465268|449364590|FG001|Overall Study|Physician Decision|1|||
125024247|NCT00441545|449711417|FG000|First Intervention|Kidney transplant|1|||
124927486|NCT02465268|449364591|FG002|Overall Study|Physician Decision|0|||
124927487|NCT01501955|449364594|FG000|Overall Study|Withdrawal by Subject|1|||
124927488|NCT01501955|449364595|FG001|Overall Study|Withdrawal by Subject|0|||
124927489|NCT01501955|449364594|FG000|Overall Study|Adverse Event|1|||
124927490|NCT01501955|449364595|FG001|Overall Study|Adverse Event|3|||
124927491|NCT02993159|449364596|FG000|Overall Study|Withdrawal by Subject|1|||
124927492|NCT02993159|449364597|FG001|Overall Study|Withdrawal by Subject|3|||
124927493|NCT02993159|449364596|FG000|Overall Study|Protocol Violation|1|||
124927494|NCT02993159|449364597|FG001|Overall Study|Protocol Violation|0|||
124927495|NCT02993159|449364596|FG000|Overall Study|Opted out of surgery|2|||
125024248|NCT00441545|449711418|FG001|First Intervention|Kidney transplant|1|||
125024249|NCT00441545|449711417|FG000|First Intervention|Lack of Efficacy|2|||
125024250|NCT00441545|449711418|FG001|First Intervention|Lack of Efficacy|0|||
125024251|NCT00441545|449711417|FG000|First Intervention|Subject exceeded safety criteria|0|||
125024252|NCT00441545|449711418|FG001|First Intervention|Subject exceeded safety criteria|1|||
125024253|NCT00441545|449711417|FG000|First Intervention|Subject met an exclusionary criteria|1|||
125024254|NCT00441545|449711418|FG001|First Intervention|Subject met an exclusionary criteria|0|||
125024255|NCT00441545|449711417|FG000|First Intervention|Extended hospitalization|1|||
125024256|NCT00441545|449711418|FG001|First Intervention|Extended hospitalization|0|||
125024257|NCT00441545|449711417|FG000|First Intervention|Site error|1|||
125024258|NCT00441545|449711418|FG001|First Intervention|Site error|0|||
125024259|NCT00441545|449711417|FG000|First Intervention|Sponsor's request|1|||
125024260|NCT00441545|449711418|FG001|First Intervention|Sponsor's request|0|||
125024261|NCT00441545|449711417|FG000|Second Intervention|Adverse Event|5|||
125024262|NCT00441545|449711418|FG001|Second Intervention|Adverse Event|2|||
125024263|NCT00441545|449711417|FG000|Second Intervention|Protocol Violation|4|||
125024264|NCT00441545|449711418|FG001|Second Intervention|Protocol Violation|1|||
125024265|NCT00441545|449711417|FG000|Second Intervention|Withdrawal by Subject|1|||
125024266|NCT00441545|449711418|FG001|Second Intervention|Withdrawal by Subject|1|||
125024267|NCT00441545|449711417|FG000|Second Intervention|Kidney Transplant|1|||
125024268|NCT00441545|449711418|FG001|Second Intervention|Kidney Transplant|1|||
125024269|NCT00441545|449711417|FG000|Second Intervention|Lack of Efficacy|0|||
125024270|NCT00441545|449711418|FG001|Second Intervention|Lack of Efficacy|1|||
125024271|NCT00441545|449711417|FG000|Second Intervention|Subject exceeded safety criteria|1|||
125024272|NCT00441545|449711418|FG001|Second Intervention|Subject exceeded safety criteria|0|||
125024273|NCT00441545|449711417|FG000|Second Intervention|Subject moved|0|||
125024274|NCT00441545|449711418|FG001|Second Intervention|Subject moved|1|||
125024275|NCT02474082|449711419|FG000|Overall Study|Adverse Event|2|||
125024276|NCT02474082|449711420|FG001|Overall Study|Adverse Event|32|||
125024277|NCT02474082|449711419|FG000|Overall Study|Withdrawal of informed consent|1|||
125024278|NCT02474082|449711420|FG001|Overall Study|Withdrawal of informed consent|11|||
125024279|NCT02474082|449711419|FG000|Overall Study|Lost to Follow-up|2|||
125024280|NCT02474082|449711420|FG001|Overall Study|Lost to Follow-up|2|||
125024281|NCT02474082|449711419|FG000|Overall Study|Dose tapering not achieved|0|||
125024282|NCT02474082|449711420|FG001|Overall Study|Dose tapering not achieved|4|||
125024283|NCT02474082|449711419|FG000|Overall Study|Participant/guardian decision|1|||
125024284|NCT02474082|449711420|FG001|Overall Study|Participant/guardian decision|2|||
125024285|NCT02474082|449711419|FG000|Overall Study|Non-compliance with study treatment|0|||
125024286|NCT02474082|449711420|FG001|Overall Study|Non-compliance with study treatment|2|||
125024287|NCT02474082|449711419|FG000|Overall Study|Protocol deviation|0|||
125024288|NCT02474082|449711420|FG001|Overall Study|Protocol deviation|1|||
125024289|NCT04317274|449711423|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
125024290|NCT04317274|449711424|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
125024291|NCT04317274|449711425|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
125024292|NCT04317274|449711426|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
125024293|NCT00744874|449711427|FG000|Overall Study|Lost to Follow-up|1|||
125024294|NCT00744874|449711427|FG000|Overall Study|Withdrawal by Subject|1|||
125024295|NCT00744874|449711427|FG000|Overall Study|Study Device not available at procedure|1|||
125024296|NCT00744874|449711427|FG000|Overall Study|Unable to accomodate schedule|1|||
125024297|NCT01017952|449711428|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
125024298|NCT01017952|449711429|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
125024299|NCT01017952|449711430|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
125024300|NCT01017952|449711431|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
125024301|NCT01017952|449711432|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
125024302|NCT01017952|449711428|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
125024303|NCT01017952|449711429|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
125024304|NCT01017952|449711430|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
125024305|NCT01017952|449711431|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
125024306|NCT01017952|449711432|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
125024307|NCT01017952|449711428|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
125119626|NCT02729896|450061320|FG000|Overall Study|Withdrawal by Subject|1|||
125119627|NCT02729896|450061321|FG001|Overall Study|Withdrawal by Subject|0|||
125119628|NCT02729896|450061322|FG002|Overall Study|Withdrawal by Subject|3|||
125119629|NCT01309919|450061341|FG000|Overall Study|Did not receive a postpartum IUD|17|||
125119630|NCT01309919|450061342|FG001|Overall Study|Did not receive a postpartum IUD|48|||
125119631|NCT00319449|450061343|FG000|Overall Study|Subject did not wish to continue|1|||
125119632|NCT00319449|450061344|FG001|Overall Study|Subject did not wish to continue|0|||
125119633|NCT00319449|450061343|FG000|Overall Study|Noncompliance with the protocol|1|||
125119634|NCT00319449|450061344|FG001|Overall Study|Noncompliance with the protocol|0|||
125119635|NCT02102490|450061345|FG000|Overall Study|Death|6|||
125119636|NCT02102490|450061345|FG000|Overall Study|Lost to Follow-up|1|||
124927496|NCT02993159|449364597|FG001|Overall Study|Opted out of surgery|0|||
124927497|NCT02993159|449364596|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
124927498|NCT02993159|449364597|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
124927499|NCT02993159|449364596|FG000|Overall Study|Physician Decision|0|||
124927500|NCT02993159|449364597|FG001|Overall Study|Physician Decision|1|||
124927501|NCT04992520|449364601|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
124927502|NCT04992520|449364602|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
124927503|NCT04992520|449364603|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
124927504|NCT04992520|449364604|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
124927505|NCT04992520|449364605|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
124927506|NCT04992520|449364606|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
124927507|NCT04992520|449364601|FG000|Part A: First Challenge|Non-compliance|0|||
124927508|NCT04992520|449364602|FG001|Part A: First Challenge|Non-compliance|0|||
124927509|NCT04992520|449364603|FG002|Part A: First Challenge|Non-compliance|0|||
124927510|NCT04992520|449364604|FG003|Part A: First Challenge|Non-compliance|1|||
124927511|NCT04992520|449364605|FG004|Part A: First Challenge|Non-compliance|0|||
124927512|NCT04992520|449364606|FG005|Part A: First Challenge|Non-compliance|0|||
124927513|NCT04992520|449364601|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
124927514|NCT04992520|449364602|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
124927515|NCT04992520|449364603|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
124927516|NCT04992520|449364604|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
124927517|NCT04992520|449364605|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
124927518|NCT04992520|449364606|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
124927519|NCT04992520|449364601|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
124927520|NCT04992520|449364602|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
124927521|NCT04992520|449364603|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
124927522|NCT04992520|449364604|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
124927523|NCT04992520|449364605|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
124927524|NCT04992520|449364606|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
124927525|NCT03625167|449364609|FG000|Overall Study|Protocol Violation|5|||
124927526|NCT00248287|449364612|FG000|Overall Study|Adverse Event|11|||
124927527|NCT00248287|449364613|FG001|Overall Study|Adverse Event|10|||
124927528|NCT00248287|449364612|FG000|Overall Study|Death|1|||
124927529|NCT00248287|449364613|FG001|Overall Study|Death|0|||
124927530|NCT00248287|449364612|FG000|Overall Study|Lost to Follow-up|0|||
124927531|NCT00248287|449364613|FG001|Overall Study|Lost to Follow-up|1|||
124927532|NCT00248287|449364612|FG000|Overall Study|Investigator Request|4|||
124927533|NCT00248287|449364613|FG001|Overall Study|Investigator Request|3|||
124927534|NCT00248287|449364612|FG000|Overall Study|Patient Request|5|||
124927535|NCT00248287|449364613|FG001|Overall Study|Patient Request|3|||
124927536|NCT00248287|449364612|FG000|Overall Study|Other|3|||
124927537|NCT00248287|449364613|FG001|Overall Study|Other|2|||
124927538|NCT04524442|449364626|FG000|Overall Study|Subject Decision|1|||
124927539|NCT05228457|449364634|FG000|Overall Study|Withdrawal by Subject|1|||
124927540|NCT05228457|449364635|FG001|Overall Study|Withdrawal by Subject|1|||
124927541|NCT03213691|449364644|FG000|Overall Study|Adverse Event|2|||
124927542|NCT03213691|449364644|FG000|Overall Study|Death|3|||
124927543|NCT03213691|449364644|FG000|Overall Study|Physician Decision|1|||
124927544|NCT03213691|449364644|FG000|Overall Study|Progressive Disease|14|||
124927545|NCT03213691|449364644|FG000|Overall Study|Ineligible|1|||
124927546|NCT01152450|449364647|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
124927547|NCT01152450|449364648|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
124927548|NCT01152450|449364649|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
125119637|NCT01346410|450061346|FG000|Overall Study|Death|1|||
125212367|NCT00548249|450403336|FG001|Overall Study|Prolonged hospitalization|0|||
124927549|NCT01152450|449364650|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
124927550|NCT01152450|449364651|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
124927551|NCT01152450|449364652|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
124927552|NCT01152450|449364647|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
124927553|NCT01152450|449364648|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
124927554|NCT01152450|449364649|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
124927555|NCT01152450|449364650|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
124927556|NCT01152450|449364651|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
124927557|NCT01152450|449364652|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
124927558|NCT01152450|449364647|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
124927559|NCT01152450|449364648|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
124927560|NCT01152450|449364649|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
125024308|NCT01017952|449711429|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
125024309|NCT01017952|449711430|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
125024310|NCT01017952|449711431|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
125024311|NCT01017952|449711432|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
125024312|NCT01017952|449711428|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
125024313|NCT01017952|449711429|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
125024314|NCT01017952|449711430|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
125024315|NCT01017952|449711431|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
125024316|NCT01017952|449711432|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
125024317|NCT01017952|449711428|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
125024318|NCT01017952|449711429|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
125024319|NCT01017952|449711430|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
125024320|NCT01017952|449711431|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
125024321|NCT01017952|449711432|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
124927561|NCT01152450|449364650|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
124927562|NCT01152450|449364651|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
124927563|NCT01152450|449364652|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
124927564|NCT05139810|449364653|FG000|Overall Study|Voluntary Withdrawal|2|||
124927565|NCT05139810|449364654|FG001|Overall Study|Voluntary Withdrawal|1|||
124927566|NCT05139810|449364655|FG002|Overall Study|Voluntary Withdrawal|0|||
124927567|NCT05139810|449364653|FG000|Overall Study|Pregnancy|1|||
124927568|NCT05139810|449364654|FG001|Overall Study|Pregnancy|0|||
124927569|NCT05139810|449364655|FG002|Overall Study|Pregnancy|0|||
124927570|NCT05139810|449364653|FG000|Overall Study|Roll Over to CS7|19|||
124927571|NCT05139810|449364654|FG001|Overall Study|Roll Over to CS7|44|||
124927572|NCT05139810|449364655|FG002|Overall Study|Roll Over to CS7|20|||
124927573|NCT02966873|449364656|FG000|Overall Study|Lost to Follow-up|16|||
124927574|NCT02966873|449364657|FG001|Overall Study|Lost to Follow-up|15|||
124927575|NCT04753697|449364660|FG000|Induction Phase|Withdrawal by Subject|12|||
124927576|NCT04753697|449364661|FG001|Induction Phase|Withdrawal by Subject|5|||
124927577|NCT04753697|449364662|FG002|Induction Phase|Withdrawal by Subject|6|||
124927578|NCT04753697|449364660|FG000|Induction Phase|Physician Decision|1|||
124927579|NCT04753697|449364661|FG001|Induction Phase|Physician Decision|0|||
124927580|NCT04753697|449364662|FG002|Induction Phase|Physician Decision|0|||
124927581|NCT04753697|449364660|FG000|Induction Phase|Lost to Follow-up|2|||
124927582|NCT04753697|449364661|FG001|Induction Phase|Lost to Follow-up|2|||
124927583|NCT04753697|449364662|FG002|Induction Phase|Lost to Follow-up|1|||
124927584|NCT04753697|449364660|FG000|Induction Phase|Lack of Efficacy|1|||
124927585|NCT04753697|449364661|FG001|Induction Phase|Lack of Efficacy|0|||
124927586|NCT04753697|449364662|FG002|Induction Phase|Lack of Efficacy|0|||
124927587|NCT04753697|449364660|FG000|Maintenance Phase|Physician Decision|0|||
124927588|NCT04753697|449364661|FG001|Maintenance Phase|Physician Decision|0|||
124927589|NCT04753697|449364662|FG002|Maintenance Phase|Physician Decision|1|||
124927590|NCT04753697|449364660|FG000|Maintenance Phase|Withdrawal by Subject|3|||
124927591|NCT04753697|449364661|FG001|Maintenance Phase|Withdrawal by Subject|4|||
124927592|NCT04753697|449364662|FG002|Maintenance Phase|Withdrawal by Subject|6|||
124927593|NCT04753697|449364660|FG000|Maintenance Phase|Lost to Follow-up|2|||
124927594|NCT04753697|449364661|FG001|Maintenance Phase|Lost to Follow-up|2|||
124927595|NCT04753697|449364662|FG002|Maintenance Phase|Lost to Follow-up|0|||
124927596|NCT04753697|449364660|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
125024322|NCT01017952|449711428|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
125024323|NCT01017952|449711429|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
125024324|NCT01017952|449711430|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
125024325|NCT01017952|449711431|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
125119638|NCT00979628|450061347|FG000|Overall Study|received regimen < 24 hours|7|||
125119639|NCT00979628|450061348|FG001|Overall Study|received regimen < 24 hours|6|||
125119640|NCT00979628|450061349|FG002|Overall Study|received regimen < 24 hours|5|||
125119641|NCT00979628|450061347|FG000|Overall Study|received steroids|1|||
125119642|NCT00979628|450061348|FG001|Overall Study|received steroids|1|||
124927597|NCT04753697|449364661|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
124927598|NCT04753697|449364662|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
124927599|NCT04753697|449364660|FG000|Maintenance Phase|Adverse Event|0|||
124927600|NCT04753697|449364661|FG001|Maintenance Phase|Adverse Event|1|||
124927601|NCT04753697|449364662|FG002|Maintenance Phase|Adverse Event|1|||
124927602|NCT04753697|449364660|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
124927603|NCT04753697|449364661|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
124927604|NCT04753697|449364662|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
124927605|NCT02626533|449364663|FG000|Overall Study|Protocol Violation|14|||
124927606|NCT02626533|449364663|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
124927607|NCT02626533|449364663|FG000|Overall Study|Withdrawal by Subject|1|||
124927608|NCT02723591|449364666|FG000|Overall Study|Adverse Event|48|||
124927609|NCT02723591|449364667|FG001|Overall Study|Adverse Event|40|||
124927610|NCT02723591|449364666|FG000|Overall Study|Death|2|||
124927611|NCT02723591|449364667|FG001|Overall Study|Death|2|||
125024326|NCT01017952|449711432|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
125024327|NCT01017952|449711428|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
125024328|NCT01017952|449711429|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
125024329|NCT01017952|449711430|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
125024330|NCT01017952|449711431|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
125024331|NCT01017952|449711432|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
125024332|NCT01017952|449711428|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
125024333|NCT01017952|449711429|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
125024334|NCT01017952|449711430|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
125024335|NCT01017952|449711431|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
125024336|NCT01017952|449711432|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
125024337|NCT01017952|449711428|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
125024338|NCT01017952|449711429|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
125024339|NCT01017952|449711430|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
125024340|NCT01017952|449711431|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
125024341|NCT01017952|449711432|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
125024342|NCT01017952|449711428|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
125024343|NCT01017952|449711429|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
125024344|NCT01017952|449711430|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
125024345|NCT01017952|449711431|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
125024346|NCT01017952|449711432|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
125024347|NCT01017952|449711428|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
125024348|NCT01017952|449711429|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
124927612|NCT02723591|449364666|FG000|Overall Study|Lack of Efficacy|4|||
124927613|NCT02723591|449364667|FG001|Overall Study|Lack of Efficacy|3|||
124927614|NCT02723591|449364666|FG000|Overall Study|Lost to Follow-up|1|||
124927615|NCT02723591|449364667|FG001|Overall Study|Lost to Follow-up|7|||
124927616|NCT02723591|449364666|FG000|Overall Study|Protocol Violation|20|||
124927617|NCT02723591|449364667|FG001|Overall Study|Protocol Violation|23|||
124927618|NCT02723591|449364666|FG000|Overall Study|Withdrawal by Subject|4|||
124927619|NCT02723591|449364667|FG001|Overall Study|Withdrawal by Subject|8|||
124927620|NCT02723591|449364666|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
124927621|NCT02723591|449364667|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
124927622|NCT02723591|449364666|FG000|Overall Study|Miscellaneous|5|||
124927623|NCT02723591|449364667|FG001|Overall Study|Miscellaneous|6|||
124927624|NCT03691935|449364668|FG000|Overall Study|Physician Decision|2|||
124927625|NCT03691935|449364669|FG001|Overall Study|Physician Decision|1|||
124927626|NCT03691935|449364668|FG000|Overall Study|Adverse Event|3|||
124927627|NCT03691935|449364669|FG001|Overall Study|Adverse Event|0|||
124927628|NCT03034356|449364681|FG000|Baseline|Lost to Follow-up|2|||
124927629|NCT03034356|449364682|FG001|Baseline|Lost to Follow-up|4|||
124927630|NCT03034356|449364681|FG000|Baseline|Withdrawal by Subject|2|||
124927631|NCT03034356|449364682|FG001|Baseline|Withdrawal by Subject|0|||
124927632|NCT03034356|449364681|FG000|Baseline|Physician Decision|0|||
124927633|NCT03034356|449364682|FG001|Baseline|Physician Decision|1|||
124927634|NCT03034356|449364681|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
124927635|NCT03034356|449364682|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
124927636|NCT03034356|449364681|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
124927637|NCT03034356|449364682|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
124927638|NCT03034356|449364681|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
124927639|NCT03034356|449364682|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
124927640|NCT03034356|449364681|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
124927641|NCT03034356|449364682|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
124927642|NCT02823145|449364683|FG000|Enrollment|Other|1|||
124927643|NCT02823145|449364684|FG001|Enrollment|Other|0|||
124927644|NCT02823145|449364683|FG000|Treatment|Adverse Event|0|||
124927645|NCT02823145|449364684|FG001|Treatment|Adverse Event|11|||
124927646|NCT02823145|449364683|FG000|Treatment|Death|0|||
124927647|NCT02823145|449364684|FG001|Treatment|Death|3|||
125119643|NCT00979628|450061349|FG002|Overall Study|received steroids|0|||
125119644|NCT00979628|450061347|FG000|Overall Study|transferred to ICU|1|||
125119645|NCT00979628|450061348|FG001|Overall Study|transferred to ICU|2|||
125119646|NCT00979628|450061349|FG002|Overall Study|transferred to ICU|1|||
125119647|NCT02146430|450063170|FG000|Overall Study|Protocol Violation|5|||
125119648|NCT02146430|450063171|FG001|Overall Study|Protocol Violation|4|||
125119649|NCT02146430|450063172|FG002|Overall Study|Protocol Violation|8|||
125119650|NCT02146430|450063173|FG003|Overall Study|Protocol Violation|6|||
124927648|NCT02823145|449364683|FG000|Treatment|Family Decision|0|||
124927649|NCT02823145|449364684|FG001|Treatment|Family Decision|1|||
124927650|NCT02823145|449364683|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
124927651|NCT02823145|449364684|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
124927652|NCT02823145|449364683|FG000|Treatment|Lack of Efficacy|0|||
124927653|NCT02823145|449364684|FG001|Treatment|Lack of Efficacy|48|||
124927654|NCT02823145|449364683|FG000|Treatment|Non-Compliance With E-Diary|0|||
124927655|NCT02823145|449364684|FG001|Treatment|Non-Compliance With E-Diary|1|||
124927656|NCT02823145|449364683|FG000|Treatment|Physician Decision|0|||
124927657|NCT02823145|449364684|FG001|Treatment|Physician Decision|2|||
124927658|NCT02823145|449364683|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
124927659|NCT02823145|449364684|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
124927660|NCT02823145|449364683|FG000|Treatment|Subject needed to take prohibited medication|0|||
124927661|NCT02823145|449364684|FG001|Treatment|Subject needed to take prohibited medication|1|||
124927662|NCT02823145|449364683|FG000|Treatment|Subject transferred to direct access programme|0|||
124927663|NCT02823145|449364684|FG001|Treatment|Subject transferred to direct access programme|1|||
124927664|NCT02823145|449364683|FG000|Treatment|Switching to commercially available drug|0|||
124927665|NCT02823145|449364684|FG001|Treatment|Switching to commercially available drug|11|||
124927666|NCT02823145|449364683|FG000|Treatment|Transitioned to commercial supply of medication|0|||
124927667|NCT02823145|449364684|FG001|Treatment|Transitioned to commercial supply of medication|1|||
124927668|NCT02823145|449364683|FG000|Treatment|Withdrawal By Caregiver|0|||
124927669|NCT02823145|449364684|FG001|Treatment|Withdrawal By Caregiver|1|||
124927670|NCT02823145|449364683|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
124927671|NCT02823145|449364684|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
124927672|NCT02823145|449364683|FG000|Treatment|Withdrawal by Subject|0|||
124927673|NCT02823145|449364684|FG001|Treatment|Withdrawal by Subject|16|||
124927674|NCT02823145|449364683|FG000|Treatment|Reason unknown|0|||
124927675|NCT02823145|449364684|FG001|Treatment|Reason unknown|1|||
124927676|NCT05292391|449364685|FG000|Overall Study|Lost to Follow-up|0|||
124927677|NCT05292391|449364686|FG001|Overall Study|Lost to Follow-up|0|||
124927678|NCT05292391|449364687|FG002|Overall Study|Lost to Follow-up|0|||
124927679|NCT05292391|449364688|FG003|Overall Study|Lost to Follow-up|1|||
124927680|NCT05292391|449364689|FG004|Overall Study|Lost to Follow-up|0|||
124927681|NCT05809453|449366173|FG000|Overall Study|Withdrawal by Subject|1|||
124927682|NCT05809453|449366174|FG001|Overall Study|Withdrawal by Subject|0|||
124927683|NCT05809453|449366175|FG002|Overall Study|Withdrawal by Subject|0|||
124927684|NCT05809453|449366176|FG003|Overall Study|Withdrawal by Subject|0|||
124927685|NCT02696707|449366177|FG000|Per Protocol Population|Physician Decision|2|||
124927686|NCT02696707|449366178|FG001|Per Protocol Population|Physician Decision|1|||
124927687|NCT02696707|449366177|FG000|Per Protocol Population|Participant Decision|0|||
124927688|NCT02696707|449366178|FG001|Per Protocol Population|Participant Decision|2|||
124927689|NCT02696707|449366177|FG000|Completed Study as Planned|Reason = LVEF|2|||
124927690|NCT02696707|449366178|FG001|Completed Study as Planned|Reason = LVEF|2|||
124927691|NCT02696707|449366177|FG000|Completed Study as Planned|Protocol Violation|2|||
124927692|NCT02696707|449366178|FG001|Completed Study as Planned|Protocol Violation|6|||
124927693|NCT02696707|449366177|FG000|Completed Study as Planned|Metastatic disease|3|||
124927694|NCT02696707|449366178|FG001|Completed Study as Planned|Metastatic disease|0|||
124927695|NCT02696707|449366177|FG000|Completed Study as Planned|Location|1|||
124927696|NCT02696707|449366178|FG001|Completed Study as Planned|Location|1|||
124927697|NCT05251909|449366183|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
124927698|NCT05251909|449366184|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
124927699|NCT05543915|449366185|FG000|Overall Study|Lost to Follow-up|0|||
124927700|NCT05543915|449366186|FG001|Overall Study|Lost to Follow-up|1|||
124927701|NCT02815566|449366191|FG000|Overall Study|Adverse Event|1|||
124927702|NCT02815566|449366192|FG001|Overall Study|Adverse Event|1|||
124927703|NCT02815566|449366191|FG000|Overall Study|Withdrawal by Subject|1|||
124927704|NCT02815566|449366192|FG001|Overall Study|Withdrawal by Subject|0|||
124927705|NCT02815566|449366191|FG000|Overall Study|Lost to Follow-up|0|||
125119651|NCT02146430|450063170|FG000|Overall Study|Lack of Efficacy|13|||
125119652|NCT02146430|450063171|FG001|Overall Study|Lack of Efficacy|11|||
125119653|NCT02146430|450063172|FG002|Overall Study|Lack of Efficacy|8|||
125119654|NCT02146430|450063173|FG003|Overall Study|Lack of Efficacy|5|||
125119655|NCT02146430|450063170|FG000|Overall Study|Adverse Event|20|||
125119656|NCT02146430|450063171|FG001|Overall Study|Adverse Event|40|||
125119657|NCT02146430|450063172|FG002|Overall Study|Adverse Event|32|||
124927706|NCT02815566|449366192|FG001|Overall Study|Lost to Follow-up|1|||
124927707|NCT03252847|449366195|FG000|Overall Study|Withdrawal by Subject|0|||
124927708|NCT03252847|449366196|FG001|Overall Study|Withdrawal by Subject|0|||
124927709|NCT03252847|449366197|FG002|Overall Study|Withdrawal by Subject|1|||
124927710|NCT03252847|449366198|FG003|Overall Study|Withdrawal by Subject|0|||
124927711|NCT03252847|449366199|FG004|Overall Study|Withdrawal by Subject|0|||
125119658|NCT02146430|450063173|FG003|Overall Study|Adverse Event|49|||
124927712|NCT03252847|449366200|FG005|Overall Study|Withdrawal by Subject|0|||
124927713|NCT03252847|449366201|FG006|Overall Study|Withdrawal by Subject|0|||
125119659|NCT02146430|450063170|FG000|Overall Study|Reason missing or not reported|2|||
125119660|NCT02146430|450063171|FG001|Overall Study|Reason missing or not reported|3|||
125212368|NCT00548249|450403337|FG002|Overall Study|Prolonged hospitalization|2|||
124927714|NCT03252847|449366195|FG000|Overall Study|Other: Patient decision|0|||
124927715|NCT03252847|449366196|FG001|Overall Study|Other: Patient decision|0|||
124927716|NCT03252847|449366197|FG002|Overall Study|Other: Patient decision|0|||
124927717|NCT03252847|449366198|FG003|Overall Study|Other: Patient decision|0|||
124927718|NCT03252847|449366199|FG004|Overall Study|Other: Patient decision|1|||
124927719|NCT03252847|449366200|FG005|Overall Study|Other: Patient decision|0|||
124927720|NCT03252847|449366201|FG006|Overall Study|Other: Patient decision|0|||
124927721|NCT05034328|449366202|FG000|Overall Study|Protocol Violation|1|||
124927722|NCT05034328|449366203|FG001|Overall Study|Protocol Violation|0|||
124927723|NCT05034328|449366202|FG000|Overall Study|Lost to Follow-up|0|||
124927724|NCT05034328|449366203|FG001|Overall Study|Lost to Follow-up|10|||
124927725|NCT02969707|449366206|FG000|Overall Study|Withdrawal by Subject|6|||
124927726|NCT02969707|449366207|FG001|Overall Study|Withdrawal by Subject|5|||
124927727|NCT02969707|449366206|FG000|Overall Study|Severe anxiety|0|||
124927728|NCT02969707|449366207|FG001|Overall Study|Severe anxiety|1|||
124927729|NCT02969707|449366206|FG000|Overall Study|Positive toxicology screen|0|||
124927730|NCT02969707|449366207|FG001|Overall Study|Positive toxicology screen|2|||
124927731|NCT02969707|449366206|FG000|Overall Study|Claustrophobia|2|||
124927732|NCT02969707|449366207|FG001|Overall Study|Claustrophobia|2|||
124927733|NCT02969707|449366206|FG000|Overall Study|Non-compliance|1|||
124927734|NCT02969707|449366207|FG001|Overall Study|Non-compliance|2|||
124927735|NCT02427464|449366211|FG000|Overall Study|Adverse Event|6|||
124927736|NCT02427464|449366212|FG001|Overall Study|Adverse Event|1|||
124927737|NCT02427464|449366211|FG000|Overall Study|Lost to Follow-up|16|||
124927738|NCT02427464|449366212|FG001|Overall Study|Lost to Follow-up|5|||
124927739|NCT02427464|449366211|FG000|Overall Study|Physician Decision|2|||
124927740|NCT02427464|449366212|FG001|Overall Study|Physician Decision|0|||
124927741|NCT02427464|449366211|FG000|Overall Study|Withdrawal by Subject|10|||
124927742|NCT02427464|449366212|FG001|Overall Study|Withdrawal by Subject|8|||
124927743|NCT02427464|449366211|FG000|Overall Study|Noncompliance|16|||
124927744|NCT02427464|449366212|FG001|Overall Study|Noncompliance|10|||
124927745|NCT02714257|449366213|FG000|Overall Study|Withdrawal by Subject|6|||
124927746|NCT02714257|449366214|FG001|Overall Study|Withdrawal by Subject|11|||
124927747|NCT02714257|449366213|FG000|Overall Study|Death|3|||
124927748|NCT02714257|449366214|FG001|Overall Study|Death|4|||
124927749|NCT02714257|449366213|FG000|Overall Study|Lost to Follow-up|1|||
124927750|NCT02714257|449366214|FG001|Overall Study|Lost to Follow-up|6|||
124927751|NCT04103580|449366215|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
124927752|NCT04103580|449366216|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
124927753|NCT04103580|449366215|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
124927754|NCT04103580|449366216|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
124927755|NCT04103580|449366215|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
124927756|NCT04103580|449366216|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
124927757|NCT04103580|449366215|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
124927758|NCT04103580|449366216|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
124927759|NCT04103580|449366215|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
124927760|NCT04103580|449366216|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
124927761|NCT04103580|449366215|FG000|Phase 1 Active Caregiving|Other|3|||
124927762|NCT04103580|449366216|FG001|Phase 1 Active Caregiving|Other|3|||
124927763|NCT04103580|449366215|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
124927764|NCT04103580|449366216|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
124927765|NCT04103580|449366215|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
124927766|NCT04103580|449366216|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
124927767|NCT04103580|449366215|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
124927768|NCT04103580|449366216|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
124927769|NCT04103580|449366215|FG000|Phase 2 Bereavement|Other|8|||
124927770|NCT04103580|449366216|FG001|Phase 2 Bereavement|Other|6|||
124927771|NCT04145440|449366217|FG000|Overall Study|Physician Decision|3|||
124927772|NCT04145440|449366218|FG001|Overall Study|Physician Decision|0|||
124927773|NCT04145440|449366217|FG000|Overall Study|Use of prohibited therapy|2|||
124927774|NCT04145440|449366218|FG001|Overall Study|Use of prohibited therapy|3|||
124927775|NCT00104676|449366219|FG000|Overall Study|Death|3|||
124927776|NCT00104676|449366220|FG001|Overall Study|Death|2|||
124927777|NCT00104676|449366219|FG000|Overall Study|Withdrawal by Subject|0|||
124927778|NCT00104676|449366220|FG001|Overall Study|Withdrawal by Subject|2|||
124927779|NCT00104676|449366219|FG000|Overall Study|treatment interruption|4|||
124927780|NCT00104676|449366220|FG001|Overall Study|treatment interruption|10|||
124927781|NCT03766685|449366234|FG000|Overall Study|Lost to Follow-up|1|||
124927782|NCT03766685|449366235|FG001|Overall Study|Lost to Follow-up|1|||
124927783|NCT03766685|449366236|FG002|Overall Study|Lost to Follow-up|0|||
124927784|NCT03766685|449366237|FG003|Overall Study|Lost to Follow-up|0|||
124927785|NCT03766685|449366234|FG000|Overall Study|Adverse Event, not fatal|0|||
124927786|NCT03766685|449366235|FG001|Overall Study|Adverse Event, not fatal|1|||
124927787|NCT03766685|449366236|FG002|Overall Study|Adverse Event, not fatal|0|||
124927788|NCT03766685|449366237|FG003|Overall Study|Adverse Event, not fatal|1|||
124927789|NCT03766685|449366234|FG000|Overall Study|Withdrawal by Subject|0|||
124927790|NCT03766685|449366235|FG001|Overall Study|Withdrawal by Subject|2|||
124927791|NCT03766685|449366236|FG002|Overall Study|Withdrawal by Subject|0|||
124927792|NCT03766685|449366237|FG003|Overall Study|Withdrawal by Subject|0|||
124927793|NCT03766685|449366234|FG000|Overall Study|Protocol Violation|0|||
124927794|NCT03766685|449366235|FG001|Overall Study|Protocol Violation|1|||
124927795|NCT03766685|449366236|FG002|Overall Study|Protocol Violation|0|||
124927796|NCT03766685|449366237|FG003|Overall Study|Protocol Violation|0|||
124927797|NCT03766685|449366234|FG000|Overall Study|Non-compliance|0|||
124927798|NCT03766685|449366235|FG001|Overall Study|Non-compliance|2|||
124927799|NCT03766685|449366236|FG002|Overall Study|Non-compliance|0|||
124927800|NCT03766685|449366237|FG003|Overall Study|Non-compliance|0|||
124927801|NCT05297565|449366240|FG000|Overall Study|Other Reasons|0|||
124927802|NCT05297565|449366241|FG001|Overall Study|Other Reasons|1|||
124927803|NCT05297565|449366240|FG000|Overall Study|Physician Decision|0|||
124927804|NCT05297565|449366241|FG001|Overall Study|Physician Decision|1|||
124927805|NCT05297565|449366240|FG000|Overall Study|Disease recurrence|1|||
124927806|NCT05297565|449366241|FG001|Overall Study|Disease recurrence|0|||
124927807|NCT04054193|449366253|FG000|Cycle 1|Physician Decision|1|||
124927808|NCT04054193|449366253|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
124927809|NCT04054193|449366253|FG000|Cycle 1|Allocated but not treated|3|||
124927810|NCT04054193|449366253|FG000|Cycles 2-3|Physician Decision|2|||
124927811|NCT04054193|449366253|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
124927812|NCT04054193|449366253|FG000|Cycles 2-3|Various reasons|17|||
124927813|NCT03084536|449366254|FG000|Overall Study|Determined to be ineligible|0|||
124927814|NCT03084536|449366255|FG001|Overall Study|Determined to be ineligible|0|||
124927815|NCT03084536|449366256|FG002|Overall Study|Determined to be ineligible|16|||
124927816|NCT03084536|449366254|FG000|Overall Study|Withdrawal by Subject|0|||
124927817|NCT03084536|449366255|FG001|Overall Study|Withdrawal by Subject|0|||
124927818|NCT03084536|449366256|FG002|Overall Study|Withdrawal by Subject|4|||
124927819|NCT03084536|449366254|FG000|Overall Study|Physician Decision|0|||
124927820|NCT03084536|449366255|FG001|Overall Study|Physician Decision|0|||
124927821|NCT03084536|449366256|FG002|Overall Study|Physician Decision|3|||
124927822|NCT03084536|449366254|FG000|Overall Study|Death|0|||
124927823|NCT03084536|449366255|FG001|Overall Study|Death|0|||
124927824|NCT03084536|449366256|FG002|Overall Study|Death|1|||
124927825|NCT03084536|449366254|FG000|Overall Study|Lost to Follow-up|0|||
124927826|NCT03084536|449366255|FG001|Overall Study|Lost to Follow-up|0|||
124927827|NCT03084536|449366256|FG002|Overall Study|Lost to Follow-up|1|||
124927828|NCT03084536|449366254|FG000|Overall Study|Protocol Violation|0|||
124927829|NCT03084536|449366255|FG001|Overall Study|Protocol Violation|0|||
124927830|NCT03084536|449366256|FG002|Overall Study|Protocol Violation|1|||
124927831|NCT03084536|449366254|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
124927832|NCT03084536|449366255|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
124927833|NCT03084536|449366256|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
124927834|NCT05704543|449366257|FG000|Overall Study|Withdrawal by Subject|1|||
124927835|NCT05704543|449366258|FG001|Overall Study|Withdrawal by Subject|1|||
124927836|NCT05704543|449366259|FG002|Overall Study|Withdrawal by Subject|0|||
124927837|NCT05704543|449366260|FG003|Overall Study|Withdrawal by Subject|2|||
124927838|NCT05704543|449366257|FG000|Overall Study|Lost to Follow-up|1|||
124927839|NCT05704543|449366258|FG001|Overall Study|Lost to Follow-up|2|||
124927840|NCT05704543|449366259|FG002|Overall Study|Lost to Follow-up|0|||
124927841|NCT05704543|449366260|FG003|Overall Study|Lost to Follow-up|0|||
124927842|NCT05073458|449366261|FG000|24-week Double-blind Period|Adverse Event|1|||
124927843|NCT05073458|449366262|FG001|24-week Double-blind Period|Adverse Event|0|||
124927844|NCT05073458|449366261|FG000|24-week Double-blind Period|Physician Decision|1|||
124927845|NCT05073458|449366262|FG001|24-week Double-blind Period|Physician Decision|0|||
124927846|NCT05073458|449366261|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
124927847|NCT05073458|449366262|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
124927848|NCT05073458|449366261|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
124927849|NCT05073458|449366262|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
124927850|NCT05073458|449366261|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
124927851|NCT05073458|449366262|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
124927852|NCT05073458|449366261|FG000|24-week Open-label Period|Adverse Event|1|||
124927853|NCT05073458|449366262|FG001|24-week Open-label Period|Adverse Event|2|||
124927854|NCT04830800|449366269|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
124927855|NCT04830800|449366270|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
125024349|NCT01017952|449711430|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
125024350|NCT01017952|449711431|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
125024351|NCT01017952|449711432|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
125024352|NCT01017952|449711428|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
124927856|NCT04830800|449366271|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
124927857|NCT04830800|449366272|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
124927858|NCT04830800|449366273|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
124927859|NCT03816332|449366276|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
124927860|NCT03816332|449366276|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
124927861|NCT03710603|449366277|FG000|Overall Study|Adverse Event|1|||
124927862|NCT03710603|449366278|FG001|Overall Study|Adverse Event|0|||
124927863|NCT03710603|449366277|FG000|Overall Study|Death|44|||
124927864|NCT03710603|449366278|FG001|Overall Study|Death|34|||
124927865|NCT03710603|449366277|FG000|Overall Study|Lost to Follow-up|3|||
124927866|NCT03710603|449366278|FG001|Overall Study|Lost to Follow-up|5|||
124927867|NCT03710603|449366277|FG000|Overall Study|Withdrawal by Subject|11|||
124927868|NCT03710603|449366278|FG001|Overall Study|Withdrawal by Subject|10|||
124927869|NCT01456949|449366279|FG000|Enrollment|PI death- incomplete data|6|||
124927870|NCT01456949|449366279|FG000|Enrollment|Death|1|||
124927871|NCT01456949|449366279|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
124927872|NCT01456949|449366279|FG000|Enrollment|Physician Decision|10|||
124927873|NCT01456949|449366279|FG000|Enrollment|Withdrawal by Subject|7|||
124927874|NCT01456949|449366279|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
124927875|NCT01456949|449366279|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
124927876|NCT01456949|449366279|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
124927877|NCT01456949|449366279|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
124927878|NCT01456949|449366279|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
124927879|NCT01456949|449366279|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
124927880|NCT01456949|449366279|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
124927881|NCT01456949|449366279|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
124927882|NCT03785964|449366280|FG000|Overall Study|Adverse Event|14|||
124927883|NCT03785964|449366281|FG001|Overall Study|Adverse Event|1|||
124927884|NCT03785964|449366280|FG000|Overall Study|Unqualified Clinical Progression|1|||
124927885|NCT03785964|449366281|FG001|Overall Study|Unqualified Clinical Progression|1|||
124927886|NCT03785964|449366280|FG000|Overall Study|Participant non-compliance|1|||
124927887|NCT03785964|449366281|FG001|Overall Study|Participant non-compliance|1|||
124927888|NCT03785964|449366280|FG000|Overall Study|Not treated|1|||
124927889|NCT03785964|449366281|FG001|Overall Study|Not treated|0|||
124927890|NCT03785964|449366280|FG000|Overall Study|Other reason|5|||
124927891|NCT03785964|449366281|FG001|Overall Study|Other reason|11|||
124927892|NCT03785964|449366280|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
124927893|NCT03785964|449366281|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
124927894|NCT04201262|449366292|FG000|Overall Study|Adverse Event|1|||
124927895|NCT04201262|449366293|FG001|Overall Study|Adverse Event|2|||
124927896|NCT04201262|449366292|FG000|Overall Study|Continuing in the study|57|||
124927897|NCT04201262|449366293|FG001|Overall Study|Continuing in the study|0|||
124927898|NCT04201262|449366292|FG000|Overall Study|Withdrawal by Subject|0|||
124927899|NCT04201262|449366293|FG001|Overall Study|Withdrawal by Subject|1|||
124927900|NCT05446168|449366296|FG000|Overall Study|Physician Decision|0|||
124927901|NCT05446168|449366297|FG001|Overall Study|Physician Decision|1|||
124927902|NCT03511664|449366301|FG000|Overall Study|Death|457|||
124927903|NCT03511664|449366302|FG001|Overall Study|Death|201|||
124927904|NCT03511664|449366303|FG002|Overall Study|Death|21|||
124927905|NCT03511664|449366301|FG000|Overall Study|Withdrew consent|40|||
124927906|NCT03511664|449366302|FG001|Overall Study|Withdrew consent|63|||
124927907|NCT03511664|449366303|FG002|Overall Study|Withdrew consent|3|||
124927908|NCT03511664|449366301|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
124927909|NCT03511664|449366302|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
124927910|NCT03511664|449366303|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
124927911|NCT03511664|449366301|FG000|Overall Study|Lost to Follow-up|8|||
124927912|NCT03511664|449366302|FG001|Overall Study|Lost to Follow-up|5|||
124927913|NCT03511664|449366303|FG002|Overall Study|Lost to Follow-up|0|||
124927914|NCT03511664|449366301|FG000|Overall Study|Physician Decision|2|||
124927915|NCT03511664|449366302|FG001|Overall Study|Physician Decision|1|||
124927916|NCT03511664|449366303|FG002|Overall Study|Physician Decision|0|||
124927917|NCT03511664|449366301|FG000|Overall Study|Patient non-compliance|1|||
124927918|NCT03511664|449366302|FG001|Overall Study|Patient non-compliance|0|||
124927919|NCT03511664|449366303|FG002|Overall Study|Patient non-compliance|0|||
124927920|NCT04577963|449366310|FG000|Part 2|Death|0|||
124927921|NCT04577963|449366311|FG001|Part 2|Death|1|||
124927922|NCT04577963|449366312|FG002|Part 2|Death|8|||
124927923|NCT04577963|449366313|FG003|Part 2|Death|0|||
124927924|NCT04577963|449366314|FG004|Part 2|Death|20|||
124927925|NCT04577963|449366310|FG000|Part 2|Lost to Follow-up|0|||
124927926|NCT04577963|449366311|FG001|Part 2|Lost to Follow-up|0|||
124927927|NCT04577963|449366312|FG002|Part 2|Lost to Follow-up|0|||
124927928|NCT04577963|449366313|FG003|Part 2|Lost to Follow-up|0|||
124927929|NCT04577963|449366314|FG004|Part 2|Lost to Follow-up|2|||
124927930|NCT04577963|449366310|FG000|Part 2|Withdrawal by Subject|0|||
124927931|NCT04577963|449366311|FG001|Part 2|Withdrawal by Subject|0|||
124927932|NCT04577963|449366312|FG002|Part 2|Withdrawal by Subject|0|||
124927933|NCT04577963|449366313|FG003|Part 2|Withdrawal by Subject|0|||
124927934|NCT04577963|449366314|FG004|Part 2|Withdrawal by Subject|10|||
124927935|NCT04577963|449366310|FG000|Part 2|Progressive disease|0|||
124927936|NCT04577963|449366311|FG001|Part 2|Progressive disease|0|||
124927937|NCT04577963|449366312|FG002|Part 2|Progressive disease|0|||
124927938|NCT04577963|449366313|FG003|Part 2|Progressive disease|0|||
124927939|NCT04577963|449366314|FG004|Part 2|Progressive disease|2|||
124927940|NCT04577963|449366310|FG000|Part 2|Investigator decision|0|||
124927941|NCT04577963|449366311|FG001|Part 2|Investigator decision|0|||
124927942|NCT04577963|449366312|FG002|Part 2|Investigator decision|0|||
124927943|NCT04577963|449366313|FG003|Part 2|Investigator decision|0|||
124927944|NCT04577963|449366314|FG004|Part 2|Investigator decision|1|||
124927945|NCT04577963|449366310|FG000|Part 2|Sponsor terminated study|0|||
124927946|NCT04577963|449366311|FG001|Part 2|Sponsor terminated study|0|||
124927947|NCT04577963|449366312|FG002|Part 2|Sponsor terminated study|3|||
124927948|NCT04577963|449366313|FG003|Part 2|Sponsor terminated study|1|||
124927949|NCT04577963|449366314|FG004|Part 2|Sponsor terminated study|4|||
124927950|NCT04857723|449366317|FG000|Overall Study|Withdrawal by Subject|2|||
124927951|NCT03221426|449366318|FG000|Overall Study|Ongoing in study|212|||
124927952|NCT03221426|449366319|FG001|Overall Study|Ongoing in study|193|||
124927953|NCT03221426|449366320|FG002|Overall Study|Ongoing in study|61|||
124927954|NCT03221426|449366321|FG003|Overall Study|Ongoing in study|55|||
124927955|NCT03221426|449366318|FG000|Overall Study|Withdrawal by Subject|12|||
124927956|NCT03221426|449366319|FG001|Overall Study|Withdrawal by Subject|4|||
124927957|NCT03221426|449366320|FG002|Overall Study|Withdrawal by Subject|2|||
124927958|NCT03221426|449366321|FG003|Overall Study|Withdrawal by Subject|3|||
124927959|NCT03221426|449366318|FG000|Overall Study|Lost to Follow-up|4|||
124927960|NCT03221426|449366319|FG001|Overall Study|Lost to Follow-up|1|||
124927961|NCT03221426|449366320|FG002|Overall Study|Lost to Follow-up|1|||
124927962|NCT03221426|449366321|FG003|Overall Study|Lost to Follow-up|0|||
124927963|NCT03221426|449366318|FG000|Overall Study|Death|174|||
124927964|NCT03221426|449366319|FG001|Overall Study|Death|204|||
124927965|NCT03221426|449366320|FG002|Overall Study|Death|36|||
124927966|NCT03221426|449366321|FG003|Overall Study|Death|45|||
124927967|NCT03257410|449368237|FG000|Overall Study|Adverse Event|2|||
124927968|NCT03257410|449368238|FG001|Overall Study|Adverse Event|3|||
124927969|NCT03257410|449368237|FG000|Overall Study|Protocol Violation|1|||
124927970|NCT03257410|449368238|FG001|Overall Study|Protocol Violation|2|||
124927971|NCT03257410|449368237|FG000|Overall Study|Lost to Follow-up|1|||
124927972|NCT03257410|449368238|FG001|Overall Study|Lost to Follow-up|0|||
124927973|NCT03257410|449368237|FG000|Overall Study|Withdrawal by Subject|1|||
124927974|NCT03257410|449368238|FG001|Overall Study|Withdrawal by Subject|2|||
124927975|NCT03257410|449368237|FG000|Overall Study|Physician Decision|1|||
124927976|NCT03257410|449368238|FG001|Overall Study|Physician Decision|1|||
124927977|NCT03257410|449368237|FG000|Overall Study|Renal transplantation|2|||
124927978|NCT03257410|449368238|FG001|Overall Study|Renal transplantation|0|||
124927979|NCT03257410|449368237|FG000|Overall Study|Switch to peritoneal dialysis|1|||
124927980|NCT03257410|449368238|FG001|Overall Study|Switch to peritoneal dialysis|0|||
124927981|NCT03257410|449368237|FG000|Overall Study|Death|3|||
124927982|NCT03257410|449368238|FG001|Overall Study|Death|2|||
124927983|NCT03257410|449368237|FG000|Overall Study|Change to another dialysis center|2|||
124927984|NCT03257410|449368238|FG001|Overall Study|Change to another dialysis center|2|||
124927985|NCT03257410|449368237|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
124927986|NCT03257410|449368238|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
124927987|NCT03257410|449368237|FG000|Overall Study|Miscellaneous|2|||
124927988|NCT03257410|449368238|FG001|Overall Study|Miscellaneous|2|||
124927989|NCT03257410|449368237|FG000|Overall Study|Other|0|||
124927990|NCT03257410|449368238|FG001|Overall Study|Other|1|||
124927991|NCT02561247|449368239|FG000|Overall Study|Protocol Violation|1|||
124927992|NCT02561247|449368239|FG000|Overall Study|Withdrawal by Subject|1|||
124927993|NCT02561247|449368239|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
124927994|NCT02276885|449368240|FG000|Overall Study|Withdrawal by Subject|2|||
124927995|NCT02276885|449368241|FG001|Overall Study|Withdrawal by Subject|0|||
124927996|NCT02276885|449368240|FG000|Overall Study|Lost to Follow-up|5|||
124927997|NCT02276885|449368241|FG001|Overall Study|Lost to Follow-up|2|||
124927998|NCT04171141|449368244|FG000|Overall Study|Adverse Event|0|||
124927999|NCT04171141|449368245|FG001|Overall Study|Adverse Event|0|||
124928000|NCT04171141|449368246|FG002|Overall Study|Adverse Event|2|||
124928001|NCT04171141|449368247|FG003|Overall Study|Adverse Event|0|||
124928002|NCT04171141|449368248|FG004|Overall Study|Adverse Event|0|||
124928003|NCT04171141|449368249|FG005|Overall Study|Adverse Event|0|||
124928004|NCT04171141|449368250|FG006|Overall Study|Adverse Event|0|||
124928005|NCT04171141|449368251|FG007|Overall Study|Adverse Event|0|||
124928006|NCT04171141|449368252|FG008|Overall Study|Adverse Event|0|||
124928007|NCT04171141|449368253|FG009|Overall Study|Adverse Event|0|||
124928008|NCT04171141|449368254|FG010|Overall Study|Adverse Event|0|||
124928009|NCT04171141|449368255|FG011|Overall Study|Adverse Event|0|||
124928010|NCT04171141|449368256|FG012|Overall Study|Adverse Event|0|||
124928011|NCT04171141|449368257|FG013|Overall Study|Adverse Event|2|||
124928012|NCT04171141|449368258|FG014|Overall Study|Adverse Event|0|||
124928013|NCT04171141|449368259|FG015|Overall Study|Adverse Event|0|||
124928014|NCT04171141|449368244|FG000|Overall Study|Physician Decision|0|||
124928015|NCT04171141|449368245|FG001|Overall Study|Physician Decision|0|||
124928016|NCT04171141|449368246|FG002|Overall Study|Physician Decision|0|||
124928017|NCT04171141|449368247|FG003|Overall Study|Physician Decision|0|||
124928018|NCT04171141|449368248|FG004|Overall Study|Physician Decision|1|||
124928019|NCT04171141|449368249|FG005|Overall Study|Physician Decision|0|||
124928020|NCT04171141|449368250|FG006|Overall Study|Physician Decision|0|||
124928021|NCT04171141|449368251|FG007|Overall Study|Physician Decision|0|||
124928022|NCT04171141|449368252|FG008|Overall Study|Physician Decision|0|||
124928023|NCT04171141|449368253|FG009|Overall Study|Physician Decision|0|||
124928024|NCT04171141|449368254|FG010|Overall Study|Physician Decision|0|||
124928025|NCT04171141|449368255|FG011|Overall Study|Physician Decision|0|||
124928026|NCT04171141|449368256|FG012|Overall Study|Physician Decision|0|||
124928027|NCT04171141|449368257|FG013|Overall Study|Physician Decision|0|||
124928028|NCT04171141|449368258|FG014|Overall Study|Physician Decision|0|||
124928029|NCT04171141|449368259|FG015|Overall Study|Physician Decision|1|||
124928030|NCT04171141|449368244|FG000|Overall Study|Progressive disease|2|||
124928031|NCT04171141|449368245|FG001|Overall Study|Progressive disease|3|||
124928032|NCT04171141|449368246|FG002|Overall Study|Progressive disease|4|||
124928033|NCT04171141|449368247|FG003|Overall Study|Progressive disease|7|||
124928034|NCT04171141|449368248|FG004|Overall Study|Progressive disease|1|||
124928035|NCT04171141|449368249|FG005|Overall Study|Progressive disease|8|||
124928036|NCT04171141|449368250|FG006|Overall Study|Progressive disease|4|||
124928037|NCT04171141|449368251|FG007|Overall Study|Progressive disease|6|||
124928038|NCT04171141|449368252|FG008|Overall Study|Progressive disease|7|||
124928039|NCT04171141|449368253|FG009|Overall Study|Progressive disease|3|||
124928040|NCT04171141|449368254|FG010|Overall Study|Progressive disease|4|||
124928041|NCT04171141|449368255|FG011|Overall Study|Progressive disease|3|||
124928042|NCT04171141|449368256|FG012|Overall Study|Progressive disease|4|||
124928043|NCT04171141|449368257|FG013|Overall Study|Progressive disease|2|||
124928044|NCT04171141|449368258|FG014|Overall Study|Progressive disease|4|||
124928045|NCT04171141|449368259|FG015|Overall Study|Progressive disease|1|||
124928046|NCT04171141|449368244|FG000|Overall Study|Withdrawal by Subject|0|||
124928047|NCT04171141|449368245|FG001|Overall Study|Withdrawal by Subject|0|||
124928048|NCT04171141|449368246|FG002|Overall Study|Withdrawal by Subject|0|||
124928049|NCT04171141|449368247|FG003|Overall Study|Withdrawal by Subject|1|||
124928050|NCT04171141|449368248|FG004|Overall Study|Withdrawal by Subject|0|||
124928051|NCT04171141|449368249|FG005|Overall Study|Withdrawal by Subject|0|||
124928052|NCT04171141|449368250|FG006|Overall Study|Withdrawal by Subject|1|||
124928053|NCT04171141|449368251|FG007|Overall Study|Withdrawal by Subject|0|||
124928054|NCT04171141|449368252|FG008|Overall Study|Withdrawal by Subject|0|||
124928055|NCT04171141|449368253|FG009|Overall Study|Withdrawal by Subject|1|||
124928056|NCT04171141|449368254|FG010|Overall Study|Withdrawal by Subject|0|||
124928057|NCT04171141|449368255|FG011|Overall Study|Withdrawal by Subject|0|||
124928058|NCT04171141|449368256|FG012|Overall Study|Withdrawal by Subject|0|||
124928059|NCT04171141|449368257|FG013|Overall Study|Withdrawal by Subject|0|||
124928060|NCT04171141|449368258|FG014|Overall Study|Withdrawal by Subject|0|||
124928061|NCT04171141|449368259|FG015|Overall Study|Withdrawal by Subject|0|||
124928062|NCT04171141|449368244|FG000|Overall Study|Global deterioration of health status|0|||
124928063|NCT04171141|449368245|FG001|Overall Study|Global deterioration of health status|0|||
124928064|NCT04171141|449368246|FG002|Overall Study|Global deterioration of health status|0|||
124928065|NCT04171141|449368247|FG003|Overall Study|Global deterioration of health status|1|||
124928066|NCT04171141|449368248|FG004|Overall Study|Global deterioration of health status|0|||
124928067|NCT04171141|449368249|FG005|Overall Study|Global deterioration of health status|2|||
124928068|NCT04171141|449368250|FG006|Overall Study|Global deterioration of health status|1|||
124928069|NCT04171141|449368251|FG007|Overall Study|Global deterioration of health status|0|||
124928070|NCT04171141|449368252|FG008|Overall Study|Global deterioration of health status|1|||
124928071|NCT04171141|449368253|FG009|Overall Study|Global deterioration of health status|0|||
124928072|NCT04171141|449368254|FG010|Overall Study|Global deterioration of health status|0|||
124928073|NCT04171141|449368255|FG011|Overall Study|Global deterioration of health status|0|||
124928074|NCT04171141|449368256|FG012|Overall Study|Global deterioration of health status|0|||
124928075|NCT04171141|449368257|FG013|Overall Study|Global deterioration of health status|0|||
124928076|NCT04171141|449368258|FG014|Overall Study|Global deterioration of health status|1|||
124928077|NCT04171141|449368259|FG015|Overall Study|Global deterioration of health status|1|||
124928078|NCT04858451|449368262|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
124928079|NCT04858451|449368263|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
124928080|NCT04858451|449368264|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
124928081|NCT04858451|449368265|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
124928082|NCT04858451|449368266|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
124928083|NCT04858451|449368267|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
124928084|NCT04858451|449368268|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
124928085|NCT04858451|449368269|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
124928086|NCT04858451|449368270|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
124928087|NCT04858451|449368262|FG000|Part 2|Discontinued|0|||
124928088|NCT04858451|449368263|FG001|Part 2|Discontinued|0|||
124928089|NCT04858451|449368264|FG002|Part 2|Discontinued|0|||
124928090|NCT04858451|449368265|FG003|Part 2|Discontinued|0|||
124928091|NCT04858451|449368266|FG004|Part 2|Discontinued|0|||
124928092|NCT04858451|449368267|FG005|Part 2|Discontinued|0|||
124928093|NCT04858451|449368268|FG006|Part 2|Discontinued|0|||
124928094|NCT04858451|449368269|FG007|Part 2|Discontinued|0|||
124928095|NCT04858451|449368270|FG008|Part 2|Discontinued|63|||
124928096|NCT03314454|449368271|FG000|Overall Study|Protocol Violation|1|||
124928097|NCT04314713|449368273|FG000|Overall Study|Lost to Follow-up|0|||
124928098|NCT04314713|449368274|FG001|Overall Study|Lost to Follow-up|0|||
124928099|NCT04314713|449368275|FG002|Overall Study|Lost to Follow-up|0|||
124928100|NCT04314713|449368276|FG003|Overall Study|Lost to Follow-up|1|||
124928101|NCT04314713|449368277|FG004|Overall Study|Lost to Follow-up|0|||
124928102|NCT04314713|449368278|FG005|Overall Study|Lost to Follow-up|0|||
124928103|NCT02927236|449368281|FG000|Characterization Phase|Physician Decision|0|||
124928104|NCT02927236|449368282|FG001|Characterization Phase|Physician Decision|3|||
124928105|NCT02927236|449368283|FG002|Characterization Phase|Physician Decision|0|||
124928106|NCT02927236|449368284|FG003|Characterization Phase|Physician Decision|2|||
124928107|NCT02927236|449368281|FG000|Characterization Phase|Lost to Follow-up|0|||
124928108|NCT02927236|449368282|FG001|Characterization Phase|Lost to Follow-up|0|||
124928109|NCT02927236|449368283|FG002|Characterization Phase|Lost to Follow-up|0|||
124928110|NCT02927236|449368284|FG003|Characterization Phase|Lost to Follow-up|3|||
124928111|NCT02927236|449368281|FG000|Characterization Phase|Withdrawal by Subject|1|||
124928112|NCT02927236|449368282|FG001|Characterization Phase|Withdrawal by Subject|0|||
124928113|NCT02927236|449368283|FG002|Characterization Phase|Withdrawal by Subject|0|||
124928114|NCT02927236|449368284|FG003|Characterization Phase|Withdrawal by Subject|1|||
124928115|NCT02927236|449368281|FG000|Treatment Phase|Adverse Event|1|||
124928116|NCT02927236|449368282|FG001|Treatment Phase|Adverse Event|0|||
124928117|NCT02927236|449368283|FG002|Treatment Phase|Adverse Event|1|||
124928118|NCT02927236|449368284|FG003|Treatment Phase|Adverse Event|1|||
124928119|NCT02927236|449368281|FG000|Treatment Phase|Protocol Violation|3|||
124928120|NCT02927236|449368282|FG001|Treatment Phase|Protocol Violation|0|||
124928121|NCT02927236|449368283|FG002|Treatment Phase|Protocol Violation|0|||
124928122|NCT02927236|449368284|FG003|Treatment Phase|Protocol Violation|1|||
124928123|NCT02927236|449368281|FG000|Treatment Phase|Lost to Follow-up|1|||
124928124|NCT02927236|449368282|FG001|Treatment Phase|Lost to Follow-up|0|||
124928125|NCT02927236|449368283|FG002|Treatment Phase|Lost to Follow-up|0|||
124928126|NCT02927236|449368284|FG003|Treatment Phase|Lost to Follow-up|0|||
124928127|NCT02927236|449368281|FG000|Follow-up Phase|Lost to Follow-up|1|||
124928128|NCT02927236|449368282|FG001|Follow-up Phase|Lost to Follow-up|0|||
124928129|NCT02927236|449368283|FG002|Follow-up Phase|Lost to Follow-up|1|||
124928130|NCT02927236|449368284|FG003|Follow-up Phase|Lost to Follow-up|0|||
124928131|NCT03656510|449368286|FG000|Overall Study|Lost to Follow-up|1|||
124928132|NCT03656510|449368287|FG001|Overall Study|Lost to Follow-up|0|||
124928133|NCT03656510|449368288|FG002|Overall Study|Lost to Follow-up|0|||
124928134|NCT03656510|449368289|FG003|Overall Study|Lost to Follow-up|0|||
124928135|NCT03656510|449368290|FG004|Overall Study|Lost to Follow-up|0|||
124928136|NCT03656510|449368291|FG005|Overall Study|Lost to Follow-up|0|||
124928137|NCT03656510|449368286|FG000|Overall Study|Withdrawal by Subject|1|||
124928138|NCT03656510|449368287|FG001|Overall Study|Withdrawal by Subject|1|||
124928139|NCT03656510|449368288|FG002|Overall Study|Withdrawal by Subject|0|||
124928140|NCT03656510|449368289|FG003|Overall Study|Withdrawal by Subject|1|||
124928141|NCT03656510|449368290|FG004|Overall Study|Withdrawal by Subject|0|||
124928142|NCT03656510|449368291|FG005|Overall Study|Withdrawal by Subject|0|||
124928143|NCT05496231|449368295|FG000|Overall Study|Adverse Event|1|||
124928144|NCT05496231|449368296|FG001|Overall Study|Adverse Event|1|||
124928145|NCT05496231|449368297|FG002|Overall Study|Adverse Event|0|||
125119661|NCT02146430|450063172|FG002|Overall Study|Reason missing or not reported|4|||
125119662|NCT02146430|450063173|FG003|Overall Study|Reason missing or not reported|5|||
125119663|NCT02146430|450063170|FG000|Overall Study|Withdrawal by Subject|27|||
125119664|NCT02146430|450063171|FG001|Overall Study|Withdrawal by Subject|29|||
124928146|NCT05496231|449368298|FG003|Overall Study|Adverse Event|4|||
124928147|NCT05496231|449368295|FG000|Overall Study|Withdrawal by Subject|5|||
124928148|NCT05496231|449368296|FG001|Overall Study|Withdrawal by Subject|5|||
124928149|NCT05496231|449368297|FG002|Overall Study|Withdrawal by Subject|4|||
124928150|NCT05496231|449368298|FG003|Overall Study|Withdrawal by Subject|11|||
124928151|NCT05496231|449368295|FG000|Overall Study|Migrated/moved from the study area|3|||
124928152|NCT05496231|449368296|FG001|Overall Study|Migrated/moved from the study area|5|||
124928153|NCT05496231|449368297|FG002|Overall Study|Migrated/moved from the study area|3|||
124928154|NCT05496231|449368298|FG003|Overall Study|Migrated/moved from the study area|3|||
124928155|NCT05496231|449368295|FG000|Overall Study|Lost to Follow-up|13|||
124928156|NCT05496231|449368296|FG001|Overall Study|Lost to Follow-up|6|||
124928157|NCT05496231|449368297|FG002|Overall Study|Lost to Follow-up|11|||
124928158|NCT05496231|449368298|FG003|Overall Study|Lost to Follow-up|6|||
124928159|NCT05496231|449368295|FG000|Overall Study|Other|9|||
124928160|NCT05496231|449368296|FG001|Overall Study|Other|7|||
124928161|NCT05496231|449368297|FG002|Overall Study|Other|7|||
124928162|NCT05496231|449368298|FG003|Overall Study|Other|8|||
124928163|NCT06232590|449368306|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
124928164|NCT06232590|449368307|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
124928165|NCT05940194|449368308|FG000|Overall Study|Adverse Event|0|||
124928166|NCT05940194|449368309|FG001|Overall Study|Adverse Event|1|||
124928167|NCT05940194|449368310|FG002|Overall Study|Adverse Event|0|||
124928168|NCT05940194|449368308|FG000|Overall Study|Migrated/Moved from the study area|2|||
124928169|NCT05940194|449368309|FG001|Overall Study|Migrated/Moved from the study area|2|||
124928170|NCT05940194|449368310|FG002|Overall Study|Migrated/Moved from the study area|4|||
124928171|NCT03085810|449368311|FG000|Main Study|Withdrawal by Subject|77|||
124928172|NCT03085810|449368312|FG001|Main Study|Withdrawal by Subject|0|||
124928173|NCT03085810|449368313|FG002|Main Study|Withdrawal by Subject|0|||
124928174|NCT03085810|449368311|FG000|Main Study|Terminated By Sponsor|14|||
124928175|NCT03085810|449368312|FG001|Main Study|Terminated By Sponsor|0|||
124928176|NCT03085810|449368313|FG002|Main Study|Terminated By Sponsor|0|||
124928177|NCT03085810|449368311|FG000|Main Study|Protocol Violation|15|||
124928178|NCT03085810|449368312|FG001|Main Study|Protocol Violation|0|||
124928179|NCT03085810|449368313|FG002|Main Study|Protocol Violation|0|||
124928180|NCT03085810|449368311|FG000|Main Study|Physician Decision|13|||
124928181|NCT03085810|449368312|FG001|Main Study|Physician Decision|0|||
124928182|NCT03085810|449368313|FG002|Main Study|Physician Decision|0|||
124928183|NCT03085810|449368311|FG000|Main Study|Lost to Follow-up|17|||
124928184|NCT03085810|449368312|FG001|Main Study|Lost to Follow-up|0|||
124928185|NCT03085810|449368313|FG002|Main Study|Lost to Follow-up|0|||
124928186|NCT03085810|449368311|FG000|Main Study|Adverse Event|25|||
124928187|NCT03085810|449368312|FG001|Main Study|Adverse Event|0|||
124928188|NCT03085810|449368313|FG002|Main Study|Adverse Event|0|||
124928189|NCT03085810|449368311|FG000|Main Study|Pregnancy|7|||
124928190|NCT03085810|449368312|FG001|Main Study|Pregnancy|0|||
124928191|NCT03085810|449368313|FG002|Main Study|Pregnancy|0|||
124928192|NCT03085810|449368311|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
124928193|NCT03085810|449368312|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
124928194|NCT03085810|449368313|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
124928195|NCT03085810|449368311|FG000|Main Study|Lack of Efficacy|10|||
124928196|NCT03085810|449368312|FG001|Main Study|Lack of Efficacy|0|||
124928197|NCT03085810|449368313|FG002|Main Study|Lack of Efficacy|0|||
124928198|NCT03085810|449368311|FG000|Main Study|Death|12|||
124928199|NCT03085810|449368312|FG001|Main Study|Death|0|||
124928200|NCT03085810|449368313|FG002|Main Study|Death|0|||
124928201|NCT03085810|449368311|FG000|Main Study|Disease progression|1|||
124928202|NCT03085810|449368312|FG001|Main Study|Disease progression|0|||
124928203|NCT03085810|449368313|FG002|Main Study|Disease progression|0|||
124928204|NCT03085810|449368311|FG000|Main Study|Site Closure|3|||
124928205|NCT03085810|449368312|FG001|Main Study|Site Closure|0|||
124928206|NCT03085810|449368313|FG002|Main Study|Site Closure|0|||
124928207|NCT03085810|449368311|FG000|Main Study|Planned pregnancy|17|||
124928208|NCT03085810|449368312|FG001|Main Study|Planned pregnancy|0|||
124928209|NCT03085810|449368313|FG002|Main Study|Planned pregnancy|0|||
124928210|NCT03085810|449368311|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
124928211|NCT03085810|449368312|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
124928212|NCT03085810|449368313|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
124928213|NCT03085810|449368311|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
124928214|NCT03085810|449368312|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
124928215|NCT03085810|449368313|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
124928216|NCT03085810|449368311|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
124928217|NCT03085810|449368312|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
124928218|NCT03085810|449368313|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
124928219|NCT03085810|449368311|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
124928220|NCT03085810|449368312|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
124928221|NCT03085810|449368313|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
124928222|NCT01959607|449368316|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
124928223|NCT01959607|449368317|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
124928224|NCT01959607|449368318|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
124928225|NCT01959607|449368319|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
124928226|NCT03235544|449368324|FG000|Overall Study|Death|11|||
124928227|NCT03235544|449368325|FG001|Overall Study|Death|31|||
124928228|NCT03235544|449368326|FG002|Overall Study|Death|19|||
124928229|NCT03235544|449368327|FG003|Overall Study|Death|34|||
124928230|NCT03235544|449368324|FG000|Overall Study|Lost to Follow-up|0|||
124928231|NCT03235544|449368325|FG001|Overall Study|Lost to Follow-up|1|||
124928232|NCT03235544|449368326|FG002|Overall Study|Lost to Follow-up|1|||
124928233|NCT03235544|449368327|FG003|Overall Study|Lost to Follow-up|1|||
124928234|NCT03235544|449368324|FG000|Overall Study|Withdrawal by Subject|0|||
124928235|NCT03235544|449368325|FG001|Overall Study|Withdrawal by Subject|3|||
124928236|NCT03235544|449368326|FG002|Overall Study|Withdrawal by Subject|1|||
124928237|NCT03235544|449368327|FG003|Overall Study|Withdrawal by Subject|5|||
124928238|NCT03235544|449368324|FG000|Overall Study|Disease Progression|0|||
124928239|NCT03235544|449368325|FG001|Overall Study|Disease Progression|1|||
124928240|NCT03235544|449368326|FG002|Overall Study|Disease Progression|0|||
124928241|NCT03235544|449368327|FG003|Overall Study|Disease Progression|2|||
124928242|NCT03235544|449368324|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
124928243|NCT03235544|449368325|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
124928244|NCT03235544|449368326|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
124928245|NCT03235544|449368327|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
124928246|NCT03235544|449368324|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
124928247|NCT03235544|449368325|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
124928248|NCT03235544|449368326|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
124928249|NCT03235544|449368327|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
124928250|NCT00950742|449368328|FG000|Overall Study|Other Adverse Event|1|||
124928251|NCT00950742|449368329|FG001|Overall Study|Other Adverse Event|0|||
125024353|NCT01017952|449711429|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
125024354|NCT01017952|449711430|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
125024355|NCT01017952|449711431|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
125024356|NCT01017952|449711432|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
124928252|NCT00950742|449368328|FG000|Overall Study|Withdrawal by Subject|3|||
124928253|NCT00950742|449368329|FG001|Overall Study|Withdrawal by Subject|0|||
125119665|NCT02146430|450063172|FG002|Overall Study|Withdrawal by Subject|30|||
124928254|NCT00950742|449368328|FG000|Overall Study|Progressive Disease|6|||
124928255|NCT00950742|449368329|FG001|Overall Study|Progressive Disease|2|||
124928256|NCT00950742|449368328|FG000|Overall Study|Dose limiting toxicity|6|||
124928257|NCT00950742|449368329|FG001|Overall Study|Dose limiting toxicity|0|||
125212369|NCT00548249|450403338|FG003|Overall Study|Prolonged hospitalization|1|||
125212370|NCT00548249|450403339|FG004|Overall Study|Prolonged hospitalization|0|||
125212371|NCT00548249|450403335|FG000|Overall Study|Withdrawal by Subject|2|||
125212372|NCT00548249|450403336|FG001|Overall Study|Withdrawal by Subject|0|||
125212373|NCT00548249|450403337|FG002|Overall Study|Withdrawal by Subject|0|||
125212374|NCT00548249|450403338|FG003|Overall Study|Withdrawal by Subject|0|||
125212375|NCT00548249|450403339|FG004|Overall Study|Withdrawal by Subject|0|||
125212376|NCT00548249|450403335|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
125212377|NCT00548249|450403336|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
125212378|NCT00548249|450403337|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
125212379|NCT00548249|450403338|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
125212380|NCT00548249|450403339|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
125212381|NCT00548249|450403335|FG000|Overall Study|Sponsor's request|0|||
125212382|NCT00548249|450403336|FG001|Overall Study|Sponsor's request|0|||
125212383|NCT00548249|450403337|FG002|Overall Study|Sponsor's request|0|||
125212384|NCT00548249|450403338|FG003|Overall Study|Sponsor's request|1|||
125212385|NCT00548249|450403339|FG004|Overall Study|Sponsor's request|0|||
125212386|NCT00938587|450403340|FG000|Overall Study|Adverse Event|2|||
125212387|NCT00938587|450403341|FG001|Overall Study|Adverse Event|0|||
125212388|NCT00938587|450403342|FG002|Overall Study|Adverse Event|0|||
125212389|NCT00938587|450403343|FG003|Overall Study|Adverse Event|2|||
124928258|NCT04447755|449368330|FG000|Overall Study|Death|8|||
124928259|NCT04447755|449368331|FG001|Overall Study|Death|14|||
124928260|NCT04447755|449368332|FG002|Overall Study|Death|8|||
124928261|NCT04447755|449368333|FG003|Overall Study|Death|9|||
124928262|NCT04447755|449368334|FG004|Overall Study|Death|7|||
125212390|NCT00938587|450403340|FG000|Overall Study|Did not meet entrance criteria|0|||
125212391|NCT00938587|450403341|FG001|Overall Study|Did not meet entrance criteria|0|||
124928263|NCT04447755|449368335|FG005|Overall Study|Death|7|||
125212392|NCT00938587|450403342|FG002|Overall Study|Did not meet entrance criteria|1|||
125119666|NCT02146430|450063173|FG003|Overall Study|Withdrawal by Subject|34|||
125119667|NCT01893905|450063174|FG000|Overall Study|Withdrawal by Subject|1|||
125119668|NCT01893905|450063175|FG001|Overall Study|Withdrawal by Subject|0|||
125119669|NCT01893905|450063174|FG000|Overall Study|Adverse Event|9|||
125119670|NCT01893905|450063175|FG001|Overall Study|Adverse Event|3|||
125119671|NCT01893905|450063174|FG000|Overall Study|Lack of Efficacy|5|||
125119672|NCT01893905|450063175|FG001|Overall Study|Lack of Efficacy|7|||
125119673|NCT01893905|450063174|FG000|Overall Study|Lost to Follow-up|1|||
125119674|NCT01893905|450063175|FG001|Overall Study|Lost to Follow-up|0|||
125119675|NCT01893905|450063174|FG000|Overall Study|Protocol Violation|6|||
125119676|NCT01893905|450063175|FG001|Overall Study|Protocol Violation|1|||
125119677|NCT01893905|450063174|FG000|Overall Study|Lack of adherence to treatment|2|||
125119678|NCT01893905|450063175|FG001|Overall Study|Lack of adherence to treatment|0|||
125119679|NCT01893905|450063174|FG000|Overall Study|Other reason|1|||
125119680|NCT01893905|450063175|FG001|Overall Study|Other reason|3|||
125119681|NCT01768858|450063176|FG000|Overall Study|Lost to Follow-up|9|||
125119682|NCT01768858|450063176|FG000|Overall Study|Lack of Efficacy|8|||
125119683|NCT01768858|450063176|FG000|Overall Study|Serious Adverse Event|1|||
125119684|NCT01768858|450063176|FG000|Overall Study|Participant moved to Germany|1|||
125119685|NCT01768858|450063176|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
125119686|NCT01768858|450063176|FG000|Overall Study|Exanthema|1|||
125119687|NCT01768858|450063176|FG000|Overall Study|Withdrawal by Subject|1|||
125119688|NCT03312530|450063177|FG000|Overall Study|Death|5|||
125119689|NCT03312530|450063178|FG001|Overall Study|Death|5|||
125119690|NCT03312530|450063179|FG002|Overall Study|Death|4|||
125119691|NCT03312530|450063180|FG003|Overall Study|Death|10|||
125119692|NCT03312530|450063181|FG004|Overall Study|Death|8|||
125119693|NCT03312530|450063177|FG000|Overall Study|Lost to Follow-up|0|||
125119694|NCT03312530|450063178|FG001|Overall Study|Lost to Follow-up|0|||
125119695|NCT03312530|450063179|FG002|Overall Study|Lost to Follow-up|0|||
125119696|NCT03312530|450063180|FG003|Overall Study|Lost to Follow-up|1|||
125119697|NCT03312530|450063181|FG004|Overall Study|Lost to Follow-up|0|||
125119698|NCT03312530|450063177|FG000|Overall Study|Participant in another sponsor study.|0|||
125119699|NCT03312530|450063178|FG001|Overall Study|Participant in another sponsor study.|0|||
125119700|NCT03312530|450063179|FG002|Overall Study|Participant in another sponsor study.|0|||
125119701|NCT03312530|450063180|FG003|Overall Study|Participant in another sponsor study.|1|||
125119702|NCT03312530|450063181|FG004|Overall Study|Participant in another sponsor study.|0|||
125119703|NCT03312530|450063177|FG000|Overall Study|Study terminated by sponsor|1|||
125119704|NCT03312530|450063178|FG001|Overall Study|Study terminated by sponsor|0|||
125119705|NCT03312530|450063179|FG002|Overall Study|Study terminated by sponsor|2|||
125119706|NCT03312530|450063180|FG003|Overall Study|Study terminated by sponsor|3|||
125119707|NCT03312530|450063181|FG004|Overall Study|Study terminated by sponsor|7|||
125119708|NCT03312530|450063177|FG000|Overall Study|Withdrawal by Subject|0|||
125119709|NCT03312530|450063178|FG001|Overall Study|Withdrawal by Subject|1|||
125119710|NCT03312530|450063179|FG002|Overall Study|Withdrawal by Subject|0|||
125119711|NCT03312530|450063180|FG003|Overall Study|Withdrawal by Subject|0|||
125119712|NCT03312530|450063181|FG004|Overall Study|Withdrawal by Subject|0|||
125119713|NCT03312530|450063177|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
125119714|NCT03312530|450063178|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
125212393|NCT00938587|450403343|FG003|Overall Study|Did not meet entrance criteria|0|||
125212394|NCT00938587|450403340|FG000|Overall Study|Withdrawal by Subject|1|||
125212395|NCT00938587|450403341|FG001|Overall Study|Withdrawal by Subject|1|||
124928264|NCT04447755|449368336|FG006|Overall Study|Death|40|||
124928265|NCT04447755|449368330|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124928266|NCT04447755|449368331|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
125119715|NCT03312530|450063179|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
125119716|NCT03312530|450063180|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
125119717|NCT03312530|450063181|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
125119718|NCT01691859|450063184|FG000|Overall Study|Adverse Event|19|||
125119719|NCT01691859|450063184|FG000|Overall Study|Lack of Efficacy|11|||
125119720|NCT01691859|450063184|FG000|Overall Study|Protocol Violation|4|||
125119721|NCT01691859|450063184|FG000|Overall Study|Product commercially available|221|||
125119722|NCT01691859|450063184|FG000|Overall Study|Study closed/terminated|50|||
125024357|NCT01017952|449711428|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125024358|NCT01017952|449711429|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
125024359|NCT01017952|449711430|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
125024360|NCT01017952|449711431|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
125024361|NCT01017952|449711432|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
125024362|NCT01017952|449711428|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
125024363|NCT01017952|449711429|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
125024364|NCT01017952|449711430|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
125024365|NCT01017952|449711431|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
125024366|NCT01017952|449711432|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
125024367|NCT01064167|449711433|FG000|Overall Study|Protocol Violation|14|||
125024368|NCT01064167|449711434|FG001|Overall Study|Protocol Violation|15|||
125024369|NCT02902120|449711435|FG000|Overall Study|Lack of Efficacy|1|||
125024370|NCT02435914|449711436|FG000|Overall Study|Ocular Adverse Event|1|||
125024371|NCT02435914|449711437|FG001|Overall Study|Ocular Adverse Event|0|||
125024372|NCT02435914|449711438|FG002|Overall Study|Ocular Adverse Event|0|||
125024373|NCT02435914|449711439|FG003|Overall Study|Ocular Adverse Event|0|||
125024374|NCT02435914|449711436|FG000|Overall Study|Withdrawal by Subject|0|||
125024375|NCT02435914|449711437|FG001|Overall Study|Withdrawal by Subject|1|||
125024376|NCT02435914|449711438|FG002|Overall Study|Withdrawal by Subject|0|||
125024377|NCT02435914|449711439|FG003|Overall Study|Withdrawal by Subject|0|||
125024378|NCT02435914|449711436|FG000|Overall Study|Other Miscellaneous Reason|0|||
125024379|NCT02435914|449711437|FG001|Overall Study|Other Miscellaneous Reason|0|||
125024380|NCT02435914|449711438|FG002|Overall Study|Other Miscellaneous Reason|1|||
125024381|NCT02435914|449711439|FG003|Overall Study|Other Miscellaneous Reason|0|||
125024382|NCT01353703|449711440|FG000|Overall Study|Migrated/moved from study area|1|||
125024383|NCT01353703|449711441|FG001|Overall Study|Migrated/moved from study area|0|||
125024384|NCT02286947|449711457|FG000|Overall Study|Withdrawal by Subject|2|||
125024385|NCT02175680|449711458|FG000|Overall Study|non-compliance|1|||
125119723|NCT01691859|450063184|FG000|Overall Study|Lost to Follow-up|5|||
125119724|NCT01691859|450063184|FG000|Overall Study|Physician Decision|6|||
125024386|NCT02175680|449711458|FG000|Overall Study|other non-medical reason|1|||
125024387|NCT03979274|449711459|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125024388|NCT03979274|449711460|FG001|Treatment Period 2|Withdrawal by Subject|1|||
125024389|NCT01665144|449711461|FG000|Core Part|Withdrawal by Subject|96|||
125119725|NCT01691859|450063184|FG000|Overall Study|Withdrawal by Subject|31|||
125119726|NCT04820842|450063185|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
125119727|NCT04820842|450063186|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
125119728|NCT04820842|450063187|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
125119729|NCT04820842|450063188|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
125119730|NCT04820842|450063189|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
125119731|NCT04820842|450063190|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
125119732|NCT04820842|450063191|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
125119733|NCT04820842|450063185|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
125119734|NCT04820842|450063186|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
125119735|NCT04820842|450063187|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
125131401|NCT03818581|450109960|FG000|Overall Study|Withdrawal by Subject|0|||
125119736|NCT04820842|450063188|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
125119737|NCT04820842|450063189|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
125119738|NCT04820842|450063190|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
125119739|NCT04820842|450063191|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
125119740|NCT04820842|450063185|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
125119741|NCT04820842|450063186|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
125119742|NCT04820842|450063187|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
125119743|NCT04820842|450063188|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
125119744|NCT04820842|450063189|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
125024390|NCT01665144|449711462|FG001|Core Part|Withdrawal by Subject|77|||
125024391|NCT01665144|449711463|FG002|Core Part|Withdrawal by Subject|0|||
125024392|NCT01665144|449711461|FG000|Core Part|Adverse Event|45|||
125024393|NCT01665144|449711462|FG001|Core Part|Adverse Event|18|||
125024394|NCT01665144|449711463|FG002|Core Part|Adverse Event|0|||
125024395|NCT01665144|449711461|FG000|Core Part|Lack of Efficacy|16|||
125024396|NCT01665144|449711462|FG001|Core Part|Lack of Efficacy|11|||
125024397|NCT01665144|449711463|FG002|Core Part|Lack of Efficacy|0|||
125024398|NCT01665144|449711461|FG000|Core Part|Lost to Follow-up|9|||
125024399|NCT01665144|449711462|FG001|Core Part|Lost to Follow-up|8|||
125024400|NCT01665144|449711463|FG002|Core Part|Lost to Follow-up|0|||
125119745|NCT04820842|450063190|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
125212396|NCT00938587|450403342|FG002|Overall Study|Withdrawal by Subject|0|||
125212397|NCT00938587|450403343|FG003|Overall Study|Withdrawal by Subject|0|||
124928267|NCT04447755|449368332|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
125119746|NCT04820842|450063191|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
125119747|NCT04820842|450063185|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
125119748|NCT04820842|450063186|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
125119749|NCT04820842|450063187|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
125119750|NCT04820842|450063188|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
125119751|NCT04820842|450063189|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
125119752|NCT04820842|450063190|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
125119753|NCT04820842|450063191|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
125119754|NCT01090765|450063194|FG000|Overall Study|Patient withdrew consent|0|||
125119755|NCT01090765|450063195|FG001|Overall Study|Patient withdrew consent|0|||
125119756|NCT01090765|450063196|FG002|Overall Study|Patient withdrew consent|0|||
125119757|NCT01090765|450063197|FG003|Overall Study|Patient withdrew consent|0|||
125119758|NCT01090765|450063198|FG004|Overall Study|Patient withdrew consent|1|||
125119759|NCT01090765|450063199|FG005|Overall Study|Patient withdrew consent|1|||
125119760|NCT01090765|450063194|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
125119761|NCT01090765|450063195|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
125119762|NCT01090765|450063196|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
125119763|NCT01090765|450063197|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
125119764|NCT01090765|450063198|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
125119765|NCT01090765|450063199|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
125119766|NCT01090765|450063194|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
125119767|NCT01090765|450063195|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
125119768|NCT01090765|450063196|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
125119769|NCT01090765|450063197|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
125119770|NCT01090765|450063198|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
125119771|NCT01090765|450063199|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
125119772|NCT02623959|450063203|FG000|Overall Study|Progression|0|||
125119773|NCT02623959|450063204|FG001|Overall Study|Progression|1|||
125119774|NCT02336737|450063207|FG000|Overall Study|Withdrawal by Subject|5|||
125119775|NCT02336737|450063207|FG000|Overall Study|Physician Decision|8|||
125119776|NCT02396381|450063208|FG000|Overall Study|Adverse Event|3|||
125119777|NCT02396381|450063209|FG001|Overall Study|Adverse Event|2|||
125119778|NCT02396381|450063208|FG000|Overall Study|Withdrawal by Subject|33|||
125119779|NCT02396381|450063209|FG001|Overall Study|Withdrawal by Subject|24|||
125119780|NCT02396381|450063208|FG000|Overall Study|Lost to Follow-up|49|||
125119781|NCT02396381|450063209|FG001|Overall Study|Lost to Follow-up|31|||
125119782|NCT02396381|450063208|FG000|Overall Study|Protocol Violation|1|||
125119783|NCT02396381|450063209|FG001|Overall Study|Protocol Violation|0|||
125119784|NCT02396381|450063208|FG000|Overall Study|Site terminated by sponsor|7|||
125119785|NCT02396381|450063209|FG001|Overall Study|Site terminated by sponsor|8|||
125119786|NCT02396381|450063208|FG000|Overall Study|Physician Decision|5|||
125119787|NCT02396381|450063209|FG001|Overall Study|Physician Decision|5|||
125024401|NCT01665144|449711461|FG000|Core Part|Physician Decision|13|||
124928268|NCT04447755|449368333|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
125212398|NCT00002525|450403348|FG000|Overall Study|Adverse Event|36|||
125212399|NCT00002525|450403349|FG001|Overall Study|Adverse Event|0|||
125212400|NCT00002525|450403348|FG000|Overall Study|Death|5|||
124928269|NCT04447755|449368334|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
125119788|NCT02396381|450063208|FG000|Overall Study|Pregnancy|2|||
125119789|NCT02396381|450063209|FG001|Overall Study|Pregnancy|0|||
125119790|NCT02396381|450063208|FG000|Overall Study|Non-compliance with study procedures|1|||
125119791|NCT02396381|450063209|FG001|Overall Study|Non-compliance with study procedures|0|||
125119792|NCT02396381|450063208|FG000|Overall Study|Moved out of town/state|1|||
125119793|NCT02396381|450063209|FG001|Overall Study|Moved out of town/state|3|||
125119794|NCT02396381|450063208|FG000|Overall Study|Could not complete visit|1|||
125119795|NCT02396381|450063209|FG001|Overall Study|Could not complete visit|0|||
125119796|NCT02396381|450063208|FG000|Overall Study|Possible conflict of interest|1|||
125119797|NCT02396381|450063209|FG001|Overall Study|Possible conflict of interest|0|||
125119798|NCT02396381|450063208|FG000|Overall Study|Randomization/Screening Error|3|||
125119799|NCT02396381|450063209|FG001|Overall Study|Randomization/Screening Error|1|||
125119800|NCT00635778|450063211|FG000|Overall Study|Adverse Event|1|||
125119801|NCT00635778|450063212|FG001|Overall Study|Adverse Event|0|||
125119802|NCT00635778|450063213|FG002|Overall Study|Adverse Event|0|||
125119803|NCT00635778|450063214|FG003|Overall Study|Adverse Event|3|||
125119804|NCT00635778|450063215|FG004|Overall Study|Adverse Event|3|||
125119805|NCT00635778|450063216|FG005|Overall Study|Adverse Event|6|||
125119806|NCT00635778|450063217|FG006|Overall Study|Adverse Event|1|||
125119807|NCT00635778|450063211|FG000|Overall Study|Withdrawal by Subject|0|||
125119808|NCT00635778|450063212|FG001|Overall Study|Withdrawal by Subject|0|||
125119809|NCT00635778|450063213|FG002|Overall Study|Withdrawal by Subject|0|||
125119810|NCT00635778|450063214|FG003|Overall Study|Withdrawal by Subject|1|||
125119811|NCT00635778|450063215|FG004|Overall Study|Withdrawal by Subject|0|||
125119812|NCT00635778|450063216|FG005|Overall Study|Withdrawal by Subject|1|||
125119813|NCT00635778|450063217|FG006|Overall Study|Withdrawal by Subject|1|||
125119814|NCT00635778|450063211|FG000|Overall Study|Progressive disease|0|||
125119815|NCT00635778|450063212|FG001|Overall Study|Progressive disease|3|||
125119816|NCT00635778|450063213|FG002|Overall Study|Progressive disease|3|||
125212401|NCT00002525|450403349|FG001|Overall Study|Death|0|||
125212402|NCT00002525|450403348|FG000|Overall Study|Withdrawal by Subject|11|||
125212403|NCT00002525|450403349|FG001|Overall Study|Withdrawal by Subject|0|||
125212404|NCT00002525|450403348|FG000|Overall Study|Start non-protocol therapy|1|||
125212405|NCT00002525|450403349|FG001|Overall Study|Start non-protocol therapy|0|||
125212406|NCT00002525|450403348|FG000|Overall Study|Other complicating disease|1|||
125212407|NCT00002525|450403349|FG001|Overall Study|Other complicating disease|0|||
125212408|NCT00002525|450403348|FG000|Overall Study|Duke's A, B1, D disease|92|||
125212409|NCT00002525|450403349|FG001|Overall Study|Duke's A, B1, D disease|0|||
125212410|NCT00002525|450403348|FG000|Overall Study|Error|6|||
125212411|NCT00002525|450403349|FG001|Overall Study|Error|0|||
125212412|NCT00002525|450403348|FG000|Overall Study|Other|26|||
125212413|NCT00002525|450403349|FG001|Overall Study|Other|0|||
125212414|NCT00002525|450403348|FG000|Overall Study|Never start protocol therapy|8|||
125212415|NCT00002525|450403349|FG001|Overall Study|Never start protocol therapy|0|||
125212416|NCT03304184|450403350|FG000|Overall Study|Withdrawal by Subject|1|||
125212417|NCT03304184|450403351|FG001|Overall Study|Withdrawal by Subject|2|||
125212418|NCT03230838|450403352|FG000|Overall Study|Withdrawal by Subject|3|||
125212419|NCT03230838|450403353|FG001|Overall Study|Withdrawal by Subject|0|||
125212420|NCT03230838|450403352|FG000|Overall Study|Temperature excursion|1|||
125212421|NCT03230838|450403353|FG001|Overall Study|Temperature excursion|0|||
125212422|NCT01915771|450403356|FG000|Day 1|Withdrawal by Subject|1|||
125212423|NCT01915771|450403356|FG000|Day 15|Withdrawal by Subject|1|||
125212424|NCT03420222|450403362|FG000|Overall Study|Withdrawal by Subject|5|||
125212425|NCT03420222|450403363|FG001|Overall Study|Withdrawal by Subject|0|||
125212426|NCT03420222|450403362|FG000|Overall Study|Physician Decision|0|||
125212427|NCT03420222|450403363|FG001|Overall Study|Physician Decision|1|||
125212428|NCT02697734|450403364|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
125212429|NCT02697734|450403365|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
125212430|NCT02697734|450403364|FG000|Core Phase - up to Week 48|Adverse Event|1|||
125212431|NCT02697734|450403365|FG001|Core Phase - up to Week 48|Adverse Event|2|||
125212432|NCT02697734|450403364|FG000|Core Phase - up to Week 48|Physician Decision|1|||
125212433|NCT02697734|450403365|FG001|Core Phase - up to Week 48|Physician Decision|0|||
125212434|NCT02697734|450403364|FG000|Optional Extension Phase|Adverse Event|5|||
125212435|NCT02697734|450403365|FG001|Optional Extension Phase|Adverse Event|1|||
125212436|NCT02697734|450403364|FG000|Optional Extension Phase|Physician Decision|0|||
125212437|NCT02697734|450403365|FG001|Optional Extension Phase|Physician Decision|1|||
125212438|NCT02334384|450403367|FG000|Overall Study|Lost to Follow-up|1|||
125212439|NCT02334384|450403368|FG001|Overall Study|Lost to Follow-up|1|||
125212440|NCT02651688|450403369|FG000|Overall Study|Non-compliance|0|||
125212441|NCT02651688|450403370|FG001|Overall Study|Non-compliance|0|||
125212442|NCT02651688|450403371|FG002|Overall Study|Non-compliance|1|||
125212443|NCT02651688|450403369|FG000|Overall Study|Principal Investigator (PI) decision|0|||
125212444|NCT02651688|450403370|FG001|Overall Study|Principal Investigator (PI) decision|2|||
125212445|NCT02651688|450403371|FG002|Overall Study|Principal Investigator (PI) decision|0|||
125212446|NCT02651688|450403369|FG000|Overall Study|Lost to Follow-up|1|||
125212447|NCT02651688|450403370|FG001|Overall Study|Lost to Follow-up|3|||
125212448|NCT02651688|450403371|FG002|Overall Study|Lost to Follow-up|0|||
125212449|NCT02651688|450403369|FG000|Overall Study|Withdrawal by Subject|1|||
125212450|NCT02651688|450403370|FG001|Overall Study|Withdrawal by Subject|0|||
125212451|NCT02651688|450403371|FG002|Overall Study|Withdrawal by Subject|2|||
125212452|NCT04527978|450403372|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
125212453|NCT04527978|450403373|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
125212454|NCT01429441|450403374|FG000|Overall Study|Adverse Event|5|||
125212455|NCT01429441|450403375|FG001|Overall Study|Adverse Event|1|||
125212456|NCT01429441|450403374|FG000|Overall Study|Death|0|||
125212457|NCT01429441|450403375|FG001|Overall Study|Death|2|||
125212458|NCT01429441|450403374|FG000|Overall Study|Lost to Follow-up|5|||
125212459|NCT01429441|450403375|FG001|Overall Study|Lost to Follow-up|2|||
125212460|NCT01429441|450403374|FG000|Overall Study|Physician Decision|1|||
125212461|NCT01429441|450403375|FG001|Overall Study|Physician Decision|0|||
125212462|NCT01429441|450403374|FG000|Overall Study|Withdrawal by Subject|27|||
125212463|NCT01429441|450403375|FG001|Overall Study|Withdrawal by Subject|18|||
125212464|NCT01578499|450403381|FG000|Overall Study|Reason not Specified|0|||
125212465|NCT01578499|450403382|FG001|Overall Study|Reason not Specified|1|||
125212466|NCT01578499|450403381|FG000|Overall Study|Lost to Follow-up|2|||
125212467|NCT01578499|450403382|FG001|Overall Study|Lost to Follow-up|1|||
125212468|NCT01578499|450403381|FG000|Overall Study|Withdrawal by Subject|10|||
125212469|NCT01578499|450403382|FG001|Overall Study|Withdrawal by Subject|16|||
125212470|NCT01578499|450403381|FG000|Overall Study|Death|20|||
125212471|NCT01578499|450403382|FG001|Overall Study|Death|25|||
125212472|NCT01578499|450403381|FG000|Overall Study|Died and End of Study Page not Completed|2|||
125212473|NCT01578499|450403382|FG001|Overall Study|Died and End of Study Page not Completed|0|||
125212474|NCT00830518|450403383|FG000|Overall Study|Progressive Disease|18|||
125212475|NCT00830518|450403384|FG001|Overall Study|Progressive Disease|8|||
125119817|NCT00635778|450063214|FG003|Overall Study|Progressive disease|4|||
125119818|NCT00635778|450063215|FG004|Overall Study|Progressive disease|5|||
125119819|NCT00635778|450063216|FG005|Overall Study|Progressive disease|14|||
125119820|NCT00635778|450063217|FG006|Overall Study|Progressive disease|4|||
125119821|NCT01884025|450063218|FG000|Overall Study|Lost to Follow-up|3|||
125119822|NCT01884025|450063219|FG001|Overall Study|Lost to Follow-up|4|||
125119823|NCT02324465|450063220|FG000|Overall Study|device failure|0|||
125119824|NCT02324465|450063221|FG001|Overall Study|device failure|1|||
125119825|NCT02655237|450063224|FG000|Overall Study|Adverse Event|10|||
125119826|NCT02655237|450063225|FG001|Overall Study|Adverse Event|7|||
125119827|NCT02655237|450063224|FG000|Overall Study|Protocol Deviation|2|||
125212476|NCT00830518|450403383|FG000|Overall Study|Symptomatic Deterioration|4|||
125119828|NCT02655237|450063225|FG001|Overall Study|Protocol Deviation|0|||
125119829|NCT02655237|450063224|FG000|Overall Study|Withdrawal by Participant|1|||
125119830|NCT02655237|450063225|FG001|Overall Study|Withdrawal by Participant|2|||
125119831|NCT02655237|450063224|FG000|Overall Study|Lack of Efficacy|0|||
125119832|NCT02655237|450063225|FG001|Overall Study|Lack of Efficacy|1|||
125119833|NCT02655237|450063224|FG000|Overall Study|Recovery Leading to Surgery|2|||
125119834|NCT02655237|450063225|FG001|Overall Study|Recovery Leading to Surgery|1|||
125119835|NCT02655237|450063224|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
125119836|NCT02655237|450063225|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
125119837|NCT02655237|450063224|FG000|Overall Study|Randomized but Not Treated|1|||
125119838|NCT02655237|450063225|FG001|Overall Study|Randomized but Not Treated|0|||
125119839|NCT01860976|450063228|FG000|Blinded Treatment|Adverse Event|1|||
125119840|NCT01860976|450063229|FG001|Blinded Treatment|Adverse Event|3|||
125119841|NCT01860976|450063228|FG000|Blinded Treatment|Lack of Efficacy|5|||
125119842|NCT01860976|450063229|FG001|Blinded Treatment|Lack of Efficacy|12|||
125119843|NCT01860976|450063228|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
125119844|NCT01860976|450063229|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
125119845|NCT01860976|450063228|FG000|Blinded Treatment|Withdrawal by Subject|3|||
125119846|NCT01860976|450063229|FG001|Blinded Treatment|Withdrawal by Subject|5|||
125119847|NCT01860976|450063228|FG000|Blinded Treatment|Subject no longer met criteria|1|||
125119848|NCT01860976|450063229|FG001|Blinded Treatment|Subject no longer met criteria|0|||
125119849|NCT01860976|450063228|FG000|Blinded Treatment|Entered Open-Label in error|0|||
125119850|NCT01860976|450063229|FG001|Blinded Treatment|Entered Open-Label in error|1|||
125119851|NCT01860976|450063228|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
125119852|NCT01860976|450063229|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
125119853|NCT01860976|450063228|FG000|Open-Label|Adverse Event|2|||
125119854|NCT01860976|450063229|FG001|Open-Label|Adverse Event|4|||
125119855|NCT01860976|450063228|FG000|Open-Label|Lack of Efficacy|16|||
125212477|NCT00830518|450403384|FG001|Overall Study|Symptomatic Deterioration|1|||
125212478|NCT00830518|450403383|FG000|Overall Study|Adverse Event|14|||
125212479|NCT00830518|450403384|FG001|Overall Study|Adverse Event|1|||
125212480|NCT00830518|450403383|FG000|Overall Study|Withdrawal by Patient|2|||
125212481|NCT00830518|450403384|FG001|Overall Study|Withdrawal by Patient|0|||
125212482|NCT00830518|450403383|FG000|Overall Study|Reason not Specified|8|||
125212483|NCT00830518|450403384|FG001|Overall Study|Reason not Specified|1|||
125212484|NCT02669667|450403388|FG000|Overall Study|Lost to Follow-up|0|||
125212485|NCT02669667|450403389|FG001|Overall Study|Lost to Follow-up|0|||
125212486|NCT02669667|450403390|FG002|Overall Study|Lost to Follow-up|0|||
125119856|NCT01860976|450063229|FG001|Open-Label|Lack of Efficacy|8|||
125119857|NCT01860976|450063228|FG000|Open-Label|Lost to Follow-up|1|||
125119858|NCT01860976|450063229|FG001|Open-Label|Lost to Follow-up|2|||
125119859|NCT01860976|450063228|FG000|Open-Label|Subject request discontinue treatment|4|||
125119860|NCT01860976|450063229|FG001|Open-Label|Subject request discontinue treatment|3|||
125119861|NCT01860976|450063228|FG000|Open-Label|Withdrawal by Subject|4|||
125119862|NCT01860976|450063229|FG001|Open-Label|Withdrawal by Subject|1|||
125119863|NCT01860976|450063228|FG000|Open-Label|Other Reasons|1|||
125119864|NCT01860976|450063229|FG001|Open-Label|Other Reasons|1|||
125119865|NCT01860976|450063228|FG000|Long Term Extension|Adverse Event|4|||
125119866|NCT01860976|450063229|FG001|Long Term Extension|Adverse Event|0|||
125119867|NCT01860976|450063228|FG000|Long Term Extension|Lack of Efficacy|2|||
125119868|NCT01860976|450063229|FG001|Long Term Extension|Lack of Efficacy|0|||
125212487|NCT02669667|450403391|FG003|Overall Study|Lost to Follow-up|0|||
125212488|NCT02669667|450403392|FG004|Overall Study|Lost to Follow-up|0|||
125119869|NCT01860976|450063228|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
125119870|NCT01860976|450063229|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
125119871|NCT01860976|450063228|FG000|Long Term Extension|Lost to Follow-up|2|||
125119872|NCT01860976|450063229|FG001|Long Term Extension|Lost to Follow-up|0|||
125119873|NCT01860976|450063228|FG000|Long Term Extension|subject withdrew consent|7|||
125212489|NCT02669667|450403393|FG005|Overall Study|Lost to Follow-up|1|||
125212490|NCT02669667|450403394|FG006|Overall Study|Lost to Follow-up|0|||
125212491|NCT02839876|450403399|FG000|Overall Study|Protocol Violation|10|||
125212492|NCT02839876|450403400|FG001|Overall Study|Protocol Violation|11|||
125212493|NCT01156051|450403404|FG000|Overall Study|Lost to Follow-up|1|||
125212494|NCT01156051|450403405|FG001|Overall Study|Lost to Follow-up|0|||
125212495|NCT01156051|450403404|FG000|Overall Study|patient not compliant with protocol|0|||
125212496|NCT01156051|450403405|FG001|Overall Study|patient not compliant with protocol|1|||
125212497|NCT01926197|450403408|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
125212498|NCT01926197|450403409|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
125212499|NCT01926197|450403408|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
125212500|NCT01926197|450403409|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
125212501|NCT01483599|450403411|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
125212502|NCT01483599|450403412|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
125212503|NCT01483599|450403413|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
125212504|NCT01483599|450403414|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
125212505|NCT01483599|450403415|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
125212506|NCT01483599|450403416|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
125212507|NCT01483599|450403417|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
125212508|NCT01483599|450403418|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
125212509|NCT01483599|450403419|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
125212510|NCT01483599|450403420|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
125212511|NCT01483599|450403421|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
125212512|NCT01483599|450403422|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
125212513|NCT01483599|450403423|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
125212514|NCT01483599|450403424|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
125212515|NCT01483599|450403411|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125212516|NCT01483599|450403412|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
125212517|NCT01483599|450403413|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125212518|NCT01483599|450403414|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
125212519|NCT01483599|450403415|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125212520|NCT01483599|450403416|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125212521|NCT01483599|450403417|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
125212522|NCT01483599|450403418|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125212523|NCT01483599|450403419|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125212524|NCT01483599|450403420|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125119874|NCT01860976|450063229|FG001|Long Term Extension|subject withdrew consent|0|||
125119875|NCT02227862|450063230|FG000|Overall Study|Protocol Violation|7|||
125119876|NCT02227862|450063231|FG001|Overall Study|Protocol Violation|9|||
125119877|NCT02227862|450063230|FG000|Overall Study|Other|0|||
125119878|NCT02227862|450063231|FG001|Overall Study|Other|2|||
125119879|NCT02227862|450063230|FG000|Overall Study|Adverse Event|4|||
125119880|NCT02227862|450063231|FG001|Overall Study|Adverse Event|3|||
125119881|NCT02227862|450063230|FG000|Overall Study|Withdrawal by Subject|7|||
125119882|NCT02227862|450063231|FG001|Overall Study|Withdrawal by Subject|6|||
125119883|NCT02227862|450063230|FG000|Overall Study|Lost to Follow-up|1|||
125119884|NCT02227862|450063231|FG001|Overall Study|Lost to Follow-up|2|||
125119885|NCT02419313|450063237|FG000|First Intervention|Lost to Follow-up|2|||
125119886|NCT02419313|450063238|FG001|First Intervention|Lost to Follow-up|0|||
125119887|NCT02419313|450063237|FG000|Second Intervention|Lost to Follow-up|1|||
125119888|NCT02419313|450063238|FG001|Second Intervention|Lost to Follow-up|0|||
125119889|NCT00620763|450063239|FG000|Period: First Intervention|Withdrawal by Subject|0|||
125119890|NCT00620763|450063240|FG001|Period: First Intervention|Withdrawal by Subject|2|||
125119891|NCT00620763|450063239|FG000|Period: First Intervention|Protocol Violation|0|||
125119892|NCT00620763|450063240|FG001|Period: First Intervention|Protocol Violation|3|||
125212525|NCT01483599|450403421|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125212526|NCT01483599|450403422|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125119893|NCT00620763|450063239|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
125119894|NCT00620763|450063240|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
125212527|NCT01483599|450403423|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125212528|NCT01483599|450403424|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125119895|NCT04956666|450063244|FG000|Overall Study|Adverse Event|18|||
125119896|NCT04956666|450063244|FG000|Overall Study|Physician Decision|5|||
125119897|NCT02907203|450063245|FG000|Overall Study|Death|1|||
125119898|NCT02907203|450063245|FG000|Overall Study|Lost to Follow-up|3|||
125119899|NCT02907203|450063245|FG000|Overall Study|Withdrawal by Subject|3|||
125119900|NCT02907203|450063245|FG000|Overall Study|Surgical bypass|1|||
125119901|NCT00783796|450063249|FG000|Overall Study|Did not receive any stent|4|||
125119902|NCT00783796|450063249|FG000|Overall Study|Received non-XIENCE V stent|1|||
125119903|NCT00783796|450063249|FG000|Overall Study|Received commercial XIENCE V stent|1|||
125119904|NCT01816477|450063250|FG000|Overall Study|Withdrawal by Subject|13|||
125119905|NCT01816477|450063251|FG001|Overall Study|Withdrawal by Subject|1|||
125119906|NCT01816477|450063250|FG000|Overall Study|Unable to tolerate catheter placement|3|||
125119907|NCT01816477|450063251|FG001|Overall Study|Unable to tolerate catheter placement|0|||
125119908|NCT00819247|450063252|FG000|Overall Study|Adverse Event|0|||
125119909|NCT00819247|450063253|FG001|Overall Study|Adverse Event|5|||
125119910|NCT00819247|450063254|FG002|Overall Study|Adverse Event|3|||
125119911|NCT00819247|450063252|FG000|Overall Study|Insufficient testosterone response|5|||
125119912|NCT00819247|450063253|FG001|Overall Study|Insufficient testosterone response|8|||
125119913|NCT00819247|450063254|FG002|Overall Study|Insufficient testosterone response|10|||
125119914|NCT00819247|450063252|FG000|Overall Study|Withdrawal by Subject|1|||
125119915|NCT00819247|450063253|FG001|Overall Study|Withdrawal by Subject|0|||
125119916|NCT00819247|450063254|FG002|Overall Study|Withdrawal by Subject|0|||
125119917|NCT00819247|450063252|FG000|Overall Study|Protocol Violation|1|||
125119918|NCT00819247|450063253|FG001|Overall Study|Protocol Violation|0|||
125119919|NCT00819247|450063254|FG002|Overall Study|Protocol Violation|1|||
125119920|NCT00819247|450063252|FG000|Overall Study|Mistakenly withdrawn|0|||
125119921|NCT00819247|450063253|FG001|Overall Study|Mistakenly withdrawn|1|||
125119922|NCT00819247|450063254|FG002|Overall Study|Mistakenly withdrawn|0|||
125119923|NCT00819247|450063252|FG000|Overall Study|Bad prostate-specific antigen response|3|||
125119924|NCT00819247|450063253|FG001|Overall Study|Bad prostate-specific antigen response|2|||
125119925|NCT00819247|450063254|FG002|Overall Study|Bad prostate-specific antigen response|0|||
125119926|NCT00819247|450063252|FG000|Overall Study|Other|1|||
125119927|NCT00819247|450063253|FG001|Overall Study|Other|0|||
125119928|NCT00819247|450063254|FG002|Overall Study|Other|0|||
125119929|NCT01766921|450063255|FG000|Overall Study|Administrative Reason|5|||
125119930|NCT01766921|450063256|FG001|Overall Study|Administrative Reason|5|||
125119931|NCT01766921|450063255|FG000|Overall Study|Death|1|||
125119932|NCT01766921|450063256|FG001|Overall Study|Death|1|||
125119933|NCT01766921|450063255|FG000|Overall Study|Lost to Follow-up|1|||
125119934|NCT01766921|450063256|FG001|Overall Study|Lost to Follow-up|3|||
125119935|NCT01766921|450063255|FG000|Overall Study|Unclassified|2|||
125119936|NCT01766921|450063256|FG001|Overall Study|Unclassified|2|||
125119937|NCT01766921|450063255|FG000|Overall Study|Protocol Violation|1|||
125119938|NCT01766921|450063256|FG001|Overall Study|Protocol Violation|1|||
125119939|NCT01766921|450063255|FG000|Overall Study|Withdrawal by Subject|14|||
125119940|NCT01766921|450063256|FG001|Overall Study|Withdrawal by Subject|5|||
125119941|NCT00698685|450063259|FG000|Overall Study|Sister withdrew as donor|1|||
125119942|NCT00698685|450063259|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
125119943|NCT02540356|450063260|FG000|Overall Study|Terminated due to disease progression|1|||
125119944|NCT02540356|450063261|FG001|Overall Study|Terminated due to disease progression|0|||
125119945|NCT02978326|450063263|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
125119946|NCT02978326|450063264|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
125119947|NCT02978326|450063265|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
125119948|NCT02978326|450063263|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
125119949|NCT02978326|450063264|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
125119950|NCT02978326|450063265|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
125119951|NCT02978326|450063263|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
125119952|NCT02978326|450063264|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
125119953|NCT02978326|450063265|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
125119954|NCT02978326|450063263|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
125119955|NCT02978326|450063264|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
125119956|NCT02978326|450063265|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
125119957|NCT01411995|450063271|FG000|Overall Study|Failed IUD insertion|0|||
125119958|NCT01411995|450063272|FG001|Overall Study|Failed IUD insertion|1|||
125119959|NCT01937364|450063273|FG000|Overall Study|Adverse Event|2|||
125119960|NCT01937364|450063274|FG001|Overall Study|Adverse Event|1|||
125119961|NCT04104646|450063275|FG000|Overall Study|Withdrawal by Subject|1|||
125119962|NCT04104646|450063276|FG001|Overall Study|Withdrawal by Subject|1|||
125119963|NCT04104646|450063275|FG000|Overall Study|Lost to Follow-up|1|||
125119964|NCT04104646|450063276|FG001|Overall Study|Lost to Follow-up|0|||
125119965|NCT04104646|450063275|FG000|Overall Study|Physician Decision|2|||
125119966|NCT04104646|450063276|FG001|Overall Study|Physician Decision|0|||
125119967|NCT02974153|450063277|FG000|Overall Study|Adverse Event|6|||
125119968|NCT02974153|450063278|FG001|Overall Study|Adverse Event|0|||
125119969|NCT02974153|450063279|FG002|Overall Study|Adverse Event|1|||
125119970|NCT02974153|450063277|FG000|Overall Study|Lack of Efficacy|6|||
125119971|NCT02974153|450063278|FG001|Overall Study|Lack of Efficacy|5|||
125119972|NCT02974153|450063279|FG002|Overall Study|Lack of Efficacy|10|||
125119973|NCT02974153|450063277|FG000|Overall Study|Lost to Follow-up|9|||
125119974|NCT02974153|450063278|FG001|Overall Study|Lost to Follow-up|10|||
125119975|NCT02974153|450063279|FG002|Overall Study|Lost to Follow-up|17|||
125119976|NCT02974153|450063277|FG000|Overall Study|Physician Decision|0|||
125119977|NCT02974153|450063278|FG001|Overall Study|Physician Decision|2|||
125119978|NCT02974153|450063279|FG002|Overall Study|Physician Decision|1|||
125119979|NCT02974153|450063277|FG000|Overall Study|Withdrawal by Subject|9|||
125119980|NCT02974153|450063278|FG001|Overall Study|Withdrawal by Subject|16|||
125119981|NCT02974153|450063279|FG002|Overall Study|Withdrawal by Subject|11|||
125119982|NCT02974153|450063277|FG000|Overall Study|Study Burden|8|||
125119983|NCT02974153|450063278|FG001|Overall Study|Study Burden|7|||
125119984|NCT02974153|450063279|FG002|Overall Study|Study Burden|3|||
125119985|NCT02974153|450063277|FG000|Overall Study|Other|14|||
125119986|NCT02974153|450063278|FG001|Overall Study|Other|8|||
125119987|NCT02974153|450063279|FG002|Overall Study|Other|7|||
125119988|NCT02277769|450063280|FG000|Overall Study|Protocol Violation|3|||
125119989|NCT02277769|450063281|FG001|Overall Study|Protocol Violation|3|||
125119990|NCT02277769|450063282|FG002|Overall Study|Protocol Violation|5|||
125119991|NCT02277769|450063280|FG000|Overall Study|Lack of Efficacy|17|||
125119992|NCT02277769|450063281|FG001|Overall Study|Lack of Efficacy|0|||
125119993|NCT02277769|450063282|FG002|Overall Study|Lack of Efficacy|4|||
125119994|NCT02277769|450063280|FG000|Overall Study|Adverse Event|14|||
125119995|NCT02277769|450063281|FG001|Overall Study|Adverse Event|2|||
125119996|NCT02277769|450063282|FG002|Overall Study|Adverse Event|4|||
125119997|NCT02277769|450063280|FG000|Overall Study|Other than specified above|12|||
125119998|NCT02277769|450063281|FG001|Overall Study|Other than specified above|8|||
125119999|NCT02277769|450063282|FG002|Overall Study|Other than specified above|5|||
125120000|NCT03504852|450063283|FG000|Overall Study|Withdrawal of informed consent|2|||
125120001|NCT03504852|450063284|FG001|Overall Study|Withdrawal of informed consent|1|||
125120002|NCT03504852|450063285|FG002|Overall Study|Withdrawal of informed consent|0|||
125120003|NCT03504852|450063283|FG000|Overall Study|Withdrawal by Subject|5|||
125120004|NCT03504852|450063284|FG001|Overall Study|Withdrawal by Subject|5|||
125120005|NCT03504852|450063285|FG002|Overall Study|Withdrawal by Subject|1|||
125120006|NCT03504852|450063283|FG000|Overall Study|Lost to Follow-up|4|||
125120007|NCT03504852|450063284|FG001|Overall Study|Lost to Follow-up|1|||
125120008|NCT03504852|450063285|FG002|Overall Study|Lost to Follow-up|0|||
125120009|NCT03504852|450063283|FG000|Overall Study|New therapy for study indication|1|||
125120010|NCT03504852|450063284|FG001|Overall Study|New therapy for study indication|0|||
125120011|NCT03504852|450063285|FG002|Overall Study|New therapy for study indication|0|||
125120012|NCT03504852|450063283|FG000|Overall Study|Lack of Efficacy|1|||
125120013|NCT03504852|450063284|FG001|Overall Study|Lack of Efficacy|2|||
125120014|NCT03504852|450063285|FG002|Overall Study|Lack of Efficacy|0|||
125120015|NCT03504852|450063283|FG000|Overall Study|Death|0|||
125120016|NCT03504852|450063284|FG001|Overall Study|Death|1|||
125120017|NCT03504852|450063285|FG002|Overall Study|Death|0|||
125120018|NCT03504852|450063283|FG000|Overall Study|Adverse Event|4|||
125120019|NCT03504852|450063284|FG001|Overall Study|Adverse Event|8|||
125120020|NCT03504852|450063285|FG002|Overall Study|Adverse Event|2|||
125120021|NCT02928848|450063286|FG000|Arm 2|Withdrawal by Subject|1|||
125120022|NCT02928848|450063287|FG001|Arm 2|Withdrawal by Subject|0|||
125120023|NCT03850509|450063288|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
125120024|NCT03850509|450063289|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
125120025|NCT00969332|450063290|FG000|Overall Study|Physician Decision|8|||
125120026|NCT00969332|450063290|FG000|Overall Study|Withdrawal by Subject|3|||
125120027|NCT00582309|450063291|FG000|Overall Study|Protocol Violation|0|||
125120028|NCT00582309|450063292|FG001|Overall Study|Protocol Violation|0|||
125120029|NCT00582309|450063293|FG002|Overall Study|Protocol Violation|2|||
125120030|NCT01565083|450063294|FG000|Overall Study|Withdrawal by Subject|6|||
125120031|NCT01565083|450063295|FG001|Overall Study|Withdrawal by Subject|4|||
125120032|NCT01565083|450063294|FG000|Overall Study|Lost to Follow-up|2|||
125120033|NCT01565083|450063295|FG001|Overall Study|Lost to Follow-up|7|||
125120034|NCT01565083|450063294|FG000|Overall Study|Death|22|||
125120035|NCT01565083|450063295|FG001|Overall Study|Death|23|||
125120036|NCT01565083|450063294|FG000|Overall Study|Other|3|||
125120037|NCT01565083|450063295|FG001|Overall Study|Other|5|||
125120038|NCT01058421|450063296|FG000|1 Month Outcomes|Death|10|||
125120039|NCT01058421|450063297|FG001|1 Month Outcomes|Death|6|||
125120040|NCT01058421|450063296|FG000|1 Month Outcomes|Lost to Follow-up|8|||
125120041|NCT01058421|450063297|FG001|1 Month Outcomes|Lost to Follow-up|7|||
125120042|NCT01058421|450063296|FG000|1 Month Outcomes|Remained in Hospital|5|||
125120043|NCT01058421|450063297|FG001|1 Month Outcomes|Remained in Hospital|12|||
125120044|NCT01058421|450063296|FG000|1 Month Outcomes|Remained in Other Facility|16|||
125120045|NCT01058421|450063297|FG001|1 Month Outcomes|Remained in Other Facility|17|||
125120046|NCT01058421|450063296|FG000|3 Month Outcomes|Death|3|||
125120047|NCT01058421|450063297|FG001|3 Month Outcomes|Death|5|||
125120048|NCT01058421|450063296|FG000|3 Month Outcomes|Lost to Follow-up|12|||
125120049|NCT01058421|450063297|FG001|3 Month Outcomes|Lost to Follow-up|11|||
125120050|NCT01058421|450063296|FG000|3 Month Outcomes|Remained in Hospital|0|||
125120051|NCT01058421|450063297|FG001|3 Month Outcomes|Remained in Hospital|2|||
125120052|NCT01058421|450063296|FG000|3 Month Outcomes|Remained in Other Facility|5|||
125120053|NCT01058421|450063297|FG001|3 Month Outcomes|Remained in Other Facility|8|||
125120054|NCT01058421|450063296|FG000|6 Month Outcomes|Death|2|||
125120055|NCT01058421|450063297|FG001|6 Month Outcomes|Death|2|||
125120056|NCT01058421|450063296|FG000|6 Month Outcomes|Lost to Follow-up|16|||
125120057|NCT01058421|450063297|FG001|6 Month Outcomes|Lost to Follow-up|21|||
125120058|NCT01058421|450063296|FG000|6 Month Outcomes|Remained in Other Facility|1|||
125120059|NCT01058421|450063297|FG001|6 Month Outcomes|Remained in Other Facility|3|||
125120060|NCT00455533|450063300|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
125120061|NCT00455533|450063301|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
125120062|NCT00455533|450063302|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
125120063|NCT00455533|450063300|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
125120064|NCT00455533|450063301|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
125120065|NCT00455533|450063302|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
125120066|NCT00455533|450063300|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
125120067|NCT00455533|450063301|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
125120068|NCT00455533|450063302|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
125120069|NCT00455533|450063300|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
125120070|NCT00455533|450063301|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
125120071|NCT00455533|450063302|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
125024402|NCT01665144|449711462|FG001|Core Part|Physician Decision|1|||
125024403|NCT01665144|449711463|FG002|Core Part|Physician Decision|0|||
125024404|NCT01665144|449711461|FG000|Core Part|Progressive disease|8|||
125024405|NCT01665144|449711462|FG001|Core Part|Progressive disease|4|||
125024406|NCT01665144|449711463|FG002|Core Part|Progressive disease|0|||
125212529|NCT01483599|450403411|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
125212530|NCT01483599|450403412|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212531|NCT01483599|450403413|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212532|NCT01483599|450403414|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212533|NCT01483599|450403415|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212534|NCT01483599|450403416|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212535|NCT01483599|450403417|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212536|NCT01483599|450403418|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125024407|NCT01665144|449711461|FG000|Core Part|Non-compliance with study treatment|5|||
125212537|NCT01483599|450403419|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212538|NCT01483599|450403420|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212539|NCT01483599|450403421|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212540|NCT01483599|450403422|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212541|NCT01483599|450403423|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212542|NCT01483599|450403424|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212543|NCT01483599|450403411|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
125212544|NCT01483599|450403412|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
125212545|NCT01483599|450403413|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
125212546|NCT01483599|450403414|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
125212547|NCT01483599|450403415|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
125212548|NCT01483599|450403416|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
125212549|NCT01483599|450403417|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
125212550|NCT01483599|450403418|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
125212551|NCT01483599|450403419|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
125212552|NCT01483599|450403420|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
125212553|NCT01483599|450403421|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
125212554|NCT01483599|450403422|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
125212555|NCT01483599|450403423|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
125212556|NCT01483599|450403424|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
125212557|NCT01483599|450403411|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
125212558|NCT01483599|450403412|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
125212559|NCT01483599|450403413|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
125212560|NCT01483599|450403414|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
124928270|NCT04447755|449368335|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
124928271|NCT04447755|449368336|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
124928272|NCT04447755|449368330|FG000|Overall Study|Ongoing in Study|1|||
124928273|NCT04447755|449368331|FG001|Overall Study|Ongoing in Study|2|||
124928274|NCT04447755|449368332|FG002|Overall Study|Ongoing in Study|0|||
124928275|NCT04447755|449368333|FG003|Overall Study|Ongoing in Study|0|||
124928276|NCT04447755|449368334|FG004|Overall Study|Ongoing in Study|2|||
124928277|NCT04447755|449368335|FG005|Overall Study|Ongoing in Study|2|||
124928278|NCT04447755|449368336|FG006|Overall Study|Ongoing in Study|26|||
124928279|NCT03701763|449368340|FG000|Placebo-controlled Phase|Adverse Event|1|||
124928280|NCT03701763|449368341|FG001|Placebo-controlled Phase|Adverse Event|5|||
124928281|NCT03701763|449368342|FG002|Placebo-controlled Phase|Adverse Event|0|||
124928282|NCT03701763|449368343|FG003|Placebo-controlled Phase|Adverse Event|0|||
124928283|NCT03701763|449368340|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
124928284|NCT03701763|449368341|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
124928285|NCT03701763|449368342|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
124928286|NCT03701763|449368343|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
124928287|NCT03701763|449368340|FG000|Placebo-controlled Phase|Miscellaneous|2|||
124928288|NCT03701763|449368341|FG001|Placebo-controlled Phase|Miscellaneous|0|||
124928289|NCT03701763|449368342|FG002|Placebo-controlled Phase|Miscellaneous|0|||
124928290|NCT03701763|449368343|FG003|Placebo-controlled Phase|Miscellaneous|0|||
124928291|NCT03701763|449368340|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
124928292|NCT03701763|449368341|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
124928293|NCT03701763|449368342|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
124928294|NCT03701763|449368343|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
124928295|NCT03701763|449368340|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
125120072|NCT00455533|450063300|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
125120073|NCT00455533|450063301|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
125120074|NCT00455533|450063302|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
125120075|NCT00455533|450063300|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
125120076|NCT00455533|450063301|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
125120077|NCT00455533|450063302|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
125120078|NCT00455533|450063300|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
124928296|NCT03701763|449368341|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
124928297|NCT03701763|449368342|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
125120079|NCT00455533|450063301|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
125120080|NCT00455533|450063302|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
125120081|NCT00455533|450063300|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
125120082|NCT00455533|450063301|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
125120083|NCT00455533|450063302|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
125120084|NCT00455533|450063300|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
124928298|NCT03701763|449368343|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
124928299|NCT03701763|449368340|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
124928300|NCT03701763|449368341|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
124928301|NCT03701763|449368342|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
124928302|NCT03701763|449368343|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
124928303|NCT03701763|449368340|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
124928304|NCT03701763|449368341|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
124928305|NCT03701763|449368342|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
124928306|NCT03701763|449368343|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
124928307|NCT03701763|449368340|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
124928308|NCT03701763|449368341|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
124928309|NCT03701763|449368342|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
124928310|NCT03701763|449368343|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
124928311|NCT03701763|449368340|FG000|Apremilast Extension Phase|Adverse Event|0|||
124928312|NCT03701763|449368341|FG001|Apremilast Extension Phase|Adverse Event|0|||
124928313|NCT03701763|449368342|FG002|Apremilast Extension Phase|Adverse Event|3|||
124928314|NCT03701763|449368343|FG003|Apremilast Extension Phase|Adverse Event|1|||
124928315|NCT03701763|449368340|FG000|Apremilast Extension Phase|Miscellaneous|0|||
124928316|NCT03701763|449368341|FG001|Apremilast Extension Phase|Miscellaneous|0|||
124928317|NCT03701763|449368342|FG002|Apremilast Extension Phase|Miscellaneous|2|||
124928318|NCT03701763|449368343|FG003|Apremilast Extension Phase|Miscellaneous|1|||
124928319|NCT03701763|449368340|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
124928320|NCT03701763|449368341|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
124928321|NCT03701763|449368342|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
124928322|NCT03701763|449368343|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
124928323|NCT03701763|449368340|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
124928324|NCT03701763|449368341|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
124928325|NCT03701763|449368342|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
124928326|NCT03701763|449368343|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
124928327|NCT03701763|449368340|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
124928328|NCT03701763|449368341|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
124928329|NCT03701763|449368342|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
124928330|NCT03701763|449368343|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
124928331|NCT03701763|449368340|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
124928332|NCT03701763|449368341|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
124928333|NCT03701763|449368342|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
124928334|NCT03701763|449368343|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
124928335|NCT03701763|449368340|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
124928336|NCT03701763|449368341|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
124928337|NCT03701763|449368342|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
124928338|NCT03701763|449368343|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
124928339|NCT03701763|449368340|FG000|14-Week Observational Follow-up Phase|Other|0|||
124928340|NCT03701763|449368341|FG001|14-Week Observational Follow-up Phase|Other|0|||
124928341|NCT03701763|449368342|FG002|14-Week Observational Follow-up Phase|Other|1|||
124928342|NCT03701763|449368343|FG003|14-Week Observational Follow-up Phase|Other|0|||
124928343|NCT03701763|449368340|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
124928344|NCT03701763|449368341|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
124928345|NCT03701763|449368342|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
124928346|NCT03701763|449368343|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
124928347|NCT03701763|449368340|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
124928348|NCT03701763|449368341|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
125024408|NCT01665144|449711462|FG001|Core Part|Non-compliance with study treatment|0|||
125024409|NCT01665144|449711463|FG002|Core Part|Non-compliance with study treatment|0|||
125024410|NCT01665144|449711461|FG000|Core Part|Death|3|||
124928349|NCT03701763|449368342|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
124928350|NCT03701763|449368343|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
124928351|NCT00592852|449368345|FG000|Overall Study|Non-compliance|1|||
124928352|NCT00592852|449368345|FG000|Overall Study|Adverse Event|3|||
124928353|NCT00592852|449368345|FG000|Overall Study|Found ineligible|1|||
124928354|NCT00592852|449368345|FG000|Overall Study|Withdrawal by Subject|1|||
124928355|NCT02589795|449368349|FG000|Overall Study|Lost to Follow-up|1|||
124928356|NCT02589795|449368350|FG001|Overall Study|Lost to Follow-up|0|||
124928357|NCT02589795|449368351|FG002|Overall Study|Lost to Follow-up|0|||
124928358|NCT02589795|449368349|FG000|Overall Study|Withdrawal by Subject|0|||
124928359|NCT02589795|449368350|FG001|Overall Study|Withdrawal by Subject|0|||
124928360|NCT02589795|449368351|FG002|Overall Study|Withdrawal by Subject|2|||
124928361|NCT02589795|449368349|FG000|Overall Study|Protocol Violation|0|||
124928362|NCT02589795|449368350|FG001|Overall Study|Protocol Violation|0|||
124928363|NCT02589795|449368351|FG002|Overall Study|Protocol Violation|1|||
124928364|NCT03599661|449368353|FG000|Overall Study|Lost to Follow-up|9|||
124928365|NCT04909801|449368354|FG000|Overall Study|Lack of Efficacy|2|||
124928366|NCT04909801|449368355|FG001|Overall Study|Lack of Efficacy|1|||
124928367|NCT04909801|449368354|FG000|Overall Study|Adverse Event|1|||
124928368|NCT04909801|449368355|FG001|Overall Study|Adverse Event|2|||
124928369|NCT04909801|449368354|FG000|Overall Study|Participant request to discontinue study treatment|1|||
124928370|NCT04909801|449368355|FG001|Overall Study|Participant request to discontinue study treatment|2|||
124928371|NCT04909801|449368354|FG000|Overall Study|Withdrawal by Subject|2|||
124928372|NCT04909801|449368355|FG001|Overall Study|Withdrawal by Subject|1|||
124928373|NCT04909801|449368354|FG000|Overall Study|other reasons|1|||
124928374|NCT04909801|449368355|FG001|Overall Study|other reasons|1|||
124928375|NCT04117347|449368358|FG000|Overall Study|Adverse Event|0|||
124928376|NCT04117347|449368359|FG001|Overall Study|Adverse Event|0|||
124928377|NCT04117347|449368360|FG002|Overall Study|Adverse Event|1|||
124928378|NCT04117347|449368358|FG000|Overall Study|No time for study|0|||
124928379|NCT04117347|449368359|FG001|Overall Study|No time for study|2|||
124928380|NCT04117347|449368360|FG002|Overall Study|No time for study|0|||
124928381|NCT04117347|449368358|FG000|Overall Study|Family emergency|1|||
124928382|NCT04117347|449368359|FG001|Overall Study|Family emergency|0|||
124928383|NCT04117347|449368360|FG002|Overall Study|Family emergency|0|||
124928384|NCT03687086|449368361|FG000|Overall Study|Withdrawal by Subject|3|||
124928385|NCT03687086|449368362|FG001|Overall Study|Withdrawal by Subject|4|||
124928386|NCT03687086|449368361|FG000|Overall Study|Lost to Follow-up|1|||
124928387|NCT03687086|449368362|FG001|Overall Study|Lost to Follow-up|1|||
124928388|NCT03687086|449368361|FG000|Overall Study|Death|1|||
124928389|NCT03687086|449368362|FG001|Overall Study|Death|0|||
124928390|NCT03687086|449368361|FG000|Overall Study|Incomplete assessment|0|||
124928391|NCT03687086|449368362|FG001|Overall Study|Incomplete assessment|2|||
124928392|NCT02505984|449368363|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
124928393|NCT02505984|449368364|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
124928394|NCT02505984|449368363|FG000|Overall Study|Unreliable self-report data|1|||
124928395|NCT02505984|449368364|FG001|Overall Study|Unreliable self-report data|0|||
124928396|NCT02505984|449368363|FG000|Overall Study|Study blind opened during assessment|0|||
124928397|NCT02505984|449368364|FG001|Overall Study|Study blind opened during assessment|1|||
124928398|NCT02505984|449368363|FG000|Overall Study|Noncompliance with study protocol|0|||
124928399|NCT02505984|449368364|FG001|Overall Study|Noncompliance with study protocol|1|||
124928400|NCT05194956|449368365|FG000|Washout Period|Withdrawal by Subject|0|||
124928401|NCT05194956|449368366|FG001|Washout Period|Withdrawal by Subject|2|||
124928402|NCT05192109|449368385|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
124928403|NCT05192109|449368386|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
125120085|NCT00455533|450063301|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
125120086|NCT00455533|450063302|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
125120087|NCT00455533|450063300|FG000|Period Two: Randomized Period|Death|0|||
125120088|NCT00455533|450063301|FG001|Period Two: Randomized Period|Death|0|||
125120089|NCT00455533|450063302|FG002|Period Two: Randomized Period|Death|3|||
125120090|NCT00455533|450063300|FG000|Period Two: Randomized Period|Disease Progression|0|||
124928404|NCT05192109|449368387|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
124928405|NCT05192109|449368388|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
124928406|NCT05192109|449368385|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
124928407|NCT05192109|449368386|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
124928408|NCT05192109|449368387|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
124928409|NCT05192109|449368388|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
124928410|NCT04498390|449368389|FG000|Overall Study|Adverse Event|0|||
124928411|NCT04498390|449368390|FG001|Overall Study|Adverse Event|0|||
124928412|NCT04498390|449368391|FG002|Overall Study|Adverse Event|1|||
124928413|NCT04498390|449368392|FG003|Overall Study|Adverse Event|0|||
124928414|NCT04498390|449368393|FG004|Overall Study|Adverse Event|0|||
124928415|NCT04498390|449368389|FG000|Overall Study|Withdrawal by Subject|0|||
124928416|NCT04498390|449368390|FG001|Overall Study|Withdrawal by Subject|0|||
124928417|NCT04498390|449368391|FG002|Overall Study|Withdrawal by Subject|0|||
124928418|NCT04498390|449368392|FG003|Overall Study|Withdrawal by Subject|1|||
124928419|NCT04498390|449368393|FG004|Overall Study|Withdrawal by Subject|0|||
124928420|NCT04971109|449368396|FG000|Overall Study|Adverse Event|4|||
124928421|NCT04971109|449368397|FG001|Overall Study|Adverse Event|3|||
124928422|NCT04971109|449368396|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
124928423|NCT04971109|449368397|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
124928424|NCT04971109|449368396|FG000|Overall Study|Lost to Follow-up|8|||
124928425|NCT04971109|449368397|FG001|Overall Study|Lost to Follow-up|2|||
124928426|NCT04971109|449368396|FG000|Overall Study|Physician Decision|5|||
124928427|NCT04971109|449368397|FG001|Overall Study|Physician Decision|0|||
124928428|NCT04971109|449368396|FG000|Overall Study|Protocol Violation|0|||
124928429|NCT04971109|449368397|FG001|Overall Study|Protocol Violation|1|||
124928430|NCT04971109|449368396|FG000|Overall Study|Withdrawal by Subject|18|||
124928431|NCT04971109|449368397|FG001|Overall Study|Withdrawal by Subject|3|||
124928432|NCT04971109|449368396|FG000|Overall Study|Subject was randomized in error|1|||
124928433|NCT04971109|449368397|FG001|Overall Study|Subject was randomized in error|0|||
124928434|NCT02709161|449368400|FG000|Overall Study|Withdrawal by Subject|1|||
124928435|NCT02709161|449368401|FG001|Overall Study|Withdrawal by Subject|0|||
124928436|NCT04231149|449370125|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
124928437|NCT04231149|449370126|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
124928438|NCT04231149|449370127|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
124928439|NCT04231149|449370128|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
124928440|NCT04231149|449370129|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
124928441|NCT04979442|449370131|FG000|Overall Study|Death|43|||
124928442|NCT04979442|449370132|FG001|Overall Study|Death|30|||
124928443|NCT04979442|449370131|FG000|Overall Study|Withdrawal by Subject|8|||
124928444|NCT04979442|449370132|FG001|Overall Study|Withdrawal by Subject|13|||
124928445|NCT04979442|449370131|FG000|Overall Study|Physician Decision|1|||
124928446|NCT04979442|449370132|FG001|Overall Study|Physician Decision|1|||
124928447|NCT04979442|449370131|FG000|Overall Study|Lost to Follow-up|0|||
124928448|NCT04979442|449370132|FG001|Overall Study|Lost to Follow-up|2|||
124928449|NCT04979442|449370131|FG000|Overall Study|do not want to continue|0|||
124928450|NCT04979442|449370132|FG001|Overall Study|do not want to continue|1|||
124928451|NCT04298983|449370135|FG000|Overall Study|Adverse Event|4|||
124928452|NCT04298983|449370135|FG000|Overall Study|Lack of Efficacy|3|||
124928453|NCT02116530|449370137|FG000|Overall Study|Withdrawal by Subject|1|||
124928454|NCT02116530|449370138|FG001|Overall Study|Withdrawal by Subject|2|||
124928455|NCT02116530|449370137|FG000|Overall Study|Adverse Event|4|||
124928456|NCT02116530|449370138|FG001|Overall Study|Adverse Event|0|||
124928457|NCT02116530|449370137|FG000|Overall Study|Physician Decision|1|||
124928458|NCT02116530|449370138|FG001|Overall Study|Physician Decision|0|||
124928459|NCT02116530|449370137|FG000|Overall Study|Lost to Follow-up|1|||
124928460|NCT02116530|449370138|FG001|Overall Study|Lost to Follow-up|0|||
124928461|NCT02116530|449370137|FG000|Overall Study|Other Medical Problems|2|||
124928462|NCT02116530|449370138|FG001|Overall Study|Other Medical Problems|2|||
124928463|NCT05029622|449370141|FG000|Overall Study|Lost to Follow-up|1|||
124928464|NCT05671653|449370142|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
124928465|NCT05671653|449370143|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
124928466|NCT05671653|449370144|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
124928467|NCT05671653|449370145|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
124928468|NCT05671653|449370146|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
124928469|NCT05671653|449370147|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
124928470|NCT05671653|449370148|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
124928471|NCT05671653|449370149|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
124928472|NCT05671653|449370150|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
124928473|NCT05671653|449370151|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
124928474|NCT05671653|449370152|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
124928475|NCT05671653|449370153|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
124928476|NCT05671653|449370154|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
124928477|NCT05671653|449370142|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928478|NCT05671653|449370143|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928479|NCT05671653|449370144|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928480|NCT05671653|449370145|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928481|NCT05671653|449370146|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928482|NCT05671653|449370147|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
124928483|NCT05671653|449370148|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928484|NCT05671653|449370149|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928485|NCT05671653|449370150|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928486|NCT05671653|449370151|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928487|NCT05671653|449370152|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928488|NCT05671653|449370153|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928489|NCT05671653|449370154|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928490|NCT05671653|449370142|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928491|NCT05671653|449370143|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928492|NCT05671653|449370144|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928493|NCT05671653|449370145|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928494|NCT05671653|449370146|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928495|NCT05671653|449370147|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
124928496|NCT05671653|449370148|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928497|NCT05671653|449370149|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928498|NCT05671653|449370150|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928499|NCT05671653|449370151|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928500|NCT05671653|449370152|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928501|NCT05671653|449370153|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928502|NCT05671653|449370154|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928503|NCT05671653|449370142|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928504|NCT05671653|449370143|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928505|NCT05671653|449370144|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928506|NCT05671653|449370145|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928507|NCT05671653|449370146|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928508|NCT05671653|449370147|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928509|NCT05671653|449370148|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928510|NCT05671653|449370149|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928511|NCT05671653|449370150|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
124928512|NCT05671653|449370151|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928513|NCT05671653|449370152|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928514|NCT05671653|449370153|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928515|NCT05671653|449370154|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928516|NCT05671653|449370142|FG000|Cohort 2 Period 2|Adverse Event|0|||
125024411|NCT01665144|449711462|FG001|Core Part|Death|1|||
125024412|NCT01665144|449711463|FG002|Core Part|Death|0|||
125024413|NCT01665144|449711461|FG000|Core Part|Protocol deviation|3|||
125024414|NCT01665144|449711462|FG001|Core Part|Protocol deviation|1|||
125024415|NCT01665144|449711463|FG002|Core Part|Protocol deviation|0|||
125024416|NCT01665144|449711461|FG000|Core Part|New therapy for study indication|2|||
125024417|NCT01665144|449711462|FG001|Core Part|New therapy for study indication|1|||
125024418|NCT01665144|449711463|FG002|Core Part|New therapy for study indication|0|||
124928517|NCT05671653|449370143|FG001|Cohort 2 Period 2|Adverse Event|0|||
124928518|NCT05671653|449370144|FG002|Cohort 2 Period 2|Adverse Event|0|||
124928519|NCT05671653|449370145|FG003|Cohort 2 Period 2|Adverse Event|0|||
124928520|NCT05671653|449370146|FG004|Cohort 2 Period 2|Adverse Event|0|||
124928521|NCT05671653|449370147|FG005|Cohort 2 Period 2|Adverse Event|0|||
124928522|NCT05671653|449370148|FG006|Cohort 2 Period 2|Adverse Event|0|||
124928523|NCT05671653|449370149|FG007|Cohort 2 Period 2|Adverse Event|0|||
124928524|NCT05671653|449370150|FG008|Cohort 2 Period 2|Adverse Event|0|||
124928525|NCT05671653|449370151|FG009|Cohort 2 Period 2|Adverse Event|0|||
124928526|NCT05671653|449370152|FG010|Cohort 2 Period 2|Adverse Event|1|||
124928527|NCT05671653|449370153|FG011|Cohort 2 Period 2|Adverse Event|0|||
124928528|NCT05671653|449370154|FG012|Cohort 2 Period 2|Adverse Event|0|||
124928529|NCT05671653|449370142|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
124928530|NCT05671653|449370143|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
124928531|NCT05671653|449370144|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
124928532|NCT05671653|449370145|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
124928533|NCT05671653|449370146|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
124928534|NCT05671653|449370147|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
124928535|NCT05671653|449370148|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
124928536|NCT05671653|449370149|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
124928537|NCT05671653|449370150|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
124928538|NCT05671653|449370151|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
124928539|NCT05671653|449370152|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
124928540|NCT05671653|449370153|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
124928541|NCT05671653|449370154|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
124928542|NCT05671653|449370142|FG000|Cohort 2 Period 2|Pregnancy|0|||
125212561|NCT01483599|450403415|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
125212562|NCT01483599|450403416|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
125212563|NCT01483599|450403417|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
125212564|NCT01483599|450403418|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
125212565|NCT01483599|450403419|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
125212566|NCT01483599|450403420|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
125212567|NCT01483599|450403421|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
125212568|NCT01483599|450403422|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
125212569|NCT01483599|450403423|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
125212570|NCT01483599|450403424|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
125212571|NCT01483599|450403411|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
125212572|NCT01483599|450403412|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
125212573|NCT01483599|450403413|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
125212574|NCT01483599|450403414|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
125212575|NCT01483599|450403415|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
125212576|NCT01483599|450403416|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
125212577|NCT01483599|450403417|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
125212578|NCT01483599|450403418|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
125212579|NCT01483599|450403419|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
125212580|NCT01483599|450403420|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
125212581|NCT01483599|450403421|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
125212582|NCT01483599|450403422|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
125212583|NCT01483599|450403423|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
124928543|NCT05671653|449370143|FG001|Cohort 2 Period 2|Pregnancy|0|||
124928544|NCT05671653|449370144|FG002|Cohort 2 Period 2|Pregnancy|0|||
124928545|NCT05671653|449370145|FG003|Cohort 2 Period 2|Pregnancy|0|||
124928546|NCT05671653|449370146|FG004|Cohort 2 Period 2|Pregnancy|0|||
124928547|NCT05671653|449370147|FG005|Cohort 2 Period 2|Pregnancy|0|||
124928548|NCT05671653|449370148|FG006|Cohort 2 Period 2|Pregnancy|0|||
124928549|NCT05671653|449370149|FG007|Cohort 2 Period 2|Pregnancy|0|||
124928550|NCT05671653|449370150|FG008|Cohort 2 Period 2|Pregnancy|0|||
124928551|NCT05671653|449370151|FG009|Cohort 2 Period 2|Pregnancy|0|||
124928552|NCT05671653|449370152|FG010|Cohort 2 Period 2|Pregnancy|1|||
124928553|NCT05671653|449370153|FG011|Cohort 2 Period 2|Pregnancy|0|||
124928554|NCT05671653|449370154|FG012|Cohort 2 Period 2|Pregnancy|0|||
124928555|NCT05671653|449370142|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928556|NCT05671653|449370143|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928557|NCT05671653|449370144|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928558|NCT05671653|449370145|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928559|NCT05671653|449370146|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928560|NCT05671653|449370147|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928561|NCT05671653|449370148|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928562|NCT05671653|449370149|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928563|NCT05671653|449370150|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928564|NCT05671653|449370151|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928565|NCT05671653|449370152|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
124928566|NCT05671653|449370153|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928567|NCT05671653|449370154|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928568|NCT05671653|449370142|FG000|Cohort 2 Period 2|Other|0|||
124928569|NCT05671653|449370143|FG001|Cohort 2 Period 2|Other|0|||
124928570|NCT05671653|449370144|FG002|Cohort 2 Period 2|Other|0|||
124928571|NCT05671653|449370145|FG003|Cohort 2 Period 2|Other|0|||
124928572|NCT05671653|449370146|FG004|Cohort 2 Period 2|Other|0|||
124928573|NCT05671653|449370147|FG005|Cohort 2 Period 2|Other|0|||
125212584|NCT01483599|450403424|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
125212585|NCT01483599|450403411|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212586|NCT01483599|450403412|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212587|NCT01483599|450403413|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212588|NCT01483599|450403414|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212589|NCT01483599|450403415|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212590|NCT01483599|450403416|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212591|NCT01483599|450403417|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212592|NCT01483599|450403418|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212593|NCT01483599|450403419|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
125212594|NCT01483599|450403420|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212595|NCT01483599|450403421|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212596|NCT01483599|450403422|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
125212597|NCT01483599|450403423|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212598|NCT01483599|450403424|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
125212599|NCT01483599|450403411|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212600|NCT01483599|450403412|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212601|NCT01483599|450403413|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212602|NCT01483599|450403414|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212603|NCT01483599|450403415|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212604|NCT01483599|450403416|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212605|NCT01483599|450403417|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212606|NCT01483599|450403418|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212607|NCT01483599|450403419|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
125212608|NCT01483599|450403420|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212609|NCT01483599|450403421|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
125212610|NCT01483599|450403422|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212611|NCT01483599|450403423|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212612|NCT01483599|450403424|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
125212613|NCT01483599|450403411|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
125212614|NCT01483599|450403412|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
125212615|NCT01483599|450403413|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
125212616|NCT01483599|450403414|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
124928574|NCT05671653|449370148|FG006|Cohort 2 Period 2|Other|0|||
124928575|NCT05671653|449370149|FG007|Cohort 2 Period 2|Other|0|||
124928576|NCT05671653|449370150|FG008|Cohort 2 Period 2|Other|0|||
124928577|NCT05671653|449370151|FG009|Cohort 2 Period 2|Other|0|||
124928578|NCT05671653|449370152|FG010|Cohort 2 Period 2|Other|1|||
124928579|NCT05671653|449370153|FG011|Cohort 2 Period 2|Other|0|||
124928580|NCT05671653|449370154|FG012|Cohort 2 Period 2|Other|0|||
124928581|NCT05671653|449370142|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928582|NCT05671653|449370143|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928583|NCT05671653|449370144|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928584|NCT05671653|449370145|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928585|NCT05671653|449370146|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928586|NCT05671653|449370147|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928587|NCT05671653|449370148|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928588|NCT05671653|449370149|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928589|NCT05671653|449370150|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928590|NCT05671653|449370151|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928591|NCT05671653|449370152|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928592|NCT05671653|449370153|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
124928593|NCT05671653|449370154|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928594|NCT03974178|449370155|FG000|Overall Study|Death|0|||
124928595|NCT03974178|449370156|FG001|Overall Study|Death|1|||
124928596|NCT05526430|449370157|FG000|Overall Study|Withdrawal by Subject|0|||
124928597|NCT05526430|449370158|FG001|Overall Study|Withdrawal by Subject|2|||
125024419|NCT01665144|449711461|FG000|Core Part|Technical problems|2|||
124928598|NCT05526430|449370159|FG002|Overall Study|Withdrawal by Subject|0|||
124928599|NCT05526430|449370160|FG003|Overall Study|Withdrawal by Subject|0|||
125212617|NCT01483599|450403415|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
125212618|NCT01483599|450403416|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
125212619|NCT01483599|450403417|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
125212620|NCT01483599|450403418|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
125212621|NCT01483599|450403419|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
125212622|NCT01483599|450403420|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
125212623|NCT01483599|450403421|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
125212624|NCT01483599|450403422|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
125212625|NCT01483599|450403423|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
125212626|NCT01483599|450403424|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
125212627|NCT01483599|450403411|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
125212628|NCT01483599|450403412|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
125212629|NCT01483599|450403413|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
125212630|NCT01483599|450403414|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
125212631|NCT01483599|450403415|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
125212632|NCT01483599|450403416|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
125212633|NCT01483599|450403417|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
125212634|NCT01483599|450403418|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
125212635|NCT01483599|450403419|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
125212636|NCT01483599|450403420|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
125212637|NCT01483599|450403421|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
125212638|NCT01483599|450403422|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
125212639|NCT01483599|450403423|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
125212640|NCT01483599|450403424|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
125212641|NCT02510820|450405413|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
125212642|NCT02510820|450405414|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
125212643|NCT02510820|450405413|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
125212644|NCT02510820|450405414|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
125212645|NCT03046056|450405415|FG000|Overall Study|Non-responder at Week 10|6|||
125212646|NCT03046056|450405416|FG001|Overall Study|Non-responder at Week 10|6|||
125212647|NCT03046056|450405417|FG002|Overall Study|Non-responder at Week 10|4|||
125212648|NCT03046056|450405415|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
125212649|NCT03046056|450405416|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
125212650|NCT03046056|450405417|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
125212651|NCT03046056|450405415|FG000|Overall Study|Adverse Event|1|||
125212652|NCT03046056|450405416|FG001|Overall Study|Adverse Event|5|||
125212653|NCT03046056|450405417|FG002|Overall Study|Adverse Event|0|||
125212654|NCT03046056|450405415|FG000|Overall Study|Non-compliance With Study Drug|0|||
125212655|NCT03046056|450405416|FG001|Overall Study|Non-compliance With Study Drug|0|||
125212656|NCT03046056|450405417|FG002|Overall Study|Non-compliance With Study Drug|2|||
125212657|NCT03046056|450405415|FG000|Overall Study|Protocol Violation|1|||
125212658|NCT03046056|450405416|FG001|Overall Study|Protocol Violation|1|||
125212659|NCT03046056|450405417|FG002|Overall Study|Protocol Violation|0|||
125212660|NCT03046056|450405415|FG000|Overall Study|Investigator's Discretion|0|||
125212661|NCT03046056|450405416|FG001|Overall Study|Investigator's Discretion|1|||
125212662|NCT03046056|450405417|FG002|Overall Study|Investigator's Discretion|0|||
125212663|NCT03046056|450405415|FG000|Overall Study|Withdrew Consent|1|||
125212664|NCT03046056|450405416|FG001|Overall Study|Withdrew Consent|0|||
125212665|NCT03046056|450405417|FG002|Overall Study|Withdrew Consent|0|||
125212666|NCT02913105|450405418|FG000|Overall Study|Adverse Event|11|||
124928600|NCT04508309|449370161|FG000|Overall Study|Death|0|||
124928601|NCT04508309|449370162|FG001|Overall Study|Death|0|||
124928602|NCT04508309|449370163|FG002|Overall Study|Death|0|||
124928603|NCT04508309|449370164|FG003|Overall Study|Death|0|||
124928604|NCT04508309|449370165|FG004|Overall Study|Death|1|||
124928605|NCT04508309|449370161|FG000|Overall Study|Lost to Follow-up|0|||
124928606|NCT04508309|449370162|FG001|Overall Study|Lost to Follow-up|0|||
124928607|NCT04508309|449370163|FG002|Overall Study|Lost to Follow-up|1|||
124928608|NCT04508309|449370164|FG003|Overall Study|Lost to Follow-up|1|||
125212667|NCT02913105|450405419|FG001|Overall Study|Adverse Event|0|||
125212668|NCT02913105|450405420|FG002|Overall Study|Adverse Event|4|||
125024420|NCT01665144|449711462|FG001|Core Part|Technical problems|0|||
125024421|NCT01665144|449711463|FG002|Core Part|Technical problems|0|||
125024422|NCT01665144|449711461|FG000|Extension Part|Patient/guardian decision|180|||
124928609|NCT04508309|449370165|FG004|Overall Study|Lost to Follow-up|0|||
124928610|NCT04508309|449370161|FG000|Overall Study|Withdrawal by Subject|0|||
124928611|NCT04508309|449370162|FG001|Overall Study|Withdrawal by Subject|0|||
124928612|NCT04508309|449370163|FG002|Overall Study|Withdrawal by Subject|0|||
124928613|NCT04508309|449370164|FG003|Overall Study|Withdrawal by Subject|0|||
124928614|NCT04508309|449370165|FG004|Overall Study|Withdrawal by Subject|1|||
124928615|NCT02305888|449370166|FG000|Overall Study|Lost to Follow-up|0|||
124928616|NCT02305888|449370167|FG001|Overall Study|Lost to Follow-up|0|||
124928617|NCT02305888|449370168|FG002|Overall Study|Lost to Follow-up|1|||
124928618|NCT02305888|449370166|FG000|Overall Study|Adverse Event|0|||
124928619|NCT02305888|449370167|FG001|Overall Study|Adverse Event|1|||
124928620|NCT02305888|449370168|FG002|Overall Study|Adverse Event|0|||
124928621|NCT04914676|449370169|FG000|Overall Study|Study termination|3|||
124928622|NCT04914676|449370170|FG001|Overall Study|Study termination|0|||
124928623|NCT05200403|449370171|FG000|Overall Study|Withdrawal by Subject|4|||
124928624|NCT05200403|449370172|FG001|Overall Study|Withdrawal by Subject|2|||
124928625|NCT05200403|449370173|FG002|Overall Study|Withdrawal by Subject|6|||
124928626|NCT03913442|449370174|FG000|Overall Study|Adverse Event|0|||
124928627|NCT03913442|449370175|FG001|Overall Study|Adverse Event|3|||
124928628|NCT03913442|449370174|FG000|Overall Study|Withdrawal by Subject|5|||
124928629|NCT03913442|449370175|FG001|Overall Study|Withdrawal by Subject|5|||
124928630|NCT03913442|449370174|FG000|Overall Study|Terminations|2|||
124928631|NCT03913442|449370175|FG001|Overall Study|Terminations|1|||
124928632|NCT03913442|449370174|FG000|Overall Study|Lost to Follow-up|2|||
124928633|NCT03913442|449370175|FG001|Overall Study|Lost to Follow-up|2|||
124928634|NCT02460458|449370176|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
124928635|NCT02460458|449370176|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
124928636|NCT02460458|449370176|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
124928637|NCT02460458|449370176|FG000|First Prospective Phase|Lost to Follow-up|84|||
124928638|NCT02460458|449370176|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
124928639|NCT05436262|449370177|FG000|Pre-Randomization|Withdrawal by Subject|1|||
124928640|NCT05436262|449370178|FG001|Pre-Randomization|Withdrawal by Subject|0|||
124928641|NCT05436262|449370179|FG002|Pre-Randomization|Withdrawal by Subject|0|||
124928642|NCT05436262|449370177|FG000|Randomization|Withdrawal by Subject|0|||
124928643|NCT05436262|449370178|FG001|Randomization|Withdrawal by Subject|1|||
124928644|NCT05436262|449370179|FG002|Randomization|Withdrawal by Subject|0|||
124928645|NCT05299073|449370180|FG000|Overall Study|Withdrawal by Subject|0|||
124928646|NCT05299073|449370181|FG001|Overall Study|Withdrawal by Subject|0|||
124928647|NCT05299073|449370182|FG002|Overall Study|Withdrawal by Subject|1|||
124928648|NCT05299073|449370180|FG000|Overall Study|Adverse Event|0|||
124928649|NCT05299073|449370181|FG001|Overall Study|Adverse Event|1|||
124928650|NCT05299073|449370182|FG002|Overall Study|Adverse Event|0|||
124928651|NCT05299073|449370180|FG000|Overall Study|Lost to Follow-up|0|||
124928652|NCT05299073|449370181|FG001|Overall Study|Lost to Follow-up|1|||
125120091|NCT00455533|450063301|FG001|Period Two: Randomized Period|Disease Progression|1|||
125120092|NCT00455533|450063302|FG002|Period Two: Randomized Period|Disease Progression|1|||
125120093|NCT00455533|450063300|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
125120094|NCT00455533|450063301|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
125120095|NCT00455533|450063302|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
125120096|NCT00455533|450063300|FG000|Period Two: Randomized Period|Other - need reasons|0|||
125120097|NCT00455533|450063301|FG001|Period Two: Randomized Period|Other - need reasons|1|||
125120098|NCT00455533|450063302|FG002|Period Two: Randomized Period|Other - need reasons|0|||
125120099|NCT00455533|450063300|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
125120100|NCT00455533|450063301|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
125120101|NCT00455533|450063302|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
125120102|NCT00455533|450063300|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
125120103|NCT00455533|450063301|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
125120104|NCT00455533|450063302|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
125120105|NCT02576990|450063307|FG000|Overall Study|Death|29|||
125120106|NCT02576990|450063308|FG001|Overall Study|Death|18|||
125120107|NCT02576990|450063307|FG000|Overall Study|Physician Decision|1|||
125212669|NCT02913105|450405418|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125212670|NCT02913105|450405419|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124928653|NCT05299073|449370182|FG002|Overall Study|Lost to Follow-up|0|||
124928654|NCT03952338|449370183|FG000|Overall Study|Lost to Follow-up|11|||
124928655|NCT03952338|449370184|FG001|Overall Study|Lost to Follow-up|17|||
124928656|NCT03952338|449370183|FG000|Overall Study|Withdrawal by Subject|1|||
124928657|NCT03952338|449370184|FG001|Overall Study|Withdrawal by Subject|1|||
124928658|NCT03952338|449370183|FG000|Overall Study|Protocol Violation|1|||
124928659|NCT03952338|449370184|FG001|Overall Study|Protocol Violation|0|||
124928660|NCT04850898|449370185|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
124928661|NCT04850898|449370186|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
124928662|NCT05002088|449370187|FG000|Overall Study|Withdrawal by Subject|9|||
124928663|NCT05002088|449370188|FG001|Overall Study|Withdrawal by Subject|0|||
124928664|NCT05002088|449370187|FG000|Overall Study|Lost to Follow-up|0|||
124928665|NCT05002088|449370188|FG001|Overall Study|Lost to Follow-up|1|||
124928666|NCT05002088|449370187|FG000|Overall Study|Death|16|||
124928667|NCT05002088|449370188|FG001|Overall Study|Death|2|||
124928668|NCT05002088|449370187|FG000|Overall Study|Protocol Violation|25|||
124928669|NCT05002088|449370188|FG001|Overall Study|Protocol Violation|7|||
124928670|NCT04068181|449370189|FG000|Overall Study|Death|17|||
124928671|NCT04068181|449370190|FG001|Overall Study|Death|12|||
124928672|NCT04068181|449370191|FG002|Overall Study|Death|4|||
124928673|NCT04068181|449370192|FG003|Overall Study|Death|7|||
124928674|NCT04068181|449370189|FG000|Overall Study|Lost to Follow-up|1|||
124928675|NCT04068181|449370190|FG001|Overall Study|Lost to Follow-up|0|||
124928676|NCT04068181|449370191|FG002|Overall Study|Lost to Follow-up|0|||
124928677|NCT04068181|449370192|FG003|Overall Study|Lost to Follow-up|0|||
124928678|NCT04068181|449370189|FG000|Overall Study|Withdrawal of consent from study|3|||
124928679|NCT04068181|449370190|FG001|Overall Study|Withdrawal of consent from study|0|||
124928680|NCT04068181|449370191|FG002|Overall Study|Withdrawal of consent from study|0|||
124928681|NCT04068181|449370192|FG003|Overall Study|Withdrawal of consent from study|0|||
124928682|NCT05070728|449370193|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
124928683|NCT05070728|449370194|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
124928684|NCT04770402|449370201|FG000|Overall Study|Lost to Follow-up|1|||
124928685|NCT04770402|449370202|FG001|Overall Study|Lost to Follow-up|2|||
124928686|NCT04770402|449370201|FG000|Overall Study|Non-compliance|1|||
124928687|NCT04770402|449370202|FG001|Overall Study|Non-compliance|0|||
124928688|NCT04770402|449370201|FG000|Overall Study|Withdrawal by Subject|0|||
124928689|NCT04770402|449370202|FG001|Overall Study|Withdrawal by Subject|1|||
124928690|NCT04550221|449370204|FG000|Overall Study|Lost to Follow-up|0|||
124928691|NCT04550221|449370205|FG001|Overall Study|Lost to Follow-up|4|||
124928692|NCT04550221|449370204|FG000|Overall Study|Withdrawn|3|||
124928693|NCT04550221|449370205|FG001|Overall Study|Withdrawn|0|||
124928694|NCT04550221|449370204|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
124928695|NCT04550221|449370205|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
124928696|NCT04811040|449370206|FG000|Overall Study|Lost to Follow-up|2|||
124928697|NCT04811040|449370207|FG001|Overall Study|Lost to Follow-up|0|||
124928698|NCT04811040|449370208|FG002|Overall Study|Lost to Follow-up|0|||
124928699|NCT04811040|449370209|FG003|Overall Study|Lost to Follow-up|0|||
124928700|NCT04811040|449370206|FG000|Overall Study|Withdrew consent|1|||
124928701|NCT04811040|449370207|FG001|Overall Study|Withdrew consent|1|||
124928702|NCT04811040|449370208|FG002|Overall Study|Withdrew consent|0|||
124928703|NCT04811040|449370209|FG003|Overall Study|Withdrew consent|0|||
124928704|NCT05274074|449370210|FG000|Overall Study|Lost to Follow-up|2|||
124928705|NCT05274074|449370211|FG001|Overall Study|Lost to Follow-up|3|||
124928706|NCT05274074|449370210|FG000|Overall Study|Withdrawal by Subject|1|||
124928707|NCT05274074|449370211|FG001|Overall Study|Withdrawal by Subject|2|||
124928708|NCT01828099|449370212|FG000|Treatment Period|Adverse Event|24|||
124928709|NCT01828099|449370213|FG001|Treatment Period|Adverse Event|23|||
124928710|NCT01828099|449370212|FG000|Treatment Period|Death|10|||
124928711|NCT01828099|449370213|FG001|Treatment Period|Death|12|||
124928712|NCT01828099|449370212|FG000|Treatment Period|Lost to Follow-up|2|||
124928713|NCT01828099|449370213|FG001|Treatment Period|Lost to Follow-up|1|||
124928714|NCT01828099|449370212|FG000|Treatment Period|Non-compliance with study treatment|1|||
124928715|NCT01828099|449370213|FG001|Treatment Period|Non-compliance with study treatment|0|||
124928716|NCT01828099|449370212|FG000|Treatment Period|Physician Decision|17|||
124928717|NCT01828099|449370213|FG001|Treatment Period|Physician Decision|16|||
124928718|NCT01828099|449370212|FG000|Treatment Period|Progressive disease|99|||
125120108|NCT02576990|450063308|FG001|Overall Study|Physician Decision|0|||
124928719|NCT01828099|449370213|FG001|Treatment Period|Progressive disease|107|||
124928720|NCT01828099|449370212|FG000|Treatment Period|Subject/guardian decision|22|||
124928721|NCT01828099|449370213|FG001|Treatment Period|Subject/guardian decision|26|||
124928722|NCT01828099|449370212|FG000|Treatment Period|Study terminated by Sponsor|13|||
124928723|NCT01828099|449370213|FG001|Treatment Period|Study terminated by Sponsor|1|||
124928724|NCT01828099|449370212|FG000|Treatment Period|Protocol deviation|1|||
124928725|NCT01828099|449370213|FG001|Treatment Period|Protocol deviation|0|||
124928726|NCT01828099|449370212|FG000|Treatment Period|No longer requires treatment|0|||
124928727|NCT01828099|449370213|FG001|Treatment Period|No longer requires treatment|1|||
124928728|NCT01828099|449370212|FG000|Extension-treatment Phase|Adverse Event|0|||
124928729|NCT01828099|449370213|FG001|Extension-treatment Phase|Adverse Event|17|||
124928730|NCT01828099|449370212|FG000|Extension-treatment Phase|Death|0|||
124928731|NCT01828099|449370213|FG001|Extension-treatment Phase|Death|11|||
124928732|NCT01828099|449370212|FG000|Extension-treatment Phase|Physician Decision|0|||
124928733|NCT01828099|449370213|FG001|Extension-treatment Phase|Physician Decision|5|||
124928734|NCT01828099|449370212|FG000|Extension-treatment Phase|Progressive disease|0|||
124928735|NCT01828099|449370213|FG001|Extension-treatment Phase|Progressive disease|54|||
124928736|NCT01828099|449370212|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
124928737|NCT01828099|449370213|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
124928738|NCT01828099|449370212|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
124928739|NCT01828099|449370213|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
124928740|NCT04568434|449370218|FG000|Overall Study|Voluntary Withdrawal|0|||
124928741|NCT04568434|449370219|FG001|Overall Study|Voluntary Withdrawal|1|||
124928742|NCT04568434|449370220|FG002|Overall Study|Voluntary Withdrawal|1|||
124928743|NCT04568434|449370218|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
124928744|NCT04568434|449370219|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
124928745|NCT04568434|449370220|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
124928746|NCT04568434|449370218|FG000|Overall Study|Investigator Judgement|1|||
124928747|NCT04568434|449370219|FG001|Overall Study|Investigator Judgement|0|||
124928748|NCT04568434|449370220|FG002|Overall Study|Investigator Judgement|0|||
124928749|NCT03905798|449370221|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
124928760|NCT05485779|449370224|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
124928761|NCT05485779|449370225|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
124928762|NCT05485779|449370226|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
124928763|NCT05485779|449370227|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
124928764|NCT05485779|449370228|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
124928765|NCT05485779|449370229|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
124928766|NCT05485779|449370230|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
124928767|NCT05485779|449370231|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
124928768|NCT05485779|449370232|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
124928769|NCT05485779|449370233|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
124928770|NCT05485779|449370234|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
124928771|NCT05485779|449370224|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
124928772|NCT05485779|449370225|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
124928773|NCT05485779|449370226|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
124928774|NCT05485779|449370227|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
124928775|NCT05485779|449370228|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
124928776|NCT05485779|449370229|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
124928777|NCT05485779|449370230|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
124928778|NCT05485779|449370231|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
124928779|NCT05485779|449370232|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
124928780|NCT05485779|449370233|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
124928781|NCT05485779|449370234|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
124928782|NCT05485779|449370224|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
124928783|NCT05485779|449370225|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
124928784|NCT05485779|449370226|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
124928785|NCT05485779|449370227|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
124928786|NCT05485779|449370228|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
124928787|NCT05485779|449370229|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
124928788|NCT05485779|449370230|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
124928789|NCT05485779|449370231|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
124928790|NCT05485779|449370232|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
124928791|NCT05485779|449370233|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
124928792|NCT05485779|449370234|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
124928793|NCT04515849|449370237|FG000|Overall Study|Adverse Event|0|||
124928794|NCT04515849|449370238|FG001|Overall Study|Adverse Event|0|||
124928795|NCT04515849|449370239|FG002|Overall Study|Adverse Event|0|||
124928796|NCT04515849|449370240|FG003|Overall Study|Adverse Event|1|||
124928797|NCT04515849|449370241|FG004|Overall Study|Adverse Event|2|||
124928798|NCT04515849|449370237|FG000|Overall Study|Death|2|||
124928799|NCT04515849|449370238|FG001|Overall Study|Death|0|||
124928800|NCT04515849|449370239|FG002|Overall Study|Death|0|||
124928801|NCT04515849|449370240|FG003|Overall Study|Death|0|||
124928802|NCT04515849|449370241|FG004|Overall Study|Death|0|||
124928803|NCT04515849|449370237|FG000|Overall Study|Other:family emergency|0|||
124928804|NCT04515849|449370238|FG001|Overall Study|Other:family emergency|0|||
124928805|NCT04515849|449370239|FG002|Overall Study|Other:family emergency|0|||
124928806|NCT04515849|449370240|FG003|Overall Study|Other:family emergency|1|||
124928807|NCT04515849|449370241|FG004|Overall Study|Other:family emergency|0|||
124928808|NCT04515849|449370237|FG000|Overall Study|Other:randomised by error|0|||
124928809|NCT04515849|449370238|FG001|Overall Study|Other:randomised by error|1|||
124928810|NCT04515849|449370239|FG002|Overall Study|Other:randomised by error|0|||
124928811|NCT04515849|449370240|FG003|Overall Study|Other:randomised by error|0|||
124928812|NCT04515849|449370241|FG004|Overall Study|Other:randomised by error|0|||
124928813|NCT04515849|449370237|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
124928814|NCT04515849|449370238|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
124928815|NCT04515849|449370239|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
124928816|NCT04515849|449370240|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
124928817|NCT04515849|449370241|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
124928818|NCT04515849|449370237|FG000|Overall Study|Physician Decision|0|||
124928819|NCT04515849|449370238|FG001|Overall Study|Physician Decision|1|||
124928820|NCT04515849|449370239|FG002|Overall Study|Physician Decision|0|||
124928821|NCT04515849|449370240|FG003|Overall Study|Physician Decision|0|||
124928822|NCT04515849|449370241|FG004|Overall Study|Physician Decision|0|||
124928823|NCT04515849|449370237|FG000|Overall Study|Withdrawal by Subject|1|||
124928824|NCT04515849|449370238|FG001|Overall Study|Withdrawal by Subject|2|||
124928825|NCT04515849|449370239|FG002|Overall Study|Withdrawal by Subject|1|||
124928826|NCT04515849|449370240|FG003|Overall Study|Withdrawal by Subject|0|||
124928827|NCT04515849|449370241|FG004|Overall Study|Withdrawal by Subject|0|||
124928828|NCT05370040|449370242|FG000|Overall Study|Lost to Follow-up|0|||
124928829|NCT05370040|449370243|FG001|Overall Study|Lost to Follow-up|0|||
124928830|NCT05370040|449370244|FG002|Overall Study|Lost to Follow-up|1|||
124928831|NCT05370040|449370245|FG003|Overall Study|Lost to Follow-up|0|||
124928832|NCT05370040|449370246|FG004|Overall Study|Lost to Follow-up|1|||
124928833|NCT05370040|449370247|FG005|Overall Study|Lost to Follow-up|0|||
124928834|NCT05093842|449370253|FG000|Overall Study|Pregnancy loss|1|||
124928835|NCT05093842|449370254|FG001|Overall Study|Pregnancy loss|1|||
124928836|NCT05093842|449370253|FG000|Overall Study|Lost to Follow-up|6|||
124928837|NCT05093842|449370254|FG001|Overall Study|Lost to Follow-up|0|||
124928838|NCT05093842|449370253|FG000|Overall Study|Physician Decision|0|||
124928839|NCT05093842|449370254|FG001|Overall Study|Physician Decision|1|||
124928840|NCT03987022|449370256|FG000|Overall Study|Lost to Follow-up|2|||
124928841|NCT03987022|449370257|FG001|Overall Study|Lost to Follow-up|2|||
124928842|NCT03987022|449370256|FG000|Overall Study|Withdrawal by Subject|1|||
124928843|NCT03987022|449370257|FG001|Overall Study|Withdrawal by Subject|0|||
124928844|NCT02887521|449370260|FG000|Overall Study|Withdrawal by Subject|0|||
124928845|NCT02887521|449370261|FG001|Overall Study|Withdrawal by Subject|3|||
124928846|NCT03571581|449370264|FG000|Overall Study|Death|2|||
124928847|NCT03571581|449370264|FG000|Overall Study|Withdrawal by Subject|2|||
124928848|NCT03663569|449371872|FG000|Overall Study|Discontinuation of study|11|||
124928849|NCT03663569|449371872|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
124928850|NCT03663569|449371872|FG000|Overall Study|Deceased patient|6|||
124928851|NCT03663569|449371872|FG000|Overall Study|Lost to Follow-up|18|||
124928852|NCT03663569|449371872|FG000|Overall Study|Withdrawal of consent|5|||
124928853|NCT03663569|449371872|FG000|Overall Study|Patient's request|11|||
124928854|NCT03663569|449371872|FG000|Overall Study|Adverse Event|4|||
124928855|NCT03663569|449371872|FG000|Overall Study|Not come to second visit|3|||
124928856|NCT03663569|449371872|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
124928857|NCT03663569|449371872|FG000|Overall Study|Serious adverse event|1|||
124928858|NCT05877976|449371873|FG000|Overall Study|Lost to Follow-up|31|||
124928859|NCT04248725|449371874|FG000|Post-Treatment|Lost to Follow-up|6|||
124928860|NCT04248725|449371875|FG001|Post-Treatment|Lost to Follow-up|5|||
124928861|NCT04248725|449371874|FG000|6-Month Follow Up|Lost to Follow-up|9|||
124928862|NCT04248725|449371875|FG001|6-Month Follow Up|Lost to Follow-up|8|||
124928863|NCT05622812|449371876|FG000|Overall Study|Withdrawal by Subject|1|||
124928864|NCT05622812|449371877|FG001|Overall Study|Withdrawal by Subject|4|||
124928865|NCT05622812|449371876|FG000|Overall Study|Lost to Follow-up|2|||
124928866|NCT05622812|449371877|FG001|Overall Study|Lost to Follow-up|1|||
124928867|NCT02844465|449371878|FG000|Overall Study|Screen Failure|36|||
124928868|NCT02844465|449371878|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
124928869|NCT02844465|449371878|FG000|Overall Study|Withdrawal by Subject|5|||
124928870|NCT02844465|449371878|FG000|Overall Study|Lost to Follow-up|1|||
124928871|NCT02844465|449371878|FG000|Overall Study|Retreatment|1|||
124928872|NCT03819153|449371880|FG000|Overall Study|Withdrawal by Subject|20|||
124928873|NCT03819153|449371881|FG001|Overall Study|Withdrawal by Subject|28|||
124928874|NCT03819153|449371880|FG000|Overall Study|Lost to Follow-up|23|||
124928875|NCT03819153|449371881|FG001|Overall Study|Lost to Follow-up|30|||
124928876|NCT03240016|449371883|FG000|Overall Study|Adverse Event|9|||
124928877|NCT03240016|449371883|FG000|Overall Study|Withdrawal by Subject|7|||
124928878|NCT03240016|449371883|FG000|Overall Study|Death|1|||
124928879|NCT03240016|449371883|FG000|Overall Study|Physician Decision|2|||
124928880|NCT05452460|449371891|FG000|Overall Study|Lost to Follow-up|3|||
124928881|NCT05452460|449371892|FG001|Overall Study|Lost to Follow-up|3|||
124928882|NCT05452460|449371891|FG000|Overall Study|Did not receive intervention|1|||
124928883|NCT05452460|449371892|FG001|Overall Study|Did not receive intervention|0|||
124928884|NCT04362254|449371897|FG000|Overall Study|Adverse Event|1|||
124928885|NCT04362254|449371897|FG000|Overall Study|Protocol Violation|1|||
124928886|NCT04362254|449371897|FG000|Overall Study|Due to early termination of the trial|10|||
124928887|NCT05469464|449371900|FG000|Overall Study|Withdrawal by Subject|8|||
124928888|NCT05469464|449371901|FG001|Overall Study|Withdrawal by Subject|7|||
124928889|NCT05469464|449371902|FG002|Overall Study|Withdrawal by Subject|4|||
124928890|NCT05469464|449371903|FG003|Overall Study|Withdrawal by Subject|5|||
124928891|NCT05469464|449371900|FG000|Overall Study|Adverse Event|8|||
124928892|NCT05469464|449371901|FG001|Overall Study|Adverse Event|14|||
124928893|NCT05469464|449371902|FG002|Overall Study|Adverse Event|13|||
124928894|NCT05469464|449371903|FG003|Overall Study|Adverse Event|2|||
124928895|NCT05469464|449371900|FG000|Overall Study|Lost to Follow-up|2|||
124928896|NCT05469464|449371901|FG001|Overall Study|Lost to Follow-up|5|||
124928897|NCT05469464|449371902|FG002|Overall Study|Lost to Follow-up|3|||
124928898|NCT05469464|449371903|FG003|Overall Study|Lost to Follow-up|3|||
124928899|NCT05469464|449371900|FG000|Overall Study|Lack of Efficacy|4|||
124928900|NCT05469464|449371901|FG001|Overall Study|Lack of Efficacy|1|||
124928901|NCT05469464|449371902|FG002|Overall Study|Lack of Efficacy|2|||
124928902|NCT05469464|449371903|FG003|Overall Study|Lack of Efficacy|2|||
124928903|NCT05469464|449371900|FG000|Overall Study|Physician Decision|0|||
124928904|NCT05469464|449371901|FG001|Overall Study|Physician Decision|0|||
124928905|NCT05469464|449371902|FG002|Overall Study|Physician Decision|0|||
124928906|NCT05469464|449371903|FG003|Overall Study|Physician Decision|1|||
124928907|NCT01208662|449371904|FG000|Induction and Consolidation|Disease Progression|23|||
124928908|NCT01208662|449371905|FG001|Induction and Consolidation|Disease Progression|13|||
124928909|NCT01208662|449371906|FG002|Induction and Consolidation|Disease Progression|0|||
124928910|NCT01208662|449371904|FG000|Induction and Consolidation|Adverse Event|16|||
124928911|NCT01208662|449371905|FG001|Induction and Consolidation|Adverse Event|18|||
124928912|NCT01208662|449371906|FG002|Induction and Consolidation|Adverse Event|2|||
124928913|NCT01208662|449371904|FG000|Induction and Consolidation|MD or Participant Decision|16|||
124928914|NCT01208662|449371905|FG001|Induction and Consolidation|MD or Participant Decision|34|||
124928915|NCT01208662|449371906|FG002|Induction and Consolidation|MD or Participant Decision|4|||
124928916|NCT01208662|449371904|FG000|Induction and Consolidation|Death|1|||
124928917|NCT01208662|449371905|FG001|Induction and Consolidation|Death|3|||
124928918|NCT01208662|449371906|FG002|Induction and Consolidation|Death|1|||
124928919|NCT01208662|449371904|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
124928920|NCT01208662|449371905|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
124928921|NCT01208662|449371906|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
124928922|NCT01208662|449371904|FG000|Maintenance|Disease Progression|156|||
124928923|NCT01208662|449371905|FG001|Maintenance|Disease Progression|102|||
124928924|NCT01208662|449371906|FG002|Maintenance|Disease Progression|0|||
125024423|NCT01665144|449711462|FG001|Extension Part|Patient/guardian decision|0|||
125024424|NCT01665144|449711463|FG002|Extension Part|Patient/guardian decision|98|||
125212671|NCT02913105|450405420|FG002|Overall Study|Non-Compliance With Study Drug|1|||
124928925|NCT01208662|449371904|FG000|Maintenance|Adverse Event|12|||
124928926|NCT01208662|449371905|FG001|Maintenance|Adverse Event|28|||
124928927|NCT01208662|449371906|FG002|Maintenance|Adverse Event|0|||
124928928|NCT01208662|449371904|FG000|Maintenance|MD or Participant Decision|24|||
124928929|NCT01208662|449371905|FG001|Maintenance|MD or Participant Decision|36|||
124928930|NCT01208662|449371906|FG002|Maintenance|MD or Participant Decision|0|||
124928931|NCT01208662|449371904|FG000|Maintenance|Death|0|||
124928932|NCT01208662|449371905|FG001|Maintenance|Death|3|||
124928933|NCT01208662|449371906|FG002|Maintenance|Death|0|||
124928934|NCT01208662|449371904|FG000|Maintenance|Discontinued for other reasons|21|||
124928935|NCT01208662|449371905|FG001|Maintenance|Discontinued for other reasons|31|||
124928936|NCT01208662|449371906|FG002|Maintenance|Discontinued for other reasons|0|||
124928937|NCT01208662|449371904|FG000|Maintenance|Still on Treatment|78|||
124928938|NCT01208662|449371905|FG001|Maintenance|Still on Treatment|89|||
125120109|NCT02576990|450063307|FG000|Overall Study|Screen failure|2|||
125120110|NCT02576990|450063308|FG001|Overall Study|Screen failure|0|||
125120111|NCT02576990|450063307|FG000|Overall Study|Sponsor's decision|24|||
125120112|NCT02576990|450063308|FG001|Overall Study|Sponsor's decision|4|||
125120113|NCT02576990|450063307|FG000|Overall Study|Withdrawal by Subject|0|||
125120114|NCT02576990|450063308|FG001|Overall Study|Withdrawal by Subject|2|||
124928939|NCT01208662|449371906|FG002|Maintenance|Still on Treatment|0|||
124928940|NCT00321048|449371907|FG000|Overall Study|Withdrawal by Subject|6|||
124928941|NCT00321048|449371908|FG001|Overall Study|Withdrawal by Subject|8|||
125120115|NCT01736553|450063313|FG000|Overall Study|Death|12|||
125120116|NCT01736553|450063314|FG001|Overall Study|Death|0|||
124928942|NCT04707625|449371909|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
124928943|NCT06473662|449371910|FG000|Overall Study|Withdrawal by Subject|1|||
124928944|NCT06473662|449371911|FG001|Overall Study|Withdrawal by Subject|6|||
124928945|NCT06473662|449371912|FG002|Overall Study|Withdrawal by Subject|5|||
124928946|NCT06473662|449371910|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
124928947|NCT06473662|449371911|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
124928948|NCT06473662|449371912|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
124928949|NCT06473662|449371910|FG000|Overall Study|Starting HbA1c below 7%|0|||
124928950|NCT06473662|449371911|FG001|Overall Study|Starting HbA1c below 7%|1|||
124928951|NCT06473662|449371912|FG002|Overall Study|Starting HbA1c below 7%|1|||
124928952|NCT06473662|449371910|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
124928953|NCT06473662|449371911|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
124928954|NCT06473662|449371912|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
125120117|NCT01736553|450063313|FG000|Overall Study|Withdrawal by Subject|5|||
125024425|NCT01665144|449711461|FG000|Extension Part|Adverse Event|104|||
125024426|NCT01665144|449711462|FG001|Extension Part|Adverse Event|0|||
125024427|NCT01665144|449711463|FG002|Extension Part|Adverse Event|59|||
125024428|NCT01665144|449711461|FG000|Extension Part|Study closed early|42|||
125024429|NCT01665144|449711462|FG001|Extension Part|Study closed early|0|||
125024430|NCT01665144|449711463|FG002|Extension Part|Study closed early|19|||
125024431|NCT01665144|449711461|FG000|Extension Part|Progressive disease|36|||
125024432|NCT01665144|449711462|FG001|Extension Part|Progressive disease|0|||
125024433|NCT01665144|449711463|FG002|Extension Part|Progressive disease|14|||
125024434|NCT01665144|449711461|FG000|Extension Part|Lack of Efficacy|37|||
125024435|NCT01665144|449711462|FG001|Extension Part|Lack of Efficacy|0|||
125024436|NCT01665144|449711463|FG002|Extension Part|Lack of Efficacy|12|||
125024437|NCT01665144|449711461|FG000|Extension Part|Physician Decision|29|||
125024438|NCT01665144|449711462|FG001|Extension Part|Physician Decision|0|||
125024439|NCT01665144|449711463|FG002|Extension Part|Physician Decision|13|||
125024440|NCT01665144|449711461|FG000|Extension Part|Technical problems|20|||
125024441|NCT01665144|449711462|FG001|Extension Part|Technical problems|0|||
125024442|NCT01665144|449711463|FG002|Extension Part|Technical problems|8|||
125024443|NCT01665144|449711461|FG000|Extension Part|Death|20|||
125024444|NCT01665144|449711462|FG001|Extension Part|Death|0|||
125024445|NCT01665144|449711463|FG002|Extension Part|Death|4|||
125024446|NCT01665144|449711461|FG000|Extension Part|Missing|12|||
125024447|NCT01665144|449711462|FG001|Extension Part|Missing|0|||
125024448|NCT01665144|449711463|FG002|Extension Part|Missing|6|||
125024449|NCT01665144|449711461|FG000|Extension Part|Lost to Follow-up|9|||
125024450|NCT01665144|449711462|FG001|Extension Part|Lost to Follow-up|0|||
125024451|NCT01665144|449711463|FG002|Extension Part|Lost to Follow-up|5|||
125024452|NCT01665144|449711461|FG000|Extension Part|New therapy for study indication|3|||
125024453|NCT01665144|449711462|FG001|Extension Part|New therapy for study indication|0|||
125024454|NCT01665144|449711463|FG002|Extension Part|New therapy for study indication|2|||
125024455|NCT01665144|449711461|FG000|Extension Part|Protocol deviation|3|||
125024456|NCT01665144|449711462|FG001|Extension Part|Protocol deviation|0|||
125024457|NCT01665144|449711463|FG002|Extension Part|Protocol deviation|0|||
125024458|NCT01913483|449711470|FG000|Overall Study|Withdrawal by Subject|1|||
125024459|NCT01913483|449711471|FG001|Overall Study|Withdrawal by Subject|2|||
125024460|NCT01913483|449711470|FG000|Overall Study|Lost to Follow-up|6|||
125024461|NCT01913483|449711471|FG001|Overall Study|Lost to Follow-up|3|||
125024462|NCT01913483|449711470|FG000|Overall Study|Death|14|||
125024463|NCT01913483|449711471|FG001|Overall Study|Death|17|||
125024464|NCT02302963|449711472|FG000|Overall Study|Withdrawal by Subject|2|||
125024465|NCT02302963|449711473|FG001|Overall Study|Withdrawal by Subject|1|||
125024466|NCT02302963|449711472|FG000|Overall Study|Steroid injection|0|||
125024467|NCT02302963|449711473|FG001|Overall Study|Steroid injection|1|||
125024468|NCT02302963|449711472|FG000|Overall Study|Physician Decision|1|||
125024469|NCT02302963|449711473|FG001|Overall Study|Physician Decision|0|||
125024470|NCT01816243|449711474|FG000|Overall Study|Adverse Event|6|||
125212672|NCT02913105|450405418|FG000|Overall Study|Reason Not Specified|3|||
125212673|NCT02913105|450405419|FG001|Overall Study|Reason Not Specified|1|||
125212674|NCT02913105|450405420|FG002|Overall Study|Reason Not Specified|1|||
124928955|NCT06473662|449371910|FG000|Overall Study|Did not take medication|2|||
124928956|NCT06473662|449371911|FG001|Overall Study|Did not take medication|3|||
124928957|NCT06473662|449371912|FG002|Overall Study|Did not take medication|2|||
124928958|NCT03463044|449371913|FG000|Overall Study|Lost to Follow-up|0|||
124928959|NCT03463044|449371914|FG001|Overall Study|Lost to Follow-up|0|||
124928960|NCT03463044|449371915|FG002|Overall Study|Lost to Follow-up|0|||
124928961|NCT03463044|449371916|FG003|Overall Study|Lost to Follow-up|0|||
124928962|NCT03463044|449371917|FG004|Overall Study|Lost to Follow-up|0|||
124928963|NCT03463044|449371918|FG005|Overall Study|Lost to Follow-up|0|||
124928964|NCT03463044|449371919|FG006|Overall Study|Lost to Follow-up|0|||
124928965|NCT03463044|449371920|FG007|Overall Study|Lost to Follow-up|1|||
124928966|NCT03463044|449371921|FG008|Overall Study|Lost to Follow-up|0|||
124928967|NCT05764525|449371922|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
124928968|NCT05764525|449371923|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
124928969|NCT05764525|449371922|FG000|Overall Study|Withdrawal by Subject|4|||
124928970|NCT05764525|449371923|FG001|Overall Study|Withdrawal by Subject|8|||
124928971|NCT05764525|449371922|FG000|Overall Study|Physician Decision|1|||
124928972|NCT05764525|449371923|FG001|Overall Study|Physician Decision|0|||
124928973|NCT03334630|449371924|FG000|Overall Study|Withdrawal by Subject|7|||
124928974|NCT03334630|449371925|FG001|Overall Study|Withdrawal by Subject|7|||
124928975|NCT03334630|449371924|FG000|Overall Study|Lost to Follow-up|3|||
124928976|NCT03334630|449371925|FG001|Overall Study|Lost to Follow-up|1|||
124928977|NCT03334630|449371924|FG000|Overall Study|Adverse Event|0|||
124928978|NCT03334630|449371925|FG001|Overall Study|Adverse Event|1|||
124928979|NCT03334630|449371924|FG000|Overall Study|Physician Decision|1|||
124928980|NCT03334630|449371925|FG001|Overall Study|Physician Decision|1|||
124928981|NCT03334630|449371924|FG000|Overall Study|Enrollment closed|2|||
124928982|NCT03334630|449371925|FG001|Overall Study|Enrollment closed|1|||
124928983|NCT03334630|449371924|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
124928984|NCT03334630|449371925|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
124928985|NCT03334630|449371924|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
124928986|NCT03334630|449371925|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
124928987|NCT03030261|449371930|FG000|Overall Study|Still receiving continuation therapy|5|||
124928988|NCT03910478|449371934|FG000|Overall Study|Death|13|||
124928989|NCT03910478|449371935|FG001|Overall Study|Death|6|||
124928990|NCT03910478|449371934|FG000|Overall Study|Withdrawal by Subject|23|||
124928991|NCT03910478|449371935|FG001|Overall Study|Withdrawal by Subject|2|||
124928992|NCT03910478|449371934|FG000|Overall Study|Physician Decision|5|||
124928993|NCT03910478|449371935|FG001|Overall Study|Physician Decision|0|||
124928994|NCT03910478|449371934|FG000|Overall Study|Protocol Violation|1|||
124928995|NCT03910478|449371935|FG001|Overall Study|Protocol Violation|0|||
124928996|NCT03910478|449371934|FG000|Overall Study|Failure to meet continuation criteria|2|||
124928997|NCT03910478|449371935|FG001|Overall Study|Failure to meet continuation criteria|0|||
124928998|NCT03910478|449371934|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
124928999|NCT03910478|449371935|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
124929000|NCT05293171|449371936|FG000|Washout 5 to 7 Days|Adverse Event|1|||
124929001|NCT05293171|449371937|FG001|Washout 5 to 7 Days|Adverse Event|1|||
125024471|NCT01816243|449711474|FG000|Overall Study|Lost to Follow-up|1|||
124929002|NCT05293171|449371938|FG002|Washout 5 to 7 Days|Adverse Event|0|||
124929003|NCT05293171|449371939|FG003|Washout 5 to 7 Days|Adverse Event|0|||
124929004|NCT05293171|449371940|FG004|Washout 5 to 7 Days|Adverse Event|0|||
124929005|NCT05293171|449371941|FG005|Washout 5 to 7 Days|Adverse Event|0|||
124929006|NCT05293171|449371942|FG006|Washout 5 to 7 Days|Adverse Event|0|||
125024472|NCT01816243|449711474|FG000|Overall Study|Lack of Efficacy|1|||
125024473|NCT01816243|449711474|FG000|Overall Study|Not eligible for the study|1|||
124929007|NCT05293171|449371943|FG007|Washout 5 to 7 Days|Adverse Event|0|||
124929008|NCT05293171|449371944|FG008|Washout 5 to 7 Days|Adverse Event|0|||
124929009|NCT05293171|449371945|FG009|Washout 5 to 7 Days|Adverse Event|0|||
124929010|NCT05293171|449371946|FG010|Washout 5 to 7 Days|Adverse Event|0|||
124929011|NCT05293171|449371947|FG011|Washout 5 to 7 Days|Adverse Event|0|||
124929012|NCT05293171|449371936|FG000|Washout 5 to 7 Days|Adverse Event|0|||
124929013|NCT05293171|449371937|FG001|Washout 5 to 7 Days|Adverse Event|0|||
124929014|NCT05293171|449371938|FG002|Washout 5 to 7 Days|Adverse Event|0|||
124929015|NCT05293171|449371939|FG003|Washout 5 to 7 Days|Adverse Event|0|||
124929016|NCT05293171|449371940|FG004|Washout 5 to 7 Days|Adverse Event|0|||
125024474|NCT01816243|449711474|FG000|Overall Study|Amputation|3|||
124929017|NCT05293171|449371941|FG005|Washout 5 to 7 Days|Adverse Event|1|||
124929018|NCT05293171|449371942|FG006|Washout 5 to 7 Days|Adverse Event|0|||
124929019|NCT05293171|449371943|FG007|Washout 5 to 7 Days|Adverse Event|0|||
124929020|NCT05293171|449371944|FG008|Washout 5 to 7 Days|Adverse Event|0|||
124929021|NCT05293171|449371945|FG009|Washout 5 to 7 Days|Adverse Event|0|||
124929022|NCT05293171|449371946|FG010|Washout 5 to 7 Days|Adverse Event|0|||
124929023|NCT05293171|449371947|FG011|Washout 5 to 7 Days|Adverse Event|0|||
124929024|NCT04066205|449371950|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
124929025|NCT04066205|449371951|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
124929026|NCT04066205|449371950|FG000|T2 Immediate Post-Intervention|did not respond|5|||
124929027|NCT04066205|449371951|FG001|T2 Immediate Post-Intervention|did not respond|3|||
124929028|NCT04766892|449371955|FG000|Overall Study|Withdrawal by Subject|1|||
124929029|NCT04766892|449371955|FG000|Overall Study|Lost to Follow-up|1|||
124929030|NCT04766892|449371955|FG000|Overall Study|Adverse Event|3|||
124929031|NCT04766892|449371955|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
124929032|NCT01712490|449371956|FG000|Overall Study|Ongoing|601|||
124929033|NCT01712490|449371957|FG001|Overall Study|Ongoing|586|||
124929034|NCT01712490|449371956|FG000|Overall Study|Other|11|||
124929035|NCT01712490|449371957|FG001|Overall Study|Other|11|||
124929036|NCT01712490|449371956|FG000|Overall Study|Withdrawal by Subject|36|||
124929037|NCT01712490|449371957|FG001|Overall Study|Withdrawal by Subject|44|||
124929038|NCT01712490|449371956|FG000|Overall Study|Lost to Follow-up|16|||
124929039|NCT01712490|449371957|FG001|Overall Study|Lost to Follow-up|29|||
124929040|NCT03478956|449371958|FG000|Randomized Treatment Period|Adverse Event|1|||
124929041|NCT03478956|449371959|FG001|Randomized Treatment Period|Adverse Event|0|||
124929042|NCT03478956|449371960|FG002|Randomized Treatment Period|Adverse Event|0|||
124929043|NCT03478956|449371961|FG003|Randomized Treatment Period|Adverse Event|0|||
124929044|NCT03478956|449371958|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
124929045|NCT03478956|449371959|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
124929046|NCT03478956|449371960|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
125212675|NCT02913105|450405418|FG000|Overall Study|Physician Decision|1|||
125212676|NCT02913105|450405419|FG001|Overall Study|Physician Decision|1|||
124929047|NCT03478956|449371961|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
124929048|NCT03478956|449371958|FG000|Open Label Extension Period|Adverse Event|0|||
124929049|NCT03478956|449371959|FG001|Open Label Extension Period|Adverse Event|0|||
124929050|NCT03478956|449371960|FG002|Open Label Extension Period|Adverse Event|4|||
124929051|NCT03478956|449371961|FG003|Open Label Extension Period|Adverse Event|0|||
125120118|NCT01736553|450063314|FG001|Overall Study|Withdrawal by Subject|2|||
124929052|NCT03478956|449371958|FG000|Open Label Extension Period|Lack of Efficacy|0|||
124929053|NCT03478956|449371959|FG001|Open Label Extension Period|Lack of Efficacy|0|||
124929054|NCT03478956|449371960|FG002|Open Label Extension Period|Lack of Efficacy|8|||
124929055|NCT03478956|449371961|FG003|Open Label Extension Period|Lack of Efficacy|0|||
124929056|NCT03478956|449371958|FG000|Open Label Extension Period|Reason Not Provided|0|||
124929057|NCT03478956|449371959|FG001|Open Label Extension Period|Reason Not Provided|0|||
124929058|NCT03478956|449371960|FG002|Open Label Extension Period|Reason Not Provided|1|||
124929059|NCT03478956|449371961|FG003|Open Label Extension Period|Reason Not Provided|0|||
124929060|NCT03478956|449371958|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
124929061|NCT03478956|449371959|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
124929062|NCT03478956|449371960|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
124929063|NCT03478956|449371961|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
124929064|NCT03478956|449371958|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
124929065|NCT03478956|449371959|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
124929066|NCT03478956|449371960|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
124929067|NCT03478956|449371961|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
124929068|NCT03478956|449371958|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
124929069|NCT03478956|449371959|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
124929070|NCT03478956|449371960|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
124929071|NCT03478956|449371961|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
124929072|NCT04800211|449371962|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
124929073|NCT04800211|449371963|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
124929074|NCT04800211|449371964|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
124929075|NCT04800211|449371962|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
124929076|NCT04800211|449371963|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
124929077|NCT04800211|449371964|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
124929078|NCT04800211|449371962|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
124929079|NCT04800211|449371963|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
124929080|NCT04800211|449371964|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
124929081|NCT04800211|449371962|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
125120119|NCT01736553|450063313|FG000|Overall Study|Lost to Follow-up|2|||
125120120|NCT01736553|450063314|FG001|Overall Study|Lost to Follow-up|2|||
125120121|NCT02415959|450063315|FG000|Overall Study|Adverse Event|0|||
125120122|NCT02415959|450063316|FG001|Overall Study|Adverse Event|1|||
125120123|NCT02415959|450063317|FG002|Overall Study|Adverse Event|0|||
125120124|NCT02415959|450063318|FG003|Overall Study|Adverse Event|0|||
125120125|NCT02415959|450063319|FG004|Overall Study|Adverse Event|0|||
125120126|NCT02415959|450063315|FG000|Overall Study|Protocol Violation|0|||
125120127|NCT02415959|450063316|FG001|Overall Study|Protocol Violation|0|||
125120128|NCT02415959|450063317|FG002|Overall Study|Protocol Violation|0|||
125120129|NCT02415959|450063318|FG003|Overall Study|Protocol Violation|1|||
125120130|NCT02415959|450063319|FG004|Overall Study|Protocol Violation|0|||
125120131|NCT00911859|450063320|FG000|Treatment Period|Adverse Event|3|||
125120132|NCT00911859|450063321|FG001|Treatment Period|Adverse Event|3|||
125120133|NCT00911859|450063322|FG002|Treatment Period|Adverse Event|7|||
125212677|NCT02913105|450405420|FG002|Overall Study|Physician Decision|0|||
125212678|NCT02913105|450405418|FG000|Overall Study|Withdrawal by Subject|0|||
125212679|NCT02913105|450405419|FG001|Overall Study|Withdrawal by Subject|3|||
125212680|NCT02913105|450405420|FG002|Overall Study|Withdrawal by Subject|1|||
125212681|NCT01317004|450405421|FG000|Overall Study|Withdrawal by Subject|1|||
125212682|NCT01317004|450405422|FG001|Overall Study|Withdrawal by Subject|4|||
124929082|NCT04800211|449371963|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
124929083|NCT04800211|449371964|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
124929084|NCT04800211|449371962|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
125120134|NCT00911859|450063320|FG000|Treatment Period|Death|1|||
125120135|NCT00911859|450063321|FG001|Treatment Period|Death|3|||
125120136|NCT00911859|450063322|FG002|Treatment Period|Death|5|||
124929085|NCT04800211|449371963|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
124929086|NCT04800211|449371964|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
124929087|NCT04800211|449371962|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
124929088|NCT04800211|449371963|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
124929089|NCT04800211|449371964|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
124929090|NCT04800211|449371962|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
124929091|NCT04800211|449371963|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
124929092|NCT04800211|449371964|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
124929093|NCT04800211|449371962|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
124929094|NCT04800211|449371963|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
124929095|NCT04800211|449371964|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
124929096|NCT04800211|449371962|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
124929097|NCT04800211|449371963|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
125024475|NCT00915343|449711475|FG000|Part B - Open Label Period|Treatment switch|0|||
125024476|NCT00915343|449711476|FG001|Part B - Open Label Period|Treatment switch|0|||
125024477|NCT00915343|449711477|FG002|Part B - Open Label Period|Treatment switch|1|||
125024478|NCT00915343|449711475|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
125024479|NCT00915343|449711476|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
125024480|NCT00915343|449711477|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
125024481|NCT01920711|449711478|FG000|Overall Study|Death|347|||
125024482|NCT01920711|449711479|FG001|Overall Study|Death|356|||
125024483|NCT01920711|449711478|FG000|Overall Study|Lost to Follow-up|13|||
125024484|NCT01920711|449711479|FG001|Overall Study|Lost to Follow-up|14|||
125024485|NCT01920711|449711478|FG000|Overall Study|Withdrawal by Subject|4|||
125024486|NCT01920711|449711479|FG001|Overall Study|Withdrawal by Subject|3|||
125024487|NCT03434379|449711480|FG000|Global Period|Lost to Follow-up|3|||
125024488|NCT03434379|449711481|FG001|Global Period|Lost to Follow-up|6|||
125024489|NCT03434379|449711482|FG002|Global Period|Lost to Follow-up|0|||
125024490|NCT03434379|449711483|FG003|Global Period|Lost to Follow-up|0|||
125024491|NCT03434379|449711480|FG000|Global Period|Death|115|||
125024492|NCT03434379|449711481|FG001|Global Period|Death|228|||
125212683|NCT01317004|450405421|FG000|Overall Study|Protocol Violation|0|||
125212684|NCT01317004|450405422|FG001|Overall Study|Protocol Violation|2|||
125212685|NCT01317004|450405421|FG000|Overall Study|Adverse Event|3|||
125212686|NCT01317004|450405422|FG001|Overall Study|Adverse Event|3|||
125212687|NCT01344759|450405426|FG000|Overall Study|Patients failed to reach sedation level|0|||
125212688|NCT01344759|450405427|FG001|Overall Study|Patients failed to reach sedation level|2|||
125212689|NCT01153009|450405428|FG000|Overall Study|Adverse Event|4|||
125212690|NCT01153009|450405429|FG001|Overall Study|Adverse Event|14|||
125212691|NCT01153009|450405430|FG002|Overall Study|Adverse Event|14|||
125212692|NCT01153009|450405431|FG003|Overall Study|Adverse Event|10|||
125212693|NCT01153009|450405428|FG000|Overall Study|Lack of Efficacy|9|||
125212694|NCT01153009|450405429|FG001|Overall Study|Lack of Efficacy|0|||
125212695|NCT01153009|450405430|FG002|Overall Study|Lack of Efficacy|2|||
125212696|NCT01153009|450405431|FG003|Overall Study|Lack of Efficacy|1|||
125212697|NCT01153009|450405428|FG000|Overall Study|Noncompliance with Study Medication|1|||
125212698|NCT01153009|450405429|FG001|Overall Study|Noncompliance with Study Medication|3|||
125212699|NCT01153009|450405430|FG002|Overall Study|Noncompliance with Study Medication|4|||
125212700|NCT01153009|450405431|FG003|Overall Study|Noncompliance with Study Medication|1|||
125212701|NCT01153009|450405428|FG000|Overall Study|Protocol Deviations|4|||
125212702|NCT01153009|450405429|FG001|Overall Study|Protocol Deviations|3|||
125212703|NCT01153009|450405430|FG002|Overall Study|Protocol Deviations|3|||
125212704|NCT01153009|450405431|FG003|Overall Study|Protocol Deviations|2|||
125212705|NCT01153009|450405428|FG000|Overall Study|Withdrawal of Consent|5|||
125212706|NCT01153009|450405429|FG001|Overall Study|Withdrawal of Consent|5|||
125024493|NCT03434379|449711482|FG002|Global Period|Death|0|||
125024494|NCT03434379|449711483|FG003|Global Period|Death|0|||
125024495|NCT03434379|449711480|FG000|Global Period|Withdrawal by Subject|20|||
125024496|NCT03434379|449711481|FG001|Global Period|Withdrawal by Subject|21|||
125024497|NCT03434379|449711482|FG002|Global Period|Withdrawal by Subject|0|||
125024498|NCT03434379|449711483|FG003|Global Period|Withdrawal by Subject|0|||
125024499|NCT03434379|449711480|FG000|Global Period|Reason Unspecified|0|||
125024500|NCT03434379|449711481|FG001|Global Period|Reason Unspecified|1|||
125024501|NCT03434379|449711482|FG002|Global Period|Reason Unspecified|0|||
125024502|NCT03434379|449711483|FG003|Global Period|Reason Unspecified|0|||
125024503|NCT03434379|449711480|FG000|Global Period|Study Ended by Sponsor|26|||
125024504|NCT03434379|449711481|FG001|Global Period|Study Ended by Sponsor|80|||
125212707|NCT01153009|450405430|FG002|Overall Study|Withdrawal of Consent|4|||
125212708|NCT01153009|450405431|FG003|Overall Study|Withdrawal of Consent|6|||
125212709|NCT01153009|450405428|FG000|Overall Study|Lost to Follow-up|8|||
125212710|NCT01153009|450405429|FG001|Overall Study|Lost to Follow-up|8|||
125024505|NCT03434379|449711482|FG002|Global Period|Study Ended by Sponsor|0|||
125024506|NCT03434379|449711483|FG003|Global Period|Study Ended by Sponsor|0|||
125212711|NCT01153009|450405430|FG002|Overall Study|Lost to Follow-up|11|||
125212712|NCT01153009|450405431|FG003|Overall Study|Lost to Follow-up|15|||
125212713|NCT01153009|450405428|FG000|Overall Study|Other|1|||
125212714|NCT01153009|450405429|FG001|Overall Study|Other|1|||
125212715|NCT01153009|450405430|FG002|Overall Study|Other|3|||
125024507|NCT03434379|449711480|FG000|Global Period|Physician Decision|1|||
125024508|NCT03434379|449711481|FG001|Global Period|Physician Decision|0|||
125024509|NCT03434379|449711482|FG002|Global Period|Physician Decision|0|||
125024510|NCT03434379|449711483|FG003|Global Period|Physician Decision|0|||
125024511|NCT03434379|449711480|FG000|China Extension Period|Lost to Follow-up|0|||
124929098|NCT04800211|449371964|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
124929099|NCT04800211|449371962|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
124929100|NCT04800211|449371963|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
124929101|NCT04800211|449371964|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
124929102|NCT04800211|449371962|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
124929103|NCT04800211|449371963|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
124929104|NCT04800211|449371964|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
125212716|NCT01153009|450405431|FG003|Overall Study|Other|2|||
125212717|NCT04003623|450405435|FG000|Overall Study|Withdrawal by Subject|1|||
125024512|NCT03434379|449711481|FG001|China Extension Period|Lost to Follow-up|0|||
125024513|NCT03434379|449711482|FG002|China Extension Period|Lost to Follow-up|2|||
125212718|NCT04003623|450405436|FG001|Overall Study|Withdrawal by Subject|0|||
125212719|NCT00703326|450405438|FG000|Overall Study|Lost to Follow-up|47|||
125212720|NCT00703326|450405439|FG001|Overall Study|Lost to Follow-up|18|||
125212721|NCT00703326|450405438|FG000|Overall Study|Withdrawal by Subject|54|||
125212722|NCT00703326|450405439|FG001|Overall Study|Withdrawal by Subject|20|||
125212723|NCT00703326|450405438|FG000|Overall Study|Adverse Event|1|||
125212724|NCT00703326|450405439|FG001|Overall Study|Adverse Event|0|||
125212725|NCT01190189|450405443|FG000|Overall Study|Lost to Follow-up|4|||
125212726|NCT01190189|450405443|FG000|Overall Study|Withdrawal by Subject|1|||
125212727|NCT01190189|450405443|FG000|Overall Study|Migrated/moved from study area|1|||
125212728|NCT03214679|450405445|FG000|Overall Study|Lost to Follow-up|12|||
125212729|NCT03214679|450405446|FG001|Overall Study|Lost to Follow-up|14|||
125212730|NCT03214679|450405445|FG000|Overall Study|not eligible|2|||
125212731|NCT03214679|450405446|FG001|Overall Study|not eligible|0|||
125212732|NCT04571385|450405461|FG000|Overall Study|Participant non-compliance|1|||
125212733|NCT04571385|450405462|FG001|Overall Study|Participant non-compliance|0|||
125212734|NCT04571385|450405463|FG002|Overall Study|Participant non-compliance|0|||
125212735|NCT04571385|450405461|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
125212736|NCT04571385|450405462|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
125212737|NCT04571385|450405463|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
125024514|NCT03434379|449711483|FG003|China Extension Period|Lost to Follow-up|3|||
125024515|NCT03434379|449711480|FG000|China Extension Period|Death|0|||
125024516|NCT03434379|449711481|FG001|China Extension Period|Death|0|||
125120137|NCT00911859|450063320|FG000|Treatment Period|Lack of Efficacy|1|||
125120138|NCT00911859|450063321|FG001|Treatment Period|Lack of Efficacy|7|||
125120139|NCT00911859|450063322|FG002|Treatment Period|Lack of Efficacy|5|||
124929111|NCT04730739|449371967|FG000|Overall Study|Death|1|||
124929112|NCT05170841|449371968|FG000|Single Dose Phase|Adverse Event|1|||
124929113|NCT05170841|449371969|FG001|Single Dose Phase|Adverse Event|2|||
124929114|NCT05170841|449371970|FG002|Single Dose Phase|Adverse Event|0|||
125212738|NCT04571385|450405461|FG000|Overall Study|Screen failure|0|||
125212739|NCT04571385|450405462|FG001|Overall Study|Screen failure|0|||
125212740|NCT04571385|450405463|FG002|Overall Study|Screen failure|1|||
125212741|NCT02263729|450405465|FG000|Overall Study|Lost to Follow-up|1|||
125212742|NCT02263729|450405466|FG001|Overall Study|Lost to Follow-up|1|||
125212743|NCT01212159|450405467|FG000|Overall Study|Withdrawal by Subject|12|||
125212744|NCT01212159|450405468|FG001|Overall Study|Withdrawal by Subject|12|||
125212745|NCT01502956|450405476|FG000|Overall Study|Death|0|||
125212746|NCT01502956|450405477|FG001|Overall Study|Death|2|||
125212747|NCT01502956|450405476|FG000|Overall Study|Lost to Follow-up|14|||
125212748|NCT01502956|450405477|FG001|Overall Study|Lost to Follow-up|11|||
124929115|NCT05170841|449371971|FG003|Single Dose Phase|Adverse Event|2|||
124929116|NCT05170841|449371968|FG000|Multiple Dose Phase|Adverse Event|1|||
124929117|NCT05170841|449371969|FG001|Multiple Dose Phase|Adverse Event|2|||
124929118|NCT05170841|449371970|FG002|Multiple Dose Phase|Adverse Event|1|||
124929119|NCT05170841|449371971|FG003|Multiple Dose Phase|Adverse Event|4|||
124929120|NCT05170841|449371968|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
124929121|NCT05170841|449371969|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
124929122|NCT05170841|449371970|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
124929123|NCT05170841|449371971|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
124929124|NCT05123586|449371974|FG000|Overall Study|Physician Decision|1|||
124929125|NCT05123586|449371975|FG001|Overall Study|Physician Decision|1|||
124929126|NCT05123586|449371974|FG000|Overall Study|Withdrawal by Subject|0|||
124929127|NCT05123586|449371975|FG001|Overall Study|Withdrawal by Subject|3|||
124929128|NCT04865289|449371976|FG000|Overall Study|Participant ongoing in study|47|||
125212749|NCT01502956|450405476|FG000|Overall Study|Physician Decision|2|||
125212750|NCT01502956|450405477|FG001|Overall Study|Physician Decision|3|||
125212751|NCT01502956|450405476|FG000|Overall Study|Withdrawal by Subject|8|||
124929129|NCT04865289|449371977|FG001|Overall Study|Participant ongoing in study|35|||
125024517|NCT03434379|449711482|FG002|China Extension Period|Death|46|||
125024518|NCT03434379|449711483|FG003|China Extension Period|Death|88|||
125024519|NCT03434379|449711480|FG000|China Extension Period|Withdrawal by Subject|0|||
125024520|NCT03434379|449711481|FG001|China Extension Period|Withdrawal by Subject|0|||
125024521|NCT03434379|449711482|FG002|China Extension Period|Withdrawal by Subject|8|||
125212752|NCT01502956|450405477|FG001|Overall Study|Withdrawal by Subject|10|||
125212753|NCT01026818|450405478|FG000|Screening Period|Entry Criteria Not Met|105|||
125212754|NCT01026818|450405479|FG001|Screening Period|Entry Criteria Not Met|0|||
125024522|NCT03434379|449711483|FG003|China Extension Period|Withdrawal by Subject|6|||
125212755|NCT01026818|450405480|FG002|Screening Period|Entry Criteria Not Met|0|||
125212756|NCT01026818|450405481|FG003|Screening Period|Entry Criteria Not Met|0|||
125212757|NCT01026818|450405478|FG000|Screening Period|Withdrawal by Subject|49|||
125212758|NCT01026818|450405479|FG001|Screening Period|Withdrawal by Subject|0|||
125212759|NCT01026818|450405480|FG002|Screening Period|Withdrawal by Subject|0|||
125212760|NCT01026818|450405481|FG003|Screening Period|Withdrawal by Subject|0|||
125212761|NCT01026818|450405478|FG000|Screening Period|Protocol Deviation|3|||
124929130|NCT04865289|449371976|FG000|Overall Study|Death|27|||
124929131|NCT04865289|449371977|FG001|Overall Study|Death|21|||
124929132|NCT04677738|449371978|FG000|Overall Study|Withdrawal by Subject|4|||
125212762|NCT01026818|450405479|FG001|Screening Period|Protocol Deviation|0|||
125212763|NCT01026818|450405480|FG002|Screening Period|Protocol Deviation|0|||
125212764|NCT01026818|450405481|FG003|Screening Period|Protocol Deviation|0|||
124929133|NCT04677738|449371979|FG001|Overall Study|Withdrawal by Subject|2|||
124929134|NCT04707469|449371980|FG000|Overall Study|Site closure|0|||
124929135|NCT04707469|449371981|FG001|Overall Study|Site closure|2|||
124929136|NCT04707469|449371982|FG002|Overall Study|Site closure|0|||
124929137|NCT04707469|449371980|FG000|Overall Study|Physician Decision|2|||
124929138|NCT04707469|449371981|FG001|Overall Study|Physician Decision|2|||
124929139|NCT04707469|449371982|FG002|Overall Study|Physician Decision|2|||
124929140|NCT04707469|449371980|FG000|Overall Study|Death|1|||
124929141|NCT04707469|449371981|FG001|Overall Study|Death|6|||
124929142|NCT04707469|449371982|FG002|Overall Study|Death|2|||
124929143|NCT04707469|449371980|FG000|Overall Study|Lost to Follow-up|9|||
124929144|NCT04707469|449371981|FG001|Overall Study|Lost to Follow-up|19|||
124929145|NCT04707469|449371982|FG002|Overall Study|Lost to Follow-up|14|||
124929146|NCT04707469|449371980|FG000|Overall Study|Withdrawal by Subject|17|||
124929147|NCT04707469|449371981|FG001|Overall Study|Withdrawal by Subject|16|||
124929148|NCT04707469|449371982|FG002|Overall Study|Withdrawal by Subject|12|||
124929149|NCT02733159|449371983|FG000|Overall Study|Adverse Event|1|||
124929150|NCT02733159|449371983|FG000|Overall Study|Lack of disease progression|1|||
124929151|NCT06122194|449371986|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
124929152|NCT06122194|449371987|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
124929153|NCT06122194|449371988|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
124929154|NCT06122194|449371989|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
124929155|NCT02724969|449371996|FG000|Overall Study|Lost to Follow-up|12|||
124929156|NCT02724969|449371997|FG001|Overall Study|Lost to Follow-up|6|||
124929157|NCT02724969|449371996|FG000|Overall Study|Withdrawal by Subject|3|||
124929158|NCT02724969|449371997|FG001|Overall Study|Withdrawal by Subject|3|||
124929159|NCT02724969|449371996|FG000|Overall Study|Infant demise|0|||
124929160|NCT02724969|449371997|FG001|Overall Study|Infant demise|2|||
124929161|NCT01309672|449372000|FG000|Overall Study|Lack of Efficacy|20|||
124929162|NCT01309672|449372000|FG000|Overall Study|Other|9|||
124929163|NCT01309672|449372000|FG000|Overall Study|Adverse Event|5|||
124929164|NCT01309672|449372000|FG000|Overall Study|Withdrawal by Subject|3|||
124929165|NCT03626220|449372002|FG000|Overall Study|Withdrawal by Subject|2|||
124929166|NCT03626220|449372003|FG001|Overall Study|Withdrawal by Subject|0|||
124929167|NCT03916185|449373160|FG000|Overall Study|Lost to Follow-up|0|||
124929168|NCT03916185|449373161|FG001|Overall Study|Lost to Follow-up|1|||
124929169|NCT03916185|449373162|FG002|Overall Study|Lost to Follow-up|0|||
124929170|NCT03916185|449373163|FG003|Overall Study|Lost to Follow-up|0|||
124929171|NCT03916185|449373160|FG000|Overall Study|Moved|1|||
124929172|NCT03916185|449373161|FG001|Overall Study|Moved|0|||
124929173|NCT03916185|449373162|FG002|Overall Study|Moved|0|||
125120140|NCT00911859|450063320|FG000|Treatment Period|Physician Decision|3|||
125120141|NCT00911859|450063321|FG001|Treatment Period|Physician Decision|3|||
125120142|NCT00911859|450063322|FG002|Treatment Period|Physician Decision|3|||
125120143|NCT00911859|450063320|FG000|Treatment Period|Withdrawal by Subject|0|||
125120144|NCT00911859|450063321|FG001|Treatment Period|Withdrawal by Subject|4|||
125120145|NCT00911859|450063322|FG002|Treatment Period|Withdrawal by Subject|5|||
124929174|NCT03916185|449373163|FG003|Overall Study|Moved|1|||
124929175|NCT03916185|449373160|FG000|Overall Study|Not Able to Get to Clinic|1|||
124929176|NCT03916185|449373161|FG001|Overall Study|Not Able to Get to Clinic|0|||
124929177|NCT03916185|449373162|FG002|Overall Study|Not Able to Get to Clinic|0|||
124929178|NCT03916185|449373163|FG003|Overall Study|Not Able to Get to Clinic|0|||
124929179|NCT02593773|449373177|FG000|Overall Study|Voluntary Withdrawal|3|||
124929180|NCT02593773|449373177|FG000|Overall Study|Study Terminated by Sponsor|31|||
124929181|NCT02593773|449373177|FG000|Overall Study|Death|1|||
124929182|NCT05934942|449373183|FG000|Run-in Period|Not treated|1|||
124929183|NCT05934942|449373183|FG000|Run-in Period|Withdrawal by Subject|1|||
125120146|NCT00911859|450063320|FG000|Treatment Period|Did not receive study treatment|0|||
125120147|NCT00911859|450063321|FG001|Treatment Period|Did not receive study treatment|1|||
125024523|NCT03434379|449711480|FG000|China Extension Period|Study Ended by Sponsor|0|||
125024524|NCT03434379|449711481|FG001|China Extension Period|Study Ended by Sponsor|0|||
125024525|NCT03434379|449711482|FG002|China Extension Period|Study Ended by Sponsor|5|||
125024526|NCT03434379|449711483|FG003|China Extension Period|Study Ended by Sponsor|36|||
125024527|NCT03687502|449711488|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
125024528|NCT03687502|449711488|FG000|Overall Study|Lumason not available|1|||
125024529|NCT04949841|449711492|FG000|Overall Study|Adverse Event|7|||
125024530|NCT04949841|449711492|FG000|Overall Study|Death|1|||
125024531|NCT04949841|449711492|FG000|Overall Study|Withdrawal by Subject|52|||
125120148|NCT00911859|450063322|FG002|Treatment Period|Did not receive study treatment|0|||
125120149|NCT00911859|450063320|FG000|Maintainance Period|Lack of Efficacy|0|||
125120150|NCT00911859|450063321|FG001|Maintainance Period|Lack of Efficacy|0|||
125120151|NCT00911859|450063322|FG002|Maintainance Period|Lack of Efficacy|9|||
125120152|NCT00911859|450063320|FG000|Maintainance Period|Physician Decision|0|||
125120153|NCT00911859|450063321|FG001|Maintainance Period|Physician Decision|0|||
125120154|NCT00911859|450063322|FG002|Maintainance Period|Physician Decision|9|||
125120155|NCT00911859|450063320|FG000|Maintainance Period|Withdrawal by Subject|0|||
125120156|NCT00911859|450063321|FG001|Maintainance Period|Withdrawal by Subject|0|||
125024532|NCT04949841|449711492|FG000|Overall Study|Pregnancy|4|||
125024533|NCT04949841|449711492|FG000|Overall Study|Lost to Follow-up|9|||
125024534|NCT04949841|449711492|FG000|Overall Study|Lack of Efficacy|55|||
125024535|NCT04949841|449711492|FG000|Overall Study|Various reasons|9|||
125024536|NCT01777581|449711493|FG000|Overall Study|Lost to Follow-up|1|||
125120157|NCT00911859|450063322|FG002|Maintainance Period|Withdrawal by Subject|3|||
125120158|NCT00911859|450063320|FG000|Follow-up Period|Death|5|||
124929184|NCT04471246|449373186|FG000|Overall Study|Lost to Follow-up|2|||
124929185|NCT04471246|449373187|FG001|Overall Study|Lost to Follow-up|2|||
124929186|NCT03386578|449373189|FG000|PK Component|Lost to Follow-up|0|||
124929187|NCT03386578|449373190|FG001|PK Component|Lost to Follow-up|1|||
124929188|NCT03386578|449373191|FG002|PK Component|Lost to Follow-up|0|||
124929189|NCT03386578|449373192|FG003|PK Component|Lost to Follow-up|0|||
124929190|NCT03386578|449373193|FG004|PK Component|Lost to Follow-up|0|||
124929191|NCT03386578|449373194|FG005|PK Component|Lost to Follow-up|0|||
124929192|NCT03386578|449373195|FG006|PK Component|Lost to Follow-up|1|||
124929193|NCT03386578|449373196|FG007|PK Component|Lost to Follow-up|0|||
124929194|NCT03386578|449373197|FG008|PK Component|Lost to Follow-up|0|||
124929195|NCT03386578|449373198|FG009|PK Component|Lost to Follow-up|0|||
124929196|NCT03386578|449373189|FG000|PK Component|Stillbirth/Abortion|0|||
124929197|NCT03386578|449373190|FG001|PK Component|Stillbirth/Abortion|0|||
124929198|NCT03386578|449373191|FG002|PK Component|Stillbirth/Abortion|0|||
124929199|NCT03386578|449373192|FG003|PK Component|Stillbirth/Abortion|0|||
124929200|NCT03386578|449373193|FG004|PK Component|Stillbirth/Abortion|0|||
124929201|NCT03386578|449373194|FG005|PK Component|Stillbirth/Abortion|2|||
124929202|NCT03386578|449373195|FG006|PK Component|Stillbirth/Abortion|0|||
124929203|NCT03386578|449373196|FG007|PK Component|Stillbirth/Abortion|0|||
124929204|NCT03386578|449373197|FG008|PK Component|Stillbirth/Abortion|0|||
124929205|NCT03386578|449373198|FG009|PK Component|Stillbirth/Abortion|0|||
124929206|NCT03386578|449373189|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
124929207|NCT03386578|449373190|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
124929208|NCT03386578|449373191|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
124929209|NCT03386578|449373192|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
124929210|NCT03386578|449373193|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
124929211|NCT03386578|449373194|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
124929212|NCT03386578|449373195|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
124929213|NCT03386578|449373196|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
124929214|NCT03386578|449373197|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
124929215|NCT03386578|449373198|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
124929216|NCT03386578|449373189|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
124929217|NCT03386578|449373190|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
124929218|NCT03386578|449373191|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
124929219|NCT03386578|449373192|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
124929220|NCT03386578|449373193|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
124929221|NCT03386578|449373194|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
124929222|NCT03386578|449373195|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
124929223|NCT03386578|449373196|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
124929224|NCT03386578|449373197|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
124929225|NCT03386578|449373198|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
124929226|NCT03386578|449373189|FG000|PrEP Comparison Component Step 1|Death|0|||
124929227|NCT03386578|449373190|FG001|PrEP Comparison Component Step 1|Death|0|||
124929228|NCT03386578|449373191|FG002|PrEP Comparison Component Step 1|Death|1|||
124929229|NCT03386578|449373192|FG003|PrEP Comparison Component Step 1|Death|0|||
125024537|NCT01777581|449711494|FG001|Overall Study|Lost to Follow-up|1|||
125024538|NCT01777581|449711493|FG000|Overall Study|Adverse Event|2|||
125024539|NCT01777581|449711494|FG001|Overall Study|Adverse Event|0|||
125024540|NCT01777581|449711493|FG000|Overall Study|Lack of Efficacy|0|||
125024541|NCT01777581|449711494|FG001|Overall Study|Lack of Efficacy|1|||
125024542|NCT01634555|449711499|FG000|Overall Study|Adverse Event|3|||
125024543|NCT01634555|449711499|FG000|Overall Study|Physician Decision|1|||
125024544|NCT06228586|449711500|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
125024545|NCT06228586|449711501|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
125024546|NCT01299766|449713018|FG000|Overall Study|Death|5|||
125024547|NCT01299766|449713019|FG001|Overall Study|Death|4|||
125024548|NCT01299766|449713018|FG000|Overall Study|Withdrawal by Subject|29|||
125024549|NCT01299766|449713019|FG001|Overall Study|Withdrawal by Subject|19|||
125024550|NCT03064763|449713022|FG000|Overall Study|Lost to Follow-up|1|||
125024551|NCT03064763|449713022|FG000|Overall Study|Death|8|||
125024552|NCT00403260|449713023|FG000|Overall Study|Adverse Event|5|||
125024553|NCT00403260|449713024|FG001|Overall Study|Adverse Event|4|||
125024554|NCT00403260|449713023|FG000|Overall Study|Withdrawal by Subject|5|||
125024555|NCT00403260|449713024|FG001|Overall Study|Withdrawal by Subject|6|||
125024556|NCT00403260|449713023|FG000|Overall Study|Lost to Follow-up|49|||
125024557|NCT00403260|449713024|FG001|Overall Study|Lost to Follow-up|25|||
125024558|NCT00403260|449713023|FG000|Overall Study|Re-appearance of P. falciparum|34|||
125024559|NCT00403260|449713024|FG001|Overall Study|Re-appearance of P. falciparum|25|||
125024560|NCT00403260|449713023|FG000|Overall Study|P. vivax infection|26|||
125024561|NCT00403260|449713024|FG001|Overall Study|P. vivax infection|4|||
125024562|NCT00403260|449713023|FG000|Overall Study|Mixed infection with P. vivax|2|||
124929230|NCT03386578|449373193|FG004|PrEP Comparison Component Step 1|Death|0|||
124929231|NCT03386578|449373194|FG005|PrEP Comparison Component Step 1|Death|0|||
124929232|NCT03386578|449373195|FG006|PrEP Comparison Component Step 1|Death|0|||
124929233|NCT03386578|449373196|FG007|PrEP Comparison Component Step 1|Death|9|||
124929234|NCT03386578|449373197|FG008|PrEP Comparison Component Step 1|Death|5|||
124929235|NCT03386578|449373198|FG009|PrEP Comparison Component Step 1|Death|0|||
124929236|NCT03386578|449373189|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
124929237|NCT03386578|449373190|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
124929238|NCT03386578|449373191|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
124929239|NCT03386578|449373192|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
124929240|NCT03386578|449373193|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
124929241|NCT03386578|449373194|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
124929242|NCT03386578|449373195|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
124929243|NCT03386578|449373196|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
124929244|NCT03386578|449373197|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
124929245|NCT03386578|449373198|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
124929246|NCT03386578|449373189|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
124929247|NCT03386578|449373190|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
124929248|NCT03386578|449373191|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
124929249|NCT03386578|449373192|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
124929250|NCT03386578|449373193|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
125120159|NCT00911859|450063321|FG001|Follow-up Period|Death|8|||
125120160|NCT00911859|450063322|FG002|Follow-up Period|Death|10|||
125120161|NCT00911859|450063320|FG000|Follow-up Period|Lost to Follow-up|1|||
125120162|NCT00911859|450063321|FG001|Follow-up Period|Lost to Follow-up|1|||
125120163|NCT00911859|450063322|FG002|Follow-up Period|Lost to Follow-up|0|||
125120164|NCT00911859|450063320|FG000|Follow-up Period|Withdrawal by Subject|0|||
125212765|NCT01026818|450405478|FG000|Screening Period|Adverse Event|2|||
125024563|NCT00403260|449713024|FG001|Overall Study|Mixed infection with P. vivax|0|||
125024564|NCT00403260|449713023|FG000|Overall Study|Mixed infection with P. falciparum|1|||
125024565|NCT00403260|449713024|FG001|Overall Study|Mixed infection with P. falciparum|0|||
125024566|NCT00403260|449713023|FG000|Overall Study|P. vivax infection at screening|1|||
125024567|NCT00403260|449713024|FG001|Overall Study|P. vivax infection at screening|0|||
125024568|NCT00403260|449713023|FG000|Overall Study|P. ovale infection|1|||
125024569|NCT00403260|449713024|FG001|Overall Study|P. ovale infection|0|||
125024570|NCT00403260|449713023|FG000|Overall Study|Gametocyte re-appearance|1|||
125024571|NCT00403260|449713024|FG001|Overall Study|Gametocyte re-appearance|1|||
125024572|NCT00403260|449713023|FG000|Overall Study|Withdrawn from study accidentally|0|||
125024573|NCT00403260|449713024|FG001|Overall Study|Withdrawn from study accidentally|1|||
125024574|NCT01354028|449713025|FG000|Overall Study|Physician Decision|0|||
125024575|NCT01354028|449713026|FG001|Overall Study|Physician Decision|2|||
124929251|NCT03386578|449373194|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
124929252|NCT03386578|449373195|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
124929253|NCT03386578|449373196|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
124929254|NCT03386578|449373197|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
124929255|NCT03386578|449373198|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
124929256|NCT03386578|449373189|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
124929257|NCT03386578|449373190|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
124929258|NCT03386578|449373191|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
124929259|NCT03386578|449373192|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
124929260|NCT03386578|449373193|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
124929261|NCT03386578|449373194|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
124929262|NCT03386578|449373195|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
124929263|NCT03386578|449373196|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
124929264|NCT03386578|449373197|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
124929265|NCT03386578|449373198|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
124929266|NCT05907174|449373199|FG000|3-Month Assessment|Withdrawal by Subject|0|||
124929267|NCT05907174|449373200|FG001|3-Month Assessment|Withdrawal by Subject|0|||
124929268|NCT05907174|449373201|FG002|3-Month Assessment|Withdrawal by Subject|0|||
124929269|NCT05907174|449373202|FG003|3-Month Assessment|Withdrawal by Subject|1|||
124929270|NCT05907174|449373199|FG000|3-Month Assessment|Lost to Follow-up|1|||
124929271|NCT05907174|449373200|FG001|3-Month Assessment|Lost to Follow-up|1|||
124929272|NCT05907174|449373201|FG002|3-Month Assessment|Lost to Follow-up|1|||
124929273|NCT05907174|449373202|FG003|3-Month Assessment|Lost to Follow-up|1|||
124929274|NCT05907174|449373199|FG000|6-Month Assessment|Death|0|||
124929275|NCT05907174|449373200|FG001|6-Month Assessment|Death|0|||
124929276|NCT05907174|449373201|FG002|6-Month Assessment|Death|3|||
124929277|NCT05907174|449373202|FG003|6-Month Assessment|Death|0|||
124929278|NCT05907174|449373199|FG000|6-Month Assessment|Withdrawal by Subject|0|||
124929279|NCT05907174|449373200|FG001|6-Month Assessment|Withdrawal by Subject|0|||
124929280|NCT05907174|449373201|FG002|6-Month Assessment|Withdrawal by Subject|1|||
124929281|NCT05907174|449373202|FG003|6-Month Assessment|Withdrawal by Subject|1|||
124929282|NCT05907174|449373199|FG000|6-Month Assessment|Lost to Follow-up|0|||
124929283|NCT05907174|449373200|FG001|6-Month Assessment|Lost to Follow-up|1|||
124929284|NCT05907174|449373201|FG002|6-Month Assessment|Lost to Follow-up|1|||
124929285|NCT05907174|449373202|FG003|6-Month Assessment|Lost to Follow-up|1|||
124929286|NCT02668692|449373206|FG000|Overall Study|Adverse Event|1|||
124929287|NCT02668692|449373207|FG001|Overall Study|Adverse Event|0|||
124929288|NCT01627574|449373212|FG000|Overall Study|Withdrawal by Subject|8|||
124929289|NCT01627574|449373213|FG001|Overall Study|Withdrawal by Subject|5|||
124929290|NCT01627574|449373212|FG000|Overall Study|Lost to Follow-up|13|||
124929291|NCT01627574|449373213|FG001|Overall Study|Lost to Follow-up|13|||
124929292|NCT03734679|449373222|FG000|Overall Study|Missed Visit|1|||
124929293|NCT03249090|449373224|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
124929294|NCT03249090|449373225|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
124929295|NCT03249090|449373224|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
124929296|NCT03249090|449373225|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
124929297|NCT03249090|449373224|FG000|3 Month Time Point|Voluntary withdrawal|6|||
124929298|NCT03249090|449373225|FG001|3 Month Time Point|Voluntary withdrawal|3|||
124929299|NCT03249090|449373224|FG000|3 Month Time Point|Changed oncology practice|4|||
124929300|NCT03249090|449373225|FG001|3 Month Time Point|Changed oncology practice|2|||
124929301|NCT03249090|449373224|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
124929302|NCT03249090|449373225|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
124929303|NCT03249090|449373224|FG000|12 Month Time Point|Voluntary withdrawal|35|||
124929304|NCT03249090|449373225|FG001|12 Month Time Point|Voluntary withdrawal|4|||
124929305|NCT03249090|449373224|FG000|12 Month Time Point|Changed oncology practice|20|||
124929306|NCT03249090|449373225|FG001|12 Month Time Point|Changed oncology practice|9|||
124929307|NCT03362476|449373233|FG000|Overall Study|Withdrawal by Subject|0|||
124929308|NCT03362476|449373234|FG001|Overall Study|Withdrawal by Subject|1|||
124929309|NCT05974501|449373235|FG000|Overall Study|Physician Decision|0|||
124929310|NCT05974501|449373236|FG001|Overall Study|Physician Decision|1|||
124929311|NCT04270942|449373237|FG000|Overall Study|Death|1|||
124929312|NCT04295512|449373247|FG000|Overall Study|Lack of family response to schedule assessment|0|||
124929313|NCT04295512|449373248|FG001|Overall Study|Lack of family response to schedule assessment|0|||
125024576|NCT01354028|449713025|FG000|Overall Study|Discharged before study start|2|||
125212766|NCT01026818|450405479|FG001|Screening Period|Adverse Event|0|||
125024577|NCT01354028|449713026|FG001|Overall Study|Discharged before study start|2|||
125024578|NCT01354028|449713025|FG000|Overall Study|No quiet alert state|0|||
125024579|NCT01354028|449713026|FG001|Overall Study|No quiet alert state|1|||
125024580|NCT00935883|449713029|FG000|Treatment Period|Physician Decision|1|||
125024581|NCT00935883|449713030|FG001|Treatment Period|Physician Decision|0|||
125024582|NCT00935883|449713029|FG000|Treatment Period|Withdrawal by Subject|0|||
125024583|NCT00935883|449713030|FG001|Treatment Period|Withdrawal by Subject|2|||
125024584|NCT00975156|449713037|FG000|Overall Study|Protocol Violation|0|||
125024585|NCT00975156|449713038|FG001|Overall Study|Protocol Violation|1|||
125024586|NCT01946178|449713043|FG000|Overall Study|Pregnancy|1|||
125024587|NCT01946178|449713043|FG000|Overall Study|Lost to Follow-up|1|||
125024588|NCT02421887|449713044|FG000|Overall Study|Lost to Follow-up|5|||
125024589|NCT02421887|449713045|FG001|Overall Study|Lost to Follow-up|0|||
125024590|NCT02421887|449713044|FG000|Overall Study|Withdrawal by Subject|8|||
125024591|NCT02421887|449713045|FG001|Overall Study|Withdrawal by Subject|5|||
125024592|NCT02421887|449713044|FG000|Overall Study|Physician Decision|2|||
125024593|NCT02421887|449713045|FG001|Overall Study|Physician Decision|4|||
125024594|NCT02421887|449713044|FG000|Overall Study|Adverse Event|2|||
125024595|NCT02421887|449713045|FG001|Overall Study|Adverse Event|0|||
125024596|NCT01622569|449713046|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
125024597|NCT01622569|449713047|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
125024598|NCT01622569|449713048|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
125024599|NCT01622569|449713049|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
125024600|NCT01622569|449713046|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
125024601|NCT01622569|449713047|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
125024602|NCT01622569|449713048|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
125024603|NCT01622569|449713049|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
125024604|NCT01622569|449713046|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
125024605|NCT01622569|449713047|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
125024606|NCT01622569|449713048|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
125024607|NCT01622569|449713049|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
125024608|NCT01622569|449713046|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
125024609|NCT01622569|449713047|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
125024610|NCT01622569|449713048|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
125024611|NCT01622569|449713049|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
125024612|NCT01622569|449713046|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
125024613|NCT01622569|449713047|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
125024614|NCT01622569|449713048|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
125024615|NCT01622569|449713049|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
125212767|NCT01026818|450405480|FG002|Screening Period|Adverse Event|0|||
124929314|NCT04295512|449373249|FG002|Overall Study|Lack of family response to schedule assessment|0|||
124929315|NCT04295512|449373250|FG003|Overall Study|Lack of family response to schedule assessment|2|||
124929316|NCT04295512|449373247|FG000|Overall Study|Therapist did not refer eligible family|7|||
124929317|NCT04295512|449373248|FG001|Overall Study|Therapist did not refer eligible family|7|||
124929318|NCT04295512|449373249|FG002|Overall Study|Therapist did not refer eligible family|0|||
124929319|NCT04295512|449373250|FG003|Overall Study|Therapist did not refer eligible family|0|||
124929320|NCT05623228|449373257|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
124929321|NCT05623228|449373258|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
125024616|NCT01622569|449713046|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
125212768|NCT01026818|450405481|FG003|Screening Period|Adverse Event|0|||
125024617|NCT01622569|449713047|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
125024618|NCT01622569|449713048|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
125024619|NCT01622569|449713049|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
125024620|NCT01622569|449713046|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
125024621|NCT01622569|449713047|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
125024622|NCT01622569|449713048|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
125024623|NCT01622569|449713049|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
125024624|NCT01622569|449713046|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
125024625|NCT01622569|449713047|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
125024626|NCT01622569|449713048|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
125024627|NCT01622569|449713049|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
125024628|NCT01505894|449713050|FG000|Overall Study|Adverse Event|1|||
124929322|NCT05623228|449373259|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
124929323|NCT05623228|449373260|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
125120165|NCT00911859|450063321|FG001|Follow-up Period|Withdrawal by Subject|4|||
125120166|NCT00911859|450063322|FG002|Follow-up Period|Withdrawal by Subject|4|||
125120167|NCT00911859|450063320|FG000|Follow-up Period|Study terminated by sponsor|5|||
125120168|NCT00911859|450063321|FG001|Follow-up Period|Study terminated by sponsor|33|||
125120169|NCT00911859|450063322|FG002|Follow-up Period|Study terminated by sponsor|27|||
125120170|NCT01048333|450063323|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
125120171|NCT01048333|450063324|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
125120172|NCT01048333|450063325|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
125120173|NCT01048333|450063326|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
125120174|NCT01048333|450063327|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
125120175|NCT01048333|450063328|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
125120176|NCT00634179|450063338|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
125120177|NCT00767325|450063339|FG000|Overall Study|Lack of Efficacy|2|||
125120178|NCT00767325|450063339|FG000|Overall Study|Adverse Event|7|||
125120179|NCT00767325|450063339|FG000|Overall Study|Lost to Follow-up|3|||
125120180|NCT00767325|450063339|FG000|Overall Study|No longer met study criteria|2|||
125120181|NCT00767325|450063339|FG000|Overall Study|Missed visit due to family reasons|1|||
125120182|NCT03538756|450063340|FG000|Long-Term Follow-up|Adverse Event|0|||
125120183|NCT03538756|450063341|FG001|Long-Term Follow-up|Adverse Event|0|||
125120184|NCT03538756|450063342|FG002|Long-Term Follow-up|Adverse Event|6|||
125120185|NCT03538756|450063340|FG000|Long-Term Follow-up|Death|0|||
125120186|NCT03538756|450063341|FG001|Long-Term Follow-up|Death|0|||
125120187|NCT03538756|450063342|FG002|Long-Term Follow-up|Death|1|||
125120188|NCT03538756|450063340|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
125120189|NCT03538756|450063341|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
125120190|NCT03538756|450063342|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
125120191|NCT03538756|450063340|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
125120192|NCT03538756|450063341|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
125120193|NCT03538756|450063342|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
125120194|NCT03538756|450063340|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
125120195|NCT03538756|450063341|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
125120196|NCT03538756|450063342|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
125120197|NCT00752856|450063343|FG000|Overall Study|randomized but did not do viral kinetics|0|||
125120198|NCT00752856|450063344|FG001|Overall Study|randomized but did not do viral kinetics|1|||
125120199|NCT03131999|450063345|FG000|Overall Study|Withdrawal by Subject|0|||
125120200|NCT03131999|450063346|FG001|Overall Study|Withdrawal by Subject|1|||
125120201|NCT02260492|450063347|FG000|Overall Study|Adverse Event|6|||
125120202|NCT02260492|450063348|FG001|Overall Study|Adverse Event|1|||
125120203|NCT02260492|450063349|FG002|Overall Study|Adverse Event|2|||
125120204|NCT02260492|450063347|FG000|Overall Study|Death|0|||
125120205|NCT02260492|450063348|FG001|Overall Study|Death|1|||
125120206|NCT02260492|450063349|FG002|Overall Study|Death|0|||
125120207|NCT02260492|450063347|FG000|Overall Study|Lost to Follow-up|12|||
125120208|NCT02260492|450063348|FG001|Overall Study|Lost to Follow-up|9|||
125120209|NCT02260492|450063349|FG002|Overall Study|Lost to Follow-up|0|||
125120210|NCT02260492|450063347|FG000|Overall Study|Physician Decision|2|||
125120211|NCT02260492|450063348|FG001|Overall Study|Physician Decision|0|||
125024629|NCT01505894|449713051|FG001|Overall Study|Adverse Event|0|||
125024630|NCT01505894|449713052|FG002|Overall Study|Adverse Event|0|||
125024631|NCT01505894|449713053|FG003|Overall Study|Adverse Event|0|||
125024632|NCT01505894|449713054|FG004|Overall Study|Adverse Event|0|||
125024633|NCT01505894|449713055|FG005|Overall Study|Adverse Event|0|||
125024634|NCT01505894|449713056|FG006|Overall Study|Adverse Event|0|||
125024635|NCT01505894|449713057|FG007|Overall Study|Adverse Event|0|||
125024636|NCT01505894|449713058|FG008|Overall Study|Adverse Event|0|||
125024637|NCT01505894|449713050|FG000|Overall Study|Other than specified|0|||
125024638|NCT01505894|449713051|FG001|Overall Study|Other than specified|0|||
125024639|NCT01505894|449713052|FG002|Overall Study|Other than specified|0|||
125024640|NCT01505894|449713053|FG003|Overall Study|Other than specified|0|||
125024641|NCT01505894|449713054|FG004|Overall Study|Other than specified|1|||
125024642|NCT01505894|449713055|FG005|Overall Study|Other than specified|0|||
125024643|NCT01505894|449713056|FG006|Overall Study|Other than specified|0|||
125024644|NCT01505894|449713057|FG007|Overall Study|Other than specified|0|||
125024645|NCT01505894|449713058|FG008|Overall Study|Other than specified|0|||
125024646|NCT01001702|449713059|FG000|Overall Study|Lost to Follow-up|7|||
125024647|NCT01001702|449713059|FG000|Overall Study|Adverse Event|7|||
125024648|NCT01001702|449713059|FG000|Overall Study|Sponsor Discontinued Study|4|||
125024649|NCT01001702|449713059|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
125024650|NCT01001702|449713059|FG000|Overall Study|Investigator withdrew Subject|10|||
125024651|NCT01001702|449713059|FG000|Overall Study|Withdrawal by Subject|19|||
125024652|NCT01001702|449713059|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
125024653|NCT01940484|449713062|FG000|Overall Study|Withdrawal by Subject|3|||
125024654|NCT01940484|449713062|FG000|Overall Study|Underwent transplantation|4|||
125024655|NCT01940484|449713062|FG000|Overall Study|Death|2|||
125212769|NCT01026818|450405478|FG000|Screening Period|Physician Decision|1|||
125212770|NCT01026818|450405479|FG001|Screening Period|Physician Decision|0|||
125024656|NCT01940484|449713062|FG000|Overall Study|Adverse Event|1|||
125024657|NCT01285908|449713065|FG000|Baseline Measurement|unable to insert catheter|1|||
125024658|NCT01285908|449713066|FG001|Baseline Measurement|unable to insert catheter|0|||
125024659|NCT01285908|449713067|FG002|Baseline Measurement|unable to insert catheter|0|||
125024660|NCT01285908|449713065|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
125024661|NCT01285908|449713066|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
125024662|NCT01285908|449713067|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
125024663|NCT01285908|449713065|FG000|Baseline Measurement|unable to tolerate procedure|1|||
125024664|NCT01285908|449713066|FG001|Baseline Measurement|unable to tolerate procedure|0|||
125024665|NCT01285908|449713067|FG002|Baseline Measurement|unable to tolerate procedure|0|||
125024666|NCT04142983|449713070|FG000|Overall Study|Lost to Follow-up|73|||
125024667|NCT04142983|449713070|FG000|Overall Study|Withdrawal by Subject|10|||
125024668|NCT04142983|449713070|FG000|Overall Study|Physician Decision|1|||
125024669|NCT04142983|449713070|FG000|Overall Study|Adverse Event|1|||
125212771|NCT01026818|450405480|FG002|Screening Period|Physician Decision|0|||
124929324|NCT05623228|449373261|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
124929325|NCT05623228|449373262|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
124929326|NCT05623228|449373263|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
124929327|NCT05623228|449373264|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
124929328|NCT05623228|449373257|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
124929329|NCT05623228|449373258|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
124929330|NCT05623228|449373259|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
124929331|NCT05623228|449373260|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
125024670|NCT04142983|449713070|FG000|Overall Study|No longer eligible|4|||
125120212|NCT02260492|450063349|FG002|Overall Study|Physician Decision|1|||
125120213|NCT02260492|450063347|FG000|Overall Study|Withdrawal by Subject|3|||
125120214|NCT02260492|450063348|FG001|Overall Study|Withdrawal by Subject|2|||
125120215|NCT02260492|450063349|FG002|Overall Study|Withdrawal by Subject|2|||
125120216|NCT00996736|450063355|FG000|Overall Study|Death|1|||
125120217|NCT00996736|450063356|FG001|Overall Study|Death|1|||
125120218|NCT00996736|450063355|FG000|Overall Study|Lost to Follow-up|15|||
125120219|NCT00996736|450063356|FG001|Overall Study|Lost to Follow-up|14|||
125120220|NCT00996736|450063355|FG000|Overall Study|Visit not within 3-month window|5|||
125120221|NCT00996736|450063356|FG001|Overall Study|Visit not within 3-month window|3|||
125120222|NCT02688608|450063357|FG000|Overall Study|Lost to Follow-up|1|||
125120223|NCT02456909|450063358|FG000|Overall Study|Did not receive allocated intervention|24|||
125120224|NCT02456909|450063359|FG001|Overall Study|Did not receive allocated intervention|26|||
125212772|NCT01026818|450405481|FG003|Screening Period|Physician Decision|0|||
125212773|NCT01026818|450405478|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
125120225|NCT02456909|450063358|FG000|Overall Study|Did not complete the primary outcome|0|||
124929332|NCT05623228|449373261|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
124929333|NCT05623228|449373262|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
124929334|NCT05623228|449373263|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
124929335|NCT05623228|449373264|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
124929336|NCT04737330|449373265|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
124929337|NCT04737330|449373266|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
124929338|NCT04737330|449373265|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
124929339|NCT04737330|449373266|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
124929340|NCT04737330|449373265|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
124929341|NCT04737330|449373266|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
124929342|NCT04737330|449373265|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
124929343|NCT04737330|449373266|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
124929344|NCT04737330|449373265|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
124929345|NCT04737330|449373266|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
124929346|NCT04737330|449373265|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
124929347|NCT04737330|449373266|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
124929348|NCT04625725|449373267|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
124929349|NCT04625725|449373268|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
124929350|NCT04625725|449373269|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
124929351|NCT04625725|449373270|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
124929352|NCT04625725|449373271|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
124929353|NCT04625725|449373272|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
124929354|NCT04625725|449373267|FG000|Provent Main Study|Withdrawal by Subject|242|||
124929355|NCT04625725|449373268|FG001|Provent Main Study|Withdrawal by Subject|144|||
124929356|NCT04625725|449373269|FG002|Provent Main Study|Withdrawal by Subject|0|||
124929357|NCT04625725|449373270|FG003|Provent Main Study|Withdrawal by Subject|0|||
125024671|NCT04142983|449713070|FG000|Overall Study|Screen Failure|10|||
125024672|NCT00643994|449713073|FG000|Overall Study|Death|24|||
125024673|NCT00643994|449713073|FG000|Overall Study|Lost to Follow-up|72|||
125024674|NCT00197054|449713074|FG000|Overall Study|Withdrawal by Subject|9|||
125024675|NCT00197054|449713075|FG001|Overall Study|Withdrawal by Subject|3|||
125024676|NCT00197054|449713076|FG002|Overall Study|Withdrawal by Subject|3|||
125024677|NCT00197054|449713074|FG000|Overall Study|Moved from area|7|||
125024678|NCT00197054|449713075|FG001|Overall Study|Moved from area|14|||
125024679|NCT00197054|449713076|FG002|Overall Study|Moved from area|9|||
125024680|NCT00197054|449713074|FG000|Overall Study|Lost to Follow-up|1|||
125024681|NCT00197054|449713075|FG001|Overall Study|Lost to Follow-up|4|||
125024682|NCT00197054|449713076|FG002|Overall Study|Lost to Follow-up|0|||
125024683|NCT04823949|449713078|FG000|Overall Study|Withdrawal by Subject|0|||
125024684|NCT04823949|449713079|FG001|Overall Study|Withdrawal by Subject|4|||
125024685|NCT04823949|449713078|FG000|Overall Study|Physician Decision|0|||
125024686|NCT04823949|449713079|FG001|Overall Study|Physician Decision|1|||
125024687|NCT00797823|449713083|FG000|First Period (Initial Randomization)|Physician Decision|1|||
125024688|NCT00797823|449713084|FG001|First Period (Initial Randomization)|Physician Decision|0|||
125024689|NCT00797823|449713085|FG002|First Period (Initial Randomization)|Physician Decision|0|||
125024690|NCT02568046|449713086|FG000|Overall Study|Adverse Event|0|||
125120226|NCT02456909|450063359|FG001|Overall Study|Did not complete the primary outcome|1|||
125120227|NCT01497938|450063360|FG000|Overall Study|Adverse Event|0|||
125120228|NCT01497938|450063361|FG001|Overall Study|Adverse Event|1|||
125120229|NCT01497938|450063360|FG000|Overall Study|Physician Decision|0|||
125120230|NCT01497938|450063361|FG001|Overall Study|Physician Decision|1|||
125120231|NCT01497938|450063360|FG000|Overall Study|Withdrawal by Subject|4|||
125120232|NCT01497938|450063361|FG001|Overall Study|Withdrawal by Subject|0|||
125120233|NCT01497938|450063360|FG000|Overall Study|Device Violation|1|||
125120234|NCT01497938|450063361|FG001|Overall Study|Device Violation|0|||
125120235|NCT00365352|450063362|FG000|Overall Study|Adverse Event|6|||
125120236|NCT00365352|450063363|FG001|Overall Study|Adverse Event|7|||
125120237|NCT00365352|450063364|FG002|Overall Study|Adverse Event|8|||
125120238|NCT00365352|450063362|FG000|Overall Study|Participant Withdrew Consent|8|||
125212774|NCT01026818|450405479|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
125212775|NCT01026818|450405480|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
125212776|NCT01026818|450405481|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
125120239|NCT00365352|450063363|FG001|Overall Study|Participant Withdrew Consent|3|||
125120240|NCT00365352|450063364|FG002|Overall Study|Participant Withdrew Consent|4|||
125120241|NCT00365352|450063362|FG000|Overall Study|Lack of Efficacy|3|||
124929358|NCT04625725|449373271|FG004|Provent Main Study|Withdrawal by Subject|0|||
124929359|NCT04625725|449373272|FG005|Provent Main Study|Withdrawal by Subject|0|||
124929360|NCT04625725|449373267|FG000|Provent Main Study|Physician Decision|5|||
124929361|NCT04625725|449373268|FG001|Provent Main Study|Physician Decision|0|||
124929362|NCT04625725|449373269|FG002|Provent Main Study|Physician Decision|0|||
124929363|NCT04625725|449373270|FG003|Provent Main Study|Physician Decision|0|||
124929364|NCT04625725|449373271|FG004|Provent Main Study|Physician Decision|0|||
124929365|NCT04625725|449373272|FG005|Provent Main Study|Physician Decision|0|||
124929366|NCT04625725|449373267|FG000|Provent Main Study|Protocol Violation|1|||
124929367|NCT04625725|449373268|FG001|Provent Main Study|Protocol Violation|0|||
124929368|NCT04625725|449373269|FG002|Provent Main Study|Protocol Violation|0|||
124929369|NCT04625725|449373270|FG003|Provent Main Study|Protocol Violation|0|||
124929370|NCT04625725|449373271|FG004|Provent Main Study|Protocol Violation|0|||
124929371|NCT04625725|449373272|FG005|Provent Main Study|Protocol Violation|0|||
124929372|NCT04625725|449373267|FG000|Provent Main Study|Lost to Follow-up|357|||
124929373|NCT04625725|449373268|FG001|Provent Main Study|Lost to Follow-up|200|||
124929374|NCT04625725|449373269|FG002|Provent Main Study|Lost to Follow-up|0|||
124929375|NCT04625725|449373270|FG003|Provent Main Study|Lost to Follow-up|0|||
124929376|NCT04625725|449373271|FG004|Provent Main Study|Lost to Follow-up|0|||
124929377|NCT04625725|449373272|FG005|Provent Main Study|Lost to Follow-up|0|||
124929378|NCT04625725|449373267|FG000|Provent Main Study|Death|22|||
124929379|NCT04625725|449373268|FG001|Provent Main Study|Death|10|||
124929380|NCT04625725|449373269|FG002|Provent Main Study|Death|0|||
124929381|NCT04625725|449373270|FG003|Provent Main Study|Death|0|||
124929382|NCT04625725|449373271|FG004|Provent Main Study|Death|0|||
124929383|NCT04625725|449373272|FG005|Provent Main Study|Death|0|||
124929384|NCT04625725|449373267|FG000|Provent Main Study|Adverse Event|2|||
124929385|NCT04625725|449373268|FG001|Provent Main Study|Adverse Event|1|||
124929386|NCT04625725|449373269|FG002|Provent Main Study|Adverse Event|0|||
124929387|NCT04625725|449373270|FG003|Provent Main Study|Adverse Event|0|||
124929388|NCT04625725|449373271|FG004|Provent Main Study|Adverse Event|0|||
124929389|NCT04625725|449373272|FG005|Provent Main Study|Adverse Event|0|||
125024691|NCT02568046|449713087|FG001|Overall Study|Adverse Event|1|||
125024692|NCT02568046|449713086|FG000|Overall Study|Death|2|||
125024693|NCT02568046|449713087|FG001|Overall Study|Death|0|||
125024694|NCT02568046|449713086|FG000|Overall Study|Progressive Disease|1|||
125024695|NCT02568046|449713087|FG001|Overall Study|Progressive Disease|0|||
125024696|NCT02568046|449713086|FG000|Overall Study|Withdrawal by Subject|2|||
125024697|NCT02568046|449713087|FG001|Overall Study|Withdrawal by Subject|1|||
125024698|NCT02568046|449713086|FG000|Overall Study|Other Events|0|||
125024699|NCT02568046|449713087|FG001|Overall Study|Other Events|1|||
125024700|NCT00523991|449713088|FG000|Overall Study|Adverse Event|6|||
125024701|NCT00523991|449713089|FG001|Overall Study|Adverse Event|5|||
125024702|NCT00523991|449713088|FG000|Overall Study|Protocol Violation|1|||
125024703|NCT00523991|449713089|FG001|Overall Study|Protocol Violation|4|||
125024704|NCT00523991|449713088|FG000|Overall Study|Lost to Follow-up|4|||
125024705|NCT00523991|449713089|FG001|Overall Study|Lost to Follow-up|1|||
125024706|NCT00523991|449713088|FG000|Overall Study|Withdrawal by Subject|7|||
125024707|NCT00523991|449713089|FG001|Overall Study|Withdrawal by Subject|17|||
125024708|NCT00523991|449713088|FG000|Overall Study|Other reason (not specified)|3|||
125024709|NCT00523991|449713089|FG001|Overall Study|Other reason (not specified)|0|||
125024710|NCT00193063|449713090|FG000|Overall Study|Lack of Efficacy|3|||
125024711|NCT00193063|449713090|FG000|Overall Study|Adverse Event|1|||
125024712|NCT00379795|449713097|FG000|Overall Study|Death|31|||
125024713|NCT00379795|449713098|FG001|Overall Study|Death|8|||
125024714|NCT00379795|449713099|FG002|Overall Study|Death|6|||
124929390|NCT04625725|449373267|FG000|Provent Main Study|Participants dosed in sub-study|310|||
124929391|NCT04625725|449373268|FG001|Provent Main Study|Participants dosed in sub-study|193|||
124929392|NCT04625725|449373269|FG002|Provent Main Study|Participants dosed in sub-study|0|||
124929393|NCT04625725|449373270|FG003|Provent Main Study|Participants dosed in sub-study|0|||
124929394|NCT04625725|449373271|FG004|Provent Main Study|Participants dosed in sub-study|0|||
124929395|NCT04625725|449373272|FG005|Provent Main Study|Participants dosed in sub-study|0|||
124929396|NCT04625725|449373267|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
124929397|NCT04625725|449373268|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
124929398|NCT04625725|449373269|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
124929399|NCT04625725|449373270|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
124929400|NCT04625725|449373271|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
124929401|NCT04625725|449373272|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
124929402|NCT04625725|449373267|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
124929403|NCT04625725|449373268|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
124929404|NCT04625725|449373269|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
124929405|NCT04625725|449373270|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
124929406|NCT04625725|449373271|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
124929407|NCT04625725|449373272|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
124929408|NCT04625725|449373267|FG000|Provent Main Study|INCARCERATION|3|||
124929409|NCT04625725|449373268|FG001|Provent Main Study|INCARCERATION|0|||
124929410|NCT04625725|449373269|FG002|Provent Main Study|INCARCERATION|0|||
124929411|NCT04625725|449373270|FG003|Provent Main Study|INCARCERATION|0|||
124929412|NCT04625725|449373271|FG004|Provent Main Study|INCARCERATION|0|||
124929413|NCT04625725|449373272|FG005|Provent Main Study|INCARCERATION|0|||
124929414|NCT04625725|449373267|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
124929415|NCT04625725|449373268|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
124929416|NCT04625725|449373269|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
124929417|NCT04625725|449373270|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
124929418|NCT04625725|449373271|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
124929419|NCT04625725|449373272|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
124929420|NCT04625725|449373267|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
124929421|NCT04625725|449373268|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
124929422|NCT04625725|449373269|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
124929423|NCT04625725|449373270|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
124929424|NCT04625725|449373271|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
124929425|NCT04625725|449373272|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
124929426|NCT04625725|449373267|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
124929427|NCT04625725|449373268|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
124929428|NCT04625725|449373269|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
124929429|NCT04625725|449373270|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
124929430|NCT04625725|449373271|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
124929431|NCT04625725|449373272|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
124929432|NCT04625725|449373267|FG000|Provent Main Study|MISSING REASON|0|||
124929433|NCT04625725|449373268|FG001|Provent Main Study|MISSING REASON|1|||
125120242|NCT00365352|450063363|FG001|Overall Study|Lack of Efficacy|0|||
124929434|NCT04625725|449373269|FG002|Provent Main Study|MISSING REASON|0|||
125120243|NCT00365352|450063364|FG002|Overall Study|Lack of Efficacy|0|||
125120244|NCT00365352|450063362|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
125120245|NCT00365352|450063363|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
125120246|NCT00365352|450063364|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
125120247|NCT00365352|450063362|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
125120248|NCT00365352|450063363|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
125120249|NCT00365352|450063364|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
125120250|NCT00365352|450063362|FG000|Overall Study|Lost to Follow-up|1|||
125120251|NCT00365352|450063363|FG001|Overall Study|Lost to Follow-up|1|||
124929435|NCT04625725|449373270|FG003|Provent Main Study|MISSING REASON|0|||
125120252|NCT00365352|450063364|FG002|Overall Study|Lost to Follow-up|0|||
125120253|NCT00365352|450063362|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
124929436|NCT04625725|449373271|FG004|Provent Main Study|MISSING REASON|0|||
124929437|NCT04625725|449373272|FG005|Provent Main Study|MISSING REASON|0|||
124929438|NCT04625725|449373267|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
124929439|NCT04625725|449373268|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
124929440|NCT04625725|449373269|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
124929441|NCT04625725|449373270|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
124929442|NCT04625725|449373271|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
124929443|NCT04625725|449373272|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
124929444|NCT04625725|449373267|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
124929445|NCT04625725|449373268|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
124929446|NCT04625725|449373269|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
124929447|NCT04625725|449373270|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
124929448|NCT04625725|449373271|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
124929449|NCT04625725|449373272|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
124929450|NCT04625725|449373267|FG000|Provent Sub Study|Lost to Follow-up|0|||
124929451|NCT04625725|449373268|FG001|Provent Sub Study|Lost to Follow-up|0|||
124929452|NCT04625725|449373269|FG002|Provent Sub Study|Lost to Follow-up|20|||
124929453|NCT04625725|449373270|FG003|Provent Sub Study|Lost to Follow-up|10|||
125212777|NCT01026818|450405478|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
124929454|NCT04625725|449373271|FG004|Provent Sub Study|Lost to Follow-up|6|||
124929455|NCT04625725|449373272|FG005|Provent Sub Study|Lost to Follow-up|4|||
125120254|NCT00365352|450063363|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
124929456|NCT04625725|449373267|FG000|Provent Sub Study|Death|0|||
125120255|NCT00365352|450063364|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
125120256|NCT02224456|450065050|FG000|Overall Study|Lack of Efficacy|1|||
125120257|NCT02224456|450065050|FG000|Overall Study|Lost to Follow-up|15|||
125120258|NCT02224456|450065050|FG000|Overall Study|Withdrawal by Subject|9|||
125120259|NCT02224456|450065050|FG000|Overall Study|Physician Decision|3|||
125120260|NCT02224456|450065050|FG000|Overall Study|Death|2|||
125120261|NCT02224456|450065050|FG000|Overall Study|Pregnancy|4|||
125120262|NCT02224456|450065050|FG000|Overall Study|Protocol Violation|1|||
125120263|NCT02224456|450065050|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
125120264|NCT01644890|450065051|FG000|Overall Study|Adverse Event|7|||
125120265|NCT01644890|450065052|FG001|Overall Study|Adverse Event|20|||
124929457|NCT04625725|449373268|FG001|Provent Sub Study|Death|0|||
125120266|NCT01644890|450065051|FG000|Overall Study|Death|1|||
125120267|NCT01644890|450065052|FG001|Overall Study|Death|3|||
125120268|NCT01644890|450065051|FG000|Overall Study|Physician Decision|3|||
125120269|NCT01644890|450065052|FG001|Overall Study|Physician Decision|9|||
125120270|NCT01644890|450065051|FG000|Overall Study|Protocol Violation|6|||
125120271|NCT01644890|450065052|FG001|Overall Study|Protocol Violation|7|||
125120272|NCT01644890|450065051|FG000|Overall Study|Withdrawal by Subject|19|||
125120273|NCT01644890|450065052|FG001|Overall Study|Withdrawal by Subject|27|||
125120274|NCT01644890|450065051|FG000|Overall Study|Progression Disease|160|||
125120275|NCT01644890|450065052|FG001|Overall Study|Progression Disease|131|||
125120276|NCT01644890|450065051|FG000|Overall Study|Clinical Progression|6|||
125120277|NCT01644890|450065052|FG001|Overall Study|Clinical Progression|6|||
125120278|NCT01644890|450065051|FG000|Overall Study|> 28 days since last dose of study drug|6|||
125120279|NCT01644890|450065052|FG001|Overall Study|> 28 days since last dose of study drug|3|||
125120280|NCT01644890|450065051|FG000|Overall Study|Other|8|||
125120281|NCT01644890|450065052|FG001|Overall Study|Other|9|||
125120282|NCT02761980|450065055|FG000|Overall Study|Adverse Event|4|||
125120283|NCT02761980|450065056|FG001|Overall Study|Adverse Event|6|||
125120284|NCT02761980|450065057|FG002|Overall Study|Adverse Event|5|||
125120285|NCT02761980|450065058|FG003|Overall Study|Adverse Event|6|||
125120286|NCT02761980|450065055|FG000|Overall Study|Withdrawal by Subject|0|||
125120287|NCT02761980|450065056|FG001|Overall Study|Withdrawal by Subject|1|||
125120288|NCT02761980|450065057|FG002|Overall Study|Withdrawal by Subject|0|||
125120289|NCT02761980|450065058|FG003|Overall Study|Withdrawal by Subject|0|||
125120290|NCT02761980|450065055|FG000|Overall Study|Other|0|||
125120291|NCT02761980|450065056|FG001|Overall Study|Other|0|||
125120292|NCT02761980|450065057|FG002|Overall Study|Other|1|||
125120293|NCT02761980|450065058|FG003|Overall Study|Other|0|||
125120294|NCT00101582|450065059|FG000|Overall Study|Ineligibility determined|0|||
124929458|NCT04625725|449373269|FG002|Provent Sub Study|Death|8|||
124929459|NCT04625725|449373270|FG003|Provent Sub Study|Death|5|||
124929460|NCT04625725|449373271|FG004|Provent Sub Study|Death|0|||
124929461|NCT04625725|449373272|FG005|Provent Sub Study|Death|1|||
124929462|NCT04625725|449373267|FG000|Provent Sub Study|Adverse Event|0|||
124929463|NCT04625725|449373268|FG001|Provent Sub Study|Adverse Event|0|||
124929464|NCT04625725|449373269|FG002|Provent Sub Study|Adverse Event|0|||
124929465|NCT04625725|449373270|FG003|Provent Sub Study|Adverse Event|0|||
124929466|NCT04625725|449373271|FG004|Provent Sub Study|Adverse Event|0|||
124929467|NCT04625725|449373272|FG005|Provent Sub Study|Adverse Event|1|||
124929468|NCT04625725|449373267|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
125024715|NCT00379795|449713100|FG003|Overall Study|Death|4|||
125024716|NCT00379795|449713101|FG004|Overall Study|Death|7|||
125024717|NCT00379795|449713097|FG000|Overall Study|Adverse Event|17|||
125024718|NCT00379795|449713098|FG001|Overall Study|Adverse Event|3|||
125024719|NCT00379795|449713099|FG002|Overall Study|Adverse Event|3|||
125024720|NCT00379795|449713100|FG003|Overall Study|Adverse Event|1|||
125024721|NCT00379795|449713101|FG004|Overall Study|Adverse Event|4|||
125024722|NCT00379795|449713097|FG000|Overall Study|Lost to Follow-up|8|||
125024723|NCT00379795|449713098|FG001|Overall Study|Lost to Follow-up|1|||
125024724|NCT00379795|449713099|FG002|Overall Study|Lost to Follow-up|2|||
125024725|NCT00379795|449713100|FG003|Overall Study|Lost to Follow-up|1|||
125024726|NCT00379795|449713101|FG004|Overall Study|Lost to Follow-up|4|||
125024727|NCT00379795|449713097|FG000|Overall Study|Physician Decision|25|||
125120295|NCT00101582|450065060|FG001|Overall Study|Ineligibility determined|1|||
125120296|NCT00101582|450065059|FG000|Overall Study|Adverse Event|1|||
125120297|NCT00101582|450065060|FG001|Overall Study|Adverse Event|4|||
125120298|NCT00101582|450065059|FG000|Overall Study|Withdrawal by Subject|6|||
125120299|NCT00101582|450065060|FG001|Overall Study|Withdrawal by Subject|4|||
125120300|NCT00101582|450065059|FG000|Overall Study|Physician Decision|1|||
125120301|NCT00101582|450065060|FG001|Overall Study|Physician Decision|0|||
125120302|NCT00101582|450065059|FG000|Overall Study|Death|3|||
125120303|NCT00101582|450065060|FG001|Overall Study|Death|5|||
125120304|NCT00101582|450065059|FG000|Overall Study|Other|0|||
125024728|NCT00379795|449713098|FG001|Overall Study|Physician Decision|0|||
125024729|NCT00379795|449713099|FG002|Overall Study|Physician Decision|2|||
125024730|NCT00379795|449713100|FG003|Overall Study|Physician Decision|2|||
125024731|NCT00379795|449713101|FG004|Overall Study|Physician Decision|2|||
125024732|NCT00379795|449713097|FG000|Overall Study|Withdrawal by Subject|94|||
125024733|NCT00379795|449713098|FG001|Overall Study|Withdrawal by Subject|11|||
125024734|NCT00379795|449713099|FG002|Overall Study|Withdrawal by Subject|19|||
125024735|NCT00379795|449713100|FG003|Overall Study|Withdrawal by Subject|7|||
125024736|NCT00379795|449713101|FG004|Overall Study|Withdrawal by Subject|14|||
125024737|NCT00379795|449713097|FG000|Overall Study|Subject non-compliance|7|||
125024738|NCT00379795|449713098|FG001|Overall Study|Subject non-compliance|2|||
125024739|NCT00379795|449713099|FG002|Overall Study|Subject non-compliance|0|||
125024740|NCT00379795|449713100|FG003|Overall Study|Subject non-compliance|0|||
125024741|NCT00379795|449713101|FG004|Overall Study|Subject non-compliance|1|||
125024742|NCT00379795|449713097|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
125024743|NCT00379795|449713098|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
125024744|NCT00379795|449713099|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
125120305|NCT00101582|450065060|FG001|Overall Study|Other|1|||
125120306|NCT00056160|450065061|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
125120307|NCT00056160|450065062|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
125024745|NCT00379795|449713100|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
125024746|NCT00379795|449713101|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
125024747|NCT00379795|449713097|FG000|Overall Study|Subjects condition mandated intervention|34|||
125120308|NCT00056160|450065061|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
124929469|NCT04625725|449373268|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
124929470|NCT04625725|449373269|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
124929471|NCT04625725|449373270|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
124929472|NCT04625725|449373271|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
124929473|NCT04625725|449373272|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
124929474|NCT04625725|449373267|FG000|Provent Sub Study|Withdrawal by Subject|0|||
124929475|NCT04625725|449373268|FG001|Provent Sub Study|Withdrawal by Subject|0|||
124929476|NCT04625725|449373269|FG002|Provent Sub Study|Withdrawal by Subject|11|||
124929477|NCT04625725|449373270|FG003|Provent Sub Study|Withdrawal by Subject|13|||
124929478|NCT04625725|449373271|FG004|Provent Sub Study|Withdrawal by Subject|5|||
125120309|NCT00056160|450065062|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
125024748|NCT00379795|449713098|FG001|Overall Study|Subjects condition mandated intervention|9|||
124929479|NCT04625725|449373272|FG005|Provent Sub Study|Withdrawal by Subject|6|||
124929480|NCT04625725|449373267|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
124929481|NCT04625725|449373268|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
124929482|NCT04625725|449373269|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
124929483|NCT04625725|449373270|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
124929484|NCT04625725|449373271|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
124929485|NCT04625725|449373272|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
124929486|NCT03298451|449373276|FG000|Overall Study|Death|275|||
124929487|NCT03298451|449373277|FG001|Overall Study|Death|260|||
124929488|NCT03298451|449373278|FG002|Overall Study|Death|122|||
125024749|NCT00379795|449713099|FG002|Overall Study|Subjects condition mandated intervention|7|||
125024750|NCT00379795|449713100|FG003|Overall Study|Subjects condition mandated intervention|5|||
125024751|NCT00379795|449713101|FG004|Overall Study|Subjects condition mandated intervention|7|||
125024752|NCT00379795|449713097|FG000|Overall Study|Sponsor's decision|257|||
124929489|NCT03298451|449373279|FG003|Overall Study|Death|280|||
124929490|NCT03298451|449373276|FG000|Overall Study|Lost to Follow-up|1|||
124929491|NCT03298451|449373277|FG001|Overall Study|Lost to Follow-up|1|||
124929492|NCT03298451|449373278|FG002|Overall Study|Lost to Follow-up|0|||
124929493|NCT03298451|449373279|FG003|Overall Study|Lost to Follow-up|7|||
124929494|NCT03298451|449373276|FG000|Overall Study|Withdrawal by Subject|9|||
124929495|NCT03298451|449373277|FG001|Overall Study|Withdrawal by Subject|7|||
124929496|NCT03298451|449373278|FG002|Overall Study|Withdrawal by Subject|1|||
124929497|NCT03298451|449373279|FG003|Overall Study|Withdrawal by Subject|20|||
124929498|NCT01651403|449373282|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
124929499|NCT01651403|449373283|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
124929500|NCT01651403|449373282|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
124929501|NCT01651403|449373283|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
124929502|NCT01651403|449373282|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
124929503|NCT01651403|449373283|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
124929504|NCT01651403|449373282|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
124929505|NCT01651403|449373283|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
124929506|NCT01651403|449373282|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
124929507|NCT01651403|449373283|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
124929508|NCT01651403|449373282|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
124929509|NCT01651403|449373283|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
124929510|NCT05873556|449373284|FG000|Overall Study|Lost to Follow-up|4|||
124929511|NCT05873556|449373285|FG001|Overall Study|Lost to Follow-up|1|||
124929512|NCT03381586|449373286|FG000|Overall Study|Adverse Event|1|||
124929513|NCT03381586|449373287|FG001|Overall Study|Adverse Event|1|||
124929514|NCT03381586|449373286|FG000|Overall Study|Protocol Violation|1|||
124929515|NCT03381586|449373287|FG001|Overall Study|Protocol Violation|0|||
124929516|NCT03381586|449373286|FG000|Overall Study|Withdrawal by Subject|1|||
124929517|NCT03381586|449373287|FG001|Overall Study|Withdrawal by Subject|2|||
125120310|NCT00056160|450065061|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
125120311|NCT00056160|450065062|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
125120312|NCT00056160|450065061|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
125120313|NCT00056160|450065062|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
125120314|NCT00056160|450065061|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
125120315|NCT00056160|450065062|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
125120316|NCT00056160|450065061|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
125120317|NCT00056160|450065062|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
125120318|NCT00056160|450065061|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
125120319|NCT00056160|450065062|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
125120320|NCT00056160|450065061|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
125120321|NCT00056160|450065062|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
124929518|NCT05299723|449374609|FG000|Overall Study|Withdrawal by Subject|0|||
124929519|NCT05299723|449374610|FG001|Overall Study|Withdrawal by Subject|2|||
124929520|NCT05299723|449374611|FG002|Overall Study|Withdrawal by Subject|0|||
124929521|NCT03220035|449374612|FG000|Overall Study|Adverse Event|1|||
124929522|NCT03220035|449374612|FG000|Overall Study|Protocol Violation|1|||
124929523|NCT03220035|449374612|FG000|Overall Study|Progressive Disease|2|||
124929524|NCT00696111|449374613|FG000|Overall Study|Withdrawal by Subject|17|||
124929525|NCT04447040|449374619|FG000|Overall Study|Lost to Follow-up|2|||
124929526|NCT04447040|449374620|FG001|Overall Study|Lost to Follow-up|1|||
124929527|NCT04447040|449374621|FG002|Overall Study|Lost to Follow-up|3|||
124929528|NCT04447040|449374622|FG003|Overall Study|Lost to Follow-up|3|||
124929529|NCT04447040|449374623|FG004|Overall Study|Lost to Follow-up|1|||
124929530|NCT04447040|449374624|FG005|Overall Study|Lost to Follow-up|3|||
124929531|NCT04447040|449374619|FG000|Overall Study|Withdrawal by Subject|0|||
124929532|NCT04447040|449374620|FG001|Overall Study|Withdrawal by Subject|1|||
124929533|NCT04447040|449374621|FG002|Overall Study|Withdrawal by Subject|1|||
124929534|NCT04447040|449374622|FG003|Overall Study|Withdrawal by Subject|1|||
124929535|NCT04447040|449374623|FG004|Overall Study|Withdrawal by Subject|0|||
124929536|NCT04447040|449374624|FG005|Overall Study|Withdrawal by Subject|0|||
124929537|NCT04076618|449374625|FG000|Overall Study|Lost to Follow-up|2|||
124929538|NCT04076618|449374626|FG001|Overall Study|Lost to Follow-up|1|||
124929539|NCT04076618|449374627|FG002|Overall Study|Lost to Follow-up|3|||
124929540|NCT04076618|449374625|FG000|Overall Study|Withdrawal by Subject|3|||
124929541|NCT04076618|449374626|FG001|Overall Study|Withdrawal by Subject|1|||
124929542|NCT04076618|449374627|FG002|Overall Study|Withdrawal by Subject|2|||
124929543|NCT04076618|449374625|FG000|Overall Study|Relocated out of state|0|||
124929544|NCT04076618|449374626|FG001|Overall Study|Relocated out of state|2|||
124929545|NCT04076618|449374627|FG002|Overall Study|Relocated out of state|0|||
124929546|NCT04076618|449374625|FG000|Overall Study|COVID concerns|0|||
124929547|NCT04076618|449374626|FG001|Overall Study|COVID concerns|1|||
124929548|NCT04076618|449374627|FG002|Overall Study|COVID concerns|0|||
124929549|NCT04076618|449374625|FG000|Overall Study|Adverse Event|0|||
125120322|NCT00056160|450065061|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
124929550|NCT04076618|449374626|FG001|Overall Study|Adverse Event|0|||
124929551|NCT04076618|449374627|FG002|Overall Study|Adverse Event|2|||
124929552|NCT01928394|449374628|FG000|Treatment Period|Disease progression|17|||
124929553|NCT01928394|449374629|FG001|Treatment Period|Disease progression|2|||
124929554|NCT01928394|449374630|FG002|Treatment Period|Disease progression|12|||
124929555|NCT01928394|449374631|FG003|Treatment Period|Disease progression|48|||
124929556|NCT01928394|449374632|FG004|Treatment Period|Disease progression|3|||
124929557|NCT01928394|449374633|FG005|Treatment Period|Disease progression|25|||
124929558|NCT01928394|449374634|FG006|Treatment Period|Disease progression|38|||
124929559|NCT01928394|449374635|FG007|Treatment Period|Disease progression|16|||
124929560|NCT01928394|449374636|FG008|Treatment Period|Disease progression|3|||
124929561|NCT01928394|449374637|FG009|Treatment Period|Disease progression|11|||
124929562|NCT01928394|449374638|FG010|Treatment Period|Disease progression|22|||
124929563|NCT01928394|449374639|FG011|Treatment Period|Disease progression|73|||
124929564|NCT01928394|449374640|FG012|Treatment Period|Disease progression|38|||
124929565|NCT01928394|449374641|FG013|Treatment Period|Disease progression|118|||
124929566|NCT01928394|449374642|FG014|Treatment Period|Disease progression|59|||
124929567|NCT01928394|449374643|FG015|Treatment Period|Disease progression|1|||
124929568|NCT01928394|449374644|FG016|Treatment Period|Disease progression|43|||
124929569|NCT01928394|449374645|FG017|Treatment Period|Disease progression|56|||
124929570|NCT01928394|449374646|FG018|Treatment Period|Disease progression|50|||
124929571|NCT01928394|449374647|FG019|Treatment Period|Disease progression|71|||
124929572|NCT01928394|449374648|FG020|Treatment Period|Disease progression|30|||
124929573|NCT01928394|449374649|FG021|Treatment Period|Disease progression|31|||
124929574|NCT01928394|449374650|FG022|Treatment Period|Disease progression|31|||
124929575|NCT01928394|449374628|FG000|Treatment Period|Study drug toxicity|1|||
124929576|NCT01928394|449374629|FG001|Treatment Period|Study drug toxicity|1|||
124929577|NCT01928394|449374630|FG002|Treatment Period|Study drug toxicity|3|||
124929578|NCT01928394|449374631|FG003|Treatment Period|Study drug toxicity|3|||
124929579|NCT01928394|449374632|FG004|Treatment Period|Study drug toxicity|0|||
124929580|NCT01928394|449374633|FG005|Treatment Period|Study drug toxicity|9|||
124929581|NCT01928394|449374634|FG006|Treatment Period|Study drug toxicity|7|||
124929582|NCT01928394|449374635|FG007|Treatment Period|Study drug toxicity|1|||
124929583|NCT01928394|449374636|FG008|Treatment Period|Study drug toxicity|0|||
124929584|NCT01928394|449374637|FG009|Treatment Period|Study drug toxicity|5|||
124929585|NCT01928394|449374638|FG010|Treatment Period|Study drug toxicity|2|||
124929586|NCT01928394|449374639|FG011|Treatment Period|Study drug toxicity|3|||
124929587|NCT01928394|449374640|FG012|Treatment Period|Study drug toxicity|7|||
124929588|NCT01928394|449374641|FG013|Treatment Period|Study drug toxicity|5|||
124929589|NCT01928394|449374642|FG014|Treatment Period|Study drug toxicity|12|||
124929590|NCT01928394|449374643|FG015|Treatment Period|Study drug toxicity|0|||
124929591|NCT01928394|449374644|FG016|Treatment Period|Study drug toxicity|3|||
124929592|NCT01928394|449374645|FG017|Treatment Period|Study drug toxicity|3|||
124929593|NCT01928394|449374646|FG018|Treatment Period|Study drug toxicity|12|||
124929594|NCT01928394|449374647|FG019|Treatment Period|Study drug toxicity|15|||
124929595|NCT01928394|449374648|FG020|Treatment Period|Study drug toxicity|4|||
124929596|NCT01928394|449374649|FG021|Treatment Period|Study drug toxicity|7|||
124929597|NCT01928394|449374650|FG022|Treatment Period|Study drug toxicity|4|||
124929598|NCT01928394|449374628|FG000|Treatment Period|AE unrelated to study drug|0|||
124929599|NCT01928394|449374629|FG001|Treatment Period|AE unrelated to study drug|0|||
124929600|NCT01928394|449374630|FG002|Treatment Period|AE unrelated to study drug|2|||
124929601|NCT01928394|449374631|FG003|Treatment Period|AE unrelated to study drug|3|||
124929602|NCT01928394|449374632|FG004|Treatment Period|AE unrelated to study drug|0|||
124929603|NCT01928394|449374633|FG005|Treatment Period|AE unrelated to study drug|5|||
124929604|NCT01928394|449374634|FG006|Treatment Period|AE unrelated to study drug|1|||
124929605|NCT01928394|449374635|FG007|Treatment Period|AE unrelated to study drug|0|||
124929606|NCT01928394|449374636|FG008|Treatment Period|AE unrelated to study drug|0|||
124929607|NCT01928394|449374637|FG009|Treatment Period|AE unrelated to study drug|2|||
124929608|NCT01928394|449374638|FG010|Treatment Period|AE unrelated to study drug|0|||
124929609|NCT01928394|449374639|FG011|Treatment Period|AE unrelated to study drug|12|||
124929610|NCT01928394|449374640|FG012|Treatment Period|AE unrelated to study drug|6|||
124929611|NCT01928394|449374641|FG013|Treatment Period|AE unrelated to study drug|13|||
124929612|NCT01928394|449374642|FG014|Treatment Period|AE unrelated to study drug|6|||
124929613|NCT01928394|449374643|FG015|Treatment Period|AE unrelated to study drug|1|||
124929614|NCT01928394|449374644|FG016|Treatment Period|AE unrelated to study drug|1|||
124929615|NCT01928394|449374645|FG017|Treatment Period|AE unrelated to study drug|6|||
124929616|NCT01928394|449374646|FG018|Treatment Period|AE unrelated to study drug|3|||
124929617|NCT01928394|449374647|FG019|Treatment Period|AE unrelated to study drug|5|||
124929618|NCT01928394|449374648|FG020|Treatment Period|AE unrelated to study drug|1|||
124929619|NCT01928394|449374649|FG021|Treatment Period|AE unrelated to study drug|1|||
124929620|NCT01928394|449374650|FG022|Treatment Period|AE unrelated to study drug|0|||
124929621|NCT01928394|449374628|FG000|Treatment Period|Participant request to stop therapy|0|||
124929622|NCT01928394|449374629|FG001|Treatment Period|Participant request to stop therapy|0|||
125212778|NCT01026818|450405479|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
124929623|NCT01928394|449374630|FG002|Treatment Period|Participant request to stop therapy|0|||
124929624|NCT01928394|449374631|FG003|Treatment Period|Participant request to stop therapy|0|||
124929625|NCT01928394|449374632|FG004|Treatment Period|Participant request to stop therapy|0|||
124929626|NCT01928394|449374633|FG005|Treatment Period|Participant request to stop therapy|3|||
124929627|NCT01928394|449374634|FG006|Treatment Period|Participant request to stop therapy|3|||
124929628|NCT01928394|449374635|FG007|Treatment Period|Participant request to stop therapy|0|||
124929629|NCT01928394|449374636|FG008|Treatment Period|Participant request to stop therapy|0|||
125024753|NCT00379795|449713098|FG001|Overall Study|Sponsor's decision|17|||
125024754|NCT00379795|449713099|FG002|Overall Study|Sponsor's decision|54|||
125024755|NCT00379795|449713100|FG003|Overall Study|Sponsor's decision|47|||
125024756|NCT00379795|449713101|FG004|Overall Study|Sponsor's decision|10|||
125024757|NCT02435849|449713102|FG000|Overall Study|Death|23|||
125024758|NCT02435849|449713103|FG001|Overall Study|Death|0|||
125024759|NCT02435849|449713102|FG000|Overall Study|Lack of Efficacy|10|||
125024760|NCT02435849|449713103|FG001|Overall Study|Lack of Efficacy|0|||
125024761|NCT02435849|449713102|FG000|Overall Study|New therapy for study indication|8|||
125024762|NCT02435849|449713103|FG001|Overall Study|New therapy for study indication|0|||
125024763|NCT02435849|449713102|FG000|Overall Study|Subject/guardian decision|5|||
125024764|NCT02435849|449713103|FG001|Overall Study|Subject/guardian decision|1|||
124929630|NCT01928394|449374637|FG009|Treatment Period|Participant request to stop therapy|0|||
124929631|NCT01928394|449374638|FG010|Treatment Period|Participant request to stop therapy|3|||
124929632|NCT01928394|449374639|FG011|Treatment Period|Participant request to stop therapy|2|||
124929633|NCT01928394|449374640|FG012|Treatment Period|Participant request to stop therapy|1|||
124929634|NCT01928394|449374641|FG013|Treatment Period|Participant request to stop therapy|2|||
124929635|NCT01928394|449374642|FG014|Treatment Period|Participant request to stop therapy|4|||
124929636|NCT01928394|449374643|FG015|Treatment Period|Participant request to stop therapy|0|||
124929637|NCT01928394|449374644|FG016|Treatment Period|Participant request to stop therapy|1|||
124929638|NCT01928394|449374645|FG017|Treatment Period|Participant request to stop therapy|3|||
124929639|NCT01928394|449374646|FG018|Treatment Period|Participant request to stop therapy|1|||
124929640|NCT01928394|449374647|FG019|Treatment Period|Participant request to stop therapy|1|||
124929641|NCT01928394|449374648|FG020|Treatment Period|Participant request to stop therapy|3|||
124929642|NCT01928394|449374649|FG021|Treatment Period|Participant request to stop therapy|1|||
124929643|NCT01928394|449374650|FG022|Treatment Period|Participant request to stop therapy|3|||
124929644|NCT01928394|449374628|FG000|Treatment Period|Participant withdrew consent|0|||
124929645|NCT01928394|449374629|FG001|Treatment Period|Participant withdrew consent|0|||
124929646|NCT01928394|449374630|FG002|Treatment Period|Participant withdrew consent|1|||
124929647|NCT01928394|449374631|FG003|Treatment Period|Participant withdrew consent|1|||
124929648|NCT01928394|449374632|FG004|Treatment Period|Participant withdrew consent|0|||
125120323|NCT00056160|450065062|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
125120324|NCT00056160|450065061|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
124929649|NCT01928394|449374633|FG005|Treatment Period|Participant withdrew consent|1|||
124929650|NCT01928394|449374634|FG006|Treatment Period|Participant withdrew consent|0|||
124929651|NCT01928394|449374635|FG007|Treatment Period|Participant withdrew consent|1|||
124929652|NCT01928394|449374636|FG008|Treatment Period|Participant withdrew consent|0|||
124929653|NCT01928394|449374637|FG009|Treatment Period|Participant withdrew consent|0|||
124929654|NCT01928394|449374638|FG010|Treatment Period|Participant withdrew consent|1|||
124929655|NCT01928394|449374639|FG011|Treatment Period|Participant withdrew consent|1|||
124929656|NCT01928394|449374640|FG012|Treatment Period|Participant withdrew consent|1|||
124929657|NCT01928394|449374641|FG013|Treatment Period|Participant withdrew consent|0|||
124929658|NCT01928394|449374642|FG014|Treatment Period|Participant withdrew consent|2|||
124929659|NCT01928394|449374643|FG015|Treatment Period|Participant withdrew consent|0|||
124929660|NCT01928394|449374644|FG016|Treatment Period|Participant withdrew consent|2|||
124929661|NCT01928394|449374645|FG017|Treatment Period|Participant withdrew consent|1|||
124929662|NCT01928394|449374646|FG018|Treatment Period|Participant withdrew consent|1|||
124929663|NCT01928394|449374647|FG019|Treatment Period|Participant withdrew consent|1|||
124929664|NCT01928394|449374648|FG020|Treatment Period|Participant withdrew consent|0|||
124929665|NCT01928394|449374649|FG021|Treatment Period|Participant withdrew consent|2|||
124929666|NCT01928394|449374650|FG022|Treatment Period|Participant withdrew consent|0|||
124929667|NCT01928394|449374628|FG000|Treatment Period|Poor/non-compliance|0|||
124929668|NCT01928394|449374629|FG001|Treatment Period|Poor/non-compliance|0|||
124929669|NCT01928394|449374630|FG002|Treatment Period|Poor/non-compliance|0|||
124929670|NCT01928394|449374631|FG003|Treatment Period|Poor/non-compliance|1|||
124929671|NCT01928394|449374632|FG004|Treatment Period|Poor/non-compliance|0|||
124929672|NCT01928394|449374633|FG005|Treatment Period|Poor/non-compliance|0|||
124929673|NCT01928394|449374634|FG006|Treatment Period|Poor/non-compliance|0|||
124929674|NCT01928394|449374635|FG007|Treatment Period|Poor/non-compliance|0|||
124929675|NCT01928394|449374636|FG008|Treatment Period|Poor/non-compliance|0|||
124929676|NCT01928394|449374637|FG009|Treatment Period|Poor/non-compliance|0|||
124929677|NCT01928394|449374638|FG010|Treatment Period|Poor/non-compliance|0|||
124929678|NCT01928394|449374639|FG011|Treatment Period|Poor/non-compliance|0|||
124929679|NCT01928394|449374640|FG012|Treatment Period|Poor/non-compliance|1|||
124929680|NCT01928394|449374641|FG013|Treatment Period|Poor/non-compliance|0|||
124929681|NCT01928394|449374642|FG014|Treatment Period|Poor/non-compliance|1|||
124929682|NCT01928394|449374643|FG015|Treatment Period|Poor/non-compliance|0|||
124929683|NCT01928394|449374644|FG016|Treatment Period|Poor/non-compliance|0|||
124929684|NCT01928394|449374645|FG017|Treatment Period|Poor/non-compliance|1|||
124929685|NCT01928394|449374646|FG018|Treatment Period|Poor/non-compliance|0|||
124929686|NCT01928394|449374647|FG019|Treatment Period|Poor/non-compliance|1|||
124929687|NCT01928394|449374648|FG020|Treatment Period|Poor/non-compliance|0|||
124929688|NCT01928394|449374649|FG021|Treatment Period|Poor/non-compliance|0|||
124929689|NCT01928394|449374650|FG022|Treatment Period|Poor/non-compliance|0|||
124929690|NCT01928394|449374628|FG000|Treatment Period|other reason|0|||
124929691|NCT01928394|449374629|FG001|Treatment Period|other reason|0|||
124929692|NCT01928394|449374630|FG002|Treatment Period|other reason|0|||
124929693|NCT01928394|449374631|FG003|Treatment Period|other reason|0|||
124929694|NCT01928394|449374632|FG004|Treatment Period|other reason|0|||
124929695|NCT01928394|449374633|FG005|Treatment Period|other reason|0|||
124929696|NCT01928394|449374634|FG006|Treatment Period|other reason|0|||
124929697|NCT01928394|449374635|FG007|Treatment Period|other reason|0|||
124929698|NCT01928394|449374636|FG008|Treatment Period|other reason|0|||
124929699|NCT01928394|449374637|FG009|Treatment Period|other reason|0|||
124929700|NCT01928394|449374638|FG010|Treatment Period|other reason|1|||
124929701|NCT01928394|449374639|FG011|Treatment Period|other reason|1|||
124929702|NCT01928394|449374640|FG012|Treatment Period|other reason|1|||
124929703|NCT01928394|449374641|FG013|Treatment Period|other reason|0|||
124929704|NCT01928394|449374642|FG014|Treatment Period|other reason|1|||
124929705|NCT01928394|449374643|FG015|Treatment Period|other reason|0|||
124929706|NCT01928394|449374644|FG016|Treatment Period|other reason|0|||
125212779|NCT01026818|450405480|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
125212780|NCT01026818|450405481|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
125212781|NCT01026818|450405478|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
125212782|NCT01026818|450405479|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
124929707|NCT01928394|449374645|FG017|Treatment Period|other reason|0|||
124929708|NCT01928394|449374646|FG018|Treatment Period|other reason|2|||
124929709|NCT01928394|449374647|FG019|Treatment Period|other reason|2|||
124929710|NCT01928394|449374648|FG020|Treatment Period|other reason|0|||
124929711|NCT01928394|449374649|FG021|Treatment Period|other reason|0|||
124929712|NCT01928394|449374650|FG022|Treatment Period|other reason|0|||
124929713|NCT01928394|449374628|FG000|Treatment Period|Maximum clinical benefit|0|||
124929714|NCT01928394|449374629|FG001|Treatment Period|Maximum clinical benefit|0|||
124929715|NCT01928394|449374630|FG002|Treatment Period|Maximum clinical benefit|0|||
124929716|NCT01928394|449374631|FG003|Treatment Period|Maximum clinical benefit|0|||
124929717|NCT01928394|449374632|FG004|Treatment Period|Maximum clinical benefit|0|||
124929718|NCT01928394|449374633|FG005|Treatment Period|Maximum clinical benefit|0|||
124929719|NCT01928394|449374634|FG006|Treatment Period|Maximum clinical benefit|0|||
124929720|NCT01928394|449374635|FG007|Treatment Period|Maximum clinical benefit|0|||
124929721|NCT01928394|449374636|FG008|Treatment Period|Maximum clinical benefit|0|||
124929722|NCT01928394|449374637|FG009|Treatment Period|Maximum clinical benefit|0|||
124929723|NCT01928394|449374638|FG010|Treatment Period|Maximum clinical benefit|1|||
124929724|NCT01928394|449374639|FG011|Treatment Period|Maximum clinical benefit|1|||
124929725|NCT01928394|449374640|FG012|Treatment Period|Maximum clinical benefit|0|||
124929726|NCT01928394|449374641|FG013|Treatment Period|Maximum clinical benefit|0|||
124929727|NCT01928394|449374642|FG014|Treatment Period|Maximum clinical benefit|1|||
124929728|NCT01928394|449374643|FG015|Treatment Period|Maximum clinical benefit|0|||
124929729|NCT01928394|449374644|FG016|Treatment Period|Maximum clinical benefit|0|||
124929730|NCT01928394|449374645|FG017|Treatment Period|Maximum clinical benefit|1|||
124929731|NCT01928394|449374646|FG018|Treatment Period|Maximum clinical benefit|1|||
124929732|NCT01928394|449374647|FG019|Treatment Period|Maximum clinical benefit|0|||
124929733|NCT01928394|449374648|FG020|Treatment Period|Maximum clinical benefit|2|||
124929734|NCT01928394|449374649|FG021|Treatment Period|Maximum clinical benefit|0|||
124929735|NCT01928394|449374650|FG022|Treatment Period|Maximum clinical benefit|0|||
124929736|NCT01928394|449374628|FG000|Treatment Period|Lost to Follow-up|0|||
124929737|NCT01928394|449374629|FG001|Treatment Period|Lost to Follow-up|0|||
124929738|NCT01928394|449374630|FG002|Treatment Period|Lost to Follow-up|0|||
124929739|NCT01928394|449374631|FG003|Treatment Period|Lost to Follow-up|0|||
124929740|NCT01928394|449374632|FG004|Treatment Period|Lost to Follow-up|0|||
124929741|NCT01928394|449374633|FG005|Treatment Period|Lost to Follow-up|0|||
124929742|NCT01928394|449374634|FG006|Treatment Period|Lost to Follow-up|0|||
124929743|NCT01928394|449374635|FG007|Treatment Period|Lost to Follow-up|0|||
124929744|NCT01928394|449374636|FG008|Treatment Period|Lost to Follow-up|0|||
124929745|NCT01928394|449374637|FG009|Treatment Period|Lost to Follow-up|0|||
124929746|NCT01928394|449374638|FG010|Treatment Period|Lost to Follow-up|0|||
124929747|NCT01928394|449374639|FG011|Treatment Period|Lost to Follow-up|0|||
124929748|NCT01928394|449374640|FG012|Treatment Period|Lost to Follow-up|0|||
124929749|NCT01928394|449374641|FG013|Treatment Period|Lost to Follow-up|0|||
124929750|NCT01928394|449374642|FG014|Treatment Period|Lost to Follow-up|0|||
124929751|NCT01928394|449374643|FG015|Treatment Period|Lost to Follow-up|0|||
124929752|NCT01928394|449374644|FG016|Treatment Period|Lost to Follow-up|0|||
124929753|NCT01928394|449374645|FG017|Treatment Period|Lost to Follow-up|0|||
124929754|NCT01928394|449374646|FG018|Treatment Period|Lost to Follow-up|0|||
124929755|NCT01928394|449374647|FG019|Treatment Period|Lost to Follow-up|0|||
124929756|NCT01928394|449374648|FG020|Treatment Period|Lost to Follow-up|0|||
124929757|NCT01928394|449374649|FG021|Treatment Period|Lost to Follow-up|0|||
124929758|NCT01928394|449374650|FG022|Treatment Period|Lost to Follow-up|1|||
124929759|NCT01928394|449374628|FG000|Treatment Period|Death|0|||
124929760|NCT01928394|449374629|FG001|Treatment Period|Death|0|||
124929761|NCT01928394|449374630|FG002|Treatment Period|Death|0|||
124929762|NCT01928394|449374631|FG003|Treatment Period|Death|0|||
124929763|NCT01928394|449374632|FG004|Treatment Period|Death|0|||
124929764|NCT01928394|449374633|FG005|Treatment Period|Death|0|||
124929765|NCT01928394|449374634|FG006|Treatment Period|Death|0|||
124929766|NCT01928394|449374635|FG007|Treatment Period|Death|0|||
124929767|NCT01928394|449374636|FG008|Treatment Period|Death|0|||
124929768|NCT01928394|449374637|FG009|Treatment Period|Death|0|||
124929769|NCT01928394|449374638|FG010|Treatment Period|Death|0|||
124929770|NCT01928394|449374639|FG011|Treatment Period|Death|0|||
124929771|NCT01928394|449374640|FG012|Treatment Period|Death|0|||
124929772|NCT01928394|449374641|FG013|Treatment Period|Death|1|||
124929773|NCT01928394|449374642|FG014|Treatment Period|Death|2|||
124929774|NCT01928394|449374643|FG015|Treatment Period|Death|0|||
124929775|NCT01928394|449374644|FG016|Treatment Period|Death|0|||
124929776|NCT01928394|449374645|FG017|Treatment Period|Death|0|||
124929777|NCT01928394|449374646|FG018|Treatment Period|Death|0|||
124929778|NCT01928394|449374647|FG019|Treatment Period|Death|0|||
124929779|NCT01928394|449374648|FG020|Treatment Period|Death|0|||
124929780|NCT01928394|449374649|FG021|Treatment Period|Death|0|||
124929781|NCT01928394|449374650|FG022|Treatment Period|Death|0|||
124929782|NCT01928394|449374628|FG000|Follow-up Period|Participant withdrew consent|3|||
124929783|NCT01928394|449374629|FG001|Follow-up Period|Participant withdrew consent|0|||
124929784|NCT01928394|449374630|FG002|Follow-up Period|Participant withdrew consent|1|||
124929785|NCT01928394|449374631|FG003|Follow-up Period|Participant withdrew consent|4|||
124929786|NCT01928394|449374632|FG004|Follow-up Period|Participant withdrew consent|0|||
124929787|NCT01928394|449374633|FG005|Follow-up Period|Participant withdrew consent|2|||
124929788|NCT01928394|449374634|FG006|Follow-up Period|Participant withdrew consent|5|||
124929789|NCT01928394|449374635|FG007|Follow-up Period|Participant withdrew consent|1|||
124929790|NCT01928394|449374636|FG008|Follow-up Period|Participant withdrew consent|0|||
124929791|NCT01928394|449374637|FG009|Follow-up Period|Participant withdrew consent|0|||
124929792|NCT01928394|449374638|FG010|Follow-up Period|Participant withdrew consent|5|||
124929793|NCT01928394|449374639|FG011|Follow-up Period|Participant withdrew consent|8|||
124929794|NCT01928394|449374640|FG012|Follow-up Period|Participant withdrew consent|2|||
124929795|NCT01928394|449374641|FG013|Follow-up Period|Participant withdrew consent|12|||
124929796|NCT01928394|449374642|FG014|Follow-up Period|Participant withdrew consent|7|||
124929797|NCT01928394|449374643|FG015|Follow-up Period|Participant withdrew consent|0|||
124929798|NCT01928394|449374644|FG016|Follow-up Period|Participant withdrew consent|5|||
124929799|NCT01928394|449374645|FG017|Follow-up Period|Participant withdrew consent|3|||
124929800|NCT01928394|449374646|FG018|Follow-up Period|Participant withdrew consent|2|||
124929801|NCT01928394|449374647|FG019|Follow-up Period|Participant withdrew consent|7|||
124929802|NCT01928394|449374648|FG020|Follow-up Period|Participant withdrew consent|4|||
124929803|NCT01928394|449374649|FG021|Follow-up Period|Participant withdrew consent|6|||
124929804|NCT01928394|449374650|FG022|Follow-up Period|Participant withdrew consent|2|||
124929805|NCT01928394|449374628|FG000|Follow-up Period|Death|0|||
124929806|NCT01928394|449374629|FG001|Follow-up Period|Death|0|||
124929807|NCT01928394|449374630|FG002|Follow-up Period|Death|2|||
124929808|NCT01928394|449374631|FG003|Follow-up Period|Death|6|||
124929809|NCT01928394|449374632|FG004|Follow-up Period|Death|0|||
124929810|NCT01928394|449374633|FG005|Follow-up Period|Death|6|||
124929811|NCT01928394|449374634|FG006|Follow-up Period|Death|6|||
124929812|NCT01928394|449374635|FG007|Follow-up Period|Death|2|||
125024765|NCT02435849|449713102|FG000|Overall Study|Lost to Follow-up|1|||
124929813|NCT01928394|449374636|FG008|Follow-up Period|Death|1|||
124929814|NCT01928394|449374637|FG009|Follow-up Period|Death|2|||
124929815|NCT01928394|449374638|FG010|Follow-up Period|Death|4|||
124929816|NCT01928394|449374639|FG011|Follow-up Period|Death|12|||
124929817|NCT01928394|449374640|FG012|Follow-up Period|Death|11|||
124929818|NCT01928394|449374641|FG013|Follow-up Period|Death|25|||
124929819|NCT01928394|449374642|FG014|Follow-up Period|Death|18|||
124929820|NCT01928394|449374643|FG015|Follow-up Period|Death|0|||
124929821|NCT01928394|449374644|FG016|Follow-up Period|Death|6|||
124929822|NCT01928394|449374645|FG017|Follow-up Period|Death|5|||
124929823|NCT01928394|449374646|FG018|Follow-up Period|Death|13|||
124929824|NCT01928394|449374647|FG019|Follow-up Period|Death|13|||
124929825|NCT01928394|449374648|FG020|Follow-up Period|Death|5|||
124929826|NCT01928394|449374649|FG021|Follow-up Period|Death|3|||
124929827|NCT01928394|449374650|FG022|Follow-up Period|Death|2|||
124929828|NCT01928394|449374628|FG000|Follow-up Period|other reason|0|||
124929829|NCT01928394|449374629|FG001|Follow-up Period|other reason|0|||
124929830|NCT01928394|449374630|FG002|Follow-up Period|other reason|0|||
124929831|NCT01928394|449374631|FG003|Follow-up Period|other reason|0|||
124929832|NCT01928394|449374632|FG004|Follow-up Period|other reason|0|||
124929833|NCT01928394|449374633|FG005|Follow-up Period|other reason|0|||
124929834|NCT01928394|449374634|FG006|Follow-up Period|other reason|1|||
124929835|NCT01928394|449374635|FG007|Follow-up Period|other reason|3|||
124929836|NCT01928394|449374636|FG008|Follow-up Period|other reason|0|||
124929837|NCT01928394|449374637|FG009|Follow-up Period|other reason|0|||
124929838|NCT01928394|449374638|FG010|Follow-up Period|other reason|2|||
124929839|NCT01928394|449374639|FG011|Follow-up Period|other reason|1|||
124929840|NCT01928394|449374640|FG012|Follow-up Period|other reason|0|||
125024766|NCT02435849|449713103|FG001|Overall Study|Lost to Follow-up|0|||
124929841|NCT01928394|449374641|FG013|Follow-up Period|other reason|1|||
124929842|NCT01928394|449374642|FG014|Follow-up Period|other reason|4|||
124929843|NCT01928394|449374643|FG015|Follow-up Period|other reason|0|||
124929844|NCT01928394|449374644|FG016|Follow-up Period|other reason|2|||
125024767|NCT02435849|449713102|FG000|Overall Study|Physician Decision|1|||
125024768|NCT02435849|449713103|FG001|Overall Study|Physician Decision|0|||
125024769|NCT04849780|449713104|FG000|Period 1|Covid-19 Related|1|||
125024770|NCT04849780|449713105|FG001|Period 1|Covid-19 Related|0|||
125024771|NCT04849780|449713104|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
125024772|NCT04849780|449713105|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
125024773|NCT04849780|449713104|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
124929845|NCT01928394|449374645|FG017|Follow-up Period|other reason|0|||
124929846|NCT01928394|449374646|FG018|Follow-up Period|other reason|1|||
124929847|NCT01928394|449374647|FG019|Follow-up Period|other reason|1|||
124929848|NCT01928394|449374648|FG020|Follow-up Period|other reason|0|||
124929849|NCT01928394|449374649|FG021|Follow-up Period|other reason|0|||
124929850|NCT01928394|449374650|FG022|Follow-up Period|other reason|1|||
124929851|NCT01928394|449374628|FG000|Follow-up Period|Lost to Follow-up|0|||
124929852|NCT01928394|449374629|FG001|Follow-up Period|Lost to Follow-up|0|||
124929853|NCT01928394|449374630|FG002|Follow-up Period|Lost to Follow-up|0|||
124929854|NCT01928394|449374631|FG003|Follow-up Period|Lost to Follow-up|0|||
124929855|NCT01928394|449374632|FG004|Follow-up Period|Lost to Follow-up|0|||
124929856|NCT01928394|449374633|FG005|Follow-up Period|Lost to Follow-up|0|||
124929857|NCT01928394|449374634|FG006|Follow-up Period|Lost to Follow-up|0|||
124929858|NCT01928394|449374635|FG007|Follow-up Period|Lost to Follow-up|0|||
124929859|NCT01928394|449374636|FG008|Follow-up Period|Lost to Follow-up|0|||
124929860|NCT01928394|449374637|FG009|Follow-up Period|Lost to Follow-up|0|||
124929861|NCT01928394|449374638|FG010|Follow-up Period|Lost to Follow-up|0|||
124929862|NCT01928394|449374639|FG011|Follow-up Period|Lost to Follow-up|1|||
124929863|NCT01928394|449374640|FG012|Follow-up Period|Lost to Follow-up|1|||
125024774|NCT04849780|449713105|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
125024775|NCT02319044|449713106|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
125024776|NCT02319044|449713107|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
125024777|NCT02319044|449713108|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
125024778|NCT02319044|449713106|FG000|Overall Study|Withdrawal by Subject|3|||
125024779|NCT02319044|449713107|FG001|Overall Study|Withdrawal by Subject|3|||
125024780|NCT02319044|449713108|FG002|Overall Study|Withdrawal by Subject|6|||
125024781|NCT02319044|449713106|FG000|Overall Study|Condition under investigation worsened|100|||
125024782|NCT02319044|449713107|FG001|Overall Study|Condition under investigation worsened|50|||
124929864|NCT01928394|449374641|FG013|Follow-up Period|Lost to Follow-up|0|||
124929865|NCT01928394|449374642|FG014|Follow-up Period|Lost to Follow-up|1|||
124929866|NCT01928394|449374643|FG015|Follow-up Period|Lost to Follow-up|0|||
124929867|NCT01928394|449374644|FG016|Follow-up Period|Lost to Follow-up|1|||
124929868|NCT01928394|449374645|FG017|Follow-up Period|Lost to Follow-up|0|||
124929869|NCT01928394|449374646|FG018|Follow-up Period|Lost to Follow-up|0|||
124929870|NCT01928394|449374647|FG019|Follow-up Period|Lost to Follow-up|0|||
125024783|NCT02319044|449713108|FG002|Overall Study|Condition under investigation worsened|46|||
125024784|NCT02319044|449713106|FG000|Overall Study|Adverse Event|17|||
125024785|NCT02319044|449713107|FG001|Overall Study|Adverse Event|2|||
124929871|NCT01928394|449374648|FG020|Follow-up Period|Lost to Follow-up|0|||
124929872|NCT01928394|449374649|FG021|Follow-up Period|Lost to Follow-up|0|||
124929873|NCT01928394|449374650|FG022|Follow-up Period|Lost to Follow-up|1|||
124929874|NCT04433208|449374651|FG000|Overall Study|Withdrawal by Subject|0|||
124929875|NCT04433208|449374652|FG001|Overall Study|Withdrawal by Subject|1|||
124929876|NCT04433208|449374653|FG002|Overall Study|Withdrawal by Subject|1|||
124929877|NCT04433208|449374654|FG003|Overall Study|Withdrawal by Subject|0|||
124929878|NCT04433208|449374655|FG004|Overall Study|Withdrawal by Subject|2|||
124929879|NCT04433208|449374656|FG005|Overall Study|Withdrawal by Subject|1|||
124929880|NCT04433208|449374651|FG000|Overall Study|Lost to Follow-up|0|||
124929881|NCT04433208|449374652|FG001|Overall Study|Lost to Follow-up|0|||
124929882|NCT04433208|449374653|FG002|Overall Study|Lost to Follow-up|0|||
124929883|NCT04433208|449374654|FG003|Overall Study|Lost to Follow-up|0|||
124929884|NCT04433208|449374655|FG004|Overall Study|Lost to Follow-up|0|||
124929885|NCT04433208|449374656|FG005|Overall Study|Lost to Follow-up|1|||
124929886|NCT04299464|449374661|FG000|Overall Study|Adverse Event|1|||
124929887|NCT04299464|449374662|FG001|Overall Study|Adverse Event|0|||
124929888|NCT04299464|449374663|FG002|Overall Study|Adverse Event|2|||
124929889|NCT04299464|449374661|FG000|Overall Study|Non-compliance with Study Drug|1|||
124929890|NCT04299464|449374662|FG001|Overall Study|Non-compliance with Study Drug|0|||
124929891|NCT04299464|449374663|FG002|Overall Study|Non-compliance with Study Drug|0|||
124929892|NCT04299464|449374661|FG000|Overall Study|Reason not Specified|0|||
124929893|NCT04299464|449374662|FG001|Overall Study|Reason not Specified|1|||
124929894|NCT04299464|449374663|FG002|Overall Study|Reason not Specified|3|||
124929895|NCT04299464|449374661|FG000|Overall Study|Physician Decision|0|||
124929896|NCT04299464|449374662|FG001|Overall Study|Physician Decision|1|||
124929897|NCT04299464|449374663|FG002|Overall Study|Physician Decision|1|||
124929898|NCT04299464|449374661|FG000|Overall Study|Withdrawal by Subject|0|||
124929899|NCT04299464|449374662|FG001|Overall Study|Withdrawal by Subject|2|||
124929900|NCT04299464|449374663|FG002|Overall Study|Withdrawal by Subject|1|||
124929901|NCT03676192|449374664|FG000|Induction Study Period|Adverse Event|21|||
124929902|NCT03676192|449374665|FG001|Induction Study Period|Adverse Event|20|||
124929903|NCT03676192|449374664|FG000|Induction Study Period|Death|23|||
124929904|NCT03676192|449374665|FG001|Induction Study Period|Death|20|||
124929905|NCT03676192|449374664|FG000|Induction Study Period|Lost to Follow-up|3|||
124929906|NCT03676192|449374665|FG001|Induction Study Period|Lost to Follow-up|3|||
124929907|NCT03676192|449374664|FG000|Induction Study Period|Physician Decision|6|||
124929908|NCT03676192|449374665|FG001|Induction Study Period|Physician Decision|3|||
124929909|NCT03676192|449374664|FG000|Induction Study Period|Progressive Disease|32|||
124929910|NCT03676192|449374665|FG001|Induction Study Period|Progressive Disease|21|||
124929911|NCT03676192|449374664|FG000|Induction Study Period|Protocol Violation|1|||
124929912|NCT03676192|449374665|FG001|Induction Study Period|Protocol Violation|2|||
124929913|NCT03676192|449374664|FG000|Induction Study Period|Withdrawal by Subject|20|||
124929914|NCT03676192|449374665|FG001|Induction Study Period|Withdrawal by Subject|15|||
124929915|NCT04079218|449374666|FG000|Overall Study|Death|1|||
124929916|NCT04079218|449374667|FG001|Overall Study|Death|0|||
124929917|NCT04079218|449374666|FG000|Overall Study|Withdrawal by Subject|3|||
124929918|NCT04079218|449374667|FG001|Overall Study|Withdrawal by Subject|0|||
124929919|NCT04079218|449374666|FG000|Overall Study|Physician Decision|4|||
124929920|NCT04079218|449374667|FG001|Overall Study|Physician Decision|0|||
124929921|NCT04079218|449374666|FG000|Overall Study|Lost to Follow-up|0|||
124929922|NCT04079218|449374667|FG001|Overall Study|Lost to Follow-up|1|||
124929923|NCT02694822|449374668|FG000|Phase 1|Death|2|||
124929924|NCT02694822|449374669|FG001|Phase 1|Death|1|||
124929925|NCT02694822|449374670|FG002|Phase 1|Death|6|||
124929926|NCT02694822|449374671|FG003|Phase 1|Death|6|||
124929927|NCT02694822|449374672|FG004|Phase 1|Death|3|||
124929928|NCT02694822|449374673|FG005|Phase 1|Death|0|||
124929929|NCT02694822|449374668|FG000|Phase 1|Withdrawal by Subject|2|||
124929930|NCT02694822|449374669|FG001|Phase 1|Withdrawal by Subject|2|||
124929931|NCT02694822|449374670|FG002|Phase 1|Withdrawal by Subject|4|||
124929932|NCT02694822|449374671|FG003|Phase 1|Withdrawal by Subject|8|||
124929933|NCT02694822|449374672|FG004|Phase 1|Withdrawal by Subject|1|||
124929934|NCT02694822|449374673|FG005|Phase 1|Withdrawal by Subject|0|||
124929935|NCT02694822|449374668|FG000|Phase 2|Death|0|||
124929936|NCT02694822|449374669|FG001|Phase 2|Death|0|||
124929937|NCT02694822|449374670|FG002|Phase 2|Death|0|||
124929938|NCT02694822|449374671|FG003|Phase 2|Death|0|||
124929939|NCT02694822|449374672|FG004|Phase 2|Death|0|||
124929940|NCT02694822|449374673|FG005|Phase 2|Death|26|||
124929941|NCT02694822|449374668|FG000|Phase 2|Withdrawal by Subject|0|||
124929942|NCT02694822|449374669|FG001|Phase 2|Withdrawal by Subject|0|||
124929943|NCT02694822|449374670|FG002|Phase 2|Withdrawal by Subject|0|||
124929944|NCT02694822|449374671|FG003|Phase 2|Withdrawal by Subject|0|||
124929945|NCT02694822|449374672|FG004|Phase 2|Withdrawal by Subject|0|||
124929946|NCT02694822|449374673|FG005|Phase 2|Withdrawal by Subject|13|||
124929947|NCT02694822|449374668|FG000|Phase 2|Administrative Study Closure|0|||
125024786|NCT02319044|449713108|FG002|Overall Study|Adverse Event|8|||
125024787|NCT02319044|449713106|FG000|Overall Study|Study specific discontinuation criteria|2|||
125024788|NCT02319044|449713107|FG001|Overall Study|Study specific discontinuation criteria|2|||
125024789|NCT02319044|449713108|FG002|Overall Study|Study specific discontinuation criteria|1|||
125024790|NCT02319044|449713106|FG000|Overall Study|Not treated|0|||
125024791|NCT02319044|449713107|FG001|Overall Study|Not treated|2|||
125024792|NCT02319044|449713108|FG002|Overall Study|Not treated|2|||
125024793|NCT01145066|449713109|FG000|Overall Study|To resume NSAIDs|2|||
125024794|NCT01145066|449713110|FG001|Overall Study|To resume NSAIDs|2|||
125024795|NCT01145066|449713111|FG002|Overall Study|To resume NSAIDs|1|||
125024796|NCT01145066|449713109|FG000|Overall Study|Non-related surgery|0|||
125024797|NCT01145066|449713110|FG001|Overall Study|Non-related surgery|0|||
125024798|NCT01145066|449713111|FG002|Overall Study|Non-related surgery|1|||
125024799|NCT01145066|449713109|FG000|Overall Study|Withdrawal by Subject|0|||
125024800|NCT01145066|449713110|FG001|Overall Study|Withdrawal by Subject|0|||
125024801|NCT01145066|449713111|FG002|Overall Study|Withdrawal by Subject|2|||
124929948|NCT02694822|449374669|FG001|Phase 2|Administrative Study Closure|0|||
124929949|NCT02694822|449374670|FG002|Phase 2|Administrative Study Closure|0|||
124929950|NCT02694822|449374671|FG003|Phase 2|Administrative Study Closure|0|||
125024802|NCT01145066|449713109|FG000|Overall Study|To start new med|1|||
125024803|NCT01145066|449713110|FG001|Overall Study|To start new med|0|||
124929951|NCT02694822|449374672|FG004|Phase 2|Administrative Study Closure|0|||
124929952|NCT02694822|449374673|FG005|Phase 2|Administrative Study Closure|2|||
124929953|NCT02694822|449374668|FG000|Phase 2|Lost to Follow-up|0|||
124929954|NCT02694822|449374669|FG001|Phase 2|Lost to Follow-up|0|||
124929955|NCT02694822|449374670|FG002|Phase 2|Lost to Follow-up|0|||
124929956|NCT02694822|449374671|FG003|Phase 2|Lost to Follow-up|0|||
124929957|NCT02694822|449374672|FG004|Phase 2|Lost to Follow-up|0|||
124929958|NCT02694822|449374673|FG005|Phase 2|Lost to Follow-up|1|||
124929959|NCT02694822|449374668|FG000|Phase 2|Participant Transferred to Another Site|0|||
124929960|NCT02694822|449374669|FG001|Phase 2|Participant Transferred to Another Site|0|||
124929961|NCT02694822|449374670|FG002|Phase 2|Participant Transferred to Another Site|0|||
124929962|NCT02694822|449374671|FG003|Phase 2|Participant Transferred to Another Site|0|||
124929963|NCT02694822|449374672|FG004|Phase 2|Participant Transferred to Another Site|0|||
124929964|NCT02694822|449374673|FG005|Phase 2|Participant Transferred to Another Site|1|||
124929965|NCT02424617|449374674|FG000|Overall Study|Adverse Event|0|||
124929966|NCT02424617|449374675|FG001|Overall Study|Adverse Event|1|||
124929967|NCT02424617|449374676|FG002|Overall Study|Adverse Event|0|||
124929968|NCT02424617|449374677|FG003|Overall Study|Adverse Event|0|||
124929969|NCT02424617|449374674|FG000|Overall Study|Investigator Decision|0|||
124929970|NCT02424617|449374675|FG001|Overall Study|Investigator Decision|0|||
124929971|NCT02424617|449374676|FG002|Overall Study|Investigator Decision|0|||
124929972|NCT02424617|449374677|FG003|Overall Study|Investigator Decision|1|||
124929973|NCT02424617|449374674|FG000|Overall Study|Withdrawal by Subject|1|||
124929974|NCT02424617|449374675|FG001|Overall Study|Withdrawal by Subject|1|||
124929975|NCT02424617|449374676|FG002|Overall Study|Withdrawal by Subject|0|||
124929976|NCT02424617|449374677|FG003|Overall Study|Withdrawal by Subject|1|||
124929977|NCT02424617|449374674|FG000|Overall Study|Progressive Disease|7|||
124929978|NCT02424617|449374675|FG001|Overall Study|Progressive Disease|6|||
124929979|NCT02424617|449374676|FG002|Overall Study|Progressive Disease|11|||
124929980|NCT02424617|449374677|FG003|Overall Study|Progressive Disease|10|||
124929981|NCT02424617|449374674|FG000|Overall Study|Other|0|||
124929982|NCT02424617|449374675|FG001|Overall Study|Other|0|||
124929983|NCT02424617|449374676|FG002|Overall Study|Other|0|||
124929984|NCT02424617|449374677|FG003|Overall Study|Other|1|||
124929985|NCT01868997|449374680|FG000|Overall Study|Adverse Event|2|||
124929986|NCT01868997|449374681|FG001|Overall Study|Adverse Event|5|||
124929987|NCT01868997|449374680|FG000|Overall Study|Lack of Efficacy|2|||
124929988|NCT01868997|449374681|FG001|Overall Study|Lack of Efficacy|0|||
124929989|NCT01868997|449374680|FG000|Overall Study|Other|3|||
124929990|NCT01868997|449374681|FG001|Overall Study|Other|1|||
124929991|NCT02052882|449374682|FG000|Overall Study|Not treated|11|||
124929992|NCT02052882|449374682|FG000|Overall Study|Protocol Violation|1|||
124929993|NCT02052882|449374682|FG000|Overall Study|Inadequate testing|1|||
124929994|NCT04778397|449374683|FG000|Overall Study|Death|59|||
124929995|NCT04778397|449374684|FG001|Overall Study|Death|54|||
124929996|NCT04778397|449374685|FG002|Overall Study|Death|11|||
124929997|NCT04778397|449374686|FG003|Overall Study|Death|9|||
124929998|NCT04778397|449374683|FG000|Overall Study|Study Terminated by Sponsor|34|||
124929999|NCT04778397|449374684|FG001|Overall Study|Study Terminated by Sponsor|42|||
124930000|NCT04778397|449374685|FG002|Overall Study|Study Terminated by Sponsor|15|||
124930001|NCT04778397|449374686|FG003|Overall Study|Study Terminated by Sponsor|12|||
124930002|NCT04778397|449374683|FG000|Overall Study|Withdrew Consent|5|||
124930003|NCT04778397|449374684|FG001|Overall Study|Withdrew Consent|4|||
124930004|NCT04778397|449374685|FG002|Overall Study|Withdrew Consent|1|||
124930005|NCT04778397|449374686|FG003|Overall Study|Withdrew Consent|1|||
124930006|NCT04778397|449374683|FG000|Overall Study|Reason Not Specified|1|||
124930007|NCT04778397|449374684|FG001|Overall Study|Reason Not Specified|3|||
124930008|NCT04778397|449374685|FG002|Overall Study|Reason Not Specified|0|||
124930009|NCT04778397|449374686|FG003|Overall Study|Reason Not Specified|2|||
124930010|NCT04778397|449374683|FG000|Overall Study|Lost to Follow-up|2|||
124930011|NCT04778397|449374684|FG001|Overall Study|Lost to Follow-up|1|||
124930012|NCT04778397|449374685|FG002|Overall Study|Lost to Follow-up|0|||
124930013|NCT04778397|449374686|FG003|Overall Study|Lost to Follow-up|1|||
124930014|NCT05906784|449374688|FG000|Overall Study|Lost to Follow-up|2|||
124930015|NCT05906784|449374689|FG001|Overall Study|Lost to Follow-up|1|||
124930016|NCT05906784|449374690|FG002|Overall Study|Lost to Follow-up|1|||
124930017|NCT05906784|449374691|FG003|Overall Study|Lost to Follow-up|1|||
124930018|NCT01346540|449374697|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
124930019|NCT01346540|449374698|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
124930020|NCT01346540|449374697|FG000|Overall Study|Adverse Event|0|||
124930021|NCT01346540|449374698|FG001|Overall Study|Adverse Event|4|||
124930022|NCT05147116|449374700|FG000|Overall Study|Withdrawal by Subject|0|||
124930023|NCT05147116|449374701|FG001|Overall Study|Withdrawal by Subject|1|||
124930024|NCT03672916|449374702|FG000|Overall Study|Death|6|||
124930025|NCT03672916|449374702|FG000|Overall Study|Lost to Follow-up|29|||
124930026|NCT03672916|449374702|FG000|Overall Study|Adverse Event|6|||
124930027|NCT03672916|449374702|FG000|Overall Study|Withdrawal by Subject|11|||
124930028|NCT04197336|449374703|FG000|Overall Study|Withdrawal by Subject|1|||
124930029|NCT04585815|449374704|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
124930030|NCT04585815|449374705|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
124930031|NCT04585815|449374706|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
124930032|NCT04585815|449374707|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
124930033|NCT04585815|449374708|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
125212783|NCT01026818|450405480|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
125212784|NCT01026818|450405481|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
124930034|NCT04585815|449374709|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
124930035|NCT04585815|449374710|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
124930036|NCT04585815|449374704|FG000|Sub-study A- Treatment Phase|Death|0|||
124930037|NCT04585815|449374705|FG001|Sub-study A- Treatment Phase|Death|1|||
124930038|NCT04585815|449374706|FG002|Sub-study A- Treatment Phase|Death|0|||
124930039|NCT04585815|449374707|FG003|Sub-study A- Treatment Phase|Death|0|||
124930040|NCT04585815|449374708|FG004|Sub-study A- Treatment Phase|Death|0|||
124930041|NCT04585815|449374709|FG005|Sub-study A- Treatment Phase|Death|0|||
124930042|NCT04585815|449374710|FG006|Sub-study A- Treatment Phase|Death|0|||
124930043|NCT04585815|449374704|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
125120325|NCT00056160|450065062|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
125120326|NCT00056160|450065061|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
125120327|NCT00056160|450065062|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
125120328|NCT00056160|450065061|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
124930044|NCT04585815|449374705|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
124930045|NCT04585815|449374706|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
124930046|NCT04585815|449374707|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
124930047|NCT04585815|449374708|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
124930048|NCT04585815|449374709|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
124930049|NCT04585815|449374710|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
125120329|NCT00056160|450065062|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
124930050|NCT04585815|449374704|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
124930051|NCT04585815|449374705|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
124930052|NCT04585815|449374706|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
124930053|NCT04585815|449374707|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
124930054|NCT04585815|449374708|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
124930055|NCT04585815|449374709|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
125120330|NCT00056160|450065061|FG000|Final Follow-up|Transferred into expanded access study.|3|||
125120331|NCT00056160|450065062|FG001|Final Follow-up|Transferred into expanded access study.|0|||
124930056|NCT04585815|449374710|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
124930057|NCT04585815|449374704|FG000|Sub-study A- Treatment Phase|Other|1|||
124930058|NCT04585815|449374705|FG001|Sub-study A- Treatment Phase|Other|0|||
124930059|NCT04585815|449374706|FG002|Sub-study A- Treatment Phase|Other|0|||
124930060|NCT04585815|449374707|FG003|Sub-study A- Treatment Phase|Other|0|||
124930061|NCT04585815|449374708|FG004|Sub-study A- Treatment Phase|Other|0|||
124930062|NCT04585815|449374709|FG005|Sub-study A- Treatment Phase|Other|0|||
124930063|NCT04585815|449374710|FG006|Sub-study A- Treatment Phase|Other|0|||
124930064|NCT04585815|449374704|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
124930065|NCT04585815|449374705|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
124930066|NCT04585815|449374706|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
124930067|NCT04585815|449374707|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
124930068|NCT04585815|449374708|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
124930069|NCT04585815|449374709|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
124930070|NCT04585815|449374710|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
124930071|NCT04585815|449374704|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
124930072|NCT04585815|449374705|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
124930073|NCT04585815|449374706|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
124930074|NCT04585815|449374707|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
124930075|NCT04585815|449374708|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
124930076|NCT04585815|449374709|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
124930077|NCT04585815|449374710|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
124930078|NCT04585815|449374704|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
124930079|NCT04585815|449374705|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
124930080|NCT04585815|449374706|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
124930081|NCT04585815|449374707|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
124930082|NCT04585815|449374708|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
124930083|NCT04585815|449374709|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
124930084|NCT04585815|449374710|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
124930085|NCT04585815|449374704|FG000|Sub-study B- Treatment Phase|Death|0|||
124930086|NCT04585815|449374705|FG001|Sub-study B- Treatment Phase|Death|0|||
124930087|NCT04585815|449374706|FG002|Sub-study B- Treatment Phase|Death|0|||
124930088|NCT04585815|449374707|FG003|Sub-study B- Treatment Phase|Death|1|||
124930089|NCT04585815|449374708|FG004|Sub-study B- Treatment Phase|Death|0|||
124930090|NCT04585815|449374709|FG005|Sub-study B- Treatment Phase|Death|0|||
124930091|NCT04585815|449374710|FG006|Sub-study B- Treatment Phase|Death|0|||
124930092|NCT04585815|449374704|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
124930093|NCT04585815|449374705|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
124930094|NCT04585815|449374706|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
124930095|NCT04585815|449374707|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
124930096|NCT04585815|449374708|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
124930097|NCT04585815|449374709|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
124930098|NCT04585815|449374710|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
124930099|NCT04585815|449374704|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
124930100|NCT04585815|449374705|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
125024804|NCT01145066|449713111|FG002|Overall Study|To start new med|0|||
125024805|NCT01145066|449713109|FG000|Overall Study|problems swallowing capsule|1|||
125024806|NCT01145066|449713110|FG001|Overall Study|problems swallowing capsule|0|||
125024807|NCT01145066|449713111|FG002|Overall Study|problems swallowing capsule|0|||
124930101|NCT04585815|449374706|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
124930102|NCT04585815|449374707|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
124930103|NCT04585815|449374708|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
124930104|NCT04585815|449374709|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
124930105|NCT04585815|449374710|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
124930106|NCT04585815|449374704|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
124930107|NCT04585815|449374705|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
124930108|NCT04585815|449374706|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
124930109|NCT04585815|449374707|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
124930110|NCT04585815|449374708|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
124930111|NCT04585815|449374709|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
124930112|NCT04585815|449374710|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
124930113|NCT04585815|449374704|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
124930114|NCT04585815|449374705|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
124930115|NCT04585815|449374706|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
124930116|NCT04585815|449374707|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
124930117|NCT04585815|449374708|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
124930118|NCT04585815|449374709|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
124930119|NCT04585815|449374710|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
124930120|NCT04585815|449374704|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
124930121|NCT04585815|449374705|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
124930122|NCT04585815|449374706|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
124930123|NCT04585815|449374707|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
124930124|NCT04585815|449374708|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
124930125|NCT04585815|449374709|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
124930126|NCT04585815|449374710|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
124930127|NCT04585815|449374704|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
124930128|NCT04585815|449374705|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
124930129|NCT04585815|449374706|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
124930130|NCT04585815|449374707|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
124930131|NCT04585815|449374708|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
124930132|NCT04585815|449374709|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
124930133|NCT04585815|449374710|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
124930134|NCT04585815|449374704|FG000|Sub-study B- Follow-up Phase|Death|0|||
124930135|NCT04585815|449374705|FG001|Sub-study B- Follow-up Phase|Death|0|||
124930136|NCT04585815|449374706|FG002|Sub-study B- Follow-up Phase|Death|1|||
124930137|NCT04585815|449374707|FG003|Sub-study B- Follow-up Phase|Death|3|||
124930138|NCT04585815|449374708|FG004|Sub-study B- Follow-up Phase|Death|0|||
124930139|NCT04585815|449374709|FG005|Sub-study B- Follow-up Phase|Death|0|||
124930140|NCT04585815|449374710|FG006|Sub-study B- Follow-up Phase|Death|1|||
124930141|NCT04587453|449374716|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
124930142|NCT04587453|449374717|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
124930143|NCT04141891|449374720|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
124930144|NCT04141891|449374721|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
124930145|NCT04141891|449374720|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
124930146|NCT04141891|449374721|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
124930147|NCT04141891|449374720|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
124930148|NCT04141891|449374721|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
124930149|NCT04141891|449374720|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
124930150|NCT04141891|449374721|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
124930151|NCT04141891|449374720|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
124930152|NCT04141891|449374721|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
124930153|NCT04141891|449374720|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
125120332|NCT00056160|450065061|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
125120333|NCT00056160|450065062|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
125120334|NCT00056160|450065061|FG000|Final Follow-up|Adverse Event|1|||
124930154|NCT04141891|449374721|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
124930155|NCT04141891|449374720|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
124930156|NCT04141891|449374721|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
124930157|NCT04141891|449374720|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
124930158|NCT04141891|449374721|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
124930159|NCT04141891|449374720|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
124930160|NCT04141891|449374721|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
124930161|NCT04141891|449374720|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
124930162|NCT04141891|449374721|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
124930163|NCT04141891|449374720|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
125120335|NCT00056160|450065062|FG001|Final Follow-up|Adverse Event|0|||
124930164|NCT04141891|449374721|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
124930165|NCT04141891|449374720|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
124930166|NCT04141891|449374721|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
125120336|NCT03093324|450065064|FG000|Overall Study|Adverse Event|4|||
124930167|NCT04141891|449374720|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
124930168|NCT04141891|449374721|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
124930169|NCT04141891|449374720|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
124930170|NCT04141891|449374721|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
124930171|NCT05090683|449374729|FG000|Overall Study|Lost to Follow-up|10|||
124930172|NCT05090683|449374730|FG001|Overall Study|Lost to Follow-up|2|||
124930173|NCT05090683|449374729|FG000|Overall Study|Withdrawal by Subject|15|||
124930174|NCT05090683|449374730|FG001|Overall Study|Withdrawal by Subject|0|||
124930175|NCT04032847|449374733|FG000|Overall Study|Study termination by sponsor|8|||
124930176|NCT04032847|449374734|FG001|Overall Study|Study termination by sponsor|0|||
125024808|NCT01145066|449713109|FG000|Overall Study|Abdominal discomfort|0|||
124930177|NCT04032847|449374735|FG002|Overall Study|Study termination by sponsor|4|||
124930178|NCT04032847|449374733|FG000|Overall Study|Death|12|||
124930179|NCT04032847|449374734|FG001|Overall Study|Death|0|||
124930180|NCT04032847|449374735|FG002|Overall Study|Death|0|||
124930181|NCT04032847|449374733|FG000|Overall Study|Progressive disease|2|||
124930182|NCT04032847|449374734|FG001|Overall Study|Progressive disease|0|||
124930183|NCT04032847|449374735|FG002|Overall Study|Progressive disease|1|||
124930184|NCT03213665|449374736|FG000|Overall Study|Adverse Event|1|||
124930185|NCT03213665|449374736|FG000|Overall Study|Physician Decision|2|||
124930186|NCT03213665|449374736|FG000|Overall Study|Withdrawal by Subject|3|||
124930187|NCT03213665|449374736|FG000|Overall Study|Progressive Disease|13|||
124930188|NCT03056573|449374737|FG000|Overall Study|Death|2|||
124930189|NCT03056573|449374738|FG001|Overall Study|Death|4|||
124930190|NCT03056573|449374737|FG000|Overall Study|Withdrawal by Subject|2|||
124930191|NCT03056573|449374738|FG001|Overall Study|Withdrawal by Subject|0|||
124930192|NCT03056573|449374737|FG000|Overall Study|Lost to Follow-up|1|||
124930193|NCT03056573|449374738|FG001|Overall Study|Lost to Follow-up|1|||
125024809|NCT01145066|449713110|FG001|Overall Study|Abdominal discomfort|1|||
125024810|NCT01145066|449713111|FG002|Overall Study|Abdominal discomfort|0|||
125024811|NCT01145066|449713109|FG000|Overall Study|Low platelet count|0|||
125024812|NCT01145066|449713110|FG001|Overall Study|Low platelet count|1|||
125024813|NCT01145066|449713111|FG002|Overall Study|Low platelet count|0|||
125024814|NCT01724528|449713113|FG000|Overall Study|Death|3|||
125024815|NCT01724528|449713114|FG001|Overall Study|Death|0|||
125024816|NCT01724528|449713113|FG000|Overall Study|Withdrawal by Subject|0|||
125024817|NCT01724528|449713114|FG001|Overall Study|Withdrawal by Subject|2|||
125024818|NCT01724528|449713113|FG000|Overall Study|Protocol Violation|0|||
125024819|NCT01724528|449713114|FG001|Overall Study|Protocol Violation|1|||
125024820|NCT01724528|449713113|FG000|Overall Study|Patient refused to attend last visit|1|||
125024821|NCT01724528|449713114|FG001|Overall Study|Patient refused to attend last visit|0|||
124930194|NCT04689256|449374739|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
124930195|NCT04689256|449374740|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
125120337|NCT03093324|450065065|FG001|Overall Study|Adverse Event|15|||
125120338|NCT03093324|450065064|FG000|Overall Study|Lost to Follow-up|1|||
125120339|NCT03093324|450065065|FG001|Overall Study|Lost to Follow-up|0|||
125120340|NCT03093324|450065064|FG000|Overall Study|Protocol Deviation|2|||
125120341|NCT03093324|450065065|FG001|Overall Study|Protocol Deviation|2|||
124930196|NCT05104463|449374743|FG000|Overall Study|Adverse Event|1|||
124930197|NCT05104463|449374744|FG001|Overall Study|Adverse Event|1|||
124930198|NCT05104463|449374743|FG000|Overall Study|Lost to Follow-up|1|||
124930199|NCT05104463|449374744|FG001|Overall Study|Lost to Follow-up|1|||
124930200|NCT05104463|449374743|FG000|Overall Study|Physician Decision|1|||
124930201|NCT05104463|449374744|FG001|Overall Study|Physician Decision|0|||
124930202|NCT05104463|449374743|FG000|Overall Study|Protocol Violation|0|||
124930203|NCT05104463|449374744|FG001|Overall Study|Protocol Violation|2|||
124930204|NCT05104463|449374743|FG000|Overall Study|Withdrawal by Subject|1|||
124930205|NCT05104463|449374744|FG001|Overall Study|Withdrawal by Subject|1|||
124930206|NCT05267470|449374748|FG000|Overall Study|Decision by sponsor|0|||
124930207|NCT05267470|449374749|FG001|Overall Study|Decision by sponsor|3|||
124930208|NCT05267470|449374750|FG002|Overall Study|Decision by sponsor|19|||
124930209|NCT05267470|449374751|FG003|Overall Study|Decision by sponsor|7|||
124930210|NCT05267470|449374752|FG004|Overall Study|Decision by sponsor|3|||
125120342|NCT03093324|450065064|FG000|Overall Study|Withdrawal by Subject|2|||
124930211|NCT05267470|449374748|FG000|Overall Study|Withdrawal by Subject|1|||
124930212|NCT05267470|449374749|FG001|Overall Study|Withdrawal by Subject|1|||
124930213|NCT05267470|449374750|FG002|Overall Study|Withdrawal by Subject|2|||
125120343|NCT03093324|450065065|FG001|Overall Study|Withdrawal by Subject|2|||
125120344|NCT04583579|450065066|FG000|Overall Study|Lost to Follow-up|4|||
125120345|NCT00278200|450065067|FG000|Overall Study|Death|1|||
124930214|NCT05267470|449374751|FG003|Overall Study|Withdrawal by Subject|2|||
124930215|NCT05267470|449374752|FG004|Overall Study|Withdrawal by Subject|0|||
124930216|NCT05267470|449374748|FG000|Overall Study|Death|3|||
125120346|NCT00278200|450065068|FG001|Overall Study|Death|3|||
125120347|NCT00278200|450065067|FG000|Overall Study|Physician Decision|0|||
124930217|NCT05267470|449374749|FG001|Overall Study|Death|5|||
125120348|NCT00278200|450065068|FG001|Overall Study|Physician Decision|1|||
125120349|NCT00135707|450065071|FG000|Overall Study|Lost to Follow-up|94|||
124930218|NCT05267470|449374750|FG002|Overall Study|Death|8|||
124930219|NCT05267470|449374751|FG003|Overall Study|Death|18|||
124930220|NCT05267470|449374752|FG004|Overall Study|Death|1|||
124930221|NCT05267470|449374748|FG000|Overall Study|Lost to Follow-up|0|||
124930222|NCT05267470|449374749|FG001|Overall Study|Lost to Follow-up|0|||
124930223|NCT05267470|449374750|FG002|Overall Study|Lost to Follow-up|0|||
124930224|NCT05267470|449374751|FG003|Overall Study|Lost to Follow-up|1|||
124930225|NCT05267470|449374752|FG004|Overall Study|Lost to Follow-up|0|||
124930226|NCT04230681|449374757|FG000|Overall Study|Physician Decision|2|||
124930227|NCT04230681|449374758|FG001|Overall Study|Physician Decision|3|||
124930228|NCT04230681|449374757|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
124930229|NCT04230681|449374758|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
124930230|NCT04230681|449374757|FG000|Overall Study|IV inadvertently removed|0|||
124930231|NCT04230681|449374758|FG001|Overall Study|IV inadvertently removed|1|||
124930232|NCT02433379|449376822|FG000|Overall Study|Screen Failures|55|||
124930233|NCT02433379|449376822|FG000|Overall Study|Death|57|||
124930234|NCT02433379|449376822|FG000|Overall Study|Total Withdrawals|209|||
124930235|NCT02038777|449376823|FG000|Overall Study|Death|0|||
124930236|NCT02038777|449376824|FG001|Overall Study|Death|2|||
124930237|NCT02038777|449376825|FG002|Overall Study|Death|0|||
124930238|NCT02038777|449376826|FG003|Overall Study|Death|1|||
124930239|NCT02038777|449376827|FG004|Overall Study|Death|2|||
124930240|NCT02038777|449376828|FG005|Overall Study|Death|4|||
125120350|NCT00135707|450065072|FG001|Overall Study|Lost to Follow-up|89|||
125120351|NCT00135707|450065071|FG000|Overall Study|Withdrawal by Subject|0|||
125120352|NCT00135707|450065072|FG001|Overall Study|Withdrawal by Subject|1|||
125120353|NCT00135707|450065071|FG000|Overall Study|Institutional review board request|1|||
125120354|NCT00135707|450065072|FG001|Overall Study|Institutional review board request|0|||
125120355|NCT00421174|450065076|FG000|Overall Study|Withdrawal by Subject|0|||
125120356|NCT00421174|450065077|FG001|Overall Study|Withdrawal by Subject|1|||
125120357|NCT00421174|450065076|FG000|Overall Study|Ineligible due to infection|2|||
125120358|NCT00421174|450065077|FG001|Overall Study|Ineligible due to infection|0|||
125120359|NCT02524379|450065078|FG000|Overall Study|Death|1|||
125212785|NCT01026818|450405478|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
124930241|NCT02038777|449376829|FG006|Overall Study|Death|0|||
124930242|NCT02038777|449376830|FG007|Overall Study|Death|11|||
124930243|NCT02038777|449376823|FG000|Overall Study|Lost to Follow-up|0|||
124930244|NCT02038777|449376824|FG001|Overall Study|Lost to Follow-up|0|||
124930245|NCT02038777|449376825|FG002|Overall Study|Lost to Follow-up|0|||
124930246|NCT02038777|449376826|FG003|Overall Study|Lost to Follow-up|1|||
124930247|NCT02038777|449376827|FG004|Overall Study|Lost to Follow-up|0|||
124930248|NCT02038777|449376828|FG005|Overall Study|Lost to Follow-up|0|||
124930249|NCT02038777|449376829|FG006|Overall Study|Lost to Follow-up|0|||
125120360|NCT01829464|450065079|FG000|Overall Study|Adverse Event|1|||
125120361|NCT01829464|450065080|FG001|Overall Study|Adverse Event|0|||
125120362|NCT01829464|450065081|FG002|Overall Study|Adverse Event|0|||
125120363|NCT01829464|450065079|FG000|Overall Study|Lost to Follow-up|0|||
124930250|NCT02038777|449376830|FG007|Overall Study|Lost to Follow-up|0|||
124930251|NCT02038777|449376823|FG000|Overall Study|Other|0|||
124930252|NCT02038777|449376824|FG001|Overall Study|Other|1|||
124930253|NCT02038777|449376825|FG002|Overall Study|Other|0|||
124930254|NCT02038777|449376826|FG003|Overall Study|Other|2|||
124930255|NCT02038777|449376827|FG004|Overall Study|Other|1|||
124930256|NCT02038777|449376828|FG005|Overall Study|Other|0|||
125120364|NCT01829464|450065080|FG001|Overall Study|Lost to Follow-up|0|||
125120365|NCT01829464|450065081|FG002|Overall Study|Lost to Follow-up|1|||
125120366|NCT01829464|450065079|FG000|Overall Study|Withdrawal by Subject|2|||
125120367|NCT01829464|450065080|FG001|Overall Study|Withdrawal by Subject|0|||
125120368|NCT01829464|450065081|FG002|Overall Study|Withdrawal by Subject|0|||
125120369|NCT01829464|450065079|FG000|Overall Study|Study terminated by sponsor|25|||
125120370|NCT01829464|450065080|FG001|Overall Study|Study terminated by sponsor|28|||
125120371|NCT01829464|450065081|FG002|Overall Study|Study terminated by sponsor|25|||
125120372|NCT01829464|450065079|FG000|Overall Study|Lack of Efficacy|0|||
125120373|NCT01829464|450065080|FG001|Overall Study|Lack of Efficacy|1|||
125120374|NCT01829464|450065081|FG002|Overall Study|Lack of Efficacy|0|||
125120375|NCT02228382|450065086|FG000|Overall Study|Death|5|||
125120376|NCT02228382|450065087|FG001|Overall Study|Death|7|||
125120377|NCT02228382|450065088|FG002|Overall Study|Death|5|||
125120378|NCT02228382|450065089|FG003|Overall Study|Death|0|||
125120379|NCT02228382|450065090|FG004|Overall Study|Death|2|||
125120380|NCT02228382|450065086|FG000|Overall Study|Participant refused further follow-up|0|||
125120381|NCT02228382|450065087|FG001|Overall Study|Participant refused further follow-up|0|||
125120382|NCT02228382|450065088|FG002|Overall Study|Participant refused further follow-up|1|||
125120383|NCT02228382|450065089|FG003|Overall Study|Participant refused further follow-up|0|||
125120384|NCT02228382|450065090|FG004|Overall Study|Participant refused further follow-up|0|||
125120385|NCT02228382|450065086|FG000|Overall Study|Study terminated by sponsor|3|||
125120386|NCT02228382|450065087|FG001|Overall Study|Study terminated by sponsor|5|||
125120387|NCT02228382|450065088|FG002|Overall Study|Study terminated by sponsor|7|||
125120388|NCT02228382|450065089|FG003|Overall Study|Study terminated by sponsor|0|||
125120389|NCT02228382|450065090|FG004|Overall Study|Study terminated by sponsor|0|||
125120390|NCT02228382|450065086|FG000|Overall Study|Lost to Follow-up|0|||
125120391|NCT02228382|450065087|FG001|Overall Study|Lost to Follow-up|0|||
125120392|NCT02228382|450065088|FG002|Overall Study|Lost to Follow-up|3|||
125120393|NCT02228382|450065089|FG003|Overall Study|Lost to Follow-up|1|||
125120394|NCT02228382|450065090|FG004|Overall Study|Lost to Follow-up|0|||
125120395|NCT02228382|450065086|FG000|Overall Study|Withdrawal by Subject|0|||
125120396|NCT02228382|450065087|FG001|Overall Study|Withdrawal by Subject|3|||
125120397|NCT02228382|450065088|FG002|Overall Study|Withdrawal by Subject|2|||
125120398|NCT02228382|450065089|FG003|Overall Study|Withdrawal by Subject|1|||
125120399|NCT02228382|450065090|FG004|Overall Study|Withdrawal by Subject|0|||
125120400|NCT02228382|450065086|FG000|Overall Study|Other|2|||
125120401|NCT02228382|450065087|FG001|Overall Study|Other|3|||
125120402|NCT02228382|450065088|FG002|Overall Study|Other|3|||
125120403|NCT02228382|450065089|FG003|Overall Study|Other|0|||
125120404|NCT02228382|450065090|FG004|Overall Study|Other|0|||
125120405|NCT00356200|450065092|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
125120406|NCT00356200|450065093|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
125120407|NCT00356200|450065092|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
125120408|NCT00356200|450065093|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
125120409|NCT00812253|450065094|FG000|Overall Study|Withdrawal by Subject|3|||
125120410|NCT00812253|450065095|FG001|Overall Study|Withdrawal by Subject|2|||
125120411|NCT00812253|450065094|FG000|Overall Study|Protocol Violation|1|||
125120412|NCT00812253|450065095|FG001|Overall Study|Protocol Violation|1|||
125120413|NCT00812253|450065094|FG000|Overall Study|Lost to Follow-up|2|||
125120414|NCT00812253|450065095|FG001|Overall Study|Lost to Follow-up|0|||
125120415|NCT03679741|450065096|FG000|Period 1|No longer meet eligibility criteria|1|||
125120416|NCT03679741|450065097|FG001|Period 1|No longer meet eligibility criteria|0|||
125120417|NCT03679741|450065096|FG000|Period 1|Lost to Follow-up|0|||
125120418|NCT03679741|450065097|FG001|Period 1|Lost to Follow-up|1|||
125120419|NCT03679741|450065096|FG000|Period 1|Adverse Event|1|||
125120420|NCT03679741|450065097|FG001|Period 1|Adverse Event|1|||
125120421|NCT03679741|450065096|FG000|Period 1|Withdrawal by Subject|0|||
125024822|NCT01227902|449714756|FG000|Overall Study|Adverse Event|12|||
125024823|NCT01227902|449714757|FG001|Overall Study|Adverse Event|8|||
125024824|NCT01227902|449714758|FG002|Overall Study|Adverse Event|11|||
125024825|NCT01227902|449714759|FG003|Overall Study|Adverse Event|4|||
125024826|NCT01227902|449714756|FG000|Overall Study|Lack of Efficacy|1|||
125024827|NCT01227902|449714757|FG001|Overall Study|Lack of Efficacy|2|||
125024828|NCT01227902|449714758|FG002|Overall Study|Lack of Efficacy|2|||
125024829|NCT01227902|449714759|FG003|Overall Study|Lack of Efficacy|1|||
125024830|NCT01227902|449714756|FG000|Overall Study|Protocol Violation|1|||
125024831|NCT01227902|449714757|FG001|Overall Study|Protocol Violation|0|||
125024832|NCT01227902|449714758|FG002|Overall Study|Protocol Violation|0|||
125024833|NCT01227902|449714759|FG003|Overall Study|Protocol Violation|0|||
125024834|NCT01227902|449714756|FG000|Overall Study|Lost to Follow-up|0|||
125024835|NCT01227902|449714757|FG001|Overall Study|Lost to Follow-up|0|||
125024836|NCT01227902|449714758|FG002|Overall Study|Lost to Follow-up|1|||
125024837|NCT01227902|449714759|FG003|Overall Study|Lost to Follow-up|2|||
125024838|NCT01227902|449714756|FG000|Overall Study|Physician Decision|0|||
125212786|NCT01026818|450405479|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
125212787|NCT01026818|450405480|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
125212788|NCT01026818|450405481|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
125212789|NCT01026818|450405478|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
125212790|NCT01026818|450405479|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
125212791|NCT01026818|450405480|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
125212792|NCT01026818|450405481|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
125212793|NCT01026818|450405478|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
124930257|NCT02038777|449376829|FG006|Overall Study|Other|0|||
124930258|NCT02038777|449376830|FG007|Overall Study|Other|0|||
124930259|NCT02038777|449376823|FG000|Overall Study|Randomized but not treated|0|||
124930260|NCT02038777|449376824|FG001|Overall Study|Randomized but not treated|1|||
124930261|NCT02038777|449376825|FG002|Overall Study|Randomized but not treated|0|||
124930262|NCT02038777|449376826|FG003|Overall Study|Randomized but not treated|0|||
124930263|NCT02038777|449376827|FG004|Overall Study|Randomized but not treated|0|||
124930264|NCT02038777|449376828|FG005|Overall Study|Randomized but not treated|0|||
124930265|NCT02038777|449376829|FG006|Overall Study|Randomized but not treated|0|||
124930266|NCT02038777|449376830|FG007|Overall Study|Randomized but not treated|0|||
124930267|NCT02038777|449376823|FG000|Overall Study|Started Chemotherapy|1|||
124930268|NCT02038777|449376824|FG001|Overall Study|Started Chemotherapy|0|||
124930269|NCT02038777|449376825|FG002|Overall Study|Started Chemotherapy|3|||
124930270|NCT02038777|449376826|FG003|Overall Study|Started Chemotherapy|0|||
124930271|NCT02038777|449376827|FG004|Overall Study|Started Chemotherapy|0|||
124930272|NCT02038777|449376828|FG005|Overall Study|Started Chemotherapy|0|||
124930273|NCT02038777|449376829|FG006|Overall Study|Started Chemotherapy|0|||
124930274|NCT02038777|449376830|FG007|Overall Study|Started Chemotherapy|0|||
124930275|NCT02038777|449376823|FG000|Overall Study|participation terminated by sponsor|0|||
125024839|NCT01227902|449714757|FG001|Overall Study|Physician Decision|1|||
125024840|NCT01227902|449714758|FG002|Overall Study|Physician Decision|1|||
124930276|NCT02038777|449376824|FG001|Overall Study|participation terminated by sponsor|0|||
124930277|NCT02038777|449376825|FG002|Overall Study|participation terminated by sponsor|0|||
124930278|NCT02038777|449376826|FG003|Overall Study|participation terminated by sponsor|0|||
124930279|NCT02038777|449376827|FG004|Overall Study|participation terminated by sponsor|0|||
124930280|NCT02038777|449376828|FG005|Overall Study|participation terminated by sponsor|0|||
124930281|NCT02038777|449376829|FG006|Overall Study|participation terminated by sponsor|1|||
124930282|NCT02038777|449376830|FG007|Overall Study|participation terminated by sponsor|1|||
124930283|NCT04294641|449376840|FG000|Overall Study|Screen failure|4|||
124930284|NCT04314778|449376857|FG000|Overall Study|Lost to Follow-up|5|||
124930285|NCT04314778|449376858|FG001|Overall Study|Lost to Follow-up|3|||
124930286|NCT04024020|449376861|FG000|Overall Study|Withdrawal by Subject|2|||
124930287|NCT04024020|449376862|FG001|Overall Study|Withdrawal by Subject|2|||
124930288|NCT05646355|449376863|FG000|Overall Study|Lost to Follow-up|1|||
124930289|NCT05646355|449376864|FG001|Overall Study|Lost to Follow-up|0|||
124930290|NCT05646355|449376863|FG000|Overall Study|translated materials not available for pilot|2|||
124930291|NCT05646355|449376864|FG001|Overall Study|translated materials not available for pilot|0|||
124930292|NCT05646355|449376863|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
124930293|NCT05646355|449376864|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
124930294|NCT03523572|449376867|FG000|Dose Escalation|Progressive disease|1|||
124930295|NCT03523572|449376868|FG001|Dose Escalation|Progressive disease|0|||
124930296|NCT03523572|449376869|FG002|Dose Escalation|Progressive disease|0|||
124930297|NCT03523572|449376870|FG003|Dose Escalation|Progressive disease|0|||
124930298|NCT03523572|449376871|FG004|Dose Escalation|Progressive disease|0|||
124930299|NCT03523572|449376872|FG005|Dose Escalation|Progressive disease|0|||
124930300|NCT03523572|449376867|FG000|Dose Escalation|Clinical Progression|0|||
124930301|NCT03523572|449376868|FG001|Dose Escalation|Clinical Progression|1|||
124930302|NCT03523572|449376869|FG002|Dose Escalation|Clinical Progression|0|||
124930303|NCT03523572|449376870|FG003|Dose Escalation|Clinical Progression|0|||
124930304|NCT03523572|449376871|FG004|Dose Escalation|Clinical Progression|0|||
124930305|NCT03523572|449376872|FG005|Dose Escalation|Clinical Progression|0|||
124930306|NCT03523572|449376867|FG000|Dose Escalation|Adverse Event|2|||
124930307|NCT03523572|449376868|FG001|Dose Escalation|Adverse Event|0|||
124930308|NCT03523572|449376869|FG002|Dose Escalation|Adverse Event|0|||
124930309|NCT03523572|449376870|FG003|Dose Escalation|Adverse Event|0|||
124930310|NCT03523572|449376871|FG004|Dose Escalation|Adverse Event|0|||
124930311|NCT03523572|449376872|FG005|Dose Escalation|Adverse Event|0|||
124930312|NCT03523572|449376867|FG000|Dose Escalation|Physician Decision|1|||
124930313|NCT03523572|449376868|FG001|Dose Escalation|Physician Decision|1|||
124930314|NCT03523572|449376869|FG002|Dose Escalation|Physician Decision|0|||
124930315|NCT03523572|449376870|FG003|Dose Escalation|Physician Decision|0|||
124930316|NCT03523572|449376871|FG004|Dose Escalation|Physician Decision|0|||
124930317|NCT03523572|449376872|FG005|Dose Escalation|Physician Decision|0|||
124930318|NCT03523572|449376867|FG000|Dose Expansion|Progressive Disease|0|||
124930319|NCT03523572|449376868|FG001|Dose Expansion|Progressive Disease|0|||
124930320|NCT03523572|449376869|FG002|Dose Expansion|Progressive Disease|9|||
124930321|NCT03523572|449376870|FG003|Dose Expansion|Progressive Disease|11|||
124930322|NCT03523572|449376871|FG004|Dose Expansion|Progressive Disease|15|||
124930323|NCT03523572|449376872|FG005|Dose Expansion|Progressive Disease|2|||
124930324|NCT03523572|449376867|FG000|Dose Expansion|Clinical Progression|0|||
124930325|NCT03523572|449376868|FG001|Dose Expansion|Clinical Progression|0|||
124930326|NCT03523572|449376869|FG002|Dose Expansion|Clinical Progression|2|||
124930327|NCT03523572|449376870|FG003|Dose Expansion|Clinical Progression|2|||
124930328|NCT03523572|449376871|FG004|Dose Expansion|Clinical Progression|2|||
124930329|NCT03523572|449376872|FG005|Dose Expansion|Clinical Progression|0|||
124930330|NCT03523572|449376867|FG000|Dose Expansion|Adverse Event|0|||
124930331|NCT03523572|449376868|FG001|Dose Expansion|Adverse Event|0|||
124930332|NCT03523572|449376869|FG002|Dose Expansion|Adverse Event|10|||
124930333|NCT03523572|449376870|FG003|Dose Expansion|Adverse Event|1|||
124930334|NCT03523572|449376871|FG004|Dose Expansion|Adverse Event|5|||
124930335|NCT03523572|449376872|FG005|Dose Expansion|Adverse Event|2|||
124930336|NCT03523572|449376867|FG000|Dose Expansion|Withdrawal by Subject|0|||
124930337|NCT03523572|449376868|FG001|Dose Expansion|Withdrawal by Subject|0|||
124930338|NCT03523572|449376869|FG002|Dose Expansion|Withdrawal by Subject|1|||
124930339|NCT03523572|449376870|FG003|Dose Expansion|Withdrawal by Subject|1|||
124930340|NCT03523572|449376871|FG004|Dose Expansion|Withdrawal by Subject|0|||
124930341|NCT03523572|449376872|FG005|Dose Expansion|Withdrawal by Subject|0|||
124930342|NCT03523572|449376867|FG000|Dose Expansion|Physician Decision|0|||
124930343|NCT03523572|449376868|FG001|Dose Expansion|Physician Decision|0|||
124930344|NCT03523572|449376869|FG002|Dose Expansion|Physician Decision|1|||
124930345|NCT03523572|449376870|FG003|Dose Expansion|Physician Decision|0|||
124930346|NCT03523572|449376871|FG004|Dose Expansion|Physician Decision|1|||
124930347|NCT03523572|449376872|FG005|Dose Expansion|Physician Decision|0|||
124930348|NCT03523572|449376867|FG000|Dose Expansion|Miscellaneous|0|||
124930349|NCT03523572|449376868|FG001|Dose Expansion|Miscellaneous|0|||
124930350|NCT03523572|449376869|FG002|Dose Expansion|Miscellaneous|0|||
124930351|NCT03523572|449376870|FG003|Dose Expansion|Miscellaneous|0|||
124930352|NCT03523572|449376871|FG004|Dose Expansion|Miscellaneous|3|||
124930353|NCT03523572|449376872|FG005|Dose Expansion|Miscellaneous|0|||
124930354|NCT05269966|449376873|FG000|Overall Study|Adverse Event|4|||
124930355|NCT05269966|449376873|FG000|Overall Study|Withdrawal by Subject|1|||
124930356|NCT05269966|449376873|FG000|Overall Study|Lost to Follow-up|4|||
124930357|NCT05269966|449376873|FG000|Overall Study|Physician Decision|1|||
124930358|NCT04685135|449376876|FG000|Overall Study|Death|126|||
124930359|NCT04685135|449376877|FG001|Overall Study|Death|53|||
124930360|NCT04685135|449376876|FG000|Overall Study|Withdrawal by Subject|12|||
124930361|NCT04685135|449376877|FG001|Overall Study|Withdrawal by Subject|16|||
124930362|NCT03519178|449376878|FG000|PF-06873600 Treatment|Adverse Event|0|||
124930363|NCT03519178|449376879|FG001|PF-06873600 Treatment|Adverse Event|0|||
124930364|NCT03519178|449376880|FG002|PF-06873600 Treatment|Adverse Event|0|||
124930365|NCT03519178|449376881|FG003|PF-06873600 Treatment|Adverse Event|0|||
124930366|NCT03519178|449376882|FG004|PF-06873600 Treatment|Adverse Event|0|||
124930367|NCT03519178|449376883|FG005|PF-06873600 Treatment|Adverse Event|0|||
124930368|NCT03519178|449376884|FG006|PF-06873600 Treatment|Adverse Event|0|||
124930369|NCT03519178|449376885|FG007|PF-06873600 Treatment|Adverse Event|2|||
124930370|NCT03519178|449376886|FG008|PF-06873600 Treatment|Adverse Event|1|||
124930371|NCT03519178|449376887|FG009|PF-06873600 Treatment|Adverse Event|0|||
124930372|NCT03519178|449376888|FG010|PF-06873600 Treatment|Adverse Event|0|||
124930373|NCT03519178|449376889|FG011|PF-06873600 Treatment|Adverse Event|0|||
124930374|NCT03519178|449376890|FG012|PF-06873600 Treatment|Adverse Event|1|||
124930375|NCT03519178|449376891|FG013|PF-06873600 Treatment|Adverse Event|3|||
124930376|NCT03519178|449376892|FG014|PF-06873600 Treatment|Adverse Event|2|||
124930377|NCT03519178|449376878|FG000|PF-06873600 Treatment|Death|0|||
124930378|NCT03519178|449376879|FG001|PF-06873600 Treatment|Death|0|||
124930379|NCT03519178|449376880|FG002|PF-06873600 Treatment|Death|0|||
124930380|NCT03519178|449376881|FG003|PF-06873600 Treatment|Death|0|||
124930381|NCT03519178|449376882|FG004|PF-06873600 Treatment|Death|0|||
124930382|NCT03519178|449376883|FG005|PF-06873600 Treatment|Death|0|||
124930383|NCT03519178|449376884|FG006|PF-06873600 Treatment|Death|0|||
124930384|NCT03519178|449376885|FG007|PF-06873600 Treatment|Death|0|||
124930385|NCT03519178|449376886|FG008|PF-06873600 Treatment|Death|1|||
124930386|NCT03519178|449376887|FG009|PF-06873600 Treatment|Death|1|||
124930387|NCT03519178|449376888|FG010|PF-06873600 Treatment|Death|0|||
124930388|NCT03519178|449376889|FG011|PF-06873600 Treatment|Death|0|||
124930389|NCT03519178|449376890|FG012|PF-06873600 Treatment|Death|0|||
124930390|NCT03519178|449376891|FG013|PF-06873600 Treatment|Death|0|||
124930391|NCT03519178|449376892|FG014|PF-06873600 Treatment|Death|1|||
124930392|NCT03519178|449376878|FG000|PF-06873600 Treatment|Physician Decision|0|||
124930393|NCT03519178|449376879|FG001|PF-06873600 Treatment|Physician Decision|0|||
124930394|NCT03519178|449376880|FG002|PF-06873600 Treatment|Physician Decision|0|||
124930395|NCT03519178|449376881|FG003|PF-06873600 Treatment|Physician Decision|0|||
124930396|NCT03519178|449376882|FG004|PF-06873600 Treatment|Physician Decision|0|||
124930397|NCT03519178|449376883|FG005|PF-06873600 Treatment|Physician Decision|0|||
124930398|NCT03519178|449376884|FG006|PF-06873600 Treatment|Physician Decision|0|||
124930399|NCT03519178|449376885|FG007|PF-06873600 Treatment|Physician Decision|1|||
124930400|NCT03519178|449376886|FG008|PF-06873600 Treatment|Physician Decision|0|||
124930401|NCT03519178|449376887|FG009|PF-06873600 Treatment|Physician Decision|0|||
124930402|NCT03519178|449376888|FG010|PF-06873600 Treatment|Physician Decision|1|||
124930403|NCT03519178|449376889|FG011|PF-06873600 Treatment|Physician Decision|0|||
124930404|NCT03519178|449376890|FG012|PF-06873600 Treatment|Physician Decision|0|||
124930405|NCT03519178|449376891|FG013|PF-06873600 Treatment|Physician Decision|4|||
124930406|NCT03519178|449376892|FG014|PF-06873600 Treatment|Physician Decision|1|||
124930407|NCT03519178|449376878|FG000|PF-06873600 Treatment|Progressive disease|1|||
124930408|NCT03519178|449376879|FG001|PF-06873600 Treatment|Progressive disease|1|||
124930409|NCT03519178|449376880|FG002|PF-06873600 Treatment|Progressive disease|1|||
124930410|NCT03519178|449376881|FG003|PF-06873600 Treatment|Progressive disease|1|||
124930411|NCT03519178|449376882|FG004|PF-06873600 Treatment|Progressive disease|6|||
124930412|NCT03519178|449376883|FG005|PF-06873600 Treatment|Progressive disease|7|||
124930413|NCT03519178|449376884|FG006|PF-06873600 Treatment|Progressive disease|3|||
124930414|NCT03519178|449376885|FG007|PF-06873600 Treatment|Progressive disease|7|||
124930415|NCT03519178|449376886|FG008|PF-06873600 Treatment|Progressive disease|3|||
124930416|NCT03519178|449376887|FG009|PF-06873600 Treatment|Progressive disease|5|||
124930417|NCT03519178|449376888|FG010|PF-06873600 Treatment|Progressive disease|4|||
124930418|NCT03519178|449376889|FG011|PF-06873600 Treatment|Progressive disease|3|||
124930419|NCT03519178|449376890|FG012|PF-06873600 Treatment|Progressive disease|4|||
124930420|NCT03519178|449376891|FG013|PF-06873600 Treatment|Progressive disease|28|||
124930421|NCT03519178|449376892|FG014|PF-06873600 Treatment|Progressive disease|7|||
124930422|NCT03519178|449376878|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
124930423|NCT03519178|449376879|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
124930424|NCT03519178|449376880|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
124930425|NCT03519178|449376881|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
124930426|NCT03519178|449376882|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
124930427|NCT03519178|449376883|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
124930428|NCT03519178|449376884|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
124930429|NCT03519178|449376885|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
124930430|NCT03519178|449376886|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
124930431|NCT03519178|449376887|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
124930432|NCT03519178|449376888|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
124930433|NCT03519178|449376889|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
124930434|NCT03519178|449376890|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
124930435|NCT03519178|449376891|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
124930436|NCT03519178|449376892|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
124930437|NCT03519178|449376878|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
124930438|NCT03519178|449376879|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
124930439|NCT03519178|449376880|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
124930440|NCT03519178|449376881|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
124930441|NCT03519178|449376882|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
124930442|NCT03519178|449376883|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
124930443|NCT03519178|449376884|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
124930444|NCT03519178|449376885|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
124930445|NCT03519178|449376886|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
124930446|NCT03519178|449376887|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
124930447|NCT03519178|449376888|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
124930448|NCT03519178|449376889|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
124930449|NCT03519178|449376890|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
124930450|NCT03519178|449376891|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
124930451|NCT03519178|449376892|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
124930452|NCT03519178|449376878|FG000|PF-06873600 Treatment|Refused further treatment|0|||
124930453|NCT03519178|449376879|FG001|PF-06873600 Treatment|Refused further treatment|1|||
124930454|NCT03519178|449376880|FG002|PF-06873600 Treatment|Refused further treatment|0|||
124930455|NCT03519178|449376881|FG003|PF-06873600 Treatment|Refused further treatment|0|||
124930456|NCT03519178|449376882|FG004|PF-06873600 Treatment|Refused further treatment|1|||
124930457|NCT03519178|449376883|FG005|PF-06873600 Treatment|Refused further treatment|0|||
124930458|NCT03519178|449376884|FG006|PF-06873600 Treatment|Refused further treatment|0|||
124930459|NCT03519178|449376885|FG007|PF-06873600 Treatment|Refused further treatment|0|||
124930460|NCT03519178|449376886|FG008|PF-06873600 Treatment|Refused further treatment|0|||
124930461|NCT03519178|449376887|FG009|PF-06873600 Treatment|Refused further treatment|0|||
124930462|NCT03519178|449376888|FG010|PF-06873600 Treatment|Refused further treatment|0|||
124930463|NCT03519178|449376889|FG011|PF-06873600 Treatment|Refused further treatment|0|||
124930464|NCT03519178|449376890|FG012|PF-06873600 Treatment|Refused further treatment|0|||
124930465|NCT03519178|449376891|FG013|PF-06873600 Treatment|Refused further treatment|0|||
124930466|NCT03519178|449376892|FG014|PF-06873600 Treatment|Refused further treatment|1|||
124930467|NCT03519178|449376878|FG000|PF-06873600 Treatment|Other|0|||
124930468|NCT03519178|449376879|FG001|PF-06873600 Treatment|Other|0|||
124930469|NCT03519178|449376880|FG002|PF-06873600 Treatment|Other|0|||
124930470|NCT03519178|449376881|FG003|PF-06873600 Treatment|Other|0|||
124930471|NCT03519178|449376882|FG004|PF-06873600 Treatment|Other|0|||
124930472|NCT03519178|449376883|FG005|PF-06873600 Treatment|Other|0|||
124930473|NCT03519178|449376884|FG006|PF-06873600 Treatment|Other|0|||
124930474|NCT03519178|449376885|FG007|PF-06873600 Treatment|Other|0|||
124930475|NCT03519178|449376886|FG008|PF-06873600 Treatment|Other|1|||
124930476|NCT03519178|449376887|FG009|PF-06873600 Treatment|Other|0|||
124930477|NCT03519178|449376888|FG010|PF-06873600 Treatment|Other|0|||
124930478|NCT03519178|449376889|FG011|PF-06873600 Treatment|Other|0|||
124930479|NCT03519178|449376890|FG012|PF-06873600 Treatment|Other|0|||
124930480|NCT03519178|449376891|FG013|PF-06873600 Treatment|Other|1|||
124930481|NCT03519178|449376892|FG014|PF-06873600 Treatment|Other|3|||
124930482|NCT03519178|449376878|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
124930483|NCT03519178|449376879|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
124930484|NCT03519178|449376880|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
124930485|NCT03519178|449376881|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
124930486|NCT03519178|449376882|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
124930487|NCT03519178|449376883|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
124930488|NCT03519178|449376884|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
124930489|NCT03519178|449376885|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
124930490|NCT03519178|449376886|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
124930491|NCT03519178|449376887|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
124930492|NCT03519178|449376888|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
124930493|NCT03519178|449376889|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
124930494|NCT03519178|449376890|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
124930495|NCT03519178|449376891|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
124930496|NCT03519178|449376892|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
124930497|NCT03519178|449376878|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930498|NCT03519178|449376879|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930499|NCT03519178|449376880|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930500|NCT03519178|449376881|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930501|NCT03519178|449376882|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930502|NCT03519178|449376883|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930503|NCT03519178|449376884|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930504|NCT03519178|449376885|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930505|NCT03519178|449376886|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930506|NCT03519178|449376887|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
125024841|NCT01227902|449714759|FG003|Overall Study|Physician Decision|0|||
124930507|NCT03519178|449376888|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930508|NCT03519178|449376889|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930509|NCT03519178|449376890|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930510|NCT03519178|449376891|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
124930511|NCT03519178|449376892|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
124930512|NCT03519178|449376878|FG000|PF-06873600 Treatment|Ongoing|0|||
124930513|NCT03519178|449376879|FG001|PF-06873600 Treatment|Ongoing|0|||
124930514|NCT03519178|449376880|FG002|PF-06873600 Treatment|Ongoing|0|||
124930515|NCT03519178|449376881|FG003|PF-06873600 Treatment|Ongoing|0|||
124930516|NCT03519178|449376882|FG004|PF-06873600 Treatment|Ongoing|0|||
124930517|NCT03519178|449376883|FG005|PF-06873600 Treatment|Ongoing|0|||
124930518|NCT03519178|449376884|FG006|PF-06873600 Treatment|Ongoing|0|||
124930519|NCT03519178|449376885|FG007|PF-06873600 Treatment|Ongoing|0|||
124930520|NCT03519178|449376886|FG008|PF-06873600 Treatment|Ongoing|0|||
124930521|NCT03519178|449376887|FG009|PF-06873600 Treatment|Ongoing|0|||
124930522|NCT03519178|449376888|FG010|PF-06873600 Treatment|Ongoing|0|||
124930523|NCT03519178|449376889|FG011|PF-06873600 Treatment|Ongoing|0|||
124930524|NCT03519178|449376890|FG012|PF-06873600 Treatment|Ongoing|0|||
124930525|NCT03519178|449376891|FG013|PF-06873600 Treatment|Ongoing|1|||
124930526|NCT03519178|449376892|FG014|PF-06873600 Treatment|Ongoing|6|||
124930527|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930528|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930529|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930530|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930531|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930532|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930533|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930534|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930535|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930536|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930537|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930538|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930539|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930540|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
124930541|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930542|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Death|0|||
124930543|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Death|0|||
124930544|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Death|0|||
124930545|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Death|0|||
124930546|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Death|0|||
124930547|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Death|0|||
124930548|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Death|0|||
124930549|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Death|0|||
124930550|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Death|0|||
124930551|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Death|1|||
124930552|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Death|0|||
124930553|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Death|0|||
124930554|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Death|0|||
124930555|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Death|0|||
124930556|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Death|1|||
124930557|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930558|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930559|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930560|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930561|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930562|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930563|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930564|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930565|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930566|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930567|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930568|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930569|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930570|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930571|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
124930572|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
125120422|NCT03679741|450065097|FG001|Period 1|Withdrawal by Subject|1|||
125120423|NCT03679741|450065096|FG000|Period 2|Adverse Event|2|||
125120424|NCT03679741|450065097|FG001|Period 2|Adverse Event|1|||
125120425|NCT03679741|450065096|FG000|Period 2|Withdrawal by Subject|1|||
125120426|NCT03679741|450065097|FG001|Period 2|Withdrawal by Subject|1|||
125120427|NCT02204371|450065107|FG000|Overall Study|Adverse Event|1|||
125120428|NCT00368966|450065110|FG000|Infant Series|Withdrawal by Subject|11|||
125120429|NCT00368966|450065111|FG001|Infant Series|Withdrawal by Subject|6|||
124930573|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930574|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930575|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930576|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930577|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930578|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930579|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930580|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930581|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930582|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930583|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930584|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930585|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
124930586|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
124930587|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930588|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930589|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930590|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930591|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930592|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930593|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930594|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930595|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930596|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
124930597|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930598|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930599|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930600|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
124930601|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
124930602|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930603|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930604|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930605|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930606|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930607|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930608|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930609|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930610|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930611|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930612|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930613|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930614|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930615|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
124930616|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
124930617|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930618|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930619|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930620|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930621|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930622|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930623|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930624|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930625|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930626|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
124930627|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930628|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
125120430|NCT00368966|450065110|FG000|Infant Series|Protocol Violation|2|||
125120431|NCT00368966|450065111|FG001|Infant Series|Protocol Violation|1|||
125120432|NCT00368966|450065110|FG000|Infant Series|Lost to Follow-up|2|||
124930629|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930630|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
124930631|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
124930632|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930633|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930634|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930635|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930636|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930637|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930638|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930639|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930640|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930641|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
124930642|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930643|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930644|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930645|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
124930646|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930647|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930648|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930649|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930650|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930651|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930652|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930653|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930654|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930655|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930656|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930657|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930658|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930659|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930660|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930661|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
124930662|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Other|0|||
124930663|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Other|0|||
124930664|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Other|0|||
124930665|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Other|0|||
124930666|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Other|0|||
124930667|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Other|0|||
124930668|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Other|0|||
124930669|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Other|0|||
124930670|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Other|0|||
124930671|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Other|0|||
124930672|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Other|0|||
124930673|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Other|0|||
124930674|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Other|0|||
124930675|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Other|1|||
124930676|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Other|3|||
124930677|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930678|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930679|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930680|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930681|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930682|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
125120433|NCT00368966|450065111|FG001|Infant Series|Lost to Follow-up|0|||
125120434|NCT00368966|450065110|FG000|Infant Series|Randomization error|0|||
125120435|NCT00368966|450065111|FG001|Infant Series|Randomization error|1|||
125120436|NCT00368966|450065110|FG000|Infant Series|Failed to meet eligibility criteria|0|||
125120437|NCT00368966|450065111|FG001|Infant Series|Failed to meet eligibility criteria|1|||
125120438|NCT00368966|450065110|FG000|Infant Series|Adverse Event|0|||
124930683|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930684|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930685|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930686|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930687|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930688|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930689|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930690|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
124930691|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
124930692|NCT03519178|449376878|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
124930693|NCT03519178|449376879|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
124930694|NCT03519178|449376880|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
124930695|NCT03519178|449376881|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
124930696|NCT03519178|449376882|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
124930697|NCT03519178|449376883|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
124930698|NCT03519178|449376884|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
124930699|NCT03519178|449376885|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
124930700|NCT03519178|449376886|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
124930701|NCT03519178|449376887|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
124930702|NCT03519178|449376888|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
124930703|NCT03519178|449376889|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
124930704|NCT03519178|449376890|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
124930705|NCT03519178|449376891|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
124930706|NCT03519178|449376892|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
124930707|NCT03519178|449376878|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
124930708|NCT03519178|449376879|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
124930709|NCT03519178|449376880|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
124930710|NCT03519178|449376881|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
124930711|NCT03519178|449376882|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
124930712|NCT03519178|449376883|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
124930713|NCT03519178|449376884|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
124930714|NCT03519178|449376885|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
124930715|NCT03519178|449376886|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
124930716|NCT03519178|449376887|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
124930717|NCT03519178|449376888|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
124930718|NCT03519178|449376889|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
124930719|NCT03519178|449376890|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
124930720|NCT03519178|449376891|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
124930721|NCT03519178|449376892|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
124930722|NCT03519178|449376878|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930723|NCT03519178|449376879|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930724|NCT03519178|449376880|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930725|NCT03519178|449376881|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930726|NCT03519178|449376882|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930727|NCT03519178|449376883|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930728|NCT03519178|449376884|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930729|NCT03519178|449376885|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930730|NCT03519178|449376886|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930731|NCT03519178|449376887|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930732|NCT03519178|449376888|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
124930733|NCT03519178|449376889|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930734|NCT03519178|449376890|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930735|NCT03519178|449376891|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930736|NCT03519178|449376892|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930737|NCT03519178|449376878|FG000|Follow-Up|Death|0|||
124930738|NCT03519178|449376879|FG001|Follow-Up|Death|0|||
125024842|NCT01227902|449714756|FG000|Overall Study|Withdrawal by Subject|4|||
125024843|NCT01227902|449714757|FG001|Overall Study|Withdrawal by Subject|2|||
125024844|NCT01227902|449714758|FG002|Overall Study|Withdrawal by Subject|4|||
125024845|NCT01227902|449714759|FG003|Overall Study|Withdrawal by Subject|3|||
125024846|NCT02527707|449714760|FG000|Overall Study|Adverse Event|1|||
125024847|NCT02527707|449714760|FG000|Overall Study|Adverse Event|1|||
125024848|NCT00930059|449714761|FG000|Overall Study|Death|1|||
125024849|NCT00930059|449714762|FG001|Overall Study|Death|0|||
125024850|NCT00930059|449714761|FG000|Overall Study|Did not meet entrance criteria|1|||
125024851|NCT00930059|449714762|FG001|Overall Study|Did not meet entrance criteria|1|||
125120439|NCT00368966|450065111|FG001|Infant Series|Adverse Event|1|||
125120440|NCT00368966|450065110|FG000|Infant Series|Failed to return|1|||
125120441|NCT00368966|450065111|FG001|Infant Series|Failed to return|0|||
125120442|NCT00368966|450065110|FG000|After Infant|Failed to return|3|||
125120443|NCT00368966|450065111|FG001|After Infant|Failed to return|1|||
124930739|NCT03519178|449376880|FG002|Follow-Up|Death|1|||
124930740|NCT03519178|449376881|FG003|Follow-Up|Death|0|||
124930741|NCT03519178|449376882|FG004|Follow-Up|Death|0|||
125120444|NCT00368966|450065110|FG000|After Infant|Adverse Event|1|||
125120445|NCT00368966|450065111|FG001|After Infant|Adverse Event|2|||
125120446|NCT00368966|450065110|FG000|After Infant|Withdrawal by Subject|1|||
125120447|NCT00368966|450065111|FG001|After Infant|Withdrawal by Subject|1|||
125120448|NCT00368966|450065110|FG000|After Infant|Death|1|||
125120449|NCT00368966|450065111|FG001|After Infant|Death|0|||
125120450|NCT00368966|450065110|FG000|After Infant|Lost to Follow-up|0|||
125120451|NCT00368966|450065111|FG001|After Infant|Lost to Follow-up|1|||
125120452|NCT00368966|450065110|FG000|Toddler Dose|Withdrawal by Subject|1|||
125120453|NCT00368966|450065111|FG001|Toddler Dose|Withdrawal by Subject|1|||
125212794|NCT01026818|450405479|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
125212795|NCT01026818|450405480|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
124930742|NCT03519178|449376883|FG005|Follow-Up|Death|0|||
124930743|NCT03519178|449376884|FG006|Follow-Up|Death|0|||
124930744|NCT03519178|449376885|FG007|Follow-Up|Death|0|||
124930745|NCT03519178|449376886|FG008|Follow-Up|Death|3|||
124930746|NCT03519178|449376887|FG009|Follow-Up|Death|1|||
124930747|NCT03519178|449376888|FG010|Follow-Up|Death|0|||
124930748|NCT03519178|449376889|FG011|Follow-Up|Death|0|||
124930749|NCT03519178|449376890|FG012|Follow-Up|Death|2|||
124930750|NCT03519178|449376891|FG013|Follow-Up|Death|0|||
124930751|NCT03519178|449376892|FG014|Follow-Up|Death|0|||
124930752|NCT03519178|449376878|FG000|Follow-Up|Lost to Follow-up|0|||
124930753|NCT03519178|449376879|FG001|Follow-Up|Lost to Follow-up|0|||
124930754|NCT03519178|449376880|FG002|Follow-Up|Lost to Follow-up|0|||
124930755|NCT03519178|449376881|FG003|Follow-Up|Lost to Follow-up|0|||
124930756|NCT03519178|449376882|FG004|Follow-Up|Lost to Follow-up|0|||
124930757|NCT03519178|449376883|FG005|Follow-Up|Lost to Follow-up|3|||
124930758|NCT03519178|449376884|FG006|Follow-Up|Lost to Follow-up|1|||
124930759|NCT03519178|449376885|FG007|Follow-Up|Lost to Follow-up|4|||
124930760|NCT03519178|449376886|FG008|Follow-Up|Lost to Follow-up|1|||
124930761|NCT03519178|449376887|FG009|Follow-Up|Lost to Follow-up|0|||
124930762|NCT03519178|449376888|FG010|Follow-Up|Lost to Follow-up|0|||
124930763|NCT03519178|449376889|FG011|Follow-Up|Lost to Follow-up|0|||
124930764|NCT03519178|449376890|FG012|Follow-Up|Lost to Follow-up|0|||
124930765|NCT03519178|449376891|FG013|Follow-Up|Lost to Follow-up|0|||
124930766|NCT03519178|449376892|FG014|Follow-Up|Lost to Follow-up|0|||
124930767|NCT03519178|449376878|FG000|Follow-Up|Withdrawal by Subject|1|||
124930768|NCT03519178|449376879|FG001|Follow-Up|Withdrawal by Subject|2|||
124930769|NCT03519178|449376880|FG002|Follow-Up|Withdrawal by Subject|2|||
124930770|NCT03519178|449376881|FG003|Follow-Up|Withdrawal by Subject|3|||
124930771|NCT03519178|449376882|FG004|Follow-Up|Withdrawal by Subject|5|||
124930772|NCT03519178|449376883|FG005|Follow-Up|Withdrawal by Subject|1|||
124930773|NCT03519178|449376884|FG006|Follow-Up|Withdrawal by Subject|2|||
124930774|NCT03519178|449376885|FG007|Follow-Up|Withdrawal by Subject|6|||
124930775|NCT03519178|449376886|FG008|Follow-Up|Withdrawal by Subject|5|||
124930776|NCT03519178|449376887|FG009|Follow-Up|Withdrawal by Subject|2|||
124930777|NCT03519178|449376888|FG010|Follow-Up|Withdrawal by Subject|3|||
124930778|NCT03519178|449376889|FG011|Follow-Up|Withdrawal by Subject|5|||
124930779|NCT03519178|449376890|FG012|Follow-Up|Withdrawal by Subject|2|||
124930780|NCT03519178|449376891|FG013|Follow-Up|Withdrawal by Subject|0|||
124930781|NCT03519178|449376892|FG014|Follow-Up|Withdrawal by Subject|0|||
124930782|NCT03519178|449376878|FG000|Follow-Up|Other|0|||
124930783|NCT03519178|449376879|FG001|Follow-Up|Other|0|||
124930784|NCT03519178|449376880|FG002|Follow-Up|Other|0|||
124930785|NCT03519178|449376881|FG003|Follow-Up|Other|0|||
124930786|NCT03519178|449376882|FG004|Follow-Up|Other|0|||
124930787|NCT03519178|449376883|FG005|Follow-Up|Other|0|||
125120454|NCT00368966|450065110|FG000|Toddler Dose|Lost to Follow-up|0|||
125120455|NCT00368966|450065111|FG001|Toddler Dose|Lost to Follow-up|2|||
125120456|NCT02866175|450065112|FG000|Overall Study|Adverse Event|56|||
124930788|NCT03519178|449376884|FG006|Follow-Up|Other|0|||
124930789|NCT03519178|449376885|FG007|Follow-Up|Other|1|||
124930790|NCT03519178|449376886|FG008|Follow-Up|Other|0|||
124930791|NCT03519178|449376887|FG009|Follow-Up|Other|0|||
124930792|NCT03519178|449376888|FG010|Follow-Up|Other|0|||
124930793|NCT03519178|449376889|FG011|Follow-Up|Other|0|||
124930794|NCT03519178|449376890|FG012|Follow-Up|Other|0|||
124930795|NCT03519178|449376891|FG013|Follow-Up|Other|0|||
124930796|NCT03519178|449376892|FG014|Follow-Up|Other|0|||
124930797|NCT03519178|449376878|FG000|Long-term Follow-up|Death|0|||
124930798|NCT03519178|449376879|FG001|Long-term Follow-up|Death|0|||
124930799|NCT03519178|449376880|FG002|Long-term Follow-up|Death|0|||
124930800|NCT03519178|449376881|FG003|Long-term Follow-up|Death|0|||
124930801|NCT03519178|449376882|FG004|Long-term Follow-up|Death|0|||
125120457|NCT02866175|450065113|FG001|Overall Study|Adverse Event|54|||
125120458|NCT02866175|450065112|FG000|Overall Study|Withdrawal by Subject|31|||
124930802|NCT03519178|449376883|FG005|Long-term Follow-up|Death|0|||
124930803|NCT03519178|449376884|FG006|Long-term Follow-up|Death|0|||
124930804|NCT03519178|449376885|FG007|Long-term Follow-up|Death|0|||
124930805|NCT03519178|449376886|FG008|Long-term Follow-up|Death|0|||
124930806|NCT03519178|449376887|FG009|Long-term Follow-up|Death|0|||
124930807|NCT03519178|449376888|FG010|Long-term Follow-up|Death|0|||
124930808|NCT03519178|449376889|FG011|Long-term Follow-up|Death|0|||
124930809|NCT03519178|449376890|FG012|Long-term Follow-up|Death|0|||
124930810|NCT03519178|449376891|FG013|Long-term Follow-up|Death|4|||
124930811|NCT03519178|449376892|FG014|Long-term Follow-up|Death|4|||
124930812|NCT03519178|449376878|FG000|Long-term Follow-up|Lost to Follow-up|0|||
124930813|NCT03519178|449376879|FG001|Long-term Follow-up|Lost to Follow-up|0|||
124930814|NCT03519178|449376880|FG002|Long-term Follow-up|Lost to Follow-up|0|||
124930815|NCT03519178|449376881|FG003|Long-term Follow-up|Lost to Follow-up|0|||
124930816|NCT03519178|449376882|FG004|Long-term Follow-up|Lost to Follow-up|0|||
124930817|NCT03519178|449376883|FG005|Long-term Follow-up|Lost to Follow-up|0|||
124930818|NCT03519178|449376884|FG006|Long-term Follow-up|Lost to Follow-up|0|||
124930819|NCT03519178|449376885|FG007|Long-term Follow-up|Lost to Follow-up|0|||
124930820|NCT03519178|449376886|FG008|Long-term Follow-up|Lost to Follow-up|0|||
124930821|NCT03519178|449376887|FG009|Long-term Follow-up|Lost to Follow-up|0|||
124930822|NCT03519178|449376888|FG010|Long-term Follow-up|Lost to Follow-up|0|||
124930823|NCT03519178|449376889|FG011|Long-term Follow-up|Lost to Follow-up|0|||
124930824|NCT03519178|449376890|FG012|Long-term Follow-up|Lost to Follow-up|0|||
124930825|NCT03519178|449376891|FG013|Long-term Follow-up|Lost to Follow-up|1|||
124930826|NCT03519178|449376892|FG014|Long-term Follow-up|Lost to Follow-up|1|||
124930827|NCT03519178|449376878|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
124930828|NCT03519178|449376879|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
124930829|NCT03519178|449376880|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
124930830|NCT03519178|449376881|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
124930831|NCT03519178|449376882|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
124930832|NCT03519178|449376883|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
124930833|NCT03519178|449376884|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
124930834|NCT03519178|449376885|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
124930835|NCT03519178|449376886|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
124930836|NCT03519178|449376887|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
124930837|NCT03519178|449376888|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
124930838|NCT03519178|449376889|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
124930839|NCT03519178|449376890|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
124930840|NCT03519178|449376891|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
124930841|NCT03519178|449376892|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
124930842|NCT03519178|449376878|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
124930843|NCT03519178|449376879|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
124930844|NCT03519178|449376880|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
124930845|NCT03519178|449376881|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
124930846|NCT03519178|449376882|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
124930847|NCT03519178|449376883|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
124930848|NCT03519178|449376884|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
124930849|NCT03519178|449376885|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
124930850|NCT03519178|449376886|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
124930851|NCT03519178|449376887|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
124930852|NCT03519178|449376888|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
124930853|NCT03519178|449376889|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
124930854|NCT03519178|449376890|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
124930855|NCT03519178|449376891|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
124930856|NCT03519178|449376892|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
124930857|NCT03519178|449376878|FG000|Long-term Follow-up|Other|0|||
124930858|NCT03519178|449376879|FG001|Long-term Follow-up|Other|0|||
124930859|NCT03519178|449376880|FG002|Long-term Follow-up|Other|0|||
124930860|NCT03519178|449376881|FG003|Long-term Follow-up|Other|0|||
124930861|NCT03519178|449376882|FG004|Long-term Follow-up|Other|0|||
124930862|NCT03519178|449376883|FG005|Long-term Follow-up|Other|0|||
124930863|NCT03519178|449376884|FG006|Long-term Follow-up|Other|0|||
124930864|NCT03519178|449376885|FG007|Long-term Follow-up|Other|0|||
124930865|NCT03519178|449376886|FG008|Long-term Follow-up|Other|0|||
124930866|NCT03519178|449376887|FG009|Long-term Follow-up|Other|0|||
124930867|NCT03519178|449376888|FG010|Long-term Follow-up|Other|0|||
124930868|NCT03519178|449376889|FG011|Long-term Follow-up|Other|0|||
124930869|NCT03519178|449376890|FG012|Long-term Follow-up|Other|0|||
124930870|NCT03519178|449376891|FG013|Long-term Follow-up|Other|0|||
124930871|NCT03519178|449376892|FG014|Long-term Follow-up|Other|1|||
124930872|NCT03519178|449376878|FG000|Long-term Follow-up|Ongoing|0|||
124930873|NCT03519178|449376879|FG001|Long-term Follow-up|Ongoing|0|||
124930874|NCT03519178|449376880|FG002|Long-term Follow-up|Ongoing|0|||
124930875|NCT03519178|449376881|FG003|Long-term Follow-up|Ongoing|0|||
124930876|NCT03519178|449376882|FG004|Long-term Follow-up|Ongoing|0|||
124930877|NCT03519178|449376883|FG005|Long-term Follow-up|Ongoing|0|||
124930878|NCT03519178|449376884|FG006|Long-term Follow-up|Ongoing|0|||
124930879|NCT03519178|449376885|FG007|Long-term Follow-up|Ongoing|0|||
124930880|NCT03519178|449376886|FG008|Long-term Follow-up|Ongoing|0|||
124930881|NCT03519178|449376887|FG009|Long-term Follow-up|Ongoing|0|||
124930882|NCT03519178|449376888|FG010|Long-term Follow-up|Ongoing|0|||
124930883|NCT03519178|449376889|FG011|Long-term Follow-up|Ongoing|0|||
124930884|NCT03519178|449376890|FG012|Long-term Follow-up|Ongoing|0|||
124930885|NCT03519178|449376891|FG013|Long-term Follow-up|Ongoing|1|||
124930886|NCT03519178|449376892|FG014|Long-term Follow-up|Ongoing|0|||
124930887|NCT02315703|449376905|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
124930888|NCT02315703|449376906|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
124930889|NCT02315703|449376907|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
124930890|NCT02315703|449376908|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
124930891|NCT02315703|449376909|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
124930892|NCT02315703|449376910|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
124930893|NCT02315703|449376911|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
124930894|NCT02315703|449376912|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
125120459|NCT02866175|450065113|FG001|Overall Study|Withdrawal by Subject|52|||
125120460|NCT02866175|450065112|FG000|Overall Study|Death|30|||
125120461|NCT02866175|450065113|FG001|Overall Study|Death|23|||
125120462|NCT02866175|450065112|FG000|Overall Study|Other|7|||
125120463|NCT02866175|450065113|FG001|Overall Study|Other|14|||
125120464|NCT02866175|450065112|FG000|Overall Study|Progressive disease|1|||
125120465|NCT02866175|450065113|FG001|Overall Study|Progressive disease|1|||
125120466|NCT02866175|450065112|FG000|Overall Study|Lost to Follow-up|2|||
125120467|NCT02866175|450065113|FG001|Overall Study|Lost to Follow-up|0|||
125120468|NCT02866175|450065112|FG000|Overall Study|Lack of Efficacy|0|||
125120469|NCT02866175|450065113|FG001|Overall Study|Lack of Efficacy|1|||
125120470|NCT02866175|450065112|FG000|Overall Study|Physician Decision|3|||
125120471|NCT02866175|450065113|FG001|Overall Study|Physician Decision|15|||
125120472|NCT02866175|450065112|FG000|Overall Study|Did not receive treatment|5|||
125120473|NCT02866175|450065113|FG001|Overall Study|Did not receive treatment|15|||
125120474|NCT01694485|450065114|FG000|Overall Study|Withdrawal by Subject|20|||
125120475|NCT01694485|450065115|FG001|Overall Study|Withdrawal by Subject|6|||
125120476|NCT01694485|450065116|FG002|Overall Study|Withdrawal by Subject|7|||
125120477|NCT01694485|450065117|FG003|Overall Study|Withdrawal by Subject|25|||
125120478|NCT01694485|450065118|FG004|Overall Study|Withdrawal by Subject|18|||
125120479|NCT01694485|450065114|FG000|Overall Study|Sponsor Decision|3|||
125120480|NCT01694485|450065115|FG001|Overall Study|Sponsor Decision|0|||
125120481|NCT01694485|450065116|FG002|Overall Study|Sponsor Decision|0|||
125120482|NCT01694485|450065117|FG003|Overall Study|Sponsor Decision|2|||
125120483|NCT01694485|450065118|FG004|Overall Study|Sponsor Decision|0|||
125120484|NCT01694485|450065114|FG000|Overall Study|Lost to Follow-up|9|||
125120485|NCT01694485|450065115|FG001|Overall Study|Lost to Follow-up|1|||
125120486|NCT01694485|450065116|FG002|Overall Study|Lost to Follow-up|6|||
125120487|NCT01694485|450065117|FG003|Overall Study|Lost to Follow-up|10|||
125120488|NCT01694485|450065118|FG004|Overall Study|Lost to Follow-up|7|||
125120489|NCT01694485|450065114|FG000|Overall Study|Death|1|||
125120490|NCT01694485|450065115|FG001|Overall Study|Death|0|||
125120491|NCT01694485|450065116|FG002|Overall Study|Death|0|||
125120492|NCT01694485|450065117|FG003|Overall Study|Death|1|||
125120493|NCT01694485|450065118|FG004|Overall Study|Death|0|||
125120494|NCT01595009|450065119|FG000|Core|Patients completed per protocol|85|||
125120495|NCT01595009|450065120|FG001|Core|Patients completed per protocol|44|||
125120496|NCT01595009|450065121|FG002|Core|Patients completed per protocol|0|||
125120497|NCT01595009|450065122|FG003|Core|Patients completed per protocol|0|||
125120498|NCT01595009|450065119|FG000|Core|Adverse Event|19|||
125120499|NCT01595009|450065120|FG001|Core|Adverse Event|23|||
125120500|NCT01595009|450065121|FG002|Core|Adverse Event|0|||
125120501|NCT01595009|450065122|FG003|Core|Adverse Event|0|||
125120502|NCT01595009|450065119|FG000|Core|Disease progression|14|||
125120503|NCT01595009|450065120|FG001|Core|Disease progression|26|||
125120504|NCT01595009|450065121|FG002|Core|Disease progression|0|||
125120505|NCT01595009|450065122|FG003|Core|Disease progression|0|||
124930895|NCT02315703|449376905|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
124930896|NCT02315703|449376906|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
125120506|NCT01595009|450065119|FG000|Core|Withdrawal by Subject|4|||
125120507|NCT01595009|450065120|FG001|Core|Withdrawal by Subject|17|||
125120508|NCT01595009|450065121|FG002|Core|Withdrawal by Subject|0|||
125120509|NCT01595009|450065122|FG003|Core|Withdrawal by Subject|0|||
125120510|NCT01595009|450065119|FG000|Core|Death|3|||
125120511|NCT01595009|450065120|FG001|Core|Death|6|||
125120512|NCT01595009|450065121|FG002|Core|Death|0|||
125120513|NCT01595009|450065122|FG003|Core|Death|0|||
125120514|NCT01595009|450065119|FG000|Core|Lost to Follow-up|1|||
125120515|NCT01595009|450065120|FG001|Core|Lost to Follow-up|2|||
125120516|NCT01595009|450065121|FG002|Core|Lost to Follow-up|0|||
125120517|NCT01595009|450065122|FG003|Core|Lost to Follow-up|0|||
125120518|NCT01595009|450065119|FG000|Core|Protocol deviation|0|||
125120519|NCT01595009|450065120|FG001|Core|Protocol deviation|1|||
125120520|NCT01595009|450065121|FG002|Core|Protocol deviation|0|||
125120521|NCT01595009|450065122|FG003|Core|Protocol deviation|0|||
125120522|NCT01595009|450065119|FG000|Core|Administrative problems|0|||
125120523|NCT01595009|450065120|FG001|Core|Administrative problems|1|||
125120524|NCT01595009|450065121|FG002|Core|Administrative problems|0|||
125120525|NCT01595009|450065122|FG003|Core|Administrative problems|0|||
125120526|NCT01595009|450065119|FG000|Extension|Administrative problems|0|||
125120527|NCT01595009|450065120|FG001|Extension|Administrative problems|0|||
125120528|NCT01595009|450065121|FG002|Extension|Administrative problems|0|||
125120529|NCT01595009|450065122|FG003|Extension|Administrative problems|1|||
125120530|NCT01595009|450065119|FG000|Extension|Patients completed per protocol|0|||
125120531|NCT01595009|450065120|FG001|Extension|Patients completed per protocol|0|||
125120532|NCT01595009|450065121|FG002|Extension|Patients completed per protocol|0|||
125120533|NCT01595009|450065122|FG003|Extension|Patients completed per protocol|2|||
125120534|NCT01595009|450065119|FG000|Extension|Disease progression|0|||
125120535|NCT01595009|450065120|FG001|Extension|Disease progression|0|||
125120536|NCT01595009|450065121|FG002|Extension|Disease progression|4|||
125120537|NCT01595009|450065122|FG003|Extension|Disease progression|7|||
125120538|NCT01595009|450065119|FG000|Extension|Adverse Event|0|||
125120539|NCT01595009|450065120|FG001|Extension|Adverse Event|0|||
125120540|NCT01595009|450065121|FG002|Extension|Adverse Event|0|||
125120541|NCT01595009|450065122|FG003|Extension|Adverse Event|1|||
125120542|NCT00662025|450065124|FG000|Overall Study|Objective progression or relapse|51|||
125120543|NCT00662025|450065124|FG000|Overall Study|Adverse Event|7|||
124930897|NCT02315703|449376907|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
124930898|NCT02315703|449376908|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
124930899|NCT02315703|449376909|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
124930900|NCT02315703|449376910|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
124930901|NCT02315703|449376911|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
124930902|NCT02315703|449376912|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
124930903|NCT02315703|449376905|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
124930904|NCT02315703|449376906|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
124930905|NCT02315703|449376907|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
124930906|NCT02315703|449376908|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
124930907|NCT02315703|449376909|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
124930908|NCT02315703|449376910|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
124930909|NCT02315703|449376911|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
124930910|NCT02315703|449376912|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
124930911|NCT02315703|449376905|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
124930912|NCT02315703|449376906|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
124930913|NCT02315703|449376907|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
124930914|NCT02315703|449376908|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
124930915|NCT02315703|449376909|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
125120544|NCT00662025|450065124|FG000|Overall Study|Withdrawal by Subject|1|||
124930916|NCT02315703|449376910|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
125120545|NCT00662025|450065124|FG000|Overall Study|Results of other clinical study|2|||
125120546|NCT00662025|450065124|FG000|Overall Study|Target lesion cannot be evaluated|1|||
125120547|NCT00662025|450065124|FG000|Overall Study|Domestic circumstances|1|||
124930917|NCT02315703|449376911|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
124930918|NCT02315703|449376912|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
125120548|NCT00626925|450065133|FG000|Overall Study|Lost to Follow-up|1|||
125120549|NCT00626925|450065134|FG001|Overall Study|Lost to Follow-up|2|||
125120550|NCT00626925|450065133|FG000|Overall Study|relapse|1|||
125120551|NCT00626925|450065134|FG001|Overall Study|relapse|0|||
125120552|NCT00626925|450065133|FG000|Overall Study|Adverse effect|6|||
125212796|NCT01026818|450405481|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
125024852|NCT00930059|449714761|FG000|Overall Study|Withdrawal by Subject|3|||
125024853|NCT00930059|449714762|FG001|Overall Study|Withdrawal by Subject|4|||
125024854|NCT00930059|449714761|FG000|Overall Study|Other|1|||
125024855|NCT00930059|449714762|FG001|Overall Study|Other|0|||
125024856|NCT00930059|449714761|FG000|Overall Study|1 site terminated by sponsor|1|||
125024857|NCT00930059|449714762|FG001|Overall Study|1 site terminated by sponsor|1|||
125024858|NCT00930059|449714761|FG000|Overall Study|Adverse Event|1|||
125024859|NCT00930059|449714762|FG001|Overall Study|Adverse Event|6|||
125024860|NCT04002310|449714763|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
125024861|NCT04002310|449714764|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
125024862|NCT04002310|449714765|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
125024863|NCT04002310|449714766|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
125024864|NCT04002310|449714767|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
125024865|NCT00542997|449714768|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
125024866|NCT00542997|449714768|FG000|Wash in / Wash Out Period|Adverse Event|3|||
125120553|NCT00626925|450065134|FG001|Overall Study|Adverse effect|2|||
125120554|NCT00626925|450065133|FG000|Overall Study|Lack of Efficacy|1|||
125120555|NCT00626925|450065134|FG001|Overall Study|Lack of Efficacy|4|||
125120556|NCT00626925|450065133|FG000|Overall Study|Time constraints|3|||
125120557|NCT00626925|450065134|FG001|Overall Study|Time constraints|1|||
125120558|NCT01215942|450065141|FG000|Treatment Period|Adverse Event|15|||
125120559|NCT01215942|450065142|FG001|Treatment Period|Adverse Event|26|||
125024867|NCT00542997|449714768|FG000|Efficacy Period|Adverse Event|3|||
125120560|NCT01215942|450065141|FG000|Treatment Period|Death|2|||
125120561|NCT01215942|450065142|FG001|Treatment Period|Death|4|||
125120562|NCT01215942|450065141|FG000|Treatment Period|Lack of Efficacy|23|||
124930919|NCT02315703|449376905|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
124930920|NCT02315703|449376906|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
124930921|NCT02315703|449376907|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
124930922|NCT02315703|449376908|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
124930923|NCT02315703|449376909|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
124930924|NCT02315703|449376910|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
124930925|NCT02315703|449376911|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
124930926|NCT02315703|449376912|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
124930927|NCT02315703|449376905|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
124930928|NCT02315703|449376906|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
124930929|NCT02315703|449376907|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
124930930|NCT02315703|449376908|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
124930931|NCT02315703|449376909|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
124930932|NCT02315703|449376910|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
124930933|NCT02315703|449376911|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
124930934|NCT02315703|449376912|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
124930935|NCT02315703|449376905|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
124930936|NCT02315703|449376906|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
124930937|NCT02315703|449376907|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
124930938|NCT02315703|449376908|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
124930939|NCT02315703|449376909|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
124930940|NCT02315703|449376910|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
124930941|NCT02315703|449376911|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
124930942|NCT02315703|449376912|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
124930943|NCT02315703|449376905|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
124930944|NCT02315703|449376906|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
124930945|NCT02315703|449376907|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
124930946|NCT02315703|449376908|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
124930947|NCT02315703|449376909|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
124930948|NCT02315703|449376910|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
124930949|NCT02315703|449376911|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
124930950|NCT02315703|449376912|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
124930951|NCT02315703|449376905|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
124930952|NCT02315703|449376906|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
124930953|NCT02315703|449376907|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
124930954|NCT02315703|449376908|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
124930955|NCT02315703|449376909|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
124930956|NCT02315703|449376910|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
124930957|NCT02315703|449376911|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
124930958|NCT02315703|449376912|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
124930959|NCT02240238|449376913|FG000|Phase 1|Adverse Event|0|||
124930960|NCT02240238|449376914|FG001|Phase 1|Adverse Event|0|||
124930961|NCT02240238|449376915|FG002|Phase 1|Adverse Event|0|||
124930962|NCT02240238|449376916|FG003|Phase 1|Adverse Event|0|||
124930963|NCT02240238|449376917|FG004|Phase 1|Adverse Event|0|||
124930964|NCT02240238|449376918|FG005|Phase 1|Adverse Event|0|||
124930965|NCT02240238|449376919|FG006|Phase 1|Adverse Event|3|||
124930966|NCT02240238|449376920|FG007|Phase 1|Adverse Event|1|||
124930967|NCT02240238|449376921|FG008|Phase 1|Adverse Event|0|||
124930968|NCT02240238|449376922|FG009|Phase 1|Adverse Event|0|||
124930969|NCT02240238|449376923|FG010|Phase 1|Adverse Event|0|||
124930970|NCT02240238|449376924|FG011|Phase 1|Adverse Event|0|||
124930971|NCT02240238|449376913|FG000|Phase 1|Death|0|||
124930972|NCT02240238|449376914|FG001|Phase 1|Death|0|||
124930973|NCT02240238|449376915|FG002|Phase 1|Death|0|||
124930974|NCT02240238|449376916|FG003|Phase 1|Death|0|||
124930975|NCT02240238|449376917|FG004|Phase 1|Death|0|||
124930976|NCT02240238|449376918|FG005|Phase 1|Death|1|||
125024868|NCT02949128|449714771|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
125024869|NCT02949128|449714771|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
125024870|NCT02949128|449714771|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
125024871|NCT02949128|449714771|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
125024872|NCT02949128|449714771|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
125024873|NCT02949128|449714771|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
125024874|NCT02949128|449714771|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
125024875|NCT02949128|449714771|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
125024876|NCT02949128|449714771|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
125024877|NCT02949128|449714771|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
125024878|NCT03160560|449714777|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
125024879|NCT03160560|449714778|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
125024880|NCT03160560|449714779|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
125024881|NCT03160560|449714780|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
125120563|NCT01215942|450065142|FG001|Treatment Period|Lack of Efficacy|62|||
124930977|NCT02240238|449376919|FG006|Phase 1|Death|0|||
124930978|NCT02240238|449376920|FG007|Phase 1|Death|0|||
124930979|NCT02240238|449376921|FG008|Phase 1|Death|0|||
124930980|NCT02240238|449376922|FG009|Phase 1|Death|0|||
124930981|NCT02240238|449376923|FG010|Phase 1|Death|0|||
124930982|NCT02240238|449376924|FG011|Phase 1|Death|0|||
124930983|NCT02240238|449376913|FG000|Phase 1|Sponsor termination|0|||
124930984|NCT02240238|449376914|FG001|Phase 1|Sponsor termination|0|||
124930985|NCT02240238|449376915|FG002|Phase 1|Sponsor termination|0|||
124930986|NCT02240238|449376916|FG003|Phase 1|Sponsor termination|0|||
124930987|NCT02240238|449376917|FG004|Phase 1|Sponsor termination|0|||
124930988|NCT02240238|449376918|FG005|Phase 1|Sponsor termination|1|||
124930989|NCT02240238|449376919|FG006|Phase 1|Sponsor termination|0|||
124930990|NCT02240238|449376920|FG007|Phase 1|Sponsor termination|0|||
124930991|NCT02240238|449376921|FG008|Phase 1|Sponsor termination|0|||
124930992|NCT02240238|449376922|FG009|Phase 1|Sponsor termination|0|||
124930993|NCT02240238|449376923|FG010|Phase 1|Sponsor termination|0|||
124930994|NCT02240238|449376924|FG011|Phase 1|Sponsor termination|0|||
124930995|NCT02240238|449376913|FG000|Phase 1|Withdrawal by Subject|0|||
124930996|NCT02240238|449376914|FG001|Phase 1|Withdrawal by Subject|0|||
124930997|NCT02240238|449376915|FG002|Phase 1|Withdrawal by Subject|0|||
124930998|NCT02240238|449376916|FG003|Phase 1|Withdrawal by Subject|0|||
124930999|NCT02240238|449376917|FG004|Phase 1|Withdrawal by Subject|0|||
124931000|NCT02240238|449376918|FG005|Phase 1|Withdrawal by Subject|2|||
124931001|NCT02240238|449376919|FG006|Phase 1|Withdrawal by Subject|0|||
124931002|NCT02240238|449376920|FG007|Phase 1|Withdrawal by Subject|0|||
124931003|NCT02240238|449376921|FG008|Phase 1|Withdrawal by Subject|0|||
124931004|NCT02240238|449376922|FG009|Phase 1|Withdrawal by Subject|0|||
124931005|NCT02240238|449376923|FG010|Phase 1|Withdrawal by Subject|0|||
124931006|NCT02240238|449376924|FG011|Phase 1|Withdrawal by Subject|0|||
124931007|NCT02240238|449376913|FG000|Phase 1|Physician Decision|0|||
124931008|NCT02240238|449376914|FG001|Phase 1|Physician Decision|0|||
124931009|NCT02240238|449376915|FG002|Phase 1|Physician Decision|0|||
124931010|NCT02240238|449376916|FG003|Phase 1|Physician Decision|0|||
124931011|NCT02240238|449376917|FG004|Phase 1|Physician Decision|0|||
124931012|NCT02240238|449376918|FG005|Phase 1|Physician Decision|2|||
124931013|NCT02240238|449376919|FG006|Phase 1|Physician Decision|0|||
124931014|NCT02240238|449376920|FG007|Phase 1|Physician Decision|0|||
124931015|NCT02240238|449376921|FG008|Phase 1|Physician Decision|0|||
124931016|NCT02240238|449376922|FG009|Phase 1|Physician Decision|0|||
124931017|NCT02240238|449376923|FG010|Phase 1|Physician Decision|0|||
124931018|NCT02240238|449376924|FG011|Phase 1|Physician Decision|0|||
124931019|NCT02240238|449376913|FG000|Phase 2|Adverse Event|0|||
124931020|NCT02240238|449376914|FG001|Phase 2|Adverse Event|0|||
124931021|NCT02240238|449376915|FG002|Phase 2|Adverse Event|0|||
124931022|NCT02240238|449376916|FG003|Phase 2|Adverse Event|0|||
124931023|NCT02240238|449376917|FG004|Phase 2|Adverse Event|0|||
124931024|NCT02240238|449376918|FG005|Phase 2|Adverse Event|0|||
124931025|NCT02240238|449376919|FG006|Phase 2|Adverse Event|0|||
124931026|NCT02240238|449376920|FG007|Phase 2|Adverse Event|0|||
124931027|NCT02240238|449376921|FG008|Phase 2|Adverse Event|0|||
124931028|NCT02240238|449376922|FG009|Phase 2|Adverse Event|7|||
124931029|NCT02240238|449376923|FG010|Phase 2|Adverse Event|14|||
124931030|NCT02240238|449376924|FG011|Phase 2|Adverse Event|2|||
124931031|NCT02240238|449376913|FG000|Phase 2|Death|0|||
124931032|NCT02240238|449376914|FG001|Phase 2|Death|0|||
124931033|NCT02240238|449376915|FG002|Phase 2|Death|0|||
124931034|NCT02240238|449376916|FG003|Phase 2|Death|0|||
124931035|NCT02240238|449376917|FG004|Phase 2|Death|0|||
124931036|NCT02240238|449376918|FG005|Phase 2|Death|0|||
124931037|NCT02240238|449376919|FG006|Phase 2|Death|0|||
125120564|NCT01215942|450065141|FG000|Treatment Period|Lost to Follow-up|3|||
125120565|NCT01215942|450065142|FG001|Treatment Period|Lost to Follow-up|4|||
124931038|NCT02240238|449376920|FG007|Phase 2|Death|0|||
124931039|NCT02240238|449376921|FG008|Phase 2|Death|0|||
124931040|NCT02240238|449376922|FG009|Phase 2|Death|3|||
124931041|NCT02240238|449376923|FG010|Phase 2|Death|2|||
124931042|NCT02240238|449376924|FG011|Phase 2|Death|1|||
124931043|NCT02240238|449376913|FG000|Phase 2|Disease progression|0|||
124931044|NCT02240238|449376914|FG001|Phase 2|Disease progression|0|||
124931045|NCT02240238|449376915|FG002|Phase 2|Disease progression|0|||
124931046|NCT02240238|449376916|FG003|Phase 2|Disease progression|0|||
124931047|NCT02240238|449376917|FG004|Phase 2|Disease progression|0|||
124931048|NCT02240238|449376918|FG005|Phase 2|Disease progression|0|||
124931049|NCT02240238|449376919|FG006|Phase 2|Disease progression|0|||
124931050|NCT02240238|449376920|FG007|Phase 2|Disease progression|0|||
124931051|NCT02240238|449376921|FG008|Phase 2|Disease progression|0|||
124931052|NCT02240238|449376922|FG009|Phase 2|Disease progression|5|||
124931053|NCT02240238|449376923|FG010|Phase 2|Disease progression|11|||
124931054|NCT02240238|449376924|FG011|Phase 2|Disease progression|1|||
124931055|NCT02240238|449376913|FG000|Phase 2|Withdrawal by Subject|0|||
124931056|NCT02240238|449376914|FG001|Phase 2|Withdrawal by Subject|0|||
124931057|NCT02240238|449376915|FG002|Phase 2|Withdrawal by Subject|0|||
124931058|NCT02240238|449376916|FG003|Phase 2|Withdrawal by Subject|0|||
124931059|NCT02240238|449376917|FG004|Phase 2|Withdrawal by Subject|0|||
124931060|NCT02240238|449376918|FG005|Phase 2|Withdrawal by Subject|0|||
124931061|NCT02240238|449376919|FG006|Phase 2|Withdrawal by Subject|0|||
124931062|NCT02240238|449376920|FG007|Phase 2|Withdrawal by Subject|0|||
124931063|NCT02240238|449376921|FG008|Phase 2|Withdrawal by Subject|0|||
124931064|NCT02240238|449376922|FG009|Phase 2|Withdrawal by Subject|1|||
124931065|NCT02240238|449376923|FG010|Phase 2|Withdrawal by Subject|1|||
124931066|NCT02240238|449376924|FG011|Phase 2|Withdrawal by Subject|0|||
124931067|NCT02240238|449376913|FG000|Phase 2|Physician Decision|0|||
124931068|NCT02240238|449376914|FG001|Phase 2|Physician Decision|0|||
124931069|NCT02240238|449376915|FG002|Phase 2|Physician Decision|0|||
124931070|NCT02240238|449376916|FG003|Phase 2|Physician Decision|0|||
124931071|NCT02240238|449376917|FG004|Phase 2|Physician Decision|0|||
124931072|NCT02240238|449376918|FG005|Phase 2|Physician Decision|0|||
124931073|NCT02240238|449376919|FG006|Phase 2|Physician Decision|0|||
124931074|NCT02240238|449376920|FG007|Phase 2|Physician Decision|0|||
124931075|NCT02240238|449376921|FG008|Phase 2|Physician Decision|0|||
124931076|NCT02240238|449376922|FG009|Phase 2|Physician Decision|1|||
124931077|NCT02240238|449376923|FG010|Phase 2|Physician Decision|3|||
124931078|NCT02240238|449376924|FG011|Phase 2|Physician Decision|0|||
124931079|NCT02240238|449376913|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931080|NCT02240238|449376914|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931081|NCT02240238|449376915|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931082|NCT02240238|449376916|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931083|NCT02240238|449376917|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931084|NCT02240238|449376918|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931085|NCT02240238|449376919|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931086|NCT02240238|449376920|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931087|NCT02240238|449376921|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931088|NCT02240238|449376922|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
124931089|NCT02240238|449376923|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931090|NCT02240238|449376924|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931091|NCT02240238|449376913|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931092|NCT02240238|449376914|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931093|NCT02240238|449376915|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931094|NCT02240238|449376916|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931095|NCT02240238|449376917|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931096|NCT02240238|449376918|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931097|NCT02240238|449376919|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931098|NCT02240238|449376920|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931099|NCT02240238|449376921|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931100|NCT02240238|449376922|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
124931101|NCT02240238|449376923|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931102|NCT02240238|449376924|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931103|NCT02240238|449376913|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
124931104|NCT02240238|449376914|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
124931105|NCT02240238|449376915|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
124931106|NCT02240238|449376916|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
124931107|NCT02240238|449376917|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
124931108|NCT02240238|449376918|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
124931109|NCT02240238|449376919|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
124931110|NCT02240238|449376920|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
124931111|NCT02240238|449376921|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
124931112|NCT02240238|449376922|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
124931113|NCT02240238|449376923|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
124931114|NCT02240238|449376924|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
125120566|NCT01215942|450065141|FG000|Treatment Period|Withdrawal by Subject|17|||
125120567|NCT01215942|450065142|FG001|Treatment Period|Withdrawal by Subject|40|||
125120568|NCT01215942|450065141|FG000|Treatment Period|Physician Decision|5|||
125120569|NCT01215942|450065142|FG001|Treatment Period|Physician Decision|5|||
125120570|NCT01215942|450065141|FG000|Treatment Period|Protocol Violation|0|||
125120571|NCT01215942|450065142|FG001|Treatment Period|Protocol Violation|1|||
125120572|NCT01215942|450065141|FG000|Treatment Period|Sponsor Decision|349|||
124931115|NCT02240238|449376913|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931116|NCT02240238|449376914|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931117|NCT02240238|449376915|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931118|NCT02240238|449376916|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931119|NCT02240238|449376917|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931120|NCT02240238|449376918|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931121|NCT02240238|449376919|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931122|NCT02240238|449376920|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931123|NCT02240238|449376921|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931124|NCT02240238|449376922|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931125|NCT02240238|449376923|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
124931126|NCT02240238|449376924|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931127|NCT02240238|449376913|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931128|NCT02240238|449376914|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931129|NCT02240238|449376915|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931130|NCT02240238|449376916|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931131|NCT02240238|449376917|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931132|NCT02240238|449376918|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931133|NCT02240238|449376919|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931134|NCT02240238|449376920|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931135|NCT02240238|449376921|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931136|NCT02240238|449376922|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931137|NCT02240238|449376923|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
124931138|NCT02240238|449376924|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931139|NCT02240238|449376913|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931140|NCT02240238|449376914|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931141|NCT02240238|449376915|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931142|NCT02240238|449376916|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931143|NCT02240238|449376917|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931144|NCT02240238|449376918|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931145|NCT02240238|449376919|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931146|NCT02240238|449376920|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931147|NCT02240238|449376921|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931148|NCT02240238|449376922|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931149|NCT02240238|449376923|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
124931150|NCT02240238|449376924|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931151|NCT02240238|449376913|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931152|NCT02240238|449376914|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931153|NCT02240238|449376915|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931154|NCT02240238|449376916|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931155|NCT02240238|449376917|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931156|NCT02240238|449376918|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931157|NCT02240238|449376919|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931158|NCT02240238|449376920|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931159|NCT02240238|449376921|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931160|NCT02240238|449376922|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931161|NCT02240238|449376923|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
124931162|NCT02240238|449376924|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931163|NCT02240238|449376913|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
124931164|NCT02240238|449376914|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
124931165|NCT02240238|449376915|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
124931166|NCT02240238|449376916|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
124931167|NCT02240238|449376917|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
124931168|NCT02240238|449376918|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
124931169|NCT02240238|449376919|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
124931170|NCT02240238|449376920|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
124931171|NCT02240238|449376921|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
124931172|NCT02240238|449376922|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
125024882|NCT03160560|449714777|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
124931173|NCT02240238|449376923|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
124931174|NCT02240238|449376924|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
124931175|NCT03476343|449376934|FG000|Overall Study|Clinical exam moved to another scanner|7|||
124931176|NCT03476343|449376934|FG000|Overall Study|Clinical order cancelled|4|||
124931177|NCT03476343|449376934|FG000|Overall Study|Neonate did not settle down for the scan|1|||
124931178|NCT03088878|449376935|FG000|Overall Study|Adverse Event|0|||
124931179|NCT03088878|449376936|FG001|Overall Study|Adverse Event|0|||
124931180|NCT03088878|449376937|FG002|Overall Study|Adverse Event|0|||
124931181|NCT03088878|449376938|FG003|Overall Study|Adverse Event|0|||
124931182|NCT03088878|449376939|FG004|Overall Study|Adverse Event|4|||
124931183|NCT03088878|449376940|FG005|Overall Study|Adverse Event|2|||
124931184|NCT03088878|449376941|FG006|Overall Study|Adverse Event|1|||
124931185|NCT03088878|449376942|FG007|Overall Study|Adverse Event|0|||
124931186|NCT03088878|449376943|FG008|Overall Study|Adverse Event|0|||
124931187|NCT03088878|449376944|FG009|Overall Study|Adverse Event|0|||
124931188|NCT03088878|449376945|FG010|Overall Study|Adverse Event|0|||
124931189|NCT03088878|449376946|FG011|Overall Study|Adverse Event|0|||
124931190|NCT03088878|449376947|FG012|Overall Study|Adverse Event|5|||
124931191|NCT03088878|449376948|FG013|Overall Study|Adverse Event|3|||
124931192|NCT03088878|449376935|FG000|Overall Study|Clinical Progression|0|||
124931193|NCT03088878|449376936|FG001|Overall Study|Clinical Progression|0|||
124931194|NCT03088878|449376937|FG002|Overall Study|Clinical Progression|0|||
124931195|NCT03088878|449376938|FG003|Overall Study|Clinical Progression|0|||
124931196|NCT03088878|449376939|FG004|Overall Study|Clinical Progression|2|||
124931197|NCT03088878|449376940|FG005|Overall Study|Clinical Progression|0|||
124931198|NCT03088878|449376941|FG006|Overall Study|Clinical Progression|0|||
124931199|NCT03088878|449376942|FG007|Overall Study|Clinical Progression|0|||
124931200|NCT03088878|449376943|FG008|Overall Study|Clinical Progression|0|||
124931201|NCT03088878|449376944|FG009|Overall Study|Clinical Progression|0|||
124931202|NCT03088878|449376945|FG010|Overall Study|Clinical Progression|0|||
124931203|NCT03088878|449376946|FG011|Overall Study|Clinical Progression|0|||
124931204|NCT03088878|449376947|FG012|Overall Study|Clinical Progression|0|||
124931205|NCT03088878|449376948|FG013|Overall Study|Clinical Progression|0|||
124931206|NCT03088878|449376935|FG000|Overall Study|Death|0|||
124931207|NCT03088878|449376936|FG001|Overall Study|Death|0|||
124931208|NCT03088878|449376937|FG002|Overall Study|Death|0|||
124931209|NCT03088878|449376938|FG003|Overall Study|Death|0|||
124931210|NCT03088878|449376939|FG004|Overall Study|Death|2|||
124931211|NCT03088878|449376940|FG005|Overall Study|Death|0|||
124931212|NCT03088878|449376941|FG006|Overall Study|Death|0|||
124931213|NCT03088878|449376942|FG007|Overall Study|Death|0|||
124931214|NCT03088878|449376943|FG008|Overall Study|Death|0|||
124931215|NCT03088878|449376944|FG009|Overall Study|Death|0|||
124931216|NCT03088878|449376945|FG010|Overall Study|Death|0|||
124931217|NCT03088878|449376946|FG011|Overall Study|Death|1|||
124931218|NCT03088878|449376947|FG012|Overall Study|Death|0|||
124931219|NCT03088878|449376948|FG013|Overall Study|Death|0|||
124931220|NCT03088878|449376935|FG000|Overall Study|Disease Progression|1|||
124931221|NCT03088878|449376936|FG001|Overall Study|Disease Progression|2|||
124931222|NCT03088878|449376937|FG002|Overall Study|Disease Progression|3|||
124931223|NCT03088878|449376938|FG003|Overall Study|Disease Progression|0|||
124931224|NCT03088878|449376939|FG004|Overall Study|Disease Progression|3|||
124931225|NCT03088878|449376940|FG005|Overall Study|Disease Progression|0|||
124931226|NCT03088878|449376941|FG006|Overall Study|Disease Progression|0|||
124931227|NCT03088878|449376942|FG007|Overall Study|Disease Progression|0|||
124931228|NCT03088878|449376943|FG008|Overall Study|Disease Progression|0|||
124931229|NCT03088878|449376944|FG009|Overall Study|Disease Progression|0|||
124931230|NCT03088878|449376945|FG010|Overall Study|Disease Progression|0|||
124931231|NCT03088878|449376946|FG011|Overall Study|Disease Progression|0|||
124931232|NCT03088878|449376947|FG012|Overall Study|Disease Progression|1|||
124931233|NCT03088878|449376948|FG013|Overall Study|Disease Progression|1|||
124931234|NCT03088878|449376935|FG000|Overall Study|Initiation of Alternative Treatment|0|||
124931235|NCT03088878|449376936|FG001|Overall Study|Initiation of Alternative Treatment|0|||
124931236|NCT03088878|449376937|FG002|Overall Study|Initiation of Alternative Treatment|0|||
124931237|NCT03088878|449376938|FG003|Overall Study|Initiation of Alternative Treatment|1|||
124931238|NCT03088878|449376939|FG004|Overall Study|Initiation of Alternative Treatment|0|||
124931239|NCT03088878|449376940|FG005|Overall Study|Initiation of Alternative Treatment|0|||
124931240|NCT03088878|449376941|FG006|Overall Study|Initiation of Alternative Treatment|0|||
124931241|NCT03088878|449376942|FG007|Overall Study|Initiation of Alternative Treatment|1|||
124931242|NCT03088878|449376943|FG008|Overall Study|Initiation of Alternative Treatment|1|||
124931243|NCT03088878|449376944|FG009|Overall Study|Initiation of Alternative Treatment|0|||
124931244|NCT03088878|449376945|FG010|Overall Study|Initiation of Alternative Treatment|0|||
124931245|NCT03088878|449376946|FG011|Overall Study|Initiation of Alternative Treatment|0|||
124931246|NCT03088878|449376947|FG012|Overall Study|Initiation of Alternative Treatment|0|||
124931247|NCT03088878|449376948|FG013|Overall Study|Initiation of Alternative Treatment|0|||
124931248|NCT03088878|449376935|FG000|Overall Study|Withdrawal by Subject|0|||
124931249|NCT03088878|449376936|FG001|Overall Study|Withdrawal by Subject|0|||
124931250|NCT03088878|449376937|FG002|Overall Study|Withdrawal by Subject|0|||
125024883|NCT03160560|449714778|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
125024884|NCT03160560|449714779|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
125024885|NCT03160560|449714780|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
125024886|NCT00808444|449714789|FG000|Overall Study|Withdrawal by Subject|1|||
125024887|NCT00808444|449714790|FG001|Overall Study|Withdrawal by Subject|0|||
125024888|NCT00808444|449714789|FG000|Overall Study|Lost to Follow-up|0|||
125024889|NCT00808444|449714790|FG001|Overall Study|Lost to Follow-up|1|||
125024890|NCT02770326|449714791|FG000|Overall Study|Death|3|||
125024891|NCT02770326|449714791|FG000|Overall Study|Lost to Follow-up|1|||
125024892|NCT02971202|449714792|FG000|Overall Study|Pregnancy|1|||
125024893|NCT02971202|449714793|FG001|Overall Study|Pregnancy|0|||
125024894|NCT02971202|449714794|FG002|Overall Study|Pregnancy|0|||
125024895|NCT02971202|449714792|FG000|Overall Study|screen fail after consent|1|||
125024896|NCT02971202|449714793|FG001|Overall Study|screen fail after consent|0|||
125024897|NCT02971202|449714794|FG002|Overall Study|screen fail after consent|1|||
125024898|NCT02634580|449714795|FG000|Double-blind Treatment Period|Subject Request|1|||
125024899|NCT02634580|449714796|FG001|Double-blind Treatment Period|Subject Request|0|||
124931251|NCT03088878|449376938|FG003|Overall Study|Withdrawal by Subject|1|||
124931252|NCT03088878|449376939|FG004|Overall Study|Withdrawal by Subject|4|||
124931253|NCT03088878|449376940|FG005|Overall Study|Withdrawal by Subject|1|||
124931254|NCT03088878|449376941|FG006|Overall Study|Withdrawal by Subject|1|||
124931255|NCT03088878|449376942|FG007|Overall Study|Withdrawal by Subject|0|||
124931256|NCT03088878|449376943|FG008|Overall Study|Withdrawal by Subject|1|||
124931257|NCT03088878|449376944|FG009|Overall Study|Withdrawal by Subject|2|||
124931258|NCT03088878|449376945|FG010|Overall Study|Withdrawal by Subject|0|||
124931259|NCT03088878|449376946|FG011|Overall Study|Withdrawal by Subject|2|||
124931260|NCT03088878|449376947|FG012|Overall Study|Withdrawal by Subject|1|||
124931261|NCT03088878|449376948|FG013|Overall Study|Withdrawal by Subject|0|||
124931262|NCT03088878|449376935|FG000|Overall Study|Terminated by Sponsor|2|||
124931263|NCT03088878|449376936|FG001|Overall Study|Terminated by Sponsor|1|||
124931264|NCT03088878|449376937|FG002|Overall Study|Terminated by Sponsor|0|||
124931265|NCT03088878|449376938|FG003|Overall Study|Terminated by Sponsor|1|||
124931266|NCT03088878|449376939|FG004|Overall Study|Terminated by Sponsor|6|||
124931267|NCT03088878|449376940|FG005|Overall Study|Terminated by Sponsor|0|||
124931268|NCT03088878|449376941|FG006|Overall Study|Terminated by Sponsor|0|||
124931269|NCT03088878|449376942|FG007|Overall Study|Terminated by Sponsor|0|||
124931270|NCT03088878|449376943|FG008|Overall Study|Terminated by Sponsor|0|||
124931271|NCT03088878|449376944|FG009|Overall Study|Terminated by Sponsor|0|||
124931272|NCT03088878|449376945|FG010|Overall Study|Terminated by Sponsor|3|||
124931273|NCT03088878|449376946|FG011|Overall Study|Terminated by Sponsor|13|||
124931274|NCT03088878|449376947|FG012|Overall Study|Terminated by Sponsor|2|||
124931275|NCT03088878|449376948|FG013|Overall Study|Terminated by Sponsor|1|||
124931276|NCT03088878|449376935|FG000|Overall Study|Completed 2 years of Treatment|0|||
124931277|NCT03088878|449376936|FG001|Overall Study|Completed 2 years of Treatment|0|||
124931278|NCT03088878|449376937|FG002|Overall Study|Completed 2 years of Treatment|0|||
124931279|NCT03088878|449376938|FG003|Overall Study|Completed 2 years of Treatment|0|||
124931280|NCT03088878|449376939|FG004|Overall Study|Completed 2 years of Treatment|0|||
124931281|NCT03088878|449376940|FG005|Overall Study|Completed 2 years of Treatment|0|||
124931282|NCT03088878|449376941|FG006|Overall Study|Completed 2 years of Treatment|1|||
124931283|NCT03088878|449376942|FG007|Overall Study|Completed 2 years of Treatment|0|||
124931284|NCT03088878|449376943|FG008|Overall Study|Completed 2 years of Treatment|0|||
124931285|NCT03088878|449376944|FG009|Overall Study|Completed 2 years of Treatment|1|||
124931286|NCT03088878|449376945|FG010|Overall Study|Completed 2 years of Treatment|0|||
124931287|NCT03088878|449376946|FG011|Overall Study|Completed 2 years of Treatment|0|||
124931288|NCT03088878|449376947|FG012|Overall Study|Completed 2 years of Treatment|8|||
124931289|NCT03088878|449376948|FG013|Overall Study|Completed 2 years of Treatment|3|||
124931290|NCT03088878|449376935|FG000|Overall Study|Physician Decision|0|||
124931291|NCT03088878|449376936|FG001|Overall Study|Physician Decision|0|||
124931292|NCT03088878|449376937|FG002|Overall Study|Physician Decision|0|||
125024900|NCT02634580|449714797|FG002|Double-blind Treatment Period|Subject Request|1|||
125024901|NCT02634580|449714798|FG003|Double-blind Treatment Period|Subject Request|1|||
125024902|NCT02634580|449714795|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
124931293|NCT03088878|449376938|FG003|Overall Study|Physician Decision|0|||
125024903|NCT02634580|449714796|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
124931294|NCT03088878|449376939|FG004|Overall Study|Physician Decision|0|||
125024904|NCT02634580|449714797|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
125024905|NCT02634580|449714798|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
125024906|NCT03106779|449714800|FG000|Overall Study|Lack of Efficacy|33|||
124931295|NCT03088878|449376940|FG005|Overall Study|Physician Decision|0|||
124931296|NCT03088878|449376941|FG006|Overall Study|Physician Decision|0|||
124931297|NCT03088878|449376942|FG007|Overall Study|Physician Decision|2|||
125024907|NCT03106779|449714801|FG001|Overall Study|Lack of Efficacy|24|||
125024908|NCT03106779|449714800|FG000|Overall Study|Adverse Event|8|||
125024909|NCT03106779|449714801|FG001|Overall Study|Adverse Event|16|||
124931298|NCT03088878|449376943|FG008|Overall Study|Physician Decision|1|||
124931299|NCT03088878|449376944|FG009|Overall Study|Physician Decision|0|||
124931300|NCT03088878|449376945|FG010|Overall Study|Physician Decision|0|||
124931301|NCT03088878|449376946|FG011|Overall Study|Physician Decision|0|||
124931302|NCT03088878|449376947|FG012|Overall Study|Physician Decision|0|||
124931303|NCT03088878|449376948|FG013|Overall Study|Physician Decision|1|||
124931304|NCT03088878|449376935|FG000|Overall Study|COVID Related noncompliance|0|||
124931305|NCT03088878|449376936|FG001|Overall Study|COVID Related noncompliance|0|||
124931306|NCT03088878|449376937|FG002|Overall Study|COVID Related noncompliance|0|||
124931307|NCT03088878|449376938|FG003|Overall Study|COVID Related noncompliance|0|||
124931308|NCT03088878|449376939|FG004|Overall Study|COVID Related noncompliance|0|||
124931309|NCT03088878|449376940|FG005|Overall Study|COVID Related noncompliance|0|||
124931310|NCT03088878|449376941|FG006|Overall Study|COVID Related noncompliance|0|||
124931311|NCT03088878|449376942|FG007|Overall Study|COVID Related noncompliance|0|||
124931312|NCT03088878|449376943|FG008|Overall Study|COVID Related noncompliance|0|||
124931313|NCT03088878|449376944|FG009|Overall Study|COVID Related noncompliance|0|||
124931314|NCT03088878|449376945|FG010|Overall Study|COVID Related noncompliance|0|||
124931315|NCT03088878|449376946|FG011|Overall Study|COVID Related noncompliance|0|||
124931316|NCT03088878|449376947|FG012|Overall Study|COVID Related noncompliance|0|||
124931317|NCT03088878|449376948|FG013|Overall Study|COVID Related noncompliance|1|||
124931318|NCT03088878|449376935|FG000|Overall Study|Drug or Study Noncompliance|0|||
124931319|NCT03088878|449376936|FG001|Overall Study|Drug or Study Noncompliance|0|||
124931320|NCT03088878|449376937|FG002|Overall Study|Drug or Study Noncompliance|0|||
124931321|NCT03088878|449376938|FG003|Overall Study|Drug or Study Noncompliance|0|||
124931322|NCT03088878|449376939|FG004|Overall Study|Drug or Study Noncompliance|0|||
124931323|NCT03088878|449376940|FG005|Overall Study|Drug or Study Noncompliance|0|||
124931324|NCT03088878|449376941|FG006|Overall Study|Drug or Study Noncompliance|0|||
124931325|NCT03088878|449376942|FG007|Overall Study|Drug or Study Noncompliance|0|||
124931326|NCT03088878|449376943|FG008|Overall Study|Drug or Study Noncompliance|0|||
124931327|NCT03088878|449376944|FG009|Overall Study|Drug or Study Noncompliance|0|||
124931328|NCT03088878|449376945|FG010|Overall Study|Drug or Study Noncompliance|0|||
124931329|NCT03088878|449376946|FG011|Overall Study|Drug or Study Noncompliance|0|||
124931330|NCT03088878|449376947|FG012|Overall Study|Drug or Study Noncompliance|1|||
124931331|NCT03088878|449376948|FG013|Overall Study|Drug or Study Noncompliance|0|||
124931332|NCT01221948|449376967|FG000|Overall Study|Physician Decision|5|||
124931333|NCT01221948|449376967|FG000|Overall Study|Withdrawal by Subject|2|||
124931334|NCT01221948|449376967|FG000|Overall Study|not disclosed|2|||
124931335|NCT01221948|449376967|FG000|Overall Study|Death|1|||
124931336|NCT01221948|449376967|FG000|Overall Study|Protocol Violation|4|||
124931337|NCT00746096|449376968|FG000|Overall Study|Adverse Event|1|||
124931338|NCT00746096|449376969|FG001|Overall Study|Adverse Event|0|||
124931339|NCT00746096|449376968|FG000|Overall Study|Withdrawal by Subject|5|||
124931340|NCT00746096|449376969|FG001|Overall Study|Withdrawal by Subject|1|||
124931341|NCT00746096|449376968|FG000|Overall Study|Lost to Follow-up|2|||
124931342|NCT00746096|449376969|FG001|Overall Study|Lost to Follow-up|1|||
124931343|NCT00746096|449376968|FG000|Overall Study|Protocol Violation|1|||
124931344|NCT00746096|449376969|FG001|Overall Study|Protocol Violation|0|||
124931345|NCT00746096|449376968|FG000|Overall Study|No study drug treatment|1|||
124931346|NCT00746096|449376969|FG001|Overall Study|No study drug treatment|1|||
124931347|NCT04059185|449376970|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
124931348|NCT04059185|449376971|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
124931349|NCT04059185|449376972|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
124931350|NCT04059185|449376970|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
124931351|NCT04059185|449376971|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
124931352|NCT04059185|449376972|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
124931353|NCT04059185|449376970|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
124931354|NCT04059185|449376971|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
124931355|NCT04059185|449376972|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
124931356|NCT04059185|449376970|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
124931357|NCT04059185|449376971|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
124931358|NCT04059185|449376972|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
124931359|NCT04059185|449376970|FG000|Longitudinal Assessment-Adults Only|Death|4|||
124931360|NCT04059185|449376971|FG001|Longitudinal Assessment-Adults Only|Death|4|||
125024910|NCT03106779|449714800|FG000|Overall Study|Physician Decision|10|||
125024911|NCT03106779|449714801|FG001|Overall Study|Physician Decision|6|||
125024912|NCT03106779|449714800|FG000|Overall Study|Patient/guardian decision|4|||
125024913|NCT03106779|449714801|FG001|Overall Study|Patient/guardian decision|3|||
125024914|NCT03106779|449714800|FG000|Overall Study|Progressive disease|1|||
124931361|NCT04059185|449376972|FG002|Longitudinal Assessment-Adults Only|Death|3|||
124931362|NCT03756662|449376973|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
124931363|NCT03295721|449376981|FG000|Overall Study|Adverse Event|1|||
124931364|NCT03295721|449376982|FG001|Overall Study|Adverse Event|0|||
124931365|NCT03295721|449376983|FG002|Overall Study|Adverse Event|0|||
124931366|NCT03295721|449376981|FG000|Overall Study|Lost to Follow-up|1|||
124931367|NCT03295721|449376982|FG001|Overall Study|Lost to Follow-up|1|||
125120573|NCT01215942|450065142|FG001|Treatment Period|Sponsor Decision|530|||
125120574|NCT01215942|450065141|FG000|Post-Treatment Follow-Up Period|Death|0|||
125120575|NCT01215942|450065142|FG001|Post-Treatment Follow-Up Period|Death|1|||
125120576|NCT01215942|450065141|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
125120577|NCT01215942|450065142|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
125120578|NCT01215942|450065141|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
125120579|NCT01215942|450065142|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
125120580|NCT01215942|450065141|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
125120581|NCT01215942|450065142|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
125120582|NCT01215942|450065141|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
125120583|NCT01215942|450065142|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
125120584|NCT01966042|450065143|FG000|Overall Study|Death|2|||
125120585|NCT03522948|450065144|FG000|Overall Study|Lost to Follow-up|1|||
125120586|NCT03305055|450065145|FG000|Overall Study|Withdrawal by Subject|0|||
125120587|NCT03305055|450065146|FG001|Overall Study|Withdrawal by Subject|1|||
125120588|NCT03305055|450065145|FG000|Overall Study|Adverse Event|1|||
125120589|NCT03305055|450065146|FG001|Overall Study|Adverse Event|1|||
125120590|NCT01802879|450065147|FG000|Overall Study|Administrative problems|2|||
125120591|NCT01802879|450065147|FG000|Overall Study|Disease progression|6|||
125120592|NCT01047345|450065152|FG000|Base Study|Adverse Event|3|||
125120593|NCT01047345|450065153|FG001|Base Study|Adverse Event|0|||
125120594|NCT01047345|450065154|FG002|Base Study|Adverse Event|0|||
125120595|NCT01047345|450065152|FG000|Base Study|Lost to Follow-up|4|||
125120596|NCT01047345|450065153|FG001|Base Study|Lost to Follow-up|1|||
125120597|NCT01047345|450065154|FG002|Base Study|Lost to Follow-up|0|||
125120598|NCT01047345|450065152|FG000|Base Study|Protocol Violation|3|||
125120599|NCT01047345|450065153|FG001|Base Study|Protocol Violation|1|||
125120600|NCT01047345|450065154|FG002|Base Study|Protocol Violation|0|||
125120601|NCT01047345|450065152|FG000|Base Study|Withdrawal by Subject|12|||
125120602|NCT01047345|450065153|FG001|Base Study|Withdrawal by Subject|4|||
125120603|NCT01047345|450065154|FG002|Base Study|Withdrawal by Subject|0|||
125120604|NCT01047345|450065152|FG000|Extension|Withdrawal by Subject|0|||
124931368|NCT03295721|449376983|FG002|Overall Study|Lost to Follow-up|1|||
124931369|NCT03295721|449376981|FG000|Overall Study|Withdrawal by Subject|1|||
124931370|NCT03295721|449376982|FG001|Overall Study|Withdrawal by Subject|0|||
124931371|NCT03295721|449376983|FG002|Overall Study|Withdrawal by Subject|1|||
124931372|NCT03295721|449376981|FG000|Overall Study|Death|0|||
124931373|NCT03295721|449376982|FG001|Overall Study|Death|0|||
124931374|NCT03295721|449376983|FG002|Overall Study|Death|1|||
124931375|NCT03325985|449376986|FG000|Overall Study|Lost to Follow-up|122|||
124931376|NCT03325985|449376987|FG001|Overall Study|Lost to Follow-up|26|||
124931377|NCT03325985|449376988|FG002|Overall Study|Lost to Follow-up|141|||
124931378|NCT03325985|449376989|FG003|Overall Study|Lost to Follow-up|28|||
124931379|NCT03325985|449376986|FG000|Overall Study|Death|99|||
124931380|NCT03325985|449376987|FG001|Overall Study|Death|36|||
124931381|NCT03325985|449376988|FG002|Overall Study|Death|94|||
124931382|NCT03325985|449376989|FG003|Overall Study|Death|32|||
124931383|NCT02684227|449376991|FG000|Overall Study|Adverse Event|1|||
124931384|NCT02684227|449376992|FG001|Overall Study|Adverse Event|7|||
124931385|NCT02684227|449376991|FG000|Overall Study|Death|0|||
124931386|NCT02684227|449376992|FG001|Overall Study|Death|2|||
124931387|NCT02684227|449376991|FG000|Overall Study|Withdrawal by Subject|0|||
124931388|NCT02684227|449376992|FG001|Overall Study|Withdrawal by Subject|1|||
124931389|NCT02684227|449376991|FG000|Overall Study|Progressive Disease|0|||
124931390|NCT02684227|449376992|FG001|Overall Study|Progressive Disease|2|||
124931391|NCT03606408|449376993|FG000|Overall Study|Adverse Event|13|||
124931392|NCT03606408|449376993|FG000|Overall Study|Withdrawal by Subject|7|||
124931393|NCT03606408|449376993|FG000|Overall Study|Physician Decision|4|||
125120605|NCT01047345|450065153|FG001|Extension|Withdrawal by Subject|0|||
125120606|NCT01047345|450065154|FG002|Extension|Withdrawal by Subject|1|||
125120607|NCT01047345|450065152|FG000|Extension|Lost to Follow-up|0|||
125120608|NCT01047345|450065153|FG001|Extension|Lost to Follow-up|0|||
125120609|NCT01047345|450065154|FG002|Extension|Lost to Follow-up|5|||
125120610|NCT02116803|450065157|FG000|Overall Study|Adverse Event|2|||
125120611|NCT02116803|450065158|FG001|Overall Study|Adverse Event|1|||
125120612|NCT02116803|450065157|FG000|Overall Study|Physician Decision|1|||
125120613|NCT02116803|450065158|FG001|Overall Study|Physician Decision|0|||
125120614|NCT02116803|450065157|FG000|Overall Study|Progressive disease|4|||
124931394|NCT03606408|449376993|FG000|Overall Study|Lack of Efficacy|2|||
124931395|NCT03606408|449376993|FG000|Overall Study|Death|1|||
124931396|NCT03606408|449376993|FG000|Overall Study|new therapy for study indication|1|||
124931397|NCT03556293|449376994|FG000|Overall Study|Ineligible for analysis|1904|||
124931398|NCT03556293|449376995|FG001|Overall Study|Ineligible for analysis|1471|||
124931399|NCT03556293|449376996|FG002|Overall Study|Ineligible for analysis|1091|||
124931400|NCT03556293|449376997|FG003|Overall Study|Ineligible for analysis|1269|||
124931401|NCT05828017|449377004|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
125120615|NCT02116803|450065158|FG001|Overall Study|Progressive disease|0|||
125120616|NCT02116803|450065157|FG000|Overall Study|Study terminated by sponsor|2|||
125024915|NCT03106779|449714801|FG001|Overall Study|Progressive disease|3|||
125024916|NCT03106779|449714800|FG000|Overall Study|Lost to Follow-up|1|||
125024917|NCT03106779|449714801|FG001|Overall Study|Lost to Follow-up|2|||
125024918|NCT03106779|449714800|FG000|Overall Study|Death|1|||
125024919|NCT03106779|449714801|FG001|Overall Study|Death|0|||
125024920|NCT03106779|449714800|FG000|Overall Study|Protocol Violation|1|||
125024921|NCT03106779|449714801|FG001|Overall Study|Protocol Violation|0|||
125024922|NCT03106779|449714800|FG000|Overall Study|Not treated|1|||
125024923|NCT03106779|449714801|FG001|Overall Study|Not treated|0|||
125024924|NCT02288247|449714802|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
125024925|NCT02288247|449714803|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
125024926|NCT02288247|449714802|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
125024927|NCT02288247|449714803|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
125024928|NCT02288247|449714802|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
125024929|NCT02288247|449714803|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
125024930|NCT02288247|449714802|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
125024931|NCT02288247|449714803|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
124931402|NCT05012163|449377005|FG000|Overall Study|Protocol Violation|0|||
124931403|NCT05012163|449377006|FG001|Overall Study|Protocol Violation|0|||
124931404|NCT05012163|449377007|FG002|Overall Study|Protocol Violation|1|||
124931405|NCT05012163|449377008|FG003|Overall Study|Protocol Violation|1|||
124931406|NCT04132518|449377015|FG000|Overall Study|Prematurely withdrawn from the study|0|||
124931407|NCT04132518|449377016|FG001|Overall Study|Prematurely withdrawn from the study|9|||
124931408|NCT04132518|449377017|FG002|Overall Study|Prematurely withdrawn from the study|1|||
124931409|NCT05524402|449377019|FG000|Overall Study|Withdrawal by Subject|3|||
124931410|NCT05524402|449377020|FG001|Overall Study|Withdrawal by Subject|1|||
124931411|NCT05524402|449377019|FG000|Overall Study|Lost to Follow-up|2|||
124931412|NCT05524402|449377020|FG001|Overall Study|Lost to Follow-up|1|||
124931413|NCT04428203|449377021|FG000|Overall Study|Adverse Event|1|||
124931414|NCT04428203|449377022|FG001|Overall Study|Adverse Event|0|||
124931415|NCT04428203|449377023|FG002|Overall Study|Adverse Event|0|||
124931416|NCT04428203|449377021|FG000|Overall Study|Withdrawal by Subject|1|||
124931417|NCT04428203|449377022|FG001|Overall Study|Withdrawal by Subject|0|||
124931418|NCT04428203|449377023|FG002|Overall Study|Withdrawal by Subject|1|||
124931419|NCT03308877|449378296|FG000|Overall Study|Lost to Follow-up|32|||
124931420|NCT03308877|449378297|FG001|Overall Study|Lost to Follow-up|28|||
124931421|NCT04359654|449378306|FG000|Overall Study|Withdrawal by Subject|1|||
124931422|NCT04359654|449378307|FG001|Overall Study|Withdrawal by Subject|0|||
124931423|NCT04359654|449378306|FG000|Overall Study|Adverse Event|0|||
124931424|NCT04359654|449378307|FG001|Overall Study|Adverse Event|1|||
124931425|NCT05863156|449378309|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
124931426|NCT05863156|449378310|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
124931427|NCT05863156|449378311|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
124931428|NCT05216406|449378312|FG000|Overall Study|Lost to Follow-up|8|||
124931429|NCT05216406|449378313|FG001|Overall Study|Lost to Follow-up|9|||
124931430|NCT04690582|449378316|FG000|Overall Study|Withdrawal by Subject|6|||
124931431|NCT04690582|449378317|FG001|Overall Study|Withdrawal by Subject|4|||
124931432|NCT03711474|449378318|FG000|Overall Study|Physician Decision|2|||
124931433|NCT03711474|449378319|FG001|Overall Study|Physician Decision|0|||
124931434|NCT03625115|449378322|FG000|Overall Study|Withdrawal by Subject|4|||
124931435|NCT03625115|449378323|FG001|Overall Study|Withdrawal by Subject|7|||
124931436|NCT03625115|449378322|FG000|Overall Study|Lost to Follow-up|17|||
124931437|NCT03625115|449378323|FG001|Overall Study|Lost to Follow-up|24|||
124931438|NCT04101357|449378325|FG000|Overall Study|Death|1|||
124931439|NCT04101357|449378326|FG001|Overall Study|Death|1|||
124931440|NCT04101357|449378327|FG002|Overall Study|Death|1|||
124931441|NCT04101357|449378328|FG003|Overall Study|Death|2|||
125024932|NCT02288247|449714802|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
125024933|NCT02288247|449714803|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
125024934|NCT02288247|449714802|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
125024935|NCT02288247|449714803|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
125024936|NCT02288247|449714802|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
125024937|NCT02288247|449714803|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
125024938|NCT02288247|449714802|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
125024939|NCT02288247|449714803|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
125024940|NCT02288247|449714802|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
125120617|NCT02116803|450065158|FG001|Overall Study|Study terminated by sponsor|1|||
125120618|NCT02116803|450065157|FG000|Overall Study|Death|1|||
124931442|NCT04101357|449378329|FG004|Overall Study|Death|4|||
125120619|NCT02116803|450065158|FG001|Overall Study|Death|0|||
124931443|NCT04101357|449378330|FG005|Overall Study|Death|11|||
124931444|NCT04101357|449378331|FG006|Overall Study|Death|4|||
124931445|NCT04101357|449378332|FG007|Overall Study|Death|4|||
124931446|NCT04101357|449378333|FG008|Overall Study|Death|5|||
124931447|NCT04101357|449378334|FG009|Overall Study|Death|2|||
124931448|NCT04101357|449378335|FG010|Overall Study|Death|3|||
124931449|NCT04101357|449378325|FG000|Overall Study|Trial closure|0|||
124931450|NCT04101357|449378326|FG001|Overall Study|Trial closure|0|||
124931451|NCT04101357|449378327|FG002|Overall Study|Trial closure|0|||
124931452|NCT04101357|449378328|FG003|Overall Study|Trial closure|0|||
124931453|NCT04101357|449378329|FG004|Overall Study|Trial closure|0|||
124931454|NCT04101357|449378330|FG005|Overall Study|Trial closure|2|||
124931455|NCT04101357|449378331|FG006|Overall Study|Trial closure|2|||
124931456|NCT04101357|449378332|FG007|Overall Study|Trial closure|0|||
124931457|NCT04101357|449378333|FG008|Overall Study|Trial closure|0|||
124931458|NCT04101357|449378334|FG009|Overall Study|Trial closure|0|||
124931459|NCT04101357|449378335|FG010|Overall Study|Trial closure|1|||
124931460|NCT04101357|449378325|FG000|Overall Study|Lost to Follow-up|0|||
124931461|NCT04101357|449378326|FG001|Overall Study|Lost to Follow-up|0|||
124931462|NCT04101357|449378327|FG002|Overall Study|Lost to Follow-up|0|||
124931463|NCT04101357|449378328|FG003|Overall Study|Lost to Follow-up|1|||
124931464|NCT04101357|449378329|FG004|Overall Study|Lost to Follow-up|0|||
124931465|NCT04101357|449378330|FG005|Overall Study|Lost to Follow-up|0|||
124931466|NCT04101357|449378331|FG006|Overall Study|Lost to Follow-up|0|||
124931467|NCT04101357|449378332|FG007|Overall Study|Lost to Follow-up|1|||
124931468|NCT04101357|449378333|FG008|Overall Study|Lost to Follow-up|0|||
125120620|NCT01974895|450065161|FG000|Overall Study|Protocol Violation|1|||
125120621|NCT01974895|450065162|FG001|Overall Study|Protocol Violation|0|||
125120622|NCT01974895|450065161|FG000|Overall Study|Lost to Follow-up|4|||
125120623|NCT01974895|450065162|FG001|Overall Study|Lost to Follow-up|6|||
125120624|NCT01974895|450065161|FG000|Overall Study|Withdrawal by Subject|0|||
125120625|NCT01974895|450065162|FG001|Overall Study|Withdrawal by Subject|1|||
125120626|NCT01974895|450065161|FG000|Overall Study|Other (Missed Visit)|1|||
125120627|NCT01974895|450065162|FG001|Overall Study|Other (Missed Visit)|0|||
125120628|NCT01974895|450065161|FG000|Overall Study|Other (Reason unknown)|9|||
124931469|NCT04101357|449378334|FG009|Overall Study|Lost to Follow-up|0|||
124931470|NCT04101357|449378335|FG010|Overall Study|Lost to Follow-up|0|||
124931471|NCT04101357|449378325|FG000|Overall Study|Withdrawal by Subject|1|||
124931472|NCT04101357|449378326|FG001|Overall Study|Withdrawal by Subject|0|||
124931473|NCT04101357|449378327|FG002|Overall Study|Withdrawal by Subject|0|||
124931474|NCT04101357|449378328|FG003|Overall Study|Withdrawal by Subject|0|||
124931475|NCT04101357|449378329|FG004|Overall Study|Withdrawal by Subject|0|||
124931476|NCT04101357|449378330|FG005|Overall Study|Withdrawal by Subject|0|||
124931477|NCT04101357|449378331|FG006|Overall Study|Withdrawal by Subject|0|||
124931478|NCT04101357|449378332|FG007|Overall Study|Withdrawal by Subject|0|||
124931479|NCT04101357|449378333|FG008|Overall Study|Withdrawal by Subject|1|||
124931480|NCT04101357|449378334|FG009|Overall Study|Withdrawal by Subject|1|||
124931481|NCT04101357|449378335|FG010|Overall Study|Withdrawal by Subject|0|||
124931482|NCT04101357|449378325|FG000|Overall Study|Other|0|||
124931483|NCT04101357|449378326|FG001|Overall Study|Other|0|||
124931484|NCT04101357|449378327|FG002|Overall Study|Other|0|||
124931485|NCT04101357|449378328|FG003|Overall Study|Other|0|||
124931486|NCT04101357|449378329|FG004|Overall Study|Other|0|||
124931487|NCT04101357|449378330|FG005|Overall Study|Other|1|||
124931488|NCT04101357|449378331|FG006|Overall Study|Other|2|||
124931489|NCT04101357|449378332|FG007|Overall Study|Other|1|||
124931490|NCT04101357|449378333|FG008|Overall Study|Other|0|||
124931491|NCT04101357|449378334|FG009|Overall Study|Other|0|||
124931492|NCT04101357|449378335|FG010|Overall Study|Other|0|||
124931493|NCT04101357|449378325|FG000|Overall Study|Enrolled but not treated|0|||
124931494|NCT04101357|449378326|FG001|Overall Study|Enrolled but not treated|0|||
124931495|NCT04101357|449378327|FG002|Overall Study|Enrolled but not treated|0|||
124931496|NCT04101357|449378328|FG003|Overall Study|Enrolled but not treated|0|||
124931497|NCT04101357|449378329|FG004|Overall Study|Enrolled but not treated|0|||
124931498|NCT04101357|449378330|FG005|Overall Study|Enrolled but not treated|1|||
124931499|NCT04101357|449378331|FG006|Overall Study|Enrolled but not treated|1|||
124931500|NCT04101357|449378332|FG007|Overall Study|Enrolled but not treated|0|||
124931501|NCT04101357|449378333|FG008|Overall Study|Enrolled but not treated|0|||
124931502|NCT04101357|449378334|FG009|Overall Study|Enrolled but not treated|0|||
124931503|NCT04101357|449378335|FG010|Overall Study|Enrolled but not treated|0|||
124931504|NCT05868382|449378336|FG000|Overall Study|Lost to Follow-up|5|||
124931505|NCT05868382|449378337|FG001|Overall Study|Lost to Follow-up|0|||
124931506|NCT05868382|449378338|FG002|Overall Study|Lost to Follow-up|6|||
124931507|NCT05868382|449378339|FG003|Overall Study|Lost to Follow-up|4|||
124931508|NCT05868382|449378340|FG004|Overall Study|Lost to Follow-up|2|||
124931509|NCT05868382|449378341|FG005|Overall Study|Lost to Follow-up|6|||
124931510|NCT05868382|449378336|FG000|Overall Study|Withdrawal by Subject|1|||
124931511|NCT05868382|449378337|FG001|Overall Study|Withdrawal by Subject|0|||
124931512|NCT05868382|449378338|FG002|Overall Study|Withdrawal by Subject|0|||
124931513|NCT05868382|449378339|FG003|Overall Study|Withdrawal by Subject|0|||
124931514|NCT05868382|449378340|FG004|Overall Study|Withdrawal by Subject|1|||
124931515|NCT05868382|449378341|FG005|Overall Study|Withdrawal by Subject|0|||
125120629|NCT01974895|450065162|FG001|Overall Study|Other (Reason unknown)|8|||
125024941|NCT02288247|449714803|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
125024942|NCT02288247|449714802|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
125024943|NCT02288247|449714803|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
125024944|NCT02288247|449714802|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
125024945|NCT02288247|449714803|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
125212797|NCT01026818|450405478|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
124931516|NCT02497950|449378342|FG000|Overall Study|Death|209|||
124931517|NCT02497950|449378342|FG000|Overall Study|Transplanted|85|||
124931518|NCT02497950|449378342|FG000|Overall Study|Explanted|8|||
124931519|NCT02497950|449378342|FG000|Overall Study|Device Permanently Deactivated|4|||
124931520|NCT02497950|449378342|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
124931521|NCT02497950|449378342|FG000|Overall Study|Lost to Follow-up|6|||
124931522|NCT02497950|449378342|FG000|Overall Study|Withdrawal by Subject|2|||
124931523|NCT02497950|449378342|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
124931524|NCT02497950|449378342|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
124931525|NCT01236781|449378343|FG000|Overall Study|Ineligible|2|||
124931526|NCT01236781|449378344|FG001|Overall Study|Ineligible|1|||
124931527|NCT01236781|449378343|FG000|Overall Study|Did not complete study imaging|5|||
124931528|NCT01236781|449378344|FG001|Overall Study|Did not complete study imaging|0|||
124931529|NCT01009788|449378357|FG000|Overall Study|Withdrawal by Subject|1|||
124931530|NCT01009788|449378358|FG001|Overall Study|Withdrawal by Subject|0|||
124931531|NCT04308681|449378359|FG000|Pre-Treatment|Not reported|1|||
124931532|NCT04308681|449378360|FG001|Pre-Treatment|Not reported|1|||
124931533|NCT04308681|449378361|FG002|Pre-Treatment|Not reported|0|||
124931534|NCT04308681|449378362|FG003|Pre-Treatment|Not reported|0|||
124931535|NCT04308681|449378363|FG004|Pre-Treatment|Not reported|0|||
124931536|NCT04308681|449378364|FG005|Pre-Treatment|Not reported|2|||
124931537|NCT04308681|449378365|FG006|Pre-Treatment|Not reported|0|||
124931538|NCT04308681|449378366|FG007|Pre-Treatment|Not reported|0|||
124931539|NCT04308681|449378359|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
124931540|NCT04308681|449378360|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
124931541|NCT04308681|449378361|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
124931542|NCT04308681|449378362|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
124931543|NCT04308681|449378363|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
124931544|NCT04308681|449378364|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
124931545|NCT04308681|449378365|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
124931546|NCT04308681|449378366|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
124931547|NCT04308681|449378359|FG000|Treatment up to Week 26|Other reasons|2|||
124931548|NCT04308681|449378360|FG001|Treatment up to Week 26|Other reasons|0|||
124931549|NCT04308681|449378361|FG002|Treatment up to Week 26|Other reasons|0|||
124931550|NCT04308681|449378362|FG003|Treatment up to Week 26|Other reasons|0|||
124931551|NCT04308681|449378363|FG004|Treatment up to Week 26|Other reasons|1|||
124931552|NCT04308681|449378364|FG005|Treatment up to Week 26|Other reasons|1|||
124931553|NCT04308681|449378365|FG006|Treatment up to Week 26|Other reasons|0|||
124931554|NCT04308681|449378366|FG007|Treatment up to Week 26|Other reasons|0|||
124931555|NCT04308681|449378359|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
124931556|NCT04308681|449378360|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
124931557|NCT04308681|449378361|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
124931558|NCT04308681|449378362|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
124931559|NCT04308681|449378363|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
124931560|NCT04308681|449378364|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
124931561|NCT04308681|449378365|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
124931562|NCT04308681|449378366|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
124931563|NCT04308681|449378359|FG000|Treatment up to Week 26|Adverse Event|6|||
124931564|NCT04308681|449378360|FG001|Treatment up to Week 26|Adverse Event|5|||
124931565|NCT04308681|449378361|FG002|Treatment up to Week 26|Adverse Event|5|||
125024946|NCT02288247|449714802|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
125024947|NCT02288247|449714803|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
124931566|NCT04308681|449378362|FG003|Treatment up to Week 26|Adverse Event|0|||
124931567|NCT04308681|449378363|FG004|Treatment up to Week 26|Adverse Event|6|||
124931568|NCT04308681|449378364|FG005|Treatment up to Week 26|Adverse Event|1|||
124931569|NCT04308681|449378365|FG006|Treatment up to Week 26|Adverse Event|0|||
124931570|NCT04308681|449378366|FG007|Treatment up to Week 26|Adverse Event|0|||
125024948|NCT02288247|449714802|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
125024949|NCT02288247|449714803|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
125024950|NCT02288247|449714802|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
125024951|NCT02288247|449714803|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
125024952|NCT02288247|449714802|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
125024953|NCT02288247|449714803|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
125024954|NCT02288247|449714802|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
124931571|NCT04308681|449378359|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
124931572|NCT04308681|449378360|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
124931573|NCT04308681|449378361|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
124931574|NCT04308681|449378362|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
124931575|NCT04308681|449378363|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
124931576|NCT04308681|449378364|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
124931577|NCT04308681|449378365|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
124931578|NCT04308681|449378366|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
124931579|NCT04308681|449378359|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
124931580|NCT04308681|449378360|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
124931581|NCT04308681|449378361|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
124931582|NCT04308681|449378362|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
124931583|NCT04308681|449378363|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
124931584|NCT04308681|449378364|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
124931585|NCT04308681|449378365|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
124931586|NCT04308681|449378366|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
124931587|NCT04308681|449378359|FG000|OTE - 26 Weeks|Death|0|||
124931588|NCT04308681|449378360|FG001|OTE - 26 Weeks|Death|1|||
124931589|NCT04308681|449378361|FG002|OTE - 26 Weeks|Death|0|||
124931590|NCT04308681|449378362|FG003|OTE - 26 Weeks|Death|0|||
124931591|NCT04308681|449378363|FG004|OTE - 26 Weeks|Death|0|||
124931592|NCT04308681|449378364|FG005|OTE - 26 Weeks|Death|0|||
124931593|NCT04308681|449378365|FG006|OTE - 26 Weeks|Death|1|||
124931594|NCT04308681|449378366|FG007|OTE - 26 Weeks|Death|0|||
124931595|NCT04308681|449378359|FG000|OTE - 26 Weeks|Adverse Event|0|||
124931596|NCT04308681|449378360|FG001|OTE - 26 Weeks|Adverse Event|2|||
124931597|NCT04308681|449378361|FG002|OTE - 26 Weeks|Adverse Event|8|||
124931598|NCT04308681|449378362|FG003|OTE - 26 Weeks|Adverse Event|3|||
124931599|NCT04308681|449378363|FG004|OTE - 26 Weeks|Adverse Event|0|||
124931600|NCT04308681|449378364|FG005|OTE - 26 Weeks|Adverse Event|1|||
124931601|NCT04308681|449378365|FG006|OTE - 26 Weeks|Adverse Event|2|||
124931602|NCT04308681|449378366|FG007|OTE - 26 Weeks|Adverse Event|0|||
124931603|NCT04308681|449378359|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
124931604|NCT04308681|449378360|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
124931605|NCT04308681|449378361|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
124931606|NCT04308681|449378362|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
124931607|NCT04308681|449378363|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
124931608|NCT04308681|449378364|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
125024955|NCT02288247|449714803|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
125024956|NCT04093531|449714804|FG000|Overall Study|failed screening|4|||
125024957|NCT02918019|449714805|FG000|Overall Study|Death|0|||
125024958|NCT02918019|449714806|FG001|Overall Study|Death|0|||
125024959|NCT02918019|449714807|FG002|Overall Study|Death|1|||
124931609|NCT04308681|449378365|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
124931610|NCT04308681|449378366|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
124931611|NCT05565820|449378367|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
124931612|NCT05565820|449378368|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
125024960|NCT02918019|449714808|FG003|Overall Study|Death|0|||
125120631|NCT01984242|450065164|FG000|Overall Study|Death|52|||
125120632|NCT01984242|450065165|FG001|Overall Study|Death|50|||
124931613|NCT05565820|449378367|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
124931614|NCT05565820|449378368|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
124931615|NCT00429364|449378370|FG000|Overall Study|Withdrawal by Subject|11|||
124931616|NCT00429364|449378371|FG001|Overall Study|Withdrawal by Subject|5|||
124931617|NCT00429364|449378370|FG000|Overall Study|Physician Decision|4|||
124931618|NCT00429364|449378371|FG001|Overall Study|Physician Decision|2|||
124931619|NCT00429364|449378370|FG000|Overall Study|Lost to Follow-up|7|||
124931620|NCT00429364|449378371|FG001|Overall Study|Lost to Follow-up|6|||
124931621|NCT00429364|449378370|FG000|Overall Study|Death|0|||
124931622|NCT00429364|449378371|FG001|Overall Study|Death|1|||
124931623|NCT00429364|449378370|FG000|Overall Study|Underwent aortic root surgery|10|||
124931624|NCT00429364|449378371|FG001|Overall Study|Underwent aortic root surgery|18|||
124931625|NCT00429364|449378370|FG000|Overall Study|Pregnancy|0|||
124931626|NCT00429364|449378371|FG001|Overall Study|Pregnancy|1|||
124931627|NCT04871529|449378372|FG000|Overall Study|Withdrawal by Subject|0|||
124931628|NCT04871529|449378373|FG001|Overall Study|Withdrawal by Subject|1|||
124931629|NCT04871529|449378372|FG000|Overall Study|Death|0|||
124931630|NCT04871529|449378373|FG001|Overall Study|Death|1|||
124931631|NCT04871529|449378372|FG000|Overall Study|Not protocol specified|0|||
124931632|NCT04871529|449378373|FG001|Overall Study|Not protocol specified|1|||
124931633|NCT04003246|449378376|FG000|Overall Study|Death|9|||
124931634|NCT05237284|449378382|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
124931635|NCT05237284|449378383|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
124931636|NCT05237284|449378384|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
124931637|NCT05237284|449378385|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
124931638|NCT05237284|449378382|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
124931639|NCT05237284|449378383|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
124931640|NCT05237284|449378384|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
124931641|NCT05237284|449378385|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
124931642|NCT05237284|449378382|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
124931643|NCT05237284|449378383|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
124931644|NCT05237284|449378384|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
124931645|NCT05237284|449378385|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
124931646|NCT05237284|449378382|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
124931647|NCT05237284|449378383|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
124931648|NCT05237284|449378384|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
124931649|NCT05237284|449378385|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
124931650|NCT05237284|449378382|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
124931651|NCT05237284|449378383|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
124931652|NCT05237284|449378384|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
124931653|NCT05237284|449378385|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
124931654|NCT05237284|449378382|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
124931655|NCT05237284|449378383|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
124931656|NCT05237284|449378384|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
124931657|NCT05237284|449378385|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
124931658|NCT05237284|449378382|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
124931659|NCT05237284|449378383|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
124931660|NCT05237284|449378384|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
124931661|NCT05237284|449378385|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
124931662|NCT05237284|449378382|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
124931663|NCT05237284|449378383|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
124931664|NCT05237284|449378384|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
124931665|NCT05237284|449378385|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
124931666|NCT05237284|449378382|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
124931667|NCT05237284|449378383|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
124931668|NCT05237284|449378384|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
124931669|NCT05237284|449378385|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
124931670|NCT03733925|449378389|FG000|Overall Study|Lost to Follow-up|1|||
124931671|NCT03733925|449378389|FG000|Overall Study|Withdrawal by Subject|2|||
124931672|NCT03733925|449378389|FG000|Overall Study|Adverse Event|2|||
124931673|NCT03733925|449378389|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124931674|NCT03213873|449378390|FG000|Overall Study|Withdrawal by Subject|8|||
124931675|NCT03213873|449378391|FG001|Overall Study|Withdrawal by Subject|9|||
124931676|NCT03213873|449378390|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
124931677|NCT03213873|449378391|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
124931678|NCT03213873|449378390|FG000|Overall Study|Lost to Follow-up|0|||
125120633|NCT01984242|450065166|FG002|Overall Study|Death|52|||
124931679|NCT03213873|449378391|FG001|Overall Study|Lost to Follow-up|2|||
124931680|NCT02852655|449378397|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
124931681|NCT02852655|449378398|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
124931682|NCT02852655|449378399|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
124931683|NCT02852655|449378397|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
124931684|NCT02852655|449378398|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
124931685|NCT02852655|449378399|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
124931686|NCT02852655|449378397|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
124931687|NCT02852655|449378398|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
124931688|NCT02852655|449378399|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
124931689|NCT02852655|449378397|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
124931690|NCT02852655|449378398|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
124931691|NCT02852655|449378399|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
124931692|NCT02852655|449378397|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
124931693|NCT02852655|449378398|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
124931694|NCT02852655|449378399|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
124931695|NCT02852655|449378397|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
124931696|NCT02852655|449378398|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
125120634|NCT01984242|450065164|FG000|Overall Study|Withdrawal by Subject|5|||
125120635|NCT01984242|450065165|FG001|Overall Study|Withdrawal by Subject|3|||
125120636|NCT01984242|450065166|FG002|Overall Study|Withdrawal by Subject|10|||
125120637|NCT01984242|450065164|FG000|Overall Study|Physician Decision|0|||
124931697|NCT02852655|449378399|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
124931698|NCT02852655|449378397|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
124931699|NCT02852655|449378398|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
124931700|NCT02852655|449378399|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
124931701|NCT02852655|449378397|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
124931702|NCT02852655|449378398|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
124931703|NCT02852655|449378399|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
124931704|NCT02852655|449378397|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
124931705|NCT02852655|449378398|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
124931706|NCT02852655|449378399|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
124931707|NCT02834390|449378403|FG000|Induction Phase|Progressive disease|0|||
124931708|NCT02834390|449378404|FG001|Induction Phase|Progressive disease|1|||
124931709|NCT02834390|449378403|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
124931710|NCT02834390|449378404|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
124931711|NCT02834390|449378403|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
124931712|NCT02834390|449378404|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
124931713|NCT02834390|449378403|FG000|Consolidation Phase|Physician Decision|1|||
124931714|NCT02834390|449378404|FG001|Consolidation Phase|Physician Decision|1|||
124931715|NCT04544007|449378405|FG000|Overall Study|Withdrawal by Subject|1|||
124931716|NCT04544007|449378405|FG000|Overall Study|Confirmed Progressive Disease|1|||
124931717|NCT02998528|449378406|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
124931718|NCT02998528|449378407|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
124931719|NCT02998528|449378408|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
124931720|NCT02998528|449378406|FG000|Randomization Period|Participant withdrew consent|0|||
124931721|NCT02998528|449378407|FG001|Randomization Period|Participant withdrew consent|3|||
124931722|NCT02998528|449378408|FG002|Randomization Period|Participant withdrew consent|0|||
124931723|NCT02998528|449378406|FG000|Randomization Period|Participant no longer meets study criteria|1|||
124931724|NCT02998528|449378407|FG001|Randomization Period|Participant no longer meets study criteria|3|||
124931725|NCT02998528|449378408|FG002|Randomization Period|Participant no longer meets study criteria|2|||
124931726|NCT02998528|449378406|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
124931727|NCT02998528|449378407|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
124931728|NCT02998528|449378408|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
124931729|NCT02998528|449378406|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
124931730|NCT02998528|449378407|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
124931731|NCT02998528|449378408|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
124931732|NCT02998528|449378406|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
124931733|NCT02998528|449378407|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
124931734|NCT02998528|449378408|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
124931735|NCT02998528|449378406|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
124931736|NCT02998528|449378407|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
125120638|NCT01984242|450065165|FG001|Overall Study|Physician Decision|0|||
125120639|NCT01984242|450065166|FG002|Overall Study|Physician Decision|1|||
125120640|NCT01984242|450065164|FG000|Overall Study|Lost to Follow-up|4|||
124931737|NCT02998528|449378408|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
124931738|NCT02998528|449378406|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
124931739|NCT02998528|449378407|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
124931740|NCT02998528|449378408|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
124931741|NCT02998528|449378406|FG000|Neoadjuvant Treatment Period|Death|1|||
124931742|NCT02998528|449378407|FG001|Neoadjuvant Treatment Period|Death|0|||
124931743|NCT02998528|449378408|FG002|Neoadjuvant Treatment Period|Death|0|||
124931744|NCT02998528|449378406|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
124931745|NCT02998528|449378407|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
124931746|NCT02998528|449378408|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
124931747|NCT02998528|449378406|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
124931748|NCT02998528|449378407|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
124931749|NCT02998528|449378408|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
124931750|NCT02998528|449378406|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
124931751|NCT02998528|449378407|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
124931752|NCT02998528|449378408|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
124931753|NCT02998528|449378406|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
124931754|NCT02998528|449378407|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
124931755|NCT02998528|449378408|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
124931756|NCT02998528|449378406|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
124931757|NCT02998528|449378407|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
124931758|NCT02998528|449378408|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
124931759|NCT02998528|449378406|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
124931760|NCT02998528|449378407|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
124931761|NCT02998528|449378408|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
124931762|NCT02413489|449378411|FG000|Overall Study|Death|11|||
124931763|NCT02413489|449378412|FG001|Overall Study|Death|3|||
124931764|NCT02413489|449378413|FG002|Overall Study|Death|4|||
124931765|NCT02413489|449378411|FG000|Overall Study|Withdrawal by Subject|2|||
124931766|NCT02413489|449378412|FG001|Overall Study|Withdrawal by Subject|0|||
124931767|NCT02413489|449378413|FG002|Overall Study|Withdrawal by Subject|0|||
124931768|NCT02413489|449378411|FG000|Overall Study|Study Terminated By Sponsor|2|||
124931769|NCT02413489|449378412|FG001|Overall Study|Study Terminated By Sponsor|13|||
124931770|NCT02413489|449378413|FG002|Overall Study|Study Terminated By Sponsor|1|||
124931771|NCT04247802|449378414|FG000|Overall Study|Withdrawal by Subject|1|||
124931772|NCT04247802|449378415|FG001|Overall Study|Withdrawal by Subject|3|||
124931773|NCT04247802|449378414|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
124931774|NCT04247802|449378415|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
124931775|NCT02575950|449378416|FG000|Overall Study|Withdrawal by Subject|0|||
124931776|NCT02575950|449378417|FG001|Overall Study|Withdrawal by Subject|0|||
124931777|NCT02575950|449378418|FG002|Overall Study|Withdrawal by Subject|0|||
124931778|NCT02575950|449378419|FG003|Overall Study|Withdrawal by Subject|2|||
124931779|NCT02575950|449378416|FG000|Overall Study|Lost to Follow-up|0|||
124931780|NCT02575950|449378417|FG001|Overall Study|Lost to Follow-up|1|||
124931781|NCT02575950|449378418|FG002|Overall Study|Lost to Follow-up|0|||
124931782|NCT02575950|449378419|FG003|Overall Study|Lost to Follow-up|3|||
124931783|NCT03209973|449379694|FG000|Overall Study|Withdrawal by Subject|7|||
124931784|NCT03209973|449379694|FG000|Overall Study|Lost to Follow-up|2|||
124931785|NCT03209973|449379694|FG000|Overall Study|Death|8|||
124931786|NCT03209973|449379694|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
124931787|NCT03209973|449379694|FG000|Overall Study|Sponsor Decision|18|||
124931788|NCT03209973|449379694|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
124931789|NCT03209973|449379694|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
124931790|NCT05218096|449379695|FG000|Primary Evaluation|Withdrawal by Subject|0|||
124931791|NCT05218096|449379696|FG001|Primary Evaluation|Withdrawal by Subject|0|||
124931792|NCT05218096|449379697|FG002|Primary Evaluation|Withdrawal by Subject|2|||
124931793|NCT05218096|449379698|FG003|Primary Evaluation|Withdrawal by Subject|0|||
124931794|NCT05218096|449379699|FG004|Primary Evaluation|Withdrawal by Subject|0|||
124931795|NCT05218096|449379695|FG000|Primary Evaluation|Physician Decision|1|||
124931796|NCT05218096|449379696|FG001|Primary Evaluation|Physician Decision|0|||
124931797|NCT05218096|449379697|FG002|Primary Evaluation|Physician Decision|0|||
124931798|NCT05218096|449379698|FG003|Primary Evaluation|Physician Decision|0|||
124931799|NCT05218096|449379699|FG004|Primary Evaluation|Physician Decision|0|||
124931800|NCT05218096|449379695|FG000|Extended Treatment|Clinical Deterioration|1|||
124931801|NCT05218096|449379696|FG001|Extended Treatment|Clinical Deterioration|1|||
124931802|NCT05218096|449379697|FG002|Extended Treatment|Clinical Deterioration|0|||
124931803|NCT05218096|449379698|FG003|Extended Treatment|Clinical Deterioration|0|||
124931804|NCT05218096|449379699|FG004|Extended Treatment|Clinical Deterioration|0|||
124931805|NCT05218096|449379695|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
124931806|NCT05218096|449379696|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
124931807|NCT05218096|449379697|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
124931808|NCT05218096|449379698|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
124931809|NCT05218096|449379699|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
124931810|NCT05218096|449379695|FG000|Extended Treatment|Withdrawal by Subject|1|||
124931811|NCT05218096|449379696|FG001|Extended Treatment|Withdrawal by Subject|3|||
124931812|NCT05218096|449379697|FG002|Extended Treatment|Withdrawal by Subject|0|||
124931813|NCT05218096|449379698|FG003|Extended Treatment|Withdrawal by Subject|2|||
124931814|NCT05218096|449379699|FG004|Extended Treatment|Withdrawal by Subject|2|||
124931815|NCT05218096|449379695|FG000|Extended Treatment|Lack of Efficacy|3|||
124931816|NCT05218096|449379696|FG001|Extended Treatment|Lack of Efficacy|0|||
124931817|NCT05218096|449379697|FG002|Extended Treatment|Lack of Efficacy|0|||
124931818|NCT05218096|449379698|FG003|Extended Treatment|Lack of Efficacy|0|||
124931819|NCT05218096|449379699|FG004|Extended Treatment|Lack of Efficacy|0|||
125212798|NCT01026818|450405479|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
125212799|NCT01026818|450405480|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
124931820|NCT05218096|449379695|FG000|Extended Treatment|Physician Decision|0|||
124931821|NCT05218096|449379696|FG001|Extended Treatment|Physician Decision|1|||
124931822|NCT05218096|449379697|FG002|Extended Treatment|Physician Decision|0|||
124931823|NCT05218096|449379698|FG003|Extended Treatment|Physician Decision|0|||
124931824|NCT05218096|449379699|FG004|Extended Treatment|Physician Decision|0|||
124931825|NCT05218096|449379695|FG000|Open-label Extension|Adverse Event|1|||
124931826|NCT05218096|449379696|FG001|Open-label Extension|Adverse Event|0|||
124931827|NCT05218096|449379697|FG002|Open-label Extension|Adverse Event|0|||
124931828|NCT05218096|449379698|FG003|Open-label Extension|Adverse Event|0|||
124931829|NCT05218096|449379699|FG004|Open-label Extension|Adverse Event|1|||
124931830|NCT05218096|449379695|FG000|Open-label Extension|Pregnancy|0|||
124931831|NCT05218096|449379696|FG001|Open-label Extension|Pregnancy|0|||
124931832|NCT05218096|449379697|FG002|Open-label Extension|Pregnancy|0|||
124931833|NCT05218096|449379698|FG003|Open-label Extension|Pregnancy|0|||
124931834|NCT05218096|449379699|FG004|Open-label Extension|Pregnancy|1|||
124931835|NCT05218096|449379695|FG000|Open-label Extension|Lack of Efficacy|1|||
124931836|NCT05218096|449379696|FG001|Open-label Extension|Lack of Efficacy|2|||
124931837|NCT05218096|449379697|FG002|Open-label Extension|Lack of Efficacy|0|||
124931838|NCT05218096|449379698|FG003|Open-label Extension|Lack of Efficacy|0|||
124931839|NCT05218096|449379699|FG004|Open-label Extension|Lack of Efficacy|0|||
124931840|NCT05218096|449379695|FG000|Open-label Extension|Lost to Follow-up|1|||
124931841|NCT05218096|449379696|FG001|Open-label Extension|Lost to Follow-up|0|||
124931842|NCT05218096|449379697|FG002|Open-label Extension|Lost to Follow-up|0|||
124931843|NCT05218096|449379698|FG003|Open-label Extension|Lost to Follow-up|0|||
124931844|NCT05218096|449379699|FG004|Open-label Extension|Lost to Follow-up|0|||
124931845|NCT05218096|449379695|FG000|Open-label Extension|Death|0|||
124931846|NCT05218096|449379696|FG001|Open-label Extension|Death|0|||
124931847|NCT05218096|449379697|FG002|Open-label Extension|Death|0|||
124931848|NCT05218096|449379698|FG003|Open-label Extension|Death|1|||
124931849|NCT05218096|449379699|FG004|Open-label Extension|Death|0|||
124931850|NCT05218096|449379695|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
124931851|NCT05218096|449379696|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
124931852|NCT05218096|449379697|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
124931853|NCT05218096|449379698|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
124931854|NCT05218096|449379699|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
124931855|NCT04797195|449379708|FG000|Overall Study|Death|8|||
124931856|NCT04797195|449379709|FG001|Overall Study|Death|15|||
124931857|NCT04797195|449379708|FG000|Overall Study|Change from PD|15|||
124931858|NCT04797195|449379709|FG001|Overall Study|Change from PD|15|||
124931859|NCT04797195|449379708|FG000|Overall Study|Withdrawal by Subject|3|||
124931860|NCT04797195|449379709|FG001|Overall Study|Withdrawal by Subject|2|||
124931861|NCT04660539|449379712|FG000|Overall Study|Adverse Event|10|||
124931862|NCT04660539|449379712|FG000|Overall Study|Lack of Efficacy|4|||
124931863|NCT04660539|449379712|FG000|Overall Study|Lost to Follow-up|5|||
124931864|NCT04660539|449379712|FG000|Overall Study|Non-Compliance With Study Drug|3|||
124931865|NCT04660539|449379712|FG000|Overall Study|Reason not Specified|12|||
124931866|NCT04660539|449379712|FG000|Overall Study|Pregnancy|2|||
125120641|NCT01984242|450065165|FG001|Overall Study|Lost to Follow-up|0|||
125120642|NCT01984242|450065166|FG002|Overall Study|Lost to Follow-up|3|||
125120643|NCT01984242|450065164|FG000|Overall Study|Sponsor Decision|1|||
125120644|NCT01984242|450065165|FG001|Overall Study|Sponsor Decision|0|||
125120645|NCT01984242|450065166|FG002|Overall Study|Sponsor Decision|0|||
125120646|NCT01984242|450065164|FG000|Overall Study|Non-Compliance|1|||
125120647|NCT01984242|450065165|FG001|Overall Study|Non-Compliance|0|||
125120648|NCT01984242|450065166|FG002|Overall Study|Non-Compliance|0|||
125120649|NCT01984242|450065164|FG000|Overall Study|Study terminated by Sponsor|38|||
124931867|NCT04660539|449379712|FG000|Overall Study|Protocol Violation|2|||
124931868|NCT04660539|449379712|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
124931869|NCT04660539|449379712|FG000|Overall Study|Withdrawal by Subject|21|||
124931870|NCT05256654|449379713|FG000|Overall Study|Adverse Event|0|||
124931871|NCT05256654|449379714|FG001|Overall Study|Adverse Event|0|||
124931872|NCT05256654|449379715|FG002|Overall Study|Adverse Event|1|||
124931873|NCT05256654|449379716|FG003|Overall Study|Adverse Event|0|||
124931874|NCT05256654|449379713|FG000|Overall Study|Lost to Follow-up|0|||
124931875|NCT05256654|449379714|FG001|Overall Study|Lost to Follow-up|0|||
124931876|NCT05256654|449379715|FG002|Overall Study|Lost to Follow-up|0|||
124931877|NCT05256654|449379716|FG003|Overall Study|Lost to Follow-up|1|||
124931878|NCT05256654|449379713|FG000|Overall Study|Withdrawal by Subject|1|||
124931879|NCT05256654|449379714|FG001|Overall Study|Withdrawal by Subject|2|||
124931880|NCT05256654|449379715|FG002|Overall Study|Withdrawal by Subject|1|||
124931881|NCT05256654|449379716|FG003|Overall Study|Withdrawal by Subject|3|||
124931882|NCT05256654|449379713|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
124931883|NCT05256654|449379714|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
124931884|NCT05256654|449379715|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
124931885|NCT05256654|449379716|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
124931886|NCT05256654|449379713|FG000|Overall Study|Other|0|||
124931887|NCT05256654|449379714|FG001|Overall Study|Other|0|||
124931888|NCT05256654|449379715|FG002|Overall Study|Other|0|||
124931889|NCT05256654|449379716|FG003|Overall Study|Other|1|||
125024961|NCT02918019|449714805|FG000|Overall Study|Lost to Follow-up|1|||
125024962|NCT02918019|449714806|FG001|Overall Study|Lost to Follow-up|1|||
125024963|NCT02918019|449714807|FG002|Overall Study|Lost to Follow-up|0|||
125024964|NCT02918019|449714808|FG003|Overall Study|Lost to Follow-up|1|||
125024965|NCT02918019|449714805|FG000|Overall Study|Principal investigator request|0|||
125024966|NCT02918019|449714806|FG001|Overall Study|Principal investigator request|0|||
125024967|NCT02918019|449714807|FG002|Overall Study|Principal investigator request|0|||
125024968|NCT02918019|449714808|FG003|Overall Study|Principal investigator request|1|||
125024969|NCT02918019|449714805|FG000|Overall Study|Physician Decision|1|||
125024970|NCT02918019|449714806|FG001|Overall Study|Physician Decision|3|||
125024971|NCT02918019|449714807|FG002|Overall Study|Physician Decision|2|||
125024972|NCT02918019|449714808|FG003|Overall Study|Physician Decision|0|||
125024973|NCT02918019|449714805|FG000|Overall Study|Protocol deviation|1|||
125024974|NCT02918019|449714806|FG001|Overall Study|Protocol deviation|1|||
125024975|NCT02918019|449714807|FG002|Overall Study|Protocol deviation|0|||
125024976|NCT02918019|449714808|FG003|Overall Study|Protocol deviation|2|||
125024977|NCT02918019|449714805|FG000|Overall Study|Withdrawal by Subject|3|||
125024978|NCT02918019|449714806|FG001|Overall Study|Withdrawal by Subject|4|||
125024979|NCT02918019|449714807|FG002|Overall Study|Withdrawal by Subject|6|||
125024980|NCT02918019|449714808|FG003|Overall Study|Withdrawal by Subject|4|||
125024981|NCT02918019|449714805|FG000|Overall Study|Adverse Event|0|||
125024982|NCT02918019|449714806|FG001|Overall Study|Adverse Event|1|||
125024983|NCT02918019|449714807|FG002|Overall Study|Adverse Event|0|||
125024984|NCT02918019|449714808|FG003|Overall Study|Adverse Event|1|||
125024985|NCT01212185|449714809|FG000|Overall Study|Protocol Violation|2|||
125120650|NCT01984242|450065165|FG001|Overall Study|Study terminated by Sponsor|50|||
124931890|NCT05167864|449379717|FG000|Overall Study|Lost to Follow-up|7|||
124931891|NCT05167864|449379718|FG001|Overall Study|Lost to Follow-up|6|||
124931892|NCT05167864|449379719|FG002|Overall Study|Lost to Follow-up|7|||
124931893|NCT05167864|449379720|FG003|Overall Study|Lost to Follow-up|9|||
124931894|NCT03852550|449379723|FG000|Overall Study|Lost to Follow-up|4|||
124931895|NCT03852550|449379724|FG001|Overall Study|Lost to Follow-up|3|||
125024986|NCT01212185|449714810|FG001|Overall Study|Protocol Violation|1|||
125024987|NCT03222349|449714811|FG000|Overall Study|Treatment B not done|5|||
125024988|NCT03222349|449714812|FG001|Overall Study|Treatment B not done|0|||
125024989|NCT03222349|449714811|FG000|Overall Study|Lost to Follow-up|1|||
125120651|NCT01984242|450065166|FG002|Overall Study|Study terminated by Sponsor|34|||
125024990|NCT03222349|449714812|FG001|Overall Study|Lost to Follow-up|2|||
125024991|NCT03222349|449714811|FG000|Overall Study|Withdrawal by Subject|1|||
125024992|NCT03222349|449714812|FG001|Overall Study|Withdrawal by Subject|0|||
125024993|NCT03222349|449714811|FG000|Overall Study|Treatment A not done|0|||
125024994|NCT03222349|449714812|FG001|Overall Study|Treatment A not done|5|||
125024995|NCT03222349|449714811|FG000|Overall Study|Study terminated by sponsor|1|||
125024996|NCT03222349|449714812|FG001|Overall Study|Study terminated by sponsor|0|||
125024997|NCT00094757|449714816|FG000|Overall Study|Adverse Event|11|||
125024998|NCT00094757|449714817|FG001|Overall Study|Adverse Event|9|||
125024999|NCT00094757|449714818|FG002|Overall Study|Adverse Event|6|||
125025000|NCT00094757|449714816|FG000|Overall Study|Lack of Efficacy|11|||
125025001|NCT00094757|449714817|FG001|Overall Study|Lack of Efficacy|15|||
125025002|NCT00094757|449714818|FG002|Overall Study|Lack of Efficacy|8|||
125025003|NCT00094757|449714816|FG000|Overall Study|Lost to Follow-up|3|||
125025004|NCT00094757|449714817|FG001|Overall Study|Lost to Follow-up|5|||
125025005|NCT00094757|449714818|FG002|Overall Study|Lost to Follow-up|6|||
125025006|NCT00094757|449714816|FG000|Overall Study|Patient Moved|2|||
125025007|NCT00094757|449714817|FG001|Overall Study|Patient Moved|1|||
125025008|NCT00094757|449714818|FG002|Overall Study|Patient Moved|1|||
125025009|NCT00094757|449714816|FG000|Overall Study|Protocol Violation|8|||
125025010|NCT00094757|449714817|FG001|Overall Study|Protocol Violation|5|||
125025011|NCT00094757|449714818|FG002|Overall Study|Protocol Violation|3|||
125025012|NCT00094757|449714816|FG000|Overall Study|Withdrawal by Subject|14|||
125025013|NCT00094757|449714817|FG001|Overall Study|Withdrawal by Subject|21|||
125025014|NCT00094757|449714818|FG002|Overall Study|Withdrawal by Subject|5|||
125025015|NCT00094757|449714816|FG000|Overall Study|Other|3|||
125025016|NCT00094757|449714817|FG001|Overall Study|Other|3|||
125025017|NCT00094757|449714818|FG002|Overall Study|Other|1|||
125025018|NCT00094757|449714816|FG000|Overall Study|Protocol specified discontinuation|1|||
125025019|NCT00094757|449714817|FG001|Overall Study|Protocol specified discontinuation|3|||
125025020|NCT00094757|449714818|FG002|Overall Study|Protocol specified discontinuation|0|||
125025021|NCT01808612|449714819|FG000|Treatment Period|Adverse Event|8|||
125025022|NCT01808612|449714820|FG001|Treatment Period|Adverse Event|4|||
125025023|NCT01808612|449714821|FG002|Treatment Period|Adverse Event|3|||
125025024|NCT01808612|449714819|FG000|Treatment Period|Lost to Follow-up|2|||
125025025|NCT01808612|449714820|FG001|Treatment Period|Lost to Follow-up|2|||
125025026|NCT01808612|449714821|FG002|Treatment Period|Lost to Follow-up|1|||
125025027|NCT01808612|449714819|FG000|Treatment Period|Protocol Violation|1|||
125025028|NCT01808612|449714820|FG001|Treatment Period|Protocol Violation|0|||
125025029|NCT01808612|449714821|FG002|Treatment Period|Protocol Violation|0|||
125025030|NCT01808612|449714819|FG000|Treatment Period|Withdrawal by Subject|1|||
125025031|NCT01808612|449714820|FG001|Treatment Period|Withdrawal by Subject|0|||
125025032|NCT01808612|449714821|FG002|Treatment Period|Withdrawal by Subject|4|||
125025033|NCT01808612|449714819|FG000|Treatment Period|Physician Decision|1|||
125025034|NCT01808612|449714820|FG001|Treatment Period|Physician Decision|0|||
125025035|NCT01808612|449714821|FG002|Treatment Period|Physician Decision|4|||
125025036|NCT01808612|449714819|FG000|Treatment Period|Sponsor Decision|1|||
125025037|NCT01808612|449714820|FG001|Treatment Period|Sponsor Decision|0|||
125025038|NCT01808612|449714821|FG002|Treatment Period|Sponsor Decision|0|||
125025039|NCT01808612|449714819|FG000|Treatment Period|Lack of Efficacy|1|||
125025040|NCT01808612|449714820|FG001|Treatment Period|Lack of Efficacy|1|||
125025041|NCT01808612|449714821|FG002|Treatment Period|Lack of Efficacy|2|||
125025042|NCT01808612|449714819|FG000|Discontinuation Period|Adverse Event|1|||
125025043|NCT01808612|449714820|FG001|Discontinuation Period|Adverse Event|0|||
125025044|NCT01808612|449714821|FG002|Discontinuation Period|Adverse Event|0|||
125025045|NCT01808612|449714819|FG000|Discontinuation Period|Physician Decision|1|||
125025046|NCT01808612|449714820|FG001|Discontinuation Period|Physician Decision|0|||
125025047|NCT01808612|449714821|FG002|Discontinuation Period|Physician Decision|0|||
125025048|NCT01808612|449714819|FG000|Discontinuation Period|Lost to Follow-up|0|||
125025049|NCT01808612|449714820|FG001|Discontinuation Period|Lost to Follow-up|1|||
125025050|NCT01808612|449714821|FG002|Discontinuation Period|Lost to Follow-up|0|||
125025051|NCT00756938|449714822|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
125025052|NCT00756938|449714823|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
125025053|NCT00756938|449714824|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
125025054|NCT00756938|449714825|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
125025055|NCT00756938|449714822|FG000|12-week Base Study|Protocol Violation|0|||
125025056|NCT00756938|449714823|FG001|12-week Base Study|Protocol Violation|0|||
125025057|NCT00756938|449714824|FG002|12-week Base Study|Protocol Violation|1|||
125025058|NCT00756938|449714825|FG003|12-week Base Study|Protocol Violation|0|||
125025059|NCT00756938|449714822|FG000|12-week Base Study|Lost to Follow-up|1|||
125025060|NCT00756938|449714823|FG001|12-week Base Study|Lost to Follow-up|0|||
125025061|NCT00756938|449714824|FG002|12-week Base Study|Lost to Follow-up|0|||
125025062|NCT00756938|449714825|FG003|12-week Base Study|Lost to Follow-up|0|||
125025063|NCT00756938|449714822|FG000|Optional Extension|Lack of Efficacy|0|||
125025064|NCT00756938|449714823|FG001|Optional Extension|Lack of Efficacy|0|||
125025065|NCT00756938|449714824|FG002|Optional Extension|Lack of Efficacy|0|||
125025066|NCT00756938|449714825|FG003|Optional Extension|Lack of Efficacy|1|||
125025067|NCT00756938|449714822|FG000|Optional Extension|End of Study|0|||
125025068|NCT00756938|449714823|FG001|Optional Extension|End of Study|0|||
125025069|NCT00756938|449714824|FG002|Optional Extension|End of Study|0|||
125025070|NCT00756938|449714825|FG003|Optional Extension|End of Study|11|||
125025071|NCT00756938|449714822|FG000|Optional Extension|Protocol-specific criteria met|0|||
125025072|NCT00756938|449714823|FG001|Optional Extension|Protocol-specific criteria met|0|||
124931896|NCT03852550|449379723|FG000|Overall Study|Only parent outcomes completed|0|||
124931897|NCT03852550|449379724|FG001|Overall Study|Only parent outcomes completed|1|||
124931898|NCT03852550|449379723|FG000|Overall Study|Withdrawal by Subject|1|||
124931899|NCT03852550|449379724|FG001|Overall Study|Withdrawal by Subject|0|||
124931900|NCT05204654|449379725|FG000|Overall Study|Study terminated due to time restraint|2|||
124931901|NCT05204654|449379726|FG001|Overall Study|Study terminated due to time restraint|2|||
124931902|NCT05207956|449379741|FG000|Overall Study|Lost to follow up|1|||
124931903|NCT05207956|449379742|FG001|Overall Study|Lost to follow up|2|||
124931904|NCT02296684|449379743|FG000|Overall Study|Withdrawal by Subject|0|||
124931905|NCT02296684|449379744|FG001|Overall Study|Withdrawal by Subject|1|||
124931906|NCT02296684|449379745|FG002|Overall Study|Withdrawal by Subject|1|||
124931907|NCT02296684|449379743|FG000|Overall Study|Death|2|||
124931908|NCT02296684|449379744|FG001|Overall Study|Death|0|||
124931909|NCT02296684|449379745|FG002|Overall Study|Death|0|||
124931910|NCT01254864|449379746|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
124931911|NCT01254864|449379747|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
124931912|NCT01254864|449379748|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
124931913|NCT01254864|449379746|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
124931914|NCT01254864|449379747|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
124931915|NCT01254864|449379748|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
124931916|NCT01254864|449379746|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
124931917|NCT01254864|449379747|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
125025073|NCT00756938|449714824|FG002|Optional Extension|Protocol-specific criteria met|0|||
125025074|NCT00756938|449714825|FG003|Optional Extension|Protocol-specific criteria met|9|||
125025075|NCT00756938|449714822|FG000|Optional Extension|Physician Decision|0|||
125025076|NCT00756938|449714823|FG001|Optional Extension|Physician Decision|0|||
125025077|NCT00756938|449714824|FG002|Optional Extension|Physician Decision|0|||
125025078|NCT00756938|449714825|FG003|Optional Extension|Physician Decision|3|||
125120652|NCT01984242|450065164|FG000|Overall Study|Disease Progression|0|||
125120653|NCT01984242|450065165|FG001|Overall Study|Disease Progression|0|||
125120654|NCT01984242|450065166|FG002|Overall Study|Disease Progression|1|||
125120655|NCT04543136|450065169|FG000|Overall Study|Withdrawal by Subject|0|||
125025079|NCT00756938|449714822|FG000|Optional Extension|Lost to Follow-up|0|||
125025080|NCT00756938|449714823|FG001|Optional Extension|Lost to Follow-up|0|||
125025081|NCT00756938|449714824|FG002|Optional Extension|Lost to Follow-up|0|||
125025082|NCT00756938|449714825|FG003|Optional Extension|Lost to Follow-up|1|||
125025083|NCT00756938|449714822|FG000|Optional Extension|Protocol Violation|0|||
125025084|NCT00756938|449714823|FG001|Optional Extension|Protocol Violation|0|||
125025085|NCT00756938|449714824|FG002|Optional Extension|Protocol Violation|0|||
125025086|NCT00756938|449714825|FG003|Optional Extension|Protocol Violation|1|||
125025087|NCT00756938|449714822|FG000|Optional Extension|Withdrawal by Subject|0|||
125025088|NCT00756938|449714823|FG001|Optional Extension|Withdrawal by Subject|0|||
125025089|NCT00756938|449714824|FG002|Optional Extension|Withdrawal by Subject|0|||
125025090|NCT00756938|449714825|FG003|Optional Extension|Withdrawal by Subject|10|||
125120656|NCT04543136|450065170|FG001|Overall Study|Withdrawal by Subject|1|||
125120657|NCT04543136|450065171|FG002|Overall Study|Withdrawal by Subject|0|||
125120658|NCT04543136|450065172|FG003|Overall Study|Withdrawal by Subject|1|||
125120659|NCT04543136|450065173|FG004|Overall Study|Withdrawal by Subject|0|||
125120660|NCT04543136|450065174|FG005|Overall Study|Withdrawal by Subject|0|||
124931918|NCT01254864|449379748|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
124931919|NCT01254864|449379746|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
124931920|NCT01254864|449379747|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
124931921|NCT01254864|449379748|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
125025091|NCT00756938|449714822|FG000|Optional Extension|Adverse Event|0|||
125025092|NCT00756938|449714823|FG001|Optional Extension|Adverse Event|0|||
125025093|NCT00756938|449714824|FG002|Optional Extension|Adverse Event|0|||
125025094|NCT00756938|449714825|FG003|Optional Extension|Adverse Event|1|||
125025095|NCT01127165|449714826|FG000|Overall Study|Adverse Event|2|||
125025096|NCT01127165|449714827|FG001|Overall Study|Adverse Event|2|||
125025097|NCT01127165|449714826|FG000|Overall Study|Lack of Efficacy|10|||
125025098|NCT01127165|449714827|FG001|Overall Study|Lack of Efficacy|8|||
125025099|NCT01127165|449714826|FG000|Overall Study|Lost to Follow-up|3|||
125025100|NCT01127165|449714827|FG001|Overall Study|Lost to Follow-up|5|||
125025101|NCT01127165|449714826|FG000|Overall Study|Withdrawal by Subject|1|||
124931922|NCT01254864|449379746|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
124931923|NCT01254864|449379747|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
124931924|NCT01254864|449379748|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
124931925|NCT01254864|449379746|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
124931926|NCT01254864|449379747|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
124931927|NCT01254864|449379748|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
124931928|NCT01254864|449379746|FG000|Randomization Phase|Adverse Event|0|||
124931929|NCT01254864|449379747|FG001|Randomization Phase|Adverse Event|5|||
124931930|NCT01254864|449379748|FG002|Randomization Phase|Adverse Event|17|||
124931931|NCT01254864|449379746|FG000|Randomization Phase|Death|0|||
124931932|NCT01254864|449379747|FG001|Randomization Phase|Death|1|||
124931933|NCT01254864|449379748|FG002|Randomization Phase|Death|0|||
124931934|NCT01254864|449379746|FG000|Randomization Phase|Lost to Follow-up|0|||
124931935|NCT01254864|449379747|FG001|Randomization Phase|Lost to Follow-up|0|||
124931936|NCT01254864|449379748|FG002|Randomization Phase|Lost to Follow-up|1|||
124931937|NCT01254864|449379746|FG000|Randomization Phase|Physician Decision|0|||
124931938|NCT01254864|449379747|FG001|Randomization Phase|Physician Decision|20|||
124931939|NCT01254864|449379748|FG002|Randomization Phase|Physician Decision|25|||
124931940|NCT01254864|449379746|FG000|Randomization Phase|Withdrawal by Subject|0|||
124931941|NCT01254864|449379747|FG001|Randomization Phase|Withdrawal by Subject|4|||
124931942|NCT01254864|449379748|FG002|Randomization Phase|Withdrawal by Subject|2|||
124931943|NCT01254864|449379746|FG000|Randomization Phase|Non-Compliance|0|||
124931944|NCT01254864|449379747|FG001|Randomization Phase|Non-Compliance|1|||
124931945|NCT01254864|449379748|FG002|Randomization Phase|Non-Compliance|0|||
124931946|NCT01254864|449379746|FG000|Randomization Phase|Comorbidities|0|||
124931947|NCT01254864|449379747|FG001|Randomization Phase|Comorbidities|2|||
124931948|NCT01254864|449379748|FG002|Randomization Phase|Comorbidities|1|||
124931949|NCT01828112|449379753|FG000|Treatment Phase|Adverse Event|7|||
124931950|NCT01828112|449379754|FG001|Treatment Phase|Adverse Event|8|||
124931951|NCT01828112|449379755|FG002|Treatment Phase|Adverse Event|0|||
124931952|NCT01828112|449379753|FG000|Treatment Phase|Death|9|||
124931953|NCT01828112|449379754|FG001|Treatment Phase|Death|5|||
124931954|NCT01828112|449379755|FG002|Treatment Phase|Death|0|||
124931955|NCT01828112|449379753|FG000|Treatment Phase|No longer required treatment|0|||
124931956|NCT01828112|449379754|FG001|Treatment Phase|No longer required treatment|1|||
124931957|NCT01828112|449379755|FG002|Treatment Phase|No longer required treatment|0|||
124931958|NCT01828112|449379753|FG000|Treatment Phase|Physician Decision|6|||
124931959|NCT01828112|449379754|FG001|Treatment Phase|Physician Decision|7|||
124931960|NCT01828112|449379755|FG002|Treatment Phase|Physician Decision|0|||
124931961|NCT01828112|449379753|FG000|Treatment Phase|Pregnancy|1|||
124931962|NCT01828112|449379754|FG001|Treatment Phase|Pregnancy|0|||
124931963|NCT01828112|449379755|FG002|Treatment Phase|Pregnancy|0|||
124931964|NCT01828112|449379753|FG000|Treatment Phase|Progressive disease|79|||
124931965|NCT01828112|449379754|FG001|Treatment Phase|Progressive disease|87|||
124931966|NCT01828112|449379755|FG002|Treatment Phase|Progressive disease|0|||
124931967|NCT01828112|449379753|FG000|Treatment Phase|Study terminated by sponsor|1|||
124931968|NCT01828112|449379754|FG001|Treatment Phase|Study terminated by sponsor|0|||
124931969|NCT01828112|449379755|FG002|Treatment Phase|Study terminated by sponsor|0|||
124931970|NCT01828112|449379753|FG000|Treatment Phase|Subject/guardian decision|12|||
124931971|NCT01828112|449379754|FG001|Treatment Phase|Subject/guardian decision|8|||
125025102|NCT01127165|449714827|FG001|Overall Study|Withdrawal by Subject|3|||
125025103|NCT01127165|449714826|FG000|Overall Study|Protocol Violation|0|||
125025104|NCT01127165|449714827|FG001|Overall Study|Protocol Violation|1|||
125025105|NCT03175549|449714828|FG000|Overall Study|Lost to Follow-up|2|||
125025106|NCT03175549|449714829|FG001|Overall Study|Lost to Follow-up|2|||
125025107|NCT03175549|449714828|FG000|Overall Study|Medication non-compliance|2|||
125025108|NCT03175549|449714829|FG001|Overall Study|Medication non-compliance|2|||
125025109|NCT00763321|449714830|FG000|Open-label Period|Adverse Event|24|||
124931972|NCT01828112|449379755|FG002|Treatment Phase|Subject/guardian decision|0|||
124931973|NCT01828112|449379753|FG000|Extension Treatment Phase|Adverse Event|0|||
124931974|NCT01828112|449379754|FG001|Extension Treatment Phase|Adverse Event|0|||
124931975|NCT01828112|449379755|FG002|Extension Treatment Phase|Adverse Event|6|||
124931976|NCT01828112|449379753|FG000|Extension Treatment Phase|Death|0|||
124931977|NCT01828112|449379754|FG001|Extension Treatment Phase|Death|0|||
124931978|NCT01828112|449379755|FG002|Extension Treatment Phase|Death|17|||
124931979|NCT01828112|449379753|FG000|Extension Treatment Phase|Physician Decision|0|||
125025110|NCT00763321|449714831|FG001|Open-label Period|Adverse Event|0|||
125025111|NCT00763321|449714832|FG002|Open-label Period|Adverse Event|0|||
125025112|NCT00763321|449714830|FG000|Open-label Period|Lost to Follow-up|14|||
125025113|NCT00763321|449714831|FG001|Open-label Period|Lost to Follow-up|0|||
124931980|NCT01828112|449379754|FG001|Extension Treatment Phase|Physician Decision|0|||
124931981|NCT01828112|449379755|FG002|Extension Treatment Phase|Physician Decision|5|||
124931982|NCT01828112|449379753|FG000|Extension Treatment Phase|Progressive disease|0|||
124931983|NCT01828112|449379754|FG001|Extension Treatment Phase|Progressive disease|0|||
124931984|NCT01828112|449379755|FG002|Extension Treatment Phase|Progressive disease|46|||
124931985|NCT01828112|449379753|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
124931986|NCT01828112|449379754|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
124931987|NCT01828112|449379755|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
124931988|NCT01828112|449379753|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
124931989|NCT01828112|449379754|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
124931990|NCT01828112|449379755|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
124931991|NCT02446236|449379765|FG000|Overall Study|Screen Failure|1|||
124931992|NCT02446236|449379766|FG001|Overall Study|Screen Failure|0|||
124931993|NCT02446236|449379767|FG002|Overall Study|Screen Failure|1|||
125025114|NCT00763321|449714832|FG002|Open-label Period|Lost to Follow-up|0|||
125025115|NCT00763321|449714830|FG000|Open-label Period|Withdrawal by Subject|7|||
125025116|NCT00763321|449714831|FG001|Open-label Period|Withdrawal by Subject|0|||
125025117|NCT00763321|449714832|FG002|Open-label Period|Withdrawal by Subject|0|||
125025118|NCT00763321|449714830|FG000|Open-label Period|Subject noncompliant|7|||
125025119|NCT00763321|449714831|FG001|Open-label Period|Subject noncompliant|0|||
125025120|NCT00763321|449714832|FG002|Open-label Period|Subject noncompliant|0|||
125025121|NCT00763321|449714830|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
125025122|NCT00763321|449714831|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
125025123|NCT00763321|449714832|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
125025124|NCT00763321|449714830|FG000|Open-label Period|Lack of Efficacy|2|||
125025125|NCT00763321|449714831|FG001|Open-label Period|Lack of Efficacy|0|||
125025126|NCT00763321|449714832|FG002|Open-label Period|Lack of Efficacy|0|||
125025127|NCT00763321|449714830|FG000|Open-label Period|Other|4|||
125025128|NCT00763321|449714831|FG001|Open-label Period|Other|0|||
125025129|NCT00763321|449714832|FG002|Open-label Period|Other|0|||
125025130|NCT00763321|449714830|FG000|Double-blind Period|Lack of Efficacy|0|||
125025131|NCT00763321|449714831|FG001|Double-blind Period|Lack of Efficacy|9|||
125025132|NCT00763321|449714832|FG002|Double-blind Period|Lack of Efficacy|17|||
125025133|NCT00763321|449714830|FG000|Double-blind Period|Adverse Event|0|||
125025134|NCT00763321|449714831|FG001|Double-blind Period|Adverse Event|4|||
125025135|NCT00763321|449714832|FG002|Double-blind Period|Adverse Event|4|||
125025136|NCT00763321|449714830|FG000|Double-blind Period|Lost to Follow-up|0|||
125025137|NCT00763321|449714831|FG001|Double-blind Period|Lost to Follow-up|4|||
125025138|NCT00763321|449714832|FG002|Double-blind Period|Lost to Follow-up|2|||
125025139|NCT00763321|449714830|FG000|Double-blind Period|Withdrawal by Subject|0|||
125025140|NCT00763321|449714831|FG001|Double-blind Period|Withdrawal by Subject|2|||
125025141|NCT00763321|449714832|FG002|Double-blind Period|Withdrawal by Subject|3|||
125025142|NCT00763321|449714830|FG000|Double-blind Period|Other|0|||
125025143|NCT00763321|449714831|FG001|Double-blind Period|Other|2|||
125025144|NCT00763321|449714832|FG002|Double-blind Period|Other|3|||
125025145|NCT02486757|449714833|FG000|Overall Study|Lost to Follow-up|1|||
125025146|NCT02793232|449714834|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
125025147|NCT02793232|449714835|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
125025148|NCT02793232|449714836|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
125025149|NCT02793232|449714837|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
125025150|NCT02793232|449714838|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
125025151|NCT02793232|449714839|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
125025152|NCT02793232|449714840|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
125025153|NCT02793232|449714841|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
125025154|NCT02793232|449714842|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
125025155|NCT01298492|449714843|FG000|Overall Study|Death|2|||
125025156|NCT01298492|449714843|FG000|Overall Study|Insufficient Clinical Response|22|||
125025157|NCT01298492|449714843|FG000|Overall Study|Lost to Follow-up|12|||
125025158|NCT01298492|449714843|FG000|Overall Study|Withdrawal by Subject|47|||
125025159|NCT01298492|449714843|FG000|Overall Study|Other (Unspecified)|7|||
125025160|NCT01298492|449714843|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
125025161|NCT01298492|449714843|FG000|Overall Study|Protocol Violation|2|||
125025162|NCT01298492|449714843|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
125025163|NCT01298492|449714843|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
125025164|NCT00352105|449714844|FG000|Overall Study|Death|5|||
125025165|NCT00352105|449714844|FG000|Overall Study|Withdrawal by Subject|5|||
125025166|NCT00352105|449714844|FG000|Overall Study|Lack of Efficacy|9|||
125025167|NCT00352105|449714844|FG000|Overall Study|Adverse Event|19|||
125025168|NCT00352105|449714844|FG000|Overall Study|Protocol Violation|2|||
125025169|NCT01405053|449714845|FG000|Overall Study|Adverse Event|3|||
125025170|NCT01405053|449714846|FG001|Overall Study|Adverse Event|0|||
124931994|NCT02446236|449379765|FG000|Overall Study|Actively Receiving Therapy|0|||
124931995|NCT02446236|449379766|FG001|Overall Study|Actively Receiving Therapy|0|||
124931996|NCT02446236|449379767|FG002|Overall Study|Actively Receiving Therapy|1|||
124931997|NCT05184452|449379768|FG000|Overall Study|Lost to Follow-up|0|||
124931998|NCT05184452|449379769|FG001|Overall Study|Lost to Follow-up|0|||
124931999|NCT05184452|449379770|FG002|Overall Study|Lost to Follow-up|0|||
124932000|NCT05184452|449379771|FG003|Overall Study|Lost to Follow-up|0|||
124932001|NCT05184452|449379772|FG004|Overall Study|Lost to Follow-up|0|||
124932002|NCT05184452|449379773|FG005|Overall Study|Lost to Follow-up|2|||
124932003|NCT05184452|449379774|FG006|Overall Study|Lost to Follow-up|0|||
124932004|NCT05184452|449379775|FG007|Overall Study|Lost to Follow-up|0|||
124932005|NCT05184452|449379776|FG008|Overall Study|Lost to Follow-up|0|||
124932006|NCT05184452|449379777|FG009|Overall Study|Lost to Follow-up|1|||
124932007|NCT05184452|449379768|FG000|Overall Study|Withdrawal by Subject|0|||
124932008|NCT05184452|449379769|FG001|Overall Study|Withdrawal by Subject|0|||
124932009|NCT05184452|449379770|FG002|Overall Study|Withdrawal by Subject|0|||
124932010|NCT05184452|449379771|FG003|Overall Study|Withdrawal by Subject|0|||
124932011|NCT05184452|449379772|FG004|Overall Study|Withdrawal by Subject|0|||
124932012|NCT05184452|449379773|FG005|Overall Study|Withdrawal by Subject|1|||
124932013|NCT05184452|449379774|FG006|Overall Study|Withdrawal by Subject|0|||
124932014|NCT05184452|449379775|FG007|Overall Study|Withdrawal by Subject|0|||
124932015|NCT05184452|449379776|FG008|Overall Study|Withdrawal by Subject|0|||
124932016|NCT05184452|449379777|FG009|Overall Study|Withdrawal by Subject|1|||
124932017|NCT05586490|449379778|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
124932018|NCT05586490|449379779|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
124932019|NCT05586490|449379780|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
124932020|NCT05586490|449379781|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
124932021|NCT05586490|449379782|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
124932022|NCT05586490|449379778|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
124932023|NCT05586490|449379779|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
124932024|NCT05586490|449379780|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
124932025|NCT05586490|449379781|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
124932026|NCT05586490|449379782|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
124932027|NCT05586490|449379778|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
124932028|NCT05586490|449379779|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
124932029|NCT05586490|449379780|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
124932030|NCT05586490|449379781|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
124932031|NCT05586490|449379782|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
124932032|NCT04786119|449379783|FG000|Overall Study|Withdrawal by Subject|2|||
124932033|NCT05076266|449379784|FG000|Overall Study|Survey not complete - Participant refusal|2|||
124932034|NCT05076266|449379785|FG001|Overall Study|Survey not complete - Participant refusal|0|||
124932035|NCT05425420|449379786|FG000|Overall Study|Physician Decision|1|||
124932036|NCT05425420|449379786|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
124932037|NCT05280574|449379787|FG000|Overall Study|Withdrawal by Subject|0|||
124932038|NCT05280574|449379788|FG001|Overall Study|Withdrawal by Subject|2|||
124932039|NCT05280574|449379789|FG002|Overall Study|Withdrawal by Subject|0|||
124932040|NCT02361216|449379797|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
124932041|NCT02361216|449379798|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
124932042|NCT02361216|449379797|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
124932043|NCT02361216|449379798|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
124932044|NCT02361216|449379797|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
124932045|NCT02361216|449379798|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
124932046|NCT02361216|449379797|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
124932047|NCT02361216|449379798|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
124932048|NCT02361216|449379797|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
125025171|NCT01405053|449714845|FG000|Overall Study|Lost to Follow-up|0|||
125025172|NCT01405053|449714846|FG001|Overall Study|Lost to Follow-up|1|||
125025173|NCT01405053|449714845|FG000|Overall Study|Participant choice|2|||
125025174|NCT01405053|449714846|FG001|Overall Study|Participant choice|1|||
125025175|NCT01405053|449714845|FG000|Overall Study|Inadequate therapeutic effect|2|||
125025176|NCT01405053|449714846|FG001|Overall Study|Inadequate therapeutic effect|1|||
125025177|NCT01405053|449714845|FG000|Overall Study|Withdrawal by Subject|3|||
125025178|NCT01405053|449714846|FG001|Overall Study|Withdrawal by Subject|4|||
125025179|NCT01405053|449714845|FG000|Overall Study|Other|0|||
124932049|NCT02361216|449379798|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
124932050|NCT02361216|449379797|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
124932051|NCT02361216|449379798|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
124932052|NCT03505008|449379799|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
124932053|NCT03505008|449379800|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
125025180|NCT01405053|449714846|FG001|Overall Study|Other|1|||
125025181|NCT02551159|449714847|FG000|Overall Study|Death|352|||
125025182|NCT02551159|449714848|FG001|Overall Study|Death|174|||
124932054|NCT03505008|449379801|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
124932055|NCT03505008|449379802|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
124932056|NCT03505008|449379799|FG000|Before Week 24 Randomization|Adverse Event|10|||
124932057|NCT03505008|449379800|FG001|Before Week 24 Randomization|Adverse Event|0|||
124932058|NCT03505008|449379801|FG002|Before Week 24 Randomization|Adverse Event|0|||
124932059|NCT03505008|449379802|FG003|Before Week 24 Randomization|Adverse Event|0|||
124932060|NCT03505008|449379799|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
124932061|NCT03505008|449379800|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
124932062|NCT03505008|449379801|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
124932063|NCT03505008|449379802|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
124932064|NCT03505008|449379799|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
124932065|NCT03505008|449379800|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
124932066|NCT03505008|449379801|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
124932067|NCT03505008|449379802|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
124932068|NCT03505008|449379799|FG000|Before Week 24 Randomization|Physician Decision|2|||
124932069|NCT03505008|449379800|FG001|Before Week 24 Randomization|Physician Decision|0|||
124932070|NCT03505008|449379801|FG002|Before Week 24 Randomization|Physician Decision|0|||
124932071|NCT03505008|449379802|FG003|Before Week 24 Randomization|Physician Decision|0|||
124932072|NCT03505008|449379799|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
124932073|NCT03505008|449379800|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
124932074|NCT03505008|449379801|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
124932075|NCT03505008|449379802|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
124932076|NCT03505008|449379799|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
124932077|NCT03505008|449379800|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
124932078|NCT03505008|449379801|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
124932079|NCT03505008|449379802|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
124932080|NCT03505008|449379799|FG000|Before Week 24 Randomization|Complication|1|||
124932081|NCT03505008|449379800|FG001|Before Week 24 Randomization|Complication|0|||
124932082|NCT03505008|449379801|FG002|Before Week 24 Randomization|Complication|0|||
124932083|NCT03505008|449379802|FG003|Before Week 24 Randomization|Complication|0|||
124932084|NCT03505008|449379799|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
124932085|NCT03505008|449379800|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
124932086|NCT03505008|449379801|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
124932087|NCT03505008|449379802|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
124932088|NCT03505008|449379799|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
124932089|NCT03505008|449379800|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
124932090|NCT03505008|449379801|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
124932091|NCT03505008|449379802|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
124932092|NCT03505008|449379799|FG000|After Week 24 Randomization|Adverse Event|0|||
124932093|NCT03505008|449379800|FG001|After Week 24 Randomization|Adverse Event|1|||
124932094|NCT03505008|449379801|FG002|After Week 24 Randomization|Adverse Event|2|||
124932095|NCT03505008|449379802|FG003|After Week 24 Randomization|Adverse Event|2|||
124932096|NCT03505008|449379799|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
124932097|NCT03505008|449379800|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
124932098|NCT03505008|449379801|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
124932099|NCT03505008|449379802|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
124932100|NCT03505008|449379799|FG000|After Week 24 Randomization|Protocol Violation|0|||
124932101|NCT03505008|449379800|FG001|After Week 24 Randomization|Protocol Violation|0|||
124932102|NCT03505008|449379801|FG002|After Week 24 Randomization|Protocol Violation|1|||
124932103|NCT03505008|449379802|FG003|After Week 24 Randomization|Protocol Violation|0|||
124932104|NCT01730937|449379803|FG000|Overall Study|Protocol Violation|5|||
124932105|NCT01730937|449379804|FG001|Overall Study|Protocol Violation|11|||
124932106|NCT02988661|449379813|FG000|Overall Study|Death|2|||
124932107|NCT02988661|449379814|FG001|Overall Study|Death|18|||
124932108|NCT02988661|449379813|FG000|Overall Study|Lost to Follow-up|0|||
124932109|NCT02988661|449379814|FG001|Overall Study|Lost to Follow-up|33|||
124932110|NCT02988661|449379813|FG000|Overall Study|Withdrawal by Subject|0|||
124932111|NCT02988661|449379814|FG001|Overall Study|Withdrawal by Subject|6|||
124932112|NCT02988661|449379813|FG000|Overall Study|Unable to complete the 18-month survey|1|||
124932113|NCT02988661|449379814|FG001|Overall Study|Unable to complete the 18-month survey|27|||
124932114|NCT03213678|449379822|FG000|Overall Study|Death|1|||
124932115|NCT03213678|449379822|FG000|Overall Study|Physician Decision|1|||
124932116|NCT03213678|449379822|FG000|Overall Study|Progressive disease|16|||
124932117|NCT04218851|449379823|FG000|Overall Study|Death|1|||
124932118|NCT04218851|449379824|FG001|Overall Study|Death|3|||
124932119|NCT05645757|449382277|FG000|Overall Study|Enrolled but treatment not administered|0|||
124932120|NCT05645757|449382278|FG001|Overall Study|Enrolled but treatment not administered|0|||
124932121|NCT05645757|449382279|FG002|Overall Study|Enrolled but treatment not administered|0|||
124932122|NCT05645757|449382280|FG003|Overall Study|Enrolled but treatment not administered|0|||
124932123|NCT05645757|449382281|FG004|Overall Study|Enrolled but treatment not administered|1|||
124932124|NCT05645757|449382282|FG005|Overall Study|Enrolled but treatment not administered|1|||
124932125|NCT05645757|449382283|FG006|Overall Study|Enrolled but treatment not administered|0|||
124932126|NCT05645757|449382284|FG007|Overall Study|Enrolled but treatment not administered|0|||
124932127|NCT03924635|449382285|FG000|Overall Study|Withdrawal by Subject|2|||
124932128|NCT03924635|449382286|FG001|Overall Study|Withdrawal by Subject|4|||
124932129|NCT00539591|449382287|FG000|Overall Study|Toxicity|3|||
124932130|NCT00539591|449382288|FG001|Overall Study|Toxicity|0|||
124932131|NCT00539591|449382289|FG002|Overall Study|Toxicity|0|||
124932132|NCT00539591|449382287|FG000|Overall Study|Disease progression|2|||
124932133|NCT00539591|449382288|FG001|Overall Study|Disease progression|2|||
124932134|NCT00539591|449382289|FG002|Overall Study|Disease progression|3|||
124932135|NCT01960452|449382290|FG000|Overall Study|Withdrawal by Subject|2|||
124932136|NCT01960452|449382291|FG001|Overall Study|Withdrawal by Subject|1|||
124932137|NCT01960452|449382290|FG000|Overall Study|Sleep apnea in Night 1|1|||
124932138|NCT01960452|449382291|FG001|Overall Study|Sleep apnea in Night 1|0|||
124932139|NCT01960452|449382290|FG000|Overall Study|Poor Sleep in Night 1|0|||
124932140|NCT01960452|449382291|FG001|Overall Study|Poor Sleep in Night 1|2|||
124932141|NCT01960452|449382290|FG000|Overall Study|No Sex/Age Match Night 1|1|||
124932142|NCT01960452|449382291|FG001|Overall Study|No Sex/Age Match Night 1|0|||
124932143|NCT01960452|449382290|FG000|Overall Study|No Sex/Age Match Night 2|0|||
124932144|NCT01960452|449382291|FG001|Overall Study|No Sex/Age Match Night 2|2|||
124932145|NCT01960452|449382290|FG000|Overall Study|Technical Difficulties Night 2|2|||
124932146|NCT01960452|449382291|FG001|Overall Study|Technical Difficulties Night 2|0|||
124932147|NCT04414722|449382292|FG000|Overall Study|Lost to Follow-up|3|||
124932148|NCT04414722|449382293|FG001|Overall Study|Lost to Follow-up|4|||
124932149|NCT04414722|449382294|FG002|Overall Study|Lost to Follow-up|3|||
124932150|NCT04414722|449382295|FG003|Overall Study|Lost to Follow-up|2|||
124932151|NCT04414722|449382296|FG004|Overall Study|Lost to Follow-up|3|||
125025183|NCT02551159|449714849|FG002|Overall Study|Death|161|||
125025184|NCT02551159|449714847|FG000|Overall Study|Withdrawal by Subject|8|||
125025185|NCT02551159|449714848|FG001|Overall Study|Withdrawal by Subject|5|||
125025186|NCT02551159|449714849|FG002|Overall Study|Withdrawal by Subject|16|||
125025187|NCT02551159|449714847|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
125025188|NCT02551159|449714848|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
125025189|NCT02551159|449714849|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
125025190|NCT00268242|449714850|FG000|Overall Study|Death|1|||
125025191|NCT00993928|449714851|FG000|Overall Study|Withdrawal by Subject|4|||
125025192|NCT00993928|449714852|FG001|Overall Study|Withdrawal by Subject|7|||
125025193|NCT00993928|449714851|FG000|Overall Study|ineligible|1|||
125025194|NCT00993928|449714852|FG001|Overall Study|ineligible|0|||
125025195|NCT04871711|449714853|FG000|Overall Study|Withdrawal by Subject|11|||
125025196|NCT04871711|449714854|FG001|Overall Study|Withdrawal by Subject|5|||
125025197|NCT04871711|449714853|FG000|Overall Study|Lack of Efficacy|5|||
125025198|NCT04871711|449714854|FG001|Overall Study|Lack of Efficacy|7|||
125025199|NCT04871711|449714853|FG000|Overall Study|Adverse Event|2|||
125025200|NCT04871711|449714854|FG001|Overall Study|Adverse Event|6|||
125025201|NCT04871711|449714853|FG000|Overall Study|Various reasons|2|||
125025202|NCT04871711|449714854|FG001|Overall Study|Various reasons|1|||
125025203|NCT04871711|449714853|FG000|Overall Study|Lost to Follow-up|0|||
125025204|NCT04871711|449714854|FG001|Overall Study|Lost to Follow-up|2|||
125025205|NCT03551743|449714863|FG000|Overall Study|Adverse Event|1|||
125025206|NCT03551743|449714864|FG001|Overall Study|Adverse Event|0|||
125025207|NCT03551743|449714865|FG002|Overall Study|Adverse Event|0|||
125025208|NCT03551743|449714866|FG003|Overall Study|Adverse Event|0|||
125025209|NCT03551743|449714863|FG000|Overall Study|Withdrawal by Subject|1|||
125120661|NCT00947427|450065179|FG000|Overall Study|Withdrawal by Subject|1|||
125120662|NCT00947427|450065180|FG001|Overall Study|Withdrawal by Subject|3|||
125120663|NCT00947427|450065179|FG000|Overall Study|Protocol Violation|0|||
125120664|NCT00947427|450065180|FG001|Overall Study|Protocol Violation|1|||
125120665|NCT00865709|450065181|FG000|Treatment|Adverse Event|9|||
124932152|NCT04414722|449382292|FG000|Overall Study|Withdrawal by Subject|6|||
124932153|NCT04414722|449382293|FG001|Overall Study|Withdrawal by Subject|3|||
124932154|NCT04414722|449382294|FG002|Overall Study|Withdrawal by Subject|1|||
124932155|NCT04414722|449382295|FG003|Overall Study|Withdrawal by Subject|5|||
124932156|NCT04414722|449382296|FG004|Overall Study|Withdrawal by Subject|1|||
125025210|NCT03551743|449714864|FG001|Overall Study|Withdrawal by Subject|0|||
125025211|NCT03551743|449714865|FG002|Overall Study|Withdrawal by Subject|0|||
125025212|NCT03551743|449714866|FG003|Overall Study|Withdrawal by Subject|0|||
125025213|NCT00911989|449714867|FG000|Overall Study|Adverse Event|1|||
125120666|NCT00865709|450065182|FG001|Treatment|Adverse Event|6|||
125120667|NCT00865709|450065181|FG000|Treatment|Withdrawal by Subject|10|||
124932157|NCT04414722|449382292|FG000|Overall Study|Physician Decision|0|||
124932158|NCT04414722|449382293|FG001|Overall Study|Physician Decision|1|||
124932159|NCT04414722|449382294|FG002|Overall Study|Physician Decision|2|||
124932160|NCT04414722|449382295|FG003|Overall Study|Physician Decision|0|||
124932161|NCT04414722|449382296|FG004|Overall Study|Physician Decision|0|||
124932162|NCT04414722|449382292|FG000|Overall Study|Non-participatory|0|||
125025214|NCT04556617|449714873|FG000|Overall Study|progressive disease|0|||
125120668|NCT00865709|450065182|FG001|Treatment|Withdrawal by Subject|7|||
124932163|NCT04414722|449382293|FG001|Overall Study|Non-participatory|1|||
124932164|NCT04414722|449382294|FG002|Overall Study|Non-participatory|1|||
124932165|NCT04414722|449382295|FG003|Overall Study|Non-participatory|0|||
124932166|NCT04414722|449382296|FG004|Overall Study|Non-participatory|0|||
124932167|NCT03655028|449382299|FG000|12-weeks Follow up|Death|1|||
124932168|NCT03655028|449382300|FG001|12-weeks Follow up|Death|0|||
124932169|NCT03655028|449382299|FG000|12-weeks Follow up|Physician Decision|3|||
124932170|NCT03655028|449382300|FG001|12-weeks Follow up|Physician Decision|3|||
124932171|NCT03655028|449382299|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
124932172|NCT03655028|449382300|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
124932173|NCT03655028|449382299|FG000|12-weeks Follow up|Lost to Follow-up|4|||
124932174|NCT03655028|449382300|FG001|12-weeks Follow up|Lost to Follow-up|4|||
124932175|NCT03655028|449382299|FG000|24-weeks|Lost to Follow-up|1|||
124932176|NCT03655028|449382300|FG001|24-weeks|Lost to Follow-up|1|||
124932177|NCT03655028|449382299|FG000|24-weeks|Death|0|||
124932178|NCT03655028|449382300|FG001|24-weeks|Death|1|||
124932179|NCT03513302|449382301|FG000|First Intervention (14 Days)|Screen failure|15|||
124932180|NCT03513302|449382302|FG001|First Intervention (14 Days)|Screen failure|16|||
124932181|NCT05618587|449382303|FG000|Overall Study|Lost to Follow-up|2|||
124932182|NCT05618587|449382304|FG001|Overall Study|Lost to Follow-up|0|||
124932183|NCT03442309|449382309|FG000|Overall Study|Lost to Follow-up|1676|||
124932184|NCT03442309|449382310|FG001|Overall Study|Lost to Follow-up|1642|||
124932185|NCT04862416|449382311|FG000|Overall Study|Withdrawal by Subject|0|||
124932186|NCT04862416|449382312|FG001|Overall Study|Withdrawal by Subject|1|||
124932187|NCT04862416|449382313|FG002|Overall Study|Withdrawal by Subject|0|||
124932188|NCT04862416|449382314|FG003|Overall Study|Withdrawal by Subject|1|||
124932189|NCT04862416|449382315|FG004|Overall Study|Withdrawal by Subject|0|||
124932190|NCT04862416|449382316|FG005|Overall Study|Withdrawal by Subject|0|||
124932191|NCT04862416|449382317|FG006|Overall Study|Withdrawal by Subject|0|||
124932192|NCT04862416|449382318|FG007|Overall Study|Withdrawal by Subject|0|||
125025215|NCT04556617|449714874|FG001|Overall Study|progressive disease|2|||
125025216|NCT04556617|449714875|FG002|Overall Study|progressive disease|2|||
125025217|NCT04556617|449714876|FG003|Overall Study|progressive disease|1|||
124932193|NCT04862234|449382319|FG000|Overall Study|Surgery cancellation|1|||
124932194|NCT04862234|449382320|FG001|Overall Study|Surgery cancellation|2|||
125025218|NCT04556617|449714877|FG004|Overall Study|progressive disease|1|||
125025219|NCT04556617|449714873|FG000|Overall Study|Physician Decision|0|||
125025220|NCT04556617|449714874|FG001|Overall Study|Physician Decision|0|||
125025221|NCT04556617|449714875|FG002|Overall Study|Physician Decision|2|||
125025222|NCT04556617|449714876|FG003|Overall Study|Physician Decision|0|||
125025223|NCT04556617|449714877|FG004|Overall Study|Physician Decision|0|||
125025224|NCT04556617|449714873|FG000|Overall Study|Adverse Event|0|||
125025225|NCT04556617|449714874|FG001|Overall Study|Adverse Event|0|||
125025226|NCT04556617|449714875|FG002|Overall Study|Adverse Event|2|||
125025227|NCT04556617|449714876|FG003|Overall Study|Adverse Event|3|||
125025228|NCT04556617|449714877|FG004|Overall Study|Adverse Event|0|||
125025229|NCT04556617|449714873|FG000|Overall Study|Withdrawal by Subject|0|||
125025230|NCT04556617|449714874|FG001|Overall Study|Withdrawal by Subject|2|||
125025231|NCT04556617|449714875|FG002|Overall Study|Withdrawal by Subject|1|||
125025232|NCT04556617|449714876|FG003|Overall Study|Withdrawal by Subject|1|||
125025233|NCT04556617|449714877|FG004|Overall Study|Withdrawal by Subject|0|||
124932195|NCT04862234|449382319|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
124932196|NCT04862234|449382320|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
124932197|NCT04862234|449382319|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
124932198|NCT04862234|449382320|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
124932199|NCT03292484|449382326|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
124932200|NCT03292484|449382326|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
125025234|NCT04556617|449714873|FG000|Overall Study|PSA increase|0|||
125025235|NCT04556617|449714874|FG001|Overall Study|PSA increase|1|||
125025236|NCT04556617|449714875|FG002|Overall Study|PSA increase|0|||
124932201|NCT03292484|449382326|FG000|Overall Study|Protocol Violation|2|||
125025237|NCT04556617|449714876|FG003|Overall Study|PSA increase|0|||
124932202|NCT03292484|449382326|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
124932203|NCT03292484|449382326|FG000|Overall Study|Sponsor decision|349|||
124932204|NCT03292484|449382326|FG000|Overall Study|Lost to Follow-up|7|||
124932205|NCT03292484|449382326|FG000|Overall Study|Coronavirus Disease 2019|1|||
124932206|NCT03292484|449382326|FG000|Overall Study|Other|20|||
124932207|NCT05290493|449382327|FG000|Overall Study|Withdrawal by Subject|2|||
124932208|NCT05290493|449382328|FG001|Overall Study|Withdrawal by Subject|2|||
124932209|NCT05290493|449382327|FG000|Overall Study|Adverse Event|1|||
124932210|NCT05290493|449382328|FG001|Overall Study|Adverse Event|0|||
124932211|NCT03677141|449382332|FG000|Overall Study|Death|2|||
124932212|NCT03677141|449382333|FG001|Overall Study|Death|1|||
124932213|NCT03677141|449382334|FG002|Overall Study|Death|6|||
124932214|NCT03677141|449382335|FG003|Overall Study|Death|9|||
124932215|NCT03677141|449382336|FG004|Overall Study|Death|5|||
124932216|NCT03677141|449382337|FG005|Overall Study|Death|3|||
124932217|NCT03677141|449382332|FG000|Overall Study|Lost to Follow-up|0|||
124932218|NCT03677141|449382333|FG001|Overall Study|Lost to Follow-up|0|||
124932219|NCT03677141|449382334|FG002|Overall Study|Lost to Follow-up|0|||
124932220|NCT03677141|449382335|FG003|Overall Study|Lost to Follow-up|2|||
124932221|NCT03677141|449382336|FG004|Overall Study|Lost to Follow-up|0|||
124932222|NCT03677141|449382337|FG005|Overall Study|Lost to Follow-up|0|||
124932223|NCT03677141|449382332|FG000|Overall Study|Screen failure or enrolled in error|0|||
124932224|NCT03677141|449382333|FG001|Overall Study|Screen failure or enrolled in error|0|||
124932225|NCT03677141|449382334|FG002|Overall Study|Screen failure or enrolled in error|0|||
124932226|NCT03677141|449382335|FG003|Overall Study|Screen failure or enrolled in error|0|||
124932227|NCT03677141|449382336|FG004|Overall Study|Screen failure or enrolled in error|2|||
124932228|NCT03677141|449382337|FG005|Overall Study|Screen failure or enrolled in error|0|||
124932229|NCT03677141|449382332|FG000|Overall Study|Physician Decision|0|||
124932230|NCT03677141|449382333|FG001|Overall Study|Physician Decision|0|||
124932231|NCT03677141|449382334|FG002|Overall Study|Physician Decision|0|||
124932232|NCT03677141|449382335|FG003|Overall Study|Physician Decision|0|||
124932233|NCT03677141|449382336|FG004|Overall Study|Physician Decision|1|||
124932234|NCT03677141|449382337|FG005|Overall Study|Physician Decision|0|||
124932235|NCT03677141|449382332|FG000|Overall Study|Withdrawal by Subject|0|||
124932236|NCT03677141|449382333|FG001|Overall Study|Withdrawal by Subject|0|||
124932237|NCT03677141|449382334|FG002|Overall Study|Withdrawal by Subject|1|||
124932238|NCT03677141|449382335|FG003|Overall Study|Withdrawal by Subject|1|||
124932239|NCT03677141|449382336|FG004|Overall Study|Withdrawal by Subject|1|||
124932240|NCT03677141|449382337|FG005|Overall Study|Withdrawal by Subject|0|||
124932241|NCT05838027|449382341|FG000|Overall Study|Lost to Follow-up|5|||
124932242|NCT05838027|449382342|FG001|Overall Study|Lost to Follow-up|1|||
124932243|NCT05838027|449382341|FG000|Overall Study|Withdrawal by Subject|1|||
124932244|NCT05838027|449382342|FG001|Overall Study|Withdrawal by Subject|0|||
124932245|NCT04056611|449382346|FG000|Overall Study|Physician Decision|1|||
125025238|NCT04556617|449714877|FG004|Overall Study|PSA increase|0|||
125025239|NCT04556617|449714873|FG000|Overall Study|Sponsor study termination|1|||
125025240|NCT04556617|449714874|FG001|Overall Study|Sponsor study termination|0|||
125025241|NCT04556617|449714875|FG002|Overall Study|Sponsor study termination|0|||
125025242|NCT04556617|449714876|FG003|Overall Study|Sponsor study termination|0|||
125025243|NCT04556617|449714877|FG004|Overall Study|Sponsor study termination|0|||
125025244|NCT03179436|449714878|FG000|Overall Study|Withdrawal by Subject|1|||
125025245|NCT03179436|449714879|FG001|Overall Study|Withdrawal by Subject|0|||
125025246|NCT03179436|449714880|FG002|Overall Study|Withdrawal by Subject|0|||
125025247|NCT03179436|449714881|FG003|Overall Study|Withdrawal by Subject|4|||
125025248|NCT03179436|449714882|FG004|Overall Study|Withdrawal by Subject|2|||
125025249|NCT03179436|449714883|FG005|Overall Study|Withdrawal by Subject|2|||
125025250|NCT03179436|449714884|FG006|Overall Study|Withdrawal by Subject|5|||
125025251|NCT03179436|449714885|FG007|Overall Study|Withdrawal by Subject|0|||
125025252|NCT03179436|449714886|FG008|Overall Study|Withdrawal by Subject|3|||
125025253|NCT03179436|449714887|FG009|Overall Study|Withdrawal by Subject|0|||
125025254|NCT03179436|449714888|FG010|Overall Study|Withdrawal by Subject|0|||
125025255|NCT03179436|449714889|FG011|Overall Study|Withdrawal by Subject|0|||
125025256|NCT03179436|449714878|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125025257|NCT03179436|449714879|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125025258|NCT03179436|449714880|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
125025259|NCT03179436|449714881|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
125025260|NCT03179436|449714882|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
125025261|NCT03179436|449714883|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
124932246|NCT02631746|449382349|FG000|Overall Study|Lack of Efficacy|3|||
124932247|NCT04571619|449382350|FG000|Phase 1|Death|22|||
124932248|NCT04571619|449382351|FG001|Phase 1|Death|18|||
124932249|NCT04571619|449382350|FG000|Phase 1|Withdrawal by Subject|7|||
124932250|NCT04571619|449382351|FG001|Phase 1|Withdrawal by Subject|2|||
125025262|NCT03179436|449714884|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
125025263|NCT03179436|449714885|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
124932251|NCT04571619|449382350|FG000|Phase 2|Death|13|||
124932252|NCT04571619|449382351|FG001|Phase 2|Death|16|||
124932253|NCT04571619|449382350|FG000|Phase 2|Withdrawal by Subject|6|||
124932254|NCT04571619|449382351|FG001|Phase 2|Withdrawal by Subject|4|||
124932255|NCT04709419|449382353|FG000|Overall Study|Physician Decision|1|||
124932256|NCT04709419|449382354|FG001|Overall Study|Physician Decision|0|||
124932257|NCT05683340|449382355|FG000|Overall Study|Adverse Event|1|||
124932258|NCT05683340|449382356|FG001|Overall Study|Adverse Event|1|||
124932259|NCT05683340|449382355|FG000|Overall Study|Protocol Violation|1|||
124932260|NCT05683340|449382356|FG001|Overall Study|Protocol Violation|0|||
124932261|NCT05683340|449382355|FG000|Overall Study|Withdrawal by Subject|0|||
124932262|NCT05683340|449382356|FG001|Overall Study|Withdrawal by Subject|2|||
124932263|NCT02224144|449382357|FG000|Overall Study|Lost to Follow-up|3|||
124932264|NCT02224144|449382358|FG001|Overall Study|Lost to Follow-up|1|||
124932265|NCT02224144|449382357|FG000|Overall Study|Death|2|||
124932266|NCT02224144|449382358|FG001|Overall Study|Death|0|||
124932267|NCT02224144|449382357|FG000|Overall Study|Withdrawal by Subject|0|||
124932268|NCT02224144|449382358|FG001|Overall Study|Withdrawal by Subject|1|||
124932269|NCT02962076|449382361|FG000|Overall Study|MHED tracer not available|5|||
124932270|NCT02962076|449382361|FG000|Overall Study|Protocol Violation|1|||
124932271|NCT02962076|449382361|FG000|Overall Study|Physician Decision|1|||
124932272|NCT04741776|449382362|FG000|Overall Study|Withdrawal by Subject|7|||
124932273|NCT04741776|449382363|FG001|Overall Study|Withdrawal by Subject|10|||
124932274|NCT04741776|449382364|FG002|Overall Study|Withdrawal by Subject|10|||
124932275|NCT04741776|449382365|FG003|Overall Study|Withdrawal by Subject|17|||
124932276|NCT04741776|449382362|FG000|Overall Study|Death|0|||
124932277|NCT04741776|449382363|FG001|Overall Study|Death|0|||
124932278|NCT04741776|449382364|FG002|Overall Study|Death|1|||
124932279|NCT04741776|449382365|FG003|Overall Study|Death|0|||
124932280|NCT04089865|449382366|FG000|Overall Study|Withdrawal by Subject|2|||
124932281|NCT04089865|449382367|FG001|Overall Study|Withdrawal by Subject|2|||
124932282|NCT04089865|449382368|FG002|Overall Study|Withdrawal by Subject|7|||
124932283|NCT04089865|449382369|FG003|Overall Study|Withdrawal by Subject|2|||
124932284|NCT02780700|449382379|FG000|Overall Study|Progressive disease|1|||
124932285|NCT03824366|449382394|FG000|Overall Study|Death|1|||
124932286|NCT03824366|449382394|FG000|Overall Study|Previously unidentified metal artifact|1|||
124932287|NCT03824366|449382394|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
124932288|NCT03824366|449382394|FG000|Overall Study|Withdrawal by Subject|1|||
124932289|NCT05069896|449382401|FG000|Overall Study|Adverse Event|0|||
124932290|NCT05069896|449382402|FG001|Overall Study|Adverse Event|1|||
124932291|NCT05069896|449382403|FG002|Overall Study|Adverse Event|1|||
124932292|NCT05069896|449382404|FG003|Overall Study|Adverse Event|0|||
124932293|NCT05069896|449382405|FG004|Overall Study|Adverse Event|0|||
124932294|NCT05069896|449382406|FG005|Overall Study|Adverse Event|0|||
124932295|NCT05069896|449382401|FG000|Overall Study|Lost to Follow-up|0|||
124932296|NCT05069896|449382402|FG001|Overall Study|Lost to Follow-up|0|||
124932297|NCT05069896|449382403|FG002|Overall Study|Lost to Follow-up|1|||
124932298|NCT05069896|449382404|FG003|Overall Study|Lost to Follow-up|0|||
124932299|NCT05069896|449382405|FG004|Overall Study|Lost to Follow-up|1|||
124932300|NCT05069896|449382406|FG005|Overall Study|Lost to Follow-up|2|||
124932301|NCT04068831|449382407|FG000|Overall Study|Disease Progression|10|||
124932302|NCT04068831|449382408|FG001|Overall Study|Disease Progression|8|||
124932303|NCT04820322|449382409|FG000|Overall Study|Adverse Event|1|||
124932304|NCT04820322|449382410|FG001|Overall Study|Adverse Event|0|||
124932305|NCT00323856|449382414|FG000|Overall Study|Withdrawal by Subject|1|||
124932306|NCT00323856|449382414|FG000|Overall Study|Was uncooperative and noncompliant|1|||
124932307|NCT00323856|449382414|FG000|Overall Study|Reason not specified|1|||
124932308|NCT00323856|449382414|FG000|Overall Study|Missing|2|||
124932309|NCT03156465|449382420|FG000|Overall Study|Withdrawal by Subject|2|||
124932310|NCT05715528|449382430|FG000|Overall Study|Randomized but never treated|11|||
124932311|NCT05715528|449382431|FG001|Overall Study|Randomized but never treated|13|||
124932312|NCT05715528|449382430|FG000|Overall Study|Withdrew consent|7|||
124932313|NCT05715528|449382431|FG001|Overall Study|Withdrew consent|15|||
124932314|NCT05715528|449382430|FG000|Overall Study|Lost to Follow-up|5|||
124932315|NCT05715528|449382431|FG001|Overall Study|Lost to Follow-up|13|||
124932316|NCT05715528|449382430|FG000|Overall Study|Investigator's discretion|3|||
124932317|NCT05715528|449382431|FG001|Overall Study|Investigator's discretion|1|||
124932318|NCT05715528|449382430|FG000|Overall Study|Protocol Violation|2|||
124932319|NCT05715528|449382431|FG001|Overall Study|Protocol Violation|0|||
124932320|NCT05715528|449382430|FG000|Overall Study|Non-compliance with study drug|0|||
124932321|NCT05715528|449382431|FG001|Overall Study|Non-compliance with study drug|1|||
124932322|NCT03485729|449382435|FG000|Overall Study|Withdrawal by Subject|0|||
124932323|NCT03485729|449382436|FG001|Overall Study|Withdrawal by Subject|0|||
124932324|NCT03485729|449382437|FG002|Overall Study|Withdrawal by Subject|1|||
124932325|NCT03485729|449382435|FG000|Overall Study|Disease progression|8|||
124932326|NCT03485729|449382436|FG001|Overall Study|Disease progression|13|||
124932327|NCT03485729|449382437|FG002|Overall Study|Disease progression|1|||
124932328|NCT03485729|449382435|FG000|Overall Study|Hospice care|1|||
124932329|NCT03485729|449382436|FG001|Overall Study|Hospice care|0|||
124932330|NCT03485729|449382437|FG002|Overall Study|Hospice care|0|||
124932331|NCT03485729|449382435|FG000|Overall Study|Poor performance status|1|||
124932332|NCT03485729|449382436|FG001|Overall Study|Poor performance status|0|||
124932333|NCT03485729|449382437|FG002|Overall Study|Poor performance status|0|||
124932334|NCT03485729|449382435|FG000|Overall Study|Illness|0|||
124932335|NCT03485729|449382436|FG001|Overall Study|Illness|1|||
124932336|NCT03485729|449382437|FG002|Overall Study|Illness|0|||
124932337|NCT05035654|449382439|FG000|Overall Study|Physician Decision|0|||
124932338|NCT05035654|449382440|FG001|Overall Study|Physician Decision|1|||
124932339|NCT05035654|449382441|FG002|Overall Study|Physician Decision|0|||
124932340|NCT05035654|449382439|FG000|Overall Study|Adverse Event|0|||
124932341|NCT05035654|449382440|FG001|Overall Study|Adverse Event|1|||
124932342|NCT05035654|449382441|FG002|Overall Study|Adverse Event|0|||
124932343|NCT05035654|449382439|FG000|Overall Study|Withdrawal by Subject|0|||
124932344|NCT05035654|449382440|FG001|Overall Study|Withdrawal by Subject|0|||
124932345|NCT05035654|449382441|FG002|Overall Study|Withdrawal by Subject|4|||
124932346|NCT05035654|449382439|FG000|Overall Study|Bilateral Dislodgement|1|||
124932347|NCT05035654|449382440|FG001|Overall Study|Bilateral Dislodgement|0|||
124932348|NCT05035654|449382441|FG002|Overall Study|Bilateral Dislodgement|0|||
124932349|NCT04880733|449382442|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
124932350|NCT04880733|449382443|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
124932351|NCT04880733|449382444|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
124932352|NCT04880733|449382442|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
124932353|NCT04880733|449382443|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
124932354|NCT04880733|449382444|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
124932355|NCT04880733|449382442|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
124932356|NCT04880733|449382443|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
124932357|NCT04880733|449382444|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
124932358|NCT04880733|449382442|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
124932359|NCT04880733|449382443|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
124932360|NCT04880733|449382444|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
124932361|NCT04880733|449382442|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
124932362|NCT04880733|449382443|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
124932363|NCT04880733|449382444|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
124932364|NCT04934072|449382446|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
124932365|NCT04934072|449382447|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
124932366|NCT04934072|449382448|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
124932367|NCT04934072|449382449|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
124932368|NCT04934072|449382450|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
124932369|NCT04934072|449382446|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
124932370|NCT04934072|449382447|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
124932371|NCT04934072|449382448|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
124932372|NCT04934072|449382449|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
124932373|NCT04934072|449382450|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
124932374|NCT04934072|449382446|FG000|Day 0 to Week 52|Other|3|||
124932375|NCT04934072|449382447|FG001|Day 0 to Week 52|Other|1|||
124932376|NCT04934072|449382448|FG002|Day 0 to Week 52|Other|0|||
124932377|NCT04934072|449382449|FG003|Day 0 to Week 52|Other|0|||
124932378|NCT04934072|449382450|FG004|Day 0 to Week 52|Other|0|||
124932379|NCT04934072|449382446|FG000|Day 0 to Week 52|Adverse Event|1|||
124932380|NCT04934072|449382447|FG001|Day 0 to Week 52|Adverse Event|3|||
125025264|NCT03179436|449714886|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
125025265|NCT03179436|449714887|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
125025266|NCT03179436|449714888|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
125025267|NCT03179436|449714889|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
124932381|NCT04934072|449382448|FG002|Day 0 to Week 52|Adverse Event|0|||
124932382|NCT04934072|449382449|FG003|Day 0 to Week 52|Adverse Event|0|||
124932383|NCT04934072|449382450|FG004|Day 0 to Week 52|Adverse Event|0|||
124932384|NCT04934072|449382446|FG000|Week 52 to Week 78|Adverse Event|0|||
124932385|NCT04934072|449382447|FG001|Week 52 to Week 78|Adverse Event|0|||
124932386|NCT04934072|449382448|FG002|Week 52 to Week 78|Adverse Event|0|||
124932387|NCT04934072|449382449|FG003|Week 52 to Week 78|Adverse Event|1|||
124932388|NCT04934072|449382450|FG004|Week 52 to Week 78|Adverse Event|1|||
124932389|NCT04934072|449382446|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
124932390|NCT04934072|449382447|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
124932391|NCT04934072|449382448|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
125025268|NCT03179436|449714878|FG000|Overall Study|Sponsor Decision|0|||
125025269|NCT03179436|449714879|FG001|Overall Study|Sponsor Decision|0|||
124932392|NCT04934072|449382449|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
124932393|NCT04934072|449382450|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
124932394|NCT04934072|449382446|FG000|Week 52 to Week 78|Other|0|||
124932395|NCT04934072|449382447|FG001|Week 52 to Week 78|Other|0|||
124932396|NCT04934072|449382448|FG002|Week 52 to Week 78|Other|1|||
124932397|NCT04934072|449382449|FG003|Week 52 to Week 78|Other|0|||
124932398|NCT04934072|449382450|FG004|Week 52 to Week 78|Other|0|||
124932399|NCT03174275|449382452|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
124932400|NCT03174275|449382452|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
124932401|NCT03174275|449382452|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
124932402|NCT03174275|449382452|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
124932403|NCT03174275|449382452|FG000|Adjuvant Chemotherapy|Progression|1|||
124932404|NCT03174275|449382452|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
124932405|NCT03174275|449382452|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
124932406|NCT03174275|449382452|FG000|Adjuvant Durvalumab|Progression|1|||
124932407|NCT03174275|449382452|FG000|Adjuvant Durvalumab|Adverse Event|3|||
124932408|NCT03174275|449382452|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
124932409|NCT03174275|449382452|FG000|Adjuvant Radiotherapy|Progression|1|||
124932410|NCT03174275|449382452|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
124932411|NCT04456296|449382453|FG000|Overall Study|Withdrawal by Subject|14|||
124932412|NCT04456296|449382454|FG001|Overall Study|Withdrawal by Subject|21|||
124932413|NCT04456296|449382455|FG002|Overall Study|Withdrawal by Subject|21|||
124932414|NCT04456296|449382453|FG000|Overall Study|Adverse Event|2|||
124932415|NCT04456296|449382454|FG001|Overall Study|Adverse Event|2|||
124932416|NCT04456296|449382455|FG002|Overall Study|Adverse Event|2|||
124932417|NCT04456296|449382453|FG000|Overall Study|Death|1|||
124932418|NCT04456296|449382454|FG001|Overall Study|Death|0|||
124932419|NCT04456296|449382455|FG002|Overall Study|Death|0|||
124932420|NCT04456296|449382453|FG000|Overall Study|Lost to Follow-up|3|||
124932421|NCT04456296|449382454|FG001|Overall Study|Lost to Follow-up|5|||
124932422|NCT04456296|449382455|FG002|Overall Study|Lost to Follow-up|6|||
124932423|NCT04456296|449382453|FG000|Overall Study|Other than specified|0|||
124932424|NCT04456296|449382454|FG001|Overall Study|Other than specified|1|||
124932425|NCT04456296|449382455|FG002|Overall Study|Other than specified|4|||
124932426|NCT04456296|449382453|FG000|Overall Study|Randomized, not treated|2|||
124932427|NCT04456296|449382454|FG001|Overall Study|Randomized, not treated|1|||
124932428|NCT04456296|449382455|FG002|Overall Study|Randomized, not treated|0|||
124932429|NCT02997202|449382456|FG000|Overall Study|Miscellaneous|2|||
124932430|NCT02997202|449382457|FG001|Overall Study|Miscellaneous|2|||
124932431|NCT02997202|449382456|FG000|Overall Study|Withdrawal by Subject|8|||
124932432|NCT02997202|449382457|FG001|Overall Study|Withdrawal by Subject|12|||
124932433|NCT02997202|449382456|FG000|Overall Study|Lost to Follow-up|5|||
124932434|NCT02997202|449382457|FG001|Overall Study|Lost to Follow-up|3|||
124932435|NCT02997202|449382456|FG000|Overall Study|Death|41|||
124932436|NCT02997202|449382457|FG001|Overall Study|Death|45|||
124932437|NCT04271046|449382459|FG000|Overall Study|Death|0|||
124932438|NCT04271046|449382460|FG001|Overall Study|Death|2|||
124932439|NCT04271046|449382461|FG002|Overall Study|Death|0|||
124932440|NCT04271046|449382462|FG003|Overall Study|Death|2|||
124932441|NCT04271046|449382459|FG000|Overall Study|Lost to Follow-up|12|||
124932442|NCT04271046|449382460|FG001|Overall Study|Lost to Follow-up|12|||
124932443|NCT04271046|449382461|FG002|Overall Study|Lost to Follow-up|11|||
124932444|NCT04271046|449382462|FG003|Overall Study|Lost to Follow-up|11|||
124932445|NCT04271046|449382459|FG000|Overall Study|Patient with Dementia Died|2|||
124932446|NCT04271046|449382460|FG001|Overall Study|Patient with Dementia Died|0|||
124932447|NCT04271046|449382461|FG002|Overall Study|Patient with Dementia Died|2|||
124932448|NCT04271046|449382462|FG003|Overall Study|Patient with Dementia Died|0|||
124932449|NCT04271046|449382459|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
124932450|NCT04271046|449382460|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
124932451|NCT04271046|449382461|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
124932452|NCT04271046|449382462|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
124932453|NCT00303459|449382463|FG000|Overall Study|Death|33|||
124932454|NCT00303459|449382464|FG001|Overall Study|Death|44|||
124932455|NCT00303459|449382463|FG000|Overall Study|Withdrawal of consent|32|||
124932456|NCT00303459|449382464|FG001|Overall Study|Withdrawal of consent|26|||
124932457|NCT00303459|449382463|FG000|Overall Study|Lost to Follow-up|5|||
124932458|NCT00303459|449382464|FG001|Overall Study|Lost to Follow-up|4|||
124932459|NCT00303459|449382463|FG000|Overall Study|Administrative reason|7|||
124932460|NCT00303459|449382464|FG001|Overall Study|Administrative reason|7|||
124932461|NCT00303459|449382463|FG000|Overall Study|Decision by the investigator|5|||
124932462|NCT00303459|449382464|FG001|Overall Study|Decision by the investigator|7|||
124932463|NCT00303459|449382463|FG000|Overall Study|Lung transplantation|1|||
124932464|NCT00303459|449382464|FG001|Overall Study|Lung transplantation|1|||
124932465|NCT01570361|449382465|FG000|Overall Study|Subject discontinued|1|||
124932466|NCT01570361|449382466|FG001|Overall Study|Subject discontinued|2|||
124932467|NCT01570361|449382465|FG000|Overall Study|Sponsor closing the study|51|||
124932468|NCT01570361|449382466|FG001|Overall Study|Sponsor closing the study|50|||
125025270|NCT03179436|449714880|FG002|Overall Study|Sponsor Decision|1|||
125025271|NCT03179436|449714881|FG003|Overall Study|Sponsor Decision|3|||
125025272|NCT03179436|449714882|FG004|Overall Study|Sponsor Decision|9|||
125025273|NCT03179436|449714883|FG005|Overall Study|Sponsor Decision|7|||
125025274|NCT03179436|449714884|FG006|Overall Study|Sponsor Decision|2|||
125025275|NCT03179436|449714885|FG007|Overall Study|Sponsor Decision|4|||
125025276|NCT03179436|449714886|FG008|Overall Study|Sponsor Decision|23|||
125025277|NCT03179436|449714887|FG009|Overall Study|Sponsor Decision|6|||
125025278|NCT03179436|449714888|FG010|Overall Study|Sponsor Decision|7|||
125025279|NCT03179436|449714889|FG011|Overall Study|Sponsor Decision|5|||
125025280|NCT03179436|449714878|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
125025281|NCT03179436|449714879|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
125025282|NCT03179436|449714880|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
125025283|NCT03179436|449714881|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
125025284|NCT03179436|449714882|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
125025285|NCT03179436|449714883|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
125025286|NCT03179436|449714884|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
125120669|NCT00865709|450065181|FG000|Treatment|Physician Decision|3|||
125120670|NCT00865709|450065182|FG001|Treatment|Physician Decision|2|||
125120671|NCT00865709|450065181|FG000|Treatment|Surgery|8|||
125120672|NCT00865709|450065182|FG001|Treatment|Surgery|3|||
125120673|NCT00429923|450065183|FG000|Overall Study|Adverse Event|0|||
125120674|NCT00429923|450065184|FG001|Overall Study|Adverse Event|2|||
125120675|NCT00429923|450065185|FG002|Overall Study|Adverse Event|3|||
125120676|NCT00429923|450065183|FG000|Overall Study|Lack of Efficacy|4|||
125120677|NCT00429923|450065184|FG001|Overall Study|Lack of Efficacy|1|||
125120678|NCT00429923|450065185|FG002|Overall Study|Lack of Efficacy|33|||
125120679|NCT00429923|450065183|FG000|Overall Study|Lost to Follow-up|0|||
125120680|NCT00429923|450065184|FG001|Overall Study|Lost to Follow-up|0|||
125120681|NCT00429923|450065185|FG002|Overall Study|Lost to Follow-up|2|||
125120682|NCT00429923|450065183|FG000|Overall Study|Withdrew Consent|1|||
125120683|NCT00429923|450065184|FG001|Overall Study|Withdrew Consent|0|||
125120684|NCT00429923|450065185|FG002|Overall Study|Withdrew Consent|1|||
125120685|NCT00429923|450065183|FG000|Overall Study|Early Termination|0|||
125120686|NCT00429923|450065184|FG001|Overall Study|Early Termination|1|||
125120687|NCT00429923|450065185|FG002|Overall Study|Early Termination|0|||
125120688|NCT00662129|450065190|FG000|Overall Study|Protocol Violation|1|||
125120689|NCT00662129|450065190|FG000|Overall Study|Cancel prior to beginning treatment|1|||
125120690|NCT00662129|450065190|FG000|Overall Study|Ineligible|1|||
125120691|NCT02153736|450065191|FG000|Overall Study|Lost to Follow-up|1|||
125120692|NCT02153736|450065192|FG001|Overall Study|Lost to Follow-up|0|||
125120693|NCT02153736|450065191|FG000|Overall Study|Medical status change made ineligible|1|||
125120694|NCT02153736|450065192|FG001|Overall Study|Medical status change made ineligible|0|||
125120695|NCT02153736|450065191|FG000|Overall Study|Death|0|||
125120696|NCT02153736|450065192|FG001|Overall Study|Death|1|||
125120697|NCT02153736|450065191|FG000|Overall Study|Withdrawal by Subject|0|||
125120698|NCT02153736|450065192|FG001|Overall Study|Withdrawal by Subject|1|||
125120699|NCT00720122|450065205|FG000|Overall Study|Lost to Follow-up|1|||
125120700|NCT00720122|450065205|FG000|Overall Study|Physician Decision|1|||
125120701|NCT00720122|450065205|FG000|Overall Study|Withdrawal by Subject|7|||
125120702|NCT02579096|450065206|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
125120703|NCT02579096|450065207|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
125120704|NCT02579096|450065206|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
125120705|NCT02579096|450065207|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
125120706|NCT02579096|450065206|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
125025287|NCT03179436|449714885|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
125025288|NCT03179436|449714886|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
125025289|NCT03179436|449714887|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
125025290|NCT03179436|449714888|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
125025291|NCT03179436|449714889|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
125120707|NCT02579096|450065207|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
125120708|NCT02579096|450065206|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
125120709|NCT02579096|450065207|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
125025292|NCT03179436|449714878|FG000|Overall Study|Lost to Follow-up|1|||
125120710|NCT02579096|450065206|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
125120711|NCT02579096|450065207|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
125120712|NCT02579096|450065206|FG000|Phase 2, Weeks 25 - 48|Death|2|||
125120713|NCT02579096|450065207|FG001|Phase 2, Weeks 25 - 48|Death|4|||
125120714|NCT02579096|450065206|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
125120715|NCT02579096|450065207|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
125120716|NCT02579096|450065206|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
125120717|NCT02579096|450065207|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
125120718|NCT02579096|450065206|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
125120719|NCT02579096|450065207|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
124932469|NCT01570361|449382465|FG000|Overall Study|Subject excluded|5|||
124932470|NCT01570361|449382466|FG001|Overall Study|Subject excluded|3|||
124932471|NCT01570361|449382465|FG000|Overall Study|Subject withdrew consent|14|||
124932472|NCT01570361|449382466|FG001|Overall Study|Subject withdrew consent|9|||
124932473|NCT01570361|449382465|FG000|Overall Study|Adverse Event|2|||
124932474|NCT01570361|449382466|FG001|Overall Study|Adverse Event|1|||
124932475|NCT01570361|449382465|FG000|Overall Study|Lost to Follow-up|4|||
124932476|NCT01570361|449382466|FG001|Overall Study|Lost to Follow-up|4|||
124932477|NCT01570361|449382465|FG000|Overall Study|Death|5|||
124932478|NCT01570361|449382466|FG001|Overall Study|Death|4|||
124932479|NCT01570361|449382465|FG000|Overall Study|Other|0|||
124932480|NCT01570361|449382466|FG001|Overall Study|Other|2|||
124932481|NCT04129554|449382467|FG000|Overall Study|Withdrawal by Subject|4|||
124932482|NCT04129554|449382468|FG001|Overall Study|Withdrawal by Subject|3|||
124932483|NCT04129554|449382467|FG000|Overall Study|Other|0|||
124932484|NCT04129554|449382468|FG001|Overall Study|Other|2|||
124932485|NCT03993392|449382476|FG000|Overall Study|Withdrawal by Subject|3|||
124932486|NCT03993392|449382476|FG000|Overall Study|Lost to Follow-up|2|||
124932487|NCT03993392|449382476|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
124932488|NCT05962814|449382481|FG000|Overall Study|failed eligibility|1|||
124932489|NCT04826471|449384461|FG000|Overall Study|Lost to Follow-up|2|||
124932490|NCT04826471|449384461|FG000|Overall Study|Protocol Violation|3|||
124932491|NCT04826471|449384461|FG000|Overall Study|Withdrawal by Subject|1|||
124932492|NCT04304144|449384463|FG000|DLT Observation Period|Physician Decision|0|||
124932493|NCT04304144|449384464|FG001|DLT Observation Period|Physician Decision|1|||
124932494|NCT04304144|449384465|FG002|DLT Observation Period|Physician Decision|0|||
124932495|NCT04304144|449384466|FG003|DLT Observation Period|Physician Decision|0|||
124932496|NCT04304144|449384463|FG000|Continued Treatment Period|Adverse Event|0|||
124932497|NCT04304144|449384464|FG001|Continued Treatment Period|Adverse Event|1|||
124932498|NCT04304144|449384465|FG002|Continued Treatment Period|Adverse Event|0|||
124932499|NCT04304144|449384466|FG003|Continued Treatment Period|Adverse Event|0|||
124932500|NCT04304144|449384463|FG000|Continued Treatment Period|Death|0|||
124932501|NCT04304144|449384464|FG001|Continued Treatment Period|Death|0|||
124932502|NCT04304144|449384465|FG002|Continued Treatment Period|Death|1|||
124932503|NCT04304144|449384466|FG003|Continued Treatment Period|Death|2|||
124932504|NCT04304144|449384463|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
124932505|NCT04304144|449384464|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
124932506|NCT04304144|449384465|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
124932507|NCT04304144|449384466|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
124932508|NCT04304144|449384463|FG000|Continued Treatment Period|Other than specified|2|||
124932509|NCT04304144|449384464|FG001|Continued Treatment Period|Other than specified|0|||
124932510|NCT04304144|449384465|FG002|Continued Treatment Period|Other than specified|1|||
124932511|NCT04304144|449384466|FG003|Continued Treatment Period|Other than specified|1|||
124932512|NCT04615273|449384469|FG000|Overall Study|Withdrawal by Subject|3|||
124932513|NCT04615273|449384470|FG001|Overall Study|Withdrawal by Subject|1|||
124932514|NCT04615273|449384471|FG002|Overall Study|Withdrawal by Subject|2|||
124932515|NCT04615273|449384469|FG000|Overall Study|Adverse Event|1|||
124932516|NCT04615273|449384470|FG001|Overall Study|Adverse Event|0|||
124932517|NCT04615273|449384471|FG002|Overall Study|Adverse Event|1|||
124932518|NCT04615273|449384469|FG000|Overall Study|Lost to Follow-up|0|||
124932519|NCT04615273|449384470|FG001|Overall Study|Lost to Follow-up|1|||
124932520|NCT04615273|449384471|FG002|Overall Study|Lost to Follow-up|0|||
124932521|NCT04615273|449384469|FG000|Overall Study|Physician Decision|0|||
124932522|NCT04615273|449384470|FG001|Overall Study|Physician Decision|0|||
124932523|NCT04615273|449384471|FG002|Overall Study|Physician Decision|1|||
124932524|NCT04615273|449384469|FG000|Overall Study|Other|0|||
124932525|NCT04615273|449384470|FG001|Overall Study|Other|1|||
124932526|NCT04615273|449384471|FG002|Overall Study|Other|0|||
124932527|NCT04615273|449384469|FG000|Overall Study|Randomized but not treated|1|||
124932528|NCT04615273|449384470|FG001|Overall Study|Randomized but not treated|3|||
124932529|NCT04615273|449384471|FG002|Overall Study|Randomized but not treated|1|||
124932530|NCT03673501|449384474|FG000|Overall Study|Participants ongoing.|36|||
124932531|NCT03673501|449384475|FG001|Overall Study|Participants ongoing.|24|||
124932532|NCT04599634|449384476|FG000|Overall Study|Dose limiting toxicity|0|||
124932533|NCT04599634|449384477|FG001|Overall Study|Dose limiting toxicity|0|||
124932534|NCT04599634|449384478|FG002|Overall Study|Dose limiting toxicity|2|||
124932535|NCT04599634|449384479|FG003|Overall Study|Dose limiting toxicity|0|||
124932536|NCT03714815|449384480|FG000|Overall Study|Physician Decision|2|||
124932537|NCT03714815|449384480|FG000|Overall Study|Withdrawal by Subject|2|||
124932538|NCT03714815|449384480|FG000|Overall Study|Death|11|||
124932539|NCT04999111|449384481|FG000|Overall Study|Lost to Follow-up|21|||
124932540|NCT04999111|449384482|FG001|Overall Study|Lost to Follow-up|16|||
124932541|NCT04999111|449384483|FG002|Overall Study|Lost to Follow-up|2|||
124932542|NCT04999111|449384484|FG003|Overall Study|Lost to Follow-up|26|||
124932543|NCT04999111|449384485|FG004|Overall Study|Lost to Follow-up|30|||
124932544|NCT04999111|449384486|FG005|Overall Study|Lost to Follow-up|6|||
124932545|NCT04999111|449384481|FG000|Overall Study|Physician Decision|1|||
124932546|NCT04999111|449384482|FG001|Overall Study|Physician Decision|3|||
124932547|NCT04999111|449384483|FG002|Overall Study|Physician Decision|0|||
124932548|NCT04999111|449384484|FG003|Overall Study|Physician Decision|1|||
124932549|NCT04999111|449384485|FG004|Overall Study|Physician Decision|2|||
124932550|NCT04999111|449384486|FG005|Overall Study|Physician Decision|0|||
124932551|NCT04999111|449384481|FG000|Overall Study|Withdrawal by Subject|23|||
124932552|NCT04999111|449384482|FG001|Overall Study|Withdrawal by Subject|29|||
124932553|NCT04999111|449384483|FG002|Overall Study|Withdrawal by Subject|15|||
124932554|NCT04999111|449384484|FG003|Overall Study|Withdrawal by Subject|30|||
124932555|NCT04999111|449384485|FG004|Overall Study|Withdrawal by Subject|35|||
124932556|NCT04999111|449384486|FG005|Overall Study|Withdrawal by Subject|10|||
124932557|NCT04999111|449384481|FG000|Overall Study|Other|6|||
124932558|NCT04999111|449384482|FG001|Overall Study|Other|6|||
124932559|NCT04999111|449384483|FG002|Overall Study|Other|3|||
124932560|NCT04999111|449384484|FG003|Overall Study|Other|8|||
124932561|NCT04999111|449384485|FG004|Overall Study|Other|8|||
124932562|NCT04999111|449384486|FG005|Overall Study|Other|5|||
124932563|NCT04999111|449384481|FG000|Overall Study|Non-compliance with study schedule|1|||
124932564|NCT04999111|449384482|FG001|Overall Study|Non-compliance with study schedule|0|||
124932565|NCT04999111|449384483|FG002|Overall Study|Non-compliance with study schedule|0|||
124932566|NCT04999111|449384484|FG003|Overall Study|Non-compliance with study schedule|1|||
124932567|NCT04999111|449384485|FG004|Overall Study|Non-compliance with study schedule|1|||
124932568|NCT04999111|449384486|FG005|Overall Study|Non-compliance with study schedule|1|||
124932569|NCT04999111|449384481|FG000|Overall Study|Randomized but not vaccinated|1|||
124932570|NCT04999111|449384482|FG001|Overall Study|Randomized but not vaccinated|2|||
124932571|NCT04999111|449384483|FG002|Overall Study|Randomized but not vaccinated|0|||
124932572|NCT04999111|449384484|FG003|Overall Study|Randomized but not vaccinated|3|||
124932573|NCT04999111|449384485|FG004|Overall Study|Randomized but not vaccinated|3|||
124932574|NCT04999111|449384486|FG005|Overall Study|Randomized but not vaccinated|0|||
124932575|NCT04999111|449384481|FG000|Overall Study|Adverse Event|1|||
124932576|NCT04999111|449384482|FG001|Overall Study|Adverse Event|1|||
124932577|NCT04999111|449384483|FG002|Overall Study|Adverse Event|0|||
124932578|NCT04999111|449384484|FG003|Overall Study|Adverse Event|0|||
124932579|NCT04999111|449384485|FG004|Overall Study|Adverse Event|0|||
124932580|NCT04999111|449384486|FG005|Overall Study|Adverse Event|0|||
124932581|NCT04999111|449384481|FG000|Overall Study|Initiated prohibited medication|0|||
124932582|NCT04999111|449384482|FG001|Overall Study|Initiated prohibited medication|0|||
124932583|NCT04999111|449384483|FG002|Overall Study|Initiated prohibited medication|0|||
124932584|NCT04999111|449384484|FG003|Overall Study|Initiated prohibited medication|0|||
124932585|NCT04999111|449384485|FG004|Overall Study|Initiated prohibited medication|1|||
124932586|NCT04999111|449384486|FG005|Overall Study|Initiated prohibited medication|0|||
124932587|NCT01314105|449384490|FG000|Overall Study|Progressive Disease|6|||
124932588|NCT01314105|449384491|FG001|Overall Study|Progressive Disease|10|||
124932589|NCT01314105|449384490|FG000|Overall Study|Refused to continue taking medication|0|||
124932590|NCT01314105|449384491|FG001|Overall Study|Refused to continue taking medication|1|||
125120720|NCT02579096|450065206|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
125120721|NCT02579096|450065207|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
125120722|NCT02579096|450065206|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
125120723|NCT02579096|450065207|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
124932591|NCT01314105|449384490|FG000|Overall Study|Other Adverse Event|1|||
124932592|NCT01314105|449384491|FG001|Overall Study|Other Adverse Event|1|||
124932593|NCT02056834|449384492|FG000|Overall Study|Lost to Follow-up|7|||
124932594|NCT06106022|449384493|FG000|Overall Study|Lost to Follow-up|1|||
124932595|NCT06106022|449384494|FG001|Overall Study|Lost to Follow-up|0|||
124932596|NCT06106022|449384493|FG000|Overall Study|Voluntary Withdrawal|0|||
124932597|NCT06106022|449384494|FG001|Overall Study|Voluntary Withdrawal|2|||
125120724|NCT02579096|450065206|FG000|Phase 3, Weeks 49 - 72|Death|3|||
124932598|NCT03276676|449384496|FG000|Overall Study|Withdrawal by Subject|2|||
124932599|NCT03276676|449384497|FG001|Overall Study|Withdrawal by Subject|1|||
124932600|NCT03926130|449384500|FG000|Overall Study|Adverse Event|9|||
125120725|NCT02579096|450065207|FG001|Phase 3, Weeks 49 - 72|Death|2|||
124932601|NCT03926130|449384501|FG001|Overall Study|Adverse Event|11|||
124932602|NCT03926130|449384502|FG002|Overall Study|Adverse Event|2|||
124932603|NCT03926130|449384503|FG003|Overall Study|Adverse Event|0|||
124932604|NCT03926130|449384500|FG000|Overall Study|Death|2|||
124932605|NCT03926130|449384501|FG001|Overall Study|Death|0|||
124932606|NCT03926130|449384502|FG002|Overall Study|Death|1|||
124932607|NCT03926130|449384503|FG003|Overall Study|Death|0|||
124932608|NCT03926130|449384500|FG000|Overall Study|Lack of Efficacy|14|||
124932609|NCT03926130|449384501|FG001|Overall Study|Lack of Efficacy|11|||
124932610|NCT03926130|449384502|FG002|Overall Study|Lack of Efficacy|7|||
124932611|NCT03926130|449384503|FG003|Overall Study|Lack of Efficacy|1|||
124932612|NCT03926130|449384500|FG000|Overall Study|Lost to Follow-up|0|||
124932613|NCT03926130|449384501|FG001|Overall Study|Lost to Follow-up|7|||
124932614|NCT03926130|449384502|FG002|Overall Study|Lost to Follow-up|1|||
124932615|NCT03926130|449384503|FG003|Overall Study|Lost to Follow-up|0|||
124932616|NCT03926130|449384500|FG000|Overall Study|As Reported by Investigator|2|||
124932617|NCT03926130|449384501|FG001|Overall Study|As Reported by Investigator|6|||
124932618|NCT03926130|449384502|FG002|Overall Study|As Reported by Investigator|6|||
124932619|NCT03926130|449384503|FG003|Overall Study|As Reported by Investigator|0|||
124932620|NCT03926130|449384500|FG000|Overall Study|Physician Decision|3|||
124932621|NCT03926130|449384501|FG001|Overall Study|Physician Decision|2|||
124932622|NCT03926130|449384502|FG002|Overall Study|Physician Decision|1|||
124932623|NCT03926130|449384503|FG003|Overall Study|Physician Decision|0|||
124932624|NCT03926130|449384500|FG000|Overall Study|Pregnancy|2|||
124932625|NCT03926130|449384501|FG001|Overall Study|Pregnancy|2|||
124932626|NCT03926130|449384502|FG002|Overall Study|Pregnancy|1|||
124932627|NCT03926130|449384503|FG003|Overall Study|Pregnancy|0|||
124932628|NCT03926130|449384500|FG000|Overall Study|Withdrawal by Subject|20|||
125120726|NCT02579096|450065206|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
125120727|NCT02579096|450065207|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
125120728|NCT02579096|450065206|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
125120729|NCT02579096|450065207|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
125120730|NCT02579096|450065206|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
125120731|NCT02579096|450065207|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
125120732|NCT02579096|450065206|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
125120733|NCT02579096|450065207|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
125131402|NCT03818581|450109961|FG001|Overall Study|Withdrawal by Subject|0|||
124932629|NCT03926130|449384501|FG001|Overall Study|Withdrawal by Subject|28|||
124932630|NCT03926130|449384502|FG002|Overall Study|Withdrawal by Subject|18|||
124932631|NCT03926130|449384503|FG003|Overall Study|Withdrawal by Subject|1|||
124932632|NCT03926130|449384500|FG000|Overall Study|Non-Compliance|1|||
124932633|NCT03926130|449384501|FG001|Overall Study|Non-Compliance|1|||
124932634|NCT03926130|449384502|FG002|Overall Study|Non-Compliance|0|||
124932635|NCT03926130|449384503|FG003|Overall Study|Non-Compliance|0|||
124932636|NCT03926130|449384500|FG000|Overall Study|Disposition Not Captured|0|||
124932637|NCT03926130|449384501|FG001|Overall Study|Disposition Not Captured|2|||
124932638|NCT03926130|449384502|FG002|Overall Study|Disposition Not Captured|1|||
124932639|NCT03926130|449384503|FG003|Overall Study|Disposition Not Captured|0|||
124932640|NCT03583333|449384504|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
124969582|NCT03520075|449517419|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969583|NCT03520075|449517420|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969584|NCT03520075|449517421|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969585|NCT03520075|449517422|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969586|NCT03520075|449517423|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
124969587|NCT03520075|449517424|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
124969588|NCT03520075|449517425|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
124969589|NCT03520075|449517426|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
124969590|NCT03520075|449517427|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
124969591|NCT03520075|449517409|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969592|NCT03520075|449517410|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969593|NCT03520075|449517411|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969594|NCT03520075|449517412|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969595|NCT03520075|449517413|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969596|NCT03520075|449517414|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969597|NCT03520075|449517415|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124932641|NCT03583333|449384505|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
124932642|NCT03583333|449384504|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
124932643|NCT03583333|449384505|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
124932644|NCT03583333|449384504|FG000|Overall Study|Withdrawal by Subject|9|||
124932645|NCT03583333|449384505|FG001|Overall Study|Withdrawal by Subject|5|||
124932646|NCT03583333|449384504|FG000|Overall Study|Physician Decision|3|||
124932647|NCT03583333|449384505|FG001|Overall Study|Physician Decision|2|||
124932648|NCT03583333|449384504|FG000|Overall Study|Death|12|||
124932649|NCT03583333|449384505|FG001|Overall Study|Death|7|||
124932650|NCT04469270|449384506|FG000|Overall Study|Adverse Event|2|||
124932651|NCT04469270|449384507|FG001|Overall Study|Adverse Event|0|||
124932652|NCT04469270|449384506|FG000|Overall Study|Lost to Follow-up|4|||
124932653|NCT04469270|449384507|FG001|Overall Study|Lost to Follow-up|3|||
124932654|NCT04469270|449384506|FG000|Overall Study|Withdrawal by Subject|7|||
124932655|NCT04469270|449384507|FG001|Overall Study|Withdrawal by Subject|3|||
124932656|NCT04469270|449384506|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
124932657|NCT04469270|449384507|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
124932658|NCT04469270|449384506|FG000|Overall Study|missing|1|||
124932659|NCT04469270|449384507|FG001|Overall Study|missing|0|||
124932660|NCT04086121|449384513|FG000|Overall Study|Other than listed|8|||
124932661|NCT04086121|449384513|FG000|Overall Study|Withdrawal by Subject|3|||
124932662|NCT04086121|449384513|FG000|Overall Study|Lost to Follow-up|2|||
124932663|NCT04086121|449384513|FG000|Overall Study|Adverse Event|1|||
124932664|NCT04580914|449384516|FG000|Overall Study|Withdrawal by Subject|6|||
124932665|NCT04580914|449384516|FG000|Overall Study|Lost to Follow-up|2|||
124932666|NCT03580356|449384517|FG000|Treatment Period|Withdrawal by Subject|13|||
124932667|NCT03580356|449384518|FG001|Treatment Period|Withdrawal by Subject|0|||
124932668|NCT03580356|449384519|FG002|Treatment Period|Withdrawal by Subject|13|||
124932669|NCT03580356|449384520|FG003|Treatment Period|Withdrawal by Subject|1|||
124932670|NCT03580356|449384521|FG004|Treatment Period|Withdrawal by Subject|17|||
124932671|NCT03580356|449384522|FG005|Treatment Period|Withdrawal by Subject|0|||
124932672|NCT03580356|449384523|FG006|Treatment Period|Withdrawal by Subject|5|||
124932673|NCT03580356|449384524|FG007|Treatment Period|Withdrawal by Subject|0|||
124932674|NCT03580356|449384517|FG000|Treatment Period|Adverse Event|10|||
124932675|NCT03580356|449384518|FG001|Treatment Period|Adverse Event|0|||
124932676|NCT03580356|449384519|FG002|Treatment Period|Adverse Event|13|||
124932677|NCT03580356|449384520|FG003|Treatment Period|Adverse Event|0|||
124932678|NCT03580356|449384521|FG004|Treatment Period|Adverse Event|5|||
124932679|NCT03580356|449384522|FG005|Treatment Period|Adverse Event|0|||
124932680|NCT03580356|449384523|FG006|Treatment Period|Adverse Event|8|||
124932681|NCT03580356|449384524|FG007|Treatment Period|Adverse Event|0|||
124932682|NCT03580356|449384517|FG000|Treatment Period|Protocol Violation|5|||
124932683|NCT03580356|449384518|FG001|Treatment Period|Protocol Violation|0|||
124932684|NCT03580356|449384519|FG002|Treatment Period|Protocol Violation|6|||
124932685|NCT03580356|449384520|FG003|Treatment Period|Protocol Violation|1|||
124932686|NCT03580356|449384521|FG004|Treatment Period|Protocol Violation|9|||
124932687|NCT03580356|449384522|FG005|Treatment Period|Protocol Violation|1|||
124932688|NCT03580356|449384523|FG006|Treatment Period|Protocol Violation|1|||
124932689|NCT03580356|449384524|FG007|Treatment Period|Protocol Violation|0|||
124932690|NCT03580356|449384517|FG000|Treatment Period|Lack of Efficacy|6|||
124932691|NCT03580356|449384518|FG001|Treatment Period|Lack of Efficacy|0|||
124932692|NCT03580356|449384519|FG002|Treatment Period|Lack of Efficacy|2|||
124932693|NCT03580356|449384520|FG003|Treatment Period|Lack of Efficacy|0|||
124932694|NCT03580356|449384521|FG004|Treatment Period|Lack of Efficacy|3|||
124932695|NCT03580356|449384522|FG005|Treatment Period|Lack of Efficacy|0|||
124932696|NCT03580356|449384523|FG006|Treatment Period|Lack of Efficacy|3|||
124932697|NCT03580356|449384524|FG007|Treatment Period|Lack of Efficacy|0|||
124932698|NCT03580356|449384517|FG000|Treatment Period|Pregnancy|1|||
124932699|NCT03580356|449384518|FG001|Treatment Period|Pregnancy|0|||
124932700|NCT03580356|449384519|FG002|Treatment Period|Pregnancy|7|||
124932701|NCT03580356|449384520|FG003|Treatment Period|Pregnancy|0|||
124932702|NCT03580356|449384521|FG004|Treatment Period|Pregnancy|2|||
124932703|NCT03580356|449384522|FG005|Treatment Period|Pregnancy|0|||
124932704|NCT03580356|449384523|FG006|Treatment Period|Pregnancy|1|||
124932705|NCT03580356|449384524|FG007|Treatment Period|Pregnancy|0|||
124932706|NCT03580356|449384517|FG000|Treatment Period|Physician Decision|2|||
124932707|NCT03580356|449384518|FG001|Treatment Period|Physician Decision|0|||
124932708|NCT03580356|449384519|FG002|Treatment Period|Physician Decision|1|||
124932709|NCT03580356|449384520|FG003|Treatment Period|Physician Decision|0|||
124932710|NCT03580356|449384521|FG004|Treatment Period|Physician Decision|4|||
124932711|NCT03580356|449384522|FG005|Treatment Period|Physician Decision|0|||
124932712|NCT03580356|449384523|FG006|Treatment Period|Physician Decision|2|||
124932713|NCT03580356|449384524|FG007|Treatment Period|Physician Decision|0|||
124932714|NCT03580356|449384517|FG000|Treatment Period|Lost to Follow-up|1|||
124932715|NCT03580356|449384518|FG001|Treatment Period|Lost to Follow-up|1|||
124932716|NCT03580356|449384519|FG002|Treatment Period|Lost to Follow-up|1|||
124932717|NCT03580356|449384520|FG003|Treatment Period|Lost to Follow-up|0|||
125025293|NCT03179436|449714879|FG001|Overall Study|Lost to Follow-up|0|||
125025294|NCT03179436|449714880|FG002|Overall Study|Lost to Follow-up|0|||
125025295|NCT03179436|449714881|FG003|Overall Study|Lost to Follow-up|1|||
125025296|NCT03179436|449714882|FG004|Overall Study|Lost to Follow-up|0|||
125025297|NCT03179436|449714883|FG005|Overall Study|Lost to Follow-up|1|||
125025298|NCT03179436|449714884|FG006|Overall Study|Lost to Follow-up|0|||
125025299|NCT03179436|449714885|FG007|Overall Study|Lost to Follow-up|0|||
125025300|NCT03179436|449714886|FG008|Overall Study|Lost to Follow-up|1|||
125025301|NCT03179436|449714887|FG009|Overall Study|Lost to Follow-up|1|||
125025302|NCT03179436|449714888|FG010|Overall Study|Lost to Follow-up|0|||
125025303|NCT03179436|449714889|FG011|Overall Study|Lost to Follow-up|0|||
125025304|NCT03179436|449714878|FG000|Overall Study|Death|12|||
125025305|NCT03179436|449714879|FG001|Overall Study|Death|17|||
125025306|NCT03179436|449714880|FG002|Overall Study|Death|7|||
125025307|NCT03179436|449714881|FG003|Overall Study|Death|32|||
125025308|NCT03179436|449714882|FG004|Overall Study|Death|29|||
125025309|NCT03179436|449714883|FG005|Overall Study|Death|30|||
125025310|NCT03179436|449714884|FG006|Overall Study|Death|33|||
125025311|NCT03179436|449714885|FG007|Overall Study|Death|9|||
125025312|NCT03179436|449714886|FG008|Overall Study|Death|84|||
125025313|NCT03179436|449714887|FG009|Overall Study|Death|33|||
124932718|NCT03580356|449384521|FG004|Treatment Period|Lost to Follow-up|3|||
124932719|NCT03580356|449384522|FG005|Treatment Period|Lost to Follow-up|0|||
124932720|NCT03580356|449384523|FG006|Treatment Period|Lost to Follow-up|1|||
124932721|NCT03580356|449384524|FG007|Treatment Period|Lost to Follow-up|0|||
124932722|NCT03580356|449384517|FG000|Treatment Period|Death|0|||
124932723|NCT03580356|449384518|FG001|Treatment Period|Death|0|||
124932724|NCT03580356|449384519|FG002|Treatment Period|Death|1|||
124932725|NCT03580356|449384520|FG003|Treatment Period|Death|0|||
124932726|NCT03580356|449384521|FG004|Treatment Period|Death|0|||
124932727|NCT03580356|449384522|FG005|Treatment Period|Death|0|||
124932728|NCT03580356|449384523|FG006|Treatment Period|Death|0|||
124932729|NCT03580356|449384524|FG007|Treatment Period|Death|0|||
124932730|NCT03580356|449384517|FG000|Treatment Period|Technical problems|0|||
124932731|NCT03580356|449384518|FG001|Treatment Period|Technical problems|0|||
124932732|NCT03580356|449384519|FG002|Treatment Period|Technical problems|0|||
124932733|NCT03580356|449384520|FG003|Treatment Period|Technical problems|0|||
124932734|NCT03580356|449384521|FG004|Treatment Period|Technical problems|1|||
124932735|NCT03580356|449384522|FG005|Treatment Period|Technical problems|0|||
124932736|NCT03580356|449384523|FG006|Treatment Period|Technical problems|0|||
124932737|NCT03580356|449384524|FG007|Treatment Period|Technical problems|0|||
124932738|NCT03580356|449384517|FG000|Treatment Period|Misrandomized, no treatment|0|||
124932739|NCT03580356|449384518|FG001|Treatment Period|Misrandomized, no treatment|0|||
124932740|NCT03580356|449384519|FG002|Treatment Period|Misrandomized, no treatment|1|||
124932741|NCT03580356|449384520|FG003|Treatment Period|Misrandomized, no treatment|0|||
124932742|NCT03580356|449384521|FG004|Treatment Period|Misrandomized, no treatment|2|||
124932743|NCT03580356|449384522|FG005|Treatment Period|Misrandomized, no treatment|0|||
124932744|NCT03580356|449384523|FG006|Treatment Period|Misrandomized, no treatment|0|||
124932745|NCT03580356|449384524|FG007|Treatment Period|Misrandomized, no treatment|0|||
124932746|NCT03580356|449384517|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
124932747|NCT03580356|449384518|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
124932748|NCT03580356|449384519|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
124932749|NCT03580356|449384520|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
124932750|NCT03580356|449384521|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
124932751|NCT03580356|449384522|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
124932752|NCT03580356|449384523|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
124932753|NCT03580356|449384524|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
124932754|NCT03580356|449384517|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
124932755|NCT03580356|449384518|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
124932756|NCT03580356|449384519|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
125025314|NCT03179436|449714888|FG010|Overall Study|Death|22|||
125025315|NCT03179436|449714889|FG011|Overall Study|Death|15|||
125025316|NCT01877083|449714893|FG000|Treatment Phase|Disease Progression|10|||
125025317|NCT01877083|449714893|FG000|Treatment Phase|Clinical Progression|1|||
124932757|NCT03580356|449384520|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
124932758|NCT03580356|449384521|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
124932759|NCT03580356|449384522|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
124932760|NCT03580356|449384523|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
125025318|NCT01877083|449714893|FG000|Treatment Phase|Adverse Event|6|||
125025319|NCT01877083|449714893|FG000|Treatment Phase|Withdrawal by Subject|2|||
125025320|NCT01877083|449714893|FG000|Treatment Phase|Lost to Follow-up|1|||
125025321|NCT01877083|449714893|FG000|Extension Phase|Disease Progression|3|||
125025322|NCT01877083|449714893|FG000|Extension Phase|Adverse Event|2|||
125025323|NCT00500682|449714896|FG000|Overall Study|Adverse Event|37|||
125025324|NCT00500682|449714897|FG001|Overall Study|Adverse Event|29|||
125025325|NCT00500682|449714896|FG000|Overall Study|Death|25|||
125025326|NCT00500682|449714897|FG001|Overall Study|Death|16|||
125025327|NCT00500682|449714896|FG000|Overall Study|Lost to Follow-up|11|||
125025328|NCT00500682|449714897|FG001|Overall Study|Lost to Follow-up|11|||
125025329|NCT00500682|449714896|FG000|Overall Study|Physician Decision|6|||
125025330|NCT00500682|449714897|FG001|Overall Study|Physician Decision|10|||
125025331|NCT00500682|449714896|FG000|Overall Study|Pregnancy|2|||
125025332|NCT00500682|449714897|FG001|Overall Study|Pregnancy|0|||
125025333|NCT00500682|449714896|FG000|Overall Study|Protocol Violation|1|||
125025334|NCT00500682|449714897|FG001|Overall Study|Protocol Violation|3|||
125025335|NCT00500682|449714896|FG000|Overall Study|Withdrawal by Subject|80|||
125025336|NCT00500682|449714897|FG001|Overall Study|Withdrawal by Subject|74|||
125025337|NCT00500682|449714896|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
125025338|NCT00500682|449714897|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
125025339|NCT00429585|449714900|FG000|Overall Study|Death|1|||
125025340|NCT00429585|449714901|FG001|Overall Study|Death|0|||
125025341|NCT00429585|449714900|FG000|Overall Study|Lost to Follow-up|27|||
125025342|NCT00429585|449714901|FG001|Overall Study|Lost to Follow-up|20|||
125120734|NCT02579096|450065206|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
125120735|NCT02579096|450065207|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
125120736|NCT02579096|450065206|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
125120737|NCT02579096|450065207|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
125120738|NCT01361126|450065208|FG000|Overall Study|Sponsor decision|0|||
125120739|NCT01361126|450065209|FG001|Overall Study|Sponsor decision|2|||
125120740|NCT00663871|450065211|FG000|Overall Study|Lost to Follow-up|5|||
125120741|NCT00663871|450065212|FG001|Overall Study|Lost to Follow-up|5|||
125120742|NCT00663871|450065211|FG000|Overall Study|Withdrawal by Subject|5|||
125120743|NCT00663871|450065212|FG001|Overall Study|Withdrawal by Subject|2|||
125120744|NCT02742181|450065213|FG000|Overall Study|Physician Decision|1|||
125120745|NCT02742181|450065214|FG001|Overall Study|Physician Decision|0|||
125120746|NCT02946385|450066943|FG000|Overall Study|Lost to Follow-up|0|||
125120747|NCT02946385|450066944|FG001|Overall Study|Lost to Follow-up|0|||
125120748|NCT02946385|450066945|FG002|Overall Study|Lost to Follow-up|3|||
125120749|NCT02946385|450066946|FG003|Overall Study|Lost to Follow-up|0|||
125120750|NCT02946385|450066947|FG004|Overall Study|Lost to Follow-up|2|||
125120751|NCT02946385|450066948|FG005|Overall Study|Lost to Follow-up|1|||
125120752|NCT00313703|450066949|FG000|Overall Study|Lost to Follow-up|11|||
125120753|NCT00313703|450066950|FG001|Overall Study|Lost to Follow-up|2|||
125120754|NCT00313703|450066951|FG002|Overall Study|Lost to Follow-up|5|||
125120755|NCT00313703|450066952|FG003|Overall Study|Lost to Follow-up|12|||
125120756|NCT01060670|450066953|FG000|Run In|screen failure|0|||
125120757|NCT01060670|450066954|FG001|Run In|screen failure|238|||
125120758|NCT03519256|450066959|FG000|Overall Study|Disease recurrence|4|||
125120759|NCT03519256|450066960|FG001|Overall Study|Disease recurrence|4|||
125120760|NCT03519256|450066961|FG002|Overall Study|Disease recurrence|5|||
125120761|NCT03519256|450066962|FG003|Overall Study|Disease recurrence|2|||
125120762|NCT03519256|450066959|FG000|Overall Study|Study drug toxicity|0|||
125120763|NCT03519256|450066960|FG001|Overall Study|Study drug toxicity|2|||
125120764|NCT03519256|450066961|FG002|Overall Study|Study drug toxicity|5|||
125120765|NCT03519256|450066962|FG003|Overall Study|Study drug toxicity|2|||
125120766|NCT03519256|450066959|FG000|Overall Study|Adverse event unrelated to study drug|0|||
125120767|NCT03519256|450066960|FG001|Overall Study|Adverse event unrelated to study drug|1|||
125120768|NCT03519256|450066961|FG002|Overall Study|Adverse event unrelated to study drug|1|||
125120769|NCT03519256|450066962|FG003|Overall Study|Adverse event unrelated to study drug|0|||
125025343|NCT00429585|449714900|FG000|Overall Study|Physician Decision|2|||
125025344|NCT00429585|449714901|FG001|Overall Study|Physician Decision|0|||
125025345|NCT01582308|449714902|FG000|Period 1|Withdrawal by Subject|0|||
125025346|NCT01582308|449714903|FG001|Period 1|Withdrawal by Subject|0|||
125025347|NCT01582308|449714904|FG002|Period 1|Withdrawal by Subject|0|||
125025348|NCT01582308|449714905|FG003|Period 1|Withdrawal by Subject|0|||
125025349|NCT01582308|449714906|FG004|Period 1|Withdrawal by Subject|0|||
125025350|NCT01582308|449714907|FG005|Period 1|Withdrawal by Subject|0|||
125120770|NCT03519256|450066959|FG000|Overall Study|Participant request to discontinue study treatment|0|||
125120771|NCT03519256|450066960|FG001|Overall Study|Participant request to discontinue study treatment|0|||
124932761|NCT03580356|449384524|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
124932762|NCT03580356|449384517|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
124932763|NCT03580356|449384518|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
124932764|NCT03580356|449384519|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
124932765|NCT03580356|449384520|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
124932766|NCT03580356|449384521|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
124932767|NCT03580356|449384522|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
124932768|NCT03580356|449384523|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
124932769|NCT03580356|449384524|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
124932770|NCT03580356|449384517|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
124932771|NCT03580356|449384518|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
124932772|NCT03580356|449384519|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
124932773|NCT03580356|449384520|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
124932774|NCT03580356|449384521|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
124932775|NCT03580356|449384522|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
124932776|NCT03580356|449384523|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
124932777|NCT03580356|449384524|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
124932778|NCT03580356|449384517|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
124932779|NCT03580356|449384518|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
124932780|NCT03580356|449384519|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
124932781|NCT03580356|449384520|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
124932782|NCT03580356|449384521|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
124932783|NCT03580356|449384522|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
124932784|NCT03580356|449384523|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
124932785|NCT03580356|449384524|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
124932786|NCT03580356|449384517|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
124932787|NCT03580356|449384518|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
124932788|NCT03580356|449384519|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
124932789|NCT03580356|449384520|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
124932790|NCT03580356|449384521|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
124932791|NCT03580356|449384522|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
124932792|NCT03580356|449384523|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
124932793|NCT03580356|449384524|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
124932794|NCT03580356|449384517|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
124932795|NCT03580356|449384518|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
124932796|NCT03580356|449384519|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
124932797|NCT03580356|449384520|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
124932798|NCT03580356|449384521|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
124932799|NCT03580356|449384522|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
124932800|NCT03580356|449384523|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
124932801|NCT03580356|449384524|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
124932802|NCT03118518|449384526|FG000|Overall Study|Early Exit after treatment|2|||
124932803|NCT03118518|449384527|FG001|Overall Study|Early Exit after treatment|8|||
124932804|NCT03118518|449384526|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
124932805|NCT03118518|449384527|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
124932806|NCT03536884|449384531|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
124932807|NCT03536884|449384532|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
124932808|NCT03536884|449384533|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
124932809|NCT03536884|449384534|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
124932810|NCT03536884|449384535|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
124932811|NCT03536884|449384536|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
124932812|NCT03536884|449384537|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
124932813|NCT03536884|449384538|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
124932814|NCT03536884|449384539|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
124932815|NCT03536884|449384540|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
124932816|NCT03536884|449384541|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
124932817|NCT03536884|449384542|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
124932818|NCT03536884|449384531|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932819|NCT03536884|449384532|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
124932820|NCT03536884|449384533|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932821|NCT03536884|449384534|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932822|NCT03536884|449384535|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932823|NCT03536884|449384536|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932824|NCT03536884|449384537|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932825|NCT03536884|449384538|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932826|NCT03536884|449384539|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932827|NCT03536884|449384540|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932828|NCT03536884|449384541|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932829|NCT03536884|449384542|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932830|NCT03536884|449384531|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
124932831|NCT03536884|449384532|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
124932832|NCT03536884|449384533|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
124932833|NCT03536884|449384534|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
124932834|NCT03536884|449384535|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
124932835|NCT03536884|449384536|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
124932836|NCT03536884|449384537|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
124932837|NCT03536884|449384538|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
124932838|NCT03536884|449384539|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
124932839|NCT03536884|449384540|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
124932840|NCT03536884|449384541|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
124932841|NCT03536884|449384542|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
124932842|NCT03536884|449384531|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932843|NCT03536884|449384532|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
124932844|NCT03536884|449384533|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932845|NCT03536884|449384534|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932846|NCT03536884|449384535|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932847|NCT03536884|449384536|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932848|NCT03536884|449384537|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932849|NCT03536884|449384538|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932850|NCT03536884|449384539|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932851|NCT03536884|449384540|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932852|NCT03536884|449384541|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932853|NCT03536884|449384542|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932854|NCT03536884|449384531|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932855|NCT03536884|449384532|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
124932856|NCT03536884|449384533|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932857|NCT03536884|449384534|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932858|NCT03536884|449384535|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932859|NCT03536884|449384536|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932860|NCT03536884|449384537|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932861|NCT03536884|449384538|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932862|NCT03536884|449384539|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932863|NCT03536884|449384540|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932864|NCT03536884|449384541|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932865|NCT03536884|449384542|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932866|NCT03536884|449384531|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
124932867|NCT03536884|449384532|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
124932868|NCT03536884|449384533|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
124932869|NCT03536884|449384534|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
124932870|NCT03536884|449384535|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
124932871|NCT03536884|449384536|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
125025351|NCT01582308|449714908|FG006|Period 1|Withdrawal by Subject|1|||
125025352|NCT01582308|449714909|FG007|Period 1|Withdrawal by Subject|0|||
125025353|NCT01582308|449714910|FG008|Period 1|Withdrawal by Subject|0|||
125025354|NCT01582308|449714911|FG009|Period 1|Withdrawal by Subject|0|||
125025355|NCT01582308|449714902|FG000|10-day Washout Following Period 1|Physician Decision|0|||
125025356|NCT01582308|449714903|FG001|10-day Washout Following Period 1|Physician Decision|0|||
125025357|NCT01582308|449714904|FG002|10-day Washout Following Period 1|Physician Decision|0|||
125025358|NCT01582308|449714905|FG003|10-day Washout Following Period 1|Physician Decision|0|||
125025359|NCT01582308|449714906|FG004|10-day Washout Following Period 1|Physician Decision|1|||
125025360|NCT01582308|449714907|FG005|10-day Washout Following Period 1|Physician Decision|0|||
125025361|NCT01582308|449714908|FG006|10-day Washout Following Period 1|Physician Decision|0|||
125025362|NCT01582308|449714909|FG007|10-day Washout Following Period 1|Physician Decision|0|||
125025363|NCT01582308|449714910|FG008|10-day Washout Following Period 1|Physician Decision|0|||
125025364|NCT01582308|449714911|FG009|10-day Washout Following Period 1|Physician Decision|0|||
125025365|NCT01582308|449714902|FG000|Period 4|Physician Decision|1|||
125025366|NCT01582308|449714903|FG001|Period 4|Physician Decision|0|||
125025367|NCT01582308|449714904|FG002|Period 4|Physician Decision|0|||
125025368|NCT01582308|449714905|FG003|Period 4|Physician Decision|0|||
125025369|NCT01582308|449714906|FG004|Period 4|Physician Decision|0|||
125025370|NCT01582308|449714907|FG005|Period 4|Physician Decision|1|||
125025371|NCT01582308|449714908|FG006|Period 4|Physician Decision|0|||
125025372|NCT01582308|449714909|FG007|Period 4|Physician Decision|0|||
125025373|NCT01582308|449714910|FG008|Period 4|Physician Decision|0|||
125025374|NCT01582308|449714911|FG009|Period 4|Physician Decision|1|||
125025375|NCT02320487|449714914|FG000|Overall Study|Reason not Specified|1|||
125025376|NCT02320487|449714914|FG000|Overall Study|Physician Decision|5|||
125025377|NCT02320487|449714914|FG000|Overall Study|Withdrawal by Subject|1|||
125025378|NCT02320487|449714914|FG000|Overall Study|Death|3|||
125025379|NCT02320487|449714914|FG000|Overall Study|Adverse Event|11|||
125025380|NCT01182428|449714915|FG000|Overall Study|Physician Decision|1|||
125025381|NCT01182428|449714916|FG001|Overall Study|Physician Decision|0|||
125025382|NCT01182428|449714915|FG000|Overall Study|Lost to Follow-up|9|||
125025383|NCT01182428|449714916|FG001|Overall Study|Lost to Follow-up|1|||
125025384|NCT01182428|449714915|FG000|Overall Study|Withdrawal by Subject|1|||
125025385|NCT01182428|449714916|FG001|Overall Study|Withdrawal by Subject|0|||
125025386|NCT05280756|449716691|FG000|Overall Study|Lost to Follow-up|1|||
125025387|NCT05280756|449716692|FG001|Overall Study|Lost to Follow-up|1|||
125025388|NCT02002975|449716699|FG000|Overall Study|Case Report Forms Uncollected|135|||
125025389|NCT02002975|449716699|FG000|Overall Study|Protocol Deviation|437|||
125025390|NCT01430442|449716702|FG000|Overall Study|Subject Withdrew Consent|3|||
125025391|NCT01430442|449716703|FG001|Overall Study|Subject Withdrew Consent|0|||
125025392|NCT01430442|449716704|FG002|Overall Study|Subject Withdrew Consent|1|||
125025393|NCT01430442|449716705|FG003|Overall Study|Subject Withdrew Consent|0|||
125025394|NCT01430442|449716706|FG004|Overall Study|Subject Withdrew Consent|2|||
125025395|NCT01430442|449716707|FG005|Overall Study|Subject Withdrew Consent|1|||
125025396|NCT01430442|449716708|FG006|Overall Study|Subject Withdrew Consent|5|||
125025397|NCT01430442|449716709|FG007|Overall Study|Subject Withdrew Consent|2|||
125025398|NCT01430442|449716702|FG000|Overall Study|Lost to Follow-up|2|||
125025399|NCT01430442|449716703|FG001|Overall Study|Lost to Follow-up|0|||
125025400|NCT01430442|449716704|FG002|Overall Study|Lost to Follow-up|1|||
125025401|NCT01430442|449716705|FG003|Overall Study|Lost to Follow-up|2|||
125025402|NCT01430442|449716706|FG004|Overall Study|Lost to Follow-up|2|||
125025403|NCT01430442|449716707|FG005|Overall Study|Lost to Follow-up|1|||
125025404|NCT01430442|449716708|FG006|Overall Study|Lost to Follow-up|5|||
125025405|NCT01430442|449716709|FG007|Overall Study|Lost to Follow-up|1|||
125025406|NCT01430442|449716702|FG000|Overall Study|Pregnancy|1|||
125025407|NCT01430442|449716703|FG001|Overall Study|Pregnancy|0|||
125025408|NCT01430442|449716704|FG002|Overall Study|Pregnancy|0|||
125025409|NCT01430442|449716705|FG003|Overall Study|Pregnancy|0|||
125025410|NCT01430442|449716706|FG004|Overall Study|Pregnancy|0|||
125025411|NCT01430442|449716707|FG005|Overall Study|Pregnancy|1|||
125025412|NCT01430442|449716708|FG006|Overall Study|Pregnancy|0|||
125025413|NCT01430442|449716709|FG007|Overall Study|Pregnancy|0|||
125025414|NCT01430442|449716702|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
125025415|NCT01430442|449716703|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
125025416|NCT01430442|449716704|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
125025417|NCT01430442|449716705|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
125025418|NCT01430442|449716706|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
125025419|NCT01430442|449716707|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
125025420|NCT01430442|449716708|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
125025421|NCT01430442|449716709|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
125025422|NCT01641939|449716710|FG000|Overall Study|Death|90|||
125025423|NCT01641939|449716711|FG001|Overall Study|Death|187|||
125025424|NCT01641939|449716712|FG002|Overall Study|Death|61|||
125025425|NCT01641939|449716710|FG000|Overall Study|Lost to Follow-up|3|||
125025426|NCT01641939|449716711|FG001|Overall Study|Lost to Follow-up|2|||
125025427|NCT01641939|449716712|FG002|Overall Study|Lost to Follow-up|1|||
125025428|NCT01641939|449716710|FG000|Overall Study|Withdrawal by Subject|14|||
125025429|NCT01641939|449716711|FG001|Overall Study|Withdrawal by Subject|11|||
125025430|NCT01641939|449716712|FG002|Overall Study|Withdrawal by Subject|5|||
125025431|NCT01641939|449716710|FG000|Overall Study|Study Terminated by Sponsor|10|||
125025432|NCT01641939|449716711|FG001|Overall Study|Study Terminated by Sponsor|28|||
125025433|NCT01641939|449716712|FG002|Overall Study|Study Terminated by Sponsor|3|||
125025434|NCT01461044|449716713|FG000|Overall Study|Death|58|||
125025435|NCT01461044|449716714|FG001|Overall Study|Death|35|||
124932872|NCT03536884|449384537|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
124932873|NCT03536884|449384538|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
124932874|NCT03536884|449384539|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
124932875|NCT03536884|449384540|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
124932876|NCT03536884|449384541|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
124932877|NCT03536884|449384542|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
124932878|NCT03536884|449384531|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
124932879|NCT03536884|449384532|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
124932880|NCT03536884|449384533|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
124932881|NCT03536884|449384534|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
124932882|NCT03536884|449384535|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
124932883|NCT03536884|449384536|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
124932884|NCT03536884|449384537|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
124932885|NCT03536884|449384538|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
124932886|NCT03536884|449384539|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
124932887|NCT03536884|449384540|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
124932888|NCT03536884|449384541|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
124932889|NCT03536884|449384542|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
124932890|NCT03536884|449384531|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
124932891|NCT03536884|449384532|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
124932892|NCT03536884|449384533|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
124932893|NCT03536884|449384534|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
124932894|NCT03536884|449384535|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
124932895|NCT03536884|449384536|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
124932896|NCT03536884|449384537|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
124932897|NCT03536884|449384538|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
124932898|NCT03536884|449384539|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
124932899|NCT03536884|449384540|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
124932900|NCT03536884|449384541|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
124932901|NCT03536884|449384542|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
124932902|NCT03536884|449384531|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
124932903|NCT03536884|449384532|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
124932904|NCT03536884|449384533|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
124932905|NCT03536884|449384534|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
124932906|NCT03536884|449384535|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
124932907|NCT03536884|449384536|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
124932908|NCT03536884|449384537|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
125025436|NCT01461044|449716713|FG000|Overall Study|Lost to Follow-up|12|||
125025437|NCT01461044|449716714|FG001|Overall Study|Lost to Follow-up|5|||
125025438|NCT00716976|449716715|FG000|Overall Study|Adverse Event|2|||
125025439|NCT00716976|449716716|FG001|Overall Study|Adverse Event|0|||
125025440|NCT00716976|449716715|FG000|Overall Study|Death|1|||
125025441|NCT00716976|449716716|FG001|Overall Study|Death|0|||
125025442|NCT00716976|449716715|FG000|Overall Study|Physician Decision|2|||
125025443|NCT00716976|449716716|FG001|Overall Study|Physician Decision|2|||
125025444|NCT00716976|449716715|FG000|Overall Study|Withdrawal by Subject|5|||
125025445|NCT00716976|449716716|FG001|Overall Study|Withdrawal by Subject|1|||
125025446|NCT00716976|449716715|FG000|Overall Study|Premature discontinuation cisplatin|5|||
125025447|NCT00716976|449716716|FG001|Overall Study|Premature discontinuation cisplatin|4|||
125025448|NCT00716976|449716715|FG000|Overall Study|Radiation during protocol|1|||
125025449|NCT00716976|449716716|FG001|Overall Study|Radiation during protocol|0|||
125025450|NCT00716976|449716715|FG000|Overall Study|Ineligibles|4|||
125025451|NCT00716976|449716716|FG001|Overall Study|Ineligibles|2|||
125025452|NCT00122135|449716717|FG000|Overall Study|Withdrawal by Subject|3|||
125025453|NCT00122135|449716718|FG001|Overall Study|Withdrawal by Subject|0|||
125025454|NCT03068325|449716719|FG000|Overall Study|Lost to Follow-up|5|||
125025455|NCT05425563|449716727|FG000|Overall Study|Withdrawal by Subject|17|||
125025456|NCT00168831|449716731|FG000|Overall Study|Adverse Event|36|||
125025457|NCT00168831|449716732|FG001|Overall Study|Adverse Event|47|||
125025458|NCT00168831|449716733|FG002|Overall Study|Adverse Event|74|||
125025459|NCT00168831|449716731|FG000|Overall Study|Lost to Follow-up|5|||
125025460|NCT00168831|449716732|FG001|Overall Study|Lost to Follow-up|6|||
125025461|NCT00168831|449716733|FG002|Overall Study|Lost to Follow-up|4|||
125025462|NCT00168831|449716731|FG000|Overall Study|Withdrawal by Subject|7|||
125025463|NCT00168831|449716732|FG001|Overall Study|Withdrawal by Subject|14|||
125025464|NCT00168831|449716733|FG002|Overall Study|Withdrawal by Subject|19|||
125025465|NCT00168831|449716731|FG000|Overall Study|Protocol Violation|6|||
125025466|NCT00168831|449716732|FG001|Overall Study|Protocol Violation|11|||
125025467|NCT00168831|449716733|FG002|Overall Study|Protocol Violation|11|||
125025468|NCT00168831|449716731|FG000|Overall Study|Other|6|||
125025469|NCT00168831|449716732|FG001|Overall Study|Other|3|||
125025470|NCT00168831|449716733|FG002|Overall Study|Other|6|||
125025471|NCT02009878|449716734|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
125025472|NCT02009878|449716735|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
125120772|NCT03519256|450066961|FG002|Overall Study|Participant request to discontinue study treatment|0|||
125120773|NCT03519256|450066962|FG003|Overall Study|Participant request to discontinue study treatment|2|||
125120774|NCT03519256|450066959|FG000|Overall Study|Other reasons|0|||
125120775|NCT03519256|450066960|FG001|Overall Study|Other reasons|0|||
125120776|NCT03519256|450066961|FG002|Overall Study|Other reasons|2|||
125120777|NCT03519256|450066962|FG003|Overall Study|Other reasons|0|||
125120778|NCT03519256|450066959|FG000|Overall Study|Disease progression|6|||
125120779|NCT03519256|450066960|FG001|Overall Study|Disease progression|3|||
125120780|NCT03519256|450066961|FG002|Overall Study|Disease progression|2|||
125120781|NCT03519256|450066962|FG003|Overall Study|Disease progression|1|||
125120782|NCT03519256|450066959|FG000|Overall Study|Lost to Follow-up|0|||
125120783|NCT03519256|450066960|FG001|Overall Study|Lost to Follow-up|1|||
125120784|NCT03519256|450066961|FG002|Overall Study|Lost to Follow-up|0|||
125120785|NCT03519256|450066962|FG003|Overall Study|Lost to Follow-up|0|||
125120786|NCT04828161|450066963|FG000|Overall Study|Withdrawal by Subject|0|||
125120787|NCT04828161|450066964|FG001|Overall Study|Withdrawal by Subject|3|||
125120788|NCT04828161|450066965|FG002|Overall Study|Withdrawal by Subject|3|||
125120789|NCT04828161|450066966|FG003|Overall Study|Withdrawal by Subject|4|||
125120790|NCT04828161|450066963|FG000|Overall Study|Lost to Follow-up|1|||
125120791|NCT04828161|450066964|FG001|Overall Study|Lost to Follow-up|4|||
125120792|NCT04828161|450066965|FG002|Overall Study|Lost to Follow-up|2|||
125120793|NCT04828161|450066966|FG003|Overall Study|Lost to Follow-up|2|||
125120794|NCT04828161|450066963|FG000|Overall Study|Other|2|||
125120795|NCT04828161|450066964|FG001|Overall Study|Other|0|||
125120796|NCT04828161|450066965|FG002|Overall Study|Other|2|||
125025473|NCT02009878|449716736|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
125120797|NCT04828161|450066966|FG003|Overall Study|Other|0|||
125025474|NCT04652804|449716739|FG000|Overall Study|Ineligible post randomization|1|||
125120798|NCT04828161|450066963|FG000|Overall Study|Death|0|||
125120799|NCT04828161|450066964|FG001|Overall Study|Death|0|||
125120800|NCT04828161|450066965|FG002|Overall Study|Death|0|||
125120801|NCT04828161|450066966|FG003|Overall Study|Death|2|||
125120802|NCT05431153|450066967|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125120803|NCT05431153|450066968|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125120804|NCT05431153|450066969|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125025475|NCT04652804|449716740|FG001|Overall Study|Ineligible post randomization|0|||
125120805|NCT05431153|450066970|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125025476|NCT04652804|449716741|FG002|Overall Study|Ineligible post randomization|1|||
125120806|NCT05431153|450066971|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
125025477|NCT04652804|449716742|FG003|Overall Study|Ineligible post randomization|0|||
125025478|NCT04652804|449716743|FG004|Overall Study|Ineligible post randomization|1|||
125212800|NCT01026818|450405481|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
124932909|NCT03536884|449384538|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
124932910|NCT03536884|449384539|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
124932911|NCT03536884|449384540|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
124932912|NCT03536884|449384541|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
124932913|NCT03536884|449384542|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
124932914|NCT03536884|449384531|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
124932915|NCT03536884|449384532|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
124932916|NCT03536884|449384533|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
124932917|NCT03536884|449384534|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
124932918|NCT03536884|449384535|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
124932919|NCT03536884|449384536|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
124932920|NCT03536884|449384537|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
124932921|NCT03536884|449384538|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
124932922|NCT03536884|449384539|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
124932923|NCT03536884|449384540|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
124932924|NCT03536884|449384541|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
124932925|NCT03536884|449384542|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
124932926|NCT03536884|449384531|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
124932927|NCT03536884|449384532|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
124932928|NCT03536884|449384533|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
124932929|NCT03536884|449384534|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
124932930|NCT03536884|449384535|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
124932931|NCT03536884|449384536|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
124932932|NCT03536884|449384537|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
124932933|NCT03536884|449384538|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
124932934|NCT03536884|449384539|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
124932935|NCT03536884|449384540|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
124932936|NCT03536884|449384541|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
124932937|NCT03536884|449384542|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
124932938|NCT03536884|449384531|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
124932939|NCT03536884|449384532|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
124932940|NCT03536884|449384533|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
124932941|NCT03536884|449384534|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
124932942|NCT03536884|449384535|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
124932943|NCT03536884|449384536|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
124932944|NCT03536884|449384537|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
124932945|NCT03536884|449384538|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
124932946|NCT03536884|449384539|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
124932947|NCT03536884|449384540|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
124932948|NCT03536884|449384541|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
124932949|NCT03536884|449384542|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
124932950|NCT03536884|449384531|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
124932951|NCT03536884|449384532|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
124932952|NCT03536884|449384533|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
124932953|NCT03536884|449384534|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
124932954|NCT03536884|449384535|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
124932955|NCT03536884|449384536|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
124932956|NCT03536884|449384537|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
124932957|NCT03536884|449384538|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
124932958|NCT03536884|449384539|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
124932959|NCT03536884|449384540|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
124932960|NCT03536884|449384541|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
124932961|NCT03536884|449384542|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
124932962|NCT03536884|449384531|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
124932963|NCT03536884|449384532|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
124932964|NCT03536884|449384533|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
124932965|NCT03536884|449384534|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
124932966|NCT03536884|449384535|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
124932967|NCT03536884|449384536|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
124932968|NCT03536884|449384537|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
124932969|NCT03536884|449384538|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
124932970|NCT03536884|449384539|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
124932971|NCT03536884|449384540|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
124932972|NCT03536884|449384541|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
124932973|NCT03536884|449384542|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
124932974|NCT03536884|449384531|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
124932975|NCT03536884|449384532|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
124932976|NCT03536884|449384533|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
124932977|NCT03536884|449384534|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
124932978|NCT03536884|449384535|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
124932979|NCT03536884|449384536|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
124932980|NCT03536884|449384537|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
124932981|NCT03536884|449384538|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
124932982|NCT03536884|449384539|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
124932983|NCT03536884|449384540|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
124932984|NCT03536884|449384541|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
124932985|NCT03536884|449384542|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
124932986|NCT03536884|449384531|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
124932987|NCT03536884|449384532|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
124932988|NCT03536884|449384533|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
124932989|NCT03536884|449384534|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
124932990|NCT03536884|449384535|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
124932991|NCT03536884|449384536|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
124932992|NCT03536884|449384537|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
124932993|NCT03536884|449384538|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
124932994|NCT03536884|449384539|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
124932995|NCT03536884|449384540|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
124932996|NCT03536884|449384541|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
124932997|NCT03536884|449384542|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
124932998|NCT03536884|449384531|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124932999|NCT03536884|449384532|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124933000|NCT03536884|449384533|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124933001|NCT03536884|449384534|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124933002|NCT03536884|449384535|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124933003|NCT03536884|449384536|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
124933004|NCT03536884|449384537|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124933005|NCT03536884|449384538|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124933006|NCT03536884|449384539|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124933007|NCT03536884|449384540|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124933008|NCT03536884|449384541|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124933009|NCT03536884|449384542|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124933010|NCT03536884|449384531|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933011|NCT03536884|449384532|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933012|NCT03536884|449384533|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933013|NCT03536884|449384534|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933014|NCT03536884|449384535|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933015|NCT03536884|449384536|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933016|NCT03536884|449384537|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
124933017|NCT03536884|449384538|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933018|NCT03536884|449384539|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933019|NCT03536884|449384540|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933020|NCT03536884|449384541|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933021|NCT03536884|449384542|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933022|NCT03536884|449384531|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933023|NCT03536884|449384532|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933024|NCT03536884|449384533|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933025|NCT03536884|449384534|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933026|NCT03536884|449384535|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933027|NCT03536884|449384536|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933028|NCT03536884|449384537|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
124933029|NCT03536884|449384538|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933030|NCT03536884|449384539|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933031|NCT03536884|449384540|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933032|NCT03536884|449384541|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933033|NCT03536884|449384542|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933034|NCT03536884|449384531|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
124933035|NCT03536884|449384532|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
124933036|NCT03536884|449384533|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
124933037|NCT03536884|449384534|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
125212801|NCT01026818|450405478|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
124933038|NCT03536884|449384535|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
124933039|NCT03536884|449384536|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
124933040|NCT03536884|449384537|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
124933041|NCT03536884|449384538|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
124933042|NCT03536884|449384539|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
124933043|NCT03536884|449384540|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
124933044|NCT03536884|449384541|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
124933045|NCT03536884|449384542|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
124933046|NCT03536884|449384531|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933047|NCT03536884|449384532|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933048|NCT03536884|449384533|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933049|NCT03536884|449384534|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933050|NCT03536884|449384535|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933051|NCT03536884|449384536|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933052|NCT03536884|449384537|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933053|NCT03536884|449384538|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933054|NCT03536884|449384539|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
124933055|NCT03536884|449384540|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933056|NCT03536884|449384541|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933057|NCT03536884|449384542|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933058|NCT03536884|449384531|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124933059|NCT03536884|449384532|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124933060|NCT03536884|449384533|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124933061|NCT03536884|449384534|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124933062|NCT03536884|449384535|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124933063|NCT03536884|449384536|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124933064|NCT03536884|449384537|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124933065|NCT03536884|449384538|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124933066|NCT03536884|449384539|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124933067|NCT03536884|449384540|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
124933068|NCT03536884|449384541|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
124933069|NCT03536884|449384542|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
125120807|NCT05431153|450066972|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125120808|NCT02458638|450066975|FG000|Overall Study|Death|309|||
125120809|NCT02458638|450066975|FG000|Overall Study|End of Cohort/End of Study|67|||
125120810|NCT02458638|450066975|FG000|Overall Study|Lost to Follow-up|31|||
125120811|NCT02458638|450066975|FG000|Overall Study|Other Reasons|4|||
124933070|NCT03536884|449384531|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124933071|NCT03536884|449384532|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124933072|NCT03536884|449384533|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125025479|NCT04652804|449716744|FG005|Overall Study|Ineligible post randomization|1|||
125025480|NCT04652804|449716739|FG000|Overall Study|Missing SVR lab results|2|||
125025481|NCT04652804|449716740|FG001|Overall Study|Missing SVR lab results|0|||
125025482|NCT04652804|449716741|FG002|Overall Study|Missing SVR lab results|0|||
125025483|NCT04652804|449716742|FG003|Overall Study|Missing SVR lab results|0|||
125025484|NCT04652804|449716743|FG004|Overall Study|Missing SVR lab results|0|||
125025485|NCT04652804|449716744|FG005|Overall Study|Missing SVR lab results|0|||
125025486|NCT00584194|449716745|FG000|Overall Study|Other|135|||
125025487|NCT03634800|449716746|FG000|Overall Study|Adverse Event|1|||
125025488|NCT03634800|449716746|FG000|Overall Study|Disease Progression|4|||
125025489|NCT03634800|449716746|FG000|Overall Study|Withdrawal by Subject|1|||
125025490|NCT00343512|449716753|FG000|Overall Study|Withdrawal by Subject|2|||
125025491|NCT00684515|449716756|FG000|Overall Study|Adverse Event|3|||
125025492|NCT00684515|449716757|FG001|Overall Study|Adverse Event|3|||
125025493|NCT00684515|449716758|FG002|Overall Study|Adverse Event|1|||
125025494|NCT00684515|449716756|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
125025495|NCT00684515|449716757|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
125025496|NCT00684515|449716758|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
125025497|NCT00634569|449716759|FG000|Overall Study|Withdrawal by Subject|0|||
125025498|NCT00634569|449716760|FG001|Overall Study|Withdrawal by Subject|4|||
125025499|NCT00634569|449716759|FG000|Overall Study|Physician Decision|0|||
125025500|NCT00634569|449716760|FG001|Overall Study|Physician Decision|1|||
125025501|NCT01700192|449716761|FG000|Overall Study|Adverse Event|73|||
125025502|NCT01700192|449716762|FG001|Overall Study|Adverse Event|18|||
125025503|NCT01700192|449716761|FG000|Overall Study|Lack of Efficacy|1|||
125025504|NCT01700192|449716762|FG001|Overall Study|Lack of Efficacy|0|||
125120812|NCT02458638|450066975|FG000|Overall Study|Physician Decision|1|||
125025505|NCT01700192|449716761|FG000|Overall Study|Lost to Follow-up|42|||
125025506|NCT01700192|449716762|FG001|Overall Study|Lost to Follow-up|29|||
125025507|NCT01700192|449716761|FG000|Overall Study|Noncompliance with study drug|0|||
125025508|NCT01700192|449716762|FG001|Overall Study|Noncompliance with study drug|5|||
125025509|NCT01700192|449716761|FG000|Overall Study|Physician Decision|2|||
125025510|NCT01700192|449716762|FG001|Overall Study|Physician Decision|3|||
124933073|NCT03536884|449384534|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124933074|NCT03536884|449384535|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124933075|NCT03536884|449384536|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124933076|NCT03536884|449384537|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124933077|NCT03536884|449384538|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124933078|NCT03536884|449384539|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124933079|NCT03536884|449384540|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
124933080|NCT03536884|449384541|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
124933081|NCT03536884|449384542|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
124933082|NCT03536884|449384531|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933083|NCT03536884|449384532|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933084|NCT03536884|449384533|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933085|NCT03536884|449384534|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933086|NCT03536884|449384535|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933087|NCT03536884|449384536|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933088|NCT03536884|449384537|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933089|NCT03536884|449384538|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933090|NCT03536884|449384539|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933091|NCT03536884|449384540|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933092|NCT03536884|449384541|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
124933093|NCT03536884|449384542|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933094|NCT03536884|449384531|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933095|NCT03536884|449384532|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933096|NCT03536884|449384533|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933097|NCT03536884|449384534|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933098|NCT03536884|449384535|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933099|NCT03536884|449384536|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933100|NCT03536884|449384537|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933101|NCT03536884|449384538|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933102|NCT03536884|449384539|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933103|NCT03536884|449384540|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933104|NCT03536884|449384541|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933105|NCT03536884|449384542|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
124933106|NCT03536884|449384531|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933107|NCT03536884|449384532|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933108|NCT03536884|449384533|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933109|NCT03536884|449384534|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933110|NCT03536884|449384535|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933111|NCT03536884|449384536|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933112|NCT03536884|449384537|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933113|NCT03536884|449384538|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933114|NCT03536884|449384539|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933115|NCT03536884|449384540|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933116|NCT03536884|449384541|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933117|NCT03536884|449384542|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
124933118|NCT02367040|449384564|FG000|Overall Study|Lost to Follow-up|1|||
124933119|NCT02367040|449384565|FG001|Overall Study|Lost to Follow-up|1|||
124933120|NCT02367040|449384564|FG000|Overall Study|Lack of Efficacy|1|||
124933121|NCT02367040|449384565|FG001|Overall Study|Lack of Efficacy|0|||
124933122|NCT02367040|449384564|FG000|Overall Study|Additional primary malignancy|0|||
124933123|NCT02367040|449384565|FG001|Overall Study|Additional primary malignancy|1|||
124933124|NCT02367040|449384564|FG000|Overall Study|AE not associated with clinical disease progression|114|||
124933125|NCT02367040|449384565|FG001|Overall Study|AE not associated with clinical disease progression|11|||
124933126|NCT02367040|449384564|FG000|Overall Study|AE associated with clinical disease progression|1|||
125025511|NCT01700192|449716761|FG000|Overall Study|Pregnancy|1|||
124933127|NCT02367040|449384565|FG001|Overall Study|AE associated with clinical disease progression|3|||
124933128|NCT02367040|449384564|FG000|Overall Study|Physician Decision|2|||
124933129|NCT02367040|449384565|FG001|Overall Study|Physician Decision|8|||
124933130|NCT02367040|449384564|FG000|Overall Study|Non-compliance with study drug|1|||
124933131|NCT02367040|449384565|FG001|Overall Study|Non-compliance with study drug|0|||
124933132|NCT02367040|449384564|FG000|Overall Study|Failure to meet continuation criteria|1|||
124933133|NCT02367040|449384565|FG001|Overall Study|Failure to meet continuation criteria|0|||
124933134|NCT02367040|449384564|FG000|Overall Study|Switching to other therapy|2|||
124933135|NCT02367040|449384565|FG001|Overall Study|Switching to other therapy|0|||
124933136|NCT02367040|449384564|FG000|Overall Study|Withdrawal by Subject|46|||
124933137|NCT02367040|449384565|FG001|Overall Study|Withdrawal by Subject|16|||
124933138|NCT02367040|449384564|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
124933139|NCT02367040|449384565|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
124933140|NCT02367040|449384564|FG000|Overall Study|Patient decision|39|||
124933141|NCT02367040|449384565|FG001|Overall Study|Patient decision|14|||
124933142|NCT02367040|449384564|FG000|Overall Study|Required procedure failed|1|||
124933143|NCT02367040|449384565|FG001|Overall Study|Required procedure failed|0|||
124933144|NCT02367040|449384564|FG000|Overall Study|Randomized by mistake with study treatment|1|||
124933145|NCT02367040|449384565|FG001|Overall Study|Randomized by mistake with study treatment|0|||
124933146|NCT02367040|449384564|FG000|Overall Study|Protocol Violation|1|||
124933147|NCT02367040|449384565|FG001|Overall Study|Protocol Violation|0|||
124933148|NCT02367040|449384564|FG000|Overall Study|Progressive disease - radiological progression|51|||
124933149|NCT02367040|449384565|FG001|Overall Study|Progressive disease - radiological progression|78|||
124933150|NCT02367040|449384564|FG000|Overall Study|Progressive disease - clinical progression|6|||
124933151|NCT02367040|449384565|FG001|Overall Study|Progressive disease - clinical progression|6|||
124933152|NCT02367040|449384564|FG000|Overall Study|Drug not administered|3|||
124933153|NCT02367040|449384565|FG001|Overall Study|Drug not administered|2|||
124933154|NCT02367040|449384564|FG000|Overall Study|Progressive disease|0|||
124933155|NCT02367040|449384565|FG001|Overall Study|Progressive disease|1|||
124933156|NCT02367040|449384564|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
124933157|NCT02367040|449384565|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
124933158|NCT02367040|449384564|FG000|Overall Study|Death|2|||
124933159|NCT02367040|449384565|FG001|Overall Study|Death|0|||
124933160|NCT05856435|449384579|FG000|Overall Study|Lost to Follow-up|6|||
124933161|NCT02323880|449384580|FG000|Overall Study|Adverse Event|2|||
124933162|NCT02323880|449384581|FG001|Overall Study|Adverse Event|0|||
124933163|NCT02323880|449384582|FG002|Overall Study|Adverse Event|1|||
124933164|NCT02323880|449384583|FG003|Overall Study|Adverse Event|1|||
124933165|NCT02323880|449384584|FG004|Overall Study|Adverse Event|1|||
124933166|NCT02323880|449384585|FG005|Overall Study|Adverse Event|0|||
124933167|NCT02323880|449384586|FG006|Overall Study|Adverse Event|1|||
124933168|NCT02323880|449384587|FG007|Overall Study|Adverse Event|0|||
124933169|NCT02323880|449384580|FG000|Overall Study|Death|0|||
124933170|NCT02323880|449384581|FG001|Overall Study|Death|0|||
124933171|NCT02323880|449384582|FG002|Overall Study|Death|0|||
124933172|NCT02323880|449384583|FG003|Overall Study|Death|0|||
124933173|NCT02323880|449384584|FG004|Overall Study|Death|0|||
124933174|NCT02323880|449384585|FG005|Overall Study|Death|1|||
124933175|NCT02323880|449384586|FG006|Overall Study|Death|0|||
124933176|NCT02323880|449384587|FG007|Overall Study|Death|0|||
124933177|NCT02323880|449384580|FG000|Overall Study|Lack of Efficacy|4|||
124933178|NCT02323880|449384581|FG001|Overall Study|Lack of Efficacy|11|||
124933179|NCT02323880|449384582|FG002|Overall Study|Lack of Efficacy|5|||
124933180|NCT02323880|449384583|FG003|Overall Study|Lack of Efficacy|5|||
124933181|NCT02323880|449384584|FG004|Overall Study|Lack of Efficacy|4|||
124933182|NCT02323880|449384585|FG005|Overall Study|Lack of Efficacy|8|||
124933183|NCT02323880|449384586|FG006|Overall Study|Lack of Efficacy|4|||
124933184|NCT02323880|449384587|FG007|Overall Study|Lack of Efficacy|6|||
124933185|NCT02323880|449384580|FG000|Overall Study|Physician Decision|0|||
124933186|NCT02323880|449384581|FG001|Overall Study|Physician Decision|0|||
124933187|NCT02323880|449384582|FG002|Overall Study|Physician Decision|0|||
124933188|NCT02323880|449384583|FG003|Overall Study|Physician Decision|0|||
124933189|NCT02323880|449384584|FG004|Overall Study|Physician Decision|1|||
124933190|NCT02323880|449384585|FG005|Overall Study|Physician Decision|1|||
124933191|NCT02323880|449384586|FG006|Overall Study|Physician Decision|1|||
124933192|NCT02323880|449384587|FG007|Overall Study|Physician Decision|0|||
124933193|NCT02323880|449384580|FG000|Overall Study|Withdrawal by Subject|0|||
124933194|NCT02323880|449384581|FG001|Overall Study|Withdrawal by Subject|2|||
124933195|NCT02323880|449384582|FG002|Overall Study|Withdrawal by Subject|0|||
124933196|NCT02323880|449384583|FG003|Overall Study|Withdrawal by Subject|0|||
124933197|NCT02323880|449384584|FG004|Overall Study|Withdrawal by Subject|0|||
124933198|NCT02323880|449384585|FG005|Overall Study|Withdrawal by Subject|0|||
124933199|NCT02323880|449384586|FG006|Overall Study|Withdrawal by Subject|0|||
124933200|NCT02323880|449384587|FG007|Overall Study|Withdrawal by Subject|0|||
124933201|NCT05660434|449384590|FG000|Overall Study|Never obtained study materials|2|||
124933202|NCT05660434|449384591|FG001|Overall Study|Never obtained study materials|1|||
124933203|NCT05424380|449384592|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
124933204|NCT05424380|449384593|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
124933205|NCT05424380|449384594|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
124933206|NCT05424380|449384595|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
124933207|NCT05424380|449384596|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
124933208|NCT05424380|449384597|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
124933209|NCT05424380|449384592|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
124933210|NCT05424380|449384593|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
124933211|NCT05424380|449384594|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
124933212|NCT05424380|449384595|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
124933213|NCT05424380|449384596|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
124933214|NCT05424380|449384597|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
124933215|NCT05424380|449384592|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
124933216|NCT05424380|449384593|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
124933217|NCT05424380|449384594|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
124933218|NCT05424380|449384595|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
124933219|NCT05424380|449384596|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
124933220|NCT05424380|449384597|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
124933221|NCT05424380|449384592|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
124933222|NCT05424380|449384593|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
124933223|NCT05424380|449384594|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
124933224|NCT05424380|449384595|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
124933225|NCT05424380|449384596|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
124933226|NCT05424380|449384597|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
124933227|NCT05424380|449384592|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
124933228|NCT05424380|449384593|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
124933229|NCT05424380|449384594|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
124933230|NCT05424380|449384595|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
124933231|NCT05424380|449384596|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
124933232|NCT05424380|449384597|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
124933233|NCT05424380|449384592|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
124933234|NCT05424380|449384593|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
124933235|NCT05424380|449384594|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
124933236|NCT05424380|449384595|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
124933237|NCT05424380|449384596|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
124933238|NCT05424380|449384597|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
124933239|NCT05424380|449384592|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
124933240|NCT05424380|449384593|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
124933241|NCT05424380|449384594|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
124933242|NCT05424380|449384595|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
124933243|NCT05424380|449384596|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
125025512|NCT01700192|449716762|FG001|Overall Study|Pregnancy|4|||
125025513|NCT01700192|449716761|FG000|Overall Study|Progressive disease|1|||
125025514|NCT01700192|449716762|FG001|Overall Study|Progressive disease|0|||
125025515|NCT01700192|449716761|FG000|Overall Study|Protocol Violation|3|||
125025516|NCT01700192|449716762|FG001|Overall Study|Protocol Violation|4|||
125025517|NCT01700192|449716761|FG000|Overall Study|Technical problems|0|||
125025518|NCT01700192|449716762|FG001|Overall Study|Technical problems|1|||
125025519|NCT01700192|449716761|FG000|Overall Study|Withdrawal by Subject|56|||
124933244|NCT05424380|449384597|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
124933245|NCT05424380|449384592|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
124933246|NCT05424380|449384593|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
124933247|NCT05424380|449384594|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
124933248|NCT05424380|449384595|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
124933249|NCT05424380|449384596|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
124933250|NCT05424380|449384597|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
125025520|NCT01700192|449716762|FG001|Overall Study|Withdrawal by Subject|64|||
125025521|NCT01700192|449716761|FG000|Overall Study|Never received study drug|1|||
125025522|NCT01700192|449716762|FG001|Overall Study|Never received study drug|0|||
125025523|NCT03403192|449716765|FG000|Overall Study|Lost to Follow-up|1|||
124933251|NCT05424380|449384592|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
124933252|NCT05424380|449384593|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
124933253|NCT05424380|449384594|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
124933254|NCT05424380|449384595|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
124933255|NCT05424380|449384596|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
124933256|NCT05424380|449384597|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
124933257|NCT05424380|449384592|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
124933258|NCT05424380|449384593|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
124933259|NCT05424380|449384594|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
124933260|NCT05424380|449384595|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
124933261|NCT05424380|449384596|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
124933262|NCT05424380|449384597|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
124933263|NCT05424380|449384592|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
124933264|NCT05424380|449384593|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
124933265|NCT05424380|449384594|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
124933266|NCT05424380|449384595|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
124933267|NCT05424380|449384596|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
124933268|NCT05424380|449384597|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
124933269|NCT05424380|449384592|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
124933270|NCT05424380|449384593|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
124933271|NCT05424380|449384594|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
124933272|NCT05424380|449384595|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
124933273|NCT05424380|449384596|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
124933274|NCT05424380|449384597|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
124933275|NCT05424380|449384592|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
124933276|NCT05424380|449384593|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
124933277|NCT05424380|449384594|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
124933278|NCT05424380|449384595|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
124933279|NCT05424380|449384596|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
124933280|NCT05424380|449384597|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
124933281|NCT05424380|449384592|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
124933282|NCT05424380|449384593|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
124933283|NCT05424380|449384594|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
124933284|NCT05424380|449384595|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
124933285|NCT05424380|449384596|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
124933286|NCT05424380|449384597|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
124933287|NCT02909686|449384598|FG000|Overall Study|Physician Decision|3|||
124933288|NCT02909686|449384598|FG000|Overall Study|Withdrawal by Subject|2|||
124933289|NCT03858517|449384599|FG000|Overall Study|Adverse Event|1|||
124933290|NCT03858517|449384599|FG000|Overall Study|Lost to Follow-up|1|||
124933291|NCT03858517|449384599|FG000|Overall Study|removed for being incarcerated|1|||
124933292|NCT03858517|449384599|FG000|Overall Study|Sponsor Closure|48|||
124933293|NCT01820611|449384604|FG000|Overall Study|Death|8|||
124933294|NCT01820611|449384604|FG000|Overall Study|Adverse Event|1|||
124933295|NCT01820611|449384604|FG000|Overall Study|Withdrawal by Subject|9|||
124933296|NCT05736458|449384605|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
124933297|NCT05736458|449384606|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
124933298|NCT05736458|449384607|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
124933299|NCT05736458|449384605|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
124933300|NCT05736458|449384606|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
124933301|NCT05736458|449384607|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
124933302|NCT05736458|449384605|FG000|TMS/fMRI #1|Physician Decision|0|||
124933303|NCT05736458|449384606|FG001|TMS/fMRI #1|Physician Decision|0|||
124933304|NCT05736458|449384607|FG002|TMS/fMRI #1|Physician Decision|2|||
124933305|NCT05736458|449384605|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
124933306|NCT05736458|449384606|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
124933307|NCT05736458|449384607|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
124933308|NCT02990338|449384608|FG000|Overall Study|Randomized and not treated|4|||
124933309|NCT02990338|449384609|FG001|Overall Study|Randomized and not treated|2|||
124933310|NCT02990338|449384608|FG000|Overall Study|Adverse Event|23|||
124933311|NCT02990338|449384609|FG001|Overall Study|Adverse Event|22|||
125025524|NCT03403192|449716766|FG001|Overall Study|Lost to Follow-up|2|||
125025525|NCT03403192|449716767|FG002|Overall Study|Lost to Follow-up|0|||
125025526|NCT03403192|449716768|FG003|Overall Study|Lost to Follow-up|0|||
125025527|NCT03403192|449716765|FG000|Overall Study|Unable to respond|0|||
125025528|NCT03403192|449716766|FG001|Overall Study|Unable to respond|1|||
125025529|NCT03403192|449716767|FG002|Overall Study|Unable to respond|0|||
125025530|NCT03403192|449716768|FG003|Overall Study|Unable to respond|0|||
125025531|NCT03403192|449716765|FG000|Overall Study|Incomplete|3|||
125025532|NCT03403192|449716766|FG001|Overall Study|Incomplete|1|||
125025533|NCT03403192|449716767|FG002|Overall Study|Incomplete|3|||
124933312|NCT02990338|449384608|FG000|Overall Study|Progressive disease|118|||
124933313|NCT02990338|449384609|FG001|Overall Study|Progressive disease|107|||
124933314|NCT02990338|449384608|FG000|Overall Study|Poor compliance to protocol|0|||
124933315|NCT02990338|449384609|FG001|Overall Study|Poor compliance to protocol|1|||
124933316|NCT02990338|449384608|FG000|Overall Study|Withdrawal by Subject|6|||
124933317|NCT02990338|449384609|FG001|Overall Study|Withdrawal by Subject|8|||
124933318|NCT02990338|449384608|FG000|Overall Study|Physician's decision|2|||
124933319|NCT02990338|449384609|FG001|Overall Study|Physician's decision|6|||
124933320|NCT02990338|449384608|FG000|Overall Study|Treatment extension study|0|||
124933321|NCT02990338|449384609|FG001|Overall Study|Treatment extension study|6|||
124933322|NCT02990338|449384608|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
124933323|NCT02990338|449384609|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
124933324|NCT02990338|449384608|FG000|Overall Study|Continue with therapy available commercially|0|||
124933325|NCT02990338|449384609|FG001|Overall Study|Continue with therapy available commercially|1|||
124933326|NCT04479761|449384611|FG000|Overall Study|could not perform the balance tasks|1|||
124933327|NCT04479761|449384612|FG001|Overall Study|could not perform the balance tasks|0|||
124933328|NCT04479761|449384613|FG002|Overall Study|could not perform the balance tasks|0|||
124933329|NCT04479761|449384611|FG000|Overall Study|Adverse Event|1|||
124933330|NCT04479761|449384612|FG001|Overall Study|Adverse Event|0|||
124933331|NCT04479761|449384613|FG002|Overall Study|Adverse Event|0|||
124933332|NCT04479761|449384611|FG000|Overall Study|one control did not meet screening criteria|0|||
124933333|NCT04479761|449384612|FG001|Overall Study|one control did not meet screening criteria|0|||
124933334|NCT04479761|449384613|FG002|Overall Study|one control did not meet screening criteria|1|||
124933335|NCT04479761|449384611|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
124933336|NCT04479761|449384612|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
124933337|NCT04479761|449384613|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
124933338|NCT04186819|449384614|FG000|Overall Study|Adverse Event|1|||
124933339|NCT04186819|449384614|FG000|Overall Study|Lost to Follow-up|1|||
124933340|NCT04186819|449384614|FG000|Overall Study|Opted for EBRT|1|||
124933341|NCT04186819|449384614|FG000|Overall Study|Opted SBRT|1|||
124933342|NCT04186819|449384614|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
124933343|NCT04186819|449384614|FG000|Overall Study|Physician Decision|1|||
124933344|NCT04186819|449384614|FG000|Overall Study|RP Delayed|1|||
124933345|NCT04186819|449384614|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
124933346|NCT04186819|449384614|FG000|Overall Study|Subject declined for financial reasons|1|||
124933347|NCT04186819|449384614|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
124933348|NCT04186819|449384614|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
124933349|NCT04186819|449384614|FG000|Overall Study|The subject opted for other treatment option|2|||
124933350|NCT04186819|449384614|FG000|Overall Study|The subject opted for other treatment options|1|||
124933351|NCT04186819|449384614|FG000|Overall Study|Withdrawal by Subject|3|||
124933352|NCT04186819|449384614|FG000|Overall Study|Reason not specified|1|||
124933353|NCT03252288|449384620|FG000|Overall Study|Death|1|||
124933354|NCT03252288|449384621|FG001|Overall Study|Death|0|||
124933355|NCT03252288|449384622|FG002|Overall Study|Death|0|||
124933356|NCT03252288|449384620|FG000|Overall Study|Death|11|||
124933357|NCT03252288|449384621|FG001|Overall Study|Death|0|||
124933358|NCT03252288|449384622|FG002|Overall Study|Death|0|||
124933359|NCT03252288|449384620|FG000|Overall Study|Withdrawal by Subject|2|||
124933360|NCT03252288|449384621|FG001|Overall Study|Withdrawal by Subject|0|||
124933361|NCT03252288|449384622|FG002|Overall Study|Withdrawal by Subject|0|||
124933362|NCT03252288|449384620|FG000|Overall Study|Lost to Follow-up|79|||
124933363|NCT03252288|449384621|FG001|Overall Study|Lost to Follow-up|0|||
124933364|NCT03252288|449384622|FG002|Overall Study|Lost to Follow-up|0|||
124933365|NCT03252288|449384620|FG000|Overall Study|Loss of baseline data on tablets|6|||
124933366|NCT03252288|449384621|FG001|Overall Study|Loss of baseline data on tablets|0|||
124933367|NCT03252288|449384622|FG002|Overall Study|Loss of baseline data on tablets|0|||
124933368|NCT05900154|449384626|FG000|Follow-Up Period|Lost to Follow-up|1|||
124933369|NCT05900154|449384627|FG001|Follow-Up Period|Lost to Follow-up|2|||
124933370|NCT05900154|449384628|FG002|Follow-Up Period|Lost to Follow-up|1|||
124933371|NCT05900154|449384629|FG003|Follow-Up Period|Lost to Follow-up|0|||
124933372|NCT05900154|449384630|FG004|Follow-Up Period|Lost to Follow-up|1|||
125025534|NCT03403192|449716768|FG003|Overall Study|Incomplete|6|||
125025535|NCT03543410|449716769|FG000|Overall Study|Adverse Event|10|||
125025536|NCT03543410|449716770|FG001|Overall Study|Adverse Event|8|||
125025537|NCT03543410|449716771|FG002|Overall Study|Adverse Event|2|||
124933373|NCT05900154|449384631|FG005|Follow-Up Period|Lost to Follow-up|1|||
124933374|NCT02865538|449384635|FG000|Overall Study|Withdrawal by Subject|0|||
124933375|NCT02865538|449384636|FG001|Overall Study|Withdrawal by Subject|0|||
124933376|NCT02865538|449384637|FG002|Overall Study|Withdrawal by Subject|1|||
124933377|NCT02865538|449384638|FG003|Overall Study|Withdrawal by Subject|0|||
124933378|NCT02865538|449384639|FG004|Overall Study|Withdrawal by Subject|0|||
124933379|NCT02865538|449384635|FG000|Overall Study|Lost to Follow-up|1|||
124933380|NCT02865538|449384636|FG001|Overall Study|Lost to Follow-up|0|||
124933381|NCT02865538|449384637|FG002|Overall Study|Lost to Follow-up|0|||
124933382|NCT02865538|449384638|FG003|Overall Study|Lost to Follow-up|0|||
124933383|NCT02865538|449384639|FG004|Overall Study|Lost to Follow-up|0|||
124933384|NCT03106740|449385872|FG000|Overall Study|Lost to Follow-up|2|||
124933385|NCT03106740|449385873|FG001|Overall Study|Lost to Follow-up|2|||
124933386|NCT03106740|449385872|FG000|Overall Study|Withdrawal by Subject|2|||
124933387|NCT03106740|449385873|FG001|Overall Study|Withdrawal by Subject|4|||
124933388|NCT03106740|449385872|FG000|Overall Study|Physician Decision|0|||
124933389|NCT03106740|449385873|FG001|Overall Study|Physician Decision|1|||
124933390|NCT03106740|449385872|FG000|Overall Study|Partial data|1|||
124933391|NCT03106740|449385873|FG001|Overall Study|Partial data|0|||
124933392|NCT04565990|449385874|FG000|Overall Study|Death|5|||
124933393|NCT04565990|449385874|FG000|Overall Study|Lost to Follow-up|1|||
124933394|NCT04565990|449385874|FG000|Overall Study|Withdrawal by Subject|1|||
124933395|NCT04797858|449385875|FG000|Overall Study|Withdrawal by Subject|0|||
124933396|NCT04797858|449385876|FG001|Overall Study|Withdrawal by Subject|1|||
124933397|NCT04797858|449385875|FG000|Overall Study|Excluded due to administrative error|7|||
124933398|NCT04797858|449385876|FG001|Overall Study|Excluded due to administrative error|8|||
124933399|NCT05363163|449385886|FG000|Overall Study|Withdrawal by Subject|13|||
124933409|NCT02839265|449385893|FG000|Overall Study|Screen Failure|2|||
124933410|NCT02839265|449385893|FG000|Overall Study|Death|1|||
124933411|NCT02839265|449385893|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
124933412|NCT05552508|449385894|FG000|Overall Study|Adverse Event|3|||
124933413|NCT06037668|449385895|FG000|Overall Study|Lost to Follow-up|1|||
124933414|NCT06037668|449385896|FG001|Overall Study|Lost to Follow-up|1|||
124933415|NCT06037668|449385895|FG000|Overall Study|Protocol Violation|1|||
124933416|NCT06037668|449385896|FG001|Overall Study|Protocol Violation|0|||
124933417|NCT06037668|449385895|FG000|Overall Study|Withdrawal by Subject|1|||
124933418|NCT06037668|449385896|FG001|Overall Study|Withdrawal by Subject|0|||
124933419|NCT06037668|449385895|FG000|Overall Study|Other Study Discontinuation Reason|1|||
124933420|NCT06037668|449385896|FG001|Overall Study|Other Study Discontinuation Reason|0|||
124933421|NCT05285137|449385898|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
124933422|NCT05285137|449385899|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
124933423|NCT05285137|449385900|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
124933424|NCT05285137|449385901|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
124933425|NCT05285137|449385902|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
124933426|NCT05285137|449385903|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
124933427|NCT05285137|449385904|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
124933428|NCT05285137|449385905|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
124933429|NCT05285137|449385906|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
124933430|NCT05285137|449385898|FG000|Overall Study|Lost to Follow-up|0|||
124933431|NCT05285137|449385899|FG001|Overall Study|Lost to Follow-up|0|||
124933432|NCT05285137|449385900|FG002|Overall Study|Lost to Follow-up|1|||
125120813|NCT02458638|450066975|FG000|Overall Study|Withdrawal by Subject|47|||
125120814|NCT03093454|450066984|FG000|Overall Study|Withdrawal by Subject|1|||
124933433|NCT05285137|449385901|FG003|Overall Study|Lost to Follow-up|3|||
124933434|NCT05285137|449385902|FG004|Overall Study|Lost to Follow-up|0|||
124933435|NCT05285137|449385903|FG005|Overall Study|Lost to Follow-up|0|||
124933436|NCT05285137|449385904|FG006|Overall Study|Lost to Follow-up|1|||
124933437|NCT05285137|449385905|FG007|Overall Study|Lost to Follow-up|0|||
124933438|NCT05285137|449385906|FG008|Overall Study|Lost to Follow-up|0|||
124933439|NCT05285137|449385898|FG000|Overall Study|Physician Decision|0|||
124933440|NCT05285137|449385899|FG001|Overall Study|Physician Decision|1|||
125120815|NCT03093454|450066985|FG001|Overall Study|Withdrawal by Subject|1|||
125120816|NCT03093454|450066984|FG000|Overall Study|Scheduling conflict|3|||
124933441|NCT05285137|449385900|FG002|Overall Study|Physician Decision|0|||
124933442|NCT05285137|449385901|FG003|Overall Study|Physician Decision|0|||
125025538|NCT03543410|449716769|FG000|Overall Study|Lack of Efficacy|0|||
125025539|NCT03543410|449716770|FG001|Overall Study|Lack of Efficacy|1|||
125025540|NCT03543410|449716771|FG002|Overall Study|Lack of Efficacy|0|||
125025541|NCT03543410|449716769|FG000|Overall Study|Lost to Follow-up|0|||
125025542|NCT03543410|449716770|FG001|Overall Study|Lost to Follow-up|1|||
125025543|NCT03543410|449716771|FG002|Overall Study|Lost to Follow-up|0|||
125025544|NCT03543410|449716769|FG000|Overall Study|Withdrawal by Subject|5|||
125025545|NCT03543410|449716770|FG001|Overall Study|Withdrawal by Subject|2|||
125025546|NCT03543410|449716771|FG002|Overall Study|Withdrawal by Subject|8|||
125025547|NCT03543410|449716769|FG000|Overall Study|Protocol Violation|0|||
125025548|NCT03543410|449716770|FG001|Overall Study|Protocol Violation|1|||
125025549|NCT03543410|449716771|FG002|Overall Study|Protocol Violation|0|||
125025550|NCT03543410|449716769|FG000|Overall Study|Due to COVID-19|4|||
125025551|NCT03543410|449716770|FG001|Overall Study|Due to COVID-19|0|||
125025552|NCT03543410|449716771|FG002|Overall Study|Due to COVID-19|2|||
125025553|NCT03543410|449716769|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
125025554|NCT03543410|449716770|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
125025555|NCT03543410|449716771|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
125025556|NCT03543410|449716769|FG000|Overall Study|Not Due to COVID-19|2|||
125025557|NCT03543410|449716770|FG001|Overall Study|Not Due to COVID-19|0|||
125025558|NCT03543410|449716771|FG002|Overall Study|Not Due to COVID-19|1|||
125025559|NCT02883244|449716772|FG000|Overall Study|Lost to Follow-up|0|||
125025560|NCT02883244|449716773|FG001|Overall Study|Lost to Follow-up|1|||
125025561|NCT00820755|449716774|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
125025562|NCT00820755|449716775|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
125025563|NCT00820755|449716776|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
125025564|NCT00820755|449716774|FG000|Period 1: Combination Therapy Phase|Death|28|||
125025565|NCT00820755|449716775|FG001|Period 1: Combination Therapy Phase|Death|0|||
125025566|NCT00820755|449716776|FG002|Period 1: Combination Therapy Phase|Death|0|||
125025567|NCT00820755|449716774|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
125025568|NCT00820755|449716775|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
125025569|NCT00820755|449716776|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
125025570|NCT00820755|449716774|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
125025571|NCT00820755|449716775|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
125025572|NCT00820755|449716776|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
125025573|NCT00820755|449716774|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
125025574|NCT00820755|449716775|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
125025575|NCT00820755|449716776|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
125025576|NCT00820755|449716774|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
125025577|NCT00820755|449716775|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
125025578|NCT00820755|449716776|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
125025579|NCT00820755|449716774|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
125025580|NCT00820755|449716775|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
125025581|NCT00820755|449716776|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
125025582|NCT00820755|449716774|FG000|Period 1: Combination Therapy Phase|Other|11|||
125025583|NCT00820755|449716775|FG001|Period 1: Combination Therapy Phase|Other|0|||
125025584|NCT00820755|449716776|FG002|Period 1: Combination Therapy Phase|Other|0|||
125025585|NCT00820755|449716774|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
125025586|NCT00820755|449716775|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
125025587|NCT00820755|449716776|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
125025588|NCT02317562|449716779|FG000|Overall Study|Physician Decision|1|||
125025589|NCT02317562|449716779|FG000|Overall Study|early termination of the study|8|||
125025590|NCT02317562|449716779|FG000|Overall Study|Lack of Efficacy|4|||
125025591|NCT02317562|449716779|FG000|Overall Study|Withdrawal by Subject|1|||
125025592|NCT00603915|449716780|FG000|Overall Study|Physician Decision|1|||
125025593|NCT03891901|449716781|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
125025594|NCT03891901|449716782|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
125025595|NCT03891901|449716783|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
125025596|NCT03891901|449716784|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
125025597|NCT03891901|449716785|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
125025598|NCT03891901|449716786|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
125025599|NCT03891901|449716787|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
125025600|NCT03891901|449716788|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
125025601|NCT03891901|449716789|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
125025602|NCT03891901|449716781|FG000|Overall Study|Adverse Event|2|||
125025603|NCT03891901|449716782|FG001|Overall Study|Adverse Event|2|||
125025604|NCT03891901|449716783|FG002|Overall Study|Adverse Event|0|||
125025605|NCT03891901|449716784|FG003|Overall Study|Adverse Event|0|||
124933443|NCT05285137|449385902|FG004|Overall Study|Physician Decision|0|||
124933444|NCT05285137|449385903|FG005|Overall Study|Physician Decision|0|||
124933445|NCT05285137|449385904|FG006|Overall Study|Physician Decision|0|||
124933446|NCT05285137|449385905|FG007|Overall Study|Physician Decision|0|||
124933447|NCT05285137|449385906|FG008|Overall Study|Physician Decision|0|||
124933448|NCT05285137|449385898|FG000|Overall Study|Pregnancy|0|||
124933449|NCT05285137|449385899|FG001|Overall Study|Pregnancy|0|||
124933450|NCT05285137|449385900|FG002|Overall Study|Pregnancy|0|||
124933451|NCT05285137|449385901|FG003|Overall Study|Pregnancy|0|||
124933452|NCT05285137|449385902|FG004|Overall Study|Pregnancy|0|||
124933453|NCT05285137|449385903|FG005|Overall Study|Pregnancy|0|||
124933454|NCT05285137|449385904|FG006|Overall Study|Pregnancy|1|||
124933455|NCT05285137|449385905|FG007|Overall Study|Pregnancy|0|||
124933456|NCT05285137|449385906|FG008|Overall Study|Pregnancy|0|||
124933457|NCT05285137|449385898|FG000|Overall Study|Withdrawal by Subject|0|||
124933458|NCT05285137|449385899|FG001|Overall Study|Withdrawal by Subject|1|||
124933459|NCT05285137|449385900|FG002|Overall Study|Withdrawal by Subject|2|||
124933460|NCT05285137|449385901|FG003|Overall Study|Withdrawal by Subject|1|||
124933461|NCT05285137|449385902|FG004|Overall Study|Withdrawal by Subject|0|||
124933462|NCT05285137|449385903|FG005|Overall Study|Withdrawal by Subject|0|||
124933463|NCT05285137|449385904|FG006|Overall Study|Withdrawal by Subject|0|||
124933464|NCT05285137|449385905|FG007|Overall Study|Withdrawal by Subject|0|||
124933465|NCT05285137|449385906|FG008|Overall Study|Withdrawal by Subject|1|||
124933466|NCT03717935|449385907|FG000|Overall Study|Withdrawal by Subject|0|||
124933467|NCT03717935|449385908|FG001|Overall Study|Withdrawal by Subject|2|||
124933468|NCT03484819|449385913|FG000|Overall Study|Death|2|||
124933469|NCT03484819|449385913|FG000|Overall Study|Adverse Event|2|||
124933470|NCT03484819|449385913|FG000|Overall Study|Physician Decision|1|||
124933471|NCT03484819|449385913|FG000|Overall Study|Withdrawal by Subject|2|||
124933472|NCT03484819|449385913|FG000|Overall Study|Disease Progression|4|||
124933473|NCT03484819|449385913|FG000|Overall Study|Complicating Condition|1|||
124933474|NCT01199133|449385918|FG000|Year 1|Adverse Event|16|||
124933475|NCT01199133|449385919|FG001|Year 1|Adverse Event|4|||
124933476|NCT01199133|449385918|FG000|Year 1|Withdrawal by Subject|8|||
124933477|NCT01199133|449385919|FG001|Year 1|Withdrawal by Subject|4|||
124933478|NCT01199133|449385918|FG000|Year 1|Any other reason not above-mentioned|6|||
124933479|NCT01199133|449385919|FG001|Year 1|Any other reason not above-mentioned|7|||
124933480|NCT01199133|449385918|FG000|Year 2|Adverse Event|1|||
124933481|NCT01199133|449385919|FG001|Year 2|Adverse Event|0|||
124933482|NCT01199133|449385918|FG000|Year 2|Withdrawal by Subject|1|||
124933483|NCT01199133|449385919|FG001|Year 2|Withdrawal by Subject|1|||
124933484|NCT01199133|449385918|FG000|Year 2|Any other reason not above-mentioned|1|||
124933485|NCT01199133|449385919|FG001|Year 2|Any other reason not above-mentioned|2|||
124933486|NCT03988621|449385920|FG000|Overall Study|Lost to Follow-up|16|||
124933487|NCT03988621|449385921|FG001|Overall Study|Lost to Follow-up|17|||
124933488|NCT03988621|449385920|FG000|Overall Study|Withdrawal by Subject|14|||
124933489|NCT03988621|449385921|FG001|Overall Study|Withdrawal by Subject|7|||
124933490|NCT03988621|449385920|FG000|Overall Study|Patient Lost to Follow Up|15|||
124933491|NCT03988621|449385921|FG001|Overall Study|Patient Lost to Follow Up|15|||
124933492|NCT03988621|449385920|FG000|Overall Study|Patient death|1|||
124933493|NCT03988621|449385921|FG001|Overall Study|Patient death|5|||
124933494|NCT05013385|449385922|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
124933495|NCT04629339|449385925|FG000|Overall Study|Death|1|||
124933496|NCT04629339|449385926|FG001|Overall Study|Death|0|||
124933497|NCT04629339|449385927|FG002|Overall Study|Death|2|||
124933498|NCT04629339|449385928|FG003|Overall Study|Death|2|||
124933499|NCT04629339|449385929|FG004|Overall Study|Death|0|||
124933500|NCT04629339|449385925|FG000|Overall Study|Disease Progression|0|||
124933501|NCT04629339|449385926|FG001|Overall Study|Disease Progression|0|||
125025606|NCT03891901|449716785|FG004|Overall Study|Adverse Event|0|||
125025607|NCT03891901|449716786|FG005|Overall Study|Adverse Event|0|||
125025608|NCT03891901|449716787|FG006|Overall Study|Adverse Event|0|||
125025609|NCT03891901|449716788|FG007|Overall Study|Adverse Event|0|||
124933502|NCT04629339|449385927|FG002|Overall Study|Disease Progression|1|||
124933503|NCT04629339|449385928|FG003|Overall Study|Disease Progression|1|||
124933504|NCT04629339|449385929|FG004|Overall Study|Disease Progression|0|||
124933505|NCT04629339|449385925|FG000|Overall Study|Lost to Follow-up|0|||
124933506|NCT04629339|449385926|FG001|Overall Study|Lost to Follow-up|0|||
125025610|NCT03891901|449716789|FG008|Overall Study|Adverse Event|0|||
124933507|NCT04629339|449385927|FG002|Overall Study|Lost to Follow-up|0|||
124933508|NCT04629339|449385928|FG003|Overall Study|Lost to Follow-up|1|||
124933509|NCT04629339|449385929|FG004|Overall Study|Lost to Follow-up|0|||
124933510|NCT04629339|449385925|FG000|Overall Study|Physician Decision|0|||
125025611|NCT03891901|449716781|FG000|Overall Study|Poor venous access|1|||
125025612|NCT03891901|449716782|FG001|Overall Study|Poor venous access|0|||
124933511|NCT04629339|449385926|FG001|Overall Study|Physician Decision|1|||
124933512|NCT04629339|449385927|FG002|Overall Study|Physician Decision|0|||
124933513|NCT04629339|449385928|FG003|Overall Study|Physician Decision|0|||
124933514|NCT04629339|449385929|FG004|Overall Study|Physician Decision|0|||
124933515|NCT04629339|449385925|FG000|Overall Study|Study Terminated by Sponsor|0|||
125025613|NCT03891901|449716783|FG002|Overall Study|Poor venous access|0|||
125025614|NCT03891901|449716784|FG003|Overall Study|Poor venous access|0|||
125025615|NCT03891901|449716785|FG004|Overall Study|Poor venous access|0|||
125025616|NCT03891901|449716786|FG005|Overall Study|Poor venous access|0|||
125025617|NCT03891901|449716787|FG006|Overall Study|Poor venous access|0|||
125025618|NCT03891901|449716788|FG007|Overall Study|Poor venous access|0|||
125025619|NCT03891901|449716789|FG008|Overall Study|Poor venous access|0|||
125025620|NCT03891901|449716781|FG000|Overall Study|Withdrawal by Subject|0|||
125025621|NCT03891901|449716782|FG001|Overall Study|Withdrawal by Subject|2|||
125025622|NCT03891901|449716783|FG002|Overall Study|Withdrawal by Subject|0|||
125025623|NCT03891901|449716784|FG003|Overall Study|Withdrawal by Subject|0|||
125025624|NCT03891901|449716785|FG004|Overall Study|Withdrawal by Subject|0|||
125025625|NCT03891901|449716786|FG005|Overall Study|Withdrawal by Subject|0|||
125025626|NCT03891901|449716787|FG006|Overall Study|Withdrawal by Subject|0|||
125025627|NCT03891901|449716788|FG007|Overall Study|Withdrawal by Subject|0|||
125025628|NCT03891901|449716789|FG008|Overall Study|Withdrawal by Subject|0|||
125025629|NCT00573794|449716795|FG000|Overall Study|Adverse Event|81|||
125025630|NCT00573794|449716795|FG000|Overall Study|Withdrew Consent|90|||
125025631|NCT00573794|449716795|FG000|Overall Study|Lost to Follow-up|13|||
125025632|NCT00573794|449716795|FG000|Overall Study|Protocol Violation|6|||
125025633|NCT00573794|449716795|FG000|Overall Study|Lack of Efficacy|94|||
125025634|NCT00573794|449716795|FG000|Overall Study|Other|46|||
125025635|NCT02026063|449716798|FG000|Overall Study|Physician Decision|0|||
125025636|NCT02026063|449716799|FG001|Overall Study|Physician Decision|10|||
125025637|NCT02026063|449716798|FG000|Overall Study|Noncompliance with Study Drug|1|||
125025638|NCT02026063|449716799|FG001|Overall Study|Noncompliance with Study Drug|1|||
125025639|NCT02026063|449716798|FG000|Overall Study|Withdrawal of Consent|1|||
125025640|NCT02026063|449716799|FG001|Overall Study|Withdrawal of Consent|6|||
125025641|NCT02026063|449716798|FG000|Overall Study|Adverse Event|5|||
125025642|NCT02026063|449716799|FG001|Overall Study|Adverse Event|20|||
125025643|NCT02026063|449716798|FG000|Overall Study|Lack of Efficacy|0|||
125025644|NCT02026063|449716799|FG001|Overall Study|Lack of Efficacy|4|||
125025645|NCT02026063|449716798|FG000|Overall Study|Lost to Follow-up|0|||
125025646|NCT02026063|449716799|FG001|Overall Study|Lost to Follow-up|1|||
125025647|NCT02026063|449716798|FG000|Overall Study|Reason not Specified|2|||
125025648|NCT02026063|449716799|FG001|Overall Study|Reason not Specified|7|||
125025649|NCT01116544|449716801|FG000|Overall Study|Protocol Violation|1|||
125025650|NCT01116544|449716802|FG001|Overall Study|Protocol Violation|0|||
125025651|NCT01116544|449716801|FG000|Overall Study|Withdrawal by Subject|1|||
125025652|NCT01116544|449716802|FG001|Overall Study|Withdrawal by Subject|1|||
125025653|NCT02183519|449716803|FG000|Overall Study|computer error|3|||
125025654|NCT02183519|449716804|FG001|Overall Study|computer error|0|||
125025655|NCT02183519|449716803|FG000|Overall Study|Did not respond to cough inducter|0|||
125025656|NCT02183519|449716804|FG001|Overall Study|Did not respond to cough inducter|3|||
125025657|NCT02542072|449716805|FG000|First Intervention (1 Month)|Adverse Event|1|||
125025658|NCT02542072|449716806|FG001|First Intervention (1 Month)|Adverse Event|1|||
125025659|NCT02542072|449716805|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
125025660|NCT02542072|449716806|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
125025661|NCT02542072|449716805|FG000|First Intervention (1 Month)|Lens discomfort|1|||
125025662|NCT02542072|449716806|FG001|First Intervention (1 Month)|Lens discomfort|2|||
125025663|NCT02542072|449716805|FG000|First Intervention (1 Month)|Protocol Violation|1|||
125025664|NCT02542072|449716806|FG001|First Intervention (1 Month)|Protocol Violation|0|||
125025665|NCT02542072|449716805|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
125025666|NCT02542072|449716806|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
125025667|NCT02542072|449716805|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
125025668|NCT02542072|449716806|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
125025669|NCT05168267|449716809|FG000|Overall Study|Withdrawal by Subject|2|||
125025670|NCT05168267|449716810|FG001|Overall Study|Withdrawal by Subject|1|||
125025671|NCT05168267|449716809|FG000|Overall Study|Withdrawn by Therapist|1|||
125025672|NCT05168267|449716810|FG001|Overall Study|Withdrawn by Therapist|1|||
125025673|NCT05168267|449716809|FG000|Overall Study|Left Facility|1|||
125025674|NCT05168267|449716810|FG001|Overall Study|Left Facility|0|||
125025675|NCT05702736|449716811|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
125025676|NCT05702736|449716812|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
125025677|NCT05702736|449716811|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
125025678|NCT05702736|449716812|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
125025679|NCT01356589|449716815|FG000|Overall Study|Enrolled, but not treated|3|||
125025680|NCT01356589|449716815|FG000|Overall Study|Dose data not recorded|2|||
125025681|NCT00695565|449716816|FG000|Overall Study|Lost to Follow-up|4|||
125025682|NCT00695565|449716817|FG001|Overall Study|Lost to Follow-up|4|||
124933516|NCT04629339|449385926|FG001|Overall Study|Study Terminated by Sponsor|0|||
124933517|NCT04629339|449385927|FG002|Overall Study|Study Terminated by Sponsor|0|||
124933518|NCT04629339|449385928|FG003|Overall Study|Study Terminated by Sponsor|1|||
124933519|NCT04629339|449385929|FG004|Overall Study|Study Terminated by Sponsor|0|||
124933520|NCT04629339|449385925|FG000|Overall Study|Withdrawal by Subject|0|||
124933521|NCT04629339|449385926|FG001|Overall Study|Withdrawal by Subject|0|||
124933522|NCT04629339|449385927|FG002|Overall Study|Withdrawal by Subject|2|||
124933523|NCT04629339|449385928|FG003|Overall Study|Withdrawal by Subject|2|||
124933524|NCT04629339|449385929|FG004|Overall Study|Withdrawal by Subject|0|||
124933525|NCT01447719|449385932|FG000|Overall Study|Image acquisition failure|2|||
124933526|NCT01447719|449385932|FG000|Overall Study|Invalid image or not imaged|3|||
124933527|NCT01447719|449385932|FG000|Overall Study|Subject still living at end of study|79|||
124933528|NCT01447719|449385932|FG000|Overall Study|Withdrawal by Subject|2|||
124933529|NCT01447719|449385932|FG000|Overall Study|Family withdrew autopsy consent|7|||
124933530|NCT03914469|449385935|FG000|Overall Study|Lost to Follow-up|1|||
124933531|NCT03914469|449385936|FG001|Overall Study|Lost to Follow-up|4|||
124933532|NCT01121588|449385943|FG000|Overall Study|Death|5|||
124933533|NCT01121588|449385944|FG001|Overall Study|Death|3|||
124933534|NCT01121588|449385945|FG002|Overall Study|Death|13|||
124933535|NCT01121588|449385943|FG000|Overall Study|Study Terminated by Sponsor|1|||
124933536|NCT01121588|449385944|FG001|Overall Study|Study Terminated by Sponsor|1|||
124933537|NCT01121588|449385945|FG002|Overall Study|Study Terminated by Sponsor|0|||
124933538|NCT01121588|449385943|FG000|Overall Study|Participant Refused Further Followup|2|||
124933539|NCT01121588|449385944|FG001|Overall Study|Participant Refused Further Followup|0|||
124933540|NCT01121588|449385945|FG002|Overall Study|Participant Refused Further Followup|2|||
124933541|NCT01121588|449385943|FG000|Overall Study|Lost to Follow-up|0|||
124933542|NCT01121588|449385944|FG001|Overall Study|Lost to Follow-up|1|||
124933543|NCT01121588|449385945|FG002|Overall Study|Lost to Follow-up|1|||
124933544|NCT01121588|449385943|FG000|Overall Study|Non-Specified Reasons|9|||
124933545|NCT01121588|449385944|FG001|Overall Study|Non-Specified Reasons|4|||
124933546|NCT01121588|449385945|FG002|Overall Study|Non-Specified Reasons|2|||
124933547|NCT02938923|449385953|FG000|Overall Study|Death|1|||
124933548|NCT02938923|449385954|FG001|Overall Study|Death|0|||
124933549|NCT02938923|449385955|FG002|Overall Study|Death|0|||
124933550|NCT02938923|449385953|FG000|Overall Study|Physician Decision|0|||
124933551|NCT02938923|449385954|FG001|Overall Study|Physician Decision|2|||
124933552|NCT02938923|449385955|FG002|Overall Study|Physician Decision|0|||
124933553|NCT02938923|449385953|FG000|Overall Study|Withdrawal by Subject|0|||
124933554|NCT02938923|449385954|FG001|Overall Study|Withdrawal by Subject|1|||
124933555|NCT02938923|449385955|FG002|Overall Study|Withdrawal by Subject|1|||
124933556|NCT04583280|449385959|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
124933557|NCT04583280|449385960|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
124933558|NCT03606512|449385963|FG000|Overall Study|Lost to Follow-up|0|||
124933559|NCT03606512|449385964|FG001|Overall Study|Lost to Follow-up|1|||
124933560|NCT03606512|449385963|FG000|Overall Study|'moved from study area|0|||
124933561|NCT03606512|449385964|FG001|Overall Study|'moved from study area|1|||
124933562|NCT05513937|449385965|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
124933563|NCT05513937|449385966|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
124933564|NCT05513937|449385967|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
124933565|NCT05513937|449385968|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
124933566|NCT05513937|449385965|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
125025683|NCT00695565|449716816|FG000|Overall Study|Adverse Event|3|||
125025684|NCT00695565|449716817|FG001|Overall Study|Adverse Event|1|||
125025685|NCT00695565|449716816|FG000|Overall Study|Protocol Violation|3|||
125025686|NCT00695565|449716817|FG001|Overall Study|Protocol Violation|1|||
125025687|NCT00695565|449716816|FG000|Overall Study|Withdrawal by Subject|1|||
125025688|NCT00695565|449716817|FG001|Overall Study|Withdrawal by Subject|1|||
125025689|NCT00695565|449716816|FG000|Overall Study|Lack of Efficacy|1|||
125025690|NCT00695565|449716817|FG001|Overall Study|Lack of Efficacy|1|||
125025691|NCT00695565|449716816|FG000|Overall Study|Subject did not follow instructions|1|||
125025692|NCT00695565|449716817|FG001|Overall Study|Subject did not follow instructions|1|||
125025693|NCT02937350|449716818|FG000|Overall Study|Withdrawal by Subject|0|||
125025694|NCT02937350|449716819|FG001|Overall Study|Withdrawal by Subject|1|||
125025695|NCT02937350|449716820|FG002|Overall Study|Withdrawal by Subject|0|||
125025696|NCT01462266|449716821|FG000|Overall Study|Adverse Event|7|||
125025697|NCT01462266|449716822|FG001|Overall Study|Adverse Event|6|||
125025698|NCT01462266|449716821|FG000|Overall Study|Death|2|||
125025699|NCT01462266|449716822|FG001|Overall Study|Death|1|||
125025700|NCT01462266|449716821|FG000|Overall Study|Lack of Efficacy|0|||
125025701|NCT01462266|449716822|FG001|Overall Study|Lack of Efficacy|2|||
124933567|NCT05513937|449385966|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
124933568|NCT05513937|449385967|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
125025702|NCT01462266|449716821|FG000|Overall Study|Lost to Follow-up|4|||
125025703|NCT01462266|449716822|FG001|Overall Study|Lost to Follow-up|3|||
124933569|NCT05513937|449385968|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
124933570|NCT05513937|449385965|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
124933571|NCT05513937|449385966|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
124933572|NCT05513937|449385967|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
124933573|NCT05513937|449385968|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
124933574|NCT05513937|449385965|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
124933575|NCT05513937|449385966|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
124933576|NCT05513937|449385967|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
124933577|NCT05513937|449385968|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
124933578|NCT05513937|449385965|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
124933579|NCT05513937|449385966|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
124933580|NCT05513937|449385967|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
124933581|NCT05513937|449385968|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
124933582|NCT05513937|449385965|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
124933583|NCT05513937|449385966|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
124933584|NCT05513937|449385967|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
124933585|NCT05513937|449385968|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
124933586|NCT02846545|449385969|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
124933587|NCT02846545|449385970|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
124933588|NCT02846545|449385969|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
124933589|NCT02846545|449385970|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
124933590|NCT02846545|449385969|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
124933591|NCT02846545|449385970|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
124933592|NCT02846545|449385969|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
124933593|NCT02846545|449385970|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
124933594|NCT02846545|449385969|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
124933595|NCT02846545|449385970|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
124933596|NCT03691298|449385973|FG000|Overall Study|Lost to Follow-up|8|||
124933597|NCT03691298|449385973|FG000|Overall Study|Sponsor terminated study|2|||
124933598|NCT02492711|449385977|FG000|Overall Study|Adverse Event|9|||
124933599|NCT02492711|449385978|FG001|Overall Study|Adverse Event|9|||
124933600|NCT02492711|449385979|FG002|Overall Study|Adverse Event|2|||
124933601|NCT02492711|449385977|FG000|Overall Study|Death|3|||
124933602|NCT02492711|449385978|FG001|Overall Study|Death|3|||
124933603|NCT02492711|449385979|FG002|Overall Study|Death|0|||
124933604|NCT02492711|449385977|FG000|Overall Study|Withdrawal by Subject|10|||
124933605|NCT02492711|449385978|FG001|Overall Study|Withdrawal by Subject|16|||
124933606|NCT02492711|449385979|FG002|Overall Study|Withdrawal by Subject|5|||
124933607|NCT02492711|449385977|FG000|Overall Study|Physician Decision|10|||
124933608|NCT02492711|449385978|FG001|Overall Study|Physician Decision|6|||
124933609|NCT02492711|449385979|FG002|Overall Study|Physician Decision|4|||
124933610|NCT02492711|449385977|FG000|Overall Study|Lost to Follow-up|0|||
124933611|NCT02492711|449385978|FG001|Overall Study|Lost to Follow-up|0|||
124933612|NCT02492711|449385979|FG002|Overall Study|Lost to Follow-up|1|||
124933613|NCT02492711|449385977|FG000|Overall Study|study treatment delay|2|||
124933614|NCT02492711|449385978|FG001|Overall Study|study treatment delay|1|||
124933615|NCT02492711|449385979|FG002|Overall Study|study treatment delay|0|||
124933616|NCT02492711|449385977|FG000|Overall Study|change in chemotherapy|0|||
124933617|NCT02492711|449385978|FG001|Overall Study|change in chemotherapy|1|||
124933618|NCT02492711|449385979|FG002|Overall Study|change in chemotherapy|0|||
124933619|NCT02492711|449385977|FG000|Overall Study|never treated|2|||
124933620|NCT02492711|449385978|FG001|Overall Study|never treated|4|||
124933621|NCT02492711|449385979|FG002|Overall Study|never treated|0|||
124933622|NCT02492711|449385977|FG000|Overall Study|Other|0|||
124933623|NCT02492711|449385978|FG001|Overall Study|Other|0|||
124933624|NCT02492711|449385979|FG002|Overall Study|Other|1|||
124933625|NCT03245840|449385984|FG000|Overall Study|Adverse Event|6|||
124933626|NCT03245840|449385985|FG001|Overall Study|Adverse Event|0|||
124933627|NCT03245840|449385984|FG000|Overall Study|Death|2|||
124933628|NCT03245840|449385985|FG001|Overall Study|Death|0|||
124933629|NCT03245840|449385984|FG000|Overall Study|Withdrawal by Subject|31|||
125025704|NCT01462266|449716821|FG000|Overall Study|Non-compliance with study drug|3|||
125025705|NCT01462266|449716822|FG001|Overall Study|Non-compliance with study drug|0|||
125025706|NCT01462266|449716821|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
124933630|NCT03245840|449385985|FG001|Overall Study|Withdrawal by Subject|1|||
124933631|NCT03245840|449385984|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
124933632|NCT03245840|449385985|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124933633|NCT03245840|449385984|FG000|Overall Study|Physician Decision|4|||
124933634|NCT03245840|449385985|FG001|Overall Study|Physician Decision|1|||
124933635|NCT03245840|449385984|FG000|Overall Study|Study Terminated by Sponsor|56|||
124933636|NCT03245840|449385985|FG001|Overall Study|Study Terminated by Sponsor|6|||
124933637|NCT03245840|449385984|FG000|Overall Study|Site Terminated by Sponsor|4|||
124933638|NCT03245840|449385985|FG001|Overall Study|Site Terminated by Sponsor|0|||
124933639|NCT03245840|449385984|FG000|Overall Study|Lost to Follow-up|12|||
124933640|NCT03245840|449385985|FG001|Overall Study|Lost to Follow-up|2|||
124933641|NCT03245840|449385984|FG000|Overall Study|Pregnancy|2|||
124933642|NCT03245840|449385985|FG001|Overall Study|Pregnancy|0|||
124933643|NCT03245840|449385984|FG000|Overall Study|Non-Compliance with Study Drug|2|||
124933644|NCT03245840|449385985|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124933645|NCT03245840|449385984|FG000|Overall Study|Not treated|1|||
124933646|NCT03245840|449385985|FG001|Overall Study|Not treated|1|||
124933647|NCT04505410|449385987|FG000|Overall Study|Adverse Event|2|||
124933648|NCT04505410|449385988|FG001|Overall Study|Adverse Event|0|||
124933649|NCT04505410|449385987|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
124933650|NCT04505410|449385988|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
124933651|NCT04505410|449385987|FG000|Overall Study|did not want to follow diet|1|||
125212802|NCT01026818|450405479|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
124933652|NCT04505410|449385988|FG001|Overall Study|did not want to follow diet|0|||
124933653|NCT04505410|449385987|FG000|Overall Study|flare up of ulcerative colitis|0|||
124933654|NCT04505410|449385988|FG001|Overall Study|flare up of ulcerative colitis|1|||
124933655|NCT04505410|449385987|FG000|Overall Study|Lost to Follow-up|0|||
125212803|NCT01026818|450405480|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
125212804|NCT01026818|450405481|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
125212805|NCT01026818|450405478|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
125212806|NCT01026818|450405479|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
125212807|NCT01026818|450405480|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
125212808|NCT01026818|450405481|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
125212809|NCT01026818|450405478|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
125212810|NCT01026818|450405479|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
125212811|NCT01026818|450405480|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
125212812|NCT01026818|450405481|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
125212813|NCT01026818|450405478|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
125212814|NCT01026818|450405479|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
125212815|NCT01026818|450405480|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
125212816|NCT01026818|450405481|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
125212817|NCT01026818|450405478|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
125212818|NCT01026818|450405479|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
125212819|NCT01026818|450405480|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
125212820|NCT01026818|450405481|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
125212821|NCT01026818|450405478|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
125212822|NCT01026818|450405479|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
125212823|NCT01026818|450405480|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
125212824|NCT01026818|450405481|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
125212825|NCT01026818|450405478|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
125212826|NCT01026818|450405479|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
125212827|NCT01026818|450405480|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
125212828|NCT01026818|450405481|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
125212829|NCT01026818|450405478|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
125212830|NCT01026818|450405479|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
125212831|NCT01026818|450405480|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
125212832|NCT01026818|450405481|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
125212833|NCT01026818|450405478|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
125212834|NCT01026818|450405479|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
124933656|NCT04505410|449385988|FG001|Overall Study|Lost to Follow-up|2|||
124933657|NCT04505410|449385987|FG000|Overall Study|Lost to Follow-up|1|||
124933658|NCT04505410|449385988|FG001|Overall Study|Lost to Follow-up|0|||
124933659|NCT04505410|449385987|FG000|Overall Study|initiated another diet on their own|0|||
124933660|NCT04505410|449385988|FG001|Overall Study|initiated another diet on their own|2|||
124933661|NCT01586910|449387154|FG000|Overall Study|Death|4|||
124933662|NCT01586910|449387155|FG001|Overall Study|Death|4|||
124933663|NCT01586910|449387154|FG000|Overall Study|Withdrawal by Subject|6|||
124933664|NCT01586910|449387155|FG001|Overall Study|Withdrawal by Subject|43|||
124933665|NCT01586910|449387154|FG000|Overall Study|Physician withdrew Subject|5|||
124933666|NCT01586910|449387155|FG001|Overall Study|Physician withdrew Subject|24|||
124933667|NCT02437136|449387160|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
125212835|NCT01026818|450405480|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
125212836|NCT01026818|450405481|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
125212837|NCT01026818|450405478|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
124933668|NCT02437136|449387161|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
124933669|NCT02437136|449387162|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
124933670|NCT02437136|449387163|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
124933671|NCT02437136|449387164|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
124933672|NCT02437136|449387165|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
125025707|NCT01462266|449716822|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
125025708|NCT01462266|449716821|FG000|Overall Study|Physician Decision|2|||
125025709|NCT01462266|449716822|FG001|Overall Study|Physician Decision|5|||
125025710|NCT01462266|449716821|FG000|Overall Study|Protocol Violation|1|||
125025711|NCT01462266|449716822|FG001|Overall Study|Protocol Violation|3|||
125025712|NCT01462266|449716821|FG000|Overall Study|Withdrawal by Subject|7|||
125025713|NCT01462266|449716822|FG001|Overall Study|Withdrawal by Subject|2|||
125025714|NCT01462266|449716821|FG000|Overall Study|Screen failure|1|||
125025715|NCT01462266|449716822|FG001|Overall Study|Screen failure|1|||
125025716|NCT01106846|449716823|FG000|Overall Study|Change in surgical procedure|0|||
125025717|NCT01106846|449716824|FG001|Overall Study|Change in surgical procedure|1|||
125120817|NCT03093454|450066985|FG001|Overall Study|Scheduling conflict|1|||
125120818|NCT03093454|450066984|FG000|Overall Study|Physician Decision|2|||
125120819|NCT03093454|450066985|FG001|Overall Study|Physician Decision|1|||
125120820|NCT04540497|450066986|FG000|Overall Study|Adverse Event|0|||
125120821|NCT04540497|450066987|FG001|Overall Study|Adverse Event|2|||
124933673|NCT02437136|449387166|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
124933674|NCT02437136|449387160|FG000|Expansion (Phase 2)|Death|0|||
124933675|NCT02437136|449387161|FG001|Expansion (Phase 2)|Death|0|||
124933676|NCT02437136|449387162|FG002|Expansion (Phase 2)|Death|0|||
124933677|NCT02437136|449387163|FG003|Expansion (Phase 2)|Death|6|||
124933678|NCT02437136|449387164|FG004|Expansion (Phase 2)|Death|37|||
124933679|NCT02437136|449387165|FG005|Expansion (Phase 2)|Death|29|||
124933680|NCT02437136|449387166|FG006|Expansion (Phase 2)|Death|24|||
124933681|NCT02437136|449387160|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
124933682|NCT02437136|449387161|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
124933683|NCT02437136|449387162|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
124933684|NCT02437136|449387163|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
124933685|NCT02437136|449387164|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
124933686|NCT02437136|449387165|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
124933687|NCT02437136|449387166|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
124933688|NCT02437136|449387160|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
124933689|NCT02437136|449387161|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
124933690|NCT02437136|449387162|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
124933691|NCT02437136|449387163|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
124933692|NCT02437136|449387164|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
124933693|NCT02437136|449387165|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
124933694|NCT02437136|449387166|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
124933695|NCT03640286|449387174|FG000|Overall Study|Adverse Event|6|||
124933696|NCT03640286|449387175|FG001|Overall Study|Adverse Event|6|||
124933697|NCT03640286|449387174|FG000|Overall Study|Lost to Follow-up|3|||
124933698|NCT03640286|449387175|FG001|Overall Study|Lost to Follow-up|6|||
124933699|NCT03640286|449387174|FG000|Overall Study|Pregnancy|1|||
124933700|NCT03640286|449387175|FG001|Overall Study|Pregnancy|0|||
124933701|NCT03640286|449387174|FG000|Overall Study|Withdrawal by Subject|10|||
124933702|NCT03640286|449387175|FG001|Overall Study|Withdrawal by Subject|10|||
124933703|NCT03640286|449387174|FG000|Overall Study|Non-compliance|4|||
124933704|NCT03640286|449387175|FG001|Overall Study|Non-compliance|10|||
124933705|NCT03640286|449387174|FG000|Overall Study|Medication change|1|||
124933706|NCT03640286|449387175|FG001|Overall Study|Medication change|0|||
124933707|NCT03640286|449387174|FG000|Overall Study|Other|1|||
124933708|NCT03640286|449387175|FG001|Overall Study|Other|2|||
124933709|NCT03640286|449387174|FG000|Overall Study|Joined another lifestyle program|0|||
124933710|NCT03640286|449387175|FG001|Overall Study|Joined another lifestyle program|1|||
124933711|NCT05524116|449387176|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
124933712|NCT05524116|449387177|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
124933713|NCT05524116|449387176|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
124933714|NCT05524116|449387177|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
124933715|NCT05524116|449387176|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
124933716|NCT05524116|449387177|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
124933717|NCT05524116|449387176|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
125025718|NCT00803179|449716835|FG000|Overall Study|Lost to Follow-up|3|||
125120822|NCT04540497|450066986|FG000|Overall Study|Lost to Follow-up|1|||
125120823|NCT04540497|450066987|FG001|Overall Study|Lost to Follow-up|0|||
124933718|NCT05524116|449387177|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
125025719|NCT02419508|449716836|FG000|Overall Study|Adverse Event|9|||
125025720|NCT02419508|449716837|FG001|Overall Study|Adverse Event|3|||
125120824|NCT04540497|450066986|FG000|Overall Study|Withdrawal by Subject|1|||
124933719|NCT05524116|449387176|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
124933720|NCT05524116|449387177|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
124933721|NCT03181516|449387178|FG000|Overall Study|Withdrawal by Subject|14|||
125025721|NCT02419508|449716836|FG000|Overall Study|Withdrawal by Subject|1|||
125120825|NCT04540497|450066987|FG001|Overall Study|Withdrawal by Subject|1|||
124933722|NCT03181516|449387179|FG001|Overall Study|Withdrawal by Subject|7|||
124933723|NCT03181516|449387178|FG000|Overall Study|Lost to Follow-up|2|||
124933724|NCT03181516|449387179|FG001|Overall Study|Lost to Follow-up|2|||
124933725|NCT05405985|449387180|FG000|Overall Study|Withdrawal by Subject|1|||
124933726|NCT05405985|449387181|FG001|Overall Study|Withdrawal by Subject|0|||
124933727|NCT03635424|449387182|FG000|Overall Study|Adverse Event|1|||
124933728|NCT03635424|449387182|FG000|Overall Study|Death|1|||
124933729|NCT03635424|449387182|FG000|Overall Study|Device not implanted|1|||
124933730|NCT05533190|449387183|FG000|Overall Study|Lost to Follow-up|19|||
124933731|NCT05533190|449387184|FG001|Overall Study|Lost to Follow-up|7|||
124933732|NCT05533190|449387183|FG000|Overall Study|Failed to download app|1|||
124933733|NCT05533190|449387184|FG001|Overall Study|Failed to download app|0|||
124933734|NCT05533190|449387183|FG000|Overall Study|Thought app was a scam|1|||
124933735|NCT05533190|449387184|FG001|Overall Study|Thought app was a scam|0|||
124933736|NCT05533190|449387183|FG000|Overall Study|Withdrawal by Subject|2|||
124933737|NCT05533190|449387184|FG001|Overall Study|Withdrawal by Subject|0|||
124933738|NCT01917084|449387185|FG000|Overall Study|Withdrawal by Subject|1|||
124933739|NCT04451772|449387193|FG000|Overall Study|Adverse Event|1|||
124933740|NCT04451772|449387194|FG001|Overall Study|Adverse Event|0|||
124933741|NCT04451772|449387195|FG002|Overall Study|Adverse Event|1|||
124933742|NCT04451772|449387196|FG003|Overall Study|Adverse Event|1|||
124933743|NCT04451772|449387197|FG004|Overall Study|Adverse Event|0|||
124933744|NCT04451772|449387198|FG005|Overall Study|Adverse Event|3|||
124933745|NCT04451772|449387193|FG000|Overall Study|Withdrawal by Subject|2|||
124933746|NCT04451772|449387194|FG001|Overall Study|Withdrawal by Subject|7|||
124933747|NCT04451772|449387195|FG002|Overall Study|Withdrawal by Subject|2|||
124933748|NCT04451772|449387196|FG003|Overall Study|Withdrawal by Subject|1|||
124933749|NCT04451772|449387197|FG004|Overall Study|Withdrawal by Subject|1|||
124933750|NCT04451772|449387198|FG005|Overall Study|Withdrawal by Subject|0|||
124933751|NCT04451772|449387193|FG000|Overall Study|Other, not specified|1|||
124933752|NCT04451772|449387194|FG001|Overall Study|Other, not specified|2|||
124933753|NCT04451772|449387195|FG002|Overall Study|Other, not specified|1|||
124933754|NCT04451772|449387196|FG003|Overall Study|Other, not specified|0|||
124933755|NCT04451772|449387197|FG004|Overall Study|Other, not specified|0|||
124933756|NCT04451772|449387198|FG005|Overall Study|Other, not specified|1|||
124933757|NCT04451772|449387193|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
124933758|NCT04451772|449387194|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
124933759|NCT04451772|449387195|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
124933760|NCT04451772|449387196|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
124933761|NCT04451772|449387197|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
124933762|NCT04451772|449387198|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
124933763|NCT04167553|449387199|FG000|Overall Study|Withdrawal by Subject|1|||
124933764|NCT04167553|449387200|FG001|Overall Study|Withdrawal by Subject|0|||
124933765|NCT04167553|449387201|FG002|Overall Study|Withdrawal by Subject|1|||
124933766|NCT04167553|449387202|FG003|Overall Study|Withdrawal by Subject|2|||
124933767|NCT04167553|449387203|FG004|Overall Study|Withdrawal by Subject|1|||
125120826|NCT04540497|450066986|FG000|Overall Study|Miscellaneous|2|||
125120827|NCT04540497|450066987|FG001|Overall Study|Miscellaneous|1|||
125120828|NCT04700449|450066994|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
125120829|NCT04700449|450066995|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
125120830|NCT04700449|450066996|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
125120831|NCT04700449|450066997|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
125120832|NCT04700449|450066994|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
125120833|NCT04700449|450066995|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
125120834|NCT04700449|450066996|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
125120835|NCT04700449|450066997|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
125120836|NCT04700449|450066994|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
125120837|NCT04700449|450066995|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
125120838|NCT04700449|450066996|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
125120839|NCT04700449|450066997|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
125120840|NCT04700449|450066994|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
125120841|NCT04700449|450066995|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
125120842|NCT04700449|450066996|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
125120843|NCT04700449|450066997|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
125120844|NCT04700449|450066994|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
124933768|NCT04167553|449387204|FG005|Overall Study|Withdrawal by Subject|0|||
124933769|NCT04167553|449387205|FG006|Overall Study|Withdrawal by Subject|0|||
124933770|NCT04167553|449387199|FG000|Overall Study|Physician Decision|0|||
124933771|NCT04167553|449387200|FG001|Overall Study|Physician Decision|0|||
124933772|NCT04167553|449387201|FG002|Overall Study|Physician Decision|0|||
124933773|NCT04167553|449387202|FG003|Overall Study|Physician Decision|0|||
124933774|NCT04167553|449387203|FG004|Overall Study|Physician Decision|2|||
124933775|NCT04167553|449387204|FG005|Overall Study|Physician Decision|2|||
125120845|NCT04700449|450066995|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
125120846|NCT04700449|450066996|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
124933776|NCT04167553|449387205|FG006|Overall Study|Physician Decision|0|||
124933777|NCT04167553|449387199|FG000|Overall Study|Lost to Follow-up|0|||
124933778|NCT04167553|449387200|FG001|Overall Study|Lost to Follow-up|0|||
124933779|NCT04167553|449387201|FG002|Overall Study|Lost to Follow-up|2|||
124933780|NCT04167553|449387202|FG003|Overall Study|Lost to Follow-up|0|||
124933781|NCT04167553|449387203|FG004|Overall Study|Lost to Follow-up|0|||
124933782|NCT04167553|449387204|FG005|Overall Study|Lost to Follow-up|0|||
124933783|NCT04167553|449387205|FG006|Overall Study|Lost to Follow-up|0|||
124933784|NCT02828358|449387213|FG000|Overall Study|Physician Decision|7|||
124933785|NCT02828358|449387214|FG001|Overall Study|Physician Decision|1|||
124933786|NCT02828358|449387213|FG000|Overall Study|Treatment Failure|6|||
124933787|NCT02828358|449387214|FG001|Overall Study|Treatment Failure|0|||
124933788|NCT02828358|449387213|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
124933789|NCT02828358|449387214|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
124933790|NCT02828358|449387213|FG000|Overall Study|Refusal of further protocol therapy|2|||
124933791|NCT02828358|449387214|FG001|Overall Study|Refusal of further protocol therapy|0|||
124933792|NCT02828358|449387213|FG000|Overall Study|Relapse|25|||
124933793|NCT02828358|449387214|FG001|Overall Study|Relapse|0|||
124933794|NCT02828358|449387213|FG000|Overall Study|Still on therapy|5|||
124933795|NCT02828358|449387214|FG001|Overall Study|Still on therapy|0|||
124933796|NCT05224544|449387217|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
124933797|NCT05224544|449387218|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
124933798|NCT04804540|449387219|FG000|Overall Study|Adverse Event|26|||
124933799|NCT04804540|449387220|FG001|Overall Study|Adverse Event|13|||
124933800|NCT05172232|449387221|FG000|Overall Study|Lost to Follow-up|3|||
124933801|NCT01828021|449387222|FG000|Overall Study|Adverse Event|5|||
124933802|NCT01828021|449387222|FG000|Overall Study|Lack of Efficacy|17|||
124933803|NCT01828021|449387222|FG000|Overall Study|Withdrawal by Subject|2|||
124933804|NCT01828021|449387222|FG000|Overall Study|Ileal obstruction, unrelated|1|||
124933805|NCT00844415|449387223|FG000|Overall Study|Withdrawal by Subject|1|||
124933806|NCT02473445|449387224|FG000|Overall Study|Withdrawal by Subject|2|||
124933807|NCT02473445|449387224|FG000|Overall Study|Sponsor Decision|20|||
124933808|NCT04881461|449387225|FG000|Overall Study|Adverse Event|2|||
124933809|NCT04881461|449387226|FG001|Overall Study|Adverse Event|4|||
124933810|NCT04881461|449387225|FG000|Overall Study|Withdrawal by Subject|19|||
124933811|NCT04881461|449387226|FG001|Overall Study|Withdrawal by Subject|19|||
124933812|NCT04881461|449387225|FG000|Overall Study|Lost to Follow-up|4|||
124933813|NCT04881461|449387226|FG001|Overall Study|Lost to Follow-up|4|||
124933814|NCT04881461|449387225|FG000|Overall Study|Lack of Efficacy|1|||
124933815|NCT04881461|449387226|FG001|Overall Study|Lack of Efficacy|0|||
124933816|NCT04881461|449387225|FG000|Overall Study|"Reason stated as other in CRF"|1|||
124933817|NCT04881461|449387226|FG001|Overall Study|"Reason stated as other in CRF"|2|||
124933818|NCT03015532|449387227|FG000|Overall Study|Adverse Event|0|||
124933819|NCT03015532|449387228|FG001|Overall Study|Adverse Event|0|||
124933820|NCT03015532|449387229|FG002|Overall Study|Adverse Event|0|||
124933821|NCT03015532|449387230|FG003|Overall Study|Adverse Event|0|||
124933822|NCT03015532|449387231|FG004|Overall Study|Adverse Event|0|||
124933823|NCT03015532|449387232|FG005|Overall Study|Adverse Event|2|||
124933824|NCT03015532|449387233|FG006|Overall Study|Adverse Event|1|||
124933825|NCT03015532|449387234|FG007|Overall Study|Adverse Event|0|||
124933826|NCT03015532|449387227|FG000|Overall Study|Withdrawal by Subject|0|||
124933827|NCT03015532|449387228|FG001|Overall Study|Withdrawal by Subject|0|||
124933828|NCT03015532|449387229|FG002|Overall Study|Withdrawal by Subject|0|||
124933829|NCT03015532|449387230|FG003|Overall Study|Withdrawal by Subject|0|||
124933830|NCT03015532|449387231|FG004|Overall Study|Withdrawal by Subject|0|||
124933831|NCT03015532|449387232|FG005|Overall Study|Withdrawal by Subject|0|||
124933832|NCT03015532|449387233|FG006|Overall Study|Withdrawal by Subject|1|||
124933833|NCT03015532|449387234|FG007|Overall Study|Withdrawal by Subject|0|||
124933834|NCT05970861|449387235|FG000|Overall Study|Physician Decision|4|||
124933835|NCT05970861|449387236|FG001|Overall Study|Physician Decision|4|||
124933836|NCT05970861|449387235|FG000|Overall Study|Lost to Follow-up|4|||
124933837|NCT05970861|449387236|FG001|Overall Study|Lost to Follow-up|3|||
124933838|NCT05100628|449387237|FG000|Overall Study|Progressive Disease|1|||
124933839|NCT05100628|449387238|FG001|Overall Study|Progressive Disease|0|||
124933840|NCT05100628|449387239|FG002|Overall Study|Progressive Disease|0|||
124933841|NCT05100628|449387240|FG003|Overall Study|Progressive Disease|0|||
125120847|NCT04700449|450066997|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
124933842|NCT05100628|449387237|FG000|Overall Study|Study Terminated by Sponsor|0|||
124933843|NCT05100628|449387238|FG001|Overall Study|Study Terminated by Sponsor|0|||
124933844|NCT05100628|449387239|FG002|Overall Study|Study Terminated by Sponsor|3|||
124933845|NCT05100628|449387240|FG003|Overall Study|Study Terminated by Sponsor|0|||
124933846|NCT05100628|449387237|FG000|Overall Study|unkown|0|||
124933847|NCT05100628|449387238|FG001|Overall Study|unkown|1|||
124933848|NCT05100628|449387239|FG002|Overall Study|unkown|0|||
124933849|NCT05100628|449387240|FG003|Overall Study|unkown|0|||
124933850|NCT00677365|449387245|FG000|Overall Study|Adverse Event|2|||
124933851|NCT00677365|449387246|FG001|Overall Study|Adverse Event|1|||
124933852|NCT00677365|449387247|FG002|Overall Study|Adverse Event|1|||
124933853|NCT00677365|449387248|FG003|Overall Study|Adverse Event|2|||
124933854|NCT00677365|449387245|FG000|Overall Study|Withdrawal by Subject|0|||
125025722|NCT02419508|449716837|FG001|Overall Study|Withdrawal by Subject|0|||
125025723|NCT02419508|449716836|FG000|Overall Study|Other - Reason not specified|0|||
125025724|NCT02419508|449716837|FG001|Overall Study|Other - Reason not specified|1|||
125025725|NCT04811716|449716838|FG000|Overall Study|Withdrawal by Subject|2|||
125025726|NCT04811716|449716839|FG001|Overall Study|Withdrawal by Subject|0|||
125025727|NCT03110900|449716840|FG000|Overall Study|Sponsor withdrew|1|||
125025728|NCT03110900|449716841|FG001|Overall Study|Sponsor withdrew|1|||
125025729|NCT02447848|449716850|FG000|Overall Study|Patient discharged|3|||
125025730|NCT02447848|449716850|FG000|Overall Study|Lack of Efficacy|4|||
125025731|NCT02447848|449716850|FG000|Overall Study|Withdrawal by Subject|4|||
125025732|NCT00684957|449716856|FG000|Overall Study|Withdrawal by Subject|1|||
125025733|NCT00684957|449716857|FG001|Overall Study|Withdrawal by Subject|1|||
125025734|NCT00684957|449716856|FG000|Overall Study|Lost to Follow-up|1|||
125025735|NCT00684957|449716857|FG001|Overall Study|Lost to Follow-up|0|||
125025736|NCT04439175|449718376|FG000|Overall Study|Never started treatment|4|||
125025737|NCT04439175|449718376|FG000|Overall Study|Ineligible|5|||
125025738|NCT04439175|449718376|FG000|Overall Study|Adverse Event|6|||
125025739|NCT04439175|449718376|FG000|Overall Study|Death|4|||
125025740|NCT04439175|449718376|FG000|Overall Study|Disease progression|44|||
125025741|NCT04439175|449718376|FG000|Overall Study|Withdrawal by Subject|4|||
124933855|NCT00677365|449387246|FG001|Overall Study|Withdrawal by Subject|0|||
124933856|NCT00677365|449387247|FG002|Overall Study|Withdrawal by Subject|1|||
124933857|NCT00677365|449387248|FG003|Overall Study|Withdrawal by Subject|0|||
124933858|NCT00677365|449387245|FG000|Overall Study|Other reason|0|||
124933859|NCT00677365|449387246|FG001|Overall Study|Other reason|0|||
124933860|NCT00677365|449387247|FG002|Overall Study|Other reason|0|||
124933861|NCT00677365|449387248|FG003|Overall Study|Other reason|1|||
124933862|NCT05422885|449387249|FG000|Overall Study|Lost to Follow-up|1|||
124933863|NCT05422885|449387249|FG000|Overall Study|Withdrawal by Subject|2|||
124933864|NCT02542631|449387252|FG000|Overall Study|Adverse Event|1|||
124933865|NCT02542631|449387253|FG001|Overall Study|Adverse Event|1|||
124933866|NCT02542631|449387252|FG000|Overall Study|Sponsor Termination|1|||
124933867|NCT02542631|449387253|FG001|Overall Study|Sponsor Termination|0|||
124933868|NCT02542631|449387252|FG000|Overall Study|Withdrawal by Subject|11|||
124933869|NCT02542631|449387253|FG001|Overall Study|Withdrawal by Subject|16|||
124933870|NCT02542631|449387252|FG000|Overall Study|Protocol Violation|1|||
124933871|NCT02542631|449387253|FG001|Overall Study|Protocol Violation|1|||
124933872|NCT02542631|449387252|FG000|Overall Study|Physician Decision|6|||
124933873|NCT02542631|449387253|FG001|Overall Study|Physician Decision|4|||
124933874|NCT02542631|449387252|FG000|Overall Study|Lost to Follow-up|6|||
124933875|NCT02542631|449387253|FG001|Overall Study|Lost to Follow-up|5|||
124933876|NCT02542631|449387252|FG000|Overall Study|Death|1|||
124933877|NCT02542631|449387253|FG001|Overall Study|Death|2|||
124933878|NCT02542631|449387252|FG000|Overall Study|Other|2|||
124933879|NCT02542631|449387253|FG001|Overall Study|Other|1|||
124933880|NCT02542631|449387252|FG000|Overall Study|Used Prohibited Medication|2|||
124933881|NCT02542631|449387253|FG001|Overall Study|Used Prohibited Medication|1|||
124933882|NCT02641730|449387254|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
124933883|NCT02641730|449387255|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
124933884|NCT02641730|449387256|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
124933885|NCT02641730|449387257|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
124933886|NCT02641730|449387258|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
124933887|NCT02641730|449387254|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
124933888|NCT02641730|449387255|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
124933889|NCT02641730|449387256|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
124933890|NCT02641730|449387257|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
124933891|NCT02641730|449387258|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
124933892|NCT02641730|449387254|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
124933893|NCT02641730|449387255|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
124933894|NCT02641730|449387256|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
124933895|NCT02641730|449387257|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
124933896|NCT02641730|449387258|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
124933897|NCT02641730|449387254|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
124933898|NCT02641730|449387255|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
124933899|NCT02641730|449387256|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
124933900|NCT02641730|449387257|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
124933901|NCT02641730|449387258|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
124933902|NCT02641730|449387254|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
124933903|NCT02641730|449387255|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
124933904|NCT02641730|449387256|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
124933905|NCT02641730|449387257|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
124933906|NCT02641730|449387258|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
124933907|NCT02641730|449387254|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
124933908|NCT02641730|449387255|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
124933909|NCT02641730|449387256|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
124933910|NCT02641730|449387257|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
124933911|NCT02641730|449387258|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
124933912|NCT00319046|449387259|FG000|Overall Study|withdrawal of subject's consent|7|||
124933913|NCT00319046|449387259|FG000|Overall Study|administrative reason|1|||
124933914|NCT00721149|449387260|FG000|Overall Study|Physician Decision|1|||
124933915|NCT00631475|449387262|FG000|Overall Study|Death|18|||
124933916|NCT00631475|449387262|FG000|Overall Study|Adverse Event|14|||
124933917|NCT00631475|449387262|FG000|Overall Study|Withdrew consent|5|||
124933918|NCT00631475|449387262|FG000|Overall Study|Preparation for lung transplant|8|||
124933919|NCT05158504|449387263|FG000|Overall Study|Lost to Follow-up|2|||
124933920|NCT05158504|449387264|FG001|Overall Study|Lost to Follow-up|3|||
124933921|NCT05652010|449387265|FG000|First Intervention|Withdrawal by Subject|0|||
124933922|NCT05652010|449387266|FG001|First Intervention|Withdrawal by Subject|1|||
124933923|NCT05652010|449387265|FG000|Second Intervention|Withdrawal by Subject|1|||
124933924|NCT05652010|449387266|FG001|Second Intervention|Withdrawal by Subject|0|||
124933925|NCT04707768|449387270|FG000|Overall Study|Adverse Event|9|||
124933926|NCT04707768|449387271|FG001|Overall Study|Adverse Event|18|||
124933927|NCT04707768|449387272|FG002|Overall Study|Adverse Event|3|||
124933928|NCT04707768|449387270|FG000|Overall Study|Investigator's Discretion|8|||
124933929|NCT04707768|449387271|FG001|Overall Study|Investigator's Discretion|4|||
124933930|NCT04707768|449387272|FG002|Overall Study|Investigator's Discretion|3|||
124933931|NCT04707768|449387270|FG000|Overall Study|Withdrawal by Subject|6|||
124933932|NCT04707768|449387271|FG001|Overall Study|Withdrawal by Subject|8|||
124933933|NCT04707768|449387272|FG002|Overall Study|Withdrawal by Subject|2|||
124933934|NCT04707768|449387270|FG000|Overall Study|Lack of Efficacy|1|||
124933935|NCT04707768|449387271|FG001|Overall Study|Lack of Efficacy|3|||
124933936|NCT04707768|449387272|FG002|Overall Study|Lack of Efficacy|0|||
124933937|NCT04707768|449387270|FG000|Overall Study|Lost to Follow-up|0|||
124933938|NCT04707768|449387271|FG001|Overall Study|Lost to Follow-up|0|||
124933939|NCT04707768|449387272|FG002|Overall Study|Lost to Follow-up|3|||
124933940|NCT04707768|449387270|FG000|Overall Study|Death|13|||
124933941|NCT04707768|449387271|FG001|Overall Study|Death|11|||
124933942|NCT04707768|449387272|FG002|Overall Study|Death|13|||
124933943|NCT04707768|449387270|FG000|Overall Study|Protocol Violation|2|||
124933944|NCT04707768|449387271|FG001|Overall Study|Protocol Violation|1|||
124933945|NCT04707768|449387272|FG002|Overall Study|Protocol Violation|0|||
124933946|NCT04707768|449387270|FG000|Overall Study|Non Compliance with Study Drug|1|||
124933947|NCT04707768|449387271|FG001|Overall Study|Non Compliance with Study Drug|0|||
124933948|NCT04707768|449387272|FG002|Overall Study|Non Compliance with Study Drug|0|||
124933949|NCT04707768|449387270|FG000|Overall Study|Transplant|4|||
124933950|NCT04707768|449387271|FG001|Overall Study|Transplant|4|||
124933951|NCT04707768|449387272|FG002|Overall Study|Transplant|8|||
124933952|NCT04707768|449387270|FG000|Overall Study|Other|9|||
124933953|NCT04707768|449387271|FG001|Overall Study|Other|5|||
124933954|NCT04707768|449387272|FG002|Overall Study|Other|2|||
124933955|NCT02518048|449387273|FG000|Overall Study|Withdrawal by Subject|1|||
124933956|NCT04678856|449387274|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
124933957|NCT04678856|449387275|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
124933958|NCT04678856|449387274|FG000|Overall Study|Withdrawal by Subject|5|||
124933959|NCT04678856|449387275|FG001|Overall Study|Withdrawal by Subject|1|||
124933960|NCT04282980|449388604|FG000|Overall Study|Remained on treatment|6|||
124933961|NCT04282980|449388604|FG000|Overall Study|Survival follow-up|11|||
124933962|NCT04282980|449388604|FG000|Overall Study|Withdrawal of informed consent|1|||
124933963|NCT04282980|449388604|FG000|Overall Study|Lost to Follow-up|1|||
124933964|NCT03571386|449388606|FG000|Overall Study|scheduling conflict|4|||
124933965|NCT03571386|449388607|FG001|Overall Study|scheduling conflict|0|||
124933966|NCT03571386|449388606|FG000|Overall Study|Withdrawal by Subject|15|||
124933967|NCT03571386|449388607|FG001|Overall Study|Withdrawal by Subject|5|||
124933968|NCT04311632|449388608|FG000|Overall Study|Withdrawal by Subject|0|||
124933969|NCT04311632|449388609|FG001|Overall Study|Withdrawal by Subject|0|||
124933970|NCT04311632|449388610|FG002|Overall Study|Withdrawal by Subject|1|||
124933971|NCT04605159|449388611|FG000|Overall Study|Adverse Event|6|||
124933972|NCT04605159|449388612|FG001|Overall Study|Adverse Event|3|||
124933973|NCT04605159|449388613|FG002|Overall Study|Adverse Event|21|||
124933974|NCT04605159|449388614|FG003|Overall Study|Adverse Event|4|||
124933975|NCT04605159|449388611|FG000|Overall Study|Lost to Follow-up|74|||
124933976|NCT04605159|449388612|FG001|Overall Study|Lost to Follow-up|45|||
124933977|NCT04605159|449388613|FG002|Overall Study|Lost to Follow-up|119|||
124933978|NCT04605159|449388614|FG003|Overall Study|Lost to Follow-up|80|||
124933979|NCT04605159|449388611|FG000|Overall Study|Protocol Violation|4|||
125025742|NCT04439175|449718376|FG000|Overall Study|Alternative Therapy|1|||
125025743|NCT04439175|449718376|FG000|Overall Study|Other|2|||
125025744|NCT02363478|449718378|FG000|Overall Study|Lost to Follow-up|4|||
125025745|NCT02363478|449718378|FG000|Overall Study|Adverse Event|4|||
125025746|NCT00768898|449718379|FG000|Overall Study|Unrelated injury|1|||
125025747|NCT00768898|449718379|FG000|Overall Study|Headache|1|||
125025748|NCT02554929|449718380|FG000|Overall Study|Lost to Follow-up|4|||
125025749|NCT02554929|449718381|FG001|Overall Study|Lost to Follow-up|4|||
125025750|NCT02554929|449718380|FG000|Overall Study|Withdrawal by Subject|2|||
125025751|NCT02554929|449718381|FG001|Overall Study|Withdrawal by Subject|8|||
125025752|NCT00546364|449718382|FG000|Overall Study|Disease progression|5|||
125025753|NCT00546364|449718383|FG001|Overall Study|Disease progression|11|||
125025754|NCT00546364|449718384|FG002|Overall Study|Disease progression|8|||
125025755|NCT00546364|449718382|FG000|Overall Study|Completed and off treatment|1|||
125025756|NCT00546364|449718383|FG001|Overall Study|Completed and off treatment|0|||
125025757|NCT00546364|449718384|FG002|Overall Study|Completed and off treatment|2|||
125120848|NCT04700449|450066994|FG000|Stage 1: Double-Blind Period|Other|0|||
125120849|NCT04700449|450066995|FG001|Stage 1: Double-Blind Period|Other|0|||
125120850|NCT04700449|450066996|FG002|Stage 1: Double-Blind Period|Other|1|||
125120851|NCT04700449|450066997|FG003|Stage 1: Double-Blind Period|Other|0|||
124933980|NCT04605159|449388612|FG001|Overall Study|Protocol Violation|5|||
124933981|NCT04605159|449388613|FG002|Overall Study|Protocol Violation|2|||
124933982|NCT04605159|449388614|FG003|Overall Study|Protocol Violation|0|||
124933983|NCT04605159|449388611|FG000|Overall Study|Withdrawal by Subject|66|||
124933984|NCT04605159|449388612|FG001|Overall Study|Withdrawal by Subject|37|||
124933985|NCT04605159|449388613|FG002|Overall Study|Withdrawal by Subject|68|||
124933986|NCT04605159|449388614|FG003|Overall Study|Withdrawal by Subject|50|||
124933987|NCT04605159|449388611|FG000|Overall Study|Migrated / moved from the study area|32|||
124933988|NCT04605159|449388612|FG001|Overall Study|Migrated / moved from the study area|22|||
124933989|NCT04605159|449388613|FG002|Overall Study|Migrated / moved from the study area|41|||
124933990|NCT04605159|449388614|FG003|Overall Study|Migrated / moved from the study area|21|||
124933991|NCT04605159|449388611|FG000|Overall Study|Other|1|||
124933992|NCT04605159|449388612|FG001|Overall Study|Other|2|||
124933993|NCT04605159|449388613|FG002|Overall Study|Other|7|||
124933994|NCT04605159|449388614|FG003|Overall Study|Other|3|||
124933995|NCT02278211|449388615|FG000|Overall Study|Unable to analyse PET scan|2|||
124933996|NCT04158739|449388616|FG000|Overall Study|Adverse Event|1|||
124933997|NCT04158739|449388617|FG001|Overall Study|Adverse Event|0|||
124933998|NCT04158739|449388616|FG000|Overall Study|Death|0|||
124933999|NCT04158739|449388617|FG001|Overall Study|Death|1|||
124934000|NCT04158739|449388616|FG000|Overall Study|Lack of Efficacy|3|||
124934001|NCT04158739|449388617|FG001|Overall Study|Lack of Efficacy|7|||
124934002|NCT04158739|449388616|FG000|Overall Study|Physician Decision|0|||
124934003|NCT04158739|449388617|FG001|Overall Study|Physician Decision|1|||
124934004|NCT04158739|449388616|FG000|Overall Study|Withdrawal by Subject|3|||
124934005|NCT04158739|449388617|FG001|Overall Study|Withdrawal by Subject|0|||
124934006|NCT04778410|449388618|FG000|Safety Run-in Period|Death|5|||
124934007|NCT04778410|449388619|FG001|Safety Run-in Period|Death|6|||
124934008|NCT04778410|449388620|FG002|Safety Run-in Period|Death|0|||
124934009|NCT04778410|449388621|FG003|Safety Run-in Period|Death|0|||
124934010|NCT04778410|449388622|FG004|Safety Run-in Period|Death|0|||
124934011|NCT04778410|449388623|FG005|Safety Run-in Period|Death|0|||
124934012|NCT04778410|449388618|FG000|Phase 2 Period|Death|0|||
124934013|NCT04778410|449388619|FG001|Phase 2 Period|Death|0|||
124934014|NCT04778410|449388620|FG002|Phase 2 Period|Death|0|||
124934015|NCT04778410|449388621|FG003|Phase 2 Period|Death|5|||
124934016|NCT04778410|449388622|FG004|Phase 2 Period|Death|18|||
124934017|NCT04778410|449388623|FG005|Phase 2 Period|Death|0|||
124934018|NCT04778410|449388618|FG000|Phase 2 Period|Lost to Follow-up|0|||
124934019|NCT04778410|449388619|FG001|Phase 2 Period|Lost to Follow-up|0|||
124934020|NCT04778410|449388620|FG002|Phase 2 Period|Lost to Follow-up|0|||
125120852|NCT04700449|450066994|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
125120853|NCT04700449|450066995|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
125025758|NCT00546364|449718382|FG000|Overall Study|Administrative reason by sponsor|1|||
125120854|NCT04700449|450066996|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
124934021|NCT04778410|449388621|FG003|Phase 2 Period|Lost to Follow-up|1|||
125025759|NCT00546364|449718383|FG001|Overall Study|Administrative reason by sponsor|0|||
125025760|NCT00546364|449718384|FG002|Overall Study|Administrative reason by sponsor|0|||
125025761|NCT00546364|449718382|FG000|Overall Study|Poor compliance/noncompliance|0|||
124934022|NCT04778410|449388622|FG004|Phase 2 Period|Lost to Follow-up|1|||
125025762|NCT00546364|449718383|FG001|Overall Study|Poor compliance/noncompliance|0|||
125025763|NCT00546364|449718384|FG002|Overall Study|Poor compliance/noncompliance|1|||
124934023|NCT04778410|449388623|FG005|Phase 2 Period|Lost to Follow-up|0|||
124934024|NCT04778410|449388618|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
124934025|NCT04778410|449388619|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
124934026|NCT04778410|449388620|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
124934027|NCT04778410|449388621|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
124934028|NCT04778410|449388622|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
124934029|NCT04778410|449388623|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
124934030|NCT04778410|449388618|FG000|Phase 2 Period|Withdrew Consent|0|||
124934031|NCT04778410|449388619|FG001|Phase 2 Period|Withdrew Consent|0|||
124934032|NCT04778410|449388620|FG002|Phase 2 Period|Withdrew Consent|0|||
124934033|NCT04778410|449388621|FG003|Phase 2 Period|Withdrew Consent|0|||
124934034|NCT04778410|449388622|FG004|Phase 2 Period|Withdrew Consent|2|||
124934035|NCT04778410|449388623|FG005|Phase 2 Period|Withdrew Consent|0|||
124934036|NCT02944968|449388624|FG000|Overall Study|Subject excluded before study procedure|1|||
124934037|NCT02944968|449388624|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
124934038|NCT02905331|449388625|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
124934039|NCT02905331|449388626|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
124934040|NCT02905331|449388627|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
124934041|NCT02905331|449388625|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
124934042|NCT02905331|449388626|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
124934043|NCT02905331|449388627|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
124934044|NCT02905331|449388625|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
124934045|NCT02905331|449388626|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
124934046|NCT02905331|449388627|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
124934047|NCT02905331|449388625|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
124934048|NCT02905331|449388626|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
124934049|NCT02905331|449388627|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
124934050|NCT02905331|449388625|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
124934051|NCT02905331|449388626|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
124934052|NCT02905331|449388627|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
124934053|NCT01385202|449388628|FG000|Overall Study|Lost to Follow-up|6|||
124934054|NCT01385202|449388628|FG000|Overall Study|Not Eligible|11|||
124934055|NCT01385202|449388628|FG000|Overall Study|Withdrawn|1|||
124934056|NCT03681262|449388629|FG000|Overall Study|Continuing on study|3|||
124934057|NCT03681262|449388630|FG001|Overall Study|Continuing on study|3|||
124934058|NCT03681262|449388629|FG000|Overall Study|Lost to Follow-up|1|||
124934059|NCT03681262|449388630|FG001|Overall Study|Lost to Follow-up|0|||
124934060|NCT04102111|449388632|FG000|Overall Study|Withdrawal by Subject|2|||
124934061|NCT04102111|449388633|FG001|Overall Study|Withdrawal by Subject|3|||
124934062|NCT04102111|449388632|FG000|Overall Study|Adverse Event|1|||
124934063|NCT04102111|449388633|FG001|Overall Study|Adverse Event|1|||
124934064|NCT04102111|449388632|FG000|Overall Study|Study terminated by sponsor|1|||
124934065|NCT04102111|449388633|FG001|Overall Study|Study terminated by sponsor|3|||
124934066|NCT02782676|449388634|FG000|Overall Study|Lost to Follow-up|0|||
124934067|NCT02782676|449388635|FG001|Overall Study|Lost to Follow-up|1|||
124934068|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
124934069|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
124934070|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
124934071|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
124934072|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
124934073|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
124934074|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
124934075|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
124934076|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
124934077|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
124934078|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
124934079|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
124934080|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
124934081|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
124934082|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
124934083|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
124934084|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
124934085|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
124934086|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
124934087|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
124934088|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
124934089|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
124934090|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
124934091|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
124934092|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
124934093|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
125025764|NCT00546364|449718382|FG000|Overall Study|No longer meets study criteria|1|||
124934094|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
124934095|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
124934096|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
124934097|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
124934098|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
124934099|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
124934100|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
124934101|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
124934102|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
124934103|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
124934104|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
124934105|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
124934106|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
124934107|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
124934108|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
124934109|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
124934110|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
124934111|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
124934112|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
124934113|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
124934114|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
124934115|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
124934116|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
124934117|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
124934118|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
124934119|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
124934120|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
124934121|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
124934122|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
124934123|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
124934124|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
124934125|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
124934126|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
124934127|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
124934128|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
124934129|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
124934130|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
124934131|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
124934132|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
124934133|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
124934134|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
124934135|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
124934136|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
124934137|NCT04055012|449388639|FG000|Overall Study|Withdrawal by Subject|1|||
124934138|NCT04055012|449388640|FG001|Overall Study|Withdrawal by Subject|3|||
124934139|NCT04055012|449388641|FG002|Overall Study|Withdrawal by Subject|1|||
124934140|NCT04055012|449388642|FG003|Overall Study|Withdrawal by Subject|0|||
124934141|NCT04055012|449388639|FG000|Overall Study|Metformin Recall|1|||
124934142|NCT04055012|449388640|FG001|Overall Study|Metformin Recall|1|||
124934143|NCT04055012|449388641|FG002|Overall Study|Metformin Recall|1|||
124934144|NCT04055012|449388642|FG003|Overall Study|Metformin Recall|0|||
124934145|NCT03663205|449388645|FG000|Overall Study|Death|144|||
124934146|NCT03663205|449388646|FG001|Overall Study|Death|69|||
124934147|NCT03663205|449388645|FG000|Overall Study|Sponsor decision|53|||
124934148|NCT03663205|449388646|FG001|Overall Study|Sponsor decision|19|||
124934149|NCT03663205|449388645|FG000|Overall Study|Withdrawal by Subject|8|||
124934150|NCT03663205|449388646|FG001|Overall Study|Withdrawal by Subject|11|||
124934151|NCT03663205|449388645|FG000|Overall Study|Lost to Follow-up|7|||
124934152|NCT03663205|449388646|FG001|Overall Study|Lost to Follow-up|9|||
124934153|NCT03663205|449388645|FG000|Overall Study|Transferred to long term extension study|11|||
124934154|NCT03663205|449388646|FG001|Overall Study|Transferred to long term extension study|3|||
124934155|NCT02326974|449388647|FG000|Overall Study|Withdrawal by Subject|2|||
124934156|NCT02326974|449388647|FG000|Overall Study|failed heterogenity evaluation|5|||
124934157|NCT02577354|449388648|FG000|Overall Study|Lack of Efficacy|4|||
124934158|NCT02577354|449388649|FG001|Overall Study|Lack of Efficacy|4|||
124934159|NCT02577354|449388648|FG000|Overall Study|Lost to Follow-up|3|||
124934160|NCT02577354|449388649|FG001|Overall Study|Lost to Follow-up|1|||
124934161|NCT02577354|449388648|FG000|Overall Study|Missed Visit|4|||
124934162|NCT02577354|449388649|FG001|Overall Study|Missed Visit|3|||
124934163|NCT02577354|449388648|FG000|Overall Study|Adverse Event|4|||
124934164|NCT02577354|449388649|FG001|Overall Study|Adverse Event|5|||
124934165|NCT04924400|449388653|FG000|Overall Study|Lost to Follow-up|3|||
124934166|NCT04924400|449388654|FG001|Overall Study|Lost to Follow-up|0|||
124934167|NCT04424316|449388655|FG000|Overall Study|Adverse Event|0|||
124934168|NCT04424316|449388656|FG001|Overall Study|Adverse Event|1|||
124934169|NCT04424316|449388657|FG002|Overall Study|Adverse Event|0|||
124934170|NCT04424316|449388658|FG003|Overall Study|Adverse Event|0|||
124934171|NCT04424316|449388655|FG000|Overall Study|Death|1|||
124934172|NCT04424316|449388656|FG001|Overall Study|Death|0|||
124934173|NCT04424316|449388657|FG002|Overall Study|Death|8|||
124934174|NCT04424316|449388658|FG003|Overall Study|Death|14|||
124934175|NCT04424316|449388655|FG000|Overall Study|Lost to Follow-up|93|||
124934176|NCT04424316|449388656|FG001|Overall Study|Lost to Follow-up|88|||
124934177|NCT04424316|449388657|FG002|Overall Study|Lost to Follow-up|224|||
124934178|NCT04424316|449388658|FG003|Overall Study|Lost to Follow-up|211|||
124934179|NCT04424316|449388655|FG000|Overall Study|No longer met eligibility criteria|1|||
124934180|NCT04424316|449388656|FG001|Overall Study|No longer met eligibility criteria|0|||
124934181|NCT04424316|449388657|FG002|Overall Study|No longer met eligibility criteria|0|||
124934182|NCT04424316|449388658|FG003|Overall Study|No longer met eligibility criteria|0|||
124934183|NCT04424316|449388655|FG000|Overall Study|Other|15|||
124934184|NCT04424316|449388656|FG001|Overall Study|Other|11|||
124934185|NCT04424316|449388657|FG002|Overall Study|Other|34|||
124934186|NCT04424316|449388658|FG003|Overall Study|Other|45|||
124934187|NCT04424316|449388655|FG000|Overall Study|Physician Decision|1|||
124934188|NCT04424316|449388656|FG001|Overall Study|Physician Decision|0|||
124934189|NCT04424316|449388657|FG002|Overall Study|Physician Decision|1|||
124934190|NCT04424316|449388658|FG003|Overall Study|Physician Decision|1|||
124934191|NCT04424316|449388655|FG000|Overall Study|Protocol Violation|0|||
124934192|NCT04424316|449388656|FG001|Overall Study|Protocol Violation|1|||
124934193|NCT04424316|449388657|FG002|Overall Study|Protocol Violation|0|||
124934194|NCT04424316|449388658|FG003|Overall Study|Protocol Violation|0|||
124934195|NCT04424316|449388655|FG000|Overall Study|Withdrawal by Subject|71|||
124934196|NCT04424316|449388656|FG001|Overall Study|Withdrawal by Subject|77|||
124934197|NCT04424316|449388657|FG002|Overall Study|Withdrawal by Subject|0|||
124934198|NCT04424316|449388658|FG003|Overall Study|Withdrawal by Subject|0|||
124934199|NCT04424316|449388655|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124934200|NCT04424316|449388656|FG001|Overall Study|Withdrawal by parent/guardian|0|||
124934201|NCT04424316|449388657|FG002|Overall Study|Withdrawal by parent/guardian|74|||
124934202|NCT04424316|449388658|FG003|Overall Study|Withdrawal by parent/guardian|81|||
124934203|NCT04424316|449388655|FG000|Overall Study|Randomized but not vaccinated|13|||
124934204|NCT04424316|449388656|FG001|Overall Study|Randomized but not vaccinated|21|||
124934205|NCT04424316|449388657|FG002|Overall Study|Randomized but not vaccinated|0|||
124934206|NCT04424316|449388658|FG003|Overall Study|Randomized but not vaccinated|0|||
124934207|NCT04424316|449388655|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
124934208|NCT04424316|449388656|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
124934209|NCT04424316|449388657|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
124934210|NCT04424316|449388658|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
124934211|NCT00412607|449388661|FG000|Overall Study|Withdrawal by Subject|9|||
124934212|NCT00412607|449388661|FG000|Overall Study|Lost to Follow-up|19|||
124934213|NCT00412607|449388661|FG000|Overall Study|Death|61|||
124934214|NCT00412607|449388661|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
124934215|NCT04109066|449388663|FG000|Pre-treatment|Participant withdrew consent|2|||
124934216|NCT04109066|449388664|FG001|Pre-treatment|Participant withdrew consent|0|||
124934217|NCT04109066|449388663|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
124934218|NCT04109066|449388664|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
124934219|NCT04109066|449388663|FG000|Treatment|Lack of Efficacy|2|||
124934220|NCT04109066|449388664|FG001|Treatment|Lack of Efficacy|4|||
124934221|NCT04109066|449388663|FG000|Treatment|Adverse Event|23|||
124934222|NCT04109066|449388664|FG001|Treatment|Adverse Event|7|||
124934223|NCT04109066|449388663|FG000|Treatment|Participant request to discontinue Study treatment|15|||
124934224|NCT04109066|449388664|FG001|Treatment|Participant request to discontinue Study treatment|14|||
124934225|NCT04109066|449388663|FG000|Treatment|Withdrawal by Subject|8|||
124934226|NCT04109066|449388664|FG001|Treatment|Withdrawal by Subject|8|||
124934227|NCT04109066|449388663|FG000|Treatment|Death|3|||
124934228|NCT04109066|449388664|FG001|Treatment|Death|0|||
124934229|NCT04109066|449388663|FG000|Treatment|Participant no longer meets study criteria|2|||
124934230|NCT04109066|449388664|FG001|Treatment|Participant no longer meets study criteria|2|||
124934231|NCT04109066|449388663|FG000|Treatment|Administrative reasons by sponsor|2|||
124934232|NCT04109066|449388664|FG001|Treatment|Administrative reasons by sponsor|3|||
124934233|NCT04109066|449388663|FG000|Treatment|Other reasons|17|||
124934234|NCT04109066|449388664|FG001|Treatment|Other reasons|23|||
124934235|NCT04109066|449388663|FG000|Treatment|Disease Progression|4|||
124934236|NCT04109066|449388664|FG001|Treatment|Disease Progression|7|||
124934237|NCT04109066|449388663|FG000|Treatment|Study drug toxicity|12|||
124934238|NCT04109066|449388664|FG001|Treatment|Study drug toxicity|5|||
124934239|NCT04109066|449388663|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
125212838|NCT01026818|450405479|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
124934240|NCT04109066|449388664|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
124934241|NCT04109066|449388663|FG000|Treatment|Disease Recurrence|0|||
124934242|NCT04109066|449388664|FG001|Treatment|Disease Recurrence|2|||
124934243|NCT04109066|449388663|FG000|Treatment|Not reported|4|||
124934244|NCT04109066|449388664|FG001|Treatment|Not reported|8|||
124934245|NCT05741294|449388666|FG000|Overall Study|Lost to Follow-up|3|||
124934246|NCT05741294|449388666|FG000|Overall Study|Protocol deviation|3|||
124934247|NCT05741294|449388666|FG000|Overall Study|Withdrawal by Subject|1|||
124934248|NCT04675034|449388669|FG000|Overall Study|Lost to Follow-up|1|||
124934249|NCT04675034|449388670|FG001|Overall Study|Lost to Follow-up|1|||
124934250|NCT04675034|449388671|FG002|Overall Study|Lost to Follow-up|0|||
124934251|NCT04675034|449388672|FG003|Overall Study|Lost to Follow-up|2|||
124934252|NCT04675034|449388673|FG004|Overall Study|Lost to Follow-up|0|||
124934253|NCT04675034|449388669|FG000|Overall Study|Protocol Violation|1|||
124934254|NCT04675034|449388670|FG001|Overall Study|Protocol Violation|0|||
124934255|NCT04675034|449388671|FG002|Overall Study|Protocol Violation|0|||
124934256|NCT04675034|449388672|FG003|Overall Study|Protocol Violation|1|||
124934257|NCT04675034|449388673|FG004|Overall Study|Protocol Violation|3|||
124934258|NCT04675034|449388669|FG000|Overall Study|Withdrawal by Subject|9|||
124934259|NCT04675034|449388670|FG001|Overall Study|Withdrawal by Subject|3|||
124934260|NCT04675034|449388671|FG002|Overall Study|Withdrawal by Subject|4|||
124934261|NCT04675034|449388672|FG003|Overall Study|Withdrawal by Subject|8|||
124934262|NCT04675034|449388673|FG004|Overall Study|Withdrawal by Subject|6|||
124934263|NCT04163991|449388674|FG000|Overall Study|Adverse Event|0|||
124934264|NCT04163991|449388675|FG001|Overall Study|Adverse Event|0|||
124934265|NCT04163991|449388676|FG002|Overall Study|Adverse Event|0|||
124934266|NCT04163991|449388677|FG003|Overall Study|Adverse Event|1|||
124934267|NCT04163991|449388678|FG004|Overall Study|Adverse Event|0|||
124934268|NCT04163991|449388674|FG000|Overall Study|Death|0|||
124934269|NCT04163991|449388675|FG001|Overall Study|Death|0|||
124934270|NCT04163991|449388676|FG002|Overall Study|Death|1|||
124934271|NCT04163991|449388677|FG003|Overall Study|Death|0|||
124934272|NCT04163991|449388678|FG004|Overall Study|Death|0|||
124934273|NCT04163991|449388674|FG000|Overall Study|Lost to Follow-up|0|||
124934274|NCT04163991|449388675|FG001|Overall Study|Lost to Follow-up|1|||
124934275|NCT04163991|449388676|FG002|Overall Study|Lost to Follow-up|0|||
124934276|NCT04163991|449388677|FG003|Overall Study|Lost to Follow-up|0|||
124934277|NCT04163991|449388678|FG004|Overall Study|Lost to Follow-up|0|||
124934278|NCT04163991|449388674|FG000|Overall Study|Withdrawal by Subject|1|||
124934279|NCT04163991|449388675|FG001|Overall Study|Withdrawal by Subject|1|||
124934280|NCT04163991|449388676|FG002|Overall Study|Withdrawal by Subject|3|||
124934281|NCT04163991|449388677|FG003|Overall Study|Withdrawal by Subject|1|||
124934282|NCT04163991|449388678|FG004|Overall Study|Withdrawal by Subject|1|||
124934283|NCT04163991|449388674|FG000|Overall Study|Other, Not Specified|0|||
124934284|NCT04163991|449388675|FG001|Overall Study|Other, Not Specified|1|||
124934285|NCT04163991|449388676|FG002|Overall Study|Other, Not Specified|1|||
124934286|NCT04163991|449388677|FG003|Overall Study|Other, Not Specified|1|||
124934287|NCT04163991|449388678|FG004|Overall Study|Other, Not Specified|0|||
124934288|NCT04078152|449388679|FG000|Overall Study|Other|83|||
124934289|NCT04078152|449388680|FG001|Overall Study|Other|22|||
124934290|NCT04078152|449388681|FG002|Overall Study|Other|25|||
124934291|NCT04078152|449388679|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
124934292|NCT04078152|449388680|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
124934293|NCT04078152|449388681|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
124934294|NCT04078152|449388679|FG000|Overall Study|Withdrawal by Subject|5|||
124934295|NCT04078152|449388680|FG001|Overall Study|Withdrawal by Subject|0|||
124934296|NCT04078152|449388681|FG002|Overall Study|Withdrawal by Subject|1|||
124934297|NCT04078152|449388679|FG000|Overall Study|Death|10|||
124934298|NCT04078152|449388680|FG001|Overall Study|Death|2|||
125212839|NCT01026818|450405480|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
125212840|NCT01026818|450405481|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
125212841|NCT01026818|450405478|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
124934299|NCT04078152|449388681|FG002|Overall Study|Death|12|||
124934300|NCT04078152|449388679|FG000|Overall Study|Adverse Event|1|||
124934301|NCT04078152|449388680|FG001|Overall Study|Adverse Event|0|||
124934302|NCT04078152|449388681|FG002|Overall Study|Adverse Event|0|||
124934303|NCT02510235|449388682|FG000|Overall Study|Withdrawal by Subject|1|||
124934304|NCT02510235|449388683|FG001|Overall Study|Withdrawal by Subject|0|||
124934305|NCT05890105|449388684|FG000|Overall Study|Adverse Event|1|||
124934306|NCT05890105|449388685|FG001|Overall Study|Adverse Event|0|||
124934307|NCT05890105|449388686|FG002|Overall Study|Adverse Event|0|||
124934308|NCT05890105|449388684|FG000|Overall Study|Other|1|||
124934309|NCT05890105|449388685|FG001|Overall Study|Other|2|||
124934310|NCT05890105|449388686|FG002|Overall Study|Other|0|||
124934311|NCT03367156|449389724|FG000|Overall Study|Lack of interest|3|||
124934312|NCT03367156|449389725|FG001|Overall Study|Lack of interest|1|||
124934313|NCT03367156|449389724|FG000|Overall Study|Death|2|||
124934314|NCT03367156|449389725|FG001|Overall Study|Death|0|||
125025765|NCT00546364|449718383|FG001|Overall Study|No longer meets study criteria|1|||
125025766|NCT00546364|449718384|FG002|Overall Study|No longer meets study criteria|0|||
125025767|NCT00546364|449718382|FG000|Overall Study|Withdrawal by Subject|5|||
125025768|NCT00546364|449718383|FG001|Overall Study|Withdrawal by Subject|6|||
125025769|NCT00546364|449718384|FG002|Overall Study|Withdrawal by Subject|3|||
125025770|NCT00546364|449718382|FG000|Overall Study|Prior taxotere|1|||
125025771|NCT00546364|449718383|FG001|Overall Study|Prior taxotere|0|||
125025772|NCT00546364|449718384|FG002|Overall Study|Prior taxotere|0|||
125025773|NCT00546364|449718382|FG000|Overall Study|Mixed response|1|||
125025774|NCT00546364|449718383|FG001|Overall Study|Mixed response|0|||
125025775|NCT00546364|449718384|FG002|Overall Study|Mixed response|0|||
125025776|NCT00546364|449718382|FG000|Overall Study|Palliative treatment|1|||
125025777|NCT00546364|449718383|FG001|Overall Study|Palliative treatment|0|||
125025778|NCT00546364|449718384|FG002|Overall Study|Palliative treatment|1|||
125025779|NCT00546364|449718382|FG000|Overall Study|Target lesions resected|1|||
125025780|NCT00546364|449718383|FG001|Overall Study|Target lesions resected|0|||
125025781|NCT00546364|449718384|FG002|Overall Study|Target lesions resected|0|||
125025782|NCT00546364|449718382|FG000|Overall Study|Physician Decision|0|||
125025783|NCT00546364|449718383|FG001|Overall Study|Physician Decision|0|||
125025784|NCT00546364|449718384|FG002|Overall Study|Physician Decision|1|||
125025785|NCT00546364|449718382|FG000|Overall Study|Sponsor decision|0|||
125025786|NCT00546364|449718383|FG001|Overall Study|Sponsor decision|0|||
125025787|NCT00546364|449718384|FG002|Overall Study|Sponsor decision|1|||
125025788|NCT00667576|449718385|FG000|Overall Study|Withdrawal by Subject|1|||
125025789|NCT00667576|449718386|FG001|Overall Study|Withdrawal by Subject|0|||
125025790|NCT00667576|449718387|FG002|Overall Study|Withdrawal by Subject|1|||
125025791|NCT00667576|449718388|FG003|Overall Study|Withdrawal by Subject|1|||
125025792|NCT00667576|449718389|FG004|Overall Study|Withdrawal by Subject|1|||
125025793|NCT00667576|449718385|FG000|Overall Study|Adverse Event|1|||
125025794|NCT00667576|449718386|FG001|Overall Study|Adverse Event|1|||
125025795|NCT00667576|449718387|FG002|Overall Study|Adverse Event|0|||
125025796|NCT00667576|449718388|FG003|Overall Study|Adverse Event|0|||
125025797|NCT00667576|449718389|FG004|Overall Study|Adverse Event|0|||
125025798|NCT00667576|449718385|FG000|Overall Study|Lost to Follow-up|0|||
125025799|NCT00667576|449718386|FG001|Overall Study|Lost to Follow-up|0|||
125025800|NCT00667576|449718387|FG002|Overall Study|Lost to Follow-up|1|||
125025801|NCT00667576|449718388|FG003|Overall Study|Lost to Follow-up|0|||
125025802|NCT00667576|449718389|FG004|Overall Study|Lost to Follow-up|0|||
125025803|NCT00667576|449718385|FG000|Overall Study|Protocol Violation|0|||
125025804|NCT00667576|449718386|FG001|Overall Study|Protocol Violation|0|||
125025805|NCT00667576|449718387|FG002|Overall Study|Protocol Violation|0|||
125025806|NCT00667576|449718388|FG003|Overall Study|Protocol Violation|1|||
125025807|NCT00667576|449718389|FG004|Overall Study|Protocol Violation|0|||
125025808|NCT00667576|449718385|FG000|Overall Study|Physician Decision|0|||
125025809|NCT00667576|449718386|FG001|Overall Study|Physician Decision|0|||
125025810|NCT00667576|449718387|FG002|Overall Study|Physician Decision|0|||
125025811|NCT00667576|449718388|FG003|Overall Study|Physician Decision|1|||
125025812|NCT00667576|449718389|FG004|Overall Study|Physician Decision|0|||
125025813|NCT00667576|449718385|FG000|Overall Study|Missed Visit|0|||
125025814|NCT00667576|449718386|FG001|Overall Study|Missed Visit|0|||
125025815|NCT00667576|449718387|FG002|Overall Study|Missed Visit|0|||
125025816|NCT00667576|449718388|FG003|Overall Study|Missed Visit|1|||
125025817|NCT00667576|449718389|FG004|Overall Study|Missed Visit|0|||
125025818|NCT01390389|449718390|FG000|Overall Study|Withdrawal by Subject|2|||
125025819|NCT01390389|449718391|FG001|Overall Study|Withdrawal by Subject|0|||
125025820|NCT01390389|449718390|FG000|Overall Study|Screen Fail|2|||
124934315|NCT03367156|449389724|FG000|Overall Study|Lost to Follow-up|2|||
124934316|NCT03367156|449389725|FG001|Overall Study|Lost to Follow-up|1|||
124934317|NCT03367156|449389724|FG000|Overall Study|Became ineligible|1|||
124934318|NCT03367156|449389725|FG001|Overall Study|Became ineligible|2|||
124934319|NCT03367156|449389724|FG000|Overall Study|Hospitalization|1|||
124934320|NCT03367156|449389725|FG001|Overall Study|Hospitalization|0|||
124934321|NCT03367156|449389724|FG000|Overall Study|Concerned about Treatment|11|||
124934322|NCT03367156|449389725|FG001|Overall Study|Concerned about Treatment|3|||
125025821|NCT01390389|449718391|FG001|Overall Study|Screen Fail|1|||
125025822|NCT03569202|449718397|FG000|Part 3|Physician Decision|1|||
125025823|NCT03569202|449718398|FG001|Part 3|Physician Decision|0|||
125025824|NCT03569202|449718397|FG000|Part 3|Other|1|||
125025825|NCT03569202|449718398|FG001|Part 3|Other|1|||
125025826|NCT00420511|449718399|FG000|Overall Study|Adverse Event|1|||
125025827|NCT00420511|449718400|FG001|Overall Study|Adverse Event|1|||
125025828|NCT00420511|449718399|FG000|Overall Study|Lost to Follow-up|1|||
125025829|NCT00420511|449718400|FG001|Overall Study|Lost to Follow-up|0|||
124934323|NCT03367156|449389724|FG000|Overall Study|Started new treatment|4|||
125025830|NCT02415712|449718401|FG000|Overall Study|Protocol Violation|16|||
125025831|NCT01668654|449718402|FG000|Overall Study|Study Closed/Terminated|3|||
124934324|NCT03367156|449389725|FG001|Overall Study|Started new treatment|1|||
124934325|NCT05507437|449389726|FG000|Overall Study|Withdrawal by Subject|1|||
124934326|NCT05507437|449389727|FG001|Overall Study|Withdrawal by Subject|1|||
124934327|NCT05507437|449389726|FG000|Overall Study|Death|3|||
124934328|NCT05507437|449389727|FG001|Overall Study|Death|0|||
124934329|NCT04084574|449389729|FG000|Overall Study|Lost to Follow-up|1|||
124934330|NCT04084574|449389730|FG001|Overall Study|Lost to Follow-up|0|||
124934331|NCT04084574|449389729|FG000|Overall Study|Physician Decision|1|||
124934332|NCT04084574|449389730|FG001|Overall Study|Physician Decision|0|||
124934333|NCT04084574|449389729|FG000|Overall Study|Relocated out of state|1|||
124934334|NCT04084574|449389730|FG001|Overall Study|Relocated out of state|0|||
124934335|NCT00942877|449389731|FG000|Overall Study|Refused further treatment|1|||
124934336|NCT00942877|449389732|FG001|Overall Study|Refused further treatment|1|||
124934337|NCT00942877|449389731|FG000|Overall Study|Patient was not treated|1|||
124934338|NCT00942877|449389732|FG001|Overall Study|Patient was not treated|0|||
124934339|NCT00942877|449389731|FG000|Overall Study|Adverse Event|1|||
124934340|NCT00942877|449389732|FG001|Overall Study|Adverse Event|0|||
124934341|NCT00942877|449389731|FG000|Overall Study|Progressive disease|42|||
124934342|NCT00942877|449389732|FG001|Overall Study|Progressive disease|3|||
124934343|NCT00887198|449389735|FG000|Randomized Period|Ongoing|42|||
124934344|NCT00887198|449389736|FG001|Randomized Period|Ongoing|0|||
124934345|NCT00887198|449389737|FG002|Randomized Period|Ongoing|0|||
124934346|NCT00887198|449389735|FG000|Randomized Period|Adverse Event|50|||
124934347|NCT00887198|449389736|FG001|Randomized Period|Adverse Event|33|||
124934348|NCT00887198|449389737|FG002|Randomized Period|Adverse Event|0|||
124934349|NCT00887198|449389735|FG000|Randomized Period|Lost to Follow-up|1|||
124934350|NCT00887198|449389736|FG001|Randomized Period|Lost to Follow-up|0|||
124934351|NCT00887198|449389737|FG002|Randomized Period|Lost to Follow-up|0|||
124934352|NCT00887198|449389735|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
124934353|NCT00887198|449389736|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
124934354|NCT00887198|449389737|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
124934355|NCT00887198|449389735|FG000|Randomized Period|Withdrawal by Subject|41|||
124934356|NCT00887198|449389736|FG001|Randomized Period|Withdrawal by Subject|56|||
124934357|NCT00887198|449389737|FG002|Randomized Period|Withdrawal by Subject|0|||
124934358|NCT00887198|449389735|FG000|Randomized Period|Progressive disease|366|||
124934359|NCT00887198|449389736|FG001|Randomized Period|Progressive disease|370|||
124934360|NCT00887198|449389737|FG002|Randomized Period|Progressive disease|0|||
124934361|NCT00887198|449389735|FG000|Randomized Period|Other|42|||
124934362|NCT00887198|449389736|FG001|Randomized Period|Other|30|||
124934363|NCT00887198|449389737|FG002|Randomized Period|Other|0|||
124934364|NCT00887198|449389735|FG000|Randomized Period|Randomized, Not treated|4|||
124934365|NCT00887198|449389736|FG001|Randomized Period|Randomized, Not treated|2|||
124934366|NCT00887198|449389737|FG002|Randomized Period|Randomized, Not treated|0|||
124934367|NCT00887198|449389735|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
124934368|NCT00887198|449389736|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
124934369|NCT00887198|449389737|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
124934370|NCT00887198|449389735|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
124934371|NCT00887198|449389736|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
124934372|NCT00887198|449389737|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
124934373|NCT00887198|449389735|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
124934374|NCT00887198|449389736|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
124934375|NCT00887198|449389737|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
124934376|NCT00887198|449389735|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
124934377|NCT00887198|449389736|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
124934378|NCT00887198|449389737|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
124934379|NCT00887198|449389735|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
124934380|NCT00887198|449389736|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
124934381|NCT00887198|449389737|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
124934382|NCT00887198|449389735|FG000|Cross Over (Placebo to AA)|Other|0|||
124934383|NCT00887198|449389736|FG001|Cross Over (Placebo to AA)|Other|0|||
124934384|NCT00887198|449389737|FG002|Cross Over (Placebo to AA)|Other|19|||
124934385|NCT03334695|449389738|FG000|Overall Study|Lost to Follow-up|3|||
124934386|NCT03334695|449389739|FG001|Overall Study|Lost to Follow-up|3|||
124934387|NCT03334695|449389738|FG000|Overall Study|Physician Decision|1|||
124934388|NCT03334695|449389739|FG001|Overall Study|Physician Decision|2|||
124934389|NCT03334695|449389738|FG000|Overall Study|Protocol Violation|0|||
124934390|NCT03334695|449389739|FG001|Overall Study|Protocol Violation|1|||
124934391|NCT05007080|449389740|FG000|Overall Study|Lost to Follow-up|0|||
124934392|NCT05007080|449389741|FG001|Overall Study|Lost to Follow-up|1|||
124934393|NCT05007080|449389742|FG002|Overall Study|Lost to Follow-up|0|||
124934394|NCT05007080|449389743|FG003|Overall Study|Lost to Follow-up|1|||
124934395|NCT05007080|449389744|FG004|Overall Study|Lost to Follow-up|1|||
124934396|NCT05007080|449389745|FG005|Overall Study|Lost to Follow-up|1|||
124934397|NCT05007080|449389740|FG000|Overall Study|Death|0|||
124934398|NCT05007080|449389741|FG001|Overall Study|Death|1|||
124934399|NCT05007080|449389742|FG002|Overall Study|Death|0|||
124934400|NCT05007080|449389743|FG003|Overall Study|Death|0|||
124934401|NCT05007080|449389744|FG004|Overall Study|Death|0|||
124934402|NCT05007080|449389745|FG005|Overall Study|Death|0|||
124934403|NCT05007080|449389740|FG000|Overall Study|Withdrawal by Subject|1|||
124934404|NCT05007080|449389741|FG001|Overall Study|Withdrawal by Subject|2|||
124934405|NCT05007080|449389742|FG002|Overall Study|Withdrawal by Subject|0|||
124934406|NCT05007080|449389743|FG003|Overall Study|Withdrawal by Subject|2|||
124934407|NCT05007080|449389744|FG004|Overall Study|Withdrawal by Subject|1|||
124934408|NCT05007080|449389745|FG005|Overall Study|Withdrawal by Subject|1|||
124934409|NCT05007080|449389740|FG000|Overall Study|Other|1|||
124934410|NCT05007080|449389741|FG001|Overall Study|Other|0|||
124934411|NCT05007080|449389742|FG002|Overall Study|Other|1|||
124934412|NCT05007080|449389743|FG003|Overall Study|Other|1|||
124934413|NCT05007080|449389744|FG004|Overall Study|Other|0|||
124934414|NCT05007080|449389745|FG005|Overall Study|Other|2|||
124934415|NCT05007080|449389740|FG000|Overall Study|Randomized not vaccinated|0|||
124934416|NCT05007080|449389741|FG001|Overall Study|Randomized not vaccinated|0|||
124934417|NCT05007080|449389742|FG002|Overall Study|Randomized not vaccinated|0|||
124934418|NCT05007080|449389743|FG003|Overall Study|Randomized not vaccinated|0|||
124934419|NCT05007080|449389744|FG004|Overall Study|Randomized not vaccinated|0|||
124934420|NCT05007080|449389745|FG005|Overall Study|Randomized not vaccinated|1|||
124934421|NCT02874742|449389746|FG000|Overall Study|Death|0|||
124934422|NCT02874742|449389747|FG001|Overall Study|Death|1|||
124934423|NCT02874742|449389748|FG002|Overall Study|Death|0|||
124934424|NCT02874742|449389746|FG000|Overall Study|Lost to Follow-up|5|||
124934425|NCT02874742|449389747|FG001|Overall Study|Lost to Follow-up|4|||
124934426|NCT02874742|449389748|FG002|Overall Study|Lost to Follow-up|1|||
124934427|NCT02874742|449389746|FG000|Overall Study|Withdrawal by Subject|17|||
124934428|NCT02874742|449389747|FG001|Overall Study|Withdrawal by Subject|8|||
124934429|NCT02874742|449389748|FG002|Overall Study|Withdrawal by Subject|0|||
124934430|NCT02874742|449389746|FG000|Overall Study|Other|4|||
124934431|NCT02874742|449389747|FG001|Overall Study|Other|1|||
124934432|NCT02874742|449389748|FG002|Overall Study|Other|0|||
124934433|NCT02874742|449389746|FG000|Overall Study|Progressive Disease|1|||
124934434|NCT02874742|449389747|FG001|Overall Study|Progressive Disease|0|||
124934435|NCT02874742|449389748|FG002|Overall Study|Progressive Disease|0|||
124934436|NCT02874742|449389746|FG000|Overall Study|Screen Failure|0|||
124934437|NCT02874742|449389747|FG001|Overall Study|Screen Failure|2|||
124934438|NCT02874742|449389748|FG002|Overall Study|Screen Failure|0|||
124934439|NCT05070741|449389758|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
124934440|NCT03582033|449389759|FG000|Part A|Other|0|||
124934441|NCT03582033|449389760|FG001|Part A|Other|0|||
124934442|NCT03582033|449389761|FG002|Part A|Other|0|||
124934443|NCT03582033|449389762|FG003|Part A|Other|0|||
124934444|NCT03582033|449389763|FG004|Part A|Other|2|||
124934445|NCT03582033|449389764|FG005|Part A|Other|0|||
124934446|NCT03582033|449389765|FG006|Part A|Other|0|||
124934447|NCT03582033|449389766|FG007|Part A|Other|0|||
124934448|NCT03582033|449389767|FG008|Part A|Other|0|||
124934449|NCT03582033|449389768|FG009|Part A|Other|0|||
124934450|NCT03582033|449389759|FG000|Part A|Death|1|||
124934451|NCT03582033|449389760|FG001|Part A|Death|1|||
124934452|NCT03582033|449389761|FG002|Part A|Death|2|||
124934453|NCT03582033|449389762|FG003|Part A|Death|4|||
124934454|NCT03582033|449389763|FG004|Part A|Death|11|||
124934455|NCT03582033|449389764|FG005|Part A|Death|0|||
124934456|NCT03582033|449389765|FG006|Part A|Death|0|||
124934457|NCT03582033|449389766|FG007|Part A|Death|0|||
124934458|NCT03582033|449389767|FG008|Part A|Death|0|||
124934459|NCT03582033|449389768|FG009|Part A|Death|0|||
125120855|NCT04700449|450066997|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
125120856|NCT04700449|450066994|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
124934460|NCT03582033|449389759|FG000|Part A|Lost to Follow-up|0|||
124934461|NCT03582033|449389760|FG001|Part A|Lost to Follow-up|0|||
124934462|NCT03582033|449389761|FG002|Part A|Lost to Follow-up|0|||
124934463|NCT03582033|449389762|FG003|Part A|Lost to Follow-up|0|||
124934464|NCT03582033|449389763|FG004|Part A|Lost to Follow-up|1|||
124934465|NCT03582033|449389764|FG005|Part A|Lost to Follow-up|0|||
124934466|NCT03582033|449389765|FG006|Part A|Lost to Follow-up|0|||
124934467|NCT03582033|449389766|FG007|Part A|Lost to Follow-up|0|||
124934468|NCT03582033|449389767|FG008|Part A|Lost to Follow-up|0|||
124934469|NCT03582033|449389768|FG009|Part A|Lost to Follow-up|0|||
124934470|NCT03582033|449389759|FG000|Part A|Study terminated by sponsor|0|||
124934471|NCT03582033|449389760|FG001|Part A|Study terminated by sponsor|0|||
124934472|NCT03582033|449389761|FG002|Part A|Study terminated by sponsor|0|||
124934473|NCT03582033|449389762|FG003|Part A|Study terminated by sponsor|2|||
124934474|NCT03582033|449389763|FG004|Part A|Study terminated by sponsor|1|||
124934475|NCT03582033|449389764|FG005|Part A|Study terminated by sponsor|0|||
124934476|NCT03582033|449389765|FG006|Part A|Study terminated by sponsor|0|||
124934477|NCT03582033|449389766|FG007|Part A|Study terminated by sponsor|0|||
124934478|NCT03582033|449389767|FG008|Part A|Study terminated by sponsor|0|||
124934479|NCT03582033|449389768|FG009|Part A|Study terminated by sponsor|0|||
124934480|NCT03582033|449389759|FG000|Part A|Withdrawal by Subject|1|||
124934481|NCT03582033|449389760|FG001|Part A|Withdrawal by Subject|1|||
124934482|NCT03582033|449389761|FG002|Part A|Withdrawal by Subject|0|||
124934483|NCT03582033|449389762|FG003|Part A|Withdrawal by Subject|1|||
124934484|NCT03582033|449389763|FG004|Part A|Withdrawal by Subject|7|||
124934485|NCT03582033|449389764|FG005|Part A|Withdrawal by Subject|0|||
124934486|NCT03582033|449389765|FG006|Part A|Withdrawal by Subject|0|||
124934487|NCT03582033|449389766|FG007|Part A|Withdrawal by Subject|0|||
124934488|NCT03582033|449389767|FG008|Part A|Withdrawal by Subject|0|||
124934489|NCT03582033|449389768|FG009|Part A|Withdrawal by Subject|0|||
124934490|NCT03582033|449389759|FG000|Part B|Death|0|||
124934491|NCT03582033|449389760|FG001|Part B|Death|0|||
124934492|NCT03582033|449389761|FG002|Part B|Death|0|||
124934493|NCT03582033|449389762|FG003|Part B|Death|0|||
124934494|NCT03582033|449389763|FG004|Part B|Death|0|||
124934495|NCT03582033|449389764|FG005|Part B|Death|2|||
124934496|NCT03582033|449389765|FG006|Part B|Death|0|||
124934497|NCT03582033|449389766|FG007|Part B|Death|0|||
124934498|NCT03582033|449389767|FG008|Part B|Death|0|||
124934499|NCT03582033|449389768|FG009|Part B|Death|0|||
124934500|NCT03582033|449389759|FG000|Part B|Study terminated by sponsor|0|||
124934501|NCT03582033|449389760|FG001|Part B|Study terminated by sponsor|0|||
124934502|NCT03582033|449389761|FG002|Part B|Study terminated by sponsor|0|||
124934503|NCT03582033|449389762|FG003|Part B|Study terminated by sponsor|0|||
124934504|NCT03582033|449389763|FG004|Part B|Study terminated by sponsor|0|||
124934505|NCT03582033|449389764|FG005|Part B|Study terminated by sponsor|12|||
124934506|NCT03582033|449389765|FG006|Part B|Study terminated by sponsor|0|||
124934507|NCT03582033|449389766|FG007|Part B|Study terminated by sponsor|0|||
124934508|NCT03582033|449389767|FG008|Part B|Study terminated by sponsor|0|||
124934509|NCT03582033|449389768|FG009|Part B|Study terminated by sponsor|0|||
124934510|NCT03582033|449389759|FG000|Part B|Withdrawal by Subject|0|||
124934511|NCT03582033|449389760|FG001|Part B|Withdrawal by Subject|0|||
124934512|NCT03582033|449389761|FG002|Part B|Withdrawal by Subject|0|||
124934513|NCT03582033|449389762|FG003|Part B|Withdrawal by Subject|0|||
124934514|NCT03582033|449389763|FG004|Part B|Withdrawal by Subject|0|||
124934515|NCT03582033|449389764|FG005|Part B|Withdrawal by Subject|6|||
124934516|NCT03582033|449389765|FG006|Part B|Withdrawal by Subject|0|||
124934517|NCT03582033|449389766|FG007|Part B|Withdrawal by Subject|0|||
124934518|NCT03582033|449389767|FG008|Part B|Withdrawal by Subject|0|||
124934519|NCT03582033|449389768|FG009|Part B|Withdrawal by Subject|0|||
124934520|NCT03582033|449389759|FG000|Part C|Other|0|||
124934521|NCT03582033|449389760|FG001|Part C|Other|0|||
124934522|NCT03582033|449389761|FG002|Part C|Other|0|||
124934523|NCT03582033|449389762|FG003|Part C|Other|0|||
124934524|NCT03582033|449389763|FG004|Part C|Other|0|||
124934525|NCT03582033|449389764|FG005|Part C|Other|0|||
124934526|NCT03582033|449389765|FG006|Part C|Other|2|||
124934527|NCT03582033|449389766|FG007|Part C|Other|0|||
124934528|NCT03582033|449389767|FG008|Part C|Other|0|||
124934529|NCT03582033|449389768|FG009|Part C|Other|0|||
124934530|NCT03582033|449389759|FG000|Part C|Death|0|||
124934531|NCT03582033|449389760|FG001|Part C|Death|0|||
124934532|NCT03582033|449389761|FG002|Part C|Death|0|||
124934533|NCT03582033|449389762|FG003|Part C|Death|0|||
124934534|NCT03582033|449389763|FG004|Part C|Death|0|||
124934535|NCT03582033|449389764|FG005|Part C|Death|0|||
124934536|NCT03582033|449389765|FG006|Part C|Death|6|||
124934537|NCT03582033|449389766|FG007|Part C|Death|1|||
124934538|NCT03582033|449389767|FG008|Part C|Death|2|||
124934539|NCT03582033|449389768|FG009|Part C|Death|0|||
124934540|NCT03582033|449389759|FG000|Part C|Study terminated by sponsor|0|||
125025832|NCT01668654|449718402|FG000|Overall Study|Withdrawal by Subject|1|||
124934541|NCT03582033|449389760|FG001|Part C|Study terminated by sponsor|0|||
124934542|NCT03582033|449389761|FG002|Part C|Study terminated by sponsor|0|||
124934543|NCT03582033|449389762|FG003|Part C|Study terminated by sponsor|0|||
124934544|NCT03582033|449389763|FG004|Part C|Study terminated by sponsor|0|||
124934545|NCT03582033|449389764|FG005|Part C|Study terminated by sponsor|0|||
124934546|NCT03582033|449389765|FG006|Part C|Study terminated by sponsor|3|||
124934547|NCT03582033|449389766|FG007|Part C|Study terminated by sponsor|3|||
124934548|NCT03582033|449389767|FG008|Part C|Study terminated by sponsor|2|||
124934549|NCT03582033|449389768|FG009|Part C|Study terminated by sponsor|0|||
124934550|NCT03582033|449389759|FG000|Part C|Withdrawal by Subject|0|||
124934551|NCT03582033|449389760|FG001|Part C|Withdrawal by Subject|0|||
124934552|NCT03582033|449389761|FG002|Part C|Withdrawal by Subject|0|||
124934553|NCT03582033|449389762|FG003|Part C|Withdrawal by Subject|0|||
125025833|NCT04557384|449718403|FG000|Overall Study|Study Terminated by Sponsor|1|||
124934554|NCT03582033|449389763|FG004|Part C|Withdrawal by Subject|0|||
124934555|NCT03582033|449389764|FG005|Part C|Withdrawal by Subject|0|||
124934556|NCT03582033|449389765|FG006|Part C|Withdrawal by Subject|1|||
124934557|NCT03582033|449389766|FG007|Part C|Withdrawal by Subject|2|||
124934558|NCT03582033|449389767|FG008|Part C|Withdrawal by Subject|1|||
124934559|NCT03582033|449389768|FG009|Part C|Withdrawal by Subject|0|||
124934560|NCT03582033|449389759|FG000|Part D|Death|0|||
124934561|NCT03582033|449389760|FG001|Part D|Death|0|||
124934562|NCT03582033|449389761|FG002|Part D|Death|0|||
125025834|NCT04557384|449718403|FG000|Overall Study|Death|1|||
125025835|NCT00454779|449718404|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
125025836|NCT00454779|449718405|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
125025837|NCT00454779|449718404|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
125025838|NCT00454779|449718405|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
125025839|NCT00454779|449718404|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
125025840|NCT00454779|449718405|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
125025841|NCT00454779|449718404|FG000|First-line Treatment Phase|Protocol Violation|0|||
125025842|NCT00454779|449718405|FG001|First-line Treatment Phase|Protocol Violation|1|||
125025843|NCT00454779|449718404|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
125025844|NCT00454779|449718405|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
125025845|NCT00454779|449718404|FG000|First-line Treatment Phase|Ongoing|1|||
125025846|NCT00454779|449718405|FG001|First-line Treatment Phase|Ongoing|0|||
125025847|NCT00454779|449718404|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
125025848|NCT00454779|449718405|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
125025849|NCT00454779|449718404|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
125025850|NCT00454779|449718405|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
125025851|NCT00454779|449718404|FG000|Second-line Treatment Phase|Ongoing|0|||
125025852|NCT00454779|449718405|FG001|Second-line Treatment Phase|Ongoing|1|||
125025853|NCT02397473|449718406|FG000|Treatment Phase|Adverse Event|1|||
125025854|NCT02397473|449718407|FG001|Treatment Phase|Adverse Event|2|||
125025855|NCT02397473|449718406|FG000|Treatment Phase|Lack of Efficacy|8|||
125025856|NCT02397473|449718407|FG001|Treatment Phase|Lack of Efficacy|1|||
125025857|NCT02397473|449718406|FG000|Treatment Phase|Lost to Follow-up|1|||
125025858|NCT02397473|449718407|FG001|Treatment Phase|Lost to Follow-up|0|||
125025859|NCT02397473|449718406|FG000|Treatment Phase|Withdrawal by Subject|2|||
125025860|NCT02397473|449718407|FG001|Treatment Phase|Withdrawal by Subject|1|||
125025861|NCT02397473|449718406|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
125025862|NCT02397473|449718407|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
125025863|NCT02397473|449718406|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
125025864|NCT02397473|449718407|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
125025865|NCT02397473|449718406|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
125025866|NCT02397473|449718407|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
124934563|NCT03582033|449389762|FG003|Part D|Death|0|||
124934564|NCT03582033|449389763|FG004|Part D|Death|0|||
124934565|NCT03582033|449389764|FG005|Part D|Death|0|||
124934566|NCT03582033|449389765|FG006|Part D|Death|0|||
124934567|NCT03582033|449389766|FG007|Part D|Death|0|||
124934568|NCT03582033|449389767|FG008|Part D|Death|0|||
124934569|NCT03582033|449389768|FG009|Part D|Death|1|||
124934570|NCT03582033|449389759|FG000|Part D|Study terminated by sponsor|0|||
124934571|NCT03582033|449389760|FG001|Part D|Study terminated by sponsor|0|||
124934572|NCT03582033|449389761|FG002|Part D|Study terminated by sponsor|0|||
124934573|NCT03582033|449389762|FG003|Part D|Study terminated by sponsor|0|||
124934574|NCT03582033|449389763|FG004|Part D|Study terminated by sponsor|0|||
124934575|NCT03582033|449389764|FG005|Part D|Study terminated by sponsor|0|||
124934576|NCT03582033|449389765|FG006|Part D|Study terminated by sponsor|0|||
125025867|NCT02397473|449718406|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
125025868|NCT02397473|449718407|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
125025869|NCT02397473|449718406|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
125025870|NCT02397473|449718407|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
125025871|NCT00927368|449718412|FG000|Overall Study|enrollment in another study|1|||
125025872|NCT00927368|449718413|FG001|Overall Study|enrollment in another study|1|||
125025873|NCT00927368|449718414|FG002|Overall Study|enrollment in another study|2|||
125025874|NCT00927368|449718412|FG000|Overall Study|Lost to Follow-up|4|||
125025875|NCT00927368|449718413|FG001|Overall Study|Lost to Follow-up|0|||
125025876|NCT00927368|449718414|FG002|Overall Study|Lost to Follow-up|0|||
125025877|NCT00927368|449718412|FG000|Overall Study|equipment failure|1|||
125025878|NCT00927368|449718413|FG001|Overall Study|equipment failure|0|||
125025879|NCT00927368|449718414|FG002|Overall Study|equipment failure|0|||
125025880|NCT00927368|449718412|FG000|Overall Study|ineligible post randomization|0|||
125025881|NCT00927368|449718413|FG001|Overall Study|ineligible post randomization|3|||
125025882|NCT00927368|449718414|FG002|Overall Study|ineligible post randomization|1|||
125025883|NCT00927368|449718412|FG000|Overall Study|cancellation of surgery|0|||
125025884|NCT00927368|449718413|FG001|Overall Study|cancellation of surgery|1|||
125025885|NCT00927368|449718414|FG002|Overall Study|cancellation of surgery|2|||
125025886|NCT02624492|449718415|FG000|Overall Study|Adverse Event|2|||
125025887|NCT02624492|449718416|FG001|Overall Study|Adverse Event|2|||
124934577|NCT03582033|449389766|FG007|Part D|Study terminated by sponsor|0|||
124934578|NCT03582033|449389767|FG008|Part D|Study terminated by sponsor|0|||
124934579|NCT03582033|449389768|FG009|Part D|Study terminated by sponsor|4|||
125025888|NCT02624492|449718417|FG002|Overall Study|Adverse Event|2|||
124934580|NCT03812614|449389769|FG000|Intervention|Withdrawal by Subject|7|||
124934581|NCT03812614|449389770|FG001|Intervention|Withdrawal by Subject|2|||
124934582|NCT03812614|449389771|FG002|Intervention|Withdrawal by Subject|7|||
124934583|NCT03812614|449389772|FG003|Intervention|Withdrawal by Subject|2|||
124934584|NCT03812614|449389769|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
124934585|NCT03812614|449389770|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
124934586|NCT03812614|449389771|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
124934587|NCT03812614|449389772|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
124934588|NCT03812614|449389769|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
124934589|NCT03812614|449389770|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
124934590|NCT03812614|449389771|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
124934591|NCT03812614|449389772|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
124934592|NCT03812614|449389769|FG000|6-month Follow-up|Lost to Follow-up|0|||
124934593|NCT03812614|449389770|FG001|6-month Follow-up|Lost to Follow-up|0|||
124934594|NCT03812614|449389771|FG002|6-month Follow-up|Lost to Follow-up|12|||
124934595|NCT03812614|449389772|FG003|6-month Follow-up|Lost to Follow-up|8|||
124934596|NCT03812614|449389769|FG000|12-month Follow-up|Lost to Follow-up|18|||
124934597|NCT03812614|449389770|FG001|12-month Follow-up|Lost to Follow-up|17|||
124934598|NCT03812614|449389771|FG002|12-month Follow-up|Lost to Follow-up|5|||
124934599|NCT03812614|449389772|FG003|12-month Follow-up|Lost to Follow-up|2|||
124934600|NCT05205161|449389773|FG000|Overall Study|Study terminated by sponsor|3|||
124934601|NCT05205161|449389774|FG001|Overall Study|Study terminated by sponsor|3|||
124934602|NCT05205161|449389775|FG002|Overall Study|Study terminated by sponsor|1|||
124934603|NCT04214418|449389780|FG000|Overall Study|Withdrawal by Subject|1|||
124934604|NCT04214418|449389781|FG001|Overall Study|Withdrawal by Subject|0|||
124934605|NCT04214418|449389782|FG002|Overall Study|Withdrawal by Subject|0|||
124934606|NCT04214418|449389783|FG003|Overall Study|Withdrawal by Subject|0|||
124934607|NCT04214418|449389784|FG004|Overall Study|Withdrawal by Subject|0|||
124934608|NCT04214418|449389785|FG005|Overall Study|Withdrawal by Subject|0|||
124934609|NCT04214418|449389780|FG000|Overall Study|Adverse Event|0|||
124934610|NCT04214418|449389781|FG001|Overall Study|Adverse Event|2|||
124934611|NCT04214418|449389782|FG002|Overall Study|Adverse Event|0|||
124934612|NCT04214418|449389783|FG003|Overall Study|Adverse Event|0|||
124934613|NCT04214418|449389784|FG004|Overall Study|Adverse Event|0|||
124934614|NCT04214418|449389785|FG005|Overall Study|Adverse Event|0|||
124934615|NCT04214418|449389780|FG000|Overall Study|Death|1|||
124934616|NCT04214418|449389781|FG001|Overall Study|Death|0|||
124934617|NCT04214418|449389782|FG002|Overall Study|Death|0|||
124934618|NCT04214418|449389783|FG003|Overall Study|Death|0|||
124934619|NCT04214418|449389784|FG004|Overall Study|Death|0|||
124934620|NCT04214418|449389785|FG005|Overall Study|Death|0|||
124934621|NCT00450216|449389789|FG000|Overall Study|Adverse Event|38|||
124934622|NCT00450216|449389790|FG001|Overall Study|Adverse Event|23|||
124934623|NCT00450216|449389789|FG000|Overall Study|Withdrawal by Subject|48|||
124934624|NCT00450216|449389790|FG001|Overall Study|Withdrawal by Subject|26|||
124934625|NCT00450216|449389789|FG000|Overall Study|Lost to Follow-up|16|||
124934626|NCT00450216|449389790|FG001|Overall Study|Lost to Follow-up|9|||
124934627|NCT00450216|449389789|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
124934628|NCT00450216|449389790|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
124934629|NCT00450216|449389789|FG000|Overall Study|misc|21|||
124934630|NCT00450216|449389790|FG001|Overall Study|misc|20|||
124934631|NCT04206787|449389791|FG000|Overall Study|Other than listed|2|||
124934632|NCT04206787|449389791|FG000|Overall Study|Investigator decision|1|||
124934633|NCT04206787|449389791|FG000|Overall Study|Death|25|||
124934634|NCT04206787|449389791|FG000|Overall Study|Lost to Follow-up|9|||
124934635|NCT04206787|449389791|FG000|Overall Study|Withdrawal of consent|9|||
124934636|NCT05008055|449389792|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
124934637|NCT05008055|449389793|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
124934638|NCT05008055|449389794|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
124934639|NCT04635059|449389796|FG000|Overall Study|Study terminated early.|4|||
124934640|NCT03011034|449389797|FG000|Overall Study|Adverse Event|1|||
124934641|NCT03011034|449389798|FG001|Overall Study|Adverse Event|0|||
124934642|NCT05123027|449389805|FG000|Overall Study|Lost to Follow-up|17|||
124934643|NCT05123027|449389806|FG001|Overall Study|Lost to Follow-up|22|||
124934644|NCT05123027|449389805|FG000|Overall Study|Incarceration|3|||
124934645|NCT05123027|449389806|FG001|Overall Study|Incarceration|4|||
124934646|NCT05123027|449389805|FG000|Overall Study|Death|2|||
124934647|NCT05123027|449389806|FG001|Overall Study|Death|2|||
124934648|NCT05123027|449389805|FG000|Overall Study|Other|2|||
124934649|NCT05123027|449389806|FG001|Overall Study|Other|0|||
124934650|NCT03735979|449389807|FG000|Overall Study|Lost to Follow-up|1|||
124934651|NCT03735979|449389808|FG001|Overall Study|Lost to Follow-up|12|||
124934652|NCT03735979|449389809|FG002|Overall Study|Lost to Follow-up|14|||
124934653|NCT03735979|449389807|FG000|Overall Study|Withdrawal by Subject|1|||
124934654|NCT03735979|449389808|FG001|Overall Study|Withdrawal by Subject|5|||
124934655|NCT03735979|449389809|FG002|Overall Study|Withdrawal by Subject|2|||
124934656|NCT03735979|449389807|FG000|Overall Study|Not due to the above reasons|1|||
124934657|NCT03735979|449389808|FG001|Overall Study|Not due to the above reasons|0|||
124934658|NCT03735979|449389809|FG002|Overall Study|Not due to the above reasons|0|||
124934659|NCT00319111|449389812|FG000|Overall Study|Adverse Event|20|||
124934660|NCT00319111|449389812|FG000|Overall Study|Withdrawal of consent|11|||
124934661|NCT00319111|449389812|FG000|Overall Study|Death|9|||
124934662|NCT00319111|449389812|FG000|Overall Study|Lack of clinical improvement|4|||
124934663|NCT00319111|449389812|FG000|Overall Study|Administrative|2|||
124934664|NCT00319111|449389812|FG000|Overall Study|Treatment failure|1|||
124934665|NCT04743973|449389814|FG000|Overall Study|Withdrawal by Subject|5|||
124934666|NCT05654662|449389815|FG000|Overall Study|Withdrawal by Subject|1|||
124934667|NCT05654662|449389816|FG001|Overall Study|Withdrawal by Subject|0|||
124934668|NCT05654662|449389815|FG000|Overall Study|A death in the family|1|||
124934669|NCT05654662|449389816|FG001|Overall Study|A death in the family|0|||
124934670|NCT03165955|449389817|FG000|Treatment|Withdrawal by Subject|3|||
124934671|NCT03165955|449389817|FG000|Treatment|Death|1|||
124934672|NCT03165955|449389817|FG000|Treatment|Adverse Event|1|||
124934673|NCT03165955|449389817|FG000|Treatment|Progressive disease|3|||
124934674|NCT04499521|449389820|FG000|Overall Study|Disease Progression|1|||
124934675|NCT04499521|449389821|FG001|Overall Study|Disease Progression|0|||
124934676|NCT03990883|449389822|FG000|Blinded Treatment Phase|Adverse Event|1|||
124934677|NCT03990883|449389823|FG001|Blinded Treatment Phase|Adverse Event|1|||
124934678|NCT03990883|449389824|FG002|Blinded Treatment Phase|Adverse Event|0|||
124934679|NCT03990883|449389822|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
124934680|NCT03990883|449389823|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
124934681|NCT03990883|449389824|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
124934682|NCT03990883|449389822|FG000|Blinded Treatment Phase|Physician Decision|1|||
124934683|NCT03990883|449389823|FG001|Blinded Treatment Phase|Physician Decision|0|||
124934684|NCT03990883|449389824|FG002|Blinded Treatment Phase|Physician Decision|0|||
124934685|NCT03990883|449389822|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
124934686|NCT03990883|449389823|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
124934687|NCT03990883|449389824|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
124934688|NCT03990883|449389822|FG000|Blinded Treatment Phase|COVID-19|3|||
124934689|NCT03990883|449389823|FG001|Blinded Treatment Phase|COVID-19|2|||
124934690|NCT03990883|449389824|FG002|Blinded Treatment Phase|COVID-19|0|||
124934691|NCT03990883|449389822|FG000|Blinded Treatment Phase|Personal Reasons|6|||
124934692|NCT03990883|449389823|FG001|Blinded Treatment Phase|Personal Reasons|3|||
124934693|NCT03990883|449389824|FG002|Blinded Treatment Phase|Personal Reasons|0|||
124934694|NCT03990883|449389822|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
124934695|NCT03990883|449389823|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
124934696|NCT03990883|449389824|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
124934697|NCT03990883|449389822|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
124934698|NCT03990883|449389823|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
124934699|NCT03990883|449389824|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
124934700|NCT03990883|449389822|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
124934701|NCT03990883|449389823|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
124934702|NCT03990883|449389824|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
124934703|NCT04427007|449390714|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
124934704|NCT04427007|449390715|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
124934705|NCT04633278|449390716|FG000|Overall Study|Adverse Event|1|||
124934706|NCT04633278|449390717|FG001|Overall Study|Adverse Event|0|||
124934707|NCT04633278|449390716|FG000|Overall Study|Withdrawal by Subject|1|||
124934708|NCT04633278|449390717|FG001|Overall Study|Withdrawal by Subject|0|||
124934709|NCT04633278|449390716|FG000|Overall Study|Death|11|||
124934710|NCT04633278|449390717|FG001|Overall Study|Death|7|||
124934711|NCT04633278|449390716|FG000|Overall Study|Sponsor Decision|3|||
124934712|NCT04633278|449390717|FG001|Overall Study|Sponsor Decision|0|||
124934713|NCT04633278|449390716|FG000|Overall Study|Not Listed|1|||
124934714|NCT04633278|449390717|FG001|Overall Study|Not Listed|0|||
124934715|NCT05247034|449390718|FG000|Overall Study|Lost to Follow-up|3|||
124934716|NCT05247034|449390719|FG001|Overall Study|Lost to Follow-up|2|||
124934717|NCT05247034|449390718|FG000|Overall Study|Organizational problems when attending appointments|1|||
124934718|NCT05247034|449390719|FG001|Overall Study|Organizational problems when attending appointments|0|||
124934719|NCT03505710|449390720|FG000|Overall Study|Progressive Disease|24|||
124934720|NCT03505710|449390721|FG001|Overall Study|Progressive Disease|17|||
124934721|NCT03505710|449390722|FG002|Overall Study|Progressive Disease|43|||
124934722|NCT03505710|449390720|FG000|Overall Study|Clinical Progression|6|||
124934723|NCT03505710|449390721|FG001|Overall Study|Clinical Progression|8|||
124934724|NCT03505710|449390722|FG002|Overall Study|Clinical Progression|3|||
124934725|NCT03505710|449390720|FG000|Overall Study|Adverse Event|12|||
124934726|NCT03505710|449390721|FG001|Overall Study|Adverse Event|6|||
124934727|NCT03505710|449390722|FG002|Overall Study|Adverse Event|28|||
124934728|NCT03505710|449390720|FG000|Overall Study|Withdrawal by Subject|1|||
124934729|NCT03505710|449390721|FG001|Overall Study|Withdrawal by Subject|3|||
125025889|NCT02624492|449718415|FG000|Overall Study|Progressive disease|0|||
125025890|NCT02624492|449718416|FG001|Overall Study|Progressive disease|2|||
125025891|NCT02624492|449718417|FG002|Overall Study|Progressive disease|3|||
125025892|NCT00364689|449718419|FG000|Overall Study|Lost to Follow-up|1|||
125025893|NCT00191451|449718423|FG000|Overall Study|Withdrawal by Subject|2|||
125025894|NCT00191451|449718424|FG001|Overall Study|Withdrawal by Subject|3|||
125025895|NCT00191451|449718425|FG002|Overall Study|Withdrawal by Subject|5|||
125025896|NCT00191451|449718423|FG000|Overall Study|Physician Decision|2|||
125025897|NCT00191451|449718424|FG001|Overall Study|Physician Decision|9|||
125025898|NCT00191451|449718425|FG002|Overall Study|Physician Decision|6|||
125025899|NCT00191451|449718423|FG000|Overall Study|Sponsor Decision|1|||
125025900|NCT00191451|449718424|FG001|Overall Study|Sponsor Decision|0|||
125025901|NCT00191451|449718425|FG002|Overall Study|Sponsor Decision|0|||
125025902|NCT00191451|449718423|FG000|Overall Study|Ineligible|0|||
125025903|NCT00191451|449718424|FG001|Overall Study|Ineligible|1|||
125025904|NCT00191451|449718425|FG002|Overall Study|Ineligible|0|||
125025905|NCT00191451|449718423|FG000|Overall Study|Reason Not Specified|2|||
125025906|NCT00191451|449718424|FG001|Overall Study|Reason Not Specified|1|||
125025907|NCT00191451|449718425|FG002|Overall Study|Reason Not Specified|3|||
125025908|NCT01114529|449718429|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
125025909|NCT01114529|449718430|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
125025910|NCT01114529|449718431|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
125025911|NCT01114529|449718429|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
125025912|NCT01114529|449718430|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
125025913|NCT01114529|449718431|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
125025914|NCT01114529|449718429|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
125025915|NCT01114529|449718430|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
125025916|NCT01114529|449718431|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
125025917|NCT01114529|449718429|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
125025918|NCT01114529|449718430|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
125025919|NCT01114529|449718431|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
125025920|NCT01114529|449718429|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
125025921|NCT01114529|449718430|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
125025922|NCT01114529|449718431|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
125025923|NCT01114529|449718429|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
125025924|NCT01114529|449718430|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
125025925|NCT01114529|449718431|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
125025926|NCT01114529|449718429|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
125025927|NCT01114529|449718430|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
125025928|NCT01114529|449718431|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
125025929|NCT01114529|449718429|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
125025930|NCT01114529|449718430|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
125025931|NCT01114529|449718431|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
125025932|NCT01114529|449718429|FG000|Completed Study Medication at Month 24|Death|2|||
125025933|NCT01114529|449718430|FG001|Completed Study Medication at Month 24|Death|1|||
125025934|NCT01114529|449718431|FG002|Completed Study Medication at Month 24|Death|2|||
125025935|NCT01114529|449718429|FG000|Completed Study Medication at Month 24|Graft loss|0|||
125025936|NCT01114529|449718430|FG001|Completed Study Medication at Month 24|Graft loss|2|||
125025937|NCT01114529|449718431|FG002|Completed Study Medication at Month 24|Graft loss|0|||
125025938|NCT01114529|449718429|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
125025939|NCT01114529|449718430|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
125025940|NCT01114529|449718431|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
125025941|NCT01114529|449718429|FG000|Completed Study Medication at Month 24|Missing|2|||
125025942|NCT01114529|449718430|FG001|Completed Study Medication at Month 24|Missing|0|||
125025943|NCT01114529|449718431|FG002|Completed Study Medication at Month 24|Missing|0|||
125025944|NCT01114529|449718429|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
125025945|NCT01114529|449718430|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
125025946|NCT01114529|449718431|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
125025947|NCT01114529|449718429|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
125025948|NCT01114529|449718430|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
125025949|NCT01114529|449718431|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
125025950|NCT01114529|449718429|FG000|Completed Study Phase at Month 24|Death|8|||
125025951|NCT01114529|449718430|FG001|Completed Study Phase at Month 24|Death|5|||
125025952|NCT01114529|449718431|FG002|Completed Study Phase at Month 24|Death|4|||
125025953|NCT01114529|449718429|FG000|Completed Study Phase at Month 24|Other|2|||
125025954|NCT01114529|449718430|FG001|Completed Study Phase at Month 24|Other|0|||
125025955|NCT01114529|449718431|FG002|Completed Study Phase at Month 24|Other|0|||
125025956|NCT01114529|449718429|FG000|Completed Study Phase at Month 24|Missing|2|||
125025957|NCT01114529|449718430|FG001|Completed Study Phase at Month 24|Missing|0|||
125025958|NCT01114529|449718431|FG002|Completed Study Phase at Month 24|Missing|0|||
125025959|NCT00272987|449718432|FG000|Overall Study|Adverse Event|1|||
125025960|NCT00272987|449718433|FG001|Overall Study|Adverse Event|0|||
125025961|NCT00272987|449718434|FG002|Overall Study|Adverse Event|0|||
125025962|NCT00272987|449718432|FG000|Overall Study|Lost to Follow-up|3|||
125025963|NCT00272987|449718433|FG001|Overall Study|Lost to Follow-up|1|||
125025964|NCT00272987|449718434|FG002|Overall Study|Lost to Follow-up|1|||
125025965|NCT00272987|449718432|FG000|Overall Study|Withdrawal by Subject|1|||
125025966|NCT00272987|449718433|FG001|Overall Study|Withdrawal by Subject|0|||
125025967|NCT00272987|449718434|FG002|Overall Study|Withdrawal by Subject|3|||
125025968|NCT00272987|449718432|FG000|Overall Study|Sponsor Terminated study|0|||
125025969|NCT00272987|449718433|FG001|Overall Study|Sponsor Terminated study|1|||
125025970|NCT00272987|449718434|FG002|Overall Study|Sponsor Terminated study|1|||
125025971|NCT00272987|449718432|FG000|Overall Study|Disease progression|1|||
125025972|NCT00272987|449718433|FG001|Overall Study|Disease progression|1|||
125025973|NCT00272987|449718434|FG002|Overall Study|Disease progression|2|||
125025974|NCT00272987|449718432|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
125025975|NCT00272987|449718433|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
125025976|NCT00272987|449718434|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
125025977|NCT00272987|449718432|FG000|Overall Study|Death|1|||
125025978|NCT00272987|449718433|FG001|Overall Study|Death|0|||
125025979|NCT00272987|449718434|FG002|Overall Study|Death|0|||
125025980|NCT00331409|449718435|FG000|Overall Study|Lack of Efficacy|4|||
125025981|NCT04428411|449718436|FG000|Overall Study|Lost to Follow-up|114|||
125025982|NCT01163786|449718438|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
125025983|NCT01163786|449718438|FG000|Treatment With Bortezomib|Adverse Event|2|||
125025984|NCT01163786|449718438|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
125025985|NCT03555266|449718443|FG000|Overall Study|Protocol Violation|6|||
125025986|NCT03555266|449718444|FG001|Overall Study|Protocol Violation|4|||
125025987|NCT02167945|449718445|FG000|Overall Study|Adverse Event|16|||
125025988|NCT02167945|449718445|FG000|Overall Study|Withdrew Consent|42|||
125025989|NCT02167945|449718445|FG000|Overall Study|Lost to Follow-up|122|||
125025990|NCT02167945|449718445|FG000|Overall Study|COVID-19 logistical restrictions|6|||
125025991|NCT02167945|449718445|FG000|Overall Study|Other, not specified|63|||
125025992|NCT00132730|449718446|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
125025993|NCT00132730|449718447|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
125025994|NCT00132730|449718448|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
125025995|NCT00132730|449718449|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
125025996|NCT00132730|449718450|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
125025997|NCT00132730|449718451|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
125025998|NCT00132730|449718446|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
125025999|NCT00132730|449718447|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
125026000|NCT00132730|449718448|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
125026001|NCT00132730|449718449|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
125026002|NCT00132730|449718450|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
125026003|NCT00132730|449718451|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
125026004|NCT00132730|449718446|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
125026005|NCT00132730|449718447|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
125026006|NCT00132730|449718448|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
125026007|NCT00132730|449718449|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
125026008|NCT00132730|449718450|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
125026009|NCT00132730|449718451|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
125026010|NCT00132730|449718446|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
125026011|NCT00132730|449718447|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
125026012|NCT00132730|449718448|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
125120857|NCT04700449|450066995|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
125120858|NCT04700449|450066996|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
125120859|NCT04700449|450066997|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
125120860|NCT04700449|450066994|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
125026013|NCT00132730|449718449|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
125026014|NCT00132730|449718450|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
125026015|NCT00132730|449718451|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
125026016|NCT00132730|449718446|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
125026017|NCT00132730|449718447|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
125026018|NCT00132730|449718448|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
125026019|NCT00132730|449718449|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
125120861|NCT04700449|450066995|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
125120862|NCT04700449|450066996|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
125120863|NCT04700449|450066997|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
125120864|NCT04700449|450066994|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
124934730|NCT03505710|449390722|FG002|Overall Study|Withdrawal by Subject|7|||
124934731|NCT03505710|449390720|FG000|Overall Study|Physician Decision|1|||
124934732|NCT03505710|449390721|FG001|Overall Study|Physician Decision|1|||
124934733|NCT03505710|449390722|FG002|Overall Study|Physician Decision|2|||
124934734|NCT03505710|449390720|FG000|Overall Study|Death|4|||
124934735|NCT03505710|449390721|FG001|Overall Study|Death|5|||
124934736|NCT03505710|449390722|FG002|Overall Study|Death|6|||
124934737|NCT03505710|449390720|FG000|Overall Study|Other Reasons|1|||
124934738|NCT03505710|449390721|FG001|Overall Study|Other Reasons|1|||
124934739|NCT03505710|449390722|FG002|Overall Study|Other Reasons|1|||
124934740|NCT03505710|449390720|FG000|Overall Study|Study Terminated by Sponsor|0|||
124934741|NCT03505710|449390721|FG001|Overall Study|Study Terminated by Sponsor|0|||
124934742|NCT03505710|449390722|FG002|Overall Study|Study Terminated by Sponsor|1|||
124934743|NCT04389957|449390726|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
124934744|NCT04389957|449390727|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
124934745|NCT04389957|449390728|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
124934746|NCT04389957|449390729|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
124934747|NCT04389957|449390730|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
124934748|NCT06655818|449390738|FG000|Overall Study|Withdrawal by Subject|1|||
124934749|NCT05147584|449390739|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
124934750|NCT05460871|449390740|FG000|Overall Study|Withdrawal by Subject|1|||
124934751|NCT05460871|449390741|FG001|Overall Study|Withdrawal by Subject|2|||
124934752|NCT04623775|449390752|FG000|Randomization|No Longer Meets Study Criteria|2|||
124934753|NCT04623775|449390753|FG001|Randomization|No Longer Meets Study Criteria|1|||
124934754|NCT04623775|449390754|FG002|Randomization|No Longer Meets Study Criteria|0|||
124934755|NCT04623775|449390755|FG003|Randomization|No Longer Meets Study Criteria|0|||
124934756|NCT04623775|449390752|FG000|Randomization|Withdrew Consent|0|||
124934757|NCT04623775|449390753|FG001|Randomization|Withdrew Consent|0|||
124934758|NCT04623775|449390754|FG002|Randomization|Withdrew Consent|0|||
124934759|NCT04623775|449390755|FG003|Randomization|Withdrew Consent|1|||
124934760|NCT04623775|449390752|FG000|Randomization|Other Reasons|0|||
124934761|NCT04623775|449390753|FG001|Randomization|Other Reasons|0|||
124934762|NCT04623775|449390754|FG002|Randomization|Other Reasons|0|||
124934763|NCT04623775|449390755|FG003|Randomization|Other Reasons|1|||
124934764|NCT04623775|449390752|FG000|Treatment Period|participant withdrew consent|4|||
124934765|NCT04623775|449390753|FG001|Treatment Period|participant withdrew consent|0|||
124934766|NCT04623775|449390754|FG002|Treatment Period|participant withdrew consent|1|||
124934767|NCT04623775|449390755|FG003|Treatment Period|participant withdrew consent|2|||
124934768|NCT04623775|449390752|FG000|Treatment Period|Death|3|||
124934769|NCT04623775|449390753|FG001|Treatment Period|Death|1|||
124934770|NCT04623775|449390754|FG002|Treatment Period|Death|4|||
124934771|NCT04623775|449390755|FG003|Treatment Period|Death|2|||
124934772|NCT04623775|449390752|FG000|Treatment Period|Lost to Follow-up|0|||
124934773|NCT04623775|449390753|FG001|Treatment Period|Lost to Follow-up|2|||
124934774|NCT04623775|449390754|FG002|Treatment Period|Lost to Follow-up|0|||
124934775|NCT04623775|449390755|FG003|Treatment Period|Lost to Follow-up|0|||
124934776|NCT04623775|449390752|FG000|Treatment Period|poor/non compliance|0|||
124934777|NCT04623775|449390753|FG001|Treatment Period|poor/non compliance|0|||
124934778|NCT04623775|449390754|FG002|Treatment Period|poor/non compliance|1|||
124934779|NCT04623775|449390755|FG003|Treatment Period|poor/non compliance|0|||
124934780|NCT04623775|449390752|FG000|Treatment Period|participant no longer meets study criteria|0|||
124934781|NCT04623775|449390753|FG001|Treatment Period|participant no longer meets study criteria|1|||
124934782|NCT04623775|449390754|FG002|Treatment Period|participant no longer meets study criteria|0|||
124934783|NCT04623775|449390755|FG003|Treatment Period|participant no longer meets study criteria|0|||
124934784|NCT04623775|449390752|FG000|Treatment Period|administrative reasons by sponsor|3|||
124934785|NCT04623775|449390753|FG001|Treatment Period|administrative reasons by sponsor|2|||
124934786|NCT04623775|449390754|FG002|Treatment Period|administrative reasons by sponsor|0|||
124934787|NCT04623775|449390755|FG003|Treatment Period|administrative reasons by sponsor|0|||
124934788|NCT04623775|449390752|FG000|Treatment Period|other reasons|2|||
124934789|NCT04623775|449390753|FG001|Treatment Period|other reasons|0|||
124934790|NCT04623775|449390754|FG002|Treatment Period|other reasons|1|||
124934791|NCT04623775|449390755|FG003|Treatment Period|other reasons|1|||
124934792|NCT04623775|449390752|FG000|Treatment Period|disease progression|40|||
124934793|NCT04623775|449390753|FG001|Treatment Period|disease progression|35|||
125026020|NCT00132730|449718450|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
124934794|NCT04623775|449390754|FG002|Treatment Period|disease progression|63|||
124934795|NCT04623775|449390755|FG003|Treatment Period|disease progression|63|||
124934796|NCT04623775|449390752|FG000|Treatment Period|study drug toxicity|12|||
124934797|NCT04623775|449390753|FG001|Treatment Period|study drug toxicity|15|||
124934798|NCT04623775|449390754|FG002|Treatment Period|study drug toxicity|13|||
124934799|NCT04623775|449390755|FG003|Treatment Period|study drug toxicity|12|||
124934800|NCT04623775|449390752|FG000|Treatment Period|AE unrelated to study drug|4|||
124934801|NCT04623775|449390753|FG001|Treatment Period|AE unrelated to study drug|9|||
124934802|NCT04623775|449390754|FG002|Treatment Period|AE unrelated to study drug|12|||
124934803|NCT04623775|449390755|FG003|Treatment Period|AE unrelated to study drug|9|||
124934804|NCT04623775|449390752|FG000|Treatment Period|participant request to discontinue treatment|0|||
124934805|NCT04623775|449390753|FG001|Treatment Period|participant request to discontinue treatment|2|||
124934806|NCT04623775|449390754|FG002|Treatment Period|participant request to discontinue treatment|2|||
124934807|NCT04623775|449390755|FG003|Treatment Period|participant request to discontinue treatment|0|||
124934808|NCT00964392|449390756|FG000|Overall Study|Withdrawal by Subject|4|||
124934809|NCT00964392|449390757|FG001|Overall Study|Withdrawal by Subject|6|||
124934810|NCT00964392|449390756|FG000|Overall Study|Lost to Follow-up|4|||
124934811|NCT00964392|449390757|FG001|Overall Study|Lost to Follow-up|10|||
124934812|NCT00964392|449390756|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
124934813|NCT00964392|449390757|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
124934814|NCT00964392|449390756|FG000|Overall Study|Not completed|44|||
124934815|NCT00964392|449390757|FG001|Overall Study|Not completed|168|||
124934816|NCT03652272|449390764|FG000|3 Month|Withdrawal by Subject|1|||
124934817|NCT03652272|449390765|FG001|3 Month|Withdrawal by Subject|1|||
124934818|NCT03652272|449390764|FG000|3 Month|Lost to Follow-up|16|||
124934819|NCT03652272|449390765|FG001|3 Month|Lost to Follow-up|14|||
124934820|NCT04173247|449390766|FG000|Overall Study|Withdrawal by Subject|0|||
124934821|NCT04173247|449390767|FG001|Overall Study|Withdrawal by Subject|2|||
124934822|NCT04173247|449390766|FG000|Overall Study|Death|1|||
124934823|NCT04173247|449390767|FG001|Overall Study|Death|0|||
124934824|NCT04173247|449390766|FG000|Overall Study|Physician Decision|1|||
124934825|NCT04173247|449390767|FG001|Overall Study|Physician Decision|0|||
124934826|NCT04214834|449390770|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
124934827|NCT04214834|449390771|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
124934828|NCT03884101|449390778|FG000|Overall Study|Participant Ongoing in Study|202|||
124934829|NCT03884101|449390779|FG001|Overall Study|Participant Ongoing in Study|186|||
124934830|NCT03884101|449390778|FG000|Overall Study|Death|212|||
124934831|NCT03884101|449390779|FG001|Overall Study|Death|224|||
124934832|NCT03884101|449390778|FG000|Overall Study|Lost to Follow-up|0|||
124934833|NCT03884101|449390779|FG001|Overall Study|Lost to Follow-up|1|||
124934834|NCT03884101|449390778|FG000|Overall Study|Withdrawal by Subject|6|||
124934835|NCT03884101|449390779|FG001|Overall Study|Withdrawal by Subject|11|||
124934836|NCT03370913|449390780|FG000|Overall Study|Death|1|||
124934837|NCT03370913|449390780|FG000|Overall Study|Lost to Follow-up|1|||
124934838|NCT03248479|449390790|FG000|Overall Study|Death|12|||
124934839|NCT03248479|449390791|FG001|Overall Study|Death|44|||
124934840|NCT03248479|449390792|FG002|Overall Study|Death|1|||
124934841|NCT03248479|449390793|FG003|Overall Study|Death|72|||
124934842|NCT03248479|449390794|FG004|Overall Study|Death|17|||
124934843|NCT03248479|449390795|FG005|Overall Study|Death|6|||
124934844|NCT03248479|449390796|FG006|Overall Study|Death|1|||
124934845|NCT03248479|449390797|FG007|Overall Study|Death|14|||
124934846|NCT03248479|449390798|FG008|Overall Study|Death|3|||
124934847|NCT03248479|449390799|FG009|Overall Study|Death|7|||
124934848|NCT03248479|449390800|FG010|Overall Study|Death|3|||
124934849|NCT03248479|449390801|FG011|Overall Study|Death|1|||
124934850|NCT03248479|449390802|FG012|Overall Study|Death|1|||
124934851|NCT03248479|449390790|FG000|Overall Study|Study terminated by sponsor|12|||
124934852|NCT03248479|449390791|FG001|Overall Study|Study terminated by sponsor|15|||
124934853|NCT03248479|449390792|FG002|Overall Study|Study terminated by sponsor|0|||
124934854|NCT03248479|449390793|FG003|Overall Study|Study terminated by sponsor|5|||
124934855|NCT03248479|449390794|FG004|Overall Study|Study terminated by sponsor|0|||
124934856|NCT03248479|449390795|FG005|Overall Study|Study terminated by sponsor|0|||
124934857|NCT03248479|449390796|FG006|Overall Study|Study terminated by sponsor|0|||
124934858|NCT03248479|449390797|FG007|Overall Study|Study terminated by sponsor|1|||
124934859|NCT03248479|449390798|FG008|Overall Study|Study terminated by sponsor|1|||
124934860|NCT03248479|449390799|FG009|Overall Study|Study terminated by sponsor|0|||
124934861|NCT03248479|449390800|FG010|Overall Study|Study terminated by sponsor|5|||
124934862|NCT03248479|449390801|FG011|Overall Study|Study terminated by sponsor|4|||
124934863|NCT03248479|449390802|FG012|Overall Study|Study terminated by sponsor|0|||
124934864|NCT03248479|449390790|FG000|Overall Study|Consent withdrawn|6|||
124934865|NCT03248479|449390791|FG001|Overall Study|Consent withdrawn|3|||
124934866|NCT03248479|449390792|FG002|Overall Study|Consent withdrawn|0|||
124934867|NCT03248479|449390793|FG003|Overall Study|Consent withdrawn|9|||
124934868|NCT03248479|449390794|FG004|Overall Study|Consent withdrawn|1|||
124934869|NCT03248479|449390795|FG005|Overall Study|Consent withdrawn|0|||
124934870|NCT03248479|449390796|FG006|Overall Study|Consent withdrawn|0|||
124934871|NCT03248479|449390797|FG007|Overall Study|Consent withdrawn|1|||
124934872|NCT03248479|449390798|FG008|Overall Study|Consent withdrawn|0|||
124934873|NCT03248479|449390799|FG009|Overall Study|Consent withdrawn|3|||
124934874|NCT03248479|449390800|FG010|Overall Study|Consent withdrawn|1|||
124934875|NCT03248479|449390801|FG011|Overall Study|Consent withdrawn|0|||
124934876|NCT03248479|449390802|FG012|Overall Study|Consent withdrawn|1|||
124934877|NCT03248479|449390790|FG000|Overall Study|Lost to Follow-up|2|||
124934878|NCT03248479|449390791|FG001|Overall Study|Lost to Follow-up|1|||
124934879|NCT03248479|449390792|FG002|Overall Study|Lost to Follow-up|0|||
124934880|NCT03248479|449390793|FG003|Overall Study|Lost to Follow-up|0|||
124934881|NCT03248479|449390794|FG004|Overall Study|Lost to Follow-up|0|||
124934882|NCT03248479|449390795|FG005|Overall Study|Lost to Follow-up|0|||
124934883|NCT03248479|449390796|FG006|Overall Study|Lost to Follow-up|0|||
124934884|NCT03248479|449390797|FG007|Overall Study|Lost to Follow-up|0|||
124934885|NCT03248479|449390798|FG008|Overall Study|Lost to Follow-up|0|||
124934886|NCT03248479|449390799|FG009|Overall Study|Lost to Follow-up|0|||
124934887|NCT03248479|449390800|FG010|Overall Study|Lost to Follow-up|0|||
124934888|NCT03248479|449390801|FG011|Overall Study|Lost to Follow-up|0|||
124934889|NCT03248479|449390802|FG012|Overall Study|Lost to Follow-up|1|||
124934890|NCT03248479|449390790|FG000|Overall Study|Not reported|0|||
124934891|NCT03248479|449390791|FG001|Overall Study|Not reported|0|||
124934892|NCT03248479|449390792|FG002|Overall Study|Not reported|0|||
124934893|NCT03248479|449390793|FG003|Overall Study|Not reported|1|||
124934894|NCT03248479|449390794|FG004|Overall Study|Not reported|1|||
124934895|NCT03248479|449390795|FG005|Overall Study|Not reported|0|||
124934896|NCT03248479|449390796|FG006|Overall Study|Not reported|0|||
124934897|NCT03248479|449390797|FG007|Overall Study|Not reported|1|||
124934898|NCT03248479|449390798|FG008|Overall Study|Not reported|1|||
124934899|NCT03248479|449390799|FG009|Overall Study|Not reported|0|||
124934900|NCT03248479|449390800|FG010|Overall Study|Not reported|0|||
124934901|NCT03248479|449390801|FG011|Overall Study|Not reported|0|||
124934902|NCT03248479|449390802|FG012|Overall Study|Not reported|0|||
124934903|NCT04679389|449390803|FG000|Overall Study|Adverse Event|1|||
124934904|NCT04679389|449390804|FG001|Overall Study|Adverse Event|0|||
124934905|NCT04679389|449390803|FG000|Overall Study|Protocol Violation|2|||
124934906|NCT04679389|449390804|FG001|Overall Study|Protocol Violation|0|||
124934907|NCT04679389|449390803|FG000|Overall Study|Physician Decision|3|||
124934908|NCT04679389|449390804|FG001|Overall Study|Physician Decision|5|||
124934909|NCT04679389|449390803|FG000|Overall Study|Withdrawal by Subject|5|||
124934910|NCT04679389|449390804|FG001|Overall Study|Withdrawal by Subject|7|||
124934911|NCT05112900|449390805|FG000|Overall Study|Withdrawal by Subject|960|||
124934912|NCT05112900|449390806|FG001|Overall Study|Withdrawal by Subject|921|||
124934913|NCT05112900|449390807|FG002|Overall Study|Withdrawal by Subject|968|||
124934914|NCT05541484|449390808|FG000|Overall Study|Withdrawal by Subject|1|||
124934915|NCT05541484|449390809|FG001|Overall Study|Withdrawal by Subject|0|||
124934916|NCT03279978|449390812|FG000|Overall Study|Withdrawal by Subject|0|||
124934917|NCT03279978|449390813|FG001|Overall Study|Withdrawal by Subject|1|||
124934918|NCT03279978|449390814|FG002|Overall Study|Withdrawal by Subject|0|||
124934919|NCT03279978|449390815|FG003|Overall Study|Withdrawal by Subject|0|||
124934920|NCT03279978|449390816|FG004|Overall Study|Withdrawal by Subject|0|||
124934921|NCT03279978|449390817|FG005|Overall Study|Withdrawal by Subject|0|||
124934922|NCT03279978|449390818|FG006|Overall Study|Withdrawal by Subject|0|||
124934923|NCT03279978|449390819|FG007|Overall Study|Withdrawal by Subject|0|||
124934924|NCT03279978|449390820|FG008|Overall Study|Withdrawal by Subject|0|||
124934925|NCT03279978|449390821|FG009|Overall Study|Withdrawal by Subject|1|||
124934926|NCT03279978|449390812|FG000|Overall Study|Lost to Follow-up|1|||
124934927|NCT03279978|449390813|FG001|Overall Study|Lost to Follow-up|0|||
124934928|NCT03279978|449390814|FG002|Overall Study|Lost to Follow-up|1|||
124934929|NCT03279978|449390815|FG003|Overall Study|Lost to Follow-up|0|||
124934930|NCT03279978|449390816|FG004|Overall Study|Lost to Follow-up|0|||
124934931|NCT03279978|449390817|FG005|Overall Study|Lost to Follow-up|0|||
124934932|NCT03279978|449390818|FG006|Overall Study|Lost to Follow-up|0|||
124934933|NCT03279978|449390819|FG007|Overall Study|Lost to Follow-up|0|||
124934934|NCT03279978|449390820|FG008|Overall Study|Lost to Follow-up|0|||
124934935|NCT03279978|449390821|FG009|Overall Study|Lost to Follow-up|0|||
124934936|NCT03279978|449390812|FG000|Overall Study|Other than stated above|0|||
124934937|NCT03279978|449390813|FG001|Overall Study|Other than stated above|0|||
124934938|NCT03279978|449390814|FG002|Overall Study|Other than stated above|0|||
124934939|NCT03279978|449390815|FG003|Overall Study|Other than stated above|0|||
124934940|NCT03279978|449390816|FG004|Overall Study|Other than stated above|0|||
124934941|NCT03279978|449390817|FG005|Overall Study|Other than stated above|0|||
124934942|NCT03279978|449390818|FG006|Overall Study|Other than stated above|1|||
124934943|NCT03279978|449390819|FG007|Overall Study|Other than stated above|0|||
124934944|NCT03279978|449390820|FG008|Overall Study|Other than stated above|0|||
124934945|NCT03279978|449390821|FG009|Overall Study|Other than stated above|0|||
124934946|NCT05525104|449390822|FG000|Overall Study|Failed caudal analgesia|1|||
124934947|NCT05525104|449390823|FG001|Overall Study|Failed caudal analgesia|3|||
124934948|NCT05525104|449390822|FG000|Overall Study|Premedication needed|0|||
124934949|NCT05525104|449390823|FG001|Overall Study|Premedication needed|1|||
124934950|NCT05525104|449390822|FG000|Overall Study|Protocol Violation|10|||
124934951|NCT05525104|449390823|FG001|Overall Study|Protocol Violation|0|||
124934952|NCT05525104|449390822|FG000|Overall Study|Cancelled operation|1|||
124934953|NCT05525104|449390823|FG001|Overall Study|Cancelled operation|0|||
124934954|NCT03636490|449392046|FG000|Overall Study|Dropped out or incomplete data|141|||
124934955|NCT04464564|449392049|FG000|Period A (Placebo lead-in)|Other|5|||
124934956|NCT04464564|449392050|FG001|Period A (Placebo lead-in)|Other|0|||
124934957|NCT04464564|449392051|FG002|Period A (Placebo lead-in)|Other|0|||
124934958|NCT04464564|449392052|FG003|Period A (Placebo lead-in)|Other|0|||
124934959|NCT04464564|449392049|FG000|Period B (Randomization Period)|Adverse Event|0|||
124934960|NCT04464564|449392050|FG001|Period B (Randomization Period)|Adverse Event|1|||
124934961|NCT04464564|449392051|FG002|Period B (Randomization Period)|Adverse Event|2|||
124934962|NCT04464564|449392052|FG003|Period B (Randomization Period)|Adverse Event|8|||
124934963|NCT04464564|449392049|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
124934964|NCT04464564|449392050|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
124934965|NCT04464564|449392051|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
124934966|NCT04464564|449392052|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
124934967|NCT04464564|449392049|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
124934968|NCT04464564|449392050|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
124934969|NCT04464564|449392051|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
124934970|NCT04464564|449392052|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
124934971|NCT04464564|449392049|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
124934972|NCT04464564|449392050|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
124934973|NCT04464564|449392051|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
124934974|NCT04464564|449392052|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
124934975|NCT04464564|449392049|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
124934976|NCT04464564|449392050|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
124934977|NCT04464564|449392051|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
124934978|NCT04464564|449392052|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
124934979|NCT04464564|449392049|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
124934980|NCT04464564|449392050|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
124934981|NCT04464564|449392051|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
124934982|NCT04464564|449392052|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
124934983|NCT04464564|449392049|FG000|Period B (Randomization Period)|Reason not Specified|0|||
124934984|NCT04464564|449392050|FG001|Period B (Randomization Period)|Reason not Specified|3|||
124934985|NCT04464564|449392051|FG002|Period B (Randomization Period)|Reason not Specified|3|||
124934986|NCT04464564|449392052|FG003|Period B (Randomization Period)|Reason not Specified|3|||
124934987|NCT02095691|449392059|FG000|Overall Study|Physician Decision|1|||
124934988|NCT03498521|449392060|FG000|Overall Study|Death|191|||
124934989|NCT03498521|449392061|FG001|Overall Study|Death|64|||
124934990|NCT03498521|449392062|FG002|Overall Study|Death|72|||
124934991|NCT03498521|449392060|FG000|Overall Study|Exclusion criteria|1|||
124934992|NCT03498521|449392061|FG001|Overall Study|Exclusion criteria|0|||
124934993|NCT03498521|449392062|FG002|Overall Study|Exclusion criteria|0|||
124934994|NCT03498521|449392060|FG000|Overall Study|Lost to Follow-up|3|||
124934995|NCT03498521|449392061|FG001|Overall Study|Lost to Follow-up|3|||
124934996|NCT03498521|449392062|FG002|Overall Study|Lost to Follow-up|3|||
124934997|NCT03498521|449392060|FG000|Overall Study|No profile due to technical failure|1|||
124934998|NCT03498521|449392061|FG001|Overall Study|No profile due to technical failure|0|||
124934999|NCT03498521|449392062|FG002|Overall Study|No profile due to technical failure|0|||
124935000|NCT03498521|449392060|FG000|Overall Study|Physician Decision|0|||
124935001|NCT03498521|449392061|FG001|Overall Study|Physician Decision|1|||
124935002|NCT03498521|449392062|FG002|Overall Study|Physician Decision|0|||
124935003|NCT03498521|449392060|FG000|Overall Study|Withdrawal by Subject|9|||
124935004|NCT03498521|449392061|FG001|Overall Study|Withdrawal by Subject|6|||
124935005|NCT03498521|449392062|FG002|Overall Study|Withdrawal by Subject|2|||
124935006|NCT03498521|449392060|FG000|Overall Study|Study ongoing|121|||
124935007|NCT03498521|449392061|FG001|Overall Study|Study ongoing|36|||
124935008|NCT03498521|449392062|FG002|Overall Study|Study ongoing|15|||
124935009|NCT02163694|449392064|FG000|Overall Study|Adverse event- related to progression|4|||
124935010|NCT02163694|449392065|FG001|Overall Study|Adverse event- related to progression|10|||
124935011|NCT02163694|449392064|FG000|Overall Study|Adverse event- not related to progression|7|||
124935012|NCT02163694|449392065|FG001|Overall Study|Adverse event- not related to progression|22|||
124935013|NCT02163694|449392064|FG000|Overall Study|Withdrew consent|13|||
124935014|NCT02163694|449392065|FG001|Overall Study|Withdrew consent|28|||
124935015|NCT02163694|449392064|FG000|Overall Study|Lost to Follow-up|2|||
124935016|NCT02163694|449392065|FG001|Overall Study|Lost to Follow-up|2|||
124935017|NCT02163694|449392064|FG000|Overall Study|Sponsor discontinued study|3|||
124935018|NCT02163694|449392065|FG001|Overall Study|Sponsor discontinued study|29|||
124935019|NCT02163694|449392064|FG000|Overall Study|Progressive disease per protocol|125|||
124935020|NCT02163694|449392065|FG001|Overall Study|Progressive disease per protocol|224|||
124935021|NCT02163694|449392064|FG000|Overall Study|Other, not specified|17|||
124935022|NCT02163694|449392065|FG001|Overall Study|Other, not specified|22|||
124935023|NCT02163694|449392064|FG000|Overall Study|Randomized but Not Treated|1|||
124935024|NCT02163694|449392065|FG001|Overall Study|Randomized but Not Treated|0|||
124935025|NCT02163694|449392064|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
124935026|NCT02163694|449392065|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
124935027|NCT04633538|449392066|FG000|Overall Study|Death|1|||
124935028|NCT04633538|449392066|FG000|Overall Study|Lost to Follow-up|3|||
124935029|NCT04633538|449392066|FG000|Overall Study|Withdrawal by Subject|1|||
124935030|NCT02938520|449392069|FG000|Overall Study|On-going at the time of analysis|258|||
124935031|NCT02938520|449392070|FG001|Overall Study|On-going at the time of analysis|261|||
124935032|NCT02938520|449392069|FG000|Overall Study|Physician Decision|2|||
124935033|NCT02938520|449392070|FG001|Overall Study|Physician Decision|5|||
124935034|NCT02938520|449392069|FG000|Overall Study|Lost to Follow-up|2|||
124935035|NCT02938520|449392070|FG001|Overall Study|Lost to Follow-up|2|||
124935036|NCT02938520|449392069|FG000|Overall Study|Withdrawal by Subject|7|||
124935037|NCT02938520|449392070|FG001|Overall Study|Withdrawal by Subject|7|||
124935038|NCT02938520|449392069|FG000|Overall Study|Protocol Violation|0|||
124935039|NCT02938520|449392070|FG001|Overall Study|Protocol Violation|1|||
124935040|NCT02938520|449392069|FG000|Overall Study|Lack of Efficacy|5|||
124935041|NCT02938520|449392070|FG001|Overall Study|Lack of Efficacy|3|||
124935042|NCT02938520|449392069|FG000|Overall Study|Adverse Event|9|||
124935043|NCT02938520|449392070|FG001|Overall Study|Adverse Event|4|||
124935044|NCT03372057|449392073|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
124935045|NCT03372057|449392074|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
124935046|NCT03372057|449392075|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
124935047|NCT03372057|449392073|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
124935048|NCT03372057|449392074|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
124935049|NCT03372057|449392075|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
124935050|NCT03372057|449392073|FG000|Dose Optimization Phase|Death|16|||
124935051|NCT03372057|449392074|FG001|Dose Optimization Phase|Death|11|||
124935052|NCT03372057|449392075|FG002|Dose Optimization Phase|Death|0|||
124935053|NCT03372057|449392073|FG000|Expansion Phase|Withdrawal by Subject|0|||
124935054|NCT03372057|449392074|FG001|Expansion Phase|Withdrawal by Subject|0|||
124935055|NCT03372057|449392075|FG002|Expansion Phase|Withdrawal by Subject|4|||
124935056|NCT03372057|449392073|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
124935057|NCT03372057|449392074|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
124935058|NCT03372057|449392075|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
124935059|NCT03372057|449392073|FG000|Expansion Phase|Death|0|||
124935060|NCT03372057|449392074|FG001|Expansion Phase|Death|0|||
124935061|NCT03372057|449392075|FG002|Expansion Phase|Death|78|||
124935062|NCT03372057|449392073|FG000|Expansion Phase|Progressive Disease|0|||
124935063|NCT03372057|449392074|FG001|Expansion Phase|Progressive Disease|0|||
124935064|NCT03372057|449392075|FG002|Expansion Phase|Progressive Disease|1|||
124935065|NCT03372057|449392073|FG000|Expansion Phase|Adverse Event|0|||
124935066|NCT03372057|449392074|FG001|Expansion Phase|Adverse Event|0|||
124935067|NCT03372057|449392075|FG002|Expansion Phase|Adverse Event|1|||
124935068|NCT05953740|449392076|FG000|Period 1|Physician Decision|0|||
124935069|NCT05953740|449392077|FG001|Period 1|Physician Decision|1|||
124935070|NCT05953740|449392078|FG002|Period 1|Physician Decision|0|||
124935071|NCT05953740|449392079|FG003|Period 1|Physician Decision|0|||
124935072|NCT05953740|449392080|FG004|Period 1|Physician Decision|0|||
124935073|NCT05953740|449392081|FG005|Period 1|Physician Decision|0|||
124935074|NCT05953740|449392082|FG006|Period 1|Physician Decision|0|||
124935075|NCT05953740|449392083|FG007|Period 1|Physician Decision|0|||
124935076|NCT05953740|449392076|FG000|Period 2|Withdrawal by Subject|0|||
124935077|NCT05953740|449392077|FG001|Period 2|Withdrawal by Subject|1|||
124935078|NCT05953740|449392078|FG002|Period 2|Withdrawal by Subject|1|||
124935079|NCT05953740|449392079|FG003|Period 2|Withdrawal by Subject|0|||
124935080|NCT05953740|449392080|FG004|Period 2|Withdrawal by Subject|0|||
124935081|NCT05953740|449392081|FG005|Period 2|Withdrawal by Subject|0|||
124935082|NCT05953740|449392082|FG006|Period 2|Withdrawal by Subject|0|||
124935083|NCT05953740|449392083|FG007|Period 2|Withdrawal by Subject|0|||
124935084|NCT03880955|449392084|FG000|Overall Study|Adverse Event|1|||
124935085|NCT03880955|449392084|FG000|Overall Study|Death|1|||
124935086|NCT03880955|449392084|FG000|Overall Study|Lost to Follow-up|12|||
124935087|NCT03880955|449392084|FG000|Overall Study|Withdrawal by Subject|4|||
124935088|NCT03880955|449392084|FG000|Overall Study|Missing- Study Site Closed|27|||
124935089|NCT01438853|449392112|FG000|Overall Study|Death|0|||
124935090|NCT01438853|449392113|FG001|Overall Study|Death|0|||
124935091|NCT01438853|449392114|FG002|Overall Study|Death|0|||
124935092|NCT01438853|449392115|FG003|Overall Study|Death|1|||
124935093|NCT01438853|449392112|FG000|Overall Study|Withdrawal by Subject|0|||
124935094|NCT01438853|449392113|FG001|Overall Study|Withdrawal by Subject|0|||
124935095|NCT01438853|449392114|FG002|Overall Study|Withdrawal by Subject|1|||
124935096|NCT01438853|449392115|FG003|Overall Study|Withdrawal by Subject|0|||
124935097|NCT02624050|449392116|FG000|Overall Study|Physician Decision|4|||
124935098|NCT02624050|449392117|FG001|Overall Study|Physician Decision|0|||
124935099|NCT02624050|449392116|FG000|Overall Study|Protocol Violation|2|||
124935100|NCT02624050|449392117|FG001|Overall Study|Protocol Violation|0|||
124935101|NCT05215054|449392118|FG000|Overall Study|Lost to Follow-up|1|||
124935102|NCT05215054|449392119|FG001|Overall Study|Lost to Follow-up|1|||
124935103|NCT05215054|449392118|FG000|Overall Study|Protocol Violation|1|||
124935104|NCT05215054|449392119|FG001|Overall Study|Protocol Violation|1|||
124935105|NCT05215054|449392118|FG000|Overall Study|Withdrawal by Subject|4|||
124935106|NCT05215054|449392119|FG001|Overall Study|Withdrawal by Subject|4|||
124935107|NCT04330040|449392123|FG000|Overall Study|Other: Adverse event|5|||
124935108|NCT04330040|449392124|FG001|Overall Study|Other: Adverse event|0|||
124935109|NCT04330040|449392125|FG002|Overall Study|Other: Adverse event|0|||
124935110|NCT04330040|449392123|FG000|Overall Study|Disease progression|38|||
124935111|NCT04330040|449392124|FG001|Overall Study|Disease progression|10|||
124935112|NCT04330040|449392125|FG002|Overall Study|Disease progression|0|||
124935113|NCT04330040|449392123|FG000|Overall Study|Physician Decision|5|||
124935114|NCT04330040|449392124|FG001|Overall Study|Physician Decision|3|||
124935115|NCT04330040|449392125|FG002|Overall Study|Physician Decision|0|||
124935116|NCT04330040|449392123|FG000|Overall Study|Lost to Follow-up|1|||
124935117|NCT04330040|449392124|FG001|Overall Study|Lost to Follow-up|1|||
124935118|NCT04330040|449392125|FG002|Overall Study|Lost to Follow-up|0|||
124935119|NCT04330040|449392123|FG000|Overall Study|Death|2|||
124935120|NCT04330040|449392124|FG001|Overall Study|Death|1|||
124935121|NCT04330040|449392125|FG002|Overall Study|Death|0|||
124935122|NCT04330040|449392123|FG000|Overall Study|Withdrawal by Subject|3|||
124935123|NCT04330040|449392124|FG001|Overall Study|Withdrawal by Subject|3|||
124935124|NCT04330040|449392125|FG002|Overall Study|Withdrawal by Subject|0|||
124935125|NCT04330040|449392123|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
124935126|NCT04330040|449392124|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
124935127|NCT04330040|449392125|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
124935128|NCT04330040|449392123|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
124935129|NCT04330040|449392124|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
124935130|NCT04330040|449392125|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
124935131|NCT04330040|449392123|FG000|Overall Study|Other: Disease progression|1|||
124935132|NCT04330040|449392124|FG001|Overall Study|Other: Disease progression|0|||
124935133|NCT04330040|449392125|FG002|Overall Study|Other: Disease progression|0|||
124935134|NCT04330040|449392123|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
124935135|NCT04330040|449392124|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
124935136|NCT04330040|449392125|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
124935137|NCT04330040|449392123|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
124935138|NCT04330040|449392124|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
124935139|NCT04330040|449392125|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
124935140|NCT04330040|449392123|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
124935141|NCT04330040|449392124|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
124935142|NCT04330040|449392125|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
124935143|NCT00626795|449392128|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
124935144|NCT00626795|449392129|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
124935145|NCT00626795|449392130|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
124935146|NCT00626795|449392128|FG000|Blinded Treatment|Lack of Efficacy|2|||
125120865|NCT04700449|450066995|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
124935147|NCT00626795|449392129|FG001|Blinded Treatment|Lack of Efficacy|0|||
124935148|NCT00626795|449392130|FG002|Blinded Treatment|Lack of Efficacy|0|||
124935149|NCT00626795|449392128|FG000|Blinded Treatment|Unacceptable adverse event|0|||
124935150|NCT00626795|449392129|FG001|Blinded Treatment|Unacceptable adverse event|0|||
124935151|NCT00626795|449392130|FG002|Blinded Treatment|Unacceptable adverse event|1|||
124935152|NCT00626795|449392128|FG000|Blinded Treatment|Protocol Violation|0|||
124935153|NCT00626795|449392129|FG001|Blinded Treatment|Protocol Violation|1|||
124935154|NCT00626795|449392130|FG002|Blinded Treatment|Protocol Violation|1|||
124935155|NCT00626795|449392128|FG000|Blinded Treatment|Withdrawal by Subject|1|||
124935156|NCT00626795|449392129|FG001|Blinded Treatment|Withdrawal by Subject|1|||
124935157|NCT00626795|449392130|FG002|Blinded Treatment|Withdrawal by Subject|0|||
124935158|NCT00626795|449392128|FG000|Blinded Treatment|Other reasons|2|||
124935159|NCT00626795|449392129|FG001|Blinded Treatment|Other reasons|0|||
124935160|NCT00626795|449392130|FG002|Blinded Treatment|Other reasons|2|||
124935161|NCT00626795|449392128|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
124935162|NCT00626795|449392129|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
124935163|NCT00626795|449392130|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
124935164|NCT04159519|449392131|FG000|Overall Study|Adverse Event|1|||
124935165|NCT04159519|449392132|FG001|Overall Study|Adverse Event|1|||
124935166|NCT04159519|449392131|FG000|Overall Study|Lack of Efficacy|1|||
124935167|NCT04159519|449392132|FG001|Overall Study|Lack of Efficacy|0|||
124935168|NCT04159519|449392131|FG000|Overall Study|Discontinued from study|1|||
124935169|NCT04159519|449392132|FG001|Overall Study|Discontinued from study|0|||
124935170|NCT04159519|449392131|FG000|Overall Study|Protocol Violation|1|||
124935171|NCT04159519|449392132|FG001|Overall Study|Protocol Violation|1|||
124935172|NCT04159519|449392131|FG000|Overall Study|Withdrawal by Subject|4|||
124935173|NCT04159519|449392132|FG001|Overall Study|Withdrawal by Subject|4|||
124935174|NCT02246127|449392905|FG000|First Course Treatment|Adverse Event|9|||
124935175|NCT02246127|449392906|FG001|First Course Treatment|Adverse Event|7|||
124935176|NCT02246127|449392905|FG000|First Course Treatment|Withdrawal by Subject|6|||
124935177|NCT02246127|449392906|FG001|First Course Treatment|Withdrawal by Subject|7|||
124935178|NCT02246127|449392905|FG000|First Course Treatment|Physician Decision|9|||
124935179|NCT02246127|449392906|FG001|First Course Treatment|Physician Decision|9|||
124935180|NCT02246127|449392905|FG000|First Course Treatment|Death|3|||
124935181|NCT02246127|449392906|FG001|First Course Treatment|Death|3|||
124935182|NCT02246127|449392905|FG000|First Course Treatment|Not reported reasons|6|||
124935183|NCT02246127|449392906|FG001|First Course Treatment|Not reported reasons|7|||
124935184|NCT02246127|449392905|FG000|First Course Treatment|Not treated|3|||
124935185|NCT02246127|449392906|FG001|First Course Treatment|Not treated|3|||
124935186|NCT05311176|449392909|FG000|Overall Study|Death|6|||
124935187|NCT05311176|449392909|FG000|Overall Study|Sponsor discontinued the study|1|||
124935188|NCT01880515|449392910|FG000|Overall Study|Lost to Follow-up|3|||
124935189|NCT01880515|449392911|FG001|Overall Study|Lost to Follow-up|2|||
124935190|NCT01880515|449392910|FG000|Overall Study|Disease Progression|5|||
124935191|NCT01880515|449392911|FG001|Overall Study|Disease Progression|7|||
124935192|NCT06262347|449392922|FG000|Overall Study|Lost to Follow-up|4|||
124935193|NCT06262347|449392923|FG001|Overall Study|Lost to Follow-up|3|||
124935194|NCT06262347|449392922|FG000|Overall Study|Withdrawal by Subject|0|||
124935195|NCT06262347|449392923|FG001|Overall Study|Withdrawal by Subject|1|||
124935196|NCT05830799|449392930|FG000|Overall Study|Withdrawal by Subject|1|||
124935197|NCT04560179|449392935|FG000|Overall Study|Physician Decision|1|||
124935198|NCT04560179|449392936|FG001|Overall Study|Physician Decision|0|||
124935199|NCT04560179|449392937|FG002|Overall Study|Physician Decision|0|||
124935200|NCT04560179|449392938|FG003|Overall Study|Physician Decision|0|||
124935201|NCT04560179|449392939|FG004|Overall Study|Physician Decision|0|||
124935202|NCT04560179|449392935|FG000|Overall Study|Adverse Event|0|||
124935203|NCT04560179|449392936|FG001|Overall Study|Adverse Event|0|||
124935204|NCT04560179|449392937|FG002|Overall Study|Adverse Event|0|||
124935205|NCT04560179|449392938|FG003|Overall Study|Adverse Event|1|||
124935206|NCT04560179|449392939|FG004|Overall Study|Adverse Event|0|||
124935207|NCT04631016|449392942|FG000|Overall Study|Adverse Event|3|||
124935208|NCT04631016|449392943|FG001|Overall Study|Adverse Event|0|||
124935209|NCT04631016|449392942|FG000|Overall Study|Withdrawal by Subject|5|||
124935210|NCT04631016|449392943|FG001|Overall Study|Withdrawal by Subject|4|||
124935211|NCT04631016|449392942|FG000|Overall Study|Reason unspecified|1|||
124935212|NCT04631016|449392943|FG001|Overall Study|Reason unspecified|0|||
124935213|NCT04631016|449392942|FG000|Overall Study|Failure to meet randomization criteria|2|||
124935214|NCT04631016|449392943|FG001|Overall Study|Failure to meet randomization criteria|1|||
124935215|NCT06010836|449392944|FG000|Overall Study|Lost to Follow-up|2|||
124935216|NCT06010836|449392945|FG001|Overall Study|Lost to Follow-up|2|||
125120866|NCT04700449|450066996|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
125120867|NCT04700449|450066997|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
125120868|NCT04700449|450066994|FG000|Stage 2 Sub-study 1|Other|1|||
125120869|NCT04700449|450066995|FG001|Stage 2 Sub-study 1|Other|2|||
125120870|NCT04700449|450066996|FG002|Stage 2 Sub-study 1|Other|0|||
125120871|NCT04700449|450066997|FG003|Stage 2 Sub-study 1|Other|0|||
125120872|NCT04700449|450066994|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
125120873|NCT04700449|450066995|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
125120874|NCT04700449|450066996|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
125120875|NCT04700449|450066997|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
125120876|NCT04700449|450066994|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
125120877|NCT04700449|450066995|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
125120878|NCT04700449|450066996|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
125120879|NCT04700449|450066997|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
125120880|NCT04700449|450066994|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
125120881|NCT04700449|450066995|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
124935217|NCT06010836|449392944|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
124935218|NCT06010836|449392945|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
124935219|NCT06010836|449392944|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
124935220|NCT06010836|449392945|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
124935221|NCT06010836|449392944|FG000|Overall Study|Did not receive intervention discussion|0|||
124935222|NCT06010836|449392945|FG001|Overall Study|Did not receive intervention discussion|4|||
124935223|NCT04496752|449392946|FG000|Second Assessment|Lost to Follow-up|3|||
124935224|NCT04496752|449392947|FG001|Second Assessment|Lost to Follow-up|3|||
124935225|NCT04496752|449392946|FG000|Second Assessment|Adverse Event|2|||
124935226|NCT04496752|449392947|FG001|Second Assessment|Adverse Event|0|||
124935227|NCT04524689|449392950|FG000|Overall Study|Withdrawal by Subject|1|||
124935228|NCT04524689|449392951|FG001|Overall Study|Withdrawal by Subject|1|||
124935229|NCT04524689|449392952|FG002|Overall Study|Withdrawal by Subject|0|||
124935230|NCT04524689|449392953|FG003|Overall Study|Withdrawal by Subject|0|||
124935231|NCT04524689|449392954|FG004|Overall Study|Withdrawal by Subject|1|||
124935232|NCT04524689|449392955|FG005|Overall Study|Withdrawal by Subject|0|||
124935233|NCT04524689|449392950|FG000|Overall Study|Not related to Coronavirus disease 2019|2|||
124935234|NCT04524689|449392951|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
124935235|NCT04524689|449392952|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
124935236|NCT04524689|449392953|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
124935237|NCT04524689|449392954|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
124935238|NCT04524689|449392955|FG005|Overall Study|Not related to Coronavirus disease 2019|0|||
124935239|NCT04524689|449392950|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|12|||
124935240|NCT04524689|449392951|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
124935241|NCT04524689|449392952|FG002|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
124935242|NCT04524689|449392953|FG003|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
124935243|NCT04524689|449392954|FG004|Overall Study|Ongoing study treatment at the time of primary analysis|5|||
124935244|NCT04524689|449392955|FG005|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
124935245|NCT04967599|449392956|FG000|Overall Study|Lost to Follow-up|35|||
124935246|NCT04967599|449392957|FG001|Overall Study|Lost to Follow-up|19|||
124935247|NCT04967599|449392958|FG002|Overall Study|Lost to Follow-up|23|||
124935248|NCT04369911|449392959|FG000|Overall Study|Lost to Follow-up|3|||
124935249|NCT04369911|449392960|FG001|Overall Study|Lost to Follow-up|3|||
124935250|NCT04369911|449392959|FG000|Overall Study|Withdrawal by Subject|1|||
124935251|NCT04369911|449392960|FG001|Overall Study|Withdrawal by Subject|2|||
124935252|NCT05451693|449392961|FG000|Overall Study|Withdrawal by Subject|1|||
124935253|NCT05451693|449392962|FG001|Overall Study|Withdrawal by Subject|1|||
124935254|NCT03662022|449392963|FG000|Year 1 2019|prevalent case|83|||
124935255|NCT03662022|449392964|FG001|Year 1 2019|prevalent case|116|||
124935256|NCT03662022|449392965|FG002|Year 1 2019|prevalent case|158|||
124935257|NCT03662022|449392966|FG003|Year 1 2019|prevalent case|99|||
124935258|NCT03662022|449392963|FG000|Year 2 2020|incident case|18|||
124935259|NCT03662022|449392964|FG001|Year 2 2020|incident case|18|||
124935260|NCT03662022|449392965|FG002|Year 2 2020|incident case|16|||
124935261|NCT03662022|449392966|FG003|Year 2 2020|incident case|26|||
124935262|NCT03662022|449392963|FG000|Year 2 2020|other case|18|||
124935263|NCT03662022|449392964|FG001|Year 2 2020|other case|16|||
124935264|NCT03662022|449392965|FG002|Year 2 2020|other case|16|||
124935265|NCT03662022|449392966|FG003|Year 2 2020|other case|24|||
124935266|NCT03662022|449392963|FG000|Year 2 2020|Lost to Follow-up|1633|||
124935267|NCT03662022|449392964|FG001|Year 2 2020|Lost to Follow-up|1183|||
125120882|NCT04700449|450066996|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
125120883|NCT04700449|450066997|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
125120884|NCT04700449|450066994|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
124935268|NCT03662022|449392965|FG002|Year 2 2020|Lost to Follow-up|1381|||
124935269|NCT03662022|449392966|FG003|Year 2 2020|Lost to Follow-up|2858|||
124935270|NCT03662022|449392963|FG000|Year 3 2021|incident case|24|||
124935271|NCT03662022|449392964|FG001|Year 3 2021|incident case|27|||
124935272|NCT03662022|449392965|FG002|Year 3 2021|incident case|24|||
124935273|NCT03662022|449392966|FG003|Year 3 2021|incident case|11|||
124935274|NCT03662022|449392963|FG000|Year 3 2021|other case|4|||
124935275|NCT03662022|449392964|FG001|Year 3 2021|other case|15|||
124935276|NCT03662022|449392965|FG002|Year 3 2021|other case|10|||
124935277|NCT03662022|449392966|FG003|Year 3 2021|other case|14|||
124935278|NCT03662022|449392963|FG000|Year 3 2021|Lost to Follow-up|179|||
124935279|NCT03662022|449392964|FG001|Year 3 2021|Lost to Follow-up|244|||
124935280|NCT03662022|449392965|FG002|Year 3 2021|Lost to Follow-up|480|||
124935281|NCT03662022|449392966|FG003|Year 3 2021|Lost to Follow-up|477|||
124935282|NCT03662022|449392963|FG000|Year 4 2022|incident case|25|||
124935283|NCT03662022|449392964|FG001|Year 4 2022|incident case|41|||
124935284|NCT03662022|449392965|FG002|Year 4 2022|incident case|28|||
124935285|NCT03662022|449392966|FG003|Year 4 2022|incident case|7|||
124935286|NCT03662022|449392963|FG000|Year 4 2022|other case|8|||
124935287|NCT03662022|449392964|FG001|Year 4 2022|other case|19|||
124935288|NCT03662022|449392965|FG002|Year 4 2022|other case|13|||
124935289|NCT03662022|449392966|FG003|Year 4 2022|other case|7|||
124935290|NCT03662022|449392963|FG000|Year 4 2022|Lost to Follow-up|986|||
124935291|NCT03662022|449392964|FG001|Year 4 2022|Lost to Follow-up|1079|||
124935292|NCT03662022|449392965|FG002|Year 4 2022|Lost to Follow-up|1236|||
124935293|NCT03662022|449392966|FG003|Year 4 2022|Lost to Follow-up|1826|||
124935294|NCT04490109|449392977|FG000|Overall Study|Lost to Follow-up|3|||
124935295|NCT04490109|449392978|FG001|Overall Study|Lost to Follow-up|10|||
124935296|NCT04490109|449392979|FG002|Overall Study|Lost to Follow-up|4|||
124935297|NCT04490109|449392977|FG000|Overall Study|Withdrawal by Subject|8|||
124935298|NCT04490109|449392978|FG001|Overall Study|Withdrawal by Subject|6|||
124935299|NCT04490109|449392979|FG002|Overall Study|Withdrawal by Subject|9|||
124935300|NCT04490109|449392977|FG000|Overall Study|Physician Decision|0|||
124935301|NCT04490109|449392978|FG001|Overall Study|Physician Decision|2|||
124935302|NCT04490109|449392979|FG002|Overall Study|Physician Decision|3|||
124935303|NCT04490109|449392977|FG000|Overall Study|Adverse Event|2|||
124935304|NCT04490109|449392978|FG001|Overall Study|Adverse Event|1|||
124935305|NCT04490109|449392979|FG002|Overall Study|Adverse Event|0|||
124935306|NCT04490109|449392977|FG000|Overall Study|Significant Non-Compliance|2|||
124935307|NCT04490109|449392978|FG001|Overall Study|Significant Non-Compliance|4|||
124935308|NCT04490109|449392979|FG002|Overall Study|Significant Non-Compliance|4|||
124935309|NCT04490109|449392977|FG000|Overall Study|Significant Clinical Event|0|||
124935310|NCT04490109|449392978|FG001|Overall Study|Significant Clinical Event|1|||
124935311|NCT04490109|449392979|FG002|Overall Study|Significant Clinical Event|0|||
124935312|NCT04490109|449392977|FG000|Overall Study|Other Reason|4|||
124935313|NCT04490109|449392978|FG001|Overall Study|Other Reason|1|||
124935314|NCT04490109|449392979|FG002|Overall Study|Other Reason|1|||
124935315|NCT03884439|449392982|FG000|Overall Study|No informed consent for publication of study results|38|||
124935316|NCT03884439|449392982|FG000|Overall Study|Contract violation/deficiency|7|||
124935317|NCT03904576|449392983|FG000|Washout Period|Protocol Violation|1|||
124935318|NCT03904576|449392984|FG001|Washout Period|Protocol Violation|1|||
124935319|NCT04780581|449392985|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
124935320|NCT04780581|449392986|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
124935321|NCT04780581|449392985|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
124935322|NCT04780581|449392986|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
124935323|NCT01756300|449392987|FG000|Overall Study|Death|1|||
124935324|NCT01756300|449392987|FG000|Overall Study|Withdrawal by Subject|1|||
124935325|NCT05836012|449393834|FG000|Overall Study|Lost to Follow-up|1|||
124935326|NCT05836012|449393835|FG001|Overall Study|Lost to Follow-up|0|||
124935327|NCT05836012|449393834|FG000|Overall Study|Withdrawal by Subject|1|||
124935328|NCT05836012|449393835|FG001|Overall Study|Withdrawal by Subject|3|||
124935329|NCT05836012|449393834|FG000|Overall Study|Reason not included in pre-specified categories|2|||
124935330|NCT05836012|449393835|FG001|Overall Study|Reason not included in pre-specified categories|1|||
124935331|NCT03817983|449393836|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
124935332|NCT03817983|449393837|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
124935333|NCT03817983|449393838|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
124935334|NCT03744676|449393839|FG000|Pre-Treatment Phase|Disease related complications|2|||
124935335|NCT03744676|449393839|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
124935336|NCT03744676|449393839|FG000|Pre-Treatment Phase|Death|7|||
124935337|NCT03744676|449393839|FG000|Pre-Treatment Phase|Other Reasons|7|||
124935338|NCT03744676|449393839|FG000|Treatment Phase|Participant withdrew consent|8|||
124935339|NCT03744676|449393839|FG000|Treatment Phase|Death|33|||
124935340|NCT03744676|449393839|FG000|Treatment Phase|other reasons|6|||
124935341|NCT03333915|449393840|FG000|Overall Study|Lost to Follow-up|0|||
124935342|NCT03333915|449393841|FG001|Overall Study|Lost to Follow-up|0|||
124935343|NCT03333915|449393842|FG002|Overall Study|Lost to Follow-up|1|||
124935344|NCT03333915|449393843|FG003|Overall Study|Lost to Follow-up|0|||
124935345|NCT03333915|449393844|FG004|Overall Study|Lost to Follow-up|0|||
124935346|NCT03333915|449393840|FG000|Overall Study|Disease Progression|0|||
124935347|NCT03333915|449393841|FG001|Overall Study|Disease Progression|1|||
124935348|NCT03333915|449393842|FG002|Overall Study|Disease Progression|0|||
124935349|NCT03333915|449393843|FG003|Overall Study|Disease Progression|0|||
124935350|NCT03333915|449393844|FG004|Overall Study|Disease Progression|0|||
124935351|NCT03333915|449393840|FG000|Overall Study|Death|0|||
124935352|NCT03333915|449393841|FG001|Overall Study|Death|0|||
124935353|NCT03333915|449393842|FG002|Overall Study|Death|0|||
124935354|NCT03333915|449393843|FG003|Overall Study|Death|37|||
125026021|NCT00132730|449718451|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
124935355|NCT03333915|449393844|FG004|Overall Study|Death|18|||
124935356|NCT03333915|449393840|FG000|Overall Study|Sponsor's Decision|0|||
124935357|NCT03333915|449393841|FG001|Overall Study|Sponsor's Decision|0|||
124935358|NCT03333915|449393842|FG002|Overall Study|Sponsor's Decision|0|||
124935359|NCT03333915|449393843|FG003|Overall Study|Sponsor's Decision|48|||
124935360|NCT03333915|449393844|FG004|Overall Study|Sponsor's Decision|4|||
124935361|NCT03333915|449393840|FG000|Overall Study|Withdrawal by Subject|0|||
124935362|NCT03333915|449393841|FG001|Overall Study|Withdrawal by Subject|0|||
124935363|NCT03333915|449393842|FG002|Overall Study|Withdrawal by Subject|0|||
124935364|NCT03333915|449393843|FG003|Overall Study|Withdrawal by Subject|5|||
124935365|NCT03333915|449393844|FG004|Overall Study|Withdrawal by Subject|1|||
124935366|NCT05454514|449393848|FG000|Overall Study|Withdrawal by Subject|4|||
124935367|NCT05785130|449393849|FG000|Overall Study|Withdrawal by Subject|1|||
124935368|NCT05785130|449393850|FG001|Overall Study|Withdrawal by Subject|0|||
124935369|NCT05785130|449393849|FG000|Overall Study|Lack of Efficacy|0|||
124935370|NCT05785130|449393850|FG001|Overall Study|Lack of Efficacy|1|||
124935371|NCT02461134|449393855|FG000|Overall Study|Adverse Event|1|||
124935372|NCT04761198|449393856|FG000|Overall Study|Progressive Disease|1|||
124935373|NCT04761198|449393857|FG001|Overall Study|Progressive Disease|0|||
124935374|NCT04761198|449393858|FG002|Overall Study|Progressive Disease|0|||
124935375|NCT04761198|449393859|FG003|Overall Study|Progressive Disease|1|||
124935376|NCT04761198|449393860|FG004|Overall Study|Progressive Disease|4|||
124935377|NCT04761198|449393861|FG005|Overall Study|Progressive Disease|1|||
124935378|NCT04761198|449393862|FG006|Overall Study|Progressive Disease|2|||
124935379|NCT04761198|449393856|FG000|Overall Study|Protocol Violation|0|||
124935380|NCT04761198|449393857|FG001|Overall Study|Protocol Violation|0|||
124935381|NCT04761198|449393858|FG002|Overall Study|Protocol Violation|0|||
124935382|NCT04761198|449393859|FG003|Overall Study|Protocol Violation|0|||
124935383|NCT04761198|449393860|FG004|Overall Study|Protocol Violation|1|||
124935384|NCT04761198|449393861|FG005|Overall Study|Protocol Violation|0|||
124935385|NCT04761198|449393862|FG006|Overall Study|Protocol Violation|0|||
124935386|NCT04761198|449393856|FG000|Overall Study|Death|2|||
124935387|NCT04761198|449393857|FG001|Overall Study|Death|1|||
124935388|NCT04761198|449393858|FG002|Overall Study|Death|2|||
124935389|NCT04761198|449393859|FG003|Overall Study|Death|5|||
124935390|NCT04761198|449393860|FG004|Overall Study|Death|14|||
124935391|NCT04761198|449393861|FG005|Overall Study|Death|2|||
124935392|NCT04761198|449393862|FG006|Overall Study|Death|5|||
124935393|NCT04761198|449393856|FG000|Overall Study|Lost to Follow-up|0|||
124935394|NCT04761198|449393857|FG001|Overall Study|Lost to Follow-up|0|||
124935395|NCT04761198|449393858|FG002|Overall Study|Lost to Follow-up|0|||
124935396|NCT04761198|449393859|FG003|Overall Study|Lost to Follow-up|0|||
124935397|NCT04761198|449393860|FG004|Overall Study|Lost to Follow-up|1|||
124935398|NCT04761198|449393861|FG005|Overall Study|Lost to Follow-up|0|||
124935399|NCT04761198|449393862|FG006|Overall Study|Lost to Follow-up|0|||
124935400|NCT04761198|449393856|FG000|Overall Study|Withdrawal by Subject|2|||
124935401|NCT04761198|449393857|FG001|Overall Study|Withdrawal by Subject|0|||
124935402|NCT04761198|449393858|FG002|Overall Study|Withdrawal by Subject|1|||
124935403|NCT04761198|449393859|FG003|Overall Study|Withdrawal by Subject|0|||
124935404|NCT04761198|449393860|FG004|Overall Study|Withdrawal by Subject|2|||
124935405|NCT04761198|449393861|FG005|Overall Study|Withdrawal by Subject|0|||
124935406|NCT04761198|449393862|FG006|Overall Study|Withdrawal by Subject|1|||
124935407|NCT04761198|449393856|FG000|Overall Study|Study Terminated by Sponsor|6|||
124935408|NCT04761198|449393857|FG001|Overall Study|Study Terminated by Sponsor|0|||
124935409|NCT04761198|449393858|FG002|Overall Study|Study Terminated by Sponsor|5|||
124935410|NCT04761198|449393859|FG003|Overall Study|Study Terminated by Sponsor|3|||
124935411|NCT04761198|449393860|FG004|Overall Study|Study Terminated by Sponsor|10|||
124935412|NCT04761198|449393861|FG005|Overall Study|Study Terminated by Sponsor|1|||
124935413|NCT04761198|449393862|FG006|Overall Study|Study Terminated by Sponsor|2|||
124935414|NCT03533257|449393863|FG000|Overall Study|Adverse Event|4|||
124935415|NCT03533257|449393864|FG001|Overall Study|Adverse Event|2|||
124935416|NCT03533257|449393863|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
124935417|NCT03533257|449393864|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
124935418|NCT03250676|449393866|FG000|Overall Study|Adverse Event|0|||
124935419|NCT03250676|449393867|FG001|Overall Study|Adverse Event|0|||
124935420|NCT03250676|449393868|FG002|Overall Study|Adverse Event|0|||
124935421|NCT03250676|449393869|FG003|Overall Study|Adverse Event|1|||
124935422|NCT03250676|449393870|FG004|Overall Study|Adverse Event|2|||
124935423|NCT03250676|449393871|FG005|Overall Study|Adverse Event|9|||
124935424|NCT03250676|449393866|FG000|Overall Study|Withdrawal by Subject|1|||
124935425|NCT03250676|449393867|FG001|Overall Study|Withdrawal by Subject|0|||
124935426|NCT03250676|449393868|FG002|Overall Study|Withdrawal by Subject|0|||
124935427|NCT03250676|449393869|FG003|Overall Study|Withdrawal by Subject|1|||
124935428|NCT03250676|449393870|FG004|Overall Study|Withdrawal by Subject|1|||
124935429|NCT03250676|449393871|FG005|Overall Study|Withdrawal by Subject|2|||
124935430|NCT03250676|449393866|FG000|Overall Study|Physician Decision|0|||
124935431|NCT03250676|449393867|FG001|Overall Study|Physician Decision|0|||
125026022|NCT00132730|449718446|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
124935432|NCT03250676|449393868|FG002|Overall Study|Physician Decision|0|||
124935433|NCT03250676|449393869|FG003|Overall Study|Physician Decision|2|||
124935434|NCT03250676|449393870|FG004|Overall Study|Physician Decision|0|||
124935435|NCT03250676|449393871|FG005|Overall Study|Physician Decision|3|||
124935436|NCT03250676|449393866|FG000|Overall Study|Withdrawal of consent|0|||
124935437|NCT03250676|449393867|FG001|Overall Study|Withdrawal of consent|0|||
124935438|NCT03250676|449393868|FG002|Overall Study|Withdrawal of consent|2|||
124935439|NCT03250676|449393869|FG003|Overall Study|Withdrawal of consent|0|||
124935440|NCT03250676|449393870|FG004|Overall Study|Withdrawal of consent|0|||
124935441|NCT03250676|449393871|FG005|Overall Study|Withdrawal of consent|2|||
124935442|NCT03250676|449393866|FG000|Overall Study|Other|1|||
124935443|NCT03250676|449393867|FG001|Overall Study|Other|0|||
124935444|NCT03250676|449393868|FG002|Overall Study|Other|0|||
124935445|NCT03250676|449393869|FG003|Overall Study|Other|0|||
124935446|NCT03250676|449393870|FG004|Overall Study|Other|0|||
124935447|NCT03250676|449393871|FG005|Overall Study|Other|0|||
124935448|NCT03250676|449393866|FG000|Overall Study|Disease progression|4|||
124935449|NCT03250676|449393867|FG001|Overall Study|Disease progression|12|||
124935450|NCT03250676|449393868|FG002|Overall Study|Disease progression|9|||
125026023|NCT00132730|449718447|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
125026024|NCT00132730|449718448|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
125026025|NCT00132730|449718449|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
125026026|NCT00132730|449718450|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
125026027|NCT00132730|449718451|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
125026028|NCT00132730|449718446|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
125026029|NCT00132730|449718447|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
125026030|NCT00132730|449718448|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
125026031|NCT00132730|449718449|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
125026032|NCT00132730|449718450|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
125026033|NCT00132730|449718451|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
125026034|NCT00132730|449718446|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
124935451|NCT03250676|449393869|FG003|Overall Study|Disease progression|7|||
124935452|NCT03250676|449393870|FG004|Overall Study|Disease progression|4|||
124935453|NCT03250676|449393871|FG005|Overall Study|Disease progression|88|||
124935454|NCT03587805|449393872|FG000|Overall Study|Adverse Event|72|||
124935455|NCT03587805|449393872|FG000|Overall Study|Death|1|||
124935456|NCT03587805|449393872|FG000|Overall Study|Lost to Follow-up|78|||
124935457|NCT03587805|449393872|FG000|Overall Study|Withdrawal by Subject|105|||
124935458|NCT03587805|449393872|FG000|Overall Study|Lack of Efficacy|119|||
124935459|NCT03587805|449393872|FG000|Overall Study|Reason unknown|26|||
124935460|NCT03587805|449393872|FG000|Overall Study|COVID_19 pandemic|4|||
124935461|NCT03587805|449393872|FG000|Overall Study|Various reasons|121|||
124935462|NCT03587805|449393872|FG000|Overall Study|Withdrawal by parent/guardian|3|||
124935463|NCT04626427|449393873|FG000|Overall Study|Death|1|||
124935464|NCT04626427|449393873|FG000|Overall Study|Withdrawal by Subject|1|||
124935465|NCT04626427|449393873|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
124935466|NCT04626427|449393873|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
124935467|NCT01651000|449393874|FG000|Overall Study|Adverse Event|2|||
124935468|NCT01651000|449393875|FG001|Overall Study|Adverse Event|8|||
124935469|NCT01651000|449393874|FG000|Overall Study|Lost to Follow-up|3|||
124935470|NCT01651000|449393875|FG001|Overall Study|Lost to Follow-up|2|||
124935471|NCT01651000|449393874|FG000|Overall Study|Protocol Violation|0|||
124935472|NCT01651000|449393875|FG001|Overall Study|Protocol Violation|3|||
124935473|NCT01651000|449393874|FG000|Overall Study|Withdrawal by Subject|2|||
124935474|NCT01651000|449393875|FG001|Overall Study|Withdrawal by Subject|10|||
124935475|NCT01651000|449393874|FG000|Overall Study|Subject noncompliance|0|||
124935476|NCT01651000|449393875|FG001|Overall Study|Subject noncompliance|3|||
124935477|NCT01651000|449393874|FG000|Overall Study|Lack of Efficacy|1|||
124935478|NCT01651000|449393875|FG001|Overall Study|Lack of Efficacy|1|||
124935479|NCT01651000|449393874|FG000|Overall Study|Physician Decision|1|||
124935480|NCT01651000|449393875|FG001|Overall Study|Physician Decision|0|||
124935481|NCT01651000|449393874|FG000|Overall Study|Administrative reason|1|||
124935482|NCT01651000|449393875|FG001|Overall Study|Administrative reason|0|||
124935483|NCT01651000|449393874|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
124935484|NCT01651000|449393875|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
124935485|NCT03982186|449393876|FG000|Overall Study|Lost to Follow-up|0|||
124935486|NCT03982186|449393877|FG001|Overall Study|Lost to Follow-up|1|||
124935487|NCT03982186|449393878|FG002|Overall Study|Lost to Follow-up|2|||
124935488|NCT03982186|449393879|FG003|Overall Study|Lost to Follow-up|1|||
124935489|NCT03982186|449393880|FG004|Overall Study|Lost to Follow-up|1|||
124935490|NCT03982186|449393881|FG005|Overall Study|Lost to Follow-up|0|||
124935491|NCT03982186|449393876|FG000|Overall Study|Physician Decision|0|||
124935492|NCT03982186|449393877|FG001|Overall Study|Physician Decision|1|||
124935493|NCT03982186|449393878|FG002|Overall Study|Physician Decision|0|||
124935494|NCT03982186|449393879|FG003|Overall Study|Physician Decision|0|||
124935495|NCT03982186|449393880|FG004|Overall Study|Physician Decision|0|||
125026035|NCT00132730|449718447|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
124935496|NCT03982186|449393881|FG005|Overall Study|Physician Decision|0|||
124935497|NCT03982186|449393876|FG000|Overall Study|Withdrawal by Subject|3|||
124935498|NCT03982186|449393877|FG001|Overall Study|Withdrawal by Subject|4|||
124935499|NCT03982186|449393878|FG002|Overall Study|Withdrawal by Subject|1|||
124935500|NCT03982186|449393879|FG003|Overall Study|Withdrawal by Subject|7|||
124935501|NCT03982186|449393880|FG004|Overall Study|Withdrawal by Subject|2|||
124935502|NCT03982186|449393881|FG005|Overall Study|Withdrawal by Subject|0|||
124935503|NCT03982186|449393876|FG000|Overall Study|Randomized and not treated|0|||
124935504|NCT03982186|449393877|FG001|Overall Study|Randomized and not treated|0|||
124935505|NCT03982186|449393878|FG002|Overall Study|Randomized and not treated|0|||
124935506|NCT03982186|449393879|FG003|Overall Study|Randomized and not treated|1|||
124935507|NCT03982186|449393880|FG004|Overall Study|Randomized and not treated|0|||
124935508|NCT03982186|449393881|FG005|Overall Study|Randomized and not treated|0|||
124935509|NCT02765412|449393882|FG000|Overall Study|Death|482|||
124935510|NCT02765412|449393883|FG001|Overall Study|Death|855|||
124935511|NCT04244175|449394788|FG000|Overall Study|Adverse Event|3|||
124935512|NCT04244175|449394789|FG001|Overall Study|Adverse Event|2|||
124935513|NCT04244175|449394790|FG002|Overall Study|Adverse Event|5|||
124935514|NCT04244175|449394788|FG000|Overall Study|Lack of Efficacy|1|||
124935515|NCT04244175|449394789|FG001|Overall Study|Lack of Efficacy|0|||
124935516|NCT04244175|449394790|FG002|Overall Study|Lack of Efficacy|1|||
124935517|NCT04244175|449394788|FG000|Overall Study|Lost to Follow-up|1|||
124935518|NCT04244175|449394789|FG001|Overall Study|Lost to Follow-up|0|||
124935519|NCT04244175|449394790|FG002|Overall Study|Lost to Follow-up|0|||
124935520|NCT04244175|449394788|FG000|Overall Study|Non-compliance with study drug|1|||
124935521|NCT04244175|449394789|FG001|Overall Study|Non-compliance with study drug|0|||
124935522|NCT04244175|449394790|FG002|Overall Study|Non-compliance with study drug|1|||
124935523|NCT04244175|449394788|FG000|Overall Study|Protocol deviation|0|||
124935524|NCT04244175|449394789|FG001|Overall Study|Protocol deviation|1|||
124935525|NCT04244175|449394790|FG002|Overall Study|Protocol deviation|0|||
124935526|NCT04244175|449394788|FG000|Overall Study|Withdrawal by Subject|1|||
124935527|NCT04244175|449394789|FG001|Overall Study|Withdrawal by Subject|3|||
124935528|NCT04244175|449394790|FG002|Overall Study|Withdrawal by Subject|1|||
124935529|NCT04244175|449394788|FG000|Overall Study|Other, not specified|0|||
124935530|NCT04244175|449394789|FG001|Overall Study|Other, not specified|1|||
124935531|NCT04244175|449394790|FG002|Overall Study|Other, not specified|2|||
124935532|NCT04595331|449394791|FG000|Overall Study|Withdrawal by Subject|0|||
124935533|NCT04595331|449394792|FG001|Overall Study|Withdrawal by Subject|1|||
124935534|NCT04595331|449394791|FG000|Overall Study|Lost to Follow-up|0|||
124935535|NCT04595331|449394792|FG001|Overall Study|Lost to Follow-up|5|||
124935536|NCT04595331|449394791|FG000|Overall Study|Medical reason|0|||
124935537|NCT04595331|449394792|FG001|Overall Study|Medical reason|1|||
124935538|NCT03781089|449394793|FG000|Overall Study|Constipation|1|||
124935539|NCT03781089|449394794|FG001|Overall Study|Constipation|0|||
124935540|NCT03781089|449394793|FG000|Overall Study|Positive pregnancy test|0|||
124935541|NCT03781089|449394794|FG001|Overall Study|Positive pregnancy test|1|||
124935542|NCT05020353|449394795|FG000|Overall Study|Protocol Violation|7|||
124935543|NCT05020353|449394795|FG000|Overall Study|Withdrawal by Subject|33|||
124935544|NCT05985395|449394804|FG000|Overall Study|Physician Decision|2|||
124935545|NCT05985395|449394805|FG001|Overall Study|Physician Decision|1|||
124935546|NCT05985395|449394804|FG000|Overall Study|Withdrawal by Subject|1|||
124935547|NCT05985395|449394805|FG001|Overall Study|Withdrawal by Subject|0|||
124935548|NCT02777593|449394817|FG000|Overall Study|Still in study|1|||
124935549|NCT02777593|449394818|FG001|Overall Study|Still in study|32|||
124935550|NCT02777593|449394819|FG002|Overall Study|Still in study|3|||
124935551|NCT02777593|449394820|FG003|Overall Study|Still in study|6|||
124935552|NCT02777593|449394821|FG004|Overall Study|Still in study|5|||
124935553|NCT02777593|449394817|FG000|Overall Study|Death|21|||
124935554|NCT02777593|449394818|FG001|Overall Study|Death|28|||
124935555|NCT02777593|449394819|FG002|Overall Study|Death|0|||
124935556|NCT02777593|449394820|FG003|Overall Study|Death|5|||
124935557|NCT02777593|449394821|FG004|Overall Study|Death|0|||
124935558|NCT02777593|449394817|FG000|Overall Study|Withdrawal by Subject|8|||
124935559|NCT02777593|449394818|FG001|Overall Study|Withdrawal by Subject|4|||
125120885|NCT04700449|450066995|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
124935560|NCT02777593|449394819|FG002|Overall Study|Withdrawal by Subject|1|||
124935561|NCT02777593|449394820|FG003|Overall Study|Withdrawal by Subject|1|||
124935562|NCT02777593|449394821|FG004|Overall Study|Withdrawal by Subject|0|||
124935563|NCT02777593|449394817|FG000|Overall Study|Lost to Follow-up|8|||
124935564|NCT02777593|449394818|FG001|Overall Study|Lost to Follow-up|16|||
124935565|NCT02777593|449394819|FG002|Overall Study|Lost to Follow-up|5|||
124935566|NCT02777593|449394820|FG003|Overall Study|Lost to Follow-up|0|||
124935567|NCT02777593|449394821|FG004|Overall Study|Lost to Follow-up|1|||
125026036|NCT00132730|449718448|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
125026037|NCT00132730|449718449|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
125026038|NCT00132730|449718450|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
125026039|NCT00132730|449718451|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
125026040|NCT00132730|449718446|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
125026041|NCT00132730|449718447|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
125026042|NCT00132730|449718448|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
125026043|NCT00132730|449718449|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
125026044|NCT00132730|449718450|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
125026045|NCT00132730|449718451|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
125026046|NCT00132730|449718446|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
125026047|NCT00132730|449718447|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
125026048|NCT00132730|449718448|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
125026049|NCT00132730|449718449|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
125026050|NCT00132730|449718450|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
125026051|NCT00132730|449718451|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
124935568|NCT02777593|449394817|FG000|Overall Study|Physician Decision|2|||
124935569|NCT02777593|449394818|FG001|Overall Study|Physician Decision|2|||
124935570|NCT02777593|449394819|FG002|Overall Study|Physician Decision|0|||
124935571|NCT02777593|449394820|FG003|Overall Study|Physician Decision|0|||
124935572|NCT02777593|449394821|FG004|Overall Study|Physician Decision|0|||
124935573|NCT02777593|449394817|FG000|Overall Study|Discontinued due to Other|1|||
124935574|NCT02777593|449394818|FG001|Overall Study|Discontinued due to Other|0|||
124935575|NCT02777593|449394819|FG002|Overall Study|Discontinued due to Other|0|||
124935576|NCT02777593|449394820|FG003|Overall Study|Discontinued due to Other|0|||
124935577|NCT02777593|449394821|FG004|Overall Study|Discontinued due to Other|0|||
124935578|NCT03547271|449394824|FG000|Overall Study|Adverse Event|1|||
124935579|NCT03547271|449394825|FG001|Overall Study|Adverse Event|1|||
124935580|NCT03547271|449394826|FG002|Overall Study|Adverse Event|0|||
124935581|NCT03547271|449394827|FG003|Overall Study|Adverse Event|0|||
124935582|NCT03547271|449394824|FG000|Overall Study|Protocol deviation|5|||
124935583|NCT03547271|449394825|FG001|Overall Study|Protocol deviation|7|||
124935584|NCT03547271|449394826|FG002|Overall Study|Protocol deviation|3|||
124935585|NCT03547271|449394827|FG003|Overall Study|Protocol deviation|0|||
124935586|NCT03547271|449394824|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
124935587|NCT03547271|449394825|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
124935588|NCT03547271|449394826|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
124935589|NCT03547271|449394827|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
124935590|NCT03547271|449394824|FG000|Overall Study|Lost to Follow-up|3|||
124935591|NCT03547271|449394825|FG001|Overall Study|Lost to Follow-up|3|||
124935592|NCT03547271|449394826|FG002|Overall Study|Lost to Follow-up|1|||
124935593|NCT03547271|449394827|FG003|Overall Study|Lost to Follow-up|0|||
124935594|NCT06065735|449394832|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
124935595|NCT06065735|449394833|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
124935596|NCT06065735|449394834|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
124935597|NCT06065735|449394832|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
124935598|NCT06065735|449394833|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
124935599|NCT06065735|449394834|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
124935600|NCT06065735|449394832|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
124935601|NCT06065735|449394833|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
124935602|NCT06065735|449394834|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
124935603|NCT06065735|449394832|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
124935604|NCT06065735|449394833|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
124935605|NCT06065735|449394834|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
124935606|NCT06065735|449394832|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
124935607|NCT06065735|449394833|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
124935608|NCT06065735|449394834|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
124935609|NCT02532621|449394835|FG000|Overall Study|Death|3|||
124935610|NCT02532621|449394835|FG000|Overall Study|Lost to Follow-up|3|||
124935611|NCT02532621|449394835|FG000|Overall Study|Withdrawal by Subject|6|||
125026052|NCT00132730|449718446|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
124935612|NCT02532621|449394835|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
124935613|NCT02532621|449394835|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
125026053|NCT00132730|449718447|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
124935614|NCT03522298|449394836|FG000|Overall Study|Adverse Event|1|||
124935615|NCT03522298|449394837|FG001|Overall Study|Adverse Event|0|||
124935616|NCT03522298|449394838|FG002|Overall Study|Adverse Event|0|||
124935617|NCT03522298|449394839|FG003|Overall Study|Adverse Event|1|||
124935618|NCT03522298|449394836|FG000|Overall Study|Death|2|||
124935619|NCT03522298|449394837|FG001|Overall Study|Death|4|||
124935620|NCT03522298|449394838|FG002|Overall Study|Death|8|||
124935621|NCT03522298|449394839|FG003|Overall Study|Death|8|||
124935622|NCT03522298|449394836|FG000|Overall Study|Patient decision|0|||
124935623|NCT03522298|449394837|FG001|Overall Study|Patient decision|2|||
124935624|NCT03522298|449394838|FG002|Overall Study|Patient decision|2|||
124935625|NCT03522298|449394839|FG003|Overall Study|Patient decision|2|||
124935626|NCT04795245|449394842|FG000|Overall Study|Unkown reason|7|||
124935627|NCT04795245|449394842|FG000|Overall Study|Death|17|||
124935628|NCT04795245|449394842|FG000|Overall Study|Other than listed|19|||
124935629|NCT04795245|449394842|FG000|Overall Study|Adverse Event|143|||
124935630|NCT04795245|449394842|FG000|Overall Study|Progressive disease|512|||
124935631|NCT04795245|449394842|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
124935632|NCT02919917|449394843|FG000|Overall Study|Withdrawal by Subject|4|||
124935633|NCT02919917|449394844|FG001|Overall Study|Withdrawal by Subject|8|||
124935634|NCT03418740|449394845|FG000|Overall Study|Lost to Follow-up|13|||
124935635|NCT03418740|449394845|FG000|Overall Study|Scheduling Issues|7|||
124935636|NCT03418740|449394845|FG000|Overall Study|Withdrawal by Subject|2|||
124935637|NCT03418740|449394845|FG000|Overall Study|Unable to Continue Consent|1|||
124935638|NCT04157517|449394850|FG000|Overall Study|Death|1|||
124935639|NCT04157517|449394851|FG001|Overall Study|Death|2|||
124935640|NCT04157517|449394852|FG002|Overall Study|Death|2|||
124935641|NCT04157517|449394853|FG003|Overall Study|Death|3|||
124935642|NCT04157517|449394854|FG004|Overall Study|Death|3|||
124935643|NCT04157517|449394855|FG005|Overall Study|Death|4|||
124935644|NCT04157517|449394856|FG006|Overall Study|Death|1|||
124935645|NCT04157517|449394857|FG007|Overall Study|Death|2|||
124935646|NCT04157517|449394858|FG008|Overall Study|Death|4|||
124935647|NCT04157517|449394859|FG009|Overall Study|Death|0|||
124935648|NCT04157517|449394850|FG000|Overall Study|Withdrawal by Subject|1|||
124935649|NCT04157517|449394851|FG001|Overall Study|Withdrawal by Subject|1|||
124935650|NCT04157517|449394852|FG002|Overall Study|Withdrawal by Subject|1|||
124935651|NCT04157517|449394853|FG003|Overall Study|Withdrawal by Subject|0|||
124935652|NCT04157517|449394854|FG004|Overall Study|Withdrawal by Subject|0|||
124935653|NCT04157517|449394855|FG005|Overall Study|Withdrawal by Subject|1|||
124935654|NCT04157517|449394856|FG006|Overall Study|Withdrawal by Subject|0|||
124935655|NCT04157517|449394857|FG007|Overall Study|Withdrawal by Subject|0|||
124935656|NCT04157517|449394858|FG008|Overall Study|Withdrawal by Subject|1|||
124935657|NCT04157517|449394859|FG009|Overall Study|Withdrawal by Subject|0|||
124935658|NCT04157517|449394850|FG000|Overall Study|Other|1|||
124935659|NCT04157517|449394851|FG001|Overall Study|Other|0|||
124935660|NCT04157517|449394852|FG002|Overall Study|Other|0|||
124935661|NCT04157517|449394853|FG003|Overall Study|Other|0|||
124935662|NCT04157517|449394854|FG004|Overall Study|Other|0|||
124935663|NCT04157517|449394855|FG005|Overall Study|Other|1|||
124935664|NCT04157517|449394856|FG006|Overall Study|Other|2|||
124935665|NCT04157517|449394857|FG007|Overall Study|Other|7|||
124935666|NCT04157517|449394858|FG008|Overall Study|Other|7|||
124935667|NCT04157517|449394859|FG009|Overall Study|Other|0|||
124935668|NCT02933489|449394860|FG000|Overall Study|Ineligible|3|||
124935669|NCT02933489|449394861|FG001|Overall Study|Ineligible|3|||
124935670|NCT02933489|449394860|FG000|Overall Study|Withdrawal by Subject|27|||
124935671|NCT02933489|449394861|FG001|Overall Study|Withdrawal by Subject|18|||
124935672|NCT02933489|449394860|FG000|Overall Study|Unable to complete exams (other)|14|||
124935673|NCT02933489|449394861|FG001|Overall Study|Unable to complete exams (other)|7|||
124935674|NCT02994927|449394862|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124935675|NCT02994927|449394863|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124935676|NCT02994927|449394862|FG000|Overall Study|Did not meet eligibility criteria|0|||
124935677|NCT02994927|449394863|FG001|Overall Study|Did not meet eligibility criteria|1|||
124935678|NCT02994927|449394862|FG000|Overall Study|Physician Decision|4|||
124935679|NCT02994927|449394863|FG001|Overall Study|Physician Decision|3|||
124935680|NCT02994927|449394862|FG000|Overall Study|Death|4|||
124935681|NCT02994927|449394863|FG001|Overall Study|Death|2|||
124935682|NCT02994927|449394862|FG000|Overall Study|Adverse Event|2|||
124935683|NCT02994927|449394863|FG001|Overall Study|Adverse Event|1|||
124935684|NCT02994927|449394862|FG000|Overall Study|Withdrawal by Subject|3|||
124935685|NCT02994927|449394863|FG001|Overall Study|Withdrawal by Subject|6|||
124935686|NCT02994927|449394862|FG000|Overall Study|Lost to Follow-up|2|||
124935687|NCT02994927|449394863|FG001|Overall Study|Lost to Follow-up|1|||
124935688|NCT04281498|449394864|FG000|Overall Study|Progression of disease|1|||
124935689|NCT04281498|449394864|FG000|Overall Study|Planned SCT|1|||
124935690|NCT04281498|449394864|FG000|Overall Study|Alternative Treatment|1|||
124935691|NCT03417284|449395128|FG000|Overall Study|Inadequate supply on study drug|1|||
124935692|NCT03417284|449395129|FG001|Overall Study|Inadequate supply on study drug|0|||
124935693|NCT03417284|449395130|FG002|Overall Study|Inadequate supply on study drug|0|||
124935694|NCT03417284|449395131|FG003|Overall Study|Inadequate supply on study drug|0|||
124935695|NCT03417284|449395128|FG000|Overall Study|Disease Progression|0|||
124935696|NCT03417284|449395129|FG001|Overall Study|Disease Progression|0|||
124935697|NCT03417284|449395130|FG002|Overall Study|Disease Progression|1|||
124935698|NCT03417284|449395131|FG003|Overall Study|Disease Progression|0|||
124935699|NCT05132400|449395132|FG000|Overall Study|Withdrawal by Subject|14|||
124935700|NCT05132400|449395133|FG001|Overall Study|Withdrawal by Subject|8|||
124935701|NCT05132400|449395132|FG000|Overall Study|Lost to Follow-up|132|||
124935702|NCT05132400|449395133|FG001|Overall Study|Lost to Follow-up|121|||
124935703|NCT02076009|449395135|FG000|Overall Study|Death|172|||
124935704|NCT02076009|449395136|FG001|Overall Study|Death|153|||
124935705|NCT02076009|449395135|FG000|Overall Study|Withdrawal by Subject|16|||
124935706|NCT02076009|449395136|FG001|Overall Study|Withdrawal by Subject|12|||
124935707|NCT02076009|449395135|FG000|Overall Study|Lost to Follow-up|4|||
124935708|NCT02076009|449395136|FG001|Overall Study|Lost to Follow-up|2|||
124935709|NCT02076009|449395135|FG000|Overall Study|Progressive Disease|1|||
124935710|NCT02076009|449395136|FG001|Overall Study|Progressive Disease|0|||
124935711|NCT02076009|449395135|FG000|Overall Study|Physician Decision|0|||
124935712|NCT02076009|449395136|FG001|Overall Study|Physician Decision|1|||
124935713|NCT02076009|449395135|FG000|Overall Study|End of data collection|90|||
124935714|NCT02076009|449395136|FG001|Overall Study|End of data collection|118|||
124935715|NCT01897441|449395143|FG000|Overall Study|Lost to Follow-up|0|||
124935716|NCT01897441|449395144|FG001|Overall Study|Lost to Follow-up|0|||
124935717|NCT01897441|449395145|FG002|Overall Study|Lost to Follow-up|1|||
124935718|NCT01897441|449395146|FG003|Overall Study|Lost to Follow-up|0|||
124935719|NCT01897441|449395147|FG004|Overall Study|Lost to Follow-up|0|||
124935720|NCT01897441|449395148|FG005|Overall Study|Lost to Follow-up|0|||
124935721|NCT01897441|449395143|FG000|Overall Study|Withdrawal by Subject|0|||
124935722|NCT01897441|449395144|FG001|Overall Study|Withdrawal by Subject|0|||
124935723|NCT01897441|449395145|FG002|Overall Study|Withdrawal by Subject|0|||
124935724|NCT01897441|449395146|FG003|Overall Study|Withdrawal by Subject|0|||
124935725|NCT01897441|449395147|FG004|Overall Study|Withdrawal by Subject|1|||
124935726|NCT01897441|449395148|FG005|Overall Study|Withdrawal by Subject|0|||
124935727|NCT01897441|449395143|FG000|Overall Study|Withdrawn by Provider|0|||
124935728|NCT01897441|449395144|FG001|Overall Study|Withdrawn by Provider|2|||
124935729|NCT01897441|449395145|FG002|Overall Study|Withdrawn by Provider|0|||
124935730|NCT01897441|449395146|FG003|Overall Study|Withdrawn by Provider|0|||
124935731|NCT01897441|449395147|FG004|Overall Study|Withdrawn by Provider|0|||
124935732|NCT01897441|449395148|FG005|Overall Study|Withdrawn by Provider|0|||
124935733|NCT04093869|449395158|FG000|Overall Study|Death|0|||
124935734|NCT04093869|449395159|FG001|Overall Study|Death|1|||
124935735|NCT04093869|449395158|FG000|Overall Study|Withdrawal by Subject|1|||
124935736|NCT04093869|449395159|FG001|Overall Study|Withdrawal by Subject|0|||
124935737|NCT02806726|449395164|FG000|Overall Study|Lost to Follow-up|1|||
124935738|NCT05129501|449395165|FG000|Overall Study|Lost to Follow-up|54|||
124935739|NCT05129501|449395166|FG001|Overall Study|Lost to Follow-up|41|||
124935740|NCT04166513|449395167|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
125026054|NCT00132730|449718448|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
125026055|NCT00132730|449718449|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
125026056|NCT00132730|449718450|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
125026057|NCT00132730|449718451|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
124935741|NCT04166513|449395168|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
124935742|NCT04166513|449395169|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
124935743|NCT04166513|449395170|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
124935744|NCT04166513|449395167|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
124935745|NCT04166513|449395168|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
124935746|NCT04166513|449395169|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
124935747|NCT04166513|449395170|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
124935748|NCT04166513|449395167|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
124935749|NCT04166513|449395168|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
124935750|NCT04166513|449395169|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
124935751|NCT04166513|449395170|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
124935752|NCT04166513|449395167|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
124935753|NCT04166513|449395168|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
124935754|NCT04166513|449395169|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
124935755|NCT04166513|449395170|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
124935756|NCT04166513|449395167|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
124935757|NCT04166513|449395168|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
124935758|NCT04166513|449395169|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
124935759|NCT04166513|449395170|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
124935760|NCT05866926|449395171|FG000|Overall Study|Death|16|||
124935761|NCT05866926|449395172|FG001|Overall Study|Death|9|||
124935762|NCT05866926|449395171|FG000|Overall Study|Lost to Follow-up|0|||
124935763|NCT05866926|449395172|FG001|Overall Study|Lost to Follow-up|1|||
124935764|NCT05866926|449395171|FG000|Overall Study|Adverse Event|1|||
124935765|NCT05866926|449395172|FG001|Overall Study|Adverse Event|0|||
124935766|NCT05866926|449395171|FG000|Overall Study|Withdrawal by Subject|5|||
124935767|NCT05866926|449395172|FG001|Overall Study|Withdrawal by Subject|1|||
124935768|NCT05866926|449395171|FG000|Overall Study|Disease progression|1|||
124935769|NCT05866926|449395172|FG001|Overall Study|Disease progression|0|||
124935770|NCT05866926|449395171|FG000|Overall Study|other causes|2|||
124935771|NCT05866926|449395172|FG001|Overall Study|other causes|1|||
124935772|NCT05267639|449395533|FG000|Overall Study|Withdrawal by Subject|1|||
124935773|NCT05267639|449395534|FG001|Overall Study|Withdrawal by Subject|0|||
124935774|NCT03816397|449395541|FG000|Overall Study|Censored at interim analysis date.|13|||
124935775|NCT03816397|449395542|FG001|Overall Study|Censored at interim analysis date.|6|||
124935776|NCT03816397|449395541|FG000|Overall Study|Withdrawal by Subject|1|||
124935777|NCT03816397|449395542|FG001|Overall Study|Withdrawal by Subject|1|||
124935778|NCT05718687|449395547|FG000|Overall Study|Withdrawal by Subject|3|||
124935779|NCT03493542|449395548|FG000|Base Study|Withdrawal by Subject|0|||
124935780|NCT03493542|449395549|FG001|Base Study|Withdrawal by Subject|4|||
124935781|NCT03493542|449395550|FG002|Base Study|Withdrawal by Subject|0|||
124935782|NCT03493542|449395548|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
124935783|NCT03493542|449395549|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
124935784|NCT03493542|449395550|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
124935785|NCT03493542|449395548|FG000|Extension Study|Withdrawal by Subject|0|||
124935786|NCT03493542|449395549|FG001|Extension Study|Withdrawal by Subject|0|||
124935787|NCT03493542|449395550|FG002|Extension Study|Withdrawal by Subject|25|||
124935788|NCT05485935|449395551|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
124935789|NCT05485935|449395552|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
124935790|NCT05485935|449395551|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
124935791|NCT05485935|449395552|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
124935792|NCT05485935|449395551|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
124935793|NCT05485935|449395552|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
124935794|NCT05485935|449395551|FG000|Period 2 (T2 and V3)|loss of contact|0|||
124935795|NCT05485935|449395552|FG001|Period 2 (T2 and V3)|loss of contact|1|||
124935796|NCT01527188|449395558|FG000|Overall Study|Adverse Event|5|||
124935797|NCT01527188|449395559|FG001|Overall Study|Adverse Event|5|||
124935798|NCT01527188|449395560|FG002|Overall Study|Adverse Event|11|||
124935799|NCT01527188|449395561|FG003|Overall Study|Adverse Event|0|||
124935800|NCT01527188|449395558|FG000|Overall Study|Withdrawal by Subject|3|||
124935801|NCT01527188|449395559|FG001|Overall Study|Withdrawal by Subject|6|||
124935802|NCT01527188|449395560|FG002|Overall Study|Withdrawal by Subject|4|||
124935803|NCT01527188|449395561|FG003|Overall Study|Withdrawal by Subject|4|||
124935804|NCT01527188|449395558|FG000|Overall Study|Any other reason not above-mentioned|6|||
124935805|NCT01527188|449395559|FG001|Overall Study|Any other reason not above-mentioned|7|||
124935806|NCT01527188|449395560|FG002|Overall Study|Any other reason not above-mentioned|8|||
124935807|NCT01527188|449395561|FG003|Overall Study|Any other reason not above-mentioned|8|||
124935808|NCT01265537|449395563|FG000|Overall Study|Adverse Event|2|||
124935809|NCT01265537|449395564|FG001|Overall Study|Adverse Event|1|||
124935810|NCT01265537|449395563|FG000|Overall Study|Physician Decision|0|||
124935811|NCT01265537|449395564|FG001|Overall Study|Physician Decision|1|||
124935812|NCT03782116|449395565|FG000|Completed Intervetion|Lost to Follow-up|11|||
124935813|NCT03782116|449395566|FG001|Completed Intervetion|Lost to Follow-up|7|||
125026058|NCT00132730|449718446|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
125026059|NCT00132730|449718447|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
124935814|NCT03782116|449395565|FG000|Completed Intervetion|Withdrawal by Subject|6|||
124935815|NCT03782116|449395566|FG001|Completed Intervetion|Withdrawal by Subject|5|||
125026060|NCT00132730|449718448|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
124935816|NCT03782116|449395565|FG000|Included in Analysis|Protocol Violation|5|||
124935817|NCT03782116|449395566|FG001|Included in Analysis|Protocol Violation|5|||
124935818|NCT03512301|449396083|FG000|Overall Study|Protocol Violation|2|||
124935819|NCT03512301|449396083|FG000|Overall Study|Did Not Qualify|3|||
124935820|NCT03512301|449396083|FG000|Overall Study|Age-ineligible|1|||
124935821|NCT03512301|449396083|FG000|Overall Study|Inadequate fluency with the English language|3|||
124935822|NCT00447980|449396084|FG000|Overall Study|Withdrawal by Subject|1|||
124935823|NCT00447980|449396085|FG001|Overall Study|Withdrawal by Subject|1|||
124935824|NCT00447980|449396086|FG002|Overall Study|Withdrawal by Subject|4|||
124935825|NCT00447980|449396087|FG003|Overall Study|Withdrawal by Subject|4|||
124935826|NCT00447980|449396084|FG000|Overall Study|Lost to Follow-up|1|||
124935827|NCT00447980|449396085|FG001|Overall Study|Lost to Follow-up|1|||
124935828|NCT00447980|449396086|FG002|Overall Study|Lost to Follow-up|0|||
124935829|NCT00447980|449396087|FG003|Overall Study|Lost to Follow-up|0|||
124935830|NCT00447980|449396084|FG000|Overall Study|Did not proceed with surgery|3|||
124935831|NCT00447980|449396085|FG001|Overall Study|Did not proceed with surgery|3|||
124935832|NCT00447980|449396086|FG002|Overall Study|Did not proceed with surgery|2|||
124935833|NCT00447980|449396087|FG003|Overall Study|Did not proceed with surgery|2|||
124935834|NCT03635567|449396090|FG000|Overall Study|Lost to Follow-up|4|||
124935835|NCT03635567|449396091|FG001|Overall Study|Lost to Follow-up|1|||
124935836|NCT03635567|449396090|FG000|Overall Study|Withdrawal by Subject|11|||
124935837|NCT03635567|449396091|FG001|Overall Study|Withdrawal by Subject|16|||
124935838|NCT03635567|449396090|FG000|Overall Study|Sponsor Decision|99|||
124935839|NCT03635567|449396091|FG001|Overall Study|Sponsor Decision|57|||
124935840|NCT03635567|449396090|FG000|Overall Study|Death|194|||
124935841|NCT03635567|449396091|FG001|Overall Study|Death|235|||
124935842|NCT05157841|449396092|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
124935843|NCT05157841|449396093|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
124935844|NCT05157841|449396094|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
124935845|NCT05157841|449396092|FG000|Part A (14 Days)|Adverse Event|1|||
124935846|NCT05157841|449396093|FG001|Part A (14 Days)|Adverse Event|0|||
124935847|NCT05157841|449396094|FG002|Part A (14 Days)|Adverse Event|0|||
124935848|NCT05157841|449396092|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
124935849|NCT05157841|449396093|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
124935850|NCT05157841|449396094|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
124935851|NCT04933474|449396097|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
124935852|NCT04933474|449396098|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
124935853|NCT04933474|449396097|FG000|Overall Study|Lost to Follow-up|19|||
124935854|NCT04933474|449396098|FG001|Overall Study|Lost to Follow-up|9|||
124935855|NCT04933474|449396097|FG000|Overall Study|Life Burden - unable to participate|6|||
124935856|NCT04933474|449396098|FG001|Overall Study|Life Burden - unable to participate|2|||
124935857|NCT04933474|449396097|FG000|Overall Study|Disease Burden - unable to participate|4|||
125026061|NCT00132730|449718449|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
125026062|NCT00132730|449718450|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
124935858|NCT04933474|449396098|FG001|Overall Study|Disease Burden - unable to participate|1|||
125026063|NCT00132730|449718451|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
125026064|NCT01554579|449718452|FG000|Overall Study|Adverse Event|6|||
125026065|NCT01554579|449718453|FG001|Overall Study|Adverse Event|25|||
125026066|NCT01554579|449718452|FG000|Overall Study|Lack of Efficacy|2|||
125026067|NCT01554579|449718453|FG001|Overall Study|Lack of Efficacy|1|||
125026068|NCT01554579|449718452|FG000|Overall Study|Withdrawal by Subject|2|||
125026069|NCT01554579|449718453|FG001|Overall Study|Withdrawal by Subject|1|||
125026070|NCT01192347|449718457|FG000|Overall Study|Death|3|||
125026071|NCT01192347|449718457|FG000|Overall Study|Lost to Follow-up|3|||
125026072|NCT01192347|449718457|FG000|Overall Study|Withdrawal by Subject|1|||
125026073|NCT01192347|449718457|FG000|Overall Study|Adverse Event|1|||
125026074|NCT01192347|449718457|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
125026075|NCT01192347|449718457|FG000|Overall Study|Patient seen in different hospital|1|||
125026076|NCT01192347|449718457|FG000|Overall Study|Patient not visiting hospital regularly|1|||
125026077|NCT01192347|449718457|FG000|Overall Study|Patient did not show up for visits|1|||
125026078|NCT01046695|449718459|FG000|Overall Study|Subject had a pacemaker|0|||
125026079|NCT01046695|449718460|FG001|Overall Study|Subject had a pacemaker|1|||
125026080|NCT01046695|449718459|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
125026081|NCT01046695|449718460|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
125026082|NCT00939692|449718461|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
125026083|NCT00939692|449718462|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
125026084|NCT00939692|449718461|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
124935859|NCT04933474|449396097|FG000|Overall Study|Surgery/Hospitalization|1|||
124935860|NCT04933474|449396098|FG001|Overall Study|Surgery/Hospitalization|2|||
124935861|NCT04933474|449396097|FG000|Overall Study|Dissatisfied with Intervention|1|||
124935862|NCT04933474|449396098|FG001|Overall Study|Dissatisfied with Intervention|1|||
124935863|NCT04933474|449396097|FG000|Overall Study|Withdrew interest in participation|1|||
125026085|NCT00939692|449718462|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
125026086|NCT03433781|449718468|FG000|Overall Study|Progression of Disease|1|||
125026087|NCT03433781|449718469|FG001|Overall Study|Progression of Disease|0|||
125026088|NCT03433781|449718470|FG002|Overall Study|Progression of Disease|0|||
125026089|NCT03433781|449718468|FG000|Overall Study|Physician Decision|0|||
125026090|NCT03433781|449718469|FG001|Overall Study|Physician Decision|1|||
125026091|NCT03433781|449718470|FG002|Overall Study|Physician Decision|0|||
125120886|NCT04700449|450066996|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
125120887|NCT04700449|450066997|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
125120888|NCT04700449|450066994|FG000|Stage 2 Sub-study 2|Other|0|||
125120889|NCT04700449|450066995|FG001|Stage 2 Sub-study 2|Other|0|||
125120890|NCT04700449|450066996|FG002|Stage 2 Sub-study 2|Other|0|||
125120891|NCT04700449|450066997|FG003|Stage 2 Sub-study 2|Other|5|||
125120892|NCT03738332|450066998|FG000|Overall Study|Withdrawal by Subject|1|||
125120893|NCT01521559|450066999|FG000|Overall Study|Adverse Event|0|||
125120894|NCT01521559|450067000|FG001|Overall Study|Adverse Event|4|||
125120895|NCT01521559|450066999|FG000|Overall Study|Death|1|||
125120896|NCT01521559|450067000|FG001|Overall Study|Death|0|||
125120897|NCT01521559|450066999|FG000|Overall Study|Withdrawal by Subject|9|||
125120898|NCT01521559|450067000|FG001|Overall Study|Withdrawal by Subject|11|||
125120899|NCT01521559|450066999|FG000|Overall Study|Lost to Follow-up|3|||
125120900|NCT01521559|450067000|FG001|Overall Study|Lost to Follow-up|1|||
125120901|NCT01521559|450066999|FG000|Overall Study|Protocol Violation|1|||
125120902|NCT01521559|450067000|FG001|Overall Study|Protocol Violation|0|||
125120903|NCT01521559|450066999|FG000|Overall Study|Other|1|||
125120904|NCT01521559|450067000|FG001|Overall Study|Other|2|||
125120905|NCT00275002|450067001|FG000|Overall Study|Death|1|||
125120906|NCT00275002|450067002|FG001|Overall Study|Death|0|||
125120907|NCT00275002|450067001|FG000|Overall Study|Disease progression|21|||
125120908|NCT00275002|450067002|FG001|Overall Study|Disease progression|15|||
125120909|NCT00275002|450067001|FG000|Overall Study|Adverse Event|0|||
125120910|NCT00275002|450067002|FG001|Overall Study|Adverse Event|1|||
125120911|NCT00576381|450067009|FG000|Overall Study|Reoperation|3|||
125120912|NCT00576381|450067009|FG000|Overall Study|Adverse Event|4|||
125120913|NCT01031537|450067013|FG000|Overall Study|medical reasons not related to study|3|||
125120914|NCT01031537|450067013|FG000|Overall Study|Lack of Efficacy|1|||
125120915|NCT01031537|450067013|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
125120916|NCT01031537|450067013|FG000|Overall Study|moved, met exclusion criteria|10|||
125120917|NCT01031537|450067013|FG000|Overall Study|Withdrawal by Subject|5|||
125120918|NCT01031537|450067013|FG000|Overall Study|PI removal, no longer met eligibility|12|||
125120919|NCT02132247|450067014|FG000|Overall Study|Protocol Violation|1|||
125120920|NCT02132247|450067015|FG001|Overall Study|Protocol Violation|0|||
125120921|NCT00520741|450067016|FG000|Overall Study|Adverse Event|16|||
125120922|NCT00520741|450067017|FG001|Overall Study|Adverse Event|56|||
125120923|NCT00520741|450067016|FG000|Overall Study|Lack of Efficacy|11|||
125120924|NCT00520741|450067017|FG001|Overall Study|Lack of Efficacy|30|||
125120925|NCT00520741|450067016|FG000|Overall Study|Withdrawal by Subject|0|||
125120926|NCT00520741|450067017|FG001|Overall Study|Withdrawal by Subject|11|||
125120927|NCT00520741|450067016|FG000|Overall Study|Protocol Violation|2|||
125120928|NCT00520741|450067017|FG001|Overall Study|Protocol Violation|15|||
125120929|NCT00520741|450067016|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
125120930|NCT00520741|450067017|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
125120931|NCT00520741|450067016|FG000|Overall Study|Lost to Follow-up|4|||
125120932|NCT00520741|450067017|FG001|Overall Study|Lost to Follow-up|4|||
125120933|NCT00520741|450067016|FG000|Overall Study|Other reasons for premature termination|0|||
125120934|NCT00520741|450067017|FG001|Overall Study|Other reasons for premature termination|6|||
125026092|NCT00408694|449718471|FG000|Overall Study|Ineligible|1|||
125026093|NCT00408694|449718471|FG000|Overall Study|No protocol treatment|1|||
125120935|NCT02750761|450067018|FG000|Overall Study|Lost to Follow-up|0|||
125120936|NCT02750761|450067019|FG001|Overall Study|Lost to Follow-up|0|||
125120937|NCT02750761|450067020|FG002|Overall Study|Lost to Follow-up|1|||
125120938|NCT02750761|450067021|FG003|Overall Study|Lost to Follow-up|0|||
125120939|NCT02750761|450067022|FG004|Overall Study|Lost to Follow-up|0|||
125120940|NCT02750761|450067023|FG005|Overall Study|Lost to Follow-up|0|||
125120941|NCT02354586|450067026|FG000|Overall Study|Death|230|||
125120942|NCT02354586|450067026|FG000|Overall Study|Withdrawal by Subject|59|||
125120943|NCT02354586|450067026|FG000|Overall Study|Lost to Follow-up|11|||
125120944|NCT02354586|450067026|FG000|Overall Study|Sponsor decision|51|||
125026094|NCT03261531|449718474|FG000|Overall Study|Withdrawal by Subject|4|||
125120945|NCT02354586|450067026|FG000|Overall Study|Site closure|2|||
125120946|NCT02354586|450067026|FG000|Overall Study|Intercurrent illness|1|||
125120947|NCT02354586|450067026|FG000|Overall Study|Protocol Violation|3|||
125120948|NCT02354586|450067026|FG000|Overall Study|Physician Decision|13|||
125120949|NCT02354586|450067026|FG000|Overall Study|Lack of Efficacy|86|||
125120950|NCT02354586|450067026|FG000|Overall Study|Adverse Event|7|||
124935864|NCT04933474|449396098|FG001|Overall Study|Withdrew interest in participation|0|||
125120951|NCT00634907|450067027|FG000|Overall Study|Withdrawal by Subject|3|||
124935865|NCT04933474|449396097|FG000|Overall Study|Had previously enrolled in the study|0|||
124935866|NCT04933474|449396098|FG001|Overall Study|Had previously enrolled in the study|1|||
124935867|NCT04174170|449396099|FG000|Placebo Run-in Period|Not Randomized|38|||
124935868|NCT04174170|449396100|FG001|Placebo Run-in Period|Not Randomized|0|||
124935869|NCT04174170|449396101|FG002|Placebo Run-in Period|Not Randomized|0|||
124935870|NCT04174170|449396102|FG003|Placebo Run-in Period|Not Randomized|0|||
124935871|NCT04174170|449396099|FG000|Double Blind Treatment Period|Adverse Event|0|||
124935872|NCT04174170|449396100|FG001|Double Blind Treatment Period|Adverse Event|9|||
124935873|NCT04174170|449396101|FG002|Double Blind Treatment Period|Adverse Event|9|||
124935874|NCT04174170|449396102|FG003|Double Blind Treatment Period|Adverse Event|8|||
124935875|NCT04174170|449396099|FG000|Double Blind Treatment Period|Death|0|||
124935876|NCT04174170|449396100|FG001|Double Blind Treatment Period|Death|1|||
124935877|NCT04174170|449396101|FG002|Double Blind Treatment Period|Death|0|||
124935878|NCT04174170|449396102|FG003|Double Blind Treatment Period|Death|0|||
124935879|NCT04174170|449396099|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
124935880|NCT04174170|449396100|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
124935881|NCT04174170|449396101|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
124935882|NCT04174170|449396102|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
124935883|NCT04174170|449396099|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
124935884|NCT04174170|449396100|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
124935885|NCT04174170|449396101|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
124935886|NCT04174170|449396102|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
124935887|NCT04174170|449396099|FG000|Double Blind Treatment Period|Physician Decision|0|||
124935888|NCT04174170|449396100|FG001|Double Blind Treatment Period|Physician Decision|1|||
124935889|NCT04174170|449396101|FG002|Double Blind Treatment Period|Physician Decision|0|||
124935890|NCT04174170|449396102|FG003|Double Blind Treatment Period|Physician Decision|1|||
124935891|NCT04174170|449396099|FG000|Double Blind Treatment Period|Pregnancy|0|||
124935892|NCT04174170|449396100|FG001|Double Blind Treatment Period|Pregnancy|1|||
124935893|NCT04174170|449396101|FG002|Double Blind Treatment Period|Pregnancy|0|||
124935894|NCT04174170|449396102|FG003|Double Blind Treatment Period|Pregnancy|1|||
124935895|NCT04174170|449396099|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
124935896|NCT04174170|449396100|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
124935897|NCT04174170|449396101|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
124935898|NCT04174170|449396102|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
124935899|NCT04174170|449396099|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
125026095|NCT00091832|449718489|FG000|Overall Study|Physician Decision|1|||
125026096|NCT00091832|449718490|FG001|Overall Study|Physician Decision|0|||
125026097|NCT00091832|449718491|FG002|Overall Study|Physician Decision|0|||
125026098|NCT00091832|449718492|FG003|Overall Study|Physician Decision|0|||
125026099|NCT00091832|449718493|FG004|Overall Study|Physician Decision|0|||
125026100|NCT00091832|449718494|FG005|Overall Study|Physician Decision|0|||
124935900|NCT04174170|449396100|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
124935901|NCT04174170|449396101|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
124935902|NCT04174170|449396102|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
124935903|NCT04174170|449396099|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
124935904|NCT04174170|449396100|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
124935905|NCT04174170|449396101|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
124935906|NCT04174170|449396102|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
124935907|NCT00942734|449396108|FG000|Overall Study|Adverse Event|2|||
124935908|NCT00942734|449396108|FG000|Overall Study|Protocol Violation|3|||
124935909|NCT00942734|449396108|FG000|Overall Study|Disease Progression|2|||
124935910|NCT00942734|449396108|FG000|Overall Study|Physician Decision|1|||
124935911|NCT04908930|449396117|FG000|Overall Study|Lost to Follow-up|1|||
124935912|NCT04908930|449396118|FG001|Overall Study|Lost to Follow-up|1|||
124935913|NCT04908930|449396119|FG002|Overall Study|Lost to Follow-up|0|||
124935914|NCT04908930|449396120|FG003|Overall Study|Lost to Follow-up|0|||
124935915|NCT04908930|449396121|FG004|Overall Study|Lost to Follow-up|0|||
124935916|NCT04908930|449396117|FG000|Overall Study|hardware in mouth|1|||
124935917|NCT04908930|449396118|FG001|Overall Study|hardware in mouth|1|||
124935918|NCT04908930|449396119|FG002|Overall Study|hardware in mouth|0|||
124935919|NCT04908930|449396120|FG003|Overall Study|hardware in mouth|0|||
124935920|NCT04908930|449396121|FG004|Overall Study|hardware in mouth|0|||
124935921|NCT04908930|449396117|FG000|Overall Study|wrong team|1|||
124935922|NCT04908930|449396118|FG001|Overall Study|wrong team|0|||
125026101|NCT00091832|449718489|FG000|Overall Study|Adverse Event|0|||
125026102|NCT00091832|449718490|FG001|Overall Study|Adverse Event|0|||
124935923|NCT04908930|449396119|FG002|Overall Study|wrong team|0|||
125026103|NCT00091832|449718491|FG002|Overall Study|Adverse Event|0|||
124935924|NCT04908930|449396120|FG003|Overall Study|wrong team|0|||
124935925|NCT04908930|449396121|FG004|Overall Study|wrong team|0|||
124935926|NCT04908930|449396117|FG000|Overall Study|quit team|2|||
124935927|NCT04908930|449396118|FG001|Overall Study|quit team|4|||
124935928|NCT04908930|449396119|FG002|Overall Study|quit team|0|||
125026104|NCT00091832|449718492|FG003|Overall Study|Adverse Event|1|||
125026105|NCT00091832|449718493|FG004|Overall Study|Adverse Event|3|||
124935929|NCT04908930|449396120|FG003|Overall Study|quit team|0|||
124935930|NCT04908930|449396121|FG004|Overall Study|quit team|0|||
124935931|NCT04908930|449396117|FG000|Overall Study|Withdrawal by Subject|1|||
124935932|NCT04908930|449396118|FG001|Overall Study|Withdrawal by Subject|2|||
124935933|NCT04908930|449396119|FG002|Overall Study|Withdrawal by Subject|0|||
124935934|NCT04908930|449396120|FG003|Overall Study|Withdrawal by Subject|0|||
124935935|NCT04908930|449396121|FG004|Overall Study|Withdrawal by Subject|0|||
124935936|NCT04908930|449396117|FG000|Overall Study|parent not liking program|0|||
124935937|NCT04908930|449396118|FG001|Overall Study|parent not liking program|1|||
124935938|NCT04908930|449396119|FG002|Overall Study|parent not liking program|0|||
124935939|NCT04908930|449396120|FG003|Overall Study|parent not liking program|0|||
124935940|NCT04908930|449396121|FG004|Overall Study|parent not liking program|0|||
124935941|NCT04586244|449396122|FG000|Overall Study|Lost to Follow-up|1|||
124935942|NCT04586244|449396123|FG001|Overall Study|Lost to Follow-up|0|||
124935943|NCT04586244|449396124|FG002|Overall Study|Lost to Follow-up|0|||
124935944|NCT04586244|449396125|FG003|Overall Study|Lost to Follow-up|1|||
124935945|NCT04586244|449396126|FG004|Overall Study|Lost to Follow-up|0|||
124935946|NCT04586244|449396122|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
124935947|NCT04586244|449396123|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
124935948|NCT04586244|449396124|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
124935949|NCT04586244|449396125|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
124935950|NCT04586244|449396126|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
124935951|NCT05771467|449396128|FG000|Overall Study|Lost to Follow-up|6|||
124935952|NCT05771467|449396129|FG001|Overall Study|Lost to Follow-up|3|||
124935953|NCT01220531|449396132|FG000|Overall Study|Death|7|||
124935954|NCT01220531|449396132|FG000|Overall Study|Lost to Follow-up|1|||
124935955|NCT04873232|449396133|FG000|Overall Study|Lost to Follow-up|1|||
124935956|NCT04873232|449396134|FG001|Overall Study|Lost to Follow-up|4|||
124935957|NCT04873232|449396133|FG000|Overall Study|Withdrawal by Subject|1|||
124935958|NCT04873232|449396134|FG001|Overall Study|Withdrawal by Subject|0|||
124935959|NCT02325154|449396137|FG000|Overall Study|Physician Decision|1|||
124935960|NCT00709956|449396138|FG000|Overall Study|Withdrawal by Subject|1|||
124935961|NCT00709956|449396139|FG001|Overall Study|Withdrawal by Subject|1|||
124935962|NCT00709956|449396138|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
124935963|NCT00709956|449396139|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
124935964|NCT03008382|449396140|FG000|Overall Study|Withdrawal by Subject|2|||
124935965|NCT03008382|449396141|FG001|Overall Study|Withdrawal by Subject|5|||
124935966|NCT03008382|449396142|FG002|Overall Study|Withdrawal by Subject|2|||
124935967|NCT03008382|449396143|FG003|Overall Study|Withdrawal by Subject|0|||
124935968|NCT03008382|449396140|FG000|Overall Study|Protocol Violation|1|||
124935969|NCT03008382|449396141|FG001|Overall Study|Protocol Violation|0|||
124935970|NCT03008382|449396142|FG002|Overall Study|Protocol Violation|0|||
124935971|NCT03008382|449396143|FG003|Overall Study|Protocol Violation|0|||
124935972|NCT03008382|449396140|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
124935973|NCT03008382|449396141|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
124935974|NCT03008382|449396142|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
124935975|NCT03008382|449396143|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
124935976|NCT03008382|449396140|FG000|Overall Study|Lost to Follow-up|0|||
124935977|NCT03008382|449396141|FG001|Overall Study|Lost to Follow-up|0|||
124935978|NCT03008382|449396142|FG002|Overall Study|Lost to Follow-up|1|||
124935979|NCT03008382|449396143|FG003|Overall Study|Lost to Follow-up|0|||
124935980|NCT03008382|449396140|FG000|Overall Study|Screenfail|0|||
124935981|NCT03008382|449396141|FG001|Overall Study|Screenfail|0|||
124935982|NCT03008382|449396142|FG002|Overall Study|Screenfail|2|||
124935983|NCT03008382|449396143|FG003|Overall Study|Screenfail|0|||
124935984|NCT02611687|449396799|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
124935985|NCT02611687|449396800|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
124935986|NCT03983382|449396804|FG000|Overall Study|Death|1|||
124935987|NCT03983382|449396804|FG000|Overall Study|Lost to Follow-up|3|||
124935988|NCT03983382|449396804|FG000|Overall Study|Physician Decision|2|||
124935989|NCT03983382|449396804|FG000|Overall Study|Withdrawal by Subject|10|||
124935990|NCT03983382|449396804|FG000|Overall Study|Change in cancer treatment|2|||
124935991|NCT04165213|449396805|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
124935992|NCT04165213|449396806|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
124935993|NCT04165213|449396805|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
124935994|NCT04165213|449396806|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
124935995|NCT04165213|449396805|FG000|Clinician Enrollment|Termination from site|0|||
124935996|NCT04165213|449396806|FG001|Clinician Enrollment|Termination from site|1|||
124935997|NCT04165213|449396805|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
124935998|NCT04165213|449396806|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
125026106|NCT00091832|449718494|FG005|Overall Study|Adverse Event|0|||
124935999|NCT04165213|449396805|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
125026107|NCT00091832|449718489|FG000|Overall Study|Withdrawal by Subject|4|||
124936000|NCT04165213|449396806|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
124936001|NCT04165213|449396805|FG000|Caregiver Enrollment|Physician Decision|1|||
124936002|NCT04165213|449396806|FG001|Caregiver Enrollment|Physician Decision|0|||
124936003|NCT04165213|449396805|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
124936004|NCT04165213|449396806|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
124936005|NCT04165213|449396805|FG000|Caregiver Enrollment|PLWD death|2|||
124936006|NCT04165213|449396806|FG001|Caregiver Enrollment|PLWD death|0|||
124936007|NCT04165213|449396805|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
124936008|NCT04165213|449396806|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
125120952|NCT00634907|450067028|FG001|Overall Study|Withdrawal by Subject|0|||
124936009|NCT04165213|449396805|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
124936010|NCT04165213|449396806|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
124936011|NCT04165213|449396805|FG000|PLWD Enrollment|Lost to Follow-up|1|||
124936012|NCT04165213|449396806|FG001|PLWD Enrollment|Lost to Follow-up|1|||
124936013|NCT04165213|449396805|FG000|PLWD Enrollment|Physician Decision|1|||
124936014|NCT04165213|449396806|FG001|PLWD Enrollment|Physician Decision|0|||
124936015|NCT04165213|449396805|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
124936016|NCT04165213|449396806|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
124936017|NCT04165213|449396805|FG000|PLWD Enrollment|Death|2|||
124936018|NCT04165213|449396806|FG001|PLWD Enrollment|Death|0|||
124936019|NCT04165213|449396805|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
124936020|NCT04165213|449396806|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
124936021|NCT04772534|449396813|FG000|Overall Study|Physician Decision|1|||
124936022|NCT04772534|449396814|FG001|Overall Study|Physician Decision|0|||
124936023|NCT04772534|449396815|FG002|Overall Study|Physician Decision|0|||
124936024|NCT04772534|449396813|FG000|Overall Study|Withdrawal by Subject|3|||
124936025|NCT04772534|449396814|FG001|Overall Study|Withdrawal by Subject|0|||
124936026|NCT04772534|449396815|FG002|Overall Study|Withdrawal by Subject|1|||
124936027|NCT04194450|449396816|FG000|Overall Study|not eligible|1|||
124936028|NCT04194450|449396817|FG001|Overall Study|not eligible|0|||
124936029|NCT03242915|449396836|FG000|Overall Study|Adverse Event|5|||
124936030|NCT03242915|449396837|FG001|Overall Study|Adverse Event|1|||
124936031|NCT03242915|449396836|FG000|Overall Study|Withdrawal by Subject|0|||
124936032|NCT03242915|449396837|FG001|Overall Study|Withdrawal by Subject|2|||
124936033|NCT03242915|449396836|FG000|Overall Study|Physician Decision|4|||
124936034|NCT03242915|449396837|FG001|Overall Study|Physician Decision|1|||
124936035|NCT05988398|449396838|FG000|Overall Study|Lack of time|21|||
124936036|NCT05988398|449396839|FG001|Overall Study|Lack of time|0|||
124936037|NCT05988398|449396838|FG000|Overall Study|Absent from school|0|||
124936038|NCT05988398|449396839|FG001|Overall Study|Absent from school|38|||
124936039|NCT05988398|449396838|FG000|Overall Study|Chose not to participate|0|||
124936040|NCT05988398|449396839|FG001|Overall Study|Chose not to participate|42|||
124936041|NCT05988398|449396838|FG000|Overall Study|Other commitments (e.g., sports)|0|||
124936042|NCT05988398|449396839|FG001|Overall Study|Other commitments (e.g., sports)|25|||
124936043|NCT03872466|449396852|FG000|Overall Study|Withdrawal by Subject|1|||
124936044|NCT03872466|449396853|FG001|Overall Study|Withdrawal by Subject|0|||
124936045|NCT03872466|449396852|FG000|Overall Study|Physician Decision|2|||
124936046|NCT03872466|449396853|FG001|Overall Study|Physician Decision|0|||
124936047|NCT01778686|449396854|FG000|Overall Study|Adverse Event|0|||
125120953|NCT00634907|450067027|FG000|Overall Study|Physician Decision|3|||
125120954|NCT00634907|450067028|FG001|Overall Study|Physician Decision|9|||
125120955|NCT00634907|450067027|FG000|Overall Study|Withdrawal by Subject|11|||
125120956|NCT00634907|450067028|FG001|Overall Study|Withdrawal by Subject|8|||
125120957|NCT02224391|450067029|FG000|Overall Study|Lost to Follow-up|26|||
125120958|NCT02224391|450067030|FG001|Overall Study|Lost to Follow-up|19|||
125120959|NCT02224391|450067029|FG000|Overall Study|Withdrawal by Subject|6|||
125120960|NCT02224391|450067030|FG001|Overall Study|Withdrawal by Subject|5|||
125120961|NCT00084084|450067032|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
124936048|NCT01778686|449396855|FG001|Overall Study|Adverse Event|0|||
124936049|NCT01778686|449396856|FG002|Overall Study|Adverse Event|1|||
124936050|NCT01499368|449396857|FG000|Overall Study|Did not meet I/E criteria|8|||
124936051|NCT01499368|449396858|FG001|Overall Study|Did not meet I/E criteria|4|||
124936052|NCT01499368|449396859|FG002|Overall Study|Did not meet I/E criteria|4|||
124936053|NCT01499368|449396857|FG000|Overall Study|Prohibited Concomitant medication|1|||
124936054|NCT01499368|449396858|FG001|Overall Study|Prohibited Concomitant medication|1|||
124936055|NCT01499368|449396859|FG002|Overall Study|Prohibited Concomitant medication|0|||
125120962|NCT00084084|450067032|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
125120963|NCT00108732|450067036|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
125120964|NCT00108732|450067036|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
125120965|NCT00108732|450067036|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
125120966|NCT00108732|450067036|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
125120967|NCT00108732|450067036|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
125120968|NCT00108732|450067036|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
125120969|NCT00108732|450067036|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
125212842|NCT01026818|450405479|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
124936056|NCT01499368|449396857|FG000|Overall Study|Withdrawal by Subject|11|||
124936057|NCT01499368|449396858|FG001|Overall Study|Withdrawal by Subject|10|||
124936058|NCT01499368|449396859|FG002|Overall Study|Withdrawal by Subject|8|||
124936059|NCT01499368|449396857|FG000|Overall Study|Lost to Follow-up|3|||
124936060|NCT01499368|449396858|FG001|Overall Study|Lost to Follow-up|2|||
124936061|NCT01499368|449396859|FG002|Overall Study|Lost to Follow-up|5|||
124936062|NCT01499368|449396857|FG000|Overall Study|Adverse Event|4|||
124936063|NCT01499368|449396858|FG001|Overall Study|Adverse Event|0|||
124936064|NCT01499368|449396859|FG002|Overall Study|Adverse Event|2|||
124936065|NCT01499368|449396857|FG000|Overall Study|Physician Decision|0|||
124936066|NCT01499368|449396858|FG001|Overall Study|Physician Decision|1|||
124936067|NCT01499368|449396859|FG002|Overall Study|Physician Decision|0|||
124936068|NCT01499368|449396857|FG000|Overall Study|Deviation from visit window|0|||
124936069|NCT01499368|449396858|FG001|Overall Study|Deviation from visit window|0|||
124936070|NCT01499368|449396859|FG002|Overall Study|Deviation from visit window|1|||
124936071|NCT01499368|449396857|FG000|Overall Study|Error of Prescriptions|0|||
124936072|NCT01499368|449396858|FG001|Overall Study|Error of Prescriptions|0|||
124936073|NCT01499368|449396859|FG002|Overall Study|Error of Prescriptions|1|||
124936074|NCT06059443|449396860|FG000|Overall Study|Withdrawal by Subject|2|||
124936075|NCT06059443|449396861|FG001|Overall Study|Withdrawal by Subject|0|||
124936076|NCT06059443|449396860|FG000|Overall Study|Lost to Follow-up|2|||
124936077|NCT06059443|449396861|FG001|Overall Study|Lost to Follow-up|2|||
124936078|NCT03092674|449396862|FG000|Overall Study|Adverse Event or Side Effects|1|||
124936079|NCT03092674|449396863|FG001|Overall Study|Adverse Event or Side Effects|4|||
124936080|NCT03092674|449396864|FG002|Overall Study|Adverse Event or Side Effects|4|||
124936081|NCT03092674|449396862|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
124936082|NCT03092674|449396863|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
124936083|NCT03092674|449396864|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
124936084|NCT03092674|449396862|FG000|Overall Study|Progression/Relapse|5|||
124936085|NCT03092674|449396863|FG001|Overall Study|Progression/Relapse|4|||
124936086|NCT03092674|449396864|FG002|Overall Study|Progression/Relapse|8|||
124936087|NCT03092674|449396862|FG000|Overall Study|Death|4|||
124936088|NCT03092674|449396863|FG001|Overall Study|Death|8|||
124936089|NCT03092674|449396864|FG002|Overall Study|Death|2|||
124936090|NCT03092674|449396862|FG000|Overall Study|Other - Not Protocol Specified|11|||
124936091|NCT03092674|449396863|FG001|Overall Study|Other - Not Protocol Specified|8|||
124936092|NCT03092674|449396864|FG002|Overall Study|Other - Not Protocol Specified|8|||
124936093|NCT01105091|449396865|FG000|Overall Study|Death|2|||
124936094|NCT01105091|449396866|FG001|Overall Study|Death|0|||
124936095|NCT03934931|449397341|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
124936096|NCT03934931|449397342|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
124936097|NCT03934931|449397343|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
124936098|NCT04227899|449397345|FG000|Overall Study|Withdrawal by Subject|6|||
124936099|NCT04227899|449397346|FG001|Overall Study|Withdrawal by Subject|3|||
124936100|NCT04227899|449397345|FG000|Overall Study|Death|12|||
124936101|NCT04227899|449397346|FG001|Overall Study|Death|6|||
124936102|NCT04227899|449397345|FG000|Overall Study|Lost to Follow-up|2|||
124936103|NCT04227899|449397346|FG001|Overall Study|Lost to Follow-up|1|||
124936104|NCT02989662|449397349|FG000|Overall Study|Lost to Follow-up|0|||
124936105|NCT02989662|449397350|FG001|Overall Study|Lost to Follow-up|0|||
124936106|NCT02989662|449397351|FG002|Overall Study|Lost to Follow-up|0|||
124936107|NCT02989662|449397352|FG003|Overall Study|Lost to Follow-up|2|||
124936108|NCT02989662|449397349|FG000|Overall Study|Physician Decision|3|||
124936109|NCT02989662|449397350|FG001|Overall Study|Physician Decision|0|||
124936110|NCT02989662|449397351|FG002|Overall Study|Physician Decision|0|||
124936111|NCT02989662|449397352|FG003|Overall Study|Physician Decision|0|||
124936112|NCT02989662|449397349|FG000|Overall Study|Withdrawal by Subject|1|||
124936113|NCT02989662|449397350|FG001|Overall Study|Withdrawal by Subject|0|||
124936114|NCT02989662|449397351|FG002|Overall Study|Withdrawal by Subject|0|||
124936115|NCT02989662|449397352|FG003|Overall Study|Withdrawal by Subject|0|||
124936116|NCT00328783|449397353|FG000|Overall Study|Could not tolerate ABC|21|||
124936117|NCT00328783|449397353|FG000|Overall Study|No heart in RT field|4|||
124936118|NCT00328783|449397353|FG000|Overall Study|Withdrawal by Subject|1|||
124936119|NCT00357682|449397354|FG000|Overall Study|Did not receive allocated Treatment|10|||
124936120|NCT00357682|449397355|FG001|Overall Study|Did not receive allocated Treatment|9|||
124936121|NCT00357682|449397356|FG002|Overall Study|Did not receive allocated Treatment|9|||
124936122|NCT00357682|449397357|FG003|Overall Study|Did not receive allocated Treatment|10|||
124936123|NCT00357682|449397354|FG000|Overall Study|Withdrew consent|6|||
124936124|NCT00357682|449397355|FG001|Overall Study|Withdrew consent|6|||
125026108|NCT00091832|449718490|FG001|Overall Study|Withdrawal by Subject|5|||
125026109|NCT00091832|449718491|FG002|Overall Study|Withdrawal by Subject|0|||
125026110|NCT00091832|449718492|FG003|Overall Study|Withdrawal by Subject|1|||
125026111|NCT00091832|449718493|FG004|Overall Study|Withdrawal by Subject|3|||
125026112|NCT00091832|449718494|FG005|Overall Study|Withdrawal by Subject|1|||
125026113|NCT00091832|449718489|FG000|Overall Study|Death|6|||
125026114|NCT00091832|449718490|FG001|Overall Study|Death|4|||
125026115|NCT00091832|449718491|FG002|Overall Study|Death|5|||
125026116|NCT00091832|449718492|FG003|Overall Study|Death|8|||
125026117|NCT00091832|449718493|FG004|Overall Study|Death|5|||
125026118|NCT00091832|449718494|FG005|Overall Study|Death|6|||
125026119|NCT00091832|449718489|FG000|Overall Study|Disease Progression|2|||
125026120|NCT00091832|449718490|FG001|Overall Study|Disease Progression|0|||
125026121|NCT00091832|449718491|FG002|Overall Study|Disease Progression|0|||
125026122|NCT00091832|449718492|FG003|Overall Study|Disease Progression|1|||
125026123|NCT00091832|449718493|FG004|Overall Study|Disease Progression|1|||
125026124|NCT00091832|449718494|FG005|Overall Study|Disease Progression|2|||
125026125|NCT00091832|449718489|FG000|Overall Study|Ineligibility Determined|0|||
125026126|NCT00091832|449718490|FG001|Overall Study|Ineligibility Determined|0|||
125026127|NCT00091832|449718491|FG002|Overall Study|Ineligibility Determined|1|||
125026128|NCT00091832|449718492|FG003|Overall Study|Ineligibility Determined|0|||
125026129|NCT00091832|449718493|FG004|Overall Study|Ineligibility Determined|1|||
125026130|NCT00091832|449718494|FG005|Overall Study|Ineligibility Determined|0|||
125026131|NCT00091832|449718489|FG000|Overall Study|Lost to Follow-up|1|||
125026132|NCT00091832|449718490|FG001|Overall Study|Lost to Follow-up|0|||
125026133|NCT00091832|449718491|FG002|Overall Study|Lost to Follow-up|3|||
125026134|NCT00091832|449718492|FG003|Overall Study|Lost to Follow-up|3|||
125026135|NCT00091832|449718493|FG004|Overall Study|Lost to Follow-up|2|||
125026136|NCT00091832|449718494|FG005|Overall Study|Lost to Follow-up|1|||
125026137|NCT00091832|449718489|FG000|Overall Study|Noncompliance|0|||
125026138|NCT00091832|449718490|FG001|Overall Study|Noncompliance|1|||
125026139|NCT00091832|449718491|FG002|Overall Study|Noncompliance|0|||
125026140|NCT00091832|449718492|FG003|Overall Study|Noncompliance|0|||
125026141|NCT00091832|449718493|FG004|Overall Study|Noncompliance|0|||
125026142|NCT00091832|449718494|FG005|Overall Study|Noncompliance|0|||
125026143|NCT00091832|449718489|FG000|Overall Study|Other|0|||
125026144|NCT00091832|449718490|FG001|Overall Study|Other|1|||
125026145|NCT00091832|449718491|FG002|Overall Study|Other|2|||
125026146|NCT00091832|449718492|FG003|Overall Study|Other|0|||
125026147|NCT00091832|449718493|FG004|Overall Study|Other|0|||
125026148|NCT00091832|449718494|FG005|Overall Study|Other|0|||
125026149|NCT00091832|449718489|FG000|Overall Study|Protocol Violation|0|||
125026150|NCT00091832|449718490|FG001|Overall Study|Protocol Violation|0|||
125026151|NCT00091832|449718491|FG002|Overall Study|Protocol Violation|1|||
125026152|NCT00091832|449718492|FG003|Overall Study|Protocol Violation|0|||
125026153|NCT00091832|449718493|FG004|Overall Study|Protocol Violation|0|||
125026154|NCT00091832|449718494|FG005|Overall Study|Protocol Violation|1|||
125026155|NCT00946309|449718495|FG000|Overall Study|Protocol Violation|1|||
125026156|NCT00946309|449718496|FG001|Overall Study|Protocol Violation|0|||
125026157|NCT00946309|449718495|FG000|Overall Study|Lost to Follow-up|0|||
125026158|NCT00946309|449718496|FG001|Overall Study|Lost to Follow-up|1|||
125026159|NCT00946309|449718495|FG000|Overall Study|Procedure cancelled/discontinued|0|||
125026160|NCT00946309|449718496|FG001|Overall Study|Procedure cancelled/discontinued|3|||
125026161|NCT00626093|449718497|FG000|Overall Study|Lost to Follow-up|5|||
125026162|NCT00626093|449718497|FG000|Overall Study|Death|1|||
125026163|NCT00626093|449718497|FG000|Overall Study|Physician Decision|4|||
125026164|NCT00626093|449718497|FG000|Overall Study|Withdrawal by Subject|6|||
125026165|NCT00626093|449718497|FG000|Overall Study|Protocol Violation|1|||
125026166|NCT00626093|449718497|FG000|Overall Study|One of the required devices not implante|6|||
125026167|NCT02154087|449718501|FG000|Overall Study|Study Termination|1|||
125026168|NCT00486278|449718502|FG000|Overall Study|Adverse Event|5|||
125026169|NCT00486278|449718502|FG000|Overall Study|Withdrawal by Subject|2|||
125026170|NCT00486278|449718502|FG000|Overall Study|Physician Decision|2|||
125026171|NCT05501119|449718503|FG000|Overall Study|Withdrawal by Subject|2|||
125026172|NCT05501119|449718503|FG000|Overall Study|Lost to Follow-up|5|||
125026173|NCT01738971|449718515|FG000|Overall Study|Lost to Follow-up|19|||
125026174|NCT01738971|449718516|FG001|Overall Study|Lost to Follow-up|30|||
125026175|NCT01738971|449718517|FG002|Overall Study|Lost to Follow-up|17|||
125026176|NCT01031446|449718518|FG000|Overall Study|Disease Progression|38|||
125026177|NCT01031446|449718518|FG000|Overall Study|Adverse Event|9|||
125026178|NCT01031446|449718518|FG000|Overall Study|Physician Decision|4|||
125026179|NCT01031446|449718518|FG000|Overall Study|Withdrawal by Subject|3|||
125026180|NCT01031446|449718518|FG000|Overall Study|Still on treatment|1|||
125026181|NCT02531646|449718522|FG000|Overall Study|equip. image processing issue|5|||
125026182|NCT02531646|449718523|FG001|Overall Study|equip. image processing issue|1|||
125026183|NCT02531646|449718524|FG002|Overall Study|equip. image processing issue|0|||
125026184|NCT04484285|449720371|FG000|Overall Study|Unable to operate stimulator|3|||
125026185|NCT04484285|449720372|FG001|Overall Study|Unable to operate stimulator|0|||
125026186|NCT05888103|449720373|FG000|Overall Study|Participant decision|3|||
125026187|NCT05888103|449720374|FG001|Overall Study|Participant decision|3|||
125026188|NCT03968419|449720375|FG000|Treatment Period|Adverse Event|0|||
125026189|NCT03968419|449720376|FG001|Treatment Period|Adverse Event|0|||
125026190|NCT03968419|449720377|FG002|Treatment Period|Adverse Event|1|||
125026191|NCT03968419|449720375|FG000|Safety Follow-up Period|Death|3|||
125026192|NCT03968419|449720376|FG001|Safety Follow-up Period|Death|2|||
125026193|NCT03968419|449720377|FG002|Safety Follow-up Period|Death|1|||
125026194|NCT03968419|449720375|FG000|Safety Follow-up Period|Subject Decision|2|||
125026195|NCT03968419|449720376|FG001|Safety Follow-up Period|Subject Decision|1|||
125026196|NCT03968419|449720377|FG002|Safety Follow-up Period|Subject Decision|0|||
125026197|NCT00772629|449720378|FG000|Overall Study|Subject was not vaccinated|1|||
125026198|NCT00772629|449720379|FG001|Overall Study|Subject was not vaccinated|0|||
125026199|NCT02894840|449720380|FG000|Overall Study|Lost to Follow-up|1|||
125026200|NCT02894840|449720381|FG001|Overall Study|Lost to Follow-up|0|||
125026201|NCT02894840|449720382|FG002|Overall Study|Lost to Follow-up|3|||
125026202|NCT02894840|449720383|FG003|Overall Study|Lost to Follow-up|0|||
125026203|NCT05162066|449720388|FG000|Overall Study|Adverse Event|1|||
125026204|NCT05162066|449720389|FG001|Overall Study|Adverse Event|0|||
125026205|NCT05162066|449720390|FG002|Overall Study|Adverse Event|0|||
125026206|NCT05162066|449720388|FG000|Overall Study|Perceived lack of efficacy|1|||
125026207|NCT05162066|449720389|FG001|Overall Study|Perceived lack of efficacy|0|||
124936125|NCT00357682|449397356|FG002|Overall Study|Withdrew consent|5|||
124936126|NCT00357682|449397357|FG003|Overall Study|Withdrew consent|5|||
124936127|NCT00357682|449397354|FG000|Overall Study|Lost to Follow-up|39|||
124936128|NCT00357682|449397355|FG001|Overall Study|Lost to Follow-up|33|||
124936129|NCT00357682|449397356|FG002|Overall Study|Lost to Follow-up|26|||
124936130|NCT00357682|449397357|FG003|Overall Study|Lost to Follow-up|35|||
124936131|NCT00357682|449397354|FG000|Overall Study|Adverse Event|24|||
124936132|NCT00357682|449397355|FG001|Overall Study|Adverse Event|32|||
124936133|NCT00357682|449397356|FG002|Overall Study|Adverse Event|22|||
124936134|NCT00357682|449397357|FG003|Overall Study|Adverse Event|27|||
124936135|NCT00357682|449397354|FG000|Overall Study|Physician Decision|32|||
124936136|NCT00357682|449397355|FG001|Overall Study|Physician Decision|20|||
124936137|NCT00357682|449397356|FG002|Overall Study|Physician Decision|24|||
124936138|NCT00357682|449397357|FG003|Overall Study|Physician Decision|30|||
124936139|NCT00357682|449397354|FG000|Overall Study|Patient decision|73|||
124936140|NCT00357682|449397355|FG001|Overall Study|Patient decision|80|||
124936141|NCT00357682|449397356|FG002|Overall Study|Patient decision|51|||
124936142|NCT00357682|449397357|FG003|Overall Study|Patient decision|59|||
124936143|NCT00357682|449397354|FG000|Overall Study|Other reason|157|||
124936144|NCT00357682|449397355|FG001|Overall Study|Other reason|130|||
124936145|NCT00357682|449397356|FG002|Overall Study|Other reason|114|||
124936146|NCT00357682|449397357|FG003|Overall Study|Other reason|99|||
124936147|NCT04408755|449397361|FG000|Period A (Placebo lead-in)|Other|11|||
124936148|NCT04408755|449397362|FG001|Period A (Placebo lead-in)|Other|0|||
124936149|NCT04408755|449397363|FG002|Period A (Placebo lead-in)|Other|0|||
124936150|NCT04408755|449397364|FG003|Period A (Placebo lead-in)|Other|0|||
124936151|NCT04408755|449397361|FG000|Period B (Randomization Period)|Adverse Event|0|||
124936152|NCT04408755|449397362|FG001|Period B (Randomization Period)|Adverse Event|3|||
124936153|NCT04408755|449397363|FG002|Period B (Randomization Period)|Adverse Event|0|||
124936154|NCT04408755|449397364|FG003|Period B (Randomization Period)|Adverse Event|1|||
124936155|NCT04408755|449397361|FG000|Period B (Randomization Period)|Death|0|||
124936156|NCT04408755|449397362|FG001|Period B (Randomization Period)|Death|0|||
124936157|NCT04408755|449397363|FG002|Period B (Randomization Period)|Death|1|||
124936158|NCT04408755|449397364|FG003|Period B (Randomization Period)|Death|0|||
124936159|NCT04408755|449397361|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
124936160|NCT04408755|449397362|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
124936161|NCT04408755|449397363|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
125026208|NCT05162066|449720390|FG002|Overall Study|Perceived lack of efficacy|0|||
124936162|NCT04408755|449397364|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
124936163|NCT04408755|449397361|FG000|Period B (Randomization Period)|Physician Decision|0|||
125026209|NCT01072344|449720391|FG000|Overall Study|Relasped-reached end point|7|||
125026210|NCT01072344|449720392|FG001|Overall Study|Relasped-reached end point|12|||
125026211|NCT01072344|449720391|FG000|Overall Study|Protocol Violation|1|||
125026212|NCT01072344|449720392|FG001|Overall Study|Protocol Violation|2|||
124936164|NCT04408755|449397362|FG001|Period B (Randomization Period)|Physician Decision|0|||
124936165|NCT04408755|449397363|FG002|Period B (Randomization Period)|Physician Decision|1|||
124936166|NCT04408755|449397364|FG003|Period B (Randomization Period)|Physician Decision|0|||
125026213|NCT01072344|449720391|FG000|Overall Study|Lost to Follow-up|3|||
124936167|NCT04408755|449397361|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
125026214|NCT01072344|449720392|FG001|Overall Study|Lost to Follow-up|4|||
125026215|NCT00167245|449720393|FG000|Overall Study|Lost to Follow-up|20|||
125026216|NCT00167245|449720394|FG001|Overall Study|Lost to Follow-up|31|||
125026217|NCT00167245|449720393|FG000|Overall Study|Withdrawal by Subject|5|||
124936168|NCT04408755|449397362|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
124936169|NCT04408755|449397363|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
124936170|NCT04408755|449397364|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
124936171|NCT04408755|449397361|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
124936172|NCT04408755|449397362|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
124936173|NCT04408755|449397363|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
124936174|NCT04408755|449397364|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
124936175|NCT04408755|449397361|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
124936176|NCT04408755|449397362|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
124936177|NCT04408755|449397363|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
124936178|NCT04408755|449397364|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
124936179|NCT04408755|449397361|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
124936180|NCT04408755|449397362|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
124936181|NCT04408755|449397363|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
124936182|NCT04408755|449397364|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
124936183|NCT04408755|449397361|FG000|Period B (Randomization Period)|Reason not Specified|0|||
124936184|NCT04408755|449397362|FG001|Period B (Randomization Period)|Reason not Specified|1|||
124936185|NCT04408755|449397363|FG002|Period B (Randomization Period)|Reason not Specified|0|||
124936186|NCT04408755|449397364|FG003|Period B (Randomization Period)|Reason not Specified|2|||
124936187|NCT02726386|449397365|FG000|Overall Study|Adverse Event|17|||
124936188|NCT02726386|449397366|FG001|Overall Study|Adverse Event|20|||
124936189|NCT02726386|449397365|FG000|Overall Study|Withdrawal by Subject|14|||
124936190|NCT02726386|449397366|FG001|Overall Study|Withdrawal by Subject|28|||
124936191|NCT02726386|449397365|FG000|Overall Study|Other reasons|7|||
124936192|NCT02726386|449397366|FG001|Overall Study|Other reasons|8|||
124936193|NCT00308997|449397367|FG000|Overall Study|Subject feigned clinical data|0|||
124936194|NCT00308997|449397368|FG001|Overall Study|Subject feigned clinical data|1|||
124936195|NCT00308997|449397367|FG000|Overall Study|Unable to tolerate intervention|1|||
124936196|NCT00308997|449397368|FG001|Overall Study|Unable to tolerate intervention|0|||
124936197|NCT04490356|449397371|FG000|Overall Study|Lost to Follow-up|1|||
124936198|NCT03733626|449397372|FG000|Overall Study|Physician Decision|4|||
124936199|NCT03733626|449397373|FG001|Overall Study|Physician Decision|4|||
124936200|NCT05424718|449397376|FG000|Overall Study|Lost to Follow-up|5|||
124936201|NCT05424718|449397377|FG001|Overall Study|Lost to Follow-up|4|||
124936202|NCT03142009|449397378|FG000|Overall Study|Lost to Follow-up|45|||
124936203|NCT03142009|449397379|FG001|Overall Study|Lost to Follow-up|30|||
124936204|NCT01553149|449397382|FG000|Overall Study|Adverse Event|0|||
124936205|NCT01553149|449397383|FG001|Overall Study|Adverse Event|9|||
124936206|NCT01553149|449397382|FG000|Overall Study|Physician Decision|5|||
124936207|NCT01553149|449397383|FG001|Overall Study|Physician Decision|10|||
124936208|NCT01553149|449397382|FG000|Overall Study|Ineligible|0|||
124936209|NCT01553149|449397383|FG001|Overall Study|Ineligible|1|||
124936210|NCT03215706|449397389|FG000|Randomization|Adverse Event unrelated to study drug|1|||
124936211|NCT03215706|449397390|FG001|Randomization|Adverse Event unrelated to study drug|0|||
124936212|NCT03215706|449397389|FG000|Randomization|participant withdrew consent|1|||
124936213|NCT03215706|449397390|FG001|Randomization|participant withdrew consent|3|||
124936214|NCT03215706|449397389|FG000|Randomization|no longer meets study criteria|1|||
124936215|NCT03215706|449397390|FG001|Randomization|no longer meets study criteria|4|||
124936216|NCT03215706|449397389|FG000|Randomization|other reasons|0|||
124936217|NCT03215706|449397390|FG001|Randomization|other reasons|2|||
124936218|NCT03215706|449397389|FG000|Treatment Period|Disease Progression|150|||
124936219|NCT03215706|449397390|FG001|Treatment Period|Disease Progression|142|||
124936220|NCT03215706|449397389|FG000|Treatment Period|Study Drug Toxicity|53|||
124936221|NCT03215706|449397390|FG001|Treatment Period|Study Drug Toxicity|21|||
124936222|NCT03215706|449397389|FG000|Treatment Period|Death|2|||
124936223|NCT03215706|449397390|FG001|Treatment Period|Death|1|||
124936224|NCT03215706|449397389|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
125120970|NCT03922477|450067041|FG000|Overall Study|Death|9|||
124936225|NCT03215706|449397390|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
124936226|NCT03215706|449397389|FG000|Treatment Period|Request to D/C treatment|1|||
124936227|NCT03215706|449397390|FG001|Treatment Period|Request to D/C treatment|6|||
124936228|NCT03215706|449397389|FG000|Treatment Period|Participant withdrew consent|3|||
125120971|NCT03922477|450067041|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
125026218|NCT00167245|449720394|FG001|Overall Study|Withdrawal by Subject|8|||
125026219|NCT00167245|449720393|FG000|Overall Study|Incarcerated|3|||
125026220|NCT00167245|449720394|FG001|Overall Study|Incarcerated|2|||
125026221|NCT00167245|449720393|FG000|Overall Study|Drowsy|1|||
125026222|NCT00167245|449720394|FG001|Overall Study|Drowsy|0|||
125026223|NCT01871090|449720397|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
125026224|NCT01871090|449720398|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
125026225|NCT01871090|449720397|FG000|Overall Study|Interrogation not completed correctly|1|||
125026226|NCT01871090|449720398|FG001|Overall Study|Interrogation not completed correctly|0|||
125026227|NCT01871090|449720397|FG000|Overall Study|Subject Non-Compliance|0|||
125026228|NCT01871090|449720398|FG001|Overall Study|Subject Non-Compliance|1|||
125026229|NCT00804687|449720401|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
125026230|NCT00804687|449720402|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
125026231|NCT00804687|449720403|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
125026232|NCT00804687|449720404|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
125026233|NCT00804687|449720405|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
125026234|NCT00804687|449720406|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
125026235|NCT00804687|449720401|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
125026236|NCT00804687|449720402|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
125026237|NCT00804687|449720403|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
125026238|NCT00804687|449720404|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
125026239|NCT00804687|449720405|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
125026240|NCT00804687|449720406|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
125026241|NCT00804687|449720401|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
125026242|NCT00804687|449720402|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
125026243|NCT00804687|449720403|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
125026244|NCT00804687|449720404|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
125026245|NCT00804687|449720405|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
125026246|NCT00804687|449720406|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
125026247|NCT00804687|449720401|FG000|Period 5: Treatment Period|Positive drug test|1|||
125026248|NCT00804687|449720402|FG001|Period 5: Treatment Period|Positive drug test|0|||
125026249|NCT00804687|449720403|FG002|Period 5: Treatment Period|Positive drug test|0|||
125026250|NCT00804687|449720404|FG003|Period 5: Treatment Period|Positive drug test|0|||
125026251|NCT00804687|449720405|FG004|Period 5: Treatment Period|Positive drug test|0|||
125026252|NCT00804687|449720406|FG005|Period 5: Treatment Period|Positive drug test|0|||
125026253|NCT00688909|449720409|FG000|Overall Study|Adverse Event|28|||
125026254|NCT00688909|449720409|FG000|Overall Study|Patient withdrew consent|2|||
125026255|NCT00688909|449720409|FG000|Overall Study|Administrative problems|1|||
125026256|NCT00688909|449720409|FG000|Overall Study|Protocol Violation|2|||
125026257|NCT01220414|449720410|FG000|Overall Study|Withdrawal by Subject|1|||
125026258|NCT01220414|449720411|FG001|Overall Study|Withdrawal by Subject|0|||
125026259|NCT01220414|449720412|FG002|Overall Study|Withdrawal by Subject|0|||
125026260|NCT01220414|449720413|FG003|Overall Study|Withdrawal by Subject|1|||
125026261|NCT00860158|449720423|FG000|Overall Study|Study Terminated|1|||
125026262|NCT00669617|449720425|FG000|Period 1|Withdrawal by Subject|0|||
125026263|NCT00669617|449720426|FG001|Period 1|Withdrawal by Subject|0|||
125026264|NCT00669617|449720427|FG002|Period 1|Withdrawal by Subject|1|||
125026265|NCT00669617|449720428|FG003|Period 1|Withdrawal by Subject|0|||
125026266|NCT00669617|449720429|FG004|Period 1|Withdrawal by Subject|0|||
125026267|NCT00669617|449720425|FG000|Period 1|Protocol Deviation|0|||
125026268|NCT00669617|449720426|FG001|Period 1|Protocol Deviation|0|||
125026269|NCT00669617|449720427|FG002|Period 1|Protocol Deviation|0|||
125026270|NCT00669617|449720428|FG003|Period 1|Protocol Deviation|0|||
125026271|NCT00669617|449720429|FG004|Period 1|Protocol Deviation|1|||
125026272|NCT00669617|449720425|FG000|Period 3|Lost to Follow-up|1|||
125026273|NCT00669617|449720426|FG001|Period 3|Lost to Follow-up|0|||
125026274|NCT00669617|449720427|FG002|Period 3|Lost to Follow-up|0|||
125026275|NCT00669617|449720428|FG003|Period 3|Lost to Follow-up|0|||
125026276|NCT00669617|449720429|FG004|Period 3|Lost to Follow-up|0|||
125026277|NCT05499520|449720430|FG000|Overall Study|Lost to Follow-up|0|||
125026278|NCT05499520|449720431|FG001|Overall Study|Lost to Follow-up|0|||
125026279|NCT05499520|449720432|FG002|Overall Study|Lost to Follow-up|38|||
125026280|NCT05499520|449720433|FG003|Overall Study|Lost to Follow-up|41|||
125026281|NCT05499520|449720434|FG004|Overall Study|Lost to Follow-up|46|||
125026282|NCT05499520|449720435|FG005|Overall Study|Lost to Follow-up|0|||
125026283|NCT05499520|449720436|FG006|Overall Study|Lost to Follow-up|31|||
125026284|NCT05499520|449720437|FG007|Overall Study|Lost to Follow-up|45|||
125026285|NCT05499520|449720438|FG008|Overall Study|Lost to Follow-up|42|||
125026286|NCT05499520|449720439|FG009|Overall Study|Lost to Follow-up|0|||
125026287|NCT05499520|449720440|FG010|Overall Study|Lost to Follow-up|0|||
125026288|NCT05499520|449720441|FG011|Overall Study|Lost to Follow-up|37|||
125026289|NCT05499520|449720442|FG012|Overall Study|Lost to Follow-up|53|||
124936229|NCT03215706|449397390|FG001|Treatment Period|Participant withdrew consent|4|||
124936230|NCT03215706|449397389|FG000|Treatment Period|Lost to Follow-up|0|||
124936231|NCT03215706|449397390|FG001|Treatment Period|Lost to Follow-up|1|||
124936232|NCT03215706|449397389|FG000|Treatment Period|Other Reasons|4|||
124936233|NCT03215706|449397390|FG001|Treatment Period|Other Reasons|5|||
124936234|NCT03215706|449397389|FG000|Treatment Period|Ongoing in the treatment period|105|||
124936235|NCT03215706|449397390|FG001|Treatment Period|Ongoing in the treatment period|43|||
124936236|NCT00945724|449397391|FG000|Overall Study|Withdrawal by Subject|2|||
124936237|NCT00945724|449397391|FG000|Overall Study|Physician Decision|1|||
124936238|NCT00945724|449397391|FG000|Overall Study|Adverse Event|5|||
124936239|NCT00945724|449397391|FG000|Overall Study|Second malignancy|1|||
124936240|NCT00994643|449398336|FG000|Overall Study|Withdrawal by Subject|1|||
124936241|NCT05412004|449398338|FG000|Overall Study|Adverse Event|0|||
124936242|NCT05412004|449398339|FG001|Overall Study|Adverse Event|2|||
124936243|NCT05412004|449398340|FG002|Overall Study|Adverse Event|1|||
124936244|NCT05412004|449398341|FG003|Overall Study|Adverse Event|5|||
124936245|NCT05412004|449398338|FG000|Overall Study|Assigned Treatment by Mistake|5|||
124936246|NCT05412004|449398339|FG001|Overall Study|Assigned Treatment by Mistake|10|||
124936247|NCT05412004|449398340|FG002|Overall Study|Assigned Treatment by Mistake|2|||
124936248|NCT05412004|449398341|FG003|Overall Study|Assigned Treatment by Mistake|5|||
124936249|NCT05412004|449398338|FG000|Overall Study|Lost to Follow-up|3|||
124936250|NCT05412004|449398339|FG001|Overall Study|Lost to Follow-up|0|||
124936251|NCT05412004|449398340|FG002|Overall Study|Lost to Follow-up|0|||
124936252|NCT05412004|449398341|FG003|Overall Study|Lost to Follow-up|0|||
124936253|NCT05412004|449398338|FG000|Overall Study|Patient could not travel to site|0|||
124936254|NCT05412004|449398339|FG001|Overall Study|Patient could not travel to site|1|||
124936255|NCT05412004|449398340|FG002|Overall Study|Patient could not travel to site|0|||
124936256|NCT05412004|449398341|FG003|Overall Study|Patient could not travel to site|0|||
124936257|NCT05412004|449398338|FG000|Overall Study|Physician Decision|0|||
124936258|NCT05412004|449398339|FG001|Overall Study|Physician Decision|1|||
124936259|NCT05412004|449398340|FG002|Overall Study|Physician Decision|0|||
124936260|NCT05412004|449398341|FG003|Overall Study|Physician Decision|0|||
124936261|NCT05412004|449398338|FG000|Overall Study|Pregnancy|0|||
124936262|NCT05412004|449398339|FG001|Overall Study|Pregnancy|1|||
124936263|NCT05412004|449398340|FG002|Overall Study|Pregnancy|0|||
124936264|NCT05412004|449398341|FG003|Overall Study|Pregnancy|0|||
124936265|NCT05412004|449398338|FG000|Overall Study|Protocol Violation|1|||
124936266|NCT05412004|449398339|FG001|Overall Study|Protocol Violation|0|||
124936267|NCT05412004|449398340|FG002|Overall Study|Protocol Violation|0|||
124936268|NCT05412004|449398341|FG003|Overall Study|Protocol Violation|0|||
124936269|NCT05412004|449398338|FG000|Overall Study|Withdrawal by Subject|4|||
124936270|NCT05412004|449398339|FG001|Overall Study|Withdrawal by Subject|19|||
124936271|NCT05412004|449398340|FG002|Overall Study|Withdrawal by Subject|4|||
124936272|NCT05412004|449398341|FG003|Overall Study|Withdrawal by Subject|14|||
124936273|NCT05412004|449398338|FG000|Overall Study|Screen Failure|0|||
124936274|NCT05412004|449398339|FG001|Overall Study|Screen Failure|0|||
124936275|NCT05412004|449398340|FG002|Overall Study|Screen Failure|0|||
124936276|NCT05412004|449398341|FG003|Overall Study|Screen Failure|1|||
124936277|NCT05412004|449398338|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
124936278|NCT05412004|449398339|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
124936279|NCT05412004|449398340|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
124936280|NCT05412004|449398341|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
124936281|NCT00968149|449398342|FG000|Overall Study|Adverse Event|5|||
124936282|NCT00968149|449398343|FG001|Overall Study|Adverse Event|1|||
124936283|NCT00968149|449398342|FG000|Overall Study|Lack of Efficacy|0|||
124936284|NCT00968149|449398343|FG001|Overall Study|Lack of Efficacy|4|||
124936285|NCT00968149|449398342|FG000|Overall Study|Lost to Follow-up|0|||
124936286|NCT00968149|449398343|FG001|Overall Study|Lost to Follow-up|1|||
124936287|NCT00968149|449398342|FG000|Overall Study|Protocol Violation|4|||
124936288|NCT00968149|449398343|FG001|Overall Study|Protocol Violation|0|||
124936289|NCT00968149|449398342|FG000|Overall Study|Withdrawal by Subject|2|||
124936290|NCT00968149|449398343|FG001|Overall Study|Withdrawal by Subject|0|||
124936291|NCT02719574|449398344|FG000|Phase 1 (Dose Escalation)|Other|0|||
124936292|NCT02719574|449398345|FG001|Phase 1 (Dose Escalation)|Other|2|||
124936293|NCT02719574|449398346|FG002|Phase 1 (Dose Escalation)|Other|1|||
124936294|NCT02719574|449398347|FG003|Phase 1 (Dose Escalation)|Other|2|||
124936295|NCT02719574|449398348|FG004|Phase 1 (Dose Escalation)|Other|2|||
124936296|NCT02719574|449398349|FG005|Phase 1 (Dose Escalation)|Other|0|||
124936297|NCT02719574|449398350|FG006|Phase 1 (Dose Escalation)|Other|0|||
124936298|NCT02719574|449398351|FG007|Phase 1 (Dose Escalation)|Other|0|||
124936299|NCT02719574|449398352|FG008|Phase 1 (Dose Escalation)|Other|0|||
124936300|NCT02719574|449398353|FG009|Phase 1 (Dose Escalation)|Other|0|||
124936301|NCT02719574|449398354|FG010|Phase 1 (Dose Escalation)|Other|0|||
124936302|NCT02719574|449398355|FG011|Phase 1 (Dose Escalation)|Other|0|||
124936303|NCT02719574|449398356|FG012|Phase 1 (Dose Escalation)|Other|0|||
124936304|NCT02719574|449398357|FG013|Phase 1 (Dose Escalation)|Other|0|||
124936305|NCT02719574|449398358|FG014|Phase 1 (Dose Escalation)|Other|0|||
124936306|NCT02719574|449398359|FG015|Phase 1 (Dose Escalation)|Other|0|||
124936307|NCT02719574|449398360|FG016|Phase 1 (Dose Escalation)|Other|0|||
124936308|NCT02719574|449398344|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
124936309|NCT02719574|449398345|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
124936310|NCT02719574|449398346|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
124936311|NCT02719574|449398347|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
124936312|NCT02719574|449398348|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
124936313|NCT02719574|449398349|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
124936314|NCT02719574|449398350|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936315|NCT02719574|449398351|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936316|NCT02719574|449398352|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936317|NCT02719574|449398353|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936318|NCT02719574|449398354|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936319|NCT02719574|449398355|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936320|NCT02719574|449398356|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936321|NCT02719574|449398357|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936322|NCT02719574|449398358|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936323|NCT02719574|449398359|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936324|NCT02719574|449398360|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936325|NCT02719574|449398344|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936326|NCT02719574|449398345|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
124936327|NCT02719574|449398346|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
124936328|NCT02719574|449398347|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936329|NCT02719574|449398348|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
124936330|NCT02719574|449398349|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
124936331|NCT02719574|449398350|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936332|NCT02719574|449398351|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936333|NCT02719574|449398352|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936334|NCT02719574|449398353|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936335|NCT02719574|449398354|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936336|NCT02719574|449398355|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936337|NCT02719574|449398356|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936338|NCT02719574|449398357|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936339|NCT02719574|449398358|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936340|NCT02719574|449398359|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936341|NCT02719574|449398360|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936342|NCT02719574|449398344|FG000|Phase 1 (Dose Escalation)|Death|2|||
124936343|NCT02719574|449398345|FG001|Phase 1 (Dose Escalation)|Death|1|||
124936344|NCT02719574|449398346|FG002|Phase 1 (Dose Escalation)|Death|1|||
124936345|NCT02719574|449398347|FG003|Phase 1 (Dose Escalation)|Death|0|||
124936346|NCT02719574|449398348|FG004|Phase 1 (Dose Escalation)|Death|0|||
124936347|NCT02719574|449398349|FG005|Phase 1 (Dose Escalation)|Death|0|||
124936348|NCT02719574|449398350|FG006|Phase 1 (Dose Escalation)|Death|0|||
124936349|NCT02719574|449398351|FG007|Phase 1 (Dose Escalation)|Death|0|||
124936350|NCT02719574|449398352|FG008|Phase 1 (Dose Escalation)|Death|0|||
124936351|NCT02719574|449398353|FG009|Phase 1 (Dose Escalation)|Death|0|||
124936352|NCT02719574|449398354|FG010|Phase 1 (Dose Escalation)|Death|0|||
124936353|NCT02719574|449398355|FG011|Phase 1 (Dose Escalation)|Death|0|||
124936354|NCT02719574|449398356|FG012|Phase 1 (Dose Escalation)|Death|0|||
124936355|NCT02719574|449398357|FG013|Phase 1 (Dose Escalation)|Death|0|||
124936356|NCT02719574|449398358|FG014|Phase 1 (Dose Escalation)|Death|0|||
124936357|NCT02719574|449398359|FG015|Phase 1 (Dose Escalation)|Death|0|||
124936358|NCT02719574|449398360|FG016|Phase 1 (Dose Escalation)|Death|0|||
124936359|NCT02719574|449398344|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936360|NCT02719574|449398345|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
124936361|NCT02719574|449398346|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936362|NCT02719574|449398347|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936363|NCT02719574|449398348|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
124936364|NCT02719574|449398349|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
124936365|NCT02719574|449398350|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936366|NCT02719574|449398351|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936367|NCT02719574|449398352|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936368|NCT02719574|449398353|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936369|NCT02719574|449398354|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936370|NCT02719574|449398355|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936371|NCT02719574|449398356|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936372|NCT02719574|449398357|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936373|NCT02719574|449398358|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936374|NCT02719574|449398359|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936375|NCT02719574|449398360|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936376|NCT02719574|449398344|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936377|NCT02719574|449398345|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936378|NCT02719574|449398346|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936379|NCT02719574|449398347|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936380|NCT02719574|449398348|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
124936381|NCT02719574|449398349|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
124936382|NCT02719574|449398350|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936383|NCT02719574|449398351|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936384|NCT02719574|449398352|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936385|NCT02719574|449398353|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936386|NCT02719574|449398354|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936387|NCT02719574|449398355|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936388|NCT02719574|449398356|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936389|NCT02719574|449398357|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936390|NCT02719574|449398358|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936391|NCT02719574|449398359|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936392|NCT02719574|449398360|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936393|NCT02719574|449398344|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936394|NCT02719574|449398345|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936395|NCT02719574|449398346|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
124936396|NCT02719574|449398347|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936397|NCT02719574|449398348|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936398|NCT02719574|449398349|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936399|NCT02719574|449398350|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936400|NCT02719574|449398351|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936401|NCT02719574|449398352|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936402|NCT02719574|449398353|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936403|NCT02719574|449398354|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936404|NCT02719574|449398355|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936405|NCT02719574|449398356|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936406|NCT02719574|449398357|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936407|NCT02719574|449398358|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936408|NCT02719574|449398359|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936409|NCT02719574|449398360|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936410|NCT02719574|449398344|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936411|NCT02719574|449398345|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936412|NCT02719574|449398346|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936413|NCT02719574|449398347|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936414|NCT02719574|449398348|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936415|NCT02719574|449398349|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936416|NCT02719574|449398350|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
124936417|NCT02719574|449398351|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
124936418|NCT02719574|449398352|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
124936419|NCT02719574|449398353|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936420|NCT02719574|449398354|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936421|NCT02719574|449398355|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936422|NCT02719574|449398356|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936423|NCT02719574|449398357|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936424|NCT02719574|449398358|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936425|NCT02719574|449398359|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936426|NCT02719574|449398360|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936427|NCT02719574|449398344|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936428|NCT02719574|449398345|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936429|NCT02719574|449398346|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936430|NCT02719574|449398347|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
125026290|NCT05499520|449720443|FG013|Overall Study|Lost to Follow-up|49|||
124936431|NCT02719574|449398348|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936432|NCT02719574|449398349|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936433|NCT02719574|449398350|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
124936434|NCT02719574|449398351|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
124936435|NCT02719574|449398352|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936436|NCT02719574|449398353|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936437|NCT02719574|449398354|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936438|NCT02719574|449398355|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
125026291|NCT05499520|449720444|FG014|Overall Study|Lost to Follow-up|0|||
124936439|NCT02719574|449398356|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936440|NCT02719574|449398357|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936441|NCT02719574|449398358|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936442|NCT02719574|449398359|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936443|NCT02719574|449398360|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936444|NCT02719574|449398344|FG000|Phase 1 (Dose Expansion)|Death|0|||
124936445|NCT02719574|449398345|FG001|Phase 1 (Dose Expansion)|Death|0|||
124936446|NCT02719574|449398346|FG002|Phase 1 (Dose Expansion)|Death|0|||
124936447|NCT02719574|449398347|FG003|Phase 1 (Dose Expansion)|Death|0|||
124936448|NCT02719574|449398348|FG004|Phase 1 (Dose Expansion)|Death|0|||
124936449|NCT02719574|449398349|FG005|Phase 1 (Dose Expansion)|Death|0|||
124936450|NCT02719574|449398350|FG006|Phase 1 (Dose Expansion)|Death|1|||
124936451|NCT02719574|449398351|FG007|Phase 1 (Dose Expansion)|Death|6|||
124936452|NCT02719574|449398352|FG008|Phase 1 (Dose Expansion)|Death|0|||
124936453|NCT02719574|449398353|FG009|Phase 1 (Dose Expansion)|Death|0|||
124936454|NCT02719574|449398354|FG010|Phase 1 (Dose Expansion)|Death|0|||
124936455|NCT02719574|449398355|FG011|Phase 1 (Dose Expansion)|Death|0|||
124936456|NCT02719574|449398356|FG012|Phase 1 (Dose Expansion)|Death|0|||
124936457|NCT02719574|449398357|FG013|Phase 1 (Dose Expansion)|Death|0|||
124936458|NCT02719574|449398358|FG014|Phase 1 (Dose Expansion)|Death|0|||
124936459|NCT02719574|449398359|FG015|Phase 1 (Dose Expansion)|Death|0|||
124936460|NCT02719574|449398360|FG016|Phase 1 (Dose Expansion)|Death|0|||
124936461|NCT02719574|449398344|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936462|NCT02719574|449398345|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936463|NCT02719574|449398346|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936464|NCT02719574|449398347|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936465|NCT02719574|449398348|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936466|NCT02719574|449398349|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936467|NCT02719574|449398350|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
124936468|NCT02719574|449398351|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
124936469|NCT02719574|449398352|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936470|NCT02719574|449398353|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936471|NCT02719574|449398354|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936472|NCT02719574|449398355|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936473|NCT02719574|449398356|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936474|NCT02719574|449398357|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936475|NCT02719574|449398358|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936476|NCT02719574|449398359|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936477|NCT02719574|449398360|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936478|NCT02719574|449398344|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936479|NCT02719574|449398345|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936480|NCT02719574|449398346|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936481|NCT02719574|449398347|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936482|NCT02719574|449398348|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936483|NCT02719574|449398349|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936484|NCT02719574|449398350|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
124936485|NCT02719574|449398351|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
124936486|NCT02719574|449398352|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936487|NCT02719574|449398353|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936488|NCT02719574|449398354|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936489|NCT02719574|449398355|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936490|NCT02719574|449398356|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936491|NCT02719574|449398357|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936492|NCT02719574|449398358|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936493|NCT02719574|449398359|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936494|NCT02719574|449398360|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936495|NCT02719574|449398344|FG000|Phase 1 (Dose Expansion)|Other|0|||
124936496|NCT02719574|449398345|FG001|Phase 1 (Dose Expansion)|Other|0|||
125120972|NCT03922477|450067041|FG000|Overall Study|Physician Decision|1|||
125120973|NCT03922477|450067041|FG000|Overall Study|Withdrawal by Subject|2|||
125120974|NCT01485536|450067049|FG000|Overall Study|Withdrawal by Subject|3|||
125120975|NCT01485536|450067049|FG000|Overall Study|Adverse Event|1|||
125120976|NCT02626949|450067050|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
125120977|NCT02626949|450067051|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
124936497|NCT02719574|449398346|FG002|Phase 1 (Dose Expansion)|Other|0|||
124936498|NCT02719574|449398347|FG003|Phase 1 (Dose Expansion)|Other|0|||
124936499|NCT02719574|449398348|FG004|Phase 1 (Dose Expansion)|Other|0|||
125120978|NCT02626949|450067050|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
125120979|NCT02626949|450067051|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
124936500|NCT02719574|449398349|FG005|Phase 1 (Dose Expansion)|Other|0|||
124936501|NCT02719574|449398350|FG006|Phase 1 (Dose Expansion)|Other|1|||
124936502|NCT02719574|449398351|FG007|Phase 1 (Dose Expansion)|Other|7|||
124936503|NCT02719574|449398352|FG008|Phase 1 (Dose Expansion)|Other|0|||
124936504|NCT02719574|449398353|FG009|Phase 1 (Dose Expansion)|Other|0|||
124936505|NCT02719574|449398354|FG010|Phase 1 (Dose Expansion)|Other|0|||
124936506|NCT02719574|449398355|FG011|Phase 1 (Dose Expansion)|Other|0|||
124936507|NCT02719574|449398356|FG012|Phase 1 (Dose Expansion)|Other|0|||
124936508|NCT02719574|449398357|FG013|Phase 1 (Dose Expansion)|Other|0|||
124936509|NCT02719574|449398358|FG014|Phase 1 (Dose Expansion)|Other|0|||
124936510|NCT02719574|449398359|FG015|Phase 1 (Dose Expansion)|Other|0|||
124936511|NCT02719574|449398360|FG016|Phase 1 (Dose Expansion)|Other|0|||
124936512|NCT02719574|449398344|FG000|Phase 2|Protocol Defined Disease Progression|0|||
124936513|NCT02719574|449398345|FG001|Phase 2|Protocol Defined Disease Progression|0|||
124936514|NCT02719574|449398346|FG002|Phase 2|Protocol Defined Disease Progression|0|||
124936515|NCT02719574|449398347|FG003|Phase 2|Protocol Defined Disease Progression|0|||
124936516|NCT02719574|449398348|FG004|Phase 2|Protocol Defined Disease Progression|0|||
124936517|NCT02719574|449398349|FG005|Phase 2|Protocol Defined Disease Progression|0|||
124936518|NCT02719574|449398350|FG006|Phase 2|Protocol Defined Disease Progression|0|||
124936519|NCT02719574|449398351|FG007|Phase 2|Protocol Defined Disease Progression|0|||
124936520|NCT02719574|449398352|FG008|Phase 2|Protocol Defined Disease Progression|0|||
124936521|NCT02719574|449398353|FG009|Phase 2|Protocol Defined Disease Progression|65|||
124936522|NCT02719574|449398354|FG010|Phase 2|Protocol Defined Disease Progression|8|||
124936523|NCT02719574|449398355|FG011|Phase 2|Protocol Defined Disease Progression|2|||
124936524|NCT02719574|449398356|FG012|Phase 2|Protocol Defined Disease Progression|4|||
124936525|NCT02719574|449398357|FG013|Phase 2|Protocol Defined Disease Progression|9|||
124936526|NCT02719574|449398358|FG014|Phase 2|Protocol Defined Disease Progression|11|||
124936527|NCT02719574|449398359|FG015|Phase 2|Protocol Defined Disease Progression|3|||
124936528|NCT02719574|449398360|FG016|Phase 2|Protocol Defined Disease Progression|4|||
124936529|NCT02719574|449398344|FG000|Phase 2|Adverse Event|0|||
124936530|NCT02719574|449398345|FG001|Phase 2|Adverse Event|0|||
124936531|NCT02719574|449398346|FG002|Phase 2|Adverse Event|0|||
124936532|NCT02719574|449398347|FG003|Phase 2|Adverse Event|0|||
124936533|NCT02719574|449398348|FG004|Phase 2|Adverse Event|0|||
124936534|NCT02719574|449398349|FG005|Phase 2|Adverse Event|0|||
124936535|NCT02719574|449398350|FG006|Phase 2|Adverse Event|0|||
124936536|NCT02719574|449398351|FG007|Phase 2|Adverse Event|0|||
124936537|NCT02719574|449398352|FG008|Phase 2|Adverse Event|0|||
124936538|NCT02719574|449398353|FG009|Phase 2|Adverse Event|27|||
124936539|NCT02719574|449398354|FG010|Phase 2|Adverse Event|0|||
124936540|NCT02719574|449398355|FG011|Phase 2|Adverse Event|1|||
124936541|NCT02719574|449398356|FG012|Phase 2|Adverse Event|1|||
124936542|NCT02719574|449398357|FG013|Phase 2|Adverse Event|1|||
124936543|NCT02719574|449398358|FG014|Phase 2|Adverse Event|2|||
124936544|NCT02719574|449398359|FG015|Phase 2|Adverse Event|2|||
124936545|NCT02719574|449398360|FG016|Phase 2|Adverse Event|3|||
124936546|NCT02719574|449398344|FG000|Phase 2|Other|0|||
124936547|NCT02719574|449398345|FG001|Phase 2|Other|0|||
124936548|NCT02719574|449398346|FG002|Phase 2|Other|0|||
124936549|NCT02719574|449398347|FG003|Phase 2|Other|0|||
124936550|NCT02719574|449398348|FG004|Phase 2|Other|0|||
124936551|NCT02719574|449398349|FG005|Phase 2|Other|0|||
124936552|NCT02719574|449398350|FG006|Phase 2|Other|0|||
124936553|NCT02719574|449398351|FG007|Phase 2|Other|0|||
124936554|NCT02719574|449398352|FG008|Phase 2|Other|0|||
124936555|NCT02719574|449398353|FG009|Phase 2|Other|20|||
124936556|NCT02719574|449398354|FG010|Phase 2|Other|7|||
124936557|NCT02719574|449398355|FG011|Phase 2|Other|0|||
124936558|NCT02719574|449398356|FG012|Phase 2|Other|5|||
124936559|NCT02719574|449398357|FG013|Phase 2|Other|7|||
124936560|NCT02719574|449398358|FG014|Phase 2|Other|0|||
124936561|NCT02719574|449398359|FG015|Phase 2|Other|1|||
124936562|NCT02719574|449398360|FG016|Phase 2|Other|4|||
124936563|NCT02719574|449398344|FG000|Phase 2|Transplant|0|||
124936564|NCT02719574|449398345|FG001|Phase 2|Transplant|0|||
124936565|NCT02719574|449398346|FG002|Phase 2|Transplant|0|||
124936566|NCT02719574|449398347|FG003|Phase 2|Transplant|0|||
124936567|NCT02719574|449398348|FG004|Phase 2|Transplant|0|||
125026292|NCT05499520|449720445|FG015|Overall Study|Lost to Follow-up|36|||
125026293|NCT05499520|449720446|FG016|Overall Study|Lost to Follow-up|58|||
125026294|NCT05499520|449720447|FG017|Overall Study|Lost to Follow-up|53|||
125026295|NCT01613326|449720448|FG000|Overall Study|Adverse Event|7|||
124936568|NCT02719574|449398349|FG005|Phase 2|Transplant|0|||
124936569|NCT02719574|449398350|FG006|Phase 2|Transplant|0|||
124936570|NCT02719574|449398351|FG007|Phase 2|Transplant|0|||
124936571|NCT02719574|449398352|FG008|Phase 2|Transplant|0|||
124936572|NCT02719574|449398353|FG009|Phase 2|Transplant|15|||
124936573|NCT02719574|449398354|FG010|Phase 2|Transplant|2|||
124936574|NCT02719574|449398355|FG011|Phase 2|Transplant|0|||
124936575|NCT02719574|449398356|FG012|Phase 2|Transplant|6|||
124936576|NCT02719574|449398357|FG013|Phase 2|Transplant|1|||
124936577|NCT02719574|449398358|FG014|Phase 2|Transplant|1|||
124936578|NCT02719574|449398359|FG015|Phase 2|Transplant|0|||
124936579|NCT02719574|449398360|FG016|Phase 2|Transplant|0|||
124936580|NCT02719574|449398344|FG000|Phase 2|Death|0|||
124936581|NCT02719574|449398345|FG001|Phase 2|Death|0|||
124936582|NCT02719574|449398346|FG002|Phase 2|Death|0|||
124936583|NCT02719574|449398347|FG003|Phase 2|Death|0|||
124936584|NCT02719574|449398348|FG004|Phase 2|Death|0|||
124936585|NCT02719574|449398349|FG005|Phase 2|Death|0|||
125026296|NCT01613326|449720449|FG001|Overall Study|Adverse Event|5|||
124936586|NCT02719574|449398350|FG006|Phase 2|Death|0|||
124936587|NCT02719574|449398351|FG007|Phase 2|Death|0|||
124936588|NCT02719574|449398352|FG008|Phase 2|Death|0|||
124936589|NCT02719574|449398353|FG009|Phase 2|Death|14|||
124936590|NCT02719574|449398354|FG010|Phase 2|Death|0|||
124936591|NCT02719574|449398355|FG011|Phase 2|Death|0|||
124936592|NCT02719574|449398356|FG012|Phase 2|Death|1|||
124936593|NCT02719574|449398357|FG013|Phase 2|Death|1|||
124936594|NCT02719574|449398358|FG014|Phase 2|Death|2|||
124936595|NCT02719574|449398359|FG015|Phase 2|Death|0|||
124936596|NCT02719574|449398360|FG016|Phase 2|Death|0|||
124936597|NCT02719574|449398344|FG000|Phase 2|Investigator Decision|0|||
124936598|NCT02719574|449398345|FG001|Phase 2|Investigator Decision|0|||
124936599|NCT02719574|449398346|FG002|Phase 2|Investigator Decision|0|||
124936600|NCT02719574|449398347|FG003|Phase 2|Investigator Decision|0|||
124936601|NCT02719574|449398348|FG004|Phase 2|Investigator Decision|0|||
124936602|NCT02719574|449398349|FG005|Phase 2|Investigator Decision|0|||
124936603|NCT02719574|449398350|FG006|Phase 2|Investigator Decision|0|||
124936604|NCT02719574|449398351|FG007|Phase 2|Investigator Decision|0|||
124936605|NCT02719574|449398352|FG008|Phase 2|Investigator Decision|0|||
124936606|NCT02719574|449398353|FG009|Phase 2|Investigator Decision|6|||
124936607|NCT02719574|449398354|FG010|Phase 2|Investigator Decision|1|||
124936608|NCT02719574|449398355|FG011|Phase 2|Investigator Decision|2|||
124936609|NCT02719574|449398356|FG012|Phase 2|Investigator Decision|3|||
124936610|NCT02719574|449398357|FG013|Phase 2|Investigator Decision|1|||
124936611|NCT02719574|449398358|FG014|Phase 2|Investigator Decision|3|||
124936612|NCT02719574|449398359|FG015|Phase 2|Investigator Decision|2|||
124936613|NCT02719574|449398360|FG016|Phase 2|Investigator Decision|0|||
124936614|NCT02719574|449398344|FG000|Phase 2|Withdrawal by Subject|0|||
124936615|NCT02719574|449398345|FG001|Phase 2|Withdrawal by Subject|0|||
124936616|NCT02719574|449398346|FG002|Phase 2|Withdrawal by Subject|0|||
124936617|NCT02719574|449398347|FG003|Phase 2|Withdrawal by Subject|0|||
124936618|NCT02719574|449398348|FG004|Phase 2|Withdrawal by Subject|0|||
124936619|NCT02719574|449398349|FG005|Phase 2|Withdrawal by Subject|0|||
124936620|NCT02719574|449398350|FG006|Phase 2|Withdrawal by Subject|0|||
124936621|NCT02719574|449398351|FG007|Phase 2|Withdrawal by Subject|0|||
124936622|NCT02719574|449398352|FG008|Phase 2|Withdrawal by Subject|0|||
124936623|NCT02719574|449398353|FG009|Phase 2|Withdrawal by Subject|5|||
124936624|NCT02719574|449398354|FG010|Phase 2|Withdrawal by Subject|0|||
124936625|NCT02719574|449398355|FG011|Phase 2|Withdrawal by Subject|0|||
124936626|NCT02719574|449398356|FG012|Phase 2|Withdrawal by Subject|0|||
124936627|NCT02719574|449398357|FG013|Phase 2|Withdrawal by Subject|1|||
124936628|NCT02719574|449398358|FG014|Phase 2|Withdrawal by Subject|1|||
124936629|NCT02719574|449398359|FG015|Phase 2|Withdrawal by Subject|2|||
124936630|NCT02719574|449398360|FG016|Phase 2|Withdrawal by Subject|0|||
124936631|NCT02719574|449398344|FG000|Phase 2|Protocol Violation|0|||
124936632|NCT02719574|449398345|FG001|Phase 2|Protocol Violation|0|||
124936633|NCT02719574|449398346|FG002|Phase 2|Protocol Violation|0|||
124936634|NCT02719574|449398347|FG003|Phase 2|Protocol Violation|0|||
124936635|NCT02719574|449398348|FG004|Phase 2|Protocol Violation|0|||
124936636|NCT02719574|449398349|FG005|Phase 2|Protocol Violation|0|||
124936637|NCT02719574|449398350|FG006|Phase 2|Protocol Violation|0|||
124936638|NCT02719574|449398351|FG007|Phase 2|Protocol Violation|0|||
124936639|NCT02719574|449398352|FG008|Phase 2|Protocol Violation|0|||
124936640|NCT02719574|449398353|FG009|Phase 2|Protocol Violation|1|||
124936641|NCT02719574|449398354|FG010|Phase 2|Protocol Violation|0|||
124936642|NCT02719574|449398355|FG011|Phase 2|Protocol Violation|0|||
124936643|NCT02719574|449398356|FG012|Phase 2|Protocol Violation|0|||
124936644|NCT02719574|449398357|FG013|Phase 2|Protocol Violation|0|||
124936645|NCT02719574|449398358|FG014|Phase 2|Protocol Violation|0|||
124936646|NCT02719574|449398359|FG015|Phase 2|Protocol Violation|0|||
124936647|NCT02719574|449398360|FG016|Phase 2|Protocol Violation|0|||
124936648|NCT02720068|449398364|FG000|Overall Study|Adverse Event|0|||
124936649|NCT02720068|449398365|FG001|Overall Study|Adverse Event|0|||
124936650|NCT02720068|449398366|FG002|Overall Study|Adverse Event|0|||
124936651|NCT02720068|449398367|FG003|Overall Study|Adverse Event|0|||
124936652|NCT02720068|449398368|FG004|Overall Study|Adverse Event|0|||
124936653|NCT02720068|449398369|FG005|Overall Study|Adverse Event|0|||
124936654|NCT02720068|449398370|FG006|Overall Study|Adverse Event|0|||
124936655|NCT02720068|449398371|FG007|Overall Study|Adverse Event|0|||
124936656|NCT02720068|449398372|FG008|Overall Study|Adverse Event|0|||
124936657|NCT02720068|449398373|FG009|Overall Study|Adverse Event|0|||
124936658|NCT02720068|449398374|FG010|Overall Study|Adverse Event|0|||
124936659|NCT02720068|449398375|FG011|Overall Study|Adverse Event|1|||
124936660|NCT02720068|449398376|FG012|Overall Study|Adverse Event|0|||
124936661|NCT02720068|449398377|FG013|Overall Study|Adverse Event|0|||
124936662|NCT02720068|449398378|FG014|Overall Study|Adverse Event|0|||
124936663|NCT02720068|449398379|FG015|Overall Study|Adverse Event|0|||
124936664|NCT02720068|449398380|FG016|Overall Study|Adverse Event|0|||
124936665|NCT02720068|449398381|FG017|Overall Study|Adverse Event|0|||
124936666|NCT02720068|449398364|FG000|Overall Study|Death|1|||
124936667|NCT02720068|449398365|FG001|Overall Study|Death|3|||
124936668|NCT02720068|449398366|FG002|Overall Study|Death|2|||
124936669|NCT02720068|449398367|FG003|Overall Study|Death|1|||
124936670|NCT02720068|449398368|FG004|Overall Study|Death|2|||
124936671|NCT02720068|449398369|FG005|Overall Study|Death|1|||
124936672|NCT02720068|449398370|FG006|Overall Study|Death|2|||
124936673|NCT02720068|449398371|FG007|Overall Study|Death|2|||
124936674|NCT02720068|449398372|FG008|Overall Study|Death|3|||
124936675|NCT02720068|449398373|FG009|Overall Study|Death|1|||
124936676|NCT02720068|449398374|FG010|Overall Study|Death|20|||
124936677|NCT02720068|449398375|FG011|Overall Study|Death|166|||
124936678|NCT02720068|449398376|FG012|Overall Study|Death|34|||
124936679|NCT02720068|449398377|FG013|Overall Study|Death|30|||
124936680|NCT02720068|449398378|FG014|Overall Study|Death|45|||
124936681|NCT02720068|449398379|FG015|Overall Study|Death|16|||
124936682|NCT02720068|449398380|FG016|Overall Study|Death|20|||
124936683|NCT02720068|449398381|FG017|Overall Study|Death|28|||
124936684|NCT02720068|449398364|FG000|Overall Study|Lost to Follow-up|0|||
124936685|NCT02720068|449398365|FG001|Overall Study|Lost to Follow-up|0|||
124936686|NCT02720068|449398366|FG002|Overall Study|Lost to Follow-up|0|||
124936687|NCT02720068|449398367|FG003|Overall Study|Lost to Follow-up|0|||
124936688|NCT02720068|449398368|FG004|Overall Study|Lost to Follow-up|0|||
124936689|NCT02720068|449398369|FG005|Overall Study|Lost to Follow-up|0|||
124936690|NCT02720068|449398370|FG006|Overall Study|Lost to Follow-up|0|||
124936691|NCT02720068|449398371|FG007|Overall Study|Lost to Follow-up|0|||
124936692|NCT02720068|449398372|FG008|Overall Study|Lost to Follow-up|0|||
124936693|NCT02720068|449398373|FG009|Overall Study|Lost to Follow-up|0|||
124936694|NCT02720068|449398374|FG010|Overall Study|Lost to Follow-up|0|||
124936695|NCT02720068|449398375|FG011|Overall Study|Lost to Follow-up|1|||
124936696|NCT02720068|449398376|FG012|Overall Study|Lost to Follow-up|0|||
124936697|NCT02720068|449398377|FG013|Overall Study|Lost to Follow-up|1|||
124936698|NCT02720068|449398378|FG014|Overall Study|Lost to Follow-up|2|||
124936699|NCT02720068|449398379|FG015|Overall Study|Lost to Follow-up|0|||
124936700|NCT02720068|449398380|FG016|Overall Study|Lost to Follow-up|0|||
124936701|NCT02720068|449398381|FG017|Overall Study|Lost to Follow-up|1|||
124936702|NCT02720068|449398364|FG000|Overall Study|Physician Decision|0|||
124936703|NCT02720068|449398365|FG001|Overall Study|Physician Decision|0|||
124936704|NCT02720068|449398366|FG002|Overall Study|Physician Decision|0|||
124936705|NCT02720068|449398367|FG003|Overall Study|Physician Decision|1|||
124936706|NCT02720068|449398368|FG004|Overall Study|Physician Decision|0|||
124936707|NCT02720068|449398369|FG005|Overall Study|Physician Decision|0|||
124936708|NCT02720068|449398370|FG006|Overall Study|Physician Decision|0|||
124936709|NCT02720068|449398371|FG007|Overall Study|Physician Decision|0|||
124936710|NCT02720068|449398372|FG008|Overall Study|Physician Decision|0|||
124936711|NCT02720068|449398373|FG009|Overall Study|Physician Decision|0|||
124936712|NCT02720068|449398374|FG010|Overall Study|Physician Decision|0|||
124936713|NCT02720068|449398375|FG011|Overall Study|Physician Decision|1|||
124936714|NCT02720068|449398376|FG012|Overall Study|Physician Decision|0|||
124936715|NCT02720068|449398377|FG013|Overall Study|Physician Decision|0|||
124936716|NCT02720068|449398378|FG014|Overall Study|Physician Decision|0|||
124936717|NCT02720068|449398379|FG015|Overall Study|Physician Decision|0|||
124936718|NCT02720068|449398380|FG016|Overall Study|Physician Decision|0|||
124936719|NCT02720068|449398381|FG017|Overall Study|Physician Decision|1|||
124936720|NCT02720068|449398364|FG000|Overall Study|Progressive Disease|2|||
124936721|NCT02720068|449398365|FG001|Overall Study|Progressive Disease|3|||
124936722|NCT02720068|449398366|FG002|Overall Study|Progressive Disease|1|||
124936723|NCT02720068|449398367|FG003|Overall Study|Progressive Disease|1|||
124936724|NCT02720068|449398368|FG004|Overall Study|Progressive Disease|1|||
124936725|NCT02720068|449398369|FG005|Overall Study|Progressive Disease|2|||
124936726|NCT02720068|449398370|FG006|Overall Study|Progressive Disease|1|||
125026297|NCT01613326|449720448|FG000|Overall Study|Withdrawal by Subject|3|||
125026298|NCT01613326|449720449|FG001|Overall Study|Withdrawal by Subject|4|||
125026299|NCT01613326|449720448|FG000|Overall Study|Abnormal test procedure result(s)|2|||
124936727|NCT02720068|449398371|FG007|Overall Study|Progressive Disease|1|||
124936728|NCT02720068|449398372|FG008|Overall Study|Progressive Disease|0|||
124936729|NCT02720068|449398373|FG009|Overall Study|Progressive Disease|1|||
124936730|NCT02720068|449398374|FG010|Overall Study|Progressive Disease|0|||
124936731|NCT02720068|449398375|FG011|Overall Study|Progressive Disease|4|||
124936732|NCT02720068|449398376|FG012|Overall Study|Progressive Disease|1|||
124936733|NCT02720068|449398377|FG013|Overall Study|Progressive Disease|0|||
124936734|NCT02720068|449398378|FG014|Overall Study|Progressive Disease|0|||
124936735|NCT02720068|449398379|FG015|Overall Study|Progressive Disease|0|||
125026300|NCT01613326|449720449|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125026301|NCT01613326|449720448|FG000|Overall Study|inability to use device|1|||
125026302|NCT01613326|449720449|FG001|Overall Study|inability to use device|0|||
125026303|NCT01613326|449720448|FG000|Overall Study|Lack of Efficacy|0|||
125026304|NCT01613326|449720449|FG001|Overall Study|Lack of Efficacy|1|||
125026305|NCT01613326|449720448|FG000|Overall Study|Lost to Follow-up|0|||
125026306|NCT01613326|449720449|FG001|Overall Study|Lost to Follow-up|1|||
125026307|NCT01613326|449720448|FG000|Overall Study|Administrative|0|||
125026308|NCT01613326|449720449|FG001|Overall Study|Administrative|2|||
125026309|NCT01613326|449720448|FG000|Overall Study|Protocol Violation|0|||
125026310|NCT01613326|449720449|FG001|Overall Study|Protocol Violation|1|||
125026311|NCT03980938|449720450|FG000|Treatment Period 1|Study Terminated|1|||
125026312|NCT03980938|449720451|FG001|Treatment Period 1|Study Terminated|1|||
125026313|NCT03980938|449720450|FG000|Treatment Period 2|Study Terminated|2|||
125026314|NCT03980938|449720451|FG001|Treatment Period 2|Study Terminated|2|||
125026315|NCT00840827|449720452|FG000|Overall Study|Adverse Event|1|||
125026316|NCT00840827|449720452|FG000|Overall Study|Lack of Efficacy|4|||
125026317|NCT00840827|449720452|FG000|Overall Study|Physician Decision|1|||
125026318|NCT01445535|449720453|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
125026319|NCT01445535|449720454|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
125026320|NCT01445535|449720455|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
125026321|NCT01445535|449720456|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
125026322|NCT01445535|449720453|FG000|Overall Study|Disease progression|1|||
125026323|NCT01445535|449720454|FG001|Overall Study|Disease progression|0|||
125026324|NCT01445535|449720455|FG002|Overall Study|Disease progression|1|||
125026325|NCT01445535|449720456|FG003|Overall Study|Disease progression|0|||
125026326|NCT01445535|449720453|FG000|Overall Study|PI discretion|0|||
125026327|NCT01445535|449720454|FG001|Overall Study|PI discretion|0|||
125026328|NCT01445535|449720455|FG002|Overall Study|PI discretion|0|||
125026329|NCT01445535|449720456|FG003|Overall Study|PI discretion|1|||
125026330|NCT01337973|449720460|FG000|Overall Study|Lost to Follow-up|2|||
125026331|NCT01337973|449720461|FG001|Overall Study|Lost to Follow-up|4|||
125026332|NCT01337973|449720462|FG002|Overall Study|Lost to Follow-up|3|||
125026333|NCT01337973|449720460|FG000|Overall Study|Death|1|||
125026334|NCT01337973|449720461|FG001|Overall Study|Death|2|||
125026335|NCT01337973|449720462|FG002|Overall Study|Death|1|||
125026336|NCT01337973|449720460|FG000|Overall Study|Withdrawal by Subject|10|||
125026337|NCT01337973|449720461|FG001|Overall Study|Withdrawal by Subject|8|||
125026338|NCT01337973|449720462|FG002|Overall Study|Withdrawal by Subject|4|||
125026339|NCT01337973|449720460|FG000|Overall Study|missing data on primary outcome|3|||
125026340|NCT01337973|449720461|FG001|Overall Study|missing data on primary outcome|1|||
125026341|NCT01337973|449720462|FG002|Overall Study|missing data on primary outcome|3|||
125026342|NCT02494596|449720463|FG000|Overall Study|Insufficient Therapeutic Response|3|||
125026343|NCT02494596|449720464|FG001|Overall Study|Insufficient Therapeutic Response|3|||
125026344|NCT02494596|449720465|FG002|Overall Study|Insufficient Therapeutic Response|1|||
125026345|NCT02494596|449720463|FG000|Overall Study|Adverse Event|0|||
125026346|NCT02494596|449720464|FG001|Overall Study|Adverse Event|1|||
125026347|NCT02494596|449720465|FG002|Overall Study|Adverse Event|0|||
125026348|NCT02494596|449720463|FG000|Overall Study|Refused Treatment|0|||
125026349|NCT02494596|449720464|FG001|Overall Study|Refused Treatment|1|||
125026350|NCT02494596|449720465|FG002|Overall Study|Refused Treatment|0|||
125026351|NCT00254566|449720466|FG000|Overall Study|Death|1|||
125026352|NCT00254566|449720467|FG001|Overall Study|Death|0|||
125026353|NCT00254566|449720466|FG000|Overall Study|Adverse Event|5|||
125026354|NCT00254566|449720467|FG001|Overall Study|Adverse Event|4|||
125026355|NCT00254566|449720466|FG000|Overall Study|Lack of Efficacy|12|||
125120980|NCT02626949|450067050|FG000|Enrolled|Lost to Follow-up|7|||
125120981|NCT02626949|450067051|FG001|Enrolled|Lost to Follow-up|6|||
125120982|NCT02626949|450067050|FG000|Enrolled|Withdrawal by Subject|3|||
125120983|NCT02626949|450067051|FG001|Enrolled|Withdrawal by Subject|2|||
125120984|NCT03072459|450067052|FG000|Overall Study|Device revised/removed|1|||
125120985|NCT03072459|450067052|FG000|Overall Study|Subject not able to return|1|||
125026356|NCT00254566|449720467|FG001|Overall Study|Lack of Efficacy|9|||
125026357|NCT00254566|449720466|FG000|Overall Study|Other|1|||
125026358|NCT00254566|449720467|FG001|Overall Study|Other|5|||
125026359|NCT00254566|449720466|FG000|Overall Study|Withdrawal by Subject|5|||
125026360|NCT00254566|449720467|FG001|Overall Study|Withdrawal by Subject|6|||
125026361|NCT00254566|449720466|FG000|Overall Study|Lost to Follow-up|7|||
125026362|NCT00254566|449720467|FG001|Overall Study|Lost to Follow-up|2|||
125026363|NCT00059202|449720468|FG000|Overall Study|Withdrawal by Subject|5|||
125026364|NCT00059202|449720469|FG001|Overall Study|Withdrawal by Subject|9|||
125026365|NCT00059202|449720468|FG000|Overall Study|Protocol Violation|1|||
125026366|NCT00059202|449720469|FG001|Overall Study|Protocol Violation|3|||
125026367|NCT00059202|449720468|FG000|Overall Study|drug toxicity|0|||
125026368|NCT00059202|449720469|FG001|Overall Study|drug toxicity|3|||
125026369|NCT02658448|449720473|FG000|Overall Study|Lost to Follow-up|1|||
125026370|NCT02623335|449720474|FG000|Overall Study|Death|8|||
124936736|NCT02720068|449398380|FG016|Overall Study|Progressive Disease|0|||
124936737|NCT02720068|449398381|FG017|Overall Study|Progressive Disease|0|||
124936738|NCT02720068|449398364|FG000|Overall Study|Sponsor Decision|0|||
124936739|NCT02720068|449398365|FG001|Overall Study|Sponsor Decision|0|||
124936740|NCT02720068|449398366|FG002|Overall Study|Sponsor Decision|0|||
124936741|NCT02720068|449398367|FG003|Overall Study|Sponsor Decision|0|||
124936742|NCT02720068|449398368|FG004|Overall Study|Sponsor Decision|0|||
124936743|NCT02720068|449398369|FG005|Overall Study|Sponsor Decision|0|||
124936744|NCT02720068|449398370|FG006|Overall Study|Sponsor Decision|0|||
124936745|NCT02720068|449398371|FG007|Overall Study|Sponsor Decision|0|||
124936746|NCT02720068|449398372|FG008|Overall Study|Sponsor Decision|0|||
124936747|NCT02720068|449398373|FG009|Overall Study|Sponsor Decision|0|||
124936748|NCT02720068|449398374|FG010|Overall Study|Sponsor Decision|0|||
124936749|NCT02720068|449398375|FG011|Overall Study|Sponsor Decision|6|||
124936750|NCT02720068|449398376|FG012|Overall Study|Sponsor Decision|3|||
124936751|NCT02720068|449398377|FG013|Overall Study|Sponsor Decision|2|||
124936752|NCT02720068|449398378|FG014|Overall Study|Sponsor Decision|4|||
124936753|NCT02720068|449398379|FG015|Overall Study|Sponsor Decision|4|||
124936754|NCT02720068|449398380|FG016|Overall Study|Sponsor Decision|0|||
124936755|NCT02720068|449398381|FG017|Overall Study|Sponsor Decision|8|||
124936756|NCT02720068|449398364|FG000|Overall Study|Withdrawal by Subject|0|||
124936757|NCT02720068|449398365|FG001|Overall Study|Withdrawal by Subject|0|||
125120986|NCT02275364|450067053|FG000|Period 1|Withdrawal by Subject|1|||
125120987|NCT02275364|450067054|FG001|Period 1|Withdrawal by Subject|0|||
125120988|NCT02275364|450067053|FG000|Period 1|Other reason|1|||
125120989|NCT02275364|450067054|FG001|Period 1|Other reason|0|||
125120990|NCT04094870|450067059|FG000|Overall Study|Lost to Follow-up|1|||
125120991|NCT04094870|450067060|FG001|Overall Study|Lost to Follow-up|1|||
125120992|NCT03384745|450067063|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
125120993|NCT03384745|450067064|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
125120994|NCT03384745|450067065|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
125120995|NCT03384745|450067066|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
125120996|NCT03384745|450067067|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
125120997|NCT03384745|450067068|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
125120998|NCT03384745|450067063|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
125120999|NCT03384745|450067064|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
125121000|NCT03384745|450067065|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
125121001|NCT03384745|450067066|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
125121002|NCT03384745|450067067|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
125121003|NCT03384745|450067068|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
125121004|NCT03384745|450067063|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
125121005|NCT03384745|450067064|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
125121006|NCT03384745|450067065|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
125121007|NCT03384745|450067066|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
125121008|NCT03384745|450067067|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
125121009|NCT03384745|450067068|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
125121010|NCT03384745|450067063|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
125121011|NCT03384745|450067064|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
125121012|NCT03384745|450067065|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
125212843|NCT01026818|450405480|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
125212844|NCT01026818|450405481|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
125212845|NCT01026818|450405478|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
125212846|NCT01026818|450405479|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
125212847|NCT01026818|450405480|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
124936758|NCT02720068|449398366|FG002|Overall Study|Withdrawal by Subject|0|||
124936759|NCT02720068|449398367|FG003|Overall Study|Withdrawal by Subject|0|||
124936760|NCT02720068|449398368|FG004|Overall Study|Withdrawal by Subject|0|||
124936761|NCT02720068|449398369|FG005|Overall Study|Withdrawal by Subject|0|||
124936762|NCT02720068|449398370|FG006|Overall Study|Withdrawal by Subject|0|||
124936763|NCT02720068|449398371|FG007|Overall Study|Withdrawal by Subject|0|||
124936764|NCT02720068|449398372|FG008|Overall Study|Withdrawal by Subject|0|||
124936765|NCT02720068|449398373|FG009|Overall Study|Withdrawal by Subject|1|||
124936766|NCT02720068|449398374|FG010|Overall Study|Withdrawal by Subject|0|||
124936767|NCT02720068|449398375|FG011|Overall Study|Withdrawal by Subject|27|||
124936768|NCT02720068|449398376|FG012|Overall Study|Withdrawal by Subject|2|||
124936769|NCT02720068|449398377|FG013|Overall Study|Withdrawal by Subject|8|||
124936770|NCT02720068|449398378|FG014|Overall Study|Withdrawal by Subject|7|||
124936771|NCT02720068|449398379|FG015|Overall Study|Withdrawal by Subject|0|||
124936772|NCT02720068|449398380|FG016|Overall Study|Withdrawal by Subject|0|||
124936773|NCT02720068|449398381|FG017|Overall Study|Withdrawal by Subject|2|||
124936774|NCT02720068|449398364|FG000|Overall Study|Protocol Violation|0|||
124936775|NCT02720068|449398365|FG001|Overall Study|Protocol Violation|0|||
124936776|NCT02720068|449398366|FG002|Overall Study|Protocol Violation|0|||
124936777|NCT02720068|449398367|FG003|Overall Study|Protocol Violation|0|||
124936778|NCT02720068|449398368|FG004|Overall Study|Protocol Violation|0|||
124936779|NCT02720068|449398369|FG005|Overall Study|Protocol Violation|0|||
124936780|NCT02720068|449398370|FG006|Overall Study|Protocol Violation|0|||
124936781|NCT02720068|449398371|FG007|Overall Study|Protocol Violation|0|||
124936782|NCT02720068|449398372|FG008|Overall Study|Protocol Violation|0|||
124936783|NCT02720068|449398373|FG009|Overall Study|Protocol Violation|0|||
124936784|NCT02720068|449398374|FG010|Overall Study|Protocol Violation|1|||
124936785|NCT02720068|449398375|FG011|Overall Study|Protocol Violation|0|||
124936786|NCT02720068|449398376|FG012|Overall Study|Protocol Violation|0|||
124936787|NCT02720068|449398377|FG013|Overall Study|Protocol Violation|0|||
124936788|NCT02720068|449398378|FG014|Overall Study|Protocol Violation|1|||
124936789|NCT02720068|449398379|FG015|Overall Study|Protocol Violation|0|||
124936790|NCT02720068|449398380|FG016|Overall Study|Protocol Violation|1|||
124936791|NCT02720068|449398381|FG017|Overall Study|Protocol Violation|0|||
124936792|NCT00495677|449398382|FG000|Stage 1 (25 Days)|Adverse Event|0|||
124936793|NCT00495677|449398383|FG001|Stage 1 (25 Days)|Adverse Event|0|||
124936794|NCT00495677|449398384|FG002|Stage 1 (25 Days)|Adverse Event|1|||
124936795|NCT00495677|449398385|FG003|Stage 1 (25 Days)|Adverse Event|0|||
124936796|NCT00495677|449398386|FG004|Stage 1 (25 Days)|Adverse Event|0|||
125026371|NCT02623335|449720475|FG001|Overall Study|Death|7|||
125026372|NCT02623335|449720474|FG000|Overall Study|Lost to Follow-up|15|||
125026373|NCT02623335|449720475|FG001|Overall Study|Lost to Follow-up|23|||
125026374|NCT02623335|449720474|FG000|Overall Study|Withdrawal by Subject|2|||
125026375|NCT02623335|449720475|FG001|Overall Study|Withdrawal by Subject|5|||
125026376|NCT02623335|449720474|FG000|Overall Study|Protocol Violation|2|||
125026377|NCT02623335|449720475|FG001|Overall Study|Protocol Violation|1|||
125026378|NCT03683394|449720476|FG000|Overall Study|Withdrawal by Subject|4|||
125026379|NCT03683394|449720477|FG001|Overall Study|Withdrawal by Subject|8|||
125026380|NCT03683394|449720476|FG000|Overall Study|Lost to Follow-up|7|||
125026381|NCT03683394|449720477|FG001|Overall Study|Lost to Follow-up|0|||
125026382|NCT03683394|449720476|FG000|Overall Study|Death|3|||
125026383|NCT03683394|449720477|FG001|Overall Study|Death|1|||
125026384|NCT03739528|449720478|FG000|Overall Study|Not treated|8|||
125026385|NCT03739528|449720479|FG001|Overall Study|Not treated|12|||
125026386|NCT03739528|449720478|FG000|Overall Study|Treatment and study discontinued|6|||
125026387|NCT03739528|449720479|FG001|Overall Study|Treatment and study discontinued|2|||
125026388|NCT03739528|449720478|FG000|Overall Study|Treatment discontinued + study completed|1|||
125026389|NCT03739528|449720479|FG001|Overall Study|Treatment discontinued + study completed|3|||
125026390|NCT02239263|449720480|FG000|Overall Study|Protocol Violation|6|||
125026391|NCT03072160|449720481|FG000|Overall Study|Adverse Event|3|||
125026392|NCT03072160|449720482|FG001|Overall Study|Adverse Event|1|||
125026393|NCT03072160|449720481|FG000|Overall Study|Refused further treatment|6|||
125026394|NCT03072160|449720482|FG001|Overall Study|Refused further treatment|1|||
125026395|NCT03072160|449720481|FG000|Overall Study|Physician Decision|1|||
125026396|NCT03072160|449720482|FG001|Overall Study|Physician Decision|0|||
125026397|NCT03072160|449720481|FG000|Overall Study|Disease progression on study|1|||
125026398|NCT03072160|449720482|FG001|Overall Study|Disease progression on study|1|||
125026399|NCT03072160|449720481|FG000|Overall Study|No contact|0|||
125026400|NCT03072160|449720482|FG001|Overall Study|No contact|1|||
125026401|NCT01058096|449720484|FG000|Double-blind Treatment Phase|Adverse Event|11|||
125026402|NCT01058096|449720485|FG001|Double-blind Treatment Phase|Adverse Event|15|||
125026403|NCT01058096|449720484|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
125026404|NCT01058096|449720485|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
125026405|NCT01058096|449720484|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
125026406|NCT01058096|449720485|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
124936797|NCT00495677|449398387|FG005|Stage 1 (25 Days)|Adverse Event|0|||
124936798|NCT00495677|449398388|FG006|Stage 1 (25 Days)|Adverse Event|0|||
124936799|NCT03786926|449398391|FG000|Overall Study|Adverse Event|0|||
124936800|NCT03786926|449398392|FG001|Overall Study|Adverse Event|0|||
124936801|NCT03786926|449398393|FG002|Overall Study|Adverse Event|0|||
124936802|NCT03786926|449398394|FG003|Overall Study|Adverse Event|0|||
124936803|NCT03786926|449398395|FG004|Overall Study|Adverse Event|0|||
124936804|NCT03786926|449398396|FG005|Overall Study|Adverse Event|0|||
124936805|NCT03786926|449398397|FG006|Overall Study|Adverse Event|0|||
124936806|NCT03786926|449398398|FG007|Overall Study|Adverse Event|1|||
124936807|NCT03786926|449398399|FG008|Overall Study|Adverse Event|1|||
124936808|NCT03786926|449398400|FG009|Overall Study|Adverse Event|0|||
124936809|NCT03786926|449398401|FG010|Overall Study|Adverse Event|1|||
124936810|NCT03786926|449398391|FG000|Overall Study|Progressive disease|3|||
124936811|NCT03786926|449398392|FG001|Overall Study|Progressive disease|0|||
124936812|NCT03786926|449398393|FG002|Overall Study|Progressive disease|3|||
124936813|NCT03786926|449398394|FG003|Overall Study|Progressive disease|1|||
124936814|NCT03786926|449398395|FG004|Overall Study|Progressive disease|2|||
124936815|NCT03786926|449398396|FG005|Overall Study|Progressive disease|2|||
124936816|NCT03786926|449398397|FG006|Overall Study|Progressive disease|1|||
124936817|NCT03786926|449398398|FG007|Overall Study|Progressive disease|6|||
124936818|NCT03786926|449398399|FG008|Overall Study|Progressive disease|1|||
124936819|NCT03786926|449398400|FG009|Overall Study|Progressive disease|1|||
124936820|NCT03786926|449398401|FG010|Overall Study|Progressive disease|1|||
125026407|NCT01058096|449720484|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
124936821|NCT03786926|449398391|FG000|Overall Study|Death|0|||
125026408|NCT01058096|449720485|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
125026409|NCT01058096|449720484|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
125026410|NCT01058096|449720485|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
125121013|NCT03384745|450067066|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
125121014|NCT03384745|450067067|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
125121015|NCT03384745|450067068|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
125121016|NCT03384745|450067063|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
125121017|NCT03384745|450067064|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
124936822|NCT03786926|449398392|FG001|Overall Study|Death|1|||
124936823|NCT03786926|449398393|FG002|Overall Study|Death|1|||
124936824|NCT03786926|449398394|FG003|Overall Study|Death|0|||
124936825|NCT03786926|449398395|FG004|Overall Study|Death|0|||
125026411|NCT01058096|449720484|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
125026412|NCT01058096|449720485|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
124936826|NCT03786926|449398396|FG005|Overall Study|Death|0|||
124936827|NCT03786926|449398397|FG006|Overall Study|Death|0|||
124936828|NCT03786926|449398398|FG007|Overall Study|Death|0|||
124936829|NCT03786926|449398399|FG008|Overall Study|Death|0|||
124936830|NCT03786926|449398400|FG009|Overall Study|Death|1|||
124936831|NCT03786926|449398401|FG010|Overall Study|Death|2|||
124936832|NCT03786926|449398391|FG000|Overall Study|Physician Decision|0|||
124936833|NCT03786926|449398392|FG001|Overall Study|Physician Decision|1|||
124936834|NCT03786926|449398393|FG002|Overall Study|Physician Decision|0|||
124936835|NCT03786926|449398394|FG003|Overall Study|Physician Decision|1|||
124936836|NCT03786926|449398395|FG004|Overall Study|Physician Decision|2|||
124936837|NCT03786926|449398396|FG005|Overall Study|Physician Decision|0|||
124936838|NCT03786926|449398397|FG006|Overall Study|Physician Decision|0|||
124936839|NCT03786926|449398398|FG007|Overall Study|Physician Decision|2|||
124936840|NCT03786926|449398399|FG008|Overall Study|Physician Decision|1|||
124936841|NCT03786926|449398400|FG009|Overall Study|Physician Decision|1|||
124936842|NCT03786926|449398401|FG010|Overall Study|Physician Decision|0|||
124936843|NCT03786926|449398391|FG000|Overall Study|Withdrawal by Subject|0|||
124936844|NCT03786926|449398392|FG001|Overall Study|Withdrawal by Subject|1|||
124936845|NCT03786926|449398393|FG002|Overall Study|Withdrawal by Subject|1|||
124936846|NCT03786926|449398394|FG003|Overall Study|Withdrawal by Subject|0|||
124936847|NCT03786926|449398395|FG004|Overall Study|Withdrawal by Subject|0|||
124936848|NCT03786926|449398396|FG005|Overall Study|Withdrawal by Subject|0|||
124936849|NCT03786926|449398397|FG006|Overall Study|Withdrawal by Subject|1|||
124936850|NCT03786926|449398398|FG007|Overall Study|Withdrawal by Subject|0|||
124936851|NCT03786926|449398399|FG008|Overall Study|Withdrawal by Subject|1|||
124936852|NCT03786926|449398400|FG009|Overall Study|Withdrawal by Subject|0|||
124936853|NCT03786926|449398401|FG010|Overall Study|Withdrawal by Subject|1|||
124936854|NCT03786926|449398391|FG000|Overall Study|Study terminated by Sponsor|0|||
124936855|NCT03786926|449398392|FG001|Overall Study|Study terminated by Sponsor|0|||
124936856|NCT03786926|449398393|FG002|Overall Study|Study terminated by Sponsor|0|||
124936857|NCT03786926|449398394|FG003|Overall Study|Study terminated by Sponsor|0|||
124936858|NCT03786926|449398395|FG004|Overall Study|Study terminated by Sponsor|1|||
124936859|NCT03786926|449398396|FG005|Overall Study|Study terminated by Sponsor|0|||
124936860|NCT03786926|449398397|FG006|Overall Study|Study terminated by Sponsor|0|||
124936861|NCT03786926|449398398|FG007|Overall Study|Study terminated by Sponsor|4|||
124936862|NCT03786926|449398399|FG008|Overall Study|Study terminated by Sponsor|0|||
124936863|NCT03786926|449398400|FG009|Overall Study|Study terminated by Sponsor|0|||
124936864|NCT03786926|449398401|FG010|Overall Study|Study terminated by Sponsor|0|||
124936865|NCT03786926|449398391|FG000|Overall Study|Anti-neoplasm treatment|0|||
124936866|NCT03786926|449398392|FG001|Overall Study|Anti-neoplasm treatment|0|||
124936867|NCT03786926|449398393|FG002|Overall Study|Anti-neoplasm treatment|0|||
124936868|NCT03786926|449398394|FG003|Overall Study|Anti-neoplasm treatment|0|||
124936869|NCT03786926|449398395|FG004|Overall Study|Anti-neoplasm treatment|1|||
124936870|NCT03786926|449398396|FG005|Overall Study|Anti-neoplasm treatment|0|||
124936871|NCT03786926|449398397|FG006|Overall Study|Anti-neoplasm treatment|1|||
124936872|NCT03786926|449398398|FG007|Overall Study|Anti-neoplasm treatment|0|||
124936873|NCT03786926|449398399|FG008|Overall Study|Anti-neoplasm treatment|0|||
124936874|NCT03786926|449398400|FG009|Overall Study|Anti-neoplasm treatment|0|||
124936875|NCT03786926|449398401|FG010|Overall Study|Anti-neoplasm treatment|0|||
124936876|NCT03786926|449398391|FG000|Overall Study|Other|0|||
124936877|NCT03786926|449398392|FG001|Overall Study|Other|0|||
124936878|NCT03786926|449398393|FG002|Overall Study|Other|0|||
124936879|NCT03786926|449398394|FG003|Overall Study|Other|1|||
124936880|NCT03786926|449398395|FG004|Overall Study|Other|0|||
124936881|NCT03786926|449398396|FG005|Overall Study|Other|1|||
124936882|NCT03786926|449398397|FG006|Overall Study|Other|0|||
124936883|NCT03786926|449398398|FG007|Overall Study|Other|0|||
124936884|NCT03786926|449398399|FG008|Overall Study|Other|2|||
125121018|NCT03384745|450067065|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
124936885|NCT03786926|449398400|FG009|Overall Study|Other|0|||
124936886|NCT03786926|449398401|FG010|Overall Study|Other|0|||
124936887|NCT05875701|449398405|FG000|Overall Study|Lost to Follow-up|2|||
124936888|NCT05875701|449398406|FG001|Overall Study|Lost to Follow-up|0|||
124936889|NCT05875701|449398405|FG000|Overall Study|Withdrawal by Subject|1|||
124936890|NCT05875701|449398406|FG001|Overall Study|Withdrawal by Subject|1|||
124936891|NCT04174560|449398408|FG000|Overall Study|Lost to Follow-up|1|||
124936892|NCT04174560|449398409|FG001|Overall Study|Lost to Follow-up|0|||
124936893|NCT04174560|449398410|FG002|Overall Study|Lost to Follow-up|0|||
124936894|NCT04174560|449398411|FG003|Overall Study|Lost to Follow-up|0|||
124936895|NCT04174560|449398408|FG000|Overall Study|Withdrawal by Subject|0|||
124936896|NCT04174560|449398409|FG001|Overall Study|Withdrawal by Subject|0|||
124936897|NCT04174560|449398410|FG002|Overall Study|Withdrawal by Subject|2|||
125121019|NCT03384745|450067066|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
125121020|NCT03384745|450067067|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
124936898|NCT04174560|449398411|FG003|Overall Study|Withdrawal by Subject|0|||
125026413|NCT04276207|449720486|FG000|Period 1|Withdrawal by Subject|0|||
125026414|NCT04276207|449720487|FG001|Period 1|Withdrawal by Subject|1|||
125026415|NCT01463098|449720488|FG000|Part A (11 Days)|Participant Choice|2|||
125026416|NCT01463098|449720489|FG001|Part A (11 Days)|Participant Choice|0|||
125026417|NCT01463098|449720490|FG002|Part A (11 Days)|Participant Choice|0|||
125026418|NCT01463098|449720491|FG003|Part A (11 Days)|Participant Choice|0|||
125026419|NCT01463098|449720492|FG004|Part A (11 Days)|Participant Choice|0|||
125026420|NCT01463098|449720493|FG005|Part A (11 Days)|Participant Choice|0|||
125026421|NCT01463098|449720494|FG006|Part A (11 Days)|Participant Choice|0|||
125026422|NCT01463098|449720495|FG007|Part A (11 Days)|Participant Choice|0|||
125026423|NCT01463098|449720496|FG008|Part A (11 Days)|Participant Choice|1|||
125026424|NCT01463098|449720497|FG009|Part A (11 Days)|Participant Choice|0|||
125026425|NCT01463098|449720498|FG010|Part A (11 Days)|Participant Choice|0|||
125026426|NCT01463098|449720499|FG011|Part A (11 Days)|Participant Choice|0|||
125026427|NCT01463098|449720500|FG012|Part A (11 Days)|Participant Choice|0|||
125026428|NCT01463098|449720501|FG013|Part A (11 Days)|Participant Choice|0|||
125026429|NCT01463098|449720488|FG000|Part A (11 Days)|Lost to Follow-up|0|||
125026430|NCT01463098|449720489|FG001|Part A (11 Days)|Lost to Follow-up|0|||
125026431|NCT01463098|449720490|FG002|Part A (11 Days)|Lost to Follow-up|0|||
125026432|NCT01463098|449720491|FG003|Part A (11 Days)|Lost to Follow-up|0|||
125026433|NCT01463098|449720492|FG004|Part A (11 Days)|Lost to Follow-up|1|||
125026434|NCT01463098|449720493|FG005|Part A (11 Days)|Lost to Follow-up|0|||
125026435|NCT01463098|449720494|FG006|Part A (11 Days)|Lost to Follow-up|0|||
125026436|NCT01463098|449720495|FG007|Part A (11 Days)|Lost to Follow-up|0|||
125026437|NCT01463098|449720496|FG008|Part A (11 Days)|Lost to Follow-up|0|||
125026438|NCT01463098|449720497|FG009|Part A (11 Days)|Lost to Follow-up|0|||
125026439|NCT01463098|449720498|FG010|Part A (11 Days)|Lost to Follow-up|0|||
125026440|NCT01463098|449720499|FG011|Part A (11 Days)|Lost to Follow-up|0|||
125026441|NCT01463098|449720500|FG012|Part A (11 Days)|Lost to Follow-up|0|||
125026442|NCT01463098|449720501|FG013|Part A (11 Days)|Lost to Follow-up|0|||
125026443|NCT01463098|449720488|FG000|Part B (11 Days)|Participant Choice|0|||
125026444|NCT01463098|449720489|FG001|Part B (11 Days)|Participant Choice|0|||
125026445|NCT01463098|449720490|FG002|Part B (11 Days)|Participant Choice|0|||
125026446|NCT01463098|449720491|FG003|Part B (11 Days)|Participant Choice|0|||
125026447|NCT01463098|449720492|FG004|Part B (11 Days)|Participant Choice|0|||
125026448|NCT01463098|449720493|FG005|Part B (11 Days)|Participant Choice|0|||
125026449|NCT01463098|449720494|FG006|Part B (11 Days)|Participant Choice|0|||
125026450|NCT01463098|449720495|FG007|Part B (11 Days)|Participant Choice|0|||
125026451|NCT01463098|449720496|FG008|Part B (11 Days)|Participant Choice|0|||
125026452|NCT01463098|449720497|FG009|Part B (11 Days)|Participant Choice|0|||
125026453|NCT01463098|449720498|FG010|Part B (11 Days)|Participant Choice|0|||
125026454|NCT01463098|449720499|FG011|Part B (11 Days)|Participant Choice|1|||
125026455|NCT01463098|449720500|FG012|Part B (11 Days)|Participant Choice|0|||
125026456|NCT01463098|449720501|FG013|Part B (11 Days)|Participant Choice|0|||
125026457|NCT04451330|449720506|FG000|Overall Study|Adverse Event|1|||
125026458|NCT04451330|449720507|FG001|Overall Study|Adverse Event|2|||
125026459|NCT04451330|449720506|FG000|Overall Study|Lost to Follow-up|5|||
125026460|NCT04451330|449720507|FG001|Overall Study|Lost to Follow-up|0|||
125026461|NCT04451330|449720506|FG000|Overall Study|Withdrawal by Subject|3|||
125026462|NCT04451330|449720507|FG001|Overall Study|Withdrawal by Subject|1|||
125026463|NCT04451330|449720506|FG000|Overall Study|Withdrawal by parent/guardian|1|||
125026464|NCT04451330|449720507|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125026465|NCT04451330|449720506|FG000|Overall Study|Other than specified|0|||
125026466|NCT04451330|449720507|FG001|Overall Study|Other than specified|1|||
125026467|NCT02769624|449720508|FG000|Overall Study|Lost to Follow-up|0|||
125026468|NCT02769624|449720509|FG001|Overall Study|Lost to Follow-up|1|||
125026469|NCT05099640|449720510|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
125026470|NCT05099640|449720511|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
125026471|NCT05099640|449720512|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
125026472|NCT05099640|449720510|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
125026473|NCT05099640|449720511|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
125026474|NCT05099640|449720512|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
125026475|NCT05099640|449720510|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
125026476|NCT05099640|449720511|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
125026477|NCT05099640|449720512|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
125026478|NCT05099640|449720510|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
125026479|NCT05099640|449720511|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
125026480|NCT05099640|449720512|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
125026481|NCT05099640|449720510|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
125026482|NCT05099640|449720511|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
125026483|NCT05099640|449720512|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
125026484|NCT05099640|449720510|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
125026485|NCT05099640|449720511|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
125026486|NCT05099640|449720512|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
125026487|NCT00179959|449720513|FG000|Overall Study|Lost to Follow-up|3|||
125026488|NCT00179959|449720514|FG001|Overall Study|Lost to Follow-up|1|||
125026489|NCT00179959|449720513|FG000|Overall Study|Withdrawal by Subject|3|||
125026490|NCT00179959|449720514|FG001|Overall Study|Withdrawal by Subject|2|||
125026491|NCT00448708|449720515|FG000|Overall Study|Death|21|||
125026492|NCT00448708|449720516|FG001|Overall Study|Death|17|||
125026493|NCT00448708|449720515|FG000|Overall Study|Withdrawal by Subject|8|||
125026494|NCT00448708|449720516|FG001|Overall Study|Withdrawal by Subject|4|||
125026495|NCT00448708|449720515|FG000|Overall Study|Lost to Follow-up|6|||
125026496|NCT00448708|449720516|FG001|Overall Study|Lost to Follow-up|8|||
125026497|NCT00448708|449720515|FG000|Overall Study|not listed|0|||
125026498|NCT00448708|449720516|FG001|Overall Study|not listed|2|||
125026499|NCT00236080|449720518|FG000|Overall Study|Adverse Event|0|||
125026500|NCT00236080|449720519|FG001|Overall Study|Adverse Event|0|||
125026501|NCT00236080|449720520|FG002|Overall Study|Adverse Event|3|||
125026502|NCT00236080|449720521|FG003|Overall Study|Adverse Event|1|||
125026503|NCT00236080|449720522|FG004|Overall Study|Adverse Event|0|||
125026504|NCT00236080|449720518|FG000|Overall Study|Lost to Follow-up|0|||
125026505|NCT00236080|449720519|FG001|Overall Study|Lost to Follow-up|1|||
125026506|NCT00236080|449720520|FG002|Overall Study|Lost to Follow-up|0|||
125026507|NCT00236080|449720521|FG003|Overall Study|Lost to Follow-up|0|||
125026508|NCT00236080|449720522|FG004|Overall Study|Lost to Follow-up|0|||
125026509|NCT00236080|449720518|FG000|Overall Study|Physician Decision|1|||
125026510|NCT00236080|449720519|FG001|Overall Study|Physician Decision|0|||
125026511|NCT00236080|449720520|FG002|Overall Study|Physician Decision|1|||
125026512|NCT00236080|449720521|FG003|Overall Study|Physician Decision|1|||
125026513|NCT00236080|449720522|FG004|Overall Study|Physician Decision|1|||
125026514|NCT00236080|449720518|FG000|Overall Study|Withdrawal by Subject|1|||
125026515|NCT00236080|449720519|FG001|Overall Study|Withdrawal by Subject|0|||
125026516|NCT00236080|449720520|FG002|Overall Study|Withdrawal by Subject|0|||
125026517|NCT00236080|449720521|FG003|Overall Study|Withdrawal by Subject|0|||
125026518|NCT00236080|449720522|FG004|Overall Study|Withdrawal by Subject|0|||
125026519|NCT00236080|449720518|FG000|Overall Study|Miscellaneous|0|||
125026520|NCT00236080|449720519|FG001|Overall Study|Miscellaneous|0|||
125026521|NCT00236080|449720520|FG002|Overall Study|Miscellaneous|1|||
125026522|NCT00236080|449720521|FG003|Overall Study|Miscellaneous|0|||
125026523|NCT00236080|449720522|FG004|Overall Study|Miscellaneous|0|||
125026524|NCT02400255|449720523|FG000|Overall Study|Relapse|4|||
125026525|NCT02400255|449720524|FG001|Overall Study|Relapse|1|||
125026526|NCT02400255|449720525|FG002|Overall Study|Relapse|1|||
125026527|NCT02400255|449720526|FG003|Overall Study|Relapse|2|||
125026528|NCT02400255|449720523|FG000|Overall Study|Adverse Event|6|||
125026529|NCT02400255|449720524|FG001|Overall Study|Adverse Event|3|||
125026530|NCT02400255|449720525|FG002|Overall Study|Adverse Event|0|||
125026531|NCT02400255|449720526|FG003|Overall Study|Adverse Event|0|||
125026532|NCT02400255|449720523|FG000|Overall Study|Physician Decision|6|||
124936899|NCT04046549|449398415|FG000|Overall Study|Adverse Event|1|||
124936900|NCT04046549|449398415|FG000|Overall Study|Physician Decision|1|||
124936901|NCT04046549|449398415|FG000|Overall Study|Withdrawal by Subject|3|||
124936902|NCT04046549|449398415|FG000|Overall Study|Other, Not Specified|5|||
124936903|NCT04012567|449398416|FG000|Overall Study|Lost to Follow-up|0|||
124936904|NCT04012567|449398417|FG001|Overall Study|Lost to Follow-up|1|||
124936905|NCT04012567|449398416|FG000|Overall Study|Withdrawal by Subject|1|||
124936906|NCT04012567|449398417|FG001|Overall Study|Withdrawal by Subject|0|||
124936907|NCT03705793|449399202|FG000|Overall Study|Lost to Follow-up|3|||
124936908|NCT03705793|449399203|FG001|Overall Study|Lost to Follow-up|4|||
124936909|NCT03705793|449399202|FG000|Overall Study|Withdrawal by Subject|2|||
124936910|NCT03705793|449399203|FG001|Overall Study|Withdrawal by Subject|1|||
124936911|NCT00113360|449399207|FG000|Overall Study|Adverse Event|3|||
124936912|NCT00113360|449399207|FG000|Overall Study|Subject required surgery|1|||
124936913|NCT00113360|449399207|FG000|Overall Study|Did not meet eligibility criteria|3|||
124936914|NCT02467270|449399210|FG000|Overall Study|Participants Never Treated|0|||
124936915|NCT02467270|449399211|FG001|Overall Study|Participants Never Treated|1|||
124936916|NCT02467270|449399212|FG002|Overall Study|Participants Never Treated|0|||
124936917|NCT02467270|449399210|FG000|Overall Study|Ongoing|50|||
124936918|NCT02467270|449399211|FG001|Overall Study|Ongoing|41|||
124936919|NCT02467270|449399212|FG002|Overall Study|Ongoing|43|||
124936920|NCT02467270|449399210|FG000|Overall Study|Adverse Event|16|||
124936921|NCT02467270|449399211|FG001|Overall Study|Adverse Event|15|||
124936922|NCT02467270|449399212|FG002|Overall Study|Adverse Event|14|||
124936923|NCT02467270|449399210|FG000|Overall Study|Progressive Disease|7|||
124936924|NCT02467270|449399211|FG001|Overall Study|Progressive Disease|7|||
124936925|NCT02467270|449399212|FG002|Overall Study|Progressive Disease|4|||
124936926|NCT02467270|449399210|FG000|Overall Study|Death|2|||
124936927|NCT02467270|449399211|FG001|Overall Study|Death|0|||
124936928|NCT02467270|449399212|FG002|Overall Study|Death|2|||
124936929|NCT02467270|449399210|FG000|Overall Study|Lack of Efficacy|12|||
124936930|NCT02467270|449399211|FG001|Overall Study|Lack of Efficacy|18|||
124936931|NCT02467270|449399212|FG002|Overall Study|Lack of Efficacy|23|||
124936932|NCT02467270|449399210|FG000|Overall Study|Non-compliance With Study Drug|0|||
124936933|NCT02467270|449399211|FG001|Overall Study|Non-compliance With Study Drug|2|||
124936934|NCT02467270|449399212|FG002|Overall Study|Non-compliance With Study Drug|1|||
124936935|NCT02467270|449399210|FG000|Overall Study|Lost to Follow-up|2|||
124936936|NCT02467270|449399211|FG001|Overall Study|Lost to Follow-up|1|||
124936937|NCT02467270|449399212|FG002|Overall Study|Lost to Follow-up|0|||
124936938|NCT02467270|449399210|FG000|Overall Study|Pregnancy|0|||
124936939|NCT02467270|449399211|FG001|Overall Study|Pregnancy|1|||
124936940|NCT02467270|449399212|FG002|Overall Study|Pregnancy|0|||
124936941|NCT02467270|449399210|FG000|Overall Study|Physician Decision|0|||
124936942|NCT02467270|449399211|FG001|Overall Study|Physician Decision|4|||
124936943|NCT02467270|449399212|FG002|Overall Study|Physician Decision|1|||
124936944|NCT02467270|449399210|FG000|Overall Study|Withdrawal by Subject|4|||
124936945|NCT02467270|449399211|FG001|Overall Study|Withdrawal by Subject|3|||
124936946|NCT02467270|449399212|FG002|Overall Study|Withdrawal by Subject|5|||
124936947|NCT02467270|449399210|FG000|Overall Study|Reason not Specified|1|||
124936948|NCT02467270|449399211|FG001|Overall Study|Reason not Specified|2|||
124936949|NCT02467270|449399212|FG002|Overall Study|Reason not Specified|1|||
125026533|NCT02400255|449720524|FG001|Overall Study|Physician Decision|0|||
125026534|NCT02400255|449720525|FG002|Overall Study|Physician Decision|0|||
125026535|NCT02400255|449720526|FG003|Overall Study|Physician Decision|0|||
125026536|NCT02400255|449720523|FG000|Overall Study|Loss of insurance|1|||
125026537|NCT02400255|449720524|FG001|Overall Study|Loss of insurance|0|||
125026538|NCT02400255|449720525|FG002|Overall Study|Loss of insurance|0|||
124936950|NCT04129164|449399219|FG000|Overall Study|Non-compliance with procedures|0|||
124936951|NCT04129164|449399220|FG001|Overall Study|Non-compliance with procedures|0|||
124936952|NCT04129164|449399221|FG002|Overall Study|Non-compliance with procedures|2|||
124936953|NCT04129164|449399222|FG003|Overall Study|Non-compliance with procedures|0|||
124936954|NCT04129164|449399219|FG000|Overall Study|Adverse Event|0|||
124936955|NCT04129164|449399220|FG001|Overall Study|Adverse Event|0|||
124936956|NCT04129164|449399221|FG002|Overall Study|Adverse Event|2|||
124936957|NCT04129164|449399222|FG003|Overall Study|Adverse Event|0|||
124936958|NCT04129164|449399219|FG000|Overall Study|Pregnancy|0|||
124936959|NCT04129164|449399220|FG001|Overall Study|Pregnancy|0|||
125026539|NCT02400255|449720526|FG003|Overall Study|Loss of insurance|0|||
125026540|NCT03604445|449720530|FG000|Overall Study|Death|0|||
125026541|NCT03604445|449720531|FG001|Overall Study|Death|0|||
125026542|NCT03604445|449720532|FG002|Overall Study|Death|0|||
125026543|NCT03604445|449720533|FG003|Overall Study|Death|0|||
125026544|NCT03604445|449720534|FG004|Overall Study|Death|0|||
125026545|NCT03604445|449720535|FG005|Overall Study|Death|0|||
125026546|NCT03604445|449720536|FG006|Overall Study|Death|0|||
125026547|NCT03604445|449720537|FG007|Overall Study|Death|0|||
125026548|NCT03604445|449720538|FG008|Overall Study|Death|1|||
125026549|NCT03604445|449720530|FG000|Overall Study|Withdrawal by Subject|0|||
125026550|NCT03604445|449720531|FG001|Overall Study|Withdrawal by Subject|0|||
125026551|NCT03604445|449720532|FG002|Overall Study|Withdrawal by Subject|0|||
125026552|NCT03604445|449720533|FG003|Overall Study|Withdrawal by Subject|0|||
125026553|NCT03604445|449720534|FG004|Overall Study|Withdrawal by Subject|0|||
125026554|NCT03604445|449720535|FG005|Overall Study|Withdrawal by Subject|0|||
125026555|NCT03604445|449720536|FG006|Overall Study|Withdrawal by Subject|1|||
125026556|NCT03604445|449720537|FG007|Overall Study|Withdrawal by Subject|0|||
125026557|NCT03604445|449720538|FG008|Overall Study|Withdrawal by Subject|0|||
125026558|NCT03604445|449720530|FG000|Overall Study|Missing visit|0|||
125026559|NCT03604445|449720531|FG001|Overall Study|Missing visit|0|||
125026560|NCT03604445|449720532|FG002|Overall Study|Missing visit|0|||
125026561|NCT03604445|449720533|FG003|Overall Study|Missing visit|0|||
125026562|NCT03604445|449720534|FG004|Overall Study|Missing visit|0|||
125026563|NCT03604445|449720535|FG005|Overall Study|Missing visit|1|||
125026564|NCT03604445|449720536|FG006|Overall Study|Missing visit|0|||
125026565|NCT03604445|449720537|FG007|Overall Study|Missing visit|1|||
125026566|NCT03604445|449720538|FG008|Overall Study|Missing visit|0|||
125026567|NCT03604445|449720530|FG000|Overall Study|Adverse Event|0|||
125026568|NCT03604445|449720531|FG001|Overall Study|Adverse Event|0|||
125026569|NCT03604445|449720532|FG002|Overall Study|Adverse Event|0|||
125026570|NCT03604445|449720533|FG003|Overall Study|Adverse Event|1|||
125026571|NCT03604445|449720534|FG004|Overall Study|Adverse Event|0|||
125026572|NCT03604445|449720535|FG005|Overall Study|Adverse Event|0|||
125026573|NCT03604445|449720536|FG006|Overall Study|Adverse Event|0|||
125026574|NCT03604445|449720537|FG007|Overall Study|Adverse Event|0|||
125026575|NCT03604445|449720538|FG008|Overall Study|Adverse Event|1|||
125026576|NCT00130286|449720541|FG000|Overall Study|Withdrawal by Subject|0|||
125026577|NCT00130286|449720542|FG001|Overall Study|Withdrawal by Subject|1|||
125026578|NCT00130286|449720543|FG002|Overall Study|Withdrawal by Subject|2|||
124936960|NCT04129164|449399221|FG002|Overall Study|Pregnancy|0|||
124936961|NCT04129164|449399222|FG003|Overall Study|Pregnancy|1|||
124936962|NCT04129164|449399219|FG000|Overall Study|Withdrawal by Subject|3|||
124936963|NCT04129164|449399220|FG001|Overall Study|Withdrawal by Subject|2|||
124936964|NCT04129164|449399221|FG002|Overall Study|Withdrawal by Subject|4|||
124936965|NCT04129164|449399222|FG003|Overall Study|Withdrawal by Subject|6|||
124936966|NCT04129164|449399219|FG000|Overall Study|Death|0|||
124936967|NCT04129164|449399220|FG001|Overall Study|Death|1|||
124936968|NCT04129164|449399221|FG002|Overall Study|Death|0|||
124936969|NCT04129164|449399222|FG003|Overall Study|Death|0|||
124936970|NCT04129164|449399219|FG000|Overall Study|Lost to Follow-up|0|||
124936971|NCT04129164|449399220|FG001|Overall Study|Lost to Follow-up|1|||
124936972|NCT04129164|449399221|FG002|Overall Study|Lost to Follow-up|0|||
124936973|NCT04129164|449399222|FG003|Overall Study|Lost to Follow-up|0|||
125026579|NCT00130286|449720544|FG003|Overall Study|Withdrawal by Subject|2|||
125026580|NCT00130286|449720541|FG000|Overall Study|Adverse Event|0|||
125026581|NCT00130286|449720542|FG001|Overall Study|Adverse Event|0|||
125026582|NCT00130286|449720543|FG002|Overall Study|Adverse Event|2|||
125026583|NCT00130286|449720544|FG003|Overall Study|Adverse Event|0|||
125026584|NCT00130286|449720541|FG000|Overall Study|Missing lab specimens|0|||
125026585|NCT00130286|449720542|FG001|Overall Study|Missing lab specimens|2|||
125026586|NCT00130286|449720543|FG002|Overall Study|Missing lab specimens|0|||
125026587|NCT00130286|449720544|FG003|Overall Study|Missing lab specimens|0|||
124936974|NCT03868930|449399223|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
124936975|NCT03868930|449399224|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
125026588|NCT00713219|449720556|FG000|Overall Study|Death|1|||
125026589|NCT00713219|449720556|FG000|Overall Study|Protocol Violation|1|||
125026590|NCT00880256|449720557|FG000|Overall Study|Lost to Follow-up|28|||
125026591|NCT03336502|449720558|FG000|Overall Study|Physician Decision|0|||
125026592|NCT03336502|449720559|FG001|Overall Study|Physician Decision|1|||
125026593|NCT03336502|449720558|FG000|Overall Study|Prohibited Drugs|1|||
125026594|NCT03336502|449720559|FG001|Overall Study|Prohibited Drugs|1|||
124936976|NCT03868930|449399223|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
125026595|NCT03336502|449720558|FG000|Overall Study|Death|1|||
125121021|NCT03384745|450067068|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
125121022|NCT03384745|450067063|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
124936977|NCT03868930|449399224|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
124936978|NCT03868930|449399223|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
124936979|NCT03868930|449399224|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
124936980|NCT03868930|449399223|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
124936981|NCT03868930|449399224|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
124936982|NCT03868930|449399223|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
124936983|NCT03868930|449399224|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
124936984|NCT03286114|449399227|FG000|Overall Study|Adverse Event|6|||
124936985|NCT03286114|449399227|FG000|Overall Study|Death|3|||
124936986|NCT01773993|449399229|FG000|Overall Study|No Visit After Treatment|35|||
124936987|NCT04664881|449399230|FG000|Overall Study|Withdrawal by Subject|1|||
124936988|NCT04664881|449399231|FG001|Overall Study|Withdrawal by Subject|8|||
124936989|NCT04664881|449399230|FG000|Overall Study|Physician Decision|0|||
124936990|NCT04664881|449399231|FG001|Overall Study|Physician Decision|5|||
124936991|NCT04664881|449399230|FG000|Overall Study|Lost to Follow-up|1|||
124936992|NCT04664881|449399231|FG001|Overall Study|Lost to Follow-up|0|||
124936993|NCT02231749|449399232|FG000|Overall Study|Disease progression|229|||
124936994|NCT02231749|449399233|FG001|Overall Study|Disease progression|297|||
124936995|NCT02231749|449399232|FG000|Overall Study|Study Drug Toxicity|134|||
124936996|NCT02231749|449399233|FG001|Overall Study|Study Drug Toxicity|63|||
124936997|NCT02231749|449399232|FG000|Overall Study|Death|1|||
124936998|NCT02231749|449399233|FG001|Overall Study|Death|1|||
124936999|NCT02231749|449399232|FG000|Overall Study|AE unrelated to Study drug|32|||
124937000|NCT02231749|449399233|FG001|Overall Study|AE unrelated to Study drug|31|||
124937001|NCT02231749|449399232|FG000|Overall Study|Participant's request to discontinue|10|||
124937002|NCT02231749|449399233|FG001|Overall Study|Participant's request to discontinue|21|||
124937003|NCT02231749|449399232|FG000|Overall Study|Participant withdrew Consent|8|||
124937004|NCT02231749|449399233|FG001|Overall Study|Participant withdrew Consent|15|||
124937005|NCT02231749|449399232|FG000|Overall Study|Lost to Follow-up|1|||
124937006|NCT02231749|449399233|FG001|Overall Study|Lost to Follow-up|2|||
124937007|NCT02231749|449399232|FG000|Overall Study|Maximum Clinical Benefit|5|||
124937008|NCT02231749|449399233|FG001|Overall Study|Maximum Clinical Benefit|8|||
124937009|NCT02231749|449399232|FG000|Overall Study|Poor/Non-Compliance|0|||
124937010|NCT02231749|449399233|FG001|Overall Study|Poor/Non-Compliance|3|||
124937011|NCT02231749|449399232|FG000|Overall Study|Pregnancy|1|||
124937012|NCT02231749|449399233|FG001|Overall Study|Pregnancy|0|||
124937013|NCT02231749|449399232|FG000|Overall Study|other|0|||
124937014|NCT02231749|449399233|FG001|Overall Study|other|8|||
124937015|NCT02231749|449399232|FG000|Overall Study|No longer meets Study Criteria|1|||
124937016|NCT02231749|449399233|FG001|Overall Study|No longer meets Study Criteria|0|||
124937017|NCT02656706|449399242|FG000|Overall Study|Insurance Denial|1|||
124937018|NCT03725332|449399243|FG000|Overall Study|Adverse Event|5|||
124937019|NCT03725332|449399244|FG001|Overall Study|Adverse Event|10|||
124937020|NCT03725332|449399243|FG000|Overall Study|Death|1|||
124937021|NCT03725332|449399244|FG001|Overall Study|Death|3|||
124937022|NCT03725332|449399243|FG000|Overall Study|Lost to Follow-up|43|||
124937023|NCT03725332|449399244|FG001|Overall Study|Lost to Follow-up|122|||
124937024|NCT03725332|449399243|FG000|Overall Study|Withdrawal by Subject|0|||
124937025|NCT03725332|449399244|FG001|Overall Study|Withdrawal by Subject|1|||
124937026|NCT03725332|449399243|FG000|Overall Study|Duplicate enrollment|0|||
124937027|NCT03725332|449399244|FG001|Overall Study|Duplicate enrollment|1|||
124937028|NCT03725332|449399243|FG000|Overall Study|Did not consent|0|||
124937029|NCT03725332|449399244|FG001|Overall Study|Did not consent|1|||
124937030|NCT05707351|449399247|FG000|Overall Study|Withdrawal by Subject|2|||
124937031|NCT05707351|449399247|FG000|Overall Study|Reason Not Specified|1|||
124937032|NCT02951052|449399251|FG000|Overall Study|Adverse Event|13|||
124937033|NCT02951052|449399252|FG001|Overall Study|Adverse Event|5|||
124937034|NCT02951052|449399251|FG000|Overall Study|Withdrawal by Subject|1|||
124937035|NCT02951052|449399252|FG001|Overall Study|Withdrawal by Subject|5|||
125121023|NCT03384745|450067064|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
124937036|NCT02951052|449399251|FG000|Overall Study|Physician Decision|2|||
124937037|NCT02951052|449399252|FG001|Overall Study|Physician Decision|0|||
124937038|NCT02951052|449399251|FG000|Overall Study|Lost to Follow-up|1|||
124937039|NCT02951052|449399252|FG001|Overall Study|Lost to Follow-up|1|||
124937040|NCT02951052|449399251|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
124937041|NCT02951052|449399252|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
124937042|NCT02951052|449399251|FG000|Overall Study|Protocol Violation|5|||
125121024|NCT03384745|450067065|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
124937043|NCT02951052|449399252|FG001|Overall Study|Protocol Violation|3|||
124937044|NCT02951052|449399251|FG000|Overall Study|Lack of Efficacy|3|||
124937045|NCT02951052|449399252|FG001|Overall Study|Lack of Efficacy|4|||
124937046|NCT02951052|449399251|FG000|Overall Study|Ongoing|1|||
124937047|NCT02951052|449399252|FG001|Overall Study|Ongoing|0|||
124937048|NCT03891758|449399259|FG000|Overall Study|Adverse Event|2|||
124937049|NCT03891758|449399260|FG001|Overall Study|Adverse Event|0|||
124937050|NCT03891758|449399259|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124937051|NCT03891758|449399260|FG001|Overall Study|Withdrawal by parent/guardian|2|||
124937052|NCT05795153|449399974|FG000|Overall Study|Adverse Event|2|||
124937053|NCT05795153|449399974|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124937054|NCT05795153|449399974|FG000|Overall Study|Lost to Follow-up|1|||
124937055|NCT05795153|449399974|FG000|Overall Study|Subject decision|2|||
124937056|NCT04644029|449399977|FG000|Overall Study|Death|1|||
124937057|NCT04644029|449399978|FG001|Overall Study|Death|0|||
124937058|NCT04644029|449399977|FG000|Overall Study|Physician Decision|1|||
124937059|NCT04644029|449399978|FG001|Overall Study|Physician Decision|2|||
124937060|NCT04644029|449399977|FG000|Overall Study|Withdrawal by Subject|21|||
124937061|NCT04644029|449399978|FG001|Overall Study|Withdrawal by Subject|19|||
124937062|NCT04644029|449399977|FG000|Overall Study|Lost to Follow-up|31|||
124937063|NCT04644029|449399978|FG001|Overall Study|Lost to Follow-up|34|||
124937064|NCT04644029|449399977|FG000|Overall Study|Study Terminated by Sponsor|308|||
124937065|NCT04644029|449399978|FG001|Overall Study|Study Terminated by Sponsor|309|||
124937066|NCT04644029|449399977|FG000|Overall Study|Randomized in Error|2|||
124937067|NCT04644029|449399978|FG001|Overall Study|Randomized in Error|1|||
124937068|NCT04644029|449399977|FG000|Overall Study|Other|0|||
124937069|NCT04644029|449399978|FG001|Overall Study|Other|1|||
124937070|NCT00739908|449399979|FG000|Overall Study|Adverse Event|5|||
124937071|NCT00739908|449399980|FG001|Overall Study|Adverse Event|6|||
124937072|NCT00739908|449399979|FG000|Overall Study|Withdrawal by Subject|4|||
124937073|NCT00739908|449399980|FG001|Overall Study|Withdrawal by Subject|2|||
124937074|NCT00739908|449399979|FG000|Overall Study|Lost to Follow-up|14|||
124937075|NCT00739908|449399980|FG001|Overall Study|Lost to Follow-up|9|||
124937076|NCT00739908|449399979|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
124937077|NCT00739908|449399980|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
124937078|NCT00739908|449399979|FG000|Overall Study|Non-Compliance With Study Medication|0|||
124937079|NCT00739908|449399980|FG001|Overall Study|Non-Compliance With Study Medication|3|||
124937080|NCT00739908|449399979|FG000|Overall Study|Lack of Efficacy|0|||
124937081|NCT00739908|449399980|FG001|Overall Study|Lack of Efficacy|1|||
124937082|NCT00739908|449399979|FG000|Overall Study|Relocation|0|||
124937083|NCT00739908|449399980|FG001|Overall Study|Relocation|1|||
124937084|NCT03875313|449399981|FG000|Overall Study|Withdrawal by Subject|1|||
124937085|NCT03875313|449399982|FG001|Overall Study|Withdrawal by Subject|3|||
124937086|NCT03875313|449399983|FG002|Overall Study|Withdrawal by Subject|0|||
124937087|NCT03875313|449399984|FG003|Overall Study|Withdrawal by Subject|0|||
124937088|NCT03875313|449399985|FG004|Overall Study|Withdrawal by Subject|0|||
124937089|NCT03875313|449399981|FG000|Overall Study|Death|0|||
124937090|NCT03875313|449399982|FG001|Overall Study|Death|0|||
124937091|NCT03875313|449399983|FG002|Overall Study|Death|0|||
124937092|NCT03875313|449399984|FG003|Overall Study|Death|0|||
124937093|NCT03875313|449399985|FG004|Overall Study|Death|1|||
124937094|NCT03875313|449399981|FG000|Overall Study|Lost to Follow-up|0|||
124937095|NCT03875313|449399982|FG001|Overall Study|Lost to Follow-up|0|||
124937096|NCT03875313|449399983|FG002|Overall Study|Lost to Follow-up|0|||
124937097|NCT03875313|449399984|FG003|Overall Study|Lost to Follow-up|0|||
124937098|NCT03875313|449399985|FG004|Overall Study|Lost to Follow-up|1|||
124937099|NCT03875313|449399981|FG000|Overall Study|Study Termination by Sponsor|0|||
125212848|NCT01026818|450405481|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
125212849|NCT03300050|450405491|FG000|Overall Study|Lost to Follow-up|2|||
124937100|NCT03875313|449399982|FG001|Overall Study|Study Termination by Sponsor|1|||
124937101|NCT03875313|449399983|FG002|Overall Study|Study Termination by Sponsor|1|||
124937102|NCT03875313|449399984|FG003|Overall Study|Study Termination by Sponsor|0|||
124937103|NCT03875313|449399985|FG004|Overall Study|Study Termination by Sponsor|1|||
124937104|NCT03875313|449399981|FG000|Overall Study|New Anticancer Treatment|0|||
124937105|NCT03875313|449399982|FG001|Overall Study|New Anticancer Treatment|1|||
124937106|NCT03875313|449399983|FG002|Overall Study|New Anticancer Treatment|2|||
125026596|NCT03336502|449720559|FG001|Overall Study|Death|2|||
124937107|NCT03875313|449399984|FG003|Overall Study|New Anticancer Treatment|1|||
124937108|NCT03875313|449399985|FG004|Overall Study|New Anticancer Treatment|0|||
124937109|NCT03875313|449399981|FG000|Overall Study|Other, Not Specified|2|||
124937110|NCT03875313|449399982|FG001|Overall Study|Other, Not Specified|11|||
124937111|NCT03875313|449399983|FG002|Overall Study|Other, Not Specified|3|||
124937112|NCT03875313|449399984|FG003|Overall Study|Other, Not Specified|3|||
124937113|NCT03875313|449399985|FG004|Overall Study|Other, Not Specified|1|||
124937114|NCT04121546|449399986|FG000|Overall Study|Lost to Follow-up|1|||
124937115|NCT04121546|449399987|FG001|Overall Study|Lost to Follow-up|3|||
124937116|NCT01046825|449399990|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
124937117|NCT01046825|449399991|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
124937118|NCT01046825|449399992|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
124937119|NCT01046825|449399993|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
124937120|NCT01046825|449399994|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
124937121|NCT01046825|449399990|FG000|Overall Study|Physician Decision|0|||
124937122|NCT01046825|449399991|FG001|Overall Study|Physician Decision|1|||
124937123|NCT01046825|449399992|FG002|Overall Study|Physician Decision|2|||
124937124|NCT01046825|449399993|FG003|Overall Study|Physician Decision|0|||
124937125|NCT01046825|449399994|FG004|Overall Study|Physician Decision|0|||
124937126|NCT01046825|449399990|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
124937127|NCT01046825|449399991|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
124937128|NCT01046825|449399992|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
124937129|NCT01046825|449399993|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
124937130|NCT01046825|449399994|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
124937131|NCT01046825|449399990|FG000|Overall Study|Found to be ineligible|0|||
124937132|NCT01046825|449399991|FG001|Overall Study|Found to be ineligible|1|||
124937133|NCT01046825|449399992|FG002|Overall Study|Found to be ineligible|0|||
124937134|NCT01046825|449399993|FG003|Overall Study|Found to be ineligible|0|||
124937135|NCT01046825|449399994|FG004|Overall Study|Found to be ineligible|0|||
124937136|NCT01046825|449399990|FG000|Overall Study|Death|0|||
124937137|NCT01046825|449399991|FG001|Overall Study|Death|0|||
124937138|NCT01046825|449399992|FG002|Overall Study|Death|0|||
124937139|NCT01046825|449399993|FG003|Overall Study|Death|1|||
124937140|NCT01046825|449399994|FG004|Overall Study|Death|0|||
124937141|NCT01046825|449399990|FG000|Overall Study|Did not submit biology samples|0|||
124937142|NCT01046825|449399991|FG001|Overall Study|Did not submit biology samples|0|||
124937143|NCT01046825|449399992|FG002|Overall Study|Did not submit biology samples|0|||
124937144|NCT01046825|449399993|FG003|Overall Study|Did not submit biology samples|0|||
124937145|NCT01046825|449399994|FG004|Overall Study|Did not submit biology samples|13|||
124937146|NCT02075554|449399996|FG000|Overall Study|Lost to Follow-up|7|||
124937147|NCT02075554|449399996|FG000|Overall Study|Withdrawal by Subject|5|||
124937148|NCT02075554|449399996|FG000|Overall Study|Physician Decision|3|||
124937149|NCT04993677|449400003|FG000|Overall Study|Lost to Follow-up|1|||
124937150|NCT04993677|449400004|FG001|Overall Study|Lost to Follow-up|0|||
124937151|NCT04993677|449400005|FG002|Overall Study|Lost to Follow-up|0|||
124937152|NCT04993677|449400006|FG003|Overall Study|Lost to Follow-up|0|||
124937153|NCT04993677|449400003|FG000|Overall Study|Death|11|||
124937154|NCT04993677|449400004|FG001|Overall Study|Death|8|||
124937155|NCT04993677|449400005|FG002|Overall Study|Death|3|||
124937156|NCT04993677|449400006|FG003|Overall Study|Death|1|||
124937157|NCT04993677|449400003|FG000|Overall Study|Subject withdrawal of consent|4|||
124937158|NCT04993677|449400004|FG001|Overall Study|Subject withdrawal of consent|3|||
124937159|NCT04993677|449400005|FG002|Overall Study|Subject withdrawal of consent|0|||
124937160|NCT04993677|449400006|FG003|Overall Study|Subject withdrawal of consent|2|||
124937161|NCT04993677|449400003|FG000|Overall Study|Study termination by sponsor|3|||
124937162|NCT04993677|449400004|FG001|Overall Study|Study termination by sponsor|25|||
124937163|NCT04993677|449400005|FG002|Overall Study|Study termination by sponsor|3|||
124937164|NCT04993677|449400006|FG003|Overall Study|Study termination by sponsor|3|||
124937165|NCT04993677|449400003|FG000|Overall Study|Other|2|||
124937166|NCT04993677|449400004|FG001|Overall Study|Other|3|||
125121025|NCT03384745|450067066|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
125121026|NCT03384745|450067067|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
125121027|NCT03384745|450067068|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
125121028|NCT03384745|450067063|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
124937167|NCT04993677|449400005|FG002|Overall Study|Other|3|||
124937168|NCT04993677|449400006|FG003|Overall Study|Other|2|||
124937169|NCT00003222|449400013|FG000|Overall Study|Physician Decision|0|||
124937170|NCT00003222|449400014|FG001|Overall Study|Physician Decision|1|||
124937171|NCT03248492|449400015|FG000|Overall Study|Progressive Disease|24|||
124937172|NCT03248492|449400016|FG001|Overall Study|Progressive Disease|23|||
124937173|NCT03248492|449400017|FG002|Overall Study|Progressive Disease|11|||
124937174|NCT03248492|449400018|FG003|Overall Study|Progressive Disease|66|||
124937175|NCT03248492|449400019|FG004|Overall Study|Progressive Disease|1|||
124937176|NCT03248492|449400015|FG000|Overall Study|Adverse Event|14|||
124937177|NCT03248492|449400016|FG001|Overall Study|Adverse Event|13|||
125121029|NCT03384745|450067064|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
124937178|NCT03248492|449400017|FG002|Overall Study|Adverse Event|9|||
124937179|NCT03248492|449400018|FG003|Overall Study|Adverse Event|22|||
124937180|NCT03248492|449400019|FG004|Overall Study|Adverse Event|2|||
124937181|NCT03248492|449400015|FG000|Overall Study|Withdrawal by Subject|5|||
124937182|NCT03248492|449400016|FG001|Overall Study|Withdrawal by Subject|4|||
124937183|NCT03248492|449400017|FG002|Overall Study|Withdrawal by Subject|0|||
124937184|NCT03248492|449400018|FG003|Overall Study|Withdrawal by Subject|8|||
124937185|NCT03248492|449400019|FG004|Overall Study|Withdrawal by Subject|1|||
124937186|NCT03248492|449400015|FG000|Overall Study|Physician Decision|1|||
124937187|NCT03248492|449400016|FG001|Overall Study|Physician Decision|1|||
124937188|NCT03248492|449400017|FG002|Overall Study|Physician Decision|1|||
124937189|NCT03248492|449400018|FG003|Overall Study|Physician Decision|7|||
124937190|NCT03248492|449400019|FG004|Overall Study|Physician Decision|0|||
124937191|NCT03248492|449400015|FG000|Overall Study|Death|1|||
124937192|NCT03248492|449400016|FG001|Overall Study|Death|1|||
124937193|NCT03248492|449400017|FG002|Overall Study|Death|0|||
124937194|NCT03248492|449400018|FG003|Overall Study|Death|6|||
124937195|NCT03248492|449400019|FG004|Overall Study|Death|0|||
124937196|NCT03248492|449400015|FG000|Overall Study|Study Terminated by Sponsor|3|||
124937197|NCT03248492|449400016|FG001|Overall Study|Study Terminated by Sponsor|1|||
124937198|NCT03248492|449400017|FG002|Overall Study|Study Terminated by Sponsor|0|||
124937199|NCT03248492|449400018|FG003|Overall Study|Study Terminated by Sponsor|7|||
124937200|NCT03248492|449400019|FG004|Overall Study|Study Terminated by Sponsor|0|||
124937201|NCT03248492|449400015|FG000|Overall Study|Other|2|||
124937202|NCT03248492|449400016|FG001|Overall Study|Other|5|||
124937203|NCT03248492|449400017|FG002|Overall Study|Other|0|||
124937204|NCT03248492|449400018|FG003|Overall Study|Other|14|||
124937205|NCT03248492|449400019|FG004|Overall Study|Other|0|||
124937206|NCT03767335|449400021|FG000|Overall Study|Physician Decision|1|||
124937207|NCT03767335|449400022|FG001|Overall Study|Physician Decision|1|||
124937208|NCT03767335|449400023|FG002|Overall Study|Physician Decision|0|||
124937209|NCT03767335|449400021|FG000|Overall Study|Withdrawal by Subject|0|||
124937210|NCT03767335|449400022|FG001|Overall Study|Withdrawal by Subject|0|||
124937211|NCT03767335|449400023|FG002|Overall Study|Withdrawal by Subject|6|||
124937212|NCT03767335|449400021|FG000|Overall Study|Participant excluded from efficacy population|0|||
124937213|NCT03767335|449400022|FG001|Overall Study|Participant excluded from efficacy population|0|||
124937214|NCT03767335|449400023|FG002|Overall Study|Participant excluded from efficacy population|1|||
124937215|NCT03767335|449400021|FG000|Overall Study|Death|0|||
124937216|NCT03767335|449400022|FG001|Overall Study|Death|0|||
124937217|NCT03767335|449400023|FG002|Overall Study|Death|2|||
124937218|NCT03767335|449400021|FG000|Overall Study|Progressive Disease|2|||
124937219|NCT03767335|449400022|FG001|Overall Study|Progressive Disease|2|||
124937220|NCT03767335|449400023|FG002|Overall Study|Progressive Disease|2|||
124937221|NCT03767335|449400021|FG000|Overall Study|Disease progression needing additional medication|0|||
124937222|NCT03767335|449400022|FG001|Overall Study|Disease progression needing additional medication|0|||
124937223|NCT03767335|449400023|FG002|Overall Study|Disease progression needing additional medication|17|||
124937224|NCT03767335|449400021|FG000|Overall Study|Sponsor decision|0|||
124937225|NCT03767335|449400022|FG001|Overall Study|Sponsor decision|0|||
124937226|NCT03767335|449400023|FG002|Overall Study|Sponsor decision|2|||
124937227|NCT03767335|449400021|FG000|Overall Study|Other Medical Reasons|0|||
124937228|NCT03767335|449400022|FG001|Overall Study|Other Medical Reasons|0|||
124937229|NCT03767335|449400023|FG002|Overall Study|Other Medical Reasons|3|||
124937230|NCT03705390|449400024|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
124937231|NCT03705390|449400024|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
124937232|NCT04495621|449400026|FG000|Overall Study|Withdrawal by Subject|0|||
124937233|NCT04495621|449400027|FG001|Overall Study|Withdrawal by Subject|3|||
124937234|NCT04495621|449400026|FG000|Overall Study|Death|7|||
124937235|NCT04495621|449400027|FG001|Overall Study|Death|11|||
124937236|NCT04495621|449400026|FG000|Overall Study|Investigator Decision|0|||
124937237|NCT04495621|449400027|FG001|Overall Study|Investigator Decision|7|||
124937238|NCT04495621|449400026|FG000|Overall Study|Lost to Follow-up|0|||
124937239|NCT04495621|449400027|FG001|Overall Study|Lost to Follow-up|1|||
124937240|NCT04757753|449400033|FG000|Overall Study|Lost to Follow-up|7|||
124937241|NCT04757753|449400034|FG001|Overall Study|Lost to Follow-up|7|||
125026597|NCT03336502|449720558|FG000|Overall Study|Adverse Event|2|||
125026598|NCT03336502|449720559|FG001|Overall Study|Adverse Event|5|||
125026599|NCT00480857|449720560|FG000|Overall Study|Lack of Efficacy|2|||
125026600|NCT01890421|449720561|FG000|Overall Study|Adverse Event|1|||
124937242|NCT04757753|449400033|FG000|Overall Study|Withdrawal by Subject|0|||
124937243|NCT04757753|449400034|FG001|Overall Study|Withdrawal by Subject|3|||
124937244|NCT04757753|449400033|FG000|Overall Study|Endodontic treatment failure|1|||
124937245|NCT04757753|449400034|FG001|Overall Study|Endodontic treatment failure|2|||
124937246|NCT04757753|449400033|FG000|Overall Study|Tooth fracture/extraction|3|||
124937247|NCT04757753|449400034|FG001|Overall Study|Tooth fracture/extraction|0|||
124937248|NCT01313559|449400035|FG000|Overall Study|Withdrawal by Subject|1|||
124937249|NCT01313559|449400036|FG001|Overall Study|Withdrawal by Subject|2|||
124937250|NCT01313559|449400035|FG000|Overall Study|Disease progression|1|||
124937251|NCT01313559|449400036|FG001|Overall Study|Disease progression|0|||
124937252|NCT01313559|449400035|FG000|Overall Study|Rising PSA|2|||
124937253|NCT01313559|449400036|FG001|Overall Study|Rising PSA|0|||
124937254|NCT03201939|449400043|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
124937255|NCT03201939|449400044|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
124937256|NCT04908514|449400049|FG000|Overall Study|Lost to Follow-up|2|||
124937257|NCT04908514|449400049|FG000|Overall Study|Withdrawal by Subject|1|||
124937258|NCT05180539|449400568|FG000|Overall Study|Lost to Follow-up|27|||
124937259|NCT05180539|449400569|FG001|Overall Study|Lost to Follow-up|30|||
124937260|NCT02566889|449400572|FG000|Overall Study|Withdrawal by Subject|3|||
124937261|NCT02566889|449400573|FG001|Overall Study|Withdrawal by Subject|1|||
124937262|NCT02566889|449400572|FG000|Overall Study|Adverse Event|4|||
124937263|NCT02566889|449400573|FG001|Overall Study|Adverse Event|2|||
124937264|NCT02566889|449400572|FG000|Overall Study|Other|6|||
124937265|NCT02566889|449400573|FG001|Overall Study|Other|2|||
124937266|NCT04518943|449400574|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
124937267|NCT04518943|449400575|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
124937268|NCT04518943|449400576|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
124937269|NCT04518943|449400577|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
124937270|NCT04518943|449400578|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
124937271|NCT04518943|449400579|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
124937272|NCT04518943|449400580|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
124937273|NCT04518943|449400581|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
124937274|NCT04518943|449400582|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
124937275|NCT04518943|449400583|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
124937276|NCT04518943|449400584|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
124937277|NCT04518943|449400585|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
124937278|NCT04518943|449400586|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
124937279|NCT04518943|449400587|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
124937280|NCT04518943|449400588|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
124937281|NCT04518943|449400589|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
124937282|NCT03699163|449400590|FG000|Overall Study|Physician Decision|12|||
124937283|NCT03699163|449400591|FG001|Overall Study|Physician Decision|0|||
124937284|NCT03699163|449400590|FG000|Overall Study|failed QC measures|205|||
124937285|NCT03699163|449400591|FG001|Overall Study|failed QC measures|206|||
124937286|NCT02701283|449400609|FG000|Overall Study|Death|25|||
124937287|NCT02701283|449400610|FG001|Overall Study|Death|29|||
124937288|NCT02701283|449400611|FG002|Overall Study|Death|19|||
124937289|NCT02701283|449400609|FG000|Overall Study|Lost to Follow-up|3|||
124937290|NCT02701283|449400610|FG001|Overall Study|Lost to Follow-up|8|||
124937291|NCT02701283|449400611|FG002|Overall Study|Lost to Follow-up|1|||
124937292|NCT02701283|449400609|FG000|Overall Study|Withdrawal by Subject|12|||
124937293|NCT02701283|449400610|FG001|Overall Study|Withdrawal by Subject|41|||
124937294|NCT02701283|449400611|FG002|Overall Study|Withdrawal by Subject|1|||
124937295|NCT02701283|449400609|FG000|Overall Study|Missed 2-year visit|22|||
124937296|NCT02701283|449400610|FG001|Overall Study|Missed 2-year visit|27|||
124937297|NCT02701283|449400611|FG002|Overall Study|Missed 2-year visit|0|||
124937298|NCT02701283|449400609|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
124937299|NCT02701283|449400610|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
124937300|NCT02701283|449400611|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
124937301|NCT01830595|449400615|FG000|First Period|Withdrawal by Subject|1|||
124937302|NCT01830595|449400616|FG001|First Period|Withdrawal by Subject|3|||
124937303|NCT01830595|449400615|FG000|Washout|Withdrawal by Subject|2|||
124937304|NCT01830595|449400616|FG001|Washout|Withdrawal by Subject|2|||
124937305|NCT04940624|449400617|FG000|Overall Study|Adverse Event|4|||
124937306|NCT04940624|449400618|FG001|Overall Study|Adverse Event|11|||
124937307|NCT04940624|449400617|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
124937308|NCT04940624|449400618|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
124937309|NCT04940624|449400617|FG000|Overall Study|Physician Decision|1|||
124937310|NCT04940624|449400618|FG001|Overall Study|Physician Decision|0|||
124937311|NCT04940624|449400617|FG000|Overall Study|Lost to Follow-up|1|||
124937312|NCT04940624|449400618|FG001|Overall Study|Lost to Follow-up|0|||
124937313|NCT04940624|449400617|FG000|Overall Study|Reason Not Specified|1|||
124937314|NCT04940624|449400618|FG001|Overall Study|Reason Not Specified|0|||
124937315|NCT04479787|449400625|FG000|Through 6 Months|Withdrawal by Subject|16|||
125026601|NCT01890421|449720561|FG000|Overall Study|Other reason|10|||
124937316|NCT04479787|449400626|FG001|Through 6 Months|Withdrawal by Subject|14|||
124937317|NCT04479787|449400625|FG000|Through 6 Months|Unsuccessful Trial|17|||
124937318|NCT04479787|449400626|FG001|Through 6 Months|Unsuccessful Trial|0|||
124937319|NCT04479787|449400625|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
124937320|NCT04479787|449400626|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
124937321|NCT04479787|449400625|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
124937322|NCT04479787|449400626|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
125026602|NCT01465659|449720562|FG000|Completed 1 Cycle of Treatment|Death|0|||
125026603|NCT01465659|449720563|FG001|Completed 1 Cycle of Treatment|Death|1|||
124937323|NCT04479787|449400625|FG000|Through 6 Months|Lost to Follow-up|3|||
124937324|NCT04479787|449400626|FG001|Through 6 Months|Lost to Follow-up|2|||
125026604|NCT01465659|449720564|FG002|Completed 1 Cycle of Treatment|Death|0|||
125121030|NCT03384745|450067065|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
125121031|NCT03384745|450067066|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
124937325|NCT04479787|449400625|FG000|Through 6 Months|Death|3|||
125121032|NCT03384745|450067067|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
125121033|NCT03384745|450067068|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
125121034|NCT03384745|450067063|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
125121035|NCT03384745|450067064|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
125121036|NCT03384745|450067065|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
125121037|NCT03384745|450067066|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
125121038|NCT03384745|450067067|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
125121039|NCT03384745|450067068|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
125121040|NCT03384745|450067063|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
125212850|NCT03300050|450405492|FG001|Overall Study|Lost to Follow-up|1|||
124937326|NCT04479787|449400626|FG001|Through 6 Months|Death|0|||
124937327|NCT04479787|449400625|FG000|Through 6 Months|Inclusion/Exclusion|2|||
124937328|NCT04479787|449400626|FG001|Through 6 Months|Inclusion/Exclusion|1|||
124937329|NCT04479787|449400625|FG000|Through 6 Months|Subject Became Pregnant|1|||
124937330|NCT04479787|449400626|FG001|Through 6 Months|Subject Became Pregnant|1|||
124937331|NCT04479787|449400625|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
124937332|NCT04479787|449400626|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
124937333|NCT04479787|449400625|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
124937334|NCT04479787|449400626|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
124937335|NCT04479787|449400625|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
124937336|NCT04479787|449400626|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
124937337|NCT04479787|449400625|FG000|After 6 Months|Withdrawal by Subject|3|||
124937338|NCT04479787|449400626|FG001|After 6 Months|Withdrawal by Subject|13|||
124937339|NCT04479787|449400625|FG000|After 6 Months|Unsuccessful Trial|0|||
124937340|NCT04479787|449400626|FG001|After 6 Months|Unsuccessful Trial|7|||
124937341|NCT04479787|449400625|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
124937342|NCT04479787|449400626|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
124937343|NCT04479787|449400625|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
124937344|NCT04479787|449400626|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
124937345|NCT04479787|449400625|FG000|After 6 Months|Death|2|||
124937346|NCT04479787|449400626|FG001|After 6 Months|Death|0|||
124937347|NCT04479787|449400625|FG000|After 6 Months|Lost to Follow-up|1|||
124937348|NCT04479787|449400626|FG001|After 6 Months|Lost to Follow-up|1|||
124937349|NCT04479787|449400625|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
124937350|NCT04479787|449400626|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
124937351|NCT04479787|449400625|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
124937352|NCT04479787|449400626|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
124937353|NCT04479787|449400625|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
124937354|NCT04479787|449400626|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
124937355|NCT04479787|449400625|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
124937356|NCT04479787|449400626|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
124937357|NCT05039021|449401349|FG000|Overall Study|Death|1|||
124937358|NCT05039021|449401349|FG000|Overall Study|Lost to Follow-up|3|||
124937359|NCT03653364|449401352|FG000|Overall Study|Withdrawal by Subject|1|||
124937360|NCT03653364|449401352|FG000|Overall Study|Enrolled in Error|1|||
124937361|NCT03653364|449401352|FG000|Overall Study|Death|1|||
124937362|NCT00686595|449401353|FG000|Overall Study|Adverse Event|3|||
124937363|NCT00686595|449401353|FG000|Overall Study|Protocol Violation|1|||
124937364|NCT00686595|449401353|FG000|Overall Study|Lost to Follow-up|1|||
124937365|NCT00686595|449401353|FG000|Overall Study|Lack of Efficacy|1|||
124937366|NCT00686595|449401353|FG000|Overall Study|Poor Compliance|1|||
124937367|NCT03213457|449401356|FG000|Screening Period|Withdrawal by Subject|0|||
124937368|NCT03213457|449401357|FG001|Screening Period|Withdrawal by Subject|1|||
124937369|NCT03213457|449401358|FG002|Screening Period|Withdrawal by Subject|0|||
124937370|NCT03213457|449401356|FG000|Screening Period|Other|1|||
124937371|NCT03213457|449401357|FG001|Screening Period|Other|0|||
124937372|NCT03213457|449401358|FG002|Screening Period|Other|0|||
124937373|NCT03213457|449401356|FG000|Double-Blind Period|Adverse Event|3|||
124937374|NCT03213457|449401357|FG001|Double-Blind Period|Adverse Event|2|||
124937375|NCT03213457|449401358|FG002|Double-Blind Period|Adverse Event|7|||
124937376|NCT03213457|449401356|FG000|Double-Blind Period|Withdrawal by Subject|14|||
124937377|NCT03213457|449401357|FG001|Double-Blind Period|Withdrawal by Subject|2|||
124937378|NCT03213457|449401358|FG002|Double-Blind Period|Withdrawal by Subject|14|||
124937379|NCT03213457|449401356|FG000|Double-Blind Period|Lost to Follow-up|2|||
124937380|NCT03213457|449401357|FG001|Double-Blind Period|Lost to Follow-up|3|||
124937381|NCT03213457|449401358|FG002|Double-Blind Period|Lost to Follow-up|9|||
124937382|NCT03213457|449401356|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
124937383|NCT03213457|449401357|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
124937384|NCT03213457|449401358|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
124937385|NCT03213457|449401356|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
124937386|NCT03213457|449401357|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
124937387|NCT03213457|449401358|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
124937388|NCT03213457|449401356|FG000|Double-Blind Period|Pregnancy|5|||
124937389|NCT03213457|449401357|FG001|Double-Blind Period|Pregnancy|0|||
124937390|NCT03213457|449401358|FG002|Double-Blind Period|Pregnancy|0|||
124937391|NCT03213457|449401356|FG000|Double-Blind Period|Other|10|||
124937392|NCT03213457|449401357|FG001|Double-Blind Period|Other|3|||
124937393|NCT03213457|449401358|FG002|Double-Blind Period|Other|17|||
124937394|NCT03213457|449401356|FG000|Open-Label Period|Adverse Event|1|||
124937395|NCT03213457|449401357|FG001|Open-Label Period|Adverse Event|2|||
124937396|NCT03213457|449401358|FG002|Open-Label Period|Adverse Event|2|||
124937397|NCT03213457|449401356|FG000|Open-Label Period|Withdrawal by Subject|12|||
124937398|NCT03213457|449401357|FG001|Open-Label Period|Withdrawal by Subject|5|||
124937399|NCT03213457|449401358|FG002|Open-Label Period|Withdrawal by Subject|24|||
124937400|NCT03213457|449401356|FG000|Open-Label Period|Lost to Follow-up|1|||
124937401|NCT03213457|449401357|FG001|Open-Label Period|Lost to Follow-up|2|||
124937402|NCT03213457|449401358|FG002|Open-Label Period|Lost to Follow-up|8|||
124937403|NCT03213457|449401356|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
124937404|NCT03213457|449401357|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
124937405|NCT03213457|449401358|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
124937406|NCT03213457|449401356|FG000|Open-Label Period|Non-compliance with study procedures|1|||
124937407|NCT03213457|449401357|FG001|Open-Label Period|Non-compliance with study procedures|1|||
124937408|NCT03213457|449401358|FG002|Open-Label Period|Non-compliance with study procedures|2|||
124937409|NCT03213457|449401356|FG000|Open-Label Period|Exclusionary medications|0|||
124937410|NCT03213457|449401357|FG001|Open-Label Period|Exclusionary medications|0|||
124937411|NCT03213457|449401358|FG002|Open-Label Period|Exclusionary medications|1|||
124937412|NCT03213457|449401356|FG000|Open-Label Period|Other|1|||
124937413|NCT03213457|449401357|FG001|Open-Label Period|Other|1|||
124937414|NCT03213457|449401358|FG002|Open-Label Period|Other|6|||
124937415|NCT03213457|449401356|FG000|Follow-Up Period|Adverse Event|16|||
125212851|NCT03300050|450405493|FG002|Overall Study|Lost to Follow-up|0|||
124937416|NCT03213457|449401357|FG001|Follow-Up Period|Adverse Event|8|||
124937417|NCT03213457|449401358|FG002|Follow-Up Period|Adverse Event|37|||
124937418|NCT03213457|449401356|FG000|Follow-Up Period|Withdrawal by Subject|18|||
124937419|NCT03213457|449401357|FG001|Follow-Up Period|Withdrawal by Subject|11|||
124937420|NCT03213457|449401358|FG002|Follow-Up Period|Withdrawal by Subject|55|||
124937421|NCT03213457|449401356|FG000|Follow-Up Period|Lost to Follow-up|28|||
124937422|NCT03213457|449401357|FG001|Follow-Up Period|Lost to Follow-up|15|||
125212852|NCT03300050|450405494|FG003|Overall Study|Lost to Follow-up|0|||
125026605|NCT01465659|449720565|FG003|Completed 1 Cycle of Treatment|Death|0|||
125026606|NCT01465659|449720562|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
125026607|NCT01465659|449720563|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
125026608|NCT01465659|449720564|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
125026609|NCT01465659|449720565|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
125026610|NCT01465659|449720562|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
124937423|NCT03213457|449401358|FG002|Follow-Up Period|Lost to Follow-up|50|||
124937424|NCT03213457|449401356|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
124937425|NCT03213457|449401357|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
124937426|NCT03213457|449401358|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
124937427|NCT03213457|449401356|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
124937428|NCT03213457|449401357|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
124937429|NCT03213457|449401358|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
124937430|NCT03213457|449401356|FG000|Follow-Up Period|Pregnancy|7|||
124937431|NCT03213457|449401357|FG001|Follow-Up Period|Pregnancy|0|||
124937432|NCT03213457|449401358|FG002|Follow-Up Period|Pregnancy|18|||
124937433|NCT03213457|449401356|FG000|Follow-Up Period|Exclusionary medications|1|||
124937434|NCT03213457|449401357|FG001|Follow-Up Period|Exclusionary medications|1|||
124937435|NCT03213457|449401358|FG002|Follow-Up Period|Exclusionary medications|5|||
124937436|NCT03213457|449401356|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
124937437|NCT03213457|449401357|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
124937438|NCT03213457|449401358|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
124937439|NCT03213457|449401356|FG000|Follow-Up Period|Other|14|||
124937440|NCT03213457|449401357|FG001|Follow-Up Period|Other|10|||
124937441|NCT03213457|449401358|FG002|Follow-Up Period|Other|31|||
124937442|NCT05934292|449401360|FG000|Overall Study|Lost to Follow-up|0|||
124937443|NCT05934292|449401361|FG001|Overall Study|Lost to Follow-up|0|||
124937444|NCT05934292|449401362|FG002|Overall Study|Lost to Follow-up|1|||
124937445|NCT05934292|449401363|FG003|Overall Study|Lost to Follow-up|0|||
124937446|NCT05714059|449401366|FG000|Overall Study|Withdrawal by Subject|2|||
124937447|NCT05714059|449401367|FG001|Overall Study|Withdrawal by Subject|2|||
124937448|NCT05714059|449401366|FG000|Overall Study|Adverse Event|0|||
124937449|NCT05714059|449401367|FG001|Overall Study|Adverse Event|1|||
124937450|NCT05714059|449401366|FG000|Overall Study|Lost to Follow-up|0|||
124937451|NCT05714059|449401367|FG001|Overall Study|Lost to Follow-up|1|||
124937452|NCT05714059|449401366|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
124937453|NCT05714059|449401367|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
124937454|NCT05714059|449401366|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
124937455|NCT05714059|449401367|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
124937456|NCT04899674|449401368|FG000|Test|Adverse Event|1|||
124937457|NCT03774472|449401369|FG000|Overall Study|Physician Decision|1|||
124937458|NCT03774472|449401370|FG001|Overall Study|Physician Decision|0|||
124937459|NCT03774472|449401371|FG002|Overall Study|Physician Decision|0|||
124937460|NCT03774472|449401369|FG000|Overall Study|Progression prior to 4 weeks|0|||
124937461|NCT03774472|449401370|FG001|Overall Study|Progression prior to 4 weeks|1|||
124937462|NCT03774472|449401371|FG002|Overall Study|Progression prior to 4 weeks|0|||
124937463|NCT03774472|449401369|FG000|Overall Study|Withdrawal by Subject|0|||
124937464|NCT03774472|449401370|FG001|Overall Study|Withdrawal by Subject|1|||
124937465|NCT03774472|449401371|FG002|Overall Study|Withdrawal by Subject|0|||
124937466|NCT05155306|449401372|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
124937467|NCT05155306|449401373|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
124937468|NCT05155306|449401374|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
124937469|NCT05155306|449401375|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
124937470|NCT05155306|449401372|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
124937471|NCT05155306|449401373|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
124937472|NCT05155306|449401374|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
124937473|NCT05155306|449401375|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
124937474|NCT05116774|449401377|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
125026611|NCT01465659|449720563|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
124937475|NCT05116774|449401378|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
124937476|NCT05116774|449401377|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
124937477|NCT05116774|449401378|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
124937478|NCT05116774|449401377|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
125212853|NCT03300050|450405495|FG004|Overall Study|Lost to Follow-up|1|||
124937479|NCT05116774|449401378|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
124937480|NCT05116774|449401377|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
124937481|NCT05116774|449401378|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
124937482|NCT03150862|449401379|FG000|Overall Study|Death|2|||
124937483|NCT03150862|449401380|FG001|Overall Study|Death|7|||
124937484|NCT03150862|449401381|FG002|Overall Study|Death|8|||
124937485|NCT03150862|449401382|FG003|Overall Study|Death|27|||
124937486|NCT03150862|449401383|FG004|Overall Study|Death|4|||
124937487|NCT03150862|449401384|FG005|Overall Study|Death|8|||
124937488|NCT03150862|449401385|FG006|Overall Study|Death|6|||
124937489|NCT03150862|449401386|FG007|Overall Study|Death|21|||
124937490|NCT03150862|449401379|FG000|Overall Study|Withdrawal by Subject|1|||
124937491|NCT03150862|449401380|FG001|Overall Study|Withdrawal by Subject|1|||
124937492|NCT03150862|449401381|FG002|Overall Study|Withdrawal by Subject|0|||
124937493|NCT03150862|449401382|FG003|Overall Study|Withdrawal by Subject|3|||
124937494|NCT03150862|449401383|FG004|Overall Study|Withdrawal by Subject|1|||
124937495|NCT03150862|449401384|FG005|Overall Study|Withdrawal by Subject|1|||
124937496|NCT03150862|449401385|FG006|Overall Study|Withdrawal by Subject|1|||
124937497|NCT03150862|449401386|FG007|Overall Study|Withdrawal by Subject|3|||
124937498|NCT03150862|449401379|FG000|Overall Study|Lost to Follow-up|0|||
124937499|NCT03150862|449401380|FG001|Overall Study|Lost to Follow-up|0|||
124937500|NCT03150862|449401381|FG002|Overall Study|Lost to Follow-up|1|||
124937501|NCT03150862|449401382|FG003|Overall Study|Lost to Follow-up|0|||
124937502|NCT03150862|449401383|FG004|Overall Study|Lost to Follow-up|0|||
124937503|NCT03150862|449401384|FG005|Overall Study|Lost to Follow-up|0|||
124937504|NCT03150862|449401385|FG006|Overall Study|Lost to Follow-up|0|||
124937505|NCT03150862|449401386|FG007|Overall Study|Lost to Follow-up|2|||
124937506|NCT03150862|449401379|FG000|Overall Study|Sponsor's decision|0|||
124937507|NCT03150862|449401380|FG001|Overall Study|Sponsor's decision|0|||
124937508|NCT03150862|449401381|FG002|Overall Study|Sponsor's decision|0|||
124937509|NCT03150862|449401382|FG003|Overall Study|Sponsor's decision|10|||
124937510|NCT03150862|449401383|FG004|Overall Study|Sponsor's decision|3|||
124937511|NCT03150862|449401384|FG005|Overall Study|Sponsor's decision|0|||
124937512|NCT03150862|449401385|FG006|Overall Study|Sponsor's decision|1|||
124937513|NCT03150862|449401386|FG007|Overall Study|Sponsor's decision|1|||
124937514|NCT03150862|449401379|FG000|Overall Study|Change in Methylation status|0|||
124937515|NCT03150862|449401380|FG001|Overall Study|Change in Methylation status|0|||
124937516|NCT03150862|449401381|FG002|Overall Study|Change in Methylation status|0|||
124937517|NCT03150862|449401382|FG003|Overall Study|Change in Methylation status|0|||
124937518|NCT03150862|449401383|FG004|Overall Study|Change in Methylation status|1|||
124937519|NCT03150862|449401384|FG005|Overall Study|Change in Methylation status|0|||
124937520|NCT03150862|449401385|FG006|Overall Study|Change in Methylation status|0|||
124937521|NCT03150862|449401386|FG007|Overall Study|Change in Methylation status|0|||
124937522|NCT03150862|449401379|FG000|Overall Study|Roll over in to Long Term Extension|0|||
124937523|NCT03150862|449401380|FG001|Overall Study|Roll over in to Long Term Extension|0|||
124937524|NCT03150862|449401381|FG002|Overall Study|Roll over in to Long Term Extension|0|||
124937525|NCT03150862|449401382|FG003|Overall Study|Roll over in to Long Term Extension|0|||
124937526|NCT03150862|449401383|FG004|Overall Study|Roll over in to Long Term Extension|0|||
124937527|NCT03150862|449401384|FG005|Overall Study|Roll over in to Long Term Extension|0|||
124937528|NCT03150862|449401385|FG006|Overall Study|Roll over in to Long Term Extension|0|||
124937529|NCT03150862|449401386|FG007|Overall Study|Roll over in to Long Term Extension|1|||
124937530|NCT03150862|449401379|FG000|Overall Study|Progressive Disease|0|||
125026612|NCT01465659|449720564|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
125026613|NCT01465659|449720565|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
125026614|NCT01465659|449720562|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
125026615|NCT01465659|449720563|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
125026616|NCT01465659|449720564|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
125026617|NCT01465659|449720565|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
125026618|NCT01465659|449720562|FG000|Completed Follow for 1 Year|Death|6|||
125026619|NCT01465659|449720563|FG001|Completed Follow for 1 Year|Death|3|||
125026620|NCT01465659|449720564|FG002|Completed Follow for 1 Year|Death|2|||
125026621|NCT01465659|449720565|FG003|Completed Follow for 1 Year|Death|4|||
125026622|NCT00428597|449720572|FG000|Overall Study|Randomized but not treated|3|||
125026623|NCT00428597|449720573|FG001|Overall Study|Randomized but not treated|3|||
125026624|NCT00428597|449720572|FG000|Overall Study|Objective Progression or Relapse|19|||
125026625|NCT00428597|449720573|FG001|Overall Study|Objective Progression or Relapse|47|||
125026626|NCT00428597|449720572|FG000|Overall Study|Study Terminated by Sponsor|41|||
125026627|NCT00428597|449720573|FG001|Overall Study|Study Terminated by Sponsor|16|||
124937531|NCT03150862|449401380|FG001|Overall Study|Progressive Disease|0|||
124937532|NCT03150862|449401381|FG002|Overall Study|Progressive Disease|0|||
124937533|NCT03150862|449401382|FG003|Overall Study|Progressive Disease|0|||
124937534|NCT03150862|449401383|FG004|Overall Study|Progressive Disease|0|||
124937535|NCT03150862|449401384|FG005|Overall Study|Progressive Disease|0|||
124937536|NCT03150862|449401385|FG006|Overall Study|Progressive Disease|0|||
124937537|NCT03150862|449401386|FG007|Overall Study|Progressive Disease|2|||
124937538|NCT04158141|449401389|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
124937539|NCT04158141|449401390|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
125026628|NCT00428597|449720572|FG000|Overall Study|Adverse Event|15|||
125026629|NCT00428597|449720573|FG001|Overall Study|Adverse Event|7|||
125026630|NCT00428597|449720572|FG000|Overall Study|Global Deterioration of Health Status|1|||
125026631|NCT00428597|449720573|FG001|Overall Study|Global Deterioration of Health Status|5|||
125026632|NCT00428597|449720572|FG000|Overall Study|Protocol Violation|2|||
125026633|NCT00428597|449720573|FG001|Overall Study|Protocol Violation|1|||
125026634|NCT00428597|449720572|FG000|Overall Study|Withdrawal by Subject|2|||
125026635|NCT00428597|449720573|FG001|Overall Study|Withdrawal by Subject|1|||
125026636|NCT00428597|449720572|FG000|Overall Study|Other|1|||
125026637|NCT00428597|449720573|FG001|Overall Study|Other|1|||
125026638|NCT00428597|449720572|FG000|Overall Study|Lost to Follow-up|0|||
125026639|NCT00428597|449720573|FG001|Overall Study|Lost to Follow-up|1|||
125026640|NCT00428597|449720572|FG000|Overall Study|Pregnancy|1|||
125026641|NCT00428597|449720573|FG001|Overall Study|Pregnancy|0|||
125026642|NCT00428597|449720572|FG000|Overall Study|Death|1|||
125026643|NCT00428597|449720573|FG001|Overall Study|Death|3|||
125026644|NCT01469000|449720574|FG000|Overall Study|Withdrawal by Subject|16|||
125026645|NCT01469000|449720575|FG001|Overall Study|Withdrawal by Subject|3|||
125026646|NCT01469000|449720574|FG000|Overall Study|Sponsor Decision|4|||
125026647|NCT01469000|449720575|FG001|Overall Study|Sponsor Decision|1|||
125026648|NCT00686647|449720576|FG000|Overall Study|Lost to Follow-up|1|||
125026649|NCT00686647|449720576|FG000|Overall Study|Death|1|||
125026650|NCT01725750|449720585|FG000|Overall Study|Adverse Event|1|||
125026651|NCT01725750|449720586|FG001|Overall Study|Adverse Event|0|||
125026652|NCT01725750|449720585|FG000|Overall Study|Lost to Follow-up|1|||
125026653|NCT01725750|449720586|FG001|Overall Study|Lost to Follow-up|1|||
125026654|NCT01725750|449720585|FG000|Overall Study|Withdrawal by Subject|0|||
125026655|NCT01725750|449720586|FG001|Overall Study|Withdrawal by Subject|9|||
125026656|NCT00654498|449720589|FG000|Overall Study|Not Treated|1|||
125026657|NCT00654498|449720590|FG001|Overall Study|Not Treated|0|||
125026658|NCT00654498|449720589|FG000|Overall Study|Adverse Event|6|||
125026659|NCT00654498|449720590|FG001|Overall Study|Adverse Event|1|||
125026660|NCT00654498|449720589|FG000|Overall Study|Protocol Violation|1|||
125026661|NCT00654498|449720590|FG001|Overall Study|Protocol Violation|1|||
125026662|NCT00654498|449720589|FG000|Overall Study|Lost to Follow-up|1|||
125026663|NCT00654498|449720590|FG001|Overall Study|Lost to Follow-up|5|||
125026664|NCT00654498|449720589|FG000|Overall Study|Withdrawal by Subject|1|||
125026665|NCT00654498|449720590|FG001|Overall Study|Withdrawal by Subject|0|||
125026666|NCT00654498|449720589|FG000|Overall Study|Other reason not defined above|4|||
125026667|NCT00654498|449720590|FG001|Overall Study|Other reason not defined above|5|||
125026668|NCT00772668|449720593|FG000|Overall Study|Physician Decision|3|||
125026669|NCT02152345|449722322|FG000|Overall Study|Case Cancellations|2|||
125026670|NCT02152345|449722323|FG001|Overall Study|Case Cancellations|4|||
125026671|NCT02152345|449722322|FG000|Overall Study|Withdrawal by Subject|2|||
125026672|NCT02152345|449722323|FG001|Overall Study|Withdrawal by Subject|1|||
125026673|NCT01916980|449722324|FG000|Overall Study|Adverse Event|4|||
125026674|NCT01916980|449722325|FG001|Overall Study|Adverse Event|2|||
125026675|NCT01916980|449722324|FG000|Overall Study|Lack of Efficacy|2|||
125026676|NCT01916980|449722325|FG001|Overall Study|Lack of Efficacy|2|||
125026677|NCT01916980|449722324|FG000|Overall Study|Withdrawal by Subject|1|||
125026678|NCT01916980|449722325|FG001|Overall Study|Withdrawal by Subject|0|||
125026679|NCT04439279|449722326|FG000|Overall Study|Adverse Event|7|||
125026680|NCT04439279|449722326|FG000|Overall Study|Death|4|||
125026681|NCT04439279|449722326|FG000|Overall Study|Disease progression|17|||
125026682|NCT04439279|449722326|FG000|Overall Study|Complicating disease|3|||
125026683|NCT04439279|449722326|FG000|Overall Study|Withdrawal by Subject|2|||
125026684|NCT04439279|449722326|FG000|Overall Study|Ineligible|1|||
125026685|NCT04439279|449722326|FG000|Overall Study|Treatment still ongoing|1|||
125026686|NCT02324270|449722327|FG000|Overall Study|Withdrawal by Subject|0|||
125026687|NCT02324270|449722328|FG001|Overall Study|Withdrawal by Subject|1|||
125121041|NCT03384745|450067064|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
125121042|NCT03384745|450067065|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
125121043|NCT03384745|450067066|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
125026688|NCT02324270|449722329|FG002|Overall Study|Withdrawal by Subject|0|||
125026689|NCT02324270|449722327|FG000|Overall Study|Lost to Follow-up|4|||
125026690|NCT02324270|449722328|FG001|Overall Study|Lost to Follow-up|3|||
125026691|NCT02324270|449722329|FG002|Overall Study|Lost to Follow-up|4|||
125026692|NCT02324270|449722327|FG000|Overall Study|Protocol Violation|0|||
125026693|NCT02324270|449722328|FG001|Overall Study|Protocol Violation|1|||
125026694|NCT02324270|449722329|FG002|Overall Study|Protocol Violation|1|||
125026695|NCT02324270|449722327|FG000|Overall Study|Non Compliance with Study Drug|1|||
125026696|NCT02324270|449722328|FG001|Overall Study|Non Compliance with Study Drug|2|||
125026697|NCT02324270|449722329|FG002|Overall Study|Non Compliance with Study Drug|0|||
125026698|NCT03521791|449722330|FG000|Overall Study|Protocol Violation|7|||
125026699|NCT03521791|449722331|FG001|Overall Study|Protocol Violation|17|||
125026700|NCT00680836|449722333|FG000|Overall Study|Withdrawal by Subject|3|||
125026701|NCT00680836|449722334|FG001|Overall Study|Withdrawal by Subject|0|||
125026702|NCT00680836|449722333|FG000|Overall Study|Lost to Follow-up|3|||
125026703|NCT00680836|449722334|FG001|Overall Study|Lost to Follow-up|1|||
125026704|NCT00680836|449722333|FG000|Overall Study|Physician Decision|2|||
125026705|NCT00680836|449722334|FG001|Overall Study|Physician Decision|1|||
125026706|NCT03786432|449722335|FG000|Overall Study|Screen Failure after consent|1|||
125026707|NCT03786432|449722335|FG000|Overall Study|Lost to Follow-up|4|||
125026708|NCT03786432|449722335|FG000|Overall Study|did not complete 12 month CT scan|1|||
125026709|NCT00925600|449722339|FG000|Overall Study|Withdrawal by Subject|16|||
125026710|NCT00925600|449722340|FG001|Overall Study|Withdrawal by Subject|14|||
125026711|NCT00925600|449722339|FG000|Overall Study|Death|4|||
125026712|NCT00925600|449722340|FG001|Overall Study|Death|3|||
125026713|NCT00925600|449722339|FG000|Overall Study|Lost to Follow-up|2|||
125026714|NCT00925600|449722340|FG001|Overall Study|Lost to Follow-up|2|||
125026715|NCT00925600|449722339|FG000|Overall Study|Disease Progression|1|||
125026716|NCT00925600|449722340|FG001|Overall Study|Disease Progression|3|||
125026717|NCT00925600|449722339|FG000|Overall Study|Administrative Decision|1|||
125026718|NCT00925600|449722340|FG001|Overall Study|Administrative Decision|1|||
125026719|NCT00925600|449722339|FG000|Overall Study|Noncompliance|2|||
125026720|NCT00925600|449722340|FG001|Overall Study|Noncompliance|0|||
125026721|NCT00925600|449722339|FG000|Overall Study|Ineligibility Determined|2|||
125026722|NCT00925600|449722340|FG001|Overall Study|Ineligibility Determined|0|||
125026723|NCT00925600|449722339|FG000|Overall Study|Protocol Deviation|0|||
125026724|NCT00925600|449722340|FG001|Overall Study|Protocol Deviation|1|||
125026725|NCT00925600|449722339|FG000|Overall Study|Requirement for Alternative Therapy|0|||
125026726|NCT00925600|449722340|FG001|Overall Study|Requirement for Alternative Therapy|1|||
125026727|NCT00925600|449722339|FG000|Overall Study|Other|3|||
125026728|NCT00925600|449722340|FG001|Overall Study|Other|1|||
125026729|NCT00925600|449722339|FG000|Overall Study|Adverse Event|1|||
125026730|NCT00925600|449722340|FG001|Overall Study|Adverse Event|2|||
125026731|NCT01974817|449722341|FG000|Overall Study|Death|4|||
125026732|NCT01974817|449722341|FG000|Overall Study|Lost to Follow-up|2|||
125026733|NCT01974817|449722341|FG000|Overall Study|Protocol Violation|2|||
124937540|NCT04158141|449401391|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
124937541|NCT04158141|449401389|FG000|Step 1: Registration|Adverse Event|1|||
124937542|NCT04158141|449401390|FG001|Step 1: Registration|Adverse Event|0|||
124937543|NCT04158141|449401391|FG002|Step 1: Registration|Adverse Event|0|||
124937544|NCT04158141|449401389|FG000|Step 1: Registration|Withdrawal by Subject|1|||
124937545|NCT04158141|449401390|FG001|Step 1: Registration|Withdrawal by Subject|0|||
124937546|NCT04158141|449401391|FG002|Step 1: Registration|Withdrawal by Subject|0|||
124937547|NCT04158141|449401389|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
124937548|NCT04158141|449401390|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
124937549|NCT04158141|449401391|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
124937550|NCT04505722|449401396|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
124937551|NCT04505722|449401397|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
124937552|NCT04505722|449401398|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
124937553|NCT04505722|449401396|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
124937554|NCT04505722|449401397|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
124937555|NCT04505722|449401398|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
124937556|NCT04505722|449401396|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
124937557|NCT04505722|449401397|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
124937558|NCT04505722|449401398|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
124937559|NCT04505722|449401396|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
124937560|NCT04505722|449401397|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
124937561|NCT04505722|449401398|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
124937562|NCT04505722|449401396|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
124937563|NCT04505722|449401397|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
124937564|NCT04505722|449401398|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
124937565|NCT04505722|449401396|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
125026734|NCT05512949|449722342|FG000|Overall Study|Lost to Follow-up|4|||
125026735|NCT05512949|449722343|FG001|Overall Study|Lost to Follow-up|6|||
125026736|NCT05512949|449722344|FG002|Overall Study|Lost to Follow-up|2|||
125121044|NCT03384745|450067067|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
125026737|NCT05512949|449722342|FG000|Overall Study|Protocol Violation|0|||
125026738|NCT05512949|449722343|FG001|Overall Study|Protocol Violation|0|||
125026739|NCT05512949|449722344|FG002|Overall Study|Protocol Violation|1|||
125026740|NCT05512949|449722342|FG000|Overall Study|Withdrawal by Subject|1|||
125026741|NCT05512949|449722343|FG001|Overall Study|Withdrawal by Subject|1|||
125026742|NCT05512949|449722344|FG002|Overall Study|Withdrawal by Subject|2|||
125121045|NCT03384745|450067068|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
125026743|NCT05512949|449722342|FG000|Overall Study|Completion status unknown|1|||
124937566|NCT04505722|449401397|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
124937567|NCT04505722|449401398|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
124937568|NCT04505722|449401396|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
124937569|NCT04505722|449401397|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
124937570|NCT04505722|449401398|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
124937571|NCT04505722|449401396|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
124937572|NCT04505722|449401397|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
124937573|NCT04505722|449401398|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
124937574|NCT04505722|449401396|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
124937575|NCT04505722|449401397|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
124937576|NCT04505722|449401398|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
124937577|NCT04505722|449401396|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
124937578|NCT04505722|449401397|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
124937579|NCT04505722|449401398|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
124937580|NCT04505722|449401396|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
124937581|NCT04505722|449401397|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
124937582|NCT04505722|449401398|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
124937583|NCT04505722|449401396|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
124937584|NCT04505722|449401397|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
124937585|NCT04505722|449401398|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
124937586|NCT04505722|449401396|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
124937587|NCT04505722|449401397|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
124937588|NCT04505722|449401398|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
124937589|NCT04505722|449401396|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
124937590|NCT04505722|449401397|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
124937591|NCT04505722|449401398|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
124937592|NCT04505722|449401396|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
124937593|NCT04505722|449401397|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
124937594|NCT04505722|449401398|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
124937595|NCT04755595|449401399|FG000|Overall Study|Lost to Follow-up|1|||
124937596|NCT00319696|449401400|FG000|Overall Study|Adverse Event|36|||
124937597|NCT00319696|449401400|FG000|Overall Study|withdrawal of consent|14|||
124937598|NCT00319696|449401400|FG000|Overall Study|administrative|7|||
124937599|NCT00319696|449401400|FG000|Overall Study|Lost to Follow-up|3|||
124937600|NCT02206828|449401401|FG000|Overall Study|Lost to Follow-up|7|||
124937601|NCT04977583|449402046|FG000|Overall Study|Lost to Follow-up|8|||
124937602|NCT04977583|449402047|FG001|Overall Study|Lost to Follow-up|4|||
124937603|NCT04977583|449402048|FG002|Overall Study|Lost to Follow-up|13|||
124937604|NCT04977583|449402046|FG000|Overall Study|Withdrawal by Subject|3|||
124937605|NCT04977583|449402047|FG001|Overall Study|Withdrawal by Subject|2|||
124937606|NCT04977583|449402048|FG002|Overall Study|Withdrawal by Subject|1|||
124937607|NCT02422615|449402049|FG000|Treatment Period|Progressive disease|314|||
124937608|NCT02422615|449402050|FG001|Treatment Period|Progressive disease|200|||
124937609|NCT02422615|449402049|FG000|Treatment Period|Adverse Event|51|||
124937610|NCT02422615|449402050|FG001|Treatment Period|Adverse Event|9|||
124937611|NCT02422615|449402049|FG000|Treatment Period|Physician Decision|32|||
124937612|NCT02422615|449402050|FG001|Treatment Period|Physician Decision|8|||
124937613|NCT02422615|449402049|FG000|Treatment Period|Subject/guardian decision|38|||
124937614|NCT02422615|449402050|FG001|Treatment Period|Subject/guardian decision|8|||
124937615|NCT02422615|449402049|FG000|Treatment Period|Death|2|||
124937616|NCT02422615|449402050|FG001|Treatment Period|Death|1|||
124937617|NCT02422615|449402049|FG000|Treatment Period|Technical problems|0|||
124937618|NCT02422615|449402050|FG001|Treatment Period|Technical problems|1|||
124937619|NCT02422615|449402049|FG000|Treatment Period|Protocol deviation|1|||
124937620|NCT02422615|449402050|FG001|Treatment Period|Protocol deviation|1|||
124937621|NCT02422615|449402049|FG000|Treatment Period|Study terminated as per protocol|46|||
124937622|NCT02422615|449402050|FG001|Treatment Period|Study terminated as per protocol|14|||
124937623|NCT02422615|449402049|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
124937624|NCT02422615|449402050|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
124937625|NCT02422615|449402049|FG000|Post-treatment Efficacy Follow-up|Death|2|||
124937626|NCT02422615|449402050|FG001|Post-treatment Efficacy Follow-up|Death|1|||
124937627|NCT02422615|449402049|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
124937628|NCT02422615|449402050|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
124937629|NCT02422615|449402049|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
124937630|NCT02422615|449402050|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
124937631|NCT02422615|449402049|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
124937632|NCT02422615|449402050|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
124937633|NCT02422615|449402049|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
124937634|NCT02422615|449402050|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
124937635|NCT01639131|449402051|FG000|Overall Study|Disease Progression|6|||
124937636|NCT01105975|449402058|FG000|Overall Study|Adverse Event|2|||
124937637|NCT01105975|449402059|FG001|Overall Study|Adverse Event|1|||
124937638|NCT01105975|449402060|FG002|Overall Study|Adverse Event|5|||
124937639|NCT01105975|449402061|FG003|Overall Study|Adverse Event|1|||
124937640|NCT01105975|449402062|FG004|Overall Study|Adverse Event|0|||
124937641|NCT01105975|449402063|FG005|Overall Study|Adverse Event|1|||
124937642|NCT01105975|449402064|FG006|Overall Study|Adverse Event|2|||
124937643|NCT01105975|449402065|FG007|Overall Study|Adverse Event|4|||
124937644|NCT01105975|449402066|FG008|Overall Study|Adverse Event|1|||
124937645|NCT01105975|449402067|FG009|Overall Study|Adverse Event|4|||
124937646|NCT01105975|449402058|FG000|Overall Study|Withdrawal by Subject|2|||
124937647|NCT01105975|449402059|FG001|Overall Study|Withdrawal by Subject|2|||
124937648|NCT01105975|449402060|FG002|Overall Study|Withdrawal by Subject|2|||
124937649|NCT01105975|449402061|FG003|Overall Study|Withdrawal by Subject|0|||
124937650|NCT01105975|449402062|FG004|Overall Study|Withdrawal by Subject|4|||
124937651|NCT01105975|449402063|FG005|Overall Study|Withdrawal by Subject|1|||
124937652|NCT01105975|449402064|FG006|Overall Study|Withdrawal by Subject|2|||
124937653|NCT01105975|449402065|FG007|Overall Study|Withdrawal by Subject|1|||
124937654|NCT01105975|449402066|FG008|Overall Study|Withdrawal by Subject|0|||
124937655|NCT01105975|449402067|FG009|Overall Study|Withdrawal by Subject|3|||
124937656|NCT01105975|449402058|FG000|Overall Study|Lost to Follow-up|1|||
124937657|NCT01105975|449402059|FG001|Overall Study|Lost to Follow-up|0|||
124937658|NCT01105975|449402060|FG002|Overall Study|Lost to Follow-up|0|||
124937659|NCT01105975|449402061|FG003|Overall Study|Lost to Follow-up|1|||
124937660|NCT01105975|449402062|FG004|Overall Study|Lost to Follow-up|1|||
124937661|NCT01105975|449402063|FG005|Overall Study|Lost to Follow-up|0|||
124937662|NCT01105975|449402064|FG006|Overall Study|Lost to Follow-up|0|||
124937663|NCT01105975|449402065|FG007|Overall Study|Lost to Follow-up|0|||
125121046|NCT03384745|450067063|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
125121047|NCT03384745|450067064|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
125121048|NCT03384745|450067065|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
125121049|NCT03384745|450067066|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
125121050|NCT03384745|450067067|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
125121051|NCT03384745|450067068|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
125121052|NCT03384745|450067063|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
125121053|NCT03384745|450067064|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
125121054|NCT03384745|450067065|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
125121055|NCT03384745|450067066|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
125121056|NCT03384745|450067067|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
125121057|NCT03384745|450067068|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
125121058|NCT02984683|450067071|FG000|Overall Study|Adverse Event|3|||
125121059|NCT02984683|450067072|FG001|Overall Study|Adverse Event|3|||
125121060|NCT02984683|450067071|FG000|Overall Study|Withdrawal by Subject|1|||
125121061|NCT02984683|450067072|FG001|Overall Study|Withdrawal by Subject|0|||
125121062|NCT02984683|450067071|FG000|Overall Study|Disease progression|7|||
125121063|NCT02984683|450067072|FG001|Overall Study|Disease progression|9|||
125121064|NCT02739984|450067073|FG000|Overall Study|Sponsor Decision|1|||
125121065|NCT02739984|450067074|FG001|Overall Study|Sponsor Decision|0|||
125121066|NCT02739984|450067073|FG000|Overall Study|Withdrawal by Subject|1|||
125121067|NCT02739984|450067074|FG001|Overall Study|Withdrawal by Subject|1|||
124937664|NCT01105975|449402066|FG008|Overall Study|Lost to Follow-up|1|||
124937665|NCT01105975|449402067|FG009|Overall Study|Lost to Follow-up|0|||
124937666|NCT01105975|449402058|FG000|Overall Study|Physician Decision|0|||
125121068|NCT02739984|450067073|FG000|Overall Study|Death|0|||
125121069|NCT02739984|450067074|FG001|Overall Study|Death|1|||
125121070|NCT02739984|450067073|FG000|Overall Study|Lost to Follow-up|3|||
125121071|NCT02739984|450067074|FG001|Overall Study|Lost to Follow-up|0|||
125121072|NCT03008460|450067075|FG000|Overall Study|Protocol deviation|0|||
125121073|NCT03008460|450067076|FG001|Overall Study|Protocol deviation|2|||
125121074|NCT03008460|450067075|FG000|Overall Study|Study drug not dispensed|0|||
124937667|NCT01105975|449402059|FG001|Overall Study|Physician Decision|0|||
124937668|NCT01105975|449402060|FG002|Overall Study|Physician Decision|0|||
124937669|NCT01105975|449402061|FG003|Overall Study|Physician Decision|0|||
124937670|NCT01105975|449402062|FG004|Overall Study|Physician Decision|0|||
124937671|NCT01105975|449402063|FG005|Overall Study|Physician Decision|0|||
124937672|NCT01105975|449402064|FG006|Overall Study|Physician Decision|2|||
124937673|NCT01105975|449402065|FG007|Overall Study|Physician Decision|0|||
124937674|NCT01105975|449402066|FG008|Overall Study|Physician Decision|0|||
125121075|NCT03008460|450067076|FG001|Overall Study|Study drug not dispensed|1|||
125121076|NCT03008460|450067075|FG000|Overall Study|Adverse Event|0|||
125121077|NCT03008460|450067076|FG001|Overall Study|Adverse Event|1|||
125121078|NCT03008460|450067075|FG000|Overall Study|Withdrawal by Subject|5|||
125121079|NCT03008460|450067076|FG001|Overall Study|Withdrawal by Subject|6|||
125121080|NCT03008460|450067075|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
124937675|NCT01105975|449402067|FG009|Overall Study|Physician Decision|0|||
124937676|NCT01105975|449402058|FG000|Overall Study|Protocol Violation|0|||
124937677|NCT01105975|449402059|FG001|Overall Study|Protocol Violation|2|||
124937678|NCT01105975|449402060|FG002|Overall Study|Protocol Violation|2|||
124937679|NCT01105975|449402061|FG003|Overall Study|Protocol Violation|0|||
124937680|NCT01105975|449402062|FG004|Overall Study|Protocol Violation|1|||
124937681|NCT01105975|449402063|FG005|Overall Study|Protocol Violation|1|||
124937682|NCT01105975|449402064|FG006|Overall Study|Protocol Violation|1|||
124937683|NCT01105975|449402065|FG007|Overall Study|Protocol Violation|1|||
124937684|NCT01105975|449402066|FG008|Overall Study|Protocol Violation|2|||
124937685|NCT01105975|449402067|FG009|Overall Study|Protocol Violation|2|||
124937686|NCT01105975|449402058|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
124937687|NCT01105975|449402059|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
124937688|NCT01105975|449402060|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
124937689|NCT01105975|449402061|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
124937690|NCT01105975|449402062|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
124937691|NCT01105975|449402063|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
124937692|NCT01105975|449402064|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
124937693|NCT01105975|449402065|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
124937694|NCT01105975|449402066|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
124937695|NCT01105975|449402067|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
124937696|NCT00087685|449402077|FG000|Overall Study|Adverse Event|5|||
124937697|NCT00087685|449402077|FG000|Overall Study|Non-Compliance|1|||
124937698|NCT00087685|449402077|FG000|Overall Study|Progressive Disease|5|||
124937699|NCT00087685|449402077|FG000|Overall Study|Withdrawal by Subject|3|||
124937700|NCT05018143|449402078|FG000|Overall Study|Lost to Follow-up|5|||
124937701|NCT05018143|449402079|FG001|Overall Study|Lost to Follow-up|4|||
124937702|NCT05018143|449402078|FG000|Overall Study|Withdrawal by Subject|0|||
124937703|NCT05018143|449402079|FG001|Overall Study|Withdrawal by Subject|1|||
124937704|NCT04018495|449402080|FG000|Overall Study|Physician Decision|1|||
124937705|NCT04059406|449402081|FG000|Overall Study|Early Treatment Termination|5|||
124937706|NCT04059406|449402082|FG001|Overall Study|Early Treatment Termination|5|||
124937707|NCT04059406|449402083|FG002|Overall Study|Early Treatment Termination|15|||
124937708|NCT05601882|449402084|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
124937709|NCT05601882|449402085|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
124937710|NCT05601882|449402086|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
124937711|NCT05601882|449402087|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
124937712|NCT05601882|449402084|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
124937713|NCT05601882|449402085|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
124937714|NCT05601882|449402086|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
124937715|NCT05601882|449402087|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
124937716|NCT05601882|449402084|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
124937717|NCT05601882|449402085|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
124937718|NCT05601882|449402086|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
124937719|NCT05601882|449402087|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
124937720|NCT05601882|449402084|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
124937721|NCT05601882|449402085|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
124937722|NCT05601882|449402086|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
124937723|NCT05601882|449402087|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
124937724|NCT05601882|449402084|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
124937725|NCT05601882|449402085|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
124937726|NCT05601882|449402086|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
124937727|NCT05601882|449402087|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
124937728|NCT05601882|449402084|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
124937729|NCT05601882|449402085|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
124937730|NCT05601882|449402086|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
124937731|NCT05601882|449402087|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
124937732|NCT04121741|449402088|FG000|Overall Study|Protocol Violation|1|||
124937733|NCT04121741|449402089|FG001|Overall Study|Protocol Violation|0|||
124937734|NCT04121741|449402090|FG002|Overall Study|Protocol Violation|0|||
124937735|NCT04121741|449402091|FG003|Overall Study|Protocol Violation|0|||
124937736|NCT04121741|449402092|FG004|Overall Study|Protocol Violation|0|||
124937737|NCT04121741|449402093|FG005|Overall Study|Protocol Violation|0|||
124937738|NCT03473223|449402094|FG000|Overall Study|Lost to Follow-up|1|||
124937739|NCT03473223|449402095|FG001|Overall Study|Lost to Follow-up|1|||
124937740|NCT03473223|449402094|FG000|Overall Study|Withdrawal by Subject|47|||
124937741|NCT03473223|449402095|FG001|Overall Study|Withdrawal by Subject|42|||
124937742|NCT03473223|449402094|FG000|Overall Study|Indirect contact|32|||
124937743|NCT03473223|449402095|FG001|Overall Study|Indirect contact|29|||
124937744|NCT03473223|449402094|FG000|Overall Study|Other (Not specified)|32|||
124937745|NCT03473223|449402095|FG001|Overall Study|Other (Not specified)|20|||
124937746|NCT03524092|449402096|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
124937747|NCT03524092|449402097|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
124937748|NCT03524092|449402098|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
124937749|NCT03524092|449402099|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
124937750|NCT03524092|449402100|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
124937751|NCT03524092|449402101|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
124937752|NCT03524092|449402096|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
124937753|NCT03524092|449402097|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
124937754|NCT03524092|449402098|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
124937755|NCT03524092|449402099|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
124937756|NCT03524092|449402100|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
124937757|NCT03524092|449402101|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
124937758|NCT03524092|449402096|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
124937759|NCT03524092|449402097|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
124937760|NCT03524092|449402098|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
124937761|NCT03524092|449402099|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
124937762|NCT03524092|449402100|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
124937763|NCT03524092|449402101|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
124937764|NCT03524092|449402096|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
124937765|NCT03524092|449402097|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
124937766|NCT03524092|449402098|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
124937767|NCT03524092|449402099|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
124937768|NCT03524092|449402100|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
124937769|NCT03524092|449402101|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
124937770|NCT03524092|449402096|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
124937771|NCT03524092|449402097|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
124937772|NCT03524092|449402098|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
124937773|NCT03524092|449402099|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
124937774|NCT03524092|449402100|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
124937775|NCT03524092|449402101|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
124937776|NCT03524092|449402096|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
124937777|NCT03524092|449402097|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
124937778|NCT03524092|449402098|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
124937779|NCT03524092|449402099|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
124937780|NCT03524092|449402100|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
124937781|NCT03524092|449402101|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
124937782|NCT03524092|449402096|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
124937783|NCT03524092|449402097|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
124937784|NCT03524092|449402098|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
124937785|NCT03524092|449402099|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
124937786|NCT03524092|449402100|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
124937787|NCT03524092|449402101|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
124937788|NCT03524092|449402096|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
124937789|NCT03524092|449402097|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
124937790|NCT03524092|449402098|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
124937791|NCT03524092|449402099|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
124937792|NCT03524092|449402100|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
124937793|NCT03524092|449402101|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
124937794|NCT03524092|449402096|FG000|Loss of Response Rescue Period|Adverse Event|0|||
124937795|NCT03524092|449402097|FG001|Loss of Response Rescue Period|Adverse Event|0|||
124937796|NCT03524092|449402098|FG002|Loss of Response Rescue Period|Adverse Event|0|||
124937797|NCT03524092|449402099|FG003|Loss of Response Rescue Period|Adverse Event|2|||
124937798|NCT03524092|449402100|FG004|Loss of Response Rescue Period|Adverse Event|0|||
124937799|NCT03524092|449402101|FG005|Loss of Response Rescue Period|Adverse Event|0|||
124937800|NCT03524092|449402096|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
124937801|NCT03524092|449402097|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
124937802|NCT03524092|449402098|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
124937803|NCT03524092|449402099|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
124937804|NCT03524092|449402100|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
124937805|NCT03524092|449402101|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
124937806|NCT03524092|449402096|FG000|Loss of Response Rescue Period|Pregnancy|0|||
125026744|NCT05512949|449722343|FG001|Overall Study|Completion status unknown|3|||
125026745|NCT05512949|449722344|FG002|Overall Study|Completion status unknown|0|||
124937807|NCT03524092|449402097|FG001|Loss of Response Rescue Period|Pregnancy|0|||
124937808|NCT03524092|449402098|FG002|Loss of Response Rescue Period|Pregnancy|0|||
124937809|NCT03524092|449402099|FG003|Loss of Response Rescue Period|Pregnancy|1|||
124937810|NCT03524092|449402100|FG004|Loss of Response Rescue Period|Pregnancy|0|||
125026746|NCT03593915|449722345|FG000|Overall Study|Adverse Event|0|||
125026747|NCT03593915|449722346|FG001|Overall Study|Adverse Event|0|||
125026748|NCT03593915|449722347|FG002|Overall Study|Adverse Event|0|||
125026749|NCT03593915|449722348|FG003|Overall Study|Adverse Event|1|||
125026750|NCT03593915|449722349|FG004|Overall Study|Adverse Event|0|||
125026751|NCT03593915|449722350|FG005|Overall Study|Adverse Event|0|||
125026752|NCT03593915|449722345|FG000|Overall Study|Physician Decision|0|||
125026753|NCT03593915|449722346|FG001|Overall Study|Physician Decision|0|||
125026754|NCT03593915|449722347|FG002|Overall Study|Physician Decision|0|||
125026755|NCT03593915|449722348|FG003|Overall Study|Physician Decision|0|||
125026756|NCT03593915|449722349|FG004|Overall Study|Physician Decision|0|||
125026757|NCT03593915|449722350|FG005|Overall Study|Physician Decision|1|||
125026758|NCT04660643|449722351|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
125026759|NCT04660643|449722352|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
125026760|NCT04660643|449722353|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
125026761|NCT04660643|449722351|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
125026762|NCT04660643|449722352|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
125026763|NCT04660643|449722353|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
125026764|NCT04660643|449722351|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
125026765|NCT04660643|449722352|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
125026766|NCT04660643|449722353|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
125026767|NCT04660643|449722351|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
125026768|NCT04660643|449722352|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
125026769|NCT04660643|449722353|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
125026770|NCT04660643|449722351|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
125026771|NCT04660643|449722352|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
125026772|NCT04660643|449722353|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
125026773|NCT04660643|449722351|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
125026774|NCT04660643|449722352|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
125026775|NCT04660643|449722353|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
125026776|NCT04660643|449722351|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
125026777|NCT04660643|449722352|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
125026778|NCT04660643|449722353|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
125026779|NCT04660643|449722351|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
125026780|NCT04660643|449722352|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
125026781|NCT04660643|449722353|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
125026782|NCT04660643|449722351|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
125026783|NCT04660643|449722352|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
125026784|NCT04660643|449722353|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
125026785|NCT04660643|449722351|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
125026786|NCT04660643|449722352|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
125026787|NCT04660643|449722353|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
125026788|NCT04660643|449722351|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
125026789|NCT04660643|449722352|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
125026790|NCT04660643|449722353|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
125026791|NCT04660643|449722351|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
125026792|NCT04660643|449722352|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
125026793|NCT04660643|449722353|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
125026794|NCT04660643|449722351|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
125026795|NCT04660643|449722352|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
125026796|NCT04660643|449722353|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
125026797|NCT04660643|449722351|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
125026798|NCT04660643|449722352|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
125026799|NCT04660643|449722353|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
125026800|NCT04660643|449722351|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
125026801|NCT04660643|449722352|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
125026802|NCT04660643|449722353|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
125026803|NCT04660643|449722351|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
125026804|NCT04660643|449722352|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
125026805|NCT04660643|449722353|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
125026806|NCT00648167|449722354|FG000|Overall Study|Adverse Event|6|||
125026807|NCT00648167|449722354|FG000|Overall Study|unable to swallow tablets|1|||
125026808|NCT01688050|449722355|FG000|Overall Study|Death|7|||
125026809|NCT01688050|449722355|FG000|Overall Study|Conversion to open repair|1|||
125026810|NCT01688050|449722355|FG000|Overall Study|Lost to Follow-up|13|||
125026811|NCT01688050|449722355|FG000|Overall Study|Withdrawal by Subject|10|||
125026812|NCT02614079|449722358|FG000|Overall Study|Withdrawal by Subject|1|||
124937811|NCT03524092|449402101|FG005|Loss of Response Rescue Period|Pregnancy|0|||
124937812|NCT03524092|449402096|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
124937813|NCT03524092|449402097|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
124937814|NCT03524092|449402098|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
124937815|NCT03524092|449402099|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
124937816|NCT03524092|449402100|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
124937817|NCT03524092|449402101|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
124937818|NCT03524092|449402096|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
124937819|NCT03524092|449402097|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
124937820|NCT03524092|449402098|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
124937821|NCT03524092|449402099|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
124937822|NCT03524092|449402100|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
124937823|NCT03524092|449402101|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
124937824|NCT03524092|449402096|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
124937825|NCT03524092|449402097|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
124937826|NCT03524092|449402098|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
124937827|NCT03524092|449402099|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
124937828|NCT03524092|449402100|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
124937829|NCT03524092|449402101|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
124937830|NCT03524092|449402096|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
124937831|NCT03524092|449402097|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
124937832|NCT03524092|449402098|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
124937833|NCT03524092|449402099|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
124937834|NCT03524092|449402100|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
124937835|NCT03524092|449402101|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
124937836|NCT03524092|449402096|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
124937837|NCT03524092|449402097|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
124937838|NCT03524092|449402098|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
124937839|NCT03524092|449402099|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
124937840|NCT03524092|449402100|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
124937841|NCT03524092|449402101|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
124937842|NCT03524092|449402096|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
124937843|NCT03524092|449402097|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
124937844|NCT03524092|449402098|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
124937845|NCT03524092|449402099|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
124937846|NCT03524092|449402100|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
124937847|NCT03524092|449402101|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
124937848|NCT03524092|449402096|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
124937849|NCT03524092|449402097|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
124937850|NCT03524092|449402098|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
124937851|NCT03524092|449402099|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
124937852|NCT03524092|449402100|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
124937853|NCT03524092|449402101|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
124937854|NCT03524092|449402096|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
124937855|NCT03524092|449402097|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
124937856|NCT03524092|449402098|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
124937857|NCT03524092|449402099|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
124937858|NCT03524092|449402100|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
124937859|NCT03524092|449402101|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
124937860|NCT03524092|449402096|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
124937861|NCT03524092|449402097|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
124937862|NCT03524092|449402098|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
124937863|NCT03524092|449402099|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
124937864|NCT03524092|449402100|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
124937865|NCT03524092|449402101|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
124937866|NCT03524092|449402096|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
125121081|NCT03008460|450067076|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
125121082|NCT03008460|450067075|FG000|Overall Study|End of study visit outside permitted time window|0|||
124937867|NCT03524092|449402097|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
124937868|NCT03524092|449402098|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
125121083|NCT03008460|450067076|FG001|Overall Study|End of study visit outside permitted time window|1|||
125121084|NCT03008460|450067075|FG000|Overall Study|Lost to Follow-up|1|||
124937869|NCT03524092|449402099|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
124937870|NCT03524092|449402100|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
124937871|NCT03524092|449402101|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
124937872|NCT03524092|449402096|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
124937873|NCT03524092|449402097|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
124937874|NCT03524092|449402098|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
124937875|NCT03524092|449402099|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
124937876|NCT03524092|449402100|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
124937877|NCT03524092|449402101|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
124937878|NCT03524092|449402096|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
124937879|NCT03524092|449402097|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
124937880|NCT03524092|449402098|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
124937881|NCT03524092|449402099|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
124937882|NCT03524092|449402100|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
124937883|NCT03524092|449402101|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
124937884|NCT03834740|449402102|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
124937885|NCT03834740|449402103|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
124937886|NCT03834740|449402104|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
124937887|NCT00115934|449402105|FG000|Overall Study|Lost to Follow-up|1|||
124937888|NCT00115934|449402106|FG001|Overall Study|Lost to Follow-up|0|||
124937889|NCT00115934|449402105|FG000|Overall Study|Did not receive intervention|3|||
124937890|NCT00115934|449402106|FG001|Overall Study|Did not receive intervention|2|||
124937891|NCT03997474|449402107|FG000|Overall Study|Death|6|||
124937892|NCT03997474|449402108|FG001|Overall Study|Death|2|||
124937893|NCT03997474|449402109|FG002|Overall Study|Death|1|||
124937894|NCT03997474|449402107|FG000|Overall Study|Physician Decision|2|||
124937895|NCT03997474|449402108|FG001|Overall Study|Physician Decision|0|||
124937896|NCT03997474|449402109|FG002|Overall Study|Physician Decision|0|||
124937897|NCT03997474|449402107|FG000|Overall Study|study terminated by sponsor|1|||
124937898|NCT03997474|449402108|FG001|Overall Study|study terminated by sponsor|0|||
124937899|NCT03997474|449402109|FG002|Overall Study|study terminated by sponsor|1|||
124937900|NCT03183050|449403056|FG000|Overall Study|Lost to Follow-up|23|||
124937901|NCT00754065|449403057|FG000|Overall Study|Never received treatment|12|||
124937902|NCT00754065|449403058|FG001|Overall Study|Never received treatment|2|||
124937903|NCT00754065|449403057|FG000|Overall Study|Adverse Event|19|||
124937904|NCT00754065|449403058|FG001|Overall Study|Adverse Event|25|||
124937905|NCT00754065|449403057|FG000|Overall Study|Lost to Follow-up|7|||
124937906|NCT00754065|449403058|FG001|Overall Study|Lost to Follow-up|11|||
124937907|NCT00754065|449403057|FG000|Overall Study|Protocol Violation|12|||
124937908|NCT00754065|449403058|FG001|Overall Study|Protocol Violation|10|||
124937909|NCT00754065|449403057|FG000|Overall Study|Withdrawal by Subject|4|||
124937910|NCT00754065|449403058|FG001|Overall Study|Withdrawal by Subject|5|||
124937911|NCT00754065|449403057|FG000|Overall Study|Pregnancy|6|||
124937912|NCT00754065|449403058|FG001|Overall Study|Pregnancy|0|||
124937913|NCT00754065|449403057|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
124937914|NCT00754065|449403058|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
124937915|NCT03776812|449403059|FG000|Overall Study|Death|27|||
124937916|NCT03776812|449403060|FG001|Overall Study|Death|19|||
124937917|NCT03776812|449403061|FG002|Overall Study|Death|29|||
124937918|NCT03776812|449403059|FG000|Overall Study|Withdrawal by Subject|1|||
124937919|NCT03776812|449403060|FG001|Overall Study|Withdrawal by Subject|7|||
124937920|NCT03776812|449403061|FG002|Overall Study|Withdrawal by Subject|1|||
124937921|NCT03776812|449403059|FG000|Overall Study|Lost to Follow-up|0|||
124937922|NCT03776812|449403060|FG001|Overall Study|Lost to Follow-up|1|||
124937923|NCT03776812|449403061|FG002|Overall Study|Lost to Follow-up|0|||
124937924|NCT03776812|449403059|FG000|Overall Study|Still on study as of March 22, 2021 data cutoff date|30|||
124937925|NCT03776812|449403060|FG001|Overall Study|Still on study as of March 22, 2021 data cutoff date|33|||
124937926|NCT03776812|449403061|FG002|Overall Study|Still on study as of March 22, 2021 data cutoff date|30|||
124937927|NCT01171976|449403065|FG000|Overall Study|Protocol Violation|0|||
124937928|NCT01171976|449403066|FG001|Overall Study|Protocol Violation|0|||
124937929|NCT01171976|449403067|FG002|Overall Study|Protocol Violation|1|||
124937930|NCT01171976|449403065|FG000|Overall Study|Death|2|||
124937931|NCT01171976|449403066|FG001|Overall Study|Death|4|||
124937932|NCT01171976|449403067|FG002|Overall Study|Death|1|||
124937933|NCT01171976|449403065|FG000|Overall Study|Lost to Follow-up|4|||
124937934|NCT01171976|449403066|FG001|Overall Study|Lost to Follow-up|0|||
124937935|NCT01171976|449403067|FG002|Overall Study|Lost to Follow-up|2|||
125121085|NCT03008460|450067076|FG001|Overall Study|Lost to Follow-up|3|||
125121086|NCT04947579|450067079|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
125121087|NCT04947579|450067080|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
124937936|NCT01171976|449403065|FG000|Overall Study|Withdrawal by Subject|1|||
124937937|NCT01171976|449403066|FG001|Overall Study|Withdrawal by Subject|5|||
124937938|NCT01171976|449403067|FG002|Overall Study|Withdrawal by Subject|6|||
124937939|NCT01171976|449403065|FG000|Overall Study|Abnormal test result|1|||
124937940|NCT01171976|449403066|FG001|Overall Study|Abnormal test result|0|||
124937941|NCT01171976|449403067|FG002|Overall Study|Abnormal test result|0|||
124937942|NCT01171976|449403065|FG000|Overall Study|Adverse Event|6|||
124937943|NCT01171976|449403066|FG001|Overall Study|Adverse Event|2|||
124937944|NCT01171976|449403067|FG002|Overall Study|Adverse Event|5|||
124937945|NCT06688357|449403068|FG000|Overall Study|Adverse Event|0|||
124937946|NCT06688357|449403069|FG001|Overall Study|Adverse Event|1|||
124937947|NCT03222609|449403072|FG000|Overall Study|Withdrew consent|2|||
124937948|NCT03222609|449403073|FG001|Overall Study|Withdrew consent|3|||
124937949|NCT03222609|449403074|FG002|Overall Study|Withdrew consent|4|||
124937950|NCT03222609|449403075|FG003|Overall Study|Withdrew consent|2|||
124937951|NCT03222609|449403072|FG000|Overall Study|Lost to Follow-up|1|||
124937952|NCT03222609|449403073|FG001|Overall Study|Lost to Follow-up|0|||
124937953|NCT03222609|449403074|FG002|Overall Study|Lost to Follow-up|0|||
124937954|NCT03222609|449403075|FG003|Overall Study|Lost to Follow-up|0|||
124937955|NCT03222609|449403072|FG000|Overall Study|Death|16|||
124937956|NCT03222609|449403073|FG001|Overall Study|Death|13|||
124937957|NCT03222609|449403074|FG002|Overall Study|Death|9|||
124937958|NCT03222609|449403075|FG003|Overall Study|Death|6|||
124937959|NCT03222609|449403072|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
124937960|NCT03222609|449403073|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
124937961|NCT03222609|449403074|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
124937962|NCT03222609|449403075|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
124937963|NCT01084863|449403076|FG000|Main Study Treatment Period|Disease progression|11|||
124937964|NCT01084863|449403077|FG001|Main Study Treatment Period|Disease progression|7|||
124937965|NCT01084863|449403076|FG000|Main Study Treatment Period|Adverse Event|5|||
124937966|NCT01084863|449403077|FG001|Main Study Treatment Period|Adverse Event|3|||
124937967|NCT01084863|449403076|FG000|Main Study Treatment Period|Other Reason|0|||
124937968|NCT01084863|449403077|FG001|Main Study Treatment Period|Other Reason|1|||
124937969|NCT01084863|449403076|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
124937970|NCT01084863|449403077|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
124937971|NCT01084863|449403076|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
124937972|NCT01084863|449403077|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
124937973|NCT01084863|449403076|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
124937974|NCT01084863|449403077|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
124937975|NCT01084863|449403076|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
124937976|NCT01084863|449403077|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
124937977|NCT01084863|449403076|FG000|Treatment Period Beyond Cycle 8|Other|0|||
124937978|NCT01084863|449403077|FG001|Treatment Period Beyond Cycle 8|Other|1|||
124937979|NCT01084863|449403076|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
124937980|NCT01084863|449403077|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
124937981|NCT04305327|449403078|FG000|Overall Study|Study early termination|2|||
124937982|NCT04305327|449403079|FG001|Overall Study|Study early termination|5|||
124937983|NCT04305327|449403080|FG002|Overall Study|Study early termination|2|||
124937984|NCT04305327|449403081|FG003|Overall Study|Study early termination|2|||
124937985|NCT04305327|449403078|FG000|Overall Study|Withdrawal by Subject|0|||
124937986|NCT04305327|449403079|FG001|Overall Study|Withdrawal by Subject|1|||
124937987|NCT04305327|449403080|FG002|Overall Study|Withdrawal by Subject|0|||
124937988|NCT04305327|449403081|FG003|Overall Study|Withdrawal by Subject|0|||
124937989|NCT03275285|449403084|FG000|Overall Study|Ongoing|45|||
124937990|NCT03275285|449403085|FG001|Overall Study|Ongoing|69|||
124937991|NCT06191679|449403086|FG000|Baseline|Lost to Follow-up|1|||
124937992|NCT06191679|449403087|FG001|Baseline|Lost to Follow-up|0|||
124937993|NCT06191679|449403088|FG002|Baseline|Lost to Follow-up|1|||
124937994|NCT06191679|449403089|FG003|Baseline|Lost to Follow-up|0|||
124937995|NCT06191679|449403086|FG000|Allocation to Group|Withdrawal by Subject|0|||
124937996|NCT06191679|449403087|FG001|Allocation to Group|Withdrawal by Subject|1|||
124937997|NCT06191679|449403088|FG002|Allocation to Group|Withdrawal by Subject|2|||
124937998|NCT06191679|449403089|FG003|Allocation to Group|Withdrawal by Subject|0|||
124937999|NCT06191679|449403086|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
125121088|NCT04947579|450067081|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
124938000|NCT06191679|449403087|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
124938001|NCT06191679|449403088|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
124938002|NCT06191679|449403089|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
124938003|NCT06191679|449403086|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
124938004|NCT06191679|449403087|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
124938005|NCT06191679|449403088|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
124938006|NCT06191679|449403089|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
124938007|NCT06191679|449403086|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
124938008|NCT06191679|449403087|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
124938009|NCT06191679|449403088|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
124938010|NCT06191679|449403089|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
124938011|NCT03656718|449403090|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
124938012|NCT03656718|449403091|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
124938013|NCT03656718|449403092|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
124938014|NCT03656718|449403093|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
124938015|NCT03656718|449403094|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
124938016|NCT03656718|449403095|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
124938017|NCT03656718|449403096|FG006|Treatment Period Parts A, B, D, and E|Disease progression|14|||
124938018|NCT03656718|449403090|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
124938019|NCT03656718|449403091|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
124938020|NCT03656718|449403092|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
124938021|NCT03656718|449403093|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
124938022|NCT03656718|449403094|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
124938023|NCT03656718|449403095|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
124938024|NCT03656718|449403096|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
124938025|NCT03656718|449403090|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
124938026|NCT03656718|449403091|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
124938027|NCT03656718|449403092|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
124938028|NCT03656718|449403093|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
124938029|NCT03656718|449403094|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
124938030|NCT03656718|449403095|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
124938031|NCT03656718|449403096|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
124938032|NCT03656718|449403090|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
124938033|NCT03656718|449403091|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
124938034|NCT03656718|449403092|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
124938035|NCT03656718|449403093|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
124938036|NCT03656718|449403094|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
124938037|NCT03656718|449403095|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
124938038|NCT03656718|449403096|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
124938039|NCT03656718|449403090|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
124938040|NCT03656718|449403091|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
124938041|NCT03656718|449403092|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
124938042|NCT03656718|449403093|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
124938043|NCT03656718|449403094|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
124938044|NCT03656718|449403095|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
124938045|NCT03656718|449403096|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
124938046|NCT03656718|449403090|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
124938047|NCT03656718|449403091|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
124938048|NCT03656718|449403092|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
124938049|NCT03656718|449403093|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
124938050|NCT03656718|449403094|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
124938051|NCT03656718|449403095|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
124938052|NCT03656718|449403096|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
124938053|NCT03656718|449403090|FG000|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
124938054|NCT03656718|449403091|FG001|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
124938055|NCT03656718|449403092|FG002|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
124938056|NCT03656718|449403093|FG003|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
124938057|NCT03656718|449403094|FG004|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
124938058|NCT03656718|449403095|FG005|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
124938059|NCT03656718|449403096|FG006|Treatment Period Parts A, B, D, and E|Continuing study treatment|14|||
124938060|NCT03656718|449403090|FG000|Treatment Period Part C|Disease progression|0|||
124938061|NCT03656718|449403091|FG001|Treatment Period Part C|Disease progression|0|||
124938062|NCT03656718|449403092|FG002|Treatment Period Part C|Disease progression|0|||
124938063|NCT03656718|449403093|FG003|Treatment Period Part C|Disease progression|0|||
124938064|NCT03656718|449403094|FG004|Treatment Period Part C|Disease progression|12|||
124938065|NCT03656718|449403095|FG005|Treatment Period Part C|Disease progression|0|||
124938066|NCT03656718|449403096|FG006|Treatment Period Part C|Disease progression|0|||
124938067|NCT03656718|449403090|FG000|Treatment Period Part C|Death|0|||
124938068|NCT03656718|449403091|FG001|Treatment Period Part C|Death|0|||
124938069|NCT03656718|449403092|FG002|Treatment Period Part C|Death|0|||
124938070|NCT03656718|449403093|FG003|Treatment Period Part C|Death|0|||
124938071|NCT03656718|449403094|FG004|Treatment Period Part C|Death|1|||
124938072|NCT03656718|449403095|FG005|Treatment Period Part C|Death|0|||
124938073|NCT03656718|449403096|FG006|Treatment Period Part C|Death|0|||
124938074|NCT03656718|449403090|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
124938075|NCT03656718|449403091|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
124938076|NCT03656718|449403092|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
124938077|NCT03656718|449403093|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
124938078|NCT03656718|449403094|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
124938079|NCT03656718|449403095|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
124938080|NCT03656718|449403096|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
124938081|NCT03656718|449403090|FG000|Treatment Period Part C|Other reasons|0|||
124938082|NCT03656718|449403091|FG001|Treatment Period Part C|Other reasons|0|||
124938083|NCT03656718|449403092|FG002|Treatment Period Part C|Other reasons|0|||
124938084|NCT03656718|449403093|FG003|Treatment Period Part C|Other reasons|0|||
124938085|NCT03656718|449403094|FG004|Treatment Period Part C|Other reasons|1|||
124938086|NCT03656718|449403095|FG005|Treatment Period Part C|Other reasons|0|||
124938087|NCT03656718|449403096|FG006|Treatment Period Part C|Other reasons|0|||
124938088|NCT03656718|449403090|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
124938089|NCT03656718|449403091|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
124938090|NCT03656718|449403092|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
124938091|NCT03656718|449403093|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
124938092|NCT03656718|449403094|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
124938093|NCT03656718|449403095|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
124938094|NCT03656718|449403096|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
124938095|NCT03211247|449403097|FG000|Overall Study|Adverse Event|8|||
124938096|NCT03211247|449403098|FG001|Overall Study|Adverse Event|0|||
124938097|NCT03211247|449403099|FG002|Overall Study|Adverse Event|1|||
124938098|NCT03211247|449403100|FG003|Overall Study|Adverse Event|0|||
124938099|NCT03211247|449403101|FG004|Overall Study|Adverse Event|0|||
124938100|NCT03211247|449403097|FG000|Overall Study|Lost to Follow-up|2|||
124938101|NCT03211247|449403098|FG001|Overall Study|Lost to Follow-up|1|||
124938102|NCT03211247|449403099|FG002|Overall Study|Lost to Follow-up|0|||
124938103|NCT03211247|449403100|FG003|Overall Study|Lost to Follow-up|0|||
124938104|NCT03211247|449403101|FG004|Overall Study|Lost to Follow-up|0|||
124938105|NCT03211247|449403097|FG000|Overall Study|Physician Decision|1|||
124938106|NCT03211247|449403098|FG001|Overall Study|Physician Decision|2|||
124938107|NCT03211247|449403099|FG002|Overall Study|Physician Decision|0|||
124938108|NCT03211247|449403100|FG003|Overall Study|Physician Decision|0|||
124938109|NCT03211247|449403101|FG004|Overall Study|Physician Decision|0|||
124938110|NCT03211247|449403097|FG000|Overall Study|Non-compliance with study drug|2|||
124938111|NCT03211247|449403098|FG001|Overall Study|Non-compliance with study drug|0|||
124938112|NCT03211247|449403099|FG002|Overall Study|Non-compliance with study drug|0|||
124938113|NCT03211247|449403100|FG003|Overall Study|Non-compliance with study drug|0|||
124938114|NCT03211247|449403101|FG004|Overall Study|Non-compliance with study drug|0|||
124938115|NCT03211247|449403097|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
124938116|NCT03211247|449403098|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
124938117|NCT03211247|449403099|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
124938118|NCT03211247|449403100|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
124938119|NCT03211247|449403101|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
124938120|NCT03211247|449403097|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
124938121|NCT03211247|449403098|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
124938122|NCT03211247|449403099|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
124938123|NCT03211247|449403100|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
124938124|NCT03211247|449403101|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
124938125|NCT03211247|449403097|FG000|Overall Study|Protocol Violation|0|||
124938126|NCT03211247|449403098|FG001|Overall Study|Protocol Violation|1|||
124938127|NCT03211247|449403099|FG002|Overall Study|Protocol Violation|0|||
124938128|NCT03211247|449403100|FG003|Overall Study|Protocol Violation|0|||
124938129|NCT03211247|449403101|FG004|Overall Study|Protocol Violation|0|||
124938130|NCT02039401|449403102|FG000|Overall Study|Adverse Event|0|||
124938131|NCT02039401|449403103|FG001|Overall Study|Adverse Event|1|||
124938132|NCT05827068|449403107|FG000|Overall Study|Lost to Follow-up|1|||
124938133|NCT05827068|449403108|FG001|Overall Study|Lost to Follow-up|4|||
124938134|NCT05827068|449403109|FG002|Overall Study|Lost to Follow-up|1|||
124938135|NCT05827068|449403110|FG003|Overall Study|Lost to Follow-up|1|||
124938136|NCT05827068|449403111|FG004|Overall Study|Lost to Follow-up|2|||
124938137|NCT05827068|449403112|FG005|Overall Study|Lost to Follow-up|4|||
124938138|NCT05827068|449403113|FG006|Overall Study|Lost to Follow-up|1|||
124938139|NCT05827068|449403107|FG000|Overall Study|Withdrawal by Subject|4|||
124938140|NCT05827068|449403108|FG001|Overall Study|Withdrawal by Subject|0|||
124938141|NCT05827068|449403109|FG002|Overall Study|Withdrawal by Subject|1|||
124938142|NCT05827068|449403110|FG003|Overall Study|Withdrawal by Subject|2|||
124938143|NCT05827068|449403111|FG004|Overall Study|Withdrawal by Subject|3|||
124938144|NCT05827068|449403112|FG005|Overall Study|Withdrawal by Subject|0|||
124938145|NCT05827068|449403113|FG006|Overall Study|Withdrawal by Subject|1|||
124938146|NCT05827068|449403107|FG000|Overall Study|Physician Decision|0|||
124938147|NCT05827068|449403108|FG001|Overall Study|Physician Decision|0|||
124938148|NCT05827068|449403109|FG002|Overall Study|Physician Decision|0|||
124938149|NCT05827068|449403110|FG003|Overall Study|Physician Decision|0|||
124938150|NCT05827068|449403111|FG004|Overall Study|Physician Decision|1|||
124938151|NCT05827068|449403112|FG005|Overall Study|Physician Decision|0|||
124938152|NCT05827068|449403113|FG006|Overall Study|Physician Decision|1|||
124938153|NCT05827068|449403107|FG000|Overall Study|Other Than Specified|0|||
124938154|NCT05827068|449403108|FG001|Overall Study|Other Than Specified|1|||
124938155|NCT05827068|449403109|FG002|Overall Study|Other Than Specified|0|||
124938156|NCT05827068|449403110|FG003|Overall Study|Other Than Specified|0|||
124938157|NCT05827068|449403111|FG004|Overall Study|Other Than Specified|0|||
124938158|NCT05827068|449403112|FG005|Overall Study|Other Than Specified|0|||
124938159|NCT05827068|449403113|FG006|Overall Study|Other Than Specified|0|||
124938160|NCT00353496|449403114|FG000|Overall Study|Adverse Event|1|||
124938161|NCT00353496|449403115|FG001|Overall Study|Adverse Event|0|||
124938162|NCT00353496|449403114|FG000|Overall Study|Protocol Violation|2|||
124938163|NCT00353496|449403115|FG001|Overall Study|Protocol Violation|2|||
124938164|NCT00353496|449403114|FG000|Overall Study|Withdrawal by Subject|3|||
124938165|NCT00353496|449403115|FG001|Overall Study|Withdrawal by Subject|4|||
124938166|NCT00353496|449403114|FG000|Overall Study|Physician Decision|6|||
124938167|NCT00353496|449403115|FG001|Overall Study|Physician Decision|9|||
124938168|NCT00353496|449403114|FG000|Overall Study|Not otherwise specified|4|||
124938169|NCT00353496|449403115|FG001|Overall Study|Not otherwise specified|2|||
124938170|NCT04980300|449403116|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
124938171|NCT04980300|449403117|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
124938172|NCT04980300|449403116|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
124938173|NCT04980300|449403117|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
124938174|NCT04980300|449403116|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
124938175|NCT04980300|449403117|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
124938176|NCT04980300|449403116|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
124938177|NCT04980300|449403117|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
124938178|NCT01470144|449403123|FG000|Overall Study|Adverse Event|2|||
124938179|NCT01470144|449403123|FG000|Overall Study|Death|1|||
124938180|NCT01470144|449403123|FG000|Overall Study|Lung transplant|6|||
124938181|NCT01470144|449403123|FG000|Overall Study|Patient's and investigator's decision|1|||
124938182|NCT03459196|449403738|FG000|Overall Study|Subject didn't receive study catheter|2|||
124938183|NCT02325466|449403739|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
124938184|NCT02325466|449403740|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
124938185|NCT02325466|449403741|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
124938186|NCT02325466|449403739|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
124938187|NCT02325466|449403740|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
124938188|NCT02325466|449403741|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
124938189|NCT02325466|449403739|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
124938190|NCT02325466|449403740|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
124938191|NCT02325466|449403741|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
124938192|NCT02325466|449403739|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
124938193|NCT02325466|449403740|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
124938194|NCT02325466|449403741|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
124938195|NCT02325466|449403739|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
124938196|NCT02325466|449403740|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
124938197|NCT02325466|449403741|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
124938198|NCT02325466|449403739|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
124938199|NCT02325466|449403740|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
124938200|NCT02325466|449403741|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
124938201|NCT02325466|449403739|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
124938202|NCT02325466|449403740|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
124938203|NCT02325466|449403741|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
124938204|NCT02325466|449403739|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
124938205|NCT02325466|449403740|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
124938206|NCT02325466|449403741|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
124938207|NCT02325466|449403739|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
124938208|NCT02325466|449403740|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
124938209|NCT02325466|449403741|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
124938210|NCT01074294|449403742|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
124938211|NCT01074294|449403743|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
124938212|NCT01074294|449403744|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
124938213|NCT01074294|449403745|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
124938214|NCT01074294|449403742|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
124938215|NCT01074294|449403743|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
124938216|NCT01074294|449403744|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
124938217|NCT01074294|449403745|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
124938218|NCT01074294|449403742|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
124938219|NCT01074294|449403743|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
124938220|NCT01074294|449403744|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
124938221|NCT01074294|449403745|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
124938222|NCT01074294|449403742|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
124938223|NCT01074294|449403743|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
124938224|NCT01074294|449403744|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
124938225|NCT01074294|449403745|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
124938226|NCT01074294|449403742|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
124938227|NCT01074294|449403743|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
124938228|NCT01074294|449403744|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
124938229|NCT01074294|449403745|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
124938230|NCT01074294|449403742|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
124938231|NCT01074294|449403743|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
124938232|NCT01074294|449403744|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
124938233|NCT01074294|449403745|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
124938234|NCT01074294|449403742|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
124938235|NCT01074294|449403743|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
124938236|NCT01074294|449403744|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
124938237|NCT01074294|449403745|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
124938238|NCT01074294|449403742|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
124938239|NCT01074294|449403743|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
124938240|NCT01074294|449403744|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
124938241|NCT01074294|449403745|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
124938242|NCT01074294|449403742|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
124938243|NCT01074294|449403743|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
124938244|NCT01074294|449403744|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
124938245|NCT01074294|449403745|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
124938246|NCT01074294|449403742|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
124938247|NCT01074294|449403743|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
124938248|NCT01074294|449403744|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
124938249|NCT01074294|449403745|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
124938250|NCT01074294|449403742|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
124938251|NCT01074294|449403743|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
124938252|NCT01074294|449403744|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
124938253|NCT01074294|449403745|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
124938254|NCT01074294|449403742|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
124938255|NCT01074294|449403743|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
124938256|NCT01074294|449403744|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
124938257|NCT01074294|449403745|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
124938258|NCT01074294|449403742|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
124938259|NCT01074294|449403743|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
124938260|NCT01074294|449403744|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
124938261|NCT01074294|449403745|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
124938262|NCT02284113|449403747|FG000|Overall Study|Adverse Event|1|||
124938263|NCT02284113|449403748|FG001|Overall Study|Adverse Event|0|||
124938264|NCT02284113|449403747|FG000|Overall Study|non-compliance|0|||
124938265|NCT02284113|449403748|FG001|Overall Study|non-compliance|1|||
124938266|NCT02284113|449403747|FG000|Overall Study|Withdrawal by Subject|0|||
124938267|NCT02284113|449403748|FG001|Overall Study|Withdrawal by Subject|1|||
124938268|NCT02284113|449403747|FG000|Overall Study|not provided|0|||
124938269|NCT02284113|449403748|FG001|Overall Study|not provided|1|||
124938270|NCT02284113|449403747|FG000|Overall Study|surgery cancelled|2|||
124938271|NCT02284113|449403748|FG001|Overall Study|surgery cancelled|0|||
124938272|NCT03885232|449403749|FG000|Overall Study|Lost to Follow-up|74|||
124938273|NCT03885232|449403750|FG001|Overall Study|Lost to Follow-up|32|||
124938274|NCT03885232|449403749|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
124938275|NCT03885232|449403750|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
124938276|NCT01315132|449403751|FG000|Overall Study|not treated due to disease progression|1|||
124938277|NCT03840902|449403754|FG000|Overall Study|Randomized but not treated|1|||
124938278|NCT03840902|449403755|FG001|Overall Study|Randomized but not treated|1|||
124938279|NCT03660930|449403756|FG000|Overall Study|Adverse Event|0|||
124938280|NCT03660930|449403757|FG001|Overall Study|Adverse Event|0|||
124938281|NCT03660930|449403758|FG002|Overall Study|Adverse Event|0|||
124938282|NCT03660930|449403759|FG003|Overall Study|Adverse Event|2|||
124938283|NCT03660930|449403760|FG004|Overall Study|Adverse Event|0|||
124938284|NCT03660930|449403761|FG005|Overall Study|Adverse Event|1|||
124938285|NCT03660930|449403762|FG006|Overall Study|Adverse Event|0|||
124938286|NCT03660930|449403763|FG007|Overall Study|Adverse Event|0|||
124938287|NCT03660930|449403756|FG000|Overall Study|Withdrawal by Subject|0|||
124938288|NCT03660930|449403757|FG001|Overall Study|Withdrawal by Subject|0|||
124938289|NCT03660930|449403758|FG002|Overall Study|Withdrawal by Subject|0|||
124938290|NCT03660930|449403759|FG003|Overall Study|Withdrawal by Subject|0|||
124938291|NCT03660930|449403760|FG004|Overall Study|Withdrawal by Subject|0|||
124938292|NCT03660930|449403761|FG005|Overall Study|Withdrawal by Subject|1|||
124938293|NCT03660930|449403762|FG006|Overall Study|Withdrawal by Subject|0|||
124938294|NCT03660930|449403763|FG007|Overall Study|Withdrawal by Subject|0|||
124938295|NCT03509909|449403764|FG000|Overall Study|Withdrawal by Subject|16|||
124938296|NCT03509909|449403765|FG001|Overall Study|Withdrawal by Subject|9|||
124938297|NCT03509909|449403764|FG000|Overall Study|Lost to Follow-up|3|||
124938298|NCT03509909|449403765|FG001|Overall Study|Lost to Follow-up|4|||
124938299|NCT03509909|449403764|FG000|Overall Study|Adverse Event|2|||
124938300|NCT03509909|449403765|FG001|Overall Study|Adverse Event|0|||
124938301|NCT05139992|449403771|FG000|Overall Study|Withdrawal by Subject|12|||
124938302|NCT05139992|449403771|FG000|Overall Study|Lost to Follow-up|6|||
124938303|NCT01208974|449403772|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
124938304|NCT01208974|449403773|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
124938305|NCT01208974|449403774|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
124938306|NCT01208974|449403775|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
124938307|NCT01208974|449403772|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
124938308|NCT01208974|449403773|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
124938309|NCT01208974|449403774|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
124938310|NCT01208974|449403775|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
124938311|NCT01208974|449403772|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
124938312|NCT01208974|449403773|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
124938313|NCT01208974|449403774|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
124938314|NCT01208974|449403775|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
124938315|NCT05521516|449403776|FG000|Overall Study|Withdrawal by Subject|1|||
124938316|NCT05521516|449403777|FG001|Overall Study|Withdrawal by Subject|1|||
124938317|NCT03777657|449403778|FG000|Overall Study|Death|397|||
124938318|NCT03777657|449403779|FG001|Overall Study|Death|431|||
124938319|NCT03777657|449403778|FG000|Overall Study|Study Closed by Sponsor|77|||
124938320|NCT03777657|449403779|FG001|Overall Study|Study Closed by Sponsor|38|||
124938321|NCT03777657|449403778|FG000|Overall Study|Withdrawal by Subject|20|||
124938322|NCT03777657|449403779|FG001|Overall Study|Withdrawal by Subject|17|||
124938323|NCT03777657|449403778|FG000|Overall Study|Lost to Follow-up|6|||
124938324|NCT03777657|449403779|FG001|Overall Study|Lost to Follow-up|10|||
124938325|NCT02500576|449403780|FG000|Overall Study|Adverse Event|0|||
124938326|NCT02500576|449403781|FG001|Overall Study|Adverse Event|1|||
124938327|NCT02500576|449403780|FG000|Overall Study|Death|2|||
124938328|NCT02500576|449403781|FG001|Overall Study|Death|1|||
124938329|NCT02500576|449403780|FG000|Overall Study|Lack of Efficacy|5|||
124938330|NCT02500576|449403781|FG001|Overall Study|Lack of Efficacy|5|||
124938331|NCT02500576|449403780|FG000|Overall Study|Withdrawal by Subject|1|||
124938332|NCT02500576|449403781|FG001|Overall Study|Withdrawal by Subject|1|||
124938333|NCT03691493|449403787|FG000|Overall Study|Withdrawal by Subject|1|||
124938334|NCT03867201|449403788|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
124938335|NCT03867201|449403789|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
124938336|NCT03867201|449403788|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
124938337|NCT03867201|449403789|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
124938338|NCT03867201|449403788|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
124938339|NCT03867201|449403789|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
124938340|NCT03867201|449403788|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
124938341|NCT03867201|449403789|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
124938342|NCT03867201|449403788|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
124938343|NCT03867201|449403789|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
124938344|NCT03867201|449403788|FG000|Open-Label Period From Week 12|Adverse Event|5|||
124938345|NCT03867201|449403789|FG001|Open-Label Period From Week 12|Adverse Event|11|||
124938346|NCT03867201|449403788|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
124938347|NCT03867201|449403789|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
124938348|NCT03867201|449403788|FG000|Open-Label Period From Week 12|Physician Decision|6|||
125026813|NCT01528787|449722363|FG000|Overall Study|Withdrawal by Subject|0|||
124938349|NCT03867201|449403789|FG001|Open-Label Period From Week 12|Physician Decision|3|||
124938350|NCT03867201|449403788|FG000|Open-Label Period From Week 12|Pregnancy|2|||
124938351|NCT03867201|449403789|FG001|Open-Label Period From Week 12|Pregnancy|2|||
124938352|NCT03867201|449403788|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
124938353|NCT03867201|449403789|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
124938354|NCT03867201|449403788|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
124938355|NCT03867201|449403789|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
124938356|NCT03867201|449403788|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
124938357|NCT03867201|449403789|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
124938358|NCT03867201|449403788|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
124938359|NCT03867201|449403789|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
124938360|NCT01983683|449403790|FG000|Overall Study|Withdrawal by Subject|14|||
124938361|NCT01983683|449403791|FG001|Overall Study|Withdrawal by Subject|18|||
124938362|NCT01983683|449403790|FG000|Overall Study|Death|11|||
124938363|NCT01983683|449403791|FG001|Overall Study|Death|15|||
124938364|NCT01983683|449403790|FG000|Overall Study|Physician Decision|8|||
124938365|NCT01983683|449403791|FG001|Overall Study|Physician Decision|9|||
124938366|NCT01983683|449403790|FG000|Overall Study|Lost to Follow-up|4|||
124938367|NCT01983683|449403791|FG001|Overall Study|Lost to Follow-up|8|||
124938368|NCT01983683|449403790|FG000|Overall Study|Sponsor Decision|1|||
124938369|NCT01983683|449403791|FG001|Overall Study|Sponsor Decision|1|||
124938370|NCT05464732|449403794|FG000|Overall Study|Lost to Follow-up|0|||
124938371|NCT05464732|449403795|FG001|Overall Study|Lost to Follow-up|1|||
124938372|NCT05464732|449403794|FG000|Overall Study|Adverse Event|1|||
124938373|NCT05464732|449403795|FG001|Overall Study|Adverse Event|0|||
124938374|NCT04039113|449403802|FG000|Overall Study|Withdrawal by Subject|8|||
124938375|NCT04039113|449403803|FG001|Overall Study|Withdrawal by Subject|11|||
124938376|NCT04039113|449403802|FG000|Overall Study|Lost to Follow-up|1|||
124938377|NCT04039113|449403803|FG001|Overall Study|Lost to Follow-up|1|||
124938378|NCT04039113|449403802|FG000|Overall Study|Adverse Event|2|||
124938379|NCT04039113|449403803|FG001|Overall Study|Adverse Event|2|||
124938380|NCT04039113|449403802|FG000|Overall Study|Death|2|||
124938381|NCT04039113|449403803|FG001|Overall Study|Death|4|||
124938382|NCT04039113|449403802|FG000|Overall Study|Site Closure|6|||
124938383|NCT04039113|449403803|FG001|Overall Study|Site Closure|0|||
124938384|NCT04039113|449403802|FG000|Overall Study|Failure to meet randomisation criteria|4|||
124938385|NCT04039113|449403803|FG001|Overall Study|Failure to meet randomisation criteria|0|||
124938386|NCT05786612|449403804|FG000|Overall Study|Adverse Event|1|||
124938387|NCT05786612|449403805|FG001|Overall Study|Adverse Event|2|||
124938388|NCT05786612|449403804|FG000|Overall Study|one screening failure|0|||
124938389|NCT05786612|449403805|FG001|Overall Study|one screening failure|2|||
124938390|NCT04926740|449403806|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
124938391|NCT04926740|449403807|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
124938392|NCT04926740|449403806|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
124938393|NCT04926740|449403807|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
124938394|NCT00655499|449404673|FG000|Overall Study|not eligible|4|||
124938395|NCT03140670|449404679|FG000|Overall Study|Withdrawal by Subject|2|||
124938396|NCT03140670|449404679|FG000|Overall Study|Lost to Follow-up|1|||
124938397|NCT03140670|449404679|FG000|Overall Study|Physician Decision|1|||
124938398|NCT00220805|449404680|FG000|Overall Study|Adverse Event|1|||
124938399|NCT00220805|449404681|FG001|Overall Study|Adverse Event|3|||
124938400|NCT00220805|449404680|FG000|Overall Study|Withdrawal by Subject|3|||
124938401|NCT00220805|449404681|FG001|Overall Study|Withdrawal by Subject|0|||
124938402|NCT00220805|449404680|FG000|Overall Study|Lack of Efficacy|1|||
124938403|NCT00220805|449404681|FG001|Overall Study|Lack of Efficacy|0|||
124938404|NCT00220805|449404680|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
124938405|NCT00220805|449404681|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
124938406|NCT00146172|449404682|FG000|Overall Study|Adverse Event|0|||
124938407|NCT00146172|449404683|FG001|Overall Study|Adverse Event|0|||
124938408|NCT00146172|449404684|FG002|Overall Study|Adverse Event|1|||
124938409|NCT00146172|449404685|FG003|Overall Study|Adverse Event|1|||
124938410|NCT00146172|449404686|FG004|Overall Study|Adverse Event|0|||
124938411|NCT00146172|449404687|FG005|Overall Study|Adverse Event|2|||
124938412|NCT00146172|449404688|FG006|Overall Study|Adverse Event|3|||
124938413|NCT00146172|449404689|FG007|Overall Study|Adverse Event|10|||
124938414|NCT00146172|449404682|FG000|Overall Study|Lost to Follow-up|0|||
124938415|NCT00146172|449404683|FG001|Overall Study|Lost to Follow-up|0|||
124938416|NCT00146172|449404684|FG002|Overall Study|Lost to Follow-up|0|||
124938417|NCT00146172|449404685|FG003|Overall Study|Lost to Follow-up|0|||
124938418|NCT00146172|449404686|FG004|Overall Study|Lost to Follow-up|0|||
124938419|NCT00146172|449404687|FG005|Overall Study|Lost to Follow-up|0|||
124938420|NCT00146172|449404688|FG006|Overall Study|Lost to Follow-up|0|||
124938421|NCT00146172|449404689|FG007|Overall Study|Lost to Follow-up|1|||
125121089|NCT04947579|450067082|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
125121090|NCT04947579|450067083|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
125121091|NCT04947579|450067084|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
125121092|NCT04947579|450067079|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
125121093|NCT04947579|450067080|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
125121094|NCT04947579|450067081|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
125121095|NCT04947579|450067082|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
125121096|NCT04947579|450067083|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
125121097|NCT04947579|450067084|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
125121098|NCT04947579|450067079|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
125121099|NCT04947579|450067080|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
125121100|NCT04947579|450067081|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
125121101|NCT04947579|450067082|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
125121102|NCT04947579|450067083|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
125121103|NCT04947579|450067084|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
125121104|NCT04947579|450067079|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
125121105|NCT04947579|450067080|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
125121106|NCT04947579|450067081|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
125121107|NCT04947579|450067082|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
125121108|NCT04947579|450067083|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
125121109|NCT04947579|450067084|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
125121110|NCT04947579|450067079|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
125121111|NCT04947579|450067080|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
125121112|NCT04947579|450067081|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
125121113|NCT04947579|450067082|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
125121114|NCT04947579|450067083|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
125121115|NCT04947579|450067084|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
125121116|NCT04947579|450067079|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
125121117|NCT04947579|450067080|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
125121118|NCT04947579|450067081|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
125121119|NCT04947579|450067082|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
125121120|NCT04947579|450067083|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
125121121|NCT04947579|450067084|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
125121122|NCT04947579|450067079|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
125121123|NCT04947579|450067080|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
125121124|NCT04947579|450067081|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
125121125|NCT04947579|450067082|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
125121126|NCT04947579|450067083|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
125121127|NCT04947579|450067084|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
125121128|NCT04947579|450067079|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
125121129|NCT04947579|450067080|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
125121130|NCT04947579|450067081|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
125121131|NCT04947579|450067082|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
125121132|NCT04947579|450067083|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
125121133|NCT04947579|450067084|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
125121134|NCT04947579|450067079|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
125121135|NCT04947579|450067080|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
125121136|NCT04947579|450067081|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
125121137|NCT04947579|450067082|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
125121138|NCT04947579|450067083|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
125121139|NCT04947579|450067084|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
125121140|NCT04947579|450067079|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
125121141|NCT04947579|450067080|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
125121142|NCT04947579|450067081|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
125121143|NCT04947579|450067082|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
125121144|NCT04947579|450067083|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
124938422|NCT00146172|449404682|FG000|Overall Study|Disease Progression|2|||
124938423|NCT00146172|449404683|FG001|Overall Study|Disease Progression|4|||
124938424|NCT00146172|449404684|FG002|Overall Study|Disease Progression|2|||
125026814|NCT01528787|449722364|FG001|Overall Study|Withdrawal by Subject|0|||
125026815|NCT01528787|449722365|FG002|Overall Study|Withdrawal by Subject|0|||
125026816|NCT01528787|449722366|FG003|Overall Study|Withdrawal by Subject|1|||
125026817|NCT01528787|449722363|FG000|Overall Study|Family Emergency|0|||
125026818|NCT01528787|449722364|FG001|Overall Study|Family Emergency|0|||
125026819|NCT01528787|449722365|FG002|Overall Study|Family Emergency|1|||
125026820|NCT01528787|449722366|FG003|Overall Study|Family Emergency|0|||
125026821|NCT03882424|449722367|FG000|Overall Study|Lost to Follow-up|3|||
125026822|NCT03882424|449722368|FG001|Overall Study|Lost to Follow-up|0|||
125026823|NCT03882424|449722369|FG002|Overall Study|Lost to Follow-up|0|||
125026824|NCT03882424|449722367|FG000|Overall Study|schedule conflict|1|||
125026825|NCT03882424|449722368|FG001|Overall Study|schedule conflict|0|||
125026826|NCT03882424|449722369|FG002|Overall Study|schedule conflict|0|||
125026827|NCT01961544|449722370|FG000|Overall Study|Protocol Violation|1|||
125026828|NCT01961544|449722370|FG000|Overall Study|Withdrawal by Subject|7|||
125026829|NCT01961544|449722370|FG000|Overall Study|Adverse Event|1|||
125026830|NCT01961544|449722370|FG000|Overall Study|Physician Decision|2|||
125026831|NCT01961544|449722370|FG000|Overall Study|Poor Tolerance|1|||
125026832|NCT01961544|449722370|FG000|Overall Study|Aggravation of Steral Pain|1|||
125026833|NCT03665285|449722371|FG000|Overall Study|Started New Anticancer Treatment|1|||
125026834|NCT03665285|449722372|FG001|Overall Study|Started New Anticancer Treatment|1|||
125026835|NCT03665285|449722373|FG002|Overall Study|Started New Anticancer Treatment|2|||
125026836|NCT03665285|449722374|FG003|Overall Study|Started New Anticancer Treatment|4|||
125026837|NCT03665285|449722375|FG004|Overall Study|Started New Anticancer Treatment|1|||
125026838|NCT03665285|449722376|FG005|Overall Study|Started New Anticancer Treatment|1|||
125026839|NCT03665285|449722377|FG006|Overall Study|Started New Anticancer Treatment|2|||
125026840|NCT03665285|449722378|FG007|Overall Study|Started New Anticancer Treatment|15|||
125026841|NCT03665285|449722379|FG008|Overall Study|Started New Anticancer Treatment|1|||
125026842|NCT03665285|449722371|FG000|Overall Study|Disease Progression|0|||
125026843|NCT03665285|449722372|FG001|Overall Study|Disease Progression|0|||
125026844|NCT03665285|449722373|FG002|Overall Study|Disease Progression|3|||
125026845|NCT03665285|449722374|FG003|Overall Study|Disease Progression|1|||
125026846|NCT03665285|449722375|FG004|Overall Study|Disease Progression|0|||
125026847|NCT03665285|449722376|FG005|Overall Study|Disease Progression|0|||
125026848|NCT03665285|449722377|FG006|Overall Study|Disease Progression|0|||
125026849|NCT03665285|449722378|FG007|Overall Study|Disease Progression|7|||
125026850|NCT03665285|449722379|FG008|Overall Study|Disease Progression|1|||
125026851|NCT03665285|449722371|FG000|Overall Study|Hospice|0|||
125026852|NCT03665285|449722372|FG001|Overall Study|Hospice|0|||
125026853|NCT03665285|449722373|FG002|Overall Study|Hospice|0|||
125026854|NCT03665285|449722374|FG003|Overall Study|Hospice|0|||
125026855|NCT03665285|449722375|FG004|Overall Study|Hospice|0|||
125026856|NCT03665285|449722376|FG005|Overall Study|Hospice|0|||
125026857|NCT03665285|449722377|FG006|Overall Study|Hospice|0|||
125026858|NCT03665285|449722378|FG007|Overall Study|Hospice|2|||
125026859|NCT03665285|449722379|FG008|Overall Study|Hospice|0|||
125026860|NCT03665285|449722371|FG000|Overall Study|Withdrawal by Subject|0|||
125026861|NCT03665285|449722372|FG001|Overall Study|Withdrawal by Subject|0|||
125026862|NCT03665285|449722373|FG002|Overall Study|Withdrawal by Subject|0|||
125026863|NCT03665285|449722374|FG003|Overall Study|Withdrawal by Subject|0|||
125026864|NCT03665285|449722375|FG004|Overall Study|Withdrawal by Subject|1|||
125026865|NCT03665285|449722376|FG005|Overall Study|Withdrawal by Subject|0|||
125026866|NCT03665285|449722377|FG006|Overall Study|Withdrawal by Subject|0|||
125026867|NCT03665285|449722378|FG007|Overall Study|Withdrawal by Subject|2|||
125026868|NCT03665285|449722379|FG008|Overall Study|Withdrawal by Subject|0|||
125026869|NCT03665285|449722371|FG000|Overall Study|Physician Decision|0|||
125026870|NCT03665285|449722372|FG001|Overall Study|Physician Decision|0|||
125026871|NCT03665285|449722373|FG002|Overall Study|Physician Decision|0|||
125026872|NCT03665285|449722374|FG003|Overall Study|Physician Decision|0|||
125026873|NCT03665285|449722375|FG004|Overall Study|Physician Decision|0|||
125026874|NCT03665285|449722376|FG005|Overall Study|Physician Decision|0|||
125026875|NCT03665285|449722377|FG006|Overall Study|Physician Decision|0|||
124938425|NCT00146172|449404685|FG003|Overall Study|Disease Progression|5|||
124938426|NCT00146172|449404686|FG004|Overall Study|Disease Progression|2|||
124938427|NCT00146172|449404687|FG005|Overall Study|Disease Progression|2|||
124938428|NCT00146172|449404688|FG006|Overall Study|Disease Progression|1|||
124938429|NCT00146172|449404689|FG007|Overall Study|Disease Progression|22|||
124938430|NCT00146172|449404682|FG000|Overall Study|Death|0|||
124938431|NCT00146172|449404683|FG001|Overall Study|Death|0|||
124938432|NCT00146172|449404684|FG002|Overall Study|Death|0|||
124938433|NCT00146172|449404685|FG003|Overall Study|Death|0|||
124938434|NCT00146172|449404686|FG004|Overall Study|Death|0|||
124938435|NCT00146172|449404687|FG005|Overall Study|Death|0|||
124938436|NCT00146172|449404688|FG006|Overall Study|Death|1|||
124938437|NCT00146172|449404689|FG007|Overall Study|Death|0|||
124938438|NCT00146172|449404682|FG000|Overall Study|Physician Decision|0|||
124938439|NCT00146172|449404683|FG001|Overall Study|Physician Decision|0|||
124938440|NCT00146172|449404684|FG002|Overall Study|Physician Decision|0|||
124938441|NCT00146172|449404685|FG003|Overall Study|Physician Decision|0|||
124938442|NCT00146172|449404686|FG004|Overall Study|Physician Decision|0|||
124938443|NCT00146172|449404687|FG005|Overall Study|Physician Decision|0|||
124938444|NCT00146172|449404688|FG006|Overall Study|Physician Decision|0|||
124938445|NCT00146172|449404689|FG007|Overall Study|Physician Decision|1|||
124938446|NCT00146172|449404682|FG000|Overall Study|Withdrawal by Subject|0|||
124938447|NCT00146172|449404683|FG001|Overall Study|Withdrawal by Subject|0|||
124938448|NCT00146172|449404684|FG002|Overall Study|Withdrawal by Subject|0|||
124938449|NCT00146172|449404685|FG003|Overall Study|Withdrawal by Subject|0|||
124938450|NCT00146172|449404686|FG004|Overall Study|Withdrawal by Subject|0|||
124938451|NCT00146172|449404687|FG005|Overall Study|Withdrawal by Subject|1|||
124938452|NCT00146172|449404688|FG006|Overall Study|Withdrawal by Subject|1|||
124938453|NCT00146172|449404689|FG007|Overall Study|Withdrawal by Subject|4|||
124938454|NCT00146172|449404682|FG000|Overall Study|Symptomatic Deterioration|1|||
124938455|NCT00146172|449404683|FG001|Overall Study|Symptomatic Deterioration|0|||
124938456|NCT00146172|449404684|FG002|Overall Study|Symptomatic Deterioration|1|||
124938457|NCT00146172|449404685|FG003|Overall Study|Symptomatic Deterioration|0|||
124938458|NCT00146172|449404686|FG004|Overall Study|Symptomatic Deterioration|1|||
124938459|NCT00146172|449404687|FG005|Overall Study|Symptomatic Deterioration|2|||
124938460|NCT00146172|449404688|FG006|Overall Study|Symptomatic Deterioration|0|||
124938461|NCT00146172|449404689|FG007|Overall Study|Symptomatic Deterioration|2|||
124938462|NCT01288443|449404692|FG000|Overall Study|Adverse Event|0|||
124938463|NCT01288443|449404693|FG001|Overall Study|Adverse Event|0|||
124938464|NCT01288443|449404694|FG002|Overall Study|Adverse Event|1|||
124938465|NCT01288443|449404695|FG003|Overall Study|Adverse Event|1|||
124938466|NCT01288443|449404696|FG004|Overall Study|Adverse Event|3|||
124938467|NCT01288443|449404697|FG005|Overall Study|Adverse Event|1|||
124938468|NCT01288443|449404692|FG000|Overall Study|Poor compliance to protocol|0|||
124938469|NCT01288443|449404693|FG001|Overall Study|Poor compliance to protocol|0|||
124938470|NCT01288443|449404694|FG002|Overall Study|Poor compliance to protocol|0|||
124938471|NCT01288443|449404695|FG003|Overall Study|Poor compliance to protocol|0|||
124938472|NCT01288443|449404696|FG004|Overall Study|Poor compliance to protocol|0|||
124938473|NCT01288443|449404697|FG005|Overall Study|Poor compliance to protocol|1|||
124938474|NCT01288443|449404692|FG000|Overall Study|Participant Moved|0|||
124938475|NCT01288443|449404693|FG001|Overall Study|Participant Moved|0|||
124938476|NCT01288443|449404694|FG002|Overall Study|Participant Moved|0|||
124938477|NCT01288443|449404695|FG003|Overall Study|Participant Moved|1|||
124938478|NCT01288443|449404696|FG004|Overall Study|Participant Moved|2|||
124938479|NCT01288443|449404697|FG005|Overall Study|Participant Moved|1|||
125026876|NCT03665285|449722378|FG007|Overall Study|Physician Decision|2|||
125026877|NCT03665285|449722379|FG008|Overall Study|Physician Decision|0|||
124938480|NCT01288443|449404692|FG000|Overall Study|Consent withdrawn by Participant|0|||
124938481|NCT01288443|449404693|FG001|Overall Study|Consent withdrawn by Participant|0|||
124938482|NCT01288443|449404694|FG002|Overall Study|Consent withdrawn by Participant|0|||
124938483|NCT01288443|449404695|FG003|Overall Study|Consent withdrawn by Participant|0|||
124938484|NCT01288443|449404696|FG004|Overall Study|Consent withdrawn by Participant|0|||
124938485|NCT01288443|449404697|FG005|Overall Study|Consent withdrawn by Participant|1|||
124938486|NCT01288443|449404692|FG000|Overall Study|Lost to Follow-up|0|||
124938487|NCT01288443|449404693|FG001|Overall Study|Lost to Follow-up|1|||
124938488|NCT01288443|449404694|FG002|Overall Study|Lost to Follow-up|0|||
124938489|NCT01288443|449404695|FG003|Overall Study|Lost to Follow-up|0|||
124938490|NCT01288443|449404696|FG004|Overall Study|Lost to Follow-up|0|||
124938491|NCT01288443|449404697|FG005|Overall Study|Lost to Follow-up|0|||
124938492|NCT01288443|449404692|FG000|Overall Study|Study drug auto-injector administration|0|||
124938493|NCT01288443|449404693|FG001|Overall Study|Study drug auto-injector administration|0|||
125026878|NCT03213366|449722384|FG000|Overall Study|Lost to Follow-up|9|||
124938494|NCT01288443|449404694|FG002|Overall Study|Study drug auto-injector administration|0|||
124938495|NCT01288443|449404695|FG003|Overall Study|Study drug auto-injector administration|0|||
124938496|NCT01288443|449404696|FG004|Overall Study|Study drug auto-injector administration|1|||
124938497|NCT01288443|449404697|FG005|Overall Study|Study drug auto-injector administration|1|||
124938498|NCT01288443|449404692|FG000|Overall Study|Other than above|0|||
124938499|NCT01288443|449404693|FG001|Overall Study|Other than above|0|||
124938500|NCT01288443|449404694|FG002|Overall Study|Other than above|0|||
124938501|NCT01288443|449404695|FG003|Overall Study|Other than above|2|||
124938502|NCT01288443|449404696|FG004|Overall Study|Other than above|1|||
124938503|NCT01288443|449404697|FG005|Overall Study|Other than above|0|||
124938504|NCT01596972|449404698|FG000|Overall Study|Physician Decision|1|||
124938505|NCT01596972|449404699|FG001|Overall Study|Physician Decision|9|||
124938506|NCT01596972|449404698|FG000|Overall Study|Lost to Follow-up|0|||
124938507|NCT01596972|449404699|FG001|Overall Study|Lost to Follow-up|4|||
124938508|NCT01596972|449404698|FG000|Overall Study|Withdrawal by Subject|0|||
124938509|NCT01596972|449404699|FG001|Overall Study|Withdrawal by Subject|1|||
124938510|NCT01964300|449404702|FG000|Overall Study|Ineligible after enrollment|0|||
124938511|NCT01964300|449404703|FG001|Overall Study|Ineligible after enrollment|1|||
124938512|NCT01964300|449404702|FG000|Overall Study|Adverse Event|1|||
124938513|NCT01964300|449404703|FG001|Overall Study|Adverse Event|1|||
124938514|NCT01964300|449404702|FG000|Overall Study|Lack of Efficacy|3|||
124938515|NCT01964300|449404703|FG001|Overall Study|Lack of Efficacy|5|||
124938516|NCT01964300|449404702|FG000|Overall Study|Withdrawal by Subject|0|||
124938517|NCT01964300|449404703|FG001|Overall Study|Withdrawal by Subject|1|||
124938518|NCT01964300|449404702|FG000|Overall Study|To receive alternative therapy|1|||
124938519|NCT01964300|449404703|FG001|Overall Study|To receive alternative therapy|2|||
124938520|NCT01964300|449404702|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
124938521|NCT01964300|449404703|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
124938522|NCT01964300|449404702|FG000|Overall Study|Weight criteria not met|0|||
124938523|NCT01964300|449404703|FG001|Overall Study|Weight criteria not met|1|||
124938524|NCT00557492|449404704|FG000|Overall Study|Change in health insurance|1|||
124938525|NCT02438137|449404705|FG000|Overall Study|Lost to Follow-up|3|||
124938526|NCT02438137|449404706|FG001|Overall Study|Lost to Follow-up|2|||
124938527|NCT02438137|449404705|FG000|Overall Study|Adverse Event|1|||
124938528|NCT02438137|449404706|FG001|Overall Study|Adverse Event|0|||
124938529|NCT02438137|449404705|FG000|Overall Study|Withdrawal by Subject|4|||
124938530|NCT02438137|449404706|FG001|Overall Study|Withdrawal by Subject|3|||
124938531|NCT02438137|449404705|FG000|Overall Study|Physician Decision|0|||
124938532|NCT02438137|449404706|FG001|Overall Study|Physician Decision|1|||
124938533|NCT02285270|449404707|FG000|Overall Study|Lost to Follow-up|1|||
124938534|NCT02285270|449404707|FG000|Overall Study|Physician Decision|3|||
124938535|NCT02285270|449404707|FG000|Overall Study|Determined to be ineligible|1|||
124938536|NCT04868617|449404708|FG000|Overall Study|Death|1|||
124938537|NCT04868617|449404709|FG001|Overall Study|Death|0|||
124938538|NCT04868617|449404708|FG000|Overall Study|Adverse Event|1|||
124938539|NCT04868617|449404709|FG001|Overall Study|Adverse Event|0|||
124938540|NCT04868617|449404708|FG000|Overall Study|Withdrawal by Subject|1|||
124938541|NCT04868617|449404709|FG001|Overall Study|Withdrawal by Subject|0|||
124938542|NCT04868617|449404708|FG000|Overall Study|Device deficiency|1|||
124938543|NCT04868617|449404709|FG001|Overall Study|Device deficiency|0|||
124938544|NCT00623194|449404710|FG000|Overall Study|Lack of Efficacy|1|||
124938545|NCT00623194|449404710|FG000|Overall Study|Protocol Violation|3|||
124938546|NCT00623194|449404710|FG000|Overall Study|Unclassified|1|||
124938547|NCT01260896|449404711|FG000|First Intervention|Withdrawn Due to Emesis|2|||
124938548|NCT01260896|449404712|FG001|First Intervention|Withdrawn Due to Emesis|0|||
124938549|NCT00312208|449404713|FG000|Overall Study|Adverse Event|97|||
124938550|NCT00312208|449404714|FG001|Overall Study|Adverse Event|61|||
124938551|NCT00312208|449404713|FG000|Overall Study|Protocol Violation|5|||
124938552|NCT00312208|449404714|FG001|Overall Study|Protocol Violation|3|||
124938553|NCT00312208|449404713|FG000|Overall Study|Death|2|||
124938554|NCT00312208|449404714|FG001|Overall Study|Death|1|||
124938555|NCT00312208|449404713|FG000|Overall Study|Lack of Efficacy|7|||
125121145|NCT04947579|450067084|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
125121146|NCT04947579|450067079|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
124938556|NCT00312208|449404714|FG001|Overall Study|Lack of Efficacy|4|||
124938557|NCT00312208|449404713|FG000|Overall Study|Lost to Follow-up|3|||
124938558|NCT00312208|449404714|FG001|Overall Study|Lost to Follow-up|5|||
124938559|NCT00312208|449404713|FG000|Overall Study|Withdrawal by Subject|53|||
124938560|NCT00312208|449404714|FG001|Overall Study|Withdrawal by Subject|42|||
124938561|NCT00312208|449404713|FG000|Overall Study|Other|5|||
124938562|NCT00312208|449404714|FG001|Overall Study|Other|7|||
124938563|NCT00982644|449404717|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
124938564|NCT00982644|449404718|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
124938565|NCT00982644|449404717|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
124938566|NCT00982644|449404718|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
124938567|NCT00982644|449404717|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
124938568|NCT00982644|449404718|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
124938569|NCT00982644|449404717|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
124938570|NCT00982644|449404718|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
124938571|NCT00982644|449404717|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
124938572|NCT00982644|449404718|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
124938573|NCT00982644|449404717|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
124938574|NCT00982644|449404718|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
124938575|NCT00982644|449404717|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
124938576|NCT00982644|449404718|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
124938577|NCT00982644|449404717|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
124938578|NCT00982644|449404718|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
124938579|NCT00982644|449404717|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
124938580|NCT00982644|449404718|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
124938581|NCT00982644|449404717|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
124938582|NCT00982644|449404718|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
124938583|NCT00943917|449404721|FG000|Stage I|Adverse Event|1|||
124938584|NCT00943917|449404722|FG001|Stage I|Adverse Event|2|||
124938585|NCT00943917|449404723|FG002|Stage I|Adverse Event|2|||
124938586|NCT00943917|449404724|FG003|Stage I|Adverse Event|0|||
124938587|NCT00943917|449404725|FG004|Stage I|Adverse Event|0|||
124938588|NCT00943917|449404726|FG005|Stage I|Adverse Event|0|||
124938589|NCT00943917|449404727|FG006|Stage I|Adverse Event|0|||
124938590|NCT00943917|449404728|FG007|Stage I|Adverse Event|0|||
124938591|NCT00943917|449404729|FG008|Stage I|Adverse Event|0|||
124938592|NCT00943917|449404730|FG009|Stage I|Adverse Event|0|||
124938593|NCT00943917|449404731|FG010|Stage I|Adverse Event|0|||
124938594|NCT00943917|449404732|FG011|Stage I|Adverse Event|0|||
124938595|NCT00943917|449404733|FG012|Stage I|Adverse Event|0|||
124938596|NCT00943917|449404734|FG013|Stage I|Adverse Event|0|||
124938597|NCT00943917|449404735|FG014|Stage I|Adverse Event|0|||
124938598|NCT00943917|449404721|FG000|Stage I|Lost to Follow-up|0|||
124938599|NCT00943917|449404722|FG001|Stage I|Lost to Follow-up|0|||
124938600|NCT00943917|449404723|FG002|Stage I|Lost to Follow-up|1|||
124938601|NCT00943917|449404724|FG003|Stage I|Lost to Follow-up|0|||
124938602|NCT00943917|449404725|FG004|Stage I|Lost to Follow-up|0|||
124938603|NCT00943917|449404726|FG005|Stage I|Lost to Follow-up|0|||
124938604|NCT00943917|449404727|FG006|Stage I|Lost to Follow-up|0|||
124938605|NCT00943917|449404728|FG007|Stage I|Lost to Follow-up|0|||
124938606|NCT00943917|449404729|FG008|Stage I|Lost to Follow-up|0|||
124938607|NCT00943917|449404730|FG009|Stage I|Lost to Follow-up|0|||
124938608|NCT00943917|449404731|FG010|Stage I|Lost to Follow-up|0|||
124938609|NCT00943917|449404732|FG011|Stage I|Lost to Follow-up|0|||
124938610|NCT00943917|449404733|FG012|Stage I|Lost to Follow-up|0|||
124938611|NCT00943917|449404734|FG013|Stage I|Lost to Follow-up|0|||
124938612|NCT00943917|449404735|FG014|Stage I|Lost to Follow-up|0|||
124938613|NCT00943917|449404721|FG000|Stage I|hyperglycemia|0|||
124938614|NCT00943917|449404722|FG001|Stage I|hyperglycemia|0|||
124938615|NCT00943917|449404723|FG002|Stage I|hyperglycemia|1|||
124938616|NCT00943917|449404724|FG003|Stage I|hyperglycemia|0|||
124938617|NCT00943917|449404725|FG004|Stage I|hyperglycemia|0|||
124938618|NCT00943917|449404726|FG005|Stage I|hyperglycemia|0|||
124938619|NCT00943917|449404727|FG006|Stage I|hyperglycemia|0|||
124938620|NCT00943917|449404728|FG007|Stage I|hyperglycemia|0|||
124938621|NCT00943917|449404729|FG008|Stage I|hyperglycemia|0|||
124938622|NCT00943917|449404730|FG009|Stage I|hyperglycemia|0|||
124938623|NCT00943917|449404731|FG010|Stage I|hyperglycemia|0|||
124938624|NCT00943917|449404732|FG011|Stage I|hyperglycemia|0|||
124938625|NCT00943917|449404733|FG012|Stage I|hyperglycemia|0|||
124938626|NCT00943917|449404734|FG013|Stage I|hyperglycemia|0|||
124938627|NCT00943917|449404735|FG014|Stage I|hyperglycemia|0|||
124938628|NCT00943917|449404721|FG000|Stage I|A1C elevation|1|||
124938629|NCT00943917|449404722|FG001|Stage I|A1C elevation|0|||
124938630|NCT00943917|449404723|FG002|Stage I|A1C elevation|0|||
124938631|NCT00943917|449404724|FG003|Stage I|A1C elevation|0|||
124938632|NCT00943917|449404725|FG004|Stage I|A1C elevation|0|||
124938633|NCT00943917|449404726|FG005|Stage I|A1C elevation|0|||
124938634|NCT00943917|449404727|FG006|Stage I|A1C elevation|0|||
124938635|NCT00943917|449404728|FG007|Stage I|A1C elevation|0|||
124938636|NCT00943917|449404729|FG008|Stage I|A1C elevation|0|||
124938637|NCT00943917|449404730|FG009|Stage I|A1C elevation|0|||
124938638|NCT00943917|449404731|FG010|Stage I|A1C elevation|0|||
124938639|NCT00943917|449404732|FG011|Stage I|A1C elevation|0|||
124938640|NCT00943917|449404733|FG012|Stage I|A1C elevation|0|||
124938641|NCT00943917|449404734|FG013|Stage I|A1C elevation|0|||
124938642|NCT00943917|449404735|FG014|Stage I|A1C elevation|0|||
124938643|NCT00943917|449404721|FG000|Stage I|Withdrawal by Subject|2|||
124938644|NCT00943917|449404722|FG001|Stage I|Withdrawal by Subject|1|||
124938645|NCT00943917|449404723|FG002|Stage I|Withdrawal by Subject|2|||
124938646|NCT00943917|449404724|FG003|Stage I|Withdrawal by Subject|0|||
124938647|NCT00943917|449404725|FG004|Stage I|Withdrawal by Subject|0|||
124938648|NCT00943917|449404726|FG005|Stage I|Withdrawal by Subject|0|||
124938649|NCT00943917|449404727|FG006|Stage I|Withdrawal by Subject|0|||
124938650|NCT00943917|449404728|FG007|Stage I|Withdrawal by Subject|0|||
124938651|NCT00943917|449404729|FG008|Stage I|Withdrawal by Subject|0|||
124938652|NCT00943917|449404730|FG009|Stage I|Withdrawal by Subject|0|||
124938653|NCT00943917|449404731|FG010|Stage I|Withdrawal by Subject|0|||
124938654|NCT00943917|449404732|FG011|Stage I|Withdrawal by Subject|0|||
124938655|NCT00943917|449404733|FG012|Stage I|Withdrawal by Subject|0|||
124938656|NCT00943917|449404734|FG013|Stage I|Withdrawal by Subject|0|||
124938657|NCT00943917|449404735|FG014|Stage I|Withdrawal by Subject|0|||
124938658|NCT00943917|449404721|FG000|Stage II|Adverse Event|0|||
124938659|NCT00943917|449404722|FG001|Stage II|Adverse Event|0|||
125212854|NCT03300050|450405491|FG000|Overall Study|Withdrawal by Subject|1|||
124938660|NCT00943917|449404723|FG002|Stage II|Adverse Event|0|||
124938661|NCT00943917|449404724|FG003|Stage II|Adverse Event|0|||
124938662|NCT00943917|449404725|FG004|Stage II|Adverse Event|0|||
125212855|NCT03300050|450405492|FG001|Overall Study|Withdrawal by Subject|1|||
124938663|NCT00943917|449404726|FG005|Stage II|Adverse Event|1|||
124938664|NCT00943917|449404727|FG006|Stage II|Adverse Event|3|||
124938665|NCT00943917|449404728|FG007|Stage II|Adverse Event|0|||
124938666|NCT00943917|449404729|FG008|Stage II|Adverse Event|1|||
124938667|NCT00943917|449404730|FG009|Stage II|Adverse Event|0|||
124938668|NCT00943917|449404731|FG010|Stage II|Adverse Event|0|||
125026879|NCT03213366|449722385|FG001|Overall Study|Lost to Follow-up|4|||
125026880|NCT00666926|449722386|FG000|Overall Study|Adverse Event|0|||
125026881|NCT00666926|449722387|FG001|Overall Study|Adverse Event|0|||
125026882|NCT00666926|449722388|FG002|Overall Study|Adverse Event|0|||
125026883|NCT00666926|449722389|FG003|Overall Study|Adverse Event|0|||
125026884|NCT00666926|449722390|FG004|Overall Study|Adverse Event|0|||
125026885|NCT00666926|449722391|FG005|Overall Study|Adverse Event|0|||
125026886|NCT00666926|449722392|FG006|Overall Study|Adverse Event|0|||
125026887|NCT00666926|449722393|FG007|Overall Study|Adverse Event|0|||
125026888|NCT00666926|449722394|FG008|Overall Study|Adverse Event|0|||
125026889|NCT00666926|449722395|FG009|Overall Study|Adverse Event|2|||
125026890|NCT00666926|449722396|FG010|Overall Study|Adverse Event|2|||
125026891|NCT00666926|449722397|FG011|Overall Study|Adverse Event|2|||
125026892|NCT00666926|449722398|FG012|Overall Study|Adverse Event|0|||
125026893|NCT00666926|449722399|FG013|Overall Study|Adverse Event|1|||
125026894|NCT00666926|449722400|FG014|Overall Study|Adverse Event|0|||
125026895|NCT00666926|449722401|FG015|Overall Study|Adverse Event|0|||
125026896|NCT00666926|449722386|FG000|Overall Study|Laboratory abnormality|0|||
125026897|NCT00666926|449722387|FG001|Overall Study|Laboratory abnormality|0|||
125026898|NCT00666926|449722388|FG002|Overall Study|Laboratory abnormality|0|||
125026899|NCT00666926|449722389|FG003|Overall Study|Laboratory abnormality|0|||
125026900|NCT00666926|449722390|FG004|Overall Study|Laboratory abnormality|0|||
125026901|NCT00666926|449722391|FG005|Overall Study|Laboratory abnormality|0|||
125026902|NCT00666926|449722392|FG006|Overall Study|Laboratory abnormality|0|||
125026903|NCT00666926|449722393|FG007|Overall Study|Laboratory abnormality|0|||
125026904|NCT00666926|449722394|FG008|Overall Study|Laboratory abnormality|0|||
125026905|NCT00666926|449722395|FG009|Overall Study|Laboratory abnormality|0|||
125026906|NCT00666926|449722396|FG010|Overall Study|Laboratory abnormality|1|||
125026907|NCT00666926|449722397|FG011|Overall Study|Laboratory abnormality|0|||
125026908|NCT00666926|449722398|FG012|Overall Study|Laboratory abnormality|0|||
125026909|NCT00666926|449722399|FG013|Overall Study|Laboratory abnormality|0|||
124938669|NCT00943917|449404732|FG011|Stage II|Adverse Event|0|||
124938670|NCT00943917|449404733|FG012|Stage II|Adverse Event|0|||
124938671|NCT00943917|449404734|FG013|Stage II|Adverse Event|0|||
124938672|NCT00943917|449404735|FG014|Stage II|Adverse Event|0|||
124938673|NCT00943917|449404721|FG000|Stage II|Withdrawal by Subject|0|||
124938674|NCT00943917|449404722|FG001|Stage II|Withdrawal by Subject|0|||
124938675|NCT00943917|449404723|FG002|Stage II|Withdrawal by Subject|0|||
124938676|NCT00943917|449404724|FG003|Stage II|Withdrawal by Subject|0|||
124938677|NCT00943917|449404725|FG004|Stage II|Withdrawal by Subject|0|||
124938678|NCT00943917|449404726|FG005|Stage II|Withdrawal by Subject|1|||
124938679|NCT00943917|449404727|FG006|Stage II|Withdrawal by Subject|0|||
124938680|NCT00943917|449404728|FG007|Stage II|Withdrawal by Subject|0|||
124938681|NCT00943917|449404729|FG008|Stage II|Withdrawal by Subject|0|||
124938682|NCT00943917|449404730|FG009|Stage II|Withdrawal by Subject|0|||
124938683|NCT00943917|449404731|FG010|Stage II|Withdrawal by Subject|0|||
124938684|NCT00943917|449404732|FG011|Stage II|Withdrawal by Subject|0|||
124938685|NCT00943917|449404733|FG012|Stage II|Withdrawal by Subject|0|||
124938686|NCT00943917|449404734|FG013|Stage II|Withdrawal by Subject|0|||
124938687|NCT00943917|449404735|FG014|Stage II|Withdrawal by Subject|0|||
124938688|NCT00943917|449404721|FG000|Stage II|Pregnancy|0|||
124938689|NCT00943917|449404722|FG001|Stage II|Pregnancy|0|||
124938690|NCT00943917|449404723|FG002|Stage II|Pregnancy|0|||
124938691|NCT00943917|449404724|FG003|Stage II|Pregnancy|0|||
124938692|NCT00943917|449404725|FG004|Stage II|Pregnancy|0|||
124938693|NCT00943917|449404726|FG005|Stage II|Pregnancy|1|||
124938694|NCT00943917|449404727|FG006|Stage II|Pregnancy|0|||
124938695|NCT00943917|449404728|FG007|Stage II|Pregnancy|0|||
124938696|NCT00943917|449404729|FG008|Stage II|Pregnancy|0|||
124938697|NCT00943917|449404730|FG009|Stage II|Pregnancy|0|||
124938698|NCT00943917|449404731|FG010|Stage II|Pregnancy|0|||
124938699|NCT00943917|449404732|FG011|Stage II|Pregnancy|0|||
124938700|NCT00943917|449404733|FG012|Stage II|Pregnancy|0|||
124938701|NCT00943917|449404734|FG013|Stage II|Pregnancy|0|||
124938702|NCT00943917|449404735|FG014|Stage II|Pregnancy|0|||
124938703|NCT00943917|449404721|FG000|Stage II Continuation|Adverse Event|0|||
124938704|NCT00943917|449404722|FG001|Stage II Continuation|Adverse Event|0|||
124938705|NCT00943917|449404723|FG002|Stage II Continuation|Adverse Event|0|||
124938706|NCT00943917|449404724|FG003|Stage II Continuation|Adverse Event|0|||
124938707|NCT00943917|449404725|FG004|Stage II Continuation|Adverse Event|0|||
124938708|NCT00943917|449404726|FG005|Stage II Continuation|Adverse Event|0|||
124938709|NCT00943917|449404727|FG006|Stage II Continuation|Adverse Event|0|||
124938710|NCT00943917|449404728|FG007|Stage II Continuation|Adverse Event|0|||
124938711|NCT00943917|449404729|FG008|Stage II Continuation|Adverse Event|0|||
124938712|NCT00943917|449404730|FG009|Stage II Continuation|Adverse Event|0|||
124938713|NCT00943917|449404731|FG010|Stage II Continuation|Adverse Event|0|||
124938714|NCT00943917|449404732|FG011|Stage II Continuation|Adverse Event|1|||
124938715|NCT00943917|449404733|FG012|Stage II Continuation|Adverse Event|2|||
124938716|NCT00943917|449404734|FG013|Stage II Continuation|Adverse Event|1|||
124938717|NCT00943917|449404735|FG014|Stage II Continuation|Adverse Event|1|||
124938718|NCT00943917|449404721|FG000|Stage II Continuation|Withdrawal by Subject|0|||
124938719|NCT00943917|449404722|FG001|Stage II Continuation|Withdrawal by Subject|0|||
124938720|NCT00943917|449404723|FG002|Stage II Continuation|Withdrawal by Subject|0|||
124938721|NCT00943917|449404724|FG003|Stage II Continuation|Withdrawal by Subject|0|||
124938722|NCT00943917|449404725|FG004|Stage II Continuation|Withdrawal by Subject|0|||
124938723|NCT00943917|449404726|FG005|Stage II Continuation|Withdrawal by Subject|0|||
124938724|NCT00943917|449404727|FG006|Stage II Continuation|Withdrawal by Subject|0|||
124938725|NCT00943917|449404728|FG007|Stage II Continuation|Withdrawal by Subject|0|||
124938726|NCT00943917|449404729|FG008|Stage II Continuation|Withdrawal by Subject|0|||
124938727|NCT00943917|449404730|FG009|Stage II Continuation|Withdrawal by Subject|0|||
124938728|NCT00943917|449404731|FG010|Stage II Continuation|Withdrawal by Subject|0|||
124938729|NCT00943917|449404732|FG011|Stage II Continuation|Withdrawal by Subject|0|||
124938730|NCT00943917|449404733|FG012|Stage II Continuation|Withdrawal by Subject|0|||
124938731|NCT00943917|449404734|FG013|Stage II Continuation|Withdrawal by Subject|1|||
124938732|NCT00943917|449404735|FG014|Stage II Continuation|Withdrawal by Subject|3|||
124938733|NCT00943917|449404721|FG000|Stage II Continuation|Protocol Violation|0|||
124938734|NCT00943917|449404722|FG001|Stage II Continuation|Protocol Violation|0|||
124938735|NCT00943917|449404723|FG002|Stage II Continuation|Protocol Violation|0|||
124938736|NCT00943917|449404724|FG003|Stage II Continuation|Protocol Violation|0|||
124938737|NCT00943917|449404725|FG004|Stage II Continuation|Protocol Violation|0|||
124938738|NCT00943917|449404726|FG005|Stage II Continuation|Protocol Violation|0|||
124938739|NCT00943917|449404727|FG006|Stage II Continuation|Protocol Violation|0|||
124938740|NCT00943917|449404728|FG007|Stage II Continuation|Protocol Violation|0|||
124938741|NCT00943917|449404729|FG008|Stage II Continuation|Protocol Violation|0|||
124938742|NCT00943917|449404730|FG009|Stage II Continuation|Protocol Violation|1|||
124938743|NCT00943917|449404731|FG010|Stage II Continuation|Protocol Violation|0|||
124938744|NCT00943917|449404732|FG011|Stage II Continuation|Protocol Violation|1|||
124938745|NCT00943917|449404733|FG012|Stage II Continuation|Protocol Violation|0|||
124938746|NCT00943917|449404734|FG013|Stage II Continuation|Protocol Violation|0|||
124938747|NCT00943917|449404735|FG014|Stage II Continuation|Protocol Violation|0|||
124938748|NCT00943917|449404721|FG000|Stage II Continuation|hypoglycemia|0|||
124938749|NCT00943917|449404722|FG001|Stage II Continuation|hypoglycemia|0|||
124938750|NCT00943917|449404723|FG002|Stage II Continuation|hypoglycemia|0|||
124938751|NCT00943917|449404724|FG003|Stage II Continuation|hypoglycemia|0|||
124938752|NCT00943917|449404725|FG004|Stage II Continuation|hypoglycemia|0|||
124938753|NCT00943917|449404726|FG005|Stage II Continuation|hypoglycemia|0|||
124938754|NCT00943917|449404727|FG006|Stage II Continuation|hypoglycemia|0|||
124938755|NCT00943917|449404728|FG007|Stage II Continuation|hypoglycemia|0|||
124938756|NCT00943917|449404729|FG008|Stage II Continuation|hypoglycemia|0|||
124938757|NCT00943917|449404730|FG009|Stage II Continuation|hypoglycemia|0|||
124938758|NCT00943917|449404731|FG010|Stage II Continuation|hypoglycemia|0|||
124938759|NCT00943917|449404732|FG011|Stage II Continuation|hypoglycemia|0|||
124938760|NCT00943917|449404733|FG012|Stage II Continuation|hypoglycemia|1|||
124938761|NCT00943917|449404734|FG013|Stage II Continuation|hypoglycemia|0|||
124938762|NCT00943917|449404735|FG014|Stage II Continuation|hypoglycemia|0|||
124938763|NCT00943917|449404721|FG000|Stage II Continuation|A1C elevation|0|||
124938764|NCT00943917|449404722|FG001|Stage II Continuation|A1C elevation|0|||
124938765|NCT00943917|449404723|FG002|Stage II Continuation|A1C elevation|0|||
124938766|NCT00943917|449404724|FG003|Stage II Continuation|A1C elevation|0|||
124938767|NCT00943917|449404725|FG004|Stage II Continuation|A1C elevation|0|||
124938768|NCT00943917|449404726|FG005|Stage II Continuation|A1C elevation|0|||
124938769|NCT00943917|449404727|FG006|Stage II Continuation|A1C elevation|0|||
124938770|NCT00943917|449404728|FG007|Stage II Continuation|A1C elevation|0|||
124938771|NCT00943917|449404729|FG008|Stage II Continuation|A1C elevation|0|||
124938772|NCT00943917|449404730|FG009|Stage II Continuation|A1C elevation|0|||
124938773|NCT00943917|449404731|FG010|Stage II Continuation|A1C elevation|0|||
124938774|NCT00943917|449404732|FG011|Stage II Continuation|A1C elevation|0|||
124938775|NCT00943917|449404733|FG012|Stage II Continuation|A1C elevation|0|||
124938776|NCT00943917|449404734|FG013|Stage II Continuation|A1C elevation|1|||
124938777|NCT00943917|449404735|FG014|Stage II Continuation|A1C elevation|0|||
124938778|NCT02844439|449404736|FG000|Overall Study|Withdrawal by Subject|1|||
124938779|NCT02844439|449404736|FG000|Overall Study|Lost to Follow-up|2|||
124938780|NCT02844439|449404736|FG000|Overall Study|Termination by Sponsor|4|||
124938781|NCT02844439|449404736|FG000|Overall Study|Death|28|||
124938782|NCT02844439|449404736|FG000|Overall Study|Other|5|||
124938783|NCT03170648|449404741|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
124938784|NCT03170648|449404741|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
124938785|NCT03500549|449404742|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
124938786|NCT03500549|449404743|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
124938787|NCT03500549|449404742|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
124938788|NCT03500549|449404743|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
124938789|NCT02754596|449404744|FG000|Overall Study|Withdrawal by Subject|3|||
124938790|NCT02754596|449404745|FG001|Overall Study|Withdrawal by Subject|4|||
124938791|NCT02754596|449404746|FG002|Overall Study|Withdrawal by Subject|0|||
124938792|NCT02754596|449404744|FG000|Overall Study|Physician Decision|1|||
124938793|NCT02754596|449404745|FG001|Overall Study|Physician Decision|1|||
124938794|NCT02754596|449404746|FG002|Overall Study|Physician Decision|1|||
124938795|NCT02754596|449404744|FG000|Overall Study|Lost to Follow-up|1|||
124938796|NCT02754596|449404745|FG001|Overall Study|Lost to Follow-up|1|||
124938797|NCT02754596|449404746|FG002|Overall Study|Lost to Follow-up|2|||
124938798|NCT02754596|449404744|FG000|Overall Study|Death|0|||
124938799|NCT02754596|449404745|FG001|Overall Study|Death|2|||
124938800|NCT02754596|449404746|FG002|Overall Study|Death|0|||
124938801|NCT02754596|449404744|FG000|Overall Study|Adverse Event|1|||
124938802|NCT02754596|449404745|FG001|Overall Study|Adverse Event|0|||
124938803|NCT02754596|449404746|FG002|Overall Study|Adverse Event|1|||
124938804|NCT02754596|449404744|FG000|Overall Study|Other|1|||
124938805|NCT02754596|449404745|FG001|Overall Study|Other|0|||
124938806|NCT02754596|449404746|FG002|Overall Study|Other|0|||
124938807|NCT02107261|449404747|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
124938808|NCT02107261|449404748|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
124938809|NCT02107261|449404747|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
124938810|NCT02107261|449404748|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
124938811|NCT04337931|449404749|FG000|Overall Study|Death|4|||
124938812|NCT04337931|449404750|FG001|Overall Study|Death|1|||
124938813|NCT04337931|449404751|FG002|Overall Study|Death|7|||
124938814|NCT04337931|449404749|FG000|Overall Study|Withdrawal by Subject|0|||
124938815|NCT04337931|449404750|FG001|Overall Study|Withdrawal by Subject|1|||
125026910|NCT00666926|449722400|FG014|Overall Study|Laboratory abnormality|0|||
125026911|NCT00666926|449722401|FG015|Overall Study|Laboratory abnormality|1|||
125026912|NCT00666926|449722386|FG000|Overall Study|Lack of Efficacy|0|||
125026913|NCT00666926|449722387|FG001|Overall Study|Lack of Efficacy|0|||
125026914|NCT00666926|449722388|FG002|Overall Study|Lack of Efficacy|0|||
125026915|NCT00666926|449722389|FG003|Overall Study|Lack of Efficacy|0|||
125026916|NCT00666926|449722390|FG004|Overall Study|Lack of Efficacy|0|||
125026917|NCT00666926|449722391|FG005|Overall Study|Lack of Efficacy|1|||
125026918|NCT00666926|449722392|FG006|Overall Study|Lack of Efficacy|0|||
125026919|NCT00666926|449722393|FG007|Overall Study|Lack of Efficacy|0|||
125026920|NCT00666926|449722394|FG008|Overall Study|Lack of Efficacy|0|||
125026921|NCT00666926|449722395|FG009|Overall Study|Lack of Efficacy|0|||
125026922|NCT00666926|449722396|FG010|Overall Study|Lack of Efficacy|0|||
125026923|NCT00666926|449722397|FG011|Overall Study|Lack of Efficacy|1|||
125026924|NCT00666926|449722398|FG012|Overall Study|Lack of Efficacy|0|||
125026925|NCT00666926|449722399|FG013|Overall Study|Lack of Efficacy|0|||
125026926|NCT00666926|449722400|FG014|Overall Study|Lack of Efficacy|0|||
125026927|NCT00666926|449722401|FG015|Overall Study|Lack of Efficacy|0|||
125026928|NCT00666926|449722386|FG000|Overall Study|Lost to Follow-up|0|||
125026929|NCT00666926|449722387|FG001|Overall Study|Lost to Follow-up|0|||
125026930|NCT00666926|449722388|FG002|Overall Study|Lost to Follow-up|0|||
125026931|NCT00666926|449722389|FG003|Overall Study|Lost to Follow-up|1|||
125026932|NCT00666926|449722390|FG004|Overall Study|Lost to Follow-up|0|||
125026933|NCT00666926|449722391|FG005|Overall Study|Lost to Follow-up|0|||
125026934|NCT00666926|449722392|FG006|Overall Study|Lost to Follow-up|0|||
125026935|NCT00666926|449722393|FG007|Overall Study|Lost to Follow-up|0|||
125026936|NCT00666926|449722394|FG008|Overall Study|Lost to Follow-up|0|||
125026937|NCT00666926|449722395|FG009|Overall Study|Lost to Follow-up|0|||
125026938|NCT00666926|449722396|FG010|Overall Study|Lost to Follow-up|0|||
125026939|NCT00666926|449722397|FG011|Overall Study|Lost to Follow-up|0|||
125026940|NCT00666926|449722398|FG012|Overall Study|Lost to Follow-up|0|||
125026941|NCT00666926|449722399|FG013|Overall Study|Lost to Follow-up|0|||
125026942|NCT00666926|449722400|FG014|Overall Study|Lost to Follow-up|0|||
125026943|NCT00666926|449722401|FG015|Overall Study|Lost to Follow-up|0|||
125026944|NCT00666926|449722386|FG000|Overall Study|Other|2|||
125026945|NCT00666926|449722387|FG001|Overall Study|Other|4|||
125026946|NCT00666926|449722388|FG002|Overall Study|Other|3|||
125026947|NCT00666926|449722389|FG003|Overall Study|Other|3|||
125212856|NCT03300050|450405493|FG002|Overall Study|Withdrawal by Subject|1|||
125212857|NCT03300050|450405494|FG003|Overall Study|Withdrawal by Subject|0|||
125212858|NCT03300050|450405495|FG004|Overall Study|Withdrawal by Subject|0|||
125212859|NCT03300050|450405491|FG000|Overall Study|Death|0|||
125212860|NCT03300050|450405492|FG001|Overall Study|Death|0|||
125212861|NCT03300050|450405493|FG002|Overall Study|Death|1|||
125212862|NCT03300050|450405494|FG003|Overall Study|Death|0|||
125026948|NCT00666926|449722390|FG004|Overall Study|Other|3|||
125026949|NCT00666926|449722391|FG005|Overall Study|Other|3|||
125026950|NCT00666926|449722392|FG006|Overall Study|Other|4|||
125026951|NCT00666926|449722393|FG007|Overall Study|Other|0|||
125026952|NCT00666926|449722394|FG008|Overall Study|Other|3|||
125026953|NCT00666926|449722395|FG009|Overall Study|Other|5|||
125026954|NCT00666926|449722396|FG010|Overall Study|Other|3|||
125026955|NCT00666926|449722397|FG011|Overall Study|Other|26|||
125026956|NCT00666926|449722398|FG012|Overall Study|Other|3|||
125026957|NCT00666926|449722399|FG013|Overall Study|Other|2|||
125026958|NCT00666926|449722400|FG014|Overall Study|Other|4|||
125026959|NCT00666926|449722401|FG015|Overall Study|Other|4|||
125026960|NCT00666926|449722386|FG000|Overall Study|Withdrawal by Subject|0|||
125026961|NCT00666926|449722387|FG001|Overall Study|Withdrawal by Subject|0|||
125026962|NCT00666926|449722388|FG002|Overall Study|Withdrawal by Subject|0|||
125026963|NCT00666926|449722389|FG003|Overall Study|Withdrawal by Subject|0|||
125026964|NCT00666926|449722390|FG004|Overall Study|Withdrawal by Subject|0|||
125026965|NCT00666926|449722391|FG005|Overall Study|Withdrawal by Subject|0|||
125026966|NCT00666926|449722392|FG006|Overall Study|Withdrawal by Subject|0|||
125026967|NCT00666926|449722393|FG007|Overall Study|Withdrawal by Subject|1|||
125026968|NCT00666926|449722394|FG008|Overall Study|Withdrawal by Subject|0|||
125026969|NCT00666926|449722395|FG009|Overall Study|Withdrawal by Subject|3|||
125212863|NCT03300050|450405495|FG004|Overall Study|Death|0|||
125212864|NCT03300050|450405491|FG000|Overall Study|Not Eligible at Randomization|0|||
125212865|NCT03300050|450405492|FG001|Overall Study|Not Eligible at Randomization|0|||
125212866|NCT03300050|450405493|FG002|Overall Study|Not Eligible at Randomization|1|||
125026970|NCT00666926|449722396|FG010|Overall Study|Withdrawal by Subject|0|||
125026971|NCT00666926|449722397|FG011|Overall Study|Withdrawal by Subject|3|||
125026972|NCT00666926|449722398|FG012|Overall Study|Withdrawal by Subject|0|||
125026973|NCT00666926|449722399|FG013|Overall Study|Withdrawal by Subject|1|||
125026974|NCT00666926|449722400|FG014|Overall Study|Withdrawal by Subject|3|||
125026975|NCT00666926|449722401|FG015|Overall Study|Withdrawal by Subject|3|||
125026976|NCT00666926|449722386|FG000|Overall Study|Death|0|||
125026977|NCT00666926|449722387|FG001|Overall Study|Death|0|||
125026978|NCT00666926|449722388|FG002|Overall Study|Death|0|||
125026979|NCT00666926|449722389|FG003|Overall Study|Death|0|||
124938816|NCT04337931|449404751|FG002|Overall Study|Withdrawal by Subject|0|||
124938817|NCT04337931|449404749|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
124938818|NCT04337931|449404750|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
124938819|NCT04337931|449404751|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
124938820|NCT04337931|449404749|FG000|Overall Study|Study terminated by sponsor|3|||
124938821|NCT04337931|449404750|FG001|Overall Study|Study terminated by sponsor|6|||
124938822|NCT04337931|449404751|FG002|Overall Study|Study terminated by sponsor|2|||
124938823|NCT04337931|449404749|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
124938824|NCT04337931|449404750|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
125212867|NCT03300050|450405494|FG003|Overall Study|Not Eligible at Randomization|1|||
125212868|NCT03300050|450405495|FG004|Overall Study|Not Eligible at Randomization|0|||
125212869|NCT00631163|450405496|FG000|Number of Participants in Year 1|Adverse Event|12|||
125212870|NCT00631163|450405496|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
124938825|NCT04337931|449404751|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
124938826|NCT04337931|449404749|FG000|Overall Study|Colorectal cancer treatment|1|||
125212871|NCT00631163|450405496|FG000|Number of Participants in Year 1|Death|6|||
125212872|NCT00631163|450405496|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
125212873|NCT00631163|450405496|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
125212874|NCT00631163|450405496|FG000|Number of Participants in Year 1|Administrative problems|6|||
125212875|NCT00631163|450405496|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
125212876|NCT00631163|450405496|FG000|Number of Participants in Year 2|Adverse Event|1|||
125212877|NCT00631163|450405496|FG000|Number of Participants in Year 2|Protocol Violation|1|||
125212878|NCT00631163|450405496|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
125212879|NCT02714036|450405497|FG000|Overall Study|Adverse Event|9|||
125212880|NCT02714036|450405498|FG001|Overall Study|Adverse Event|2|||
125212881|NCT02714036|450405497|FG000|Overall Study|Withdrawal by Subject|3|||
125212882|NCT02714036|450405498|FG001|Overall Study|Withdrawal by Subject|2|||
125212883|NCT01597492|450405499|FG000|Overall Study|Withdrawal by Subject|1|||
125212884|NCT01597492|450405500|FG001|Overall Study|Withdrawal by Subject|2|||
124938827|NCT04337931|449404750|FG001|Overall Study|Colorectal cancer treatment|0|||
124938828|NCT04337931|449404751|FG002|Overall Study|Colorectal cancer treatment|0|||
124938829|NCT04337931|449404749|FG000|Overall Study|Participant decision|0|||
124938830|NCT04337931|449404750|FG001|Overall Study|Participant decision|1|||
124938831|NCT04337931|449404751|FG002|Overall Study|Participant decision|0|||
124938832|NCT04436289|449404753|FG000|Overall Study|Death prior to hospital discharge|8|||
124938833|NCT04436289|449404754|FG001|Overall Study|Death prior to hospital discharge|5|||
124938834|NCT04436289|449404755|FG002|Overall Study|Death prior to hospital discharge|0|||
124938835|NCT04436289|449404756|FG003|Overall Study|Death prior to hospital discharge|1|||
124938836|NCT04436289|449404753|FG000|Overall Study|Withdrawal by Subject|0|||
124938837|NCT04436289|449404754|FG001|Overall Study|Withdrawal by Subject|1|||
124938838|NCT04436289|449404755|FG002|Overall Study|Withdrawal by Subject|4|||
124938839|NCT04436289|449404756|FG003|Overall Study|Withdrawal by Subject|0|||
124938840|NCT04436289|449404753|FG000|Overall Study|Extended hospital stay|0|||
124938841|NCT04436289|449404754|FG001|Overall Study|Extended hospital stay|1|||
124938842|NCT04436289|449404755|FG002|Overall Study|Extended hospital stay|0|||
124938843|NCT04436289|449404756|FG003|Overall Study|Extended hospital stay|0|||
124938844|NCT04436289|449404753|FG000|Overall Study|Lost to Follow-up|0|||
124938845|NCT04436289|449404754|FG001|Overall Study|Lost to Follow-up|4|||
124938846|NCT04436289|449404755|FG002|Overall Study|Lost to Follow-up|1|||
124938847|NCT04436289|449404756|FG003|Overall Study|Lost to Follow-up|3|||
124938848|NCT03357952|449404759|FG000|Overall Study|Withdrawal by Subject|0|||
124938849|NCT03357952|449404760|FG001|Overall Study|Withdrawal by Subject|1|||
124938850|NCT03357952|449404759|FG000|Overall Study|Sponsor Decision|9|||
124938851|NCT03357952|449404760|FG001|Overall Study|Sponsor Decision|0|||
124938852|NCT01371994|449404761|FG000|Overall Study|Adverse Event|3|||
124938853|NCT01371994|449404762|FG001|Overall Study|Adverse Event|6|||
124938854|NCT01371994|449404761|FG000|Overall Study|Lack of Efficacy|3|||
124938855|NCT01371994|449404762|FG001|Overall Study|Lack of Efficacy|0|||
124938856|NCT01371994|449404761|FG000|Overall Study|Withdrawal by Subject|13|||
124938857|NCT01371994|449404762|FG001|Overall Study|Withdrawal by Subject|7|||
124938858|NCT01371994|449404761|FG000|Overall Study|Lost to Follow-up|1|||
124938859|NCT01371994|449404762|FG001|Overall Study|Lost to Follow-up|1|||
124938860|NCT01371994|449404761|FG000|Overall Study|Protocol Violation|24|||
124938861|NCT01371994|449404762|FG001|Overall Study|Protocol Violation|17|||
124938862|NCT01371994|449404761|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
124938863|NCT01371994|449404762|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
125026980|NCT00666926|449722390|FG004|Overall Study|Death|0|||
125026981|NCT00666926|449722391|FG005|Overall Study|Death|0|||
125212885|NCT01597492|450405499|FG000|Overall Study|Adverse Event|3|||
125212886|NCT01597492|450405500|FG001|Overall Study|Adverse Event|0|||
125212887|NCT01597492|450405499|FG000|Overall Study|Lost to Follow-up|0|||
125026982|NCT00666926|449722392|FG006|Overall Study|Death|0|||
124938864|NCT01371994|449404761|FG000|Overall Study|Physician Decision|1|||
124938865|NCT01371994|449404762|FG001|Overall Study|Physician Decision|1|||
124938866|NCT01371994|449404761|FG000|Overall Study|Miscellaneous Reasons|6|||
124938867|NCT01371994|449404762|FG001|Overall Study|Miscellaneous Reasons|4|||
124938868|NCT03280030|449404763|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
124938869|NCT03280030|449404764|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
124938870|NCT03280030|449404765|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
124938871|NCT03280030|449404763|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
124938872|NCT03280030|449404764|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
124938873|NCT03280030|449404765|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
124938874|NCT03280030|449404763|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
124938875|NCT03280030|449404764|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
124938876|NCT03280030|449404765|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
124938877|NCT03280030|449404763|FG000|Part 2 - Efficacy|Adverse Event|0|||
124938878|NCT03280030|449404764|FG001|Part 2 - Efficacy|Adverse Event|4|||
124938879|NCT03280030|449404765|FG002|Part 2 - Efficacy|Adverse Event|6|||
124938880|NCT03280030|449404763|FG000|Part 2 - Efficacy|Death|0|||
124938881|NCT03280030|449404764|FG001|Part 2 - Efficacy|Death|3|||
124938882|NCT03280030|449404765|FG002|Part 2 - Efficacy|Death|0|||
124938883|NCT03280030|449404763|FG000|Part 2 - Efficacy|Physician Decision|0|||
124938884|NCT03280030|449404764|FG001|Part 2 - Efficacy|Physician Decision|10|||
124938885|NCT03280030|449404765|FG002|Part 2 - Efficacy|Physician Decision|16|||
124938886|NCT03280030|449404763|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
124938887|NCT03280030|449404764|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
124938888|NCT03280030|449404765|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
124938889|NCT03280030|449404763|FG000|Part 2 - Efficacy|Progressive disease|0|||
124938890|NCT03280030|449404764|FG001|Part 2 - Efficacy|Progressive disease|7|||
124938891|NCT03280030|449404765|FG002|Part 2 - Efficacy|Progressive disease|5|||
124938892|NCT00747565|449404766|FG000|Overall Study|Withdrawal by Subject|10|||
124938893|NCT00747565|449404767|FG001|Overall Study|Withdrawal by Subject|6|||
124938894|NCT00747565|449404766|FG000|Overall Study|Lost to Follow-up|4|||
124938895|NCT00747565|449404767|FG001|Overall Study|Lost to Follow-up|1|||
124938896|NCT00319020|449404770|FG000|Overall Study|Death|2|||
125121147|NCT04947579|450067080|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
125121148|NCT04947579|450067081|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
125121149|NCT04947579|450067082|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
125121150|NCT04947579|450067083|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
125121151|NCT04947579|450067084|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
125121152|NCT01575054|450067085|FG000|Overall Study|Other Reasons|5|||
125121153|NCT01575054|450067086|FG001|Overall Study|Other Reasons|3|||
125121154|NCT01575054|450067085|FG000|Overall Study|Protocol Violation|2|||
125121155|NCT01575054|450067086|FG001|Overall Study|Protocol Violation|1|||
125121156|NCT01575054|450067085|FG000|Overall Study|Personal Reasons|10|||
125121157|NCT01575054|450067086|FG001|Overall Study|Personal Reasons|11|||
125121158|NCT01575054|450067085|FG000|Overall Study|Lost to Follow-up|3|||
125121159|NCT01575054|450067086|FG001|Overall Study|Lost to Follow-up|3|||
125121160|NCT01575054|450067085|FG000|Overall Study|Adverse Event|9|||
125121161|NCT01575054|450067086|FG001|Overall Study|Adverse Event|8|||
125121162|NCT05200858|450067097|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
125121163|NCT05200858|450067098|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
125121164|NCT05200858|450067099|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
125121165|NCT05200858|450067100|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
125121166|NCT01691508|450068789|FG000|Overall Study|Adverse Event|3|||
125121167|NCT01691508|450068790|FG001|Overall Study|Adverse Event|3|||
125121168|NCT01691508|450068789|FG000|Overall Study|Withdrawal by Subject|1|||
125121169|NCT01691508|450068790|FG001|Overall Study|Withdrawal by Subject|0|||
125121170|NCT02322047|450068791|FG000|Overall Study|Physician Decision|1|||
125121171|NCT02322047|450068792|FG001|Overall Study|Physician Decision|0|||
125121172|NCT02322047|450068793|FG002|Overall Study|Physician Decision|0|||
125121173|NCT02322047|450068794|FG003|Overall Study|Physician Decision|0|||
125121174|NCT02322047|450068791|FG000|Overall Study|Withdrawal by Subject|1|||
125212888|NCT01597492|450405500|FG001|Overall Study|Lost to Follow-up|2|||
124938897|NCT00319020|449404771|FG001|Overall Study|Death|2|||
124938898|NCT00319020|449404770|FG000|Overall Study|Withdrawal by Subject|4|||
124938899|NCT00319020|449404771|FG001|Overall Study|Withdrawal by Subject|1|||
124938900|NCT00319020|449404770|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
124938901|NCT00319020|449404771|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
124938902|NCT00319020|449404770|FG000|Overall Study|Administrative reason|0|||
124938903|NCT00319020|449404771|FG001|Overall Study|Administrative reason|5|||
124938904|NCT00319020|449404770|FG000|Overall Study|Disease progression|0|||
124938905|NCT00319020|449404771|FG001|Overall Study|Disease progression|2|||
124938906|NCT00319020|449404770|FG000|Overall Study|Transplant|0|||
125121175|NCT02322047|450068792|FG001|Overall Study|Withdrawal by Subject|0|||
125121176|NCT02322047|450068793|FG002|Overall Study|Withdrawal by Subject|0|||
125121177|NCT02322047|450068794|FG003|Overall Study|Withdrawal by Subject|1|||
125121178|NCT02322047|450068791|FG000|Overall Study|Adverse Event|0|||
125121179|NCT02322047|450068792|FG001|Overall Study|Adverse Event|1|||
124938907|NCT00319020|449404771|FG001|Overall Study|Transplant|1|||
125121180|NCT02322047|450068793|FG002|Overall Study|Adverse Event|0|||
124938908|NCT00319020|449404770|FG000|Overall Study|Treatment failure|0|||
124938909|NCT00319020|449404771|FG001|Overall Study|Treatment failure|1|||
124938910|NCT00319020|449404770|FG000|Overall Study|Adverse Event|0|||
124938911|NCT00319020|449404771|FG001|Overall Study|Adverse Event|1|||
124938912|NCT00227266|449404772|FG000|Overall Study|Withdrawal by Subject|0|||
124938913|NCT00227266|449404773|FG001|Overall Study|Withdrawal by Subject|0|||
124938914|NCT00227266|449404774|FG002|Overall Study|Withdrawal by Subject|1|||
124938915|NCT00227266|449404772|FG000|Overall Study|Protocol Violation|1|||
124938916|NCT00227266|449404773|FG001|Overall Study|Protocol Violation|0|||
124938917|NCT00227266|449404774|FG002|Overall Study|Protocol Violation|1|||
124938918|NCT00227266|449404772|FG000|Overall Study|Excessive weight gain|0|||
124938919|NCT00227266|449404773|FG001|Overall Study|Excessive weight gain|0|||
124938920|NCT00227266|449404774|FG002|Overall Study|Excessive weight gain|2|||
124938921|NCT04153890|449404775|FG000|Overall Study|Lost to Follow-up|9|||
124938922|NCT04153890|449404776|FG001|Overall Study|Lost to Follow-up|0|||
124938923|NCT04153890|449404777|FG002|Overall Study|Lost to Follow-up|9|||
124938924|NCT04153890|449404778|FG003|Overall Study|Lost to Follow-up|0|||
124938925|NCT04153890|449404775|FG000|Overall Study|Death|0|||
124938926|NCT04153890|449404776|FG001|Overall Study|Death|2|||
124938927|NCT04153890|449404777|FG002|Overall Study|Death|0|||
124938928|NCT04153890|449404778|FG003|Overall Study|Death|0|||
124938929|NCT04153890|449404775|FG000|Overall Study|Withdrawal by Subject|0|||
124938930|NCT04153890|449404776|FG001|Overall Study|Withdrawal by Subject|0|||
124938931|NCT04153890|449404777|FG002|Overall Study|Withdrawal by Subject|0|||
124938932|NCT04153890|449404778|FG003|Overall Study|Withdrawal by Subject|2|||
124938933|NCT00593840|449404779|FG000|Overall Study|Withdrawal by Subject|1|||
124938934|NCT01637402|449405997|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
124938935|NCT01637402|449405998|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
124938936|NCT01637402|449405997|FG000|Standard Dose Regimen|Adverse Event|1|||
124938937|NCT01637402|449405998|FG001|Standard Dose Regimen|Adverse Event|0|||
124938938|NCT01637402|449405997|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
124938939|NCT01637402|449405998|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
125121181|NCT02322047|450068794|FG003|Overall Study|Adverse Event|0|||
125121182|NCT02322047|450068791|FG000|Overall Study|Lost to Follow-up|0|||
125121183|NCT02322047|450068792|FG001|Overall Study|Lost to Follow-up|0|||
125121184|NCT02322047|450068793|FG002|Overall Study|Lost to Follow-up|1|||
125121185|NCT02322047|450068794|FG003|Overall Study|Lost to Follow-up|1|||
125121186|NCT02207231|450068795|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
125121187|NCT02207231|450068796|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
125121188|NCT02207231|450068797|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
125121189|NCT02207231|450068798|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
125121190|NCT02207231|450068795|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
125121191|NCT02207231|450068796|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
125121192|NCT02207231|450068797|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
125121193|NCT02207231|450068798|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
125121194|NCT02207231|450068795|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
125121195|NCT02207231|450068796|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
125121196|NCT02207231|450068797|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
125121197|NCT02207231|450068798|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
125121198|NCT02207231|450068795|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
125121199|NCT02207231|450068796|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
125121200|NCT02207231|450068797|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
125121201|NCT02207231|450068798|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
125121202|NCT02207231|450068795|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
125121203|NCT02207231|450068796|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
125121204|NCT02207231|450068797|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
125121205|NCT02207231|450068798|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
125121206|NCT02207231|450068795|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
125121207|NCT02207231|450068796|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
125121208|NCT02207231|450068797|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
125121209|NCT02207231|450068798|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
124938940|NCT01637402|449405997|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
124938941|NCT01637402|449405998|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
124938942|NCT01637402|449405997|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
124938943|NCT01637402|449405998|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
124938944|NCT01637402|449405997|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
124938945|NCT01637402|449405998|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
125121210|NCT02207231|450068795|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
125121211|NCT02207231|450068796|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
125212889|NCT01597492|450405499|FG000|Overall Study|Other Reason|2|||
125212890|NCT01597492|450405500|FG001|Overall Study|Other Reason|0|||
124938946|NCT02111096|449405999|FG000|Overall Study|Adverse Event|4|||
124938947|NCT02111096|449406000|FG001|Overall Study|Adverse Event|1|||
124938948|NCT02111096|449406001|FG002|Overall Study|Adverse Event|2|||
124938949|NCT02111096|449405999|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124938950|NCT02111096|449406000|FG001|Overall Study|Non-Compliance with Study Drug|1|||
124938951|NCT02111096|449406001|FG002|Overall Study|Non-Compliance with Study Drug|0|||
124938952|NCT02111096|449405999|FG000|Overall Study|Lost to Follow Up|1|||
124938953|NCT02111096|449406000|FG001|Overall Study|Lost to Follow Up|1|||
124938954|NCT02111096|449406001|FG002|Overall Study|Lost to Follow Up|1|||
124938955|NCT02111096|449405999|FG000|Overall Study|Physician Decision|0|||
125121212|NCT02207231|450068797|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
125121213|NCT02207231|450068798|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
125121214|NCT02207231|450068795|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
125121215|NCT02207231|450068796|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
125121216|NCT02207231|450068797|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
125121217|NCT02207231|450068798|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
125121218|NCT02207231|450068795|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
125121219|NCT02207231|450068796|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
125121220|NCT02207231|450068797|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
125121221|NCT02207231|450068798|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
125121222|NCT02207231|450068795|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
125121223|NCT02207231|450068796|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
125121224|NCT02207231|450068797|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
125121225|NCT02207231|450068798|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
125121226|NCT02207231|450068795|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
125121227|NCT02207231|450068796|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
125121228|NCT02207231|450068797|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
125121229|NCT02207231|450068798|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
125121230|NCT02207231|450068795|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
125121231|NCT02207231|450068796|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
125121232|NCT02207231|450068797|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
125121233|NCT02207231|450068798|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
125121234|NCT02207231|450068795|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
125121235|NCT02207231|450068796|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
125121236|NCT02207231|450068797|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
125121237|NCT02207231|450068798|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
125121238|NCT02207231|450068795|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
125121239|NCT02207231|450068796|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
125121240|NCT02207231|450068797|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
125121241|NCT02207231|450068798|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
125121242|NCT02207231|450068795|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
125121243|NCT02207231|450068796|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
125121244|NCT02207231|450068797|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
125121245|NCT02207231|450068798|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
125121246|NCT02207231|450068795|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
125121247|NCT02207231|450068796|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
125121248|NCT02207231|450068797|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
125121249|NCT02207231|450068798|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
125121250|NCT02207231|450068795|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
125121251|NCT02207231|450068796|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
125121252|NCT02207231|450068797|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
125121253|NCT02207231|450068798|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
125121254|NCT02207231|450068795|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
125121255|NCT02207231|450068796|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
125121256|NCT02207231|450068797|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
125121257|NCT02207231|450068798|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
125121258|NCT02207231|450068795|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
125121259|NCT02207231|450068796|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
125121260|NCT02207231|450068797|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
125121261|NCT02207231|450068798|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
125121262|NCT02207231|450068795|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
125212891|NCT03624569|450405501|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
124938956|NCT02111096|449406000|FG001|Overall Study|Physician Decision|1|||
124938957|NCT02111096|449406001|FG002|Overall Study|Physician Decision|0|||
124938958|NCT02111096|449405999|FG000|Overall Study|Protocol Violation|1|||
124938959|NCT02111096|449406000|FG001|Overall Study|Protocol Violation|0|||
124938960|NCT02111096|449406001|FG002|Overall Study|Protocol Violation|1|||
124938961|NCT02111096|449405999|FG000|Overall Study|Terminated by Sponsor|53|||
124938962|NCT02111096|449406000|FG001|Overall Study|Terminated by Sponsor|35|||
125212892|NCT03624569|450405502|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
125212893|NCT03624569|450405501|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
125212894|NCT03624569|450405502|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
125212895|NCT03517449|450405513|FG000|Overall Study|Death|184|||
125212896|NCT03517449|450405514|FG001|Overall Study|Death|236|||
125212897|NCT03517449|450405513|FG000|Overall Study|Lost to Follow-up|0|||
125212898|NCT03517449|450405514|FG001|Overall Study|Lost to Follow-up|2|||
125212899|NCT03517449|450405513|FG000|Overall Study|Withdrawal by Subject|7|||
125212900|NCT03517449|450405514|FG001|Overall Study|Withdrawal by Subject|26|||
125212901|NCT03517449|450405513|FG000|Overall Study|Participants Ongoing|220|||
125212902|NCT03517449|450405514|FG001|Overall Study|Participants Ongoing|152|||
125212903|NCT01119846|450405515|FG000|Overall Study|Adverse Event|1|||
125212904|NCT01119846|450405516|FG001|Overall Study|Adverse Event|0|||
125212905|NCT01119846|450405517|FG002|Overall Study|Adverse Event|6|||
125212906|NCT01119846|450405515|FG000|Overall Study|Physician Decision|1|||
125212907|NCT01119846|450405516|FG001|Overall Study|Physician Decision|0|||
124938963|NCT02111096|449406001|FG002|Overall Study|Terminated by Sponsor|54|||
125212908|NCT01119846|450405517|FG002|Overall Study|Physician Decision|0|||
125212909|NCT01119846|450405515|FG000|Overall Study|Protocol Violation|0|||
125212910|NCT01119846|450405516|FG001|Overall Study|Protocol Violation|0|||
125212911|NCT01119846|450405517|FG002|Overall Study|Protocol Violation|1|||
125212912|NCT01119846|450405515|FG000|Overall Study|Withdrawal by Subject|0|||
125212913|NCT01119846|450405516|FG001|Overall Study|Withdrawal by Subject|0|||
124938964|NCT02111096|449405999|FG000|Overall Study|Withdrawal by Subject|4|||
124938965|NCT02111096|449406000|FG001|Overall Study|Withdrawal by Subject|2|||
124938966|NCT02111096|449406001|FG002|Overall Study|Withdrawal by Subject|8|||
124938967|NCT03709706|449406002|FG000|Overall Study|Adverse Event|0|||
124938968|NCT03709706|449406003|FG001|Overall Study|Adverse Event|1|||
124938969|NCT03709706|449406002|FG000|Overall Study|Physician Decision|14|||
124938970|NCT03709706|449406003|FG001|Overall Study|Physician Decision|8|||
124938971|NCT03709706|449406002|FG000|Overall Study|Withdrawal by Subject|2|||
124938972|NCT03709706|449406003|FG001|Overall Study|Withdrawal by Subject|1|||
124938973|NCT03709706|449406002|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
124938974|NCT03709706|449406003|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
124938975|NCT00609869|449406004|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
124938976|NCT00609869|449406004|FG000|Overall Study|Severe hematologic toxicity|1|||
124938977|NCT00609869|449406004|FG000|Overall Study|Withdrawal by Subject|1|||
124938978|NCT00609869|449406004|FG000|Overall Study|Seizures|1|||
124938979|NCT00609869|449406004|FG000|Overall Study|Severe tumor flare reaction|1|||
124938980|NCT00609869|449406004|FG000|Overall Study|Hepatitis B infection|1|||
124938981|NCT00609869|449406004|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
124938982|NCT00609869|449406004|FG000|Overall Study|Mantle cell: not evaluable|4|||
124938983|NCT01627561|449406005|FG000|Overall Study|Lost to Follow-up|1|||
124938984|NCT01627561|449406006|FG001|Overall Study|Lost to Follow-up|0|||
124938985|NCT01627561|449406005|FG000|Overall Study|Withdrawal by Subject|0|||
124938986|NCT01627561|449406006|FG001|Overall Study|Withdrawal by Subject|1|||
124938987|NCT01627561|449406005|FG000|Overall Study|Migrated/moved from study area|0|||
124938988|NCT01627561|449406006|FG001|Overall Study|Migrated/moved from study area|2|||
125121263|NCT02207231|450068796|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
125121264|NCT02207231|450068797|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
125121265|NCT02207231|450068798|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
125121266|NCT02207231|450068795|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
125121267|NCT02207231|450068796|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
125121268|NCT02207231|450068797|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
125121269|NCT02207231|450068798|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
125121270|NCT01290263|450068802|FG000|Overall Study|Adverse Event|0|||
125121271|NCT01290263|450068803|FG001|Overall Study|Adverse Event|0|||
125121272|NCT01290263|450068804|FG002|Overall Study|Adverse Event|0|||
125121273|NCT01290263|450068805|FG003|Overall Study|Adverse Event|1|||
125121274|NCT01290263|450068806|FG004|Overall Study|Adverse Event|1|||
125121275|NCT01290263|450068802|FG000|Overall Study|Lack of Efficacy|8|||
125121276|NCT01290263|450068803|FG001|Overall Study|Lack of Efficacy|2|||
125121277|NCT01290263|450068804|FG002|Overall Study|Lack of Efficacy|7|||
125212914|NCT01119846|450405517|FG002|Overall Study|Withdrawal by Subject|4|||
125212915|NCT01370616|450405522|FG000|Overall Study|Adverse Event|11|||
125212916|NCT01370616|450405523|FG001|Overall Study|Adverse Event|16|||
124938989|NCT00890591|449406008|FG000|Overall Study|Lack of Efficacy|20|||
124938990|NCT01579318|449406011|FG000|Overall Study|Disease Progression|1|||
124938991|NCT02797132|449406012|FG000|Part A (15 Days)|Adverse Event|1|||
124938992|NCT02797132|449406012|FG000|Part B (24 Weeks)|Adverse Event|3|||
124938993|NCT02347332|449406013|FG000|Overall Study|Not treated|5|||
124938994|NCT02347332|449406014|FG001|Overall Study|Not treated|2|||
125121278|NCT01290263|450068805|FG003|Overall Study|Lack of Efficacy|24|||
125121279|NCT01290263|450068806|FG004|Overall Study|Lack of Efficacy|33|||
125121280|NCT01290263|450068802|FG000|Overall Study|Withdrawal by Subject|3|||
125212917|NCT01370616|450405522|FG000|Overall Study|Death|1|||
125212918|NCT01370616|450405523|FG001|Overall Study|Death|0|||
125121281|NCT01290263|450068803|FG001|Overall Study|Withdrawal by Subject|1|||
125121282|NCT01290263|450068804|FG002|Overall Study|Withdrawal by Subject|0|||
125121283|NCT01290263|450068805|FG003|Overall Study|Withdrawal by Subject|1|||
125121284|NCT01290263|450068806|FG004|Overall Study|Withdrawal by Subject|2|||
125121285|NCT01290263|450068802|FG000|Overall Study|Participant Non-Compliance|0|||
125121286|NCT01290263|450068803|FG001|Overall Study|Participant Non-Compliance|0|||
125121287|NCT01290263|450068804|FG002|Overall Study|Participant Non-Compliance|0|||
124938995|NCT02347332|449406013|FG000|Overall Study|Progressive disease|141|||
124938996|NCT02347332|449406014|FG001|Overall Study|Progressive disease|159|||
124938997|NCT02347332|449406013|FG000|Overall Study|Adverse Event|50|||
124938998|NCT02347332|449406014|FG001|Overall Study|Adverse Event|41|||
125121288|NCT01290263|450068805|FG003|Overall Study|Participant Non-Compliance|1|||
125121289|NCT01290263|450068806|FG004|Overall Study|Participant Non-Compliance|1|||
125121290|NCT02309099|450068812|FG000|Overall Study|Adverse Event|2|||
125121291|NCT02309099|450068813|FG001|Overall Study|Adverse Event|0|||
125121292|NCT02016300|450068814|FG000|Overall Study|Lost to Follow-up|0|||
125121293|NCT02016300|450068815|FG001|Overall Study|Lost to Follow-up|3|||
125121294|NCT06165744|450068816|FG000|Overall Study|Non device-related adverse event|1|||
125121295|NCT05456529|450068817|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
125121296|NCT05456529|450068817|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
125121297|NCT05456529|450068817|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
125121298|NCT05456529|450068817|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
125121299|NCT05456529|450068817|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
125121300|NCT05456529|450068817|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
125121301|NCT05456529|450068817|FG000|44-week Long-term Safety Period|Physician Decision|2|||
125121302|NCT05456529|450068817|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
125121303|NCT05456529|450068817|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
124938999|NCT02347332|449406013|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
124939000|NCT02347332|449406014|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
124939001|NCT02347332|449406013|FG000|Overall Study|Protocol Violation|1|||
125121304|NCT05456529|450068817|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
124939002|NCT02347332|449406014|FG001|Overall Study|Protocol Violation|1|||
124939003|NCT02347332|449406013|FG000|Overall Study|Lost to Follow-up|2|||
124939004|NCT02347332|449406014|FG001|Overall Study|Lost to Follow-up|1|||
124939005|NCT02347332|449406013|FG000|Overall Study|Physician Decision|4|||
124939006|NCT02347332|449406014|FG001|Overall Study|Physician Decision|3|||
124939007|NCT02347332|449406013|FG000|Overall Study|Withdrawal by Subject|20|||
124939008|NCT02347332|449406014|FG001|Overall Study|Withdrawal by Subject|14|||
124939009|NCT02347332|449406013|FG000|Overall Study|Protocol requirement|1|||
124939010|NCT02347332|449406014|FG001|Overall Study|Protocol requirement|1|||
124939011|NCT02347332|449406013|FG000|Overall Study|Switch Post-Trial program|0|||
124939012|NCT02347332|449406014|FG001|Overall Study|Switch Post-Trial program|1|||
124939013|NCT01970007|449406015|FG000|Overall Study|Death|5|||
124939014|NCT01970007|449406015|FG000|Overall Study|Withdrawal by Subject|23|||
124939015|NCT01970007|449406015|FG000|Overall Study|Lost to Follow-up|24|||
124939016|NCT01970007|449406015|FG000|Overall Study|"Other endpoint"|3|||
124939017|NCT00112359|449406019|FG000|Overall Study|Unrelated adverse event|16|||
124939018|NCT00112359|449406020|FG001|Overall Study|Unrelated adverse event|8|||
124939019|NCT00112359|449406019|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
124939020|NCT00112359|449406020|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
124939021|NCT00112359|449406019|FG000|Overall Study|Related adverse event|5|||
124939022|NCT00112359|449406020|FG001|Overall Study|Related adverse event|3|||
124939023|NCT00112359|449406019|FG000|Overall Study|Lost to Follow-up|0|||
124939024|NCT00112359|449406020|FG001|Overall Study|Lost to Follow-up|1|||
124939025|NCT00112359|449406019|FG000|Overall Study|Personal/administrative|1|||
124939026|NCT00112359|449406020|FG001|Overall Study|Personal/administrative|1|||
124939027|NCT00112359|449406019|FG000|Overall Study|Other|3|||
124939028|NCT00112359|449406020|FG001|Overall Study|Other|0|||
124939029|NCT01961609|449406021|FG000|Initiation|Missing|3|||
124939030|NCT01961609|449406022|FG001|Initiation|Missing|2|||
124939031|NCT01961609|449406023|FG002|Initiation|Missing|0|||
124939032|NCT01961609|449406024|FG003|Initiation|Missing|0|||
124939033|NCT01961609|449406021|FG000|Initiation|Protocol deviation|1|||
124939034|NCT01961609|449406022|FG001|Initiation|Protocol deviation|0|||
124939035|NCT01961609|449406023|FG002|Initiation|Protocol deviation|0|||
124939036|NCT01961609|449406024|FG003|Initiation|Protocol deviation|0|||
124939037|NCT01961609|449406021|FG000|Initiation|Death|0|||
124939038|NCT01961609|449406022|FG001|Initiation|Death|1|||
124939039|NCT01961609|449406023|FG002|Initiation|Death|0|||
124939040|NCT01961609|449406024|FG003|Initiation|Death|0|||
124939041|NCT01961609|449406021|FG000|Initiation|Administrative problems|1|||
124939042|NCT01961609|449406022|FG001|Initiation|Administrative problems|0|||
124939043|NCT01961609|449406023|FG002|Initiation|Administrative problems|0|||
124939044|NCT01961609|449406024|FG003|Initiation|Administrative problems|0|||
124939045|NCT01961609|449406021|FG000|Initiation|Withdrawal by Subject|1|||
124939046|NCT01961609|449406022|FG001|Initiation|Withdrawal by Subject|2|||
124939047|NCT01961609|449406023|FG002|Initiation|Withdrawal by Subject|0|||
124939048|NCT01961609|449406024|FG003|Initiation|Withdrawal by Subject|0|||
124939049|NCT01961609|449406021|FG000|Initiation|Lack of Efficacy|2|||
124939050|NCT01961609|449406022|FG001|Initiation|Lack of Efficacy|1|||
124939051|NCT01961609|449406023|FG002|Initiation|Lack of Efficacy|0|||
124939052|NCT01961609|449406024|FG003|Initiation|Lack of Efficacy|0|||
124939053|NCT01961609|449406021|FG000|Initiation|Abnormal lab values|0|||
124939054|NCT01961609|449406022|FG001|Initiation|Abnormal lab values|1|||
124939055|NCT01961609|449406023|FG002|Initiation|Abnormal lab values|0|||
124939056|NCT01961609|449406024|FG003|Initiation|Abnormal lab values|0|||
124939057|NCT01961609|449406021|FG000|Initiation|Adverse Event|3|||
124939058|NCT01961609|449406022|FG001|Initiation|Adverse Event|5|||
124939059|NCT01961609|449406023|FG002|Initiation|Adverse Event|0|||
124939060|NCT01961609|449406024|FG003|Initiation|Adverse Event|0|||
124939061|NCT01961609|449406021|FG000|Initiation|Randomized but not treated|1|||
124939062|NCT01961609|449406022|FG001|Initiation|Randomized but not treated|1|||
124939063|NCT01961609|449406023|FG002|Initiation|Randomized but not treated|0|||
124939064|NCT01961609|449406024|FG003|Initiation|Randomized but not treated|0|||
124939065|NCT01961609|449406021|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
124939066|NCT01961609|449406022|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
124939067|NCT01961609|449406023|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
125026983|NCT00666926|449722393|FG007|Overall Study|Death|0|||
125026984|NCT00666926|449722394|FG008|Overall Study|Death|0|||
125026985|NCT00666926|449722395|FG009|Overall Study|Death|0|||
125026986|NCT00666926|449722396|FG010|Overall Study|Death|0|||
125026987|NCT00666926|449722397|FG011|Overall Study|Death|1|||
125026988|NCT00666926|449722398|FG012|Overall Study|Death|0|||
125026989|NCT00666926|449722399|FG013|Overall Study|Death|0|||
125026990|NCT00666926|449722400|FG014|Overall Study|Death|0|||
125026991|NCT00666926|449722401|FG015|Overall Study|Death|0|||
124939068|NCT01961609|449406024|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
124939069|NCT01961609|449406021|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
125026992|NCT01727258|449722402|FG000|Overall Study|Adverse Event|0|||
125212919|NCT01370616|450405522|FG000|Overall Study|Lack of Efficacy|6|||
125212920|NCT01370616|450405523|FG001|Overall Study|Lack of Efficacy|2|||
125212921|NCT01370616|450405522|FG000|Overall Study|Lost to Follow-up|0|||
125212922|NCT01370616|450405523|FG001|Overall Study|Lost to Follow-up|3|||
124939070|NCT01961609|449406022|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
124939071|NCT01961609|449406023|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
124939072|NCT01961609|449406024|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
124939073|NCT01961609|449406021|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
124939074|NCT01961609|449406022|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
124939075|NCT01961609|449406023|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
125121305|NCT05456529|450068817|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
125121306|NCT01631864|450068818|FG000|Overall Study|Withdrawal by Subject|0|||
125121307|NCT01631864|450068819|FG001|Overall Study|Withdrawal by Subject|1|||
125121308|NCT01631864|450068818|FG000|Overall Study|Adverse Event|2|||
125121309|NCT01631864|450068819|FG001|Overall Study|Adverse Event|3|||
125121310|NCT00527423|450068846|FG000|Overall Study|Protocol Violation|1|||
125121311|NCT00527423|450068846|FG000|Overall Study|Adverse Event|5|||
125121312|NCT00527423|450068846|FG000|Overall Study|Physician Decision|4|||
125121313|NCT00527423|450068846|FG000|Overall Study|Withdrawal by Subject|10|||
125121314|NCT00527423|450068846|FG000|Overall Study|Lost to Follow-up|4|||
125121315|NCT00527423|450068846|FG000|Overall Study|OTHER|4|||
125121316|NCT00527423|450068846|FG000|Overall Study|Death|9|||
125121317|NCT01957488|450068847|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
125121318|NCT01957488|450068848|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
125121319|NCT01957488|450068849|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
125121320|NCT01957488|450068850|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
125212923|NCT01370616|450405522|FG000|Overall Study|Physician Decision|6|||
125026993|NCT01727258|449722403|FG001|Overall Study|Adverse Event|2|||
125026994|NCT01727258|449722404|FG002|Overall Study|Adverse Event|0|||
125026995|NCT01727258|449722402|FG000|Overall Study|Noncompliance with Study Drug|0|||
125026996|NCT01727258|449722403|FG001|Overall Study|Noncompliance with Study Drug|0|||
125026997|NCT01727258|449722404|FG002|Overall Study|Noncompliance with Study Drug|1|||
125026998|NCT01727258|449722402|FG000|Overall Study|Withdrawal by Subject|1|||
125026999|NCT01727258|449722403|FG001|Overall Study|Withdrawal by Subject|1|||
125027000|NCT01727258|449722404|FG002|Overall Study|Withdrawal by Subject|0|||
125027001|NCT01727258|449722402|FG000|Overall Study|Lost to Follow-up|1|||
125027002|NCT01727258|449722403|FG001|Overall Study|Lost to Follow-up|0|||
125027003|NCT01727258|449722404|FG002|Overall Study|Lost to Follow-up|0|||
125027004|NCT02471716|449722409|FG000|Overall Study|Withdrawal by Subject|0|||
125027005|NCT02471716|449722410|FG001|Overall Study|Withdrawal by Subject|1|||
125027006|NCT02471716|449722411|FG002|Overall Study|Withdrawal by Subject|0|||
125027007|NCT02471716|449722412|FG003|Overall Study|Withdrawal by Subject|2|||
125027008|NCT02471716|449722413|FG004|Overall Study|Withdrawal by Subject|5|||
125027009|NCT02471716|449722409|FG000|Overall Study|Study Terminiated by sponsor|0|||
125212924|NCT01370616|450405523|FG001|Overall Study|Physician Decision|6|||
125212925|NCT01370616|450405522|FG000|Overall Study|Progressive Disease|0|||
125212926|NCT01370616|450405523|FG001|Overall Study|Progressive Disease|1|||
125212927|NCT01370616|450405522|FG000|Overall Study|Recovery|1|||
125212928|NCT01370616|450405523|FG001|Overall Study|Recovery|0|||
125212929|NCT01370616|450405522|FG000|Overall Study|Technical Problems|3|||
125212930|NCT01370616|450405523|FG001|Overall Study|Technical Problems|5|||
125212931|NCT01370616|450405522|FG000|Overall Study|Withdrawal by Subject|34|||
125212932|NCT01370616|450405523|FG001|Overall Study|Withdrawal by Subject|34|||
125212933|NCT02324699|450405524|FG000|Overall Study|study terminated|1|||
125212934|NCT01605825|450405529|FG000|Overall Study|Adverse Event|4|||
125212935|NCT01605825|450405530|FG001|Overall Study|Adverse Event|2|||
125212936|NCT01605825|450405529|FG000|Overall Study|Withdrawal by Subject|0|||
125212937|NCT01605825|450405530|FG001|Overall Study|Withdrawal by Subject|1|||
125212938|NCT01605825|450405529|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
125212939|NCT01605825|450405530|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
125212940|NCT01605825|450405529|FG000|Overall Study|Non-Compliance with Protocol|3|||
125212941|NCT01605825|450405530|FG001|Overall Study|Non-Compliance with Protocol|0|||
125212942|NCT03469999|450405537|FG000|Overall Study|Lost to Follow-up|2|||
125212943|NCT00394771|450405541|FG000|Overall Study|Did not meet protocol requirements|1|||
125212944|NCT00394771|450405542|FG001|Overall Study|Did not meet protocol requirements|0|||
125212945|NCT00394771|450405543|FG002|Overall Study|Did not meet protocol requirements|2|||
125212946|NCT00394771|450405544|FG003|Overall Study|Did not meet protocol requirements|0|||
125212947|NCT00394771|450405541|FG000|Overall Study|Protocol Violation|2|||
125212948|NCT00394771|450405542|FG001|Overall Study|Protocol Violation|4|||
124939076|NCT01961609|449406024|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
124939077|NCT01961609|449406021|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
124939078|NCT01961609|449406022|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
124939079|NCT01961609|449406023|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
124939080|NCT01961609|449406024|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
124939081|NCT01961609|449406021|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
124939082|NCT01961609|449406022|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
124939083|NCT01961609|449406023|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
124939084|NCT01961609|449406024|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
124939085|NCT01961609|449406021|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
124939086|NCT01961609|449406022|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
124939087|NCT01961609|449406023|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
124939088|NCT01961609|449406024|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
124939089|NCT01961609|449406021|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
124939090|NCT01961609|449406022|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
124939091|NCT01961609|449406023|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
124939092|NCT01961609|449406024|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
124939093|NCT01961609|449406021|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
124939094|NCT01961609|449406022|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
124939095|NCT01961609|449406023|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
124939096|NCT01961609|449406024|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
124939097|NCT01961609|449406021|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
125027010|NCT02471716|449722410|FG001|Overall Study|Study Terminiated by sponsor|0|||
125027011|NCT02471716|449722411|FG002|Overall Study|Study Terminiated by sponsor|0|||
125027012|NCT02471716|449722412|FG003|Overall Study|Study Terminiated by sponsor|1|||
125027013|NCT02471716|449722413|FG004|Overall Study|Study Terminiated by sponsor|0|||
125027014|NCT02471716|449722409|FG000|Overall Study|Lost to Follow-up|0|||
125212949|NCT00394771|450405543|FG002|Overall Study|Protocol Violation|9|||
125212950|NCT00394771|450405544|FG003|Overall Study|Protocol Violation|7|||
125212951|NCT00394771|450405541|FG000|Overall Study|Withdrawal by Subject|10|||
125212952|NCT00394771|450405542|FG001|Overall Study|Withdrawal by Subject|6|||
125212953|NCT00394771|450405543|FG002|Overall Study|Withdrawal by Subject|8|||
125212954|NCT00394771|450405544|FG003|Overall Study|Withdrawal by Subject|12|||
125212955|NCT00394771|450405541|FG000|Overall Study|Adverse Event|10|||
125212956|NCT00394771|450405542|FG001|Overall Study|Adverse Event|5|||
125212957|NCT00394771|450405543|FG002|Overall Study|Adverse Event|12|||
125212958|NCT00394771|450405544|FG003|Overall Study|Adverse Event|8|||
125212959|NCT00394771|450405541|FG000|Overall Study|Participant pregnant|0|||
125212960|NCT00394771|450405542|FG001|Overall Study|Participant pregnant|1|||
125212961|NCT00394771|450405543|FG002|Overall Study|Participant pregnant|2|||
125212962|NCT00394771|450405544|FG003|Overall Study|Participant pregnant|2|||
125212963|NCT00394771|450405541|FG000|Overall Study|Lost to Follow-up|15|||
125212964|NCT00394771|450405542|FG001|Overall Study|Lost to Follow-up|15|||
125212965|NCT00394771|450405543|FG002|Overall Study|Lost to Follow-up|13|||
125212966|NCT00394771|450405544|FG003|Overall Study|Lost to Follow-up|10|||
125212967|NCT00394771|450405541|FG000|Overall Study|Other|3|||
125212968|NCT00394771|450405542|FG001|Overall Study|Other|3|||
125212969|NCT00394771|450405543|FG002|Overall Study|Other|1|||
125212970|NCT00394771|450405544|FG003|Overall Study|Other|0|||
125212971|NCT00520767|450405545|FG000|Overall Study|Death|2|||
125212972|NCT03597139|450405546|FG000|Overall Study|Adverse Event|3|||
125212973|NCT03597139|450405547|FG001|Overall Study|Adverse Event|0|||
125212974|NCT03597139|450405546|FG000|Overall Study|Protocol Non-compliance|1|||
125212975|NCT03597139|450405547|FG001|Overall Study|Protocol Non-compliance|0|||
125212976|NCT00382109|450405549|FG000|Overall Study|Adverse Event|3|||
125212977|NCT00382109|450405550|FG001|Overall Study|Adverse Event|0|||
125212978|NCT00382109|450405549|FG000|Overall Study|Physician Decision|6|||
125212979|NCT00382109|450405550|FG001|Overall Study|Physician Decision|1|||
125212980|NCT00382109|450405549|FG000|Overall Study|Withdrawal by Subject|1|||
125212981|NCT00382109|450405550|FG001|Overall Study|Withdrawal by Subject|0|||
124939098|NCT01961609|449406022|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
124939099|NCT01961609|449406023|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
124939100|NCT01961609|449406024|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
124939101|NCT01961609|449406021|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
124939102|NCT01961609|449406022|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
124939103|NCT01961609|449406023|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
124939104|NCT01961609|449406024|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
124939105|NCT01961609|449406021|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
124939106|NCT01961609|449406022|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
124939107|NCT01961609|449406023|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
124939108|NCT01961609|449406024|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
124939109|NCT01961609|449406021|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
124939110|NCT01961609|449406022|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
124939111|NCT01961609|449406023|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
124939112|NCT01961609|449406024|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
124939113|NCT01988402|449406025|FG000|Overall Study|Adverse Event|1|||
124939114|NCT01988402|449406026|FG001|Overall Study|Adverse Event|2|||
124939115|NCT01988402|449406025|FG000|Overall Study|Withdrawal by Subject|1|||
124939116|NCT01988402|449406026|FG001|Overall Study|Withdrawal by Subject|0|||
124939117|NCT00582972|449406028|FG000|Overall Study|Protocol Violation|2|||
124939118|NCT01566890|449406031|FG000|Overall Study|Adverse Event|1|||
124939119|NCT01566890|449406032|FG001|Overall Study|Adverse Event|0|||
125027015|NCT02471716|449722410|FG001|Overall Study|Lost to Follow-up|0|||
125027016|NCT02471716|449722411|FG002|Overall Study|Lost to Follow-up|0|||
125027017|NCT02471716|449722412|FG003|Overall Study|Lost to Follow-up|3|||
125027018|NCT02471716|449722413|FG004|Overall Study|Lost to Follow-up|2|||
125027019|NCT02471716|449722409|FG000|Overall Study|Death|0|||
125027020|NCT02471716|449722410|FG001|Overall Study|Death|0|||
125027021|NCT02471716|449722411|FG002|Overall Study|Death|0|||
125027022|NCT02471716|449722412|FG003|Overall Study|Death|1|||
125027023|NCT02471716|449722413|FG004|Overall Study|Death|0|||
125027024|NCT02471716|449722409|FG000|Overall Study|Other|0|||
125027025|NCT02471716|449722410|FG001|Overall Study|Other|0|||
125027026|NCT02471716|449722411|FG002|Overall Study|Other|0|||
125027027|NCT02471716|449722412|FG003|Overall Study|Other|8|||
125027028|NCT02471716|449722413|FG004|Overall Study|Other|9|||
124939120|NCT01566890|449406033|FG002|Overall Study|Adverse Event|0|||
125027029|NCT01360645|449722418|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
125027030|NCT01360645|449722419|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
125212982|NCT00382109|450405549|FG000|Overall Study|ineligible|2|||
125212983|NCT00382109|450405550|FG001|Overall Study|ineligible|0|||
125212984|NCT00382109|450405549|FG000|Overall Study|Other|0|||
125212985|NCT00382109|450405550|FG001|Overall Study|Other|2|||
125212986|NCT00382109|450405549|FG000|Overall Study|consent withdrawal|0|||
125212987|NCT00382109|450405550|FG001|Overall Study|consent withdrawal|1|||
125212988|NCT00248833|450405553|FG000|Overall Study|Adverse Event|2|||
125027031|NCT01360645|449722420|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
125027032|NCT01360645|449722421|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
125027033|NCT01360645|449722418|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
125027034|NCT01360645|449722419|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
125027035|NCT01360645|449722420|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
125027036|NCT01360645|449722421|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
125027037|NCT01360645|449722418|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
125027038|NCT01360645|449722419|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
125027039|NCT01360645|449722420|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
125027040|NCT01360645|449722421|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
125027041|NCT01360645|449722418|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
125027042|NCT01360645|449722419|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
125027043|NCT01360645|449722420|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
125027044|NCT01360645|449722421|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
125027045|NCT01360645|449722418|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
125027046|NCT01360645|449722419|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
125027047|NCT01360645|449722420|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
125027048|NCT01360645|449722421|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
125027049|NCT01360645|449722418|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
125027050|NCT01360645|449722419|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
125027051|NCT01360645|449722420|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
125027052|NCT01360645|449722421|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
125027053|NCT01360645|449722418|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
125027054|NCT01360645|449722419|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
125027055|NCT01360645|449722420|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
125027056|NCT01360645|449722421|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
125027057|NCT01360645|449722418|FG000|Phase B (6 Weeks)|Adverse Event|0|||
125027058|NCT01360645|449722419|FG001|Phase B (6 Weeks)|Adverse Event|6|||
125027059|NCT01360645|449722420|FG002|Phase B (6 Weeks)|Adverse Event|0|||
125027060|NCT01360645|449722421|FG003|Phase B (6 Weeks)|Adverse Event|0|||
125027061|NCT01360645|449722418|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
125027062|NCT01360645|449722419|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
125027063|NCT01360645|449722420|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
125121321|NCT01957488|450068851|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
125121322|NCT01957488|450068852|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
125027064|NCT01360645|449722421|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
125027065|NCT01360645|449722418|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
125027066|NCT01360645|449722419|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
125027067|NCT01360645|449722420|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
125027068|NCT01360645|449722421|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
125027069|NCT01360645|449722418|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
125027070|NCT01360645|449722419|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
125121323|NCT01957488|450068847|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
125121324|NCT01957488|450068848|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
125121325|NCT01957488|450068849|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
125121326|NCT01957488|450068850|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
125121327|NCT01957488|450068851|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
125121328|NCT01957488|450068852|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
125121329|NCT01957488|450068847|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
125121330|NCT01957488|450068848|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
125121331|NCT01957488|450068849|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
125121332|NCT01957488|450068850|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
125121333|NCT01957488|450068851|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
125121334|NCT01957488|450068852|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
125121335|NCT01957488|450068847|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
125121336|NCT01957488|450068848|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
125121337|NCT01957488|450068849|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
125121338|NCT01957488|450068850|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
125121339|NCT01957488|450068851|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
125121340|NCT01957488|450068852|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
125121341|NCT01957488|450068847|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
125121342|NCT01957488|450068848|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
125121343|NCT01957488|450068849|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
125121344|NCT01957488|450068850|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
125121345|NCT01957488|450068851|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
125121346|NCT01957488|450068852|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
125121347|NCT01957488|450068847|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
125121348|NCT01957488|450068848|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
125121349|NCT01957488|450068849|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
124939121|NCT01566890|449406034|FG003|Overall Study|Adverse Event|0|||
124939122|NCT01566890|449406035|FG004|Overall Study|Adverse Event|0|||
124939123|NCT01566890|449406031|FG000|Overall Study|Withdrawal by Subject|3|||
124939124|NCT01566890|449406032|FG001|Overall Study|Withdrawal by Subject|1|||
124939125|NCT01566890|449406033|FG002|Overall Study|Withdrawal by Subject|1|||
124939126|NCT01566890|449406034|FG003|Overall Study|Withdrawal by Subject|1|||
124939127|NCT01566890|449406035|FG004|Overall Study|Withdrawal by Subject|0|||
124939128|NCT01566890|449406031|FG000|Overall Study|Screen failure|6|||
124939129|NCT01566890|449406032|FG001|Overall Study|Screen failure|0|||
124939130|NCT01566890|449406033|FG002|Overall Study|Screen failure|1|||
124939131|NCT01566890|449406034|FG003|Overall Study|Screen failure|1|||
124939132|NCT01566890|449406035|FG004|Overall Study|Screen failure|0|||
124939133|NCT01566890|449406031|FG000|Overall Study|Incomplete CEU data|1|||
124939134|NCT01566890|449406032|FG001|Overall Study|Incomplete CEU data|3|||
124939135|NCT01566890|449406033|FG002|Overall Study|Incomplete CEU data|5|||
124939136|NCT01566890|449406034|FG003|Overall Study|Incomplete CEU data|8|||
124939137|NCT01566890|449406035|FG004|Overall Study|Incomplete CEU data|0|||
124939138|NCT01566890|449406031|FG000|Overall Study|Lost to Follow-up|0|||
124939139|NCT01566890|449406032|FG001|Overall Study|Lost to Follow-up|0|||
124939140|NCT01566890|449406033|FG002|Overall Study|Lost to Follow-up|4|||
124939141|NCT01566890|449406034|FG003|Overall Study|Lost to Follow-up|4|||
124939142|NCT01566890|449406035|FG004|Overall Study|Lost to Follow-up|0|||
124939143|NCT01566890|449406031|FG000|Overall Study|Other|0|||
124939144|NCT01566890|449406032|FG001|Overall Study|Other|0|||
124939145|NCT01566890|449406033|FG002|Overall Study|Other|0|||
124939146|NCT01566890|449406034|FG003|Overall Study|Other|0|||
124939147|NCT01566890|449406035|FG004|Overall Study|Other|7|||
124939148|NCT01211184|449406045|FG000|Overall Study|Withdrawal by Subject|0|||
124939149|NCT01211184|449406046|FG001|Overall Study|Withdrawal by Subject|2|||
124939150|NCT01211184|449406047|FG002|Overall Study|Withdrawal by Subject|1|||
124939151|NCT00822120|449406048|FG000|Initial Registration|Adverse Event|1|||
124939152|NCT00822120|449406049|FG001|Initial Registration|Adverse Event|0|||
124939153|NCT00822120|449406050|FG002|Initial Registration|Adverse Event|0|||
124939154|NCT00822120|449406051|FG003|Initial Registration|Adverse Event|0|||
124939155|NCT00822120|449406052|FG004|Initial Registration|Adverse Event|0|||
124939156|NCT00822120|449406053|FG005|Initial Registration|Adverse Event|0|||
124939157|NCT00822120|449406048|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
124939158|NCT00822120|449406049|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
124939159|NCT00822120|449406050|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
124939160|NCT00822120|449406051|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
124939161|NCT00822120|449406052|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
124939162|NCT00822120|449406053|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
124939163|NCT00822120|449406048|FG000|Initial Registration|Reasons not Protocol Specified|2|||
124939164|NCT00822120|449406049|FG001|Initial Registration|Reasons not Protocol Specified|0|||
124939165|NCT00822120|449406050|FG002|Initial Registration|Reasons not Protocol Specified|0|||
124939166|NCT00822120|449406051|FG003|Initial Registration|Reasons not Protocol Specified|0|||
124939167|NCT00822120|449406052|FG004|Initial Registration|Reasons not Protocol Specified|0|||
124939168|NCT00822120|449406053|FG005|Initial Registration|Reasons not Protocol Specified|0|||
124939169|NCT00822120|449406048|FG000|Initial Registration|Ineligible|22|||
124939170|NCT00822120|449406049|FG001|Initial Registration|Ineligible|1|||
124939171|NCT00822120|449406050|FG002|Initial Registration|Ineligible|0|||
124939172|NCT00822120|449406051|FG003|Initial Registration|Ineligible|0|||
124939173|NCT00822120|449406052|FG004|Initial Registration|Ineligible|0|||
124939174|NCT00822120|449406053|FG005|Initial Registration|Ineligible|0|||
124939175|NCT00822120|449406048|FG000|PET-directed Therapy|Adverse Event|0|||
124939176|NCT00822120|449406049|FG001|PET-directed Therapy|Adverse Event|0|||
124939177|NCT00822120|449406050|FG002|PET-directed Therapy|Adverse Event|0|||
124939178|NCT00822120|449406051|FG003|PET-directed Therapy|Adverse Event|1|||
124939179|NCT00822120|449406052|FG004|PET-directed Therapy|Adverse Event|0|||
124939180|NCT00822120|449406053|FG005|PET-directed Therapy|Adverse Event|0|||
124939181|NCT00822120|449406048|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
124939182|NCT00822120|449406049|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
124939183|NCT00822120|449406050|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
124939184|NCT00822120|449406051|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
124939185|NCT00822120|449406052|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
124939186|NCT00822120|449406053|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
124939187|NCT00822120|449406048|FG000|PET-directed Therapy|Death|0|||
124939188|NCT00822120|449406049|FG001|PET-directed Therapy|Death|0|||
124939189|NCT00822120|449406050|FG002|PET-directed Therapy|Death|0|||
124939190|NCT00822120|449406051|FG003|PET-directed Therapy|Death|2|||
124939191|NCT00822120|449406052|FG004|PET-directed Therapy|Death|0|||
124939192|NCT00822120|449406053|FG005|PET-directed Therapy|Death|0|||
124939193|NCT00822120|449406048|FG000|PET-directed Therapy|Protocol Violation|0|||
124939194|NCT00822120|449406049|FG001|PET-directed Therapy|Protocol Violation|0|||
124939195|NCT00822120|449406050|FG002|PET-directed Therapy|Protocol Violation|0|||
125212989|NCT00248833|450405554|FG001|Overall Study|Adverse Event|0|||
125212990|NCT00248833|450405555|FG002|Overall Study|Adverse Event|0|||
125212991|NCT00248833|450405553|FG000|Overall Study|Withdrawal by Subject|0|||
125212992|NCT00248833|450405554|FG001|Overall Study|Withdrawal by Subject|1|||
125212993|NCT00248833|450405555|FG002|Overall Study|Withdrawal by Subject|1|||
125212994|NCT00248833|450405553|FG000|Overall Study|Lost to Follow-up|1|||
125212995|NCT00248833|450405554|FG001|Overall Study|Lost to Follow-up|1|||
125212996|NCT00248833|450405555|FG002|Overall Study|Lost to Follow-up|1|||
125212997|NCT00248833|450405553|FG000|Overall Study|Other|0|||
125212998|NCT00248833|450405554|FG001|Overall Study|Other|1|||
125212999|NCT00248833|450405555|FG002|Overall Study|Other|0|||
125213000|NCT01900899|450405556|FG000|Overall Study|Withdrawal by Subject|7|||
125213001|NCT01900899|450405557|FG001|Overall Study|Withdrawal by Subject|1|||
125213002|NCT01900899|450405556|FG000|Overall Study|Migrated from study area|2|||
125213003|NCT01900899|450405557|FG001|Overall Study|Migrated from study area|0|||
125213004|NCT00723697|450405560|FG000|Overall Study|Physician questionnaires not received|2|||
125213005|NCT00723697|450405560|FG000|Overall Study|Missing Informed Consent Form|10|||
125213006|NCT00723697|450405560|FG000|Overall Study|Other exclusion criteria applied|6|||
125213007|NCT00385827|450407170|FG000|Part 1|Adverse Event|1|||
125213008|NCT00385827|450407171|FG001|Part 1|Adverse Event|0|||
125213009|NCT00385827|450407172|FG002|Part 1|Adverse Event|0|||
125213010|NCT00385827|450407170|FG000|Part 1|Death|2|||
125213011|NCT00385827|450407171|FG001|Part 1|Death|0|||
125213012|NCT00385827|450407172|FG002|Part 1|Death|0|||
125213013|NCT00385827|450407170|FG000|Part 1|Lack of Efficacy|5|||
125213014|NCT00385827|450407171|FG001|Part 1|Lack of Efficacy|0|||
125213015|NCT00385827|450407172|FG002|Part 1|Lack of Efficacy|0|||
124939196|NCT00822120|449406051|FG003|PET-directed Therapy|Protocol Violation|6|||
124939197|NCT00822120|449406052|FG004|PET-directed Therapy|Protocol Violation|0|||
124939198|NCT00822120|449406053|FG005|PET-directed Therapy|Protocol Violation|0|||
124939199|NCT01324310|449406054|FG000|Overall Study|Adverse Event|1|||
124939200|NCT01324310|449406054|FG000|Overall Study|Disease Progression|1|||
124939201|NCT04060212|449406056|FG000|Overall Study|Withdrawal by Subject|7|||
124939202|NCT02787005|449406077|FG000|Overall Study|Adverse Event|24|||
124939203|NCT02787005|449406078|FG001|Overall Study|Adverse Event|9|||
124939204|NCT02787005|449406079|FG002|Overall Study|Adverse Event|9|||
124939205|NCT02787005|449406080|FG003|Overall Study|Adverse Event|7|||
124939206|NCT02787005|449406081|FG004|Overall Study|Adverse Event|2|||
124939207|NCT02787005|449406077|FG000|Overall Study|Death|100|||
124939208|NCT02787005|449406078|FG001|Overall Study|Death|53|||
124939209|NCT02787005|449406079|FG002|Overall Study|Death|48|||
124939210|NCT02787005|449406080|FG003|Overall Study|Death|69|||
124939211|NCT02787005|449406081|FG004|Overall Study|Death|38|||
124939212|NCT02787005|449406077|FG000|Overall Study|Sponsor Decision|7|||
124939213|NCT02787005|449406078|FG001|Overall Study|Sponsor Decision|4|||
124939214|NCT02787005|449406079|FG002|Overall Study|Sponsor Decision|0|||
124939215|NCT02787005|449406080|FG003|Overall Study|Sponsor Decision|4|||
124939216|NCT02787005|449406081|FG004|Overall Study|Sponsor Decision|5|||
124939217|NCT02787005|449406077|FG000|Overall Study|Withdrawal by Subject|2|||
124939218|NCT02787005|449406078|FG001|Overall Study|Withdrawal by Subject|1|||
124939219|NCT02787005|449406079|FG002|Overall Study|Withdrawal by Subject|1|||
124939220|NCT02787005|449406080|FG003|Overall Study|Withdrawal by Subject|0|||
124939221|NCT02787005|449406081|FG004|Overall Study|Withdrawal by Subject|1|||
124939222|NCT02787005|449406077|FG000|Overall Study|Screen Failure|0|||
124939223|NCT02787005|449406078|FG001|Overall Study|Screen Failure|2|||
124939224|NCT02787005|449406079|FG002|Overall Study|Screen Failure|0|||
124939225|NCT02787005|449406080|FG003|Overall Study|Screen Failure|0|||
124939226|NCT02787005|449406081|FG004|Overall Study|Screen Failure|1|||
125213016|NCT00385827|450407170|FG000|Part 1|Other|1|||
125213017|NCT00385827|450407171|FG001|Part 1|Other|0|||
125213018|NCT00385827|450407172|FG002|Part 1|Other|0|||
125213019|NCT00385827|450407170|FG000|Part 2|Adverse Event|0|||
125213020|NCT00385827|450407171|FG001|Part 2|Adverse Event|6|||
125213021|NCT00385827|450407172|FG002|Part 2|Adverse Event|10|||
124939227|NCT02787005|449406077|FG000|Overall Study|Lost to Follow-up|0|||
125213022|NCT00385827|450407170|FG000|Part 2|Death|0|||
125213023|NCT00385827|450407171|FG001|Part 2|Death|0|||
124939228|NCT02787005|449406078|FG001|Overall Study|Lost to Follow-up|0|||
124939229|NCT02787005|449406079|FG002|Overall Study|Lost to Follow-up|0|||
124939230|NCT02787005|449406080|FG003|Overall Study|Lost to Follow-up|1|||
125213024|NCT00385827|450407172|FG002|Part 2|Death|2|||
125213025|NCT00385827|450407170|FG000|Part 2|Lack of Efficacy|0|||
125213026|NCT00385827|450407171|FG001|Part 2|Lack of Efficacy|14|||
124939231|NCT02787005|449406081|FG004|Overall Study|Lost to Follow-up|0|||
124939232|NCT02016872|449406085|FG000|Overall Study|Withdrawal by Subject|10|||
125213027|NCT00385827|450407172|FG002|Part 2|Lack of Efficacy|13|||
125213028|NCT00385827|450407170|FG000|Part 2|Randomized but not treated|0|||
124939233|NCT02016872|449406085|FG000|Overall Study|Death Progression|2|||
125213029|NCT00385827|450407171|FG001|Part 2|Randomized but not treated|2|||
125213030|NCT00385827|450407172|FG002|Part 2|Randomized but not treated|2|||
125213031|NCT00385827|450407170|FG000|Part 2|Other|0|||
125213032|NCT00385827|450407171|FG001|Part 2|Other|11|||
125121350|NCT01957488|450068850|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
125121351|NCT01957488|450068851|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
125121352|NCT01957488|450068852|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
125121353|NCT01957488|450068847|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
125121354|NCT01957488|450068848|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
125121355|NCT01957488|450068849|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
125121356|NCT01957488|450068850|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
125121357|NCT01957488|450068851|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
124939234|NCT02016872|449406085|FG000|Overall Study|No FMISO scan|1|||
124939235|NCT02016872|449406085|FG000|Overall Study|Ineligible|2|||
124939236|NCT03477175|449406088|FG000|Overall Study|Unable to travel due to COVID-19|0|||
124939237|NCT03477175|449406089|FG001|Overall Study|Unable to travel due to COVID-19|1|||
124939238|NCT03477175|449406088|FG000|Overall Study|Physician Decision|1|||
124939239|NCT03477175|449406089|FG001|Overall Study|Physician Decision|0|||
124939240|NCT03477175|449406088|FG000|Overall Study|Transitioned to commercial drug|6|||
124939241|NCT03477175|449406089|FG001|Overall Study|Transitioned to commercial drug|6|||
124939242|NCT03477175|449406088|FG000|Overall Study|Lost to Follow-up|1|||
124939243|NCT03477175|449406089|FG001|Overall Study|Lost to Follow-up|1|||
124939244|NCT03477175|449406088|FG000|Overall Study|Withdrawal by Subject|3|||
124939245|NCT03477175|449406089|FG001|Overall Study|Withdrawal by Subject|1|||
124939246|NCT03477175|449406088|FG000|Overall Study|Adverse Event|1|||
124939247|NCT03477175|449406089|FG001|Overall Study|Adverse Event|5|||
124939248|NCT03477175|449406088|FG000|Overall Study|Disease Progression|7|||
124939249|NCT03477175|449406089|FG001|Overall Study|Disease Progression|7|||
124939250|NCT03593226|449406090|FG000|Overall Study|Disease progression|6|||
124939251|NCT03593226|449406091|FG001|Overall Study|Disease progression|13|||
124939252|NCT03593226|449406092|FG002|Overall Study|Disease progression|5|||
124939253|NCT03593226|449406093|FG003|Overall Study|Disease progression|6|||
124939254|NCT03593226|449406090|FG000|Overall Study|Adverse Event|0|||
124939255|NCT03593226|449406091|FG001|Overall Study|Adverse Event|1|||
124939256|NCT03593226|449406092|FG002|Overall Study|Adverse Event|0|||
124939257|NCT03593226|449406093|FG003|Overall Study|Adverse Event|0|||
124939258|NCT03593226|449406090|FG000|Overall Study|Withdrawal by Subject|0|||
124939259|NCT03593226|449406091|FG001|Overall Study|Withdrawal by Subject|4|||
124939260|NCT03593226|449406092|FG002|Overall Study|Withdrawal by Subject|1|||
124939261|NCT03593226|449406093|FG003|Overall Study|Withdrawal by Subject|0|||
124939262|NCT03593226|449406090|FG000|Overall Study|Physician Decision|0|||
124939263|NCT03593226|449406091|FG001|Overall Study|Physician Decision|1|||
124939264|NCT03593226|449406092|FG002|Overall Study|Physician Decision|0|||
124939265|NCT03593226|449406093|FG003|Overall Study|Physician Decision|0|||
124939266|NCT03593226|449406090|FG000|Overall Study|Clinical disease progression|0|||
124939267|NCT03593226|449406091|FG001|Overall Study|Clinical disease progression|0|||
124939268|NCT03593226|449406092|FG002|Overall Study|Clinical disease progression|1|||
124939269|NCT03593226|449406093|FG003|Overall Study|Clinical disease progression|0|||
124939270|NCT00545545|449406094|FG000|Overall Study|Progressive Neoplastic Disease|1|||
124939271|NCT00545545|449406095|FG001|Overall Study|Progressive Neoplastic Disease|5|||
124939272|NCT00545545|449406096|FG002|Overall Study|Progressive Neoplastic Disease|0|||
124939273|NCT00545545|449406097|FG003|Overall Study|Progressive Neoplastic Disease|4|||
124939274|NCT00545545|449406098|FG004|Overall Study|Progressive Neoplastic Disease|8|||
124939275|NCT00545545|449406099|FG005|Overall Study|Progressive Neoplastic Disease|7|||
124939276|NCT00545545|449406094|FG000|Overall Study|Withdrawal by Subject|0|||
124939277|NCT00545545|449406095|FG001|Overall Study|Withdrawal by Subject|1|||
124939278|NCT00545545|449406096|FG002|Overall Study|Withdrawal by Subject|0|||
125121358|NCT01957488|450068852|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
125121359|NCT01957488|450068847|FG000|Test Period 2 (2 Weeks)|Other|1|||
125121360|NCT01957488|450068848|FG001|Test Period 2 (2 Weeks)|Other|0|||
124939279|NCT00545545|449406097|FG003|Overall Study|Withdrawal by Subject|0|||
124939280|NCT00545545|449406098|FG004|Overall Study|Withdrawal by Subject|0|||
124939281|NCT00545545|449406099|FG005|Overall Study|Withdrawal by Subject|0|||
125121361|NCT01957488|450068849|FG002|Test Period 2 (2 Weeks)|Other|0|||
125121362|NCT01957488|450068850|FG003|Test Period 2 (2 Weeks)|Other|0|||
124939282|NCT00545545|449406094|FG000|Overall Study|Physician Decision|1|||
124939283|NCT00545545|449406095|FG001|Overall Study|Physician Decision|0|||
124939284|NCT00545545|449406096|FG002|Overall Study|Physician Decision|0|||
124939285|NCT00545545|449406097|FG003|Overall Study|Physician Decision|0|||
124939286|NCT00545545|449406098|FG004|Overall Study|Physician Decision|0|||
124939287|NCT00545545|449406099|FG005|Overall Study|Physician Decision|1|||
124939288|NCT00545545|449406094|FG000|Overall Study|Irinotecan intolerance|1|||
124939289|NCT00545545|449406095|FG001|Overall Study|Irinotecan intolerance|1|||
124939290|NCT00545545|449406096|FG002|Overall Study|Irinotecan intolerance|0|||
124939291|NCT00545545|449406097|FG003|Overall Study|Irinotecan intolerance|0|||
124939292|NCT00545545|449406098|FG004|Overall Study|Irinotecan intolerance|0|||
124939293|NCT00545545|449406099|FG005|Overall Study|Irinotecan intolerance|0|||
124939294|NCT00545545|449406094|FG000|Overall Study|No target lesions to track post surgery|0|||
124939295|NCT00545545|449406095|FG001|Overall Study|No target lesions to track post surgery|0|||
124939296|NCT00545545|449406096|FG002|Overall Study|No target lesions to track post surgery|0|||
124939297|NCT00545545|449406097|FG003|Overall Study|No target lesions to track post surgery|0|||
124939298|NCT00545545|449406098|FG004|Overall Study|No target lesions to track post surgery|1|||
124939299|NCT00545545|449406099|FG005|Overall Study|No target lesions to track post surgery|1|||
124939300|NCT03978637|449406112|FG000|Overall Study|Death|0|||
124939301|NCT03978637|449406113|FG001|Overall Study|Death|2|||
124939302|NCT03978637|449406114|FG002|Overall Study|Death|2|||
124939303|NCT03978637|449406115|FG003|Overall Study|Death|0|||
124939304|NCT03978637|449406112|FG000|Overall Study|Withdrawal by Subject|0|||
124939305|NCT03978637|449406113|FG001|Overall Study|Withdrawal by Subject|0|||
124939306|NCT03978637|449406114|FG002|Overall Study|Withdrawal by Subject|1|||
124939307|NCT03978637|449406115|FG003|Overall Study|Withdrawal by Subject|0|||
124939308|NCT03978637|449406112|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
124939309|NCT03978637|449406113|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
124939310|NCT03978637|449406114|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
124939311|NCT03978637|449406115|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
124939312|NCT03959423|449406116|FG000|Overall Study|Withdrawal by Subject|2|||
125121363|NCT01957488|450068851|FG004|Test Period 2 (2 Weeks)|Other|0|||
125121364|NCT01957488|450068852|FG005|Test Period 2 (2 Weeks)|Other|0|||
125121365|NCT01957488|450068847|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
125121366|NCT01957488|450068848|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
125121367|NCT01957488|450068849|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
125121368|NCT01957488|450068850|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
125121369|NCT01957488|450068851|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
125121370|NCT01957488|450068852|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
125121371|NCT01957488|450068847|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
125121372|NCT01957488|450068848|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
125121373|NCT01957488|450068849|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
125121374|NCT01957488|450068850|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
125121375|NCT01957488|450068851|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
125121376|NCT01957488|450068852|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
125121377|NCT01957488|450068847|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
125121378|NCT01957488|450068848|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
125121379|NCT01957488|450068849|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
125121380|NCT01957488|450068850|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
125121381|NCT01957488|450068851|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
125121382|NCT01957488|450068852|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
125121383|NCT01957488|450068847|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
125121384|NCT01957488|450068848|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
125121385|NCT01957488|450068849|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
125121386|NCT01957488|450068850|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
125121387|NCT01957488|450068851|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
125121388|NCT01957488|450068852|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
125121389|NCT01957488|450068847|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
125121390|NCT01957488|450068848|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
125121391|NCT01957488|450068849|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
125121392|NCT01957488|450068850|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
125121393|NCT01957488|450068851|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
125121394|NCT01957488|450068852|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
125121395|NCT01439165|450068854|FG000|Overall Study|Protocol Violation|3|||
124939313|NCT03959423|449406117|FG001|Overall Study|Withdrawal by Subject|3|||
124939314|NCT03959423|449406116|FG000|Overall Study|Physician Decision|0|||
124939315|NCT03959423|449406117|FG001|Overall Study|Physician Decision|1|||
124939316|NCT03959423|449406116|FG000|Overall Study|Lost to Follow-up|1|||
124939317|NCT03959423|449406117|FG001|Overall Study|Lost to Follow-up|0|||
125121396|NCT01439165|450068855|FG001|Overall Study|Protocol Violation|0|||
124939318|NCT03959423|449406116|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
125121397|NCT01439165|450068854|FG000|Overall Study|Lost to Follow-up|11|||
124939319|NCT03959423|449406117|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125213033|NCT00385827|450407172|FG002|Part 2|Other|21|||
125213034|NCT00410072|450407173|FG000|Day 1 to Week 48|Adverse Event|1|||
125213035|NCT00410072|450407174|FG001|Day 1 to Week 48|Adverse Event|2|||
125213036|NCT00410072|450407173|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
125213037|NCT00410072|450407174|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
125213038|NCT00410072|450407173|FG000|Day 1 to Week 48|Other|0|||
125213039|NCT00410072|450407174|FG001|Day 1 to Week 48|Other|1|||
125213040|NCT00410072|450407173|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
125213041|NCT00410072|450407174|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
125213042|NCT00410072|450407173|FG000|Day 1 to Week 48|Pregnancy|0|||
125213043|NCT00410072|450407174|FG001|Day 1 to Week 48|Pregnancy|2|||
125213044|NCT00410072|450407173|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
125213045|NCT00410072|450407174|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
125213046|NCT00410072|450407173|FG000|After Week 48 to Week 96|Adverse Event|1|||
125213047|NCT00410072|450407174|FG001|After Week 48 to Week 96|Adverse Event|2|||
125213048|NCT00410072|450407173|FG000|After Week 48 to Week 96|Death|0|||
125213049|NCT00410072|450407174|FG001|After Week 48 to Week 96|Death|1|||
125213050|NCT00410072|450407173|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
125213051|NCT00410072|450407174|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
125213052|NCT00410072|450407173|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
125213053|NCT00410072|450407174|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
125213054|NCT00410072|450407173|FG000|After Week 48 to Week 96|Other|2|||
125213055|NCT00410072|450407174|FG001|After Week 48 to Week 96|Other|0|||
125213056|NCT00410072|450407173|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
125213057|NCT00410072|450407174|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
125213058|NCT00410072|450407173|FG000|After Week 48 to Week 96|Pregnancy|0|||
125213059|NCT00410072|450407174|FG001|After Week 48 to Week 96|Pregnancy|2|||
125213060|NCT00410072|450407173|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
125213061|NCT00410072|450407174|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
125213062|NCT01421147|450407179|FG000|Treatment Period|Adverse Event|2|||
125213063|NCT01421147|450407180|FG001|Treatment Period|Adverse Event|3|||
125213064|NCT01421147|450407179|FG000|Treatment Period|Lost to Follow-up|2|||
125213065|NCT01421147|450407180|FG001|Treatment Period|Lost to Follow-up|1|||
124939320|NCT02549352|449406118|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
124939321|NCT02549352|449406119|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
124939322|NCT02549352|449406118|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
124939323|NCT02549352|449406119|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
124939324|NCT02549352|449406118|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
124939325|NCT02549352|449406119|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
124939326|NCT02549352|449406118|FG000|12-month Follow-up|Withdrawal by Subject|4|||
124939327|NCT02549352|449406119|FG001|12-month Follow-up|Withdrawal by Subject|5|||
124939328|NCT02549352|449406118|FG000|12-month Follow-up|Lost to Follow-up|3|||
124939329|NCT02549352|449406119|FG001|12-month Follow-up|Lost to Follow-up|2|||
124939330|NCT02549352|449406118|FG000|12-month Follow-up|Death|0|||
124939331|NCT02549352|449406119|FG001|12-month Follow-up|Death|1|||
124939332|NCT02549352|449406118|FG000|12-month Follow-up|Protocol Violation|0|||
124939333|NCT02549352|449406119|FG001|12-month Follow-up|Protocol Violation|1|||
124939334|NCT02549352|449406118|FG000|12-month Follow-up|Other|1|||
125213066|NCT01421147|450407179|FG000|Treatment Period|Physician Decision|2|||
125213067|NCT01421147|450407180|FG001|Treatment Period|Physician Decision|2|||
125213068|NCT01421147|450407179|FG000|Treatment Period|Withdrawal by Subject|10|||
125213069|NCT01421147|450407180|FG001|Treatment Period|Withdrawal by Subject|5|||
125213070|NCT01421147|450407179|FG000|Extension Period|Adverse Event|0|||
125213071|NCT01421147|450407180|FG001|Extension Period|Adverse Event|2|||
124939335|NCT02549352|449406119|FG001|12-month Follow-up|Other|3|||
124939336|NCT04530487|449407435|FG000|Overall Study|Death|1|||
124939337|NCT03876457|449407436|FG000|Overall Study|Lost to Follow-up|1|||
124939338|NCT03876457|449407437|FG001|Overall Study|Lost to Follow-up|3|||
124939339|NCT01184326|449407438|FG000|Overall Study|Adverse Event|1|||
124939340|NCT01184326|449407439|FG001|Overall Study|Adverse Event|2|||
124939341|NCT01184326|449407440|FG002|Overall Study|Adverse Event|0|||
124939342|NCT01184326|449407438|FG000|Overall Study|Death|0|||
124939343|NCT01184326|449407439|FG001|Overall Study|Death|0|||
124939344|NCT01184326|449407440|FG002|Overall Study|Death|1|||
124939345|NCT01184326|449407438|FG000|Overall Study|Withdrawal by Subject|0|||
124939346|NCT01184326|449407439|FG001|Overall Study|Withdrawal by Subject|0|||
124939347|NCT01184326|449407440|FG002|Overall Study|Withdrawal by Subject|1|||
124939348|NCT01184326|449407438|FG000|Overall Study|Physician Decision|1|||
124939349|NCT01184326|449407439|FG001|Overall Study|Physician Decision|1|||
124939350|NCT01184326|449407440|FG002|Overall Study|Physician Decision|0|||
124939351|NCT01184326|449407438|FG000|Overall Study|Disease Progression|1|||
124939352|NCT01184326|449407439|FG001|Overall Study|Disease Progression|3|||
124939353|NCT01184326|449407440|FG002|Overall Study|Disease Progression|12|||
124939354|NCT01036724|449407441|FG000|Overall Study|Adverse Event|1|||
124939355|NCT01036724|449407442|FG001|Overall Study|Adverse Event|2|||
125213072|NCT01421147|450407179|FG000|Extension Period|Death|0|||
125213073|NCT01421147|450407180|FG001|Extension Period|Death|1|||
125213074|NCT01421147|450407179|FG000|Extension Period|Lost to Follow-up|2|||
125213075|NCT01421147|450407180|FG001|Extension Period|Lost to Follow-up|5|||
125213076|NCT01421147|450407179|FG000|Extension Period|Physician Decision|1|||
125213077|NCT01421147|450407180|FG001|Extension Period|Physician Decision|0|||
125213078|NCT01421147|450407179|FG000|Extension Period|Withdrawal by Subject|5|||
125213079|NCT01421147|450407180|FG001|Extension Period|Withdrawal by Subject|3|||
125213080|NCT01270321|450407181|FG000|Overall Study|Death|3|||
125213081|NCT01270321|450407182|FG001|Overall Study|Death|1|||
124939356|NCT01036724|449407441|FG000|Overall Study|Lack of Efficacy|1|||
124939357|NCT01036724|449407442|FG001|Overall Study|Lack of Efficacy|1|||
124939358|NCT01036724|449407441|FG000|Overall Study|Protocol Violation|4|||
124939359|NCT01036724|449407442|FG001|Overall Study|Protocol Violation|5|||
124939360|NCT04213807|449407449|FG000|Overall Study|Physician Decision|0|||
124939361|NCT04213807|449407450|FG001|Overall Study|Physician Decision|0|||
124939362|NCT04213807|449407451|FG002|Overall Study|Physician Decision|1|||
124939363|NCT01574716|449407452|FG000|Part 1|Death|3|||
124939364|NCT01574716|449407453|FG001|Part 1|Death|1|||
124939365|NCT01574716|449407454|FG002|Part 1|Death|8|||
124939366|NCT01574716|449407455|FG003|Part 1|Death|0|||
124939367|NCT01574716|449407456|FG004|Part 1|Death|0|||
124939368|NCT01574716|449407452|FG000|Part 1|Discontinuation of study by sponsor|0|||
124939369|NCT01574716|449407453|FG001|Part 1|Discontinuation of study by sponsor|0|||
124939370|NCT01574716|449407454|FG002|Part 1|Discontinuation of study by sponsor|1|||
124939371|NCT01574716|449407455|FG003|Part 1|Discontinuation of study by sponsor|0|||
124939372|NCT01574716|449407456|FG004|Part 1|Discontinuation of study by sponsor|0|||
124939373|NCT01574716|449407452|FG000|Part 1|Withdrawal by Subject|0|||
124939374|NCT01574716|449407453|FG001|Part 1|Withdrawal by Subject|2|||
124939375|NCT01574716|449407454|FG002|Part 1|Withdrawal by Subject|0|||
124939376|NCT01574716|449407455|FG003|Part 1|Withdrawal by Subject|0|||
124939377|NCT01574716|449407456|FG004|Part 1|Withdrawal by Subject|0|||
124939378|NCT01574716|449407452|FG000|Part 1|Lost to Follow-up|0|||
124939379|NCT01574716|449407453|FG001|Part 1|Lost to Follow-up|1|||
124939380|NCT01574716|449407454|FG002|Part 1|Lost to Follow-up|0|||
124939381|NCT01574716|449407455|FG003|Part 1|Lost to Follow-up|0|||
124939382|NCT01574716|449407456|FG004|Part 1|Lost to Follow-up|0|||
124939383|NCT01574716|449407452|FG000|Part 2|Progressive disease|0|||
124939384|NCT01574716|449407453|FG001|Part 2|Progressive disease|0|||
124939385|NCT01574716|449407454|FG002|Part 2|Progressive disease|0|||
124939386|NCT01574716|449407455|FG003|Part 2|Progressive disease|1|||
124939387|NCT01574716|449407456|FG004|Part 2|Progressive disease|0|||
124939388|NCT01574716|449407452|FG000|Part 2|Death|0|||
124939389|NCT01574716|449407453|FG001|Part 2|Death|0|||
124939390|NCT01574716|449407454|FG002|Part 2|Death|0|||
124939391|NCT01574716|449407455|FG003|Part 2|Death|76|||
124939392|NCT01574716|449407456|FG004|Part 2|Death|35|||
124939393|NCT01574716|449407452|FG000|Part 2|Discontinuation of study by sponsor|0|||
124939394|NCT01574716|449407453|FG001|Part 2|Discontinuation of study by sponsor|0|||
124939395|NCT01574716|449407454|FG002|Part 2|Discontinuation of study by sponsor|0|||
124939396|NCT01574716|449407455|FG003|Part 2|Discontinuation of study by sponsor|51|||
124939397|NCT01574716|449407456|FG004|Part 2|Discontinuation of study by sponsor|31|||
124939398|NCT01574716|449407452|FG000|Part 2|Withdrawal by Subject|0|||
124939399|NCT01574716|449407453|FG001|Part 2|Withdrawal by Subject|0|||
124939400|NCT01574716|449407454|FG002|Part 2|Withdrawal by Subject|0|||
124939401|NCT01574716|449407455|FG003|Part 2|Withdrawal by Subject|5|||
124939402|NCT01574716|449407456|FG004|Part 2|Withdrawal by Subject|4|||
124939403|NCT01574716|449407452|FG000|Part 2|Brain metastases|0|||
124939404|NCT01574716|449407453|FG001|Part 2|Brain metastases|0|||
124939405|NCT01574716|449407454|FG002|Part 2|Brain metastases|0|||
124939406|NCT01574716|449407455|FG003|Part 2|Brain metastases|1|||
124939407|NCT01574716|449407456|FG004|Part 2|Brain metastases|0|||
124939408|NCT01574716|449407452|FG000|Part 2|Lost to Follow-up|0|||
124939409|NCT01574716|449407453|FG001|Part 2|Lost to Follow-up|0|||
125213082|NCT01270321|450407183|FG002|Overall Study|Death|4|||
125213083|NCT01270321|450407181|FG000|Overall Study|Adverse Event|7|||
124939410|NCT01574716|449407454|FG002|Part 2|Lost to Follow-up|0|||
124939411|NCT01574716|449407455|FG003|Part 2|Lost to Follow-up|3|||
124939412|NCT01574716|449407456|FG004|Part 2|Lost to Follow-up|0|||
124939413|NCT00692913|449407458|FG000|Overall Study|Adverse Event|8|||
124939414|NCT00692913|449407459|FG001|Overall Study|Adverse Event|4|||
124939415|NCT00692913|449407458|FG000|Overall Study|Lost to Follow-up|3|||
124939416|NCT00692913|449407459|FG001|Overall Study|Lost to Follow-up|5|||
124939417|NCT00692913|449407458|FG000|Overall Study|Physician Decision|2|||
124939418|NCT00692913|449407459|FG001|Overall Study|Physician Decision|0|||
125027071|NCT01360645|449722420|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
125027072|NCT01360645|449722421|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
125213084|NCT01270321|450407182|FG001|Overall Study|Adverse Event|9|||
125027073|NCT01360645|449722418|FG000|Phase A+|Lost to Follow-up|0|||
125027074|NCT01360645|449722419|FG001|Phase A+|Lost to Follow-up|0|||
125027075|NCT01360645|449722420|FG002|Phase A+|Lost to Follow-up|0|||
125027076|NCT01360645|449722421|FG003|Phase A+|Lost to Follow-up|7|||
125027077|NCT01360645|449722418|FG000|Phase A+|Adverse Event|0|||
125027078|NCT01360645|449722419|FG001|Phase A+|Adverse Event|0|||
125027079|NCT01360645|449722420|FG002|Phase A+|Adverse Event|0|||
125027080|NCT01360645|449722421|FG003|Phase A+|Adverse Event|2|||
125027081|NCT01360645|449722418|FG000|Phase A+|Met Withdrawal Criteria|0|||
125027082|NCT01360645|449722419|FG001|Phase A+|Met Withdrawal Criteria|0|||
125027083|NCT01360645|449722420|FG002|Phase A+|Met Withdrawal Criteria|0|||
125027084|NCT01360645|449722421|FG003|Phase A+|Met Withdrawal Criteria|4|||
125027085|NCT01360645|449722418|FG000|Phase A+|Physician Decision|0|||
125027086|NCT01360645|449722419|FG001|Phase A+|Physician Decision|0|||
125027087|NCT01360645|449722420|FG002|Phase A+|Physician Decision|0|||
125027088|NCT01360645|449722421|FG003|Phase A+|Physician Decision|2|||
125027089|NCT01360645|449722418|FG000|Phase A+|Withdrawal by Subject|0|||
125027090|NCT01360645|449722419|FG001|Phase A+|Withdrawal by Subject|0|||
125027091|NCT01360645|449722420|FG002|Phase A+|Withdrawal by Subject|0|||
125027092|NCT01360645|449722421|FG003|Phase A+|Withdrawal by Subject|5|||
125027093|NCT01360645|449722418|FG000|Phase A+|Protocol Deviation|0|||
125027094|NCT01360645|449722419|FG001|Phase A+|Protocol Deviation|0|||
125027095|NCT01360645|449722420|FG002|Phase A+|Protocol Deviation|0|||
125027096|NCT01360645|449722421|FG003|Phase A+|Protocol Deviation|4|||
125027097|NCT01014585|449722422|FG000|Overall Study|Adverse Event|0|||
125027098|NCT01014585|449722423|FG001|Overall Study|Adverse Event|2|||
125027099|NCT01014585|449722424|FG002|Overall Study|Adverse Event|0|||
125027100|NCT01014585|449722425|FG003|Overall Study|Adverse Event|3|||
125027101|NCT01014585|449722422|FG000|Overall Study|Withdrawal by Subject|2|||
125213085|NCT01270321|450407183|FG002|Overall Study|Adverse Event|5|||
125213086|NCT01393106|450407186|FG000|Overall Study|Adverse Event|3|||
125213087|NCT01393106|450407186|FG000|Overall Study|Withdrawal by Subject|1|||
125213088|NCT01393106|450407186|FG000|Overall Study|Lack of Efficacy|1|||
125213089|NCT03307837|450407187|FG000|Overall Study|Withdrawal by Subject|0|||
125213090|NCT03307837|450407188|FG001|Overall Study|Withdrawal by Subject|0|||
125213091|NCT03307837|450407189|FG002|Overall Study|Withdrawal by Subject|1|||
125213092|NCT03307837|450407190|FG003|Overall Study|Withdrawal by Subject|0|||
125213093|NCT03307837|450407191|FG004|Overall Study|Withdrawal by Subject|0|||
125213094|NCT03307837|450407192|FG005|Overall Study|Withdrawal by Subject|1|||
125213095|NCT03307837|450407187|FG000|Overall Study|Lost to Follow-up|1|||
125213096|NCT03307837|450407188|FG001|Overall Study|Lost to Follow-up|1|||
125213097|NCT03307837|450407189|FG002|Overall Study|Lost to Follow-up|0|||
125213098|NCT03307837|450407190|FG003|Overall Study|Lost to Follow-up|0|||
125213099|NCT03307837|450407191|FG004|Overall Study|Lost to Follow-up|0|||
125213100|NCT03307837|450407192|FG005|Overall Study|Lost to Follow-up|1|||
125027102|NCT01014585|449722423|FG001|Overall Study|Withdrawal by Subject|0|||
125027103|NCT01014585|449722424|FG002|Overall Study|Withdrawal by Subject|1|||
125027104|NCT01014585|449722425|FG003|Overall Study|Withdrawal by Subject|3|||
125027105|NCT01014585|449722422|FG000|Overall Study|Lost to Follow-up|0|||
125213101|NCT05437640|450407193|FG000|Washout (1 Week)|Adverse Event|1|||
125213102|NCT05437640|450407194|FG001|Washout (1 Week)|Adverse Event|0|||
125213103|NCT00904917|450407195|FG000|Overall Study|Lost to Follow-up|2|||
125213104|NCT00904917|450407196|FG001|Overall Study|Lost to Follow-up|2|||
125213105|NCT00904917|450407197|FG002|Overall Study|Lost to Follow-up|2|||
125213106|NCT00904917|450407198|FG003|Overall Study|Lost to Follow-up|2|||
125213107|NCT04228965|450407201|FG000|Overall Study|Lost to Follow-up|26|||
125027106|NCT01014585|449722423|FG001|Overall Study|Lost to Follow-up|0|||
125027107|NCT01014585|449722424|FG002|Overall Study|Lost to Follow-up|0|||
125027108|NCT01014585|449722425|FG003|Overall Study|Lost to Follow-up|2|||
125027109|NCT01014585|449722422|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
125027110|NCT01014585|449722423|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
125027111|NCT01014585|449722424|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
125213108|NCT04228965|450407202|FG001|Overall Study|Lost to Follow-up|11|||
125213109|NCT04228965|450407201|FG000|Overall Study|Withdrawal by Subject|18|||
125213110|NCT04228965|450407202|FG001|Overall Study|Withdrawal by Subject|5|||
124939419|NCT00692913|449407458|FG000|Overall Study|Protocol Violation|1|||
124939420|NCT00692913|449407459|FG001|Overall Study|Protocol Violation|1|||
124939421|NCT00692913|449407458|FG000|Overall Study|Withdrawal by Subject|15|||
124939422|NCT00692913|449407459|FG001|Overall Study|Withdrawal by Subject|20|||
124939423|NCT03801148|449407460|FG000|Period 1 (2 Days)|Adverse Event|1|||
124939424|NCT03801148|449407461|FG001|Period 1 (2 Days)|Adverse Event|1|||
124939425|NCT03801148|449407462|FG002|Period 1 (2 Days)|Adverse Event|0|||
124939426|NCT03801148|449407463|FG003|Period 1 (2 Days)|Adverse Event|0|||
124939427|NCT03801148|449407460|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
124939428|NCT03801148|449407461|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
124939429|NCT03801148|449407462|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
124939430|NCT03801148|449407463|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
124939431|NCT03801148|449407460|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
124939432|NCT03801148|449407461|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
124939433|NCT03801148|449407462|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
124939434|NCT03801148|449407463|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
124939435|NCT03801148|449407460|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
124939436|NCT03801148|449407461|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
124939437|NCT03801148|449407462|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
125027112|NCT01014585|449722425|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
125027113|NCT04178772|449722426|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
125027114|NCT04178772|449722426|FG000|Overall Study|study terminated early due to COVID-19|7|||
125027115|NCT00773279|449722430|FG000|Period 1|Adverse Event|2|||
125027116|NCT00773279|449722431|FG001|Period 1|Adverse Event|1|||
125027117|NCT00773279|449722430|FG000|Period 1|Lack of Efficacy|0|||
125027118|NCT00773279|449722431|FG001|Period 1|Lack of Efficacy|2|||
125027119|NCT00773279|449722430|FG000|Period 1|Unclassified|5|||
125027120|NCT00773279|449722431|FG001|Period 1|Unclassified|1|||
125027121|NCT00773279|449722430|FG000|Period 2|Adverse Event|0|||
125027122|NCT00773279|449722431|FG001|Period 2|Adverse Event|1|||
125027123|NCT00773279|449722430|FG000|Period 2|Lack of Efficacy|1|||
125027124|NCT00773279|449722431|FG001|Period 2|Lack of Efficacy|0|||
125027125|NCT00773279|449722430|FG000|Period 2|Protocol Violation|0|||
125027126|NCT00773279|449722431|FG001|Period 2|Protocol Violation|3|||
125027127|NCT00773279|449722430|FG000|Period 2|Unclassified|2|||
125027128|NCT00773279|449722431|FG001|Period 2|Unclassified|2|||
125027129|NCT02817087|449722432|FG000|Overall Study|Withdrawal by Subject|2|||
125027130|NCT02817087|449722433|FG001|Overall Study|Withdrawal by Subject|0|||
125027131|NCT00508391|449722434|FG000|First Treatment|Withdrawal by Subject|6|||
125027132|NCT00508391|449722435|FG001|First Treatment|Withdrawal by Subject|3|||
125027133|NCT00508391|449722434|FG000|Second Treatment|Withdrawal by Subject|2|||
125027134|NCT00508391|449722435|FG001|Second Treatment|Withdrawal by Subject|0|||
125027135|NCT00802360|449722436|FG000|Overall Study|Stimulation failure|4|||
125027136|NCT00802360|449722437|FG001|Overall Study|Stimulation failure|0|||
125027137|NCT00802360|449722438|FG002|Overall Study|Stimulation failure|3|||
125027138|NCT00802360|449722439|FG003|Overall Study|Stimulation failure|3|||
125027139|NCT00802360|449722436|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
125027140|NCT00802360|449722437|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
125027141|NCT00802360|449722438|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
125027142|NCT00802360|449722439|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
125027143|NCT00802360|449722436|FG000|Overall Study|Cycle cancelled|0|||
125027144|NCT00802360|449722437|FG001|Overall Study|Cycle cancelled|1|||
125027145|NCT00802360|449722438|FG002|Overall Study|Cycle cancelled|1|||
125027146|NCT00802360|449722439|FG003|Overall Study|Cycle cancelled|1|||
125027147|NCT00802360|449722436|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
125027148|NCT00802360|449722437|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
125027149|NCT00802360|449722438|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
125027150|NCT00802360|449722439|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
125027151|NCT00802360|449722436|FG000|Overall Study|No positive serum pregnancy|17|||
125027152|NCT00802360|449722437|FG001|Overall Study|No positive serum pregnancy|20|||
125027153|NCT00802360|449722438|FG002|Overall Study|No positive serum pregnancy|14|||
125027154|NCT00802360|449722439|FG003|Overall Study|No positive serum pregnancy|10|||
125027155|NCT00802360|449722436|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
125027156|NCT00802360|449722437|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
125027157|NCT00802360|449722438|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
125027158|NCT00802360|449722439|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
125027159|NCT00802360|449722436|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
125027160|NCT00802360|449722437|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
124939438|NCT03801148|449407463|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
124939439|NCT04334317|449407464|FG000|Overall Study|Adverse Event|1|||
124939440|NCT04334317|449407465|FG001|Overall Study|Adverse Event|2|||
124939441|NCT04334317|449407466|FG002|Overall Study|Adverse Event|0|||
125027161|NCT00802360|449722438|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
125027162|NCT00802360|449722439|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
125027163|NCT00802360|449722436|FG000|Overall Study|Other|2|||
124939442|NCT04334317|449407467|FG003|Overall Study|Adverse Event|0|||
124939443|NCT04334317|449407464|FG000|Overall Study|Protocol Deviation|0|||
124939444|NCT04334317|449407465|FG001|Overall Study|Protocol Deviation|1|||
124939445|NCT04334317|449407466|FG002|Overall Study|Protocol Deviation|0|||
124939446|NCT04334317|449407467|FG003|Overall Study|Protocol Deviation|0|||
124939447|NCT04334317|449407464|FG000|Overall Study|Withdrawal by Subject|2|||
124939448|NCT04334317|449407465|FG001|Overall Study|Withdrawal by Subject|2|||
124939449|NCT04334317|449407466|FG002|Overall Study|Withdrawal by Subject|0|||
124939450|NCT04334317|449407467|FG003|Overall Study|Withdrawal by Subject|0|||
124939451|NCT03621735|449407468|FG000|Overall Study|Withdrawal by Subject|13|||
124939452|NCT03621735|449407469|FG001|Overall Study|Withdrawal by Subject|13|||
124939453|NCT01128595|449407472|FG000|Treatment Period 3|Withdrawal by Subject|0|||
124939454|NCT01128595|449407473|FG001|Treatment Period 3|Withdrawal by Subject|1|||
124939455|NCT01128595|449407474|FG002|Treatment Period 3|Withdrawal by Subject|0|||
124939456|NCT01128595|449407475|FG003|Treatment Period 3|Withdrawal by Subject|0|||
124939457|NCT00605306|449407476|FG000|Overall Study|Adverse Event|0|||
124939458|NCT00605306|449407477|FG001|Overall Study|Adverse Event|1|||
124939459|NCT00372775|449407478|FG000|Overall Study|Adverse Event|8|||
124939460|NCT00372775|449407478|FG000|Overall Study|Death|15|||
124939461|NCT00372775|449407478|FG000|Overall Study|Objective progression or relapse|30|||
124939462|NCT00372775|449407478|FG000|Overall Study|Global deterioration of health status|6|||
124939463|NCT00372775|449407478|FG000|Overall Study|Withdrawal by Subject|1|||
124939464|NCT00372775|449407478|FG000|Overall Study|Other|1|||
124939465|NCT00372775|449407478|FG000|Overall Study|Not Treated|2|||
124939466|NCT00336505|449407484|FG000|Overall Study|Adverse Event|10|||
124939467|NCT00336505|449407485|FG001|Overall Study|Adverse Event|9|||
124939468|NCT00336505|449407484|FG000|Overall Study|Lack of Efficacy|8|||
124939469|NCT00336505|449407485|FG001|Overall Study|Lack of Efficacy|4|||
124939470|NCT00336505|449407484|FG000|Overall Study|Lost to Follow-up|7|||
124939471|NCT00336505|449407485|FG001|Overall Study|Lost to Follow-up|4|||
124939472|NCT00336505|449407484|FG000|Overall Study|Withdrawal by Subject|5|||
124939473|NCT00336505|449407485|FG001|Overall Study|Withdrawal by Subject|3|||
124939474|NCT00336505|449407484|FG000|Overall Study|Other|7|||
124939475|NCT00336505|449407485|FG001|Overall Study|Other|7|||
124939476|NCT01561300|449407486|FG000|Run in on Placebo|Adverse Event|1|||
124939477|NCT01561300|449407487|FG001|Run in on Placebo|Adverse Event|0|||
124939478|NCT00724126|449407490|FG000|Overall Study|Adverse Event|2|||
124939479|NCT00724126|449407491|FG001|Overall Study|Adverse Event|0|||
124939480|NCT00724126|449407490|FG000|Overall Study|Withdrawal by Subject|8|||
124939481|NCT00724126|449407491|FG001|Overall Study|Withdrawal by Subject|6|||
124939482|NCT00724126|449407490|FG000|Overall Study|Lost to Follow-up|6|||
124939483|NCT00724126|449407491|FG001|Overall Study|Lost to Follow-up|6|||
124939484|NCT00724126|449407490|FG000|Overall Study|Noncompliance|2|||
124939485|NCT00724126|449407491|FG001|Overall Study|Noncompliance|1|||
125121398|NCT01439165|450068855|FG001|Overall Study|Lost to Follow-up|1|||
125121399|NCT01439165|450068854|FG000|Overall Study|Withdrawal by Subject|7|||
125121400|NCT01439165|450068855|FG001|Overall Study|Withdrawal by Subject|1|||
125121401|NCT00623103|450068856|FG000|Overall Study|Adverse Event|70|||
125121402|NCT00623103|450068857|FG001|Overall Study|Adverse Event|60|||
125121403|NCT00623103|450068856|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
125121404|NCT00623103|450068857|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
125121405|NCT00623103|450068856|FG000|Overall Study|Withdrawal by Subject|18|||
125121406|NCT00623103|450068857|FG001|Overall Study|Withdrawal by Subject|24|||
125213111|NCT00734656|450407205|FG000|Lab Session 1|Withdrawal by Subject|2|||
125213112|NCT00734656|450407206|FG001|Lab Session 1|Withdrawal by Subject|0|||
124939486|NCT00724126|449407490|FG000|Overall Study|Subject randomized although ineligible|1|||
124939487|NCT00724126|449407491|FG001|Overall Study|Subject randomized although ineligible|1|||
124939488|NCT00724126|449407490|FG000|Overall Study|Subject had to leave vicinity of site|0|||
124939489|NCT00724126|449407491|FG001|Overall Study|Subject had to leave vicinity of site|1|||
124939490|NCT02502526|449407493|FG000|Overall Study|Lost to Follow-up|2|||
124939491|NCT02502526|449407494|FG001|Overall Study|Lost to Follow-up|2|||
124939492|NCT02502526|449407495|FG002|Overall Study|Lost to Follow-up|3|||
124939493|NCT02502526|449407493|FG000|Overall Study|Withdrawal by Subject|0|||
124939494|NCT02502526|449407494|FG001|Overall Study|Withdrawal by Subject|1|||
124939495|NCT02502526|449407495|FG002|Overall Study|Withdrawal by Subject|1|||
125027164|NCT00802360|449722437|FG001|Overall Study|Other|3|||
125027165|NCT00802360|449722438|FG002|Overall Study|Other|6|||
125027166|NCT00802360|449722439|FG003|Overall Study|Other|3|||
125027167|NCT02041962|449722440|FG000|Overall Study|Lost Aetna Coverage|43|||
125027168|NCT02041962|449722441|FG001|Overall Study|Lost Aetna Coverage|40|||
125027169|NCT02041962|449722440|FG000|Overall Study|Death|1|||
125027170|NCT02041962|449722441|FG001|Overall Study|Death|1|||
125027171|NCT02041962|449722440|FG000|Overall Study|Lost to Follow-up|37|||
125027172|NCT02041962|449722441|FG001|Overall Study|Lost to Follow-up|32|||
125027173|NCT02041962|449722440|FG000|Overall Study|Withdrawal by Subject|0|||
125027174|NCT02041962|449722441|FG001|Overall Study|Withdrawal by Subject|11|||
125027175|NCT01225562|449722442|FG000|Overall Study|Withdrawal by Subject|52|||
125027176|NCT01225562|449722443|FG001|Overall Study|Withdrawal by Subject|50|||
125027177|NCT01225562|449722444|FG002|Overall Study|Withdrawal by Subject|52|||
125027178|NCT01225562|449722442|FG000|Overall Study|Lost to Follow-up|3|||
125027179|NCT01225562|449722443|FG001|Overall Study|Lost to Follow-up|6|||
125027180|NCT01225562|449722444|FG002|Overall Study|Lost to Follow-up|1|||
125027181|NCT01481896|449722445|FG000|Overall Study|Lost to Follow-up|12|||
125027182|NCT01818726|449722448|FG000|Overall Study|Administrative reasons|5|||
125027183|NCT01818726|449722449|FG001|Overall Study|Administrative reasons|1|||
125027184|NCT01818726|449722448|FG000|Overall Study|Withdrawal by Subject|0|||
125027185|NCT01818726|449722449|FG001|Overall Study|Withdrawal by Subject|1|||
125027186|NCT01818726|449722448|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
125027187|NCT01818726|449722449|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
125027188|NCT00611247|449722451|FG000|Overall Study|Death|1|||
125027189|NCT00611247|449722452|FG001|Overall Study|Death|5|||
125027190|NCT00611247|449722451|FG000|Overall Study|Lack of Efficacy|1|||
125027191|NCT00611247|449722452|FG001|Overall Study|Lack of Efficacy|16|||
125027192|NCT00565617|449722453|FG000|Overall Study|Withdrawal by Subject|1|||
125027193|NCT01446419|449722457|FG000|Overall Study|Death|1|||
125027194|NCT01446419|449722458|FG001|Overall Study|Death|0|||
125027195|NCT01446419|449722457|FG000|Overall Study|Withdrawal by Subject|1|||
125027196|NCT01446419|449722458|FG001|Overall Study|Withdrawal by Subject|1|||
125027197|NCT01446419|449722457|FG000|Overall Study|Terminated per protocol|3|||
125027198|NCT01446419|449722458|FG001|Overall Study|Terminated per protocol|0|||
125027199|NCT00464178|449722459|FG000|Overall Study|Protocol Violation|1|||
125027200|NCT00464178|449722459|FG000|Overall Study|Withdrawal by Subject|1|||
125027201|NCT01557166|449722464|FG000|Overall Study|Adverse Event|20|||
125027202|NCT01557166|449722465|FG001|Overall Study|Adverse Event|6|||
125027203|NCT01557166|449722464|FG000|Overall Study|Lack of Efficacy|2|||
125027204|NCT01557166|449722465|FG001|Overall Study|Lack of Efficacy|1|||
125027205|NCT01557166|449722464|FG000|Overall Study|Protocol Violation|8|||
125027206|NCT01557166|449722465|FG001|Overall Study|Protocol Violation|5|||
125027207|NCT01557166|449722464|FG000|Overall Study|Withdrawn consent|12|||
125027208|NCT01557166|449722465|FG001|Overall Study|Withdrawn consent|20|||
125027209|NCT01557166|449722464|FG000|Overall Study|Target dose not tolerated|1|||
125027210|NCT01557166|449722465|FG001|Overall Study|Target dose not tolerated|0|||
125027211|NCT01557166|449722464|FG000|Overall Study|Psychiatric disorder|1|||
125121407|NCT00623103|450068856|FG000|Overall Study|Lost to Follow-up|4|||
125121408|NCT00623103|450068857|FG001|Overall Study|Lost to Follow-up|1|||
125121409|NCT00623103|450068856|FG000|Overall Study|Administrative problems|2|||
125121410|NCT00623103|450068857|FG001|Overall Study|Administrative problems|4|||
125121411|NCT00623103|450068856|FG000|Overall Study|Death|11|||
125121412|NCT00623103|450068857|FG001|Overall Study|Death|11|||
125121413|NCT00623103|450068856|FG000|Overall Study|Protocol deviation|2|||
125121414|NCT00623103|450068857|FG001|Overall Study|Protocol deviation|1|||
125121415|NCT00688064|450068859|FG000|Overall Study|Protocol Violation|0|||
125121416|NCT00688064|450068860|FG001|Overall Study|Protocol Violation|1|||
125121417|NCT00688064|450068859|FG000|Overall Study|Adverse Event|2|||
125121418|NCT00688064|450068860|FG001|Overall Study|Adverse Event|4|||
125213113|NCT00734656|450407207|FG002|Lab Session 1|Withdrawal by Subject|0|||
125213114|NCT00734656|450407208|FG003|Lab Session 1|Withdrawal by Subject|0|||
125213115|NCT00734656|450407205|FG000|Washout 1|Withdrawal by Subject|1|||
125213116|NCT00734656|450407206|FG001|Washout 1|Withdrawal by Subject|5|||
125027212|NCT01557166|449722465|FG001|Overall Study|Psychiatric disorder|0|||
125027213|NCT01557166|449722464|FG000|Overall Study|Unclassified|2|||
125027214|NCT01557166|449722465|FG001|Overall Study|Unclassified|5|||
125027215|NCT02445586|449722470|FG000|Overall Study|Death|14|||
125027216|NCT02445586|449722470|FG000|Overall Study|Withdrawal by Subject|13|||
125027217|NCT02445586|449722470|FG000|Overall Study|Disease Progression|10|||
125027218|NCT02445586|449722470|FG000|Overall Study|Protocol Violation|1|||
125027219|NCT02445586|449722470|FG000|Overall Study|Medical Condition|1|||
125121419|NCT00688064|450068859|FG000|Overall Study|Withdrawal by Subject|7|||
125121420|NCT00688064|450068860|FG001|Overall Study|Withdrawal by Subject|7|||
124939496|NCT02502526|449407493|FG000|Overall Study|Disqualified due to cataract grading|0|||
124939497|NCT02502526|449407494|FG001|Overall Study|Disqualified due to cataract grading|0|||
124939498|NCT02502526|449407495|FG002|Overall Study|Disqualified due to cataract grading|1|||
124939499|NCT02502526|449407493|FG000|Overall Study|Enrollment suspension|4|||
124939500|NCT02502526|449407494|FG001|Overall Study|Enrollment suspension|1|||
124939501|NCT02502526|449407495|FG002|Overall Study|Enrollment suspension|1|||
124939502|NCT01952366|449407496|FG000|Overall Study|Death|22|||
124939503|NCT01952366|449407496|FG000|Overall Study|Withdrawal by Subject|9|||
124939504|NCT00571649|449407497|FG000|Treatment Period|Adverse Event|438|||
124939505|NCT00571649|449407498|FG001|Treatment Period|Adverse Event|385|||
124939506|NCT00571649|449407497|FG000|Treatment Period|Clinical endpoint reached|50|||
124939507|NCT00571649|449407498|FG001|Treatment Period|Clinical endpoint reached|56|||
124939508|NCT00571649|449407497|FG000|Treatment Period|Withdrawal by Subject|285|||
124939509|NCT00571649|449407498|FG001|Treatment Period|Withdrawal by Subject|255|||
124939510|NCT00571649|449407497|FG000|Treatment Period|Death|76|||
124939511|NCT00571649|449407498|FG001|Treatment Period|Death|59|||
124939512|NCT00571649|449407497|FG000|Treatment Period|Physician Decision|8|||
124939513|NCT00571649|449407498|FG001|Treatment Period|Physician Decision|9|||
124939514|NCT00571649|449407497|FG000|Treatment Period|Lost to Follow-up|43|||
124939515|NCT00571649|449407498|FG001|Treatment Period|Lost to Follow-up|41|||
124939516|NCT00571649|449407497|FG000|Treatment Period|Non-compliant with study medication|88|||
124939517|NCT00571649|449407498|FG001|Treatment Period|Non-compliant with study medication|89|||
124939518|NCT00571649|449407497|FG000|Treatment Period|Patient convenience|11|||
124939519|NCT00571649|449407498|FG001|Treatment Period|Patient convenience|13|||
124939520|NCT00571649|449407497|FG000|Treatment Period|Protocol Violation|90|||
124939521|NCT00571649|449407498|FG001|Treatment Period|Protocol Violation|92|||
124939522|NCT00571649|449407497|FG000|Treatment Period|Technical problems|3|||
124939523|NCT00571649|449407498|FG001|Treatment Period|Technical problems|5|||
124939524|NCT00571649|449407497|FG000|Follow-up Period|Adverse Event|46|||
124939525|NCT00571649|449407498|FG001|Follow-up Period|Adverse Event|40|||
124939526|NCT00571649|449407497|FG000|Follow-up Period|Clinical endpoint reached|5|||
124939527|NCT00571649|449407498|FG001|Follow-up Period|Clinical endpoint reached|2|||
124939528|NCT00571649|449407497|FG000|Follow-up Period|Withdrawal by Subject|119|||
124939529|NCT00571649|449407498|FG001|Follow-up Period|Withdrawal by Subject|115|||
124939530|NCT00571649|449407497|FG000|Follow-up Period|Death|132|||
124939531|NCT00571649|449407498|FG001|Follow-up Period|Death|133|||
124939532|NCT00571649|449407497|FG000|Follow-up Period|Physician Decision|7|||
124939533|NCT00571649|449407498|FG001|Follow-up Period|Physician Decision|13|||
124939534|NCT00571649|449407497|FG000|Follow-up Period|Lost to Follow-up|95|||
124939535|NCT00571649|449407498|FG001|Follow-up Period|Lost to Follow-up|92|||
124939536|NCT00571649|449407497|FG000|Follow-up Period|Patient convenience|136|||
124939537|NCT00571649|449407498|FG001|Follow-up Period|Patient convenience|121|||
124939538|NCT00571649|449407497|FG000|Follow-up Period|Protocol Violation|5|||
124939539|NCT00571649|449407498|FG001|Follow-up Period|Protocol Violation|12|||
124939540|NCT01421667|449407499|FG000|Overall Study|Withdrawal by Subject|0|||
124939541|NCT01421667|449407500|FG001|Overall Study|Withdrawal by Subject|1|||
124939542|NCT01421667|449407501|FG002|Overall Study|Withdrawal by Subject|2|||
124939543|NCT01421667|449407502|FG003|Overall Study|Withdrawal by Subject|1|||
124939544|NCT01421667|449407499|FG000|Overall Study|Lost to Follow-up|0|||
124939545|NCT01421667|449407500|FG001|Overall Study|Lost to Follow-up|1|||
124939546|NCT01421667|449407501|FG002|Overall Study|Lost to Follow-up|0|||
124939547|NCT01421667|449407502|FG003|Overall Study|Lost to Follow-up|0|||
124939548|NCT00503906|449407503|FG000|Overall Study|Withdrawal by Subject|1|||
124939549|NCT01387516|449407504|FG000|Overall Study|Lost to Follow-up|4|||
124939550|NCT01387516|449407505|FG001|Overall Study|Lost to Follow-up|4|||
124939551|NCT01387516|449407506|FG002|Overall Study|Lost to Follow-up|2|||
124939552|NCT01387516|449407507|FG003|Overall Study|Lost to Follow-up|3|||
124939553|NCT01387516|449407504|FG000|Overall Study|Withdrawal by Subject|1|||
124939554|NCT01387516|449407505|FG001|Overall Study|Withdrawal by Subject|1|||
124939555|NCT01387516|449407506|FG002|Overall Study|Withdrawal by Subject|2|||
124939556|NCT01387516|449407507|FG003|Overall Study|Withdrawal by Subject|0|||
124939557|NCT01387516|449407504|FG000|Overall Study|Death|0|||
124939558|NCT01387516|449407505|FG001|Overall Study|Death|0|||
124939559|NCT01387516|449407506|FG002|Overall Study|Death|0|||
124939560|NCT01387516|449407507|FG003|Overall Study|Death|1|||
125027220|NCT01990261|449722474|FG000|Overall Study|Death Before Treatment Start|2|||
125027221|NCT01990261|449722474|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
125027222|NCT01990261|449722474|FG000|Overall Study|Death From other Causes|1|||
125027223|NCT01990261|449722474|FG000|Overall Study|Disease Progression (PD)|8|||
125121421|NCT00688064|450068859|FG000|Overall Study|Lost to Follow-up|10|||
125121422|NCT00688064|450068860|FG001|Overall Study|Lost to Follow-up|10|||
125121423|NCT00688064|450068859|FG000|Overall Study|Lack of Efficacy|0|||
125121424|NCT00688064|450068860|FG001|Overall Study|Lack of Efficacy|1|||
125121425|NCT00688064|450068859|FG000|Overall Study|Pregnancy|1|||
125121426|NCT00688064|450068860|FG001|Overall Study|Pregnancy|0|||
125121427|NCT00688064|450068859|FG000|Overall Study|Any other reasons|1|||
125121428|NCT00688064|450068860|FG001|Overall Study|Any other reasons|3|||
125121429|NCT00001849|450068861|FG000|Overall Study|Death|4|||
125121430|NCT00001849|450068861|FG000|Overall Study|Lost to Follow-up|2|||
125121431|NCT00001849|450068861|FG000|Overall Study|Withdrawal by Subject|2|||
125121432|NCT00001849|450068861|FG000|Overall Study|tumor remained occult|6|||
125121433|NCT00442936|450068862|FG000|Overall Study|Protocol Violation|1|||
125121434|NCT00442936|450068863|FG001|Overall Study|Protocol Violation|0|||
125121435|NCT00442936|450068864|FG002|Overall Study|Protocol Violation|1|||
125121436|NCT00442936|450068865|FG003|Overall Study|Protocol Violation|1|||
125121437|NCT02433678|450068867|FG000|Overall Study|Lost to Follow-up|1|||
125121438|NCT02433678|450068868|FG001|Overall Study|Lost to Follow-up|2|||
125121439|NCT01506947|450068872|FG000|Overall Study|Lost to Follow-up|7|||
125121440|NCT01506947|450068872|FG000|Overall Study|Adverse Event|5|||
125121441|NCT01506947|450068872|FG000|Overall Study|Death|1|||
125121442|NCT01506947|450068872|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
125121443|NCT01700621|450068873|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
125121444|NCT01700621|450068874|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
125121445|NCT01700621|450068873|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
125121446|NCT01700621|450068874|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
125121447|NCT01700621|450068873|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
125121448|NCT01700621|450068874|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
125121449|NCT02166697|450068875|FG000|Overall Study|Protocol Violation|347|||
125121450|NCT02720510|450068879|FG000|Overall Study|Study Terminated by the sponsor|2|||
125121451|NCT02720510|450068880|FG001|Overall Study|Study Terminated by the sponsor|0|||
125121452|NCT02720510|450068879|FG000|Overall Study|Adverse Event|0|||
125121453|NCT02720510|450068880|FG001|Overall Study|Adverse Event|1|||
125027224|NCT01990261|449722474|FG000|Overall Study|PD Before Treatment Start|1|||
125027225|NCT01990261|449722474|FG000|Overall Study|Dossier not Approved|1|||
125027226|NCT01990261|449722474|FG000|Overall Study|Lost to Follow-up|2|||
125027227|NCT01445678|449722483|FG000|Overall Study|Adverse Event|12|||
125027228|NCT01445678|449722484|FG001|Overall Study|Adverse Event|8|||
125027229|NCT01445678|449722483|FG000|Overall Study|Lack of Efficacy|0|||
125027230|NCT01445678|449722484|FG001|Overall Study|Lack of Efficacy|2|||
125027231|NCT01445678|449722483|FG000|Overall Study|Lost to Follow-up|8|||
125027232|NCT01445678|449722484|FG001|Overall Study|Lost to Follow-up|5|||
125027233|NCT01445678|449722483|FG000|Overall Study|Protocol Violation|1|||
125027234|NCT01445678|449722484|FG001|Overall Study|Protocol Violation|1|||
125121454|NCT02720510|450068879|FG000|Overall Study|Physician Decision|1|||
124939561|NCT04517435|449407527|FG000|Overall Study|Withdrawal by Subject|0|||
124939562|NCT04517435|449407528|FG001|Overall Study|Withdrawal by Subject|0|||
124939563|NCT04517435|449407529|FG002|Overall Study|Withdrawal by Subject|1|||
124939564|NCT04517435|449407527|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
125027235|NCT01445678|449722483|FG000|Overall Study|Withdrawal by Subject|9|||
125027236|NCT01445678|449722484|FG001|Overall Study|Withdrawal by Subject|5|||
125027237|NCT02307370|449722485|FG000|Overall Study|Death|5|||
124939565|NCT04517435|449407528|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
125121455|NCT02720510|450068880|FG001|Overall Study|Physician Decision|2|||
125121456|NCT01618266|450068886|FG000|Overall Study|Lost to Follow-up|9|||
124939566|NCT04517435|449407529|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
124939567|NCT02415127|449407530|FG000|Overall Study|Adverse Event|1|||
124939568|NCT02415127|449407531|FG001|Overall Study|Adverse Event|0|||
124939569|NCT04882917|449407535|FG000|Overall Study|Adverse Event|0|||
124939570|NCT04882917|449407536|FG001|Overall Study|Adverse Event|1|||
124939571|NCT04882917|449407537|FG002|Overall Study|Adverse Event|2|||
124939572|NCT04882917|449407538|FG003|Overall Study|Adverse Event|2|||
124939573|NCT04882917|449407535|FG000|Overall Study|Withdrawal by Subject|1|||
124939574|NCT04882917|449407536|FG001|Overall Study|Withdrawal by Subject|0|||
124939575|NCT04882917|449407537|FG002|Overall Study|Withdrawal by Subject|2|||
124939576|NCT04882917|449407538|FG003|Overall Study|Withdrawal by Subject|1|||
124939577|NCT04882917|449407535|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
124939578|NCT04882917|449407536|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
124939579|NCT04882917|449407537|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
124939580|NCT04882917|449407538|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
124939581|NCT02678689|449407539|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
124939582|NCT02678689|449407540|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
124939583|NCT03160885|449407541|FG000|Initial Treatment Period|Not dosed|2|||
124939584|NCT03160885|449407542|FG001|Initial Treatment Period|Not dosed|0|||
124939585|NCT03160885|449407543|FG002|Initial Treatment Period|Not dosed|0|||
124939586|NCT03160885|449407544|FG003|Initial Treatment Period|Not dosed|0|||
124939587|NCT03160885|449407545|FG004|Initial Treatment Period|Not dosed|0|||
124939588|NCT03160885|449407546|FG005|Initial Treatment Period|Not dosed|0|||
124939589|NCT03160885|449407547|FG006|Initial Treatment Period|Not dosed|0|||
124939590|NCT03160885|449407541|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
124939591|NCT03160885|449407542|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
124939592|NCT03160885|449407543|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124939593|NCT03160885|449407544|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124939594|NCT03160885|449407545|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124939595|NCT03160885|449407546|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124939596|NCT03160885|449407547|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124939597|NCT03160885|449407541|FG000|Open-label Treatment|Not dosed|0|||
124939598|NCT03160885|449407542|FG001|Open-label Treatment|Not dosed|0|||
124939599|NCT03160885|449407543|FG002|Open-label Treatment|Not dosed|0|||
124939600|NCT03160885|449407544|FG003|Open-label Treatment|Not dosed|0|||
124939601|NCT03160885|449407545|FG004|Open-label Treatment|Not dosed|0|||
124939602|NCT03160885|449407546|FG005|Open-label Treatment|Not dosed|0|||
124939603|NCT03160885|449407547|FG006|Open-label Treatment|Not dosed|2|||
124939604|NCT03160885|449407541|FG000|Open-label Treatment|Discontinued IMP|0|||
124939605|NCT03160885|449407542|FG001|Open-label Treatment|Discontinued IMP|0|||
124939606|NCT03160885|449407543|FG002|Open-label Treatment|Discontinued IMP|0|||
124939607|NCT03160885|449407544|FG003|Open-label Treatment|Discontinued IMP|0|||
124939608|NCT03160885|449407545|FG004|Open-label Treatment|Discontinued IMP|0|||
124939609|NCT03160885|449407546|FG005|Open-label Treatment|Discontinued IMP|0|||
124939610|NCT03160885|449407547|FG006|Open-label Treatment|Discontinued IMP|131|||
124939611|NCT03160885|449407541|FG000|Open-label Treatment|Completed Week 50|0|||
124939612|NCT03160885|449407542|FG001|Open-label Treatment|Completed Week 50|0|||
124939613|NCT03160885|449407543|FG002|Open-label Treatment|Completed Week 50|0|||
125121457|NCT01618266|450068886|FG000|Overall Study|Treatment satisfaction|10|||
125121458|NCT01618266|450068886|FG000|Overall Study|Other reasons|11|||
125121459|NCT01618266|450068886|FG000|Overall Study|Lack of Efficacy|23|||
125121460|NCT01618266|450068886|FG000|Overall Study|Protocol Violation|43|||
125121461|NCT02985151|450068887|FG000|Original Randomization|Withdrawal by Subject|0|||
125121462|NCT02985151|450068888|FG001|Original Randomization|Withdrawal by Subject|1|||
125121463|NCT00625807|450068891|FG000|Overall Study|schedule conflict|2|||
125121464|NCT00625807|450068892|FG001|Overall Study|schedule conflict|8|||
125121465|NCT02187042|450068893|FG000|Overall Study|Death|1|||
125121466|NCT02187042|450068894|FG001|Overall Study|Death|1|||
125121467|NCT02187042|450068893|FG000|Overall Study|Toxicity|6|||
125121468|NCT02187042|450068894|FG001|Overall Study|Toxicity|5|||
125121469|NCT02187042|450068893|FG000|Overall Study|Participant choice|1|||
125121470|NCT02187042|450068894|FG001|Overall Study|Participant choice|0|||
125121471|NCT02187042|450068893|FG000|Overall Study|Doctor choice|1|||
125121472|NCT02187042|450068894|FG001|Overall Study|Doctor choice|0|||
125121473|NCT02187042|450068893|FG000|Overall Study|Progressive disease|4|||
125121474|NCT02187042|450068894|FG001|Overall Study|Progressive disease|8|||
125121475|NCT00536575|450068896|FG000|Overall Study|Withdrawal by Subject|1|||
125121476|NCT00536575|450068896|FG000|Overall Study|Death|1|||
125121477|NCT00788957|450068899|FG000|Part 1|Death|8|||
125213117|NCT00734656|450407207|FG002|Washout 1|Withdrawal by Subject|2|||
125213118|NCT00734656|450407208|FG003|Washout 1|Withdrawal by Subject|3|||
124939614|NCT03160885|449407544|FG003|Open-label Treatment|Completed Week 50|0|||
124939615|NCT03160885|449407545|FG004|Open-label Treatment|Completed Week 50|0|||
125121478|NCT00788957|450068900|FG001|Part 1|Death|0|||
125121479|NCT00788957|450068901|FG002|Part 1|Death|0|||
125121480|NCT00788957|450068902|FG003|Part 1|Death|0|||
124939616|NCT03160885|449407546|FG005|Open-label Treatment|Completed Week 50|0|||
124939617|NCT03160885|449407547|FG006|Open-label Treatment|Completed Week 50|4|||
124939618|NCT03160885|449407541|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
124939619|NCT03160885|449407542|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
124939620|NCT03160885|449407543|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
124939621|NCT03160885|449407544|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
124939622|NCT03160885|449407545|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
124939623|NCT03160885|449407546|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
124939624|NCT03160885|449407547|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
124939625|NCT03160885|449407541|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
124939626|NCT03160885|449407542|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
124939627|NCT03160885|449407543|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
124939628|NCT03160885|449407544|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
124939629|NCT03160885|449407545|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
124939630|NCT03160885|449407546|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
124939631|NCT03160885|449407547|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
124939632|NCT03160885|449407541|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
124939633|NCT03160885|449407542|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
124939634|NCT03160885|449407543|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
124939635|NCT03160885|449407544|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
124939636|NCT03160885|449407545|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
124939637|NCT03160885|449407546|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
124939638|NCT03160885|449407547|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
124939639|NCT03160885|449407541|FG000|Maintenance Treatment Period|Completed Week 50|0|||
124939640|NCT03160885|449407542|FG001|Maintenance Treatment Period|Completed Week 50|0|||
124939641|NCT03160885|449407543|FG002|Maintenance Treatment Period|Completed Week 50|1|||
124939642|NCT03160885|449407544|FG003|Maintenance Treatment Period|Completed Week 50|0|||
124939643|NCT03160885|449407545|FG004|Maintenance Treatment Period|Completed Week 50|0|||
124939644|NCT03160885|449407546|FG005|Maintenance Treatment Period|Completed Week 50|0|||
124939645|NCT03160885|449407547|FG006|Maintenance Treatment Period|Completed Week 50|0|||
124939646|NCT02761187|449407548|FG000|Overall Study|Too ill to Participate|13|||
124939647|NCT02761187|449407549|FG001|Overall Study|Too ill to Participate|8|||
125121481|NCT00788957|450068903|FG004|Part 1|Death|0|||
125121482|NCT00788957|450068904|FG005|Part 1|Death|0|||
125121483|NCT00788957|450068899|FG000|Part 1|Lost to Follow-up|1|||
125027238|NCT02307370|449722485|FG000|Overall Study|Lost to Follow-up|1|||
125027239|NCT02307370|449722485|FG000|Overall Study|Withdrawal by Subject|1|||
125027240|NCT02307370|449722485|FG000|Overall Study|Declined Addendum ICF|6|||
125027241|NCT02307370|449722485|FG000|Overall Study|No response during telephone contact|5|||
125027242|NCT02307370|449722485|FG000|Overall Study|Protocol Violation|1|||
125027243|NCT03344003|449722486|FG000|Overall Study|Switched to alternative treatment|1|||
125027244|NCT03344003|449722487|FG001|Overall Study|Switched to alternative treatment|0|||
125027245|NCT03344003|449722486|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
125027246|NCT03344003|449722487|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
125027247|NCT03631706|449722488|FG000|Overall Study|Randomized, not treated|1|||
125027248|NCT03631706|449722489|FG001|Overall Study|Randomized, not treated|0|||
125027249|NCT06272370|449725461|FG000|Overall Study|Lost to Follow-up|0|||
125027250|NCT06272370|449725462|FG001|Overall Study|Lost to Follow-up|3|||
125027251|NCT06272370|449725463|FG002|Overall Study|Lost to Follow-up|1|||
124939648|NCT02761187|449407548|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
124939649|NCT02761187|449407549|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
124939650|NCT02761187|449407548|FG000|Overall Study|Patient withdrew consent|64|||
124939651|NCT02761187|449407549|FG001|Overall Study|Patient withdrew consent|58|||
124939652|NCT02761187|449407548|FG000|Overall Study|Physician discretion|4|||
124939653|NCT02761187|449407549|FG001|Overall Study|Physician discretion|8|||
124939654|NCT02761187|449407548|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
124939655|NCT02761187|449407549|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
124939656|NCT02761187|449407548|FG000|Overall Study|On Hospice|20|||
124939657|NCT02761187|449407549|FG001|Overall Study|On Hospice|26|||
124939658|NCT02761187|449407548|FG000|Overall Study|Deceased|474|||
124939659|NCT02761187|449407549|FG001|Overall Study|Deceased|642|||
124939660|NCT02761187|449407548|FG000|Overall Study|Lost to Follow-up|73|||
124939661|NCT02761187|449407549|FG001|Overall Study|Lost to Follow-up|63|||
124939662|NCT02761187|449407548|FG000|Overall Study|Due to study discontinued at site|100|||
124939663|NCT02761187|449407549|FG001|Overall Study|Due to study discontinued at site|85|||
124939664|NCT02761187|449407548|FG000|Overall Study|Reason not Specified|1484|||
124939665|NCT02761187|449407549|FG001|Overall Study|Reason not Specified|937|||
124939666|NCT02307682|449407550|FG000|Overall Study|Adverse Event|9|||
124939667|NCT02307682|449407551|FG001|Overall Study|Adverse Event|8|||
124939668|NCT02307682|449407552|FG002|Overall Study|Adverse Event|12|||
124939669|NCT02307682|449407550|FG000|Overall Study|Lack of Efficacy|1|||
124939670|NCT02307682|449407551|FG001|Overall Study|Lack of Efficacy|0|||
124939671|NCT02307682|449407552|FG002|Overall Study|Lack of Efficacy|1|||
124939672|NCT02307682|449407550|FG000|Overall Study|Physician Decision|2|||
124939673|NCT02307682|449407551|FG001|Overall Study|Physician Decision|2|||
124939674|NCT02307682|449407552|FG002|Overall Study|Physician Decision|8|||
124939675|NCT02307682|449407550|FG000|Overall Study|Progressive Disease|1|||
124939676|NCT02307682|449407551|FG001|Overall Study|Progressive Disease|0|||
124939677|NCT02307682|449407552|FG002|Overall Study|Progressive Disease|0|||
124939678|NCT02307682|449407550|FG000|Overall Study|Withdrawal by Subject|26|||
125027252|NCT06272370|449725464|FG003|Overall Study|Lost to Follow-up|1|||
125027253|NCT00544869|449725466|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
124939679|NCT02307682|449407551|FG001|Overall Study|Withdrawal by Subject|34|||
124939680|NCT02307682|449407552|FG002|Overall Study|Withdrawal by Subject|23|||
124939681|NCT02307682|449407550|FG000|Overall Study|Death|9|||
125027254|NCT00544869|449725467|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
124939682|NCT02307682|449407551|FG001|Overall Study|Death|7|||
124939683|NCT02307682|449407552|FG002|Overall Study|Death|12|||
124939684|NCT02307682|449407550|FG000|Overall Study|Lost to Follow-up|1|||
124939685|NCT02307682|449407551|FG001|Overall Study|Lost to Follow-up|5|||
125027255|NCT00544869|449725468|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
125027256|NCT00544869|449725466|FG000|Overall Study|Adverse Event|6|||
125027257|NCT00544869|449725467|FG001|Overall Study|Adverse Event|1|||
125027258|NCT00544869|449725468|FG002|Overall Study|Adverse Event|0|||
125027259|NCT00544869|449725466|FG000|Overall Study|Lack of Efficacy|1|||
125027260|NCT00544869|449725467|FG001|Overall Study|Lack of Efficacy|1|||
125027261|NCT00544869|449725468|FG002|Overall Study|Lack of Efficacy|0|||
125027262|NCT00544869|449725466|FG000|Overall Study|Physician Decision|2|||
125027263|NCT00544869|449725467|FG001|Overall Study|Physician Decision|0|||
125027264|NCT00544869|449725468|FG002|Overall Study|Physician Decision|0|||
125027265|NCT03988907|449725469|FG000|Overall Study|Unable to complete visit|0|||
125027266|NCT03988907|449725470|FG001|Overall Study|Unable to complete visit|1|||
125027267|NCT02810964|449725471|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
125027268|NCT02810964|449725472|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
125027269|NCT02810964|449725471|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
125027270|NCT02810964|449725472|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
125027271|NCT02810964|449725471|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
125027272|NCT02810964|449725472|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
125121484|NCT00788957|450068900|FG001|Part 1|Lost to Follow-up|0|||
125121485|NCT00788957|450068901|FG002|Part 1|Lost to Follow-up|0|||
125121486|NCT00788957|450068902|FG003|Part 1|Lost to Follow-up|0|||
125121487|NCT00788957|450068903|FG004|Part 1|Lost to Follow-up|0|||
125121488|NCT00788957|450068904|FG005|Part 1|Lost to Follow-up|0|||
125121489|NCT00788957|450068899|FG000|Part 2|Withdrawal by Subject|0|||
125121490|NCT00788957|450068900|FG001|Part 2|Withdrawal by Subject|9|||
125121491|NCT00788957|450068901|FG002|Part 2|Withdrawal by Subject|5|||
125121492|NCT00788957|450068902|FG003|Part 2|Withdrawal by Subject|3|||
125121493|NCT00788957|450068903|FG004|Part 2|Withdrawal by Subject|0|||
124939686|NCT02307682|449407552|FG002|Overall Study|Lost to Follow-up|6|||
124939687|NCT02307682|449407550|FG000|Overall Study|Protocol Deviation|0|||
124939688|NCT02307682|449407551|FG001|Overall Study|Protocol Deviation|0|||
124939689|NCT02307682|449407552|FG002|Overall Study|Protocol Deviation|2|||
124939690|NCT02307682|449407550|FG000|Overall Study|Other|1|||
124939691|NCT02307682|449407551|FG001|Overall Study|Other|1|||
124939692|NCT02307682|449407552|FG002|Overall Study|Other|0|||
124939693|NCT05630833|449407553|FG000|Overall Study|Adverse Event|3|||
124939694|NCT05630833|449407554|FG001|Overall Study|Adverse Event|0|||
124939695|NCT05630833|449407553|FG000|Overall Study|Lack of Efficacy|0|||
124939696|NCT05630833|449407554|FG001|Overall Study|Lack of Efficacy|1|||
124939697|NCT05630833|449407553|FG000|Overall Study|Lost to Follow-up|1|||
124939698|NCT05630833|449407554|FG001|Overall Study|Lost to Follow-up|0|||
124939699|NCT05630833|449407553|FG000|Overall Study|Withdrawal by Subject|3|||
124939700|NCT05630833|449407554|FG001|Overall Study|Withdrawal by Subject|1|||
124939701|NCT03170349|449407556|FG000|From Implant to the 30-Day Visit|Death|1|||
124939702|NCT03170349|449407556|FG000|From 30-Day to 6-Month Visit|Death|3|||
124939703|NCT03170349|449407556|FG000|From 30-Day to 6-Month Visit|Withdrawal by Subject|1|||
124939704|NCT03170349|449407556|FG000|From 30-Day to 6-Month Visit|Exited for Other Reasons|5|||
124939705|NCT03170349|449407556|FG000|From 6-Month to 1-Year Visit|Death|6|||
124939706|NCT03170349|449407556|FG000|From 6-Month to 1-Year Visit|Exited for Other Reasons|2|||
124939707|NCT03170349|449407556|FG000|From 1-Year to 2-Year Visit|Death|13|||
124939708|NCT03170349|449407556|FG000|From 1-Year to 2-Year Visit|Withdrawal by Subject|1|||
124939709|NCT03170349|449407556|FG000|From 1-Year to 2-Year Visit|Missed Visit|4|||
124939710|NCT03170349|449407556|FG000|From 2-Year to 3-Year Visit|Death|10|||
124939711|NCT03170349|449407556|FG000|From 2-Year to 3-Year Visit|Lost to Follow-up|2|||
124939712|NCT03170349|449407556|FG000|From 2-Year to 3-Year Visit|Withdrawal by Subject|2|||
124939713|NCT03170349|449407556|FG000|From 2-Year to 3-Year Visit|Missed Visit|1|||
124939714|NCT04551066|449407557|FG000|Overall Study|Death|5|||
124939715|NCT04551066|449407558|FG001|Overall Study|Death|3|||
124939716|NCT04551066|449407557|FG000|Overall Study|Lost to Follow-up|1|||
124939717|NCT04551066|449407558|FG001|Overall Study|Lost to Follow-up|0|||
124939718|NCT04551066|449407557|FG000|Overall Study|Sponsor Decision|103|||
124939719|NCT04551066|449407558|FG001|Overall Study|Sponsor Decision|117|||
124939720|NCT04551066|449407557|FG000|Overall Study|Withdrawal by Subject|8|||
124939721|NCT04551066|449407558|FG001|Overall Study|Withdrawal by Subject|2|||
124939722|NCT04551066|449407557|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
124939723|NCT04551066|449407558|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
124939724|NCT04551066|449407557|FG000|Overall Study|Adverse Event|2|||
124939725|NCT04551066|449407558|FG001|Overall Study|Adverse Event|0|||
124939726|NCT04551066|449407557|FG000|Overall Study|Physician Decision|2|||
124939727|NCT04551066|449407558|FG001|Overall Study|Physician Decision|0|||
124939728|NCT04551066|449407557|FG000|Overall Study|Protocol Violation|1|||
124939729|NCT04551066|449407558|FG001|Overall Study|Protocol Violation|0|||
124939730|NCT04551066|449407557|FG000|Overall Study|Lack of Efficacy|0|||
124939731|NCT04551066|449407558|FG001|Overall Study|Lack of Efficacy|1|||
124939732|NCT04551066|449407557|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
124939733|NCT04551066|449407558|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
124939734|NCT05529992|449407559|FG000|Overall Study|Withdrawal by Subject|1|||
124939735|NCT00536120|449408498|FG000|Overall Study|Lost to Follow-up|1|||
124939736|NCT00536120|449408499|FG001|Overall Study|Lost to Follow-up|0|||
124939737|NCT00536120|449408498|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
124939738|NCT00536120|449408499|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
124939739|NCT00536120|449408498|FG000|Overall Study|Non-compliance|1|||
124939740|NCT00536120|449408499|FG001|Overall Study|Non-compliance|0|||
124939741|NCT00536120|449408498|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
124939742|NCT00536120|449408499|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
124939743|NCT00536120|449408498|FG000|Overall Study|Steroid Use|0|||
124939744|NCT00536120|449408499|FG001|Overall Study|Steroid Use|2|||
125121494|NCT00788957|450068904|FG005|Part 2|Withdrawal by Subject|0|||
125121495|NCT00788957|450068899|FG000|Part 2|Death|0|||
125121496|NCT00788957|450068900|FG001|Part 2|Death|32|||
125121497|NCT00788957|450068901|FG002|Part 2|Death|35|||
125121498|NCT00788957|450068902|FG003|Part 2|Death|37|||
125121499|NCT00788957|450068903|FG004|Part 2|Death|0|||
124939745|NCT00536120|449408498|FG000|Overall Study|Missed Study Visit|0|||
124939746|NCT00536120|449408499|FG001|Overall Study|Missed Study Visit|1|||
124939747|NCT02760654|449408500|FG000|Overall Study|Lost to Follow-up|3|||
124939748|NCT02760654|449408501|FG001|Overall Study|Lost to Follow-up|3|||
124939749|NCT02760654|449408500|FG000|Overall Study|Withdrawal by Subject|4|||
124939750|NCT02760654|449408501|FG001|Overall Study|Withdrawal by Subject|3|||
124939751|NCT01084694|449408503|FG000|Overall Study|Withdrawal by Subject|2|||
124939752|NCT01084694|449408504|FG001|Overall Study|Withdrawal by Subject|1|||
124939753|NCT01084694|449408503|FG000|Overall Study|Death|2|||
124939754|NCT01084694|449408504|FG001|Overall Study|Death|12|||
124939755|NCT01084694|449408503|FG000|Overall Study|eligibility not maintained|2|||
124939756|NCT01084694|449408504|FG001|Overall Study|eligibility not maintained|7|||
124939757|NCT00945321|449408507|FG000|Period 1|Adverse Event|0|||
124939758|NCT00945321|449408508|FG001|Period 1|Adverse Event|0|||
124939759|NCT00945321|449408509|FG002|Period 1|Adverse Event|0|||
124939760|NCT00945321|449408510|FG003|Period 1|Adverse Event|0|||
124939761|NCT00945321|449408511|FG004|Period 1|Adverse Event|1|||
124939762|NCT00945321|449408512|FG005|Period 1|Adverse Event|0|||
124939763|NCT00945321|449408507|FG000|Period 4|Lost to Follow-up|0|||
124939764|NCT00945321|449408508|FG001|Period 4|Lost to Follow-up|0|||
124939765|NCT00945321|449408509|FG002|Period 4|Lost to Follow-up|0|||
124939766|NCT00945321|449408510|FG003|Period 4|Lost to Follow-up|0|||
124939767|NCT00945321|449408511|FG004|Period 4|Lost to Follow-up|0|||
124939768|NCT00945321|449408512|FG005|Period 4|Lost to Follow-up|1|||
124939769|NCT02633215|449408513|FG000|Overall Study|Lost to Follow-up|2|||
124939770|NCT02633215|449408514|FG001|Overall Study|Lost to Follow-up|3|||
124939771|NCT04017611|449408515|FG000|Overall Study|Withdrawn prior to completion|1|||
124939772|NCT02291913|449408524|FG000|Overall Study|Progressive Disease|32|||
124939773|NCT02291913|449408524|FG000|Overall Study|Adverse Event|11|||
124939774|NCT02291913|449408524|FG000|Overall Study|Death|2|||
124939775|NCT02291913|449408524|FG000|Overall Study|Physician Decision|1|||
124939776|NCT02291913|449408524|FG000|Overall Study|Withdrawal by Subject|1|||
124939777|NCT02291913|449408524|FG000|Overall Study|Protocol Violation|1|||
124939778|NCT04876417|449408527|FG000|Overall Study|Lost to Follow-up|5|||
124939779|NCT04876417|449408528|FG001|Overall Study|Lost to Follow-up|8|||
124939780|NCT04876417|449408529|FG002|Overall Study|Lost to Follow-up|0|||
124939781|NCT04876417|449408530|FG003|Overall Study|Lost to Follow-up|0|||
124939782|NCT02866942|449408531|FG000|Overall Study|Invalid consent|1|||
124939783|NCT00439270|449408532|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
124939784|NCT00439270|449408533|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
124939785|NCT00439270|449408534|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
124939786|NCT00439270|449408535|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
124939787|NCT00439270|449408536|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
124939788|NCT00439270|449408532|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
124939789|NCT00439270|449408533|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
124939790|NCT00439270|449408534|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
124939791|NCT00439270|449408535|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
124939792|NCT00439270|449408536|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
124939793|NCT00439270|449408532|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
124939794|NCT00439270|449408533|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
124939795|NCT00439270|449408534|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
124939796|NCT00439270|449408535|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
124939797|NCT00439270|449408536|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
124939798|NCT00439270|449408532|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
124939799|NCT00439270|449408533|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
124939800|NCT00439270|449408534|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
124939801|NCT00439270|449408535|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
124939802|NCT00439270|449408536|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
124939803|NCT00439270|449408532|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
124939804|NCT00439270|449408533|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
124939805|NCT00439270|449408534|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
124939806|NCT00439270|449408535|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
124939807|NCT00439270|449408536|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
124939808|NCT00439270|449408532|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
124939809|NCT00439270|449408533|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
124939810|NCT00439270|449408534|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
124939811|NCT00439270|449408535|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
124939812|NCT00439270|449408536|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
124939813|NCT00439270|449408532|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
124939814|NCT00439270|449408533|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
124939815|NCT00439270|449408534|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
124939816|NCT00439270|449408535|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
124939817|NCT00439270|449408536|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
124939818|NCT00439270|449408532|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
124939819|NCT00439270|449408533|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
124939820|NCT00439270|449408534|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
124939821|NCT00439270|449408535|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
124939822|NCT00439270|449408536|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
124939823|NCT00439270|449408532|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
124939824|NCT00439270|449408533|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
124939825|NCT00439270|449408534|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
124939826|NCT00439270|449408535|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
124939827|NCT00439270|449408536|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
124939828|NCT00439270|449408532|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
124939829|NCT00439270|449408533|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
124939830|NCT00439270|449408534|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
124939831|NCT00439270|449408535|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
124939832|NCT00439270|449408536|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
124939833|NCT01268306|449408537|FG000|Overall Study|Lost to Follow-up|1|||
124939834|NCT02568215|449408539|FG000|Overall Study|Death|1|||
124939835|NCT02568215|449408540|FG001|Overall Study|Death|2|||
124939836|NCT02568215|449408541|FG002|Overall Study|Death|0|||
124939837|NCT02568215|449408539|FG000|Overall Study|Physician Decision|2|||
124939838|NCT02568215|449408540|FG001|Overall Study|Physician Decision|2|||
124939839|NCT02568215|449408541|FG002|Overall Study|Physician Decision|2|||
124939840|NCT02568215|449408539|FG000|Overall Study|Lost to Follow-up|29|||
124939841|NCT02568215|449408540|FG001|Overall Study|Lost to Follow-up|32|||
124939842|NCT02568215|449408541|FG002|Overall Study|Lost to Follow-up|41|||
124939843|NCT02568215|449408539|FG000|Overall Study|Withdrawal by Subject|21|||
124939844|NCT02568215|449408540|FG001|Overall Study|Withdrawal by Subject|19|||
124939845|NCT02568215|449408541|FG002|Overall Study|Withdrawal by Subject|22|||
124939846|NCT02568215|449408539|FG000|Overall Study|Protocol Violation|1|||
124939847|NCT02568215|449408540|FG001|Overall Study|Protocol Violation|1|||
124939848|NCT02568215|449408541|FG002|Overall Study|Protocol Violation|0|||
124939849|NCT02568215|449408539|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
124939850|NCT02568215|449408540|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
124939851|NCT02568215|449408541|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
124939852|NCT02568215|449408539|FG000|Overall Study|Other|0|||
124939853|NCT02568215|449408540|FG001|Overall Study|Other|1|||
124939854|NCT02568215|449408541|FG002|Overall Study|Other|4|||
124939855|NCT00246805|449408542|FG000|Phase 1|Lost to Follow-up|1|||
124939856|NCT00246805|449408543|FG001|Phase 1|Lost to Follow-up|0|||
124939857|NCT00293397|449408544|FG000|Overall Study|Death|2|||
124939858|NCT01218009|449408545|FG000|Overall Study|Protocol Violation|2|||
124939859|NCT01218009|449408546|FG001|Overall Study|Protocol Violation|1|||
124939860|NCT01218009|449408545|FG000|Overall Study|Withdrawal by Subject|3|||
124939861|NCT01218009|449408546|FG001|Overall Study|Withdrawal by Subject|1|||
124939862|NCT01218009|449408545|FG000|Overall Study|Sponsor terminated study|161|||
124939863|NCT01218009|449408546|FG001|Overall Study|Sponsor terminated study|163|||
124939864|NCT00174252|449408547|FG000|Overall Study|Protocol Violation|2|||
124939865|NCT03170882|449408548|FG000|Overall Study|Death|17|||
124939866|NCT03170882|449408549|FG001|Overall Study|Death|29|||
124939867|NCT03170882|449408548|FG000|Overall Study|Lost to Follow-up|0|||
124939868|NCT03170882|449408549|FG001|Overall Study|Lost to Follow-up|1|||
124939869|NCT03170882|449408548|FG000|Overall Study|Withdrawal by Subject|4|||
124939870|NCT03170882|449408549|FG001|Overall Study|Withdrawal by Subject|7|||
124939871|NCT03170882|449408548|FG000|Overall Study|Reason not Specified|28|||
124939872|NCT03170882|449408549|FG001|Overall Study|Reason not Specified|36|||
124939873|NCT03802994|449408550|FG000|Overall Study|Lost to Follow-up|0|||
124939874|NCT03802994|449408551|FG001|Overall Study|Lost to Follow-up|2|||
124939875|NCT03802994|449408552|FG002|Overall Study|Lost to Follow-up|3|||
124939876|NCT03802994|449408553|FG003|Overall Study|Lost to Follow-up|2|||
124939877|NCT03802994|449408554|FG004|Overall Study|Lost to Follow-up|2|||
124939878|NCT01753999|449408557|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
124939879|NCT01753999|449408558|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
124939880|NCT01753999|449408557|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
124939881|NCT01753999|449408558|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
124939882|NCT01753999|449408557|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
125121500|NCT00788957|450068904|FG005|Part 2|Death|0|||
125121501|NCT00788957|450068899|FG000|Part 2|Lost to Follow-up|0|||
125121502|NCT00788957|450068900|FG001|Part 2|Lost to Follow-up|0|||
125121503|NCT00788957|450068901|FG002|Part 2|Lost to Follow-up|3|||
125121504|NCT00788957|450068902|FG003|Part 2|Lost to Follow-up|0|||
125121505|NCT00788957|450068903|FG004|Part 2|Lost to Follow-up|0|||
125121506|NCT00788957|450068904|FG005|Part 2|Lost to Follow-up|0|||
125121507|NCT00788957|450068899|FG000|Part 2|On-study at time of data cut-off|0|||
125121508|NCT00788957|450068900|FG001|Part 2|On-study at time of data cut-off|1|||
125121509|NCT00788957|450068901|FG002|Part 2|On-study at time of data cut-off|1|||
125121510|NCT00788957|450068902|FG003|Part 2|On-study at time of data cut-off|1|||
125121511|NCT00788957|450068903|FG004|Part 2|On-study at time of data cut-off|0|||
125121512|NCT00788957|450068904|FG005|Part 2|On-study at time of data cut-off|0|||
125121513|NCT00788957|450068899|FG000|Part 3|Withdrawal by Subject|0|||
125121514|NCT00788957|450068900|FG001|Part 3|Withdrawal by Subject|0|||
125121515|NCT00788957|450068901|FG002|Part 3|Withdrawal by Subject|0|||
125121516|NCT00788957|450068902|FG003|Part 3|Withdrawal by Subject|0|||
125121517|NCT00788957|450068903|FG004|Part 3|Withdrawal by Subject|0|||
125121518|NCT00788957|450068904|FG005|Part 3|Withdrawal by Subject|2|||
125121519|NCT00788957|450068899|FG000|Part 3|Death|0|||
125121520|NCT00788957|450068900|FG001|Part 3|Death|0|||
125121521|NCT00788957|450068901|FG002|Part 3|Death|0|||
125121522|NCT00788957|450068902|FG003|Part 3|Death|0|||
125121523|NCT00788957|450068903|FG004|Part 3|Death|8|||
125121524|NCT00788957|450068904|FG005|Part 3|Death|8|||
125121525|NCT00788957|450068899|FG000|Part 3|On-study at time of data cut-off|0|||
125121526|NCT00788957|450068900|FG001|Part 3|On-study at time of data cut-off|0|||
125121527|NCT00788957|450068901|FG002|Part 3|On-study at time of data cut-off|0|||
125121528|NCT00788957|450068902|FG003|Part 3|On-study at time of data cut-off|0|||
125121529|NCT00788957|450068903|FG004|Part 3|On-study at time of data cut-off|1|||
125121530|NCT00788957|450068904|FG005|Part 3|On-study at time of data cut-off|0|||
125121531|NCT03387098|450068905|FG000|Overall Study|progressive disease|1|||
125121532|NCT03387098|450068905|FG000|Overall Study|Withdrawal by Subject|2|||
125121533|NCT03387098|450068905|FG000|Overall Study|study terminated by sponsor|1|||
125121534|NCT03276975|450068906|FG000|Overall Study|Withdrawal by Subject|1|||
125121535|NCT03276975|450068907|FG001|Overall Study|Withdrawal by Subject|0|||
125121536|NCT00918567|450068908|FG000|Overall Study|Lack of Efficacy|3|||
125121537|NCT00918567|450068909|FG001|Overall Study|Lack of Efficacy|1|||
125121538|NCT00918567|450068908|FG000|Overall Study|Withdrawal by Subject|1|||
125121539|NCT00918567|450068909|FG001|Overall Study|Withdrawal by Subject|1|||
124939883|NCT01753999|449408558|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
124939884|NCT01753999|449408557|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
124939885|NCT01753999|449408558|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
124939886|NCT01753999|449408557|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
124939887|NCT01753999|449408558|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
124939888|NCT01753999|449408557|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
124939889|NCT01753999|449408558|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
124939890|NCT02392234|449408559|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
124939891|NCT02392234|449408560|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
124939892|NCT02392234|449408561|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
124939893|NCT02392234|449408562|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
124939894|NCT02392234|449408563|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
124939895|NCT02392234|449408564|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
124939896|NCT02392234|449408559|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
124939897|NCT02392234|449408560|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
124939898|NCT02392234|449408561|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
125121540|NCT00918567|450068908|FG000|Overall Study|Adverse Event|1|||
125121541|NCT00918567|450068909|FG001|Overall Study|Adverse Event|0|||
125121542|NCT02568384|450068916|FG000|Overall Study|Mobile devices incompatible with App|2|||
125121543|NCT03283709|450068921|FG000|Overall Study|trial terminated|0|||
125121544|NCT03283709|450068922|FG001|Overall Study|trial terminated|1|||
125121545|NCT00796510|450068923|FG000|Overall Study|Death|1|||
125121546|NCT00796510|450068924|FG001|Overall Study|Death|0|||
125121547|NCT00796510|450068923|FG000|Overall Study|Study Terminated|2|||
125121548|NCT00796510|450068924|FG001|Overall Study|Study Terminated|0|||
125121549|NCT02799602|450068925|FG000|Overall Study|Protocol Violation|1|||
125121550|NCT02799602|450068926|FG001|Overall Study|Protocol Violation|0|||
125121551|NCT02799602|450068925|FG000|Overall Study|Physician Decision|5|||
124939899|NCT02392234|449408562|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
124939900|NCT02392234|449408563|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
124939901|NCT02392234|449408564|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
124939902|NCT02392234|449408559|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
124939903|NCT02392234|449408560|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
124939904|NCT02392234|449408561|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
124939905|NCT02392234|449408562|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
124939906|NCT02392234|449408563|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
124939907|NCT02392234|449408564|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
124939908|NCT02392234|449408559|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
124939909|NCT02392234|449408560|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
124939910|NCT02392234|449408561|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
124939911|NCT02392234|449408562|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
124939912|NCT02392234|449408563|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
124939913|NCT02392234|449408564|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
124939914|NCT02392234|449408559|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
124939915|NCT02392234|449408560|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
124939916|NCT02392234|449408561|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
124939917|NCT02392234|449408562|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
124939918|NCT02392234|449408563|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
124939919|NCT02392234|449408564|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
124939920|NCT02392234|449408559|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
124939921|NCT02392234|449408560|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
124939922|NCT02392234|449408561|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
124939923|NCT02392234|449408562|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
124939924|NCT02392234|449408563|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
124939925|NCT02392234|449408564|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
124939926|NCT02392234|449408559|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
124939927|NCT02392234|449408560|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
124939928|NCT02392234|449408561|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
124939929|NCT02392234|449408562|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
124939930|NCT02392234|449408563|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
124939931|NCT02392234|449408564|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
124939932|NCT02392234|449408559|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
124939933|NCT02392234|449408560|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
124939934|NCT02392234|449408561|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
124939935|NCT02392234|449408562|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
124939936|NCT02392234|449408563|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
124939937|NCT02392234|449408564|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
124939938|NCT02029235|449408565|FG000|Overall Study|Non-compliance with study meds or diary|4|||
124939939|NCT02029235|449408566|FG001|Overall Study|Non-compliance with study meds or diary|1|||
124939940|NCT01738438|449408567|FG000|Overall Study|Disease Progression|32|||
124939941|NCT01738438|449408567|FG000|Overall Study|Adverse Event|3|||
124939942|NCT02928172|449408568|FG000|Overall Study|Device did not record data|1|||
124939943|NCT04066075|449408569|FG000|Overall Study|Lost to Follow-up|3|||
124939944|NCT04066075|449408570|FG001|Overall Study|Lost to Follow-up|3|||
124939945|NCT04066075|449408569|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
124939946|NCT04066075|449408570|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
124939947|NCT04066075|449408569|FG000|Overall Study|Withdrawal by Subject|2|||
124939948|NCT04066075|449408570|FG001|Overall Study|Withdrawal by Subject|2|||
124939949|NCT00309166|449408571|FG000|Overall Study|Adverse event, non-fatal|1|||
124939950|NCT00309166|449408572|FG001|Overall Study|Adverse event, non-fatal|0|||
124939951|NCT00309166|449408571|FG000|Overall Study|Withdrawal by Subject|4|||
124939952|NCT00309166|449408572|FG001|Overall Study|Withdrawal by Subject|3|||
124939953|NCT00701701|449408573|FG000|Overall Study|Withdrawal by Subject|0|||
124939954|NCT00701701|449408574|FG001|Overall Study|Withdrawal by Subject|1|||
124939955|NCT00701701|449408573|FG000|Overall Study|Adverse Event|0|||
124939956|NCT00701701|449408574|FG001|Overall Study|Adverse Event|1|||
124939957|NCT03789110|449408577|FG000|Overall Study|Adverse Event|2|||
124939958|NCT03789110|449408577|FG000|Overall Study|Physician Decision|1|||
124939959|NCT03789110|449408577|FG000|Overall Study|Withdrawal by Subject|2|||
124939960|NCT03789110|449408577|FG000|Overall Study|Lack of Efficacy|22|||
124939961|NCT03789110|449408577|FG000|Overall Study|still on treatment|3|||
124939962|NCT01855750|449408578|FG000|Overall Study|Death|78|||
125027273|NCT02810964|449725471|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
125027274|NCT02810964|449725472|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
125121552|NCT02799602|450068926|FG001|Overall Study|Physician Decision|6|||
125121553|NCT02799602|450068925|FG000|Overall Study|Lost to Follow-up|4|||
125121554|NCT02799602|450068926|FG001|Overall Study|Lost to Follow-up|2|||
124939963|NCT01855750|449408579|FG001|Overall Study|Death|78|||
124939964|NCT01855750|449408578|FG000|Overall Study|Lost to Follow-up|9|||
124939965|NCT01855750|449408579|FG001|Overall Study|Lost to Follow-up|23|||
124939966|NCT01855750|449408578|FG000|Overall Study|Withdrawal by Subject|35|||
124939967|NCT01855750|449408579|FG001|Overall Study|Withdrawal by Subject|28|||
124939968|NCT01855750|449408578|FG000|Overall Study|Sponsor ends the study|297|||
124939969|NCT01855750|449408579|FG001|Overall Study|Sponsor ends the study|290|||
124939970|NCT04300023|449408580|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
124939971|NCT04300023|449408581|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
124939972|NCT05525572|449408582|FG000|Overall Study|Lost to Follow-up|2|||
124939973|NCT04057131|449408583|FG000|Overall Study|Protocol Violation|24|||
125121555|NCT02799602|450068925|FG000|Overall Study|Additional primary malignancy|11|||
125121556|NCT02799602|450068926|FG001|Overall Study|Additional primary malignancy|6|||
125121557|NCT02799602|450068925|FG000|Overall Study|Non-compliance with study drug|14|||
125121558|NCT02799602|450068926|FG001|Overall Study|Non-compliance with study drug|12|||
125121559|NCT02799602|450068925|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
125121560|NCT02799602|450068926|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
125121561|NCT02799602|450068925|FG000|Overall Study|Withdrawal by Subject|26|||
125121562|NCT02799602|450068926|FG001|Overall Study|Withdrawal by Subject|40|||
125121563|NCT02799602|450068925|FG000|Overall Study|Progressive disease - clinical progression|131|||
125121564|NCT02799602|450068926|FG001|Overall Study|Progressive disease - clinical progression|276|||
125121565|NCT02799602|450068925|FG000|Overall Study|Progressive disease - radiological progression|90|||
125121566|NCT02799602|450068926|FG001|Overall Study|Progressive disease - radiological progression|133|||
125121567|NCT02799602|450068925|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
125121568|NCT02799602|450068926|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
125121569|NCT02799602|450068925|FG000|Overall Study|Death|9|||
125121570|NCT02799602|450068926|FG001|Overall Study|Death|5|||
125121571|NCT02799602|450068925|FG000|Overall Study|Other|287|||
125121572|NCT02799602|450068926|FG001|Overall Study|Other|118|||
125121573|NCT02799602|450068925|FG000|Overall Study|Study drug never administered|0|||
125121574|NCT02799602|450068926|FG001|Overall Study|Study drug never administered|3|||
125121575|NCT01734772|450068927|FG000|Overall Study|Adverse Event|1|||
125121576|NCT01734772|450068928|FG001|Overall Study|Adverse Event|2|||
125121577|NCT01734772|450068927|FG000|Overall Study|Withdrawal by Subject|0|||
125121578|NCT01734772|450068928|FG001|Overall Study|Withdrawal by Subject|1|||
125121579|NCT00329602|450068929|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
125121580|NCT00329602|450068930|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
125121581|NCT00329602|450068931|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
125121582|NCT00329602|450068929|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
125121583|NCT00329602|450068930|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
125121584|NCT00329602|450068931|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
125121585|NCT00329602|450068929|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
125121586|NCT00329602|450068930|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
125121587|NCT00329602|450068931|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
125121588|NCT00329602|450068929|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
125121589|NCT00329602|450068930|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
125121590|NCT00329602|450068931|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
125121591|NCT00329602|450068929|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
125121592|NCT00329602|450068930|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
125121593|NCT00329602|450068931|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
125121594|NCT00329602|450068929|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
125121595|NCT00329602|450068930|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
125121596|NCT00329602|450068931|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
125121597|NCT02097121|450068934|FG000|Overall Study|Other, not specified|4|||
125121598|NCT02097121|450068935|FG001|Overall Study|Other, not specified|2|||
125121599|NCT02097121|450068936|FG002|Overall Study|Other, not specified|3|||
125121600|NCT02097121|450068934|FG000|Overall Study|Lack of Efficacy|2|||
124939974|NCT03425682|449408584|FG000|Overall Study|Lost to Follow-up|2|||
124939975|NCT03425682|449408585|FG001|Overall Study|Lost to Follow-up|4|||
124939976|NCT03425682|449408584|FG000|Overall Study|Withdrawal by Subject|0|||
124939977|NCT03425682|449408585|FG001|Overall Study|Withdrawal by Subject|3|||
124939978|NCT03425682|449408584|FG000|Overall Study|Subject did not meet I/E|4|||
125121601|NCT02097121|450068935|FG001|Overall Study|Lack of Efficacy|1|||
125121602|NCT02097121|450068936|FG002|Overall Study|Lack of Efficacy|3|||
125121603|NCT02097121|450068934|FG000|Overall Study|Withdrawal by Subject|0|||
124939979|NCT03425682|449408585|FG001|Overall Study|Subject did not meet I/E|10|||
124939980|NCT03277989|449408589|FG000|Overall Study|Lost to Follow-up|6|||
124939981|NCT03277989|449408589|FG000|Overall Study|Adverse Event|6|||
124939982|NCT03277989|449408589|FG000|Overall Study|Withdrawal by Subject|3|||
124939983|NCT03277989|449408589|FG000|Overall Study|Didn't Receive Study Device|7|||
124939984|NCT03277989|449408589|FG000|Overall Study|Site Closure|26|||
124939985|NCT03277989|449408589|FG000|Overall Study|Sponsor Closure|107|||
124939986|NCT05704725|449408592|FG000|Overall Study|Lost to Follow-up|0|||
124939987|NCT05704725|449408593|FG001|Overall Study|Lost to Follow-up|1|||
124939988|NCT05704725|449408592|FG000|Overall Study|Withdrawal by Subject|1|||
124939989|NCT05704725|449408593|FG001|Overall Study|Withdrawal by Subject|0|||
124939990|NCT03227861|449408594|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
124939991|NCT03227861|449408594|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
124939992|NCT03227861|449408594|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
125121604|NCT02097121|450068935|FG001|Overall Study|Withdrawal by Subject|1|||
125121605|NCT02097121|450068936|FG002|Overall Study|Withdrawal by Subject|2|||
125121606|NCT02097121|450068934|FG000|Overall Study|Adverse Event|0|||
125121607|NCT02097121|450068935|FG001|Overall Study|Adverse Event|1|||
125121608|NCT02097121|450068936|FG002|Overall Study|Adverse Event|0|||
125121609|NCT02097121|450068934|FG000|Overall Study|Lost to Follow-up|1|||
125121610|NCT02097121|450068935|FG001|Overall Study|Lost to Follow-up|1|||
125121611|NCT02097121|450068936|FG002|Overall Study|Lost to Follow-up|2|||
125121612|NCT00661999|450068937|FG000|Overall Study|Adverse Event|11|||
125121613|NCT00661999|450068938|FG001|Overall Study|Adverse Event|5|||
125121614|NCT00661999|450068939|FG002|Overall Study|Adverse Event|8|||
125121615|NCT00661999|450068937|FG000|Overall Study|Death|8|||
125121616|NCT00661999|450068938|FG001|Overall Study|Death|6|||
125121617|NCT00661999|450068939|FG002|Overall Study|Death|3|||
125121618|NCT00661999|450068937|FG000|Overall Study|Other Reasons|5|||
125121619|NCT00661999|450068938|FG001|Overall Study|Other Reasons|12|||
125121620|NCT00661999|450068939|FG002|Overall Study|Other Reasons|23|||
125121621|NCT00661999|450068937|FG000|Overall Study|Withdrawal by Subject|30|||
125121622|NCT00661999|450068938|FG001|Overall Study|Withdrawal by Subject|23|||
125121623|NCT00661999|450068939|FG002|Overall Study|Withdrawal by Subject|14|||
125121624|NCT00661999|450068937|FG000|Overall Study|Alternative Treatment|1|||
125121625|NCT00661999|450068938|FG001|Overall Study|Alternative Treatment|0|||
125121626|NCT00661999|450068939|FG002|Overall Study|Alternative Treatment|0|||
124939993|NCT03227861|449408594|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
124939994|NCT03227861|449408594|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
125121627|NCT00661999|450068937|FG000|Overall Study|Other Medical Problems|4|||
125121628|NCT00661999|450068938|FG001|Overall Study|Other Medical Problems|4|||
125121629|NCT00661999|450068939|FG002|Overall Study|Other Medical Problems|9|||
125121630|NCT03066999|450068940|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
125121631|NCT03066999|450068941|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
125213119|NCT00734656|450407205|FG000|Lab Session 2|Withdrawal by Subject|1|||
125213120|NCT00734656|450407206|FG001|Lab Session 2|Withdrawal by Subject|0|||
125213121|NCT00734656|450407207|FG002|Lab Session 2|Withdrawal by Subject|0|||
125213122|NCT00734656|450407208|FG003|Lab Session 2|Withdrawal by Subject|1|||
125213123|NCT00734656|450407205|FG000|Washout 2|Withdrawal by Subject|1|||
125213124|NCT00734656|450407206|FG001|Washout 2|Withdrawal by Subject|1|||
125213125|NCT00734656|450407207|FG002|Washout 2|Withdrawal by Subject|1|||
125213126|NCT00734656|450407208|FG003|Washout 2|Withdrawal by Subject|0|||
125213127|NCT00734656|450407205|FG000|Washout 3|Withdrawal by Subject|1|||
125213128|NCT00734656|450407206|FG001|Washout 3|Withdrawal by Subject|0|||
125213129|NCT00734656|450407207|FG002|Washout 3|Withdrawal by Subject|0|||
125213130|NCT00734656|450407208|FG003|Washout 3|Withdrawal by Subject|1|||
125213131|NCT00734656|450407205|FG000|Lab Session 4|Withdrawal by Subject|0|||
125213132|NCT00734656|450407206|FG001|Lab Session 4|Withdrawal by Subject|0|||
125213133|NCT00734656|450407207|FG002|Lab Session 4|Withdrawal by Subject|0|||
125213134|NCT00734656|450407208|FG003|Lab Session 4|Withdrawal by Subject|1|||
125213135|NCT03915626|450407209|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
125213136|NCT04676152|450407210|FG000|Overall Study|screen fail|9|||
125213137|NCT02626000|450407223|FG000|Overall Study|Decision by Sponsor|1|||
125213138|NCT02626000|450407223|FG000|Overall Study|Death|29|||
125213139|NCT02164318|450407224|FG000|Overall Study|Withdrawal by Subject|0|||
125213140|NCT02164318|450407225|FG001|Overall Study|Withdrawal by Subject|1|||
125213141|NCT02164318|450407226|FG002|Overall Study|Withdrawal by Subject|0|||
125213142|NCT02164318|450407227|FG003|Overall Study|Withdrawal by Subject|1|||
125213143|NCT02335346|450407248|FG000|Overall Study|Adverse Event|11|||
125213144|NCT02335346|450407248|FG000|Overall Study|Withdrawal by Subject|1|||
125213145|NCT02769312|450407252|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
125213146|NCT02769312|450407253|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
125213147|NCT02769312|450407252|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
125213148|NCT02769312|450407253|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
125213149|NCT02769312|450407252|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
125213150|NCT02769312|450407253|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
125213151|NCT02769312|450407252|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
125213152|NCT02769312|450407253|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
125213153|NCT02769312|450407252|FG000|Follow-up|Lost to Follow-up|1|||
125213154|NCT02769312|450407253|FG001|Follow-up|Lost to Follow-up|1|||
125213155|NCT02178358|450407254|FG000|Overall Study|Withdrawal by Subject|0|||
125213156|NCT02178358|450407255|FG001|Overall Study|Withdrawal by Subject|2|||
125213157|NCT02178358|450407256|FG002|Overall Study|Withdrawal by Subject|2|||
125213158|NCT02178358|450407254|FG000|Overall Study|Lost to Follow-up|1|||
125213159|NCT02178358|450407255|FG001|Overall Study|Lost to Follow-up|0|||
125213160|NCT02178358|450407256|FG002|Overall Study|Lost to Follow-up|0|||
125213161|NCT01066663|450407258|FG000|Overall Study|Adverse Event|0|||
125213162|NCT01066663|450407259|FG001|Overall Study|Adverse Event|0|||
125213163|NCT01066663|450407260|FG002|Overall Study|Adverse Event|1|||
125213164|NCT02985021|450407261|FG000|Overall Study|Inability to comply with study procedures|1|||
125213165|NCT02756819|450407262|FG000|Overall Study|Lost for observation|23|||
125213166|NCT02756819|450407262|FG000|Overall Study|Patient's unwillingness|16|||
125213167|NCT02756819|450407262|FG000|Overall Study|Insufficient efficacy|2|||
125213168|NCT02756819|450407262|FG000|Overall Study|Adverse Event|2|||
125213169|NCT02756819|450407262|FG000|Overall Study|Reason not Specified|9|||
125213170|NCT01090050|450407263|FG000|Overall Study|Lost to Follow-up|0|||
125121632|NCT00510510|450068942|FG000|Overall Study|Adverse Event|4|||
125121633|NCT00510510|450068943|FG001|Overall Study|Adverse Event|3|||
125121634|NCT00510510|450068944|FG002|Overall Study|Adverse Event|6|||
125121635|NCT00510510|450068942|FG000|Overall Study|Lack of Efficacy|0|||
125121636|NCT00510510|450068943|FG001|Overall Study|Lack of Efficacy|1|||
125121637|NCT00510510|450068944|FG002|Overall Study|Lack of Efficacy|1|||
125121638|NCT00510510|450068942|FG000|Overall Study|Subjects no longer requires study drug|0|||
125121639|NCT00510510|450068943|FG001|Overall Study|Subjects no longer requires study drug|0|||
125121640|NCT00510510|450068944|FG002|Overall Study|Subjects no longer requires study drug|2|||
125121641|NCT00510510|450068942|FG000|Overall Study|Withdrawal by Subject|1|||
125213171|NCT01090050|450407264|FG001|Overall Study|Lost to Follow-up|1|||
125213172|NCT01090050|450407263|FG000|Overall Study|Lack of Efficacy|1|||
125213173|NCT01090050|450407264|FG001|Overall Study|Lack of Efficacy|5|||
125213174|NCT01090050|450407263|FG000|Overall Study|Physician Decision|0|||
125213175|NCT01090050|450407264|FG001|Overall Study|Physician Decision|1|||
125213176|NCT03539484|450407265|FG000|Overall Study|Death|1|||
125213177|NCT03539484|450407266|FG001|Overall Study|Death|0|||
125213178|NCT03539484|450407267|FG002|Overall Study|Death|0|||
125213179|NCT03539484|450407268|FG003|Overall Study|Death|2|||
125213180|NCT03539484|450407269|FG004|Overall Study|Death|8|||
125213181|NCT03539484|450407270|FG005|Overall Study|Death|3|||
125121642|NCT00510510|450068943|FG001|Overall Study|Withdrawal by Subject|2|||
125121643|NCT00510510|450068944|FG002|Overall Study|Withdrawal by Subject|3|||
124939995|NCT03227861|449408594|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
124939996|NCT03227861|449408594|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
124939997|NCT03227861|449408594|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
124939998|NCT03227861|449408594|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
124939999|NCT03227861|449408594|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
124940000|NCT03516942|449408595|FG000|Registration Through Baseline Survey Com|Withdrawal by Subject|36|||
124940001|NCT03516942|449408595|FG000|Registration Through Baseline Survey Com|Death|8|||
124940002|NCT03516942|449408595|FG000|Registration Through Baseline Survey Com|Could not contact patient after enrollment|58|||
125213182|NCT03539484|450407271|FG006|Overall Study|Death|0|||
125213183|NCT03539484|450407265|FG000|Overall Study|Lost to Follow-up|0|||
125213184|NCT03539484|450407266|FG001|Overall Study|Lost to Follow-up|1|||
125213185|NCT03539484|450407267|FG002|Overall Study|Lost to Follow-up|0|||
125213186|NCT03539484|450407268|FG003|Overall Study|Lost to Follow-up|0|||
125213187|NCT03539484|450407269|FG004|Overall Study|Lost to Follow-up|1|||
125213188|NCT03539484|450407270|FG005|Overall Study|Lost to Follow-up|0|||
125213189|NCT03539484|450407271|FG006|Overall Study|Lost to Follow-up|0|||
125213190|NCT03539484|450407265|FG000|Overall Study|Withdrawal by Subject|0|||
125213191|NCT03539484|450407266|FG001|Overall Study|Withdrawal by Subject|0|||
125213192|NCT03539484|450407267|FG002|Overall Study|Withdrawal by Subject|0|||
125213193|NCT03539484|450407268|FG003|Overall Study|Withdrawal by Subject|0|||
125213194|NCT03539484|450407269|FG004|Overall Study|Withdrawal by Subject|2|||
125213195|NCT03539484|450407270|FG005|Overall Study|Withdrawal by Subject|0|||
125213196|NCT03539484|450407271|FG006|Overall Study|Withdrawal by Subject|1|||
125213197|NCT03539484|450407265|FG000|Overall Study|Study Terminated by Sponsor|0|||
125213198|NCT03539484|450407266|FG001|Overall Study|Study Terminated by Sponsor|0|||
125213199|NCT03539484|450407267|FG002|Overall Study|Study Terminated by Sponsor|1|||
125213200|NCT03539484|450407268|FG003|Overall Study|Study Terminated by Sponsor|1|||
125213201|NCT03539484|450407269|FG004|Overall Study|Study Terminated by Sponsor|2|||
125213202|NCT03539484|450407270|FG005|Overall Study|Study Terminated by Sponsor|2|||
125213203|NCT03539484|450407271|FG006|Overall Study|Study Terminated by Sponsor|1|||
125213204|NCT02232061|450407272|FG000|Overall Study|Administrative problems|1|||
125213205|NCT02232061|450407272|FG000|Overall Study|Withdrawal by Subject|1|||
125213206|NCT00560703|450407274|FG000|Overall Study|Adverse Event|0|||
125213207|NCT00560703|450407275|FG001|Overall Study|Adverse Event|2|||
125213208|NCT00560703|450407274|FG000|Overall Study|Protocol Violation|0|||
125213209|NCT00560703|450407275|FG001|Overall Study|Protocol Violation|2|||
125213210|NCT00560703|450407274|FG000|Overall Study|Withdrawal by Subject|0|||
125213211|NCT00560703|450407275|FG001|Overall Study|Withdrawal by Subject|1|||
125213212|NCT00560703|450407274|FG000|Overall Study|non-compliance|0|||
125213213|NCT00560703|450407275|FG001|Overall Study|non-compliance|1|||
124940003|NCT03516942|449408595|FG000|T0: Baseline|LOST|13|||
124940004|NCT03516942|449408595|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
124940005|NCT03516942|449408595|FG000|T1: 3 Months Survey|Death|10|||
124940006|NCT03516942|449408595|FG000|T1: 3 Months Survey|Lost|163|||
124940007|NCT03516942|449408595|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
124940008|NCT03516942|449408595|FG000|T2: 6 Month Survey|Death|14|||
124940009|NCT03516942|449408595|FG000|T2: 6 Month Survey|Lost|180|||
124940010|NCT03516942|449408595|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
124940011|NCT03516942|449408595|FG000|T3: 12 Month Survey|Death|19|||
124940012|NCT03516942|449408595|FG000|T3: 12 Month Survey|Lost|209|||
124940013|NCT00490139|449408597|FG000|Overall Study|Lost to Follow-up|249|||
124940014|NCT00490139|449408598|FG001|Overall Study|Lost to Follow-up|216|||
124940015|NCT00490139|449408599|FG002|Overall Study|Lost to Follow-up|205|||
124940016|NCT00490139|449408600|FG003|Overall Study|Lost to Follow-up|229|||
124940017|NCT00490139|449408597|FG000|Overall Study|Withdrawal by Subject|333|||
124940018|NCT00490139|449408598|FG001|Overall Study|Withdrawal by Subject|322|||
124940019|NCT00490139|449408599|FG002|Overall Study|Withdrawal by Subject|396|||
124940020|NCT00490139|449408600|FG003|Overall Study|Withdrawal by Subject|295|||
124940021|NCT00490139|449408597|FG000|Overall Study|Patient did not sign ICF 12|169|||
125121644|NCT00510510|450068942|FG000|Overall Study|Lost to Follow-up|0|||
124940022|NCT00490139|449408598|FG001|Overall Study|Patient did not sign ICF 12|176|||
124940023|NCT00490139|449408599|FG002|Overall Study|Patient did not sign ICF 12|139|||
124940024|NCT00490139|449408600|FG003|Overall Study|Patient did not sign ICF 12|167|||
124940025|NCT00490139|449408597|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
124940026|NCT00490139|449408598|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
125121645|NCT00510510|450068943|FG001|Overall Study|Lost to Follow-up|0|||
125121646|NCT00510510|450068944|FG002|Overall Study|Lost to Follow-up|1|||
125121647|NCT00510510|450068942|FG000|Overall Study|Protocol Violation|0|||
125121648|NCT00510510|450068943|FG001|Overall Study|Protocol Violation|3|||
125121649|NCT00510510|450068944|FG002|Overall Study|Protocol Violation|4|||
125121650|NCT03595657|450068945|FG000|Overall Study|Adverse Event|14|||
125121651|NCT03595657|450068945|FG000|Overall Study|Death|1|||
125121652|NCT03595657|450068945|FG000|Overall Study|Lack of Efficacy|40|||
125213214|NCT00339833|450407285|FG000|Overall Study|Withdrawal by Subject|1|||
125213215|NCT00339833|450407286|FG001|Overall Study|Withdrawal by Subject|2|||
124940027|NCT00490139|449408599|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
124940028|NCT00490139|449408600|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
124940029|NCT00490139|449408597|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
124940030|NCT00490139|449408598|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
124940031|NCT00490139|449408599|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
124940032|NCT00490139|449408600|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
124940033|NCT00490139|449408597|FG000|Overall Study|Other reasons as defined per protocol|98|||
124940034|NCT00490139|449408598|FG001|Overall Study|Other reasons as defined per protocol|84|||
124940035|NCT00490139|449408599|FG002|Overall Study|Other reasons as defined per protocol|82|||
124940036|NCT00490139|449408600|FG003|Overall Study|Other reasons as defined per protocol|105|||
124940037|NCT02798471|449408603|FG000|Overall Study|Adverse Event|7|||
124940038|NCT02798471|449408604|FG001|Overall Study|Adverse Event|2|||
124940039|NCT02798471|449408603|FG000|Overall Study|Physician Decision|3|||
124940040|NCT02798471|449408604|FG001|Overall Study|Physician Decision|7|||
124940041|NCT02798471|449408603|FG000|Overall Study|Death|2|||
124940042|NCT02798471|449408604|FG001|Overall Study|Death|3|||
124940043|NCT02798471|449408603|FG000|Overall Study|Lost to Follow-up|0|||
124940044|NCT02798471|449408604|FG001|Overall Study|Lost to Follow-up|1|||
124940045|NCT02798471|449408603|FG000|Overall Study|Other|5|||
124940046|NCT02798471|449408604|FG001|Overall Study|Other|3|||
124940047|NCT02798471|449408603|FG000|Overall Study|Subject withdrew consent|0|||
124940048|NCT02798471|449408604|FG001|Overall Study|Subject withdrew consent|6|||
124940049|NCT02798471|449408603|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
124940050|NCT02798471|449408604|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
124940051|NCT02798471|449408603|FG000|Overall Study|Randomized, but not treated|0|||
124940052|NCT02798471|449408604|FG001|Overall Study|Randomized, but not treated|2|||
124940053|NCT05293717|449408605|FG000|Overall Study|Physician Decision|1|||
124940054|NCT04989816|449409776|FG000|Overall Study|Death|77|||
124940055|NCT04989816|449409776|FG000|Overall Study|Lost to Follow-up|3|||
124940056|NCT01982682|449409777|FG000|Overall Study|Physician Decision|1|||
124940057|NCT00065182|449409779|FG000|Overall Study|Adverse Event|24|||
124940058|NCT00065182|449409780|FG001|Overall Study|Adverse Event|17|||
124940059|NCT00065182|449409779|FG000|Overall Study|Lost to Follow-up|0|||
124940060|NCT00065182|449409780|FG001|Overall Study|Lost to Follow-up|4|||
124940061|NCT00065182|449409779|FG000|Overall Study|Protocol Violation|3|||
124940062|NCT00065182|449409780|FG001|Overall Study|Protocol Violation|4|||
124940063|NCT00065182|449409779|FG000|Overall Study|Serious adverse events (SAE)|1|||
124940064|NCT00065182|449409780|FG001|Overall Study|Serious adverse events (SAE)|0|||
124940065|NCT00065182|449409779|FG000|Overall Study|Sponsor Decision|11|||
124940066|NCT00065182|449409780|FG001|Overall Study|Sponsor Decision|7|||
124940067|NCT00065182|449409779|FG000|Overall Study|Withdrawal by Subject|8|||
124940068|NCT00065182|449409780|FG001|Overall Study|Withdrawal by Subject|3|||
124940069|NCT00065182|449409779|FG000|Overall Study|No clinical benefit|1|||
124940070|NCT00065182|449409780|FG001|Overall Study|No clinical benefit|0|||
124940071|NCT00065182|449409779|FG000|Overall Study|Death|0|||
124940072|NCT00065182|449409780|FG001|Overall Study|Death|1|||
124940073|NCT00065182|449409779|FG000|Overall Study|Decline in Status|0|||
124940074|NCT00065182|449409780|FG001|Overall Study|Decline in Status|1|||
124940075|NCT00754325|449409781|FG000|Initial Treatment|Continuing Active Treatment|4|||
124940076|NCT00754325|449409782|FG001|Initial Treatment|Continuing Active Treatment|5|||
124940077|NCT00754325|449409781|FG000|Initial Treatment|Adverse Event|7|||
124940078|NCT00754325|449409782|FG001|Initial Treatment|Adverse Event|6|||
124940079|NCT00754325|449409781|FG000|Initial Treatment|Withdrawal by Subject|2|||
124940080|NCT00754325|449409782|FG001|Initial Treatment|Withdrawal by Subject|2|||
125213216|NCT00339833|450407285|FG000|Overall Study|toothache|0|||
124940081|NCT00754325|449409781|FG000|Initial Treatment|Physician Decision|2|||
124940082|NCT00754325|449409782|FG001|Initial Treatment|Physician Decision|0|||
124940083|NCT00754325|449409781|FG000|Initial Treatment|Sponsor Request|0|||
124940084|NCT00754325|449409782|FG001|Initial Treatment|Sponsor Request|1|||
124940085|NCT00754325|449409781|FG000|Initial Treatment|Disease Progression|35|||
124940086|NCT00754325|449409782|FG001|Initial Treatment|Disease Progression|35|||
124940087|NCT01750684|449409787|FG000|Overall Study|Death|1|||
124940088|NCT01750684|449409788|FG001|Overall Study|Death|0|||
124940089|NCT01750684|449409787|FG000|Overall Study|Non-compliance with Study Drug|0|||
124940090|NCT01750684|449409788|FG001|Overall Study|Non-compliance with Study Drug|1|||
124940091|NCT01750684|449409787|FG000|Overall Study|Withdrawn by Sponsor|0|||
124940092|NCT01750684|449409788|FG001|Overall Study|Withdrawn by Sponsor|1|||
124940093|NCT01750684|449409787|FG000|Overall Study|Protocol Violation|1|||
124940094|NCT01750684|449409788|FG001|Overall Study|Protocol Violation|0|||
124940095|NCT02185794|449409790|FG000|Overall Study|Enrolled but Never Dosed|1|||
124940096|NCT02185794|449409791|FG001|Overall Study|Enrolled but Never Dosed|6|||
124940097|NCT02185794|449409792|FG002|Overall Study|Enrolled but Never Dosed|3|||
124940098|NCT02185794|449409793|FG003|Overall Study|Enrolled but Never Dosed|1|||
124940099|NCT02185794|449409794|FG004|Overall Study|Enrolled but Never Dosed|1|||
124940100|NCT02185794|449409795|FG005|Overall Study|Enrolled but Never Dosed|0|||
124940101|NCT02185794|449409790|FG000|Overall Study|Investigator's Discretion|1|||
124940102|NCT02185794|449409791|FG001|Overall Study|Investigator's Discretion|0|||
124940103|NCT02185794|449409792|FG002|Overall Study|Investigator's Discretion|1|||
124940104|NCT02185794|449409793|FG003|Overall Study|Investigator's Discretion|2|||
124940105|NCT02185794|449409794|FG004|Overall Study|Investigator's Discretion|2|||
124940106|NCT02185794|449409795|FG005|Overall Study|Investigator's Discretion|15|||
124940107|NCT02185794|449409790|FG000|Overall Study|Withdrew Consent|2|||
124940108|NCT02185794|449409791|FG001|Overall Study|Withdrew Consent|5|||
124940109|NCT02185794|449409792|FG002|Overall Study|Withdrew Consent|10|||
124940110|NCT02185794|449409793|FG003|Overall Study|Withdrew Consent|2|||
124940111|NCT02185794|449409794|FG004|Overall Study|Withdrew Consent|0|||
125121653|NCT03595657|450068945|FG000|Overall Study|Withdrawal by Subject|10|||
124940112|NCT02185794|449409795|FG005|Overall Study|Withdrew Consent|0|||
124940113|NCT02185794|449409790|FG000|Overall Study|Lost to Follow-up|1|||
124940114|NCT02185794|449409791|FG001|Overall Study|Lost to Follow-up|2|||
124940115|NCT02185794|449409792|FG002|Overall Study|Lost to Follow-up|2|||
125121654|NCT03595657|450068945|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
125121655|NCT03595657|450068945|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
125121656|NCT03481309|450068949|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
125121657|NCT03481309|450068950|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
125121658|NCT03481309|450068951|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
124940116|NCT02185794|449409793|FG003|Overall Study|Lost to Follow-up|3|||
124940117|NCT02185794|449409794|FG004|Overall Study|Lost to Follow-up|0|||
124940118|NCT02185794|449409795|FG005|Overall Study|Lost to Follow-up|1|||
125213217|NCT00339833|450407286|FG001|Overall Study|toothache|1|||
124940119|NCT01092416|449409796|FG000|Enrollment|Atherectomy device not inserted|3|||
124940120|NCT01092416|449409796|FG000|30-Day Follow-up|Death|2|||
124940121|NCT01092416|449409796|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
124940122|NCT01092416|449409796|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
124940123|NCT01092416|449409796|FG000|12-Month Follow-up|Death|16|||
124940124|NCT01092416|449409796|FG000|12-Month Follow-up|Lost to Follow-up|4|||
124940125|NCT01092416|449409796|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
124940126|NCT01092416|449409796|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
124940127|NCT01092416|449409796|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
124940128|NCT00366249|449409797|FG000|Overall Study|Adverse Event|53|||
124940129|NCT00366249|449409798|FG001|Overall Study|Adverse Event|28|||
124940130|NCT00366249|449409797|FG000|Overall Study|Death|0|||
124940131|NCT00366249|449409798|FG001|Overall Study|Death|1|||
124940132|NCT00366249|449409797|FG000|Overall Study|Physician Decision|5|||
124940133|NCT00366249|449409798|FG001|Overall Study|Physician Decision|2|||
124940134|NCT00366249|449409797|FG000|Overall Study|Lost to Follow-up|2|||
124940135|NCT00366249|449409798|FG001|Overall Study|Lost to Follow-up|0|||
124940136|NCT00366249|449409797|FG000|Overall Study|Protocol Violation|1|||
124940137|NCT00366249|449409798|FG001|Overall Study|Protocol Violation|2|||
124940138|NCT00366249|449409797|FG000|Overall Study|Withdrawal by Subject|18|||
124940139|NCT00366249|449409798|FG001|Overall Study|Withdrawal by Subject|4|||
124940140|NCT00366249|449409797|FG000|Overall Study|Lack of Efficacy|21|||
124940141|NCT00366249|449409798|FG001|Overall Study|Lack of Efficacy|21|||
124940142|NCT00366249|449409797|FG000|Overall Study|Most due to osteomylitis status|31|||
124940143|NCT00366249|449409798|FG001|Overall Study|Most due to osteomylitis status|20|||
124940144|NCT00777049|449409799|FG000|Overall Study|Withdrawal by Subject|1|||
124940145|NCT00777049|449409800|FG001|Overall Study|Withdrawal by Subject|0|||
124940146|NCT00777049|449409799|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
124940147|NCT00777049|449409800|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
124940148|NCT03478969|449409801|FG000|Overall Study|Withdrawal by Subject|4|||
124940149|NCT03478969|449409802|FG001|Overall Study|Withdrawal by Subject|7|||
124940150|NCT03478969|449409803|FG002|Overall Study|Withdrawal by Subject|6|||
124940151|NCT03478969|449409801|FG000|Overall Study|Adverse Event|2|||
124940152|NCT03478969|449409802|FG001|Overall Study|Adverse Event|0|||
124940153|NCT03478969|449409803|FG002|Overall Study|Adverse Event|1|||
124940154|NCT03478969|449409801|FG000|Overall Study|Pregnancy|1|||
125121659|NCT03481309|450068952|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
125121660|NCT03481309|450068953|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
125121661|NCT03481309|450068954|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
125121662|NCT03495869|450068955|FG000|Overall Study|Lost to Follow-up|4|||
125121663|NCT03495869|450068956|FG001|Overall Study|Lost to Follow-up|17|||
125121664|NCT03495869|450068957|FG002|Overall Study|Lost to Follow-up|8|||
125121665|NCT03495869|450068958|FG003|Overall Study|Lost to Follow-up|14|||
125121666|NCT03495869|450068955|FG000|Overall Study|Withdrawal by Subject|0|||
125121667|NCT03495869|450068956|FG001|Overall Study|Withdrawal by Subject|3|||
125121668|NCT03495869|450068957|FG002|Overall Study|Withdrawal by Subject|0|||
125121669|NCT03495869|450068958|FG003|Overall Study|Withdrawal by Subject|3|||
125121670|NCT03495869|450068955|FG000|Overall Study|Dropped from study|0|||
125121671|NCT03495869|450068956|FG001|Overall Study|Dropped from study|7|||
125121672|NCT03495869|450068957|FG002|Overall Study|Dropped from study|2|||
125121673|NCT03495869|450068958|FG003|Overall Study|Dropped from study|4|||
125121674|NCT02346201|450068959|FG000|Overall Study|Adverse Event|3|||
125121675|NCT02346201|450068960|FG001|Overall Study|Adverse Event|2|||
125121676|NCT02346201|450068959|FG000|Overall Study|Lost to Follow-up|1|||
125121677|NCT02346201|450068960|FG001|Overall Study|Lost to Follow-up|0|||
125121678|NCT02346201|450068959|FG000|Overall Study|Withdrawal by Subject|6|||
125121679|NCT02346201|450068960|FG001|Overall Study|Withdrawal by Subject|3|||
125121680|NCT02346201|450068959|FG000|Overall Study|Unavailable for future follow-up|0|||
125121681|NCT02346201|450068960|FG001|Overall Study|Unavailable for future follow-up|1|||
125121682|NCT02346201|450068959|FG000|Overall Study|Physician Decision|0|||
125121683|NCT02346201|450068960|FG001|Overall Study|Physician Decision|1|||
125213218|NCT00339833|450407285|FG000|Overall Study|indigestion|0|||
125213219|NCT00339833|450407286|FG001|Overall Study|indigestion|1|||
125121684|NCT02346201|450068959|FG000|Overall Study|Missed final visit|0|||
125121685|NCT02346201|450068960|FG001|Overall Study|Missed final visit|2|||
124940155|NCT03478969|449409802|FG001|Overall Study|Pregnancy|0|||
124940156|NCT03478969|449409803|FG002|Overall Study|Pregnancy|0|||
124940157|NCT03478969|449409801|FG000|Overall Study|Personal Reasons|1|||
124940158|NCT03478969|449409802|FG001|Overall Study|Personal Reasons|0|||
124940159|NCT03478969|449409803|FG002|Overall Study|Personal Reasons|1|||
124940160|NCT03478969|449409801|FG000|Overall Study|Covid-19|1|||
124940161|NCT03478969|449409802|FG001|Overall Study|Covid-19|4|||
124940162|NCT03478969|449409803|FG002|Overall Study|Covid-19|3|||
124940163|NCT03478969|449409801|FG000|Overall Study|Multiple Reasons|0|||
124940164|NCT03478969|449409802|FG001|Overall Study|Multiple Reasons|1|||
124940165|NCT03478969|449409803|FG002|Overall Study|Multiple Reasons|1|||
124940166|NCT03478969|449409801|FG000|Overall Study|Eligibility Criteria|0|||
124940167|NCT03478969|449409802|FG001|Overall Study|Eligibility Criteria|0|||
124940168|NCT03478969|449409803|FG002|Overall Study|Eligibility Criteria|5|||
124940169|NCT03478969|449409801|FG000|Overall Study|Lost to Follow-up|0|||
124940170|NCT03478969|449409802|FG001|Overall Study|Lost to Follow-up|0|||
124940171|NCT03478969|449409803|FG002|Overall Study|Lost to Follow-up|1|||
124940172|NCT01185600|449409804|FG000|Overall Study|Adverse Event|1|||
124940173|NCT01185600|449409805|FG001|Overall Study|Adverse Event|1|||
124940174|NCT01185600|449409804|FG000|Overall Study|Death|0|||
124940175|NCT01185600|449409805|FG001|Overall Study|Death|1|||
124940176|NCT01185600|449409804|FG000|Overall Study|Lost to Follow-up|0|||
124940177|NCT01185600|449409805|FG001|Overall Study|Lost to Follow-up|5|||
124940178|NCT01185600|449409804|FG000|Overall Study|Physician Decision|29|||
124940179|NCT01185600|449409805|FG001|Overall Study|Physician Decision|35|||
124940180|NCT01185600|449409804|FG000|Overall Study|Withdrawal by Subject|1|||
124940181|NCT01185600|449409805|FG001|Overall Study|Withdrawal by Subject|1|||
124940182|NCT01185600|449409804|FG000|Overall Study|Hold by DSMB|1|||
124940183|NCT01185600|449409805|FG001|Overall Study|Hold by DSMB|2|||
124940184|NCT02941549|449409806|FG000|Overall Study|Adverse Event|1|||
124940185|NCT02941549|449409807|FG001|Overall Study|Adverse Event|0|||
124940186|NCT02941549|449409808|FG002|Overall Study|Adverse Event|0|||
124940187|NCT02941549|449409806|FG000|Overall Study|Withdrawal by Subject|2|||
124940188|NCT02941549|449409807|FG001|Overall Study|Withdrawal by Subject|1|||
124940189|NCT02941549|449409808|FG002|Overall Study|Withdrawal by Subject|2|||
124940190|NCT01436175|449409810|FG000|Overall Study|Adverse Event|111|||
124940191|NCT01436175|449409810|FG000|Overall Study|Protocol Violation|49|||
125121686|NCT03708211|450068961|FG000|Overall Study|Progressive Disease|10|||
125121687|NCT03708211|450068962|FG001|Overall Study|Progressive Disease|7|||
125121688|NCT03708211|450068961|FG000|Overall Study|Withdrawal by Subject|0|||
125121689|NCT03708211|450068962|FG001|Overall Study|Withdrawal by Subject|1|||
125121690|NCT03708211|450068961|FG000|Overall Study|Other|2|||
125121691|NCT03708211|450068962|FG001|Overall Study|Other|0|||
125121692|NCT01508936|450068963|FG000|Overall Study|Adverse Event|11|||
125121693|NCT01508936|450068964|FG001|Overall Study|Adverse Event|32|||
125121694|NCT01508936|450068963|FG000|Overall Study|Lack of Efficacy|0|||
125121695|NCT01508936|450068964|FG001|Overall Study|Lack of Efficacy|1|||
125121696|NCT01508936|450068963|FG000|Overall Study|Withdrawal by Subject|4|||
125121697|NCT01508936|450068964|FG001|Overall Study|Withdrawal by Subject|18|||
125121698|NCT01508936|450068963|FG000|Overall Study|Protocol Violation|2|||
125121699|NCT01508936|450068964|FG001|Overall Study|Protocol Violation|3|||
125121700|NCT01508936|450068963|FG000|Overall Study|Lost to Follow-up|2|||
125121701|NCT01508936|450068964|FG001|Overall Study|Lost to Follow-up|9|||
125121702|NCT01508936|450068963|FG000|Overall Study|Other|0|||
125121703|NCT01508936|450068964|FG001|Overall Study|Other|5|||
125121704|NCT01508936|450068963|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
125121705|NCT01508936|450068964|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
125121706|NCT00462982|450068965|FG000|Overall Study|Adverse Event|1|||
125121707|NCT00462982|450068965|FG000|Overall Study|Patient Not Treated|2|||
125121708|NCT00679367|450068966|FG000|Overall Study|Adverse Event|7|||
125121709|NCT00679367|450068966|FG000|Overall Study|inability to swallow oral drugs|1|||
125121710|NCT00679367|450068966|FG000|Overall Study|Lack of Efficacy|3|||
124940192|NCT01436175|449409810|FG000|Overall Study|Withdrawal by Subject|108|||
124940193|NCT01436175|449409810|FG000|Overall Study|Lost to Follow-up|89|||
124940194|NCT01436175|449409810|FG000|Overall Study|Lack of Efficacy|24|||
124940195|NCT01436175|449409810|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
124940196|NCT01436175|449409810|FG000|Overall Study|Other|826|||
124940197|NCT03577106|449409813|FG000|Overall Study|Withdrawal by Subject|3|||
124940198|NCT03601715|449409816|FG000|Second Intervention|Lost to Follow-up|1|||
124940199|NCT03601715|449409817|FG001|Second Intervention|Lost to Follow-up|1|||
124940200|NCT03601715|449409818|FG002|Second Intervention|Lost to Follow-up|0|||
125121711|NCT00679367|450068966|FG000|Overall Study|Withdrawal by Subject|1|||
125121712|NCT02109133|450068967|FG000|Overall Study|Lost to Follow-up|1|||
125213220|NCT00339833|450407285|FG000|Overall Study|Chest pain|0|||
125121713|NCT02109133|450068968|FG001|Overall Study|Lost to Follow-up|0|||
125121714|NCT00409578|450068969|FG000|Overall Study|Adverse Event|27|||
125121715|NCT00409578|450068970|FG001|Overall Study|Adverse Event|37|||
125121716|NCT00409578|450068971|FG002|Overall Study|Adverse Event|25|||
125121717|NCT00409578|450068972|FG003|Overall Study|Adverse Event|33|||
125121718|NCT00409578|450068969|FG000|Overall Study|Abnormal laboratory value(s)|2|||
124940201|NCT00918333|449409821|FG000|Overall Study|Drug not taken per protocol|1|||
124940202|NCT00918333|449409822|FG001|Overall Study|Drug not taken per protocol|0|||
124940203|NCT00918333|449409821|FG000|Overall Study|Inadequate amount of drugs provided|1|||
124940204|NCT00918333|449409822|FG001|Overall Study|Inadequate amount of drugs provided|4|||
124940205|NCT00918333|449409821|FG000|Overall Study|Ineligible|1|||
124940206|NCT00918333|449409822|FG001|Overall Study|Ineligible|0|||
124940207|NCT00918333|449409821|FG000|Overall Study|Withdrawal by Subject|0|||
124940208|NCT00918333|449409822|FG001|Overall Study|Withdrawal by Subject|1|||
124940209|NCT01313884|449409824|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
124940210|NCT00263757|449409825|FG000|Overall Study|Withdrawal by Subject|5|||
124940211|NCT00263757|449409826|FG001|Overall Study|Withdrawal by Subject|4|||
125121719|NCT00409578|450068970|FG001|Overall Study|Abnormal laboratory value(s)|2|||
125121720|NCT00409578|450068971|FG002|Overall Study|Abnormal laboratory value(s)|2|||
125121721|NCT00409578|450068972|FG003|Overall Study|Abnormal laboratory value(s)|4|||
125121722|NCT00409578|450068969|FG000|Overall Study|Lack of Efficacy|0|||
125121723|NCT00409578|450068970|FG001|Overall Study|Lack of Efficacy|0|||
125121724|NCT00409578|450068971|FG002|Overall Study|Lack of Efficacy|0|||
125121725|NCT00409578|450068972|FG003|Overall Study|Lack of Efficacy|2|||
125121726|NCT00409578|450068969|FG000|Overall Study|Subject no longer requires study drug|0|||
125121727|NCT00409578|450068970|FG001|Overall Study|Subject no longer requires study drug|0|||
125121728|NCT00409578|450068971|FG002|Overall Study|Subject no longer requires study drug|0|||
125121729|NCT00409578|450068972|FG003|Overall Study|Subject no longer requires study drug|1|||
125121730|NCT00409578|450068969|FG000|Overall Study|Withdrawal by Subject|8|||
125121731|NCT00409578|450068970|FG001|Overall Study|Withdrawal by Subject|15|||
125121732|NCT00409578|450068971|FG002|Overall Study|Withdrawal by Subject|16|||
125121733|NCT00409578|450068972|FG003|Overall Study|Withdrawal by Subject|17|||
125121734|NCT00409578|450068969|FG000|Overall Study|Lost to Follow-up|2|||
125121735|NCT00409578|450068970|FG001|Overall Study|Lost to Follow-up|0|||
125121736|NCT00409578|450068971|FG002|Overall Study|Lost to Follow-up|2|||
125121737|NCT00409578|450068972|FG003|Overall Study|Lost to Follow-up|2|||
125121738|NCT00409578|450068969|FG000|Overall Study|Administrative problems|8|||
125121739|NCT00409578|450068970|FG001|Overall Study|Administrative problems|9|||
125121740|NCT00409578|450068971|FG002|Overall Study|Administrative problems|2|||
125121741|NCT00409578|450068972|FG003|Overall Study|Administrative problems|4|||
125121742|NCT00409578|450068969|FG000|Overall Study|Death|2|||
125121743|NCT00409578|450068970|FG001|Overall Study|Death|4|||
125121744|NCT00409578|450068971|FG002|Overall Study|Death|4|||
125121745|NCT00409578|450068972|FG003|Overall Study|Death|2|||
125121746|NCT00409578|450068969|FG000|Overall Study|Protocol Violation|3|||
125121747|NCT00409578|450068970|FG001|Overall Study|Protocol Violation|2|||
125121748|NCT00409578|450068971|FG002|Overall Study|Protocol Violation|3|||
125121749|NCT00409578|450068972|FG003|Overall Study|Protocol Violation|1|||
125121750|NCT00409578|450068969|FG000|Overall Study|Missing|0|||
125121751|NCT00409578|450068970|FG001|Overall Study|Missing|1|||
125121752|NCT00409578|450068971|FG002|Overall Study|Missing|0|||
125121753|NCT00409578|450068972|FG003|Overall Study|Missing|1|||
125121754|NCT00922779|450068973|FG000|Overall Study|Adverse Event|67|||
124940212|NCT00263757|449409825|FG000|Overall Study|Screen failure|0|||
125121755|NCT00922779|450068973|FG000|Overall Study|Pregnancy|7|||
125121756|NCT00922779|450068973|FG000|Overall Study|Withdrawal by Subject|308|||
125121757|NCT00922779|450068973|FG000|Overall Study|Lost to Follow-up|44|||
125121758|NCT00922779|450068973|FG000|Overall Study|Other|27|||
125121759|NCT00922779|450068973|FG000|Overall Study|Missing|1874|||
125121760|NCT02448771|450068974|FG000|Overall Study|Disease Progression|30|||
125121761|NCT02448771|450068974|FG000|Overall Study|Unacceptable Toxicity|1|||
125121762|NCT02448771|450068974|FG000|Overall Study|Physician Decision|3|||
125121763|NCT02448771|450068974|FG000|Overall Study|Started new therapy|2|||
125213221|NCT00339833|450407286|FG001|Overall Study|Chest pain|1|||
125213222|NCT00339833|450407285|FG000|Overall Study|minor infection|0|||
125213223|NCT00339833|450407286|FG001|Overall Study|minor infection|1|||
125121764|NCT00770315|450068975|FG000|Overall Study|Adverse Event|11|||
125121765|NCT00770315|450068976|FG001|Overall Study|Adverse Event|17|||
125121766|NCT00770315|450068977|FG002|Overall Study|Adverse Event|16|||
125121767|NCT00770315|450068978|FG003|Overall Study|Adverse Event|6|||
125121768|NCT00770315|450068975|FG000|Overall Study|Lost to Follow-up|9|||
125121769|NCT00770315|450068976|FG001|Overall Study|Lost to Follow-up|5|||
125121770|NCT00770315|450068977|FG002|Overall Study|Lost to Follow-up|10|||
125121771|NCT00770315|450068978|FG003|Overall Study|Lost to Follow-up|3|||
125121772|NCT00770315|450068975|FG000|Overall Study|Withdrawal by Subject|13|||
125121773|NCT00770315|450068976|FG001|Overall Study|Withdrawal by Subject|17|||
125121774|NCT00770315|450068977|FG002|Overall Study|Withdrawal by Subject|24|||
125121775|NCT00770315|450068978|FG003|Overall Study|Withdrawal by Subject|20|||
125121776|NCT00770315|450068975|FG000|Overall Study|Noncompliance with Protocol|7|||
125121777|NCT00770315|450068976|FG001|Overall Study|Noncompliance with Protocol|4|||
125121778|NCT00770315|450068977|FG002|Overall Study|Noncompliance with Protocol|7|||
125121779|NCT00770315|450068978|FG003|Overall Study|Noncompliance with Protocol|9|||
125121780|NCT02683187|450068979|FG000|Overall Study|Failed IV access|3|||
125121781|NCT02683187|450068979|FG000|Overall Study|Withdrawal by Subject|5|||
125121782|NCT02585258|450068980|FG000|Overall Study|Adverse Event|28|||
125121783|NCT02585258|450068981|FG001|Overall Study|Adverse Event|29|||
125121784|NCT02585258|450068980|FG000|Overall Study|Death|3|||
125121785|NCT02585258|450068981|FG001|Overall Study|Death|2|||
125121786|NCT02585258|450068980|FG000|Overall Study|Lack of Efficacy|7|||
124940213|NCT00263757|449409826|FG001|Overall Study|Screen failure|1|||
125121787|NCT02585258|450068981|FG001|Overall Study|Lack of Efficacy|9|||
125121788|NCT02585258|450068980|FG000|Overall Study|includes covid-related access problems|42|||
125121789|NCT02585258|450068981|FG001|Overall Study|includes covid-related access problems|46|||
125121790|NCT02585258|450068980|FG000|Overall Study|Lost to Follow-up|5|||
125121791|NCT02585258|450068981|FG001|Overall Study|Lost to Follow-up|2|||
125121792|NCT03702621|450071485|FG000|Overall Study|Physician Decision|6|||
125121793|NCT03702621|450071486|FG001|Overall Study|Physician Decision|6|||
125121794|NCT03194464|450071488|FG000|Overall Study|data not usable|2|||
125121795|NCT03103100|450071489|FG000|Overall Study|Adverse Event|1|||
125121796|NCT03103100|450071490|FG001|Overall Study|Adverse Event|0|||
125121797|NCT03103100|450071491|FG002|Overall Study|Adverse Event|0|||
125213224|NCT00339833|450407285|FG000|Overall Study|Poor venous access|2|||
125121798|NCT03103100|450071489|FG000|Overall Study|Physician Decision|1|||
125121799|NCT03103100|450071490|FG001|Overall Study|Physician Decision|0|||
125121800|NCT03103100|450071491|FG002|Overall Study|Physician Decision|2|||
124940214|NCT00263757|449409825|FG000|Overall Study|Adverse Event|3|||
124940215|NCT00263757|449409826|FG001|Overall Study|Adverse Event|3|||
124940216|NCT01342367|449409827|FG000|Overall Study|Death|1|||
124940217|NCT01342367|449409828|FG001|Overall Study|Death|0|||
124940218|NCT01342367|449409827|FG000|Overall Study|Withdrawal by Subject|1|||
124940219|NCT01342367|449409828|FG001|Overall Study|Withdrawal by Subject|2|||
124940220|NCT02964741|449409829|FG000|Overall Study|Protocol Violation|1|||
124940221|NCT02964741|449409830|FG001|Overall Study|Protocol Violation|0|||
124940222|NCT02964741|449409831|FG002|Overall Study|Protocol Violation|0|||
124940223|NCT02964741|449409829|FG000|Overall Study|Withdrawal by Subject|0|||
124940224|NCT02964741|449409830|FG001|Overall Study|Withdrawal by Subject|1|||
124940225|NCT02964741|449409831|FG002|Overall Study|Withdrawal by Subject|0|||
124940226|NCT02964741|449409829|FG000|Overall Study|claustrophobia|1|||
124940227|NCT02964741|449409830|FG001|Overall Study|claustrophobia|0|||
124940228|NCT02964741|449409831|FG002|Overall Study|claustrophobia|0|||
124940229|NCT00640159|449409832|FG000|Overall Study|Lost to Follow-up|2|||
124940230|NCT01500200|449409833|FG000|Stage 1|Adverse Event|1|||
124940231|NCT01500200|449409834|FG001|Stage 1|Adverse Event|4|||
124940232|NCT01500200|449409835|FG002|Stage 1|Adverse Event|5|||
124940233|NCT01500200|449409836|FG003|Stage 1|Adverse Event|0|||
124940234|NCT01500200|449409837|FG004|Stage 1|Adverse Event|0|||
124940235|NCT01500200|449409838|FG005|Stage 1|Adverse Event|0|||
124940236|NCT01500200|449409833|FG000|Stage 1|Lost to Follow-up|2|||
124940237|NCT01500200|449409834|FG001|Stage 1|Lost to Follow-up|2|||
124940238|NCT01500200|449409835|FG002|Stage 1|Lost to Follow-up|1|||
124940239|NCT01500200|449409836|FG003|Stage 1|Lost to Follow-up|0|||
124940240|NCT01500200|449409837|FG004|Stage 1|Lost to Follow-up|0|||
124940241|NCT01500200|449409838|FG005|Stage 1|Lost to Follow-up|0|||
124940242|NCT01500200|449409833|FG000|Stage 1|Withdrawal by Subject|3|||
124940243|NCT01500200|449409834|FG001|Stage 1|Withdrawal by Subject|0|||
124940244|NCT01500200|449409835|FG002|Stage 1|Withdrawal by Subject|0|||
124940245|NCT01500200|449409836|FG003|Stage 1|Withdrawal by Subject|0|||
124940246|NCT01500200|449409837|FG004|Stage 1|Withdrawal by Subject|0|||
124940247|NCT01500200|449409838|FG005|Stage 1|Withdrawal by Subject|0|||
124940248|NCT01500200|449409833|FG000|Stage 1|Noncompliance with Study Drug|1|||
124940249|NCT01500200|449409834|FG001|Stage 1|Noncompliance with Study Drug|0|||
124940250|NCT01500200|449409835|FG002|Stage 1|Noncompliance with Study Drug|0|||
124940251|NCT01500200|449409836|FG003|Stage 1|Noncompliance with Study Drug|0|||
124940252|NCT01500200|449409837|FG004|Stage 1|Noncompliance with Study Drug|0|||
124940253|NCT01500200|449409838|FG005|Stage 1|Noncompliance with Study Drug|0|||
124940254|NCT01500200|449409833|FG000|Stage 1|Physician Decision|1|||
124940255|NCT01500200|449409834|FG001|Stage 1|Physician Decision|0|||
124940256|NCT01500200|449409835|FG002|Stage 1|Physician Decision|0|||
124940257|NCT01500200|449409836|FG003|Stage 1|Physician Decision|0|||
124940258|NCT01500200|449409837|FG004|Stage 1|Physician Decision|0|||
124940259|NCT01500200|449409838|FG005|Stage 1|Physician Decision|0|||
124940260|NCT01500200|449409833|FG000|Stage 2|Adverse Event|0|||
124940261|NCT01500200|449409834|FG001|Stage 2|Adverse Event|0|||
124940262|NCT01500200|449409835|FG002|Stage 2|Adverse Event|0|||
124940263|NCT01500200|449409836|FG003|Stage 2|Adverse Event|0|||
124940264|NCT01500200|449409837|FG004|Stage 2|Adverse Event|5|||
124940265|NCT01500200|449409838|FG005|Stage 2|Adverse Event|4|||
124940266|NCT04860505|449409845|FG000|Overall Study|Lost to Follow-up|2|||
125121801|NCT00436007|450071494|FG000|Overall Study|Withdrawal by Subject|5|||
125121802|NCT00436007|450071495|FG001|Overall Study|Withdrawal by Subject|3|||
125121803|NCT00436007|450071496|FG002|Overall Study|Withdrawal by Subject|4|||
125121804|NCT00436007|450071494|FG000|Overall Study|Lost to Follow-up|14|||
125121805|NCT00436007|450071495|FG001|Overall Study|Lost to Follow-up|10|||
125121806|NCT00436007|450071496|FG002|Overall Study|Lost to Follow-up|13|||
125121807|NCT00436007|450071494|FG000|Overall Study|Physician Decision|0|||
125121808|NCT00436007|450071495|FG001|Overall Study|Physician Decision|0|||
124940267|NCT01212744|449409854|FG000|Overall Study|Withdrawal by Subject|1|||
124940268|NCT02167451|449409855|FG000|Overall Study|Withdrawal by Subject|1|||
124940269|NCT01218659|449409856|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
124940270|NCT01218659|449409857|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
125121809|NCT00436007|450071496|FG002|Overall Study|Physician Decision|2|||
125121810|NCT00436007|450071494|FG000|Overall Study|Death|0|||
125121811|NCT00436007|450071495|FG001|Overall Study|Death|1|||
124940271|NCT01218659|449409858|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
124940272|NCT01218659|449409856|FG000|18-Month Randomized Period|Did not receive study drug|0|||
124940273|NCT01218659|449409857|FG001|18-Month Randomized Period|Did not receive study drug|3|||
124940274|NCT01218659|449409858|FG002|18-Month Randomized Period|Did not receive study drug|0|||
124940275|NCT01218659|449409856|FG000|12-Month OLE|Withdrawal by Subject|0|||
125121812|NCT00436007|450071496|FG002|Overall Study|Death|3|||
124940276|NCT01218659|449409857|FG001|12-Month OLE|Withdrawal by Subject|0|||
124940277|NCT01218659|449409858|FG002|12-Month OLE|Withdrawal by Subject|2|||
124940278|NCT01218659|449409856|FG000|12-Month OLE|Physician Decision|0|||
124940279|NCT01218659|449409857|FG001|12-Month OLE|Physician Decision|0|||
124940280|NCT01218659|449409858|FG002|12-Month OLE|Physician Decision|1|||
124940281|NCT01218659|449409856|FG000|12-Month OLE|Lost to Follow-up|0|||
124940282|NCT01218659|449409857|FG001|12-Month OLE|Lost to Follow-up|0|||
124940283|NCT01218659|449409858|FG002|12-Month OLE|Lost to Follow-up|1|||
124940284|NCT01218659|449409856|FG000|12-Month OLE|Pregnancy|0|||
124940285|NCT01218659|449409857|FG001|12-Month OLE|Pregnancy|0|||
124940286|NCT01218659|449409858|FG002|12-Month OLE|Pregnancy|1|||
124940287|NCT01218659|449409856|FG000|12-Month OLE|Lack of Efficacy|0|||
124940288|NCT01218659|449409857|FG001|12-Month OLE|Lack of Efficacy|0|||
124940289|NCT01218659|449409858|FG002|12-Month OLE|Lack of Efficacy|1|||
124940290|NCT01218659|449409856|FG000|12-Month OLE|Declined to participate in the OLE|0|||
124940291|NCT01218659|449409857|FG001|12-Month OLE|Declined to participate in the OLE|0|||
124940292|NCT01218659|449409858|FG002|12-Month OLE|Declined to participate in the OLE|4|||
124940293|NCT03066609|449409863|FG000|INDUCTION|Pregnancy|0|||
124940294|NCT03066609|449409864|FG001|INDUCTION|Pregnancy|0|||
124940295|NCT03066609|449409865|FG002|INDUCTION|Pregnancy|1|||
124940296|NCT03066609|449409866|FG003|INDUCTION|Pregnancy|0|||
124940297|NCT03066609|449409863|FG000|INDUCTION|Lack of Efficacy|0|||
124940298|NCT03066609|449409864|FG001|INDUCTION|Lack of Efficacy|0|||
124940299|NCT03066609|449409865|FG002|INDUCTION|Lack of Efficacy|1|||
124940300|NCT03066609|449409866|FG003|INDUCTION|Lack of Efficacy|0|||
124940301|NCT03066609|449409863|FG000|INDUCTION|Adverse Event|2|||
124940302|NCT03066609|449409864|FG001|INDUCTION|Adverse Event|2|||
124940303|NCT03066609|449409865|FG002|INDUCTION|Adverse Event|0|||
124940304|NCT03066609|449409866|FG003|INDUCTION|Adverse Event|0|||
125121813|NCT00436007|450071494|FG000|Overall Study|Other|0|||
125121814|NCT00436007|450071495|FG001|Overall Study|Other|0|||
125121815|NCT00436007|450071496|FG002|Overall Study|Other|1|||
125121816|NCT00810368|450071497|FG000|Overall Study|Lost to Follow-up|4|||
125121817|NCT00810368|450071498|FG001|Overall Study|Lost to Follow-up|2|||
125121818|NCT00810368|450071497|FG000|Overall Study|Lack of Efficacy|2|||
125121819|NCT00810368|450071498|FG001|Overall Study|Lack of Efficacy|0|||
125121820|NCT03331042|450071499|FG000|Overall Study|Protocol Violation|1|||
125121821|NCT03331042|450071500|FG001|Overall Study|Protocol Violation|0|||
125121822|NCT03331042|450071501|FG002|Overall Study|Protocol Violation|0|||
125121823|NCT03331042|450071502|FG003|Overall Study|Protocol Violation|0|||
125121824|NCT03331042|450071499|FG000|Overall Study|Physician Decision|0|||
125121825|NCT03331042|450071500|FG001|Overall Study|Physician Decision|0|||
125121826|NCT03331042|450071501|FG002|Overall Study|Physician Decision|1|||
125121827|NCT03331042|450071502|FG003|Overall Study|Physician Decision|0|||
125121828|NCT03331042|450071499|FG000|Overall Study|Lost to Follow-up|0|||
125121829|NCT03331042|450071500|FG001|Overall Study|Lost to Follow-up|0|||
125121830|NCT03331042|450071501|FG002|Overall Study|Lost to Follow-up|0|||
125121831|NCT03331042|450071502|FG003|Overall Study|Lost to Follow-up|1|||
125121832|NCT00720096|450071507|FG000|Overall Study|Withdrawal by Subject|0|||
125121833|NCT00720096|450071508|FG001|Overall Study|Withdrawal by Subject|2|||
125121834|NCT00524459|450071509|FG000|Overall Study|Withdrawal by Subject|1|||
125121835|NCT00524459|450071509|FG000|Overall Study|Other|1|||
125121836|NCT02428699|450071510|FG000|Washout Period 1|Screen Failure|1|||
125121837|NCT02428699|450071511|FG001|Washout Period 1|Screen Failure|2|||
125121838|NCT01574248|450071514|FG000|Overall Study|Withdrawal by Subject|2|||
125121839|NCT01574248|450071515|FG001|Overall Study|Withdrawal by Subject|0|||
125121840|NCT01574248|450071514|FG000|Overall Study|Missing primary endpoint data|1|||
125121841|NCT01574248|450071515|FG001|Overall Study|Missing primary endpoint data|0|||
125121842|NCT01781286|450071518|FG000|Overall Study|Lost to Follow-up|0|||
125121843|NCT01781286|450071519|FG001|Overall Study|Lost to Follow-up|0|||
125121844|NCT01781286|450071520|FG002|Overall Study|Lost to Follow-up|0|||
125121845|NCT01781286|450071521|FG003|Overall Study|Lost to Follow-up|0|||
124940305|NCT03066609|449409863|FG000|MAINTENANCE|Adverse Event|0|||
124940306|NCT03066609|449409864|FG001|MAINTENANCE|Adverse Event|0|||
124940307|NCT03066609|449409865|FG002|MAINTENANCE|Adverse Event|0|||
125121846|NCT01781286|450071522|FG004|Overall Study|Lost to Follow-up|0|||
125121847|NCT01781286|450071523|FG005|Overall Study|Lost to Follow-up|1|||
125121848|NCT01781286|450071518|FG000|Overall Study|Time Constraints|2|||
125121849|NCT01781286|450071519|FG001|Overall Study|Time Constraints|0|||
124940308|NCT03066609|449409866|FG003|MAINTENANCE|Adverse Event|1|||
125121850|NCT01781286|450071520|FG002|Overall Study|Time Constraints|2|||
125121851|NCT01781286|450071521|FG003|Overall Study|Time Constraints|0|||
125121852|NCT01781286|450071522|FG004|Overall Study|Time Constraints|0|||
124940309|NCT03066609|449409863|FG000|MAINTENANCE|Withdrawal by Subject|4|||
125121853|NCT01781286|450071523|FG005|Overall Study|Time Constraints|0|||
125121854|NCT01781286|450071518|FG000|Overall Study|Noncompliance|0|||
125121855|NCT01781286|450071519|FG001|Overall Study|Noncompliance|0|||
125121856|NCT01781286|450071520|FG002|Overall Study|Noncompliance|0|||
125121857|NCT01781286|450071521|FG003|Overall Study|Noncompliance|1|||
125121858|NCT01781286|450071522|FG004|Overall Study|Noncompliance|0|||
125121859|NCT01781286|450071523|FG005|Overall Study|Noncompliance|0|||
125121860|NCT00995410|450071524|FG000|Overall Study|Adverse Event|51|||
125121861|NCT00995410|450071524|FG000|Overall Study|Withdrawal by Subject|7|||
125121862|NCT00995410|450071524|FG000|Overall Study|Lost to Follow-up|2|||
125121863|NCT00995410|450071524|FG000|Overall Study|Misc|28|||
125121864|NCT03594123|450071525|FG000|Overall Study|Lost to Follow-up|0|||
125121865|NCT03594123|450071526|FG001|Overall Study|Lost to Follow-up|1|||
125121866|NCT03594123|450071525|FG000|Overall Study|Adverse Event|8|||
125121867|NCT03594123|450071526|FG001|Overall Study|Adverse Event|5|||
125121868|NCT03594123|450071525|FG000|Overall Study|Site Terminated by Sponsor|4|||
125121869|NCT03594123|450071526|FG001|Overall Study|Site Terminated by Sponsor|1|||
125121870|NCT03594123|450071525|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
125121871|NCT03594123|450071526|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
125121872|NCT03594123|450071525|FG000|Overall Study|Lack of Efficacy|1|||
125121873|NCT03594123|450071526|FG001|Overall Study|Lack of Efficacy|0|||
124940310|NCT03066609|449409864|FG001|MAINTENANCE|Withdrawal by Subject|2|||
124940311|NCT03066609|449409865|FG002|MAINTENANCE|Withdrawal by Subject|1|||
124940312|NCT03066609|449409866|FG003|MAINTENANCE|Withdrawal by Subject|1|||
124940313|NCT03066609|449409863|FG000|MAINTENANCE|Lost to Follow-up|0|||
124940314|NCT03066609|449409864|FG001|MAINTENANCE|Lost to Follow-up|1|||
124940315|NCT03066609|449409865|FG002|MAINTENANCE|Lost to Follow-up|1|||
124940316|NCT03066609|449409866|FG003|MAINTENANCE|Lost to Follow-up|0|||
124940317|NCT03066609|449409863|FG000|MAINTENANCE|Pregnancy|1|||
124940318|NCT03066609|449409864|FG001|MAINTENANCE|Pregnancy|0|||
124940319|NCT03066609|449409865|FG002|MAINTENANCE|Pregnancy|0|||
124940320|NCT03066609|449409866|FG003|MAINTENANCE|Pregnancy|0|||
124940321|NCT03066609|449409863|FG000|MAINTENANCE|Lack of Efficacy|2|||
124940322|NCT03066609|449409864|FG001|MAINTENANCE|Lack of Efficacy|1|||
124940323|NCT03066609|449409865|FG002|MAINTENANCE|Lack of Efficacy|0|||
124940324|NCT03066609|449409866|FG003|MAINTENANCE|Lack of Efficacy|1|||
124940325|NCT03066609|449409863|FG000|OVERALL STUDY|Adverse Event|2|||
124940326|NCT03066609|449409864|FG001|OVERALL STUDY|Adverse Event|2|||
124940327|NCT03066609|449409865|FG002|OVERALL STUDY|Adverse Event|0|||
124940328|NCT03066609|449409866|FG003|OVERALL STUDY|Adverse Event|1|||
124940329|NCT03066609|449409863|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
124940330|NCT03066609|449409864|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
124940331|NCT03066609|449409865|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
124940332|NCT03066609|449409866|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
124940333|NCT03066609|449409863|FG000|OVERALL STUDY|Lost to Follow-up|1|||
124940334|NCT03066609|449409864|FG001|OVERALL STUDY|Lost to Follow-up|1|||
124940335|NCT03066609|449409865|FG002|OVERALL STUDY|Lost to Follow-up|1|||
124940336|NCT03066609|449409866|FG003|OVERALL STUDY|Lost to Follow-up|1|||
124940337|NCT03066609|449409863|FG000|OVERALL STUDY|Pregnancy|1|||
124940338|NCT03066609|449409864|FG001|OVERALL STUDY|Pregnancy|0|||
124940339|NCT03066609|449409865|FG002|OVERALL STUDY|Pregnancy|1|||
124940340|NCT03066609|449409866|FG003|OVERALL STUDY|Pregnancy|0|||
124940341|NCT03066609|449409863|FG000|OVERALL STUDY|Lack of Efficacy|2|||
124940342|NCT03066609|449409864|FG001|OVERALL STUDY|Lack of Efficacy|1|||
124940343|NCT03066609|449409865|FG002|OVERALL STUDY|Lack of Efficacy|1|||
124940344|NCT03066609|449409866|FG003|OVERALL STUDY|Lack of Efficacy|1|||
124940345|NCT03066609|449409863|FG000|OVERALL STUDY|discontinued follow up|0|||
124940346|NCT03066609|449409864|FG001|OVERALL STUDY|discontinued follow up|2|||
124940347|NCT03066609|449409865|FG002|OVERALL STUDY|discontinued follow up|0|||
124940348|NCT03066609|449409866|FG003|OVERALL STUDY|discontinued follow up|0|||
124940349|NCT00523419|449409871|FG000|Overall Study|Adverse Event|1|||
125121874|NCT03594123|450071525|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
125121875|NCT03594123|450071526|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
125121876|NCT03365375|450071527|FG000|Overall Study|Withdrawal by Subject|0|||
125121877|NCT03365375|450071528|FG001|Overall Study|Withdrawal by Subject|1|||
125121878|NCT03365375|450071527|FG000|Overall Study|Lost to Follow-up|0|||
125121879|NCT03365375|450071528|FG001|Overall Study|Lost to Follow-up|4|||
124940350|NCT00523419|449409871|FG000|Overall Study|Withdrawal by Subject|1|||
124940351|NCT00523419|449409871|FG000|Overall Study|Physician Decision|2|||
124940352|NCT00523419|449409871|FG000|Overall Study|Progressive Disease|22|||
125121880|NCT02483975|450071529|FG000|Overall Study|Adverse Event|0|||
125121881|NCT02483975|450071530|FG001|Overall Study|Adverse Event|1|||
125121882|NCT02483975|450071529|FG000|Overall Study|Lost to Follow-up|0|||
124940353|NCT00523419|449409871|FG000|Overall Study|Death due to Study Disease|4|||
124940354|NCT00523419|449409871|FG000|Overall Study|Death due to Adverse Event|2|||
124940355|NCT01437319|449409874|FG000|Phase I|Lost to Follow-up|2|||
124940356|NCT01437319|449409875|FG001|Phase I|Lost to Follow-up|0|||
124940357|NCT01437319|449409876|FG002|Phase I|Lost to Follow-up|0|||
124940358|NCT01437319|449409874|FG000|Phase I|Protocol Violation|1|||
125121883|NCT02483975|450071530|FG001|Overall Study|Lost to Follow-up|1|||
124940359|NCT01437319|449409875|FG001|Phase I|Protocol Violation|0|||
124940360|NCT01437319|449409876|FG002|Phase I|Protocol Violation|0|||
124940361|NCT01437319|449409874|FG000|Phase I|Study related symptoms/complaints|27|||
124940362|NCT01437319|449409875|FG001|Phase I|Study related symptoms/complaints|0|||
124940363|NCT01437319|449409876|FG002|Phase I|Study related symptoms/complaints|0|||
124940364|NCT01437319|449409874|FG000|Phase I|Withdrawal by Subject|25|||
124940365|NCT01437319|449409875|FG001|Phase I|Withdrawal by Subject|0|||
124940366|NCT01437319|449409876|FG002|Phase I|Withdrawal by Subject|0|||
124940367|NCT01437319|449409874|FG000|Phase II|Withdrawal by Subject|0|||
124940368|NCT01437319|449409875|FG001|Phase II|Withdrawal by Subject|8|||
124940369|NCT01437319|449409876|FG002|Phase II|Withdrawal by Subject|16|||
124940370|NCT01437319|449409874|FG000|Phase II|Lost to Follow-up|0|||
124940371|NCT01437319|449409875|FG001|Phase II|Lost to Follow-up|7|||
124940372|NCT01437319|449409876|FG002|Phase II|Lost to Follow-up|2|||
124940373|NCT01437319|449409874|FG000|Phase II|Study related symptoms/complaints|0|||
124940374|NCT01437319|449409875|FG001|Phase II|Study related symptoms/complaints|28|||
124940375|NCT01437319|449409876|FG002|Phase II|Study related symptoms/complaints|19|||
124940376|NCT01437319|449409874|FG000|Phase II|Protocol Violation|0|||
124940377|NCT01437319|449409875|FG001|Phase II|Protocol Violation|1|||
124940378|NCT01437319|449409876|FG002|Phase II|Protocol Violation|0|||
124940379|NCT01499849|449409877|FG000|Overall Study|Adverse Event|28|||
124940380|NCT01499849|449409878|FG001|Overall Study|Adverse Event|32|||
124940381|NCT01499849|449409877|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
124940382|NCT01499849|449409878|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
124940383|NCT01499849|449409877|FG000|Overall Study|Withdrawal by Subject|43|||
124940384|NCT01499849|449409878|FG001|Overall Study|Withdrawal by Subject|43|||
124940385|NCT01499849|449409877|FG000|Overall Study|Death|5|||
124940386|NCT01499849|449409878|FG001|Overall Study|Death|7|||
124940387|NCT01499849|449409877|FG000|Overall Study|Disease Progression|11|||
124940388|NCT01499849|449409878|FG001|Overall Study|Disease Progression|10|||
124940389|NCT01499849|449409877|FG000|Overall Study|Protocol Violation|11|||
124940390|NCT01499849|449409878|FG001|Overall Study|Protocol Violation|11|||
124940391|NCT01499849|449409877|FG000|Overall Study|Physician Decision|20|||
124940392|NCT01499849|449409878|FG001|Overall Study|Physician Decision|19|||
124940393|NCT01499849|449409877|FG000|Overall Study|Lack of Efficacy|3|||
124940394|NCT01499849|449409878|FG001|Overall Study|Lack of Efficacy|4|||
124940395|NCT01499849|449409877|FG000|Overall Study|Lost to Follow-up|6|||
124940396|NCT01499849|449409878|FG001|Overall Study|Lost to Follow-up|3|||
125027275|NCT00568555|449725482|FG000|Overall Study|Withdrawal by Subject|1|||
125027276|NCT00568555|449725483|FG001|Overall Study|Withdrawal by Subject|1|||
124940397|NCT01499849|449409877|FG000|Overall Study|Other Reasons|27|||
124940398|NCT01499849|449409878|FG001|Overall Study|Other Reasons|30|||
124940399|NCT00811941|449409879|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
124940400|NCT00811941|449409880|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
124940401|NCT00811941|449409879|FG000|All Treated Patients|Adverse Event|2|||
124940402|NCT00811941|449409880|FG001|All Treated Patients|Adverse Event|43|||
124940403|NCT00811941|449409879|FG000|All Treated Patients|Lack of Efficacy|2|||
124940404|NCT00811941|449409880|FG001|All Treated Patients|Lack of Efficacy|3|||
124940405|NCT00811941|449409879|FG000|All Treated Patients|Non-compliance|1|||
125027277|NCT01307033|449725484|FG000|8-week Double-blind Period|Adverse Event|2|||
125027278|NCT01307033|449725485|FG001|8-week Double-blind Period|Adverse Event|0|||
125027279|NCT01307033|449725486|FG002|8-week Double-blind Period|Adverse Event|0|||
125027280|NCT01307033|449725487|FG003|8-week Double-blind Period|Adverse Event|0|||
125027281|NCT01307033|449725484|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
125027282|NCT01307033|449725485|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
125027283|NCT01307033|449725486|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
125027284|NCT01307033|449725487|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
125027285|NCT01307033|449725484|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
125027286|NCT01307033|449725485|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
125027287|NCT01307033|449725486|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
125027288|NCT01307033|449725487|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
125027289|NCT01307033|449725484|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
125027290|NCT01307033|449725485|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
125027291|NCT01307033|449725486|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
125027292|NCT01307033|449725487|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
125027293|NCT01307033|449725484|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
125027294|NCT01307033|449725485|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
125027295|NCT01307033|449725486|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
125027296|NCT01307033|449725487|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
125027297|NCT01307033|449725484|FG000|44-week Open-label Extension|Adverse Event|0|||
125027298|NCT01307033|449725485|FG001|44-week Open-label Extension|Adverse Event|0|||
125027299|NCT01307033|449725486|FG002|44-week Open-label Extension|Adverse Event|2|||
124940406|NCT00811941|449409880|FG001|All Treated Patients|Non-compliance|8|||
124940407|NCT00811941|449409879|FG000|All Treated Patients|Protocol Violation|5|||
124940408|NCT00811941|449409880|FG001|All Treated Patients|Protocol Violation|17|||
124940409|NCT00811941|449409879|FG000|All Treated Patients|Withdrawal by Subject|35|||
124940410|NCT00811941|449409880|FG001|All Treated Patients|Withdrawal by Subject|94|||
124940411|NCT00811941|449409879|FG000|All Treated Patients|Lost to Follow-up|3|||
124940412|NCT00811941|449409880|FG001|All Treated Patients|Lost to Follow-up|12|||
124940413|NCT00811941|449409879|FG000|All Treated Patients|Other Reason|4|||
124940414|NCT00811941|449409880|FG001|All Treated Patients|Other Reason|14|||
124940415|NCT00622700|449409883|FG000|Core Treatment Period|Randomized but Not Treated|0|||
124940416|NCT00622700|449409884|FG001|Core Treatment Period|Randomized but Not Treated|2|||
124940417|NCT00622700|449409885|FG002|Core Treatment Period|Randomized but Not Treated|2|||
124940418|NCT00622700|449409886|FG003|Core Treatment Period|Randomized but Not Treated|0|||
124940419|NCT00622700|449409887|FG004|Core Treatment Period|Randomized but Not Treated|0|||
124940420|NCT00622700|449409888|FG005|Core Treatment Period|Randomized but Not Treated|0|||
124940421|NCT00622700|449409889|FG006|Core Treatment Period|Randomized but Not Treated|0|||
124940422|NCT00622700|449409883|FG000|Core Treatment Period|Adverse Event|18|||
124940423|NCT00622700|449409884|FG001|Core Treatment Period|Adverse Event|25|||
124940424|NCT00622700|449409885|FG002|Core Treatment Period|Adverse Event|18|||
124940425|NCT00622700|449409886|FG003|Core Treatment Period|Adverse Event|0|||
124940426|NCT00622700|449409887|FG004|Core Treatment Period|Adverse Event|0|||
124940427|NCT00622700|449409888|FG005|Core Treatment Period|Adverse Event|0|||
124940428|NCT00622700|449409889|FG006|Core Treatment Period|Adverse Event|0|||
124940429|NCT00622700|449409883|FG000|Core Treatment Period|Lack of Efficacy|19|||
124940430|NCT00622700|449409884|FG001|Core Treatment Period|Lack of Efficacy|6|||
124940431|NCT00622700|449409885|FG002|Core Treatment Period|Lack of Efficacy|12|||
124940432|NCT00622700|449409886|FG003|Core Treatment Period|Lack of Efficacy|0|||
124940433|NCT00622700|449409887|FG004|Core Treatment Period|Lack of Efficacy|0|||
124940434|NCT00622700|449409888|FG005|Core Treatment Period|Lack of Efficacy|0|||
124940435|NCT00622700|449409889|FG006|Core Treatment Period|Lack of Efficacy|0|||
124940436|NCT00622700|449409883|FG000|Core Treatment Period|Lost to Follow-up|1|||
124940437|NCT00622700|449409884|FG001|Core Treatment Period|Lost to Follow-up|1|||
124940438|NCT00622700|449409885|FG002|Core Treatment Period|Lost to Follow-up|1|||
124940439|NCT00622700|449409886|FG003|Core Treatment Period|Lost to Follow-up|0|||
124940440|NCT00622700|449409887|FG004|Core Treatment Period|Lost to Follow-up|0|||
124940441|NCT00622700|449409888|FG005|Core Treatment Period|Lost to Follow-up|0|||
124940442|NCT00622700|449409889|FG006|Core Treatment Period|Lost to Follow-up|0|||
124940443|NCT00622700|449409883|FG000|Core Treatment Period|Death|1|||
124940444|NCT00622700|449409884|FG001|Core Treatment Period|Death|0|||
124940445|NCT00622700|449409885|FG002|Core Treatment Period|Death|0|||
124940446|NCT00622700|449409886|FG003|Core Treatment Period|Death|0|||
124940447|NCT00622700|449409887|FG004|Core Treatment Period|Death|0|||
124940448|NCT00622700|449409888|FG005|Core Treatment Period|Death|0|||
124940449|NCT00622700|449409889|FG006|Core Treatment Period|Death|0|||
124940450|NCT00622700|449409883|FG000|Core Treatment Period|Progressive Disease|3|||
124940451|NCT00622700|449409884|FG001|Core Treatment Period|Progressive Disease|1|||
125121884|NCT02483975|450071529|FG000|Overall Study|Physician Decision|2|||
125121885|NCT02483975|450071530|FG001|Overall Study|Physician Decision|0|||
125121886|NCT03992196|450071531|FG000|Enrollment|lost to follow-up prior dosing|1|||
125121887|NCT03992196|450071532|FG001|Enrollment|lost to follow-up prior dosing|0|||
125121888|NCT03992196|450071533|FG002|Enrollment|lost to follow-up prior dosing|0|||
125121889|NCT03992196|450071531|FG000|Treatment|Protocol Violation|0|||
125121890|NCT03992196|450071532|FG001|Treatment|Protocol Violation|0|||
125121891|NCT03992196|450071533|FG002|Treatment|Protocol Violation|1|||
125121892|NCT03992196|450071531|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
125121893|NCT03992196|450071532|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
124940452|NCT00622700|449409885|FG002|Core Treatment Period|Progressive Disease|0|||
124940453|NCT00622700|449409886|FG003|Core Treatment Period|Progressive Disease|0|||
125121894|NCT03992196|450071533|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
125121895|NCT03992196|450071531|FG000|Treatment|Withdrawal due to non-compliance|0|||
125121896|NCT03992196|450071532|FG001|Treatment|Withdrawal due to non-compliance|0|||
124940454|NCT00622700|449409887|FG004|Core Treatment Period|Progressive Disease|0|||
124940455|NCT00622700|449409888|FG005|Core Treatment Period|Progressive Disease|0|||
124940456|NCT00622700|449409889|FG006|Core Treatment Period|Progressive Disease|0|||
124940457|NCT00622700|449409883|FG000|Core Treatment Period|Withdrawal by Subject|12|||
124940458|NCT00622700|449409884|FG001|Core Treatment Period|Withdrawal by Subject|18|||
124940459|NCT00622700|449409885|FG002|Core Treatment Period|Withdrawal by Subject|15|||
125121897|NCT03992196|450071533|FG002|Treatment|Withdrawal due to non-compliance|1|||
124940460|NCT00622700|449409886|FG003|Core Treatment Period|Withdrawal by Subject|0|||
124940461|NCT00622700|449409887|FG004|Core Treatment Period|Withdrawal by Subject|0|||
124940462|NCT00622700|449409888|FG005|Core Treatment Period|Withdrawal by Subject|0|||
124940463|NCT00622700|449409889|FG006|Core Treatment Period|Withdrawal by Subject|0|||
124940464|NCT00622700|449409883|FG000|Core Treatment Period|Other than specified above|2|||
124940465|NCT00622700|449409884|FG001|Core Treatment Period|Other than specified above|2|||
124940466|NCT00622700|449409885|FG002|Core Treatment Period|Other than specified above|5|||
124940467|NCT00622700|449409886|FG003|Core Treatment Period|Other than specified above|0|||
124940468|NCT00622700|449409887|FG004|Core Treatment Period|Other than specified above|0|||
124940469|NCT00622700|449409888|FG005|Core Treatment Period|Other than specified above|0|||
124940470|NCT00622700|449409889|FG006|Core Treatment Period|Other than specified above|0|||
124940471|NCT00622700|449409883|FG000|Extension Treatment Period|Adverse Event|0|||
124940472|NCT00622700|449409884|FG001|Extension Treatment Period|Adverse Event|0|||
124940473|NCT00622700|449409885|FG002|Extension Treatment Period|Adverse Event|0|||
124940474|NCT00622700|449409886|FG003|Extension Treatment Period|Adverse Event|5|||
124940475|NCT00622700|449409887|FG004|Extension Treatment Period|Adverse Event|9|||
124940476|NCT00622700|449409888|FG005|Extension Treatment Period|Adverse Event|6|||
124940477|NCT00622700|449409889|FG006|Extension Treatment Period|Adverse Event|8|||
124940478|NCT00622700|449409883|FG000|Extension Treatment Period|Lack of Efficacy|0|||
124940479|NCT00622700|449409884|FG001|Extension Treatment Period|Lack of Efficacy|0|||
124940480|NCT00622700|449409885|FG002|Extension Treatment Period|Lack of Efficacy|0|||
124940481|NCT00622700|449409886|FG003|Extension Treatment Period|Lack of Efficacy|2|||
124940482|NCT00622700|449409887|FG004|Extension Treatment Period|Lack of Efficacy|8|||
124940483|NCT00622700|449409888|FG005|Extension Treatment Period|Lack of Efficacy|1|||
124940484|NCT00622700|449409889|FG006|Extension Treatment Period|Lack of Efficacy|9|||
124940485|NCT00622700|449409883|FG000|Extension Treatment Period|Protocol Violation|0|||
124940486|NCT00622700|449409884|FG001|Extension Treatment Period|Protocol Violation|0|||
124940487|NCT00622700|449409885|FG002|Extension Treatment Period|Protocol Violation|0|||
124940488|NCT00622700|449409886|FG003|Extension Treatment Period|Protocol Violation|0|||
125027300|NCT01307033|449725487|FG003|44-week Open-label Extension|Adverse Event|1|||
125213225|NCT00339833|450407286|FG001|Overall Study|Poor venous access|2|||
125213226|NCT00339833|450407285|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
125213227|NCT00339833|450407286|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
125213228|NCT00339833|450407285|FG000|Overall Study|Error in data records|1|||
125213229|NCT00339833|450407286|FG001|Overall Study|Error in data records|0|||
125213230|NCT03077607|450407287|FG000|Period 1 (15 Days)|Adverse Event|1|||
125213231|NCT03077607|450407288|FG001|Period 1 (15 Days)|Adverse Event|0|||
125213232|NCT03077607|450407287|FG000|Period 1 (15 Days)|Death|1|||
125213233|NCT03077607|450407288|FG001|Period 1 (15 Days)|Death|0|||
125213234|NCT03077607|450407287|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
125213235|NCT03077607|450407288|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
125213236|NCT03077607|450407287|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
125213237|NCT03077607|450407288|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
125213238|NCT02476916|450407289|FG000|Core Period|Adverse Event|2|||
125213239|NCT02476916|450407290|FG001|Core Period|Adverse Event|2|||
125213240|NCT02476916|450407289|FG000|Core Period|Investigator decision|1|||
125213241|NCT02476916|450407290|FG001|Core Period|Investigator decision|1|||
125213242|NCT02476916|450407289|FG000|Core Period|Withdrawal by Subject|3|||
125213243|NCT02476916|450407290|FG001|Core Period|Withdrawal by Subject|0|||
125213244|NCT02476916|450407289|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
125213245|NCT02476916|450407290|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
125213246|NCT02476916|450407289|FG000|Extension Period|On Treatment|12|||
125213247|NCT02476916|450407290|FG001|Extension Period|On Treatment|17|||
125213248|NCT06010732|450407291|FG000|Crossover Period 1|Protocol Violation|0|||
125213249|NCT06010732|450407292|FG001|Crossover Period 1|Protocol Violation|0|||
125213250|NCT06010732|450407293|FG002|Crossover Period 1|Protocol Violation|1|||
125213251|NCT06010732|450407294|FG003|Crossover Period 1|Protocol Violation|0|||
125213252|NCT06010732|450407295|FG004|Crossover Period 1|Protocol Violation|1|||
125213253|NCT06010732|450407296|FG005|Crossover Period 1|Protocol Violation|0|||
124940489|NCT00622700|449409887|FG004|Extension Treatment Period|Protocol Violation|0|||
124940490|NCT00622700|449409888|FG005|Extension Treatment Period|Protocol Violation|2|||
124940491|NCT00622700|449409889|FG006|Extension Treatment Period|Protocol Violation|0|||
124940492|NCT00622700|449409883|FG000|Extension Treatment Period|Lost to Follow-up|0|||
125027301|NCT01307033|449725484|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
125213254|NCT06010732|450407291|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
125213255|NCT06010732|450407292|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
125213256|NCT06010732|450407293|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
125213257|NCT06010732|450407294|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
125213258|NCT06010732|450407295|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
124940493|NCT00622700|449409884|FG001|Extension Treatment Period|Lost to Follow-up|0|||
124940494|NCT00622700|449409885|FG002|Extension Treatment Period|Lost to Follow-up|0|||
124940495|NCT00622700|449409886|FG003|Extension Treatment Period|Lost to Follow-up|0|||
124940496|NCT00622700|449409887|FG004|Extension Treatment Period|Lost to Follow-up|1|||
124940497|NCT00622700|449409888|FG005|Extension Treatment Period|Lost to Follow-up|0|||
124940498|NCT00622700|449409889|FG006|Extension Treatment Period|Lost to Follow-up|0|||
124940499|NCT00622700|449409883|FG000|Extension Treatment Period|Progressive Disease|0|||
124940500|NCT00622700|449409884|FG001|Extension Treatment Period|Progressive Disease|0|||
124940501|NCT00622700|449409885|FG002|Extension Treatment Period|Progressive Disease|0|||
124940502|NCT00622700|449409886|FG003|Extension Treatment Period|Progressive Disease|1|||
124940503|NCT00622700|449409887|FG004|Extension Treatment Period|Progressive Disease|2|||
124940504|NCT00622700|449409888|FG005|Extension Treatment Period|Progressive Disease|0|||
124940505|NCT00622700|449409889|FG006|Extension Treatment Period|Progressive Disease|2|||
124940506|NCT00622700|449409883|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
124940507|NCT00622700|449409884|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
124940508|NCT00622700|449409885|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
124940509|NCT00622700|449409886|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
124940510|NCT00622700|449409887|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
124940511|NCT00622700|449409888|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
124940512|NCT00622700|449409889|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
124940513|NCT00622700|449409883|FG000|Extension Treatment Period|Missing|0|||
124940514|NCT00622700|449409884|FG001|Extension Treatment Period|Missing|0|||
124940515|NCT00622700|449409885|FG002|Extension Treatment Period|Missing|0|||
124940516|NCT00622700|449409886|FG003|Extension Treatment Period|Missing|2|||
124940517|NCT00622700|449409887|FG004|Extension Treatment Period|Missing|3|||
124940518|NCT00622700|449409888|FG005|Extension Treatment Period|Missing|1|||
124940519|NCT00622700|449409889|FG006|Extension Treatment Period|Missing|0|||
124940520|NCT00622700|449409883|FG000|Extension Treatment Period|Other than specified above|0|||
124940521|NCT00622700|449409884|FG001|Extension Treatment Period|Other than specified above|0|||
124940522|NCT00622700|449409885|FG002|Extension Treatment Period|Other than specified above|0|||
124940523|NCT00622700|449409886|FG003|Extension Treatment Period|Other than specified above|0|||
124940524|NCT00622700|449409887|FG004|Extension Treatment Period|Other than specified above|0|||
124940525|NCT00622700|449409888|FG005|Extension Treatment Period|Other than specified above|1|||
124940526|NCT00622700|449409889|FG006|Extension Treatment Period|Other than specified above|1|||
124940527|NCT03611556|449409890|FG000|Overall Study|Death|7|||
124940528|NCT03611556|449409891|FG001|Overall Study|Death|7|||
124940529|NCT03611556|449409892|FG002|Overall Study|Death|3|||
124940530|NCT03611556|449409893|FG003|Overall Study|Death|8|||
124940531|NCT03611556|449409894|FG004|Overall Study|Death|47|||
124940532|NCT03611556|449409895|FG005|Overall Study|Death|32|||
124940533|NCT03611556|449409896|FG006|Overall Study|Death|53|||
124940534|NCT03611556|449409890|FG000|Overall Study|Withdrawal by Subject|0|||
124940535|NCT03611556|449409891|FG001|Overall Study|Withdrawal by Subject|0|||
124940536|NCT03611556|449409892|FG002|Overall Study|Withdrawal by Subject|0|||
124940537|NCT03611556|449409893|FG003|Overall Study|Withdrawal by Subject|0|||
124940538|NCT03611556|449409894|FG004|Overall Study|Withdrawal by Subject|4|||
124940539|NCT03611556|449409895|FG005|Overall Study|Withdrawal by Subject|2|||
124940540|NCT03611556|449409896|FG006|Overall Study|Withdrawal by Subject|4|||
124940541|NCT03611556|449409890|FG000|Overall Study|Sponsor decision|0|||
124940542|NCT03611556|449409891|FG001|Overall Study|Sponsor decision|0|||
124940543|NCT03611556|449409892|FG002|Overall Study|Sponsor decision|0|||
124940544|NCT03611556|449409893|FG003|Overall Study|Sponsor decision|0|||
124940545|NCT03611556|449409894|FG004|Overall Study|Sponsor decision|9|||
124940546|NCT03611556|449409895|FG005|Overall Study|Sponsor decision|4|||
124940547|NCT03611556|449409896|FG006|Overall Study|Sponsor decision|12|||
124940548|NCT03611556|449409890|FG000|Overall Study|Reasons|0|||
124940549|NCT03611556|449409891|FG001|Overall Study|Reasons|0|||
124940550|NCT03611556|449409892|FG002|Overall Study|Reasons|0|||
124940551|NCT03611556|449409893|FG003|Overall Study|Reasons|0|||
124940552|NCT03611556|449409894|FG004|Overall Study|Reasons|2|||
124940553|NCT03611556|449409895|FG005|Overall Study|Reasons|0|||
124940554|NCT03611556|449409896|FG006|Overall Study|Reasons|1|||
124940555|NCT02078648|449409906|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
125121898|NCT03992196|450071531|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
124940556|NCT02078648|449409907|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
124940557|NCT02078648|449409906|FG000|Overall Study|Adverse Event|0|||
124940558|NCT02078648|449409907|FG001|Overall Study|Adverse Event|1|||
124940559|NCT02078648|449409906|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
124940560|NCT02078648|449409907|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
124940561|NCT02078648|449409906|FG000|Overall Study|Withdrawal by Subject|3|||
124940562|NCT02078648|449409907|FG001|Overall Study|Withdrawal by Subject|1|||
124940563|NCT02078648|449409906|FG000|Overall Study|Investigator Decision|5|||
124940564|NCT02078648|449409907|FG001|Overall Study|Investigator Decision|7|||
124940565|NCT02078648|449409906|FG000|Overall Study|Death|1|||
124940566|NCT02078648|449409907|FG001|Overall Study|Death|1|||
124940567|NCT02078648|449409906|FG000|Overall Study|Undefined|0|||
124940568|NCT02078648|449409907|FG001|Overall Study|Undefined|1|||
124940569|NCT04088227|449409908|FG000|Overall Study|Withdrawal by Subject|1|||
124940570|NCT04088227|449409909|FG001|Overall Study|Withdrawal by Subject|0|||
124940571|NCT04088227|449409908|FG000|Overall Study|Surgery postponed >5weeks|1|||
124940572|NCT04088227|449409909|FG001|Overall Study|Surgery postponed >5weeks|0|||
124940573|NCT01675492|449409910|FG000|Overall Study|study completed early - product approval|42|||
124940574|NCT03762850|449411772|FG000|Overall Study|Death|0|||
124940575|NCT03762850|449411773|FG001|Overall Study|Death|1|||
124940576|NCT03762850|449411772|FG000|Overall Study|Lost to Follow-up|0|||
124940577|NCT03762850|449411773|FG001|Overall Study|Lost to Follow-up|1|||
124940578|NCT03762850|449411772|FG000|Overall Study|Physician Decision|0|||
124940579|NCT03762850|449411773|FG001|Overall Study|Physician Decision|1|||
124940580|NCT03762850|449411772|FG000|Overall Study|Withdrawal by Subject|4|||
124940581|NCT03762850|449411773|FG001|Overall Study|Withdrawal by Subject|9|||
124940582|NCT03083366|449411774|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
124940583|NCT03083366|449411775|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
124940584|NCT03083366|449411774|FG000|Enrollment Period|Lack of Efficacy|1|||
124940585|NCT03083366|449411775|FG001|Enrollment Period|Lack of Efficacy|0|||
124940586|NCT02036970|449411783|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
124940587|NCT02036970|449411784|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
124940588|NCT02036970|449411785|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
124940589|NCT02036970|449411786|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
124940590|NCT02036970|449411787|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
124940591|NCT02036970|449411788|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
124940592|NCT02036970|449411789|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
124940593|NCT02036970|449411790|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
124940594|NCT02036970|449411791|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
124940595|NCT02036970|449411792|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
124940596|NCT02036970|449411783|FG000|Part 1: Day 1 Through Week 16|Death|0|||
124940597|NCT02036970|449411784|FG001|Part 1: Day 1 Through Week 16|Death|0|||
124940598|NCT02036970|449411785|FG002|Part 1: Day 1 Through Week 16|Death|0|||
124940599|NCT02036970|449411786|FG003|Part 1: Day 1 Through Week 16|Death|0|||
124940600|NCT02036970|449411787|FG004|Part 1: Day 1 Through Week 16|Death|0|||
124940601|NCT02036970|449411788|FG005|Part 1: Day 1 Through Week 16|Death|0|||
124940602|NCT02036970|449411789|FG006|Part 1: Day 1 Through Week 16|Death|0|||
124940603|NCT02036970|449411790|FG007|Part 1: Day 1 Through Week 16|Death|0|||
124940604|NCT02036970|449411791|FG008|Part 1: Day 1 Through Week 16|Death|1|||
125121899|NCT03992196|450071532|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
125121900|NCT03992196|450071533|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
125121901|NCT03992196|450071531|FG000|Treatment|Withdrawal by parent/guardian|0|||
125121902|NCT03992196|450071532|FG001|Treatment|Withdrawal by parent/guardian|0|||
125121903|NCT03992196|450071533|FG002|Treatment|Withdrawal by parent/guardian|2|||
125121904|NCT02684578|450071534|FG000|Overall Study|Withdrawal by Subject|10|||
125121905|NCT02684578|450071535|FG001|Overall Study|Withdrawal by Subject|7|||
125121906|NCT02684578|450071534|FG000|Overall Study|Lost to Follow-up|0|||
125121907|NCT02684578|450071535|FG001|Overall Study|Lost to Follow-up|3|||
125121908|NCT02684578|450071534|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
125121909|NCT02684578|450071535|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
125121910|NCT02684578|450071534|FG000|Overall Study|Missing follow-up data|0|||
125121911|NCT02684578|450071535|FG001|Overall Study|Missing follow-up data|1|||
125121912|NCT01505530|450071536|FG000|Overall Study|Progressive Disease|19|||
125213259|NCT06010732|450407296|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
124940605|NCT02036970|449411792|FG009|Part 1: Day 1 Through Week 16|Death|0|||
125213260|NCT06010732|450407291|FG000|Crossover Period 2|Adverse Event|0|||
124940606|NCT02036970|449411783|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
125121913|NCT01505530|450071537|FG001|Overall Study|Progressive Disease|17|||
125121914|NCT01505530|450071538|FG002|Overall Study|Progressive Disease|18|||
125121915|NCT01505530|450071536|FG000|Overall Study|Adverse Event|1|||
124940607|NCT02036970|449411784|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
124940608|NCT02036970|449411785|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
124940609|NCT02036970|449411786|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
124940610|NCT02036970|449411787|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
124940611|NCT02036970|449411788|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
124940612|NCT02036970|449411789|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
124940613|NCT02036970|449411790|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
124940614|NCT02036970|449411791|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
124940615|NCT02036970|449411792|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
124940616|NCT02036970|449411783|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
124940617|NCT02036970|449411784|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
124940618|NCT02036970|449411785|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
124940619|NCT02036970|449411786|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
124940620|NCT02036970|449411787|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
124940621|NCT02036970|449411788|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
124940622|NCT02036970|449411789|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
124940623|NCT02036970|449411790|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
124940624|NCT02036970|449411791|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
124940625|NCT02036970|449411792|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
124940626|NCT02036970|449411783|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
124940627|NCT02036970|449411784|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
124940628|NCT02036970|449411785|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
124940629|NCT02036970|449411786|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
124940630|NCT02036970|449411787|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
124940631|NCT02036970|449411788|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
124940632|NCT02036970|449411789|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
124940633|NCT02036970|449411790|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
124940634|NCT02036970|449411791|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
124940635|NCT02036970|449411792|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
124940636|NCT02036970|449411783|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
124940637|NCT02036970|449411784|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
124940638|NCT02036970|449411785|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
124940639|NCT02036970|449411786|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
124940640|NCT02036970|449411787|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
124940641|NCT02036970|449411788|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
124940642|NCT02036970|449411789|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
124940643|NCT02036970|449411790|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
124940644|NCT02036970|449411791|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
124940645|NCT02036970|449411792|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
124940646|NCT02036970|449411783|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
124940647|NCT02036970|449411784|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
124940648|NCT02036970|449411785|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
124940649|NCT02036970|449411786|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
124940650|NCT02036970|449411787|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
124940651|NCT02036970|449411788|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
124940652|NCT02036970|449411789|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
124940653|NCT02036970|449411790|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
124940654|NCT02036970|449411791|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
124940655|NCT02036970|449411792|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
124940656|NCT02036970|449411783|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
124940657|NCT02036970|449411784|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
124940658|NCT02036970|449411785|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
125121916|NCT01505530|450071537|FG001|Overall Study|Adverse Event|1|||
125121917|NCT01505530|450071538|FG002|Overall Study|Adverse Event|0|||
125121918|NCT01505530|450071536|FG000|Overall Study|Withdrawal by Subject|7|||
125121919|NCT01505530|450071537|FG001|Overall Study|Withdrawal by Subject|8|||
125121920|NCT01505530|450071538|FG002|Overall Study|Withdrawal by Subject|6|||
125121921|NCT01505530|450071536|FG000|Overall Study|Physician Decision|6|||
124940659|NCT02036970|449411786|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
124940660|NCT02036970|449411787|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
124940661|NCT02036970|449411788|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
125121922|NCT01505530|450071537|FG001|Overall Study|Physician Decision|2|||
124940662|NCT02036970|449411789|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
124940663|NCT02036970|449411790|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
125121923|NCT01505530|450071538|FG002|Overall Study|Physician Decision|5|||
125121924|NCT01505530|450071536|FG000|Overall Study|Sponsor Decision|1|||
125121925|NCT01505530|450071537|FG001|Overall Study|Sponsor Decision|8|||
125121926|NCT01505530|450071538|FG002|Overall Study|Sponsor Decision|7|||
125121927|NCT01505530|450071536|FG000|Overall Study|Death|7|||
125213261|NCT06010732|450407292|FG001|Crossover Period 2|Adverse Event|1|||
124940664|NCT02036970|449411791|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
124940665|NCT02036970|449411792|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
124940666|NCT02036970|449411783|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
124940667|NCT02036970|449411784|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
124940668|NCT02036970|449411785|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
124940669|NCT02036970|449411786|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
124940670|NCT02036970|449411787|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
124940671|NCT02036970|449411788|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
124940672|NCT02036970|449411789|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
124940673|NCT02036970|449411790|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
124940674|NCT02036970|449411791|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
124940675|NCT02036970|449411792|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
124940676|NCT02386098|449411797|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
124940677|NCT02386098|449411798|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
124940678|NCT02386098|449411799|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
124940679|NCT02386098|449411800|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
124940680|NCT02386098|449411801|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
124940681|NCT02386098|449411797|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
124940682|NCT02386098|449411798|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
124940683|NCT02386098|449411799|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
124940684|NCT02386098|449411800|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
124940685|NCT02386098|449411801|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
124940686|NCT02386098|449411797|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
124940687|NCT02386098|449411798|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
124940688|NCT02386098|449411799|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
124940689|NCT02386098|449411800|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
124940690|NCT02386098|449411801|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
124940691|NCT02386098|449411797|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
124940692|NCT02386098|449411798|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
124940693|NCT02386098|449411799|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
124940694|NCT02386098|449411800|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
124940695|NCT02386098|449411801|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
124940696|NCT02386098|449411797|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
124940697|NCT02386098|449411798|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
124940698|NCT02386098|449411799|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
124940699|NCT02386098|449411800|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
125121928|NCT01505530|450071537|FG001|Overall Study|Death|6|||
125121929|NCT01505530|450071538|FG002|Overall Study|Death|5|||
125121930|NCT01505530|450071536|FG000|Overall Study|entry criteria not met|0|||
125121931|NCT01505530|450071537|FG001|Overall Study|entry criteria not met|1|||
125121932|NCT01505530|450071538|FG002|Overall Study|entry criteria not met|0|||
125121933|NCT02492958|450071542|FG000|Overall Study|Withdrawal by Subject|0|||
125121934|NCT02492958|450071543|FG001|Overall Study|Withdrawal by Subject|0|||
125121935|NCT02492958|450071544|FG002|Overall Study|Withdrawal by Subject|1|||
125121936|NCT02492958|450071545|FG003|Overall Study|Withdrawal by Subject|0|||
125121937|NCT02492958|450071542|FG000|Overall Study|Adverse Event|1|||
125121938|NCT02492958|450071543|FG001|Overall Study|Adverse Event|0|||
125121939|NCT02492958|450071544|FG002|Overall Study|Adverse Event|1|||
125121940|NCT02492958|450071545|FG003|Overall Study|Adverse Event|0|||
125121941|NCT01193608|450071546|FG000|Overall Study|Other|0|||
125121942|NCT01193608|450071547|FG001|Overall Study|Other|1|||
125121943|NCT01193608|450071548|FG002|Overall Study|Other|0|||
125121944|NCT01193608|450071549|FG003|Overall Study|Other|0|||
125121945|NCT01193608|450071550|FG004|Overall Study|Other|0|||
125121946|NCT01193608|450071551|FG005|Overall Study|Other|0|||
125121947|NCT01193608|450071546|FG000|Overall Study|Withdrawal by Subject|0|||
125121948|NCT01193608|450071547|FG001|Overall Study|Withdrawal by Subject|1|||
125121949|NCT01193608|450071548|FG002|Overall Study|Withdrawal by Subject|2|||
124940700|NCT02386098|449411801|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
124940701|NCT02386098|449411797|FG000|Stage 1 (96 Weeks)|Other|1|||
125121950|NCT01193608|450071549|FG003|Overall Study|Withdrawal by Subject|3|||
125121951|NCT01193608|450071550|FG004|Overall Study|Withdrawal by Subject|3|||
125121952|NCT01193608|450071551|FG005|Overall Study|Withdrawal by Subject|0|||
125121953|NCT01193608|450071546|FG000|Overall Study|Lost to Follow-up|0|||
124940702|NCT02386098|449411798|FG001|Stage 1 (96 Weeks)|Other|0|||
124940703|NCT02386098|449411799|FG002|Stage 1 (96 Weeks)|Other|0|||
124940704|NCT02386098|449411800|FG003|Stage 1 (96 Weeks)|Other|0|||
124940705|NCT02386098|449411801|FG004|Stage 1 (96 Weeks)|Other|0|||
124940706|NCT02386098|449411797|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
124940707|NCT02386098|449411798|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
124940708|NCT02386098|449411799|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
124940709|NCT02386098|449411800|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
124940710|NCT02386098|449411801|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
124940711|NCT04503681|449411802|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
124940712|NCT04503681|449411803|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
124940713|NCT03352713|449411804|FG000|Overall Study|Lost to Follow-up|8|||
124940714|NCT03352713|449411804|FG000|Overall Study|Withdrawn by investigator|5|||
124940715|NCT03352713|449411804|FG000|Overall Study|Completed 0 EMAs|8|||
124940716|NCT03352713|449411804|FG000|Overall Study|Device incompatible/stolen|5|||
124940717|NCT01812759|449411805|FG000|Overall Study|Physician Decision|0|||
124940718|NCT01812759|449411806|FG001|Overall Study|Physician Decision|0|||
124940719|NCT01812759|449411807|FG002|Overall Study|Physician Decision|1|||
124940720|NCT00360269|449411808|FG000|Overall Study|Lost to Follow-up|7|||
124940721|NCT00360269|449411809|FG001|Overall Study|Lost to Follow-up|9|||
124940722|NCT00360269|449411808|FG000|Overall Study|Physician Decision|1|||
124940723|NCT00360269|449411809|FG001|Overall Study|Physician Decision|2|||
124940724|NCT00360269|449411808|FG000|Overall Study|Adverse Event|1|||
124940725|NCT00360269|449411809|FG001|Overall Study|Adverse Event|0|||
124940726|NCT00360269|449411808|FG000|Overall Study|Withdrawal by Subject|1|||
124940727|NCT00360269|449411809|FG001|Overall Study|Withdrawal by Subject|1|||
124940728|NCT03437733|449411815|FG000|Overall Study|Eligibility criteria not met|0|||
124940729|NCT03437733|449411816|FG001|Overall Study|Eligibility criteria not met|3|||
124940730|NCT00210106|449411817|FG000|Overall Study|Death|1|||
124940731|NCT00210106|449411817|FG000|Overall Study|Protocol Violation|13|||
124940732|NCT05405244|449411825|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
124940733|NCT05405244|449411826|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
124940734|NCT05405244|449411825|FG000|Washout (2 Weeks)|Adverse Event|2|||
124940735|NCT05405244|449411826|FG001|Washout (2 Weeks)|Adverse Event|0|||
124940736|NCT05405244|449411825|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
124940737|NCT05405244|449411826|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
124940738|NCT00739934|449411827|FG000|Voriconazole IV|Adverse Event|6|||
124940739|NCT00739934|449411827|FG000|Voriconazole Oral|Other|3|||
124940740|NCT03418922|449411828|FG000|Overall Study|Withdrawal by Subject|0|||
124940741|NCT03418922|449411829|FG001|Overall Study|Withdrawal by Subject|2|||
124940742|NCT03418922|449411828|FG000|Overall Study|Adverse Event|2|||
124940743|NCT03418922|449411829|FG001|Overall Study|Adverse Event|2|||
124940744|NCT03418922|449411828|FG000|Overall Study|Death|0|||
124940745|NCT03418922|449411829|FG001|Overall Study|Death|1|||
124940746|NCT03418922|449411828|FG000|Overall Study|Physician Decision|0|||
124940747|NCT03418922|449411829|FG001|Overall Study|Physician Decision|1|||
124940748|NCT03451422|449411830|FG000|Overall Study|Lost to Follow-up|0|||
124940749|NCT03451422|449411831|FG001|Overall Study|Lost to Follow-up|0|||
124940750|NCT03451422|449411832|FG002|Overall Study|Lost to Follow-up|0|||
124940751|NCT03451422|449411833|FG003|Overall Study|Lost to Follow-up|0|||
124940752|NCT03451422|449411834|FG004|Overall Study|Lost to Follow-up|0|||
124940753|NCT03451422|449411835|FG005|Overall Study|Lost to Follow-up|1|||
125121954|NCT01193608|450071547|FG001|Overall Study|Lost to Follow-up|0|||
124940754|NCT03451422|449411830|FG000|Overall Study|Decision by sponsor|1|||
124940755|NCT03451422|449411831|FG001|Overall Study|Decision by sponsor|0|||
124940756|NCT03451422|449411832|FG002|Overall Study|Decision by sponsor|1|||
124940757|NCT03451422|449411833|FG003|Overall Study|Decision by sponsor|0|||
124940758|NCT03451422|449411834|FG004|Overall Study|Decision by sponsor|0|||
124940759|NCT03451422|449411835|FG005|Overall Study|Decision by sponsor|0|||
124940760|NCT03451422|449411830|FG000|Overall Study|Withdrawal by Subject|0|||
124940761|NCT03451422|449411831|FG001|Overall Study|Withdrawal by Subject|0|||
125121955|NCT01193608|450071548|FG002|Overall Study|Lost to Follow-up|0|||
124940762|NCT03451422|449411832|FG002|Overall Study|Withdrawal by Subject|2|||
124940763|NCT03451422|449411833|FG003|Overall Study|Withdrawal by Subject|3|||
124940764|NCT03451422|449411834|FG004|Overall Study|Withdrawal by Subject|2|||
124940765|NCT03451422|449411835|FG005|Overall Study|Withdrawal by Subject|1|||
124940766|NCT03355573|449411836|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
124940767|NCT03355573|449411836|FG000|Overall Study|Sponsor's decision|1|||
124940768|NCT03355573|449411836|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
124940769|NCT03355573|449411836|FG000|Overall Study|PI's decision|2|||
124940770|NCT03355573|449411836|FG000|Overall Study|Withdrawal by Subject|23|||
124940771|NCT03355573|449411836|FG000|Overall Study|Lost to Follow-up|4|||
124940772|NCT03355573|449411836|FG000|Overall Study|Lack of Efficacy|2|||
124940773|NCT03355573|449411836|FG000|Overall Study|Adverse Event, non-fatal|17|||
124940774|NCT03355573|449411836|FG000|Overall Study|Adverse Event, serious fatal|2|||
124940775|NCT04191824|449411841|FG000|Overall Study|Death|13|||
124940776|NCT04191824|449411842|FG001|Overall Study|Death|12|||
124940777|NCT04191824|449411841|FG000|Overall Study|Lost to Follow-up|456|||
124940778|NCT04191824|449411842|FG001|Overall Study|Lost to Follow-up|435|||
124940779|NCT04191824|449411841|FG000|Overall Study|Physician Decision|2|||
124940780|NCT04191824|449411842|FG001|Overall Study|Physician Decision|1|||
124940781|NCT04191824|449411841|FG000|Overall Study|Protocol Violation|0|||
124940782|NCT04191824|449411842|FG001|Overall Study|Protocol Violation|2|||
124940783|NCT04191824|449411841|FG000|Overall Study|Withdrawal by Subject|16|||
124940784|NCT04191824|449411842|FG001|Overall Study|Withdrawal by Subject|18|||
124940785|NCT04191824|449411841|FG000|Overall Study|Early site closure|24|||
124940786|NCT04191824|449411842|FG001|Overall Study|Early site closure|22|||
124940787|NCT03631407|449411843|FG000|Overall Study|Withdrawal by Subject|3|||
124940788|NCT03631407|449411844|FG001|Overall Study|Withdrawal by Subject|2|||
124940789|NCT03631407|449411843|FG000|Overall Study|Sponsor Decision|0|||
124940790|NCT03631407|449411844|FG001|Overall Study|Sponsor Decision|2|||
124940791|NCT03631407|449411843|FG000|Overall Study|Death|16|||
124940792|NCT03631407|449411844|FG001|Overall Study|Death|16|||
124940793|NCT03631407|449411843|FG000|Overall Study|Randomized by mistake without study treatment|1|||
124940794|NCT03631407|449411844|FG001|Overall Study|Randomized by mistake without study treatment|0|||
124940795|NCT02646618|449411849|FG000|Overall Study|Lost to Follow-up|10|||
124940796|NCT02646618|449411850|FG001|Overall Study|Lost to Follow-up|14|||
124940797|NCT00390884|449411851|FG000|Overall Study|Withdrawal by Subject|2|||
124940798|NCT00390884|449411852|FG001|Overall Study|Withdrawal by Subject|2|||
124940799|NCT03304587|449411853|FG000|Overall Study|Headache after intervention|0|||
124940800|NCT03304587|449411854|FG001|Overall Study|Headache after intervention|1|||
124940801|NCT03304587|449411853|FG000|Overall Study|Withdrawal by Subject|1|||
124940802|NCT03304587|449411854|FG001|Overall Study|Withdrawal by Subject|0|||
124940803|NCT01458366|449411856|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
124940804|NCT01458366|449411857|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
124940805|NCT01458366|449411858|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
124940806|NCT01458366|449411859|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
124940807|NCT01458366|449411860|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
124940808|NCT01458366|449411856|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
124940809|NCT01458366|449411857|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
124940810|NCT01458366|449411858|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
124940811|NCT01458366|449411859|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
124940812|NCT01458366|449411860|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
124940813|NCT02397096|449411861|FG000|Day 1 to Week 24|Adverse Event|7|||
124940814|NCT02397096|449411862|FG001|Day 1 to Week 24|Adverse Event|1|||
124940815|NCT02397096|449411861|FG000|Day 1 to Week 24|Death|1|||
124940816|NCT02397096|449411862|FG001|Day 1 to Week 24|Death|0|||
124940817|NCT02397096|449411861|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
124940818|NCT02397096|449411862|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
124940819|NCT02397096|449411861|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
124940820|NCT02397096|449411862|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
124940821|NCT02397096|449411861|FG000|Day 1 to Week 24|Physician Decision|2|||
124940822|NCT02397096|449411862|FG001|Day 1 to Week 24|Physician Decision|3|||
124940823|NCT02397096|449411861|FG000|Day 1 to Week 24|Protocol Violation|1|||
124940824|NCT02397096|449411862|FG001|Day 1 to Week 24|Protocol Violation|4|||
124940825|NCT02397096|449411861|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
124940826|NCT02397096|449411862|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
124940827|NCT02397096|449411861|FG000|Day 1 to Week 24|Randomized, not treated|3|||
124940828|NCT02397096|449411862|FG001|Day 1 to Week 24|Randomized, not treated|0|||
124940829|NCT02397096|449411861|FG000|Week 24 to Week 48|Adverse Event|6|||
124940830|NCT02397096|449411862|FG001|Week 24 to Week 48|Adverse Event|2|||
124940831|NCT02397096|449411861|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
124940832|NCT02397096|449411862|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
124940833|NCT02397096|449411861|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
124940834|NCT02397096|449411862|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
124940835|NCT02397096|449411861|FG000|Week 24 to Week 48|Physician Decision|2|||
125027302|NCT01307033|449725485|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
124940836|NCT02397096|449411862|FG001|Week 24 to Week 48|Physician Decision|1|||
124940837|NCT02397096|449411861|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
124940838|NCT02397096|449411862|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
124940839|NCT02397096|449411861|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
124940840|NCT02397096|449411862|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
124940841|NCT02397096|449411861|FG000|Study Extension 1|Adverse Event|7|||
124940842|NCT02397096|449411862|FG001|Study Extension 1|Adverse Event|5|||
124940843|NCT02397096|449411861|FG000|Study Extension 1|Death|1|||
124940844|NCT02397096|449411862|FG001|Study Extension 1|Death|0|||
124940845|NCT02397096|449411861|FG000|Study Extension 1|Lack of Efficacy|2|||
124940846|NCT02397096|449411862|FG001|Study Extension 1|Lack of Efficacy|5|||
124940847|NCT02397096|449411861|FG000|Study Extension 1|Lost to Follow-up|2|||
124940848|NCT02397096|449411862|FG001|Study Extension 1|Lost to Follow-up|3|||
124940849|NCT02397096|449411861|FG000|Study Extension 1|Non-compliance with study drug|3|||
124940850|NCT02397096|449411862|FG001|Study Extension 1|Non-compliance with study drug|0|||
124940851|NCT02397096|449411861|FG000|Study Extension 1|Physician Decision|4|||
124940852|NCT02397096|449411862|FG001|Study Extension 1|Physician Decision|2|||
124940853|NCT02397096|449411861|FG000|Study Extension 1|Pregnancy|1|||
124940854|NCT02397096|449411862|FG001|Study Extension 1|Pregnancy|0|||
124940855|NCT02397096|449411861|FG000|Study Extension 1|Protocol Violation|0|||
124940856|NCT02397096|449411862|FG001|Study Extension 1|Protocol Violation|1|||
124940857|NCT02397096|449411861|FG000|Study Extension 1|Withdrawal by Subject|21|||
124940858|NCT02397096|449411862|FG001|Study Extension 1|Withdrawal by Subject|7|||
124940859|NCT02397096|449411861|FG000|Study Extension 2|Adverse Event|3|||
124940860|NCT02397096|449411862|FG001|Study Extension 2|Adverse Event|3|||
124940861|NCT02397096|449411861|FG000|Study Extension 2|Availability of study medication locally|152|||
124940862|NCT02397096|449411862|FG001|Study Extension 2|Availability of study medication locally|64|||
124940863|NCT02397096|449411861|FG000|Study Extension 2|Death|2|||
124940864|NCT02397096|449411862|FG001|Study Extension 2|Death|0|||
124940865|NCT02397096|449411861|FG000|Study Extension 2|Lack of Efficacy|1|||
124940866|NCT02397096|449411862|FG001|Study Extension 2|Lack of Efficacy|0|||
124940867|NCT02397096|449411861|FG000|Study Extension 2|Lost to Follow-up|2|||
124940868|NCT02397096|449411862|FG001|Study Extension 2|Lost to Follow-up|1|||
124940869|NCT02397096|449411861|FG000|Study Extension 2|Non-compliance with study drug|1|||
125121956|NCT01193608|450071549|FG003|Overall Study|Lost to Follow-up|0|||
125121957|NCT01193608|450071550|FG004|Overall Study|Lost to Follow-up|1|||
125121958|NCT01193608|450071551|FG005|Overall Study|Lost to Follow-up|2|||
125121959|NCT01193608|450071546|FG000|Overall Study|Adverse Event|0|||
125121960|NCT01193608|450071547|FG001|Overall Study|Adverse Event|0|||
125121961|NCT01193608|450071548|FG002|Overall Study|Adverse Event|0|||
125121962|NCT01193608|450071549|FG003|Overall Study|Adverse Event|0|||
125121963|NCT01193608|450071550|FG004|Overall Study|Adverse Event|1|||
125121964|NCT01193608|450071551|FG005|Overall Study|Adverse Event|0|||
125121965|NCT00266409|450071552|FG000|Overall Study|Lack of Efficacy|2|||
125121966|NCT00266409|450071553|FG001|Overall Study|Lack of Efficacy|6|||
125121967|NCT00266409|450071554|FG002|Overall Study|Lack of Efficacy|1|||
125121968|NCT00266409|450071555|FG003|Overall Study|Lack of Efficacy|2|||
125121969|NCT00266409|450071552|FG000|Overall Study|Adverse Event|7|||
125121970|NCT00266409|450071553|FG001|Overall Study|Adverse Event|2|||
125121971|NCT00266409|450071554|FG002|Overall Study|Adverse Event|1|||
125121972|NCT00266409|450071555|FG003|Overall Study|Adverse Event|1|||
125121973|NCT00266409|450071552|FG000|Overall Study|Lost to Follow-up|18|||
125121974|NCT00266409|450071553|FG001|Overall Study|Lost to Follow-up|21|||
124940870|NCT02397096|449411862|FG001|Study Extension 2|Non-compliance with study drug|0|||
124940871|NCT02397096|449411861|FG000|Study Extension 2|Physician Decision|2|||
124940872|NCT02397096|449411862|FG001|Study Extension 2|Physician Decision|5|||
124940873|NCT02397096|449411861|FG000|Study Extension 2|Pregnancy|1|||
124940874|NCT02397096|449411862|FG001|Study Extension 2|Pregnancy|0|||
124940875|NCT02397096|449411861|FG000|Study Extension 2|Withdrawal by Subject|10|||
124940876|NCT02397096|449411862|FG001|Study Extension 2|Withdrawal by Subject|3|||
124940877|NCT02397096|449411861|FG000|Study Extension 3|Adverse Event|1|||
125121975|NCT00266409|450071554|FG002|Overall Study|Lost to Follow-up|6|||
124940878|NCT02397096|449411862|FG001|Study Extension 3|Adverse Event|0|||
124940879|NCT02397096|449411861|FG000|Study Extension 3|Availability of study medication locally|11|||
125121976|NCT00266409|450071555|FG003|Overall Study|Lost to Follow-up|8|||
125121977|NCT00266409|450071552|FG000|Overall Study|Withdrawal by Subject|6|||
125121978|NCT00266409|450071553|FG001|Overall Study|Withdrawal by Subject|10|||
125121979|NCT00266409|450071554|FG002|Overall Study|Withdrawal by Subject|3|||
125121980|NCT00266409|450071555|FG003|Overall Study|Withdrawal by Subject|9|||
124940880|NCT02397096|449411862|FG001|Study Extension 3|Availability of study medication locally|3|||
124940881|NCT02397096|449411861|FG000|Study Extension 3|Lost to Follow-up|1|||
125121981|NCT00266409|450071552|FG000|Overall Study|Protocol Violation|5|||
125121982|NCT00266409|450071553|FG001|Overall Study|Protocol Violation|3|||
125121983|NCT00266409|450071554|FG002|Overall Study|Protocol Violation|4|||
125121984|NCT00266409|450071555|FG003|Overall Study|Protocol Violation|2|||
125121985|NCT00266409|450071552|FG000|Overall Study|Other|7|||
125121986|NCT00266409|450071553|FG001|Overall Study|Other|4|||
124940882|NCT02397096|449411862|FG001|Study Extension 3|Lost to Follow-up|0|||
124940883|NCT02397096|449411861|FG000|Study Extension 3|Withdrawal by Subject|2|||
124940884|NCT02397096|449411862|FG001|Study Extension 3|Withdrawal by Subject|1|||
125121987|NCT00266409|450071554|FG002|Overall Study|Other|2|||
125121988|NCT00266409|450071555|FG003|Overall Study|Other|0|||
125121989|NCT00712010|450071556|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
125121990|NCT00635154|450071557|FG000|Overall Study|Alternative Treatment|8|||
125121991|NCT00635154|450071557|FG000|Overall Study|Other|4|||
125121992|NCT00635154|450071557|FG000|Overall Study|Still on treatment|21|||
125121993|NCT01399736|450071558|FG000|Overall Study|Withdrawal by Subject|4|||
125121994|NCT01399736|450071559|FG001|Overall Study|Withdrawal by Subject|2|||
125121995|NCT01399736|450071558|FG000|Overall Study|Lost to Follow-up|0|||
124940885|NCT05580003|449411863|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940886|NCT05580003|449411864|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940887|NCT05580003|449411865|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940888|NCT05580003|449411866|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940889|NCT05580003|449411867|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940890|NCT05580003|449411868|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940891|NCT05580003|449411869|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
124940892|NCT05580003|449411870|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940893|NCT05580003|449411871|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940894|NCT05580003|449411872|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940895|NCT05580003|449411873|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940896|NCT05580003|449411874|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940897|NCT05580003|449411875|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940898|NCT05580003|449411876|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940899|NCT05580003|449411877|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940900|NCT05580003|449411878|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940901|NCT05580003|449411879|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940902|NCT05580003|449411880|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940903|NCT05580003|449411881|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940904|NCT05580003|449411882|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940905|NCT05580003|449411883|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940906|NCT05580003|449411884|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940907|NCT05580003|449411885|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940908|NCT05580003|449411886|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940909|NCT05580003|449411887|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940910|NCT05580003|449411888|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940911|NCT05580003|449411889|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940912|NCT05580003|449411890|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940913|NCT05580003|449411863|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940914|NCT05580003|449411864|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940915|NCT05580003|449411865|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940916|NCT05580003|449411866|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125121996|NCT01399736|450071559|FG001|Overall Study|Lost to Follow-up|2|||
125121997|NCT03500484|450071560|FG000|Overall Study|Adverse Event|2|||
125121998|NCT03500484|450071561|FG001|Overall Study|Adverse Event|0|||
124940917|NCT05580003|449411867|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940918|NCT05580003|449411868|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
125121999|NCT03500484|450071560|FG000|Overall Study|Physician Decision|1|||
125122000|NCT03500484|450071561|FG001|Overall Study|Physician Decision|0|||
125122001|NCT03500484|450071560|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
125122002|NCT03500484|450071561|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
125122003|NCT02795104|450071562|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
124940919|NCT05580003|449411869|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940920|NCT05580003|449411870|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940921|NCT05580003|449411871|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940922|NCT05580003|449411872|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125122004|NCT02795104|450071563|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
125122005|NCT02795104|450071564|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
125122006|NCT02795104|450071562|FG000|Overall Study|Withdrawal by Subject|0|||
125122007|NCT02795104|450071563|FG001|Overall Study|Withdrawal by Subject|2|||
125122008|NCT02795104|450071564|FG002|Overall Study|Withdrawal by Subject|0|||
125122009|NCT02795104|450071562|FG000|Overall Study|Lost to Follow-up|0|||
124940923|NCT05580003|449411873|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940924|NCT05580003|449411874|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940925|NCT05580003|449411875|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940926|NCT05580003|449411876|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940927|NCT05580003|449411877|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940928|NCT05580003|449411878|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940929|NCT05580003|449411879|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940930|NCT05580003|449411880|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940931|NCT05580003|449411881|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940932|NCT05580003|449411882|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940933|NCT05580003|449411883|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940934|NCT05580003|449411884|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940935|NCT05580003|449411885|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940936|NCT05580003|449411886|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940937|NCT05580003|449411887|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940938|NCT05580003|449411888|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940939|NCT05580003|449411889|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940940|NCT05580003|449411890|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940941|NCT05580003|449411863|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940942|NCT05580003|449411864|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940943|NCT05580003|449411865|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940944|NCT05580003|449411866|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
124940945|NCT05580003|449411867|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940946|NCT05580003|449411868|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940947|NCT05580003|449411869|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940948|NCT05580003|449411870|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940949|NCT05580003|449411871|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940950|NCT05580003|449411872|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940951|NCT05580003|449411873|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940952|NCT05580003|449411874|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940953|NCT05580003|449411875|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940954|NCT05580003|449411876|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940955|NCT05580003|449411877|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940956|NCT05580003|449411878|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940957|NCT05580003|449411879|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940958|NCT05580003|449411880|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940959|NCT05580003|449411881|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940960|NCT05580003|449411882|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940961|NCT05580003|449411883|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940962|NCT05580003|449411884|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940963|NCT05580003|449411885|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940964|NCT05580003|449411886|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940965|NCT05580003|449411887|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940966|NCT05580003|449411888|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940967|NCT05580003|449411889|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940968|NCT05580003|449411890|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940969|NCT05580003|449411863|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940970|NCT05580003|449411864|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
124940971|NCT05580003|449411865|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940972|NCT05580003|449411866|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940973|NCT05580003|449411867|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940974|NCT05580003|449411868|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940975|NCT05580003|449411869|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940976|NCT05580003|449411870|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940977|NCT05580003|449411871|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940978|NCT05580003|449411872|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940979|NCT05580003|449411873|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940980|NCT05580003|449411874|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125122010|NCT02795104|450071563|FG001|Overall Study|Lost to Follow-up|0|||
125122011|NCT02795104|450071564|FG002|Overall Study|Lost to Follow-up|1|||
125122012|NCT01089647|450071568|FG000|Overall Study|Lost to Follow-up|2|||
125122013|NCT01089647|450071569|FG001|Overall Study|Lost to Follow-up|2|||
125122014|NCT01089647|450071568|FG000|Overall Study|Withdrawal by Subject|2|||
125122015|NCT01089647|450071569|FG001|Overall Study|Withdrawal by Subject|1|||
125122016|NCT01089647|450071568|FG000|Overall Study|Adverse Event|0|||
124940981|NCT05580003|449411875|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940982|NCT05580003|449411876|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940983|NCT05580003|449411877|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940984|NCT05580003|449411878|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940985|NCT05580003|449411879|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940986|NCT05580003|449411880|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940987|NCT05580003|449411881|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940988|NCT05580003|449411882|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940989|NCT05580003|449411883|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940990|NCT05580003|449411884|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940991|NCT05580003|449411885|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940992|NCT05580003|449411886|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940993|NCT05580003|449411887|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940994|NCT05580003|449411888|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940995|NCT05580003|449411889|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940996|NCT05580003|449411890|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940997|NCT05580003|449411863|FG000|Part 2 (up to 10 Days)|Other|0|||
124940998|NCT05580003|449411864|FG001|Part 2 (up to 10 Days)|Other|0|||
124940999|NCT05580003|449411865|FG002|Part 2 (up to 10 Days)|Other|0|||
124941000|NCT05580003|449411866|FG003|Part 2 (up to 10 Days)|Other|0|||
124941001|NCT05580003|449411867|FG004|Part 2 (up to 10 Days)|Other|0|||
124941002|NCT05580003|449411868|FG005|Part 2 (up to 10 Days)|Other|0|||
124941003|NCT05580003|449411869|FG006|Part 2 (up to 10 Days)|Other|0|||
124941004|NCT05580003|449411870|FG007|Part 2 (up to 10 Days)|Other|0|||
124941005|NCT05580003|449411871|FG008|Part 2 (up to 10 Days)|Other|0|||
124941006|NCT05580003|449411872|FG009|Part 2 (up to 10 Days)|Other|1|||
124941007|NCT05580003|449411873|FG010|Part 2 (up to 10 Days)|Other|0|||
124941008|NCT05580003|449411874|FG011|Part 2 (up to 10 Days)|Other|0|||
124941009|NCT05580003|449411875|FG012|Part 2 (up to 10 Days)|Other|0|||
124941010|NCT05580003|449411876|FG013|Part 2 (up to 10 Days)|Other|0|||
124941011|NCT05580003|449411877|FG014|Part 2 (up to 10 Days)|Other|0|||
124941012|NCT05580003|449411878|FG015|Part 2 (up to 10 Days)|Other|0|||
124941013|NCT05580003|449411879|FG016|Part 2 (up to 10 Days)|Other|0|||
124941014|NCT05580003|449411880|FG017|Part 2 (up to 10 Days)|Other|0|||
124941015|NCT05580003|449411881|FG018|Part 2 (up to 10 Days)|Other|0|||
124941016|NCT05580003|449411882|FG019|Part 2 (up to 10 Days)|Other|0|||
124941017|NCT05580003|449411883|FG020|Part 2 (up to 10 Days)|Other|0|||
124941018|NCT05580003|449411884|FG021|Part 2 (up to 10 Days)|Other|0|||
124941019|NCT05580003|449411885|FG022|Part 2 (up to 10 Days)|Other|0|||
124941020|NCT05580003|449411886|FG023|Part 2 (up to 10 Days)|Other|0|||
124941021|NCT05580003|449411887|FG024|Part 2 (up to 10 Days)|Other|0|||
124941022|NCT05580003|449411888|FG025|Part 2 (up to 10 Days)|Other|0|||
124941023|NCT05580003|449411889|FG026|Part 2 (up to 10 Days)|Other|0|||
124941024|NCT05580003|449411890|FG027|Part 2 (up to 10 Days)|Other|0|||
124941025|NCT05580003|449411863|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941026|NCT05580003|449411864|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941027|NCT05580003|449411865|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941028|NCT05580003|449411866|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941029|NCT05580003|449411867|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941030|NCT05580003|449411868|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941031|NCT05580003|449411869|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941032|NCT05580003|449411870|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941033|NCT05580003|449411871|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125027303|NCT01307033|449725486|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
125027304|NCT01307033|449725487|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
125027305|NCT01307033|449725484|FG000|44-week Open-label Extension|Physician Decision|0|||
124941034|NCT05580003|449411872|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941035|NCT05580003|449411873|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941036|NCT05580003|449411874|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941037|NCT05580003|449411875|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125027306|NCT01307033|449725485|FG001|44-week Open-label Extension|Physician Decision|0|||
125027307|NCT01307033|449725486|FG002|44-week Open-label Extension|Physician Decision|1|||
125027308|NCT01307033|449725487|FG003|44-week Open-label Extension|Physician Decision|0|||
125027309|NCT01307033|449725484|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
125027310|NCT01307033|449725485|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
125027311|NCT01307033|449725486|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
125027312|NCT01307033|449725487|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
125027313|NCT01307033|449725484|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
125027314|NCT01307033|449725485|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
125122017|NCT01089647|450071569|FG001|Overall Study|Adverse Event|1|||
124941038|NCT05580003|449411876|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941039|NCT05580003|449411877|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941040|NCT05580003|449411878|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125027315|NCT01307033|449725486|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
125213262|NCT06010732|450407293|FG002|Crossover Period 2|Adverse Event|0|||
125213263|NCT06010732|450407294|FG003|Crossover Period 2|Adverse Event|0|||
125213264|NCT06010732|450407295|FG004|Crossover Period 2|Adverse Event|0|||
125213265|NCT06010732|450407296|FG005|Crossover Period 2|Adverse Event|0|||
125213266|NCT06010732|450407291|FG000|Crossover Period 2|broken denture|0|||
125213267|NCT06010732|450407292|FG001|Crossover Period 2|broken denture|0|||
125213268|NCT06010732|450407293|FG002|Crossover Period 2|broken denture|1|||
125213269|NCT06010732|450407294|FG003|Crossover Period 2|broken denture|0|||
125213270|NCT06010732|450407295|FG004|Crossover Period 2|broken denture|0|||
125213271|NCT06010732|450407296|FG005|Crossover Period 2|broken denture|0|||
125213272|NCT04401202|450407297|FG000|Overall Study|Lost to Follow-up|2|||
125213273|NCT04401202|450407298|FG001|Overall Study|Lost to Follow-up|2|||
124941041|NCT05580003|449411879|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941042|NCT05580003|449411880|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941043|NCT05580003|449411881|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941044|NCT05580003|449411882|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
124941045|NCT05580003|449411883|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941046|NCT05580003|449411884|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941047|NCT05580003|449411885|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941048|NCT05580003|449411886|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941049|NCT05580003|449411887|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941050|NCT05580003|449411888|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941051|NCT05580003|449411889|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941052|NCT05580003|449411890|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941053|NCT05580003|449411863|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941054|NCT05580003|449411864|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941055|NCT05580003|449411865|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941056|NCT05580003|449411866|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941057|NCT05580003|449411867|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941058|NCT05580003|449411868|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941059|NCT05580003|449411869|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941060|NCT05580003|449411870|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941061|NCT05580003|449411871|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941062|NCT05580003|449411872|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941063|NCT05580003|449411873|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941064|NCT05580003|449411874|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941065|NCT05580003|449411875|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941066|NCT05580003|449411876|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941067|NCT05580003|449411877|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941068|NCT05580003|449411878|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941069|NCT05580003|449411879|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941070|NCT05580003|449411880|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941071|NCT05580003|449411881|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941072|NCT05580003|449411882|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941073|NCT05580003|449411883|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
124941074|NCT05580003|449411884|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941075|NCT05580003|449411885|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941076|NCT05580003|449411886|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941077|NCT05580003|449411887|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941078|NCT05580003|449411888|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941079|NCT05580003|449411889|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125027316|NCT01307033|449725487|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
125027317|NCT01307033|449725484|FG000|44-week Open-label Extension|Death|0|||
125027318|NCT01307033|449725485|FG001|44-week Open-label Extension|Death|0|||
125027319|NCT01307033|449725486|FG002|44-week Open-label Extension|Death|0|||
125027320|NCT01307033|449725487|FG003|44-week Open-label Extension|Death|1|||
125027321|NCT01231555|449725488|FG000|Overall Study|Study terminated|8|||
125027322|NCT01231555|449725489|FG001|Overall Study|Study terminated|5|||
125027323|NCT01231555|449725490|FG002|Overall Study|Study terminated|8|||
125027324|NCT01231555|449725488|FG000|Overall Study|Withdrawal by Subject|0|||
125027325|NCT01231555|449725489|FG001|Overall Study|Withdrawal by Subject|2|||
125027326|NCT01231555|449725490|FG002|Overall Study|Withdrawal by Subject|0|||
125027327|NCT00947531|449725491|FG000|Overall Study|Withdrawal by Subject|10|||
125027328|NCT00947531|449725492|FG001|Overall Study|Withdrawal by Subject|7|||
125027329|NCT00947531|449725491|FG000|Overall Study|Administrative Reason|0|||
125213274|NCT04401202|450407297|FG000|Overall Study|Adverse Event|0|||
125213275|NCT04401202|450407298|FG001|Overall Study|Adverse Event|1|||
125213276|NCT04401202|450407297|FG000|Overall Study|Hospitalized|4|||
125213277|NCT04401202|450407298|FG001|Overall Study|Hospitalized|1|||
125213278|NCT03004924|450407302|FG000|Overall Study|Adverse Event|6|||
124941080|NCT05580003|449411890|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941081|NCT05580003|449411863|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941082|NCT05580003|449411864|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941083|NCT05580003|449411865|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941084|NCT05580003|449411866|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941085|NCT05580003|449411867|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941086|NCT05580003|449411868|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941087|NCT05580003|449411869|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941088|NCT05580003|449411870|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941089|NCT05580003|449411871|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941090|NCT05580003|449411872|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941091|NCT05580003|449411873|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941092|NCT05580003|449411874|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941093|NCT05580003|449411875|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941094|NCT05580003|449411876|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941095|NCT05580003|449411877|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941096|NCT05580003|449411878|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941097|NCT05580003|449411879|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941098|NCT05580003|449411880|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941099|NCT05580003|449411881|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941100|NCT05580003|449411882|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941101|NCT05580003|449411883|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941102|NCT05580003|449411884|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
124941103|NCT05580003|449411885|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941104|NCT05580003|449411886|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941105|NCT05580003|449411887|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941106|NCT05580003|449411888|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941107|NCT05580003|449411889|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125213279|NCT03004924|450407303|FG001|Overall Study|Adverse Event|5|||
124941108|NCT05580003|449411890|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941109|NCT05580003|449411863|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941110|NCT05580003|449411864|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941111|NCT05580003|449411865|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941112|NCT05580003|449411866|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941113|NCT05580003|449411867|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941114|NCT05580003|449411868|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941115|NCT05580003|449411869|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941116|NCT05580003|449411870|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941117|NCT05580003|449411871|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941118|NCT05580003|449411872|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941119|NCT05580003|449411873|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941120|NCT05580003|449411874|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941121|NCT05580003|449411875|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941122|NCT05580003|449411876|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941123|NCT05580003|449411877|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941124|NCT05580003|449411878|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941125|NCT05580003|449411879|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941126|NCT05580003|449411880|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941127|NCT05580003|449411881|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941128|NCT05580003|449411882|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941129|NCT05580003|449411883|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941130|NCT05580003|449411884|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125213280|NCT03004924|450407304|FG002|Overall Study|Adverse Event|10|||
125213281|NCT03004924|450407302|FG000|Overall Study|Protocol Violation|4|||
125213282|NCT03004924|450407303|FG001|Overall Study|Protocol Violation|0|||
125213283|NCT03004924|450407304|FG002|Overall Study|Protocol Violation|1|||
125213284|NCT03004924|450407302|FG000|Overall Study|Withdrawal by Subject|5|||
124941131|NCT05580003|449411885|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941132|NCT05580003|449411886|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941133|NCT05580003|449411887|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941134|NCT05580003|449411888|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941135|NCT05580003|449411889|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125213285|NCT03004924|450407303|FG001|Overall Study|Withdrawal by Subject|3|||
125213286|NCT03004924|450407304|FG002|Overall Study|Withdrawal by Subject|5|||
124941136|NCT05580003|449411890|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
124941137|NCT05580003|449411863|FG000|Part 6 Period 2 (Day 1)|Other|0|||
124941138|NCT05580003|449411864|FG001|Part 6 Period 2 (Day 1)|Other|0|||
125213287|NCT03004924|450407302|FG000|Overall Study|Lost to Follow-up|6|||
124941139|NCT05580003|449411865|FG002|Part 6 Period 2 (Day 1)|Other|0|||
124941140|NCT05580003|449411866|FG003|Part 6 Period 2 (Day 1)|Other|0|||
124941141|NCT05580003|449411867|FG004|Part 6 Period 2 (Day 1)|Other|0|||
124941142|NCT05580003|449411868|FG005|Part 6 Period 2 (Day 1)|Other|0|||
124941143|NCT05580003|449411869|FG006|Part 6 Period 2 (Day 1)|Other|0|||
124941144|NCT05580003|449411870|FG007|Part 6 Period 2 (Day 1)|Other|0|||
124941145|NCT05580003|449411871|FG008|Part 6 Period 2 (Day 1)|Other|0|||
124941146|NCT05580003|449411872|FG009|Part 6 Period 2 (Day 1)|Other|0|||
124941147|NCT05580003|449411873|FG010|Part 6 Period 2 (Day 1)|Other|0|||
124941148|NCT05580003|449411874|FG011|Part 6 Period 2 (Day 1)|Other|0|||
124941149|NCT05580003|449411875|FG012|Part 6 Period 2 (Day 1)|Other|0|||
124941150|NCT05580003|449411876|FG013|Part 6 Period 2 (Day 1)|Other|0|||
124941151|NCT05580003|449411877|FG014|Part 6 Period 2 (Day 1)|Other|0|||
124941152|NCT05580003|449411878|FG015|Part 6 Period 2 (Day 1)|Other|0|||
124941153|NCT05580003|449411879|FG016|Part 6 Period 2 (Day 1)|Other|0|||
124941154|NCT05580003|449411880|FG017|Part 6 Period 2 (Day 1)|Other|0|||
124941155|NCT05580003|449411881|FG018|Part 6 Period 2 (Day 1)|Other|0|||
124941156|NCT05580003|449411882|FG019|Part 6 Period 2 (Day 1)|Other|0|||
124941157|NCT05580003|449411883|FG020|Part 6 Period 2 (Day 1)|Other|0|||
124941158|NCT05580003|449411884|FG021|Part 6 Period 2 (Day 1)|Other|0|||
124941159|NCT05580003|449411885|FG022|Part 6 Period 2 (Day 1)|Other|0|||
124941160|NCT05580003|449411886|FG023|Part 6 Period 2 (Day 1)|Other|0|||
124941161|NCT05580003|449411887|FG024|Part 6 Period 2 (Day 1)|Other|1|||
124941162|NCT05580003|449411888|FG025|Part 6 Period 2 (Day 1)|Other|0|||
124941163|NCT05580003|449411889|FG026|Part 6 Period 2 (Day 1)|Other|0|||
124941164|NCT05580003|449411890|FG027|Part 6 Period 2 (Day 1)|Other|0|||
124941165|NCT04795167|449411891|FG000|Overall Study|Death|1|||
124941166|NCT04795167|449411892|FG001|Overall Study|Death|18|||
124941167|NCT04795167|449411893|FG002|Overall Study|Death|1|||
124941168|NCT04795167|449411891|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
124941169|NCT04795167|449411892|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
124941170|NCT04795167|449411893|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
124941171|NCT02052440|449411894|FG000|Overall Study|Withdrawal by Subject|0|||
124941172|NCT02052440|449411895|FG001|Overall Study|Withdrawal by Subject|1|||
124941173|NCT03333109|449411898|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
124941174|NCT03333109|449411899|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
124941175|NCT03333109|449411900|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
124941176|NCT03333109|449411898|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
124941177|NCT03333109|449411899|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
124941178|NCT03333109|449411900|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
124941179|NCT03333109|449411898|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
125213288|NCT03004924|450407303|FG001|Overall Study|Lost to Follow-up|1|||
125213289|NCT03004924|450407304|FG002|Overall Study|Lost to Follow-up|4|||
124941180|NCT03333109|449411899|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
124941181|NCT03333109|449411900|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
124941182|NCT03333109|449411898|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
124941183|NCT03333109|449411899|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
124941184|NCT03333109|449411900|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
124941185|NCT03333109|449411898|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
124941186|NCT03333109|449411899|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
124941187|NCT03333109|449411900|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
125027330|NCT00947531|449725492|FG001|Overall Study|Administrative Reason|1|||
125027331|NCT00947531|449725491|FG000|Overall Study|Adverse Event|2|||
125027332|NCT00947531|449725492|FG001|Overall Study|Adverse Event|2|||
125027333|NCT00947531|449725491|FG000|Overall Study|Lack of Efficacy|1|||
125027334|NCT00947531|449725492|FG001|Overall Study|Lack of Efficacy|0|||
125027335|NCT00947531|449725491|FG000|Overall Study|Other|1|||
125027336|NCT00947531|449725492|FG001|Overall Study|Other|1|||
125027337|NCT01773421|449725494|FG000|Treatment Phase|Other|0|||
125027338|NCT01773421|449725495|FG001|Treatment Phase|Other|0|||
125027339|NCT01773421|449725496|FG002|Treatment Phase|Other|2|||
125027340|NCT01773421|449725497|FG003|Treatment Phase|Other|0|||
125027341|NCT01773421|449725498|FG004|Treatment Phase|Other|0|||
125027342|NCT01773421|449725499|FG005|Treatment Phase|Other|0|||
125027343|NCT01773421|449725500|FG006|Treatment Phase|Other|0|||
125027344|NCT01773421|449725494|FG000|Treatment Phase|Adverse Event|0|||
125027345|NCT01773421|449725495|FG001|Treatment Phase|Adverse Event|0|||
125027346|NCT01773421|449725496|FG002|Treatment Phase|Adverse Event|3|||
125027347|NCT01773421|449725497|FG003|Treatment Phase|Adverse Event|1|||
125027348|NCT01773421|449725498|FG004|Treatment Phase|Adverse Event|0|||
125027349|NCT01773421|449725499|FG005|Treatment Phase|Adverse Event|0|||
125027350|NCT01773421|449725500|FG006|Treatment Phase|Adverse Event|0|||
125027351|NCT01773421|449725494|FG000|Treatment Phase|Withdrawal by Subject|0|||
125027352|NCT01773421|449725495|FG001|Treatment Phase|Withdrawal by Subject|0|||
125027353|NCT01773421|449725496|FG002|Treatment Phase|Withdrawal by Subject|1|||
125027354|NCT01773421|449725497|FG003|Treatment Phase|Withdrawal by Subject|1|||
125027355|NCT01773421|449725498|FG004|Treatment Phase|Withdrawal by Subject|0|||
125027356|NCT01773421|449725499|FG005|Treatment Phase|Withdrawal by Subject|0|||
125027357|NCT01773421|449725500|FG006|Treatment Phase|Withdrawal by Subject|0|||
125027358|NCT01773421|449725494|FG000|Extension Phase|Other|0|||
125027359|NCT01773421|449725495|FG001|Extension Phase|Other|0|||
125027360|NCT01773421|449725496|FG002|Extension Phase|Other|0|||
125027361|NCT01773421|449725497|FG003|Extension Phase|Other|0|||
125027362|NCT01773421|449725498|FG004|Extension Phase|Other|1|||
125027363|NCT01773421|449725499|FG005|Extension Phase|Other|2|||
125027364|NCT01773421|449725500|FG006|Extension Phase|Other|0|||
125027365|NCT01773421|449725494|FG000|Extension Phase|Adverse Event|0|||
125027366|NCT01773421|449725495|FG001|Extension Phase|Adverse Event|0|||
125122018|NCT00995553|450071570|FG000|Overall Study|Withdrawal by Subject|2|||
125122019|NCT00995553|450071571|FG001|Overall Study|Withdrawal by Subject|6|||
125122020|NCT00927810|450071572|FG000|Overall Study|Withdrawal by Subject|0|||
125122021|NCT00927810|450071573|FG001|Overall Study|Withdrawal by Subject|3|||
125122022|NCT00927810|450071574|FG002|Overall Study|Withdrawal by Subject|0|||
125122023|NCT00927810|450071575|FG003|Overall Study|Withdrawal by Subject|1|||
125122024|NCT00927810|450071572|FG000|Overall Study|Lost to Follow-up|0|||
125122025|NCT00927810|450071573|FG001|Overall Study|Lost to Follow-up|2|||
125122026|NCT00927810|450071574|FG002|Overall Study|Lost to Follow-up|1|||
125122027|NCT00927810|450071575|FG003|Overall Study|Lost to Follow-up|1|||
125122028|NCT00927810|450071572|FG000|Overall Study|Death|0|||
125122029|NCT00927810|450071573|FG001|Overall Study|Death|2|||
125122030|NCT00927810|450071574|FG002|Overall Study|Death|0|||
125122031|NCT00927810|450071575|FG003|Overall Study|Death|0|||
125122032|NCT00927810|450071572|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125122033|NCT00927810|450071573|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125122034|NCT00927810|450071574|FG002|Overall Study|Abnormal laboratory value(s)|0|||
125122035|NCT00927810|450071575|FG003|Overall Study|Abnormal laboratory value(s)|0|||
125122036|NCT00198029|450071581|FG000|Overall Study|Withdrawal by Subject|4|||
125122037|NCT01626079|450071584|FG000|Overall Study|Death|167|||
125122038|NCT01626079|450071585|FG001|Overall Study|Death|192|||
125122039|NCT01626079|450071586|FG002|Overall Study|Death|39|||
125122040|NCT01626079|450071584|FG000|Overall Study|Withdrawal by Subject|23|||
125122041|NCT01626079|450071585|FG001|Overall Study|Withdrawal by Subject|37|||
125122042|NCT01626079|450071586|FG002|Overall Study|Withdrawal by Subject|5|||
125122043|NCT01626079|450071584|FG000|Overall Study|Lost to Follow-up|7|||
125122044|NCT01626079|450071585|FG001|Overall Study|Lost to Follow-up|4|||
125122045|NCT01626079|450071586|FG002|Overall Study|Lost to Follow-up|2|||
125122046|NCT01626079|450071584|FG000|Overall Study|Missed Visits|1|||
125122047|NCT01626079|450071585|FG001|Overall Study|Missed Visits|4|||
125122048|NCT01626079|450071586|FG002|Overall Study|Missed Visits|6|||
125122049|NCT01457053|450071588|FG000|Overall Study|Unable to undergo selected treatment|1|||
125122050|NCT01457053|450071589|FG001|Overall Study|Unable to undergo selected treatment|1|||
125122051|NCT00814463|450071590|FG000|Overall Study|Lost to Follow-up|1|||
125122052|NCT03982433|450071591|FG000|Overall Study|Lost to Follow-up|1|||
125122053|NCT00368277|450071592|FG000|Overall Study|Adverse Event|33|||
125122054|NCT00368277|450071593|FG001|Overall Study|Adverse Event|49|||
125122055|NCT00368277|450071592|FG000|Overall Study|Death|2|||
125122056|NCT00368277|450071593|FG001|Overall Study|Death|1|||
125122057|NCT00368277|450071592|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
125122058|NCT00368277|450071593|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
125122059|NCT00368277|450071592|FG000|Overall Study|Protocol deviation|7|||
125122060|NCT00368277|450071593|FG001|Overall Study|Protocol deviation|0|||
125122061|NCT00368277|450071592|FG000|Overall Study|Patient withdrew consent|32|||
125122062|NCT00368277|450071593|FG001|Overall Study|Patient withdrew consent|28|||
125122063|NCT00368277|450071592|FG000|Overall Study|Lost to Follow-up|8|||
125122064|NCT00368277|450071593|FG001|Overall Study|Lost to Follow-up|6|||
125122065|NCT00984295|450071594|FG000|Overall Study|Lost to Follow-up|31|||
125122066|NCT00984295|450071595|FG001|Overall Study|Lost to Follow-up|12|||
125122067|NCT00984295|450071596|FG002|Overall Study|Lost to Follow-up|13|||
125027367|NCT01773421|449725496|FG002|Extension Phase|Adverse Event|0|||
125122068|NCT00984295|450071594|FG000|Overall Study|Protocol Violation|2|||
125122069|NCT00984295|450071595|FG001|Overall Study|Protocol Violation|1|||
125122070|NCT00984295|450071596|FG002|Overall Study|Protocol Violation|4|||
125122071|NCT00984295|450071594|FG000|Overall Study|Withdrawal by Subject|18|||
125122072|NCT00984295|450071595|FG001|Overall Study|Withdrawal by Subject|9|||
125122073|NCT00984295|450071596|FG002|Overall Study|Withdrawal by Subject|12|||
125122074|NCT00984295|450071594|FG000|Overall Study|CAE - discontinued test vaccine|0|||
125122075|NCT00984295|450071595|FG001|Overall Study|CAE - discontinued test vaccine|1|||
125027368|NCT01773421|449725497|FG003|Extension Phase|Adverse Event|0|||
125027369|NCT01773421|449725498|FG004|Extension Phase|Adverse Event|2|||
125027370|NCT01773421|449725499|FG005|Extension Phase|Adverse Event|0|||
125027371|NCT01773421|449725500|FG006|Extension Phase|Adverse Event|0|||
125027372|NCT02804763|449725501|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
125122076|NCT00984295|450071596|FG002|Overall Study|CAE - discontinued test vaccine|3|||
124941188|NCT03333109|449411898|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
124941189|NCT03333109|449411899|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
124941190|NCT03333109|449411900|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
124941191|NCT03333109|449411898|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
124941192|NCT03333109|449411899|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
124941193|NCT03333109|449411900|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
124941194|NCT03333109|449411898|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
124941195|NCT03333109|449411899|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
124941196|NCT03333109|449411900|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
124941197|NCT00918203|449411904|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
124941198|NCT00918203|449411905|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
124941199|NCT00918203|449411906|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
124941200|NCT00918203|449411904|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
124941201|NCT00918203|449411905|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
124941202|NCT00918203|449411906|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
124941203|NCT00918203|449411904|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
124941204|NCT00918203|449411905|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
124941205|NCT00918203|449411906|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
124941206|NCT00918203|449411904|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
124941207|NCT00918203|449411905|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
124941208|NCT00918203|449411906|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
124941209|NCT00589875|449411909|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
124941210|NCT00589875|449411909|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
124941211|NCT03488719|449411912|FG000|Overall Study|Adverse Event|0|||
124941212|NCT03488719|449411913|FG001|Overall Study|Adverse Event|4|||
124941213|NCT03488719|449411914|FG002|Overall Study|Adverse Event|2|||
124941214|NCT03488719|449411912|FG000|Overall Study|Other|0|||
124941215|NCT03488719|449411913|FG001|Overall Study|Other|0|||
124941216|NCT03488719|449411914|FG002|Overall Study|Other|5|||
124941217|NCT05025384|449411915|FG000|Overall Study|Physician Decision|5|||
124941218|NCT05025384|449411916|FG001|Overall Study|Physician Decision|6|||
124941219|NCT03610581|449411917|FG000|Overall Study|Study terminated by sponsor|2|||
124941220|NCT03610581|449411918|FG001|Overall Study|Study terminated by sponsor|0|||
124941221|NCT03610581|449411917|FG000|Overall Study|Other|0|||
124941222|NCT03610581|449411918|FG001|Overall Study|Other|1|||
124941223|NCT03610581|449411917|FG000|Overall Study|Withdrawal by Subject|1|||
124941224|NCT03610581|449411918|FG001|Overall Study|Withdrawal by Subject|0|||
124941225|NCT05485805|449411927|FG000|Overall Study|Withdrawal by Subject|1|||
124941226|NCT05485805|449411928|FG001|Overall Study|Withdrawal by Subject|2|||
124941227|NCT05485805|449411929|FG002|Overall Study|Withdrawal by Subject|2|||
124941228|NCT05485805|449411930|FG003|Overall Study|Withdrawal by Subject|0|||
124941229|NCT05485805|449411931|FG004|Overall Study|Withdrawal by Subject|2|||
124941230|NCT05485805|449411927|FG000|Overall Study|Adverse Event|0|||
124941231|NCT05485805|449411928|FG001|Overall Study|Adverse Event|1|||
124941232|NCT05485805|449411929|FG002|Overall Study|Adverse Event|0|||
124941233|NCT05485805|449411930|FG003|Overall Study|Adverse Event|0|||
124941234|NCT05485805|449411931|FG004|Overall Study|Adverse Event|0|||
124941235|NCT05485805|449411927|FG000|Overall Study|Lost to Follow-up|1|||
124941236|NCT05485805|449411928|FG001|Overall Study|Lost to Follow-up|1|||
124941237|NCT05485805|449411929|FG002|Overall Study|Lost to Follow-up|3|||
124941238|NCT05485805|449411930|FG003|Overall Study|Lost to Follow-up|1|||
124941239|NCT05485805|449411931|FG004|Overall Study|Lost to Follow-up|0|||
124941240|NCT04218357|449411933|FG000|1st Allocation|Withdrawal by Subject|1|||
124941241|NCT04218357|449411934|FG001|1st Allocation|Withdrawal by Subject|0|||
124941242|NCT05349838|449411935|FG000|Overall Study|Virological Failure|1|||
125122077|NCT00984295|450071594|FG000|Overall Study|Missed one or more blood samplings|3|||
125122078|NCT00984295|450071595|FG001|Overall Study|Missed one or more blood samplings|7|||
125122079|NCT00984295|450071596|FG002|Overall Study|Missed one or more blood samplings|2|||
125122080|NCT00984295|450071594|FG000|Overall Study|Incomplete safety follow-up|11|||
124941243|NCT05349838|449411936|FG001|Overall Study|Virological Failure|2|||
124941244|NCT05349838|449411935|FG000|Overall Study|Withdrawal by Subject|2|||
124941245|NCT05349838|449411936|FG001|Overall Study|Withdrawal by Subject|3|||
124941246|NCT05349838|449411935|FG000|Overall Study|Adverse Event|3|||
124941247|NCT05349838|449411936|FG001|Overall Study|Adverse Event|1|||
124941248|NCT05349838|449411935|FG000|Overall Study|Lost to Follow-up|1|||
124941249|NCT05349838|449411936|FG001|Overall Study|Lost to Follow-up|2|||
124941250|NCT05349838|449411935|FG000|Overall Study|Other reasons|5|||
124941251|NCT05349838|449411936|FG001|Overall Study|Other reasons|1|||
124941252|NCT02488408|449411938|FG000|Part A|Adverse Event|2|||
124941253|NCT02488408|449411939|FG001|Part A|Adverse Event|0|||
124941254|NCT02488408|449411940|FG002|Part A|Adverse Event|0|||
124941255|NCT02488408|449411941|FG003|Part A|Adverse Event|0|||
125122081|NCT00984295|450071595|FG001|Overall Study|Incomplete safety follow-up|2|||
125122082|NCT00984295|450071596|FG002|Overall Study|Incomplete safety follow-up|3|||
124941256|NCT02488408|449411942|FG004|Part A|Adverse Event|0|||
125122083|NCT04799158|450071597|FG000|Run-In Period|Adverse Event|6|||
125122084|NCT04799158|450071598|FG001|Run-In Period|Adverse Event|0|||
125122085|NCT04799158|450071599|FG002|Run-In Period|Adverse Event|0|||
125122086|NCT04799158|450071600|FG003|Run-In Period|Adverse Event|0|||
125122087|NCT04799158|450071601|FG004|Run-In Period|Adverse Event|0|||
124941257|NCT02488408|449411943|FG005|Part A|Adverse Event|0|||
124941258|NCT02488408|449411944|FG006|Part A|Adverse Event|0|||
124941259|NCT02488408|449411945|FG007|Part A|Adverse Event|0|||
124941260|NCT02488408|449411946|FG008|Part A|Adverse Event|0|||
124941261|NCT02488408|449411947|FG009|Part A|Adverse Event|0|||
124941262|NCT02488408|449411938|FG000|Part A|Death|1|||
124941263|NCT02488408|449411939|FG001|Part A|Death|5|||
124941264|NCT02488408|449411940|FG002|Part A|Death|0|||
124941265|NCT02488408|449411941|FG003|Part A|Death|0|||
124941266|NCT02488408|449411942|FG004|Part A|Death|3|||
124941267|NCT02488408|449411943|FG005|Part A|Death|0|||
124941268|NCT02488408|449411944|FG006|Part A|Death|0|||
124941269|NCT02488408|449411945|FG007|Part A|Death|0|||
124941270|NCT02488408|449411946|FG008|Part A|Death|0|||
124941271|NCT02488408|449411947|FG009|Part A|Death|0|||
124941272|NCT02488408|449411938|FG000|Part A|Disease Progression|2|||
124941273|NCT02488408|449411939|FG001|Part A|Disease Progression|8|||
124941274|NCT02488408|449411940|FG002|Part A|Disease Progression|2|||
125122088|NCT04799158|450071597|FG000|Run-In Period|Lost to Follow-up|4|||
125122089|NCT04799158|450071598|FG001|Run-In Period|Lost to Follow-up|0|||
125122090|NCT04799158|450071599|FG002|Run-In Period|Lost to Follow-up|0|||
125122091|NCT04799158|450071600|FG003|Run-In Period|Lost to Follow-up|0|||
125122092|NCT04799158|450071601|FG004|Run-In Period|Lost to Follow-up|0|||
124941275|NCT02488408|449411941|FG003|Part A|Disease Progression|3|||
124941276|NCT02488408|449411942|FG004|Part A|Disease Progression|4|||
124941277|NCT02488408|449411943|FG005|Part A|Disease Progression|0|||
125122093|NCT04799158|450071597|FG000|Run-In Period|Significant Protocol Deviation|1|||
125122094|NCT04799158|450071598|FG001|Run-In Period|Significant Protocol Deviation|0|||
125122095|NCT04799158|450071599|FG002|Run-In Period|Significant Protocol Deviation|0|||
124941278|NCT02488408|449411944|FG006|Part A|Disease Progression|0|||
124941279|NCT02488408|449411945|FG007|Part A|Disease Progression|0|||
124941280|NCT02488408|449411946|FG008|Part A|Disease Progression|0|||
125213290|NCT03004924|450407302|FG000|Overall Study|Lack of Efficacy|2|||
124941281|NCT02488408|449411947|FG009|Part A|Disease Progression|0|||
124941282|NCT02488408|449411938|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
124941283|NCT02488408|449411939|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
124941284|NCT02488408|449411940|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
124941285|NCT02488408|449411941|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
124941286|NCT02488408|449411942|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
124941287|NCT02488408|449411943|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
124941288|NCT02488408|449411944|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
124941289|NCT02488408|449411945|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
124941290|NCT02488408|449411946|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
124941291|NCT02488408|449411947|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
124941292|NCT02488408|449411938|FG000|Part A|Investigator Decision|0|||
124941293|NCT02488408|449411939|FG001|Part A|Investigator Decision|1|||
125122096|NCT04799158|450071600|FG003|Run-In Period|Significant Protocol Deviation|0|||
125122097|NCT04799158|450071601|FG004|Run-In Period|Significant Protocol Deviation|0|||
125122098|NCT04799158|450071597|FG000|Run-In Period|Withdrawal by Subject|11|||
125122099|NCT04799158|450071598|FG001|Run-In Period|Withdrawal by Subject|0|||
125122100|NCT04799158|450071599|FG002|Run-In Period|Withdrawal by Subject|0|||
125122101|NCT04799158|450071600|FG003|Run-In Period|Withdrawal by Subject|0|||
125122102|NCT04799158|450071601|FG004|Run-In Period|Withdrawal by Subject|0|||
125122103|NCT04799158|450071597|FG000|Run-In Period|Miscellaneous|3|||
125122104|NCT04799158|450071598|FG001|Run-In Period|Miscellaneous|0|||
125122105|NCT04799158|450071599|FG002|Run-In Period|Miscellaneous|0|||
125122106|NCT04799158|450071600|FG003|Run-In Period|Miscellaneous|0|||
125122107|NCT04799158|450071601|FG004|Run-In Period|Miscellaneous|0|||
125122108|NCT04799158|450071597|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
125122109|NCT04799158|450071598|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
125122110|NCT04799158|450071599|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
125122111|NCT04799158|450071600|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
125122112|NCT04799158|450071601|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
125122113|NCT04799158|450071597|FG000|On-Demand Treatment Period|Adverse Event|0|||
125122114|NCT04799158|450071598|FG001|On-Demand Treatment Period|Adverse Event|1|||
125122115|NCT04799158|450071599|FG002|On-Demand Treatment Period|Adverse Event|0|||
125122116|NCT04799158|450071600|FG003|On-Demand Treatment Period|Adverse Event|0|||
125122117|NCT04799158|450071601|FG004|On-Demand Treatment Period|Adverse Event|1|||
125122118|NCT04799158|450071597|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
124941294|NCT02488408|449411940|FG002|Part A|Investigator Decision|1|||
124941295|NCT02488408|449411941|FG003|Part A|Investigator Decision|0|||
124941296|NCT02488408|449411942|FG004|Part A|Investigator Decision|0|||
124941297|NCT02488408|449411943|FG005|Part A|Investigator Decision|0|||
125122119|NCT04799158|450071598|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
125122120|NCT04799158|450071599|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
125122121|NCT04799158|450071600|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
125122122|NCT04799158|450071601|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
125122123|NCT04799158|450071597|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
125122124|NCT04799158|450071598|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
125122125|NCT04799158|450071599|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
125122126|NCT04799158|450071600|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
125122127|NCT04799158|450071601|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
125122128|NCT04799158|450071597|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
125122129|NCT04799158|450071598|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
125122130|NCT04799158|450071599|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
125122131|NCT04799158|450071600|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
125122132|NCT04799158|450071601|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
125122133|NCT04799158|450071597|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
125122134|NCT04799158|450071598|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
125122135|NCT04799158|450071599|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
125122136|NCT04799158|450071600|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
125122137|NCT04799158|450071601|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
125122138|NCT04799158|450071597|FG000|On-Demand Treatment Period|Miscellaneous|0|||
125122139|NCT04799158|450071598|FG001|On-Demand Treatment Period|Miscellaneous|0|||
125122140|NCT04799158|450071599|FG002|On-Demand Treatment Period|Miscellaneous|0|||
125122141|NCT04799158|450071600|FG003|On-Demand Treatment Period|Miscellaneous|0|||
124941298|NCT02488408|449411944|FG006|Part A|Investigator Decision|0|||
125122142|NCT04799158|450071601|FG004|On-Demand Treatment Period|Miscellaneous|1|||
125122143|NCT01790568|450071608|FG000|Overall Study|Progression prior to transplant|0|||
125122144|NCT01790568|450071609|FG001|Overall Study|Progression prior to transplant|1|||
125122145|NCT02994056|450071610|FG000|Overall Study|Death|8|||
125122146|NCT02994056|450071610|FG000|Overall Study|Withdrew Consent|1|||
125122147|NCT02199509|450071613|FG000|Overall Study|Suicidal Ideation|0|||
125122148|NCT02199509|450071614|FG001|Overall Study|Suicidal Ideation|1|||
125122149|NCT02199509|450071613|FG000|Overall Study|Misunderstood titration schedule|1|||
124941299|NCT02488408|449411945|FG007|Part A|Investigator Decision|0|||
124941300|NCT02488408|449411946|FG008|Part A|Investigator Decision|0|||
124941301|NCT02488408|449411947|FG009|Part A|Investigator Decision|0|||
124941302|NCT02488408|449411938|FG000|Part A|Withdrawal by Subject|0|||
124941303|NCT02488408|449411939|FG001|Part A|Withdrawal by Subject|0|||
124941304|NCT02488408|449411940|FG002|Part A|Withdrawal by Subject|2|||
124941305|NCT02488408|449411941|FG003|Part A|Withdrawal by Subject|0|||
124941306|NCT02488408|449411942|FG004|Part A|Withdrawal by Subject|0|||
124941307|NCT02488408|449411943|FG005|Part A|Withdrawal by Subject|0|||
124941308|NCT02488408|449411944|FG006|Part A|Withdrawal by Subject|0|||
124941309|NCT02488408|449411945|FG007|Part A|Withdrawal by Subject|0|||
124941310|NCT02488408|449411946|FG008|Part A|Withdrawal by Subject|0|||
124941311|NCT02488408|449411947|FG009|Part A|Withdrawal by Subject|0|||
124941312|NCT02488408|449411938|FG000|Part A|Other|1|||
124941313|NCT02488408|449411939|FG001|Part A|Other|0|||
124941314|NCT02488408|449411940|FG002|Part A|Other|0|||
124941315|NCT02488408|449411941|FG003|Part A|Other|0|||
124941316|NCT02488408|449411942|FG004|Part A|Other|0|||
124941317|NCT02488408|449411943|FG005|Part A|Other|0|||
124941318|NCT02488408|449411944|FG006|Part A|Other|0|||
124941319|NCT02488408|449411945|FG007|Part A|Other|0|||
124941320|NCT02488408|449411946|FG008|Part A|Other|0|||
124941321|NCT02488408|449411947|FG009|Part A|Other|0|||
124941322|NCT02488408|449411938|FG000|Part B|Adverse Event|0|||
124941323|NCT02488408|449411939|FG001|Part B|Adverse Event|0|||
124941324|NCT02488408|449411940|FG002|Part B|Adverse Event|0|||
124941325|NCT02488408|449411941|FG003|Part B|Adverse Event|0|||
124941326|NCT02488408|449411942|FG004|Part B|Adverse Event|0|||
124941327|NCT02488408|449411943|FG005|Part B|Adverse Event|2|||
124941328|NCT02488408|449411944|FG006|Part B|Adverse Event|2|||
124941329|NCT02488408|449411945|FG007|Part B|Adverse Event|7|||
124941330|NCT02488408|449411946|FG008|Part B|Adverse Event|2|||
124941331|NCT02488408|449411947|FG009|Part B|Adverse Event|2|||
124941332|NCT02488408|449411938|FG000|Part B|Death|0|||
124941333|NCT02488408|449411939|FG001|Part B|Death|0|||
124941334|NCT02488408|449411940|FG002|Part B|Death|0|||
124941335|NCT02488408|449411941|FG003|Part B|Death|0|||
124941336|NCT02488408|449411942|FG004|Part B|Death|0|||
124941337|NCT02488408|449411943|FG005|Part B|Death|3|||
124941338|NCT02488408|449411944|FG006|Part B|Death|1|||
124941339|NCT02488408|449411945|FG007|Part B|Death|2|||
124941340|NCT02488408|449411946|FG008|Part B|Death|2|||
124941341|NCT02488408|449411947|FG009|Part B|Death|2|||
124941342|NCT02488408|449411938|FG000|Part B|Death due to Disease Progression|0|||
124941343|NCT02488408|449411939|FG001|Part B|Death due to Disease Progression|0|||
124941344|NCT02488408|449411940|FG002|Part B|Death due to Disease Progression|0|||
124941345|NCT02488408|449411941|FG003|Part B|Death due to Disease Progression|0|||
124941346|NCT02488408|449411942|FG004|Part B|Death due to Disease Progression|0|||
125122150|NCT02199509|450071614|FG001|Overall Study|Misunderstood titration schedule|0|||
125122151|NCT03309956|450071615|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
125122152|NCT02768298|450071616|FG000|Overall Study|Adverse Event|1|||
125122153|NCT02768298|450071617|FG001|Overall Study|Adverse Event|4|||
125122154|NCT02768298|450071616|FG000|Overall Study|Death|2|||
125122155|NCT02768298|450071617|FG001|Overall Study|Death|1|||
125122156|NCT02768298|450071616|FG000|Overall Study|Non-compliance with study treatment|0|||
125122157|NCT02768298|450071617|FG001|Overall Study|Non-compliance with study treatment|1|||
125122158|NCT02768298|450071616|FG000|Overall Study|Subject/guardian decision|1|||
125122159|NCT02768298|450071617|FG001|Overall Study|Subject/guardian decision|0|||
125122160|NCT02768298|450071616|FG000|Overall Study|Withdrawal of informed consent|0|||
125122161|NCT02768298|450071617|FG001|Overall Study|Withdrawal of informed consent|1|||
125122162|NCT04603937|450071621|FG000|Overall Study|Adverse Event|9|||
125122163|NCT04603937|450071622|FG001|Overall Study|Adverse Event|10|||
125213291|NCT03004924|450407303|FG001|Overall Study|Lack of Efficacy|4|||
125213292|NCT03004924|450407304|FG002|Overall Study|Lack of Efficacy|2|||
125213293|NCT03004924|450407302|FG000|Overall Study|Physician Decision|1|||
124941347|NCT02488408|449411943|FG005|Part B|Death due to Disease Progression|2|||
124941348|NCT02488408|449411944|FG006|Part B|Death due to Disease Progression|2|||
125213294|NCT03004924|450407303|FG001|Overall Study|Physician Decision|0|||
125213295|NCT03004924|450407304|FG002|Overall Study|Physician Decision|1|||
124941349|NCT02488408|449411945|FG007|Part B|Death due to Disease Progression|1|||
124941350|NCT02488408|449411946|FG008|Part B|Death due to Disease Progression|1|||
124941351|NCT02488408|449411947|FG009|Part B|Death due to Disease Progression|1|||
124941352|NCT02488408|449411938|FG000|Part B|Disease Progression|0|||
124941353|NCT02488408|449411939|FG001|Part B|Disease Progression|0|||
124941354|NCT02488408|449411940|FG002|Part B|Disease Progression|0|||
124941355|NCT02488408|449411941|FG003|Part B|Disease Progression|0|||
124941356|NCT02488408|449411942|FG004|Part B|Disease Progression|0|||
124941357|NCT02488408|449411943|FG005|Part B|Disease Progression|6|||
124941358|NCT02488408|449411944|FG006|Part B|Disease Progression|9|||
124941359|NCT02488408|449411945|FG007|Part B|Disease Progression|7|||
124941360|NCT02488408|449411946|FG008|Part B|Disease Progression|9|||
124941361|NCT02488408|449411947|FG009|Part B|Disease Progression|11|||
124941362|NCT02488408|449411938|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
124941363|NCT02488408|449411939|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
124941364|NCT02488408|449411940|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
124941365|NCT02488408|449411941|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
124941366|NCT02488408|449411942|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
124941367|NCT02488408|449411943|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
124941368|NCT02488408|449411944|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
124941369|NCT02488408|449411945|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
124941370|NCT02488408|449411946|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
124941371|NCT02488408|449411947|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
124941372|NCT02488408|449411938|FG000|Part B|Investigator Decision|0|||
124941373|NCT02488408|449411939|FG001|Part B|Investigator Decision|0|||
124941374|NCT02488408|449411940|FG002|Part B|Investigator Decision|0|||
124941375|NCT02488408|449411941|FG003|Part B|Investigator Decision|0|||
124941376|NCT02488408|449411942|FG004|Part B|Investigator Decision|0|||
124941377|NCT02488408|449411943|FG005|Part B|Investigator Decision|0|||
124941378|NCT02488408|449411944|FG006|Part B|Investigator Decision|1|||
124941379|NCT02488408|449411945|FG007|Part B|Investigator Decision|0|||
124941380|NCT02488408|449411946|FG008|Part B|Investigator Decision|2|||
124941381|NCT02488408|449411947|FG009|Part B|Investigator Decision|1|||
124941382|NCT04701203|449411950|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
124941383|NCT04701203|449411951|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
124941384|NCT04701203|449411952|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
124941385|NCT04701203|449411950|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
124941386|NCT04701203|449411951|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
124941387|NCT04701203|449411952|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
124941388|NCT04701203|449411950|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
124941389|NCT04701203|449411951|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
124941390|NCT04701203|449411952|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
124941391|NCT04701203|449411950|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
124941392|NCT04701203|449411951|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
124941393|NCT04701203|449411952|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
124941394|NCT06140290|449411953|FG000|Period 1|Adverse Event|1|||
124941395|NCT06140290|449411954|FG001|Period 1|Adverse Event|0|||
124941396|NCT06140290|449411953|FG000|Period 2|Assigned but not treated|0|||
124941397|NCT06140290|449411954|FG001|Period 2|Assigned but not treated|1|||
124941398|NCT06140290|449411953|FG000|Period 2|Withdrawal by Subject|0|||
124941399|NCT06140290|449411954|FG001|Period 2|Withdrawal by Subject|1|||
124941400|NCT03752684|449413137|FG000|Overall Study|Lost to Follow-up|4|||
124941401|NCT02722434|449413140|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
124941402|NCT02722434|449413141|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
124941403|NCT02722434|449413140|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
124941404|NCT02722434|449413141|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
125027373|NCT02804763|449725502|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
125027374|NCT02804763|449725503|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
125027375|NCT02804763|449725504|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
125027376|NCT02804763|449725501|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
125027377|NCT02804763|449725502|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
125027378|NCT02804763|449725503|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
125027379|NCT02804763|449725504|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
125027380|NCT02804763|449725501|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
125027381|NCT02804763|449725502|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
125027382|NCT02804763|449725503|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
125027383|NCT02804763|449725504|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
125027384|NCT02804763|449725501|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
125027385|NCT02804763|449725502|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
125027386|NCT02804763|449725503|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
125027387|NCT02804763|449725504|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
125027388|NCT02804763|449725501|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
125027389|NCT02804763|449725502|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
125027390|NCT02804763|449725503|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
125027391|NCT02804763|449725504|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
125027392|NCT02804763|449725501|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
125027393|NCT02804763|449725502|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
125027394|NCT02804763|449725503|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
124941405|NCT02200705|449413142|FG000|Overall Study|Excluded|12|||
125122164|NCT04603937|450071621|FG000|Overall Study|Withdrawal by Subject|7|||
125122165|NCT04603937|450071622|FG001|Overall Study|Withdrawal by Subject|6|||
124941406|NCT02200705|449413142|FG000|Overall Study|Death|21|||
124941407|NCT02200705|449413142|FG000|Overall Study|Withdrawal by Subject|22|||
125122166|NCT04603937|450071621|FG000|Overall Study|Lost to Follow-up|5|||
125122167|NCT04603937|450071622|FG001|Overall Study|Lost to Follow-up|6|||
124941408|NCT02200705|449413142|FG000|Overall Study|Lost to Follow-up|13|||
124941409|NCT02200705|449413142|FG000|Overall Study|Physician Decision|5|||
124941410|NCT02200705|449413142|FG000|Overall Study|Adverse Event|2|||
124941411|NCT00786864|449413143|FG000|Overall Study|Lost to Follow-up|0|||
124941412|NCT00786864|449413144|FG001|Overall Study|Lost to Follow-up|1|||
124941413|NCT00786864|449413143|FG000|Overall Study|Sustained serious back injury|1|||
124941414|NCT00786864|449413144|FG001|Overall Study|Sustained serious back injury|0|||
124941415|NCT03442777|449413148|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
124941416|NCT03442777|449413149|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
124941417|NCT03442777|449413150|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
124941418|NCT00442104|449413152|FG000|Overall Study|Adverse Event|5|||
124941419|NCT00442104|449413152|FG000|Overall Study|Death|2|||
124941420|NCT00442104|449413152|FG000|Overall Study|Lost to Follow-up|3|||
124941421|NCT00442104|449413152|FG000|Overall Study|Withdrawal by Subject|5|||
124941422|NCT00442104|449413152|FG000|Overall Study|Insufficient Clinical Response|10|||
124941423|NCT00442104|449413152|FG000|Overall Study|Other|21|||
124941424|NCT00442104|449413152|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
124941425|NCT00463229|449413158|FG000|Overall Study|Lost to Follow-up|5|||
124941426|NCT00463229|449413159|FG001|Overall Study|Lost to Follow-up|7|||
124941427|NCT00463229|449413158|FG000|Overall Study|Death|4|||
124941428|NCT00463229|449413159|FG001|Overall Study|Death|3|||
124941429|NCT01932970|449413160|FG000|Overall Study|Withdrawal by Subject|5|||
124941430|NCT01932970|449413160|FG000|Overall Study|Death|1|||
124941431|NCT01932970|449413160|FG000|Overall Study|Lost to Follow-up|2|||
124941432|NCT01932970|449413160|FG000|Overall Study|Protocol Specified Criteria|10|||
124941433|NCT01767467|449413161|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
124941434|NCT01767467|449413162|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
124941435|NCT01767467|449413161|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
125027395|NCT02804763|449725504|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
124941436|NCT01767467|449413162|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
124941437|NCT01767467|449413161|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
124941438|NCT01767467|449413162|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
124941439|NCT01767467|449413161|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
125027396|NCT04656990|449725505|FG000|Baseline|pandemic|20|||
125027397|NCT04656990|449725506|FG001|Baseline|pandemic|24|||
125027398|NCT04656990|449725505|FG000|Follow Up Period|Lost to Follow-up|61|||
125027399|NCT04656990|449725506|FG001|Follow Up Period|Lost to Follow-up|73|||
125027400|NCT00282243|449725509|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
125027401|NCT00282243|449725509|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
125027402|NCT00282243|449725509|FG000|Extension Treatment Period|Adverse Event|15|||
125027403|NCT00282243|449725509|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
125027404|NCT00282243|449725509|FG000|Extension Treatment Period|Non-compliance|2|||
125027405|NCT00282243|449725509|FG000|Extension Treatment Period|Physician Decision|1|||
125027406|NCT01070329|449725510|FG000|Overall Study|Adverse Event|13|||
125027407|NCT01070329|449725511|FG001|Overall Study|Adverse Event|10|||
125027408|NCT01070329|449725510|FG000|Overall Study|Lost to Follow-up|22|||
125027409|NCT01070329|449725511|FG001|Overall Study|Lost to Follow-up|12|||
125027410|NCT01070329|449725510|FG000|Overall Study|Withdrawal by Subject|9|||
125027411|NCT01070329|449725511|FG001|Overall Study|Withdrawal by Subject|11|||
125027412|NCT01070329|449725510|FG000|Overall Study|Protocol Violation|3|||
125027413|NCT01070329|449725511|FG001|Overall Study|Protocol Violation|8|||
125027414|NCT01070329|449725510|FG000|Overall Study|Lack of Efficacy|2|||
125027415|NCT01070329|449725511|FG001|Overall Study|Lack of Efficacy|6|||
125027416|NCT01070329|449725510|FG000|Overall Study|Physician Decision|2|||
125027417|NCT01070329|449725511|FG001|Overall Study|Physician Decision|1|||
125027418|NCT01070329|449725510|FG000|Overall Study|Entry Criteria Not Met|1|||
125027419|NCT01070329|449725511|FG001|Overall Study|Entry Criteria Not Met|0|||
125027420|NCT01070329|449725510|FG000|Overall Study|Sponsor Decision|0|||
125027421|NCT01070329|449725511|FG001|Overall Study|Sponsor Decision|1|||
125027422|NCT02863848|449725512|FG000|Overall Study|Lost to Follow-up|1|||
125027423|NCT02863848|449725513|FG001|Overall Study|Lost to Follow-up|1|||
125027424|NCT02863848|449725512|FG000|Overall Study|Protocol Violation|1|||
125027425|NCT02863848|449725513|FG001|Overall Study|Protocol Violation|2|||
125027426|NCT00700180|449725517|FG000|Overall Study|Death|99|||
125027427|NCT00700180|449725518|FG001|Overall Study|Death|114|||
125027428|NCT00700180|449725517|FG000|Overall Study|Alive on treatment|5|||
125027429|NCT00700180|449725518|FG001|Overall Study|Alive on treatment|3|||
125027430|NCT00700180|449725517|FG000|Overall Study|Alive in follow-up|46|||
125027431|NCT00700180|449725518|FG001|Overall Study|Alive in follow-up|27|||
125027432|NCT00700180|449725517|FG000|Overall Study|Lost to Follow-up|4|||
125027433|NCT00700180|449725518|FG001|Overall Study|Lost to Follow-up|5|||
125027434|NCT03588741|449725520|FG000|Overall Study|Withdrawal by Subject|1|||
125027435|NCT00793793|449725521|FG000|Overall Study|Adverse Event|0|||
125027436|NCT00793793|449725522|FG001|Overall Study|Adverse Event|0|||
125027437|NCT00793793|449725523|FG002|Overall Study|Adverse Event|1|||
125027438|NCT00793793|449725524|FG003|Overall Study|Adverse Event|1|||
125027439|NCT00793793|449725525|FG004|Overall Study|Adverse Event|0|||
124941440|NCT01767467|449413162|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
124941441|NCT01767467|449413161|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
124941442|NCT01767467|449413162|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
124941443|NCT01767467|449413161|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
124941444|NCT01767467|449413162|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
124941445|NCT01767467|449413161|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
125122168|NCT04603937|450071621|FG000|Overall Study|Physician Decision|0|||
125122169|NCT04603937|450071622|FG001|Overall Study|Physician Decision|1|||
125122170|NCT04603937|450071621|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
125122171|NCT04603937|450071622|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
125122172|NCT02518685|450071623|FG000|Overall Study|Adverse Event|29|||
125122173|NCT02518685|450071624|FG001|Overall Study|Adverse Event|1|||
125122174|NCT02518685|450071623|FG000|Overall Study|Withdrawal by Subject|10|||
125122175|NCT02518685|450071624|FG001|Overall Study|Withdrawal by Subject|3|||
125122176|NCT02518685|450071623|FG000|Overall Study|relocation, study fatigue|7|||
125122177|NCT02518685|450071624|FG001|Overall Study|relocation, study fatigue|2|||
125122178|NCT02518685|450071623|FG000|Overall Study|Pregnancy|1|||
125122179|NCT02518685|450071624|FG001|Overall Study|Pregnancy|0|||
125122180|NCT02518685|450071623|FG000|Overall Study|Physician Decision|1|||
125122181|NCT02518685|450071624|FG001|Overall Study|Physician Decision|0|||
125122182|NCT02518685|450071623|FG000|Overall Study|Lost to Follow-up|1|||
125122183|NCT02518685|450071624|FG001|Overall Study|Lost to Follow-up|4|||
125122184|NCT01922349|450071625|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
125122185|NCT01922349|450071626|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
125122186|NCT01922349|450071627|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
125122187|NCT01922349|450071628|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
125122188|NCT01611090|450071629|FG000|Randomized Period|Lost to Follow-up|8|||
125122189|NCT01611090|450071630|FG001|Randomized Period|Lost to Follow-up|3|||
125122190|NCT01611090|450071631|FG002|Randomized Period|Lost to Follow-up|0|||
125122191|NCT01611090|450071629|FG000|Randomized Period|Withdrawal by Subject|22|||
125122192|NCT01611090|450071630|FG001|Randomized Period|Withdrawal by Subject|26|||
125122193|NCT01611090|450071631|FG002|Randomized Period|Withdrawal by Subject|0|||
125122194|NCT01611090|450071629|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
125122195|NCT01611090|450071630|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
125122196|NCT01611090|450071631|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
125122197|NCT01611090|450071629|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
125122198|NCT01611090|450071630|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
125122199|NCT01611090|450071631|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
125122200|NCT01919190|450073996|FG000|Overall Study|Intra-op findings, etc.|3|||
125122201|NCT01919190|450073997|FG001|Overall Study|Intra-op findings, etc.|0|||
125122202|NCT01545076|450074002|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
125122203|NCT01545076|450074003|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
125122204|NCT01545076|450074004|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
125122205|NCT01545076|450074005|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
125122206|NCT01545076|450074006|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
125122207|NCT01545076|450074002|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
125122208|NCT01545076|450074003|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
125122209|NCT01545076|450074004|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
125122210|NCT01545076|450074005|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
125122211|NCT01545076|450074006|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
125122212|NCT01545076|450074002|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
125122213|NCT01545076|450074003|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
125122214|NCT01545076|450074004|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
125122215|NCT01545076|450074005|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
125122216|NCT01545076|450074006|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
125122217|NCT01545076|450074002|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
125122218|NCT01545076|450074003|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
125122219|NCT01545076|450074004|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
125122220|NCT01545076|450074005|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
125122221|NCT01545076|450074006|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
125122222|NCT01545076|450074002|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
125122223|NCT01545076|450074003|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
125122224|NCT01545076|450074004|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
125122225|NCT01545076|450074005|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
125122226|NCT01545076|450074006|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
125122227|NCT01545076|450074002|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
125213296|NCT03004924|450407302|FG000|Overall Study|Withdrawal by parent/guardian|1|||
124941446|NCT01767467|449413162|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
125122228|NCT01545076|450074003|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
125213297|NCT03004924|450407303|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125213298|NCT03004924|450407304|FG002|Overall Study|Withdrawal by parent/guardian|2|||
125213299|NCT03004924|450407302|FG000|Overall Study|Screen Failure|1|||
125213300|NCT03004924|450407303|FG001|Overall Study|Screen Failure|0|||
125213301|NCT03004924|450407304|FG002|Overall Study|Screen Failure|0|||
125213302|NCT03004924|450407302|FG000|Overall Study|Pregnancy|0|||
125213303|NCT03004924|450407303|FG001|Overall Study|Pregnancy|1|||
125213304|NCT03004924|450407304|FG002|Overall Study|Pregnancy|0|||
125213305|NCT03004924|450407302|FG000|Overall Study|Terminated by Sponsor|0|||
125213306|NCT03004924|450407303|FG001|Overall Study|Terminated by Sponsor|0|||
125213307|NCT03004924|450407304|FG002|Overall Study|Terminated by Sponsor|1|||
125213308|NCT03004924|450407302|FG000|Overall Study|Missed Study Visit|0|||
125213309|NCT03004924|450407303|FG001|Overall Study|Missed Study Visit|0|||
125213310|NCT03004924|450407304|FG002|Overall Study|Missed Study Visit|2|||
125213311|NCT03004924|450407302|FG000|Overall Study|HSV1 Positive|1|||
125213312|NCT03004924|450407303|FG001|Overall Study|HSV1 Positive|0|||
125213313|NCT03004924|450407304|FG002|Overall Study|HSV1 Positive|0|||
125213314|NCT00269477|450407305|FG000|Overall Study|Protocol Violation|5|||
125213315|NCT00269477|450407306|FG001|Overall Study|Protocol Violation|5|||
125213316|NCT00269477|450407307|FG002|Overall Study|Protocol Violation|1|||
125213317|NCT00269477|450407308|FG003|Overall Study|Protocol Violation|0|||
125213318|NCT00269477|450407305|FG000|Overall Study|Missed post-vaccination blood draw|0|||
125213319|NCT00269477|450407306|FG001|Overall Study|Missed post-vaccination blood draw|1|||
125213320|NCT00269477|450407307|FG002|Overall Study|Missed post-vaccination blood draw|0|||
125213321|NCT00269477|450407308|FG003|Overall Study|Missed post-vaccination blood draw|0|||
125213322|NCT02670382|450407311|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
125213323|NCT02670382|450407312|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
125213324|NCT03244618|450407313|FG000|Overall Study|Lost to Follow-up|3|||
125213325|NCT03244618|450407314|FG001|Overall Study|Lost to Follow-up|4|||
125213326|NCT03244618|450407313|FG000|Overall Study|Protocol Violation|4|||
125213327|NCT03244618|450407314|FG001|Overall Study|Protocol Violation|3|||
125213328|NCT03244618|450407313|FG000|Overall Study|Withdrawal by Subject|0|||
125213329|NCT03244618|450407314|FG001|Overall Study|Withdrawal by Subject|2|||
125213330|NCT01863732|450407315|FG000|Overall Study|Adverse Event|2|||
125213331|NCT01863732|450407316|FG001|Overall Study|Adverse Event|0|||
125213332|NCT01863732|450407317|FG002|Overall Study|Adverse Event|3|||
125213333|NCT01863732|450407318|FG003|Overall Study|Adverse Event|3|||
125213334|NCT01863732|450407315|FG000|Overall Study|Lack of Efficacy|1|||
125213335|NCT01863732|450407316|FG001|Overall Study|Lack of Efficacy|0|||
125213336|NCT01863732|450407317|FG002|Overall Study|Lack of Efficacy|2|||
125213337|NCT01863732|450407318|FG003|Overall Study|Lack of Efficacy|1|||
125213338|NCT01863732|450407315|FG000|Overall Study|Lost to Follow-up|2|||
125213339|NCT01863732|450407316|FG001|Overall Study|Lost to Follow-up|2|||
125213340|NCT01863732|450407317|FG002|Overall Study|Lost to Follow-up|1|||
125213341|NCT01863732|450407318|FG003|Overall Study|Lost to Follow-up|1|||
125213342|NCT01863732|450407315|FG000|Overall Study|Physician Decision|1|||
125213343|NCT01863732|450407316|FG001|Overall Study|Physician Decision|0|||
125213344|NCT01863732|450407317|FG002|Overall Study|Physician Decision|1|||
125213345|NCT01863732|450407318|FG003|Overall Study|Physician Decision|0|||
125213346|NCT01863732|450407315|FG000|Overall Study|Pregnancy|0|||
125213347|NCT01863732|450407316|FG001|Overall Study|Pregnancy|0|||
125213348|NCT01863732|450407317|FG002|Overall Study|Pregnancy|0|||
125213349|NCT01863732|450407318|FG003|Overall Study|Pregnancy|1|||
125213350|NCT01863732|450407315|FG000|Overall Study|Technical problems|0|||
125213351|NCT01863732|450407316|FG001|Overall Study|Technical problems|1|||
125213352|NCT01863732|450407317|FG002|Overall Study|Technical problems|1|||
125213353|NCT01863732|450407318|FG003|Overall Study|Technical problems|0|||
125213354|NCT01863732|450407315|FG000|Overall Study|Subject/guardian decision|6|||
125213355|NCT01863732|450407316|FG001|Overall Study|Subject/guardian decision|9|||
125213356|NCT01863732|450407317|FG002|Overall Study|Subject/guardian decision|3|||
125213357|NCT01863732|450407318|FG003|Overall Study|Subject/guardian decision|1|||
125213358|NCT01863732|450407315|FG000|Overall Study|Death|1|||
124941447|NCT01767467|449413161|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
124941448|NCT01767467|449413162|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
125213359|NCT01863732|450407316|FG001|Overall Study|Death|0|||
125213360|NCT01863732|450407317|FG002|Overall Study|Death|0|||
125213361|NCT01863732|450407318|FG003|Overall Study|Death|1|||
124941449|NCT01767467|449413161|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
125213362|NCT01603394|450407323|FG000|Overall Study|Adverse Event|1|||
125213363|NCT00840034|450407325|FG000|Acute Treatment Phase|Adverse Event|6|||
125213364|NCT00840034|450407326|FG001|Acute Treatment Phase|Adverse Event|8|||
125213365|NCT00840034|450407325|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
125213366|NCT00840034|450407326|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
125213367|NCT00840034|450407325|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
125213368|NCT00840034|450407326|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
125213369|NCT00840034|450407325|FG000|Acute Treatment Phase|Physician Decision|0|||
125213370|NCT00840034|450407326|FG001|Acute Treatment Phase|Physician Decision|1|||
125213371|NCT00840034|450407325|FG000|Acute Treatment Phase|Protocol Violation|2|||
125213372|NCT00840034|450407326|FG001|Acute Treatment Phase|Protocol Violation|4|||
125213373|NCT00840034|450407325|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
125213374|NCT00840034|450407326|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
125213375|NCT00840034|450407325|FG000|Taper Phase|Adverse Event|1|||
125213376|NCT00840034|450407326|FG001|Taper Phase|Adverse Event|0|||
125213377|NCT00840034|450407325|FG000|Taper Phase|Lost to Follow-up|1|||
125213378|NCT00840034|450407326|FG001|Taper Phase|Lost to Follow-up|1|||
125213379|NCT00840034|450407325|FG000|Taper Phase|Withdrawal by Subject|1|||
125213380|NCT00840034|450407326|FG001|Taper Phase|Withdrawal by Subject|1|||
125213381|NCT01215435|450407327|FG000|Overall Study|Adverse Event|1|||
125213382|NCT01215435|450407328|FG001|Overall Study|Adverse Event|0|||
124941450|NCT01767467|449413162|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
124941451|NCT01767467|449413161|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
124941452|NCT01767467|449413162|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
124941453|NCT01767467|449413161|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
125213383|NCT01215435|450407327|FG000|Overall Study|Protocol Violation|2|||
125213384|NCT01215435|450407328|FG001|Overall Study|Protocol Violation|0|||
124941454|NCT01767467|449413162|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
124941455|NCT01767467|449413161|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
124941456|NCT01767467|449413162|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
124941457|NCT01767467|449413161|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
124941458|NCT01767467|449413162|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
124941459|NCT01767467|449413161|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
124941460|NCT01767467|449413162|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
124941461|NCT01787032|449413169|FG000|Overall Study|Protocol Violation|0|||
124941462|NCT01787032|449413170|FG001|Overall Study|Protocol Violation|0|||
124941463|NCT01787032|449413171|FG002|Overall Study|Protocol Violation|0|||
124941464|NCT01787032|449413172|FG003|Overall Study|Protocol Violation|0|||
124941465|NCT01787032|449413173|FG004|Overall Study|Protocol Violation|1|||
124941466|NCT01787032|449413174|FG005|Overall Study|Protocol Violation|1|||
124941467|NCT00776009|449413175|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
124941468|NCT00776009|449413176|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
124941469|NCT00776009|449413177|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
124941470|NCT00776009|449413178|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
124941471|NCT00776009|449413179|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
124941472|NCT00776009|449413180|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
124941473|NCT00776009|449413175|FG000|Period 1: First Intervention|Protocol Violation|0|||
125122229|NCT01545076|450074004|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
125122230|NCT01545076|450074005|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
125122231|NCT01545076|450074006|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
125122232|NCT01545076|450074002|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
125122233|NCT01545076|450074003|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
125122234|NCT01545076|450074004|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
125122235|NCT01545076|450074005|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
125122236|NCT01545076|450074006|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
125122237|NCT01545076|450074002|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
125122238|NCT01545076|450074003|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
125122239|NCT01545076|450074004|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
125122240|NCT01545076|450074005|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
125122241|NCT01545076|450074006|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
125122242|NCT01545076|450074002|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
125122243|NCT01545076|450074003|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
125122244|NCT01545076|450074004|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
125122245|NCT01545076|450074005|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
125122246|NCT01545076|450074006|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
125122247|NCT02518113|450074007|FG000|Overall Study|Adverse Event|1|||
125122248|NCT02518113|450074008|FG001|Overall Study|Adverse Event|0|||
125122249|NCT02518113|450074009|FG002|Overall Study|Adverse Event|1|||
125122250|NCT02518113|450074010|FG003|Overall Study|Adverse Event|0|||
125122251|NCT02518113|450074007|FG000|Overall Study|Death|1|||
125122252|NCT02518113|450074008|FG001|Overall Study|Death|2|||
125122253|NCT02518113|450074009|FG002|Overall Study|Death|0|||
125122254|NCT02518113|450074010|FG003|Overall Study|Death|0|||
125122255|NCT02518113|450074007|FG000|Overall Study|Physician Decision|0|||
125122256|NCT02518113|450074008|FG001|Overall Study|Physician Decision|1|||
125122257|NCT02518113|450074009|FG002|Overall Study|Physician Decision|0|||
125122258|NCT02518113|450074010|FG003|Overall Study|Physician Decision|0|||
125122259|NCT02518113|450074007|FG000|Overall Study|Progressive Disease|1|||
125122260|NCT02518113|450074008|FG001|Overall Study|Progressive Disease|2|||
125122261|NCT02518113|450074009|FG002|Overall Study|Progressive Disease|3|||
125122262|NCT02518113|450074010|FG003|Overall Study|Progressive Disease|0|||
125122263|NCT00797108|450074011|FG000|Overall Study|Adverse Event|1|||
125122264|NCT00797108|450074012|FG001|Overall Study|Adverse Event|0|||
125122265|NCT00797108|450074013|FG002|Overall Study|Adverse Event|3|||
125122266|NCT00797108|450074011|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
125122267|NCT00797108|450074012|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
125122268|NCT00797108|450074013|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
125122269|NCT00797108|450074011|FG000|Overall Study|Global Deterioration of Health Status|0|||
125122270|NCT00797108|450074012|FG001|Overall Study|Global Deterioration of Health Status|1|||
125122271|NCT00797108|450074013|FG002|Overall Study|Global Deterioration of Health Status|0|||
125122272|NCT00797108|450074011|FG000|Overall Study|Lack of Efficacy|1|||
125122273|NCT00797108|450074012|FG001|Overall Study|Lack of Efficacy|0|||
125122274|NCT00797108|450074013|FG002|Overall Study|Lack of Efficacy|1|||
124941474|NCT00776009|449413176|FG001|Period 1: First Intervention|Protocol Violation|1|||
124941475|NCT00776009|449413177|FG002|Period 1: First Intervention|Protocol Violation|0|||
124941476|NCT00776009|449413178|FG003|Period 1: First Intervention|Protocol Violation|0|||
124941477|NCT00776009|449413179|FG004|Period 1: First Intervention|Protocol Violation|1|||
125122275|NCT00797108|450074011|FG000|Overall Study|Other|0|||
125122276|NCT00797108|450074012|FG001|Overall Study|Other|0|||
125027440|NCT00793793|449725526|FG005|Overall Study|Adverse Event|1|||
125027441|NCT00793793|449725527|FG006|Overall Study|Adverse Event|2|||
125027442|NCT00793793|449725528|FG007|Overall Study|Adverse Event|0|||
125027443|NCT00793793|449725529|FG008|Overall Study|Adverse Event|0|||
125027444|NCT00793793|449725530|FG009|Overall Study|Adverse Event|0|||
125027445|NCT00793793|449725531|FG010|Overall Study|Adverse Event|0|||
125027446|NCT00793793|449725532|FG011|Overall Study|Adverse Event|2|||
125027447|NCT00793793|449725521|FG000|Overall Study|Protocol Violation|0|||
125027448|NCT00793793|449725522|FG001|Overall Study|Protocol Violation|0|||
125027449|NCT00793793|449725523|FG002|Overall Study|Protocol Violation|0|||
125027450|NCT00793793|449725524|FG003|Overall Study|Protocol Violation|1|||
125027451|NCT00793793|449725525|FG004|Overall Study|Protocol Violation|0|||
125027452|NCT00793793|449725526|FG005|Overall Study|Protocol Violation|0|||
125027453|NCT00793793|449725527|FG006|Overall Study|Protocol Violation|0|||
125027454|NCT00793793|449725528|FG007|Overall Study|Protocol Violation|0|||
125027455|NCT00793793|449725529|FG008|Overall Study|Protocol Violation|0|||
125027456|NCT00793793|449725530|FG009|Overall Study|Protocol Violation|0|||
125027457|NCT00793793|449725531|FG010|Overall Study|Protocol Violation|0|||
125027458|NCT00793793|449725532|FG011|Overall Study|Protocol Violation|0|||
125027459|NCT00793793|449725521|FG000|Overall Study|Lost to Follow-up|0|||
125027460|NCT00793793|449725522|FG001|Overall Study|Lost to Follow-up|0|||
125027461|NCT00793793|449725523|FG002|Overall Study|Lost to Follow-up|1|||
125027462|NCT00793793|449725524|FG003|Overall Study|Lost to Follow-up|0|||
125027463|NCT00793793|449725525|FG004|Overall Study|Lost to Follow-up|0|||
125027464|NCT00793793|449725526|FG005|Overall Study|Lost to Follow-up|0|||
125027465|NCT00793793|449725527|FG006|Overall Study|Lost to Follow-up|0|||
125027466|NCT00793793|449725528|FG007|Overall Study|Lost to Follow-up|0|||
125027467|NCT00793793|449725529|FG008|Overall Study|Lost to Follow-up|1|||
125027468|NCT00793793|449725530|FG009|Overall Study|Lost to Follow-up|3|||
125027469|NCT00793793|449725531|FG010|Overall Study|Lost to Follow-up|1|||
125027470|NCT00793793|449725532|FG011|Overall Study|Lost to Follow-up|0|||
125027471|NCT00793793|449725521|FG000|Overall Study|Withdrawal by Subject|0|||
125027472|NCT00793793|449725522|FG001|Overall Study|Withdrawal by Subject|0|||
125027473|NCT00793793|449725523|FG002|Overall Study|Withdrawal by Subject|0|||
125027474|NCT00793793|449725524|FG003|Overall Study|Withdrawal by Subject|0|||
125027475|NCT00793793|449725525|FG004|Overall Study|Withdrawal by Subject|1|||
125027476|NCT00793793|449725526|FG005|Overall Study|Withdrawal by Subject|0|||
125027477|NCT00793793|449725527|FG006|Overall Study|Withdrawal by Subject|0|||
125027478|NCT00793793|449725528|FG007|Overall Study|Withdrawal by Subject|0|||
125027479|NCT00793793|449725529|FG008|Overall Study|Withdrawal by Subject|1|||
125027480|NCT00793793|449725530|FG009|Overall Study|Withdrawal by Subject|0|||
125027481|NCT00793793|449725531|FG010|Overall Study|Withdrawal by Subject|0|||
125027482|NCT00793793|449725532|FG011|Overall Study|Withdrawal by Subject|0|||
125027483|NCT00793793|449725521|FG000|Overall Study|reason not specified|0|||
125027484|NCT00793793|449725522|FG001|Overall Study|reason not specified|1|||
125027485|NCT00793793|449725523|FG002|Overall Study|reason not specified|0|||
125027486|NCT00793793|449725524|FG003|Overall Study|reason not specified|1|||
125027487|NCT00793793|449725525|FG004|Overall Study|reason not specified|1|||
125027488|NCT00793793|449725526|FG005|Overall Study|reason not specified|1|||
125027489|NCT00793793|449725527|FG006|Overall Study|reason not specified|2|||
125027490|NCT00793793|449725528|FG007|Overall Study|reason not specified|0|||
125027491|NCT00793793|449725529|FG008|Overall Study|reason not specified|7|||
125027492|NCT00793793|449725530|FG009|Overall Study|reason not specified|6|||
125027493|NCT00793793|449725531|FG010|Overall Study|reason not specified|2|||
125027494|NCT00793793|449725532|FG011|Overall Study|reason not specified|4|||
125027495|NCT00950170|449725533|FG000|Overall Study|Parent/Legal Guardian Request|1|||
125027496|NCT00950170|449725533|FG000|Overall Study|Adverse Event|2|||
125027497|NCT00950170|449725533|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
125027498|NCT02661594|449725534|FG000|Overall Study|Protocol Violation|1|||
125027499|NCT02661594|449725535|FG001|Overall Study|Protocol Violation|0|||
125027500|NCT02661594|449725536|FG002|Overall Study|Protocol Violation|1|||
125027501|NCT02661594|449725537|FG003|Overall Study|Protocol Violation|0|||
125027502|NCT02522767|449725538|FG000|Double-blind|Withdrawal by Subject|8|||
125027503|NCT02522767|449725539|FG001|Double-blind|Withdrawal by Subject|11|||
125027504|NCT02522767|449725538|FG000|Double-blind|Lost to Follow-up|1|||
125027505|NCT02522767|449725539|FG001|Double-blind|Lost to Follow-up|0|||
125027506|NCT02522767|449725538|FG000|Double-blind|Adverse Event|1|||
125027507|NCT02522767|449725539|FG001|Double-blind|Adverse Event|10|||
125027508|NCT02522767|449725538|FG000|Double-blind|Protocol Violation|0|||
125027509|NCT02522767|449725539|FG001|Double-blind|Protocol Violation|1|||
125027510|NCT02522767|449725538|FG000|Double-blind|Lack of Efficacy|0|||
125027511|NCT02522767|449725539|FG001|Double-blind|Lack of Efficacy|2|||
125027512|NCT02522767|449725538|FG000|Double-blind|Protocol Deviation|1|||
125027513|NCT02522767|449725539|FG001|Double-blind|Protocol Deviation|0|||
125027514|NCT02522767|449725538|FG000|Open-label|Withdrawal by Subject|2|||
125027515|NCT02522767|449725539|FG001|Open-label|Withdrawal by Subject|3|||
125027516|NCT02522767|449725538|FG000|Open-label|Lost to Follow-up|0|||
125027517|NCT02522767|449725539|FG001|Open-label|Lost to Follow-up|1|||
125027518|NCT02522767|449725538|FG000|Open-label|Adverse Event|2|||
125027519|NCT02522767|449725539|FG001|Open-label|Adverse Event|1|||
125213385|NCT01215435|450407327|FG000|Overall Study|Withdrawal Criteria|8|||
125213386|NCT01215435|450407328|FG001|Overall Study|Withdrawal Criteria|11|||
125213387|NCT01215435|450407327|FG000|Overall Study|Lost to Follow-up|3|||
125213388|NCT01215435|450407328|FG001|Overall Study|Lost to Follow-up|0|||
125213389|NCT01215435|450407327|FG000|Overall Study|Unclassified|5|||
125213390|NCT01215435|450407328|FG001|Overall Study|Unclassified|5|||
125213391|NCT00586898|450407337|FG000|Overall Study|Adverse Event|1|||
125213392|NCT00586898|450407337|FG000|Overall Study|Patiemt Non-compliance|1|||
125213393|NCT00586898|450407337|FG000|Overall Study|Evaluable for Toxicity Only|5|||
125213394|NCT03816007|450407338|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
125213395|NCT03816007|450407339|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
125213396|NCT03816007|450407338|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
125213397|NCT03816007|450407339|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
125213398|NCT03816007|450407338|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
125213399|NCT03816007|450407339|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
125213400|NCT01249833|450407340|FG000|Overall Study|Lost to Follow-up|0|||
125213401|NCT01249833|450407341|FG001|Overall Study|Lost to Follow-up|1|||
125213402|NCT03796676|450407342|FG000|Overall Study|Adverse Event|2|||
125213403|NCT03796676|450407343|FG001|Overall Study|Adverse Event|1|||
125213404|NCT03796676|450407344|FG002|Overall Study|Adverse Event|2|||
125213405|NCT03796676|450407342|FG000|Overall Study|Lost to Follow-up|2|||
125213406|NCT03796676|450407343|FG001|Overall Study|Lost to Follow-up|1|||
125213407|NCT03796676|450407344|FG002|Overall Study|Lost to Follow-up|0|||
125213408|NCT03796676|450407342|FG000|Overall Study|Protocol Violation|0|||
125213409|NCT03796676|450407343|FG001|Overall Study|Protocol Violation|0|||
125213410|NCT03796676|450407344|FG002|Overall Study|Protocol Violation|1|||
125213411|NCT03796676|450407342|FG000|Overall Study|Withdrawal by Subject|1|||
125213412|NCT03796676|450407343|FG001|Overall Study|Withdrawal by Subject|1|||
125213413|NCT03796676|450407344|FG002|Overall Study|Withdrawal by Subject|0|||
125213414|NCT03796676|450407342|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
125213415|NCT03796676|450407343|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
125213416|NCT03796676|450407344|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
125213417|NCT02432144|450407346|FG000|Overall Study|Participant Non-Compliance|1|||
125213418|NCT00448812|450407347|FG000|Year 2|Missed visit but remained in study|4|||
125213419|NCT00448812|450407348|FG001|Year 2|Missed visit but remained in study|1|||
125213420|NCT00448812|450407347|FG000|Year 3|Withdrawal by Subject|1|||
125213421|NCT00448812|450407348|FG001|Year 3|Withdrawal by Subject|3|||
125213422|NCT00448812|450407347|FG000|Year 3|Lost to Follow-up|1|||
125213423|NCT00448812|450407348|FG001|Year 3|Lost to Follow-up|0|||
125213424|NCT00448812|450407347|FG000|Year 3|Missed visit but remained in study|2|||
125213425|NCT00448812|450407348|FG001|Year 3|Missed visit but remained in study|0|||
125213426|NCT00448812|450407347|FG000|Year 5|Missed visit but remained in study|1|||
125213427|NCT00448812|450407348|FG001|Year 5|Missed visit but remained in study|0|||
125213428|NCT01859949|450409640|FG000|Overall Study|Family Matters|0|||
125213429|NCT01859949|450409641|FG001|Overall Study|Family Matters|1|||
125213430|NCT01859949|450409640|FG000|Overall Study|Physician Decision|2|||
125213431|NCT01859949|450409641|FG001|Overall Study|Physician Decision|4|||
125213432|NCT01859949|450409640|FG000|Overall Study|Withdrawal by Subject|11|||
125213433|NCT01859949|450409641|FG001|Overall Study|Withdrawal by Subject|10|||
125027520|NCT02522767|449725538|FG000|Open-label|Lack of Efficacy|1|||
125027521|NCT02522767|449725539|FG001|Open-label|Lack of Efficacy|1|||
125027522|NCT02522767|449725538|FG000|Open-label|Protocol Violation|0|||
125027523|NCT02522767|449725539|FG001|Open-label|Protocol Violation|1|||
125027524|NCT01705691|449725540|FG000|Overall Study|Death|1|||
125027525|NCT01705691|449725541|FG001|Overall Study|Death|2|||
125027526|NCT01705691|449725540|FG000|Overall Study|Withdrawal by Subject|1|||
125027527|NCT01705691|449725541|FG001|Overall Study|Withdrawal by Subject|2|||
125027528|NCT01705691|449725540|FG000|Overall Study|Lost to Follow-up|1|||
125027529|NCT01705691|449725541|FG001|Overall Study|Lost to Follow-up|1|||
125027530|NCT01705691|449725540|FG000|Overall Study|Other|0|||
125027531|NCT01705691|449725541|FG001|Overall Study|Other|1|||
125027532|NCT00214461|449725542|FG000|Overall Study|Adverse Event|0|||
125027533|NCT00214461|449725543|FG001|Overall Study|Adverse Event|0|||
125213434|NCT01859949|450409640|FG000|Overall Study|Protocol Violation|1|||
125213435|NCT01859949|450409641|FG001|Overall Study|Protocol Violation|1|||
125213436|NCT01859949|450409640|FG000|Overall Study|Adverse Event|0|||
125027534|NCT00214461|449725544|FG002|Overall Study|Adverse Event|1|||
125027535|NCT00214461|449725545|FG003|Overall Study|Adverse Event|1|||
125027536|NCT00214461|449725542|FG000|Overall Study|Withdrawal by Subject|0|||
125213437|NCT01859949|450409641|FG001|Overall Study|Adverse Event|1|||
125213438|NCT01890759|450409642|FG000|Overall Study|Protocol Violation|0|||
124941478|NCT00776009|449413180|FG005|Period 1: First Intervention|Protocol Violation|0|||
124941479|NCT00776009|449413175|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
124941480|NCT00776009|449413176|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
124941481|NCT00776009|449413177|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
124941482|NCT00776009|449413178|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
124941483|NCT00776009|449413179|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
124941484|NCT00776009|449413180|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
124941485|NCT00776009|449413175|FG000|Period 2: Second Intervention|Protocol Violation|1|||
125122277|NCT00797108|450074013|FG002|Overall Study|Other|2|||
124941486|NCT00776009|449413176|FG001|Period 2: Second Intervention|Protocol Violation|0|||
124941487|NCT00776009|449413177|FG002|Period 2: Second Intervention|Protocol Violation|1|||
124941488|NCT00776009|449413178|FG003|Period 2: Second Intervention|Protocol Violation|0|||
124941489|NCT00776009|449413179|FG004|Period 2: Second Intervention|Protocol Violation|0|||
124941490|NCT00776009|449413180|FG005|Period 2: Second Intervention|Protocol Violation|0|||
124941491|NCT00776009|449413175|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
124941492|NCT00776009|449413176|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
124941493|NCT00776009|449413177|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
124941494|NCT00776009|449413178|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
124941495|NCT00776009|449413179|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
124941496|NCT00776009|449413180|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
124941497|NCT01640951|449413181|FG000|Overall Study|Adverse Event|8|||
124941498|NCT01640951|449413182|FG001|Overall Study|Adverse Event|3|||
124941499|NCT01640951|449413183|FG002|Overall Study|Adverse Event|10|||
124941500|NCT01640951|449413184|FG003|Overall Study|Adverse Event|6|||
125027537|NCT00214461|449725543|FG001|Overall Study|Withdrawal by Subject|0|||
124941501|NCT01640951|449413185|FG004|Overall Study|Adverse Event|1|||
124941502|NCT01640951|449413186|FG005|Overall Study|Adverse Event|11|||
124941503|NCT01640951|449413187|FG006|Overall Study|Adverse Event|1|||
124941504|NCT01640951|449413188|FG007|Overall Study|Adverse Event|3|||
124941505|NCT01640951|449413181|FG000|Overall Study|Lack of Efficacy|20|||
125027538|NCT00214461|449725544|FG002|Overall Study|Withdrawal by Subject|1|||
125027539|NCT00214461|449725545|FG003|Overall Study|Withdrawal by Subject|0|||
125027540|NCT02913313|449725546|FG000|Overall Study|DISEASE PROGRESSION|1|||
125027541|NCT02913313|449725547|FG001|Overall Study|DISEASE PROGRESSION|2|||
125027542|NCT02913313|449725548|FG002|Overall Study|DISEASE PROGRESSION|2|||
125027543|NCT02913313|449725549|FG003|Overall Study|DISEASE PROGRESSION|4|||
125027544|NCT02913313|449725550|FG004|Overall Study|DISEASE PROGRESSION|6|||
125027545|NCT02913313|449725551|FG005|Overall Study|DISEASE PROGRESSION|4|||
125027546|NCT02913313|449725552|FG006|Overall Study|DISEASE PROGRESSION|19|||
125027547|NCT02913313|449725553|FG007|Overall Study|DISEASE PROGRESSION|3|||
125027548|NCT02913313|449725554|FG008|Overall Study|DISEASE PROGRESSION|4|||
125027549|NCT02913313|449725555|FG009|Overall Study|DISEASE PROGRESSION|4|||
125027550|NCT02913313|449725556|FG010|Overall Study|DISEASE PROGRESSION|11|||
125027551|NCT02913313|449725557|FG011|Overall Study|DISEASE PROGRESSION|5|||
125027552|NCT02913313|449725558|FG012|Overall Study|DISEASE PROGRESSION|14|||
125027553|NCT02913313|449725559|FG013|Overall Study|DISEASE PROGRESSION|3|||
125027554|NCT02913313|449725546|FG000|Overall Study|Not Reported|0|||
125027555|NCT02913313|449725547|FG001|Overall Study|Not Reported|0|||
125027556|NCT02913313|449725548|FG002|Overall Study|Not Reported|0|||
125027557|NCT02913313|449725549|FG003|Overall Study|Not Reported|0|||
125027558|NCT02913313|449725550|FG004|Overall Study|Not Reported|1|||
125027559|NCT02913313|449725551|FG005|Overall Study|Not Reported|0|||
125027560|NCT02913313|449725552|FG006|Overall Study|Not Reported|0|||
125027561|NCT02913313|449725553|FG007|Overall Study|Not Reported|0|||
125027562|NCT02913313|449725554|FG008|Overall Study|Not Reported|0|||
125027563|NCT02913313|449725555|FG009|Overall Study|Not Reported|0|||
125027564|NCT02913313|449725556|FG010|Overall Study|Not Reported|4|||
125027565|NCT02913313|449725557|FG011|Overall Study|Not Reported|0|||
125027566|NCT02913313|449725558|FG012|Overall Study|Not Reported|0|||
125027567|NCT02913313|449725559|FG013|Overall Study|Not Reported|0|||
125027568|NCT02913313|449725546|FG000|Overall Study|Other reasons|0|||
125027569|NCT02913313|449725547|FG001|Overall Study|Other reasons|0|||
125027570|NCT02913313|449725548|FG002|Overall Study|Other reasons|0|||
125027571|NCT02913313|449725549|FG003|Overall Study|Other reasons|0|||
125027572|NCT02913313|449725550|FG004|Overall Study|Other reasons|1|||
125027573|NCT02913313|449725551|FG005|Overall Study|Other reasons|0|||
125027574|NCT02913313|449725552|FG006|Overall Study|Other reasons|0|||
125027575|NCT02913313|449725553|FG007|Overall Study|Other reasons|0|||
125027576|NCT02913313|449725554|FG008|Overall Study|Other reasons|0|||
125027577|NCT02913313|449725555|FG009|Overall Study|Other reasons|0|||
125027578|NCT02913313|449725556|FG010|Overall Study|Other reasons|1|||
125027579|NCT02913313|449725557|FG011|Overall Study|Other reasons|0|||
125027580|NCT02913313|449725558|FG012|Overall Study|Other reasons|0|||
125027581|NCT02913313|449725559|FG013|Overall Study|Other reasons|0|||
125027582|NCT02913313|449725546|FG000|Overall Study|Withdrawal by Subject|0|||
125027583|NCT02913313|449725547|FG001|Overall Study|Withdrawal by Subject|0|||
125027584|NCT02913313|449725548|FG002|Overall Study|Withdrawal by Subject|1|||
125027585|NCT02913313|449725549|FG003|Overall Study|Withdrawal by Subject|0|||
125027586|NCT02913313|449725550|FG004|Overall Study|Withdrawal by Subject|0|||
125027587|NCT02913313|449725551|FG005|Overall Study|Withdrawal by Subject|0|||
124941506|NCT01640951|449413182|FG001|Overall Study|Lack of Efficacy|1|||
125027588|NCT02913313|449725552|FG006|Overall Study|Withdrawal by Subject|1|||
125027589|NCT02913313|449725553|FG007|Overall Study|Withdrawal by Subject|1|||
125027590|NCT02913313|449725554|FG008|Overall Study|Withdrawal by Subject|0|||
125027591|NCT02913313|449725555|FG009|Overall Study|Withdrawal by Subject|0|||
125027592|NCT02913313|449725556|FG010|Overall Study|Withdrawal by Subject|1|||
125027593|NCT02913313|449725557|FG011|Overall Study|Withdrawal by Subject|0|||
124941507|NCT01640951|449413183|FG002|Overall Study|Lack of Efficacy|7|||
124941508|NCT01640951|449413184|FG003|Overall Study|Lack of Efficacy|14|||
124941509|NCT01640951|449413185|FG004|Overall Study|Lack of Efficacy|0|||
124941510|NCT01640951|449413186|FG005|Overall Study|Lack of Efficacy|6|||
124941511|NCT01640951|449413187|FG006|Overall Study|Lack of Efficacy|5|||
124941512|NCT01640951|449413188|FG007|Overall Study|Lack of Efficacy|6|||
124941513|NCT01640951|449413181|FG000|Overall Study|Lost to Follow-up|1|||
124941514|NCT01640951|449413182|FG001|Overall Study|Lost to Follow-up|0|||
124941515|NCT01640951|449413183|FG002|Overall Study|Lost to Follow-up|6|||
124941516|NCT01640951|449413184|FG003|Overall Study|Lost to Follow-up|2|||
124941517|NCT01640951|449413185|FG004|Overall Study|Lost to Follow-up|2|||
124941518|NCT01640951|449413186|FG005|Overall Study|Lost to Follow-up|3|||
124941519|NCT01640951|449413187|FG006|Overall Study|Lost to Follow-up|1|||
124941520|NCT01640951|449413188|FG007|Overall Study|Lost to Follow-up|1|||
124941521|NCT01640951|449413181|FG000|Overall Study|Non-compliance with study treatment|0|||
124941522|NCT01640951|449413182|FG001|Overall Study|Non-compliance with study treatment|0|||
124941523|NCT01640951|449413183|FG002|Overall Study|Non-compliance with study treatment|1|||
124941524|NCT01640951|449413184|FG003|Overall Study|Non-compliance with study treatment|1|||
124941525|NCT01640951|449413185|FG004|Overall Study|Non-compliance with study treatment|1|||
124941526|NCT01640951|449413186|FG005|Overall Study|Non-compliance with study treatment|4|||
124941527|NCT01640951|449413187|FG006|Overall Study|Non-compliance with study treatment|1|||
124941528|NCT01640951|449413188|FG007|Overall Study|Non-compliance with study treatment|0|||
124941529|NCT01640951|449413181|FG000|Overall Study|Physician Decision|2|||
124941530|NCT01640951|449413182|FG001|Overall Study|Physician Decision|5|||
125122278|NCT00797108|450074011|FG000|Overall Study|Randomized but not Treated|2|||
125122279|NCT00797108|450074012|FG001|Overall Study|Randomized but not Treated|0|||
125122280|NCT00797108|450074013|FG002|Overall Study|Randomized but not Treated|0|||
125122281|NCT02270736|450074014|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
125122282|NCT02270736|450074015|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
125122283|NCT02270736|450074016|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
125122284|NCT02270736|450074017|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
125122285|NCT02270736|450074018|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
125122286|NCT02270736|450074014|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
125122287|NCT02270736|450074015|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
125122288|NCT02270736|450074016|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
125122289|NCT02270736|450074017|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
125122290|NCT02270736|450074018|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
125122291|NCT02270736|450074014|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
125122292|NCT02270736|450074015|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
125122293|NCT02270736|450074016|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
125122294|NCT02270736|450074017|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
125122295|NCT02270736|450074018|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
125122296|NCT02270736|450074014|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
125122297|NCT02270736|450074015|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
125122298|NCT02270736|450074016|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
125122299|NCT02270736|450074017|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
125122300|NCT02270736|450074018|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
125122301|NCT02270736|450074014|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
125122302|NCT02270736|450074015|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
125122303|NCT02270736|450074016|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
125122304|NCT02270736|450074017|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
125122305|NCT02270736|450074018|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
125122306|NCT02270736|450074014|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
125122307|NCT02270736|450074015|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
125122308|NCT02270736|450074016|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
125122309|NCT02270736|450074017|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
125122310|NCT02270736|450074018|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
125122311|NCT02270736|450074014|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
125122312|NCT02270736|450074015|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
125122313|NCT02270736|450074016|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
125122314|NCT02270736|450074017|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
125122315|NCT02270736|450074018|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
125122316|NCT02270736|450074014|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
125122317|NCT02270736|450074015|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
125122318|NCT02270736|450074016|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
125122319|NCT02270736|450074017|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
124941531|NCT01640951|449413183|FG002|Overall Study|Physician Decision|2|||
124941532|NCT01640951|449413184|FG003|Overall Study|Physician Decision|2|||
124941533|NCT01640951|449413185|FG004|Overall Study|Physician Decision|2|||
124941534|NCT01640951|449413186|FG005|Overall Study|Physician Decision|3|||
124941535|NCT01640951|449413187|FG006|Overall Study|Physician Decision|3|||
124941536|NCT01640951|449413188|FG007|Overall Study|Physician Decision|0|||
125213439|NCT01890759|450409643|FG001|Overall Study|Protocol Violation|2|||
124941537|NCT01640951|449413181|FG000|Overall Study|Pregnancy|3|||
124941538|NCT01640951|449413182|FG001|Overall Study|Pregnancy|0|||
124941539|NCT01640951|449413183|FG002|Overall Study|Pregnancy|0|||
124941540|NCT01640951|449413184|FG003|Overall Study|Pregnancy|4|||
124941541|NCT01640951|449413185|FG004|Overall Study|Pregnancy|0|||
124941542|NCT01640951|449413186|FG005|Overall Study|Pregnancy|0|||
124941543|NCT01640951|449413187|FG006|Overall Study|Pregnancy|2|||
124941544|NCT01640951|449413188|FG007|Overall Study|Pregnancy|0|||
124941545|NCT01640951|449413181|FG000|Overall Study|Protocol Deviation|0|||
124941546|NCT01640951|449413182|FG001|Overall Study|Protocol Deviation|1|||
124941547|NCT01640951|449413183|FG002|Overall Study|Protocol Deviation|2|||
124941548|NCT01640951|449413184|FG003|Overall Study|Protocol Deviation|1|||
124941549|NCT01640951|449413185|FG004|Overall Study|Protocol Deviation|0|||
124941550|NCT01640951|449413186|FG005|Overall Study|Protocol Deviation|1|||
124941551|NCT01640951|449413187|FG006|Overall Study|Protocol Deviation|0|||
124941552|NCT01640951|449413188|FG007|Overall Study|Protocol Deviation|0|||
124941553|NCT01640951|449413181|FG000|Overall Study|Subject/Guardian decision|12|||
124941554|NCT01640951|449413182|FG001|Overall Study|Subject/Guardian decision|4|||
124941555|NCT01640951|449413183|FG002|Overall Study|Subject/Guardian decision|13|||
124941556|NCT01640951|449413184|FG003|Overall Study|Subject/Guardian decision|15|||
124941557|NCT01640951|449413185|FG004|Overall Study|Subject/Guardian decision|7|||
124941558|NCT01640951|449413186|FG005|Overall Study|Subject/Guardian decision|19|||
124941559|NCT01640951|449413187|FG006|Overall Study|Subject/Guardian decision|5|||
124941560|NCT01640951|449413188|FG007|Overall Study|Subject/Guardian decision|4|||
124941561|NCT01640951|449413181|FG000|Overall Study|Death|0|||
124941562|NCT01640951|449413182|FG001|Overall Study|Death|1|||
124941563|NCT01640951|449413183|FG002|Overall Study|Death|1|||
124941564|NCT01640951|449413184|FG003|Overall Study|Death|0|||
124941565|NCT01640951|449413185|FG004|Overall Study|Death|0|||
124941566|NCT01640951|449413186|FG005|Overall Study|Death|0|||
124941567|NCT01640951|449413187|FG006|Overall Study|Death|0|||
125213440|NCT01890759|450409642|FG000|Overall Study|Lost to Follow-up|0|||
125213441|NCT01890759|450409643|FG001|Overall Study|Lost to Follow-up|2|||
125213442|NCT01890759|450409642|FG000|Overall Study|Withdrawal by Subject|2|||
125213443|NCT01890759|450409643|FG001|Overall Study|Withdrawal by Subject|8|||
125213444|NCT00171158|450409644|FG000|Core Study|Death|27|||
125213445|NCT00171158|450409644|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
124941568|NCT01640951|449413188|FG007|Overall Study|Death|2|||
124941569|NCT02406092|449413189|FG000|Overall Study|Screen failure|10|||
124941570|NCT02406092|449413190|FG001|Overall Study|Screen failure|7|||
124941571|NCT02406092|449413189|FG000|Overall Study|Death|22|||
124941572|NCT02406092|449413190|FG001|Overall Study|Death|5|||
125213446|NCT00171158|450409644|FG000|Core Study|Protocol Violation|4|||
125213447|NCT00171158|450409644|FG000|Core Study|Administrative problems|1|||
125213448|NCT00171158|450409644|FG000|Core Study|Adverse event, non-fatal|21|||
125213449|NCT00171158|450409644|FG000|Core Study|Consent withdrawn by subject|6|||
125213450|NCT00171158|450409644|FG000|Core Study|No longer required drug (BMT)|14|||
125213451|NCT00171158|450409644|FG000|Core Study|Abnormal Laboratory Values|2|||
125213452|NCT00171158|450409644|FG000|Core Study|Lost to Follow-up|1|||
125213453|NCT00171158|450409644|FG000|E2 Extension|Other|7|||
124941573|NCT02406092|449413189|FG000|Overall Study|Lost to Follow-up|4|||
124941574|NCT02406092|449413190|FG001|Overall Study|Lost to Follow-up|1|||
124941575|NCT02406092|449413189|FG000|Overall Study|Adverse Event|1|||
124941576|NCT02406092|449413190|FG001|Overall Study|Adverse Event|0|||
124941577|NCT02406092|449413189|FG000|Overall Study|Withdrawal by Subject|1|||
124941578|NCT02406092|449413190|FG001|Overall Study|Withdrawal by Subject|0|||
124941579|NCT03041233|449413193|FG000|Overall Study|Death|5|||
124941580|NCT03041233|449413193|FG000|Overall Study|Physician Decision|1|||
124941581|NCT03041233|449413193|FG000|Overall Study|Lost to Follow-up|16|||
124941582|NCT03041233|449413193|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
125213454|NCT03536663|450409649|FG000|Endexo|Protocol Violation|1|||
124941583|NCT03041233|449413193|FG000|Overall Study|Sponsor Request|1|||
125213455|NCT01471444|450409652|FG000|Overall Study|Physician Decision|3|||
125213456|NCT01471444|450409653|FG001|Overall Study|Physician Decision|2|||
124941584|NCT03041233|449413193|FG000|Overall Study|Duplicate subject|1|||
124941585|NCT03041233|449413193|FG000|Overall Study|Re-ablation|1|||
124941586|NCT00942266|449413194|FG000|Overall Study|Withdrawal by Subject|1|||
124941587|NCT00942266|449413195|FG001|Overall Study|Withdrawal by Subject|0|||
124941588|NCT00942266|449413194|FG000|Overall Study|Adverse Event|2|||
124941589|NCT00942266|449413195|FG001|Overall Study|Adverse Event|1|||
124941590|NCT00942266|449413194|FG000|Overall Study|Disease Progression|38|||
124941591|NCT00942266|449413195|FG001|Overall Study|Disease Progression|11|||
124941592|NCT00942266|449413194|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
124941593|NCT00942266|449413195|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
124941594|NCT00942266|449413194|FG000|Overall Study|Intercurrent illness|0|||
124941595|NCT00942266|449413195|FG001|Overall Study|Intercurrent illness|1|||
125213457|NCT01471444|450409652|FG000|Overall Study|Withdrawal by Subject|0|||
125213458|NCT01471444|450409653|FG001|Overall Study|Withdrawal by Subject|1|||
125213459|NCT01031004|450409654|FG000|Overall Study|Protocol Violation|0|||
125213460|NCT01031004|450409655|FG001|Overall Study|Protocol Violation|1|||
125213461|NCT01031004|450409654|FG000|Overall Study|Lost to Follow-up|1|||
125213462|NCT01031004|450409655|FG001|Overall Study|Lost to Follow-up|0|||
125213463|NCT02634801|450409656|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
125213464|NCT02634801|450409657|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
125213465|NCT02634801|450409658|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
125213466|NCT02634801|450409656|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
125213467|NCT02634801|450409657|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
125213468|NCT02634801|450409658|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
125213469|NCT02634801|450409656|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
125213470|NCT02634801|450409657|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
125213471|NCT02634801|450409658|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
125213472|NCT02634801|450409656|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
125213473|NCT02634801|450409657|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
125213474|NCT02634801|450409658|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
125213475|NCT02634801|450409656|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
125213476|NCT02634801|450409657|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
125213477|NCT02634801|450409658|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
125213478|NCT02634801|450409656|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
125213479|NCT02634801|450409657|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
125213480|NCT02634801|450409658|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
125213481|NCT02634801|450409656|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
125213482|NCT02634801|450409657|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
125213483|NCT02634801|450409658|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
125213484|NCT02634801|450409656|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
125213485|NCT02634801|450409657|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
125213486|NCT02634801|450409658|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
125213487|NCT02634801|450409656|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
125213488|NCT02634801|450409657|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
125213489|NCT02634801|450409658|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
125213490|NCT02634801|450409656|FG000|Follow-up Period|Lost to Follow-up|3|||
125213491|NCT02634801|450409657|FG001|Follow-up Period|Lost to Follow-up|1|||
125213492|NCT02634801|450409658|FG002|Follow-up Period|Lost to Follow-up|2|||
125213493|NCT02634801|450409656|FG000|Follow-up Period|Physician Decision|0|||
125213494|NCT02634801|450409657|FG001|Follow-up Period|Physician Decision|0|||
125213495|NCT02634801|450409658|FG002|Follow-up Period|Physician Decision|1|||
125213496|NCT02634801|450409656|FG000|Follow-up Period|Withdrawal by Subject|1|||
125213497|NCT02634801|450409657|FG001|Follow-up Period|Withdrawal by Subject|2|||
125213498|NCT02634801|450409658|FG002|Follow-up Period|Withdrawal by Subject|5|||
125213499|NCT02634801|450409656|FG000|Follow-up Period|Adverse Event|1|||
125213500|NCT02634801|450409657|FG001|Follow-up Period|Adverse Event|5|||
125213501|NCT02634801|450409658|FG002|Follow-up Period|Adverse Event|0|||
125213502|NCT00582426|450409659|FG000|Overall Study|Lost to Follow-up|0|||
125213503|NCT00582426|450409660|FG001|Overall Study|Lost to Follow-up|2|||
125213504|NCT00582426|450409659|FG000|Overall Study|Adverse Event|4|||
125213505|NCT00582426|450409660|FG001|Overall Study|Adverse Event|2|||
125213506|NCT00582426|450409659|FG000|Overall Study|Protocol Violation|6|||
125213507|NCT00582426|450409660|FG001|Overall Study|Protocol Violation|2|||
125213508|NCT00582426|450409659|FG000|Overall Study|Death|4|||
125213509|NCT00582426|450409660|FG001|Overall Study|Death|3|||
125213510|NCT00582426|450409659|FG000|Overall Study|Withdrawal by Subject|3|||
125213511|NCT00582426|450409660|FG001|Overall Study|Withdrawal by Subject|2|||
125213512|NCT00582426|450409659|FG000|Overall Study|Disease Progression|2|||
125213513|NCT00582426|450409660|FG001|Overall Study|Disease Progression|2|||
125213514|NCT00582426|450409659|FG000|Overall Study|Use of illicit drugs|1|||
125213515|NCT00582426|450409660|FG001|Overall Study|Use of illicit drugs|0|||
125213516|NCT00662311|450409661|FG000|Overall Study|Respiratory Infection|1|||
125213517|NCT00662311|450409662|FG001|Overall Study|Respiratory Infection|0|||
125213518|NCT00662311|450409663|FG002|Overall Study|Respiratory Infection|0|||
125213519|NCT01467271|450409666|FG000|Overall Study|Death|84|||
125213520|NCT01467271|450409666|FG000|Overall Study|Lost to Follow-up|83|||
125213521|NCT01467271|450409666|FG000|Overall Study|Retraction of patient's consent|21|||
125213522|NCT01467271|450409666|FG000|Overall Study|Other reason|14|||
125213523|NCT01548768|450409667|FG000|Overall Study|Withdrawal by Subject|0|||
125213524|NCT01548768|450409668|FG001|Overall Study|Withdrawal by Subject|2|||
125213525|NCT01548768|450409669|FG002|Overall Study|Withdrawal by Subject|1|||
125213526|NCT01548768|450409670|FG003|Overall Study|Withdrawal by Subject|0|||
125213527|NCT01548768|450409667|FG000|Overall Study|Physician Decision|1|||
125213528|NCT01548768|450409668|FG001|Overall Study|Physician Decision|0|||
125213529|NCT01548768|450409669|FG002|Overall Study|Physician Decision|0|||
125213530|NCT01548768|450409670|FG003|Overall Study|Physician Decision|0|||
125213531|NCT01548768|450409667|FG000|Overall Study|Adverse Event|0|||
125213532|NCT01548768|450409668|FG001|Overall Study|Adverse Event|0|||
124941596|NCT00942266|449413194|FG000|Overall Study|Physician Decision|2|||
124941597|NCT00942266|449413195|FG001|Overall Study|Physician Decision|0|||
124941598|NCT00942266|449413194|FG000|Overall Study|medical deterioration (pneumonia)|0|||
124941599|NCT00942266|449413195|FG001|Overall Study|medical deterioration (pneumonia)|1|||
124941600|NCT00756574|449413199|FG000|Overall Study|Withdrawal by Subject|9|||
124941601|NCT00756574|449413200|FG001|Overall Study|Withdrawal by Subject|7|||
124941602|NCT00756574|449413199|FG000|Overall Study|Lost to Follow-up|4|||
124941603|NCT00756574|449413200|FG001|Overall Study|Lost to Follow-up|4|||
124941604|NCT04035447|449413201|FG000|Treatment Period|Lost to Follow-up|6|||
124941605|NCT04035447|449413202|FG001|Treatment Period|Lost to Follow-up|5|||
124941606|NCT04035447|449413201|FG000|Treatment Period|Physician Decision|0|||
125213533|NCT01548768|450409669|FG002|Overall Study|Adverse Event|0|||
125213534|NCT01548768|450409670|FG003|Overall Study|Adverse Event|1|||
125213535|NCT01548768|450409667|FG000|Overall Study|Non-Compliance|0|||
125213536|NCT01548768|450409668|FG001|Overall Study|Non-Compliance|0|||
125213537|NCT01548768|450409669|FG002|Overall Study|Non-Compliance|0|||
125213538|NCT01548768|450409670|FG003|Overall Study|Non-Compliance|3|||
125213539|NCT04126317|450409687|FG000|Overall Study|Adverse Event|0|||
125213540|NCT04126317|450409688|FG001|Overall Study|Adverse Event|1|||
125213541|NCT04126317|450409687|FG000|Overall Study|Withdrawal by Subject|4|||
125213542|NCT04126317|450409688|FG001|Overall Study|Withdrawal by Subject|1|||
125213543|NCT01796301|450409689|FG000|Overall Study|Withdrawal by Subject|15|||
125213544|NCT01796301|450409690|FG001|Overall Study|Withdrawal by Subject|15|||
125213545|NCT01796301|450409689|FG000|Overall Study|Lost to Follow-up|3|||
125213546|NCT01796301|450409690|FG001|Overall Study|Lost to Follow-up|3|||
125213547|NCT01796301|450409689|FG000|Overall Study|Death|0|||
125213548|NCT01796301|450409690|FG001|Overall Study|Death|1|||
125213549|NCT01796301|450409689|FG000|Overall Study|Decision by Sponsor|0|||
125213550|NCT01796301|450409690|FG001|Overall Study|Decision by Sponsor|1|||
125213551|NCT00667563|450409691|FG000|Overall Study|Protocol Violation|24|||
125213552|NCT00264290|450409692|FG000|Intervention (8 Weeks)|Adverse Event|1|||
125213553|NCT00264290|450409693|FG001|Intervention (8 Weeks)|Adverse Event|0|||
125213554|NCT01939223|450409694|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
125213555|NCT01939223|450409695|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
125213556|NCT01939223|450409694|FG000|Overall Study|Disease recurrence (radiological)|1|||
125213557|NCT01939223|450409695|FG001|Overall Study|Disease recurrence (radiological)|3|||
125213558|NCT01939223|450409694|FG000|Overall Study|Study stopped by Sponsor|5|||
125213559|NCT01939223|450409695|FG001|Overall Study|Study stopped by Sponsor|7|||
125213560|NCT01939223|450409694|FG000|Overall Study|Withdrawal by Subject|6|||
125213561|NCT01939223|450409695|FG001|Overall Study|Withdrawal by Subject|0|||
125213562|NCT01557517|450409696|FG000|Overall Study|Death|1|||
125213563|NCT01557517|450409697|FG001|Overall Study|Death|0|||
125213564|NCT01557517|450409696|FG000|Overall Study|Refused further treatment|0|||
125213565|NCT01557517|450409697|FG001|Overall Study|Refused further treatment|2|||
125213566|NCT01557517|450409696|FG000|Overall Study|Adverse Event|0|||
125213567|NCT01557517|450409697|FG001|Overall Study|Adverse Event|2|||
125213568|NCT01557517|450409696|FG000|Overall Study|Pt declined before treatment started|1|||
125213569|NCT01557517|450409697|FG001|Overall Study|Pt declined before treatment started|0|||
125213570|NCT00162097|450409698|FG000|Overall Study|Participant no longer met study criteria|0|||
125213571|NCT00162097|450409699|FG001|Overall Study|Participant no longer met study criteria|0|||
125213572|NCT00162097|450409700|FG002|Overall Study|Participant no longer met study criteria|0|||
125213573|NCT00162097|450409701|FG003|Overall Study|Participant no longer met study criteria|1|||
125213574|NCT03585712|450409704|FG000|Treatment Period 1|Protocol Violation|1|||
125213575|NCT03585712|450409705|FG001|Treatment Period 1|Protocol Violation|0|||
125213576|NCT03585712|450409706|FG002|Treatment Period 1|Protocol Violation|0|||
125213577|NCT03585712|450409704|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
125213578|NCT03585712|450409705|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
125213579|NCT03585712|450409706|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
125213580|NCT03585712|450409704|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
125213581|NCT03585712|450409705|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
125213582|NCT03585712|450409706|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
125213583|NCT03585712|450409704|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
125213584|NCT03585712|450409705|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
125213585|NCT03585712|450409706|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
125213586|NCT01280682|450409713|FG000|Overall Study|Lost to Follow-up|0|||
124941607|NCT04035447|449413202|FG001|Treatment Period|Physician Decision|2|||
124941608|NCT02816398|449413204|FG000|Overall Study|Death|5|||
125027594|NCT02913313|449725558|FG012|Overall Study|Withdrawal by Subject|0|||
125213587|NCT01280682|450409714|FG001|Overall Study|Lost to Follow-up|6|||
125213588|NCT01280682|450409713|FG000|Overall Study|Withdrawal by Subject|0|||
125213589|NCT01280682|450409714|FG001|Overall Study|Withdrawal by Subject|7|||
125213590|NCT01964716|450409723|FG000|Overall Study|Withdrawal by Subject|2|||
125213591|NCT01964716|450409724|FG001|Overall Study|Withdrawal by Subject|3|||
125213592|NCT01964716|450409723|FG000|Overall Study|Lost to Follow-up|1|||
125213593|NCT01964716|450409724|FG001|Overall Study|Lost to Follow-up|2|||
125027595|NCT02913313|449725559|FG013|Overall Study|Withdrawal by Subject|0|||
125027596|NCT02913313|449725546|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125027597|NCT02913313|449725547|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125027598|NCT02913313|449725548|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125027599|NCT02913313|449725549|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125027600|NCT02913313|449725550|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125122320|NCT02270736|450074018|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
125122321|NCT02270736|450074014|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
125122322|NCT02270736|450074015|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
125122323|NCT02270736|450074016|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
125122324|NCT02270736|450074017|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
125122325|NCT02270736|450074018|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
125122326|NCT04471207|450074021|FG000|Overall Study|Lost to Follow-up|4|||
125122327|NCT04471207|450074022|FG001|Overall Study|Lost to Follow-up|1|||
125122328|NCT04471207|450074021|FG000|Overall Study|Medication Contraindication|0|||
125122329|NCT04471207|450074022|FG001|Overall Study|Medication Contraindication|1|||
125122330|NCT04471207|450074021|FG000|Overall Study|Loss of Interest|2|||
125122331|NCT04471207|450074022|FG001|Overall Study|Loss of Interest|1|||
125122332|NCT04471207|450074021|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
125122333|NCT04471207|450074022|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
125122334|NCT04471207|450074021|FG000|Overall Study|Scheduling Conflicts|3|||
125122335|NCT04471207|450074022|FG001|Overall Study|Scheduling Conflicts|1|||
125122336|NCT04471207|450074021|FG000|Overall Study|Physician Decision|1|||
125122337|NCT04471207|450074022|FG001|Overall Study|Physician Decision|0|||
125122338|NCT04471207|450074021|FG000|Overall Study|Unwilling to Use System|0|||
125122339|NCT04471207|450074022|FG001|Overall Study|Unwilling to Use System|1|||
125122340|NCT00561730|450074023|FG000|Overall Study|Adverse Event|2|||
125122341|NCT00561730|450074023|FG000|Overall Study|Handling of the drug|1|||
125122342|NCT00561730|450074023|FG000|Overall Study|Lost to Follow-up|5|||
125122343|NCT00561730|450074023|FG000|Overall Study|Not specified reasons|1|||
125122344|NCT00376220|450074024|FG000|Overall Study|Lost to Follow-up|7|||
125122345|NCT00376220|450074025|FG001|Overall Study|Lost to Follow-up|10|||
125122346|NCT00376220|450074024|FG000|Overall Study|Withdrawal by Subject|3|||
125122347|NCT00376220|450074025|FG001|Overall Study|Withdrawal by Subject|2|||
125122348|NCT00531206|450074030|FG000|Overall Study|Adverse Event related|5|||
125122349|NCT00531206|450074030|FG000|Overall Study|Lack of Efficacy|2|||
125122350|NCT00531206|450074030|FG000|Overall Study|Lost to Follow-up|5|||
125122351|NCT00531206|450074030|FG000|Overall Study|including non-related adverse events|8|||
125122352|NCT00920140|450074031|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
125122353|NCT00920140|450074032|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
125122354|NCT00920140|450074033|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
125122355|NCT00920140|450074034|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
125122356|NCT00920140|450074035|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
125122357|NCT00920140|450074031|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
125122358|NCT00920140|450074032|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
125122359|NCT00920140|450074033|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
125122360|NCT00920140|450074034|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
125027601|NCT02913313|449725551|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125027602|NCT02913313|449725552|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125027603|NCT02913313|449725553|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125027604|NCT02913313|449725554|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125027605|NCT02913313|449725555|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125027606|NCT02913313|449725556|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
125027607|NCT02913313|449725557|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125027608|NCT02913313|449725558|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
125027609|NCT02913313|449725559|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
125027610|NCT02913313|449725546|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
125027611|NCT02913313|449725547|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
125027612|NCT02913313|449725548|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
125027613|NCT02913313|449725549|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
125027614|NCT02913313|449725550|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
125027615|NCT02913313|449725551|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
125122361|NCT00920140|450074035|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
125122362|NCT00920140|450074031|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125122363|NCT00920140|450074032|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
125122364|NCT00920140|450074033|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125122365|NCT00920140|450074034|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125027616|NCT02913313|449725552|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
125027617|NCT02913313|449725553|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
125027618|NCT02913313|449725554|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
125027619|NCT02913313|449725555|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
125027620|NCT02913313|449725556|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
125027621|NCT02913313|449725557|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
125027622|NCT02913313|449725558|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
125027623|NCT02913313|449725559|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
125027624|NCT04233229|449725562|FG000|Overall Study|Withdrawal by Subject|0|||
125027625|NCT04233229|449725563|FG001|Overall Study|Withdrawal by Subject|1|||
125027626|NCT04233229|449725562|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
125027627|NCT04233229|449725563|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
125027628|NCT04233229|449725562|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
125027629|NCT04233229|449725563|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
125027630|NCT00841763|449725564|FG000|Overall Study|Withdrawal by Subject|60|||
125027631|NCT00841763|449725565|FG001|Overall Study|Withdrawal by Subject|17|||
125027632|NCT00841763|449725566|FG002|Overall Study|Withdrawal by Subject|4|||
125027633|NCT00841763|449725567|FG003|Overall Study|Withdrawal by Subject|1|||
125027634|NCT00841763|449725564|FG000|Overall Study|Adverse Event|9|||
125027635|NCT00841763|449725565|FG001|Overall Study|Adverse Event|10|||
125027636|NCT00841763|449725566|FG002|Overall Study|Adverse Event|3|||
125027637|NCT00841763|449725567|FG003|Overall Study|Adverse Event|2|||
125027638|NCT00841763|449725564|FG000|Overall Study|Lost to Follow-up|63|||
125027639|NCT00841763|449725565|FG001|Overall Study|Lost to Follow-up|25|||
125027640|NCT00841763|449725566|FG002|Overall Study|Lost to Follow-up|0|||
125027641|NCT00841763|449725567|FG003|Overall Study|Lost to Follow-up|0|||
125027642|NCT00841763|449725564|FG000|Overall Study|Protocol Violation|20|||
125027643|NCT00841763|449725565|FG001|Overall Study|Protocol Violation|3|||
125027644|NCT00841763|449725566|FG002|Overall Study|Protocol Violation|1|||
125027645|NCT00841763|449725567|FG003|Overall Study|Protocol Violation|0|||
125027646|NCT00841763|449725564|FG000|Overall Study|Administrative Reasons|3|||
125027647|NCT00841763|449725565|FG001|Overall Study|Administrative Reasons|1|||
125027648|NCT00841763|449725566|FG002|Overall Study|Administrative Reasons|0|||
125027649|NCT00841763|449725567|FG003|Overall Study|Administrative Reasons|0|||
125027650|NCT00841763|449725564|FG000|Overall Study|Unable to Classify|7|||
125027651|NCT00841763|449725565|FG001|Overall Study|Unable to Classify|1|||
125027652|NCT00841763|449725566|FG002|Overall Study|Unable to Classify|0|||
125027653|NCT00841763|449725567|FG003|Overall Study|Unable to Classify|0|||
125027654|NCT02631538|449725568|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
125027655|NCT02631538|449725569|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
125027656|NCT02631538|449725570|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
125027657|NCT02631538|449725571|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
125027658|NCT02631538|449725568|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
125122366|NCT00920140|450074035|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125122367|NCT00920140|450074031|FG000|Phase 2|Adverse Event|0|||
125122368|NCT00920140|450074032|FG001|Phase 2|Adverse Event|0|||
125122369|NCT00920140|450074033|FG002|Phase 2|Adverse Event|14|||
125122370|NCT00920140|450074034|FG003|Phase 2|Adverse Event|2|||
125122371|NCT00920140|450074035|FG004|Phase 2|Adverse Event|3|||
125122372|NCT00920140|450074031|FG000|Phase 2|Lack of Efficacy|0|||
125122373|NCT00920140|450074032|FG001|Phase 2|Lack of Efficacy|0|||
125122374|NCT00920140|450074033|FG002|Phase 2|Lack of Efficacy|29|||
125122375|NCT00920140|450074034|FG003|Phase 2|Lack of Efficacy|14|||
125122376|NCT00920140|450074035|FG004|Phase 2|Lack of Efficacy|5|||
125122377|NCT00920140|450074031|FG000|Phase 2|Lost to Follow-up|0|||
125122378|NCT00920140|450074032|FG001|Phase 2|Lost to Follow-up|0|||
125122379|NCT00920140|450074033|FG002|Phase 2|Lost to Follow-up|0|||
125122380|NCT00920140|450074034|FG003|Phase 2|Lost to Follow-up|1|||
125122381|NCT00920140|450074035|FG004|Phase 2|Lost to Follow-up|0|||
125122382|NCT00920140|450074031|FG000|Phase 2|Physician Decision|0|||
125122383|NCT00920140|450074032|FG001|Phase 2|Physician Decision|0|||
125027659|NCT02631538|449725569|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
125027660|NCT02631538|449725570|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
125027661|NCT02631538|449725571|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
125027662|NCT02631538|449725568|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
125027663|NCT02631538|449725569|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
125027664|NCT02631538|449725570|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
125122384|NCT00920140|450074033|FG002|Phase 2|Physician Decision|3|||
125122385|NCT00920140|450074034|FG003|Phase 2|Physician Decision|3|||
125122386|NCT00920140|450074035|FG004|Phase 2|Physician Decision|2|||
125122387|NCT00920140|450074031|FG000|Phase 2|Withdrawal by Subject|0|||
125122388|NCT00920140|450074032|FG001|Phase 2|Withdrawal by Subject|0|||
125122389|NCT00920140|450074033|FG002|Phase 2|Withdrawal by Subject|4|||
125122390|NCT00920140|450074034|FG003|Phase 2|Withdrawal by Subject|2|||
124941609|NCT02816398|449413204|FG000|Overall Study|Lack of Efficacy|8|||
124941610|NCT02816398|449413204|FG000|Overall Study|Lost to Follow-up|1|||
124941611|NCT01588951|449413205|FG000|Overall Study|Ineligible in retrospect|0|||
124941612|NCT01588951|449413206|FG001|Overall Study|Ineligible in retrospect|0|||
124941613|NCT01588951|449413207|FG002|Overall Study|Ineligible in retrospect|1|||
124941614|NCT02130557|449413210|FG000|Overall Study|Withdrawal by Subject|12|||
124941615|NCT02130557|449413211|FG001|Overall Study|Withdrawal by Subject|12|||
124941616|NCT02130557|449413210|FG000|Overall Study|Investigator Request|0|||
124941617|NCT02130557|449413211|FG001|Overall Study|Investigator Request|2|||
124941618|NCT02130557|449413210|FG000|Overall Study|Deceased|14|||
124941619|NCT02130557|449413211|FG001|Overall Study|Deceased|14|||
124941620|NCT02130557|449413210|FG000|Overall Study|Lost to Follow-up|6|||
124941621|NCT02130557|449413211|FG001|Overall Study|Lost to Follow-up|7|||
124941622|NCT02130557|449413210|FG000|Overall Study|Other|2|||
124941623|NCT02130557|449413211|FG001|Overall Study|Other|1|||
124941624|NCT02130557|449413210|FG000|Overall Study|Missing|2|||
124941625|NCT02130557|449413211|FG001|Overall Study|Missing|1|||
125027665|NCT02631538|449725571|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
125027666|NCT02631538|449725568|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
125027667|NCT02631538|449725569|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
125027668|NCT02631538|449725570|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
125027669|NCT02631538|449725571|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
125027670|NCT02631538|449725568|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
125027671|NCT02631538|449725569|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
125027672|NCT02631538|449725570|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
125027673|NCT02631538|449725571|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
125027674|NCT02631538|449725568|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
125027675|NCT02631538|449725569|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
125027676|NCT02631538|449725570|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
125027677|NCT02631538|449725571|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
125027678|NCT00440726|449725576|FG000|Phase 1|Dose-Limiting Toxicity|0|||
125027679|NCT00440726|449725577|FG001|Phase 1|Dose-Limiting Toxicity|1|||
125027680|NCT00440726|449725578|FG002|Phase 1|Dose-Limiting Toxicity|0|||
125027681|NCT00440726|449725576|FG000|Phase 1|Physician Decision|1|||
125027682|NCT00440726|449725577|FG001|Phase 1|Physician Decision|0|||
125027683|NCT00440726|449725578|FG002|Phase 1|Physician Decision|0|||
125027684|NCT00440726|449725576|FG000|Phase 2|Death|0|||
125027685|NCT00440726|449725577|FG001|Phase 2|Death|0|||
125027686|NCT00440726|449725578|FG002|Phase 2|Death|1|||
125027687|NCT00440726|449725576|FG000|Phase 2|Adverse Event|0|||
125027688|NCT00440726|449725577|FG001|Phase 2|Adverse Event|0|||
125027689|NCT00440726|449725578|FG002|Phase 2|Adverse Event|1|||
125027690|NCT01482910|449725579|FG000|Overall Study|Adverse Event|6|||
125027691|NCT01482910|449725580|FG001|Overall Study|Adverse Event|5|||
125027692|NCT01482910|449725579|FG000|Overall Study|Lost to Follow-up|0|||
125027693|NCT01482910|449725580|FG001|Overall Study|Lost to Follow-up|1|||
125027694|NCT01482910|449725579|FG000|Overall Study|Protocol Violation|1|||
125027695|NCT01482910|449725580|FG001|Overall Study|Protocol Violation|1|||
125122391|NCT00920140|450074035|FG004|Phase 2|Withdrawal by Subject|1|||
124941626|NCT02408887|449413212|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
125122392|NCT01124149|450074036|FG000|Acute Phase|Withdrawal by Subject|22|||
125122393|NCT01124149|450074036|FG000|Acute Phase|Adverse Event|21|||
125122394|NCT01124149|450074036|FG000|Acute Phase|Lack of Efficacy|17|||
125122395|NCT01124149|450074036|FG000|Acute Phase|Protocol Violation|14|||
125122396|NCT01124149|450074036|FG000|Acute Phase|Lost to Follow-up|2|||
125122397|NCT01124149|450074036|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
125122398|NCT01124149|450074036|FG000|Acute Phase|Sponsor request|1|||
125122399|NCT01124149|450074036|FG000|Acute Phase|UC symptoms not ameliorated|1|||
125122400|NCT01124149|450074036|FG000|Acute Phase|Non-compliance|1|||
125122401|NCT01124149|450074036|FG000|Acute Phase|Low hemoglobin|1|||
125122402|NCT01124149|450074036|FG000|Acute Phase|Travelling to another country|1|||
125122403|NCT01124149|450074036|FG000|Acute Phase|Sponsor decision|1|||
125122404|NCT01124149|450074036|FG000|Maintenance Phase|Lack of Efficacy|40|||
125122405|NCT01124149|450074036|FG000|Maintenance Phase|Adverse Event|24|||
125122406|NCT01124149|450074036|FG000|Maintenance Phase|Lost to Follow-up|15|||
125122407|NCT01124149|450074036|FG000|Maintenance Phase|Withdrawal by Subject|10|||
125122408|NCT01124149|450074036|FG000|Maintenance Phase|Protocol Violation|5|||
125122409|NCT01124149|450074036|FG000|Maintenance Phase|Coordinator error|1|||
125122410|NCT01124149|450074036|FG000|Maintenance Phase|Non-compliance|1|||
125122411|NCT01644500|450074037|FG000|Overall Study|Adverse Event|6|||
125122412|NCT01644500|450074038|FG001|Overall Study|Adverse Event|1|||
125122413|NCT01644500|450074039|FG002|Overall Study|Adverse Event|2|||
125122414|NCT01644500|450074037|FG000|Overall Study|Death|0|||
125122415|NCT01644500|450074038|FG001|Overall Study|Death|1|||
125122416|NCT01644500|450074039|FG002|Overall Study|Death|0|||
125122417|NCT01644500|450074037|FG000|Overall Study|Lost to Follow-up|3|||
125122418|NCT01644500|450074038|FG001|Overall Study|Lost to Follow-up|8|||
125122419|NCT01644500|450074039|FG002|Overall Study|Lost to Follow-up|0|||
125122420|NCT01644500|450074037|FG000|Overall Study|Protocol Violation|1|||
125122421|NCT01644500|450074038|FG001|Overall Study|Protocol Violation|1|||
125122422|NCT01644500|450074039|FG002|Overall Study|Protocol Violation|0|||
125122423|NCT01644500|450074037|FG000|Overall Study|Withdrawal by Subject|11|||
125122424|NCT01644500|450074038|FG001|Overall Study|Withdrawal by Subject|12|||
125122425|NCT01644500|450074039|FG002|Overall Study|Withdrawal by Subject|12|||
125122426|NCT01644500|450074037|FG000|Overall Study|Physician Decision|1|||
125122427|NCT01644500|450074038|FG001|Overall Study|Physician Decision|1|||
125122428|NCT01644500|450074039|FG002|Overall Study|Physician Decision|1|||
125122429|NCT02153398|450074046|FG000|Overall Study|Withdrawal by Subject|1|||
125122430|NCT02153398|450074047|FG001|Overall Study|Withdrawal by Subject|0|||
125122431|NCT02153398|450074048|FG002|Overall Study|Withdrawal by Subject|0|||
125122432|NCT02153398|450074049|FG003|Overall Study|Withdrawal by Subject|0|||
125122433|NCT02153398|450074050|FG004|Overall Study|Withdrawal by Subject|0|||
125122434|NCT02153398|450074046|FG000|Overall Study|Adverse Event|0|||
125122435|NCT02153398|450074047|FG001|Overall Study|Adverse Event|0|||
125122436|NCT02153398|450074048|FG002|Overall Study|Adverse Event|1|||
125122437|NCT02153398|450074049|FG003|Overall Study|Adverse Event|1|||
125122438|NCT02153398|450074050|FG004|Overall Study|Adverse Event|0|||
125122439|NCT00721409|450074051|FG000|Overall Study|Global deterioration of health status|2|||
125122440|NCT00721409|450074052|FG001|Overall Study|Global deterioration of health status|6|||
125122441|NCT00721409|450074053|FG002|Overall Study|Global deterioration of health status|3|||
125122442|NCT00721409|450074051|FG000|Overall Study|Death|0|||
125122443|NCT00721409|450074052|FG001|Overall Study|Death|1|||
125122444|NCT00721409|450074053|FG002|Overall Study|Death|0|||
125122445|NCT00721409|450074051|FG000|Overall Study|Randomized not Treated|0|||
125122446|NCT00721409|450074052|FG001|Overall Study|Randomized not Treated|1|||
125122447|NCT00721409|450074053|FG002|Overall Study|Randomized not Treated|4|||
125213594|NCT01964716|450409723|FG000|Overall Study|No longer met eligibility criteria|1|||
125122448|NCT00721409|450074051|FG000|Overall Study|Reason not specified|1|||
125122449|NCT00721409|450074052|FG001|Overall Study|Reason not specified|0|||
125122450|NCT00721409|450074053|FG002|Overall Study|Reason not specified|2|||
125122451|NCT00721409|450074051|FG000|Overall Study|Adverse Event|0|||
125213595|NCT01964716|450409724|FG001|Overall Study|No longer met eligibility criteria|1|||
125122452|NCT00721409|450074052|FG001|Overall Study|Adverse Event|13|||
125213596|NCT01964716|450409723|FG000|Overall Study|Death|1|||
125213597|NCT01964716|450409724|FG001|Overall Study|Death|0|||
125213598|NCT01464619|450409725|FG000|Overall Study|Lost to Follow-up|3|||
125213599|NCT01464619|450409726|FG001|Overall Study|Lost to Follow-up|4|||
125213600|NCT02179749|450409732|FG000|Overall Study|Adverse Event|0|||
125213601|NCT02179749|450409733|FG001|Overall Study|Adverse Event|0|||
125213602|NCT02179749|450409734|FG002|Overall Study|Adverse Event|1|||
125213603|NCT02179749|450409732|FG000|Overall Study|Withdrawal by Subject|0|||
125213604|NCT02179749|450409733|FG001|Overall Study|Withdrawal by Subject|0|||
125213605|NCT02179749|450409734|FG002|Overall Study|Withdrawal by Subject|1|||
125213606|NCT02756364|450409735|FG000|Overall Study|Site Terminated by Sponsor|24|||
125213607|NCT02756364|450409736|FG001|Overall Study|Site Terminated by Sponsor|30|||
125213608|NCT02756364|450409737|FG002|Overall Study|Site Terminated by Sponsor|21|||
125213609|NCT02756364|450409735|FG000|Overall Study|Death|20|||
125213610|NCT02756364|450409736|FG001|Overall Study|Death|15|||
125213611|NCT02756364|450409737|FG002|Overall Study|Death|18|||
125213612|NCT02756364|450409735|FG000|Overall Study|Withdrawal by Patient|2|||
125213613|NCT02756364|450409736|FG001|Overall Study|Withdrawal by Patient|1|||
125213614|NCT02756364|450409737|FG002|Overall Study|Withdrawal by Patient|8|||
125213615|NCT02756364|450409735|FG000|Overall Study|Lost to Follow-up|0|||
125213616|NCT02756364|450409736|FG001|Overall Study|Lost to Follow-up|1|||
125213617|NCT02756364|450409737|FG002|Overall Study|Lost to Follow-up|1|||
125213618|NCT02655016|450409738|FG000|Overall Study|Disease progression|6|||
125213619|NCT02655016|450409739|FG001|Overall Study|Disease progression|4|||
125213620|NCT02655016|450409738|FG000|Overall Study|Site closed|0|||
125213621|NCT02655016|450409739|FG001|Overall Study|Site closed|1|||
125213622|NCT02655016|450409738|FG000|Overall Study|Death|30|||
125213623|NCT02655016|450409739|FG001|Overall Study|Death|48|||
125213624|NCT02655016|450409738|FG000|Overall Study|Lost to Follow-up|1|||
125213625|NCT02655016|450409739|FG001|Overall Study|Lost to Follow-up|1|||
125213626|NCT02655016|450409738|FG000|Overall Study|Withdrawal by Subject|18|||
125213627|NCT02655016|450409739|FG001|Overall Study|Withdrawal by Subject|36|||
125213628|NCT02223364|450409740|FG000|Overall Study|Protocol Violation|3|||
125213629|NCT02223364|450409741|FG001|Overall Study|Protocol Violation|0|||
125213630|NCT02223364|450409742|FG002|Overall Study|Protocol Violation|3|||
125213631|NCT02223364|450409740|FG000|Overall Study|subject expired before surgery|1|||
125213632|NCT02223364|450409741|FG001|Overall Study|subject expired before surgery|0|||
125213633|NCT02223364|450409742|FG002|Overall Study|subject expired before surgery|0|||
125213634|NCT02223364|450409740|FG000|Overall Study|Physician Decision|1|||
125213635|NCT02223364|450409741|FG001|Overall Study|Physician Decision|0|||
125122453|NCT00721409|450074053|FG002|Overall Study|Adverse Event|2|||
125122454|NCT00721409|450074051|FG000|Overall Study|Lost to Follow-up|0|||
125122455|NCT00721409|450074052|FG001|Overall Study|Lost to Follow-up|0|||
125122456|NCT00721409|450074053|FG002|Overall Study|Lost to Follow-up|1|||
125122457|NCT00721409|450074051|FG000|Overall Study|Withdrawal by Subject|1|||
125122458|NCT00721409|450074052|FG001|Overall Study|Withdrawal by Subject|6|||
125122459|NCT00721409|450074053|FG002|Overall Study|Withdrawal by Subject|5|||
125122460|NCT00721409|450074051|FG000|Overall Study|Objective progression or relapse|8|||
125122461|NCT00721409|450074052|FG001|Overall Study|Objective progression or relapse|55|||
125122462|NCT00721409|450074053|FG002|Overall Study|Objective progression or relapse|62|||
125122463|NCT02402166|450074054|FG000|Overall Study|Adverse Event|2|||
125122464|NCT02402166|450074054|FG000|Overall Study|Withdrawal by Subject|2|||
125122465|NCT02402166|450074054|FG000|Overall Study|Lost to Follow-up|1|||
125122466|NCT00322491|450074058|FG000|Overall Study|Adverse Event|1|||
125122467|NCT00322491|450074059|FG001|Overall Study|Adverse Event|0|||
125122468|NCT00322491|450074058|FG000|Overall Study|Death|1|||
125122469|NCT00322491|450074059|FG001|Overall Study|Death|2|||
125122470|NCT01400425|450074060|FG000|Overall Study|Withdrawal by Subject|10|||
125122471|NCT01424722|450074062|FG000|Overall Study|Sponsor terminated investigation|2258|||
125122472|NCT00818883|450074063|FG000|Overall Study|Adverse Event|28|||
125122473|NCT00818883|450074064|FG001|Overall Study|Adverse Event|19|||
125122474|NCT00818883|450074063|FG000|Overall Study|Protocol Violation|2|||
125122475|NCT00818883|450074064|FG001|Overall Study|Protocol Violation|2|||
125122476|NCT00818883|450074063|FG000|Overall Study|Lost to Follow-up|3|||
125122477|NCT00818883|450074064|FG001|Overall Study|Lost to Follow-up|2|||
125122478|NCT00818883|450074063|FG000|Overall Study|Withdrawal by Subject|16|||
125122479|NCT00818883|450074064|FG001|Overall Study|Withdrawal by Subject|14|||
125122480|NCT00818883|450074063|FG000|Overall Study|Lack of Efficacy|0|||
125122481|NCT00818883|450074064|FG001|Overall Study|Lack of Efficacy|2|||
125122482|NCT00818883|450074063|FG000|Overall Study|Other|2|||
125122483|NCT00818883|450074064|FG001|Overall Study|Other|7|||
125122484|NCT00048048|450074067|FG000|Core Treatment|Withdrawal by Subject|0|||
125122485|NCT00048048|450074068|FG001|Core Treatment|Withdrawal by Subject|0|||
125122486|NCT00048048|450074069|FG002|Core Treatment|Withdrawal by Subject|1|||
125122487|NCT00048048|450074070|FG003|Core Treatment|Withdrawal by Subject|0|||
125122488|NCT00048048|450074071|FG004|Core Treatment|Withdrawal by Subject|0|||
125122489|NCT00048048|450074072|FG005|Core Treatment|Withdrawal by Subject|0|||
125122490|NCT00048048|450074073|FG006|Core Treatment|Withdrawal by Subject|0|||
125122491|NCT00048048|450074074|FG007|Core Treatment|Withdrawal by Subject|0|||
125122492|NCT00048048|450074075|FG008|Core Treatment|Withdrawal by Subject|0|||
124941627|NCT02408887|449413213|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
124941628|NCT02408887|449413212|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
124941629|NCT02408887|449413213|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
124941630|NCT02517268|449413214|FG000|Overall Study|Withdrawal by Subject|1|||
124941631|NCT02517268|449413215|FG001|Overall Study|Withdrawal by Subject|0|||
124941632|NCT04912856|449413225|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
124941633|NCT04912856|449413226|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
124941634|NCT04912856|449413225|FG000|Overall Study|Not reported in synoptic CSR.|0|||
124941635|NCT04912856|449413226|FG001|Overall Study|Not reported in synoptic CSR.|1|||
124941636|NCT05613907|449413227|FG000|Overall Study|Lost to Follow-up|5|||
124941637|NCT05613907|449413227|FG000|Overall Study|Death|3|||
124941638|NCT05613907|449413227|FG000|Overall Study|Withdrawal by Subject|2|||
124941639|NCT00748709|449413230|FG000|Overall Study|Progressive disease|15|||
124941640|NCT00748709|449413230|FG000|Overall Study|Drug reducing Toxity|2|||
124941641|NCT00748709|449413230|FG000|Overall Study|Other Adverse Event|1|||
124941642|NCT00748709|449413230|FG000|Overall Study|Withdrawal by Subject|1|||
124941643|NCT00748709|449413230|FG000|Overall Study|Other Reasons|1|||
125122493|NCT00048048|450074076|FG009|Core Treatment|Withdrawal by Subject|0|||
125122494|NCT00048048|450074077|FG010|Core Treatment|Withdrawal by Subject|0|||
125122495|NCT00048048|450074078|FG011|Core Treatment|Withdrawal by Subject|0|||
125122496|NCT00048048|450074067|FG000|Core Treatment|Adverse Event|0|||
125122497|NCT00048048|450074068|FG001|Core Treatment|Adverse Event|0|||
125122498|NCT00048048|450074069|FG002|Core Treatment|Adverse Event|0|||
125122499|NCT00048048|450074070|FG003|Core Treatment|Adverse Event|0|||
125122500|NCT00048048|450074071|FG004|Core Treatment|Adverse Event|0|||
125122501|NCT00048048|450074072|FG005|Core Treatment|Adverse Event|0|||
125122502|NCT00048048|450074073|FG006|Core Treatment|Adverse Event|0|||
125122503|NCT00048048|450074074|FG007|Core Treatment|Adverse Event|1|||
125122504|NCT00048048|450074075|FG008|Core Treatment|Adverse Event|0|||
125122505|NCT00048048|450074076|FG009|Core Treatment|Adverse Event|0|||
125122506|NCT00048048|450074077|FG010|Core Treatment|Adverse Event|0|||
125122507|NCT00048048|450074078|FG011|Core Treatment|Adverse Event|0|||
125122508|NCT00048048|450074067|FG000|Extension Year 1|Early withdrawals|0|||
125122509|NCT00048048|450074068|FG001|Extension Year 1|Early withdrawals|0|||
125122510|NCT00048048|450074069|FG002|Extension Year 1|Early withdrawals|0|||
125122511|NCT00048048|450074070|FG003|Extension Year 1|Early withdrawals|0|||
125122512|NCT00048048|450074071|FG004|Extension Year 1|Early withdrawals|0|||
125122513|NCT00048048|450074072|FG005|Extension Year 1|Early withdrawals|0|||
125122514|NCT00048048|450074073|FG006|Extension Year 1|Early withdrawals|0|||
125122515|NCT00048048|450074074|FG007|Extension Year 1|Early withdrawals|0|||
125122516|NCT00048048|450074075|FG008|Extension Year 1|Early withdrawals|0|||
125122517|NCT00048048|450074076|FG009|Extension Year 1|Early withdrawals|2|||
125122518|NCT00048048|450074077|FG010|Extension Year 1|Early withdrawals|2|||
125122519|NCT00048048|450074078|FG011|Extension Year 1|Early withdrawals|4|||
124941644|NCT02751528|449413235|FG000|Overall Study|Withdrawal by Subject|1|||
124941645|NCT02751528|449413235|FG000|Overall Study|Adverse Event|1|||
124941646|NCT05071430|449413236|FG000|Overall Study|Adverse Event|1|||
124941647|NCT05071430|449413237|FG001|Overall Study|Adverse Event|2|||
124941648|NCT05071430|449413236|FG000|Overall Study|Lost to Follow-up|4|||
124941649|NCT05071430|449413237|FG001|Overall Study|Lost to Follow-up|4|||
124941650|NCT05071430|449413236|FG000|Overall Study|Protocol Violation|1|||
124941651|NCT05071430|449413237|FG001|Overall Study|Protocol Violation|0|||
124941652|NCT05071430|449413236|FG000|Overall Study|Withdrawal by Subject|3|||
124941653|NCT05071430|449413237|FG001|Overall Study|Withdrawal by Subject|2|||
125027696|NCT01482910|449725579|FG000|Overall Study|Withdrawal by Subject|7|||
125027697|NCT01482910|449725580|FG001|Overall Study|Withdrawal by Subject|2|||
125027698|NCT01482910|449725579|FG000|Overall Study|Death|1|||
125027699|NCT01482910|449725580|FG001|Overall Study|Death|0|||
125027700|NCT03370770|449725582|FG000|Overall Study|Patient was followed in another hospital center|1|||
125027701|NCT03370770|449725582|FG000|Overall Study|Progressive Disease|98|||
125027702|NCT03370770|449725582|FG000|Overall Study|Adverse Event|2|||
125027703|NCT03370770|449725582|FG000|Overall Study|Death|5|||
125027704|NCT00234039|449725583|FG000|Overall Study|Adverse Event|2|||
125027705|NCT00234039|449725583|FG000|Overall Study|Progression/relapse|34|||
125027706|NCT00234039|449725583|FG000|Overall Study|Other - Not Protocol Specified|3|||
125027707|NCT00234039|449725583|FG000|Overall Study|Ineligible|9|||
125027708|NCT00234039|449725583|FG000|Overall Study|No Protocol Treatment Received|2|||
125027709|NCT00110019|449725586|FG000|Overall Study|Lack of Efficacy|253|||
125027710|NCT00110019|449725587|FG001|Overall Study|Lack of Efficacy|285|||
125027711|NCT00110019|449725586|FG000|Overall Study|Adverse Event|61|||
125027712|NCT00110019|449725587|FG001|Overall Study|Adverse Event|40|||
125027713|NCT00110019|449725586|FG000|Overall Study|Death|13|||
125027714|NCT00110019|449725587|FG001|Overall Study|Death|15|||
124941654|NCT05071430|449413236|FG000|Overall Study|Other|1|||
124941655|NCT05071430|449413237|FG001|Overall Study|Other|1|||
124941656|NCT01958021|449413238|FG000|Treatment|Progressive disease|206|||
124941657|NCT01958021|449413239|FG001|Treatment|Progressive disease|265|||
125027715|NCT00110019|449725586|FG000|Overall Study|Withdrawal by Subject|21|||
125027716|NCT00110019|449725587|FG001|Overall Study|Withdrawal by Subject|9|||
125027717|NCT00110019|449725586|FG000|Overall Study|alternative therapy|5|||
125027718|NCT00110019|449725587|FG001|Overall Study|alternative therapy|1|||
125027719|NCT00110019|449725586|FG000|Overall Study|complicating disease|1|||
125027720|NCT00110019|449725587|FG001|Overall Study|complicating disease|1|||
125027721|NCT00110019|449725586|FG000|Overall Study|symptom deterioration|13|||
125027722|NCT00110019|449725587|FG001|Overall Study|symptom deterioration|16|||
125027723|NCT00110019|449725586|FG000|Overall Study|Not start protocol therapy|17|||
125027724|NCT00110019|449725587|FG001|Overall Study|Not start protocol therapy|16|||
125027725|NCT00110019|449725586|FG000|Overall Study|other reasons|22|||
125027726|NCT00110019|449725587|FG001|Overall Study|other reasons|30|||
125027727|NCT04426695|449725590|FG000|Overall Study|Death|2|||
125027728|NCT04426695|449725591|FG001|Overall Study|Death|0|||
125027729|NCT04426695|449725592|FG002|Overall Study|Death|1|||
125027730|NCT04426695|449725593|FG003|Overall Study|Death|27|||
125027731|NCT04426695|449725594|FG004|Overall Study|Death|25|||
125027732|NCT04426695|449725595|FG005|Overall Study|Death|21|||
125027733|NCT04426695|449725596|FG006|Overall Study|Death|42|||
125027734|NCT04426695|449725597|FG007|Overall Study|Death|23|||
125027735|NCT04426695|449725598|FG008|Overall Study|Death|37|||
125027736|NCT04426695|449725599|FG009|Overall Study|Death|14|||
125027737|NCT04426695|449725600|FG010|Overall Study|Death|8|||
125027738|NCT04426695|449725601|FG011|Overall Study|Death|7|||
125027739|NCT04426695|449725602|FG012|Overall Study|Death|13|||
125027740|NCT04426695|449725603|FG013|Overall Study|Death|25|||
125027741|NCT04426695|449725604|FG014|Overall Study|Death|19|||
125027742|NCT04426695|449725605|FG015|Overall Study|Death|7|||
125027743|NCT04426695|449725606|FG016|Overall Study|Death|8|||
125027744|NCT04426695|449725607|FG017|Overall Study|Death|4|||
125027745|NCT04426695|449725590|FG000|Overall Study|Lost to Follow-up|2|||
125027746|NCT04426695|449725591|FG001|Overall Study|Lost to Follow-up|4|||
125027747|NCT04426695|449725592|FG002|Overall Study|Lost to Follow-up|1|||
125027748|NCT04426695|449725593|FG003|Overall Study|Lost to Follow-up|19|||
125027749|NCT04426695|449725594|FG004|Overall Study|Lost to Follow-up|10|||
125027750|NCT04426695|449725595|FG005|Overall Study|Lost to Follow-up|14|||
125027751|NCT04426695|449725596|FG006|Overall Study|Lost to Follow-up|5|||
125027752|NCT04426695|449725597|FG007|Overall Study|Lost to Follow-up|14|||
125027753|NCT04426695|449725598|FG008|Overall Study|Lost to Follow-up|10|||
125027754|NCT04426695|449725599|FG009|Overall Study|Lost to Follow-up|11|||
125027755|NCT04426695|449725600|FG010|Overall Study|Lost to Follow-up|12|||
125027756|NCT04426695|449725601|FG011|Overall Study|Lost to Follow-up|6|||
125027757|NCT04426695|449725602|FG012|Overall Study|Lost to Follow-up|2|||
125027758|NCT04426695|449725603|FG013|Overall Study|Lost to Follow-up|2|||
125027759|NCT04426695|449725604|FG014|Overall Study|Lost to Follow-up|2|||
125027760|NCT04426695|449725605|FG015|Overall Study|Lost to Follow-up|0|||
125027761|NCT04426695|449725606|FG016|Overall Study|Lost to Follow-up|0|||
125027762|NCT04426695|449725607|FG017|Overall Study|Lost to Follow-up|0|||
125027763|NCT04426695|449725590|FG000|Overall Study|Participant Decision|1|||
125027764|NCT04426695|449725591|FG001|Overall Study|Participant Decision|2|||
125027765|NCT04426695|449725592|FG002|Overall Study|Participant Decision|2|||
125027766|NCT04426695|449725593|FG003|Overall Study|Participant Decision|12|||
125027767|NCT04426695|449725594|FG004|Overall Study|Participant Decision|18|||
125027768|NCT04426695|449725595|FG005|Overall Study|Participant Decision|22|||
125027769|NCT04426695|449725596|FG006|Overall Study|Participant Decision|13|||
125027770|NCT04426695|449725597|FG007|Overall Study|Participant Decision|13|||
125027771|NCT04426695|449725598|FG008|Overall Study|Participant Decision|10|||
125027772|NCT04426695|449725599|FG009|Overall Study|Participant Decision|15|||
125027773|NCT04426695|449725600|FG010|Overall Study|Participant Decision|16|||
125027774|NCT04426695|449725601|FG011|Overall Study|Participant Decision|17|||
125027775|NCT04426695|449725602|FG012|Overall Study|Participant Decision|2|||
125027776|NCT04426695|449725603|FG013|Overall Study|Participant Decision|1|||
125027777|NCT04426695|449725604|FG014|Overall Study|Participant Decision|2|||
125027778|NCT04426695|449725605|FG015|Overall Study|Participant Decision|0|||
125027779|NCT04426695|449725606|FG016|Overall Study|Participant Decision|0|||
125027780|NCT04426695|449725607|FG017|Overall Study|Participant Decision|0|||
125027781|NCT04426695|449725590|FG000|Overall Study|Adverse Event|0|||
125027782|NCT04426695|449725591|FG001|Overall Study|Adverse Event|0|||
125027783|NCT04426695|449725592|FG002|Overall Study|Adverse Event|0|||
125027784|NCT04426695|449725593|FG003|Overall Study|Adverse Event|0|||
125027785|NCT04426695|449725594|FG004|Overall Study|Adverse Event|0|||
125027786|NCT04426695|449725595|FG005|Overall Study|Adverse Event|0|||
125213636|NCT02223364|450409742|FG002|Overall Study|Physician Decision|0|||
125027787|NCT04426695|449725596|FG006|Overall Study|Adverse Event|0|||
125027788|NCT04426695|449725597|FG007|Overall Study|Adverse Event|1|||
125027789|NCT04426695|449725598|FG008|Overall Study|Adverse Event|0|||
125027790|NCT04426695|449725599|FG009|Overall Study|Adverse Event|0|||
125027791|NCT04426695|449725600|FG010|Overall Study|Adverse Event|1|||
125027792|NCT04426695|449725601|FG011|Overall Study|Adverse Event|1|||
125027793|NCT04426695|449725602|FG012|Overall Study|Adverse Event|0|||
125027794|NCT04426695|449725603|FG013|Overall Study|Adverse Event|0|||
125027795|NCT04426695|449725604|FG014|Overall Study|Adverse Event|0|||
125027796|NCT04426695|449725605|FG015|Overall Study|Adverse Event|0|||
125027797|NCT04426695|449725606|FG016|Overall Study|Adverse Event|0|||
125122520|NCT00048048|450074067|FG000|Extension Year 2|Early withdrawals|0|||
125122521|NCT00048048|450074068|FG001|Extension Year 2|Early withdrawals|0|||
125122522|NCT00048048|450074069|FG002|Extension Year 2|Early withdrawals|0|||
125122523|NCT00048048|450074070|FG003|Extension Year 2|Early withdrawals|0|||
125122524|NCT00048048|450074071|FG004|Extension Year 2|Early withdrawals|0|||
125122525|NCT00048048|450074072|FG005|Extension Year 2|Early withdrawals|0|||
125122526|NCT00048048|450074073|FG006|Extension Year 2|Early withdrawals|0|||
125122527|NCT00048048|450074074|FG007|Extension Year 2|Early withdrawals|0|||
124941658|NCT01958021|449413238|FG000|Treatment|Adverse Event|38|||
124941659|NCT01958021|449413239|FG001|Treatment|Adverse Event|10|||
124941660|NCT01958021|449413238|FG000|Treatment|Subject/guardian decision|29|||
124941661|NCT01958021|449413239|FG001|Treatment|Subject/guardian decision|25|||
124941662|NCT01958021|449413238|FG000|Treatment|Physician Decision|28|||
124941663|NCT01958021|449413239|FG001|Treatment|Physician Decision|21|||
124941664|NCT01958021|449413238|FG000|Treatment|Death|6|||
124941665|NCT01958021|449413239|FG001|Treatment|Death|1|||
124941666|NCT01958021|449413238|FG000|Treatment|Protocol deviation|3|||
124941667|NCT01958021|449413239|FG001|Treatment|Protocol deviation|1|||
124941668|NCT01958021|449413238|FG000|Treatment|Sponsor decision|24|||
124941669|NCT01958021|449413239|FG001|Treatment|Sponsor decision|11|||
125122528|NCT00048048|450074075|FG008|Extension Year 2|Early withdrawals|0|||
125122529|NCT00048048|450074076|FG009|Extension Year 2|Early withdrawals|0|||
125122530|NCT00048048|450074077|FG010|Extension Year 2|Early withdrawals|4|||
124941670|NCT01958021|449413238|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
125122531|NCT00048048|450074078|FG011|Extension Year 2|Early withdrawals|2|||
125122532|NCT00973700|450074079|FG000|Overall Study|Withdrawal by Subject|2|||
125122533|NCT00973700|450074080|FG001|Overall Study|Withdrawal by Subject|2|||
125122534|NCT00973700|450074081|FG002|Overall Study|Withdrawal by Subject|8|||
125122535|NCT00973700|450074082|FG003|Overall Study|Withdrawal by Subject|4|||
125122536|NCT00973700|450074083|FG004|Overall Study|Withdrawal by Subject|4|||
124941671|NCT01958021|449413239|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
124941672|NCT01958021|449413238|FG000|Post-treatment Efficacy Follow-up|Death|1|||
124941673|NCT01958021|449413239|FG001|Post-treatment Efficacy Follow-up|Death|0|||
124941674|NCT01958021|449413238|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
124941675|NCT01958021|449413239|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
124941676|NCT01958021|449413238|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
124941677|NCT01958021|449413239|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
124941678|NCT01958021|449413238|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
124941679|NCT01958021|449413239|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
124941680|NCT01958021|449413238|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
124941681|NCT01958021|449413239|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
124941682|NCT01958021|449413238|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
124941683|NCT01958021|449413239|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
124941684|NCT04484623|449413241|FG000|Overall Study|Lost to Follow-up|0|||
124941685|NCT04484623|449413242|FG001|Overall Study|Lost to Follow-up|1|||
124941686|NCT04484623|449413241|FG000|Overall Study|Protocol Deviation|1|||
124941687|NCT04484623|449413242|FG001|Overall Study|Protocol Deviation|0|||
124941688|NCT04484623|449413241|FG000|Overall Study|Physician Decision|1|||
124941689|NCT04484623|449413242|FG001|Overall Study|Physician Decision|0|||
124941690|NCT04484623|449413241|FG000|Overall Study|Withdrawal by Subject|11|||
124941691|NCT04484623|449413242|FG001|Overall Study|Withdrawal by Subject|8|||
124941692|NCT04484623|449413241|FG000|Overall Study|Ongoing|94|||
125027798|NCT04426695|449725607|FG017|Overall Study|Adverse Event|0|||
125027799|NCT04426695|449725590|FG000|Overall Study|Sponsor Request|0|||
125027800|NCT04426695|449725591|FG001|Overall Study|Sponsor Request|0|||
125027801|NCT04426695|449725592|FG002|Overall Study|Sponsor Request|0|||
125027802|NCT04426695|449725593|FG003|Overall Study|Sponsor Request|0|||
125027803|NCT04426695|449725594|FG004|Overall Study|Sponsor Request|0|||
125027804|NCT04426695|449725595|FG005|Overall Study|Sponsor Request|0|||
125027805|NCT04426695|449725596|FG006|Overall Study|Sponsor Request|1|||
125027806|NCT04426695|449725597|FG007|Overall Study|Sponsor Request|0|||
125027807|NCT04426695|449725598|FG008|Overall Study|Sponsor Request|0|||
125027808|NCT04426695|449725599|FG009|Overall Study|Sponsor Request|0|||
125027809|NCT04426695|449725600|FG010|Overall Study|Sponsor Request|0|||
125027810|NCT04426695|449725601|FG011|Overall Study|Sponsor Request|0|||
125027811|NCT04426695|449725602|FG012|Overall Study|Sponsor Request|0|||
125027812|NCT04426695|449725603|FG013|Overall Study|Sponsor Request|0|||
125027813|NCT04426695|449725604|FG014|Overall Study|Sponsor Request|0|||
125027814|NCT04426695|449725605|FG015|Overall Study|Sponsor Request|0|||
125027815|NCT04426695|449725606|FG016|Overall Study|Sponsor Request|0|||
125027816|NCT04426695|449725607|FG017|Overall Study|Sponsor Request|0|||
125027817|NCT04426695|449725590|FG000|Overall Study|Physician Decision|0|||
125027818|NCT04426695|449725591|FG001|Overall Study|Physician Decision|0|||
125027819|NCT04426695|449725592|FG002|Overall Study|Physician Decision|0|||
125027820|NCT04426695|449725593|FG003|Overall Study|Physician Decision|0|||
125027821|NCT04426695|449725594|FG004|Overall Study|Physician Decision|0|||
125027822|NCT04426695|449725595|FG005|Overall Study|Physician Decision|0|||
125027823|NCT04426695|449725596|FG006|Overall Study|Physician Decision|0|||
125027824|NCT04426695|449725597|FG007|Overall Study|Physician Decision|0|||
125027825|NCT04426695|449725598|FG008|Overall Study|Physician Decision|0|||
125027826|NCT04426695|449725599|FG009|Overall Study|Physician Decision|1|||
125027827|NCT04426695|449725600|FG010|Overall Study|Physician Decision|0|||
125027828|NCT04426695|449725601|FG011|Overall Study|Physician Decision|0|||
125027829|NCT04426695|449725602|FG012|Overall Study|Physician Decision|1|||
125027830|NCT04426695|449725603|FG013|Overall Study|Physician Decision|0|||
125027831|NCT04426695|449725604|FG014|Overall Study|Physician Decision|0|||
125027832|NCT04426695|449725605|FG015|Overall Study|Physician Decision|0|||
125027833|NCT04426695|449725606|FG016|Overall Study|Physician Decision|0|||
125027834|NCT04426695|449725607|FG017|Overall Study|Physician Decision|0|||
125027835|NCT04426695|449725590|FG000|Overall Study|Randomized but Never Treated|3|||
125027836|NCT04426695|449725591|FG001|Overall Study|Randomized but Never Treated|1|||
124941693|NCT04484623|449413242|FG001|Overall Study|Ongoing|84|||
124941694|NCT04649047|449413243|FG000|Overall Study|Withdrawal by Subject|3|||
124941695|NCT00719888|449413244|FG000|Overall Study|Death|24|||
124941696|NCT00719888|449413245|FG001|Overall Study|Death|9|||
124941697|NCT00719888|449413244|FG000|Overall Study|Relapse|8|||
124941698|NCT00719888|449413245|FG001|Overall Study|Relapse|3|||
124941699|NCT00719888|449413244|FG000|Overall Study|Physician Decision|1|||
124941700|NCT00719888|449413245|FG001|Overall Study|Physician Decision|0|||
125027837|NCT04426695|449725592|FG002|Overall Study|Randomized but Never Treated|0|||
125027838|NCT04426695|449725593|FG003|Overall Study|Randomized but Never Treated|4|||
124941701|NCT00719888|449413244|FG000|Overall Study|Withdrawal by Subject|1|||
124941702|NCT00719888|449413245|FG001|Overall Study|Withdrawal by Subject|0|||
124941703|NCT05037513|449413246|FG000|Intervention Period|Lost to Follow-up|1|||
124941704|NCT05037513|449413247|FG001|Intervention Period|Lost to Follow-up|2|||
124941705|NCT05037513|449413246|FG000|Follow Up Period|Lost to Follow-up|16|||
124941706|NCT05037513|449413247|FG001|Follow Up Period|Lost to Follow-up|21|||
124941707|NCT05037513|449413246|FG000|Follow Up Period|Death|0|||
124941708|NCT05037513|449413247|FG001|Follow Up Period|Death|1|||
124941709|NCT05037513|449413246|FG000|Follow Up Period|Incarcerated|4|||
125213637|NCT00793546|450409743|FG000|Overall Study|Death|3|||
125213638|NCT00793546|450409744|FG001|Overall Study|Death|0|||
125213639|NCT00793546|450409743|FG000|Overall Study|Lost to Follow-up|1|||
125213640|NCT00793546|450409744|FG001|Overall Study|Lost to Follow-up|0|||
125213641|NCT00793546|450409743|FG000|Overall Study|Withdrawal by Subject|1|||
125213642|NCT00793546|450409744|FG001|Overall Study|Withdrawal by Subject|1|||
125213643|NCT00793546|450409743|FG000|Overall Study|Study Terminated by Sponsor|8|||
125213644|NCT00793546|450409744|FG001|Overall Study|Study Terminated by Sponsor|27|||
125213645|NCT00793546|450409743|FG000|Overall Study|Other|1|||
125213646|NCT00793546|450409744|FG001|Overall Study|Other|0|||
125213647|NCT01841567|450409745|FG000|Overall Study|Adverse Event|3|||
125213648|NCT01416155|450409746|FG000|Overall Study|Adverse Event|8|||
125213649|NCT01416155|450409746|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
125213650|NCT01416155|450409746|FG000|Overall Study|Withdrawal by Subject|33|||
125213651|NCT01416155|450409746|FG000|Overall Study|Investigator decision|8|||
125213652|NCT01416155|450409746|FG000|Overall Study|Other|7|||
125213653|NCT01573754|450409751|FG000|Overall Study|Noncompliance or remission not achieved|3|||
125213654|NCT01573754|450409752|FG001|Overall Study|Noncompliance or remission not achieved|15|||
125213655|NCT00829829|450409754|FG000|Overall Study|Protocol Violation|0|||
125213656|NCT00829829|450409755|FG001|Overall Study|Protocol Violation|3|||
125213657|NCT00829829|450409756|FG002|Overall Study|Protocol Violation|0|||
125213658|NCT00829829|450409754|FG000|Overall Study|Adverse Event|4|||
125213659|NCT00829829|450409755|FG001|Overall Study|Adverse Event|4|||
125213660|NCT00829829|450409756|FG002|Overall Study|Adverse Event|3|||
125213661|NCT00829829|450409754|FG000|Overall Study|Withdrawal by Subject|8|||
125213662|NCT00829829|450409755|FG001|Overall Study|Withdrawal by Subject|4|||
125213663|NCT00829829|450409756|FG002|Overall Study|Withdrawal by Subject|2|||
125213664|NCT00829829|450409754|FG000|Overall Study|Decision by the Sponsor|1|||
125213665|NCT00829829|450409755|FG001|Overall Study|Decision by the Sponsor|0|||
125213666|NCT00829829|450409756|FG002|Overall Study|Decision by the Sponsor|2|||
125213667|NCT00829829|450409754|FG000|Overall Study|Lost to Follow-up|7|||
125213668|NCT00829829|450409755|FG001|Overall Study|Lost to Follow-up|3|||
125213669|NCT00829829|450409756|FG002|Overall Study|Lost to Follow-up|3|||
125213670|NCT00829829|450409754|FG000|Overall Study|Other than specified above|2|||
125213671|NCT00829829|450409755|FG001|Overall Study|Other than specified above|2|||
125213672|NCT00829829|450409756|FG002|Overall Study|Other than specified above|1|||
125213673|NCT02984267|450409757|FG000|Overall Study|Protocol Violation|1|||
124941710|NCT05037513|449413247|FG001|Follow Up Period|Incarcerated|2|||
124941711|NCT05886777|449413248|FG000|Overall Study|Lost to Follow-up|1|||
124941712|NCT05886777|449413249|FG001|Overall Study|Lost to Follow-up|0|||
124941713|NCT05886777|449413250|FG002|Overall Study|Lost to Follow-up|2|||
124941714|NCT05886777|449413251|FG003|Overall Study|Lost to Follow-up|1|||
125027839|NCT04426695|449725594|FG004|Overall Study|Randomized but Never Treated|5|||
125213674|NCT02984267|450409758|FG001|Overall Study|Protocol Violation|0|||
125213675|NCT02984267|450409757|FG000|Overall Study|Withdrawal by Subject|0|||
125213676|NCT02984267|450409758|FG001|Overall Study|Withdrawal by Subject|1|||
124941715|NCT05886777|449413252|FG004|Overall Study|Lost to Follow-up|0|||
125027840|NCT04426695|449725595|FG005|Overall Study|Randomized but Never Treated|5|||
124941716|NCT05886777|449413253|FG005|Overall Study|Lost to Follow-up|2|||
124941717|NCT05886777|449413254|FG006|Overall Study|Lost to Follow-up|0|||
124941718|NCT05886777|449413248|FG000|Overall Study|Other|0|||
125213677|NCT02685072|450409759|FG000|Treatment Period|Lost to Follow-up|12|||
125213678|NCT02685072|450409760|FG001|Treatment Period|Lost to Follow-up|6|||
125213679|NCT02685072|450409759|FG000|Treatment Period|Withdrawal by Subject|1|||
125213680|NCT02685072|450409760|FG001|Treatment Period|Withdrawal by Subject|3|||
125213681|NCT02685072|450409759|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
125213682|NCT02685072|450409760|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
125213683|NCT00742027|450409761|FG000|Overall Study|Disease Progression|76|||
124941719|NCT05886777|449413249|FG001|Overall Study|Other|2|||
124941720|NCT05886777|449413250|FG002|Overall Study|Other|1|||
124941721|NCT05886777|449413251|FG003|Overall Study|Other|0|||
124941722|NCT05886777|449413252|FG004|Overall Study|Other|0|||
124941723|NCT05886777|449413253|FG005|Overall Study|Other|0|||
124941724|NCT05886777|449413254|FG006|Overall Study|Other|0|||
124941725|NCT05886777|449413248|FG000|Overall Study|Withdrawal by Subject|1|||
124941726|NCT05886777|449413249|FG001|Overall Study|Withdrawal by Subject|0|||
124941727|NCT05886777|449413250|FG002|Overall Study|Withdrawal by Subject|1|||
124941728|NCT05886777|449413251|FG003|Overall Study|Withdrawal by Subject|4|||
124941729|NCT05886777|449413252|FG004|Overall Study|Withdrawal by Subject|3|||
124941730|NCT05886777|449413253|FG005|Overall Study|Withdrawal by Subject|1|||
124941731|NCT05886777|449413254|FG006|Overall Study|Withdrawal by Subject|1|||
124941732|NCT05886777|449413248|FG000|Overall Study|Protocol Violation|0|||
124941733|NCT05886777|449413249|FG001|Overall Study|Protocol Violation|0|||
124941734|NCT05886777|449413250|FG002|Overall Study|Protocol Violation|1|||
124941735|NCT05886777|449413251|FG003|Overall Study|Protocol Violation|0|||
124941736|NCT05886777|449413252|FG004|Overall Study|Protocol Violation|0|||
124941737|NCT05886777|449413253|FG005|Overall Study|Protocol Violation|0|||
124941738|NCT05886777|449413254|FG006|Overall Study|Protocol Violation|0|||
124941739|NCT05886777|449413248|FG000|Overall Study|No longer met eligibility criteria|0|||
124941740|NCT05886777|449413249|FG001|Overall Study|No longer met eligibility criteria|1|||
124941741|NCT05886777|449413250|FG002|Overall Study|No longer met eligibility criteria|0|||
124941742|NCT05886777|449413251|FG003|Overall Study|No longer met eligibility criteria|0|||
124941743|NCT05886777|449413252|FG004|Overall Study|No longer met eligibility criteria|0|||
124941744|NCT05886777|449413253|FG005|Overall Study|No longer met eligibility criteria|0|||
124941745|NCT05886777|449413254|FG006|Overall Study|No longer met eligibility criteria|0|||
124941746|NCT03664804|449413256|FG000|Overall Study|Withdrawal by Subject|7|||
124941747|NCT03002194|449414784|FG000|Overall Study|Lost to Follow-up|6|||
124941748|NCT03002194|449414784|FG000|Overall Study|Adverse Event|1|||
124941749|NCT03002194|449414784|FG000|Overall Study|Lack of Efficacy|1|||
124941750|NCT03002194|449414784|FG000|Overall Study|Withdrawal by Subject|2|||
124941751|NCT00048932|449414785|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
124941752|NCT00048932|449414786|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
124941753|NCT00048932|449414787|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
124941754|NCT00048932|449414785|FG000|Double Blind Period (DB)|Adverse Event|51|||
124941755|NCT00048932|449414786|FG001|Double Blind Period (DB)|Adverse Event|19|||
124941756|NCT00048932|449414787|FG002|Double Blind Period (DB)|Adverse Event|0|||
124941757|NCT00048932|449414785|FG000|Double Blind Period (DB)|Death|5|||
124941758|NCT00048932|449414786|FG001|Double Blind Period (DB)|Death|3|||
124941759|NCT00048932|449414787|FG002|Double Blind Period (DB)|Death|0|||
124941760|NCT00048932|449414785|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
124941761|NCT00048932|449414786|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
124941762|NCT00048932|449414787|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
124941763|NCT00048932|449414785|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
124941764|NCT00048932|449414786|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
124941765|NCT00048932|449414787|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
124941766|NCT00048932|449414785|FG000|Double Blind Period (DB)|Relocation|1|||
124941767|NCT00048932|449414786|FG001|Double Blind Period (DB)|Relocation|0|||
124941768|NCT00048932|449414787|FG002|Double Blind Period (DB)|Relocation|0|||
124941769|NCT00048932|449414785|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
125122537|NCT00973700|450074079|FG000|Overall Study|Lost to Follow-up|5|||
125122538|NCT00973700|450074080|FG001|Overall Study|Lost to Follow-up|0|||
125122539|NCT00973700|450074081|FG002|Overall Study|Lost to Follow-up|1|||
125122540|NCT00973700|450074082|FG003|Overall Study|Lost to Follow-up|8|||
125122541|NCT00973700|450074083|FG004|Overall Study|Lost to Follow-up|5|||
125122542|NCT00973700|450074079|FG000|Overall Study|Inappropriate enrolment|0|||
125122543|NCT00973700|450074080|FG001|Overall Study|Inappropriate enrolment|0|||
125122544|NCT00973700|450074081|FG002|Overall Study|Inappropriate enrolment|0|||
125122545|NCT00973700|450074082|FG003|Overall Study|Inappropriate enrolment|4|||
125122546|NCT00973700|450074083|FG004|Overall Study|Inappropriate enrolment|0|||
125122547|NCT00973700|450074079|FG000|Overall Study|Unable to Classify|0|||
125213684|NCT00742027|450409761|FG000|Overall Study|New Cancer Therapy|19|||
125213685|NCT00742027|450409761|FG000|Overall Study|Withdrawal by Subject|18|||
125213686|NCT00742027|450409761|FG000|Overall Study|Death|7|||
125213687|NCT00742027|450409761|FG000|Overall Study|Lost to Follow-up|4|||
125213688|NCT00742027|450409761|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
125213689|NCT00742027|450409761|FG000|Overall Study|Missing|2|||
125213690|NCT00742027|450409761|FG000|Overall Study|Administrative Problems|1|||
125213691|NCT02634710|450409762|FG000|Overall Study|Death|4|||
125213692|NCT02717442|450409766|FG000|Overall Study|Study Terminated by Sponsor|31|||
125213693|NCT02717442|450409767|FG001|Overall Study|Study Terminated by Sponsor|29|||
125213694|NCT02717442|450409766|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
125213695|NCT02717442|450409767|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
125213696|NCT02717442|450409766|FG000|Overall Study|Other - Not Specified|2|||
125213697|NCT02717442|450409767|FG001|Overall Study|Other - Not Specified|0|||
125213698|NCT00528372|450409771|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
125213699|NCT00528372|450409772|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
125213700|NCT00528372|450409773|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
125213701|NCT00528372|450409774|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
125213702|NCT00528372|450409775|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
125213703|NCT00528372|450409776|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
125213704|NCT00528372|450409777|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
125213705|NCT00528372|450409778|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
125213706|NCT00528372|450409779|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
125213707|NCT00528372|450409771|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
125213708|NCT00528372|450409772|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
125213709|NCT00528372|450409773|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
125213710|NCT00528372|450409774|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
125213711|NCT00528372|450409775|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
125213712|NCT00528372|450409776|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
125213713|NCT00528372|450409777|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
125213714|NCT00528372|450409778|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
125213715|NCT00528372|450409779|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
125213716|NCT00528372|450409771|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
125213717|NCT00528372|450409772|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
125213718|NCT00528372|450409773|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
125213719|NCT00528372|450409774|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
125213720|NCT00528372|450409775|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
125213721|NCT00528372|450409776|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
125213722|NCT00528372|450409777|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
125213723|NCT00528372|450409778|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
125213724|NCT00528372|450409779|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
125027841|NCT04426695|449725596|FG006|Overall Study|Randomized but Never Treated|4|||
125213725|NCT00528372|450409771|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
125213726|NCT00528372|450409772|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
125213727|NCT00528372|450409773|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
125213728|NCT00528372|450409774|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
125213729|NCT00528372|450409775|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
125213730|NCT00528372|450409776|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
125213731|NCT00528372|450409777|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
125213732|NCT00528372|450409778|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
125213733|NCT00528372|450409779|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
125213734|NCT00528372|450409771|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
125213735|NCT00528372|450409772|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
125213736|NCT00528372|450409773|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
125027842|NCT04426695|449725597|FG007|Overall Study|Randomized but Never Treated|6|||
125027843|NCT04426695|449725598|FG008|Overall Study|Randomized but Never Treated|6|||
125027844|NCT04426695|449725599|FG009|Overall Study|Randomized but Never Treated|3|||
125027845|NCT04426695|449725600|FG010|Overall Study|Randomized but Never Treated|3|||
125027846|NCT04426695|449725601|FG011|Overall Study|Randomized but Never Treated|6|||
125027847|NCT04426695|449725602|FG012|Overall Study|Randomized but Never Treated|1|||
125027848|NCT04426695|449725603|FG013|Overall Study|Randomized but Never Treated|2|||
125027849|NCT04426695|449725604|FG014|Overall Study|Randomized but Never Treated|0|||
125027850|NCT04426695|449725605|FG015|Overall Study|Randomized but Never Treated|0|||
125027851|NCT04426695|449725606|FG016|Overall Study|Randomized but Never Treated|0|||
125027852|NCT04426695|449725607|FG017|Overall Study|Randomized but Never Treated|0|||
125027853|NCT04303000|449725608|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
125027854|NCT04303000|449725609|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
124941770|NCT00048932|449414786|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
124941771|NCT00048932|449414787|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
124941772|NCT00048932|449414785|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
124941773|NCT00048932|449414786|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
124941774|NCT00048932|449414787|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
124941775|NCT00048932|449414785|FG000|Double Blind Period (DB)|Pregnancy|1|||
124941776|NCT00048932|449414786|FG001|Double Blind Period (DB)|Pregnancy|0|||
124941777|NCT00048932|449414787|FG002|Double Blind Period (DB)|Pregnancy|0|||
124941778|NCT00048932|449414785|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
125027855|NCT04303000|449725610|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
125027856|NCT00559273|449725611|FG000|Correction Period (20 Weeks)|Death|3|||
125027857|NCT00559273|449725612|FG001|Correction Period (20 Weeks)|Death|4|||
125027858|NCT00559273|449725611|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
125027859|NCT00559273|449725612|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
125027860|NCT00559273|449725611|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
125027861|NCT00559273|449725612|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
125027862|NCT00559273|449725611|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
125027863|NCT00559273|449725612|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
125027864|NCT00559273|449725611|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
125027865|NCT00559273|449725612|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
125027866|NCT00559273|449725611|FG000|Evaluation Period (8 Weeks)|Death|1|||
125027867|NCT00559273|449725612|FG001|Evaluation Period (8 Weeks)|Death|3|||
125027868|NCT00559273|449725611|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
125027869|NCT00559273|449725612|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
125027870|NCT00559273|449725611|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
125027871|NCT00559273|449725612|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
125027872|NCT00559273|449725611|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
125213737|NCT00528372|450409774|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
125213738|NCT00528372|450409775|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
125213739|NCT00528372|450409776|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
125213740|NCT00528372|450409777|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
125213741|NCT00528372|450409778|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
125213742|NCT00528372|450409779|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
125213743|NCT00528372|450409771|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
125213744|NCT00528372|450409772|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
125213745|NCT00528372|450409773|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
125213746|NCT00528372|450409774|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
125213747|NCT00528372|450409775|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
125213748|NCT00528372|450409776|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
125213749|NCT00528372|450409777|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
125213750|NCT00528372|450409778|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
125213751|NCT00528372|450409779|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
125213752|NCT00528372|450409771|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
125213753|NCT00528372|450409772|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
125213754|NCT00528372|450409773|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
125213755|NCT00528372|450409774|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
124941779|NCT00048932|449414786|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
124941780|NCT00048932|449414787|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
124941781|NCT00048932|449414785|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
124941782|NCT00048932|449414786|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
124941783|NCT00048932|449414787|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
124941784|NCT00048932|449414785|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
124941785|NCT00048932|449414786|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
124941786|NCT00048932|449414787|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
124941787|NCT00048932|449414785|FG000|Open Label Period (OL)|Death|0|||
124941788|NCT00048932|449414786|FG001|Open Label Period (OL)|Death|0|||
124941789|NCT00048932|449414787|FG002|Open Label Period (OL)|Death|25|||
124941790|NCT00048932|449414785|FG000|Open Label Period (OL)|Adverse Event|0|||
125027873|NCT00559273|449725612|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
125027874|NCT00395967|449725617|FG000|Treatment Period|Failed Mobilization|1|||
125027875|NCT00395967|449725617|FG000|Follow-up Period|Death|1|||
125027876|NCT00395967|449725617|FG000|Follow-up Period|Lost to Follow-up|1|||
125027877|NCT03118947|449725618|FG000|Overall Study|Adverse Event|7|||
125027878|NCT03118947|449725618|FG000|Overall Study|Death|3|||
125027879|NCT03118947|449725618|FG000|Overall Study|Lack of Efficacy|4|||
125027880|NCT03118947|449725618|FG000|Overall Study|Non-compliance with study drug|1|||
125027881|NCT03118947|449725618|FG000|Overall Study|Protocol Violation|2|||
125027882|NCT03118947|449725618|FG000|Overall Study|Withdrawal by Subject|3|||
125027883|NCT03118947|449725618|FG000|Overall Study|Withdrawal by caregiver|3|||
125027884|NCT03118947|449725618|FG000|Overall Study|Change in patient's living situation|4|||
125027885|NCT03118947|449725618|FG000|Overall Study|Lost to Follow-up|2|||
125027886|NCT03653390|449725619|FG000|Overall Study|Lost to Follow-up|12|||
125027887|NCT03653390|449725620|FG001|Overall Study|Lost to Follow-up|8|||
125027888|NCT03653390|449725621|FG002|Overall Study|Lost to Follow-up|7|||
125027889|NCT03653390|449725619|FG000|Overall Study|Withdrawal by Subject|6|||
125027890|NCT03653390|449725620|FG001|Overall Study|Withdrawal by Subject|1|||
125027891|NCT03653390|449725621|FG002|Overall Study|Withdrawal by Subject|1|||
125027892|NCT03653390|449725619|FG000|Overall Study|Death|1|||
125027893|NCT03653390|449725620|FG001|Overall Study|Death|0|||
125027894|NCT03653390|449725621|FG002|Overall Study|Death|0|||
125027895|NCT03653390|449725619|FG000|Overall Study|Paper Survey Lost|1|||
125027896|NCT03653390|449725620|FG001|Overall Study|Paper Survey Lost|0|||
125027897|NCT03653390|449725621|FG002|Overall Study|Paper Survey Lost|0|||
125027898|NCT01109940|449725622|FG000|Overall Study|Administrative problems|2|||
125027899|NCT01109940|449725623|FG001|Overall Study|Administrative problems|0|||
125027900|NCT01109940|449725624|FG002|Overall Study|Administrative problems|0|||
125027901|NCT01109940|449725625|FG003|Overall Study|Administrative problems|0|||
125027902|NCT01109940|449725622|FG000|Overall Study|Serious Adverse Event|2|||
125027903|NCT01109940|449725623|FG001|Overall Study|Serious Adverse Event|1|||
125027904|NCT01109940|449725624|FG002|Overall Study|Serious Adverse Event|0|||
125027905|NCT01109940|449725625|FG003|Overall Study|Serious Adverse Event|0|||
125027906|NCT01109940|449725622|FG000|Overall Study|Lost to Follow-up|1|||
125027907|NCT01109940|449725623|FG001|Overall Study|Lost to Follow-up|0|||
125027908|NCT01109940|449725624|FG002|Overall Study|Lost to Follow-up|0|||
125027909|NCT01109940|449725625|FG003|Overall Study|Lost to Follow-up|0|||
125027910|NCT01109940|449725622|FG000|Overall Study|Patient withdrew consent|1|||
125027911|NCT01109940|449725623|FG001|Overall Study|Patient withdrew consent|1|||
125027912|NCT01109940|449725624|FG002|Overall Study|Patient withdrew consent|0|||
125027913|NCT01109940|449725625|FG003|Overall Study|Patient withdrew consent|0|||
125027914|NCT01109940|449725622|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125027915|NCT01109940|449725623|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125027916|NCT01109940|449725624|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
125027917|NCT01109940|449725625|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
125027918|NCT01262976|449725626|FG000|Up to Month 2|Serious Adverse Event|0|||
125027919|NCT01262976|449725627|FG001|Up to Month 2|Serious Adverse Event|0|||
125027920|NCT01262976|449725628|FG002|Up to Month 2|Serious Adverse Event|1|||
125027921|NCT01262976|449725629|FG003|Up to Month 2|Serious Adverse Event|0|||
125027922|NCT01262976|449725630|FG004|Up to Month 2|Serious Adverse Event|0|||
125027923|NCT01262976|449725631|FG005|Up to Month 2|Serious Adverse Event|0|||
125027924|NCT01262976|449725626|FG000|Up to Month 2|Withdrawal by Subject|1|||
125027925|NCT01262976|449725627|FG001|Up to Month 2|Withdrawal by Subject|0|||
125027926|NCT01262976|449725628|FG002|Up to Month 2|Withdrawal by Subject|0|||
125122548|NCT00973700|450074080|FG001|Overall Study|Unable to Classify|0|||
125122549|NCT00973700|450074081|FG002|Overall Study|Unable to Classify|1|||
125122550|NCT00973700|450074082|FG003|Overall Study|Unable to Classify|2|||
125122551|NCT00973700|450074083|FG004|Overall Study|Unable to Classify|1|||
125122552|NCT01901055|450074084|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
125122553|NCT01901055|450074085|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
125122554|NCT01901055|450074084|FG000|Randomization But Not Titrated|Physician Decision|0|||
125122555|NCT01901055|450074085|FG001|Randomization But Not Titrated|Physician Decision|1|||
125122556|NCT01901055|450074084|FG000|Started Protocol to Week 6|Physician Decision|2|||
125122557|NCT01901055|450074085|FG001|Started Protocol to Week 6|Physician Decision|1|||
125122558|NCT01901055|450074084|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
125122559|NCT01901055|450074085|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
125122560|NCT01901055|450074084|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
125122561|NCT01901055|450074085|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
125122562|NCT01901055|450074084|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
125122563|NCT01901055|450074085|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
125122564|NCT01901055|450074084|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
125122565|NCT01901055|450074085|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
125122566|NCT01901055|450074084|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
125122567|NCT01901055|450074085|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
125122568|NCT01901055|450074084|FG000|Week 24|Withdrawal by Subject|13|||
125122569|NCT01901055|450074085|FG001|Week 24|Withdrawal by Subject|19|||
125122570|NCT01901055|450074084|FG000|Week 24|Physician Decision|1|||
125122571|NCT01901055|450074085|FG001|Week 24|Physician Decision|0|||
125122572|NCT01901055|450074084|FG000|Week 36|Withdrawal by Subject|0|||
125122573|NCT01901055|450074085|FG001|Week 36|Withdrawal by Subject|5|||
125122574|NCT00525590|450074091|FG000|Overall Study|Adverse Event|3|||
125122575|NCT00525590|450074091|FG000|Overall Study|Physician Decision|3|||
125122576|NCT00525590|450074091|FG000|Overall Study|Withdrawal by Subject|16|||
125122577|NCT00525590|450074091|FG000|Overall Study|Lost to Follow-up|1|||
125122578|NCT00525590|450074091|FG000|Overall Study|Death|9|||
125122579|NCT00525590|450074091|FG000|Overall Study|Other|13|||
125122580|NCT00948675|450074092|FG000|Overall Study|Lost to Follow-up|1|||
125122581|NCT00948675|450074093|FG001|Overall Study|Lost to Follow-up|0|||
125122582|NCT00770510|450074099|FG000|Overall Study|Lost to Follow-up|2|||
125122583|NCT00770510|450074099|FG000|Overall Study|Pregnancy|1|||
125122584|NCT00770510|450074099|FG000|Overall Study|Withdrawal by Subject|2|||
125122585|NCT02192099|450074103|FG000|Overall Study|Adverse Event|1|||
125122586|NCT02192099|450074103|FG000|Overall Study|Lost to Follow-up|2|||
125122587|NCT02192099|450074103|FG000|Overall Study|Physician Decision|1|||
125122588|NCT02192099|450074103|FG000|Overall Study|Pregnancy|1|||
125213756|NCT00528372|450409775|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
125122589|NCT02192099|450074103|FG000|Overall Study|Protocol Violation|8|||
125122590|NCT02192099|450074103|FG000|Overall Study|Study Terminated by Sponsor|32|||
125122591|NCT02192099|450074103|FG000|Overall Study|Withdrawal by Subject|11|||
125122592|NCT02192099|450074103|FG000|Overall Study|Miscellaneous Reasons|5|||
125122593|NCT02796664|450074106|FG000|Overall Study|Withdrawal by Subject|0|||
125122594|NCT02796664|450074107|FG001|Overall Study|Withdrawal by Subject|3|||
125122595|NCT02796664|450074106|FG000|Overall Study|Noncompliance|1|||
125122596|NCT02796664|450074107|FG001|Overall Study|Noncompliance|1|||
125122597|NCT02796664|450074106|FG000|Overall Study|Death|0|||
125122598|NCT02796664|450074107|FG001|Overall Study|Death|1|||
125122599|NCT02246478|450074108|FG000|Multiple-dose Phase|Protocol Violation|1|||
125122600|NCT02246478|450074109|FG001|Multiple-dose Phase|Protocol Violation|0|||
125122601|NCT02246478|450074110|FG002|Multiple-dose Phase|Protocol Violation|0|||
125213757|NCT00528372|450409776|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
124941791|NCT00048932|449414786|FG001|Open Label Period (OL)|Adverse Event|0|||
124941792|NCT00048932|449414787|FG002|Open Label Period (OL)|Adverse Event|103|||
124941793|NCT00048932|449414785|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
124941794|NCT00048932|449414786|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
124941795|NCT00048932|449414787|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
124941796|NCT00048932|449414785|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
124941797|NCT00048932|449414786|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
124941798|NCT00048932|449414787|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
125213758|NCT00528372|450409777|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
125213759|NCT00528372|450409778|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
125213760|NCT00528372|450409779|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
125213761|NCT00528372|450409771|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
125213762|NCT00528372|450409772|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
125213763|NCT00528372|450409773|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
125213764|NCT00528372|450409774|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
125213765|NCT00528372|450409775|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
125213766|NCT00528372|450409776|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
125213767|NCT00528372|450409777|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
125213768|NCT00528372|450409778|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
125213769|NCT00528372|450409779|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
125213770|NCT00528372|450409771|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
125213771|NCT00528372|450409772|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
125213772|NCT00528372|450409773|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
125213773|NCT00528372|450409774|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
125213774|NCT00528372|450409775|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
125213775|NCT00528372|450409776|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
125213776|NCT00528372|450409777|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
125213777|NCT00528372|450409778|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
125213778|NCT00528372|450409779|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
125213779|NCT00528372|450409771|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
125213780|NCT00528372|450409772|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
125213781|NCT00528372|450409773|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
125213782|NCT00528372|450409774|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
125213783|NCT00528372|450409775|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
125213784|NCT00528372|450409776|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
125213785|NCT00528372|450409777|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
125213786|NCT00528372|450409778|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
125213787|NCT00528372|450409779|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
125213788|NCT00528372|450409771|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
125213789|NCT00528372|450409772|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
125213790|NCT00528372|450409773|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
125213791|NCT00528372|450409774|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
125213792|NCT00528372|450409775|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
125213793|NCT00528372|450409776|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
125213794|NCT00528372|450409777|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
125213795|NCT00528372|450409778|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
125213796|NCT00528372|450409779|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
125213797|NCT00528372|450409771|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
125213798|NCT00528372|450409772|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
125213799|NCT00528372|450409773|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
125213800|NCT00528372|450409774|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
125213801|NCT00528372|450409775|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
125213802|NCT00528372|450409776|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
125213803|NCT00528372|450409777|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
125213804|NCT00528372|450409778|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
125213805|NCT00528372|450409779|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
125213806|NCT00528372|450409771|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
125213807|NCT00528372|450409772|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
125213808|NCT00528372|450409773|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
125213809|NCT00528372|450409774|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
125213810|NCT00528372|450409775|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
125213811|NCT00528372|450409776|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
125213812|NCT00528372|450409777|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
125213813|NCT00528372|450409778|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
125213814|NCT00528372|450409779|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
125213815|NCT00528372|450409771|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
125213816|NCT00528372|450409772|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
125213817|NCT00528372|450409773|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
125122602|NCT02246478|450074111|FG003|Multiple-dose Phase|Protocol Violation|1|||
125122603|NCT01531205|450074116|FG000|Overall Study|Did not proceed to surgery|1|||
125122604|NCT02001558|450074117|FG000|Overall Study|Lost to Follow-up|8|||
125122605|NCT02001558|450074118|FG001|Overall Study|Lost to Follow-up|14|||
125122606|NCT04128007|450074119|FG000|Overall Study|Withdrawal by Subject|9|||
125122607|NCT04128007|450074120|FG001|Overall Study|Withdrawal by Subject|6|||
125122608|NCT04128007|450074119|FG000|Overall Study|Protocol Violation|1|||
125122609|NCT04128007|450074120|FG001|Overall Study|Protocol Violation|0|||
125122610|NCT04128007|450074119|FG000|Overall Study|Lost to Follow-up|8|||
125122611|NCT04128007|450074120|FG001|Overall Study|Lost to Follow-up|7|||
125122612|NCT04128007|450074119|FG000|Overall Study|Adverse Event|5|||
125122613|NCT04128007|450074120|FG001|Overall Study|Adverse Event|2|||
125122614|NCT04128007|450074119|FG000|Overall Study|Not reported|0|||
125122615|NCT04128007|450074120|FG001|Overall Study|Not reported|2|||
125122616|NCT04117607|450074121|FG000|Overall Study|Early Termination|0|||
125122617|NCT04117607|450074122|FG001|Overall Study|Early Termination|1|||
125122618|NCT04117607|450074123|FG002|Overall Study|Early Termination|0|||
125122619|NCT04117607|450074124|FG003|Overall Study|Early Termination|0|||
125122620|NCT04117607|450074125|FG004|Overall Study|Early Termination|0|||
125122621|NCT04117607|450074126|FG005|Overall Study|Early Termination|0|||
125122622|NCT04117607|450074127|FG006|Overall Study|Early Termination|1|||
125122623|NCT04117607|450074128|FG007|Overall Study|Early Termination|0|||
125122624|NCT04117607|450074129|FG008|Overall Study|Early Termination|0|||
125122625|NCT04117607|450074130|FG009|Overall Study|Early Termination|0|||
125122626|NCT04117607|450074131|FG010|Overall Study|Early Termination|0|||
125122627|NCT04117607|450074132|FG011|Overall Study|Early Termination|0|||
125122628|NCT04117607|450074133|FG012|Overall Study|Early Termination|0|||
125122629|NCT04117607|450074134|FG013|Overall Study|Early Termination|0|||
125122630|NCT00950807|450074138|FG000|Treatment Period 1|Lack of Efficacy|1|||
125122631|NCT00950807|450074139|FG001|Treatment Period 1|Lack of Efficacy|0|||
125122632|NCT00950807|450074140|FG002|Treatment Period 1|Lack of Efficacy|0|||
125122633|NCT00950807|450074141|FG003|Treatment Period 1|Lack of Efficacy|0|||
125122634|NCT00950807|450074142|FG004|Treatment Period 1|Lack of Efficacy|0|||
125122635|NCT00950807|450074143|FG005|Treatment Period 1|Lack of Efficacy|1|||
125122636|NCT00950807|450074144|FG006|Treatment Period 1|Lack of Efficacy|0|||
125122637|NCT00950807|450074145|FG007|Treatment Period 1|Lack of Efficacy|0|||
125122638|NCT00950807|450074146|FG008|Treatment Period 1|Lack of Efficacy|0|||
125122639|NCT00950807|450074147|FG009|Treatment Period 1|Lack of Efficacy|0|||
125122640|NCT00950807|450074138|FG000|Treatment Period 1|Protocol Violation|1|||
125122641|NCT00950807|450074139|FG001|Treatment Period 1|Protocol Violation|0|||
125122642|NCT00950807|450074140|FG002|Treatment Period 1|Protocol Violation|0|||
125122643|NCT00950807|450074141|FG003|Treatment Period 1|Protocol Violation|0|||
125122644|NCT00950807|450074142|FG004|Treatment Period 1|Protocol Violation|0|||
125122645|NCT00950807|450074143|FG005|Treatment Period 1|Protocol Violation|0|||
125122646|NCT00950807|450074144|FG006|Treatment Period 1|Protocol Violation|0|||
125122647|NCT00950807|450074145|FG007|Treatment Period 1|Protocol Violation|0|||
125122648|NCT00950807|450074146|FG008|Treatment Period 1|Protocol Violation|0|||
125122649|NCT00950807|450074147|FG009|Treatment Period 1|Protocol Violation|0|||
125122650|NCT00950807|450074138|FG000|Treatment Period 1|Lost to Follow-up|0|||
125122651|NCT00950807|450074139|FG001|Treatment Period 1|Lost to Follow-up|0|||
125122652|NCT00950807|450074140|FG002|Treatment Period 1|Lost to Follow-up|1|||
125213818|NCT00528372|450409774|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
125213819|NCT00528372|450409775|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
125122653|NCT00950807|450074141|FG003|Treatment Period 1|Lost to Follow-up|0|||
125122654|NCT00950807|450074142|FG004|Treatment Period 1|Lost to Follow-up|0|||
125122655|NCT00950807|450074143|FG005|Treatment Period 1|Lost to Follow-up|0|||
125122656|NCT00950807|450074144|FG006|Treatment Period 1|Lost to Follow-up|0|||
125122657|NCT00950807|450074145|FG007|Treatment Period 1|Lost to Follow-up|0|||
125122658|NCT00950807|450074146|FG008|Treatment Period 1|Lost to Follow-up|0|||
125122659|NCT00950807|450074147|FG009|Treatment Period 1|Lost to Follow-up|0|||
125122660|NCT00950807|450074138|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125122661|NCT00950807|450074139|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125122662|NCT00950807|450074140|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125213820|NCT00528372|450409776|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
125122663|NCT00950807|450074141|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125122664|NCT00950807|450074142|FG004|Treatment Period 1|Withdrawal by Subject|1|||
125122665|NCT00950807|450074143|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125122666|NCT00950807|450074144|FG006|Treatment Period 1|Withdrawal by Subject|0|||
125122667|NCT00950807|450074145|FG007|Treatment Period 1|Withdrawal by Subject|0|||
125122668|NCT00950807|450074146|FG008|Treatment Period 1|Withdrawal by Subject|1|||
125122669|NCT00950807|450074147|FG009|Treatment Period 1|Withdrawal by Subject|0|||
125122670|NCT00950807|450074138|FG000|Treatment Period 1|Adverse Event|0|||
125122671|NCT00950807|450074139|FG001|Treatment Period 1|Adverse Event|0|||
125122672|NCT00950807|450074140|FG002|Treatment Period 1|Adverse Event|0|||
125122673|NCT00950807|450074141|FG003|Treatment Period 1|Adverse Event|0|||
125122674|NCT00950807|450074142|FG004|Treatment Period 1|Adverse Event|0|||
125027927|NCT01262976|449725629|FG003|Up to Month 2|Withdrawal by Subject|0|||
125027928|NCT01262976|449725630|FG004|Up to Month 2|Withdrawal by Subject|0|||
125027929|NCT01262976|449725631|FG005|Up to Month 2|Withdrawal by Subject|0|||
125027930|NCT01262976|449725626|FG000|Up to Month 2|Migrated/moved from study area|0|||
125027931|NCT01262976|449725627|FG001|Up to Month 2|Migrated/moved from study area|1|||
125027932|NCT01262976|449725628|FG002|Up to Month 2|Migrated/moved from study area|0|||
125027933|NCT01262976|449725629|FG003|Up to Month 2|Migrated/moved from study area|0|||
125027934|NCT01262976|449725630|FG004|Up to Month 2|Migrated/moved from study area|1|||
125027935|NCT01262976|449725631|FG005|Up to Month 2|Migrated/moved from study area|1|||
125027936|NCT01262976|449725626|FG000|Up to Month 2|Lost to Follow-up|1|||
125027937|NCT01262976|449725627|FG001|Up to Month 2|Lost to Follow-up|0|||
125027938|NCT01262976|449725628|FG002|Up to Month 2|Lost to Follow-up|0|||
125027939|NCT01262976|449725629|FG003|Up to Month 2|Lost to Follow-up|1|||
125027940|NCT01262976|449725630|FG004|Up to Month 2|Lost to Follow-up|1|||
125027941|NCT01262976|449725631|FG005|Up to Month 2|Lost to Follow-up|1|||
125027942|NCT01262976|449725626|FG000|Up to Month 2|Other|1|||
125027943|NCT01262976|449725627|FG001|Up to Month 2|Other|0|||
125027944|NCT01262976|449725628|FG002|Up to Month 2|Other|0|||
125027945|NCT01262976|449725629|FG003|Up to Month 2|Other|1|||
125027946|NCT01262976|449725630|FG004|Up to Month 2|Other|0|||
125027947|NCT01262976|449725631|FG005|Up to Month 2|Other|2|||
125027948|NCT01262976|449725626|FG000|Up to Month 7|Serious Adverse Event|0|||
125027949|NCT01262976|449725627|FG001|Up to Month 7|Serious Adverse Event|0|||
125027950|NCT01262976|449725628|FG002|Up to Month 7|Serious Adverse Event|2|||
125027951|NCT01262976|449725629|FG003|Up to Month 7|Serious Adverse Event|0|||
125027952|NCT01262976|449725630|FG004|Up to Month 7|Serious Adverse Event|0|||
125027953|NCT01262976|449725631|FG005|Up to Month 7|Serious Adverse Event|0|||
125027954|NCT01262976|449725626|FG000|Up to Month 7|Withdrawal by Subject|1|||
125027955|NCT01262976|449725627|FG001|Up to Month 7|Withdrawal by Subject|0|||
125122675|NCT00950807|450074143|FG005|Treatment Period 1|Adverse Event|1|||
125122676|NCT00950807|450074144|FG006|Treatment Period 1|Adverse Event|0|||
125122677|NCT00950807|450074145|FG007|Treatment Period 1|Adverse Event|0|||
125122678|NCT00950807|450074146|FG008|Treatment Period 1|Adverse Event|0|||
125122679|NCT00950807|450074147|FG009|Treatment Period 1|Adverse Event|0|||
125122680|NCT00950807|450074138|FG000|Washout Period 1|Lack of Efficacy|0|||
125122681|NCT00950807|450074139|FG001|Washout Period 1|Lack of Efficacy|0|||
125122682|NCT00950807|450074140|FG002|Washout Period 1|Lack of Efficacy|0|||
125122683|NCT00950807|450074141|FG003|Washout Period 1|Lack of Efficacy|0|||
125122684|NCT00950807|450074142|FG004|Washout Period 1|Lack of Efficacy|0|||
125122685|NCT00950807|450074143|FG005|Washout Period 1|Lack of Efficacy|0|||
125122686|NCT00950807|450074144|FG006|Washout Period 1|Lack of Efficacy|1|||
125122687|NCT00950807|450074145|FG007|Washout Period 1|Lack of Efficacy|0|||
125122688|NCT00950807|450074146|FG008|Washout Period 1|Lack of Efficacy|0|||
125122689|NCT00950807|450074147|FG009|Washout Period 1|Lack of Efficacy|0|||
125122690|NCT00950807|450074138|FG000|Washout Period 1|Withdrawal by Subject|0|||
125122691|NCT00950807|450074139|FG001|Washout Period 1|Withdrawal by Subject|0|||
125122692|NCT00950807|450074140|FG002|Washout Period 1|Withdrawal by Subject|0|||
125122693|NCT00950807|450074141|FG003|Washout Period 1|Withdrawal by Subject|0|||
125122694|NCT00950807|450074142|FG004|Washout Period 1|Withdrawal by Subject|0|||
125122695|NCT00950807|450074143|FG005|Washout Period 1|Withdrawal by Subject|0|||
125122696|NCT00950807|450074144|FG006|Washout Period 1|Withdrawal by Subject|0|||
125122697|NCT00950807|450074145|FG007|Washout Period 1|Withdrawal by Subject|0|||
125122698|NCT00950807|450074146|FG008|Washout Period 1|Withdrawal by Subject|1|||
125122699|NCT00950807|450074147|FG009|Washout Period 1|Withdrawal by Subject|0|||
125122700|NCT00950807|450074138|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
125122701|NCT00950807|450074139|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
125122702|NCT00950807|450074140|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
125122703|NCT00950807|450074141|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
125122704|NCT00950807|450074142|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
125122705|NCT00950807|450074143|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
125122706|NCT00950807|450074144|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
125122707|NCT00950807|450074145|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
125122708|NCT00950807|450074146|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
125122709|NCT00950807|450074147|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
125122710|NCT00950807|450074138|FG000|Washout Period 1|Adverse Event|2|||
125122711|NCT00950807|450074139|FG001|Washout Period 1|Adverse Event|0|||
125122712|NCT00950807|450074140|FG002|Washout Period 1|Adverse Event|0|||
125122713|NCT00950807|450074141|FG003|Washout Period 1|Adverse Event|1|||
125122714|NCT00950807|450074142|FG004|Washout Period 1|Adverse Event|1|||
125122715|NCT00950807|450074143|FG005|Washout Period 1|Adverse Event|0|||
125122716|NCT00950807|450074144|FG006|Washout Period 1|Adverse Event|0|||
125027956|NCT01262976|449725628|FG002|Up to Month 7|Withdrawal by Subject|0|||
125027957|NCT01262976|449725629|FG003|Up to Month 7|Withdrawal by Subject|0|||
125027958|NCT01262976|449725630|FG004|Up to Month 7|Withdrawal by Subject|0|||
125027959|NCT01262976|449725631|FG005|Up to Month 7|Withdrawal by Subject|0|||
125027960|NCT01262976|449725626|FG000|Up to Month 7|Migrated/moved from study area|0|||
125027961|NCT01262976|449725627|FG001|Up to Month 7|Migrated/moved from study area|0|||
125027962|NCT01262976|449725628|FG002|Up to Month 7|Migrated/moved from study area|1|||
125027963|NCT01262976|449725629|FG003|Up to Month 7|Migrated/moved from study area|3|||
125027964|NCT01262976|449725630|FG004|Up to Month 7|Migrated/moved from study area|1|||
125027965|NCT01262976|449725631|FG005|Up to Month 7|Migrated/moved from study area|1|||
125027966|NCT01262976|449725626|FG000|Up to Month 7|Lost to Follow-up|1|||
125027967|NCT01262976|449725627|FG001|Up to Month 7|Lost to Follow-up|0|||
125027968|NCT01262976|449725628|FG002|Up to Month 7|Lost to Follow-up|1|||
125027969|NCT01262976|449725629|FG003|Up to Month 7|Lost to Follow-up|3|||
125027970|NCT01262976|449725630|FG004|Up to Month 7|Lost to Follow-up|1|||
125027971|NCT01262976|449725631|FG005|Up to Month 7|Lost to Follow-up|3|||
125027972|NCT01262976|449725626|FG000|Up to Month 7|Other|3|||
125027973|NCT01262976|449725627|FG001|Up to Month 7|Other|0|||
125027974|NCT01262976|449725628|FG002|Up to Month 7|Other|2|||
125027975|NCT01262976|449725629|FG003|Up to Month 7|Other|0|||
125027976|NCT01262976|449725630|FG004|Up to Month 7|Other|0|||
125027977|NCT01262976|449725631|FG005|Up to Month 7|Other|0|||
125027978|NCT01262976|449725626|FG000|Up to Year 1|Serious Adverse Event|0|||
125027979|NCT01262976|449725627|FG001|Up to Year 1|Serious Adverse Event|0|||
125027980|NCT01262976|449725628|FG002|Up to Year 1|Serious Adverse Event|2|||
125122717|NCT00950807|450074145|FG007|Washout Period 1|Adverse Event|0|||
125122718|NCT00950807|450074146|FG008|Washout Period 1|Adverse Event|0|||
125122719|NCT00950807|450074147|FG009|Washout Period 1|Adverse Event|0|||
125122720|NCT00950807|450074138|FG000|Treatment Period 2|Lack of Efficacy|1|||
125122721|NCT00950807|450074139|FG001|Treatment Period 2|Lack of Efficacy|0|||
125122722|NCT00950807|450074140|FG002|Treatment Period 2|Lack of Efficacy|0|||
125122723|NCT00950807|450074141|FG003|Treatment Period 2|Lack of Efficacy|0|||
125122724|NCT00950807|450074142|FG004|Treatment Period 2|Lack of Efficacy|0|||
125122725|NCT00950807|450074143|FG005|Treatment Period 2|Lack of Efficacy|0|||
125122726|NCT00950807|450074144|FG006|Treatment Period 2|Lack of Efficacy|0|||
125122727|NCT00950807|450074145|FG007|Treatment Period 2|Lack of Efficacy|0|||
125122728|NCT00950807|450074146|FG008|Treatment Period 2|Lack of Efficacy|0|||
125122729|NCT00950807|450074147|FG009|Treatment Period 2|Lack of Efficacy|0|||
125122730|NCT00950807|450074138|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125122731|NCT00950807|450074139|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125122732|NCT00950807|450074140|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125122733|NCT00950807|450074141|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125122734|NCT00950807|450074142|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125122735|NCT00950807|450074143|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125122736|NCT00950807|450074144|FG006|Treatment Period 2|Withdrawal by Subject|1|||
125122737|NCT00950807|450074145|FG007|Treatment Period 2|Withdrawal by Subject|2|||
125122738|NCT00950807|450074146|FG008|Treatment Period 2|Withdrawal by Subject|0|||
125122739|NCT00950807|450074147|FG009|Treatment Period 2|Withdrawal by Subject|0|||
125122740|NCT00950807|450074138|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
125122741|NCT00950807|450074139|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125122742|NCT00950807|450074140|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125122743|NCT00950807|450074141|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125122744|NCT00950807|450074142|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125122745|NCT00950807|450074143|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125122746|NCT00950807|450074144|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125122747|NCT00950807|450074145|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125122748|NCT00950807|450074146|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125122749|NCT00950807|450074147|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125122750|NCT00950807|450074138|FG000|Treatment Period 2|Adverse Event|0|||
125122751|NCT00950807|450074139|FG001|Treatment Period 2|Adverse Event|1|||
125122752|NCT00950807|450074140|FG002|Treatment Period 2|Adverse Event|0|||
125122753|NCT00950807|450074141|FG003|Treatment Period 2|Adverse Event|1|||
125122754|NCT00950807|450074142|FG004|Treatment Period 2|Adverse Event|0|||
125122755|NCT00950807|450074143|FG005|Treatment Period 2|Adverse Event|1|||
125122756|NCT00950807|450074144|FG006|Treatment Period 2|Adverse Event|0|||
125122757|NCT00950807|450074145|FG007|Treatment Period 2|Adverse Event|1|||
125122758|NCT00950807|450074146|FG008|Treatment Period 2|Adverse Event|0|||
125122759|NCT00950807|450074147|FG009|Treatment Period 2|Adverse Event|0|||
125027981|NCT01262976|449725629|FG003|Up to Year 1|Serious Adverse Event|0|||
125027982|NCT01262976|449725630|FG004|Up to Year 1|Serious Adverse Event|0|||
125027983|NCT01262976|449725631|FG005|Up to Year 1|Serious Adverse Event|0|||
125027984|NCT01262976|449725626|FG000|Up to Year 1|Withdrawal by Subject|1|||
125122760|NCT00950807|450074138|FG000|Washout Period 2|Lack of Efficacy|1|||
125122761|NCT00950807|450074139|FG001|Washout Period 2|Lack of Efficacy|0|||
125122762|NCT00950807|450074140|FG002|Washout Period 2|Lack of Efficacy|0|||
125122763|NCT00950807|450074141|FG003|Washout Period 2|Lack of Efficacy|0|||
125027985|NCT01262976|449725627|FG001|Up to Year 1|Withdrawal by Subject|0|||
125027986|NCT01262976|449725628|FG002|Up to Year 1|Withdrawal by Subject|0|||
125027987|NCT01262976|449725629|FG003|Up to Year 1|Withdrawal by Subject|0|||
125027988|NCT01262976|449725630|FG004|Up to Year 1|Withdrawal by Subject|0|||
125213821|NCT00528372|450409777|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
125213822|NCT00528372|450409778|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
125213823|NCT00528372|450409779|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
125213824|NCT00528372|450409771|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
125213825|NCT00528372|450409772|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
125213826|NCT00528372|450409773|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
125213827|NCT00528372|450409774|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
125213828|NCT00528372|450409775|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
125213829|NCT00528372|450409776|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
125213830|NCT00528372|450409777|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
125213831|NCT00528372|450409778|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
125213832|NCT00528372|450409779|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
125213833|NCT02772809|450409780|FG000|Overall Study|not completed some tasks|6|||
125213834|NCT02774005|450409786|FG000|Overall Study|Adverse Event|8|||
125213835|NCT02774005|450409786|FG000|Overall Study|Withdrawal by Subject|23|||
125213836|NCT02774005|450409786|FG000|Overall Study|Lost to Follow-up|7|||
125213837|NCT02774005|450409786|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
125213838|NCT02774005|450409786|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
125213839|NCT02774005|450409786|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
125213840|NCT02774005|450409786|FG000|Overall Study|Death|1|||
125213841|NCT02774005|450409786|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
125213842|NCT02774005|450409786|FG000|Overall Study|Lack of compliance with study medication|4|||
125213843|NCT02774005|450409786|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
125213844|NCT02774005|450409786|FG000|Overall Study|another study|1|||
125213845|NCT02774005|450409786|FG000|Overall Study|cardiologist imposed travel restriction|1|||
125213846|NCT00534105|450409787|FG000|Overall Study|Lost to Follow-up|23|||
125213847|NCT00534105|450409788|FG001|Overall Study|Lost to Follow-up|39|||
125213848|NCT03275389|450409791|FG000|Overall Study|Lost to Follow-up|10|||
125213849|NCT03275389|450409792|FG001|Overall Study|Lost to Follow-up|10|||
125213850|NCT03275389|450409793|FG002|Overall Study|Lost to Follow-up|19|||
125213851|NCT03275389|450409794|FG003|Overall Study|Lost to Follow-up|12|||
125213852|NCT03275389|450409795|FG004|Overall Study|Lost to Follow-up|11|||
125213853|NCT03275389|450409796|FG005|Overall Study|Lost to Follow-up|12|||
125213854|NCT03275389|450409797|FG006|Overall Study|Lost to Follow-up|21|||
125213855|NCT03275389|450409798|FG007|Overall Study|Lost to Follow-up|15|||
125213856|NCT03275389|450409799|FG008|Overall Study|Lost to Follow-up|12|||
125213857|NCT03275389|450409800|FG009|Overall Study|Lost to Follow-up|14|||
125213858|NCT03275389|450409791|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
125213859|NCT03275389|450409792|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
125213860|NCT03275389|450409793|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
125213861|NCT03275389|450409794|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
125213862|NCT03275389|450409795|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
125213863|NCT03275389|450409796|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
125213864|NCT03275389|450409797|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
125213865|NCT03275389|450409798|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
125213866|NCT03275389|450409799|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
125213867|NCT03275389|450409800|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
125213868|NCT03275389|450409791|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
125213869|NCT03275389|450409792|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
125213870|NCT03275389|450409793|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
125213871|NCT03275389|450409794|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
125213872|NCT03275389|450409795|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
125213873|NCT03275389|450409796|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
125213874|NCT03275389|450409797|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
125213875|NCT03275389|450409798|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
125213876|NCT03275389|450409799|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
125213877|NCT03275389|450409800|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
124941799|NCT00048932|449414785|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
124941800|NCT00048932|449414786|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
124941801|NCT00048932|449414787|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
124941802|NCT00048932|449414785|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
124941803|NCT00048932|449414786|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
124941804|NCT00048932|449414787|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
124941805|NCT00048932|449414785|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
124941806|NCT00048932|449414786|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
124941807|NCT00048932|449414787|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
124941808|NCT00048932|449414785|FG000|Open Label Period (OL)|Pregnancy|0|||
124941809|NCT00048932|449414786|FG001|Open Label Period (OL)|Pregnancy|0|||
124941810|NCT00048932|449414787|FG002|Open Label Period (OL)|Pregnancy|6|||
124941811|NCT00048932|449414785|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
124941812|NCT00048932|449414786|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
125027989|NCT01262976|449725631|FG005|Up to Year 1|Withdrawal by Subject|0|||
125027990|NCT01262976|449725626|FG000|Up to Year 1|Migrated/moved from study area|1|||
125027991|NCT01262976|449725627|FG001|Up to Year 1|Migrated/moved from study area|0|||
125027992|NCT01262976|449725628|FG002|Up to Year 1|Migrated/moved from study area|0|||
125027993|NCT01262976|449725629|FG003|Up to Year 1|Migrated/moved from study area|3|||
125027994|NCT01262976|449725630|FG004|Up to Year 1|Migrated/moved from study area|3|||
125027995|NCT01262976|449725631|FG005|Up to Year 1|Migrated/moved from study area|2|||
125027996|NCT01262976|449725626|FG000|Up to Year 1|Lost to Follow-up|4|||
125027997|NCT01262976|449725627|FG001|Up to Year 1|Lost to Follow-up|0|||
125027998|NCT01262976|449725628|FG002|Up to Year 1|Lost to Follow-up|0|||
125027999|NCT01262976|449725629|FG003|Up to Year 1|Lost to Follow-up|1|||
125028000|NCT01262976|449725630|FG004|Up to Year 1|Lost to Follow-up|6|||
125028001|NCT01262976|449725631|FG005|Up to Year 1|Lost to Follow-up|5|||
125028002|NCT01262976|449725626|FG000|Up to Year 1|Other|3|||
125028003|NCT01262976|449725627|FG001|Up to Year 1|Other|1|||
125028004|NCT01262976|449725628|FG002|Up to Year 1|Other|0|||
125028005|NCT01262976|449725629|FG003|Up to Year 1|Other|0|||
124941813|NCT00048932|449414787|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
124941814|NCT00048932|449414785|FG000|Open Label Period (OL)|Investigator Retiring|0|||
124941815|NCT00048932|449414786|FG001|Open Label Period (OL)|Investigator Retiring|0|||
124941816|NCT00048932|449414787|FG002|Open Label Period (OL)|Investigator Retiring|2|||
124941817|NCT00048932|449414785|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
124941818|NCT00048932|449414786|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
124941819|NCT00048932|449414787|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
124941820|NCT00048932|449414785|FG000|Open Label Period (OL)|Participant Relocated|0|||
124941821|NCT00048932|449414786|FG001|Open Label Period (OL)|Participant Relocated|0|||
124941822|NCT00048932|449414787|FG002|Open Label Period (OL)|Participant Relocated|6|||
124941823|NCT00048932|449414785|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
124941824|NCT00048932|449414786|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
124941825|NCT00048932|449414787|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
124941826|NCT00048932|449414785|FG000|Open Label Period (OL)|Site Closure|0|||
124941827|NCT00048932|449414786|FG001|Open Label Period (OL)|Site Closure|0|||
124941828|NCT00048932|449414787|FG002|Open Label Period (OL)|Site Closure|3|||
124941829|NCT00048932|449414785|FG000|Open Label Period (OL)|Trial Terminated|0|||
124941830|NCT00048932|449414786|FG001|Open Label Period (OL)|Trial Terminated|0|||
124941831|NCT00048932|449414787|FG002|Open Label Period (OL)|Trial Terminated|1|||
124941832|NCT00048932|449414785|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
124941833|NCT00048932|449414786|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
125122764|NCT00950807|450074142|FG004|Washout Period 2|Lack of Efficacy|0|||
125122765|NCT00950807|450074143|FG005|Washout Period 2|Lack of Efficacy|0|||
125122766|NCT00950807|450074144|FG006|Washout Period 2|Lack of Efficacy|0|||
125122767|NCT00950807|450074145|FG007|Washout Period 2|Lack of Efficacy|0|||
125122768|NCT00950807|450074146|FG008|Washout Period 2|Lack of Efficacy|0|||
125122769|NCT00950807|450074147|FG009|Washout Period 2|Lack of Efficacy|0|||
125122770|NCT00950807|450074138|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
125122771|NCT00950807|450074139|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
125122772|NCT00950807|450074140|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
125122773|NCT00950807|450074141|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
125122774|NCT00950807|450074142|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
125122775|NCT00950807|450074143|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
125122776|NCT00950807|450074144|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
125122777|NCT00950807|450074145|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
125122778|NCT00950807|450074146|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
125122779|NCT00950807|450074147|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
125122780|NCT00950807|450074138|FG000|Washout Period 2|Adverse Event|3|||
125122781|NCT00950807|450074139|FG001|Washout Period 2|Adverse Event|0|||
125122782|NCT00950807|450074140|FG002|Washout Period 2|Adverse Event|0|||
125122783|NCT00950807|450074141|FG003|Washout Period 2|Adverse Event|1|||
125122784|NCT00950807|450074142|FG004|Washout Period 2|Adverse Event|0|||
125122785|NCT00950807|450074143|FG005|Washout Period 2|Adverse Event|0|||
125122786|NCT00950807|450074144|FG006|Washout Period 2|Adverse Event|0|||
125122787|NCT00950807|450074145|FG007|Washout Period 2|Adverse Event|0|||
125122788|NCT00950807|450074146|FG008|Washout Period 2|Adverse Event|0|||
125122789|NCT00950807|450074147|FG009|Washout Period 2|Adverse Event|0|||
125122790|NCT00950807|450074138|FG000|Treatment Period 3|Withdrawal by Subject|0|||
125122791|NCT00950807|450074139|FG001|Treatment Period 3|Withdrawal by Subject|0|||
125122792|NCT00950807|450074140|FG002|Treatment Period 3|Withdrawal by Subject|0|||
125122793|NCT00950807|450074141|FG003|Treatment Period 3|Withdrawal by Subject|0|||
125122794|NCT00950807|450074142|FG004|Treatment Period 3|Withdrawal by Subject|0|||
125122795|NCT00950807|450074143|FG005|Treatment Period 3|Withdrawal by Subject|0|||
125122796|NCT00950807|450074144|FG006|Treatment Period 3|Withdrawal by Subject|0|||
125122797|NCT00950807|450074145|FG007|Treatment Period 3|Withdrawal by Subject|0|||
125122798|NCT00950807|450074146|FG008|Treatment Period 3|Withdrawal by Subject|0|||
125213878|NCT03275389|450409791|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125122799|NCT00950807|450074147|FG009|Treatment Period 3|Withdrawal by Subject|1|||
124941834|NCT00048932|449414787|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
124941835|NCT00048932|449414785|FG000|Open Label Period (OL)|Patient Decision|0|||
124941836|NCT00048932|449414786|FG001|Open Label Period (OL)|Patient Decision|0|||
124941837|NCT00048932|449414787|FG002|Open Label Period (OL)|Patient Decision|4|||
124941838|NCT00048932|449414785|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
124941839|NCT00048932|449414786|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
124941840|NCT00048932|449414787|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
124941841|NCT00048932|449414785|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
124941842|NCT00048932|449414786|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
124941843|NCT00048932|449414787|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
124941844|NCT00048932|449414785|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
124941845|NCT00048932|449414786|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
124941846|NCT00048932|449414787|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
124941847|NCT00048932|449414785|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
124941848|NCT00048932|449414786|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
124941849|NCT00048932|449414787|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
124941850|NCT00048932|449414785|FG000|Open Label Period (OL)|Investigator Decision|0|||
124941851|NCT00048932|449414786|FG001|Open Label Period (OL)|Investigator Decision|0|||
124941852|NCT00048932|449414787|FG002|Open Label Period (OL)|Investigator Decision|4|||
124941853|NCT00048932|449414785|FG000|Open Label Period (OL)|Site Staff Issues|0|||
124941854|NCT00048932|449414786|FG001|Open Label Period (OL)|Site Staff Issues|0|||
124941855|NCT00048932|449414787|FG002|Open Label Period (OL)|Site Staff Issues|2|||
124941856|NCT00048932|449414785|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
124941857|NCT00048932|449414786|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
124941858|NCT00048932|449414787|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
124941859|NCT00048932|449414785|FG000|Open Label Period (OL)|Participant Surgery|0|||
124941860|NCT00048932|449414786|FG001|Open Label Period (OL)|Participant Surgery|0|||
124941861|NCT00048932|449414787|FG002|Open Label Period (OL)|Participant Surgery|1|||
124941862|NCT02232737|449414788|FG000|Overall Study|Lost to Follow-up|18|||
124941863|NCT02232737|449414789|FG001|Overall Study|Lost to Follow-up|28|||
124941864|NCT02232737|449414790|FG002|Overall Study|Lost to Follow-up|33|||
124941865|NCT02232737|449414788|FG000|Overall Study|Personal reasons|7|||
124941866|NCT02232737|449414789|FG001|Overall Study|Personal reasons|8|||
124941867|NCT02232737|449414790|FG002|Overall Study|Personal reasons|14|||
124941868|NCT02232737|449414788|FG000|Overall Study|Adverse Event|6|||
124941869|NCT02232737|449414789|FG001|Overall Study|Adverse Event|3|||
124941870|NCT02232737|449414790|FG002|Overall Study|Adverse Event|8|||
124941871|NCT02232737|449414788|FG000|Overall Study|Incarcerated|2|||
124941872|NCT02232737|449414789|FG001|Overall Study|Incarcerated|1|||
124941873|NCT02232737|449414790|FG002|Overall Study|Incarcerated|2|||
124941874|NCT02232737|449414788|FG000|Overall Study|Withdrawal by Subject|0|||
124941875|NCT02232737|449414789|FG001|Overall Study|Withdrawal by Subject|1|||
124941876|NCT02232737|449414790|FG002|Overall Study|Withdrawal by Subject|2|||
124941877|NCT02232737|449414788|FG000|Overall Study|Death|0|||
124941878|NCT02232737|449414789|FG001|Overall Study|Death|1|||
124941879|NCT02232737|449414790|FG002|Overall Study|Death|1|||
124941880|NCT02232737|449414788|FG000|Overall Study|Physician Decision|1|||
124941881|NCT02232737|449414789|FG001|Overall Study|Physician Decision|3|||
124941882|NCT02232737|449414790|FG002|Overall Study|Physician Decision|1|||
124941883|NCT02232737|449414788|FG000|Overall Study|Protocol Violation|1|||
124941884|NCT02232737|449414789|FG001|Overall Study|Protocol Violation|0|||
124941885|NCT02232737|449414790|FG002|Overall Study|Protocol Violation|1|||
124941886|NCT02232737|449414788|FG000|Overall Study|Reason unknown|1|||
124941887|NCT02232737|449414789|FG001|Overall Study|Reason unknown|0|||
124941888|NCT02232737|449414790|FG002|Overall Study|Reason unknown|0|||
124941889|NCT04559698|449414800|FG000|Overall Study|Lost to Follow-up|14|||
124941890|NCT04559698|449414801|FG001|Overall Study|Lost to Follow-up|15|||
124941891|NCT04559698|449414800|FG000|Overall Study|Withdrawal by Subject|0|||
124941892|NCT04559698|449414801|FG001|Overall Study|Withdrawal by Subject|1|||
124941893|NCT01641900|449414806|FG000|Overall Study|Withdrawal by Subject|2|||
124941894|NCT01641900|449414807|FG001|Overall Study|Withdrawal by Subject|2|||
124941895|NCT03220724|449414813|FG000|Overall Study|Lost to Follow-up|2|||
124941896|NCT03220724|449414814|FG001|Overall Study|Lost to Follow-up|2|||
125028006|NCT01262976|449725630|FG004|Up to Year 1|Other|2|||
125028007|NCT01262976|449725631|FG005|Up to Year 1|Other|1|||
125028008|NCT01262976|449725626|FG000|Up to Year 1|Subjects with unknown completion status|0|||
125028009|NCT01262976|449725627|FG001|Up to Year 1|Subjects with unknown completion status|0|||
125028010|NCT01262976|449725628|FG002|Up to Year 1|Subjects with unknown completion status|1|||
125028011|NCT01262976|449725629|FG003|Up to Year 1|Subjects with unknown completion status|0|||
125028012|NCT01262976|449725630|FG004|Up to Year 1|Subjects with unknown completion status|0|||
125028013|NCT01262976|449725631|FG005|Up to Year 1|Subjects with unknown completion status|1|||
125028014|NCT01262976|449725626|FG000|Up to Year 2|Serious Adverse Event|0|||
125028015|NCT01262976|449725627|FG001|Up to Year 2|Serious Adverse Event|0|||
125028016|NCT01262976|449725628|FG002|Up to Year 2|Serious Adverse Event|2|||
125028017|NCT01262976|449725629|FG003|Up to Year 2|Serious Adverse Event|0|||
125028018|NCT01262976|449725630|FG004|Up to Year 2|Serious Adverse Event|0|||
125028019|NCT01262976|449725631|FG005|Up to Year 2|Serious Adverse Event|0|||
125028020|NCT01262976|449725626|FG000|Up to Year 2|Withdrawal by Subject|1|||
125028021|NCT01262976|449725627|FG001|Up to Year 2|Withdrawal by Subject|0|||
125028022|NCT01262976|449725628|FG002|Up to Year 2|Withdrawal by Subject|0|||
125028023|NCT01262976|449725629|FG003|Up to Year 2|Withdrawal by Subject|0|||
125028024|NCT01262976|449725630|FG004|Up to Year 2|Withdrawal by Subject|0|||
125028025|NCT01262976|449725631|FG005|Up to Year 2|Withdrawal by Subject|0|||
125028026|NCT01262976|449725626|FG000|Up to Year 2|Migrated/moved from study area|0|||
125028027|NCT01262976|449725627|FG001|Up to Year 2|Migrated/moved from study area|0|||
125028028|NCT01262976|449725628|FG002|Up to Year 2|Migrated/moved from study area|0|||
125028029|NCT01262976|449725629|FG003|Up to Year 2|Migrated/moved from study area|2|||
125028030|NCT01262976|449725630|FG004|Up to Year 2|Migrated/moved from study area|1|||
125028031|NCT01262976|449725631|FG005|Up to Year 2|Migrated/moved from study area|2|||
125028032|NCT01262976|449725626|FG000|Up to Year 2|Lost to Follow-up|1|||
125028033|NCT01262976|449725627|FG001|Up to Year 2|Lost to Follow-up|1|||
125028034|NCT01262976|449725628|FG002|Up to Year 2|Lost to Follow-up|2|||
125028035|NCT01262976|449725629|FG003|Up to Year 2|Lost to Follow-up|2|||
125028036|NCT01262976|449725630|FG004|Up to Year 2|Lost to Follow-up|3|||
125028037|NCT01262976|449725631|FG005|Up to Year 2|Lost to Follow-up|3|||
125028038|NCT01262976|449725626|FG000|Up to Year 2|Subjects with unknown completion status|0|||
125028039|NCT01262976|449725627|FG001|Up to Year 2|Subjects with unknown completion status|0|||
125028040|NCT01262976|449725628|FG002|Up to Year 2|Subjects with unknown completion status|1|||
125028041|NCT01262976|449725629|FG003|Up to Year 2|Subjects with unknown completion status|0|||
124941897|NCT03220724|449414815|FG002|Overall Study|Lost to Follow-up|0|||
124941898|NCT03220724|449414816|FG003|Overall Study|Lost to Follow-up|3|||
124941899|NCT03220724|449414817|FG004|Overall Study|Lost to Follow-up|1|||
124941900|NCT03220724|449414818|FG005|Overall Study|Lost to Follow-up|0|||
124941901|NCT03220724|449414819|FG006|Overall Study|Lost to Follow-up|2|||
124941902|NCT03220724|449414820|FG007|Overall Study|Lost to Follow-up|1|||
124941903|NCT03220724|449414821|FG008|Overall Study|Lost to Follow-up|0|||
124941904|NCT03220724|449414813|FG000|Overall Study|Withdrawal by Subject|1|||
124941905|NCT03220724|449414814|FG001|Overall Study|Withdrawal by Subject|0|||
124941906|NCT03220724|449414815|FG002|Overall Study|Withdrawal by Subject|1|||
124941907|NCT03220724|449414816|FG003|Overall Study|Withdrawal by Subject|0|||
124941908|NCT03220724|449414817|FG004|Overall Study|Withdrawal by Subject|0|||
124941909|NCT03220724|449414818|FG005|Overall Study|Withdrawal by Subject|0|||
124941910|NCT03220724|449414819|FG006|Overall Study|Withdrawal by Subject|0|||
124941911|NCT03220724|449414820|FG007|Overall Study|Withdrawal by Subject|0|||
124941912|NCT03220724|449414821|FG008|Overall Study|Withdrawal by Subject|0|||
124941913|NCT01478594|449414826|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
124941914|NCT01478594|449414827|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
124941915|NCT01478594|449414826|FG000|Overall Study|Death|45|||
125028042|NCT01262976|449725630|FG004|Up to Year 2|Subjects with unknown completion status|0|||
125028043|NCT01262976|449725631|FG005|Up to Year 2|Subjects with unknown completion status|0|||
125028044|NCT01262976|449725626|FG000|Up to Year 2|Other|3|||
125028045|NCT01262976|449725627|FG001|Up to Year 2|Other|0|||
125028046|NCT01262976|449725628|FG002|Up to Year 2|Other|0|||
125028047|NCT01262976|449725629|FG003|Up to Year 2|Other|0|||
125028048|NCT01262976|449725630|FG004|Up to Year 2|Other|0|||
125028049|NCT01262976|449725631|FG005|Up to Year 2|Other|0|||
124941916|NCT01478594|449414827|FG001|Overall Study|Death|18|||
124941917|NCT01478594|449414826|FG000|Overall Study|Lost to Follow-up|3|||
124941918|NCT01478594|449414827|FG001|Overall Study|Lost to Follow-up|1|||
124941919|NCT01478594|449414826|FG000|Overall Study|Withdrawal by Subject|9|||
124941920|NCT01478594|449414827|FG001|Overall Study|Withdrawal by Subject|3|||
124941921|NCT01478594|449414826|FG000|Overall Study|Study Closed by Sponsor|8|||
124941922|NCT01478594|449414827|FG001|Overall Study|Study Closed by Sponsor|5|||
124941923|NCT02463448|449414834|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
124941924|NCT02463448|449414834|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
124941925|NCT02463448|449414834|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
124941926|NCT02463448|449414834|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
124941927|NCT01359150|449414835|FG000|Overall Study|Lack of Efficacy|1|||
124941928|NCT01359150|449414836|FG001|Overall Study|Lack of Efficacy|1|||
124941929|NCT01359150|449414835|FG000|Overall Study|Withdrawal by Subject|1|||
124941930|NCT01359150|449414836|FG001|Overall Study|Withdrawal by Subject|1|||
124941931|NCT01359150|449414835|FG000|Overall Study|Adverse Event|4|||
124941932|NCT01359150|449414836|FG001|Overall Study|Adverse Event|3|||
124941933|NCT01359150|449414835|FG000|Overall Study|Other|1|||
124941934|NCT01359150|449414836|FG001|Overall Study|Other|0|||
124941935|NCT03113409|449414837|FG000|Overall Study|Withdrawal by Subject|5|||
124941936|NCT03113409|449414838|FG001|Overall Study|Withdrawal by Subject|0|||
124941937|NCT03113409|449414839|FG002|Overall Study|Withdrawal by Subject|0|||
124941938|NCT01536093|449414840|FG000|Overall Study|Death|1|||
124941939|NCT01536093|449414841|FG001|Overall Study|Death|2|||
124941940|NCT01536093|449414840|FG000|Overall Study|absence of maternal colostrum|2|||
124941941|NCT01536093|449414841|FG001|Overall Study|absence of maternal colostrum|0|||
124941942|NCT01536093|449414840|FG000|Overall Study|Withdrawal by Subject|0|||
124941943|NCT01536093|449414841|FG001|Overall Study|Withdrawal by Subject|1|||
124941944|NCT02275611|449414844|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
124941945|NCT02275611|449414845|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
124941946|NCT02275611|449414846|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
124941947|NCT02275611|449414847|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
124941948|NCT01759862|449414851|FG000|Overall Study|Physician Decision|3|||
124941949|NCT01759862|449414852|FG001|Overall Study|Physician Decision|1|||
124941950|NCT01759862|449414851|FG000|Overall Study|Adverse Event|0|||
124941951|NCT01759862|449414852|FG001|Overall Study|Adverse Event|1|||
124941952|NCT03890289|449414855|FG000|Overall Study|Adverse Event|1|||
124941953|NCT03890289|449414855|FG000|Overall Study|Physician Decision|1|||
124941954|NCT03890289|449414855|FG000|Overall Study|Lack of Efficacy|2|||
124941955|NCT00274261|449414858|FG000|Overall Study|Adverse Event|19|||
124941956|NCT00274261|449414859|FG001|Overall Study|Adverse Event|11|||
124941957|NCT00274261|449414858|FG000|Overall Study|Pregnancy|114|||
124941958|NCT00274261|449414859|FG001|Overall Study|Pregnancy|83|||
124941959|NCT00274261|449414858|FG000|Overall Study|Withdrawal by Subject|179|||
124941960|NCT00274261|449414859|FG001|Overall Study|Withdrawal by Subject|126|||
124941961|NCT00274261|449414858|FG000|Overall Study|Protocol Violation|71|||
124941962|NCT00274261|449414859|FG001|Overall Study|Protocol Violation|42|||
124941963|NCT00274261|449414858|FG000|Overall Study|Lost to Follow-up|106|||
124941964|NCT00274261|449414859|FG001|Overall Study|Lost to Follow-up|75|||
124941965|NCT02628626|449414868|FG000|Overall Study|Withdrawal by Subject|2|||
124941966|NCT02628626|449414869|FG001|Overall Study|Withdrawal by Subject|2|||
124941967|NCT02972359|449414874|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
124941968|NCT02972359|449414874|FG000|Overall Study|Lack of Efficacy|1|||
124941969|NCT02972359|449414874|FG000|Overall Study|Adverse Event|4|||
124941970|NCT02972359|449414874|FG000|Overall Study|Death|1|||
124941971|NCT02972359|449414874|FG000|Overall Study|Withdrawal by Subject|30|||
124941972|NCT02972359|449414874|FG000|Overall Study|Protocol Violation|1|||
124941973|NCT02972359|449414874|FG000|Overall Study|Lost to Follow-up|26|||
124941974|NCT02972359|449414874|FG000|Overall Study|Other reasons|5|||
124941975|NCT02972359|449414874|FG000|Overall Study|Missing|1|||
124941976|NCT02063659|449414875|FG000|Double-Blind Treatment Period|Adverse Event|1|||
125213879|NCT03275389|450409792|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
125213880|NCT03275389|450409793|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125213881|NCT03275389|450409794|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
125213882|NCT03275389|450409795|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125213883|NCT03275389|450409796|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125213884|NCT03275389|450409797|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125213885|NCT03275389|450409798|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124941977|NCT02063659|449414876|FG001|Double-Blind Treatment Period|Adverse Event|2|||
124941978|NCT02063659|449414877|FG002|Double-Blind Treatment Period|Adverse Event|0|||
124941979|NCT02063659|449414878|FG003|Double-Blind Treatment Period|Adverse Event|0|||
124941980|NCT02063659|449414875|FG000|Double-Blind Treatment Period|Physician Decision|1|||
124941981|NCT02063659|449414876|FG001|Double-Blind Treatment Period|Physician Decision|0|||
124941982|NCT02063659|449414877|FG002|Double-Blind Treatment Period|Physician Decision|0|||
124941983|NCT02063659|449414878|FG003|Double-Blind Treatment Period|Physician Decision|0|||
125028050|NCT01262976|449725626|FG000|Up to Year 3|Serious Adverse Event|0|||
125028051|NCT01262976|449725627|FG001|Up to Year 3|Serious Adverse Event|0|||
125028052|NCT01262976|449725628|FG002|Up to Year 3|Serious Adverse Event|2|||
125028053|NCT01262976|449725629|FG003|Up to Year 3|Serious Adverse Event|0|||
125028054|NCT01262976|449725630|FG004|Up to Year 3|Serious Adverse Event|0|||
125028055|NCT01262976|449725631|FG005|Up to Year 3|Serious Adverse Event|0|||
125028056|NCT01262976|449725626|FG000|Up to Year 3|Withdrawal by Subject|1|||
125028057|NCT01262976|449725627|FG001|Up to Year 3|Withdrawal by Subject|0|||
124941984|NCT02063659|449414875|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
124941985|NCT02063659|449414876|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
124941986|NCT02063659|449414877|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
124941987|NCT02063659|449414878|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
125028058|NCT01262976|449725628|FG002|Up to Year 3|Withdrawal by Subject|0|||
125028059|NCT01262976|449725629|FG003|Up to Year 3|Withdrawal by Subject|0|||
125028060|NCT01262976|449725630|FG004|Up to Year 3|Withdrawal by Subject|0|||
124941988|NCT02063659|449414875|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
124941989|NCT02063659|449414876|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
124941990|NCT02063659|449414877|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
124941991|NCT02063659|449414878|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
124941992|NCT02063659|449414875|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
124941993|NCT02063659|449414876|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
124941994|NCT02063659|449414877|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
124941995|NCT02063659|449414878|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
124941996|NCT02063659|449414875|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
124941997|NCT02063659|449414876|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
124941998|NCT02063659|449414877|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
124941999|NCT02063659|449414878|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
124942000|NCT02063659|449414875|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
124942001|NCT02063659|449414876|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
124942002|NCT02063659|449414877|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
124942003|NCT02063659|449414878|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
124942004|NCT02063659|449414875|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
124942005|NCT02063659|449414876|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
124942006|NCT02063659|449414877|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
124942007|NCT02063659|449414878|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
124942008|NCT01532999|449414879|FG000|Overall Study|Lost to Follow-up|14|||
125122800|NCT00950807|450074138|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
125122801|NCT00950807|450074139|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125122802|NCT00950807|450074140|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125122803|NCT00950807|450074141|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125122804|NCT00950807|450074142|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125122805|NCT00950807|450074143|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125122806|NCT00950807|450074144|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125122807|NCT00950807|450074145|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
125122808|NCT00950807|450074146|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125122809|NCT00950807|450074147|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125122810|NCT00950807|450074138|FG000|Treatment Period 3|Adverse Event|0|||
124942009|NCT01532999|449414880|FG001|Overall Study|Lost to Follow-up|8|||
124942010|NCT01532999|449414879|FG000|Overall Study|Physician Decision|1|||
124942011|NCT01532999|449414880|FG001|Overall Study|Physician Decision|2|||
124942012|NCT01532999|449414879|FG000|Overall Study|Withdrawal by Subject|5|||
124942013|NCT01532999|449414880|FG001|Overall Study|Withdrawal by Subject|0|||
124942014|NCT01532999|449414879|FG000|Overall Study|Relocated|2|||
124942015|NCT01532999|449414880|FG001|Overall Study|Relocated|0|||
124942016|NCT01532999|449414879|FG000|Overall Study|should not have been randomized|1|||
124942017|NCT01532999|449414880|FG001|Overall Study|should not have been randomized|0|||
124942018|NCT01532999|449414879|FG000|Overall Study|substantial noncompliance|2|||
124942019|NCT01532999|449414880|FG001|Overall Study|substantial noncompliance|0|||
124942020|NCT01532999|449414879|FG000|Overall Study|no show for week 9 assessments|6|||
124942021|NCT01532999|449414880|FG001|Overall Study|no show for week 9 assessments|4|||
124942022|NCT01532999|449414879|FG000|Overall Study|Adverse Event|0|||
124942023|NCT01532999|449414880|FG001|Overall Study|Adverse Event|1|||
124942024|NCT01532999|449414879|FG000|Overall Study|incarcerated|0|||
124942025|NCT01532999|449414880|FG001|Overall Study|incarcerated|1|||
124942026|NCT01532999|449414879|FG000|Overall Study|New job|0|||
124942027|NCT01532999|449414880|FG001|Overall Study|New job|2|||
124942028|NCT00914966|449414881|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
124942029|NCT00914966|449414881|FG000|Step 1: 1500 Units|Physician Decision|1|||
124942030|NCT00914966|449414881|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
124942031|NCT03598907|449414888|FG000|Overall Study|Physician Decision|14|||
124942032|NCT03598907|449414889|FG001|Overall Study|Physician Decision|19|||
125122811|NCT00950807|450074139|FG001|Treatment Period 3|Adverse Event|0|||
125122812|NCT00950807|450074140|FG002|Treatment Period 3|Adverse Event|0|||
125122813|NCT00950807|450074141|FG003|Treatment Period 3|Adverse Event|0|||
124942033|NCT04021862|449414890|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
124942034|NCT04021862|449414891|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
124942035|NCT04021862|449414892|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
124942036|NCT04021862|449414893|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
124942037|NCT04021862|449414894|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
124942038|NCT04021862|449414895|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
124942039|NCT04021862|449414890|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
124942040|NCT04021862|449414891|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
124942041|NCT04021862|449414892|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
124942042|NCT04021862|449414893|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
124942043|NCT04021862|449414894|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
124942044|NCT04021862|449414895|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
124942045|NCT04021862|449414890|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
125122814|NCT00950807|450074142|FG004|Treatment Period 3|Adverse Event|0|||
124942046|NCT04021862|449414891|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
124942047|NCT04021862|449414892|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
125122815|NCT00950807|450074143|FG005|Treatment Period 3|Adverse Event|0|||
125122816|NCT00950807|450074144|FG006|Treatment Period 3|Adverse Event|1|||
124942048|NCT04021862|449414893|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
124942049|NCT04021862|449414894|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
124942050|NCT04021862|449414895|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
124942051|NCT04021862|449414890|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
124942052|NCT04021862|449414891|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
124942053|NCT04021862|449414892|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
124942054|NCT04021862|449414893|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
124942055|NCT04021862|449414894|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
124942056|NCT04021862|449414895|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
124942057|NCT04021862|449414890|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
124942058|NCT04021862|449414891|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
124942059|NCT04021862|449414892|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
124942060|NCT04021862|449414893|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
124942061|NCT04021862|449414894|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
124942062|NCT04021862|449414895|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
124942063|NCT05251363|449414896|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
124942064|NCT05251363|449414896|FG000|Overall Study After Implant Period|Death|9|||
124942065|NCT05251363|449414896|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
124942066|NCT05251363|449414896|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
124942067|NCT05251363|449414896|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
124942068|NCT05251363|449414896|FG000|Overall Study After Implant Period|Physician Decision|1|||
124942069|NCT05251363|449414896|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
124942070|NCT03835754|449414899|FG000|Overall Study|Death|4|||
124942071|NCT02830204|449414900|FG000|Overall Study|Death|9|||
124942072|NCT02830204|449414900|FG000|Overall Study|Withdrawal by Subject|1|||
124942073|NCT01690624|449414903|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
124942074|NCT01690624|449414904|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
124942075|NCT01690624|449414905|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
124942076|NCT01690624|449414906|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
124942077|NCT01690624|449414903|FG000|Overall Study|Adverse event (other than DLT)|3|||
124942078|NCT01690624|449414904|FG001|Overall Study|Adverse event (other than DLT)|1|||
124942079|NCT01690624|449414905|FG002|Overall Study|Adverse event (other than DLT)|1|||
124942080|NCT01690624|449414906|FG003|Overall Study|Adverse event (other than DLT)|1|||
124942081|NCT01690624|449414903|FG000|Overall Study|Withdrawal by Subject|0|||
124942082|NCT01690624|449414904|FG001|Overall Study|Withdrawal by Subject|0|||
124942083|NCT01690624|449414905|FG002|Overall Study|Withdrawal by Subject|1|||
124942084|NCT01690624|449414906|FG003|Overall Study|Withdrawal by Subject|0|||
124942085|NCT01690624|449414903|FG000|Overall Study|Sponsor is ending trial|0|||
125122817|NCT00950807|450074145|FG007|Treatment Period 3|Adverse Event|0|||
125122818|NCT00950807|450074146|FG008|Treatment Period 3|Adverse Event|0|||
125122819|NCT00950807|450074147|FG009|Treatment Period 3|Adverse Event|0|||
125122820|NCT00337077|450074148|FG000|Overall Study|Progressive disease|25|||
125122821|NCT00337077|450074149|FG001|Overall Study|Progressive disease|37|||
125122822|NCT00337077|450074150|FG002|Overall Study|Progressive disease|19|||
125122823|NCT00337077|450074148|FG000|Overall Study|Adverse Event|7|||
125122824|NCT00337077|450074149|FG001|Overall Study|Adverse Event|7|||
125122825|NCT00337077|450074150|FG002|Overall Study|Adverse Event|1|||
125122826|NCT00337077|450074148|FG000|Overall Study|Death|0|||
125122827|NCT00337077|450074149|FG001|Overall Study|Death|1|||
125122828|NCT00337077|450074150|FG002|Overall Study|Death|0|||
125122829|NCT00337077|450074148|FG000|Overall Study|Withdrawal by Subject|7|||
125122830|NCT00337077|450074149|FG001|Overall Study|Withdrawal by Subject|2|||
125122831|NCT00337077|450074150|FG002|Overall Study|Withdrawal by Subject|2|||
125122832|NCT00337077|450074148|FG000|Overall Study|Alternative therapy|1|||
125122833|NCT00337077|450074149|FG001|Overall Study|Alternative therapy|0|||
125122834|NCT00337077|450074150|FG002|Overall Study|Alternative therapy|0|||
125122835|NCT00337077|450074148|FG000|Overall Study|Physician Decision|1|||
125122836|NCT00337077|450074149|FG001|Overall Study|Physician Decision|4|||
125122837|NCT00337077|450074150|FG002|Overall Study|Physician Decision|2|||
125122838|NCT00337077|450074148|FG000|Overall Study|Never started treatment|1|||
125122839|NCT00337077|450074149|FG001|Overall Study|Never started treatment|1|||
125122840|NCT00337077|450074150|FG002|Overall Study|Never started treatment|0|||
125122841|NCT00337077|450074148|FG000|Overall Study|Ineligible|1|||
125122842|NCT00337077|450074149|FG001|Overall Study|Ineligible|1|||
125122843|NCT00337077|450074150|FG002|Overall Study|Ineligible|1|||
125122844|NCT02430870|450074163|FG000|Part 2|Voluntary Withdrawal|0|||
125122845|NCT02430870|450074164|FG001|Part 2|Voluntary Withdrawal|0|||
125122846|NCT02430870|450074165|FG002|Part 2|Voluntary Withdrawal|0|||
125122847|NCT02430870|450074166|FG003|Part 2|Voluntary Withdrawal|0|||
124942086|NCT01690624|449414904|FG001|Overall Study|Sponsor is ending trial|0|||
124942087|NCT01690624|449414905|FG002|Overall Study|Sponsor is ending trial|0|||
125122848|NCT02430870|450074167|FG004|Part 2|Voluntary Withdrawal|0|||
125122849|NCT02430870|450074168|FG005|Part 2|Voluntary Withdrawal|0|||
125122850|NCT02430870|450074169|FG006|Part 2|Voluntary Withdrawal|1|||
125122851|NCT02430870|450074170|FG007|Part 2|Voluntary Withdrawal|0|||
125122852|NCT02430870|450074163|FG000|Part 2|Other Reason Not Specified|0|||
125122853|NCT02430870|450074164|FG001|Part 2|Other Reason Not Specified|0|||
125122854|NCT02430870|450074165|FG002|Part 2|Other Reason Not Specified|0|||
125122855|NCT02430870|450074166|FG003|Part 2|Other Reason Not Specified|0|||
125122856|NCT02430870|450074167|FG004|Part 2|Other Reason Not Specified|0|||
124942088|NCT01690624|449414906|FG003|Overall Study|Sponsor is ending trial|1|||
124942089|NCT01690624|449414903|FG000|Overall Study|Physician Decision|0|||
124942090|NCT01690624|449414904|FG001|Overall Study|Physician Decision|0|||
124942091|NCT01690624|449414905|FG002|Overall Study|Physician Decision|0|||
124942092|NCT01690624|449414906|FG003|Overall Study|Physician Decision|1|||
124942093|NCT01690624|449414903|FG000|Overall Study|Withdrawal by Subject|0|||
124942094|NCT01690624|449414904|FG001|Overall Study|Withdrawal by Subject|1|||
124942095|NCT01690624|449414905|FG002|Overall Study|Withdrawal by Subject|0|||
124942096|NCT01690624|449414906|FG003|Overall Study|Withdrawal by Subject|0|||
124942097|NCT01690624|449414903|FG000|Overall Study|Lack of Efficacy|1|||
124942098|NCT01690624|449414904|FG001|Overall Study|Lack of Efficacy|1|||
124942099|NCT01690624|449414905|FG002|Overall Study|Lack of Efficacy|3|||
124942100|NCT01690624|449414906|FG003|Overall Study|Lack of Efficacy|0|||
124942101|NCT04686266|449414908|FG000|Overall Study|Withdrawal by Subject|0|||
124942102|NCT04686266|449414909|FG001|Overall Study|Withdrawal by Subject|1|||
124942103|NCT04306367|449414910|FG000|Overall Study|Progression of Disease|9|||
124942104|NCT04306367|449414910|FG000|Overall Study|Adverse Event|3|||
124942105|NCT04306367|449414910|FG000|Overall Study|Withdrawal by Subject|1|||
124942106|NCT02401815|449414911|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
124942107|NCT02401815|449414912|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
124942108|NCT02401815|449414913|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
124942109|NCT02401815|449414914|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
124942110|NCT02401815|449414915|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
124942111|NCT02401815|449414916|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
124942112|NCT02401815|449414917|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
124942113|NCT02401815|449414918|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
124942114|NCT02401815|449414919|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
124942115|NCT02401815|449414920|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
124942116|NCT02401815|449414911|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
124942117|NCT02401815|449414912|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
124942118|NCT02401815|449414913|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
124942119|NCT02401815|449414914|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
124942120|NCT02401815|449414915|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
124942121|NCT02401815|449414916|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
124942122|NCT02401815|449414917|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
124942123|NCT02401815|449414918|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
124942124|NCT02401815|449414919|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
124942125|NCT02401815|449414920|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
124942126|NCT02401815|449414911|FG000|Dose Escalation (up to 670 Days)|Death|1|||
124942127|NCT02401815|449414912|FG001|Dose Escalation (up to 670 Days)|Death|2|||
124942128|NCT02401815|449414913|FG002|Dose Escalation (up to 670 Days)|Death|3|||
124942129|NCT02401815|449414914|FG003|Dose Escalation (up to 670 Days)|Death|5|||
124942130|NCT02401815|449414915|FG004|Dose Escalation (up to 670 Days)|Death|4|||
124942131|NCT02401815|449414916|FG005|Dose Escalation (up to 670 Days)|Death|0|||
124942132|NCT02401815|449414917|FG006|Dose Escalation (up to 670 Days)|Death|0|||
124942133|NCT02401815|449414918|FG007|Dose Escalation (up to 670 Days)|Death|0|||
125028061|NCT01262976|449725631|FG005|Up to Year 3|Withdrawal by Subject|0|||
125028062|NCT01262976|449725626|FG000|Up to Year 3|Migrated/moved from study area|0|||
125028063|NCT01262976|449725627|FG001|Up to Year 3|Migrated/moved from study area|0|||
125028064|NCT01262976|449725628|FG002|Up to Year 3|Migrated/moved from study area|0|||
125028065|NCT01262976|449725629|FG003|Up to Year 3|Migrated/moved from study area|2|||
125213886|NCT03275389|450409799|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125213887|NCT03275389|450409800|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125213888|NCT03275389|450409791|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
125213889|NCT03275389|450409792|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
125213890|NCT03275389|450409793|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
125213891|NCT03275389|450409794|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
125213892|NCT03275389|450409795|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
125213893|NCT03275389|450409796|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
125213894|NCT03275389|450409797|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
125213895|NCT03275389|450409798|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
125213896|NCT03275389|450409799|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
125213897|NCT03275389|450409800|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
125213898|NCT03275389|450409791|FG000|Overall Study|Other|0|||
125213899|NCT03275389|450409792|FG001|Overall Study|Other|4|||
125213900|NCT03275389|450409793|FG002|Overall Study|Other|3|||
125213901|NCT03275389|450409794|FG003|Overall Study|Other|2|||
125213902|NCT03275389|450409795|FG004|Overall Study|Other|2|||
125213903|NCT03275389|450409796|FG005|Overall Study|Other|2|||
125213904|NCT03275389|450409797|FG006|Overall Study|Other|0|||
125213905|NCT03275389|450409798|FG007|Overall Study|Other|0|||
125213906|NCT03275389|450409799|FG008|Overall Study|Other|1|||
125213907|NCT03275389|450409800|FG009|Overall Study|Other|0|||
125213908|NCT00978341|450409802|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
125213909|NCT00978341|450409803|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
125213910|NCT03035916|450409804|FG000|Overall Study|Puncture failed|0|||
125213911|NCT03035916|450409805|FG001|Overall Study|Puncture failed|2|||
125213912|NCT03035916|450409806|FG002|Overall Study|Puncture failed|0|||
125028066|NCT01262976|449725630|FG004|Up to Year 3|Migrated/moved from study area|1|||
125028067|NCT01262976|449725631|FG005|Up to Year 3|Migrated/moved from study area|1|||
125213913|NCT03885999|450409807|FG000|Overall Study|Adverse Event|1|||
124942134|NCT02401815|449414919|FG008|Dose Escalation (up to 670 Days)|Death|0|||
124942135|NCT02401815|449414920|FG009|Dose Escalation (up to 670 Days)|Death|0|||
124942136|NCT02401815|449414911|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
124942137|NCT02401815|449414912|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
124942138|NCT02401815|449414913|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
124942139|NCT02401815|449414914|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
124942140|NCT02401815|449414915|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
124942141|NCT02401815|449414916|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
124942142|NCT02401815|449414917|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
124942143|NCT02401815|449414918|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
124942144|NCT02401815|449414919|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
124942145|NCT02401815|449414920|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
124942146|NCT02401815|449414911|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
124942147|NCT02401815|449414912|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
124942148|NCT02401815|449414913|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
124942149|NCT02401815|449414914|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
124942150|NCT02401815|449414915|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
124942151|NCT02401815|449414916|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
124942152|NCT02401815|449414917|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
124942153|NCT02401815|449414918|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
124942154|NCT02401815|449414919|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
124942155|NCT02401815|449414920|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
124942156|NCT02401815|449414911|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
124942157|NCT02401815|449414912|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
124942158|NCT02401815|449414913|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
124942159|NCT02401815|449414914|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
124942160|NCT02401815|449414915|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
125213914|NCT02452554|450409808|FG000|Overall Study|Death|2|||
125213915|NCT02452554|450409809|FG001|Overall Study|Death|1|||
125213916|NCT02452554|450409810|FG002|Overall Study|Death|0|||
125213917|NCT02452554|450409811|FG003|Overall Study|Death|0|||
125213918|NCT02452554|450409812|FG004|Overall Study|Death|0|||
125028068|NCT01262976|449725626|FG000|Up to Year 3|Lost to Follow-up|2|||
125028069|NCT01262976|449725627|FG001|Up to Year 3|Lost to Follow-up|2|||
125213919|NCT02452554|450409813|FG005|Overall Study|Death|0|||
125213920|NCT02452554|450409808|FG000|Overall Study|Lack of Efficacy|13|||
125213921|NCT02452554|450409809|FG001|Overall Study|Lack of Efficacy|14|||
124942161|NCT02401815|449414916|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
124942162|NCT02401815|449414917|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
124942163|NCT02401815|449414918|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
124942164|NCT02401815|449414919|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
124942165|NCT02401815|449414920|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
124942166|NCT02401815|449414911|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942167|NCT02401815|449414912|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942168|NCT02401815|449414913|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942169|NCT02401815|449414914|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942170|NCT02401815|449414915|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942171|NCT02401815|449414916|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942172|NCT02401815|449414917|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
124942173|NCT02401815|449414918|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942174|NCT02401815|449414919|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942175|NCT02401815|449414920|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942176|NCT02401815|449414911|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
124942177|NCT02401815|449414912|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
124942178|NCT02401815|449414913|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
124942179|NCT02401815|449414914|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
124942180|NCT02401815|449414915|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
124942181|NCT02401815|449414916|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
124942182|NCT02401815|449414917|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
124942183|NCT02401815|449414918|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
124942184|NCT02401815|449414919|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
124942185|NCT02401815|449414920|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
125028070|NCT01262976|449725628|FG002|Up to Year 3|Lost to Follow-up|4|||
125213922|NCT02452554|450409810|FG002|Overall Study|Lack of Efficacy|9|||
125213923|NCT02452554|450409811|FG003|Overall Study|Lack of Efficacy|1|||
125213924|NCT02452554|450409812|FG004|Overall Study|Lack of Efficacy|5|||
125213925|NCT02452554|450409813|FG005|Overall Study|Lack of Efficacy|8|||
125213926|NCT02452554|450409808|FG000|Overall Study|Physician Decision|0|||
125213927|NCT02452554|450409809|FG001|Overall Study|Physician Decision|1|||
125213928|NCT02452554|450409810|FG002|Overall Study|Physician Decision|0|||
125213929|NCT02452554|450409811|FG003|Overall Study|Physician Decision|0|||
125213930|NCT02452554|450409812|FG004|Overall Study|Physician Decision|0|||
125213931|NCT02452554|450409813|FG005|Overall Study|Physician Decision|0|||
125213932|NCT02452554|450409808|FG000|Overall Study|Withdrawal by Subject|1|||
125213933|NCT02452554|450409809|FG001|Overall Study|Withdrawal by Subject|0|||
125213934|NCT02452554|450409810|FG002|Overall Study|Withdrawal by Subject|2|||
125213935|NCT02452554|450409811|FG003|Overall Study|Withdrawal by Subject|0|||
125213936|NCT02452554|450409812|FG004|Overall Study|Withdrawal by Subject|0|||
125213937|NCT02452554|450409813|FG005|Overall Study|Withdrawal by Subject|1|||
125213938|NCT02452554|450409808|FG000|Overall Study|Ineligible|0|||
125213939|NCT02452554|450409809|FG001|Overall Study|Ineligible|1|||
125213940|NCT02452554|450409810|FG002|Overall Study|Ineligible|0|||
125213941|NCT02452554|450409811|FG003|Overall Study|Ineligible|0|||
125213942|NCT02452554|450409812|FG004|Overall Study|Ineligible|0|||
125213943|NCT02452554|450409813|FG005|Overall Study|Ineligible|0|||
125213944|NCT02452554|450409808|FG000|Overall Study|Never Received Treatment|1|||
125213945|NCT02452554|450409809|FG001|Overall Study|Never Received Treatment|0|||
125213946|NCT02452554|450409810|FG002|Overall Study|Never Received Treatment|0|||
125213947|NCT02452554|450409811|FG003|Overall Study|Never Received Treatment|0|||
125213948|NCT02452554|450409812|FG004|Overall Study|Never Received Treatment|0|||
125213949|NCT02452554|450409813|FG005|Overall Study|Never Received Treatment|0|||
125213950|NCT05188729|450409814|FG000|Overall Study|Withdrawal by Subject|0|||
125213951|NCT05188729|450409815|FG001|Overall Study|Withdrawal by Subject|0|||
125213952|NCT05188729|450409816|FG002|Overall Study|Withdrawal by Subject|0|||
125213953|NCT05188729|450409817|FG003|Overall Study|Withdrawal by Subject|0|||
125213954|NCT05188729|450409818|FG004|Overall Study|Withdrawal by Subject|0|||
125213955|NCT05188729|450409819|FG005|Overall Study|Withdrawal by Subject|0|||
125213956|NCT05188729|450409820|FG006|Overall Study|Withdrawal by Subject|0|||
125213957|NCT05188729|450409821|FG007|Overall Study|Withdrawal by Subject|0|||
125213958|NCT05188729|450409822|FG008|Overall Study|Withdrawal by Subject|0|||
125213959|NCT05188729|450409823|FG009|Overall Study|Withdrawal by Subject|1|||
125213960|NCT05188729|450409824|FG010|Overall Study|Withdrawal by Subject|0|||
125213961|NCT05188729|450409825|FG011|Overall Study|Withdrawal by Subject|0|||
125213962|NCT05188729|450409826|FG012|Overall Study|Withdrawal by Subject|0|||
125213963|NCT05188729|450409814|FG000|Overall Study|Lost to Follow-up|0|||
125213964|NCT05188729|450409815|FG001|Overall Study|Lost to Follow-up|0|||
125213965|NCT05188729|450409816|FG002|Overall Study|Lost to Follow-up|0|||
125213966|NCT05188729|450409817|FG003|Overall Study|Lost to Follow-up|0|||
125213967|NCT05188729|450409818|FG004|Overall Study|Lost to Follow-up|0|||
125213968|NCT05188729|450409819|FG005|Overall Study|Lost to Follow-up|0|||
125213969|NCT05188729|450409820|FG006|Overall Study|Lost to Follow-up|0|||
125213970|NCT05188729|450409821|FG007|Overall Study|Lost to Follow-up|0|||
125213971|NCT05188729|450409822|FG008|Overall Study|Lost to Follow-up|0|||
125213972|NCT05188729|450409823|FG009|Overall Study|Lost to Follow-up|0|||
125213973|NCT05188729|450409824|FG010|Overall Study|Lost to Follow-up|1|||
125213974|NCT05188729|450409825|FG011|Overall Study|Lost to Follow-up|1|||
125213975|NCT05188729|450409826|FG012|Overall Study|Lost to Follow-up|0|||
125213976|NCT02552888|450409827|FG000|Overall Study|Lost to Follow-up|1|||
125213977|NCT02552888|450409828|FG001|Overall Study|Lost to Follow-up|1|||
125213978|NCT02442206|450411201|FG000|Period 1|Adverse Event|1|||
125213979|NCT02442206|450411202|FG001|Period 1|Adverse Event|1|||
125213980|NCT02442206|450411201|FG000|Period 1|withdrew consent|0|||
125213981|NCT02442206|450411202|FG001|Period 1|withdrew consent|1|||
125213982|NCT02442206|450411201|FG000|Period 1|COPD exacerbation|0|||
125213983|NCT02442206|450411202|FG001|Period 1|COPD exacerbation|1|||
125213984|NCT02442206|450411201|FG000|Period 2|Adverse Event|1|||
125213985|NCT02442206|450411202|FG001|Period 2|Adverse Event|0|||
125213986|NCT00497146|450411203|FG000|Treatment Period|Adverse Event|6|||
125213987|NCT00497146|450411204|FG001|Treatment Period|Adverse Event|2|||
124942186|NCT02401815|449414911|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
125213988|NCT00497146|450411203|FG000|Treatment Period|Withdrawal by Subject|5|||
125213989|NCT00497146|450411204|FG001|Treatment Period|Withdrawal by Subject|9|||
125213990|NCT00497146|450411203|FG000|Treatment Period|Lost to Follow-up|1|||
125213991|NCT00497146|450411204|FG001|Treatment Period|Lost to Follow-up|3|||
125213992|NCT00497146|450411203|FG000|Treatment Period|Required dialysis|4|||
125213993|NCT00497146|450411204|FG001|Treatment Period|Required dialysis|1|||
125213994|NCT00497146|450411203|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
125213995|NCT00497146|450411204|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
125213996|NCT00497146|450411203|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
125213997|NCT00497146|450411204|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
125213998|NCT00497146|450411203|FG000|Treatment Period|Other Reason|2|||
125213999|NCT00497146|450411204|FG001|Treatment Period|Other Reason|3|||
124942187|NCT02401815|449414912|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
124942188|NCT02401815|449414913|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
124942189|NCT02401815|449414914|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
124942190|NCT02401815|449414915|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
124942191|NCT02401815|449414916|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
124942192|NCT02401815|449414917|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
124942193|NCT02401815|449414918|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
124942194|NCT02401815|449414919|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
124942195|NCT02401815|449414920|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
124942196|NCT02401815|449414911|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
124942197|NCT02401815|449414912|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
124942198|NCT02401815|449414913|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
124942199|NCT02401815|449414914|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
124942200|NCT02401815|449414915|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
124942201|NCT02401815|449414916|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
124942202|NCT02401815|449414917|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
124942203|NCT02401815|449414918|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
124942204|NCT02401815|449414919|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
124942205|NCT02401815|449414920|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
124942206|NCT02401815|449414911|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942207|NCT02401815|449414912|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942208|NCT02401815|449414913|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942209|NCT02401815|449414914|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942210|NCT02401815|449414915|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
125214000|NCT00497146|450411203|FG000|Long-term Follow-up Period|Adverse Event|2|||
125214001|NCT00497146|450411204|FG001|Long-term Follow-up Period|Adverse Event|2|||
125214002|NCT00497146|450411203|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
125214003|NCT00497146|450411204|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
125214004|NCT00497146|450411203|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
125214005|NCT00497146|450411204|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
125214006|NCT00497146|450411203|FG000|Long-term Follow-up Period|Other|0|||
125214007|NCT00497146|450411204|FG001|Long-term Follow-up Period|Other|1|||
125214008|NCT02155309|450411205|FG000|Overall Study|Protocol Violation|0|||
125214009|NCT02155309|450411206|FG001|Overall Study|Protocol Violation|0|||
125214010|NCT02155309|450411207|FG002|Overall Study|Protocol Violation|1|||
125214011|NCT03084302|450411208|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
125214012|NCT03084302|450411208|FG000|Overall Study|No valid objective monitor data|6|||
125214013|NCT00929994|450411209|FG000|Overall Study|Withdrawal by Subject|1|||
125214014|NCT00929994|450411209|FG000|Overall Study|medical issue unrelated to intervention|4|||
124942211|NCT02401815|449414916|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
125214015|NCT00929994|450411209|FG000|Overall Study|employment|1|||
124942212|NCT02401815|449414917|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942213|NCT02401815|449414918|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942214|NCT02401815|449414919|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
124942215|NCT02401815|449414920|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
124942216|NCT02401815|449414911|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
124942217|NCT02401815|449414912|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
124942218|NCT02401815|449414913|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
124942219|NCT02401815|449414914|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
124942220|NCT02401815|449414915|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
124942221|NCT02401815|449414916|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
124942222|NCT02401815|449414917|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
124942223|NCT02401815|449414918|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
124942224|NCT02401815|449414919|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
124942225|NCT02401815|449414920|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
124942226|NCT02401815|449414911|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
124942227|NCT02401815|449414912|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
124942228|NCT02401815|449414913|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
124942229|NCT02401815|449414914|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
124942230|NCT02401815|449414915|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
125214016|NCT01411319|450411210|FG000|Overall Study|Lost to Follow-up|1|||
125214017|NCT01214668|450411211|FG000|Overall Study|Adverse Event|0|||
125214018|NCT01214668|450411212|FG001|Overall Study|Adverse Event|1|||
125214019|NCT01214668|450411213|FG002|Overall Study|Adverse Event|0|||
125214020|NCT01214668|450411214|FG003|Overall Study|Adverse Event|2|||
124942231|NCT02401815|449414916|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
124942232|NCT02401815|449414917|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
124942233|NCT02401815|449414918|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
124942234|NCT02401815|449414919|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
124942235|NCT02401815|449414920|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
124942236|NCT02401815|449414911|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
124942237|NCT02401815|449414912|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
124942238|NCT02401815|449414913|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
124942239|NCT02401815|449414914|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
124942240|NCT02401815|449414915|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
124942241|NCT02401815|449414916|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
124942242|NCT02401815|449414917|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
124942243|NCT02401815|449414918|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
124942244|NCT02401815|449414919|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
124942245|NCT02401815|449414920|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
124942246|NCT03773107|449414934|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
124942247|NCT03773107|449414935|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
124942248|NCT03773107|449414936|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
124942249|NCT03773107|449414937|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
124942250|NCT05864209|449416618|FG000|Overall Study|Lost to Follow-up|2|||
124942251|NCT05864209|449416619|FG001|Overall Study|Lost to Follow-up|3|||
124942252|NCT00092534|449416622|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
124942253|NCT00092534|449416623|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
124942254|NCT00092534|449416624|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
124942255|NCT00092534|449416625|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
124942256|NCT00092534|449416626|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
124942257|NCT00092534|449416622|FG000|Base Study Vaccination Period|Adverse Event|3|||
124942258|NCT00092534|449416623|FG001|Base Study Vaccination Period|Adverse Event|1|||
124942259|NCT00092534|449416624|FG002|Base Study Vaccination Period|Adverse Event|0|||
124942260|NCT00092534|449416625|FG003|Base Study Vaccination Period|Adverse Event|0|||
124942261|NCT00092534|449416626|FG004|Base Study Vaccination Period|Adverse Event|0|||
124942262|NCT00092534|449416622|FG000|Base Study Vaccination Period|Death|5|||
124942263|NCT00092534|449416623|FG001|Base Study Vaccination Period|Death|4|||
124942264|NCT00092534|449416624|FG002|Base Study Vaccination Period|Death|0|||
124942265|NCT00092534|449416625|FG003|Base Study Vaccination Period|Death|0|||
124942266|NCT00092534|449416626|FG004|Base Study Vaccination Period|Death|0|||
124942267|NCT00092534|449416622|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
124942268|NCT00092534|449416623|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
124942269|NCT00092534|449416624|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
124942270|NCT00092534|449416625|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
124942271|NCT00092534|449416626|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
124942272|NCT00092534|449416622|FG000|Base Study Vaccination Period|Physician Decision|1|||
124942273|NCT00092534|449416623|FG001|Base Study Vaccination Period|Physician Decision|0|||
124942274|NCT00092534|449416624|FG002|Base Study Vaccination Period|Physician Decision|0|||
124942275|NCT00092534|449416625|FG003|Base Study Vaccination Period|Physician Decision|0|||
124942276|NCT00092534|449416626|FG004|Base Study Vaccination Period|Physician Decision|0|||
124942277|NCT00092534|449416622|FG000|Base Study Vaccination Period|Pregnancy|9|||
124942278|NCT00092534|449416623|FG001|Base Study Vaccination Period|Pregnancy|7|||
124942279|NCT00092534|449416624|FG002|Base Study Vaccination Period|Pregnancy|0|||
124942280|NCT00092534|449416625|FG003|Base Study Vaccination Period|Pregnancy|0|||
124942281|NCT00092534|449416626|FG004|Base Study Vaccination Period|Pregnancy|0|||
124942282|NCT00092534|449416622|FG000|Base Study Vaccination Period|Protocol Violation|2|||
124942283|NCT00092534|449416623|FG001|Base Study Vaccination Period|Protocol Violation|1|||
124942284|NCT00092534|449416624|FG002|Base Study Vaccination Period|Protocol Violation|0|||
124942285|NCT00092534|449416625|FG003|Base Study Vaccination Period|Protocol Violation|0|||
124942286|NCT00092534|449416626|FG004|Base Study Vaccination Period|Protocol Violation|0|||
124942287|NCT00092534|449416622|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
124942288|NCT00092534|449416623|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
124942289|NCT00092534|449416624|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
124942290|NCT00092534|449416625|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
124942291|NCT00092534|449416626|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
124942292|NCT00092534|449416622|FG000|Base Study Vaccination Period|Moved|14|||
124942293|NCT00092534|449416623|FG001|Base Study Vaccination Period|Moved|12|||
124942294|NCT00092534|449416624|FG002|Base Study Vaccination Period|Moved|0|||
124942295|NCT00092534|449416625|FG003|Base Study Vaccination Period|Moved|0|||
124942296|NCT00092534|449416626|FG004|Base Study Vaccination Period|Moved|0|||
124942297|NCT00092534|449416622|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
125028071|NCT01262976|449725629|FG003|Up to Year 3|Lost to Follow-up|3|||
125028072|NCT01262976|449725630|FG004|Up to Year 3|Lost to Follow-up|1|||
124942298|NCT00092534|449416623|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
124942299|NCT00092534|449416624|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
124942300|NCT00092534|449416625|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
124942301|NCT00092534|449416626|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
124942302|NCT00092534|449416622|FG000|Base Study Vaccination Period|Travel|1|||
124942303|NCT00092534|449416623|FG001|Base Study Vaccination Period|Travel|0|||
124942304|NCT00092534|449416624|FG002|Base Study Vaccination Period|Travel|0|||
124942305|NCT00092534|449416625|FG003|Base Study Vaccination Period|Travel|0|||
124942306|NCT00092534|449416626|FG004|Base Study Vaccination Period|Travel|0|||
124942307|NCT00092534|449416622|FG000|Base Study Vaccination Period|Site Closed|0|||
124942308|NCT00092534|449416623|FG001|Base Study Vaccination Period|Site Closed|1|||
124942309|NCT00092534|449416624|FG002|Base Study Vaccination Period|Site Closed|0|||
124942310|NCT00092534|449416625|FG003|Base Study Vaccination Period|Site Closed|0|||
124942311|NCT00092534|449416626|FG004|Base Study Vaccination Period|Site Closed|0|||
124942312|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Adverse Event|2|||
124942313|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Adverse Event|4|||
124942314|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Adverse Event|0|||
124942315|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Adverse Event|0|||
124942316|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Adverse Event|0|||
124942317|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Death|2|||
124942318|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Death|1|||
124942319|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Death|0|||
124942320|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Death|0|||
124942321|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Death|0|||
124942322|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
124942323|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
124942324|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
124942325|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
124942326|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
124942327|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Pregnancy|6|||
124942328|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Pregnancy|10|||
124942329|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Pregnancy|0|||
124942330|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Pregnancy|0|||
124942331|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Pregnancy|0|||
124942332|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
124942333|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
124942334|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
124942335|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
124942336|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
124942337|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
124942338|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
124942339|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
124942340|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
124942341|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
124942342|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Moved|62|||
124942343|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Moved|58|||
124942344|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Moved|0|||
124942345|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Moved|0|||
124942346|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Moved|0|||
124942347|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Travel|10|||
124942348|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Travel|7|||
124942349|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Travel|0|||
124942350|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Travel|0|||
124942351|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Travel|0|||
124942352|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Site Closed|0|||
124942353|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Site Closed|2|||
124942354|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Site Closed|0|||
124942355|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Site Closed|0|||
124942356|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Site Closed|0|||
124942357|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
124942358|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
124942359|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
124942360|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
124942361|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
124942362|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
124942363|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
124942364|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
124942365|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
124942366|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
124942367|NCT00092534|449416622|FG000|Base Study EXT|Lost to Follow-up|0|||
124942368|NCT00092534|449416623|FG001|Base Study EXT|Lost to Follow-up|0|||
124942369|NCT00092534|449416624|FG002|Base Study EXT|Lost to Follow-up|41|||
124942370|NCT00092534|449416625|FG003|Base Study EXT|Lost to Follow-up|0|||
124942371|NCT00092534|449416626|FG004|Base Study EXT|Lost to Follow-up|0|||
124942372|NCT00092534|449416622|FG000|Base Study EXT|Physician Decision|0|||
124942373|NCT00092534|449416623|FG001|Base Study EXT|Physician Decision|0|||
124942374|NCT00092534|449416624|FG002|Base Study EXT|Physician Decision|1|||
124942375|NCT00092534|449416625|FG003|Base Study EXT|Physician Decision|0|||
125122857|NCT02430870|450074168|FG005|Part 2|Other Reason Not Specified|0|||
124942376|NCT00092534|449416626|FG004|Base Study EXT|Physician Decision|0|||
124942377|NCT00092534|449416622|FG000|Base Study EXT|Pregnancy|0|||
124942378|NCT00092534|449416623|FG001|Base Study EXT|Pregnancy|0|||
124942379|NCT00092534|449416624|FG002|Base Study EXT|Pregnancy|12|||
124942380|NCT00092534|449416625|FG003|Base Study EXT|Pregnancy|0|||
124942381|NCT00092534|449416626|FG004|Base Study EXT|Pregnancy|0|||
124942382|NCT00092534|449416622|FG000|Base Study EXT|Withdrawal by Subject|0|||
124942383|NCT00092534|449416623|FG001|Base Study EXT|Withdrawal by Subject|0|||
124942384|NCT00092534|449416624|FG002|Base Study EXT|Withdrawal by Subject|18|||
124942385|NCT00092534|449416625|FG003|Base Study EXT|Withdrawal by Subject|0|||
124942386|NCT00092534|449416626|FG004|Base Study EXT|Withdrawal by Subject|0|||
124942387|NCT00092534|449416622|FG000|Base Study EXT|Participant moved|0|||
124942388|NCT00092534|449416623|FG001|Base Study EXT|Participant moved|0|||
124942389|NCT00092534|449416624|FG002|Base Study EXT|Participant moved|6|||
124942390|NCT00092534|449416625|FG003|Base Study EXT|Participant moved|0|||
124942391|NCT00092534|449416626|FG004|Base Study EXT|Participant moved|0|||
124942392|NCT00092534|449416622|FG000|Base Study EXT|Travel|0|||
124942393|NCT00092534|449416623|FG001|Base Study EXT|Travel|0|||
124942394|NCT00092534|449416624|FG002|Base Study EXT|Travel|2|||
124942395|NCT00092534|449416625|FG003|Base Study EXT|Travel|0|||
124942396|NCT00092534|449416626|FG004|Base Study EXT|Travel|0|||
124942397|NCT00092534|449416622|FG000|Base Study EXT|Site closed|0|||
124942398|NCT00092534|449416623|FG001|Base Study EXT|Site closed|0|||
124942399|NCT00092534|449416624|FG002|Base Study EXT|Site closed|21|||
124942400|NCT00092534|449416625|FG003|Base Study EXT|Site closed|0|||
124942401|NCT00092534|449416626|FG004|Base Study EXT|Site closed|0|||
124942402|NCT00092534|449416622|FG000|Base Study EXT|Study ended|0|||
124942403|NCT00092534|449416623|FG001|Base Study EXT|Study ended|0|||
124942404|NCT00092534|449416624|FG002|Base Study EXT|Study ended|29|||
124942405|NCT00092534|449416625|FG003|Base Study EXT|Study ended|0|||
124942406|NCT00092534|449416626|FG004|Base Study EXT|Study ended|0|||
124942407|NCT00092534|449416622|FG000|Base Study EXT|Protocol Violation|0|||
124942408|NCT00092534|449416623|FG001|Base Study EXT|Protocol Violation|0|||
124942409|NCT00092534|449416624|FG002|Base Study EXT|Protocol Violation|15|||
124942410|NCT00092534|449416625|FG003|Base Study EXT|Protocol Violation|0|||
124942411|NCT00092534|449416626|FG004|Base Study EXT|Protocol Violation|0|||
124942412|NCT00092534|449416622|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
124942413|NCT00092534|449416623|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
124942414|NCT00092534|449416624|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
124942415|NCT00092534|449416625|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
124942416|NCT00092534|449416626|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
124942417|NCT05029284|449416627|FG000|Overall Study|Lost to Follow-up|1|||
124942418|NCT04001829|449416628|FG000|Overall Study|Never start protocol therapy|5|||
124942419|NCT04001829|449416629|FG001|Overall Study|Never start protocol therapy|5|||
124942420|NCT04001829|449416628|FG000|Overall Study|Adverse Event|11|||
124942421|NCT04001829|449416629|FG001|Overall Study|Adverse Event|7|||
124942422|NCT04001829|449416628|FG000|Overall Study|Alternative therapy|1|||
124942423|NCT04001829|449416629|FG001|Overall Study|Alternative therapy|2|||
124942424|NCT04001829|449416628|FG000|Overall Study|Disease progression/relapse|2|||
124942425|NCT04001829|449416629|FG001|Overall Study|Disease progression/relapse|1|||
124942426|NCT04001829|449416628|FG000|Overall Study|Other complicating disease|1|||
124942427|NCT04001829|449416629|FG001|Overall Study|Other complicating disease|0|||
124942428|NCT04001829|449416628|FG000|Overall Study|Withdrawal by Subject|1|||
124942429|NCT04001829|449416629|FG001|Overall Study|Withdrawal by Subject|4|||
124942430|NCT04001829|449416628|FG000|Overall Study|Ineligible|2|||
124942431|NCT04001829|449416629|FG001|Overall Study|Ineligible|2|||
124942432|NCT04001829|449416628|FG000|Overall Study|Reason missing due to delinquent data|1|||
124942433|NCT04001829|449416629|FG001|Overall Study|Reason missing due to delinquent data|0|||
125028073|NCT01262976|449725631|FG005|Up to Year 3|Lost to Follow-up|3|||
125028074|NCT01262976|449725626|FG000|Up to Year 3|Subjects with unknown completion status|0|||
125028075|NCT01262976|449725627|FG001|Up to Year 3|Subjects with unknown completion status|0|||
124942434|NCT03678688|449416630|FG000|Overall Study|Reason not Specified|0|||
124942435|NCT03678688|449416631|FG001|Overall Study|Reason not Specified|0|||
124942436|NCT03678688|449416632|FG002|Overall Study|Reason not Specified|3|||
124942437|NCT03678688|449416633|FG003|Overall Study|Reason not Specified|0|||
125028076|NCT01262976|449725628|FG002|Up to Year 3|Subjects with unknown completion status|1|||
124942438|NCT03678688|449416634|FG004|Overall Study|Reason not Specified|1|||
124942439|NCT03678688|449416635|FG005|Overall Study|Reason not Specified|0|||
124942440|NCT03678688|449416636|FG006|Overall Study|Reason not Specified|0|||
124942441|NCT03678688|449416637|FG007|Overall Study|Reason not Specified|0|||
124942442|NCT03678688|449416638|FG008|Overall Study|Reason not Specified|0|||
124942443|NCT03678688|449416630|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
124942444|NCT03678688|449416631|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
124942445|NCT03678688|449416632|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
124942446|NCT03678688|449416633|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
125028077|NCT01262976|449725629|FG003|Up to Year 3|Subjects with unknown completion status|0|||
124942447|NCT03678688|449416634|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
125214021|NCT01214668|450411215|FG004|Overall Study|Adverse Event|1|||
125214022|NCT01214668|450411216|FG005|Overall Study|Adverse Event|1|||
125214023|NCT01214668|450411211|FG000|Overall Study|Death|0|||
125214024|NCT01214668|450411212|FG001|Overall Study|Death|0|||
125214025|NCT01214668|450411213|FG002|Overall Study|Death|1|||
125214026|NCT01214668|450411214|FG003|Overall Study|Death|0|||
125214027|NCT01214668|450411215|FG004|Overall Study|Death|0|||
125214028|NCT01214668|450411216|FG005|Overall Study|Death|0|||
125214029|NCT01214668|450411211|FG000|Overall Study|Progressive Disease|4|||
125214030|NCT01214668|450411212|FG001|Overall Study|Progressive Disease|2|||
125214031|NCT01214668|450411213|FG002|Overall Study|Progressive Disease|5|||
125214032|NCT01214668|450411214|FG003|Overall Study|Progressive Disease|4|||
125214033|NCT01214668|450411215|FG004|Overall Study|Progressive Disease|4|||
125214034|NCT01214668|450411216|FG005|Overall Study|Progressive Disease|5|||
125214035|NCT01214668|450411211|FG000|Overall Study|Withdrawal by Subject|0|||
125214036|NCT01214668|450411212|FG001|Overall Study|Withdrawal by Subject|0|||
124942448|NCT03678688|449416635|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
124942449|NCT03678688|449416636|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
124942450|NCT03678688|449416637|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
124942451|NCT03678688|449416638|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
124942452|NCT03678688|449416630|FG000|Overall Study|Covid Related Adverse Event|0|||
124942453|NCT03678688|449416631|FG001|Overall Study|Covid Related Adverse Event|0|||
124942454|NCT03678688|449416632|FG002|Overall Study|Covid Related Adverse Event|0|||
124942455|NCT03678688|449416633|FG003|Overall Study|Covid Related Adverse Event|0|||
124942456|NCT03678688|449416634|FG004|Overall Study|Covid Related Adverse Event|0|||
124942457|NCT03678688|449416635|FG005|Overall Study|Covid Related Adverse Event|3|||
124942458|NCT03678688|449416636|FG006|Overall Study|Covid Related Adverse Event|1|||
124942459|NCT03678688|449416637|FG007|Overall Study|Covid Related Adverse Event|1|||
124942460|NCT03678688|449416638|FG008|Overall Study|Covid Related Adverse Event|0|||
124942461|NCT03678688|449416630|FG000|Overall Study|Physician Decision|0|||
124942462|NCT03678688|449416631|FG001|Overall Study|Physician Decision|0|||
124942463|NCT03678688|449416632|FG002|Overall Study|Physician Decision|0|||
124942464|NCT03678688|449416633|FG003|Overall Study|Physician Decision|0|||
125214037|NCT01214668|450411213|FG002|Overall Study|Withdrawal by Subject|0|||
125214038|NCT01214668|450411214|FG003|Overall Study|Withdrawal by Subject|0|||
125214039|NCT01214668|450411215|FG004|Overall Study|Withdrawal by Subject|1|||
125214040|NCT01214668|450411216|FG005|Overall Study|Withdrawal by Subject|0|||
125028078|NCT01262976|449725630|FG004|Up to Year 3|Subjects with unknown completion status|0|||
124942465|NCT03678688|449416634|FG004|Overall Study|Physician Decision|0|||
124942466|NCT03678688|449416635|FG005|Overall Study|Physician Decision|1|||
124942467|NCT03678688|449416636|FG006|Overall Study|Physician Decision|0|||
124942468|NCT03678688|449416637|FG007|Overall Study|Physician Decision|0|||
124942469|NCT03678688|449416638|FG008|Overall Study|Physician Decision|0|||
124942470|NCT03678688|449416630|FG000|Overall Study|Withdrawal by Subject|0|||
124942471|NCT03678688|449416631|FG001|Overall Study|Withdrawal by Subject|0|||
124942472|NCT03678688|449416632|FG002|Overall Study|Withdrawal by Subject|0|||
124942473|NCT03678688|449416633|FG003|Overall Study|Withdrawal by Subject|0|||
124942474|NCT03678688|449416634|FG004|Overall Study|Withdrawal by Subject|0|||
124942475|NCT03678688|449416635|FG005|Overall Study|Withdrawal by Subject|0|||
124942476|NCT03678688|449416636|FG006|Overall Study|Withdrawal by Subject|2|||
124942477|NCT03678688|449416637|FG007|Overall Study|Withdrawal by Subject|1|||
124942478|NCT03678688|449416638|FG008|Overall Study|Withdrawal by Subject|0|||
124942479|NCT00985088|449416644|FG000|Overall Study|Serious Adverse Event|1|||
124942480|NCT00985088|449416645|FG001|Overall Study|Serious Adverse Event|1|||
124942481|NCT00985088|449416646|FG002|Overall Study|Serious Adverse Event|0|||
124942482|NCT00985088|449416647|FG003|Overall Study|Serious Adverse Event|0|||
124942483|NCT00985088|449416648|FG004|Overall Study|Serious Adverse Event|0|||
124942484|NCT00985088|449416649|FG005|Overall Study|Serious Adverse Event|0|||
124942485|NCT00985088|449416650|FG006|Overall Study|Serious Adverse Event|0|||
124942486|NCT00985088|449416651|FG007|Overall Study|Serious Adverse Event|1|||
124942487|NCT00985088|449416644|FG000|Overall Study|Adverse Event|0|||
124942488|NCT00985088|449416645|FG001|Overall Study|Adverse Event|0|||
124942489|NCT00985088|449416646|FG002|Overall Study|Adverse Event|1|||
124942490|NCT00985088|449416647|FG003|Overall Study|Adverse Event|0|||
124942491|NCT00985088|449416648|FG004|Overall Study|Adverse Event|0|||
124942492|NCT00985088|449416649|FG005|Overall Study|Adverse Event|0|||
124942493|NCT00985088|449416650|FG006|Overall Study|Adverse Event|0|||
124942494|NCT00985088|449416651|FG007|Overall Study|Adverse Event|0|||
124942495|NCT00985088|449416644|FG000|Overall Study|Withdrawal by Subject|4|||
124942496|NCT00985088|449416645|FG001|Overall Study|Withdrawal by Subject|0|||
124942497|NCT00985088|449416646|FG002|Overall Study|Withdrawal by Subject|0|||
124942498|NCT00985088|449416647|FG003|Overall Study|Withdrawal by Subject|1|||
124942499|NCT00985088|449416648|FG004|Overall Study|Withdrawal by Subject|3|||
124942500|NCT00985088|449416649|FG005|Overall Study|Withdrawal by Subject|2|||
124942501|NCT00985088|449416650|FG006|Overall Study|Withdrawal by Subject|1|||
124942502|NCT00985088|449416651|FG007|Overall Study|Withdrawal by Subject|2|||
124942503|NCT00985088|449416644|FG000|Overall Study|Migrated/moved from study area|0|||
124942504|NCT00985088|449416645|FG001|Overall Study|Migrated/moved from study area|0|||
124942505|NCT00985088|449416646|FG002|Overall Study|Migrated/moved from study area|1|||
124942506|NCT00985088|449416647|FG003|Overall Study|Migrated/moved from study area|0|||
124942507|NCT00985088|449416648|FG004|Overall Study|Migrated/moved from study area|0|||
124942508|NCT00985088|449416649|FG005|Overall Study|Migrated/moved from study area|0|||
124942509|NCT00985088|449416650|FG006|Overall Study|Migrated/moved from study area|0|||
124942510|NCT00985088|449416651|FG007|Overall Study|Migrated/moved from study area|1|||
124942511|NCT00985088|449416644|FG000|Overall Study|Lost to Follow-up|6|||
124942512|NCT00985088|449416645|FG001|Overall Study|Lost to Follow-up|1|||
124942513|NCT00985088|449416646|FG002|Overall Study|Lost to Follow-up|2|||
124942514|NCT00985088|449416647|FG003|Overall Study|Lost to Follow-up|6|||
124942515|NCT00985088|449416648|FG004|Overall Study|Lost to Follow-up|6|||
124942516|NCT00985088|449416649|FG005|Overall Study|Lost to Follow-up|5|||
124942517|NCT00985088|449416650|FG006|Overall Study|Lost to Follow-up|3|||
124942518|NCT00985088|449416651|FG007|Overall Study|Lost to Follow-up|2|||
124942519|NCT01278030|449416654|FG000|Overall Study|Withdrawal by Subject|8|||
124942520|NCT01278030|449416655|FG001|Overall Study|Withdrawal by Subject|4|||
124942521|NCT00458783|449416657|FG000|Overall Study|Protocol Violation|1228|||
124942522|NCT00458783|449416658|FG001|Overall Study|Protocol Violation|1220|||
124942523|NCT01737398|449416659|FG000|Overall Study|Adverse event or SAE|16|||
124942524|NCT01737398|449416660|FG001|Overall Study|Adverse event or SAE|1|||
125214041|NCT01964989|450411217|FG000|Overall Study|Protocol Violation|3|||
125214042|NCT01964989|450411218|FG001|Overall Study|Protocol Violation|4|||
124942525|NCT01737398|449416659|FG000|Overall Study|Stopping rule met|2|||
124942526|NCT01737398|449416660|FG001|Overall Study|Stopping rule met|1|||
124942527|NCT01737398|449416659|FG000|Overall Study|Voluntary withdrawal|2|||
125028079|NCT01262976|449725631|FG005|Up to Year 3|Subjects with unknown completion status|0|||
125214043|NCT01964989|450411217|FG000|Overall Study|Administrative Reason|103|||
125214044|NCT01964989|450411218|FG001|Overall Study|Administrative Reason|95|||
125214045|NCT01964989|450411217|FG000|Overall Study|Adverse Event|0|||
124942528|NCT01737398|449416660|FG001|Overall Study|Voluntary withdrawal|3|||
124942529|NCT01737398|449416659|FG000|Overall Study|Ineligibility|1|||
124942530|NCT01737398|449416660|FG001|Overall Study|Ineligibility|0|||
124942531|NCT01737398|449416659|FG000|Overall Study|Liver transplant|1|||
124942532|NCT01737398|449416660|FG001|Overall Study|Liver transplant|0|||
124942533|NCT01737398|449416659|FG000|Overall Study|Disease progression|2|||
124942534|NCT01737398|449416660|FG001|Overall Study|Disease progression|3|||
124942535|NCT01737398|449416659|FG000|Overall Study|Sponsor's decision|2|||
124942536|NCT01737398|449416660|FG001|Overall Study|Sponsor's decision|0|||
124942537|NCT02962284|449416662|FG000|Overall Study|Death|2|||
124942538|NCT02962284|449416663|FG001|Overall Study|Death|0|||
124942539|NCT02962284|449416662|FG000|Overall Study|Progressive disease|2|||
124942540|NCT02962284|449416663|FG001|Overall Study|Progressive disease|3|||
124942541|NCT02962284|449416662|FG000|Overall Study|Withdrawal by Subject|1|||
124942542|NCT02962284|449416663|FG001|Overall Study|Withdrawal by Subject|0|||
124942543|NCT00357994|449416666|FG000|Overall Study|Adverse Event|1|||
124942544|NCT00357994|449416667|FG001|Overall Study|Adverse Event|2|||
124942545|NCT00357994|449416666|FG000|Overall Study|Lack of Efficacy|0|||
124942546|NCT00357994|449416667|FG001|Overall Study|Lack of Efficacy|1|||
124942547|NCT00357994|449416666|FG000|Overall Study|Protocol Violation|1|||
124942548|NCT00357994|449416667|FG001|Overall Study|Protocol Violation|0|||
124942549|NCT04162210|449416672|FG000|Overall Study|Lost to Follow-up|4|||
124942550|NCT04162210|449416673|FG001|Overall Study|Lost to Follow-up|1|||
124942551|NCT04162210|449416672|FG000|Overall Study|Withdrawal by Subject|17|||
124942552|NCT04162210|449416673|FG001|Overall Study|Withdrawal by Subject|9|||
124942553|NCT04162210|449416672|FG000|Overall Study|Ongoing|113|||
124942554|NCT04162210|449416673|FG001|Overall Study|Ongoing|59|||
124942555|NCT03244800|449416674|FG000|Overall Study|Adverse Event|0|||
124942556|NCT03244800|449416675|FG001|Overall Study|Adverse Event|1|||
124942557|NCT03244800|449416676|FG002|Overall Study|Adverse Event|0|||
124942558|NCT03244800|449416677|FG003|Overall Study|Adverse Event|1|||
124942559|NCT03244800|449416674|FG000|Overall Study|Withdrew treatment|0|||
124942560|NCT03244800|449416675|FG001|Overall Study|Withdrew treatment|0|||
124942561|NCT03244800|449416676|FG002|Overall Study|Withdrew treatment|0|||
124942562|NCT03244800|449416677|FG003|Overall Study|Withdrew treatment|1|||
124942563|NCT00371345|449416680|FG000|Overall Study|Disease Progression|21|||
124942564|NCT00371345|449416681|FG001|Overall Study|Disease Progression|35|||
124942565|NCT00371345|449416680|FG000|Overall Study|Study Drug Toxicity|1|||
124942566|NCT00371345|449416681|FG001|Overall Study|Study Drug Toxicity|7|||
124942567|NCT00371345|449416680|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
124942568|NCT00371345|449416681|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
124942569|NCT00371345|449416680|FG000|Overall Study|Participant Request|1|||
124942570|NCT00371345|449416681|FG001|Overall Study|Participant Request|1|||
124942571|NCT00371345|449416680|FG000|Overall Study|Participant Withdrew Consent|0|||
124942572|NCT00371345|449416681|FG001|Overall Study|Participant Withdrew Consent|1|||
124942573|NCT00713596|449416682|FG000|Overall Study|Study was terminated|2|||
124942574|NCT00713596|449416683|FG001|Overall Study|Study was terminated|3|||
124942575|NCT00713596|449416684|FG002|Overall Study|Study was terminated|2|||
124942576|NCT04545619|449416685|FG000|Overall Study|due to equipment challenges|1|||
124942577|NCT03712371|449416686|FG000|Overall Study|Lack of Efficacy|0|||
124942578|NCT03712371|449416687|FG001|Overall Study|Lack of Efficacy|0|||
124942579|NCT03712371|449416688|FG002|Overall Study|Lack of Efficacy|0|||
124942580|NCT03712371|449416689|FG003|Overall Study|Lack of Efficacy|1|||
124942581|NCT02788981|449416690|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
124942582|NCT02788981|449416691|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
124942583|NCT00229658|449416692|FG000|Overall Study|Administrative|2|||
124942584|NCT00229658|449416693|FG001|Overall Study|Administrative|1|||
124942585|NCT00229658|449416692|FG000|Overall Study|Investigator decision|13|||
124942586|NCT00229658|449416693|FG001|Overall Study|Investigator decision|10|||
124942587|NCT00229658|449416692|FG000|Overall Study|Other|80|||
124942588|NCT00229658|449416693|FG001|Overall Study|Other|60|||
124942589|NCT00229658|449416692|FG000|Overall Study|Lost to Follow-up|82|||
124942590|NCT00229658|449416693|FG001|Overall Study|Lost to Follow-up|55|||
124942591|NCT00229658|449416692|FG000|Overall Study|Serious Adverse Event|2|||
124942592|NCT00229658|449416693|FG001|Overall Study|Serious Adverse Event|2|||
124942593|NCT00229658|449416692|FG000|Overall Study|Withdrawal of consent|46|||
124942594|NCT00229658|449416693|FG001|Overall Study|Withdrawal of consent|39|||
124942595|NCT00249769|449416694|FG000|Overall Study|Withdrawal by Subject|1|||
124942596|NCT00249769|449416695|FG001|Overall Study|Withdrawal by Subject|10|||
124942597|NCT00249769|449416696|FG002|Overall Study|Withdrawal by Subject|6|||
124942598|NCT00249769|449416694|FG000|Overall Study|Migration from Study Area|1|||
124942599|NCT00249769|449416695|FG001|Overall Study|Migration from Study Area|3|||
124942600|NCT00249769|449416696|FG002|Overall Study|Migration from Study Area|14|||
124942601|NCT00249769|449416694|FG000|Overall Study|Miscellaneous|0|||
124942602|NCT00249769|449416695|FG001|Overall Study|Miscellaneous|2|||
124942603|NCT00249769|449416696|FG002|Overall Study|Miscellaneous|2|||
124942604|NCT00249769|449416694|FG000|Overall Study|Adverse Event|0|||
124942605|NCT00249769|449416695|FG001|Overall Study|Adverse Event|0|||
124942606|NCT00249769|449416696|FG002|Overall Study|Adverse Event|1|||
124942607|NCT00249769|449416694|FG000|Overall Study|Physician Decision|0|||
124942608|NCT00249769|449416695|FG001|Overall Study|Physician Decision|0|||
124942609|NCT00249769|449416696|FG002|Overall Study|Physician Decision|2|||
124942610|NCT00249769|449416694|FG000|Overall Study|Lost to Follow-up|0|||
124942611|NCT00249769|449416695|FG001|Overall Study|Lost to Follow-up|0|||
124942612|NCT00249769|449416696|FG002|Overall Study|Lost to Follow-up|3|||
124942613|NCT01953224|449416697|FG000|Overall Study|Lost to Follow-up|1|||
124942614|NCT01953224|449416698|FG001|Overall Study|Lost to Follow-up|1|||
124942615|NCT01953224|449416697|FG000|Overall Study|Withdrawal by Subject|1|||
124942616|NCT01953224|449416698|FG001|Overall Study|Withdrawal by Subject|2|||
124942617|NCT00857766|449416705|FG000|Overall Study|Adverse Event|13|||
124942618|NCT00857766|449416706|FG001|Overall Study|Adverse Event|12|||
125214046|NCT01964989|450411218|FG001|Overall Study|Adverse Event|1|||
125214047|NCT01964989|450411217|FG000|Overall Study|Death|1|||
125214048|NCT01964989|450411218|FG001|Overall Study|Death|3|||
125214049|NCT01964989|450411217|FG000|Overall Study|Withdrawal by Subject|156|||
125214050|NCT01964989|450411218|FG001|Overall Study|Withdrawal by Subject|160|||
125214051|NCT01964989|450411217|FG000|Overall Study|Lost to Follow-up|254|||
125214052|NCT01964989|450411218|FG001|Overall Study|Lost to Follow-up|232|||
125214053|NCT01964989|450411217|FG000|Overall Study|Other|267|||
125214054|NCT01964989|450411218|FG001|Overall Study|Other|252|||
125214055|NCT00424593|450411219|FG000|Acute Double-Blind Period|Adverse Event|16|||
125214056|NCT00424593|450411220|FG001|Acute Double-Blind Period|Adverse Event|7|||
125214057|NCT00424593|450411219|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
125214058|NCT00424593|450411220|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
125214059|NCT00424593|450411219|FG000|Acute Double-Blind Period|Protocol Violation|2|||
125214060|NCT00424593|450411220|FG001|Acute Double-Blind Period|Protocol Violation|2|||
125214061|NCT00424593|450411219|FG000|Acute Double-Blind Period|Physician Decision|1|||
125214062|NCT00424593|450411220|FG001|Acute Double-Blind Period|Physician Decision|2|||
125214063|NCT00424593|450411219|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
125214064|NCT00424593|450411220|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
125214065|NCT00424593|450411219|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
125214066|NCT00424593|450411220|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
125214067|NCT00424593|450411219|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
125214068|NCT00424593|450411220|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
125214069|NCT00424593|450411219|FG000|Dose-Blind Extension Period|Adverse Event|18|||
125214070|NCT00424593|450411220|FG001|Dose-Blind Extension Period|Adverse Event|0|||
125214071|NCT00424593|450411219|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
125214072|NCT00424593|450411220|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
125214073|NCT00424593|450411219|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
125214074|NCT00424593|450411220|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
125214075|NCT00424593|450411219|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
125214076|NCT00424593|450411220|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
125214077|NCT00424593|450411219|FG000|Dose-Blind Extension Period|Physician Decision|3|||
125214078|NCT00424593|450411220|FG001|Dose-Blind Extension Period|Physician Decision|0|||
125214079|NCT03042910|450411221|FG000|Overall Study|Adverse Event|1|||
125214080|NCT03042910|450411221|FG000|Overall Study|Disease Progression|2|||
125214081|NCT03042910|450411221|FG000|Overall Study|Withdrawal by Subject|3|||
125214082|NCT03042910|450411221|FG000|Overall Study|Enrolled but not treated|1|||
125214083|NCT01491841|450411225|FG000|Overall Study|Screen Failure|10|||
125214084|NCT01491841|450411225|FG000|Overall Study|Withdrawal by Subject|1|||
125214085|NCT02933528|450411226|FG000|Overall Study|Lost to Follow-up|2|||
125214086|NCT02784288|450411228|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
125214087|NCT02734862|450411229|FG000|Part A|Death|3|||
125214088|NCT02734862|450411230|FG001|Part A|Death|4|||
125214089|NCT02734862|450411231|FG002|Part A|Death|6|||
125214090|NCT02734862|450411229|FG000|Part A|Lost to Follow-up|2|||
125214091|NCT02734862|450411230|FG001|Part A|Lost to Follow-up|1|||
125214092|NCT02734862|450411231|FG002|Part A|Lost to Follow-up|1|||
125214093|NCT02734862|450411229|FG000|Part A|Withdrawal by Subject|1|||
125214094|NCT02734862|450411230|FG001|Part A|Withdrawal by Subject|1|||
125214095|NCT02734862|450411231|FG002|Part A|Withdrawal by Subject|2|||
125214096|NCT02734862|450411229|FG000|Part A|Physician Decision|2|||
125214097|NCT02734862|450411230|FG001|Part A|Physician Decision|0|||
125214098|NCT02734862|450411231|FG002|Part A|Physician Decision|1|||
124942619|NCT00857766|449416705|FG000|Overall Study|Protocol Violation|11|||
124942620|NCT00857766|449416706|FG001|Overall Study|Protocol Violation|11|||
124942621|NCT00857766|449416705|FG000|Overall Study|Lost to Follow-up|1|||
124942622|NCT00857766|449416706|FG001|Overall Study|Lost to Follow-up|0|||
124942623|NCT00857766|449416705|FG000|Overall Study|Investigator Discretion|2|||
124942624|NCT00857766|449416706|FG001|Overall Study|Investigator Discretion|3|||
124942625|NCT00857766|449416705|FG000|Overall Study|Participant Withdrew Consent|4|||
124942626|NCT00857766|449416706|FG001|Overall Study|Participant Withdrew Consent|4|||
125214099|NCT02734862|450411229|FG000|Part A|Adverse Event|2|||
125214100|NCT02734862|450411230|FG001|Part A|Adverse Event|0|||
125214101|NCT02734862|450411231|FG002|Part A|Adverse Event|1|||
124942627|NCT02040870|449416707|FG000|Overall Study|Completed treatment phase|6|||
124942628|NCT02040870|449416707|FG000|Overall Study|Adverse Event|7|||
124942629|NCT02040870|449416707|FG000|Overall Study|Progressive disease|58|||
124942630|NCT02040870|449416707|FG000|Overall Study|Physician Decision|6|||
124942631|NCT02040870|449416707|FG000|Overall Study|Subject/guardian decision|10|||
124942632|NCT02040870|449416707|FG000|Overall Study|Lost to Follow-up|3|||
124942633|NCT02040870|449416707|FG000|Overall Study|Death|13|||
124942634|NCT04971733|449416708|FG000|Overall Study|Adverse Event|1|||
124942635|NCT04971733|449416709|FG001|Overall Study|Adverse Event|1|||
124942636|NCT04971733|449416708|FG000|Overall Study|Subject choice|2|||
124942637|NCT04971733|449416709|FG001|Overall Study|Subject choice|0|||
124942638|NCT04971733|449416708|FG000|Overall Study|Withdrawal by Subject|1|||
124942639|NCT04971733|449416709|FG001|Overall Study|Withdrawal by Subject|0|||
124942640|NCT04971733|449416708|FG000|Overall Study|Other|1|||
124942641|NCT04971733|449416709|FG001|Overall Study|Other|0|||
124942642|NCT01367236|449416715|FG000|Overall Study|Withdrawal by Subject|3|||
124942643|NCT01367236|449416716|FG001|Overall Study|Withdrawal by Subject|1|||
124942644|NCT01593020|449416719|FG000|Overall Study|Adverse Event|1|||
124942645|NCT01593020|449416720|FG001|Overall Study|Adverse Event|1|||
124942646|NCT01593020|449416719|FG000|Overall Study|Death|0|||
124942647|NCT01593020|449416720|FG001|Overall Study|Death|1|||
124942648|NCT01593020|449416719|FG000|Overall Study|Ineligible|1|||
124942649|NCT01593020|449416720|FG001|Overall Study|Ineligible|0|||
124942650|NCT02350634|449416721|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
124942651|NCT01400958|449416730|FG000|Overall Study|Physician Decision|0|||
124942652|NCT01400958|449416731|FG001|Overall Study|Physician Decision|1|||
124942653|NCT01400958|449416730|FG000|Overall Study|Withdrawal by Subject|0|||
124942654|NCT01400958|449416731|FG001|Overall Study|Withdrawal by Subject|1|||
124942655|NCT01400958|449416730|FG000|Overall Study|Adverse Event|1|||
124942656|NCT01400958|449416731|FG001|Overall Study|Adverse Event|0|||
124942657|NCT04445831|449416735|FG000|Overall Study|Withdrawal by Subject|2|||
124942658|NCT04445831|449416736|FG001|Overall Study|Withdrawal by Subject|1|||
124942659|NCT04445831|449416737|FG002|Overall Study|Withdrawal by Subject|1|||
124942660|NCT04445831|449416738|FG003|Overall Study|Withdrawal by Subject|0|||
124942661|NCT04445831|449416739|FG004|Overall Study|Withdrawal by Subject|0|||
124942662|NCT04445831|449416740|FG005|Overall Study|Withdrawal by Subject|0|||
124942663|NCT04445831|449416741|FG006|Overall Study|Withdrawal by Subject|0|||
124942664|NCT04445831|449416735|FG000|Overall Study|Subject withdrawal by caregiver|0|||
124942665|NCT04445831|449416736|FG001|Overall Study|Subject withdrawal by caregiver|1|||
124942666|NCT04445831|449416737|FG002|Overall Study|Subject withdrawal by caregiver|0|||
124942667|NCT04445831|449416738|FG003|Overall Study|Subject withdrawal by caregiver|0|||
124942668|NCT04445831|449416739|FG004|Overall Study|Subject withdrawal by caregiver|0|||
124942669|NCT04445831|449416740|FG005|Overall Study|Subject withdrawal by caregiver|0|||
124942670|NCT04445831|449416741|FG006|Overall Study|Subject withdrawal by caregiver|0|||
124942671|NCT05810285|449416742|FG000|Overall Study|Death|4|||
124942672|NCT05810285|449416743|FG001|Overall Study|Death|21|||
124942673|NCT05810285|449416742|FG000|Overall Study|Adverse Event|18|||
124942674|NCT05810285|449416743|FG001|Overall Study|Adverse Event|16|||
124942675|NCT05470114|449416744|FG000|Overall Study|Withdrawal by Subject|1|||
124942676|NCT05470114|449416745|FG001|Overall Study|Withdrawal by Subject|0|||
125122858|NCT02430870|450074169|FG006|Part 2|Other Reason Not Specified|0|||
124942677|NCT05470114|449416744|FG000|Overall Study|Lost to Follow-up|1|||
124942678|NCT05470114|449416745|FG001|Overall Study|Lost to Follow-up|0|||
124942679|NCT05325294|449416746|FG000|Overall Study|Adverse Event|3|||
124942680|NCT05325294|449416747|FG001|Overall Study|Adverse Event|3|||
124942681|NCT05325294|449416746|FG000|Overall Study|Physician Decision|0|||
124942682|NCT05325294|449416747|FG001|Overall Study|Physician Decision|1|||
124942683|NCT05325294|449416746|FG000|Overall Study|Withdrawal by Subject|0|||
124942684|NCT05325294|449416747|FG001|Overall Study|Withdrawal by Subject|3|||
124942685|NCT05325294|449416746|FG000|Overall Study|Lost to Follow-up|1|||
125122859|NCT02430870|450074170|FG007|Part 2|Other Reason Not Specified|1|||
125122860|NCT01265784|450074171|FG000|Overall Study|Lost to Follow-up|5|||
124942686|NCT05325294|449416747|FG001|Overall Study|Lost to Follow-up|0|||
124942687|NCT05325294|449416746|FG000|Overall Study|Sponsor Request|0|||
124942688|NCT05325294|449416747|FG001|Overall Study|Sponsor Request|2|||
124942689|NCT01563185|449416749|FG000|Overall Study|Withdrawal by Subject|1|||
124942690|NCT01563185|449416749|FG000|Overall Study|Non-Compliance with study drug|1|||
124942691|NCT04577651|449416750|FG000|Overall Study|Screen Failure|7|||
124942692|NCT04577651|449416750|FG000|Overall Study|Adverse Event|1|||
124942693|NCT04577651|449416750|FG000|Overall Study|Death|1|||
124942694|NCT04577651|449416750|FG000|Overall Study|Physician Decision|1|||
124942695|NCT04577651|449416750|FG000|Overall Study|Withdrawal by Subject|3|||
124942696|NCT03214081|449417863|FG000|Overall Study|Case Report Forms Uncollected|9|||
124942697|NCT03214081|449417863|FG000|Overall Study|Protocol Deviation|54|||
124942698|NCT01372085|449417866|FG000|Washout Period 2|Physician Decision|0|||
124942699|NCT01372085|449417867|FG001|Washout Period 2|Physician Decision|0|||
124942700|NCT01372085|449417868|FG002|Washout Period 2|Physician Decision|0|||
124942701|NCT01372085|449417869|FG003|Washout Period 2|Physician Decision|0|||
124942702|NCT01372085|449417870|FG004|Washout Period 2|Physician Decision|1|||
124942703|NCT01372085|449417871|FG005|Washout Period 2|Physician Decision|0|||
124942704|NCT01372085|449417872|FG006|Washout Period 2|Physician Decision|0|||
124942705|NCT01372085|449417873|FG007|Washout Period 2|Physician Decision|0|||
124942706|NCT01372085|449417874|FG008|Washout Period 2|Physician Decision|0|||
124942707|NCT01372085|449417875|FG009|Washout Period 2|Physician Decision|0|||
124942708|NCT01372085|449417866|FG000|Washout Period 3|Withdrawal by Subject|0|||
124942709|NCT01372085|449417867|FG001|Washout Period 3|Withdrawal by Subject|0|||
124942710|NCT01372085|449417868|FG002|Washout Period 3|Withdrawal by Subject|0|||
124942711|NCT01372085|449417869|FG003|Washout Period 3|Withdrawal by Subject|0|||
124942712|NCT01372085|449417870|FG004|Washout Period 3|Withdrawal by Subject|0|||
124942713|NCT01372085|449417871|FG005|Washout Period 3|Withdrawal by Subject|2|||
124942714|NCT01372085|449417872|FG006|Washout Period 3|Withdrawal by Subject|0|||
124942715|NCT01372085|449417873|FG007|Washout Period 3|Withdrawal by Subject|0|||
124942716|NCT01372085|449417874|FG008|Washout Period 3|Withdrawal by Subject|0|||
124942717|NCT01372085|449417875|FG009|Washout Period 3|Withdrawal by Subject|0|||
124942718|NCT00790569|449417876|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
124942719|NCT00790569|449417877|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
125028080|NCT01262976|449725626|FG000|Up to Year 3|Other|3|||
125028081|NCT01262976|449725627|FG001|Up to Year 3|Other|0|||
125028082|NCT01262976|449725628|FG002|Up to Year 3|Other|0|||
124942720|NCT00790569|449417878|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
124942721|NCT00790569|449417876|FG000|End of Treatment (6 Month Interview)|Death|0|||
124942722|NCT00790569|449417877|FG001|End of Treatment (6 Month Interview)|Death|2|||
124942723|NCT00790569|449417878|FG002|End of Treatment (6 Month Interview)|Death|1|||
124942724|NCT00790569|449417876|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
124942725|NCT00790569|449417877|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
124942726|NCT00790569|449417878|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
124942727|NCT00790569|449417876|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
124942728|NCT00790569|449417877|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
124942729|NCT00790569|449417878|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
124942730|NCT00790569|449417876|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
124942731|NCT00790569|449417877|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
124942732|NCT00790569|449417878|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
124942733|NCT00790569|449417876|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
124942734|NCT00790569|449417877|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
124942735|NCT00790569|449417878|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
124942736|NCT00512252|449417882|FG000|Overall Study|Lost to Follow-up|0|||
124942737|NCT00512252|449417883|FG001|Overall Study|Lost to Follow-up|0|||
124942738|NCT00512252|449417884|FG002|Overall Study|Lost to Follow-up|1|||
124942739|NCT00512252|449417882|FG000|Overall Study|Protocol Violation|0|||
124942740|NCT00512252|449417883|FG001|Overall Study|Protocol Violation|0|||
124942741|NCT00512252|449417884|FG002|Overall Study|Protocol Violation|1|||
125214102|NCT02734862|450411229|FG000|Part A|Noncompliance|1|||
125214103|NCT02734862|450411230|FG001|Part A|Noncompliance|1|||
124942742|NCT00512252|449417882|FG000|Overall Study|Death|0|||
124942743|NCT00512252|449417883|FG001|Overall Study|Death|0|||
124942744|NCT00512252|449417884|FG002|Overall Study|Death|1|||
124942745|NCT00705406|449417885|FG000|Overall Study|Lost to Follow-up|3|||
124942746|NCT00705406|449417886|FG001|Overall Study|Lost to Follow-up|3|||
124942747|NCT00705406|449417885|FG000|Overall Study|Did not receive study drug|1|||
125028083|NCT01262976|449725629|FG003|Up to Year 3|Other|0|||
125214104|NCT02734862|450411231|FG002|Part A|Noncompliance|0|||
125214105|NCT02734862|450411229|FG000|Part A|Other|1|||
125214106|NCT02734862|450411230|FG001|Part A|Other|1|||
125214107|NCT02734862|450411231|FG002|Part A|Other|3|||
125214108|NCT02734862|450411229|FG000|Part B|Death|8|||
125214109|NCT02734862|450411230|FG001|Part B|Death|3|||
125214110|NCT02734862|450411231|FG002|Part B|Death|5|||
125214111|NCT02734862|450411229|FG000|Part B|Lost to Follow-up|2|||
125214112|NCT02734862|450411230|FG001|Part B|Lost to Follow-up|2|||
125214113|NCT02734862|450411231|FG002|Part B|Lost to Follow-up|0|||
125214114|NCT02734862|450411229|FG000|Part B|Withdrawal by Subject|3|||
125214115|NCT02734862|450411230|FG001|Part B|Withdrawal by Subject|1|||
125214116|NCT02734862|450411231|FG002|Part B|Withdrawal by Subject|0|||
125214117|NCT02734862|450411229|FG000|Part B|Other|0|||
125214118|NCT02734862|450411230|FG001|Part B|Other|1|||
125214119|NCT02734862|450411231|FG002|Part B|Other|0|||
125214120|NCT02757625|450411232|FG000|Overall Study|Investigator's discretion|0|||
125214121|NCT02757625|450411233|FG001|Overall Study|Investigator's discretion|0|||
124942748|NCT00705406|449417886|FG001|Overall Study|Did not receive study drug|2|||
124942749|NCT01079806|449417887|FG000|Day 1 to Week 96|Adverse Event|0|||
124942750|NCT01079806|449417888|FG001|Day 1 to Week 96|Adverse Event|3|||
124942751|NCT01079806|449417887|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
124942752|NCT01079806|449417888|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
124942753|NCT01079806|449417887|FG000|Day 1 to Week 96|Pregnancy|0|||
124942754|NCT01079806|449417888|FG001|Day 1 to Week 96|Pregnancy|1|||
124942755|NCT01079806|449417887|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
124942756|NCT01079806|449417888|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
124942757|NCT01079806|449417887|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
124942758|NCT01079806|449417888|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
124942759|NCT01079806|449417887|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
124942760|NCT01079806|449417888|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
124942761|NCT01079806|449417887|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
124942762|NCT01079806|449417888|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
124942763|NCT01079806|449417887|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
124942764|NCT01079806|449417888|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
124942765|NCT01079806|449417887|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
124942766|NCT01079806|449417888|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
124942767|NCT01079806|449417887|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
124942768|NCT01079806|449417888|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
124942769|NCT03732807|449417889|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
124942770|NCT03732807|449417890|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
124942771|NCT03732807|449417891|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
124942772|NCT03732807|449417892|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
124942773|NCT03732807|449417893|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
124942774|NCT03732807|449417894|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
124942775|NCT03732807|449417895|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
124942776|NCT03732807|449417889|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
124942777|NCT03732807|449417890|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
124942778|NCT03732807|449417891|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
124942779|NCT03732807|449417892|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
124942780|NCT03732807|449417893|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
125214122|NCT02757625|450411234|FG002|Overall Study|Investigator's discretion|1|||
125214123|NCT02757625|450411235|FG003|Overall Study|Investigator's discretion|0|||
125214124|NCT02757625|450411232|FG000|Overall Study|Adverse Event|0|||
125214125|NCT02757625|450411233|FG001|Overall Study|Adverse Event|0|||
125214126|NCT02757625|450411234|FG002|Overall Study|Adverse Event|1|||
125214127|NCT02757625|450411235|FG003|Overall Study|Adverse Event|0|||
125214128|NCT04854057|450411236|FG000|Overall Study|Adverse Event|0|||
125214129|NCT04854057|450411237|FG001|Overall Study|Adverse Event|1|||
125214130|NCT02131233|450411238|FG000|Overall Study|Not Treated|2|||
124942781|NCT03732807|449417894|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
124942782|NCT03732807|449417895|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
124942783|NCT03732807|449417889|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
124942784|NCT03732807|449417890|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
125214131|NCT02131233|450411239|FG001|Overall Study|Not Treated|3|||
124942785|NCT03732807|449417891|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
125214132|NCT02131233|450411238|FG000|Overall Study|Adverse Event|7|||
125214133|NCT02131233|450411239|FG001|Overall Study|Adverse Event|6|||
125214134|NCT02131233|450411238|FG000|Overall Study|Death|0|||
124942786|NCT03732807|449417892|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
124942787|NCT03732807|449417893|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
124942788|NCT03732807|449417894|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
124942789|NCT03732807|449417895|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
124942790|NCT03732807|449417889|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
124942791|NCT03732807|449417890|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
124942792|NCT03732807|449417891|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
124942793|NCT03732807|449417892|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
124942794|NCT03732807|449417893|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
124942795|NCT03732807|449417894|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
124942796|NCT03732807|449417895|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
124942797|NCT03732807|449417889|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
124942798|NCT03732807|449417890|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
124942799|NCT03732807|449417891|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
124942800|NCT03732807|449417892|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
124942801|NCT03732807|449417893|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
124942802|NCT03732807|449417894|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
124942803|NCT03732807|449417895|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
124942804|NCT03732807|449417889|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
124942805|NCT03732807|449417890|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
124942806|NCT03732807|449417891|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
124942807|NCT03732807|449417892|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
124942808|NCT03732807|449417893|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
124942809|NCT03732807|449417894|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
124942810|NCT03732807|449417895|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
124942811|NCT03732807|449417889|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
124942812|NCT03732807|449417890|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
124942813|NCT03732807|449417891|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
124942814|NCT03732807|449417892|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
124942815|NCT03732807|449417893|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
124942816|NCT03732807|449417894|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
124942817|NCT03732807|449417895|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
124942818|NCT03732807|449417889|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
124942819|NCT03732807|449417890|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
124942820|NCT03732807|449417891|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
125028084|NCT01262976|449725630|FG004|Up to Year 3|Other|0|||
124942821|NCT03732807|449417892|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
124942822|NCT03732807|449417893|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
124942823|NCT03732807|449417894|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
124942824|NCT03732807|449417895|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
124942825|NCT03732807|449417889|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
124942826|NCT03732807|449417890|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
124942827|NCT03732807|449417891|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
124942828|NCT03732807|449417892|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
124942829|NCT03732807|449417893|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
124942830|NCT03732807|449417894|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
124942831|NCT03732807|449417895|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
124942832|NCT03732807|449417889|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
124942833|NCT03732807|449417890|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
124942834|NCT03732807|449417891|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
124942835|NCT03732807|449417892|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
124942836|NCT03732807|449417893|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
124942837|NCT03732807|449417894|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
125028085|NCT01262976|449725631|FG005|Up to Year 3|Other|0|||
125028086|NCT01552681|449725635|FG000|Overall Study|Withdrawal by Subject|4|||
125028087|NCT01552681|449725636|FG001|Overall Study|Withdrawal by Subject|0|||
125028088|NCT01552681|449725635|FG000|Overall Study|Physician Decision|1|||
124942838|NCT03732807|449417895|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
124942839|NCT03732807|449417889|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
124942840|NCT03732807|449417890|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
125028089|NCT01552681|449725636|FG001|Overall Study|Physician Decision|0|||
125028090|NCT01552681|449725635|FG000|Overall Study|Subject moved away|0|||
125028091|NCT01552681|449725636|FG001|Overall Study|Subject moved away|1|||
125028092|NCT02690194|449725637|FG000|Overall Study|Withdrawal by Subject|1|||
125028093|NCT02690194|449725638|FG001|Overall Study|Withdrawal by Subject|4|||
125028094|NCT02690194|449725639|FG002|Overall Study|Withdrawal by Subject|0|||
125028095|NCT01987908|449725640|FG000|Placebo Lead-in Period|Adverse Event|2|||
125028096|NCT01987908|449725641|FG001|Placebo Lead-in Period|Adverse Event|0|||
125028097|NCT01987908|449725642|FG002|Placebo Lead-in Period|Adverse Event|0|||
125028098|NCT01987908|449725640|FG000|Placebo Lead-in Period|Physician Decision|2|||
125028099|NCT01987908|449725641|FG001|Placebo Lead-in Period|Physician Decision|0|||
125028100|NCT01987908|449725642|FG002|Placebo Lead-in Period|Physician Decision|0|||
125028101|NCT01987908|449725640|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
125028102|NCT01987908|449725641|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
125028103|NCT01987908|449725642|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
125028104|NCT01987908|449725640|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
125122861|NCT01265784|450074172|FG001|Overall Study|Lost to Follow-up|3|||
124942841|NCT03732807|449417891|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
124942842|NCT03732807|449417892|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
124942843|NCT03732807|449417893|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
124942844|NCT03732807|449417894|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
124942845|NCT03732807|449417895|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
124942846|NCT03732807|449417889|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
124942847|NCT03732807|449417890|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
124942848|NCT03732807|449417891|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
124942849|NCT03732807|449417892|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
124942850|NCT03732807|449417893|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
124942851|NCT03732807|449417894|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
124942852|NCT03732807|449417895|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
124942853|NCT03732807|449417889|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
125122862|NCT01265784|450074173|FG002|Overall Study|Lost to Follow-up|2|||
125122863|NCT01265784|450074171|FG000|Overall Study|Withdrawal by Subject|0|||
125122864|NCT01265784|450074172|FG001|Overall Study|Withdrawal by Subject|5|||
125122865|NCT01265784|450074173|FG002|Overall Study|Withdrawal by Subject|0|||
125122866|NCT01265784|450074171|FG000|Overall Study|Physician Decision|1|||
125122867|NCT01265784|450074172|FG001|Overall Study|Physician Decision|0|||
125122868|NCT01265784|450074173|FG002|Overall Study|Physician Decision|1|||
125122869|NCT01265784|450074171|FG000|Overall Study|Adverse Event|1|||
125122870|NCT01265784|450074172|FG001|Overall Study|Adverse Event|0|||
125122871|NCT01265784|450074173|FG002|Overall Study|Adverse Event|0|||
125122872|NCT01265784|450074171|FG000|Overall Study|Death|3|||
125122873|NCT01265784|450074172|FG001|Overall Study|Death|0|||
125122874|NCT01265784|450074173|FG002|Overall Study|Death|0|||
125122875|NCT01265784|450074171|FG000|Overall Study|Protocol Violation|2|||
125122876|NCT01265784|450074172|FG001|Overall Study|Protocol Violation|0|||
125122877|NCT01265784|450074173|FG002|Overall Study|Protocol Violation|0|||
125122878|NCT01265784|450074171|FG000|Overall Study|Incorrectly Randomized|0|||
125122879|NCT01265784|450074172|FG001|Overall Study|Incorrectly Randomized|0|||
125122880|NCT01265784|450074173|FG002|Overall Study|Incorrectly Randomized|1|||
125122881|NCT00796822|450074174|FG000|Overall Study|Lost to Follow-up|2|||
125122882|NCT00796822|450074175|FG001|Overall Study|Lost to Follow-up|0|||
125122883|NCT00796822|450074174|FG000|Overall Study|Adverse Event|1|||
125122884|NCT00796822|450074175|FG001|Overall Study|Adverse Event|0|||
125122885|NCT02603952|450074176|FG000|Overall Study|Withdrawal by Subject|1|||
125122886|NCT02603952|450074177|FG001|Overall Study|Withdrawal by Subject|0|||
125122887|NCT02603952|450074178|FG002|Overall Study|Withdrawal by Subject|0|||
125122888|NCT02603952|450074179|FG003|Overall Study|Withdrawal by Subject|0|||
125122889|NCT02603952|450074176|FG000|Overall Study|Received oseltamivir by error|0|||
125122890|NCT02603952|450074177|FG001|Overall Study|Received oseltamivir by error|0|||
125122891|NCT02603952|450074178|FG002|Overall Study|Received oseltamivir by error|0|||
125122892|NCT02603952|450074179|FG003|Overall Study|Received oseltamivir by error|1|||
125122893|NCT04646109|450074182|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
125122894|NCT04646109|450074183|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
125122895|NCT01867242|450074186|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
125122896|NCT01867242|450074187|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
125122897|NCT01867242|450074188|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
125122898|NCT03184441|450074195|FG000|Overall Study|Withdrawal by Subject|1|||
125122899|NCT00264810|450074196|FG000|Baseline|Withdrawal by Subject|10|||
125122900|NCT00264810|450074197|FG001|Baseline|Withdrawal by Subject|10|||
125122901|NCT00264810|450074196|FG000|Baseline|Physician Decision|7|||
125122902|NCT00264810|450074197|FG001|Baseline|Physician Decision|8|||
125122903|NCT00264810|450074196|FG000|Baseline|Subject Compliance Failure|3|||
125122904|NCT00264810|450074197|FG001|Baseline|Subject Compliance Failure|3|||
125122905|NCT00264810|450074196|FG000|Baseline|Insufficient Seizure Frequency|2|||
125122906|NCT00264810|450074197|FG001|Baseline|Insufficient Seizure Frequency|2|||
125122907|NCT00264810|450074196|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
125122908|NCT00264810|450074197|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
125122909|NCT00264810|450074196|FG000|Baseline|Other|0|||
125122910|NCT00264810|450074197|FG001|Baseline|Other|1|||
125122911|NCT00264810|450074196|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
125122912|NCT00264810|450074197|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
125122913|NCT00264810|450074196|FG000|Stimulation Optimization Period|Death|0|||
125122914|NCT00264810|450074197|FG001|Stimulation Optimization Period|Death|1|||
125122915|NCT00264810|450074196|FG000|Blinded Evaluation Period|Explant due to infection|1|||
125122916|NCT00264810|450074197|FG001|Blinded Evaluation Period|Explant due to infection|1|||
125028105|NCT01987908|449725641|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
125028106|NCT01987908|449725642|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
125028107|NCT01987908|449725640|FG000|Treatment Period|Adverse Event|0|||
125028108|NCT01987908|449725641|FG001|Treatment Period|Adverse Event|1|||
125028109|NCT01987908|449725642|FG002|Treatment Period|Adverse Event|1|||
125028110|NCT01987908|449725640|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
125028111|NCT01987908|449725641|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
125028112|NCT01987908|449725642|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
125028113|NCT01987908|449725640|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
125028114|NCT01987908|449725641|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
125028115|NCT01987908|449725642|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
125028116|NCT00354601|449725645|FG000|Overall Study|Protocol Violation|1|||
125028117|NCT00354601|449725645|FG000|Overall Study|progression|1|||
125028118|NCT03603652|449725646|FG000|Overall Study|Death|2|||
125028119|NCT02532855|449725647|FG000|Overall Study|Lost to Follow-up|4|||
125028120|NCT02532855|449725648|FG001|Overall Study|Lost to Follow-up|3|||
125028121|NCT02532855|449725647|FG000|Overall Study|Withdrawal by Subject|4|||
125028122|NCT02532855|449725648|FG001|Overall Study|Withdrawal by Subject|8|||
125028123|NCT01960855|449725649|FG000|Overall Study|Subject noncompliant|1|||
125028124|NCT01960855|449725650|FG001|Overall Study|Subject noncompliant|0|||
125028125|NCT01960855|449725651|FG002|Overall Study|Subject noncompliant|0|||
125028126|NCT01960855|449725652|FG003|Overall Study|Subject noncompliant|0|||
125028127|NCT01960855|449725653|FG004|Overall Study|Subject noncompliant|0|||
125028128|NCT01960855|449725649|FG000|Overall Study|Adverse Event|2|||
125028129|NCT01960855|449725650|FG001|Overall Study|Adverse Event|0|||
125028130|NCT01960855|449725651|FG002|Overall Study|Adverse Event|6|||
125028131|NCT01960855|449725652|FG003|Overall Study|Adverse Event|2|||
125028132|NCT01960855|449725653|FG004|Overall Study|Adverse Event|2|||
125028133|NCT01960855|449725649|FG000|Overall Study|Lack of Efficacy|1|||
125028134|NCT01960855|449725650|FG001|Overall Study|Lack of Efficacy|1|||
125028135|NCT01960855|449725651|FG002|Overall Study|Lack of Efficacy|0|||
125028136|NCT01960855|449725652|FG003|Overall Study|Lack of Efficacy|0|||
125028137|NCT01960855|449725653|FG004|Overall Study|Lack of Efficacy|0|||
125028138|NCT01960855|449725649|FG000|Overall Study|Other|2|||
125028139|NCT01960855|449725650|FG001|Overall Study|Other|1|||
125028140|NCT01960855|449725651|FG002|Overall Study|Other|1|||
125028141|NCT01960855|449725652|FG003|Overall Study|Other|1|||
125028142|NCT01960855|449725653|FG004|Overall Study|Other|0|||
125028143|NCT01960855|449725649|FG000|Overall Study|Consent withdrawn by subject|3|||
125028144|NCT01960855|449725650|FG001|Overall Study|Consent withdrawn by subject|1|||
125122917|NCT00264810|450074196|FG000|Open Label Evaluation Period|Explant due to infection|1|||
124942854|NCT03732807|449417890|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
124942855|NCT03732807|449417891|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
124942856|NCT03732807|449417892|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
124942857|NCT03732807|449417893|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
124942858|NCT03732807|449417894|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
124942859|NCT03732807|449417895|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
124942860|NCT03732807|449417889|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
124942861|NCT03732807|449417890|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
124942862|NCT03732807|449417891|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
124942863|NCT03732807|449417892|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
124942864|NCT03732807|449417893|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
124942865|NCT03732807|449417894|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
124942866|NCT03732807|449417895|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
124942867|NCT01779700|449417896|FG000|Overall Study|Adverse Event|4|||
124942868|NCT01779700|449417897|FG001|Overall Study|Adverse Event|3|||
124942869|NCT01779700|449417896|FG000|Overall Study|Withdrawal by Subject|0|||
124942870|NCT01779700|449417897|FG001|Overall Study|Withdrawal by Subject|2|||
124942871|NCT00683800|449417900|FG000|Overall Study|Adverse Event|195|||
124942872|NCT00683800|449417901|FG001|Overall Study|Adverse Event|102|||
124942873|NCT00683800|449417900|FG000|Overall Study|Death|0|||
124942874|NCT00683800|449417901|FG001|Overall Study|Death|1|||
124942875|NCT00683800|449417900|FG000|Overall Study|Lost to Follow-up|57|||
124942876|NCT00683800|449417901|FG001|Overall Study|Lost to Follow-up|44|||
124942877|NCT00683800|449417900|FG000|Overall Study|Other|5|||
124942878|NCT00683800|449417901|FG001|Overall Study|Other|2|||
124942879|NCT00683800|449417900|FG000|Overall Study|Protocol Violation|13|||
125028145|NCT01960855|449725651|FG002|Overall Study|Consent withdrawn by subject|2|||
125028146|NCT01960855|449725652|FG003|Overall Study|Consent withdrawn by subject|1|||
125028147|NCT01960855|449725653|FG004|Overall Study|Consent withdrawn by subject|1|||
125028148|NCT01960855|449725649|FG000|Overall Study|Lost to Follow-up|2|||
125028149|NCT01960855|449725650|FG001|Overall Study|Lost to Follow-up|1|||
125028150|NCT01960855|449725651|FG002|Overall Study|Lost to Follow-up|0|||
125028151|NCT01960855|449725652|FG003|Overall Study|Lost to Follow-up|0|||
125214135|NCT02131233|450411239|FG001|Overall Study|Death|1|||
124942880|NCT00683800|449417901|FG001|Overall Study|Protocol Violation|16|||
124942881|NCT00683800|449417900|FG000|Overall Study|Withdrawal by Subject|66|||
124942882|NCT00683800|449417901|FG001|Overall Study|Withdrawal by Subject|64|||
124942883|NCT00683800|449417900|FG000|Overall Study|Lack of Efficacy|61|||
124942884|NCT00683800|449417901|FG001|Overall Study|Lack of Efficacy|104|||
124942885|NCT00683800|449417900|FG000|Overall Study|Randomized, not treated|35|||
124942886|NCT00683800|449417901|FG001|Overall Study|Randomized, not treated|33|||
124942887|NCT01700205|449417905|FG000|Overall Study|Withdrawal by Subject|13|||
124942888|NCT01700205|449417906|FG001|Overall Study|Withdrawal by Subject|13|||
124942889|NCT01700205|449417905|FG000|Overall Study|Protocol Violation|2|||
124942890|NCT01700205|449417906|FG001|Overall Study|Protocol Violation|2|||
124942891|NCT02251652|449417907|FG000|Overall Study|Withdrawal by Subject|1|||
124942892|NCT00983294|449417911|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
124942893|NCT00983294|449417911|FG000|Colchicine With Azithromycin|Adverse Event|1|||
124942894|NCT03229408|449417915|FG000|Overall Study|Withdrawal by Subject|4|||
124942895|NCT03229408|449417916|FG001|Overall Study|Withdrawal by Subject|1|||
124942896|NCT03229408|449417915|FG000|Overall Study|Adverse Event|2|||
124942897|NCT03229408|449417916|FG001|Overall Study|Adverse Event|0|||
124942898|NCT03229408|449417915|FG000|Overall Study|Pregnancy|0|||
124942899|NCT03229408|449417916|FG001|Overall Study|Pregnancy|1|||
124942900|NCT03229408|449417915|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
124942901|NCT03229408|449417916|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
124942902|NCT04200664|449417917|FG000|Overall Study|Withdrawal by Subject|1|||
124942903|NCT04200664|449417918|FG001|Overall Study|Withdrawal by Subject|0|||
124942904|NCT04200664|449417919|FG002|Overall Study|Withdrawal by Subject|0|||
124942905|NCT04541589|449417921|FG000|Treatment Period|Adverse Event|8|||
124942906|NCT04541589|449417922|FG001|Treatment Period|Adverse Event|2|||
124942907|NCT04541589|449417921|FG000|Treatment Period|Physician Decision|3|||
124942908|NCT04541589|449417922|FG001|Treatment Period|Physician Decision|1|||
124942909|NCT04541589|449417921|FG000|Treatment Period|Subject decision|7|||
124942910|NCT04541589|449417922|FG001|Treatment Period|Subject decision|4|||
124942911|NCT04541589|449417921|FG000|Treatment Period|Withdrawal by Subject|1|||
124942912|NCT04541589|449417922|FG001|Treatment Period|Withdrawal by Subject|0|||
124942913|NCT04541589|449417921|FG000|Safety Follow-up Period|Adverse Event|2|||
124942914|NCT04541589|449417922|FG001|Safety Follow-up Period|Adverse Event|1|||
124942915|NCT04541589|449417921|FG000|Safety Follow-up Period|Physician Decision|1|||
124942916|NCT04541589|449417922|FG001|Safety Follow-up Period|Physician Decision|0|||
125122918|NCT00264810|450074197|FG001|Open Label Evaluation Period|Explant due to infection|1|||
125122919|NCT00264810|450074196|FG000|Open Label Evaluation Period|Death|3|||
125122920|NCT00264810|450074197|FG001|Open Label Evaluation Period|Death|2|||
125122921|NCT00264810|450074196|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
125122922|NCT00264810|450074197|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
125122923|NCT02093689|450074201|FG000|Overall Study|Physician Decision|4|||
125122924|NCT02093689|450074202|FG001|Overall Study|Physician Decision|0|||
125122925|NCT02093689|450074203|FG002|Overall Study|Physician Decision|0|||
125122926|NCT04634409|450074204|FG000|Overall Study|Death|0|||
125122927|NCT04634409|450074205|FG001|Overall Study|Death|0|||
125122928|NCT04634409|450074206|FG002|Overall Study|Death|0|||
125122929|NCT04634409|450074207|FG003|Overall Study|Death|0|||
125122930|NCT04634409|450074208|FG004|Overall Study|Death|0|||
125122931|NCT04634409|450074209|FG005|Overall Study|Death|0|||
125122932|NCT04634409|450074210|FG006|Overall Study|Death|0|||
125122933|NCT04634409|450074211|FG007|Overall Study|Death|0|||
125122934|NCT04634409|450074212|FG008|Overall Study|Death|0|||
125122935|NCT04634409|450074213|FG009|Overall Study|Death|0|||
125122936|NCT04634409|450074214|FG010|Overall Study|Death|1|||
125122937|NCT04634409|450074215|FG011|Overall Study|Death|0|||
125122938|NCT04634409|450074216|FG012|Overall Study|Death|1|||
125122939|NCT04634409|450074217|FG013|Overall Study|Death|0|||
125122940|NCT04634409|450074218|FG014|Overall Study|Death|0|||
125122941|NCT04634409|450074219|FG015|Overall Study|Death|0|||
125122942|NCT04634409|450074220|FG016|Overall Study|Death|0|||
125122943|NCT04634409|450074221|FG017|Overall Study|Death|0|||
125122944|NCT04634409|450074222|FG018|Overall Study|Death|0|||
125122945|NCT04634409|450074223|FG019|Overall Study|Death|0|||
125122946|NCT04634409|450074224|FG020|Overall Study|Death|0|||
125122947|NCT04634409|450074225|FG021|Overall Study|Death|0|||
125122948|NCT04634409|450074226|FG022|Overall Study|Death|0|||
125122949|NCT04634409|450074227|FG023|Overall Study|Death|0|||
124942917|NCT04541589|449417921|FG000|Safety Follow-up Period|Subject decision|5|||
124942918|NCT04541589|449417922|FG001|Safety Follow-up Period|Subject decision|3|||
125122950|NCT04634409|450074228|FG024|Overall Study|Death|0|||
125122951|NCT04634409|450074229|FG025|Overall Study|Death|0|||
125122952|NCT04634409|450074230|FG026|Overall Study|Death|0|||
125122953|NCT04634409|450074204|FG000|Overall Study|Adverse Event|0|||
125122954|NCT04634409|450074205|FG001|Overall Study|Adverse Event|0|||
125122955|NCT04634409|450074206|FG002|Overall Study|Adverse Event|1|||
125122956|NCT04634409|450074207|FG003|Overall Study|Adverse Event|0|||
125122957|NCT04634409|450074208|FG004|Overall Study|Adverse Event|0|||
125122958|NCT04634409|450074209|FG005|Overall Study|Adverse Event|1|||
125122959|NCT04634409|450074210|FG006|Overall Study|Adverse Event|0|||
125122960|NCT04634409|450074211|FG007|Overall Study|Adverse Event|0|||
125122961|NCT04634409|450074212|FG008|Overall Study|Adverse Event|0|||
125122962|NCT04634409|450074213|FG009|Overall Study|Adverse Event|0|||
124942919|NCT04541589|449417921|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
124942920|NCT04541589|449417922|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
124942921|NCT02426138|449417923|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
124942922|NCT02426138|449417924|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
124942923|NCT03582475|449417931|FG000|Treatment Period|Withdrawal by Subject|0|||
124942924|NCT03582475|449417932|FG001|Treatment Period|Withdrawal by Subject|1|||
124942925|NCT03582475|449417931|FG000|Follow-up Period|Withdrawal by Subject|0|||
124942926|NCT03582475|449417932|FG001|Follow-up Period|Withdrawal by Subject|1|||
124942927|NCT01706159|449417935|FG000|Overall Study|Withdrawal Criteria|2|||
124942928|NCT01706159|449417936|FG001|Overall Study|Withdrawal Criteria|1|||
124942929|NCT01706159|449417935|FG000|Overall Study|Unclassified|6|||
124942930|NCT01706159|449417936|FG001|Overall Study|Unclassified|1|||
124942931|NCT03362190|449417937|FG000|Overall Study|Adverse Event|0|||
124942932|NCT03362190|449417938|FG001|Overall Study|Adverse Event|0|||
124942933|NCT03362190|449417939|FG002|Overall Study|Adverse Event|0|||
124942934|NCT03362190|449417940|FG003|Overall Study|Adverse Event|1|||
124942935|NCT03362190|449417937|FG000|Overall Study|Withdrawal by Subject|0|||
124942936|NCT03362190|449417938|FG001|Overall Study|Withdrawal by Subject|0|||
124942937|NCT03362190|449417939|FG002|Overall Study|Withdrawal by Subject|0|||
124942938|NCT03362190|449417940|FG003|Overall Study|Withdrawal by Subject|1|||
124942939|NCT00687219|449417941|FG000|Overall Study|Adverse Event|8|||
124942940|NCT00687219|449417941|FG000|Overall Study|Discontinuance criteria met|7|||
124942941|NCT00687219|449417941|FG000|Overall Study|HCV-RNA positive conversion|34|||
124942942|NCT00687219|449417941|FG000|Overall Study|Withdrawal by Subject|1|||
124942943|NCT00687219|449417941|FG000|Overall Study|Lack of Efficacy|1|||
124942944|NCT03775486|449417946|FG000|Initial Therapy Phase|Other reason provided|0|||
124942945|NCT03775486|449417947|FG001|Initial Therapy Phase|Other reason provided|15|||
124942946|NCT03775486|449417946|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
124942947|NCT03775486|449417947|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
124942948|NCT03775486|449417946|FG000|Initial Therapy Phase|Protocol Violation|0|||
124942949|NCT03775486|449417947|FG001|Initial Therapy Phase|Protocol Violation|2|||
124942950|NCT03775486|449417946|FG000|Initial Therapy Phase|Adverse Event|0|||
124942951|NCT03775486|449417947|FG001|Initial Therapy Phase|Adverse Event|34|||
124942952|NCT03775486|449417946|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
124942953|NCT03775486|449417947|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
124942954|NCT03775486|449417946|FG000|Maintenance Phase|Withdrawal by Subject|13|||
124942955|NCT03775486|449417947|FG001|Maintenance Phase|Withdrawal by Subject|12|||
124942956|NCT03775486|449417946|FG000|Maintenance Phase|Death|44|||
124942957|NCT03775486|449417947|FG001|Maintenance Phase|Death|45|||
124942958|NCT02744066|449417953|FG000|Overall Study|Withdrawal by parent|0|||
124942959|NCT02744066|449417954|FG001|Overall Study|Withdrawal by parent|1|||
124942960|NCT02744066|449417953|FG000|Overall Study|Discharged from NICU prior to completion|0|||
124942961|NCT02744066|449417954|FG001|Overall Study|Discharged from NICU prior to completion|4|||
124942962|NCT02454959|449417955|FG000|Overall Study|Protocol-Specified Criteria|3|||
124942963|NCT02454959|449417955|FG000|Overall Study|Physician Decision|1|||
124942964|NCT02454959|449417955|FG000|Overall Study|Withdrawal by Subject|3|||
124942965|NCT02454959|449417955|FG000|Overall Study|Adverse Event|2|||
124942966|NCT00647387|449417966|FG000|Overall Study|Lost to Follow-up|6|||
124942967|NCT00647387|449417966|FG000|Overall Study|Unsuccessful implant|5|||
124942968|NCT00647387|449417966|FG000|Overall Study|Device explanted|3|||
124942969|NCT00647387|449417966|FG000|Overall Study|Other Reason|3|||
124942970|NCT00647387|449417966|FG000|Overall Study|Death|2|||
124942971|NCT02969356|449417968|FG000|Overall Study|Adverse Event|7|||
124942972|NCT02969356|449417968|FG000|Overall Study|Consent withdrawn|2|||
124942973|NCT02969356|449417968|FG000|Overall Study|Lost to Follow-up|3|||
124942974|NCT02969356|449417968|FG000|Overall Study|Did not need to be reinjected|6|||
124942975|NCT02969356|449417968|FG000|Overall Study|Personal reasons|5|||
124942976|NCT04172675|449419793|FG000|Overall Study|Withdrawal by Subject|7|||
124942977|NCT04172675|449419794|FG001|Overall Study|Withdrawal by Subject|5|||
124942978|NCT04172675|449419795|FG002|Overall Study|Withdrawal by Subject|1|||
124942979|NCT04172675|449419796|FG003|Overall Study|Withdrawal by Subject|4|||
124942980|NCT03945773|449419797|FG000|Overall Study|Consent Withdrawn|1|||
124942981|NCT03945773|449419798|FG001|Overall Study|Consent Withdrawn|1|||
124942982|NCT03945773|449419797|FG000|Overall Study|Lost to Follow-up|1|||
124942983|NCT03945773|449419798|FG001|Overall Study|Lost to Follow-up|0|||
124942984|NCT03945773|449419797|FG000|Overall Study|Death|46|||
124942985|NCT03945773|449419798|FG001|Overall Study|Death|22|||
124942986|NCT03945773|449419797|FG000|Overall Study|Physician Decision|1|||
124942987|NCT03945773|449419798|FG001|Overall Study|Physician Decision|0|||
124942988|NCT03945773|449419797|FG000|Overall Study|Other|1|||
124942989|NCT03945773|449419798|FG001|Overall Study|Other|0|||
124942990|NCT03945773|449419797|FG000|Overall Study|Ongoing at the time of DCO|4|||
124942991|NCT03945773|449419798|FG001|Overall Study|Ongoing at the time of DCO|3|||
124942992|NCT05349721|449419799|FG000|Part A (24 Weeks)|Adverse Event|9|||
124942993|NCT05349721|449419800|FG001|Part A (24 Weeks)|Adverse Event|2|||
124942994|NCT05349721|449419799|FG000|Part A (24 Weeks)|Death|8|||
124942995|NCT05349721|449419800|FG001|Part A (24 Weeks)|Death|3|||
124942996|NCT05349721|449419799|FG000|Part A (24 Weeks)|Disease Progression|1|||
124942997|NCT05349721|449419800|FG001|Part A (24 Weeks)|Disease Progression|1|||
124942998|NCT05349721|449419799|FG000|Part A (24 Weeks)|Screen Failure|2|||
124942999|NCT05349721|449419800|FG001|Part A (24 Weeks)|Screen Failure|0|||
124943000|NCT05349721|449419799|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
124943001|NCT05349721|449419800|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
124943002|NCT05349721|449419799|FG000|Part A (24 Weeks)|Other Than Specified|5|||
124943003|NCT05349721|449419800|FG001|Part A (24 Weeks)|Other Than Specified|1|||
124943004|NCT05349721|449419799|FG000|Part B (28 Weeks)|Adverse Event|3|||
124943005|NCT05349721|449419800|FG001|Part B (28 Weeks)|Adverse Event|0|||
124943006|NCT05349721|449419799|FG000|Part B (28 Weeks)|Death|21|||
124943007|NCT05349721|449419800|FG001|Part B (28 Weeks)|Death|11|||
124943008|NCT05349721|449419799|FG000|Part B (28 Weeks)|Disease Progression|2|||
124943009|NCT05349721|449419800|FG001|Part B (28 Weeks)|Disease Progression|1|||
124943010|NCT05349721|449419799|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
124943011|NCT05349721|449419800|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
124943012|NCT05349721|449419799|FG000|Part B (28 Weeks)|Physician Decision|1|||
124943013|NCT05349721|449419800|FG001|Part B (28 Weeks)|Physician Decision|0|||
124943014|NCT05349721|449419799|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
125028152|NCT01960855|449725653|FG004|Overall Study|Lost to Follow-up|2|||
124943015|NCT05349721|449419800|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
124943016|NCT05349721|449419799|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
124943017|NCT05349721|449419800|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
125122963|NCT04634409|450074214|FG010|Overall Study|Adverse Event|0|||
125122964|NCT04634409|450074215|FG011|Overall Study|Adverse Event|0|||
125122965|NCT04634409|450074216|FG012|Overall Study|Adverse Event|0|||
125122966|NCT04634409|450074217|FG013|Overall Study|Adverse Event|0|||
125122967|NCT04634409|450074218|FG014|Overall Study|Adverse Event|0|||
124943018|NCT05349721|449419799|FG000|Part B (28 Weeks)|Other Than Specified|4|||
124943019|NCT05349721|449419800|FG001|Part B (28 Weeks)|Other Than Specified|2|||
124943020|NCT05349721|449419799|FG000|Part C (108 Weeks)|Death|0|||
124943021|NCT05349721|449419800|FG001|Part C (108 Weeks)|Death|1|||
124943022|NCT05349721|449419799|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
124943023|NCT05349721|449419800|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
124943024|NCT05349721|449419799|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
124943025|NCT05349721|449419800|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
124943026|NCT05349721|449419799|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
124943027|NCT05349721|449419800|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
124943028|NCT03070392|449419801|FG000|Overall Study|Not Treated|7|||
124943029|NCT03070392|449419802|FG001|Overall Study|Not Treated|0|||
124943030|NCT03070392|449419803|FG002|Overall Study|Not Treated|3|||
124943031|NCT03070392|449419804|FG003|Overall Study|Not Treated|12|||
124943032|NCT03070392|449419801|FG000|Overall Study|Death|3|||
124943033|NCT03070392|449419802|FG001|Overall Study|Death|0|||
124943034|NCT03070392|449419803|FG002|Overall Study|Death|0|||
124943035|NCT03070392|449419804|FG003|Overall Study|Death|1|||
124943036|NCT03070392|449419801|FG000|Overall Study|Withdrawal by Subject|7|||
124943037|NCT03070392|449419802|FG001|Overall Study|Withdrawal by Subject|0|||
124943038|NCT03070392|449419803|FG002|Overall Study|Withdrawal by Subject|0|||
124943039|NCT03070392|449419804|FG003|Overall Study|Withdrawal by Subject|3|||
124943040|NCT03070392|449419801|FG000|Overall Study|Physician Decision|1|||
124943041|NCT03070392|449419802|FG001|Overall Study|Physician Decision|0|||
124943042|NCT03070392|449419803|FG002|Overall Study|Physician Decision|0|||
124943043|NCT03070392|449419804|FG003|Overall Study|Physician Decision|2|||
124943044|NCT03070392|449419801|FG000|Overall Study|Progressive Disease|154|||
124943045|NCT03070392|449419802|FG001|Overall Study|Progressive Disease|6|||
124943046|NCT03070392|449419803|FG002|Overall Study|Progressive Disease|2|||
124943047|NCT03070392|449419804|FG003|Overall Study|Progressive Disease|70|||
124943048|NCT03070392|449419801|FG000|Overall Study|Adverse Event|6|||
124943049|NCT03070392|449419802|FG001|Overall Study|Adverse Event|1|||
125122968|NCT04634409|450074219|FG015|Overall Study|Adverse Event|0|||
125122969|NCT04634409|450074220|FG016|Overall Study|Adverse Event|0|||
125122970|NCT04634409|450074221|FG017|Overall Study|Adverse Event|0|||
125122971|NCT04634409|450074222|FG018|Overall Study|Adverse Event|0|||
125122972|NCT04634409|450074223|FG019|Overall Study|Adverse Event|0|||
125122973|NCT04634409|450074224|FG020|Overall Study|Adverse Event|0|||
125122974|NCT04634409|450074225|FG021|Overall Study|Adverse Event|0|||
125122975|NCT04634409|450074226|FG022|Overall Study|Adverse Event|0|||
125122976|NCT04634409|450074227|FG023|Overall Study|Adverse Event|0|||
125122977|NCT04634409|450074228|FG024|Overall Study|Adverse Event|0|||
125122978|NCT04634409|450074229|FG025|Overall Study|Adverse Event|0|||
125122979|NCT04634409|450074230|FG026|Overall Study|Adverse Event|0|||
125122980|NCT04634409|450074204|FG000|Overall Study|Lost to Follow-up|3|||
125122981|NCT04634409|450074205|FG001|Overall Study|Lost to Follow-up|1|||
125122982|NCT04634409|450074206|FG002|Overall Study|Lost to Follow-up|1|||
125122983|NCT04634409|450074207|FG003|Overall Study|Lost to Follow-up|3|||
125122984|NCT04634409|450074208|FG004|Overall Study|Lost to Follow-up|1|||
125122985|NCT04634409|450074209|FG005|Overall Study|Lost to Follow-up|1|||
125122986|NCT04634409|450074210|FG006|Overall Study|Lost to Follow-up|1|||
125122987|NCT04634409|450074211|FG007|Overall Study|Lost to Follow-up|3|||
125122988|NCT04634409|450074212|FG008|Overall Study|Lost to Follow-up|3|||
125122989|NCT04634409|450074213|FG009|Overall Study|Lost to Follow-up|11|||
125122990|NCT04634409|450074214|FG010|Overall Study|Lost to Follow-up|8|||
125122991|NCT04634409|450074215|FG011|Overall Study|Lost to Follow-up|15|||
124943050|NCT03070392|449419803|FG002|Overall Study|Adverse Event|1|||
125122992|NCT04634409|450074216|FG012|Overall Study|Lost to Follow-up|3|||
125122993|NCT04634409|450074217|FG013|Overall Study|Lost to Follow-up|2|||
125122994|NCT04634409|450074218|FG014|Overall Study|Lost to Follow-up|7|||
124943051|NCT03070392|449419804|FG003|Overall Study|Adverse Event|3|||
124943052|NCT03070392|449419801|FG000|Overall Study|Alternate anticancer treatment|1|||
124943053|NCT03070392|449419802|FG001|Overall Study|Alternate anticancer treatment|0|||
124943054|NCT03070392|449419803|FG002|Overall Study|Alternate anticancer treatment|0|||
124943055|NCT03070392|449419804|FG003|Overall Study|Alternate anticancer treatment|1|||
124943056|NCT03070392|449419801|FG000|Overall Study|Ongoing|73|||
124943057|NCT03070392|449419802|FG001|Overall Study|Ongoing|0|||
124943058|NCT03070392|449419803|FG002|Overall Study|Ongoing|0|||
124943059|NCT03070392|449419804|FG003|Overall Study|Ongoing|11|||
125122995|NCT04634409|450074219|FG015|Overall Study|Lost to Follow-up|0|||
125122996|NCT04634409|450074220|FG016|Overall Study|Lost to Follow-up|0|||
125122997|NCT04634409|450074221|FG017|Overall Study|Lost to Follow-up|0|||
125122998|NCT04634409|450074222|FG018|Overall Study|Lost to Follow-up|0|||
125122999|NCT04634409|450074223|FG019|Overall Study|Lost to Follow-up|0|||
125123000|NCT04634409|450074224|FG020|Overall Study|Lost to Follow-up|0|||
125028153|NCT02058147|449725654|FG000|Overall Study|Randomized but not treated|0|||
125028154|NCT02058147|449725655|FG001|Overall Study|Randomized but not treated|0|||
125028155|NCT02058147|449725656|FG002|Overall Study|Randomized but not treated|1|||
125028156|NCT02058147|449725654|FG000|Overall Study|Adverse Event|12|||
125028157|NCT02058147|449725655|FG001|Overall Study|Adverse Event|9|||
125028158|NCT02058147|449725656|FG002|Overall Study|Adverse Event|21|||
125028159|NCT02058147|449725654|FG000|Overall Study|Lack of Efficacy|1|||
125028160|NCT02058147|449725655|FG001|Overall Study|Lack of Efficacy|0|||
125028161|NCT02058147|449725656|FG002|Overall Study|Lack of Efficacy|3|||
125028162|NCT02058147|449725654|FG000|Overall Study|Poor compliance to protocol|8|||
125028163|NCT02058147|449725655|FG001|Overall Study|Poor compliance to protocol|9|||
125028164|NCT02058147|449725656|FG002|Overall Study|Poor compliance to protocol|4|||
125028165|NCT02058147|449725654|FG000|Overall Study|Other than specified|8|||
125028166|NCT02058147|449725655|FG001|Overall Study|Other than specified|9|||
125028167|NCT02058147|449725656|FG002|Overall Study|Other than specified|0|||
125028168|NCT02154425|449725659|FG000|Screening Period|Adverse Event|1|||
125028169|NCT02908516|449725660|FG000|Overall Study|Study Terminated|3|||
125028170|NCT02908516|449725661|FG001|Overall Study|Study Terminated|3|||
125028171|NCT01162421|449725662|FG000|Overall Study|Did not receive study drug|2|||
125028172|NCT01162421|449725663|FG001|Overall Study|Did not receive study drug|1|||
125028173|NCT01162421|449725662|FG000|Overall Study|Adverse Event|2|||
125028174|NCT01162421|449725663|FG001|Overall Study|Adverse Event|5|||
125028175|NCT01162421|449725662|FG000|Overall Study|Lost to Follow-up|0|||
125028176|NCT01162421|449725663|FG001|Overall Study|Lost to Follow-up|2|||
125028177|NCT01162421|449725662|FG000|Overall Study|Lack of Efficacy|2|||
125028178|NCT01162421|449725663|FG001|Overall Study|Lack of Efficacy|2|||
125028179|NCT01162421|449725662|FG000|Overall Study|Other|2|||
125028180|NCT01162421|449725663|FG001|Overall Study|Other|3|||
125028181|NCT02867761|449725669|FG000|Overall Study|Participant withdrawn by investigator|0|||
125028182|NCT02867761|449725670|FG001|Overall Study|Participant withdrawn by investigator|1|||
124943060|NCT02972034|449419805|FG000|Overall Study|Death|11|||
124943061|NCT02972034|449419806|FG001|Overall Study|Death|1|||
124943062|NCT02972034|449419807|FG002|Overall Study|Death|3|||
124943063|NCT02972034|449419808|FG003|Overall Study|Death|3|||
124943064|NCT02972034|449419809|FG004|Overall Study|Death|2|||
124943065|NCT02972034|449419810|FG005|Overall Study|Death|2|||
124943066|NCT02972034|449419811|FG006|Overall Study|Death|3|||
124943067|NCT02972034|449419812|FG007|Overall Study|Death|4|||
124943068|NCT02972034|449419813|FG008|Overall Study|Death|8|||
124943069|NCT02972034|449419814|FG009|Overall Study|Death|11|||
124943070|NCT02972034|449419815|FG010|Overall Study|Death|3|||
124943071|NCT02972034|449419816|FG011|Overall Study|Death|2|||
124943072|NCT02972034|449419817|FG012|Overall Study|Death|11|||
124943073|NCT02972034|449419818|FG013|Overall Study|Death|10|||
124943074|NCT02972034|449419819|FG014|Overall Study|Death|9|||
124943075|NCT02972034|449419805|FG000|Overall Study|Lost to Follow-up|0|||
124943076|NCT02972034|449419806|FG001|Overall Study|Lost to Follow-up|0|||
124943077|NCT02972034|449419807|FG002|Overall Study|Lost to Follow-up|0|||
124943078|NCT02972034|449419808|FG003|Overall Study|Lost to Follow-up|0|||
124943079|NCT02972034|449419809|FG004|Overall Study|Lost to Follow-up|1|||
124943080|NCT02972034|449419810|FG005|Overall Study|Lost to Follow-up|0|||
124943081|NCT02972034|449419811|FG006|Overall Study|Lost to Follow-up|0|||
124943082|NCT02972034|449419812|FG007|Overall Study|Lost to Follow-up|1|||
124943083|NCT02972034|449419813|FG008|Overall Study|Lost to Follow-up|0|||
124943084|NCT02972034|449419814|FG009|Overall Study|Lost to Follow-up|0|||
124943085|NCT02972034|449419815|FG010|Overall Study|Lost to Follow-up|0|||
124943086|NCT02972034|449419816|FG011|Overall Study|Lost to Follow-up|0|||
124943087|NCT02972034|449419817|FG012|Overall Study|Lost to Follow-up|0|||
124943088|NCT02972034|449419818|FG013|Overall Study|Lost to Follow-up|0|||
124943089|NCT02972034|449419819|FG014|Overall Study|Lost to Follow-up|1|||
124943090|NCT02972034|449419805|FG000|Overall Study|Physician Decision|0|||
124943091|NCT02972034|449419806|FG001|Overall Study|Physician Decision|0|||
124943092|NCT02972034|449419807|FG002|Overall Study|Physician Decision|0|||
124943093|NCT02972034|449419808|FG003|Overall Study|Physician Decision|0|||
124943094|NCT02972034|449419809|FG004|Overall Study|Physician Decision|0|||
124943095|NCT02972034|449419810|FG005|Overall Study|Physician Decision|0|||
124943096|NCT02972034|449419811|FG006|Overall Study|Physician Decision|0|||
124943097|NCT02972034|449419812|FG007|Overall Study|Physician Decision|1|||
124943098|NCT02972034|449419813|FG008|Overall Study|Physician Decision|0|||
125028183|NCT02867761|449725669|FG000|Overall Study|Lost to Follow-up|25|||
125028184|NCT02867761|449725670|FG001|Overall Study|Lost to Follow-up|18|||
125028185|NCT02867761|449725669|FG000|Overall Study|Unable to complete protocol|3|||
125028186|NCT02867761|449725670|FG001|Overall Study|Unable to complete protocol|7|||
124943099|NCT02972034|449419814|FG009|Overall Study|Physician Decision|0|||
124943100|NCT02972034|449419815|FG010|Overall Study|Physician Decision|1|||
124943101|NCT02972034|449419816|FG011|Overall Study|Physician Decision|0|||
124943102|NCT02972034|449419817|FG012|Overall Study|Physician Decision|0|||
124943103|NCT02972034|449419818|FG013|Overall Study|Physician Decision|0|||
124943104|NCT02972034|449419819|FG014|Overall Study|Physician Decision|0|||
125028187|NCT04506294|449725671|FG000|Overall Study|Lost to Follow-up|70|||
125028188|NCT04506294|449725672|FG001|Overall Study|Lost to Follow-up|20|||
125028189|NCT04506294|449725671|FG000|Overall Study|Withdrawal by Subject|16|||
125028190|NCT04506294|449725672|FG001|Overall Study|Withdrawal by Subject|2|||
125028191|NCT01931059|449725673|FG000|Day 1|Pregnancy|0|||
125028192|NCT01931059|449725674|FG001|Day 1|Pregnancy|1|||
125028193|NCT01931059|449725673|FG000|Day3|Lost to Follow-up|1|||
125028194|NCT01931059|449725674|FG001|Day3|Lost to Follow-up|0|||
125028195|NCT00578643|449725675|FG000|Overall Study|Death|1|||
125028196|NCT00578643|449725675|FG000|Overall Study|Lost to Follow-up|1|||
125028197|NCT04698629|449725676|FG000|Overall Study|Adverse Event|1|||
125028198|NCT03641560|449725677|FG000|Overall Study|Withdrawal by Subject|6|||
125028199|NCT03641560|449725677|FG000|Overall Study|Progressive disease|40|||
125028200|NCT03641560|449725677|FG000|Overall Study|Death|6|||
125028201|NCT05847686|449727459|FG000|Overall Study|Withdrawal by Subject|3|||
125028202|NCT00352534|449727461|FG000|Initial Staging|Ineligible|8|||
125028203|NCT00352534|449727462|FG001|Initial Staging|Ineligible|9|||
125028204|NCT00352534|449727463|FG002|Initial Staging|Ineligible|0|||
125028205|NCT00352534|449727464|FG003|Initial Staging|Ineligible|0|||
125028206|NCT00352534|449727465|FG004|Initial Staging|Ineligible|0|||
125028207|NCT00352534|449727466|FG005|Initial Staging|Ineligible|0|||
125028208|NCT00352534|449727467|FG006|Initial Staging|Ineligible|0|||
125123001|NCT04634409|450074225|FG021|Overall Study|Lost to Follow-up|0|||
125123002|NCT04634409|450074226|FG022|Overall Study|Lost to Follow-up|0|||
124943105|NCT02972034|449419805|FG000|Overall Study|Sponsor Decision|0|||
124943106|NCT02972034|449419806|FG001|Overall Study|Sponsor Decision|0|||
124943107|NCT02972034|449419807|FG002|Overall Study|Sponsor Decision|0|||
124943108|NCT02972034|449419808|FG003|Overall Study|Sponsor Decision|1|||
124943109|NCT02972034|449419809|FG004|Overall Study|Sponsor Decision|0|||
124943110|NCT02972034|449419810|FG005|Overall Study|Sponsor Decision|0|||
124943111|NCT02972034|449419811|FG006|Overall Study|Sponsor Decision|1|||
124943112|NCT02972034|449419812|FG007|Overall Study|Sponsor Decision|1|||
124943113|NCT02972034|449419813|FG008|Overall Study|Sponsor Decision|1|||
124943114|NCT02972034|449419814|FG009|Overall Study|Sponsor Decision|2|||
124943115|NCT02972034|449419815|FG010|Overall Study|Sponsor Decision|2|||
124943116|NCT02972034|449419816|FG011|Overall Study|Sponsor Decision|0|||
124943117|NCT02972034|449419817|FG012|Overall Study|Sponsor Decision|1|||
124943118|NCT02972034|449419818|FG013|Overall Study|Sponsor Decision|0|||
125028209|NCT00352534|449727461|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
125028210|NCT00352534|449727462|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
125028211|NCT00352534|449727463|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
125028212|NCT00352534|449727464|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
125123003|NCT04634409|450074227|FG023|Overall Study|Lost to Follow-up|0|||
125123004|NCT04634409|450074228|FG024|Overall Study|Lost to Follow-up|0|||
125123005|NCT04634409|450074229|FG025|Overall Study|Lost to Follow-up|0|||
125123006|NCT04634409|450074230|FG026|Overall Study|Lost to Follow-up|0|||
125123007|NCT04634409|450074204|FG000|Overall Study|Withdrawal by Subject|3|||
125123008|NCT04634409|450074205|FG001|Overall Study|Withdrawal by Subject|1|||
125123009|NCT04634409|450074206|FG002|Overall Study|Withdrawal by Subject|6|||
125123010|NCT04634409|450074207|FG003|Overall Study|Withdrawal by Subject|4|||
125123011|NCT04634409|450074208|FG004|Overall Study|Withdrawal by Subject|2|||
125123012|NCT04634409|450074209|FG005|Overall Study|Withdrawal by Subject|0|||
125123013|NCT04634409|450074210|FG006|Overall Study|Withdrawal by Subject|0|||
125123014|NCT04634409|450074211|FG007|Overall Study|Withdrawal by Subject|2|||
125123015|NCT04634409|450074212|FG008|Overall Study|Withdrawal by Subject|3|||
125123016|NCT04634409|450074213|FG009|Overall Study|Withdrawal by Subject|2|||
125123017|NCT04634409|450074214|FG010|Overall Study|Withdrawal by Subject|3|||
125123018|NCT04634409|450074215|FG011|Overall Study|Withdrawal by Subject|2|||
125123019|NCT04634409|450074216|FG012|Overall Study|Withdrawal by Subject|2|||
125028213|NCT00352534|449727465|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
124943119|NCT02972034|449419819|FG014|Overall Study|Sponsor Decision|1|||
124943120|NCT02972034|449419805|FG000|Overall Study|Withdrawal by Subject|3|||
124943121|NCT02972034|449419806|FG001|Overall Study|Withdrawal by Subject|0|||
124943122|NCT02972034|449419807|FG002|Overall Study|Withdrawal by Subject|0|||
125028214|NCT00352534|449727466|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
125028215|NCT00352534|449727467|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
125028216|NCT00352534|449727461|FG000|Final Risk Group Assignment|Physician Decision|0|||
125123020|NCT04634409|450074217|FG013|Overall Study|Withdrawal by Subject|1|||
125123021|NCT04634409|450074218|FG014|Overall Study|Withdrawal by Subject|5|||
125123022|NCT04634409|450074219|FG015|Overall Study|Withdrawal by Subject|0|||
125123023|NCT04634409|450074220|FG016|Overall Study|Withdrawal by Subject|0|||
124943123|NCT02972034|449419808|FG003|Overall Study|Withdrawal by Subject|0|||
124943124|NCT02972034|449419809|FG004|Overall Study|Withdrawal by Subject|1|||
125028217|NCT00352534|449727462|FG001|Final Risk Group Assignment|Physician Decision|0|||
125123024|NCT04634409|450074221|FG017|Overall Study|Withdrawal by Subject|1|||
124943125|NCT02972034|449419810|FG005|Overall Study|Withdrawal by Subject|1|||
124943126|NCT02972034|449419811|FG006|Overall Study|Withdrawal by Subject|0|||
124943127|NCT02972034|449419812|FG007|Overall Study|Withdrawal by Subject|0|||
124943128|NCT02972034|449419813|FG008|Overall Study|Withdrawal by Subject|1|||
124943129|NCT02972034|449419814|FG009|Overall Study|Withdrawal by Subject|1|||
124943130|NCT02972034|449419815|FG010|Overall Study|Withdrawal by Subject|2|||
124943131|NCT02972034|449419816|FG011|Overall Study|Withdrawal by Subject|1|||
124943132|NCT02972034|449419817|FG012|Overall Study|Withdrawal by Subject|1|||
124943133|NCT02972034|449419818|FG013|Overall Study|Withdrawal by Subject|1|||
124943134|NCT02972034|449419819|FG014|Overall Study|Withdrawal by Subject|0|||
124943135|NCT02972034|449419805|FG000|Overall Study|Screen Failure|0|||
124943136|NCT02972034|449419806|FG001|Overall Study|Screen Failure|0|||
124943137|NCT02972034|449419807|FG002|Overall Study|Screen Failure|0|||
124943138|NCT02972034|449419808|FG003|Overall Study|Screen Failure|0|||
124943139|NCT02972034|449419809|FG004|Overall Study|Screen Failure|0|||
124943140|NCT02972034|449419810|FG005|Overall Study|Screen Failure|0|||
124943141|NCT02972034|449419811|FG006|Overall Study|Screen Failure|0|||
124943142|NCT02972034|449419812|FG007|Overall Study|Screen Failure|0|||
124943143|NCT02972034|449419813|FG008|Overall Study|Screen Failure|0|||
124943144|NCT02972034|449419814|FG009|Overall Study|Screen Failure|0|||
124943145|NCT02972034|449419815|FG010|Overall Study|Screen Failure|0|||
124943146|NCT02972034|449419816|FG011|Overall Study|Screen Failure|0|||
124943147|NCT02972034|449419817|FG012|Overall Study|Screen Failure|1|||
124943148|NCT02972034|449419818|FG013|Overall Study|Screen Failure|0|||
124943149|NCT02972034|449419819|FG014|Overall Study|Screen Failure|0|||
124943150|NCT03861052|449419820|FG000|Overall Study|Adverse Event|1|||
124943151|NCT03861052|449419821|FG001|Overall Study|Adverse Event|1|||
124943152|NCT03861052|449419822|FG002|Overall Study|Adverse Event|2|||
124943153|NCT03861052|449419823|FG003|Overall Study|Adverse Event|4|||
124943154|NCT03861052|449419820|FG000|Overall Study|Lost to Follow-up|0|||
124943155|NCT03861052|449419821|FG001|Overall Study|Lost to Follow-up|0|||
124943156|NCT03861052|449419822|FG002|Overall Study|Lost to Follow-up|0|||
124943157|NCT03861052|449419823|FG003|Overall Study|Lost to Follow-up|1|||
124943158|NCT03861052|449419820|FG000|Overall Study|Physician Decision|0|||
124943159|NCT03861052|449419821|FG001|Overall Study|Physician Decision|1|||
124943160|NCT03861052|449419822|FG002|Overall Study|Physician Decision|0|||
124943161|NCT03861052|449419823|FG003|Overall Study|Physician Decision|0|||
124943162|NCT03861052|449419820|FG000|Overall Study|Withdrawal by Subject|2|||
124943163|NCT03861052|449419821|FG001|Overall Study|Withdrawal by Subject|5|||
124943164|NCT03861052|449419822|FG002|Overall Study|Withdrawal by Subject|3|||
124943165|NCT03861052|449419823|FG003|Overall Study|Withdrawal by Subject|0|||
124943166|NCT03861052|449419820|FG000|Overall Study|Relocation to other city|1|||
124943167|NCT03861052|449419821|FG001|Overall Study|Relocation to other city|0|||
124943168|NCT03861052|449419822|FG002|Overall Study|Relocation to other city|0|||
124943169|NCT03861052|449419823|FG003|Overall Study|Relocation to other city|0|||
124943170|NCT03823703|449419824|FG000|Overall Study|Sponsor request|0|||
124943171|NCT03823703|449419825|FG001|Overall Study|Sponsor request|3|||
124943172|NCT03823703|449419826|FG002|Overall Study|Sponsor request|4|||
124943173|NCT03823703|449419824|FG000|Overall Study|Adverse Event|3|||
125123025|NCT04634409|450074222|FG018|Overall Study|Withdrawal by Subject|0|||
124943174|NCT03823703|449419825|FG001|Overall Study|Adverse Event|1|||
124943175|NCT03823703|449419826|FG002|Overall Study|Adverse Event|0|||
124943176|NCT03823703|449419824|FG000|Overall Study|Withdrawal by Subject|0|||
124943177|NCT03823703|449419825|FG001|Overall Study|Withdrawal by Subject|1|||
124943178|NCT03823703|449419826|FG002|Overall Study|Withdrawal by Subject|0|||
125214136|NCT02131233|450411238|FG000|Overall Study|Lack of Efficacy|6|||
124943179|NCT03137459|449419827|FG000|2-month Assessment|Withdrawal by Subject|13|||
124943180|NCT03137459|449419828|FG001|2-month Assessment|Withdrawal by Subject|3|||
124943181|NCT03137459|449419827|FG000|2-month Assessment|Unable to reach|42|||
124943182|NCT03137459|449419828|FG001|2-month Assessment|Unable to reach|32|||
124943183|NCT03137459|449419827|FG000|2-month Assessment|Refused assessment|7|||
124943184|NCT03137459|449419828|FG001|2-month Assessment|Refused assessment|5|||
124943185|NCT03137459|449419827|FG000|2-month Assessment|Acutely ill|6|||
124943186|NCT03137459|449419828|FG001|2-month Assessment|Acutely ill|2|||
124943187|NCT03137459|449419827|FG000|4-month Assessment|Death|4|||
124943188|NCT03137459|449419828|FG001|4-month Assessment|Death|2|||
124943189|NCT03137459|449419827|FG000|4-month Assessment|Withdrawal by Subject|4|||
124943190|NCT03137459|449419828|FG001|4-month Assessment|Withdrawal by Subject|2|||
124943191|NCT03137459|449419827|FG000|4-month Assessment|Unable to reach|44|||
124943192|NCT03137459|449419828|FG001|4-month Assessment|Unable to reach|29|||
124943193|NCT03137459|449419827|FG000|4-month Assessment|Refused assessment|24|||
124943194|NCT03137459|449419828|FG001|4-month Assessment|Refused assessment|10|||
124943195|NCT03137459|449419827|FG000|4-month Assessment|Acutely ill|2|||
124943196|NCT03137459|449419828|FG001|4-month Assessment|Acutely ill|3|||
124943197|NCT03137459|449419827|FG000|6-months|Lost to Follow-up|14|||
124943198|NCT03137459|449419828|FG001|6-months|Lost to Follow-up|11|||
124943199|NCT03137459|449419827|FG000|6-months|Death|0|||
124943200|NCT03137459|449419828|FG001|6-months|Death|2|||
124943201|NCT03137459|449419827|FG000|6-months|Refused assessment|6|||
124943202|NCT03137459|449419828|FG001|6-months|Refused assessment|3|||
124943203|NCT03137459|449419827|FG000|6-months|Acutely ill|1|||
124943204|NCT03137459|449419828|FG001|6-months|Acutely ill|1|||
124943205|NCT01970878|449419830|FG000|Overall Study|Withdrawal by Subject|11|||
124943206|NCT01970878|449419831|FG001|Overall Study|Withdrawal by Subject|10|||
124943207|NCT01970878|449419832|FG002|Overall Study|Withdrawal by Subject|14|||
124943208|NCT01970878|449419833|FG003|Overall Study|Withdrawal by Subject|7|||
124943209|NCT01970878|449419830|FG000|Overall Study|Lost to Follow-up|1|||
124943210|NCT01970878|449419831|FG001|Overall Study|Lost to Follow-up|3|||
124943211|NCT01970878|449419832|FG002|Overall Study|Lost to Follow-up|2|||
124943212|NCT01970878|449419833|FG003|Overall Study|Lost to Follow-up|4|||
124943213|NCT01970878|449419830|FG000|Overall Study|Administrative Reasons|1|||
124943214|NCT01970878|449419831|FG001|Overall Study|Administrative Reasons|0|||
124943215|NCT01970878|449419832|FG002|Overall Study|Administrative Reasons|0|||
124943216|NCT01970878|449419833|FG003|Overall Study|Administrative Reasons|4|||
124943217|NCT01970878|449419830|FG000|Overall Study|Lack of Efficacy|2|||
124943218|NCT01970878|449419831|FG001|Overall Study|Lack of Efficacy|1|||
124943219|NCT01970878|449419832|FG002|Overall Study|Lack of Efficacy|2|||
124943220|NCT01970878|449419833|FG003|Overall Study|Lack of Efficacy|0|||
124943221|NCT01970878|449419830|FG000|Overall Study|Adverse Event|12|||
124943222|NCT01970878|449419831|FG001|Overall Study|Adverse Event|7|||
124943223|NCT01970878|449419832|FG002|Overall Study|Adverse Event|4|||
124943224|NCT01970878|449419833|FG003|Overall Study|Adverse Event|3|||
124943225|NCT01970878|449419830|FG000|Overall Study|Protocol Specified Criteria|10|||
124943226|NCT01970878|449419831|FG001|Overall Study|Protocol Specified Criteria|4|||
124943227|NCT01970878|449419832|FG002|Overall Study|Protocol Specified Criteria|3|||
124943228|NCT01970878|449419833|FG003|Overall Study|Protocol Specified Criteria|6|||
124943229|NCT01970878|449419830|FG000|Overall Study|Physician Decision|0|||
124943230|NCT01970878|449419831|FG001|Overall Study|Physician Decision|1|||
124943231|NCT01970878|449419832|FG002|Overall Study|Physician Decision|1|||
124943232|NCT01970878|449419833|FG003|Overall Study|Physician Decision|0|||
124943233|NCT01970878|449419830|FG000|Overall Study|No Completion Status|0|||
124943234|NCT01970878|449419831|FG001|Overall Study|No Completion Status|1|||
124943235|NCT01970878|449419832|FG002|Overall Study|No Completion Status|0|||
124943236|NCT01970878|449419833|FG003|Overall Study|No Completion Status|0|||
124943237|NCT00925548|449419834|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
124943238|NCT00925548|449419835|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
124943239|NCT04921358|449419836|FG000|Overall Study|Withdrawal by Subject|6|||
124943240|NCT04921358|449419837|FG001|Overall Study|Withdrawal by Subject|13|||
124943241|NCT04921358|449419836|FG000|Overall Study|Lost to Follow-up|3|||
124943242|NCT04921358|449419837|FG001|Overall Study|Lost to Follow-up|6|||
124943243|NCT04921358|449419836|FG000|Overall Study|Study Terminated by Sponsor|86|||
124943244|NCT04921358|449419837|FG001|Overall Study|Study Terminated by Sponsor|89|||
124943245|NCT04921358|449419836|FG000|Overall Study|Death|92|||
124943246|NCT04921358|449419837|FG001|Overall Study|Death|82|||
124943247|NCT02278796|449419838|FG000|Overall Study|Death|2|||
124943248|NCT02278796|449419839|FG001|Overall Study|Death|3|||
125123026|NCT04634409|450074223|FG019|Overall Study|Withdrawal by Subject|0|||
125123027|NCT04634409|450074224|FG020|Overall Study|Withdrawal by Subject|0|||
125123028|NCT04634409|450074225|FG021|Overall Study|Withdrawal by Subject|0|||
125123029|NCT04634409|450074226|FG022|Overall Study|Withdrawal by Subject|0|||
125123030|NCT04634409|450074227|FG023|Overall Study|Withdrawal by Subject|1|||
125123031|NCT04634409|450074228|FG024|Overall Study|Withdrawal by Subject|0|||
125123032|NCT04634409|450074229|FG025|Overall Study|Withdrawal by Subject|0|||
125123033|NCT04634409|450074230|FG026|Overall Study|Withdrawal by Subject|0|||
125123034|NCT04634409|450074204|FG000|Overall Study|Other - As reported by Investigator|1|||
124943249|NCT04926857|449419840|FG000|Overall Study|Withdrawal by Subject|40|||
124943250|NCT04926857|449419840|FG000|Overall Study|Death|9|||
124943251|NCT04926857|449419840|FG000|Overall Study|Study product no longer in use|44|||
124943252|NCT04926857|449419840|FG000|Overall Study|Inadequate data to address primary objective|16|||
124943253|NCT02372799|449419845|FG000|Treatment Period|Adverse Event|3|||
124943254|NCT02372799|449419846|FG001|Treatment Period|Adverse Event|10|||
124943255|NCT02372799|449419847|FG002|Treatment Period|Adverse Event|6|||
124943256|NCT02372799|449419845|FG000|Treatment Period|Insufficient therapeutic response|2|||
124943257|NCT02372799|449419846|FG001|Treatment Period|Insufficient therapeutic response|2|||
124943258|NCT02372799|449419847|FG002|Treatment Period|Insufficient therapeutic response|0|||
124943259|NCT02372799|449419845|FG000|Treatment Period|Withdrawal by Subject|10|||
124943260|NCT02372799|449419846|FG001|Treatment Period|Withdrawal by Subject|10|||
124943261|NCT02372799|449419847|FG002|Treatment Period|Withdrawal by Subject|2|||
124943262|NCT02372799|449419845|FG000|Treatment Period|Lost to Follow-up|11|||
124943263|NCT02372799|449419846|FG001|Treatment Period|Lost to Follow-up|5|||
124943264|NCT02372799|449419847|FG002|Treatment Period|Lost to Follow-up|3|||
124943265|NCT02372799|449419845|FG000|Treatment Period|Protocol Violation|3|||
124943266|NCT02372799|449419846|FG001|Treatment Period|Protocol Violation|0|||
124943267|NCT02372799|449419847|FG002|Treatment Period|Protocol Violation|0|||
124943268|NCT02372799|449419845|FG000|Treatment Period|Non-compliance with study drug|4|||
124943269|NCT02372799|449419846|FG001|Treatment Period|Non-compliance with study drug|4|||
124943270|NCT02372799|449419847|FG002|Treatment Period|Non-compliance with study drug|4|||
124943271|NCT02372799|449419845|FG000|Treatment Period|Miscellaneous Reasons|1|||
124943272|NCT02372799|449419846|FG001|Treatment Period|Miscellaneous Reasons|1|||
124943273|NCT02372799|449419847|FG002|Treatment Period|Miscellaneous Reasons|0|||
124943274|NCT02372799|449419845|FG000|Down-taper Period|Lost to Follow-up|1|||
124943275|NCT02372799|449419846|FG001|Down-taper Period|Lost to Follow-up|2|||
124943276|NCT02372799|449419847|FG002|Down-taper Period|Lost to Follow-up|2|||
124943277|NCT02637063|449419849|FG000|Overall Study|Lost to Follow-up|3|||
124943278|NCT02637063|449419850|FG001|Overall Study|Lost to Follow-up|2|||
124943279|NCT02637063|449419851|FG002|Overall Study|Lost to Follow-up|3|||
124943280|NCT02637063|449419849|FG000|Overall Study|Withdrawal by Subject|2|||
124943281|NCT02637063|449419850|FG001|Overall Study|Withdrawal by Subject|2|||
124943282|NCT02637063|449419851|FG002|Overall Study|Withdrawal by Subject|3|||
124943283|NCT00491400|449419852|FG000|Overall Study|Withdrawal by Subject|5|||
124943284|NCT00491400|449419853|FG001|Overall Study|Withdrawal by Subject|4|||
124943285|NCT00747006|449419854|FG000|Overall Study|Adverse Event|1|||
124943286|NCT00747006|449419855|FG001|Overall Study|Adverse Event|0|||
124943287|NCT00747006|449419856|FG002|Overall Study|Adverse Event|0|||
124943288|NCT00747006|449419854|FG000|Overall Study|Lost to Follow-up|0|||
124943289|NCT00747006|449419855|FG001|Overall Study|Lost to Follow-up|1|||
124943290|NCT00747006|449419856|FG002|Overall Study|Lost to Follow-up|0|||
124943291|NCT00747006|449419854|FG000|Overall Study|Physician Decision|2|||
124943292|NCT00747006|449419855|FG001|Overall Study|Physician Decision|0|||
124943293|NCT00747006|449419856|FG002|Overall Study|Physician Decision|1|||
125123035|NCT04634409|450074205|FG001|Overall Study|Other - As reported by Investigator|0|||
125123036|NCT04634409|450074206|FG002|Overall Study|Other - As reported by Investigator|0|||
124943294|NCT00345046|449419861|FG000|Overall Study|Protocol Violation|1|||
124943295|NCT00345046|449419862|FG001|Overall Study|Protocol Violation|1|||
124943296|NCT00345046|449419863|FG002|Overall Study|Protocol Violation|2|||
124943297|NCT02824198|449419864|FG000|Overall Study|Non-compliance with the protocol|5|||
124943298|NCT02824198|449419865|FG001|Overall Study|Non-compliance with the protocol|1|||
124943299|NCT02824198|449419864|FG000|Overall Study|Lost to Follow-up|5|||
124943300|NCT02824198|449419865|FG001|Overall Study|Lost to Follow-up|2|||
124943301|NCT02824198|449419864|FG000|Overall Study|Withdrawal by Subject|5|||
124943302|NCT02824198|449419865|FG001|Overall Study|Withdrawal by Subject|0|||
124943303|NCT00562094|449419866|FG000|Overall Study|Lost to Follow-up|62|||
124943304|NCT03689946|449419869|FG000|Overall Study|Withdrawal by Subject|3|||
124943305|NCT03689946|449419869|FG000|Overall Study|Lost to Follow-up|3|||
124943306|NCT03689946|449419869|FG000|Overall Study|Data corruption|2|||
124943307|NCT01555138|449419870|FG000|Overall Study|Death|0|||
124943308|NCT01555138|449419871|FG001|Overall Study|Death|1|||
124943309|NCT01555138|449419870|FG000|Overall Study|Lost to Follow-up|1|||
124943310|NCT01555138|449419871|FG001|Overall Study|Lost to Follow-up|0|||
124943311|NCT01555138|449419870|FG000|Overall Study|Abnormal Lab reults|1|||
124943312|NCT01555138|449419871|FG001|Overall Study|Abnormal Lab reults|3|||
124943313|NCT01555138|449419870|FG000|Overall Study|Lack of Efficacy|2|||
124943314|NCT01555138|449419871|FG001|Overall Study|Lack of Efficacy|2|||
124943315|NCT01555138|449419870|FG000|Overall Study|Protocol Violation|5|||
124943316|NCT01555138|449419871|FG001|Overall Study|Protocol Violation|3|||
124943317|NCT01555138|449419870|FG000|Overall Study|Administrative problems|8|||
124943318|NCT01555138|449419871|FG001|Overall Study|Administrative problems|0|||
124943319|NCT01555138|449419870|FG000|Overall Study|Withdrawal by Subject|16|||
125123037|NCT04634409|450074207|FG003|Overall Study|Other - As reported by Investigator|0|||
125123038|NCT04634409|450074208|FG004|Overall Study|Other - As reported by Investigator|0|||
125123039|NCT04634409|450074209|FG005|Overall Study|Other - As reported by Investigator|0|||
125123040|NCT04634409|450074210|FG006|Overall Study|Other - As reported by Investigator|0|||
125123041|NCT04634409|450074211|FG007|Overall Study|Other - As reported by Investigator|6|||
125123042|NCT04634409|450074212|FG008|Overall Study|Other - As reported by Investigator|4|||
125123043|NCT04634409|450074213|FG009|Overall Study|Other - As reported by Investigator|0|||
125123044|NCT04634409|450074214|FG010|Overall Study|Other - As reported by Investigator|1|||
125123045|NCT04634409|450074215|FG011|Overall Study|Other - As reported by Investigator|2|||
125123046|NCT04634409|450074216|FG012|Overall Study|Other - As reported by Investigator|2|||
125123047|NCT04634409|450074217|FG013|Overall Study|Other - As reported by Investigator|1|||
125123048|NCT04634409|450074218|FG014|Overall Study|Other - As reported by Investigator|0|||
125123049|NCT04634409|450074219|FG015|Overall Study|Other - As reported by Investigator|0|||
125123050|NCT04634409|450074220|FG016|Overall Study|Other - As reported by Investigator|0|||
125123051|NCT04634409|450074221|FG017|Overall Study|Other - As reported by Investigator|0|||
125123052|NCT04634409|450074222|FG018|Overall Study|Other - As reported by Investigator|0|||
125123053|NCT04634409|450074223|FG019|Overall Study|Other - As reported by Investigator|0|||
125123054|NCT04634409|450074224|FG020|Overall Study|Other - As reported by Investigator|0|||
125123055|NCT04634409|450074225|FG021|Overall Study|Other - As reported by Investigator|0|||
125123056|NCT04634409|450074226|FG022|Overall Study|Other - As reported by Investigator|0|||
125123057|NCT04634409|450074227|FG023|Overall Study|Other - As reported by Investigator|0|||
125123058|NCT04634409|450074228|FG024|Overall Study|Other - As reported by Investigator|0|||
124943320|NCT01555138|449419871|FG001|Overall Study|Withdrawal by Subject|15|||
124943321|NCT01555138|449419870|FG000|Overall Study|Adverse Event|14|||
124943322|NCT01555138|449419871|FG001|Overall Study|Adverse Event|14|||
124943323|NCT01613417|449419872|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
124943324|NCT01613417|449419873|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
124943325|NCT02357966|449419876|FG000|Overall Study|Death|0|||
124943326|NCT02357966|449419877|FG001|Overall Study|Death|0|||
124943327|NCT02357966|449419878|FG002|Overall Study|Death|1|||
124943328|NCT02357966|449419879|FG003|Overall Study|Death|0|||
124943329|NCT02357966|449419880|FG004|Overall Study|Death|2|||
124943330|NCT02357966|449419881|FG005|Overall Study|Death|0|||
124943331|NCT02357966|449419876|FG000|Overall Study|Physician Decision|1|||
124943332|NCT02357966|449419877|FG001|Overall Study|Physician Decision|0|||
124943333|NCT02357966|449419878|FG002|Overall Study|Physician Decision|0|||
124943334|NCT02357966|449419879|FG003|Overall Study|Physician Decision|0|||
124943335|NCT02357966|449419880|FG004|Overall Study|Physician Decision|1|||
124943336|NCT02357966|449419881|FG005|Overall Study|Physician Decision|0|||
124943337|NCT00019604|449419882|FG000|Overall Study|Death|1|||
124943338|NCT00019604|449419882|FG000|Overall Study|Progressive disease|23|||
124943339|NCT00019604|449419882|FG000|Overall Study|Refused treatment|1|||
124943340|NCT00019604|449419882|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
124943341|NCT00019604|449419882|FG000|Overall Study|Going to have liver transplant|1|||
124943342|NCT00019604|449419882|FG000|Overall Study|Move to a different study|1|||
125123059|NCT04634409|450074229|FG025|Overall Study|Other - As reported by Investigator|0|||
124943343|NCT00019604|449419882|FG000|Overall Study|Non compliant on systemic CH|1|||
124943344|NCT00019604|449419882|FG000|Overall Study|Non compliant|1|||
124943345|NCT00019604|449419882|FG000|Overall Study|Resectable disease|1|||
124943346|NCT00019604|449419882|FG000|Overall Study|Started new chemo regimen|1|||
125123060|NCT04634409|450074230|FG026|Overall Study|Other - As reported by Investigator|0|||
125123061|NCT01402908|450075727|FG000|Overall Study|Withdrawal by Subject|30|||
125123062|NCT01402908|450075728|FG001|Overall Study|Withdrawal by Subject|17|||
125123063|NCT01402908|450075727|FG000|Overall Study|Lost to Follow-up|3|||
125123064|NCT01402908|450075728|FG001|Overall Study|Lost to Follow-up|1|||
125123065|NCT01402908|450075727|FG000|Overall Study|Physician Decision|1|||
125123066|NCT01402908|450075728|FG001|Overall Study|Physician Decision|0|||
125123067|NCT01739790|450075729|FG000|Overall Study|Early Trial Termination|2|||
125123068|NCT01739790|450075730|FG001|Overall Study|Early Trial Termination|4|||
125123069|NCT02581345|450075731|FG000|Part 1: up to Week 16|Adverse Event|3|||
125123070|NCT02581345|450075732|FG001|Part 1: up to Week 16|Adverse Event|8|||
125123071|NCT02581345|450075733|FG002|Part 1: up to Week 16|Adverse Event|0|||
125123072|NCT02581345|450075734|FG003|Part 1: up to Week 16|Adverse Event|0|||
125123073|NCT02581345|450075731|FG000|Part 1: up to Week 16|Physician Decision|2|||
125123074|NCT02581345|450075732|FG001|Part 1: up to Week 16|Physician Decision|4|||
125123075|NCT02581345|450075733|FG002|Part 1: up to Week 16|Physician Decision|0|||
125123076|NCT02581345|450075734|FG003|Part 1: up to Week 16|Physician Decision|0|||
125123077|NCT02581345|450075731|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
125123078|NCT02581345|450075732|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
125123079|NCT02581345|450075733|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
125123080|NCT02581345|450075734|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
125123081|NCT02581345|450075731|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
125123082|NCT02581345|450075732|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
125123083|NCT02581345|450075733|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
125123084|NCT02581345|450075734|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
125123085|NCT02581345|450075731|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
125123086|NCT02581345|450075732|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
125123087|NCT02581345|450075733|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
125123088|NCT02581345|450075734|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
125123089|NCT02581345|450075731|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
125123090|NCT02581345|450075732|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
125123091|NCT02581345|450075733|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
125123092|NCT02581345|450075734|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
125123093|NCT02581345|450075731|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
125123094|NCT02581345|450075732|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
125123095|NCT02581345|450075733|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
125123096|NCT02581345|450075734|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
125123097|NCT02581345|450075731|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
125123098|NCT02581345|450075732|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
125123099|NCT02581345|450075733|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
125123100|NCT02581345|450075734|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
125123101|NCT02581345|450075731|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
125123102|NCT02581345|450075732|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
125123103|NCT02581345|450075733|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
125123104|NCT02581345|450075734|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
125123105|NCT02581345|450075731|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
125123106|NCT02581345|450075732|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
125123107|NCT02581345|450075733|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
125123108|NCT02581345|450075734|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
125123109|NCT02581345|450075731|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
125123110|NCT02581345|450075732|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
125123111|NCT02581345|450075733|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
125123112|NCT02581345|450075734|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
125123113|NCT02581345|450075731|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
125123114|NCT02581345|450075732|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
125123115|NCT02581345|450075733|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
125123116|NCT02581345|450075734|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
125123117|NCT01244126|450075740|FG000|Overall Study|Protocol Violation|3|||
125123118|NCT01244126|450075741|FG001|Overall Study|Protocol Violation|3|||
125123119|NCT01244126|450075742|FG002|Overall Study|Protocol Violation|9|||
125123120|NCT01451762|450075743|FG000|Overall Study|Lost to Follow-up|3|||
125123121|NCT01451762|450075744|FG001|Overall Study|Lost to Follow-up|6|||
125123122|NCT01451762|450075745|FG002|Overall Study|Lost to Follow-up|6|||
125123123|NCT00863746|450075750|FG000|Treatment|Not treated|4|||
125123124|NCT00863746|450075751|FG001|Treatment|Not treated|2|||
125123125|NCT00863746|450075750|FG000|Treatment|Adverse Event|41|||
125123126|NCT00863746|450075751|FG001|Treatment|Adverse Event|16|||
125123127|NCT00863746|450075750|FG000|Treatment|non-compliant with study medication|4|||
125123128|NCT00863746|450075751|FG001|Treatment|non-compliant with study medication|0|||
125123129|NCT00863746|450075750|FG000|Treatment|Consent withdrawn|15|||
125123130|NCT00863746|450075751|FG001|Treatment|Consent withdrawn|14|||
125123131|NCT00863746|450075750|FG000|Treatment|Lost to Follow-up|1|||
125123132|NCT00863746|450075751|FG001|Treatment|Lost to Follow-up|0|||
125214137|NCT02131233|450411239|FG001|Overall Study|Lack of Efficacy|3|||
124943347|NCT00019604|449419882|FG000|Overall Study|Pt going to immunotherapy study|1|||
125214138|NCT02131233|450411238|FG000|Overall Study|Lost to Follow-up|14|||
125214139|NCT02131233|450411239|FG001|Overall Study|Lost to Follow-up|13|||
125214140|NCT02131233|450411238|FG000|Overall Study|Non-Compliance With Study Drug|8|||
125214141|NCT02131233|450411239|FG001|Overall Study|Non-Compliance With Study Drug|5|||
124943348|NCT00019604|449419882|FG000|Overall Study|Too much disease|1|||
124943349|NCT00019604|449419882|FG000|Overall Study|Unable to evaluate|1|||
124943350|NCT00019604|449419882|FG000|Overall Study|Details for other not available|4|||
124943351|NCT04608409|449419883|FG000|Overall Study|Physician Decision|1|||
124943352|NCT04608409|449419884|FG001|Overall Study|Physician Decision|1|||
125214142|NCT02131233|450411238|FG000|Overall Study|Physician Decision|7|||
125214143|NCT02131233|450411239|FG001|Overall Study|Physician Decision|0|||
125214144|NCT02131233|450411238|FG000|Overall Study|Pregnancy|4|||
125214145|NCT02131233|450411239|FG001|Overall Study|Pregnancy|0|||
125214146|NCT02131233|450411238|FG000|Overall Study|Withdrawal by Subject|18|||
125214147|NCT02131233|450411239|FG001|Overall Study|Withdrawal by Subject|11|||
125214148|NCT00790556|450411240|FG000|Treatment Period 1|Physician Decision|1|||
125214149|NCT00790556|450411241|FG001|Treatment Period 1|Physician Decision|0|||
125214150|NCT00790556|450411240|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125214151|NCT00790556|450411241|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125214152|NCT00217581|450411244|FG000|Overall Study|Withdrawal by Subject|1|||
125214153|NCT04399889|450411245|FG000|Overall Study|Death|5|||
124943353|NCT04608409|449419885|FG002|Overall Study|Physician Decision|2|||
124943354|NCT00599196|449419886|FG000|Overall Study|Lack of Efficacy|22|||
124943355|NCT00599196|449419886|FG000|Overall Study|Adverse Event|93|||
124943356|NCT00599196|449419886|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
124943357|NCT00599196|449419886|FG000|Overall Study|Subject withdrew consent|43|||
124943358|NCT00599196|449419886|FG000|Overall Study|Study ended per sponsor|197|||
124943359|NCT00599196|449419886|FG000|Overall Study|Lost to Follow-up|17|||
124943360|NCT00599196|449419886|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
124943361|NCT00599196|449419886|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
124943362|NCT00599196|449419886|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
124943363|NCT00599196|449419886|FG000|Overall Study|Other: Pt Moved To Australia|1|||
124943364|NCT00599196|449419886|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
124943365|NCT00599196|449419886|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
124943366|NCT04497415|449419904|FG000|Overall Study|Lost to Follow-up|43|||
124943367|NCT04497415|449419905|FG001|Overall Study|Lost to Follow-up|27|||
124943368|NCT00734578|449419908|FG000|Overall Study|Adverse Event|4|||
124943369|NCT00734578|449419909|FG001|Overall Study|Adverse Event|6|||
124943370|NCT00734578|449419910|FG002|Overall Study|Adverse Event|1|||
124943371|NCT00734578|449419908|FG000|Overall Study|Protocol Violation|8|||
124943372|NCT00734578|449419909|FG001|Overall Study|Protocol Violation|6|||
124943373|NCT00734578|449419910|FG002|Overall Study|Protocol Violation|3|||
124943374|NCT00734578|449419908|FG000|Overall Study|Withdrawal by Subject|7|||
124943375|NCT00734578|449419909|FG001|Overall Study|Withdrawal by Subject|8|||
124943376|NCT00734578|449419910|FG002|Overall Study|Withdrawal by Subject|11|||
124943377|NCT00734578|449419908|FG000|Overall Study|Lost to Follow-up|9|||
124943378|NCT00734578|449419909|FG001|Overall Study|Lost to Follow-up|3|||
124943379|NCT00734578|449419910|FG002|Overall Study|Lost to Follow-up|5|||
124943380|NCT00734578|449419908|FG000|Overall Study|Lack of Efficacy|3|||
124943381|NCT00734578|449419909|FG001|Overall Study|Lack of Efficacy|2|||
124943382|NCT00734578|449419910|FG002|Overall Study|Lack of Efficacy|5|||
124943383|NCT00734578|449419908|FG000|Overall Study|Randomized in error|1|||
124943384|NCT00734578|449419909|FG001|Overall Study|Randomized in error|0|||
124943385|NCT00734578|449419910|FG002|Overall Study|Randomized in error|0|||
124943386|NCT00734578|449419908|FG000|Overall Study|Exclusion criteria|1|||
124943387|NCT00734578|449419909|FG001|Overall Study|Exclusion criteria|0|||
124943388|NCT00734578|449419910|FG002|Overall Study|Exclusion criteria|0|||
124943389|NCT02085941|449419914|FG000|Overall Study|Lack of Efficacy|1|||
124943390|NCT02085941|449419915|FG001|Overall Study|Lack of Efficacy|0|||
124943391|NCT02085941|449419914|FG000|Overall Study|Death|6|||
124943392|NCT02085941|449419915|FG001|Overall Study|Death|1|||
124943393|NCT02085941|449419914|FG000|Overall Study|Lost to Follow-up|1|||
124943394|NCT02085941|449419915|FG001|Overall Study|Lost to Follow-up|0|||
124943395|NCT02085941|449419914|FG000|Overall Study|Physician Decision|0|||
124943396|NCT02085941|449419915|FG001|Overall Study|Physician Decision|2|||
124943397|NCT04652726|449419920|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
124943398|NCT04652726|449419921|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
124943399|NCT04652726|449419922|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
124943400|NCT04652726|449419920|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
124943401|NCT04652726|449419921|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
124943402|NCT04652726|449419922|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
124943403|NCT02157116|449419923|FG000|Overall Study|Withdrawal by Subject|4|||
124943404|NCT02157116|449419923|FG000|Overall Study|Physician Decision|3|||
124943405|NCT02157116|449419923|FG000|Overall Study|Failed Screening|2|||
124943406|NCT00093496|449419924|FG000|Overall Study|Protocol Violation|1|||
124943407|NCT00093496|449419925|FG001|Overall Study|Protocol Violation|3|||
124943408|NCT03274076|449419927|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
124943409|NCT03274076|449419928|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
124943410|NCT03274076|449419929|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
124943411|NCT03274076|449419930|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
124943412|NCT03274076|449419927|FG000|24 Weeks Open Label|Adverse Event|0|||
124943413|NCT03274076|449419928|FG001|24 Weeks Open Label|Adverse Event|0|||
124943414|NCT03274076|449419929|FG002|24 Weeks Open Label|Adverse Event|2|||
124943415|NCT03274076|449419930|FG003|24 Weeks Open Label|Adverse Event|0|||
124943416|NCT03274076|449419927|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
124943417|NCT03274076|449419928|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
124943418|NCT03274076|449419929|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
124943419|NCT03274076|449419930|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
124943420|NCT00975585|449419931|FG000|Overall Study|Adverse Event|0|||
124943421|NCT00975585|449419932|FG001|Overall Study|Adverse Event|4|||
124943422|NCT00975585|449419931|FG000|Overall Study|Lost to Follow-up|3|||
124943423|NCT00975585|449419932|FG001|Overall Study|Lost to Follow-up|5|||
124943424|NCT00975585|449419931|FG000|Overall Study|Withdrawal by Subject|2|||
124943425|NCT00975585|449419932|FG001|Overall Study|Withdrawal by Subject|1|||
124943426|NCT00975585|449419931|FG000|Overall Study|Lens issue|2|||
124943427|NCT00975585|449419932|FG001|Overall Study|Lens issue|2|||
124943428|NCT00795184|449419933|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
124943429|NCT00795184|449419934|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
124943430|NCT00205179|449419937|FG000|Overall Study|Death|0|||
124943431|NCT00205179|449419938|FG001|Overall Study|Death|2|||
124943432|NCT00205179|449419937|FG000|Overall Study|Physician Decision|1|||
124943433|NCT00205179|449419938|FG001|Overall Study|Physician Decision|1|||
124943434|NCT00205179|449419937|FG000|Overall Study|Adverse Event|1|||
124943435|NCT00205179|449419938|FG001|Overall Study|Adverse Event|1|||
124943436|NCT00586313|449419939|FG000|Overall Study|Lack of Efficacy|2|||
124943437|NCT02079649|449419940|FG000|Overall Study|Lost to Follow-up|0|||
124943438|NCT02079649|449419941|FG001|Overall Study|Lost to Follow-up|0|||
124943439|NCT02079649|449419942|FG002|Overall Study|Lost to Follow-up|0|||
124943440|NCT02079649|449419943|FG003|Overall Study|Lost to Follow-up|1|||
124943441|NCT02079649|449419940|FG000|Overall Study|Withdrawal by Subject|0|||
124943442|NCT02079649|449419941|FG001|Overall Study|Withdrawal by Subject|0|||
124943443|NCT02079649|449419942|FG002|Overall Study|Withdrawal by Subject|0|||
124943444|NCT02079649|449419943|FG003|Overall Study|Withdrawal by Subject|1|||
124943445|NCT02079649|449419940|FG000|Overall Study|Randomization error (prior to treatment)|1|||
124943446|NCT02079649|449419941|FG001|Overall Study|Randomization error (prior to treatment)|0|||
124943447|NCT02079649|449419942|FG002|Overall Study|Randomization error (prior to treatment)|1|||
124943448|NCT02079649|449419943|FG003|Overall Study|Randomization error (prior to treatment)|0|||
124943449|NCT00853580|449419965|FG000|Overall Study|Lost to Follow-up|3|||
124943450|NCT00853580|449419966|FG001|Overall Study|Lost to Follow-up|5|||
124943451|NCT00853580|449419965|FG000|Overall Study|Protocol Violation|2|||
124943452|NCT00853580|449419966|FG001|Overall Study|Protocol Violation|1|||
124943453|NCT00853580|449419965|FG000|Overall Study|Withdrawal by Subject|2|||
124943454|NCT00853580|449419966|FG001|Overall Study|Withdrawal by Subject|8|||
124943455|NCT00853580|449419965|FG000|Overall Study|Commenced contraindicated therapy|0|||
124943456|NCT00853580|449419966|FG001|Overall Study|Commenced contraindicated therapy|2|||
124943457|NCT01968967|449419969|FG000|Treatment Period|Other|22|||
124943458|NCT01968967|449419970|FG001|Treatment Period|Other|22|||
124943459|NCT01968967|449419971|FG002|Treatment Period|Other|0|||
124943460|NCT01968967|449419972|FG003|Treatment Period|Other|0|||
124943461|NCT01968967|449419973|FG004|Treatment Period|Other|0|||
124943462|NCT01968967|449419969|FG000|Treatment Period|Withdrawal by Subject|71|||
124943463|NCT01968967|449419970|FG001|Treatment Period|Withdrawal by Subject|61|||
124943464|NCT01968967|449419971|FG002|Treatment Period|Withdrawal by Subject|0|||
124943465|NCT01968967|449419972|FG003|Treatment Period|Withdrawal by Subject|0|||
124943466|NCT01968967|449419973|FG004|Treatment Period|Withdrawal by Subject|0|||
124943467|NCT01968967|449419969|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
124943468|NCT01968967|449419970|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
124943469|NCT01968967|449419971|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
124943470|NCT01968967|449419972|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
124943471|NCT01968967|449419973|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
124943472|NCT01968967|449419969|FG000|Treatment Period|Lost to Follow-up|26|||
124943473|NCT01968967|449419970|FG001|Treatment Period|Lost to Follow-up|31|||
124943474|NCT01968967|449419971|FG002|Treatment Period|Lost to Follow-up|0|||
124943475|NCT01968967|449419972|FG003|Treatment Period|Lost to Follow-up|0|||
124943476|NCT01968967|449419973|FG004|Treatment Period|Lost to Follow-up|0|||
124943477|NCT01968967|449419969|FG000|Treatment Period|Protocol Violation|1|||
124943478|NCT01968967|449419970|FG001|Treatment Period|Protocol Violation|2|||
124943479|NCT01968967|449419971|FG002|Treatment Period|Protocol Violation|0|||
124943480|NCT01968967|449419972|FG003|Treatment Period|Protocol Violation|0|||
124943481|NCT01968967|449419973|FG004|Treatment Period|Protocol Violation|0|||
124943482|NCT01968967|449419969|FG000|Treatment Period|Adverse Event|9|||
124943483|NCT01968967|449419970|FG001|Treatment Period|Adverse Event|8|||
125123133|NCT00863746|450075750|FG000|Treatment|Protocol Violation|5|||
125123134|NCT00863746|450075751|FG001|Treatment|Protocol Violation|3|||
125123135|NCT00863746|450075750|FG000|Treatment|Other|1|||
125123136|NCT00863746|450075751|FG001|Treatment|Other|0|||
125123137|NCT00863746|450075750|FG000|Survival Follow up|Death|244|||
125123138|NCT00863746|450075751|FG001|Survival Follow up|Death|271|||
125123139|NCT00863746|450075750|FG000|Survival Follow up|Lost to Follow-up|2|||
124943484|NCT01968967|449419971|FG002|Treatment Period|Adverse Event|0|||
124943485|NCT01968967|449419972|FG003|Treatment Period|Adverse Event|0|||
124943486|NCT01968967|449419973|FG004|Treatment Period|Adverse Event|0|||
124943487|NCT01968967|449419969|FG000|Treatment Period|Death|9|||
124943488|NCT01968967|449419970|FG001|Treatment Period|Death|2|||
124943489|NCT01968967|449419971|FG002|Treatment Period|Death|0|||
124943490|NCT01968967|449419972|FG003|Treatment Period|Death|0|||
125123140|NCT00863746|450075751|FG001|Survival Follow up|Lost to Follow-up|1|||
125123141|NCT00863746|450075750|FG000|Survival Follow up|Consent Withdrawn|7|||
125123142|NCT00863746|450075751|FG001|Survival Follow up|Consent Withdrawn|8|||
125123143|NCT00862979|450075757|FG000|Overall Study|Adverse Event|6|||
124943491|NCT01968967|449419973|FG004|Treatment Period|Death|0|||
124943492|NCT01968967|449419969|FG000|Treatment Period|Randomized Not Treated|6|||
124943493|NCT01968967|449419970|FG001|Treatment Period|Randomized Not Treated|5|||
124943494|NCT01968967|449419971|FG002|Treatment Period|Randomized Not Treated|0|||
125123144|NCT00862979|450075758|FG001|Overall Study|Adverse Event|3|||
125123145|NCT00862979|450075757|FG000|Overall Study|Protocol Violation|0|||
124943495|NCT01968967|449419972|FG003|Treatment Period|Randomized Not Treated|0|||
124943496|NCT01968967|449419973|FG004|Treatment Period|Randomized Not Treated|0|||
124943497|NCT01968967|449419969|FG000|Extension Period|Withdrew Consent|0|||
124943498|NCT01968967|449419970|FG001|Extension Period|Withdrew Consent|0|||
124943499|NCT01968967|449419971|FG002|Extension Period|Withdrew Consent|2|||
124943500|NCT01968967|449419972|FG003|Extension Period|Withdrew Consent|0|||
124943501|NCT01968967|449419973|FG004|Extension Period|Withdrew Consent|5|||
124943502|NCT01170208|449419974|FG000|Overall Study|Withdrawal by Subject|5|||
124943503|NCT01170208|449419975|FG001|Overall Study|Withdrawal by Subject|0|||
124943504|NCT01170208|449419976|FG002|Overall Study|Withdrawal by Subject|1|||
124943505|NCT01170208|449419974|FG000|Overall Study|Protocol Violation|1|||
125123146|NCT00862979|450075758|FG001|Overall Study|Protocol Violation|1|||
125123147|NCT00862979|450075757|FG000|Overall Study|Patient withdrew consent|2|||
125123148|NCT00862979|450075758|FG001|Overall Study|Patient withdrew consent|1|||
125123149|NCT00862979|450075757|FG000|Overall Study|Administrative problems|0|||
125123150|NCT00862979|450075758|FG001|Overall Study|Administrative problems|1|||
125123151|NCT00862979|450075757|FG000|Overall Study|Death|0|||
125123152|NCT00862979|450075758|FG001|Overall Study|Death|1|||
125214154|NCT04399889|450411246|FG001|Overall Study|Death|1|||
124943506|NCT01170208|449419975|FG001|Overall Study|Protocol Violation|0|||
124943507|NCT01170208|449419976|FG002|Overall Study|Protocol Violation|1|||
124943508|NCT01160354|449419987|FG000|Overall Study|Death|0|||
124943509|NCT01160354|449419988|FG001|Overall Study|Death|1|||
124943510|NCT01160354|449419989|FG002|Overall Study|Death|1|||
124943511|NCT02743819|449419992|FG000|Overall Study|Lack of Efficacy|5|||
124943512|NCT02743819|449419992|FG000|Overall Study|Death|2|||
124943513|NCT02743819|449419992|FG000|Overall Study|Adverse Event|1|||
124943514|NCT03683576|449420001|FG000|Overall Study|Withdrawal by Subject|2|||
124943515|NCT03683576|449420002|FG001|Overall Study|Withdrawal by Subject|0|||
124943516|NCT03683576|449420003|FG002|Overall Study|Withdrawal by Subject|8|||
124943517|NCT03683576|449420004|FG003|Overall Study|Withdrawal by Subject|3|||
124943518|NCT03683576|449420001|FG000|Overall Study|Adverse Event|3|||
124943519|NCT03683576|449420002|FG001|Overall Study|Adverse Event|0|||
125123153|NCT01367275|450075761|FG000|Overall Study|Ineligible|1|||
124943520|NCT03683576|449420003|FG002|Overall Study|Adverse Event|0|||
124943521|NCT03683576|449420004|FG003|Overall Study|Adverse Event|4|||
124943522|NCT03683576|449420001|FG000|Overall Study|Lack of Efficacy|1|||
124943523|NCT03683576|449420002|FG001|Overall Study|Lack of Efficacy|0|||
125214155|NCT04399889|450411247|FG002|Overall Study|Death|1|||
124943524|NCT03683576|449420003|FG002|Overall Study|Lack of Efficacy|1|||
124943525|NCT03683576|449420004|FG003|Overall Study|Lack of Efficacy|1|||
124943526|NCT03683576|449420001|FG000|Overall Study|Lost to Follow-up|0|||
124943527|NCT03683576|449420002|FG001|Overall Study|Lost to Follow-up|1|||
124943528|NCT03683576|449420003|FG002|Overall Study|Lost to Follow-up|2|||
124943529|NCT03683576|449420004|FG003|Overall Study|Lost to Follow-up|0|||
124943530|NCT03683576|449420001|FG000|Overall Study|Other, Not Specified|0|||
124943531|NCT03683576|449420002|FG001|Overall Study|Other, Not Specified|2|||
124943532|NCT03683576|449420003|FG002|Overall Study|Other, Not Specified|0|||
124943533|NCT03683576|449420004|FG003|Overall Study|Other, Not Specified|0|||
124943534|NCT03683576|449420001|FG000|Overall Study|Protocol Violation|0|||
124943535|NCT03683576|449420002|FG001|Overall Study|Protocol Violation|1|||
124943536|NCT03683576|449420003|FG002|Overall Study|Protocol Violation|1|||
124943537|NCT03683576|449420004|FG003|Overall Study|Protocol Violation|0|||
124943538|NCT01827839|449420005|FG000|Overall Study|Adverse Event|1|||
124943539|NCT01827839|449420005|FG000|Overall Study|Consent Withdrawal|2|||
124943540|NCT00491894|449420006|FG000|Overall Study|Adverse Event|14|||
124943541|NCT00491894|449420006|FG000|Overall Study|Withdrawal by Subject|5|||
124943542|NCT00491894|449420006|FG000|Overall Study|Death|3|||
124943543|NCT00491894|449420006|FG000|Overall Study|Lost to Follow-up|3|||
124943544|NCT00491894|449420006|FG000|Overall Study|Lack of Efficacy|2|||
124943545|NCT00491894|449420006|FG000|Overall Study|Other-Failed to meet any criteria|2|||
124943546|NCT00491894|449420006|FG000|Overall Study|Physician Decision|2|||
124943547|NCT00491894|449420006|FG000|Overall Study|Protocol Violation|2|||
124943548|NCT00491894|449420006|FG000|Overall Study|Other-Intake of prohibited medication|1|||
124943549|NCT03499964|449421914|FG000|Overall Study|Lack of Efficacy|6|||
124943550|NCT03499964|449421915|FG001|Overall Study|Lack of Efficacy|26|||
124943551|NCT03499964|449421914|FG000|Overall Study|Adverse Event|1|||
124943552|NCT03499964|449421915|FG001|Overall Study|Adverse Event|0|||
124943553|NCT03499964|449421914|FG000|Overall Study|Death|1|||
124943554|NCT03499964|449421915|FG001|Overall Study|Death|0|||
124943555|NCT03499964|449421914|FG000|Overall Study|Withdrawal by Subject|2|||
124943556|NCT03499964|449421915|FG001|Overall Study|Withdrawal by Subject|1|||
124943557|NCT03499964|449421914|FG000|Overall Study|Lost to Follow-up|1|||
124943558|NCT03499964|449421915|FG001|Overall Study|Lost to Follow-up|0|||
124943559|NCT03739866|449421919|FG000|Overall Study|Lost to Follow-up|0|||
124943560|NCT03739866|449421920|FG001|Overall Study|Lost to Follow-up|0|||
124943561|NCT03739866|449421921|FG002|Overall Study|Lost to Follow-up|0|||
124943562|NCT03739866|449421922|FG003|Overall Study|Lost to Follow-up|1|||
124943563|NCT03739866|449421923|FG004|Overall Study|Lost to Follow-up|0|||
124943564|NCT03739866|449421924|FG005|Overall Study|Lost to Follow-up|0|||
124943565|NCT03739866|449421925|FG006|Overall Study|Lost to Follow-up|0|||
124943566|NCT03739866|449421926|FG007|Overall Study|Lost to Follow-up|0|||
124943567|NCT03739866|449421919|FG000|Overall Study|Enrolled but not treated|0|||
124943568|NCT03739866|449421920|FG001|Overall Study|Enrolled but not treated|0|||
124943569|NCT03739866|449421921|FG002|Overall Study|Enrolled but not treated|1|||
124943570|NCT03739866|449421922|FG003|Overall Study|Enrolled but not treated|0|||
124943571|NCT03739866|449421923|FG004|Overall Study|Enrolled but not treated|1|||
124943572|NCT03739866|449421924|FG005|Overall Study|Enrolled but not treated|0|||
124943573|NCT03739866|449421925|FG006|Overall Study|Enrolled but not treated|0|||
124943574|NCT03739866|449421926|FG007|Overall Study|Enrolled but not treated|0|||
124943575|NCT01728324|449421927|FG000|Termination of DBV|Adverse Event|14|||
124943576|NCT01728324|449421928|FG001|Termination of DBV|Adverse Event|13|||
125123154|NCT01367275|450075761|FG000|Overall Study|Disease Progression|2|||
125123155|NCT00502775|450075764|FG000|Overall Study|Adverse Event|1|||
125123156|NCT00502775|450075765|FG001|Overall Study|Adverse Event|2|||
125123157|NCT00502775|450075766|FG002|Overall Study|Adverse Event|1|||
125123158|NCT00502775|450075764|FG000|Overall Study|Protocol Violation|1|||
125123159|NCT00502775|450075765|FG001|Overall Study|Protocol Violation|5|||
125123160|NCT00502775|450075766|FG002|Overall Study|Protocol Violation|2|||
124943577|NCT01728324|449421929|FG002|Termination of DBV|Adverse Event|4|||
124943578|NCT01728324|449421927|FG000|Termination of DBV|Lack of Efficacy|14|||
124943579|NCT01728324|449421928|FG001|Termination of DBV|Lack of Efficacy|12|||
124943580|NCT01728324|449421929|FG002|Termination of DBV|Lack of Efficacy|8|||
124943581|NCT01728324|449421927|FG000|Termination of DBV|Withdrawal by Subject|9|||
124943582|NCT01728324|449421928|FG001|Termination of DBV|Withdrawal by Subject|6|||
124943583|NCT01728324|449421929|FG002|Termination of DBV|Withdrawal by Subject|2|||
124943584|NCT01728324|449421927|FG000|Termination of DBV|Other than stated|1|||
125123161|NCT00502775|450075764|FG000|Overall Study|Withdrawal by Subject|1|||
124943585|NCT01728324|449421928|FG001|Termination of DBV|Other than stated|3|||
124943586|NCT01728324|449421929|FG002|Termination of DBV|Other than stated|0|||
124943587|NCT01728324|449421927|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
124943588|NCT01728324|449421928|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
124943589|NCT01728324|449421929|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
124943590|NCT01728324|449421927|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
124943591|NCT01728324|449421928|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
125123162|NCT00502775|450075765|FG001|Overall Study|Withdrawal by Subject|1|||
124943592|NCT01728324|449421929|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
124943593|NCT01728324|449421927|FG000|Termination of FDV|Adverse Event|14|||
124943594|NCT01728324|449421928|FG001|Termination of FDV|Adverse Event|13|||
124943595|NCT01728324|449421929|FG002|Termination of FDV|Adverse Event|4|||
124943596|NCT01728324|449421927|FG000|Termination of FDV|Lack of Efficacy|14|||
124943597|NCT01728324|449421928|FG001|Termination of FDV|Lack of Efficacy|12|||
124943598|NCT01728324|449421929|FG002|Termination of FDV|Lack of Efficacy|8|||
124943599|NCT01728324|449421927|FG000|Termination of FDV|Withdrawal by Subject|9|||
124943600|NCT01728324|449421928|FG001|Termination of FDV|Withdrawal by Subject|6|||
124943601|NCT01728324|449421929|FG002|Termination of FDV|Withdrawal by Subject|2|||
125123163|NCT00502775|450075766|FG002|Overall Study|Withdrawal by Subject|2|||
124943602|NCT01728324|449421927|FG000|Termination of FDV|Other than stated|1|||
124943603|NCT01728324|449421928|FG001|Termination of FDV|Other than stated|3|||
124943604|NCT01728324|449421929|FG002|Termination of FDV|Other than stated|0|||
124943605|NCT01728324|449421927|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
124943606|NCT01728324|449421928|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
124943607|NCT01728324|449421929|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
124943608|NCT01728324|449421927|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
124943609|NCT01728324|449421928|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
124943610|NCT01728324|449421929|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
124943611|NCT01728324|449421927|FG000|Termination of RBV|Adverse Event|15|||
124943612|NCT01728324|449421928|FG001|Termination of RBV|Adverse Event|16|||
124943613|NCT01728324|449421929|FG002|Termination of RBV|Adverse Event|5|||
124943614|NCT01728324|449421927|FG000|Termination of RBV|Lack of Efficacy|14|||
124943615|NCT01728324|449421928|FG001|Termination of RBV|Lack of Efficacy|11|||
124943616|NCT01728324|449421929|FG002|Termination of RBV|Lack of Efficacy|7|||
124943617|NCT01728324|449421927|FG000|Termination of RBV|Withdrawal by Subject|9|||
124943618|NCT01728324|449421928|FG001|Termination of RBV|Withdrawal by Subject|5|||
124943619|NCT01728324|449421929|FG002|Termination of RBV|Withdrawal by Subject|2|||
124943620|NCT01728324|449421927|FG000|Termination of RBV|Other than stated|1|||
124943621|NCT01728324|449421928|FG001|Termination of RBV|Other than stated|3|||
124943622|NCT01728324|449421929|FG002|Termination of RBV|Other than stated|1|||
124943623|NCT01728324|449421927|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
124943624|NCT01728324|449421928|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
124943625|NCT01728324|449421929|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
124943626|NCT01728324|449421927|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
124943627|NCT01728324|449421928|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
124943628|NCT01728324|449421929|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
124943629|NCT03057600|449421932|FG000|Overall Study|Adverse Event|0|||
124943630|NCT03057600|449421933|FG001|Overall Study|Adverse Event|0|||
124943631|NCT03057600|449421934|FG002|Overall Study|Adverse Event|4|||
124943632|NCT03057600|449421935|FG003|Overall Study|Adverse Event|0|||
124943633|NCT03057600|449421932|FG000|Overall Study|Radiologic Disease Progression|8|||
124943634|NCT03057600|449421933|FG001|Overall Study|Radiologic Disease Progression|7|||
124943635|NCT03057600|449421934|FG002|Overall Study|Radiologic Disease Progression|13|||
124943636|NCT03057600|449421935|FG003|Overall Study|Radiologic Disease Progression|10|||
124943637|NCT03057600|449421932|FG000|Overall Study|Symptomatic Deterioration|0|||
124943638|NCT03057600|449421933|FG001|Overall Study|Symptomatic Deterioration|1|||
124943639|NCT03057600|449421934|FG002|Overall Study|Symptomatic Deterioration|1|||
124943640|NCT03057600|449421935|FG003|Overall Study|Symptomatic Deterioration|0|||
124943641|NCT03057600|449421932|FG000|Overall Study|Investigator Decision|0|||
124943642|NCT03057600|449421933|FG001|Overall Study|Investigator Decision|0|||
124943643|NCT03057600|449421934|FG002|Overall Study|Investigator Decision|1|||
124943644|NCT03057600|449421935|FG003|Overall Study|Investigator Decision|0|||
124943645|NCT03057600|449421932|FG000|Overall Study|Study Termination by Sponsor|0|||
124943646|NCT03057600|449421933|FG001|Overall Study|Study Termination by Sponsor|0|||
124943647|NCT03057600|449421934|FG002|Overall Study|Study Termination by Sponsor|0|||
124943648|NCT03057600|449421935|FG003|Overall Study|Study Termination by Sponsor|2|||
124943649|NCT03057600|449421932|FG000|Overall Study|Withdrawal by Subject|0|||
124943650|NCT03057600|449421933|FG001|Overall Study|Withdrawal by Subject|1|||
124943651|NCT03057600|449421934|FG002|Overall Study|Withdrawal by Subject|0|||
124943652|NCT03057600|449421935|FG003|Overall Study|Withdrawal by Subject|0|||
124943653|NCT03057600|449421932|FG000|Overall Study|Other, Not Specified|1|||
124943654|NCT03057600|449421933|FG001|Overall Study|Other, Not Specified|1|||
124943655|NCT03057600|449421934|FG002|Overall Study|Other, Not Specified|1|||
124943656|NCT03057600|449421935|FG003|Overall Study|Other, Not Specified|1|||
124943657|NCT03489369|449421936|FG000|Overall Study|Documented Progressive Disease|3|||
124943658|NCT03489369|449421937|FG001|Overall Study|Documented Progressive Disease|2|||
125123164|NCT00502775|450075764|FG000|Overall Study|Sponsor Terminated Study|1|||
125123165|NCT00502775|450075765|FG001|Overall Study|Sponsor Terminated Study|0|||
124943659|NCT03489369|449421938|FG002|Overall Study|Documented Progressive Disease|3|||
124943660|NCT03489369|449421939|FG003|Overall Study|Documented Progressive Disease|6|||
124943661|NCT03489369|449421936|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
124943662|NCT03489369|449421937|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
124943663|NCT03489369|449421938|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
124943664|NCT03489369|449421939|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
124943665|NCT03335488|449421944|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
124943666|NCT03335488|449421945|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
124943667|NCT03335488|449421944|FG000|Safety Extension Period|Adverse Event|1|||
124943668|NCT03335488|449421945|FG001|Safety Extension Period|Adverse Event|0|||
124943669|NCT03335488|449421944|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
124943670|NCT03335488|449421945|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
124943671|NCT00388726|449421946|FG000|Overall Study|Adverse Event|50|||
124943672|NCT00388726|449421947|FG001|Overall Study|Adverse Event|24|||
124943673|NCT00388726|449421946|FG000|Overall Study|Progressive Disease|336|||
124943674|NCT00388726|449421947|FG001|Overall Study|Progressive Disease|153|||
124943675|NCT00388726|449421946|FG000|Overall Study|Clinical Progression|61|||
124943676|NCT00388726|449421947|FG001|Overall Study|Clinical Progression|36|||
124943677|NCT00388726|449421946|FG000|Overall Study|Withdrawal by Subject|10|||
124943678|NCT00388726|449421947|FG001|Overall Study|Withdrawal by Subject|7|||
124943679|NCT00388726|449421946|FG000|Overall Study|Administrative|6|||
124943680|NCT00388726|449421947|FG001|Overall Study|Administrative|9|||
124943681|NCT00388726|449421946|FG000|Overall Study|Physician Decision|18|||
124943682|NCT00388726|449421947|FG001|Overall Study|Physician Decision|13|||
124943683|NCT00388726|449421946|FG000|Overall Study|Death|3|||
124943684|NCT00388726|449421947|FG001|Overall Study|Death|2|||
124943685|NCT01953692|449421948|FG000|Overall Study|Adverse Event|5|||
124943686|NCT01953692|449421949|FG001|Overall Study|Adverse Event|2|||
124943687|NCT01953692|449421950|FG002|Overall Study|Adverse Event|4|||
124943688|NCT01953692|449421951|FG003|Overall Study|Adverse Event|2|||
124943689|NCT01953692|449421952|FG004|Overall Study|Adverse Event|1|||
124943690|NCT01953692|449421953|FG005|Overall Study|Adverse Event|2|||
124943691|NCT01953692|449421954|FG006|Overall Study|Adverse Event|0|||
124943692|NCT01953692|449421955|FG007|Overall Study|Adverse Event|0|||
124943693|NCT01953692|449421956|FG008|Overall Study|Adverse Event|0|||
125214156|NCT02829047|450411251|FG000|Overall Study|Withdrawal by Subject|1|||
125214157|NCT01909973|450411253|FG000|Overall Study|Lost to Follow-up|1|||
125214158|NCT01909973|450411254|FG001|Overall Study|Lost to Follow-up|0|||
125214159|NCT00460239|450411255|FG000|Overall Study|Physician Decision|0|||
125214160|NCT00460239|450411256|FG001|Overall Study|Physician Decision|1|||
125214161|NCT00460239|450411257|FG002|Overall Study|Physician Decision|0|||
125214162|NCT00460239|450411258|FG003|Overall Study|Physician Decision|0|||
125214163|NCT00460239|450411259|FG004|Overall Study|Physician Decision|0|||
125214164|NCT00460239|450411260|FG005|Overall Study|Physician Decision|2|||
125214165|NCT00460239|450411261|FG006|Overall Study|Physician Decision|0|||
125214166|NCT00460239|450411262|FG007|Overall Study|Physician Decision|0|||
125214167|NCT00460239|450411263|FG008|Overall Study|Physician Decision|0|||
125214168|NCT00460239|450411255|FG000|Overall Study|Withdrawal by Subject|0|||
125214169|NCT00460239|450411256|FG001|Overall Study|Withdrawal by Subject|0|||
125214170|NCT00460239|450411257|FG002|Overall Study|Withdrawal by Subject|0|||
125214171|NCT00460239|450411258|FG003|Overall Study|Withdrawal by Subject|0|||
125214172|NCT00460239|450411259|FG004|Overall Study|Withdrawal by Subject|0|||
125214173|NCT00460239|450411260|FG005|Overall Study|Withdrawal by Subject|1|||
125214174|NCT00460239|450411261|FG006|Overall Study|Withdrawal by Subject|0|||
125214175|NCT00460239|450411262|FG007|Overall Study|Withdrawal by Subject|0|||
125214176|NCT00460239|450411263|FG008|Overall Study|Withdrawal by Subject|0|||
125214177|NCT01005901|450411270|FG000|Overall Study|Withdrawal by Subject|38|||
125214178|NCT01005901|450411271|FG001|Overall Study|Withdrawal by Subject|14|||
125214179|NCT01005901|450411270|FG000|Overall Study|Adverse Event|30|||
125214180|NCT01005901|450411271|FG001|Overall Study|Adverse Event|16|||
125214181|NCT01005901|450411270|FG000|Overall Study|Administrative problems|21|||
125214182|NCT01005901|450411271|FG001|Overall Study|Administrative problems|13|||
124943694|NCT01953692|449421948|FG000|Overall Study|Clinical Progression|0|||
124943695|NCT01953692|449421949|FG001|Overall Study|Clinical Progression|15|||
125214183|NCT01005901|450411270|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
125214184|NCT01005901|450411271|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
125214185|NCT01005901|450411270|FG000|Overall Study|Protocol Violation|4|||
125214186|NCT01005901|450411271|FG001|Overall Study|Protocol Violation|3|||
125028218|NCT00352534|449727463|FG002|Final Risk Group Assignment|Physician Decision|0|||
125214187|NCT01005901|450411270|FG000|Overall Study|Death|2|||
125214188|NCT01005901|450411271|FG001|Overall Study|Death|3|||
125214189|NCT01005901|450411270|FG000|Overall Study|Lost to Follow-up|1|||
124943696|NCT01953692|449421950|FG002|Overall Study|Clinical Progression|7|||
124943697|NCT01953692|449421951|FG003|Overall Study|Clinical Progression|5|||
125028219|NCT00352534|449727464|FG003|Final Risk Group Assignment|Physician Decision|0|||
125028220|NCT00352534|449727465|FG004|Final Risk Group Assignment|Physician Decision|0|||
125214190|NCT01005901|450411271|FG001|Overall Study|Lost to Follow-up|2|||
125214191|NCT01005901|450411270|FG000|Overall Study|Patient's inability to use the device|1|||
125214192|NCT01005901|450411271|FG001|Overall Study|Patient's inability to use the device|1|||
125214193|NCT01005901|450411270|FG000|Overall Study|No longer requires study drug|0|||
125214194|NCT01005901|450411271|FG001|Overall Study|No longer requires study drug|1|||
125214195|NCT00760487|450411272|FG000|Overall Study|Unilateral implantation|3|||
125214196|NCT06360588|450411274|FG000|Overall Study|Adverse Event|3|||
125214197|NCT06360588|450411274|FG000|Overall Study|Death|2|||
125214198|NCT06360588|450411274|FG000|Overall Study|Disease Progression|14|||
125214199|NCT06360588|450411274|FG000|Overall Study|Withdrawal by Subject|1|||
125214200|NCT06360588|450411274|FG000|Overall Study|Lack of Efficacy|1|||
125214201|NCT06360588|450411274|FG000|Overall Study|Ineligible|1|||
125214202|NCT02087943|450411276|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
125214203|NCT02087943|450411277|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
125214204|NCT02087943|450411278|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
125214205|NCT02087943|450411279|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
125214206|NCT02087943|450411280|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
125214207|NCT02087943|450411276|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
125214208|NCT02087943|450411277|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
125214209|NCT02087943|450411278|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
125214210|NCT02087943|450411279|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
125214211|NCT02087943|450411280|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
125214212|NCT02087943|450411276|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
125214213|NCT02087943|450411277|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
125214214|NCT02087943|450411278|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
125214215|NCT02087943|450411279|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
125214216|NCT02087943|450411280|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
125214217|NCT02087943|450411276|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
125214218|NCT02087943|450411277|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
125214219|NCT02087943|450411278|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
125214220|NCT02087943|450411279|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
125214221|NCT02087943|450411280|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
125214222|NCT02087943|450411276|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
125214223|NCT02087943|450411277|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
125214224|NCT02087943|450411278|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
125214225|NCT02087943|450411279|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
125123166|NCT00502775|450075766|FG002|Overall Study|Sponsor Terminated Study|1|||
125123167|NCT00502775|450075764|FG000|Overall Study|Non-compliance with eDiary|4|||
125123168|NCT00502775|450075765|FG001|Overall Study|Non-compliance with eDiary|1|||
125123169|NCT00502775|450075766|FG002|Overall Study|Non-compliance with eDiary|1|||
125123170|NCT00502775|450075764|FG000|Overall Study|Subject unable to swallow capsule|1|||
125123171|NCT00502775|450075765|FG001|Overall Study|Subject unable to swallow capsule|0|||
125123172|NCT00502775|450075766|FG002|Overall Study|Subject unable to swallow capsule|1|||
125123173|NCT00502775|450075764|FG000|Overall Study|Logpad compliance <80%|1|||
125123174|NCT00502775|450075765|FG001|Overall Study|Logpad compliance <80%|0|||
125123175|NCT00502775|450075766|FG002|Overall Study|Logpad compliance <80%|0|||
125123176|NCT00502775|450075764|FG000|Overall Study|Randomized in error|0|||
125123177|NCT00502775|450075765|FG001|Overall Study|Randomized in error|1|||
125123178|NCT00502775|450075766|FG002|Overall Study|Randomized in error|1|||
125123179|NCT00502775|450075764|FG000|Overall Study|Non-compliance|0|||
125123180|NCT00502775|450075765|FG001|Overall Study|Non-compliance|2|||
125123181|NCT00502775|450075766|FG002|Overall Study|Non-compliance|2|||
125123182|NCT00502775|450075764|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
125123183|NCT00502775|450075765|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
125123184|NCT00502775|450075766|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
125123185|NCT00502775|450075764|FG000|Overall Study|Declining pollen counts|0|||
125123186|NCT00502775|450075765|FG001|Overall Study|Declining pollen counts|1|||
125123187|NCT00502775|450075766|FG002|Overall Study|Declining pollen counts|1|||
125123188|NCT00502775|450075764|FG000|Overall Study|Subject in jail|0|||
125123189|NCT00502775|450075765|FG001|Overall Study|Subject in jail|1|||
125123190|NCT00502775|450075766|FG002|Overall Study|Subject in jail|0|||
125123191|NCT00502775|450075764|FG000|Overall Study|Subject took disallowed drug|0|||
125123192|NCT00502775|450075765|FG001|Overall Study|Subject took disallowed drug|0|||
125123193|NCT00502775|450075766|FG002|Overall Study|Subject took disallowed drug|1|||
125123194|NCT00287118|450075768|FG000|Overall Study|Adverse Event|30|||
125214226|NCT02087943|450411280|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
125123195|NCT00287118|450075768|FG000|Overall Study|Death|1|||
125123196|NCT00287118|450075768|FG000|Overall Study|Lack of Efficacy|11|||
125123197|NCT00287118|450075768|FG000|Overall Study|Lost to Follow-up|1|||
125123198|NCT00287118|450075768|FG000|Overall Study|Protocol Violation|2|||
125123199|NCT00287118|450075768|FG000|Overall Study|Other|7|||
124943698|NCT01953692|449421952|FG004|Overall Study|Clinical Progression|0|||
124943699|NCT01953692|449421953|FG005|Overall Study|Clinical Progression|7|||
124943700|NCT01953692|449421954|FG006|Overall Study|Clinical Progression|20|||
124943701|NCT01953692|449421955|FG007|Overall Study|Clinical Progression|3|||
124943702|NCT01953692|449421956|FG008|Overall Study|Clinical Progression|3|||
124943703|NCT01953692|449421948|FG000|Overall Study|Death|5|||
124943704|NCT01953692|449421949|FG001|Overall Study|Death|0|||
124943705|NCT01953692|449421950|FG002|Overall Study|Death|2|||
124943706|NCT01953692|449421951|FG003|Overall Study|Death|2|||
124943707|NCT01953692|449421952|FG004|Overall Study|Death|1|||
124943708|NCT01953692|449421953|FG005|Overall Study|Death|3|||
124943709|NCT01953692|449421954|FG006|Overall Study|Death|6|||
124943710|NCT01953692|449421955|FG007|Overall Study|Death|2|||
124943711|NCT01953692|449421956|FG008|Overall Study|Death|1|||
124943712|NCT01953692|449421948|FG000|Overall Study|Excluded Medication|1|||
124943713|NCT01953692|449421949|FG001|Overall Study|Excluded Medication|0|||
124943714|NCT01953692|449421950|FG002|Overall Study|Excluded Medication|0|||
124943715|NCT01953692|449421951|FG003|Overall Study|Excluded Medication|0|||
124943716|NCT01953692|449421952|FG004|Overall Study|Excluded Medication|0|||
124943717|NCT01953692|449421953|FG005|Overall Study|Excluded Medication|0|||
124943718|NCT01953692|449421954|FG006|Overall Study|Excluded Medication|0|||
124943719|NCT01953692|449421955|FG007|Overall Study|Excluded Medication|0|||
124943720|NCT01953692|449421956|FG008|Overall Study|Excluded Medication|0|||
124943721|NCT01953692|449421948|FG000|Overall Study|Lost to Follow-up|1|||
124943722|NCT01953692|449421949|FG001|Overall Study|Lost to Follow-up|0|||
124943723|NCT01953692|449421950|FG002|Overall Study|Lost to Follow-up|3|||
124943724|NCT01953692|449421951|FG003|Overall Study|Lost to Follow-up|1|||
124943725|NCT01953692|449421952|FG004|Overall Study|Lost to Follow-up|0|||
124943726|NCT01953692|449421953|FG005|Overall Study|Lost to Follow-up|1|||
124943727|NCT01953692|449421954|FG006|Overall Study|Lost to Follow-up|0|||
124943728|NCT01953692|449421955|FG007|Overall Study|Lost to Follow-up|0|||
125123200|NCT00262600|450075769|FG000|Overall Study|Lost to Follow-up|17|||
125123201|NCT00262600|450075770|FG001|Overall Study|Lost to Follow-up|31|||
124943729|NCT01953692|449421956|FG008|Overall Study|Lost to Follow-up|0|||
124943730|NCT01953692|449421948|FG000|Overall Study|Physician Decision|11|||
124943731|NCT01953692|449421949|FG001|Overall Study|Physician Decision|4|||
124943732|NCT01953692|449421950|FG002|Overall Study|Physician Decision|2|||
124943733|NCT01953692|449421951|FG003|Overall Study|Physician Decision|2|||
124943734|NCT01953692|449421952|FG004|Overall Study|Physician Decision|1|||
124943735|NCT01953692|449421953|FG005|Overall Study|Physician Decision|2|||
124943736|NCT01953692|449421954|FG006|Overall Study|Physician Decision|4|||
124943737|NCT01953692|449421955|FG007|Overall Study|Physician Decision|1|||
124943738|NCT01953692|449421956|FG008|Overall Study|Physician Decision|0|||
124943739|NCT01953692|449421948|FG000|Overall Study|Protocol Violation|0|||
124943740|NCT01953692|449421949|FG001|Overall Study|Protocol Violation|2|||
124943741|NCT01953692|449421950|FG002|Overall Study|Protocol Violation|1|||
124943742|NCT01953692|449421951|FG003|Overall Study|Protocol Violation|0|||
124943743|NCT01953692|449421952|FG004|Overall Study|Protocol Violation|0|||
124943744|NCT01953692|449421953|FG005|Overall Study|Protocol Violation|0|||
124943745|NCT01953692|449421954|FG006|Overall Study|Protocol Violation|0|||
124943746|NCT01953692|449421955|FG007|Overall Study|Protocol Violation|1|||
124943747|NCT01953692|449421956|FG008|Overall Study|Protocol Violation|0|||
124943748|NCT01953692|449421948|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
124943749|NCT01953692|449421949|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
124943750|NCT01953692|449421950|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
124943751|NCT01953692|449421951|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
124943752|NCT01953692|449421952|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
124943753|NCT01953692|449421953|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
124943754|NCT01953692|449421954|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
124943755|NCT01953692|449421955|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
125123202|NCT00262600|450075771|FG002|Overall Study|Lost to Follow-up|41|||
125123203|NCT00262600|450075769|FG000|Overall Study|Withdrawal by Subject|128|||
125123204|NCT00262600|450075770|FG001|Overall Study|Withdrawal by Subject|145|||
124943756|NCT01953692|449421956|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
124943757|NCT01953692|449421948|FG000|Overall Study|Withdrawal by Subject|4|||
124943758|NCT01953692|449421949|FG001|Overall Study|Withdrawal by Subject|2|||
124943759|NCT01953692|449421950|FG002|Overall Study|Withdrawal by Subject|1|||
124943760|NCT01953692|449421951|FG003|Overall Study|Withdrawal by Subject|2|||
124943761|NCT01953692|449421952|FG004|Overall Study|Withdrawal by Subject|0|||
124943762|NCT01953692|449421953|FG005|Overall Study|Withdrawal by Subject|3|||
124943763|NCT01953692|449421954|FG006|Overall Study|Withdrawal by Subject|2|||
124943764|NCT01953692|449421955|FG007|Overall Study|Withdrawal by Subject|1|||
124943765|NCT01953692|449421956|FG008|Overall Study|Withdrawal by Subject|1|||
124943766|NCT04638816|449421957|FG000|Overall Study|Withdrawal by Subject|0|||
124943767|NCT04638816|449421958|FG001|Overall Study|Withdrawal by Subject|1|||
124943768|NCT04638816|449421957|FG000|Overall Study|Lost to Follow-up|0|||
124943769|NCT04638816|449421958|FG001|Overall Study|Lost to Follow-up|1|||
125123205|NCT00262600|450075771|FG002|Overall Study|Withdrawal by Subject|139|||
124943770|NCT00109031|449421961|FG000|Overall Study|Adverse Event|0|||
124943771|NCT00109031|449421962|FG001|Overall Study|Adverse Event|0|||
124943772|NCT00109031|449421963|FG002|Overall Study|Adverse Event|1|||
124943773|NCT00109031|449421964|FG003|Overall Study|Adverse Event|0|||
125214227|NCT02087943|450411276|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
125214228|NCT02087943|450411277|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
125214229|NCT02087943|450411278|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
125214230|NCT02087943|450411279|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
125214231|NCT02087943|450411280|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
125214232|NCT02087943|450411276|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
125214233|NCT02087943|450411277|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
125214234|NCT02087943|450411278|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
125214235|NCT02087943|450411279|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
125214236|NCT02087943|450411280|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
125214237|NCT02087943|450411276|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
125214238|NCT02087943|450411277|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
125214239|NCT02087943|450411278|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
124943774|NCT00109031|449421961|FG000|Overall Study|Withdrawal by Subject|0|||
124943775|NCT00109031|449421962|FG001|Overall Study|Withdrawal by Subject|1|||
124943776|NCT00109031|449421963|FG002|Overall Study|Withdrawal by Subject|0|||
124943777|NCT00109031|449421964|FG003|Overall Study|Withdrawal by Subject|0|||
124943778|NCT00109031|449421961|FG000|Overall Study|Physician Decision|0|||
124943779|NCT00109031|449421962|FG001|Overall Study|Physician Decision|1|||
124943780|NCT00109031|449421963|FG002|Overall Study|Physician Decision|0|||
124943781|NCT00109031|449421964|FG003|Overall Study|Physician Decision|0|||
124943782|NCT00109031|449421961|FG000|Overall Study|Protocol Violation|0|||
124943783|NCT00109031|449421962|FG001|Overall Study|Protocol Violation|0|||
125214240|NCT02087943|450411279|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
125214241|NCT02087943|450411280|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
125214242|NCT02087943|450411276|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
124943784|NCT00109031|449421963|FG002|Overall Study|Protocol Violation|1|||
124943785|NCT00109031|449421964|FG003|Overall Study|Protocol Violation|0|||
124943786|NCT01822756|449421965|FG000|Overall Study|Adverse Event|0|||
125214243|NCT02087943|450411277|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
125214244|NCT02087943|450411278|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
124943787|NCT01822756|449421966|FG001|Overall Study|Adverse Event|0|||
124943788|NCT01822756|449421967|FG002|Overall Study|Adverse Event|0|||
124943789|NCT01822756|449421968|FG003|Overall Study|Adverse Event|2|||
124943790|NCT01822756|449421969|FG004|Overall Study|Adverse Event|0|||
124943791|NCT01822756|449421965|FG000|Overall Study|Disease progression|11|||
124943792|NCT01822756|449421966|FG001|Overall Study|Disease progression|1|||
124943793|NCT01822756|449421967|FG002|Overall Study|Disease progression|7|||
124943794|NCT01822756|449421968|FG003|Overall Study|Disease progression|2|||
124943795|NCT01822756|449421969|FG004|Overall Study|Disease progression|6|||
124943796|NCT01822756|449421965|FG000|Overall Study|Death|2|||
124943797|NCT01822756|449421966|FG001|Overall Study|Death|2|||
124943798|NCT01822756|449421967|FG002|Overall Study|Death|1|||
124943799|NCT01822756|449421968|FG003|Overall Study|Death|0|||
124943800|NCT01822756|449421969|FG004|Overall Study|Death|0|||
124943801|NCT01822756|449421965|FG000|Overall Study|Lost to Follow-up|1|||
124943802|NCT01822756|449421966|FG001|Overall Study|Lost to Follow-up|0|||
124943803|NCT01822756|449421967|FG002|Overall Study|Lost to Follow-up|1|||
124943804|NCT01822756|449421968|FG003|Overall Study|Lost to Follow-up|0|||
124943805|NCT01822756|449421969|FG004|Overall Study|Lost to Follow-up|1|||
124943806|NCT01822756|449421965|FG000|Overall Study|Physician Decision|0|||
124943807|NCT01822756|449421966|FG001|Overall Study|Physician Decision|1|||
124943808|NCT01822756|449421967|FG002|Overall Study|Physician Decision|0|||
124943809|NCT01822756|449421968|FG003|Overall Study|Physician Decision|0|||
124943810|NCT01822756|449421969|FG004|Overall Study|Physician Decision|0|||
124943811|NCT01822756|449421965|FG000|Overall Study|disease progression & patient preference|2|||
125123206|NCT00262600|450075769|FG000|Overall Study|Not Treated|32|||
125123207|NCT00262600|450075770|FG001|Overall Study|Not Treated|17|||
125123208|NCT00262600|450075771|FG002|Overall Study|Not Treated|24|||
125123209|NCT00262600|450075769|FG000|Overall Study|Other|58|||
125123210|NCT00262600|450075770|FG001|Overall Study|Other|59|||
125123211|NCT00262600|450075771|FG002|Overall Study|Other|62|||
125123212|NCT02906709|450075778|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
125123213|NCT02906709|450075779|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
125123214|NCT02906709|450075778|FG000|Phase A (Week 0 to Week 16)|Death|0|||
125123215|NCT02906709|450075779|FG001|Phase A (Week 0 to Week 16)|Death|1|||
125123216|NCT02906709|450075778|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
125123217|NCT02906709|450075779|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
125123218|NCT02906709|450075778|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
125123219|NCT02906709|450075779|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
125123220|NCT05518487|450075781|FG000|Overall Study|Withdrawal by Subject|3|||
125123221|NCT02752776|450075785|FG000|Overall Study|Adverse Event|15|||
125123222|NCT02752776|450075786|FG001|Overall Study|Adverse Event|23|||
125123223|NCT02752776|450075787|FG002|Overall Study|Adverse Event|11|||
125123224|NCT02752776|450075785|FG000|Overall Study|Lack of Efficacy|2|||
125123225|NCT02752776|450075786|FG001|Overall Study|Lack of Efficacy|6|||
125123226|NCT02752776|450075787|FG002|Overall Study|Lack of Efficacy|14|||
125123227|NCT02752776|450075785|FG000|Overall Study|Lost to Follow-up|11|||
125123228|NCT02752776|450075786|FG001|Overall Study|Lost to Follow-up|12|||
125123229|NCT02752776|450075787|FG002|Overall Study|Lost to Follow-up|4|||
125123230|NCT02752776|450075785|FG000|Overall Study|Non-compliance with study treatment|0|||
125123231|NCT02752776|450075786|FG001|Overall Study|Non-compliance with study treatment|0|||
125123232|NCT02752776|450075787|FG002|Overall Study|Non-compliance with study treatment|1|||
125123233|NCT02752776|450075785|FG000|Overall Study|Physician Decision|2|||
125123234|NCT02752776|450075786|FG001|Overall Study|Physician Decision|6|||
125123235|NCT02752776|450075787|FG002|Overall Study|Physician Decision|2|||
125123236|NCT02752776|450075785|FG000|Overall Study|Pregnancy|1|||
125123237|NCT02752776|450075786|FG001|Overall Study|Pregnancy|6|||
125123238|NCT02752776|450075787|FG002|Overall Study|Pregnancy|3|||
125123239|NCT02752776|450075785|FG000|Overall Study|Protocol Violation|10|||
125123240|NCT02752776|450075786|FG001|Overall Study|Protocol Violation|13|||
125123241|NCT02752776|450075787|FG002|Overall Study|Protocol Violation|6|||
125123242|NCT02752776|450075785|FG000|Overall Study|Subject/guardian decision|8|||
125123243|NCT02752776|450075786|FG001|Overall Study|Subject/guardian decision|6|||
125123244|NCT02752776|450075787|FG002|Overall Study|Subject/guardian decision|4|||
125123245|NCT02752776|450075785|FG000|Overall Study|Death|0|||
125123246|NCT02752776|450075786|FG001|Overall Study|Death|0|||
125123247|NCT02752776|450075787|FG002|Overall Study|Death|1|||
125123248|NCT02752776|450075785|FG000|Overall Study|Withdrawal by Subject|3|||
125123249|NCT02752776|450075786|FG001|Overall Study|Withdrawal by Subject|4|||
125123250|NCT02752776|450075787|FG002|Overall Study|Withdrawal by Subject|2|||
125123251|NCT01946165|450075788|FG000|Overall Study|Physician Decision|2|||
125123252|NCT01946165|450075789|FG001|Overall Study|Physician Decision|0|||
124943812|NCT01822756|449421966|FG001|Overall Study|disease progression & patient preference|0|||
124943813|NCT01822756|449421967|FG002|Overall Study|disease progression & patient preference|1|||
124943814|NCT01822756|449421968|FG003|Overall Study|disease progression & patient preference|0|||
124943815|NCT01822756|449421969|FG004|Overall Study|disease progression & patient preference|0|||
125123253|NCT01946165|450075788|FG000|Overall Study|Withdrawal by Subject|0|||
125123254|NCT01946165|450075789|FG001|Overall Study|Withdrawal by Subject|2|||
125123255|NCT01179919|450075790|FG000|Overall Study|Protocol Violation|1|||
125123256|NCT01179919|450075790|FG000|Overall Study|Adverse Event|1|||
125123257|NCT00806156|450075791|FG000|Overall Study|Death|35|||
125123258|NCT00806156|450075792|FG001|Overall Study|Death|95|||
124943816|NCT01328496|449421975|FG000|Overall Study|Significant Change in Health Status|1|||
124943817|NCT01328496|449421976|FG001|Overall Study|Significant Change in Health Status|0|||
124943818|NCT00853593|449421983|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
124943819|NCT00853593|449421983|FG000|Overall Study|Model 4396 lead not attempted|29|||
124943820|NCT00853593|449421983|FG000|Overall Study|Implant not attempted|4|||
124943821|NCT00600353|449421986|FG000|Overall Study|history of malignancy within 5 years|1|||
124943822|NCT00600353|449421987|FG001|Overall Study|history of malignancy within 5 years|0|||
124943823|NCT00600353|449421986|FG000|Overall Study|History of prepartive regimen|0|||
124943824|NCT00600353|449421987|FG001|Overall Study|History of prepartive regimen|1|||
124943825|NCT05966155|449421988|FG000|Overall Study|Death|1|||
124943826|NCT05966155|449421989|FG001|Overall Study|Death|2|||
124943827|NCT05966155|449421988|FG000|Overall Study|Lost to Follow-up|63|||
124943828|NCT05966155|449421989|FG001|Overall Study|Lost to Follow-up|67|||
124943829|NCT05966155|449421988|FG000|Overall Study|Protocol Violation|1|||
124943830|NCT05966155|449421989|FG001|Overall Study|Protocol Violation|0|||
124943831|NCT05966155|449421988|FG000|Overall Study|Withdrawal by Subject|8|||
125028221|NCT00352534|449727466|FG005|Final Risk Group Assignment|Physician Decision|8|||
124943832|NCT05966155|449421989|FG001|Overall Study|Withdrawal by Subject|9|||
124943833|NCT05966155|449421988|FG000|Overall Study|Enrolled Erroneously|0|||
125214245|NCT02087943|450411279|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
125214246|NCT02087943|450411280|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
125214247|NCT02087943|450411276|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
125214248|NCT02087943|450411277|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
125214249|NCT02087943|450411278|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
125214250|NCT02087943|450411279|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
125214251|NCT02087943|450411280|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
125214252|NCT03836209|450411281|FG000|Overall Study|Adverse Event|5|||
125214253|NCT03836209|450411282|FG001|Overall Study|Adverse Event|2|||
125214254|NCT03836209|450411281|FG000|Overall Study|Death|4|||
125214255|NCT03836209|450411282|FG001|Overall Study|Death|1|||
125214256|NCT03836209|450411281|FG000|Overall Study|Lack of Efficacy|7|||
125214257|NCT03836209|450411282|FG001|Overall Study|Lack of Efficacy|10|||
125214258|NCT03836209|450411281|FG000|Overall Study|Physician Decision|7|||
125214259|NCT03836209|450411282|FG001|Overall Study|Physician Decision|11|||
125214260|NCT03836209|450411281|FG000|Overall Study|Protocol Violation|0|||
125214261|NCT03836209|450411282|FG001|Overall Study|Protocol Violation|3|||
125214262|NCT03836209|450411281|FG000|Overall Study|Withdrawal by Subject|2|||
125214263|NCT03836209|450411282|FG001|Overall Study|Withdrawal by Subject|10|||
125214264|NCT03836209|450411281|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
125214265|NCT03836209|450411282|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
125214266|NCT03739710|450411283|FG000|Overall Study|Screen Failed|81|||
125214267|NCT01753115|450411284|FG000|Overall Study|Lost to Follow-up|3|||
125214268|NCT01753115|450411285|FG001|Overall Study|Lost to Follow-up|6|||
125214269|NCT01753115|450411286|FG002|Overall Study|Lost to Follow-up|8|||
125214270|NCT01753115|450411284|FG000|Overall Study|Withdrawal by Subject|6|||
125214271|NCT01753115|450411285|FG001|Overall Study|Withdrawal by Subject|5|||
125214272|NCT01753115|450411286|FG002|Overall Study|Withdrawal by Subject|6|||
125214273|NCT01753115|450411284|FG000|Overall Study|Subject non-compliant|3|||
125214274|NCT01753115|450411285|FG001|Overall Study|Subject non-compliant|3|||
125214275|NCT01753115|450411286|FG002|Overall Study|Subject non-compliant|0|||
125214276|NCT01753115|450411284|FG000|Overall Study|Used excluded drug|0|||
125214277|NCT01753115|450411285|FG001|Overall Study|Used excluded drug|1|||
125214278|NCT01753115|450411286|FG002|Overall Study|Used excluded drug|0|||
125214279|NCT01424241|450411290|FG000|Overall Study|Withdrawal by Subject|1|||
125214280|NCT01424241|450411290|FG000|Overall Study|Time constraints|2|||
125214281|NCT05259917|450411291|FG000|Overall Study|Protocol Violation|0|||
125214282|NCT05259917|450411292|FG001|Overall Study|Protocol Violation|0|||
125214283|NCT05259917|450411293|FG002|Overall Study|Protocol Violation|1|||
125214284|NCT05259917|450411294|FG003|Overall Study|Protocol Violation|0|||
124943834|NCT05966155|449421989|FG001|Overall Study|Enrolled Erroneously|1|||
124943835|NCT05966155|449421988|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
124943836|NCT05966155|449421989|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
124943837|NCT00553332|449421990|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
124943838|NCT02235298|449421992|FG000|Overall Study|Lost to Follow-up|6|||
124943839|NCT02235298|449421993|FG001|Overall Study|Lost to Follow-up|5|||
124943840|NCT02235298|449421992|FG000|Overall Study|Adverse Event|2|||
124943841|NCT02235298|449421993|FG001|Overall Study|Adverse Event|2|||
124943842|NCT02235298|449421992|FG000|Overall Study|Withdrawal by Subject|0|||
124943843|NCT02235298|449421993|FG001|Overall Study|Withdrawal by Subject|1|||
124943844|NCT02309294|449421996|FG000|Overall Study|Withdrawal by Subject|2|||
124943845|NCT03520036|449421997|FG000|Overall Study|Adverse Event|1|||
124943846|NCT03520036|449421998|FG001|Overall Study|Adverse Event|2|||
124943847|NCT03520036|449421999|FG002|Overall Study|Adverse Event|0|||
124943848|NCT03520036|449421997|FG000|Overall Study|Protocol Violation|1|||
124943849|NCT03520036|449421998|FG001|Overall Study|Protocol Violation|0|||
124943850|NCT03520036|449421999|FG002|Overall Study|Protocol Violation|0|||
124943851|NCT03520036|449421997|FG000|Overall Study|Withdrawal by Subject|0|||
124943852|NCT03520036|449421998|FG001|Overall Study|Withdrawal by Subject|1|||
124943853|NCT03520036|449421999|FG002|Overall Study|Withdrawal by Subject|4|||
124943854|NCT03520036|449421997|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
124943855|NCT03520036|449421998|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
124943856|NCT03520036|449421999|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
124943857|NCT05426109|449422004|FG000|Overall Study|Withdrawal by Subject|0|||
125214285|NCT05259917|450411295|FG004|Overall Study|Protocol Violation|0|||
125214286|NCT05259917|450411296|FG005|Overall Study|Protocol Violation|0|||
125214287|NCT05259917|450411291|FG000|Overall Study|Lost to Follow-up|0|||
124943858|NCT05426109|449422005|FG001|Overall Study|Withdrawal by Subject|1|||
125214288|NCT05259917|450411292|FG001|Overall Study|Lost to Follow-up|0|||
124943859|NCT03102034|449422006|FG000|Overall Study|Withdrawal by Subject|1|||
124943860|NCT03102034|449422007|FG001|Overall Study|Withdrawal by Subject|0|||
124943861|NCT02222493|449422008|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
124943862|NCT02222493|449422009|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
124943863|NCT02222493|449422008|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
124943864|NCT02222493|449422009|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
124943865|NCT02222493|449422008|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
124943866|NCT02222493|449422009|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
124943867|NCT02222493|449422008|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
124943868|NCT02222493|449422009|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
125028222|NCT00352534|449727467|FG006|Final Risk Group Assignment|Physician Decision|0|||
125028223|NCT00352534|449727461|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
125028224|NCT00352534|449727462|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
125028225|NCT00352534|449727463|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
125028226|NCT00352534|449727464|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
125028227|NCT00352534|449727465|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
125028228|NCT00352534|449727466|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
125028229|NCT00352534|449727467|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
125028230|NCT00352534|449727461|FG000|Final Risk Group Assignment|Ineligible|0|||
125028231|NCT00352534|449727462|FG001|Final Risk Group Assignment|Ineligible|0|||
125028232|NCT00352534|449727463|FG002|Final Risk Group Assignment|Ineligible|3|||
125028233|NCT00352534|449727464|FG003|Final Risk Group Assignment|Ineligible|1|||
125028234|NCT00352534|449727465|FG004|Final Risk Group Assignment|Ineligible|0|||
125028235|NCT00352534|449727466|FG005|Final Risk Group Assignment|Ineligible|13|||
125028236|NCT00352534|449727467|FG006|Final Risk Group Assignment|Ineligible|0|||
125028237|NCT00352534|449727461|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
125028238|NCT00352534|449727462|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
125028239|NCT00352534|449727463|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
125028240|NCT00352534|449727464|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
125028241|NCT00352534|449727465|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
125028242|NCT00352534|449727466|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
125028243|NCT00352534|449727467|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
125028244|NCT00352534|449727461|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
125028245|NCT00352534|449727462|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
125028246|NCT00352534|449727463|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
125028247|NCT00352534|449727464|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
125028248|NCT00352534|449727465|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
125028249|NCT00352534|449727466|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
125028250|NCT00352534|449727467|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
125028251|NCT00352534|449727461|FG000|Final Risk Group Assignment|Death|0|||
125028252|NCT00352534|449727462|FG001|Final Risk Group Assignment|Death|0|||
125028253|NCT00352534|449727463|FG002|Final Risk Group Assignment|Death|0|||
125028254|NCT00352534|449727464|FG003|Final Risk Group Assignment|Death|0|||
125028255|NCT00352534|449727465|FG004|Final Risk Group Assignment|Death|0|||
125028256|NCT00352534|449727466|FG005|Final Risk Group Assignment|Death|2|||
125028257|NCT00352534|449727467|FG006|Final Risk Group Assignment|Death|0|||
125028258|NCT01602341|449727468|FG000|Overall Study|Adverse Event|0|||
125028259|NCT01602341|449727469|FG001|Overall Study|Adverse Event|1|||
125028260|NCT02090855|449727470|FG000|Overall Study|no evaluable Standard of Truth results|2|||
125028261|NCT00388947|449727471|FG000|Overall Study|Protocol Violation|47|||
125028262|NCT03038308|449727472|FG000|Overall Study|Surgical resection|1|||
125028263|NCT03038308|449727472|FG000|Overall Study|Withdrawal by Subject|2|||
125028264|NCT03038308|449727472|FG000|Overall Study|Lost to Follow-up|1|||
125028265|NCT04187092|449727473|FG000|Overall Study|Lost to Follow-up|1|||
125028266|NCT04187092|449727474|FG001|Overall Study|Lost to Follow-up|1|||
125028267|NCT04187092|449727473|FG000|Overall Study|Withdrawal by Subject|1|||
125028268|NCT04187092|449727474|FG001|Overall Study|Withdrawal by Subject|1|||
125028269|NCT04187092|449727473|FG000|Overall Study|Adverse Event|0|||
125028270|NCT04187092|449727474|FG001|Overall Study|Adverse Event|1|||
125028271|NCT01777763|449727488|FG000|Overall Study|Adverse Event|2|||
125028272|NCT01777763|449727489|FG001|Overall Study|Adverse Event|32|||
125028273|NCT01777763|449727488|FG000|Overall Study|Protocol Violation|1|||
124943869|NCT02222493|449422008|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
124943870|NCT02222493|449422009|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
125028274|NCT01777763|449727489|FG001|Overall Study|Protocol Violation|7|||
125028275|NCT01777763|449727488|FG000|Overall Study|Withdrawal by Subject|0|||
125028276|NCT01777763|449727489|FG001|Overall Study|Withdrawal by Subject|2|||
125028277|NCT01777763|449727488|FG000|Overall Study|Treatment Failure|1|||
125028278|NCT01777763|449727489|FG001|Overall Study|Treatment Failure|6|||
125028279|NCT03969875|449727496|FG000|Overall Study|did not receive allocated intervention|3|||
125028280|NCT03969875|449727497|FG001|Overall Study|did not receive allocated intervention|3|||
124943871|NCT02222493|449422008|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
124943872|NCT02222493|449422009|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
124943873|NCT02222493|449422008|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
125028281|NCT03969875|449727498|FG002|Overall Study|did not receive allocated intervention|4|||
125028282|NCT03969875|449727496|FG000|Overall Study|Protocol Violation|4|||
125028283|NCT03969875|449727497|FG001|Overall Study|Protocol Violation|2|||
125028284|NCT03969875|449727498|FG002|Overall Study|Protocol Violation|2|||
125028285|NCT02327260|449727499|FG000|Overall Study|Lost to Follow-up|2|||
125028286|NCT02327260|449727500|FG001|Overall Study|Lost to Follow-up|3|||
125028287|NCT02327260|449727501|FG002|Overall Study|Lost to Follow-up|2|||
125028288|NCT02327260|449727499|FG000|Overall Study|invalid phone number|1|||
125028289|NCT02327260|449727500|FG001|Overall Study|invalid phone number|1|||
125028290|NCT02327260|449727501|FG002|Overall Study|invalid phone number|0|||
125028291|NCT02327260|449727499|FG000|Overall Study|non-adherence to protocol|2|||
125028292|NCT02327260|449727500|FG001|Overall Study|non-adherence to protocol|0|||
125028293|NCT02327260|449727501|FG002|Overall Study|non-adherence to protocol|0|||
125028294|NCT02327260|449727499|FG000|Overall Study|cognitive concerns|1|||
125028295|NCT02327260|449727500|FG001|Overall Study|cognitive concerns|0|||
125028296|NCT02327260|449727501|FG002|Overall Study|cognitive concerns|0|||
125028297|NCT03502330|449727502|FG000|Overall Study|Adverse Event|2|||
125028298|NCT03502330|449727503|FG001|Overall Study|Adverse Event|1|||
125028299|NCT03502330|449727504|FG002|Overall Study|Adverse Event|0|||
125028300|NCT03502330|449727505|FG003|Overall Study|Adverse Event|0|||
125028301|NCT03502330|449727506|FG004|Overall Study|Adverse Event|1|||
125028302|NCT03502330|449727507|FG005|Overall Study|Adverse Event|0|||
125028303|NCT03502330|449727508|FG006|Overall Study|Adverse Event|1|||
125028304|NCT03502330|449727509|FG007|Overall Study|Adverse Event|1|||
125028305|NCT03502330|449727510|FG008|Overall Study|Adverse Event|0|||
125214289|NCT05259917|450411293|FG002|Overall Study|Lost to Follow-up|1|||
125214290|NCT05259917|450411294|FG003|Overall Study|Lost to Follow-up|0|||
125214291|NCT05259917|450411295|FG004|Overall Study|Lost to Follow-up|0|||
125214292|NCT05259917|450411296|FG005|Overall Study|Lost to Follow-up|1|||
125028306|NCT03502330|449727502|FG000|Overall Study|Lack of Efficacy|1|||
125028307|NCT03502330|449727503|FG001|Overall Study|Lack of Efficacy|5|||
125214293|NCT05259917|450411291|FG000|Overall Study|Physician Decision|0|||
125214294|NCT05259917|450411292|FG001|Overall Study|Physician Decision|1|||
125214295|NCT05259917|450411293|FG002|Overall Study|Physician Decision|0|||
125214296|NCT05259917|450411294|FG003|Overall Study|Physician Decision|0|||
125028308|NCT03502330|449727504|FG002|Overall Study|Lack of Efficacy|3|||
125028309|NCT03502330|449727505|FG003|Overall Study|Lack of Efficacy|5|||
125028310|NCT03502330|449727506|FG004|Overall Study|Lack of Efficacy|1|||
125028311|NCT03502330|449727507|FG005|Overall Study|Lack of Efficacy|5|||
125028312|NCT03502330|449727508|FG006|Overall Study|Lack of Efficacy|5|||
125028313|NCT03502330|449727509|FG007|Overall Study|Lack of Efficacy|6|||
125028314|NCT03502330|449727510|FG008|Overall Study|Lack of Efficacy|0|||
125028315|NCT03502330|449727502|FG000|Overall Study|Physician Decision|0|||
125214297|NCT05259917|450411295|FG004|Overall Study|Physician Decision|0|||
125214298|NCT05259917|450411296|FG005|Overall Study|Physician Decision|0|||
125214299|NCT05259917|450411291|FG000|Overall Study|Withdrawal by Subject|0|||
125214300|NCT05259917|450411292|FG001|Overall Study|Withdrawal by Subject|1|||
125028316|NCT03502330|449727503|FG001|Overall Study|Physician Decision|0|||
125028317|NCT03502330|449727504|FG002|Overall Study|Physician Decision|0|||
125028318|NCT03502330|449727505|FG003|Overall Study|Physician Decision|0|||
125028319|NCT03502330|449727506|FG004|Overall Study|Physician Decision|1|||
125028320|NCT03502330|449727507|FG005|Overall Study|Physician Decision|0|||
125028321|NCT03502330|449727508|FG006|Overall Study|Physician Decision|0|||
125028322|NCT03502330|449727509|FG007|Overall Study|Physician Decision|0|||
125028323|NCT03502330|449727510|FG008|Overall Study|Physician Decision|0|||
125214301|NCT05259917|450411293|FG002|Overall Study|Withdrawal by Subject|0|||
125028324|NCT03502330|449727502|FG000|Overall Study|Withdrawal by Subject|0|||
125028325|NCT03502330|449727503|FG001|Overall Study|Withdrawal by Subject|0|||
124943874|NCT02222493|449422009|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
124943875|NCT02222493|449422008|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
124943876|NCT02222493|449422009|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
124943877|NCT02222493|449422008|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
124943878|NCT02222493|449422009|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
124943879|NCT02222493|449422008|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
124943880|NCT02222493|449422009|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
124943881|NCT02222493|449422008|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
124943882|NCT02222493|449422009|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
124943883|NCT02222493|449422008|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
124943884|NCT02222493|449422009|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
124943885|NCT02222493|449422008|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
124943886|NCT02222493|449422009|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
124943887|NCT02222493|449422008|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
124943888|NCT02222493|449422009|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
124943889|NCT02222493|449422008|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
124943890|NCT02222493|449422009|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
124943891|NCT02222493|449422008|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
125123259|NCT00806156|450075791|FG000|Overall Study|Did not meet eligibility criteria|1|||
125123260|NCT00806156|450075792|FG001|Overall Study|Did not meet eligibility criteria|0|||
125123261|NCT00806156|450075791|FG000|Overall Study|Study terminated by Sponsor|2|||
125123262|NCT00806156|450075792|FG001|Overall Study|Study terminated by Sponsor|40|||
125123263|NCT00806156|450075791|FG000|Overall Study|Consent withdrawn by subject|1|||
125123264|NCT00806156|450075792|FG001|Overall Study|Consent withdrawn by subject|3|||
125123265|NCT00806156|450075791|FG000|Overall Study|Lost to Follow-up|0|||
125123266|NCT00806156|450075792|FG001|Overall Study|Lost to Follow-up|1|||
125123267|NCT00337571|450075796|FG000|Overall Study|Lack of Efficacy|3|||
125123268|NCT00337571|450075797|FG001|Overall Study|Lack of Efficacy|0|||
124943892|NCT02222493|449422009|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
124943893|NCT02222493|449422008|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
124943894|NCT02222493|449422009|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
124943895|NCT02222493|449422008|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
124943896|NCT02222493|449422009|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
124943897|NCT02222493|449422008|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
124943898|NCT02222493|449422009|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
124943899|NCT02222493|449422008|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
124943900|NCT02222493|449422009|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
124943901|NCT02222493|449422008|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
124943902|NCT02222493|449422009|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
124943903|NCT02222493|449422008|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
124943904|NCT02222493|449422009|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
124943905|NCT03611075|449422012|FG000|Overall Study|Physician Decision|0|||
125123269|NCT00337571|450075798|FG002|Overall Study|Lack of Efficacy|0|||
125123270|NCT00337571|450075799|FG003|Overall Study|Lack of Efficacy|0|||
125123271|NCT00337571|450075796|FG000|Overall Study|Adverse Event|4|||
125123272|NCT00337571|450075797|FG001|Overall Study|Adverse Event|5|||
125123273|NCT00337571|450075798|FG002|Overall Study|Adverse Event|8|||
125123274|NCT00337571|450075799|FG003|Overall Study|Adverse Event|4|||
125123275|NCT00337571|450075796|FG000|Overall Study|Withdrawal by Subject|2|||
125123276|NCT00337571|450075797|FG001|Overall Study|Withdrawal by Subject|2|||
125123277|NCT00337571|450075798|FG002|Overall Study|Withdrawal by Subject|1|||
125123278|NCT00337571|450075799|FG003|Overall Study|Withdrawal by Subject|0|||
124943906|NCT03611075|449422013|FG001|Overall Study|Physician Decision|1|||
124943907|NCT03611075|449422014|FG002|Overall Study|Physician Decision|1|||
124943908|NCT03611075|449422015|FG003|Overall Study|Physician Decision|0|||
124943909|NCT03611075|449422016|FG004|Overall Study|Physician Decision|0|||
124943910|NCT03611075|449422017|FG005|Overall Study|Physician Decision|0|||
124943911|NCT03611075|449422018|FG006|Overall Study|Physician Decision|0|||
124943912|NCT03611075|449422019|FG007|Overall Study|Physician Decision|0|||
124943913|NCT03611075|449422020|FG008|Overall Study|Physician Decision|0|||
124943914|NCT03611075|449422012|FG000|Overall Study|Lost to Follow-up|1|||
124943915|NCT03611075|449422013|FG001|Overall Study|Lost to Follow-up|0|||
124943916|NCT03611075|449422014|FG002|Overall Study|Lost to Follow-up|0|||
125123279|NCT00337571|450075796|FG000|Overall Study|Lost to Follow-up|3|||
125123280|NCT00337571|450075797|FG001|Overall Study|Lost to Follow-up|1|||
125123281|NCT00337571|450075798|FG002|Overall Study|Lost to Follow-up|0|||
125123282|NCT00337571|450075799|FG003|Overall Study|Lost to Follow-up|1|||
124943917|NCT03611075|449422015|FG003|Overall Study|Lost to Follow-up|2|||
124943918|NCT03611075|449422016|FG004|Overall Study|Lost to Follow-up|0|||
124943919|NCT03611075|449422017|FG005|Overall Study|Lost to Follow-up|0|||
124943920|NCT03611075|449422018|FG006|Overall Study|Lost to Follow-up|0|||
124943921|NCT03611075|449422019|FG007|Overall Study|Lost to Follow-up|0|||
124943922|NCT03611075|449422020|FG008|Overall Study|Lost to Follow-up|0|||
124943923|NCT03611075|449422012|FG000|Overall Study|Withdrawal by Subject|0|||
124943924|NCT03611075|449422013|FG001|Overall Study|Withdrawal by Subject|1|||
124943925|NCT03611075|449422014|FG002|Overall Study|Withdrawal by Subject|1|||
124943926|NCT03611075|449422015|FG003|Overall Study|Withdrawal by Subject|1|||
124943927|NCT03611075|449422016|FG004|Overall Study|Withdrawal by Subject|0|||
124943928|NCT03611075|449422017|FG005|Overall Study|Withdrawal by Subject|0|||
124943929|NCT03611075|449422018|FG006|Overall Study|Withdrawal by Subject|1|||
124943930|NCT03611075|449422019|FG007|Overall Study|Withdrawal by Subject|0|||
124943931|NCT03611075|449422020|FG008|Overall Study|Withdrawal by Subject|0|||
124943932|NCT03611075|449422012|FG000|Overall Study|Reason unknown|0|||
124943933|NCT03611075|449422013|FG001|Overall Study|Reason unknown|0|||
124943934|NCT03611075|449422014|FG002|Overall Study|Reason unknown|0|||
124943935|NCT03611075|449422015|FG003|Overall Study|Reason unknown|1|||
124943936|NCT03611075|449422016|FG004|Overall Study|Reason unknown|0|||
124943937|NCT03611075|449422017|FG005|Overall Study|Reason unknown|0|||
124943938|NCT03611075|449422018|FG006|Overall Study|Reason unknown|1|||
124943939|NCT03611075|449422019|FG007|Overall Study|Reason unknown|0|||
124943940|NCT03611075|449422020|FG008|Overall Study|Reason unknown|0|||
124943941|NCT00676091|449422021|FG000|Infant Series|Parent or legal guardian request|10|||
124943942|NCT00676091|449422022|FG001|Infant Series|Parent or legal guardian request|8|||
124943943|NCT00676091|449422021|FG000|Infant Series|Protocol Violation|6|||
124943944|NCT00676091|449422022|FG001|Infant Series|Protocol Violation|3|||
124943945|NCT00676091|449422021|FG000|Infant Series|Adverse Event|2|||
124943946|NCT00676091|449422022|FG001|Infant Series|Adverse Event|3|||
124943947|NCT00676091|449422021|FG000|Infant Series|Failed to return|1|||
124943948|NCT00676091|449422022|FG001|Infant Series|Failed to return|3|||
124943949|NCT00676091|449422021|FG000|Infant Series|Lost to Follow-up|1|||
124943950|NCT00676091|449422022|FG001|Infant Series|Lost to Follow-up|0|||
124943951|NCT00676091|449422021|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
124943952|NCT00676091|449422022|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
124943953|NCT00676091|449422021|FG000|After Infant Series|Adverse Event|0|||
124943954|NCT00676091|449422022|FG001|After Infant Series|Adverse Event|1|||
124943955|NCT00676091|449422021|FG000|After Infant Series|Protocol Violation|0|||
124943956|NCT00676091|449422022|FG001|After Infant Series|Protocol Violation|1|||
124943957|NCT00676091|449422021|FG000|After Infant Series|Failed to return|1|||
124943958|NCT00676091|449422022|FG001|After Infant Series|Failed to return|1|||
124943959|NCT00676091|449422021|FG000|Toddler Dose|Failed to return|2|||
124943960|NCT00676091|449422022|FG001|Toddler Dose|Failed to return|0|||
124943961|NCT00676091|449422021|FG000|Toddler Dose|Parent or legal guardian request|1|||
124943962|NCT00676091|449422022|FG001|Toddler Dose|Parent or legal guardian request|0|||
124943963|NCT01701401|449422026|FG000|Overall Study|Randomized But Not Treated|3|||
124943964|NCT01701401|449422027|FG001|Overall Study|Randomized But Not Treated|1|||
124943965|NCT01701401|449422028|FG002|Overall Study|Randomized But Not Treated|0|||
124943966|NCT01701401|449422029|FG003|Overall Study|Randomized But Not Treated|1|||
124943967|NCT01701401|449422026|FG000|Overall Study|Lost to Follow-up|5|||
124943968|NCT01701401|449422027|FG001|Overall Study|Lost to Follow-up|5|||
124943969|NCT01701401|449422028|FG002|Overall Study|Lost to Follow-up|1|||
124943970|NCT01701401|449422029|FG003|Overall Study|Lost to Follow-up|3|||
124943971|NCT01701401|449422026|FG000|Overall Study|Withdrew Consent|0|||
124943972|NCT01701401|449422027|FG001|Overall Study|Withdrew Consent|3|||
124943973|NCT01701401|449422028|FG002|Overall Study|Withdrew Consent|1|||
124943974|NCT01701401|449422029|FG003|Overall Study|Withdrew Consent|2|||
125214302|NCT05259917|450411294|FG003|Overall Study|Withdrawal by Subject|0|||
124943975|NCT01701401|449422026|FG000|Overall Study|Lack of Efficacy|1|||
124943976|NCT01701401|449422027|FG001|Overall Study|Lack of Efficacy|0|||
124943977|NCT01701401|449422028|FG002|Overall Study|Lack of Efficacy|2|||
124943978|NCT01701401|449422029|FG003|Overall Study|Lack of Efficacy|0|||
124943979|NCT01701401|449422026|FG000|Overall Study|Adverse Event|1|||
124943980|NCT01701401|449422027|FG001|Overall Study|Adverse Event|0|||
124943981|NCT01701401|449422028|FG002|Overall Study|Adverse Event|0|||
124943982|NCT01701401|449422029|FG003|Overall Study|Adverse Event|0|||
124943983|NCT01701401|449422026|FG000|Overall Study|Protocol Violation|0|||
124943984|NCT01701401|449422027|FG001|Overall Study|Protocol Violation|0|||
124943985|NCT01701401|449422028|FG002|Overall Study|Protocol Violation|1|||
124943986|NCT01701401|449422029|FG003|Overall Study|Protocol Violation|0|||
124943987|NCT00933270|449422030|FG000|Overall Study|Withdrawal by Subject|26|||
124943988|NCT00933270|449422030|FG000|Overall Study|Insufficient Follow-up|10|||
124943989|NCT00933270|449422030|FG000|Overall Study|Lost to Follow-up|14|||
124943990|NCT00933270|449422030|FG000|Overall Study|Adverse Event|1|||
124943991|NCT00933270|449422030|FG000|Overall Study|Missed Visit|2|||
124943992|NCT00933270|449422030|FG000|Overall Study|Death|24|||
124943993|NCT00933270|449422030|FG000|Overall Study|Moved or would not return|10|||
124943994|NCT01000805|449422031|FG000|Overall Study|Adverse Event|21|||
124943995|NCT01000805|449422032|FG001|Overall Study|Adverse Event|9|||
124943996|NCT01000805|449422031|FG000|Overall Study|Lack of Efficacy|5|||
124943997|NCT01000805|449422032|FG001|Overall Study|Lack of Efficacy|16|||
124943998|NCT01000805|449422031|FG000|Overall Study|Lost to Follow-up|16|||
124943999|NCT01000805|449422032|FG001|Overall Study|Lost to Follow-up|21|||
124944000|NCT01000805|449422031|FG000|Overall Study|Physician Decision|0|||
124944001|NCT01000805|449422032|FG001|Overall Study|Physician Decision|1|||
124944002|NCT01000805|449422031|FG000|Overall Study|Protocol Violation|12|||
124944003|NCT01000805|449422032|FG001|Overall Study|Protocol Violation|8|||
124944004|NCT01000805|449422031|FG000|Overall Study|Withdrawal by Subject|16|||
124944005|NCT01000805|449422032|FG001|Overall Study|Withdrawal by Subject|6|||
124944006|NCT01000805|449422031|FG000|Overall Study|Sponsor Decision|0|||
124944007|NCT01000805|449422032|FG001|Overall Study|Sponsor Decision|1|||
124944008|NCT00989196|449422033|FG000|Treatment Period|Lost to Follow-up|1|||
124944009|NCT00989196|449422034|FG001|Treatment Period|Lost to Follow-up|0|||
124944010|NCT02409680|449422035|FG000|Overall Study|Lost to Follow-up|15|||
124944011|NCT02409680|449422036|FG001|Overall Study|Lost to Follow-up|30|||
124944012|NCT03343704|449422040|FG000|Overall Study|Refused to complete follow up|0|||
124944013|NCT03343704|449422041|FG001|Overall Study|Refused to complete follow up|1|||
124944014|NCT03343704|449422040|FG000|Overall Study|Death|0|||
124944015|NCT03343704|449422041|FG001|Overall Study|Death|1|||
124944016|NCT03343704|449422040|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
124944017|NCT03343704|449422041|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
124944018|NCT03789656|449422046|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
124944019|NCT03789656|449422047|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
124944020|NCT03789656|449422048|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
124944021|NCT03789656|449422049|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
124944022|NCT03789656|449422050|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
124944023|NCT03789656|449422046|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
124944024|NCT03789656|449422047|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
124944025|NCT03789656|449422048|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
124944026|NCT03789656|449422049|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
124944027|NCT03789656|449422050|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
124944028|NCT03789656|449422046|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
124944029|NCT03789656|449422047|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
124944030|NCT03789656|449422048|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
124944031|NCT03789656|449422049|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
124944032|NCT03789656|449422050|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
124944033|NCT03789656|449422046|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
124944034|NCT03789656|449422047|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
124944035|NCT03789656|449422048|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
124944036|NCT03789656|449422049|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
124944037|NCT03789656|449422050|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
124944038|NCT02434328|449422058|FG000|Overall Study|Adverse Event|9|||
124944039|NCT02434328|449422059|FG001|Overall Study|Adverse Event|4|||
124944040|NCT02434328|449422058|FG000|Overall Study|Lack of Efficacy|0|||
124944041|NCT02434328|449422059|FG001|Overall Study|Lack of Efficacy|2|||
124944042|NCT02434328|449422058|FG000|Overall Study|Physician Decision|0|||
125123283|NCT00337571|450075796|FG000|Overall Study|Poor/noncompliance|1|||
125123284|NCT00337571|450075797|FG001|Overall Study|Poor/noncompliance|1|||
125123285|NCT00337571|450075798|FG002|Overall Study|Poor/noncompliance|1|||
125123286|NCT00337571|450075799|FG003|Overall Study|Poor/noncompliance|1|||
125123287|NCT00337571|450075796|FG000|Overall Study|No longer met study criteria|1|||
125123288|NCT00337571|450075797|FG001|Overall Study|No longer met study criteria|0|||
124944043|NCT02434328|449422059|FG001|Overall Study|Physician Decision|1|||
124944044|NCT02434328|449422058|FG000|Overall Study|Withdrawal by Subject|12|||
124944045|NCT02434328|449422059|FG001|Overall Study|Withdrawal by Subject|21|||
124944046|NCT02434328|449422058|FG000|Overall Study|Death|4|||
124944047|NCT02434328|449422059|FG001|Overall Study|Death|7|||
125123289|NCT00337571|450075798|FG002|Overall Study|No longer met study criteria|0|||
124944048|NCT02434328|449422058|FG000|Overall Study|Lost to Follow-up|1|||
124944049|NCT02434328|449422059|FG001|Overall Study|Lost to Follow-up|6|||
124944050|NCT02434328|449422058|FG000|Overall Study|Other|4|||
124944051|NCT02434328|449422059|FG001|Overall Study|Other|1|||
124944052|NCT00302211|449422066|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
124944053|NCT00302211|449422067|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
124944054|NCT00302211|449422068|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
125214303|NCT05259917|450411295|FG004|Overall Study|Withdrawal by Subject|1|||
125214304|NCT05259917|450411296|FG005|Overall Study|Withdrawal by Subject|1|||
125214305|NCT05259917|450411291|FG000|Overall Study|Trial Termination by Sponsor|7|||
125214306|NCT05259917|450411292|FG001|Overall Study|Trial Termination by Sponsor|2|||
125214307|NCT05259917|450411293|FG002|Overall Study|Trial Termination by Sponsor|3|||
125214308|NCT05259917|450411294|FG003|Overall Study|Trial Termination by Sponsor|5|||
124944055|NCT00302211|449422069|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
124944056|NCT00302211|449422070|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
124944057|NCT00302211|449422066|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
124944058|NCT00302211|449422067|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
124944059|NCT00302211|449422068|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
125214309|NCT05259917|450411295|FG004|Overall Study|Trial Termination by Sponsor|11|||
125214310|NCT05259917|450411296|FG005|Overall Study|Trial Termination by Sponsor|4|||
125214311|NCT05259917|450411291|FG000|Overall Study|Other|1|||
125214312|NCT05259917|450411292|FG001|Overall Study|Other|0|||
124944060|NCT00302211|449422069|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
124944061|NCT00302211|449422070|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
124944062|NCT00302211|449422066|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
124944063|NCT00302211|449422067|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
125214313|NCT05259917|450411293|FG002|Overall Study|Other|2|||
124944064|NCT00302211|449422068|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
124944065|NCT00302211|449422069|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
124944066|NCT00302211|449422070|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
124944067|NCT00302211|449422066|FG000|Double Blind Period (New Patients)|Disease progression|0|||
124944068|NCT00302211|449422067|FG001|Double Blind Period (New Patients)|Disease progression|1|||
124944069|NCT00302211|449422068|FG002|Double Blind Period (New Patients)|Disease progression|1|||
124944070|NCT00302211|449422069|FG003|Double Blind Period (New Patients)|Disease progression|0|||
124944071|NCT00302211|449422070|FG004|Double Blind Period (New Patients)|Disease progression|0|||
124944072|NCT00302211|449422066|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
124944073|NCT00302211|449422067|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
125214314|NCT05259917|450411294|FG003|Overall Study|Other|0|||
124944074|NCT00302211|449422068|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
124944075|NCT00302211|449422069|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
124944076|NCT00302211|449422070|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
124944077|NCT00302211|449422066|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
124944078|NCT00302211|449422067|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
124944079|NCT00302211|449422068|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
125028326|NCT03502330|449727504|FG002|Overall Study|Withdrawal by Subject|0|||
125028327|NCT03502330|449727505|FG003|Overall Study|Withdrawal by Subject|0|||
125028328|NCT03502330|449727506|FG004|Overall Study|Withdrawal by Subject|0|||
125028329|NCT03502330|449727507|FG005|Overall Study|Withdrawal by Subject|1|||
125028330|NCT03502330|449727508|FG006|Overall Study|Withdrawal by Subject|0|||
125028331|NCT03502330|449727509|FG007|Overall Study|Withdrawal by Subject|1|||
125028332|NCT03502330|449727510|FG008|Overall Study|Withdrawal by Subject|0|||
125028333|NCT03502330|449727502|FG000|Overall Study|Death|0|||
125028334|NCT03502330|449727503|FG001|Overall Study|Death|0|||
125028335|NCT03502330|449727504|FG002|Overall Study|Death|0|||
125028336|NCT03502330|449727505|FG003|Overall Study|Death|0|||
125028337|NCT03502330|449727506|FG004|Overall Study|Death|0|||
125028338|NCT03502330|449727507|FG005|Overall Study|Death|0|||
125028339|NCT03502330|449727508|FG006|Overall Study|Death|2|||
125028340|NCT03502330|449727509|FG007|Overall Study|Death|0|||
125028341|NCT03502330|449727510|FG008|Overall Study|Death|0|||
125028342|NCT00548548|449727511|FG000|Overall Study|Death|345|||
125028343|NCT00548548|449727512|FG001|Overall Study|Death|348|||
125028344|NCT00548548|449727511|FG000|Overall Study|Lost to Follow-up|17|||
125028345|NCT00548548|449727512|FG001|Overall Study|Lost to Follow-up|18|||
125028346|NCT03617705|449727517|FG000|Overall Study|Withdrawal by Subject|2|||
125028347|NCT03617705|449727517|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
125028348|NCT03617705|449727517|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
125028349|NCT03502187|449727518|FG000|Overall Study|Withdrawal by Subject|4|||
125028350|NCT03502187|449727519|FG001|Overall Study|Withdrawal by Subject|3|||
125028351|NCT03502187|449727520|FG002|Overall Study|Withdrawal by Subject|3|||
125028352|NCT03502187|449727518|FG000|Overall Study|Lost to Follow-up|5|||
125028353|NCT03502187|449727519|FG001|Overall Study|Lost to Follow-up|4|||
125028354|NCT03502187|449727520|FG002|Overall Study|Lost to Follow-up|5|||
124944080|NCT00302211|449422069|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
124944081|NCT00302211|449422070|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
124944082|NCT00302211|449422066|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
124944083|NCT00302211|449422067|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
124944084|NCT00302211|449422068|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
124944085|NCT00302211|449422069|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
124944086|NCT00302211|449422070|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
124944087|NCT00302211|449422066|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
124944088|NCT00302211|449422067|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
124944089|NCT00302211|449422068|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
124944090|NCT00302211|449422069|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
124944091|NCT00302211|449422070|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
124944092|NCT00302211|449422066|FG000|Open Label-Patients From Double-Blind|Death|0|||
124944093|NCT00302211|449422067|FG001|Open Label-Patients From Double-Blind|Death|0|||
124944094|NCT00302211|449422068|FG002|Open Label-Patients From Double-Blind|Death|0|||
124944095|NCT00302211|449422069|FG003|Open Label-Patients From Double-Blind|Death|1|||
124944096|NCT00302211|449422070|FG004|Open Label-Patients From Double-Blind|Death|1|||
124944097|NCT00302211|449422066|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
124944098|NCT00302211|449422067|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
124944099|NCT00302211|449422068|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
124944100|NCT00302211|449422069|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
124944101|NCT00302211|449422070|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
124944102|NCT00302211|449422066|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
124944103|NCT00302211|449422067|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
124944104|NCT00302211|449422068|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
124944105|NCT00302211|449422069|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
124944106|NCT00302211|449422070|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
124944107|NCT00302211|449422066|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
124944108|NCT00302211|449422067|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
124944109|NCT00302211|449422068|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
124944110|NCT00302211|449422069|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
124944111|NCT00302211|449422070|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
124944112|NCT02294461|449422071|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
124944113|NCT02294461|449422072|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
124944114|NCT02294461|449422073|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
124944115|NCT02294461|449422071|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
124944116|NCT02294461|449422072|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
124944117|NCT02294461|449422073|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
124944118|NCT02294461|449422071|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
124944119|NCT02294461|449422072|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
124944120|NCT02294461|449422073|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
124944121|NCT02294461|449422071|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
124944122|NCT02294461|449422072|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
124944123|NCT02294461|449422073|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
124944124|NCT02294461|449422071|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
124944125|NCT02294461|449422072|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
124944126|NCT02294461|449422073|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
124944127|NCT02294461|449422071|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
124944128|NCT02294461|449422072|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
124944129|NCT02294461|449422073|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
124944130|NCT02294461|449422071|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
124944131|NCT02294461|449422072|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
124944132|NCT02294461|449422073|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
124944133|NCT02294461|449422071|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
124944134|NCT02294461|449422072|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
124944135|NCT02294461|449422073|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
124944136|NCT02294461|449422071|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
124944137|NCT02294461|449422072|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
124944138|NCT02294461|449422073|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
124944139|NCT02294461|449422071|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
124944140|NCT02294461|449422072|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
124944141|NCT02294461|449422073|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
124944142|NCT02294461|449422071|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
125028355|NCT01061008|449727521|FG000|Overall Study|Badiocephalic fistula failed|3|||
125028356|NCT01061008|449727522|FG001|Overall Study|Badiocephalic fistula failed|2|||
125028357|NCT01061008|449727521|FG000|Overall Study|Death|1|||
124944143|NCT02294461|449422072|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
124944144|NCT02294461|449422073|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
124944145|NCT02294461|449422071|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
124944146|NCT02294461|449422072|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
124944147|NCT02294461|449422073|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
124944148|NCT02294461|449422071|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
125028358|NCT01061008|449727522|FG001|Overall Study|Death|0|||
124944149|NCT02294461|449422072|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
124944150|NCT02294461|449422073|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
124944151|NCT02294461|449422071|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
124944152|NCT02294461|449422072|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
124944153|NCT02294461|449422073|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
124944154|NCT05432986|449422074|FG000|Overall Study|Withdrawal by Subject|2|||
124944155|NCT05432986|449422074|FG000|Overall Study|incomplete measurement|7|||
124944156|NCT03009344|449423147|FG000|Overall Study|Lack of Efficacy|5|||
124944157|NCT03009344|449423147|FG000|Overall Study|Withdrawal by Subject|1|||
124944158|NCT03009344|449423147|FG000|Overall Study|Adverse Event|1|||
124944159|NCT00378898|449423148|FG000|Overall Study|Withdrawal by Subject|10|||
124944160|NCT00378898|449423149|FG001|Overall Study|Withdrawal by Subject|5|||
124944161|NCT00378898|449423148|FG000|Overall Study|Protocol Violation|1|||
124944162|NCT00378898|449423149|FG001|Overall Study|Protocol Violation|1|||
124944163|NCT02534233|449423152|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
124944164|NCT00551421|449423153|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
124944165|NCT03136159|449423155|FG000|Overall Study|chorioamnionitis|2|||
124944166|NCT03136159|449423156|FG001|Overall Study|chorioamnionitis|0|||
124944167|NCT03136159|449423155|FG000|Overall Study|vertical skin incision|1|||
124944168|NCT03136159|449423156|FG001|Overall Study|vertical skin incision|0|||
124944169|NCT03136159|449423155|FG000|Overall Study|additional dressing|1|||
124944170|NCT03136159|449423156|FG001|Overall Study|additional dressing|0|||
124944171|NCT03136159|449423155|FG000|Overall Study|never got dressing placed|1|||
124944172|NCT03136159|449423156|FG001|Overall Study|never got dressing placed|0|||
124944173|NCT01732757|449423158|FG000|Overall Study|Lost to Follow-up|1|||
124944174|NCT01732757|449423159|FG001|Overall Study|Lost to Follow-up|0|||
124944175|NCT01732757|449423160|FG002|Overall Study|Lost to Follow-up|0|||
124944176|NCT00089609|449423166|FG000|Overall Study|Withdrawal by Subject|3|||
124944177|NCT00089609|449423167|FG001|Overall Study|Withdrawal by Subject|1|||
124944178|NCT03116464|449423168|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
124944179|NCT00597376|449423169|FG000|Overall Study|Withdrawal by Subject|4|||
124944180|NCT00597376|449423170|FG001|Overall Study|Withdrawal by Subject|3|||
124944181|NCT00597376|449423169|FG000|Overall Study|Adverse Event|4|||
124944182|NCT00597376|449423170|FG001|Overall Study|Adverse Event|1|||
124944183|NCT04693637|449423175|FG000|Overall Study|Death|4|||
124944184|NCT04693637|449423175|FG000|Overall Study|Withdrawal by Subject|3|||
124944185|NCT04693637|449423175|FG000|Overall Study|Physician Decision|2|||
124944186|NCT04693637|449423175|FG000|Overall Study|Lost to Follow-up|1|||
124944187|NCT04237792|449423176|FG000|Treatment (Day 1)|Adverse Event|1|||
124944188|NCT04237792|449423177|FG001|Treatment (Day 1)|Adverse Event|0|||
125028359|NCT01061008|449727521|FG000|Overall Study|Withdrawal by Subject|1|||
125028360|NCT01061008|449727522|FG001|Overall Study|Withdrawal by Subject|3|||
125028361|NCT01061008|449727521|FG000|Overall Study|Unable to exercise following surgery|1|||
125028362|NCT01061008|449727522|FG001|Overall Study|Unable to exercise following surgery|0|||
125028363|NCT01061008|449727521|FG000|Overall Study|Adverse Event|0|||
125028364|NCT01061008|449727522|FG001|Overall Study|Adverse Event|1|||
125028365|NCT02908100|449727524|FG000|Overall Study|Adverse Event|7|||
125028366|NCT02908100|449727525|FG001|Overall Study|Adverse Event|6|||
125028367|NCT02908100|449727526|FG002|Overall Study|Adverse Event|9|||
125028368|NCT02908100|449727524|FG000|Overall Study|Death|2|||
125028369|NCT02908100|449727525|FG001|Overall Study|Death|0|||
125028370|NCT02908100|449727526|FG002|Overall Study|Death|0|||
125028371|NCT02908100|449727524|FG000|Overall Study|Lack of Efficacy|2|||
125028372|NCT02908100|449727525|FG001|Overall Study|Lack of Efficacy|3|||
125028373|NCT02908100|449727526|FG002|Overall Study|Lack of Efficacy|3|||
125028374|NCT02908100|449727524|FG000|Overall Study|Lost to Follow-up|0|||
125028375|NCT02908100|449727525|FG001|Overall Study|Lost to Follow-up|1|||
125028376|NCT02908100|449727526|FG002|Overall Study|Lost to Follow-up|2|||
125028377|NCT02908100|449727524|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125028378|NCT02908100|449727525|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125028379|NCT02908100|449727526|FG002|Overall Study|Non-Compliance With Study Drug|2|||
125028380|NCT02908100|449727524|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
125028381|NCT02908100|449727525|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
125028382|NCT02908100|449727526|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
125028383|NCT02908100|449727524|FG000|Overall Study|Physician Decision|0|||
125028384|NCT02908100|449727525|FG001|Overall Study|Physician Decision|1|||
125028385|NCT02908100|449727526|FG002|Overall Study|Physician Decision|0|||
125028386|NCT02908100|449727524|FG000|Overall Study|Pregnancy|1|||
124944189|NCT04237792|449423178|FG002|Treatment (Day 1)|Adverse Event|0|||
124944190|NCT04237792|449423179|FG003|Treatment (Day 1)|Adverse Event|0|||
125028387|NCT02908100|449727525|FG001|Overall Study|Pregnancy|2|||
125028388|NCT02908100|449727526|FG002|Overall Study|Pregnancy|0|||
125028389|NCT02908100|449727524|FG000|Overall Study|Withdrawal by Subject|8|||
124944191|NCT04237792|449423180|FG004|Treatment (Day 1)|Adverse Event|1|||
124944192|NCT04237792|449423181|FG005|Treatment (Day 1)|Adverse Event|1|||
124944193|NCT04237792|449423176|FG000|Treatment (Day 1)|Other|0|||
124944194|NCT04237792|449423177|FG001|Treatment (Day 1)|Other|0|||
124944195|NCT04237792|449423178|FG002|Treatment (Day 1)|Other|1|||
124944196|NCT04237792|449423179|FG003|Treatment (Day 1)|Other|0|||
124944197|NCT04237792|449423180|FG004|Treatment (Day 1)|Other|0|||
124944198|NCT04237792|449423181|FG005|Treatment (Day 1)|Other|1|||
124944199|NCT04237792|449423176|FG000|Treatment (Day 1)|Not treated|1|||
124944200|NCT04237792|449423177|FG001|Treatment (Day 1)|Not treated|1|||
124944201|NCT04237792|449423178|FG002|Treatment (Day 1)|Not treated|2|||
124944202|NCT04237792|449423179|FG003|Treatment (Day 1)|Not treated|1|||
124944203|NCT04237792|449423180|FG004|Treatment (Day 1)|Not treated|0|||
124944204|NCT04237792|449423181|FG005|Treatment (Day 1)|Not treated|1|||
124944205|NCT03205566|449423184|FG000|Phase 1|Protocol Violation|1|||
124944206|NCT03205566|449423185|FG001|Phase 1|Protocol Violation|1|||
124944207|NCT02022670|449423186|FG000|Overall Study|Adverse Event|1|||
124944208|NCT02022670|449423187|FG001|Overall Study|Adverse Event|0|||
124944209|NCT02022670|449423188|FG002|Overall Study|Adverse Event|1|||
124944210|NCT02113449|449423189|FG000|Overall Study|Adverse Event|4|||
124944211|NCT01957163|449423192|FG000|Overall Study|Adverse Event|5|||
124944212|NCT01957163|449423193|FG001|Overall Study|Adverse Event|2|||
124944213|NCT01957163|449423194|FG002|Overall Study|Adverse Event|4|||
124944214|NCT01957163|449423192|FG000|Overall Study|Lack of Efficacy|5|||
124944215|NCT01957163|449423193|FG001|Overall Study|Lack of Efficacy|4|||
124944216|NCT01957163|449423194|FG002|Overall Study|Lack of Efficacy|9|||
124944217|NCT01957163|449423192|FG000|Overall Study|Protocol Violation|1|||
124944218|NCT01957163|449423193|FG001|Overall Study|Protocol Violation|2|||
124944219|NCT01957163|449423194|FG002|Overall Study|Protocol Violation|0|||
124944220|NCT01957163|449423192|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
124944221|NCT01957163|449423193|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
124944222|NCT01957163|449423194|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
124944223|NCT01957163|449423192|FG000|Overall Study|Lost to Follow-up|0|||
124944224|NCT01957163|449423193|FG001|Overall Study|Lost to Follow-up|1|||
124944225|NCT01957163|449423194|FG002|Overall Study|Lost to Follow-up|0|||
124944226|NCT01957163|449423192|FG000|Overall Study|Withdrawal by Subject|4|||
124944227|NCT01957163|449423193|FG001|Overall Study|Withdrawal by Subject|2|||
124944228|NCT01957163|449423194|FG002|Overall Study|Withdrawal by Subject|4|||
125028390|NCT02908100|449727525|FG001|Overall Study|Withdrawal by Subject|7|||
125028391|NCT02908100|449727526|FG002|Overall Study|Withdrawal by Subject|5|||
125028392|NCT02908100|449727524|FG000|Overall Study|Randomised in Error|1|||
125028393|NCT02908100|449727525|FG001|Overall Study|Randomised in Error|0|||
125028394|NCT02908100|449727526|FG002|Overall Study|Randomised in Error|0|||
125028395|NCT04088409|449727527|FG000|Part A|Withdrawal by Subject|2|||
125028396|NCT04088409|449727528|FG001|Part A|Withdrawal by Subject|1|||
125028397|NCT04088409|449727527|FG000|Part A|Did Not Meet Randomization Criteria|2|||
125028398|NCT04088409|449727528|FG001|Part A|Did Not Meet Randomization Criteria|0|||
125028399|NCT04088409|449727527|FG000|Part A|Lack of Efficacy|9|||
125028400|NCT04088409|449727528|FG001|Part A|Lack of Efficacy|0|||
124944229|NCT03697603|449423195|FG000|Overall Study|Adverse Event|3|||
124944230|NCT03697603|449423196|FG001|Overall Study|Adverse Event|18|||
124944231|NCT03697603|449423197|FG002|Overall Study|Adverse Event|3|||
124944232|NCT03697603|449423195|FG000|Overall Study|Physician Decision|1|||
124944233|NCT03697603|449423196|FG001|Overall Study|Physician Decision|0|||
125028401|NCT04088409|449727527|FG000|Part A|Lost to Follow-up|1|||
125028402|NCT04088409|449727528|FG001|Part A|Lost to Follow-up|0|||
124944234|NCT03697603|449423197|FG002|Overall Study|Physician Decision|2|||
124944235|NCT03697603|449423195|FG000|Overall Study|Protocol Violation|3|||
124944236|NCT03697603|449423196|FG001|Overall Study|Protocol Violation|8|||
124944237|NCT03697603|449423197|FG002|Overall Study|Protocol Violation|5|||
124944238|NCT03697603|449423195|FG000|Overall Study|Withdrawal by Subject|5|||
124944239|NCT03697603|449423196|FG001|Overall Study|Withdrawal by Subject|1|||
124944240|NCT03697603|449423197|FG002|Overall Study|Withdrawal by Subject|1|||
124944241|NCT03697603|449423195|FG000|Overall Study|Protocol Violation|0|||
124944242|NCT03697603|449423196|FG001|Overall Study|Protocol Violation|0|||
124944243|NCT03697603|449423197|FG002|Overall Study|Protocol Violation|1|||
124944244|NCT02686658|449423198|FG000|Overall Study|Adverse Event|0|||
124944245|NCT02686658|449423199|FG001|Overall Study|Adverse Event|0|||
124944246|NCT02686658|449423200|FG002|Overall Study|Adverse Event|1|||
124944247|NCT02686658|449423201|FG003|Overall Study|Adverse Event|1|||
125214315|NCT05259917|450411295|FG004|Overall Study|Other|0|||
125214316|NCT05259917|450411296|FG005|Overall Study|Other|0|||
125214317|NCT00482170|450411297|FG000|Overall Study|Adverse Event|5|||
125214318|NCT00482170|450411298|FG001|Overall Study|Adverse Event|14|||
125214319|NCT00482170|450411297|FG000|Overall Study|Withdrawal by Subject|6|||
125214320|NCT00482170|450411298|FG001|Overall Study|Withdrawal by Subject|1|||
125214321|NCT00482170|450411297|FG000|Overall Study|Protocol Violation|2|||
125214322|NCT00482170|450411298|FG001|Overall Study|Protocol Violation|3|||
125214323|NCT00482170|450411297|FG000|Overall Study|Lost to Follow-up|2|||
125214324|NCT00482170|450411298|FG001|Overall Study|Lost to Follow-up|0|||
125214325|NCT00482170|450411297|FG000|Overall Study|Unspecified reason|0|||
125214326|NCT00482170|450411298|FG001|Overall Study|Unspecified reason|2|||
125214327|NCT01658904|450411301|FG000|Overall Study|Principal Investigator discretion|2|||
124944248|NCT02686658|449423202|FG004|Overall Study|Adverse Event|2|||
124944249|NCT02686658|449423203|FG005|Overall Study|Adverse Event|1|||
124944250|NCT02686658|449423198|FG000|Overall Study|Investigator decision|0|||
124944251|NCT02686658|449423199|FG001|Overall Study|Investigator decision|0|||
124944252|NCT02686658|449423200|FG002|Overall Study|Investigator decision|0|||
124944253|NCT02686658|449423201|FG003|Overall Study|Investigator decision|1|||
124944254|NCT02686658|449423202|FG004|Overall Study|Investigator decision|2|||
124944255|NCT02686658|449423203|FG005|Overall Study|Investigator decision|1|||
124944256|NCT02686658|449423198|FG000|Overall Study|Sponsor decision|1|||
124944257|NCT02686658|449423199|FG001|Overall Study|Sponsor decision|2|||
124944258|NCT02686658|449423200|FG002|Overall Study|Sponsor decision|1|||
124944259|NCT02686658|449423201|FG003|Overall Study|Sponsor decision|5|||
124944260|NCT02686658|449423202|FG004|Overall Study|Sponsor decision|13|||
124944261|NCT02686658|449423203|FG005|Overall Study|Sponsor decision|2|||
124944262|NCT02686658|449423198|FG000|Overall Study|Lost to Follow-up|0|||
124944263|NCT02686658|449423199|FG001|Overall Study|Lost to Follow-up|0|||
124944264|NCT02686658|449423200|FG002|Overall Study|Lost to Follow-up|2|||
124944265|NCT02686658|449423201|FG003|Overall Study|Lost to Follow-up|0|||
124944266|NCT02686658|449423202|FG004|Overall Study|Lost to Follow-up|0|||
124944267|NCT02686658|449423203|FG005|Overall Study|Lost to Follow-up|1|||
124944268|NCT02686658|449423198|FG000|Overall Study|Death|1|||
124944269|NCT02686658|449423199|FG001|Overall Study|Death|0|||
124944270|NCT02686658|449423200|FG002|Overall Study|Death|0|||
124944271|NCT02686658|449423201|FG003|Overall Study|Death|1|||
124944272|NCT02686658|449423202|FG004|Overall Study|Death|1|||
124944273|NCT02686658|449423203|FG005|Overall Study|Death|1|||
124944274|NCT02686658|449423198|FG000|Overall Study|Withdrawal by Subject|2|||
124944275|NCT02686658|449423199|FG001|Overall Study|Withdrawal by Subject|5|||
124944276|NCT02686658|449423200|FG002|Overall Study|Withdrawal by Subject|4|||
124944277|NCT02686658|449423201|FG003|Overall Study|Withdrawal by Subject|4|||
124944278|NCT02686658|449423202|FG004|Overall Study|Withdrawal by Subject|17|||
124944279|NCT02686658|449423203|FG005|Overall Study|Withdrawal by Subject|8|||
124944280|NCT02686658|449423198|FG000|Overall Study|Placed in hospice care|0|||
124944281|NCT02686658|449423199|FG001|Overall Study|Placed in hospice care|0|||
124944282|NCT02686658|449423200|FG002|Overall Study|Placed in hospice care|1|||
124944283|NCT02686658|449423201|FG003|Overall Study|Placed in hospice care|0|||
124944284|NCT02686658|449423202|FG004|Overall Study|Placed in hospice care|0|||
125214328|NCT01658904|450411302|FG001|Overall Study|Principal Investigator discretion|0|||
124944285|NCT02686658|449423203|FG005|Overall Study|Placed in hospice care|0|||
124944286|NCT02686658|449423198|FG000|Overall Study|Participant non-compliance|0|||
124944287|NCT02686658|449423199|FG001|Overall Study|Participant non-compliance|0|||
124944288|NCT02686658|449423200|FG002|Overall Study|Participant non-compliance|0|||
124944289|NCT02686658|449423201|FG003|Overall Study|Participant non-compliance|0|||
124944290|NCT02686658|449423202|FG004|Overall Study|Participant non-compliance|0|||
124944291|NCT02686658|449423203|FG005|Overall Study|Participant non-compliance|1|||
124944292|NCT02686658|449423198|FG000|Overall Study|Concern over coronavirus disease care|0|||
124944293|NCT02686658|449423199|FG001|Overall Study|Concern over coronavirus disease care|0|||
124944294|NCT02686658|449423200|FG002|Overall Study|Concern over coronavirus disease care|0|||
124944295|NCT02686658|449423201|FG003|Overall Study|Concern over coronavirus disease care|0|||
125214329|NCT01658904|450411303|FG002|Overall Study|Principal Investigator discretion|0|||
125214330|NCT00080483|450411304|FG000|Overall Study|Lost to Follow-up|1|||
125028403|NCT04088409|449727527|FG000|Part A|Adverse Event|1|||
125028404|NCT04088409|449727528|FG001|Part A|Adverse Event|0|||
124944296|NCT02686658|449423202|FG004|Overall Study|Concern over coronavirus disease care|2|||
124944297|NCT02686658|449423203|FG005|Overall Study|Concern over coronavirus disease care|1|||
124944298|NCT00467272|449423204|FG000|Overall Study|Pneumonia|2|||
124944299|NCT00467272|449423204|FG000|Overall Study|Thrombophlebitis|1|||
124944300|NCT00570505|449423205|FG000|Overall Study|Adverse Event|7|||
124944301|NCT00570505|449423205|FG000|Overall Study|Withdrawal by Subject|7|||
124944302|NCT00570505|449423205|FG000|Overall Study|Lost to Follow-up|23|||
124944303|NCT00570505|449423205|FG000|Overall Study|Other loss to follow-up|4|||
124944304|NCT00614614|449423208|FG000|Primary Vaccination Phase|Adverse Event|6|||
124944305|NCT00614614|449423209|FG001|Primary Vaccination Phase|Adverse Event|0|||
124944306|NCT00614614|449423210|FG002|Primary Vaccination Phase|Adverse Event|0|||
124944307|NCT00614614|449423211|FG003|Primary Vaccination Phase|Adverse Event|0|||
124944308|NCT00614614|449423212|FG004|Primary Vaccination Phase|Adverse Event|0|||
124944309|NCT00614614|449423208|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
124944310|NCT00614614|449423209|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
124944311|NCT00614614|449423210|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
124944312|NCT00614614|449423211|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
124944313|NCT00614614|449423212|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
124944314|NCT00614614|449423208|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
124944315|NCT00614614|449423209|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
124944316|NCT00614614|449423210|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
124944317|NCT00614614|449423211|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
124944318|NCT00614614|449423212|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
124944319|NCT00614614|449423208|FG000|Primary Vaccination Phase|Protocol Violation|9|||
124944320|NCT00614614|449423209|FG001|Primary Vaccination Phase|Protocol Violation|3|||
125028405|NCT04088409|449727527|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
125028406|NCT04088409|449727528|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
125028407|NCT04088409|449727527|FG000|Part B|Ongoing Treatment|10|||
125028408|NCT04088409|449727528|FG001|Part B|Ongoing Treatment|0|||
125028409|NCT00400400|449727529|FG000|Overall Study|Adverse Event|9|||
125028410|NCT00400400|449727530|FG001|Overall Study|Adverse Event|8|||
125123290|NCT00337571|450075799|FG003|Overall Study|No longer met study criteria|0|||
125123291|NCT00337571|450075796|FG000|Overall Study|High Potassium level|0|||
125123292|NCT00337571|450075797|FG001|Overall Study|High Potassium level|0|||
125123293|NCT00337571|450075798|FG002|Overall Study|High Potassium level|0|||
125123294|NCT00337571|450075799|FG003|Overall Study|High Potassium level|1|||
125123295|NCT00449150|450075803|FG000|Overall Study|Adverse Event|11|||
125123296|NCT00449150|450075804|FG001|Overall Study|Adverse Event|18|||
125123297|NCT00449150|450075805|FG002|Overall Study|Adverse Event|9|||
125123298|NCT00449150|450075803|FG000|Overall Study|Lack of Efficacy|1|||
125123299|NCT00449150|450075804|FG001|Overall Study|Lack of Efficacy|2|||
125123300|NCT00449150|450075805|FG002|Overall Study|Lack of Efficacy|2|||
125123301|NCT00449150|450075803|FG000|Overall Study|Other|16|||
125123302|NCT00449150|450075804|FG001|Overall Study|Other|13|||
125123303|NCT00449150|450075805|FG002|Overall Study|Other|14|||
125123304|NCT00449150|450075803|FG000|Overall Study|Withdrawal by Subject|17|||
125123305|NCT00449150|450075804|FG001|Overall Study|Withdrawal by Subject|18|||
125123306|NCT00449150|450075805|FG002|Overall Study|Withdrawal by Subject|21|||
125123307|NCT00449150|450075803|FG000|Overall Study|Protocol Violation|1|||
125123308|NCT00449150|450075804|FG001|Overall Study|Protocol Violation|2|||
125123309|NCT00449150|450075805|FG002|Overall Study|Protocol Violation|1|||
125123310|NCT02674334|450075806|FG000|Overall Study|Lost to Follow-up|5|||
125123311|NCT02674334|450075807|FG001|Overall Study|Lost to Follow-up|3|||
125123312|NCT02674334|450075806|FG000|Overall Study|participant difficulty breathing|1|||
125123313|NCT02674334|450075807|FG001|Overall Study|participant difficulty breathing|0|||
125123314|NCT02674334|450075806|FG000|Overall Study|NIRS not recording|1|||
125123315|NCT02674334|450075807|FG001|Overall Study|NIRS not recording|0|||
125123316|NCT03552757|450075808|FG000|Overall Study|Withdrawal by Subject|10|||
125123317|NCT03552757|450075809|FG001|Overall Study|Withdrawal by Subject|5|||
125214331|NCT00080483|450411305|FG001|Overall Study|Lost to Follow-up|1|||
125123318|NCT03552757|450075810|FG002|Overall Study|Withdrawal by Subject|12|||
124944321|NCT00614614|449423210|FG002|Primary Vaccination Phase|Protocol Violation|0|||
124944322|NCT00614614|449423211|FG003|Primary Vaccination Phase|Protocol Violation|0|||
124944323|NCT00614614|449423212|FG004|Primary Vaccination Phase|Protocol Violation|0|||
124944324|NCT00614614|449423208|FG000|Primary Vaccination Phase|Other|4|||
124944325|NCT00614614|449423209|FG001|Primary Vaccination Phase|Other|0|||
124944326|NCT00614614|449423210|FG002|Primary Vaccination Phase|Other|0|||
125123319|NCT03552757|450075808|FG000|Overall Study|Lost to Follow-up|2|||
125123320|NCT03552757|450075809|FG001|Overall Study|Lost to Follow-up|7|||
125123321|NCT03552757|450075810|FG002|Overall Study|Lost to Follow-up|7|||
125123322|NCT03552757|450075808|FG000|Overall Study|Death|1|||
125123323|NCT03552757|450075809|FG001|Overall Study|Death|1|||
125028411|NCT00400400|449727529|FG000|Overall Study|Protocol Violation|2|||
125028412|NCT00400400|449727530|FG001|Overall Study|Protocol Violation|0|||
125028413|NCT00400400|449727529|FG000|Overall Study|Withdrawal by Subject|1|||
125028414|NCT00400400|449727530|FG001|Overall Study|Withdrawal by Subject|3|||
125028415|NCT00400400|449727529|FG000|Overall Study|Administrative Problem|1|||
125028416|NCT00400400|449727530|FG001|Overall Study|Administrative Problem|0|||
125028417|NCT00400400|449727529|FG000|Overall Study|Lost to Follow-up|0|||
125028418|NCT00400400|449727530|FG001|Overall Study|Lost to Follow-up|1|||
125028419|NCT00400400|449727529|FG000|Overall Study|Did not receive study drug|1|||
125028420|NCT00400400|449727530|FG001|Overall Study|Did not receive study drug|3|||
125028421|NCT00189462|449727531|FG000|Overall Study|Lack of Efficacy|5|||
125028422|NCT00189462|449727532|FG001|Overall Study|Lack of Efficacy|1|||
125028423|NCT00189462|449727531|FG000|Overall Study|Lost to Follow-up|18|||
125028424|NCT00189462|449727532|FG001|Overall Study|Lost to Follow-up|20|||
125028425|NCT01262625|449727535|FG000|Overall Study|Administrative Error|1|||
125028426|NCT01262625|449727536|FG001|Overall Study|Administrative Error|1|||
125028427|NCT01262625|449727535|FG000|Overall Study|Site Closed|1|||
125028428|NCT01262625|449727536|FG001|Overall Study|Site Closed|0|||
125028429|NCT02789657|449727537|FG000|Overall Study|Withdrawal by Subject|2|||
125028430|NCT02789657|449727538|FG001|Overall Study|Withdrawal by Subject|0|||
125028431|NCT02789657|449727539|FG002|Overall Study|Withdrawal by Subject|0|||
125028432|NCT02789657|449727540|FG003|Overall Study|Withdrawal by Subject|0|||
125028433|NCT01214044|449727541|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
125028434|NCT01214044|449727541|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
125028435|NCT01214044|449727541|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
125028436|NCT01214044|449727541|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
125028437|NCT01214044|449727541|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
125028438|NCT01214044|449727541|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
125028439|NCT02772757|449727543|FG000|Overall Study|Withdrawal by Subject|1|||
125028440|NCT02772757|449727544|FG001|Overall Study|Withdrawal by Subject|0|||
125028441|NCT02772757|449727545|FG002|Overall Study|Withdrawal by Subject|1|||
125028442|NCT02772757|449727543|FG000|Overall Study|Protocol Violation|0|||
125028443|NCT02772757|449727544|FG001|Overall Study|Protocol Violation|0|||
125028444|NCT02772757|449727545|FG002|Overall Study|Protocol Violation|1|||
125028445|NCT02772757|449727543|FG000|Overall Study|Physician Decision|0|||
125028446|NCT02772757|449727544|FG001|Overall Study|Physician Decision|3|||
125028447|NCT02772757|449727545|FG002|Overall Study|Physician Decision|3|||
125028448|NCT04698525|449727550|FG000|Overall Study|Lost to Follow-up|1|||
125028449|NCT04698525|449727551|FG001|Overall Study|Lost to Follow-up|2|||
125028450|NCT04698525|449727550|FG000|Overall Study|Three suffered of Covid-19|2|||
125028451|NCT04698525|449727551|FG001|Overall Study|Three suffered of Covid-19|1|||
125028452|NCT00510276|449727557|FG000|Acute Double-Blind Phase|Adverse Event|21|||
125028453|NCT00510276|449727558|FG001|Acute Double-Blind Phase|Adverse Event|6|||
125028454|NCT00510276|449727557|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
125028455|NCT00510276|449727558|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
125028456|NCT00510276|449727557|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
125028457|NCT00510276|449727558|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
125028458|NCT00510276|449727557|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
125028459|NCT00510276|449727558|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
125028460|NCT00510276|449727557|FG000|Acute Double-Blind Phase|Physician Decision|0|||
125028461|NCT00510276|449727558|FG001|Acute Double-Blind Phase|Physician Decision|3|||
125028462|NCT00510276|449727557|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
125028463|NCT00510276|449727558|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
125028464|NCT00510276|449727557|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
125028465|NCT00510276|449727558|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
125123324|NCT03552757|450075810|FG002|Overall Study|Death|1|||
125123325|NCT02660242|450075814|FG000|Glucose Tabs|Lost to Follow-up|1|||
125123326|NCT02660242|450075814|FG000|Glucagon Injection|Lost to Follow-up|1|||
125123327|NCT01345019|450075816|FG000|Blinded Treatment Phase|Death|147|||
125123328|NCT01345019|450075817|FG001|Blinded Treatment Phase|Death|137|||
125123329|NCT01345019|450075816|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
125028466|NCT00510276|449727557|FG000|Acute Double-Blind Phase|Subject Decision|26|||
125028467|NCT00510276|449727558|FG001|Acute Double-Blind Phase|Subject Decision|28|||
125028468|NCT00510276|449727557|FG000|Extension Open-Label Phase|Adverse Event|9|||
125028469|NCT00510276|449727558|FG001|Extension Open-Label Phase|Adverse Event|18|||
125028470|NCT00510276|449727557|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
125028471|NCT00510276|449727558|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
125028472|NCT00510276|449727557|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
125028473|NCT00510276|449727558|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
125028474|NCT00510276|449727557|FG000|Extension Open-Label Phase|Physician Decision|2|||
125123330|NCT01345019|450075817|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
124944327|NCT00614614|449423211|FG003|Primary Vaccination Phase|Other|0|||
124944328|NCT00614614|449423212|FG004|Primary Vaccination Phase|Other|0|||
124944329|NCT00614614|449423208|FG000|Booster Vaccination Phase|Adverse Event|0|||
124944330|NCT00614614|449423209|FG001|Booster Vaccination Phase|Adverse Event|0|||
124944331|NCT00614614|449423210|FG002|Booster Vaccination Phase|Adverse Event|1|||
124944332|NCT00614614|449423211|FG003|Booster Vaccination Phase|Adverse Event|1|||
124944333|NCT00614614|449423212|FG004|Booster Vaccination Phase|Adverse Event|0|||
124944334|NCT00614614|449423208|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
124944335|NCT00614614|449423209|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
124944336|NCT00614614|449423210|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
124944337|NCT00614614|449423211|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
124944338|NCT00614614|449423212|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
124944339|NCT00614614|449423208|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
124944340|NCT00614614|449423209|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
124944341|NCT00614614|449423210|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
124944342|NCT00614614|449423211|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
124944343|NCT00614614|449423212|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
124944344|NCT00614614|449423208|FG000|Booster Vaccination Phase|Protocol Violation|0|||
124944345|NCT00614614|449423209|FG001|Booster Vaccination Phase|Protocol Violation|0|||
124944346|NCT00614614|449423210|FG002|Booster Vaccination Phase|Protocol Violation|2|||
124944347|NCT00614614|449423211|FG003|Booster Vaccination Phase|Protocol Violation|3|||
124944348|NCT00614614|449423212|FG004|Booster Vaccination Phase|Protocol Violation|0|||
124944349|NCT00614614|449423208|FG000|Booster Vaccination Phase|Other|0|||
124944350|NCT00614614|449423209|FG001|Booster Vaccination Phase|Other|1|||
124944351|NCT00614614|449423210|FG002|Booster Vaccination Phase|Other|3|||
124944352|NCT00614614|449423211|FG003|Booster Vaccination Phase|Other|2|||
124944353|NCT00614614|449423212|FG004|Booster Vaccination Phase|Other|1|||
124944354|NCT05212285|449423213|FG000|Overall Study|Lack of Efficacy|12|||
124944355|NCT05212285|449423214|FG001|Overall Study|Lack of Efficacy|8|||
124944356|NCT05212285|449423213|FG000|Overall Study|Withdrawal by Subject|8|||
124944357|NCT05212285|449423214|FG001|Overall Study|Withdrawal by Subject|1|||
124944358|NCT05212285|449423213|FG000|Overall Study|Lost to Follow-up|13|||
124944359|NCT05212285|449423214|FG001|Overall Study|Lost to Follow-up|1|||
124944360|NCT05212285|449423213|FG000|Overall Study|miss data|21|||
124944361|NCT05212285|449423214|FG001|Overall Study|miss data|2|||
124944362|NCT03924869|449423218|FG000|Overall Study|Death|66|||
124944363|NCT03924869|449423219|FG001|Overall Study|Death|53|||
124944364|NCT03924869|449423218|FG000|Overall Study|Lost to Follow-up|2|||
124944365|NCT03924869|449423219|FG001|Overall Study|Lost to Follow-up|0|||
124944366|NCT03924869|449423218|FG000|Overall Study|Physician Decision|0|||
124944367|NCT03924869|449423219|FG001|Overall Study|Physician Decision|3|||
124944368|NCT03924869|449423218|FG000|Overall Study|Withdrawal by Subject|5|||
124944369|NCT03924869|449423219|FG001|Overall Study|Withdrawal by Subject|1|||
124944370|NCT03924869|449423218|FG000|Overall Study|Participants Ongoing|154|||
124944371|NCT03924869|449423219|FG001|Overall Study|Participants Ongoing|164|||
125123331|NCT01345019|450075816|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
125123332|NCT01345019|450075817|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
125123333|NCT01345019|450075816|FG000|Blinded Treatment Phase|Disease Progression|12|||
125123334|NCT01345019|450075817|FG001|Blinded Treatment Phase|Disease Progression|10|||
125123335|NCT01345019|450075816|FG000|Blinded Treatment Phase|Adverse Event|6|||
125123336|NCT01345019|450075817|FG001|Blinded Treatment Phase|Adverse Event|13|||
125123337|NCT01345019|450075816|FG000|Blinded Treatment Phase|Administrative Decision|10|||
125123338|NCT01345019|450075817|FG001|Blinded Treatment Phase|Administrative Decision|8|||
125123339|NCT01345019|450075816|FG000|Blinded Treatment Phase|Noncompliance|5|||
125123340|NCT01345019|450075817|FG001|Blinded Treatment Phase|Noncompliance|3|||
125123341|NCT01345019|450075816|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
125123342|NCT01345019|450075817|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
125123343|NCT01345019|450075816|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
125123344|NCT01345019|450075817|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
125123345|NCT01345019|450075816|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
125123346|NCT01345019|450075817|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
125123347|NCT01345019|450075816|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
125123348|NCT01345019|450075817|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
125123349|NCT01345019|450075816|FG000|Open Label Treatment Phase|Death|49|||
125123350|NCT01345019|450075817|FG001|Open Label Treatment Phase|Death|48|||
124944372|NCT02542943|449423220|FG000|Overall Study|Lost to Follow-up|1|||
124944373|NCT02542943|449423221|FG001|Overall Study|Lost to Follow-up|0|||
124944374|NCT02542943|449423222|FG002|Overall Study|Lost to Follow-up|0|||
124944375|NCT02542943|449423220|FG000|Overall Study|Withdrawal by Subject|0|||
124944376|NCT02542943|449423221|FG001|Overall Study|Withdrawal by Subject|1|||
124944377|NCT02542943|449423222|FG002|Overall Study|Withdrawal by Subject|0|||
124944378|NCT03476798|449423228|FG000|Overall Study|Death|1|||
124944379|NCT03476798|449423228|FG000|Overall Study|Withdrawal by Subject|2|||
124944380|NCT03476798|449423228|FG000|Overall Study|Protocol Violation|2|||
125123351|NCT01345019|450075816|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
125028475|NCT00510276|449727558|FG001|Extension Open-Label Phase|Physician Decision|3|||
125028476|NCT00510276|449727557|FG000|Extension Open-Label Phase|Protocol Violation|0|||
125214332|NCT00080483|450411304|FG000|Overall Study|Physician Decision|1|||
125214333|NCT00080483|450411305|FG001|Overall Study|Physician Decision|1|||
125214334|NCT01808222|450411306|FG000|Overall Study|mpMR scan was not performed|1|||
125214335|NCT00460746|450411314|FG000|Overall Study|Adverse Event|1|||
125028477|NCT00510276|449727558|FG001|Extension Open-Label Phase|Protocol Violation|1|||
125028478|NCT00510276|449727557|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
125028479|NCT00510276|449727558|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
125028480|NCT00510276|449727557|FG000|Extension Open-Label Phase|Subject Decision|7|||
125028481|NCT00510276|449727558|FG001|Extension Open-Label Phase|Subject Decision|9|||
125028482|NCT03486392|449727561|FG000|Overall Study|Lost to Follow-up|0|||
125028483|NCT03486392|449727562|FG001|Overall Study|Lost to Follow-up|0|||
125028484|NCT03486392|449727563|FG002|Overall Study|Lost to Follow-up|8|||
125214336|NCT00460746|450411314|FG000|Overall Study|Lost to Follow-up|1|||
125214337|NCT04399538|450411319|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
124944381|NCT05824559|449423229|FG000|Overall Study|Adverse Event|2|||
124944382|NCT05824559|449423229|FG000|Overall Study|Physician Decision|2|||
125028485|NCT03486392|449727564|FG003|Overall Study|Lost to Follow-up|5|||
125028486|NCT03486392|449727565|FG004|Overall Study|Lost to Follow-up|2|||
125028487|NCT03486392|449727561|FG000|Overall Study|Withdrawal by Subject|3|||
125028488|NCT03486392|449727562|FG001|Overall Study|Withdrawal by Subject|0|||
125028489|NCT03486392|449727563|FG002|Overall Study|Withdrawal by Subject|6|||
125028490|NCT03486392|449727564|FG003|Overall Study|Withdrawal by Subject|4|||
125028491|NCT03486392|449727565|FG004|Overall Study|Withdrawal by Subject|1|||
125028492|NCT03486392|449727561|FG000|Overall Study|Death|0|||
125028493|NCT03486392|449727562|FG001|Overall Study|Death|0|||
125028494|NCT03486392|449727563|FG002|Overall Study|Death|0|||
125028495|NCT03486392|449727564|FG003|Overall Study|Death|0|||
125028496|NCT03486392|449727565|FG004|Overall Study|Death|1|||
125028497|NCT01731678|449727568|FG000|Overall Study|Withdrawal by Subject|3|||
125028498|NCT01731678|449727568|FG000|Overall Study|Did not meet inclusion criteria|1|||
125028499|NCT01731678|449727568|FG000|Overall Study|RMT too high, making TMS difficult|3|||
125028500|NCT00888355|449727573|FG000|Overall Study|Adverse Event|10|||
125028501|NCT00888355|449727574|FG001|Overall Study|Adverse Event|0|||
125028502|NCT00888355|449727575|FG002|Overall Study|Adverse Event|3|||
125028503|NCT00888355|449727576|FG003|Overall Study|Adverse Event|3|||
125028504|NCT00888355|449727573|FG000|Overall Study|Lack of Efficacy|9|||
125028505|NCT00888355|449727574|FG001|Overall Study|Lack of Efficacy|2|||
125028506|NCT00888355|449727575|FG002|Overall Study|Lack of Efficacy|5|||
125028507|NCT00888355|449727576|FG003|Overall Study|Lack of Efficacy|2|||
125028508|NCT00888355|449727573|FG000|Overall Study|Lost to Follow-up|0|||
125028509|NCT00888355|449727574|FG001|Overall Study|Lost to Follow-up|2|||
125028510|NCT00888355|449727575|FG002|Overall Study|Lost to Follow-up|2|||
125028511|NCT00888355|449727576|FG003|Overall Study|Lost to Follow-up|0|||
125028512|NCT00888355|449727573|FG000|Overall Study|Protocol Violation|3|||
125028513|NCT00888355|449727574|FG001|Overall Study|Protocol Violation|2|||
125028514|NCT00888355|449727575|FG002|Overall Study|Protocol Violation|1|||
125028515|NCT00888355|449727576|FG003|Overall Study|Protocol Violation|2|||
125028516|NCT00888355|449727573|FG000|Overall Study|Withdrawal by Subject|0|||
125028517|NCT00888355|449727574|FG001|Overall Study|Withdrawal by Subject|3|||
125028518|NCT00888355|449727575|FG002|Overall Study|Withdrawal by Subject|1|||
125028519|NCT00888355|449727576|FG003|Overall Study|Withdrawal by Subject|3|||
124944383|NCT05824559|449423229|FG000|Overall Study|Progressive Disease|16|||
124944384|NCT05824559|449423229|FG000|Overall Study|Study Terminated by Sponsor|1|||
124944385|NCT05824559|449423229|FG000|Overall Study|Withdrawal by Subject|2|||
124944386|NCT04602728|449423239|FG000|Overall Study|Lost to Follow-up|4|||
124944387|NCT04602728|449423240|FG001|Overall Study|Lost to Follow-up|4|||
124944388|NCT05865392|449423241|FG000|Overall Study|Withdrawal by Subject|4|||
124944389|NCT05865392|449423242|FG001|Overall Study|Withdrawal by Subject|0|||
124944390|NCT05865392|449423241|FG000|Overall Study|Didn't meet inclusion criteria|4|||
124944391|NCT05865392|449423242|FG001|Overall Study|Didn't meet inclusion criteria|0|||
124944392|NCT05366751|449423245|FG000|Overall Study|Adverse Event|25|||
124944393|NCT05366751|449423245|FG000|Overall Study|Physician Decision|3|||
125028520|NCT01551693|449727578|FG000|Overall Study|Disease Progression|1|||
124944394|NCT05366751|449423245|FG000|Overall Study|Lost to Follow-up|2|||
125028521|NCT01551693|449727579|FG001|Overall Study|Disease Progression|0|||
125028522|NCT01551693|449727578|FG000|Overall Study|Adverse Event|0|||
125028523|NCT01551693|449727579|FG001|Overall Study|Adverse Event|1|||
125028524|NCT01551693|449727578|FG000|Overall Study|Withdrawal by Subject|0|||
125028525|NCT01551693|449727579|FG001|Overall Study|Withdrawal by Subject|1|||
125028526|NCT04897867|449727581|FG000|Overall Study|Withdrawal of Consent|1|||
125028527|NCT04897867|449727581|FG000|Overall Study|Pregnancy|1|||
125028528|NCT04897867|449727581|FG000|Overall Study|Lost to Follow-up|7|||
125028529|NCT04897867|449727581|FG000|Overall Study|Reason not Specified|2|||
124944395|NCT05366751|449423245|FG000|Overall Study|Withdrawal by Subject|14|||
124944396|NCT05366751|449423245|FG000|Overall Study|Study Terminated by Sponsor|50|||
124944397|NCT05366751|449423245|FG000|Overall Study|Site Terminated by Sponsor|3|||
125028530|NCT02251912|449727582|FG000|Overall Study|Withdrawal by Subject|2|||
124944398|NCT04937504|449423246|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
124944399|NCT04937504|449423247|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
124944400|NCT04937504|449423246|FG000|9 Months Assessment|Lost to Follow-up|3|||
124944401|NCT04937504|449423247|FG001|9 Months Assessment|Lost to Follow-up|2|||
124944402|NCT04118894|449423248|FG000|Overall Study|Lost to Follow-up|21|||
124944403|NCT04118894|449423248|FG000|Overall Study|Withdrawal by Subject|10|||
124944404|NCT04118894|449423248|FG000|Overall Study|Adverse Event|4|||
124944405|NCT02634307|449424270|FG000|Overall Study|Adverse Event|50|||
124944406|NCT02634307|449424271|FG001|Overall Study|Adverse Event|24|||
124944407|NCT02634307|449424272|FG002|Overall Study|Adverse Event|14|||
124944408|NCT02634307|449424270|FG000|Overall Study|Lost to Follow-up|21|||
124944409|NCT02634307|449424271|FG001|Overall Study|Lost to Follow-up|5|||
124944410|NCT02634307|449424272|FG002|Overall Study|Lost to Follow-up|6|||
124944411|NCT02634307|449424270|FG000|Overall Study|Pregnancy|5|||
124944412|NCT02634307|449424271|FG001|Overall Study|Pregnancy|1|||
124944413|NCT02634307|449424272|FG002|Overall Study|Pregnancy|3|||
124944414|NCT02634307|449424270|FG000|Overall Study|Withdrawal by Subject|38|||
124944415|NCT02634307|449424271|FG001|Overall Study|Withdrawal by Subject|24|||
124944416|NCT02634307|449424272|FG002|Overall Study|Withdrawal by Subject|18|||
124944417|NCT02634307|449424270|FG000|Overall Study|Non-Compliance with Study Drug|0|||
124944418|NCT02634307|449424271|FG001|Overall Study|Non-Compliance with Study Drug|2|||
124944419|NCT02634307|449424272|FG002|Overall Study|Non-Compliance with Study Drug|2|||
124944420|NCT02634307|449424270|FG000|Overall Study|Lack of Efficacy|1|||
124944421|NCT02634307|449424271|FG001|Overall Study|Lack of Efficacy|5|||
125028531|NCT02251912|449727583|FG001|Overall Study|Withdrawal by Subject|3|||
125028532|NCT02251912|449727582|FG000|Overall Study|Adverse Event|0|||
125028533|NCT02251912|449727583|FG001|Overall Study|Adverse Event|2|||
125028534|NCT01107444|449727584|FG000|Overall Study|Withdrawal by Subject|8|||
125028535|NCT01107444|449727585|FG001|Overall Study|Withdrawal by Subject|12|||
125028536|NCT01107444|449727584|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
125028537|NCT01107444|449727585|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
125028538|NCT01948830|449727588|FG000|Overall Study|Physician Decision|1|||
125028539|NCT01948830|449727589|FG001|Overall Study|Physician Decision|3|||
125028540|NCT01948830|449727588|FG000|Overall Study|Protocol deviation|1|||
125028541|NCT01948830|449727589|FG001|Overall Study|Protocol deviation|2|||
125028542|NCT01948830|449727588|FG000|Overall Study|Lost to Follow-up|5|||
125028543|NCT01948830|449727589|FG001|Overall Study|Lost to Follow-up|4|||
125028544|NCT01948830|449727588|FG000|Overall Study|Withdrawal by Subject|14|||
125028545|NCT01948830|449727589|FG001|Overall Study|Withdrawal by Subject|17|||
125028546|NCT01948830|449727588|FG000|Overall Study|Adverse Event|9|||
125028547|NCT01948830|449727589|FG001|Overall Study|Adverse Event|2|||
125028548|NCT01948830|449727588|FG000|Overall Study|Death|3|||
125028549|NCT01948830|449727589|FG001|Overall Study|Death|4|||
125028550|NCT01133171|449727590|FG000|Overall Study|Withdrawal by Subject|1|||
125028551|NCT01133171|449727591|FG001|Overall Study|Withdrawal by Subject|2|||
125028552|NCT01133171|449727592|FG002|Overall Study|Withdrawal by Subject|0|||
125028553|NCT02526550|449727593|FG000|Overall Study|Lost to Follow-up|1|||
125028554|NCT03969888|449727596|FG000|Overall Study|Never Received Study Drug|0|||
125028555|NCT03969888|449727597|FG001|Overall Study|Never Received Study Drug|0|||
125028556|NCT03969888|449727598|FG002|Overall Study|Never Received Study Drug|1|||
125028557|NCT03969888|449727599|FG003|Overall Study|Never Received Study Drug|0|||
125028558|NCT03969888|449727600|FG004|Overall Study|Never Received Study Drug|0|||
125028559|NCT03969888|449727601|FG005|Overall Study|Never Received Study Drug|0|||
124944422|NCT02634307|449424272|FG002|Overall Study|Lack of Efficacy|3|||
124944423|NCT02634307|449424270|FG000|Overall Study|Physician Decision|7|||
124944424|NCT02634307|449424271|FG001|Overall Study|Physician Decision|5|||
124944425|NCT02634307|449424272|FG002|Overall Study|Physician Decision|5|||
125028560|NCT03969888|449727602|FG006|Overall Study|Never Received Study Drug|1|||
125028561|NCT03969888|449727603|FG007|Overall Study|Never Received Study Drug|0|||
125028562|NCT03969888|449727596|FG000|Overall Study|Reason Not Specified|0|||
125028563|NCT03969888|449727597|FG001|Overall Study|Reason Not Specified|0|||
125028564|NCT03969888|449727598|FG002|Overall Study|Reason Not Specified|0|||
125028565|NCT03969888|449727599|FG003|Overall Study|Reason Not Specified|0|||
125028566|NCT03969888|449727600|FG004|Overall Study|Reason Not Specified|0|||
125028567|NCT03969888|449727601|FG005|Overall Study|Reason Not Specified|0|||
125028568|NCT03969888|449727602|FG006|Overall Study|Reason Not Specified|0|||
125028569|NCT03969888|449727603|FG007|Overall Study|Reason Not Specified|1|||
125028570|NCT01282229|449727613|FG000|Overall Study|Protocol Violation|2|||
125028571|NCT00769119|449727615|FG000|Overall Study|Voluntary discontinuation|0|||
124944426|NCT02634307|449424270|FG000|Overall Study|Reason not Specified|3|||
124944427|NCT02634307|449424271|FG001|Overall Study|Reason not Specified|5|||
125028572|NCT00769119|449727616|FG001|Overall Study|Voluntary discontinuation|2|||
125028573|NCT00769119|449727615|FG000|Overall Study|Adverse Event|1|||
125028574|NCT00769119|449727616|FG001|Overall Study|Adverse Event|1|||
125028575|NCT00769119|449727615|FG000|Overall Study|Disallowed medication|1|||
125028576|NCT00769119|449727616|FG001|Overall Study|Disallowed medication|0|||
124944428|NCT02634307|449424272|FG002|Overall Study|Reason not Specified|10|||
124944429|NCT02698475|449424273|FG000|Main Study Period|Lack of Efficacy|1|||
124944430|NCT02698475|449424273|FG000|Main Study Period|Protocol Violation|2|||
124944431|NCT02698475|449424273|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
124944432|NCT02698475|449424273|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
124944433|NCT02698475|449424273|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
124944434|NCT02698475|449424273|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
124944435|NCT02698475|449424273|FG000|Long-Term Extension Period|Other|1|||
124944436|NCT02132949|449424274|FG000|Overall Study|Death|7|||
124944437|NCT02132949|449424275|FG001|Overall Study|Death|13|||
124944438|NCT02132949|449424274|FG000|Overall Study|Lost to Follow-up|14|||
124944439|NCT02132949|449424275|FG001|Overall Study|Lost to Follow-up|4|||
124944440|NCT02132949|449424274|FG000|Overall Study|Withdrawal by Subject|6|||
124944441|NCT02132949|449424275|FG001|Overall Study|Withdrawal by Subject|5|||
124944442|NCT02132949|449424274|FG000|Overall Study|Noncompliance|5|||
124944443|NCT02132949|449424275|FG001|Overall Study|Noncompliance|1|||
124944444|NCT02132949|449424274|FG000|Overall Study|Physician Decision|3|||
124944445|NCT02132949|449424275|FG001|Overall Study|Physician Decision|1|||
124944446|NCT02132949|449424274|FG000|Overall Study|Disease Progression|3|||
124944447|NCT02132949|449424275|FG001|Overall Study|Disease Progression|0|||
124944448|NCT02132949|449424274|FG000|Overall Study|Adverse Event|2|||
124944449|NCT02132949|449424275|FG001|Overall Study|Adverse Event|1|||
124944450|NCT02132949|449424274|FG000|Overall Study|Withdrew Prior to Treatment|1|||
124944451|NCT02132949|449424275|FG001|Overall Study|Withdrew Prior to Treatment|2|||
124944452|NCT02132949|449424274|FG000|Overall Study|Reason Unspecified|0|||
124944453|NCT02132949|449424275|FG001|Overall Study|Reason Unspecified|1|||
124944454|NCT01823224|449424276|FG000|Overall Study|Lost to Follow-up|5|||
124944455|NCT01823224|449424277|FG001|Overall Study|Lost to Follow-up|6|||
124944456|NCT01823224|449424276|FG000|Overall Study|didn't qualify|1|||
124944457|NCT01823224|449424277|FG001|Overall Study|didn't qualify|2|||
124944458|NCT01823224|449424276|FG000|Overall Study|pharmacy error|0|||
124944459|NCT01823224|449424277|FG001|Overall Study|pharmacy error|1|||
124944460|NCT01823224|449424276|FG000|Overall Study|missed med dose|0|||
124944461|NCT01823224|449424277|FG001|Overall Study|missed med dose|1|||
124944462|NCT01823224|449424276|FG000|Overall Study|Withdrawal by Subject|0|||
124944463|NCT01823224|449424277|FG001|Overall Study|Withdrawal by Subject|1|||
124944464|NCT00745875|449424283|FG000|Overall Study|Continuing study treatment|4|||
124944465|NCT00745875|449424284|FG001|Overall Study|Continuing study treatment|4|||
124944466|NCT01532648|449424285|FG000|Overall Study|Lost to Follow-up|3|||
124944467|NCT01532648|449424286|FG001|Overall Study|Lost to Follow-up|4|||
124944468|NCT01532648|449424285|FG000|Overall Study|Lack of Efficacy|4|||
124944469|NCT01532648|449424286|FG001|Overall Study|Lack of Efficacy|1|||
124944470|NCT01532648|449424285|FG000|Overall Study|Protocol Violation|1|||
124944471|NCT01532648|449424286|FG001|Overall Study|Protocol Violation|1|||
124944472|NCT01532648|449424285|FG000|Overall Study|Adverse Event|12|||
124944473|NCT01532648|449424286|FG001|Overall Study|Adverse Event|9|||
124944474|NCT01532648|449424285|FG000|Overall Study|Withdrawal by Subject|16|||
124944475|NCT01532648|449424286|FG001|Overall Study|Withdrawal by Subject|2|||
124944476|NCT02310581|449424287|FG000|Overall Study|Adverse Event|1|||
124944477|NCT02310581|449424288|FG001|Overall Study|Adverse Event|1|||
124944478|NCT02310581|449424289|FG002|Overall Study|Adverse Event|1|||
124944479|NCT02310581|449424290|FG003|Overall Study|Adverse Event|0|||
124944480|NCT02310581|449424287|FG000|Overall Study|Withdrawal by Subject|2|||
124944481|NCT02310581|449424288|FG001|Overall Study|Withdrawal by Subject|1|||
124944482|NCT02310581|449424289|FG002|Overall Study|Withdrawal by Subject|0|||
124944483|NCT02310581|449424290|FG003|Overall Study|Withdrawal by Subject|1|||
124944484|NCT01737021|449424291|FG000|Overall Study|Lost to Follow-up|5|||
124944485|NCT01737021|449424292|FG001|Overall Study|Lost to Follow-up|3|||
124944486|NCT04652869|449424293|FG000|Overall Study|Withdrawal by Subject|0|||
124944487|NCT04652869|449424294|FG001|Overall Study|Withdrawal by Subject|2|||
124944488|NCT04652869|449424295|FG002|Overall Study|Withdrawal by Subject|0|||
124944489|NCT04658784|449424300|FG000|6-month Follow-up|Lost to Follow-up|2|||
124944490|NCT04658784|449424301|FG001|6-month Follow-up|Lost to Follow-up|5|||
124944491|NCT02095145|449424303|FG000|Overall Study|Withdrawal by Subject|1|||
124944492|NCT02095145|449424304|FG001|Overall Study|Withdrawal by Subject|0|||
124944493|NCT02630186|449424305|FG000|Overall Study|Withdrawal by Subject|1|||
124944494|NCT01034306|449424314|FG000|Overall Study|Adverse Event|1|||
124944495|NCT01034306|449424315|FG001|Overall Study|Adverse Event|0|||
124944496|NCT01034306|449424314|FG000|Overall Study|Lost to Follow-up|0|||
124944497|NCT01034306|449424315|FG001|Overall Study|Lost to Follow-up|1|||
124944498|NCT01034306|449424314|FG000|Overall Study|Withdrawal by Subject|2|||
124944499|NCT01034306|449424315|FG001|Overall Study|Withdrawal by Subject|2|||
124944500|NCT01034306|449424314|FG000|Overall Study|hospitalized and decided to stop|1|||
124944501|NCT01034306|449424315|FG001|Overall Study|hospitalized and decided to stop|0|||
124944502|NCT01034306|449424314|FG000|Overall Study|Noncomplience|1|||
124944503|NCT01034306|449424315|FG001|Overall Study|Noncomplience|0|||
124944504|NCT00836498|449424316|FG000|Overall Study|Adverse Event|1|||
124944505|NCT00836498|449424317|FG001|Overall Study|Adverse Event|0|||
124944506|NCT00836498|449424316|FG000|Overall Study|Lost to Follow-up|1|||
124944507|NCT00836498|449424317|FG001|Overall Study|Lost to Follow-up|0|||
124944508|NCT00836498|449424316|FG000|Overall Study|Withdrawal by Subject|2|||
124944509|NCT00836498|449424317|FG001|Overall Study|Withdrawal by Subject|1|||
124944510|NCT01619059|449424318|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
124944511|NCT01619059|449424319|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
124944512|NCT01619059|449424318|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
124944513|NCT01619059|449424319|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
124944514|NCT01619059|449424318|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
124944515|NCT01619059|449424319|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
124944516|NCT01619059|449424318|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
124944517|NCT01619059|449424319|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
124944518|NCT01619059|449424318|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
124944519|NCT01619059|449424319|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
124944520|NCT01619059|449424318|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
124944521|NCT01619059|449424319|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
124944522|NCT01619059|449424318|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
124944523|NCT01619059|449424319|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
124944524|NCT01619059|449424318|FG000|Long-Term (LT) Treatment Period|Death|1|||
124944525|NCT01619059|449424319|FG001|Long-Term (LT) Treatment Period|Death|0|||
124944526|NCT01619059|449424318|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
124944527|NCT01619059|449424319|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
124944528|NCT01619059|449424318|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
124944529|NCT01619059|449424319|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
124944530|NCT03418545|449424320|FG000|Overall Study|Withdrawal by Participant|2|||
124944531|NCT03418545|449424321|FG001|Overall Study|Withdrawal by Participant|4|||
124944532|NCT03418545|449424320|FG000|Overall Study|Lost to Follow-up|3|||
124944533|NCT03418545|449424321|FG001|Overall Study|Lost to Follow-up|5|||
124944534|NCT03418545|449424320|FG000|Overall Study|Reason Not Specified|0|||
124944535|NCT03418545|449424321|FG001|Overall Study|Reason Not Specified|1|||
124944536|NCT03418545|449424320|FG000|Overall Study|Missing Completion Status|0|||
124944537|NCT03418545|449424321|FG001|Overall Study|Missing Completion Status|1|||
124944538|NCT02384382|449424329|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
124944539|NCT02384382|449424329|FG000|Overall Study|Death|1|||
124944540|NCT02384382|449424329|FG000|Overall Study|Adverse Event|1|||
124944541|NCT02384382|449424329|FG000|Overall Study|Disease progression|16|||
124944542|NCT01074242|449424338|FG000|Overall Study|Case report before date of contract|40|||
124944543|NCT01074242|449424338|FG000|Overall Study|Lost to Follow-up|1|||
124944544|NCT01074242|449424338|FG000|Overall Study|Case report unclear|6|||
124944545|NCT01074242|449424338|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
124944546|NCT01074242|449424338|FG000|Overall Study|Duplicate Case Report Form|5|||
124944547|NCT03567616|449424339|FG000|Overall Study|Disease progression|4|||
124944548|NCT03567616|449424339|FG000|Overall Study|Withdrawal by Subject|1|||
124944549|NCT03567616|449424339|FG000|Overall Study|Physician Decision|1|||
124944550|NCT03567616|449424339|FG000|Overall Study|Death|1|||
124944551|NCT03567616|449424339|FG000|Overall Study|Adverse Event|1|||
124944552|NCT04447027|449424354|FG000|Dose Escalation|Withdrawal by Subject|1|||
124944553|NCT04447027|449424355|FG001|Dose Escalation|Withdrawal by Subject|4|||
124944554|NCT04447027|449424356|FG002|Dose Escalation|Withdrawal by Subject|3|||
124944555|NCT04447027|449424357|FG003|Dose Escalation|Withdrawal by Subject|3|||
124944556|NCT04447027|449424358|FG004|Dose Escalation|Withdrawal by Subject|1|||
124944557|NCT04447027|449424359|FG005|Dose Escalation|Withdrawal by Subject|0|||
124944558|NCT04447027|449424360|FG006|Dose Escalation|Withdrawal by Subject|0|||
124944559|NCT04447027|449424361|FG007|Dose Escalation|Withdrawal by Subject|0|||
124944560|NCT04447027|449424362|FG008|Dose Escalation|Withdrawal by Subject|0|||
124944561|NCT04447027|449424354|FG000|Dose Escalation|Refused further treatment|0|||
124944562|NCT04447027|449424355|FG001|Dose Escalation|Refused further treatment|1|||
124944563|NCT04447027|449424356|FG002|Dose Escalation|Refused further treatment|1|||
124944564|NCT04447027|449424357|FG003|Dose Escalation|Refused further treatment|0|||
124944565|NCT04447027|449424358|FG004|Dose Escalation|Refused further treatment|0|||
124944566|NCT04447027|449424359|FG005|Dose Escalation|Refused further treatment|0|||
124944567|NCT04447027|449424360|FG006|Dose Escalation|Refused further treatment|0|||
124944568|NCT04447027|449424361|FG007|Dose Escalation|Refused further treatment|0|||
124944569|NCT04447027|449424362|FG008|Dose Escalation|Refused further treatment|0|||
124944570|NCT04447027|449424354|FG000|Dose Expansion|Withdrawal by Subject|0|||
124944571|NCT04447027|449424355|FG001|Dose Expansion|Withdrawal by Subject|0|||
124944572|NCT04447027|449424356|FG002|Dose Expansion|Withdrawal by Subject|0|||
124944573|NCT04447027|449424357|FG003|Dose Expansion|Withdrawal by Subject|0|||
124944574|NCT04447027|449424358|FG004|Dose Expansion|Withdrawal by Subject|0|||
124944575|NCT04447027|449424359|FG005|Dose Expansion|Withdrawal by Subject|2|||
124944576|NCT04447027|449424360|FG006|Dose Expansion|Withdrawal by Subject|0|||
124944577|NCT04447027|449424361|FG007|Dose Expansion|Withdrawal by Subject|2|||
124944578|NCT04447027|449424362|FG008|Dose Expansion|Withdrawal by Subject|0|||
124944579|NCT02831049|449424363|FG000|Overall Study|Lost to Follow-up|0|||
124944580|NCT02831049|449424364|FG001|Overall Study|Lost to Follow-up|0|||
124944581|NCT02831049|449424365|FG002|Overall Study|Lost to Follow-up|1|||
124944582|NCT02831049|449424363|FG000|Overall Study|Withdrawal by Subject|0|||
124944583|NCT02831049|449424364|FG001|Overall Study|Withdrawal by Subject|1|||
124944584|NCT02831049|449424365|FG002|Overall Study|Withdrawal by Subject|1|||
124944585|NCT02831049|449424363|FG000|Overall Study|Pandemic shutdown|1|||
124944586|NCT02831049|449424364|FG001|Overall Study|Pandemic shutdown|0|||
124944587|NCT02831049|449424365|FG002|Overall Study|Pandemic shutdown|0|||
124944588|NCT04224272|449424366|FG000|Part 1 - Dose Finding|Death|4|||
124944589|NCT04224272|449424366|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
124944590|NCT04224272|449424366|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
124944591|NCT04224272|449424366|FG000|Part 2 - Dose Expansion|Death|10|||
124944592|NCT04224272|449424366|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
124944593|NCT02609048|449424367|FG000|Overall Study|Adverse Event|3|||
124944594|NCT02609048|449424368|FG001|Overall Study|Adverse Event|0|||
124944595|NCT02609048|449424369|FG002|Overall Study|Adverse Event|0|||
124944596|NCT02609048|449424367|FG000|Overall Study|Randomized but never treated|1|||
124944597|NCT02609048|449424368|FG001|Overall Study|Randomized but never treated|1|||
124944598|NCT02609048|449424369|FG002|Overall Study|Randomized but never treated|1|||
124944599|NCT02609048|449424367|FG000|Overall Study|Withdrawal of informed consent|1|||
124944600|NCT02609048|449424368|FG001|Overall Study|Withdrawal of informed consent|0|||
124944601|NCT02609048|449424369|FG002|Overall Study|Withdrawal of informed consent|0|||
124944602|NCT02609048|449424367|FG000|Overall Study|Reason not specified|6|||
124944603|NCT02609048|449424368|FG001|Overall Study|Reason not specified|9|||
124944604|NCT02609048|449424369|FG002|Overall Study|Reason not specified|9|||
124944605|NCT02485925|449424370|FG000|Overall Study|Withdrawal by Subject|3|||
124944606|NCT02485925|449424370|FG000|Overall Study|Death|1|||
124944607|NCT02485925|449424370|FG000|Overall Study|Lost to Follow-up|11|||
124944608|NCT05995977|449424371|FG000|Overall Study|Withdrawal by Subject|1|||
124944609|NCT05995977|449424372|FG001|Overall Study|Withdrawal by Subject|4|||
124944610|NCT05995977|449424371|FG000|Overall Study|Lost to Follow-up|2|||
124944611|NCT05995977|449424372|FG001|Overall Study|Lost to Follow-up|0|||
124944612|NCT04181788|449424373|FG000|TREATMENT|Adverse Event|0|||
124944613|NCT04181788|449424374|FG001|TREATMENT|Adverse Event|2|||
124944614|NCT04181788|449424375|FG002|TREATMENT|Adverse Event|1|||
124944615|NCT04181788|449424376|FG003|TREATMENT|Adverse Event|0|||
124944616|NCT04181788|449424377|FG004|TREATMENT|Adverse Event|1|||
125028577|NCT03094195|449727624|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
125028578|NCT03094195|449727625|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
124944617|NCT04181788|449424378|FG005|TREATMENT|Adverse Event|3|||
124944618|NCT04181788|449424373|FG000|TREATMENT|Death|0|||
124944619|NCT04181788|449424374|FG001|TREATMENT|Death|0|||
124944620|NCT04181788|449424375|FG002|TREATMENT|Death|0|||
124944621|NCT04181788|449424376|FG003|TREATMENT|Death|0|||
124944622|NCT04181788|449424377|FG004|TREATMENT|Death|8|||
124944623|NCT04181788|449424378|FG005|TREATMENT|Death|8|||
124944624|NCT04181788|449424373|FG000|TREATMENT|Physician Decision|0|||
124944625|NCT04181788|449424374|FG001|TREATMENT|Physician Decision|0|||
124944626|NCT04181788|449424375|FG002|TREATMENT|Physician Decision|0|||
124944627|NCT04181788|449424376|FG003|TREATMENT|Physician Decision|0|||
124944628|NCT04181788|449424377|FG004|TREATMENT|Physician Decision|0|||
124944629|NCT04181788|449424378|FG005|TREATMENT|Physician Decision|1|||
124944630|NCT04181788|449424373|FG000|TREATMENT|Progressive disease|3|||
124944631|NCT04181788|449424374|FG001|TREATMENT|Progressive disease|3|||
124944632|NCT04181788|449424375|FG002|TREATMENT|Progressive disease|5|||
124944633|NCT04181788|449424376|FG003|TREATMENT|Progressive disease|7|||
124944634|NCT04181788|449424377|FG004|TREATMENT|Progressive disease|20|||
124944635|NCT04181788|449424378|FG005|TREATMENT|Progressive disease|38|||
124944636|NCT04181788|449424373|FG000|TREATMENT|Global deterioration of health status|0|||
124944637|NCT04181788|449424374|FG001|TREATMENT|Global deterioration of health status|2|||
124944638|NCT04181788|449424375|FG002|TREATMENT|Global deterioration of health status|0|||
124944639|NCT04181788|449424376|FG003|TREATMENT|Global deterioration of health status|0|||
124944640|NCT04181788|449424377|FG004|TREATMENT|Global deterioration of health status|2|||
124944641|NCT04181788|449424378|FG005|TREATMENT|Global deterioration of health status|8|||
124944642|NCT04181788|449424373|FG000|TREATMENT|Withdrawal by Subject|1|||
124944643|NCT04181788|449424374|FG001|TREATMENT|Withdrawal by Subject|2|||
124944644|NCT04181788|449424375|FG002|TREATMENT|Withdrawal by Subject|0|||
124944645|NCT04181788|449424376|FG003|TREATMENT|Withdrawal by Subject|0|||
124944646|NCT04181788|449424377|FG004|TREATMENT|Withdrawal by Subject|3|||
124944647|NCT04181788|449424378|FG005|TREATMENT|Withdrawal by Subject|5|||
125028579|NCT03094195|449727626|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
125028580|NCT03094195|449727627|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
125028581|NCT03094195|449727628|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
125028582|NCT03094195|449727629|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
125028583|NCT03094195|449727630|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
125028584|NCT03094195|449727631|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
125028585|NCT03094195|449727624|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
125028586|NCT03094195|449727625|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
125028587|NCT03094195|449727626|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
125214338|NCT04399538|450411320|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
125214339|NCT04399538|450411321|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
125214340|NCT04399538|450411322|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
125214341|NCT04399538|450411323|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
125214342|NCT04399538|450411319|FG000|Double-Blind Treatment|Adverse Event|0|||
125214343|NCT04399538|450411320|FG001|Double-Blind Treatment|Adverse Event|0|||
125214344|NCT04399538|450411321|FG002|Double-Blind Treatment|Adverse Event|0|||
125214345|NCT04399538|450411322|FG003|Double-Blind Treatment|Adverse Event|0|||
124944648|NCT04181788|449424373|FG000|TREATMENT|Other unspecified|0|||
124944649|NCT04181788|449424374|FG001|TREATMENT|Other unspecified|0|||
124944650|NCT04181788|449424375|FG002|TREATMENT|Other unspecified|0|||
124944651|NCT04181788|449424376|FG003|TREATMENT|Other unspecified|0|||
124944652|NCT04181788|449424377|FG004|TREATMENT|Other unspecified|0|||
124944653|NCT04181788|449424378|FG005|TREATMENT|Other unspecified|2|||
124944654|NCT04181788|449424373|FG000|TREATMENT|Ongoing|0|||
124944655|NCT04181788|449424374|FG001|TREATMENT|Ongoing|3|||
124944656|NCT04181788|449424375|FG002|TREATMENT|Ongoing|0|||
124944657|NCT04181788|449424376|FG003|TREATMENT|Ongoing|5|||
124944658|NCT04181788|449424377|FG004|TREATMENT|Ongoing|7|||
124944659|NCT04181788|449424378|FG005|TREATMENT|Ongoing|15|||
124944660|NCT04181788|449424373|FG000|FOLLOW-UP|Death|0|||
124944661|NCT04181788|449424374|FG001|FOLLOW-UP|Death|0|||
124944662|NCT04181788|449424375|FG002|FOLLOW-UP|Death|1|||
124944663|NCT04181788|449424376|FG003|FOLLOW-UP|Death|2|||
124944664|NCT04181788|449424377|FG004|FOLLOW-UP|Death|8|||
124944665|NCT04181788|449424378|FG005|FOLLOW-UP|Death|20|||
124944666|NCT04181788|449424373|FG000|FOLLOW-UP|Lost to Follow-up|0|||
124944667|NCT04181788|449424374|FG001|FOLLOW-UP|Lost to Follow-up|0|||
124944668|NCT04181788|449424375|FG002|FOLLOW-UP|Lost to Follow-up|0|||
124944669|NCT04181788|449424376|FG003|FOLLOW-UP|Lost to Follow-up|0|||
124944670|NCT04181788|449424377|FG004|FOLLOW-UP|Lost to Follow-up|0|||
124944671|NCT04181788|449424378|FG005|FOLLOW-UP|Lost to Follow-up|2|||
124944672|NCT04181788|449424373|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
124944673|NCT04181788|449424374|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
124944674|NCT04181788|449424375|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
124944675|NCT04181788|449424376|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
124944676|NCT04181788|449424377|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
124944677|NCT04181788|449424378|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
124944678|NCT04181788|449424373|FG000|FOLLOW-UP|Other unspecified|0|||
124944679|NCT04181788|449424374|FG001|FOLLOW-UP|Other unspecified|1|||
124944680|NCT04181788|449424375|FG002|FOLLOW-UP|Other unspecified|0|||
124944681|NCT04181788|449424376|FG003|FOLLOW-UP|Other unspecified|0|||
124944682|NCT04181788|449424377|FG004|FOLLOW-UP|Other unspecified|0|||
124944683|NCT04181788|449424378|FG005|FOLLOW-UP|Other unspecified|3|||
124944684|NCT04181788|449424373|FG000|FOLLOW-UP|Ongoing|0|||
124944685|NCT04181788|449424374|FG001|FOLLOW-UP|Ongoing|0|||
124944686|NCT04181788|449424375|FG002|FOLLOW-UP|Ongoing|1|||
124944687|NCT04181788|449424376|FG003|FOLLOW-UP|Ongoing|3|||
124944688|NCT04181788|449424377|FG004|FOLLOW-UP|Ongoing|2|||
124944689|NCT04181788|449424378|FG005|FOLLOW-UP|Ongoing|2|||
124944690|NCT04535414|449424379|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
124944691|NCT04535414|449424380|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
124944692|NCT04535414|449424379|FG000|Overall Study|Cancelled appointment|1|||
125028588|NCT03094195|449727627|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
125214346|NCT04399538|450411323|FG004|Double-Blind Treatment|Adverse Event|1|||
125214347|NCT04399538|450411319|FG000|Follow-Up|Adverse Event|0|||
125214348|NCT04399538|450411320|FG001|Follow-Up|Adverse Event|0|||
125214349|NCT04399538|450411321|FG002|Follow-Up|Adverse Event|0|||
125214350|NCT04399538|450411322|FG003|Follow-Up|Adverse Event|0|||
125214351|NCT04399538|450411323|FG004|Follow-Up|Adverse Event|1|||
125214352|NCT04399538|450411319|FG000|Follow-Up|Withdrawal by Subject|0|||
125214353|NCT04399538|450411320|FG001|Follow-Up|Withdrawal by Subject|0|||
125028589|NCT03094195|449727628|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
125028590|NCT03094195|449727629|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
125028591|NCT03094195|449727630|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
125028592|NCT03094195|449727631|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
125028593|NCT03094195|449727624|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
125028594|NCT03094195|449727625|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
125214354|NCT04399538|450411321|FG002|Follow-Up|Withdrawal by Subject|0|||
125214355|NCT04399538|450411322|FG003|Follow-Up|Withdrawal by Subject|2|||
125214356|NCT04399538|450411323|FG004|Follow-Up|Withdrawal by Subject|0|||
125214357|NCT00636961|450411330|FG000|Period 1|Administrative problems|1|||
125214358|NCT00636961|450411331|FG001|Period 1|Administrative problems|1|||
125214359|NCT00636961|450411330|FG000|Period 2|Adverse Event|1|||
125214360|NCT00636961|450411331|FG001|Period 2|Adverse Event|0|||
125214361|NCT01994902|450411333|FG000|Test Period 1|Withdrawal by Subject|3|||
125214362|NCT01994902|450411334|FG001|Test Period 1|Withdrawal by Subject|0|||
125214363|NCT01994902|450411333|FG000|Test Period 1|device deficiency with adverse event|0|||
125214364|NCT01994902|450411334|FG001|Test Period 1|device deficiency with adverse event|1|||
125214365|NCT01994902|450411333|FG000|Test Period 1|Adverse Event|2|||
125214366|NCT01994902|450411334|FG001|Test Period 1|Adverse Event|1|||
125214367|NCT01994902|450411333|FG000|Test Period 1|Lack of Efficacy|0|||
125214368|NCT01994902|450411334|FG001|Test Period 1|Lack of Efficacy|1|||
125214369|NCT01994902|450411333|FG000|Test Period 1|bag too small|1|||
125214370|NCT01994902|450411334|FG001|Test Period 1|bag too small|0|||
125214371|NCT01994902|450411333|FG000|Test Period 2|Withdrawal by Subject|0|||
125214372|NCT01994902|450411334|FG001|Test Period 2|Withdrawal by Subject|2|||
125214373|NCT01994902|450411333|FG000|Test Period 2|Lack of Efficacy|0|||
125214374|NCT01994902|450411334|FG001|Test Period 2|Lack of Efficacy|1|||
125214375|NCT01994902|450411333|FG000|Test Period 2|Other|0|||
125214376|NCT01994902|450411334|FG001|Test Period 2|Other|3|||
125214377|NCT00467558|450411335|FG000|Overall Study|Lost to Follow-up|2|||
125214378|NCT00467558|450411336|FG001|Overall Study|Lost to Follow-up|0|||
125214379|NCT02636439|450411338|FG000|Overall Study|Adverse Event|2|||
125214380|NCT02636439|450411339|FG001|Overall Study|Adverse Event|2|||
124944693|NCT04535414|449424380|FG001|Overall Study|Cancelled appointment|0|||
124944694|NCT04535414|449424379|FG000|Overall Study|cancelled - food in stomach|2|||
124944695|NCT04535414|449424380|FG001|Overall Study|cancelled - food in stomach|0|||
124944696|NCT04535414|449424379|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
124944697|NCT04535414|449424380|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
124944698|NCT04535414|449424379|FG000|Overall Study|Withdrawal by Subject|0|||
124944699|NCT04535414|449424380|FG001|Overall Study|Withdrawal by Subject|1|||
124944700|NCT03662659|449424381|FG000|Pre-treatment|Participant no longer met study criteria|1|||
124944701|NCT03662659|449424382|FG001|Pre-treatment|Participant no longer met study criteria|1|||
124944702|NCT03662659|449424381|FG000|Pre-treatment|Other reasons|1|||
125028595|NCT03094195|449727626|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
124944703|NCT03662659|449424382|FG001|Pre-treatment|Other reasons|0|||
124944704|NCT03662659|449424381|FG000|Treatment|Completed Treatment|0|||
124944705|NCT03662659|449424382|FG001|Treatment|Completed Treatment|2|||
124944706|NCT03662659|449424381|FG000|Treatment|Disease Progression|85|||
124944707|NCT03662659|449424382|FG001|Treatment|Disease Progression|97|||
124944708|NCT03662659|449424381|FG000|Treatment|Study Drug Toxicity|19|||
124944709|NCT03662659|449424382|FG001|Treatment|Study Drug Toxicity|9|||
124944710|NCT03662659|449424381|FG000|Treatment|Death|11|||
124944711|NCT03662659|449424382|FG001|Treatment|Death|9|||
125028596|NCT03094195|449727627|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
125123352|NCT01345019|450075817|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
125123353|NCT01345019|450075816|FG000|Open Label Treatment Phase|Adverse Event|30|||
125123354|NCT01345019|450075817|FG001|Open Label Treatment Phase|Adverse Event|51|||
125123355|NCT01345019|450075816|FG000|Open Label Treatment Phase|Administrative Decision|30|||
125123356|NCT01345019|450075817|FG001|Open Label Treatment Phase|Administrative Decision|15|||
125123357|NCT01345019|450075816|FG000|Open Label Treatment Phase|Disease Progression|17|||
125123358|NCT01345019|450075817|FG001|Open Label Treatment Phase|Disease Progression|18|||
125123359|NCT01345019|450075816|FG000|Open Label Treatment Phase|Noncompliance|5|||
125123360|NCT01345019|450075817|FG001|Open Label Treatment Phase|Noncompliance|4|||
125123361|NCT01345019|450075816|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
125214381|NCT02636439|450411338|FG000|Overall Study|Lost to Follow-up|1|||
125214382|NCT02636439|450411339|FG001|Overall Study|Lost to Follow-up|0|||
125214383|NCT02636439|450411338|FG000|Overall Study|Non-compliance|1|||
124944712|NCT03662659|449424381|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
124944713|NCT03662659|449424382|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
124944714|NCT03662659|449424381|FG000|Treatment|Withdrawal by Subject|1|||
124944715|NCT03662659|449424382|FG001|Treatment|Withdrawal by Subject|1|||
124944716|NCT03662659|449424381|FG000|Treatment|Poor/Non-compliance|1|||
124944717|NCT03662659|449424382|FG001|Treatment|Poor/Non-compliance|0|||
124944718|NCT03662659|449424381|FG000|Treatment|Participant no longer meets study criteria|1|||
124944719|NCT03662659|449424382|FG001|Treatment|Participant no longer meets study criteria|0|||
124944720|NCT03662659|449424381|FG000|Treatment|Other reasons|10|||
124944721|NCT03662659|449424382|FG001|Treatment|Other reasons|8|||
124944722|NCT03662659|449424381|FG000|Treatment|Administrative reasons by sponsor|1|||
124944723|NCT03662659|449424382|FG001|Treatment|Administrative reasons by sponsor|0|||
124944724|NCT03662659|449424381|FG000|Treatment|maximum clinical benefit|0|||
124944725|NCT03662659|449424382|FG001|Treatment|maximum clinical benefit|2|||
124944726|NCT02556918|449426444|FG000|Overall Study|Protocol Violation|5|||
124944727|NCT02556918|449426445|FG001|Overall Study|Protocol Violation|6|||
124944728|NCT02556918|449426444|FG000|Overall Study|Withdrawal by Subject|4|||
124944729|NCT02556918|449426445|FG001|Overall Study|Withdrawal by Subject|4|||
124944730|NCT02148705|449426461|FG000|Overall Study|Death|2|||
124944731|NCT02148705|449426462|FG001|Overall Study|Death|0|||
124944732|NCT02148705|449426463|FG002|Overall Study|Death|0|||
124944733|NCT02148705|449426461|FG000|Overall Study|Lost to Follow-up|13|||
124944734|NCT02148705|449426462|FG001|Overall Study|Lost to Follow-up|4|||
124944735|NCT02148705|449426463|FG002|Overall Study|Lost to Follow-up|10|||
124944736|NCT02148705|449426461|FG000|Overall Study|Withdrawal by Subject|3|||
124944737|NCT02148705|449426462|FG001|Overall Study|Withdrawal by Subject|0|||
124944738|NCT02148705|449426463|FG002|Overall Study|Withdrawal by Subject|2|||
124944739|NCT02148705|449426461|FG000|Overall Study|Not Treated|0|||
124944740|NCT02148705|449426462|FG001|Overall Study|Not Treated|1|||
124944741|NCT02148705|449426463|FG002|Overall Study|Not Treated|5|||
124944742|NCT01583166|449426464|FG000|Overall Study|Withdrawal by Subject|4|||
124944743|NCT01583166|449426465|FG001|Overall Study|Withdrawal by Subject|6|||
124944744|NCT01833455|449426466|FG000|Overall Study|Withdrawal by Subject|1|||
124944745|NCT01833455|449426467|FG001|Overall Study|Withdrawal by Subject|0|||
124944746|NCT00887224|449426468|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
124944747|NCT00887224|449426469|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
124944748|NCT00887224|449426470|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
124944749|NCT00887224|449426468|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
124944750|NCT00887224|449426469|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
124944751|NCT00887224|449426470|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
124944752|NCT00887224|449426468|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
124944753|NCT00887224|449426469|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
124944754|NCT00887224|449426470|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
124944755|NCT00887224|449426468|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
124944756|NCT00887224|449426469|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
124944757|NCT00887224|449426470|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
124944758|NCT00887224|449426468|FG000|Open-label Response (OLR) Phase|Other|1|||
124944759|NCT00887224|449426469|FG001|Open-label Response (OLR) Phase|Other|0|||
124944760|NCT00887224|449426470|FG002|Open-label Response (OLR) Phase|Other|0|||
124944761|NCT00887224|449426468|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
124944762|NCT00887224|449426469|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
124944763|NCT00887224|449426470|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
124944764|NCT00887224|449426468|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
124944765|NCT00887224|449426469|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
124944766|NCT00887224|449426470|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
124944767|NCT00887224|449426468|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
124944768|NCT00887224|449426469|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
124944769|NCT00887224|449426470|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
124944770|NCT00887224|449426468|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
124944771|NCT00887224|449426469|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
124944772|NCT00887224|449426470|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
124944773|NCT00887224|449426468|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
124944774|NCT00887224|449426469|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
124944775|NCT00887224|449426470|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
125028597|NCT03094195|449727628|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
124944776|NCT00887224|449426468|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
124944777|NCT00887224|449426469|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
125028598|NCT03094195|449727629|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
125028599|NCT03094195|449727630|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
125028600|NCT03094195|449727631|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
124944778|NCT00887224|449426470|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
124944779|NCT00887224|449426468|FG000|Open-label Stability (OLS) Phase|Other|1|||
124944780|NCT00887224|449426469|FG001|Open-label Stability (OLS) Phase|Other|0|||
124944781|NCT00887224|449426470|FG002|Open-label Stability (OLS) Phase|Other|0|||
124944782|NCT00887224|449426468|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
124944783|NCT00887224|449426469|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
124944784|NCT00887224|449426470|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
124944785|NCT00887224|449426468|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
124944786|NCT00887224|449426469|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
124944787|NCT00887224|449426470|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
124944788|NCT00887224|449426468|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
125028601|NCT03094195|449727624|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
125028602|NCT03094195|449727625|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
125214384|NCT02636439|450411339|FG001|Overall Study|Non-compliance|1|||
125214385|NCT02636439|450411338|FG000|Overall Study|Personal reasons|2|||
125028603|NCT03094195|449727626|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
125028604|NCT03094195|449727627|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
125028605|NCT03094195|449727628|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
125028606|NCT03094195|449727629|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
125028607|NCT03094195|449727630|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
125028608|NCT03094195|449727631|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
125028609|NCT01961115|449727634|FG000|Overall Study|Disease Progression|1|||
125028610|NCT01961115|449727635|FG001|Overall Study|Disease Progression|0|||
125028611|NCT01961115|449727636|FG002|Overall Study|Disease Progression|3|||
125028612|NCT01961115|449727634|FG000|Overall Study|Adverse Event|1|||
125028613|NCT01961115|449727635|FG001|Overall Study|Adverse Event|0|||
125028614|NCT01961115|449727636|FG002|Overall Study|Adverse Event|1|||
125028615|NCT02440581|449727640|FG000|Overall Study|Death|0|||
125028616|NCT02440581|449727641|FG001|Overall Study|Death|0|||
125028617|NCT02440581|449727642|FG002|Overall Study|Death|7|||
125028618|NCT02440581|449727643|FG003|Overall Study|Death|5|||
125028619|NCT02440581|449727640|FG000|Overall Study|Transplanted|1|||
125028620|NCT02440581|449727641|FG001|Overall Study|Transplanted|0|||
125028621|NCT02440581|449727642|FG002|Overall Study|Transplanted|3|||
125028622|NCT02440581|449727643|FG003|Overall Study|Transplanted|2|||
125028623|NCT02440581|449727640|FG000|Overall Study|Withdrawal by Subject|4|||
125214386|NCT02636439|450411339|FG001|Overall Study|Personal reasons|0|||
125214387|NCT00762034|450412798|FG000|Induction Period|Protocol Violation|1|||
124944789|NCT00887224|449426469|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
125028624|NCT02440581|449727641|FG001|Overall Study|Withdrawal by Subject|11|||
124944790|NCT00887224|449426470|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
124944791|NCT00887224|449426468|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
124944792|NCT00887224|449426469|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
124944793|NCT00887224|449426470|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
124944794|NCT00887224|449426468|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
124944795|NCT00887224|449426469|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
124944796|NCT00887224|449426470|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
124944797|NCT00887224|449426468|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
124944798|NCT00887224|449426469|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
124944799|NCT00887224|449426470|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
124944800|NCT00887224|449426468|FG000|OL Taper Phase / OL Follow Up|Other|30|||
124944801|NCT00887224|449426469|FG001|OL Taper Phase / OL Follow Up|Other|0|||
124944802|NCT00887224|449426470|FG002|OL Taper Phase / OL Follow Up|Other|0|||
124944803|NCT00887224|449426468|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
124944804|NCT00887224|449426469|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
124944805|NCT00887224|449426470|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
124944806|NCT00887224|449426468|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
124944807|NCT00887224|449426469|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
124944808|NCT00887224|449426470|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
125028625|NCT02440581|449727642|FG002|Overall Study|Withdrawal by Subject|3|||
125214388|NCT00762034|450412799|FG001|Induction Period|Protocol Violation|2|||
124944809|NCT00887224|449426468|FG000|Double-blind (DB) Phase|Adverse Event|0|||
124944810|NCT00887224|449426469|FG001|Double-blind (DB) Phase|Adverse Event|7|||
124944811|NCT00887224|449426470|FG002|Double-blind (DB) Phase|Adverse Event|2|||
124944812|NCT00887224|449426468|FG000|Double-blind (DB) Phase|Failed to return|0|||
125028626|NCT02440581|449727643|FG003|Overall Study|Withdrawal by Subject|7|||
125028627|NCT03828487|449727644|FG000|Overall Study|Physician Decision|1|||
125028628|NCT03430986|449727645|FG000|24-week Control Period|Adverse Event|1|||
125028629|NCT03430986|449727646|FG001|24-week Control Period|Adverse Event|0|||
125214389|NCT00762034|450412798|FG000|Induction Period|Entry Criterion Not Met|12|||
124944813|NCT00887224|449426469|FG001|Double-blind (DB) Phase|Failed to return|2|||
124944814|NCT00887224|449426470|FG002|Double-blind (DB) Phase|Failed to return|2|||
124944815|NCT00887224|449426468|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
124944816|NCT00887224|449426469|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
124944817|NCT00887224|449426470|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
124944818|NCT00887224|449426468|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
124944819|NCT00887224|449426469|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
124944820|NCT00887224|449426470|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
124944821|NCT00887224|449426468|FG000|Double-blind (DB) Phase|Other|0|||
124944822|NCT00887224|449426469|FG001|Double-blind (DB) Phase|Other|2|||
124944823|NCT00887224|449426470|FG002|Double-blind (DB) Phase|Other|0|||
124944824|NCT00887224|449426468|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
124944825|NCT00887224|449426469|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
124944826|NCT00887224|449426470|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
124944827|NCT00887224|449426468|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
124944828|NCT00887224|449426469|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
124944829|NCT00887224|449426470|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
124944830|NCT00887224|449426468|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
124944831|NCT00887224|449426469|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
124944832|NCT00887224|449426470|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
124944833|NCT00887224|449426468|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
124944834|NCT00887224|449426469|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
124944835|NCT00887224|449426470|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
124944836|NCT00887224|449426468|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
124944837|NCT00887224|449426469|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
124944838|NCT00887224|449426470|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
124944839|NCT00887224|449426468|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
124944840|NCT00887224|449426469|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
124944841|NCT00887224|449426470|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
124944842|NCT00887224|449426468|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
124944843|NCT00887224|449426469|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
124944844|NCT00887224|449426470|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
124944845|NCT00887224|449426468|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
124944846|NCT00887224|449426469|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
124944847|NCT00887224|449426470|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
124944848|NCT00887224|449426468|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
124944849|NCT00887224|449426469|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
124944850|NCT00887224|449426470|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
124944851|NCT03883828|449426471|FG000|Overall Study|Did not start radiotherapy|1|||
124944852|NCT03883828|449426472|FG001|Overall Study|Did not start radiotherapy|2|||
124944853|NCT01256359|449426473|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
124944854|NCT01256359|449426474|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
124944855|NCT01256359|449426473|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
124944856|NCT01256359|449426474|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
124944857|NCT02000752|449426477|FG000|Overall Study|Dystocic delivery|19|||
124944858|NCT02000752|449426478|FG001|Overall Study|Dystocic delivery|8|||
124944859|NCT02000752|449426477|FG000|Overall Study|Shift Changes|12|||
124944860|NCT02000752|449426478|FG001|Overall Study|Shift Changes|5|||
124944861|NCT04938453|449426482|FG000|Washout Period 1|Adverse Event|1|||
124944862|NCT04938453|449426483|FG001|Washout Period 1|Adverse Event|0|||
124944863|NCT04938453|449426482|FG000|Washout Period 1|Physician Decision|0|||
124944864|NCT04938453|449426483|FG001|Washout Period 1|Physician Decision|1|||
124944865|NCT00273052|449426484|FG000|Overall Study|Withdrawal by Subject|16|||
124944866|NCT00273052|449426485|FG001|Overall Study|Withdrawal by Subject|19|||
124944867|NCT00273052|449426484|FG000|Overall Study|Adverse Event|21|||
124944868|NCT00273052|449426485|FG001|Overall Study|Adverse Event|19|||
124944869|NCT00273052|449426484|FG000|Overall Study|Protocol Violation|14|||
124944870|NCT00273052|449426485|FG001|Overall Study|Protocol Violation|18|||
124944871|NCT00273052|449426484|FG000|Overall Study|Lost to Follow-up|7|||
124944872|NCT00273052|449426485|FG001|Overall Study|Lost to Follow-up|25|||
124944873|NCT00273052|449426484|FG000|Overall Study|Lack of Efficacy|6|||
124944874|NCT00273052|449426485|FG001|Overall Study|Lack of Efficacy|4|||
124944875|NCT00273052|449426484|FG000|Overall Study|Non-Compliance|3|||
124944876|NCT00273052|449426485|FG001|Overall Study|Non-Compliance|1|||
124944877|NCT00273052|449426484|FG000|Overall Study|Other|2|||
124944878|NCT00273052|449426485|FG001|Overall Study|Other|0|||
124944879|NCT00273052|449426484|FG000|Overall Study|Worsening serum lipid levels|0|||
124944880|NCT00273052|449426485|FG001|Overall Study|Worsening serum lipid levels|2|||
124944881|NCT00454194|449426487|FG000|Overall Study|Adverse Event|7|||
124944882|NCT00454194|449426488|FG001|Overall Study|Adverse Event|2|||
124944883|NCT00454194|449426487|FG000|Overall Study|Withdrawal by Subject|12|||
124944884|NCT00454194|449426488|FG001|Overall Study|Withdrawal by Subject|8|||
124944885|NCT00454194|449426487|FG000|Overall Study|Other Medical Problems|1|||
124944886|NCT00454194|449426488|FG001|Overall Study|Other Medical Problems|2|||
124944887|NCT00454194|449426487|FG000|Overall Study|Other Unspecified Reason|2|||
124944888|NCT00454194|449426488|FG001|Overall Study|Other Unspecified Reason|2|||
124944889|NCT02827201|449426489|FG000|Overall Study|Death|1|||
124944890|NCT02827201|449426490|FG001|Overall Study|Death|2|||
124944891|NCT02827201|449426489|FG000|Overall Study|Patients not treated|1|||
124944892|NCT02827201|449426490|FG001|Overall Study|Patients not treated|1|||
124944893|NCT03345979|449426491|FG000|Overall Study|Withdrawal by Subject|20|||
124944894|NCT03345979|449426492|FG001|Overall Study|Withdrawal by Subject|31|||
124944895|NCT03345979|449426491|FG000|Overall Study|Adverse Event|10|||
124944896|NCT03345979|449426492|FG001|Overall Study|Adverse Event|11|||
124944897|NCT03345979|449426491|FG000|Overall Study|Lost to Follow-up|8|||
124944898|NCT03345979|449426492|FG001|Overall Study|Lost to Follow-up|9|||
124944899|NCT03345979|449426491|FG000|Overall Study|Lack of Efficacy|4|||
124944900|NCT03345979|449426492|FG001|Overall Study|Lack of Efficacy|2|||
124944901|NCT03345979|449426491|FG000|Overall Study|Protocol Violation|1|||
124944902|NCT03345979|449426492|FG001|Overall Study|Protocol Violation|3|||
124944903|NCT03345979|449426491|FG000|Overall Study|Physician Decision|0|||
124944904|NCT03345979|449426492|FG001|Overall Study|Physician Decision|2|||
124944905|NCT00999596|449426493|FG000|Overall Study|Statistical population not required|101|||
124944906|NCT00439218|449426496|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
124944907|NCT03176407|449426497|FG000|Overall Study|Protocol Violation|1|||
124944908|NCT03176407|449426497|FG000|Overall Study|human failure|1|||
125123362|NCT01345019|450075817|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
124944909|NCT03176407|449426497|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
124944910|NCT00670488|449426498|FG000|Overall Study|Adverse Event|0|||
124944911|NCT00670488|449426499|FG001|Overall Study|Adverse Event|7|||
124944912|NCT00670488|449426500|FG002|Overall Study|Adverse Event|0|||
125123363|NCT01345019|450075816|FG000|Open Label Treatment Phase|Pregnancy|1|||
124944913|NCT00670488|449426501|FG003|Overall Study|Adverse Event|3|||
124944914|NCT00670488|449426502|FG004|Overall Study|Adverse Event|1|||
124944915|NCT00670488|449426503|FG005|Overall Study|Adverse Event|1|||
125123364|NCT01345019|450075817|FG001|Open Label Treatment Phase|Pregnancy|0|||
124944916|NCT00670488|449426504|FG006|Overall Study|Adverse Event|5|||
124944917|NCT00670488|449426505|FG007|Overall Study|Adverse Event|1|||
124944918|NCT00670488|449426506|FG008|Overall Study|Adverse Event|0|||
124944919|NCT00670488|449426507|FG009|Overall Study|Adverse Event|1|||
124944920|NCT00670488|449426498|FG000|Overall Study|Physician Decision|1|||
124944921|NCT00670488|449426499|FG001|Overall Study|Physician Decision|9|||
124944922|NCT00670488|449426500|FG002|Overall Study|Physician Decision|0|||
124944923|NCT00670488|449426501|FG003|Overall Study|Physician Decision|1|||
124944924|NCT00670488|449426502|FG004|Overall Study|Physician Decision|0|||
124944925|NCT00670488|449426503|FG005|Overall Study|Physician Decision|0|||
124944926|NCT00670488|449426504|FG006|Overall Study|Physician Decision|0|||
124944927|NCT00670488|449426505|FG007|Overall Study|Physician Decision|0|||
124944928|NCT00670488|449426506|FG008|Overall Study|Physician Decision|0|||
124944929|NCT00670488|449426507|FG009|Overall Study|Physician Decision|0|||
124944930|NCT00670488|449426498|FG000|Overall Study|Progressive Disease|2|||
124944931|NCT00670488|449426499|FG001|Overall Study|Progressive Disease|41|||
124944932|NCT00670488|449426500|FG002|Overall Study|Progressive Disease|3|||
124944933|NCT00670488|449426501|FG003|Overall Study|Progressive Disease|2|||
124944934|NCT00670488|449426502|FG004|Overall Study|Progressive Disease|2|||
124944935|NCT00670488|449426503|FG005|Overall Study|Progressive Disease|4|||
124944936|NCT00670488|449426504|FG006|Overall Study|Progressive Disease|11|||
124944937|NCT00670488|449426505|FG007|Overall Study|Progressive Disease|2|||
124944938|NCT00670488|449426506|FG008|Overall Study|Progressive Disease|2|||
124944939|NCT00670488|449426507|FG009|Overall Study|Progressive Disease|1|||
124944940|NCT00670488|449426498|FG000|Overall Study|Withdrawal by Subject|0|||
124944941|NCT00670488|449426499|FG001|Overall Study|Withdrawal by Subject|1|||
124944942|NCT00670488|449426500|FG002|Overall Study|Withdrawal by Subject|0|||
124944943|NCT00670488|449426501|FG003|Overall Study|Withdrawal by Subject|1|||
124944944|NCT00670488|449426502|FG004|Overall Study|Withdrawal by Subject|0|||
124944945|NCT00670488|449426503|FG005|Overall Study|Withdrawal by Subject|0|||
124944946|NCT00670488|449426504|FG006|Overall Study|Withdrawal by Subject|1|||
124944947|NCT00670488|449426505|FG007|Overall Study|Withdrawal by Subject|0|||
124944948|NCT00670488|449426506|FG008|Overall Study|Withdrawal by Subject|1|||
124944949|NCT00670488|449426507|FG009|Overall Study|Withdrawal by Subject|0|||
124944950|NCT01124045|449426510|FG000|Overall Study|Lost to Follow-up|0|||
124944951|NCT01124045|449426511|FG001|Overall Study|Lost to Follow-up|1|||
124944952|NCT01124045|449426510|FG000|Overall Study|Physician Decision|0|||
124944953|NCT01124045|449426511|FG001|Overall Study|Physician Decision|2|||
124944954|NCT03298087|449426512|FG000|Overall Study|Withdrawal by Subject|4|||
124944955|NCT05553366|449426515|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
124944956|NCT05553366|449426516|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
124944957|NCT05553366|449426517|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
124944958|NCT05553366|449426515|FG000|Overall Study|Lost to Follow-up|3|||
124944959|NCT05553366|449426516|FG001|Overall Study|Lost to Follow-up|3|||
124944960|NCT05553366|449426517|FG002|Overall Study|Lost to Follow-up|3|||
124944961|NCT05553366|449426515|FG000|Overall Study|Other non-compliance|1|||
124944962|NCT05553366|449426516|FG001|Overall Study|Other non-compliance|1|||
124944963|NCT05553366|449426517|FG002|Overall Study|Other non-compliance|0|||
124944964|NCT05553366|449426515|FG000|Overall Study|Randomized but not dosed|0|||
124944965|NCT05553366|449426516|FG001|Overall Study|Randomized but not dosed|0|||
124944966|NCT05553366|449426517|FG002|Overall Study|Randomized but not dosed|2|||
124944967|NCT02022657|449426518|FG000|Overall Study|Withdrawal by Subject|2|||
124944968|NCT02022657|449426519|FG001|Overall Study|Withdrawal by Subject|0|||
124944969|NCT02022657|449426520|FG002|Overall Study|Withdrawal by Subject|1|||
124944970|NCT02022657|449426521|FG003|Overall Study|Withdrawal by Subject|0|||
124944971|NCT02022657|449426522|FG004|Overall Study|Withdrawal by Subject|0|||
124944972|NCT02022657|449426523|FG005|Overall Study|Withdrawal by Subject|0|||
125028630|NCT03430986|449727645|FG000|24-week Control Period|Lost to Follow-up|2|||
125028631|NCT03430986|449727646|FG001|24-week Control Period|Lost to Follow-up|2|||
125028632|NCT03430986|449727645|FG000|24-week Control Period|Withdrawal by Participant|5|||
125028633|NCT03430986|449727646|FG001|24-week Control Period|Withdrawal by Participant|0|||
125028634|NCT03430986|449727645|FG000|24-week Control Period|Protocol Deviation|0|||
125028635|NCT03430986|449727646|FG001|24-week Control Period|Protocol Deviation|2|||
125028636|NCT03430986|449727645|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
125028637|NCT03430986|449727646|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
125028638|NCT03430986|449727645|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
125028639|NCT03430986|449727646|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
125028640|NCT01078805|449727648|FG000|Overall Study|Clinically significant abnormal lab|5|||
125028641|NCT01078805|449727648|FG000|Overall Study|Death|134|||
124944973|NCT02022657|449426518|FG000|Overall Study|Physician Decision|0|||
124944974|NCT02022657|449426519|FG001|Overall Study|Physician Decision|0|||
124944975|NCT02022657|449426520|FG002|Overall Study|Physician Decision|0|||
124944976|NCT02022657|449426521|FG003|Overall Study|Physician Decision|0|||
124944977|NCT02022657|449426522|FG004|Overall Study|Physician Decision|0|||
124944978|NCT02022657|449426523|FG005|Overall Study|Physician Decision|1|||
125028642|NCT01078805|449727648|FG000|Overall Study|Lost to Follow-up|676|||
125028643|NCT01078805|449727648|FG000|Overall Study|Physician Decision|169|||
125028644|NCT01078805|449727648|FG000|Overall Study|Serious adverse event|26|||
125028645|NCT01078805|449727648|FG000|Overall Study|Sponsor decision|46|||
125028646|NCT01078805|449727648|FG000|Overall Study|Withdrawal by Subject|739|||
125028647|NCT01078805|449727648|FG000|Overall Study|Other|173|||
125028648|NCT01078805|449727648|FG000|Overall Study|Didn't take study drug|82|||
125028649|NCT01609842|449727649|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
125028650|NCT01609842|449727650|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
125028651|NCT02474329|449727651|FG000|Overall Study|Withdraw or did not contribute data.|13|||
125028652|NCT03186989|449727652|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
125028653|NCT03186989|449727653|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
125028654|NCT03186989|449727654|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
125028655|NCT03186989|449727655|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
125028656|NCT03186989|449727656|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
125028657|NCT03186989|449727657|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
125028658|NCT03186989|449727658|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
125028659|NCT03186989|449727659|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
125028660|NCT03186989|449727660|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
125028661|NCT03186989|449727661|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
125028662|NCT03186989|449727662|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
125028663|NCT03186989|449727652|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
125028664|NCT03186989|449727653|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
125028665|NCT03186989|449727654|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
125028666|NCT03186989|449727655|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
125028667|NCT03186989|449727656|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
124944979|NCT01530334|449426524|FG000|Overall Study|Adverse Event|3|||
124944980|NCT01530334|449426524|FG000|Overall Study|unknown reason|1|||
124944981|NCT01530334|449426524|FG000|Overall Study|Progressive disease|47|||
124944982|NCT01485887|449426526|FG000|Overall Study|Withdrawal by Subject|2|||
124944983|NCT01485887|449426526|FG000|Overall Study|Adverse Event|8|||
124944984|NCT01485887|449426526|FG000|Overall Study|Deterioration of primary disease|1|||
124944985|NCT01485887|449426526|FG000|Overall Study|Primary disease markedly improved|1|||
124944986|NCT00659373|449426531|FG000|Overall Study|Withdrawal by Subject|3|||
124944987|NCT00659373|449426532|FG001|Overall Study|Withdrawal by Subject|5|||
124944988|NCT00659373|449426531|FG000|Overall Study|Assessment Missed|2|||
124944989|NCT00659373|449426532|FG001|Overall Study|Assessment Missed|2|||
124944990|NCT02382640|449426533|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
124944991|NCT02382640|449426534|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
124944992|NCT02382640|449426535|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
124944993|NCT02382640|449426536|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
124944994|NCT03162614|449426539|FG000|Overall Study|Lost to Follow-up|2|||
124944995|NCT03162614|449426540|FG001|Overall Study|Lost to Follow-up|1|||
124944996|NCT03162614|449426541|FG002|Overall Study|Lost to Follow-up|1|||
124944997|NCT03162614|449426542|FG003|Overall Study|Lost to Follow-up|1|||
124944998|NCT03162614|449426543|FG004|Overall Study|Lost to Follow-up|2|||
124944999|NCT03162614|449426544|FG005|Overall Study|Lost to Follow-up|0|||
124945000|NCT03162614|449426539|FG000|Overall Study|Protocol Violation|0|||
124945001|NCT03162614|449426540|FG001|Overall Study|Protocol Violation|1|||
124945002|NCT03162614|449426541|FG002|Overall Study|Protocol Violation|0|||
125028668|NCT03186989|449727657|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
125028669|NCT03186989|449727658|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
125028670|NCT03186989|449727659|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
124945003|NCT03162614|449426542|FG003|Overall Study|Protocol Violation|1|||
124945004|NCT03162614|449426543|FG004|Overall Study|Protocol Violation|0|||
124945005|NCT03162614|449426544|FG005|Overall Study|Protocol Violation|0|||
124945006|NCT03162614|449426539|FG000|Overall Study|Withdrawal by Subject|2|||
124945007|NCT03162614|449426540|FG001|Overall Study|Withdrawal by Subject|1|||
124945008|NCT03162614|449426541|FG002|Overall Study|Withdrawal by Subject|1|||
125028671|NCT03186989|449727660|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
125028672|NCT03186989|449727661|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
125028673|NCT03186989|449727662|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
125028674|NCT03186989|449727652|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
125028675|NCT03186989|449727653|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
124945009|NCT03162614|449426542|FG003|Overall Study|Withdrawal by Subject|1|||
124945010|NCT03162614|449426543|FG004|Overall Study|Withdrawal by Subject|0|||
124945011|NCT03162614|449426544|FG005|Overall Study|Withdrawal by Subject|0|||
124945012|NCT03162614|449426539|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
124945013|NCT03162614|449426540|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
125028676|NCT03186989|449727654|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
125028677|NCT03186989|449727655|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
124945014|NCT03162614|449426541|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
124945015|NCT03162614|449426542|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
124945016|NCT03162614|449426543|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
124945017|NCT03162614|449426544|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
124945018|NCT00380250|449426545|FG000|Overall Study|Withdrawal by Subject|39|||
124945019|NCT00380250|449426546|FG001|Overall Study|Withdrawal by Subject|28|||
124945020|NCT00380250|449426545|FG000|Overall Study|Adverse Event|20|||
124945021|NCT00380250|449426546|FG001|Overall Study|Adverse Event|9|||
124945022|NCT00380250|449426545|FG000|Overall Study|Lack of Efficacy|10|||
124945023|NCT00380250|449426546|FG001|Overall Study|Lack of Efficacy|8|||
124945024|NCT00380250|449426545|FG000|Overall Study|Protocol Violation|15|||
124945025|NCT00380250|449426546|FG001|Overall Study|Protocol Violation|5|||
124945026|NCT00380250|449426545|FG000|Overall Study|Lost to Follow-up|14|||
124945027|NCT00380250|449426546|FG001|Overall Study|Lost to Follow-up|5|||
124945028|NCT00380250|449426545|FG000|Overall Study|Physician Decision|1|||
124945029|NCT00380250|449426546|FG001|Overall Study|Physician Decision|0|||
124945030|NCT02630966|449426547|FG000|Overall Study|Adverse Event|1|||
124945031|NCT02630966|449426548|FG001|Overall Study|Adverse Event|3|||
124945032|NCT02630966|449426547|FG000|Overall Study|Significant Protocol Deviation|0|||
124945033|NCT02630966|449426548|FG001|Overall Study|Significant Protocol Deviation|2|||
124945034|NCT02630966|449426547|FG000|Overall Study|Voluntary Withdrawal|1|||
124945035|NCT02630966|449426548|FG001|Overall Study|Voluntary Withdrawal|1|||
124945036|NCT02630966|449426547|FG000|Overall Study|Lack of Efficacy|0|||
124945037|NCT02630966|449426548|FG001|Overall Study|Lack of Efficacy|2|||
124945038|NCT00641537|449426549|FG000|96-week Period|Adverse Event|0|||
124945039|NCT00641537|449426550|FG001|96-week Period|Adverse Event|1|||
124945040|NCT00641537|449426551|FG002|96-week Period|Adverse Event|3|||
124945041|NCT00641537|449426552|FG003|96-week Period|Adverse Event|0|||
124945042|NCT00641537|449426553|FG004|96-week Period|Adverse Event|2|||
124945043|NCT00641537|449426554|FG005|96-week Period|Adverse Event|0|||
124945044|NCT00641537|449426555|FG006|96-week Period|Adverse Event|0|||
124945045|NCT00641537|449426556|FG007|96-week Period|Adverse Event|0|||
124945046|NCT00641537|449426549|FG000|96-week Period|Lost to Follow-up|3|||
124945047|NCT00641537|449426550|FG001|96-week Period|Lost to Follow-up|1|||
124945048|NCT00641537|449426551|FG002|96-week Period|Lost to Follow-up|2|||
124945049|NCT00641537|449426552|FG003|96-week Period|Lost to Follow-up|2|||
124945050|NCT00641537|449426553|FG004|96-week Period|Lost to Follow-up|4|||
124945051|NCT00641537|449426554|FG005|96-week Period|Lost to Follow-up|0|||
124945052|NCT00641537|449426555|FG006|96-week Period|Lost to Follow-up|1|||
124945053|NCT00641537|449426556|FG007|96-week Period|Lost to Follow-up|0|||
124945054|NCT00641537|449426549|FG000|96-week Period|Protocol Violation|0|||
124945055|NCT00641537|449426550|FG001|96-week Period|Protocol Violation|1|||
124945056|NCT00641537|449426551|FG002|96-week Period|Protocol Violation|0|||
124945057|NCT00641537|449426552|FG003|96-week Period|Protocol Violation|1|||
124945058|NCT00641537|449426553|FG004|96-week Period|Protocol Violation|0|||
124945059|NCT00641537|449426554|FG005|96-week Period|Protocol Violation|1|||
124945060|NCT00641537|449426555|FG006|96-week Period|Protocol Violation|0|||
124945061|NCT00641537|449426556|FG007|96-week Period|Protocol Violation|0|||
124945062|NCT00641537|449426549|FG000|96-week Period|Death|2|||
124945063|NCT00641537|449426550|FG001|96-week Period|Death|0|||
124945064|NCT00641537|449426551|FG002|96-week Period|Death|1|||
124945065|NCT00641537|449426552|FG003|96-week Period|Death|0|||
124945066|NCT00641537|449426553|FG004|96-week Period|Death|0|||
124945067|NCT00641537|449426554|FG005|96-week Period|Death|0|||
124945068|NCT00641537|449426555|FG006|96-week Period|Death|0|||
124945069|NCT00641537|449426556|FG007|96-week Period|Death|0|||
124945070|NCT00641537|449426549|FG000|96-week Period|Other|4|||
124945071|NCT00641537|449426550|FG001|96-week Period|Other|7|||
124945072|NCT00641537|449426551|FG002|96-week Period|Other|14|||
124945073|NCT00641537|449426552|FG003|96-week Period|Other|9|||
124945074|NCT00641537|449426553|FG004|96-week Period|Other|11|||
124945075|NCT00641537|449426554|FG005|96-week Period|Other|6|||
124945076|NCT00641537|449426555|FG006|96-week Period|Other|4|||
124945077|NCT00641537|449426556|FG007|96-week Period|Other|6|||
124945078|NCT00641537|449426549|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
124945079|NCT00641537|449426550|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
124945080|NCT00641537|449426551|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
124945081|NCT00641537|449426552|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
124945082|NCT00641537|449426553|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
124945083|NCT00641537|449426554|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
124945084|NCT00641537|449426555|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
124945085|NCT00641537|449426556|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
124945086|NCT00641537|449426549|FG000|24-Week Supplemental Follow-up Period|Other|0|||
124945087|NCT00641537|449426550|FG001|24-Week Supplemental Follow-up Period|Other|2|||
124945088|NCT00641537|449426551|FG002|24-Week Supplemental Follow-up Period|Other|2|||
124945089|NCT00641537|449426552|FG003|24-Week Supplemental Follow-up Period|Other|1|||
124945090|NCT00641537|449426553|FG004|24-Week Supplemental Follow-up Period|Other|3|||
124945091|NCT00641537|449426554|FG005|24-Week Supplemental Follow-up Period|Other|0|||
124945092|NCT00641537|449426555|FG006|24-Week Supplemental Follow-up Period|Other|1|||
124945093|NCT00641537|449426556|FG007|24-Week Supplemental Follow-up Period|Other|1|||
124945094|NCT01801007|449426557|FG000|Overall Study|Adverse Event|2|||
124945095|NCT01801007|449426557|FG000|Overall Study|Lost to Follow-up|4|||
124945096|NCT01801007|449426557|FG000|Overall Study|Withdrawal by Subject|5|||
124945097|NCT00665392|449426558|FG000|Overall Study|not treated|1|||
124945098|NCT00243867|449426559|FG000|Overall Study|Adverse Event|24|||
124945099|NCT00243867|449426560|FG001|Overall Study|Adverse Event|34|||
124945100|NCT00243867|449426559|FG000|Overall Study|Lack of Efficacy|115|||
124945101|NCT00243867|449426560|FG001|Overall Study|Lack of Efficacy|78|||
124945102|NCT00243867|449426559|FG000|Overall Study|Withdrawal by Subject|11|||
124945103|NCT00243867|449426560|FG001|Overall Study|Withdrawal by Subject|23|||
124945104|NCT00243867|449426559|FG000|Overall Study|Lost to Follow-up|2|||
124945105|NCT00243867|449426560|FG001|Overall Study|Lost to Follow-up|1|||
124945106|NCT00243867|449426559|FG000|Overall Study|Physician Decision|2|||
124945107|NCT00243867|449426560|FG001|Overall Study|Physician Decision|7|||
124945108|NCT00243867|449426559|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
124945109|NCT00243867|449426560|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
124945110|NCT01321073|449426565|FG000|Overall Study|Did not attempt implant|4|||
124945111|NCT01321073|449426565|FG000|Overall Study|Death|3|||
124945112|NCT01638000|449426572|FG000|Overall Study|Randomized but Never Received Drug|7|||
124945113|NCT01638000|449426573|FG001|Overall Study|Randomized but Never Received Drug|10|||
124945114|NCT01638000|449426572|FG000|Overall Study|Adverse Event|14|||
124945115|NCT01638000|449426573|FG001|Overall Study|Adverse Event|16|||
124945116|NCT01638000|449426572|FG000|Overall Study|Lack of Efficacy|5|||
124945117|NCT01638000|449426573|FG001|Overall Study|Lack of Efficacy|6|||
124945118|NCT01638000|449426572|FG000|Overall Study|Protocol Violation|11|||
124945119|NCT01638000|449426573|FG001|Overall Study|Protocol Violation|13|||
124945120|NCT01638000|449426572|FG000|Overall Study|Withdrawal by Subject|21|||
124945121|NCT01638000|449426573|FG001|Overall Study|Withdrawal by Subject|24|||
124945122|NCT01638000|449426572|FG000|Overall Study|Miscellaneous|2|||
124945123|NCT01638000|449426573|FG001|Overall Study|Miscellaneous|2|||
124945124|NCT05352230|449426574|FG000|First Intervention (3 Months)|study terminated|2|||
124945125|NCT05352230|449426575|FG001|First Intervention (3 Months)|study terminated|2|||
124945126|NCT01683409|449426576|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
124945127|NCT01683409|449426577|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
124945128|NCT01683409|449426578|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
124945129|NCT01683409|449426579|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
124945130|NCT01683409|449426580|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
124945131|NCT01683409|449426576|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
124945132|NCT01683409|449426577|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
124945133|NCT01683409|449426578|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
124945134|NCT01683409|449426579|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
124945135|NCT01683409|449426580|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
124945136|NCT01683409|449426576|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
124945137|NCT01683409|449426577|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
124945138|NCT01683409|449426578|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
124945139|NCT01683409|449426579|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
124945140|NCT01683409|449426580|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
124945141|NCT01683409|449426576|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
124945142|NCT01683409|449426577|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
124945143|NCT01683409|449426578|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
124945144|NCT01683409|449426579|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
124945145|NCT01683409|449426580|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
124945146|NCT01683409|449426576|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
124945147|NCT01683409|449426577|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
124945148|NCT01683409|449426578|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
124945149|NCT01683409|449426579|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
124945150|NCT01683409|449426580|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
124945151|NCT01683409|449426576|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
124945152|NCT01683409|449426577|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
124945153|NCT01683409|449426578|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
124945154|NCT01683409|449426579|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
124945155|NCT01683409|449426580|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
124945156|NCT01683409|449426576|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
124945157|NCT01683409|449426577|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
124945158|NCT01683409|449426578|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
124945159|NCT01683409|449426579|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
124945160|NCT01683409|449426580|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
124945161|NCT01683409|449426576|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
124945162|NCT01683409|449426577|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
124945163|NCT01683409|449426578|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
124945164|NCT01683409|449426579|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
124945165|NCT01683409|449426580|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
125123365|NCT01345019|450075816|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
125123366|NCT01345019|450075817|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
125123367|NCT01345019|450075816|FG000|Open Label Treatment Phase|Protocol Violation|0|||
125123368|NCT01345019|450075817|FG001|Open Label Treatment Phase|Protocol Violation|1|||
125123369|NCT03830164|450075820|FG000|Overall Study|Adverse Event|0|||
125123370|NCT03830164|450075821|FG001|Overall Study|Adverse Event|2|||
125123371|NCT03830164|450075822|FG002|Overall Study|Adverse Event|0|||
125123372|NCT03830164|450075820|FG000|Overall Study|Lack of Efficacy|1|||
125123373|NCT03830164|450075821|FG001|Overall Study|Lack of Efficacy|5|||
125123374|NCT03830164|450075822|FG002|Overall Study|Lack of Efficacy|0|||
125123375|NCT03830164|450075820|FG000|Overall Study|Lost to Follow-up|0|||
125123376|NCT03830164|450075821|FG001|Overall Study|Lost to Follow-up|1|||
125123377|NCT03830164|450075822|FG002|Overall Study|Lost to Follow-up|0|||
125123378|NCT03830164|450075820|FG000|Overall Study|Withdrawal by Subject|1|||
125123379|NCT03830164|450075821|FG001|Overall Study|Withdrawal by Subject|0|||
125123380|NCT03830164|450075822|FG002|Overall Study|Withdrawal by Subject|0|||
125123381|NCT00386009|450075823|FG000|Overall Study|Adverse Event|0|||
125123382|NCT00386009|450075824|FG001|Overall Study|Adverse Event|2|||
125123383|NCT00386009|450075823|FG000|Overall Study|Death|1|||
125123384|NCT00386009|450075824|FG001|Overall Study|Death|0|||
125123385|NCT00386009|450075823|FG000|Overall Study|Entry Criteria Not Met|0|||
125123386|NCT00386009|450075824|FG001|Overall Study|Entry Criteria Not Met|2|||
125123387|NCT00386009|450075823|FG000|Overall Study|Lost to Follow-up|1|||
125123388|NCT00386009|450075824|FG001|Overall Study|Lost to Follow-up|1|||
125123389|NCT00386009|450075823|FG000|Overall Study|Protocol Violation|1|||
125123390|NCT00386009|450075824|FG001|Overall Study|Protocol Violation|0|||
125123391|NCT00386009|450075823|FG000|Overall Study|Sponsor Decision|1|||
125123392|NCT00386009|450075824|FG001|Overall Study|Sponsor Decision|1|||
125123393|NCT00386009|450075823|FG000|Overall Study|Withdrawal by Subject|5|||
125123394|NCT00386009|450075824|FG001|Overall Study|Withdrawal by Subject|4|||
125123395|NCT01492400|450075826|FG000|Overall Study|Miscellaneous Reasons|2|||
125123396|NCT01492400|450075827|FG001|Overall Study|Miscellaneous Reasons|3|||
125123397|NCT01492400|450075826|FG000|Overall Study|Personal Reasons|0|||
125123398|NCT01492400|450075827|FG001|Overall Study|Personal Reasons|5|||
125123399|NCT01492400|450075826|FG000|Overall Study|Lost to Follow-up|3|||
125123400|NCT01492400|450075827|FG001|Overall Study|Lost to Follow-up|1|||
125123401|NCT01492400|450075826|FG000|Overall Study|Pregnancy|0|||
125123402|NCT01492400|450075827|FG001|Overall Study|Pregnancy|1|||
125123403|NCT01492400|450075826|FG000|Overall Study|Lack of Efficacy|1|||
125123404|NCT01492400|450075827|FG001|Overall Study|Lack of Efficacy|1|||
125123405|NCT01492400|450075826|FG000|Overall Study|Adverse Event|10|||
125123406|NCT01492400|450075827|FG001|Overall Study|Adverse Event|5|||
125123407|NCT00604500|450075828|FG000|Overall Study|Adverse Event|2|||
125123408|NCT00604500|450075828|FG000|Overall Study|Protocol Violation|2|||
125123409|NCT00604500|450075828|FG000|Overall Study|Treatment Failure|1|||
125123410|NCT00604500|450075828|FG000|Overall Study|Withdrawal by Subject|4|||
125123411|NCT00604500|450075828|FG000|Overall Study|Administrative|1|||
125123412|NCT00604500|450075828|FG000|Overall Study|Did not meet protocol eligibility|1|||
125123413|NCT00320112|450075830|FG000|Overall Study|Lost to Follow-up|3|||
125123414|NCT00320112|450075831|FG001|Overall Study|Lost to Follow-up|4|||
125123415|NCT00320112|450075830|FG000|Overall Study|Withdrawal by Subject|3|||
125123416|NCT00320112|450075831|FG001|Overall Study|Withdrawal by Subject|0|||
125123417|NCT00320112|450075830|FG000|Overall Study|Death|2|||
125123418|NCT00320112|450075831|FG001|Overall Study|Death|1|||
125123419|NCT02899338|450075832|FG000|Overall Study|Adverse Event|1|||
125123420|NCT02899338|450075833|FG001|Overall Study|Adverse Event|2|||
125123421|NCT02899338|450075832|FG000|Overall Study|Withdrawal by Subject|2|||
125123422|NCT02899338|450075833|FG001|Overall Study|Withdrawal by Subject|0|||
125123423|NCT02353169|450075834|FG000|Overall Study|QTc > 450 msec|1|||
125123424|NCT02353169|450075835|FG001|Overall Study|QTc > 450 msec|1|||
125123425|NCT02353169|450075836|FG002|Overall Study|QTc > 450 msec|1|||
125123426|NCT02353169|450075837|FG003|Overall Study|QTc > 450 msec|1|||
125123427|NCT02353169|450075834|FG000|Overall Study|OR team declined|2|||
125123428|NCT02353169|450075835|FG001|Overall Study|OR team declined|0|||
124945166|NCT01683409|449426576|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
124945167|NCT01683409|449426577|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
124945168|NCT01683409|449426578|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
124945169|NCT01683409|449426579|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
124945170|NCT01683409|449426580|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
124945171|NCT01683409|449426576|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
124945172|NCT01683409|449426577|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
124945173|NCT01683409|449426578|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
124945174|NCT01683409|449426579|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
124945175|NCT01683409|449426580|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
124945176|NCT01683409|449426576|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
124945177|NCT01683409|449426577|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
124945178|NCT01683409|449426578|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
124945179|NCT01683409|449426579|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
124945180|NCT01683409|449426580|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
124945181|NCT04218864|449426581|FG000|Overall Study|Lost to Follow-up|8|||
124945182|NCT04218864|449426582|FG001|Overall Study|Lost to Follow-up|4|||
124945183|NCT04218864|449426581|FG000|Overall Study|Withdrawal by Subject|1|||
124945184|NCT04218864|449426582|FG001|Overall Study|Withdrawal by Subject|3|||
124945185|NCT01227421|449426583|FG000|Overall Study|Lost to Follow-up|6|||
124945186|NCT01227421|449426584|FG001|Overall Study|Lost to Follow-up|7|||
124945187|NCT01227421|449426585|FG002|Overall Study|Lost to Follow-up|5|||
125123429|NCT02353169|450075836|FG002|Overall Study|OR team declined|0|||
125123430|NCT02353169|450075837|FG003|Overall Study|OR team declined|0|||
125123431|NCT02353169|450075834|FG000|Overall Study|Inhalational induction|0|||
125123432|NCT02353169|450075835|FG001|Overall Study|Inhalational induction|2|||
125123433|NCT02353169|450075836|FG002|Overall Study|Inhalational induction|0|||
125123434|NCT02353169|450075837|FG003|Overall Study|Inhalational induction|0|||
125123435|NCT02353169|450075834|FG000|Overall Study|ECG data error|0|||
125123436|NCT02353169|450075835|FG001|Overall Study|ECG data error|3|||
125123437|NCT02353169|450075836|FG002|Overall Study|ECG data error|2|||
125123438|NCT02353169|450075837|FG003|Overall Study|ECG data error|2|||
125123439|NCT02353169|450075834|FG000|Overall Study|Pre-op medication|0|||
125123440|NCT02353169|450075835|FG001|Overall Study|Pre-op medication|0|||
125123441|NCT02353169|450075836|FG002|Overall Study|Pre-op medication|1|||
125123442|NCT02353169|450075837|FG003|Overall Study|Pre-op medication|0|||
125123443|NCT00906347|450075838|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
125123444|NCT00906347|450075839|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
124945188|NCT01227421|449426583|FG000|Overall Study|Adverse Event|2|||
124945189|NCT01227421|449426584|FG001|Overall Study|Adverse Event|7|||
124945190|NCT01227421|449426585|FG002|Overall Study|Adverse Event|2|||
124945191|NCT01227421|449426583|FG000|Overall Study|Withdrawal by Subject|1|||
124945192|NCT01227421|449426584|FG001|Overall Study|Withdrawal by Subject|2|||
124945193|NCT01227421|449426585|FG002|Overall Study|Withdrawal by Subject|1|||
124945194|NCT01227421|449426583|FG000|Overall Study|Protocol Violation|1|||
124945195|NCT01227421|449426584|FG001|Overall Study|Protocol Violation|1|||
124945196|NCT01227421|449426585|FG002|Overall Study|Protocol Violation|2|||
124945197|NCT01227421|449426583|FG000|Overall Study|Randomized in error|1|||
124945198|NCT01227421|449426584|FG001|Overall Study|Randomized in error|1|||
124945199|NCT01227421|449426585|FG002|Overall Study|Randomized in error|0|||
124945200|NCT02499328|449426586|FG000|Overall Study|Withdrawal by Subject|1|||
124945201|NCT02499328|449426587|FG001|Overall Study|Withdrawal by Subject|1|||
124945202|NCT02499328|449426588|FG002|Overall Study|Withdrawal by Subject|5|||
124945203|NCT02499328|449426589|FG003|Overall Study|Withdrawal by Subject|3|||
124945204|NCT02499328|449426590|FG004|Overall Study|Withdrawal by Subject|5|||
124945205|NCT02499328|449426591|FG005|Overall Study|Withdrawal by Subject|0|||
124945206|NCT02499328|449426592|FG006|Overall Study|Withdrawal by Subject|0|||
124945207|NCT02499328|449426593|FG007|Overall Study|Withdrawal by Subject|0|||
124945208|NCT02499328|449426594|FG008|Overall Study|Withdrawal by Subject|2|||
124945209|NCT02499328|449426595|FG009|Overall Study|Withdrawal by Subject|2|||
124945210|NCT02499328|449426596|FG010|Overall Study|Withdrawal by Subject|0|||
124945211|NCT02499328|449426597|FG011|Overall Study|Withdrawal by Subject|3|||
124945212|NCT02499328|449426598|FG012|Overall Study|Withdrawal by Subject|7|||
124945213|NCT02499328|449426599|FG013|Overall Study|Withdrawal by Subject|3|||
124945214|NCT02499328|449426600|FG014|Overall Study|Withdrawal by Subject|1|||
124945215|NCT02499328|449426601|FG015|Overall Study|Withdrawal by Subject|0|||
124945216|NCT02499328|449426602|FG016|Overall Study|Withdrawal by Subject|0|||
124945217|NCT02499328|449426603|FG017|Overall Study|Withdrawal by Subject|3|||
125123445|NCT00906347|450075838|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
125123446|NCT00906347|450075839|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
124945218|NCT02499328|449426604|FG018|Overall Study|Withdrawal by Subject|0|||
124945219|NCT02499328|449426586|FG000|Overall Study|Lost to Follow-up|0|||
124945220|NCT02499328|449426587|FG001|Overall Study|Lost to Follow-up|1|||
125123447|NCT00906347|450075838|FG000|Received Study Drug|Refused study drug|1|||
125123448|NCT00906347|450075839|FG001|Received Study Drug|Refused study drug|0|||
125214390|NCT00762034|450412799|FG001|Induction Period|Entry Criterion Not Met|11|||
125214391|NCT00762034|450412798|FG000|Induction Period|Adverse Event|27|||
125214392|NCT00762034|450412799|FG001|Induction Period|Adverse Event|38|||
125214393|NCT00762034|450412798|FG000|Induction Period|Lost to Follow-up|1|||
124945221|NCT02499328|449426588|FG002|Overall Study|Lost to Follow-up|1|||
125214394|NCT00762034|450412799|FG001|Induction Period|Lost to Follow-up|1|||
125214395|NCT00762034|450412798|FG000|Induction Period|Progressive Disease|73|||
125214396|NCT00762034|450412799|FG001|Induction Period|Progressive Disease|55|||
125214397|NCT00762034|450412798|FG000|Induction Period|Physician Decision|21|||
125214398|NCT00762034|450412799|FG001|Induction Period|Physician Decision|20|||
125214399|NCT00762034|450412798|FG000|Induction Period|Withdrawal by Subject|15|||
125214400|NCT00762034|450412799|FG001|Induction Period|Withdrawal by Subject|19|||
125214401|NCT00762034|450412798|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
125214402|NCT00762034|450412799|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
125214403|NCT00762034|450412798|FG000|Induction Period|Deaths Due to Study Disease|9|||
125214404|NCT00762034|450412799|FG001|Induction Period|Deaths Due to Study Disease|9|||
125214405|NCT00762034|450412798|FG000|Maintenance Period|Protocol Violation|1|||
125214406|NCT00762034|450412799|FG001|Maintenance Period|Protocol Violation|3|||
125214407|NCT00762034|450412798|FG000|Maintenance Period|Entry Criterion Not Met|0|||
125214408|NCT00762034|450412799|FG001|Maintenance Period|Entry Criterion Not Met|2|||
125214409|NCT00762034|450412798|FG000|Maintenance Period|Adverse Event|42|||
125214410|NCT00762034|450412799|FG001|Maintenance Period|Adverse Event|26|||
125214411|NCT00762034|450412798|FG000|Maintenance Period|Progressive Disease|186|||
125214412|NCT00762034|450412799|FG001|Maintenance Period|Progressive Disease|224|||
125214413|NCT00762034|450412798|FG000|Maintenance Period|Physician Decision|25|||
125214414|NCT00762034|450412799|FG001|Maintenance Period|Physician Decision|20|||
125214415|NCT00762034|450412798|FG000|Maintenance Period|Withdrawal by Subject|34|||
125214416|NCT00762034|450412799|FG001|Maintenance Period|Withdrawal by Subject|14|||
125214417|NCT00762034|450412798|FG000|Maintenance Period|Death not due to study disease|2|||
124945222|NCT02499328|449426589|FG003|Overall Study|Lost to Follow-up|2|||
124945223|NCT02499328|449426590|FG004|Overall Study|Lost to Follow-up|0|||
124945224|NCT02499328|449426591|FG005|Overall Study|Lost to Follow-up|0|||
124945225|NCT02499328|449426592|FG006|Overall Study|Lost to Follow-up|0|||
124945226|NCT02499328|449426593|FG007|Overall Study|Lost to Follow-up|2|||
124945227|NCT02499328|449426594|FG008|Overall Study|Lost to Follow-up|3|||
124945228|NCT02499328|449426595|FG009|Overall Study|Lost to Follow-up|0|||
124945229|NCT02499328|449426596|FG010|Overall Study|Lost to Follow-up|0|||
124945230|NCT02499328|449426597|FG011|Overall Study|Lost to Follow-up|0|||
124945231|NCT02499328|449426598|FG012|Overall Study|Lost to Follow-up|0|||
124945232|NCT02499328|449426599|FG013|Overall Study|Lost to Follow-up|0|||
124945233|NCT02499328|449426600|FG014|Overall Study|Lost to Follow-up|0|||
124945234|NCT02499328|449426601|FG015|Overall Study|Lost to Follow-up|0|||
124945235|NCT02499328|449426602|FG016|Overall Study|Lost to Follow-up|0|||
124945236|NCT02499328|449426603|FG017|Overall Study|Lost to Follow-up|0|||
124945237|NCT02499328|449426604|FG018|Overall Study|Lost to Follow-up|1|||
124945238|NCT02499328|449426586|FG000|Overall Study|Death|0|||
124945239|NCT02499328|449426587|FG001|Overall Study|Death|3|||
124945240|NCT02499328|449426588|FG002|Overall Study|Death|3|||
124945241|NCT02499328|449426589|FG003|Overall Study|Death|2|||
124945242|NCT02499328|449426590|FG004|Overall Study|Death|4|||
124945243|NCT02499328|449426591|FG005|Overall Study|Death|7|||
124945244|NCT02499328|449426592|FG006|Overall Study|Death|3|||
124945245|NCT02499328|449426593|FG007|Overall Study|Death|0|||
124945246|NCT02499328|449426594|FG008|Overall Study|Death|2|||
124945247|NCT02499328|449426595|FG009|Overall Study|Death|6|||
124945248|NCT02499328|449426596|FG010|Overall Study|Death|6|||
124945249|NCT02499328|449426597|FG011|Overall Study|Death|20|||
125028678|NCT03186989|449727656|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
124945250|NCT02499328|449426598|FG012|Overall Study|Death|9|||
124945251|NCT02499328|449426599|FG013|Overall Study|Death|7|||
125028679|NCT03186989|449727657|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
125214418|NCT00762034|450412799|FG001|Maintenance Period|Death not due to study disease|5|||
125214419|NCT00762034|450412798|FG000|Maintenance Period|Death due to study disease|3|||
125214420|NCT00762034|450412799|FG001|Maintenance Period|Death due to study disease|3|||
125214421|NCT00762034|450412798|FG000|Maintenance Period|Other|1|||
125214422|NCT00762034|450412799|FG001|Maintenance Period|Other|1|||
124945252|NCT02499328|449426600|FG014|Overall Study|Death|3|||
124945253|NCT02499328|449426601|FG015|Overall Study|Death|1|||
124945254|NCT02499328|449426602|FG016|Overall Study|Death|1|||
124945255|NCT02499328|449426603|FG017|Overall Study|Death|16|||
124945256|NCT02499328|449426604|FG018|Overall Study|Death|5|||
124945257|NCT02499328|449426586|FG000|Overall Study|"Other"|2|||
124945258|NCT02499328|449426587|FG001|Overall Study|"Other"|2|||
124945259|NCT02499328|449426588|FG002|Overall Study|"Other"|1|||
124945260|NCT02499328|449426589|FG003|Overall Study|"Other"|3|||
124945261|NCT02499328|449426590|FG004|Overall Study|"Other"|6|||
125214423|NCT01299896|450412802|FG000|Overall Study|Withdrawal by Subject|1|||
125214424|NCT01299896|450412803|FG001|Overall Study|Withdrawal by Subject|7|||
125214425|NCT01299896|450412802|FG000|Overall Study|Lost to Follow-up|0|||
125214426|NCT01299896|450412803|FG001|Overall Study|Lost to Follow-up|11|||
125214427|NCT02107313|450412804|FG000|Overall Study|One participant did not do the FED cohor|0|||
125214428|NCT02107313|450412805|FG001|Overall Study|One participant did not do the FED cohor|1|||
125214429|NCT02090283|450412810|FG000|Overall Study|Withdrawal by Subject|6|||
125214430|NCT02090283|450412811|FG001|Overall Study|Withdrawal by Subject|6|||
125214431|NCT02090283|450412812|FG002|Overall Study|Withdrawal by Subject|6|||
125214432|NCT02090283|450412810|FG000|Overall Study|Sponsor Terminated Study|6|||
125214433|NCT02090283|450412811|FG001|Overall Study|Sponsor Terminated Study|6|||
125214434|NCT02090283|450412812|FG002|Overall Study|Sponsor Terminated Study|1|||
125214435|NCT02090283|450412810|FG000|Overall Study|Lost to Follow-up|2|||
125214436|NCT02090283|450412811|FG001|Overall Study|Lost to Follow-up|2|||
125214437|NCT02090283|450412812|FG002|Overall Study|Lost to Follow-up|3|||
125214438|NCT02090283|450412810|FG000|Overall Study|Adverse Event|1|||
125214439|NCT02090283|450412811|FG001|Overall Study|Adverse Event|1|||
125214440|NCT02090283|450412812|FG002|Overall Study|Adverse Event|0|||
125214441|NCT02090283|450412810|FG000|Overall Study|Protocol Violation|2|||
125214442|NCT02090283|450412811|FG001|Overall Study|Protocol Violation|0|||
125214443|NCT02090283|450412812|FG002|Overall Study|Protocol Violation|0|||
125214444|NCT05205005|450412832|FG000|Overall Study|Withdrawal by Subject|1|||
125214445|NCT05205005|450412833|FG001|Overall Study|Withdrawal by Subject|0|||
125214446|NCT05205005|450412832|FG000|Overall Study|Adverse Event|1|||
125214447|NCT05205005|450412833|FG001|Overall Study|Adverse Event|0|||
125214448|NCT01148459|450412836|FG000|Overall Study|Serious Adverse Event|5|||
125214449|NCT01148459|450412837|FG001|Overall Study|Serious Adverse Event|4|||
125214450|NCT01148459|450412836|FG000|Overall Study|Withdrawal by Subject|1|||
125214451|NCT01148459|450412837|FG001|Overall Study|Withdrawal by Subject|0|||
125214452|NCT01148459|450412836|FG000|Overall Study|Migrated/moved from study area|3|||
125028680|NCT03186989|449727658|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
125028681|NCT03186989|449727659|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
125028682|NCT03186989|449727660|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
125028683|NCT03186989|449727661|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
125028684|NCT03186989|449727662|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
125028685|NCT03186989|449727652|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
125028686|NCT03186989|449727653|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
125028687|NCT03186989|449727654|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
125028688|NCT03186989|449727655|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
125028689|NCT03186989|449727656|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
125028690|NCT03186989|449727657|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
125214453|NCT01148459|450412837|FG001|Overall Study|Migrated/moved from study area|6|||
125214454|NCT01148459|450412836|FG000|Overall Study|Lost to Follow-up|2|||
124945262|NCT02499328|449426591|FG005|Overall Study|"Other"|2|||
124945263|NCT02499328|449426592|FG006|Overall Study|"Other"|3|||
125214455|NCT01148459|450412837|FG001|Overall Study|Lost to Follow-up|0|||
125214456|NCT01148459|450412836|FG000|Overall Study|Refusal|1|||
125214457|NCT01148459|450412837|FG001|Overall Study|Refusal|0|||
125214458|NCT01148459|450412836|FG000|Overall Study|Failure to comply with study procedures|0|||
125214459|NCT01148459|450412837|FG001|Overall Study|Failure to comply with study procedures|1|||
125214460|NCT02187029|450412838|FG000|Overall Study|Adverse Event|0|||
124945264|NCT02499328|449426593|FG007|Overall Study|"Other"|4|||
124945265|NCT02499328|449426594|FG008|Overall Study|"Other"|6|||
124945266|NCT02499328|449426595|FG009|Overall Study|"Other"|16|||
124945267|NCT02499328|449426596|FG010|Overall Study|"Other"|13|||
124945268|NCT02499328|449426597|FG011|Overall Study|"Other"|31|||
124945269|NCT02499328|449426598|FG012|Overall Study|"Other"|8|||
124945270|NCT02499328|449426599|FG013|Overall Study|"Other"|7|||
124945271|NCT02499328|449426600|FG014|Overall Study|"Other"|6|||
124945272|NCT02499328|449426601|FG015|Overall Study|"Other"|0|||
124945273|NCT02499328|449426602|FG016|Overall Study|"Other"|0|||
124945274|NCT02499328|449426603|FG017|Overall Study|"Other"|34|||
124945275|NCT02499328|449426604|FG018|Overall Study|"Other"|43|||
124945276|NCT02499328|449426586|FG000|Overall Study|Disease Progression|0|||
124945277|NCT02499328|449426587|FG001|Overall Study|Disease Progression|0|||
124945278|NCT02499328|449426588|FG002|Overall Study|Disease Progression|0|||
124945279|NCT02499328|449426589|FG003|Overall Study|Disease Progression|0|||
124945280|NCT02499328|449426590|FG004|Overall Study|Disease Progression|0|||
124945281|NCT02499328|449426591|FG005|Overall Study|Disease Progression|0|||
124945282|NCT02499328|449426592|FG006|Overall Study|Disease Progression|1|||
124945283|NCT02499328|449426593|FG007|Overall Study|Disease Progression|0|||
124945284|NCT02499328|449426594|FG008|Overall Study|Disease Progression|1|||
124945285|NCT02499328|449426595|FG009|Overall Study|Disease Progression|0|||
124945286|NCT02499328|449426596|FG010|Overall Study|Disease Progression|1|||
124945287|NCT02499328|449426597|FG011|Overall Study|Disease Progression|0|||
124945288|NCT02499328|449426598|FG012|Overall Study|Disease Progression|0|||
124945289|NCT02499328|449426599|FG013|Overall Study|Disease Progression|0|||
124945290|NCT02499328|449426600|FG014|Overall Study|Disease Progression|0|||
124945291|NCT02499328|449426601|FG015|Overall Study|Disease Progression|0|||
124945292|NCT02499328|449426602|FG016|Overall Study|Disease Progression|0|||
124945293|NCT02499328|449426603|FG017|Overall Study|Disease Progression|2|||
124945294|NCT02499328|449426604|FG018|Overall Study|Disease Progression|0|||
124945295|NCT02499328|449426586|FG000|Overall Study|Adverse Event|1|||
124945296|NCT02499328|449426587|FG001|Overall Study|Adverse Event|0|||
124945297|NCT02499328|449426588|FG002|Overall Study|Adverse Event|0|||
124945298|NCT02499328|449426589|FG003|Overall Study|Adverse Event|1|||
124945299|NCT02499328|449426590|FG004|Overall Study|Adverse Event|0|||
124945300|NCT02499328|449426591|FG005|Overall Study|Adverse Event|0|||
124945301|NCT02499328|449426592|FG006|Overall Study|Adverse Event|0|||
124945302|NCT02499328|449426593|FG007|Overall Study|Adverse Event|0|||
124945303|NCT02499328|449426594|FG008|Overall Study|Adverse Event|0|||
124945304|NCT02499328|449426595|FG009|Overall Study|Adverse Event|0|||
124945305|NCT02499328|449426596|FG010|Overall Study|Adverse Event|0|||
124945306|NCT02499328|449426597|FG011|Overall Study|Adverse Event|0|||
124945307|NCT02499328|449426598|FG012|Overall Study|Adverse Event|1|||
125028691|NCT03186989|449727658|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
125028692|NCT03186989|449727659|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
125028693|NCT03186989|449727660|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
125028694|NCT03186989|449727661|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
125028695|NCT03186989|449727662|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
125028696|NCT00865020|449727671|FG000|Overall Study|Withdrawal by Subject|22|||
125028697|NCT00865020|449727672|FG001|Overall Study|Withdrawal by Subject|16|||
125028698|NCT00865020|449727671|FG000|Overall Study|Adverse Event|9|||
125028699|NCT00865020|449727672|FG001|Overall Study|Adverse Event|14|||
125028700|NCT00865020|449727671|FG000|Overall Study|Abnormal test procedure result(s)|6|||
125028701|NCT00865020|449727672|FG001|Overall Study|Abnormal test procedure result(s)|8|||
125028702|NCT00865020|449727671|FG000|Overall Study|Lost to Follow-up|6|||
125028703|NCT00865020|449727672|FG001|Overall Study|Lost to Follow-up|4|||
125028704|NCT00865020|449727671|FG000|Overall Study|Protocol deviation|4|||
125028705|NCT00865020|449727672|FG001|Overall Study|Protocol deviation|1|||
125028706|NCT00865020|449727671|FG000|Overall Study|Administrative problems|0|||
125028707|NCT00865020|449727672|FG001|Overall Study|Administrative problems|2|||
125028708|NCT00865020|449727671|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125028709|NCT00865020|449727672|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125028710|NCT00865020|449727671|FG000|Overall Study|Death|0|||
125028711|NCT00865020|449727672|FG001|Overall Study|Death|1|||
125028712|NCT00865020|449727671|FG000|Overall Study|Randomized but discontinued|2|||
125214461|NCT02187029|450412839|FG001|Overall Study|Adverse Event|1|||
124945308|NCT02499328|449426599|FG013|Overall Study|Adverse Event|0|||
125028713|NCT00865020|449727672|FG001|Overall Study|Randomized but discontinued|4|||
125028714|NCT05900115|449729164|FG000|Overall Study|Lost to Follow-up|129|||
125214462|NCT02187029|450412840|FG002|Overall Study|Adverse Event|1|||
124945309|NCT02499328|449426600|FG014|Overall Study|Adverse Event|0|||
124945310|NCT02499328|449426601|FG015|Overall Study|Adverse Event|0|||
124945311|NCT02499328|449426602|FG016|Overall Study|Adverse Event|0|||
124945312|NCT02499328|449426603|FG017|Overall Study|Adverse Event|0|||
124945313|NCT02499328|449426604|FG018|Overall Study|Adverse Event|0|||
124945314|NCT00145470|449426605|FG000|Overall Study|Adverse Event|19|||
124945315|NCT00145470|449426606|FG001|Overall Study|Adverse Event|25|||
124945316|NCT00145470|449426605|FG000|Overall Study|Lack of Efficacy|27|||
124945317|NCT00145470|449426606|FG001|Overall Study|Lack of Efficacy|13|||
124945318|NCT00145470|449426605|FG000|Overall Study|Withdrawal by Subject|36|||
124945319|NCT00145470|449426606|FG001|Overall Study|Withdrawal by Subject|34|||
124945320|NCT00145470|449426605|FG000|Overall Study|Lost to Follow-up|21|||
124945321|NCT00145470|449426606|FG001|Overall Study|Lost to Follow-up|17|||
124945322|NCT00145470|449426605|FG000|Overall Study|Reason Not Reported|9|||
124945323|NCT00145470|449426606|FG001|Overall Study|Reason Not Reported|9|||
124945324|NCT06269003|449426608|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
124945325|NCT06269003|449426609|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
124945326|NCT06269003|449426610|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
124945327|NCT06269003|449426611|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
124945328|NCT04186247|449426612|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
124945329|NCT04186247|449426613|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
124945330|NCT04186247|449426614|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
124945331|NCT04186247|449426615|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
124945332|NCT04186247|449426616|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
124945333|NCT04323800|449428194|FG000|Overall Study|Withdrawal by Subject|4|||
124945334|NCT04323800|449428195|FG001|Overall Study|Withdrawal by Subject|4|||
124945335|NCT04323800|449428194|FG000|Overall Study|Incomplete transfusion|1|||
124945336|NCT04323800|449428195|FG001|Overall Study|Incomplete transfusion|0|||
124945337|NCT04323800|449428194|FG000|Overall Study|Other|0|||
124945338|NCT04323800|449428195|FG001|Overall Study|Other|1|||
124945339|NCT04323800|449428194|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
124945340|NCT04323800|449428195|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
124945341|NCT00489554|449428196|FG000|Overall Study|Adverse Event|2|||
124945342|NCT00489554|449428196|FG000|Overall Study|Withdrawal by Subject|1|||
124945343|NCT00489554|449428196|FG000|Overall Study|Lost to Follow-up|1|||
124945344|NCT06571695|449428197|FG000|Overall Study|Lost to Follow-up|1|||
124945345|NCT06571695|449428198|FG001|Overall Study|Lost to Follow-up|6|||
124945346|NCT01380145|449428199|FG000|Overall Study|Progressive disease|4|||
124945347|NCT02038049|449428204|FG000|Overall Study|Lost to Follow-up|1|||
124945348|NCT02038049|449428205|FG001|Overall Study|Lost to Follow-up|0|||
124945349|NCT01808534|449428206|FG000|Overall Study|Disease progression|3|||
124945350|NCT01808534|449428206|FG000|Overall Study|Physician Decision|1|||
124945351|NCT02660086|449428207|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
124945352|NCT02660086|449428208|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
124945353|NCT02660086|449428207|FG000|Overall Study- 12-month|Left full-time employment|12|||
124945354|NCT02660086|449428208|FG001|Overall Study- 12-month|Left full-time employment|20|||
124945355|NCT02660086|449428207|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
124945356|NCT02660086|449428208|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
124945357|NCT02660086|449428207|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
124945358|NCT02660086|449428208|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
125028715|NCT05900115|449729165|FG001|Overall Study|Lost to Follow-up|98|||
125028716|NCT00619502|449729166|FG000|Overall Study|Lost to Follow-up|8|||
125028717|NCT00619502|449729167|FG001|Overall Study|Lost to Follow-up|10|||
125028718|NCT00771472|449729168|FG000|Overall Study|Physician Decision|2|||
125028719|NCT00771472|449729169|FG001|Overall Study|Physician Decision|3|||
125028720|NCT00771472|449729168|FG000|Overall Study|Progressive Disease|3|||
125028721|NCT00771472|449729169|FG001|Overall Study|Progressive Disease|1|||
125028722|NCT00771472|449729168|FG000|Overall Study|Protocol Violation|1|||
125028723|NCT00771472|449729169|FG001|Overall Study|Protocol Violation|0|||
125028724|NCT00880750|449729172|FG000|First Intervention|Adverse Event|1|||
125028725|NCT00880750|449729173|FG001|First Intervention|Adverse Event|0|||
125028726|NCT00880750|449729172|FG000|First Intervention|Unable to collect urine|4|||
125028727|NCT00880750|449729173|FG001|First Intervention|Unable to collect urine|0|||
125028728|NCT00880750|449729172|FG000|First Intervention|Non-compliance with meals|0|||
125028729|NCT00880750|449729173|FG001|First Intervention|Non-compliance with meals|1|||
125028730|NCT00880750|449729172|FG000|First Intervention|Withdrawal by Subject|2|||
125028731|NCT00880750|449729173|FG001|First Intervention|Withdrawal by Subject|0|||
125028732|NCT00880750|449729172|FG000|First Intervention|Lost to Follow-up|2|||
125028733|NCT00880750|449729173|FG001|First Intervention|Lost to Follow-up|0|||
125028734|NCT00880750|449729172|FG000|Second Intervention|Withdrawal by Subject|2|||
125028735|NCT00880750|449729173|FG001|Second Intervention|Withdrawal by Subject|2|||
125028736|NCT00880750|449729172|FG000|Second Intervention|Protocol Violation|1|||
125028737|NCT00880750|449729173|FG001|Second Intervention|Protocol Violation|0|||
125028738|NCT00880750|449729172|FG000|Second Intervention|Unable to collect urine|1|||
125028739|NCT00880750|449729173|FG001|Second Intervention|Unable to collect urine|0|||
125028740|NCT00483327|449729174|FG000|Overall Study|Adverse Event|1|||
125028741|NCT00483327|449729174|FG000|Overall Study|Withdrawal by Subject|3|||
124945359|NCT02660086|449428207|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
124945360|NCT02660086|449428208|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
124945361|NCT02660086|449428207|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
124945362|NCT02660086|449428208|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
124945363|NCT00667017|449428211|FG000|Overall Study|Withdrawal by Subject|1|||
124945364|NCT01673594|449428219|FG000|Overall Study|Adverse Event|3|||
124945365|NCT01673594|449428220|FG001|Overall Study|Adverse Event|1|||
124945366|NCT01673594|449428219|FG000|Overall Study|Lost to Follow-up|1|||
124945367|NCT01673594|449428220|FG001|Overall Study|Lost to Follow-up|0|||
124945368|NCT01673594|449428219|FG000|Overall Study|Physician Decision|2|||
124945369|NCT01673594|449428220|FG001|Overall Study|Physician Decision|4|||
124945370|NCT01673594|449428219|FG000|Overall Study|Withdrawal by Subject|0|||
124945371|NCT01673594|449428220|FG001|Overall Study|Withdrawal by Subject|1|||
124945372|NCT02605174|449428226|FG000|Overall Study|Adverse Event|0|||
124945373|NCT02605174|449428227|FG001|Overall Study|Adverse Event|0|||
124945374|NCT02605174|449428228|FG002|Overall Study|Adverse Event|1|||
124945375|NCT02605174|449428229|FG003|Overall Study|Adverse Event|0|||
124945376|NCT02605174|449428230|FG004|Overall Study|Adverse Event|4|||
124945377|NCT02605174|449428231|FG005|Overall Study|Adverse Event|0|||
124945378|NCT02605174|449428232|FG006|Overall Study|Adverse Event|0|||
124945379|NCT02605174|449428226|FG000|Overall Study|Lost to Follow-up|20|||
124945380|NCT02605174|449428227|FG001|Overall Study|Lost to Follow-up|7|||
124945381|NCT02605174|449428228|FG002|Overall Study|Lost to Follow-up|27|||
124945382|NCT02605174|449428229|FG003|Overall Study|Lost to Follow-up|10|||
124945383|NCT02605174|449428230|FG004|Overall Study|Lost to Follow-up|20|||
124945384|NCT02605174|449428231|FG005|Overall Study|Lost to Follow-up|10|||
125123449|NCT00906347|450075838|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
125123450|NCT00906347|450075839|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
125123451|NCT00577460|450075842|FG000|Overall Study|Adverse Event|11|||
125123452|NCT00577460|450075843|FG001|Overall Study|Adverse Event|7|||
125123453|NCT00577460|450075844|FG002|Overall Study|Adverse Event|14|||
125123454|NCT00577460|450075842|FG000|Overall Study|Protocol Violation|0|||
125123455|NCT00577460|450075843|FG001|Overall Study|Protocol Violation|1|||
125123456|NCT00577460|450075844|FG002|Overall Study|Protocol Violation|1|||
125123457|NCT00577460|450075842|FG000|Overall Study|Lost to Follow-up|0|||
125123458|NCT00577460|450075843|FG001|Overall Study|Lost to Follow-up|3|||
125123459|NCT00577460|450075844|FG002|Overall Study|Lost to Follow-up|4|||
125123460|NCT00577460|450075842|FG000|Overall Study|Withdrawal by Subject|5|||
125123461|NCT00577460|450075843|FG001|Overall Study|Withdrawal by Subject|5|||
125123462|NCT00577460|450075844|FG002|Overall Study|Withdrawal by Subject|6|||
125123463|NCT00577460|450075842|FG000|Overall Study|Other|0|||
124945385|NCT02605174|449428232|FG006|Overall Study|Lost to Follow-up|29|||
124945386|NCT02605174|449428226|FG000|Overall Study|Protocol Violation|10|||
124945387|NCT02605174|449428227|FG001|Overall Study|Protocol Violation|4|||
124945388|NCT02605174|449428228|FG002|Overall Study|Protocol Violation|14|||
124945389|NCT02605174|449428229|FG003|Overall Study|Protocol Violation|6|||
124945390|NCT02605174|449428230|FG004|Overall Study|Protocol Violation|7|||
125123464|NCT00577460|450075843|FG001|Overall Study|Other|3|||
125123465|NCT00577460|450075844|FG002|Overall Study|Other|2|||
125123466|NCT04591626|450075845|FG000|Overall Study|Adverse Event|4|||
125123467|NCT04591626|450075846|FG001|Overall Study|Adverse Event|0|||
125123468|NCT04591626|450075845|FG000|Overall Study|Withdrawal by Subject|5|||
125123469|NCT04591626|450075846|FG001|Overall Study|Withdrawal by Subject|3|||
124945391|NCT02605174|449428231|FG005|Overall Study|Protocol Violation|7|||
124945392|NCT02605174|449428232|FG006|Overall Study|Protocol Violation|12|||
124945393|NCT02605174|449428226|FG000|Overall Study|Pregnancy|1|||
124945394|NCT02605174|449428227|FG001|Overall Study|Pregnancy|0|||
124945395|NCT02605174|449428228|FG002|Overall Study|Pregnancy|0|||
124945396|NCT02605174|449428229|FG003|Overall Study|Pregnancy|2|||
124945397|NCT02605174|449428230|FG004|Overall Study|Pregnancy|0|||
124945398|NCT02605174|449428231|FG005|Overall Study|Pregnancy|0|||
124945399|NCT02605174|449428232|FG006|Overall Study|Pregnancy|0|||
124945400|NCT02605174|449428226|FG000|Overall Study|Withdrawal by Subject|9|||
124945401|NCT02605174|449428227|FG001|Overall Study|Withdrawal by Subject|6|||
124945402|NCT02605174|449428228|FG002|Overall Study|Withdrawal by Subject|14|||
124945403|NCT02605174|449428229|FG003|Overall Study|Withdrawal by Subject|11|||
124945404|NCT02605174|449428230|FG004|Overall Study|Withdrawal by Subject|6|||
124945405|NCT02605174|449428231|FG005|Overall Study|Withdrawal by Subject|4|||
124945406|NCT02605174|449428232|FG006|Overall Study|Withdrawal by Subject|15|||
124945407|NCT02605174|449428226|FG000|Overall Study|Physician Decision|2|||
124945408|NCT02605174|449428227|FG001|Overall Study|Physician Decision|0|||
124945409|NCT02605174|449428228|FG002|Overall Study|Physician Decision|0|||
124945410|NCT02605174|449428229|FG003|Overall Study|Physician Decision|0|||
124945411|NCT02605174|449428230|FG004|Overall Study|Physician Decision|0|||
125123470|NCT04591626|450075845|FG000|Overall Study|Physician Decision|0|||
125123471|NCT04591626|450075846|FG001|Overall Study|Physician Decision|1|||
125123472|NCT04591626|450075845|FG000|Overall Study|Death|0|||
125123473|NCT04591626|450075846|FG001|Overall Study|Death|1|||
125123474|NCT04591626|450075845|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125028742|NCT00483327|449729174|FG000|Overall Study|Lost to Follow-up|4|||
125028743|NCT00483327|449729174|FG000|Overall Study|Patient Non Compliance|2|||
125028744|NCT00670007|449729175|FG000|Overall Study|Drug abuse|1|||
125028745|NCT00670007|449729175|FG000|Overall Study|Lung transplant|1|||
125028746|NCT00670007|449729175|FG000|Overall Study|Travel/Vacation|1|||
125028747|NCT00670007|449729175|FG000|Overall Study|Adverse event, serious fatal|1|||
125028748|NCT00670007|449729175|FG000|Overall Study|Adverse Event|1|||
125028749|NCT00670007|449729175|FG000|Overall Study|Withdrawal by Subject|4|||
125028750|NCT00618722|449729176|FG000|Overall Study|Refusal of Treatment|0|||
125028751|NCT00618722|449729177|FG001|Overall Study|Refusal of Treatment|0|||
124945412|NCT02605174|449428231|FG005|Overall Study|Physician Decision|0|||
125028752|NCT00618722|449729178|FG002|Overall Study|Refusal of Treatment|1|||
125028753|NCT00618722|449729179|FG003|Overall Study|Refusal of Treatment|0|||
125028754|NCT00618722|449729176|FG000|Overall Study|Patient Request|1|||
125028755|NCT00618722|449729177|FG001|Overall Study|Patient Request|1|||
125028756|NCT00618722|449729178|FG002|Overall Study|Patient Request|1|||
125028757|NCT00618722|449729179|FG003|Overall Study|Patient Request|1|||
125028758|NCT00618722|449729176|FG000|Overall Study|Inability to Complete Study Procedure|0|||
125028759|NCT00618722|449729177|FG001|Overall Study|Inability to Complete Study Procedure|1|||
125028760|NCT00618722|449729178|FG002|Overall Study|Inability to Complete Study Procedure|0|||
125028761|NCT00618722|449729179|FG003|Overall Study|Inability to Complete Study Procedure|0|||
125028762|NCT00618722|449729176|FG000|Overall Study|Lost to Follow-up|2|||
125028763|NCT00618722|449729177|FG001|Overall Study|Lost to Follow-up|0|||
125028764|NCT00618722|449729178|FG002|Overall Study|Lost to Follow-up|0|||
125028765|NCT00618722|449729179|FG003|Overall Study|Lost to Follow-up|2|||
125028766|NCT00618722|449729176|FG000|Overall Study|Miscellaneous Reasons|0|||
124945413|NCT02605174|449428232|FG006|Overall Study|Physician Decision|3|||
124945414|NCT02605174|449428226|FG000|Overall Study|Randomization Failure|22|||
124945415|NCT02605174|449428227|FG001|Overall Study|Randomization Failure|6|||
124945416|NCT02605174|449428228|FG002|Overall Study|Randomization Failure|20|||
124945417|NCT02605174|449428229|FG003|Overall Study|Randomization Failure|7|||
124945418|NCT02605174|449428230|FG004|Overall Study|Randomization Failure|16|||
124945419|NCT02605174|449428231|FG005|Overall Study|Randomization Failure|11|||
124945420|NCT02605174|449428232|FG006|Overall Study|Randomization Failure|30|||
124945421|NCT03737110|449428234|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
124945422|NCT03737110|449428235|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
124945423|NCT03737110|449428236|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
124945424|NCT03737110|449428237|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
125028767|NCT00618722|449729177|FG001|Overall Study|Miscellaneous Reasons|0|||
125028768|NCT00618722|449729178|FG002|Overall Study|Miscellaneous Reasons|1|||
125028769|NCT00618722|449729179|FG003|Overall Study|Miscellaneous Reasons|1|||
125028770|NCT00200057|449729184|FG000|Overall Study|Lack of Efficacy|3|||
125028771|NCT00200057|449729184|FG000|Overall Study|Exited due to terminal illness of PI|2|||
125028772|NCT00200057|449729184|FG000|Overall Study|Withdrawal by Subject|1|||
125028773|NCT00200057|449729184|FG000|Overall Study|Change in medical condition|1|||
125028774|NCT00200057|449729184|FG000|Overall Study|Infection|1|||
125028775|NCT00200057|449729184|FG000|Overall Study|Death|1|||
125028776|NCT00778830|449729185|FG000|Overall Study|Ongoing at data cut-off|0|||
125028777|NCT00778830|449729186|FG001|Overall Study|Ongoing at data cut-off|1|||
125028778|NCT01891643|449729187|FG000|Overall Study|Adverse event unrelated to study drug|2|||
125028779|NCT01891643|449729188|FG001|Overall Study|Adverse event unrelated to study drug|5|||
125028780|NCT01891643|449729187|FG000|Overall Study|Disease Progression|4|||
125028781|NCT01891643|449729188|FG001|Overall Study|Disease Progression|3|||
125028782|NCT01891643|449729187|FG000|Overall Study|Study Drug Toxicity|3|||
125028783|NCT01891643|449729188|FG001|Overall Study|Study Drug Toxicity|0|||
125028784|NCT01891643|449729187|FG000|Overall Study|Maximum Clinical Benefit|0|||
125028785|NCT01891643|449729188|FG001|Overall Study|Maximum Clinical Benefit|1|||
125028786|NCT01891643|449729187|FG000|Overall Study|Poor/Non-compliance|0|||
125028787|NCT01891643|449729188|FG001|Overall Study|Poor/Non-compliance|1|||
125028788|NCT01891643|449729187|FG000|Overall Study|Participant request to discontinue|1|||
125028789|NCT01891643|449729188|FG001|Overall Study|Participant request to discontinue|0|||
125028790|NCT01583179|449729191|FG000|Overall Study|Screen failure|1|||
125028791|NCT01583179|449729192|FG001|Overall Study|Screen failure|2|||
125028792|NCT01246206|449729193|FG000|Overall Study|Patient did not receive study regiments.|1|||
125028793|NCT02965716|449729194|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
125028794|NCT02965716|449729195|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
125028795|NCT02965716|449729194|FG000|Overall Study|Progression/Relapse|8|||
125028796|NCT02965716|449729195|FG001|Overall Study|Progression/Relapse|16|||
125028797|NCT02965716|449729194|FG000|Overall Study|Death|1|||
125028798|NCT02965716|449729195|FG001|Overall Study|Death|0|||
125028799|NCT02965716|449729194|FG000|Overall Study|Not Protocol Specified|1|||
125028800|NCT02965716|449729195|FG001|Overall Study|Not Protocol Specified|3|||
125028801|NCT04047797|449729196|FG000|Overall Study|Progressive Disease|1|||
124945425|NCT03737110|449428238|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
124945426|NCT03737110|449428239|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
125028802|NCT03523351|449729197|FG000|Overall Study|Death|13|||
125028803|NCT03523351|449729198|FG001|Overall Study|Death|11|||
124945427|NCT03737110|449428234|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
124945428|NCT03737110|449428235|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
124945429|NCT03737110|449428236|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
124945430|NCT03737110|449428237|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
124945431|NCT03737110|449428238|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
124945432|NCT03737110|449428239|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
124945433|NCT03737110|449428234|FG000|Run-in (RI) Period|Adverse Event|4|||
124945434|NCT03737110|449428235|FG001|Run-in (RI) Period|Adverse Event|0|||
124945435|NCT03737110|449428236|FG002|Run-in (RI) Period|Adverse Event|0|||
124945436|NCT03737110|449428237|FG003|Run-in (RI) Period|Adverse Event|0|||
124945437|NCT03737110|449428238|FG004|Run-in (RI) Period|Adverse Event|0|||
124945438|NCT03737110|449428239|FG005|Run-in (RI) Period|Adverse Event|0|||
124945439|NCT03737110|449428234|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
124945440|NCT03737110|449428235|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
124945441|NCT03737110|449428236|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
124945442|NCT03737110|449428237|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
124945443|NCT03737110|449428238|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
124945444|NCT03737110|449428239|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
124945445|NCT03737110|449428234|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
124945446|NCT03737110|449428235|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
124945447|NCT03737110|449428236|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
124945448|NCT03737110|449428237|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
124945449|NCT03737110|449428238|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
124945450|NCT03737110|449428239|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
124945451|NCT03737110|449428234|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
124945452|NCT03737110|449428235|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
124945453|NCT03737110|449428236|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
124945454|NCT03737110|449428237|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
124945455|NCT03737110|449428238|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
124945456|NCT03737110|449428239|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
124945457|NCT03737110|449428234|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
124945458|NCT03737110|449428235|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
124945459|NCT03737110|449428236|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
124945460|NCT03737110|449428237|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
124945461|NCT03737110|449428238|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
124945462|NCT03737110|449428239|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
124945463|NCT03737110|449428234|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
124945464|NCT03737110|449428235|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
124945465|NCT03737110|449428236|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
124945466|NCT03737110|449428237|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
124945467|NCT03737110|449428238|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
124945468|NCT03737110|449428239|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
124945469|NCT02575365|449428244|FG000|Overall Study|Lost to Follow-up|4|||
124945470|NCT03392194|449428245|FG000|Overall Study|Withdrawal by Subject|1|||
124945471|NCT03392194|449428246|FG001|Overall Study|Withdrawal by Subject|2|||
124945472|NCT03392194|449428245|FG000|Overall Study|Conflicts with personal schedule|1|||
124945473|NCT03392194|449428246|FG001|Overall Study|Conflicts with personal schedule|0|||
124945474|NCT03865732|449428247|FG000|Overall Study|Adverse Event|0|||
124945475|NCT03865732|449428248|FG001|Overall Study|Adverse Event|1|||
124945476|NCT01951703|449428262|FG000|First Intervention|Withdrawal by Subject|1|||
124945477|NCT01951703|449428263|FG001|First Intervention|Withdrawal by Subject|0|||
124945478|NCT01951703|449428262|FG000|First Intervention|Subject was not compliant|1|||
124945479|NCT01951703|449428263|FG001|First Intervention|Subject was not compliant|1|||
124945480|NCT01951703|449428262|FG000|First Intervention|Physician Decision|1|||
124945481|NCT01951703|449428263|FG001|First Intervention|Physician Decision|0|||
124945482|NCT01951703|449428262|FG000|Second Intervention|Protocol Violation|0|||
124945483|NCT01951703|449428263|FG001|Second Intervention|Protocol Violation|1|||
124945484|NCT01951703|449428262|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
124945485|NCT01951703|449428263|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
124945486|NCT01009645|449428264|FG000|Overall Study|Lost to Follow-up|2|||
124945487|NCT01009645|449428265|FG001|Overall Study|Lost to Follow-up|8|||
124945488|NCT01009645|449428266|FG002|Overall Study|Lost to Follow-up|4|||
125028804|NCT03523351|449729197|FG000|Overall Study|Lost to Follow-up|2|||
124945489|NCT01009645|449428267|FG003|Overall Study|Lost to Follow-up|5|||
124945490|NCT00620854|449428268|FG000|Washout 1|Withdrawal by Subject|0|||
124945491|NCT00620854|449428269|FG001|Washout 1|Withdrawal by Subject|0|||
125028805|NCT03523351|449729198|FG001|Overall Study|Lost to Follow-up|3|||
125028806|NCT03523351|449729197|FG000|Overall Study|Withdrawal by Subject|4|||
124945492|NCT00620854|449428270|FG002|Washout 1|Withdrawal by Subject|1|||
124945493|NCT00620854|449428271|FG003|Washout 1|Withdrawal by Subject|1|||
124945494|NCT00620854|449428272|FG004|Washout 1|Withdrawal by Subject|0|||
124945495|NCT00620854|449428273|FG005|Washout 1|Withdrawal by Subject|0|||
124945496|NCT05124210|449428275|FG000|Overall Study|Lost to Follow-up|1|||
124945497|NCT05124210|449428276|FG001|Overall Study|Lost to Follow-up|0|||
124945498|NCT05124210|449428275|FG000|Overall Study|Withdrawal by Subject|1|||
124945499|NCT05124210|449428276|FG001|Overall Study|Withdrawal by Subject|0|||
124945500|NCT01428583|449428278|FG000|Overall Study|Adverse Event|75|||
124945501|NCT01428583|449428278|FG000|Overall Study|Withdrawal by Subject|51|||
124945502|NCT01428583|449428278|FG000|Overall Study|Lack of Efficacy|37|||
124945503|NCT01428583|449428278|FG000|Overall Study|Lost to Follow-up|17|||
124945504|NCT01428583|449428278|FG000|Overall Study|Death|1|||
124945505|NCT01428583|449428278|FG000|Overall Study|Pregnancy|1|||
124945506|NCT01428583|449428278|FG000|Overall Study|Protocol Violation|1|||
124945507|NCT01428583|449428278|FG000|Overall Study|Physician Decision|12|||
124945508|NCT01428583|449428278|FG000|Overall Study|Non-compliant|25|||
124945509|NCT01428583|449428278|FG000|Overall Study|Confirmed positive urine drug test|8|||
124945510|NCT01428583|449428278|FG000|Overall Study|Sponsor's request|3|||
124945511|NCT01428583|449428278|FG000|Overall Study|Other|6|||
124945512|NCT00768755|449428281|FG000|Phase 1|Death|6|||
124945513|NCT00768755|449428282|FG001|Phase 1|Death|0|||
124945514|NCT00768755|449428283|FG002|Phase 1|Death|0|||
124945515|NCT00768755|449428284|FG003|Phase 1|Death|0|||
124945516|NCT00768755|449428281|FG000|Phase 1|Other|4|||
124945517|NCT00768755|449428282|FG001|Phase 1|Other|0|||
124945518|NCT00768755|449428283|FG002|Phase 1|Other|0|||
124945519|NCT00768755|449428284|FG003|Phase 1|Other|0|||
124945520|NCT00768755|449428281|FG000|Phase 2|Death|0|||
124945521|NCT00768755|449428282|FG001|Phase 2|Death|37|||
124945522|NCT00768755|449428283|FG002|Phase 2|Death|48|||
124945523|NCT00768755|449428284|FG003|Phase 2|Death|31|||
124945524|NCT00768755|449428281|FG000|Phase 2|Protocol Violation|0|||
124945525|NCT00768755|449428282|FG001|Phase 2|Protocol Violation|2|||
124945526|NCT00768755|449428283|FG002|Phase 2|Protocol Violation|0|||
124945527|NCT00768755|449428284|FG003|Phase 2|Protocol Violation|1|||
124945528|NCT00768755|449428281|FG000|Phase 2|Lost to Follow-up|0|||
124945529|NCT00768755|449428282|FG001|Phase 2|Lost to Follow-up|1|||
124945530|NCT00768755|449428283|FG002|Phase 2|Lost to Follow-up|1|||
124945531|NCT00768755|449428284|FG003|Phase 2|Lost to Follow-up|4|||
124945532|NCT00768755|449428281|FG000|Phase 2|Withdrawal by Subject|0|||
124945533|NCT00768755|449428282|FG001|Phase 2|Withdrawal by Subject|1|||
124945534|NCT00768755|449428283|FG002|Phase 2|Withdrawal by Subject|0|||
124945535|NCT00768755|449428284|FG003|Phase 2|Withdrawal by Subject|1|||
124945536|NCT00768755|449428281|FG000|Phase 2|Other|0|||
124945537|NCT00768755|449428282|FG001|Phase 2|Other|1|||
124945538|NCT00768755|449428283|FG002|Phase 2|Other|2|||
124945539|NCT00768755|449428284|FG003|Phase 2|Other|4|||
124945540|NCT00768755|449428281|FG000|Phase 2|Study Terminated by Sponsor|0|||
124945541|NCT00768755|449428282|FG001|Phase 2|Study Terminated by Sponsor|13|||
124945542|NCT00768755|449428283|FG002|Phase 2|Study Terminated by Sponsor|7|||
124945543|NCT00768755|449428284|FG003|Phase 2|Study Terminated by Sponsor|14|||
124945544|NCT00768755|449428281|FG000|Phase 2|Randomized but not treated|0|||
124945545|NCT00768755|449428282|FG001|Phase 2|Randomized but not treated|0|||
124945546|NCT00768755|449428283|FG002|Phase 2|Randomized but not treated|0|||
124945547|NCT00768755|449428284|FG003|Phase 2|Randomized but not treated|2|||
124945548|NCT03184987|449428288|FG000|Overall Study|Withdrawal by Subject|0|||
124945549|NCT03184987|449428289|FG001|Overall Study|Withdrawal by Subject|1|||
124945550|NCT03184987|449428290|FG002|Overall Study|Withdrawal by Subject|2|||
124945551|NCT03184987|449428288|FG000|Overall Study|Physician Decision|0|||
124945552|NCT03184987|449428289|FG001|Overall Study|Physician Decision|0|||
124945553|NCT03184987|449428290|FG002|Overall Study|Physician Decision|1|||
124945554|NCT03184987|449428288|FG000|Overall Study|Adverse Event|1|||
124945555|NCT03184987|449428289|FG001|Overall Study|Adverse Event|0|||
124945556|NCT03184987|449428290|FG002|Overall Study|Adverse Event|1|||
124945557|NCT01220999|449428291|FG000|Overall Study|Progressive disease|0|||
124945558|NCT01220999|449428292|FG001|Overall Study|Progressive disease|0|||
124945559|NCT01220999|449428293|FG002|Overall Study|Progressive disease|1|||
124945560|NCT01220999|449428294|FG003|Overall Study|Progressive disease|0|||
124945561|NCT01220999|449428295|FG004|Overall Study|Progressive disease|0|||
125028807|NCT03523351|449729198|FG001|Overall Study|Withdrawal by Subject|0|||
124945562|NCT01560429|449428296|FG000|Overall Study|Protocol Violation|3|||
124945563|NCT01560429|449428297|FG001|Overall Study|Protocol Violation|6|||
124945564|NCT03026166|449428306|FG000|Overall Study|Death|22|||
124945565|NCT03026166|449428307|FG001|Overall Study|Death|7|||
125033625|NCT01701258|449743824|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
124945566|NCT03026166|449428306|FG000|Overall Study|Physician Decision|2|||
124945567|NCT03026166|449428307|FG001|Overall Study|Physician Decision|0|||
124945568|NCT03026166|449428306|FG000|Overall Study|Withdrawal by Subject|1|||
124945569|NCT03026166|449428307|FG001|Overall Study|Withdrawal by Subject|2|||
124945570|NCT03026166|449428306|FG000|Overall Study|Lost to Follow-up|1|||
124945571|NCT03026166|449428307|FG001|Overall Study|Lost to Follow-up|0|||
124945572|NCT03026166|449428306|FG000|Overall Study|Study Terminated by Sponsor|3|||
125028808|NCT03523351|449729197|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
125028809|NCT03523351|449729198|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
125028810|NCT01097629|449729207|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
125028811|NCT01097629|449729208|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
125028812|NCT01097629|449729209|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
125028813|NCT01097629|449729210|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
125028814|NCT01097629|449729211|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
125028815|NCT01097629|449729212|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
125028816|NCT01097629|449729213|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
125028817|NCT01097629|449729214|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
125028818|NCT01097629|449729207|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
125028819|NCT01097629|449729208|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
125028820|NCT01097629|449729209|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
125214463|NCT02187029|450412841|FG003|Overall Study|Adverse Event|0|||
125214464|NCT02187029|450412838|FG000|Overall Study|Study Terminated by Sponsor|0|||
125028821|NCT01097629|449729210|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
125028822|NCT01097629|449729211|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
125028823|NCT01097629|449729212|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
125028824|NCT01097629|449729213|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
125028825|NCT01097629|449729214|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
125028826|NCT01097629|449729207|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
125028827|NCT01097629|449729208|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
125028828|NCT01097629|449729209|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
124945573|NCT03026166|449428307|FG001|Overall Study|Study Terminated by Sponsor|3|||
124945574|NCT03026166|449428306|FG000|Overall Study|Other|1|||
124945575|NCT03026166|449428307|FG001|Overall Study|Other|0|||
124945576|NCT03035942|449428308|FG000|Overall Study|Adverse Event|8|||
124945577|NCT03035942|449428309|FG001|Overall Study|Adverse Event|4|||
124945578|NCT03035942|449428310|FG002|Overall Study|Adverse Event|5|||
124945579|NCT05270460|449428311|FG000|Overall Study|Adverse Event|0|||
124945580|NCT05270460|449428312|FG001|Overall Study|Adverse Event|1|||
124945581|NCT05270460|449428313|FG002|Overall Study|Adverse Event|0|||
124945582|NCT05270460|449428311|FG000|Overall Study|Early Termination|0|||
124945583|NCT05270460|449428312|FG001|Overall Study|Early Termination|1|||
124945584|NCT05270460|449428313|FG002|Overall Study|Early Termination|0|||
124945585|NCT02091752|449428314|FG000|Overall Study|Study terminated by Sponsor|2|||
124945586|NCT02091752|449428314|FG000|Overall Study|Adverse Event|1|||
124945587|NCT01989104|449428315|FG000|Overall Study|Withdrawal by Subject|3|||
124945588|NCT01989104|449428316|FG001|Overall Study|Withdrawal by Subject|0|||
124945589|NCT01989104|449428317|FG002|Overall Study|Withdrawal by Subject|0|||
125028829|NCT01097629|449729210|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
124945590|NCT01989104|449428318|FG003|Overall Study|Withdrawal by Subject|0|||
124945591|NCT01989104|449428319|FG004|Overall Study|Withdrawal by Subject|0|||
125028830|NCT01097629|449729211|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
125028831|NCT01097629|449729212|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
125028832|NCT01097629|449729213|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
125028833|NCT01097629|449729214|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
125028834|NCT01097629|449729207|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
125028835|NCT01097629|449729208|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
125028836|NCT01097629|449729209|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
125028837|NCT01097629|449729210|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125028838|NCT01097629|449729211|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125028839|NCT01097629|449729212|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125028840|NCT01097629|449729213|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125028841|NCT01097629|449729214|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125028842|NCT01097629|449729207|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
125028843|NCT01097629|449729208|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
125028844|NCT01097629|449729209|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
125028845|NCT01097629|449729210|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
125028846|NCT01097629|449729211|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
125028847|NCT01097629|449729212|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
125028848|NCT01097629|449729213|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
125028849|NCT01097629|449729214|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
125214465|NCT02187029|450412839|FG001|Overall Study|Study Terminated by Sponsor|0|||
125214466|NCT02187029|450412840|FG002|Overall Study|Study Terminated by Sponsor|10|||
124945592|NCT04029090|449428321|FG000|Overall Study|Protocol Violation|1|||
124945593|NCT04029090|449428322|FG001|Overall Study|Protocol Violation|0|||
124945594|NCT04029090|449428323|FG002|Overall Study|Protocol Violation|0|||
125214467|NCT02187029|450412841|FG003|Overall Study|Study Terminated by Sponsor|3|||
124945595|NCT04029090|449428321|FG000|Overall Study|Withdrawal by Subject|0|||
124945596|NCT04029090|449428322|FG001|Overall Study|Withdrawal by Subject|1|||
124945597|NCT04029090|449428323|FG002|Overall Study|Withdrawal by Subject|0|||
124945598|NCT01065779|449428327|FG000|Overall Study|Duplicate Investigation|1|||
124945599|NCT01065779|449428327|FG000|Overall Study|Investigation Before Contract Date|37|||
124945600|NCT01065779|449428327|FG000|Overall Study|Non-enrollment Period Administration|10|||
124945601|NCT01065779|449428327|FG000|Overall Study|Not Administered With Study Drug|17|||
124945602|NCT01065779|449428327|FG000|Overall Study|Failed to Follow-up|10|||
124945603|NCT01065779|449428327|FG000|Overall Study|Inclusion Criteria Violation|7|||
124945604|NCT02157948|449428328|FG000|Overall Study|Withdrawal by Subject|4|||
124945605|NCT02157948|449428329|FG001|Overall Study|Withdrawal by Subject|5|||
124945606|NCT02157948|449428328|FG000|Overall Study|Lost to Follow-up|3|||
124945607|NCT02157948|449428329|FG001|Overall Study|Lost to Follow-up|2|||
124945608|NCT02157948|449428328|FG000|Overall Study|Protocol Specified Criteria|2|||
124945609|NCT02157948|449428329|FG001|Overall Study|Protocol Specified Criteria|1|||
124945610|NCT02157948|449428328|FG000|Overall Study|Decision by Sponsor|0|||
124945611|NCT02157948|449428329|FG001|Overall Study|Decision by Sponsor|1|||
124945612|NCT01604824|449428330|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
124945613|NCT01604824|449428331|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
124945614|NCT01604824|449428332|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
124945615|NCT01604824|449428333|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
124945616|NCT01604824|449428334|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
124945617|NCT01604824|449428335|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
124945618|NCT01604824|449428330|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
124945619|NCT01604824|449428331|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
124945620|NCT01604824|449428332|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
124945621|NCT01604824|449428333|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
124945622|NCT01604824|449428334|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
124945623|NCT01604824|449428335|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
124945624|NCT03775213|449428342|FG000|Overall Study|Withdrawal by Subject|51|||
124945625|NCT03775213|449428343|FG001|Overall Study|Withdrawal by Subject|53|||
125214468|NCT02187029|450412838|FG000|Overall Study|Withdrawal by Subject|1|||
125214469|NCT02187029|450412839|FG001|Overall Study|Withdrawal by Subject|0|||
125214470|NCT02187029|450412840|FG002|Overall Study|Withdrawal by Subject|0|||
125214471|NCT02187029|450412841|FG003|Overall Study|Withdrawal by Subject|0|||
125214472|NCT00694356|450412843|FG000|Overall Study|Adverse Event|1|||
125214473|NCT00694356|450412844|FG001|Overall Study|Adverse Event|0|||
125214474|NCT00694356|450412845|FG002|Overall Study|Adverse Event|0|||
125214475|NCT00694356|450412843|FG000|Overall Study|Progressive Disease|2|||
125214476|NCT00694356|450412844|FG001|Overall Study|Progressive Disease|6|||
125214477|NCT00694356|450412845|FG002|Overall Study|Progressive Disease|6|||
125214478|NCT01301079|450412855|FG000|Overall Study|Lost to Follow-up|2|||
125214479|NCT01301079|450412856|FG001|Overall Study|Lost to Follow-up|2|||
125214480|NCT02496039|450412857|FG000|Overall Study|Adverse Event|3|||
125214481|NCT02496039|450412857|FG000|Overall Study|Protocol Violation|1|||
125214482|NCT04472494|450412858|FG000|Pre-treatment|Other reasons|2|||
125214483|NCT04472494|450412859|FG001|Pre-treatment|Other reasons|0|||
125214484|NCT04472494|450412858|FG000|Treatment|Death|5|||
124945626|NCT03775213|449428342|FG000|Overall Study|Incomplete Survey|7|||
124945627|NCT03775213|449428343|FG001|Overall Study|Incomplete Survey|7|||
124945628|NCT04821271|449428344|FG000|Period 1|Withdrawal by Subject|2|||
124945629|NCT04821271|449428345|FG001|Period 1|Withdrawal by Subject|0|||
124945630|NCT01567852|449429172|FG000|Overall Study|Withdrawal by Subject|3|||
124945631|NCT01567852|449429173|FG001|Overall Study|Withdrawal by Subject|6|||
124945632|NCT01567852|449429172|FG000|Overall Study|ECT discontinued|1|||
124945633|NCT01567852|449429173|FG001|Overall Study|ECT discontinued|1|||
124945634|NCT04809623|449429174|FG000|Overall Study|Study Terminated by Sponsor|1|||
124945635|NCT04809623|449429175|FG001|Overall Study|Study Terminated by Sponsor|0|||
124945636|NCT02202317|449429176|FG000|Overall Study|Lost to Follow-up|1|||
124945637|NCT01450007|449429182|FG000|Overall Study|Late exclusion before treatment|2|||
124945638|NCT01450007|449429183|FG001|Overall Study|Late exclusion before treatment|3|||
124945639|NCT01450007|449429184|FG002|Overall Study|Late exclusion before treatment|2|||
124945640|NCT01450007|449429182|FG000|Overall Study|Protocol Violation|0|||
124945641|NCT01450007|449429183|FG001|Overall Study|Protocol Violation|1|||
124945642|NCT01450007|449429184|FG002|Overall Study|Protocol Violation|1|||
124945643|NCT01450007|449429182|FG000|Overall Study|Adverse Event|0|||
124945644|NCT01450007|449429183|FG001|Overall Study|Adverse Event|1|||
124945645|NCT01450007|449429184|FG002|Overall Study|Adverse Event|0|||
124945646|NCT01852045|449429191|FG000|Overall Study|Adverse Event|1|||
124945647|NCT01852045|449429192|FG001|Overall Study|Adverse Event|0|||
124945648|NCT01852045|449429193|FG002|Overall Study|Adverse Event|0|||
124945649|NCT01852045|449429191|FG000|Overall Study|Lack of Efficacy|3|||
124945650|NCT01852045|449429192|FG001|Overall Study|Lack of Efficacy|0|||
124945651|NCT01852045|449429193|FG002|Overall Study|Lack of Efficacy|0|||
124945652|NCT01852045|449429191|FG000|Overall Study|Lost to Follow-up|0|||
124945653|NCT01852045|449429192|FG001|Overall Study|Lost to Follow-up|1|||
124945654|NCT01852045|449429193|FG002|Overall Study|Lost to Follow-up|1|||
124945655|NCT01852045|449429191|FG000|Overall Study|Withdrawal by Subject|1|||
124945656|NCT01852045|449429192|FG001|Overall Study|Withdrawal by Subject|0|||
124945657|NCT01852045|449429193|FG002|Overall Study|Withdrawal by Subject|1|||
124945658|NCT01852045|449429191|FG000|Overall Study|Other Miscellaneous Reasons|1|||
124945659|NCT01852045|449429192|FG001|Overall Study|Other Miscellaneous Reasons|3|||
124945660|NCT01852045|449429193|FG002|Overall Study|Other Miscellaneous Reasons|2|||
124945661|NCT00487240|449429196|FG000|Overall Study|Withdrawal by Subject|12|||
124945662|NCT00487240|449429197|FG001|Overall Study|Withdrawal by Subject|6|||
124945663|NCT00487240|449429196|FG000|Overall Study|Lost to Follow-up|7|||
124945664|NCT00487240|449429197|FG001|Overall Study|Lost to Follow-up|6|||
124945665|NCT00487240|449429196|FG000|Overall Study|Adverse Event|0|||
124945666|NCT00487240|449429197|FG001|Overall Study|Adverse Event|4|||
124945667|NCT00487240|449429196|FG000|Overall Study|Protocol Violation|5|||
124945668|NCT00487240|449429197|FG001|Overall Study|Protocol Violation|5|||
124945669|NCT00487240|449429196|FG000|Overall Study|Entry Criteria Not Met|3|||
124945670|NCT00487240|449429197|FG001|Overall Study|Entry Criteria Not Met|4|||
124945671|NCT00487240|449429196|FG000|Overall Study|Sponsor Decision|2|||
124945672|NCT00487240|449429197|FG001|Overall Study|Sponsor Decision|1|||
124945673|NCT00487240|449429196|FG000|Overall Study|Physician Decision|2|||
124945674|NCT00487240|449429197|FG001|Overall Study|Physician Decision|0|||
124945675|NCT01698918|449429198|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
124945676|NCT01698918|449429198|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
124945677|NCT01698918|449429198|FG000|First Line Treatment (Core+Extension)|Death|2|||
124945678|NCT01698918|449429198|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
124945679|NCT01698918|449429198|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
124945680|NCT01698918|449429198|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
124945681|NCT01698918|449429198|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
124945682|NCT01698918|449429198|FG000|Second Line Treatment (Core+Extension)|Death|1|||
124945683|NCT01698918|449429198|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
124945684|NCT01698918|449429198|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
124945685|NCT01019135|449429199|FG000|Overall Study|Did not receive allocated intervention|12|||
124945686|NCT01019135|449429200|FG001|Overall Study|Did not receive allocated intervention|6|||
124945687|NCT01019135|449429201|FG002|Overall Study|Did not receive allocated intervention|25|||
124945688|NCT01019135|449429199|FG000|Overall Study|Did not attend CR|8|||
124945689|NCT01019135|449429200|FG001|Overall Study|Did not attend CR|13|||
124945690|NCT01019135|449429201|FG002|Overall Study|Did not attend CR|6|||
124945691|NCT02095678|449429204|FG000|Overall Study|Withdrawal by Subject|0|||
124945692|NCT02095678|449429205|FG001|Overall Study|Withdrawal by Subject|1|||
124945693|NCT02095678|449429204|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
124945694|NCT02095678|449429205|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
124945695|NCT02095678|449429204|FG000|Overall Study|lesion impacted by previous treatment|1|||
124945696|NCT02095678|449429205|FG001|Overall Study|lesion impacted by previous treatment|1|||
124945697|NCT02095678|449429204|FG000|Overall Study|No Confirmed Diagnosis|0|||
124945698|NCT02095678|449429205|FG001|Overall Study|No Confirmed Diagnosis|3|||
124945699|NCT02095678|449429204|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
124945700|NCT02095678|449429205|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
124945701|NCT02095678|449429204|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
124945702|NCT02095678|449429205|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
124945703|NCT02203799|449429206|FG000|Overall Study|Withdrawal by Subject|3|||
124945704|NCT00681109|449429207|FG000|Overall Study|Lost to Follow-up|2|||
124945705|NCT00681109|449429208|FG001|Overall Study|Lost to Follow-up|6|||
124945706|NCT00681109|449429209|FG002|Overall Study|Lost to Follow-up|0|||
124945707|NCT04660799|449429210|FG000|Overall Study|Progressive Disease|1|||
124945708|NCT04660799|449429211|FG001|Overall Study|Progressive Disease|1|||
124945709|NCT04660799|449429210|FG000|Overall Study|Death|2|||
124945710|NCT04660799|449429211|FG001|Overall Study|Death|1|||
124945711|NCT04660799|449429210|FG000|Overall Study|Adverse Event|2|||
124945712|NCT04660799|449429211|FG001|Overall Study|Adverse Event|1|||
124945713|NCT04660799|449429210|FG000|Overall Study|Withdrawal by Subject|2|||
124945714|NCT04660799|449429211|FG001|Overall Study|Withdrawal by Subject|5|||
124945715|NCT02106884|449429216|FG000|Overall Study|Change of diagnosis/exclusion|0|||
125028850|NCT01097629|449729207|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
124945716|NCT02106884|449429217|FG001|Overall Study|Change of diagnosis/exclusion|1|||
124945717|NCT02037568|449429220|FG000|Overall Study|Withdrawal by Subject|17|||
124945718|NCT02037568|449429221|FG001|Overall Study|Withdrawal by Subject|24|||
124945719|NCT02037568|449429220|FG000|Overall Study|Lost to Follow-up|16|||
124945720|NCT02037568|449429221|FG001|Overall Study|Lost to Follow-up|13|||
124945721|NCT02037568|449429220|FG000|Overall Study|Screen Failure|3|||
124945722|NCT02037568|449429221|FG001|Overall Study|Screen Failure|1|||
125214485|NCT04472494|450412859|FG001|Treatment|Death|2|||
124945723|NCT02037568|449429220|FG000|Overall Study|Patient did not receive transplant|0|||
124945724|NCT02037568|449429221|FG001|Overall Study|Patient did not receive transplant|1|||
124945725|NCT03861234|449429222|FG000|Overall Study|Not treated|0|||
124945726|NCT03861234|449429223|FG001|Overall Study|Not treated|0|||
124945727|NCT03861234|449429224|FG002|Overall Study|Not treated|0|||
124945728|NCT03861234|449429225|FG003|Overall Study|Not treated|0|||
124945729|NCT03861234|449429226|FG004|Overall Study|Not treated|0|||
124945730|NCT03861234|449429227|FG005|Overall Study|Not treated|1|||
124945731|NCT03861234|449429228|FG006|Overall Study|Not treated|0|||
124945732|NCT03861234|449429229|FG007|Overall Study|Not treated|0|||
124945733|NCT03861234|449429222|FG000|Overall Study|Adverse Event|0|||
124945734|NCT03861234|449429223|FG001|Overall Study|Adverse Event|0|||
124945735|NCT03861234|449429224|FG002|Overall Study|Adverse Event|0|||
124945736|NCT03861234|449429225|FG003|Overall Study|Adverse Event|0|||
125123475|NCT04591626|450075846|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124945737|NCT03861234|449429226|FG004|Overall Study|Adverse Event|0|||
124945738|NCT03861234|449429227|FG005|Overall Study|Adverse Event|1|||
124945739|NCT03861234|449429228|FG006|Overall Study|Adverse Event|0|||
124945740|NCT03861234|449429229|FG007|Overall Study|Adverse Event|0|||
124945741|NCT03861234|449429222|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
124945742|NCT03861234|449429223|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
124945743|NCT03861234|449429224|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
124945744|NCT03861234|449429225|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
124945745|NCT03861234|449429226|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
124945746|NCT03861234|449429227|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
124945747|NCT03861234|449429228|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
124945748|NCT03861234|449429229|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
124945749|NCT03861234|449429222|FG000|Overall Study|As per sponsor decision|0|||
124945750|NCT03861234|449429223|FG001|Overall Study|As per sponsor decision|0|||
124945751|NCT03861234|449429224|FG002|Overall Study|As per sponsor decision|0|||
124945752|NCT03861234|449429225|FG003|Overall Study|As per sponsor decision|0|||
124945753|NCT03861234|449429226|FG004|Overall Study|As per sponsor decision|0|||
124945754|NCT03861234|449429227|FG005|Overall Study|As per sponsor decision|0|||
124945755|NCT03861234|449429228|FG006|Overall Study|As per sponsor decision|1|||
124945756|NCT03861234|449429229|FG007|Overall Study|As per sponsor decision|0|||
124945757|NCT03861234|449429222|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
124945758|NCT03861234|449429223|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
124945759|NCT03861234|449429224|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
124945760|NCT03861234|449429225|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
124945761|NCT03861234|449429226|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
124945762|NCT03861234|449429227|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
124945763|NCT03861234|449429228|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
125123476|NCT02672553|450075847|FG000|Overall Study|Death|3|||
125123477|NCT02672553|450075848|FG001|Overall Study|Death|5|||
125123478|NCT02672553|450075847|FG000|Overall Study|Valve Explant|1|||
125123479|NCT02672553|450075848|FG001|Overall Study|Valve Explant|0|||
125123480|NCT02672553|450075847|FG000|Overall Study|Conversion to Commercial Valve|3|||
125123481|NCT02672553|450075848|FG001|Overall Study|Conversion to Commercial Valve|0|||
125123482|NCT02672553|450075847|FG000|Overall Study|Withdrawal by Subject|3|||
125123483|NCT02672553|450075848|FG001|Overall Study|Withdrawal by Subject|3|||
125123484|NCT02672553|450075847|FG000|Overall Study|Intraoperative screen failure|2|||
125123485|NCT02672553|450075848|FG001|Overall Study|Intraoperative screen failure|0|||
125123486|NCT00182091|450075850|FG000|Overall Study|Withdrawal by Subject|1|||
125123487|NCT00182091|450075851|FG001|Overall Study|Withdrawal by Subject|0|||
125123488|NCT00182091|450075852|FG002|Overall Study|Withdrawal by Subject|0|||
125123489|NCT00182091|450075853|FG003|Overall Study|Withdrawal by Subject|0|||
125123490|NCT00522457|450075857|FG000|Overall Study|Due to disease progression|16|||
125123491|NCT00522457|450075857|FG000|Overall Study|Adverse Event|2|||
124945764|NCT03861234|449429229|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
124945765|NCT00621842|449429230|FG000|Overall Study|Adverse Event|6|||
124945766|NCT00621842|449429230|FG000|Overall Study|Withdrawal by Subject|7|||
124945767|NCT00621842|449429230|FG000|Overall Study|Protocol Violation|4|||
124945768|NCT00621842|449429230|FG000|Overall Study|Lack of Efficacy|2|||
124945769|NCT02066636|449429231|FG000|Overall Study|Disease progression|51|||
124945770|NCT02066636|449429232|FG001|Overall Study|Disease progression|60|||
124945771|NCT02066636|449429233|FG002|Overall Study|Disease progression|700|||
124945772|NCT02066636|449429231|FG000|Overall Study|Study drug toxicity|13|||
124945773|NCT02066636|449429232|FG001|Overall Study|Study drug toxicity|2|||
125123492|NCT01691248|450075858|FG000|Overall Study|Protocol Violation|43|||
125123493|NCT01691248|450075859|FG001|Overall Study|Protocol Violation|27|||
124945774|NCT02066636|449429233|FG002|Overall Study|Study drug toxicity|58|||
124945775|NCT02066636|449429231|FG000|Overall Study|Death|4|||
124945776|NCT02066636|449429232|FG001|Overall Study|Death|2|||
124945777|NCT02066636|449429233|FG002|Overall Study|Death|158|||
124945778|NCT02066636|449429231|FG000|Overall Study|Adverse event unrelated to study drug|6|||
124945779|NCT02066636|449429232|FG001|Overall Study|Adverse event unrelated to study drug|4|||
124945780|NCT02066636|449429233|FG002|Overall Study|Adverse event unrelated to study drug|45|||
124945781|NCT02066636|449429231|FG000|Overall Study|Participant request to discontinue treatment|12|||
124945782|NCT02066636|449429232|FG001|Overall Study|Participant request to discontinue treatment|12|||
124945783|NCT02066636|449429233|FG002|Overall Study|Participant request to discontinue treatment|70|||
124945784|NCT02066636|449429231|FG000|Overall Study|Participant withdrew consent|10|||
124945785|NCT02066636|449429232|FG001|Overall Study|Participant withdrew consent|18|||
124945786|NCT02066636|449429233|FG002|Overall Study|Participant withdrew consent|61|||
124945787|NCT02066636|449429231|FG000|Overall Study|Lost to Follow-up|0|||
124945788|NCT02066636|449429232|FG001|Overall Study|Lost to Follow-up|2|||
124945789|NCT02066636|449429233|FG002|Overall Study|Lost to Follow-up|2|||
124945790|NCT02066636|449429231|FG000|Overall Study|Maximum clinical benefit|2|||
124945791|NCT02066636|449429232|FG001|Overall Study|Maximum clinical benefit|2|||
124945792|NCT02066636|449429233|FG002|Overall Study|Maximum clinical benefit|3|||
124945793|NCT02066636|449429231|FG000|Overall Study|Poor/non-compliance|2|||
124945794|NCT02066636|449429232|FG001|Overall Study|Poor/non-compliance|1|||
124945795|NCT02066636|449429233|FG002|Overall Study|Poor/non-compliance|1|||
124945796|NCT02066636|449429231|FG000|Overall Study|Participant no loner meets study criteria|3|||
124945797|NCT02066636|449429232|FG001|Overall Study|Participant no loner meets study criteria|2|||
124945798|NCT02066636|449429233|FG002|Overall Study|Participant no loner meets study criteria|28|||
124945799|NCT02066636|449429231|FG000|Overall Study|Administrative reasons by sponsor|8|||
124945800|NCT02066636|449429232|FG001|Overall Study|Administrative reasons by sponsor|5|||
124945801|NCT02066636|449429233|FG002|Overall Study|Administrative reasons by sponsor|0|||
124945802|NCT02066636|449429231|FG000|Overall Study|Other reasons|16|||
124945803|NCT02066636|449429232|FG001|Overall Study|Other reasons|15|||
124945804|NCT02066636|449429233|FG002|Overall Study|Other reasons|50|||
124945805|NCT00391170|449429240|FG000|Overall Study|Withdrawal by Subject|1|||
124945806|NCT00391170|449429241|FG001|Overall Study|Withdrawal by Subject|0|||
125028851|NCT01097629|449729208|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
124945807|NCT00391170|449429240|FG000|Overall Study|Adverse Event|3|||
125028852|NCT01097629|449729209|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125214486|NCT04472494|450412858|FG000|Treatment|Hospital discharge|1|||
125028853|NCT01097629|449729210|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125028854|NCT01097629|449729211|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125028855|NCT01097629|449729212|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125028856|NCT01097629|449729213|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125028857|NCT01097629|449729214|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125028858|NCT01097629|449729207|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
125028859|NCT01097629|449729208|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
125028860|NCT01097629|449729209|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
125028861|NCT01097629|449729210|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125028862|NCT01097629|449729211|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125028863|NCT01097629|449729212|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125028864|NCT01097629|449729213|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125028865|NCT01097629|449729214|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125028866|NCT01097629|449729207|FG000|DB RO Phase|Withdrawal by Subject|0|||
125028867|NCT01097629|449729208|FG001|DB RO Phase|Withdrawal by Subject|0|||
125028868|NCT01097629|449729209|FG002|DB RO Phase|Withdrawal by Subject|0|||
125028869|NCT01097629|449729210|FG003|DB RO Phase|Withdrawal by Subject|0|||
125028870|NCT01097629|449729211|FG004|DB RO Phase|Withdrawal by Subject|0|||
125028871|NCT01097629|449729212|FG005|DB RO Phase|Withdrawal by Subject|0|||
125028872|NCT01097629|449729213|FG006|DB RO Phase|Withdrawal by Subject|0|||
125028873|NCT01097629|449729214|FG007|DB RO Phase|Withdrawal by Subject|1|||
125028874|NCT01097629|449729207|FG000|DB RO Phase|Protocol Violation|0|||
125028875|NCT01097629|449729208|FG001|DB RO Phase|Protocol Violation|0|||
125028876|NCT01097629|449729209|FG002|DB RO Phase|Protocol Violation|0|||
125028877|NCT01097629|449729210|FG003|DB RO Phase|Protocol Violation|1|||
125028878|NCT01097629|449729211|FG004|DB RO Phase|Protocol Violation|0|||
125028879|NCT01097629|449729212|FG005|DB RO Phase|Protocol Violation|1|||
125028880|NCT01097629|449729213|FG006|DB RO Phase|Protocol Violation|1|||
125028881|NCT01097629|449729214|FG007|DB RO Phase|Protocol Violation|0|||
124945808|NCT00391170|449429241|FG001|Overall Study|Adverse Event|2|||
124945809|NCT00391170|449429240|FG000|Overall Study|Physician Decision|2|||
125028882|NCT01097629|449729207|FG000|DB RO Phase|Lost to Follow-up|0|||
125028883|NCT01097629|449729208|FG001|DB RO Phase|Lost to Follow-up|0|||
124945810|NCT00391170|449429241|FG001|Overall Study|Physician Decision|2|||
124945811|NCT01218594|449429245|FG000|Overall Study|Death|1|||
124945812|NCT01218594|449429245|FG000|Overall Study|Withdrawal by Subject|3|||
124945813|NCT01218594|449429245|FG000|Overall Study|Adverse Event|2|||
124945814|NCT01218594|449429245|FG000|Overall Study|Physician Decision|6|||
124945815|NCT00452114|449429246|FG000|Overall Study|Physician Decision|3|||
124945816|NCT00452114|449429247|FG001|Overall Study|Physician Decision|3|||
124945817|NCT00949117|449430904|FG000|Overall Study|Lack of Efficacy|2|||
124945818|NCT00949117|449430905|FG001|Overall Study|Lack of Efficacy|3|||
124945819|NCT00949117|449430904|FG000|Overall Study|Protocol Violation|1|||
124945820|NCT00949117|449430905|FG001|Overall Study|Protocol Violation|1|||
124945821|NCT00949117|449430904|FG000|Overall Study|Adverse Event|0|||
124945822|NCT00949117|449430905|FG001|Overall Study|Adverse Event|1|||
124945823|NCT01214200|449430906|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
124945824|NCT01214200|449430906|FG000|Overall Study|Withdrawal by Subject|2|||
124945825|NCT01719172|449430907|FG000|Overall Study|Lost to Follow-up|1|||
124945826|NCT01719172|449430907|FG000|Overall Study|Death|1|||
124945827|NCT04250636|449430910|FG000|Overall Study|Lost to Follow-up|2|||
124945828|NCT03041090|449430911|FG000|Overall Study|technical error|0|||
124945829|NCT03041090|449430912|FG001|Overall Study|technical error|3|||
124945830|NCT01353274|449430913|FG000|Overall Study|No case report form (CRF) collected|28|||
124945831|NCT01409837|449430914|FG000|Overall Study|Withdrawal by Subject|2|||
124945832|NCT01409837|449430915|FG001|Overall Study|Withdrawal by Subject|1|||
124945833|NCT01409837|449430914|FG000|Overall Study|Lost to Follow-up|1|||
124945834|NCT01409837|449430915|FG001|Overall Study|Lost to Follow-up|0|||
124945835|NCT01409837|449430914|FG000|Overall Study|Physician Decision|0|||
124945836|NCT01409837|449430915|FG001|Overall Study|Physician Decision|1|||
124945837|NCT03960645|449430916|FG000|Overall Study|Protocol Violation|1|||
124945838|NCT03960645|449430917|FG001|Overall Study|Protocol Violation|0|||
124945839|NCT03292406|449430918|FG000|Overall Study|Progressive Disease|6|||
124945840|NCT03292406|449430919|FG001|Overall Study|Progressive Disease|3|||
124945841|NCT03292406|449430920|FG002|Overall Study|Progressive Disease|4|||
124945842|NCT03292406|449430918|FG000|Overall Study|Adverse Event|7|||
124945843|NCT03292406|449430919|FG001|Overall Study|Adverse Event|1|||
124945844|NCT03292406|449430920|FG002|Overall Study|Adverse Event|4|||
124945845|NCT03292406|449430918|FG000|Overall Study|Withdrawal by Subject|0|||
124945846|NCT03292406|449430919|FG001|Overall Study|Withdrawal by Subject|7|||
124945847|NCT03292406|449430920|FG002|Overall Study|Withdrawal by Subject|2|||
124945848|NCT03292406|449430918|FG000|Overall Study|Protocol Violation|0|||
124945849|NCT03292406|449430919|FG001|Overall Study|Protocol Violation|1|||
124945850|NCT03292406|449430920|FG002|Overall Study|Protocol Violation|1|||
124945851|NCT03292406|449430918|FG000|Overall Study|Other|0|||
124945852|NCT03292406|449430919|FG001|Overall Study|Other|1|||
124945853|NCT03292406|449430920|FG002|Overall Study|Other|2|||
124945854|NCT00403494|449430921|FG000|Overall Study|Adverse Event|10|||
124945855|NCT00403494|449430922|FG001|Overall Study|Adverse Event|8|||
124945856|NCT00403494|449430921|FG000|Overall Study|Withdrew Consent|3|||
124945857|NCT00403494|449430922|FG001|Overall Study|Withdrew Consent|2|||
124945858|NCT00403494|449430921|FG000|Overall Study|Inappropriately enrolled|0|||
124945859|NCT00403494|449430922|FG001|Overall Study|Inappropriately enrolled|1|||
124945860|NCT00403494|449430921|FG000|Overall Study|Lost to Follow-up|0|||
124945861|NCT00403494|449430922|FG001|Overall Study|Lost to Follow-up|2|||
124945862|NCT00403494|449430921|FG000|Overall Study|Protocol noncompliance|0|||
124945863|NCT00403494|449430922|FG001|Overall Study|Protocol noncompliance|1|||
124945864|NCT00403494|449430921|FG000|Overall Study|Death|1|||
124945865|NCT00403494|449430922|FG001|Overall Study|Death|0|||
124945866|NCT00403494|449430921|FG000|Overall Study|Sponsor Request|1|||
124945867|NCT00403494|449430922|FG001|Overall Study|Sponsor Request|0|||
124945868|NCT03851094|449430924|FG000|Overall Study|Withdrawal by Subject|0|||
124945869|NCT03851094|449430925|FG001|Overall Study|Withdrawal by Subject|1|||
125028884|NCT01097629|449729209|FG002|DB RO Phase|Lost to Follow-up|0|||
125028885|NCT01097629|449729210|FG003|DB RO Phase|Lost to Follow-up|0|||
125028886|NCT01097629|449729211|FG004|DB RO Phase|Lost to Follow-up|0|||
124945870|NCT03851094|449430924|FG000|Overall Study|Participant lost device|0|||
124945871|NCT03851094|449430925|FG001|Overall Study|Participant lost device|1|||
124945872|NCT03851094|449430924|FG000|Overall Study|Participant returned device|0|||
124945873|NCT03851094|449430925|FG001|Overall Study|Participant returned device|2|||
124945874|NCT01536704|449430926|FG000|Washout Period 1|Withdrawal by Subject|1|||
124945875|NCT01536704|449430927|FG001|Washout Period 1|Withdrawal by Subject|2|||
124945876|NCT01536704|449430928|FG002|Washout Period 1|Withdrawal by Subject|0|||
124945877|NCT01536704|449430929|FG003|Washout Period 1|Withdrawal by Subject|0|||
124945878|NCT01536704|449430926|FG000|Washout Period 2|Adverse Event|1|||
124945879|NCT01536704|449430927|FG001|Washout Period 2|Adverse Event|0|||
124945880|NCT01536704|449430928|FG002|Washout Period 2|Adverse Event|0|||
124945881|NCT01536704|449430929|FG003|Washout Period 2|Adverse Event|0|||
124945882|NCT01536704|449430926|FG000|Washout Period 2|Withdrawal by Subject|0|||
124945883|NCT01536704|449430927|FG001|Washout Period 2|Withdrawal by Subject|0|||
124945884|NCT01536704|449430928|FG002|Washout Period 2|Withdrawal by Subject|0|||
124945885|NCT01536704|449430929|FG003|Washout Period 2|Withdrawal by Subject|1|||
124945886|NCT01536704|449430926|FG000|Period 3|Adverse Event|0|||
124945887|NCT01536704|449430927|FG001|Period 3|Adverse Event|0|||
124945888|NCT01536704|449430928|FG002|Period 3|Adverse Event|0|||
124945889|NCT01536704|449430929|FG003|Period 3|Adverse Event|1|||
124945890|NCT01536704|449430926|FG000|Washout Period 3|Adverse Event|0|||
124945891|NCT01536704|449430927|FG001|Washout Period 3|Adverse Event|0|||
124945892|NCT01536704|449430928|FG002|Washout Period 3|Adverse Event|1|||
124945893|NCT01536704|449430929|FG003|Washout Period 3|Adverse Event|0|||
124945894|NCT00047385|449430930|FG000|Overall Study|Death before any screening|2|||
124945895|NCT00047385|449430931|FG001|Overall Study|Death before any screening|5|||
124945896|NCT00047385|449430930|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
124945897|NCT00047385|449430931|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
124945898|NCT00047385|449430930|FG000|Overall Study|Eligible for screening but had no screen|260|||
124945899|NCT00047385|449430931|FG001|Overall Study|Eligible for screening but had no screen|492|||
124945900|NCT03490032|449430932|FG000|Overall Study|family issue (child custody)|1|||
124945901|NCT03490032|449430933|FG001|Overall Study|family issue (child custody)|0|||
124945902|NCT03490032|449430934|FG002|Overall Study|family issue (child custody)|0|||
124945903|NCT00310037|449430937|FG000|Overall Study|Adverse Event|7|||
124945904|NCT00310037|449430938|FG001|Overall Study|Adverse Event|14|||
124945905|NCT00310037|449430937|FG000|Overall Study|Withdrawal by Subject|4|||
124945906|NCT00310037|449430938|FG001|Overall Study|Withdrawal by Subject|3|||
124945907|NCT00310037|449430937|FG000|Overall Study|Progression|6|||
124945908|NCT00310037|449430938|FG001|Overall Study|Progression|0|||
124945909|NCT00310037|449430937|FG000|Overall Study|Non-protocol treatment|1|||
124945910|NCT00310037|449430938|FG001|Overall Study|Non-protocol treatment|0|||
124945911|NCT02128269|449430943|FG000|Treatment Period|Adverse Event|1|||
124945912|NCT02128269|449430943|FG000|Treatment Period|Physician Decision|1|||
125123494|NCT01691248|450075858|FG000|Overall Study|Adverse Event|24|||
124945913|NCT00878189|449430944|FG000|Overall Study|Death|0|||
124945914|NCT00878189|449430945|FG001|Overall Study|Death|1|||
124945915|NCT00878189|449430946|FG002|Overall Study|Death|0|||
124945916|NCT00878189|449430947|FG003|Overall Study|Death|1|||
124945917|NCT00878189|449430948|FG004|Overall Study|Death|0|||
124945918|NCT00878189|449430949|FG005|Overall Study|Death|0|||
124945919|NCT00878189|449430950|FG006|Overall Study|Death|0|||
124945920|NCT00878189|449430951|FG007|Overall Study|Death|0|||
124945921|NCT00878189|449430952|FG008|Overall Study|Death|1|||
124945922|NCT00878189|449430944|FG000|Overall Study|Participant Refused to Follow-up|0|||
124945923|NCT00878189|449430945|FG001|Overall Study|Participant Refused to Follow-up|0|||
124945924|NCT00878189|449430946|FG002|Overall Study|Participant Refused to Follow-up|0|||
124945925|NCT00878189|449430947|FG003|Overall Study|Participant Refused to Follow-up|0|||
124945926|NCT00878189|449430948|FG004|Overall Study|Participant Refused to Follow-up|0|||
124945927|NCT00878189|449430949|FG005|Overall Study|Participant Refused to Follow-up|4|||
124945928|NCT00878189|449430950|FG006|Overall Study|Participant Refused to Follow-up|0|||
124945929|NCT00878189|449430951|FG007|Overall Study|Participant Refused to Follow-up|0|||
124945930|NCT00878189|449430952|FG008|Overall Study|Participant Refused to Follow-up|0|||
124945931|NCT00878189|449430944|FG000|Overall Study|Other|3|||
124945932|NCT00878189|449430945|FG001|Overall Study|Other|2|||
124945933|NCT00878189|449430946|FG002|Overall Study|Other|4|||
124945934|NCT00878189|449430947|FG003|Overall Study|Other|7|||
124945935|NCT00878189|449430948|FG004|Overall Study|Other|4|||
124945936|NCT00878189|449430949|FG005|Overall Study|Other|18|||
124945937|NCT00878189|449430950|FG006|Overall Study|Other|15|||
124945938|NCT00878189|449430951|FG007|Overall Study|Other|3|||
124945939|NCT00878189|449430952|FG008|Overall Study|Other|4|||
124945940|NCT00878189|449430944|FG000|Overall Study|Lost to Follow-up|0|||
124945941|NCT00878189|449430945|FG001|Overall Study|Lost to Follow-up|0|||
124945942|NCT00878189|449430946|FG002|Overall Study|Lost to Follow-up|0|||
124945943|NCT00878189|449430947|FG003|Overall Study|Lost to Follow-up|0|||
124945944|NCT00878189|449430948|FG004|Overall Study|Lost to Follow-up|0|||
125028887|NCT01097629|449729212|FG005|DB RO Phase|Lost to Follow-up|0|||
125028888|NCT01097629|449729213|FG006|DB RO Phase|Lost to Follow-up|2|||
125028889|NCT01097629|449729214|FG007|DB RO Phase|Lost to Follow-up|0|||
125028890|NCT00132041|449729216|FG000|Baseline|Ineligible|6|||
125028891|NCT00132041|449729216|FG000|3 Months Post Ablation|Transplant|1|||
125028892|NCT00132041|449729216|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
125028893|NCT00132041|449729216|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
125028894|NCT00132041|449729216|FG000|6 Months Post Ablation|Death|2|||
125028895|NCT00132041|449729216|FG000|6 Months Post Ablation|Transplant|6|||
125028896|NCT00132041|449729216|FG000|9 Months Post Ablation|Death|1|||
125028897|NCT00132041|449729216|FG000|9 Months Post Ablation|Transplant|1|||
125028898|NCT00132041|449729216|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
125028899|NCT00132041|449729216|FG000|12 Months Post Ablation|Death|1|||
125028900|NCT00132041|449729216|FG000|12 Months Post Ablation|Transplant|1|||
125028901|NCT00132041|449729216|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
125028902|NCT00132041|449729216|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
125028903|NCT00132041|449729216|FG000|15 Months Post Ablation|Death|1|||
125028904|NCT00132041|449729216|FG000|15 Months Post Ablation|Transplant|5|||
125028905|NCT00132041|449729216|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
125028906|NCT00132041|449729216|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
125028907|NCT00132041|449729216|FG000|18 Months Post Ablation|Transplant|1|||
125028908|NCT00132041|449729216|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
125028909|NCT00132041|449729216|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
125028910|NCT03609619|449729217|FG000|Overall Study|Adverse Event|1|||
125028911|NCT03609619|449729218|FG001|Overall Study|Adverse Event|0|||
125028912|NCT03609619|449729217|FG000|Overall Study|Lack of Efficacy|1|||
125028913|NCT03609619|449729218|FG001|Overall Study|Lack of Efficacy|2|||
125028914|NCT03609619|449729217|FG000|Overall Study|Protocol Violation|5|||
125028915|NCT03609619|449729218|FG001|Overall Study|Protocol Violation|0|||
125028916|NCT03609619|449729217|FG000|Overall Study|Withdrawal by Subject|2|||
125028917|NCT03609619|449729218|FG001|Overall Study|Withdrawal by Subject|3|||
125028918|NCT03609619|449729217|FG000|Overall Study|Lost to Follow-up|1|||
125028919|NCT03609619|449729218|FG001|Overall Study|Lost to Follow-up|1|||
125028920|NCT01171820|449729219|FG000|Overall Study|Death|3|||
125028921|NCT01171820|449729220|FG001|Overall Study|Death|3|||
125028922|NCT01171820|449729219|FG000|Overall Study|Lost to Follow-up|0|||
125028923|NCT01171820|449729220|FG001|Overall Study|Lost to Follow-up|1|||
125028924|NCT01171820|449729219|FG000|Overall Study|Withdrawal by Subject|2|||
125028925|NCT01171820|449729220|FG001|Overall Study|Withdrawal by Subject|0|||
125028926|NCT01171820|449729219|FG000|Overall Study|Physician Decision|0|||
125028927|NCT01171820|449729220|FG001|Overall Study|Physician Decision|1|||
125028928|NCT01171820|449729219|FG000|Overall Study|1-Year Missed Visit|1|||
125028929|NCT01171820|449729220|FG001|Overall Study|1-Year Missed Visit|1|||
125028930|NCT00956943|449729221|FG000|Overall Study|Lost to Follow-up|9|||
125028931|NCT00956943|449729222|FG001|Overall Study|Lost to Follow-up|10|||
125028932|NCT02613208|449729223|FG000|Overall Study|Withdrawal by Subject|1|||
125028933|NCT02613208|449729223|FG000|Overall Study|Change of address|2|||
125028934|NCT02613208|449729223|FG000|Overall Study|Physician Decision|2|||
125028935|NCT02613208|449729223|FG000|Overall Study|Lost to Follow-up|5|||
125028936|NCT02613208|449729223|FG000|Overall Study|Death|37|||
125123495|NCT01691248|450075859|FG001|Overall Study|Adverse Event|22|||
125123496|NCT01691248|450075858|FG000|Overall Study|Withdrawal by Subject|20|||
125123497|NCT01691248|450075859|FG001|Overall Study|Withdrawal by Subject|18|||
125123498|NCT01691248|450075858|FG000|Overall Study|Confirmed CDAD|14|||
125123499|NCT01691248|450075859|FG001|Overall Study|Confirmed CDAD|31|||
125028937|NCT02663895|449729224|FG000|Overall Study|Adverse Event|3|||
125028938|NCT02663895|449729224|FG000|Overall Study|Physician Decision|2|||
125028939|NCT02663895|449729224|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
125028940|NCT02663895|449729224|FG000|Overall Study|Withdrawal by Subject|1|||
125028941|NCT02472847|449729230|FG000|Overall Study|Withdrawal by Subject|1|||
125028942|NCT02472847|449729231|FG001|Overall Study|Withdrawal by Subject|5|||
125028943|NCT00623831|449729232|FG000|Overall Study|Withdrawal by Subject|1|||
125028944|NCT00623831|449729233|FG001|Overall Study|Withdrawal by Subject|0|||
125028945|NCT00623831|449729232|FG000|Overall Study|Progressive Disease|0|||
125028946|NCT00623831|449729233|FG001|Overall Study|Progressive Disease|1|||
125028947|NCT00270894|449729234|FG000|Overall Study|Adverse Event|1|||
125028948|NCT00270894|449729234|FG000|Overall Study|Withdrawal by Subject|1|||
125028949|NCT01748071|449729237|FG000|Overall Study|Adverse Event|2|||
125028950|NCT01748071|449729238|FG001|Overall Study|Adverse Event|2|||
125028951|NCT01748071|449729239|FG002|Overall Study|Adverse Event|0|||
125028952|NCT00605267|449729240|FG000|Overall Study|Adverse Event|0|||
125028953|NCT00605267|449729241|FG001|Overall Study|Adverse Event|1|||
125028954|NCT00605267|449729240|FG000|Overall Study|Lack of Efficacy|1|||
125028955|NCT00605267|449729241|FG001|Overall Study|Lack of Efficacy|5|||
125028956|NCT00605267|449729240|FG000|Overall Study|Withdrawal by Subject|2|||
125028957|NCT00605267|449729241|FG001|Overall Study|Withdrawal by Subject|3|||
125028958|NCT02939131|449729242|FG000|Overall Study|Unable to get to clinic|6|||
125028959|NCT02939131|449729243|FG001|Overall Study|Unable to get to clinic|4|||
124945945|NCT00878189|449430949|FG005|Overall Study|Lost to Follow-up|1|||
124945946|NCT00878189|449430950|FG006|Overall Study|Lost to Follow-up|1|||
124945947|NCT00878189|449430951|FG007|Overall Study|Lost to Follow-up|0|||
125123500|NCT01691248|450075858|FG000|Overall Study|Lost to Follow-up|2|||
125123501|NCT01691248|450075859|FG001|Overall Study|Lost to Follow-up|5|||
125123502|NCT01691248|450075858|FG000|Overall Study|Reason not provided|4|||
124945948|NCT00878189|449430952|FG008|Overall Study|Lost to Follow-up|0|||
124945949|NCT00878189|449430944|FG000|Overall Study|Objection Progression or Relapse|0|||
124945950|NCT00878189|449430945|FG001|Overall Study|Objection Progression or Relapse|0|||
124945951|NCT00878189|449430946|FG002|Overall Study|Objection Progression or Relapse|0|||
124945952|NCT00878189|449430947|FG003|Overall Study|Objection Progression or Relapse|0|||
124945953|NCT00878189|449430948|FG004|Overall Study|Objection Progression or Relapse|0|||
124945954|NCT00878189|449430949|FG005|Overall Study|Objection Progression or Relapse|0|||
124945955|NCT00878189|449430950|FG006|Overall Study|Objection Progression or Relapse|0|||
124945956|NCT00878189|449430951|FG007|Overall Study|Objection Progression or Relapse|0|||
124945957|NCT00878189|449430952|FG008|Overall Study|Objection Progression or Relapse|3|||
124945958|NCT02007070|449430953|FG000|Overall Study|Adverse Event|4|||
124945959|NCT02007070|449430953|FG000|Overall Study|Clinical Progression|4|||
124945960|NCT02007070|449430953|FG000|Overall Study|Death|1|||
124945961|NCT02007070|449430953|FG000|Overall Study|Protocol Violation|2|||
124945962|NCT02007070|449430953|FG000|Overall Study|Physician Decision|1|||
124945963|NCT02007070|449430953|FG000|Overall Study|Progressive Disease|21|||
124945964|NCT00703092|449430954|FG000|Overall Study|Withdrawal by Subject|2|||
124945965|NCT02708498|449430955|FG000|Overall Study|Death|20|||
124945966|NCT02708498|449430956|FG001|Overall Study|Death|19|||
124945967|NCT02708498|449430957|FG002|Overall Study|Death|0|||
124945968|NCT02708498|449430958|FG003|Overall Study|Death|0|||
124945969|NCT02708498|449430959|FG004|Overall Study|Death|1|||
124945970|NCT02708498|449430960|FG005|Overall Study|Death|0|||
124945971|NCT02708498|449430961|FG006|Overall Study|Death|0|||
124945972|NCT02708498|449430962|FG007|Overall Study|Death|0|||
124945973|NCT02708498|449430955|FG000|Overall Study|Unknown reason, missing data|0|||
124945974|NCT02708498|449430956|FG001|Overall Study|Unknown reason, missing data|0|||
124945975|NCT02708498|449430957|FG002|Overall Study|Unknown reason, missing data|62|||
124945976|NCT02708498|449430958|FG003|Overall Study|Unknown reason, missing data|51|||
124945977|NCT02708498|449430959|FG004|Overall Study|Unknown reason, missing data|195|||
124945978|NCT02708498|449430960|FG005|Overall Study|Unknown reason, missing data|132|||
124945979|NCT02708498|449430961|FG006|Overall Study|Unknown reason, missing data|0|||
124945980|NCT02708498|449430962|FG007|Overall Study|Unknown reason, missing data|0|||
124945981|NCT01021748|449430964|FG000|Overall Study|Adverse Event|2|||
124945982|NCT01021748|449430965|FG001|Overall Study|Adverse Event|1|||
124945983|NCT01021748|449430966|FG002|Overall Study|Adverse Event|2|||
124945984|NCT01021748|449430967|FG003|Overall Study|Adverse Event|0|||
124945985|NCT01021748|449430968|FG004|Overall Study|Adverse Event|2|||
124945986|NCT01021748|449430969|FG005|Overall Study|Adverse Event|0|||
124945987|NCT01021748|449430970|FG006|Overall Study|Adverse Event|1|||
124945988|NCT01021748|449430971|FG007|Overall Study|Adverse Event|0|||
124945989|NCT01021748|449430972|FG008|Overall Study|Adverse Event|7|||
124945990|NCT01021748|449430964|FG000|Overall Study|Physician Decision|1|||
124945991|NCT01021748|449430965|FG001|Overall Study|Physician Decision|0|||
124945992|NCT01021748|449430966|FG002|Overall Study|Physician Decision|1|||
124945993|NCT01021748|449430967|FG003|Overall Study|Physician Decision|1|||
124945994|NCT01021748|449430968|FG004|Overall Study|Physician Decision|0|||
124945995|NCT01021748|449430969|FG005|Overall Study|Physician Decision|0|||
125123503|NCT01691248|450075859|FG001|Overall Study|Reason not provided|4|||
125123504|NCT01691248|450075858|FG000|Overall Study|Not Treated|4|||
125123505|NCT01691248|450075859|FG001|Overall Study|Not Treated|7|||
124945996|NCT01021748|449430970|FG006|Overall Study|Physician Decision|1|||
124945997|NCT01021748|449430971|FG007|Overall Study|Physician Decision|1|||
124945998|NCT01021748|449430972|FG008|Overall Study|Physician Decision|2|||
124945999|NCT01021748|449430964|FG000|Overall Study|Progressive Disease|3|||
124946000|NCT01021748|449430965|FG001|Overall Study|Progressive Disease|3|||
124946001|NCT01021748|449430966|FG002|Overall Study|Progressive Disease|4|||
124946002|NCT01021748|449430967|FG003|Overall Study|Progressive Disease|6|||
125123506|NCT02863575|450075860|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
125214487|NCT04472494|450412859|FG001|Treatment|Hospital discharge|1|||
124946003|NCT01021748|449430968|FG004|Overall Study|Progressive Disease|7|||
124946004|NCT01021748|449430969|FG005|Overall Study|Progressive Disease|3|||
124946005|NCT01021748|449430970|FG006|Overall Study|Progressive Disease|0|||
124946006|NCT01021748|449430971|FG007|Overall Study|Progressive Disease|5|||
124946007|NCT01021748|449430972|FG008|Overall Study|Progressive Disease|6|||
124946008|NCT01021748|449430964|FG000|Overall Study|Withdrawal by Subject|0|||
124946009|NCT01021748|449430965|FG001|Overall Study|Withdrawal by Subject|0|||
124946010|NCT01021748|449430966|FG002|Overall Study|Withdrawal by Subject|0|||
124946011|NCT01021748|449430967|FG003|Overall Study|Withdrawal by Subject|0|||
124946012|NCT01021748|449430968|FG004|Overall Study|Withdrawal by Subject|0|||
124946013|NCT01021748|449430969|FG005|Overall Study|Withdrawal by Subject|0|||
124946014|NCT01021748|449430970|FG006|Overall Study|Withdrawal by Subject|1|||
124946015|NCT01021748|449430971|FG007|Overall Study|Withdrawal by Subject|0|||
124946016|NCT01021748|449430972|FG008|Overall Study|Withdrawal by Subject|1|||
124946017|NCT01021748|449430964|FG000|Overall Study|Not Treated|0|||
124946018|NCT01021748|449430965|FG001|Overall Study|Not Treated|1|||
124946019|NCT01021748|449430966|FG002|Overall Study|Not Treated|0|||
124946020|NCT01021748|449430967|FG003|Overall Study|Not Treated|0|||
124946021|NCT01021748|449430968|FG004|Overall Study|Not Treated|0|||
124946022|NCT01021748|449430969|FG005|Overall Study|Not Treated|0|||
124946023|NCT01021748|449430970|FG006|Overall Study|Not Treated|0|||
124946024|NCT01021748|449430971|FG007|Overall Study|Not Treated|0|||
124946025|NCT01021748|449430972|FG008|Overall Study|Not Treated|0|||
124946026|NCT03316170|449430979|FG000|Overall Study|Death|1|||
124946027|NCT03316170|449430980|FG001|Overall Study|Death|0|||
124946028|NCT03316170|449430979|FG000|Overall Study|Lost to Follow-up|6|||
124946029|NCT03316170|449430980|FG001|Overall Study|Lost to Follow-up|7|||
124946030|NCT03052517|449430981|FG000|Overall Study|Study Terminated By Sponsor|928|||
124946031|NCT03052517|449430982|FG001|Overall Study|Study Terminated By Sponsor|938|||
124946032|NCT03052517|449430983|FG002|Overall Study|Study Terminated By Sponsor|296|||
124946033|NCT03052517|449430981|FG000|Overall Study|Subject/Guardian Decision|50|||
124946034|NCT03052517|449430982|FG001|Overall Study|Subject/Guardian Decision|45|||
124946035|NCT03052517|449430983|FG002|Overall Study|Subject/Guardian Decision|22|||
124946036|NCT03052517|449430981|FG000|Overall Study|Lack of Efficacy|23|||
124946037|NCT03052517|449430982|FG001|Overall Study|Lack of Efficacy|14|||
124946038|NCT03052517|449430983|FG002|Overall Study|Lack of Efficacy|7|||
124946039|NCT03052517|449430981|FG000|Overall Study|Adverse Event|6|||
124946040|NCT03052517|449430982|FG001|Overall Study|Adverse Event|5|||
124946041|NCT03052517|449430983|FG002|Overall Study|Adverse Event|0|||
124946042|NCT03052517|449430981|FG000|Overall Study|Physician Decision|4|||
124946043|NCT03052517|449430982|FG001|Overall Study|Physician Decision|5|||
124946044|NCT03052517|449430983|FG002|Overall Study|Physician Decision|1|||
124946045|NCT03052517|449430981|FG000|Overall Study|Death|3|||
124946046|NCT03052517|449430982|FG001|Overall Study|Death|0|||
124946047|NCT03052517|449430983|FG002|Overall Study|Death|1|||
124946048|NCT03052517|449430981|FG000|Overall Study|Lost to Follow-up|2|||
124946049|NCT03052517|449430982|FG001|Overall Study|Lost to Follow-up|4|||
124946050|NCT03052517|449430983|FG002|Overall Study|Lost to Follow-up|0|||
124946051|NCT03052517|449430981|FG000|Overall Study|Pregnancy|1|||
124946052|NCT03052517|449430982|FG001|Overall Study|Pregnancy|0|||
124946053|NCT03052517|449430983|FG002|Overall Study|Pregnancy|1|||
124946054|NCT03052517|449430981|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
124946055|NCT03052517|449430982|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
124946056|NCT03052517|449430983|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
124946057|NCT03052517|449430981|FG000|Overall Study|Technical Problems|0|||
124946058|NCT03052517|449430982|FG001|Overall Study|Technical Problems|1|||
124946059|NCT03052517|449430983|FG002|Overall Study|Technical Problems|0|||
124946060|NCT01640288|449430984|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
124946061|NCT01640288|449430985|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
124946062|NCT01640288|449430984|FG000|Overall Study|Screen Failure|20|||
125123507|NCT02863575|450075861|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
125123508|NCT02863575|450075862|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
125123509|NCT02863575|450075860|FG000|Overall Study|Withdrawal by Subject|0|||
125123510|NCT02863575|450075861|FG001|Overall Study|Withdrawal by Subject|1|||
125123511|NCT02863575|450075862|FG002|Overall Study|Withdrawal by Subject|1|||
125123512|NCT02863575|450075860|FG000|Overall Study|Adverse Event|0|||
125123513|NCT02863575|450075861|FG001|Overall Study|Adverse Event|1|||
124946063|NCT01640288|449430985|FG001|Overall Study|Screen Failure|18|||
124946064|NCT01640288|449430984|FG000|Overall Study|Withdrawn by PI|5|||
124946065|NCT01640288|449430985|FG001|Overall Study|Withdrawn by PI|0|||
124946066|NCT01640288|449430984|FG000|Overall Study|Withdrawal by Subject|1|||
124946067|NCT01640288|449430985|FG001|Overall Study|Withdrawal by Subject|0|||
124946068|NCT04803734|449430986|FG000|Overall Study|Withdrawal by Subject|0|||
124946069|NCT04803734|449430987|FG001|Overall Study|Withdrawal by Subject|1|||
124946070|NCT04803734|449430986|FG000|Overall Study|Protocol Violation|0|||
124946071|NCT04803734|449430987|FG001|Overall Study|Protocol Violation|1|||
124946072|NCT00195819|449430995|FG000|Double-Blind|Withdrawal by Subject|1|||
124946073|NCT00195819|449430996|FG001|Double-Blind|Withdrawal by Subject|0|||
124946074|NCT00195819|449430995|FG000|Double-Blind|Moved|1|||
124946075|NCT00195819|449430996|FG001|Double-Blind|Moved|0|||
124946076|NCT00195819|449430995|FG000|Open-label|Adverse Event|0|||
124946077|NCT00195819|449430996|FG001|Open-label|Adverse Event|9|||
124946078|NCT00195819|449430995|FG000|Open-label|Lack of Efficacy|0|||
124946079|NCT00195819|449430996|FG001|Open-label|Lack of Efficacy|2|||
124946080|NCT00195819|449430995|FG000|Open-label|Pregnancy|0|||
124946081|NCT00195819|449430996|FG001|Open-label|Pregnancy|1|||
124946082|NCT00195819|449430995|FG000|Open-label|Protocol Violation|0|||
124946083|NCT00195819|449430996|FG001|Open-label|Protocol Violation|2|||
124946084|NCT00195819|449430995|FG000|Open-label|Moved|0|||
124946085|NCT00195819|449430996|FG001|Open-label|Moved|1|||
124946086|NCT00195819|449430995|FG000|Open-label|Withdrawal by Subject|0|||
124946087|NCT00195819|449430996|FG001|Open-label|Withdrawal by Subject|5|||
124946088|NCT01629589|449430999|FG000|Overall Study|Protocol Violation|4|||
124946089|NCT01629589|449431000|FG001|Overall Study|Protocol Violation|2|||
124946090|NCT01629589|449430999|FG000|Overall Study|Lost to Follow-up|2|||
124946091|NCT01629589|449431000|FG001|Overall Study|Lost to Follow-up|1|||
124946092|NCT01629589|449430999|FG000|Overall Study|Withdrawal by Subject|2|||
124946093|NCT01629589|449431000|FG001|Overall Study|Withdrawal by Subject|3|||
124946094|NCT01629589|449430999|FG000|Overall Study|Did not receive study vaccine|0|||
124946095|NCT01629589|449431000|FG001|Overall Study|Did not receive study vaccine|1|||
124946096|NCT03781375|449431001|FG000|Double-blind Phase|Adverse Event|0|||
124946097|NCT03781375|449431002|FG001|Double-blind Phase|Adverse Event|1|||
124946098|NCT03781375|449431001|FG000|Double-blind Phase|Lack of Response|6|||
124946099|NCT03781375|449431002|FG001|Double-blind Phase|Lack of Response|2|||
124946100|NCT03781375|449431001|FG000|Double-blind Phase|Other|1|||
124946101|NCT03781375|449431002|FG001|Double-blind Phase|Other|3|||
124946102|NCT03781375|449431001|FG000|Open-label Phase|Protocol Issues|0|||
124946103|NCT03781375|449431002|FG001|Open-label Phase|Protocol Issues|1|||
124946104|NCT03781375|449431001|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
124946105|NCT03781375|449431002|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
124946106|NCT03781375|449431001|FG000|Open-label Phase|Other|2|||
124946107|NCT03781375|449431002|FG001|Open-label Phase|Other|2|||
124946108|NCT01303510|449431005|FG000|Overall Study|Lost to Follow-up|1|||
124946109|NCT01303510|449431006|FG001|Overall Study|Lost to Follow-up|0|||
124946110|NCT02404441|449431007|FG000|Phase 1 Part|Adverse Event|1|||
124946111|NCT02404441|449431008|FG001|Phase 1 Part|Adverse Event|0|||
124946112|NCT02404441|449431009|FG002|Phase 1 Part|Adverse Event|0|||
124946113|NCT02404441|449431010|FG003|Phase 1 Part|Adverse Event|0|||
124946114|NCT02404441|449431011|FG004|Phase 1 Part|Adverse Event|0|||
124946115|NCT02404441|449431012|FG005|Phase 1 Part|Adverse Event|0|||
124946116|NCT02404441|449431013|FG006|Phase 1 Part|Adverse Event|0|||
124946117|NCT02404441|449431014|FG007|Phase 1 Part|Adverse Event|0|||
124946118|NCT02404441|449431015|FG008|Phase 1 Part|Adverse Event|0|||
124946119|NCT02404441|449431016|FG009|Phase 1 Part|Adverse Event|0|||
124946120|NCT02404441|449431007|FG000|Phase 1 Part|Physician Decision|0|||
124946121|NCT02404441|449431008|FG001|Phase 1 Part|Physician Decision|1|||
124946122|NCT02404441|449431009|FG002|Phase 1 Part|Physician Decision|0|||
124946123|NCT02404441|449431010|FG003|Phase 1 Part|Physician Decision|0|||
124946124|NCT02404441|449431011|FG004|Phase 1 Part|Physician Decision|0|||
124946125|NCT02404441|449431012|FG005|Phase 1 Part|Physician Decision|0|||
124946126|NCT02404441|449431013|FG006|Phase 1 Part|Physician Decision|0|||
124946127|NCT02404441|449431014|FG007|Phase 1 Part|Physician Decision|0|||
124946128|NCT02404441|449431015|FG008|Phase 1 Part|Physician Decision|0|||
124946129|NCT02404441|449431016|FG009|Phase 1 Part|Physician Decision|0|||
124946130|NCT02404441|449431007|FG000|Phase 1 Part|Progressive Disease|14|||
124946131|NCT02404441|449431008|FG001|Phase 1 Part|Progressive Disease|11|||
124946132|NCT02404441|449431009|FG002|Phase 1 Part|Progressive Disease|7|||
124946133|NCT02404441|449431010|FG003|Phase 1 Part|Progressive Disease|6|||
124946134|NCT02404441|449431011|FG004|Phase 1 Part|Progressive Disease|9|||
124946135|NCT02404441|449431012|FG005|Phase 1 Part|Progressive Disease|0|||
124946136|NCT02404441|449431013|FG006|Phase 1 Part|Progressive Disease|0|||
124946137|NCT02404441|449431014|FG007|Phase 1 Part|Progressive Disease|0|||
124946138|NCT02404441|449431015|FG008|Phase 1 Part|Progressive Disease|0|||
124946139|NCT02404441|449431016|FG009|Phase 1 Part|Progressive Disease|0|||
124946140|NCT02404441|449431007|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
124946141|NCT02404441|449431008|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
124946142|NCT02404441|449431009|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
124946143|NCT02404441|449431010|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
124946144|NCT02404441|449431011|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
124946145|NCT02404441|449431012|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
124946146|NCT02404441|449431013|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
124946147|NCT02404441|449431014|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
124946148|NCT02404441|449431015|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
124946149|NCT02404441|449431016|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
124946150|NCT02404441|449431007|FG000|Phase 1 Part|Death|1|||
124946151|NCT02404441|449431008|FG001|Phase 1 Part|Death|1|||
124946152|NCT02404441|449431009|FG002|Phase 1 Part|Death|1|||
124946153|NCT02404441|449431010|FG003|Phase 1 Part|Death|0|||
124946154|NCT02404441|449431011|FG004|Phase 1 Part|Death|1|||
124946155|NCT02404441|449431012|FG005|Phase 1 Part|Death|0|||
124946156|NCT02404441|449431013|FG006|Phase 1 Part|Death|0|||
124946157|NCT02404441|449431014|FG007|Phase 1 Part|Death|0|||
124946158|NCT02404441|449431015|FG008|Phase 1 Part|Death|0|||
124946159|NCT02404441|449431016|FG009|Phase 1 Part|Death|0|||
124946160|NCT02404441|449431007|FG000|Phase 2 Part|Adverse Event|0|||
124946161|NCT02404441|449431008|FG001|Phase 2 Part|Adverse Event|0|||
124946162|NCT02404441|449431009|FG002|Phase 2 Part|Adverse Event|0|||
124946163|NCT02404441|449431010|FG003|Phase 2 Part|Adverse Event|0|||
124946164|NCT02404441|449431011|FG004|Phase 2 Part|Adverse Event|0|||
124946165|NCT02404441|449431012|FG005|Phase 2 Part|Adverse Event|2|||
124946166|NCT02404441|449431013|FG006|Phase 2 Part|Adverse Event|3|||
124946167|NCT02404441|449431014|FG007|Phase 2 Part|Adverse Event|3|||
124946168|NCT02404441|449431015|FG008|Phase 2 Part|Adverse Event|6|||
124946169|NCT02404441|449431016|FG009|Phase 2 Part|Adverse Event|1|||
124946170|NCT02404441|449431007|FG000|Phase 2 Part|Physician Decision|0|||
124946171|NCT02404441|449431008|FG001|Phase 2 Part|Physician Decision|0|||
124946172|NCT02404441|449431009|FG002|Phase 2 Part|Physician Decision|0|||
124946173|NCT02404441|449431010|FG003|Phase 2 Part|Physician Decision|0|||
124946174|NCT02404441|449431011|FG004|Phase 2 Part|Physician Decision|0|||
124946175|NCT02404441|449431012|FG005|Phase 2 Part|Physician Decision|7|||
124946176|NCT02404441|449431013|FG006|Phase 2 Part|Physician Decision|9|||
124946177|NCT02404441|449431014|FG007|Phase 2 Part|Physician Decision|2|||
124946178|NCT02404441|449431015|FG008|Phase 2 Part|Physician Decision|1|||
124946179|NCT02404441|449431016|FG009|Phase 2 Part|Physician Decision|3|||
124946180|NCT02404441|449431007|FG000|Phase 2 Part|Progressive disease|0|||
124946181|NCT02404441|449431008|FG001|Phase 2 Part|Progressive disease|0|||
124946182|NCT02404441|449431009|FG002|Phase 2 Part|Progressive disease|0|||
124946183|NCT02404441|449431010|FG003|Phase 2 Part|Progressive disease|0|||
124946184|NCT02404441|449431011|FG004|Phase 2 Part|Progressive disease|0|||
124946185|NCT02404441|449431012|FG005|Phase 2 Part|Progressive disease|43|||
124946186|NCT02404441|449431013|FG006|Phase 2 Part|Progressive disease|32|||
124946187|NCT02404441|449431014|FG007|Phase 2 Part|Progressive disease|31|||
124946188|NCT02404441|449431015|FG008|Phase 2 Part|Progressive disease|39|||
124946189|NCT02404441|449431016|FG009|Phase 2 Part|Progressive disease|27|||
124946190|NCT02404441|449431007|FG000|Phase 2 Part|Subject/guardian decision|0|||
124946191|NCT02404441|449431008|FG001|Phase 2 Part|Subject/guardian decision|0|||
124946192|NCT02404441|449431009|FG002|Phase 2 Part|Subject/guardian decision|0|||
124946193|NCT02404441|449431010|FG003|Phase 2 Part|Subject/guardian decision|0|||
124946194|NCT02404441|449431011|FG004|Phase 2 Part|Subject/guardian decision|0|||
124946195|NCT02404441|449431012|FG005|Phase 2 Part|Subject/guardian decision|3|||
124946196|NCT02404441|449431013|FG006|Phase 2 Part|Subject/guardian decision|9|||
124946197|NCT02404441|449431014|FG007|Phase 2 Part|Subject/guardian decision|0|||
124946198|NCT02404441|449431015|FG008|Phase 2 Part|Subject/guardian decision|3|||
124946199|NCT02404441|449431016|FG009|Phase 2 Part|Subject/guardian decision|2|||
124946200|NCT02404441|449431007|FG000|Phase 2 Part|Death|0|||
124946201|NCT02404441|449431008|FG001|Phase 2 Part|Death|0|||
124946202|NCT02404441|449431009|FG002|Phase 2 Part|Death|0|||
124946203|NCT02404441|449431010|FG003|Phase 2 Part|Death|0|||
124946204|NCT02404441|449431011|FG004|Phase 2 Part|Death|0|||
124946205|NCT02404441|449431012|FG005|Phase 2 Part|Death|4|||
124946206|NCT02404441|449431013|FG006|Phase 2 Part|Death|8|||
124946207|NCT02404441|449431014|FG007|Phase 2 Part|Death|4|||
124946208|NCT02404441|449431015|FG008|Phase 2 Part|Death|10|||
124946209|NCT02404441|449431016|FG009|Phase 2 Part|Death|9|||
124946210|NCT00822900|449431017|FG000|Overall Study|Withdrawal by Subject|14|||
124946211|NCT00822900|449431018|FG001|Overall Study|Withdrawal by Subject|14|||
124946212|NCT00822900|449431017|FG000|Overall Study|Lost to Follow-up|9|||
124946213|NCT00822900|449431018|FG001|Overall Study|Lost to Follow-up|9|||
124946214|NCT00822900|449431017|FG000|Overall Study|Death|83|||
124946215|NCT00822900|449431018|FG001|Overall Study|Death|69|||
124946216|NCT00822900|449431017|FG000|Overall Study|Became a ward of the state|2|||
124946217|NCT00822900|449431018|FG001|Overall Study|Became a ward of the state|1|||
124946218|NCT04679675|449431019|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
124946219|NCT04679675|449431020|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
124946220|NCT04679675|449431021|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
124946221|NCT04679675|449431022|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
124946222|NCT04679675|449431019|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
124946223|NCT04679675|449431020|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
124946224|NCT04679675|449431021|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
124946225|NCT04679675|449431022|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
124946226|NCT02234141|449431023|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
124946227|NCT02234141|449431024|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
124946228|NCT02234141|449431025|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
124946229|NCT02234141|449431026|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
124946230|NCT02234141|449431027|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
124946231|NCT02234141|449431028|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
124946232|NCT02234141|449431029|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
124946233|NCT02234141|449431023|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
124946234|NCT02234141|449431024|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
124946235|NCT02234141|449431025|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
124946236|NCT02234141|449431026|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
124946237|NCT02234141|449431027|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
124946238|NCT02234141|449431028|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
124946239|NCT02234141|449431029|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
124946240|NCT02234141|449431023|FG000|Treatment Period (24 Weeks)|Death|1|||
124946241|NCT02234141|449431024|FG001|Treatment Period (24 Weeks)|Death|2|||
124946242|NCT02234141|449431025|FG002|Treatment Period (24 Weeks)|Death|0|||
124946243|NCT02234141|449431026|FG003|Treatment Period (24 Weeks)|Death|1|||
124946244|NCT02234141|449431027|FG004|Treatment Period (24 Weeks)|Death|0|||
124946245|NCT02234141|449431028|FG005|Treatment Period (24 Weeks)|Death|0|||
124946246|NCT02234141|449431029|FG006|Treatment Period (24 Weeks)|Death|0|||
124946247|NCT02234141|449431023|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
124946248|NCT02234141|449431024|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
124946249|NCT02234141|449431025|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
124946250|NCT02234141|449431026|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
124946251|NCT02234141|449431027|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
124946252|NCT02234141|449431028|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
124946253|NCT02234141|449431029|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
124946254|NCT02234141|449431023|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
124946255|NCT02234141|449431024|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
124946256|NCT02234141|449431025|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
124946257|NCT02234141|449431026|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
124946258|NCT02234141|449431027|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
124946259|NCT02234141|449431028|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
124946260|NCT02234141|449431029|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
124946261|NCT02234141|449431023|FG000|Long-Term Treatment Period|Death|0|||
124946262|NCT02234141|449431024|FG001|Long-Term Treatment Period|Death|0|||
124946263|NCT02234141|449431025|FG002|Long-Term Treatment Period|Death|0|||
124946264|NCT02234141|449431026|FG003|Long-Term Treatment Period|Death|0|||
124946265|NCT02234141|449431027|FG004|Long-Term Treatment Period|Death|0|||
124946266|NCT02234141|449431028|FG005|Long-Term Treatment Period|Death|1|||
124946267|NCT02234141|449431029|FG006|Long-Term Treatment Period|Death|0|||
124946268|NCT02234141|449431023|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
124946269|NCT02234141|449431024|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
124946270|NCT02234141|449431025|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
124946271|NCT02234141|449431026|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
124946272|NCT02234141|449431027|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
124946273|NCT02234141|449431028|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
124946274|NCT02234141|449431029|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
124946275|NCT02234141|449431023|FG000|Long-Term Treatment Period|Adverse Event|4|||
124946276|NCT02234141|449431024|FG001|Long-Term Treatment Period|Adverse Event|0|||
124946277|NCT02234141|449431025|FG002|Long-Term Treatment Period|Adverse Event|5|||
124946278|NCT02234141|449431026|FG003|Long-Term Treatment Period|Adverse Event|0|||
124946279|NCT02234141|449431027|FG004|Long-Term Treatment Period|Adverse Event|1|||
124946280|NCT02234141|449431028|FG005|Long-Term Treatment Period|Adverse Event|1|||
124946281|NCT02234141|449431029|FG006|Long-Term Treatment Period|Adverse Event|1|||
124946282|NCT02234141|449431023|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
124946283|NCT02234141|449431024|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
124946284|NCT02234141|449431025|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
124946285|NCT02234141|449431026|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
124946286|NCT02234141|449431027|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
124946287|NCT02234141|449431028|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
124946288|NCT02234141|449431029|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
124946289|NCT02234141|449431023|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
125123514|NCT02863575|450075862|FG002|Overall Study|Adverse Event|0|||
124946290|NCT02234141|449431024|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
124946291|NCT02234141|449431025|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
124946292|NCT02234141|449431026|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
124946293|NCT02234141|449431027|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
125123515|NCT00993616|450075863|FG000|Overall Study|No tumor at entry|1|||
124946294|NCT02234141|449431028|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
124946295|NCT02234141|449431029|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
124946296|NCT00701415|449431030|FG000|Overall Study|Adverse Event|0|||
124946297|NCT00701415|449431031|FG001|Overall Study|Adverse Event|1|||
124946298|NCT00701415|449431030|FG000|Overall Study|Social/family issues and needle phobia|1|||
124946299|NCT00701415|449431031|FG001|Overall Study|Social/family issues and needle phobia|0|||
124946300|NCT02161458|449431032|FG000|Overall Study|Withdrawal by Subject|0|||
124946301|NCT02161458|449431033|FG001|Overall Study|Withdrawal by Subject|4|||
124946302|NCT02161458|449431034|FG002|Overall Study|Withdrawal by Subject|4|||
124946303|NCT02161458|449431035|FG003|Overall Study|Withdrawal by Subject|0|||
124946304|NCT02161458|449431032|FG000|Overall Study|Lost to Follow-up|0|||
124946305|NCT02161458|449431033|FG001|Overall Study|Lost to Follow-up|2|||
124946306|NCT02161458|449431034|FG002|Overall Study|Lost to Follow-up|1|||
124946307|NCT02161458|449431035|FG003|Overall Study|Lost to Follow-up|0|||
124946308|NCT03042767|449431036|FG000|Overall Study|Lost to Follow-up|1|||
124946309|NCT03042767|449431037|FG001|Overall Study|Lost to Follow-up|2|||
124946310|NCT00705159|449431039|FG000|Overall Study|Withdrawal by Subject|0|||
124946311|NCT00705159|449431040|FG001|Overall Study|Withdrawal by Subject|1|||
124946312|NCT00705159|449431041|FG002|Overall Study|Withdrawal by Subject|1|||
124946313|NCT00705159|449431042|FG003|Overall Study|Withdrawal by Subject|1|||
124946314|NCT00705159|449431039|FG000|Overall Study|Protocol Violation|0|||
124946315|NCT00705159|449431040|FG001|Overall Study|Protocol Violation|1|||
124946316|NCT00705159|449431041|FG002|Overall Study|Protocol Violation|0|||
124946317|NCT00705159|449431042|FG003|Overall Study|Protocol Violation|0|||
124946318|NCT00705159|449431039|FG000|Overall Study|Adverse Event|0|||
124946319|NCT00705159|449431040|FG001|Overall Study|Adverse Event|0|||
124946320|NCT00705159|449431041|FG002|Overall Study|Adverse Event|1|||
124946321|NCT00705159|449431042|FG003|Overall Study|Adverse Event|0|||
124946322|NCT00705159|449431039|FG000|Overall Study|Lost to Follow-up|0|||
124946323|NCT00705159|449431040|FG001|Overall Study|Lost to Follow-up|0|||
124946324|NCT00705159|449431041|FG002|Overall Study|Lost to Follow-up|3|||
124946325|NCT00705159|449431042|FG003|Overall Study|Lost to Follow-up|2|||
124946326|NCT00705159|449431039|FG000|Overall Study|Screen Failure|0|||
124946327|NCT00705159|449431040|FG001|Overall Study|Screen Failure|0|||
124946328|NCT00705159|449431041|FG002|Overall Study|Screen Failure|0|||
124946329|NCT00705159|449431042|FG003|Overall Study|Screen Failure|1|||
124946330|NCT00526994|449431043|FG000|Overall Study|Lost to Follow-up|98|||
124946331|NCT00526994|449431044|FG001|Overall Study|Lost to Follow-up|108|||
124946332|NCT00526994|449431045|FG002|Overall Study|Lost to Follow-up|96|||
124946333|NCT00526994|449431043|FG000|Overall Study|Death|4|||
124946334|NCT00526994|449431044|FG001|Overall Study|Death|3|||
124946335|NCT00526994|449431045|FG002|Overall Study|Death|3|||
124946336|NCT00526994|449431043|FG000|Overall Study|Withdrawal by Subject|2|||
124946337|NCT00526994|449431044|FG001|Overall Study|Withdrawal by Subject|7|||
124946338|NCT00526994|449431045|FG002|Overall Study|Withdrawal by Subject|5|||
124946339|NCT00526994|449431043|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
124946340|NCT00526994|449431044|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
124946341|NCT00526994|449431045|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
124946342|NCT02833948|449431051|FG000|Overall Study|Death|2|||
124946343|NCT02833948|449431052|FG001|Overall Study|Death|3|||
124946344|NCT02833948|449431051|FG000|Overall Study|were not scanned|8|||
124946345|NCT02833948|449431052|FG001|Overall Study|were not scanned|13|||
124946346|NCT02833948|449431051|FG000|Overall Study|scans could not be evaluated|5|||
124946347|NCT02833948|449431052|FG001|Overall Study|scans could not be evaluated|2|||
124946348|NCT02644122|449431053|FG000|Overall Study|Withdrawal by Subject|1|||
124946349|NCT03182244|449431054|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
124946350|NCT03182244|449431055|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
124946351|NCT03182244|449431054|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
124946352|NCT03182244|449431055|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
124946353|NCT03182244|449431054|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
124946354|NCT03182244|449431055|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
124946355|NCT03182244|449431054|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
124946356|NCT03182244|449431055|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
124946357|NCT03182244|449431054|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
124946358|NCT03182244|449431055|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
124946359|NCT03182244|449431054|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
124946360|NCT03182244|449431055|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
124946361|NCT03182244|449431054|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
124946362|NCT03182244|449431055|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
124946363|NCT03182244|449431054|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
124946364|NCT03182244|449431055|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
124946365|NCT03182244|449431054|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
124946366|NCT03182244|449431055|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
124946367|NCT03182244|449431054|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
124946368|NCT03182244|449431055|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
124946369|NCT03182244|449431054|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
124946370|NCT03182244|449431055|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
125028960|NCT02939131|449729242|FG000|Overall Study|Lost to Follow-up|2|||
125028961|NCT02939131|449729243|FG001|Overall Study|Lost to Follow-up|4|||
125028962|NCT02939131|449729242|FG000|Overall Study|severe debilitation|1|||
125028963|NCT02939131|449729243|FG001|Overall Study|severe debilitation|0|||
125028964|NCT02939131|449729242|FG000|Overall Study|Other|0|||
125028965|NCT02939131|449729243|FG001|Overall Study|Other|1|||
125028966|NCT02939131|449729242|FG000|Overall Study|not willing to adhere to protocol|2|||
125028967|NCT02939131|449729243|FG001|Overall Study|not willing to adhere to protocol|0|||
125028968|NCT02720757|449729244|FG000|Overall Study|Other reason|5|||
125028969|NCT02720757|449729244|FG000|Overall Study|Loss of contact|4|||
125028970|NCT02720757|449729244|FG000|Overall Study|Informed consent withdrawal|1|||
125028971|NCT02720757|449729244|FG000|Overall Study|Patients wish to withdraw|2|||
125028972|NCT02720757|449729244|FG000|Overall Study|Missing|3|||
125028973|NCT02720757|449729244|FG000|Overall Study|General exclusion|3|||
125028974|NCT00883493|449729245|FG000|Overall Study|Adverse Event|11|||
125028975|NCT00883493|449729246|FG001|Overall Study|Adverse Event|12|||
125028976|NCT00883493|449729245|FG000|Overall Study|Lack of Efficacy|4|||
125028977|NCT00883493|449729246|FG001|Overall Study|Lack of Efficacy|3|||
125028978|NCT00883493|449729245|FG000|Overall Study|Lost to Follow-up|7|||
125028979|NCT00883493|449729246|FG001|Overall Study|Lost to Follow-up|6|||
125028980|NCT00883493|449729245|FG000|Overall Study|Withdrawal by Subject|11|||
125028981|NCT00883493|449729246|FG001|Overall Study|Withdrawal by Subject|20|||
125028982|NCT00883493|449729245|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
125028983|NCT00883493|449729246|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
125028984|NCT00883493|449729245|FG000|Overall Study|Study specific disc. criteria|2|||
125028985|NCT00883493|449729246|FG001|Overall Study|Study specific disc. criteria|0|||
125028986|NCT00883493|449729245|FG000|Overall Study|Other|5|||
125028987|NCT00883493|449729246|FG001|Overall Study|Other|3|||
125028988|NCT01084551|449729247|FG000|Overall Study|Adverse Event|2|||
125028989|NCT01084551|449729248|FG001|Overall Study|Adverse Event|9|||
125028990|NCT01084551|449729249|FG002|Overall Study|Adverse Event|4|||
125028991|NCT01084551|449729247|FG000|Overall Study|Lack of Efficacy|2|||
125028992|NCT01084551|449729248|FG001|Overall Study|Lack of Efficacy|0|||
125028993|NCT01084551|449729249|FG002|Overall Study|Lack of Efficacy|1|||
125028994|NCT01084551|449729247|FG000|Overall Study|Withdrawal by Subject|2|||
125028995|NCT01084551|449729248|FG001|Overall Study|Withdrawal by Subject|1|||
125028996|NCT01084551|449729249|FG002|Overall Study|Withdrawal by Subject|0|||
125028997|NCT01084551|449729247|FG000|Overall Study|Protocol Violation|2|||
125028998|NCT01084551|449729248|FG001|Overall Study|Protocol Violation|4|||
125028999|NCT01084551|449729249|FG002|Overall Study|Protocol Violation|0|||
125029000|NCT01084551|449729247|FG000|Overall Study|Lost to Follow-up|0|||
125029001|NCT01084551|449729248|FG001|Overall Study|Lost to Follow-up|0|||
125029002|NCT01084551|449729249|FG002|Overall Study|Lost to Follow-up|3|||
125029003|NCT01084551|449729247|FG000|Overall Study|Physician Decision|1|||
125029004|NCT01084551|449729248|FG001|Overall Study|Physician Decision|0|||
125029005|NCT01084551|449729249|FG002|Overall Study|Physician Decision|0|||
125029006|NCT00463476|449729250|FG000|Overall Study|Withdrawal by Subject|1|||
125029007|NCT00463476|449729251|FG001|Overall Study|Withdrawal by Subject|2|||
125029008|NCT00463476|449729250|FG000|Overall Study|Lost to Follow-up|1|||
125029009|NCT00463476|449729251|FG001|Overall Study|Lost to Follow-up|1|||
125123516|NCT00993616|450075863|FG000|Overall Study|Never treated|1|||
125123517|NCT03815942|450077278|FG000|Overall Study|Withdrawal by Subject|0|||
125029010|NCT00988247|449729252|FG000|Overall Study|Adverse Event|17|||
125029011|NCT00988247|449729253|FG001|Overall Study|Adverse Event|3|||
125029012|NCT00988247|449729252|FG000|Overall Study|Withdrawal by Subject|44|||
125029013|NCT00988247|449729253|FG001|Overall Study|Withdrawal by Subject|13|||
125029014|NCT00988247|449729252|FG000|Overall Study|Pregnancy|1|||
125029015|NCT00988247|449729253|FG001|Overall Study|Pregnancy|2|||
125029016|NCT00988247|449729252|FG000|Overall Study|Lost to Follow-up|11|||
125029017|NCT00988247|449729253|FG001|Overall Study|Lost to Follow-up|2|||
125029018|NCT00988247|449729252|FG000|Overall Study|Protocol Violation|4|||
125029019|NCT00988247|449729253|FG001|Overall Study|Protocol Violation|5|||
125029020|NCT00988247|449729252|FG000|Overall Study|Sponsor requested withdrawal|3|||
125029021|NCT00988247|449729253|FG001|Overall Study|Sponsor requested withdrawal|1|||
125029022|NCT00988247|449729252|FG000|Overall Study|Other|3|||
125029023|NCT00988247|449729253|FG001|Overall Study|Other|0|||
125029024|NCT00289913|449729254|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125029025|NCT00289913|449729255|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
125029026|NCT00289913|449729256|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125029027|NCT00289913|449729257|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125029028|NCT00289913|449729258|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125029029|NCT00289913|449729254|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
125029030|NCT00289913|449729255|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
125029031|NCT00289913|449729256|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
125029032|NCT00289913|449729257|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
125029033|NCT00289913|449729258|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
125029034|NCT00289913|449729254|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
125029035|NCT00289913|449729255|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
125029036|NCT00289913|449729256|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
125029037|NCT00289913|449729257|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
125029038|NCT00289913|449729258|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
125029039|NCT00289913|449729254|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
125029040|NCT00289913|449729255|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
125029041|NCT00289913|449729256|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
125029042|NCT00289913|449729257|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
125029043|NCT00289913|449729258|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
125029044|NCT00289913|449729254|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
125029045|NCT00289913|449729255|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
125029046|NCT00289913|449729256|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
125029047|NCT00289913|449729257|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
125029048|NCT00289913|449729258|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
125029049|NCT00289913|449729254|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
125029050|NCT00289913|449729255|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
125029051|NCT00289913|449729256|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
125029052|NCT00289913|449729257|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
125214488|NCT00571103|450412860|FG000|Overall Study|Withdrawal by Subject|1|||
125214489|NCT00571103|450412860|FG000|Overall Study|Lost to Follow-up|1|||
125214490|NCT01308463|450412862|FG000|Overall Study|Study Discontinued|23|||
125214491|NCT01308463|450412862|FG000|Overall Study|Death|4|||
125214492|NCT01308463|450412862|FG000|Overall Study|Revision|2|||
125214493|NCT03297021|450412863|FG000|Overall Study|Incomplete/illegible data sheet|4|||
125214494|NCT03297021|450412864|FG001|Overall Study|Incomplete/illegible data sheet|2|||
125214495|NCT03297021|450412865|FG002|Overall Study|Incomplete/illegible data sheet|3|||
125214496|NCT03297021|450412863|FG000|Overall Study|Missing Post-Op Data|1|||
125214497|NCT03297021|450412864|FG001|Overall Study|Missing Post-Op Data|2|||
125214498|NCT03297021|450412865|FG002|Overall Study|Missing Post-Op Data|1|||
125214499|NCT00948922|450412867|FG000|Overall Study|Did not start study treatment|2|||
125214500|NCT00948922|450412868|FG001|Overall Study|Did not start study treatment|5|||
125214501|NCT00948922|450412869|FG002|Overall Study|Did not start study treatment|0|||
125214502|NCT00948922|450412867|FG000|Overall Study|Withdrawal by Subject|0|||
125214503|NCT00948922|450412868|FG001|Overall Study|Withdrawal by Subject|2|||
125214504|NCT00948922|450412869|FG002|Overall Study|Withdrawal by Subject|1|||
125214505|NCT00948922|450412867|FG000|Overall Study|Death|3|||
125214506|NCT00948922|450412868|FG001|Overall Study|Death|0|||
125214507|NCT00948922|450412869|FG002|Overall Study|Death|0|||
125214508|NCT00948922|450412867|FG000|Overall Study|Disease progression|0|||
125214509|NCT00948922|450412868|FG001|Overall Study|Disease progression|1|||
125214510|NCT00948922|450412869|FG002|Overall Study|Disease progression|0|||
125214511|NCT00948922|450412867|FG000|Overall Study|Insurance issues|1|||
125214512|NCT00948922|450412868|FG001|Overall Study|Insurance issues|0|||
125214513|NCT00948922|450412869|FG002|Overall Study|Insurance issues|0|||
125029053|NCT00289913|449729258|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
125029054|NCT00289913|449729254|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
125029055|NCT00289913|449729255|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
125029056|NCT00289913|449729256|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
125029057|NCT00289913|449729257|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
125029058|NCT00289913|449729258|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
125029059|NCT00289913|449729254|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
125029060|NCT00289913|449729255|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
125029061|NCT00289913|449729256|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
125029062|NCT00289913|449729257|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
124946371|NCT03182244|449431054|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
124946372|NCT03182244|449431055|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
124946373|NCT03182244|449431054|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
124946374|NCT03182244|449431055|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
124946375|NCT02852824|449431058|FG000|Overall Study|Withdrawal by Subject|1|||
124946376|NCT02852824|449431059|FG001|Overall Study|Withdrawal by Subject|0|||
124946377|NCT02852824|449431060|FG002|Overall Study|Withdrawal by Subject|0|||
125029063|NCT00289913|449729258|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
125214514|NCT00948922|450412867|FG000|Overall Study|Transplant eligibility issues|2|||
125214515|NCT00948922|450412868|FG001|Overall Study|Transplant eligibility issues|3|||
124946378|NCT02852824|449431061|FG003|Overall Study|Withdrawal by Subject|0|||
124946379|NCT02852824|449431062|FG004|Overall Study|Withdrawal by Subject|0|||
125214516|NCT00948922|450412869|FG002|Overall Study|Transplant eligibility issues|0|||
124946380|NCT02852824|449431063|FG005|Overall Study|Withdrawal by Subject|0|||
124946381|NCT02852824|449431064|FG006|Overall Study|Withdrawal by Subject|0|||
124946382|NCT02852824|449431058|FG000|Overall Study|Adverse Event|0|||
124946383|NCT02852824|449431059|FG001|Overall Study|Adverse Event|0|||
124946384|NCT02852824|449431060|FG002|Overall Study|Adverse Event|0|||
124946385|NCT02852824|449431061|FG003|Overall Study|Adverse Event|0|||
124946386|NCT02852824|449431062|FG004|Overall Study|Adverse Event|2|||
124946387|NCT02852824|449431063|FG005|Overall Study|Adverse Event|0|||
124946388|NCT02852824|449431064|FG006|Overall Study|Adverse Event|0|||
124946389|NCT00680771|449431065|FG000|Overall Study|Withdrawal by Subject|1|||
124946390|NCT00680771|449431066|FG001|Overall Study|Withdrawal by Subject|0|||
124946391|NCT00680771|449431065|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
124946392|NCT00680771|449431066|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
124946393|NCT00680771|449431065|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
124946394|NCT00680771|449431066|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
124946395|NCT04076059|449431072|FG000|Double Blind Phase|Progressive disease|22|||
124946396|NCT04076059|449431073|FG001|Double Blind Phase|Progressive disease|26|||
124946397|NCT04076059|449431074|FG002|Double Blind Phase|Progressive disease|0|||
124946398|NCT04076059|449431072|FG000|Double Blind Phase|Withdrawal by Subject|4|||
124946399|NCT04076059|449431073|FG001|Double Blind Phase|Withdrawal by Subject|11|||
124946400|NCT04076059|449431074|FG002|Double Blind Phase|Withdrawal by Subject|0|||
124946401|NCT04076059|449431072|FG000|Double Blind Phase|Death|1|||
124946402|NCT04076059|449431073|FG001|Double Blind Phase|Death|1|||
124946403|NCT04076059|449431074|FG002|Double Blind Phase|Death|0|||
124946404|NCT04076059|449431072|FG000|Double Blind Phase|Lost to Follow-up|1|||
124946405|NCT04076059|449431073|FG001|Double Blind Phase|Lost to Follow-up|0|||
124946406|NCT04076059|449431074|FG002|Double Blind Phase|Lost to Follow-up|0|||
124946407|NCT04076059|449431072|FG000|Double Blind Phase|Adverse Event|5|||
124946408|NCT04076059|449431073|FG001|Double Blind Phase|Adverse Event|1|||
124946409|NCT04076059|449431074|FG002|Double Blind Phase|Adverse Event|0|||
124946410|NCT04076059|449431072|FG000|Double Blind Phase|Ongoing Participants|82|||
125029064|NCT00289913|449729254|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
125029065|NCT00289913|449729255|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
125029066|NCT00289913|449729256|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
125029067|NCT00289913|449729257|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
125029068|NCT00289913|449729258|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
125029069|NCT00289913|449729254|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125029070|NCT00289913|449729255|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125029071|NCT00289913|449729256|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
125029072|NCT00289913|449729257|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125029073|NCT00289913|449729258|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125029074|NCT00289913|449729254|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
125029075|NCT00289913|449729255|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
125029076|NCT00289913|449729256|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
125029077|NCT00289913|449729257|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
125029078|NCT00289913|449729258|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
125029079|NCT00289913|449729254|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
125029080|NCT00289913|449729255|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
125029081|NCT00289913|449729256|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
125029082|NCT00289913|449729257|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
125029083|NCT00289913|449729258|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
125029084|NCT00289913|449729254|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
125029085|NCT00289913|449729255|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
125029086|NCT00289913|449729256|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
125029087|NCT00289913|449729257|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
125029088|NCT00289913|449729258|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
125029089|NCT00289913|449729254|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
125029090|NCT00289913|449729255|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
125123518|NCT03815942|450077279|FG001|Overall Study|Withdrawal by Subject|17|||
125123519|NCT02785913|450077280|FG000|Overall Study|Adverse Event|5|||
125123520|NCT02785913|450077280|FG000|Overall Study|Death|2|||
125123521|NCT02785913|450077280|FG000|Overall Study|Progression|18|||
125123522|NCT02785913|450077280|FG000|Overall Study|Not protocol specified|1|||
125123523|NCT03717064|450077281|FG000|Period 2|Adverse Event|1|||
124946411|NCT04076059|449431073|FG001|Double Blind Phase|Ongoing Participants|18|||
124946412|NCT04076059|449431074|FG002|Double Blind Phase|Ongoing Participants|0|||
124946413|NCT04076059|449431072|FG000|Double Blind Phase|Miscellaneous|3|||
125123524|NCT01298570|450077282|FG000|Overall Study|Disease progression, relapse during acti|64|||
125123525|NCT01298570|450077283|FG001|Overall Study|Disease progression, relapse during acti|40|||
125123526|NCT01298570|450077282|FG000|Overall Study|Adverse Event|20|||
125123527|NCT01298570|450077283|FG001|Overall Study|Adverse Event|2|||
125123528|NCT01298570|450077282|FG000|Overall Study|Withdrawal by Subject|21|||
125123529|NCT01298570|450077283|FG001|Overall Study|Withdrawal by Subject|6|||
125123530|NCT01298570|450077282|FG000|Overall Study|Treatment delay > 4 weeks|4|||
125123531|NCT01298570|450077283|FG001|Overall Study|Treatment delay > 4 weeks|5|||
125123532|NCT01298570|450077282|FG000|Overall Study|Physician Decision|4|||
125123533|NCT01298570|450077283|FG001|Overall Study|Physician Decision|2|||
125123534|NCT01298570|450077282|FG000|Overall Study|Other complicating disease|2|||
125123535|NCT01298570|450077283|FG001|Overall Study|Other complicating disease|1|||
125123536|NCT01298570|450077282|FG000|Overall Study|Surgery|2|||
125123537|NCT01298570|450077283|FG001|Overall Study|Surgery|1|||
125123538|NCT01298570|450077282|FG000|Overall Study|Symptomatic progression/deterioration|3|||
125123539|NCT01298570|450077283|FG001|Overall Study|Symptomatic progression/deterioration|2|||
125123540|NCT01298570|450077282|FG000|Overall Study|Death|0|||
124946414|NCT04076059|449431073|FG001|Double Blind Phase|Miscellaneous|1|||
124946415|NCT04076059|449431074|FG002|Double Blind Phase|Miscellaneous|0|||
124946416|NCT04076059|449431072|FG000|Double Blind Phase|Protocol Deviation|1|||
124946417|NCT04076059|449431073|FG001|Double Blind Phase|Protocol Deviation|1|||
124946418|NCT04076059|449431074|FG002|Double Blind Phase|Protocol Deviation|0|||
124946419|NCT04076059|449431072|FG000|Double Blind Phase|Did not take study drug|1|||
124946420|NCT04076059|449431073|FG001|Double Blind Phase|Did not take study drug|1|||
124946421|NCT04076059|449431074|FG002|Double Blind Phase|Did not take study drug|0|||
124946422|NCT04076059|449431072|FG000|Open Label Phase|Progressive disease|0|||
124946423|NCT04076059|449431073|FG001|Open Label Phase|Progressive disease|0|||
124946424|NCT04076059|449431074|FG002|Open Label Phase|Progressive disease|7|||
124946425|NCT04076059|449431072|FG000|Open Label Phase|Withdrawal by Subject|0|||
124946426|NCT04076059|449431073|FG001|Open Label Phase|Withdrawal by Subject|0|||
124946427|NCT04076059|449431074|FG002|Open Label Phase|Withdrawal by Subject|3|||
124946428|NCT04076059|449431072|FG000|Open Label Phase|Death|0|||
124946429|NCT04076059|449431073|FG001|Open Label Phase|Death|0|||
124946430|NCT04076059|449431074|FG002|Open Label Phase|Death|2|||
124946431|NCT04076059|449431072|FG000|Open Label Phase|Ongoing Participants|0|||
124946432|NCT04076059|449431073|FG001|Open Label Phase|Ongoing Participants|0|||
124946433|NCT04076059|449431074|FG002|Open Label Phase|Ongoing Participants|11|||
124946434|NCT02521493|449431075|FG000|Overall Study|Death|3|||
124946435|NCT02521493|449431076|FG001|Overall Study|Death|4|||
124946436|NCT02521493|449431077|FG002|Overall Study|Death|1|||
124946437|NCT02521493|449431075|FG000|Overall Study|Physician Decision|19|||
124946438|NCT02521493|449431076|FG001|Overall Study|Physician Decision|1|||
124946439|NCT02521493|449431077|FG002|Overall Study|Physician Decision|2|||
124946440|NCT02521493|449431075|FG000|Overall Study|Withdrawal by Subject|3|||
124946441|NCT02521493|449431076|FG001|Overall Study|Withdrawal by Subject|0|||
124946442|NCT02521493|449431077|FG002|Overall Study|Withdrawal by Subject|0|||
124946443|NCT02521493|449431075|FG000|Overall Study|Ineligible|0|||
125123541|NCT01298570|450077283|FG001|Overall Study|Death|1|||
125123542|NCT01298570|450077282|FG000|Overall Study|Ineligibility|0|||
125123543|NCT01298570|450077283|FG001|Overall Study|Ineligibility|1|||
125123544|NCT02841709|450077284|FG000|5th Intervention|Adverse Event|2|||
125123545|NCT02841709|450077285|FG001|5th Intervention|Adverse Event|0|||
125123546|NCT02841709|450077286|FG002|5th Intervention|Adverse Event|0|||
125123547|NCT02841709|450077287|FG003|5th Intervention|Adverse Event|0|||
125123548|NCT02841709|450077288|FG004|5th Intervention|Adverse Event|2|||
125123549|NCT01929109|450077289|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
125123550|NCT01929109|450077290|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
125123551|NCT01929109|450077291|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
125123552|NCT01929109|450077292|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
125123553|NCT01929109|450077293|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
125123554|NCT00076102|450077294|FG000|Overall Study|Clinical progression|1|||
125123555|NCT00076102|450077294|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
125123556|NCT00076102|450077294|FG000|Overall Study|plexiform neurofibroma surgery|1|||
125123557|NCT00076102|450077294|FG000|Overall Study|refusal of further therapy|2|||
124946444|NCT02521493|449431076|FG001|Overall Study|Ineligible|1|||
124946445|NCT02521493|449431077|FG002|Overall Study|Ineligible|0|||
124946446|NCT02521493|449431075|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
125123558|NCT01210001|450077295|FG000|Overall Study|Not treated|1|||
125123559|NCT01210001|450077296|FG001|Overall Study|Not treated|0|||
125123560|NCT01210001|450077297|FG002|Overall Study|Not treated|0|||
125123561|NCT01210001|450077295|FG000|Overall Study|Adverse Event|4|||
125123562|NCT01210001|450077296|FG001|Overall Study|Adverse Event|2|||
125123563|NCT01210001|450077297|FG002|Overall Study|Adverse Event|5|||
125123564|NCT01210001|450077295|FG000|Overall Study|Non compliant with protocol|2|||
125123565|NCT01210001|450077296|FG001|Overall Study|Non compliant with protocol|2|||
125123566|NCT01210001|450077297|FG002|Overall Study|Non compliant with protocol|3|||
125123567|NCT01210001|450077295|FG000|Overall Study|Lost to Follow-up|4|||
125123568|NCT01210001|450077296|FG001|Overall Study|Lost to Follow-up|3|||
125123569|NCT01210001|450077297|FG002|Overall Study|Lost to Follow-up|2|||
125123570|NCT01210001|450077295|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
125123571|NCT01210001|450077296|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
125123572|NCT01210001|450077297|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
125123573|NCT01210001|450077295|FG000|Overall Study|Other reason not defined above|2|||
124946447|NCT02521493|449431076|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
124946448|NCT02521493|449431077|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
125123574|NCT01210001|450077296|FG001|Overall Study|Other reason not defined above|2|||
124946449|NCT02521493|449431075|FG000|Overall Study|No MRD result|0|||
124946450|NCT02521493|449431076|FG001|Overall Study|No MRD result|0|||
124946451|NCT02521493|449431077|FG002|Overall Study|No MRD result|4|||
124946452|NCT04748341|449431078|FG000|Overall Study|Lost to Follow-up|1|||
125123575|NCT01210001|450077297|FG002|Overall Study|Other reason not defined above|1|||
125123576|NCT00788125|450077298|FG000|Overall Study|Death|6|||
125123577|NCT05346055|450077309|FG000|Overall Study|Withdrawal by Subject|1|||
125123578|NCT05346055|450077309|FG000|Overall Study|Protocol Violation|1|||
124946453|NCT04748341|449431079|FG001|Overall Study|Lost to Follow-up|1|||
124946454|NCT03769090|449432681|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
124946455|NCT03769090|449432682|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
125029091|NCT00289913|449729256|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
125029092|NCT00289913|449729257|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
125029093|NCT00289913|449729258|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
124946456|NCT03769090|449432683|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
124946457|NCT03769090|449432681|FG000|Overall Study|Withdrawal by Subject|52|||
124946458|NCT03769090|449432682|FG001|Overall Study|Withdrawal by Subject|62|||
124946459|NCT03769090|449432683|FG002|Overall Study|Withdrawal by Subject|74|||
124946460|NCT03769090|449432681|FG000|Overall Study|Death|4|||
124946461|NCT03769090|449432682|FG001|Overall Study|Death|2|||
125029094|NCT00289913|449729254|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
125029095|NCT00289913|449729255|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
125029096|NCT00289913|449729256|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
125029097|NCT00289913|449729257|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
125029098|NCT00289913|449729258|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
125029099|NCT00289913|449729254|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
125029100|NCT00289913|449729255|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
125029101|NCT00289913|449729256|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
125029102|NCT00289913|449729257|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
125029103|NCT00289913|449729258|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
125029104|NCT00289913|449729254|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
125029105|NCT00289913|449729255|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
125029106|NCT00289913|449729256|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
125029107|NCT00289913|449729257|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
125029108|NCT00289913|449729258|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
125029109|NCT00289913|449729254|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
125029110|NCT00289913|449729255|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
125029111|NCT00289913|449729256|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
125029112|NCT00289913|449729257|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
125029113|NCT00289913|449729258|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
125029114|NCT00289913|449729254|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
125029115|NCT00289913|449729255|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
125029116|NCT00289913|449729256|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
125029117|NCT00289913|449729257|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
125029118|NCT00289913|449729258|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
125029119|NCT00289913|449729254|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
124946462|NCT03769090|449432683|FG002|Overall Study|Death|2|||
125123579|NCT05346055|450077309|FG000|Overall Study|Therapist decision|1|||
125123580|NCT00977106|450077310|FG000|Overall Study|Adverse Event|5|||
125123581|NCT00977106|450077311|FG001|Overall Study|Adverse Event|6|||
125123582|NCT00977106|450077310|FG000|Overall Study|Withdrawal by Subject|2|||
125123583|NCT00977106|450077311|FG001|Overall Study|Withdrawal by Subject|2|||
125123584|NCT00977106|450077310|FG000|Overall Study|Lack of Efficacy|2|||
125123585|NCT00977106|450077311|FG001|Overall Study|Lack of Efficacy|2|||
125123586|NCT00977106|450077310|FG000|Overall Study|Protocol Violation|0|||
125123587|NCT00977106|450077311|FG001|Overall Study|Protocol Violation|1|||
124946463|NCT03769090|449432681|FG000|Overall Study|Adverse Event|7|||
124946464|NCT03769090|449432682|FG001|Overall Study|Adverse Event|7|||
124946465|NCT03769090|449432683|FG002|Overall Study|Adverse Event|8|||
124946466|NCT03769090|449432681|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
124946467|NCT03769090|449432682|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
124946468|NCT03769090|449432683|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
124946469|NCT03769090|449432681|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
124946470|NCT03769090|449432682|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
124946471|NCT03769090|449432683|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
124946472|NCT03769090|449432681|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
124946473|NCT03769090|449432682|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
124946474|NCT03769090|449432683|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
124946475|NCT03769090|449432681|FG000|Overall Study|Protocol Violation|5|||
124946476|NCT03769090|449432682|FG001|Overall Study|Protocol Violation|6|||
124946477|NCT03769090|449432683|FG002|Overall Study|Protocol Violation|8|||
124946478|NCT03769090|449432681|FG000|Overall Study|Pregnancy|1|||
124946479|NCT03769090|449432682|FG001|Overall Study|Pregnancy|0|||
124946480|NCT03769090|449432683|FG002|Overall Study|Pregnancy|3|||
124946481|NCT03769090|449432681|FG000|Overall Study|Lost to Follow-up|19|||
124946482|NCT03769090|449432682|FG001|Overall Study|Lost to Follow-up|25|||
124946483|NCT03769090|449432683|FG002|Overall Study|Lost to Follow-up|21|||
124946484|NCT03769090|449432681|FG000|Overall Study|Condition under investigation worsened|2|||
124946485|NCT03769090|449432682|FG001|Overall Study|Condition under investigation worsened|0|||
124946486|NCT03769090|449432683|FG002|Overall Study|Condition under investigation worsened|1|||
124946487|NCT03769090|449432681|FG000|Overall Study|Lack of Efficacy|1|||
124946488|NCT03769090|449432682|FG001|Overall Study|Lack of Efficacy|2|||
124946489|NCT03769090|449432683|FG002|Overall Study|Lack of Efficacy|2|||
124946490|NCT03769090|449432681|FG000|Overall Study|Other reasons|8|||
124946491|NCT03769090|449432682|FG001|Overall Study|Other reasons|12|||
124946492|NCT03769090|449432683|FG002|Overall Study|Other reasons|15|||
124946493|NCT00799409|449432684|FG000|Overall Study|Withdrawal by Subject|1|||
124946494|NCT00799409|449432685|FG001|Overall Study|Withdrawal by Subject|0|||
124946495|NCT00799409|449432686|FG002|Overall Study|Withdrawal by Subject|0|||
124946496|NCT00799409|449432684|FG000|Overall Study|Lost to Follow-up|1|||
124946497|NCT00799409|449432685|FG001|Overall Study|Lost to Follow-up|0|||
124946498|NCT00799409|449432686|FG002|Overall Study|Lost to Follow-up|0|||
125029120|NCT00289913|449729255|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
125029121|NCT00289913|449729256|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
125029122|NCT00289913|449729257|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
125029123|NCT00289913|449729258|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
125029124|NCT00289913|449729254|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
125029125|NCT00289913|449729255|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
125029126|NCT00289913|449729256|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
125029127|NCT00289913|449729257|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
125029128|NCT00289913|449729258|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
125029129|NCT00289913|449729254|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
125029130|NCT00289913|449729255|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
125029131|NCT00289913|449729256|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
125029132|NCT00289913|449729257|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
125029133|NCT00289913|449729258|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
125029134|NCT00289913|449729254|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
125029135|NCT00289913|449729255|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
125029136|NCT00289913|449729256|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
125029137|NCT00289913|449729257|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
125029138|NCT00289913|449729258|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
125029139|NCT00289913|449729254|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125029140|NCT00289913|449729255|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
125029141|NCT00289913|449729256|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125029142|NCT00289913|449729257|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125029143|NCT00289913|449729258|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125029144|NCT00289913|449729254|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
125029145|NCT00289913|449729255|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
125029146|NCT00289913|449729256|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
125029147|NCT00289913|449729257|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
125029148|NCT00289913|449729258|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
125029149|NCT00289913|449729254|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
125029150|NCT00289913|449729255|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
125029151|NCT00289913|449729256|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
125029152|NCT00289913|449729257|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
125029153|NCT00289913|449729258|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
125029154|NCT00289913|449729254|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
125029155|NCT00289913|449729255|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
125029156|NCT00289913|449729256|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
125029157|NCT00289913|449729257|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
125029158|NCT00289913|449729258|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
125029159|NCT00289913|449729254|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
125029160|NCT00289913|449729255|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
125029161|NCT00289913|449729256|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
125029162|NCT00289913|449729257|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
125029163|NCT00289913|449729258|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
125029164|NCT00289913|449729254|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
125029165|NCT00289913|449729255|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
125029166|NCT00289913|449729256|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
125029167|NCT00289913|449729257|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
125029168|NCT00289913|449729258|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
125029169|NCT00289913|449729254|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
125029170|NCT00289913|449729255|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
125029171|NCT00289913|449729256|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
125029172|NCT00289913|449729257|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
124946499|NCT00799409|449432684|FG000|Overall Study|Optimal Dose Not Achieved|2|||
124946500|NCT00799409|449432685|FG001|Overall Study|Optimal Dose Not Achieved|0|||
124946501|NCT00799409|449432686|FG002|Overall Study|Optimal Dose Not Achieved|0|||
124946502|NCT00799409|449432684|FG000|Overall Study|Failure to follow study protocol)|1|||
124946503|NCT00799409|449432685|FG001|Overall Study|Failure to follow study protocol)|0|||
124946504|NCT00799409|449432686|FG002|Overall Study|Failure to follow study protocol)|0|||
124946505|NCT00799409|449432684|FG000|Overall Study|Did not attend lab school day 1|1|||
124946506|NCT00799409|449432685|FG001|Overall Study|Did not attend lab school day 1|0|||
124946507|NCT00799409|449432686|FG002|Overall Study|Did not attend lab school day 1|0|||
124946508|NCT00799409|449432684|FG000|Overall Study|medication compliance|1|||
124946509|NCT00799409|449432685|FG001|Overall Study|medication compliance|0|||
124946510|NCT00799409|449432686|FG002|Overall Study|medication compliance|0|||
124946511|NCT03964974|449432687|FG000|Overall Study|Lost to Follow-up|3|||
124946512|NCT03964974|449432688|FG001|Overall Study|Lost to Follow-up|2|||
124946513|NCT03964974|449432687|FG000|Overall Study|Withdrawal by Subject|0|||
124946514|NCT03964974|449432688|FG001|Overall Study|Withdrawal by Subject|3|||
124946515|NCT01779050|449432691|FG000|Overall Study|Withdrawal by Subject|1|||
124946516|NCT01779050|449432692|FG001|Overall Study|Withdrawal by Subject|0|||
124946517|NCT00022672|449432695|FG000|Main Phase: 24 Months|Adverse Event|6|||
124946518|NCT00022672|449432696|FG001|Main Phase: 24 Months|Adverse Event|0|||
124946519|NCT00022672|449432695|FG000|Main Phase: 24 Months|Death|0|||
124946520|NCT00022672|449432696|FG001|Main Phase: 24 Months|Death|3|||
124946521|NCT00022672|449432695|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
124946522|NCT00022672|449432696|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
124946523|NCT00022672|449432695|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
124946524|NCT00022672|449432696|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
124946525|NCT00022672|449432695|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
124946526|NCT00022672|449432696|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
124946527|NCT00022672|449432695|FG000|Main Phase: 24 Months|Refused Treatment|3|||
124946528|NCT00022672|449432696|FG001|Main Phase: 24 Months|Refused Treatment|4|||
124946529|NCT00022672|449432695|FG000|Main Phase: 24 Months|Failure to Return|1|||
124946530|NCT00022672|449432696|FG001|Main Phase: 24 Months|Failure to Return|1|||
124946531|NCT00022672|449432695|FG000|Main Phase: 24 Months|Other|1|||
124946532|NCT00022672|449432696|FG001|Main Phase: 24 Months|Other|0|||
124946533|NCT00022672|449432695|FG000|Extension Phase|Adverse Event|1|||
124946534|NCT00022672|449432696|FG001|Extension Phase|Adverse Event|3|||
124946535|NCT00022672|449432695|FG000|Extension Phase|Death|0|||
124946536|NCT00022672|449432696|FG001|Extension Phase|Death|1|||
124946537|NCT00022672|449432695|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
124946538|NCT00022672|449432696|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
124946539|NCT00022672|449432695|FG000|Extension Phase|Refused Treatment|0|||
124946540|NCT00022672|449432696|FG001|Extension Phase|Refused Treatment|2|||
124946541|NCT00022672|449432695|FG000|Extension Phase|Other|1|||
124946542|NCT00022672|449432696|FG001|Extension Phase|Other|1|||
124946543|NCT01332266|449432697|FG000|Phase 1b|Death|3|||
124946544|NCT01332266|449432698|FG001|Phase 1b|Death|3|||
124946545|NCT01332266|449432699|FG002|Phase 1b|Death|2|||
124946546|NCT01332266|449432700|FG003|Phase 1b|Death|0|||
124946547|NCT01332266|449432701|FG004|Phase 1b|Death|0|||
124946548|NCT01332266|449432697|FG000|Phase 1b|Lost to Follow-up|0|||
124946549|NCT01332266|449432698|FG001|Phase 1b|Lost to Follow-up|1|||
124946550|NCT01332266|449432699|FG002|Phase 1b|Lost to Follow-up|0|||
124946551|NCT01332266|449432700|FG003|Phase 1b|Lost to Follow-up|0|||
124946552|NCT01332266|449432701|FG004|Phase 1b|Lost to Follow-up|0|||
124946553|NCT01332266|449432697|FG000|Phase 1b|Withdrawal by Subject|1|||
124946554|NCT01332266|449432698|FG001|Phase 1b|Withdrawal by Subject|1|||
124946555|NCT01332266|449432699|FG002|Phase 1b|Withdrawal by Subject|1|||
124946556|NCT01332266|449432700|FG003|Phase 1b|Withdrawal by Subject|0|||
124946557|NCT01332266|449432701|FG004|Phase 1b|Withdrawal by Subject|0|||
124946558|NCT01332266|449432697|FG000|Phase 2|Death|0|||
124946559|NCT01332266|449432698|FG001|Phase 2|Death|0|||
124946560|NCT01332266|449432699|FG002|Phase 2|Death|0|||
124946561|NCT01332266|449432700|FG003|Phase 2|Death|33|||
124946562|NCT01332266|449432701|FG004|Phase 2|Death|36|||
125029173|NCT00289913|449729258|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
125029174|NCT00289913|449729254|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
125029175|NCT00289913|449729255|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
125029176|NCT00289913|449729256|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
125029177|NCT00289913|449729257|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
125029178|NCT00289913|449729258|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
125029179|NCT04173741|449729259|FG000|Overall Study|IVC measurement cannot be done|1|||
125029180|NCT04173741|449729260|FG001|Overall Study|IVC measurement cannot be done|1|||
125029181|NCT01169779|449729263|FG000|Overall Study|Adverse Event|3|||
125029182|NCT01169779|449729264|FG001|Overall Study|Adverse Event|11|||
125029183|NCT01169779|449729263|FG000|Overall Study|Lack of Efficacy|1|||
125029184|NCT01169779|449729264|FG001|Overall Study|Lack of Efficacy|0|||
125029185|NCT01169779|449729263|FG000|Overall Study|Protocol Violation|1|||
124946563|NCT01332266|449432697|FG000|Phase 2|Lost to Follow-up|0|||
124946564|NCT01332266|449432698|FG001|Phase 2|Lost to Follow-up|0|||
124946565|NCT01332266|449432699|FG002|Phase 2|Lost to Follow-up|0|||
124946566|NCT01332266|449432700|FG003|Phase 2|Lost to Follow-up|2|||
124946567|NCT01332266|449432701|FG004|Phase 2|Lost to Follow-up|0|||
124946568|NCT01332266|449432697|FG000|Phase 2|Physician Decision|0|||
124946569|NCT01332266|449432698|FG001|Phase 2|Physician Decision|0|||
124946570|NCT01332266|449432699|FG002|Phase 2|Physician Decision|0|||
124946571|NCT01332266|449432700|FG003|Phase 2|Physician Decision|3|||
124946572|NCT01332266|449432701|FG004|Phase 2|Physician Decision|1|||
124946573|NCT01332266|449432697|FG000|Phase 2|Symptomatic deterioration|0|||
124946574|NCT01332266|449432698|FG001|Phase 2|Symptomatic deterioration|0|||
124946575|NCT01332266|449432699|FG002|Phase 2|Symptomatic deterioration|0|||
125123588|NCT00977106|450077310|FG000|Overall Study|Other|1|||
125123589|NCT00977106|450077311|FG001|Overall Study|Other|0|||
125123590|NCT02319148|450077318|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
125123591|NCT02319148|450077319|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
125123592|NCT02319148|450077320|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
125123593|NCT02319148|450077321|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
124946576|NCT01332266|449432700|FG003|Phase 2|Symptomatic deterioration|0|||
124946577|NCT01332266|449432701|FG004|Phase 2|Symptomatic deterioration|1|||
124946578|NCT01332266|449432697|FG000|Phase 2|Progression Disease|0|||
124946579|NCT01332266|449432698|FG001|Phase 2|Progression Disease|0|||
124946580|NCT01332266|449432699|FG002|Phase 2|Progression Disease|0|||
124946581|NCT01332266|449432700|FG003|Phase 2|Progression Disease|2|||
124946582|NCT01332266|449432701|FG004|Phase 2|Progression Disease|1|||
124946583|NCT01332266|449432697|FG000|Phase 2|Withdrawal by Subject|0|||
124946584|NCT01332266|449432698|FG001|Phase 2|Withdrawal by Subject|0|||
125029186|NCT01169779|449729264|FG001|Overall Study|Protocol Violation|1|||
125029187|NCT01169779|449729263|FG000|Overall Study|Withdrawal by Subject|3|||
125029188|NCT01169779|449729264|FG001|Overall Study|Withdrawal by Subject|2|||
125029189|NCT01169779|449729263|FG000|Overall Study|Familial and personal reasons|3|||
125029190|NCT01169779|449729264|FG001|Overall Study|Familial and personal reasons|3|||
125029191|NCT02024971|449729265|FG000|Overall Study|Data Not Available|30|||
125029192|NCT02024971|449729265|FG000|Overall Study|Lost to Follow-up|6|||
125029193|NCT00849667|449729277|FG000|Overall Study|Withdrawal by Subject|16|||
125029194|NCT00849667|449729278|FG001|Overall Study|Withdrawal by Subject|33|||
125029195|NCT00849667|449729279|FG002|Overall Study|Withdrawal by Subject|35|||
125029196|NCT00849667|449729277|FG000|Overall Study|Lost to Follow-up|8|||
125029197|NCT00849667|449729278|FG001|Overall Study|Lost to Follow-up|8|||
125029198|NCT00849667|449729279|FG002|Overall Study|Lost to Follow-up|8|||
125029199|NCT00849667|449729277|FG000|Overall Study|Adverse Event|1|||
125029200|NCT00849667|449729278|FG001|Overall Study|Adverse Event|2|||
125029201|NCT00849667|449729279|FG002|Overall Study|Adverse Event|0|||
125029202|NCT00849667|449729277|FG000|Overall Study|Other|18|||
125029203|NCT00849667|449729278|FG001|Overall Study|Other|19|||
125029204|NCT00849667|449729279|FG002|Overall Study|Other|18|||
125029205|NCT00849667|449729277|FG000|Overall Study|Progressive disease|119|||
125029206|NCT00849667|449729278|FG001|Overall Study|Progressive disease|100|||
125029207|NCT00849667|449729279|FG002|Overall Study|Progressive disease|112|||
125029208|NCT00849667|449729277|FG000|Overall Study|Sponsor decision|208|||
125029209|NCT00849667|449729278|FG001|Overall Study|Sponsor decision|204|||
125029210|NCT00849667|449729279|FG002|Overall Study|Sponsor decision|190|||
125029211|NCT00849667|449729277|FG000|Overall Study|Investigator discretion|0|||
125029212|NCT00849667|449729278|FG001|Overall Study|Investigator discretion|0|||
125029213|NCT00849667|449729279|FG002|Overall Study|Investigator discretion|1|||
125029214|NCT00944034|449729282|FG000|Overall Study|Inappropriate enrollment|0|||
125029215|NCT00944034|449729283|FG001|Overall Study|Inappropriate enrollment|1|||
125029216|NCT00944034|449729284|FG002|Overall Study|Inappropriate enrollment|0|||
125029217|NCT00944034|449729285|FG003|Overall Study|Inappropriate enrollment|1|||
125029218|NCT00944034|449729286|FG004|Overall Study|Inappropriate enrollment|2|||
125029219|NCT00944034|449729287|FG005|Overall Study|Inappropriate enrollment|1|||
125029220|NCT00944034|449729288|FG006|Overall Study|Inappropriate enrollment|0|||
125029221|NCT00944034|449729289|FG007|Overall Study|Inappropriate enrollment|0|||
125029222|NCT00944034|449729290|FG008|Overall Study|Inappropriate enrollment|1|||
125029223|NCT00944034|449729291|FG009|Overall Study|Inappropriate enrollment|1|||
125029224|NCT00944034|449729292|FG010|Overall Study|Inappropriate enrollment|0|||
125029225|NCT00944034|449729293|FG011|Overall Study|Inappropriate enrollment|0|||
125029226|NCT00944034|449729282|FG000|Overall Study|Withdrawal by Subject|3|||
125029227|NCT00944034|449729283|FG001|Overall Study|Withdrawal by Subject|2|||
125029228|NCT00944034|449729284|FG002|Overall Study|Withdrawal by Subject|6|||
125029229|NCT00944034|449729285|FG003|Overall Study|Withdrawal by Subject|2|||
125029230|NCT00944034|449729286|FG004|Overall Study|Withdrawal by Subject|5|||
125029231|NCT00944034|449729287|FG005|Overall Study|Withdrawal by Subject|8|||
125029232|NCT00944034|449729288|FG006|Overall Study|Withdrawal by Subject|2|||
125029233|NCT00944034|449729289|FG007|Overall Study|Withdrawal by Subject|2|||
125123594|NCT02319148|450077318|FG000|Second Intervention Period|No longer willing to participate|0|||
125123595|NCT02319148|450077319|FG001|Second Intervention Period|No longer willing to participate|1|||
125123596|NCT02319148|450077320|FG002|Second Intervention Period|No longer willing to participate|0|||
125123597|NCT02319148|450077321|FG003|Second Intervention Period|No longer willing to participate|0|||
125123598|NCT02319148|450077318|FG000|Second Intervention Period|Other|0|||
125123599|NCT02319148|450077319|FG001|Second Intervention Period|Other|0|||
125123600|NCT02319148|450077320|FG002|Second Intervention Period|Other|0|||
125123601|NCT02319148|450077321|FG003|Second Intervention Period|Other|1|||
125123602|NCT02388763|450077324|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
125123603|NCT02388763|450077325|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
125123604|NCT02388763|450077324|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
125123605|NCT02388763|450077325|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
125123606|NCT01153984|450077326|FG000|Overall Study|Withdrawal by Subject|1|||
125123607|NCT01153984|450077326|FG000|Overall Study|Adverse Event|1|||
125123608|NCT02460159|450077327|FG000|Overall Study|Adverse Event|4|||
125123609|NCT02460159|450077328|FG001|Overall Study|Adverse Event|1|||
125123610|NCT02460159|450077327|FG000|Overall Study|Withdrawal by Subject|2|||
125123611|NCT02460159|450077328|FG001|Overall Study|Withdrawal by Subject|0|||
125123612|NCT02194998|450077335|FG000|On-HCV Treatment|Did not pick up study medication|0|||
125123613|NCT02194998|450077336|FG001|On-HCV Treatment|Did not pick up study medication|1|||
125123614|NCT02194998|450077337|FG002|On-HCV Treatment|Did not pick up study medication|0|||
125123615|NCT02194998|450077338|FG003|On-HCV Treatment|Did not pick up study medication|0|||
125123616|NCT02194998|450077335|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
125029234|NCT00944034|449729290|FG008|Overall Study|Withdrawal by Subject|3|||
125029235|NCT00944034|449729291|FG009|Overall Study|Withdrawal by Subject|4|||
125029236|NCT00944034|449729292|FG010|Overall Study|Withdrawal by Subject|0|||
125029237|NCT00944034|449729293|FG011|Overall Study|Withdrawal by Subject|4|||
125029238|NCT00944034|449729282|FG000|Overall Study|Lost to Follow-up|0|||
124946585|NCT01332266|449432699|FG002|Phase 2|Withdrawal by Subject|0|||
124946586|NCT01332266|449432700|FG003|Phase 2|Withdrawal by Subject|2|||
124946587|NCT01332266|449432701|FG004|Phase 2|Withdrawal by Subject|2|||
124946588|NCT02392507|449432704|FG000|Induction Regimen|Death|3|||
125123617|NCT02194998|450077336|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
125123618|NCT02194998|450077337|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
125123619|NCT02194998|450077338|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
125123620|NCT01458405|450077341|FG000|Phase 1 (up to 12 Months)|Other|0|||
125123621|NCT01458405|450077342|FG001|Phase 1 (up to 12 Months)|Other|1|||
125123622|NCT01458405|450077343|FG002|Phase 1 (up to 12 Months)|Other|0|||
125123623|NCT01458405|450077344|FG003|Phase 1 (up to 12 Months)|Other|0|||
125123624|NCT01458405|450077341|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
125123625|NCT01458405|450077342|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
125123626|NCT01458405|450077343|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
125123627|NCT01458405|450077344|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
125123628|NCT01458405|450077341|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
125123629|NCT01458405|450077342|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
125123630|NCT01458405|450077343|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
125123631|NCT01458405|450077344|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
125123632|NCT01458405|450077341|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
125123633|NCT01458405|450077342|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
125123634|NCT01458405|450077343|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
125123635|NCT01458405|450077344|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
125123636|NCT02497781|450077345|FG000|Overall Study|Withdrawal by Subject|2|||
125123637|NCT02497781|450077346|FG001|Overall Study|Withdrawal by Subject|0|||
125123638|NCT02497781|450077345|FG000|Overall Study|Lack of Efficacy|0|||
125123639|NCT02497781|450077346|FG001|Overall Study|Lack of Efficacy|1|||
125123640|NCT02497781|450077345|FG000|Overall Study|Randomised but not treated|1|||
125123641|NCT02497781|450077346|FG001|Overall Study|Randomised but not treated|1|||
125123642|NCT02497781|450077345|FG000|Overall Study|Lost to Follow-up|1|||
125123643|NCT02497781|450077346|FG001|Overall Study|Lost to Follow-up|1|||
125123644|NCT02236130|450077347|FG000|Overall Study|Lost to Follow-up|7|||
125123645|NCT02236130|450077348|FG001|Overall Study|Lost to Follow-up|12|||
125123646|NCT00454636|450077349|FG000|Overall Study|Adverse Event|10|||
125123647|NCT00454636|450077350|FG001|Overall Study|Adverse Event|6|||
125123648|NCT00454636|450077351|FG002|Overall Study|Adverse Event|9|||
125123649|NCT00454636|450077352|FG003|Overall Study|Adverse Event|15|||
125123650|NCT00454636|450077349|FG000|Overall Study|Disease Progression|11|||
125123651|NCT00454636|450077350|FG001|Overall Study|Disease Progression|12|||
125123652|NCT00454636|450077351|FG002|Overall Study|Disease Progression|4|||
125123653|NCT00454636|450077352|FG003|Overall Study|Disease Progression|11|||
125123654|NCT00454636|450077349|FG000|Overall Study|Protocol Violation|3|||
125123655|NCT00454636|450077350|FG001|Overall Study|Protocol Violation|2|||
125123656|NCT00454636|450077351|FG002|Overall Study|Protocol Violation|3|||
125123657|NCT00454636|450077352|FG003|Overall Study|Protocol Violation|3|||
125123658|NCT00454636|450077349|FG000|Overall Study|Death|6|||
125123659|NCT00454636|450077350|FG001|Overall Study|Death|1|||
125123660|NCT00454636|450077351|FG002|Overall Study|Death|1|||
125123661|NCT00454636|450077352|FG003|Overall Study|Death|1|||
125123662|NCT00454636|450077349|FG000|Overall Study|Patient refusal|1|||
125123663|NCT00454636|450077350|FG001|Overall Study|Patient refusal|1|||
125123664|NCT00454636|450077351|FG002|Overall Study|Patient refusal|3|||
125123665|NCT00454636|450077352|FG003|Overall Study|Patient refusal|2|||
125123666|NCT00454636|450077349|FG000|Overall Study|Lost to Follow-up|0|||
125123667|NCT00454636|450077350|FG001|Overall Study|Lost to Follow-up|1|||
125123668|NCT00454636|450077351|FG002|Overall Study|Lost to Follow-up|0|||
125123669|NCT00454636|450077352|FG003|Overall Study|Lost to Follow-up|0|||
124946589|NCT02392507|449432704|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
124946590|NCT02392507|449432704|FG000|Induction Regimen|Physician Decision|1|||
124946591|NCT02392507|449432704|FG000|Induction Regimen|Withdrawal by Subject|2|||
125123670|NCT01400113|450077353|FG000|Overall Study|Withdrawal by Subject|1|||
124946592|NCT02392507|449432704|FG000|Maintenance Regimen|Death|1|||
125123671|NCT01400113|450077354|FG001|Overall Study|Withdrawal by Subject|1|||
125123672|NCT01025037|450077359|FG000|Overall Study|Adverse Event|3|||
125123673|NCT01025037|450077359|FG000|Overall Study|Lost to Follow-up|7|||
125123674|NCT01025037|450077359|FG000|Overall Study|Withdrawal by Subject|1|||
125123675|NCT01890915|450077361|FG000|Overall Study|Adverse Event|1|||
125123676|NCT01890915|450077362|FG001|Overall Study|Adverse Event|0|||
125123677|NCT01890915|450077361|FG000|Overall Study|Protocol Violation|2|||
125123678|NCT01890915|450077362|FG001|Overall Study|Protocol Violation|0|||
125123679|NCT01890915|450077361|FG000|Overall Study|Equipment Malfunction|0|||
124946593|NCT02392507|449432704|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
124946594|NCT02224755|449432705|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
125123680|NCT01890915|450077362|FG001|Overall Study|Equipment Malfunction|1|||
125123681|NCT02114697|450077363|FG000|Overall Study|Study terminated|5|||
124946595|NCT02224755|449432706|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
124946596|NCT02224755|449432705|FG000|Two Year Follow up Post-implant|Death|103|||
124946597|NCT02224755|449432706|FG001|Two Year Follow up Post-implant|Death|98|||
124946598|NCT02224755|449432705|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
124946599|NCT02224755|449432706|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
124946600|NCT02224755|449432705|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
124946601|NCT02224755|449432706|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
124946602|NCT02224755|449432705|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
124946603|NCT02224755|449432706|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
124946604|NCT01829711|449432707|FG000|Overall Study|Lost to Follow-up|2|||
124946605|NCT01829711|449432707|FG000|Overall Study|Withdrawal by Subject|3|||
124946606|NCT01829711|449432707|FG000|Overall Study|Death|4|||
124946607|NCT01829711|449432707|FG000|Overall Study|Started new therapies|17|||
124946608|NCT01829711|449432707|FG000|Overall Study|Adverse Event|3|||
124946609|NCT01829711|449432707|FG000|Overall Study|Due to progression of disease|13|||
124946610|NCT01829711|449432707|FG000|Overall Study|Due to lack of response|1|||
124946611|NCT01480258|449432710|FG000|Infant Series|Protocol Violation|2|||
124946612|NCT01480258|449432711|FG001|Infant Series|Protocol Violation|0|||
125123682|NCT02114697|450077364|FG001|Overall Study|Study terminated|4|||
124946613|NCT01480258|449432710|FG000|Infant Series|Physician Decision|0|||
125123683|NCT00424489|450077365|FG000|Overall Study|Death|3|||
125123684|NCT00860405|450077375|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
125123685|NCT00860405|450077376|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
125123686|NCT02465567|450077377|FG000|Overall Study|Adverse Event|118|||
125123687|NCT02465567|450077378|FG001|Overall Study|Adverse Event|113|||
125123688|NCT02465567|450077379|FG002|Overall Study|Adverse Event|147|||
124946614|NCT01480258|449432711|FG001|Infant Series|Physician Decision|1|||
124946615|NCT01480258|449432710|FG000|Infant Series|Not Vaccinated|3|||
124946616|NCT01480258|449432711|FG001|Infant Series|Not Vaccinated|0|||
124946617|NCT01480258|449432710|FG000|Infant Series|Adverse Event|1|||
124946618|NCT01480258|449432711|FG001|Infant Series|Adverse Event|1|||
124946619|NCT01480258|449432710|FG000|Infant Series|Withdrawal by Subject|1|||
124946620|NCT01480258|449432711|FG001|Infant Series|Withdrawal by Subject|6|||
124946621|NCT01480258|449432710|FG000|Interim Period|Lost to Follow-up|0|||
124946622|NCT01480258|449432711|FG001|Interim Period|Lost to Follow-up|2|||
124946623|NCT01480258|449432710|FG000|Interim Period|Physician Decision|1|||
124946624|NCT01480258|449432711|FG001|Interim Period|Physician Decision|0|||
124946625|NCT01480258|449432710|FG000|Interim Period|Protocol Violation|0|||
124946626|NCT01480258|449432711|FG001|Interim Period|Protocol Violation|1|||
124946627|NCT01480258|449432710|FG000|Interim Period|Withdrawal by Subject|9|||
124946628|NCT01480258|449432711|FG001|Interim Period|Withdrawal by Subject|6|||
124946629|NCT02169414|449432712|FG000|Overall Study|Withdrawal by Subject|1|||
124946630|NCT02169414|449432713|FG001|Overall Study|Withdrawal by Subject|0|||
124946631|NCT02169414|449432714|FG002|Overall Study|Withdrawal by Subject|0|||
124946632|NCT02169414|449432715|FG003|Overall Study|Withdrawal by Subject|0|||
124946633|NCT02169414|449432712|FG000|Overall Study|Adverse Event|0|||
124946634|NCT02169414|449432713|FG001|Overall Study|Adverse Event|1|||
124946635|NCT02169414|449432714|FG002|Overall Study|Adverse Event|0|||
124946636|NCT02169414|449432715|FG003|Overall Study|Adverse Event|0|||
124946637|NCT03374254|449432716|FG000|Overall Study|Death|5|||
124946638|NCT03374254|449432717|FG001|Overall Study|Death|16|||
124946639|NCT03374254|449432718|FG002|Overall Study|Death|13|||
124946640|NCT03374254|449432719|FG003|Overall Study|Death|11|||
124946641|NCT03374254|449432720|FG004|Overall Study|Death|9|||
124946642|NCT03374254|449432721|FG005|Overall Study|Death|12|||
124946643|NCT03374254|449432722|FG006|Overall Study|Death|11|||
124946644|NCT03374254|449432723|FG007|Overall Study|Death|6|||
124946645|NCT03374254|449432724|FG008|Overall Study|Death|7|||
124946646|NCT03374254|449432716|FG000|Overall Study|Lost to Follow-up|0|||
124946647|NCT03374254|449432717|FG001|Overall Study|Lost to Follow-up|0|||
124946648|NCT03374254|449432718|FG002|Overall Study|Lost to Follow-up|0|||
124946649|NCT03374254|449432719|FG003|Overall Study|Lost to Follow-up|0|||
125123689|NCT02465567|450077380|FG003|Overall Study|Adverse Event|138|||
125123690|NCT02465567|450077377|FG000|Overall Study|Lack of Efficacy|103|||
124946650|NCT03374254|449432720|FG004|Overall Study|Lost to Follow-up|0|||
124946651|NCT03374254|449432721|FG005|Overall Study|Lost to Follow-up|0|||
124946652|NCT03374254|449432722|FG006|Overall Study|Lost to Follow-up|2|||
124946653|NCT03374254|449432723|FG007|Overall Study|Lost to Follow-up|0|||
124946654|NCT03374254|449432724|FG008|Overall Study|Lost to Follow-up|0|||
124946655|NCT03374254|449432716|FG000|Overall Study|Sponsor Decision|1|||
124946656|NCT03374254|449432717|FG001|Overall Study|Sponsor Decision|0|||
124946657|NCT03374254|449432718|FG002|Overall Study|Sponsor Decision|2|||
124946658|NCT03374254|449432719|FG003|Overall Study|Sponsor Decision|3|||
124946659|NCT03374254|449432720|FG004|Overall Study|Sponsor Decision|2|||
124946660|NCT03374254|449432721|FG005|Overall Study|Sponsor Decision|3|||
124946661|NCT03374254|449432722|FG006|Overall Study|Sponsor Decision|3|||
125123691|NCT02465567|450077378|FG001|Overall Study|Lack of Efficacy|102|||
125029239|NCT00944034|449729283|FG001|Overall Study|Lost to Follow-up|4|||
125029240|NCT00944034|449729284|FG002|Overall Study|Lost to Follow-up|2|||
125029241|NCT00944034|449729285|FG003|Overall Study|Lost to Follow-up|0|||
125029242|NCT00944034|449729286|FG004|Overall Study|Lost to Follow-up|5|||
125029243|NCT00944034|449729287|FG005|Overall Study|Lost to Follow-up|7|||
125214517|NCT00948922|450412867|FG000|Overall Study|Not evaluable at time of analysis|0|||
125214518|NCT00948922|450412868|FG001|Overall Study|Not evaluable at time of analysis|3|||
125214519|NCT00948922|450412869|FG002|Overall Study|Not evaluable at time of analysis|0|||
125214520|NCT03519919|450412870|FG000|Overall Study|Withdrawal by Subject|1|||
125214521|NCT03519919|450412870|FG000|Overall Study|Lack of Efficacy|1|||
125214522|NCT03519919|450412870|FG000|Overall Study|Screen Failure|1|||
125214523|NCT00645671|450412871|FG000|Overall Study|Protocol Violation|1|||
125214524|NCT00645671|450412872|FG001|Overall Study|Protocol Violation|0|||
125214525|NCT00645671|450412871|FG000|Overall Study|Withdrawal by Subject|0|||
125214526|NCT00645671|450412872|FG001|Overall Study|Withdrawal by Subject|4|||
125214527|NCT00645671|450412871|FG000|Overall Study|Adverse Event|0|||
125214528|NCT00645671|450412872|FG001|Overall Study|Adverse Event|1|||
125214529|NCT00645671|450412871|FG000|Overall Study|Physician Decision|0|||
125214530|NCT00645671|450412872|FG001|Overall Study|Physician Decision|1|||
125214531|NCT02095197|450412873|FG000|Overall Study|Lost to Follow-up|0|||
125214532|NCT02095197|450412874|FG001|Overall Study|Lost to Follow-up|3|||
125214533|NCT05114564|450412875|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
125029244|NCT00944034|449729288|FG006|Overall Study|Lost to Follow-up|0|||
125029245|NCT00944034|449729289|FG007|Overall Study|Lost to Follow-up|1|||
125214534|NCT05114564|450412876|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
125214535|NCT05114564|450412875|FG000|First Intervention|Adverse Event|0|||
125214536|NCT05114564|450412876|FG001|First Intervention|Adverse Event|1|||
125029246|NCT00944034|449729290|FG008|Overall Study|Lost to Follow-up|5|||
124946662|NCT03374254|449432723|FG007|Overall Study|Sponsor Decision|3|||
124946663|NCT03374254|449432724|FG008|Overall Study|Sponsor Decision|4|||
124946664|NCT03374254|449432716|FG000|Overall Study|Withdrawal by Subject|0|||
124946665|NCT03374254|449432717|FG001|Overall Study|Withdrawal by Subject|0|||
124946666|NCT03374254|449432718|FG002|Overall Study|Withdrawal by Subject|0|||
124946667|NCT03374254|449432719|FG003|Overall Study|Withdrawal by Subject|2|||
124946668|NCT03374254|449432720|FG004|Overall Study|Withdrawal by Subject|0|||
124946669|NCT03374254|449432721|FG005|Overall Study|Withdrawal by Subject|1|||
124946670|NCT03374254|449432722|FG006|Overall Study|Withdrawal by Subject|0|||
124946671|NCT03374254|449432723|FG007|Overall Study|Withdrawal by Subject|0|||
124946672|NCT03374254|449432724|FG008|Overall Study|Withdrawal by Subject|0|||
124946673|NCT02309515|449432725|FG000|Overall Study|Withdrawal by Subject|0|||
124946674|NCT02309515|449432726|FG001|Overall Study|Withdrawal by Subject|1|||
124946675|NCT00624377|449432730|FG000|Overall Study|Lost to Follow-up|355|||
124946676|NCT00624377|449432730|FG000|Overall Study|Withdrawal by Subject|100|||
124946677|NCT00624377|449432730|FG000|Overall Study|Adverse Event|14|||
124946678|NCT00624377|449432730|FG000|Overall Study|Other|91|||
124946679|NCT00624377|449432730|FG000|Overall Study|Non-evaluable population|84|||
124946680|NCT05260437|449432731|FG000|Overall Study|Lost to Follow-up|5|||
124946681|NCT05260437|449432732|FG001|Overall Study|Lost to Follow-up|2|||
124946682|NCT05260437|449432733|FG002|Overall Study|Lost to Follow-up|1|||
124946683|NCT05260437|449432734|FG003|Overall Study|Lost to Follow-up|2|||
124946684|NCT05260437|449432735|FG004|Overall Study|Lost to Follow-up|2|||
124946685|NCT05260437|449432731|FG000|Overall Study|Withdrawal by Subject|3|||
124946686|NCT05260437|449432732|FG001|Overall Study|Withdrawal by Subject|0|||
124946687|NCT05260437|449432733|FG002|Overall Study|Withdrawal by Subject|4|||
124946688|NCT05260437|449432734|FG003|Overall Study|Withdrawal by Subject|5|||
124946689|NCT05260437|449432735|FG004|Overall Study|Withdrawal by Subject|0|||
124946690|NCT05260437|449432731|FG000|Overall Study|Vaccine Not Administered|0|||
124946691|NCT05260437|449432732|FG001|Overall Study|Vaccine Not Administered|1|||
124946692|NCT05260437|449432733|FG002|Overall Study|Vaccine Not Administered|0|||
124946693|NCT05260437|449432734|FG003|Overall Study|Vaccine Not Administered|0|||
124946694|NCT05260437|449432735|FG004|Overall Study|Vaccine Not Administered|0|||
124946695|NCT00910962|449432736|FG000|Overall Study|Adverse Event|5|||
124946696|NCT00910962|449432737|FG001|Overall Study|Adverse Event|20|||
124946697|NCT00910962|449432738|FG002|Overall Study|Adverse Event|17|||
124946698|NCT00910962|449432736|FG000|Overall Study|Protocol Violation|1|||
124946699|NCT00910962|449432737|FG001|Overall Study|Protocol Violation|3|||
124946700|NCT00910962|449432738|FG002|Overall Study|Protocol Violation|3|||
124946701|NCT00910962|449432736|FG000|Overall Study|Lost to Follow-up|0|||
124946702|NCT00910962|449432737|FG001|Overall Study|Lost to Follow-up|3|||
124946703|NCT00910962|449432738|FG002|Overall Study|Lost to Follow-up|1|||
124946704|NCT00910962|449432736|FG000|Overall Study|Physician Decision|0|||
124946705|NCT00910962|449432737|FG001|Overall Study|Physician Decision|6|||
124946706|NCT00910962|449432738|FG002|Overall Study|Physician Decision|6|||
124946707|NCT00910962|449432736|FG000|Overall Study|Withdrawal by Subject|25|||
124946708|NCT00910962|449432737|FG001|Overall Study|Withdrawal by Subject|32|||
124946709|NCT00910962|449432738|FG002|Overall Study|Withdrawal by Subject|32|||
124946710|NCT00910962|449432736|FG000|Overall Study|Reached defined stopping criteria|12|||
124946711|NCT00910962|449432737|FG001|Overall Study|Reached defined stopping criteria|14|||
124946712|NCT00910962|449432738|FG002|Overall Study|Reached defined stopping criteria|17|||
124946713|NCT00923078|449432739|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
124946714|NCT00923078|449432740|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
124946715|NCT00923078|449432741|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
124946716|NCT00923078|449432739|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
124946717|NCT00923078|449432740|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
124946718|NCT00923078|449432741|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
124946719|NCT01858688|449432742|FG000|Overall Study|Withdrawal by Subject|8|||
124946720|NCT01858688|449432742|FG000|Overall Study|Participant began another therapy|3|||
124946721|NCT01858688|449432742|FG000|Overall Study|Physician Decision|2|||
124946722|NCT01858688|449432742|FG000|Overall Study|Progressive Disease|2|||
124946723|NCT01858688|449432742|FG000|Overall Study|Reason not reproted|5|||
124946724|NCT01999335|449432743|FG000|Overall Study|Discontinued before receiving treatment|0|||
124946725|NCT01999335|449432744|FG001|Overall Study|Discontinued before receiving treatment|0|||
124946726|NCT01999335|449432745|FG002|Overall Study|Discontinued before receiving treatment|0|||
124946727|NCT01999335|449432746|FG003|Overall Study|Discontinued before receiving treatment|0|||
124946728|NCT01999335|449432747|FG004|Overall Study|Discontinued before receiving treatment|2|||
124946729|NCT00787176|449432748|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
124946730|NCT00787176|449432749|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
124946731|NCT00787176|449432750|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
124946732|NCT00787176|449432751|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
124946733|NCT02449902|449432756|FG000|Overall Study|Adverse Event|0|||
124946734|NCT02449902|449432757|FG001|Overall Study|Adverse Event|1|||
125029247|NCT00944034|449729291|FG009|Overall Study|Lost to Follow-up|1|||
125214537|NCT01951573|450412877|FG000|Washout Period|Adverse Event|0|||
125214538|NCT01951573|450412878|FG001|Washout Period|Adverse Event|1|||
125214539|NCT02020889|450412897|FG000|Overall Study|Adverse Event|0|||
125214540|NCT02020889|450412898|FG001|Overall Study|Adverse Event|1|||
125214541|NCT02020889|450412897|FG000|Overall Study|Lack of Efficacy|1|||
125214542|NCT02020889|450412898|FG001|Overall Study|Lack of Efficacy|0|||
125214543|NCT02020889|450412897|FG000|Overall Study|Lost to Follow-up|1|||
124946735|NCT02449902|449432756|FG000|Overall Study|Withdrawal by Subject|0|||
124946736|NCT02449902|449432757|FG001|Overall Study|Withdrawal by Subject|1|||
124946737|NCT02362789|449432758|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
124946738|NCT02362789|449432759|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
124946739|NCT02362789|449432760|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
124946740|NCT02362789|449432758|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
124946741|NCT02362789|449432759|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
124946742|NCT02362789|449432760|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
124946743|NCT02362789|449432758|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
124946744|NCT02362789|449432759|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
124946745|NCT02362789|449432760|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
124946746|NCT02362789|449432758|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
124946747|NCT02362789|449432759|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
124946748|NCT02362789|449432760|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
124946749|NCT02362789|449432758|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
124946750|NCT02362789|449432759|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
124946751|NCT02362789|449432760|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
124946752|NCT03326856|449432761|FG000|Overall Study|Lost to Follow-up|1|||
124946753|NCT03326856|449432762|FG001|Overall Study|Lost to Follow-up|1|||
124946754|NCT03326856|449432763|FG002|Overall Study|Lost to Follow-up|0|||
124946755|NCT03326856|449432764|FG003|Overall Study|Lost to Follow-up|0|||
124946756|NCT03326856|449432765|FG004|Overall Study|Lost to Follow-up|0|||
124946757|NCT03692871|449432766|FG000|Overall Study|Death|1|||
124946758|NCT03692871|449432767|FG001|Overall Study|Death|1|||
124946759|NCT03692871|449432766|FG000|Overall Study|Lost to Follow-up|24|||
124946760|NCT03692871|449432767|FG001|Overall Study|Lost to Follow-up|9|||
124946761|NCT03692871|449432766|FG000|Overall Study|Physician Decision|22|||
124946762|NCT03692871|449432767|FG001|Overall Study|Physician Decision|7|||
124946763|NCT03692871|449432766|FG000|Overall Study|Protocol Deviation|1|||
124946764|NCT03692871|449432767|FG001|Overall Study|Protocol Deviation|0|||
124946765|NCT03692871|449432766|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
124946766|NCT03692871|449432767|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
124946767|NCT01316913|449432770|FG000|Overall Study|Adverse Event|17|||
124946768|NCT01316913|449432771|FG001|Overall Study|Adverse Event|20|||
124946769|NCT01316913|449432772|FG002|Overall Study|Adverse Event|15|||
124946770|NCT01316913|449432773|FG003|Overall Study|Adverse Event|11|||
124946771|NCT01316913|449432770|FG000|Overall Study|Lack of Efficacy|22|||
124946772|NCT01316913|449432771|FG001|Overall Study|Lack of Efficacy|12|||
124946773|NCT01316913|449432772|FG002|Overall Study|Lack of Efficacy|9|||
124946774|NCT01316913|449432773|FG003|Overall Study|Lack of Efficacy|13|||
124946775|NCT01316913|449432770|FG000|Overall Study|Protocol Violation|1|||
124946776|NCT01316913|449432771|FG001|Overall Study|Protocol Violation|4|||
124946777|NCT01316913|449432772|FG002|Overall Study|Protocol Violation|4|||
124946778|NCT01316913|449432773|FG003|Overall Study|Protocol Violation|1|||
124946779|NCT01316913|449432770|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
124946780|NCT01316913|449432771|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
124946781|NCT01316913|449432772|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
124946782|NCT01316913|449432773|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
124946783|NCT01316913|449432770|FG000|Overall Study|Lost to Follow-up|0|||
124946784|NCT01316913|449432771|FG001|Overall Study|Lost to Follow-up|1|||
124946785|NCT01316913|449432772|FG002|Overall Study|Lost to Follow-up|0|||
124946786|NCT01316913|449432773|FG003|Overall Study|Lost to Follow-up|2|||
124946787|NCT01316913|449432770|FG000|Overall Study|Withdrawal by Subject|10|||
124946788|NCT01316913|449432771|FG001|Overall Study|Withdrawal by Subject|9|||
124946789|NCT01316913|449432772|FG002|Overall Study|Withdrawal by Subject|10|||
124946790|NCT01316913|449432773|FG003|Overall Study|Withdrawal by Subject|6|||
124946791|NCT02691702|449432774|FG000|Overall Study|Adverse Event|1|||
124946792|NCT02691702|449432775|FG001|Overall Study|Adverse Event|0|||
124946793|NCT02691702|449432776|FG002|Overall Study|Adverse Event|0|||
124946794|NCT02691702|449432777|FG003|Overall Study|Adverse Event|0|||
124946795|NCT02691702|449432778|FG004|Overall Study|Adverse Event|0|||
124946796|NCT02691702|449432779|FG005|Overall Study|Adverse Event|0|||
125214544|NCT02020889|450412898|FG001|Overall Study|Lost to Follow-up|0|||
125214545|NCT02020889|450412897|FG000|Overall Study|Physician Decision|2|||
124946797|NCT02691702|449432780|FG006|Overall Study|Adverse Event|0|||
124946798|NCT02691702|449432781|FG007|Overall Study|Adverse Event|0|||
124946799|NCT02691702|449432782|FG008|Overall Study|Adverse Event|1|||
125029248|NCT00944034|449729292|FG010|Overall Study|Lost to Follow-up|1|||
124946800|NCT02691702|449432783|FG009|Overall Study|Adverse Event|0|||
124946801|NCT02691702|449432784|FG010|Overall Study|Adverse Event|1|||
124946802|NCT02691702|449432774|FG000|Overall Study|Lost to Follow-up|0|||
124946803|NCT02691702|449432775|FG001|Overall Study|Lost to Follow-up|0|||
124946804|NCT02691702|449432776|FG002|Overall Study|Lost to Follow-up|1|||
124946805|NCT02691702|449432777|FG003|Overall Study|Lost to Follow-up|0|||
124946806|NCT02691702|449432778|FG004|Overall Study|Lost to Follow-up|0|||
124946807|NCT02691702|449432779|FG005|Overall Study|Lost to Follow-up|2|||
124946808|NCT02691702|449432780|FG006|Overall Study|Lost to Follow-up|0|||
124946809|NCT02691702|449432781|FG007|Overall Study|Lost to Follow-up|0|||
124946810|NCT02691702|449432782|FG008|Overall Study|Lost to Follow-up|0|||
124946811|NCT02691702|449432783|FG009|Overall Study|Lost to Follow-up|0|||
124946812|NCT02691702|449432784|FG010|Overall Study|Lost to Follow-up|1|||
124946813|NCT02691702|449432774|FG000|Overall Study|Withdrawal by Subject|1|||
124946814|NCT02691702|449432775|FG001|Overall Study|Withdrawal by Subject|1|||
124946815|NCT02691702|449432776|FG002|Overall Study|Withdrawal by Subject|0|||
124946816|NCT02691702|449432777|FG003|Overall Study|Withdrawal by Subject|0|||
124946817|NCT02691702|449432778|FG004|Overall Study|Withdrawal by Subject|0|||
124946818|NCT02691702|449432779|FG005|Overall Study|Withdrawal by Subject|1|||
124946819|NCT02691702|449432780|FG006|Overall Study|Withdrawal by Subject|2|||
124946820|NCT02691702|449432781|FG007|Overall Study|Withdrawal by Subject|0|||
124946821|NCT02691702|449432782|FG008|Overall Study|Withdrawal by Subject|0|||
124946822|NCT02691702|449432783|FG009|Overall Study|Withdrawal by Subject|0|||
124946823|NCT02691702|449432784|FG010|Overall Study|Withdrawal by Subject|0|||
124946824|NCT02691702|449432774|FG000|Overall Study|Other|0|||
124946825|NCT02691702|449432775|FG001|Overall Study|Other|0|||
124946826|NCT02691702|449432776|FG002|Overall Study|Other|0|||
124946827|NCT02691702|449432777|FG003|Overall Study|Other|0|||
124946828|NCT02691702|449432778|FG004|Overall Study|Other|0|||
124946829|NCT02691702|449432779|FG005|Overall Study|Other|0|||
124946830|NCT02691702|449432780|FG006|Overall Study|Other|1|||
124946831|NCT02691702|449432781|FG007|Overall Study|Other|0|||
124946832|NCT02691702|449432782|FG008|Overall Study|Other|1|||
124946833|NCT02691702|449432783|FG009|Overall Study|Other|0|||
125123692|NCT02465567|450077379|FG002|Overall Study|Lack of Efficacy|171|||
125123693|NCT02465567|450077380|FG003|Overall Study|Lack of Efficacy|135|||
125123694|NCT02465567|450077377|FG000|Overall Study|Withdrawal by Subject|104|||
125123695|NCT02465567|450077378|FG001|Overall Study|Withdrawal by Subject|94|||
125123696|NCT02465567|450077379|FG002|Overall Study|Withdrawal by Subject|123|||
125123697|NCT02465567|450077380|FG003|Overall Study|Withdrawal by Subject|130|||
124946834|NCT02691702|449432784|FG010|Overall Study|Other|0|||
124946835|NCT02691702|449432774|FG000|Overall Study|Protocol Violation|0|||
124946836|NCT02691702|449432775|FG001|Overall Study|Protocol Violation|0|||
124946837|NCT02691702|449432776|FG002|Overall Study|Protocol Violation|0|||
124946838|NCT02691702|449432777|FG003|Overall Study|Protocol Violation|0|||
124946839|NCT02691702|449432778|FG004|Overall Study|Protocol Violation|0|||
124946840|NCT02691702|449432779|FG005|Overall Study|Protocol Violation|0|||
124946841|NCT02691702|449432780|FG006|Overall Study|Protocol Violation|0|||
124946842|NCT02691702|449432781|FG007|Overall Study|Protocol Violation|0|||
124946843|NCT02691702|449432782|FG008|Overall Study|Protocol Violation|0|||
124946844|NCT02691702|449432783|FG009|Overall Study|Protocol Violation|2|||
124946845|NCT02691702|449432784|FG010|Overall Study|Protocol Violation|0|||
124946846|NCT05169684|449432785|FG000|Overall Study|Adverse Event|1|||
124946847|NCT05169684|449432786|FG001|Overall Study|Adverse Event|3|||
124946848|NCT05169684|449432785|FG000|Overall Study|Physician Decision|0|||
124946849|NCT05169684|449432786|FG001|Overall Study|Physician Decision|1|||
124946850|NCT05169684|449432785|FG000|Overall Study|Progressive Disease|1|||
124946851|NCT05169684|449432786|FG001|Overall Study|Progressive Disease|1|||
124946852|NCT05169684|449432785|FG000|Overall Study|Participant request to discontinue treatment|0|||
124946853|NCT05169684|449432786|FG001|Overall Study|Participant request to discontinue treatment|1|||
124946854|NCT05169684|449432785|FG000|Overall Study|Other Reason|0|||
125123698|NCT02465567|450077377|FG000|Overall Study|Physician Decision|23|||
125123699|NCT02465567|450077378|FG001|Overall Study|Physician Decision|33|||
125123700|NCT02465567|450077379|FG002|Overall Study|Physician Decision|38|||
124946855|NCT05169684|449432786|FG001|Overall Study|Other Reason|1|||
124946856|NCT01668719|449432787|FG000|Phase I|On treatment|1|||
124946857|NCT01668719|449432788|FG001|Phase I|On treatment|0|||
124946858|NCT01668719|449432789|FG002|Phase I|On treatment|0|||
124946859|NCT01668719|449432787|FG000|Phase I|Adverse Event|2|||
124946860|NCT01668719|449432788|FG001|Phase I|Adverse Event|0|||
124946861|NCT01668719|449432789|FG002|Phase I|Adverse Event|0|||
124946862|NCT01668719|449432787|FG000|Phase I|Progression/relapse|1|||
124946863|NCT01668719|449432788|FG001|Phase I|Progression/relapse|0|||
124946864|NCT01668719|449432789|FG002|Phase I|Progression/relapse|0|||
125214546|NCT02020889|450412898|FG001|Overall Study|Physician Decision|0|||
124946865|NCT01668719|449432787|FG000|Phase I|not protocol specified|2|||
124946866|NCT01668719|449432788|FG001|Phase I|not protocol specified|0|||
124946867|NCT01668719|449432789|FG002|Phase I|not protocol specified|0|||
124946868|NCT01668719|449432787|FG000|Phase II|On treatment|0|||
124946869|NCT01668719|449432788|FG001|Phase II|On treatment|4|||
124946870|NCT01668719|449432789|FG002|Phase II|On treatment|3|||
125029249|NCT00944034|449729293|FG011|Overall Study|Lost to Follow-up|0|||
125029250|NCT00944034|449729282|FG000|Overall Study|Death|0|||
125029251|NCT00944034|449729283|FG001|Overall Study|Death|0|||
125029252|NCT00944034|449729284|FG002|Overall Study|Death|1|||
125029253|NCT00944034|449729285|FG003|Overall Study|Death|0|||
125029254|NCT00944034|449729286|FG004|Overall Study|Death|0|||
125029255|NCT00944034|449729287|FG005|Overall Study|Death|0|||
125029256|NCT00944034|449729288|FG006|Overall Study|Death|0|||
125029257|NCT00944034|449729289|FG007|Overall Study|Death|0|||
125029258|NCT00944034|449729290|FG008|Overall Study|Death|0|||
125029259|NCT00944034|449729291|FG009|Overall Study|Death|0|||
125029260|NCT00944034|449729292|FG010|Overall Study|Death|0|||
125029261|NCT00944034|449729293|FG011|Overall Study|Death|0|||
125029262|NCT00944034|449729282|FG000|Overall Study|Protocol Violation|2|||
125029263|NCT00944034|449729283|FG001|Overall Study|Protocol Violation|0|||
125029264|NCT00944034|449729284|FG002|Overall Study|Protocol Violation|0|||
125029265|NCT00944034|449729285|FG003|Overall Study|Protocol Violation|1|||
125029266|NCT00944034|449729286|FG004|Overall Study|Protocol Violation|2|||
125029267|NCT00944034|449729287|FG005|Overall Study|Protocol Violation|3|||
125029268|NCT00944034|449729288|FG006|Overall Study|Protocol Violation|0|||
125029269|NCT00944034|449729289|FG007|Overall Study|Protocol Violation|1|||
125029270|NCT00944034|449729290|FG008|Overall Study|Protocol Violation|1|||
125029271|NCT00944034|449729291|FG009|Overall Study|Protocol Violation|4|||
125029272|NCT00944034|449729292|FG010|Overall Study|Protocol Violation|0|||
125029273|NCT00944034|449729293|FG011|Overall Study|Protocol Violation|0|||
125029274|NCT00944034|449729282|FG000|Overall Study|Unable to classify|0|||
125029275|NCT00944034|449729283|FG001|Overall Study|Unable to classify|0|||
125029276|NCT00944034|449729284|FG002|Overall Study|Unable to classify|0|||
125029277|NCT00944034|449729285|FG003|Overall Study|Unable to classify|0|||
125029278|NCT00944034|449729286|FG004|Overall Study|Unable to classify|0|||
125123701|NCT02465567|450077380|FG003|Overall Study|Physician Decision|28|||
125123702|NCT02465567|450077377|FG000|Overall Study|Major Protocol Deviation|24|||
125123703|NCT02465567|450077378|FG001|Overall Study|Major Protocol Deviation|26|||
125123704|NCT02465567|450077379|FG002|Overall Study|Major Protocol Deviation|22|||
125123705|NCT02465567|450077380|FG003|Overall Study|Major Protocol Deviation|25|||
125123706|NCT02465567|450077377|FG000|Overall Study|Lost to Follow-up|25|||
125123707|NCT02465567|450077378|FG001|Overall Study|Lost to Follow-up|21|||
125029279|NCT00944034|449729287|FG005|Overall Study|Unable to classify|1|||
125029280|NCT00944034|449729288|FG006|Overall Study|Unable to classify|1|||
125029281|NCT00944034|449729289|FG007|Overall Study|Unable to classify|1|||
125123708|NCT02465567|450077379|FG002|Overall Study|Lost to Follow-up|19|||
125123709|NCT02465567|450077380|FG003|Overall Study|Lost to Follow-up|15|||
125123710|NCT02465567|450077377|FG000|Overall Study|Protocol Specified Criteria|20|||
125123711|NCT02465567|450077378|FG001|Overall Study|Protocol Specified Criteria|10|||
125123712|NCT02465567|450077379|FG002|Overall Study|Protocol Specified Criteria|9|||
125123713|NCT02465567|450077380|FG003|Overall Study|Protocol Specified Criteria|12|||
125123714|NCT02465567|450077377|FG000|Overall Study|Administrative Reasons|12|||
125123715|NCT02465567|450077378|FG001|Overall Study|Administrative Reasons|9|||
125123716|NCT02465567|450077379|FG002|Overall Study|Administrative Reasons|11|||
125123717|NCT02465567|450077380|FG003|Overall Study|Administrative Reasons|5|||
125123718|NCT02465567|450077377|FG000|Overall Study|Randomized but not treated|1|||
125123719|NCT02465567|450077378|FG001|Overall Study|Randomized but not treated|5|||
125123720|NCT02465567|450077379|FG002|Overall Study|Randomized but not treated|4|||
125123721|NCT02465567|450077380|FG003|Overall Study|Randomized but not treated|5|||
125123722|NCT02465567|450077377|FG000|Overall Study|enrolled in >1 studies|18|||
125123723|NCT02465567|450077378|FG001|Overall Study|enrolled in >1 studies|11|||
125123724|NCT02465567|450077379|FG002|Overall Study|enrolled in >1 studies|19|||
125123725|NCT02465567|450077380|FG003|Overall Study|enrolled in >1 studies|15|||
125123726|NCT02465567|450077377|FG000|Overall Study|missing PI Signature|1|||
125123727|NCT02465567|450077378|FG001|Overall Study|missing PI Signature|0|||
125123728|NCT02465567|450077379|FG002|Overall Study|missing PI Signature|0|||
125123729|NCT02465567|450077380|FG003|Overall Study|missing PI Signature|0|||
125123730|NCT01074554|450077383|FG000|Overall Study|Adverse Event|3|||
125123731|NCT01074554|450077384|FG001|Overall Study|Adverse Event|3|||
125123732|NCT01074554|450077383|FG000|Overall Study|Lost to Follow-up|0|||
125123733|NCT01074554|450077384|FG001|Overall Study|Lost to Follow-up|1|||
125029282|NCT00944034|449729290|FG008|Overall Study|Unable to classify|0|||
125029283|NCT00944034|449729291|FG009|Overall Study|Unable to classify|0|||
125029284|NCT00944034|449729292|FG010|Overall Study|Unable to classify|0|||
125029285|NCT00944034|449729293|FG011|Overall Study|Unable to classify|0|||
125029286|NCT00944034|449729282|FG000|Overall Study|Administrative reason|0|||
125123734|NCT00497796|450077385|FG000|Overall Study|Adverse event (not related)|9|||
124946871|NCT01668719|449432787|FG000|Phase II|Adverse Event|0|||
124946872|NCT01668719|449432788|FG001|Phase II|Adverse Event|18|||
124946873|NCT01668719|449432789|FG002|Phase II|Adverse Event|18|||
124946874|NCT01668719|449432787|FG000|Phase II|Refusal unrelated to adverse event|0|||
124946875|NCT01668719|449432788|FG001|Phase II|Refusal unrelated to adverse event|4|||
124946876|NCT01668719|449432789|FG002|Phase II|Refusal unrelated to adverse event|1|||
124946877|NCT01668719|449432787|FG000|Phase II|Progression/relapse|0|||
124946878|NCT01668719|449432788|FG001|Phase II|Progression/relapse|13|||
124946879|NCT01668719|449432789|FG002|Phase II|Progression/relapse|17|||
124946880|NCT01668719|449432787|FG000|Phase II|Death|0|||
124946881|NCT01668719|449432788|FG001|Phase II|Death|0|||
124946882|NCT01668719|449432789|FG002|Phase II|Death|2|||
124946883|NCT01668719|449432787|FG000|Phase II|not protocol specified|0|||
124946884|NCT01668719|449432788|FG001|Phase II|not protocol specified|13|||
124946885|NCT01668719|449432789|FG002|Phase II|not protocol specified|7|||
124946886|NCT03539055|449432790|FG000|Overall Study|Death|4|||
124946887|NCT03539055|449432790|FG000|Overall Study|Lost to Follow-up|1|||
124946888|NCT03539055|449432790|FG000|Overall Study|Withdrawal by Subject|2|||
124946889|NCT03539055|449432790|FG000|Overall Study|Screen Fail|7|||
124946890|NCT03539055|449432790|FG000|Overall Study|Drug Intolerance|2|||
124946891|NCT02060487|449432791|FG000|Overall Study|Other|1|||
124946892|NCT02060487|449432792|FG001|Overall Study|Other|2|||
124946893|NCT02060487|449432793|FG002|Overall Study|Other|1|||
124946894|NCT02060487|449432791|FG000|Overall Study|Lack of Efficacy|0|||
124946895|NCT02060487|449432792|FG001|Overall Study|Lack of Efficacy|1|||
124946896|NCT02060487|449432793|FG002|Overall Study|Lack of Efficacy|0|||
124946897|NCT02060487|449432791|FG000|Overall Study|Withdrawal by Subject|3|||
124946898|NCT02060487|449432792|FG001|Overall Study|Withdrawal by Subject|10|||
124946899|NCT02060487|449432793|FG002|Overall Study|Withdrawal by Subject|4|||
124946900|NCT02060487|449432791|FG000|Overall Study|Study Terminated By Sponsor|87|||
124946901|NCT02060487|449432792|FG001|Overall Study|Study Terminated By Sponsor|89|||
124946902|NCT02060487|449432793|FG002|Overall Study|Study Terminated By Sponsor|100|||
124946903|NCT02060487|449432791|FG000|Overall Study|Randomized in error|1|||
124946904|NCT02060487|449432792|FG001|Overall Study|Randomized in error|0|||
124946905|NCT02060487|449432793|FG002|Overall Study|Randomized in error|0|||
124946906|NCT02060487|449432791|FG000|Overall Study|Protocol Violation|0|||
124946907|NCT02060487|449432792|FG001|Overall Study|Protocol Violation|1|||
124946908|NCT02060487|449432793|FG002|Overall Study|Protocol Violation|1|||
124946909|NCT02060487|449432791|FG000|Overall Study|Lost to Follow-up|3|||
124946910|NCT02060487|449432792|FG001|Overall Study|Lost to Follow-up|0|||
124946911|NCT02060487|449432793|FG002|Overall Study|Lost to Follow-up|2|||
124946912|NCT02060487|449432791|FG000|Overall Study|Death|34|||
124946913|NCT02060487|449432792|FG001|Overall Study|Death|25|||
124946914|NCT02060487|449432793|FG002|Overall Study|Death|19|||
125029287|NCT00944034|449729283|FG001|Overall Study|Administrative reason|0|||
124946915|NCT02060487|449432791|FG000|Overall Study|Adverse Event|0|||
124946916|NCT02060487|449432792|FG001|Overall Study|Adverse Event|0|||
124946917|NCT02060487|449432793|FG002|Overall Study|Adverse Event|1|||
124946918|NCT05484661|449432794|FG000|Overall Study|Withdrawal by Subject|1|||
125029288|NCT00944034|449729284|FG002|Overall Study|Administrative reason|0|||
125029289|NCT00944034|449729285|FG003|Overall Study|Administrative reason|0|||
125029290|NCT00944034|449729286|FG004|Overall Study|Administrative reason|0|||
125029291|NCT00944034|449729287|FG005|Overall Study|Administrative reason|0|||
125029292|NCT00944034|449729288|FG006|Overall Study|Administrative reason|1|||
125029293|NCT00944034|449729289|FG007|Overall Study|Administrative reason|0|||
125029294|NCT00944034|449729290|FG008|Overall Study|Administrative reason|0|||
125029295|NCT00944034|449729291|FG009|Overall Study|Administrative reason|0|||
125029296|NCT00944034|449729292|FG010|Overall Study|Administrative reason|0|||
125029297|NCT00944034|449729293|FG011|Overall Study|Administrative reason|0|||
125029298|NCT00531960|449729294|FG000|Overall Study|Adverse Event|5|||
125029299|NCT00531960|449729295|FG001|Overall Study|Adverse Event|4|||
125029300|NCT00531960|449729294|FG000|Overall Study|Death|3|||
125029301|NCT00531960|449729295|FG001|Overall Study|Death|2|||
125029302|NCT00531960|449729294|FG000|Overall Study|Lack of Efficacy|42|||
125029303|NCT00531960|449729295|FG001|Overall Study|Lack of Efficacy|41|||
125029304|NCT00531960|449729294|FG000|Overall Study|Violation of Selection Criteria|2|||
125029305|NCT00531960|449729295|FG001|Overall Study|Violation of Selection Criteria|0|||
125029306|NCT00531960|449729294|FG000|Overall Study|Refused Treatment|5|||
125029307|NCT00531960|449729295|FG001|Overall Study|Refused Treatment|6|||
125029308|NCT00531960|449729294|FG000|Overall Study|Other|4|||
125029309|NCT00531960|449729295|FG001|Overall Study|Other|10|||
124946919|NCT05484661|449432795|FG001|Overall Study|Withdrawal by Subject|0|||
124946920|NCT01856569|449432796|FG000|Overall Study|Other|1|||
124946921|NCT01856569|449432796|FG000|Overall Study|Changed Site/Structure|1|||
124946922|NCT01856569|449432796|FG000|Overall Study|Lost to Follow-up|3|||
124946923|NCT01856569|449432796|FG000|Overall Study|Did not met inclusion criteria|8|||
124946924|NCT01860079|449432797|FG000|Overall Study|Physician Decision|14|||
124946925|NCT01860079|449432798|FG001|Overall Study|Physician Decision|22|||
124946926|NCT02950961|449432806|FG000|Overall Study|Study had to stop due to COVID.|7|||
124946927|NCT02241785|449432807|FG000|Overall Study|Sponsor Termination|43|||
124946928|NCT02241785|449432807|FG000|Overall Study|Withdrawal by Subject|1|||
124946929|NCT02241785|449432807|FG000|Overall Study|Lost to Follow-up|2|||
124946930|NCT02241785|449432807|FG000|Overall Study|Adverse Event|1|||
124946931|NCT03055988|449432810|FG000|Period 1|Adverse Event|0|||
124946932|NCT03055988|449432811|FG001|Period 1|Adverse Event|1|||
124946933|NCT03055988|449432810|FG000|Period 1|Lost to Follow-up|1|||
124946934|NCT03055988|449432811|FG001|Period 1|Lost to Follow-up|0|||
124946935|NCT03055988|449432810|FG000|Period 1|Withdrawal by Subject|0|||
124946936|NCT03055988|449432811|FG001|Period 1|Withdrawal by Subject|4|||
124946937|NCT03055988|449432810|FG000|Period 2|Adverse Event|0|||
124946938|NCT03055988|449432811|FG001|Period 2|Adverse Event|1|||
124946939|NCT03055988|449432810|FG000|Period 2|Other than listed|1|||
125214547|NCT02020889|450412897|FG000|Overall Study|Withdrawal by Subject|3|||
125214548|NCT02020889|450412898|FG001|Overall Study|Withdrawal by Subject|2|||
125214549|NCT04217317|450412902|FG000|Overall Study|Lack of Efficacy|4|||
125214550|NCT04217317|450412902|FG000|Overall Study|Physician Decision|1|||
125214551|NCT01690299|450412903|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
125214552|NCT01690299|450412904|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
125214553|NCT01690299|450412905|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
125214554|NCT01690299|450412906|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
125214555|NCT01690299|450412907|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
125214556|NCT01690299|450412908|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
125214557|NCT01690299|450412903|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
125214558|NCT01690299|450412904|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125214559|NCT01690299|450412905|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125214560|NCT01690299|450412906|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125214561|NCT01690299|450412907|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125214562|NCT01690299|450412908|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125214563|NCT01690299|450412903|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
125214564|NCT01690299|450412904|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
125214565|NCT01690299|450412905|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125214566|NCT01690299|450412906|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125214567|NCT01690299|450412907|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125214568|NCT01690299|450412908|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125214569|NCT01690299|450412903|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
125214570|NCT01690299|450412904|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
125214571|NCT01690299|450412905|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
125214572|NCT01690299|450412906|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
125214573|NCT01690299|450412907|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
125214574|NCT01690299|450412908|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
125214575|NCT01690299|450412903|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
125214576|NCT01690299|450412904|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
125214577|NCT01690299|450412905|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
125214578|NCT01690299|450412906|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
125214579|NCT01690299|450412907|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
125214580|NCT01690299|450412908|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
125214581|NCT01690299|450412903|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
125214582|NCT01690299|450412904|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
125214583|NCT01690299|450412905|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
125214584|NCT01690299|450412906|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
125214585|NCT01690299|450412907|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
125214586|NCT01690299|450412908|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
125214587|NCT01690299|450412903|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
125214588|NCT01690299|450412904|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
125214589|NCT01690299|450412905|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
124946940|NCT03055988|449432811|FG001|Period 2|Other than listed|1|||
124946941|NCT00845520|449432812|FG000|Overall Study|Death|1|||
124946942|NCT00845520|449432813|FG001|Overall Study|Death|2|||
124946943|NCT00845520|449432814|FG002|Overall Study|Death|0|||
124946944|NCT00845520|449432812|FG000|Overall Study|Lost to Follow-up|1|||
124946945|NCT00845520|449432813|FG001|Overall Study|Lost to Follow-up|0|||
124946946|NCT00845520|449432814|FG002|Overall Study|Lost to Follow-up|0|||
124946947|NCT00845520|449432812|FG000|Overall Study|Adverse Event|0|||
124946948|NCT00845520|449432813|FG001|Overall Study|Adverse Event|0|||
124946949|NCT00845520|449432814|FG002|Overall Study|Adverse Event|1|||
124946950|NCT01736475|449432815|FG000|Overall Study|Adverse Event|4|||
124946951|NCT01736475|449432816|FG001|Overall Study|Adverse Event|0|||
124946952|NCT01736475|449432815|FG000|Overall Study|Withdrawal by Subject|2|||
124946953|NCT01736475|449432816|FG001|Overall Study|Withdrawal by Subject|0|||
124946954|NCT01736475|449432815|FG000|Overall Study|Protocol Violation|4|||
124946955|NCT01736475|449432816|FG001|Overall Study|Protocol Violation|0|||
124946956|NCT01736475|449432815|FG000|Overall Study|Other - Screen failure|1|||
124946957|NCT01736475|449432816|FG001|Overall Study|Other - Screen failure|0|||
124946958|NCT01736475|449432815|FG000|Overall Study|Other - Surgical procedure|1|||
124946959|NCT01736475|449432816|FG001|Overall Study|Other - Surgical procedure|0|||
124946960|NCT02807857|449432817|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
124946961|NCT02807857|449432817|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
124946962|NCT02807857|449432817|FG000|Follow-Up Set|Withdrawal by Subject|8|||
124946963|NCT02807857|449432817|FG000|Follow-Up Set|Lost to Follow-up|7|||
124946964|NCT02807857|449432817|FG000|Follow-Up Set|Physician Decision|6|||
124946965|NCT02807857|449432817|FG000|Follow-Up Set|Adverse Event|3|||
124946966|NCT02807857|449432817|FG000|Follow-Up Set|Death|27|||
124946967|NCT02807857|449432817|FG000|Follow-Up Set|Relocation|2|||
124946968|NCT03905642|449432821|FG000|Overall Study|Withdrawal by Subject|3|||
124946969|NCT03905642|449432821|FG000|Overall Study|Pregnancy|1|||
124946970|NCT03905642|449432821|FG000|Overall Study|Adverse Event|1|||
124946971|NCT03905642|449432821|FG000|Overall Study|Lack of Efficacy|1|||
124946972|NCT03905642|449432821|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
124946973|NCT00443820|449434251|FG000|Overall Study|Adverse Event|1|||
124946974|NCT00443820|449434252|FG001|Overall Study|Adverse Event|1|||
124946975|NCT00443820|449434253|FG002|Overall Study|Adverse Event|0|||
124946976|NCT00443820|449434254|FG003|Overall Study|Adverse Event|0|||
124946977|NCT00443820|449434251|FG000|Overall Study|Lack of Efficacy|3|||
124946978|NCT00443820|449434252|FG001|Overall Study|Lack of Efficacy|2|||
124946979|NCT00443820|449434253|FG002|Overall Study|Lack of Efficacy|1|||
124946980|NCT00443820|449434254|FG003|Overall Study|Lack of Efficacy|1|||
124946981|NCT00443820|449434251|FG000|Overall Study|Protocol Violation|2|||
124946982|NCT00443820|449434252|FG001|Overall Study|Protocol Violation|1|||
124946983|NCT00443820|449434253|FG002|Overall Study|Protocol Violation|2|||
124946984|NCT00443820|449434254|FG003|Overall Study|Protocol Violation|1|||
124946985|NCT00443820|449434251|FG000|Overall Study|Withdrawal by Subject|6|||
124946986|NCT00443820|449434252|FG001|Overall Study|Withdrawal by Subject|7|||
124946987|NCT00443820|449434253|FG002|Overall Study|Withdrawal by Subject|8|||
124946988|NCT00443820|449434254|FG003|Overall Study|Withdrawal by Subject|9|||
124946989|NCT00443820|449434251|FG000|Overall Study|Lost to Follow-up|9|||
124946990|NCT00443820|449434252|FG001|Overall Study|Lost to Follow-up|8|||
124946991|NCT00443820|449434253|FG002|Overall Study|Lost to Follow-up|6|||
124946992|NCT00443820|449434254|FG003|Overall Study|Lost to Follow-up|5|||
124946993|NCT00443820|449434251|FG000|Overall Study|Administrative problems|0|||
124946994|NCT00443820|449434252|FG001|Overall Study|Administrative problems|0|||
124946995|NCT00443820|449434253|FG002|Overall Study|Administrative problems|0|||
124946996|NCT00443820|449434254|FG003|Overall Study|Administrative problems|1|||
124946997|NCT00443820|449434251|FG000|Overall Study|Death|0|||
124946998|NCT00443820|449434252|FG001|Overall Study|Death|0|||
124946999|NCT00443820|449434253|FG002|Overall Study|Death|1|||
124947000|NCT00443820|449434254|FG003|Overall Study|Death|0|||
124947001|NCT04633200|449434255|FG000|Overall Study|Lost to Follow-up|3|||
124947002|NCT04633200|449434256|FG001|Overall Study|Lost to Follow-up|5|||
124947003|NCT02713594|449434257|FG000|Overall Study|Withdrawal by Subject|32|||
124947004|NCT02713594|449434258|FG001|Overall Study|Withdrawal by Subject|22|||
124947005|NCT02713594|449434257|FG000|Overall Study|Lost to Follow-up|358|||
124947006|NCT02713594|449434258|FG001|Overall Study|Lost to Follow-up|374|||
124947007|NCT00670449|449434259|FG000|Overall Study|Adverse Event|6|||
124947008|NCT00670449|449434260|FG001|Overall Study|Adverse Event|2|||
124947009|NCT00670449|449434261|FG002|Overall Study|Adverse Event|8|||
124947010|NCT00670449|449434262|FG003|Overall Study|Adverse Event|5|||
124947011|NCT00670449|449434259|FG000|Overall Study|Protocol Deviation|1|||
124947012|NCT00670449|449434260|FG001|Overall Study|Protocol Deviation|2|||
124947013|NCT00670449|449434261|FG002|Overall Study|Protocol Deviation|0|||
124947014|NCT00670449|449434262|FG003|Overall Study|Protocol Deviation|1|||
124947015|NCT00670449|449434259|FG000|Overall Study|Administrative Problems|0|||
124947016|NCT00670449|449434260|FG001|Overall Study|Administrative Problems|2|||
124947017|NCT00670449|449434261|FG002|Overall Study|Administrative Problems|0|||
124947018|NCT00670449|449434262|FG003|Overall Study|Administrative Problems|1|||
124947019|NCT00670449|449434259|FG000|Overall Study|Subject Withdrew Consent|0|||
124947020|NCT00670449|449434260|FG001|Overall Study|Subject Withdrew Consent|2|||
124947021|NCT00670449|449434261|FG002|Overall Study|Subject Withdrew Consent|0|||
124947022|NCT00670449|449434262|FG003|Overall Study|Subject Withdrew Consent|1|||
124947023|NCT00670449|449434259|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
124947024|NCT00670449|449434260|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124947025|NCT00670449|449434261|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
124947026|NCT00670449|449434262|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124947027|NCT00670449|449434259|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
124947028|NCT00670449|449434260|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
124947029|NCT00670449|449434261|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
124947030|NCT00670449|449434262|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
124947031|NCT02771366|449434263|FG000|Period 1|Withdrawal by Subject|0|||
124947032|NCT02771366|449434264|FG001|Period 1|Withdrawal by Subject|2|||
124947033|NCT02771366|449434263|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
124947034|NCT02771366|449434264|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
124947035|NCT00671853|449434265|FG000|Overall Study|Lack of Efficacy|3|||
124947036|NCT00671853|449434266|FG001|Overall Study|Lack of Efficacy|7|||
124947037|NCT00671853|449434265|FG000|Overall Study|Adverse Event|7|||
124947038|NCT00671853|449434266|FG001|Overall Study|Adverse Event|1|||
124947039|NCT00671853|449434265|FG000|Overall Study|Withdrawal by Subject|1|||
124947040|NCT00671853|449434266|FG001|Overall Study|Withdrawal by Subject|5|||
125123735|NCT00497796|450077386|FG001|Overall Study|Adverse event (not related)|9|||
125123736|NCT00497796|450077385|FG000|Overall Study|Adverse event (related)|5|||
125123737|NCT00497796|450077386|FG001|Overall Study|Adverse event (related)|4|||
125123738|NCT00497796|450077385|FG000|Overall Study|CMV infection or disease treatment|30|||
125123739|NCT00497796|450077386|FG001|Overall Study|CMV infection or disease treatment|4|||
125123740|NCT00497796|450077385|FG000|Overall Study|Consent withdrawn|10|||
125123741|NCT00497796|450077386|FG001|Overall Study|Consent withdrawn|3|||
125123742|NCT00497796|450077385|FG000|Overall Study|Investigator/sponsor discretion|31|||
125123743|NCT00497796|450077386|FG001|Overall Study|Investigator/sponsor discretion|34|||
125123744|NCT00497796|450077385|FG000|Overall Study|Lost to Follow-up|0|||
125123745|NCT00497796|450077386|FG001|Overall Study|Lost to Follow-up|1|||
125123746|NCT00497796|450077385|FG000|Overall Study|Not applicable (randomized not treated)|0|||
125123747|NCT00497796|450077386|FG001|Overall Study|Not applicable (randomized not treated)|4|||
125123748|NCT04276883|450077389|FG000|Overall Study|Withdrawal by Subject|2|||
125123749|NCT04276883|450077390|FG001|Overall Study|Withdrawal by Subject|3|||
125123750|NCT04276883|450077391|FG002|Overall Study|Withdrawal by Subject|6|||
125123751|NCT04276883|450077389|FG000|Overall Study|Lost to Follow-up|1|||
125123752|NCT04276883|450077390|FG001|Overall Study|Lost to Follow-up|3|||
125123753|NCT04276883|450077391|FG002|Overall Study|Lost to Follow-up|0|||
125123754|NCT04276883|450077389|FG000|Overall Study|Adverse Event|0|||
125123755|NCT04276883|450077390|FG001|Overall Study|Adverse Event|1|||
125123756|NCT04276883|450077391|FG002|Overall Study|Adverse Event|0|||
124947041|NCT00671853|449434265|FG000|Overall Study|Lost to Follow-up|8|||
124947042|NCT00671853|449434266|FG001|Overall Study|Lost to Follow-up|8|||
124947043|NCT00671853|449434265|FG000|Overall Study|Physician Decision|0|||
124947044|NCT00671853|449434266|FG001|Overall Study|Physician Decision|2|||
124947045|NCT00671853|449434265|FG000|Overall Study|Non-adherence with study procedures|1|||
124947046|NCT00671853|449434266|FG001|Overall Study|Non-adherence with study procedures|4|||
124947047|NCT00587171|449434268|FG000|Overall Study|Lost to Follow-up|1|||
124947048|NCT00587171|449434269|FG001|Overall Study|Lost to Follow-up|1|||
124947049|NCT01848483|449434270|FG000|Overall Study|Death|2|||
124947050|NCT01848483|449434271|FG001|Overall Study|Death|1|||
124947051|NCT01848483|449434270|FG000|Overall Study|Lost to Follow-up|6|||
124947052|NCT01848483|449434271|FG001|Overall Study|Lost to Follow-up|8|||
124947053|NCT01848483|449434270|FG000|Overall Study|Withdrawal by Subject|1|||
124947054|NCT01848483|449434271|FG001|Overall Study|Withdrawal by Subject|0|||
124947055|NCT01848483|449434270|FG000|Overall Study|Incarceration|2|||
124947056|NCT01848483|449434271|FG001|Overall Study|Incarceration|2|||
124947057|NCT01148017|449434272|FG000|Overall Study|Withdrawal by Subject|31|||
124947058|NCT01148017|449434273|FG001|Overall Study|Withdrawal by Subject|14|||
124947059|NCT01148017|449434274|FG002|Overall Study|Withdrawal by Subject|0|||
124947060|NCT01148017|449434275|FG003|Overall Study|Withdrawal by Subject|0|||
124947061|NCT01148017|449434272|FG000|Overall Study|Lost to Follow-up|23|||
124947062|NCT01148017|449434273|FG001|Overall Study|Lost to Follow-up|10|||
124947063|NCT01148017|449434274|FG002|Overall Study|Lost to Follow-up|0|||
124947064|NCT01148017|449434275|FG003|Overall Study|Lost to Follow-up|0|||
124947065|NCT01148017|449434272|FG000|Overall Study|Inappropriate enrollment|1|||
124947066|NCT01148017|449434273|FG001|Overall Study|Inappropriate enrollment|0|||
124947067|NCT01148017|449434274|FG002|Overall Study|Inappropriate enrollment|0|||
124947068|NCT01148017|449434275|FG003|Overall Study|Inappropriate enrollment|0|||
124947069|NCT01148017|449434272|FG000|Overall Study|Administrative reason|22|||
124947070|NCT01148017|449434273|FG001|Overall Study|Administrative reason|9|||
124947071|NCT01148017|449434274|FG002|Overall Study|Administrative reason|0|||
124947072|NCT01148017|449434275|FG003|Overall Study|Administrative reason|0|||
124947073|NCT01148017|449434272|FG000|Overall Study|Unable to classify|3|||
124947074|NCT01148017|449434273|FG001|Overall Study|Unable to classify|1|||
124947075|NCT01148017|449434274|FG002|Overall Study|Unable to classify|0|||
124947076|NCT01148017|449434275|FG003|Overall Study|Unable to classify|0|||
125123757|NCT04276883|450077389|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
125123758|NCT04276883|450077390|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
125123759|NCT04276883|450077391|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
125123760|NCT01876706|450077392|FG000|Overall Study|BPH Intervention|9|||
125123761|NCT01876706|450077392|FG000|Overall Study|Lost to Follow-up|7|||
125123762|NCT01876706|450077392|FG000|Overall Study|Withdrawals|6|||
125123763|NCT01876706|450077392|FG000|Overall Study|Death|3|||
124947077|NCT03928743|449434276|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
124969598|NCT03520075|449517416|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124947078|NCT03928743|449434277|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
124947079|NCT03928743|449434278|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
124947080|NCT03928743|449434276|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
124947081|NCT03928743|449434277|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
124947082|NCT03928743|449434278|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
125214590|NCT01690299|450412906|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
125214591|NCT01690299|450412907|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
125214592|NCT01690299|450412908|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
125214593|NCT01690299|450412903|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
125214594|NCT01690299|450412904|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
125214595|NCT01690299|450412905|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
125214596|NCT01690299|450412906|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
125214597|NCT01690299|450412907|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
125214598|NCT01690299|450412908|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
125214599|NCT01690299|450412903|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
125214600|NCT01690299|450412904|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
125214601|NCT01690299|450412905|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
125214602|NCT01690299|450412906|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
125214603|NCT01690299|450412907|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
125214604|NCT01690299|450412908|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
125214605|NCT01690299|450412903|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
125214606|NCT01690299|450412904|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
125214607|NCT01690299|450412905|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
125214608|NCT01690299|450412906|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
124947083|NCT03928743|449434276|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
124947084|NCT03928743|449434277|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
125214609|NCT01690299|450412907|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
125214610|NCT01690299|450412908|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
125214611|NCT04313400|450412909|FG000|Overall Study|Withdrawal by Subject|0|||
125214612|NCT04313400|450412910|FG001|Overall Study|Withdrawal by Subject|0|||
125214613|NCT04313400|450412911|FG002|Overall Study|Withdrawal by Subject|0|||
125214614|NCT04313400|450412912|FG003|Overall Study|Withdrawal by Subject|0|||
125214615|NCT04313400|450412913|FG004|Overall Study|Withdrawal by Subject|0|||
125214616|NCT04313400|450412914|FG005|Overall Study|Withdrawal by Subject|4|||
125214617|NCT04313400|450412915|FG006|Overall Study|Withdrawal by Subject|1|||
125214618|NCT04313400|450412909|FG000|Overall Study|Adverse Event|0|||
125214619|NCT04313400|450412910|FG001|Overall Study|Adverse Event|0|||
125214620|NCT04313400|450412911|FG002|Overall Study|Adverse Event|0|||
125214621|NCT04313400|450412912|FG003|Overall Study|Adverse Event|0|||
125214622|NCT04313400|450412913|FG004|Overall Study|Adverse Event|0|||
125214623|NCT04313400|450412914|FG005|Overall Study|Adverse Event|1|||
125214624|NCT04313400|450412915|FG006|Overall Study|Adverse Event|0|||
125214625|NCT04313400|450412909|FG000|Overall Study|Lost to Follow-up|0|||
125214626|NCT04313400|450412910|FG001|Overall Study|Lost to Follow-up|0|||
125214627|NCT04313400|450412911|FG002|Overall Study|Lost to Follow-up|0|||
125214628|NCT04313400|450412912|FG003|Overall Study|Lost to Follow-up|0|||
125214629|NCT04313400|450412913|FG004|Overall Study|Lost to Follow-up|0|||
125214630|NCT04313400|450412914|FG005|Overall Study|Lost to Follow-up|1|||
125214631|NCT04313400|450412915|FG006|Overall Study|Lost to Follow-up|0|||
125214632|NCT00496587|450412920|FG000|Overall Study|Adverse Event|2|||
125214633|NCT00496587|450412920|FG000|Overall Study|Progressive Disease|24|||
125214634|NCT00496587|450412920|FG000|Overall Study|Withdrawal by Subject|2|||
125214635|NCT00496587|450412920|FG000|Overall Study|Death|1|||
125214636|NCT00496587|450412920|FG000|Overall Study|Complications unrelated|2|||
125214637|NCT02383355|450412922|FG000|Overall Study|Adverse Event|2|||
125214638|NCT02383355|450412923|FG001|Overall Study|Adverse Event|0|||
125214639|NCT01146561|450412924|FG000|Overall Study|Withdrawal by Subject|1|||
125214640|NCT01146561|450412924|FG000|Overall Study|Lost to Follow-up|1|||
125214641|NCT01778751|450412926|FG000|Overall Study|Lost to Follow-up|1|||
125214642|NCT01778751|450412927|FG001|Overall Study|Lost to Follow-up|0|||
125214643|NCT01778751|450412926|FG000|Overall Study|Withdrawal by Subject|0|||
124947085|NCT03928743|449434278|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
124947086|NCT03928743|449434276|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
124947087|NCT03928743|449434277|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
124947088|NCT03928743|449434278|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
125214644|NCT01778751|450412927|FG001|Overall Study|Withdrawal by Subject|2|||
125214645|NCT01778751|450412926|FG000|Overall Study|Transfered care|1|||
125214646|NCT01778751|450412927|FG001|Overall Study|Transfered care|0|||
125214647|NCT03628716|450412929|FG000|Overall Study|Adverse Event|1|||
125214648|NCT03628716|450412930|FG001|Overall Study|Adverse Event|1|||
124947089|NCT03928743|449434276|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
124947090|NCT03928743|449434277|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
124947091|NCT03928743|449434278|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
124947092|NCT03928743|449434276|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
124947093|NCT03928743|449434277|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
124947094|NCT03928743|449434278|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
124947095|NCT03928743|449434276|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
124947096|NCT03928743|449434277|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
124947097|NCT03928743|449434278|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
124947098|NCT03928743|449434276|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
124947099|NCT03928743|449434277|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
124947100|NCT03928743|449434278|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
124947101|NCT03928743|449434276|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
124947102|NCT03928743|449434277|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
124947103|NCT03928743|449434278|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
124947104|NCT03928743|449434276|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
124947105|NCT03928743|449434277|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
124947106|NCT03928743|449434278|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
124947107|NCT03928743|449434276|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
124947108|NCT03928743|449434277|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
124947109|NCT03928743|449434278|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
124947110|NCT01128959|449434279|FG000|Lead in Period|Adverse Event|3|||
124947111|NCT01128959|449434279|FG000|Treatment Period|Adverse Event|3|||
124947112|NCT01128959|449434279|FG000|Treatment Period|Withdrawal by Subject|1|||
124947113|NCT02338999|449434280|FG000|First Intervention|Withdrawal by Subject|3|||
124947114|NCT02338999|449434281|FG001|First Intervention|Withdrawal by Subject|1|||
124947115|NCT02338999|449434280|FG000|Washout Period|Withdrawal by Subject|0|||
124947116|NCT02338999|449434281|FG001|Washout Period|Withdrawal by Subject|2|||
124947117|NCT02338999|449434280|FG000|Second Intervention|Withdrawal by Subject|0|||
124947118|NCT02338999|449434281|FG001|Second Intervention|Withdrawal by Subject|2|||
124947119|NCT02958553|449434282|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
124947120|NCT02958553|449434282|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
124947121|NCT00308308|449434283|FG000|Overall Study|Adverse Event|17|||
124947122|NCT00308308|449434284|FG001|Overall Study|Adverse Event|2|||
124947123|NCT00308308|449434283|FG000|Overall Study|Lost to Follow-up|5|||
124947124|NCT00308308|449434284|FG001|Overall Study|Lost to Follow-up|5|||
124947125|NCT00308308|449434283|FG000|Overall Study|Physician Decision|15|||
124947126|NCT00308308|449434284|FG001|Overall Study|Physician Decision|7|||
124947127|NCT00308308|449434283|FG000|Overall Study|Protocol Violation|3|||
124947128|NCT00308308|449434284|FG001|Overall Study|Protocol Violation|14|||
124947129|NCT00308308|449434283|FG000|Overall Study|Withdrawal by Subject|47|||
124947130|NCT00308308|449434284|FG001|Overall Study|Withdrawal by Subject|19|||
125123764|NCT01370408|450077397|FG000|Overall Study|treatment failure|9|||
125123765|NCT02073643|450077399|FG000|Overall Study|Lost to Follow-up|24|||
125123766|NCT02780687|450077402|FG000|Overall Study|Adverse Event|1|||
125123767|NCT02780687|450077403|FG001|Overall Study|Adverse Event|1|||
125123768|NCT02780687|450077402|FG000|Overall Study|Withdrawal by Subject|2|||
125123769|NCT02780687|450077403|FG001|Overall Study|Withdrawal by Subject|1|||
125123770|NCT02780687|450077402|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
125123771|NCT02780687|450077403|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
125123772|NCT02780687|450077402|FG000|Overall Study|progressive disease|29|||
125123773|NCT02780687|450077403|FG001|Overall Study|progressive disease|6|||
125123774|NCT01062256|450077404|FG000|Overall Study|Adverse Event|1|||
125123775|NCT01062256|450077405|FG001|Overall Study|Adverse Event|0|||
125123776|NCT01062256|450077406|FG002|Overall Study|Adverse Event|0|||
125123777|NCT01062256|450077404|FG000|Overall Study|Withdrawal by Subject|1|||
125123778|NCT01062256|450077405|FG001|Overall Study|Withdrawal by Subject|1|||
125123779|NCT01062256|450077406|FG002|Overall Study|Withdrawal by Subject|1|||
125123780|NCT01062256|450077404|FG000|Overall Study|Ineligible|1|||
125123781|NCT01062256|450077405|FG001|Overall Study|Ineligible|4|||
125123782|NCT01062256|450077406|FG002|Overall Study|Ineligible|3|||
125123783|NCT01062256|450077404|FG000|Overall Study|Administrative|0|||
124947131|NCT00308308|449434283|FG000|Overall Study|Various|7|||
124947132|NCT00308308|449434284|FG001|Overall Study|Various|5|||
124947133|NCT00308308|449434283|FG000|Overall Study|Randomized but not dosed|8|||
124947134|NCT00308308|449434284|FG001|Overall Study|Randomized but not dosed|16|||
124947135|NCT00308308|449434283|FG000|Overall Study|Other|1|||
124947136|NCT00308308|449434284|FG001|Overall Study|Other|0|||
124947137|NCT01686152|449434285|FG000|Overall Study|Withdrawal by Subject|11|||
124947138|NCT01686152|449434286|FG001|Overall Study|Withdrawal by Subject|11|||
124947139|NCT01686152|449434287|FG002|Overall Study|Withdrawal by Subject|3|||
125123784|NCT01062256|450077405|FG001|Overall Study|Administrative|2|||
125123785|NCT01062256|450077406|FG002|Overall Study|Administrative|0|||
125214649|NCT03628716|450412929|FG000|Overall Study|Death|1|||
125214650|NCT03628716|450412930|FG001|Overall Study|Death|0|||
125214651|NCT03628716|450412929|FG000|Overall Study|Lack of Efficacy|15|||
125214652|NCT03628716|450412930|FG001|Overall Study|Lack of Efficacy|20|||
125214653|NCT03628716|450412929|FG000|Overall Study|Withdrawal by Subject|1|||
125214654|NCT03628716|450412930|FG001|Overall Study|Withdrawal by Subject|2|||
125214655|NCT03628716|450412929|FG000|Overall Study|Study Terminated by Sponsor|1|||
125214656|NCT03628716|450412930|FG001|Overall Study|Study Terminated by Sponsor|0|||
125214657|NCT00856843|450412931|FG000|Overall Study|Withdrawal by Subject|1|||
125214658|NCT00856843|450412932|FG001|Overall Study|Withdrawal by Subject|5|||
125214659|NCT00856843|450412931|FG000|Overall Study|Lack of Efficacy|1|||
125214660|NCT00856843|450412932|FG001|Overall Study|Lack of Efficacy|0|||
125214661|NCT01366638|450412936|FG000|Overall Study|Withdrawal by Subject|0|||
125214662|NCT01366638|450412937|FG001|Overall Study|Withdrawal by Subject|0|||
125214663|NCT01366638|450412938|FG002|Overall Study|Withdrawal by Subject|6|||
125214664|NCT01366638|450412936|FG000|Overall Study|Other|1|||
125214665|NCT01366638|450412937|FG001|Overall Study|Other|0|||
125214666|NCT01366638|450412938|FG002|Overall Study|Other|0|||
125214667|NCT00401193|450414833|FG000|Overall Study|Adverse Event|1|||
125214668|NCT00401193|450414834|FG001|Overall Study|Adverse Event|3|||
124947140|NCT01686152|449434285|FG000|Overall Study|Drug Code Unblinded|0|||
125123786|NCT03049488|450077407|FG000|Overall Study|Lost to Follow-up|1|||
125123787|NCT03049488|450077408|FG001|Overall Study|Lost to Follow-up|1|||
125123788|NCT03049488|450077409|FG002|Overall Study|Lost to Follow-up|0|||
125123789|NCT03049488|450077410|FG003|Overall Study|Lost to Follow-up|0|||
125123790|NCT03049488|450077411|FG004|Overall Study|Lost to Follow-up|0|||
125123791|NCT03049488|450077412|FG005|Overall Study|Lost to Follow-up|0|||
125123792|NCT03049488|450077407|FG000|Overall Study|Moved from Area|1|||
125123793|NCT03049488|450077408|FG001|Overall Study|Moved from Area|0|||
125123794|NCT03049488|450077409|FG002|Overall Study|Moved from Area|0|||
125123795|NCT03049488|450077410|FG003|Overall Study|Moved from Area|1|||
125123796|NCT03049488|450077411|FG004|Overall Study|Moved from Area|1|||
125123797|NCT03049488|450077412|FG005|Overall Study|Moved from Area|0|||
125123798|NCT03049488|450077407|FG000|Overall Study|Physician Decision|0|||
125123799|NCT03049488|450077408|FG001|Overall Study|Physician Decision|1|||
125123800|NCT03049488|450077409|FG002|Overall Study|Physician Decision|0|||
125123801|NCT03049488|450077410|FG003|Overall Study|Physician Decision|0|||
125123802|NCT03049488|450077411|FG004|Overall Study|Physician Decision|0|||
125123803|NCT03049488|450077412|FG005|Overall Study|Physician Decision|0|||
125123804|NCT03049488|450077407|FG000|Overall Study|Withdrawal by Subject|0|||
125123805|NCT03049488|450077408|FG001|Overall Study|Withdrawal by Subject|0|||
125123806|NCT03049488|450077409|FG002|Overall Study|Withdrawal by Subject|0|||
125123807|NCT03049488|450077410|FG003|Overall Study|Withdrawal by Subject|1|||
125123808|NCT03049488|450077411|FG004|Overall Study|Withdrawal by Subject|1|||
125123809|NCT03049488|450077412|FG005|Overall Study|Withdrawal by Subject|0|||
125123810|NCT00891293|450077415|FG000|Overall Study|Adverse Event|2|||
125123811|NCT00891293|450077415|FG000|Overall Study|Protocol Violation|2|||
125123812|NCT00891293|450077415|FG000|Overall Study|Laboratory abnormality|4|||
125123813|NCT00891293|450077415|FG000|Overall Study|Lost to Follow-up|7|||
125123814|NCT00891293|450077415|FG000|Overall Study|Subject withdrew consent|7|||
125123815|NCT00891293|450077415|FG000|Overall Study|Sponsor termination|62|||
125123816|NCT01448057|450077416|FG000|Overall Study|Protocol Violation|3|||
125123817|NCT01448057|450077417|FG001|Overall Study|Protocol Violation|2|||
125123818|NCT01448057|450077416|FG000|Overall Study|Lost to Follow-up|3|||
124947141|NCT01686152|449434286|FG001|Overall Study|Drug Code Unblinded|1|||
124947142|NCT01686152|449434287|FG002|Overall Study|Drug Code Unblinded|0|||
124947143|NCT01686152|449434285|FG000|Overall Study|Protocol Violation|6|||
124947144|NCT01686152|449434286|FG001|Overall Study|Protocol Violation|1|||
124947145|NCT01686152|449434287|FG002|Overall Study|Protocol Violation|0|||
124947146|NCT01686152|449434285|FG000|Overall Study|Adverse Event|12|||
124947147|NCT01686152|449434286|FG001|Overall Study|Adverse Event|11|||
124947148|NCT01686152|449434287|FG002|Overall Study|Adverse Event|0|||
124947149|NCT01686152|449434285|FG000|Overall Study|Lack of Efficacy|0|||
125123819|NCT01448057|450077417|FG001|Overall Study|Lost to Follow-up|0|||
125123820|NCT01448057|450077416|FG000|Overall Study|Adverse Event|0|||
125123821|NCT01448057|450077417|FG001|Overall Study|Adverse Event|2|||
125123822|NCT01448057|450077416|FG000|Overall Study|Withdrawal by Subject|2|||
125123823|NCT01448057|450077417|FG001|Overall Study|Withdrawal by Subject|0|||
125123824|NCT02507375|450077421|FG000|Overall Study|Progressive Disease|4|||
125123825|NCT02507375|450077422|FG001|Overall Study|Progressive Disease|5|||
125123826|NCT02507375|450077421|FG000|Overall Study|Death|0|||
125123827|NCT02507375|450077422|FG001|Overall Study|Death|1|||
125123828|NCT02507375|450077421|FG000|Overall Study|Refused treatment|0|||
125123829|NCT02507375|450077422|FG001|Overall Study|Refused treatment|1|||
125123830|NCT02507375|450077421|FG000|Overall Study|Adverse Event|0|||
125123831|NCT02507375|450077422|FG001|Overall Study|Adverse Event|1|||
125123832|NCT02777528|450078639|FG000|Overall Study|Still in study|24|||
125123833|NCT02777528|450078640|FG001|Overall Study|Still in study|10|||
125123834|NCT02777528|450078641|FG002|Overall Study|Still in study|1|||
124947150|NCT01686152|449434286|FG001|Overall Study|Lack of Efficacy|0|||
124947151|NCT01686152|449434287|FG002|Overall Study|Lack of Efficacy|1|||
124947152|NCT01686152|449434285|FG000|Overall Study|IP Non-compliance|5|||
124947153|NCT01686152|449434286|FG001|Overall Study|IP Non-compliance|5|||
124947154|NCT01686152|449434287|FG002|Overall Study|IP Non-compliance|0|||
124947155|NCT01686152|449434285|FG000|Overall Study|Lost to Follow-up|7|||
124947156|NCT01686152|449434286|FG001|Overall Study|Lost to Follow-up|6|||
124947157|NCT01686152|449434287|FG002|Overall Study|Lost to Follow-up|5|||
124947158|NCT01802333|449434288|FG000|Overall Study|Ineligible|2|||
124947159|NCT01802333|449434289|FG001|Overall Study|Ineligible|6|||
124947160|NCT01802333|449434290|FG002|Overall Study|Ineligible|8|||
124947161|NCT01802333|449434288|FG000|Overall Study|Adverse Event|1|||
124947162|NCT01802333|449434289|FG001|Overall Study|Adverse Event|8|||
124947163|NCT01802333|449434290|FG002|Overall Study|Adverse Event|8|||
124947164|NCT01802333|449434288|FG000|Overall Study|Withdrawal by Subject|6|||
124947165|NCT01802333|449434289|FG001|Overall Study|Withdrawal by Subject|6|||
124947166|NCT01802333|449434290|FG002|Overall Study|Withdrawal by Subject|5|||
124947167|NCT01802333|449434288|FG000|Overall Study|Progression/relapse|1|||
125123835|NCT02777528|450078639|FG000|Overall Study|Study Device Explanted|1|||
125123836|NCT02777528|450078640|FG001|Overall Study|Study Device Explanted|0|||
125123837|NCT02777528|450078641|FG002|Overall Study|Study Device Explanted|0|||
125123838|NCT02777528|450078639|FG000|Overall Study|Death|14|||
125123839|NCT02777528|450078640|FG001|Overall Study|Death|7|||
125123840|NCT02777528|450078641|FG002|Overall Study|Death|1|||
125123841|NCT02777528|450078639|FG000|Overall Study|Withdrawal by Subject|2|||
125123842|NCT02777528|450078640|FG001|Overall Study|Withdrawal by Subject|2|||
125123843|NCT02777528|450078641|FG002|Overall Study|Withdrawal by Subject|1|||
125123844|NCT02777528|450078639|FG000|Overall Study|Physician Decision|2|||
125123845|NCT02777528|450078640|FG001|Overall Study|Physician Decision|1|||
125123846|NCT02777528|450078641|FG002|Overall Study|Physician Decision|0|||
125123847|NCT02777528|450078639|FG000|Overall Study|Lost to Follow-up|2|||
125123848|NCT02777528|450078640|FG001|Overall Study|Lost to Follow-up|0|||
125123849|NCT02777528|450078641|FG002|Overall Study|Lost to Follow-up|0|||
125123850|NCT02777528|450078639|FG000|Overall Study|Discontinued due to Other|1|||
125123851|NCT02777528|450078640|FG001|Overall Study|Discontinued due to Other|0|||
124947168|NCT01802333|449434289|FG001|Overall Study|Progression/relapse|3|||
124947169|NCT01802333|449434290|FG002|Overall Study|Progression/relapse|0|||
124947170|NCT01802333|449434288|FG000|Overall Study|Death|7|||
125029310|NCT01500057|449729296|FG000|Overall Study|Lost to Follow-up|6|||
125029311|NCT01500057|449729297|FG001|Overall Study|Lost to Follow-up|4|||
125029312|NCT01318122|449729301|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125029313|NCT01318122|449729302|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125029314|NCT01318122|449729303|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
125029315|NCT01318122|449729304|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
125029316|NCT01318122|449729301|FG000|Enrolled - Long-Term Extension Study|Other|1|||
125029317|NCT01318122|449729302|FG001|Enrolled - Long-Term Extension Study|Other|0|||
125029318|NCT01318122|449729303|FG002|Enrolled - Long-Term Extension Study|Other|0|||
125123852|NCT02777528|450078641|FG002|Overall Study|Discontinued due to Other|0|||
124947171|NCT01802333|449434289|FG001|Overall Study|Death|14|||
124947172|NCT01802333|449434290|FG002|Overall Study|Death|13|||
124947173|NCT01802333|449434288|FG000|Overall Study|Other - not protocol specified|32|||
124947174|NCT01802333|449434289|FG001|Overall Study|Other - not protocol specified|22|||
124947175|NCT01802333|449434290|FG002|Overall Study|Other - not protocol specified|24|||
124947176|NCT01802333|449434288|FG000|Overall Study|Did not start treatment|0|||
124947177|NCT01802333|449434289|FG001|Overall Study|Did not start treatment|2|||
124947178|NCT01802333|449434290|FG002|Overall Study|Did not start treatment|5|||
124947179|NCT01947491|449434292|FG000|Overall Study|Lost to Follow-up|5|||
124947180|NCT01947491|449434293|FG001|Overall Study|Lost to Follow-up|3|||
124947181|NCT01947491|449434294|FG002|Overall Study|Lost to Follow-up|1|||
124947182|NCT01947491|449434295|FG003|Overall Study|Lost to Follow-up|2|||
124947183|NCT01947491|449434292|FG000|Overall Study|Lack of Efficacy|1|||
124947184|NCT01947491|449434293|FG001|Overall Study|Lack of Efficacy|0|||
124947185|NCT01947491|449434294|FG002|Overall Study|Lack of Efficacy|0|||
124947186|NCT01947491|449434295|FG003|Overall Study|Lack of Efficacy|1|||
124947187|NCT01947491|449434292|FG000|Overall Study|Protocol Violation|1|||
125123853|NCT00453362|450078642|FG000|Overall Study|Adverse Event|5|||
125123854|NCT00453362|450078642|FG000|Overall Study|Death|7|||
125123855|NCT00453362|450078642|FG000|Overall Study|Physician Decision|2|||
125123856|NCT00453362|450078642|FG000|Overall Study|Withdrawal by Subject|3|||
125123857|NCT00453362|450078642|FG000|Overall Study|Progression of disease|56|||
125123858|NCT00453362|450078642|FG000|Overall Study|Screening Failure|14|||
125123859|NCT04885296|450078643|FG000|Period 1|Covid-19 Related|1|||
125123860|NCT04885296|450078644|FG001|Period 1|Covid-19 Related|0|||
125123861|NCT04885296|450078643|FG000|Period 1|Adverse Event|0|||
125123862|NCT04885296|450078644|FG001|Period 1|Adverse Event|1|||
125123863|NCT04885296|450078643|FG000|Period 1|Withdrawal by Subject|1|||
125123864|NCT04885296|450078644|FG001|Period 1|Withdrawal by Subject|1|||
124947188|NCT01947491|449434293|FG001|Overall Study|Protocol Violation|0|||
124947189|NCT01947491|449434294|FG002|Overall Study|Protocol Violation|0|||
124947190|NCT01947491|449434295|FG003|Overall Study|Protocol Violation|0|||
124947191|NCT01947491|449434292|FG000|Overall Study|Withdrawal by Subject|1|||
124947192|NCT01947491|449434293|FG001|Overall Study|Withdrawal by Subject|1|||
124947193|NCT01947491|449434294|FG002|Overall Study|Withdrawal by Subject|1|||
124947194|NCT01947491|449434295|FG003|Overall Study|Withdrawal by Subject|0|||
124947195|NCT01947491|449434292|FG000|Overall Study|Worsening of condition|0|||
124947196|NCT01947491|449434293|FG001|Overall Study|Worsening of condition|1|||
124947197|NCT01947491|449434294|FG002|Overall Study|Worsening of condition|0|||
124947198|NCT01947491|449434295|FG003|Overall Study|Worsening of condition|0|||
124947199|NCT01947491|449434292|FG000|Overall Study|Adverse Event|0|||
124947200|NCT01947491|449434293|FG001|Overall Study|Adverse Event|1|||
124947201|NCT01947491|449434294|FG002|Overall Study|Adverse Event|0|||
125123865|NCT04885296|450078643|FG000|Period 1|Test Article No Longer Available|1|||
124947202|NCT01947491|449434295|FG003|Overall Study|Adverse Event|2|||
124947203|NCT02067663|449434296|FG000|Overall Study|Lost to Follow-up|13|||
125123866|NCT04885296|450078644|FG001|Period 1|Test Article No Longer Available|0|||
124947204|NCT02067663|449434297|FG001|Overall Study|Lost to Follow-up|14|||
124947205|NCT00704340|449434298|FG000|Overall Study|Lost to Follow-up|2|||
124947206|NCT00704340|449434299|FG001|Overall Study|Lost to Follow-up|1|||
125123867|NCT04885296|450078643|FG000|Period 1|Dispensed Study lens in Error|1|||
124947207|NCT00704340|449434298|FG000|Overall Study|Death|0|||
124947208|NCT00704340|449434299|FG001|Overall Study|Death|1|||
124947209|NCT03137784|449434300|FG000|Overall Study|Adverse Event|1|||
124947210|NCT03137784|449434301|FG001|Overall Study|Adverse Event|1|||
124947211|NCT03137784|449434302|FG002|Overall Study|Adverse Event|0|||
124947212|NCT03137784|449434303|FG003|Overall Study|Adverse Event|0|||
124947213|NCT03137784|449434304|FG004|Overall Study|Adverse Event|0|||
124947214|NCT03137784|449434305|FG005|Overall Study|Adverse Event|0|||
124947215|NCT03137784|449434300|FG000|Overall Study|Subject/guardian decision|1|||
124947216|NCT03137784|449434301|FG001|Overall Study|Subject/guardian decision|0|||
124947217|NCT03137784|449434302|FG002|Overall Study|Subject/guardian decision|0|||
124947218|NCT03137784|449434303|FG003|Overall Study|Subject/guardian decision|0|||
124947219|NCT03137784|449434304|FG004|Overall Study|Subject/guardian decision|0|||
124947220|NCT03137784|449434305|FG005|Overall Study|Subject/guardian decision|0|||
124947221|NCT03137784|449434300|FG000|Overall Study|Non-compliance with study treatment|0|||
124947222|NCT03137784|449434301|FG001|Overall Study|Non-compliance with study treatment|0|||
124947223|NCT03137784|449434302|FG002|Overall Study|Non-compliance with study treatment|0|||
124947224|NCT03137784|449434303|FG003|Overall Study|Non-compliance with study treatment|0|||
124947225|NCT03137784|449434304|FG004|Overall Study|Non-compliance with study treatment|1|||
124947226|NCT03137784|449434305|FG005|Overall Study|Non-compliance with study treatment|0|||
124947227|NCT02736188|449434306|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
124947228|NCT02736188|449434306|FG000|Overall Study|Adverse Event|1|||
124947229|NCT02736188|449434306|FG000|Overall Study|Withdrawal by Subject|1|||
124947230|NCT02736188|449434306|FG000|Overall Study|Other|6|||
124947231|NCT04070105|449434307|FG000|Overall Study|Lost to Follow-up|0|||
124947232|NCT04070105|449434308|FG001|Overall Study|Lost to Follow-up|0|||
124947233|NCT04070105|449434309|FG002|Overall Study|Lost to Follow-up|0|||
124947234|NCT04070105|449434310|FG003|Overall Study|Lost to Follow-up|0|||
124947235|NCT04070105|449434311|FG004|Overall Study|Lost to Follow-up|0|||
124947236|NCT04070105|449434312|FG005|Overall Study|Lost to Follow-up|1|||
124947237|NCT03547154|449434326|FG000|Overall Study|Disease Progression/Recurrence|6|||
124947238|NCT03547154|449434327|FG001|Overall Study|Disease Progression/Recurrence|14|||
124947239|NCT03547154|449434326|FG000|Overall Study|Adverse Event|26|||
124947240|NCT03547154|449434327|FG001|Overall Study|Adverse Event|31|||
124947241|NCT03547154|449434326|FG000|Overall Study|Protocol Violation|6|||
124947242|NCT03547154|449434327|FG001|Overall Study|Protocol Violation|1|||
124947243|NCT03547154|449434326|FG000|Overall Study|Physician Decision|4|||
124947244|NCT03547154|449434327|FG001|Overall Study|Physician Decision|3|||
124947245|NCT03547154|449434326|FG000|Overall Study|Insufficient Therapeutic Response|13|||
124947246|NCT03547154|449434327|FG001|Overall Study|Insufficient Therapeutic Response|10|||
124947247|NCT03547154|449434326|FG000|Overall Study|Withdrawal by Subject|10|||
124947248|NCT03547154|449434327|FG001|Overall Study|Withdrawal by Subject|6|||
124947249|NCT03547154|449434326|FG000|Overall Study|Not Selected|0|||
124947250|NCT03547154|449434327|FG001|Overall Study|Not Selected|1|||
125029319|NCT01318122|449729304|FG003|Enrolled - Long-Term Extension Study|Other|0|||
124947251|NCT03547154|449434326|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
124947252|NCT03547154|449434327|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
124947253|NCT00895245|449434328|FG000|Overall Study|Lack of Efficacy|6|||
124947254|NCT02706483|449434329|FG000|Overall Study|Adverse Event|97|||
125029320|NCT01318122|449729301|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
125029321|NCT01318122|449729302|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
125029322|NCT01318122|449729303|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
125029323|NCT01318122|449729304|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
125029324|NCT01318122|449729301|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
125029325|NCT01318122|449729302|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
125029326|NCT01318122|449729303|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
125029327|NCT01318122|449729304|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
125029328|NCT01318122|449729301|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
125029329|NCT01318122|449729302|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
125029330|NCT01318122|449729303|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
125029331|NCT01318122|449729304|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
125029332|NCT01318122|449729301|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
125029333|NCT01318122|449729302|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
125029334|NCT01318122|449729303|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
125029335|NCT01318122|449729304|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
125029336|NCT01486199|449729305|FG000|Two Year Period Between Study Days|Physician Decision|1|||
125029337|NCT01486199|449729306|FG001|Two Year Period Between Study Days|Physician Decision|0|||
125029338|NCT01400932|449730653|FG000|Overall Study|Adverse Event|10|||
125029339|NCT01400932|449730654|FG001|Overall Study|Adverse Event|5|||
125029340|NCT01400932|449730653|FG000|Overall Study|Lack of Efficacy|0|||
125029341|NCT01400932|449730654|FG001|Overall Study|Lack of Efficacy|3|||
124947255|NCT02706483|449434329|FG000|Overall Study|Death|1|||
124947256|NCT02706483|449434329|FG000|Overall Study|Lack of Efficacy|39|||
124947257|NCT02706483|449434329|FG000|Overall Study|Lost to Follow-up|101|||
124947258|NCT02706483|449434329|FG000|Overall Study|Non-compliance with study drug|15|||
124947259|NCT02706483|449434329|FG000|Overall Study|Physician Decision|6|||
124947260|NCT02706483|449434329|FG000|Overall Study|Pregnancy|6|||
124947261|NCT02706483|449434329|FG000|Overall Study|Protocol Violation|18|||
124947262|NCT02706483|449434329|FG000|Overall Study|Withdrawal by Subject|136|||
124947263|NCT02706483|449434329|FG000|Overall Study|Non-compliance with visits|6|||
124947264|NCT02706483|449434329|FG000|Overall Study|Site closure|4|||
124947265|NCT02706483|449434329|FG000|Overall Study|Subject moved|1|||
124947266|NCT01972776|449434330|FG000|Part 1|Withdrawal by Subject|0|||
124947267|NCT01972776|449434331|FG001|Part 1|Withdrawal by Subject|0|||
124947268|NCT01972776|449434332|FG002|Part 1|Withdrawal by Subject|1|||
124947269|NCT01972776|449434333|FG003|Part 1|Withdrawal by Subject|0|||
124947270|NCT01972776|449434334|FG004|Part 1|Withdrawal by Subject|0|||
124947271|NCT01972776|449434335|FG005|Part 1|Withdrawal by Subject|0|||
124947272|NCT01972776|449434330|FG000|Part 1|Adverse Event|0|||
124947273|NCT01972776|449434331|FG001|Part 1|Adverse Event|0|||
124947274|NCT01972776|449434332|FG002|Part 1|Adverse Event|1|||
124947275|NCT01972776|449434333|FG003|Part 1|Adverse Event|1|||
124947276|NCT01972776|449434334|FG004|Part 1|Adverse Event|0|||
124947277|NCT01972776|449434335|FG005|Part 1|Adverse Event|0|||
124947278|NCT01972776|449434330|FG000|Part 2|Adverse Event|0|||
124947279|NCT01972776|449434331|FG001|Part 2|Adverse Event|0|||
124947280|NCT01972776|449434332|FG002|Part 2|Adverse Event|0|||
124947281|NCT01972776|449434333|FG003|Part 2|Adverse Event|0|||
124947282|NCT01972776|449434334|FG004|Part 2|Adverse Event|3|||
124947283|NCT01972776|449434335|FG005|Part 2|Adverse Event|0|||
124947284|NCT01972776|449434330|FG000|Part 2|Administrative problems|0|||
124947285|NCT01972776|449434331|FG001|Part 2|Administrative problems|0|||
124947286|NCT01972776|449434332|FG002|Part 2|Administrative problems|0|||
124947287|NCT01972776|449434333|FG003|Part 2|Administrative problems|0|||
125123868|NCT04885296|450078644|FG001|Period 1|Dispensed Study lens in Error|0|||
125123869|NCT04885296|450078643|FG000|Period 1|Lost to Follow-up|1|||
125123870|NCT04885296|450078644|FG001|Period 1|Lost to Follow-up|0|||
125123871|NCT04885296|450078643|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
125123872|NCT04885296|450078644|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
125123873|NCT01027143|450078646|FG000|Overall Study|Lost to Follow-up|9|||
125123874|NCT01027143|450078647|FG001|Overall Study|Lost to Follow-up|4|||
125123875|NCT02564263|450078648|FG000|Overall Study|Adverse Event|31|||
125123876|NCT02564263|450078649|FG001|Overall Study|Adverse Event|29|||
125123877|NCT02564263|450078648|FG000|Overall Study|Death|270|||
125123878|NCT02564263|450078649|FG001|Overall Study|Death|262|||
125123879|NCT02564263|450078648|FG000|Overall Study|Withdrawal by Subject|4|||
125123880|NCT02564263|450078649|FG001|Overall Study|Withdrawal by Subject|19|||
125123881|NCT02564263|450078648|FG000|Overall Study|Sponsor's decision|9|||
125123882|NCT02564263|450078649|FG001|Overall Study|Sponsor's decision|4|||
125123883|NCT01087970|450078653|FG000|Overall Study|Protocol Violation|2|||
125123884|NCT00264797|450078654|FG000|Overall Study|Withdrawal by Subject|11|||
125123885|NCT00264797|450078655|FG001|Overall Study|Withdrawal by Subject|11|||
125214669|NCT00401193|450414835|FG002|Overall Study|Adverse Event|1|||
124947288|NCT01972776|449434334|FG004|Part 2|Administrative problems|10|||
124947289|NCT01972776|449434335|FG005|Part 2|Administrative problems|7|||
124947290|NCT01543204|449434336|FG000|Overall Study|Non-compliance|1|||
124947291|NCT01543204|449434336|FG000|Overall Study|Adverse Event|1|||
124947292|NCT01543204|449434336|FG000|Overall Study|Withdrawal by Subject|4|||
124947293|NCT01543204|449434336|FG000|Overall Study|Requirement for Alternative Therapy|1|||
124947294|NCT01543204|449434336|FG000|Overall Study|Lost to Follow-up|1|||
124947295|NCT03938272|449434344|FG000|Overall Study|Withdrawal by Subject|1|||
124947296|NCT03938272|449434345|FG001|Overall Study|Withdrawal by Subject|0|||
124947297|NCT03938272|449434344|FG000|Overall Study|Physician Decision|0|||
124947298|NCT03938272|449434345|FG001|Overall Study|Physician Decision|2|||
124947299|NCT03938272|449434344|FG000|Overall Study|Study termination by sponsor|10|||
124947300|NCT03938272|449434345|FG001|Overall Study|Study termination by sponsor|8|||
124947301|NCT00068107|449434348|FG000|Overall Study|end-stage renal disease|6|||
124947302|NCT00068107|449434348|FG000|Overall Study|Death|2|||
124947303|NCT00068107|449434348|FG000|Overall Study|Withdrawal by Subject|1|||
124947304|NCT03288506|449434349|FG000|Overall Study|Withdrawal by Subject|52|||
124947305|NCT01419184|449434352|FG000|Overall Study|Site data not available|3|||
124947306|NCT01419184|449434353|FG001|Overall Study|Site data not available|2|||
124947307|NCT01419184|449434352|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
124947308|NCT01419184|449434353|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
125123886|NCT00264797|450078654|FG000|Overall Study|Lost to Follow-up|9|||
125123887|NCT00264797|450078655|FG001|Overall Study|Lost to Follow-up|17|||
125123888|NCT00264797|450078654|FG000|Overall Study|Moved from area|3|||
124947309|NCT01419184|449434352|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
125123889|NCT00264797|450078655|FG001|Overall Study|Moved from area|1|||
124947310|NCT01419184|449434353|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
125123890|NCT00264797|450078654|FG000|Overall Study|Practical Problems|2|||
124947311|NCT01419184|449434352|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
124947312|NCT01419184|449434353|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
124947313|NCT01419184|449434352|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
124947314|NCT01419184|449434353|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
124947315|NCT01419184|449434352|FG000|Overall Study|Participant randomized, not treated|1|||
124947316|NCT01419184|449434353|FG001|Overall Study|Participant randomized, not treated|0|||
124947317|NCT00875706|449434354|FG000|Overall Study|Withdrawal by Subject|1|||
124947318|NCT00875706|449434355|FG001|Overall Study|Withdrawal by Subject|0|||
124947319|NCT00875706|449434356|FG002|Overall Study|Withdrawal by Subject|0|||
124947320|NCT00786188|449434357|FG000|Overall Study|Adverse Event|3|||
124947321|NCT00786188|449434358|FG001|Overall Study|Adverse Event|1|||
124947322|NCT00786188|449434357|FG000|Overall Study|Withdrawal by Subject|2|||
124947323|NCT00786188|449434358|FG001|Overall Study|Withdrawal by Subject|0|||
124947324|NCT02279732|449434360|FG000|Overall Study|Death|23|||
124947325|NCT02279732|449434361|FG001|Overall Study|Death|20|||
124947326|NCT02279732|449434360|FG000|Overall Study|Disease Progression|13|||
124947327|NCT02279732|449434361|FG001|Overall Study|Disease Progression|3|||
124947328|NCT02279732|449434360|FG000|Overall Study|Withdrawal by Subject|2|||
124947329|NCT02279732|449434361|FG001|Overall Study|Withdrawal by Subject|7|||
124947330|NCT02279732|449434360|FG000|Overall Study|Adverse Event|1|||
124947331|NCT02279732|449434361|FG001|Overall Study|Adverse Event|2|||
124947332|NCT02279732|449434360|FG000|Overall Study|Administrative Reason By Sponsor|0|||
124947333|NCT02279732|449434361|FG001|Overall Study|Administrative Reason By Sponsor|2|||
124947334|NCT02279732|449434360|FG000|Overall Study|Study Drug Toxicity|2|||
124947335|NCT02279732|449434361|FG001|Overall Study|Study Drug Toxicity|0|||
124947336|NCT02279732|449434360|FG000|Overall Study|Lost to Follow-up|0|||
124947337|NCT02279732|449434361|FG001|Overall Study|Lost to Follow-up|1|||
124947338|NCT02279732|449434360|FG000|Overall Study|Maximum Clinical Benefit|1|||
124947339|NCT02279732|449434361|FG001|Overall Study|Maximum Clinical Benefit|0|||
124947340|NCT02279732|449434360|FG000|Overall Study|Subject Requested to Discontinue|0|||
124947341|NCT02279732|449434361|FG001|Overall Study|Subject Requested to Discontinue|1|||
124947342|NCT02279732|449434360|FG000|Overall Study|Other|53|||
124947343|NCT02279732|449434361|FG001|Overall Study|Other|67|||
124947344|NCT02279732|449434360|FG000|Overall Study|Other|3|||
124947345|NCT02279732|449434361|FG001|Overall Study|Other|3|||
124947346|NCT02970318|449434362|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
124947347|NCT02970318|449434363|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
124947348|NCT02970318|449434364|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
124947349|NCT02970318|449434365|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
124947350|NCT02970318|449434362|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
124947351|NCT02970318|449434363|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
124947352|NCT02970318|449434364|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
124947353|NCT02970318|449434365|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
124947354|NCT02970318|449434362|FG000|Overall for Arm A & Main for Arm B|Death|41|||
124947355|NCT02970318|449434363|FG001|Overall for Arm A & Main for Arm B|Death|33|||
124947356|NCT02970318|449434364|FG002|Overall for Arm A & Main for Arm B|Death|0|||
124947357|NCT02970318|449434365|FG003|Overall for Arm A & Main for Arm B|Death|0|||
124947358|NCT02970318|449434362|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
124947359|NCT02970318|449434363|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
124947360|NCT02970318|449434364|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
124947361|NCT02970318|449434365|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
124947362|NCT02970318|449434362|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
124947363|NCT02970318|449434363|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
124947364|NCT02970318|449434364|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
124947365|NCT02970318|449434365|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
124947366|NCT02970318|449434362|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
124947367|NCT02970318|449434363|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
124947368|NCT02970318|449434364|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
124947369|NCT02970318|449434365|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
124947370|NCT02970318|449434362|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
124947371|NCT02970318|449434363|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
124947372|NCT02970318|449434364|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
124947373|NCT02970318|449434365|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
124947374|NCT00824408|449434366|FG000|Run-in Phase|Progressive disease|4|||
124947375|NCT00824408|449434367|FG001|Run-in Phase|Progressive disease|4|||
124947376|NCT00824408|449434368|FG002|Run-in Phase|Progressive disease|0|||
124947377|NCT00824408|449434369|FG003|Run-in Phase|Progressive disease|0|||
124947378|NCT00824408|449434370|FG004|Run-in Phase|Progressive disease|0|||
124947379|NCT00824408|449434366|FG000|Run-in Phase|Adverse Event|1|||
124947380|NCT00824408|449434367|FG001|Run-in Phase|Adverse Event|1|||
125214670|NCT00401193|450414833|FG000|Overall Study|Protocol Violation|3|||
125214671|NCT00401193|450414834|FG001|Overall Study|Protocol Violation|1|||
125214672|NCT00401193|450414835|FG002|Overall Study|Protocol Violation|1|||
125214673|NCT00401193|450414833|FG000|Overall Study|Lost to Follow-up|6|||
125214674|NCT00401193|450414834|FG001|Overall Study|Lost to Follow-up|5|||
125214675|NCT00401193|450414835|FG002|Overall Study|Lost to Follow-up|1|||
125214676|NCT00401193|450414833|FG000|Overall Study|Withdrawal by Subject|2|||
125214677|NCT00401193|450414834|FG001|Overall Study|Withdrawal by Subject|0|||
125214678|NCT00401193|450414835|FG002|Overall Study|Withdrawal by Subject|1|||
125214679|NCT00401193|450414833|FG000|Overall Study|Other Event|3|||
124947381|NCT00824408|449434368|FG002|Run-in Phase|Adverse Event|0|||
124947382|NCT00824408|449434369|FG003|Run-in Phase|Adverse Event|0|||
124947383|NCT00824408|449434370|FG004|Run-in Phase|Adverse Event|0|||
124947384|NCT00824408|449434366|FG000|Run-in Phase|Refused to continue medication|1|||
124947385|NCT00824408|449434367|FG001|Run-in Phase|Refused to continue medication|0|||
124947386|NCT00824408|449434368|FG002|Run-in Phase|Refused to continue medication|0|||
124947387|NCT00824408|449434369|FG003|Run-in Phase|Refused to continue medication|0|||
124947388|NCT00824408|449434370|FG004|Run-in Phase|Refused to continue medication|0|||
124947389|NCT00824408|449434366|FG000|Run-in Phase|Other reason not defined above|0|||
124947390|NCT00824408|449434367|FG001|Run-in Phase|Other reason not defined above|1|||
124947391|NCT00824408|449434368|FG002|Run-in Phase|Other reason not defined above|0|||
124947392|NCT00824408|449434369|FG003|Run-in Phase|Other reason not defined above|0|||
124947393|NCT00824408|449434370|FG004|Run-in Phase|Other reason not defined above|0|||
124947394|NCT00824408|449434366|FG000|Randomized Phase|Not treated|0|||
124947395|NCT00824408|449434367|FG001|Randomized Phase|Not treated|0|||
124947396|NCT00824408|449434368|FG002|Randomized Phase|Not treated|1|||
124947397|NCT00824408|449434369|FG003|Randomized Phase|Not treated|1|||
124947398|NCT00824408|449434370|FG004|Randomized Phase|Not treated|1|||
124947399|NCT00824408|449434366|FG000|Randomized Phase|Progressive disease|0|||
124947400|NCT00824408|449434367|FG001|Randomized Phase|Progressive disease|0|||
124947401|NCT00824408|449434368|FG002|Randomized Phase|Progressive disease|25|||
124947402|NCT00824408|449434369|FG003|Randomized Phase|Progressive disease|36|||
124947403|NCT00824408|449434370|FG004|Randomized Phase|Progressive disease|34|||
124947404|NCT00824408|449434366|FG000|Randomized Phase|Adverse Event|0|||
124947405|NCT00824408|449434367|FG001|Randomized Phase|Adverse Event|0|||
124947406|NCT00824408|449434368|FG002|Randomized Phase|Adverse Event|4|||
124947407|NCT00824408|449434369|FG003|Randomized Phase|Adverse Event|5|||
124947408|NCT00824408|449434370|FG004|Randomized Phase|Adverse Event|5|||
124947409|NCT00824408|449434366|FG000|Randomized Phase|Refused to continue medication|0|||
124947410|NCT00824408|449434367|FG001|Randomized Phase|Refused to continue medication|0|||
124947411|NCT00824408|449434368|FG002|Randomized Phase|Refused to continue medication|2|||
124947412|NCT00824408|449434369|FG003|Randomized Phase|Refused to continue medication|2|||
124947413|NCT00824408|449434370|FG004|Randomized Phase|Refused to continue medication|2|||
124947414|NCT00824408|449434366|FG000|Randomized Phase|Other reason not defined above|0|||
124947415|NCT00824408|449434367|FG001|Randomized Phase|Other reason not defined above|0|||
125214680|NCT00401193|450414834|FG001|Overall Study|Other Event|2|||
125214681|NCT00401193|450414835|FG002|Overall Study|Other Event|2|||
125214682|NCT00398216|450414836|FG000|Overall Study|Adverse Event|4|||
125214683|NCT00398216|450414837|FG001|Overall Study|Adverse Event|2|||
125214684|NCT00398216|450414838|FG002|Overall Study|Adverse Event|5|||
124947416|NCT00824408|449434368|FG002|Randomized Phase|Other reason not defined above|4|||
124947417|NCT00824408|449434369|FG003|Randomized Phase|Other reason not defined above|2|||
124947418|NCT00824408|449434370|FG004|Randomized Phase|Other reason not defined above|4|||
124947419|NCT01880736|449434371|FG000|Overall Study|Adverse Event|0|||
124947420|NCT01880736|449434372|FG001|Overall Study|Adverse Event|0|||
124947421|NCT01880736|449434373|FG002|Overall Study|Adverse Event|0|||
124947422|NCT01880736|449434374|FG003|Overall Study|Adverse Event|1|||
124947423|NCT01880736|449434371|FG000|Overall Study|Withdrawal Criteria|1|||
124947424|NCT01880736|449434372|FG001|Overall Study|Withdrawal Criteria|2|||
124947425|NCT01880736|449434373|FG002|Overall Study|Withdrawal Criteria|1|||
124947426|NCT01880736|449434374|FG003|Overall Study|Withdrawal Criteria|5|||
124947427|NCT00266656|449434378|FG000|Overall Study|Death|1|||
124947428|NCT00266656|449434379|FG001|Overall Study|Death|0|||
124947429|NCT00266656|449434378|FG000|Overall Study|Lost to Follow-up|4|||
124947430|NCT00266656|449434379|FG001|Overall Study|Lost to Follow-up|1|||
124947431|NCT00266656|449434378|FG000|Overall Study|Withdrawal by Subject|4|||
124947432|NCT00266656|449434379|FG001|Overall Study|Withdrawal by Subject|2|||
124947433|NCT00266656|449434378|FG000|Overall Study|Did Not Reach Final Height|4|||
124947434|NCT00266656|449434379|FG001|Overall Study|Did Not Reach Final Height|8|||
124947435|NCT00266656|449434378|FG000|Overall Study|Parent/Caregiver Decision|1|||
124947436|NCT00266656|449434379|FG001|Overall Study|Parent/Caregiver Decision|2|||
124947437|NCT02915783|449434380|FG000|Overall Study|Death|21|||
124947438|NCT02915783|449434380|FG000|Overall Study|Lost to Follow-up|1|||
124947439|NCT02915783|449434380|FG000|Overall Study|Withdrawal by Subject|2|||
124947440|NCT02203032|449434381|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
124947441|NCT02203032|449434382|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
124947442|NCT02203032|449434383|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
124947443|NCT02203032|449434384|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
124947444|NCT02203032|449434381|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
124947445|NCT02203032|449434382|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
124947446|NCT02203032|449434383|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
124947447|NCT02203032|449434384|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
124947448|NCT02203032|449434381|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
124947449|NCT02203032|449434382|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
124947450|NCT02203032|449434383|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
124947451|NCT02203032|449434384|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
124947452|NCT02203032|449434381|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
124947453|NCT02203032|449434382|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
124947454|NCT02203032|449434383|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
124947455|NCT02203032|449434384|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
124947456|NCT02203032|449434381|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
124947457|NCT02203032|449434382|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
124947458|NCT02203032|449434383|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
124947459|NCT02203032|449434384|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
124947460|NCT02203032|449434381|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
124947461|NCT02203032|449434382|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
124947462|NCT02203032|449434383|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
124947463|NCT02203032|449434384|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
124947464|NCT02203032|449434381|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
124947465|NCT02203032|449434382|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
124947466|NCT02203032|449434383|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
124947467|NCT02203032|449434384|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
124947468|NCT02203032|449434381|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
124947469|NCT02203032|449434382|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
124947470|NCT02203032|449434383|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
124947471|NCT02203032|449434384|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
124947472|NCT02203032|449434381|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
124947473|NCT02203032|449434382|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
124947474|NCT02203032|449434383|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
124947475|NCT02203032|449434384|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
124947476|NCT02203032|449434381|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
124947477|NCT02203032|449434382|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
125029342|NCT01400932|449730653|FG000|Overall Study|Withdrawal by Subject|2|||
124947478|NCT02203032|449434383|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
124947479|NCT02203032|449434384|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
124947480|NCT02203032|449434381|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
124947481|NCT02203032|449434382|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
124947482|NCT02203032|449434383|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
125214685|NCT00398216|450414839|FG003|Overall Study|Adverse Event|7|||
125214686|NCT00398216|450414840|FG004|Overall Study|Adverse Event|2|||
125214687|NCT00398216|450414836|FG000|Overall Study|Protocol Violation|2|||
125214688|NCT00398216|450414837|FG001|Overall Study|Protocol Violation|4|||
125214689|NCT00398216|450414838|FG002|Overall Study|Protocol Violation|5|||
125214690|NCT00398216|450414839|FG003|Overall Study|Protocol Violation|7|||
125214691|NCT00398216|450414840|FG004|Overall Study|Protocol Violation|5|||
125214692|NCT00398216|450414836|FG000|Overall Study|Lost to Follow-up|1|||
125214693|NCT00398216|450414837|FG001|Overall Study|Lost to Follow-up|6|||
125214694|NCT00398216|450414838|FG002|Overall Study|Lost to Follow-up|4|||
124947483|NCT02203032|449434384|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
124947484|NCT02203032|449434381|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
125214695|NCT00398216|450414839|FG003|Overall Study|Lost to Follow-up|4|||
124947485|NCT02203032|449434382|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
124947486|NCT02203032|449434383|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
124947487|NCT02203032|449434384|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
124947488|NCT01915914|449434385|FG000|Acute Phase|Withdrawal by Subject|4|||
124947489|NCT01915914|449434386|FG001|Acute Phase|Withdrawal by Subject|0|||
124947490|NCT01915914|449434387|FG002|Acute Phase|Withdrawal by Subject|0|||
124947491|NCT01915914|449434388|FG003|Acute Phase|Withdrawal by Subject|0|||
124947492|NCT01915914|449434385|FG000|Acute Phase|Lost to Follow-up|4|||
124947493|NCT01915914|449434386|FG001|Acute Phase|Lost to Follow-up|0|||
124947494|NCT01915914|449434387|FG002|Acute Phase|Lost to Follow-up|0|||
124947495|NCT01915914|449434388|FG003|Acute Phase|Lost to Follow-up|0|||
124947496|NCT01915914|449434385|FG000|Acute Phase|Physician Decision|1|||
124947497|NCT01915914|449434386|FG001|Acute Phase|Physician Decision|0|||
124947498|NCT01915914|449434387|FG002|Acute Phase|Physician Decision|0|||
124947499|NCT01915914|449434388|FG003|Acute Phase|Physician Decision|0|||
124947500|NCT01915914|449434385|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
124947501|NCT01915914|449434386|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
124947502|NCT01915914|449434387|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
124947503|NCT01915914|449434388|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
124947504|NCT01915914|449434385|FG000|Acute Phase|"Not Achieved treatment success"|1|||
125214696|NCT00398216|450414840|FG004|Overall Study|Lost to Follow-up|1|||
125214697|NCT00398216|450414836|FG000|Overall Study|Death|0|||
125214698|NCT00398216|450414837|FG001|Overall Study|Death|3|||
125214699|NCT00398216|450414838|FG002|Overall Study|Death|0|||
124947505|NCT01915914|449434386|FG001|Acute Phase|"Not Achieved treatment success"|0|||
124947506|NCT01915914|449434387|FG002|Acute Phase|"Not Achieved treatment success"|0|||
124947507|NCT01915914|449434388|FG003|Acute Phase|"Not Achieved treatment success"|0|||
124947508|NCT01915914|449434385|FG000|Acute Phase|Missing|1|||
124947509|NCT01915914|449434386|FG001|Acute Phase|Missing|0|||
124947510|NCT01915914|449434387|FG002|Acute Phase|Missing|0|||
124947511|NCT01915914|449434388|FG003|Acute Phase|Missing|0|||
124947512|NCT01915914|449434385|FG000|Maintenance Phase|Withdrawal by Subject|0|||
124947513|NCT01915914|449434386|FG001|Maintenance Phase|Withdrawal by Subject|1|||
124947514|NCT01915914|449434387|FG002|Maintenance Phase|Withdrawal by Subject|1|||
124947515|NCT01915914|449434388|FG003|Maintenance Phase|Withdrawal by Subject|0|||
124947516|NCT01915914|449434385|FG000|Maintenance Phase|Lost to Follow-up|0|||
124947517|NCT01915914|449434386|FG001|Maintenance Phase|Lost to Follow-up|4|||
125214700|NCT00398216|450414839|FG003|Overall Study|Death|0|||
125214701|NCT00398216|450414840|FG004|Overall Study|Death|0|||
125214702|NCT00398216|450414836|FG000|Overall Study|Withdrawal by Subject|1|||
125214703|NCT00398216|450414837|FG001|Overall Study|Withdrawal by Subject|0|||
125214704|NCT00398216|450414838|FG002|Overall Study|Withdrawal by Subject|3|||
124947518|NCT01915914|449434387|FG002|Maintenance Phase|Lost to Follow-up|1|||
124947519|NCT01915914|449434388|FG003|Maintenance Phase|Lost to Follow-up|0|||
124947520|NCT01915914|449434385|FG000|Maintenance Phase|Missing|0|||
124947521|NCT01915914|449434386|FG001|Maintenance Phase|Missing|1|||
124947522|NCT01915914|449434387|FG002|Maintenance Phase|Missing|0|||
124947523|NCT01915914|449434388|FG003|Maintenance Phase|Missing|0|||
124947524|NCT01915914|449434385|FG000|Follow-up Phase|Withdrawal by Subject|0|||
124947525|NCT01915914|449434386|FG001|Follow-up Phase|Withdrawal by Subject|0|||
124947526|NCT01915914|449434387|FG002|Follow-up Phase|Withdrawal by Subject|0|||
124947527|NCT01915914|449434388|FG003|Follow-up Phase|Withdrawal by Subject|1|||
125214705|NCT00398216|450414839|FG003|Overall Study|Withdrawal by Subject|1|||
125214706|NCT00398216|450414840|FG004|Overall Study|Withdrawal by Subject|2|||
125214707|NCT00398216|450414836|FG000|Overall Study|administrative reasons|3|||
125214708|NCT00398216|450414837|FG001|Overall Study|administrative reasons|4|||
124947528|NCT01915914|449434385|FG000|Follow-up Phase|Physician Decision|0|||
124947529|NCT01915914|449434386|FG001|Follow-up Phase|Physician Decision|0|||
124947530|NCT01915914|449434387|FG002|Follow-up Phase|Physician Decision|0|||
124947531|NCT01915914|449434388|FG003|Follow-up Phase|Physician Decision|1|||
124947532|NCT00116649|449434389|FG000|Overall Study|Adverse Event|20|||
124947533|NCT00116649|449434389|FG000|Overall Study|Lack of Efficacy|1|||
124947534|NCT00116649|449434389|FG000|Overall Study|Lost to Follow-up|32|||
124947535|NCT00116649|449434389|FG000|Overall Study|Withdrawal by Subject|68|||
124947536|NCT00116649|449434389|FG000|Overall Study|Local Skin Reaction|9|||
124947537|NCT00116649|449434389|FG000|Overall Study|Various Reasons|18|||
124947538|NCT00116649|449434389|FG000|Overall Study|Protocol Specified|7|||
124947539|NCT02114515|449434390|FG000|Overall Study|Lost to Follow-up|52|||
124947540|NCT02114515|449434391|FG001|Overall Study|Lost to Follow-up|55|||
124947541|NCT02114515|449434390|FG000|Overall Study|Death|12|||
124947542|NCT02114515|449434391|FG001|Overall Study|Death|12|||
124947543|NCT02114515|449434390|FG000|Overall Study|Withdrawal by Subject|4|||
124947544|NCT02114515|449434391|FG001|Overall Study|Withdrawal by Subject|22|||
124947545|NCT02114515|449434390|FG000|Overall Study|Other|65|||
124947546|NCT02114515|449434391|FG001|Overall Study|Other|61|||
124947547|NCT02659540|449434394|FG000|Overall Study|Adverse Event|3|||
124947548|NCT02659540|449434395|FG001|Overall Study|Adverse Event|2|||
124947549|NCT02659540|449434394|FG000|Overall Study|Death|1|||
124947550|NCT02659540|449434395|FG001|Overall Study|Death|0|||
124947551|NCT02659540|449434394|FG000|Overall Study|Progressive disease|2|||
124947552|NCT02659540|449434395|FG001|Overall Study|Progressive disease|6|||
124947553|NCT01075152|449434398|FG000|Overall Study|Withdrawal by Subject|1|||
124947554|NCT01075152|449434399|FG001|Overall Study|Withdrawal by Subject|0|||
124947555|NCT04820491|449434400|FG000|Overall Study|Withdrawal by Subject|1|||
124947556|NCT04820491|449434401|FG001|Overall Study|Withdrawal by Subject|0|||
124947557|NCT02334215|449434402|FG000|Overall Study|Death|1|||
124947558|NCT02334215|449434403|FG001|Overall Study|Death|1|||
124947559|NCT02334215|449434404|FG002|Overall Study|Death|0|||
124947560|NCT02334215|449434402|FG000|Overall Study|Lost to Follow-up|1|||
124947561|NCT02334215|449434403|FG001|Overall Study|Lost to Follow-up|0|||
124947562|NCT02334215|449434404|FG002|Overall Study|Lost to Follow-up|4|||
124947563|NCT02334215|449434402|FG000|Overall Study|Withdrawal by Subject|2|||
124947564|NCT02334215|449434403|FG001|Overall Study|Withdrawal by Subject|2|||
124947565|NCT02334215|449434404|FG002|Overall Study|Withdrawal by Subject|1|||
124947566|NCT02334215|449434402|FG000|Overall Study|Not released from incarceration on time|3|||
124947567|NCT02334215|449434403|FG001|Overall Study|Not released from incarceration on time|3|||
124947568|NCT02334215|449434404|FG002|Overall Study|Not released from incarceration on time|3|||
124947569|NCT02334215|449434402|FG000|Overall Study|Incarcerated|0|||
124947570|NCT02334215|449434403|FG001|Overall Study|Incarcerated|0|||
124947571|NCT02334215|449434404|FG002|Overall Study|Incarcerated|7|||
124947572|NCT03976323|449434407|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
124947573|NCT03976323|449434408|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
124947574|NCT03976323|449434409|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
124947575|NCT03976323|449434407|FG000|Induction Phase|Death|80|||
124947576|NCT03976323|449434408|FG001|Induction Phase|Death|0|||
124947577|NCT03976323|449434409|FG002|Induction Phase|Death|0|||
124947578|NCT03976323|449434407|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
124947579|NCT03976323|449434408|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
124947580|NCT03976323|449434409|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
124947581|NCT03976323|449434407|FG000|Maintenance Phase|Withdrawal by Subject|0|||
124947582|NCT03976323|449434408|FG001|Maintenance Phase|Withdrawal by Subject|9|||
124947583|NCT03976323|449434409|FG002|Maintenance Phase|Withdrawal by Subject|3|||
124947584|NCT03976323|449434407|FG000|Maintenance Phase|Physician Decision|0|||
124947585|NCT03976323|449434408|FG001|Maintenance Phase|Physician Decision|0|||
124947586|NCT03976323|449434409|FG002|Maintenance Phase|Physician Decision|1|||
124947587|NCT03976323|449434407|FG000|Maintenance Phase|Death|0|||
124947588|NCT03976323|449434408|FG001|Maintenance Phase|Death|228|||
124947589|NCT03976323|449434409|FG002|Maintenance Phase|Death|234|||
125029343|NCT01400932|449730654|FG001|Overall Study|Withdrawal by Subject|6|||
125029344|NCT01400932|449730653|FG000|Overall Study|Lost to Follow-up|1|||
124947590|NCT00535626|449436407|FG000|Overall Study|Death|15|||
124947591|NCT00535626|449436407|FG000|Overall Study|Lost to Follow-up|29|||
124947592|NCT00535626|449436407|FG000|Overall Study|Withdrawal by Subject|20|||
124947593|NCT00535626|449436407|FG000|Overall Study|Removal/revision of study component|8|||
124947594|NCT00535626|449436407|FG000|Overall Study|Subject terminated|31|||
124947595|NCT00535626|449436407|FG000|Overall Study|Unable to return|2|||
124947596|NCT02710669|449436408|FG000|Overall Study|Physician Decision|2|||
124947597|NCT02710669|449436409|FG001|Overall Study|Physician Decision|1|||
124947598|NCT02710669|449436410|FG002|Overall Study|Physician Decision|0|||
124947599|NCT02710669|449436408|FG000|Overall Study|Institutional delays (including COVID)|2|||
124947600|NCT02710669|449436409|FG001|Overall Study|Institutional delays (including COVID)|2|||
124947601|NCT02710669|449436410|FG002|Overall Study|Institutional delays (including COVID)|0|||
124947602|NCT02710669|449436408|FG000|Overall Study|arrived in afib/aflutter|10|||
124947603|NCT02710669|449436409|FG001|Overall Study|arrived in afib/aflutter|8|||
124947604|NCT02710669|449436410|FG002|Overall Study|arrived in afib/aflutter|2|||
124947605|NCT02014402|449436416|FG000|Overall Study|Adverse Event|1|||
124947606|NCT02014402|449436417|FG001|Overall Study|Adverse Event|0|||
124947607|NCT02014402|449436418|FG002|Overall Study|Adverse Event|0|||
124947608|NCT02014402|449436419|FG003|Overall Study|Adverse Event|0|||
124947609|NCT02014402|449436416|FG000|Overall Study|Withdrawal by Subject|1|||
124947610|NCT02014402|449436417|FG001|Overall Study|Withdrawal by Subject|2|||
124947611|NCT02014402|449436418|FG002|Overall Study|Withdrawal by Subject|2|||
124947612|NCT02014402|449436419|FG003|Overall Study|Withdrawal by Subject|1|||
124947613|NCT02014402|449436416|FG000|Overall Study|Subject did not have transportation|0|||
124947614|NCT02014402|449436417|FG001|Overall Study|Subject did not have transportation|1|||
124947615|NCT02014402|449436418|FG002|Overall Study|Subject did not have transportation|0|||
124947616|NCT02014402|449436419|FG003|Overall Study|Subject did not have transportation|0|||
124947617|NCT02014402|449436416|FG000|Overall Study|Lost to Follow-up|0|||
124947618|NCT02014402|449436417|FG001|Overall Study|Lost to Follow-up|0|||
124947619|NCT02014402|449436418|FG002|Overall Study|Lost to Follow-up|1|||
124947620|NCT02014402|449436419|FG003|Overall Study|Lost to Follow-up|2|||
124947621|NCT01190124|449436421|FG000|Overall Study|Death|3|||
124947622|NCT01190124|449436422|FG001|Overall Study|Death|0|||
124947623|NCT01190124|449436423|FG002|Overall Study|Death|0|||
124947624|NCT01190124|449436421|FG000|Overall Study|Therapeutic Failure|12|||
124947625|NCT01190124|449436422|FG001|Overall Study|Therapeutic Failure|0|||
124947626|NCT01190124|449436423|FG002|Overall Study|Therapeutic Failure|1|||
124947627|NCT01190124|449436421|FG000|Overall Study|Lost to Follow-up|2|||
124947628|NCT01190124|449436422|FG001|Overall Study|Lost to Follow-up|0|||
124947629|NCT01190124|449436423|FG002|Overall Study|Lost to Follow-up|0|||
124947630|NCT03493282|449436424|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
124947631|NCT03493282|449436425|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
124947632|NCT03493282|449436426|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
124947633|NCT03493282|449436424|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
124947634|NCT03493282|449436425|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
124947635|NCT03493282|449436426|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
124947636|NCT00070707|449436427|FG000|Overall Study|Adverse Event|1|||
124947637|NCT00070707|449436428|FG001|Overall Study|Adverse Event|2|||
124947638|NCT00070707|449436427|FG000|Overall Study|Lack of Efficacy|4|||
124947639|NCT00070707|449436428|FG001|Overall Study|Lack of Efficacy|1|||
124947640|NCT00070707|449436427|FG000|Overall Study|Protocol Violation|8|||
124947641|NCT00070707|449436428|FG001|Overall Study|Protocol Violation|4|||
124947642|NCT00070707|449436427|FG000|Overall Study|Unrelated to Study Medication|1|||
124947643|NCT00070707|449436428|FG001|Overall Study|Unrelated to Study Medication|0|||
124947644|NCT01523392|449436429|FG000|Treatment Period 1|Withdrawal by Subject|2|||
124947645|NCT01523392|449436430|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124947646|NCT01523392|449436429|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
124947647|NCT01523392|449436430|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
124947648|NCT01523392|449436429|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
124947649|NCT01523392|449436430|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
124947650|NCT02002689|449436432|FG000|Overall Study|Disease Progression|7|||
124947651|NCT02002689|449436432|FG000|Overall Study|Adverse Event|3|||
124947652|NCT01377844|449436433|FG000|Overall Study|Withdrawal by Subject|25|||
124947653|NCT01377844|449436434|FG001|Overall Study|Withdrawal by Subject|28|||
124947654|NCT01377844|449436433|FG000|Overall Study|Protocol Violation|2|||
124947655|NCT01377844|449436434|FG001|Overall Study|Protocol Violation|3|||
124947656|NCT01377844|449436433|FG000|Overall Study|Adverse Event|3|||
124947657|NCT01377844|449436434|FG001|Overall Study|Adverse Event|0|||
124947658|NCT01377844|449436433|FG000|Overall Study|Physician Decision|6|||
124947659|NCT01377844|449436434|FG001|Overall Study|Physician Decision|3|||
124947660|NCT01377844|449436433|FG000|Overall Study|Study terminated by Sponsor|0|||
124947661|NCT01377844|449436434|FG001|Overall Study|Study terminated by Sponsor|1|||
124947662|NCT02236611|449436436|FG000|Overall Study|Adverse Event|10|||
124947663|NCT02236611|449436437|FG001|Overall Study|Adverse Event|16|||
124947664|NCT02236611|449436436|FG000|Overall Study|Lack of Efficacy|4|||
124947665|NCT02236611|449436437|FG001|Overall Study|Lack of Efficacy|7|||
124947666|NCT02236611|449436436|FG000|Overall Study|Lost to Follow-up|0|||
124947667|NCT02236611|449436437|FG001|Overall Study|Lost to Follow-up|2|||
124947668|NCT02236611|449436436|FG000|Overall Study|Protocol deviation|3|||
124947669|NCT02236611|449436437|FG001|Overall Study|Protocol deviation|5|||
124947670|NCT02236611|449436436|FG000|Overall Study|Withdrew consent|9|||
124947671|NCT02236611|449436437|FG001|Overall Study|Withdrew consent|4|||
124947672|NCT03403036|449436441|FG000|Overall Study|Lack of Efficacy|5|||
124947673|NCT02701296|449436444|FG000|Overall Study|Incomplete Data|0|||
124947674|NCT02701296|449436445|FG001|Overall Study|Incomplete Data|2|||
124947675|NCT00240994|449436446|FG000|Overall Study|Lost to Follow-up|1|||
124947676|NCT00240994|449436446|FG000|Overall Study|Protocol Violation|1|||
124947677|NCT00240994|449436446|FG000|Overall Study|Graft failure|1|||
124947678|NCT01437540|449436447|FG000|Overall Study|Not listed below|7|||
124947679|NCT01437540|449436448|FG001|Overall Study|Not listed below|6|||
124947680|NCT01437540|449436447|FG000|Overall Study|COPD exacerbation|13|||
124947681|NCT01437540|449436448|FG001|Overall Study|COPD exacerbation|3|||
124947682|NCT01437540|449436447|FG000|Overall Study|Lost to Follow-up|3|||
124947683|NCT01437540|449436448|FG001|Overall Study|Lost to Follow-up|5|||
124947684|NCT01437540|449436447|FG000|Overall Study|Lack of Efficacy|23|||
124947685|NCT01437540|449436448|FG001|Overall Study|Lack of Efficacy|11|||
124947686|NCT01437540|449436447|FG000|Overall Study|Protocol Violation|24|||
124947687|NCT01437540|449436448|FG001|Overall Study|Protocol Violation|12|||
124947688|NCT01437540|449436447|FG000|Overall Study|Adverse Event|26|||
124947689|NCT01437540|449436448|FG001|Overall Study|Adverse Event|13|||
124947690|NCT01437540|449436447|FG000|Overall Study|Withdrawal by Subject|31|||
124947691|NCT01437540|449436448|FG001|Overall Study|Withdrawal by Subject|15|||
124947692|NCT03142932|449436449|FG000|Overall Study|Lost to Follow-up|2|||
124947693|NCT03142932|449436450|FG001|Overall Study|Lost to Follow-up|11|||
124947694|NCT00749944|449436455|FG000|Overall Study|Lost to Follow-up|2|||
124947695|NCT00749944|449436456|FG001|Overall Study|Lost to Follow-up|1|||
124947696|NCT00749944|449436455|FG000|Overall Study|Other|1|||
124947697|NCT00749944|449436456|FG001|Overall Study|Other|0|||
124947698|NCT00749944|449436455|FG000|Overall Study|Withdrawal by Subject|2|||
124947699|NCT00749944|449436456|FG001|Overall Study|Withdrawal by Subject|0|||
124947700|NCT02547974|449436457|FG000|Overall Study|Withdrawal by Subject|1|||
124947701|NCT02547974|449436458|FG001|Overall Study|Withdrawal by Subject|0|||
124947702|NCT02547974|449436459|FG002|Overall Study|Withdrawal by Subject|0|||
124947703|NCT02547974|449436460|FG003|Overall Study|Withdrawal by Subject|0|||
124947704|NCT01393600|449436464|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
124947705|NCT01393600|449436465|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
124947706|NCT01393600|449436466|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
124947707|NCT01393600|449436467|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
124947708|NCT01393600|449436464|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
124947709|NCT01393600|449436465|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
124947710|NCT01393600|449436466|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
124947711|NCT01393600|449436467|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
124947712|NCT01393600|449436464|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
124947713|NCT01393600|449436465|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
124947714|NCT01393600|449436466|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
124947715|NCT01393600|449436467|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
124947716|NCT01393600|449436464|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
124947717|NCT01393600|449436465|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
124947718|NCT01393600|449436466|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
124947719|NCT01393600|449436467|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
124947720|NCT01393600|449436464|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
124947721|NCT01393600|449436465|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
124947722|NCT01393600|449436466|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
124947723|NCT01393600|449436467|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
124947724|NCT01393600|449436464|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
124947725|NCT01393600|449436465|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
124947726|NCT01393600|449436466|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
125123891|NCT00264797|450078655|FG001|Overall Study|Practical Problems|3|||
125123892|NCT00264797|450078654|FG000|Overall Study|Incarceration|4|||
125123893|NCT00264797|450078655|FG001|Overall Study|Incarceration|5|||
125123894|NCT00264797|450078654|FG000|Overall Study|Pressure/advice from Outsiders|1|||
125123895|NCT00264797|450078655|FG001|Overall Study|Pressure/advice from Outsiders|1|||
125123896|NCT00264797|450078654|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
125123897|NCT00264797|450078655|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
125123898|NCT00264797|450078654|FG000|Overall Study|Other|3|||
125123899|NCT00264797|450078655|FG001|Overall Study|Other|4|||
125123900|NCT02636907|450078661|FG000|Autoinjector Assessment Period|Adverse Event|2|||
125123901|NCT02636907|450078661|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
125123902|NCT02636907|450078661|FG000|Extension Phase|Adverse Event|2|||
125123903|NCT02636907|450078661|FG000|Extension Phase|Withdrawal by Subject|4|||
125123904|NCT02636907|450078661|FG000|Extension Phase|Physician Decision|1|||
125123905|NCT02636907|450078661|FG000|Extension Phase|Lost to Follow-up|2|||
125123906|NCT02636907|450078661|FG000|Extension Phase|Lack of Efficacy|1|||
125214709|NCT00398216|450414838|FG002|Overall Study|administrative reasons|4|||
124947727|NCT01393600|449436467|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
124947728|NCT01393600|449436464|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
124947729|NCT01393600|449436465|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
124947730|NCT01393600|449436466|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
124947731|NCT01393600|449436467|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
124947732|NCT00603798|449436468|FG000|Overall Study|Adverse Event|4|||
125123907|NCT00762086|450078662|FG000|Overall Study|Adverse Event|2|||
125214710|NCT00398216|450414839|FG003|Overall Study|administrative reasons|3|||
124947733|NCT00603798|449436469|FG001|Overall Study|Adverse Event|2|||
124947734|NCT00603798|449436470|FG002|Overall Study|Adverse Event|1|||
124947735|NCT00603798|449436468|FG000|Overall Study|Withdrawal by Subject|4|||
124947736|NCT00603798|449436469|FG001|Overall Study|Withdrawal by Subject|3|||
124947737|NCT00603798|449436470|FG002|Overall Study|Withdrawal by Subject|4|||
124947738|NCT00603798|449436468|FG000|Overall Study|Lost to Follow-up|1|||
124947739|NCT00603798|449436469|FG001|Overall Study|Lost to Follow-up|0|||
124947740|NCT00603798|449436470|FG002|Overall Study|Lost to Follow-up|1|||
124947741|NCT00603798|449436468|FG000|Overall Study|Non-compliance with study procedures|0|||
124947742|NCT00603798|449436469|FG001|Overall Study|Non-compliance with study procedures|1|||
124947743|NCT00603798|449436470|FG002|Overall Study|Non-compliance with study procedures|0|||
124947744|NCT00603798|449436468|FG000|Overall Study|Not due to AE|1|||
124947745|NCT00603798|449436469|FG001|Overall Study|Not due to AE|1|||
124947746|NCT00603798|449436470|FG002|Overall Study|Not due to AE|4|||
124947747|NCT04766996|449436471|FG000|Overall Study|Withdrawal by Subject|1|||
124947748|NCT04766996|449436472|FG001|Overall Study|Withdrawal by Subject|0|||
124947749|NCT04766996|449436473|FG002|Overall Study|Withdrawal by Subject|13|||
124947750|NCT02988713|449436476|FG000|Overall Study|Withdrawal by Subject|1|||
124947751|NCT02988713|449436476|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
124947752|NCT04248868|449436482|FG000|Overall Study|Death|1|||
124947753|NCT04248868|449436482|FG000|Overall Study|Lost to Follow-up|3|||
124947754|NCT04248868|449436482|FG000|Overall Study|Protocol Violation|2|||
124947755|NCT03131713|449436483|FG000|Overall Study|Lost to Follow-up|5|||
124947756|NCT03131713|449436484|FG001|Overall Study|Lost to Follow-up|0|||
124947757|NCT02208843|449436485|FG000|Overall Study|Clinical symptoms of progression|2|||
124947758|NCT02208843|449436485|FG000|Overall Study|Progression disease according to RECIST|24|||
124947759|NCT02208843|449436485|FG000|Overall Study|Adverse Event|12|||
124947760|NCT02208843|449436485|FG000|Overall Study|Protocol Violation|1|||
124947761|NCT02208843|449436485|FG000|Overall Study|Withdrawal by Subject|1|||
124947762|NCT02208843|449436485|FG000|Overall Study|Switched to commercial afatinib|20|||
124947763|NCT01976507|449436486|FG000|Overall Study|Adverse Event|6|||
124947764|NCT01976507|449436486|FG000|Overall Study|ablation not done, drug not given|1|||
124947765|NCT01794299|449436496|FG000|Overall Study|ATIR manufacturing not possible|1|||
124947766|NCT01794299|449436496|FG000|Overall Study|Death|14|||
124947767|NCT01794299|449436496|FG000|Overall Study|Graft failure|1|||
124947768|NCT01794299|449436496|FG000|Overall Study|ATIR batch rejected|2|||
124947769|NCT01794299|449436496|FG000|Overall Study|Relapse|2|||
124947770|NCT01794299|449436496|FG000|Overall Study|Discontinued from active follow-up|1|||
124947771|NCT01794299|449436496|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
124947772|NCT01029704|449436497|FG000|Overall Study|Adverse Event|0|||
124947773|NCT01029704|449436498|FG001|Overall Study|Adverse Event|0|||
124947774|NCT01029704|449436499|FG002|Overall Study|Adverse Event|0|||
124947775|NCT01029704|449436500|FG003|Overall Study|Adverse Event|0|||
124947776|NCT01029704|449436501|FG004|Overall Study|Adverse Event|0|||
124947777|NCT01029704|449436502|FG005|Overall Study|Adverse Event|0|||
124947778|NCT01029704|449436503|FG006|Overall Study|Adverse Event|1|||
124947779|NCT01029704|449436504|FG007|Overall Study|Adverse Event|1|||
124947780|NCT01029704|449436505|FG008|Overall Study|Adverse Event|0|||
124947781|NCT01029704|449436497|FG000|Overall Study|Withdrawal by Subject|0|||
124947782|NCT01029704|449436498|FG001|Overall Study|Withdrawal by Subject|0|||
124947783|NCT01029704|449436499|FG002|Overall Study|Withdrawal by Subject|0|||
124947784|NCT01029704|449436500|FG003|Overall Study|Withdrawal by Subject|0|||
124947785|NCT01029704|449436501|FG004|Overall Study|Withdrawal by Subject|2|||
124947786|NCT01029704|449436502|FG005|Overall Study|Withdrawal by Subject|1|||
124947787|NCT01029704|449436503|FG006|Overall Study|Withdrawal by Subject|1|||
124947788|NCT01029704|449436504|FG007|Overall Study|Withdrawal by Subject|1|||
124947789|NCT01029704|449436505|FG008|Overall Study|Withdrawal by Subject|0|||
124947790|NCT01029704|449436497|FG000|Overall Study|Lost to Follow-up|0|||
124947791|NCT01029704|449436498|FG001|Overall Study|Lost to Follow-up|0|||
124947792|NCT01029704|449436499|FG002|Overall Study|Lost to Follow-up|0|||
124947793|NCT01029704|449436500|FG003|Overall Study|Lost to Follow-up|0|||
124947794|NCT01029704|449436501|FG004|Overall Study|Lost to Follow-up|0|||
124947795|NCT01029704|449436502|FG005|Overall Study|Lost to Follow-up|0|||
124947796|NCT01029704|449436503|FG006|Overall Study|Lost to Follow-up|1|||
124947797|NCT01029704|449436504|FG007|Overall Study|Lost to Follow-up|1|||
125123908|NCT00762086|450078663|FG001|Overall Study|Adverse Event|0|||
124947798|NCT01029704|449436505|FG008|Overall Study|Lost to Follow-up|1|||
124947799|NCT01029704|449436497|FG000|Overall Study|Lack of Efficacy|0|||
124947800|NCT01029704|449436498|FG001|Overall Study|Lack of Efficacy|0|||
124947801|NCT01029704|449436499|FG002|Overall Study|Lack of Efficacy|0|||
124947802|NCT01029704|449436500|FG003|Overall Study|Lack of Efficacy|0|||
124947803|NCT01029704|449436501|FG004|Overall Study|Lack of Efficacy|2|||
124947804|NCT01029704|449436502|FG005|Overall Study|Lack of Efficacy|3|||
124947805|NCT01029704|449436503|FG006|Overall Study|Lack of Efficacy|1|||
124947806|NCT01029704|449436504|FG007|Overall Study|Lack of Efficacy|2|||
124947807|NCT01029704|449436505|FG008|Overall Study|Lack of Efficacy|0|||
124947808|NCT01029704|449436497|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
124947809|NCT01029704|449436498|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
124947810|NCT01029704|449436499|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
124947811|NCT01029704|449436500|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
124947812|NCT01029704|449436501|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
124947813|NCT01029704|449436502|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
124947814|NCT01029704|449436503|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
124947815|NCT01029704|449436504|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
124947816|NCT01029704|449436505|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
124947817|NCT00089791|449436509|FG000|Overall Study|Physician Decision|6|||
124947818|NCT00089791|449436510|FG001|Overall Study|Physician Decision|3|||
124947819|NCT00089791|449436509|FG000|Overall Study|Adverse Event|81|||
124947820|NCT00089791|449436510|FG001|Overall Study|Adverse Event|93|||
124947821|NCT00089791|449436509|FG000|Overall Study|Withdrawal by Subject|403|||
124947822|NCT00089791|449436510|FG001|Overall Study|Withdrawal by Subject|344|||
124947823|NCT00089791|449436509|FG000|Overall Study|Death|78|||
124947824|NCT00089791|449436510|FG001|Overall Study|Death|62|||
124947825|NCT00089791|449436509|FG000|Overall Study|Disease progression|7|||
124947826|NCT00089791|449436510|FG001|Overall Study|Disease progression|3|||
124947827|NCT00089791|449436509|FG000|Overall Study|Ineligibility determined|12|||
124947828|NCT00089791|449436510|FG001|Overall Study|Ineligibility determined|9|||
124947829|NCT00089791|449436509|FG000|Overall Study|Lost to Follow-up|57|||
124947830|NCT00089791|449436510|FG001|Overall Study|Lost to Follow-up|57|||
124947831|NCT00089791|449436509|FG000|Overall Study|Noncompliance|17|||
124947832|NCT00089791|449436510|FG001|Overall Study|Noncompliance|13|||
124947833|NCT00089791|449436509|FG000|Overall Study|Other|20|||
124947834|NCT00089791|449436510|FG001|Overall Study|Other|32|||
124947835|NCT00089791|449436509|FG000|Overall Study|Protocol deviation|12|||
124947836|NCT00089791|449436510|FG001|Overall Study|Protocol deviation|10|||
124947837|NCT00089791|449436509|FG000|Overall Study|Requirement for alternative therapy|7|||
124947838|NCT00089791|449436510|FG001|Overall Study|Requirement for alternative therapy|4|||
124947839|NCT00148122|449436511|FG000|Overall Study|Withdrawal by Subject|2|||
124947840|NCT05376397|449436514|FG000|Overall Study|Lost to Follow-up|1|||
124947841|NCT01137682|449436515|FG000|Overall Study|Adverse Event-CORE|2|||
124947842|NCT01137682|449436516|FG001|Overall Study|Adverse Event-CORE|4|||
124947843|NCT01137682|449436517|FG002|Overall Study|Adverse Event-CORE|0|||
124947844|NCT01137682|449436515|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
124947845|NCT01137682|449436516|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
124947846|NCT01137682|449436517|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
124947847|NCT01137682|449436515|FG000|Overall Study|Administrative problems-CORE|2|||
124947848|NCT01137682|449436516|FG001|Overall Study|Administrative problems-CORE|1|||
124947849|NCT01137682|449436517|FG002|Overall Study|Administrative problems-CORE|0|||
124947850|NCT01137682|449436515|FG000|Overall Study|Protocol Violation-CORE|0|||
124947851|NCT01137682|449436516|FG001|Overall Study|Protocol Violation-CORE|1|||
124947852|NCT01137682|449436517|FG002|Overall Study|Protocol Violation-CORE|1|||
124947853|NCT01137682|449436515|FG000|Overall Study|Adverse Event-Extension|4|||
124947854|NCT01137682|449436516|FG001|Overall Study|Adverse Event-Extension|8|||
124947855|NCT01137682|449436517|FG002|Overall Study|Adverse Event-Extension|7|||
124947856|NCT01137682|449436515|FG000|Overall Study|Lack of Efficacy-Extension|15|||
124947857|NCT01137682|449436516|FG001|Overall Study|Lack of Efficacy-Extension|9|||
124947858|NCT01137682|449436517|FG002|Overall Study|Lack of Efficacy-Extension|13|||
124947859|NCT01137682|449436515|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
124947860|NCT01137682|449436516|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
124947861|NCT01137682|449436517|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
124947862|NCT01137682|449436515|FG000|Overall Study|Lost to Follow Up-Extension|0|||
124947863|NCT01137682|449436516|FG001|Overall Study|Lost to Follow Up-Extension|1|||
124947864|NCT01137682|449436517|FG002|Overall Study|Lost to Follow Up-Extension|0|||
124947865|NCT01137682|449436515|FG000|Overall Study|Administrative problems-Extension|0|||
125029345|NCT01400932|449730654|FG001|Overall Study|Lost to Follow-up|0|||
125029346|NCT01400932|449730653|FG000|Overall Study|Protocol Deviation|0|||
125029347|NCT01400932|449730654|FG001|Overall Study|Protocol Deviation|1|||
125029348|NCT01400932|449730653|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
125029349|NCT01400932|449730654|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
125029350|NCT03244059|449730671|FG000|Specific Aim 1|Physician Decision|1|||
125029351|NCT03244059|449730672|FG001|Specific Aim 1|Physician Decision|0|||
125029352|NCT03244059|449730671|FG000|Specific Aim 2|Physician Decision|1|||
125029353|NCT03244059|449730672|FG001|Specific Aim 2|Physician Decision|0|||
125214711|NCT00398216|450414840|FG004|Overall Study|administrative reasons|3|||
124947866|NCT01137682|449436516|FG001|Overall Study|Administrative problems-Extension|2|||
124947867|NCT01137682|449436517|FG002|Overall Study|Administrative problems-Extension|0|||
124947868|NCT01137682|449436515|FG000|Overall Study|Death-Extension|2|||
124947869|NCT01137682|449436516|FG001|Overall Study|Death-Extension|0|||
124947870|NCT01137682|449436517|FG002|Overall Study|Death-Extension|0|||
124947871|NCT01137682|449436515|FG000|Overall Study|Protocol Violation-Extension|2|||
124947872|NCT01137682|449436516|FG001|Overall Study|Protocol Violation-Extension|1|||
125029354|NCT01276821|449730673|FG000|Overall Study|Protocol Violation|0|||
124947873|NCT01137682|449436517|FG002|Overall Study|Protocol Violation-Extension|0|||
124947874|NCT01137682|449436515|FG000|Overall Study|Did not enter extension|2|||
124947875|NCT01137682|449436516|FG001|Overall Study|Did not enter extension|3|||
124947876|NCT01137682|449436517|FG002|Overall Study|Did not enter extension|2|||
124947877|NCT01137682|449436515|FG000|Overall Study|Did not receive treatment in extension|0|||
124947878|NCT01137682|449436516|FG001|Overall Study|Did not receive treatment in extension|0|||
124947879|NCT01137682|449436517|FG002|Overall Study|Did not receive treatment in extension|1|||
124947880|NCT01365546|449436518|FG000|Overall Study|Withdrawal by Subject|1|||
124947881|NCT01365546|449436518|FG000|Overall Study|Screen failure|9|||
124947882|NCT01365546|449436518|FG000|Overall Study|Study termination|1|||
124947883|NCT00721734|449436519|FG000|Overall Study|Progressive Disease|3|||
124947884|NCT00721734|449436520|FG001|Overall Study|Progressive Disease|10|||
124947885|NCT00721734|449436521|FG002|Overall Study|Progressive Disease|4|||
124947886|NCT00721734|449436522|FG003|Overall Study|Progressive Disease|5|||
124947887|NCT00721734|449436523|FG004|Overall Study|Progressive Disease|2|||
124947888|NCT00721734|449436519|FG000|Overall Study|Adverse Event|3|||
124947889|NCT00721734|449436520|FG001|Overall Study|Adverse Event|1|||
124947890|NCT00721734|449436521|FG002|Overall Study|Adverse Event|4|||
124947891|NCT00721734|449436522|FG003|Overall Study|Adverse Event|0|||
124947892|NCT00721734|449436523|FG004|Overall Study|Adverse Event|3|||
124947893|NCT00721734|449436519|FG000|Overall Study|Withdrawal by Subject|2|||
124947894|NCT00721734|449436520|FG001|Overall Study|Withdrawal by Subject|1|||
124947895|NCT00721734|449436521|FG002|Overall Study|Withdrawal by Subject|0|||
124947896|NCT00721734|449436522|FG003|Overall Study|Withdrawal by Subject|0|||
124947897|NCT00721734|449436523|FG004|Overall Study|Withdrawal by Subject|1|||
124947898|NCT00721734|449436519|FG000|Overall Study|Other|0|||
124947899|NCT00721734|449436520|FG001|Overall Study|Other|0|||
124947900|NCT00721734|449436521|FG002|Overall Study|Other|0|||
124947901|NCT00721734|449436522|FG003|Overall Study|Other|1|||
124947902|NCT00721734|449436523|FG004|Overall Study|Other|0|||
124947903|NCT00472082|449436524|FG000|Overall Study|Study prematurely terminated|5|||
124947904|NCT04617847|449436525|FG000|Overall Study|Withdrawal by Subject|1|||
124947905|NCT04617847|449436526|FG001|Overall Study|Withdrawal by Subject|0|||
124947906|NCT04617847|449436525|FG000|Overall Study|Adverse Event|0|||
124947907|NCT04617847|449436526|FG001|Overall Study|Adverse Event|2|||
124947908|NCT04617847|449436525|FG000|Overall Study|Death|0|||
124947909|NCT04617847|449436526|FG001|Overall Study|Death|1|||
124947910|NCT04617847|449436525|FG000|Overall Study|Termination of Study by Sponsor|2|||
124947911|NCT04617847|449436526|FG001|Overall Study|Termination of Study by Sponsor|21|||
124947912|NCT01989689|449436527|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
124947913|NCT01989689|449436528|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
124947914|NCT01989689|449436527|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
124947915|NCT01989689|449436528|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
124947916|NCT00761267|449436529|FG000|Overall Study|Death|1|||
124947917|NCT00761267|449436530|FG001|Overall Study|Death|2|||
124947918|NCT00761267|449436531|FG002|Overall Study|Death|5|||
124947919|NCT00761267|449436529|FG000|Overall Study|Lost to Follow-up|0|||
124947920|NCT00761267|449436530|FG001|Overall Study|Lost to Follow-up|0|||
124947921|NCT00761267|449436531|FG002|Overall Study|Lost to Follow-up|1|||
124947922|NCT00761267|449436529|FG000|Overall Study|Randomized but not treated|1|||
125123909|NCT00762086|450078662|FG000|Overall Study|Lost to Follow-up|0|||
124947923|NCT00761267|449436530|FG001|Overall Study|Randomized but not treated|1|||
124947924|NCT00761267|449436531|FG002|Overall Study|Randomized but not treated|0|||
124947925|NCT00761267|449436529|FG000|Overall Study|Withdrawal by Subject|0|||
124947926|NCT00761267|449436530|FG001|Overall Study|Withdrawal by Subject|1|||
124947927|NCT00761267|449436531|FG002|Overall Study|Withdrawal by Subject|0|||
124947928|NCT04492475|449436532|FG000|Overall Study|Enrolled but not treated|8|||
124947929|NCT04492475|449436533|FG001|Overall Study|Enrolled but not treated|8|||
124947930|NCT04492475|449436532|FG000|Overall Study|Withdrawal by Subject|4|||
125123910|NCT00762086|450078663|FG001|Overall Study|Lost to Follow-up|2|||
124947931|NCT04492475|449436533|FG001|Overall Study|Withdrawal by Subject|0|||
124947932|NCT04492475|449436532|FG000|Overall Study|Became ineligible after enrollment|2|||
124947933|NCT04492475|449436533|FG001|Overall Study|Became ineligible after enrollment|0|||
124947934|NCT03989232|449436534|FG000|Overall Study|Lost to Follow-up|3|||
124947935|NCT03989232|449436535|FG001|Overall Study|Lost to Follow-up|10|||
124947936|NCT03989232|449436534|FG000|Overall Study|Withdrawal by Subject|6|||
124947937|NCT03989232|449436535|FG001|Overall Study|Withdrawal by Subject|6|||
124947938|NCT03989232|449436534|FG000|Overall Study|Death|1|||
124947939|NCT03989232|449436535|FG001|Overall Study|Death|2|||
124947940|NCT01323790|449436545|FG000|Overall Study|Other|3|||
124947941|NCT01323790|449436546|FG001|Overall Study|Other|2|||
124947942|NCT01323790|449436547|FG002|Overall Study|Other|1|||
124947943|NCT01323790|449436545|FG000|Overall Study|Lost to Follow-up|11|||
124947944|NCT01323790|449436546|FG001|Overall Study|Lost to Follow-up|9|||
124947945|NCT01323790|449436547|FG002|Overall Study|Lost to Follow-up|9|||
124947946|NCT01323790|449436545|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
124947947|NCT01323790|449436546|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
125123911|NCT00762086|450078662|FG000|Overall Study|Non compliance|1|||
124947948|NCT01323790|449436547|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
124947949|NCT01323790|449436545|FG000|Overall Study|Lack of Efficacy|3|||
124947950|NCT01323790|449436546|FG001|Overall Study|Lack of Efficacy|0|||
124947951|NCT01323790|449436547|FG002|Overall Study|Lack of Efficacy|3|||
124947952|NCT01323790|449436545|FG000|Overall Study|Adverse Event|11|||
124947953|NCT01323790|449436546|FG001|Overall Study|Adverse Event|24|||
124947954|NCT01323790|449436547|FG002|Overall Study|Adverse Event|12|||
124947955|NCT01323790|449436545|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
124947956|NCT01323790|449436546|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
124947957|NCT01323790|449436547|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
124947958|NCT01323790|449436545|FG000|Overall Study|Withdrawal by Subject|23|||
124947959|NCT01323790|449436546|FG001|Overall Study|Withdrawal by Subject|20|||
124947960|NCT01323790|449436547|FG002|Overall Study|Withdrawal by Subject|13|||
124947961|NCT01323790|449436545|FG000|Overall Study|Did Not Receive Treatment|2|||
124947962|NCT01323790|449436546|FG001|Overall Study|Did Not Receive Treatment|0|||
124947963|NCT01323790|449436547|FG002|Overall Study|Did Not Receive Treatment|1|||
124947964|NCT01323790|449436545|FG000|Overall Study|Severe non-compliance with protocol|2|||
124947965|NCT01323790|449436546|FG001|Overall Study|Severe non-compliance with protocol|2|||
124947966|NCT01323790|449436547|FG002|Overall Study|Severe non-compliance with protocol|2|||
124947967|NCT01263496|449436548|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
124947968|NCT01263496|449436549|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
124947969|NCT01263496|449436550|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
124947970|NCT01263496|449436551|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
124947971|NCT01263496|449436552|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
124947972|NCT01263496|449436553|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
124947973|NCT01263496|449436554|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
124947974|NCT01263496|449436555|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
124947975|NCT01263496|449436556|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
124947976|NCT01263496|449436548|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124947977|NCT01263496|449436549|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124947978|NCT01263496|449436550|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124947979|NCT01263496|449436551|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
124947980|NCT01263496|449436552|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
124947981|NCT01263496|449436553|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124947982|NCT01263496|449436554|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124947983|NCT01263496|449436555|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124947984|NCT01263496|449436556|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124947985|NCT01263496|449436548|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
124947986|NCT01263496|449436549|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
124947987|NCT01263496|449436550|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
124947988|NCT01263496|449436551|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
124947989|NCT01263496|449436552|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
124947990|NCT01263496|449436553|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
124947991|NCT01263496|449436554|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
124947992|NCT01263496|449436555|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
124947993|NCT01263496|449436556|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
124947994|NCT01263496|449436548|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
124947995|NCT01263496|449436549|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
124947996|NCT01263496|449436550|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
124947997|NCT01263496|449436551|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
124947998|NCT01263496|449436552|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
124947999|NCT01263496|449436553|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
124948000|NCT01263496|449436554|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
124948001|NCT01263496|449436555|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
124948002|NCT01263496|449436556|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
124948003|NCT01263496|449436548|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
124948004|NCT01263496|449436549|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
124948005|NCT01263496|449436550|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
124948006|NCT01263496|449436551|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
124948007|NCT01263496|449436552|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
125029355|NCT01276821|449730674|FG001|Overall Study|Protocol Violation|1|||
125029356|NCT00556426|449730675|FG000|Overall Study|Withdrawal by Subject|3|||
125214712|NCT00398216|450414836|FG000|Overall Study|entrance criteria|0|||
124948008|NCT01263496|449436553|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
124948009|NCT01263496|449436554|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
125029357|NCT00556426|449730675|FG000|Overall Study|Death|6|||
124948010|NCT01263496|449436555|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
124948011|NCT01263496|449436556|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
124948012|NCT01263496|449436548|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
124948013|NCT01263496|449436549|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
124948014|NCT01263496|449436550|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
124948015|NCT01263496|449436551|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
124948016|NCT01263496|449436552|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
124948017|NCT01263496|449436553|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
124948018|NCT01263496|449436554|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
124948019|NCT01263496|449436555|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
124948020|NCT01263496|449436556|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
124948021|NCT01263496|449436548|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
124948022|NCT01263496|449436549|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
124948023|NCT01263496|449436550|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
124948024|NCT01263496|449436551|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
124948025|NCT01263496|449436552|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
124948026|NCT01263496|449436553|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
124948027|NCT01263496|449436554|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
124948028|NCT01263496|449436555|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
124948029|NCT01263496|449436556|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
124948030|NCT02432274|449436557|FG000|Overall Study|Death|2|||
124948031|NCT02432274|449436558|FG001|Overall Study|Death|6|||
124948032|NCT02432274|449436559|FG002|Overall Study|Death|7|||
124948033|NCT02432274|449436560|FG003|Overall Study|Death|0|||
124948034|NCT02432274|449436561|FG004|Overall Study|Death|27|||
124948035|NCT02432274|449436562|FG005|Overall Study|Death|7|||
124948036|NCT02432274|449436563|FG006|Overall Study|Death|9|||
124948037|NCT02432274|449436564|FG007|Overall Study|Death|14|||
124948038|NCT02432274|449436557|FG000|Overall Study|Withdrawal of Consent|0|||
124948039|NCT02432274|449436558|FG001|Overall Study|Withdrawal of Consent|0|||
124948040|NCT02432274|449436559|FG002|Overall Study|Withdrawal of Consent|0|||
124948041|NCT02432274|449436560|FG003|Overall Study|Withdrawal of Consent|0|||
124948042|NCT02432274|449436561|FG004|Overall Study|Withdrawal of Consent|2|||
124948043|NCT02432274|449436562|FG005|Overall Study|Withdrawal of Consent|0|||
124948044|NCT02432274|449436563|FG006|Overall Study|Withdrawal of Consent|1|||
124948045|NCT02432274|449436564|FG007|Overall Study|Withdrawal of Consent|2|||
124948046|NCT00513071|449436567|FG000|Overall Study|Adverse Event|1|||
124948047|NCT00513071|449436567|FG000|Overall Study|Withdrawal by Subject|1|||
124948048|NCT00513071|449436567|FG000|Overall Study|Physician Decision|3|||
124948049|NCT00667732|449436570|FG000|Run -In (8 Weeks)|Adverse Event|4|||
124948050|NCT00667732|449436571|FG001|Run -In (8 Weeks)|Adverse Event|0|||
124948051|NCT00667732|449436572|FG002|Run -In (8 Weeks)|Adverse Event|0|||
124948052|NCT00667732|449436570|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
124948053|NCT00667732|449436571|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
124948054|NCT00667732|449436572|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
124948055|NCT00667732|449436570|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
124948056|NCT00667732|449436571|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
124948057|NCT00667732|449436572|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
124948058|NCT01240590|449436573|FG000|Phase I|Refused further treatment|0|||
124948059|NCT01240590|449436574|FG001|Phase I|Refused further treatment|0|||
124948060|NCT01240590|449436575|FG002|Phase I|Refused further treatment|3|||
124948061|NCT01240590|449436576|FG003|Phase I|Refused further treatment|0|||
124948062|NCT01240590|449436577|FG004|Phase I|Refused further treatment|0|||
124948063|NCT01240590|449436573|FG000|Phase II|Refused further treatment|0|||
124948064|NCT01240590|449436574|FG001|Phase II|Refused further treatment|0|||
124948065|NCT01240590|449436575|FG002|Phase II|Refused further treatment|0|||
124948066|NCT01240590|449436576|FG003|Phase II|Refused further treatment|2|||
124948067|NCT01240590|449436577|FG004|Phase II|Refused further treatment|1|||
124948068|NCT03890484|449436578|FG000|Overall Study|Lost to Follow-up|1|||
124948069|NCT03890484|449436579|FG001|Overall Study|Lost to Follow-up|1|||
124948070|NCT02106325|449436580|FG000|Phase 1|Lost to Follow-up|2|||
124948071|NCT02106325|449436581|FG001|Phase 1|Lost to Follow-up|2|||
125123912|NCT00762086|450078663|FG001|Overall Study|Non compliance|0|||
125123913|NCT00762086|450078662|FG000|Overall Study|Withdrawal by Subject|2|||
125123914|NCT00762086|450078663|FG001|Overall Study|Withdrawal by Subject|2|||
125123915|NCT00762086|450078662|FG000|Overall Study|Ineligible to participate in the study|1|||
125123916|NCT00762086|450078663|FG001|Overall Study|Ineligible to participate in the study|0|||
125123917|NCT03883906|450078671|FG000|Overall Study|Withdrawal by Subject|2|||
124948072|NCT02106325|449436580|FG000|Phase 2|Lost to Follow-up|2|||
124948073|NCT02106325|449436581|FG001|Phase 2|Lost to Follow-up|3|||
124948074|NCT02106325|449436580|FG000|Phase 3|Lost to Follow-up|2|||
124948075|NCT02106325|449436581|FG001|Phase 3|Lost to Follow-up|1|||
124948076|NCT00824850|449436582|FG000|Overall Study|Withdrawal by Subject|0|||
124948077|NCT00824850|449436583|FG001|Overall Study|Withdrawal by Subject|1|||
124948078|NCT01185340|449438087|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
124948079|NCT01185340|449438088|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
124948080|NCT01185340|449438089|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
124948081|NCT01185340|449438090|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
124948082|NCT01185340|449438087|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
124948083|NCT01185340|449438088|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
124948084|NCT01185340|449438089|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
124948085|NCT01185340|449438090|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
124948086|NCT01185340|449438087|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
124948087|NCT01185340|449438088|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
124948088|NCT01185340|449438089|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
124948089|NCT01185340|449438090|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
124948090|NCT01185340|449438087|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
124948091|NCT01185340|449438088|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
124948092|NCT01185340|449438089|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
124948093|NCT01185340|449438090|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
124948094|NCT01185340|449438087|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
124948095|NCT01185340|449438088|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
124948096|NCT01185340|449438089|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
124948097|NCT01185340|449438090|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
124948098|NCT01185340|449438087|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
124948099|NCT01185340|449438088|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
124948100|NCT01185340|449438089|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
124948101|NCT01185340|449438090|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
124948102|NCT01185340|449438087|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
124948103|NCT01185340|449438088|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
124948104|NCT01185340|449438089|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
124948105|NCT01185340|449438090|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
124948106|NCT01185340|449438087|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
124948107|NCT01185340|449438088|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
124948108|NCT01185340|449438089|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
124948109|NCT01185340|449438090|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
124948110|NCT01185340|449438087|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
124948111|NCT01185340|449438088|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
124948112|NCT01185340|449438089|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
124948113|NCT01185340|449438090|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
124948114|NCT01185340|449438087|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
124948115|NCT01185340|449438088|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
124948116|NCT01185340|449438089|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
124948117|NCT01185340|449438090|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
124948118|NCT01185340|449438087|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
124948119|NCT01185340|449438088|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
124948120|NCT01185340|449438089|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
124948121|NCT01185340|449438090|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
124948122|NCT01185340|449438087|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
124948123|NCT01185340|449438088|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
124948124|NCT01185340|449438089|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
124948125|NCT01185340|449438090|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
124948126|NCT01185340|449438087|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
124948127|NCT01185340|449438088|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
124948128|NCT01185340|449438089|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
124948129|NCT01185340|449438090|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
124948130|NCT01185340|449438087|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
124948131|NCT01185340|449438088|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
124948132|NCT01185340|449438089|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
124948133|NCT01185340|449438090|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
124948134|NCT00087516|449438091|FG000|Overall Study|Adverse Event|10|||
124948135|NCT00087516|449438092|FG001|Overall Study|Adverse Event|10|||
124948136|NCT00087516|449438093|FG002|Overall Study|Adverse Event|3|||
124948137|NCT00087516|449438094|FG003|Overall Study|Adverse Event|6|||
124948138|NCT00087516|449438091|FG000|Overall Study|Lack of Efficacy|82|||
124948139|NCT00087516|449438092|FG001|Overall Study|Lack of Efficacy|80|||
124948140|NCT00087516|449438093|FG002|Overall Study|Lack of Efficacy|39|||
124948141|NCT00087516|449438094|FG003|Overall Study|Lack of Efficacy|29|||
124948142|NCT00087516|449438091|FG000|Overall Study|Lost to Follow-up|8|||
124948143|NCT00087516|449438092|FG001|Overall Study|Lost to Follow-up|6|||
125029358|NCT01299727|449730677|FG000|Overall Study|Withdrawal by Subject|1|||
124948144|NCT00087516|449438093|FG002|Overall Study|Lost to Follow-up|5|||
124948145|NCT00087516|449438094|FG003|Overall Study|Lost to Follow-up|5|||
124948146|NCT00087516|449438091|FG000|Overall Study|Protocol Violation|4|||
124948147|NCT00087516|449438092|FG001|Overall Study|Protocol Violation|8|||
124948148|NCT00087516|449438093|FG002|Overall Study|Protocol Violation|3|||
124948149|NCT00087516|449438094|FG003|Overall Study|Protocol Violation|6|||
124948150|NCT00087516|449438091|FG000|Overall Study|Withdrawal by Subject|16|||
124948151|NCT00087516|449438092|FG001|Overall Study|Withdrawal by Subject|27|||
124948152|NCT00087516|449438093|FG002|Overall Study|Withdrawal by Subject|11|||
124948153|NCT00087516|449438094|FG003|Overall Study|Withdrawal by Subject|12|||
124948154|NCT00087516|449438091|FG000|Overall Study|Site terminated|0|||
124948155|NCT00087516|449438092|FG001|Overall Study|Site terminated|2|||
124948156|NCT00087516|449438093|FG002|Overall Study|Site terminated|1|||
124948157|NCT00087516|449438094|FG003|Overall Study|Site terminated|0|||
124948158|NCT00087516|449438091|FG000|Overall Study|Protocol specified discontinuation|35|||
124948159|NCT00087516|449438092|FG001|Overall Study|Protocol specified discontinuation|33|||
124948160|NCT00087516|449438093|FG002|Overall Study|Protocol specified discontinuation|33|||
124948161|NCT00087516|449438094|FG003|Overall Study|Protocol specified discontinuation|26|||
124948162|NCT00087516|449438091|FG000|Overall Study|Patient moved|3|||
124948163|NCT00087516|449438092|FG001|Overall Study|Patient moved|2|||
124948164|NCT00087516|449438093|FG002|Overall Study|Patient moved|1|||
124948165|NCT00087516|449438094|FG003|Overall Study|Patient moved|0|||
124948166|NCT00087516|449438091|FG000|Overall Study|Patient was non-compliant|3|||
124948167|NCT00087516|449438092|FG001|Overall Study|Patient was non-compliant|1|||
124948168|NCT00087516|449438093|FG002|Overall Study|Patient was non-compliant|0|||
124948169|NCT00087516|449438094|FG003|Overall Study|Patient was non-compliant|0|||
124948170|NCT00087516|449438091|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
124948171|NCT00087516|449438092|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
124948172|NCT00087516|449438093|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
124948173|NCT00087516|449438094|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
124948174|NCT00087516|449438091|FG000|Overall Study|Other|0|||
124948175|NCT00087516|449438092|FG001|Overall Study|Other|0|||
124948176|NCT00087516|449438093|FG002|Overall Study|Other|1|||
124948177|NCT00087516|449438094|FG003|Overall Study|Other|0|||
124948178|NCT02065895|449438095|FG000|Overall Study|Protocol Violation|1|||
124948179|NCT02065895|449438096|FG001|Overall Study|Protocol Violation|0|||
124948180|NCT02065895|449438097|FG002|Overall Study|Protocol Violation|0|||
124948181|NCT02065895|449438098|FG003|Overall Study|Protocol Violation|1|||
124948182|NCT02065895|449438099|FG004|Overall Study|Protocol Violation|0|||
124948183|NCT02065895|449438100|FG005|Overall Study|Protocol Violation|0|||
124948184|NCT02065895|449438095|FG000|Overall Study|Scheduling conflicts|0|||
124948185|NCT02065895|449438096|FG001|Overall Study|Scheduling conflicts|1|||
124948186|NCT02065895|449438097|FG002|Overall Study|Scheduling conflicts|0|||
124948187|NCT02065895|449438098|FG003|Overall Study|Scheduling conflicts|0|||
124948188|NCT02065895|449438099|FG004|Overall Study|Scheduling conflicts|0|||
124948189|NCT02065895|449438100|FG005|Overall Study|Scheduling conflicts|0|||
124948190|NCT00569166|449438105|FG000|Overall Study|Withdrawal by Subject|7|||
124948191|NCT00569166|449438106|FG001|Overall Study|Withdrawal by Subject|5|||
124948192|NCT00569166|449438107|FG002|Overall Study|Withdrawal by Subject|3|||
124948193|NCT00569166|449438105|FG000|Overall Study|Lost to Follow-up|2|||
124948194|NCT00569166|449438106|FG001|Overall Study|Lost to Follow-up|1|||
124948195|NCT00569166|449438107|FG002|Overall Study|Lost to Follow-up|1|||
124948196|NCT05005247|449438108|FG000|Overall Study|Withdrawal by Subject|0|||
124948197|NCT05005247|449438109|FG001|Overall Study|Withdrawal by Subject|1|||
124948198|NCT05005247|449438110|FG002|Overall Study|Withdrawal by Subject|0|||
125123918|NCT03883906|450078671|FG000|Overall Study|Physician Decision|5|||
125123919|NCT00486837|450078672|FG000|Overall Study|Withdrawal by Subject|1|||
125123920|NCT00486837|450078673|FG001|Overall Study|Withdrawal by Subject|0|||
125123921|NCT00486837|450078672|FG000|Overall Study|Adverse Event|1|||
125123922|NCT00486837|450078673|FG001|Overall Study|Adverse Event|1|||
125123923|NCT00486837|450078672|FG000|Overall Study|Protocol Violation|4|||
125123924|NCT00486837|450078673|FG001|Overall Study|Protocol Violation|2|||
125123925|NCT00486837|450078672|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
125123926|NCT00486837|450078673|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
124948199|NCT00484198|449438111|FG000|Overall Study|Participant Withdrew Consent|12|||
124948200|NCT00484198|449438112|FG001|Overall Study|Participant Withdrew Consent|21|||
124948201|NCT00484198|449438113|FG002|Overall Study|Participant Withdrew Consent|47|||
124948202|NCT00484198|449438114|FG003|Overall Study|Participant Withdrew Consent|59|||
124948203|NCT00484198|449438111|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
124948204|NCT00484198|449438112|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
124948205|NCT00484198|449438113|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
124948206|NCT00484198|449438114|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
124948207|NCT00484198|449438111|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
124948208|NCT00484198|449438112|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
124948209|NCT00484198|449438113|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
125123927|NCT02468778|450078674|FG000|Overall Study|Death|2|||
125123928|NCT02468778|450078675|FG001|Overall Study|Death|1|||
125123929|NCT02468778|450078676|FG002|Overall Study|Death|0|||
125123930|NCT02468778|450078674|FG000|Overall Study|Lost to Follow-up|1|||
125123931|NCT02468778|450078675|FG001|Overall Study|Lost to Follow-up|2|||
125123932|NCT02468778|450078676|FG002|Overall Study|Lost to Follow-up|2|||
125123933|NCT02468778|450078674|FG000|Overall Study|Withdrawal by Subject|0|||
125123934|NCT02468778|450078675|FG001|Overall Study|Withdrawal by Subject|1|||
125123935|NCT02468778|450078676|FG002|Overall Study|Withdrawal by Subject|1|||
125123936|NCT03130699|450078684|FG000|Overall Study|Lost to Follow-up|34|||
125123937|NCT03130699|450078685|FG001|Overall Study|Lost to Follow-up|37|||
125123938|NCT03130699|450078686|FG002|Overall Study|Lost to Follow-up|26|||
125123939|NCT03130699|450078684|FG000|Overall Study|Withdrawal by Subject|5|||
125123940|NCT03130699|450078685|FG001|Overall Study|Withdrawal by Subject|1|||
125123941|NCT03130699|450078686|FG002|Overall Study|Withdrawal by Subject|0|||
125123942|NCT03130699|450078684|FG000|Overall Study|Withdrawal by PI|1|||
125123943|NCT03130699|450078685|FG001|Overall Study|Withdrawal by PI|2|||
125123944|NCT03130699|450078686|FG002|Overall Study|Withdrawal by PI|5|||
125123945|NCT03130699|450078684|FG000|Overall Study|Death|0|||
125123946|NCT03130699|450078685|FG001|Overall Study|Death|0|||
125123947|NCT03130699|450078686|FG002|Overall Study|Death|1|||
125214713|NCT00398216|450414837|FG001|Overall Study|entrance criteria|0|||
125214714|NCT00398216|450414838|FG002|Overall Study|entrance criteria|0|||
125214715|NCT00398216|450414839|FG003|Overall Study|entrance criteria|0|||
124948210|NCT00484198|449438114|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
124948211|NCT00484198|449438111|FG000|Overall Study|Adverse Event|3|||
124948212|NCT00484198|449438112|FG001|Overall Study|Adverse Event|11|||
124948213|NCT00484198|449438113|FG002|Overall Study|Adverse Event|32|||
124948214|NCT00484198|449438114|FG003|Overall Study|Adverse Event|31|||
124948215|NCT00484198|449438111|FG000|Overall Study|Protocol Violation|0|||
124948216|NCT00484198|449438112|FG001|Overall Study|Protocol Violation|5|||
124948217|NCT00484198|449438113|FG002|Overall Study|Protocol Violation|6|||
124948218|NCT00484198|449438114|FG003|Overall Study|Protocol Violation|8|||
124948219|NCT00484198|449438111|FG000|Overall Study|Other|7|||
124948220|NCT00484198|449438112|FG001|Overall Study|Other|10|||
124948221|NCT00484198|449438113|FG002|Overall Study|Other|31|||
124948222|NCT00484198|449438114|FG003|Overall Study|Other|28|||
124948223|NCT00486954|449438116|FG000|Pilot Part|Adverse Event|4|||
124948224|NCT00486954|449438117|FG001|Pilot Part|Adverse Event|0|||
124948225|NCT00486954|449438118|FG002|Pilot Part|Adverse Event|5|||
124948226|NCT00486954|449438119|FG003|Pilot Part|Adverse Event|0|||
124948227|NCT00486954|449438120|FG004|Pilot Part|Adverse Event|0|||
125029359|NCT01299727|449730678|FG001|Overall Study|Withdrawal by Subject|0|||
125029360|NCT01299727|449730679|FG002|Overall Study|Withdrawal by Subject|0|||
125029361|NCT01299727|449730677|FG000|Overall Study|Adverse Event|0|||
125029362|NCT01299727|449730678|FG001|Overall Study|Adverse Event|0|||
125029363|NCT01299727|449730679|FG002|Overall Study|Adverse Event|1|||
125029364|NCT01299727|449730677|FG000|Overall Study|Completed the Treatment Period|3|||
125029365|NCT01299727|449730678|FG001|Overall Study|Completed the Treatment Period|4|||
125029366|NCT01299727|449730679|FG002|Overall Study|Completed the Treatment Period|3|||
125029367|NCT00441792|449730682|FG000|Overall Study|Lost to Follow-up|0|||
125029368|NCT00441792|449730683|FG001|Overall Study|Lost to Follow-up|2|||
125029369|NCT01879410|449730693|FG000|Overall Study|Adverse Event|9|||
125029370|NCT01879410|449730694|FG001|Overall Study|Adverse Event|14|||
125029371|NCT01879410|449730693|FG000|Overall Study|Lack of Efficacy|4|||
125029372|NCT01879410|449730694|FG001|Overall Study|Lack of Efficacy|6|||
125029373|NCT01879410|449730693|FG000|Overall Study|Protocol Violation|1|||
125029374|NCT01879410|449730694|FG001|Overall Study|Protocol Violation|7|||
125029375|NCT01879410|449730693|FG000|Overall Study|Lost to Follow-up|2|||
124948228|NCT00486954|449438116|FG000|Pilot Part|Disease Progression|2|||
124948229|NCT00486954|449438117|FG001|Pilot Part|Disease Progression|0|||
125029376|NCT01879410|449730694|FG001|Overall Study|Lost to Follow-up|1|||
124948230|NCT00486954|449438118|FG002|Pilot Part|Disease Progression|1|||
124948231|NCT00486954|449438119|FG003|Pilot Part|Disease Progression|0|||
124948232|NCT00486954|449438120|FG004|Pilot Part|Disease Progression|0|||
124948233|NCT00486954|449438116|FG000|Randomized Part|Lost to Follow-up|0|||
125029377|NCT01879410|449730693|FG000|Overall Study|Withdrawal by Subject|7|||
125029378|NCT01879410|449730694|FG001|Overall Study|Withdrawal by Subject|8|||
125029379|NCT01879410|449730693|FG000|Overall Study|Randomised in Error|1|||
125029380|NCT01879410|449730694|FG001|Overall Study|Randomised in Error|2|||
125029381|NCT02649634|449730695|FG000|Overall Study|Withdrawal by Subject|3|||
125123948|NCT01199861|450078687|FG000|Overall Study|Administrative problems|1|||
125123949|NCT01199861|450078688|FG001|Overall Study|Administrative problems|0|||
125123950|NCT01199861|450078687|FG000|Overall Study|Adverse Event|1|||
125123951|NCT01199861|450078688|FG001|Overall Study|Adverse Event|0|||
124948234|NCT00486954|449438117|FG001|Randomized Part|Lost to Follow-up|0|||
124948235|NCT00486954|449438118|FG002|Randomized Part|Lost to Follow-up|0|||
124948236|NCT00486954|449438119|FG003|Randomized Part|Lost to Follow-up|0|||
125214716|NCT00398216|450414840|FG004|Overall Study|entrance criteria|2|||
125214717|NCT01048944|450414843|FG000|Overall Study|Protocol Violation|8|||
124948237|NCT00486954|449438120|FG004|Randomized Part|Lost to Follow-up|1|||
124948238|NCT00486954|449438116|FG000|Randomized Part|Withdrawal by Subject|0|||
124948239|NCT00486954|449438117|FG001|Randomized Part|Withdrawal by Subject|0|||
124948240|NCT00486954|449438118|FG002|Randomized Part|Withdrawal by Subject|0|||
124948241|NCT00486954|449438119|FG003|Randomized Part|Withdrawal by Subject|1|||
124948242|NCT00486954|449438120|FG004|Randomized Part|Withdrawal by Subject|0|||
124948243|NCT00486954|449438116|FG000|Randomized Part|Sponsor Terminated Study|0|||
124948244|NCT00486954|449438117|FG001|Randomized Part|Sponsor Terminated Study|0|||
124948245|NCT00486954|449438118|FG002|Randomized Part|Sponsor Terminated Study|0|||
124948246|NCT00486954|449438119|FG003|Randomized Part|Sponsor Terminated Study|19|||
124948247|NCT00486954|449438120|FG004|Randomized Part|Sponsor Terminated Study|13|||
124948248|NCT00929526|449438121|FG000|Overall Study|Withdrawal by Subject|1|||
124948249|NCT00929526|449438122|FG001|Overall Study|Withdrawal by Subject|11|||
124948250|NCT00929526|449438121|FG000|Overall Study|Lost to Follow-up|8|||
124948251|NCT00929526|449438122|FG001|Overall Study|Lost to Follow-up|12|||
124948252|NCT00929526|449438121|FG000|Overall Study|Other|8|||
124948253|NCT00929526|449438122|FG001|Overall Study|Other|6|||
124948254|NCT01836523|449438123|FG000|Overall Study|Adverse Event|15|||
124948255|NCT01836523|449438124|FG001|Overall Study|Adverse Event|41|||
124948256|NCT01836523|449438125|FG002|Overall Study|Adverse Event|49|||
124948257|NCT01836523|449438126|FG003|Overall Study|Adverse Event|14|||
124948258|NCT01836523|449438123|FG000|Overall Study|Protocol Violation|6|||
124948259|NCT01836523|449438124|FG001|Overall Study|Protocol Violation|3|||
124948260|NCT01836523|449438125|FG002|Overall Study|Protocol Violation|2|||
124948261|NCT01836523|449438126|FG003|Overall Study|Protocol Violation|4|||
124948262|NCT01836523|449438123|FG000|Overall Study|Met Withdrawal Criteria|13|||
124948263|NCT01836523|449438124|FG001|Overall Study|Met Withdrawal Criteria|13|||
124948264|NCT01836523|449438125|FG002|Overall Study|Met Withdrawal Criteria|21|||
124948265|NCT01836523|449438126|FG003|Overall Study|Met Withdrawal Criteria|27|||
124948266|NCT01836523|449438123|FG000|Overall Study|Unclassified|17|||
125214718|NCT01048944|450414844|FG001|Overall Study|Protocol Violation|10|||
125214719|NCT01048944|450414845|FG002|Overall Study|Protocol Violation|10|||
124948267|NCT01836523|449438124|FG001|Overall Study|Unclassified|28|||
124948268|NCT01836523|449438125|FG002|Overall Study|Unclassified|19|||
124948269|NCT01836523|449438126|FG003|Overall Study|Unclassified|29|||
124948270|NCT00813709|449438129|FG000|Double Blind Period|Adverse Event|4|||
124948271|NCT00813709|449438130|FG001|Double Blind Period|Adverse Event|1|||
124948272|NCT00813709|449438131|FG002|Double Blind Period|Adverse Event|4|||
124948273|NCT00813709|449438132|FG003|Double Blind Period|Adverse Event|0|||
124948274|NCT00813709|449438133|FG004|Double Blind Period|Adverse Event|0|||
124948275|NCT00813709|449438134|FG005|Double Blind Period|Adverse Event|0|||
124948276|NCT00813709|449438129|FG000|Double Blind Period|Lost to Follow-up|3|||
124948277|NCT00813709|449438130|FG001|Double Blind Period|Lost to Follow-up|2|||
124948278|NCT00813709|449438131|FG002|Double Blind Period|Lost to Follow-up|2|||
124948279|NCT00813709|449438132|FG003|Double Blind Period|Lost to Follow-up|0|||
124948280|NCT00813709|449438133|FG004|Double Blind Period|Lost to Follow-up|0|||
124948281|NCT00813709|449438134|FG005|Double Blind Period|Lost to Follow-up|0|||
124948282|NCT00813709|449438129|FG000|Double Blind Period|Switched to open label phase|9|||
124948283|NCT00813709|449438130|FG001|Double Blind Period|Switched to open label phase|26|||
124948284|NCT00813709|449438131|FG002|Double Blind Period|Switched to open label phase|18|||
124948285|NCT00813709|449438132|FG003|Double Blind Period|Switched to open label phase|0|||
124948286|NCT00813709|449438133|FG004|Double Blind Period|Switched to open label phase|0|||
124948287|NCT00813709|449438134|FG005|Double Blind Period|Switched to open label phase|0|||
124948288|NCT00813709|449438129|FG000|Double Blind Period|Randomized but not treated|1|||
124948289|NCT00813709|449438130|FG001|Double Blind Period|Randomized but not treated|3|||
124948290|NCT00813709|449438131|FG002|Double Blind Period|Randomized but not treated|1|||
124948291|NCT00813709|449438132|FG003|Double Blind Period|Randomized but not treated|0|||
124948292|NCT00813709|449438133|FG004|Double Blind Period|Randomized but not treated|0|||
124948293|NCT00813709|449438134|FG005|Double Blind Period|Randomized but not treated|0|||
124948294|NCT00813709|449438129|FG000|Double Blind Period|Other|14|||
124948295|NCT00813709|449438130|FG001|Double Blind Period|Other|9|||
124948296|NCT00813709|449438131|FG002|Double Blind Period|Other|6|||
124948297|NCT00813709|449438132|FG003|Double Blind Period|Other|0|||
124948298|NCT00813709|449438133|FG004|Double Blind Period|Other|0|||
124948299|NCT00813709|449438134|FG005|Double Blind Period|Other|0|||
124948300|NCT00813709|449438129|FG000|Open Label Period|Adverse Event|0|||
124948301|NCT00813709|449438130|FG001|Open Label Period|Adverse Event|0|||
124948302|NCT00813709|449438131|FG002|Open Label Period|Adverse Event|0|||
124948303|NCT00813709|449438132|FG003|Open Label Period|Adverse Event|5|||
124948304|NCT00813709|449438133|FG004|Open Label Period|Adverse Event|4|||
124948305|NCT00813709|449438134|FG005|Open Label Period|Adverse Event|3|||
124948306|NCT00813709|449438129|FG000|Open Label Period|Lack of Efficacy|0|||
124948307|NCT00813709|449438130|FG001|Open Label Period|Lack of Efficacy|0|||
125123952|NCT00669864|450078691|FG000|Overall Study|Lost to Follow-up|2|||
125123953|NCT00669864|450078691|FG000|Overall Study|Protocol Violation|2|||
125123954|NCT00669864|450078691|FG000|Overall Study|Withdrawal by Subject|3|||
125123955|NCT00669864|450078691|FG000|Overall Study|Other|2|||
125123956|NCT00680121|450078697|FG000|Overall Study|Lost to Follow-up|27|||
125123957|NCT00680121|450078698|FG001|Overall Study|Lost to Follow-up|23|||
125123958|NCT02545998|450078707|FG000|Overall Study|Lost to Follow-up|12|||
125123959|NCT02545998|450078708|FG001|Overall Study|Lost to Follow-up|3|||
125123960|NCT02545998|450078707|FG000|Overall Study|Withdrawal by Subject|3|||
125214720|NCT01048944|450414846|FG003|Overall Study|Protocol Violation|2|||
125214721|NCT00376532|450414847|FG000|Overall Study|Lack sufficient blood sample|6|||
124948308|NCT00813709|449438131|FG002|Open Label Period|Lack of Efficacy|0|||
124948309|NCT00813709|449438132|FG003|Open Label Period|Lack of Efficacy|3|||
124948310|NCT00813709|449438133|FG004|Open Label Period|Lack of Efficacy|1|||
124948311|NCT00813709|449438134|FG005|Open Label Period|Lack of Efficacy|1|||
124948312|NCT00813709|449438129|FG000|Open Label Period|Randomized but not treated|0|||
124948313|NCT00813709|449438130|FG001|Open Label Period|Randomized but not treated|0|||
124948314|NCT00813709|449438131|FG002|Open Label Period|Randomized but not treated|0|||
124948315|NCT00813709|449438132|FG003|Open Label Period|Randomized but not treated|1|||
124948316|NCT00813709|449438133|FG004|Open Label Period|Randomized but not treated|0|||
124948317|NCT00813709|449438134|FG005|Open Label Period|Randomized but not treated|1|||
124948318|NCT00813709|449438129|FG000|Open Label Period|Other|0|||
124948319|NCT00813709|449438130|FG001|Open Label Period|Other|0|||
124948320|NCT00813709|449438131|FG002|Open Label Period|Other|0|||
124948321|NCT00813709|449438132|FG003|Open Label Period|Other|11|||
124948322|NCT00813709|449438133|FG004|Open Label Period|Other|5|||
124948323|NCT00813709|449438134|FG005|Open Label Period|Other|6|||
124948324|NCT02753075|449438135|FG000|Overall Study|Adverse Event|2|||
124948325|NCT02753075|449438136|FG001|Overall Study|Adverse Event|1|||
124948326|NCT02753075|449438137|FG002|Overall Study|Adverse Event|0|||
124948327|NCT02753075|449438135|FG000|Overall Study|Lost to Follow-up|2|||
125214722|NCT00376532|450414848|FG001|Overall Study|Lack sufficient blood sample|6|||
125123961|NCT02545998|450078708|FG001|Overall Study|Withdrawal by Subject|2|||
125214723|NCT01844817|450414849|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
125214724|NCT01844817|450414850|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
125214725|NCT01844817|450414849|FG000|Treatment|Progressive Disease|27|||
125214726|NCT01844817|450414850|FG001|Treatment|Progressive Disease|36|||
125214727|NCT01844817|450414849|FG000|Treatment|Adverse Event|17|||
125214728|NCT01844817|450414850|FG001|Treatment|Adverse Event|9|||
125214729|NCT01844817|450414849|FG000|Treatment|Withdrawal by Subject|10|||
125214730|NCT01844817|450414850|FG001|Treatment|Withdrawal by Subject|6|||
125214731|NCT01844817|450414849|FG000|Treatment|Death|10|||
125214732|NCT01844817|450414850|FG001|Treatment|Death|8|||
125214733|NCT01844817|450414849|FG000|Treatment|Lost to Follow-up|0|||
125214734|NCT01844817|450414850|FG001|Treatment|Lost to Follow-up|1|||
125214735|NCT01844817|450414849|FG000|Treatment|Other|0|||
125214736|NCT01844817|450414850|FG001|Treatment|Other|3|||
125214737|NCT04227405|450414851|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
125214738|NCT04227405|450414852|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
125214739|NCT04227405|450414851|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
125214740|NCT04227405|450414852|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
125214741|NCT04227405|450414851|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
125214742|NCT04227405|450414852|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
125214743|NCT02207400|450414853|FG000|Overall Study|Adverse Event|1|||
125214744|NCT02207400|450414854|FG001|Overall Study|Adverse Event|1|||
125214745|NCT02207400|450414853|FG000|Overall Study|Lost to Follow-up|6|||
125214746|NCT02207400|450414854|FG001|Overall Study|Lost to Follow-up|7|||
125214747|NCT02207400|450414853|FG000|Overall Study|Protocol Violation|1|||
124948328|NCT02753075|449438136|FG001|Overall Study|Lost to Follow-up|0|||
124948329|NCT02753075|449438137|FG002|Overall Study|Lost to Follow-up|0|||
124948330|NCT02753075|449438135|FG000|Overall Study|Withdrawal of Consent|1|||
125214748|NCT02207400|450414854|FG001|Overall Study|Protocol Violation|1|||
125214749|NCT02207400|450414853|FG000|Overall Study|Withdrawal by Subject|8|||
125214750|NCT02207400|450414854|FG001|Overall Study|Withdrawal by Subject|4|||
125214751|NCT02207400|450414853|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
124948331|NCT02753075|449438136|FG001|Overall Study|Withdrawal of Consent|1|||
124948332|NCT02753075|449438137|FG002|Overall Study|Withdrawal of Consent|3|||
124948333|NCT02753075|449438135|FG000|Overall Study|Physician Decision|3|||
124948334|NCT02753075|449438136|FG001|Overall Study|Physician Decision|1|||
124948335|NCT02753075|449438137|FG002|Overall Study|Physician Decision|0|||
124948336|NCT02245620|449438138|FG000|Overall Study|Physician Decision|1|||
124948337|NCT02245620|449438139|FG001|Overall Study|Physician Decision|1|||
124948338|NCT01102426|449438140|FG000|Overall Study|Randomized but not treated|4|||
124948339|NCT01102426|449438141|FG001|Overall Study|Randomized but not treated|1|||
124948340|NCT01102426|449438140|FG000|Overall Study|Adverse Events (treatment-related)|15|||
124948341|NCT01102426|449438141|FG001|Overall Study|Adverse Events (treatment-related)|8|||
124948342|NCT01102426|449438140|FG000|Overall Study|Physician Decision|9|||
124948343|NCT01102426|449438141|FG001|Overall Study|Physician Decision|6|||
124948344|NCT01102426|449438140|FG000|Overall Study|Progressive Disease|85|||
124948345|NCT01102426|449438141|FG001|Overall Study|Progressive Disease|44|||
124948346|NCT01102426|449438140|FG000|Overall Study|Adverse Events (unrelated to|9|||
124948347|NCT01102426|449438141|FG001|Overall Study|Adverse Events (unrelated to|1|||
124948348|NCT01102426|449438140|FG000|Overall Study|Patient Refusal|24|||
124948349|NCT01102426|449438141|FG001|Overall Study|Patient Refusal|12|||
124948350|NCT01102426|449438140|FG000|Overall Study|Death (due to adverse events|0|||
124948351|NCT01102426|449438141|FG001|Overall Study|Death (due to adverse events|1|||
124948352|NCT01102426|449438140|FG000|Overall Study|Death (non-related to the study|19|||
124948353|NCT01102426|449438141|FG001|Overall Study|Death (non-related to the study|8|||
124948354|NCT00889863|449438142|FG000|Part I: Open Label|Death|1|||
124948355|NCT00889863|449438143|FG001|Part I: Open Label|Death|0|||
124948356|NCT00889863|449438142|FG000|Part I: Open Label|Adverse Event|4|||
124948357|NCT00889863|449438143|FG001|Part I: Open Label|Adverse Event|0|||
124948358|NCT00889863|449438142|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
124948359|NCT00889863|449438143|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
125214752|NCT02207400|450414854|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
125214753|NCT03396822|450414855|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
125214754|NCT03396822|450414855|FG000|Overall Study|Physician Decision|1|||
125214755|NCT02757352|450414858|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
125214756|NCT02757352|450414859|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
124948360|NCT00889863|449438142|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
124948361|NCT00889863|449438143|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
124948362|NCT00889863|449438142|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
125214757|NCT02757352|450414860|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
124948363|NCT00889863|449438143|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
125214758|NCT02757352|450414861|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
125214759|NCT02757352|450414862|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
125214760|NCT02757352|450414863|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
125214761|NCT02757352|450414864|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
125029382|NCT02649634|449730696|FG001|Overall Study|Withdrawal by Subject|5|||
125029383|NCT02649634|449730695|FG000|Overall Study|Lost to Follow-up|0|||
125029384|NCT02649634|449730696|FG001|Overall Study|Lost to Follow-up|1|||
125029385|NCT02211261|449730703|FG000|Overall Study|Withdrawal by Subject|0|||
125029386|NCT02211261|449730704|FG001|Overall Study|Withdrawal by Subject|0|||
125029387|NCT02211261|449730705|FG002|Overall Study|Withdrawal by Subject|1|||
125029388|NCT02211261|449730706|FG003|Overall Study|Withdrawal by Subject|0|||
125029389|NCT02211261|449730707|FG004|Overall Study|Withdrawal by Subject|2|||
125029390|NCT02211261|449730708|FG005|Overall Study|Withdrawal by Subject|0|||
125029391|NCT02211261|449730709|FG006|Overall Study|Withdrawal by Subject|0|||
125029392|NCT02211261|449730710|FG007|Overall Study|Withdrawal by Subject|0|||
125029393|NCT02211261|449730711|FG008|Overall Study|Withdrawal by Subject|0|||
125029394|NCT02211261|449730712|FG009|Overall Study|Withdrawal by Subject|0|||
125029395|NCT02211261|449730713|FG010|Overall Study|Withdrawal by Subject|0|||
125029396|NCT02211261|449730703|FG000|Overall Study|Other|0|||
125029397|NCT02211261|449730704|FG001|Overall Study|Other|0|||
125029398|NCT02211261|449730705|FG002|Overall Study|Other|0|||
125029399|NCT02211261|449730706|FG003|Overall Study|Other|0|||
125029400|NCT02211261|449730707|FG004|Overall Study|Other|0|||
125029401|NCT02211261|449730708|FG005|Overall Study|Other|1|||
125029402|NCT02211261|449730709|FG006|Overall Study|Other|0|||
125029403|NCT02211261|449730710|FG007|Overall Study|Other|0|||
125029404|NCT02211261|449730711|FG008|Overall Study|Other|0|||
125029405|NCT02211261|449730712|FG009|Overall Study|Other|2|||
125029406|NCT02211261|449730713|FG010|Overall Study|Other|0|||
125029407|NCT02211261|449730703|FG000|Overall Study|Lost to Follow-up|0|||
125029408|NCT02211261|449730704|FG001|Overall Study|Lost to Follow-up|0|||
125029409|NCT02211261|449730705|FG002|Overall Study|Lost to Follow-up|0|||
125029410|NCT02211261|449730706|FG003|Overall Study|Lost to Follow-up|0|||
125029411|NCT02211261|449730707|FG004|Overall Study|Lost to Follow-up|0|||
125029412|NCT02211261|449730708|FG005|Overall Study|Lost to Follow-up|0|||
125029413|NCT02211261|449730709|FG006|Overall Study|Lost to Follow-up|0|||
125029414|NCT02211261|449730710|FG007|Overall Study|Lost to Follow-up|1|||
125029415|NCT02211261|449730711|FG008|Overall Study|Lost to Follow-up|0|||
125029416|NCT02211261|449730712|FG009|Overall Study|Lost to Follow-up|0|||
125029417|NCT02211261|449730713|FG010|Overall Study|Lost to Follow-up|0|||
125029418|NCT01737931|449730714|FG000|Overall Study|Withdrawal by Subject|0|||
125029419|NCT01737931|449730715|FG001|Overall Study|Withdrawal by Subject|1|||
125029420|NCT01737931|449730716|FG002|Overall Study|Withdrawal by Subject|1|||
125029421|NCT01737931|449730714|FG000|Overall Study|Physician Decision|0|||
125029422|NCT01737931|449730715|FG001|Overall Study|Physician Decision|1|||
125029423|NCT01737931|449730716|FG002|Overall Study|Physician Decision|0|||
125029424|NCT03183128|449730726|FG000|Overall Study|Adverse Event|1|||
125214762|NCT02757352|450414865|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
125214763|NCT02757352|450414866|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
125029425|NCT03183128|449730727|FG001|Overall Study|Adverse Event|2|||
125029426|NCT03183128|449730726|FG000|Overall Study|Withdrawal by Subject|1|||
125029427|NCT03183128|449730727|FG001|Overall Study|Withdrawal by Subject|8|||
125029428|NCT03183128|449730726|FG000|Overall Study|Protocol Violation|2|||
125029429|NCT03183128|449730727|FG001|Overall Study|Protocol Violation|0|||
125214764|NCT02757352|450414867|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
125214765|NCT02757352|450414858|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
125214766|NCT02757352|450414859|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
125214767|NCT02757352|450414860|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
125214768|NCT02757352|450414861|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
125029430|NCT03183128|449730726|FG000|Overall Study|Lack of Efficacy|4|||
125029431|NCT03183128|449730727|FG001|Overall Study|Lack of Efficacy|27|||
125029432|NCT03183128|449730726|FG000|Overall Study|Lost to Follow-up|1|||
125029433|NCT03183128|449730727|FG001|Overall Study|Lost to Follow-up|0|||
125029434|NCT03183128|449730726|FG000|Overall Study|Death|2|||
125029435|NCT03183128|449730727|FG001|Overall Study|Death|0|||
125029436|NCT03183128|449730726|FG000|Overall Study|Physician Decision|1|||
125029437|NCT03183128|449730727|FG001|Overall Study|Physician Decision|0|||
125029438|NCT00330187|449730732|FG000|Overall Study|Lost to Follow-up|12|||
125029439|NCT00330187|449730733|FG001|Overall Study|Lost to Follow-up|13|||
125029440|NCT00330187|449730734|FG002|Overall Study|Lost to Follow-up|14|||
125029441|NCT00330187|449730735|FG003|Overall Study|Lost to Follow-up|10|||
125214769|NCT02757352|450414862|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
125029442|NCT00330187|449730732|FG000|Overall Study|Withdrawal by Subject|8|||
125029443|NCT00330187|449730733|FG001|Overall Study|Withdrawal by Subject|5|||
125029444|NCT00330187|449730734|FG002|Overall Study|Withdrawal by Subject|4|||
125029445|NCT00330187|449730735|FG003|Overall Study|Withdrawal by Subject|4|||
124948364|NCT00889863|449438142|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
124948365|NCT00889863|449438143|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
124948366|NCT00889863|449438142|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
124948367|NCT00889863|449438143|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
124948368|NCT04361617|449438144|FG000|Overall Study|Withdrawal by Subject|0|||
124948369|NCT04361617|449438145|FG001|Overall Study|Withdrawal by Subject|1|||
124948370|NCT00930644|449438146|FG000|Overall Study|Withdrawal by Subject|4|||
124948371|NCT00930644|449438146|FG000|Overall Study|Physician Decision|2|||
124948372|NCT00930644|449438146|FG000|Overall Study|Death|1|||
124948373|NCT00930644|449438146|FG000|Overall Study|Adverse Event|16|||
124948374|NCT01918033|449438148|FG000|Overall Study|Adverse Event|1|||
124948375|NCT01918033|449438149|FG001|Overall Study|Adverse Event|0|||
124948376|NCT01918033|449438150|FG002|Overall Study|Adverse Event|2|||
124948377|NCT01918033|449438148|FG000|Overall Study|Lost to Follow-up|0|||
124948378|NCT01918033|449438149|FG001|Overall Study|Lost to Follow-up|1|||
124948379|NCT01918033|449438150|FG002|Overall Study|Lost to Follow-up|0|||
124948380|NCT01918033|449438148|FG000|Overall Study|Protocol Violation|2|||
124948381|NCT01918033|449438149|FG001|Overall Study|Protocol Violation|0|||
124948382|NCT01918033|449438150|FG002|Overall Study|Protocol Violation|1|||
124948383|NCT01918033|449438148|FG000|Overall Study|Withdrawal by Subject|2|||
124948384|NCT01918033|449438149|FG001|Overall Study|Withdrawal by Subject|1|||
124948385|NCT01918033|449438150|FG002|Overall Study|Withdrawal by Subject|0|||
124948386|NCT03259568|449438158|FG000|Overall Study|Participant performance was low|3|||
124948387|NCT03136861|449438159|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
124948388|NCT03136861|449438160|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
124948389|NCT03136861|449438161|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
124948390|NCT03136861|449438162|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
124948391|NCT03136861|449438163|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
124948392|NCT03136861|449438164|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
124948393|NCT03136861|449438165|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
124948394|NCT03136861|449438159|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
124948395|NCT03136861|449438160|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
124948396|NCT03136861|449438161|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
124948397|NCT03136861|449438162|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
124948398|NCT03136861|449438163|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
124948399|NCT03136861|449438164|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
124948400|NCT03136861|449438165|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
124948401|NCT03136861|449438159|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
124948402|NCT03136861|449438160|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
124948403|NCT03136861|449438161|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
124948404|NCT03136861|449438162|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
124948405|NCT03136861|449438163|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
124948406|NCT03136861|449438164|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
124948407|NCT03136861|449438165|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
124948408|NCT03136861|449438159|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
124948409|NCT03136861|449438160|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
124948410|NCT03136861|449438161|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
124948411|NCT03136861|449438162|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
124948412|NCT03136861|449438163|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
124948413|NCT03136861|449438164|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
124948414|NCT03136861|449438165|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
124948415|NCT03136861|449438159|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
124948416|NCT03136861|449438160|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
124948417|NCT03136861|449438161|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
124948418|NCT03136861|449438162|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
124948419|NCT03136861|449438163|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
124948420|NCT03136861|449438164|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
124948421|NCT03136861|449438165|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
124948422|NCT03136861|449438159|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
124948423|NCT03136861|449438160|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
124948424|NCT03136861|449438161|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
124948425|NCT03136861|449438162|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
124948426|NCT03136861|449438163|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
124948427|NCT03136861|449438164|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
124948428|NCT03136861|449438165|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
124948429|NCT03136861|449438159|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
124948430|NCT03136861|449438160|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
124948431|NCT03136861|449438161|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
124948432|NCT03136861|449438162|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
124948433|NCT03136861|449438163|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
124948434|NCT03136861|449438164|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
124948435|NCT03136861|449438165|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
124948436|NCT03136861|449438159|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
124948437|NCT03136861|449438160|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
124948438|NCT03136861|449438161|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
124948439|NCT03136861|449438162|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
124948440|NCT03136861|449438163|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
124948441|NCT03136861|449438164|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
124948442|NCT03136861|449438165|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
124948443|NCT03200574|449438181|FG000|Overall Study|Death|4|||
124948444|NCT03200574|449438181|FG000|Overall Study|Withdrawal by Subject|8|||
124948445|NCT03200574|449438181|FG000|Overall Study|Long-Term need for anticoagulation|1|||
124948446|NCT03200574|449438181|FG000|Overall Study|Relocation|2|||
124948447|NCT03200574|449438181|FG000|Overall Study|Lost to Follow-up|2|||
124948448|NCT04183491|449438182|FG000|Overall Study|Withdrawal by Subject|0|||
124948449|NCT04183491|449438183|FG001|Overall Study|Withdrawal by Subject|0|||
124948450|NCT04183491|449438184|FG002|Overall Study|Withdrawal by Subject|1|||
124948451|NCT04183491|449438185|FG003|Overall Study|Withdrawal by Subject|0|||
124948452|NCT04183491|449438186|FG004|Overall Study|Withdrawal by Subject|0|||
124948453|NCT04183491|449438187|FG005|Overall Study|Withdrawal by Subject|1|||
124948454|NCT04183491|449438188|FG006|Overall Study|Withdrawal by Subject|0|||
124948455|NCT01262456|449438189|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
124948456|NCT01262456|449438190|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
124948457|NCT01262456|449438191|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
124948458|NCT01262456|449438189|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
124948459|NCT01262456|449438190|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
124948460|NCT01262456|449438191|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
124948461|NCT01262456|449438189|FG000|3-Month Double-Blind Period|Adverse Event|6|||
124948462|NCT01262456|449438190|FG001|3-Month Double-Blind Period|Adverse Event|4|||
124948463|NCT01262456|449438191|FG002|3-Month Double-Blind Period|Adverse Event|8|||
124948464|NCT01262456|449438189|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
124948465|NCT01262456|449438190|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
124948466|NCT01262456|449438191|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
124948467|NCT01262456|449438189|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
124948468|NCT01262456|449438190|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
125029446|NCT03258814|449730736|FG000|Overall Study|Early Termination|4|||
125029447|NCT03258814|449730737|FG001|Overall Study|Early Termination|3|||
125029448|NCT03258814|449730738|FG002|Overall Study|Early Termination|10|||
125029449|NCT01413958|449730739|FG000|Overall Study|Lost to Follow-up|0|||
125029450|NCT01413958|449730740|FG001|Overall Study|Lost to Follow-up|1|||
125029451|NCT01900002|449730741|FG000|Overall Study|Withdrawal by Subject|2|||
125029452|NCT01900002|449730741|FG000|Overall Study|ineligible for Y-90|4|||
125029453|NCT00364182|449730748|FG000|First Intervention|Secondary prophylaxis|1|||
125029454|NCT00364182|449730749|FG001|First Intervention|Secondary prophylaxis|0|||
125029455|NCT00364182|449730750|FG002|First Intervention|Secondary prophylaxis|0|||
125029456|NCT00364182|449730748|FG000|First Intervention|Withdrawal by Subject|2|||
125029457|NCT00364182|449730749|FG001|First Intervention|Withdrawal by Subject|0|||
125029458|NCT00364182|449730750|FG002|First Intervention|Withdrawal by Subject|0|||
125029459|NCT00364182|449730748|FG000|Second Intervention|non-compliance|0|||
125029460|NCT00364182|449730749|FG001|Second Intervention|non-compliance|1|||
125029461|NCT00364182|449730750|FG002|Second Intervention|non-compliance|1|||
125029462|NCT00364182|449730748|FG000|Second Intervention|Protocol Violation|0|||
125029463|NCT00364182|449730749|FG001|Second Intervention|Protocol Violation|1|||
125029464|NCT00364182|449730750|FG002|Second Intervention|Protocol Violation|0|||
125029465|NCT00364182|449730748|FG000|Second Intervention|Adverse Event|0|||
125029466|NCT00364182|449730749|FG001|Second Intervention|Adverse Event|0|||
125029467|NCT00364182|449730750|FG002|Second Intervention|Adverse Event|1|||
125029468|NCT00364182|449730748|FG000|Third Intervention|non-compliance|0|||
125029469|NCT00364182|449730749|FG001|Third Intervention|non-compliance|1|||
125029470|NCT00364182|449730750|FG002|Third Intervention|non-compliance|0|||
125029471|NCT00364182|449730748|FG000|Third Intervention|Lost to Follow-up|0|||
125029472|NCT00364182|449730749|FG001|Third Intervention|Lost to Follow-up|0|||
125029473|NCT00364182|449730750|FG002|Third Intervention|Lost to Follow-up|1|||
125029474|NCT02601573|449730754|FG000|Overall Study|Lost to Follow-up|0|||
125029475|NCT02601573|449730755|FG001|Overall Study|Lost to Follow-up|3|||
125029476|NCT02601573|449730756|FG002|Overall Study|Lost to Follow-up|1|||
125029477|NCT02601573|449730757|FG003|Overall Study|Lost to Follow-up|0|||
125029478|NCT02601573|449730758|FG004|Overall Study|Lost to Follow-up|2|||
125029479|NCT02601573|449730754|FG000|Overall Study|Withdrawal by Subject|0|||
125029480|NCT02601573|449730755|FG001|Overall Study|Withdrawal by Subject|1|||
125214770|NCT02757352|450414863|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
125214771|NCT02757352|450414864|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
125214772|NCT02757352|450414865|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
125214773|NCT02757352|450414866|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
125214774|NCT02757352|450414867|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
125214775|NCT02757352|450414858|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
125214776|NCT02757352|450414859|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
125214777|NCT02757352|450414860|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
125214778|NCT02757352|450414861|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
125214779|NCT02757352|450414862|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
125214780|NCT02757352|450414863|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
125214781|NCT02757352|450414864|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
125214782|NCT02757352|450414865|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
125214783|NCT02757352|450414866|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
125214784|NCT02757352|450414867|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
125214785|NCT02757352|450414858|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
124948469|NCT01262456|449438191|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
124948470|NCT01262456|449438189|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
124948471|NCT01262456|449438190|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
124948472|NCT01262456|449438191|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
124948473|NCT01262456|449438189|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
124948474|NCT01262456|449438190|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
124948475|NCT01262456|449438191|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
124948476|NCT01262456|449438189|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
124948477|NCT01262456|449438190|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
124948478|NCT01262456|449438191|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
124948479|NCT01262456|449438189|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
124948480|NCT01262456|449438190|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
124948481|NCT01262456|449438191|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
124948482|NCT02538094|449438192|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
124948483|NCT02538094|449438193|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
124948484|NCT02538094|449438192|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
124948485|NCT02538094|449438193|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
124948486|NCT03652610|449438199|FG000|Overall Study|Lost to Follow-up|1|||
124948487|NCT03652610|449438200|FG001|Overall Study|Lost to Follow-up|0|||
124948488|NCT03652610|449438199|FG000|Overall Study|Withdrawal by Subject|3|||
124948489|NCT03652610|449438200|FG001|Overall Study|Withdrawal by Subject|5|||
124948490|NCT00326183|449438201|FG000|Overall Study|Lost to Follow-up|104|||
124948491|NCT00326183|449438202|FG001|Overall Study|Lost to Follow-up|56|||
124948492|NCT00326183|449438201|FG000|Overall Study|Protocol Violation|6|||
124948493|NCT00326183|449438202|FG001|Overall Study|Protocol Violation|3|||
124948494|NCT00326183|449438201|FG000|Overall Study|Withdrawal by Subject|35|||
124948495|NCT00326183|449438202|FG001|Overall Study|Withdrawal by Subject|7|||
124948496|NCT00326183|449438201|FG000|Overall Study|Subject Moved|7|||
124948497|NCT00326183|449438202|FG001|Overall Study|Subject Moved|4|||
124948498|NCT00326183|449438201|FG000|Overall Study|Other|47|||
124948499|NCT00326183|449438202|FG001|Overall Study|Other|13|||
124948500|NCT00326183|449438201|FG000|Overall Study|Adverse Event|1|||
124948501|NCT00326183|449438202|FG001|Overall Study|Adverse Event|0|||
124948502|NCT01528605|449438211|FG000|Overall Study|Lost to Follow-up|1|||
124948503|NCT01528605|449438212|FG001|Overall Study|Lost to Follow-up|0|||
124948504|NCT01528605|449438213|FG002|Overall Study|Lost to Follow-up|1|||
124948505|NCT01528605|449438214|FG003|Overall Study|Lost to Follow-up|1|||
124948506|NCT01528605|449438215|FG004|Overall Study|Lost to Follow-up|0|||
124948507|NCT01528605|449438216|FG005|Overall Study|Lost to Follow-up|0|||
124948508|NCT01528605|449438211|FG000|Overall Study|Death|1|||
124948509|NCT01528605|449438212|FG001|Overall Study|Death|0|||
124948510|NCT01528605|449438213|FG002|Overall Study|Death|0|||
124948511|NCT01528605|449438214|FG003|Overall Study|Death|0|||
124948512|NCT01528605|449438215|FG004|Overall Study|Death|0|||
124948513|NCT01528605|449438216|FG005|Overall Study|Death|0|||
124948514|NCT01156675|449438217|FG000|Overall Study|Death|5|||
124948515|NCT01156675|449438218|FG001|Overall Study|Death|3|||
124948516|NCT01156675|449438219|FG002|Overall Study|Death|0|||
124948517|NCT01156675|449438217|FG000|Overall Study|No data|29|||
124948518|NCT01156675|449438218|FG001|Overall Study|No data|22|||
124948519|NCT01156675|449438219|FG002|Overall Study|No data|2|||
124948520|NCT02326220|449438220|FG000|Double-blind Treatment Period|Adverse Event|1|||
124948521|NCT02326220|449438221|FG001|Double-blind Treatment Period|Adverse Event|2|||
124948522|NCT02326220|449438222|FG002|Double-blind Treatment Period|Adverse Event|0|||
125214786|NCT02757352|450414859|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
125214787|NCT02757352|450414860|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
125214788|NCT02757352|450414861|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
125214789|NCT02757352|450414862|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
125214790|NCT02757352|450414863|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
125214791|NCT02757352|450414864|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
125214792|NCT02757352|450414865|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
125214793|NCT02757352|450414866|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
125214794|NCT02757352|450414867|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
125214795|NCT02757352|450414858|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214796|NCT02757352|450414859|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
125214797|NCT02757352|450414860|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214798|NCT02757352|450414861|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214799|NCT02757352|450414862|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214800|NCT02757352|450414863|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214801|NCT02757352|450414864|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
124948523|NCT02326220|449438220|FG000|Double-blind Treatment Period|Protocol Violation|0|||
124948524|NCT02326220|449438221|FG001|Double-blind Treatment Period|Protocol Violation|1|||
124948525|NCT02326220|449438222|FG002|Double-blind Treatment Period|Protocol Violation|0|||
124948526|NCT02326220|449438220|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
124948527|NCT02326220|449438221|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
124948528|NCT02326220|449438222|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
124948529|NCT02326220|449438220|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
124948530|NCT02326220|449438221|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
124948531|NCT02326220|449438222|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
124948532|NCT02326220|449438220|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
124948533|NCT02326220|449438221|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
124948534|NCT02326220|449438222|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
124948535|NCT02699099|449438223|FG000|Overall Study|Adverse Event|1|||
124948536|NCT02699099|449438224|FG001|Overall Study|Adverse Event|0|||
124948537|NCT02699099|449438225|FG002|Overall Study|Adverse Event|2|||
124948538|NCT02699099|449438223|FG000|Overall Study|Lost to Follow-up|0|||
124948539|NCT02699099|449438224|FG001|Overall Study|Lost to Follow-up|1|||
124948540|NCT02699099|449438225|FG002|Overall Study|Lost to Follow-up|0|||
124948541|NCT02699099|449438223|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
124948542|NCT02699099|449438224|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
124948543|NCT02699099|449438225|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
124948544|NCT05184062|449438227|FG000|Overall Study|Lost to Follow-up|5|||
124948545|NCT05184062|449438228|FG001|Overall Study|Lost to Follow-up|1|||
124948546|NCT05184062|449438227|FG000|Overall Study|Withdrawal by Subject|1|||
124948547|NCT05184062|449438228|FG001|Overall Study|Withdrawal by Subject|0|||
124948548|NCT03659136|449438233|FG000|Overall Study|Not treated|2|||
124948549|NCT03659136|449438234|FG001|Overall Study|Not treated|0|||
124948550|NCT03659136|449438233|FG000|Overall Study|Covid-19 related|1|||
124948551|NCT03659136|449438234|FG001|Overall Study|Covid-19 related|1|||
124948552|NCT03659136|449438233|FG000|Overall Study|Withdrawal by Subject|1|||
124948553|NCT03659136|449438234|FG001|Overall Study|Withdrawal by Subject|6|||
124948554|NCT03659136|449438233|FG000|Overall Study|Adverse Event|4|||
124948555|NCT03659136|449438234|FG001|Overall Study|Adverse Event|6|||
124948556|NCT03659136|449438233|FG000|Overall Study|Progressive disease|37|||
124948557|NCT03659136|449438234|FG001|Overall Study|Progressive disease|31|||
124948558|NCT03659136|449438233|FG000|Overall Study|Study closure|2|||
124948559|NCT03659136|449438234|FG001|Overall Study|Study closure|2|||
124948560|NCT03659136|449438233|FG000|Overall Study|Sponsor decision/recommendation|3|||
124948561|NCT03659136|449438234|FG001|Overall Study|Sponsor decision/recommendation|2|||
124948562|NCT03659136|449438233|FG000|Overall Study|Switched to other drug/therapy|2|||
125214802|NCT02757352|450414865|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214803|NCT02757352|450414866|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
124948563|NCT03659136|449438234|FG001|Overall Study|Switched to other drug/therapy|2|||
124948564|NCT03659136|449438233|FG000|Overall Study|Lack of clinical benefit|0|||
124948565|NCT03659136|449438234|FG001|Overall Study|Lack of clinical benefit|1|||
124948566|NCT02830893|449439983|FG000|Overall Study|Relocation to out of the country|1|||
124948567|NCT02830893|449439984|FG001|Overall Study|Relocation to out of the country|0|||
124948568|NCT02830893|449439983|FG000|Overall Study|Lost to Follow-up|0|||
125029481|NCT02601573|449730756|FG002|Overall Study|Withdrawal by Subject|0|||
125214804|NCT02757352|450414867|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
124948569|NCT02830893|449439984|FG001|Overall Study|Lost to Follow-up|2|||
124948570|NCT02830893|449439983|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
124948571|NCT02830893|449439984|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
124948572|NCT01277302|449439985|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
124948573|NCT01277302|449439986|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
124948574|NCT01277302|449439987|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
124948575|NCT01277302|449439985|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
124948576|NCT01277302|449439986|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
124948577|NCT01277302|449439987|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
124948578|NCT01277302|449439985|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
124948579|NCT01277302|449439986|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
124948580|NCT01277302|449439987|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
124948581|NCT01277302|449439985|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
124948582|NCT01277302|449439986|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
124948583|NCT01277302|449439987|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
124948584|NCT01277302|449439985|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
124948585|NCT01277302|449439986|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
124948586|NCT01277302|449439987|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
124948587|NCT01277302|449439985|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
124948588|NCT01277302|449439986|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
124948589|NCT01277302|449439987|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
124948590|NCT01277302|449439985|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
124948591|NCT01277302|449439986|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
124948592|NCT01277302|449439987|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
124948593|NCT01277302|449439985|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
124948594|NCT01277302|449439986|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
124948595|NCT01277302|449439987|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
124948596|NCT01277302|449439985|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
124948597|NCT01277302|449439986|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
124948598|NCT01277302|449439987|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
124948599|NCT00731692|449439988|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
124948600|NCT00731692|449439989|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
124948601|NCT00731692|449439990|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
124948602|NCT00731692|449439988|FG000|Core Study (36 Months)|Physician Decision|1|||
124948603|NCT00731692|449439989|FG001|Core Study (36 Months)|Physician Decision|0|||
124948604|NCT00731692|449439990|FG002|Core Study (36 Months)|Physician Decision|2|||
124948605|NCT00731692|449439988|FG000|Core Study (36 Months)|Death|2|||
124948606|NCT00731692|449439989|FG001|Core Study (36 Months)|Death|1|||
124948607|NCT00731692|449439990|FG002|Core Study (36 Months)|Death|2|||
124948608|NCT00731692|449439988|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
124948609|NCT00731692|449439989|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
124948610|NCT00731692|449439990|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
124948611|NCT00731692|449439988|FG000|Core Study (36 Months)|Administrative|2|||
124948612|NCT00731692|449439989|FG001|Core Study (36 Months)|Administrative|2|||
124948613|NCT00731692|449439990|FG002|Core Study (36 Months)|Administrative|6|||
124948614|NCT00731692|449439988|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
124948615|NCT00731692|449439989|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
124948616|NCT00731692|449439990|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
124948617|NCT00731692|449439988|FG000|Core Study (36 Months)|Protocol Violation|4|||
124948618|NCT00731692|449439989|FG001|Core Study (36 Months)|Protocol Violation|5|||
124948619|NCT00731692|449439990|FG002|Core Study (36 Months)|Protocol Violation|8|||
124948620|NCT00731692|449439988|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
124948621|NCT00731692|449439989|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
124948622|NCT00731692|449439990|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
124948623|NCT00731692|449439988|FG000|Core Study (36 Months)|Adverse Event|25|||
124948624|NCT00731692|449439989|FG001|Core Study (36 Months)|Adverse Event|28|||
124948625|NCT00731692|449439990|FG002|Core Study (36 Months)|Adverse Event|29|||
124948626|NCT00731692|449439988|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
124948627|NCT00731692|449439989|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
124948628|NCT00731692|449439990|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
124948629|NCT00731692|449439988|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
124948630|NCT00731692|449439989|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
124948631|NCT00731692|449439990|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
124948632|NCT00731692|449439988|FG000|Extension Phase|Abnormal test procedure|0|||
124948633|NCT00731692|449439989|FG001|Extension Phase|Abnormal test procedure|0|||
124948634|NCT00731692|449439990|FG002|Extension Phase|Abnormal test procedure|1|||
124948635|NCT00731692|449439988|FG000|Extension Phase|Abnormal lab values|0|||
124948636|NCT00731692|449439989|FG001|Extension Phase|Abnormal lab values|0|||
124948637|NCT00731692|449439990|FG002|Extension Phase|Abnormal lab values|1|||
124948638|NCT00731692|449439988|FG000|Extension Phase|Lost to Follow-up|0|||
124948639|NCT00731692|449439989|FG001|Extension Phase|Lost to Follow-up|1|||
124948640|NCT00731692|449439990|FG002|Extension Phase|Lost to Follow-up|4|||
124948641|NCT00731692|449439988|FG000|Extension Phase|Withdrawal by Subject|4|||
124948642|NCT00731692|449439989|FG001|Extension Phase|Withdrawal by Subject|5|||
124948643|NCT00731692|449439990|FG002|Extension Phase|Withdrawal by Subject|3|||
124948644|NCT00731692|449439988|FG000|Extension Phase|Adverse Event|1|||
124948645|NCT00731692|449439989|FG001|Extension Phase|Adverse Event|1|||
124948646|NCT00731692|449439990|FG002|Extension Phase|Adverse Event|15|||
124948647|NCT03332589|449439991|FG000|Overall Study|Lack of Efficacy|2|||
124948648|NCT03332589|449439992|FG001|Overall Study|Lack of Efficacy|0|||
124948649|NCT03332589|449439993|FG002|Overall Study|Lack of Efficacy|0|||
124948650|NCT03332589|449439991|FG000|Overall Study|Adverse Event|1|||
124948651|NCT03332589|449439992|FG001|Overall Study|Adverse Event|0|||
124948652|NCT03332589|449439993|FG002|Overall Study|Adverse Event|0|||
124948653|NCT03332589|449439991|FG000|Overall Study|Death|1|||
124948654|NCT03332589|449439992|FG001|Overall Study|Death|0|||
124948655|NCT03332589|449439993|FG002|Overall Study|Death|0|||
124948656|NCT00108355|449439997|FG000|Overall Study|Peritonitis at index paracentesis|1|||
124948657|NCT00108355|449439998|FG001|Overall Study|Peritonitis at index paracentesis|1|||
124948658|NCT00108355|449439997|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
124948659|NCT00108355|449439998|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
124948660|NCT00647699|449439999|FG000|Overall Study|Lost to Follow-up|5|||
125214805|NCT02757352|450414858|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
124948661|NCT00647699|449440000|FG001|Overall Study|Lost to Follow-up|4|||
124948662|NCT00647699|449439999|FG000|Overall Study|Withdrawal by Subject|3|||
124948663|NCT00647699|449440000|FG001|Overall Study|Withdrawal by Subject|8|||
124948664|NCT00413283|449440001|FG000|Overall Study|Withdrawal by Subject|1|||
124948665|NCT00413283|449440002|FG001|Overall Study|Withdrawal by Subject|0|||
124948666|NCT00413283|449440003|FG002|Overall Study|Withdrawal by Subject|0|||
124948667|NCT00413283|449440004|FG003|Overall Study|Withdrawal by Subject|1|||
124948668|NCT00413283|449440001|FG000|Overall Study|Death|0|||
124948669|NCT00413283|449440002|FG001|Overall Study|Death|0|||
124948670|NCT00413283|449440003|FG002|Overall Study|Death|1|||
124948671|NCT00413283|449440004|FG003|Overall Study|Death|1|||
124948672|NCT00413283|449440001|FG000|Overall Study|Adverse Event|0|||
124948673|NCT00413283|449440002|FG001|Overall Study|Adverse Event|0|||
124948674|NCT00413283|449440003|FG002|Overall Study|Adverse Event|0|||
124948675|NCT00413283|449440004|FG003|Overall Study|Adverse Event|1|||
124948676|NCT00413283|449440001|FG000|Overall Study|Ineligibility determined|0|||
124948677|NCT00413283|449440002|FG001|Overall Study|Ineligibility determined|0|||
124948678|NCT00413283|449440003|FG002|Overall Study|Ineligibility determined|0|||
124948679|NCT00413283|449440004|FG003|Overall Study|Ineligibility determined|1|||
124948680|NCT00413283|449440001|FG000|Overall Study|Protocol deviation|0|||
124948681|NCT00413283|449440002|FG001|Overall Study|Protocol deviation|1|||
124948682|NCT00413283|449440003|FG002|Overall Study|Protocol deviation|0|||
124948683|NCT00413283|449440004|FG003|Overall Study|Protocol deviation|0|||
124948684|NCT00413283|449440001|FG000|Overall Study|Requirement for alternative therapy|0|||
124948685|NCT00413283|449440002|FG001|Overall Study|Requirement for alternative therapy|2|||
124948686|NCT00413283|449440003|FG002|Overall Study|Requirement for alternative therapy|0|||
124948687|NCT00413283|449440004|FG003|Overall Study|Requirement for alternative therapy|0|||
124948688|NCT00413283|449440001|FG000|Overall Study|Other|0|||
124948689|NCT00413283|449440002|FG001|Overall Study|Other|0|||
124948690|NCT00413283|449440003|FG002|Overall Study|Other|1|||
124948691|NCT00413283|449440004|FG003|Overall Study|Other|0|||
124948692|NCT02354417|449440005|FG000|Overall Study|Physician Decision|1|||
124948693|NCT00246129|449440006|FG000|Overall Study|Lost to Follow-up|1|||
124948694|NCT00246129|449440007|FG001|Overall Study|Lost to Follow-up|0|||
124948695|NCT00246129|449440006|FG000|Overall Study|Death|2|||
124948696|NCT00246129|449440007|FG001|Overall Study|Death|1|||
124948697|NCT00246129|449440006|FG000|Overall Study|suffered primary non-function|1|||
124948698|NCT00246129|449440007|FG001|Overall Study|suffered primary non-function|0|||
124948699|NCT00246129|449440006|FG000|Overall Study|grafts failed|3|||
124948700|NCT00246129|449440007|FG001|Overall Study|grafts failed|1|||
124948701|NCT03469258|449440008|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
124948702|NCT03340961|449440012|FG000|Overall Study|Adverse Event|1|||
124948703|NCT03340961|449440013|FG001|Overall Study|Adverse Event|3|||
124948704|NCT03340961|449440014|FG002|Overall Study|Adverse Event|2|||
124948705|NCT03340961|449440015|FG003|Overall Study|Adverse Event|4|||
124948706|NCT03340961|449440012|FG000|Overall Study|Lost to Follow-up|0|||
124948707|NCT03340961|449440013|FG001|Overall Study|Lost to Follow-up|1|||
124948708|NCT03340961|449440014|FG002|Overall Study|Lost to Follow-up|0|||
124948709|NCT03340961|449440015|FG003|Overall Study|Lost to Follow-up|1|||
124948710|NCT03340961|449440012|FG000|Overall Study|Withdrawal by Subject|3|||
124948711|NCT03340961|449440013|FG001|Overall Study|Withdrawal by Subject|2|||
124948712|NCT03340961|449440014|FG002|Overall Study|Withdrawal by Subject|4|||
124948713|NCT03340961|449440015|FG003|Overall Study|Withdrawal by Subject|7|||
124948714|NCT03340961|449440012|FG000|Overall Study|Use of prohibited treatment|0|||
124948715|NCT03340961|449440013|FG001|Overall Study|Use of prohibited treatment|3|||
124948716|NCT03340961|449440014|FG002|Overall Study|Use of prohibited treatment|2|||
124948717|NCT03340961|449440015|FG003|Overall Study|Use of prohibited treatment|4|||
124948718|NCT03340961|449440012|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
124948719|NCT03340961|449440013|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
124948720|NCT03340961|449440014|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
124948721|NCT03340961|449440015|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
124948722|NCT03340961|449440012|FG000|Overall Study|Subject developed an exclusion criterion|0|||
124948723|NCT03340961|449440013|FG001|Overall Study|Subject developed an exclusion criterion|1|||
124948724|NCT03340961|449440014|FG002|Overall Study|Subject developed an exclusion criterion|0|||
124948725|NCT03340961|449440015|FG003|Overall Study|Subject developed an exclusion criterion|0|||
124948726|NCT03340961|449440012|FG000|Overall Study|Protocol Violation|1|||
124948727|NCT03340961|449440013|FG001|Overall Study|Protocol Violation|0|||
124948728|NCT03340961|449440014|FG002|Overall Study|Protocol Violation|1|||
124948729|NCT03340961|449440015|FG003|Overall Study|Protocol Violation|0|||
124948730|NCT03340961|449440012|FG000|Overall Study|Adverse Event|1|||
125214806|NCT02757352|450414859|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
124948731|NCT03340961|449440013|FG001|Overall Study|Adverse Event|1|||
124948732|NCT03340961|449440014|FG002|Overall Study|Adverse Event|0|||
124948733|NCT03340961|449440015|FG003|Overall Study|Adverse Event|0|||
124948734|NCT03340961|449440012|FG000|Overall Study|Lack of Efficacy|0|||
124948735|NCT03340961|449440013|FG001|Overall Study|Lack of Efficacy|0|||
124948736|NCT03340961|449440014|FG002|Overall Study|Lack of Efficacy|0|||
124948737|NCT03340961|449440015|FG003|Overall Study|Lack of Efficacy|1|||
124948738|NCT01853384|449440016|FG000|Randomized|Adverse Event|5|||
124948739|NCT01853384|449440017|FG001|Randomized|Adverse Event|3|||
124948740|NCT01853384|449440016|FG000|Randomized|Death|1|||
124948741|NCT01853384|449440017|FG001|Randomized|Death|2|||
124948742|NCT01853384|449440016|FG000|Randomized|Lost to Follow-up|1|||
124948743|NCT01853384|449440017|FG001|Randomized|Lost to Follow-up|1|||
124948744|NCT01853384|449440016|FG000|Randomized|Withdrawal by Subject|5|||
124948745|NCT01853384|449440017|FG001|Randomized|Withdrawal by Subject|3|||
124948746|NCT01853384|449440016|FG000|Randomized|Sponsor Decision|47|||
124948747|NCT01853384|449440017|FG001|Randomized|Sponsor Decision|34|||
124948748|NCT01853384|449440016|FG000|Randomized|Other|3|||
124948749|NCT01853384|449440017|FG001|Randomized|Other|3|||
124948750|NCT01853384|449440016|FG000|Completed Follow up Visit 1|Early Termination|13|||
124948751|NCT01853384|449440017|FG001|Completed Follow up Visit 1|Early Termination|9|||
124948752|NCT01853384|449440016|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
124948753|NCT01853384|449440017|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
124948754|NCT01853384|449440016|FG000|Completed Follow up Visit 2|Adverse Event|1|||
124948755|NCT01853384|449440017|FG001|Completed Follow up Visit 2|Adverse Event|0|||
124948756|NCT01853384|449440016|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
124948757|NCT01853384|449440017|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
124948758|NCT01853384|449440016|FG000|Completed Follow up Visit 2|Death|1|||
124948759|NCT01853384|449440017|FG001|Completed Follow up Visit 2|Death|0|||
124948760|NCT01853384|449440016|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
124948761|NCT01853384|449440017|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
124948762|NCT04311983|449440018|FG000|Overall Study|Lost to Follow-up|421|||
124948763|NCT04311983|449440019|FG001|Overall Study|Lost to Follow-up|456|||
124948764|NCT04311983|449440018|FG000|Overall Study|Incomplete survey|7|||
124948765|NCT04311983|449440019|FG001|Overall Study|Incomplete survey|9|||
124948766|NCT04311983|449440018|FG000|Overall Study|Death|1|||
124948767|NCT04311983|449440019|FG001|Overall Study|Death|0|||
124948768|NCT01205126|449440023|FG000|Titration Phase|Adverse Event|5|||
124948769|NCT01205126|449440024|FG001|Titration Phase|Adverse Event|3|||
124948770|NCT01205126|449440023|FG000|Titration Phase|Withdrawal by Subject|5|||
124948771|NCT01205126|449440024|FG001|Titration Phase|Withdrawal by Subject|5|||
124948772|NCT01205126|449440023|FG000|Titration Phase|Lost to Follow-up|2|||
124948773|NCT01205126|449440024|FG001|Titration Phase|Lost to Follow-up|2|||
124948774|NCT01205126|449440023|FG000|Titration Phase|No stable titration dose|1|||
124948775|NCT01205126|449440024|FG001|Titration Phase|No stable titration dose|0|||
124948776|NCT01205126|449440023|FG000|Titration Phase|More than maximum dosage required|2|||
124948777|NCT01205126|449440024|FG001|Titration Phase|More than maximum dosage required|3|||
124948778|NCT01205126|449440023|FG000|Titration Phase|Other|8|||
124948779|NCT01205126|449440024|FG001|Titration Phase|Other|6|||
124948780|NCT01205126|449440023|FG000|Between Titration & Maintenance Phase|Other|0|||
124948781|NCT01205126|449440024|FG001|Between Titration & Maintenance Phase|Other|4|||
124948782|NCT01205126|449440023|FG000|Maintenance Phase|Adverse Event|3|||
124948783|NCT01205126|449440024|FG001|Maintenance Phase|Adverse Event|7|||
124948784|NCT01205126|449440023|FG000|Maintenance Phase|Death|4|||
124948785|NCT01205126|449440024|FG001|Maintenance Phase|Death|4|||
124948786|NCT01205126|449440023|FG000|Maintenance Phase|More than the maximum dosage required|5|||
124948787|NCT01205126|449440024|FG001|Maintenance Phase|More than the maximum dosage required|5|||
124948788|NCT01205126|449440023|FG000|Maintenance Phase|Prohibited drugs used|1|||
124948789|NCT01205126|449440024|FG001|Maintenance Phase|Prohibited drugs used|0|||
124948790|NCT01205126|449440023|FG000|Maintenance Phase|Other|11|||
124948791|NCT01205126|449440024|FG001|Maintenance Phase|Other|8|||
124948792|NCT01205126|449440023|FG000|Maintenance Phase|Lost to Follow-up|5|||
124948793|NCT01205126|449440024|FG001|Maintenance Phase|Lost to Follow-up|5|||
124948794|NCT01205126|449440023|FG000|Maintenance Phase|Withdrawal by Subject|8|||
124948795|NCT01205126|449440024|FG001|Maintenance Phase|Withdrawal by Subject|11|||
124948796|NCT00638456|449440027|FG000|Overall Study|Withdrawal by Subject|6|||
124948797|NCT00638456|449440028|FG001|Overall Study|Withdrawal by Subject|2|||
124948798|NCT03236779|449440029|FG000|Overall Study|Lost to Follow-up|13|||
124948799|NCT03236779|449440030|FG001|Overall Study|Lost to Follow-up|21|||
124948800|NCT00687297|449440032|FG000|Randomization|Withdrawal by Subject|2|||
124948801|NCT00687297|449440033|FG001|Randomization|Withdrawal by Subject|0|||
125029482|NCT02601573|449730757|FG003|Overall Study|Withdrawal by Subject|1|||
124948802|NCT00687297|449440032|FG000|Randomization|Withdrew before treatment, ineligible|1|||
124948803|NCT00687297|449440033|FG001|Randomization|Withdrew before treatment, ineligible|1|||
124948804|NCT00687297|449440032|FG000|Induction|Withdrawal by Subject|4|||
124948805|NCT00687297|449440033|FG001|Induction|Withdrawal by Subject|4|||
124948806|NCT00687297|449440032|FG000|Induction|Adverse Event|16|||
124948807|NCT00687297|449440033|FG001|Induction|Adverse Event|15|||
125029483|NCT02601573|449730758|FG004|Overall Study|Withdrawal by Subject|0|||
125029484|NCT02921425|449730759|FG000|Overall Study|Protocol Violation|9|||
125029485|NCT03403400|449730760|FG000|Overall Study|Lost to Follow-up|1|||
125029486|NCT03403400|449730761|FG001|Overall Study|Lost to Follow-up|0|||
125029487|NCT03403400|449730762|FG002|Overall Study|Lost to Follow-up|1|||
125029488|NCT03403400|449730760|FG000|Overall Study|Hospitalization|1|||
125029489|NCT03403400|449730761|FG001|Overall Study|Hospitalization|0|||
125029490|NCT03403400|449730762|FG002|Overall Study|Hospitalization|0|||
125029491|NCT03403400|449730760|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
125029492|NCT03403400|449730761|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
124948808|NCT00687297|449440032|FG000|Induction|Death|7|||
124948809|NCT00687297|449440033|FG001|Induction|Death|11|||
125029493|NCT03403400|449730762|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
125029494|NCT01384292|449730766|FG000|Part B|Severe non-compliance to protocol|1|||
124948810|NCT00687297|449440032|FG000|Induction|Lack of Efficacy|17|||
124948811|NCT00687297|449440033|FG001|Induction|Lack of Efficacy|21|||
124948812|NCT00687297|449440032|FG000|Induction|Ineligible|0|||
124948813|NCT00687297|449440033|FG001|Induction|Ineligible|1|||
124948814|NCT00687297|449440032|FG000|Induction|Patient Noncompliance|1|||
124948815|NCT00687297|449440033|FG001|Induction|Patient Noncompliance|0|||
124948816|NCT00687297|449440032|FG000|Induction|Physician Decision|0|||
124948817|NCT00687297|449440033|FG001|Induction|Physician Decision|2|||
124948818|NCT00687297|449440032|FG000|Induction|Other|0|||
124948819|NCT00687297|449440033|FG001|Induction|Other|1|||
124948820|NCT03006393|449440034|FG000|Overall Study|Withdrawal by Subject|1|||
124948821|NCT03006393|449440035|FG001|Overall Study|Withdrawal by Subject|1|||
124948822|NCT03006393|449440034|FG000|Overall Study|Pregnancy|0|||
124948823|NCT03006393|449440035|FG001|Overall Study|Pregnancy|1|||
124948824|NCT03006393|449440034|FG000|Overall Study|Lost to Follow-up|0|||
124948825|NCT03006393|449440035|FG001|Overall Study|Lost to Follow-up|1|||
124948826|NCT01584648|449440036|FG000|Overall Study|Death|136|||
124948827|NCT01584648|449440037|FG001|Overall Study|Death|146|||
124948828|NCT01584648|449440036|FG000|Overall Study|Lost to Follow-up|9|||
124948829|NCT01584648|449440037|FG001|Overall Study|Lost to Follow-up|9|||
124948830|NCT01584648|449440036|FG000|Overall Study|Investigator discretion|3|||
124948831|NCT01584648|449440037|FG001|Overall Study|Investigator discretion|2|||
124948832|NCT01584648|449440036|FG000|Overall Study|Withdrew consent|13|||
124948833|NCT01584648|449440037|FG001|Overall Study|Withdrew consent|4|||
124948834|NCT01584648|449440036|FG000|Overall Study|Study closed/terminated|50|||
124948835|NCT01584648|449440037|FG001|Overall Study|Study closed/terminated|23|||
124948836|NCT01584648|449440036|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
124948837|NCT01584648|449440037|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
124948838|NCT01328756|449440038|FG000|Overall Study|Protocol Violation|4|||
124948839|NCT01328756|449440038|FG000|Overall Study|Adverse Event|39|||
124948840|NCT01328756|449440038|FG000|Overall Study|Lack of Efficacy|5|||
124948841|NCT01328756|449440038|FG000|Overall Study|Withdrawal by Subject|41|||
124948842|NCT01328756|449440038|FG000|Overall Study|Lost to Follow-up|5|||
124948843|NCT01328756|449440038|FG000|Overall Study|Other|29|||
124948844|NCT00244751|449440043|FG000|Overall Study|Adverse Event|7|||
124948845|NCT00244751|449440044|FG001|Overall Study|Adverse Event|7|||
124948846|NCT00244751|449440045|FG002|Overall Study|Adverse Event|5|||
124948847|NCT00244751|449440043|FG000|Overall Study|Lost to Follow-up|0|||
124948848|NCT00244751|449440044|FG001|Overall Study|Lost to Follow-up|1|||
124948849|NCT00244751|449440045|FG002|Overall Study|Lost to Follow-up|0|||
124948850|NCT00244751|449440043|FG000|Overall Study|Protocol Violation|1|||
124948851|NCT00244751|449440044|FG001|Overall Study|Protocol Violation|0|||
124948852|NCT00244751|449440045|FG002|Overall Study|Protocol Violation|1|||
124948853|NCT00244751|449440043|FG000|Overall Study|Withdrawal by Subject|7|||
124948854|NCT00244751|449440044|FG001|Overall Study|Withdrawal by Subject|5|||
124948855|NCT00244751|449440045|FG002|Overall Study|Withdrawal by Subject|3|||
124948856|NCT00244751|449440043|FG000|Overall Study|Elevated liver enzymes|1|||
124948857|NCT00244751|449440044|FG001|Overall Study|Elevated liver enzymes|0|||
124948858|NCT00244751|449440045|FG002|Overall Study|Elevated liver enzymes|0|||
124948859|NCT00244751|449440043|FG000|Overall Study|Lack of compliance with protocol|0|||
124948860|NCT00244751|449440044|FG001|Overall Study|Lack of compliance with protocol|1|||
124948861|NCT00244751|449440045|FG002|Overall Study|Lack of compliance with protocol|0|||
124948862|NCT00244751|449440043|FG000|Overall Study|Safety reasons|0|||
125123962|NCT00117949|450078731|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
125123963|NCT00117949|450078732|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
125123964|NCT00117949|450078733|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
125123965|NCT00117949|450078734|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
125123966|NCT00117949|450078731|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
125123967|NCT00117949|450078732|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
125123968|NCT00117949|450078733|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
125123969|NCT00117949|450078734|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
125123970|NCT00117949|450078731|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
125123971|NCT00117949|450078732|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
124948863|NCT00244751|449440044|FG001|Overall Study|Safety reasons|1|||
125123972|NCT00117949|450078733|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
125214807|NCT02757352|450414860|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
124948864|NCT00244751|449440045|FG002|Overall Study|Safety reasons|0|||
124948865|NCT00244751|449440043|FG000|Overall Study|Participant randomized by mistake|0|||
124948866|NCT00244751|449440044|FG001|Overall Study|Participant randomized by mistake|0|||
124948867|NCT00244751|449440045|FG002|Overall Study|Participant randomized by mistake|1|||
124948868|NCT02206607|449440046|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
124948869|NCT02206607|449440047|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
124948870|NCT02206607|449440048|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
124948871|NCT02206607|449440049|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
124948872|NCT02206607|449440050|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
124948873|NCT02206607|449440046|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
125123973|NCT00117949|450078734|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
125214808|NCT02757352|450414861|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214809|NCT02757352|450414862|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214810|NCT02757352|450414863|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214811|NCT02757352|450414864|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214812|NCT02757352|450414865|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214813|NCT02757352|450414866|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214814|NCT02757352|450414867|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214815|NCT02757352|450414858|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
125214816|NCT02757352|450414859|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
125214817|NCT02757352|450414860|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
125214818|NCT02757352|450414861|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
125214819|NCT02757352|450414862|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
125214820|NCT02757352|450414863|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
125214821|NCT02757352|450414864|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
125214822|NCT02757352|450414865|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
125214823|NCT02757352|450414866|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
125214824|NCT02757352|450414867|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
125214825|NCT02757352|450414858|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
125214826|NCT02757352|450414859|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
125214827|NCT02757352|450414860|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
125214828|NCT02757352|450414861|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
125214829|NCT02757352|450414862|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
125214830|NCT02757352|450414863|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
125214831|NCT02757352|450414864|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
125214832|NCT02757352|450414865|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
125214833|NCT02757352|450414866|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
125214834|NCT02757352|450414867|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
125214835|NCT02757352|450414858|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214836|NCT02757352|450414859|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214837|NCT02757352|450414860|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214838|NCT02757352|450414861|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
125214839|NCT02757352|450414862|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
125214840|NCT02757352|450414863|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
125214841|NCT02757352|450414864|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214842|NCT02757352|450414865|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214843|NCT02757352|450414866|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214844|NCT02757352|450414867|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214845|NCT02757352|450414858|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
125214846|NCT02757352|450414859|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
125214847|NCT02757352|450414860|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
125214848|NCT02757352|450414861|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
125214849|NCT02757352|450414862|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
125214850|NCT02757352|450414863|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
124948874|NCT02206607|449440047|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
124948875|NCT02206607|449440048|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
124948876|NCT02206607|449440049|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
124948877|NCT02206607|449440050|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
124948878|NCT00879710|449440051|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
124948879|NCT00879710|449440052|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
124948880|NCT00879710|449440053|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
124948881|NCT00879710|449440054|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
124948882|NCT00879710|449440051|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
124948883|NCT00879710|449440052|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
124948884|NCT00879710|449440053|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
124948885|NCT00879710|449440054|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
124948886|NCT04085614|449440055|FG000|Overall Study|Protocol Violation|9|||
124948887|NCT04085614|449440056|FG001|Overall Study|Protocol Violation|6|||
124948888|NCT02399449|449440057|FG000|Overall Study|Withdrawal by Subject|3|||
124948889|NCT02399449|449440058|FG001|Overall Study|Withdrawal by Subject|9|||
124948890|NCT02399449|449440057|FG000|Overall Study|Physician Decision|0|||
124948891|NCT02399449|449440058|FG001|Overall Study|Physician Decision|1|||
124948892|NCT02516202|449440059|FG000|Overall Study|Withdrawal by Subject|1|||
124948893|NCT02516202|449440060|FG001|Overall Study|Withdrawal by Subject|0|||
124948894|NCT02516202|449440061|FG002|Overall Study|Withdrawal by Subject|1|||
124948895|NCT02516202|449440059|FG000|Overall Study|Lost to Follow-up|1|||
124948896|NCT02516202|449440060|FG001|Overall Study|Lost to Follow-up|1|||
124948897|NCT02516202|449440061|FG002|Overall Study|Lost to Follow-up|1|||
124948898|NCT02516202|449440059|FG000|Overall Study|Stopped Follow-up|0|||
124948899|NCT02516202|449440060|FG001|Overall Study|Stopped Follow-up|0|||
124948900|NCT02516202|449440061|FG002|Overall Study|Stopped Follow-up|1|||
124948901|NCT00337610|449440062|FG000|Overall Study|Adverse Event|2|||
124948902|NCT00337610|449440063|FG001|Overall Study|Adverse Event|2|||
124948903|NCT00337610|449440062|FG000|Overall Study|Death|0|||
124948904|NCT00337610|449440063|FG001|Overall Study|Death|1|||
124948905|NCT00337610|449440062|FG000|Overall Study|Lack of Efficacy|6|||
124948906|NCT00337610|449440063|FG001|Overall Study|Lack of Efficacy|3|||
124948907|NCT00337610|449440062|FG000|Overall Study|Lost to Follow-up|3|||
124948908|NCT00337610|449440063|FG001|Overall Study|Lost to Follow-up|3|||
124948909|NCT00337610|449440062|FG000|Overall Study|Withdrawal by Subject|6|||
124948910|NCT00337610|449440063|FG001|Overall Study|Withdrawal by Subject|5|||
124948911|NCT03541369|449440064|FG000|Overall Study|Death|0|||
124948912|NCT03541369|449440065|FG001|Overall Study|Death|0|||
124948913|NCT03541369|449440066|FG002|Overall Study|Death|0|||
124948914|NCT03541369|449440067|FG003|Overall Study|Death|0|||
124948915|NCT03541369|449440068|FG004|Overall Study|Death|1|||
124948916|NCT03541369|449440069|FG005|Overall Study|Death|1|||
124948917|NCT03541369|449440070|FG006|Overall Study|Death|0|||
124948918|NCT03541369|449440071|FG007|Overall Study|Death|2|||
124948919|NCT03541369|449440072|FG008|Overall Study|Death|1|||
124948920|NCT03541369|449440073|FG009|Overall Study|Death|2|||
124948921|NCT03541369|449440074|FG010|Overall Study|Death|1|||
124948922|NCT03541369|449440075|FG011|Overall Study|Death|0|||
124948923|NCT03541369|449440076|FG012|Overall Study|Death|2|||
124948924|NCT03541369|449440077|FG013|Overall Study|Death|1|||
124948925|NCT03541369|449440078|FG014|Overall Study|Death|1|||
124948926|NCT03541369|449440079|FG015|Overall Study|Death|1|||
124948927|NCT03541369|449440080|FG016|Overall Study|Death|0|||
124948928|NCT03541369|449440081|FG017|Overall Study|Death|1|||
124948929|NCT03541369|449440064|FG000|Overall Study|Decision by sponsor|0|||
124948930|NCT03541369|449440065|FG001|Overall Study|Decision by sponsor|0|||
124948931|NCT03541369|449440066|FG002|Overall Study|Decision by sponsor|0|||
124948932|NCT03541369|449440067|FG003|Overall Study|Decision by sponsor|1|||
124948933|NCT03541369|449440068|FG004|Overall Study|Decision by sponsor|0|||
124948934|NCT03541369|449440069|FG005|Overall Study|Decision by sponsor|2|||
124948935|NCT03541369|449440070|FG006|Overall Study|Decision by sponsor|0|||
124948936|NCT03541369|449440071|FG007|Overall Study|Decision by sponsor|1|||
124948937|NCT03541369|449440072|FG008|Overall Study|Decision by sponsor|2|||
124948938|NCT03541369|449440073|FG009|Overall Study|Decision by sponsor|0|||
124948939|NCT03541369|449440074|FG010|Overall Study|Decision by sponsor|0|||
124948940|NCT03541369|449440075|FG011|Overall Study|Decision by sponsor|0|||
124948941|NCT03541369|449440076|FG012|Overall Study|Decision by sponsor|2|||
124948942|NCT03541369|449440077|FG013|Overall Study|Decision by sponsor|2|||
124948943|NCT03541369|449440078|FG014|Overall Study|Decision by sponsor|0|||
124948944|NCT03541369|449440079|FG015|Overall Study|Decision by sponsor|1|||
124948945|NCT03541369|449440080|FG016|Overall Study|Decision by sponsor|1|||
124948946|NCT03541369|449440081|FG017|Overall Study|Decision by sponsor|1|||
124948947|NCT03541369|449440064|FG000|Overall Study|Withdrawal by Subject|0|||
124948948|NCT03541369|449440065|FG001|Overall Study|Withdrawal by Subject|0|||
124948949|NCT03541369|449440066|FG002|Overall Study|Withdrawal by Subject|0|||
124948950|NCT03541369|449440067|FG003|Overall Study|Withdrawal by Subject|0|||
124948951|NCT03541369|449440068|FG004|Overall Study|Withdrawal by Subject|0|||
124948952|NCT03541369|449440069|FG005|Overall Study|Withdrawal by Subject|0|||
124948953|NCT03541369|449440070|FG006|Overall Study|Withdrawal by Subject|1|||
124948954|NCT03541369|449440071|FG007|Overall Study|Withdrawal by Subject|0|||
124948955|NCT03541369|449440072|FG008|Overall Study|Withdrawal by Subject|0|||
124948956|NCT03541369|449440073|FG009|Overall Study|Withdrawal by Subject|0|||
124948957|NCT03541369|449440074|FG010|Overall Study|Withdrawal by Subject|0|||
124948958|NCT03541369|449440075|FG011|Overall Study|Withdrawal by Subject|1|||
124948959|NCT03541369|449440076|FG012|Overall Study|Withdrawal by Subject|0|||
124948960|NCT03541369|449440077|FG013|Overall Study|Withdrawal by Subject|0|||
124948961|NCT03541369|449440078|FG014|Overall Study|Withdrawal by Subject|3|||
124948962|NCT03541369|449440079|FG015|Overall Study|Withdrawal by Subject|0|||
124948963|NCT03541369|449440080|FG016|Overall Study|Withdrawal by Subject|4|||
124948964|NCT03541369|449440081|FG017|Overall Study|Withdrawal by Subject|2|||
124948965|NCT03541369|449440064|FG000|Overall Study|Lost to Follow-up|0|||
124948966|NCT03541369|449440065|FG001|Overall Study|Lost to Follow-up|0|||
124948967|NCT03541369|449440066|FG002|Overall Study|Lost to Follow-up|0|||
124948968|NCT03541369|449440067|FG003|Overall Study|Lost to Follow-up|0|||
124948969|NCT03541369|449440068|FG004|Overall Study|Lost to Follow-up|1|||
124948970|NCT03541369|449440069|FG005|Overall Study|Lost to Follow-up|0|||
124948971|NCT03541369|449440070|FG006|Overall Study|Lost to Follow-up|0|||
124948972|NCT03541369|449440071|FG007|Overall Study|Lost to Follow-up|0|||
124948973|NCT03541369|449440072|FG008|Overall Study|Lost to Follow-up|1|||
124948974|NCT03541369|449440073|FG009|Overall Study|Lost to Follow-up|0|||
124948975|NCT03541369|449440074|FG010|Overall Study|Lost to Follow-up|0|||
125214851|NCT02757352|450414864|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
125214852|NCT02757352|450414865|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
125214853|NCT02757352|450414866|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
125214854|NCT02757352|450414867|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
125214855|NCT02757352|450414858|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
125214856|NCT02757352|450414859|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
125214857|NCT02757352|450414860|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
125214858|NCT02757352|450414861|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
125214859|NCT02757352|450414862|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
125214860|NCT02757352|450414863|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
125214861|NCT02757352|450414864|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
125214862|NCT02757352|450414865|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
125214863|NCT02757352|450414866|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
125214864|NCT02757352|450414867|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
124948976|NCT03541369|449440075|FG011|Overall Study|Lost to Follow-up|0|||
124948977|NCT03541369|449440076|FG012|Overall Study|Lost to Follow-up|1|||
124948978|NCT03541369|449440077|FG013|Overall Study|Lost to Follow-up|0|||
124948979|NCT03541369|449440078|FG014|Overall Study|Lost to Follow-up|0|||
124948980|NCT03541369|449440079|FG015|Overall Study|Lost to Follow-up|0|||
124948981|NCT03541369|449440080|FG016|Overall Study|Lost to Follow-up|0|||
124948982|NCT03541369|449440081|FG017|Overall Study|Lost to Follow-up|0|||
124948983|NCT03205488|449440084|FG000|Overall Study|Adverse Event|1|||
124948984|NCT03205488|449440085|FG001|Overall Study|Adverse Event|2|||
124948985|NCT03205488|449440086|FG002|Overall Study|Adverse Event|4|||
124948986|NCT03205488|449440084|FG000|Overall Study|Protocol Violation|0|||
124948987|NCT03205488|449440085|FG001|Overall Study|Protocol Violation|0|||
124948988|NCT03205488|449440086|FG002|Overall Study|Protocol Violation|1|||
124948989|NCT04867382|449440087|FG000|Overall Study|Did not complete the survey|2|||
124948990|NCT04867382|449440088|FG001|Overall Study|Did not complete the survey|1|||
124948991|NCT05445557|449440096|FG000|Double Blind Part|Lost to Follow-up|1|||
124948992|NCT02008916|449440097|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
125214865|NCT02757352|450414858|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214866|NCT02757352|450414859|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
124948993|NCT02008916|449440098|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
125214867|NCT02757352|450414860|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214868|NCT02757352|450414861|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
125214869|NCT02757352|450414862|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
125214870|NCT02757352|450414863|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
125214871|NCT02757352|450414864|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214872|NCT02757352|450414865|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
124948994|NCT02008916|449440099|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
124948995|NCT02008916|449440097|FG000|Week 16 - 156|Adverse Event|4|||
124948996|NCT02008916|449440098|FG001|Week 16 - 156|Adverse Event|2|||
124948997|NCT02008916|449440099|FG002|Week 16 - 156|Adverse Event|3|||
124948998|NCT02008916|449440097|FG000|Week 16 - 156|Withdrawal by Subject|7|||
124948999|NCT02008916|449440098|FG001|Week 16 - 156|Withdrawal by Subject|3|||
124949000|NCT02008916|449440099|FG002|Week 16 - 156|Withdrawal by Subject|5|||
124949001|NCT02008916|449440097|FG000|Week 16 - 156|No longer requires treatment|0|||
124949002|NCT02008916|449440098|FG001|Week 16 - 156|No longer requires treatment|1|||
124949003|NCT02008916|449440099|FG002|Week 16 - 156|No longer requires treatment|0|||
124949004|NCT02008916|449440097|FG000|Week 16 - 156|Lost to Follow-up|5|||
124949005|NCT02008916|449440098|FG001|Week 16 - 156|Lost to Follow-up|0|||
124949006|NCT02008916|449440099|FG002|Week 16 - 156|Lost to Follow-up|0|||
124949007|NCT02008916|449440097|FG000|Week 16 - 156|Lack of Efficacy|3|||
124949008|NCT02008916|449440098|FG001|Week 16 - 156|Lack of Efficacy|5|||
124949009|NCT02008916|449440099|FG002|Week 16 - 156|Lack of Efficacy|2|||
124949010|NCT02008916|449440097|FG000|Week 16 - 156|Pregnancy|0|||
124949011|NCT02008916|449440098|FG001|Week 16 - 156|Pregnancy|1|||
124949012|NCT02008916|449440099|FG002|Week 16 - 156|Pregnancy|0|||
124949013|NCT02008916|449440097|FG000|Week 16 - 156|Physician Decision|0|||
124949014|NCT02008916|449440098|FG001|Week 16 - 156|Physician Decision|1|||
124949015|NCT02008916|449440099|FG002|Week 16 - 156|Physician Decision|0|||
124949016|NCT03803475|449440100|FG000|Overall Study|Physician Decision|1|||
124949017|NCT00392197|449440103|FG000|Overall Study|Adverse Event|4|||
124949018|NCT00392197|449440104|FG001|Overall Study|Adverse Event|12|||
124949019|NCT00392197|449440103|FG000|Overall Study|Lack of Efficacy|3|||
124949020|NCT00392197|449440104|FG001|Overall Study|Lack of Efficacy|4|||
124949021|NCT00392197|449440103|FG000|Overall Study|Lost to Follow-up|0|||
124949022|NCT00392197|449440104|FG001|Overall Study|Lost to Follow-up|1|||
124949023|NCT00392197|449440103|FG000|Overall Study|Physician Decision|3|||
124949024|NCT00392197|449440104|FG001|Overall Study|Physician Decision|2|||
124949025|NCT00392197|449440103|FG000|Overall Study|Protocol Violation|7|||
124949026|NCT00392197|449440104|FG001|Overall Study|Protocol Violation|5|||
124949027|NCT00392197|449440103|FG000|Overall Study|Withdrawal by Subject|4|||
124949028|NCT00392197|449440104|FG001|Overall Study|Withdrawal by Subject|6|||
124949029|NCT00428714|449440106|FG000|Overall Study|Progressive Disease|28|||
124949030|NCT00428714|449440107|FG001|Overall Study|Progressive Disease|36|||
125123974|NCT00117949|450078731|FG000|Overall Study|PSA increase >=10ng/mL|0|||
125123975|NCT00117949|450078732|FG001|Overall Study|PSA increase >=10ng/mL|1|||
125123976|NCT00117949|450078733|FG002|Overall Study|PSA increase >=10ng/mL|1|||
125123977|NCT00117949|450078734|FG003|Overall Study|PSA increase >=10ng/mL|0|||
125123978|NCT00117949|450078731|FG000|Overall Study|PSA reduction <=50%|0|||
125123979|NCT00117949|450078732|FG001|Overall Study|PSA reduction <=50%|2|||
125123980|NCT00117949|450078733|FG002|Overall Study|PSA reduction <=50%|2|||
125123981|NCT00117949|450078734|FG003|Overall Study|PSA reduction <=50%|4|||
125123982|NCT00117949|450078731|FG000|Overall Study|Hepatic abnormalities|0|||
124949031|NCT00428714|449440106|FG000|Overall Study|Withdrawal by Subject|0|||
124949032|NCT00428714|449440107|FG001|Overall Study|Withdrawal by Subject|3|||
124949033|NCT00428714|449440106|FG000|Overall Study|Adverse Event|0|||
124949034|NCT00428714|449440107|FG001|Overall Study|Adverse Event|2|||
124949035|NCT00428714|449440106|FG000|Overall Study|Physician Decision|1|||
124949036|NCT00428714|449440107|FG001|Overall Study|Physician Decision|1|||
125123983|NCT00117949|450078732|FG001|Overall Study|Hepatic abnormalities|1|||
125123984|NCT00117949|450078733|FG002|Overall Study|Hepatic abnormalities|0|||
124949037|NCT00428714|449440106|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
124949038|NCT00428714|449440107|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
124949039|NCT00428714|449440106|FG000|Overall Study|Death due to other then PD|1|||
124949040|NCT00428714|449440107|FG001|Overall Study|Death due to other then PD|0|||
124949041|NCT01681511|449440108|FG000|Overall Study|No Treatment Received|1|||
124949042|NCT01681511|449440109|FG001|Overall Study|No Treatment Received|3|||
124949043|NCT01681511|449440108|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
124949044|NCT01681511|449440109|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
125123985|NCT00117949|450078734|FG003|Overall Study|Hepatic abnormalities|1|||
125123986|NCT01226797|450078735|FG000|Overall Study|Adverse Event|1|||
125123987|NCT01226797|450078736|FG001|Overall Study|Adverse Event|0|||
125123988|NCT01226797|450078735|FG000|Overall Study|No longer willing to participate|1|||
124949045|NCT01681511|449440108|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
124949046|NCT01681511|449440109|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
124949047|NCT01681511|449440108|FG000|Overall Study|No Daily Urine Sample Collected|0|||
124949048|NCT01681511|449440109|FG001|Overall Study|No Daily Urine Sample Collected|1|||
124949049|NCT01681511|449440108|FG000|Overall Study|No post-catheter sample collected|11|||
124949050|NCT01681511|449440109|FG001|Overall Study|No post-catheter sample collected|4|||
124949051|NCT00090519|449440123|FG000|Overall Study|Adverse Event|5|||
124949052|NCT00090519|449440124|FG001|Overall Study|Adverse Event|4|||
124949053|NCT00090519|449440123|FG000|Overall Study|Death|9|||
124949054|NCT00090519|449440124|FG001|Overall Study|Death|9|||
124949055|NCT00090519|449440123|FG000|Overall Study|Lost to Follow-up|26|||
125214873|NCT02757352|450414866|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214874|NCT02757352|450414867|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214875|NCT02757352|450414858|FG000|Follow-Up Period|Adverse Event|0|||
125214876|NCT02757352|450414859|FG001|Follow-Up Period|Adverse Event|0|||
125214877|NCT02757352|450414860|FG002|Follow-Up Period|Adverse Event|0|||
125214878|NCT02757352|450414861|FG003|Follow-Up Period|Adverse Event|0|||
125214879|NCT02757352|450414862|FG004|Follow-Up Period|Adverse Event|0|||
125214880|NCT02757352|450414863|FG005|Follow-Up Period|Adverse Event|0|||
125214881|NCT02757352|450414864|FG006|Follow-Up Period|Adverse Event|1|||
125214882|NCT02757352|450414865|FG007|Follow-Up Period|Adverse Event|0|||
125214883|NCT02757352|450414866|FG008|Follow-Up Period|Adverse Event|2|||
125214884|NCT02757352|450414867|FG009|Follow-Up Period|Adverse Event|0|||
125214885|NCT02757352|450414858|FG000|Follow-Up Period|Lost to Follow-up|0|||
125214886|NCT02757352|450414859|FG001|Follow-Up Period|Lost to Follow-up|0|||
125214887|NCT02757352|450414860|FG002|Follow-Up Period|Lost to Follow-up|0|||
125214888|NCT02757352|450414861|FG003|Follow-Up Period|Lost to Follow-up|0|||
125214889|NCT02757352|450414862|FG004|Follow-Up Period|Lost to Follow-up|0|||
125214890|NCT02757352|450414863|FG005|Follow-Up Period|Lost to Follow-up|0|||
125214891|NCT02757352|450414864|FG006|Follow-Up Period|Lost to Follow-up|0|||
125214892|NCT02757352|450414865|FG007|Follow-Up Period|Lost to Follow-up|0|||
125214893|NCT02757352|450414866|FG008|Follow-Up Period|Lost to Follow-up|1|||
125214894|NCT02757352|450414867|FG009|Follow-Up Period|Lost to Follow-up|0|||
125214895|NCT02757352|450414858|FG000|Follow-Up Period|Lack of Efficacy|0|||
125214896|NCT02757352|450414859|FG001|Follow-Up Period|Lack of Efficacy|0|||
125214897|NCT02757352|450414860|FG002|Follow-Up Period|Lack of Efficacy|0|||
125214898|NCT02757352|450414861|FG003|Follow-Up Period|Lack of Efficacy|0|||
125214899|NCT02757352|450414862|FG004|Follow-Up Period|Lack of Efficacy|0|||
125214900|NCT02757352|450414863|FG005|Follow-Up Period|Lack of Efficacy|0|||
125214901|NCT02757352|450414864|FG006|Follow-Up Period|Lack of Efficacy|0|||
125214902|NCT02757352|450414865|FG007|Follow-Up Period|Lack of Efficacy|0|||
125214903|NCT02757352|450414866|FG008|Follow-Up Period|Lack of Efficacy|1|||
125214904|NCT02757352|450414867|FG009|Follow-Up Period|Lack of Efficacy|1|||
125214905|NCT02757352|450414858|FG000|Follow-Up Period|Withdrawal by Subject|0|||
125214906|NCT02757352|450414859|FG001|Follow-Up Period|Withdrawal by Subject|0|||
125214907|NCT02757352|450414860|FG002|Follow-Up Period|Withdrawal by Subject|0|||
125214908|NCT02757352|450414861|FG003|Follow-Up Period|Withdrawal by Subject|0|||
125214909|NCT02757352|450414862|FG004|Follow-Up Period|Withdrawal by Subject|0|||
125214910|NCT02757352|450414863|FG005|Follow-Up Period|Withdrawal by Subject|0|||
125214911|NCT02757352|450414864|FG006|Follow-Up Period|Withdrawal by Subject|0|||
125214912|NCT02757352|450414865|FG007|Follow-Up Period|Withdrawal by Subject|1|||
125214913|NCT02757352|450414866|FG008|Follow-Up Period|Withdrawal by Subject|6|||
125214914|NCT02757352|450414867|FG009|Follow-Up Period|Withdrawal by Subject|2|||
124949056|NCT00090519|449440124|FG001|Overall Study|Lost to Follow-up|29|||
124949057|NCT00090519|449440123|FG000|Overall Study|Withdrawal by Subject|28|||
124949058|NCT00090519|449440124|FG001|Overall Study|Withdrawal by Subject|29|||
124949059|NCT00090519|449440123|FG000|Overall Study|Physician Decision|2|||
124949060|NCT00090519|449440124|FG001|Overall Study|Physician Decision|3|||
124949061|NCT00090519|449440123|FG000|Overall Study|Sponsor Decision|3|||
124949062|NCT00090519|449440124|FG001|Overall Study|Sponsor Decision|1|||
124949063|NCT02161146|449440125|FG000|Overall Study|Adverse Event|1|||
124949064|NCT02161146|449440126|FG001|Overall Study|Adverse Event|1|||
124949065|NCT02161146|449440127|FG002|Overall Study|Adverse Event|0|||
124949066|NCT02161146|449440128|FG003|Overall Study|Adverse Event|1|||
124949067|NCT02161146|449440129|FG004|Overall Study|Adverse Event|0|||
124949068|NCT02161146|449440125|FG000|Overall Study|Lost to Follow-up|0|||
124949069|NCT02161146|449440126|FG001|Overall Study|Lost to Follow-up|1|||
124949070|NCT02161146|449440127|FG002|Overall Study|Lost to Follow-up|0|||
124949071|NCT02161146|449440128|FG003|Overall Study|Lost to Follow-up|0|||
124949072|NCT02161146|449440129|FG004|Overall Study|Lost to Follow-up|0|||
124949073|NCT02161146|449440125|FG000|Overall Study|Personal Reasons|0|||
124949074|NCT02161146|449440126|FG001|Overall Study|Personal Reasons|1|||
124949075|NCT02161146|449440127|FG002|Overall Study|Personal Reasons|0|||
124949076|NCT02161146|449440128|FG003|Overall Study|Personal Reasons|2|||
124949077|NCT02161146|449440129|FG004|Overall Study|Personal Reasons|1|||
124949078|NCT02161146|449440125|FG000|Overall Study|Other Miscellaneous Reasons|0|||
124949079|NCT02161146|449440126|FG001|Overall Study|Other Miscellaneous Reasons|1|||
124949080|NCT02161146|449440127|FG002|Overall Study|Other Miscellaneous Reasons|0|||
124949081|NCT02161146|449440128|FG003|Overall Study|Other Miscellaneous Reasons|0|||
124949082|NCT02161146|449440129|FG004|Overall Study|Other Miscellaneous Reasons|0|||
124949083|NCT02613403|449440132|FG000|Overall Study|Lost to Follow-up|0|||
124949084|NCT02613403|449440133|FG001|Overall Study|Lost to Follow-up|1|||
124949085|NCT02613403|449440134|FG002|Overall Study|Lost to Follow-up|0|||
124949086|NCT02613403|449440135|FG003|Overall Study|Lost to Follow-up|0|||
124949087|NCT02613403|449440136|FG004|Overall Study|Lost to Follow-up|0|||
124949088|NCT02613403|449440132|FG000|Overall Study|Withdrawal by Subject|2|||
124949089|NCT02613403|449440133|FG001|Overall Study|Withdrawal by Subject|0|||
124949090|NCT02613403|449440134|FG002|Overall Study|Withdrawal by Subject|0|||
124949091|NCT02613403|449440135|FG003|Overall Study|Withdrawal by Subject|0|||
124949092|NCT02613403|449440136|FG004|Overall Study|Withdrawal by Subject|0|||
124949093|NCT02189759|449440137|FG000|Overall Study|Lost to Follow-up|0|||
124949094|NCT02189759|449440138|FG001|Overall Study|Lost to Follow-up|0|||
124949095|NCT02189759|449440139|FG002|Overall Study|Lost to Follow-up|2|||
124949096|NCT02189759|449440140|FG003|Overall Study|Lost to Follow-up|5|||
124949097|NCT00800176|449440143|FG000|Overall Study|Adverse Event|2|||
124949098|NCT00800176|449440144|FG001|Overall Study|Adverse Event|1|||
124949099|NCT00800176|449440145|FG002|Overall Study|Adverse Event|0|||
124949100|NCT00800176|449440146|FG003|Overall Study|Adverse Event|2|||
124949101|NCT00800176|449440147|FG004|Overall Study|Adverse Event|1|||
124949102|NCT00800176|449440148|FG005|Overall Study|Adverse Event|1|||
124949103|NCT00800176|449440143|FG000|Overall Study|Refused treatment|3|||
124949104|NCT00800176|449440144|FG001|Overall Study|Refused treatment|2|||
124949105|NCT00800176|449440145|FG002|Overall Study|Refused treatment|0|||
124949106|NCT00800176|449440146|FG003|Overall Study|Refused treatment|0|||
124949107|NCT00800176|449440147|FG004|Overall Study|Refused treatment|1|||
124949108|NCT00800176|449440148|FG005|Overall Study|Refused treatment|4|||
124949109|NCT00800176|449440143|FG000|Overall Study|Failure to return|3|||
124949110|NCT00800176|449440144|FG001|Overall Study|Failure to return|3|||
125214915|NCT03638466|450414868|FG000|Overall Study|Early Termination|0|||
125214916|NCT03638466|450414869|FG001|Overall Study|Early Termination|1|||
125214917|NCT03251482|450414870|FG000|Overall Study|Withdrawal by Subject|0|||
124949111|NCT00800176|449440145|FG002|Overall Study|Failure to return|0|||
124949112|NCT00800176|449440146|FG003|Overall Study|Failure to return|2|||
124949113|NCT00800176|449440147|FG004|Overall Study|Failure to return|0|||
124949114|NCT00800176|449440148|FG005|Overall Study|Failure to return|0|||
124949115|NCT00800176|449440143|FG000|Overall Study|Other|1|||
124949116|NCT00800176|449440144|FG001|Overall Study|Other|0|||
124949117|NCT00800176|449440145|FG002|Overall Study|Other|0|||
124949118|NCT00800176|449440146|FG003|Overall Study|Other|0|||
124949119|NCT00800176|449440147|FG004|Overall Study|Other|2|||
124949120|NCT00800176|449440148|FG005|Overall Study|Other|0|||
125029495|NCT01384292|449730767|FG001|Part B|Severe non-compliance to protocol|0|||
124949121|NCT02548585|449440151|FG000|Overall Study|Withdrawal by Subject|0|||
124949122|NCT02548585|449440152|FG001|Overall Study|Withdrawal by Subject|0|||
124949123|NCT02548585|449440153|FG002|Overall Study|Withdrawal by Subject|0|||
124949124|NCT02548585|449440154|FG003|Overall Study|Withdrawal by Subject|0|||
124949125|NCT02548585|449440155|FG004|Overall Study|Withdrawal by Subject|0|||
125214918|NCT03251482|450414871|FG001|Overall Study|Withdrawal by Subject|1|||
125214919|NCT03251482|450414872|FG002|Overall Study|Withdrawal by Subject|0|||
124949126|NCT02548585|449440156|FG005|Overall Study|Withdrawal by Subject|1|||
124949127|NCT02548585|449440157|FG006|Overall Study|Withdrawal by Subject|0|||
124949128|NCT02548585|449440151|FG000|Overall Study|Lost to Follow-up|1|||
124949129|NCT02548585|449440152|FG001|Overall Study|Lost to Follow-up|0|||
124949130|NCT02548585|449440153|FG002|Overall Study|Lost to Follow-up|0|||
124949131|NCT02548585|449440154|FG003|Overall Study|Lost to Follow-up|0|||
124949132|NCT02548585|449440155|FG004|Overall Study|Lost to Follow-up|0|||
124949133|NCT02548585|449440156|FG005|Overall Study|Lost to Follow-up|0|||
124949134|NCT02548585|449440157|FG006|Overall Study|Lost to Follow-up|0|||
124949135|NCT02548585|449440151|FG000|Overall Study|Other|1|||
124949136|NCT02548585|449440152|FG001|Overall Study|Other|0|||
124949137|NCT02548585|449440153|FG002|Overall Study|Other|0|||
124949138|NCT02548585|449440154|FG003|Overall Study|Other|2|||
124949139|NCT02548585|449440155|FG004|Overall Study|Other|3|||
124949140|NCT02548585|449440156|FG005|Overall Study|Other|0|||
124949141|NCT02548585|449440157|FG006|Overall Study|Other|1|||
124949142|NCT02548585|449440151|FG000|Overall Study|Randomized but not treated|0|||
124949143|NCT02548585|449440152|FG001|Overall Study|Randomized but not treated|0|||
124949144|NCT02548585|449440153|FG002|Overall Study|Randomized but not treated|0|||
124949145|NCT02548585|449440154|FG003|Overall Study|Randomized but not treated|0|||
124949146|NCT02548585|449440155|FG004|Overall Study|Randomized but not treated|0|||
124949147|NCT02548585|449440156|FG005|Overall Study|Randomized but not treated|1|||
124949148|NCT02548585|449440157|FG006|Overall Study|Randomized but not treated|0|||
124949149|NCT03242863|449440161|FG000|Study Week 1|Withdrawal by Subject|0|||
124949150|NCT03242863|449440162|FG001|Study Week 1|Withdrawal by Subject|1|||
124949151|NCT03242863|449440163|FG002|Study Week 1|Withdrawal by Subject|0|||
124949152|NCT03242863|449440164|FG003|Study Week 1|Withdrawal by Subject|0|||
125123989|NCT01226797|450078736|FG001|Overall Study|No longer willing to participate|0|||
125123990|NCT01226797|450078735|FG000|Overall Study|Protocol Violation|0|||
125123991|NCT01226797|450078736|FG001|Overall Study|Protocol Violation|1|||
124949153|NCT03242863|449440165|FG004|Study Week 1|Withdrawal by Subject|3|||
124949154|NCT03242863|449440166|FG005|Study Week 1|Withdrawal by Subject|0|||
124949155|NCT01079949|449440170|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
124949156|NCT01079949|449440171|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
124949157|NCT01079949|449440170|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
124949158|NCT01079949|449440171|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
124949159|NCT01079949|449440170|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
124949160|NCT01079949|449440171|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
124949161|NCT01079949|449440170|FG000|Overall Study|Randomized but not treated|1|||
124949162|NCT01079949|449440171|FG001|Overall Study|Randomized but not treated|0|||
124949163|NCT02144285|449440172|FG000|Overall Study|Withdrawal by Subject|0|||
124949164|NCT02144285|449440173|FG001|Overall Study|Withdrawal by Subject|0|||
124949165|NCT02144285|449440174|FG002|Overall Study|Withdrawal by Subject|0|||
124949166|NCT02144285|449440175|FG003|Overall Study|Withdrawal by Subject|0|||
124949167|NCT02144285|449440176|FG004|Overall Study|Withdrawal by Subject|1|||
124949168|NCT02144285|449440177|FG005|Overall Study|Withdrawal by Subject|0|||
124949169|NCT02144285|449440178|FG006|Overall Study|Withdrawal by Subject|0|||
124949170|NCT02144285|449440179|FG007|Overall Study|Withdrawal by Subject|0|||
124949171|NCT02144285|449440180|FG008|Overall Study|Withdrawal by Subject|0|||
124949172|NCT02144285|449440181|FG009|Overall Study|Withdrawal by Subject|0|||
124949173|NCT01529632|449440182|FG000|Overall Study|Administrative problem|2|||
124949174|NCT01529632|449440183|FG001|Overall Study|Administrative problem|1|||
124949175|NCT01529632|449440182|FG000|Overall Study|Protocol Violation|0|||
124949176|NCT01529632|449440183|FG001|Overall Study|Protocol Violation|1|||
124949177|NCT01529632|449440182|FG000|Overall Study|Adverse Event|1|||
124949178|NCT01529632|449440183|FG001|Overall Study|Adverse Event|1|||
124949179|NCT01276509|449441778|FG000|Overall Study|Adverse Event|9|||
124949180|NCT01276509|449441779|FG001|Overall Study|Adverse Event|8|||
124949181|NCT01276509|449441780|FG002|Overall Study|Adverse Event|4|||
124949182|NCT01276509|449441781|FG003|Overall Study|Adverse Event|3|||
124949183|NCT01276509|449441778|FG000|Overall Study|Lack of Efficacy|2|||
125123992|NCT01606306|450078738|FG000|Overall Study|Lack of Efficacy|2|||
124949184|NCT01276509|449441779|FG001|Overall Study|Lack of Efficacy|1|||
124949185|NCT01276509|449441780|FG002|Overall Study|Lack of Efficacy|1|||
124949186|NCT01276509|449441781|FG003|Overall Study|Lack of Efficacy|2|||
124949187|NCT01276509|449441778|FG000|Overall Study|Pregnancy|1|||
124949188|NCT01276509|449441779|FG001|Overall Study|Pregnancy|0|||
124949189|NCT01276509|449441780|FG002|Overall Study|Pregnancy|0|||
124949190|NCT01276509|449441781|FG003|Overall Study|Pregnancy|0|||
124949191|NCT01276509|449441778|FG000|Overall Study|Withdrawal by Subject|1|||
124949192|NCT01276509|449441779|FG001|Overall Study|Withdrawal by Subject|2|||
124949193|NCT01276509|449441780|FG002|Overall Study|Withdrawal by Subject|0|||
124949194|NCT01276509|449441781|FG003|Overall Study|Withdrawal by Subject|0|||
124949195|NCT01276509|449441778|FG000|Overall Study|Other|0|||
124949196|NCT01276509|449441779|FG001|Overall Study|Other|1|||
125123993|NCT01606306|450078739|FG001|Overall Study|Lack of Efficacy|1|||
125123994|NCT01606306|450078740|FG002|Overall Study|Lack of Efficacy|4|||
124949197|NCT01276509|449441780|FG002|Overall Study|Other|0|||
124949198|NCT01276509|449441781|FG003|Overall Study|Other|0|||
124949199|NCT02196259|449441787|FG000|Overall Study|Researcher choice|0|||
124949200|NCT02196259|449441788|FG001|Overall Study|Researcher choice|0|||
124949201|NCT02196259|449441789|FG002|Overall Study|Researcher choice|1|||
124949202|NCT02196259|449441787|FG000|Overall Study|Partial data analysis|0|||
124949203|NCT02196259|449441788|FG001|Overall Study|Partial data analysis|3|||
124949204|NCT02196259|449441789|FG002|Overall Study|Partial data analysis|0|||
124949205|NCT01668355|449441790|FG000|Overall Study|Death|3|||
124949206|NCT01668355|449441791|FG001|Overall Study|Death|1|||
124949207|NCT01668355|449441790|FG000|Overall Study|Withdrawal by Subject|6|||
124949208|NCT01668355|449441791|FG001|Overall Study|Withdrawal by Subject|1|||
124949209|NCT00215943|449441792|FG000|Overall Study|Disease Progression|3|||
124949210|NCT00215943|449441793|FG001|Overall Study|Disease Progression|5|||
125029496|NCT01384292|449730768|FG002|Part B|Severe non-compliance to protocol|0|||
125029497|NCT01171612|449730769|FG000|Overall Study|Lost to Follow-up|51|||
125029498|NCT00243659|449730770|FG000|Overall Study|Withdrawal by Subject|1|||
125029499|NCT00243659|449730771|FG001|Overall Study|Withdrawal by Subject|1|||
125029500|NCT00243659|449730770|FG000|Overall Study|Protocol Violation|1|||
125029501|NCT00243659|449730771|FG001|Overall Study|Protocol Violation|2|||
125029502|NCT03310970|449730772|FG000|Overall Study|Withdrawal by Subject|0|||
125029503|NCT03310970|449730773|FG001|Overall Study|Withdrawal by Subject|1|||
125029504|NCT01273064|449730774|FG000|Overall Study|Adverse Event|5|||
125029505|NCT01273064|449730775|FG001|Overall Study|Adverse Event|1|||
125029506|NCT01273064|449730776|FG002|Overall Study|Adverse Event|3|||
125029507|NCT01273064|449730777|FG003|Overall Study|Adverse Event|2|||
125029508|NCT01273064|449730778|FG004|Overall Study|Adverse Event|1|||
125029509|NCT01273064|449730774|FG000|Overall Study|Withdrawal by Subject|4|||
125029510|NCT01273064|449730775|FG001|Overall Study|Withdrawal by Subject|2|||
125029511|NCT01273064|449730776|FG002|Overall Study|Withdrawal by Subject|2|||
125029512|NCT01273064|449730777|FG003|Overall Study|Withdrawal by Subject|2|||
125029513|NCT01273064|449730778|FG004|Overall Study|Withdrawal by Subject|0|||
125029514|NCT01273064|449730774|FG000|Overall Study|Study Termination|13|||
125029515|NCT01273064|449730775|FG001|Overall Study|Study Termination|27|||
125029516|NCT01273064|449730776|FG002|Overall Study|Study Termination|26|||
125029517|NCT01273064|449730777|FG003|Overall Study|Study Termination|16|||
125029518|NCT01273064|449730778|FG004|Overall Study|Study Termination|8|||
125029519|NCT01273064|449730774|FG000|Overall Study|Lost to Follow-up|1|||
125029520|NCT01273064|449730775|FG001|Overall Study|Lost to Follow-up|0|||
125029521|NCT01273064|449730776|FG002|Overall Study|Lost to Follow-up|0|||
125029522|NCT01273064|449730777|FG003|Overall Study|Lost to Follow-up|0|||
125029523|NCT01273064|449730778|FG004|Overall Study|Lost to Follow-up|0|||
125029524|NCT01273064|449730774|FG000|Overall Study|Physician Decision|0|||
125029525|NCT01273064|449730775|FG001|Overall Study|Physician Decision|0|||
125029526|NCT01273064|449730776|FG002|Overall Study|Physician Decision|0|||
125029527|NCT01273064|449730777|FG003|Overall Study|Physician Decision|0|||
125029528|NCT01273064|449730778|FG004|Overall Study|Physician Decision|1|||
125029529|NCT04062214|449730779|FG000|Week 12|Death|1|||
125029530|NCT04062214|449730780|FG001|Week 12|Death|1|||
125029531|NCT04062214|449730779|FG000|Week 12|Withdrawal by Subject|14|||
125029532|NCT04062214|449730780|FG001|Week 12|Withdrawal by Subject|13|||
125029533|NCT04062214|449730779|FG000|Week 12|Lost to Follow-up|55|||
125029534|NCT04062214|449730780|FG001|Week 12|Lost to Follow-up|68|||
125029535|NCT04062214|449730779|FG000|Week 12|Intermittent missing|31|||
125029536|NCT04062214|449730780|FG001|Week 12|Intermittent missing|29|||
125029537|NCT04062214|449730779|FG000|Week 36|Withdrawal by Subject|4|||
125029538|NCT04062214|449730780|FG001|Week 36|Withdrawal by Subject|5|||
125029539|NCT04062214|449730779|FG000|Week 36|Lost to Follow-up|50|||
125029540|NCT04062214|449730780|FG001|Week 36|Lost to Follow-up|46|||
125029541|NCT04062214|449730779|FG000|Week 36|Death|0|||
125029542|NCT04062214|449730780|FG001|Week 36|Death|1|||
125029543|NCT00291551|449730781|FG000|Overall Study|Death|7|||
125029544|NCT00291551|449730781|FG000|Overall Study|Withdrawal by Subject|6|||
125029545|NCT04666038|449730782|FG000|Overall Study|Progressive Disease|2|||
125029546|NCT04666038|449730783|FG001|Overall Study|Progressive Disease|0|||
125029547|NCT04666038|449730782|FG000|Overall Study|Death|38|||
125029548|NCT04666038|449730783|FG001|Overall Study|Death|32|||
125029549|NCT04666038|449730782|FG000|Overall Study|Withdrawal by Subject|10|||
125029550|NCT04666038|449730783|FG001|Overall Study|Withdrawal by Subject|19|||
125029551|NCT04666038|449730782|FG000|Overall Study|Lost to Follow-up|0|||
125029552|NCT04666038|449730783|FG001|Overall Study|Lost to Follow-up|2|||
125029553|NCT04666038|449730782|FG000|Overall Study|On Study Treatment|46|||
125029554|NCT04666038|449730783|FG001|Overall Study|On Study Treatment|5|||
125029555|NCT04666038|449730782|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
125029556|NCT04666038|449730783|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
125029557|NCT03887130|449730788|FG000|Overall Study|Progressive disease|23|||
125029558|NCT03887130|449730789|FG001|Overall Study|Progressive disease|14|||
125029559|NCT03887130|449730790|FG002|Overall Study|Progressive disease|7|||
125029560|NCT03887130|449730788|FG000|Overall Study|Protocol Violation|3|||
125029561|NCT03887130|449730789|FG001|Overall Study|Protocol Violation|1|||
125029562|NCT03887130|449730790|FG002|Overall Study|Protocol Violation|2|||
125029563|NCT03887130|449730788|FG000|Overall Study|Drug related toxicity|7|||
125029564|NCT03887130|449730789|FG001|Overall Study|Drug related toxicity|7|||
125029565|NCT03887130|449730790|FG002|Overall Study|Drug related toxicity|13|||
125029566|NCT03887130|449730788|FG000|Overall Study|Non drug related toxicity|3|||
125029567|NCT03887130|449730789|FG001|Overall Study|Non drug related toxicity|0|||
125029568|NCT03887130|449730790|FG002|Overall Study|Non drug related toxicity|0|||
125123995|NCT01606306|450078741|FG003|Overall Study|Lack of Efficacy|4|||
125123996|NCT01606306|450078742|FG004|Overall Study|Lack of Efficacy|1|||
125123997|NCT01606306|450078743|FG005|Overall Study|Lack of Efficacy|2|||
125123998|NCT01606306|450078738|FG000|Overall Study|Adverse Event|1|||
125123999|NCT01606306|450078739|FG001|Overall Study|Adverse Event|0|||
125124000|NCT01606306|450078740|FG002|Overall Study|Adverse Event|1|||
125124001|NCT01606306|450078741|FG003|Overall Study|Adverse Event|1|||
125124002|NCT01606306|450078742|FG004|Overall Study|Adverse Event|2|||
125124003|NCT01606306|450078743|FG005|Overall Study|Adverse Event|0|||
125124004|NCT01606306|450078738|FG000|Overall Study|Lost to Follow-up|7|||
125124005|NCT01606306|450078739|FG001|Overall Study|Lost to Follow-up|4|||
125124006|NCT01606306|450078740|FG002|Overall Study|Lost to Follow-up|5|||
125124007|NCT01606306|450078741|FG003|Overall Study|Lost to Follow-up|4|||
125124008|NCT01606306|450078742|FG004|Overall Study|Lost to Follow-up|3|||
125124009|NCT01606306|450078743|FG005|Overall Study|Lost to Follow-up|5|||
125124010|NCT01606306|450078738|FG000|Overall Study|Withdrawal by Subject|4|||
125124011|NCT01606306|450078739|FG001|Overall Study|Withdrawal by Subject|3|||
125124012|NCT01606306|450078740|FG002|Overall Study|Withdrawal by Subject|4|||
125124013|NCT01606306|450078741|FG003|Overall Study|Withdrawal by Subject|4|||
125124014|NCT01606306|450078742|FG004|Overall Study|Withdrawal by Subject|5|||
125124015|NCT01606306|450078743|FG005|Overall Study|Withdrawal by Subject|4|||
125124016|NCT01606306|450078738|FG000|Overall Study|Physician Decision|1|||
125124017|NCT01606306|450078739|FG001|Overall Study|Physician Decision|2|||
125124018|NCT01606306|450078740|FG002|Overall Study|Physician Decision|0|||
125124019|NCT01606306|450078741|FG003|Overall Study|Physician Decision|0|||
125124020|NCT01606306|450078742|FG004|Overall Study|Physician Decision|0|||
125124021|NCT01606306|450078743|FG005|Overall Study|Physician Decision|0|||
125124022|NCT00841100|450078746|FG000|Phase 1 (28 Days)|Adverse Event|1|||
125124023|NCT00841100|450078746|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
125124024|NCT01355081|450078747|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
125124025|NCT01355081|450078748|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
125124026|NCT01355081|450078749|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
125124027|NCT01355081|450078747|FG000|Overall Study|Major Protocol Deviation|0|||
125124028|NCT01355081|450078748|FG001|Overall Study|Major Protocol Deviation|1|||
125124029|NCT01355081|450078749|FG002|Overall Study|Major Protocol Deviation|0|||
125124030|NCT01355081|450078747|FG000|Overall Study|Lost to Follow-up|0|||
125124031|NCT01355081|450078748|FG001|Overall Study|Lost to Follow-up|0|||
125124032|NCT01355081|450078749|FG002|Overall Study|Lost to Follow-up|1|||
125124033|NCT01355081|450078747|FG000|Overall Study|Withdrawal of Consent|2|||
125124034|NCT01355081|450078748|FG001|Overall Study|Withdrawal of Consent|3|||
125124035|NCT01355081|450078749|FG002|Overall Study|Withdrawal of Consent|3|||
125124036|NCT01355081|450078747|FG000|Overall Study|Lack of Efficacy|2|||
125124037|NCT01355081|450078748|FG001|Overall Study|Lack of Efficacy|1|||
125124038|NCT01355081|450078749|FG002|Overall Study|Lack of Efficacy|1|||
125124039|NCT01355081|450078747|FG000|Overall Study|Non Compliance with Study Medication|0|||
125124040|NCT01355081|450078748|FG001|Overall Study|Non Compliance with Study Medication|1|||
125124041|NCT01355081|450078749|FG002|Overall Study|Non Compliance with Study Medication|0|||
125124042|NCT04803357|450078754|FG000|Overall Study|Withdrawal by Subject|31|||
125124043|NCT04803357|450078755|FG001|Overall Study|Withdrawal by Subject|5|||
125124044|NCT01046253|450078756|FG000|Second Intervention|Adverse Event|0|||
125124045|NCT01046253|450078757|FG001|Second Intervention|Adverse Event|1|||
125124046|NCT01046253|450078756|FG000|Second Intervention|Protocol Violation|0|||
125124047|NCT01046253|450078757|FG001|Second Intervention|Protocol Violation|1|||
125124048|NCT02339909|450078760|FG000|Overall Study|Became ineligible after randomisation|89|||
125124049|NCT02339909|450078761|FG001|Overall Study|Became ineligible after randomisation|63|||
125124050|NCT02339909|450078762|FG002|Overall Study|Became ineligible after randomisation|71|||
125124051|NCT00860028|450078765|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
125124052|NCT00860028|450078766|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
125029569|NCT03887130|449730788|FG000|Overall Study|Death|2|||
125029570|NCT03887130|449730789|FG001|Overall Study|Death|2|||
125124053|NCT01658943|450078768|FG000|Overall Study|Adverse Event|6|||
125124054|NCT01658943|450078769|FG001|Overall Study|Adverse Event|13|||
125124055|NCT01658943|450078768|FG000|Overall Study|Withdrawal by Subject|9|||
124949211|NCT00215943|449441792|FG000|Overall Study|Alternate therapy|0|||
124949212|NCT00215943|449441793|FG001|Overall Study|Alternate therapy|1|||
124949213|NCT00215943|449441792|FG000|Overall Study|Adverse Event|3|||
124949214|NCT00215943|449441793|FG001|Overall Study|Adverse Event|6|||
124949215|NCT00215943|449441792|FG000|Overall Study|Other disease|0|||
124949216|NCT00215943|449441793|FG001|Overall Study|Other disease|1|||
124949217|NCT00215943|449441792|FG000|Overall Study|Other complications|3|||
124949218|NCT00215943|449441793|FG001|Overall Study|Other complications|1|||
124949219|NCT00403845|449441800|FG000|Treatment Period 1|Subject withdrew consent|1|||
124949220|NCT00403845|449441801|FG001|Treatment Period 1|Subject withdrew consent|0|||
124949221|NCT00403845|449441802|FG002|Treatment Period 1|Subject withdrew consent|0|||
124949222|NCT00403845|449441803|FG003|Treatment Period 1|Subject withdrew consent|0|||
124949223|NCT00403845|449441800|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
124949224|NCT00403845|449441801|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
124949225|NCT00403845|449441802|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
124949226|NCT00403845|449441803|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
124949227|NCT00403845|449441800|FG000|Treatment Period 2|Subject withdrew consent|1|||
124949228|NCT00403845|449441801|FG001|Treatment Period 2|Subject withdrew consent|0|||
124949229|NCT00403845|449441802|FG002|Treatment Period 2|Subject withdrew consent|0|||
124949230|NCT00403845|449441803|FG003|Treatment Period 2|Subject withdrew consent|0|||
124949231|NCT00403845|449441800|FG000|Treatment Period 3|Subject withdrew consent|0|||
124949232|NCT00403845|449441801|FG001|Treatment Period 3|Subject withdrew consent|0|||
124949233|NCT00403845|449441802|FG002|Treatment Period 3|Subject withdrew consent|0|||
124949234|NCT00403845|449441803|FG003|Treatment Period 3|Subject withdrew consent|1|||
124949235|NCT00403845|449441800|FG000|Treatment Period 3|Adverse Event|0|||
124949236|NCT00403845|449441801|FG001|Treatment Period 3|Adverse Event|0|||
124949237|NCT00403845|449441802|FG002|Treatment Period 3|Adverse Event|0|||
124949238|NCT00403845|449441803|FG003|Treatment Period 3|Adverse Event|1|||
124949239|NCT00805792|449441804|FG000|Overall Study|Death|3|||
124949240|NCT00805792|449441804|FG000|Overall Study|Lost to Follow-up|2|||
124949241|NCT02152384|449441805|FG000|Period 1|Withdrawal by Subject|0|||
124949242|NCT02152384|449441806|FG001|Period 1|Withdrawal by Subject|1|||
124949243|NCT02152384|449441805|FG000|Period 1|Adverse Event|1|||
124949244|NCT02152384|449441806|FG001|Period 1|Adverse Event|1|||
124949245|NCT01393964|449441811|FG000|Overall Study|Disease Progression|4|||
124949246|NCT01393964|449441812|FG001|Overall Study|Disease Progression|3|||
124949247|NCT01393964|449441813|FG002|Overall Study|Disease Progression|5|||
125124056|NCT01658943|450078769|FG001|Overall Study|Withdrawal by Subject|2|||
125124057|NCT01658943|450078768|FG000|Overall Study|Progression/Relapse|39|||
125124058|NCT01658943|450078769|FG001|Overall Study|Progression/Relapse|40|||
125124059|NCT01658943|450078768|FG000|Overall Study|Death|4|||
125124060|NCT01658943|450078769|FG001|Overall Study|Death|2|||
125124061|NCT01658943|450078768|FG000|Overall Study|not protocol specified|4|||
124949248|NCT01393964|449441811|FG000|Overall Study|Study drug toxicity|1|||
124949249|NCT01393964|449441812|FG001|Overall Study|Study drug toxicity|0|||
124949250|NCT01393964|449441813|FG002|Overall Study|Study drug toxicity|0|||
125214920|NCT03251482|450414873|FG003|Overall Study|Withdrawal by Subject|0|||
124949251|NCT01393964|449441811|FG000|Overall Study|Withdrawal by Subject|0|||
124949252|NCT01393964|449441812|FG001|Overall Study|Withdrawal by Subject|0|||
124949253|NCT01393964|449441813|FG002|Overall Study|Withdrawal by Subject|1|||
124949254|NCT01393964|449441811|FG000|Overall Study|Adverse event unrelated to study drug|0|||
124949255|NCT01393964|449441812|FG001|Overall Study|Adverse event unrelated to study drug|3|||
124949256|NCT01393964|449441813|FG002|Overall Study|Adverse event unrelated to study drug|0|||
124949257|NCT01393964|449441811|FG000|Overall Study|Subject request stop study treatment|0|||
125029571|NCT03887130|449730790|FG002|Overall Study|Death|1|||
125029572|NCT03887130|449730788|FG000|Overall Study|Withdrawal by Subject|7|||
125029573|NCT03887130|449730789|FG001|Overall Study|Withdrawal by Subject|6|||
125029574|NCT03887130|449730790|FG002|Overall Study|Withdrawal by Subject|11|||
125029575|NCT03887130|449730788|FG000|Overall Study|other reason|6|||
125029576|NCT03887130|449730789|FG001|Overall Study|other reason|20|||
125029577|NCT03887130|449730790|FG002|Overall Study|other reason|17|||
125029578|NCT04082663|449730791|FG000|Overall Study|Adverse Event|6|||
125029579|NCT04082663|449730791|FG000|Overall Study|Lost to Follow-up|1|||
125029580|NCT00705263|449730792|FG000|Overall Study|Withdrawal by Subject|2|||
125029581|NCT01752023|449730793|FG000|Overall Study|Physician Decision|2|||
125029582|NCT01752023|449730794|FG001|Overall Study|Physician Decision|1|||
125029583|NCT02899156|449730795|FG000|Overall Study|Death|1|||
125214921|NCT03251482|450414874|FG004|Overall Study|Withdrawal by Subject|0|||
125214922|NCT02447328|450414875|FG000|Overall Study|Withdrawal by Subject|1|||
125029584|NCT02899156|449730796|FG001|Overall Study|Death|0|||
125029585|NCT02899156|449730795|FG000|Overall Study|Physician Decision|0|||
125029586|NCT02899156|449730796|FG001|Overall Study|Physician Decision|1|||
125029587|NCT00787787|449730800|FG000|Overall Study|Lack of Efficacy|4|||
125029588|NCT00787787|449730800|FG000|Overall Study|Adverse Event|3|||
125029589|NCT01412957|449730801|FG000|Overall Study|Withdrawal by Subject|6|||
125029590|NCT01412957|449730802|FG001|Overall Study|Withdrawal by Subject|22|||
125029591|NCT01412957|449730801|FG000|Overall Study|Lost to Follow-up|7|||
125029592|NCT01412957|449730802|FG001|Overall Study|Lost to Follow-up|2|||
125029593|NCT01412957|449730801|FG000|Overall Study|Death|136|||
125029594|NCT01412957|449730802|FG001|Overall Study|Death|133|||
125029595|NCT04722991|449730803|FG000|Overall Study|Adverse Event|12|||
125029596|NCT04722991|449730804|FG001|Overall Study|Adverse Event|4|||
125029597|NCT04722991|449730803|FG000|Overall Study|Death|2|||
125029598|NCT04722991|449730804|FG001|Overall Study|Death|0|||
125029599|NCT04722991|449730803|FG000|Overall Study|Lost to Follow-up|1|||
125029600|NCT04722991|449730804|FG001|Overall Study|Lost to Follow-up|1|||
125029601|NCT04722991|449730803|FG000|Overall Study|Withdrawal cirterion met|2|||
125029602|NCT04722991|449730804|FG001|Overall Study|Withdrawal cirterion met|2|||
125029603|NCT04722991|449730803|FG000|Overall Study|Other|1|||
125029604|NCT04722991|449730804|FG001|Overall Study|Other|0|||
125029605|NCT04722991|449730803|FG000|Overall Study|Non-compliance|0|||
125029606|NCT04722991|449730804|FG001|Overall Study|Non-compliance|1|||
125029607|NCT04722991|449730803|FG000|Overall Study|Withdrawal by Subject|0|||
125029608|NCT04722991|449730804|FG001|Overall Study|Withdrawal by Subject|1|||
125029609|NCT02246621|449730807|FG000|Overall Study|Withdrawal by Subject|28|||
125029610|NCT02246621|449730808|FG001|Overall Study|Withdrawal by Subject|16|||
125029611|NCT02246621|449730807|FG000|Overall Study|Lost to Follow-up|1|||
125029612|NCT02246621|449730808|FG001|Overall Study|Lost to Follow-up|0|||
125029613|NCT02246621|449730807|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
125029614|NCT02246621|449730808|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
125029615|NCT01583374|449730809|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
125029616|NCT01583374|449730810|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
125029617|NCT01583374|449730811|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
125029618|NCT01583374|449730812|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125029619|NCT01583374|449730813|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125029620|NCT01583374|449730814|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125029621|NCT01583374|449730815|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125124062|NCT01658943|450078769|FG001|Overall Study|not protocol specified|1|||
124949258|NCT01393964|449441812|FG001|Overall Study|Subject request stop study treatment|1|||
125124063|NCT01658943|450078768|FG000|Overall Study|Not eligible|7|||
125124064|NCT01658943|450078769|FG001|Overall Study|Not eligible|9|||
125124065|NCT01658943|450078768|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
125124066|NCT01658943|450078769|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
125124067|NCT03144687|450078771|FG000|Overall Study|Death|0|||
125124068|NCT03144687|450078772|FG001|Overall Study|Death|2|||
125124069|NCT03144687|450078771|FG000|Overall Study|Lost to Follow-up|0|||
125124070|NCT03144687|450078772|FG001|Overall Study|Lost to Follow-up|1|||
125124071|NCT03144687|450078771|FG000|Overall Study|Physician Decision|0|||
125124072|NCT03144687|450078772|FG001|Overall Study|Physician Decision|1|||
125124073|NCT03144687|450078771|FG000|Overall Study|Withdrawal by Subject|1|||
125124074|NCT03144687|450078772|FG001|Overall Study|Withdrawal by Subject|3|||
125124075|NCT03144687|450078771|FG000|Overall Study|Not Reported|2|||
125124076|NCT03144687|450078772|FG001|Overall Study|Not Reported|0|||
125124077|NCT01054599|450078773|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
125124078|NCT01054599|450078774|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
125124079|NCT01054599|450078773|FG000|Overall Study|Protocol Violation|1|||
125124080|NCT01054599|450078774|FG001|Overall Study|Protocol Violation|0|||
125124081|NCT01054599|450078773|FG000|Overall Study|Spells/seizure-like episodes|1|||
125124082|NCT01054599|450078774|FG001|Overall Study|Spells/seizure-like episodes|1|||
125124083|NCT01054599|450078773|FG000|Overall Study|Timing/scheduling difficulties|1|||
125124084|NCT01054599|450078774|FG001|Overall Study|Timing/scheduling difficulties|1|||
125124085|NCT01054599|450078773|FG000|Overall Study|Visual impairment, WTAR <80|0|||
125124086|NCT01054599|450078774|FG001|Overall Study|Visual impairment, WTAR <80|1|||
125124087|NCT01054599|450078773|FG000|Overall Study|Lost to Follow-up|0|||
125124088|NCT01054599|450078774|FG001|Overall Study|Lost to Follow-up|2|||
125124089|NCT01054599|450078773|FG000|Overall Study|Adverse Event|0|||
125124090|NCT01054599|450078774|FG001|Overall Study|Adverse Event|1|||
125124091|NCT01054599|450078773|FG000|Overall Study|Withdrawal by Subject|0|||
125124092|NCT01054599|450078774|FG001|Overall Study|Withdrawal by Subject|1|||
125124093|NCT00475020|450078775|FG000|Overall Study|Physician Decision|3|||
125124094|NCT00475020|450078775|FG000|Overall Study|Insurance Denial|1|||
125124095|NCT00475020|450078775|FG000|Overall Study|Donor not able to donate the last minute|1|||
125124096|NCT02514174|450078779|FG000|Overall Study|Patient refused to continue medication|1|||
125124097|NCT02514174|450078779|FG000|Overall Study|Adverse Event|2|||
125124098|NCT02514174|450078779|FG000|Overall Study|Study closed by sponsor|9|||
125124099|NCT02514174|450078779|FG000|Overall Study|Progressive disease|11|||
125124100|NCT02514174|450078779|FG000|Overall Study|Treatment change|1|||
125124101|NCT02514174|450078779|FG000|Overall Study|Treated off study with Afatinib.|1|||
125124102|NCT02170688|450078780|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
125124103|NCT02170688|450078781|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
125124104|NCT02170688|450078782|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
125124105|NCT02170688|450078783|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
125124106|NCT02170688|450078784|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
125124107|NCT02170688|450078780|FG000|Overall Study|Full dose not received|0|||
125124108|NCT02170688|450078781|FG001|Overall Study|Full dose not received|1|||
125124109|NCT02170688|450078782|FG002|Overall Study|Full dose not received|0|||
125124110|NCT02170688|450078783|FG003|Overall Study|Full dose not received|0|||
125124111|NCT02170688|450078784|FG004|Overall Study|Full dose not received|0|||
125124112|NCT02170688|450078780|FG000|Overall Study|Physician Decision|0|||
125124113|NCT02170688|450078781|FG001|Overall Study|Physician Decision|0|||
125124114|NCT02170688|450078782|FG002|Overall Study|Physician Decision|1|||
125124115|NCT02170688|450078783|FG003|Overall Study|Physician Decision|0|||
125124116|NCT02170688|450078784|FG004|Overall Study|Physician Decision|0|||
125124117|NCT00543309|450080705|FG000|Overall Study|Physician Decision|0|||
125124118|NCT00543309|450080706|FG001|Overall Study|Physician Decision|1|||
125124119|NCT00543309|450080707|FG002|Overall Study|Physician Decision|0|||
125124120|NCT02143102|450080710|FG000|Overall Study|Lost to Follow-up|11|||
125124121|NCT02143102|450080711|FG001|Overall Study|Lost to Follow-up|0|||
125124122|NCT03247556|450080716|FG000|Overall Study|Adverse Event|1|||
125124123|NCT03247556|450080717|FG001|Overall Study|Adverse Event|4|||
125124124|NCT03247556|450080718|FG002|Overall Study|Adverse Event|5|||
125124125|NCT03247556|450080716|FG000|Overall Study|Lost to Follow-up|5|||
125124126|NCT03247556|450080717|FG001|Overall Study|Lost to Follow-up|5|||
125124127|NCT03247556|450080718|FG002|Overall Study|Lost to Follow-up|4|||
125124128|NCT03247556|450080716|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
125124129|NCT03247556|450080717|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
125124130|NCT03247556|450080718|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
125124131|NCT03247556|450080716|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
125124132|NCT03247556|450080717|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
125124133|NCT03247556|450080718|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
125124134|NCT03247556|450080716|FG000|Overall Study|Protocol Violation|2|||
125124135|NCT03247556|450080717|FG001|Overall Study|Protocol Violation|0|||
125124136|NCT03247556|450080718|FG002|Overall Study|Protocol Violation|1|||
125124137|NCT03247556|450080716|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
125124138|NCT03247556|450080717|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
125124139|NCT03247556|450080718|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
125124140|NCT01203878|450080719|FG000|Overall Study|Withdrawal by Subject|0|||
125124141|NCT01203878|450080720|FG001|Overall Study|Withdrawal by Subject|0|||
125124142|NCT01203878|450080721|FG002|Overall Study|Withdrawal by Subject|1|||
125124143|NCT01203878|450080719|FG000|Overall Study|Adverse Event|0|||
125124144|NCT01203878|450080720|FG001|Overall Study|Adverse Event|0|||
125124145|NCT01203878|450080721|FG002|Overall Study|Adverse Event|2|||
125124146|NCT03952143|450080722|FG000|Lead-In Period|Adverse Event|2|||
125124147|NCT03952143|450080723|FG001|Lead-In Period|Adverse Event|0|||
125124148|NCT03952143|450080724|FG002|Lead-In Period|Adverse Event|0|||
125124149|NCT03952143|450080722|FG000|Lead-In Period|Lack of Efficacy|2|||
125124150|NCT03952143|450080723|FG001|Lead-In Period|Lack of Efficacy|0|||
125124151|NCT03952143|450080724|FG002|Lead-In Period|Lack of Efficacy|0|||
125124152|NCT03952143|450080722|FG000|Lead-In Period|Physician Decision|5|||
125124153|NCT03952143|450080723|FG001|Lead-In Period|Physician Decision|0|||
125124154|NCT03952143|450080724|FG002|Lead-In Period|Physician Decision|0|||
125124155|NCT03952143|450080722|FG000|Lead-In Period|Protocol Violation|5|||
125124156|NCT03952143|450080723|FG001|Lead-In Period|Protocol Violation|0|||
125124157|NCT03952143|450080724|FG002|Lead-In Period|Protocol Violation|0|||
125124158|NCT03952143|450080722|FG000|Lead-In Period|Withdrawal by Subject|19|||
125124159|NCT03952143|450080723|FG001|Lead-In Period|Withdrawal by Subject|0|||
125124160|NCT03952143|450080724|FG002|Lead-In Period|Withdrawal by Subject|0|||
125214923|NCT02362425|450414876|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
125214924|NCT02362425|450414877|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
125124161|NCT03952143|450080722|FG000|Treatment Period|Adverse Event|0|||
125124162|NCT03952143|450080723|FG001|Treatment Period|Adverse Event|0|||
125124163|NCT03952143|450080724|FG002|Treatment Period|Adverse Event|1|||
125124164|NCT03952143|450080722|FG000|Treatment Period|Lost to Follow-up|0|||
125124165|NCT03952143|450080723|FG001|Treatment Period|Lost to Follow-up|2|||
125124166|NCT03952143|450080724|FG002|Treatment Period|Lost to Follow-up|0|||
125124167|NCT03952143|450080722|FG000|Treatment Period|Physician Decision|0|||
125124168|NCT03952143|450080723|FG001|Treatment Period|Physician Decision|0|||
125124169|NCT03952143|450080724|FG002|Treatment Period|Physician Decision|2|||
125124170|NCT03952143|450080722|FG000|Treatment Period|Protocol Violation|0|||
125124171|NCT03952143|450080723|FG001|Treatment Period|Protocol Violation|0|||
125124172|NCT03952143|450080724|FG002|Treatment Period|Protocol Violation|1|||
125124173|NCT03952143|450080722|FG000|Treatment Period|Withdrawal by Subject|0|||
125124174|NCT03952143|450080723|FG001|Treatment Period|Withdrawal by Subject|5|||
125124175|NCT03952143|450080724|FG002|Treatment Period|Withdrawal by Subject|26|||
125124176|NCT03952143|450080722|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
125124177|NCT03952143|450080723|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
125124178|NCT03952143|450080724|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
125124179|NCT03952143|450080722|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
125124180|NCT03952143|450080723|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
125124181|NCT03952143|450080724|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
125124182|NCT01866319|450080725|FG000|Overall Study|Adverse Event|12|||
125124183|NCT01866319|450080726|FG001|Overall Study|Adverse Event|5|||
125124184|NCT01866319|450080727|FG002|Overall Study|Adverse Event|9|||
125124185|NCT01866319|450080725|FG000|Overall Study|Clinical progression|3|||
125124186|NCT01866319|450080726|FG001|Overall Study|Clinical progression|2|||
125124187|NCT01866319|450080727|FG002|Overall Study|Clinical progression|2|||
125124188|NCT01866319|450080725|FG000|Overall Study|Death|153|||
125124189|NCT01866319|450080726|FG001|Overall Study|Death|154|||
125124190|NCT01866319|450080727|FG002|Overall Study|Death|147|||
125124191|NCT01866319|450080725|FG000|Overall Study|Lost to Follow-up|6|||
125124192|NCT01866319|450080726|FG001|Overall Study|Lost to Follow-up|3|||
125124193|NCT01866319|450080727|FG002|Overall Study|Lost to Follow-up|8|||
125124194|NCT01866319|450080725|FG000|Overall Study|Physician Decision|1|||
125124195|NCT01866319|450080726|FG001|Overall Study|Physician Decision|0|||
125124196|NCT01866319|450080727|FG002|Overall Study|Physician Decision|1|||
125124197|NCT01866319|450080725|FG000|Overall Study|Protocol Violation|0|||
125124198|NCT01866319|450080726|FG001|Overall Study|Protocol Violation|0|||
125124199|NCT01866319|450080727|FG002|Overall Study|Protocol Violation|1|||
125124200|NCT01866319|450080725|FG000|Overall Study|Withdrawal by Subject|32|||
125124201|NCT01866319|450080726|FG001|Overall Study|Withdrawal by Subject|14|||
125124202|NCT01866319|450080727|FG002|Overall Study|Withdrawal by Subject|12|||
125124203|NCT03980483|450080731|FG000|Overall Study|Adverse Event|13|||
125124204|NCT03980483|450080732|FG001|Overall Study|Adverse Event|29|||
125124205|NCT03980483|450080733|FG002|Overall Study|Adverse Event|11|||
125124206|NCT03980483|450080734|FG003|Overall Study|Adverse Event|2|||
125124207|NCT03980483|450080735|FG004|Overall Study|Adverse Event|2|||
125214925|NCT02362425|450414878|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
125214926|NCT02362425|450414879|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
125214927|NCT02362425|450414876|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
125214928|NCT02362425|450414877|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
125124208|NCT03980483|450080736|FG005|Overall Study|Adverse Event|2|||
125124209|NCT03980483|450080731|FG000|Overall Study|Lack of Efficacy|7|||
125124210|NCT03980483|450080732|FG001|Overall Study|Lack of Efficacy|6|||
125124211|NCT03980483|450080733|FG002|Overall Study|Lack of Efficacy|0|||
125124212|NCT03980483|450080734|FG003|Overall Study|Lack of Efficacy|3|||
125124213|NCT03980483|450080735|FG004|Overall Study|Lack of Efficacy|1|||
125124214|NCT03980483|450080736|FG005|Overall Study|Lack of Efficacy|1|||
125124215|NCT03980483|450080731|FG000|Overall Study|Lost to Follow-up|2|||
125124216|NCT03980483|450080732|FG001|Overall Study|Lost to Follow-up|4|||
125124217|NCT03980483|450080733|FG002|Overall Study|Lost to Follow-up|2|||
125124218|NCT03980483|450080734|FG003|Overall Study|Lost to Follow-up|1|||
125124219|NCT03980483|450080735|FG004|Overall Study|Lost to Follow-up|2|||
125124220|NCT03980483|450080736|FG005|Overall Study|Lost to Follow-up|0|||
125124221|NCT03980483|450080731|FG000|Overall Study|Protocol Violation|4|||
125124222|NCT03980483|450080732|FG001|Overall Study|Protocol Violation|2|||
125124223|NCT03980483|450080733|FG002|Overall Study|Protocol Violation|1|||
125124224|NCT03980483|450080734|FG003|Overall Study|Protocol Violation|1|||
125124225|NCT03980483|450080735|FG004|Overall Study|Protocol Violation|0|||
125124226|NCT03980483|450080736|FG005|Overall Study|Protocol Violation|0|||
125124227|NCT03980483|450080731|FG000|Overall Study|Physician Decision|14|||
125124228|NCT03980483|450080732|FG001|Overall Study|Physician Decision|10|||
125124229|NCT03980483|450080733|FG002|Overall Study|Physician Decision|7|||
125124230|NCT03980483|450080734|FG003|Overall Study|Physician Decision|4|||
125124231|NCT03980483|450080735|FG004|Overall Study|Physician Decision|4|||
125124232|NCT03980483|450080736|FG005|Overall Study|Physician Decision|2|||
125124233|NCT03980483|450080731|FG000|Overall Study|Withdrawal by Subject|38|||
125124234|NCT03980483|450080732|FG001|Overall Study|Withdrawal by Subject|21|||
125124235|NCT03980483|450080733|FG002|Overall Study|Withdrawal by Subject|15|||
125124236|NCT03980483|450080734|FG003|Overall Study|Withdrawal by Subject|5|||
125124237|NCT03980483|450080735|FG004|Overall Study|Withdrawal by Subject|3|||
125124238|NCT03980483|450080736|FG005|Overall Study|Withdrawal by Subject|4|||
125124239|NCT03980483|450080731|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
125124240|NCT03980483|450080732|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
125124241|NCT03980483|450080733|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
125124242|NCT03980483|450080734|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
125124243|NCT03980483|450080735|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
125214929|NCT02362425|450414878|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
125124244|NCT03980483|450080736|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
124949259|NCT01393964|449441813|FG002|Overall Study|Subject request stop study treatment|0|||
125124245|NCT03980483|450080731|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
125124246|NCT03980483|450080732|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
125124247|NCT03980483|450080733|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
125124248|NCT03980483|450080734|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
125124249|NCT03980483|450080735|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
125124250|NCT03980483|450080736|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
125124251|NCT03980483|450080731|FG000|Overall Study|Other|0|||
125124252|NCT03980483|450080732|FG001|Overall Study|Other|1|||
125214930|NCT02362425|450414879|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
125029622|NCT01583374|449730816|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125029623|NCT01583374|449730817|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125029624|NCT01583374|449730809|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
125029625|NCT01583374|449730810|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
125029626|NCT01583374|449730811|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
125029627|NCT01583374|449730812|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125029628|NCT01583374|449730813|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125029629|NCT01583374|449730814|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125029630|NCT01583374|449730815|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125029631|NCT01583374|449730816|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125029632|NCT01583374|449730817|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125029633|NCT01583374|449730809|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
125029634|NCT01583374|449730810|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
125029635|NCT01583374|449730811|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125029636|NCT01583374|449730812|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125029637|NCT01583374|449730813|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125029638|NCT01583374|449730814|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125029639|NCT01583374|449730815|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125029640|NCT01583374|449730816|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125029641|NCT01583374|449730817|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125029642|NCT01583374|449730809|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
125029643|NCT01583374|449730810|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
125029644|NCT01583374|449730811|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
125029645|NCT01583374|449730812|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125029646|NCT01583374|449730813|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125029647|NCT01583374|449730814|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125029648|NCT01583374|449730815|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125029649|NCT01583374|449730816|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125029650|NCT01583374|449730817|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125029651|NCT01583374|449730809|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
125029652|NCT01583374|449730810|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
125029653|NCT01583374|449730811|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
125029654|NCT01583374|449730812|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
125029655|NCT01583374|449730813|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
125029656|NCT01583374|449730814|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
124949260|NCT01393964|449441811|FG000|Overall Study|Subject decided to move to transplant|1|||
125124253|NCT03980483|450080733|FG002|Overall Study|Other|0|||
125124254|NCT03980483|450080734|FG003|Overall Study|Other|0|||
125124255|NCT03980483|450080735|FG004|Overall Study|Other|0|||
125124256|NCT03980483|450080736|FG005|Overall Study|Other|0|||
125124257|NCT00760266|450080739|FG000|Overall Study|Adverse Event|13|||
125124258|NCT00760266|450080740|FG001|Overall Study|Adverse Event|7|||
125124259|NCT00760266|450080739|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125124260|NCT00760266|450080740|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125124261|NCT00760266|450080739|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125124262|NCT00760266|450080740|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125124263|NCT00760266|450080739|FG000|Overall Study|Lack of Efficacy|2|||
125124264|NCT00760266|450080740|FG001|Overall Study|Lack of Efficacy|2|||
125124265|NCT00760266|450080739|FG000|Overall Study|Protocol deviation|2|||
125124266|NCT00760266|450080740|FG001|Overall Study|Protocol deviation|4|||
125124267|NCT00760266|450080739|FG000|Overall Study|Patient withdrew consent|3|||
125124268|NCT00760266|450080740|FG001|Overall Study|Patient withdrew consent|3|||
125124269|NCT00760266|450080739|FG000|Overall Study|Lost to Follow-up|2|||
125124270|NCT00760266|450080740|FG001|Overall Study|Lost to Follow-up|1|||
125124271|NCT00760266|450080739|FG000|Overall Study|Administrative Problems|0|||
125124272|NCT00760266|450080740|FG001|Overall Study|Administrative Problems|1|||
125124273|NCT01225146|450080741|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
125124274|NCT01225146|450080742|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
125124275|NCT00659607|450080745|FG000|Overall Study|No blood pressure recorded|147|||
125124276|NCT00659607|450080745|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
125124277|NCT00659607|450080745|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
125124278|NCT00659607|450080745|FG000|Overall Study|No recorded efficacy data|15|||
125124279|NCT00659607|450080745|FG000|Overall Study|Inconsistent BP measuring date|2|||
125124280|NCT02191891|450080746|FG000|Overall Study|Withdrawal by Subject|0|||
125124281|NCT02191891|450080747|FG001|Overall Study|Withdrawal by Subject|1|||
125124282|NCT02191891|450080748|FG002|Overall Study|Withdrawal by Subject|0|||
125124283|NCT02191891|450080749|FG003|Overall Study|Withdrawal by Subject|0|||
125124284|NCT02191891|450080750|FG004|Overall Study|Withdrawal by Subject|1|||
125124285|NCT02191891|450080746|FG000|Overall Study|Adverse Event|0|||
125124286|NCT02191891|450080747|FG001|Overall Study|Adverse Event|1|||
125124287|NCT02191891|450080748|FG002|Overall Study|Adverse Event|0|||
125124288|NCT02191891|450080749|FG003|Overall Study|Adverse Event|0|||
125124289|NCT02191891|450080750|FG004|Overall Study|Adverse Event|2|||
125124290|NCT02191891|450080746|FG000|Overall Study|Disease Progression|4|||
125124291|NCT02191891|450080747|FG001|Overall Study|Disease Progression|10|||
125124292|NCT02191891|450080748|FG002|Overall Study|Disease Progression|4|||
125124293|NCT02191891|450080749|FG003|Overall Study|Disease Progression|2|||
125124294|NCT02191891|450080750|FG004|Overall Study|Disease Progression|7|||
125124295|NCT00874237|450080756|FG000|Overall Study|Physician Decision|0|||
125124296|NCT00874237|450080757|FG001|Overall Study|Physician Decision|1|||
125124297|NCT00874237|450080758|FG002|Overall Study|Physician Decision|0|||
125124298|NCT00874237|450080759|FG003|Overall Study|Physician Decision|0|||
125124299|NCT00874237|450080760|FG004|Overall Study|Physician Decision|0|||
125124300|NCT00874237|450080761|FG005|Overall Study|Physician Decision|0|||
125124301|NCT00874237|450080756|FG000|Overall Study|Withdrawal by Subject|0|||
125124302|NCT00874237|450080757|FG001|Overall Study|Withdrawal by Subject|0|||
125124303|NCT00874237|450080758|FG002|Overall Study|Withdrawal by Subject|1|||
125124304|NCT00874237|450080759|FG003|Overall Study|Withdrawal by Subject|0|||
125124305|NCT00874237|450080760|FG004|Overall Study|Withdrawal by Subject|0|||
125124306|NCT00874237|450080761|FG005|Overall Study|Withdrawal by Subject|0|||
125124307|NCT03912337|450080764|FG000|Overall Study|Withdrawal of Consent From Study|1|||
124949261|NCT01393964|449441812|FG001|Overall Study|Subject decided to move to transplant|0|||
124949262|NCT01393964|449441813|FG002|Overall Study|Subject decided to move to transplant|0|||
124949263|NCT01393964|449441811|FG000|Overall Study|Subject switched to commercial supply|1|||
124949264|NCT01393964|449441812|FG001|Overall Study|Subject switched to commercial supply|0|||
124949265|NCT01393964|449441813|FG002|Overall Study|Subject switched to commercial supply|2|||
124949266|NCT01393964|449441811|FG000|Overall Study|Subject plateaued in terms of effect|1|||
124949267|NCT01393964|449441812|FG001|Overall Study|Subject plateaued in terms of effect|0|||
124949268|NCT01393964|449441813|FG002|Overall Study|Subject plateaued in terms of effect|0|||
124949269|NCT01393964|449441811|FG000|Overall Study|Investigator removed subject from study|0|||
124949270|NCT01393964|449441812|FG001|Overall Study|Investigator removed subject from study|1|||
124949271|NCT01393964|449441813|FG002|Overall Study|Investigator removed subject from study|0|||
124949272|NCT01393964|449441811|FG000|Overall Study|Subject converted to roll-over study|0|||
124949273|NCT01393964|449441812|FG001|Overall Study|Subject converted to roll-over study|1|||
124949274|NCT01393964|449441813|FG002|Overall Study|Subject converted to roll-over study|0|||
124949275|NCT01393964|449441811|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
124949276|NCT01393964|449441812|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
124949277|NCT01393964|449441813|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
124949278|NCT03265132|449441820|FG000|Overall Study|Adverse Event|0|||
124949279|NCT03265132|449441821|FG001|Overall Study|Adverse Event|1|||
124949280|NCT03265132|449441820|FG000|Overall Study|Lack of Efficacy|0|||
124949281|NCT03265132|449441821|FG001|Overall Study|Lack of Efficacy|2|||
124949282|NCT03265132|449441820|FG000|Overall Study|Progressive disease|0|||
124949283|NCT03265132|449441821|FG001|Overall Study|Progressive disease|2|||
124949284|NCT03265132|449441820|FG000|Overall Study|Withdrawal by Subject|0|||
124949285|NCT03265132|449441821|FG001|Overall Study|Withdrawal by Subject|1|||
124949286|NCT00088166|449441822|FG000|Overall Study|Adverse Event|11|||
124949287|NCT00088166|449441823|FG001|Overall Study|Adverse Event|9|||
124949288|NCT00088166|449441822|FG000|Overall Study|Death|3|||
124949289|NCT00088166|449441823|FG001|Overall Study|Death|1|||
124949290|NCT00088166|449441822|FG000|Overall Study|Lost to Follow-up|0|||
124949291|NCT00088166|449441823|FG001|Overall Study|Lost to Follow-up|1|||
124949292|NCT00088166|449441822|FG000|Overall Study|Physician Decision|4|||
124949293|NCT00088166|449441823|FG001|Overall Study|Physician Decision|1|||
124949294|NCT00088166|449441822|FG000|Overall Study|Protocol Violation|1|||
124949295|NCT00088166|449441823|FG001|Overall Study|Protocol Violation|5|||
124949296|NCT00088166|449441822|FG000|Overall Study|Patient deterioration|29|||
124949297|NCT00088166|449441823|FG001|Overall Study|Patient deterioration|39|||
124949298|NCT00088166|449441822|FG000|Overall Study|Withdrawal by Subject|5|||
124949299|NCT00088166|449441823|FG001|Overall Study|Withdrawal by Subject|5|||
124949300|NCT02671266|449441824|FG000|Overall Study|Withdrawal by Subject|1|||
124949301|NCT02671266|449441825|FG001|Overall Study|Withdrawal by Subject|1|||
124949302|NCT00666705|449441826|FG000|Overall Study|Withdrawal by Subject|1|||
124949303|NCT01109979|449441827|FG000|Overall Study|Physician Decision|2|||
124949304|NCT01109979|449441828|FG001|Overall Study|Physician Decision|0|||
124949305|NCT01109979|449441827|FG000|Overall Study|Withdrawal by Subject|0|||
124949306|NCT01109979|449441828|FG001|Overall Study|Withdrawal by Subject|1|||
124949307|NCT01228734|449441829|FG000|Overall Study|Randomized, but not treated|0|||
124949308|NCT01228734|449441830|FG001|Overall Study|Randomized, but not treated|4|||
124949309|NCT03128099|449441834|FG000|Overall Study|High dose task was too long|0|||
124949310|NCT03128099|449441835|FG001|Overall Study|High dose task was too long|4|||
124949311|NCT03128099|449441836|FG002|Overall Study|High dose task was too long|0|||
124949312|NCT03128099|449441834|FG000|Overall Study|Participant got a full time job.|1|||
124949313|NCT03128099|449441835|FG001|Overall Study|Participant got a full time job.|0|||
124949314|NCT03128099|449441836|FG002|Overall Study|Participant got a full time job.|0|||
124949315|NCT03128099|449441834|FG000|Overall Study|Became homeless and lost contact|1|||
124949316|NCT03128099|449441835|FG001|Overall Study|Became homeless and lost contact|0|||
124949317|NCT03128099|449441836|FG002|Overall Study|Became homeless and lost contact|0|||
124949318|NCT03128099|449441834|FG000|Overall Study|Did not complete all the assessments|0|||
124949319|NCT03128099|449441835|FG001|Overall Study|Did not complete all the assessments|0|||
124949320|NCT03128099|449441836|FG002|Overall Study|Did not complete all the assessments|1|||
124949321|NCT03456856|449441837|FG000|Overall Study|Lost to Follow-up|2|||
124949322|NCT03456856|449441837|FG000|Overall Study|Withdrawal by Subject|1|||
124949323|NCT02542696|449441842|FG000|Overall Study|Adverse Event|167|||
124949324|NCT02542696|449441842|FG000|Overall Study|Lack of Efficacy|26|||
124949325|NCT02542696|449441842|FG000|Overall Study|Lost to Follow-up|6|||
124949326|NCT02542696|449441842|FG000|Overall Study|Withdrawal by Subject|104|||
124949327|NCT02542696|449441842|FG000|Overall Study|Protocol Violation|5|||
124949328|NCT02542696|449441842|FG000|Overall Study|Death|8|||
124949329|NCT02542696|449441842|FG000|Overall Study|DECREASED OFF TIME|1|||
124949330|NCT02542696|449441842|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
124949331|NCT02542696|449441842|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
124949332|NCT02542696|449441842|FG000|Overall Study|MEDICAL HISTORY|1|||
124949333|NCT02542696|449441842|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
124949334|NCT02542696|449441842|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
124949335|NCT02542696|449441842|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
124949336|NCT02542696|449441842|FG000|Overall Study|SPONSOR DECISION|3|||
124949337|NCT02542696|449441842|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
125124308|NCT03912337|450080765|FG001|Overall Study|Withdrawal of Consent From Study|0|||
125124309|NCT03912337|450080764|FG000|Overall Study|Lost to Follow-up|1|||
125124310|NCT03912337|450080765|FG001|Overall Study|Lost to Follow-up|1|||
125124311|NCT03752528|450080766|FG000|Part A|Lost to Follow-up|1|||
125124312|NCT03752528|450080766|FG000|Part A|Protocol Violation|1|||
125124313|NCT03752528|450080766|FG000|Part B|Protocol Violation|1|||
125124314|NCT03752528|450080766|FG000|Part B|Study terminated by sponsor|3|||
125124315|NCT00414765|450080767|FG000|Overall Study|Adverse Event|5|||
125124316|NCT00414765|450080768|FG001|Overall Study|Adverse Event|9|||
125124317|NCT00414765|450080767|FG000|Overall Study|Withdrawal by Subject|1|||
125124318|NCT00414765|450080768|FG001|Overall Study|Withdrawal by Subject|1|||
125124319|NCT00414765|450080767|FG000|Overall Study|Disease Progression|0|||
125124320|NCT00414765|450080768|FG001|Overall Study|Disease Progression|1|||
125124321|NCT02458469|450080769|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
125124322|NCT02458469|450080770|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
125124323|NCT02458469|450080771|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
125124324|NCT02458469|450080772|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
125214931|NCT02362425|450414876|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
124949338|NCT02542696|449441842|FG000|Overall Study|SUBJECT DECISION|2|||
124949339|NCT02410278|449441843|FG000|Run-in Period|Adverse Event|5|||
124949340|NCT02410278|449441844|FG001|Run-in Period|Adverse Event|0|||
124949341|NCT02410278|449441845|FG002|Run-in Period|Adverse Event|0|||
124949342|NCT02410278|449441843|FG000|Run-in Period|GSRS Threshold Not Met|30|||
124949343|NCT02410278|449441844|FG001|Run-in Period|GSRS Threshold Not Met|0|||
124949344|NCT02410278|449441845|FG002|Run-in Period|GSRS Threshold Not Met|0|||
124949345|NCT02410278|449441843|FG000|Run-in Period|Lost to Follow-up|1|||
124949346|NCT02410278|449441844|FG001|Run-in Period|Lost to Follow-up|0|||
124949347|NCT02410278|449441845|FG002|Run-in Period|Lost to Follow-up|0|||
124949348|NCT02410278|449441843|FG000|Run-in Period|Withdrawal by Subject|1|||
125029657|NCT01583374|449730815|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
125029658|NCT01583374|449730816|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
124949349|NCT02410278|449441844|FG001|Run-in Period|Withdrawal by Subject|0|||
124949350|NCT02410278|449441845|FG002|Run-in Period|Withdrawal by Subject|0|||
125029659|NCT01583374|449730817|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
125029660|NCT01583374|449730809|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125029661|NCT01583374|449730810|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125029662|NCT01583374|449730811|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
125029663|NCT01583374|449730812|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125029664|NCT01583374|449730813|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125029665|NCT01583374|449730814|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125029666|NCT01583374|449730815|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125029667|NCT01583374|449730816|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125029668|NCT01583374|449730817|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125029669|NCT01583374|449730809|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
125029670|NCT01583374|449730810|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
125029671|NCT01583374|449730811|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
125029672|NCT01583374|449730812|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
125029673|NCT01583374|449730813|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
125029674|NCT01583374|449730814|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
125029675|NCT01583374|449730815|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
125029676|NCT01583374|449730816|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
125029677|NCT01583374|449730817|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
125029678|NCT01583374|449730809|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
125029679|NCT01583374|449730810|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
125029680|NCT01583374|449730811|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
125029681|NCT01583374|449730812|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
125029682|NCT01583374|449730813|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
125029683|NCT01583374|449730814|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
124949351|NCT02410278|449441843|FG000|Run-in Period|Pregnancy|1|||
124949352|NCT02410278|449441844|FG001|Run-in Period|Pregnancy|0|||
124949353|NCT02410278|449441845|FG002|Run-in Period|Pregnancy|0|||
124949354|NCT02410278|449441843|FG000|Study Treatment Period|Adverse Event|0|||
124949355|NCT02410278|449441844|FG001|Study Treatment Period|Adverse Event|6|||
124949356|NCT02410278|449441845|FG002|Study Treatment Period|Adverse Event|3|||
124949357|NCT02410278|449441843|FG000|Study Treatment Period|Physician Decision|0|||
124949358|NCT02410278|449441844|FG001|Study Treatment Period|Physician Decision|0|||
124949359|NCT02410278|449441845|FG002|Study Treatment Period|Physician Decision|1|||
124949360|NCT02410278|449441843|FG000|Study Treatment Period|Withdrawal by Subject|0|||
124949361|NCT02410278|449441844|FG001|Study Treatment Period|Withdrawal by Subject|1|||
124949362|NCT02410278|449441845|FG002|Study Treatment Period|Withdrawal by Subject|0|||
124949363|NCT02410278|449441843|FG000|Study Treatment Period|Other|0|||
124949364|NCT02410278|449441844|FG001|Study Treatment Period|Other|3|||
124949365|NCT02410278|449441845|FG002|Study Treatment Period|Other|0|||
124949366|NCT02410278|449441843|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
124949367|NCT02410278|449441844|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
124949368|NCT02410278|449441845|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
124949369|NCT03695185|449441847|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
124949370|NCT03695185|449441847|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
124949371|NCT03695185|449441847|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
124949372|NCT03695185|449441847|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
124949373|NCT03695185|449441847|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
125029684|NCT01583374|449730815|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
125029685|NCT01583374|449730816|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
125029686|NCT01583374|449730817|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
125029687|NCT01583374|449730809|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
125029688|NCT01583374|449730810|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
125029689|NCT01583374|449730811|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
125029690|NCT01583374|449730812|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
125029691|NCT01583374|449730813|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
125029692|NCT01583374|449730814|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
125029693|NCT01583374|449730815|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
125029694|NCT01583374|449730816|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
125029695|NCT01583374|449730817|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
125029696|NCT01583374|449730809|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
125029697|NCT01583374|449730810|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
125029698|NCT01583374|449730811|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
125029699|NCT01583374|449730812|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
125029700|NCT01583374|449730813|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
125029701|NCT01583374|449730814|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
125029702|NCT01583374|449730815|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
125029703|NCT01583374|449730816|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
125029704|NCT01583374|449730817|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
125029705|NCT01583374|449730809|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
125029706|NCT01583374|449730810|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
125029707|NCT01583374|449730811|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
125029708|NCT01583374|449730812|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
125029709|NCT01583374|449730813|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
125029710|NCT01583374|449730814|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
125029711|NCT01583374|449730815|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
125029712|NCT01583374|449730816|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
125029713|NCT01583374|449730817|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
125029714|NCT01583374|449730809|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
124949374|NCT03695185|449441847|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
124949375|NCT02137785|449441850|FG000|Overall Study|Lost to Follow-up|1|||
124949376|NCT02137785|449441851|FG001|Overall Study|Lost to Follow-up|0|||
124949377|NCT02137785|449441850|FG000|Overall Study|Withdrawal by Subject|1|||
124949378|NCT02137785|449441851|FG001|Overall Study|Withdrawal by Subject|4|||
124949379|NCT02137785|449441850|FG000|Overall Study|subject moved out of state|1|||
124949380|NCT02137785|449441851|FG001|Overall Study|subject moved out of state|0|||
124949381|NCT02584257|449441852|FG000|Period 1|Withdrawal by Subject|0|||
124949382|NCT02584257|449441853|FG001|Period 1|Withdrawal by Subject|0|||
124949383|NCT02584257|449441854|FG002|Period 1|Withdrawal by Subject|0|||
124949384|NCT02584257|449441855|FG003|Period 1|Withdrawal by Subject|0|||
124949385|NCT02584257|449441856|FG004|Period 1|Withdrawal by Subject|0|||
124949386|NCT02584257|449441857|FG005|Period 1|Withdrawal by Subject|0|||
124949387|NCT02584257|449441858|FG006|Period 1|Withdrawal by Subject|1|||
124949388|NCT02584257|449441859|FG007|Period 1|Withdrawal by Subject|0|||
124949389|NCT02584257|449441860|FG008|Period 1|Withdrawal by Subject|0|||
124949390|NCT02584257|449441852|FG000|Period 2|Physician Decision|1|||
124949391|NCT02584257|449441853|FG001|Period 2|Physician Decision|0|||
124949392|NCT02584257|449441854|FG002|Period 2|Physician Decision|0|||
124949393|NCT02584257|449441855|FG003|Period 2|Physician Decision|0|||
124949394|NCT02584257|449441856|FG004|Period 2|Physician Decision|0|||
125029715|NCT01583374|449730810|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
125214932|NCT02362425|450414877|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
125214933|NCT02362425|450414878|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
125214934|NCT02362425|450414879|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
124949395|NCT02584257|449441857|FG005|Period 2|Physician Decision|0|||
124949396|NCT02584257|449441858|FG006|Period 2|Physician Decision|0|||
124949397|NCT02584257|449441859|FG007|Period 2|Physician Decision|0|||
124949398|NCT02584257|449441860|FG008|Period 2|Physician Decision|0|||
124949399|NCT02584257|449441852|FG000|Period 2|Adverse Event|0|||
124949400|NCT02584257|449441853|FG001|Period 2|Adverse Event|1|||
125029716|NCT01583374|449730811|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
124949401|NCT02584257|449441854|FG002|Period 2|Adverse Event|0|||
124949402|NCT02584257|449441855|FG003|Period 2|Adverse Event|0|||
125214935|NCT02362425|450414876|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
125214936|NCT02362425|450414877|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
125214937|NCT02362425|450414878|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
125214938|NCT02362425|450414879|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
125214939|NCT02362425|450414876|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
125214940|NCT02362425|450414877|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
125214941|NCT02362425|450414878|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
125214942|NCT02362425|450414879|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
125214943|NCT02362425|450414876|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
125214944|NCT02362425|450414877|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
125214945|NCT02362425|450414878|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
125214946|NCT02362425|450414879|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
125214947|NCT02362425|450414876|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
125214948|NCT02362425|450414877|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
125214949|NCT02362425|450414878|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
125214950|NCT02362425|450414879|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
125214951|NCT02362425|450414876|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
125214952|NCT02362425|450414877|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
125214953|NCT02362425|450414878|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
125214954|NCT02362425|450414879|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
125214955|NCT00802672|450414882|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
125214956|NCT00802672|450414883|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
125214957|NCT00802672|450414884|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
125214958|NCT00802672|450414882|FG000|Overall Study|Adverse Event|1|||
125214959|NCT00802672|450414883|FG001|Overall Study|Adverse Event|1|||
125214960|NCT00802672|450414884|FG002|Overall Study|Adverse Event|1|||
125214961|NCT00802672|450414882|FG000|Overall Study|Protocol Violation|2|||
125214962|NCT00802672|450414883|FG001|Overall Study|Protocol Violation|1|||
125214963|NCT00802672|450414884|FG002|Overall Study|Protocol Violation|1|||
125214964|NCT00802672|450414882|FG000|Overall Study|Lost to Follow-up|5|||
125214965|NCT00802672|450414883|FG001|Overall Study|Lost to Follow-up|5|||
125214966|NCT00802672|450414884|FG002|Overall Study|Lost to Follow-up|3|||
125214967|NCT00802672|450414882|FG000|Overall Study|Withdrawal by Subject|1|||
125214968|NCT00802672|450414883|FG001|Overall Study|Withdrawal by Subject|1|||
125214969|NCT00802672|450414884|FG002|Overall Study|Withdrawal by Subject|2|||
125214970|NCT00802672|450414882|FG000|Overall Study|other|3|||
125214971|NCT00802672|450414883|FG001|Overall Study|other|1|||
125214972|NCT00802672|450414884|FG002|Overall Study|other|2|||
125214973|NCT02579382|450414887|FG000|Main Study Phase|Lost to Follow-up|0|||
125214974|NCT02579382|450414888|FG001|Main Study Phase|Lost to Follow-up|0|||
125214975|NCT02579382|450414889|FG002|Main Study Phase|Lost to Follow-up|2|||
125214976|NCT02579382|450414890|FG003|Main Study Phase|Lost to Follow-up|0|||
124949403|NCT02584257|449441856|FG004|Period 2|Adverse Event|0|||
124949404|NCT02584257|449441857|FG005|Period 2|Adverse Event|0|||
124949405|NCT02584257|449441858|FG006|Period 2|Adverse Event|0|||
124949406|NCT02584257|449441859|FG007|Period 2|Adverse Event|0|||
124949407|NCT02584257|449441860|FG008|Period 2|Adverse Event|0|||
124949408|NCT01670877|449441861|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
124949409|NCT01670877|449441862|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
125214977|NCT02579382|450414887|FG000|Main Study Phase|Withdrew Consent|0|||
124949410|NCT01670877|449441863|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
124949411|NCT01670877|449441864|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
124949412|NCT01670877|449441865|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
124949413|NCT01670877|449441866|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
124949414|NCT01670877|449441861|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
124949415|NCT01670877|449441862|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
124949416|NCT01670877|449441863|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
124949417|NCT01670877|449441864|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
124949418|NCT01670877|449441865|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
124949419|NCT01670877|449441866|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
124949420|NCT01670877|449441861|FG000|Part I and Part 2|Grade 2 vomiting|0|||
124949421|NCT01670877|449441862|FG001|Part I and Part 2|Grade 2 vomiting|0|||
124949422|NCT01670877|449441863|FG002|Part I and Part 2|Grade 2 vomiting|0|||
124949423|NCT01670877|449441864|FG003|Part I and Part 2|Grade 2 vomiting|1|||
124949424|NCT01670877|449441865|FG004|Part I and Part 2|Grade 2 vomiting|0|||
124949425|NCT01670877|449441866|FG005|Part I and Part 2|Grade 2 vomiting|0|||
124949426|NCT01670877|449441861|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
124949427|NCT01670877|449441862|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
124949428|NCT01670877|449441863|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
124949429|NCT01670877|449441864|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
124949430|NCT01670877|449441865|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
124949431|NCT01670877|449441866|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
124949432|NCT01670877|449441861|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
124949433|NCT01670877|449441862|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
124949434|NCT01670877|449441863|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
124949435|NCT01670877|449441864|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
124949436|NCT01670877|449441865|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
124949437|NCT01670877|449441866|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
124949438|NCT03390166|449441867|FG000|Overall Study|Death|0|||
125214978|NCT02579382|450414888|FG001|Main Study Phase|Withdrew Consent|0|||
125214979|NCT02579382|450414889|FG002|Main Study Phase|Withdrew Consent|0|||
124949439|NCT03390166|449441868|FG001|Overall Study|Death|1|||
124949440|NCT03390166|449441867|FG000|Overall Study|Lost to Follow-up|6|||
124949441|NCT03390166|449441868|FG001|Overall Study|Lost to Follow-up|4|||
124949442|NCT03390166|449441867|FG000|Overall Study|Physician Decision|2|||
124949443|NCT03390166|449441868|FG001|Overall Study|Physician Decision|1|||
124949444|NCT03390166|449441867|FG000|Overall Study|Move from study area|3|||
124949445|NCT03390166|449441868|FG001|Overall Study|Move from study area|2|||
124949446|NCT03390166|449441867|FG000|Overall Study|To militarycamp for conscript|1|||
124949447|NCT03390166|449441868|FG001|Overall Study|To militarycamp for conscript|0|||
124949448|NCT03390166|449441867|FG000|Overall Study|To drug therapy course|0|||
125214980|NCT02579382|450414890|FG003|Main Study Phase|Withdrew Consent|2|||
124949449|NCT03390166|449441868|FG001|Overall Study|To drug therapy course|1|||
124949450|NCT03390166|449441867|FG000|Overall Study|Move to work oversea|0|||
124949451|NCT03390166|449441868|FG001|Overall Study|Move to work oversea|1|||
124949452|NCT03693989|449441871|FG000|Overall Study|Protocol Violation|3|||
124949453|NCT03693989|449441872|FG001|Overall Study|Protocol Violation|4|||
124949454|NCT00113529|449441873|FG000|Overall Study|Adverse Event|4|||
124949455|NCT00113529|449441873|FG000|Overall Study|Lack of Efficacy|20|||
124949456|NCT00113529|449441873|FG000|Overall Study|Decision of sponsor|6|||
124949457|NCT00113529|449441873|FG000|Overall Study|Withdrawal by Subject|4|||
124949458|NCT02825550|449441875|FG000|Overall Study|Physician Decision|1|||
124949459|NCT00042939|449441876|FG000|Overall Study|Adverse Event|6|||
124949460|NCT00042939|449441877|FG001|Overall Study|Adverse Event|7|||
124949461|NCT00042939|449441876|FG000|Overall Study|Death|3|||
124949462|NCT00042939|449441877|FG001|Overall Study|Death|2|||
124949463|NCT00042939|449441876|FG000|Overall Study|Withdrawal by Subject|3|||
124949464|NCT00042939|449441877|FG001|Overall Study|Withdrawal by Subject|4|||
124949465|NCT00042939|449441876|FG000|Overall Study|Other disease|1|||
124949466|NCT00042939|449441877|FG001|Overall Study|Other disease|0|||
124949467|NCT00042939|449441876|FG000|Overall Study|Ineligible|2|||
124949468|NCT00042939|449441877|FG001|Overall Study|Ineligible|2|||
124949469|NCT00042939|449441876|FG000|Overall Study|Deterioration of health|3|||
124949470|NCT00042939|449441877|FG001|Overall Study|Deterioration of health|4|||
124949471|NCT00042939|449441876|FG000|Overall Study|QOL diminished|1|||
124949472|NCT00042939|449441877|FG001|Overall Study|QOL diminished|0|||
124949473|NCT00042939|449441876|FG000|Overall Study|Rising ca 19-9|1|||
124949474|NCT00042939|449441877|FG001|Overall Study|Rising ca 19-9|0|||
124949475|NCT00042939|449441876|FG000|Overall Study|Patient non-compliance|1|||
124949476|NCT00042939|449441877|FG001|Overall Study|Patient non-compliance|0|||
124949477|NCT00042939|449441876|FG000|Overall Study|Still on treatment|1|||
124949478|NCT00042939|449441877|FG001|Overall Study|Still on treatment|0|||
124949479|NCT00042939|449441876|FG000|Overall Study|Treatment break > 4 weeks|0|||
124949480|NCT00042939|449441877|FG001|Overall Study|Treatment break > 4 weeks|1|||
124949481|NCT00042939|449441876|FG000|Overall Study|Did not start treatment|2|||
124949482|NCT00042939|449441877|FG001|Overall Study|Did not start treatment|1|||
124949483|NCT00795639|449441878|FG000|Overall Study|Death|1|||
125124325|NCT02458469|450080773|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
125124326|NCT02458469|450080774|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
125124327|NCT02458469|450080769|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
125124328|NCT02458469|450080770|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
125124329|NCT02458469|450080771|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
125124330|NCT02458469|450080772|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
125124331|NCT02458469|450080773|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
125124332|NCT02458469|450080774|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
125124333|NCT02458469|450080769|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
125124334|NCT02458469|450080770|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
125124335|NCT02458469|450080771|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
125124336|NCT02458469|450080772|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
125124337|NCT02458469|450080773|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
125124338|NCT02458469|450080774|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
125124339|NCT00661505|450080775|FG000|Overall Study|Adverse Event|3|||
125124340|NCT00661505|450080775|FG000|Overall Study|Protocol Violation|14|||
125124341|NCT00661505|450080775|FG000|Overall Study|Withdrawal by Subject|8|||
125124342|NCT00661505|450080775|FG000|Overall Study|Lost to Follow-up|3|||
125124343|NCT00661505|450080775|FG000|Overall Study|Other|2|||
125124344|NCT04534283|450080776|FG000|Overall Study|Physician Decision|2|||
125124345|NCT04534283|450080776|FG000|Overall Study|Withdrawal by Subject|1|||
125124346|NCT04534283|450080776|FG000|Overall Study|Disease Progression|12|||
124949484|NCT00795639|449441879|FG001|Overall Study|Death|6|||
124949485|NCT00795639|449441878|FG000|Overall Study|Withdrawal by Subject|1|||
124949486|NCT00795639|449441879|FG001|Overall Study|Withdrawal by Subject|3|||
124949487|NCT00795639|449441878|FG000|Overall Study|Pregnancy|1|||
125124347|NCT04534283|450080776|FG000|Overall Study|Adverse Event|1|||
124949488|NCT00795639|449441879|FG001|Overall Study|Pregnancy|0|||
124949489|NCT00795639|449441878|FG000|Overall Study|Adverse Event|5|||
124949490|NCT00795639|449441879|FG001|Overall Study|Adverse Event|2|||
124949491|NCT00795639|449441878|FG000|Overall Study|Other|0|||
124949492|NCT00795639|449441879|FG001|Overall Study|Other|2|||
124949493|NCT00795639|449441878|FG000|Overall Study|Terminated by sponsor|13|||
124949494|NCT00795639|449441879|FG001|Overall Study|Terminated by sponsor|12|||
124949495|NCT00795639|449441878|FG000|Overall Study|Randomized and not treated|0|||
124949496|NCT00795639|449441879|FG001|Overall Study|Randomized and not treated|1|||
124949497|NCT02525744|449441880|FG000|Period 1|Physician Decision|0|||
125214981|NCT02579382|450414887|FG000|Main Study Phase|Lack of Efficacy|0|||
125214982|NCT02579382|450414888|FG001|Main Study Phase|Lack of Efficacy|0|||
125214983|NCT02579382|450414889|FG002|Main Study Phase|Lack of Efficacy|0|||
124949498|NCT02525744|449441881|FG001|Period 1|Physician Decision|0|||
124949499|NCT02525744|449441882|FG002|Period 1|Physician Decision|1|||
124949500|NCT02525744|449441883|FG003|Period 1|Physician Decision|0|||
124949501|NCT02525744|449441880|FG000|Period 3|Adverse Event|0|||
124949502|NCT02525744|449441881|FG001|Period 3|Adverse Event|1|||
124949503|NCT02525744|449441882|FG002|Period 3|Adverse Event|0|||
124949504|NCT02525744|449441883|FG003|Period 3|Adverse Event|0|||
124949505|NCT02525744|449441880|FG000|Period 4|Withdrawal by Subject|1|||
124949506|NCT02525744|449441881|FG001|Period 4|Withdrawal by Subject|0|||
124949507|NCT02525744|449441882|FG002|Period 4|Withdrawal by Subject|0|||
124949508|NCT02525744|449441883|FG003|Period 4|Withdrawal by Subject|0|||
124949509|NCT02525744|449441880|FG000|Period 5|Physician Decision|1|||
124949510|NCT02525744|449441881|FG001|Period 5|Physician Decision|0|||
124949511|NCT02525744|449441882|FG002|Period 5|Physician Decision|0|||
124949512|NCT02525744|449441883|FG003|Period 5|Physician Decision|0|||
124949513|NCT01138657|449441886|FG000|Overall Study|Adverse Event|3|||
124949514|NCT01138657|449441887|FG001|Overall Study|Adverse Event|10|||
124949515|NCT01138657|449441886|FG000|Overall Study|Lack of Efficacy|2|||
124949516|NCT01138657|449441887|FG001|Overall Study|Lack of Efficacy|1|||
124949517|NCT01138657|449441886|FG000|Overall Study|Lost to Follow-up|0|||
124949518|NCT01138657|449441887|FG001|Overall Study|Lost to Follow-up|3|||
124949519|NCT01138657|449441886|FG000|Overall Study|Miscellaneous Reasons|3|||
124949520|NCT01138657|449441887|FG001|Overall Study|Miscellaneous Reasons|4|||
124949521|NCT03150589|449441888|FG000|Overall Study|Withdrawal by Subject|16|||
124949522|NCT03150589|449441889|FG001|Overall Study|Withdrawal by Subject|9|||
124949523|NCT03150589|449441888|FG000|Overall Study|Adverse Event|7|||
124949524|NCT03150589|449441889|FG001|Overall Study|Adverse Event|6|||
124949525|NCT03150589|449441888|FG000|Overall Study|Protocol Violation|4|||
124949526|NCT03150589|449441889|FG001|Overall Study|Protocol Violation|3|||
124949527|NCT03150589|449441888|FG000|Overall Study|Lost to Follow-up|3|||
124949528|NCT03150589|449441889|FG001|Overall Study|Lost to Follow-up|3|||
124949529|NCT03150589|449441888|FG000|Overall Study|Death|2|||
124949530|NCT03150589|449441889|FG001|Overall Study|Death|3|||
124949531|NCT03150589|449441888|FG000|Overall Study|IP non-compliance and other reasons|12|||
124949532|NCT03150589|449441889|FG001|Overall Study|IP non-compliance and other reasons|3|||
124949533|NCT01000649|449441892|FG000|Overall Study|Adverse Event|5|||
124949534|NCT01000649|449441893|FG001|Overall Study|Adverse Event|1|||
124949535|NCT01000649|449441894|FG002|Overall Study|Adverse Event|2|||
124949536|NCT01000649|449441895|FG003|Overall Study|Adverse Event|4|||
124949537|NCT01000649|449441892|FG000|Overall Study|Lost to Follow-up|0|||
124949538|NCT01000649|449441893|FG001|Overall Study|Lost to Follow-up|2|||
124949539|NCT01000649|449441894|FG002|Overall Study|Lost to Follow-up|0|||
124949540|NCT01000649|449441895|FG003|Overall Study|Lost to Follow-up|2|||
124949541|NCT00346398|449441896|FG000|Overall Study|Lost to Follow-up|3|||
124949542|NCT00346398|449441897|FG001|Overall Study|Lost to Follow-up|0|||
124949543|NCT00346398|449441896|FG000|Overall Study|Withdrawal by Subject|0|||
124949544|NCT00346398|449441897|FG001|Overall Study|Withdrawal by Subject|2|||
124949545|NCT03979040|449441898|FG000|Overall Study|Withdrawal by Subject|24|||
124949546|NCT03979040|449441899|FG001|Overall Study|Withdrawal by Subject|32|||
124949547|NCT03979040|449441898|FG000|Overall Study|randomized but never started treatment|32|||
124949548|NCT03979040|449441899|FG001|Overall Study|randomized but never started treatment|39|||
124949549|NCT03979040|449441898|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
124949550|NCT03979040|449441899|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
124949551|NCT02607956|449441900|FG000|Double-Blinded Phase|Withdrew Consent|17|||
125214984|NCT02579382|450414890|FG003|Main Study Phase|Lack of Efficacy|1|||
125214985|NCT02579382|450414887|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
125214986|NCT02579382|450414888|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
125214987|NCT02579382|450414889|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
124949552|NCT02607956|449441901|FG001|Double-Blinded Phase|Withdrew Consent|19|||
124949553|NCT02607956|449441902|FG002|Double-Blinded Phase|Withdrew Consent|0|||
124949554|NCT02607956|449441903|FG003|Double-Blinded Phase|Withdrew Consent|0|||
125214988|NCT02579382|450414890|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
125214989|NCT02579382|450414887|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
124949555|NCT02607956|449441900|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
124949556|NCT02607956|449441901|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
124949557|NCT02607956|449441902|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
124949558|NCT02607956|449441903|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
124949559|NCT02607956|449441900|FG000|Double-Blinded Phase|Randomized but never treated|7|||
124949560|NCT02607956|449441901|FG001|Double-Blinded Phase|Randomized but never treated|5|||
124949561|NCT02607956|449441902|FG002|Double-Blinded Phase|Randomized but never treated|0|||
124949562|NCT02607956|449441903|FG003|Double-Blinded Phase|Randomized but never treated|0|||
124949563|NCT02607956|449441900|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
124949564|NCT02607956|449441901|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
124949565|NCT02607956|449441902|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
124949566|NCT02607956|449441903|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
124949567|NCT02607956|449441900|FG000|Double-Blinded Phase|Death|4|||
125217430|NCT01348100|450423524|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124949568|NCT02607956|449441901|FG001|Double-Blinded Phase|Death|4|||
124949569|NCT02607956|449441902|FG002|Double-Blinded Phase|Death|0|||
124949570|NCT02607956|449441903|FG003|Double-Blinded Phase|Death|0|||
124949571|NCT02607956|449441900|FG000|Double-Blinded Phase|Adverse Event|4|||
124949572|NCT02607956|449441901|FG001|Double-Blinded Phase|Adverse Event|3|||
124949573|NCT02607956|449441902|FG002|Double-Blinded Phase|Adverse Event|0|||
124949574|NCT02607956|449441903|FG003|Double-Blinded Phase|Adverse Event|0|||
124949575|NCT02607956|449441900|FG000|Double-Blinded Phase|Protocol Violation|3|||
124949576|NCT02607956|449441901|FG001|Double-Blinded Phase|Protocol Violation|1|||
124949577|NCT02607956|449441902|FG002|Double-Blinded Phase|Protocol Violation|0|||
124949578|NCT02607956|449441903|FG003|Double-Blinded Phase|Protocol Violation|0|||
124949579|NCT02607956|449441900|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
124949580|NCT02607956|449441901|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
124949581|NCT02607956|449441902|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
124949582|NCT02607956|449441903|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
125124348|NCT03561883|450080777|FG000|Overall Study|Adverse Event|10|||
125124349|NCT03561883|450080778|FG001|Overall Study|Adverse Event|13|||
125124350|NCT03561883|450080777|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125124351|NCT03561883|450080778|FG001|Overall Study|Non-Compliance With Study Drug|2|||
125124352|NCT03561883|450080777|FG000|Overall Study|Protocol Violation|2|||
125124353|NCT03561883|450080778|FG001|Overall Study|Protocol Violation|3|||
125124354|NCT03561883|450080777|FG000|Overall Study|Withdrawal by Subject|14|||
125124355|NCT03561883|450080778|FG001|Overall Study|Withdrawal by Subject|6|||
125124356|NCT03561883|450080777|FG000|Overall Study|Lost to Follow-up|2|||
125124357|NCT03561883|450080778|FG001|Overall Study|Lost to Follow-up|6|||
125124358|NCT03561883|450080777|FG000|Overall Study|Study Terminated by Sponsor|12|||
125124359|NCT03561883|450080778|FG001|Overall Study|Study Terminated by Sponsor|11|||
125124360|NCT03561883|450080777|FG000|Overall Study|Physician Decision|1|||
125124361|NCT03561883|450080778|FG001|Overall Study|Physician Decision|0|||
125124362|NCT03561883|450080777|FG000|Overall Study|Randomized by Mistake|1|||
125124363|NCT03561883|450080778|FG001|Overall Study|Randomized by Mistake|0|||
125124364|NCT03561883|450080777|FG000|Overall Study|Other, Not Specified|3|||
125124365|NCT03561883|450080778|FG001|Overall Study|Other, Not Specified|2|||
125124366|NCT01318499|450080779|FG000|Overall Study|Adverse Event|16|||
125124367|NCT01318499|450080780|FG001|Overall Study|Adverse Event|11|||
125124368|NCT01318499|450080781|FG002|Overall Study|Adverse Event|6|||
125124369|NCT01318499|450080779|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
125124370|NCT01318499|450080780|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
125124371|NCT01318499|450080781|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
125124372|NCT01318499|450080779|FG000|Overall Study|Noncompliance|2|||
125124373|NCT01318499|450080780|FG001|Overall Study|Noncompliance|3|||
125124374|NCT01318499|450080781|FG002|Overall Study|Noncompliance|0|||
125124375|NCT01318499|450080779|FG000|Overall Study|Treatment Failure|19|||
125124376|NCT01318499|450080780|FG001|Overall Study|Treatment Failure|19|||
125124377|NCT01318499|450080781|FG002|Overall Study|Treatment Failure|101|||
124949583|NCT02607956|449441900|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
124949584|NCT02607956|449441901|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
124949585|NCT02607956|449441902|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
124949586|NCT02607956|449441903|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
124949587|NCT02607956|449441900|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
124949588|NCT02607956|449441901|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
124949589|NCT02607956|449441902|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
124949590|NCT02607956|449441903|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
124949591|NCT02607956|449441900|FG000|Open-Label Extension Phase|Death|0|||
125029717|NCT01583374|449730812|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
124949592|NCT02607956|449441901|FG001|Open-Label Extension Phase|Death|0|||
124949593|NCT02607956|449441902|FG002|Open-Label Extension Phase|Death|1|||
124949594|NCT02607956|449441903|FG003|Open-Label Extension Phase|Death|3|||
124949595|NCT02607956|449441900|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
124949596|NCT02607956|449441901|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
124949597|NCT02607956|449441902|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
124949598|NCT02607956|449441903|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
124949599|NCT02607956|449441900|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
124949600|NCT02607956|449441901|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
124949601|NCT02607956|449441902|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
124949602|NCT02607956|449441903|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
124949603|NCT02607956|449441900|FG000|Open-Label Extension Phase|Protocol Violation|0|||
124949604|NCT02607956|449441901|FG001|Open-Label Extension Phase|Protocol Violation|0|||
124949605|NCT02607956|449441902|FG002|Open-Label Extension Phase|Protocol Violation|0|||
124949606|NCT02607956|449441903|FG003|Open-Label Extension Phase|Protocol Violation|2|||
124949607|NCT02607956|449441900|FG000|Open-Label Extension Phase|Pregnancy|0|||
124949608|NCT02607956|449441901|FG001|Open-Label Extension Phase|Pregnancy|0|||
124949609|NCT02607956|449441902|FG002|Open-Label Extension Phase|Pregnancy|0|||
124949610|NCT02607956|449441903|FG003|Open-Label Extension Phase|Pregnancy|1|||
124949611|NCT01005914|449441904|FG000|Overall Study|Adverse Event|4|||
124949612|NCT01005914|449441904|FG000|Overall Study|Death|4|||
124949613|NCT01005914|449441904|FG000|Overall Study|Lack of Efficacy|1|||
124949614|NCT01005914|449441904|FG000|Overall Study|Withdrawal by Subject|1|||
124949616|NCT01240785|449441907|FG000|Overall Study|Lost to Follow-up|1|||
124949617|NCT01240785|449441908|FG001|Overall Study|Lost to Follow-up|0|||
124949618|NCT01240785|449441907|FG000|Overall Study|Protocol Violation|0|||
124949619|NCT01240785|449441908|FG001|Overall Study|Protocol Violation|3|||
124949620|NCT00696241|449441909|FG000|Overall Study|Adverse Event|11|||
124949621|NCT00696241|449441910|FG001|Overall Study|Adverse Event|3|||
124949622|NCT00696241|449441911|FG002|Overall Study|Adverse Event|6|||
124949623|NCT00696241|449441912|FG003|Overall Study|Adverse Event|4|||
124949624|NCT00696241|449441913|FG004|Overall Study|Adverse Event|5|||
125029718|NCT01583374|449730813|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
125029719|NCT01583374|449730814|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
125029720|NCT01583374|449730815|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
125029721|NCT01583374|449730816|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
125029722|NCT01583374|449730817|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
125029723|NCT01583374|449730809|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
124949625|NCT00696241|449441909|FG000|Overall Study|Protocol Violation|1|||
124949626|NCT00696241|449441910|FG001|Overall Study|Protocol Violation|1|||
124949627|NCT00696241|449441911|FG002|Overall Study|Protocol Violation|2|||
124949628|NCT00696241|449441912|FG003|Overall Study|Protocol Violation|0|||
124949629|NCT00696241|449441913|FG004|Overall Study|Protocol Violation|3|||
124949630|NCT00696241|449441909|FG000|Overall Study|Lost to Follow-up|1|||
124949631|NCT00696241|449441910|FG001|Overall Study|Lost to Follow-up|4|||
124949632|NCT00696241|449441911|FG002|Overall Study|Lost to Follow-up|1|||
124949633|NCT00696241|449441912|FG003|Overall Study|Lost to Follow-up|2|||
124949634|NCT00696241|449441913|FG004|Overall Study|Lost to Follow-up|0|||
124949635|NCT00696241|449441909|FG000|Overall Study|Withdrawal by Subject|4|||
124949636|NCT00696241|449441910|FG001|Overall Study|Withdrawal by Subject|8|||
124949637|NCT00696241|449441911|FG002|Overall Study|Withdrawal by Subject|6|||
124949638|NCT00696241|449441912|FG003|Overall Study|Withdrawal by Subject|1|||
124949639|NCT00696241|449441913|FG004|Overall Study|Withdrawal by Subject|0|||
124949640|NCT00696241|449441909|FG000|Overall Study|Lack of Efficacy|1|||
124949641|NCT00696241|449441910|FG001|Overall Study|Lack of Efficacy|5|||
124949642|NCT00696241|449441911|FG002|Overall Study|Lack of Efficacy|4|||
124949643|NCT00696241|449441912|FG003|Overall Study|Lack of Efficacy|5|||
124949644|NCT00696241|449441913|FG004|Overall Study|Lack of Efficacy|3|||
124949645|NCT00696241|449441909|FG000|Overall Study|Other|6|||
124949646|NCT00696241|449441910|FG001|Overall Study|Other|1|||
124949647|NCT00696241|449441911|FG002|Overall Study|Other|5|||
125124378|NCT01318499|450080779|FG000|Overall Study|Protocol Violation|2|||
125124379|NCT01318499|450080780|FG001|Overall Study|Protocol Violation|4|||
125124380|NCT01318499|450080781|FG002|Overall Study|Protocol Violation|2|||
125124381|NCT01318499|450080779|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
124949648|NCT00696241|449441912|FG003|Overall Study|Other|2|||
124949649|NCT00696241|449441913|FG004|Overall Study|Other|1|||
125124382|NCT01318499|450080780|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
124949650|NCT03347396|449441916|FG000|Part A (26 Weeks)|Adverse Event|1|||
124949651|NCT03347396|449441917|FG001|Part A (26 Weeks)|Adverse Event|0|||
125124383|NCT01318499|450080781|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
125124384|NCT01318499|450080779|FG000|Overall Study|Other|7|||
125124385|NCT01318499|450080780|FG001|Overall Study|Other|10|||
125124386|NCT01318499|450080781|FG002|Overall Study|Other|22|||
125124387|NCT01974141|450080787|FG000|Overall Study|Other Reasons|28|||
125124388|NCT01974141|450080788|FG001|Overall Study|Other Reasons|18|||
125124389|NCT01974141|450080787|FG000|Overall Study|Protocol Violation|2|||
125124390|NCT01974141|450080788|FG001|Overall Study|Protocol Violation|6|||
124949652|NCT03347396|449441916|FG000|Part A (26 Weeks)|Death|0|||
124949653|NCT03347396|449441917|FG001|Part A (26 Weeks)|Death|1|||
124949654|NCT03347396|449441916|FG000|Part B (149 Weeks)|Adverse Event|1|||
124949655|NCT03347396|449441917|FG001|Part B (149 Weeks)|Adverse Event|1|||
124949656|NCT03347396|449441916|FG000|Part B (149 Weeks)|Death|1|||
124949657|NCT03347396|449441917|FG001|Part B (149 Weeks)|Death|0|||
124949658|NCT03060525|449441918|FG000|Overall Study|moved out of state|1|||
124949659|NCT03060525|449441919|FG001|Overall Study|moved out of state|1|||
124949660|NCT03060525|449441920|FG002|Overall Study|moved out of state|1|||
124949661|NCT03060525|449441921|FG003|Overall Study|moved out of state|1|||
124949662|NCT03060525|449441918|FG000|Overall Study|unable to meet time commitment required of study|2|||
124949663|NCT03060525|449441919|FG001|Overall Study|unable to meet time commitment required of study|3|||
124949664|NCT03060525|449441920|FG002|Overall Study|unable to meet time commitment required of study|3|||
124949665|NCT03060525|449441921|FG003|Overall Study|unable to meet time commitment required of study|1|||
124949666|NCT03060525|449441918|FG000|Overall Study|no longer interested in doing intervention|0|||
124949667|NCT03060525|449441919|FG001|Overall Study|no longer interested in doing intervention|0|||
125029724|NCT01583374|449730810|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
125029725|NCT01583374|449730811|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
125029726|NCT01583374|449730812|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
125029727|NCT01583374|449730813|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
125029728|NCT01583374|449730814|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
125029729|NCT01583374|449730815|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
125029730|NCT01583374|449730816|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
125029731|NCT01583374|449730817|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
125124391|NCT01974141|450080787|FG000|Overall Study|Personal Reasons|21|||
125124392|NCT01974141|450080788|FG001|Overall Study|Personal Reasons|20|||
125124393|NCT01974141|450080787|FG000|Overall Study|Lost to Follow-up|38|||
125124394|NCT01974141|450080788|FG001|Overall Study|Lost to Follow-up|29|||
125124395|NCT01974141|450080787|FG000|Overall Study|Pregnancy|3|||
125124396|NCT01974141|450080788|FG001|Overall Study|Pregnancy|3|||
125124397|NCT01974141|450080787|FG000|Overall Study|Lack of Efficacy|0|||
125124398|NCT01974141|450080788|FG001|Overall Study|Lack of Efficacy|1|||
125124399|NCT01974141|450080787|FG000|Overall Study|Adverse Event|4|||
125124400|NCT01974141|450080788|FG001|Overall Study|Adverse Event|5|||
125124401|NCT04977336|450080789|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
125124402|NCT04977336|450080790|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
125124403|NCT04977336|450080791|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
125124404|NCT04977336|450080792|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
124949668|NCT03060525|449441920|FG002|Overall Study|no longer interested in doing intervention|0|||
124949669|NCT03060525|449441921|FG003|Overall Study|no longer interested in doing intervention|1|||
125124405|NCT04977336|450080793|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
125124406|NCT04977336|450080789|FG000|Overall Study|Lost to Follow-up|0|||
125124407|NCT04977336|450080790|FG001|Overall Study|Lost to Follow-up|0|||
125124408|NCT04977336|450080791|FG002|Overall Study|Lost to Follow-up|1|||
125124409|NCT04977336|450080792|FG003|Overall Study|Lost to Follow-up|0|||
125124410|NCT04977336|450080793|FG004|Overall Study|Lost to Follow-up|0|||
124949670|NCT00747149|449443476|FG000|Overall Study|Adverse Event|0|||
124949671|NCT00747149|449443477|FG001|Overall Study|Adverse Event|15|||
125124411|NCT01347710|450080794|FG000|Overall Study|Withdrawal by Subject|2|||
125124412|NCT01347710|450080794|FG000|Overall Study|Adverse Event|4|||
125124413|NCT01347710|450080794|FG000|Overall Study|Angio or SPECT not completed|18|||
125214990|NCT02579382|450414888|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
125214991|NCT02579382|450414889|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
124949672|NCT00747149|449443476|FG000|Overall Study|Lost to Follow-up|0|||
124949673|NCT00747149|449443477|FG001|Overall Study|Lost to Follow-up|10|||
124949674|NCT00747149|449443476|FG000|Overall Study|Withdrawal by Subject|0|||
124949675|NCT00747149|449443477|FG001|Overall Study|Withdrawal by Subject|6|||
124949676|NCT00747149|449443476|FG000|Overall Study|Did not receive treatment|0|||
124949677|NCT00747149|449443477|FG001|Overall Study|Did not receive treatment|1|||
124949678|NCT00747149|449443476|FG000|Overall Study|Incorrect enrollment|0|||
124949679|NCT00747149|449443477|FG001|Overall Study|Incorrect enrollment|6|||
124949680|NCT00747149|449443476|FG000|Overall Study|Severe non-compliance to protocol|0|||
124949681|NCT00747149|449443477|FG001|Overall Study|Severe non-compliance to protocol|1|||
124949682|NCT00747149|449443476|FG000|Overall Study|Not reported|1|||
124949683|NCT00747149|449443477|FG001|Overall Study|Not reported|4|||
124949684|NCT05522777|449443478|FG000|Overall Study|Lack of Efficacy|1|||
124949685|NCT05522777|449443478|FG000|Overall Study|Withdrawal by Subject|1|||
124949686|NCT05006703|449443479|FG000|Overall Study|Withdrawal by Subject|1|||
124949687|NCT05006703|449443480|FG001|Overall Study|Withdrawal by Subject|0|||
124949688|NCT05006703|449443479|FG000|Overall Study|Lost to Follow-up|13|||
124949689|NCT05006703|449443480|FG001|Overall Study|Lost to Follow-up|5|||
124949690|NCT01381549|449443481|FG000|Overall Study|Ineligible: No organisms isolated|0|||
124949691|NCT01381549|449443482|FG001|Overall Study|Ineligible: No organisms isolated|0|||
124949692|NCT01381549|449443483|FG002|Overall Study|Ineligible: No organisms isolated|1|||
124949693|NCT01416285|449443484|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
125214992|NCT02579382|450414890|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
124949694|NCT01416285|449443485|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
124949695|NCT00578344|449443486|FG000|Overall Study|Insurance problems|1|||
124949696|NCT00578344|449443486|FG000|Overall Study|Graft failure|1|||
124949697|NCT02935673|449443487|FG000|Overall Study|Adverse Event|0|||
125124414|NCT01347710|450080794|FG000|Overall Study|issue with vitals prior to dosing|1|||
125124415|NCT01347710|450080794|FG000|Overall Study|Lost to Follow-up|1|||
125124416|NCT01347710|450080794|FG000|Overall Study|Physician Decision|2|||
125124417|NCT01347710|450080794|FG000|Overall Study|Other|3|||
124949698|NCT02935673|449443488|FG001|Overall Study|Adverse Event|1|||
124949699|NCT02935673|449443489|FG002|Overall Study|Adverse Event|0|||
124949700|NCT02935673|449443487|FG000|Overall Study|Withdrawal by Subject|1|||
124949701|NCT02935673|449443488|FG001|Overall Study|Withdrawal by Subject|2|||
124949702|NCT02935673|449443489|FG002|Overall Study|Withdrawal by Subject|0|||
125124418|NCT01004172|450080798|FG000|Overall Study|Progressive Disease in CNS Only|16|||
125124419|NCT01004172|450080798|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
125124420|NCT01004172|450080798|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
125124421|NCT01004172|450080798|FG000|Overall Study|Adverse Event|1|||
125124422|NCT01004172|450080798|FG000|Overall Study|Physician Decision|1|||
125124423|NCT01004172|450080798|FG000|Overall Study|Symptomatic Deterioration|2|||
125124424|NCT00950872|450080799|FG000|Overall Study|Withdrawal by Subject|1|||
125124425|NCT00950872|450080799|FG000|Overall Study|Did not have surgery|2|||
125124426|NCT00970281|450080802|FG000|Overall Study|Lack of Efficacy|1|||
125124427|NCT00970281|450080803|FG001|Overall Study|Lack of Efficacy|14|||
125124428|NCT00970281|450080802|FG000|Overall Study|Withdrawal by Subject|0|||
125124429|NCT00970281|450080803|FG001|Overall Study|Withdrawal by Subject|1|||
125124430|NCT00970281|450080802|FG000|Overall Study|Physician Decision|1|||
125124431|NCT00970281|450080803|FG001|Overall Study|Physician Decision|1|||
125124432|NCT00408902|450080804|FG000|Overall Study|Lack of Efficacy|7|||
125124433|NCT00408902|450080804|FG000|Overall Study|Adverse Event|3|||
125124434|NCT01139164|450080806|FG000|Overall Study|Withdrawn prior to study start|0|||
125124435|NCT01139164|450080807|FG001|Overall Study|Withdrawn prior to study start|2|||
125124436|NCT01139164|450080808|FG002|Overall Study|Withdrawn prior to study start|0|||
125124437|NCT02003183|450080809|FG000|Overall Study|Lost to Follow-up|0|||
125124438|NCT02003183|450080810|FG001|Overall Study|Lost to Follow-up|2|||
125124439|NCT00878995|450080811|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
125124440|NCT00878995|450080812|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
125124441|NCT01759290|450080815|FG000|Overall Study|Subjects withdrawn consent|5|||
125124442|NCT01759290|450080815|FG000|Overall Study|Physician Decision|2|||
125124443|NCT01759290|450080815|FG000|Overall Study|Death|17|||
124949703|NCT04328467|449443490|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
124949704|NCT04328467|449443491|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
124949705|NCT04328467|449443492|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
124949706|NCT00990184|449443493|FG000|Overall Study|Physician Decision|1|||
124949707|NCT01090739|449443496|FG000|Enrollment|Withdrawal by Subject|24|||
124949708|NCT01090739|449443496|FG000|Enrollment|Protocol Violation|14|||
124949709|NCT01090739|449443496|FG000|Enrollment|Lost to Follow-up|5|||
124949710|NCT01090739|449443496|FG000|Enrollment|Physician Decision|5|||
124949711|NCT01090739|449443496|FG000|Enrollment|Sponsor termination of site|4|||
124949712|NCT01090739|449443496|FG000|Enrollment|Study implant limit reached|2|||
125124444|NCT01759290|450080815|FG000|Overall Study|Lost to Follow-up|53|||
124949713|NCT01090739|449443496|FG000|Enrollment|Adverse Event|1|||
124949714|NCT01090739|449443496|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
125124445|NCT01759290|450080815|FG000|Overall Study|Unknown reason|4|||
125124446|NCT03338972|450080818|FG000|Overall Study|Death|1|||
125124447|NCT03338972|450080819|FG001|Overall Study|Death|1|||
125124448|NCT03338972|450080820|FG002|Overall Study|Death|0|||
125029732|NCT01583374|449730809|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
125029733|NCT01583374|449730810|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
125029734|NCT01583374|449730811|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
125029735|NCT01583374|449730812|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
125029736|NCT01583374|449730813|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
125029737|NCT01583374|449730814|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
125029738|NCT01583374|449730815|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
125029739|NCT01583374|449730816|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
125029740|NCT01583374|449730817|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
125029741|NCT01583374|449730809|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
125029742|NCT01583374|449730810|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
125029743|NCT01583374|449730811|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
125029744|NCT01583374|449730812|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
125029745|NCT01583374|449730813|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
125029746|NCT01583374|449730814|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
125029747|NCT01583374|449730815|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
125029748|NCT01583374|449730816|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
125029749|NCT01583374|449730817|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
125029750|NCT01583374|449730809|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
125029751|NCT01583374|449730810|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
125029752|NCT01583374|449730811|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
125029753|NCT01583374|449730812|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
125029754|NCT01583374|449730813|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
125029755|NCT01583374|449730814|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
125029756|NCT01583374|449730815|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
125029757|NCT01583374|449730816|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
125029758|NCT01583374|449730817|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
125029759|NCT01583374|449730809|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
125029760|NCT01583374|449730810|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
125029761|NCT01583374|449730811|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
125029762|NCT01583374|449730812|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
125029763|NCT01583374|449730813|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
125029764|NCT01583374|449730814|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
125029765|NCT01583374|449730815|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
125029766|NCT01583374|449730816|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
125029767|NCT01583374|449730817|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
125029768|NCT01583374|449730809|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
125029769|NCT01583374|449730810|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
125029770|NCT01583374|449730811|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
125029771|NCT01583374|449730812|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
125029772|NCT01583374|449730813|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
125029773|NCT01583374|449730814|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
125029774|NCT01583374|449730815|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
125029775|NCT01583374|449730816|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
125029776|NCT01583374|449730817|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
125029777|NCT01583374|449730809|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
125029778|NCT01583374|449730810|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
125029779|NCT01583374|449730811|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
125124449|NCT03338972|450080821|FG003|Overall Study|Death|0|||
125124450|NCT03338972|450080818|FG000|Overall Study|Withdrawal by Subject|1|||
125124451|NCT03338972|450080819|FG001|Overall Study|Withdrawal by Subject|0|||
125124452|NCT03338972|450080820|FG002|Overall Study|Withdrawal by Subject|0|||
125124453|NCT03338972|450080821|FG003|Overall Study|Withdrawal by Subject|0|||
125124454|NCT02480764|450080822|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
125124455|NCT02480764|450080823|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
125124456|NCT02480764|450080824|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
125124457|NCT02480764|450080822|FG000|Overall Study|Major Protocol Deviation|1|||
125124458|NCT02480764|450080823|FG001|Overall Study|Major Protocol Deviation|4|||
125124459|NCT02480764|450080824|FG002|Overall Study|Major Protocol Deviation|3|||
125124460|NCT02480764|450080822|FG000|Overall Study|Lost to Follow-up|0|||
125124461|NCT02480764|450080823|FG001|Overall Study|Lost to Follow-up|1|||
125214993|NCT02579382|450414887|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
125124462|NCT02480764|450080824|FG002|Overall Study|Lost to Follow-up|2|||
125124463|NCT02480764|450080822|FG000|Overall Study|Voluntary Withdrawal|6|||
125124464|NCT02480764|450080823|FG001|Overall Study|Voluntary Withdrawal|5|||
125124465|NCT02480764|450080824|FG002|Overall Study|Voluntary Withdrawal|10|||
125124466|NCT02480764|450080822|FG000|Overall Study|Lack of Efficacy|0|||
125124467|NCT02480764|450080823|FG001|Overall Study|Lack of Efficacy|3|||
125124468|NCT02480764|450080824|FG002|Overall Study|Lack of Efficacy|3|||
125124469|NCT02480764|450080822|FG000|Overall Study|Reason not Specified|0|||
125124470|NCT02480764|450080823|FG001|Overall Study|Reason not Specified|1|||
125124471|NCT02480764|450080824|FG002|Overall Study|Reason not Specified|0|||
125124472|NCT03629249|450080825|FG000|Overall Study|Study terminated by sponsor|197|||
125124473|NCT03629249|450080826|FG001|Overall Study|Study terminated by sponsor|197|||
125124474|NCT03629249|450080827|FG002|Overall Study|Study terminated by sponsor|194|||
125124475|NCT03629249|450080825|FG000|Overall Study|Protocol deviation|0|||
125124476|NCT03629249|450080826|FG001|Overall Study|Protocol deviation|2|||
125124477|NCT03629249|450080827|FG002|Overall Study|Protocol deviation|5|||
125124478|NCT03629249|450080825|FG000|Overall Study|Subject decision|1|||
125124479|NCT03629249|450080826|FG001|Overall Study|Subject decision|1|||
125124480|NCT03629249|450080827|FG002|Overall Study|Subject decision|3|||
125124481|NCT03629249|450080825|FG000|Overall Study|Adverse Event|1|||
125124482|NCT03629249|450080826|FG001|Overall Study|Adverse Event|1|||
125124483|NCT03629249|450080827|FG002|Overall Study|Adverse Event|0|||
125124484|NCT03629249|450080825|FG000|Overall Study|Death|1|||
125124485|NCT03629249|450080826|FG001|Overall Study|Death|0|||
125124486|NCT03629249|450080827|FG002|Overall Study|Death|0|||
125124487|NCT03629249|450080825|FG000|Overall Study|Physician Decision|1|||
125124488|NCT03629249|450080826|FG001|Overall Study|Physician Decision|0|||
125124489|NCT03629249|450080827|FG002|Overall Study|Physician Decision|0|||
125214994|NCT02579382|450414888|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
125124490|NCT01475474|450080830|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
125124491|NCT01475474|450080830|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
125124492|NCT01030965|450080831|FG000|Overall Study|Lack of Efficacy|3|||
124949715|NCT01090739|449443496|FG000|12 Month Follow-up|Lost to Follow-up|1|||
124949716|NCT01090739|449443496|FG000|12 Month Follow-up|Physician Decision|1|||
124949717|NCT01090739|449443496|FG000|12 Month Follow-up|Death|1|||
124949718|NCT01090739|449443496|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
124949719|NCT01090739|449443496|FG000|24 Month Follow-up|Lost to Follow-up|1|||
124949720|NCT01090739|449443496|FG000|24 Month Follow-up|Death|1|||
124949721|NCT01090739|449443496|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
124949722|NCT01090739|449443496|FG000|36 Month Follow-up|Visit still pending|17|||
124949723|NCT00441168|449443497|FG000|Treatment Period|Death|3|||
124949724|NCT00441168|449443498|FG001|Treatment Period|Death|0|||
124949725|NCT00441168|449443497|FG000|Treatment Period|Adverse Event|1|||
124949726|NCT00441168|449443498|FG001|Treatment Period|Adverse Event|2|||
124949727|NCT00441168|449443497|FG000|Treatment Period|Progressive Disease|0|||
124949728|NCT00441168|449443498|FG001|Treatment Period|Progressive Disease|2|||
124949729|NCT00441168|449443497|FG000|Treatment Period|Protocol Violation|0|||
124949730|NCT00441168|449443498|FG001|Treatment Period|Protocol Violation|1|||
124949731|NCT00441168|449443497|FG000|Treatment Period|Lost to Follow-up|0|||
124949732|NCT00441168|449443498|FG001|Treatment Period|Lost to Follow-up|1|||
124949733|NCT00441168|449443497|FG000|Treatment Period|Withdrawal by Subject|3|||
124949734|NCT00441168|449443498|FG001|Treatment Period|Withdrawal by Subject|0|||
125124493|NCT01030965|450080832|FG001|Overall Study|Lack of Efficacy|2|||
125124494|NCT01030965|450080833|FG002|Overall Study|Lack of Efficacy|0|||
125124495|NCT01030965|450080834|FG003|Overall Study|Lack of Efficacy|3|||
125124496|NCT01030965|450080831|FG000|Overall Study|Protocol Violation|1|||
125124497|NCT01030965|450080832|FG001|Overall Study|Protocol Violation|1|||
125124498|NCT01030965|450080833|FG002|Overall Study|Protocol Violation|1|||
125124499|NCT01030965|450080834|FG003|Overall Study|Protocol Violation|1|||
125124500|NCT01030965|450080831|FG000|Overall Study|Adverse Event|0|||
125124501|NCT01030965|450080832|FG001|Overall Study|Adverse Event|1|||
125124502|NCT01030965|450080833|FG002|Overall Study|Adverse Event|2|||
125124503|NCT01030965|450080834|FG003|Overall Study|Adverse Event|1|||
125124504|NCT01030965|450080831|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
124949735|NCT00441168|449443497|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
125124505|NCT01030965|450080832|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
125124506|NCT01030965|450080833|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
125124507|NCT01030965|450080834|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
125124508|NCT01030965|450080831|FG000|Overall Study|Withdrawal by Subject|0|||
125124509|NCT01030965|450080832|FG001|Overall Study|Withdrawal by Subject|1|||
125124510|NCT01030965|450080833|FG002|Overall Study|Withdrawal by Subject|0|||
125124511|NCT01030965|450080834|FG003|Overall Study|Withdrawal by Subject|2|||
125124512|NCT02097290|450080837|FG000|Overall Study|Death|6|||
125124513|NCT02097290|450080837|FG000|Overall Study|Total Withdrawals|3|||
125124514|NCT02097290|450080837|FG000|Overall Study|Attempt|8|||
125124515|NCT05277389|450080838|FG000|Overall Study|Lost to Follow-up|1|||
125124516|NCT05277389|450080839|FG001|Overall Study|Lost to Follow-up|4|||
125124517|NCT06096168|450080840|FG000|Overall Study|Death|30|||
125124518|NCT06096168|450080840|FG000|Overall Study|Revision|2|||
125124519|NCT01868009|450080841|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
125214995|NCT02579382|450414889|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
124949736|NCT00441168|449443498|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
124949737|NCT00441168|449443497|FG000|Treatment Period|refractory disease|1|||
125124520|NCT01868009|450080842|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
125124521|NCT01868009|450080841|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
125124522|NCT01868009|450080842|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
125124523|NCT01868009|450080841|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
125124524|NCT01868009|450080842|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
125124525|NCT00743197|450080843|FG000|Overall Study|Study terminated due to departure of PI.|1|||
125029780|NCT01583374|449730812|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
125029781|NCT01583374|449730813|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
125029782|NCT01583374|449730814|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
125029783|NCT01583374|449730815|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
124949738|NCT00441168|449443498|FG001|Treatment Period|refractory disease|0|||
124949739|NCT00441168|449443497|FG000|Follow-up Period|Death|3|||
124949740|NCT00441168|449443498|FG001|Follow-up Period|Death|0|||
124949741|NCT00441168|449443497|FG000|Follow-up Period|Lost to Follow-up|5|||
124949742|NCT00441168|449443498|FG001|Follow-up Period|Lost to Follow-up|6|||
124949743|NCT00441168|449443497|FG000|Follow-up Period|Withdrawal by Subject|3|||
124949744|NCT00441168|449443498|FG001|Follow-up Period|Withdrawal by Subject|0|||
124949745|NCT00441168|449443497|FG000|Follow-up Period|Other|1|||
124949746|NCT00441168|449443498|FG001|Follow-up Period|Other|3|||
124949747|NCT03909100|449443499|FG000|Overall Study|Protocol Deviation|2|||
124949748|NCT03909100|449443499|FG000|Overall Study|Technical Problems|4|||
124949749|NCT03909100|449443499|FG000|Overall Study|Withdrawal by Subject|4|||
124949750|NCT03909100|449443499|FG000|Overall Study|Lost to Follow-up|1|||
124949751|NCT03909100|449443499|FG000|Overall Study|Reason not Specified|4|||
124949752|NCT00807599|449443500|FG000|Overall Study|Not treated on protocol study|0|||
124949753|NCT00807599|449443501|FG001|Overall Study|Not treated on protocol study|0|||
124949754|NCT00807599|449443502|FG002|Overall Study|Not treated on protocol study|2|||
124949755|NCT00807599|449443500|FG000|Overall Study|Adverse Event|0|||
124949756|NCT00807599|449443501|FG001|Overall Study|Adverse Event|0|||
124949757|NCT00807599|449443502|FG002|Overall Study|Adverse Event|5|||
124949758|NCT00807599|449443500|FG000|Overall Study|Inadequate response to induction|0|||
124949759|NCT00807599|449443501|FG001|Overall Study|Inadequate response to induction|0|||
124949760|NCT00807599|449443502|FG002|Overall Study|Inadequate response to induction|9|||
124949761|NCT00807599|449443500|FG000|Overall Study|Withdrawal by Subject|0|||
125029784|NCT01583374|449730816|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
125029785|NCT01583374|449730817|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
125029786|NCT02591615|449732696|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
125029787|NCT02591615|449732697|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
125029788|NCT02591615|449732698|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
125029789|NCT02591615|449732699|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
125029790|NCT02591615|449732696|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
125029791|NCT02591615|449732697|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
125029792|NCT02591615|449732698|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
125029793|NCT02591615|449732699|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
125029794|NCT02591615|449732696|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
125029795|NCT02591615|449732697|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
125124526|NCT00743197|450080844|FG001|Overall Study|Study terminated due to departure of PI.|2|||
125029796|NCT02591615|449732698|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
125029797|NCT02591615|449732699|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
125124527|NCT01478620|450080845|FG000|Overall Study|Lost to Follow-up|6|||
125124528|NCT02130466|450080850|FG000|Overall Study|Death|4|||
124949762|NCT00807599|449443501|FG001|Overall Study|Withdrawal by Subject|0|||
124949763|NCT00807599|449443502|FG002|Overall Study|Withdrawal by Subject|1|||
124949764|NCT00529529|449443503|FG000|Overall Study|Adverse Event|12|||
124949765|NCT00529529|449443504|FG001|Overall Study|Adverse Event|17|||
124949766|NCT00529529|449443505|FG002|Overall Study|Adverse Event|8|||
124949767|NCT00529529|449443503|FG000|Overall Study|Subject withdrew consent|12|||
124949768|NCT00529529|449443504|FG001|Overall Study|Subject withdrew consent|9|||
124949769|NCT00529529|449443505|FG002|Overall Study|Subject withdrew consent|12|||
124949770|NCT00529529|449443503|FG000|Overall Study|Protocol deviation|8|||
124949771|NCT00529529|449443504|FG001|Overall Study|Protocol deviation|12|||
124949772|NCT00529529|449443505|FG002|Overall Study|Protocol deviation|5|||
124949773|NCT00529529|449443503|FG000|Overall Study|Lost to Follow-up|5|||
124949774|NCT00529529|449443504|FG001|Overall Study|Lost to Follow-up|3|||
124949775|NCT00529529|449443505|FG002|Overall Study|Lost to Follow-up|1|||
124949776|NCT00529529|449443503|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124949777|NCT00529529|449443504|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124949778|NCT00529529|449443505|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
124949779|NCT00529529|449443503|FG000|Overall Study|Death|2|||
124949780|NCT00529529|449443504|FG001|Overall Study|Death|0|||
124949781|NCT00529529|449443505|FG002|Overall Study|Death|0|||
124949782|NCT00529529|449443503|FG000|Overall Study|Abnormal test procedure result(s)|1|||
124949783|NCT00529529|449443504|FG001|Overall Study|Abnormal test procedure result(s)|0|||
124949784|NCT00529529|449443505|FG002|Overall Study|Abnormal test procedure result(s)|0|||
124949785|NCT00529529|449443503|FG000|Overall Study|Administrative problems|1|||
124949786|NCT00529529|449443504|FG001|Overall Study|Administrative problems|0|||
124949787|NCT00529529|449443505|FG002|Overall Study|Administrative problems|3|||
124949788|NCT01020435|449443506|FG000|Overall Study|Lost to Follow-up|0|||
124949789|NCT01020435|449443507|FG001|Overall Study|Lost to Follow-up|1|||
124949790|NCT00103857|449443508|FG000|54-Week Base Study|Adverse Event|12|||
124949791|NCT00103857|449443509|FG001|54-Week Base Study|Adverse Event|9|||
124949792|NCT00103857|449443510|FG002|54-Week Base Study|Adverse Event|11|||
124949793|NCT00103857|449443511|FG003|54-Week Base Study|Adverse Event|6|||
124949794|NCT00103857|449443512|FG004|54-Week Base Study|Adverse Event|5|||
124949795|NCT00103857|449443513|FG005|54-Week Base Study|Adverse Event|11|||
124949796|NCT00103857|449443514|FG006|54-Week Base Study|Adverse Event|3|||
124949797|NCT00103857|449443508|FG000|54-Week Base Study|Death|0|||
124949798|NCT00103857|449443509|FG001|54-Week Base Study|Death|0|||
124949799|NCT00103857|449443510|FG002|54-Week Base Study|Death|0|||
124949800|NCT00103857|449443511|FG003|54-Week Base Study|Death|0|||
124949801|NCT00103857|449443512|FG004|54-Week Base Study|Death|1|||
124949802|NCT00103857|449443513|FG005|54-Week Base Study|Death|1|||
125124529|NCT02130466|450080851|FG001|Overall Study|Death|1|||
125124530|NCT02130466|450080852|FG002|Overall Study|Death|1|||
125124531|NCT02130466|450080853|FG003|Overall Study|Death|3|||
124949803|NCT00103857|449443514|FG006|54-Week Base Study|Death|0|||
124949804|NCT00103857|449443508|FG000|54-Week Base Study|Lack of Efficacy|11|||
124949805|NCT00103857|449443509|FG001|54-Week Base Study|Lack of Efficacy|14|||
124949806|NCT00103857|449443510|FG002|54-Week Base Study|Lack of Efficacy|8|||
124949807|NCT00103857|449443511|FG003|54-Week Base Study|Lack of Efficacy|4|||
124949808|NCT00103857|449443512|FG004|54-Week Base Study|Lack of Efficacy|3|||
124949809|NCT00103857|449443513|FG005|54-Week Base Study|Lack of Efficacy|14|||
124949810|NCT00103857|449443514|FG006|54-Week Base Study|Lack of Efficacy|19|||
125124532|NCT02130466|450080854|FG004|Overall Study|Death|2|||
124949811|NCT00103857|449443508|FG000|54-Week Base Study|Lost to Follow-up|5|||
124949812|NCT00103857|449443509|FG001|54-Week Base Study|Lost to Follow-up|4|||
124949813|NCT00103857|449443510|FG002|54-Week Base Study|Lost to Follow-up|7|||
124949814|NCT00103857|449443511|FG003|54-Week Base Study|Lost to Follow-up|5|||
124949815|NCT00103857|449443512|FG004|54-Week Base Study|Lost to Follow-up|10|||
124949816|NCT00103857|449443513|FG005|54-Week Base Study|Lost to Follow-up|9|||
124949817|NCT00103857|449443514|FG006|54-Week Base Study|Lost to Follow-up|3|||
124949818|NCT00103857|449443508|FG000|54-Week Base Study|Physician Decision|1|||
124949819|NCT00103857|449443509|FG001|54-Week Base Study|Physician Decision|1|||
124949820|NCT00103857|449443510|FG002|54-Week Base Study|Physician Decision|0|||
124949821|NCT00103857|449443511|FG003|54-Week Base Study|Physician Decision|0|||
124949822|NCT00103857|449443512|FG004|54-Week Base Study|Physician Decision|1|||
124949823|NCT00103857|449443513|FG005|54-Week Base Study|Physician Decision|0|||
124949824|NCT00103857|449443514|FG006|54-Week Base Study|Physician Decision|0|||
124949825|NCT00103857|449443508|FG000|54-Week Base Study|Pregnancy|1|||
124949826|NCT00103857|449443509|FG001|54-Week Base Study|Pregnancy|0|||
124949827|NCT00103857|449443510|FG002|54-Week Base Study|Pregnancy|0|||
124949828|NCT00103857|449443511|FG003|54-Week Base Study|Pregnancy|0|||
124949829|NCT00103857|449443512|FG004|54-Week Base Study|Pregnancy|1|||
124949830|NCT00103857|449443513|FG005|54-Week Base Study|Pregnancy|0|||
125214996|NCT02579382|450414890|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
125214997|NCT02579382|450414887|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
125214998|NCT02579382|450414888|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
125214999|NCT02579382|450414889|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
125215000|NCT02579382|450414890|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
125215001|NCT02579382|450414887|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
125215002|NCT02579382|450414888|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
125215003|NCT02579382|450414889|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
125215004|NCT02579382|450414890|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
124949831|NCT00103857|449443514|FG006|54-Week Base Study|Pregnancy|1|||
124949832|NCT00103857|449443508|FG000|54-Week Base Study|Protocol Violation|6|||
125215005|NCT02579382|450414887|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
124949833|NCT00103857|449443509|FG001|54-Week Base Study|Protocol Violation|4|||
124949834|NCT00103857|449443510|FG002|54-Week Base Study|Protocol Violation|2|||
124949835|NCT00103857|449443511|FG003|54-Week Base Study|Protocol Violation|4|||
124949836|NCT00103857|449443512|FG004|54-Week Base Study|Protocol Violation|0|||
124949837|NCT00103857|449443513|FG005|54-Week Base Study|Protocol Violation|3|||
124949838|NCT00103857|449443514|FG006|54-Week Base Study|Protocol Violation|3|||
124949839|NCT00103857|449443508|FG000|54-Week Base Study|Withdrawal by Subject|17|||
124949840|NCT00103857|449443509|FG001|54-Week Base Study|Withdrawal by Subject|16|||
124949841|NCT00103857|449443510|FG002|54-Week Base Study|Withdrawal by Subject|16|||
124949842|NCT00103857|449443511|FG003|54-Week Base Study|Withdrawal by Subject|15|||
124949843|NCT00103857|449443512|FG004|54-Week Base Study|Withdrawal by Subject|10|||
124949844|NCT00103857|449443513|FG005|54-Week Base Study|Withdrawal by Subject|15|||
124949845|NCT00103857|449443514|FG006|54-Week Base Study|Withdrawal by Subject|4|||
125124533|NCT02130466|450080855|FG005|Overall Study|Death|30|||
125124534|NCT02130466|450080856|FG006|Overall Study|Death|45|||
125124535|NCT02130466|450080857|FG007|Overall Study|Death|2|||
125124536|NCT02130466|450080858|FG008|Overall Study|Death|3|||
125124537|NCT02130466|450080859|FG009|Overall Study|Death|4|||
125124538|NCT02130466|450080860|FG010|Overall Study|Death|5|||
125124539|NCT02130466|450080861|FG011|Overall Study|Death|3|||
125124540|NCT02130466|450080862|FG012|Overall Study|Death|11|||
125124541|NCT02130466|450080863|FG013|Overall Study|Death|7|||
125124542|NCT02130466|450080850|FG000|Overall Study|Lost to Follow-up|1|||
125124543|NCT02130466|450080851|FG001|Overall Study|Lost to Follow-up|0|||
125124544|NCT02130466|450080852|FG002|Overall Study|Lost to Follow-up|0|||
125124545|NCT02130466|450080853|FG003|Overall Study|Lost to Follow-up|0|||
125124546|NCT02130466|450080854|FG004|Overall Study|Lost to Follow-up|0|||
125124547|NCT02130466|450080855|FG005|Overall Study|Lost to Follow-up|1|||
125124548|NCT02130466|450080856|FG006|Overall Study|Lost to Follow-up|0|||
124949846|NCT00103857|449443508|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
124949847|NCT00103857|449443509|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
125124549|NCT02130466|450080857|FG007|Overall Study|Lost to Follow-up|0|||
125124550|NCT02130466|450080858|FG008|Overall Study|Lost to Follow-up|0|||
125124551|NCT02130466|450080859|FG009|Overall Study|Lost to Follow-up|0|||
125124552|NCT02130466|450080860|FG010|Overall Study|Lost to Follow-up|0|||
125124553|NCT02130466|450080861|FG011|Overall Study|Lost to Follow-up|0|||
124949848|NCT00103857|449443510|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
124949849|NCT00103857|449443511|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
124949850|NCT00103857|449443512|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
124949851|NCT00103857|449443513|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
124949852|NCT00103857|449443514|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
124949853|NCT00103857|449443508|FG000|54-Week Base Study|patient moved|0|||
124949854|NCT00103857|449443509|FG001|54-Week Base Study|patient moved|1|||
124949855|NCT00103857|449443510|FG002|54-Week Base Study|patient moved|1|||
125124554|NCT02130466|450080862|FG012|Overall Study|Lost to Follow-up|1|||
125124555|NCT02130466|450080863|FG013|Overall Study|Lost to Follow-up|0|||
125124556|NCT02130466|450080850|FG000|Overall Study|Physician Decision|0|||
125124557|NCT02130466|450080851|FG001|Overall Study|Physician Decision|0|||
125124558|NCT02130466|450080852|FG002|Overall Study|Physician Decision|0|||
125124559|NCT02130466|450080853|FG003|Overall Study|Physician Decision|0|||
125124560|NCT02130466|450080854|FG004|Overall Study|Physician Decision|0|||
125124561|NCT02130466|450080855|FG005|Overall Study|Physician Decision|1|||
125124562|NCT02130466|450080856|FG006|Overall Study|Physician Decision|1|||
125124563|NCT02130466|450080857|FG007|Overall Study|Physician Decision|0|||
125124564|NCT02130466|450080858|FG008|Overall Study|Physician Decision|0|||
125124565|NCT02130466|450080859|FG009|Overall Study|Physician Decision|0|||
125124566|NCT02130466|450080860|FG010|Overall Study|Physician Decision|0|||
125124567|NCT02130466|450080861|FG011|Overall Study|Physician Decision|0|||
125124568|NCT02130466|450080862|FG012|Overall Study|Physician Decision|0|||
125124569|NCT02130466|450080863|FG013|Overall Study|Physician Decision|0|||
124949856|NCT00103857|449443511|FG003|54-Week Base Study|patient moved|2|||
125124570|NCT02130466|450080850|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
125124571|NCT02130466|450080851|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
125124572|NCT02130466|450080852|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
125124573|NCT02130466|450080853|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
125124574|NCT02130466|450080854|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
124949857|NCT00103857|449443512|FG004|54-Week Base Study|patient moved|3|||
124949858|NCT00103857|449443513|FG005|54-Week Base Study|patient moved|1|||
124949859|NCT00103857|449443514|FG006|54-Week Base Study|patient moved|0|||
124949860|NCT00103857|449443508|FG000|54-Week Base Study|non-compliance with study procedures|1|||
124949861|NCT00103857|449443509|FG001|54-Week Base Study|non-compliance with study procedures|2|||
124949862|NCT00103857|449443510|FG002|54-Week Base Study|non-compliance with study procedures|0|||
124949863|NCT00103857|449443511|FG003|54-Week Base Study|non-compliance with study procedures|0|||
124949864|NCT00103857|449443512|FG004|54-Week Base Study|non-compliance with study procedures|0|||
124949865|NCT00103857|449443513|FG005|54-Week Base Study|non-compliance with study procedures|2|||
124949866|NCT00103857|449443514|FG006|54-Week Base Study|non-compliance with study procedures|0|||
124949867|NCT00103857|449443508|FG000|54-Week Base Study|patient incarcerated|0|||
124949868|NCT00103857|449443509|FG001|54-Week Base Study|patient incarcerated|0|||
124949869|NCT00103857|449443510|FG002|54-Week Base Study|patient incarcerated|0|||
124949870|NCT00103857|449443511|FG003|54-Week Base Study|patient incarcerated|0|||
124949871|NCT00103857|449443512|FG004|54-Week Base Study|patient incarcerated|1|||
124949872|NCT00103857|449443513|FG005|54-Week Base Study|patient incarcerated|1|||
124949873|NCT00103857|449443514|FG006|54-Week Base Study|patient incarcerated|0|||
124949874|NCT00103857|449443508|FG000|54-Week Base Study|laboratory reporting error|0|||
124949875|NCT00103857|449443509|FG001|54-Week Base Study|laboratory reporting error|0|||
124949876|NCT00103857|449443510|FG002|54-Week Base Study|laboratory reporting error|0|||
124949877|NCT00103857|449443511|FG003|54-Week Base Study|laboratory reporting error|0|||
124949878|NCT00103857|449443512|FG004|54-Week Base Study|laboratory reporting error|1|||
124949879|NCT00103857|449443513|FG005|54-Week Base Study|laboratory reporting error|0|||
124949880|NCT00103857|449443514|FG006|54-Week Base Study|laboratory reporting error|0|||
124949881|NCT00103857|449443508|FG000|54-Week Base Study|site error|0|||
124949882|NCT00103857|449443509|FG001|54-Week Base Study|site error|0|||
124949883|NCT00103857|449443510|FG002|54-Week Base Study|site error|0|||
124949884|NCT00103857|449443511|FG003|54-Week Base Study|site error|0|||
124949885|NCT00103857|449443512|FG004|54-Week Base Study|site error|0|||
124949886|NCT00103857|449443513|FG005|54-Week Base Study|site error|1|||
124949887|NCT00103857|449443514|FG006|54-Week Base Study|site error|0|||
124949888|NCT00103857|449443508|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
124949889|NCT00103857|449443509|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
124949890|NCT00103857|449443510|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
124949891|NCT00103857|449443511|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
124949892|NCT00103857|449443512|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
124949893|NCT00103857|449443513|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
124949894|NCT00103857|449443514|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
124949895|NCT00103857|449443508|FG000|50-Week Extension Study|Adverse Event|2|||
124949896|NCT00103857|449443509|FG001|50-Week Extension Study|Adverse Event|3|||
124949897|NCT00103857|449443510|FG002|50-Week Extension Study|Adverse Event|2|||
124949898|NCT00103857|449443511|FG003|50-Week Extension Study|Adverse Event|0|||
124949899|NCT00103857|449443512|FG004|50-Week Extension Study|Adverse Event|1|||
124949900|NCT00103857|449443513|FG005|50-Week Extension Study|Adverse Event|1|||
124949901|NCT00103857|449443514|FG006|50-Week Extension Study|Adverse Event|0|||
124949902|NCT00103857|449443508|FG000|50-Week Extension Study|Death|0|||
124949903|NCT00103857|449443509|FG001|50-Week Extension Study|Death|0|||
124949904|NCT00103857|449443510|FG002|50-Week Extension Study|Death|0|||
124949905|NCT00103857|449443511|FG003|50-Week Extension Study|Death|1|||
124949906|NCT00103857|449443512|FG004|50-Week Extension Study|Death|0|||
125029798|NCT02591615|449732696|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
125029799|NCT02591615|449732697|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
125029800|NCT02591615|449732698|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
125029801|NCT02591615|449732699|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
125029802|NCT02591615|449732696|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
125029803|NCT02591615|449732697|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
125124575|NCT02130466|450080855|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
125124576|NCT02130466|450080856|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
125124577|NCT02130466|450080857|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
124949907|NCT00103857|449443513|FG005|50-Week Extension Study|Death|1|||
125029804|NCT02591615|449732698|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
125029805|NCT02591615|449732699|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
125029806|NCT02591615|449732696|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
125029807|NCT02591615|449732697|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
125029808|NCT02591615|449732698|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
125029809|NCT02591615|449732699|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
124949908|NCT00103857|449443514|FG006|50-Week Extension Study|Death|0|||
124949909|NCT00103857|449443508|FG000|50-Week Extension Study|Lack of Efficacy|26|||
124949910|NCT00103857|449443509|FG001|50-Week Extension Study|Lack of Efficacy|15|||
124949911|NCT00103857|449443510|FG002|50-Week Extension Study|Lack of Efficacy|13|||
124949912|NCT00103857|449443511|FG003|50-Week Extension Study|Lack of Efficacy|16|||
124949913|NCT00103857|449443512|FG004|50-Week Extension Study|Lack of Efficacy|8|||
124949914|NCT00103857|449443513|FG005|50-Week Extension Study|Lack of Efficacy|8|||
124949915|NCT00103857|449443514|FG006|50-Week Extension Study|Lack of Efficacy|0|||
124949916|NCT00103857|449443508|FG000|50-Week Extension Study|Lost to Follow-up|4|||
124949917|NCT00103857|449443509|FG001|50-Week Extension Study|Lost to Follow-up|0|||
124949918|NCT00103857|449443510|FG002|50-Week Extension Study|Lost to Follow-up|1|||
124949919|NCT00103857|449443511|FG003|50-Week Extension Study|Lost to Follow-up|4|||
124949920|NCT00103857|449443512|FG004|50-Week Extension Study|Lost to Follow-up|3|||
124949921|NCT00103857|449443513|FG005|50-Week Extension Study|Lost to Follow-up|3|||
124949922|NCT00103857|449443514|FG006|50-Week Extension Study|Lost to Follow-up|0|||
124949923|NCT00103857|449443508|FG000|50-Week Extension Study|Physician Decision|0|||
124949924|NCT00103857|449443509|FG001|50-Week Extension Study|Physician Decision|1|||
124949925|NCT00103857|449443510|FG002|50-Week Extension Study|Physician Decision|1|||
124949926|NCT00103857|449443511|FG003|50-Week Extension Study|Physician Decision|0|||
124949927|NCT00103857|449443512|FG004|50-Week Extension Study|Physician Decision|0|||
124949928|NCT00103857|449443513|FG005|50-Week Extension Study|Physician Decision|0|||
124949929|NCT00103857|449443514|FG006|50-Week Extension Study|Physician Decision|0|||
124949930|NCT00103857|449443508|FG000|50-Week Extension Study|Pregnancy|0|||
124949931|NCT00103857|449443509|FG001|50-Week Extension Study|Pregnancy|0|||
124949932|NCT00103857|449443510|FG002|50-Week Extension Study|Pregnancy|1|||
124949933|NCT00103857|449443511|FG003|50-Week Extension Study|Pregnancy|0|||
124949934|NCT00103857|449443512|FG004|50-Week Extension Study|Pregnancy|1|||
124949935|NCT00103857|449443513|FG005|50-Week Extension Study|Pregnancy|0|||
124949936|NCT00103857|449443514|FG006|50-Week Extension Study|Pregnancy|0|||
124949937|NCT00103857|449443508|FG000|50-Week Extension Study|Protocol Violation|1|||
124949938|NCT00103857|449443509|FG001|50-Week Extension Study|Protocol Violation|1|||
124949939|NCT00103857|449443510|FG002|50-Week Extension Study|Protocol Violation|1|||
124949940|NCT00103857|449443511|FG003|50-Week Extension Study|Protocol Violation|2|||
124949941|NCT00103857|449443512|FG004|50-Week Extension Study|Protocol Violation|0|||
124949942|NCT00103857|449443513|FG005|50-Week Extension Study|Protocol Violation|1|||
124949943|NCT00103857|449443514|FG006|50-Week Extension Study|Protocol Violation|0|||
124949944|NCT00103857|449443508|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
124949945|NCT00103857|449443509|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
124949946|NCT00103857|449443510|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
124949947|NCT00103857|449443511|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
124949948|NCT00103857|449443512|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
124949949|NCT00103857|449443513|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
124949950|NCT00103857|449443514|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
124949951|NCT00103857|449443508|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
124949952|NCT00103857|449443509|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
124949953|NCT00103857|449443510|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
124949954|NCT00103857|449443511|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
124949955|NCT00103857|449443512|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
124949956|NCT00103857|449443513|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
124949957|NCT00103857|449443514|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
124949958|NCT00103857|449443508|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
124949959|NCT00103857|449443509|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
124949960|NCT00103857|449443510|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
124949961|NCT00103857|449443511|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
124949962|NCT00103857|449443512|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
124949963|NCT00103857|449443513|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
124949964|NCT00103857|449443514|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
124949965|NCT00103857|449443508|FG000|50-Week Extension Study|patient moved|0|||
124949966|NCT00103857|449443509|FG001|50-Week Extension Study|patient moved|0|||
124949967|NCT00103857|449443510|FG002|50-Week Extension Study|patient moved|1|||
124949968|NCT00103857|449443511|FG003|50-Week Extension Study|patient moved|2|||
124949969|NCT00103857|449443512|FG004|50-Week Extension Study|patient moved|0|||
124949970|NCT00103857|449443513|FG005|50-Week Extension Study|patient moved|0|||
125124578|NCT02130466|450080858|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
125124579|NCT02130466|450080859|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
125124580|NCT02130466|450080860|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
125124581|NCT02130466|450080861|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
125124582|NCT02130466|450080862|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
124949971|NCT00103857|449443514|FG006|50-Week Extension Study|patient moved|0|||
124949972|NCT00103857|449443508|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
124949973|NCT00103857|449443509|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
124949974|NCT00103857|449443510|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
124949975|NCT00103857|449443511|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
124949976|NCT00103857|449443512|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
124949977|NCT00103857|449443513|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
124949978|NCT00103857|449443514|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
124949979|NCT00103857|449443508|FG000|50-Week Extension Study|reason unspecified|0|||
124949980|NCT00103857|449443509|FG001|50-Week Extension Study|reason unspecified|0|||
124949981|NCT00103857|449443510|FG002|50-Week Extension Study|reason unspecified|0|||
124949982|NCT00103857|449443511|FG003|50-Week Extension Study|reason unspecified|0|||
124949983|NCT00103857|449443512|FG004|50-Week Extension Study|reason unspecified|1|||
124949984|NCT00103857|449443513|FG005|50-Week Extension Study|reason unspecified|0|||
124949985|NCT00103857|449443514|FG006|50-Week Extension Study|reason unspecified|0|||
124949986|NCT02132195|449443517|FG000|Initial Assignment|Relapsed|14|||
124949987|NCT02132195|449443518|FG001|Initial Assignment|Relapsed|0|||
124949988|NCT02132195|449443519|FG002|Initial Assignment|Relapsed|0|||
124949989|NCT02132195|449443517|FG000|Rescue Therapy|Relapsed|0|||
124949990|NCT02132195|449443518|FG001|Rescue Therapy|Relapsed|0|||
124949991|NCT02132195|449443519|FG002|Rescue Therapy|Relapsed|7|||
124949992|NCT02132195|449443517|FG000|Rescue Therapy|Physician Decision|0|||
124949993|NCT02132195|449443518|FG001|Rescue Therapy|Physician Decision|0|||
124949994|NCT02132195|449443519|FG002|Rescue Therapy|Physician Decision|1|||
124949995|NCT02132195|449443517|FG000|Rescue Therapy|Withdrawal by Subject|0|||
124949996|NCT02132195|449443518|FG001|Rescue Therapy|Withdrawal by Subject|0|||
124949997|NCT02132195|449443519|FG002|Rescue Therapy|Withdrawal by Subject|1|||
124949998|NCT02132195|449443517|FG000|Rescue Therapy|Adverse Event|0|||
124949999|NCT02132195|449443518|FG001|Rescue Therapy|Adverse Event|0|||
124950000|NCT02132195|449443519|FG002|Rescue Therapy|Adverse Event|2|||
124950001|NCT03065400|449443522|FG000|Overall Study|Adverse Event|1|||
124950002|NCT03065400|449443522|FG000|Overall Study|Physician Decision|3|||
124950003|NCT03065400|449443522|FG000|Overall Study|Withdrawal by Subject|1|||
124950004|NCT03065400|449443522|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
124950005|NCT02102724|449443523|FG000|Overall Study|Lost to Follow-up|1|||
124950006|NCT02102724|449443524|FG001|Overall Study|Lost to Follow-up|0|||
124950007|NCT02102724|449443523|FG000|Overall Study|surgery for brain aneurysm|1|||
124950008|NCT02102724|449443524|FG001|Overall Study|surgery for brain aneurysm|1|||
124950009|NCT03072862|449443525|FG000|Overall Study|Withdrawal by Subject|4|||
124950010|NCT03072862|449443525|FG000|Overall Study|Lost to Follow-up|6|||
124950011|NCT03072862|449443525|FG000|Overall Study|Protocol Violation|4|||
124950012|NCT03072862|449443525|FG000|Overall Study|Physician Decision|2|||
124950013|NCT03072862|449443525|FG000|Overall Study|Death|1|||
124950014|NCT03072862|449443525|FG000|Overall Study|Adverse Event|1|||
124950015|NCT02203513|449443526|FG000|Overall Study|Refused further treatment|2|||
124950016|NCT02203513|449443527|FG001|Overall Study|Refused further treatment|0|||
124950017|NCT02203513|449443528|FG002|Overall Study|Refused further treatment|1|||
124950018|NCT02203513|449443529|FG003|Overall Study|Refused further treatment|0|||
124950019|NCT02203513|449443530|FG004|Overall Study|Refused further treatment|0|||
124950020|NCT02203513|449443526|FG000|Overall Study|Switched to alternative treatment|3|||
124950021|NCT02203513|449443527|FG001|Overall Study|Switched to alternative treatment|4|||
124950022|NCT02203513|449443528|FG002|Overall Study|Switched to alternative treatment|0|||
124950023|NCT02203513|449443529|FG003|Overall Study|Switched to alternative treatment|0|||
124950024|NCT02203513|449443530|FG004|Overall Study|Switched to alternative treatment|4|||
124950025|NCT02203513|449443526|FG000|Overall Study|Did not receive investigational product (IP)|0|||
124950026|NCT02203513|449443527|FG001|Overall Study|Did not receive investigational product (IP)|1|||
124950027|NCT02203513|449443528|FG002|Overall Study|Did not receive investigational product (IP)|0|||
124950028|NCT02203513|449443529|FG003|Overall Study|Did not receive investigational product (IP)|0|||
124950029|NCT02203513|449443530|FG004|Overall Study|Did not receive investigational product (IP)|0|||
124950030|NCT02203513|449443526|FG000|Overall Study|Death (unrelated to study therapy)|1|||
124950031|NCT02203513|449443527|FG001|Overall Study|Death (unrelated to study therapy)|3|||
124950032|NCT02203513|449443528|FG002|Overall Study|Death (unrelated to study therapy)|1|||
124950033|NCT02203513|449443529|FG003|Overall Study|Death (unrelated to study therapy)|0|||
125029810|NCT02591615|449732696|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
125029811|NCT02591615|449732697|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
125029812|NCT02591615|449732698|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
125029813|NCT02591615|449732699|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
125029814|NCT02591615|449732696|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
125029815|NCT02591615|449732697|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
125029816|NCT02591615|449732698|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
125029817|NCT02591615|449732699|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
125029818|NCT02591615|449732696|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
125029819|NCT02591615|449732697|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
124950034|NCT02203513|449443530|FG004|Overall Study|Death (unrelated to study therapy)|2|||
124950035|NCT02203513|449443526|FG000|Overall Study|Lost to Follow-up|0|||
124950036|NCT02203513|449443527|FG001|Overall Study|Lost to Follow-up|0|||
124950037|NCT02203513|449443528|FG002|Overall Study|Lost to Follow-up|1|||
124950038|NCT02203513|449443529|FG003|Overall Study|Lost to Follow-up|1|||
124950039|NCT02203513|449443530|FG004|Overall Study|Lost to Follow-up|0|||
124950040|NCT02513667|449443531|FG000|Overall Study|Withdrawal by Subject|0|||
124950041|NCT02513667|449443532|FG001|Overall Study|Withdrawal by Subject|1|||
124950042|NCT01964547|449443543|FG000|Overall Study|Adverse Event|8|||
125215006|NCT02579382|450414888|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
125215007|NCT02579382|450414889|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
125215008|NCT02579382|450414890|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
124950043|NCT01964547|449443544|FG001|Overall Study|Adverse Event|2|||
124950044|NCT01964547|449443543|FG000|Overall Study|Withdrawal by Subject|4|||
124950045|NCT01964547|449443544|FG001|Overall Study|Withdrawal by Subject|7|||
124950046|NCT01964547|449443543|FG000|Overall Study|Lost to Follow-up|0|||
124950047|NCT01964547|449443544|FG001|Overall Study|Lost to Follow-up|1|||
124950048|NCT01964547|449443543|FG000|Overall Study|Withdrawal by Investigator|0|||
124950049|NCT01964547|449443544|FG001|Overall Study|Withdrawal by Investigator|1|||
124950050|NCT00912964|449443545|FG000|Overall Study|Eligibility criterion not met|1|||
124950051|NCT00912964|449443546|FG001|Overall Study|Eligibility criterion not met|1|||
124950052|NCT00912964|449443547|FG002|Overall Study|Eligibility criterion not met|0|||
124950053|NCT00912964|449443545|FG000|Overall Study|Adverse Event|15|||
124950054|NCT00912964|449443546|FG001|Overall Study|Adverse Event|18|||
124950055|NCT00912964|449443547|FG002|Overall Study|Adverse Event|12|||
124950056|NCT00912964|449443545|FG000|Overall Study|Lack of Efficacy|11|||
124950057|NCT00912964|449443546|FG001|Overall Study|Lack of Efficacy|4|||
124950058|NCT00912964|449443547|FG002|Overall Study|Lack of Efficacy|3|||
124950059|NCT00912964|449443545|FG000|Overall Study|Withdrawal by Subject|20|||
124950060|NCT00912964|449443546|FG001|Overall Study|Withdrawal by Subject|12|||
124950061|NCT00912964|449443547|FG002|Overall Study|Withdrawal by Subject|18|||
124950062|NCT00912964|449443545|FG000|Overall Study|Lost to Follow-up|4|||
124950063|NCT00912964|449443546|FG001|Overall Study|Lost to Follow-up|3|||
124950064|NCT00912964|449443547|FG002|Overall Study|Lost to Follow-up|3|||
124950065|NCT00912964|449443545|FG000|Overall Study|Protocol Violation|5|||
124950066|NCT00912964|449443546|FG001|Overall Study|Protocol Violation|3|||
124950067|NCT00912964|449443547|FG002|Overall Study|Protocol Violation|8|||
124950068|NCT00912964|449443545|FG000|Overall Study|Taking exclusionary medications|7|||
124950069|NCT00912964|449443546|FG001|Overall Study|Taking exclusionary medications|4|||
124950070|NCT00912964|449443547|FG002|Overall Study|Taking exclusionary medications|8|||
124950071|NCT00912964|449443545|FG000|Overall Study|Medical History|1|||
124950072|NCT00912964|449443546|FG001|Overall Study|Medical History|0|||
124950073|NCT00912964|449443547|FG002|Overall Study|Medical History|0|||
124950074|NCT00912964|449443545|FG000|Overall Study|Non-compliance with study procedures|2|||
124950075|NCT00912964|449443546|FG001|Overall Study|Non-compliance with study procedures|0|||
124950076|NCT00912964|449443547|FG002|Overall Study|Non-compliance with study procedures|0|||
124950077|NCT00912964|449443545|FG000|Overall Study|Violation of exclusion criterion|0|||
124950078|NCT00912964|449443546|FG001|Overall Study|Violation of exclusion criterion|0|||
124950079|NCT00912964|449443547|FG002|Overall Study|Violation of exclusion criterion|2|||
124950080|NCT00912964|449443545|FG000|Overall Study|Randomized but never received study drug|0|||
124950081|NCT00912964|449443546|FG001|Overall Study|Randomized but never received study drug|1|||
124950082|NCT00912964|449443547|FG002|Overall Study|Randomized but never received study drug|0|||
124950083|NCT02978716|449443548|FG000|Overall Study|Death|25|||
124950084|NCT02978716|449443549|FG001|Overall Study|Death|13|||
125215009|NCT03026283|450414892|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
125215010|NCT03026283|450414893|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
125215011|NCT03026283|450414894|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
125215012|NCT03026283|450414895|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
125215013|NCT03026283|450414896|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
125215014|NCT03026283|450414897|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
125215015|NCT03026283|450414898|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
125215016|NCT03026283|450414899|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
125215017|NCT03026283|450414892|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
125215018|NCT03026283|450414893|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
124950085|NCT02978716|449443550|FG002|Overall Study|Death|20|||
125029820|NCT02591615|449732698|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
125029821|NCT02591615|449732699|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
124950086|NCT02978716|449443548|FG000|Overall Study|Lost to Follow-up|0|||
124950087|NCT02978716|449443549|FG001|Overall Study|Lost to Follow-up|0|||
124950088|NCT02978716|449443550|FG002|Overall Study|Lost to Follow-up|1|||
125029822|NCT02591615|449732696|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
124950089|NCT02978716|449443548|FG000|Overall Study|Withdrawal by Subject|6|||
124950090|NCT02978716|449443549|FG001|Overall Study|Withdrawal by Subject|4|||
124950091|NCT02978716|449443550|FG002|Overall Study|Withdrawal by Subject|5|||
124950092|NCT02978716|449443548|FG000|Overall Study|Sponsor terminated|2|||
124950093|NCT02978716|449443549|FG001|Overall Study|Sponsor terminated|13|||
124950094|NCT02978716|449443550|FG002|Overall Study|Sponsor terminated|9|||
124950095|NCT02978716|449443548|FG000|Overall Study|Other|1|||
124950096|NCT02978716|449443549|FG001|Overall Study|Other|3|||
125029823|NCT02591615|449732697|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
125029824|NCT02591615|449732698|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
125029825|NCT02591615|449732699|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
125029826|NCT02591615|449732696|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
125029827|NCT02591615|449732697|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
125029828|NCT02591615|449732698|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
125029829|NCT02591615|449732699|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
125029830|NCT02591615|449732696|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
125029831|NCT02591615|449732697|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
125029832|NCT02591615|449732698|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
125029833|NCT02591615|449732699|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
125029834|NCT02591615|449732696|FG000|Maintenance MK-3475|Adverse Event|0|||
125029835|NCT02591615|449732697|FG001|Maintenance MK-3475|Adverse Event|3|||
125029836|NCT02591615|449732698|FG002|Maintenance MK-3475|Adverse Event|1|||
125029837|NCT02591615|449732699|FG003|Maintenance MK-3475|Adverse Event|2|||
125029838|NCT02591615|449732696|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
125029839|NCT02591615|449732697|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
125029840|NCT02591615|449732698|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
125029841|NCT02591615|449732699|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
125029842|NCT02591615|449732696|FG000|Maintenance MK-3475|Death|0|||
125029843|NCT02591615|449732697|FG001|Maintenance MK-3475|Death|1|||
125029844|NCT02591615|449732698|FG002|Maintenance MK-3475|Death|1|||
125029845|NCT02591615|449732699|FG003|Maintenance MK-3475|Death|0|||
125029846|NCT02591615|449732696|FG000|Maintenance MK-3475|Physician discretion|0|||
125029847|NCT02591615|449732697|FG001|Maintenance MK-3475|Physician discretion|0|||
125029848|NCT02591615|449732698|FG002|Maintenance MK-3475|Physician discretion|1|||
125029849|NCT02591615|449732699|FG003|Maintenance MK-3475|Physician discretion|0|||
125029850|NCT02591615|449732696|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
125029851|NCT02591615|449732697|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
125029852|NCT02591615|449732698|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
125029853|NCT02591615|449732699|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
125029854|NCT02591615|449732696|FG000|Maintenance MK-3475|In active treatment|2|||
125029855|NCT02591615|449732697|FG001|Maintenance MK-3475|In active treatment|0|||
125029856|NCT02591615|449732698|FG002|Maintenance MK-3475|In active treatment|0|||
125029857|NCT02591615|449732699|FG003|Maintenance MK-3475|In active treatment|1|||
125124583|NCT02130466|450080863|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
125124584|NCT02130466|450080850|FG000|Overall Study|Withdrawal by Subject|1|||
125124585|NCT02130466|450080851|FG001|Overall Study|Withdrawal by Subject|0|||
125124586|NCT02130466|450080852|FG002|Overall Study|Withdrawal by Subject|0|||
125124587|NCT02130466|450080853|FG003|Overall Study|Withdrawal by Subject|0|||
125124588|NCT02130466|450080854|FG004|Overall Study|Withdrawal by Subject|0|||
125124589|NCT02130466|450080855|FG005|Overall Study|Withdrawal by Subject|1|||
125124590|NCT02130466|450080856|FG006|Overall Study|Withdrawal by Subject|0|||
125124591|NCT02130466|450080857|FG007|Overall Study|Withdrawal by Subject|0|||
125124592|NCT02130466|450080858|FG008|Overall Study|Withdrawal by Subject|1|||
125124593|NCT02130466|450080859|FG009|Overall Study|Withdrawal by Subject|0|||
125124594|NCT02130466|450080860|FG010|Overall Study|Withdrawal by Subject|0|||
125124595|NCT02130466|450080861|FG011|Overall Study|Withdrawal by Subject|0|||
125124596|NCT02130466|450080862|FG012|Overall Study|Withdrawal by Subject|0|||
125124597|NCT02130466|450080863|FG013|Overall Study|Withdrawal by Subject|0|||
125124598|NCT04529109|450080864|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
125124599|NCT04529109|450080865|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
125124600|NCT01411332|450080866|FG000|Enrollment|Protocol Violation|0|||
125124601|NCT01411332|450080867|FG001|Enrollment|Protocol Violation|1|||
125124602|NCT01411332|450080866|FG000|Enrollment|Withdrawal by Subject|0|||
125124603|NCT01411332|450080867|FG001|Enrollment|Withdrawal by Subject|1|||
125124604|NCT01411332|450080866|FG000|Treatment|Lost to Follow-up|1|||
125124605|NCT01411332|450080867|FG001|Treatment|Lost to Follow-up|0|||
125124606|NCT01471522|450080869|FG000|Overall Study|Withdrawal by Subject|28|||
125124607|NCT01471522|450080870|FG001|Overall Study|Withdrawal by Subject|22|||
125124608|NCT01471522|450080869|FG000|Overall Study|Lost to Follow-up|36|||
125124609|NCT01471522|450080870|FG001|Overall Study|Lost to Follow-up|26|||
125124610|NCT00444145|450082387|FG000|Overall Study|Withdrawal by Subject|2|||
125124611|NCT00444145|450082387|FG000|Overall Study|Lost to Follow-up|1|||
125124612|NCT00444145|450082387|FG000|Overall Study|non-compliant|11|||
125124613|NCT00444145|450082387|FG000|Overall Study|Screen Failures|5|||
125124614|NCT01374919|450082388|FG000|Overall Study|Withdrawal by Subject|2|||
125124615|NCT00090857|450082389|FG000|Overall Study|Lost to Follow-up|0|||
125124616|NCT00090857|450082390|FG001|Overall Study|Lost to Follow-up|1|||
125124617|NCT00090857|450082389|FG000|Overall Study|Withdrawal by Subject|2|||
125124618|NCT00090857|450082390|FG001|Overall Study|Withdrawal by Subject|0|||
125029858|NCT04188197|449732700|FG000|Overall Study|Lost to Follow-up|4|||
125029859|NCT04188197|449732701|FG001|Overall Study|Lost to Follow-up|1|||
124950097|NCT02978716|449443550|FG002|Overall Study|Other|0|||
124950098|NCT00960206|449443551|FG000|Overall Study|Death|7|||
124950099|NCT00960206|449443552|FG001|Overall Study|Death|4|||
124950100|NCT00960206|449443553|FG002|Overall Study|Death|1|||
124950101|NCT00960206|449443551|FG000|Overall Study|Unwilling/Unable to return|1|||
124950102|NCT00960206|449443552|FG001|Overall Study|Unwilling/Unable to return|2|||
124950103|NCT00960206|449443553|FG002|Overall Study|Unwilling/Unable to return|0|||
124950104|NCT00960206|449443551|FG000|Overall Study|Lost to Follow-up|8|||
124950105|NCT00960206|449443552|FG001|Overall Study|Lost to Follow-up|14|||
124950106|NCT00960206|449443553|FG002|Overall Study|Lost to Follow-up|8|||
124950107|NCT00960206|449443551|FG000|Overall Study|Withdrawal by Subject|2|||
124950108|NCT00960206|449443552|FG001|Overall Study|Withdrawal by Subject|4|||
124950109|NCT00960206|449443553|FG002|Overall Study|Withdrawal by Subject|0|||
124950110|NCT00960206|449443551|FG000|Overall Study|Revision of study component|2|||
124950111|NCT00960206|449443552|FG001|Overall Study|Revision of study component|2|||
124950112|NCT00960206|449443553|FG002|Overall Study|Revision of study component|2|||
124950113|NCT00960206|449443551|FG000|Overall Study|Missing 10 year data|20|||
124950114|NCT00960206|449443552|FG001|Overall Study|Missing 10 year data|1|||
124950115|NCT00960206|449443553|FG002|Overall Study|Missing 10 year data|1|||
124950116|NCT02470806|449443554|FG000|Overall Study|Lost to Follow-up|1|||
124950117|NCT02470806|449443555|FG001|Overall Study|Lost to Follow-up|1|||
124950118|NCT02470806|449443554|FG000|Overall Study|Adverse Event|5|||
124950119|NCT02470806|449443555|FG001|Overall Study|Adverse Event|2|||
124950120|NCT02470806|449443554|FG000|Overall Study|Protocol Violation|4|||
124950121|NCT02470806|449443555|FG001|Overall Study|Protocol Violation|11|||
124950122|NCT02470806|449443554|FG000|Overall Study|Physician Decision|0|||
124950123|NCT02470806|449443555|FG001|Overall Study|Physician Decision|3|||
124950124|NCT02470806|449443554|FG000|Overall Study|Withdrawal by Subject|3|||
124950125|NCT02470806|449443555|FG001|Overall Study|Withdrawal by Subject|10|||
124950126|NCT02470806|449443554|FG000|Overall Study|Lack of Efficacy|5|||
124950127|NCT02470806|449443555|FG001|Overall Study|Lack of Efficacy|15|||
124950128|NCT01147471|449443556|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
124950129|NCT01147471|449443557|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
124950130|NCT01147471|449443556|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
124950131|NCT01147471|449443557|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
124950132|NCT01147471|449443556|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
124950133|NCT01147471|449443557|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
124950134|NCT01147471|449443556|FG000|3 Month Follow Up|Lost to Follow-up|1|||
124950135|NCT01147471|449443557|FG001|3 Month Follow Up|Lost to Follow-up|1|||
124950136|NCT01147471|449443556|FG000|3 Month Follow Up|Physician Decision|0|||
124950137|NCT01147471|449443557|FG001|3 Month Follow Up|Physician Decision|1|||
124950138|NCT01147471|449443556|FG000|6 Month Follow Up|Lost to Follow-up|4|||
124950139|NCT01147471|449443557|FG001|6 Month Follow Up|Lost to Follow-up|2|||
124950140|NCT01294644|449443565|FG000|Overall Study|Adverse Event|2|||
124950141|NCT01294644|449443566|FG001|Overall Study|Adverse Event|0|||
124950142|NCT01294644|449443567|FG002|Overall Study|Adverse Event|1|||
124950143|NCT01294644|449443565|FG000|Overall Study|Withdrawal by Subject|3|||
124950144|NCT01294644|449443566|FG001|Overall Study|Withdrawal by Subject|7|||
124950145|NCT01294644|449443567|FG002|Overall Study|Withdrawal by Subject|4|||
124950146|NCT01294644|449443565|FG000|Overall Study|Lost to Follow-up|3|||
124950147|NCT01294644|449443566|FG001|Overall Study|Lost to Follow-up|2|||
124950148|NCT01294644|449443567|FG002|Overall Study|Lost to Follow-up|5|||
124950149|NCT01294644|449443565|FG000|Overall Study|Miscellaneous Reason|2|||
124950150|NCT01294644|449443566|FG001|Overall Study|Miscellaneous Reason|1|||
124950151|NCT01294644|449443567|FG002|Overall Study|Miscellaneous Reason|4|||
124950152|NCT03075878|449443568|FG000|Overall Study|Physician Decision|1|||
124950153|NCT02188459|449443569|FG000|Overall Study|Lost to Follow-up|3|||
124950154|NCT02188459|449443570|FG001|Overall Study|Lost to Follow-up|4|||
124950155|NCT02188459|449443569|FG000|Overall Study|Early Termination|0|||
124950156|NCT02188459|449443570|FG001|Overall Study|Early Termination|3|||
124950157|NCT01986348|449443571|FG000|Overall Study|Death|8|||
124950158|NCT01986348|449443572|FG001|Overall Study|Death|22|||
124950159|NCT01986348|449443573|FG002|Overall Study|Death|10|||
124950160|NCT01986348|449443574|FG003|Overall Study|Death|21|||
125215019|NCT03026283|450414894|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
124950161|NCT01986348|449443571|FG000|Overall Study|Lost to Follow-up|0|||
124950162|NCT01986348|449443572|FG001|Overall Study|Lost to Follow-up|0|||
124950163|NCT01986348|449443573|FG002|Overall Study|Lost to Follow-up|0|||
124950164|NCT01986348|449443574|FG003|Overall Study|Lost to Follow-up|2|||
124950165|NCT01986348|449443571|FG000|Overall Study|Physician Decision|0|||
124950166|NCT01986348|449443572|FG001|Overall Study|Physician Decision|0|||
124950167|NCT01986348|449443573|FG002|Overall Study|Physician Decision|0|||
124950168|NCT01986348|449443574|FG003|Overall Study|Physician Decision|1|||
124950169|NCT01986348|449443571|FG000|Overall Study|Progressive Disease|0|||
124950170|NCT01986348|449443572|FG001|Overall Study|Progressive Disease|0|||
124950171|NCT01986348|449443573|FG002|Overall Study|Progressive Disease|2|||
124950172|NCT01986348|449443574|FG003|Overall Study|Progressive Disease|0|||
124950173|NCT01986348|449443571|FG000|Overall Study|Withdrawal by Participant|0|||
124950174|NCT01986348|449443572|FG001|Overall Study|Withdrawal by Participant|1|||
124950175|NCT01986348|449443573|FG002|Overall Study|Withdrawal by Participant|2|||
124950176|NCT01986348|449443574|FG003|Overall Study|Withdrawal by Participant|1|||
124950177|NCT01986348|449443571|FG000|Overall Study|Study Terminated by Sponsor|0|||
124950178|NCT01986348|449443572|FG001|Overall Study|Study Terminated by Sponsor|0|||
124950179|NCT01986348|449443573|FG002|Overall Study|Study Terminated by Sponsor|0|||
124950180|NCT01986348|449443574|FG003|Overall Study|Study Terminated by Sponsor|3|||
124950181|NCT01986348|449443571|FG000|Overall Study|Other-unspecified|0|||
124950182|NCT01986348|449443572|FG001|Overall Study|Other-unspecified|1|||
124950183|NCT01986348|449443573|FG002|Overall Study|Other-unspecified|0|||
124950184|NCT01986348|449443574|FG003|Overall Study|Other-unspecified|2|||
124950185|NCT02935894|449443579|FG000|Overall Study|Subject dismissed|1|||
124950186|NCT00853957|449443580|FG000|Overall Study|Adverse Event|9|||
124950187|NCT00853957|449443581|FG001|Overall Study|Adverse Event|3|||
124950188|NCT00853957|449443580|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124950189|NCT00853957|449443581|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124950190|NCT00853957|449443580|FG000|Overall Study|Subject withdrew consent|4|||
124950191|NCT00853957|449443581|FG001|Overall Study|Subject withdrew consent|5|||
124950192|NCT00853957|449443580|FG000|Overall Study|Lost to Follow-up|1|||
124950193|NCT00853957|449443581|FG001|Overall Study|Lost to Follow-up|6|||
124950194|NCT00853957|449443580|FG000|Overall Study|Protocol deviation|0|||
124950195|NCT00853957|449443581|FG001|Overall Study|Protocol deviation|3|||
124950196|NCT02158806|449443582|FG000|Overall Study|Death|2|||
124950197|NCT02158806|449443583|FG001|Overall Study|Death|0|||
124950198|NCT02158806|449443582|FG000|Overall Study|Withdrawal by Subject|2|||
124950199|NCT02158806|449443583|FG001|Overall Study|Withdrawal by Subject|0|||
124950200|NCT02158806|449443582|FG000|Overall Study|Lost to Follow-up|0|||
124950201|NCT02158806|449443583|FG001|Overall Study|Lost to Follow-up|3|||
124950202|NCT02158806|449443582|FG000|Overall Study|Moved out of area|0|||
124950203|NCT02158806|449443583|FG001|Overall Study|Moved out of area|1|||
124950204|NCT02158806|449443582|FG000|Overall Study|Transferred to palliative care|0|||
124950205|NCT02158806|449443583|FG001|Overall Study|Transferred to palliative care|1|||
124950206|NCT01898299|449443587|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
124950207|NCT01898299|449443588|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
124950208|NCT04895085|449443589|FG000|Overall Study|Death|1|||
124950209|NCT04895085|449443589|FG000|Overall Study|Withdrawal by Subject|1|||
124950210|NCT04895085|449443589|FG000|Overall Study|No longer eligible: Moved from area|1|||
124950211|NCT04919499|449443590|FG000|Overall Study|Adverse Event|0|||
124950212|NCT04919499|449443591|FG001|Overall Study|Adverse Event|0|||
124950213|NCT04919499|449443592|FG002|Overall Study|Adverse Event|0|||
124950214|NCT04919499|449443593|FG003|Overall Study|Adverse Event|0|||
124950215|NCT04919499|449443594|FG004|Overall Study|Adverse Event|2|||
124950216|NCT04919499|449443590|FG000|Overall Study|Not treated|0|||
124950217|NCT04919499|449443591|FG001|Overall Study|Not treated|0|||
124950218|NCT04919499|449443592|FG002|Overall Study|Not treated|0|||
124950219|NCT04919499|449443593|FG003|Overall Study|Not treated|1|||
124950220|NCT04919499|449443594|FG004|Overall Study|Not treated|0|||
124950221|NCT04520256|449443598|FG000|Overall Study|Lost to Follow-up|6|||
124950222|NCT04520256|449443599|FG001|Overall Study|Lost to Follow-up|4|||
124950223|NCT04520256|449443600|FG002|Overall Study|Lost to Follow-up|2|||
124950224|NCT04520256|449443601|FG003|Overall Study|Lost to Follow-up|3|||
124950225|NCT04520256|449443602|FG004|Overall Study|Lost to Follow-up|6|||
124950226|NCT04520256|449443603|FG005|Overall Study|Lost to Follow-up|6|||
124950227|NCT04520256|449443604|FG006|Overall Study|Lost to Follow-up|4|||
124950228|NCT04520256|449443605|FG007|Overall Study|Lost to Follow-up|6|||
124950229|NCT04520256|449443606|FG008|Overall Study|Lost to Follow-up|1|||
124950230|NCT04520256|449443607|FG009|Overall Study|Lost to Follow-up|3|||
124950231|NCT04520256|449443608|FG010|Overall Study|Lost to Follow-up|3|||
124950232|NCT04520256|449443609|FG011|Overall Study|Lost to Follow-up|2|||
124950233|NCT04520256|449443610|FG012|Overall Study|Lost to Follow-up|5|||
124950234|NCT04520256|449443611|FG013|Overall Study|Lost to Follow-up|3|||
124950235|NCT04520256|449443612|FG014|Overall Study|Lost to Follow-up|3|||
124950236|NCT04520256|449443613|FG015|Overall Study|Lost to Follow-up|6|||
124950237|NCT04520256|449443614|FG016|Overall Study|Lost to Follow-up|6|||
124950238|NCT04520256|449443615|FG017|Overall Study|Lost to Follow-up|4|||
124950239|NCT04520256|449443616|FG018|Overall Study|Lost to Follow-up|3|||
124950240|NCT04520256|449443617|FG019|Overall Study|Lost to Follow-up|3|||
124950241|NCT04520256|449443618|FG020|Overall Study|Lost to Follow-up|7|||
124950242|NCT04520256|449443619|FG021|Overall Study|Lost to Follow-up|3|||
124950243|NCT04520256|449443620|FG022|Overall Study|Lost to Follow-up|3|||
124950244|NCT04520256|449443621|FG023|Overall Study|Lost to Follow-up|8|||
124950245|NCT04520256|449443622|FG024|Overall Study|Lost to Follow-up|5|||
124950246|NCT04520256|449443623|FG025|Overall Study|Lost to Follow-up|4|||
124950247|NCT04520256|449443624|FG026|Overall Study|Lost to Follow-up|3|||
124950248|NCT04520256|449443625|FG027|Overall Study|Lost to Follow-up|4|||
124950249|NCT04520256|449443626|FG028|Overall Study|Lost to Follow-up|3|||
124950250|NCT04520256|449443627|FG029|Overall Study|Lost to Follow-up|4|||
124950251|NCT04520256|449443628|FG030|Overall Study|Lost to Follow-up|4|||
124950252|NCT04520256|449443629|FG031|Overall Study|Lost to Follow-up|4|||
124950253|NCT03786471|449443630|FG000|Overall Study|Death|254|||
124950254|NCT03786471|449443631|FG001|Overall Study|Death|223|||
124950255|NCT03786471|449443632|FG002|Overall Study|Death|37|||
124950256|NCT03786471|449443630|FG000|Overall Study|Lost to Follow-up|63|||
124950257|NCT03786471|449443631|FG001|Overall Study|Lost to Follow-up|50|||
124950258|NCT03786471|449443632|FG002|Overall Study|Lost to Follow-up|15|||
124950259|NCT03786471|449443630|FG000|Overall Study|Withdrawal by Subject|99|||
124950260|NCT03786471|449443631|FG001|Overall Study|Withdrawal by Subject|81|||
124950261|NCT03786471|449443632|FG002|Overall Study|Withdrawal by Subject|11|||
124969599|NCT03520075|449517417|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969600|NCT03520075|449517418|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969601|NCT03520075|449517419|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969602|NCT03520075|449517420|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969603|NCT03520075|449517421|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969604|NCT03520075|449517422|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969605|NCT03520075|449517423|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
124969606|NCT03520075|449517424|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
124969607|NCT03520075|449517425|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969608|NCT03520075|449517426|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969609|NCT03520075|449517427|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
124969610|NCT03520075|449517409|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969611|NCT03520075|449517410|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969612|NCT03520075|449517411|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969613|NCT03520075|449517412|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969614|NCT03520075|449517413|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969615|NCT03520075|449517414|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969616|NCT03520075|449517415|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969617|NCT03520075|449517416|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969618|NCT03520075|449517417|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969619|NCT03520075|449517418|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969620|NCT03520075|449517419|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969621|NCT03520075|449517420|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969622|NCT03520075|449517421|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969623|NCT03520075|449517422|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
124969624|NCT03520075|449517423|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969625|NCT03520075|449517424|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969626|NCT03520075|449517425|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
124969627|NCT03520075|449517426|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
124969628|NCT03520075|449517427|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969629|NCT05382039|449517428|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
124969630|NCT05382039|449517429|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
124969631|NCT05382039|449517430|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
124969632|NCT05382039|449517428|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
124969633|NCT05382039|449517429|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
124969634|NCT05382039|449517430|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
124969635|NCT05382039|449517428|FG000|Overall Study|waiting for confirmation|0|||
124969636|NCT05382039|449517429|FG001|Overall Study|waiting for confirmation|0|||
124969637|NCT05382039|449517430|FG002|Overall Study|waiting for confirmation|1|||
124969638|NCT01432626|449517431|FG000|Overall Study|LV function recovered|2|||
124969639|NCT01432626|449517431|FG000|Overall Study|Withdrawal by Subject|2|||
124969640|NCT01432626|449517431|FG000|Overall Study|Only 1 image competed|2|||
124969641|NCT01432626|449517431|FG000|Overall Study|Imaging agent not available|1|||
125124619|NCT00090857|450082389|FG000|Overall Study|Adverse Event|2|||
125124620|NCT00090857|450082390|FG001|Overall Study|Adverse Event|2|||
125124621|NCT05097326|450082391|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
125124622|NCT05097326|450082392|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
125124623|NCT02684344|450082393|FG000|Overall Study|Withdrawal by Subject|0|||
125124624|NCT02684344|450082394|FG001|Overall Study|Withdrawal by Subject|1|||
125124625|NCT03480425|450082395|FG000|Overall Study|Force transducer technical failure|1|||
125124626|NCT02424188|450082396|FG000|Overall Study|Death|2|||
125124627|NCT02424188|450082397|FG001|Overall Study|Death|2|||
125124628|NCT02424188|450082396|FG000|Overall Study|Lost to Follow-up|1|||
125124629|NCT02424188|450082397|FG001|Overall Study|Lost to Follow-up|3|||
125124630|NCT02424188|450082396|FG000|Overall Study|Incarceration|1|||
125124631|NCT02424188|450082397|FG001|Overall Study|Incarceration|0|||
125124632|NCT00630305|450082398|FG000|Overall Study|Withdrawal by Subject|1|||
125124633|NCT00630305|450082398|FG000|Overall Study|Inability to insert contact lens|1|||
125215020|NCT03026283|450414895|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
125215021|NCT03026283|450414896|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
124950262|NCT04369664|449445336|FG000|Overall Study|Physician Decision|1|||
124950263|NCT04369664|449445337|FG001|Overall Study|Physician Decision|0|||
124950264|NCT03840200|449445338|FG000|Overall Study|Death|6|||
124950265|NCT03840200|449445339|FG001|Overall Study|Death|3|||
124950266|NCT03840200|449445340|FG002|Overall Study|Death|6|||
124950267|NCT03840200|449445341|FG003|Overall Study|Death|10|||
124950268|NCT03840200|449445338|FG000|Overall Study|Reason Not Specified|2|||
124950269|NCT03840200|449445339|FG001|Overall Study|Reason Not Specified|2|||
124950270|NCT03840200|449445340|FG002|Overall Study|Reason Not Specified|1|||
124950271|NCT03840200|449445341|FG003|Overall Study|Reason Not Specified|15|||
124950272|NCT03840200|449445338|FG000|Overall Study|Physician Decision|0|||
124950273|NCT03840200|449445339|FG001|Overall Study|Physician Decision|0|||
124950274|NCT03840200|449445340|FG002|Overall Study|Physician Decision|0|||
124950275|NCT03840200|449445341|FG003|Overall Study|Physician Decision|2|||
124950276|NCT03840200|449445338|FG000|Overall Study|Progressive Disease|0|||
124950277|NCT03840200|449445339|FG001|Overall Study|Progressive Disease|0|||
124950278|NCT03840200|449445340|FG002|Overall Study|Progressive Disease|0|||
124950279|NCT03840200|449445341|FG003|Overall Study|Progressive Disease|1|||
124950280|NCT03840200|449445338|FG000|Overall Study|Withdrawal by Subject|0|||
124950281|NCT03840200|449445339|FG001|Overall Study|Withdrawal by Subject|1|||
124950282|NCT03840200|449445340|FG002|Overall Study|Withdrawal by Subject|0|||
124950283|NCT03840200|449445341|FG003|Overall Study|Withdrawal by Subject|2|||
124950284|NCT05487300|449445346|FG000|Overall Study|Withdrawal by Subject|1|||
124950285|NCT05487300|449445347|FG001|Overall Study|Withdrawal by Subject|0|||
124950286|NCT02880293|449445350|FG000|Overall Study|Inevaluable|5|||
124950287|NCT00264576|449445351|FG000|Overall Study|Lost to Follow-up|1|||
124950288|NCT00264576|449445352|FG001|Overall Study|Lost to Follow-up|1|||
124950289|NCT03976102|449445357|FG000|Overall Study|Withdrawal by Subject|4|||
124950290|NCT03976102|449445358|FG001|Overall Study|Withdrawal by Subject|4|||
124950291|NCT03976102|449445357|FG000|Overall Study|Adverse Event|2|||
124950292|NCT03976102|449445358|FG001|Overall Study|Adverse Event|4|||
124950293|NCT03976102|449445357|FG000|Overall Study|Not related to Covid-19|9|||
124950294|NCT03976102|449445358|FG001|Overall Study|Not related to Covid-19|13|||
124950295|NCT03976102|449445357|FG000|Overall Study|Lost to Follow-up|0|||
124950296|NCT03976102|449445358|FG001|Overall Study|Lost to Follow-up|2|||
124950297|NCT03976102|449445357|FG000|Overall Study|Death|3|||
124950298|NCT03976102|449445358|FG001|Overall Study|Death|2|||
124950299|NCT03976102|449445357|FG000|Overall Study|Physician Decision|1|||
124950300|NCT03976102|449445358|FG001|Overall Study|Physician Decision|1|||
124950301|NCT00092456|449445364|FG000|Overall Study|Adverse Event|0|||
124950302|NCT00092456|449445365|FG001|Overall Study|Adverse Event|0|||
124950303|NCT00092456|449445366|FG002|Overall Study|Adverse Event|1|||
125124634|NCT01494506|450082399|FG000|Overall Study|Lack of Efficacy|77|||
125124635|NCT01494506|450082400|FG001|Overall Study|Lack of Efficacy|83|||
125124636|NCT01494506|450082401|FG002|Overall Study|Lack of Efficacy|57|||
125124637|NCT01494506|450082399|FG000|Overall Study|Adverse Event|17|||
125124638|NCT01494506|450082400|FG001|Overall Study|Adverse Event|10|||
125124639|NCT01494506|450082401|FG002|Overall Study|Adverse Event|11|||
125124640|NCT01494506|450082399|FG000|Overall Study|Death|9|||
125124641|NCT01494506|450082400|FG001|Overall Study|Death|5|||
125124642|NCT01494506|450082401|FG002|Overall Study|Death|2|||
125124643|NCT01494506|450082399|FG000|Overall Study|Physician Decision|7|||
125124644|NCT01494506|450082400|FG001|Overall Study|Physician Decision|5|||
125124645|NCT01494506|450082401|FG002|Overall Study|Physician Decision|4|||
125124646|NCT01494506|450082399|FG000|Overall Study|Withdrawal by Subject|17|||
125124647|NCT01494506|450082400|FG001|Overall Study|Withdrawal by Subject|20|||
125124648|NCT01494506|450082401|FG002|Overall Study|Withdrawal by Subject|14|||
125124649|NCT01494506|450082399|FG000|Overall Study|Clinical Deterioration|21|||
125124650|NCT01494506|450082400|FG001|Overall Study|Clinical Deterioration|17|||
125124651|NCT01494506|450082401|FG002|Overall Study|Clinical Deterioration|13|||
125124652|NCT01494506|450082399|FG000|Overall Study|Sponsor Decision|0|||
125124653|NCT01494506|450082400|FG001|Overall Study|Sponsor Decision|0|||
124950304|NCT00092456|449445367|FG003|Overall Study|Adverse Event|1|||
125124654|NCT01494506|450082401|FG002|Overall Study|Sponsor Decision|1|||
124950305|NCT00092456|449445364|FG000|Overall Study|Lost to Follow-up|2|||
124950306|NCT00092456|449445365|FG001|Overall Study|Lost to Follow-up|2|||
124950307|NCT00092456|449445366|FG002|Overall Study|Lost to Follow-up|1|||
124950308|NCT00092456|449445367|FG003|Overall Study|Lost to Follow-up|2|||
124950309|NCT00092456|449445364|FG000|Overall Study|Protocol Violation|5|||
125124655|NCT01494506|450082399|FG000|Overall Study|Other|0|||
125124656|NCT01494506|450082400|FG001|Overall Study|Other|3|||
125124657|NCT01494506|450082401|FG002|Overall Study|Other|1|||
125124658|NCT03100903|450082413|FG000|Overall Study|Withdrawal by Subject|0|||
124950310|NCT00092456|449445365|FG001|Overall Study|Protocol Violation|7|||
124950311|NCT00092456|449445366|FG002|Overall Study|Protocol Violation|8|||
124950312|NCT00092456|449445367|FG003|Overall Study|Protocol Violation|6|||
124950313|NCT00092456|449445364|FG000|Overall Study|Withdrawal by Subject|13|||
124950314|NCT00092456|449445365|FG001|Overall Study|Withdrawal by Subject|5|||
125124659|NCT03100903|450082414|FG001|Overall Study|Withdrawal by Subject|0|||
125124660|NCT03100903|450082415|FG002|Overall Study|Withdrawal by Subject|1|||
124950315|NCT00092456|449445366|FG002|Overall Study|Withdrawal by Subject|16|||
124950316|NCT00092456|449445367|FG003|Overall Study|Withdrawal by Subject|6|||
124950317|NCT00092456|449445364|FG000|Overall Study|Moved|1|||
124950318|NCT00092456|449445365|FG001|Overall Study|Moved|1|||
124950319|NCT00092456|449445366|FG002|Overall Study|Moved|0|||
124950320|NCT00092456|449445367|FG003|Overall Study|Moved|1|||
124950321|NCT00092456|449445364|FG000|Overall Study|Other|4|||
124950322|NCT00092456|449445365|FG001|Overall Study|Other|2|||
124950323|NCT00092456|449445366|FG002|Overall Study|Other|3|||
124950324|NCT00092456|449445367|FG003|Overall Study|Other|0|||
124950325|NCT04783389|449445368|FG000|Overall Study|Withdrawal by Subject|2|||
124950326|NCT04783389|449445369|FG001|Overall Study|Withdrawal by Subject|0|||
124950327|NCT04783389|449445370|FG002|Overall Study|Withdrawal by Subject|0|||
124950328|NCT04783389|449445368|FG000|Overall Study|Termination of Study by Sponsor|10|||
124950329|NCT04783389|449445369|FG001|Overall Study|Termination of Study by Sponsor|12|||
124950330|NCT04783389|449445370|FG002|Overall Study|Termination of Study by Sponsor|14|||
124950331|NCT00451906|449445371|FG000|Overall Study|Adverse Event|515|||
124950332|NCT00451906|449445371|FG000|Overall Study|Lost to Follow-up|31|||
124950333|NCT00451906|449445371|FG000|Overall Study|Withdrawal by Subject|111|||
124950334|NCT00451906|449445371|FG000|Overall Study|Protocol Violation|21|||
124950335|NCT00451906|449445371|FG000|Overall Study|Progressive disease|1328|||
124950336|NCT00451906|449445371|FG000|Overall Study|Termination of the study|108|||
124950337|NCT00451906|449445371|FG000|Overall Study|Other Reasons|121|||
124950338|NCT00451906|449445371|FG000|Overall Study|Did not complete final visit|4|||
124950339|NCT02121808|449445373|FG000|Overall Study|Technical problem|3|||
124950340|NCT04820023|449445378|FG000|Overall Study|Death|0|||
124950341|NCT04820023|449445379|FG001|Overall Study|Death|0|||
124950342|NCT04820023|449445380|FG002|Overall Study|Death|0|||
124950343|NCT04820023|449445381|FG003|Overall Study|Death|0|||
124950344|NCT04820023|449445382|FG004|Overall Study|Death|0|||
124950345|NCT04820023|449445383|FG005|Overall Study|Death|0|||
124950346|NCT04820023|449445384|FG006|Overall Study|Death|1|||
124950347|NCT04820023|449445385|FG007|Overall Study|Death|0|||
124950348|NCT04820023|449445386|FG008|Overall Study|Death|1|||
124950349|NCT04820023|449445378|FG000|Overall Study|Withdrawal by Subject|1|||
124950350|NCT04820023|449445379|FG001|Overall Study|Withdrawal by Subject|2|||
124950351|NCT04820023|449445380|FG002|Overall Study|Withdrawal by Subject|2|||
124950352|NCT04820023|449445381|FG003|Overall Study|Withdrawal by Subject|1|||
124950353|NCT04820023|449445382|FG004|Overall Study|Withdrawal by Subject|4|||
124950354|NCT04820023|449445383|FG005|Overall Study|Withdrawal by Subject|3|||
124950355|NCT04820023|449445384|FG006|Overall Study|Withdrawal by Subject|3|||
124950356|NCT04820023|449445385|FG007|Overall Study|Withdrawal by Subject|6|||
124950357|NCT04820023|449445386|FG008|Overall Study|Withdrawal by Subject|5|||
124950358|NCT04820023|449445378|FG000|Overall Study|Progressive Disease|3|||
124950359|NCT04820023|449445379|FG001|Overall Study|Progressive Disease|0|||
124950360|NCT04820023|449445380|FG002|Overall Study|Progressive Disease|2|||
124950361|NCT04820023|449445381|FG003|Overall Study|Progressive Disease|2|||
124950362|NCT04820023|449445382|FG004|Overall Study|Progressive Disease|2|||
124950363|NCT04820023|449445383|FG005|Overall Study|Progressive Disease|0|||
124950364|NCT04820023|449445384|FG006|Overall Study|Progressive Disease|1|||
124950365|NCT04820023|449445385|FG007|Overall Study|Progressive Disease|1|||
124950366|NCT04820023|449445386|FG008|Overall Study|Progressive Disease|0|||
124950367|NCT04820023|449445378|FG000|Overall Study|New anti-cancer therapy|0|||
124950368|NCT04820023|449445379|FG001|Overall Study|New anti-cancer therapy|0|||
124950369|NCT04820023|449445380|FG002|Overall Study|New anti-cancer therapy|0|||
124950370|NCT04820023|449445381|FG003|Overall Study|New anti-cancer therapy|0|||
124950371|NCT04820023|449445382|FG004|Overall Study|New anti-cancer therapy|2|||
124950372|NCT04820023|449445383|FG005|Overall Study|New anti-cancer therapy|0|||
124950373|NCT04820023|449445384|FG006|Overall Study|New anti-cancer therapy|0|||
124950374|NCT04820023|449445385|FG007|Overall Study|New anti-cancer therapy|0|||
124950375|NCT04820023|449445386|FG008|Overall Study|New anti-cancer therapy|0|||
124950376|NCT04820023|449445378|FG000|Overall Study|Other|0|||
124950377|NCT04820023|449445379|FG001|Overall Study|Other|1|||
124950378|NCT04820023|449445380|FG002|Overall Study|Other|0|||
124950379|NCT04820023|449445381|FG003|Overall Study|Other|0|||
125029860|NCT04188197|449732700|FG000|Overall Study|Withdrawal by Subject|1|||
125029861|NCT04188197|449732701|FG001|Overall Study|Withdrawal by Subject|1|||
125029862|NCT04188197|449732700|FG000|Overall Study|Pregnancy|0|||
125029863|NCT04188197|449732701|FG001|Overall Study|Pregnancy|1|||
125029864|NCT02107703|449732702|FG000|Overall Study|Withdrawal by Subject|46|||
124950380|NCT04820023|449445382|FG004|Overall Study|Other|0|||
124950381|NCT04820023|449445383|FG005|Overall Study|Other|0|||
124950382|NCT04820023|449445384|FG006|Overall Study|Other|0|||
124950383|NCT04820023|449445385|FG007|Overall Study|Other|2|||
124950384|NCT04820023|449445386|FG008|Overall Study|Other|0|||
124950385|NCT05066230|449445387|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
124950386|NCT05066230|449445388|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
124950387|NCT05066230|449445387|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
124950388|NCT05066230|449445388|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
125215022|NCT03026283|450414897|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
124950389|NCT05066230|449445387|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
124950390|NCT05066230|449445388|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
124950391|NCT05066230|449445387|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
124950392|NCT05066230|449445388|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
124950393|NCT05066230|449445387|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
124950394|NCT05066230|449445388|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
124950395|NCT05066230|449445387|FG000|After Week 48|Adverse Event|1|||
124950396|NCT05066230|449445388|FG001|After Week 48|Adverse Event|0|||
124950397|NCT05066230|449445387|FG000|After Week 48|Non-compliance with study schedule|1|||
124950398|NCT05066230|449445388|FG001|After Week 48|Non-compliance with study schedule|0|||
124950399|NCT05066230|449445387|FG000|After Week 48|Withdrawal by Subject|0|||
124950400|NCT05066230|449445388|FG001|After Week 48|Withdrawal by Subject|1|||
124950401|NCT05066230|449445387|FG000|After Week 48|Lost to Follow-up|3|||
124950402|NCT05066230|449445388|FG001|After Week 48|Lost to Follow-up|3|||
124950403|NCT05066230|449445387|FG000|After Week 48|Sponsor Request|115|||
124950404|NCT05066230|449445388|FG001|After Week 48|Sponsor Request|111|||
124950405|NCT02164578|449445389|FG000|Treatment Period|Withdrawal by Subject|3|||
124950406|NCT02164578|449445390|FG001|Treatment Period|Withdrawal by Subject|3|||
124950407|NCT02164578|449445389|FG000|Treatment Period|Adverse Event|13|||
124950408|NCT02164578|449445390|FG001|Treatment Period|Adverse Event|6|||
124950409|NCT02164578|449445389|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
124950410|NCT02164578|449445390|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
124950411|NCT02164578|449445389|FG000|Treatment Period|Protocol Violation|0|||
124950412|NCT02164578|449445390|FG001|Treatment Period|Protocol Violation|2|||
125124661|NCT00433147|450082416|FG000|Overall Study|Adverse Event|0|||
125124662|NCT00433147|450082417|FG001|Overall Study|Adverse Event|1|||
125124663|NCT00433147|450082418|FG002|Overall Study|Adverse Event|0|||
125124664|NCT00433147|450082419|FG003|Overall Study|Adverse Event|0|||
125124665|NCT01882647|450082420|FG000|Overall Study|Lost to Follow-up|2|||
125124666|NCT01882647|450082421|FG001|Overall Study|Lost to Follow-up|2|||
125124667|NCT01882647|450082420|FG000|Overall Study|Withdrawal by Subject|0|||
125124668|NCT01882647|450082421|FG001|Overall Study|Withdrawal by Subject|4|||
125124669|NCT03311646|450082424|FG000|Overall Study|Physician Decision|1|||
125124670|NCT03311646|450082424|FG000|Overall Study|Withdrawal by Subject|5|||
125124671|NCT03311646|450082424|FG000|Overall Study|Lost to Follow-up|5|||
125124672|NCT03311646|450082424|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
125124673|NCT01492361|450082425|FG000|Overall Study|Withdrawal by Subject|281|||
125124674|NCT01492361|450082426|FG001|Overall Study|Withdrawal by Subject|297|||
125124675|NCT01492361|450082425|FG000|Overall Study|Physician Decision|12|||
125124676|NCT01492361|450082426|FG001|Overall Study|Physician Decision|12|||
125124677|NCT01492361|450082425|FG000|Overall Study|Lost to Follow-up|6|||
125124678|NCT01492361|450082426|FG001|Overall Study|Lost to Follow-up|13|||
125124679|NCT01492361|450082425|FG000|Overall Study|Other than specified above|106|||
125124680|NCT01492361|450082426|FG001|Overall Study|Other than specified above|138|||
125124681|NCT03444038|450082427|FG000|Overall Study|Adverse Event|12|||
125124682|NCT03444038|450082427|FG000|Overall Study|Withdrawal by Subject|7|||
125124683|NCT03444038|450082427|FG000|Overall Study|Lost to Follow-up|1|||
125124684|NCT03444038|450082427|FG000|Overall Study|Physician Decision|2|||
125124685|NCT03444038|450082427|FG000|Overall Study|Lack of Efficacy|7|||
125124686|NCT00728949|450082438|FG000|Overall Study|Adverse Event|8|||
125124687|NCT00728949|450082439|FG001|Overall Study|Adverse Event|0|||
125124688|NCT00728949|450082438|FG000|Overall Study|Withdrawal by Subject|2|||
125124689|NCT00728949|450082439|FG001|Overall Study|Withdrawal by Subject|2|||
125124690|NCT00728949|450082438|FG000|Overall Study|Abnormal Lab Results|0|||
125124691|NCT00728949|450082439|FG001|Overall Study|Abnormal Lab Results|2|||
125124692|NCT00728949|450082438|FG000|Overall Study|On treatment at cutoff date|1|||
125124693|NCT00728949|450082439|FG001|Overall Study|On treatment at cutoff date|0|||
125124694|NCT03127137|450082441|FG000|Overall Study|Requested sedation after consent|1|||
125124695|NCT03127137|450082442|FG001|Overall Study|Requested sedation after consent|0|||
125124696|NCT03127137|450082441|FG000|Overall Study|Malfunction in electronic data collection|1|||
125124697|NCT03127137|450082442|FG001|Overall Study|Malfunction in electronic data collection|0|||
125124698|NCT03127137|450082441|FG000|Overall Study|Post procedure testing could not be obtained|0|||
125124699|NCT03127137|450082442|FG001|Overall Study|Post procedure testing could not be obtained|1|||
125124700|NCT01996033|450082443|FG000|Overall Study|Death|1|||
125124701|NCT01996033|450082443|FG000|Overall Study|Physician Decision|1|||
125124702|NCT01996033|450082443|FG000|Overall Study|Withdrawal by Subject|4|||
125124703|NCT01996033|450082443|FG000|Overall Study|Lost to Follow-up|3|||
124950413|NCT02164578|449445389|FG000|Extension Period|Withdrawal by Subject|2|||
124950414|NCT02164578|449445390|FG001|Extension Period|Withdrawal by Subject|0|||
124950415|NCT02164578|449445389|FG000|Extension Period|Adverse Event|4|||
124950416|NCT02164578|449445390|FG001|Extension Period|Adverse Event|0|||
124950417|NCT02164578|449445389|FG000|Extension Period|Expiry of study medication|1|||
124950418|NCT02164578|449445390|FG001|Extension Period|Expiry of study medication|0|||
124950419|NCT02164578|449445389|FG000|Extension Period|Protocol Violation|0|||
124950420|NCT02164578|449445390|FG001|Extension Period|Protocol Violation|1|||
124950421|NCT02507297|449445391|FG000|Overall Study|Withdrawal by Subject|1|||
124950422|NCT02507297|449445392|FG001|Overall Study|Withdrawal by Subject|0|||
124950423|NCT02507297|449445391|FG000|Overall Study|Lost to Follow-up|0|||
124950424|NCT02507297|449445392|FG001|Overall Study|Lost to Follow-up|1|||
124950425|NCT01018992|449445393|FG000|Overall Study|Adverse Event|8|||
124950426|NCT01018992|449445394|FG001|Overall Study|Adverse Event|3|||
124950427|NCT01018992|449445393|FG000|Overall Study|Withdrawal by Subject|3|||
124950428|NCT01018992|449445394|FG001|Overall Study|Withdrawal by Subject|8|||
124950429|NCT01018992|449445393|FG000|Overall Study|Protocol Violation|0|||
124950430|NCT01018992|449445394|FG001|Overall Study|Protocol Violation|4|||
124950431|NCT01018992|449445393|FG000|Overall Study|Lost to Follow-up|5|||
124950432|NCT01018992|449445394|FG001|Overall Study|Lost to Follow-up|1|||
124950433|NCT03029585|449445395|FG000|Overall Study|Death|1|||
124950434|NCT03029585|449445396|FG001|Overall Study|Death|1|||
124950435|NCT03029585|449445395|FG000|Overall Study|Withdrawal by Subject|1|||
124950436|NCT03029585|449445396|FG001|Overall Study|Withdrawal by Subject|0|||
124950437|NCT02092285|449445397|FG000|Induction Phase|Adverse Event|7|||
124950438|NCT02092285|449445397|FG000|Induction Phase|Physician Decision|4|||
124950439|NCT02092285|449445397|FG000|Induction Phase|Pregnancy|1|||
124950440|NCT02092285|449445397|FG000|Induction Phase|Relapse/Recurrence|7|||
124950441|NCT02092285|449445397|FG000|Induction Phase|Withdrawal by Subject|2|||
124950442|NCT02092285|449445397|FG000|Induction Phase|Lack of Efficacy|14|||
124950443|NCT02092285|449445397|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
124950444|NCT02092285|449445397|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
124950445|NCT02092285|449445397|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
124950446|NCT02092285|449445397|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
124950447|NCT02092285|449445397|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
124950448|NCT02092285|449445397|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
124950449|NCT02092285|449445397|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
124950450|NCT02092285|449445397|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
124950451|NCT02092285|449445397|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
124950452|NCT01825785|449445398|FG000|Overall Study|Adverse Event|0|||
124950453|NCT01825785|449445399|FG001|Overall Study|Adverse Event|0|||
124950454|NCT01825785|449445400|FG002|Overall Study|Adverse Event|0|||
124950455|NCT01825785|449445401|FG003|Overall Study|Adverse Event|0|||
124950456|NCT01825785|449445402|FG004|Overall Study|Adverse Event|1|||
125029865|NCT02107703|449732703|FG001|Overall Study|Withdrawal by Subject|21|||
125029866|NCT02107703|449732702|FG000|Overall Study|Lost to Follow-up|20|||
125029867|NCT02107703|449732703|FG001|Overall Study|Lost to Follow-up|9|||
125029868|NCT02107703|449732702|FG000|Overall Study|On study treatment/follow up|48|||
125029869|NCT02107703|449732703|FG001|Overall Study|On study treatment/follow up|5|||
125029870|NCT04574999|449732704|FG000|Overall Study|Adverse Event|1|||
125029871|NCT04574999|449732705|FG001|Overall Study|Adverse Event|0|||
125029872|NCT04574999|449732704|FG000|Overall Study|Lack of Efficacy|2|||
125029873|NCT04574999|449732705|FG001|Overall Study|Lack of Efficacy|3|||
125029874|NCT04574999|449732704|FG000|Overall Study|Protocol Violation|1|||
125029875|NCT04574999|449732705|FG001|Overall Study|Protocol Violation|0|||
125029876|NCT04574999|449732704|FG000|Overall Study|Withdrawal by Subject|2|||
125029877|NCT04574999|449732705|FG001|Overall Study|Withdrawal by Subject|2|||
125029878|NCT04574999|449732704|FG000|Overall Study|Lost to Follow-up|1|||
125029879|NCT04574999|449732705|FG001|Overall Study|Lost to Follow-up|0|||
125029880|NCT04574999|449732704|FG000|Overall Study|Personal problems|1|||
125029881|NCT04574999|449732705|FG001|Overall Study|Personal problems|0|||
125029882|NCT04574999|449732704|FG000|Overall Study|Previous planned surgery|1|||
125029883|NCT04574999|449732705|FG001|Overall Study|Previous planned surgery|0|||
125029884|NCT00008385|449732707|FG000|Overall Study|Off treatment reasons not reported|79|||
125029885|NCT00008385|449732708|FG001|Overall Study|Off treatment reasons not reported|70|||
125029886|NCT00008385|449732707|FG000|Overall Study|Progressive disease|52|||
125029887|NCT00008385|449732708|FG001|Overall Study|Progressive disease|117|||
125029888|NCT00008385|449732707|FG000|Overall Study|Adverse Event|8|||
125029889|NCT00008385|449732708|FG001|Overall Study|Adverse Event|20|||
125029890|NCT00008385|449732707|FG000|Overall Study|Death|12|||
125029891|NCT00008385|449732708|FG001|Overall Study|Death|18|||
124950457|NCT01825785|449445403|FG005|Overall Study|Adverse Event|0|||
125029892|NCT00008385|449732707|FG000|Overall Study|Withdrawal by Subject|67|||
125029893|NCT00008385|449732708|FG001|Overall Study|Withdrawal by Subject|157|||
125029894|NCT00008385|449732707|FG000|Overall Study|Start non-protocol therapy|3|||
124950458|NCT01825785|449445404|FG006|Overall Study|Adverse Event|0|||
124950459|NCT01825785|449445398|FG000|Overall Study|Withdrawal by Subject|0|||
125029895|NCT00008385|449732708|FG001|Overall Study|Start non-protocol therapy|1|||
125029896|NCT00008385|449732707|FG000|Overall Study|Other complicating disease|17|||
125029897|NCT00008385|449732708|FG001|Overall Study|Other complicating disease|30|||
125029898|NCT00008385|449732707|FG000|Overall Study|Maximum dose reached|0|||
125029899|NCT00008385|449732708|FG001|Overall Study|Maximum dose reached|2|||
124950460|NCT01825785|449445399|FG001|Overall Study|Withdrawal by Subject|0|||
125029900|NCT00008385|449732707|FG000|Overall Study|Other|105|||
125029901|NCT00008385|449732708|FG001|Overall Study|Other|212|||
125029902|NCT00008385|449732707|FG000|Overall Study|Not start protocol therapy|44|||
125029903|NCT00008385|449732708|FG001|Overall Study|Not start protocol therapy|175|||
125029904|NCT00398112|449732709|FG000|Overall Study|Adverse Event|4|||
125029905|NCT00398112|449732709|FG000|Overall Study|Disease progression|9|||
125029906|NCT00398112|449732709|FG000|Overall Study|Alternative treatment|1|||
125029907|NCT00398112|449732709|FG000|Overall Study|Withdrawal by Subject|3|||
125029908|NCT00398112|449732709|FG000|Overall Study|Death|1|||
125029909|NCT00365989|449732712|FG000|Overall Study|Withdrawal by Subject|1|||
125029910|NCT00365989|449732712|FG000|Overall Study|Non-compliance|1|||
125029911|NCT02318095|449732713|FG000|Overall Study|Adverse Event|1|||
125029912|NCT00686127|449732714|FG000|Overall Study|Withdrawal by Subject|14|||
125029913|NCT00686127|449732715|FG001|Overall Study|Withdrawal by Subject|6|||
125029914|NCT06441877|449732716|FG000|Overall Study|Withdrawal by Subject|0|||
125029915|NCT06441877|449732717|FG001|Overall Study|Withdrawal by Subject|2|||
125029916|NCT06441877|449732718|FG002|Overall Study|Withdrawal by Subject|0|||
125029917|NCT06441877|449732719|FG003|Overall Study|Withdrawal by Subject|0|||
125029918|NCT00066690|449732720|FG000|Overall Study|Adverse Event|145|||
125029919|NCT00066690|449732721|FG001|Overall Study|Adverse Event|58|||
125029920|NCT00066690|449732722|FG002|Overall Study|Adverse Event|126|||
125029921|NCT00066690|449732720|FG000|Overall Study|Death|3|||
125029922|NCT00066690|449732721|FG001|Overall Study|Death|0|||
125029923|NCT00066690|449732722|FG002|Overall Study|Death|2|||
125029924|NCT00066690|449732720|FG000|Overall Study|Lack of Efficacy|114|||
125029925|NCT00066690|449732721|FG001|Overall Study|Lack of Efficacy|110|||
125029926|NCT00066690|449732722|FG002|Overall Study|Lack of Efficacy|76|||
125029927|NCT00066690|449732720|FG000|Overall Study|Lost to Follow-up|40|||
125029928|NCT00066690|449732721|FG001|Overall Study|Lost to Follow-up|21|||
125029929|NCT00066690|449732722|FG002|Overall Study|Lost to Follow-up|29|||
125029930|NCT00066690|449732720|FG000|Overall Study|Withdrawal by Subject|50|||
125029931|NCT00066690|449732721|FG001|Overall Study|Withdrawal by Subject|55|||
125029932|NCT00066690|449732722|FG002|Overall Study|Withdrawal by Subject|49|||
125029933|NCT00066690|449732720|FG000|Overall Study|Treatment Ongoing|246|||
125029934|NCT00066690|449732721|FG001|Overall Study|Treatment Ongoing|278|||
125029935|NCT00066690|449732722|FG002|Overall Study|Treatment Ongoing|282|||
125029936|NCT03706365|449732726|FG000|Overall Study|Lost to Follow-up|7|||
125029937|NCT03706365|449732727|FG001|Overall Study|Lost to Follow-up|0|||
125029938|NCT03706365|449732726|FG000|Overall Study|Withdrawal by Subject|17|||
124950461|NCT01825785|449445400|FG002|Overall Study|Withdrawal by Subject|0|||
124950462|NCT01825785|449445401|FG003|Overall Study|Withdrawal by Subject|0|||
125029939|NCT03706365|449732727|FG001|Overall Study|Withdrawal by Subject|15|||
125029940|NCT03706365|449732726|FG000|Overall Study|On Study Treatment|51|||
125029941|NCT03706365|449732727|FG001|Overall Study|On Study Treatment|51|||
125029942|NCT02162862|449732728|FG000|Overall Study|Lost to Follow-up|0|||
124950463|NCT01825785|449445402|FG004|Overall Study|Withdrawal by Subject|1|||
124950464|NCT01825785|449445403|FG005|Overall Study|Withdrawal by Subject|1|||
124950465|NCT01825785|449445404|FG006|Overall Study|Withdrawal by Subject|0|||
124950466|NCT01304940|449445406|FG000|Overall Study|not meet symptom severity requirement|3|||
124950467|NCT01304940|449445407|FG001|Overall Study|not meet symptom severity requirement|0|||
124950468|NCT00278395|449445408|FG000|Overall Study|Adverse Event|2|||
124950469|NCT00278395|449445408|FG000|Overall Study|Nonevaluable|1|||
124950470|NCT03740737|449445411|FG000|Overall Study|Protocol deviation|13|||
125215023|NCT03026283|450414898|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
125215024|NCT03026283|450414899|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
124950471|NCT03740737|449445412|FG001|Overall Study|Protocol deviation|0|||
124950472|NCT03740737|449445411|FG000|Overall Study|Adverse Event|2|||
124950473|NCT03740737|449445412|FG001|Overall Study|Adverse Event|0|||
124950474|NCT03740737|449445411|FG000|Overall Study|Lost to Follow-up|1|||
125029943|NCT02162862|449732729|FG001|Overall Study|Lost to Follow-up|11|||
125029944|NCT02162862|449732730|FG002|Overall Study|Lost to Follow-up|0|||
125029945|NCT02162862|449732728|FG000|Overall Study|Subject did not feel the med was needed|0|||
125029946|NCT02162862|449732729|FG001|Overall Study|Subject did not feel the med was needed|0|||
124950475|NCT03740737|449445412|FG001|Overall Study|Lost to Follow-up|0|||
124950476|NCT03740737|449445411|FG000|Overall Study|Randomization failure|1|||
125029947|NCT02162862|449732730|FG002|Overall Study|Subject did not feel the med was needed|4|||
125029948|NCT03116113|449732731|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
125029949|NCT03116113|449732732|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
125029950|NCT03116113|449732733|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
125029951|NCT03116113|449732734|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
125215025|NCT03026283|450414892|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
125215026|NCT03026283|450414893|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
125215027|NCT03026283|450414894|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
125215028|NCT03026283|450414895|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
125215029|NCT03026283|450414896|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
125215030|NCT03026283|450414897|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
125215031|NCT03026283|450414898|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
125215032|NCT03026283|450414899|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
125215033|NCT03026283|450414892|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
125215034|NCT03026283|450414893|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
125215035|NCT03026283|450414894|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
125215036|NCT03026283|450414895|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
125215037|NCT03026283|450414896|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
125215038|NCT03026283|450414897|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
125215039|NCT03026283|450414898|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
125215040|NCT03026283|450414899|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
125215041|NCT03026283|450414892|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
125215042|NCT03026283|450414893|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
125215043|NCT03026283|450414894|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
125215044|NCT03026283|450414895|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
125215045|NCT03026283|450414896|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
125215046|NCT03026283|450414897|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
125215047|NCT03026283|450414898|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
125215048|NCT03026283|450414899|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
125215049|NCT03026283|450414892|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
125215050|NCT03026283|450414893|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
125215051|NCT03026283|450414894|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
125215052|NCT03026283|450414895|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
125215053|NCT03026283|450414896|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
124950477|NCT03740737|449445412|FG001|Overall Study|Randomization failure|0|||
124950478|NCT03740737|449445411|FG000|Overall Study|Participant withdrew consent|1|||
124950479|NCT03740737|449445412|FG001|Overall Study|Participant withdrew consent|0|||
124950480|NCT03740737|449445411|FG000|Overall Study|Participant withdrew from trial|2|||
124950481|NCT03740737|449445412|FG001|Overall Study|Participant withdrew from trial|1|||
124950482|NCT01286311|449445414|FG000|Overall Study|Physician did not want outreach sent|14|||
124950483|NCT01286311|449445415|FG001|Overall Study|Physician did not want outreach sent|0|||
124950484|NCT02981953|449445421|FG000|Overall Study|Death|9|||
124950485|NCT02981953|449445421|FG000|Overall Study|Withdrawal by Subject|1|||
124950486|NCT02981953|449445421|FG000|Overall Study|Withdrawal to non-compliance|1|||
124950487|NCT02889900|449445422|FG000|Overall Study|Adverse Event|11|||
124950488|NCT02889900|449445422|FG000|Overall Study|Condition under investigation worsened|32|||
124950489|NCT02889900|449445422|FG000|Overall Study|Other|5|||
124950490|NCT02889900|449445422|FG000|Overall Study|Withdrawal by Subject|7|||
124950491|NCT02889900|449445422|FG000|Overall Study|Not treated|2|||
124950492|NCT03146845|449445424|FG000|Overall Study|Reference ulcer healed|1|||
124950493|NCT03146845|449445425|FG001|Overall Study|Reference ulcer healed|0|||
124950494|NCT03146845|449445424|FG000|Overall Study|Physician Decision|1|||
124950495|NCT03146845|449445425|FG001|Overall Study|Physician Decision|0|||
124950496|NCT03146845|449445424|FG000|Overall Study|Adverse Event|1|||
124950497|NCT03146845|449445425|FG001|Overall Study|Adverse Event|0|||
124950498|NCT03146845|449445424|FG000|Overall Study|Withdrawal by Subject|2|||
124950499|NCT03146845|449445425|FG001|Overall Study|Withdrawal by Subject|0|||
124950500|NCT03146845|449445424|FG000|Overall Study|Noncompliance|0|||
124950501|NCT03146845|449445425|FG001|Overall Study|Noncompliance|1|||
124950502|NCT03146845|449445424|FG000|Overall Study|Protocol Violation|0|||
124950503|NCT03146845|449445425|FG001|Overall Study|Protocol Violation|2|||
124950504|NCT03146845|449445424|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
124950505|NCT03146845|449445425|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
124950506|NCT01535261|449445432|FG000|Overall Study|Physician Decision|8|||
124950507|NCT01535261|449445432|FG000|Overall Study|Protocol Violation|3|||
124950508|NCT01535261|449445432|FG000|Overall Study|Death|5|||
125215054|NCT03026283|450414897|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
124950509|NCT01535261|449445432|FG000|Overall Study|Lost to Follow-up|8|||
124950510|NCT01535261|449445432|FG000|Overall Study|Withdrawal by Subject|14|||
124950511|NCT01535261|449445432|FG000|Overall Study|Adverse Event|12|||
124950512|NCT01757288|449445436|FG000|Overall Study|Consent withdrawal|0|||
124950513|NCT01757288|449445437|FG001|Overall Study|Consent withdrawal|4|||
125215055|NCT03026283|450414898|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
125215056|NCT03026283|450414899|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
125215057|NCT03026283|450414892|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
125215058|NCT03026283|450414893|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
125215059|NCT03026283|450414894|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
125215060|NCT03026283|450414895|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
125215061|NCT03026283|450414896|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
125215062|NCT03026283|450414897|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
124950514|NCT01757288|449445438|FG002|Overall Study|Consent withdrawal|4|||
124950515|NCT01757288|449445436|FG000|Overall Study|Patient off study, IRB hold.|0|||
124950516|NCT01757288|449445437|FG001|Overall Study|Patient off study, IRB hold.|0|||
124950517|NCT01757288|449445438|FG002|Overall Study|Patient off study, IRB hold.|1|||
124950518|NCT01757288|449445436|FG000|Overall Study|Patient death prior to starting treatment|0|||
124950519|NCT01757288|449445437|FG001|Overall Study|Patient death prior to starting treatment|0|||
124950520|NCT01757288|449445438|FG002|Overall Study|Patient death prior to starting treatment|1|||
124950521|NCT01757288|449445436|FG000|Overall Study|Wrong medication administered|0|||
124950522|NCT01757288|449445437|FG001|Overall Study|Wrong medication administered|1|||
124950523|NCT01757288|449445438|FG002|Overall Study|Wrong medication administered|0|||
124950524|NCT01757288|449445436|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
124950525|NCT01757288|449445437|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
124950526|NCT01757288|449445438|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
124950527|NCT01757288|449445436|FG000|Overall Study|Not meeting protocol constraints|0|||
124950528|NCT01757288|449445437|FG001|Overall Study|Not meeting protocol constraints|1|||
124950529|NCT01757288|449445438|FG002|Overall Study|Not meeting protocol constraints|1|||
124950530|NCT01757288|449445436|FG000|Overall Study|Multiple missed appointments|0|||
124950531|NCT01757288|449445437|FG001|Overall Study|Multiple missed appointments|1|||
124950532|NCT01757288|449445438|FG002|Overall Study|Multiple missed appointments|0|||
124950533|NCT01757288|449445436|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
124950534|NCT01757288|449445437|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
124950535|NCT01757288|449445438|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
124950536|NCT01757288|449445436|FG000|Overall Study|>2 weeks treatment break|0|||
124950537|NCT01757288|449445437|FG001|Overall Study|>2 weeks treatment break|0|||
124950538|NCT01757288|449445438|FG002|Overall Study|>2 weeks treatment break|1|||
124950539|NCT03349476|449445444|FG000|Overall Study|Physician Decision|3|||
124950540|NCT04421456|449445451|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
124950541|NCT04421456|449445452|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
124950542|NCT04421456|449445453|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
124950543|NCT04421456|449445451|FG000|Randomized Treatment Period|Adverse Event|0|||
124950544|NCT04421456|449445452|FG001|Randomized Treatment Period|Adverse Event|1|||
125215063|NCT03026283|450414898|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
124950545|NCT04421456|449445453|FG002|Randomized Treatment Period|Adverse Event|0|||
124950546|NCT04421456|449445451|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
124950547|NCT04421456|449445452|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
124950548|NCT04421456|449445453|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
124950549|NCT04421456|449445451|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
124950550|NCT04421456|449445452|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
124950551|NCT04421456|449445453|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
124950552|NCT04421456|449445451|FG000|Randomized Treatment Period|Participant non-compliance|1|||
124950553|NCT04421456|449445452|FG001|Randomized Treatment Period|Participant non-compliance|1|||
124950554|NCT04421456|449445453|FG002|Randomized Treatment Period|Participant non-compliance|2|||
124950555|NCT04421456|449445451|FG000|Randomized Treatment Period|Other|0|||
124950556|NCT04421456|449445452|FG001|Randomized Treatment Period|Other|1|||
124950557|NCT04421456|449445453|FG002|Randomized Treatment Period|Other|3|||
124950558|NCT00274287|449445454|FG000|Overall Study|Withdrawal by Subject|1|||
124950559|NCT00274287|449445454|FG000|Overall Study|subject non-compliance|1|||
124950560|NCT01777932|449445457|FG000|Overall Study|Disease progression|136|||
124950561|NCT01777932|449445457|FG000|Overall Study|Death|3|||
124950562|NCT01777932|449445457|FG000|Overall Study|Adverse Event|34|||
124950563|NCT01777932|449445457|FG000|Overall Study|Lost to Follow-up|3|||
124950564|NCT01777932|449445457|FG000|Overall Study|Investigator decision|10|||
124950565|NCT01777932|449445457|FG000|Overall Study|Reimbursement limit|9|||
124950566|NCT01777932|449445457|FG000|Overall Study|Patient refused further treatment|10|||
124950567|NCT03031782|449445465|FG000|Treatment Period 1|Lack of Efficacy|3|||
124950568|NCT03031782|449445466|FG001|Treatment Period 1|Lack of Efficacy|0|||
124950569|NCT03031782|449445467|FG002|Treatment Period 1|Lack of Efficacy|0|||
124950570|NCT03031782|449445468|FG003|Treatment Period 1|Lack of Efficacy|0|||
124950571|NCT03031782|449445469|FG004|Treatment Period 1|Lack of Efficacy|0|||
124950572|NCT03031782|449445465|FG000|Treatment Period 2|Physician Decision|0|||
124950573|NCT03031782|449445466|FG001|Treatment Period 2|Physician Decision|1|||
124950574|NCT03031782|449445467|FG002|Treatment Period 2|Physician Decision|0|||
124950575|NCT03031782|449445468|FG003|Treatment Period 2|Physician Decision|0|||
124950576|NCT03031782|449445469|FG004|Treatment Period 2|Physician Decision|3|||
124950577|NCT03031782|449445465|FG000|Treatment Period 2|Lack of Efficacy|0|||
124950578|NCT03031782|449445466|FG001|Treatment Period 2|Lack of Efficacy|1|||
124950579|NCT03031782|449445467|FG002|Treatment Period 2|Lack of Efficacy|0|||
124950580|NCT03031782|449445468|FG003|Treatment Period 2|Lack of Efficacy|0|||
124950581|NCT03031782|449445469|FG004|Treatment Period 2|Lack of Efficacy|1|||
124950582|NCT03031782|449445465|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124950583|NCT03031782|449445466|FG001|Treatment Period 2|Withdrawal by Subject|3|||
124950584|NCT03031782|449445467|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124950585|NCT03031782|449445468|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124950586|NCT03031782|449445469|FG004|Treatment Period 2|Withdrawal by Subject|1|||
124950587|NCT03031782|449445465|FG000|Treatment Period 2|Adverse Event|0|||
124950588|NCT03031782|449445466|FG001|Treatment Period 2|Adverse Event|1|||
125029952|NCT03116113|449732735|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
125029953|NCT03116113|449732736|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
125029954|NCT03116113|449732737|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
125029955|NCT03116113|449732738|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
125029956|NCT03116113|449732739|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
125029957|NCT02159807|449732741|FG000|Overall Study|Adverse Event|0|||
125029958|NCT02159807|449732742|FG001|Overall Study|Adverse Event|0|||
125029959|NCT02159807|449732743|FG002|Overall Study|Adverse Event|1|||
125029960|NCT02159807|449732741|FG000|Overall Study|No CSF|1|||
125029961|NCT02159807|449732742|FG001|Overall Study|No CSF|1|||
125029962|NCT02159807|449732743|FG002|Overall Study|No CSF|1|||
125029963|NCT02159807|449732741|FG000|Overall Study|elevated blood pressure|0|||
125029964|NCT02159807|449732742|FG001|Overall Study|elevated blood pressure|0|||
125029965|NCT02159807|449732743|FG002|Overall Study|elevated blood pressure|1|||
125029966|NCT05195528|449732744|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
125029967|NCT05195528|449732745|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
125029968|NCT05195528|449732746|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
125029969|NCT05195528|449732747|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
125029970|NCT05195528|449732748|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
125029971|NCT05195528|449732744|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
125029972|NCT05195528|449732745|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
125029973|NCT05195528|449732746|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
125029974|NCT05195528|449732747|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
125029975|NCT05195528|449732748|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
125029976|NCT05195528|449732744|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
125029977|NCT05195528|449732745|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
125029978|NCT05195528|449732746|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
125029979|NCT05195528|449732747|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
125029980|NCT05195528|449732748|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
124950589|NCT03031782|449445467|FG002|Treatment Period 2|Adverse Event|2|||
124950590|NCT03031782|449445468|FG003|Treatment Period 2|Adverse Event|0|||
124950591|NCT03031782|449445469|FG004|Treatment Period 2|Adverse Event|0|||
124950592|NCT03031782|449445465|FG000|Treatment Period 3|Withdrawal by Subject|0|||
124950593|NCT03031782|449445466|FG001|Treatment Period 3|Withdrawal by Subject|0|||
124950594|NCT03031782|449445467|FG002|Treatment Period 3|Withdrawal by Subject|0|||
124950595|NCT03031782|449445468|FG003|Treatment Period 3|Withdrawal by Subject|1|||
124950596|NCT03031782|449445469|FG004|Treatment Period 3|Withdrawal by Subject|0|||
124950597|NCT01930188|449445470|FG000|Overall Study|unclassified|4|||
124950598|NCT01930188|449445471|FG001|Overall Study|unclassified|5|||
124950599|NCT01930188|449445472|FG002|Overall Study|unclassified|3|||
124950600|NCT01930188|449445470|FG000|Overall Study|Missing follow-up information|2|||
124950601|NCT01930188|449445471|FG001|Overall Study|Missing follow-up information|2|||
124950602|NCT01930188|449445472|FG002|Overall Study|Missing follow-up information|3|||
124950603|NCT01930188|449445470|FG000|Overall Study|Lost to Follow-up|5|||
124950604|NCT01930188|449445471|FG001|Overall Study|Lost to Follow-up|2|||
124950605|NCT01930188|449445472|FG002|Overall Study|Lost to Follow-up|2|||
124950606|NCT01930188|449445470|FG000|Overall Study|Death|2|||
124950607|NCT01930188|449445471|FG001|Overall Study|Death|1|||
124950608|NCT01930188|449445472|FG002|Overall Study|Death|3|||
124950609|NCT01930188|449445470|FG000|Overall Study|Withdrawal by Subject|9|||
124950610|NCT01930188|449445471|FG001|Overall Study|Withdrawal by Subject|11|||
124950611|NCT01930188|449445472|FG002|Overall Study|Withdrawal by Subject|8|||
124950612|NCT02514824|449445473|FG000|Overall Study|Withdrawal by Subject|1|||
124950613|NCT02514824|449445474|FG001|Overall Study|Withdrawal by Subject|0|||
124950614|NCT02514824|449445475|FG002|Overall Study|Withdrawal by Subject|0|||
124950615|NCT02514824|449445476|FG003|Overall Study|Withdrawal by Subject|0|||
124950616|NCT02514824|449445473|FG000|Overall Study|Dose-Limiting Toxicity|0|||
124950617|NCT02514824|449445474|FG001|Overall Study|Dose-Limiting Toxicity|1|||
124950618|NCT02514824|449445475|FG002|Overall Study|Dose-Limiting Toxicity|0|||
124950619|NCT02514824|449445476|FG003|Overall Study|Dose-Limiting Toxicity|0|||
124950620|NCT02170207|449445479|FG000|Overall Study|Case report forms unavailable|5|||
124950621|NCT00886834|449445480|FG000|Overall Study|Protocol Violation|0|||
124950622|NCT00886834|449445481|FG001|Overall Study|Protocol Violation|3|||
124950623|NCT03122860|449445482|FG000|Overall Study|Discontinued Before Treatment|1|||
124950624|NCT03122860|449445483|FG001|Overall Study|Discontinued Before Treatment|1|||
124950625|NCT03122860|449445484|FG002|Overall Study|Discontinued Before Treatment|2|||
124950626|NCT03122860|449445485|FG003|Overall Study|Discontinued Before Treatment|0|||
124950627|NCT03122860|449445486|FG004|Overall Study|Discontinued Before Treatment|1|||
124950628|NCT03122860|449445487|FG005|Overall Study|Discontinued Before Treatment|0|||
124950629|NCT03122860|449445482|FG000|Overall Study|Adverse Event|1|||
124950630|NCT03122860|449445483|FG001|Overall Study|Adverse Event|0|||
124950631|NCT03122860|449445484|FG002|Overall Study|Adverse Event|1|||
124950632|NCT03122860|449445485|FG003|Overall Study|Adverse Event|1|||
124950633|NCT03122860|449445486|FG004|Overall Study|Adverse Event|0|||
124950634|NCT03122860|449445487|FG005|Overall Study|Adverse Event|0|||
124950635|NCT03122860|449445482|FG000|Overall Study|Lost to Follow-up|5|||
124950636|NCT03122860|449445483|FG001|Overall Study|Lost to Follow-up|2|||
124950637|NCT03122860|449445484|FG002|Overall Study|Lost to Follow-up|3|||
124950638|NCT03122860|449445485|FG003|Overall Study|Lost to Follow-up|3|||
124950639|NCT03122860|449445486|FG004|Overall Study|Lost to Follow-up|5|||
124950640|NCT03122860|449445487|FG005|Overall Study|Lost to Follow-up|4|||
124950641|NCT03122860|449445482|FG000|Overall Study|Subject Non-Compliance|0|||
124950642|NCT03122860|449445483|FG001|Overall Study|Subject Non-Compliance|0|||
124950643|NCT03122860|449445484|FG002|Overall Study|Subject Non-Compliance|1|||
125124704|NCT01249664|450082444|FG000|Overall Study|Withdrawal by Subject|5|||
125124705|NCT01249664|450082445|FG001|Overall Study|Withdrawal by Subject|0|||
125124706|NCT01249664|450082444|FG000|Overall Study|Adverse Event|1|||
125124707|NCT01249664|450082445|FG001|Overall Study|Adverse Event|0|||
125124708|NCT01682083|450082446|FG000|Overall Study|Lost to Follow-up|11|||
125124709|NCT01682083|450082447|FG001|Overall Study|Lost to Follow-up|18|||
125124710|NCT01682083|450082446|FG000|Overall Study|Withdrawal by Subject|31|||
125124711|NCT01682083|450082447|FG001|Overall Study|Withdrawal by Subject|40|||
125124712|NCT01682083|450082446|FG000|Overall Study|Death|60|||
124950644|NCT03122860|449445485|FG003|Overall Study|Subject Non-Compliance|0|||
124950645|NCT03122860|449445486|FG004|Overall Study|Subject Non-Compliance|0|||
124950646|NCT03122860|449445487|FG005|Overall Study|Subject Non-Compliance|0|||
124950647|NCT03122860|449445482|FG000|Overall Study|Withdrawal by Subject|3|||
124950648|NCT03122860|449445483|FG001|Overall Study|Withdrawal by Subject|2|||
124950649|NCT03122860|449445484|FG002|Overall Study|Withdrawal by Subject|5|||
124950650|NCT03122860|449445485|FG003|Overall Study|Withdrawal by Subject|7|||
124950651|NCT03122860|449445486|FG004|Overall Study|Withdrawal by Subject|9|||
124950652|NCT03122860|449445487|FG005|Overall Study|Withdrawal by Subject|8|||
124950653|NCT03875729|449445488|FG000|Overall Study|Adverse Event|0|||
124950654|NCT03875729|449445489|FG001|Overall Study|Adverse Event|5|||
124950655|NCT03875729|449445488|FG000|Overall Study|Withdrawal by Subject|8|||
124950656|NCT03875729|449445489|FG001|Overall Study|Withdrawal by Subject|11|||
124950657|NCT03875729|449445488|FG000|Overall Study|Pregnancy|0|||
124950658|NCT03875729|449445489|FG001|Overall Study|Pregnancy|1|||
124950659|NCT03875729|449445488|FG000|Overall Study|Lost to Follow-up|0|||
124950660|NCT03875729|449445489|FG001|Overall Study|Lost to Follow-up|5|||
124950661|NCT03875729|449445488|FG000|Overall Study|Personal reasons|2|||
124950662|NCT03875729|449445489|FG001|Overall Study|Personal reasons|0|||
124950663|NCT02764320|449445490|FG000|Overall Study|Withdrawal by Subject|35|||
124950664|NCT02764320|449445491|FG001|Overall Study|Withdrawal by Subject|38|||
124950665|NCT02764320|449445490|FG000|Overall Study|Protocol Violation|11|||
124950666|NCT02764320|449445491|FG001|Overall Study|Protocol Violation|6|||
124950667|NCT02764320|449445490|FG000|Overall Study|Adverse Event|2|||
124950668|NCT02764320|449445491|FG001|Overall Study|Adverse Event|0|||
124950669|NCT02764320|449445490|FG000|Overall Study|Health Issues unable to continue|2|||
124950670|NCT02764320|449445491|FG001|Overall Study|Health Issues unable to continue|0|||
124950671|NCT02764320|449445490|FG000|Overall Study|Did not meet inclusion criteria|1|||
124950672|NCT02764320|449445491|FG001|Overall Study|Did not meet inclusion criteria|0|||
124950673|NCT02764320|449445490|FG000|Overall Study|Subject moved|0|||
124950674|NCT02764320|449445491|FG001|Overall Study|Subject moved|2|||
124950675|NCT02764320|449445490|FG000|Overall Study|Overused medication unavailable|0|||
124950676|NCT02764320|449445491|FG001|Overall Study|Overused medication unavailable|1|||
124950677|NCT02764320|449445490|FG000|Overall Study|Seeking care outside site|0|||
124950678|NCT02764320|449445491|FG001|Overall Study|Seeking care outside site|1|||
124950679|NCT02764320|449445490|FG000|Overall Study|Technology barriers|0|||
124950680|NCT02764320|449445491|FG001|Overall Study|Technology barriers|1|||
124950681|NCT01405508|449445494|FG000|Overall Study|AE, non-serious non-fatal|1|||
124950682|NCT01405508|449445495|FG001|Overall Study|AE, non-serious non-fatal|1|||
124950683|NCT01405508|449445496|FG002|Overall Study|AE, non-serious non-fatal|0|||
124950684|NCT01405508|449445497|FG003|Overall Study|AE, non-serious non-fatal|0|||
124950685|NCT00476957|449445502|FG000|Overall Study|Lost to Follow-up|176|||
124950686|NCT00476957|449445503|FG001|Overall Study|Lost to Follow-up|193|||
124950687|NCT02159352|449445504|FG000|Overall Study|Adverse Event|3|||
124950688|NCT02159352|449445505|FG001|Overall Study|Adverse Event|1|||
124950689|NCT02159352|449445504|FG000|Overall Study|Withdrawal by Subject|0|||
124950690|NCT02159352|449445505|FG001|Overall Study|Withdrawal by Subject|1|||
124950691|NCT04620733|449447343|FG000|Overall Study|Adverse Event|4|||
124950692|NCT04620733|449447344|FG001|Overall Study|Adverse Event|3|||
124950693|NCT04620733|449447343|FG000|Overall Study|Withdrawal by Subject|2|||
124950694|NCT04620733|449447344|FG001|Overall Study|Withdrawal by Subject|5|||
124950695|NCT04620733|449447343|FG000|Overall Study|Lost to Follow-up|1|||
124950696|NCT04620733|449447344|FG001|Overall Study|Lost to Follow-up|1|||
124950697|NCT04620733|449447343|FG000|Overall Study|Protocol Deviation|1|||
124950698|NCT04620733|449447344|FG001|Overall Study|Protocol Deviation|1|||
124950699|NCT04620733|449447343|FG000|Overall Study|Reason Not Specified|0|||
124950700|NCT04620733|449447344|FG001|Overall Study|Reason Not Specified|1|||
124950701|NCT02659059|449447351|FG000|Overall Study|Other reasons|6|||
124950702|NCT02659059|449447352|FG001|Overall Study|Other reasons|1|||
124950703|NCT02659059|449447351|FG000|Overall Study|Disease Progression|143|||
124950704|NCT02659059|449447352|FG001|Overall Study|Disease Progression|16|||
124950705|NCT02659059|449447351|FG000|Overall Study|Study Drug toxicity|56|||
125124713|NCT01682083|450082447|FG001|Overall Study|Death|93|||
125124714|NCT01682083|450082446|FG000|Overall Study|Physician Decision|5|||
125124715|NCT01682083|450082447|FG001|Overall Study|Physician Decision|4|||
125124716|NCT01239121|450082449|FG000|Overall Study|Withdrawal by Subject|2|||
125124717|NCT01239121|450082450|FG001|Overall Study|Withdrawal by Subject|4|||
125124718|NCT01239121|450082451|FG002|Overall Study|Withdrawal by Subject|0|||
125124719|NCT01856309|450082454|FG000|Overall Study|Death|4|||
125124720|NCT01856309|450082455|FG001|Overall Study|Death|6|||
125124721|NCT01856309|450082456|FG002|Overall Study|Death|11|||
125124722|NCT01856309|450082457|FG003|Overall Study|Death|6|||
125124723|NCT01856309|450082454|FG000|Overall Study|Lost to Follow-up|6|||
125124724|NCT01856309|450082455|FG001|Overall Study|Lost to Follow-up|2|||
125124725|NCT01856309|450082456|FG002|Overall Study|Lost to Follow-up|4|||
125215064|NCT03026283|450414899|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
124950706|NCT02659059|449447352|FG001|Overall Study|Study Drug toxicity|9|||
124950707|NCT02659059|449447351|FG000|Overall Study|Death|3|||
124950708|NCT02659059|449447352|FG001|Overall Study|Death|1|||
124950709|NCT02659059|449447351|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
124950710|NCT02659059|449447352|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
125124726|NCT01856309|450082457|FG003|Overall Study|Lost to Follow-up|8|||
124950711|NCT02659059|449447351|FG000|Overall Study|Participant request to discontinue study treatment|5|||
124950712|NCT02659059|449447352|FG001|Overall Study|Participant request to discontinue study treatment|0|||
124950713|NCT02659059|449447351|FG000|Overall Study|Participant withdrew consent|6|||
124950714|NCT02659059|449447352|FG001|Overall Study|Participant withdrew consent|1|||
125124727|NCT01856309|450082454|FG000|Overall Study|Withdrawal by Subject|11|||
125215065|NCT03026283|450414892|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
125215066|NCT03026283|450414893|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
125215067|NCT03026283|450414894|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
125215068|NCT03026283|450414895|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
125215069|NCT03026283|450414896|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
125215070|NCT03026283|450414897|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
125215071|NCT03026283|450414898|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
125215072|NCT03026283|450414899|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
125215073|NCT03026283|450414892|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
124950715|NCT03072238|449447355|FG000|Overall Study|Withdrawal by Subject|44|||
124950716|NCT03072238|449447356|FG001|Overall Study|Withdrawal by Subject|64|||
124950717|NCT03072238|449447355|FG000|Overall Study|Lost to Follow-up|14|||
124950718|NCT03072238|449447356|FG001|Overall Study|Lost to Follow-up|5|||
124950719|NCT03072238|449447355|FG000|Overall Study|Physician Decision|4|||
124950720|NCT03072238|449447356|FG001|Overall Study|Physician Decision|6|||
124950721|NCT03072238|449447355|FG000|Overall Study|Death|351|||
124950722|NCT03072238|449447356|FG001|Overall Study|Death|318|||
124950723|NCT03072238|449447355|FG000|Overall Study|Progressive Disease|3|||
124950724|NCT03072238|449447356|FG001|Overall Study|Progressive Disease|4|||
124950725|NCT03072238|449447355|FG000|Overall Study|Reason Not Specified|138|||
124950726|NCT03072238|449447356|FG001|Overall Study|Reason Not Specified|150|||
124950727|NCT03924193|449447362|FG000|Overall Study|Adverse Event|10|||
124950728|NCT03924193|449447363|FG001|Overall Study|Adverse Event|0|||
124950729|NCT03924193|449447364|FG002|Overall Study|Adverse Event|10|||
124950730|NCT03924193|449447362|FG000|Overall Study|Withdrawal by Subject|5|||
124950731|NCT03924193|449447363|FG001|Overall Study|Withdrawal by Subject|10|||
124950732|NCT03924193|449447364|FG002|Overall Study|Withdrawal by Subject|2|||
124950733|NCT02489799|449447365|FG000|Overall Study|Lost to Follow-up|4|||
124950734|NCT02489799|449447366|FG001|Overall Study|Lost to Follow-up|1|||
124950735|NCT02489799|449447365|FG000|Overall Study|Failure to Maintain Eligibility|4|||
124950736|NCT02489799|449447366|FG001|Overall Study|Failure to Maintain Eligibility|6|||
124950737|NCT02489799|449447365|FG000|Overall Study|Withdrawal by Subject|1|||
124950738|NCT02489799|449447366|FG001|Overall Study|Withdrawal by Subject|1|||
124950739|NCT02489799|449447365|FG000|Overall Study|Death|0|||
124950740|NCT02489799|449447366|FG001|Overall Study|Death|1|||
124950741|NCT04909593|449447367|FG000|Overall Study|Withdrawal by Subject|1|||
124950742|NCT01241448|449447368|FG000|Overall Study|Adverse Event|1|||
124950743|NCT01241448|449447369|FG001|Overall Study|Adverse Event|0|||
124950744|NCT01241448|449447370|FG002|Overall Study|Adverse Event|2|||
124950745|NCT01241448|449447371|FG003|Overall Study|Adverse Event|2|||
124950746|NCT01241448|449447368|FG000|Overall Study|Lost to Follow-up|2|||
124950747|NCT01241448|449447369|FG001|Overall Study|Lost to Follow-up|1|||
124950748|NCT01241448|449447370|FG002|Overall Study|Lost to Follow-up|1|||
124950749|NCT01241448|449447371|FG003|Overall Study|Lost to Follow-up|1|||
124950750|NCT01241448|449447368|FG000|Overall Study|Physician Decision|0|||
124950751|NCT01241448|449447369|FG001|Overall Study|Physician Decision|2|||
124950752|NCT01241448|449447370|FG002|Overall Study|Physician Decision|0|||
124950753|NCT01241448|449447371|FG003|Overall Study|Physician Decision|0|||
124950754|NCT01241448|449447368|FG000|Overall Study|Protocol Violation|10|||
124950755|NCT01241448|449447369|FG001|Overall Study|Protocol Violation|5|||
124950756|NCT01241448|449447370|FG002|Overall Study|Protocol Violation|3|||
124950757|NCT01241448|449447371|FG003|Overall Study|Protocol Violation|6|||
125215074|NCT03026283|450414893|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
125215075|NCT03026283|450414894|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
124950758|NCT01241448|449447368|FG000|Overall Study|Sponsor Decision|17|||
124950759|NCT01241448|449447369|FG001|Overall Study|Sponsor Decision|14|||
124950760|NCT01241448|449447370|FG002|Overall Study|Sponsor Decision|12|||
124950761|NCT01241448|449447371|FG003|Overall Study|Sponsor Decision|6|||
124950762|NCT01241448|449447368|FG000|Overall Study|Withdrawal by Subject|4|||
124950763|NCT01241448|449447369|FG001|Overall Study|Withdrawal by Subject|5|||
124950764|NCT01241448|449447370|FG002|Overall Study|Withdrawal by Subject|3|||
124950765|NCT01241448|449447371|FG003|Overall Study|Withdrawal by Subject|6|||
124950766|NCT01241448|449447368|FG000|Overall Study|Excluded due to data integrity issues|3|||
124950767|NCT01241448|449447369|FG001|Overall Study|Excluded due to data integrity issues|2|||
124950768|NCT01241448|449447370|FG002|Overall Study|Excluded due to data integrity issues|2|||
124950769|NCT01241448|449447371|FG003|Overall Study|Excluded due to data integrity issues|2|||
124950770|NCT02165202|449447375|FG000|Oral Phase|Refused further participation|5|||
124950771|NCT02165202|449447376|FG001|Oral Phase|Refused further participation|1|||
124950772|NCT02165202|449447375|FG000|Oral Phase|Study product Related Toxicity|1|||
124950773|NCT02165202|449447376|FG001|Oral Phase|Study product Related Toxicity|0|||
124950774|NCT02165202|449447375|FG000|Oral Phase|Unable to contact Participant|1|||
124950775|NCT02165202|449447376|FG001|Oral Phase|Unable to contact Participant|1|||
124950776|NCT02165202|449447375|FG000|Oral Phase|Clinical reasons|1|||
124950777|NCT02165202|449447376|FG001|Oral Phase|Clinical reasons|0|||
124950778|NCT02165202|449447375|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
124950779|NCT02165202|449447376|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
124950780|NCT02165202|449447375|FG000|Oral Phase|CMC advised termination|1|||
124950781|NCT02165202|449447376|FG001|Oral Phase|CMC advised termination|0|||
124950782|NCT02165202|449447375|FG000|Oral Phase|Relocated, no follow-up planned|1|||
124950783|NCT02165202|449447376|FG001|Oral Phase|Relocated, no follow-up planned|0|||
124950784|NCT02165202|449447375|FG000|Oral Phase|Abnormal EKG|0|||
124950785|NCT02165202|449447376|FG001|Oral Phase|Abnormal EKG|1|||
124950786|NCT02165202|449447375|FG000|Injection Phase|Abnormal Lab Value|5|||
124950787|NCT02165202|449447376|FG001|Injection Phase|Abnormal Lab Value|1|||
125124728|NCT01856309|450082455|FG001|Overall Study|Withdrawal by Subject|13|||
125124729|NCT01856309|450082456|FG002|Overall Study|Withdrawal by Subject|28|||
125124730|NCT01856309|450082457|FG003|Overall Study|Withdrawal by Subject|26|||
125124731|NCT01856309|450082454|FG000|Overall Study|Other|227|||
125124732|NCT01856309|450082455|FG001|Overall Study|Other|225|||
125124733|NCT01856309|450082456|FG002|Overall Study|Other|447|||
125124734|NCT01856309|450082457|FG003|Overall Study|Other|469|||
125124735|NCT01856309|450082454|FG000|Overall Study|Lack of Efficacy|14|||
125124736|NCT01856309|450082455|FG001|Overall Study|Lack of Efficacy|9|||
125124737|NCT01856309|450082456|FG002|Overall Study|Lack of Efficacy|40|||
125124738|NCT01856309|450082457|FG003|Overall Study|Lack of Efficacy|25|||
125124739|NCT01856309|450082454|FG000|Overall Study|Adverse Event|31|||
125124740|NCT01856309|450082455|FG001|Overall Study|Adverse Event|31|||
125124741|NCT01856309|450082456|FG002|Overall Study|Adverse Event|55|||
125124742|NCT01856309|450082457|FG003|Overall Study|Adverse Event|65|||
125124743|NCT01856309|450082454|FG000|Overall Study|Pregnancy|0|||
125124744|NCT01856309|450082455|FG001|Overall Study|Pregnancy|0|||
125124745|NCT01856309|450082456|FG002|Overall Study|Pregnancy|0|||
125124746|NCT01856309|450082457|FG003|Overall Study|Pregnancy|1|||
125124747|NCT01856309|450082454|FG000|Overall Study|Physician Decision|6|||
125124748|NCT01856309|450082455|FG001|Overall Study|Physician Decision|1|||
125124749|NCT01856309|450082456|FG002|Overall Study|Physician Decision|6|||
125124750|NCT01856309|450082457|FG003|Overall Study|Physician Decision|8|||
125124751|NCT01856309|450082454|FG000|Overall Study|Noncompliance With Study Drug|0|||
125124752|NCT01856309|450082455|FG001|Overall Study|Noncompliance With Study Drug|1|||
125124753|NCT01856309|450082456|FG002|Overall Study|Noncompliance With Study Drug|4|||
125124754|NCT01856309|450082457|FG003|Overall Study|Noncompliance With Study Drug|1|||
125124755|NCT00220337|450082460|FG000|Overall Study|Adverse Event|70|||
125124756|NCT00220337|450082460|FG000|Overall Study|Lack of Efficacy|17|||
125124757|NCT00220337|450082460|FG000|Overall Study|Withdrawal by Subject|68|||
125124758|NCT00220337|450082460|FG000|Overall Study|Protocol Violation|2|||
125124759|NCT00220337|450082460|FG000|Overall Study|Lost to Follow-up|5|||
125124760|NCT00220337|450082460|FG000|Overall Study|Other|12|||
125124761|NCT00220337|450082460|FG000|Overall Study|Unsatisfactory compliance|5|||
125124762|NCT00944697|450082461|FG000|Overall Study|Withdrawal by Subject|1|||
125124763|NCT00944697|450082462|FG001|Overall Study|Withdrawal by Subject|1|||
125124764|NCT00944697|450082461|FG000|Overall Study|Adverse Event|0|||
125124765|NCT00944697|450082462|FG001|Overall Study|Adverse Event|3|||
125124766|NCT00944697|450082461|FG000|Overall Study|Administrative|1|||
125124767|NCT00944697|450082462|FG001|Overall Study|Administrative|1|||
125124768|NCT01273181|450082463|FG000|Phase I, Dose 1|Study termination|1|||
125124769|NCT01273181|450082464|FG001|Phase I, Dose 1|Study termination|0|||
125124770|NCT01273181|450082465|FG002|Phase I, Dose 1|Study termination|0|||
125124771|NCT01273181|450082466|FG003|Phase I, Dose 1|Study termination|0|||
125124772|NCT01273181|450082463|FG000|Phase I, Dose 2|Death during treatment|0|||
125124773|NCT01273181|450082464|FG001|Phase I, Dose 2|Death during treatment|1|||
125124774|NCT01273181|450082465|FG002|Phase I, Dose 2|Death during treatment|0|||
125124775|NCT01273181|450082466|FG003|Phase I, Dose 2|Death during treatment|0|||
125124776|NCT01273181|450082463|FG000|Phase 2, Dose 1|Study termination|0|||
125124777|NCT01273181|450082464|FG001|Phase 2, Dose 1|Study termination|0|||
125124778|NCT01273181|450082465|FG002|Phase 2, Dose 1|Study termination|1|||
125124779|NCT01273181|450082466|FG003|Phase 2, Dose 1|Study termination|0|||
125124780|NCT01273181|450082463|FG000|Phase 2, Dose 2|Death during treatment|0|||
125124781|NCT01273181|450082464|FG001|Phase 2, Dose 2|Death during treatment|0|||
124950788|NCT02165202|449447375|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
124950789|NCT02165202|449447376|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
125124782|NCT01273181|450082465|FG002|Phase 2, Dose 2|Death during treatment|0|||
125124783|NCT01273181|450082466|FG003|Phase 2, Dose 2|Death during treatment|1|||
124950790|NCT02165202|449447375|FG000|Injection Phase|Unable to attend within Visit Window|1|||
124950791|NCT02165202|449447376|FG001|Injection Phase|Unable to attend within Visit Window|0|||
124950792|NCT02165202|449447375|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
124950793|NCT02165202|449447376|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
124950794|NCT02165202|449447375|FG000|Injection Phase|End of Study|2|||
124950795|NCT02165202|449447376|FG001|Injection Phase|End of Study|1|||
124950796|NCT02165202|449447375|FG000|Injection Phase|Study Product related Toxicity|1|||
124950797|NCT02165202|449447376|FG001|Injection Phase|Study Product related Toxicity|0|||
124950798|NCT02165202|449447375|FG000|Injection Phase|No longer interested|0|||
124950799|NCT02165202|449447376|FG001|Injection Phase|No longer interested|1|||
124950800|NCT02165202|449447375|FG000|Injection Phase|Participant unwilling to comply|1|||
124950801|NCT02165202|449447376|FG001|Injection Phase|Participant unwilling to comply|0|||
124950802|NCT01655498|449447392|FG000|Overall Study|Unrelated health issue|2|||
124950803|NCT01655498|449447392|FG000|Overall Study|Protocol Violation|2|||
124950804|NCT01655498|449447392|FG000|Overall Study|Withdrawal by Subject|1|||
124950805|NCT02291861|449447399|FG000|Overall Study|Adverse Event|2|||
124950806|NCT02291861|449447400|FG001|Overall Study|Adverse Event|4|||
124950807|NCT02291861|449447401|FG002|Overall Study|Adverse Event|1|||
124950808|NCT02291861|449447402|FG003|Overall Study|Adverse Event|2|||
124950809|NCT02291861|449447399|FG000|Overall Study|Death|0|||
124950810|NCT02291861|449447400|FG001|Overall Study|Death|0|||
124950811|NCT02291861|449447401|FG002|Overall Study|Death|1|||
124950812|NCT02291861|449447402|FG003|Overall Study|Death|1|||
124950813|NCT02291861|449447399|FG000|Overall Study|Protocol Violation|1|||
124950814|NCT02291861|449447400|FG001|Overall Study|Protocol Violation|0|||
124950815|NCT02291861|449447401|FG002|Overall Study|Protocol Violation|0|||
125124784|NCT03657160|450082467|FG000|Overall Study|Adverse Event|5|||
125124785|NCT03657160|450082468|FG001|Overall Study|Adverse Event|6|||
125124786|NCT03657160|450082467|FG000|Overall Study|Protocol Deviation|3|||
125124787|NCT03657160|450082468|FG001|Overall Study|Protocol Deviation|0|||
125124788|NCT03657160|450082467|FG000|Overall Study|Withdrawal by Subject|18|||
125124789|NCT03657160|450082468|FG001|Overall Study|Withdrawal by Subject|16|||
125124790|NCT03657160|450082467|FG000|Overall Study|Site Termination|1|||
125124791|NCT03657160|450082468|FG001|Overall Study|Site Termination|0|||
125124792|NCT03657160|450082467|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
125124793|NCT03657160|450082468|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
125124794|NCT03657160|450082467|FG000|Overall Study|Death|33|||
125124795|NCT03657160|450082468|FG001|Overall Study|Death|26|||
125124796|NCT03657160|450082467|FG000|Overall Study|Death (COVID-19-Related)|1|||
125124797|NCT03657160|450082468|FG001|Overall Study|Death (COVID-19-Related)|0|||
125124798|NCT03657160|450082467|FG000|Overall Study|Reason Not Specified|5|||
125124799|NCT03657160|450082468|FG001|Overall Study|Reason Not Specified|5|||
125124800|NCT03657160|450082467|FG000|Overall Study|Other (COVID-19-Related)|0|||
125124801|NCT03657160|450082468|FG001|Overall Study|Other (COVID-19-Related)|1|||
125124802|NCT02732210|450082470|FG000|Overall Study|Site Closed|0|||
125124803|NCT02732210|450082471|FG001|Overall Study|Site Closed|11|||
125124804|NCT02732210|450082470|FG000|Overall Study|Study Ended|13|||
125124805|NCT02732210|450082471|FG001|Overall Study|Study Ended|13|||
125215076|NCT03026283|450414895|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
125215077|NCT03026283|450414896|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
125217431|NCT01348100|450423525|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
124950816|NCT02291861|449447402|FG003|Overall Study|Protocol Violation|1|||
124950817|NCT02291861|449447399|FG000|Overall Study|Withdrawal by Subject|1|||
124950818|NCT02291861|449447400|FG001|Overall Study|Withdrawal by Subject|2|||
124950819|NCT02291861|449447401|FG002|Overall Study|Withdrawal by Subject|1|||
124950820|NCT02291861|449447402|FG003|Overall Study|Withdrawal by Subject|4|||
124950821|NCT02291861|449447399|FG000|Overall Study|Noncompliance|1|||
124950822|NCT02291861|449447400|FG001|Overall Study|Noncompliance|1|||
124950823|NCT02291861|449447401|FG002|Overall Study|Noncompliance|2|||
125029981|NCT05195528|449732744|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
125029982|NCT05195528|449732745|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
125029983|NCT05195528|449732746|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
125029984|NCT05195528|449732747|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
125029985|NCT05195528|449732748|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
125029986|NCT05195528|449732744|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
125029987|NCT05195528|449732745|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
125029988|NCT05195528|449732746|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
125029989|NCT05195528|449732747|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
125029990|NCT05195528|449732748|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
125029991|NCT05195528|449732744|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
125029992|NCT05195528|449732745|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
125029993|NCT05195528|449732746|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
125029994|NCT05195528|449732747|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
125029995|NCT05195528|449732748|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
125124806|NCT02732210|450082470|FG000|Overall Study|Withdrawal by Subject|28|||
124950824|NCT02291861|449447402|FG003|Overall Study|Noncompliance|1|||
124950825|NCT02291861|449447399|FG000|Overall Study|Lost to Follow-up|2|||
124950826|NCT02291861|449447400|FG001|Overall Study|Lost to Follow-up|1|||
124950827|NCT02291861|449447401|FG002|Overall Study|Lost to Follow-up|4|||
124950828|NCT02291861|449447402|FG003|Overall Study|Lost to Follow-up|0|||
124950829|NCT02291861|449447399|FG000|Overall Study|Other|0|||
124950830|NCT02291861|449447400|FG001|Overall Study|Other|0|||
124950831|NCT02291861|449447401|FG002|Overall Study|Other|0|||
124950832|NCT02291861|449447402|FG003|Overall Study|Other|1|||
124950833|NCT00963924|449447403|FG000|Overall Study|Adverse Event|1|||
124950834|NCT00963924|449447404|FG001|Overall Study|Adverse Event|0|||
124950835|NCT00963924|449447403|FG000|Overall Study|Withdrawal by Subject|0|||
124950836|NCT00963924|449447404|FG001|Overall Study|Withdrawal by Subject|1|||
124950837|NCT00963924|449447403|FG000|Overall Study|Changed antipsychotic|0|||
124950838|NCT00963924|449447404|FG001|Overall Study|Changed antipsychotic|1|||
124950839|NCT00963924|449447403|FG000|Overall Study|Lost to Follow-up|0|||
124950840|NCT00963924|449447404|FG001|Overall Study|Lost to Follow-up|1|||
124950841|NCT00237809|449447405|FG000|Overall Study|Lost to Follow-up|11|||
124950842|NCT00237809|449447406|FG001|Overall Study|Lost to Follow-up|10|||
124950843|NCT00237809|449447407|FG002|Overall Study|Lost to Follow-up|9|||
124950844|NCT00237809|449447408|FG003|Overall Study|Lost to Follow-up|9|||
124950845|NCT00871715|449447413|FG000|Overall Study|Withdrawal by Subject|6|||
124950846|NCT00871715|449447414|FG001|Overall Study|Withdrawal by Subject|10|||
124950847|NCT00871715|449447415|FG002|Overall Study|Withdrawal by Subject|15|||
124950848|NCT00871715|449447413|FG000|Overall Study|Physician Decision|6|||
124950849|NCT00871715|449447414|FG001|Overall Study|Physician Decision|0|||
124950850|NCT00871715|449447415|FG002|Overall Study|Physician Decision|2|||
124950851|NCT00871715|449447413|FG000|Overall Study|Lost to Follow-up|3|||
124950852|NCT00871715|449447414|FG001|Overall Study|Lost to Follow-up|6|||
124950853|NCT00871715|449447415|FG002|Overall Study|Lost to Follow-up|9|||
124950854|NCT03015220|449447416|FG000|Overall Study|Withdrawal by Subject|3|||
124950855|NCT03015220|449447417|FG001|Overall Study|Withdrawal by Subject|2|||
124950856|NCT03015220|449447418|FG002|Overall Study|Withdrawal by Subject|2|||
124950857|NCT03015220|449447419|FG003|Overall Study|Withdrawal by Subject|2|||
124950858|NCT03015220|449447416|FG000|Overall Study|Lost to Follow-up|0|||
124950859|NCT03015220|449447417|FG001|Overall Study|Lost to Follow-up|0|||
124950860|NCT03015220|449447418|FG002|Overall Study|Lost to Follow-up|1|||
124950861|NCT03015220|449447419|FG003|Overall Study|Lost to Follow-up|0|||
124950862|NCT01670526|449447421|FG000|Overall Study|Withdrawal by Subject|3|||
124950863|NCT01670526|449447422|FG001|Overall Study|Withdrawal by Subject|1|||
124950864|NCT01670526|449447421|FG000|Overall Study|Lost to Follow-up|9|||
124950865|NCT01670526|449447422|FG001|Overall Study|Lost to Follow-up|5|||
124950866|NCT02291549|449447423|FG000|Overall Study|Lost to Follow-up|1|||
124950867|NCT02291549|449447424|FG001|Overall Study|Lost to Follow-up|0|||
124950868|NCT02291549|449447423|FG000|Overall Study|Withdrawal by Subject|0|||
124950869|NCT02291549|449447424|FG001|Overall Study|Withdrawal by Subject|1|||
124950870|NCT01970527|449447426|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
124950871|NCT01970527|449447427|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
124950872|NCT01970527|449447426|FG000|Treatment|Disease progression|0|||
124950873|NCT01970527|449447427|FG001|Treatment|Disease progression|1|||
124950874|NCT01970527|449447426|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
124950875|NCT01970527|449447427|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
124950876|NCT01970527|449447426|FG000|Treatment|Death|0|||
124950877|NCT01970527|449447427|FG001|Treatment|Death|1|||
124950878|NCT01970527|449447426|FG000|Follow-up Clinic Visit|Disease progression|1|||
124950879|NCT01970527|449447427|FG001|Follow-up Clinic Visit|Disease progression|1|||
124950880|NCT01970527|449447426|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
124950881|NCT01970527|449447427|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
124950882|NCT01970527|449447426|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
124950883|NCT01970527|449447427|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
124950884|NCT01115309|449447428|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
124950885|NCT01115309|449447428|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
124950886|NCT01115309|449447428|FG000|Long-term Follow-up|Lost to Follow-up|6|||
124950887|NCT04447287|449447429|FG000|Period 1: Run-in Period|Adverse Event|3|||
124950888|NCT04447287|449447430|FG001|Period 1: Run-in Period|Adverse Event|0|||
124950889|NCT04447287|449447431|FG002|Period 1: Run-in Period|Adverse Event|0|||
124950890|NCT04447287|449447429|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
124950891|NCT04447287|449447430|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
124950892|NCT04447287|449447431|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
124950893|NCT04447287|449447429|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
124950894|NCT04447287|449447430|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
124950895|NCT04447287|449447431|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
124950896|NCT05700851|449447432|FG000|Overall Study|Received a kidney transplant|1|||
124950897|NCT05700851|449447432|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
124950898|NCT05700851|449447432|FG000|Overall Study|Withdrawal by Subject|1|||
124950899|NCT02147093|449447435|FG000|Period 1|Lost to Follow-up|0|||
124950900|NCT02147093|449447436|FG001|Period 1|Lost to Follow-up|1|||
124950901|NCT02147093|449447435|FG000|Period 2|Protocol Violation|2|||
124950902|NCT02147093|449447436|FG001|Period 2|Protocol Violation|0|||
124950903|NCT03246724|449447437|FG000|Overall Study|Withdrawal by Subject|5|||
124950904|NCT03246724|449447438|FG001|Overall Study|Withdrawal by Subject|2|||
124950905|NCT03246724|449447439|FG002|Overall Study|Withdrawal by Subject|4|||
124950906|NCT03246724|449447440|FG003|Overall Study|Withdrawal by Subject|2|||
124950907|NCT03246724|449447437|FG000|Overall Study|Ineligible on day of surgery|7|||
124950908|NCT03246724|449447438|FG001|Overall Study|Ineligible on day of surgery|2|||
124950909|NCT03246724|449447439|FG002|Overall Study|Ineligible on day of surgery|0|||
124950910|NCT03246724|449447440|FG003|Overall Study|Ineligible on day of surgery|3|||
124950911|NCT03246724|449447437|FG000|Overall Study|Study completed before surgical date|2|||
124950912|NCT03246724|449447438|FG001|Overall Study|Study completed before surgical date|1|||
124950913|NCT03246724|449447439|FG002|Overall Study|Study completed before surgical date|8|||
124950914|NCT03246724|449447440|FG003|Overall Study|Study completed before surgical date|1|||
124950915|NCT03246724|449447437|FG000|Overall Study|Transferred to other arm|0|||
124950916|NCT03246724|449447438|FG001|Overall Study|Transferred to other arm|0|||
124950917|NCT03246724|449447439|FG002|Overall Study|Transferred to other arm|1|||
124950918|NCT03246724|449447440|FG003|Overall Study|Transferred to other arm|0|||
124950919|NCT03246724|449447437|FG000|Overall Study|Unable to obtain medication timely|0|||
124950920|NCT03246724|449447438|FG001|Overall Study|Unable to obtain medication timely|2|||
124950921|NCT03246724|449447439|FG002|Overall Study|Unable to obtain medication timely|2|||
124950922|NCT03246724|449447440|FG003|Overall Study|Unable to obtain medication timely|1|||
124950923|NCT03246724|449447437|FG000|Overall Study|Re-consented to participate|0|||
124950924|NCT03246724|449447438|FG001|Overall Study|Re-consented to participate|0|||
124950925|NCT03246724|449447439|FG002|Overall Study|Re-consented to participate|0|||
124950926|NCT03246724|449447440|FG003|Overall Study|Re-consented to participate|1|||
124950927|NCT00655824|449447441|FG000|Overall Study|Adverse Event|3|||
124950928|NCT00655824|449447441|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
124950929|NCT00655824|449447441|FG000|Overall Study|Protocol Violation|1|||
124950930|NCT00655824|449447441|FG000|Overall Study|Withdrawal by Subject|4|||
125124807|NCT02732210|450082471|FG001|Overall Study|Withdrawal by Subject|87|||
125124808|NCT02732210|450082470|FG000|Overall Study|Lost to Follow-up|5|||
125124809|NCT02732210|450082471|FG001|Overall Study|Lost to Follow-up|57|||
125124810|NCT02732210|450082470|FG000|Overall Study|Death|4|||
125124811|NCT02732210|450082471|FG001|Overall Study|Death|15|||
125124812|NCT02732210|450082470|FG000|Overall Study|Other|35|||
125124813|NCT02732210|450082471|FG001|Overall Study|Other|103|||
125124814|NCT02732210|450082470|FG000|Overall Study|Missing|0|||
124950931|NCT00655824|449447441|FG000|Overall Study|Deterioration of Trial Disease|2|||
124950932|NCT00589628|449447442|FG000|Overall Study|Lost to Follow-up|0|||
125124815|NCT02732210|450082471|FG001|Overall Study|Missing|8|||
124950933|NCT00589628|449447443|FG001|Overall Study|Lost to Follow-up|1|||
124950934|NCT03032198|449447451|FG000|Overall Study|Screen Fail|1|||
124950935|NCT01307800|449447453|FG000|Overall Study|Adverse Event|9|||
124950936|NCT01307800|449447454|FG001|Overall Study|Adverse Event|8|||
124950937|NCT01307800|449447455|FG002|Overall Study|Adverse Event|10|||
124950938|NCT01307800|449447456|FG003|Overall Study|Adverse Event|14|||
124950939|NCT01307800|449447453|FG000|Overall Study|Entry Criteria Not Met|0|||
124950940|NCT01307800|449447454|FG001|Overall Study|Entry Criteria Not Met|0|||
124950941|NCT01307800|449447455|FG002|Overall Study|Entry Criteria Not Met|0|||
124950942|NCT01307800|449447456|FG003|Overall Study|Entry Criteria Not Met|2|||
124950943|NCT01307800|449447453|FG000|Overall Study|Lost to Follow-up|5|||
124950944|NCT01307800|449447454|FG001|Overall Study|Lost to Follow-up|6|||
124950945|NCT01307800|449447455|FG002|Overall Study|Lost to Follow-up|2|||
124950946|NCT01307800|449447456|FG003|Overall Study|Lost to Follow-up|8|||
124950947|NCT01307800|449447453|FG000|Overall Study|Perceived Lack of Efficacy|24|||
124950948|NCT01307800|449447454|FG001|Overall Study|Perceived Lack of Efficacy|23|||
124950949|NCT01307800|449447455|FG002|Overall Study|Perceived Lack of Efficacy|20|||
124950950|NCT01307800|449447456|FG003|Overall Study|Perceived Lack of Efficacy|33|||
124950951|NCT01307800|449447453|FG000|Overall Study|Protocol Violation|0|||
124950952|NCT01307800|449447454|FG001|Overall Study|Protocol Violation|3|||
124950953|NCT01307800|449447455|FG002|Overall Study|Protocol Violation|4|||
124950954|NCT01307800|449447456|FG003|Overall Study|Protocol Violation|5|||
124950955|NCT01307800|449447453|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
124950956|NCT01307800|449447454|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
124950957|NCT01307800|449447455|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
124950958|NCT01307800|449447456|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
124950959|NCT01307800|449447453|FG000|Overall Study|Sponsor Decision|6|||
124950960|NCT01307800|449447454|FG001|Overall Study|Sponsor Decision|9|||
124950961|NCT01307800|449447455|FG002|Overall Study|Sponsor Decision|12|||
124950962|NCT01307800|449447456|FG003|Overall Study|Sponsor Decision|28|||
124950963|NCT01307800|449447453|FG000|Overall Study|Withdrawal by Subject|10|||
124950964|NCT01307800|449447454|FG001|Overall Study|Withdrawal by Subject|11|||
124950965|NCT01307800|449447455|FG002|Overall Study|Withdrawal by Subject|8|||
124950966|NCT01307800|449447456|FG003|Overall Study|Withdrawal by Subject|15|||
124950967|NCT01307800|449447453|FG000|Overall Study|Participant Moved|0|||
124950968|NCT01307800|449447454|FG001|Overall Study|Participant Moved|2|||
124950969|NCT01307800|449447455|FG002|Overall Study|Participant Moved|1|||
124950970|NCT01307800|449447456|FG003|Overall Study|Participant Moved|3|||
124950971|NCT02892019|449447457|FG000|Overall Study|randomized but not treated|0|||
124950972|NCT02892019|449447458|FG001|Overall Study|randomized but not treated|1|||
124950973|NCT02892019|449447457|FG000|Overall Study|Withdrawal by Subject|0|||
124950974|NCT02892019|449447458|FG001|Overall Study|Withdrawal by Subject|1|||
124950975|NCT02892019|449447457|FG000|Overall Study|Adverse Event|1|||
124950976|NCT02892019|449447458|FG001|Overall Study|Adverse Event|1|||
124950977|NCT00689351|449447459|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
124950978|NCT00689351|449447460|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
124950979|NCT00689351|449447459|FG000|Infant Series of Dosing|Adverse Event|1|||
124950980|NCT00689351|449447460|FG001|Infant Series of Dosing|Adverse Event|0|||
124950981|NCT00689351|449447459|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
124950982|NCT00689351|449447460|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
124950983|NCT00689351|449447459|FG000|After Infant Series|Parent/legal guardian request|1|||
124950984|NCT00689351|449447460|FG001|After Infant Series|Parent/legal guardian request|0|||
124950985|NCT01766206|449447461|FG000|Overall Study|Withdrawal by Subject|22|||
124950986|NCT01766206|449447461|FG000|Overall Study|Lost to Follow-up|10|||
124950987|NCT01766206|449447461|FG000|Overall Study|Inappropriate enrollment|18|||
124950988|NCT01766206|449447461|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
124950989|NCT01662505|449447462|FG000|Overall Study|Progressive disease|6|||
124950990|NCT01662505|449447463|FG001|Overall Study|Progressive disease|1|||
124950991|NCT01662505|449447464|FG002|Overall Study|Progressive disease|5|||
124950992|NCT01662505|449447462|FG000|Overall Study|Refused cont. medication|0|||
124950993|NCT01662505|449447463|FG001|Overall Study|Refused cont. medication|0|||
124950994|NCT01662505|449447464|FG002|Overall Study|Refused cont. medication|1|||
124950995|NCT01662505|449447462|FG000|Overall Study|Not specified above|1|||
124950996|NCT01662505|449447463|FG001|Overall Study|Not specified above|3|||
124950997|NCT01662505|449447464|FG002|Overall Study|Not specified above|2|||
125029996|NCT05195528|449732744|FG000|Placebo-controlled Treatment Period|Other|0|||
125029997|NCT05195528|449732745|FG001|Placebo-controlled Treatment Period|Other|0|||
124950998|NCT01313663|449447465|FG000|Overall Study|Study Closed/Terminated|2|||
124950999|NCT01313663|449447466|FG001|Overall Study|Study Closed/Terminated|4|||
125029998|NCT05195528|449732746|FG002|Placebo-controlled Treatment Period|Other|1|||
124951000|NCT01313663|449447465|FG000|Overall Study|Lost to Follow-up|0|||
124951001|NCT01313663|449447466|FG001|Overall Study|Lost to Follow-up|1|||
124951002|NCT01313663|449447465|FG000|Overall Study|Physician Decision|0|||
124951003|NCT01313663|449447466|FG001|Overall Study|Physician Decision|2|||
124951004|NCT01313663|449447465|FG000|Overall Study|Withdrawal by Subject|2|||
124951005|NCT01313663|449447466|FG001|Overall Study|Withdrawal by Subject|1|||
124951006|NCT02255474|449447467|FG000|Overall Study|Lost to Follow-up|1|||
124951007|NCT02255474|449447468|FG001|Overall Study|Lost to Follow-up|1|||
124951008|NCT02255474|449447469|FG002|Overall Study|Lost to Follow-up|3|||
124951009|NCT02255474|449447467|FG000|Overall Study|Withdrawal by Subject|1|||
124951010|NCT02255474|449447468|FG001|Overall Study|Withdrawal by Subject|1|||
124951011|NCT02255474|449447469|FG002|Overall Study|Withdrawal by Subject|0|||
124951012|NCT01229176|449447473|FG000|Overall Study|Withdrawal by Subject|0|||
124951013|NCT01229176|449447474|FG001|Overall Study|Withdrawal by Subject|0|||
124951014|NCT01229176|449447475|FG002|Overall Study|Withdrawal by Subject|0|||
124951015|NCT01229176|449447476|FG003|Overall Study|Withdrawal by Subject|1|||
124951016|NCT01229176|449447477|FG004|Overall Study|Withdrawal by Subject|1|||
124951017|NCT01229176|449447478|FG005|Overall Study|Withdrawal by Subject|1|||
124951018|NCT01229176|449447479|FG006|Overall Study|Withdrawal by Subject|0|||
124951019|NCT01229176|449447480|FG007|Overall Study|Withdrawal by Subject|1|||
124951020|NCT01229176|449447473|FG000|Overall Study|Lost to Follow-up|0|||
124951021|NCT01229176|449447474|FG001|Overall Study|Lost to Follow-up|3|||
124951022|NCT01229176|449447475|FG002|Overall Study|Lost to Follow-up|0|||
124951023|NCT01229176|449447476|FG003|Overall Study|Lost to Follow-up|0|||
124951024|NCT01229176|449447477|FG004|Overall Study|Lost to Follow-up|1|||
124951025|NCT01229176|449447478|FG005|Overall Study|Lost to Follow-up|1|||
124951026|NCT01229176|449447479|FG006|Overall Study|Lost to Follow-up|0|||
124951027|NCT01229176|449447480|FG007|Overall Study|Lost to Follow-up|2|||
124951028|NCT02367794|449447488|FG000|Overall Study|Death|252|||
124951029|NCT02367794|449447489|FG001|Overall Study|Death|245|||
124951030|NCT02367794|449447490|FG002|Overall Study|Death|243|||
124951031|NCT02367794|449447488|FG000|Overall Study|Lost to Follow-up|1|||
124951032|NCT02367794|449447489|FG001|Overall Study|Lost to Follow-up|2|||
124951033|NCT02367794|449447490|FG002|Overall Study|Lost to Follow-up|2|||
124951034|NCT02367794|449447488|FG000|Overall Study|Physician Decision|0|||
124951035|NCT02367794|449447489|FG001|Overall Study|Physician Decision|5|||
124951036|NCT02367794|449447490|FG002|Overall Study|Physician Decision|3|||
124951037|NCT02367794|449447488|FG000|Overall Study|Protocol Violation|1|||
124951038|NCT02367794|449447489|FG001|Overall Study|Protocol Violation|0|||
124951039|NCT02367794|449447490|FG002|Overall Study|Protocol Violation|1|||
124951040|NCT02367794|449447488|FG000|Overall Study|Withdrawal by Subject|25|||
124951041|NCT02367794|449447489|FG001|Overall Study|Withdrawal by Subject|12|||
124951042|NCT02367794|449447490|FG002|Overall Study|Withdrawal by Subject|20|||
124951043|NCT02367794|449447488|FG000|Overall Study|Brain metastasis|1|||
124951044|NCT02367794|449447489|FG001|Overall Study|Brain metastasis|0|||
124951045|NCT02367794|449447490|FG002|Overall Study|Brain metastasis|0|||
124951046|NCT02367794|449447488|FG000|Overall Study|Randomized in error|0|||
124951047|NCT02367794|449447489|FG001|Overall Study|Randomized in error|0|||
124951048|NCT02367794|449447490|FG002|Overall Study|Randomized in error|1|||
124951049|NCT02367794|449447488|FG000|Overall Study|Patient unable to receive carboplatin|0|||
124951050|NCT02367794|449447489|FG001|Overall Study|Patient unable to receive carboplatin|0|||
124951051|NCT02367794|449447490|FG002|Overall Study|Patient unable to receive carboplatin|1|||
124951052|NCT02367794|449447488|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
124951053|NCT02367794|449447489|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
124951054|NCT02367794|449447490|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
124951055|NCT02367794|449447488|FG000|Overall Study|Adverse Event|0|||
124951056|NCT02367794|449447489|FG001|Overall Study|Adverse Event|0|||
124951057|NCT02367794|449447490|FG002|Overall Study|Adverse Event|2|||
124951058|NCT02367794|449447488|FG000|Overall Study|Study Terminated By Sponsor|0|||
124951059|NCT02367794|449447489|FG001|Overall Study|Study Terminated By Sponsor|1|||
124951060|NCT02367794|449447490|FG002|Overall Study|Study Terminated By Sponsor|1|||
124951061|NCT02367794|449447488|FG000|Overall Study|Moved to Roll-Over Study|0|||
125215078|NCT03026283|450414897|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
125215079|NCT03026283|450414898|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
125215080|NCT03026283|450414899|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
125215081|NCT03782571|450414900|FG000|Period 1|Withdrawal by Subject|1|||
125215082|NCT03782571|450414901|FG001|Period 1|Withdrawal by Subject|0|||
125215083|NCT03782571|450414902|FG002|Period 1|Withdrawal by Subject|0|||
124951062|NCT02367794|449447489|FG001|Overall Study|Moved to Roll-Over Study|15|||
125215084|NCT03782571|450414903|FG003|Period 1|Withdrawal by Subject|0|||
124951063|NCT02367794|449447490|FG002|Overall Study|Moved to Roll-Over Study|13|||
124951064|NCT02367794|449447488|FG000|Overall Study|Sponsor Request|60|||
124951065|NCT02367794|449447489|FG001|Overall Study|Sponsor Request|57|||
124951066|NCT02367794|449447490|FG002|Overall Study|Sponsor Request|45|||
124951067|NCT02367794|449447488|FG000|Overall Study|Moved into PTAP Study|0|||
124951068|NCT02367794|449447489|FG001|Overall Study|Moved into PTAP Study|2|||
124951069|NCT02367794|449447490|FG002|Overall Study|Moved into PTAP Study|3|||
124951070|NCT02367794|449447488|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
124951071|NCT02367794|449447489|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
124951072|NCT02367794|449447490|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
125029999|NCT05195528|449732747|FG003|Placebo-controlled Treatment Period|Other|0|||
125030000|NCT05195528|449732748|FG004|Placebo-controlled Treatment Period|Other|0|||
124951073|NCT02367794|449447488|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
124951074|NCT02367794|449447489|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
124951075|NCT02367794|449447490|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
124951076|NCT02367794|449447488|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
124951077|NCT02367794|449447489|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
124951078|NCT02367794|449447490|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
124951079|NCT02367794|449447488|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
124951080|NCT02367794|449447489|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
125124816|NCT04638153|450082472|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125124817|NCT04638153|450082473|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125124818|NCT04638153|450082474|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125124819|NCT04638153|450082472|FG000|Overall Study|Study terminated by sponsor|4|||
125124820|NCT04638153|450082473|FG001|Overall Study|Study terminated by sponsor|2|||
125124821|NCT04638153|450082474|FG002|Overall Study|Study terminated by sponsor|14|||
125124822|NCT04006171|450082475|FG000|Overall Study|Withdrawal by Subject|8|||
125124823|NCT04006171|450082476|FG001|Overall Study|Withdrawal by Subject|7|||
125124824|NCT04006171|450082475|FG000|Overall Study|missing serum samples|2|||
125124825|NCT04006171|450082476|FG001|Overall Study|missing serum samples|2|||
125124826|NCT04006171|450082475|FG000|Overall Study|insufficient sample volume|2|||
125124827|NCT04006171|450082476|FG001|Overall Study|insufficient sample volume|3|||
125124828|NCT01440283|450082477|FG000|Overall Study|Death|3|||
125124829|NCT01440283|450082477|FG000|Overall Study|Withdrawal by Subject|4|||
125124830|NCT01440283|450082477|FG000|Overall Study|Physician Decision|3|||
124951081|NCT02367794|449447490|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
124951082|NCT00882050|449447491|FG000|Overall Study|Physician Decision|1|||
124951083|NCT00882050|449447492|FG001|Overall Study|Physician Decision|0|||
124951084|NCT00882050|449447493|FG002|Overall Study|Physician Decision|0|||
124951085|NCT02010684|449447494|FG000|Overall Study|Lost to Follow-up|8|||
125124831|NCT00537030|450082478|FG000|Overall Study|Physician Decision|2|||
125124832|NCT00537030|450082478|FG000|Overall Study|Withdrawal by Subject|2|||
125124833|NCT00537030|450082478|FG000|Overall Study|≥ Grade 2 allergy|7|||
125124834|NCT00537030|450082478|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
125124835|NCT00537030|450082478|FG000|Overall Study|Ineligible|2|||
125124836|NCT00537030|450082478|FG000|Overall Study|Inevaluable|2|||
125124837|NCT06354270|450082479|FG000|Overall Study|Withdrawal by Subject|1|||
125124838|NCT06354270|450082480|FG001|Overall Study|Withdrawal by Subject|0|||
125124839|NCT01939197|450082481|FG000|Overall Study|Withdrawal by Subject|1|||
125124840|NCT01939197|450082482|FG001|Overall Study|Withdrawal by Subject|0|||
125124841|NCT01939197|450082483|FG002|Overall Study|Withdrawal by Subject|0|||
125124842|NCT01939197|450082484|FG003|Overall Study|Withdrawal by Subject|0|||
125124843|NCT01939197|450082485|FG004|Overall Study|Withdrawal by Subject|1|||
125124844|NCT01939197|450082486|FG005|Overall Study|Withdrawal by Subject|0|||
124951086|NCT02010684|449447495|FG001|Overall Study|Lost to Follow-up|18|||
124951087|NCT02010684|449447494|FG000|Overall Study|Withdrawal by Subject|4|||
124951088|NCT02010684|449447495|FG001|Overall Study|Withdrawal by Subject|5|||
124951089|NCT02612285|449447496|FG000|Overall Study|Withdrawal by Subject|1|||
124951090|NCT00805441|449447497|FG000|Overall Study|Adverse Event|5|||
124951091|NCT00805441|449447498|FG001|Overall Study|Adverse Event|2|||
124951092|NCT00805441|449447497|FG000|Overall Study|Lack of Efficacy|0|||
124951093|NCT00805441|449447498|FG001|Overall Study|Lack of Efficacy|2|||
124951094|NCT00805441|449447497|FG000|Overall Study|Protocol Violation|4|||
124951095|NCT00805441|449447498|FG001|Overall Study|Protocol Violation|8|||
124951096|NCT00805441|449447497|FG000|Overall Study|Lost to Follow-up|10|||
124951097|NCT00805441|449447498|FG001|Overall Study|Lost to Follow-up|13|||
124951098|NCT00805441|449447497|FG000|Overall Study|Withdrawal by Subject|15|||
124951099|NCT00805441|449447498|FG001|Overall Study|Withdrawal by Subject|9|||
124951100|NCT00805441|449447497|FG000|Overall Study|Physician Decision|0|||
124951101|NCT00805441|449447498|FG001|Overall Study|Physician Decision|1|||
124951102|NCT00805441|449447497|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
124951103|NCT00805441|449447498|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
124951104|NCT01884571|449447503|FG000|Overall Study|Adverse Event|1|||
124951105|NCT01884571|449447503|FG000|Overall Study|Death|2|||
124951106|NCT01884571|449447503|FG000|Overall Study|Withdrawal by Subject|2|||
124951107|NCT01884571|449447503|FG000|Overall Study|Disease progression|3|||
124951108|NCT00091572|449447504|FG000|Overall Study|Lost to Follow-up|1|||
124951109|NCT00091572|449447505|FG001|Overall Study|Lost to Follow-up|1|||
124951110|NCT00091572|449447504|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
124951111|NCT00091572|449447505|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
124951112|NCT00091572|449447504|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
124951113|NCT00091572|449447505|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
124951114|NCT00091572|449447504|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
124951115|NCT00091572|449447505|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
124951116|NCT00091572|449447504|FG000|Overall Study|Other Reason|6|||
124951117|NCT00091572|449447505|FG001|Overall Study|Other Reason|13|||
124951118|NCT00091572|449447504|FG000|Overall Study|Ongoing (still on treatment)|8|||
124951119|NCT00091572|449447505|FG001|Overall Study|Ongoing (still on treatment)|12|||
124951120|NCT00091572|449447504|FG000|Overall Study|Major Protocol Violation|2|||
124951121|NCT00091572|449447505|FG001|Overall Study|Major Protocol Violation|0|||
124951122|NCT00091572|449447504|FG000|Overall Study|Toxicity (Related AE)|53|||
124951123|NCT00091572|449447505|FG001|Overall Study|Toxicity (Related AE)|9|||
124951124|NCT02942771|449447507|FG000|Overall Study|Adverse Event|1|||
124951125|NCT02942771|449447508|FG001|Overall Study|Adverse Event|0|||
124951126|NCT02942771|449447509|FG002|Overall Study|Adverse Event|0|||
124951127|NCT02942771|449447510|FG003|Overall Study|Adverse Event|0|||
124951128|NCT02942771|449447511|FG004|Overall Study|Adverse Event|2|||
124951129|NCT02942771|449447507|FG000|Overall Study|Lost to Follow-up|1|||
124951130|NCT02942771|449447508|FG001|Overall Study|Lost to Follow-up|0|||
124951131|NCT02942771|449447509|FG002|Overall Study|Lost to Follow-up|0|||
124951132|NCT02942771|449447510|FG003|Overall Study|Lost to Follow-up|0|||
124951133|NCT02942771|449447511|FG004|Overall Study|Lost to Follow-up|0|||
124951134|NCT02942771|449447507|FG000|Overall Study|Withdrawal by Subject|1|||
124951135|NCT02942771|449447508|FG001|Overall Study|Withdrawal by Subject|0|||
124951136|NCT02942771|449447509|FG002|Overall Study|Withdrawal by Subject|0|||
124951137|NCT02942771|449447510|FG003|Overall Study|Withdrawal by Subject|0|||
124951138|NCT02942771|449447511|FG004|Overall Study|Withdrawal by Subject|2|||
124951139|NCT02340806|449447515|FG000|Overall Study|Protocol Violation|2|||
124951140|NCT02340806|449447516|FG001|Overall Study|Protocol Violation|0|||
124951141|NCT02340806|449447515|FG000|Overall Study|epidural catheter replaced|2|||
124951142|NCT02340806|449447516|FG001|Overall Study|epidural catheter replaced|1|||
124951143|NCT02340806|449447515|FG000|Overall Study|history of chronic pain medication|1|||
124951144|NCT02340806|449447516|FG001|Overall Study|history of chronic pain medication|0|||
124951145|NCT02340806|449447515|FG000|Overall Study|re-dose < 90 min of CSE|1|||
124951146|NCT02340806|449447516|FG001|Overall Study|re-dose < 90 min of CSE|3|||
124951147|NCT01186809|449447517|FG000|Overall Study|Death|30|||
125030001|NCT05195528|449732744|FG000|Extension Period|PTE or AE or SAE|0|||
125030002|NCT05195528|449732745|FG001|Extension Period|PTE or AE or SAE|4|||
125030003|NCT05195528|449732746|FG002|Extension Period|PTE or AE or SAE|5|||
124951148|NCT00452452|449447518|FG000|Overall Study|Protocol Violation|0|||
124951149|NCT00452452|449447519|FG001|Overall Study|Protocol Violation|0|||
124951150|NCT00452452|449447520|FG002|Overall Study|Protocol Violation|1|||
124951151|NCT00452452|449447518|FG000|Overall Study|Withdrawal by Subject|1|||
124951152|NCT00452452|449447519|FG001|Overall Study|Withdrawal by Subject|0|||
124951153|NCT00452452|449447520|FG002|Overall Study|Withdrawal by Subject|0|||
124951154|NCT00452452|449447518|FG000|Overall Study|Lost to Follow-up|1|||
124951155|NCT00452452|449447519|FG001|Overall Study|Lost to Follow-up|0|||
125030004|NCT05195528|449732747|FG003|Extension Period|PTE or AE or SAE|4|||
125030005|NCT05195528|449732748|FG004|Extension Period|PTE or AE or SAE|4|||
124951156|NCT00452452|449447520|FG002|Overall Study|Lost to Follow-up|0|||
124951157|NCT01159600|449447526|FG000|Overall Study|Not treated|0|||
124951158|NCT01159600|449447527|FG001|Overall Study|Not treated|0|||
124951159|NCT01159600|449447528|FG002|Overall Study|Not treated|1|||
124951160|NCT01159600|449447529|FG003|Overall Study|Not treated|0|||
124951161|NCT01159600|449447530|FG004|Overall Study|Not treated|0|||
124951162|NCT01159600|449447531|FG005|Overall Study|Not treated|1|||
124951163|NCT01159600|449447532|FG006|Overall Study|Not treated|2|||
124951164|NCT01159600|449447533|FG007|Overall Study|Not treated|2|||
124951165|NCT01159600|449447526|FG000|Overall Study|Adverse Event|7|||
124951166|NCT01159600|449447527|FG001|Overall Study|Adverse Event|2|||
124951167|NCT01159600|449447528|FG002|Overall Study|Adverse Event|5|||
124951168|NCT01159600|449447529|FG003|Overall Study|Adverse Event|1|||
124951169|NCT01159600|449447530|FG004|Overall Study|Adverse Event|8|||
124951170|NCT01159600|449447531|FG005|Overall Study|Adverse Event|6|||
124951171|NCT01159600|449447532|FG006|Overall Study|Adverse Event|7|||
124951172|NCT01159600|449447533|FG007|Overall Study|Adverse Event|5|||
124951173|NCT01159600|449447526|FG000|Overall Study|Lack of Efficacy|0|||
124951174|NCT01159600|449447527|FG001|Overall Study|Lack of Efficacy|0|||
124951175|NCT01159600|449447528|FG002|Overall Study|Lack of Efficacy|0|||
124951176|NCT01159600|449447529|FG003|Overall Study|Lack of Efficacy|0|||
124951177|NCT01159600|449447530|FG004|Overall Study|Lack of Efficacy|2|||
124951178|NCT01159600|449447531|FG005|Overall Study|Lack of Efficacy|0|||
124951179|NCT01159600|449447532|FG006|Overall Study|Lack of Efficacy|0|||
124951180|NCT01159600|449447533|FG007|Overall Study|Lack of Efficacy|1|||
124951181|NCT01159600|449447526|FG000|Overall Study|Non compliant with protocol|2|||
124951182|NCT01159600|449447527|FG001|Overall Study|Non compliant with protocol|1|||
124951183|NCT01159600|449447528|FG002|Overall Study|Non compliant with protocol|0|||
124951184|NCT01159600|449447529|FG003|Overall Study|Non compliant with protocol|0|||
124951185|NCT01159600|449447530|FG004|Overall Study|Non compliant with protocol|2|||
124951186|NCT01159600|449447531|FG005|Overall Study|Non compliant with protocol|0|||
124951187|NCT01159600|449447532|FG006|Overall Study|Non compliant with protocol|2|||
124951188|NCT01159600|449447533|FG007|Overall Study|Non compliant with protocol|0|||
124951189|NCT01159600|449447526|FG000|Overall Study|Lost to Follow-up|2|||
124951190|NCT01159600|449447527|FG001|Overall Study|Lost to Follow-up|3|||
124951191|NCT01159600|449447528|FG002|Overall Study|Lost to Follow-up|4|||
124951192|NCT01159600|449447529|FG003|Overall Study|Lost to Follow-up|3|||
124951193|NCT01159600|449447530|FG004|Overall Study|Lost to Follow-up|3|||
124951194|NCT01159600|449447531|FG005|Overall Study|Lost to Follow-up|0|||
124951195|NCT01159600|449447532|FG006|Overall Study|Lost to Follow-up|3|||
124951196|NCT01159600|449447533|FG007|Overall Study|Lost to Follow-up|2|||
124951197|NCT01159600|449447526|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
124951198|NCT01159600|449447527|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
124951199|NCT01159600|449447528|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
124951200|NCT01159600|449447529|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
124951201|NCT01159600|449447530|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
124951202|NCT01159600|449447531|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
124951203|NCT01159600|449447532|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
124951204|NCT01159600|449447533|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
124951205|NCT01159600|449447526|FG000|Overall Study|Other reason not defined above|3|||
124951206|NCT01159600|449447527|FG001|Overall Study|Other reason not defined above|0|||
124951207|NCT01159600|449447528|FG002|Overall Study|Other reason not defined above|4|||
124951208|NCT01159600|449447529|FG003|Overall Study|Other reason not defined above|2|||
124951209|NCT01159600|449447530|FG004|Overall Study|Other reason not defined above|5|||
124951210|NCT01159600|449447531|FG005|Overall Study|Other reason not defined above|7|||
124951211|NCT01159600|449447532|FG006|Overall Study|Other reason not defined above|3|||
124951212|NCT01159600|449447533|FG007|Overall Study|Other reason not defined above|3|||
124951213|NCT04433091|449447534|FG000|Overall Study|Lost to Follow-up|1|||
124951214|NCT04433091|449447535|FG001|Overall Study|Lost to Follow-up|0|||
124951215|NCT04433091|449447534|FG000|Overall Study|Withdrawn .|2|||
124951216|NCT04433091|449447535|FG001|Overall Study|Withdrawn .|4|||
124951217|NCT04097535|449447536|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
124951218|NCT03070301|449447537|FG000|Overall Study|Progression of disease|16|||
124951219|NCT03070301|449447537|FG000|Overall Study|Physician Decision|3|||
124951220|NCT03070301|449447537|FG000|Overall Study|Withdrawal by Subject|1|||
124951221|NCT01975701|449449421|FG000|Overall Study|Lost to Follow-up|1|||
124951222|NCT01975701|449449421|FG000|Overall Study|Death|23|||
124951223|NCT01975701|449449421|FG000|Overall Study|Physician Decision|1|||
124951224|NCT01072149|449449424|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951225|NCT01072149|449449425|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951226|NCT01072149|449449426|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
124951227|NCT01072149|449449427|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951228|NCT01072149|449449428|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951229|NCT01072149|449449429|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951230|NCT01072149|449449430|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951231|NCT01072149|449449431|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951232|NCT01072149|449449432|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951233|NCT01072149|449449433|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951234|NCT01072149|449449434|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951235|NCT01072149|449449435|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951236|NCT01072149|449449436|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951237|NCT01072149|449449437|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951238|NCT01072149|449449438|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951239|NCT01072149|449449439|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951240|NCT01072149|449449440|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951241|NCT01072149|449449441|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951242|NCT01072149|449449424|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951243|NCT01072149|449449425|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951244|NCT01072149|449449426|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951245|NCT01072149|449449427|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951246|NCT01072149|449449428|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951247|NCT01072149|449449429|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951248|NCT01072149|449449430|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951249|NCT01072149|449449431|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951250|NCT01072149|449449432|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951251|NCT01072149|449449433|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951252|NCT01072149|449449434|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951253|NCT01072149|449449435|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951254|NCT01072149|449449436|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951255|NCT01072149|449449437|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951256|NCT01072149|449449438|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951257|NCT01072149|449449439|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951258|NCT01072149|449449440|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951259|NCT01072149|449449441|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
124951260|NCT01072149|449449424|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951261|NCT01072149|449449425|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951262|NCT01072149|449449426|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951263|NCT01072149|449449427|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951264|NCT01072149|449449428|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951265|NCT01072149|449449429|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951266|NCT01072149|449449430|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951267|NCT01072149|449449431|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951268|NCT01072149|449449432|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951269|NCT01072149|449449433|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951270|NCT01072149|449449434|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
124951271|NCT01072149|449449435|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951272|NCT01072149|449449436|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951273|NCT01072149|449449437|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951274|NCT01072149|449449438|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951275|NCT01072149|449449439|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951276|NCT01072149|449449440|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951277|NCT01072149|449449441|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951278|NCT01072149|449449424|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951279|NCT01072149|449449425|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
124951280|NCT01072149|449449426|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951281|NCT01072149|449449427|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951282|NCT01072149|449449428|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951283|NCT01072149|449449429|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951284|NCT01072149|449449430|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951285|NCT01072149|449449431|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951286|NCT01072149|449449432|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951287|NCT01072149|449449433|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951288|NCT01072149|449449434|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951289|NCT01072149|449449435|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951290|NCT01072149|449449436|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951291|NCT01072149|449449437|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951292|NCT01072149|449449438|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951293|NCT01072149|449449439|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125030006|NCT05195528|449732744|FG000|Extension Period|Protocol Violation|0|||
125030007|NCT05195528|449732745|FG001|Extension Period|Protocol Violation|2|||
124951294|NCT01072149|449449440|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951295|NCT01072149|449449441|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951296|NCT01072149|449449424|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951297|NCT01072149|449449425|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951298|NCT01072149|449449426|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
124951299|NCT01072149|449449427|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951300|NCT01072149|449449428|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951301|NCT01072149|449449429|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951302|NCT01072149|449449430|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951303|NCT01072149|449449431|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951304|NCT01072149|449449432|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951305|NCT01072149|449449433|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951306|NCT01072149|449449434|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951307|NCT01072149|449449435|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951308|NCT01072149|449449436|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951309|NCT01072149|449449437|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951310|NCT01072149|449449438|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951311|NCT01072149|449449439|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951312|NCT01072149|449449440|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951313|NCT01072149|449449441|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951314|NCT01072149|449449424|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951315|NCT01072149|449449425|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951316|NCT01072149|449449426|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951317|NCT01072149|449449427|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951318|NCT01072149|449449428|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951319|NCT01072149|449449429|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951320|NCT01072149|449449430|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951321|NCT01072149|449449431|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
124951322|NCT01072149|449449432|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951323|NCT01072149|449449433|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951324|NCT01072149|449449434|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951325|NCT01072149|449449435|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951326|NCT01072149|449449436|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951327|NCT01072149|449449437|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951328|NCT01072149|449449438|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951329|NCT01072149|449449439|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951330|NCT01072149|449449440|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951331|NCT01072149|449449441|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951332|NCT01072149|449449424|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
124951333|NCT01072149|449449425|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
124951334|NCT01072149|449449426|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
124951335|NCT01072149|449449427|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
125124845|NCT01939197|450082487|FG006|Overall Study|Withdrawal by Subject|0|||
125124846|NCT01939197|450082481|FG000|Overall Study|Lost to Follow-up|0|||
125124847|NCT01939197|450082482|FG001|Overall Study|Lost to Follow-up|1|||
124951336|NCT01072149|449449428|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
125124848|NCT01939197|450082483|FG002|Overall Study|Lost to Follow-up|0|||
124951337|NCT01072149|449449429|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
124951338|NCT01072149|449449430|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
124951339|NCT01072149|449449431|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
124951340|NCT01072149|449449432|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
124951341|NCT01072149|449449433|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
124951342|NCT01072149|449449434|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
124951343|NCT01072149|449449435|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
124951344|NCT01072149|449449436|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
124951345|NCT01072149|449449437|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
124951346|NCT01072149|449449438|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
124951347|NCT01072149|449449439|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
124951348|NCT01072149|449449440|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
124951349|NCT01072149|449449441|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
124951350|NCT01072149|449449424|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951351|NCT01072149|449449425|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951352|NCT01072149|449449426|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951353|NCT01072149|449449427|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951354|NCT01072149|449449428|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951355|NCT01072149|449449429|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951356|NCT01072149|449449430|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951357|NCT01072149|449449431|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951358|NCT01072149|449449432|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951359|NCT01072149|449449433|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951360|NCT01072149|449449434|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951361|NCT01072149|449449435|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951362|NCT01072149|449449436|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951363|NCT01072149|449449437|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951364|NCT01072149|449449438|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951365|NCT01072149|449449439|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
124951366|NCT01072149|449449440|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951367|NCT01072149|449449441|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951368|NCT01072149|449449424|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
124951369|NCT01072149|449449425|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
124951370|NCT01072149|449449426|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
124951371|NCT01072149|449449427|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
124951372|NCT01072149|449449428|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
124951373|NCT01072149|449449429|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
124951374|NCT01072149|449449430|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
124951375|NCT01072149|449449431|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
124951376|NCT01072149|449449432|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
124951377|NCT01072149|449449433|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
124951378|NCT01072149|449449434|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
124951379|NCT01072149|449449435|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
124951380|NCT01072149|449449436|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
124951381|NCT01072149|449449437|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
124951382|NCT01072149|449449438|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
124951383|NCT01072149|449449439|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
124951384|NCT01072149|449449440|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
124951385|NCT01072149|449449441|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
124951386|NCT01072149|449449424|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951387|NCT01072149|449449425|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951388|NCT01072149|449449426|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951389|NCT01072149|449449427|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951390|NCT01072149|449449428|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
125030008|NCT05195528|449732746|FG002|Extension Period|Protocol Violation|1|||
125030009|NCT05195528|449732747|FG003|Extension Period|Protocol Violation|0|||
125030010|NCT05195528|449732748|FG004|Extension Period|Protocol Violation|1|||
125030011|NCT05195528|449732744|FG000|Extension Period|Lost to Follow-up|0|||
125030012|NCT05195528|449732745|FG001|Extension Period|Lost to Follow-up|6|||
125030013|NCT05195528|449732746|FG002|Extension Period|Lost to Follow-up|13|||
125030014|NCT05195528|449732747|FG003|Extension Period|Lost to Follow-up|3|||
125030015|NCT05195528|449732748|FG004|Extension Period|Lost to Follow-up|7|||
125030016|NCT05195528|449732744|FG000|Extension Period|Withdrawal by Subject|0|||
125030017|NCT05195528|449732745|FG001|Extension Period|Withdrawal by Subject|12|||
125030018|NCT05195528|449732746|FG002|Extension Period|Withdrawal by Subject|9|||
125030019|NCT05195528|449732747|FG003|Extension Period|Withdrawal by Subject|6|||
125030020|NCT05195528|449732748|FG004|Extension Period|Withdrawal by Subject|5|||
125030021|NCT05195528|449732744|FG000|Extension Period|Lack of Efficacy|0|||
125030022|NCT05195528|449732745|FG001|Extension Period|Lack of Efficacy|3|||
125030023|NCT05195528|449732746|FG002|Extension Period|Lack of Efficacy|0|||
125030024|NCT05195528|449732747|FG003|Extension Period|Lack of Efficacy|0|||
125030025|NCT05195528|449732748|FG004|Extension Period|Lack of Efficacy|2|||
124951391|NCT01072149|449449429|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951392|NCT01072149|449449430|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951393|NCT01072149|449449431|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951394|NCT01072149|449449432|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951395|NCT01072149|449449433|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951396|NCT01072149|449449434|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
125215085|NCT03782571|450414900|FG000|Period 3|Subject Unable to Attend V5|1|||
125215086|NCT03782571|450414901|FG001|Period 3|Subject Unable to Attend V5|0|||
125215087|NCT03782571|450414902|FG002|Period 3|Subject Unable to Attend V5|0|||
125215088|NCT03782571|450414903|FG003|Period 3|Subject Unable to Attend V5|0|||
125215089|NCT03782571|450414900|FG000|Period 3|Adverse Event|1|||
125215090|NCT03782571|450414901|FG001|Period 3|Adverse Event|0|||
125215091|NCT03782571|450414902|FG002|Period 3|Adverse Event|0|||
125215092|NCT03782571|450414903|FG003|Period 3|Adverse Event|0|||
125215093|NCT02213380|450414906|FG000|Underwent Randomization|Withdrawal by Subject|2|||
125215094|NCT02213380|450414907|FG001|Underwent Randomization|Withdrawal by Subject|0|||
124951397|NCT01072149|449449435|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951398|NCT01072149|449449436|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
124951399|NCT01072149|449449437|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951400|NCT01072149|449449438|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951401|NCT01072149|449449439|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951402|NCT01072149|449449440|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951403|NCT01072149|449449441|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951404|NCT01072149|449449424|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951405|NCT01072149|449449425|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951406|NCT01072149|449449426|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
124951407|NCT01072149|449449427|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951408|NCT01072149|449449428|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951409|NCT01072149|449449429|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951410|NCT01072149|449449430|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951411|NCT01072149|449449431|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951412|NCT01072149|449449432|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951413|NCT01072149|449449433|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951414|NCT01072149|449449434|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951415|NCT01072149|449449435|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951416|NCT01072149|449449436|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951417|NCT01072149|449449437|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
124951418|NCT01072149|449449438|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951419|NCT01072149|449449439|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951420|NCT01072149|449449440|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951421|NCT01072149|449449441|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951422|NCT02784834|449449442|FG000|Overall Study|Lack of Efficacy|1|||
125124849|NCT01939197|450082484|FG003|Overall Study|Lost to Follow-up|1|||
124951423|NCT02143713|449449443|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
124951424|NCT02143713|449449444|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
124951425|NCT02143713|449449445|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
125124850|NCT01939197|450082485|FG004|Overall Study|Lost to Follow-up|3|||
125124851|NCT01939197|450082486|FG005|Overall Study|Lost to Follow-up|1|||
125124852|NCT01939197|450082487|FG006|Overall Study|Lost to Follow-up|2|||
125124853|NCT00745095|450082488|FG000|Overall Study|Declined to participate|1|||
125124854|NCT00745095|450082489|FG001|Overall Study|Declined to participate|0|||
125124855|NCT00745095|450082490|FG002|Overall Study|Declined to participate|0|||
125124856|NCT00745095|450082491|FG003|Overall Study|Declined to participate|0|||
125124857|NCT00745095|450082492|FG004|Overall Study|Declined to participate|92|||
125124858|NCT00745095|450082493|FG005|Overall Study|Declined to participate|95|||
125124859|NCT00745095|450082488|FG000|Overall Study|Ineligible due to GFR criteria|0|||
125124860|NCT00745095|450082489|FG001|Overall Study|Ineligible due to GFR criteria|2|||
125124861|NCT00745095|450082490|FG002|Overall Study|Ineligible due to GFR criteria|3|||
125124862|NCT00745095|450082491|FG003|Overall Study|Ineligible due to GFR criteria|3|||
125124863|NCT00745095|450082492|FG004|Overall Study|Ineligible due to GFR criteria|30|||
125124864|NCT00745095|450082493|FG005|Overall Study|Ineligible due to GFR criteria|28|||
125124865|NCT00958243|450082494|FG000|Overall Study|Withdrawal by Subject|0|||
125124866|NCT00958243|450082495|FG001|Overall Study|Withdrawal by Subject|1|||
124951426|NCT02143713|449449446|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
124951427|NCT02143713|449449443|FG000|Treatment Period (6 Months)|Adverse Event|7|||
124951428|NCT02143713|449449444|FG001|Treatment Period (6 Months)|Adverse Event|8|||
124951429|NCT02143713|449449445|FG002|Treatment Period (6 Months)|Adverse Event|8|||
124951430|NCT02143713|449449446|FG003|Treatment Period (6 Months)|Adverse Event|9|||
124951431|NCT02143713|449449443|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
124951432|NCT02143713|449449444|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
124951433|NCT02143713|449449445|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
124951434|NCT02143713|449449446|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
124951435|NCT02143713|449449443|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
124951436|NCT02143713|449449444|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
124951437|NCT02143713|449449445|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
124951438|NCT02143713|449449446|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
124951439|NCT02143713|449449443|FG000|Treatment Period (6 Months)|Pregnancy|0|||
124951440|NCT02143713|449449444|FG001|Treatment Period (6 Months)|Pregnancy|2|||
124951441|NCT02143713|449449445|FG002|Treatment Period (6 Months)|Pregnancy|2|||
124951442|NCT02143713|449449446|FG003|Treatment Period (6 Months)|Pregnancy|0|||
124951443|NCT02143713|449449443|FG000|Treatment Period (6 Months)|Non-compliance|1|||
124951444|NCT02143713|449449444|FG001|Treatment Period (6 Months)|Non-compliance|0|||
124951445|NCT02143713|449449445|FG002|Treatment Period (6 Months)|Non-compliance|0|||
125124867|NCT00958243|450082496|FG002|Overall Study|Withdrawal by Subject|3|||
124951446|NCT02143713|449449446|FG003|Treatment Period (6 Months)|Non-compliance|3|||
124951447|NCT02143713|449449443|FG000|Treatment Period (6 Months)|Other|3|||
125124868|NCT00958243|450082497|FG003|Overall Study|Withdrawal by Subject|1|||
125124869|NCT00958243|450082498|FG004|Overall Study|Withdrawal by Subject|1|||
125124870|NCT00958243|450082499|FG005|Overall Study|Withdrawal by Subject|5|||
125124871|NCT00958243|450082494|FG000|Overall Study|Lost to Follow-up|2|||
125124872|NCT00958243|450082495|FG001|Overall Study|Lost to Follow-up|5|||
125124873|NCT00958243|450082496|FG002|Overall Study|Lost to Follow-up|11|||
125124874|NCT00958243|450082497|FG003|Overall Study|Lost to Follow-up|2|||
125124875|NCT00958243|450082498|FG004|Overall Study|Lost to Follow-up|8|||
125124876|NCT00958243|450082499|FG005|Overall Study|Lost to Follow-up|5|||
125124877|NCT00162123|450082502|FG000|Overall Study|Disease progression|27|||
125124878|NCT00162123|450082503|FG001|Overall Study|Disease progression|19|||
125124879|NCT00162123|450082504|FG002|Overall Study|Disease progression|10|||
125124880|NCT00162123|450082505|FG003|Overall Study|Disease progression|4|||
125124881|NCT00162123|450082506|FG004|Overall Study|Disease progression|8|||
125124882|NCT00162123|450082507|FG005|Overall Study|Disease progression|3|||
125124883|NCT00162123|450082508|FG006|Overall Study|Disease progression|1|||
125124884|NCT00162123|450082509|FG007|Overall Study|Disease progression|0|||
125124885|NCT00162123|450082502|FG000|Overall Study|Study drug toxicity|6|||
125124886|NCT00162123|450082503|FG001|Overall Study|Study drug toxicity|1|||
125124887|NCT00162123|450082504|FG002|Overall Study|Study drug toxicity|5|||
125124888|NCT00162123|450082505|FG003|Overall Study|Study drug toxicity|0|||
125124889|NCT00162123|450082506|FG004|Overall Study|Study drug toxicity|4|||
125124890|NCT00162123|450082507|FG005|Overall Study|Study drug toxicity|1|||
125124891|NCT00162123|450082508|FG006|Overall Study|Study drug toxicity|1|||
125124892|NCT00162123|450082509|FG007|Overall Study|Study drug toxicity|0|||
125124893|NCT00162123|450082502|FG000|Overall Study|Death|3|||
125124894|NCT00162123|450082503|FG001|Overall Study|Death|3|||
125124895|NCT00162123|450082504|FG002|Overall Study|Death|1|||
125124896|NCT00162123|450082505|FG003|Overall Study|Death|1|||
125124897|NCT00162123|450082506|FG004|Overall Study|Death|1|||
125124898|NCT00162123|450082507|FG005|Overall Study|Death|1|||
125124899|NCT00162123|450082508|FG006|Overall Study|Death|0|||
125124900|NCT00162123|450082509|FG007|Overall Study|Death|0|||
125124901|NCT00162123|450082502|FG000|Overall Study|Withdrawal by Subject|2|||
125124902|NCT00162123|450082503|FG001|Overall Study|Withdrawal by Subject|0|||
125124903|NCT00162123|450082504|FG002|Overall Study|Withdrawal by Subject|2|||
124951448|NCT02143713|449449444|FG001|Treatment Period (6 Months)|Other|0|||
124951449|NCT02143713|449449445|FG002|Treatment Period (6 Months)|Other|3|||
124951450|NCT02143713|449449446|FG003|Treatment Period (6 Months)|Other|2|||
124951451|NCT02143713|449449443|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
124951452|NCT02143713|449449444|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
124951453|NCT02143713|449449445|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
124951454|NCT02143713|449449446|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
125124904|NCT00162123|450082505|FG003|Overall Study|Withdrawal by Subject|1|||
125124905|NCT00162123|450082506|FG004|Overall Study|Withdrawal by Subject|1|||
125124906|NCT00162123|450082507|FG005|Overall Study|Withdrawal by Subject|2|||
125124907|NCT00162123|450082508|FG006|Overall Study|Withdrawal by Subject|1|||
125124908|NCT00162123|450082509|FG007|Overall Study|Withdrawal by Subject|0|||
125124909|NCT00162123|450082502|FG000|Overall Study|Deterioration without progression|2|||
125124910|NCT00162123|450082503|FG001|Overall Study|Deterioration without progression|2|||
125124911|NCT00162123|450082504|FG002|Overall Study|Deterioration without progression|3|||
125124912|NCT00162123|450082505|FG003|Overall Study|Deterioration without progression|0|||
125215095|NCT02213380|450414906|FG000|Underwent Randomization|Not treated|3|||
125215096|NCT02213380|450414907|FG001|Underwent Randomization|Not treated|3|||
125215097|NCT02213380|450414906|FG000|Per-protocol Analysis|Protocol Violation|32|||
125215098|NCT02213380|450414907|FG001|Per-protocol Analysis|Protocol Violation|36|||
125215099|NCT03498313|450414910|FG000|Experimental Period 1|Adverse Event|1|||
125215100|NCT03498313|450414911|FG001|Experimental Period 1|Adverse Event|0|||
125215101|NCT03498313|450414912|FG002|Experimental Period 1|Adverse Event|0|||
125215102|NCT03498313|450414913|FG003|Experimental Period 1|Adverse Event|1|||
125215103|NCT03498313|450414914|FG004|Experimental Period 1|Adverse Event|0|||
125215104|NCT03498313|450414915|FG005|Experimental Period 1|Adverse Event|0|||
125215105|NCT03498313|450414910|FG000|Experimental Period 1|Withdrawal by Subject|0|||
125215106|NCT03498313|450414911|FG001|Experimental Period 1|Withdrawal by Subject|1|||
125030026|NCT05195528|449732744|FG000|Extension Period|Not Treated|0|||
125030027|NCT05195528|449732745|FG001|Extension Period|Not Treated|0|||
125030028|NCT05195528|449732746|FG002|Extension Period|Not Treated|2|||
125030029|NCT05195528|449732747|FG003|Extension Period|Not Treated|3|||
125030030|NCT05195528|449732748|FG004|Extension Period|Not Treated|0|||
125030031|NCT05195528|449732744|FG000|Extension Period|Other|0|||
125030032|NCT05195528|449732745|FG001|Extension Period|Other|1|||
125030033|NCT05195528|449732746|FG002|Extension Period|Other|1|||
125030034|NCT05195528|449732747|FG003|Extension Period|Other|0|||
125030035|NCT05195528|449732748|FG004|Extension Period|Other|0|||
125030036|NCT01552902|449732749|FG000|Overall Study|Adverse Event|1|||
125030037|NCT01552902|449732750|FG001|Overall Study|Adverse Event|15|||
125030038|NCT01552902|449732751|FG002|Overall Study|Adverse Event|14|||
125030039|NCT01552902|449732749|FG000|Overall Study|Protocol Violation|3|||
125030040|NCT01552902|449732750|FG001|Overall Study|Protocol Violation|3|||
125030041|NCT01552902|449732751|FG002|Overall Study|Protocol Violation|3|||
125030042|NCT01552902|449732749|FG000|Overall Study|Lack of Efficacy|4|||
125030043|NCT01552902|449732750|FG001|Overall Study|Lack of Efficacy|3|||
125030044|NCT01552902|449732751|FG002|Overall Study|Lack of Efficacy|1|||
125030045|NCT01552902|449732749|FG000|Overall Study|Withdrawal by Subject|1|||
125030046|NCT01552902|449732750|FG001|Overall Study|Withdrawal by Subject|9|||
125030047|NCT01552902|449732751|FG002|Overall Study|Withdrawal by Subject|6|||
125030048|NCT01552902|449732749|FG000|Overall Study|Lost to Follow-up|1|||
125030049|NCT01552902|449732750|FG001|Overall Study|Lost to Follow-up|3|||
125030050|NCT01552902|449732751|FG002|Overall Study|Lost to Follow-up|6|||
125030051|NCT01552902|449732749|FG000|Overall Study|Other|3|||
125030052|NCT01552902|449732750|FG001|Overall Study|Other|4|||
125030053|NCT01552902|449732751|FG002|Overall Study|Other|3|||
125030054|NCT02487108|449732755|FG000|Overall Study|Adverse Event|1|||
125030055|NCT02487108|449732756|FG001|Overall Study|Adverse Event|6|||
125030056|NCT02487108|449732757|FG002|Overall Study|Adverse Event|12|||
125030057|NCT02487108|449732758|FG003|Overall Study|Adverse Event|6|||
125030058|NCT02487108|449732755|FG000|Overall Study|Withdrawal by Subject|8|||
125124913|NCT00162123|450082506|FG004|Overall Study|Deterioration without progression|1|||
125124914|NCT00162123|450082507|FG005|Overall Study|Deterioration without progression|0|||
125124915|NCT00162123|450082508|FG006|Overall Study|Deterioration without progression|0|||
125124916|NCT00162123|450082509|FG007|Overall Study|Deterioration without progression|0|||
125124917|NCT00162123|450082502|FG000|Overall Study|Adverse Event|1|||
125124918|NCT00162123|450082503|FG001|Overall Study|Adverse Event|2|||
125124919|NCT00162123|450082504|FG002|Overall Study|Adverse Event|0|||
125124920|NCT00162123|450082505|FG003|Overall Study|Adverse Event|2|||
125124921|NCT00162123|450082506|FG004|Overall Study|Adverse Event|1|||
125124922|NCT00162123|450082507|FG005|Overall Study|Adverse Event|0|||
125215107|NCT03498313|450414912|FG002|Experimental Period 1|Withdrawal by Subject|0|||
125215108|NCT03498313|450414913|FG003|Experimental Period 1|Withdrawal by Subject|0|||
125215109|NCT03498313|450414914|FG004|Experimental Period 1|Withdrawal by Subject|0|||
125030059|NCT02487108|449732756|FG001|Overall Study|Withdrawal by Subject|5|||
125030060|NCT02487108|449732757|FG002|Overall Study|Withdrawal by Subject|5|||
125030061|NCT02487108|449732758|FG003|Overall Study|Withdrawal by Subject|0|||
125030062|NCT02487108|449732755|FG000|Overall Study|Non-compliance to study medication|3|||
125030063|NCT02487108|449732756|FG001|Overall Study|Non-compliance to study medication|2|||
125030064|NCT02487108|449732757|FG002|Overall Study|Non-compliance to study medication|5|||
125030065|NCT02487108|449732758|FG003|Overall Study|Non-compliance to study medication|4|||
125030066|NCT02487108|449732755|FG000|Overall Study|Protocol Violation|1|||
125030067|NCT02487108|449732756|FG001|Overall Study|Protocol Violation|1|||
125030068|NCT02487108|449732757|FG002|Overall Study|Protocol Violation|2|||
125030069|NCT02487108|449732758|FG003|Overall Study|Protocol Violation|0|||
125030070|NCT02487108|449732755|FG000|Overall Study|Non-compliance to study procedures|0|||
125030071|NCT02487108|449732756|FG001|Overall Study|Non-compliance to study procedures|0|||
125030072|NCT02487108|449732757|FG002|Overall Study|Non-compliance to study procedures|0|||
125030073|NCT02487108|449732758|FG003|Overall Study|Non-compliance to study procedures|1|||
125030074|NCT02487108|449732755|FG000|Overall Study|Other than specified|3|||
125124923|NCT00162123|450082508|FG006|Overall Study|Adverse Event|0|||
125124924|NCT00162123|450082509|FG007|Overall Study|Adverse Event|0|||
125215110|NCT03498313|450414915|FG005|Experimental Period 1|Withdrawal by Subject|0|||
125215111|NCT03498313|450414910|FG000|Washout Period 1|Anovulation|1|||
125215112|NCT03498313|450414911|FG001|Washout Period 1|Anovulation|0|||
125215113|NCT03498313|450414912|FG002|Washout Period 1|Anovulation|0|||
125215114|NCT03498313|450414913|FG003|Washout Period 1|Anovulation|0|||
125215115|NCT03498313|450414914|FG004|Washout Period 1|Anovulation|0|||
125215116|NCT03498313|450414915|FG005|Washout Period 1|Anovulation|0|||
125215117|NCT03498313|450414910|FG000|Washout Period 1|Withdrawal by Subject|0|||
125215118|NCT03498313|450414911|FG001|Washout Period 1|Withdrawal by Subject|3|||
125215119|NCT03498313|450414912|FG002|Washout Period 1|Withdrawal by Subject|0|||
125215120|NCT03498313|450414913|FG003|Washout Period 1|Withdrawal by Subject|1|||
125215121|NCT03498313|450414914|FG004|Washout Period 1|Withdrawal by Subject|0|||
125215122|NCT03498313|450414915|FG005|Washout Period 1|Withdrawal by Subject|1|||
125215123|NCT03498313|450414910|FG000|Experimental Period 2|Adverse Event|0|||
125215124|NCT03498313|450414911|FG001|Experimental Period 2|Adverse Event|0|||
125215125|NCT03498313|450414912|FG002|Experimental Period 2|Adverse Event|0|||
125215126|NCT03498313|450414913|FG003|Experimental Period 2|Adverse Event|0|||
125215127|NCT03498313|450414914|FG004|Experimental Period 2|Adverse Event|1|||
125215128|NCT03498313|450414915|FG005|Experimental Period 2|Adverse Event|2|||
125215129|NCT03498313|450414910|FG000|Washout Period 2|Physician Decision|1|||
125215130|NCT03498313|450414911|FG001|Washout Period 2|Physician Decision|0|||
125215131|NCT03498313|450414912|FG002|Washout Period 2|Physician Decision|0|||
125215132|NCT03498313|450414913|FG003|Washout Period 2|Physician Decision|1|||
125215133|NCT03498313|450414914|FG004|Washout Period 2|Physician Decision|0|||
125215134|NCT03498313|450414915|FG005|Washout Period 2|Physician Decision|1|||
125215135|NCT03498313|450414910|FG000|Washout Period 2|Withdrawal by Subject|3|||
125215136|NCT03498313|450414911|FG001|Washout Period 2|Withdrawal by Subject|2|||
125215137|NCT03498313|450414912|FG002|Washout Period 2|Withdrawal by Subject|0|||
125215138|NCT03498313|450414913|FG003|Washout Period 2|Withdrawal by Subject|0|||
124951455|NCT02143713|449449443|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
124951456|NCT02143713|449449444|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
124951457|NCT02143713|449449445|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
124951458|NCT02143713|449449446|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
124951459|NCT02143713|449449443|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
124951460|NCT02143713|449449444|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
124951461|NCT02143713|449449445|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
124951462|NCT02143713|449449446|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
124951463|NCT02143713|449449443|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
124951464|NCT02143713|449449444|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
124951465|NCT02143713|449449445|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
124951466|NCT02143713|449449446|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
124951467|NCT02143713|449449443|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
124951468|NCT02143713|449449444|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
124951469|NCT02143713|449449445|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
124951470|NCT02143713|449449446|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
124951471|NCT02143713|449449443|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
124951472|NCT02143713|449449444|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
124951473|NCT02143713|449449445|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
124951474|NCT02143713|449449446|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
124951475|NCT02143713|449449443|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
124951476|NCT02143713|449449444|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
124951477|NCT02143713|449449445|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
124951478|NCT02143713|449449446|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
124951479|NCT02143713|449449443|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
124951480|NCT02143713|449449444|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
124951481|NCT02143713|449449445|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
124951482|NCT02143713|449449446|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
124951483|NCT02143713|449449443|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
124951484|NCT02143713|449449444|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
124951485|NCT02143713|449449445|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
124951486|NCT02143713|449449446|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
124951487|NCT01768572|449449449|FG000|Overall Study|Adverse Event|7|||
124951488|NCT01768572|449449450|FG001|Overall Study|Adverse Event|8|||
124951489|NCT01768572|449449451|FG002|Overall Study|Adverse Event|4|||
125215139|NCT03498313|450414914|FG004|Washout Period 2|Withdrawal by Subject|2|||
125215140|NCT03498313|450414915|FG005|Washout Period 2|Withdrawal by Subject|0|||
125215141|NCT03498313|450414910|FG000|Washout Period 2|Anovulation|0|||
125215142|NCT03498313|450414911|FG001|Washout Period 2|Anovulation|0|||
125215143|NCT03498313|450414912|FG002|Washout Period 2|Anovulation|0|||
125215144|NCT03498313|450414913|FG003|Washout Period 2|Anovulation|0|||
125215145|NCT03498313|450414914|FG004|Washout Period 2|Anovulation|0|||
124951490|NCT01768572|449449449|FG000|Overall Study|Lack of Efficacy|1|||
124951491|NCT01768572|449449450|FG001|Overall Study|Lack of Efficacy|3|||
124951492|NCT01768572|449449451|FG002|Overall Study|Lack of Efficacy|1|||
124951493|NCT01768572|449449449|FG000|Overall Study|Other, Not due to an adverse event|1|||
124951494|NCT01768572|449449450|FG001|Overall Study|Other, Not due to an adverse event|1|||
124951495|NCT01768572|449449451|FG002|Overall Study|Other, Not due to an adverse event|1|||
124951496|NCT00080119|449449452|FG000|Overall Study|Discontinued because of study closure|0|||
124951497|NCT00080119|449449453|FG001|Overall Study|Discontinued because of study closure|0|||
124951498|NCT00080119|449449454|FG002|Overall Study|Discontinued because of study closure|130|||
124951499|NCT00080119|449449455|FG003|Overall Study|Discontinued because of study closure|141|||
124951500|NCT00080119|449449452|FG000|Overall Study|Unable to get to clinic|24|||
124951501|NCT00080119|449449453|FG001|Overall Study|Unable to get to clinic|24|||
124951502|NCT00080119|449449454|FG002|Overall Study|Unable to get to clinic|7|||
124951503|NCT00080119|449449455|FG003|Overall Study|Unable to get to clinic|1|||
124951504|NCT00080119|449449452|FG000|Overall Study|Consent withdrawn|13|||
124951505|NCT00080119|449449453|FG001|Overall Study|Consent withdrawn|17|||
124951506|NCT00080119|449449454|FG002|Overall Study|Consent withdrawn|4|||
124951507|NCT00080119|449449455|FG003|Overall Study|Consent withdrawn|6|||
124951508|NCT00080119|449449452|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
124951509|NCT00080119|449449453|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
124951510|NCT00080119|449449454|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
124951511|NCT00080119|449449455|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
124951512|NCT00080119|449449452|FG000|Overall Study|Lost to Follow-up|16|||
124951513|NCT00080119|449449453|FG001|Overall Study|Lost to Follow-up|19|||
124951514|NCT00080119|449449454|FG002|Overall Study|Lost to Follow-up|19|||
124951515|NCT00080119|449449455|FG003|Overall Study|Lost to Follow-up|14|||
124951516|NCT01919489|449449457|FG000|Overall Study|Rejected the need of injections|4|||
124951517|NCT01919489|449449458|FG001|Overall Study|Rejected the need of injections|7|||
124951518|NCT01919489|449449457|FG000|Overall Study|Adverse Event|10|||
124951519|NCT01919489|449449458|FG001|Overall Study|Adverse Event|0|||
124951520|NCT01919489|449449457|FG000|Overall Study|Hospital readmission|2|||
124951521|NCT01919489|449449458|FG001|Overall Study|Hospital readmission|9|||
124951522|NCT01919489|449449457|FG000|Overall Study|Death|2|||
124951523|NCT01919489|449449458|FG001|Overall Study|Death|1|||
125030075|NCT02487108|449732756|FG001|Overall Study|Other than specified|2|||
125030076|NCT02487108|449732757|FG002|Overall Study|Other than specified|2|||
124951524|NCT01919489|449449457|FG000|Overall Study|Lost to Follow-up|38|||
124951525|NCT01919489|449449458|FG001|Overall Study|Lost to Follow-up|27|||
124951526|NCT01322386|449449459|FG000|Overall Study|Protocol Violation|0|||
124951527|NCT01322386|449449460|FG001|Overall Study|Protocol Violation|1|||
124951528|NCT01322386|449449459|FG000|Overall Study|Physician Decision|0|||
124951529|NCT01322386|449449460|FG001|Overall Study|Physician Decision|1|||
124951530|NCT00871494|449449463|FG000|Overall Study|Protocol Violation|5|||
124951531|NCT00871494|449449463|FG000|Overall Study|Lack of Efficacy|4|||
124951532|NCT00871494|449449463|FG000|Overall Study|Adverse Event|4|||
124951533|NCT00871494|449449463|FG000|Overall Study|Lost to Follow-up|1|||
124951534|NCT03761849|449449464|FG000|Overall Study|transferred to OpenLabelExtension|35|||
124951535|NCT03761849|449449465|FG001|Overall Study|transferred to OpenLabelExtension|34|||
124951536|NCT03761849|449449466|FG002|Overall Study|transferred to OpenLabelExtension|36|||
124951537|NCT03761849|449449467|FG003|Overall Study|transferred to OpenLabelExtension|0|||
124951538|NCT03761849|449449468|FG004|Overall Study|transferred to OpenLabelExtension|0|||
124951539|NCT03761849|449449469|FG005|Overall Study|transferred to OpenLabelExtension|0|||
124951540|NCT03761849|449449464|FG000|Overall Study|Adverse Event|1|||
124951541|NCT03761849|449449465|FG001|Overall Study|Adverse Event|0|||
124951542|NCT03761849|449449466|FG002|Overall Study|Adverse Event|0|||
124951543|NCT03761849|449449467|FG003|Overall Study|Adverse Event|0|||
124951544|NCT03761849|449449468|FG004|Overall Study|Adverse Event|2|||
124951545|NCT03761849|449449469|FG005|Overall Study|Adverse Event|3|||
124951546|NCT03761849|449449464|FG000|Overall Study|Withdrawal by Subject|0|||
124951547|NCT03761849|449449465|FG001|Overall Study|Withdrawal by Subject|0|||
124951548|NCT03761849|449449466|FG002|Overall Study|Withdrawal by Subject|0|||
124951549|NCT03761849|449449467|FG003|Overall Study|Withdrawal by Subject|41|||
124951550|NCT03761849|449449468|FG004|Overall Study|Withdrawal by Subject|43|||
124951551|NCT03761849|449449469|FG005|Overall Study|Withdrawal by Subject|35|||
124951552|NCT03761849|449449464|FG000|Overall Study|Lost to Follow-up|0|||
124951553|NCT03761849|449449465|FG001|Overall Study|Lost to Follow-up|1|||
124951554|NCT03761849|449449466|FG002|Overall Study|Lost to Follow-up|0|||
124951555|NCT03761849|449449467|FG003|Overall Study|Lost to Follow-up|2|||
124951556|NCT03761849|449449468|FG004|Overall Study|Lost to Follow-up|4|||
124951557|NCT03761849|449449469|FG005|Overall Study|Lost to Follow-up|5|||
124951558|NCT03761849|449449464|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
124951559|NCT03761849|449449465|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
125030077|NCT02487108|449732758|FG003|Overall Study|Other than specified|0|||
124951560|NCT03761849|449449466|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
124951561|NCT03761849|449449467|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
124951562|NCT03761849|449449468|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
124951563|NCT03761849|449449469|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
124951564|NCT03761849|449449464|FG000|Overall Study|Physician Decision|0|||
124951565|NCT03761849|449449465|FG001|Overall Study|Physician Decision|0|||
124951566|NCT03761849|449449466|FG002|Overall Study|Physician Decision|0|||
124951567|NCT03761849|449449467|FG003|Overall Study|Physician Decision|1|||
124951568|NCT03761849|449449468|FG004|Overall Study|Physician Decision|4|||
124951569|NCT03761849|449449469|FG005|Overall Study|Physician Decision|4|||
124951570|NCT03761849|449449464|FG000|Overall Study|Death|0|||
124951571|NCT03761849|449449465|FG001|Overall Study|Death|0|||
124951572|NCT03761849|449449466|FG002|Overall Study|Death|0|||
124951573|NCT03761849|449449467|FG003|Overall Study|Death|1|||
124951574|NCT03761849|449449468|FG004|Overall Study|Death|1|||
124951575|NCT03761849|449449469|FG005|Overall Study|Death|3|||
124951576|NCT03761849|449449464|FG000|Overall Study|Protocol Violation|0|||
124951577|NCT03761849|449449465|FG001|Overall Study|Protocol Violation|0|||
124951578|NCT03761849|449449466|FG002|Overall Study|Protocol Violation|0|||
124951579|NCT03761849|449449467|FG003|Overall Study|Protocol Violation|2|||
124951580|NCT03761849|449449468|FG004|Overall Study|Protocol Violation|2|||
124951581|NCT03761849|449449469|FG005|Overall Study|Protocol Violation|1|||
124951582|NCT03761849|449449464|FG000|Overall Study|Participant could not come to site|0|||
124951583|NCT03761849|449449465|FG001|Overall Study|Participant could not come to site|0|||
124951584|NCT03761849|449449466|FG002|Overall Study|Participant could not come to site|0|||
124951585|NCT03761849|449449467|FG003|Overall Study|Participant could not come to site|0|||
124951586|NCT03761849|449449468|FG004|Overall Study|Participant could not come to site|1|||
124951587|NCT03761849|449449469|FG005|Overall Study|Participant could not come to site|0|||
124951588|NCT03761849|449449464|FG000|Overall Study|SF- safety Finding|0|||
124951589|NCT03761849|449449465|FG001|Overall Study|SF- safety Finding|0|||
124951590|NCT03761849|449449466|FG002|Overall Study|SF- safety Finding|0|||
124951591|NCT03761849|449449467|FG003|Overall Study|SF- safety Finding|0|||
124951592|NCT03761849|449449468|FG004|Overall Study|SF- safety Finding|0|||
124951593|NCT03761849|449449469|FG005|Overall Study|SF- safety Finding|1|||
124951594|NCT03761849|449449464|FG000|Overall Study|Patient did not attend visit|0|||
124951595|NCT03761849|449449465|FG001|Overall Study|Patient did not attend visit|0|||
125124925|NCT00162123|450082502|FG000|Overall Study|Not specified (before treatment)|2|||
125124926|NCT00162123|450082503|FG001|Overall Study|Not specified (before treatment)|0|||
125124927|NCT00162123|450082504|FG002|Overall Study|Not specified (before treatment)|0|||
125124928|NCT00162123|450082505|FG003|Overall Study|Not specified (before treatment)|0|||
125124929|NCT00162123|450082506|FG004|Overall Study|Not specified (before treatment)|12|||
125124930|NCT00162123|450082507|FG005|Overall Study|Not specified (before treatment)|1|||
125124931|NCT00162123|450082508|FG006|Overall Study|Not specified (before treatment)|0|||
125124932|NCT00162123|450082509|FG007|Overall Study|Not specified (before treatment)|0|||
125124933|NCT00162123|450082502|FG000|Overall Study|Not specified (after start of treatment)|0|||
125124934|NCT00162123|450082503|FG001|Overall Study|Not specified (after start of treatment)|0|||
125124935|NCT00162123|450082504|FG002|Overall Study|Not specified (after start of treatment)|0|||
125124936|NCT00162123|450082505|FG003|Overall Study|Not specified (after start of treatment)|0|||
125124937|NCT00162123|450082506|FG004|Overall Study|Not specified (after start of treatment)|3|||
125124938|NCT00162123|450082507|FG005|Overall Study|Not specified (after start of treatment)|0|||
125124939|NCT00162123|450082508|FG006|Overall Study|Not specified (after start of treatment)|0|||
125124940|NCT00162123|450082509|FG007|Overall Study|Not specified (after start of treatment)|0|||
125124941|NCT00162123|450082502|FG000|Overall Study|Physician Decision|1|||
125124942|NCT00162123|450082503|FG001|Overall Study|Physician Decision|2|||
125124943|NCT00162123|450082504|FG002|Overall Study|Physician Decision|0|||
125124944|NCT00162123|450082505|FG003|Overall Study|Physician Decision|0|||
125124945|NCT00162123|450082506|FG004|Overall Study|Physician Decision|0|||
125124946|NCT00162123|450082507|FG005|Overall Study|Physician Decision|1|||
125124947|NCT00162123|450082508|FG006|Overall Study|Physician Decision|1|||
125124948|NCT00162123|450082509|FG007|Overall Study|Physician Decision|0|||
125124949|NCT00162123|450082502|FG000|Overall Study|Tumor assessment only (not treated)|0|||
125124950|NCT00162123|450082503|FG001|Overall Study|Tumor assessment only (not treated)|0|||
124951596|NCT03761849|449449466|FG002|Overall Study|Patient did not attend visit|0|||
125124951|NCT00162123|450082504|FG002|Overall Study|Tumor assessment only (not treated)|0|||
125124952|NCT00162123|450082505|FG003|Overall Study|Tumor assessment only (not treated)|0|||
125124953|NCT00162123|450082506|FG004|Overall Study|Tumor assessment only (not treated)|0|||
125124954|NCT00162123|450082507|FG005|Overall Study|Tumor assessment only (not treated)|0|||
124951597|NCT03761849|449449467|FG003|Overall Study|Patient did not attend visit|0|||
124951598|NCT03761849|449449468|FG004|Overall Study|Patient did not attend visit|0|||
124951599|NCT03761849|449449469|FG005|Overall Study|Patient did not attend visit|1|||
125215146|NCT03498313|450414915|FG005|Washout Period 2|Anovulation|1|||
124951600|NCT03344458|449449473|FG000|Overall Study|Physician Decision|1|||
124951601|NCT03344458|449449473|FG000|Overall Study|Withdrawal by Subject|16|||
124951602|NCT03344458|449449473|FG000|Overall Study|Other reasons|10|||
125124955|NCT00162123|450082508|FG006|Overall Study|Tumor assessment only (not treated)|0|||
124951603|NCT03344458|449449473|FG000|Overall Study|Lost to Follow-up|9|||
124951604|NCT03344458|449449473|FG000|Overall Study|Protocol Violation|3|||
124951605|NCT03840993|449449474|FG000|Overall Study|Adverse Event|1|||
124951606|NCT03840993|449449475|FG001|Overall Study|Adverse Event|0|||
124951607|NCT03840993|449449474|FG000|Overall Study|Lost to Follow-up|4|||
124951608|NCT03840993|449449475|FG001|Overall Study|Lost to Follow-up|0|||
124951609|NCT03840993|449449474|FG000|Overall Study|Physician Decision|0|||
124951610|NCT03840993|449449475|FG001|Overall Study|Physician Decision|1|||
124951611|NCT03840993|449449474|FG000|Overall Study|Pregnancy|0|||
124951612|NCT03840993|449449475|FG001|Overall Study|Pregnancy|1|||
124951613|NCT03840993|449449474|FG000|Overall Study|Withdrawal by Subject|1|||
124951614|NCT03840993|449449475|FG001|Overall Study|Withdrawal by Subject|3|||
124951615|NCT03840993|449449474|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
124951616|NCT03840993|449449475|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
124951617|NCT00988429|449449476|FG000|Overall Study|Adverse Event|9|||
124951618|NCT00988429|449449477|FG001|Overall Study|Adverse Event|21|||
124951619|NCT00988429|449449478|FG002|Overall Study|Adverse Event|45|||
124951620|NCT00988429|449449476|FG000|Overall Study|Lack of Efficacy|0|||
124951621|NCT00988429|449449477|FG001|Overall Study|Lack of Efficacy|0|||
124951622|NCT00988429|449449478|FG002|Overall Study|Lack of Efficacy|1|||
124951623|NCT00988429|449449476|FG000|Overall Study|Non-Compliance with Study Drug|5|||
124951624|NCT00988429|449449477|FG001|Overall Study|Non-Compliance with Study Drug|1|||
124951625|NCT00988429|449449478|FG002|Overall Study|Non-Compliance with Study Drug|3|||
124951626|NCT00988429|449449476|FG000|Overall Study|Physician Decision|1|||
124951627|NCT00988429|449449477|FG001|Overall Study|Physician Decision|0|||
124951628|NCT00988429|449449478|FG002|Overall Study|Physician Decision|3|||
124951629|NCT00988429|449449476|FG000|Overall Study|Pregnancy|2|||
124951630|NCT00988429|449449477|FG001|Overall Study|Pregnancy|1|||
125030078|NCT01254669|449732759|FG000|Overall Study|Withdrawal by Subject|0|||
125030079|NCT01254669|449732760|FG001|Overall Study|Withdrawal by Subject|1|||
124951631|NCT00988429|449449478|FG002|Overall Study|Pregnancy|0|||
124951632|NCT00988429|449449476|FG000|Overall Study|Protocol Violation|4|||
124951633|NCT00988429|449449477|FG001|Overall Study|Protocol Violation|3|||
124951634|NCT00988429|449449478|FG002|Overall Study|Protocol Violation|3|||
124951635|NCT00988429|449449476|FG000|Overall Study|Withdrawal by Subject|7|||
125030080|NCT01254669|449732759|FG000|Overall Study|time constraint|2|||
125030081|NCT01254669|449732760|FG001|Overall Study|time constraint|2|||
125030082|NCT01254669|449732759|FG000|Overall Study|called to clinic during intervention|1|||
125030083|NCT01254669|449732760|FG001|Overall Study|called to clinic during intervention|1|||
125030084|NCT00600171|449732761|FG000|Overall Study|Adverse Event|0|||
125030085|NCT00600171|449732762|FG001|Overall Study|Adverse Event|1|||
125030086|NCT00600171|449732763|FG002|Overall Study|Adverse Event|0|||
125030087|NCT00600171|449732764|FG003|Overall Study|Adverse Event|0|||
125030088|NCT00600171|449732765|FG004|Overall Study|Adverse Event|1|||
125030089|NCT00600171|449732766|FG005|Overall Study|Adverse Event|0|||
125030090|NCT00600171|449732761|FG000|Overall Study|Lack of Efficacy|9|||
125030091|NCT00600171|449732762|FG001|Overall Study|Lack of Efficacy|12|||
125030092|NCT00600171|449732763|FG002|Overall Study|Lack of Efficacy|3|||
125030093|NCT00600171|449732764|FG003|Overall Study|Lack of Efficacy|5|||
125030094|NCT00600171|449732765|FG004|Overall Study|Lack of Efficacy|4|||
125030095|NCT00600171|449732766|FG005|Overall Study|Lack of Efficacy|0|||
125030096|NCT00600171|449732761|FG000|Overall Study|Protocol Violation|1|||
125030097|NCT00600171|449732762|FG001|Overall Study|Protocol Violation|2|||
125030098|NCT00600171|449732763|FG002|Overall Study|Protocol Violation|0|||
124951636|NCT00988429|449449477|FG001|Overall Study|Withdrawal by Subject|7|||
124951637|NCT00988429|449449478|FG002|Overall Study|Withdrawal by Subject|12|||
124951638|NCT00988429|449449476|FG000|Overall Study|Administrative Reasons|1|||
125030099|NCT00600171|449732764|FG003|Overall Study|Protocol Violation|1|||
125030100|NCT00600171|449732765|FG004|Overall Study|Protocol Violation|0|||
125030101|NCT00600171|449732766|FG005|Overall Study|Protocol Violation|0|||
125030102|NCT00600171|449732761|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
125030103|NCT00600171|449732762|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
125030104|NCT00600171|449732763|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
125030105|NCT00600171|449732764|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
125030106|NCT00600171|449732765|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
125030107|NCT00600171|449732766|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
125030108|NCT00600171|449732761|FG000|Overall Study|Withdrawal by Subject|3|||
125030109|NCT00600171|449732762|FG001|Overall Study|Withdrawal by Subject|0|||
125030110|NCT00600171|449732763|FG002|Overall Study|Withdrawal by Subject|0|||
125124956|NCT00162123|450082509|FG007|Overall Study|Tumor assessment only (not treated)|1|||
125124957|NCT00162123|450082502|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
125124958|NCT00162123|450082503|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
125124959|NCT00162123|450082504|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
125124960|NCT00162123|450082505|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
125124961|NCT00162123|450082506|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
125124962|NCT00162123|450082507|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
125124963|NCT00162123|450082508|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
125124964|NCT00162123|450082509|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
124951639|NCT00988429|449449477|FG001|Overall Study|Administrative Reasons|2|||
124951640|NCT00988429|449449478|FG002|Overall Study|Administrative Reasons|1|||
124951641|NCT00988429|449449476|FG000|Overall Study|other reasons|8|||
124951642|NCT00988429|449449477|FG001|Overall Study|other reasons|8|||
124951643|NCT00988429|449449478|FG002|Overall Study|other reasons|1|||
124951644|NCT01074229|449449479|FG000|Overall Study|Lost to Follow-up|1|||
124951645|NCT01074229|449449480|FG001|Overall Study|Lost to Follow-up|0|||
124951646|NCT01074229|449449481|FG002|Overall Study|Lost to Follow-up|0|||
124951647|NCT01074229|449449479|FG000|Overall Study|Change to open surgical procedure|1|||
124951648|NCT01074229|449449480|FG001|Overall Study|Change to open surgical procedure|3|||
124951649|NCT01074229|449449481|FG002|Overall Study|Change to open surgical procedure|4|||
124951650|NCT02823574|449449487|FG000|Randomization|Disease Progression|0|||
124951651|NCT02823574|449449488|FG001|Randomization|Disease Progression|0|||
124951652|NCT02823574|449449489|FG002|Randomization|Disease Progression|1|||
124951653|NCT02823574|449449490|FG003|Randomization|Disease Progression|0|||
124951654|NCT02823574|449449487|FG000|Randomization|AE unrelated to Study Drug|1|||
124951655|NCT02823574|449449488|FG001|Randomization|AE unrelated to Study Drug|0|||
124951656|NCT02823574|449449489|FG002|Randomization|AE unrelated to Study Drug|0|||
124951657|NCT02823574|449449490|FG003|Randomization|AE unrelated to Study Drug|0|||
124951658|NCT02823574|449449487|FG000|Treatment Period|Poor/Non Compliance|1|||
124951659|NCT02823574|449449488|FG001|Treatment Period|Poor/Non Compliance|0|||
124951660|NCT02823574|449449489|FG002|Treatment Period|Poor/Non Compliance|0|||
124951661|NCT02823574|449449490|FG003|Treatment Period|Poor/Non Compliance|1|||
124951662|NCT02823574|449449487|FG000|Treatment Period|Maximum Clinical Benefit|8|||
124951663|NCT02823574|449449488|FG001|Treatment Period|Maximum Clinical Benefit|4|||
124951664|NCT02823574|449449489|FG002|Treatment Period|Maximum Clinical Benefit|7|||
124951665|NCT02823574|449449490|FG003|Treatment Period|Maximum Clinical Benefit|1|||
124951666|NCT02823574|449449487|FG000|Treatment Period|Lost to Follow-up|1|||
124951667|NCT02823574|449449488|FG001|Treatment Period|Lost to Follow-up|1|||
124951668|NCT02823574|449449489|FG002|Treatment Period|Lost to Follow-up|0|||
124951669|NCT02823574|449449490|FG003|Treatment Period|Lost to Follow-up|0|||
124951670|NCT02823574|449449487|FG000|Treatment Period|Participant withdrew consent|4|||
124951671|NCT02823574|449449488|FG001|Treatment Period|Participant withdrew consent|0|||
124951672|NCT02823574|449449489|FG002|Treatment Period|Participant withdrew consent|0|||
124951673|NCT02823574|449449490|FG003|Treatment Period|Participant withdrew consent|1|||
124951674|NCT02823574|449449487|FG000|Treatment Period|Participant request to discontinue|5|||
124951675|NCT02823574|449449488|FG001|Treatment Period|Participant request to discontinue|0|||
124951676|NCT02823574|449449489|FG002|Treatment Period|Participant request to discontinue|3|||
124951677|NCT02823574|449449490|FG003|Treatment Period|Participant request to discontinue|2|||
124951678|NCT02823574|449449487|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
124951679|NCT02823574|449449488|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
124951680|NCT02823574|449449489|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
124951681|NCT02823574|449449490|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
124951682|NCT02823574|449449487|FG000|Treatment Period|Study Drug Toxicity|11|||
124951683|NCT02823574|449449488|FG001|Treatment Period|Study Drug Toxicity|2|||
124951684|NCT02823574|449449489|FG002|Treatment Period|Study Drug Toxicity|14|||
124951685|NCT02823574|449449490|FG003|Treatment Period|Study Drug Toxicity|4|||
124951686|NCT02823574|449449487|FG000|Treatment Period|Disease Progression|113|||
124951687|NCT02823574|449449488|FG001|Treatment Period|Disease Progression|64|||
124951688|NCT02823574|449449489|FG002|Treatment Period|Disease Progression|82|||
124951689|NCT02823574|449449490|FG003|Treatment Period|Disease Progression|43|||
124951690|NCT02823574|449449487|FG000|Treatment Period|Other reasons|5|||
124951691|NCT02823574|449449488|FG001|Treatment Period|Other reasons|9|||
125215147|NCT02499263|450414916|FG000|Overall Study|Lost to Follow-up|9|||
124951692|NCT02823574|449449489|FG002|Treatment Period|Other reasons|3|||
124951693|NCT02823574|449449490|FG003|Treatment Period|Other reasons|6|||
124951694|NCT02823574|449449487|FG000|Treatment Period|Participant no longer meets study criteria|0|||
125124965|NCT01936948|450082513|FG000|Overall Study|no 30-day follow-up data|0|||
124951695|NCT02823574|449449488|FG001|Treatment Period|Participant no longer meets study criteria|0|||
124951696|NCT02823574|449449489|FG002|Treatment Period|Participant no longer meets study criteria|1|||
124951697|NCT02823574|449449490|FG003|Treatment Period|Participant no longer meets study criteria|0|||
124951698|NCT02823574|449449487|FG000|Treatment Period|Death|0|||
125124966|NCT01936948|450082514|FG001|Overall Study|no 30-day follow-up data|3|||
125124967|NCT01936948|450082515|FG002|Overall Study|no 30-day follow-up data|3|||
125124968|NCT01936948|450082516|FG003|Overall Study|no 30-day follow-up data|3|||
124951699|NCT02823574|449449488|FG001|Treatment Period|Death|0|||
124951700|NCT02823574|449449489|FG002|Treatment Period|Death|3|||
124951701|NCT02823574|449449490|FG003|Treatment Period|Death|1|||
124951702|NCT00590759|449449491|FG000|Overall Study|Death|52|||
124951703|NCT00590759|449449491|FG000|Overall Study|Lost to Follow-up|28|||
124951704|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
124951705|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
124951706|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
124951707|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
124951708|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Death|0|||
124951709|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Death|0|||
124951710|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Death|1|||
124951711|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Death|0|||
124951712|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
124951713|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
124951714|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
124951715|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
124951716|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
124951717|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
124951718|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
124951719|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
124951720|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
124951721|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
124951722|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
124951723|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
124951724|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
124951725|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
124951726|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
124951727|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
124951728|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
124951729|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
124951730|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
124951731|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
124951732|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Other|2|||
124951733|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Other|0|||
124951734|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Other|0|||
124951735|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Other|0|||
124951736|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
124951737|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
124951738|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
125124969|NCT02781727|450082517|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
125124970|NCT02781727|450082518|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
125124971|NCT02781727|450082517|FG000|Treatment Period|Withdrawal by Subject|1|||
125124972|NCT02781727|450082518|FG001|Treatment Period|Withdrawal by Subject|0|||
125124973|NCT02781727|450082517|FG000|Treatment Period|Lost to Follow-up|0|||
125124974|NCT02781727|450082518|FG001|Treatment Period|Lost to Follow-up|1|||
125124975|NCT02327130|450082519|FG000|Overall Study|Discharged in less than 5 days|5|||
125124976|NCT02327130|450082519|FG000|Overall Study|Physician Decision|2|||
125124977|NCT02327130|450082519|FG000|Overall Study|Unable to provide breath sample|1|||
125124978|NCT02327130|450082519|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
125124979|NCT02327130|450082519|FG000|Overall Study|Met exclusion criteria|3|||
125124980|NCT00406848|450082520|FG000|Overall Study|Withdrawal by Subject|27|||
125124981|NCT00406848|450082521|FG001|Overall Study|Withdrawal by Subject|22|||
125124982|NCT00406848|450082520|FG000|Overall Study|Adverse Event|38|||
125124983|NCT00406848|450082521|FG001|Overall Study|Adverse Event|7|||
124951739|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
124951740|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
124951741|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
124951742|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
124951743|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
124951744|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
124951745|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
124951746|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
124951747|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
125124984|NCT00406848|450082520|FG000|Overall Study|Lack of Efficacy|9|||
125124985|NCT00406848|450082521|FG001|Overall Study|Lack of Efficacy|14|||
125124986|NCT00406848|450082520|FG000|Overall Study|Protocol Violation|10|||
125124987|NCT00406848|450082521|FG001|Overall Study|Protocol Violation|6|||
125124988|NCT00406848|450082520|FG000|Overall Study|Lost to Follow-up|6|||
125124989|NCT00406848|450082521|FG001|Overall Study|Lost to Follow-up|2|||
125124990|NCT00406848|450082520|FG000|Overall Study|Physician Decision|2|||
124951748|NCT03845517|449449498|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
124951749|NCT03845517|449449499|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
124951750|NCT03845517|449449500|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
124951751|NCT03845517|449449501|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
124951752|NCT03845517|449449498|FG000|Follow-up Period (4 Weeks)|Death|0|||
124951753|NCT03845517|449449499|FG001|Follow-up Period (4 Weeks)|Death|0|||
124951754|NCT03845517|449449500|FG002|Follow-up Period (4 Weeks)|Death|1|||
124951755|NCT03845517|449449501|FG003|Follow-up Period (4 Weeks)|Death|1|||
124951756|NCT03845517|449449498|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
124951757|NCT03845517|449449499|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
124951758|NCT03845517|449449500|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
124951759|NCT03845517|449449501|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
125215148|NCT02499263|450414916|FG000|Overall Study|Participant's withdrawal of consent|4|||
125215149|NCT02499263|450414916|FG000|Overall Study|Lack of Efficacy|22|||
125215150|NCT02499263|450414916|FG000|Overall Study|investigator's judgment|12|||
125215151|NCT02499263|450414916|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
125215152|NCT02499263|450414916|FG000|Overall Study|Participant's decision|3|||
125215153|NCT02499263|450414916|FG000|Overall Study|Pregnancy|1|||
125215154|NCT00184002|450414917|FG000|Overall Study|Adverse Event|9|||
125215155|NCT00184002|450414917|FG000|Overall Study|Death|3|||
125215156|NCT00184002|450414917|FG000|Overall Study|Physician Decision|1|||
125215157|NCT00184002|450414917|FG000|Overall Study|Withdrawal by Subject|4|||
125215158|NCT02075008|450414922|FG000|Overall Study|Technical problems|1|||
124951760|NCT03845517|449449498|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
124951761|NCT03845517|449449499|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
124951762|NCT03845517|449449500|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
124951763|NCT03845517|449449501|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
124951764|NCT03845517|449449498|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
124951765|NCT03845517|449449499|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
124951766|NCT03845517|449449500|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
124951767|NCT03845517|449449501|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
124951768|NCT03845517|449449498|FG000|Follow-up Period (4 Weeks)|Other|1|||
124951769|NCT03845517|449449499|FG001|Follow-up Period (4 Weeks)|Other|0|||
124951770|NCT03845517|449449500|FG002|Follow-up Period (4 Weeks)|Other|1|||
124951771|NCT03845517|449449501|FG003|Follow-up Period (4 Weeks)|Other|0|||
124951772|NCT03845517|449449498|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
124951773|NCT03845517|449449499|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
124951774|NCT03845517|449449500|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
124951775|NCT03845517|449449501|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
125215159|NCT02075008|450414922|FG000|Overall Study|Pregnancy|1|||
125215160|NCT02075008|450414922|FG000|Overall Study|Physician Decision|1|||
125215161|NCT02075008|450414922|FG000|Overall Study|Lost to Follow-up|1|||
125215162|NCT02075008|450414922|FG000|Overall Study|Lack of Efficacy|1|||
125215163|NCT02075008|450414922|FG000|Overall Study|Death|1|||
125215164|NCT02075008|450414922|FG000|Overall Study|Adverse Event|5|||
125215165|NCT02075008|450414922|FG000|Overall Study|Withdrawal by Subject|6|||
125215166|NCT02075008|450414922|FG000|Overall Study|Study terminated by Sponsor|159|||
125215167|NCT00660595|450414923|FG000|Overall Study|Lost to Follow-up|0|||
125215168|NCT00660595|450414924|FG001|Overall Study|Lost to Follow-up|1|||
125215169|NCT00660595|450414923|FG000|Overall Study|Did not consent to participate in study|12|||
125215170|NCT00660595|450414924|FG001|Overall Study|Did not consent to participate in study|8|||
125215171|NCT00660595|450414923|FG000|Overall Study|Participant left hospital|1|||
125215172|NCT00660595|450414924|FG001|Overall Study|Participant left hospital|0|||
125215173|NCT00660595|450414923|FG000|Overall Study|Non Specified reasons|5|||
124951776|NCT03845517|449449498|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
124951777|NCT03845517|449449499|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
124951778|NCT03845517|449449500|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
125215174|NCT00660595|450414924|FG001|Overall Study|Non Specified reasons|0|||
125215175|NCT00493311|450414925|FG000|Overall Study|Need for rescue medication|2|||
125215176|NCT00493311|450414926|FG001|Overall Study|Need for rescue medication|2|||
125215177|NCT02779075|450414927|FG000|Overall Study|Withdrawal by Subject|1|||
124951779|NCT03845517|449449501|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
124951780|NCT03845517|449449498|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
124951781|NCT03845517|449449499|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
124951782|NCT03845517|449449500|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
124951783|NCT03845517|449449501|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
124951784|NCT01494467|449449502|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
124951785|NCT01494467|449449503|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
124951786|NCT01494467|449449502|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
124951787|NCT01494467|449449503|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
124951788|NCT01494467|449449502|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
124951789|NCT01494467|449449503|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
124951790|NCT01494467|449449502|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
124951791|NCT01494467|449449503|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
124951792|NCT01494467|449449502|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
124951793|NCT01494467|449449503|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
124951794|NCT01494467|449449502|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
124951795|NCT01494467|449449503|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
124951796|NCT01494467|449449502|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
124951797|NCT01494467|449449503|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
124951798|NCT01494467|449449502|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
124951799|NCT01494467|449449503|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
124951800|NCT01494467|449449502|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
124951801|NCT01494467|449449503|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
124951802|NCT01494467|449449502|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
124951803|NCT01494467|449449503|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
124951804|NCT01494467|449449502|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
124951805|NCT01494467|449449503|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
124951806|NCT01494467|449449502|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
124951807|NCT01494467|449449503|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
124951808|NCT01494467|449449502|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
124951809|NCT01494467|449449503|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
124951810|NCT01494467|449449502|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
124951811|NCT01494467|449449503|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
124951812|NCT00417885|449449504|FG000|Overall Study|Adverse Event|1|||
124951813|NCT00417885|449449504|FG000|Overall Study|Objective Progression or Relapse|3|||
124951814|NCT00417885|449449504|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
124951815|NCT01190436|449449505|FG000|Overall Study|Lost to Follow-up|35|||
124951816|NCT01190436|449449505|FG000|Overall Study|Other|4|||
124951817|NCT02721147|449449506|FG000|Overall Study|Lost to Follow-up|2|||
124951818|NCT02721147|449449507|FG001|Overall Study|Lost to Follow-up|0|||
124951819|NCT02721147|449449508|FG002|Overall Study|Lost to Follow-up|0|||
124951820|NCT01722097|449449509|FG000|Overall Study|Patient sheets not returned|6|||
124951821|NCT01722097|449449510|FG001|Overall Study|Patient sheets not returned|5|||
124951822|NCT02009332|449449513|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
124951823|NCT02009332|449449514|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
124951824|NCT02009332|449449515|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
125124991|NCT00406848|450082521|FG001|Overall Study|Physician Decision|2|||
125124992|NCT00406848|450082520|FG000|Overall Study|Sponsor Decision|1|||
125124993|NCT00406848|450082521|FG001|Overall Study|Sponsor Decision|1|||
125124994|NCT00352690|450082522|FG000|Overall Study|Determined to be ineligible|2|||
125124995|NCT00352690|450082523|FG001|Overall Study|Determined to be ineligible|0|||
125124996|NCT02719522|450082528|FG000|Overall Study|Implant Failure|4|||
125124997|NCT02719522|450082528|FG000|Overall Study|Death|2|||
125124998|NCT02719522|450082528|FG000|Overall Study|Lost to Follow-up|5|||
125124999|NCT04025879|450082532|FG000|Randomization|Participant withdrew consent|0|||
125125000|NCT04025879|450082533|FG001|Randomization|Participant withdrew consent|1|||
125125001|NCT04025879|450082532|FG000|Randomization|Participant no longer met study criteria|1|||
125125002|NCT04025879|450082533|FG001|Randomization|Participant no longer met study criteria|1|||
125125003|NCT04025879|450082532|FG000|Treatment|Ongoing treatment|10|||
125125004|NCT04025879|450082533|FG001|Treatment|Ongoing treatment|8|||
125125005|NCT04025879|450082532|FG000|Treatment|Disease progression/recurrence|36|||
124951825|NCT02009332|449449516|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
124951826|NCT02009332|449449517|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
124951827|NCT02009332|449449518|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
124951828|NCT02009332|449449513|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
125125006|NCT04025879|450082533|FG001|Treatment|Disease progression/recurrence|72|||
125125007|NCT04025879|450082532|FG000|Treatment|Study drug toxicity|36|||
125125008|NCT04025879|450082533|FG001|Treatment|Study drug toxicity|13|||
125125009|NCT04025879|450082532|FG000|Treatment|Death|2|||
125125010|NCT04025879|450082533|FG001|Treatment|Death|0|||
125030111|NCT00600171|449732764|FG003|Overall Study|Withdrawal by Subject|1|||
125030112|NCT00600171|449732765|FG004|Overall Study|Withdrawal by Subject|1|||
125030113|NCT00600171|449732766|FG005|Overall Study|Withdrawal by Subject|1|||
125030114|NCT00600171|449732761|FG000|Overall Study|Physician Decision|0|||
125030115|NCT00600171|449732762|FG001|Overall Study|Physician Decision|1|||
125030116|NCT00600171|449732763|FG002|Overall Study|Physician Decision|0|||
125030117|NCT00600171|449732764|FG003|Overall Study|Physician Decision|1|||
125030118|NCT00600171|449732765|FG004|Overall Study|Physician Decision|0|||
125030119|NCT00600171|449732766|FG005|Overall Study|Physician Decision|2|||
125030120|NCT00600171|449732761|FG000|Overall Study|Lost to Follow-up|0|||
125030121|NCT00600171|449732762|FG001|Overall Study|Lost to Follow-up|0|||
125030122|NCT00600171|449732763|FG002|Overall Study|Lost to Follow-up|0|||
125030123|NCT00600171|449732764|FG003|Overall Study|Lost to Follow-up|1|||
125030124|NCT00600171|449732765|FG004|Overall Study|Lost to Follow-up|0|||
125030125|NCT00600171|449732766|FG005|Overall Study|Lost to Follow-up|0|||
125030126|NCT02367521|449732767|FG000|Overall Study|severe headache after intervention|2|||
125030127|NCT02367521|449732768|FG001|Overall Study|severe headache after intervention|0|||
125030128|NCT02367521|449732767|FG000|Overall Study|unable to find transportation|2|||
125030129|NCT02367521|449732768|FG001|Overall Study|unable to find transportation|0|||
125030130|NCT00469612|449732772|FG000|Overall Study|Study terminated before data collected|2|||
125030131|NCT00469612|449732773|FG001|Overall Study|Study terminated before data collected|0|||
125030132|NCT00542191|449732774|FG000|Overall Study|Death|3|||
125030133|NCT00103012|449732777|FG000|Overall Study|Withdrawal by Subject|2|||
125030134|NCT00103012|449732778|FG001|Overall Study|Withdrawal by Subject|1|||
125030135|NCT00103012|449732779|FG002|Overall Study|Withdrawal by Subject|2|||
125030136|NCT00103012|449732777|FG000|Overall Study|Pregnancy|1|||
125030137|NCT00103012|449732778|FG001|Overall Study|Pregnancy|0|||
125030138|NCT00103012|449732779|FG002|Overall Study|Pregnancy|0|||
125030139|NCT00103012|449732777|FG000|Overall Study|Adverse Event|0|||
125030140|NCT00103012|449732778|FG001|Overall Study|Adverse Event|0|||
125030141|NCT00103012|449732779|FG002|Overall Study|Adverse Event|1|||
125030142|NCT00103012|449732777|FG000|Overall Study|Subject non-compliant with medications|0|||
125030143|NCT00103012|449732778|FG001|Overall Study|Subject non-compliant with medications|0|||
125030144|NCT00103012|449732779|FG002|Overall Study|Subject non-compliant with medications|1|||
125030145|NCT00430755|449732780|FG000|Overall Study|Withdrawal by Subject|53|||
125030146|NCT04684420|449732786|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125030147|NCT04684420|449732787|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125030148|NCT04684420|449732788|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
125030149|NCT04684420|449732789|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
125030150|NCT04684420|449732786|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
125030151|NCT04684420|449732787|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
125030152|NCT04684420|449732788|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
125030153|NCT04684420|449732789|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
125030154|NCT03480802|449732791|FG000|Overall Study|Lost to Follow-up|5|||
125030155|NCT03480802|449732792|FG001|Overall Study|Lost to Follow-up|1|||
125030156|NCT03480802|449732791|FG000|Overall Study|Withdrawal by Subject|2|||
125030157|NCT03480802|449732792|FG001|Overall Study|Withdrawal by Subject|1|||
125030158|NCT03480802|449732791|FG000|Overall Study|Relocated|0|||
125030159|NCT03480802|449732792|FG001|Overall Study|Relocated|1|||
125030160|NCT03822884|449732793|FG000|Overall Study|Withdrawal by Subject|0|||
125030161|NCT03822884|449732794|FG001|Overall Study|Withdrawal by Subject|0|||
125030162|NCT03822884|449732795|FG002|Overall Study|Withdrawal by Subject|0|||
125030163|NCT03822884|449732796|FG003|Overall Study|Withdrawal by Subject|0|||
125030164|NCT03822884|449732797|FG004|Overall Study|Withdrawal by Subject|1|||
125030165|NCT03822884|449732798|FG005|Overall Study|Withdrawal by Subject|0|||
125215178|NCT02779075|450414928|FG001|Overall Study|Withdrawal by Subject|3|||
125215179|NCT02779075|450414927|FG000|Overall Study|IV lost during 2nd study|1|||
125215180|NCT02779075|450414928|FG001|Overall Study|IV lost during 2nd study|0|||
125215181|NCT03959527|450414929|FG000|Overall Study|Withdrawal by Subject|8|||
125215182|NCT03959527|450414930|FG001|Overall Study|Withdrawal by Subject|3|||
125215183|NCT03959527|450414929|FG000|Overall Study|Lost to Follow-up|31|||
125215184|NCT03959527|450414930|FG001|Overall Study|Lost to Follow-up|15|||
125215185|NCT03959527|450414929|FG000|Overall Study|Did not meet eligibility criteria|1|||
125030166|NCT01279057|449732807|FG000|Overall Study|Adverse Event|1|||
125030167|NCT01279057|449732808|FG001|Overall Study|Adverse Event|0|||
125030168|NCT01279057|449732809|FG002|Overall Study|Adverse Event|1|||
125030169|NCT01279057|449732807|FG000|Overall Study|Insufficient therapeutic response|0|||
125030170|NCT01279057|449732808|FG001|Overall Study|Insufficient therapeutic response|0|||
125030171|NCT01279057|449732809|FG002|Overall Study|Insufficient therapeutic response|1|||
125030172|NCT01279057|449732807|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
125030173|NCT01279057|449732808|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
125030174|NCT01279057|449732809|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
125030175|NCT01279057|449732807|FG000|Overall Study|Withdrew consent|2|||
125030176|NCT01279057|449732808|FG001|Overall Study|Withdrew consent|0|||
125125011|NCT04025879|450082532|FG000|Treatment|Adverse event unrelated to study drug|21|||
125125012|NCT04025879|450082533|FG001|Treatment|Adverse event unrelated to study drug|14|||
125125013|NCT04025879|450082532|FG000|Treatment|Participant request to discontinue study treatment|16|||
125125014|NCT04025879|450082533|FG001|Treatment|Participant request to discontinue study treatment|8|||
125125015|NCT04025879|450082532|FG000|Treatment|Participant withdrew consent|1|||
125125016|NCT04025879|450082533|FG001|Treatment|Participant withdrew consent|3|||
125125017|NCT04025879|450082532|FG000|Treatment|Participant no longer meets study criteria|3|||
125125018|NCT04025879|450082533|FG001|Treatment|Participant no longer meets study criteria|2|||
124951829|NCT02009332|449449514|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
124951830|NCT02009332|449449515|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
124951831|NCT02009332|449449516|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
124951832|NCT02009332|449449517|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
124951833|NCT02009332|449449518|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
124951834|NCT02009332|449449513|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
124951835|NCT02009332|449449514|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
124951836|NCT02009332|449449515|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
124951837|NCT02009332|449449516|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
124951838|NCT02009332|449449517|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
124951839|NCT02009332|449449518|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
124951840|NCT01912599|449449519|FG000|Overall Study|Withdrawal by Subject|0|||
124951841|NCT01912599|449449520|FG001|Overall Study|Withdrawal by Subject|1|||
124951842|NCT04739306|449449521|FG000|Main Study Period|Adverse Event|6|||
124951843|NCT04739306|449449522|FG001|Main Study Period|Adverse Event|7|||
124951844|NCT04739306|449449521|FG000|Main Study Period|Lost to Follow-up|4|||
124951845|NCT04739306|449449522|FG001|Main Study Period|Lost to Follow-up|6|||
124951846|NCT04739306|449449521|FG000|Main Study Period|Physician Decision|1|||
124951847|NCT04739306|449449522|FG001|Main Study Period|Physician Decision|1|||
124951848|NCT04739306|449449521|FG000|Main Study Period|Withdrawal by Subject|8|||
124951849|NCT04739306|449449522|FG001|Main Study Period|Withdrawal by Subject|6|||
124951850|NCT04739306|449449521|FG000|Main Study Period|Protocol Violation|0|||
124951851|NCT04739306|449449522|FG001|Main Study Period|Protocol Violation|1|||
124951852|NCT04739306|449449521|FG000|Main Study Period|War in Ukraine|1|||
125125019|NCT04025879|450082532|FG000|Treatment|Lost to Follow-up|1|||
125125020|NCT04025879|450082533|FG001|Treatment|Lost to Follow-up|0|||
125125021|NCT04025879|450082532|FG000|Treatment|Other reasons|15|||
125125022|NCT04025879|450082533|FG001|Treatment|Other reasons|17|||
125125023|NCT04025879|450082532|FG000|Treatment|Administrative reason by sponsor|0|||
125125024|NCT04025879|450082533|FG001|Treatment|Administrative reason by sponsor|1|||
125125025|NCT04025879|450082532|FG000|Treatment|Not reported|2|||
125125026|NCT04025879|450082533|FG001|Treatment|Not reported|0|||
125125027|NCT02888171|450082534|FG000|Overall Study|Lost to Follow-up|2|||
125125028|NCT02888171|450082535|FG001|Overall Study|Lost to Follow-up|1|||
125125029|NCT02888171|450082534|FG000|Overall Study|Withdrawal by Subject|3|||
125125030|NCT02888171|450082535|FG001|Overall Study|Withdrawal by Subject|2|||
125125031|NCT02888171|450082534|FG000|Overall Study|Adverse Event|0|||
125125032|NCT02888171|450082535|FG001|Overall Study|Adverse Event|1|||
125125033|NCT03805438|450084074|FG000|Overall Study|Lack of Efficacy|1|||
125125034|NCT03805438|450084074|FG000|Overall Study|Protocol Violation|1|||
125125035|NCT00366899|450084075|FG000|Infant Series|Withdrawal by Subject|4|||
125125036|NCT00366899|450084076|FG001|Infant Series|Withdrawal by Subject|7|||
125125037|NCT00366899|450084075|FG000|Infant Series|Protocol Violation|2|||
125125038|NCT00366899|450084076|FG001|Infant Series|Protocol Violation|1|||
125125039|NCT00366899|450084075|FG000|Infant Series|Failed to return|1|||
125125040|NCT00366899|450084076|FG001|Infant Series|Failed to return|1|||
125125041|NCT00366899|450084075|FG000|Infant Series|Lost to Follow-up|0|||
125125042|NCT00366899|450084076|FG001|Infant Series|Lost to Follow-up|2|||
125125043|NCT00366899|450084075|FG000|Infant Series|Adverse Event|0|||
124951853|NCT04739306|449449522|FG001|Main Study Period|War in Ukraine|1|||
124951854|NCT03386344|449449523|FG000|Overall Study|Adverse Event|6|||
124951855|NCT03386344|449449524|FG001|Overall Study|Adverse Event|3|||
124951856|NCT03386344|449449525|FG002|Overall Study|Adverse Event|1|||
124951857|NCT03386344|449449523|FG000|Overall Study|Poor Compliance to Protocol|0|||
124951858|NCT03386344|449449524|FG001|Overall Study|Poor Compliance to Protocol|1|||
124951859|NCT03386344|449449525|FG002|Overall Study|Poor Compliance to Protocol|0|||
124951860|NCT03386344|449449523|FG000|Overall Study|Study Terminated by Sponsor|101|||
124951861|NCT03386344|449449524|FG001|Overall Study|Study Terminated by Sponsor|102|||
124951862|NCT03386344|449449525|FG002|Overall Study|Study Terminated by Sponsor|106|||
124951863|NCT03386344|449449523|FG000|Overall Study|Lost to Follow-up|3|||
124951864|NCT03386344|449449524|FG001|Overall Study|Lost to Follow-up|2|||
124951865|NCT03386344|449449525|FG002|Overall Study|Lost to Follow-up|1|||
124951866|NCT03386344|449449523|FG000|Overall Study|At the Participant's own Request|7|||
124951867|NCT03386344|449449524|FG001|Overall Study|At the Participant's own Request|7|||
125125044|NCT00366899|450084076|FG001|Infant Series|Adverse Event|1|||
125125045|NCT00366899|450084075|FG000|Infant Series|Physician Decision|1|||
125125046|NCT00366899|450084076|FG001|Infant Series|Physician Decision|0|||
125030177|NCT01279057|449732809|FG002|Overall Study|Withdrew consent|1|||
125030178|NCT01279057|449732807|FG000|Overall Study|Pregnancy|0|||
125030179|NCT01279057|449732808|FG001|Overall Study|Pregnancy|1|||
125030180|NCT01279057|449732809|FG002|Overall Study|Pregnancy|0|||
125030181|NCT01279057|449732807|FG000|Overall Study|Other|3|||
125030182|NCT01279057|449732808|FG001|Overall Study|Other|3|||
125030183|NCT01279057|449732809|FG002|Overall Study|Other|0|||
125030184|NCT01427309|449732811|FG000|Overall Study|Lost to Follow-up|130|||
125030185|NCT01427309|449732812|FG001|Overall Study|Lost to Follow-up|145|||
125030186|NCT01427309|449732813|FG002|Overall Study|Lost to Follow-up|122|||
125030187|NCT01427309|449732814|FG003|Overall Study|Lost to Follow-up|135|||
125030188|NCT01427309|449732811|FG000|Overall Study|Protocol Violation|42|||
125030189|NCT01427309|449732812|FG001|Overall Study|Protocol Violation|69|||
125030190|NCT01427309|449732813|FG002|Overall Study|Protocol Violation|125|||
125030191|NCT01427309|449732814|FG003|Overall Study|Protocol Violation|124|||
125030192|NCT01427309|449732811|FG000|Overall Study|Adverse Event|0|||
125030193|NCT01427309|449732812|FG001|Overall Study|Adverse Event|0|||
125030194|NCT01427309|449732813|FG002|Overall Study|Adverse Event|3|||
125030195|NCT01427309|449732814|FG003|Overall Study|Adverse Event|1|||
125030196|NCT01427309|449732811|FG000|Overall Study|Serious adverse event|52|||
125030197|NCT01427309|449732812|FG001|Overall Study|Serious adverse event|45|||
125030198|NCT01427309|449732813|FG002|Overall Study|Serious adverse event|50|||
125030199|NCT01427309|449732814|FG003|Overall Study|Serious adverse event|61|||
125030200|NCT01427309|449732811|FG000|Overall Study|Withdrawal by Subject|148|||
125030201|NCT01427309|449732812|FG001|Overall Study|Withdrawal by Subject|148|||
125030202|NCT01427309|449732813|FG002|Overall Study|Withdrawal by Subject|61|||
125030203|NCT01427309|449732814|FG003|Overall Study|Withdrawal by Subject|55|||
125030204|NCT00849017|449732815|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
125030205|NCT00849017|449732816|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
125030206|NCT00849017|449732817|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
125030207|NCT00849017|449732815|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
125030208|NCT00849017|449732816|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
125030209|NCT00849017|449732817|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
125030210|NCT00849017|449732815|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
125030211|NCT00849017|449732816|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
125030212|NCT00849017|449732817|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
125030213|NCT00849017|449732815|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
125030214|NCT00849017|449732816|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
125030215|NCT00849017|449732817|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
125030216|NCT00849017|449732815|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
125030217|NCT00849017|449732816|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
125030218|NCT00849017|449732817|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
125030219|NCT00849017|449732815|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
125030220|NCT00849017|449732816|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
125030221|NCT00849017|449732817|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
125030222|NCT00849017|449732815|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
125030223|NCT00849017|449732816|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
125030224|NCT00849017|449732817|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
125030225|NCT00849017|449732815|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
125030226|NCT00849017|449732816|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
125030227|NCT00849017|449732817|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
125030228|NCT00849017|449732815|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
125030229|NCT00849017|449732816|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
125030230|NCT00849017|449732817|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
125030231|NCT00849017|449732815|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
125030232|NCT00849017|449732816|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
125030233|NCT00849017|449732817|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
125030234|NCT00849017|449732815|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
125030235|NCT00849017|449732816|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
125125047|NCT00366899|450084075|FG000|Infant Series|Randomized but not consented|1|||
125125048|NCT00366899|450084076|FG001|Infant Series|Randomized but not consented|0|||
125125049|NCT00366899|450084075|FG000|After Infant Series|Lost to Follow-up|4|||
125125050|NCT00366899|450084076|FG001|After Infant Series|Lost to Follow-up|3|||
125125051|NCT00366899|450084075|FG000|After Infant Series|Withdrawal by Subject|1|||
125030236|NCT00849017|449732817|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
125030237|NCT00849017|449732815|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
125030238|NCT00849017|449732816|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
125030239|NCT00849017|449732817|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
125030240|NCT00849017|449732815|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
125030241|NCT00849017|449732816|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
125030242|NCT00849017|449732817|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
125215186|NCT03959527|450414930|FG001|Overall Study|Did not meet eligibility criteria|1|||
125215187|NCT03959527|450414929|FG000|Overall Study|Protocol Violation|10|||
125215188|NCT03959527|450414930|FG001|Overall Study|Protocol Violation|5|||
125215189|NCT00707980|450414931|FG000|Overall Study|Adverse Event|49|||
125215190|NCT00707980|450414931|FG000|Overall Study|Lack of Efficacy|35|||
124951868|NCT03386344|449449525|FG002|Overall Study|At the Participant's own Request|8|||
124951869|NCT03386344|449449523|FG000|Overall Study|Reason not Specified|0|||
124951870|NCT03386344|449449524|FG001|Overall Study|Reason not Specified|1|||
124951871|NCT03386344|449449525|FG002|Overall Study|Reason not Specified|0|||
124951872|NCT03481725|449449526|FG000|Overall Study|Withdrawal by Subject|1|||
124951873|NCT03481725|449449527|FG001|Overall Study|Withdrawal by Subject|0|||
124951874|NCT02991118|449449530|FG000|Overall Study|Death|3|||
124951875|NCT02991118|449449531|FG001|Overall Study|Death|8|||
124951876|NCT02991118|449449530|FG000|Overall Study|Protocol Violation|0|||
124951877|NCT02991118|449449531|FG001|Overall Study|Protocol Violation|3|||
124951878|NCT02991118|449449530|FG000|Overall Study|Physician Decision|0|||
124951879|NCT02991118|449449531|FG001|Overall Study|Physician Decision|1|||
124951880|NCT02991118|449449530|FG000|Overall Study|Moved out of the country|0|||
124951881|NCT02991118|449449531|FG001|Overall Study|Moved out of the country|1|||
124951882|NCT02991118|449449530|FG000|Overall Study|Adverse Event|2|||
124951883|NCT02991118|449449531|FG001|Overall Study|Adverse Event|2|||
124951884|NCT02991118|449449530|FG000|Overall Study|Withdrawal by Subject|1|||
124951885|NCT02991118|449449531|FG001|Overall Study|Withdrawal by Subject|7|||
124951886|NCT02991118|449449530|FG000|Overall Study|Could not attend study visits|0|||
124951887|NCT02991118|449449531|FG001|Overall Study|Could not attend study visits|1|||
124951888|NCT02991118|449449530|FG000|Overall Study|Lost to Follow-up|1|||
124951889|NCT02991118|449449531|FG001|Overall Study|Lost to Follow-up|9|||
124951890|NCT00595959|449449532|FG000|Overall Study|Withdrawal by Subject|1|||
124951891|NCT00595959|449449532|FG000|Overall Study|Lost to Follow-up|1|||
124951892|NCT02077374|449449536|FG000|Overall Study|Withdrawal by Subject|0|||
124951893|NCT02077374|449449537|FG001|Overall Study|Withdrawal by Subject|1|||
124951894|NCT02077374|449449536|FG000|Overall Study|Protocol Violation|0|||
124951895|NCT02077374|449449537|FG001|Overall Study|Protocol Violation|1|||
124951896|NCT00446095|449449538|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
124951897|NCT00446095|449449539|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
124951898|NCT00446095|449449540|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
124951899|NCT00446095|449449541|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
124951900|NCT00446095|449449542|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
124951901|NCT00446095|449449538|FG000|Phase II (8 Weeks)|Adverse Event|0|||
124951902|NCT00446095|449449539|FG001|Phase II (8 Weeks)|Adverse Event|1|||
124951903|NCT00446095|449449540|FG002|Phase II (8 Weeks)|Adverse Event|1|||
124951904|NCT00446095|449449541|FG003|Phase II (8 Weeks)|Adverse Event|0|||
125125052|NCT00366899|450084076|FG001|After Infant Series|Withdrawal by Subject|4|||
125125053|NCT00366899|450084075|FG000|After Infant Series|Adverse Event|1|||
125125054|NCT00366899|450084076|FG001|After Infant Series|Adverse Event|2|||
125125055|NCT00366899|450084075|FG000|After Infant Series|Protocol Violation|1|||
125125056|NCT00366899|450084076|FG001|After Infant Series|Protocol Violation|0|||
125125057|NCT00366899|450084075|FG000|Toddler Dose|Withdrawal by Subject|1|||
125125058|NCT00366899|450084076|FG001|Toddler Dose|Withdrawal by Subject|1|||
125125059|NCT00366899|450084075|FG000|Toddler Dose|Protocol Violation|1|||
125125060|NCT00366899|450084076|FG001|Toddler Dose|Protocol Violation|0|||
125125061|NCT01619800|450084077|FG000|Overall Study|study terminated|2|||
125125062|NCT01619800|450084078|FG001|Overall Study|study terminated|0|||
125125063|NCT00419770|450084080|FG000|Overall Study|Withdrawal by Subject|5|||
125125064|NCT00419770|450084081|FG001|Overall Study|Withdrawal by Subject|1|||
125125065|NCT02848326|450084082|FG000|Treatment Period|Adverse Event|5|||
125125066|NCT02848326|450084083|FG001|Treatment Period|Adverse Event|4|||
125125067|NCT02848326|450084084|FG002|Treatment Period|Adverse Event|11|||
125125068|NCT02848326|450084085|FG003|Treatment Period|Adverse Event|6|||
125125069|NCT02848326|450084086|FG004|Treatment Period|Adverse Event|5|||
125125070|NCT02848326|450084087|FG005|Treatment Period|Adverse Event|7|||
125125071|NCT02848326|450084082|FG000|Treatment Period|Withdrawal of Consent|20|||
125125072|NCT02848326|450084083|FG001|Treatment Period|Withdrawal of Consent|6|||
125125073|NCT02848326|450084084|FG002|Treatment Period|Withdrawal of Consent|9|||
125125074|NCT02848326|450084085|FG003|Treatment Period|Withdrawal of Consent|6|||
125215191|NCT00707980|450414931|FG000|Overall Study|Non-Compliance with Study Drug|28|||
125215192|NCT00707980|450414931|FG000|Overall Study|Protocol Deviations|19|||
124951905|NCT00446095|449449542|FG004|Phase II (8 Weeks)|Adverse Event|0|||
124951906|NCT00446095|449449538|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
124951907|NCT00446095|449449539|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
124951908|NCT00446095|449449540|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
124951909|NCT00446095|449449541|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
124951910|NCT00446095|449449542|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
125215193|NCT00707980|450414931|FG000|Overall Study|Withdrawal of Consent|81|||
125215194|NCT00707980|450414931|FG000|Overall Study|Lost to Follow-up|59|||
124951911|NCT00446095|449449538|FG000|Phase II (8 Weeks)|Physician Decision|1|||
125125075|NCT02848326|450084086|FG004|Treatment Period|Withdrawal of Consent|9|||
125215195|NCT00707980|450414931|FG000|Overall Study|Other|39|||
124951912|NCT00446095|449449539|FG001|Phase II (8 Weeks)|Physician Decision|0|||
124951913|NCT00446095|449449540|FG002|Phase II (8 Weeks)|Physician Decision|0|||
124951914|NCT00446095|449449541|FG003|Phase II (8 Weeks)|Physician Decision|0|||
124951915|NCT00446095|449449542|FG004|Phase II (8 Weeks)|Physician Decision|0|||
124951916|NCT00446095|449449538|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
124951917|NCT00446095|449449539|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
124951918|NCT00446095|449449540|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
124951919|NCT00446095|449449541|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
124951920|NCT00446095|449449542|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
124951921|NCT00446095|449449538|FG000|Phase II (8 Weeks)|Ongoing|0|||
124951922|NCT00446095|449449539|FG001|Phase II (8 Weeks)|Ongoing|0|||
124951923|NCT00446095|449449540|FG002|Phase II (8 Weeks)|Ongoing|1|||
124951924|NCT00446095|449449541|FG003|Phase II (8 Weeks)|Ongoing|0|||
124951925|NCT00446095|449449542|FG004|Phase II (8 Weeks)|Ongoing|0|||
124951926|NCT00446095|449449538|FG000|Phase I (28 Days)|Adverse Event|0|||
124951927|NCT00446095|449449539|FG001|Phase I (28 Days)|Adverse Event|0|||
124951928|NCT00446095|449449540|FG002|Phase I (28 Days)|Adverse Event|0|||
124951929|NCT00446095|449449541|FG003|Phase I (28 Days)|Adverse Event|1|||
124951930|NCT00446095|449449542|FG004|Phase I (28 Days)|Adverse Event|0|||
124951931|NCT00446095|449449538|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
124951932|NCT00446095|449449539|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
124951933|NCT00446095|449449540|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
124951934|NCT00446095|449449541|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
124951935|NCT00446095|449449542|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
124951936|NCT00409747|449449543|FG000|Overall Study|Withdrawal by Subject|1|||
124951937|NCT01916109|449449546|FG000|Overall Study|Withdrawal by Subject|1|||
124951938|NCT00636168|449449549|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
124951939|NCT00636168|449449550|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
124951940|NCT00636168|449449549|FG000|Randomized to Study Drug|Adverse Event|1|||
124951941|NCT00636168|449449550|FG001|Randomized to Study Drug|Adverse Event|0|||
124951942|NCT00636168|449449549|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
124951943|NCT00636168|449449550|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
124951944|NCT00636168|449449549|FG000|Treated With Study Drug|Recurrence of disease|135|||
124951945|NCT00636168|449449550|FG001|Treated With Study Drug|Recurrence of disease|282|||
124951946|NCT00636168|449449549|FG000|Treated With Study Drug|Adverse Event|250|||
124951947|NCT00636168|449449550|FG001|Treated With Study Drug|Adverse Event|22|||
124951948|NCT00636168|449449549|FG000|Treated With Study Drug|Participant withdrew consent|16|||
124951949|NCT00636168|449449550|FG001|Treated With Study Drug|Participant withdrew consent|21|||
124951950|NCT00636168|449449549|FG000|Treated With Study Drug|Poor/non-compliance|1|||
124951951|NCT00636168|449449550|FG001|Treated With Study Drug|Poor/non-compliance|3|||
124951952|NCT00636168|449449549|FG000|Treated With Study Drug|Death|3|||
124951953|NCT00636168|449449550|FG001|Treated With Study Drug|Death|0|||
124951954|NCT00636168|449449549|FG000|Treated With Study Drug|Pregnancy|1|||
124951955|NCT00636168|449449550|FG001|Treated With Study Drug|Pregnancy|0|||
124951956|NCT00636168|449449549|FG000|Treated With Study Drug|No longer meets study criteria|1|||
124951957|NCT00636168|449449550|FG001|Treated With Study Drug|No longer meets study criteria|0|||
124951958|NCT00636168|449449549|FG000|Treated With Study Drug|Other reason|1|||
124951959|NCT00636168|449449550|FG001|Treated With Study Drug|Other reason|3|||
124951960|NCT00636168|449449549|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
124951961|NCT00636168|449449550|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
124951962|NCT00636168|449449549|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
124951963|NCT00636168|449449550|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
124951964|NCT00636168|449449549|FG000|Long Term Follow-Up|Death|8|||
124951965|NCT00636168|449449550|FG001|Long Term Follow-Up|Death|9|||
124951966|NCT02707952|449449553|FG000|Overall Study|Adverse Event|1|||
124951967|NCT02707952|449449554|FG001|Overall Study|Adverse Event|0|||
124951968|NCT02707952|449449555|FG002|Overall Study|Adverse Event|0|||
124951969|NCT02707952|449449556|FG003|Overall Study|Adverse Event|0|||
124951970|NCT02707952|449449553|FG000|Overall Study|Lost to Follow-up|1|||
124951971|NCT02707952|449449554|FG001|Overall Study|Lost to Follow-up|0|||
124951972|NCT02707952|449449555|FG002|Overall Study|Lost to Follow-up|0|||
124951973|NCT02707952|449449556|FG003|Overall Study|Lost to Follow-up|0|||
124951974|NCT02707952|449449553|FG000|Overall Study|Withdrawal by Subject|0|||
124951975|NCT02707952|449449554|FG001|Overall Study|Withdrawal by Subject|1|||
124951976|NCT02707952|449449555|FG002|Overall Study|Withdrawal by Subject|2|||
124951977|NCT02707952|449449556|FG003|Overall Study|Withdrawal by Subject|0|||
124951978|NCT02006641|449449557|FG000|Overall Study|Withdrawal before treatment|2|||
124951979|NCT02006641|449449558|FG001|Overall Study|Withdrawal before treatment|5|||
124951980|NCT02006641|449449559|FG002|Overall Study|Withdrawal before treatment|3|||
124951981|NCT02006641|449449557|FG000|Overall Study|Adverse Event|15|||
124951982|NCT02006641|449449558|FG001|Overall Study|Adverse Event|11|||
124951983|NCT02006641|449449559|FG002|Overall Study|Adverse Event|15|||
124951984|NCT02006641|449449557|FG000|Overall Study|Protocol Violation|0|||
124951985|NCT02006641|449449558|FG001|Overall Study|Protocol Violation|2|||
124951986|NCT02006641|449449559|FG002|Overall Study|Protocol Violation|2|||
124951987|NCT02006641|449449557|FG000|Overall Study|Lost to Follow-up|0|||
124951988|NCT02006641|449449558|FG001|Overall Study|Lost to Follow-up|1|||
124951989|NCT02006641|449449559|FG002|Overall Study|Lost to Follow-up|0|||
124951990|NCT02006641|449449557|FG000|Overall Study|Withdrawal by Subject|7|||
124951991|NCT02006641|449449558|FG001|Overall Study|Withdrawal by Subject|12|||
124951992|NCT02006641|449449559|FG002|Overall Study|Withdrawal by Subject|11|||
124951993|NCT02006641|449449557|FG000|Overall Study|Other reason: patient didn't show up|1|||
124951994|NCT02006641|449449558|FG001|Overall Study|Other reason: patient didn't show up|0|||
124951995|NCT02006641|449449559|FG002|Overall Study|Other reason: patient didn't show up|0|||
124951996|NCT02006641|449449557|FG000|Overall Study|Other reason:patient didn't want to come|0|||
124951997|NCT02006641|449449558|FG001|Overall Study|Other reason:patient didn't want to come|0|||
124951998|NCT02006641|449449559|FG002|Overall Study|Other reason:patient didn't want to come|1|||
124951999|NCT02006641|449449557|FG000|Overall Study|Other reason: patient has moved|1|||
124952000|NCT02006641|449449558|FG001|Overall Study|Other reason: patient has moved|0|||
124952001|NCT02006641|449449559|FG002|Overall Study|Other reason: patient has moved|1|||
124952002|NCT02006641|449449557|FG000|Overall Study|Other reason: caregiver in hospital|0|||
124952003|NCT02006641|449449558|FG001|Overall Study|Other reason: caregiver in hospital|1|||
124952004|NCT02006641|449449559|FG002|Overall Study|Other reason: caregiver in hospital|0|||
124952005|NCT02006641|449449557|FG000|Overall Study|Other reason: patient's wife has died|0|||
124952006|NCT02006641|449449558|FG001|Overall Study|Other reason: patient's wife has died|0|||
124952007|NCT02006641|449449559|FG002|Overall Study|Other reason: patient's wife has died|1|||
125125076|NCT02848326|450084087|FG005|Treatment Period|Withdrawal of Consent|6|||
124952008|NCT02006641|449449557|FG000|Overall Study|Other reason: hospitalisation|0|||
124952009|NCT02006641|449449558|FG001|Overall Study|Other reason: hospitalisation|1|||
124952010|NCT02006641|449449559|FG002|Overall Study|Other reason: hospitalisation|0|||
124952011|NCT02006641|449449557|FG000|Overall Study|Other reason: caregiver impossibility|0|||
125125077|NCT02848326|450084082|FG000|Treatment Period|Lost to Follow-up|5|||
124952012|NCT02006641|449449558|FG001|Overall Study|Other reason: caregiver impossibility|0|||
124952013|NCT02006641|449449559|FG002|Overall Study|Other reason: caregiver impossibility|1|||
124952014|NCT02006641|449449557|FG000|Overall Study|Other reason: protocol non-compliance|0|||
124952015|NCT02006641|449449558|FG001|Overall Study|Other reason: protocol non-compliance|0|||
124952016|NCT02006641|449449559|FG002|Overall Study|Other reason: protocol non-compliance|1|||
124952017|NCT01287832|449449560|FG000|Overall Study|Adverse Event|1|||
124952018|NCT01287832|449449561|FG001|Overall Study|Adverse Event|0|||
124952019|NCT01287832|449449560|FG000|Overall Study|Death|0|||
124952020|NCT01287832|449449561|FG001|Overall Study|Death|1|||
124952021|NCT04749797|449449563|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
124952022|NCT04749797|449449564|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
125125078|NCT02848326|450084083|FG001|Treatment Period|Lost to Follow-up|1|||
125125079|NCT02848326|450084084|FG002|Treatment Period|Lost to Follow-up|11|||
125125080|NCT02848326|450084085|FG003|Treatment Period|Lost to Follow-up|7|||
125125081|NCT02848326|450084086|FG004|Treatment Period|Lost to Follow-up|2|||
125125082|NCT02848326|450084087|FG005|Treatment Period|Lost to Follow-up|3|||
125125083|NCT02848326|450084082|FG000|Treatment Period|Pregnancy|0|||
125125084|NCT02848326|450084083|FG001|Treatment Period|Pregnancy|0|||
125125085|NCT02848326|450084084|FG002|Treatment Period|Pregnancy|1|||
125125086|NCT02848326|450084085|FG003|Treatment Period|Pregnancy|1|||
125125087|NCT02848326|450084086|FG004|Treatment Period|Pregnancy|0|||
125125088|NCT02848326|450084087|FG005|Treatment Period|Pregnancy|1|||
125125089|NCT02848326|450084082|FG000|Treatment Period|Protocol Violation|4|||
125125090|NCT02848326|450084083|FG001|Treatment Period|Protocol Violation|3|||
125125091|NCT02848326|450084084|FG002|Treatment Period|Protocol Violation|4|||
125125092|NCT02848326|450084085|FG003|Treatment Period|Protocol Violation|2|||
125125093|NCT02848326|450084086|FG004|Treatment Period|Protocol Violation|3|||
125215196|NCT01152996|450414932|FG000|Overall Study|Withdrawal by Subject|142|||
124952023|NCT04749797|449449565|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
124952024|NCT00632736|449449566|FG000|Overall Study|Adverse Event|104|||
125125094|NCT02848326|450084087|FG005|Treatment Period|Protocol Violation|3|||
125125095|NCT02848326|450084082|FG000|Treatment Period|Non-compliance with Study Drug|4|||
125125096|NCT02848326|450084083|FG001|Treatment Period|Non-compliance with Study Drug|0|||
125215197|NCT01152996|450414932|FG000|Overall Study|Adverse Event|115|||
125125097|NCT02848326|450084084|FG002|Treatment Period|Non-compliance with Study Drug|0|||
125125098|NCT02848326|450084085|FG003|Treatment Period|Non-compliance with Study Drug|1|||
125125099|NCT02848326|450084086|FG004|Treatment Period|Non-compliance with Study Drug|0|||
124952025|NCT00632736|449449566|FG000|Overall Study|Lost to Follow-up|15|||
125125100|NCT02848326|450084087|FG005|Treatment Period|Non-compliance with Study Drug|0|||
124952026|NCT00632736|449449566|FG000|Overall Study|Protocol Violation|14|||
124952027|NCT00632736|449449566|FG000|Overall Study|Withdrawal by Subject|99|||
124952028|NCT00632736|449449566|FG000|Overall Study|Lack of Efficacy|5|||
124952029|NCT00632736|449449566|FG000|Overall Study|Sponsor terminated study|5|||
124952030|NCT00632736|449449566|FG000|Overall Study|Non-compliance|10|||
124952031|NCT00632736|449449566|FG000|Overall Study|Other|16|||
124952032|NCT01441596|449449567|FG000|Overall Study|Other reason not defined below|0|||
124952033|NCT01441596|449449568|FG001|Overall Study|Other reason not defined below|2|||
124952034|NCT01441596|449449569|FG002|Overall Study|Other reason not defined below|1|||
124952035|NCT01441596|449449567|FG000|Overall Study|Withdrawal by Subject|4|||
124952036|NCT01441596|449449568|FG001|Overall Study|Withdrawal by Subject|0|||
124952037|NCT01441596|449449569|FG002|Overall Study|Withdrawal by Subject|2|||
124952038|NCT01441596|449449567|FG000|Overall Study|Not treated|0|||
124952039|NCT01441596|449449568|FG001|Overall Study|Not treated|1|||
124952040|NCT01441596|449449569|FG002|Overall Study|Not treated|1|||
124952041|NCT01794689|449449570|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
124952042|NCT01794689|449449571|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
124952043|NCT01794689|449449572|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
124952044|NCT01794689|449449573|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
124952045|NCT01794689|449449570|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
124952046|NCT01794689|449449571|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
124952047|NCT01794689|449449572|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
124952048|NCT01794689|449449573|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
124952049|NCT01794689|449449570|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
124952050|NCT01794689|449449571|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
124952051|NCT01794689|449449572|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
124952052|NCT01794689|449449573|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
124952053|NCT01794689|449449570|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
124952054|NCT01794689|449449571|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
124952055|NCT01794689|449449572|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
124952056|NCT01794689|449449573|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
124952057|NCT01697956|449449574|FG000|Overall Study|Protocol Violation|1|||
124952058|NCT01697956|449449575|FG001|Overall Study|Protocol Violation|1|||
124952059|NCT00736502|449449586|FG000|Overall Study|Adverse Event|22|||
124952060|NCT00736502|449449586|FG000|Overall Study|Lack of Efficacy|16|||
124952061|NCT00736502|449449586|FG000|Overall Study|Lost to Follow-up|27|||
124952062|NCT00866619|449449587|FG000|Overall Study|Adverse Event|112|||
124952063|NCT00866619|449449588|FG001|Overall Study|Adverse Event|106|||
124952064|NCT00866619|449449589|FG002|Overall Study|Adverse Event|47|||
124952065|NCT00866619|449449590|FG003|Overall Study|Adverse Event|44|||
124952066|NCT00866619|449449587|FG000|Overall Study|Protocol Violation|2|||
124952067|NCT00866619|449449588|FG001|Overall Study|Protocol Violation|39|||
124952068|NCT00866619|449449589|FG002|Overall Study|Protocol Violation|2|||
124952069|NCT00866619|449449590|FG003|Overall Study|Protocol Violation|17|||
124952070|NCT00866619|449449587|FG000|Overall Study|Withdrawal by Subject|587|||
124952071|NCT00866619|449449588|FG001|Overall Study|Withdrawal by Subject|295|||
124952072|NCT00866619|449449589|FG002|Overall Study|Withdrawal by Subject|272|||
124952073|NCT00866619|449449590|FG003|Overall Study|Withdrawal by Subject|144|||
124952074|NCT00866619|449449587|FG000|Overall Study|Lost to Follow-up|1145|||
124952075|NCT00866619|449449588|FG001|Overall Study|Lost to Follow-up|830|||
124952076|NCT00866619|449449589|FG002|Overall Study|Lost to Follow-up|568|||
124952077|NCT00866619|449449590|FG003|Overall Study|Lost to Follow-up|425|||
124952078|NCT00645411|449449591|FG000|Overall Study|Adverse Event|0|||
124952079|NCT00645411|449449592|FG001|Overall Study|Adverse Event|0|||
124952080|NCT00645411|449449593|FG002|Overall Study|Adverse Event|0|||
125030243|NCT00849017|449732815|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
124952081|NCT00645411|449449594|FG003|Overall Study|Adverse Event|2|||
124952082|NCT00645411|449449591|FG000|Overall Study|Withdrawal by Subject|2|||
124952083|NCT00645411|449449592|FG001|Overall Study|Withdrawal by Subject|1|||
124952084|NCT00645411|449449593|FG002|Overall Study|Withdrawal by Subject|19|||
125030244|NCT00849017|449732816|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
125030245|NCT00849017|449732817|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
125030246|NCT00849017|449732815|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
125030247|NCT00849017|449732816|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
125030248|NCT00849017|449732817|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
125030249|NCT00849017|449732815|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
125030250|NCT00849017|449732816|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
124952085|NCT00645411|449449594|FG003|Overall Study|Withdrawal by Subject|21|||
124952086|NCT00645411|449449591|FG000|Overall Study|Lost to Follow-up|10|||
124952087|NCT00645411|449449592|FG001|Overall Study|Lost to Follow-up|5|||
124952088|NCT00645411|449449593|FG002|Overall Study|Lost to Follow-up|124|||
124952089|NCT00645411|449449594|FG003|Overall Study|Lost to Follow-up|75|||
124952090|NCT00645411|449449591|FG000|Overall Study|Protocol Violation|1|||
124952091|NCT00645411|449449592|FG001|Overall Study|Protocol Violation|0|||
124952092|NCT00645411|449449593|FG002|Overall Study|Protocol Violation|1|||
124952093|NCT00645411|449449594|FG003|Overall Study|Protocol Violation|0|||
124952094|NCT00645411|449449591|FG000|Overall Study|Inappropriate enrollment|0|||
124952095|NCT00645411|449449592|FG001|Overall Study|Inappropriate enrollment|0|||
124952096|NCT00645411|449449593|FG002|Overall Study|Inappropriate enrollment|4|||
124952097|NCT00645411|449449594|FG003|Overall Study|Inappropriate enrollment|1|||
124952098|NCT00645411|449449591|FG000|Overall Study|Unable to classify|0|||
124952099|NCT00645411|449449592|FG001|Overall Study|Unable to classify|0|||
124952100|NCT00645411|449449593|FG002|Overall Study|Unable to classify|3|||
124952101|NCT00645411|449449594|FG003|Overall Study|Unable to classify|4|||
124952102|NCT03987074|449449595|FG000|Overall Study|Withdrew Consent|1|||
124952103|NCT03987074|449449596|FG001|Overall Study|Withdrew Consent|1|||
124952104|NCT03987074|449449597|FG002|Overall Study|Withdrew Consent|0|||
124952105|NCT03987074|449449598|FG003|Overall Study|Withdrew Consent|2|||
124952106|NCT03987074|449449599|FG004|Overall Study|Withdrew Consent|1|||
124952107|NCT03987074|449449595|FG000|Overall Study|Adverse Event|2|||
124952108|NCT03987074|449449596|FG001|Overall Study|Adverse Event|1|||
124952109|NCT03987074|449449597|FG002|Overall Study|Adverse Event|0|||
124952110|NCT03987074|449449598|FG003|Overall Study|Adverse Event|0|||
124952111|NCT03987074|449449599|FG004|Overall Study|Adverse Event|1|||
124952112|NCT03987074|449449595|FG000|Overall Study|Lost to Follow-up|0|||
124952113|NCT03987074|449449596|FG001|Overall Study|Lost to Follow-up|0|||
124952114|NCT03987074|449449597|FG002|Overall Study|Lost to Follow-up|1|||
124952115|NCT03987074|449449598|FG003|Overall Study|Lost to Follow-up|1|||
124952116|NCT03987074|449449599|FG004|Overall Study|Lost to Follow-up|0|||
124952117|NCT03987074|449449595|FG000|Overall Study|Investigator's Discretion|0|||
124952118|NCT03987074|449449596|FG001|Overall Study|Investigator's Discretion|0|||
124952119|NCT03987074|449449597|FG002|Overall Study|Investigator's Discretion|0|||
124952120|NCT03987074|449449598|FG003|Overall Study|Investigator's Discretion|1|||
124952121|NCT03987074|449449599|FG004|Overall Study|Investigator's Discretion|0|||
124952122|NCT03100370|449449600|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
124952123|NCT03100370|449449601|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
124952124|NCT03100370|449449602|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
124952125|NCT03100370|449449603|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
124952126|NCT03100370|449449604|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
124952127|NCT03100370|449449605|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
124952128|NCT01562275|449450878|FG000|Stage 1|Adverse Event|0|||
124952129|NCT01562275|449450879|FG001|Stage 1|Adverse Event|0|||
124952130|NCT01562275|449450880|FG002|Stage 1|Adverse Event|0|||
124952131|NCT01562275|449450881|FG003|Stage 1|Adverse Event|1|||
124952132|NCT01562275|449450882|FG004|Stage 1|Adverse Event|1|||
124952133|NCT01562275|449450883|FG005|Stage 1|Adverse Event|0|||
124952134|NCT01562275|449450884|FG006|Stage 1|Adverse Event|0|||
124952135|NCT01562275|449450885|FG007|Stage 1|Adverse Event|0|||
124952136|NCT01562275|449450886|FG008|Stage 1|Adverse Event|0|||
124952137|NCT01562275|449450887|FG009|Stage 1|Adverse Event|1|||
124952138|NCT01562275|449450888|FG010|Stage 1|Adverse Event|0|||
124952139|NCT01562275|449450889|FG011|Stage 1|Adverse Event|0|||
124952140|NCT01562275|449450890|FG012|Stage 1|Adverse Event|0|||
124952141|NCT01562275|449450878|FG000|Stage 1|Death|1|||
124952142|NCT01562275|449450879|FG001|Stage 1|Death|0|||
124952143|NCT01562275|449450880|FG002|Stage 1|Death|0|||
124952144|NCT01562275|449450881|FG003|Stage 1|Death|0|||
124952145|NCT01562275|449450882|FG004|Stage 1|Death|0|||
124952146|NCT01562275|449450883|FG005|Stage 1|Death|0|||
124952147|NCT01562275|449450884|FG006|Stage 1|Death|0|||
124952148|NCT01562275|449450885|FG007|Stage 1|Death|0|||
124952149|NCT01562275|449450886|FG008|Stage 1|Death|0|||
124952150|NCT01562275|449450887|FG009|Stage 1|Death|0|||
124952151|NCT01562275|449450888|FG010|Stage 1|Death|0|||
124952152|NCT01562275|449450889|FG011|Stage 1|Death|0|||
124952153|NCT01562275|449450890|FG012|Stage 1|Death|0|||
124952154|NCT01562275|449450878|FG000|Stage 1|Non Compliance|0|||
124952155|NCT01562275|449450879|FG001|Stage 1|Non Compliance|0|||
124952156|NCT01562275|449450880|FG002|Stage 1|Non Compliance|1|||
124952157|NCT01562275|449450881|FG003|Stage 1|Non Compliance|0|||
124952158|NCT01562275|449450882|FG004|Stage 1|Non Compliance|0|||
124952159|NCT01562275|449450883|FG005|Stage 1|Non Compliance|0|||
124952160|NCT01562275|449450884|FG006|Stage 1|Non Compliance|0|||
124952161|NCT01562275|449450885|FG007|Stage 1|Non Compliance|0|||
124952162|NCT01562275|449450886|FG008|Stage 1|Non Compliance|0|||
124952163|NCT01562275|449450887|FG009|Stage 1|Non Compliance|0|||
124952164|NCT01562275|449450888|FG010|Stage 1|Non Compliance|0|||
124952165|NCT01562275|449450889|FG011|Stage 1|Non Compliance|0|||
124952166|NCT01562275|449450890|FG012|Stage 1|Non Compliance|0|||
124952167|NCT01562275|449450878|FG000|Stage 1|Physician Decision|0|||
124952168|NCT01562275|449450879|FG001|Stage 1|Physician Decision|0|||
124952169|NCT01562275|449450880|FG002|Stage 1|Physician Decision|0|||
124952170|NCT01562275|449450881|FG003|Stage 1|Physician Decision|0|||
124952171|NCT01562275|449450882|FG004|Stage 1|Physician Decision|1|||
124952172|NCT01562275|449450883|FG005|Stage 1|Physician Decision|0|||
124952173|NCT01562275|449450884|FG006|Stage 1|Physician Decision|1|||
124952174|NCT01562275|449450885|FG007|Stage 1|Physician Decision|0|||
124952175|NCT01562275|449450886|FG008|Stage 1|Physician Decision|1|||
124952176|NCT01562275|449450887|FG009|Stage 1|Physician Decision|0|||
124952177|NCT01562275|449450888|FG010|Stage 1|Physician Decision|0|||
124952178|NCT01562275|449450889|FG011|Stage 1|Physician Decision|0|||
124952179|NCT01562275|449450890|FG012|Stage 1|Physician Decision|0|||
124952180|NCT01562275|449450878|FG000|Stage 1|Progression of Disease|2|||
124952181|NCT01562275|449450879|FG001|Stage 1|Progression of Disease|6|||
124952182|NCT01562275|449450880|FG002|Stage 1|Progression of Disease|2|||
124952183|NCT01562275|449450881|FG003|Stage 1|Progression of Disease|1|||
124952184|NCT01562275|449450882|FG004|Stage 1|Progression of Disease|2|||
124952185|NCT01562275|449450883|FG005|Stage 1|Progression of Disease|4|||
124952186|NCT01562275|449450884|FG006|Stage 1|Progression of Disease|1|||
124952187|NCT01562275|449450885|FG007|Stage 1|Progression of Disease|7|||
124952188|NCT01562275|449450886|FG008|Stage 1|Progression of Disease|2|||
124952189|NCT01562275|449450887|FG009|Stage 1|Progression of Disease|5|||
124952190|NCT01562275|449450888|FG010|Stage 1|Progression of Disease|3|||
124952191|NCT01562275|449450889|FG011|Stage 1|Progression of Disease|0|||
124952192|NCT01562275|449450890|FG012|Stage 1|Progression of Disease|0|||
124952193|NCT01562275|449450878|FG000|Stage 1|Withdrawal by Subject|0|||
124952194|NCT01562275|449450879|FG001|Stage 1|Withdrawal by Subject|1|||
124952195|NCT01562275|449450880|FG002|Stage 1|Withdrawal by Subject|0|||
124952196|NCT01562275|449450881|FG003|Stage 1|Withdrawal by Subject|2|||
124952197|NCT01562275|449450882|FG004|Stage 1|Withdrawal by Subject|0|||
124952198|NCT01562275|449450883|FG005|Stage 1|Withdrawal by Subject|0|||
124952199|NCT01562275|449450884|FG006|Stage 1|Withdrawal by Subject|1|||
124952200|NCT01562275|449450885|FG007|Stage 1|Withdrawal by Subject|0|||
124952201|NCT01562275|449450886|FG008|Stage 1|Withdrawal by Subject|0|||
124952202|NCT01562275|449450887|FG009|Stage 1|Withdrawal by Subject|1|||
124952203|NCT01562275|449450888|FG010|Stage 1|Withdrawal by Subject|0|||
124952204|NCT01562275|449450889|FG011|Stage 1|Withdrawal by Subject|0|||
124952205|NCT01562275|449450890|FG012|Stage 1|Withdrawal by Subject|0|||
124952206|NCT01562275|449450878|FG000|Stage 2|Death|0|||
124952207|NCT01562275|449450879|FG001|Stage 2|Death|0|||
124952208|NCT01562275|449450880|FG002|Stage 2|Death|0|||
124952209|NCT01562275|449450881|FG003|Stage 2|Death|0|||
124952210|NCT01562275|449450882|FG004|Stage 2|Death|0|||
124952211|NCT01562275|449450883|FG005|Stage 2|Death|0|||
124952212|NCT01562275|449450884|FG006|Stage 2|Death|0|||
124952213|NCT01562275|449450885|FG007|Stage 2|Death|0|||
124952214|NCT01562275|449450886|FG008|Stage 2|Death|0|||
124952215|NCT01562275|449450887|FG009|Stage 2|Death|0|||
124952216|NCT01562275|449450888|FG010|Stage 2|Death|0|||
124952217|NCT01562275|449450889|FG011|Stage 2|Death|2|||
124952218|NCT01562275|449450890|FG012|Stage 2|Death|1|||
124952219|NCT01562275|449450878|FG000|Stage 2|Progression of Disease|0|||
124952220|NCT01562275|449450879|FG001|Stage 2|Progression of Disease|0|||
124952221|NCT01562275|449450880|FG002|Stage 2|Progression of Disease|0|||
124952222|NCT01562275|449450881|FG003|Stage 2|Progression of Disease|0|||
124952223|NCT01562275|449450882|FG004|Stage 2|Progression of Disease|0|||
124952224|NCT01562275|449450883|FG005|Stage 2|Progression of Disease|0|||
124952225|NCT01562275|449450884|FG006|Stage 2|Progression of Disease|0|||
124952226|NCT01562275|449450885|FG007|Stage 2|Progression of Disease|0|||
124952227|NCT01562275|449450886|FG008|Stage 2|Progression of Disease|0|||
124952228|NCT01562275|449450887|FG009|Stage 2|Progression of Disease|0|||
124952229|NCT01562275|449450888|FG010|Stage 2|Progression of Disease|0|||
124952230|NCT01562275|449450889|FG011|Stage 2|Progression of Disease|12|||
124952231|NCT01562275|449450890|FG012|Stage 2|Progression of Disease|4|||
124952232|NCT01863368|449450891|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
124952233|NCT01863368|449450892|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
124952234|NCT01863368|449450891|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
124952235|NCT01863368|449450892|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
124952236|NCT01863368|449450891|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
124952237|NCT01863368|449450892|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
125030251|NCT00849017|449732817|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
125030252|NCT00849017|449732815|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
125030253|NCT00849017|449732816|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
125030254|NCT00849017|449732817|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
125030255|NCT00849017|449732815|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
125030256|NCT00849017|449732816|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
125215198|NCT01152996|450414932|FG000|Overall Study|Lost to Follow-up|112|||
124952238|NCT01863368|449450891|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
124952239|NCT01863368|449450892|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
124952240|NCT01863368|449450891|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
124952241|NCT01863368|449450892|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
124952242|NCT01863368|449450891|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
124952243|NCT01863368|449450892|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
124952244|NCT01020487|449450894|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
124952245|NCT01020487|449450895|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
125030257|NCT00849017|449732817|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
125215199|NCT01152996|450414932|FG000|Overall Study|Lack of Efficacy|68|||
125215200|NCT01152996|450414932|FG000|Overall Study|Noncompliance|41|||
125215201|NCT01152996|450414932|FG000|Overall Study|Other|36|||
125215202|NCT01152996|450414932|FG000|Overall Study|Protocol Violation|22|||
125215203|NCT01152996|450414932|FG000|Overall Study|Elevated liver enzymes|1|||
125215204|NCT02072941|450414934|FG000|Overall Study|Withdrawal by Subject|29|||
125215205|NCT02072941|450414935|FG001|Overall Study|Withdrawal by Subject|21|||
125215206|NCT02072941|450414934|FG000|Overall Study|Lost to Follow-up|4|||
125215207|NCT02072941|450414935|FG001|Overall Study|Lost to Follow-up|4|||
125215208|NCT02072941|450414934|FG000|Overall Study|Death|3|||
125215209|NCT02072941|450414935|FG001|Overall Study|Death|2|||
124952246|NCT01020487|449450896|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
124952247|NCT01020487|449450894|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
124952248|NCT01020487|449450895|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
124952249|NCT01020487|449450896|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
124952250|NCT01020487|449450894|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
124952251|NCT01020487|449450895|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
124952252|NCT01020487|449450896|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
124952253|NCT01020487|449450894|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
124952254|NCT01020487|449450895|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
124952255|NCT01020487|449450896|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
124952256|NCT01020487|449450894|FG000|Part 2 Open-label Period|Adverse Event|0|||
124952257|NCT01020487|449450895|FG001|Part 2 Open-label Period|Adverse Event|4|||
124952258|NCT01020487|449450896|FG002|Part 2 Open-label Period|Adverse Event|1|||
124952259|NCT04049578|449450897|FG000|Overall Study|Physician Decision|1|||
124952260|NCT02400749|449450900|FG000|Week 0 -16|Withdrawal by Subject|5|||
124952261|NCT02400749|449450901|FG001|Week 0 -16|Withdrawal by Subject|5|||
124952262|NCT02400749|449450900|FG000|Week 0 -16|Adverse Event|3|||
124952263|NCT02400749|449450901|FG001|Week 0 -16|Adverse Event|1|||
124952264|NCT02400749|449450900|FG000|Week 0 -16|Lost to Follow-up|2|||
124952265|NCT02400749|449450901|FG001|Week 0 -16|Lost to Follow-up|0|||
124952266|NCT02400749|449450900|FG000|Week 0 -16|Protocol Violation|1|||
124952267|NCT02400749|449450901|FG001|Week 0 -16|Protocol Violation|0|||
124952268|NCT02400749|449450900|FG000|Week 17 - 32|Withdrawal by Subject|3|||
124952269|NCT02400749|449450901|FG001|Week 17 - 32|Withdrawal by Subject|2|||
124952270|NCT02400749|449450900|FG000|Week 17 - 32|Adverse Event|2|||
124952271|NCT02400749|449450901|FG001|Week 17 - 32|Adverse Event|1|||
124952272|NCT04425252|449450904|FG000|Overall Study|Withdrawal by Subject|2|||
124952273|NCT04425252|449450905|FG001|Overall Study|Withdrawal by Subject|1|||
125215210|NCT02072941|450414934|FG000|Overall Study|Removed by Study Staff|2|||
125215211|NCT02072941|450414935|FG001|Overall Study|Removed by Study Staff|2|||
125215212|NCT03146741|450414936|FG000|Overall Study|Txp with non-HCV+ heart|4|||
125215213|NCT03146741|450414936|FG000|Overall Study|Listeted for MOT|2|||
125215214|NCT03146741|450414936|FG000|Overall Study|Physician Decision|2|||
125215215|NCT03146741|450414936|FG000|Overall Study|Awaiting txp|2|||
124952274|NCT04425252|449450904|FG000|Overall Study|Lost to Follow-up|1|||
124952275|NCT04425252|449450905|FG001|Overall Study|Lost to Follow-up|0|||
124952276|NCT04425252|449450904|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
124952277|NCT04425252|449450905|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
124952278|NCT00307489|449450906|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
124952279|NCT00307489|449450907|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
124952280|NCT00307489|449450906|FG000|Baseline Through Week 48|Physician Decision|1|||
124952281|NCT00307489|449450907|FG001|Baseline Through Week 48|Physician Decision|0|||
124952282|NCT00307489|449450906|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
124952283|NCT00307489|449450907|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
124952284|NCT00307489|449450906|FG000|Week 48 Through Week 168|Adverse Event|1|||
124952285|NCT00307489|449450907|FG001|Week 48 Through Week 168|Adverse Event|0|||
124952286|NCT00307489|449450906|FG000|Week 48 Through Week 168|Physician Decision|1|||
124952287|NCT00307489|449450907|FG001|Week 48 Through Week 168|Physician Decision|0|||
124952288|NCT00307489|449450906|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
124952289|NCT00307489|449450907|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
124952290|NCT00307489|449450906|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
124952291|NCT00307489|449450907|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
124952292|NCT00307489|449450906|FG000|Week 48 Through Week 168|Death|0|||
124952293|NCT00307489|449450907|FG001|Week 48 Through Week 168|Death|1|||
124952294|NCT00307489|449450906|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
124952295|NCT00307489|449450907|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
124952296|NCT00307489|449450906|FG000|Week 48 Through Week 168|Seroconversion|1|||
124952297|NCT00307489|449450907|FG001|Week 48 Through Week 168|Seroconversion|0|||
124952298|NCT02446015|449450909|FG000|Overall Study|Adverse Event|0|||
124952299|NCT02446015|449450910|FG001|Overall Study|Adverse Event|1|||
124952300|NCT02446015|449450909|FG000|Overall Study|Withdrawal by Subject|1|||
124952301|NCT02446015|449450910|FG001|Overall Study|Withdrawal by Subject|0|||
124952302|NCT02964234|449450912|FG000|Overall Study|Lost to Follow-up|22|||
124952303|NCT02964234|449450913|FG001|Overall Study|Lost to Follow-up|13|||
124952304|NCT02163499|449450914|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
124952305|NCT02163499|449450914|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
124952306|NCT02163499|449450914|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
124952307|NCT02163499|449450914|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
124952308|NCT02163499|449450914|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
124952309|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
124952310|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
124952311|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
124952312|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
124952313|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
124952314|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
124952315|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
124952316|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
124952317|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
124952318|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Death|8|||
124952319|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
124952320|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
124952321|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
124952322|NCT00857311|449450915|FG000|Overall Study|Lost to Follow-up|1|||
124952323|NCT00857311|449450916|FG001|Overall Study|Lost to Follow-up|0|||
124952324|NCT00857311|449450917|FG002|Overall Study|Lost to Follow-up|0|||
124952325|NCT00857311|449450918|FG003|Overall Study|Lost to Follow-up|0|||
124952326|NCT00828139|449450923|FG000|Overall Study|Adverse Event|8|||
124952327|NCT00828139|449450924|FG001|Overall Study|Adverse Event|1|||
124952328|NCT00828139|449450925|FG002|Overall Study|Adverse Event|10|||
124952329|NCT00828139|449450926|FG003|Overall Study|Adverse Event|5|||
124952330|NCT00828139|449450923|FG000|Overall Study|Death|2|||
124952331|NCT00828139|449450924|FG001|Overall Study|Death|1|||
124952332|NCT00828139|449450925|FG002|Overall Study|Death|0|||
124952333|NCT00828139|449450926|FG003|Overall Study|Death|2|||
124952334|NCT00828139|449450923|FG000|Overall Study|Refusal unrelated to toxicity|3|||
124952335|NCT00828139|449450924|FG001|Overall Study|Refusal unrelated to toxicity|4|||
124952336|NCT00828139|449450925|FG002|Overall Study|Refusal unrelated to toxicity|5|||
124952337|NCT00828139|449450926|FG003|Overall Study|Refusal unrelated to toxicity|3|||
124952338|NCT00828139|449450923|FG000|Overall Study|Disease Progression|24|||
124952339|NCT00828139|449450924|FG001|Overall Study|Disease Progression|33|||
124952340|NCT00828139|449450925|FG002|Overall Study|Disease Progression|35|||
125215216|NCT03224624|450414937|FG000|Overall Study|Lost to Follow-up|9|||
125215217|NCT03224624|450414938|FG001|Overall Study|Lost to Follow-up|4|||
125215218|NCT03224624|450414937|FG000|Overall Study|Death|1|||
125215219|NCT03224624|450414938|FG001|Overall Study|Death|0|||
125215220|NCT01884545|450414939|FG000|Overall Study|Lost to Follow-up|6|||
125215221|NCT01884545|450414940|FG001|Overall Study|Lost to Follow-up|4|||
125215222|NCT01884545|450414941|FG002|Overall Study|Lost to Follow-up|9|||
125215223|NCT01884545|450414942|FG003|Overall Study|Lost to Follow-up|4|||
125215224|NCT01884545|450414939|FG000|Overall Study|Patient withdrawn|7|||
125215225|NCT01884545|450414940|FG001|Overall Study|Patient withdrawn|12|||
125215226|NCT01884545|450414941|FG002|Overall Study|Patient withdrawn|5|||
125215227|NCT01884545|450414942|FG003|Overall Study|Patient withdrawn|5|||
125215228|NCT01884545|450414939|FG000|Overall Study|Non-adherence|0|||
125215229|NCT01884545|450414940|FG001|Overall Study|Non-adherence|2|||
125215230|NCT01884545|450414941|FG002|Overall Study|Non-adherence|0|||
125215231|NCT01884545|450414942|FG003|Overall Study|Non-adherence|0|||
125215232|NCT02521792|450414948|FG000|Overall Study|Study Terminated|6|||
125215233|NCT02937636|450414950|FG000|Overall Study|Other (Not specified)|3|||
125215234|NCT02937636|450414951|FG001|Overall Study|Other (Not specified)|2|||
125215235|NCT00770913|450414956|FG000|Overall Study|Adverse Event|1|||
125215236|NCT00770913|450414957|FG001|Overall Study|Adverse Event|3|||
125215237|NCT00770913|450414958|FG002|Overall Study|Adverse Event|6|||
124952341|NCT00828139|449450926|FG003|Overall Study|Disease Progression|39|||
124952342|NCT00828139|449450923|FG000|Overall Study|Other|4|||
124952343|NCT00828139|449450924|FG001|Overall Study|Other|2|||
124952344|NCT00828139|449450925|FG002|Overall Study|Other|5|||
124952345|NCT00828139|449450926|FG003|Overall Study|Other|2|||
124952346|NCT01714947|449450927|FG000|Part B|Progressive Disease|3|||
124952347|NCT01922102|449450928|FG000|Overall Study|Withdrawal by Subject|7|||
124952348|NCT01922102|449450929|FG001|Overall Study|Withdrawal by Subject|3|||
124952349|NCT01922102|449450930|FG002|Overall Study|Withdrawal by Subject|7|||
124952350|NCT01922102|449450928|FG000|Overall Study|Physician Decision|0|||
124952351|NCT01922102|449450929|FG001|Overall Study|Physician Decision|2|||
124952352|NCT01922102|449450930|FG002|Overall Study|Physician Decision|1|||
124952353|NCT01922102|449450928|FG000|Overall Study|Adverse Event|1|||
124952354|NCT01922102|449450929|FG001|Overall Study|Adverse Event|2|||
124952355|NCT01922102|449450930|FG002|Overall Study|Adverse Event|0|||
124952356|NCT01922102|449450928|FG000|Overall Study|Lost to Follow-up|1|||
124952357|NCT01922102|449450929|FG001|Overall Study|Lost to Follow-up|0|||
124952358|NCT01922102|449450930|FG002|Overall Study|Lost to Follow-up|0|||
124952359|NCT01922102|449450928|FG000|Overall Study|Administrative problems|0|||
124952360|NCT01922102|449450929|FG001|Overall Study|Administrative problems|2|||
124952361|NCT01922102|449450930|FG002|Overall Study|Administrative problems|0|||
124952362|NCT01123356|449450934|FG000|Overall Study|Adverse Event|2|||
124952363|NCT01123356|449450934|FG000|Overall Study|Lack of Efficacy|4|||
124952364|NCT01123356|449450934|FG000|Overall Study|Withdrawal by Subject|1|||
124952365|NCT03262389|449450937|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
124952366|NCT03262389|449450937|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
124952367|NCT03262389|449450937|FG000|Overall Study|opted out of PET/MR|1|||
124952368|NCT01052272|449450938|FG000|Overall Study|Death|0|||
124952369|NCT01052272|449450939|FG001|Overall Study|Death|0|||
124952370|NCT01052272|449450940|FG002|Overall Study|Death|1|||
124952371|NCT01052272|449450941|FG003|Overall Study|Death|1|||
124952372|NCT01052272|449450938|FG000|Overall Study|Physician Decision|0|||
124952373|NCT01052272|449450939|FG001|Overall Study|Physician Decision|1|||
124952374|NCT01052272|449450940|FG002|Overall Study|Physician Decision|0|||
124952375|NCT01052272|449450941|FG003|Overall Study|Physician Decision|0|||
124952376|NCT01052272|449450938|FG000|Overall Study|patient refuses follow-up|5|||
124952377|NCT01052272|449450939|FG001|Overall Study|patient refuses follow-up|4|||
125215238|NCT00770913|450414956|FG000|Overall Study|Refusal to continue participation|6|||
125215239|NCT00770913|450414957|FG001|Overall Study|Refusal to continue participation|4|||
124952378|NCT01052272|449450940|FG002|Overall Study|patient refuses follow-up|2|||
124952379|NCT01052272|449450941|FG003|Overall Study|patient refuses follow-up|4|||
124952380|NCT01052272|449450938|FG000|Overall Study|Withdrawal by Subject|0|||
124952381|NCT01052272|449450939|FG001|Overall Study|Withdrawal by Subject|2|||
124952382|NCT01052272|449450940|FG002|Overall Study|Withdrawal by Subject|3|||
124952383|NCT01052272|449450941|FG003|Overall Study|Withdrawal by Subject|2|||
124952384|NCT01052272|449450938|FG000|Overall Study|placed in long-term care|0|||
124952385|NCT01052272|449450939|FG001|Overall Study|placed in long-term care|0|||
124952386|NCT01052272|449450940|FG002|Overall Study|placed in long-term care|1|||
125215240|NCT00770913|450414958|FG002|Overall Study|Refusal to continue participation|5|||
125215241|NCT00770913|450414956|FG000|Overall Study|Physician Decision|0|||
124952387|NCT01052272|449450941|FG003|Overall Study|placed in long-term care|0|||
124952388|NCT01052272|449450938|FG000|Overall Study|decline in health|0|||
124952389|NCT01052272|449450939|FG001|Overall Study|decline in health|0|||
124952390|NCT01052272|449450940|FG002|Overall Study|decline in health|1|||
125215242|NCT00770913|450414957|FG001|Overall Study|Physician Decision|1|||
125215243|NCT00770913|450414958|FG002|Overall Study|Physician Decision|1|||
125215244|NCT00770913|450414956|FG000|Overall Study|Protocol Violation|3|||
125125101|NCT02848326|450084082|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
125125102|NCT02848326|450084083|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
125125103|NCT02848326|450084084|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
125125104|NCT02848326|450084085|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
125125105|NCT02848326|450084086|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
125125106|NCT02848326|450084087|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
125125107|NCT02848326|450084082|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
125125108|NCT02848326|450084083|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
125125109|NCT02848326|450084084|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
125125110|NCT02848326|450084085|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
125125111|NCT02848326|450084086|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
125125112|NCT02848326|450084087|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
125125113|NCT04526210|450084094|FG000|Overall Study|Sponsor decision|7|||
125125114|NCT04526210|450084095|FG001|Overall Study|Sponsor decision|5|||
125125115|NCT04526210|450084094|FG000|Overall Study|Withdrawal by Subject|3|||
125125116|NCT04526210|450084095|FG001|Overall Study|Withdrawal by Subject|2|||
125125117|NCT01781637|450084096|FG000|Overall Study|Adverse Event|1|||
125125118|NCT01781637|450084097|FG001|Overall Study|Adverse Event|0|||
125125119|NCT01781637|450084096|FG000|Overall Study|Lack of Efficacy|2|||
125125120|NCT01781637|450084097|FG001|Overall Study|Lack of Efficacy|6|||
125125121|NCT01781637|450084096|FG000|Overall Study|Withdrawal by Subject|1|||
125125122|NCT01781637|450084097|FG001|Overall Study|Withdrawal by Subject|0|||
125125123|NCT02999178|450084098|FG000|Overall Study|Adverse Event|85|||
125125124|NCT02999178|450084099|FG001|Overall Study|Adverse Event|62|||
125125125|NCT02999178|450084098|FG000|Overall Study|Protocol Violation|1|||
125125126|NCT02999178|450084099|FG001|Overall Study|Protocol Violation|2|||
125125127|NCT02999178|450084098|FG000|Overall Study|Lost to Follow-up|0|||
125125128|NCT02999178|450084099|FG001|Overall Study|Lost to Follow-up|2|||
125125129|NCT02999178|450084098|FG000|Overall Study|Withdrawal by Subject|21|||
125125130|NCT02999178|450084099|FG001|Overall Study|Withdrawal by Subject|21|||
125125131|NCT02999178|450084098|FG000|Overall Study|Other reason not defined above|7|||
125125132|NCT02999178|450084099|FG001|Overall Study|Other reason not defined above|13|||
125125133|NCT03471078|450084107|FG000|Overall Study|Withdrawal by Subject|9|||
125125134|NCT03471078|450084108|FG001|Overall Study|Withdrawal by Subject|1|||
125125135|NCT03471078|450084107|FG000|Overall Study|Adverse Event|4|||
124952391|NCT01052272|449450941|FG003|Overall Study|decline in health|0|||
124952392|NCT01077284|449450943|FG000|Overall Study|Adverse Event|2|||
124952393|NCT01077284|449450944|FG001|Overall Study|Adverse Event|0|||
124952394|NCT01077284|449450945|FG002|Overall Study|Adverse Event|1|||
124952395|NCT01077284|449450943|FG000|Overall Study|Lost to Follow-up|1|||
124952396|NCT01077284|449450944|FG001|Overall Study|Lost to Follow-up|2|||
124952397|NCT01077284|449450945|FG002|Overall Study|Lost to Follow-up|0|||
124952398|NCT01077284|449450943|FG000|Overall Study|Withdrawal by Subject|2|||
124952399|NCT01077284|449450944|FG001|Overall Study|Withdrawal by Subject|3|||
124952400|NCT01077284|449450945|FG002|Overall Study|Withdrawal by Subject|1|||
124952401|NCT01077284|449450943|FG000|Overall Study|Other|0|||
124952402|NCT01077284|449450944|FG001|Overall Study|Other|0|||
124952403|NCT01077284|449450945|FG002|Overall Study|Other|1|||
124952404|NCT01280721|449450946|FG000|Overall Study|Adverse Event|4|||
124952405|NCT01280721|449450946|FG000|Overall Study|Physician Decision|3|||
124952406|NCT01280721|449450946|FG000|Overall Study|Withdrawal by Subject|6|||
124952407|NCT01280721|449450946|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
124952408|NCT01280721|449450946|FG000|Overall Study|No tolerability for the lowest dose|2|||
124952409|NCT01180400|449450947|FG000|Overall Study|Withdrawal by Subject|5|||
124952410|NCT01180400|449450948|FG001|Overall Study|Withdrawal by Subject|6|||
124952411|NCT01180400|449450947|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124952412|NCT01180400|449450948|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
124952413|NCT01180400|449450947|FG000|Overall Study|Adverse Event|12|||
124952414|NCT01180400|449450948|FG001|Overall Study|Adverse Event|10|||
124952415|NCT01180400|449450947|FG000|Overall Study|Severe non-compliance to protocol|1|||
124952416|NCT01180400|449450948|FG001|Overall Study|Severe non-compliance to protocol|2|||
124952417|NCT01180400|449450947|FG000|Overall Study|Condition under investigation worsened|2|||
125125136|NCT03471078|450084108|FG001|Overall Study|Adverse Event|1|||
125125137|NCT03471078|450084107|FG000|Overall Study|Physician Decision|3|||
124952418|NCT01180400|449450948|FG001|Overall Study|Condition under investigation worsened|1|||
124952419|NCT01180400|449450947|FG000|Overall Study|Lack of Efficacy|2|||
124952420|NCT01180400|449450948|FG001|Overall Study|Lack of Efficacy|0|||
124952421|NCT01180400|449450947|FG000|Overall Study|Study-specific withdrawal criteria|1|||
125125138|NCT03471078|450084108|FG001|Overall Study|Physician Decision|2|||
125125139|NCT03471078|450084107|FG000|Overall Study|Death|2|||
125125140|NCT03471078|450084108|FG001|Overall Study|Death|0|||
125125141|NCT03471078|450084107|FG000|Overall Study|Other|3|||
125125142|NCT03471078|450084108|FG001|Overall Study|Other|2|||
124952422|NCT01180400|449450948|FG001|Overall Study|Study-specific withdrawal criteria|2|||
125125143|NCT02473640|450084109|FG000|Treatment Period 1|Adverse Event|1|||
125125144|NCT02127281|450084110|FG000|Overall Study|Lost to Follow-up|1|||
125125145|NCT02127281|450084111|FG001|Overall Study|Lost to Follow-up|0|||
124952423|NCT01180400|449450947|FG000|Overall Study|Lost to Follow-up|2|||
124952424|NCT01180400|449450948|FG001|Overall Study|Lost to Follow-up|3|||
124952425|NCT01180400|449450947|FG000|Overall Study|Other|0|||
124952426|NCT01180400|449450948|FG001|Overall Study|Other|1|||
124952427|NCT00096278|449450950|FG000|Overall Study|No follow-up data|15|||
124952428|NCT00096278|449450951|FG001|Overall Study|No follow-up data|18|||
124952429|NCT00096278|449450950|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
124952430|NCT00096278|449450951|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
124952431|NCT00248794|449450952|FG000|Overall Study|Lost to Follow-up|6|||
124952432|NCT00248794|449450953|FG001|Overall Study|Lost to Follow-up|8|||
124952433|NCT00248794|449450954|FG002|Overall Study|Lost to Follow-up|3|||
124952434|NCT03449979|449450955|FG000|Overall Study|Technical difficulty|0|||
124952435|NCT03449979|449450956|FG001|Overall Study|Technical difficulty|0|||
124952436|NCT03449979|449450957|FG002|Overall Study|Technical difficulty|0|||
124952437|NCT03449979|449450958|FG003|Overall Study|Technical difficulty|1|||
124952438|NCT02632747|449450959|FG000|Wash-out Period|Adverse Event|1|||
124952439|NCT02632747|449450960|FG001|Wash-out Period|Adverse Event|0|||
124952440|NCT02069379|449450961|FG000|Baseline Measurements|Lost to Follow-up|1|||
124952441|NCT02069379|449450962|FG001|Baseline Measurements|Lost to Follow-up|0|||
124952442|NCT02069379|449450963|FG002|Baseline Measurements|Lost to Follow-up|0|||
124952443|NCT02069379|449450964|FG003|Baseline Measurements|Lost to Follow-up|0|||
124952444|NCT02069379|449450961|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
124952445|NCT02069379|449450962|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
124952446|NCT02069379|449450963|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
124952447|NCT02069379|449450964|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
124952448|NCT02069379|449450961|FG000|First Treatment Arm|Lost to Follow-up|0|||
124952449|NCT02069379|449450962|FG001|First Treatment Arm|Lost to Follow-up|1|||
124952450|NCT02069379|449450963|FG002|First Treatment Arm|Lost to Follow-up|1|||
124952451|NCT02069379|449450964|FG003|First Treatment Arm|Lost to Follow-up|0|||
124952452|NCT02069379|449450961|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
124952453|NCT02069379|449450962|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
124952454|NCT02069379|449450963|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
124952455|NCT02069379|449450964|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
124952456|NCT02069379|449450961|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
124952457|NCT02069379|449450962|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
124952458|NCT02069379|449450963|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
124952459|NCT02069379|449450964|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
124952460|NCT02069379|449450961|FG000|Second Treatment Arm|Lost to Follow-up|0|||
124952461|NCT02069379|449450962|FG001|Second Treatment Arm|Lost to Follow-up|0|||
124952462|NCT02069379|449450963|FG002|Second Treatment Arm|Lost to Follow-up|1|||
124952463|NCT02069379|449450964|FG003|Second Treatment Arm|Lost to Follow-up|0|||
124952464|NCT00700999|449450967|FG000|Overall Study|Lost to Follow-up|7|||
125125146|NCT03292653|450084115|FG000|Overall Study|Adverse Event|0|||
125125147|NCT03292653|450084116|FG001|Overall Study|Adverse Event|0|||
125125148|NCT03292653|450084117|FG002|Overall Study|Adverse Event|1|||
125125149|NCT03292653|450084115|FG000|Overall Study|Did not Receive Treatment|1|||
125125150|NCT03292653|450084116|FG001|Overall Study|Did not Receive Treatment|0|||
125125151|NCT03292653|450084117|FG002|Overall Study|Did not Receive Treatment|0|||
125125152|NCT04720664|450084118|FG000|Overall Study|Adverse Event|2|||
125125153|NCT04720664|450084118|FG000|Overall Study|Lack of Efficacy|9|||
125125154|NCT05628675|450084119|FG000|Overall Study|Lost to Follow-up|2|||
125125155|NCT05628675|450084119|FG000|Overall Study|Withdrawal by Subject|1|||
125125156|NCT05818137|450084123|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
125125157|NCT05818137|450084123|FG000|Extension Treatment Period|Ongoing participants|44|||
125125158|NCT01648166|450084126|FG000|Overall Study|inadequate toenail samples|53|||
125125159|NCT01648166|450084127|FG001|Overall Study|inadequate toenail samples|100|||
125125160|NCT00883090|450084128|FG000|Overall Study|Sponsor's decision|1|||
125125161|NCT00883090|450084128|FG000|Overall Study|Withdrawal by Subject|1|||
125125162|NCT01475838|450084131|FG000|Randomized Phase|Randomized but Not Treated|0|||
124952465|NCT00700999|449450968|FG001|Overall Study|Lost to Follow-up|7|||
124952466|NCT00700999|449450967|FG000|Overall Study|Excluded - did not meet study criteria|0|||
124952467|NCT00700999|449450968|FG001|Overall Study|Excluded - did not meet study criteria|1|||
125125163|NCT01475838|450084132|FG001|Randomized Phase|Randomized but Not Treated|5|||
125125164|NCT01475838|450084131|FG000|Randomized Phase|Adverse Event|6|||
125125165|NCT01475838|450084132|FG001|Randomized Phase|Adverse Event|1|||
124952468|NCT00700999|449450967|FG000|Overall Study|Withdrawal by Subject|8|||
124952469|NCT00700999|449450968|FG001|Overall Study|Withdrawal by Subject|1|||
124952470|NCT03651271|449450969|FG000|Overall Study|Death|4|||
124952471|NCT03651271|449450970|FG001|Overall Study|Death|37|||
124952472|NCT03651271|449450971|FG002|Overall Study|Death|0|||
124952473|NCT03651271|449450972|FG003|Overall Study|Death|2|||
124952474|NCT03651271|449450973|FG004|Overall Study|Death|6|||
124952475|NCT03651271|449450969|FG000|Overall Study|Lost to Follow-up|1|||
124952476|NCT03651271|449450970|FG001|Overall Study|Lost to Follow-up|5|||
124952477|NCT03651271|449450971|FG002|Overall Study|Lost to Follow-up|0|||
124952478|NCT03651271|449450972|FG003|Overall Study|Lost to Follow-up|1|||
124952479|NCT03651271|449450973|FG004|Overall Study|Lost to Follow-up|0|||
124952480|NCT03651271|449450969|FG000|Overall Study|Physician Decision|0|||
124952481|NCT03651271|449450970|FG001|Overall Study|Physician Decision|2|||
124952482|NCT03651271|449450971|FG002|Overall Study|Physician Decision|0|||
124952483|NCT03651271|449450972|FG003|Overall Study|Physician Decision|0|||
124952484|NCT03651271|449450973|FG004|Overall Study|Physician Decision|0|||
124952485|NCT03651271|449450969|FG000|Overall Study|Withdrawal by Subject|1|||
124952486|NCT03651271|449450970|FG001|Overall Study|Withdrawal by Subject|15|||
124952487|NCT03651271|449450971|FG002|Overall Study|Withdrawal by Subject|0|||
124952488|NCT03651271|449450972|FG003|Overall Study|Withdrawal by Subject|0|||
124952489|NCT03651271|449450973|FG004|Overall Study|Withdrawal by Subject|1|||
124952490|NCT03651271|449450969|FG000|Overall Study|Patient medically unable to continue|0|||
124952491|NCT03651271|449450970|FG001|Overall Study|Patient medically unable to continue|0|||
124952492|NCT03651271|449450971|FG002|Overall Study|Patient medically unable to continue|0|||
124952493|NCT03651271|449450972|FG003|Overall Study|Patient medically unable to continue|1|||
124952494|NCT03651271|449450973|FG004|Overall Study|Patient medically unable to continue|0|||
124952495|NCT03444155|449450976|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
124952496|NCT03444155|449450977|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
124952497|NCT00821093|449450978|FG000|Overall Study|Adverse Event|20|||
124952498|NCT00821093|449450979|FG001|Overall Study|Adverse Event|12|||
124952499|NCT00821093|449450978|FG000|Overall Study|Withdrawal by Subject|9|||
124952500|NCT00821093|449450979|FG001|Overall Study|Withdrawal by Subject|13|||
124952501|NCT00821093|449450978|FG000|Overall Study|Lost to Follow-up|9|||
124952502|NCT00821093|449450979|FG001|Overall Study|Lost to Follow-up|3|||
124952503|NCT00821093|449450978|FG000|Overall Study|Protocol deviation|3|||
124952504|NCT00821093|449450979|FG001|Overall Study|Protocol deviation|6|||
124952505|NCT00821093|449450978|FG000|Overall Study|Abnormal laboratory value(s)|2|||
124952506|NCT00821093|449450979|FG001|Overall Study|Abnormal laboratory value(s)|0|||
124952507|NCT00821093|449450978|FG000|Overall Study|Lack of Efficacy|2|||
124952508|NCT00821093|449450979|FG001|Overall Study|Lack of Efficacy|2|||
124952509|NCT00821093|449450978|FG000|Overall Study|Death|2|||
124952510|NCT00821093|449450979|FG001|Overall Study|Death|1|||
124952511|NCT00821093|449450978|FG000|Overall Study|Abnormal test procedure result(s)|1|||
124952512|NCT00821093|449450979|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125125166|NCT01475838|450084131|FG000|Randomized Phase|Pregnancy|0|||
125125167|NCT01475838|450084132|FG001|Randomized Phase|Pregnancy|1|||
125125168|NCT01475838|450084131|FG000|Randomized Phase|Investigators Discretion|1|||
125125169|NCT01475838|450084132|FG001|Randomized Phase|Investigators Discretion|2|||
125125170|NCT01475838|450084131|FG000|Randomized Phase|Withdrew Consent|10|||
125125171|NCT01475838|450084132|FG001|Randomized Phase|Withdrew Consent|14|||
125125172|NCT01475838|450084131|FG000|Randomized Phase|Lost to Follow-up|3|||
125125173|NCT01475838|450084132|FG001|Randomized Phase|Lost to Follow-up|4|||
125125174|NCT01475838|450084131|FG000|Randomized Phase|Participant Noncompliance|1|||
125125175|NCT01475838|450084132|FG001|Randomized Phase|Participant Noncompliance|5|||
125125176|NCT01475838|450084131|FG000|Randomized Phase|Protocol Violation|9|||
125125177|NCT01475838|450084132|FG001|Randomized Phase|Protocol Violation|4|||
125125178|NCT01475838|450084131|FG000|Extension Phase|Participant Noncompliance|1|||
125125179|NCT01475838|450084132|FG001|Extension Phase|Participant Noncompliance|0|||
125125180|NCT00048568|450084133|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
125125181|NCT00048568|450084134|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
125125182|NCT00048568|450084135|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
125125183|NCT00048568|450084133|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
125125184|NCT00048568|450084134|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
125125185|NCT00048568|450084135|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
125125186|NCT00048568|450084133|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
125125187|NCT00048568|450084134|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
125125188|NCT00048568|450084135|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
125125189|NCT00048568|450084133|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
125125190|NCT00048568|450084134|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
125125191|NCT00048568|450084135|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
125125192|NCT00048568|450084133|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
125125193|NCT00048568|450084134|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
124952513|NCT00821093|449450978|FG000|Overall Study|Administrative problems|1|||
124952514|NCT00821093|449450979|FG001|Overall Study|Administrative problems|2|||
125125194|NCT00048568|450084135|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
124952515|NCT02877680|449450984|FG000|Overall Study|Lost to Follow-up|1|||
124952516|NCT02877680|449450985|FG001|Overall Study|Lost to Follow-up|1|||
124952517|NCT01133678|449450986|FG000|Overall Study|Death|1|||
124952518|NCT01133678|449450987|FG001|Overall Study|Death|1|||
124952519|NCT05104242|449450994|FG000|Overall Study|Withdrawal by Subject|1|||
124952520|NCT05104242|449450995|FG001|Overall Study|Withdrawal by Subject|5|||
125215245|NCT00770913|450414957|FG001|Overall Study|Protocol Violation|0|||
125215246|NCT00770913|450414958|FG002|Overall Study|Protocol Violation|1|||
125215247|NCT00770913|450414956|FG000|Overall Study|Incorrect drug was allocated|1|||
125215248|NCT00770913|450414957|FG001|Overall Study|Incorrect drug was allocated|0|||
125215249|NCT00770913|450414958|FG002|Overall Study|Incorrect drug was allocated|0|||
125215250|NCT00359294|450414962|FG000|Overall Study|Progressive disease|1|||
125215251|NCT00359294|450414963|FG001|Overall Study|Progressive disease|1|||
125215252|NCT00359294|450414964|FG002|Overall Study|Progressive disease|2|||
125215253|NCT00359294|450414965|FG003|Overall Study|Progressive disease|3|||
125215254|NCT00359294|450414966|FG004|Overall Study|Progressive disease|2|||
125215255|NCT00359294|450414962|FG000|Overall Study|Withdrawal by Subject|0|||
125215256|NCT00359294|450414963|FG001|Overall Study|Withdrawal by Subject|0|||
125215257|NCT00359294|450414964|FG002|Overall Study|Withdrawal by Subject|0|||
125215258|NCT00359294|450414965|FG003|Overall Study|Withdrawal by Subject|0|||
125215259|NCT00359294|450414966|FG004|Overall Study|Withdrawal by Subject|1|||
125215260|NCT00359294|450414962|FG000|Overall Study|Not treated|0|||
125215261|NCT00359294|450414963|FG001|Overall Study|Not treated|0|||
124952521|NCT05104242|449450994|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
124952522|NCT05104242|449450995|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
124952523|NCT01864200|449450996|FG000|Overall Study|Lost to Follow-up|1|||
124952524|NCT01864200|449450997|FG001|Overall Study|Lost to Follow-up|3|||
124952525|NCT01864200|449450996|FG000|Overall Study|Protocol Violation|1|||
124952526|NCT01864200|449450997|FG001|Overall Study|Protocol Violation|0|||
124952527|NCT00424476|449450999|FG000|Overall Study|Withdrawal by Subject|7|||
124952528|NCT00424476|449451000|FG001|Overall Study|Withdrawal by Subject|6|||
124952529|NCT00424476|449451001|FG002|Overall Study|Withdrawal by Subject|3|||
124952530|NCT00424476|449450999|FG000|Overall Study|Adverse Event|19|||
124952531|NCT00424476|449451000|FG001|Overall Study|Adverse Event|16|||
124952532|NCT00424476|449451001|FG002|Overall Study|Adverse Event|15|||
124952533|NCT00424476|449450999|FG000|Overall Study|Lack of Efficacy|16|||
124952534|NCT00424476|449451000|FG001|Overall Study|Lack of Efficacy|12|||
124952535|NCT00424476|449451001|FG002|Overall Study|Lack of Efficacy|12|||
124952536|NCT00424476|449450999|FG000|Overall Study|Lack of Compliance|1|||
124952537|NCT00424476|449451000|FG001|Overall Study|Lack of Compliance|1|||
124952538|NCT00424476|449451001|FG002|Overall Study|Lack of Compliance|1|||
124952539|NCT00424476|449450999|FG000|Overall Study|Lost to Follow-up|4|||
124952540|NCT00424476|449451000|FG001|Overall Study|Lost to Follow-up|6|||
124952541|NCT00424476|449451001|FG002|Overall Study|Lost to Follow-up|3|||
124952542|NCT00424476|449450999|FG000|Overall Study|Protocol Violation|7|||
124952543|NCT00424476|449451000|FG001|Overall Study|Protocol Violation|2|||
124952544|NCT00424476|449451001|FG002|Overall Study|Protocol Violation|3|||
124952545|NCT00424476|449450999|FG000|Overall Study|Physician Decision|3|||
124952546|NCT00424476|449451000|FG001|Overall Study|Physician Decision|2|||
124952547|NCT00424476|449451001|FG002|Overall Study|Physician Decision|3|||
124952548|NCT00424476|449450999|FG000|Overall Study|Other|4|||
124952549|NCT00424476|449451000|FG001|Overall Study|Other|3|||
124952550|NCT00424476|449451001|FG002|Overall Study|Other|9|||
124952551|NCT02574286|449451002|FG000|Overall Study|Adverse Event|3|||
124952552|NCT02574286|449451002|FG000|Overall Study|Withdrawal by Subject|2|||
124952553|NCT01280656|449451003|FG000|Overall Study|Adverse Event|1|||
125215262|NCT00359294|450414964|FG002|Overall Study|Not treated|0|||
125215263|NCT00359294|450414965|FG003|Overall Study|Not treated|1|||
124952554|NCT01280656|449451004|FG001|Overall Study|Adverse Event|14|||
124952555|NCT01280656|449451005|FG002|Overall Study|Adverse Event|13|||
124952556|NCT01280656|449451003|FG000|Overall Study|Lack of Efficacy|1|||
124952557|NCT01280656|449451004|FG001|Overall Study|Lack of Efficacy|22|||
124952558|NCT01280656|449451005|FG002|Overall Study|Lack of Efficacy|38|||
124952559|NCT01280656|449451003|FG000|Overall Study|Treatment shortening (RGT)|0|||
124952560|NCT01280656|449451004|FG001|Overall Study|Treatment shortening (RGT)|4|||
124952561|NCT01280656|449451005|FG002|Overall Study|Treatment shortening (RGT)|5|||
124952562|NCT01280656|449451003|FG000|Overall Study|Other|1|||
124952563|NCT01280656|449451004|FG001|Overall Study|Other|7|||
124952564|NCT01280656|449451005|FG002|Overall Study|Other|7|||
124952565|NCT02138838|449451006|FG000|Overall Study|Study Closure|7|||
124952566|NCT02138838|449451007|FG001|Overall Study|Study Closure|6|||
124952567|NCT02138838|449451006|FG000|Overall Study|Withdrawal by Subject|1|||
124952568|NCT02138838|449451007|FG001|Overall Study|Withdrawal by Subject|5|||
124952569|NCT02993926|449451010|FG000|Enantone Treatment Phase|Adverse Event|1|||
124952570|NCT02993926|449451011|FG001|Enantone Treatment Phase|Adverse Event|0|||
124952571|NCT02993926|449451012|FG002|Enantone Treatment Phase|Adverse Event|0|||
124952572|NCT02993926|449451010|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
124952573|NCT02993926|449451011|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
124952574|NCT02993926|449451012|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
124952575|NCT02993926|449451010|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
124952576|NCT02993926|449451011|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
124952577|NCT02993926|449451012|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
124952578|NCT02993926|449451010|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
124952579|NCT02993926|449451011|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
124952580|NCT02993926|449451012|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
124952581|NCT01084772|449451014|FG000|Baseline|Withdrawal by Subject|7|||
124952582|NCT01084772|449451015|FG001|Baseline|Withdrawal by Subject|6|||
124952583|NCT01084772|449451014|FG000|3 Months|Death|1|||
124952584|NCT01084772|449451015|FG001|3 Months|Death|0|||
124952585|NCT01084772|449451014|FG000|3 Months|Study Termination|2|||
124952586|NCT01084772|449451015|FG001|3 Months|Study Termination|2|||
124952587|NCT01084772|449451014|FG000|1 Year|Withdrawal by Subject|0|||
124952588|NCT01084772|449451015|FG001|1 Year|Withdrawal by Subject|1|||
124952589|NCT01084772|449451014|FG000|1 Year|Lost to Follow-up|3|||
124952590|NCT01084772|449451015|FG001|1 Year|Lost to Follow-up|0|||
124952591|NCT01084772|449451014|FG000|1 Year|Study Termination|0|||
124952592|NCT01084772|449451015|FG001|1 Year|Study Termination|7|||
124952593|NCT01084772|449451014|FG000|2 Years|Withdrawal by Subject|1|||
124952594|NCT01084772|449451015|FG001|2 Years|Withdrawal by Subject|0|||
124952595|NCT01084772|449451014|FG000|2 Years|Lost to Follow-up|5|||
124952596|NCT01084772|449451015|FG001|2 Years|Lost to Follow-up|2|||
124952597|NCT01084772|449451014|FG000|2 Years|Study Termination|3|||
124952598|NCT01084772|449451015|FG001|2 Years|Study Termination|2|||
124952599|NCT01867307|449451016|FG000|Overall Study|Protocol Violation|2|||
124952600|NCT01867307|449451017|FG001|Overall Study|Protocol Violation|0|||
124952601|NCT01867307|449451016|FG000|Overall Study|Other Adverse Event|1|||
124952602|NCT01867307|449451017|FG001|Overall Study|Other Adverse Event|3|||
124952603|NCT00518206|449451018|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
124952604|NCT00518206|449451019|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
125125195|NCT00048568|450084133|FG000|Double-Blind Period Days 170 to 365|Death|1|||
125125196|NCT00048568|450084134|FG001|Double-Blind Period Days 170 to 365|Death|1|||
125125197|NCT00048568|450084135|FG002|Double-Blind Period Days 170 to 365|Death|0|||
125125198|NCT00048568|450084133|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
125125199|NCT00048568|450084134|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
125125200|NCT00048568|450084135|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
125125201|NCT00048568|450084133|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
125125202|NCT00048568|450084134|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
125125203|NCT00048568|450084135|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
125125204|NCT00048568|450084133|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
125125205|NCT00048568|450084134|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
124952605|NCT00518206|449451018|FG000|Overall Study|Withdrawal by Subject|2|||
124952606|NCT00518206|449451019|FG001|Overall Study|Withdrawal by Subject|0|||
124952607|NCT00518206|449451018|FG000|Overall Study|Drug Supply Issue|1|||
124952608|NCT00518206|449451019|FG001|Overall Study|Drug Supply Issue|0|||
124952609|NCT00518206|449451018|FG000|Overall Study|Reason Unknown|1|||
124952610|NCT00518206|449451019|FG001|Overall Study|Reason Unknown|0|||
124952611|NCT00518206|449451018|FG000|Overall Study|Completion Status Unknown|1|||
125125206|NCT00048568|450084135|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
125215264|NCT00359294|450414966|FG004|Overall Study|Not treated|0|||
124952612|NCT00518206|449451019|FG001|Overall Study|Completion Status Unknown|0|||
124952613|NCT01199302|449451022|FG000|Overall Study|Adverse Event|1|||
124952614|NCT01199302|449451023|FG001|Overall Study|Adverse Event|1|||
124952615|NCT01199302|449451024|FG002|Overall Study|Adverse Event|2|||
124952616|NCT01199302|449451025|FG003|Overall Study|Adverse Event|0|||
124952617|NCT01199302|449451022|FG000|Overall Study|Withdrawal by Subject|2|||
124952618|NCT01199302|449451023|FG001|Overall Study|Withdrawal by Subject|2|||
124952619|NCT01199302|449451024|FG002|Overall Study|Withdrawal by Subject|3|||
124952620|NCT01199302|449451025|FG003|Overall Study|Withdrawal by Subject|0|||
124952621|NCT01199302|449451022|FG000|Overall Study|Disease Progression|3|||
124952622|NCT01199302|449451023|FG001|Overall Study|Disease Progression|4|||
124952623|NCT01199302|449451024|FG002|Overall Study|Disease Progression|4|||
124952624|NCT01199302|449451025|FG003|Overall Study|Disease Progression|2|||
124952625|NCT01199302|449451022|FG000|Overall Study|Study Termination|13|||
124952626|NCT01199302|449451023|FG001|Overall Study|Study Termination|8|||
124952627|NCT01199302|449451024|FG002|Overall Study|Study Termination|11|||
124952628|NCT01199302|449451025|FG003|Overall Study|Study Termination|9|||
124952629|NCT01199302|449451022|FG000|Overall Study|Lost to Follow-up|0|||
124952630|NCT01199302|449451023|FG001|Overall Study|Lost to Follow-up|1|||
124952631|NCT01199302|449451024|FG002|Overall Study|Lost to Follow-up|0|||
124952632|NCT01199302|449451025|FG003|Overall Study|Lost to Follow-up|0|||
124952633|NCT01199302|449451022|FG000|Overall Study|Other|1|||
124952634|NCT01199302|449451023|FG001|Overall Study|Other|0|||
124952635|NCT01199302|449451024|FG002|Overall Study|Other|0|||
124952636|NCT01199302|449451025|FG003|Overall Study|Other|0|||
124952637|NCT03820024|449451028|FG000|Overall Study|Physician Decision|1|||
124952638|NCT03820024|449451029|FG001|Overall Study|Physician Decision|2|||
124952639|NCT01945593|449453109|FG000|Overall Study|Adverse Event|0|||
124952640|NCT01945593|449453110|FG001|Overall Study|Adverse Event|0|||
124952641|NCT01945593|449453111|FG002|Overall Study|Adverse Event|0|||
124952642|NCT01945593|449453112|FG003|Overall Study|Adverse Event|5|||
124952643|NCT01945593|449453109|FG000|Overall Study|Physician Decision|0|||
124952644|NCT01945593|449453110|FG001|Overall Study|Physician Decision|0|||
124952645|NCT01945593|449453111|FG002|Overall Study|Physician Decision|1|||
124952646|NCT01945593|449453112|FG003|Overall Study|Physician Decision|1|||
124952647|NCT01945593|449453109|FG000|Overall Study|Withdrawal by Subject|0|||
124952648|NCT01945593|449453110|FG001|Overall Study|Withdrawal by Subject|2|||
124952649|NCT01945593|449453111|FG002|Overall Study|Withdrawal by Subject|0|||
124952650|NCT01945593|449453112|FG003|Overall Study|Withdrawal by Subject|4|||
124952651|NCT01945593|449453109|FG000|Overall Study|Protocol Violation|0|||
124952652|NCT01945593|449453110|FG001|Overall Study|Protocol Violation|2|||
124952653|NCT01945593|449453111|FG002|Overall Study|Protocol Violation|1|||
124952654|NCT01945593|449453112|FG003|Overall Study|Protocol Violation|3|||
124952655|NCT01945593|449453109|FG000|Overall Study|Death|0|||
124952656|NCT01945593|449453110|FG001|Overall Study|Death|0|||
124952657|NCT01945593|449453111|FG002|Overall Study|Death|1|||
124952658|NCT01945593|449453112|FG003|Overall Study|Death|0|||
124952659|NCT01945593|449453109|FG000|Overall Study|Other: Terminated|0|||
124952660|NCT01945593|449453110|FG001|Overall Study|Other: Terminated|0|||
124952661|NCT01945593|449453111|FG002|Overall Study|Other: Terminated|0|||
124952662|NCT01945593|449453112|FG003|Overall Study|Other: Terminated|1|||
124952663|NCT01945593|449453109|FG000|Overall Study|Other: Surgical Procedure|0|||
124952664|NCT01945593|449453110|FG001|Overall Study|Other: Surgical Procedure|2|||
124952665|NCT01945593|449453111|FG002|Overall Study|Other: Surgical Procedure|0|||
124952666|NCT01945593|449453112|FG003|Overall Study|Other: Surgical Procedure|6|||
124952667|NCT01945593|449453109|FG000|Overall Study|Other: Screen Failure|0|||
124952668|NCT01945593|449453110|FG001|Overall Study|Other: Screen Failure|2|||
124952669|NCT01945593|449453111|FG002|Overall Study|Other: Screen Failure|0|||
124952670|NCT01945593|449453112|FG003|Overall Study|Other: Screen Failure|0|||
124952671|NCT01540474|449453115|FG000|Vaccination Period|Lost to Follow-up|0|||
124952672|NCT01540474|449453116|FG001|Vaccination Period|Lost to Follow-up|1|||
124952673|NCT01540474|449453117|FG002|Vaccination Period|Lost to Follow-up|0|||
125030258|NCT00849017|449732815|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
125030259|NCT00849017|449732816|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
125030260|NCT00849017|449732817|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
125030261|NCT05254418|449732821|FG000|Overall Study|Adverse Event|2|||
125030262|NCT03624946|449732826|FG000|Overall Study|Lost to Follow-up|0|||
125030263|NCT03624946|449732827|FG001|Overall Study|Lost to Follow-up|1|||
125030264|NCT01869348|449732829|FG000|Overall Study|Withdrawal by Subject|1|||
125030265|NCT01869348|449732830|FG001|Overall Study|Withdrawal by Subject|1|||
125030266|NCT00624520|449732831|FG000|Overall Study|Withdrawal by Subject|12|||
125030267|NCT00624520|449732832|FG001|Overall Study|Withdrawal by Subject|7|||
125030268|NCT00624520|449732831|FG000|Overall Study|Death|0|||
125030269|NCT00624520|449732832|FG001|Overall Study|Death|1|||
125030270|NCT03075163|449732833|FG000|Overall Study|not eligible for treatment limb|138|||
125030271|NCT03075163|449732834|FG001|Overall Study|not eligible for treatment limb|138|||
125030272|NCT01925209|449732835|FG000|Treatment Epoch|Physician Decision|1|||
125030273|NCT01925209|449732836|FG001|Treatment Epoch|Physician Decision|0|||
125030274|NCT01925209|449732837|FG002|Treatment Epoch|Physician Decision|0|||
125030275|NCT01925209|449732838|FG003|Treatment Epoch|Physician Decision|0|||
125030276|NCT01925209|449732835|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
125030277|NCT01925209|449732836|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
125030278|NCT01925209|449732837|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
125030279|NCT01925209|449732838|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
125125207|NCT00048568|450084133|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
125125208|NCT00048568|450084134|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
125125209|NCT00048568|450084135|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
125125210|NCT00048568|450084133|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
125125211|NCT00048568|450084134|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
125125212|NCT00048568|450084135|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
125125213|NCT00048568|450084133|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
124952674|NCT01540474|449453118|FG003|Vaccination Period|Lost to Follow-up|0|||
124952675|NCT04454125|449453119|FG000|Overall Study|Lost to Follow-up|0|||
124952676|NCT04454125|449453120|FG001|Overall Study|Lost to Follow-up|1|||
124952677|NCT01587703|449453121|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
124952678|NCT01587703|449453122|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952679|NCT01587703|449453123|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952680|NCT01587703|449453124|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952681|NCT01587703|449453125|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952682|NCT01587703|449453126|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952683|NCT01587703|449453127|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952684|NCT01587703|449453128|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952685|NCT01587703|449453129|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952686|NCT01587703|449453130|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952687|NCT01587703|449453131|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952688|NCT01587703|449453132|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952689|NCT01587703|449453133|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952690|NCT01587703|449453134|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952691|NCT01587703|449453135|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952692|NCT01587703|449453136|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952693|NCT01587703|449453137|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952694|NCT01587703|449453138|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952695|NCT01587703|449453139|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952696|NCT01587703|449453121|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952697|NCT01587703|449453122|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952698|NCT01587703|449453123|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952699|NCT01587703|449453124|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952700|NCT01587703|449453125|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952701|NCT01587703|449453126|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
124952702|NCT01587703|449453127|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952703|NCT01587703|449453128|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
124952704|NCT01587703|449453129|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952705|NCT01587703|449453130|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952706|NCT01587703|449453131|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952707|NCT01587703|449453132|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952708|NCT01587703|449453133|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952709|NCT01587703|449453134|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952710|NCT01587703|449453135|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952711|NCT01587703|449453136|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952712|NCT01587703|449453137|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952713|NCT01587703|449453138|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952714|NCT01587703|449453139|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952715|NCT01587703|449453121|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952716|NCT01587703|449453122|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952717|NCT01587703|449453123|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952718|NCT01587703|449453124|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952719|NCT01587703|449453125|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952720|NCT01587703|449453126|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952721|NCT01587703|449453127|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
124952722|NCT01587703|449453128|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952723|NCT01587703|449453129|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952724|NCT01587703|449453130|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952725|NCT01587703|449453131|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952726|NCT01587703|449453132|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125125214|NCT00048568|450084134|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
125125215|NCT00048568|450084135|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
125125216|NCT00048568|450084133|FG000|Open-Label Period|Death|0|||
125125217|NCT00048568|450084134|FG001|Open-Label Period|Death|0|||
124952727|NCT01587703|449453133|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125125218|NCT00048568|450084135|FG002|Open-Label Period|Death|13|||
125125219|NCT00048568|450084133|FG000|Open-Label Period|Adverse Event|0|||
124952728|NCT01587703|449453134|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952729|NCT01587703|449453135|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952730|NCT01587703|449453136|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952731|NCT01587703|449453137|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952732|NCT01587703|449453138|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952733|NCT01587703|449453139|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952734|NCT01587703|449453121|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
124952735|NCT01587703|449453122|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
124952736|NCT01587703|449453123|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
124952737|NCT01587703|449453124|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
124952738|NCT01587703|449453125|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
124952739|NCT01587703|449453126|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
124952740|NCT01587703|449453127|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
124952741|NCT01587703|449453128|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
124952742|NCT01587703|449453129|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952743|NCT01587703|449453130|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952744|NCT01587703|449453131|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952745|NCT01587703|449453132|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952746|NCT01587703|449453133|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952747|NCT01587703|449453134|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952748|NCT01587703|449453135|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952749|NCT01587703|449453136|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952750|NCT01587703|449453137|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952751|NCT01587703|449453138|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952752|NCT01587703|449453139|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952753|NCT01587703|449453121|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952754|NCT01587703|449453122|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952755|NCT01587703|449453123|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952756|NCT01587703|449453124|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952757|NCT01587703|449453125|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952758|NCT01587703|449453126|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952759|NCT01587703|449453127|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952760|NCT01587703|449453128|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952761|NCT01587703|449453129|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
124952762|NCT01587703|449453130|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
124952763|NCT01587703|449453131|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
124952764|NCT01587703|449453132|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952765|NCT01587703|449453133|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952766|NCT01587703|449453134|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952767|NCT01587703|449453135|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952768|NCT01587703|449453136|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952769|NCT01587703|449453137|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952770|NCT01587703|449453138|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952771|NCT01587703|449453139|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952772|NCT01587703|449453121|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952773|NCT01587703|449453122|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952774|NCT01587703|449453123|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952775|NCT01587703|449453124|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952776|NCT01587703|449453125|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952777|NCT01587703|449453126|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952778|NCT01587703|449453127|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952779|NCT01587703|449453128|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952780|NCT01587703|449453129|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
124952781|NCT01587703|449453130|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952782|NCT01587703|449453131|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
124952783|NCT01587703|449453132|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952784|NCT01587703|449453133|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
125030280|NCT01925209|449732835|FG000|Treatment Epoch|Death|1|||
125030281|NCT01925209|449732836|FG001|Treatment Epoch|Death|0|||
125030282|NCT01925209|449732837|FG002|Treatment Epoch|Death|0|||
125030283|NCT01925209|449732838|FG003|Treatment Epoch|Death|0|||
125030284|NCT01925209|449732835|FG000|Treatment Epoch|Protocol deviation|0|||
125030285|NCT01925209|449732836|FG001|Treatment Epoch|Protocol deviation|0|||
125030286|NCT01925209|449732837|FG002|Treatment Epoch|Protocol deviation|1|||
125030287|NCT01925209|449732838|FG003|Treatment Epoch|Protocol deviation|1|||
125030288|NCT01925209|449732835|FG000|Treatment Epoch|Withdrawal by Subject|4|||
125030289|NCT01925209|449732836|FG001|Treatment Epoch|Withdrawal by Subject|3|||
125125220|NCT00048568|450084134|FG001|Open-Label Period|Adverse Event|0|||
125125221|NCT00048568|450084135|FG002|Open-Label Period|Adverse Event|49|||
125125222|NCT00048568|450084133|FG000|Open-Label Period|Lack of Efficacy|0|||
124952785|NCT01587703|449453134|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952786|NCT01587703|449453135|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952787|NCT01587703|449453136|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952788|NCT01587703|449453137|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952789|NCT01587703|449453138|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952790|NCT01587703|449453139|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952791|NCT01587703|449453121|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952792|NCT01587703|449453122|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952793|NCT01587703|449453123|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952794|NCT01587703|449453124|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952795|NCT01587703|449453125|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952796|NCT01587703|449453126|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952797|NCT01587703|449453127|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952798|NCT01587703|449453128|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952799|NCT01587703|449453129|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952800|NCT01587703|449453130|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
124952801|NCT01587703|449453131|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
124952802|NCT01587703|449453132|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952803|NCT01587703|449453133|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952804|NCT01587703|449453134|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952805|NCT01587703|449453135|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952806|NCT01587703|449453136|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952807|NCT01587703|449453137|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952808|NCT01587703|449453138|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952809|NCT01587703|449453139|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952810|NCT01587703|449453121|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952811|NCT01587703|449453122|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952812|NCT01587703|449453123|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952813|NCT01587703|449453124|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952814|NCT01587703|449453125|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952815|NCT01587703|449453126|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952816|NCT01587703|449453127|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952817|NCT01587703|449453128|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952818|NCT01587703|449453129|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
124952819|NCT01587703|449453130|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952820|NCT01587703|449453131|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952821|NCT01587703|449453132|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952822|NCT01587703|449453133|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952823|NCT01587703|449453134|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952824|NCT01587703|449453135|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952825|NCT01587703|449453136|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952826|NCT01587703|449453137|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952827|NCT01587703|449453138|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952828|NCT01587703|449453139|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952829|NCT01587703|449453121|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952830|NCT01587703|449453122|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952831|NCT01587703|449453123|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952832|NCT01587703|449453124|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952833|NCT01587703|449453125|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952834|NCT01587703|449453126|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952835|NCT01587703|449453127|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952836|NCT01587703|449453128|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952837|NCT01587703|449453129|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952838|NCT01587703|449453130|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952839|NCT01587703|449453131|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952840|NCT01587703|449453132|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952841|NCT01587703|449453133|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952842|NCT01587703|449453134|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
125125223|NCT00048568|450084134|FG001|Open-Label Period|Lack of Efficacy|0|||
125125224|NCT00048568|450084135|FG002|Open-Label Period|Lack of Efficacy|32|||
125030290|NCT01925209|449732837|FG002|Treatment Epoch|Withdrawal by Subject|3|||
125030291|NCT01925209|449732838|FG003|Treatment Epoch|Withdrawal by Subject|2|||
125030292|NCT01925209|449732835|FG000|Treatment Epoch|Adverse Event|3|||
125030293|NCT01925209|449732836|FG001|Treatment Epoch|Adverse Event|5|||
125030294|NCT01925209|449732837|FG002|Treatment Epoch|Adverse Event|3|||
125030295|NCT01925209|449732838|FG003|Treatment Epoch|Adverse Event|1|||
125030296|NCT01925209|449732835|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
125030297|NCT01925209|449732836|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
125030298|NCT01925209|449732837|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
125030299|NCT01925209|449732838|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
125030300|NCT01925209|449732835|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
125030301|NCT01925209|449732836|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
125030302|NCT01925209|449732837|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
125030303|NCT01925209|449732838|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
125030304|NCT01925209|449732835|FG000|Follow-up|Adverse Event|1|||
125030305|NCT01925209|449732836|FG001|Follow-up|Adverse Event|4|||
125030306|NCT01925209|449732837|FG002|Follow-up|Adverse Event|0|||
125030307|NCT01925209|449732838|FG003|Follow-up|Adverse Event|1|||
125030308|NCT01925209|449732835|FG000|Follow-up|Physician Decision|0|||
125030309|NCT01925209|449732836|FG001|Follow-up|Physician Decision|0|||
125030310|NCT01925209|449732837|FG002|Follow-up|Physician Decision|1|||
125030311|NCT01925209|449732838|FG003|Follow-up|Physician Decision|0|||
125030312|NCT01925209|449732835|FG000|Follow-up|Non-compliance with study treatment|0|||
125030313|NCT01925209|449732836|FG001|Follow-up|Non-compliance with study treatment|0|||
125030314|NCT01925209|449732837|FG002|Follow-up|Non-compliance with study treatment|0|||
125125225|NCT00048568|450084133|FG000|Open-Label Period|Withdrawal by Subject|0|||
125125226|NCT00048568|450084134|FG001|Open-Label Period|Withdrawal by Subject|0|||
125125227|NCT00048568|450084135|FG002|Open-Label Period|Withdrawal by Subject|26|||
125125228|NCT00048568|450084133|FG000|Open-Label Period|Pregnancy|0|||
125125229|NCT00048568|450084134|FG001|Open-Label Period|Pregnancy|0|||
125125230|NCT00048568|450084135|FG002|Open-Label Period|Pregnancy|5|||
125125231|NCT00048568|450084133|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
125125232|NCT00048568|450084134|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
125125233|NCT00048568|450084135|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
125125234|NCT00048568|450084133|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
125125235|NCT00048568|450084134|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
125125236|NCT00048568|450084135|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
125125237|NCT00048568|450084133|FG000|Open-Label Period|Unknown Reasons|0|||
125125238|NCT00048568|450084134|FG001|Open-Label Period|Unknown Reasons|0|||
125125239|NCT00048568|450084135|FG002|Open-Label Period|Unknown Reasons|25|||
125125240|NCT00048568|450084133|FG000|Open-Label Period|Lost to Follow-up|0|||
125125241|NCT00048568|450084134|FG001|Open-Label Period|Lost to Follow-up|0|||
125125242|NCT00048568|450084135|FG002|Open-Label Period|Lost to Follow-up|7|||
125030315|NCT01925209|449732838|FG003|Follow-up|Non-compliance with study treatment|1|||
125030316|NCT01925209|449732835|FG000|Follow-up|Withdrawal by Subject|0|||
125030317|NCT01925209|449732836|FG001|Follow-up|Withdrawal by Subject|2|||
125030318|NCT01925209|449732837|FG002|Follow-up|Withdrawal by Subject|0|||
125030319|NCT01925209|449732838|FG003|Follow-up|Withdrawal by Subject|2|||
125030320|NCT02796755|449732839|FG000|Overall Study|Adverse Event|2|||
125125243|NCT03831048|450084136|FG000|Overall Study|Protocol Violation|9|||
125125244|NCT03831048|450084137|FG001|Overall Study|Protocol Violation|3|||
125125245|NCT03831048|450084136|FG000|Overall Study|Death|4|||
125125246|NCT03831048|450084137|FG001|Overall Study|Death|9|||
125030321|NCT02796755|449732840|FG001|Overall Study|Adverse Event|0|||
125030322|NCT00675025|449732841|FG000|Overall Study|Study Terminated by Sponsor|38|||
125030323|NCT00675025|449732842|FG001|Overall Study|Study Terminated by Sponsor|42|||
125030324|NCT00675025|449732841|FG000|Overall Study|Adverse Event|6|||
125030325|NCT00675025|449732842|FG001|Overall Study|Adverse Event|11|||
125030326|NCT00675025|449732841|FG000|Overall Study|Lost to Follow-up|6|||
125030327|NCT00675025|449732842|FG001|Overall Study|Lost to Follow-up|4|||
125030328|NCT00675025|449732841|FG000|Overall Study|Withdrawal by Subject|4|||
125030329|NCT00675025|449732842|FG001|Overall Study|Withdrawal by Subject|6|||
125030330|NCT00110994|449732843|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
125030331|NCT00110994|449732844|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
125030332|NCT00110994|449732843|FG000|Double-blind (DB) Treatment|Death|1|||
125030333|NCT00110994|449732844|FG001|Double-blind (DB) Treatment|Death|0|||
125030334|NCT00110994|449732843|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
125125247|NCT03831048|450084136|FG000|Overall Study|Re-transplant|0|||
125125248|NCT03831048|450084137|FG001|Overall Study|Re-transplant|2|||
125125249|NCT03831048|450084136|FG000|Overall Study|Protocol violation and death|1|||
125125250|NCT03831048|450084137|FG001|Overall Study|Protocol violation and death|1|||
125125251|NCT00560235|450084141|FG000|Phase 1|Discontinued|8|||
124952843|NCT01587703|449453135|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952844|NCT01587703|449453136|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952845|NCT01587703|449453137|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952846|NCT01587703|449453138|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952847|NCT01587703|449453139|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
124952848|NCT01587703|449453121|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952849|NCT01587703|449453122|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952850|NCT01587703|449453123|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952851|NCT01587703|449453124|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952852|NCT01587703|449453125|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952853|NCT01587703|449453126|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952854|NCT01587703|449453127|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952855|NCT01587703|449453128|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952856|NCT01587703|449453129|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952857|NCT01587703|449453130|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952858|NCT01587703|449453131|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952859|NCT01587703|449453132|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952860|NCT01587703|449453133|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952861|NCT01587703|449453134|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952862|NCT01587703|449453135|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952863|NCT01587703|449453136|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952864|NCT01587703|449453137|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952865|NCT01587703|449453138|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
124952866|NCT01587703|449453139|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
124952867|NCT01587703|449453121|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952868|NCT01587703|449453122|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952869|NCT01587703|449453123|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952870|NCT01587703|449453124|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952871|NCT01587703|449453125|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952872|NCT01587703|449453126|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952873|NCT01587703|449453127|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952874|NCT01587703|449453128|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952875|NCT01587703|449453129|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952876|NCT01587703|449453130|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952877|NCT01587703|449453131|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952878|NCT01587703|449453132|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952879|NCT01587703|449453133|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952880|NCT01587703|449453134|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952881|NCT01587703|449453135|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952882|NCT01587703|449453136|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
124952883|NCT01587703|449453137|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952884|NCT01587703|449453138|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952885|NCT01587703|449453139|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952886|NCT01587703|449453121|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952887|NCT01587703|449453122|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952888|NCT01587703|449453123|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952889|NCT01587703|449453124|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952890|NCT01587703|449453125|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952891|NCT01587703|449453126|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952892|NCT01587703|449453127|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952893|NCT01587703|449453128|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952894|NCT01587703|449453129|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952895|NCT01587703|449453130|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952896|NCT01587703|449453131|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952897|NCT01587703|449453132|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
124952898|NCT01587703|449453133|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952899|NCT01587703|449453134|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952900|NCT01587703|449453135|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
124952901|NCT01587703|449453136|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952902|NCT01587703|449453137|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952903|NCT01587703|449453138|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952904|NCT01587703|449453139|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952905|NCT01587703|449453121|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952906|NCT01587703|449453122|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952907|NCT01587703|449453123|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952908|NCT01587703|449453124|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952909|NCT01587703|449453125|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952910|NCT01587703|449453126|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952911|NCT01587703|449453127|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952912|NCT01587703|449453128|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952913|NCT01587703|449453129|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952914|NCT01587703|449453130|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952915|NCT01587703|449453131|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952916|NCT01587703|449453132|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
124952917|NCT01587703|449453133|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
124952918|NCT01587703|449453134|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
124952919|NCT01587703|449453135|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
124952920|NCT01587703|449453136|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
124952921|NCT01587703|449453137|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
124952922|NCT01587703|449453138|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952923|NCT01587703|449453139|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952924|NCT01587703|449453121|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952925|NCT01587703|449453122|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952926|NCT01587703|449453123|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952927|NCT01587703|449453124|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952928|NCT01587703|449453125|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952929|NCT01587703|449453126|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952930|NCT01587703|449453127|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952931|NCT01587703|449453128|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952932|NCT01587703|449453129|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952933|NCT01587703|449453130|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952934|NCT01587703|449453131|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952935|NCT01587703|449453132|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
124952936|NCT01587703|449453133|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
124952937|NCT01587703|449453134|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
124952938|NCT01587703|449453135|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
124952939|NCT01587703|449453136|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
124952940|NCT01587703|449453137|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
124952941|NCT01587703|449453138|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952942|NCT01587703|449453139|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952943|NCT01587703|449453121|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952944|NCT01587703|449453122|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952945|NCT01587703|449453123|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952946|NCT01587703|449453124|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952947|NCT01587703|449453125|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952948|NCT01587703|449453126|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952949|NCT01587703|449453127|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952950|NCT01587703|449453128|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952951|NCT01587703|449453129|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952952|NCT01587703|449453130|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952953|NCT01587703|449453131|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952954|NCT01587703|449453132|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
124952955|NCT01587703|449453133|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952956|NCT01587703|449453134|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952957|NCT01587703|449453135|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952958|NCT01587703|449453136|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952959|NCT01587703|449453137|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952960|NCT01587703|449453138|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952961|NCT01587703|449453139|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952962|NCT01799993|449453140|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
124952963|NCT01799993|449453141|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
124952964|NCT01799993|449453140|FG000|Overall Study|Death|61|||
124952965|NCT01799993|449453141|FG001|Overall Study|Death|45|||
124952966|NCT01799993|449453140|FG000|Overall Study|Withdrawal by Subject|23|||
124952967|NCT01799993|449453141|FG001|Overall Study|Withdrawal by Subject|24|||
124952968|NCT01799993|449453140|FG000|Overall Study|Lost to Follow-up|5|||
124952969|NCT01799993|449453141|FG001|Overall Study|Lost to Follow-up|8|||
124952970|NCT01799993|449453140|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
124952971|NCT01799993|449453141|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
124952972|NCT01799993|449453140|FG000|Overall Study|Protocol driven decision point|0|||
124952973|NCT01799993|449453141|FG001|Overall Study|Protocol driven decision point|3|||
124952974|NCT01799993|449453140|FG000|Overall Study|Protocol Violation|1|||
124952975|NCT01799993|449453141|FG001|Overall Study|Protocol Violation|1|||
124952976|NCT01799993|449453140|FG000|Overall Study|Deterioration of general conditions|2|||
124952977|NCT01799993|449453141|FG001|Overall Study|Deterioration of general conditions|0|||
124952978|NCT01799993|449453140|FG000|Overall Study|Screen failure|0|||
124952979|NCT01799993|449453141|FG001|Overall Study|Screen failure|1|||
124952980|NCT01799993|449453140|FG000|Overall Study|Adverse Event|1|||
124952981|NCT01799993|449453141|FG001|Overall Study|Adverse Event|0|||
124952982|NCT01799993|449453140|FG000|Overall Study|Lack of Efficacy|1|||
124952983|NCT01799993|449453141|FG001|Overall Study|Lack of Efficacy|0|||
124952984|NCT01799993|449453140|FG000|Overall Study|Recovery|0|||
124952985|NCT01799993|449453141|FG001|Overall Study|Recovery|1|||
124952986|NCT01799993|449453140|FG000|Overall Study|Logistical difficulties|1|||
124952987|NCT01799993|449453141|FG001|Overall Study|Logistical difficulties|0|||
124952988|NCT01799993|449453140|FG000|Overall Study|Protocol deviation|1|||
124952989|NCT01799993|449453141|FG001|Overall Study|Protocol deviation|0|||
124952990|NCT01799993|449453140|FG000|Overall Study|Non-compliance with medical device|1|||
124952991|NCT01799993|449453141|FG001|Overall Study|Non-compliance with medical device|0|||
124952992|NCT01799993|449453140|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124952993|NCT01799993|449453141|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124952994|NCT01799993|449453140|FG000|Overall Study|Other|1|||
124952995|NCT01799993|449453141|FG001|Overall Study|Other|0|||
124952996|NCT01799993|449453140|FG000|Overall Study|Subject didn't return for follow-up|0|||
124952997|NCT01799993|449453141|FG001|Overall Study|Subject didn't return for follow-up|1|||
124952998|NCT04271254|449453142|FG000|Overall Study|Withdrawal by Subject|3|||
124952999|NCT04410445|449453143|FG000|Overall Study|Lost to Follow-up|3|||
124953000|NCT04410445|449453144|FG001|Overall Study|Lost to Follow-up|9|||
124953001|NCT04410445|449453143|FG000|Overall Study|Withdrawal by Subject|27|||
125030335|NCT00110994|449732844|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
125215265|NCT00359294|450414962|FG000|Overall Study|Physician Decision|0|||
125215266|NCT00359294|450414963|FG001|Overall Study|Physician Decision|0|||
125215267|NCT00359294|450414964|FG002|Overall Study|Physician Decision|1|||
125215268|NCT00359294|450414965|FG003|Overall Study|Physician Decision|0|||
125215269|NCT00359294|450414966|FG004|Overall Study|Physician Decision|0|||
125215270|NCT01398358|450414973|FG000|Overall Study|Lost to Follow-up|11|||
125215271|NCT01398358|450414974|FG001|Overall Study|Lost to Follow-up|21|||
125215272|NCT01398358|450414975|FG002|Overall Study|Lost to Follow-up|18|||
124953002|NCT04410445|449453144|FG001|Overall Study|Withdrawal by Subject|15|||
124953003|NCT01320683|449453145|FG000|Overall Study|Positive antibody response|1|||
124953004|NCT00759681|449453146|FG000|Overall Study|Death|2|||
124953005|NCT00759681|449453147|FG001|Overall Study|Death|5|||
124953006|NCT00759681|449453146|FG000|Overall Study|Lost to Follow-up|8|||
124953007|NCT00759681|449453147|FG001|Overall Study|Lost to Follow-up|5|||
124953008|NCT00476151|449453148|FG000|Overall Study|Adverse Event|0|||
124953009|NCT00476151|449453149|FG001|Overall Study|Adverse Event|2|||
124953010|NCT00476151|449453148|FG000|Overall Study|Protocol Violation|1|||
124953011|NCT00476151|449453149|FG001|Overall Study|Protocol Violation|3|||
124953012|NCT00476151|449453148|FG000|Overall Study|Withdrawal by Subject|2|||
124953013|NCT00476151|449453149|FG001|Overall Study|Withdrawal by Subject|0|||
124953014|NCT00476151|449453148|FG000|Overall Study|Physician Decision|0|||
124953015|NCT00476151|449453149|FG001|Overall Study|Physician Decision|2|||
124953016|NCT02005484|449453157|FG000|Overall Study|Death|1|||
124953017|NCT02005484|449453157|FG000|Overall Study|Disease progression|1|||
124953018|NCT02005484|449453157|FG000|Overall Study|Changed to a Different Study|1|||
124953019|NCT02005484|449453157|FG000|Overall Study|Sponsor decision|1|||
124953020|NCT01129011|449453158|FG000|Overall Study|Adverse Event|20|||
124953021|NCT01129011|449453159|FG001|Overall Study|Adverse Event|30|||
124953022|NCT01129011|449453158|FG000|Overall Study|Withdrawal by Subject|24|||
124953023|NCT01129011|449453159|FG001|Overall Study|Withdrawal by Subject|8|||
124953024|NCT01129011|449453158|FG000|Overall Study|Lost to Follow-up|6|||
124953025|NCT01129011|449453159|FG001|Overall Study|Lost to Follow-up|7|||
124953026|NCT01129011|449453158|FG000|Overall Study|Duodenal Ulcer|2|||
124953027|NCT01129011|449453159|FG001|Overall Study|Duodenal Ulcer|8|||
125030336|NCT00110994|449732843|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
125030337|NCT00110994|449732844|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
125030338|NCT00110994|449732843|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
125030339|NCT00110994|449732844|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
125030340|NCT00110994|449732843|FG000|Double-blind (DB) Treatment|other reasons|2|||
125030341|NCT00110994|449732844|FG001|Double-blind (DB) Treatment|other reasons|3|||
125030342|NCT00110994|449732843|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
125030343|NCT00110994|449732844|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
125030344|NCT00110994|449732843|FG000|Active Follow-up|Other reasons|0|||
125030345|NCT00110994|449732844|FG001|Active Follow-up|Other reasons|2|||
125030346|NCT00110994|449732843|FG000|Long Term Follow-up|Death|19|||
125030347|NCT00110994|449732844|FG001|Long Term Follow-up|Death|17|||
125030348|NCT00974220|449732848|FG000|Treatment Period 1|Adverse Event|2|||
125030349|NCT00974220|449732849|FG001|Treatment Period 1|Adverse Event|1|||
125030350|NCT00974220|449732848|FG000|Treatment Period 1|noncompliant subjects|0|||
125030351|NCT00974220|449732849|FG001|Treatment Period 1|noncompliant subjects|1|||
125030352|NCT01176916|449732850|FG000|Overall Study|Adverse Event|61|||
125030353|NCT01176916|449732850|FG000|Overall Study|Death|1|||
125030354|NCT01176916|449732850|FG000|Overall Study|Lost to Follow-up|15|||
125030355|NCT01176916|449732850|FG000|Overall Study|Objective progression or relapse|17|||
125030356|NCT01176916|449732850|FG000|Overall Study|Protocol Violation|24|||
125030357|NCT01176916|449732850|FG000|Overall Study|Withdrawal by Subject|37|||
125030358|NCT01176916|449732850|FG000|Overall Study|Other|6|||
125030359|NCT01176916|449732850|FG000|Overall Study|Withdrawal prior to Treatment|6|||
125030360|NCT03158220|449732851|FG000|Overall Study|Screen Failure|0|||
125030361|NCT03158220|449732852|FG001|Overall Study|Screen Failure|1|||
125030362|NCT03158220|449732851|FG000|Overall Study|Withdrawal by Subject|8|||
125030363|NCT03158220|449732852|FG001|Overall Study|Withdrawal by Subject|9|||
125030364|NCT03158220|449732851|FG000|Overall Study|Status unknown|0|||
125030365|NCT03158220|449732852|FG001|Overall Study|Status unknown|1|||
125030366|NCT03158220|449732851|FG000|Overall Study|Lost to Follow-up|8|||
125030367|NCT03158220|449732852|FG001|Overall Study|Lost to Follow-up|5|||
124953028|NCT01129011|449453158|FG000|Overall Study|misc|7|||
124953029|NCT01129011|449453159|FG001|Overall Study|misc|4|||
124953030|NCT01767376|449453163|FG000|Overall Study|Lost to Follow-up|3|||
124953031|NCT01767376|449453164|FG001|Overall Study|Lost to Follow-up|2|||
124953032|NCT01767376|449453165|FG002|Overall Study|Lost to Follow-up|0|||
125030368|NCT03158220|449732851|FG000|Overall Study|Physician Decision|1|||
125030369|NCT03158220|449732852|FG001|Overall Study|Physician Decision|0|||
125215273|NCT01398358|450414973|FG000|Overall Study|Withdrawal by Subject|3|||
124953033|NCT01767376|449453163|FG000|Overall Study|Withdrawal by Subject|1|||
124953034|NCT01767376|449453164|FG001|Overall Study|Withdrawal by Subject|1|||
125215274|NCT01398358|450414974|FG001|Overall Study|Withdrawal by Subject|2|||
124953035|NCT01767376|449453165|FG002|Overall Study|Withdrawal by Subject|0|||
125125252|NCT00560235|450084142|FG001|Phase 1|Discontinued|0|||
125125253|NCT00560235|450084143|FG002|Phase 1|Discontinued|0|||
125125254|NCT00560235|450084141|FG000|Phase 1B|Discontinued|0|||
125125255|NCT00560235|450084142|FG001|Phase 1B|Discontinued|19|||
125125256|NCT00560235|450084143|FG002|Phase 1B|Discontinued|0|||
125125257|NCT00560235|450084141|FG000|Phase 2|Discontinued|0|||
124953036|NCT01113541|449453166|FG000|Overall Study|Withdrawal by Subject|1|||
124953037|NCT01113541|449453166|FG000|Overall Study|Protocol Violation|1|||
124953038|NCT01113541|449453166|FG000|Overall Study|Study Terminated by Sponsor|7|||
124953039|NCT01113541|449453166|FG000|Overall Study|Adverse Event|4|||
124953040|NCT03745651|449453167|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
124953041|NCT03745651|449453168|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
124953042|NCT03745651|449453169|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
124953043|NCT03745651|449453170|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
124953044|NCT03745651|449453171|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
124953045|NCT03745651|449453172|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
124953046|NCT03745651|449453173|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
124953047|NCT03745651|449453167|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
124953048|NCT03745651|449453168|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
124953049|NCT03745651|449453169|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
124953050|NCT03745651|449453170|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124953051|NCT03745651|449453171|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124953052|NCT03745651|449453172|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124953053|NCT03745651|449453173|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124953054|NCT03745651|449453167|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
124953055|NCT03745651|449453168|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
124953056|NCT03745651|449453169|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
124953057|NCT03745651|449453170|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
124953058|NCT03745651|449453171|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
124953059|NCT03745651|449453172|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
124953060|NCT03745651|449453173|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
124953061|NCT03745651|449453167|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
124953062|NCT03745651|449453168|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
124953063|NCT03745651|449453169|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
124953064|NCT03745651|449453170|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
124953065|NCT03745651|449453171|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
124953066|NCT03745651|449453172|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
124953067|NCT03745651|449453173|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
124953068|NCT03745651|449453167|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
124953069|NCT03745651|449453168|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
124953070|NCT03745651|449453169|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
124953071|NCT03745651|449453170|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124953072|NCT03745651|449453171|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124953073|NCT03745651|449453172|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124953074|NCT03745651|449453173|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125030370|NCT01959165|449732854|FG000|Overall Study|Adverse Event|0|||
125030371|NCT01959165|449732855|FG001|Overall Study|Adverse Event|0|||
125030372|NCT01959165|449732856|FG002|Overall Study|Adverse Event|0|||
125030373|NCT01959165|449732857|FG003|Overall Study|Adverse Event|1|||
125030374|NCT01959165|449732854|FG000|Overall Study|Lack of Efficacy|1|||
125030375|NCT01959165|449732855|FG001|Overall Study|Lack of Efficacy|0|||
125030376|NCT01959165|449732856|FG002|Overall Study|Lack of Efficacy|0|||
125030377|NCT01959165|449732857|FG003|Overall Study|Lack of Efficacy|0|||
125030378|NCT01959165|449732854|FG000|Overall Study|overdose|0|||
125030379|NCT01959165|449732855|FG001|Overall Study|overdose|0|||
125030380|NCT01959165|449732856|FG002|Overall Study|overdose|0|||
125030381|NCT01959165|449732857|FG003|Overall Study|overdose|1|||
125030382|NCT01959165|449732854|FG000|Overall Study|Welfare recipient|0|||
125030383|NCT01959165|449732855|FG001|Overall Study|Welfare recipient|1|||
125030384|NCT01959165|449732856|FG002|Overall Study|Welfare recipient|0|||
125030385|NCT01959165|449732857|FG003|Overall Study|Welfare recipient|0|||
125030386|NCT03686969|449732858|FG000|Overall Study|Study terminated|1|||
125030387|NCT03686969|449732859|FG001|Overall Study|Study terminated|0|||
125030388|NCT00560755|449732860|FG000|Overall Study|Protocol Violation|15|||
125030389|NCT00560755|449732860|FG000|Overall Study|Withdrawal by Subject|26|||
125030390|NCT00560755|449732860|FG000|Overall Study|Lost to Follow-up|9|||
125030391|NCT00560755|449732860|FG000|Overall Study|Adverse Event|8|||
125030392|NCT00560755|449732860|FG000|Overall Study|Physician Decision|2|||
125030393|NCT00848120|449732861|FG000|Overall Study|Adverse Event|1|||
125030394|NCT01988090|449732865|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
125030395|NCT01988090|449732866|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
125030396|NCT01988090|449732865|FG000|Start Treament After Randomization|Protocol Violation|0|||
125030397|NCT01988090|449732866|FG001|Start Treament After Randomization|Protocol Violation|1|||
125030398|NCT01988090|449732865|FG000|Complete Study After Start|Withdrawal by Subject|2|||
125030399|NCT01988090|449732866|FG001|Complete Study After Start|Withdrawal by Subject|0|||
125030400|NCT01988090|449732865|FG000|Complete Study After Start|Protocol Violation|1|||
125030401|NCT01988090|449732866|FG001|Complete Study After Start|Protocol Violation|1|||
125030402|NCT00927563|449732883|FG000|Overall Study|Lost to Follow-up|1|||
125030403|NCT00927563|449732883|FG000|Overall Study|Withdrawal by Subject|1|||
125030404|NCT00413959|449732890|FG000|Overall Study|Pt had only one cycle.|1|||
125030405|NCT04343651|449732892|FG000|Overall Study|Physician Decision|2|||
125030406|NCT04343651|449732893|FG001|Overall Study|Physician Decision|1|||
125030407|NCT04343651|449732892|FG000|Overall Study|Lost to Follow-up|2|||
125030408|NCT04343651|449732893|FG001|Overall Study|Lost to Follow-up|1|||
125030409|NCT04343651|449732892|FG000|Overall Study|Protocol Violation|4|||
125030410|NCT04343651|449732893|FG001|Overall Study|Protocol Violation|6|||
125030411|NCT04343651|449732892|FG000|Overall Study|Missing|3|||
125030412|NCT04343651|449732893|FG001|Overall Study|Missing|9|||
125030413|NCT04343651|449732892|FG000|Overall Study|Withdrawal by Subject|0|||
125030414|NCT04343651|449732893|FG001|Overall Study|Withdrawal by Subject|4|||
125030415|NCT04343651|449732892|FG000|Overall Study|Death|0|||
125030416|NCT04343651|449732893|FG001|Overall Study|Death|1|||
125030417|NCT04343651|449732892|FG000|Overall Study|Did not start treatment|1|||
125030418|NCT04343651|449732893|FG001|Overall Study|Did not start treatment|1|||
125030419|NCT04343651|449732892|FG000|Overall Study|Patient did not complete visits 3-6|0|||
125030420|NCT04343651|449732893|FG001|Overall Study|Patient did not complete visits 3-6|1|||
125030421|NCT01292057|449732899|FG000|Overall Study|Protocol Violation|1|||
125030422|NCT01292057|449732900|FG001|Overall Study|Protocol Violation|1|||
125030423|NCT01292057|449732899|FG000|Overall Study|Lost to Follow-up|1|||
125030424|NCT01292057|449732900|FG001|Overall Study|Lost to Follow-up|1|||
125030425|NCT01459614|449732901|FG000|Overall Study|Adverse Event|1|||
125030426|NCT01459614|449732902|FG001|Overall Study|Adverse Event|0|||
125030427|NCT01506882|449732906|FG000|Overall Study|Lack of Efficacy|4|||
125030428|NCT01506882|449732907|FG001|Overall Study|Lack of Efficacy|3|||
125030429|NCT01506882|449732906|FG000|Overall Study|Lost to Follow-up|1|||
125030430|NCT01506882|449732907|FG001|Overall Study|Lost to Follow-up|0|||
125030431|NCT01506882|449732906|FG000|Overall Study|Withdrawal by Subject|9|||
125030432|NCT01506882|449732907|FG001|Overall Study|Withdrawal by Subject|3|||
125030433|NCT01506882|449732906|FG000|Overall Study|SAE, non-fatal|2|||
125030434|NCT01506882|449732907|FG001|Overall Study|SAE, non-fatal|0|||
125030435|NCT01506882|449732906|FG000|Overall Study|AE, non-serious non-fatal|3|||
125030436|NCT01506882|449732907|FG001|Overall Study|AE, non-serious non-fatal|1|||
125030437|NCT01506882|449732906|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
125030438|NCT01506882|449732907|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
125030439|NCT01506882|449732906|FG000|Overall Study|Other Reason|2|||
124953075|NCT03745651|449453167|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
124953076|NCT03745651|449453168|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
124953077|NCT03745651|449453169|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
124953078|NCT03745651|449453170|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
124953079|NCT03745651|449453171|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
124953080|NCT03745651|449453172|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
124953081|NCT03745651|449453173|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
124953082|NCT03745651|449453167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
125030440|NCT01506882|449732907|FG001|Overall Study|Other Reason|0|||
125030441|NCT00821678|449732912|FG000|Overall Study|Withdrawal by Subject|8|||
125030442|NCT00821678|449732913|FG001|Overall Study|Withdrawal by Subject|0|||
125030443|NCT00821678|449732912|FG000|Overall Study|Lost to Follow-up|13|||
125030444|NCT00821678|449732913|FG001|Overall Study|Lost to Follow-up|12|||
125030445|NCT00821678|449732912|FG000|Overall Study|Death|0|||
125030446|NCT00821678|449732913|FG001|Overall Study|Death|2|||
125030447|NCT05742984|449734943|FG000|Overall Study|Adverse Event|0|||
125030448|NCT05742984|449734944|FG001|Overall Study|Adverse Event|0|||
125030449|NCT05742984|449734945|FG002|Overall Study|Adverse Event|1|||
125030450|NCT05742984|449734946|FG003|Overall Study|Adverse Event|0|||
125030451|NCT05742984|449734947|FG004|Overall Study|Adverse Event|1|||
125030452|NCT05742984|449734948|FG005|Overall Study|Adverse Event|1|||
125030453|NCT05742984|449734943|FG000|Overall Study|Withdrawal by Subject|0|||
125030454|NCT05742984|449734944|FG001|Overall Study|Withdrawal by Subject|1|||
125030455|NCT05742984|449734945|FG002|Overall Study|Withdrawal by Subject|0|||
125030456|NCT05742984|449734946|FG003|Overall Study|Withdrawal by Subject|0|||
125030457|NCT05742984|449734947|FG004|Overall Study|Withdrawal by Subject|0|||
125030458|NCT05742984|449734948|FG005|Overall Study|Withdrawal by Subject|2|||
124953083|NCT03745651|449453168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
124953084|NCT03745651|449453169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
124953085|NCT03745651|449453170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
124953086|NCT03745651|449453171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
124953087|NCT03745651|449453172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
124953088|NCT03745651|449453173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
124953089|NCT03745651|449453167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
124953090|NCT03745651|449453168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
124953091|NCT03745651|449453169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
124953092|NCT03745651|449453170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
124953093|NCT03745651|449453171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
124953094|NCT03745651|449453172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
124953095|NCT03745651|449453173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
124953096|NCT03745651|449453167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
124953097|NCT03745651|449453168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
124953098|NCT03745651|449453169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
124953099|NCT03745651|449453170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
124953100|NCT03745651|449453171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
124953101|NCT03745651|449453172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
124953102|NCT03745651|449453173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
124953103|NCT03745651|449453167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
124953104|NCT03745651|449453168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
124953105|NCT03745651|449453169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
124953106|NCT03745651|449453170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
124953107|NCT03745651|449453171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
124953108|NCT03745651|449453172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
124953109|NCT03745651|449453173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
124953110|NCT03745651|449453167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
124953111|NCT03745651|449453168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
124953112|NCT03745651|449453169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
124953113|NCT03745651|449453170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
124953114|NCT03745651|449453171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
124953115|NCT03745651|449453172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
124953116|NCT03745651|449453173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
124953117|NCT03745651|449453167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
124953118|NCT03745651|449453168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
124953119|NCT03745651|449453169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
124953120|NCT03745651|449453170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
124953121|NCT03745651|449453171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
124953122|NCT03745651|449453172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
124953123|NCT03745651|449453173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
124953124|NCT03745651|449453167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
124953125|NCT03745651|449453168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
124953126|NCT03745651|449453169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
124953127|NCT03745651|449453170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
124953128|NCT03745651|449453171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
124953129|NCT03745651|449453172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
124953130|NCT03745651|449453173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
124953131|NCT03745651|449453167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
124953132|NCT03745651|449453168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
124953133|NCT03745651|449453169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
124953134|NCT03745651|449453170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
124953135|NCT03745651|449453171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
124953136|NCT03745651|449453172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
124953137|NCT03745651|449453173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
124953138|NCT00946088|449453174|FG000|Overall Study|Withdrawal by Subject|0|||
124953139|NCT00946088|449453175|FG001|Overall Study|Withdrawal by Subject|1|||
124953140|NCT04883541|449453176|FG000|Overall Study|Not attending regular yoga class|16|||
124953141|NCT04883541|449453177|FG001|Overall Study|Not attending regular yoga class|0|||
124953142|NCT04883541|449453176|FG000|Overall Study|Not attending the pregnancy school|0|||
124953143|NCT04883541|449453177|FG001|Overall Study|Not attending the pregnancy school|9|||
124953144|NCT02309892|449453182|FG000|Overall Study|Physician Decision|1|||
124953145|NCT02309892|449453183|FG001|Overall Study|Physician Decision|0|||
124953146|NCT02309892|449453184|FG002|Overall Study|Physician Decision|0|||
124953147|NCT02309892|449453185|FG003|Overall Study|Physician Decision|0|||
124953148|NCT02309892|449453186|FG004|Overall Study|Physician Decision|0|||
124953149|NCT02309892|449453187|FG005|Overall Study|Physician Decision|0|||
124953150|NCT02309892|449453188|FG006|Overall Study|Physician Decision|0|||
124953151|NCT02309892|449453182|FG000|Overall Study|Adverse Event|1|||
124953152|NCT02309892|449453183|FG001|Overall Study|Adverse Event|0|||
124953153|NCT02309892|449453184|FG002|Overall Study|Adverse Event|1|||
124953154|NCT02309892|449453185|FG003|Overall Study|Adverse Event|0|||
124953155|NCT02309892|449453186|FG004|Overall Study|Adverse Event|0|||
124953156|NCT02309892|449453187|FG005|Overall Study|Adverse Event|0|||
124953157|NCT02309892|449453188|FG006|Overall Study|Adverse Event|0|||
124953158|NCT02309892|449453182|FG000|Overall Study|Progressive Disease|0|||
124953159|NCT02309892|449453183|FG001|Overall Study|Progressive Disease|1|||
124953160|NCT02309892|449453184|FG002|Overall Study|Progressive Disease|0|||
124953161|NCT02309892|449453185|FG003|Overall Study|Progressive Disease|0|||
124953162|NCT02309892|449453186|FG004|Overall Study|Progressive Disease|1|||
124953163|NCT02309892|449453187|FG005|Overall Study|Progressive Disease|0|||
124953164|NCT02309892|449453188|FG006|Overall Study|Progressive Disease|0|||
124953165|NCT02309892|449453182|FG000|Overall Study|Death|0|||
124953166|NCT02309892|449453183|FG001|Overall Study|Death|0|||
124953167|NCT02309892|449453184|FG002|Overall Study|Death|0|||
124953168|NCT02309892|449453185|FG003|Overall Study|Death|0|||
124953169|NCT02309892|449453186|FG004|Overall Study|Death|0|||
124953170|NCT02309892|449453187|FG005|Overall Study|Death|1|||
124953171|NCT02309892|449453188|FG006|Overall Study|Death|0|||
124953172|NCT01901302|449453189|FG000|Overall Study|Adverse Event|2|||
124953173|NCT01901302|449453190|FG001|Overall Study|Adverse Event|1|||
124953174|NCT01901302|449453189|FG000|Overall Study|Lack of Efficacy|0|||
124953175|NCT01901302|449453190|FG001|Overall Study|Lack of Efficacy|2|||
124953176|NCT01901302|449453189|FG000|Overall Study|Study Terminated by Sponsor|23|||
124953177|NCT01901302|449453190|FG001|Overall Study|Study Terminated by Sponsor|20|||
124953178|NCT01901302|449453189|FG000|Overall Study|Withdrawal by Subject|2|||
124953179|NCT01901302|449453190|FG001|Overall Study|Withdrawal by Subject|0|||
124953180|NCT01124916|449453191|FG000|Overall Study|Lost to Follow-up|3|||
124953181|NCT01124916|449453192|FG001|Overall Study|Lost to Follow-up|2|||
124953182|NCT01029925|449453198|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
124953183|NCT01029925|449453198|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
124953184|NCT01029925|449453198|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
124953185|NCT05265247|449453199|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
124953186|NCT05265247|449453200|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
124953187|NCT05265247|449453199|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
124953188|NCT05265247|449453200|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
124953189|NCT05265247|449453199|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
124953190|NCT05265247|449453200|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
124953191|NCT00134056|449453208|FG000|Randomization|Not eligible for assigned treatment|22|||
124953192|NCT00134056|449453209|FG001|Randomization|Not eligible for assigned treatment|20|||
124953193|NCT00134056|449453208|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
124953194|NCT00134056|449453209|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
124953195|NCT00134056|449453208|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
124953196|NCT00134056|449453209|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
124953197|NCT00134056|449453208|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
124953198|NCT00134056|449453209|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
124953199|NCT00134056|449453208|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
124953200|NCT00134056|449453209|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
124953201|NCT02555397|449453213|FG000|Overall Study|Withdrawal by Subject|1|||
124953202|NCT02555397|449453214|FG001|Overall Study|Withdrawal by Subject|0|||
124953203|NCT02555397|449453215|FG002|Overall Study|Withdrawal by Subject|0|||
124953204|NCT02555397|449453216|FG003|Overall Study|Withdrawal by Subject|0|||
124953205|NCT02555397|449453217|FG004|Overall Study|Withdrawal by Subject|0|||
124953206|NCT00537914|449453221|FG000|Overall Study|Death|1|||
124953207|NCT00537914|449453221|FG000|Overall Study|Adverse Event|7|||
124953208|NCT00537914|449453221|FG000|Overall Study|Treatment failure|10|||
124953209|NCT00537914|449453221|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
124953210|NCT00537914|449453221|FG000|Overall Study|Lost to Follow-up|19|||
124953211|NCT00537914|449453221|FG000|Overall Study|Withdrawal of informed consent|59|||
124953212|NCT02312258|449453222|FG000|Overall Study|Lost to Follow-up|8|||
124953213|NCT02312258|449453223|FG001|Overall Study|Lost to Follow-up|8|||
124953214|NCT02312258|449453222|FG000|Overall Study|Withdrawal by Patient|49|||
124953215|NCT02312258|449453223|FG001|Overall Study|Withdrawal by Patient|76|||
124953216|NCT02312258|449453222|FG000|Overall Study|Reason not Specified|107|||
124953217|NCT02312258|449453223|FG001|Overall Study|Reason not Specified|159|||
124953218|NCT02312258|449453222|FG000|Overall Study|Missing|2|||
124953219|NCT02312258|449453223|FG001|Overall Study|Missing|1|||
124953220|NCT02312258|449453222|FG000|Overall Study|Death|115|||
124953221|NCT02312258|449453223|FG001|Overall Study|Death|181|||
124953222|NCT01468597|449453225|FG000|Overall Study|Found ineligible|17|||
125030459|NCT00379340|449734949|FG000|Overall Study|Death|0|||
125125258|NCT00560235|450084142|FG001|Phase 2|Discontinued|0|||
125125259|NCT00560235|450084143|FG002|Phase 2|Discontinued|96|||
125125260|NCT00560235|450084141|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
125125261|NCT00560235|450084142|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
125125262|NCT00560235|450084143|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
125125263|NCT01315249|450084146|FG000|Overall Study|Adverse Event|22|||
125125264|NCT01315249|450084147|FG001|Overall Study|Adverse Event|26|||
125125265|NCT01315249|450084146|FG000|Overall Study|Withdrawal by Subject|11|||
125125266|NCT01315249|450084147|FG001|Overall Study|Withdrawal by Subject|10|||
125125267|NCT01315249|450084146|FG000|Overall Study|Protocol Violation|8|||
125125268|NCT01315249|450084147|FG001|Overall Study|Protocol Violation|5|||
125125269|NCT01315249|450084146|FG000|Overall Study|Abnormal test results|1|||
125125270|NCT01315249|450084147|FG001|Overall Study|Abnormal test results|2|||
125125271|NCT01315249|450084146|FG000|Overall Study|Administrative problems|1|||
125125272|NCT01315249|450084147|FG001|Overall Study|Administrative problems|0|||
125125273|NCT01315249|450084146|FG000|Overall Study|inability to use device|1|||
124953223|NCT01468597|449453225|FG000|Overall Study|concomitant valves|12|||
124953224|NCT01468597|449453225|FG000|Overall Study|off-pump CABG|1|||
124953225|NCT01468597|449453225|FG000|Overall Study|no platelet function data|5|||
124953226|NCT02260154|449453226|FG000|Overall Study|Screening failure|2|||
124953227|NCT02561195|449453228|FG000|Vaccination 1 to 3|Adverse Event|4|||
124953228|NCT02561195|449453229|FG001|Vaccination 1 to 3|Adverse Event|5|||
124953229|NCT02561195|449453230|FG002|Vaccination 1 to 3|Adverse Event|0|||
124953230|NCT02561195|449453231|FG003|Vaccination 1 to 3|Adverse Event|3|||
124953231|NCT02561195|449453232|FG004|Vaccination 1 to 3|Adverse Event|4|||
124953232|NCT02561195|449453233|FG005|Vaccination 1 to 3|Adverse Event|0|||
124953233|NCT02561195|449453234|FG006|Vaccination 1 to 3|Adverse Event|0|||
124953234|NCT02561195|449453235|FG007|Vaccination 1 to 3|Adverse Event|0|||
124953235|NCT02561195|449453236|FG008|Vaccination 1 to 3|Adverse Event|0|||
124953236|NCT02561195|449453237|FG009|Vaccination 1 to 3|Adverse Event|0|||
124953237|NCT02561195|449453238|FG010|Vaccination 1 to 3|Adverse Event|0|||
124953238|NCT02561195|449453239|FG011|Vaccination 1 to 3|Adverse Event|0|||
124953239|NCT02561195|449453240|FG012|Vaccination 1 to 3|Adverse Event|0|||
124953240|NCT02561195|449453241|FG013|Vaccination 1 to 3|Adverse Event|0|||
124953241|NCT02561195|449453228|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
124953242|NCT02561195|449453229|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
124953243|NCT02561195|449453230|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
124953244|NCT02561195|449453231|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
124953245|NCT02561195|449453232|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
124953246|NCT02561195|449453233|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
124953247|NCT02561195|449453234|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
124953248|NCT02561195|449453235|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
124953249|NCT02561195|449453236|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
124953250|NCT02561195|449453237|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
124953251|NCT02561195|449453238|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
124953252|NCT02561195|449453239|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
124953253|NCT02561195|449453240|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
124953254|NCT02561195|449453241|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
124953255|NCT02561195|449453228|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
124953256|NCT02561195|449453229|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
124953257|NCT02561195|449453230|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
124953258|NCT02561195|449453231|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
124953259|NCT02561195|449453232|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
124953260|NCT02561195|449453233|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
124953261|NCT02561195|449453234|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
124953262|NCT02561195|449453235|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
124953263|NCT02561195|449453236|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
124953264|NCT02561195|449453237|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
124953265|NCT02561195|449453238|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
124953266|NCT02561195|449453239|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
124953267|NCT02561195|449453240|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
124953268|NCT02561195|449453241|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
124953269|NCT02561195|449453228|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
124953270|NCT02561195|449453229|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
124953271|NCT02561195|449453230|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
124953272|NCT02561195|449453231|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
124953273|NCT02561195|449453232|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
124953274|NCT02561195|449453233|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
124953275|NCT02561195|449453234|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
125125274|NCT01315249|450084147|FG001|Overall Study|inability to use device|0|||
125125275|NCT01315249|450084146|FG000|Overall Study|Lack of Efficacy|0|||
124953276|NCT02561195|449453235|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
124953277|NCT02561195|449453236|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
124953278|NCT02561195|449453237|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
124953279|NCT02561195|449453238|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
124953280|NCT02561195|449453239|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
124953281|NCT02561195|449453240|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
124953282|NCT02561195|449453241|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
124953283|NCT02561195|449453228|FG000|Vaccination 1 to 3|Other|7|||
124953284|NCT02561195|449453229|FG001|Vaccination 1 to 3|Other|3|||
124953285|NCT02561195|449453230|FG002|Vaccination 1 to 3|Other|1|||
124953286|NCT02561195|449453231|FG003|Vaccination 1 to 3|Other|7|||
124953287|NCT02561195|449453232|FG004|Vaccination 1 to 3|Other|5|||
124953288|NCT02561195|449453233|FG005|Vaccination 1 to 3|Other|1|||
124953289|NCT02561195|449453234|FG006|Vaccination 1 to 3|Other|0|||
124953290|NCT02561195|449453235|FG007|Vaccination 1 to 3|Other|0|||
124953291|NCT02561195|449453236|FG008|Vaccination 1 to 3|Other|0|||
124953292|NCT02561195|449453237|FG009|Vaccination 1 to 3|Other|0|||
124953293|NCT02561195|449453238|FG010|Vaccination 1 to 3|Other|0|||
124953294|NCT02561195|449453239|FG011|Vaccination 1 to 3|Other|0|||
124953295|NCT02561195|449453240|FG012|Vaccination 1 to 3|Other|0|||
124953296|NCT02561195|449453241|FG013|Vaccination 1 to 3|Other|0|||
124953297|NCT02561195|449453228|FG000|Vaccination 1 to 3|Protocol Violation|1|||
124953298|NCT02561195|449453229|FG001|Vaccination 1 to 3|Protocol Violation|0|||
124953299|NCT02561195|449453230|FG002|Vaccination 1 to 3|Protocol Violation|1|||
124953300|NCT02561195|449453231|FG003|Vaccination 1 to 3|Protocol Violation|2|||
124953301|NCT02561195|449453232|FG004|Vaccination 1 to 3|Protocol Violation|5|||
124953302|NCT02561195|449453233|FG005|Vaccination 1 to 3|Protocol Violation|2|||
124953303|NCT02561195|449453234|FG006|Vaccination 1 to 3|Protocol Violation|0|||
124953304|NCT02561195|449453235|FG007|Vaccination 1 to 3|Protocol Violation|0|||
124953305|NCT02561195|449453236|FG008|Vaccination 1 to 3|Protocol Violation|0|||
124953306|NCT02561195|449453237|FG009|Vaccination 1 to 3|Protocol Violation|0|||
124953307|NCT02561195|449453238|FG010|Vaccination 1 to 3|Protocol Violation|0|||
124953308|NCT02561195|449453239|FG011|Vaccination 1 to 3|Protocol Violation|0|||
124953309|NCT02561195|449453240|FG012|Vaccination 1 to 3|Protocol Violation|0|||
124953310|NCT02561195|449453241|FG013|Vaccination 1 to 3|Protocol Violation|0|||
124953311|NCT02561195|449453228|FG000|Vaccination 1 to 3|Death|2|||
124953312|NCT02561195|449453229|FG001|Vaccination 1 to 3|Death|1|||
124953313|NCT02561195|449453230|FG002|Vaccination 1 to 3|Death|0|||
124953314|NCT02561195|449453231|FG003|Vaccination 1 to 3|Death|2|||
124953315|NCT02561195|449453232|FG004|Vaccination 1 to 3|Death|0|||
124953316|NCT02561195|449453233|FG005|Vaccination 1 to 3|Death|0|||
124953317|NCT02561195|449453234|FG006|Vaccination 1 to 3|Death|0|||
124953318|NCT02561195|449453235|FG007|Vaccination 1 to 3|Death|0|||
124953319|NCT02561195|449453236|FG008|Vaccination 1 to 3|Death|0|||
124953320|NCT02561195|449453237|FG009|Vaccination 1 to 3|Death|0|||
124953321|NCT02561195|449453238|FG010|Vaccination 1 to 3|Death|0|||
124953322|NCT02561195|449453239|FG011|Vaccination 1 to 3|Death|0|||
124953323|NCT02561195|449453240|FG012|Vaccination 1 to 3|Death|0|||
124953324|NCT02561195|449453241|FG013|Vaccination 1 to 3|Death|0|||
124953325|NCT02561195|449453228|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
124953326|NCT02561195|449453229|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
124953327|NCT02561195|449453230|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
124953328|NCT02561195|449453231|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
124953329|NCT02561195|449453232|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
124953330|NCT02561195|449453233|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
124953331|NCT02561195|449453234|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
124953332|NCT02561195|449453235|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
124953333|NCT02561195|449453236|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
124953334|NCT02561195|449453237|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
124953335|NCT02561195|449453238|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
124953336|NCT02561195|449453239|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
124953337|NCT02561195|449453240|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
124953338|NCT02561195|449453241|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
124953339|NCT02561195|449453228|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
124953340|NCT02561195|449453229|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
124953341|NCT02561195|449453230|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
124953342|NCT02561195|449453231|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
124953343|NCT02561195|449453232|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
124953344|NCT02561195|449453233|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
124953345|NCT02561195|449453234|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
124953346|NCT02561195|449453235|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
124953347|NCT02561195|449453236|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
124953348|NCT02561195|449453237|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
124953349|NCT02561195|449453238|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
124953350|NCT02561195|449453239|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
124953351|NCT02561195|449453240|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
124953352|NCT02561195|449453241|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
124953353|NCT02561195|449453228|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
124953354|NCT02561195|449453229|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
124953355|NCT02561195|449453230|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
124953356|NCT02561195|449453231|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
124953357|NCT02561195|449453232|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
124953358|NCT02561195|449453233|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
124953359|NCT02561195|449453234|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
124953360|NCT02561195|449453235|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
124953361|NCT02561195|449453236|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
124953362|NCT02561195|449453237|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
124953363|NCT02561195|449453238|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
124953364|NCT02561195|449453239|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
124953365|NCT02561195|449453240|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
124953366|NCT02561195|449453241|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
124953367|NCT02561195|449453228|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953368|NCT02561195|449453229|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953369|NCT02561195|449453230|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953370|NCT02561195|449453231|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953371|NCT02561195|449453232|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953372|NCT02561195|449453233|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953373|NCT02561195|449453234|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953374|NCT02561195|449453235|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953375|NCT02561195|449453236|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953376|NCT02561195|449453237|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953377|NCT02561195|449453238|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953378|NCT02561195|449453239|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953379|NCT02561195|449453240|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
125030460|NCT00379340|449734950|FG001|Overall Study|Death|0|||
125030461|NCT00379340|449734951|FG002|Overall Study|Death|0|||
125030462|NCT00379340|449734952|FG003|Overall Study|Death|2|||
125030463|NCT00379340|449734953|FG004|Overall Study|Death|0|||
125030464|NCT00379340|449734949|FG000|Overall Study|Lack of Efficacy|6|||
125030465|NCT00379340|449734950|FG001|Overall Study|Lack of Efficacy|1|||
125030466|NCT00379340|449734951|FG002|Overall Study|Lack of Efficacy|0|||
125030467|NCT00379340|449734952|FG003|Overall Study|Lack of Efficacy|4|||
125030468|NCT00379340|449734953|FG004|Overall Study|Lack of Efficacy|3|||
125030469|NCT00379340|449734949|FG000|Overall Study|Physician Decision|6|||
125030470|NCT00379340|449734950|FG001|Overall Study|Physician Decision|2|||
125030471|NCT00379340|449734951|FG002|Overall Study|Physician Decision|1|||
125030472|NCT00379340|449734952|FG003|Overall Study|Physician Decision|2|||
125030473|NCT00379340|449734953|FG004|Overall Study|Physician Decision|3|||
125030474|NCT00379340|449734949|FG000|Overall Study|Withdrawal by Subject|0|||
125030475|NCT00379340|449734950|FG001|Overall Study|Withdrawal by Subject|0|||
125030476|NCT00379340|449734951|FG002|Overall Study|Withdrawal by Subject|0|||
125030477|NCT00379340|449734952|FG003|Overall Study|Withdrawal by Subject|1|||
125030478|NCT00379340|449734953|FG004|Overall Study|Withdrawal by Subject|0|||
125030479|NCT00379340|449734949|FG000|Overall Study|Refusal of further protocol therapy|1|||
125030480|NCT00379340|449734950|FG001|Overall Study|Refusal of further protocol therapy|0|||
125030481|NCT00379340|449734951|FG002|Overall Study|Refusal of further protocol therapy|1|||
125030482|NCT00379340|449734952|FG003|Overall Study|Refusal of further protocol therapy|1|||
125030483|NCT00379340|449734953|FG004|Overall Study|Refusal of further protocol therapy|7|||
125030484|NCT00379340|449734949|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
125030485|NCT00379340|449734950|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
125030486|NCT00379340|449734951|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
125030487|NCT00379340|449734952|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
125030488|NCT00379340|449734953|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
125030489|NCT00379340|449734949|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
125030490|NCT00379340|449734950|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
125030491|NCT00379340|449734951|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
125030492|NCT00379340|449734952|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
125030493|NCT00379340|449734953|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
125030494|NCT05019131|449734959|FG000|Overall Study|Lost to Follow-up|0|||
125030495|NCT05019131|449734960|FG001|Overall Study|Lost to Follow-up|3|||
125030496|NCT01703000|449734961|FG000|Overall Study|Death|1|||
125030497|NCT06118385|449734963|FG000|Overall Study|Protocol Violation|0|||
125030498|NCT06118385|449734964|FG001|Overall Study|Protocol Violation|0|||
125030499|NCT06118385|449734965|FG002|Overall Study|Protocol Violation|0|||
125215275|NCT01398358|450414975|FG002|Overall Study|Withdrawal by Subject|2|||
125215276|NCT01398358|450414973|FG000|Overall Study|no longer eligible|1|||
125030500|NCT06118385|449734966|FG003|Overall Study|Protocol Violation|0|||
125030501|NCT06118385|449734967|FG004|Overall Study|Protocol Violation|0|||
125030502|NCT06118385|449734968|FG005|Overall Study|Protocol Violation|0|||
125030503|NCT06118385|449734969|FG006|Overall Study|Protocol Violation|0|||
125030504|NCT06118385|449734970|FG007|Overall Study|Protocol Violation|0|||
124953380|NCT02561195|449453241|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
124953381|NCT02561195|449453228|FG000|Extension Stage (Vaccination 4)|Death|0|||
124953382|NCT02561195|449453229|FG001|Extension Stage (Vaccination 4)|Death|0|||
124953383|NCT02561195|449453230|FG002|Extension Stage (Vaccination 4)|Death|0|||
124953384|NCT02561195|449453231|FG003|Extension Stage (Vaccination 4)|Death|0|||
124953385|NCT02561195|449453232|FG004|Extension Stage (Vaccination 4)|Death|0|||
124953386|NCT02561195|449453233|FG005|Extension Stage (Vaccination 4)|Death|0|||
124953387|NCT02561195|449453234|FG006|Extension Stage (Vaccination 4)|Death|0|||
124953388|NCT02561195|449453235|FG007|Extension Stage (Vaccination 4)|Death|0|||
124953389|NCT02561195|449453236|FG008|Extension Stage (Vaccination 4)|Death|0|||
124953390|NCT02561195|449453237|FG009|Extension Stage (Vaccination 4)|Death|1|||
124953391|NCT02561195|449453238|FG010|Extension Stage (Vaccination 4)|Death|0|||
124953392|NCT02561195|449453239|FG011|Extension Stage (Vaccination 4)|Death|0|||
124953393|NCT02561195|449453240|FG012|Extension Stage (Vaccination 4)|Death|0|||
124953394|NCT02561195|449453241|FG013|Extension Stage (Vaccination 4)|Death|0|||
124953395|NCT02561195|449453228|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
124953396|NCT02561195|449453229|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
124953397|NCT02561195|449453230|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
124953398|NCT02561195|449453231|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
124953399|NCT02561195|449453232|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
124953400|NCT02561195|449453233|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
124953401|NCT02561195|449453234|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
124953402|NCT02561195|449453235|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
124953403|NCT02561195|449453236|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
124953404|NCT02561195|449453237|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
124953405|NCT02561195|449453238|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
124953406|NCT02561195|449453239|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
124953407|NCT02561195|449453240|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
124953408|NCT02561195|449453241|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
124953409|NCT02561195|449453228|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
124953410|NCT02561195|449453229|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
124953411|NCT02561195|449453230|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
124953412|NCT02561195|449453231|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
124953413|NCT02561195|449453232|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
124953414|NCT02561195|449453233|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
124953415|NCT02561195|449453234|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
124953416|NCT02561195|449453235|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
124953417|NCT02561195|449453236|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
125030505|NCT06118385|449734971|FG008|Overall Study|Protocol Violation|1|||
125030506|NCT06118385|449734972|FG009|Overall Study|Protocol Violation|0|||
125030507|NCT06118385|449734973|FG010|Overall Study|Protocol Violation|0|||
125030508|NCT06118385|449734974|FG011|Overall Study|Protocol Violation|0|||
125030509|NCT06118385|449734963|FG000|Overall Study|Out-of-range blood tests|0|||
125030510|NCT06118385|449734964|FG001|Overall Study|Out-of-range blood tests|0|||
125030511|NCT06118385|449734965|FG002|Overall Study|Out-of-range blood tests|0|||
125030512|NCT06118385|449734966|FG003|Overall Study|Out-of-range blood tests|0|||
125030513|NCT06118385|449734967|FG004|Overall Study|Out-of-range blood tests|0|||
125030514|NCT06118385|449734968|FG005|Overall Study|Out-of-range blood tests|0|||
125030515|NCT06118385|449734969|FG006|Overall Study|Out-of-range blood tests|0|||
125030516|NCT06118385|449734970|FG007|Overall Study|Out-of-range blood tests|0|||
125030517|NCT06118385|449734971|FG008|Overall Study|Out-of-range blood tests|1|||
125030518|NCT06118385|449734972|FG009|Overall Study|Out-of-range blood tests|0|||
125030519|NCT06118385|449734973|FG010|Overall Study|Out-of-range blood tests|0|||
125030520|NCT06118385|449734974|FG011|Overall Study|Out-of-range blood tests|0|||
125030521|NCT01323478|449734975|FG000|Overall Study|Adverse Event|7|||
125030522|NCT01323478|449734975|FG000|Overall Study|Lack of Efficacy|4|||
125030523|NCT01323478|449734975|FG000|Overall Study|Non-compliance With Study Product|3|||
125030524|NCT01323478|449734975|FG000|Overall Study|Protocol Violation|1|||
125030525|NCT01323478|449734975|FG000|Overall Study|Withdrawal of Consent|1|||
125030526|NCT01323478|449734975|FG000|Overall Study|Administrative or Other Reasons|8|||
125030527|NCT02411448|449734976|FG000|Overall Study|Withdrawal by Subject|1|||
125030528|NCT02411448|449734977|FG001|Overall Study|Withdrawal by Subject|14|||
125030529|NCT02411448|449734978|FG002|Overall Study|Withdrawal by Subject|9|||
125030530|NCT02411448|449734976|FG000|Overall Study|Other|0|||
125030531|NCT02411448|449734977|FG001|Overall Study|Other|2|||
125030532|NCT02411448|449734978|FG002|Overall Study|Other|0|||
125030533|NCT02411448|449734976|FG000|Overall Study|Did not receive study treatment|0|||
125125276|NCT01315249|450084147|FG001|Overall Study|Lack of Efficacy|1|||
125030534|NCT02411448|449734977|FG001|Overall Study|Did not receive study treatment|3|||
125030535|NCT02411448|449734978|FG002|Overall Study|Did not receive study treatment|0|||
125030536|NCT02411448|449734976|FG000|Overall Study|Alive on study treatment|3|||
125030537|NCT02411448|449734977|FG001|Overall Study|Alive on study treatment|64|||
125125277|NCT01315249|450084146|FG000|Overall Study|Lost to Follow-up|0|||
125125278|NCT01315249|450084147|FG001|Overall Study|Lost to Follow-up|2|||
125125279|NCT01315249|450084146|FG000|Overall Study|Death|0|||
125125280|NCT01315249|450084147|FG001|Overall Study|Death|1|||
125125281|NCT03227445|450084152|FG000|Period 1 (28 Days)|Adverse Event|1|||
125125282|NCT03227445|450084153|FG001|Period 1 (28 Days)|Adverse Event|2|||
125125283|NCT03227445|450084154|FG002|Period 1 (28 Days)|Adverse Event|0|||
125125284|NCT03227445|450084155|FG003|Period 1 (28 Days)|Adverse Event|1|||
125125285|NCT03227445|450084152|FG000|Period 1 (28 Days)|Protocol Violation|1|||
125125286|NCT03227445|450084153|FG001|Period 1 (28 Days)|Protocol Violation|0|||
125125287|NCT03227445|450084154|FG002|Period 1 (28 Days)|Protocol Violation|0|||
125125288|NCT03227445|450084155|FG003|Period 1 (28 Days)|Protocol Violation|0|||
125125289|NCT03227445|450084152|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
125125290|NCT03227445|450084153|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
125125291|NCT03227445|450084154|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
125125292|NCT03227445|450084155|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
125125293|NCT03227445|450084152|FG000|Period 2 (28 Days)|Adverse Event|1|||
125125294|NCT03227445|450084153|FG001|Period 2 (28 Days)|Adverse Event|0|||
125125295|NCT03227445|450084154|FG002|Period 2 (28 Days)|Adverse Event|2|||
125125296|NCT03227445|450084155|FG003|Period 2 (28 Days)|Adverse Event|1|||
125125297|NCT03227445|450084152|FG000|Period 2 (28 Days)|Protocol Violation|0|||
125125298|NCT03227445|450084153|FG001|Period 2 (28 Days)|Protocol Violation|0|||
125125299|NCT03227445|450084154|FG002|Period 2 (28 Days)|Protocol Violation|0|||
125125300|NCT03227445|450084155|FG003|Period 2 (28 Days)|Protocol Violation|1|||
125125301|NCT03227445|450084152|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
125125302|NCT03227445|450084153|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
125125303|NCT03227445|450084154|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
125125304|NCT03227445|450084155|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
125125305|NCT00755196|450084157|FG000|Overall Study|Lost to Follow-up|1|||
125125306|NCT00755196|450084157|FG000|Overall Study|Lack of Efficiency|1|||
125125307|NCT01703832|450084158|FG000|Overall Study|Withdrawal by Subject|1|||
125125308|NCT01703832|450084159|FG001|Overall Study|Withdrawal by Subject|0|||
125125309|NCT01991470|450084160|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
125125310|NCT01991470|450084160|FG000|Enlite 1 Period|Adverse Event|1|||
125125311|NCT01991470|450084160|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
125125312|NCT01991470|450084160|FG000|Enlite 3 Period|Lost to Follow-up|1|||
125125313|NCT01991470|450084160|FG000|Enlite 3 Period|Physician Decision|2|||
125125314|NCT01991470|450084160|FG000|Enlite 3 Period|Physician Decision|8|||
125125315|NCT01991470|450084160|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
125125316|NCT00623779|450084178|FG000|Overall Study|Adverse Event|1|||
125125317|NCT00623779|450084179|FG001|Overall Study|Adverse Event|3|||
125125318|NCT00623779|450084180|FG002|Overall Study|Adverse Event|0|||
125125319|NCT00623779|450084178|FG000|Overall Study|Criteria from CSR|2|||
125125320|NCT00623779|450084179|FG001|Overall Study|Criteria from CSR|0|||
125125321|NCT00623779|450084180|FG002|Overall Study|Criteria from CSR|1|||
125125322|NCT01434693|450084183|FG000|Overall Study|Adverse Event|1|||
125125323|NCT01434693|450084184|FG001|Overall Study|Adverse Event|0|||
125125324|NCT01434693|450084185|FG002|Overall Study|Adverse Event|0|||
125125325|NCT01434693|450084186|FG003|Overall Study|Adverse Event|0|||
125125326|NCT01434693|450084183|FG000|Overall Study|Withdrawal by Subject|1|||
125125327|NCT01434693|450084184|FG001|Overall Study|Withdrawal by Subject|0|||
125125328|NCT01434693|450084185|FG002|Overall Study|Withdrawal by Subject|1|||
125125329|NCT01434693|450084186|FG003|Overall Study|Withdrawal by Subject|1|||
125125330|NCT01434693|450084183|FG000|Overall Study|Lost to Follow-up|1|||
125125331|NCT01434693|450084184|FG001|Overall Study|Lost to Follow-up|0|||
125125332|NCT01434693|450084185|FG002|Overall Study|Lost to Follow-up|0|||
125125333|NCT01434693|450084186|FG003|Overall Study|Lost to Follow-up|0|||
125125334|NCT00440557|450084188|FG000|Overall Study|Withdrawal by Subject|10|||
125125335|NCT00440557|450084189|FG001|Overall Study|Withdrawal by Subject|5|||
125125336|NCT00440557|450084190|FG002|Overall Study|Withdrawal by Subject|11|||
124953418|NCT02561195|449453237|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
124953419|NCT02561195|449453238|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
124953420|NCT02561195|449453239|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
125125337|NCT00440557|450084188|FG000|Overall Study|Lost to Follow-up|1|||
125125338|NCT00440557|450084189|FG001|Overall Study|Lost to Follow-up|2|||
125125339|NCT00440557|450084190|FG002|Overall Study|Lost to Follow-up|6|||
125125340|NCT00440557|450084188|FG000|Overall Study|Adverse Event|3|||
125125341|NCT00440557|450084189|FG001|Overall Study|Adverse Event|3|||
125125342|NCT00440557|450084190|FG002|Overall Study|Adverse Event|5|||
125125343|NCT00440557|450084188|FG000|Overall Study|Death|2|||
125125344|NCT00440557|450084189|FG001|Overall Study|Death|6|||
125125345|NCT00440557|450084190|FG002|Overall Study|Death|3|||
125125346|NCT00440557|450084188|FG000|Overall Study|Began Dialysis|4|||
125125347|NCT00440557|450084189|FG001|Overall Study|Began Dialysis|1|||
125125348|NCT00440557|450084190|FG002|Overall Study|Began Dialysis|4|||
125125349|NCT00440557|450084188|FG000|Overall Study|Principal Investigator decision|0|||
125125350|NCT00440557|450084189|FG001|Overall Study|Principal Investigator decision|3|||
125215277|NCT01398358|450414974|FG001|Overall Study|no longer eligible|0|||
125125351|NCT00440557|450084190|FG002|Overall Study|Principal Investigator decision|1|||
125125352|NCT00440557|450084188|FG000|Overall Study|Patient moved|1|||
125125353|NCT00440557|450084189|FG001|Overall Study|Patient moved|2|||
125125354|NCT00440557|450084190|FG002|Overall Study|Patient moved|1|||
125125355|NCT00440557|450084188|FG000|Overall Study|Principal Investigator's office closed|3|||
125125356|NCT00440557|450084189|FG001|Overall Study|Principal Investigator's office closed|6|||
125125357|NCT00440557|450084190|FG002|Overall Study|Principal Investigator's office closed|4|||
125125358|NCT00440557|450084188|FG000|Overall Study|Patient transferred to nursing home|0|||
125125359|NCT00440557|450084189|FG001|Overall Study|Patient transferred to nursing home|1|||
125125360|NCT00440557|450084190|FG002|Overall Study|Patient transferred to nursing home|0|||
125125361|NCT00440557|450084188|FG000|Overall Study|Patient had surgery|1|||
125125362|NCT00440557|450084189|FG001|Overall Study|Patient had surgery|0|||
125125363|NCT00440557|450084190|FG002|Overall Study|Patient had surgery|0|||
125125364|NCT01378975|450084193|FG000|Overall Study|Death|77|||
125125365|NCT01378975|450084194|FG001|Overall Study|Death|46|||
125125366|NCT01378975|450084193|FG000|Overall Study|Investigator Request|1|||
125125367|NCT01378975|450084194|FG001|Overall Study|Investigator Request|0|||
125125368|NCT01378975|450084193|FG000|Overall Study|Lost to Follow-up|4|||
125125369|NCT01378975|450084194|FG001|Overall Study|Lost to Follow-up|1|||
125125370|NCT01378975|450084193|FG000|Overall Study|Withdrew Consent|4|||
125125371|NCT01378975|450084194|FG001|Overall Study|Withdrew Consent|3|||
125125372|NCT02343120|450084198|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
125125373|NCT02343120|450084199|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
125125374|NCT02343120|450084200|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
125125375|NCT02343120|450084201|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
125125376|NCT02343120|450084202|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
125125377|NCT02343120|450084198|FG000|Part 1: Dose Escalation|Death|1|||
125125378|NCT02343120|450084199|FG001|Part 1: Dose Escalation|Death|2|||
125125379|NCT02343120|450084200|FG002|Part 1: Dose Escalation|Death|2|||
125125380|NCT02343120|450084201|FG003|Part 1: Dose Escalation|Death|2|||
125125381|NCT02343120|450084202|FG004|Part 1: Dose Escalation|Death|1|||
125125382|NCT02343120|450084198|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
125125383|NCT02343120|450084199|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
125125384|NCT02343120|450084200|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
125125385|NCT02343120|450084201|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
125125386|NCT02343120|450084202|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
125125387|NCT02343120|450084198|FG000|Part 2: Expansion|Sponsor decision|0|||
125125388|NCT02343120|450084199|FG001|Part 2: Expansion|Sponsor decision|0|||
125125389|NCT02343120|450084200|FG002|Part 2: Expansion|Sponsor decision|0|||
125125390|NCT02343120|450084201|FG003|Part 2: Expansion|Sponsor decision|165|||
125125391|NCT02343120|450084202|FG004|Part 2: Expansion|Sponsor decision|67|||
125125392|NCT02343120|450084198|FG000|Part 2: Expansion|Death|0|||
125125393|NCT02343120|450084199|FG001|Part 2: Expansion|Death|0|||
125125394|NCT02343120|450084200|FG002|Part 2: Expansion|Death|0|||
125125395|NCT02343120|450084201|FG003|Part 2: Expansion|Death|74|||
125125396|NCT02343120|450084202|FG004|Part 2: Expansion|Death|17|||
125125397|NCT02343120|450084198|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
125125398|NCT02343120|450084199|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
125125399|NCT02343120|450084200|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
125125400|NCT02343120|450084201|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
125125401|NCT02343120|450084202|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
125125402|NCT02343120|450084198|FG000|Part 2: Expansion|Lost to Follow-up|0|||
125125403|NCT02343120|450084199|FG001|Part 2: Expansion|Lost to Follow-up|0|||
125125404|NCT02343120|450084200|FG002|Part 2: Expansion|Lost to Follow-up|0|||
125125405|NCT02343120|450084201|FG003|Part 2: Expansion|Lost to Follow-up|5|||
125125406|NCT02343120|450084202|FG004|Part 2: Expansion|Lost to Follow-up|2|||
125125407|NCT02343120|450084198|FG000|Part 2: Expansion|Other|0|||
125125408|NCT02343120|450084199|FG001|Part 2: Expansion|Other|0|||
125125409|NCT02343120|450084200|FG002|Part 2: Expansion|Other|0|||
125125410|NCT02343120|450084201|FG003|Part 2: Expansion|Other|1|||
125125411|NCT02343120|450084202|FG004|Part 2: Expansion|Other|5|||
125125412|NCT02343120|450084198|FG000|Part 2: Expansion|Adverse Event|0|||
125125413|NCT02343120|450084199|FG001|Part 2: Expansion|Adverse Event|0|||
125125414|NCT02343120|450084200|FG002|Part 2: Expansion|Adverse Event|0|||
125125415|NCT02343120|450084201|FG003|Part 2: Expansion|Adverse Event|1|||
125125416|NCT02343120|450084202|FG004|Part 2: Expansion|Adverse Event|1|||
125125417|NCT03544138|450084205|FG000|Overall Study|Lost to Follow-up|29|||
125125418|NCT01766778|450084206|FG000|Overall Study|Adverse Event|4|||
125125419|NCT01766778|450084207|FG001|Overall Study|Adverse Event|4|||
125125420|NCT01766778|450084206|FG000|Overall Study|Withdrawal by Subject|1|||
125125421|NCT01766778|450084207|FG001|Overall Study|Withdrawal by Subject|0|||
125125422|NCT01104662|450084208|FG000|Overall Study|Adverse Event|2|||
125125423|NCT01104662|450084209|FG001|Overall Study|Adverse Event|2|||
125125424|NCT01104662|450084210|FG002|Overall Study|Adverse Event|0|||
124953421|NCT02561195|449453240|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
124953422|NCT02561195|449453241|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
124953423|NCT02561195|449453228|FG000|Extension Stage (Vaccination 4)|Other|0|||
124953424|NCT02561195|449453229|FG001|Extension Stage (Vaccination 4)|Other|0|||
124953425|NCT02561195|449453230|FG002|Extension Stage (Vaccination 4)|Other|0|||
124953426|NCT02561195|449453231|FG003|Extension Stage (Vaccination 4)|Other|0|||
124953427|NCT02561195|449453232|FG004|Extension Stage (Vaccination 4)|Other|0|||
124953428|NCT02561195|449453233|FG005|Extension Stage (Vaccination 4)|Other|0|||
124953429|NCT02561195|449453234|FG006|Extension Stage (Vaccination 4)|Other|0|||
124953430|NCT02561195|449453235|FG007|Extension Stage (Vaccination 4)|Other|0|||
124953431|NCT02561195|449453236|FG008|Extension Stage (Vaccination 4)|Other|0|||
124953432|NCT02561195|449453237|FG009|Extension Stage (Vaccination 4)|Other|0|||
124953433|NCT02561195|449453238|FG010|Extension Stage (Vaccination 4)|Other|2|||
124953434|NCT02561195|449453239|FG011|Extension Stage (Vaccination 4)|Other|2|||
124953435|NCT02561195|449453240|FG012|Extension Stage (Vaccination 4)|Other|1|||
124953436|NCT02561195|449453241|FG013|Extension Stage (Vaccination 4)|Other|0|||
124953437|NCT02561195|449453228|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
124953438|NCT02561195|449453229|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
124953439|NCT02561195|449453230|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
124953440|NCT02561195|449453231|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
124953441|NCT02561195|449453232|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
124953442|NCT02561195|449453233|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
124953443|NCT02561195|449453234|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
124953444|NCT02561195|449453235|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
124953445|NCT02561195|449453236|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
124953446|NCT02561195|449453237|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
124953447|NCT02561195|449453238|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
124953448|NCT02561195|449453239|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
124953449|NCT02561195|449453240|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
124953450|NCT02561195|449453241|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
124953451|NCT03905512|449453242|FG000|Overall Study|Withdrawal by Subject|9|||
124953452|NCT03905512|449453243|FG001|Overall Study|Withdrawal by Subject|8|||
124953453|NCT03905512|449453242|FG000|Overall Study|Adverse Event|1|||
124953454|NCT03905512|449453243|FG001|Overall Study|Adverse Event|2|||
124953455|NCT03905512|449453242|FG000|Overall Study|Lost to Follow-up|4|||
124953456|NCT03905512|449453243|FG001|Overall Study|Lost to Follow-up|3|||
124953457|NCT03905512|449453242|FG000|Overall Study|Other than Specified|7|||
124953458|NCT03905512|449453243|FG001|Overall Study|Other than Specified|4|||
124953459|NCT03560206|449453246|FG000|Overall Study|Lost to Follow-up|19|||
124953460|NCT03560206|449453247|FG001|Overall Study|Lost to Follow-up|11|||
124953461|NCT03560206|449453246|FG000|Overall Study|Withdrawal by Subject|2|||
124953462|NCT03560206|449453247|FG001|Overall Study|Withdrawal by Subject|4|||
124953463|NCT03560206|449453246|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
124953464|NCT03560206|449453247|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
124953465|NCT03560206|449453246|FG000|Overall Study|Busy schedule|14|||
124953466|NCT03560206|449453247|FG001|Overall Study|Busy schedule|2|||
124953467|NCT03560206|449453246|FG000|Overall Study|patients' new health condition such as cancer|10|||
124953468|NCT03560206|449453247|FG001|Overall Study|patients' new health condition such as cancer|1|||
124953469|NCT03138499|449453252|FG000|Overall Study|Lost to Follow-up|1|||
124953470|NCT03138499|449453253|FG001|Overall Study|Lost to Follow-up|0|||
124953471|NCT03138499|449453252|FG000|Overall Study|Participants withdrew consent|1|||
124953472|NCT03138499|449453253|FG001|Overall Study|Participants withdrew consent|0|||
125125425|NCT01104662|450084211|FG003|Overall Study|Adverse Event|1|||
124953473|NCT03138499|449453252|FG000|Overall Study|Participant discontinued study before treatment|0|||
125125426|NCT01104662|450084212|FG004|Overall Study|Adverse Event|1|||
125125427|NCT01104662|450084213|FG005|Overall Study|Adverse Event|1|||
125125428|NCT01104662|450084214|FG006|Overall Study|Adverse Event|0|||
124953474|NCT03138499|449453253|FG001|Overall Study|Participant discontinued study before treatment|1|||
124953475|NCT03138499|449453252|FG000|Overall Study|Disease Progression|2|||
124953476|NCT03138499|449453253|FG001|Overall Study|Disease Progression|6|||
124953477|NCT03138499|449453252|FG000|Overall Study|Study drug toxicity|2|||
124953478|NCT03138499|449453253|FG001|Overall Study|Study drug toxicity|2|||
124953479|NCT03138499|449453252|FG000|Overall Study|Participant request to discontinue study treatment|1|||
124953480|NCT03138499|449453253|FG001|Overall Study|Participant request to discontinue study treatment|1|||
124953481|NCT03138499|449453252|FG000|Overall Study|Other reasons|2|||
124953482|NCT03138499|449453253|FG001|Overall Study|Other reasons|0|||
124953483|NCT01334606|449453254|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
124953484|NCT02674399|449453255|FG000|Overall Study|Lost to Follow-up|2|||
124953485|NCT02674399|449453256|FG001|Overall Study|Lost to Follow-up|0|||
124953486|NCT01661972|449453257|FG000|Overall Study|Adverse Event|1|||
124953487|NCT01661972|449453258|FG001|Overall Study|Adverse Event|2|||
124953488|NCT01661972|449453257|FG000|Overall Study|Death during Treatment period|1|||
124953489|NCT01661972|449453258|FG001|Overall Study|Death during Treatment period|1|||
124953490|NCT01661972|449453257|FG000|Overall Study|Withdrawal by Subject|0|||
124953491|NCT01661972|449453258|FG001|Overall Study|Withdrawal by Subject|1|||
124953492|NCT01634165|449453270|FG000|Period 2|Adverse Event|0|||
124953493|NCT01634165|449453271|FG001|Period 2|Adverse Event|1|||
124953494|NCT01634165|449453272|FG002|Period 2|Adverse Event|0|||
124953495|NCT01634165|449453273|FG003|Period 2|Adverse Event|0|||
124953496|NCT05379400|449454682|FG000|Overall Study|Lost to Follow-up|1|||
124953497|NCT05379400|449454683|FG001|Overall Study|Lost to Follow-up|1|||
124953498|NCT03978130|449454685|FG000|Overall Study|Lost to Follow-up|13|||
124953499|NCT03978130|449454686|FG001|Overall Study|Lost to Follow-up|14|||
124953500|NCT03978130|449454685|FG000|Overall Study|Withdrawal by Subject|12|||
124953501|NCT03978130|449454686|FG001|Overall Study|Withdrawal by Subject|2|||
124953502|NCT03978130|449454685|FG000|Overall Study|Adverse Event|2|||
124953503|NCT03978130|449454686|FG001|Overall Study|Adverse Event|1|||
125125429|NCT01104662|450084215|FG007|Overall Study|Adverse Event|0|||
125125430|NCT01104662|450084208|FG000|Overall Study|Clinical Failure|1|||
124953504|NCT00515112|449454687|FG000|Overall Study|Death|0|||
124953505|NCT00515112|449454688|FG001|Overall Study|Death|1|||
124953506|NCT00515112|449454687|FG000|Overall Study|The study was terminated|3|||
124953507|NCT00515112|449454688|FG001|Overall Study|The study was terminated|2|||
124953508|NCT00304278|449454692|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
124953509|NCT00304278|449454692|FG000|Overall Study|PT had medical condition preventing TX|1|||
124953510|NCT00409006|449454693|FG000|Overall Study|Death|15|||
124953511|NCT00409006|449454694|FG001|Overall Study|Death|6|||
124953512|NCT00409006|449454693|FG000|Overall Study|Lost to Follow-up|1|||
124953513|NCT00409006|449454694|FG001|Overall Study|Lost to Follow-up|2|||
124953514|NCT00409006|449454693|FG000|Overall Study|Withdrawal by Subject|3|||
124953515|NCT00409006|449454694|FG001|Overall Study|Withdrawal by Subject|2|||
124953516|NCT00409006|449454693|FG000|Overall Study|Physician Decision|1|||
124953517|NCT00409006|449454694|FG001|Overall Study|Physician Decision|2|||
124953518|NCT00228813|449454695|FG000|Overall Study|Death|4|||
125125431|NCT01104662|450084209|FG001|Overall Study|Clinical Failure|0|||
125125432|NCT01104662|450084210|FG002|Overall Study|Clinical Failure|0|||
125125433|NCT01104662|450084211|FG003|Overall Study|Clinical Failure|0|||
125125434|NCT01104662|450084212|FG004|Overall Study|Clinical Failure|0|||
125125435|NCT01104662|450084213|FG005|Overall Study|Clinical Failure|1|||
125125436|NCT01104662|450084214|FG006|Overall Study|Clinical Failure|0|||
125125437|NCT01104662|450084215|FG007|Overall Study|Clinical Failure|0|||
125125438|NCT01104662|450084208|FG000|Overall Study|Participant left investigator's care|1|||
125125439|NCT01104662|450084209|FG001|Overall Study|Participant left investigator's care|1|||
125125440|NCT01104662|450084210|FG002|Overall Study|Participant left investigator's care|0|||
125125441|NCT01104662|450084211|FG003|Overall Study|Participant left investigator's care|0|||
125125442|NCT01104662|450084212|FG004|Overall Study|Participant left investigator's care|0|||
125125443|NCT01104662|450084213|FG005|Overall Study|Participant left investigator's care|0|||
125125444|NCT01104662|450084214|FG006|Overall Study|Participant left investigator's care|0|||
125125445|NCT01104662|450084215|FG007|Overall Study|Participant left investigator's care|0|||
124953519|NCT00507429|449454696|FG000|Treatment Phase|Disease Progression|12|||
124953520|NCT00507429|449454697|FG001|Treatment Phase|Disease Progression|5|||
124953521|NCT00507429|449454696|FG000|Treatment Phase|Adverse Event|12|||
124953522|NCT00507429|449454697|FG001|Treatment Phase|Adverse Event|5|||
125215278|NCT01398358|450414975|FG002|Overall Study|no longer eligible|1|||
124953523|NCT00507429|449454696|FG000|Treatment Phase|Withdrawal by Subject|3|||
124953524|NCT00507429|449454697|FG001|Treatment Phase|Withdrawal by Subject|3|||
124953525|NCT00507429|449454696|FG000|Treatment Phase|Physician Decision|4|||
124953526|NCT00507429|449454697|FG001|Treatment Phase|Physician Decision|2|||
124953527|NCT00507429|449454696|FG000|Treatment Phase|Other|6|||
124953528|NCT00507429|449454697|FG001|Treatment Phase|Other|3|||
124953529|NCT00507429|449454696|FG000|Maintenance Phase|Progressive Disease|14|||
124953530|NCT00507429|449454697|FG001|Maintenance Phase|Progressive Disease|0|||
124953531|NCT04025762|449454699|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
125125446|NCT01104662|450084208|FG000|Overall Study|Reason not specified|3|||
124953532|NCT04025762|449454700|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
124953533|NCT00608959|449454703|FG000|Part 1|Did not meet eligibility criteria|1|||
124953534|NCT01005602|449454706|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
124953535|NCT01005602|449454707|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
124953536|NCT01248715|449454708|FG000|Overall Study|Not influenza positive|501|||
124953537|NCT01248715|449454709|FG001|Overall Study|Not influenza positive|510|||
124953538|NCT03409276|449454715|FG000|Overall Study|Withdrawal by Subject|0|||
124953539|NCT03409276|449454716|FG001|Overall Study|Withdrawal by Subject|0|||
124953540|NCT03409276|449454717|FG002|Overall Study|Withdrawal by Subject|0|||
124953541|NCT03409276|449454718|FG003|Overall Study|Withdrawal by Subject|0|||
124953542|NCT03409276|449454719|FG004|Overall Study|Withdrawal by Subject|1|||
124953543|NCT03409276|449454715|FG000|Overall Study|Lost to Follow-up|0|||
124953544|NCT03409276|449454716|FG001|Overall Study|Lost to Follow-up|0|||
124953545|NCT03409276|449454717|FG002|Overall Study|Lost to Follow-up|0|||
124953546|NCT03409276|449454718|FG003|Overall Study|Lost to Follow-up|2|||
124953547|NCT03409276|449454719|FG004|Overall Study|Lost to Follow-up|2|||
124953548|NCT03605745|449454720|FG000|Overall Study|Study was terminated for business reasons|47|||
124953549|NCT01279447|449454721|FG000|Overall Study|Lost to Follow-up|3|||
124953550|NCT01279447|449454722|FG001|Overall Study|Lost to Follow-up|1|||
124953551|NCT01215253|449454723|FG000|Overall Study|Withdrawal by Subject|57|||
124953552|NCT01215253|449454724|FG001|Overall Study|Withdrawal by Subject|35|||
124953553|NCT01215253|449454723|FG000|Overall Study|Physician Decision|9|||
124953554|NCT01215253|449454724|FG001|Overall Study|Physician Decision|12|||
124953555|NCT01215253|449454723|FG000|Overall Study|Lost to Follow-up|6|||
124953556|NCT01215253|449454724|FG001|Overall Study|Lost to Follow-up|4|||
124953557|NCT01215253|449454723|FG000|Overall Study|Other|14|||
124953558|NCT01215253|449454724|FG001|Overall Study|Other|12|||
124953559|NCT01131325|449454731|FG000|Overall Study|Adverse Event|1|||
124953560|NCT01131325|449454731|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
124953561|NCT03884478|449454732|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
124953562|NCT03884478|449454733|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
124953563|NCT03884478|449454734|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
124953564|NCT03884478|449454732|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
124953565|NCT03884478|449454733|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
124953566|NCT03884478|449454734|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
124953567|NCT03884478|449454732|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
124953568|NCT03884478|449454733|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
124953569|NCT03884478|449454734|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
124953570|NCT03884478|449454732|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
124953571|NCT03884478|449454733|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
124953572|NCT03884478|449454734|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
124953573|NCT02213094|449454737|FG000|Overall Study|Adverse Event|1|||
124953574|NCT02213094|449454738|FG001|Overall Study|Adverse Event|0|||
124953575|NCT01807234|449454739|FG000|Overall Study|Lost to Follow-up|2|||
124953576|NCT01807234|449454740|FG001|Overall Study|Lost to Follow-up|5|||
124953577|NCT01807234|449454741|FG002|Overall Study|Lost to Follow-up|1|||
124953578|NCT01807234|449454742|FG003|Overall Study|Lost to Follow-up|1|||
124953579|NCT01807234|449454743|FG004|Overall Study|Lost to Follow-up|1|||
124953580|NCT01807234|449454744|FG005|Overall Study|Lost to Follow-up|2|||
124953581|NCT01807234|449454739|FG000|Overall Study|Withdrawal by Subject|3|||
124953582|NCT01807234|449454740|FG001|Overall Study|Withdrawal by Subject|1|||
124953583|NCT01807234|449454741|FG002|Overall Study|Withdrawal by Subject|1|||
124953584|NCT01807234|449454742|FG003|Overall Study|Withdrawal by Subject|1|||
124953585|NCT01807234|449454743|FG004|Overall Study|Withdrawal by Subject|2|||
124953586|NCT01807234|449454744|FG005|Overall Study|Withdrawal by Subject|1|||
124953587|NCT01807234|449454739|FG000|Overall Study|Lack of Efficacy|0|||
124953588|NCT01807234|449454740|FG001|Overall Study|Lack of Efficacy|0|||
124953589|NCT01807234|449454741|FG002|Overall Study|Lack of Efficacy|0|||
124953590|NCT01807234|449454742|FG003|Overall Study|Lack of Efficacy|0|||
124953591|NCT01807234|449454743|FG004|Overall Study|Lack of Efficacy|1|||
124953592|NCT01807234|449454744|FG005|Overall Study|Lack of Efficacy|1|||
124953593|NCT00538629|449454745|FG000|Overall Study|At subject's request|1|||
124953594|NCT00538629|449454745|FG000|Overall Study|Adverse Event|2|||
124953595|NCT00538629|449454745|FG000|Overall Study|Lack of Efficacy|12|||
124953596|NCT00538629|449454745|FG000|Overall Study|Lost to Follow-up|6|||
124953597|NCT00538629|449454745|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
124953598|NCT00555620|449454747|FG000|Overall Study|Death|0|||
124953599|NCT00555620|449454748|FG001|Overall Study|Death|1|||
124953600|NCT00555620|449454749|FG002|Overall Study|Death|0|||
124953601|NCT00555620|449454750|FG003|Overall Study|Death|0|||
124953602|NCT00555620|449454751|FG004|Overall Study|Death|0|||
124953603|NCT00555620|449454752|FG005|Overall Study|Death|1|||
124953604|NCT00555620|449454747|FG000|Overall Study|Study terminated by sponsor|0|||
124953605|NCT00555620|449454748|FG001|Overall Study|Study terminated by sponsor|0|||
124953606|NCT00555620|449454749|FG002|Overall Study|Study terminated by sponsor|1|||
124953607|NCT00555620|449454750|FG003|Overall Study|Study terminated by sponsor|0|||
124953608|NCT00555620|449454751|FG004|Overall Study|Study terminated by sponsor|0|||
124953609|NCT00555620|449454752|FG005|Overall Study|Study terminated by sponsor|0|||
124953610|NCT00555620|449454747|FG000|Overall Study|Adverse Event|0|||
124953611|NCT00555620|449454748|FG001|Overall Study|Adverse Event|0|||
124953612|NCT00555620|449454749|FG002|Overall Study|Adverse Event|1|||
124953613|NCT00555620|449454750|FG003|Overall Study|Adverse Event|5|||
124953614|NCT00555620|449454751|FG004|Overall Study|Adverse Event|0|||
124953615|NCT00555620|449454752|FG005|Overall Study|Adverse Event|1|||
124953616|NCT00555620|449454747|FG000|Overall Study|Objective progression or relapse|6|||
124953617|NCT00555620|449454748|FG001|Overall Study|Objective progression or relapse|5|||
124953618|NCT00555620|449454749|FG002|Overall Study|Objective progression or relapse|12|||
124953619|NCT00555620|449454750|FG003|Overall Study|Objective progression or relapse|17|||
124953620|NCT00555620|449454751|FG004|Overall Study|Objective progression or relapse|3|||
124953621|NCT00555620|449454752|FG005|Overall Study|Objective progression or relapse|16|||
124953622|NCT00555620|449454747|FG000|Overall Study|Participant refused treatment|0|||
124953623|NCT00555620|449454748|FG001|Overall Study|Participant refused treatment|1|||
124953624|NCT00555620|449454749|FG002|Overall Study|Participant refused treatment|1|||
124953625|NCT00555620|449454750|FG003|Overall Study|Participant refused treatment|0|||
124953626|NCT00555620|449454751|FG004|Overall Study|Participant refused treatment|0|||
124953627|NCT00555620|449454752|FG005|Overall Study|Participant refused treatment|1|||
124953628|NCT00555620|449454747|FG000|Overall Study|Other|0|||
124953629|NCT00555620|449454748|FG001|Overall Study|Other|0|||
124953630|NCT00555620|449454749|FG002|Overall Study|Other|0|||
124953631|NCT00555620|449454750|FG003|Overall Study|Other|1|||
124953632|NCT00555620|449454751|FG004|Overall Study|Other|0|||
124953633|NCT00555620|449454752|FG005|Overall Study|Other|3|||
124953634|NCT05203822|449454753|FG000|Overall Study|Adverse Event|1|||
124953635|NCT05203822|449454753|FG000|Overall Study|Withdrawal by Subject|1|||
124953636|NCT01345253|449454755|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
124953637|NCT01345253|449454756|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
124953638|NCT01345253|449454755|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
124953639|NCT01345253|449454756|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
124953640|NCT01345253|449454755|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
124953641|NCT01345253|449454756|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
124953642|NCT01345253|449454755|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
124953643|NCT01345253|449454756|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
124953644|NCT01345253|449454755|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
124953645|NCT01345253|449454756|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
124953646|NCT01345253|449454755|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
124953647|NCT01345253|449454756|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
124953648|NCT01345253|449454755|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
124953649|NCT01345253|449454756|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
124953650|NCT01345253|449454755|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
125030538|NCT02411448|449734978|FG002|Overall Study|Alive on study treatment|43|||
125215279|NCT03148067|450414976|FG000|Overall Study|Lost to Follow-up|3|||
124953651|NCT01345253|449454756|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
124953652|NCT01345253|449454755|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
124953653|NCT01345253|449454756|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
124953654|NCT01345253|449454755|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
124953655|NCT01345253|449454756|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
125215280|NCT03148067|450414976|FG000|Overall Study|Death|1|||
124953656|NCT01345253|449454755|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
124953657|NCT01345253|449454756|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
124953658|NCT01345253|449454755|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
124953659|NCT01345253|449454756|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
124953660|NCT01345253|449454755|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
124953661|NCT01345253|449454756|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
124953662|NCT01345253|449454755|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
124953663|NCT01345253|449454756|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
124953664|NCT01345253|449454755|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
124953665|NCT01345253|449454756|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
124953666|NCT00648895|449454759|FG000|Overall Study|Lack of Efficacy|0|||
124953667|NCT00648895|449454760|FG001|Overall Study|Lack of Efficacy|1|||
124953668|NCT02865083|449454761|FG000|Overall Study|Early Termination|3|||
124953669|NCT02865083|449454762|FG001|Overall Study|Early Termination|1|||
124953670|NCT00841321|449454763|FG000|Overall Study|Lost to Follow-up|1|||
124953671|NCT00841321|449454764|FG001|Overall Study|Lost to Follow-up|1|||
124953672|NCT00841321|449454763|FG000|Overall Study|Adverse Event|0|||
124953673|NCT00841321|449454764|FG001|Overall Study|Adverse Event|2|||
124953674|NCT02379078|449454765|FG000|Overall Study|Lost to Follow-up|33|||
124953675|NCT02379078|449454766|FG001|Overall Study|Lost to Follow-up|30|||
124953676|NCT02379078|449454765|FG000|Overall Study|Withdrawal by Subject|6|||
124953677|NCT02379078|449454766|FG001|Overall Study|Withdrawal by Subject|5|||
124953678|NCT04908488|449454767|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
124953679|NCT04908488|449454768|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
124953680|NCT04908488|449454767|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
124953681|NCT04908488|449454768|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
124953682|NCT01894620|449454772|FG000|Overall Study|Withdrawal by Subject|0|||
124953683|NCT01894620|449454773|FG001|Overall Study|Withdrawal by Subject|1|||
124953684|NCT00657709|449454774|FG000|Overall Study|AE or Death|7|||
124953685|NCT00657709|449454775|FG001|Overall Study|AE or Death|7|||
124953686|NCT00657709|449454776|FG002|Overall Study|AE or Death|6|||
124953687|NCT00657709|449454777|FG003|Overall Study|AE or Death|7|||
124953688|NCT00657709|449454778|FG004|Overall Study|AE or Death|1|||
124953689|NCT00657709|449454774|FG000|Overall Study|Withdrawal by Subject|7|||
124953690|NCT00657709|449454775|FG001|Overall Study|Withdrawal by Subject|15|||
124953691|NCT00657709|449454776|FG002|Overall Study|Withdrawal by Subject|15|||
124953692|NCT00657709|449454777|FG003|Overall Study|Withdrawal by Subject|5|||
124953693|NCT00657709|449454778|FG004|Overall Study|Withdrawal by Subject|9|||
124953694|NCT00657709|449454774|FG000|Overall Study|Lost to Follow-up|9|||
124953695|NCT00657709|449454775|FG001|Overall Study|Lost to Follow-up|9|||
124953696|NCT00657709|449454776|FG002|Overall Study|Lost to Follow-up|7|||
124953697|NCT00657709|449454777|FG003|Overall Study|Lost to Follow-up|1|||
124953698|NCT00657709|449454778|FG004|Overall Study|Lost to Follow-up|21|||
124953699|NCT00657709|449454774|FG000|Overall Study|Protocol Violation|0|||
124953700|NCT00657709|449454775|FG001|Overall Study|Protocol Violation|2|||
124953701|NCT00657709|449454776|FG002|Overall Study|Protocol Violation|0|||
124953702|NCT00657709|449454777|FG003|Overall Study|Protocol Violation|1|||
124953703|NCT00657709|449454778|FG004|Overall Study|Protocol Violation|2|||
124953704|NCT00901459|449454779|FG000|Overall Study|Withdrawal by Subject|6|||
124953705|NCT04765046|449454780|FG000|Overall Study|Screen Failure|2|||
124953706|NCT04765046|449454780|FG000|Overall Study|Withdrawal by Subject|4|||
124953707|NCT04765046|449454780|FG000|Overall Study|Physician Decision|4|||
124953708|NCT04765046|449454780|FG000|Overall Study|Surgery Cancelled|8|||
124953709|NCT04930263|449454785|FG000|Overall Study|Withdrawal by Subject|3|||
124953710|NCT04930263|449454786|FG001|Overall Study|Withdrawal by Subject|5|||
124953711|NCT00850993|449454789|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
124953712|NCT00850993|449454790|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
124953713|NCT00850993|449454791|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
124953714|NCT00850993|449454792|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
124953715|NCT03839355|449454793|FG000|Overall Study|Withdrawal by Subject|1|||
124953716|NCT03839355|449454794|FG001|Overall Study|Withdrawal by Subject|0|||
124953717|NCT03547167|449454800|FG000|Overall Study|Withdrawal by Subject|34|||
124953718|NCT03547167|449454801|FG001|Overall Study|Withdrawal by Subject|12|||
124953719|NCT03547167|449454800|FG000|Overall Study|Screen Failure|0|||
124953720|NCT03547167|449454801|FG001|Overall Study|Screen Failure|1|||
124953721|NCT03547167|449454800|FG000|Overall Study|Lost to Follow-up|59|||
124953722|NCT03547167|449454801|FG001|Overall Study|Lost to Follow-up|15|||
124953723|NCT03547167|449454800|FG000|Overall Study|Death|4|||
124953724|NCT03547167|449454801|FG001|Overall Study|Death|2|||
124953725|NCT02009865|449454805|FG000|Overall Study|Adverse Event|0|||
124953726|NCT02009865|449454806|FG001|Overall Study|Adverse Event|2|||
124953727|NCT02009865|449454805|FG000|Overall Study|Protocol Violation|0|||
124953728|NCT02009865|449454806|FG001|Overall Study|Protocol Violation|2|||
124953729|NCT02009865|449454805|FG000|Overall Study|Withdrawal by Subject|1|||
124953730|NCT02009865|449454806|FG001|Overall Study|Withdrawal by Subject|1|||
124953731|NCT01760876|449454807|FG000|Overall Study|Non-cardiac death (head injury)|1|||
124953732|NCT01760876|449454807|FG000|Overall Study|Carcinoma of prostate|1|||
124953733|NCT01760876|449454807|FG000|Overall Study|Impaired renal function|1|||
124953734|NCT01760876|449454807|FG000|Overall Study|Major depression|1|||
124953735|NCT01760876|449454807|FG000|Overall Study|Very poor baseline OCT quality|2|||
124953736|NCT01517282|449454810|FG000|Overall Study|Consent withdrawn|0|||
124953737|NCT01517282|449454811|FG001|Overall Study|Consent withdrawn|1|||
124953738|NCT01517282|449454812|FG002|Overall Study|Consent withdrawn|1|||
124953739|NCT01517282|449454813|FG003|Overall Study|Consent withdrawn|1|||
124953740|NCT01517282|449454810|FG000|Overall Study|Physician Decision|1|||
124953741|NCT01517282|449454811|FG001|Overall Study|Physician Decision|0|||
124953742|NCT01517282|449454812|FG002|Overall Study|Physician Decision|0|||
124953743|NCT01517282|449454813|FG003|Overall Study|Physician Decision|0|||
124953744|NCT00525915|449454814|FG000|Overall Study|Non-Compliance|0|||
124953745|NCT00525915|449454815|FG001|Overall Study|Non-Compliance|1|||
124953746|NCT00525915|449454814|FG000|Overall Study|Disease Progression|5|||
124953747|NCT00525915|449454815|FG001|Overall Study|Disease Progression|6|||
124953748|NCT00525915|449454814|FG000|Overall Study|Withdrawal by Subject|1|||
124953749|NCT00525915|449454815|FG001|Overall Study|Withdrawal by Subject|0|||
124953750|NCT00525915|449454814|FG000|Overall Study|Refused Surgery|1|||
124953751|NCT00525915|449454815|FG001|Overall Study|Refused Surgery|2|||
124953752|NCT00525915|449454814|FG000|Overall Study|Unrelated illness|1|||
124953753|NCT00525915|449454815|FG001|Overall Study|Unrelated illness|0|||
124953754|NCT00760877|449456105|FG000|Overall Study|Protocol Violation|1|||
124953755|NCT00760877|449456106|FG001|Overall Study|Protocol Violation|0|||
124953756|NCT00760877|449456105|FG000|Overall Study|Non-compliance with protocol treatment|2|||
124953757|NCT00760877|449456106|FG001|Overall Study|Non-compliance with protocol treatment|1|||
124953758|NCT00760877|449456105|FG000|Overall Study|Pregnancy|1|||
124953759|NCT00760877|449456106|FG001|Overall Study|Pregnancy|4|||
124953760|NCT00760877|449456105|FG000|Overall Study|Death|2|||
124953761|NCT00760877|449456106|FG001|Overall Study|Death|1|||
124953762|NCT00760877|449456105|FG000|Overall Study|Withdrawal by Subject|7|||
124953763|NCT00760877|449456106|FG001|Overall Study|Withdrawal by Subject|3|||
124953764|NCT00760877|449456105|FG000|Overall Study|Adverse Event|19|||
125125447|NCT01104662|450084209|FG001|Overall Study|Reason not specified|3|||
125125448|NCT01104662|450084210|FG002|Overall Study|Reason not specified|0|||
125125449|NCT01104662|450084211|FG003|Overall Study|Reason not specified|0|||
125125450|NCT01104662|450084212|FG004|Overall Study|Reason not specified|0|||
125125451|NCT01104662|450084213|FG005|Overall Study|Reason not specified|1|||
125125452|NCT01104662|450084214|FG006|Overall Study|Reason not specified|0|||
124953765|NCT00760877|449456106|FG001|Overall Study|Adverse Event|12|||
124953766|NCT00760877|449456105|FG000|Overall Study|Participant diagnosed with AML|0|||
124953767|NCT00760877|449456106|FG001|Overall Study|Participant diagnosed with AML|1|||
124953768|NCT00760877|449456105|FG000|Overall Study|Participant not eligible to cross-over|0|||
124953769|NCT00760877|449456106|FG001|Overall Study|Participant not eligible to cross-over|1|||
124953770|NCT00760877|449456105|FG000|Overall Study|Physician Decision|1|||
124953771|NCT00760877|449456106|FG001|Overall Study|Physician Decision|2|||
124953772|NCT00760877|449456105|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
124953773|NCT00760877|449456106|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
124953774|NCT00760877|449456105|FG000|Overall Study|Treatment failure|1|||
125125453|NCT01104662|450084215|FG007|Overall Study|Reason not specified|0|||
125125454|NCT01104662|450084208|FG000|Overall Study|Randomized but not treated|3|||
124953775|NCT00760877|449456106|FG001|Overall Study|Treatment failure|0|||
124953776|NCT00711555|449456109|FG000|Overall Study|Adverse Event|3|||
124953777|NCT00946998|449456110|FG000|Overall Study|Exited prior to first outcome assessment|5|||
124953778|NCT00946998|449456111|FG001|Overall Study|Exited prior to first outcome assessment|3|||
124953779|NCT03020914|449456112|FG000|Overall Study|Surgery Cancelled|1|||
124953780|NCT03020914|449456113|FG001|Overall Study|Surgery Cancelled|0|||
124953781|NCT00668746|449456117|FG000|Overall Study|Lost to Follow-up|2|||
124953782|NCT00668746|449456118|FG001|Overall Study|Lost to Follow-up|1|||
124953783|NCT02109172|449456119|FG000|Overall Study|Withdrawal by Subject|1|||
125215281|NCT02559570|450414978|FG000|Overall Study|Adverse Event|0|||
124953784|NCT02109172|449456120|FG001|Overall Study|Withdrawal by Subject|0|||
124953785|NCT02109172|449456121|FG002|Overall Study|Withdrawal by Subject|0|||
124953786|NCT02109172|449456122|FG003|Overall Study|Withdrawal by Subject|1|||
124953787|NCT02109172|449456123|FG004|Overall Study|Withdrawal by Subject|0|||
124953788|NCT02109172|449456124|FG005|Overall Study|Withdrawal by Subject|0|||
124953789|NCT02109172|449456119|FG000|Overall Study|Adverse Event|0|||
124953790|NCT02109172|449456120|FG001|Overall Study|Adverse Event|0|||
124953791|NCT02109172|449456121|FG002|Overall Study|Adverse Event|1|||
124953792|NCT02109172|449456122|FG003|Overall Study|Adverse Event|0|||
124953793|NCT02109172|449456123|FG004|Overall Study|Adverse Event|0|||
124953794|NCT02109172|449456124|FG005|Overall Study|Adverse Event|1|||
124953795|NCT02109172|449456119|FG000|Overall Study|Death|0|||
124953796|NCT02109172|449456120|FG001|Overall Study|Death|0|||
124953797|NCT02109172|449456121|FG002|Overall Study|Death|0|||
124953798|NCT02109172|449456122|FG003|Overall Study|Death|0|||
124953799|NCT02109172|449456123|FG004|Overall Study|Death|1|||
124953800|NCT02109172|449456124|FG005|Overall Study|Death|0|||
124953801|NCT02011568|449456125|FG000|Overall Study|Withdrawal by Subject|8|||
124953802|NCT02011568|449456126|FG001|Overall Study|Withdrawal by Subject|10|||
124953803|NCT02011568|449456125|FG000|Overall Study|Physician Decision|1|||
124953804|NCT02011568|449456126|FG001|Overall Study|Physician Decision|3|||
124953805|NCT01816165|449456128|FG000|Overall Study|Adverse Event|1|||
124953806|NCT01816165|449456129|FG001|Overall Study|Adverse Event|0|||
124953807|NCT01816165|449456130|FG002|Overall Study|Adverse Event|0|||
124953808|NCT01816165|449456131|FG003|Overall Study|Adverse Event|0|||
124953809|NCT01322347|449456137|FG000|Overall Study|Adverse Event|7|||
124953810|NCT01322347|449456138|FG001|Overall Study|Adverse Event|2|||
124953811|NCT01322347|449456137|FG000|Overall Study|Death|5|||
124953812|NCT01322347|449456138|FG001|Overall Study|Death|3|||
124953813|NCT01322347|449456137|FG000|Overall Study|Physician Decision|2|||
124953814|NCT01322347|449456138|FG001|Overall Study|Physician Decision|1|||
124953815|NCT01322347|449456137|FG000|Overall Study|Protocol Violation|5|||
124953816|NCT01322347|449456138|FG001|Overall Study|Protocol Violation|2|||
124953817|NCT01322347|449456137|FG000|Overall Study|Withdrawal by Subject|1|||
124953818|NCT01322347|449456138|FG001|Overall Study|Withdrawal by Subject|4|||
124953819|NCT01322347|449456137|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
124953820|NCT01322347|449456138|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
124953821|NCT01322347|449456137|FG000|Overall Study|blood transfusion|5|||
124953822|NCT01322347|449456138|FG001|Overall Study|blood transfusion|5|||
124953823|NCT01322347|449456137|FG000|Overall Study|sponsor decision|1|||
124953824|NCT01322347|449456138|FG001|Overall Study|sponsor decision|3|||
124953825|NCT01322347|449456137|FG000|Overall Study|ineligible|6|||
124953826|NCT01322347|449456138|FG001|Overall Study|ineligible|3|||
124953827|NCT01322347|449456137|FG000|Overall Study|kidney transplant|3|||
124953828|NCT01322347|449456138|FG001|Overall Study|kidney transplant|1|||
124953829|NCT01322347|449456137|FG000|Overall Study|study drug withheld > 12 wks|0|||
124953830|NCT01322347|449456138|FG001|Overall Study|study drug withheld > 12 wks|1|||
124953831|NCT01322347|449456137|FG000|Overall Study|moved/changed dialysis|2|||
124953832|NCT01322347|449456138|FG001|Overall Study|moved/changed dialysis|4|||
124953833|NCT01369147|449456140|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
124953834|NCT01369147|449456141|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
124953835|NCT01369147|449456142|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
124953836|NCT00379210|449456146|FG000|Overall Study|Withdrawal by Subject|10|||
124953837|NCT00379210|449456147|FG001|Overall Study|Withdrawal by Subject|7|||
124953838|NCT01525875|449456148|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
124953839|NCT01525875|449456149|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
124953840|NCT01525875|449456148|FG000|Open-label Period|Lost to Follow-up|0|||
124953841|NCT01525875|449456149|FG001|Open-label Period|Lost to Follow-up|2|||
124953842|NCT01762345|449456150|FG000|Overall Study|Adverse Event|5|||
124953843|NCT01762345|449456150|FG000|Overall Study|Protocol Violation|2|||
124953844|NCT01358175|449456151|FG000|Overall Study|Death|1|||
125030539|NCT04067518|449734981|FG000|Overall Study|Adverse Event|1|||
125030540|NCT04067518|449734982|FG001|Overall Study|Adverse Event|3|||
125030541|NCT04067518|449734981|FG000|Overall Study|Screen failures|0|||
125030542|NCT04067518|449734982|FG001|Overall Study|Screen failures|1|||
125030543|NCT04067518|449734981|FG000|Overall Study|Enrolled but not treated|0|||
125030544|NCT04067518|449734982|FG001|Overall Study|Enrolled but not treated|1|||
125030545|NCT02771522|449734983|FG000|Overall Study|Lost to Follow-up|3|||
125030546|NCT02771522|449734983|FG000|Overall Study|Withdrawal by Subject|2|||
125030547|NCT02771522|449734983|FG000|Overall Study|No white spot lesions|3|||
125030548|NCT05655377|449734986|FG000|Overall Study|Withdrawal by Subject|2|||
124953845|NCT01358175|449456152|FG001|Overall Study|Death|0|||
124953846|NCT01358175|449456153|FG002|Overall Study|Death|1|||
125030549|NCT01256177|449734987|FG000|Overall Study|Withdrawal by Subject|23|||
125125455|NCT01104662|450084209|FG001|Overall Study|Randomized but not treated|4|||
125125456|NCT01104662|450084210|FG002|Overall Study|Randomized but not treated|1|||
125125457|NCT01104662|450084211|FG003|Overall Study|Randomized but not treated|0|||
125030550|NCT01256177|449734988|FG001|Overall Study|Withdrawal by Subject|22|||
125030551|NCT01256177|449734987|FG000|Overall Study|Lost to Follow-up|2|||
125030552|NCT01256177|449734988|FG001|Overall Study|Lost to Follow-up|2|||
125030553|NCT01256177|449734987|FG000|Overall Study|Adverse Event|8|||
125030554|NCT01256177|449734988|FG001|Overall Study|Adverse Event|9|||
125030555|NCT01256177|449734987|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
125030556|NCT01256177|449734988|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
125030557|NCT01256177|449734987|FG000|Overall Study|Condition under Investigation Worsened|1|||
125030558|NCT01256177|449734988|FG001|Overall Study|Condition under Investigation Worsened|0|||
125030559|NCT01256177|449734987|FG000|Overall Study|Lack of Efficacy|11|||
125030560|NCT01256177|449734988|FG001|Overall Study|Lack of Efficacy|2|||
125030561|NCT01256177|449734987|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
125030562|NCT01256177|449734988|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
125030563|NCT00553462|449734990|FG000|Overall Study|Adverse Event|4|||
125030564|NCT00553462|449734990|FG000|Overall Study|Progression|4|||
125030565|NCT00553462|449734990|FG000|Overall Study|Withdrawal by Subject|5|||
125030566|NCT00553462|449734990|FG000|Overall Study|Physician Decision|1|||
125030567|NCT01728779|449734991|FG000|Overall Study|Withdrawal by Subject|1|||
125030568|NCT04398732|449734992|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
125030569|NCT01596257|449734994|FG000|Overall Study|Inadequate Collection|23|||
125030570|NCT01596257|449734995|FG001|Overall Study|Inadequate Collection|19|||
125030571|NCT01570244|449734996|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
125030572|NCT02318784|449735003|FG000|Overall Study|Adverse Event|13|||
125125458|NCT01104662|450084212|FG004|Overall Study|Randomized but not treated|0|||
125125459|NCT01104662|450084213|FG005|Overall Study|Randomized but not treated|1|||
125125460|NCT01104662|450084214|FG006|Overall Study|Randomized but not treated|0|||
125125461|NCT01104662|450084215|FG007|Overall Study|Randomized but not treated|0|||
125125462|NCT02158936|450084216|FG000|Overall Study|Study closed/ terminated|57|||
125125463|NCT02158936|450084217|FG001|Overall Study|Study closed/ terminated|77|||
124953847|NCT01358175|449456151|FG000|Overall Study|Withdrawal by Subject|9|||
124953848|NCT01358175|449456152|FG001|Overall Study|Withdrawal by Subject|5|||
124953849|NCT01358175|449456153|FG002|Overall Study|Withdrawal by Subject|10|||
124953850|NCT01358175|449456151|FG000|Overall Study|Technical issues|0|||
124953851|NCT01358175|449456152|FG001|Overall Study|Technical issues|1|||
124953852|NCT01358175|449456153|FG002|Overall Study|Technical issues|0|||
124953853|NCT01358175|449456151|FG000|Overall Study|Pregnancy|0|||
124953854|NCT01358175|449456152|FG001|Overall Study|Pregnancy|1|||
124953855|NCT01358175|449456153|FG002|Overall Study|Pregnancy|0|||
124953856|NCT01358175|449456151|FG000|Overall Study|Physician Decision|1|||
124953857|NCT01358175|449456152|FG001|Overall Study|Physician Decision|0|||
124953858|NCT01358175|449456153|FG002|Overall Study|Physician Decision|0|||
124953859|NCT01358175|449456151|FG000|Overall Study|Non Compliance with Study Treatment|0|||
124953860|NCT01358175|449456152|FG001|Overall Study|Non Compliance with Study Treatment|1|||
124953861|NCT01358175|449456153|FG002|Overall Study|Non Compliance with Study Treatment|1|||
124953862|NCT01358175|449456151|FG000|Overall Study|Lost to Follow-up|1|||
124953863|NCT01358175|449456152|FG001|Overall Study|Lost to Follow-up|1|||
124953864|NCT01358175|449456153|FG002|Overall Study|Lost to Follow-up|3|||
124953865|NCT01358175|449456151|FG000|Overall Study|Lack of Efficacy|3|||
124953866|NCT01358175|449456152|FG001|Overall Study|Lack of Efficacy|8|||
124953867|NCT01358175|449456153|FG002|Overall Study|Lack of Efficacy|6|||
124953868|NCT01358175|449456151|FG000|Overall Study|Adverse Event|6|||
124953869|NCT01358175|449456152|FG001|Overall Study|Adverse Event|11|||
124953870|NCT01358175|449456153|FG002|Overall Study|Adverse Event|11|||
124953871|NCT05072795|449456154|FG000|Overall Study|Lost to Follow-up|5|||
124953872|NCT01107912|449456157|FG000|Period 1|Adverse Event|0|||
124953873|NCT01107912|449456158|FG001|Period 1|Adverse Event|0|||
124953874|NCT01107912|449456159|FG002|Period 1|Adverse Event|0|||
124953875|NCT01107912|449456160|FG003|Period 1|Adverse Event|0|||
124953876|NCT01107912|449456161|FG004|Period 1|Adverse Event|2|||
124953877|NCT01107912|449456162|FG005|Period 1|Adverse Event|0|||
124953878|NCT01107912|449456157|FG000|Period 1|Physician Decision|0|||
124953879|NCT01107912|449456158|FG001|Period 1|Physician Decision|0|||
125125464|NCT02158936|450084216|FG000|Overall Study|Azacitidine tx discontinued|53|||
125125465|NCT02158936|450084217|FG001|Overall Study|Azacitidine tx discontinued|46|||
124953880|NCT01107912|449456159|FG002|Period 1|Physician Decision|0|||
124953881|NCT01107912|449456160|FG003|Period 1|Physician Decision|0|||
124953882|NCT01107912|449456161|FG004|Period 1|Physician Decision|1|||
124953883|NCT01107912|449456162|FG005|Period 1|Physician Decision|0|||
125030573|NCT02318784|449735003|FG000|Overall Study|Death|2|||
125030574|NCT02318784|449735003|FG000|Overall Study|Progressive Disease|37|||
125030575|NCT02318784|449735003|FG000|Overall Study|Withdrawal by Subject|10|||
125030576|NCT00934102|449735004|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
125125466|NCT02158936|450084216|FG000|Overall Study|Adverse Event|39|||
124953884|NCT01107912|449456157|FG000|Period 1|Withdrawal by Subject|1|||
124953885|NCT01107912|449456158|FG001|Period 1|Withdrawal by Subject|0|||
124953886|NCT01107912|449456159|FG002|Period 1|Withdrawal by Subject|0|||
124953887|NCT01107912|449456160|FG003|Period 1|Withdrawal by Subject|0|||
124953888|NCT01107912|449456161|FG004|Period 1|Withdrawal by Subject|0|||
124953889|NCT01107912|449456162|FG005|Period 1|Withdrawal by Subject|0|||
124953890|NCT01107912|449456157|FG000|Period 2|Physician Decision|0|||
124953891|NCT01107912|449456158|FG001|Period 2|Physician Decision|0|||
124953892|NCT01107912|449456159|FG002|Period 2|Physician Decision|1|||
124953893|NCT01107912|449456160|FG003|Period 2|Physician Decision|0|||
124953894|NCT01107912|449456161|FG004|Period 2|Physician Decision|0|||
124953895|NCT01107912|449456162|FG005|Period 2|Physician Decision|0|||
124953896|NCT01107912|449456157|FG000|Period 3|Adverse Event|0|||
124953897|NCT01107912|449456158|FG001|Period 3|Adverse Event|1|||
124953898|NCT01107912|449456159|FG002|Period 3|Adverse Event|1|||
124953899|NCT01107912|449456160|FG003|Period 3|Adverse Event|0|||
124953900|NCT01107912|449456161|FG004|Period 3|Adverse Event|0|||
124953901|NCT01107912|449456162|FG005|Period 3|Adverse Event|0|||
124953902|NCT01107912|449456157|FG000|Period 3|Withdrawal by Subject|0|||
124953903|NCT01107912|449456158|FG001|Period 3|Withdrawal by Subject|0|||
124953904|NCT01107912|449456159|FG002|Period 3|Withdrawal by Subject|0|||
124953905|NCT01107912|449456160|FG003|Period 3|Withdrawal by Subject|1|||
124953906|NCT01107912|449456161|FG004|Period 3|Withdrawal by Subject|0|||
124953907|NCT01107912|449456162|FG005|Period 3|Withdrawal by Subject|0|||
124953908|NCT01601821|449456163|FG000|Overall Study|Death|2|||
124953909|NCT01601821|449456164|FG001|Overall Study|Death|5|||
124953910|NCT01601821|449456163|FG000|Overall Study|Protocol Violation|2|||
124953911|NCT01601821|449456164|FG001|Overall Study|Protocol Violation|2|||
124953912|NCT01601821|449456163|FG000|Overall Study|Lost to Follow-up|6|||
124953913|NCT01601821|449456164|FG001|Overall Study|Lost to Follow-up|14|||
124953914|NCT01601821|449456163|FG000|Overall Study|Withdrawal by Subject|1|||
124953915|NCT01601821|449456164|FG001|Overall Study|Withdrawal by Subject|0|||
124953916|NCT01601821|449456163|FG000|Overall Study|Graft Loss|6|||
124953917|NCT01601821|449456164|FG001|Overall Study|Graft Loss|6|||
124953918|NCT01601821|449456163|FG000|Overall Study|Study Events|7|||
124953919|NCT01601821|449456164|FG001|Overall Study|Study Events|1|||
124953920|NCT01601821|449456163|FG000|Overall Study|Other|5|||
124953921|NCT01601821|449456164|FG001|Overall Study|Other|1|||
124953922|NCT00442559|449456172|FG000|Overall Study|Lost to Follow-up|32|||
124953923|NCT00442559|449456173|FG001|Overall Study|Lost to Follow-up|34|||
124953924|NCT00442559|449456172|FG000|Overall Study|Protocol Violation|1|||
124953925|NCT00442559|449456173|FG001|Overall Study|Protocol Violation|1|||
124953926|NCT00442559|449456172|FG000|Overall Study|Withdrawal by Subject|1|||
124953927|NCT00442559|449456173|FG001|Overall Study|Withdrawal by Subject|0|||
124953928|NCT00753896|449456182|FG000|Overall Study|Adverse Event|4|||
124953929|NCT00753896|449456182|FG000|Overall Study|Death|1|||
124953930|NCT00753896|449456182|FG000|Overall Study|Lost to Follow-up|2|||
124953931|NCT00753896|449456182|FG000|Overall Study|Protocol Violation|1|||
124953932|NCT00753896|449456182|FG000|Overall Study|Withdrawal by Subject|4|||
124953933|NCT00753896|449456182|FG000|Overall Study|Entry Criteria Not Met|4|||
124953934|NCT02959866|449456183|FG000|Overall Study|Withdrawal by Subject|1|||
124953935|NCT00952523|449456184|FG000|Overall Study|Withdrawal by Subject|7|||
124953936|NCT00848198|449456185|FG000|Overall Study|Incomplete Case Report Forms|15|||
124953937|NCT03708744|449456186|FG000|Overall Study|Withdrawal by Subject|0|||
124953938|NCT03708744|449456187|FG001|Overall Study|Withdrawal by Subject|0|||
124953939|NCT03708744|449456188|FG002|Overall Study|Withdrawal by Subject|1|||
124953940|NCT03708744|449456189|FG003|Overall Study|Withdrawal by Subject|0|||
124953941|NCT03529942|449456190|FG000|Overall Study|Withdrawal by Subject|13|||
124953942|NCT03529942|449456190|FG000|Overall Study|Physician Decision|1|||
124953943|NCT03529942|449456190|FG000|Overall Study|Lost to Follow-up|7|||
124953944|NCT03529942|449456190|FG000|Overall Study|Needle inserted but no drug administered|1|||
124953945|NCT03529942|449456190|FG000|Overall Study|Personal reasons|1|||
124953946|NCT01989156|449456191|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
124953947|NCT01989156|449456192|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
124953948|NCT01989156|449456193|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
124953949|NCT01989156|449456191|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
124953950|NCT01989156|449456192|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
124953951|NCT01989156|449456193|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
124953952|NCT01989156|449456191|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
124953953|NCT01989156|449456192|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
125125467|NCT02158936|450084217|FG001|Overall Study|Adverse Event|24|||
125125468|NCT02158936|450084216|FG000|Overall Study|Withdrawal by Subject|15|||
124953954|NCT01989156|449456193|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
124953955|NCT01989156|449456191|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
124953956|NCT01989156|449456192|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
124953957|NCT01989156|449456193|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
124953958|NCT01989156|449456191|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
124953959|NCT01989156|449456192|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
124953960|NCT01989156|449456193|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
124953961|NCT01989156|449456191|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
124953962|NCT01989156|449456192|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
124953963|NCT01989156|449456193|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
124953964|NCT01989156|449456191|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
124953965|NCT01989156|449456192|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
124953966|NCT01989156|449456193|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
124953967|NCT01989156|449456191|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
124953968|NCT01989156|449456192|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
124953969|NCT01989156|449456193|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
124953970|NCT01721109|449456197|FG000|Overall Study|Lack of Efficacy|1|||
124953971|NCT01721109|449456197|FG000|Overall Study|Non- Compliance with Study Drug|3|||
124953972|NCT01721109|449456197|FG000|Overall Study|Withdrew Consent|1|||
124953973|NCT01721109|449456197|FG000|Overall Study|Lost to Follow-up|2|||
124953974|NCT04362176|449456198|FG000|Overall Study|Lost to Follow-up|5|||
124953975|NCT04362176|449456199|FG001|Overall Study|Lost to Follow-up|8|||
124953976|NCT04362176|449456198|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
124953977|NCT04362176|449456199|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
124953978|NCT00742560|449456200|FG000|Overall Study|Adverse Event|0|||
124953979|NCT00742560|449456201|FG001|Overall Study|Adverse Event|0|||
124953980|NCT00742560|449456202|FG002|Overall Study|Adverse Event|1|||
124953981|NCT00742560|449456203|FG003|Overall Study|Adverse Event|1|||
124953982|NCT00742560|449456204|FG004|Overall Study|Adverse Event|1|||
124953983|NCT00742560|449456200|FG000|Overall Study|Death|0|||
124953984|NCT00742560|449456201|FG001|Overall Study|Death|2|||
124953985|NCT00742560|449456202|FG002|Overall Study|Death|0|||
124953986|NCT00742560|449456203|FG003|Overall Study|Death|2|||
124953987|NCT00742560|449456204|FG004|Overall Study|Death|3|||
124953988|NCT00742560|449456200|FG000|Overall Study|Subject's Decision|1|||
124953989|NCT00742560|449456201|FG001|Overall Study|Subject's Decision|0|||
124953990|NCT00742560|449456202|FG002|Overall Study|Subject's Decision|2|||
124953991|NCT00742560|449456203|FG003|Overall Study|Subject's Decision|3|||
124953992|NCT00742560|449456204|FG004|Overall Study|Subject's Decision|3|||
124953993|NCT00742560|449456200|FG000|Overall Study|Investigator's Decision|0|||
124953994|NCT00742560|449456201|FG001|Overall Study|Investigator's Decision|0|||
124953995|NCT00742560|449456202|FG002|Overall Study|Investigator's Decision|4|||
124953996|NCT00742560|449456203|FG003|Overall Study|Investigator's Decision|1|||
124953997|NCT00742560|449456204|FG004|Overall Study|Investigator's Decision|0|||
124953998|NCT00742560|449456200|FG000|Overall Study|Disease Progression|1|||
124953999|NCT00742560|449456201|FG001|Overall Study|Disease Progression|0|||
124954000|NCT00742560|449456202|FG002|Overall Study|Disease Progression|5|||
124954001|NCT00742560|449456203|FG003|Overall Study|Disease Progression|17|||
124954002|NCT00742560|449456204|FG004|Overall Study|Disease Progression|16|||
124954003|NCT00742560|449456200|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
124954004|NCT00742560|449456201|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
124954005|NCT00742560|449456202|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
124954006|NCT00742560|449456203|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
124954007|NCT00742560|449456204|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
124954008|NCT00742560|449456200|FG000|Overall Study|Other|0|||
124954009|NCT00742560|449456201|FG001|Overall Study|Other|1|||
124954010|NCT00742560|449456202|FG002|Overall Study|Other|8|||
124954011|NCT00742560|449456203|FG003|Overall Study|Other|9|||
124954012|NCT00742560|449456204|FG004|Overall Study|Other|9|||
124954013|NCT00742560|449456200|FG000|Overall Study|MIssing|0|||
124954014|NCT00742560|449456201|FG001|Overall Study|MIssing|0|||
124954015|NCT00742560|449456202|FG002|Overall Study|MIssing|0|||
124954016|NCT00742560|449456203|FG003|Overall Study|MIssing|0|||
124954017|NCT00742560|449456204|FG004|Overall Study|MIssing|1|||
125125469|NCT02158936|450084217|FG001|Overall Study|Withdrawal by Subject|16|||
124954018|NCT01426217|449456206|FG000|Overall Study|lost sample|8|||
124954019|NCT01426217|449456207|FG001|Overall Study|lost sample|14|||
124954020|NCT01536795|449456208|FG000|Overall Study|Lost to Follow-up|0|||
124954021|NCT01536795|449456209|FG001|Overall Study|Lost to Follow-up|2|||
124954022|NCT01536795|449456208|FG000|Overall Study|Lack of Efficacy|1|||
124954023|NCT01536795|449456209|FG001|Overall Study|Lack of Efficacy|0|||
124954024|NCT01812837|449456210|FG000|Overall Study|Lost to Follow-up|1|||
124954025|NCT01812837|449456211|FG001|Overall Study|Lost to Follow-up|1|||
124954026|NCT01812837|449456212|FG002|Overall Study|Lost to Follow-up|0|||
125125470|NCT02158936|450084216|FG000|Overall Study|Physician Decision|15|||
125125471|NCT02158936|450084217|FG001|Overall Study|Physician Decision|13|||
125030577|NCT00934102|449735005|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
125030578|NCT00934102|449735006|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
125030579|NCT00792298|449735007|FG000|Treatment Period 1|Adverse Event|0|||
125030580|NCT00792298|449735008|FG001|Treatment Period 1|Adverse Event|1|||
125030581|NCT00792298|449735009|FG002|Treatment Period 1|Adverse Event|0|||
125030582|NCT00792298|449735010|FG003|Treatment Period 1|Adverse Event|1|||
125030583|NCT00792298|449735011|FG004|Treatment Period 1|Adverse Event|0|||
125030584|NCT00792298|449735012|FG005|Treatment Period 1|Adverse Event|1|||
125030585|NCT00792298|449735013|FG006|Treatment Period 1|Adverse Event|1|||
125030586|NCT00792298|449735014|FG007|Treatment Period 1|Adverse Event|0|||
125030587|NCT00792298|449735007|FG000|Treatment Period 1|Lack of Efficacy|0|||
125030588|NCT00792298|449735008|FG001|Treatment Period 1|Lack of Efficacy|0|||
125030589|NCT00792298|449735009|FG002|Treatment Period 1|Lack of Efficacy|1|||
125030590|NCT00792298|449735010|FG003|Treatment Period 1|Lack of Efficacy|0|||
125030591|NCT00792298|449735011|FG004|Treatment Period 1|Lack of Efficacy|0|||
125030592|NCT00792298|449735012|FG005|Treatment Period 1|Lack of Efficacy|0|||
125030593|NCT00792298|449735013|FG006|Treatment Period 1|Lack of Efficacy|0|||
125030594|NCT00792298|449735014|FG007|Treatment Period 1|Lack of Efficacy|0|||
125030595|NCT00792298|449735007|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125030596|NCT00792298|449735008|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125030597|NCT00792298|449735009|FG002|Treatment Period 1|Withdrawal by Subject|1|||
125030598|NCT00792298|449735010|FG003|Treatment Period 1|Withdrawal by Subject|2|||
125030599|NCT00792298|449735011|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125030600|NCT00792298|449735012|FG005|Treatment Period 1|Withdrawal by Subject|2|||
125030601|NCT00792298|449735013|FG006|Treatment Period 1|Withdrawal by Subject|1|||
125030602|NCT00792298|449735014|FG007|Treatment Period 1|Withdrawal by Subject|0|||
125030603|NCT00792298|449735007|FG000|Treatment Period 1|Lost to Follow-up|0|||
125030604|NCT00792298|449735008|FG001|Treatment Period 1|Lost to Follow-up|0|||
125030605|NCT00792298|449735009|FG002|Treatment Period 1|Lost to Follow-up|0|||
125030606|NCT00792298|449735010|FG003|Treatment Period 1|Lost to Follow-up|0|||
125030607|NCT00792298|449735011|FG004|Treatment Period 1|Lost to Follow-up|0|||
125030608|NCT00792298|449735012|FG005|Treatment Period 1|Lost to Follow-up|0|||
125030609|NCT00792298|449735013|FG006|Treatment Period 1|Lost to Follow-up|1|||
125030610|NCT00792298|449735014|FG007|Treatment Period 1|Lost to Follow-up|0|||
125030611|NCT00792298|449735007|FG000|Treatment Period 1|Physician Decision|0|||
125030612|NCT00792298|449735008|FG001|Treatment Period 1|Physician Decision|0|||
125030613|NCT00792298|449735009|FG002|Treatment Period 1|Physician Decision|0|||
125030614|NCT00792298|449735010|FG003|Treatment Period 1|Physician Decision|1|||
125030615|NCT00792298|449735011|FG004|Treatment Period 1|Physician Decision|0|||
125030616|NCT00792298|449735012|FG005|Treatment Period 1|Physician Decision|0|||
125030617|NCT00792298|449735013|FG006|Treatment Period 1|Physician Decision|1|||
125030618|NCT00792298|449735014|FG007|Treatment Period 1|Physician Decision|0|||
125030619|NCT00792298|449735007|FG000|Treatment Period 1|Protocol Violation|0|||
125030620|NCT00792298|449735008|FG001|Treatment Period 1|Protocol Violation|0|||
125030621|NCT00792298|449735009|FG002|Treatment Period 1|Protocol Violation|0|||
125030622|NCT00792298|449735010|FG003|Treatment Period 1|Protocol Violation|0|||
125030623|NCT00792298|449735011|FG004|Treatment Period 1|Protocol Violation|0|||
125030624|NCT00792298|449735012|FG005|Treatment Period 1|Protocol Violation|0|||
125030625|NCT00792298|449735013|FG006|Treatment Period 1|Protocol Violation|0|||
125030626|NCT00792298|449735014|FG007|Treatment Period 1|Protocol Violation|1|||
125030627|NCT00792298|449735007|FG000|Washout|Adverse Event|0|||
125030628|NCT00792298|449735008|FG001|Washout|Adverse Event|0|||
125030629|NCT00792298|449735009|FG002|Washout|Adverse Event|0|||
125030630|NCT00792298|449735010|FG003|Washout|Adverse Event|0|||
125030631|NCT00792298|449735011|FG004|Washout|Adverse Event|0|||
125030632|NCT00792298|449735012|FG005|Washout|Adverse Event|1|||
125030633|NCT00792298|449735013|FG006|Washout|Adverse Event|0|||
125030634|NCT00792298|449735014|FG007|Washout|Adverse Event|0|||
125030635|NCT00792298|449735007|FG000|Washout|Withdrawal by Subject|0|||
125030636|NCT00792298|449735008|FG001|Washout|Withdrawal by Subject|0|||
125030637|NCT00792298|449735009|FG002|Washout|Withdrawal by Subject|1|||
125030638|NCT00792298|449735010|FG003|Washout|Withdrawal by Subject|0|||
125030639|NCT00792298|449735011|FG004|Washout|Withdrawal by Subject|0|||
125030640|NCT00792298|449735012|FG005|Washout|Withdrawal by Subject|1|||
125215282|NCT02559570|450414979|FG001|Overall Study|Adverse Event|2|||
125030641|NCT00792298|449735013|FG006|Washout|Withdrawal by Subject|0|||
125215283|NCT02559570|450414980|FG002|Overall Study|Adverse Event|0|||
125030642|NCT00792298|449735014|FG007|Washout|Withdrawal by Subject|0|||
125030643|NCT00792298|449735007|FG000|Treatment Period 2|Lack of Efficacy|0|||
125030644|NCT00792298|449735008|FG001|Treatment Period 2|Lack of Efficacy|0|||
125030645|NCT00792298|449735009|FG002|Treatment Period 2|Lack of Efficacy|0|||
125030646|NCT00792298|449735010|FG003|Treatment Period 2|Lack of Efficacy|0|||
125030647|NCT00792298|449735011|FG004|Treatment Period 2|Lack of Efficacy|1|||
125030648|NCT00792298|449735012|FG005|Treatment Period 2|Lack of Efficacy|0|||
125030649|NCT00792298|449735013|FG006|Treatment Period 2|Lack of Efficacy|0|||
125030650|NCT00792298|449735014|FG007|Treatment Period 2|Lack of Efficacy|0|||
125030651|NCT00792298|449735007|FG000|Treatment Period 2|Physician Decision|0|||
124954027|NCT01812837|449456210|FG000|Overall Study|Protocol Violation|1|||
124954028|NCT01812837|449456211|FG001|Overall Study|Protocol Violation|0|||
124954029|NCT01812837|449456212|FG002|Overall Study|Protocol Violation|0|||
124954030|NCT05008224|449456214|FG000|Overall Study|Death|3|||
124954031|NCT05008224|449456214|FG000|Overall Study|Lost to Follow-up|2|||
124954032|NCT05008224|449456214|FG000|Overall Study|Did Not Continue on Extension Study|39|||
124954033|NCT05008224|449456214|FG000|Overall Study|Transferred to Extension Study|100|||
124954034|NCT05008224|449456214|FG000|Overall Study|Withdrawal by Subject|2|||
124954035|NCT05234632|449456215|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
124954036|NCT05234632|449456216|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
124954037|NCT05234632|449456215|FG000|Overall Study|Withdrawal by Subject|2|||
124954038|NCT05234632|449456216|FG001|Overall Study|Withdrawal by Subject|0|||
124954039|NCT05234632|449456215|FG000|Overall Study|Adverse Event|0|||
124954040|NCT05234632|449456216|FG001|Overall Study|Adverse Event|4|||
124954041|NCT05234632|449456215|FG000|Overall Study|Physician Decision|1|||
124954042|NCT05234632|449456216|FG001|Overall Study|Physician Decision|1|||
124954043|NCT05234632|449456215|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
124954044|NCT05234632|449456216|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
124954045|NCT05234632|449456215|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
124954046|NCT05234632|449456216|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
124954047|NCT00658632|449456217|FG000|Overall Study|Adverse Event|13|||
124954048|NCT00658632|449456218|FG001|Overall Study|Adverse Event|11|||
124954049|NCT00658632|449456217|FG000|Overall Study|Lost to Follow-up|25|||
124954050|NCT00658632|449456218|FG001|Overall Study|Lost to Follow-up|23|||
124954051|NCT00658632|449456217|FG000|Overall Study|Withdrawal by Subject|10|||
124954052|NCT00658632|449456218|FG001|Overall Study|Withdrawal by Subject|7|||
124954053|NCT00658632|449456217|FG000|Overall Study|Lack of Efficacy|0|||
124954054|NCT00658632|449456218|FG001|Overall Study|Lack of Efficacy|1|||
124954055|NCT00658632|449456217|FG000|Overall Study|Withdrawal of consent|8|||
124954056|NCT00658632|449456218|FG001|Overall Study|Withdrawal of consent|14|||
124954057|NCT00658632|449456217|FG000|Overall Study|Pregnancy|1|||
124954058|NCT00658632|449456218|FG001|Overall Study|Pregnancy|1|||
124954059|NCT00658632|449456217|FG000|Overall Study|Other|7|||
124954060|NCT00658632|449456218|FG001|Overall Study|Other|8|||
124954061|NCT02991456|449456220|FG000|Overall Study|Adverse Event|2|||
124954062|NCT02991456|449456221|FG001|Overall Study|Adverse Event|0|||
124954063|NCT02991456|449456220|FG000|Overall Study|Lost to Follow-up|0|||
124954064|NCT02991456|449456221|FG001|Overall Study|Lost to Follow-up|2|||
124954065|NCT02991456|449456220|FG000|Overall Study|Withdrawal by Subject|1|||
124954066|NCT02991456|449456221|FG001|Overall Study|Withdrawal by Subject|0|||
124954067|NCT01699178|449456222|FG000|Overall Study|Adverse Event|1|||
124954068|NCT01699178|449456223|FG001|Overall Study|Adverse Event|5|||
124954069|NCT01699178|449456222|FG000|Overall Study|Lost to Follow-up|1|||
124954070|NCT01699178|449456223|FG001|Overall Study|Lost to Follow-up|6|||
124954071|NCT01699178|449456222|FG000|Overall Study|Non-compliance with Study Drug|3|||
124954072|NCT01699178|449456223|FG001|Overall Study|Non-compliance with Study Drug|1|||
124954073|NCT01699178|449456222|FG000|Overall Study|Physician Decision|1|||
124954074|NCT01699178|449456223|FG001|Overall Study|Physician Decision|0|||
124954075|NCT01699178|449456222|FG000|Overall Study|Withdrawal by Subject|4|||
124954076|NCT01699178|449456223|FG001|Overall Study|Withdrawal by Subject|12|||
124954077|NCT01699178|449456222|FG000|Overall Study|Hematocrit >54%|1|||
124954078|NCT01699178|449456223|FG001|Overall Study|Hematocrit >54%|1|||
124954079|NCT01699178|449456222|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
124954080|NCT01699178|449456223|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
124954081|NCT01699178|449456222|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
124954082|NCT01699178|449456223|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
124954083|NCT00738400|449456226|FG000|Overall Study|Adverse Event|3|||
124954084|NCT00738400|449456227|FG001|Overall Study|Adverse Event|1|||
124954085|NCT00738400|449456226|FG000|Overall Study|Withdrawal by Subject|0|||
124954086|NCT00738400|449456227|FG001|Overall Study|Withdrawal by Subject|1|||
124954087|NCT00738400|449456226|FG000|Overall Study|Lack of Efficacy|0|||
124954088|NCT00738400|449456227|FG001|Overall Study|Lack of Efficacy|1|||
124954089|NCT00738400|449456226|FG000|Overall Study|Lost to Follow-up|0|||
124954090|NCT00738400|449456227|FG001|Overall Study|Lost to Follow-up|3|||
124954091|NCT00738400|449456226|FG000|Overall Study|Protocol Violation|1|||
124954092|NCT00738400|449456227|FG001|Overall Study|Protocol Violation|0|||
124954093|NCT00738400|449456226|FG000|Overall Study|Non-compliant with study medication|0|||
124954094|NCT00738400|449456227|FG001|Overall Study|Non-compliant with study medication|1|||
124954095|NCT02312245|449456228|FG000|Overall Study|Death|0|||
124954096|NCT02312245|449456229|FG001|Overall Study|Death|0|||
124954097|NCT02312245|449456230|FG002|Overall Study|Death|0|||
124954098|NCT02312245|449456231|FG003|Overall Study|Death|1|||
124954099|NCT02312245|449456228|FG000|Overall Study|Withdrawal by Subject|1|||
124954100|NCT02312245|449456229|FG001|Overall Study|Withdrawal by Subject|1|||
124954101|NCT02312245|449456230|FG002|Overall Study|Withdrawal by Subject|0|||
124954102|NCT02312245|449456231|FG003|Overall Study|Withdrawal by Subject|2|||
124954103|NCT02312245|449456228|FG000|Overall Study|Alternative Therapy|1|||
125125472|NCT02158936|450084216|FG000|Overall Study|Lost to Follow-up|0|||
125125473|NCT02158936|450084217|FG001|Overall Study|Lost to Follow-up|1|||
125125474|NCT01706926|450084218|FG000|Overall Study|Lost to Follow-up|0|||
125125475|NCT01706926|450084219|FG001|Overall Study|Lost to Follow-up|0|||
125125476|NCT01706926|450084220|FG002|Overall Study|Lost to Follow-up|1|||
125125477|NCT01706926|450084221|FG003|Overall Study|Lost to Follow-up|0|||
124954104|NCT02312245|449456229|FG001|Overall Study|Alternative Therapy|0|||
124954105|NCT02312245|449456230|FG002|Overall Study|Alternative Therapy|0|||
124954106|NCT02312245|449456231|FG003|Overall Study|Alternative Therapy|0|||
124954107|NCT02312245|449456228|FG000|Overall Study|Progression|0|||
124954108|NCT02312245|449456229|FG001|Overall Study|Progression|0|||
124954109|NCT02312245|449456230|FG002|Overall Study|Progression|0|||
124954110|NCT02312245|449456231|FG003|Overall Study|Progression|5|||
124954111|NCT02312245|449456228|FG000|Overall Study|Patient went to hospice|0|||
124954112|NCT02312245|449456229|FG001|Overall Study|Patient went to hospice|0|||
124954113|NCT02312245|449456230|FG002|Overall Study|Patient went to hospice|0|||
124954114|NCT02312245|449456231|FG003|Overall Study|Patient went to hospice|1|||
124954115|NCT02312245|449456228|FG000|Overall Study|Ineligible|1|||
124954116|NCT02312245|449456229|FG001|Overall Study|Ineligible|0|||
124954117|NCT02312245|449456230|FG002|Overall Study|Ineligible|0|||
124954118|NCT02312245|449456231|FG003|Overall Study|Ineligible|0|||
124954119|NCT00508144|449456232|FG000|Overall Study|Not eligible|6|||
124954120|NCT00508144|449456232|FG000|Overall Study|Death|5|||
124954121|NCT03122548|449456237|FG000|Overall Study|Death|2|||
124954122|NCT03122548|449456237|FG000|Overall Study|Progression - subject went into hospice|1|||
124954123|NCT03122548|449456237|FG000|Overall Study|Study Terminated by Sponsor|2|||
124954124|NCT02332889|449456240|FG000|Overall Study|Physician Decision|1|||
124954125|NCT04448561|449456242|FG000|Overall Study|Noncompliance|1|||
124954126|NCT04448561|449456243|FG001|Overall Study|Noncompliance|0|||
124954127|NCT05356130|449457628|FG000|Overall Study|Withdrawal by Subject|0|||
124954128|NCT05356130|449457629|FG001|Overall Study|Withdrawal by Subject|0|||
124954129|NCT05356130|449457630|FG002|Overall Study|Withdrawal by Subject|3|||
124954130|NCT03141177|449457631|FG000|Overall Study|Death|62|||
124954131|NCT03141177|449457632|FG001|Overall Study|Death|13|||
124954132|NCT03141177|449457633|FG002|Overall Study|Death|84|||
124954133|NCT03141177|449457631|FG000|Overall Study|Participant withdrew consent|9|||
124954134|NCT03141177|449457632|FG001|Overall Study|Participant withdrew consent|2|||
124954135|NCT03141177|449457633|FG002|Overall Study|Participant withdrew consent|13|||
124954136|NCT03141177|449457631|FG000|Overall Study|Not reported|1|||
124954137|NCT03141177|449457632|FG001|Overall Study|Not reported|0|||
124954138|NCT03141177|449457633|FG002|Overall Study|Not reported|1|||
124954139|NCT03141177|449457631|FG000|Overall Study|Lost to Follow-up|2|||
124954140|NCT03141177|449457632|FG001|Overall Study|Lost to Follow-up|1|||
124954141|NCT03141177|449457633|FG002|Overall Study|Lost to Follow-up|1|||
124954142|NCT03141177|449457631|FG000|Overall Study|Other reasons|4|||
124954143|NCT03141177|449457632|FG001|Overall Study|Other reasons|0|||
124954144|NCT03141177|449457633|FG002|Overall Study|Other reasons|11|||
124954145|NCT03141177|449457631|FG000|Overall Study|Participants did not start treatment period|3|||
124954146|NCT03141177|449457632|FG001|Overall Study|Participants did not start treatment period|0|||
124954147|NCT03141177|449457633|FG002|Overall Study|Participants did not start treatment period|8|||
124954148|NCT03696342|449457642|FG000|Overall Study|Lost to Follow-up|1|||
124954149|NCT03696342|449457643|FG001|Overall Study|Lost to Follow-up|0|||
124954150|NCT05361304|449457646|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
124954151|NCT05361304|449457647|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
124954152|NCT05361304|449457646|FG000|Overall Study|COVID-19 Related|1|||
124954153|NCT05361304|449457647|FG001|Overall Study|COVID-19 Related|2|||
124954154|NCT05361304|449457646|FG000|Overall Study|Withdrawal by Subject|1|||
124954155|NCT05361304|449457647|FG001|Overall Study|Withdrawal by Subject|0|||
124954156|NCT02409732|449457648|FG000|Overall Study|Withdrawal by Subject|4|||
124954157|NCT02409732|449457648|FG000|Overall Study|Lost to Follow-up|2|||
124954158|NCT00376259|449457651|FG000|Overall Study|Sponsor request - study termination|21|||
124954159|NCT00376259|449457652|FG001|Overall Study|Sponsor request - study termination|21|||
125125478|NCT01706926|450084218|FG000|Overall Study|Withdrawal by Subject|2|||
125125479|NCT01706926|450084219|FG001|Overall Study|Withdrawal by Subject|0|||
125125480|NCT01706926|450084220|FG002|Overall Study|Withdrawal by Subject|1|||
125125481|NCT01706926|450084221|FG003|Overall Study|Withdrawal by Subject|2|||
124954160|NCT00376259|449457651|FG000|Overall Study|Patient request|1|||
124954161|NCT00376259|449457652|FG001|Overall Study|Patient request|0|||
124954162|NCT01877720|449457654|FG000|Overall Study|Adverse Event|1|||
124954163|NCT01877720|449457655|FG001|Overall Study|Adverse Event|0|||
124954164|NCT00447499|449457656|FG000|Overall Study|Adverse Event|1|||
124954165|NCT00447499|449457656|FG000|Overall Study|Patient Decision|4|||
125125482|NCT01706926|450084218|FG000|Overall Study|Other|4|||
125125483|NCT01706926|450084219|FG001|Overall Study|Other|4|||
125125484|NCT01706926|450084220|FG002|Overall Study|Other|4|||
125125485|NCT01706926|450084221|FG003|Overall Study|Other|3|||
125125486|NCT00414466|450085743|FG000|Overall Study|Adverse Event|0|||
124954166|NCT00447499|449457656|FG000|Overall Study|Sponsor Decision|1|||
124954167|NCT00447499|449457656|FG000|Overall Study|Physician Decision|1|||
124954168|NCT02068352|449457657|FG000|Overall Study|Lost to Follow-up|0|||
124954169|NCT02068352|449457658|FG001|Overall Study|Lost to Follow-up|2|||
124954170|NCT02068352|449457659|FG002|Overall Study|Lost to Follow-up|0|||
124954171|NCT02068352|449457657|FG000|Overall Study|Adverse Event|4|||
124954172|NCT02068352|449457658|FG001|Overall Study|Adverse Event|2|||
124954173|NCT02068352|449457659|FG002|Overall Study|Adverse Event|7|||
124954174|NCT02068352|449457657|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
124954175|NCT02068352|449457658|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
124954176|NCT02068352|449457659|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
124954177|NCT02068352|449457657|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
124954178|NCT02068352|449457658|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
124954179|NCT02068352|449457659|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
124954180|NCT02068352|449457657|FG000|Overall Study|Protocol Deviation|0|||
124954181|NCT02068352|449457658|FG001|Overall Study|Protocol Deviation|0|||
124954182|NCT02068352|449457659|FG002|Overall Study|Protocol Deviation|1|||
124954183|NCT03960437|449457661|FG000|Overall Study|Removed by PI|4|||
124954184|NCT03960437|449457661|FG000|Overall Study|Lost to Follow-up|2|||
124954185|NCT03960437|449457661|FG000|Overall Study|Withdrawal by Subject|1|||
124954186|NCT03960437|449457661|FG000|Overall Study|Death|2|||
124954187|NCT00473512|449457664|FG000|Period 1 (Phase 1)|Adverse Event|0|||
124954188|NCT00473512|449457665|FG001|Period 1 (Phase 1)|Adverse Event|0|||
124954189|NCT00473512|449457666|FG002|Period 1 (Phase 1)|Adverse Event|0|||
124954190|NCT00473512|449457667|FG003|Period 1 (Phase 1)|Adverse Event|5|||
124954191|NCT00473512|449457668|FG004|Period 1 (Phase 1)|Adverse Event|0|||
124954192|NCT00473512|449457664|FG000|Period 1 (Phase 1)|Death|0|||
124954193|NCT00473512|449457665|FG001|Period 1 (Phase 1)|Death|0|||
124954194|NCT00473512|449457666|FG002|Period 1 (Phase 1)|Death|0|||
124954195|NCT00473512|449457667|FG003|Period 1 (Phase 1)|Death|1|||
124954196|NCT00473512|449457668|FG004|Period 1 (Phase 1)|Death|0|||
124954197|NCT00473512|449457664|FG000|Period 1 (Phase 1)|Disease Progression|1|||
124954198|NCT00473512|449457665|FG001|Period 1 (Phase 1)|Disease Progression|1|||
124954199|NCT00473512|449457666|FG002|Period 1 (Phase 1)|Disease Progression|0|||
124954200|NCT00473512|449457667|FG003|Period 1 (Phase 1)|Disease Progression|10|||
124954201|NCT00473512|449457668|FG004|Period 1 (Phase 1)|Disease Progression|1|||
124954202|NCT00473512|449457664|FG000|Period 1 (Phase 1)|Other|0|||
124954203|NCT00473512|449457665|FG001|Period 1 (Phase 1)|Other|0|||
124954204|NCT00473512|449457666|FG002|Period 1 (Phase 1)|Other|0|||
124954205|NCT00473512|449457667|FG003|Period 1 (Phase 1)|Other|1|||
124954206|NCT00473512|449457668|FG004|Period 1 (Phase 1)|Other|0|||
124954207|NCT00473512|449457664|FG000|Period 2 (Phase 2)|Adverse Event|0|||
124954208|NCT00473512|449457665|FG001|Period 2 (Phase 2)|Adverse Event|0|||
124954209|NCT00473512|449457666|FG002|Period 2 (Phase 2)|Adverse Event|0|||
124954210|NCT00473512|449457667|FG003|Period 2 (Phase 2)|Adverse Event|1|||
124954211|NCT00473512|449457668|FG004|Period 2 (Phase 2)|Adverse Event|0|||
124954212|NCT00473512|449457664|FG000|Period 2 (Phase 2)|Death|0|||
124954213|NCT00473512|449457665|FG001|Period 2 (Phase 2)|Death|0|||
124954214|NCT00473512|449457666|FG002|Period 2 (Phase 2)|Death|0|||
124954215|NCT00473512|449457667|FG003|Period 2 (Phase 2)|Death|1|||
124954216|NCT00473512|449457668|FG004|Period 2 (Phase 2)|Death|1|||
125030652|NCT00792298|449735008|FG001|Treatment Period 2|Physician Decision|0|||
125030653|NCT00792298|449735009|FG002|Treatment Period 2|Physician Decision|0|||
125030654|NCT00792298|449735010|FG003|Treatment Period 2|Physician Decision|0|||
125030655|NCT00792298|449735011|FG004|Treatment Period 2|Physician Decision|0|||
125030656|NCT00792298|449735012|FG005|Treatment Period 2|Physician Decision|0|||
125030657|NCT00792298|449735013|FG006|Treatment Period 2|Physician Decision|1|||
125030658|NCT00792298|449735014|FG007|Treatment Period 2|Physician Decision|0|||
125030659|NCT00792298|449735007|FG000|Treatment Period 2|Pregnancy|0|||
124954217|NCT00473512|449457664|FG000|Period 2 (Phase 2)|Disease Progression|0|||
124954218|NCT00473512|449457665|FG001|Period 2 (Phase 2)|Disease Progression|2|||
124954219|NCT00473512|449457666|FG002|Period 2 (Phase 2)|Disease Progression|2|||
124954220|NCT00473512|449457667|FG003|Period 2 (Phase 2)|Disease Progression|17|||
124954221|NCT00473512|449457668|FG004|Period 2 (Phase 2)|Disease Progression|1|||
124954222|NCT00473512|449457664|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
124954223|NCT00473512|449457665|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
125030660|NCT00792298|449735008|FG001|Treatment Period 2|Pregnancy|0|||
125030661|NCT00792298|449735009|FG002|Treatment Period 2|Pregnancy|1|||
124954224|NCT00473512|449457666|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
125030662|NCT00792298|449735010|FG003|Treatment Period 2|Pregnancy|0|||
124954225|NCT00473512|449457667|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
124954226|NCT00473512|449457668|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
124954227|NCT00473512|449457664|FG000|Period 2 (Phase 2)|Other|1|||
125030663|NCT00792298|449735011|FG004|Treatment Period 2|Pregnancy|0|||
124954228|NCT00473512|449457665|FG001|Period 2 (Phase 2)|Other|0|||
124954229|NCT00473512|449457666|FG002|Period 2 (Phase 2)|Other|0|||
124954230|NCT00473512|449457667|FG003|Period 2 (Phase 2)|Other|3|||
124954231|NCT00473512|449457668|FG004|Period 2 (Phase 2)|Other|0|||
124954232|NCT00267956|449457669|FG000|Controlled Period|Adverse Event|4|||
124954233|NCT00267956|449457670|FG001|Controlled Period|Adverse Event|1|||
124954234|NCT00267956|449457671|FG002|Controlled Period|Adverse Event|0|||
124954235|NCT00267956|449457672|FG003|Controlled Period|Adverse Event|0|||
124954236|NCT00267956|449457669|FG000|Controlled Period|Lack of Efficacy|4|||
124954237|NCT00267956|449457670|FG001|Controlled Period|Lack of Efficacy|2|||
124954238|NCT00267956|449457671|FG002|Controlled Period|Lack of Efficacy|0|||
124954239|NCT00267956|449457672|FG003|Controlled Period|Lack of Efficacy|0|||
124954240|NCT00267956|449457669|FG000|Controlled Period|Lost to Follow-up|2|||
124954241|NCT00267956|449457670|FG001|Controlled Period|Lost to Follow-up|0|||
124954242|NCT00267956|449457671|FG002|Controlled Period|Lost to Follow-up|0|||
124954243|NCT00267956|449457672|FG003|Controlled Period|Lost to Follow-up|0|||
124954244|NCT00267956|449457669|FG000|Controlled Period|Withdrew consent|3|||
124954245|NCT00267956|449457670|FG001|Controlled Period|Withdrew consent|1|||
124954246|NCT00267956|449457671|FG002|Controlled Period|Withdrew consent|0|||
124954247|NCT00267956|449457672|FG003|Controlled Period|Withdrew consent|0|||
124954248|NCT00267956|449457669|FG000|After Controlled Period|Adverse Event|0|||
124954249|NCT00267956|449457670|FG001|After Controlled Period|Adverse Event|0|||
124954250|NCT00267956|449457671|FG002|After Controlled Period|Adverse Event|2|||
124954251|NCT00267956|449457672|FG003|After Controlled Period|Adverse Event|1|||
124954252|NCT00267956|449457669|FG000|After Controlled Period|Lack of Efficacy|0|||
124954253|NCT00267956|449457670|FG001|After Controlled Period|Lack of Efficacy|0|||
124954254|NCT00267956|449457671|FG002|After Controlled Period|Lack of Efficacy|1|||
124954255|NCT00267956|449457672|FG003|After Controlled Period|Lack of Efficacy|1|||
124954256|NCT00267956|449457669|FG000|After Controlled Period|Lost to Follow-up|0|||
124954257|NCT00267956|449457670|FG001|After Controlled Period|Lost to Follow-up|0|||
124954258|NCT00267956|449457671|FG002|After Controlled Period|Lost to Follow-up|1|||
124954259|NCT00267956|449457672|FG003|After Controlled Period|Lost to Follow-up|0|||
124954260|NCT00267956|449457669|FG000|After Controlled Period|Withdrew consent|0|||
124954261|NCT00267956|449457670|FG001|After Controlled Period|Withdrew consent|0|||
124954262|NCT00267956|449457671|FG002|After Controlled Period|Withdrew consent|1|||
124954263|NCT00267956|449457672|FG003|After Controlled Period|Withdrew consent|0|||
124954264|NCT01263223|449457673|FG000|Period 2|Withdrawal by Subject|0|||
124954265|NCT01263223|449457674|FG001|Period 2|Withdrawal by Subject|1|||
124954266|NCT01263223|449457673|FG000|7-day Follow-up|Withdrawal by Subject|0|||
124954267|NCT01263223|449457674|FG001|7-day Follow-up|Withdrawal by Subject|1|||
124954268|NCT01263223|449457673|FG000|7-day Follow-up|Lost to Follow-up|1|||
124954269|NCT01263223|449457674|FG001|7-day Follow-up|Lost to Follow-up|0|||
124954270|NCT02246647|449457675|FG000|Overall Study|Withdrawal by Subject|1|||
124954271|NCT02246647|449457676|FG001|Overall Study|Withdrawal by Subject|1|||
124954272|NCT01012999|449457678|FG000|Overall Study|Protocol Violation|1|||
124954273|NCT03557307|449457679|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
124954274|NCT03557307|449457679|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
124954275|NCT03557307|449457679|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
124954276|NCT03557307|449457679|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
124954277|NCT03557307|449457679|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
124954278|NCT03557307|449457679|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
124954279|NCT03557307|449457679|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
124954280|NCT03557307|449457679|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
124954281|NCT03557307|449457679|FG000|Period 2: Maintenance Phase|Death|3|||
124954282|NCT03557307|449457679|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
124954283|NCT03557307|449457679|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
124954284|NCT03557307|449457679|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
125030664|NCT00792298|449735012|FG005|Treatment Period 2|Pregnancy|0|||
124954285|NCT03557307|449457679|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
124954286|NCT03557307|449457679|FG000|Period 2: Maintenance Phase|other|3|||
124954287|NCT04175834|449457680|FG000|Overall Study|Withdrawal by Subject|1|||
124954288|NCT04175834|449457681|FG001|Overall Study|Withdrawal by Subject|0|||
124954289|NCT03184519|449457682|FG000|Overall Study|Lost to Follow-up|6|||
124954290|NCT03184519|449457682|FG000|Overall Study|Physician Decision|21|||
125030665|NCT00792298|449735013|FG006|Treatment Period 2|Pregnancy|0|||
125030666|NCT00792298|449735014|FG007|Treatment Period 2|Pregnancy|0|||
125030667|NCT00792298|449735007|FG000|Treatment Period 2|Withdrawal by Subject|1|||
125030668|NCT00792298|449735008|FG001|Treatment Period 2|Withdrawal by Subject|1|||
124954291|NCT04239911|449457683|FG000|Overall Study|Lost to Follow-up|2|||
124954292|NCT04239911|449457684|FG001|Overall Study|Lost to Follow-up|1|||
124954293|NCT00584909|449457690|FG000|Overall Study|Adverse Event|4|||
124954294|NCT03345407|449457691|FG000|Overall Study|Withdrawal by Subject|11|||
124954295|NCT03345407|449457692|FG001|Overall Study|Withdrawal by Subject|1|||
124954296|NCT03345407|449457693|FG002|Overall Study|Withdrawal by Subject|5|||
124954297|NCT03345407|449457694|FG003|Overall Study|Withdrawal by Subject|6|||
124954298|NCT03345407|449457695|FG004|Overall Study|Withdrawal by Subject|3|||
124954299|NCT03345407|449457696|FG005|Overall Study|Withdrawal by Subject|6|||
124954300|NCT03345407|449457697|FG006|Overall Study|Withdrawal by Subject|16|||
124954301|NCT03345407|449457691|FG000|Overall Study|Physician Decision|3|||
124954302|NCT03345407|449457692|FG001|Overall Study|Physician Decision|1|||
124954303|NCT03345407|449457693|FG002|Overall Study|Physician Decision|0|||
124954304|NCT03345407|449457694|FG003|Overall Study|Physician Decision|0|||
124954305|NCT03345407|449457695|FG004|Overall Study|Physician Decision|1|||
124954306|NCT03345407|449457696|FG005|Overall Study|Physician Decision|2|||
124954307|NCT03345407|449457697|FG006|Overall Study|Physician Decision|3|||
124954308|NCT03345407|449457691|FG000|Overall Study|Lost to Follow-up|2|||
124954309|NCT03345407|449457692|FG001|Overall Study|Lost to Follow-up|0|||
124954310|NCT03345407|449457693|FG002|Overall Study|Lost to Follow-up|1|||
124954311|NCT03345407|449457694|FG003|Overall Study|Lost to Follow-up|0|||
124954312|NCT03345407|449457695|FG004|Overall Study|Lost to Follow-up|1|||
124954313|NCT03345407|449457696|FG005|Overall Study|Lost to Follow-up|2|||
124954314|NCT03345407|449457697|FG006|Overall Study|Lost to Follow-up|3|||
124954315|NCT03345407|449457691|FG000|Overall Study|Protocol-defined stopping criteria|9|||
124954316|NCT03345407|449457692|FG001|Overall Study|Protocol-defined stopping criteria|0|||
124954317|NCT03345407|449457693|FG002|Overall Study|Protocol-defined stopping criteria|0|||
124954318|NCT03345407|449457694|FG003|Overall Study|Protocol-defined stopping criteria|0|||
124954319|NCT03345407|449457695|FG004|Overall Study|Protocol-defined stopping criteria|2|||
124954320|NCT03345407|449457696|FG005|Overall Study|Protocol-defined stopping criteria|1|||
124954321|NCT03345407|449457697|FG006|Overall Study|Protocol-defined stopping criteria|1|||
124954322|NCT03345407|449457691|FG000|Overall Study|Protocol Violation|2|||
124954323|NCT03345407|449457692|FG001|Overall Study|Protocol Violation|0|||
124954324|NCT03345407|449457693|FG002|Overall Study|Protocol Violation|0|||
124954325|NCT03345407|449457694|FG003|Overall Study|Protocol Violation|0|||
124954326|NCT03345407|449457695|FG004|Overall Study|Protocol Violation|1|||
124954327|NCT03345407|449457696|FG005|Overall Study|Protocol Violation|0|||
124954328|NCT03345407|449457697|FG006|Overall Study|Protocol Violation|3|||
124954329|NCT03345407|449457691|FG000|Overall Study|Lack of Efficacy|1|||
124954330|NCT03345407|449457692|FG001|Overall Study|Lack of Efficacy|1|||
124954331|NCT03345407|449457693|FG002|Overall Study|Lack of Efficacy|1|||
124954332|NCT03345407|449457694|FG003|Overall Study|Lack of Efficacy|1|||
124954333|NCT03345407|449457695|FG004|Overall Study|Lack of Efficacy|1|||
124954334|NCT03345407|449457696|FG005|Overall Study|Lack of Efficacy|0|||
124954335|NCT03345407|449457697|FG006|Overall Study|Lack of Efficacy|3|||
124954336|NCT03345407|449457691|FG000|Overall Study|Adverse Event|4|||
124954337|NCT03345407|449457692|FG001|Overall Study|Adverse Event|0|||
124954338|NCT03345407|449457693|FG002|Overall Study|Adverse Event|5|||
124954339|NCT03345407|449457694|FG003|Overall Study|Adverse Event|4|||
124954340|NCT03345407|449457695|FG004|Overall Study|Adverse Event|6|||
124954341|NCT03345407|449457696|FG005|Overall Study|Adverse Event|5|||
124954342|NCT03345407|449457697|FG006|Overall Study|Adverse Event|16|||
124954343|NCT02256553|449457700|FG000|Period I|Adverse Event|5|||
124954344|NCT02256553|449457700|FG000|Period I|Protocol Violation|1|||
124954345|NCT02256553|449457700|FG000|Period II|Adverse Event|1|||
124954346|NCT02256553|449457700|FG000|Period II|Subject Moved|1|||
124954347|NCT02256553|449457700|FG000|Period III|Adverse Event|3|||
124954348|NCT02092909|449457701|FG000|Overall Study|Adverse Event|0|||
124954349|NCT02092909|449457702|FG001|Overall Study|Adverse Event|0|||
124954350|NCT02092909|449457703|FG002|Overall Study|Adverse Event|4|||
124954351|NCT02092909|449457704|FG003|Overall Study|Adverse Event|2|||
124954352|NCT02092909|449457701|FG000|Overall Study|Lack of Efficacy|0|||
124954353|NCT02092909|449457702|FG001|Overall Study|Lack of Efficacy|2|||
124954354|NCT02092909|449457703|FG002|Overall Study|Lack of Efficacy|1|||
124954355|NCT02092909|449457704|FG003|Overall Study|Lack of Efficacy|0|||
124954356|NCT02092909|449457701|FG000|Overall Study|Withdrawal by Subject|0|||
124954357|NCT02092909|449457702|FG001|Overall Study|Withdrawal by Subject|0|||
124954358|NCT02092909|449457703|FG002|Overall Study|Withdrawal by Subject|2|||
124954359|NCT02092909|449457704|FG003|Overall Study|Withdrawal by Subject|1|||
124954360|NCT02092909|449457701|FG000|Overall Study|Study terminated by Sponsor|0|||
124954361|NCT02092909|449457702|FG001|Overall Study|Study terminated by Sponsor|0|||
124954362|NCT02092909|449457703|FG002|Overall Study|Study terminated by Sponsor|0|||
124954363|NCT02092909|449457704|FG003|Overall Study|Study terminated by Sponsor|2|||
124954364|NCT02092909|449457701|FG000|Overall Study|Miscellaneous|1|||
124954365|NCT02092909|449457702|FG001|Overall Study|Miscellaneous|1|||
124954366|NCT02092909|449457703|FG002|Overall Study|Miscellaneous|2|||
124954367|NCT02092909|449457704|FG003|Overall Study|Miscellaneous|1|||
124954368|NCT03436797|449457705|FG000|Main Study|Withdrawal by Subject|2|||
124954369|NCT03436797|449457705|FG000|Main Study|Adverse Event|4|||
124954370|NCT03436797|449457705|FG000|Main Study|Lost to Follow-up|1|||
124954371|NCT03436797|449457705|FG000|Main Study|Death|1|||
124954372|NCT03436797|449457705|FG000|Main Study|Non-Specific|2|||
124954373|NCT03436797|449457705|FG000|Extended Dosing|Patient decision|1|||
124954374|NCT04626128|449457708|FG000|Overall Study|Withdrawal by Subject|0|||
124954375|NCT04626128|449457709|FG001|Overall Study|Withdrawal by Subject|1|||
124954376|NCT04626128|449457710|FG002|Overall Study|Withdrawal by Subject|0|||
124954377|NCT04626128|449457711|FG003|Overall Study|Withdrawal by Subject|0|||
124954378|NCT01182285|449457712|FG000|First Intervention Week 1-10|Disease progression|1|||
124954379|NCT01182285|449457713|FG001|First Intervention Week 1-10|Disease progression|0|||
124954380|NCT01182285|449457714|FG002|First Intervention Week 1-10|Disease progression|0|||
124954381|NCT01182285|449457712|FG000|First Intervention Week 1-10|Adverse Event|1|||
124954382|NCT01182285|449457713|FG001|First Intervention Week 1-10|Adverse Event|0|||
124954383|NCT01182285|449457714|FG002|First Intervention Week 1-10|Adverse Event|0|||
124954384|NCT01182285|449457712|FG000|First Intervention Week 1-10|Non-compliance|1|||
124954385|NCT01182285|449457713|FG001|First Intervention Week 1-10|Non-compliance|0|||
124954386|NCT01182285|449457714|FG002|First Intervention Week 1-10|Non-compliance|0|||
124954387|NCT01182285|449457712|FG000|Third Intervention Week 11-52|Disease Progression|0|||
124954388|NCT01182285|449457713|FG001|Third Intervention Week 11-52|Disease Progression|0|||
124954389|NCT01182285|449457714|FG002|Third Intervention Week 11-52|Disease Progression|6|||
124954390|NCT01182285|449457712|FG000|Third Intervention Week 11-52|Other|0|||
124954391|NCT01182285|449457713|FG001|Third Intervention Week 11-52|Other|0|||
124954392|NCT01182285|449457714|FG002|Third Intervention Week 11-52|Other|2|||
124954393|NCT01951105|449457717|FG000|Overall Study|Adverse Event|0|||
124954394|NCT01951105|449457718|FG001|Overall Study|Adverse Event|5|||
124954395|NCT01951105|449457719|FG002|Overall Study|Adverse Event|0|||
124954396|NCT01951105|449457717|FG000|Overall Study|Lost to Follow-up|0|||
124954397|NCT01951105|449457718|FG001|Overall Study|Lost to Follow-up|1|||
124954398|NCT01951105|449457719|FG002|Overall Study|Lost to Follow-up|0|||
124954399|NCT01951105|449457717|FG000|Overall Study|Protocol Violation|1|||
124954400|NCT01951105|449457718|FG001|Overall Study|Protocol Violation|1|||
124954401|NCT01951105|449457719|FG002|Overall Study|Protocol Violation|1|||
124954402|NCT01951105|449457717|FG000|Overall Study|Withdrawal by Subject|0|||
124954403|NCT01951105|449457718|FG001|Overall Study|Withdrawal by Subject|3|||
124954404|NCT01951105|449457719|FG002|Overall Study|Withdrawal by Subject|1|||
124954405|NCT03209492|449457720|FG000|Overall Study|Case Report Forms Uncollected|5|||
124954406|NCT02604199|449457723|FG000|Overall Study|Pregnancy|0|||
124954407|NCT02604199|449457724|FG001|Overall Study|Pregnancy|0|||
124954408|NCT02604199|449457725|FG002|Overall Study|Pregnancy|0|||
124954409|NCT02604199|449457726|FG003|Overall Study|Pregnancy|1|||
124954410|NCT02604199|449457723|FG000|Overall Study|Study terminated by sponsor|0|||
124954411|NCT02604199|449457724|FG001|Overall Study|Study terminated by sponsor|2|||
124954412|NCT02604199|449457725|FG002|Overall Study|Study terminated by sponsor|0|||
124954413|NCT02604199|449457726|FG003|Overall Study|Study terminated by sponsor|2|||
124954414|NCT02604199|449457723|FG000|Overall Study|Withdrawal by Subject|0|||
124954415|NCT02604199|449457724|FG001|Overall Study|Withdrawal by Subject|1|||
124954416|NCT02604199|449457725|FG002|Overall Study|Withdrawal by Subject|0|||
124954417|NCT02604199|449457726|FG003|Overall Study|Withdrawal by Subject|0|||
124954418|NCT02812706|449457727|FG000|Phase 1|Adverse Event|0|||
124954419|NCT02812706|449457728|FG001|Phase 1|Adverse Event|2|||
124954420|NCT02812706|449457729|FG002|Phase 1|Adverse Event|0|||
124954421|NCT02812706|449457727|FG000|Phase 1|Progressive disease|3|||
124954422|NCT02812706|449457728|FG001|Phase 1|Progressive disease|3|||
124954423|NCT02812706|449457729|FG002|Phase 1|Progressive disease|0|||
124954424|NCT02812706|449457727|FG000|Phase 2|Adverse Event|0|||
125030669|NCT00792298|449735009|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125030670|NCT00792298|449735010|FG003|Treatment Period 2|Withdrawal by Subject|2|||
125125487|NCT00414466|450085744|FG001|Overall Study|Adverse Event|0|||
125125488|NCT00414466|450085745|FG002|Overall Study|Adverse Event|1|||
125125489|NCT00414466|450085746|FG003|Overall Study|Adverse Event|1|||
125125490|NCT00414466|450085743|FG000|Overall Study|Lack of Efficacy|1|||
125125491|NCT00414466|450085744|FG001|Overall Study|Lack of Efficacy|0|||
125125492|NCT00414466|450085745|FG002|Overall Study|Lack of Efficacy|0|||
125125493|NCT00414466|450085746|FG003|Overall Study|Lack of Efficacy|0|||
124954425|NCT02812706|449457728|FG001|Phase 2|Adverse Event|0|||
124954426|NCT02812706|449457729|FG002|Phase 2|Adverse Event|2|||
124954427|NCT02812706|449457727|FG000|Phase 2|Progressive disease|0|||
125125494|NCT00414466|450085743|FG000|Overall Study|Withdrawn by Sponsor|1|||
125125495|NCT00414466|450085744|FG001|Overall Study|Withdrawn by Sponsor|0|||
125125496|NCT00414466|450085745|FG002|Overall Study|Withdrawn by Sponsor|0|||
125125497|NCT00414466|450085746|FG003|Overall Study|Withdrawn by Sponsor|0|||
125125498|NCT02637232|450085747|FG000|Overall Study|Lost to Follow-up|42|||
125125499|NCT02637232|450085747|FG000|Overall Study|Adverse Event|11|||
124954428|NCT02812706|449457728|FG001|Phase 2|Progressive disease|0|||
124954429|NCT02812706|449457729|FG002|Phase 2|Progressive disease|22|||
124954430|NCT02812706|449457727|FG000|Phase 2|Other-Unspecified|0|||
124954431|NCT02812706|449457728|FG001|Phase 2|Other-Unspecified|0|||
124954432|NCT02812706|449457729|FG002|Phase 2|Other-Unspecified|4|||
124954433|NCT03166215|449457735|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
124954434|NCT03166215|449457736|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
124954435|NCT03166215|449457737|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
124954436|NCT03166215|449457735|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
124954437|NCT03166215|449457736|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
124954438|NCT03166215|449457737|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
124954439|NCT02632045|449457738|FG000|Overall Study|Withdrawal by Subject|1|||
124954440|NCT02632045|449457739|FG001|Overall Study|Withdrawal by Subject|2|||
124954441|NCT01613599|449457740|FG000|Overall Study|Death|9|||
124954442|NCT01613599|449457740|FG000|Overall Study|Lost to Follow-up|5|||
124954443|NCT01613599|449457740|FG000|Overall Study|Withdrawal by Subject|8|||
124954444|NCT01613599|449457740|FG000|Overall Study|Reason not specified|3|||
124954445|NCT01075815|449457742|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
124954446|NCT01075815|449457743|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
124954447|NCT01075815|449457742|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
124954448|NCT01075815|449457743|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
124954449|NCT01075815|449457742|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
124954450|NCT01075815|449457743|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
124954451|NCT00617708|449457744|FG000|Overall Study|Adverse Event|0|||
124954452|NCT00617708|449457745|FG001|Overall Study|Adverse Event|6|||
124954453|NCT00617708|449457746|FG002|Overall Study|Adverse Event|9|||
124954454|NCT00617708|449457744|FG000|Overall Study|Withdrawal by Subject|1|||
124954455|NCT00617708|449457745|FG001|Overall Study|Withdrawal by Subject|1|||
124954456|NCT00617708|449457746|FG002|Overall Study|Withdrawal by Subject|7|||
124954457|NCT00617708|449457744|FG000|Overall Study|Death|0|||
124954458|NCT00617708|449457745|FG001|Overall Study|Death|6|||
124954459|NCT00617708|449457746|FG002|Overall Study|Death|5|||
124954460|NCT00617708|449457744|FG000|Overall Study|Progression/Relapse|7|||
124954461|NCT00617708|449457745|FG001|Overall Study|Progression/Relapse|40|||
124954462|NCT00617708|449457746|FG002|Overall Study|Progression/Relapse|36|||
124954463|NCT00617708|449457744|FG000|Overall Study|Not protocol specified|1|||
124954464|NCT00617708|449457745|FG001|Overall Study|Not protocol specified|4|||
125125500|NCT02637232|450085747|FG000|Overall Study|patient 's decision|2|||
125125501|NCT02395822|450085751|FG000|Overall Study|Withdrawal by Subject|1|||
125125502|NCT02395822|450085751|FG000|Overall Study|Death|1|||
125125503|NCT02937701|450085752|FG000|Day 1 to Week 22|Adverse Event|11|||
125125504|NCT02937701|450085753|FG001|Day 1 to Week 22|Adverse Event|14|||
125125505|NCT02937701|450085754|FG002|Day 1 to Week 22|Adverse Event|0|||
125125506|NCT02937701|450085755|FG003|Day 1 to Week 22|Adverse Event|0|||
124954465|NCT00617708|449457746|FG002|Overall Study|Not protocol specified|2|||
124954466|NCT00617708|449457744|FG000|Overall Study|Not eligible|1|||
124954467|NCT00617708|449457745|FG001|Overall Study|Not eligible|3|||
124954468|NCT00617708|449457746|FG002|Overall Study|Not eligible|5|||
124954469|NCT02058992|449457747|FG000|Overall Study|Lost to Follow-up|4|||
124954470|NCT02058992|449457747|FG000|Overall Study|Protocol Violation|92|||
124954471|NCT02058992|449457747|FG000|Overall Study|CRF Uncollected|20|||
124954472|NCT03503188|449457748|FG000|Overall Study|Non eligible in the sub study|0|||
124954473|NCT03503188|449457749|FG001|Overall Study|Non eligible in the sub study|1|||
124954474|NCT03747575|449457756|FG000|Overall Study|Withdrawal by Subject|6|||
125125507|NCT02937701|450085756|FG004|Day 1 to Week 22|Adverse Event|0|||
125125508|NCT02937701|450085752|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
125125509|NCT02937701|450085753|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
125125510|NCT02937701|450085754|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
125125511|NCT02937701|450085755|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
125125512|NCT02937701|450085756|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
125215284|NCT02559570|450414981|FG003|Overall Study|Adverse Event|1|||
124954475|NCT03747575|449457757|FG001|Overall Study|Withdrawal by Subject|3|||
124954476|NCT03747575|449457756|FG000|Overall Study|Lost to Follow-up|3|||
124954477|NCT03747575|449457757|FG001|Overall Study|Lost to Follow-up|3|||
124954478|NCT03747575|449457756|FG000|Overall Study|Adverse Event|0|||
124954479|NCT03747575|449457757|FG001|Overall Study|Adverse Event|1|||
125125513|NCT02937701|450085752|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
124954480|NCT00321555|449457758|FG000|Overall Study|Developed antibodies|1|||
124954481|NCT00321555|449457758|FG000|Overall Study|Switched to alternative treatment|3|||
124954482|NCT00321555|449457758|FG000|Overall Study|Physician Decision|1|||
124954483|NCT00321555|449457758|FG000|Overall Study|Disease progression on study|1|||
124954484|NCT02066389|449457763|FG000|Overall Study|Adverse Event|1|||
124954485|NCT02066389|449457764|FG001|Overall Study|Adverse Event|1|||
124954486|NCT02066389|449457765|FG002|Overall Study|Adverse Event|1|||
124954487|NCT02066389|449457766|FG003|Overall Study|Adverse Event|1|||
124954488|NCT02066389|449457767|FG004|Overall Study|Adverse Event|5|||
124954489|NCT02066389|449457768|FG005|Overall Study|Adverse Event|1|||
124954490|NCT02066389|449457763|FG000|Overall Study|Withdrawal by Subject|4|||
124954491|NCT02066389|449457764|FG001|Overall Study|Withdrawal by Subject|0|||
124954492|NCT02066389|449457765|FG002|Overall Study|Withdrawal by Subject|5|||
124954493|NCT02066389|449457766|FG003|Overall Study|Withdrawal by Subject|1|||
124954494|NCT02066389|449457767|FG004|Overall Study|Withdrawal by Subject|1|||
124954495|NCT02066389|449457768|FG005|Overall Study|Withdrawal by Subject|2|||
124954496|NCT02066389|449457763|FG000|Overall Study|Lost to Follow-up|0|||
124954497|NCT02066389|449457764|FG001|Overall Study|Lost to Follow-up|0|||
124954498|NCT02066389|449457765|FG002|Overall Study|Lost to Follow-up|0|||
124954499|NCT02066389|449457766|FG003|Overall Study|Lost to Follow-up|1|||
124954500|NCT02066389|449457767|FG004|Overall Study|Lost to Follow-up|1|||
124954501|NCT02066389|449457768|FG005|Overall Study|Lost to Follow-up|1|||
124954502|NCT02066389|449457763|FG000|Overall Study|Randomized in Error|0|||
124954503|NCT02066389|449457764|FG001|Overall Study|Randomized in Error|0|||
124954504|NCT02066389|449457765|FG002|Overall Study|Randomized in Error|0|||
124954505|NCT02066389|449457766|FG003|Overall Study|Randomized in Error|0|||
124954506|NCT02066389|449457767|FG004|Overall Study|Randomized in Error|0|||
124954507|NCT02066389|449457768|FG005|Overall Study|Randomized in Error|1|||
124954508|NCT01755598|449457771|FG000|Overall Study|Other|109|||
124954509|NCT01755598|449457772|FG001|Overall Study|Other|109|||
124954510|NCT01755598|449457771|FG000|Overall Study|Lost to Follow-up|32|||
124954511|NCT01755598|449457772|FG001|Overall Study|Lost to Follow-up|43|||
124954512|NCT01755598|449457771|FG000|Overall Study|Migrated/moved from study area|76|||
124954513|NCT01755598|449457772|FG001|Overall Study|Migrated/moved from study area|65|||
124954514|NCT01755598|449457771|FG000|Overall Study|Withdrawal by Subject|22|||
124954515|NCT01755598|449457772|FG001|Overall Study|Withdrawal by Subject|31|||
124954516|NCT01755598|449457771|FG000|Overall Study|Protocol Violation|7|||
124954517|NCT01755598|449457772|FG001|Overall Study|Protocol Violation|7|||
124954518|NCT01755598|449457771|FG000|Overall Study|Adverse Event|19|||
124954519|NCT01755598|449457772|FG001|Overall Study|Adverse Event|28|||
124954520|NCT02924051|449457775|FG000|Overall Study|Withdrawal by Subject|1|||
124954521|NCT02924051|449457776|FG001|Overall Study|Withdrawal by Subject|9|||
124954522|NCT03005106|449457779|FG000|Overall Study|Lost to Follow-up|16|||
124954523|NCT03005106|449457779|FG000|Overall Study|Adverse Event|1|||
124954524|NCT03005106|449457779|FG000|Overall Study|Physician Decision|1|||
124954525|NCT03005106|449457779|FG000|Overall Study|Death|2|||
124954526|NCT00321672|449457780|FG000|Overall Study|Withdrawal by Subject|5|||
124954527|NCT00321672|449457781|FG001|Overall Study|Withdrawal by Subject|1|||
124954528|NCT00321672|449457782|FG002|Overall Study|Withdrawal by Subject|2|||
124954529|NCT00321672|449457783|FG003|Overall Study|Withdrawal by Subject|0|||
124954530|NCT00321672|449457780|FG000|Overall Study|Noncompliance|1|||
124954531|NCT00321672|449457781|FG001|Overall Study|Noncompliance|2|||
124954532|NCT00321672|449457782|FG002|Overall Study|Noncompliance|1|||
124954533|NCT00321672|449457783|FG003|Overall Study|Noncompliance|0|||
124954534|NCT00321672|449457780|FG000|Overall Study|Adverse Event|1|||
124954535|NCT00321672|449457781|FG001|Overall Study|Adverse Event|1|||
124954536|NCT00321672|449457782|FG002|Overall Study|Adverse Event|0|||
124954537|NCT00321672|449457783|FG003|Overall Study|Adverse Event|0|||
124954538|NCT00321672|449457780|FG000|Overall Study|Lack of Efficacy|1|||
124954539|NCT00321672|449457781|FG001|Overall Study|Lack of Efficacy|1|||
124954540|NCT00321672|449457782|FG002|Overall Study|Lack of Efficacy|0|||
124954541|NCT00321672|449457783|FG003|Overall Study|Lack of Efficacy|0|||
124954542|NCT00321672|449457780|FG000|Overall Study|Lost to Follow-up|2|||
124954543|NCT00321672|449457781|FG001|Overall Study|Lost to Follow-up|0|||
124954544|NCT00321672|449457782|FG002|Overall Study|Lost to Follow-up|4|||
124954545|NCT00321672|449457783|FG003|Overall Study|Lost to Follow-up|2|||
124954546|NCT00321672|449457780|FG000|Overall Study|Death|1|||
124954547|NCT00321672|449457781|FG001|Overall Study|Death|0|||
124954548|NCT00321672|449457782|FG002|Overall Study|Death|0|||
124954549|NCT00321672|449457783|FG003|Overall Study|Death|0|||
124954550|NCT00321672|449457780|FG000|Overall Study|Too far to travel for visits|1|||
124954551|NCT00321672|449457781|FG001|Overall Study|Too far to travel for visits|0|||
124954552|NCT00321672|449457782|FG002|Overall Study|Too far to travel for visits|0|||
124954553|NCT00321672|449457783|FG003|Overall Study|Too far to travel for visits|0|||
124954554|NCT00321672|449457780|FG000|Overall Study|Incarcerated|0|||
124954555|NCT00321672|449457781|FG001|Overall Study|Incarcerated|0|||
124954556|NCT00321672|449457782|FG002|Overall Study|Incarcerated|2|||
124954557|NCT00321672|449457783|FG003|Overall Study|Incarcerated|0|||
124954558|NCT00321672|449457780|FG000|Overall Study|Moved out of state|0|||
124954559|NCT00321672|449457781|FG001|Overall Study|Moved out of state|1|||
124954560|NCT00321672|449457782|FG002|Overall Study|Moved out of state|1|||
124954561|NCT00321672|449457783|FG003|Overall Study|Moved out of state|0|||
124954562|NCT00321672|449457780|FG000|Overall Study|Protocol Violation|0|||
124954563|NCT00321672|449457781|FG001|Overall Study|Protocol Violation|0|||
124954564|NCT00321672|449457782|FG002|Overall Study|Protocol Violation|1|||
124954565|NCT00321672|449457783|FG003|Overall Study|Protocol Violation|0|||
124954566|NCT00321672|449457780|FG000|Overall Study|Diagnosis of testicular cancer|0|||
124954567|NCT00321672|449457781|FG001|Overall Study|Diagnosis of testicular cancer|1|||
124954568|NCT00321672|449457782|FG002|Overall Study|Diagnosis of testicular cancer|0|||
124954569|NCT00321672|449457783|FG003|Overall Study|Diagnosis of testicular cancer|0|||
124954570|NCT00321672|449457780|FG000|Overall Study|Extensive travel required for new job|0|||
124954571|NCT00321672|449457781|FG001|Overall Study|Extensive travel required for new job|1|||
124954572|NCT00321672|449457782|FG002|Overall Study|Extensive travel required for new job|0|||
124954573|NCT00321672|449457783|FG003|Overall Study|Extensive travel required for new job|0|||
124954574|NCT00512902|449457786|FG000|Overall Study|Adverse Event|7|||
124954575|NCT00512902|449457786|FG000|Overall Study|Lost to Follow-up|1|||
124954576|NCT01730118|449458978|FG000|Dose Escalation|Death on study|5|||
124954577|NCT01730118|449458979|FG001|Dose Escalation|Death on study|7|||
124954578|NCT01730118|449458980|FG002|Dose Escalation|Death on study|2|||
124954579|NCT01730118|449458981|FG003|Dose Escalation|Death on study|6|||
124954580|NCT01730118|449458982|FG004|Dose Escalation|Death on study|0|||
124954581|NCT01730118|449458983|FG005|Dose Escalation|Death on study|0|||
124954582|NCT01730118|449458984|FG006|Dose Escalation|Death on study|0|||
124954583|NCT01730118|449458978|FG000|Dose Escalation|Died before treatment|0|||
124954584|NCT01730118|449458979|FG001|Dose Escalation|Died before treatment|0|||
124954585|NCT01730118|449458980|FG002|Dose Escalation|Died before treatment|0|||
124954586|NCT01730118|449458981|FG003|Dose Escalation|Died before treatment|0|||
124954587|NCT01730118|449458982|FG004|Dose Escalation|Died before treatment|0|||
124954588|NCT01730118|449458983|FG005|Dose Escalation|Died before treatment|0|||
124954589|NCT01730118|449458984|FG006|Dose Escalation|Died before treatment|1|||
124954590|NCT01730118|449458978|FG000|Dose Escalation|Chose to start a different treatment|1|||
124954591|NCT01730118|449458979|FG001|Dose Escalation|Chose to start a different treatment|0|||
124954592|NCT01730118|449458980|FG002|Dose Escalation|Chose to start a different treatment|0|||
124954593|NCT01730118|449458981|FG003|Dose Escalation|Chose to start a different treatment|0|||
124954594|NCT01730118|449458982|FG004|Dose Escalation|Chose to start a different treatment|0|||
124954595|NCT01730118|449458983|FG005|Dose Escalation|Chose to start a different treatment|0|||
124954596|NCT01730118|449458984|FG006|Dose Escalation|Chose to start a different treatment|0|||
124954597|NCT01730118|449458978|FG000|Dose Escalation|Withdrawal by Subject|0|||
124954598|NCT01730118|449458979|FG001|Dose Escalation|Withdrawal by Subject|0|||
124954599|NCT01730118|449458980|FG002|Dose Escalation|Withdrawal by Subject|1|||
124954600|NCT01730118|449458981|FG003|Dose Escalation|Withdrawal by Subject|0|||
124954601|NCT01730118|449458982|FG004|Dose Escalation|Withdrawal by Subject|0|||
124954602|NCT01730118|449458983|FG005|Dose Escalation|Withdrawal by Subject|0|||
124954603|NCT01730118|449458984|FG006|Dose Escalation|Withdrawal by Subject|0|||
124954604|NCT01730118|449458978|FG000|Dose Escalation|Disease progression prior to treatment|0|||
124954605|NCT01730118|449458979|FG001|Dose Escalation|Disease progression prior to treatment|0|||
124954606|NCT01730118|449458980|FG002|Dose Escalation|Disease progression prior to treatment|0|||
124954607|NCT01730118|449458981|FG003|Dose Escalation|Disease progression prior to treatment|0|||
124954608|NCT01730118|449458982|FG004|Dose Escalation|Disease progression prior to treatment|0|||
124954609|NCT01730118|449458983|FG005|Dose Escalation|Disease progression prior to treatment|0|||
124954610|NCT01730118|449458984|FG006|Dose Escalation|Disease progression prior to treatment|1|||
124954611|NCT01730118|449458978|FG000|Dose Expansion|Death|0|||
124954612|NCT01730118|449458979|FG001|Dose Expansion|Death|0|||
124954613|NCT01730118|449458980|FG002|Dose Expansion|Death|0|||
124954614|NCT01730118|449458981|FG003|Dose Expansion|Death|0|||
125215285|NCT02559570|450414982|FG004|Overall Study|Adverse Event|0|||
125215286|NCT02559570|450414978|FG000|Overall Study|Withdrawal of Consent|0|||
124954615|NCT01730118|449458982|FG004|Dose Expansion|Death|1|||
124954616|NCT01730118|449458983|FG005|Dose Expansion|Death|0|||
124954617|NCT01730118|449458984|FG006|Dose Expansion|Death|0|||
124954618|NCT01730118|449458978|FG000|Dose Expansion|Other medical condition|0|||
124954619|NCT01730118|449458979|FG001|Dose Expansion|Other medical condition|0|||
124954620|NCT01730118|449458980|FG002|Dose Expansion|Other medical condition|0|||
124954621|NCT01730118|449458981|FG003|Dose Expansion|Other medical condition|0|||
124954622|NCT01730118|449458982|FG004|Dose Expansion|Other medical condition|1|||
124954623|NCT01730118|449458983|FG005|Dose Expansion|Other medical condition|0|||
124954624|NCT01730118|449458984|FG006|Dose Expansion|Other medical condition|0|||
124954625|NCT01730118|449458978|FG000|Dose Expansion|Withdrawal by Subject|0|||
124954626|NCT01730118|449458979|FG001|Dose Expansion|Withdrawal by Subject|0|||
124954627|NCT01730118|449458980|FG002|Dose Expansion|Withdrawal by Subject|0|||
124954628|NCT01730118|449458981|FG003|Dose Expansion|Withdrawal by Subject|0|||
124954629|NCT01730118|449458982|FG004|Dose Expansion|Withdrawal by Subject|1|||
124954630|NCT01730118|449458983|FG005|Dose Expansion|Withdrawal by Subject|0|||
124954631|NCT01730118|449458984|FG006|Dose Expansion|Withdrawal by Subject|0|||
124954632|NCT01730118|449458978|FG000|Dose Expansion|Disease progression|0|||
124954633|NCT01730118|449458979|FG001|Dose Expansion|Disease progression|0|||
124954634|NCT01730118|449458980|FG002|Dose Expansion|Disease progression|0|||
124954635|NCT01730118|449458981|FG003|Dose Expansion|Disease progression|0|||
124954636|NCT01730118|449458982|FG004|Dose Expansion|Disease progression|0|||
124954637|NCT01730118|449458983|FG005|Dose Expansion|Disease progression|1|||
124954638|NCT01730118|449458984|FG006|Dose Expansion|Disease progression|0|||
124954639|NCT01730118|449458978|FG000|Dose Expansion|Inability to return|0|||
124954640|NCT01730118|449458979|FG001|Dose Expansion|Inability to return|0|||
124954641|NCT01730118|449458980|FG002|Dose Expansion|Inability to return|0|||
124954642|NCT01730118|449458981|FG003|Dose Expansion|Inability to return|0|||
124954643|NCT01730118|449458982|FG004|Dose Expansion|Inability to return|0|||
124954644|NCT01730118|449458983|FG005|Dose Expansion|Inability to return|1|||
124954645|NCT01730118|449458984|FG006|Dose Expansion|Inability to return|0|||
124954646|NCT01730118|449458978|FG000|Dose Expansion|Physician Decision|0|||
124954647|NCT01730118|449458979|FG001|Dose Expansion|Physician Decision|0|||
124954648|NCT01730118|449458980|FG002|Dose Expansion|Physician Decision|0|||
124954649|NCT01730118|449458981|FG003|Dose Expansion|Physician Decision|0|||
124954650|NCT01730118|449458982|FG004|Dose Expansion|Physician Decision|0|||
124954651|NCT01730118|449458983|FG005|Dose Expansion|Physician Decision|1|||
124954652|NCT01730118|449458984|FG006|Dose Expansion|Physician Decision|0|||
124954653|NCT00489489|449458986|FG000|Overall Study|Not treated due to protocol violation|0|||
124954654|NCT00489489|449458987|FG001|Overall Study|Not treated due to protocol violation|1|||
124954655|NCT00489489|449458988|FG002|Overall Study|Not treated due to protocol violation|1|||
124954656|NCT00489489|449458986|FG000|Overall Study|Adverse Event|1|||
124954657|NCT00489489|449458987|FG001|Overall Study|Adverse Event|1|||
124954658|NCT00489489|449458988|FG002|Overall Study|Adverse Event|1|||
124954659|NCT00489489|449458986|FG000|Overall Study|Protocol Violation|1|||
124954660|NCT00489489|449458987|FG001|Overall Study|Protocol Violation|0|||
124954661|NCT00489489|449458988|FG002|Overall Study|Protocol Violation|1|||
124954662|NCT00489489|449458986|FG000|Overall Study|Progressive disease|0|||
124954663|NCT00489489|449458987|FG001|Overall Study|Progressive disease|1|||
124954664|NCT00489489|449458988|FG002|Overall Study|Progressive disease|0|||
124954665|NCT00489489|449458986|FG000|Overall Study|Participant did not wish to continue|1|||
124954666|NCT00489489|449458987|FG001|Overall Study|Participant did not wish to continue|1|||
124954667|NCT00489489|449458988|FG002|Overall Study|Participant did not wish to continue|0|||
124954668|NCT00489489|449458986|FG000|Overall Study|Other than above|0|||
124954669|NCT00489489|449458987|FG001|Overall Study|Other than above|1|||
124954670|NCT00489489|449458988|FG002|Overall Study|Other than above|0|||
124954671|NCT04851587|449458991|FG000|Overall Study|Lost to Follow-up|18|||
124954672|NCT02101554|449458995|FG000|Overall Study|Protocol Violation|0|||
124954673|NCT02101554|449458996|FG001|Overall Study|Protocol Violation|1|||
124954674|NCT02101554|449458997|FG002|Overall Study|Protocol Violation|0|||
124954675|NCT02101554|449458995|FG000|Overall Study|Insufficient Clinical Response|0|||
124954676|NCT02101554|449458996|FG001|Overall Study|Insufficient Clinical Response|2|||
124954677|NCT02101554|449458997|FG002|Overall Study|Insufficient Clinical Response|0|||
124954678|NCT02101554|449458995|FG000|Overall Study|Adverse Event|2|||
124954679|NCT02101554|449458996|FG001|Overall Study|Adverse Event|1|||
124954680|NCT02101554|449458997|FG002|Overall Study|Adverse Event|1|||
124954681|NCT02101554|449458995|FG000|Overall Study|Lost to Follow-up|0|||
124954682|NCT02101554|449458996|FG001|Overall Study|Lost to Follow-up|1|||
124954683|NCT02101554|449458997|FG002|Overall Study|Lost to Follow-up|0|||
124954684|NCT02101554|449458995|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
124954685|NCT02101554|449458996|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
124954686|NCT02101554|449458997|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
124954687|NCT01350102|449458998|FG000|Overall Study|Adverse Event|0|||
124954688|NCT01350102|449458999|FG001|Overall Study|Adverse Event|0|||
124954689|NCT01350102|449459000|FG002|Overall Study|Adverse Event|1|||
124954690|NCT01350102|449459001|FG003|Overall Study|Adverse Event|0|||
124954691|NCT02136797|449459004|FG000|Overall Study|Not Treated|8|||
124954692|NCT04523571|449459005|FG000|Received 2 Doses|Withdrawal by Subject|0|||
124954693|NCT04523571|449459006|FG001|Received 2 Doses|Withdrawal by Subject|0|||
124954694|NCT04523571|449459007|FG002|Received 2 Doses|Withdrawal by Subject|0|||
125215287|NCT02559570|450414979|FG001|Overall Study|Withdrawal of Consent|0|||
125215288|NCT02559570|450414980|FG002|Overall Study|Withdrawal of Consent|1|||
124954695|NCT04523571|449459008|FG003|Received 2 Doses|Withdrawal by Subject|1|||
124954696|NCT04523571|449459009|FG004|Received 2 Doses|Withdrawal by Subject|1|||
124954697|NCT04523571|449459010|FG005|Received 2 Doses|Withdrawal by Subject|0|||
124954698|NCT04523571|449459005|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
124954699|NCT04523571|449459006|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
124954700|NCT04523571|449459007|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
124954701|NCT04523571|449459008|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
124954702|NCT04523571|449459009|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
124954703|NCT04523571|449459010|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
124954704|NCT04523571|449459005|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
124954705|NCT04523571|449459006|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
124954706|NCT04523571|449459007|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
124954707|NCT04523571|449459008|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
124954708|NCT04523571|449459009|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
124954709|NCT04523571|449459010|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
124954710|NCT04523571|449459005|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
124954711|NCT04523571|449459006|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
124954712|NCT04523571|449459007|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
124954713|NCT04523571|449459008|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
124954714|NCT04523571|449459009|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
124954715|NCT04523571|449459010|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
124954716|NCT03694210|449459012|FG000|Overall Study|Death|1|||
124954717|NCT03694210|449459012|FG000|Overall Study|Screen Failure|7|||
124954718|NCT03050372|449459013|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
124954719|NCT03050372|449459014|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
124954720|NCT03050372|449459013|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
124954721|NCT03050372|449459014|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
124954722|NCT04385849|449459015|FG000|Overall Study|Lost to Follow-up|1|||
124954723|NCT04385849|449459016|FG001|Overall Study|Lost to Follow-up|0|||
124954724|NCT01375777|449459017|FG000|Overall Study|Withdrawal by Subject|0|||
124954725|NCT01375777|449459018|FG001|Overall Study|Withdrawal by Subject|2|||
124954726|NCT01375777|449459019|FG002|Overall Study|Withdrawal by Subject|1|||
124954727|NCT01375777|449459020|FG003|Overall Study|Withdrawal by Subject|0|||
124954728|NCT01375777|449459021|FG004|Overall Study|Withdrawal by Subject|1|||
124954729|NCT01375777|449459022|FG005|Overall Study|Withdrawal by Subject|1|||
124954730|NCT01375777|449459023|FG006|Overall Study|Withdrawal by Subject|1|||
124954731|NCT01375777|449459024|FG007|Overall Study|Withdrawal by Subject|2|||
124954732|NCT01375777|449459025|FG008|Overall Study|Withdrawal by Subject|1|||
124954733|NCT01375777|449459017|FG000|Overall Study|Lost to Follow-up|1|||
124954734|NCT01375777|449459018|FG001|Overall Study|Lost to Follow-up|0|||
124954735|NCT01375777|449459019|FG002|Overall Study|Lost to Follow-up|0|||
124954736|NCT01375777|449459020|FG003|Overall Study|Lost to Follow-up|0|||
124954737|NCT01375777|449459021|FG004|Overall Study|Lost to Follow-up|0|||
124954738|NCT01375777|449459022|FG005|Overall Study|Lost to Follow-up|0|||
124954739|NCT01375777|449459023|FG006|Overall Study|Lost to Follow-up|1|||
124954740|NCT01375777|449459024|FG007|Overall Study|Lost to Follow-up|0|||
124954741|NCT01375777|449459025|FG008|Overall Study|Lost to Follow-up|0|||
124954742|NCT01375777|449459017|FG000|Overall Study|Other|1|||
124954743|NCT01375777|449459018|FG001|Overall Study|Other|1|||
124954744|NCT01375777|449459019|FG002|Overall Study|Other|0|||
124954745|NCT01375777|449459020|FG003|Overall Study|Other|0|||
124954746|NCT01375777|449459021|FG004|Overall Study|Other|0|||
124954747|NCT01375777|449459022|FG005|Overall Study|Other|0|||
124954748|NCT01375777|449459023|FG006|Overall Study|Other|0|||
124954749|NCT01375777|449459024|FG007|Overall Study|Other|0|||
124954750|NCT01375777|449459025|FG008|Overall Study|Other|1|||
124954751|NCT01838499|449459028|FG000|Overall Study|Protocol Violation|0|||
124954752|NCT01838499|449459029|FG001|Overall Study|Protocol Violation|1|||
124954753|NCT01838499|449459028|FG000|Overall Study|Lost to Follow-up|2|||
124954754|NCT01838499|449459029|FG001|Overall Study|Lost to Follow-up|4|||
124954755|NCT01838499|449459028|FG000|Overall Study|Lack of Efficacy|1|||
124954756|NCT01838499|449459029|FG001|Overall Study|Lack of Efficacy|2|||
124954757|NCT01838499|449459028|FG000|Overall Study|Adverse Event|2|||
124954758|NCT01838499|449459029|FG001|Overall Study|Adverse Event|1|||
124954759|NCT01838499|449459028|FG000|Overall Study|Withdrawal by Subject|19|||
124954760|NCT01838499|449459029|FG001|Overall Study|Withdrawal by Subject|9|||
124954761|NCT02368691|449459030|FG000|Overall Study|Death|13|||
125125514|NCT02937701|450085753|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
124954762|NCT02368691|449459030|FG000|Overall Study|Lack of Efficacy|15|||
124954763|NCT02368691|449459030|FG000|Overall Study|Physician Decision|4|||
124954764|NCT03314233|449459033|FG000|Overall Study|No longer eligible at time of delivery|1|||
124954765|NCT01114217|449459034|FG000|Overall Study|Adverse Event|5|||
124954766|NCT01114217|449459035|FG001|Overall Study|Adverse Event|3|||
124954767|NCT01114217|449459034|FG000|Overall Study|Lost to Follow-up|17|||
124954768|NCT01114217|449459035|FG001|Overall Study|Lost to Follow-up|33|||
124954769|NCT01114217|449459034|FG000|Overall Study|Withdrawal by Subject|21|||
124954770|NCT01114217|449459035|FG001|Overall Study|Withdrawal by Subject|28|||
124954771|NCT01114217|449459034|FG000|Overall Study|Other-Clerical Error|3|||
124954772|NCT01114217|449459035|FG001|Overall Study|Other-Clerical Error|0|||
124954773|NCT01114217|449459034|FG000|Overall Study|Other-Early termination|6|||
124954774|NCT01114217|449459035|FG001|Overall Study|Other-Early termination|10|||
124954775|NCT01114217|449459034|FG000|Overall Study|Other-Procedure|1|||
124954776|NCT01114217|449459035|FG001|Overall Study|Other-Procedure|1|||
124954777|NCT01114217|449459034|FG000|Overall Study|Other-Pregnancy|2|||
124954778|NCT01114217|449459035|FG001|Overall Study|Other-Pregnancy|4|||
124954779|NCT01114217|449459034|FG000|Overall Study|Other-Protocol Violation|1|||
124954780|NCT01114217|449459035|FG001|Overall Study|Other-Protocol Violation|3|||
124954781|NCT01114217|449459034|FG000|Overall Study|Other-Lack of Efficacy|1|||
124954782|NCT01114217|449459035|FG001|Overall Study|Other-Lack of Efficacy|0|||
124954783|NCT01114217|449459034|FG000|Overall Study|Other-Non Compliance|2|||
124954784|NCT01114217|449459035|FG001|Overall Study|Other-Non Compliance|0|||
124954785|NCT01114217|449459034|FG000|Overall Study|Other-Physician Decision|1|||
124954786|NCT01114217|449459035|FG001|Overall Study|Other-Physician Decision|1|||
124954787|NCT01114217|449459034|FG000|Overall Study|Other-Sponsor Decision|10|||
124954788|NCT01114217|449459035|FG001|Overall Study|Other-Sponsor Decision|12|||
124954789|NCT01114217|449459034|FG000|Overall Study|Other-Study Termination|0|||
124954790|NCT01114217|449459035|FG001|Overall Study|Other-Study Termination|1|||
124954791|NCT01114217|449459034|FG000|Overall Study|Other-Study Withdrawn|1|||
124954792|NCT01114217|449459035|FG001|Overall Study|Other-Study Withdrawn|1|||
124954793|NCT01114217|449459034|FG000|Overall Study|Other-Site Stopped Communicating|2|||
124954794|NCT01114217|449459035|FG001|Overall Study|Other-Site Stopped Communicating|0|||
124954795|NCT01114217|449459034|FG000|Overall Study|Other-Lost to Follow-up|1|||
124954796|NCT01114217|449459035|FG001|Overall Study|Other-Lost to Follow-up|0|||
124954797|NCT01114217|449459034|FG000|Overall Study|Other-Withdrawal by Subject|1|||
124954798|NCT01114217|449459035|FG001|Overall Study|Other-Withdrawal by Subject|1|||
124954799|NCT01183013|449459036|FG000|Overall Study|Adverse Event|6|||
124954800|NCT01183013|449459037|FG001|Overall Study|Adverse Event|8|||
124954801|NCT01183013|449459038|FG002|Overall Study|Adverse Event|5|||
124954802|NCT01183013|449459039|FG003|Overall Study|Adverse Event|5|||
124954803|NCT01183013|449459040|FG004|Overall Study|Adverse Event|10|||
124954804|NCT01183013|449459041|FG005|Overall Study|Adverse Event|10|||
124954805|NCT01183013|449459042|FG006|Overall Study|Adverse Event|6|||
124954806|NCT01183013|449459036|FG000|Overall Study|Lack of Efficacy|3|||
124954807|NCT01183013|449459037|FG001|Overall Study|Lack of Efficacy|2|||
124954808|NCT01183013|449459038|FG002|Overall Study|Lack of Efficacy|1|||
124954809|NCT01183013|449459039|FG003|Overall Study|Lack of Efficacy|2|||
124954810|NCT01183013|449459040|FG004|Overall Study|Lack of Efficacy|1|||
124954811|NCT01183013|449459041|FG005|Overall Study|Lack of Efficacy|2|||
124954812|NCT01183013|449459042|FG006|Overall Study|Lack of Efficacy|0|||
124954813|NCT01183013|449459036|FG000|Overall Study|Protocol Violation|5|||
124954814|NCT01183013|449459037|FG001|Overall Study|Protocol Violation|2|||
124954815|NCT01183013|449459038|FG002|Overall Study|Protocol Violation|4|||
124954816|NCT01183013|449459039|FG003|Overall Study|Protocol Violation|0|||
124954817|NCT01183013|449459040|FG004|Overall Study|Protocol Violation|4|||
124954818|NCT01183013|449459041|FG005|Overall Study|Protocol Violation|3|||
124954819|NCT01183013|449459042|FG006|Overall Study|Protocol Violation|3|||
124954820|NCT01183013|449459036|FG000|Overall Study|Lost to Follow-up|7|||
124954821|NCT01183013|449459037|FG001|Overall Study|Lost to Follow-up|3|||
124954822|NCT01183013|449459038|FG002|Overall Study|Lost to Follow-up|4|||
124954823|NCT01183013|449459039|FG003|Overall Study|Lost to Follow-up|3|||
124954824|NCT01183013|449459040|FG004|Overall Study|Lost to Follow-up|2|||
124954825|NCT01183013|449459041|FG005|Overall Study|Lost to Follow-up|6|||
124954826|NCT01183013|449459042|FG006|Overall Study|Lost to Follow-up|5|||
124954827|NCT01183013|449459036|FG000|Overall Study|Withdrawal by Subject|9|||
124954828|NCT01183013|449459037|FG001|Overall Study|Withdrawal by Subject|13|||
124954829|NCT01183013|449459038|FG002|Overall Study|Withdrawal by Subject|10|||
124954830|NCT01183013|449459039|FG003|Overall Study|Withdrawal by Subject|8|||
124954831|NCT01183013|449459040|FG004|Overall Study|Withdrawal by Subject|7|||
124954832|NCT01183013|449459041|FG005|Overall Study|Withdrawal by Subject|9|||
124954833|NCT01183013|449459042|FG006|Overall Study|Withdrawal by Subject|10|||
124954834|NCT01183013|449459036|FG000|Overall Study|Reasons other than stated above|15|||
124954835|NCT01183013|449459037|FG001|Overall Study|Reasons other than stated above|11|||
124954836|NCT01183013|449459038|FG002|Overall Study|Reasons other than stated above|17|||
124954837|NCT01183013|449459039|FG003|Overall Study|Reasons other than stated above|12|||
124954838|NCT01183013|449459040|FG004|Overall Study|Reasons other than stated above|12|||
124954839|NCT01183013|449459041|FG005|Overall Study|Reasons other than stated above|15|||
124954840|NCT01183013|449459042|FG006|Overall Study|Reasons other than stated above|13|||
124954841|NCT02722278|449459045|FG000|Overall Study|Withdrawal by Subject|5|||
124954842|NCT02722278|449459046|FG001|Overall Study|Withdrawal by Subject|3|||
124954843|NCT02722278|449459045|FG000|Overall Study|Adverse Event|4|||
124954844|NCT02722278|449459046|FG001|Overall Study|Adverse Event|1|||
124954845|NCT02722278|449459045|FG000|Overall Study|Lost to Follow-up|2|||
124954846|NCT02722278|449459046|FG001|Overall Study|Lost to Follow-up|0|||
124954847|NCT02722278|449459045|FG000|Overall Study|Protocol Violation|1|||
124954848|NCT02722278|449459046|FG001|Overall Study|Protocol Violation|0|||
124954849|NCT02722278|449459045|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
124954850|NCT02722278|449459046|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
124954851|NCT02722278|449459045|FG000|Overall Study|Subject declined after tx assignment|0|||
124954852|NCT02722278|449459046|FG001|Overall Study|Subject declined after tx assignment|1|||
124954853|NCT02722278|449459045|FG000|Overall Study|Site closure not study related|0|||
124954854|NCT02722278|449459046|FG001|Overall Study|Site closure not study related|1|||
124954855|NCT04175392|449459047|FG000|Overall Study|Withdrawal by Subject|3|||
124954856|NCT04175392|449459048|FG001|Overall Study|Withdrawal by Subject|2|||
124954857|NCT02727998|449459049|FG000|Overall Study|Lost to Follow-up|3|||
124954858|NCT02727998|449459050|FG001|Overall Study|Lost to Follow-up|3|||
124954859|NCT02727998|449459049|FG000|Overall Study|Withdrawal by Subject|0|||
124954860|NCT02727998|449459050|FG001|Overall Study|Withdrawal by Subject|1|||
124954861|NCT02105688|449459051|FG000|Part A: Double-Blind|Adverse Event|1|||
124954862|NCT02105688|449459052|FG001|Part A: Double-Blind|Adverse Event|0|||
124954863|NCT02105688|449459051|FG000|Part A: Double-Blind|Death|0|||
124954864|NCT02105688|449459052|FG001|Part A: Double-Blind|Death|1|||
124954865|NCT02105688|449459051|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
124954866|NCT02105688|449459052|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
124954867|NCT02105688|449459051|FG000|Part A: Double-Blind|Physician Decision|0|||
124954868|NCT02105688|449459052|FG001|Part A: Double-Blind|Physician Decision|1|||
124954869|NCT02105688|449459051|FG000|Part A: Double-Blind|Status Unknown|0|||
124954870|NCT02105688|449459052|FG001|Part A: Double-Blind|Status Unknown|2|||
124954871|NCT02105688|449459051|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
124954872|NCT02105688|449459052|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
124954873|NCT02105688|449459051|FG000|Part B: Observational Follow-up|Death|2|||
124954874|NCT02105688|449459052|FG001|Part B: Observational Follow-up|Death|1|||
124954875|NCT02105688|449459051|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
124954876|NCT02105688|449459052|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
124954877|NCT02105688|449459051|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
124954878|NCT02105688|449459052|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
124954879|NCT02105688|449459051|FG000|Part B: Observational Follow-up|Physician Decision|3|||
124954880|NCT02105688|449459052|FG001|Part B: Observational Follow-up|Physician Decision|1|||
124954881|NCT01757171|449459056|FG000|Overall Study|Adverse Event|5|||
124954882|NCT01757171|449459057|FG001|Overall Study|Adverse Event|1|||
124954883|NCT01757171|449459056|FG000|Overall Study|Disease Progression|1|||
124954884|NCT01757171|449459057|FG001|Overall Study|Disease Progression|0|||
124954885|NCT01757171|449459056|FG000|Overall Study|Hospitalization|1|||
124954886|NCT01757171|449459057|FG001|Overall Study|Hospitalization|0|||
124954887|NCT01757171|449459056|FG000|Overall Study|ECOG decline|1|||
124954888|NCT01757171|449459057|FG001|Overall Study|ECOG decline|0|||
124954889|NCT05878522|449459061|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954890|NCT05878522|449459062|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954891|NCT05878522|449459063|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954892|NCT05878522|449459064|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954893|NCT05878522|449459065|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954894|NCT05878522|449459066|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954895|NCT05878522|449459067|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954896|NCT05878522|449459068|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954897|NCT05878522|449459069|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
124954898|NCT05878522|449459070|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954899|NCT05878522|449459071|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954900|NCT05878522|449459072|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954901|NCT05878522|449459061|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
124954902|NCT05878522|449459062|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
124954903|NCT05878522|449459063|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
124954904|NCT05878522|449459064|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
124954905|NCT05878522|449459065|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
124954906|NCT05878522|449459066|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
124954907|NCT05878522|449459067|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
124954908|NCT05878522|449459068|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
124954909|NCT05878522|449459069|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
124954910|NCT05878522|449459070|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
124954911|NCT05878522|449459071|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
124954912|NCT05878522|449459072|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
124954913|NCT05878522|449459061|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
125030671|NCT00792298|449735011|FG004|Treatment Period 2|Withdrawal by Subject|1|||
125030672|NCT00792298|449735012|FG005|Treatment Period 2|Withdrawal by Subject|0|||
124954914|NCT05878522|449459062|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
124954915|NCT05878522|449459063|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
124954916|NCT05878522|449459064|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
124954917|NCT05878522|449459065|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
124954918|NCT05878522|449459066|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
124954919|NCT05878522|449459067|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
124954920|NCT05878522|449459068|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
124954921|NCT05878522|449459069|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
124954922|NCT05878522|449459070|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
124954923|NCT05878522|449459071|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
124954924|NCT05878522|449459072|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
124954925|NCT05878522|449459061|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954926|NCT05878522|449459062|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954927|NCT05878522|449459063|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954928|NCT05878522|449459064|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954929|NCT05878522|449459065|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
124954930|NCT05878522|449459066|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954931|NCT05878522|449459067|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954932|NCT05878522|449459068|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954933|NCT05878522|449459069|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954934|NCT05878522|449459070|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954935|NCT05878522|449459071|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954936|NCT05878522|449459072|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954937|NCT02252172|449459073|FG000|Overall Study|Lost to Follow-up|3|||
124954938|NCT02252172|449459074|FG001|Overall Study|Lost to Follow-up|1|||
124954939|NCT02252172|449459073|FG000|Overall Study|Ongoing|276|||
124954940|NCT02252172|449459074|FG001|Overall Study|Ongoing|298|||
124954941|NCT05740371|449459075|FG000|Overall Study|Death|1|||
124954942|NCT03019289|449459079|FG000|Overall Study|Adverse Event|1|||
124954943|NCT03019289|449459080|FG001|Overall Study|Adverse Event|0|||
124954944|NCT03019289|449459081|FG002|Overall Study|Adverse Event|0|||
124954945|NCT03019289|449459082|FG003|Overall Study|Adverse Event|0|||
124954946|NCT03019289|449459083|FG004|Overall Study|Adverse Event|0|||
124954947|NCT03019289|449459084|FG005|Overall Study|Adverse Event|0|||
124954948|NCT03019289|449459085|FG006|Overall Study|Adverse Event|0|||
124954949|NCT03019289|449459086|FG007|Overall Study|Adverse Event|0|||
124954950|NCT03019289|449459087|FG008|Overall Study|Adverse Event|1|||
124954951|NCT03019289|449459079|FG000|Overall Study|Other|1|||
124954952|NCT03019289|449459080|FG001|Overall Study|Other|0|||
124954953|NCT03019289|449459081|FG002|Overall Study|Other|0|||
124954954|NCT03019289|449459082|FG003|Overall Study|Other|0|||
124954955|NCT03019289|449459083|FG004|Overall Study|Other|0|||
124954956|NCT03019289|449459084|FG005|Overall Study|Other|0|||
124954957|NCT03019289|449459085|FG006|Overall Study|Other|0|||
124954958|NCT03019289|449459086|FG007|Overall Study|Other|0|||
124954959|NCT03019289|449459087|FG008|Overall Study|Other|0|||
124954960|NCT02389894|449459088|FG000|Overall Study|Death|4|||
124954961|NCT02389894|449459089|FG001|Overall Study|Death|5|||
124954962|NCT02389894|449459090|FG002|Overall Study|Death|3|||
124954963|NCT02389894|449459088|FG000|Overall Study|Withdrawal by Subject|2|||
124954964|NCT02389894|449459089|FG001|Overall Study|Withdrawal by Subject|4|||
124954965|NCT02389894|449459090|FG002|Overall Study|Withdrawal by Subject|5|||
124954966|NCT02389894|449459088|FG000|Overall Study|Lost to Follow-up|2|||
124954967|NCT02389894|449459089|FG001|Overall Study|Lost to Follow-up|1|||
124954968|NCT02389894|449459090|FG002|Overall Study|Lost to Follow-up|1|||
124954969|NCT00145496|449459093|FG000|Overall Study|Adverse Event|42|||
124954970|NCT00145496|449459094|FG001|Overall Study|Adverse Event|30|||
124954971|NCT00145496|449459093|FG000|Overall Study|Lack of Efficacy|12|||
124954972|NCT00145496|449459094|FG001|Overall Study|Lack of Efficacy|7|||
124954973|NCT00145496|449459093|FG000|Overall Study|Withdrawal by Subject|32|||
124954974|NCT00145496|449459094|FG001|Overall Study|Withdrawal by Subject|26|||
124954975|NCT00145496|449459093|FG000|Overall Study|Lost to Follow-up|12|||
124954976|NCT00145496|449459094|FG001|Overall Study|Lost to Follow-up|5|||
124954977|NCT00145496|449459093|FG000|Overall Study|Other|25|||
124954978|NCT00145496|449459094|FG001|Overall Study|Other|13|||
124954979|NCT01549951|449459098|FG000|Overall Study|Adverse Event|15|||
124954980|NCT01549951|449459098|FG000|Overall Study|Withdrawal by Subject|2|||
124954981|NCT01549951|449459098|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
124954982|NCT01549951|449459098|FG000|Overall Study|Progressive disease|29|||
124954983|NCT01549951|449459098|FG000|Overall Study|Symptomatic deterioration|1|||
124954984|NCT01549951|449459098|FG000|Overall Study|Other|2|||
124954985|NCT01123200|449459099|FG000|Overall Study|Withdrawal by Subject|1|||
124954986|NCT03689452|449459103|FG000|Overall Study|Lost to Follow-up|1|||
124954987|NCT03689452|449459104|FG001|Overall Study|Lost to Follow-up|1|||
124954988|NCT02676778|449459105|FG000|Overall Study|Disease Progression|7|||
124954989|NCT02676778|449459106|FG001|Overall Study|Disease Progression|3|||
124954990|NCT02676778|449459107|FG002|Overall Study|Disease Progression|1|||
124954991|NCT02676778|449459105|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
124954992|NCT02676778|449459106|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
124954993|NCT02676778|449459107|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
124954994|NCT02676778|449459105|FG000|Overall Study|Withdrawal by Subject|3|||
124954995|NCT02676778|449459106|FG001|Overall Study|Withdrawal by Subject|2|||
124954996|NCT02676778|449459107|FG002|Overall Study|Withdrawal by Subject|0|||
124954997|NCT02676778|449459105|FG000|Overall Study|Other|4|||
124954998|NCT02676778|449459106|FG001|Overall Study|Other|3|||
124954999|NCT02676778|449459107|FG002|Overall Study|Other|0|||
124955000|NCT02676778|449459105|FG000|Overall Study|Adverse Event|2|||
124955001|NCT02676778|449459106|FG001|Overall Study|Adverse Event|3|||
124955002|NCT02676778|449459107|FG002|Overall Study|Adverse Event|0|||
124955003|NCT00732498|449459108|FG000|Overall Study|Ineligible|1|||
124955004|NCT00732498|449459108|FG000|Overall Study|Adverse Event|2|||
124955005|NCT00732498|449459108|FG000|Overall Study|Physician Decision|3|||
124955006|NCT03394508|449459116|FG000|Overall Study|Protocol Violation|0|||
124955007|NCT03394508|449459117|FG001|Overall Study|Protocol Violation|3|||
124955008|NCT03394508|449459116|FG000|Overall Study|Lost to Follow-up|1|||
124955009|NCT03394508|449459117|FG001|Overall Study|Lost to Follow-up|0|||
124955010|NCT01288729|449459118|FG000|Overall Study|Withdrawal by Subject|1|||
124955011|NCT01288729|449459119|FG001|Overall Study|Withdrawal by Subject|0|||
124955012|NCT03214198|449459120|FG000|Overall Study|Case Report Forms Uncollected|18|||
124955013|NCT03214198|449459120|FG000|Overall Study|Protocol Deviation|18|||
124955014|NCT04295499|449459121|FG000|Overall Study|moving out of state|1|||
124955015|NCT04295499|449459122|FG001|Overall Study|moving out of state|0|||
124955016|NCT04295499|449459121|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
124955017|NCT04295499|449459122|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
124955018|NCT02135445|449459123|FG000|Overall Study|Lost to Follow-up|1|||
124955019|NCT02135445|449459124|FG001|Overall Study|Lost to Follow-up|0|||
124955020|NCT02135445|449459123|FG000|Overall Study|Withdrawal by Subject|1|||
124955021|NCT02135445|449459124|FG001|Overall Study|Withdrawal by Subject|0|||
124955022|NCT03451292|449460355|FG000|Overall Study|Death|44|||
124955023|NCT03451292|449460356|FG001|Overall Study|Death|59|||
124955024|NCT03451292|449460355|FG000|Overall Study|Withdrawal by Subject|18|||
124955025|NCT03451292|449460356|FG001|Overall Study|Withdrawal by Subject|13|||
124955026|NCT03451292|449460355|FG000|Overall Study|Transplantation|18|||
124955027|NCT03451292|449460356|FG001|Overall Study|Transplantation|12|||
124955028|NCT03451292|449460355|FG000|Overall Study|Lost to Follow-up|4|||
124955029|NCT03451292|449460356|FG001|Overall Study|Lost to Follow-up|12|||
124955030|NCT03451292|449460355|FG000|Overall Study|Physician Decision|4|||
124955031|NCT03451292|449460356|FG001|Overall Study|Physician Decision|3|||
124955032|NCT03451292|449460355|FG000|Overall Study|Adverse Event|3|||
124955033|NCT03451292|449460356|FG001|Overall Study|Adverse Event|3|||
124955034|NCT03451292|449460355|FG000|Overall Study|Non-compliance with Study Drug|2|||
124955035|NCT03451292|449460356|FG001|Overall Study|Non-compliance with Study Drug|0|||
124955036|NCT05878990|449460359|FG000|Overall Study|Lost to Follow-up|7|||
124955037|NCT05878990|449460359|FG000|Overall Study|Withdrawal by Subject|1|||
124955038|NCT02543294|449460362|FG000|Overall Study|Lost to Follow-up|3|||
124955039|NCT02543294|449460362|FG000|Overall Study|Physician Decision|2|||
124955040|NCT02543294|449460362|FG000|Overall Study|Withdrawal by Subject|7|||
124955041|NCT03672188|449460363|FG000|Overall Study|Withdrawal by Subject|0|||
124955042|NCT03672188|449460364|FG001|Overall Study|Withdrawal by Subject|0|||
124955043|NCT03672188|449460365|FG002|Overall Study|Withdrawal by Subject|0|||
124955044|NCT03672188|449460366|FG003|Overall Study|Withdrawal by Subject|3|||
124955045|NCT03672188|449460367|FG004|Overall Study|Withdrawal by Subject|0|||
124955046|NCT03672188|449460368|FG005|Overall Study|Withdrawal by Subject|0|||
124955047|NCT03672188|449460369|FG006|Overall Study|Withdrawal by Subject|0|||
124955048|NCT03672188|449460370|FG007|Overall Study|Withdrawal by Subject|0|||
124955049|NCT03672188|449460371|FG008|Overall Study|Withdrawal by Subject|0|||
124955050|NCT03672188|449460372|FG009|Overall Study|Withdrawal by Subject|0|||
124955051|NCT03672188|449460373|FG010|Overall Study|Withdrawal by Subject|0|||
124955052|NCT03672188|449460374|FG011|Overall Study|Withdrawal by Subject|0|||
124955053|NCT03672188|449460375|FG012|Overall Study|Withdrawal by Subject|0|||
124955054|NCT03672188|449460376|FG013|Overall Study|Withdrawal by Subject|0|||
124955055|NCT03672188|449460377|FG014|Overall Study|Withdrawal by Subject|0|||
124955056|NCT03672188|449460363|FG000|Overall Study|Death|0|||
124955057|NCT03672188|449460364|FG001|Overall Study|Death|0|||
124955058|NCT03672188|449460365|FG002|Overall Study|Death|0|||
124955059|NCT03672188|449460366|FG003|Overall Study|Death|0|||
124955060|NCT03672188|449460367|FG004|Overall Study|Death|0|||
124955061|NCT03672188|449460368|FG005|Overall Study|Death|0|||
124955062|NCT03672188|449460369|FG006|Overall Study|Death|0|||
124955063|NCT03672188|449460370|FG007|Overall Study|Death|0|||
124955064|NCT03672188|449460371|FG008|Overall Study|Death|0|||
124955065|NCT03672188|449460372|FG009|Overall Study|Death|0|||
124955066|NCT03672188|449460373|FG010|Overall Study|Death|0|||
124955067|NCT03672188|449460374|FG011|Overall Study|Death|0|||
124955068|NCT03672188|449460375|FG012|Overall Study|Death|1|||
124955069|NCT03672188|449460376|FG013|Overall Study|Death|0|||
124955070|NCT03672188|449460377|FG014|Overall Study|Death|0|||
124955071|NCT03672188|449460363|FG000|Overall Study|Lost to Follow-up|0|||
124955072|NCT03672188|449460364|FG001|Overall Study|Lost to Follow-up|0|||
124955073|NCT03672188|449460365|FG002|Overall Study|Lost to Follow-up|1|||
124955074|NCT03672188|449460366|FG003|Overall Study|Lost to Follow-up|0|||
124955075|NCT03672188|449460367|FG004|Overall Study|Lost to Follow-up|0|||
124955076|NCT03672188|449460368|FG005|Overall Study|Lost to Follow-up|0|||
124955077|NCT03672188|449460369|FG006|Overall Study|Lost to Follow-up|0|||
124955078|NCT03672188|449460370|FG007|Overall Study|Lost to Follow-up|0|||
124955079|NCT03672188|449460371|FG008|Overall Study|Lost to Follow-up|0|||
124955080|NCT03672188|449460372|FG009|Overall Study|Lost to Follow-up|0|||
124955081|NCT03672188|449460373|FG010|Overall Study|Lost to Follow-up|0|||
124955082|NCT03672188|449460374|FG011|Overall Study|Lost to Follow-up|0|||
124955083|NCT03672188|449460375|FG012|Overall Study|Lost to Follow-up|0|||
124955084|NCT03672188|449460376|FG013|Overall Study|Lost to Follow-up|0|||
124955085|NCT03672188|449460377|FG014|Overall Study|Lost to Follow-up|0|||
124955086|NCT00396409|449460383|FG000|Period 1 - 2007|Adverse Event|0|||
124955087|NCT00396409|449460384|FG001|Period 1 - 2007|Adverse Event|1|||
124955088|NCT00396409|449460383|FG000|Period 1 - 2007|Lack of Efficacy|0|||
124955089|NCT00396409|449460384|FG001|Period 1 - 2007|Lack of Efficacy|1|||
124955090|NCT00396409|449460383|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
124955091|NCT00396409|449460384|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
124955092|NCT00396409|449460383|FG000|Period 1 - 2007|Lost to Follow-up|2|||
124955093|NCT00396409|449460384|FG001|Period 1 - 2007|Lost to Follow-up|3|||
124955094|NCT00396409|449460383|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
124955095|NCT00396409|449460384|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
124955096|NCT00396409|449460383|FG000|Period 2 - 2008|Protocol Violation|1|||
124955097|NCT00396409|449460384|FG001|Period 2 - 2008|Protocol Violation|0|||
124955098|NCT00396409|449460383|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
124955099|NCT00396409|449460384|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
124955100|NCT00396409|449460383|FG000|Period 2 - 2008|Lost to Follow-up|3|||
124955101|NCT00396409|449460384|FG001|Period 2 - 2008|Lost to Follow-up|1|||
124955102|NCT04203199|449460387|FG000|First Intervention Period|Lost to Follow-up|0|||
124955103|NCT04203199|449460388|FG001|First Intervention Period|Lost to Follow-up|1|||
124955104|NCT04203199|449460387|FG000|Second Intervention Period|Medication change|1|||
124955105|NCT04203199|449460388|FG001|Second Intervention Period|Medication change|0|||
124955106|NCT03320941|449460389|FG000|Overall Study|subject/guardian decision|0|||
124955107|NCT03320941|449460390|FG001|Overall Study|subject/guardian decision|0|||
124955108|NCT03320941|449460391|FG002|Overall Study|subject/guardian decision|0|||
124955109|NCT03320941|449460392|FG003|Overall Study|subject/guardian decision|1|||
124955110|NCT03320941|449460393|FG004|Overall Study|subject/guardian decision|0|||
124955111|NCT03614923|449460394|FG000|Overall Study|Withdrawal by Subject|2|||
124955112|NCT03614923|449460395|FG001|Overall Study|Withdrawal by Subject|1|||
124955113|NCT03614923|449460396|FG002|Overall Study|Withdrawal by Subject|1|||
124955114|NCT03614923|449460394|FG000|Overall Study|Adverse Event|0|||
124955115|NCT03614923|449460395|FG001|Overall Study|Adverse Event|2|||
124955116|NCT03614923|449460396|FG002|Overall Study|Adverse Event|1|||
124955117|NCT03614923|449460394|FG000|Overall Study|Lost to Follow-up|1|||
124955118|NCT03614923|449460395|FG001|Overall Study|Lost to Follow-up|0|||
125030673|NCT00792298|449735013|FG006|Treatment Period 2|Withdrawal by Subject|0|||
125030674|NCT00792298|449735014|FG007|Treatment Period 2|Withdrawal by Subject|2|||
125030675|NCT02388295|449735016|FG000|Dose Escalation Week 1|Adverse Event|1|||
124955119|NCT03614923|449460396|FG002|Overall Study|Lost to Follow-up|1|||
124955120|NCT03614923|449460394|FG000|Overall Study|Lack of Efficacy|2|||
124955121|NCT03614923|449460395|FG001|Overall Study|Lack of Efficacy|0|||
124955122|NCT03614923|449460396|FG002|Overall Study|Lack of Efficacy|1|||
124955123|NCT03614923|449460394|FG000|Overall Study|Non-compliance|0|||
124955124|NCT03614923|449460395|FG001|Overall Study|Non-compliance|1|||
124955125|NCT03614923|449460396|FG002|Overall Study|Non-compliance|0|||
124955126|NCT03614923|449460394|FG000|Overall Study|Other|0|||
124955127|NCT03614923|449460395|FG001|Overall Study|Other|1|||
124955128|NCT03614923|449460396|FG002|Overall Study|Other|1|||
124955129|NCT01107353|449460397|FG000|Overall Study|Positive Drug Screen|1|||
124955130|NCT01107353|449460398|FG001|Overall Study|Positive Drug Screen|0|||
124955131|NCT01136733|449460399|FG000|Phase 1b|Adverse Event|0|||
124955132|NCT01136733|449460400|FG001|Phase 1b|Adverse Event|3|||
124955133|NCT01136733|449460401|FG002|Phase 1b|Adverse Event|1|||
124955134|NCT01136733|449460402|FG003|Phase 1b|Adverse Event|0|||
124955135|NCT01136733|449460403|FG004|Phase 1b|Adverse Event|0|||
124955136|NCT01136733|449460404|FG005|Phase 1b|Adverse Event|0|||
124955137|NCT01136733|449460405|FG006|Phase 1b|Adverse Event|0|||
124955138|NCT01136733|449460399|FG000|Phase 1b|Participant Choice|0|||
124955139|NCT01136733|449460400|FG001|Phase 1b|Participant Choice|0|||
124955140|NCT01136733|449460401|FG002|Phase 1b|Participant Choice|1|||
124955141|NCT01136733|449460402|FG003|Phase 1b|Participant Choice|0|||
124955142|NCT01136733|449460403|FG004|Phase 1b|Participant Choice|0|||
124955143|NCT01136733|449460404|FG005|Phase 1b|Participant Choice|0|||
124955144|NCT01136733|449460405|FG006|Phase 1b|Participant Choice|0|||
124955145|NCT01136733|449460399|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
124955146|NCT01136733|449460400|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
124955147|NCT01136733|449460401|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
124955148|NCT01136733|449460402|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
124955149|NCT01136733|449460403|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
124955150|NCT01136733|449460404|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
124955151|NCT01136733|449460405|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
124955152|NCT01136733|449460399|FG000|Phase 1b|Clinical Progression|1|||
124955153|NCT01136733|449460400|FG001|Phase 1b|Clinical Progression|1|||
124955154|NCT01136733|449460401|FG002|Phase 1b|Clinical Progression|0|||
124955155|NCT01136733|449460402|FG003|Phase 1b|Clinical Progression|0|||
124955156|NCT01136733|449460403|FG004|Phase 1b|Clinical Progression|0|||
124955157|NCT01136733|449460404|FG005|Phase 1b|Clinical Progression|0|||
124955158|NCT01136733|449460405|FG006|Phase 1b|Clinical Progression|0|||
124955159|NCT01136733|449460399|FG000|Phase 2|Disease Progression|0|||
124955160|NCT01136733|449460400|FG001|Phase 2|Disease Progression|0|||
124955161|NCT01136733|449460401|FG002|Phase 2|Disease Progression|0|||
124955162|NCT01136733|449460402|FG003|Phase 2|Disease Progression|0|||
124955163|NCT01136733|449460403|FG004|Phase 2|Disease Progression|30|||
124955164|NCT01136733|449460404|FG005|Phase 2|Disease Progression|32|||
124955165|NCT01136733|449460405|FG006|Phase 2|Disease Progression|38|||
124955166|NCT01136733|449460399|FG000|Phase 2|Adverse Event|0|||
124955167|NCT01136733|449460400|FG001|Phase 2|Adverse Event|0|||
124955168|NCT01136733|449460401|FG002|Phase 2|Adverse Event|0|||
124955169|NCT01136733|449460402|FG003|Phase 2|Adverse Event|0|||
124955170|NCT01136733|449460403|FG004|Phase 2|Adverse Event|11|||
124955171|NCT01136733|449460404|FG005|Phase 2|Adverse Event|13|||
125030676|NCT02388295|449735017|FG001|Dose Escalation Week 1|Adverse Event|2|||
125030677|NCT02388295|449735018|FG002|Dose Escalation Week 1|Adverse Event|1|||
125030678|NCT02388295|449735016|FG000|Dose Escalation Week 1|Determined not eligible|1|||
125030679|NCT02388295|449735017|FG001|Dose Escalation Week 1|Determined not eligible|1|||
125030680|NCT02388295|449735018|FG002|Dose Escalation Week 1|Determined not eligible|1|||
125030681|NCT02388295|449735016|FG000|Dose Escalation Week 2|Protocol Violation|0|||
125030682|NCT02388295|449735017|FG001|Dose Escalation Week 2|Protocol Violation|1|||
125030683|NCT02388295|449735018|FG002|Dose Escalation Week 2|Protocol Violation|0|||
125030684|NCT02388295|449735016|FG000|Dose Escalation Week 2|Determined not eligible|1|||
125030685|NCT02388295|449735017|FG001|Dose Escalation Week 2|Determined not eligible|1|||
125030686|NCT02388295|449735018|FG002|Dose Escalation Week 2|Determined not eligible|1|||
125030687|NCT02388295|449735016|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
125030688|NCT02388295|449735017|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
125030689|NCT02388295|449735018|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
125030690|NCT04007159|449735019|FG000|Induction Phase|(missed study visits)|16|||
125030691|NCT04007159|449735019|FG000|Induction Phase|Withdrawal by Subject|4|||
125030692|NCT04007159|449735019|FG000|Induction Phase|Adverse Event|2|||
125030693|NCT04007159|449735019|FG000|Challenge Phase|missed study visits|3|||
124955172|NCT01136733|449460405|FG006|Phase 2|Adverse Event|5|||
124955173|NCT01136733|449460399|FG000|Phase 2|Participant Choice|0|||
124955174|NCT01136733|449460400|FG001|Phase 2|Participant Choice|0|||
125030694|NCT04258579|449735021|FG000|Overall Study|Withdrawal by Subject|7|||
125030695|NCT04258579|449735021|FG000|Overall Study|Lost to Follow-up|3|||
125125515|NCT02937701|450085754|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
125125516|NCT02937701|450085755|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
125125517|NCT02937701|450085756|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
124955175|NCT01136733|449460401|FG002|Phase 2|Participant Choice|0|||
125030696|NCT04258579|449735021|FG000|Overall Study|Protocol Violation|2|||
125125518|NCT02937701|450085752|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
124955176|NCT01136733|449460402|FG003|Phase 2|Participant Choice|0|||
124955177|NCT01136733|449460403|FG004|Phase 2|Participant Choice|3|||
124955178|NCT01136733|449460404|FG005|Phase 2|Participant Choice|0|||
124955179|NCT01136733|449460405|FG006|Phase 2|Participant Choice|1|||
124955180|NCT01136733|449460399|FG000|Phase 2|Administrative-Withdrew Consent|0|||
124955181|NCT01136733|449460400|FG001|Phase 2|Administrative-Withdrew Consent|0|||
124955182|NCT01136733|449460401|FG002|Phase 2|Administrative-Withdrew Consent|0|||
124955183|NCT01136733|449460402|FG003|Phase 2|Administrative-Withdrew Consent|0|||
124955184|NCT01136733|449460403|FG004|Phase 2|Administrative-Withdrew Consent|1|||
125030697|NCT04258579|449735021|FG000|Overall Study|Adverse Event|1|||
125030698|NCT02076165|449735022|FG000|Overall Study|Lost to Follow-up|7|||
124955185|NCT01136733|449460404|FG005|Phase 2|Administrative-Withdrew Consent|0|||
124955186|NCT01136733|449460405|FG006|Phase 2|Administrative-Withdrew Consent|0|||
124955187|NCT01136733|449460399|FG000|Phase 2|Other|0|||
124955188|NCT01136733|449460400|FG001|Phase 2|Other|0|||
124955189|NCT01136733|449460401|FG002|Phase 2|Other|0|||
124955190|NCT01136733|449460402|FG003|Phase 2|Other|0|||
124955191|NCT01136733|449460403|FG004|Phase 2|Other|6|||
124955192|NCT01136733|449460404|FG005|Phase 2|Other|7|||
124955193|NCT01136733|449460405|FG006|Phase 2|Other|6|||
124955194|NCT03360071|449460407|FG000|Overall Study|Lost to Follow-up|1|||
124955195|NCT03360071|449460408|FG001|Overall Study|Lost to Follow-up|0|||
124955196|NCT02504502|449460413|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
124955197|NCT02504502|449460414|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
124955198|NCT02504502|449460413|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
124955199|NCT02504502|449460414|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
124955200|NCT01014013|449460415|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
124955201|NCT01014013|449460416|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
124955202|NCT01014013|449460415|FG000|Overall Study|Clinical adverse experience|4|||
124955203|NCT01014013|449460416|FG001|Overall Study|Clinical adverse experience|2|||
124955204|NCT01014013|449460415|FG000|Overall Study|Laboratory adverse experience|1|||
124955205|NCT01014013|449460416|FG001|Overall Study|Laboratory adverse experience|1|||
124955206|NCT01014013|449460415|FG000|Overall Study|Protocol Violation|1|||
124955207|NCT01014013|449460416|FG001|Overall Study|Protocol Violation|3|||
124955208|NCT01014013|449460415|FG000|Overall Study|Withdrawal by Subject|7|||
124955209|NCT01014013|449460416|FG001|Overall Study|Withdrawal by Subject|4|||
124955210|NCT01014013|449460415|FG000|Overall Study|Clinical/microbiologic failure|1|||
124955211|NCT01014013|449460416|FG001|Overall Study|Clinical/microbiologic failure|2|||
124955212|NCT01014013|449460415|FG000|Overall Study|Pathogen culture = no growth|26|||
124955213|NCT01014013|449460416|FG001|Overall Study|Pathogen culture = no growth|34|||
124955214|NCT01014013|449460415|FG000|Overall Study|Negative urine culture|2|||
124955215|NCT01014013|449460416|FG001|Overall Study|Negative urine culture|0|||
124955216|NCT01014013|449460415|FG000|Overall Study|Pathogen resistant|7|||
124955217|NCT01014013|449460416|FG001|Overall Study|Pathogen resistant|4|||
124955218|NCT01014013|449460415|FG000|Overall Study|Physician Decision|0|||
124955219|NCT01014013|449460416|FG001|Overall Study|Physician Decision|1|||
124955220|NCT01014013|449460415|FG000|Overall Study|Another antibiotic therapy required|0|||
124955221|NCT01014013|449460416|FG001|Overall Study|Another antibiotic therapy required|1|||
124955222|NCT01014013|449460415|FG000|Overall Study|Appendectomy|1|||
124955223|NCT01014013|449460416|FG001|Overall Study|Appendectomy|0|||
124955224|NCT01014013|449460415|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
124955225|NCT01014013|449460416|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
124955226|NCT00316121|449460417|FG000|Overall Study|Death|1|||
124955227|NCT00316121|449460418|FG001|Overall Study|Death|0|||
124955228|NCT00316121|449460417|FG000|Overall Study|Lost to Follow-up|14|||
124955229|NCT00316121|449460418|FG001|Overall Study|Lost to Follow-up|8|||
124955230|NCT00316121|449460417|FG000|Overall Study|Withdrawal by Subject|2|||
124955231|NCT00316121|449460418|FG001|Overall Study|Withdrawal by Subject|0|||
124955232|NCT00316121|449460417|FG000|Overall Study|Reason is missing|1|||
124955233|NCT00316121|449460418|FG001|Overall Study|Reason is missing|0|||
124955234|NCT00316121|449460417|FG000|Overall Study|Subject relocated|1|||
124955235|NCT00316121|449460418|FG001|Overall Study|Subject relocated|1|||
124955236|NCT00316121|449460417|FG000|Overall Study|Subject refused to return|1|||
124955237|NCT00316121|449460418|FG001|Overall Study|Subject refused to return|0|||
124955238|NCT00316121|449460417|FG000|Overall Study|Subject no show for visit x 3|1|||
124955239|NCT00316121|449460418|FG001|Overall Study|Subject no show for visit x 3|0|||
124955240|NCT00316121|449460417|FG000|Overall Study|Subject did not have 24 month visit|1|||
124955241|NCT00316121|449460418|FG001|Overall Study|Subject did not have 24 month visit|0|||
124955242|NCT02305797|449460419|FG000|Overall Study|Adverse Event|11|||
124955243|NCT02305797|449460420|FG001|Overall Study|Adverse Event|2|||
124955244|NCT02305797|449460419|FG000|Overall Study|Withdrawal by Subject|9|||
124955245|NCT02305797|449460420|FG001|Overall Study|Withdrawal by Subject|10|||
124955246|NCT02305797|449460419|FG000|Overall Study|Lack of Efficacy|6|||
124955247|NCT02305797|449460420|FG001|Overall Study|Lack of Efficacy|0|||
124955248|NCT02305797|449460419|FG000|Overall Study|Lost to Follow-up|5|||
124955249|NCT02305797|449460420|FG001|Overall Study|Lost to Follow-up|11|||
124955250|NCT02305797|449460419|FG000|Overall Study|Pregnancy|0|||
124955251|NCT02305797|449460420|FG001|Overall Study|Pregnancy|2|||
124955252|NCT02305797|449460419|FG000|Overall Study|Noncompliance|14|||
124955253|NCT02305797|449460420|FG001|Overall Study|Noncompliance|12|||
124955254|NCT02305797|449460419|FG000|Overall Study|Reason not collected|0|||
124955255|NCT02305797|449460420|FG001|Overall Study|Reason not collected|1|||
124955256|NCT00460577|449460423|FG000|Overall Study|Protocol Violation|2|||
124955257|NCT00460577|449460424|FG001|Overall Study|Protocol Violation|6|||
124955258|NCT02213458|449460425|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
124955259|NCT02213458|449460426|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
124955260|NCT02213458|449460425|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
124955261|NCT02213458|449460426|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
124955262|NCT02213458|449460425|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
124955263|NCT02213458|449460426|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
125125519|NCT02937701|450085753|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
125030699|NCT02076165|449735023|FG001|Overall Study|Lost to Follow-up|5|||
125030700|NCT02076165|449735022|FG000|Overall Study|Refused follow-up assessment|1|||
125030701|NCT02076165|449735023|FG001|Overall Study|Refused follow-up assessment|1|||
125030702|NCT01950819|449735028|FG000|Overall Study|Graft Loss|35|||
125030703|NCT01950819|449735029|FG001|Overall Study|Graft Loss|30|||
125030704|NCT01950819|449735028|FG000|Overall Study|Death|29|||
125030705|NCT01950819|449735029|FG001|Overall Study|Death|34|||
125030706|NCT01950819|449735028|FG000|Overall Study|Subject / Gardian decision|54|||
125030707|NCT01950819|449735029|FG001|Overall Study|Subject / Gardian decision|51|||
124955264|NCT02213458|449460425|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
124955265|NCT02213458|449460426|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
124955266|NCT02213458|449460425|FG000|Overall Study|Refused re-consent|6|||
124955267|NCT02213458|449460426|FG001|Overall Study|Refused re-consent|0|||
124955268|NCT02213458|449460425|FG000|Overall Study|Lost to Follow-up|2|||
124955269|NCT02213458|449460426|FG001|Overall Study|Lost to Follow-up|2|||
124955270|NCT02213458|449460425|FG000|Overall Study|Withdrawal by Subject|26|||
124955271|NCT02213458|449460426|FG001|Overall Study|Withdrawal by Subject|8|||
124955272|NCT00910871|449460427|FG000|Overall Study|Adverse Event|5|||
124955273|NCT00910871|449460427|FG000|Overall Study|Death|12|||
125030708|NCT01950819|449735028|FG000|Overall Study|technical problems|2|||
125030709|NCT01950819|449735029|FG001|Overall Study|technical problems|0|||
125030710|NCT01950819|449735028|FG000|Overall Study|Pregnancy|0|||
125030711|NCT01950819|449735029|FG001|Overall Study|Pregnancy|2|||
125030712|NCT01950819|449735028|FG000|Overall Study|Lost to Follow-up|9|||
125030713|NCT01950819|449735029|FG001|Overall Study|Lost to Follow-up|17|||
125030714|NCT04134494|449735030|FG000|Overall Study|Lost to Follow-up|2|||
125030715|NCT00781365|449735031|FG000|Overall Study|Withdrawal by Subject|13|||
125030716|NCT00781365|449735032|FG001|Overall Study|Withdrawal by Subject|8|||
125030717|NCT00781365|449735031|FG000|Overall Study|Did Not Attend Visit|20|||
125030718|NCT00781365|449735032|FG001|Overall Study|Did Not Attend Visit|28|||
125030719|NCT00781365|449735031|FG000|Overall Study|Language barrier|1|||
125030720|NCT00781365|449735032|FG001|Overall Study|Language barrier|0|||
125030721|NCT01756456|449735037|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
125030722|NCT01756456|449735038|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
125030723|NCT01756456|449735039|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
125030724|NCT01756456|449735040|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
125030725|NCT01756456|449735041|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
125030726|NCT01756456|449735042|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
125030727|NCT01756456|449735037|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
125030728|NCT01756456|449735038|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
125030729|NCT01756456|449735039|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
125030730|NCT01756456|449735040|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
125030731|NCT01756456|449735041|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
125030732|NCT01756456|449735042|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
125030733|NCT01756456|449735037|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
125030734|NCT01756456|449735038|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
124955274|NCT00910871|449460427|FG000|Overall Study|Lost to Follow-up|8|||
125030735|NCT01756456|449735039|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
125030736|NCT01756456|449735040|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
125030737|NCT01756456|449735041|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
125030738|NCT01756456|449735042|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
125030739|NCT01756456|449735037|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
124955275|NCT00910871|449460427|FG000|Overall Study|Protocol Violation|11|||
124955276|NCT00910871|449460427|FG000|Overall Study|Withdrawal by Subject|12|||
124955277|NCT00910871|449460427|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
124955278|NCT00910871|449460427|FG000|Overall Study|Undefined|1|||
125030740|NCT01756456|449735038|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
125030741|NCT01756456|449735039|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
125125520|NCT02937701|450085754|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
124955279|NCT01878253|449460428|FG000|Overall Study|Death|1|||
125030742|NCT01756456|449735040|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
125030743|NCT01756456|449735041|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
125125521|NCT02937701|450085755|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
125030744|NCT01756456|449735042|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
125125522|NCT02937701|450085756|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
124955280|NCT01878253|449460428|FG000|Overall Study|SIdus System Removal|3|||
124955281|NCT01878253|449460428|FG000|Overall Study|Withdrawal by Subject|1|||
124955282|NCT01878253|449460428|FG000|Overall Study|Lost to Follow-up|2|||
124955283|NCT01878253|449460428|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
124955284|NCT04043806|449460429|FG000|Overall Study|Commercial drug is available for participants|13|||
124955285|NCT04043806|449460429|FG000|Overall Study|Physician Decision|2|||
124955286|NCT04043806|449460429|FG000|Overall Study|Other|12|||
124955287|NCT04043806|449460429|FG000|Overall Study|Adverse Event|2|||
124955288|NCT04043806|449460429|FG000|Overall Study|Lost to Follow-up|6|||
124955289|NCT04043806|449460429|FG000|Overall Study|Other non-compliance|2|||
124955290|NCT04043806|449460429|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
124955291|NCT04043806|449460429|FG000|Overall Study|Never Dosed|1|||
124955292|NCT01622088|449460430|FG000|Overall Study|Adverse Event|20|||
124955293|NCT01622088|449460430|FG000|Overall Study|Lost to Follow-up|1|||
124955294|NCT01622088|449460430|FG000|Overall Study|Withdrawal by Subject|20|||
124955295|NCT01622088|449460430|FG000|Overall Study|Investigator Decision|1|||
124955296|NCT01622088|449460430|FG000|Overall Study|Death|53|||
124955297|NCT01622088|449460430|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
124955298|NCT04799587|449460432|FG000|Overall Study|Withdrawal by Subject|0|||
124955299|NCT04799587|449460433|FG001|Overall Study|Withdrawal by Subject|1|||
124955300|NCT04598776|449460434|FG000|Overall Study|Protocol Violation|5|||
124955301|NCT04598776|449460434|FG000|Overall Study|Physician Decision|4|||
124955302|NCT06312566|449460441|FG000|Overall Study|Protocol Violation|0|||
124955303|NCT06312566|449460442|FG001|Overall Study|Protocol Violation|1|||
124955304|NCT04736472|449460443|FG000|Overall Study|Lost to Follow-up|1|||
124955305|NCT04736472|449460444|FG001|Overall Study|Lost to Follow-up|0|||
124955306|NCT04736472|449460445|FG002|Overall Study|Lost to Follow-up|0|||
124955307|NCT04736472|449460443|FG000|Overall Study|Withdrawal by Subject|2|||
124955308|NCT04736472|449460444|FG001|Overall Study|Withdrawal by Subject|0|||
124955309|NCT04736472|449460445|FG002|Overall Study|Withdrawal by Subject|0|||
124955310|NCT04736472|449460443|FG000|Overall Study|Protocol Violation|48|||
124955311|NCT04736472|449460444|FG001|Overall Study|Protocol Violation|0|||
124955312|NCT04736472|449460445|FG002|Overall Study|Protocol Violation|6|||
124955313|NCT02116582|449460446|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
124955314|NCT02116582|449460446|FG000|Overall Study|Adverse Event|22|||
124955315|NCT02116582|449460446|FG000|Overall Study|Death|9|||
124955316|NCT02116582|449460446|FG000|Overall Study|Progressive Disease|148|||
124955317|NCT02116582|449460446|FG000|Overall Study|Protocol Violation|3|||
124955318|NCT02116582|449460446|FG000|Overall Study|Withdrawal by Subject|8|||
124955319|NCT02116582|449460446|FG000|Overall Study|Other: Miscellaneous|11|||
124955320|NCT02116582|449460446|FG000|Overall Study|Lost to Follow-up|1|||
124955321|NCT02116582|449460446|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
124955322|NCT03861078|449460447|FG000|Overall Study|COVID-19 shut down|4|||
124955323|NCT03861078|449460447|FG000|Overall Study|Lost to Follow-up|1|||
124955324|NCT03861078|449460447|FG000|Overall Study|Protocol Violation|2|||
124955325|NCT03861078|449460447|FG000|Overall Study|lack of venous access|1|||
124955326|NCT02971683|449460448|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
124955327|NCT02971683|449460449|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
124955328|NCT02971683|449460448|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
124955329|NCT02971683|449460449|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
124955330|NCT02971683|449460448|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
124955331|NCT02971683|449460449|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
124955332|NCT02971683|449460448|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
124955333|NCT02971683|449460449|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
124955334|NCT02971683|449460448|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
124955335|NCT02971683|449460449|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
124955336|NCT02971683|449460448|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
124955337|NCT02971683|449460449|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
124955338|NCT02971683|449460448|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
124955339|NCT02971683|449460449|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
124955340|NCT02971683|449460448|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
124955341|NCT02971683|449460449|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
124955342|NCT02971683|449460448|FG000|Open-Label|Lost to Follow-up|1|||
124955343|NCT02971683|449460449|FG001|Open-Label|Lost to Follow-up|0|||
124955344|NCT02971683|449460448|FG000|Open-Label|Participants withdrew consent|0|||
124955345|NCT02971683|449460449|FG001|Open-Label|Participants withdrew consent|2|||
124955346|NCT02971683|449460448|FG000|Open-Label|Participant request to discontinue study treatment|1|||
124955347|NCT02971683|449460449|FG001|Open-Label|Participant request to discontinue study treatment|0|||
124955348|NCT02971683|449460448|FG000|Open-Label|Lack of Efficacy|2|||
124955349|NCT02971683|449460449|FG001|Open-Label|Lack of Efficacy|0|||
124955350|NCT02971683|449460448|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
124955351|NCT02971683|449460449|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
124955352|NCT02971683|449460448|FG000|Long-Term Open Label|Participant withdrew consent|1|||
125215289|NCT02559570|450414981|FG003|Overall Study|Withdrawal of Consent|2|||
125215290|NCT02559570|450414982|FG004|Overall Study|Withdrawal of Consent|1|||
125215291|NCT02559570|450414978|FG000|Overall Study|Lost to Follow-up|1|||
125215292|NCT02559570|450414979|FG001|Overall Study|Lost to Follow-up|0|||
125215293|NCT02559570|450414980|FG002|Overall Study|Lost to Follow-up|0|||
124955353|NCT02971683|449460449|FG001|Long-Term Open Label|Participant withdrew consent|0|||
124955354|NCT02971683|449460448|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
124955355|NCT02971683|449460449|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
124955356|NCT02971683|449460448|FG000|Long-Term Open Label|Adverse Event|1|||
124955357|NCT02971683|449460449|FG001|Long-Term Open Label|Adverse Event|2|||
124955358|NCT02971683|449460448|FG000|Long-Term Open Label|Lack of Efficacy|1|||
124955359|NCT02971683|449460449|FG001|Long-Term Open Label|Lack of Efficacy|1|||
124955360|NCT02268526|449460452|FG000|Overall Study|Adverse Event|0|||
124955361|NCT02268526|449460453|FG001|Overall Study|Adverse Event|2|||
124955362|NCT02268526|449460454|FG002|Overall Study|Adverse Event|1|||
124955363|NCT02268526|449460452|FG000|Overall Study|Death|1|||
124955364|NCT02268526|449460453|FG001|Overall Study|Death|11|||
124955365|NCT02268526|449460454|FG002|Overall Study|Death|0|||
124955366|NCT02268526|449460452|FG000|Overall Study|protocol deviation|0|||
124955367|NCT02268526|449460453|FG001|Overall Study|protocol deviation|1|||
124955368|NCT02268526|449460454|FG002|Overall Study|protocol deviation|0|||
124955369|NCT02268526|449460452|FG000|Overall Study|Physician Decision|0|||
124955370|NCT02268526|449460453|FG001|Overall Study|Physician Decision|0|||
124955371|NCT02268526|449460454|FG002|Overall Study|Physician Decision|1|||
124955372|NCT02268526|449460452|FG000|Overall Study|Subject/guardian decision|0|||
124955373|NCT02268526|449460453|FG001|Overall Study|Subject/guardian decision|7|||
124955374|NCT02268526|449460454|FG002|Overall Study|Subject/guardian decision|3|||
124955375|NCT00596960|449460455|FG000|Overall Study|Death|1|||
124955376|NCT00596960|449460456|FG001|Overall Study|Death|2|||
124955377|NCT00596960|449460455|FG000|Overall Study|Lost to Follow-up|6|||
124955378|NCT00596960|449460456|FG001|Overall Study|Lost to Follow-up|5|||
124955379|NCT00596960|449460455|FG000|Overall Study|Withdrawal by Subject|1|||
124955380|NCT00596960|449460456|FG001|Overall Study|Withdrawal by Subject|0|||
124955381|NCT00596960|449460455|FG000|Overall Study|Incarcerated|2|||
124955382|NCT00596960|449460456|FG001|Overall Study|Incarcerated|0|||
124955383|NCT00596960|449460455|FG000|Overall Study|Physician Decision|1|||
124955384|NCT00596960|449460456|FG001|Overall Study|Physician Decision|0|||
124955385|NCT00596960|449460455|FG000|Overall Study|Protocol Violation|0|||
124955386|NCT00596960|449460456|FG001|Overall Study|Protocol Violation|1|||
124955387|NCT00596960|449460455|FG000|Overall Study|No alcohol use data|0|||
124955388|NCT00596960|449460456|FG001|Overall Study|No alcohol use data|1|||
124955389|NCT02130401|449460462|FG000|Overall Study|Poor enrollment|6|||
124955390|NCT00936065|449460463|FG000|Overall Study|Adverse Event|1|||
124955391|NCT00936065|449460464|FG001|Overall Study|Adverse Event|0|||
124955392|NCT00936065|449460465|FG002|Overall Study|Adverse Event|1|||
124955393|NCT00936065|449460463|FG000|Overall Study|Lack of Efficacy|1|||
124955394|NCT00936065|449460464|FG001|Overall Study|Lack of Efficacy|0|||
124955395|NCT00936065|449460465|FG002|Overall Study|Lack of Efficacy|1|||
124955396|NCT00936065|449460463|FG000|Overall Study|Lost to Follow-up|1|||
124955397|NCT00936065|449460464|FG001|Overall Study|Lost to Follow-up|0|||
124955398|NCT00936065|449460465|FG002|Overall Study|Lost to Follow-up|0|||
125030745|NCT01756456|449735037|FG000|Treatment Period: Phase I/II|Other causes|0|||
125030746|NCT01756456|449735038|FG001|Treatment Period: Phase I/II|Other causes|0|||
125030747|NCT01756456|449735039|FG002|Treatment Period: Phase I/II|Other causes|0|||
125030748|NCT01756456|449735040|FG003|Treatment Period: Phase I/II|Other causes|1|||
125030749|NCT01756456|449735041|FG004|Treatment Period: Phase I/II|Other causes|2|||
125030750|NCT01756456|449735042|FG005|Treatment Period: Phase I/II|Other causes|2|||
125030751|NCT01756456|449735037|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
125030752|NCT01756456|449735038|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
125030753|NCT01756456|449735039|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
125030754|NCT01756456|449735040|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
125030755|NCT01756456|449735041|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
125030756|NCT01756456|449735042|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
125030757|NCT01756456|449735037|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
125030758|NCT01756456|449735038|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
125030759|NCT01756456|449735039|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
124955399|NCT00936065|449460463|FG000|Overall Study|Protocol Violation|1|||
124955400|NCT00936065|449460464|FG001|Overall Study|Protocol Violation|2|||
124955401|NCT00936065|449460465|FG002|Overall Study|Protocol Violation|1|||
124955402|NCT00936065|449460463|FG000|Overall Study|Withdrawal by Subject|0|||
124955403|NCT00936065|449460464|FG001|Overall Study|Withdrawal by Subject|2|||
124955404|NCT00936065|449460465|FG002|Overall Study|Withdrawal by Subject|4|||
124955405|NCT00070317|449460466|FG000|Overall Study|Inevaluable (Never Treated)|1|||
124955406|NCT00070317|449460466|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
125125523|NCT02937701|450085752|FG000|Day 1 to Week 22|Death|1|||
125125524|NCT02937701|450085753|FG001|Day 1 to Week 22|Death|1|||
125125525|NCT02937701|450085754|FG002|Day 1 to Week 22|Death|0|||
125125526|NCT02937701|450085755|FG003|Day 1 to Week 22|Death|0|||
125125527|NCT02937701|450085756|FG004|Day 1 to Week 22|Death|0|||
125125528|NCT02937701|450085752|FG000|Day 1 to Week 22|Protocol Violation|1|||
124955407|NCT00070317|449460466|FG000|Overall Study|Ineligible required test not done|1|||
124955408|NCT00070317|449460466|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
124955409|NCT00070317|449460466|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
124955410|NCT01429285|449460467|FG000|Overall Study|Protocol Violation|9|||
124955411|NCT01429285|449460468|FG001|Overall Study|Protocol Violation|4|||
124955412|NCT01429285|449460467|FG000|Overall Study|Missing Data|5|||
124955413|NCT01429285|449460468|FG001|Overall Study|Missing Data|3|||
124955414|NCT01429285|449460467|FG000|Overall Study|Erroneously Enrolled Twice|8|||
124955415|NCT01429285|449460468|FG001|Overall Study|Erroneously Enrolled Twice|2|||
124955416|NCT01885559|449460469|FG000|Overall Study|Lost to Follow-up|15|||
124955417|NCT01885559|449460470|FG001|Overall Study|Lost to Follow-up|16|||
124955418|NCT01885559|449460469|FG000|Overall Study|Less than full participation|9|||
124955419|NCT01885559|449460470|FG001|Overall Study|Less than full participation|19|||
124955420|NCT01885559|449460469|FG000|Overall Study|Protocol Violation|0|||
124955421|NCT01885559|449460470|FG001|Overall Study|Protocol Violation|1|||
124955422|NCT01052714|449460474|FG000|Overall Study|Adverse Event|6|||
124955423|NCT01052714|449460475|FG001|Overall Study|Adverse Event|3|||
124955424|NCT01052714|449460476|FG002|Overall Study|Adverse Event|0|||
124955425|NCT01052714|449460474|FG000|Overall Study|Death|1|||
124955426|NCT01052714|449460475|FG001|Overall Study|Death|2|||
124955427|NCT01052714|449460476|FG002|Overall Study|Death|0|||
124955428|NCT01052714|449460474|FG000|Overall Study|Lost to Follow-up|2|||
124955429|NCT01052714|449460475|FG001|Overall Study|Lost to Follow-up|3|||
124955430|NCT01052714|449460476|FG002|Overall Study|Lost to Follow-up|0|||
124955431|NCT01052714|449460474|FG000|Overall Study|Physician Decision|9|||
124955432|NCT01052714|449460475|FG001|Overall Study|Physician Decision|9|||
124955433|NCT01052714|449460476|FG002|Overall Study|Physician Decision|1|||
124955434|NCT01052714|449460474|FG000|Overall Study|Withdrawal by Subject|7|||
124955435|NCT01052714|449460475|FG001|Overall Study|Withdrawal by Subject|12|||
124955436|NCT01052714|449460476|FG002|Overall Study|Withdrawal by Subject|1|||
124955437|NCT00644332|449462255|FG000|Overall Study|Adverse Event|11|||
124955438|NCT00644332|449462255|FG000|Overall Study|Withdrawal by Subject|6|||
124955439|NCT00644332|449462255|FG000|Overall Study|Completion Status Unknown|2|||
124955440|NCT00644332|449462255|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
124955441|NCT00644332|449462255|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
124955442|NCT00627523|449462259|FG000|Overall Study|Lack of Efficacy|1|||
124955443|NCT00627523|449462260|FG001|Overall Study|Lack of Efficacy|0|||
124955444|NCT00627523|449462259|FG000|Overall Study|Withdrawal by Subject|0|||
124955445|NCT00627523|449462260|FG001|Overall Study|Withdrawal by Subject|2|||
124955446|NCT00627523|449462259|FG000|Overall Study|Other|1|||
124955447|NCT00627523|449462260|FG001|Overall Study|Other|0|||
124955448|NCT00355784|449462264|FG000|Overall Study|Withdrawal by Subject|0|||
124955449|NCT00355784|449462265|FG001|Overall Study|Withdrawal by Subject|0|||
124955450|NCT00355784|449462266|FG002|Overall Study|Withdrawal by Subject|2|||
124955451|NCT03602053|449462270|FG000|Overall Study|Withdrawal by Subject|7|||
124955452|NCT03602053|449462271|FG001|Overall Study|Withdrawal by Subject|9|||
124955453|NCT03602053|449462272|FG002|Overall Study|Withdrawal by Subject|7|||
124955454|NCT03602053|449462270|FG000|Overall Study|Lost to Follow-up|5|||
124955455|NCT03602053|449462271|FG001|Overall Study|Lost to Follow-up|6|||
124955456|NCT03602053|449462272|FG002|Overall Study|Lost to Follow-up|0|||
124955457|NCT03602053|449462270|FG000|Overall Study|Protocol Violation|3|||
124955458|NCT03602053|449462271|FG001|Overall Study|Protocol Violation|0|||
124955459|NCT03602053|449462272|FG002|Overall Study|Protocol Violation|4|||
124955460|NCT03602053|449462270|FG000|Overall Study|Physician Decision|1|||
124955461|NCT03602053|449462271|FG001|Overall Study|Physician Decision|0|||
124955462|NCT03602053|449462272|FG002|Overall Study|Physician Decision|0|||
125125529|NCT02937701|450085753|FG001|Day 1 to Week 22|Protocol Violation|1|||
125125530|NCT02937701|450085754|FG002|Day 1 to Week 22|Protocol Violation|0|||
125125531|NCT02937701|450085755|FG003|Day 1 to Week 22|Protocol Violation|0|||
125215294|NCT02559570|450414981|FG003|Overall Study|Lost to Follow-up|0|||
124955463|NCT03602053|449462270|FG000|Overall Study|migration|2|||
124955464|NCT03602053|449462271|FG001|Overall Study|migration|3|||
124955465|NCT03602053|449462272|FG002|Overall Study|migration|0|||
124955466|NCT03602053|449462270|FG000|Overall Study|Other|1|||
124955467|NCT03602053|449462271|FG001|Overall Study|Other|0|||
124955468|NCT03602053|449462272|FG002|Overall Study|Other|0|||
124955469|NCT01038128|449462273|FG000|Overall Study|Lack of Efficacy|1|||
124955470|NCT01038128|449462273|FG000|Overall Study|Lost to Follow-up|1|||
124955471|NCT01038128|449462273|FG000|Overall Study|Withdrawal by Subject|2|||
124955472|NCT01193283|449462280|FG000|Overall Study|Death|1|||
124955473|NCT01838447|449462283|FG000|Overall Study|Change in surgical plan|1|||
125125532|NCT02937701|450085756|FG004|Day 1 to Week 22|Protocol Violation|0|||
124955474|NCT01838447|449462284|FG001|Overall Study|Change in surgical plan|2|||
125215295|NCT02559570|450414982|FG004|Overall Study|Lost to Follow-up|0|||
125125533|NCT02937701|450085752|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
125125534|NCT02937701|450085753|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
124955475|NCT01838447|449462283|FG000|Overall Study|Withdrawal by Subject|1|||
124955476|NCT01838447|449462284|FG001|Overall Study|Withdrawal by Subject|1|||
124955477|NCT00168805|449462285|FG000|Overall Study|Adverse Event|7|||
124955478|NCT00168805|449462286|FG001|Overall Study|Adverse Event|11|||
124955479|NCT00168805|449462287|FG002|Overall Study|Adverse Event|16|||
124955480|NCT00168805|449462285|FG000|Overall Study|Protocol Violation|12|||
124955481|NCT00168805|449462286|FG001|Overall Study|Protocol Violation|11|||
124955482|NCT00168805|449462287|FG002|Overall Study|Protocol Violation|8|||
124955483|NCT00168805|449462285|FG000|Overall Study|Lost to Follow-up|12|||
124955484|NCT00168805|449462286|FG001|Overall Study|Lost to Follow-up|17|||
124955485|NCT00168805|449462287|FG002|Overall Study|Lost to Follow-up|11|||
124955486|NCT00168805|449462285|FG000|Overall Study|Withdrawal by Subject|16|||
124955487|NCT00168805|449462286|FG001|Overall Study|Withdrawal by Subject|18|||
124955488|NCT00168805|449462287|FG002|Overall Study|Withdrawal by Subject|21|||
124955489|NCT00168805|449462285|FG000|Overall Study|Other|24|||
124955490|NCT00168805|449462286|FG001|Overall Study|Other|21|||
124955491|NCT00168805|449462287|FG002|Overall Study|Other|22|||
124955492|NCT00168805|449462285|FG000|Treatment|Adverse Event|25|||
124955493|NCT00168805|449462286|FG001|Treatment|Adverse Event|26|||
124955494|NCT00168805|449462287|FG002|Treatment|Adverse Event|32|||
124955495|NCT00168805|449462285|FG000|Treatment|Protocol Violation|3|||
124955496|NCT00168805|449462286|FG001|Treatment|Protocol Violation|5|||
124955497|NCT00168805|449462287|FG002|Treatment|Protocol Violation|5|||
124955498|NCT00168805|449462285|FG000|Treatment|Withdrawal by Subject|3|||
124955499|NCT00168805|449462286|FG001|Treatment|Withdrawal by Subject|7|||
124955500|NCT00168805|449462287|FG002|Treatment|Withdrawal by Subject|8|||
124955501|NCT00168805|449462285|FG000|Treatment|Other|18|||
124955502|NCT00168805|449462286|FG001|Treatment|Other|18|||
124955503|NCT00168805|449462287|FG002|Treatment|Other|17|||
124955504|NCT00472199|449462310|FG000|Overall Study|Adverse Event|19|||
124955505|NCT00472199|449462311|FG001|Overall Study|Adverse Event|23|||
124955506|NCT00472199|449462310|FG000|Overall Study|Lack of Efficacy|4|||
124955507|NCT00472199|449462311|FG001|Overall Study|Lack of Efficacy|25|||
124955508|NCT00472199|449462310|FG000|Overall Study|Lost to Follow-up|2|||
124955509|NCT00472199|449462311|FG001|Overall Study|Lost to Follow-up|4|||
124955510|NCT00472199|449462310|FG000|Overall Study|Protocol Violation|3|||
124955511|NCT00472199|449462311|FG001|Overall Study|Protocol Violation|2|||
124955512|NCT00472199|449462310|FG000|Overall Study|Withdrawal by Subject|6|||
124955513|NCT00472199|449462311|FG001|Overall Study|Withdrawal by Subject|5|||
124955514|NCT00472199|449462310|FG000|Overall Study|personal reason|0|||
124955515|NCT00472199|449462311|FG001|Overall Study|personal reason|1|||
124955516|NCT00472199|449462310|FG000|Overall Study|patient was asymptomatic|1|||
124955517|NCT00472199|449462311|FG001|Overall Study|patient was asymptomatic|0|||
124955518|NCT02446912|449462313|FG000|Overall Study|Adverse Event|3|||
124955519|NCT02446912|449462314|FG001|Overall Study|Adverse Event|13|||
124955520|NCT02446912|449462315|FG002|Overall Study|Adverse Event|5|||
124955521|NCT02446912|449462313|FG000|Overall Study|Condition under investigation worsened|0|||
124955522|NCT02446912|449462314|FG001|Overall Study|Condition under investigation worsened|1|||
124955523|NCT02446912|449462315|FG002|Overall Study|Condition under investigation worsened|1|||
124955524|NCT02446912|449462313|FG000|Overall Study|Study-specific withdrawal criteria|1|||
124955525|NCT02446912|449462314|FG001|Overall Study|Study-specific withdrawal criteria|0|||
124955526|NCT02446912|449462315|FG002|Overall Study|Study-specific withdrawal criteria|0|||
125125535|NCT02937701|450085754|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
125125536|NCT02937701|450085755|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
125125537|NCT02937701|450085756|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
125125538|NCT02937701|450085752|FG000|Day 1 to Week 22|Physician Decision|2|||
125125539|NCT02937701|450085753|FG001|Day 1 to Week 22|Physician Decision|0|||
124955527|NCT02446912|449462313|FG000|Overall Study|Lack of Efficacy|1|||
124955528|NCT02446912|449462314|FG001|Overall Study|Lack of Efficacy|4|||
125125540|NCT02937701|450085754|FG002|Day 1 to Week 22|Physician Decision|0|||
125125541|NCT02937701|450085755|FG003|Day 1 to Week 22|Physician Decision|0|||
125125542|NCT02937701|450085756|FG004|Day 1 to Week 22|Physician Decision|0|||
124955529|NCT02446912|449462315|FG002|Overall Study|Lack of Efficacy|7|||
124955530|NCT02446912|449462313|FG000|Overall Study|Lost to Follow-up|0|||
124955531|NCT02446912|449462314|FG001|Overall Study|Lost to Follow-up|0|||
124955532|NCT02446912|449462315|FG002|Overall Study|Lost to Follow-up|2|||
124955533|NCT02446912|449462313|FG000|Overall Study|Severe non-compliance to protocol|1|||
124955534|NCT02446912|449462314|FG001|Overall Study|Severe non-compliance to protocol|0|||
124955535|NCT02446912|449462315|FG002|Overall Study|Severe non-compliance to protocol|1|||
124955536|NCT02446912|449462313|FG000|Overall Study|Withdrawal by Subject|10|||
124955537|NCT02446912|449462314|FG001|Overall Study|Withdrawal by Subject|15|||
124955538|NCT02446912|449462315|FG002|Overall Study|Withdrawal by Subject|15|||
124955539|NCT02446912|449462313|FG000|Overall Study|Miscellaneous|2|||
124955540|NCT02446912|449462314|FG001|Overall Study|Miscellaneous|2|||
124955541|NCT02446912|449462315|FG002|Overall Study|Miscellaneous|4|||
124955542|NCT01268488|449462316|FG000|Overall Study|Adverse Event|3|||
125125543|NCT02937701|450085752|FG000|Day 1 to Week 22|Other|1|||
125125544|NCT02937701|450085753|FG001|Day 1 to Week 22|Other|0|||
125125545|NCT02937701|450085754|FG002|Day 1 to Week 22|Other|0|||
125125546|NCT02937701|450085755|FG003|Day 1 to Week 22|Other|0|||
125125547|NCT02937701|450085756|FG004|Day 1 to Week 22|Other|0|||
125125548|NCT02937701|450085752|FG000|Week 22 to Week 50|Adverse Event|0|||
125125549|NCT02937701|450085753|FG001|Week 22 to Week 50|Adverse Event|0|||
125125550|NCT02937701|450085754|FG002|Week 22 to Week 50|Adverse Event|10|||
125125551|NCT02937701|450085755|FG003|Week 22 to Week 50|Adverse Event|3|||
125125552|NCT02937701|450085756|FG004|Week 22 to Week 50|Adverse Event|3|||
125125553|NCT02937701|450085752|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
125125554|NCT02937701|450085753|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
125125555|NCT02937701|450085754|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
125125556|NCT02937701|450085755|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
125125557|NCT02937701|450085756|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
125125558|NCT02937701|450085752|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
125125559|NCT02937701|450085753|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
125125560|NCT02937701|450085754|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
125125561|NCT02937701|450085755|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
125125562|NCT02937701|450085756|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
125125563|NCT02937701|450085752|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
124955543|NCT01268488|449462316|FG000|Overall Study|Physician Decision|2|||
124955544|NCT00147745|449462319|FG000|Overall Study|Withdrawal by Subject|1|||
124955545|NCT00147745|449462320|FG001|Overall Study|Withdrawal by Subject|0|||
124955546|NCT00147745|449462321|FG002|Overall Study|Withdrawal by Subject|0|||
124955547|NCT05274906|449462325|FG000|Overall Study|Withdrawal by Subject|2|||
124955548|NCT05274906|449462326|FG001|Overall Study|Withdrawal by Subject|1|||
124955549|NCT03508830|449462327|FG000|Overall Study|Withdrawal by Subject|3|||
124955550|NCT03508830|449462328|FG001|Overall Study|Withdrawal by Subject|4|||
124955551|NCT03508830|449462327|FG000|Overall Study|Physician Decision|2|||
124955552|NCT03508830|449462328|FG001|Overall Study|Physician Decision|2|||
124955553|NCT02522299|449462329|FG000|Overall Study|Adverse Event|2|||
124955554|NCT02522299|449462330|FG001|Overall Study|Adverse Event|0|||
124955555|NCT02522299|449462329|FG000|Overall Study|Physician Decision|0|||
124955556|NCT02522299|449462330|FG001|Overall Study|Physician Decision|1|||
124955557|NCT02522299|449462329|FG000|Overall Study|Withdrawal by Subject|2|||
124955558|NCT02522299|449462330|FG001|Overall Study|Withdrawal by Subject|0|||
124955559|NCT04908800|449462333|FG000|Overall Study|Adverse Event|0|||
124955560|NCT04908800|449462334|FG001|Overall Study|Adverse Event|0|||
124955561|NCT04908800|449462335|FG002|Overall Study|Adverse Event|0|||
124955562|NCT04908800|449462336|FG003|Overall Study|Adverse Event|0|||
124955563|NCT04908800|449462337|FG004|Overall Study|Adverse Event|0|||
124955564|NCT04908800|449462338|FG005|Overall Study|Adverse Event|0|||
124955565|NCT04908800|449462339|FG006|Overall Study|Adverse Event|0|||
124955566|NCT04908800|449462340|FG007|Overall Study|Adverse Event|0|||
124955567|NCT04908800|449462341|FG008|Overall Study|Adverse Event|0|||
124955568|NCT04908800|449462342|FG009|Overall Study|Adverse Event|0|||
124955569|NCT04908800|449462343|FG010|Overall Study|Adverse Event|1|||
124955570|NCT04908800|449462344|FG011|Overall Study|Adverse Event|0|||
124955571|NCT04908800|449462345|FG012|Overall Study|Adverse Event|0|||
124955572|NCT02267746|449462346|FG000|Overall Study|Adverse Event|0|||
124955573|NCT02267746|449462347|FG001|Overall Study|Adverse Event|2|||
124955574|NCT02267746|449462348|FG002|Overall Study|Adverse Event|1|||
124955575|NCT02267746|449462346|FG000|Overall Study|Protocol Violation|8|||
124955576|NCT02267746|449462347|FG001|Overall Study|Protocol Violation|7|||
125125564|NCT02937701|450085753|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
125125565|NCT02937701|450085754|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
125125566|NCT02937701|450085755|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
125125567|NCT02937701|450085756|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
124955577|NCT02267746|449462348|FG002|Overall Study|Protocol Violation|3|||
124955578|NCT02267746|449462346|FG000|Overall Study|Lack of Efficacy|11|||
124955579|NCT02267746|449462347|FG001|Overall Study|Lack of Efficacy|11|||
124955580|NCT02267746|449462348|FG002|Overall Study|Lack of Efficacy|15|||
124955581|NCT02267746|449462346|FG000|Overall Study|Protocol Violation|1|||
124955582|NCT02267746|449462347|FG001|Overall Study|Protocol Violation|2|||
124955583|NCT02267746|449462348|FG002|Overall Study|Protocol Violation|1|||
125125568|NCT02937701|450085752|FG000|Week 22 to Week 50|Physician Decision|0|||
124955584|NCT02267746|449462346|FG000|Overall Study|Miscellaneous|1|||
124955585|NCT02267746|449462347|FG001|Overall Study|Miscellaneous|0|||
124955586|NCT02267746|449462348|FG002|Overall Study|Miscellaneous|1|||
124955587|NCT00728884|449462353|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
124955588|NCT00728884|449462353|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
124955589|NCT00348283|449462354|FG000|Induction|Adverse Event|0|||
124955590|NCT00348283|449462355|FG001|Induction|Adverse Event|2|||
125125569|NCT02937701|450085753|FG001|Week 22 to Week 50|Physician Decision|0|||
125125570|NCT02937701|450085754|FG002|Week 22 to Week 50|Physician Decision|2|||
125125571|NCT02937701|450085755|FG003|Week 22 to Week 50|Physician Decision|0|||
125125572|NCT02937701|450085756|FG004|Week 22 to Week 50|Physician Decision|1|||
124955591|NCT00348283|449462354|FG000|Induction|Protocol Violation|0|||
124955592|NCT00348283|449462355|FG001|Induction|Protocol Violation|4|||
124955593|NCT00348283|449462354|FG000|Double Blind|Adverse Event|2|||
124955594|NCT00348283|449462355|FG001|Double Blind|Adverse Event|5|||
124955595|NCT00348283|449462354|FG000|Double Blind|Withdrawal by Subject|1|||
124955596|NCT00348283|449462355|FG001|Double Blind|Withdrawal by Subject|1|||
124955597|NCT00348283|449462354|FG000|Double Blind|Protocol Violation|0|||
124955598|NCT00348283|449462355|FG001|Double Blind|Protocol Violation|1|||
124955599|NCT00348283|449462354|FG000|Double Blind|Lack of Efficacy|2|||
124955600|NCT00348283|449462355|FG001|Double Blind|Lack of Efficacy|2|||
124955601|NCT00348283|449462354|FG000|Double Blind|Pregnancy|0|||
124955602|NCT00348283|449462355|FG001|Double Blind|Pregnancy|1|||
124955603|NCT00348283|449462354|FG000|Open Label|Adverse Event|0|||
124955604|NCT00348283|449462355|FG001|Open Label|Adverse Event|8|||
124955605|NCT00348283|449462354|FG000|Open Label|Withdrawal by Subject|0|||
124955606|NCT00348283|449462355|FG001|Open Label|Withdrawal by Subject|4|||
124955607|NCT00348283|449462354|FG000|Open Label|Lost to Follow-up|0|||
124955608|NCT00348283|449462355|FG001|Open Label|Lost to Follow-up|1|||
124955609|NCT00348283|449462354|FG000|Open Label|Lack of Efficacy|0|||
124955610|NCT00348283|449462355|FG001|Open Label|Lack of Efficacy|13|||
124955611|NCT00348283|449462354|FG000|Open Label|Administrative reasons|0|||
124955612|NCT00348283|449462355|FG001|Open Label|Administrative reasons|5|||
124955613|NCT00348283|449462354|FG000|Open Label|Subject moved to the United States|0|||
124955614|NCT00348283|449462355|FG001|Open Label|Subject moved to the United States|1|||
124955615|NCT00348283|449462354|FG000|Open Label|Pregnancy|0|||
124955616|NCT00348283|449462355|FG001|Open Label|Pregnancy|1|||
124955617|NCT00348283|449462354|FG000|Open Label|Sponsor decision|0|||
124955618|NCT00348283|449462355|FG001|Open Label|Sponsor decision|1|||
124955619|NCT04372186|449462359|FG000|Overall Study|Death|24|||
124955620|NCT04372186|449462360|FG001|Overall Study|Death|11|||
124955621|NCT04372186|449462359|FG000|Overall Study|Transferred to a different facility for care|0|||
124955622|NCT04372186|449462360|FG001|Overall Study|Transferred to a different facility for care|2|||
124955623|NCT02374476|449462362|FG000|VT Induced Ablation|Screening Failures|36|||
124955624|NCT02374476|449462363|FG001|VT Induced Ablation|Screening Failures|0|||
124955625|NCT02374476|449462364|FG002|VT Induced Ablation|Screening Failures|0|||
124955626|NCT02374476|449462362|FG000|Arm Assignment|Withdrawal by Subject|0|||
124955627|NCT02374476|449462363|FG001|Arm Assignment|Withdrawal by Subject|0|||
124955628|NCT02374476|449462364|FG002|Arm Assignment|Withdrawal by Subject|1|||
124955629|NCT03305458|449462365|FG000|Overall Study|Withdrawal by Subject|50|||
124955630|NCT03305458|449462366|FG001|Overall Study|Withdrawal by Subject|46|||
124955631|NCT03305458|449462367|FG002|Overall Study|Withdrawal by Subject|93|||
124955632|NCT03305458|449462365|FG000|Overall Study|Lost to Follow-up|85|||
124955633|NCT03305458|449462366|FG001|Overall Study|Lost to Follow-up|85|||
124955634|NCT03305458|449462367|FG002|Overall Study|Lost to Follow-up|35|||
124955635|NCT05431543|449462368|FG000|Overall Study|Medical History|1|||
124955636|NCT05431543|449462369|FG001|Overall Study|Medical History|0|||
124955637|NCT05431543|449462370|FG002|Overall Study|Medical History|0|||
124955638|NCT00440037|449462371|FG000|Overall Study|Withdrawal by Subject|6|||
124955639|NCT00440037|449462371|FG000|Overall Study|Administrative decision|3|||
124955640|NCT00498797|449462372|FG000|Overall Study|Withdrawal by Subject|4|||
124955641|NCT00498797|449462373|FG001|Overall Study|Withdrawal by Subject|2|||
124955642|NCT00498797|449462372|FG000|Overall Study|Adverse Event|12|||
124955643|NCT00498797|449462373|FG001|Overall Study|Adverse Event|5|||
124955644|NCT00498797|449462372|FG000|Overall Study|Condition under investigation worsened|19|||
124955645|NCT00498797|449462373|FG001|Overall Study|Condition under investigation worsened|21|||
124955646|NCT00498797|449462372|FG000|Overall Study|Other|3|||
124955647|NCT00498797|449462373|FG001|Overall Study|Other|1|||
124955648|NCT00914732|449462374|FG000|Overall Study|Lost to Follow-up|6|||
124955649|NCT00914732|449462375|FG001|Overall Study|Lost to Follow-up|7|||
124955650|NCT00914732|449462376|FG002|Overall Study|Lost to Follow-up|9|||
124955651|NCT00914732|449462374|FG000|Overall Study|Withdrawal by Subject|3|||
124955652|NCT00914732|449462375|FG001|Overall Study|Withdrawal by Subject|0|||
125125573|NCT02937701|450085752|FG000|Week 22 to Week 50|Other|0|||
124955653|NCT00914732|449462376|FG002|Overall Study|Withdrawal by Subject|2|||
125125574|NCT02937701|450085753|FG001|Week 22 to Week 50|Other|0|||
125125575|NCT02937701|450085754|FG002|Week 22 to Week 50|Other|0|||
125125576|NCT02937701|450085755|FG003|Week 22 to Week 50|Other|0|||
124955654|NCT00914732|449462374|FG000|Overall Study|Adverse Event|1|||
124955655|NCT00914732|449462375|FG001|Overall Study|Adverse Event|0|||
124955656|NCT00914732|449462376|FG002|Overall Study|Adverse Event|0|||
124955657|NCT01855399|449462379|FG000|6 Month|Lost to Follow-up|12|||
124955658|NCT01855399|449462380|FG001|6 Month|Lost to Follow-up|9|||
124955659|NCT01855399|449462379|FG000|6 Month|Withdrawal by Subject|8|||
124955660|NCT01855399|449462380|FG001|6 Month|Withdrawal by Subject|6|||
124955661|NCT01855399|449462379|FG000|12 Month|Lost to Follow-up|7|||
124955662|NCT01855399|449462380|FG001|12 Month|Lost to Follow-up|11|||
124955663|NCT03953079|449462381|FG000|Core Study|Withdrawal by Subject|1|||
124955664|NCT03953079|449462382|FG001|Core Study|Withdrawal by Subject|2|||
124955665|NCT03953079|449462383|FG002|Core Study|Withdrawal by Subject|1|||
124955666|NCT03953079|449462381|FG000|Core Study|COVID-19|0|||
125125577|NCT02937701|450085756|FG004|Week 22 to Week 50|Other|1|||
124955667|NCT03953079|449462382|FG001|Core Study|COVID-19|1|||
124955668|NCT03953079|449462383|FG002|Core Study|COVID-19|0|||
124955669|NCT03953079|449462381|FG000|Core Study|Difficulties leaving the house|0|||
124955670|NCT03953079|449462382|FG001|Core Study|Difficulties leaving the house|1|||
124955671|NCT03953079|449462383|FG002|Core Study|Difficulties leaving the house|0|||
124955672|NCT03953079|449462381|FG000|Extension Study|Withdrawal by Subject|1|||
124955673|NCT03953079|449462382|FG001|Extension Study|Withdrawal by Subject|0|||
124955674|NCT03953079|449462383|FG002|Extension Study|Withdrawal by Subject|0|||
124955675|NCT03953079|449462381|FG000|Extension Study|Received Rescue Treatment|5|||
124955676|NCT03953079|449462382|FG001|Extension Study|Received Rescue Treatment|6|||
124955677|NCT03953079|449462383|FG002|Extension Study|Received Rescue Treatment|5|||
124955678|NCT04394624|449462384|FG000|Overall Study|Adverse Event|6|||
124955679|NCT04394624|449462385|FG001|Overall Study|Adverse Event|0|||
124955680|NCT04394624|449462384|FG000|Overall Study|Progressive disease|24|||
124955681|NCT04394624|449462385|FG001|Overall Study|Progressive disease|0|||
124955682|NCT04394624|449462384|FG000|Overall Study|Not related to COVID-19|1|||
124955683|NCT04394624|449462385|FG001|Overall Study|Not related to COVID-19|0|||
124955684|NCT00448344|449462391|FG000|Overall Study|Lost to Follow-up|20|||
124955685|NCT00448344|449462392|FG001|Overall Study|Lost to Follow-up|22|||
124955686|NCT00448344|449462391|FG000|Overall Study|Withdrawal by Subject|6|||
124955687|NCT00448344|449462392|FG001|Overall Study|Withdrawal by Subject|8|||
124955688|NCT00448344|449462391|FG000|Overall Study|Death|3|||
124955689|NCT00448344|449462392|FG001|Overall Study|Death|4|||
124955690|NCT00448344|449462391|FG000|Overall Study|Physician Decision|1|||
124955691|NCT00448344|449462392|FG001|Overall Study|Physician Decision|2|||
124955692|NCT00141271|449462395|FG000|Overall Study|Adverse Event|31|||
124955693|NCT00141271|449462396|FG001|Overall Study|Adverse Event|19|||
124955694|NCT00141271|449462397|FG002|Overall Study|Adverse Event|17|||
124955695|NCT00141271|449462395|FG000|Overall Study|Laboratory Abnormality|2|||
124955696|NCT00141271|449462396|FG001|Overall Study|Laboratory Abnormality|1|||
124955697|NCT00141271|449462397|FG002|Overall Study|Laboratory Abnormality|1|||
124955698|NCT00141271|449462395|FG000|Overall Study|Lack of Efficacy|7|||
124955699|NCT00141271|449462396|FG001|Overall Study|Lack of Efficacy|7|||
124955700|NCT00141271|449462397|FG002|Overall Study|Lack of Efficacy|3|||
124955701|NCT00141271|449462395|FG000|Overall Study|Lost to Follow-up|15|||
124955702|NCT00141271|449462396|FG001|Overall Study|Lost to Follow-up|15|||
124955703|NCT00141271|449462397|FG002|Overall Study|Lost to Follow-up|21|||
124955704|NCT00141271|449462395|FG000|Overall Study|Withdrawal by Subject|14|||
124955705|NCT00141271|449462396|FG001|Overall Study|Withdrawal by Subject|9|||
124955706|NCT00141271|449462397|FG002|Overall Study|Withdrawal by Subject|10|||
124955707|NCT00141271|449462395|FG000|Overall Study|Other|11|||
124955708|NCT00141271|449462396|FG001|Overall Study|Other|12|||
124955709|NCT00141271|449462397|FG002|Overall Study|Other|5|||
124955710|NCT00990314|449462398|FG000|Overall Study|Death|2|||
124955711|NCT00990314|449462398|FG000|Overall Study|Adverse Event|2|||
124955712|NCT00990314|449462398|FG000|Overall Study|Withdrawal by Subject|3|||
124955713|NCT00990314|449462398|FG000|Overall Study|Non-Compliance|1|||
124955714|NCT00990314|449462398|FG000|Overall Study|Physician Decision|3|||
124955715|NCT00990314|449462398|FG000|Overall Study|Lack of Efficacy|1|||
124955716|NCT00267865|449462405|FG000|Induction Treatment|Died before completing.|2|||
124955717|NCT00267865|449462405|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
124955718|NCT03686176|449462406|FG000|Overall Study|Procedure cancelled|1|||
124955719|NCT03686176|449462407|FG001|Overall Study|Procedure cancelled|0|||
124955720|NCT03686176|449462408|FG002|Overall Study|Procedure cancelled|0|||
124955721|NCT03686176|449462406|FG000|Overall Study|VR Malfunction|1|||
124955722|NCT03686176|449462407|FG001|Overall Study|VR Malfunction|0|||
124955723|NCT03686176|449462408|FG002|Overall Study|VR Malfunction|0|||
124955724|NCT01636778|449462411|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
124955725|NCT01636778|449462412|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
124955726|NCT01636778|449462413|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
124955727|NCT01636778|449462411|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
124955728|NCT01636778|449462412|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
124955729|NCT01636778|449462413|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
124955730|NCT01636778|449462411|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
124955731|NCT01636778|449462412|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
124955732|NCT01636778|449462413|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
124955733|NCT01636778|449462411|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
124955734|NCT01636778|449462412|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
124955735|NCT01636778|449462413|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
124955736|NCT01636778|449462411|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
124955737|NCT01636778|449462412|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
124955738|NCT01636778|449462413|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
124955739|NCT01636778|449462411|FG000|Follow-up Period After Part 2|Other|0|||
125125578|NCT01101022|450085763|FG000|Overall Study|Adverse Event|6|||
125125579|NCT01101022|450085764|FG001|Overall Study|Adverse Event|2|||
125125580|NCT01101022|450085763|FG000|Overall Study|Protocol Violation|4|||
125125581|NCT01101022|450085764|FG001|Overall Study|Protocol Violation|3|||
125125582|NCT01101022|450085763|FG000|Overall Study|Withdrawal by Subject|3|||
124955740|NCT01636778|449462412|FG001|Follow-up Period After Part 2|Other|0|||
124955741|NCT01636778|449462413|FG002|Follow-up Period After Part 2|Other|1|||
124955742|NCT01636778|449462411|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
124955743|NCT01636778|449462412|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
124955744|NCT01636778|449462413|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
124955745|NCT01636778|449462411|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
124955746|NCT01636778|449462412|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
124955747|NCT01636778|449462413|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
124955748|NCT03530345|449462422|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
124955749|NCT03530345|449462423|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
124955750|NCT03530345|449462422|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
124955751|NCT03530345|449462423|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
124955752|NCT03530345|449462422|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
124955753|NCT03530345|449462423|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
124955754|NCT03530345|449462422|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
124955755|NCT03530345|449462423|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
124955756|NCT04853394|449462426|FG000|Follow-up Interviews|Lost to Follow-up|22|||
124955757|NCT04853394|449462427|FG001|Follow-up Interviews|Lost to Follow-up|15|||
124955758|NCT04212299|449462428|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
124955759|NCT00705614|449464218|FG000|Initial Intervention|Adverse Event|40|||
124955760|NCT00705614|449464219|FG001|Initial Intervention|Adverse Event|21|||
124955761|NCT00705614|449464218|FG000|Initial Intervention|Lost to Follow-up|310|||
124955762|NCT00705614|449464219|FG001|Initial Intervention|Lost to Follow-up|191|||
124955763|NCT00705614|449464218|FG000|Initial Intervention|Withdrawal by Subject|114|||
124955764|NCT00705614|449464219|FG001|Initial Intervention|Withdrawal by Subject|71|||
124955765|NCT00705614|449464218|FG000|Initial Intervention|Administrative Reason|51|||
124955766|NCT00705614|449464219|FG001|Initial Intervention|Administrative Reason|38|||
124955767|NCT00705614|449464218|FG000|Initial Intervention|Status completion unknown|3|||
124955768|NCT00705614|449464219|FG001|Initial Intervention|Status completion unknown|0|||
124955769|NCT00705614|449464218|FG000|Switch to Remicade|Adverse Event|0|||
124955770|NCT00705614|449464219|FG001|Switch to Remicade|Adverse Event|5|||
124955771|NCT00705614|449464218|FG000|Switch to Remicade|Lost to Follow-up|0|||
124955772|NCT00705614|449464219|FG001|Switch to Remicade|Lost to Follow-up|23|||
124955773|NCT00705614|449464218|FG000|Switch to Remicade|Withdrawal by Subject|0|||
124955774|NCT00705614|449464219|FG001|Switch to Remicade|Withdrawal by Subject|12|||
124955775|NCT00705614|449464218|FG000|Switch to Remicade|Administrative Reason|0|||
124955776|NCT00705614|449464219|FG001|Switch to Remicade|Administrative Reason|9|||
124955777|NCT00676195|449464222|FG000|Overall Study|Lost to Follow-up|1|||
124955778|NCT00676195|449464222|FG000|Overall Study|Adverse Event|1|||
124955779|NCT00676195|449464222|FG000|Overall Study|Physician Decision|1|||
124955780|NCT02878590|449464223|FG000|Overall Study|Withdrawal by Subject|2|||
124955781|NCT02661490|449464224|FG000|Overall Study|Lost to Follow-up|0|||
124955782|NCT02661490|449464225|FG001|Overall Study|Lost to Follow-up|1|||
124955783|NCT02661490|449464226|FG002|Overall Study|Lost to Follow-up|0|||
124955784|NCT02661490|449464227|FG003|Overall Study|Lost to Follow-up|0|||
124955785|NCT02661490|449464228|FG004|Overall Study|Lost to Follow-up|2|||
124955786|NCT02661490|449464224|FG000|Overall Study|Withdrawal by Subject|2|||
124955787|NCT02661490|449464225|FG001|Overall Study|Withdrawal by Subject|0|||
124955788|NCT02661490|449464226|FG002|Overall Study|Withdrawal by Subject|2|||
124955789|NCT02661490|449464227|FG003|Overall Study|Withdrawal by Subject|0|||
124955790|NCT02661490|449464228|FG004|Overall Study|Withdrawal by Subject|0|||
124955791|NCT02661490|449464224|FG000|Overall Study|Death|1|||
124955792|NCT02661490|449464225|FG001|Overall Study|Death|1|||
124955793|NCT02661490|449464226|FG002|Overall Study|Death|0|||
124955794|NCT02661490|449464227|FG003|Overall Study|Death|1|||
124955795|NCT02661490|449464228|FG004|Overall Study|Death|0|||
124955796|NCT02661490|449464224|FG000|Overall Study|Reason not Specified|0|||
124955797|NCT02661490|449464225|FG001|Overall Study|Reason not Specified|0|||
124955798|NCT02661490|449464226|FG002|Overall Study|Reason not Specified|0|||
124955799|NCT02661490|449464227|FG003|Overall Study|Reason not Specified|0|||
125125583|NCT01101022|450085764|FG001|Overall Study|Withdrawal by Subject|8|||
125125584|NCT01101022|450085763|FG000|Overall Study|Lost to Follow-up|1|||
125125585|NCT01101022|450085764|FG001|Overall Study|Lost to Follow-up|4|||
125125586|NCT01101022|450085763|FG000|Overall Study|Lack of Efficacy|0|||
125125587|NCT01101022|450085764|FG001|Overall Study|Lack of Efficacy|7|||
125125588|NCT01101022|450085763|FG000|Overall Study|Sponsor decision|1|||
125125589|NCT01101022|450085764|FG001|Overall Study|Sponsor decision|1|||
125125590|NCT01101022|450085763|FG000|Overall Study|Non-compliance|1|||
124955800|NCT02661490|449464228|FG004|Overall Study|Reason not Specified|1|||
124955801|NCT02706834|449464229|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
125125591|NCT01101022|450085764|FG001|Overall Study|Non-compliance|0|||
125125592|NCT01101022|450085763|FG000|Overall Study|Work schedule|1|||
124955802|NCT02706834|449464230|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
124955803|NCT02706834|449464231|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
124955804|NCT02706834|449464232|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
124955805|NCT02706834|449464233|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
124955806|NCT02706834|449464234|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
124955807|NCT02706834|449464235|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
124955808|NCT02706834|449464236|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
124955809|NCT02706834|449464237|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
124955810|NCT02706834|449464238|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
124955811|NCT02706834|449464239|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
124955812|NCT02706834|449464229|FG000|Overall Study|Lost to Follow-up|0|||
124955813|NCT02706834|449464230|FG001|Overall Study|Lost to Follow-up|0|||
124955814|NCT02706834|449464231|FG002|Overall Study|Lost to Follow-up|1|||
124955815|NCT02706834|449464232|FG003|Overall Study|Lost to Follow-up|0|||
124955816|NCT02706834|449464233|FG004|Overall Study|Lost to Follow-up|0|||
124955817|NCT02706834|449464234|FG005|Overall Study|Lost to Follow-up|0|||
124955818|NCT02706834|449464235|FG006|Overall Study|Lost to Follow-up|0|||
124955819|NCT02706834|449464236|FG007|Overall Study|Lost to Follow-up|0|||
124955820|NCT02706834|449464237|FG008|Overall Study|Lost to Follow-up|0|||
124955821|NCT02706834|449464238|FG009|Overall Study|Lost to Follow-up|0|||
124955822|NCT02706834|449464239|FG010|Overall Study|Lost to Follow-up|0|||
124955823|NCT02706834|449464229|FG000|Overall Study|Voluntary Withdrawal|1|||
124955824|NCT02706834|449464230|FG001|Overall Study|Voluntary Withdrawal|0|||
124955825|NCT02706834|449464231|FG002|Overall Study|Voluntary Withdrawal|0|||
124955826|NCT02706834|449464232|FG003|Overall Study|Voluntary Withdrawal|0|||
124955827|NCT02706834|449464233|FG004|Overall Study|Voluntary Withdrawal|0|||
124955828|NCT02706834|449464234|FG005|Overall Study|Voluntary Withdrawal|0|||
124955829|NCT02706834|449464235|FG006|Overall Study|Voluntary Withdrawal|0|||
124955830|NCT02706834|449464236|FG007|Overall Study|Voluntary Withdrawal|0|||
124955831|NCT02706834|449464237|FG008|Overall Study|Voluntary Withdrawal|0|||
124955832|NCT02706834|449464238|FG009|Overall Study|Voluntary Withdrawal|1|||
124955833|NCT02706834|449464239|FG010|Overall Study|Voluntary Withdrawal|0|||
124955834|NCT02706834|449464229|FG000|Overall Study|Other Reason Not Specified|1|||
124955835|NCT02706834|449464230|FG001|Overall Study|Other Reason Not Specified|0|||
124955836|NCT02706834|449464231|FG002|Overall Study|Other Reason Not Specified|0|||
124955837|NCT02706834|449464232|FG003|Overall Study|Other Reason Not Specified|0|||
124955838|NCT02706834|449464233|FG004|Overall Study|Other Reason Not Specified|1|||
124955839|NCT02706834|449464234|FG005|Overall Study|Other Reason Not Specified|0|||
124955840|NCT02706834|449464235|FG006|Overall Study|Other Reason Not Specified|0|||
124955841|NCT02706834|449464236|FG007|Overall Study|Other Reason Not Specified|0|||
124955842|NCT02706834|449464237|FG008|Overall Study|Other Reason Not Specified|0|||
124955843|NCT02706834|449464238|FG009|Overall Study|Other Reason Not Specified|0|||
124955844|NCT02706834|449464239|FG010|Overall Study|Other Reason Not Specified|0|||
124955845|NCT03034772|449464255|FG000|Overall Study|Adverse Event|0|||
124955846|NCT03034772|449464256|FG001|Overall Study|Adverse Event|1|||
124955847|NCT03034772|449464255|FG000|Overall Study|Withdrawal by Subject|0|||
124955848|NCT03034772|449464256|FG001|Overall Study|Withdrawal by Subject|1|||
124955849|NCT00116584|449464259|FG000|Overall Study|Withdrawal by Subject|1|||
124955850|NCT00116584|449464260|FG001|Overall Study|Withdrawal by Subject|0|||
124955851|NCT00116584|449464259|FG000|Overall Study|Protocol Violation|1|||
125030760|NCT01756456|449735040|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
125030761|NCT01756456|449735041|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
125030762|NCT01756456|449735042|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
125030763|NCT01756456|449735037|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
125030764|NCT01756456|449735038|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
125030765|NCT01756456|449735039|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
125030766|NCT01756456|449735040|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
125030767|NCT01756456|449735041|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
125030768|NCT01756456|449735042|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
125030769|NCT01756456|449735037|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
125125593|NCT01101022|450085764|FG001|Overall Study|Work schedule|1|||
124955852|NCT00116584|449464260|FG001|Overall Study|Protocol Violation|1|||
124955853|NCT01745380|449464261|FG000|Overall Study|Lost to Follow-up|1|||
124955854|NCT01745380|449464262|FG001|Overall Study|Lost to Follow-up|0|||
124955855|NCT01745380|449464261|FG000|Overall Study|Lack of Efficacy|0|||
124955856|NCT01745380|449464262|FG001|Overall Study|Lack of Efficacy|1|||
124955857|NCT01882088|449464263|FG000|Overall Study|Intolerance of esophageal manometry|1|||
124955858|NCT01882088|449464263|FG000|Overall Study|no possibility to place the catheter|1|||
124955859|NCT01882088|449464263|FG000|Overall Study|Protocol Violation|1|||
124955860|NCT01882088|449464263|FG000|Overall Study|inadequate pH-impedance tracings|2|||
124955861|NCT01797705|449464268|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
124955862|NCT01797705|449464268|FG000|Overall Study|Withdrawal by Subject|1|||
124955863|NCT01533181|449464271|FG000|Overall Study|Disease progression pre-active treatment|0|||
124955864|NCT01533181|449464272|FG001|Overall Study|Disease progression pre-active treatment|1|||
124955865|NCT01533181|449464271|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
124955866|NCT01533181|449464272|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
124955867|NCT01837719|449464273|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
124955868|NCT01837719|449464273|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
124955869|NCT01703988|449464274|FG000|Overall Study|Investigator Judgment|0|||
124955870|NCT01703988|449464275|FG001|Overall Study|Investigator Judgment|0|||
124955871|NCT01703988|449464276|FG002|Overall Study|Investigator Judgment|0|||
124955872|NCT01703988|449464277|FG003|Overall Study|Investigator Judgment|1|||
124955873|NCT02995733|449464278|FG000|Overall Study|Study site closed|9|||
124955874|NCT02995733|449464279|FG001|Overall Study|Study site closed|10|||
124955875|NCT02995733|449464278|FG000|Overall Study|Death|3|||
124955876|NCT02995733|449464279|FG001|Overall Study|Death|4|||
124955877|NCT02995733|449464278|FG000|Overall Study|Withdrawal by Subject|6|||
124955878|NCT02995733|449464279|FG001|Overall Study|Withdrawal by Subject|2|||
124955879|NCT02995733|449464278|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
124955880|NCT02995733|449464279|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
124955881|NCT02995733|449464278|FG000|Overall Study|Lost to Follow-up|48|||
124955882|NCT02995733|449464279|FG001|Overall Study|Lost to Follow-up|37|||
124955883|NCT02995733|449464278|FG000|Overall Study|Other|0|||
124955884|NCT02995733|449464279|FG001|Overall Study|Other|1|||
124955885|NCT03785210|449464285|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
124955886|NCT03785210|449464286|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
124955887|NCT04879823|449464287|FG000|Overall Study|Physician Decision|3|||
124955888|NCT04879823|449464288|FG001|Overall Study|Physician Decision|1|||
124955889|NCT04879823|449464287|FG000|Overall Study|Protocol Violation|2|||
124955890|NCT04879823|449464288|FG001|Overall Study|Protocol Violation|3|||
124955891|NCT04879823|449464287|FG000|Overall Study|Lost to Follow-up|43|||
124955892|NCT04879823|449464288|FG001|Overall Study|Lost to Follow-up|35|||
124955893|NCT04468633|449464291|FG000|Overall Study|Withdrawal by Subject|4|||
124955894|NCT04468633|449464292|FG001|Overall Study|Withdrawal by Subject|0|||
124955895|NCT00460434|449464295|FG000|Overall Study|Lost to Follow-up|3|||
124955896|NCT00460434|449464296|FG001|Overall Study|Lost to Follow-up|7|||
124955897|NCT02465866|449464297|FG000|Period 3|Withdrawal by Subject|0|||
124955898|NCT02465866|449464298|FG001|Period 3|Withdrawal by Subject|1|||
124955899|NCT02465866|449464299|FG002|Period 3|Withdrawal by Subject|0|||
124955900|NCT02465866|449464300|FG003|Period 3|Withdrawal by Subject|0|||
124955901|NCT00203502|449464301|FG000|Overall Study|Death|1|||
124955902|NCT01403805|449464302|FG000|Overall Study|Withdrawal by Subject|0|||
124955903|NCT01403805|449464303|FG001|Overall Study|Withdrawal by Subject|4|||
124955904|NCT01403805|449464302|FG000|Overall Study|Lost to Follow-up|0|||
124955905|NCT01403805|449464303|FG001|Overall Study|Lost to Follow-up|2|||
124955906|NCT01403805|449464302|FG000|Overall Study|Death|0|||
124955907|NCT01403805|449464303|FG001|Overall Study|Death|1|||
124955908|NCT01103141|449464306|FG000|Overall Study|Death|0|||
124955909|NCT01103141|449464307|FG001|Overall Study|Death|1|||
124955910|NCT01103141|449464306|FG000|Overall Study|Lost to Follow-up|2|||
124955911|NCT01103141|449464307|FG001|Overall Study|Lost to Follow-up|1|||
124955912|NCT01695993|449464308|FG000|Overall Study|Lost to Follow-up|2|||
124955913|NCT01695993|449464309|FG001|Overall Study|Lost to Follow-up|1|||
124955914|NCT01695993|449464310|FG002|Overall Study|Lost to Follow-up|3|||
124955915|NCT01695993|449464308|FG000|Overall Study|Withdrawal by Subject|2|||
124955916|NCT01695993|449464309|FG001|Overall Study|Withdrawal by Subject|2|||
124955917|NCT01695993|449464310|FG002|Overall Study|Withdrawal by Subject|2|||
124955918|NCT01695993|449464308|FG000|Overall Study|To ill to continue|1|||
124955919|NCT01695993|449464309|FG001|Overall Study|To ill to continue|2|||
124955920|NCT01695993|449464310|FG002|Overall Study|To ill to continue|0|||
124955921|NCT01695993|449464308|FG000|Overall Study|Changed Medical Facility|0|||
125030770|NCT01756456|449735038|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
125215296|NCT02559570|450414978|FG000|Overall Study|Protocol Violation|1|||
125215297|NCT02559570|450414979|FG001|Overall Study|Protocol Violation|0|||
124955922|NCT01695993|449464309|FG001|Overall Study|Changed Medical Facility|0|||
124955923|NCT01695993|449464310|FG002|Overall Study|Changed Medical Facility|1|||
124955924|NCT04057937|449464311|FG000|Placebo-controlled Phase|Adverse Event|3|||
124955925|NCT04057937|449464312|FG001|Placebo-controlled Phase|Adverse Event|0|||
124955926|NCT04057937|449464311|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
124955927|NCT04057937|449464312|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
124955928|NCT04057937|449464311|FG000|Active-treatment Phase|Pregnancy|0|||
124955929|NCT04057937|449464312|FG001|Active-treatment Phase|Pregnancy|1|||
124955930|NCT04057937|449464311|FG000|Active-treatment Phase|Physician Decision|0|||
124955931|NCT04057937|449464312|FG001|Active-treatment Phase|Physician Decision|1|||
124955932|NCT00422162|449464322|FG000|Overall Study|Adverse Event|11|||
124955933|NCT00422162|449464323|FG001|Overall Study|Adverse Event|9|||
124955934|NCT00422162|449464322|FG000|Overall Study|Lack of Efficacy|4|||
124955935|NCT00422162|449464323|FG001|Overall Study|Lack of Efficacy|10|||
124955936|NCT00422162|449464322|FG000|Overall Study|Withdrawal by Subject|7|||
124955937|NCT00422162|449464323|FG001|Overall Study|Withdrawal by Subject|6|||
124955938|NCT00422162|449464322|FG000|Overall Study|Lost to Follow-up|1|||
124955939|NCT00422162|449464323|FG001|Overall Study|Lost to Follow-up|2|||
124955940|NCT00422162|449464322|FG000|Overall Study|Non-Compliant with Protocol|1|||
124955941|NCT00422162|449464323|FG001|Overall Study|Non-Compliant with Protocol|1|||
124955942|NCT00422162|449464322|FG000|Overall Study|Other|0|||
124955943|NCT00422162|449464323|FG001|Overall Study|Other|1|||
124955944|NCT00422162|449464322|FG000|Overall Study|Didn't Receive Treatment|0|||
124955945|NCT00422162|449464323|FG001|Overall Study|Didn't Receive Treatment|1|||
124955946|NCT01047306|449464327|FG000|Overall Study|Withdrawal by Subject|2|||
124955947|NCT01047306|449464328|FG001|Overall Study|Withdrawal by Subject|0|||
124955948|NCT01047306|449464327|FG000|Overall Study|Lost to Follow-up|1|||
124955949|NCT01047306|449464328|FG001|Overall Study|Lost to Follow-up|0|||
124955950|NCT00274846|449464331|FG000|Overall Study|Did not receive adequate NK cells|1|||
124955951|NCT01648699|449464334|FG000|Overall Study|Death|1|||
124955952|NCT01648699|449464334|FG000|Overall Study|Lost to Follow-up|2|||
124955953|NCT01648699|449464334|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
124955954|NCT02038803|449464335|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
124955955|NCT02038803|449464335|FG000|Overall Study|Lost to Follow-up|1|||
124955956|NCT02588027|449464336|FG000|Overall Study|Withdrawal by Subject|1|||
124955957|NCT02588027|449464337|FG001|Overall Study|Withdrawal by Subject|3|||
124955958|NCT02588027|449464336|FG000|Overall Study|Protocol Violation|4|||
124955959|NCT02588027|449464337|FG001|Overall Study|Protocol Violation|1|||
124955960|NCT03219216|449464338|FG000|Overall Study|Lost to Follow-up|0|||
124955961|NCT03219216|449464339|FG001|Overall Study|Lost to Follow-up|1|||
124955962|NCT02332824|449464340|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
124955963|NCT02332824|449464341|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
124955964|NCT02332824|449464342|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
124955965|NCT02332824|449464343|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
124955966|NCT02332824|449464344|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
124955967|NCT02332824|449464345|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
124955968|NCT02332824|449464340|FG000|Overall Study|Voluntary Withdrawal|1|||
124955969|NCT02332824|449464341|FG001|Overall Study|Voluntary Withdrawal|0|||
124955970|NCT02332824|449464342|FG002|Overall Study|Voluntary Withdrawal|0|||
124955971|NCT02332824|449464343|FG003|Overall Study|Voluntary Withdrawal|0|||
124955972|NCT02332824|449464344|FG004|Overall Study|Voluntary Withdrawal|0|||
124955973|NCT02332824|449464345|FG005|Overall Study|Voluntary Withdrawal|0|||
124955974|NCT02332824|449464340|FG000|Overall Study|Inconvenient schedule|1|||
124955975|NCT02332824|449464341|FG001|Overall Study|Inconvenient schedule|1|||
124955976|NCT02332824|449464342|FG002|Overall Study|Inconvenient schedule|0|||
124955977|NCT02332824|449464343|FG003|Overall Study|Inconvenient schedule|0|||
124955978|NCT02332824|449464344|FG004|Overall Study|Inconvenient schedule|0|||
124955979|NCT02332824|449464345|FG005|Overall Study|Inconvenient schedule|0|||
124955980|NCT02332824|449464340|FG000|Overall Study|Transfer|0|||
124955981|NCT02332824|449464341|FG001|Overall Study|Transfer|0|||
124955982|NCT02332824|449464342|FG002|Overall Study|Transfer|1|||
124955983|NCT02332824|449464343|FG003|Overall Study|Transfer|1|||
124955984|NCT02332824|449464344|FG004|Overall Study|Transfer|0|||
124955985|NCT02332824|449464345|FG005|Overall Study|Transfer|0|||
124955986|NCT03840148|449464346|FG000|Study Drug Disposition|Adverse Event|13|||
124955987|NCT03840148|449464347|FG001|Study Drug Disposition|Adverse Event|2|||
124955988|NCT03840148|449464346|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
124955989|NCT03840148|449464347|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
124955990|NCT03840148|449464346|FG000|Study Drug Disposition|Lack of Efficacy|3|||
124955991|NCT03840148|449464347|FG001|Study Drug Disposition|Lack of Efficacy|0|||
124955992|NCT03840148|449464346|FG000|Study Drug Disposition|Physician Decision|2|||
124955993|NCT03840148|449464347|FG001|Study Drug Disposition|Physician Decision|0|||
124955994|NCT03840148|449464346|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
124955995|NCT03840148|449464347|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
124955996|NCT03840148|449464346|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
124955997|NCT03840148|449464347|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
124955998|NCT03840148|449464346|FG000|Study Completion Disposition|Physician Decision|2|||
124955999|NCT03840148|449464347|FG001|Study Completion Disposition|Physician Decision|0|||
124956000|NCT03840148|449464346|FG000|Study Completion Disposition|Covid-19 related|2|||
124956001|NCT03840148|449464347|FG001|Study Completion Disposition|Covid-19 related|0|||
124956002|NCT03840148|449464346|FG000|Study Completion Disposition|Lost to Follow-up|1|||
124956003|NCT03840148|449464347|FG001|Study Completion Disposition|Lost to Follow-up|1|||
124956004|NCT03840148|449464346|FG000|Study Completion Disposition|Death|1|||
124956005|NCT03840148|449464347|FG001|Study Completion Disposition|Death|0|||
124956006|NCT03840148|449464346|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
125215298|NCT02559570|450414980|FG002|Overall Study|Protocol Violation|0|||
125215299|NCT02559570|450414981|FG003|Overall Study|Protocol Violation|0|||
124956007|NCT03840148|449464347|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
124956008|NCT03615404|449464348|FG000|Overall Study|Death|1|||
124956009|NCT03615404|449464348|FG000|Overall Study|vaccine did not pass quality assurance|1|||
124956010|NCT01774929|449464349|FG000|Overall Study|Adverse Event|3|||
124956011|NCT02577315|449464351|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
124956012|NCT02577315|449464352|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
124956013|NCT01945086|449464353|FG000|Overall Study|Withdrawal by Subject|1|||
124956014|NCT01945086|449464354|FG001|Overall Study|Withdrawal by Subject|0|||
124956015|NCT01945086|449464355|FG002|Overall Study|Withdrawal by Subject|1|||
124956016|NCT01945086|449464353|FG000|Overall Study|Adverse Event|0|||
124956017|NCT01945086|449464354|FG001|Overall Study|Adverse Event|0|||
124956018|NCT01945086|449464355|FG002|Overall Study|Adverse Event|1|||
124956019|NCT04413149|449466003|FG000|Overall Study|Death|10|||
124956020|NCT04413149|449466004|FG001|Overall Study|Death|5|||
124956021|NCT04413149|449466003|FG000|Overall Study|Lung transplantation|1|||
124956022|NCT04413149|449466004|FG001|Overall Study|Lung transplantation|0|||
124956023|NCT05335005|449466008|FG000|Overall Study|Lost to Follow-up|1|||
124956024|NCT04050722|449466009|FG000|Overall Study|Withdrawal by Subject|1|||
124956025|NCT04050722|449466010|FG001|Overall Study|Withdrawal by Subject|0|||
124956026|NCT00443755|449466014|FG000|Overall Study|Withdrawal by Subject|2|||
124956027|NCT00443755|449466015|FG001|Overall Study|Withdrawal by Subject|1|||
124956028|NCT00678899|449466016|FG000|Overall Study|Adverse Event|1|||
124956029|NCT02339506|449466028|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
124956030|NCT02339506|449466029|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
124956031|NCT02339506|449466028|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
124956032|NCT02339506|449466029|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
124956033|NCT01572493|449466030|FG000|Overall Study|Physician Decision|1|||
124956034|NCT01572493|449466031|FG001|Overall Study|Physician Decision|0|||
124956035|NCT01572493|449466032|FG002|Overall Study|Physician Decision|0|||
124956036|NCT01572493|449466033|FG003|Overall Study|Physician Decision|0|||
124956037|NCT01572493|449466034|FG004|Overall Study|Physician Decision|0|||
124956038|NCT01572493|449466035|FG005|Overall Study|Physician Decision|0|||
124956039|NCT01572493|449466036|FG006|Overall Study|Physician Decision|0|||
124956040|NCT01572493|449466037|FG007|Overall Study|Physician Decision|0|||
124956041|NCT01572493|449466038|FG008|Overall Study|Physician Decision|0|||
124956042|NCT01572493|449466030|FG000|Overall Study|Switched to alternative treatment|0|||
124956043|NCT01572493|449466031|FG001|Overall Study|Switched to alternative treatment|1|||
124956044|NCT01572493|449466032|FG002|Overall Study|Switched to alternative treatment|2|||
124956045|NCT01572493|449466033|FG003|Overall Study|Switched to alternative treatment|1|||
124956046|NCT01572493|449466034|FG004|Overall Study|Switched to alternative treatment|2|||
124956047|NCT01572493|449466035|FG005|Overall Study|Switched to alternative treatment|0|||
124956048|NCT01572493|449466036|FG006|Overall Study|Switched to alternative treatment|2|||
124956049|NCT01572493|449466037|FG007|Overall Study|Switched to alternative treatment|0|||
124956050|NCT01572493|449466038|FG008|Overall Study|Switched to alternative treatment|2|||
124956051|NCT01572493|449466030|FG000|Overall Study|Death|0|||
124956052|NCT01572493|449466031|FG001|Overall Study|Death|0|||
124956053|NCT01572493|449466032|FG002|Overall Study|Death|0|||
124956054|NCT01572493|449466033|FG003|Overall Study|Death|1|||
124956055|NCT01572493|449466034|FG004|Overall Study|Death|0|||
124956056|NCT01572493|449466035|FG005|Overall Study|Death|1|||
124956057|NCT01572493|449466036|FG006|Overall Study|Death|0|||
124956058|NCT01572493|449466037|FG007|Overall Study|Death|0|||
124956059|NCT01572493|449466038|FG008|Overall Study|Death|0|||
124956060|NCT01572493|449466030|FG000|Overall Study|Adverse Event|0|||
125030771|NCT01756456|449735039|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
125030772|NCT01756456|449735040|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
125030773|NCT01756456|449735041|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
125030774|NCT01756456|449735042|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
125030775|NCT01756456|449735037|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
125030776|NCT01756456|449735038|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
125030777|NCT01756456|449735039|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
125030778|NCT01756456|449735040|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
125030779|NCT01756456|449735041|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
125030780|NCT01756456|449735042|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
125030781|NCT01756456|449735037|FG000|Follow Up Period Phase I/II|Other causes|0|||
125215300|NCT02559570|450414982|FG004|Overall Study|Protocol Violation|1|||
124956061|NCT01572493|449466031|FG001|Overall Study|Adverse Event|0|||
124956062|NCT01572493|449466032|FG002|Overall Study|Adverse Event|0|||
124956063|NCT01572493|449466033|FG003|Overall Study|Adverse Event|0|||
124956064|NCT01572493|449466034|FG004|Overall Study|Adverse Event|0|||
124956065|NCT01572493|449466035|FG005|Overall Study|Adverse Event|0|||
124956066|NCT01572493|449466036|FG006|Overall Study|Adverse Event|1|||
124956067|NCT01572493|449466037|FG007|Overall Study|Adverse Event|0|||
124956068|NCT01572493|449466038|FG008|Overall Study|Adverse Event|0|||
124956069|NCT00609245|449466039|FG000|Overall Study|Adverse Event|1|||
124956070|NCT01234675|449466040|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
124956071|NCT01234675|449466041|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
124956072|NCT01234675|449466040|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
124956073|NCT01234675|449466041|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
124956074|NCT00331799|449466042|FG000|Overall Study|Withdrawal by Subject|2|||
124956075|NCT00331799|449466042|FG000|Overall Study|Sedation|1|||
124956076|NCT02889809|449466043|FG000|Overall Study|Withdrawal by Subject|30|||
124956077|NCT02889809|449466044|FG001|Overall Study|Withdrawal by Subject|21|||
124956078|NCT02889809|449466043|FG000|Overall Study|Lost to Follow-up|1|||
124956079|NCT02889809|449466044|FG001|Overall Study|Lost to Follow-up|1|||
124956080|NCT02889809|449466043|FG000|Overall Study|Site Closed|12|||
124956081|NCT02889809|449466044|FG001|Overall Study|Site Closed|11|||
124956082|NCT01090076|449466047|FG000|Overall Study|Death|1|||
124956083|NCT01090076|449466048|FG001|Overall Study|Death|1|||
124956084|NCT01090076|449466047|FG000|Overall Study|Withdrawal by Subject|0|||
124956085|NCT01090076|449466048|FG001|Overall Study|Withdrawal by Subject|1|||
124956086|NCT01116440|449466053|FG000|Treatment|Withdrawal by Subject|2|||
124956087|NCT01116440|449466054|FG001|Treatment|Withdrawal by Subject|2|||
124956088|NCT01116440|449466053|FG000|Treatment|Lost to Follow-up|1|||
124956089|NCT01116440|449466054|FG001|Treatment|Lost to Follow-up|1|||
124956090|NCT01116440|449466053|FG000|Treatment|Protocol Violation|0|||
124956091|NCT01116440|449466054|FG001|Treatment|Protocol Violation|2|||
124956092|NCT01116440|449466053|FG000|Treatment|Lack of Efficacy|0|||
124956093|NCT01116440|449466054|FG001|Treatment|Lack of Efficacy|1|||
124956094|NCT01116440|449466053|FG000|Treatment|Adverse Event|0|||
124956095|NCT01116440|449466054|FG001|Treatment|Adverse Event|1|||
124956096|NCT01116440|449466053|FG000|Withdrawal|Withdrawal by Subject|0|||
124956097|NCT01116440|449466054|FG001|Withdrawal|Withdrawal by Subject|1|||
124956098|NCT01116440|449466053|FG000|Withdrawal|Lost to Follow-up|0|||
124956099|NCT01116440|449466054|FG001|Withdrawal|Lost to Follow-up|1|||
124956100|NCT01116440|449466053|FG000|Follow-up|Lost to Follow-up|0|||
124956101|NCT01116440|449466054|FG001|Follow-up|Lost to Follow-up|1|||
124956102|NCT01116440|449466053|FG000|Follow-up|Withdrawal by Subject|0|||
124956103|NCT01116440|449466054|FG001|Follow-up|Withdrawal by Subject|1|||
124956104|NCT01870999|449466057|FG000|Overall Study|Adverse Event|0|||
124956105|NCT01870999|449466058|FG001|Overall Study|Adverse Event|4|||
124956106|NCT01870999|449466059|FG002|Overall Study|Adverse Event|1|||
124956107|NCT01870999|449466057|FG000|Overall Study|Subject met withdrawal criteria|3|||
124956108|NCT01870999|449466058|FG001|Overall Study|Subject met withdrawal criteria|2|||
124956109|NCT01870999|449466059|FG002|Overall Study|Subject met withdrawal criteria|0|||
124956110|NCT01870999|449466057|FG000|Overall Study|Subject withdrawn by Investigator|1|||
124956111|NCT01870999|449466058|FG001|Overall Study|Subject withdrawn by Investigator|0|||
124956112|NCT01870999|449466059|FG002|Overall Study|Subject withdrawn by Investigator|0|||
124956113|NCT01870999|449466057|FG000|Overall Study|Withdrawal by Subject|0|||
124956114|NCT01870999|449466058|FG001|Overall Study|Withdrawal by Subject|2|||
124956115|NCT01870999|449466059|FG002|Overall Study|Withdrawal by Subject|5|||
124956116|NCT01870999|449466057|FG000|Overall Study|Protocol Violation|0|||
124956117|NCT01870999|449466058|FG001|Overall Study|Protocol Violation|0|||
124956118|NCT01870999|449466059|FG002|Overall Study|Protocol Violation|1|||
124956119|NCT01636258|449466060|FG000|Overall Study|Lost to Follow-up|1|||
124956120|NCT01636258|449466061|FG001|Overall Study|Lost to Follow-up|0|||
125030782|NCT01756456|449735038|FG001|Follow Up Period Phase I/II|Other causes|0|||
125030783|NCT01756456|449735039|FG002|Follow Up Period Phase I/II|Other causes|0|||
125030784|NCT01756456|449735040|FG003|Follow Up Period Phase I/II|Other causes|1|||
125030785|NCT01756456|449735041|FG004|Follow Up Period Phase I/II|Other causes|3|||
125030786|NCT01756456|449735042|FG005|Follow Up Period Phase I/II|Other causes|5|||
125030787|NCT01573910|449735043|FG000|Overall Study|Adverse Event|4|||
125030788|NCT01573910|449735044|FG001|Overall Study|Adverse Event|4|||
125030789|NCT01573910|449735043|FG000|Overall Study|Lost to Follow-up|2|||
125030790|NCT01573910|449735044|FG001|Overall Study|Lost to Follow-up|1|||
125030791|NCT01573910|449735043|FG000|Overall Study|Withdrawal by Subject|0|||
125030792|NCT01573910|449735044|FG001|Overall Study|Withdrawal by Subject|1|||
125030793|NCT01573910|449735043|FG000|Overall Study|Protocol Violation|3|||
125030794|NCT01573910|449735044|FG001|Overall Study|Protocol Violation|0|||
125030795|NCT01573910|449735043|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
125030796|NCT01573910|449735044|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
125030797|NCT01850615|449735051|FG000|Overall Study|Protocol Violation|4|||
125030798|NCT01850615|449735052|FG001|Overall Study|Protocol Violation|1|||
124956121|NCT02798861|449466064|FG000|Overall Study|Lost to Follow-up|22|||
124956122|NCT02798861|449466064|FG000|Overall Study|Withdrawal by Subject|1|||
124956123|NCT02186015|449466065|FG000|Overall Study|Physician Decision|1|||
125030799|NCT01850615|449735051|FG000|Overall Study|Adverse Event|2|||
125030800|NCT01850615|449735052|FG001|Overall Study|Adverse Event|1|||
125030801|NCT01850615|449735051|FG000|Overall Study|Withdrawal by Subject|3|||
125030802|NCT01850615|449735052|FG001|Overall Study|Withdrawal by Subject|1|||
125030803|NCT01850615|449735051|FG000|Overall Study|Lost to Follow-up|0|||
124956124|NCT02186015|449466066|FG001|Overall Study|Physician Decision|0|||
124956125|NCT00907517|449466067|FG000|Overall Study|Progressive Disease|3|||
124956126|NCT00907517|449466068|FG001|Overall Study|Progressive Disease|3|||
124956127|NCT00907517|449466069|FG002|Overall Study|Progressive Disease|4|||
124956128|NCT00907517|449466070|FG003|Overall Study|Progressive Disease|4|||
124956129|NCT00907517|449466071|FG004|Overall Study|Progressive Disease|4|||
124956130|NCT00907517|449466067|FG000|Overall Study|Symptomatic Deterioration|0|||
124956131|NCT00907517|449466068|FG001|Overall Study|Symptomatic Deterioration|0|||
124956132|NCT00907517|449466069|FG002|Overall Study|Symptomatic Deterioration|0|||
124956133|NCT00907517|449466070|FG003|Overall Study|Symptomatic Deterioration|0|||
124956134|NCT00907517|449466071|FG004|Overall Study|Symptomatic Deterioration|1|||
124956135|NCT02660034|449466072|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
124956136|NCT02660034|449466073|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
124956137|NCT02660034|449466074|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
124956138|NCT02660034|449466075|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
124956139|NCT02660034|449466076|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
124956140|NCT02660034|449466077|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
124956141|NCT02660034|449466078|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
124956142|NCT02660034|449466079|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
124956143|NCT02660034|449466080|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
124956144|NCT02660034|449466081|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
124956145|NCT02660034|449466082|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
124956146|NCT02660034|449466083|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
124956147|NCT02660034|449466084|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
124956148|NCT02660034|449466085|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
124956149|NCT02660034|449466072|FG000|Overall Study|Progressive Disease (Clinical)|7|||
124956150|NCT02660034|449466073|FG001|Overall Study|Progressive Disease (Clinical)|8|||
124956151|NCT02660034|449466074|FG002|Overall Study|Progressive Disease (Clinical)|3|||
124956152|NCT02660034|449466075|FG003|Overall Study|Progressive Disease (Clinical)|9|||
124956153|NCT02660034|449466076|FG004|Overall Study|Progressive Disease (Clinical)|3|||
124956154|NCT02660034|449466077|FG005|Overall Study|Progressive Disease (Clinical)|0|||
124956155|NCT02660034|449466078|FG006|Overall Study|Progressive Disease (Clinical)|0|||
124956156|NCT02660034|449466079|FG007|Overall Study|Progressive Disease (Clinical)|0|||
124956157|NCT02660034|449466080|FG008|Overall Study|Progressive Disease (Clinical)|0|||
124956158|NCT02660034|449466081|FG009|Overall Study|Progressive Disease (Clinical)|0|||
124956159|NCT02660034|449466082|FG010|Overall Study|Progressive Disease (Clinical)|0|||
124956160|NCT02660034|449466083|FG011|Overall Study|Progressive Disease (Clinical)|0|||
124956161|NCT02660034|449466084|FG012|Overall Study|Progressive Disease (Clinical)|0|||
124956162|NCT02660034|449466085|FG013|Overall Study|Progressive Disease (Clinical)|0|||
124956163|NCT02660034|449466072|FG000|Overall Study|Lost to Follow-up|0|||
124956164|NCT02660034|449466073|FG001|Overall Study|Lost to Follow-up|0|||
124956165|NCT02660034|449466074|FG002|Overall Study|Lost to Follow-up|1|||
124956166|NCT02660034|449466075|FG003|Overall Study|Lost to Follow-up|1|||
124956167|NCT02660034|449466076|FG004|Overall Study|Lost to Follow-up|0|||
124956168|NCT02660034|449466077|FG005|Overall Study|Lost to Follow-up|0|||
124956169|NCT02660034|449466078|FG006|Overall Study|Lost to Follow-up|0|||
124956170|NCT02660034|449466079|FG007|Overall Study|Lost to Follow-up|0|||
124956171|NCT02660034|449466080|FG008|Overall Study|Lost to Follow-up|0|||
124956172|NCT02660034|449466081|FG009|Overall Study|Lost to Follow-up|1|||
124956173|NCT02660034|449466082|FG010|Overall Study|Lost to Follow-up|1|||
124956174|NCT02660034|449466083|FG011|Overall Study|Lost to Follow-up|1|||
124956175|NCT02660034|449466084|FG012|Overall Study|Lost to Follow-up|0|||
124956176|NCT02660034|449466085|FG013|Overall Study|Lost to Follow-up|0|||
124956177|NCT02660034|449466072|FG000|Overall Study|Participant moved into special access scheme|1|||
124956178|NCT02660034|449466073|FG001|Overall Study|Participant moved into special access scheme|2|||
124956179|NCT02660034|449466074|FG002|Overall Study|Participant moved into special access scheme|0|||
124956180|NCT02660034|449466075|FG003|Overall Study|Participant moved into special access scheme|0|||
124956181|NCT02660034|449466076|FG004|Overall Study|Participant moved into special access scheme|0|||
124956182|NCT02660034|449466077|FG005|Overall Study|Participant moved into special access scheme|0|||
124956183|NCT02660034|449466078|FG006|Overall Study|Participant moved into special access scheme|0|||
124956184|NCT02660034|449466079|FG007|Overall Study|Participant moved into special access scheme|0|||
124956185|NCT02660034|449466080|FG008|Overall Study|Participant moved into special access scheme|0|||
124956186|NCT02660034|449466081|FG009|Overall Study|Participant moved into special access scheme|0|||
124956187|NCT02660034|449466082|FG010|Overall Study|Participant moved into special access scheme|0|||
124956188|NCT02660034|449466083|FG011|Overall Study|Participant moved into special access scheme|0|||
124956189|NCT02660034|449466084|FG012|Overall Study|Participant moved into special access scheme|0|||
124956190|NCT02660034|449466085|FG013|Overall Study|Participant moved into special access scheme|0|||
124956191|NCT02660034|449466072|FG000|Overall Study|Adverse Event|1|||
124956192|NCT02660034|449466073|FG001|Overall Study|Adverse Event|0|||
124956193|NCT02660034|449466074|FG002|Overall Study|Adverse Event|0|||
124956194|NCT02660034|449466075|FG003|Overall Study|Adverse Event|0|||
124956195|NCT02660034|449466076|FG004|Overall Study|Adverse Event|0|||
124956196|NCT02660034|449466077|FG005|Overall Study|Adverse Event|0|||
124956197|NCT02660034|449466078|FG006|Overall Study|Adverse Event|0|||
124956198|NCT02660034|449466079|FG007|Overall Study|Adverse Event|0|||
124956199|NCT02660034|449466080|FG008|Overall Study|Adverse Event|0|||
124956200|NCT02660034|449466081|FG009|Overall Study|Adverse Event|0|||
124956201|NCT02660034|449466082|FG010|Overall Study|Adverse Event|0|||
124956202|NCT02660034|449466083|FG011|Overall Study|Adverse Event|0|||
124956203|NCT02660034|449466084|FG012|Overall Study|Adverse Event|0|||
124956204|NCT02660034|449466085|FG013|Overall Study|Adverse Event|0|||
124956205|NCT02660034|449466072|FG000|Overall Study|Sponsor Decision|0|||
124956206|NCT02660034|449466073|FG001|Overall Study|Sponsor Decision|1|||
124956207|NCT02660034|449466074|FG002|Overall Study|Sponsor Decision|2|||
124956208|NCT02660034|449466075|FG003|Overall Study|Sponsor Decision|2|||
124956209|NCT02660034|449466076|FG004|Overall Study|Sponsor Decision|3|||
124956210|NCT02660034|449466077|FG005|Overall Study|Sponsor Decision|0|||
124956211|NCT02660034|449466078|FG006|Overall Study|Sponsor Decision|0|||
124956212|NCT02660034|449466079|FG007|Overall Study|Sponsor Decision|0|||
124956213|NCT02660034|449466080|FG008|Overall Study|Sponsor Decision|0|||
124956214|NCT02660034|449466081|FG009|Overall Study|Sponsor Decision|0|||
124956215|NCT02660034|449466082|FG010|Overall Study|Sponsor Decision|0|||
124956216|NCT02660034|449466083|FG011|Overall Study|Sponsor Decision|0|||
124956217|NCT02660034|449466084|FG012|Overall Study|Sponsor Decision|0|||
124956218|NCT02660034|449466085|FG013|Overall Study|Sponsor Decision|1|||
124956219|NCT02660034|449466072|FG000|Overall Study|Withdrawal by Subject|0|||
124956220|NCT02660034|449466073|FG001|Overall Study|Withdrawal by Subject|0|||
124956221|NCT02660034|449466074|FG002|Overall Study|Withdrawal by Subject|0|||
124956222|NCT02660034|449466075|FG003|Overall Study|Withdrawal by Subject|0|||
124956223|NCT02660034|449466076|FG004|Overall Study|Withdrawal by Subject|0|||
124956224|NCT02660034|449466077|FG005|Overall Study|Withdrawal by Subject|0|||
124956225|NCT02660034|449466078|FG006|Overall Study|Withdrawal by Subject|1|||
124956226|NCT02660034|449466079|FG007|Overall Study|Withdrawal by Subject|1|||
124956227|NCT02660034|449466080|FG008|Overall Study|Withdrawal by Subject|1|||
124956228|NCT02660034|449466081|FG009|Overall Study|Withdrawal by Subject|0|||
124956229|NCT02660034|449466082|FG010|Overall Study|Withdrawal by Subject|0|||
124956230|NCT02660034|449466083|FG011|Overall Study|Withdrawal by Subject|1|||
124956231|NCT02660034|449466084|FG012|Overall Study|Withdrawal by Subject|2|||
124956232|NCT02660034|449466085|FG013|Overall Study|Withdrawal by Subject|0|||
124956233|NCT02660034|449466072|FG000|Overall Study|Death|0|||
124956234|NCT02660034|449466073|FG001|Overall Study|Death|0|||
124956235|NCT02660034|449466074|FG002|Overall Study|Death|0|||
124956236|NCT02660034|449466075|FG003|Overall Study|Death|0|||
124956237|NCT02660034|449466076|FG004|Overall Study|Death|0|||
124956238|NCT02660034|449466077|FG005|Overall Study|Death|13|||
124956239|NCT02660034|449466078|FG006|Overall Study|Death|14|||
124956240|NCT02660034|449466079|FG007|Overall Study|Death|10|||
124956241|NCT02660034|449466080|FG008|Overall Study|Death|9|||
124956242|NCT02660034|449466081|FG009|Overall Study|Death|21|||
124956243|NCT02660034|449466082|FG010|Overall Study|Death|17|||
124956244|NCT02660034|449466083|FG011|Overall Study|Death|15|||
124956245|NCT02660034|449466084|FG012|Overall Study|Death|18|||
124956246|NCT02660034|449466085|FG013|Overall Study|Death|7|||
124956247|NCT02660034|449466072|FG000|Overall Study|Physician Decision|0|||
124956248|NCT02660034|449466073|FG001|Overall Study|Physician Decision|0|||
124956249|NCT02660034|449466074|FG002|Overall Study|Physician Decision|0|||
124956250|NCT02660034|449466075|FG003|Overall Study|Physician Decision|0|||
124956251|NCT02660034|449466076|FG004|Overall Study|Physician Decision|0|||
124956252|NCT02660034|449466077|FG005|Overall Study|Physician Decision|0|||
124956253|NCT02660034|449466078|FG006|Overall Study|Physician Decision|0|||
124956254|NCT02660034|449466079|FG007|Overall Study|Physician Decision|0|||
124956255|NCT02660034|449466080|FG008|Overall Study|Physician Decision|0|||
124956256|NCT02660034|449466081|FG009|Overall Study|Physician Decision|0|||
124956257|NCT02660034|449466082|FG010|Overall Study|Physician Decision|0|||
124956258|NCT02660034|449466083|FG011|Overall Study|Physician Decision|0|||
124956259|NCT02660034|449466084|FG012|Overall Study|Physician Decision|0|||
124956260|NCT02660034|449466085|FG013|Overall Study|Physician Decision|1|||
124956261|NCT02660034|449466072|FG000|Overall Study|Participants transferred to LTE|0|||
124956262|NCT02660034|449466073|FG001|Overall Study|Participants transferred to LTE|0|||
124956263|NCT02660034|449466074|FG002|Overall Study|Participants transferred to LTE|0|||
124956264|NCT02660034|449466075|FG003|Overall Study|Participants transferred to LTE|0|||
124956265|NCT02660034|449466076|FG004|Overall Study|Participants transferred to LTE|0|||
124956266|NCT02660034|449466077|FG005|Overall Study|Participants transferred to LTE|10|||
124956267|NCT02660034|449466078|FG006|Overall Study|Participants transferred to LTE|8|||
124956268|NCT02660034|449466079|FG007|Overall Study|Participants transferred to LTE|8|||
124956269|NCT02660034|449466080|FG008|Overall Study|Participants transferred to LTE|10|||
124956270|NCT02660034|449466081|FG009|Overall Study|Participants transferred to LTE|1|||
124956271|NCT02660034|449466082|FG010|Overall Study|Participants transferred to LTE|2|||
124956272|NCT02660034|449466083|FG011|Overall Study|Participants transferred to LTE|4|||
124956273|NCT02660034|449466084|FG012|Overall Study|Participants transferred to LTE|1|||
124956274|NCT02660034|449466085|FG013|Overall Study|Participants transferred to LTE|1|||
124956275|NCT02030847|449466086|FG000|Overall Study|Death|10|||
124956276|NCT02030847|449466086|FG000|Overall Study|Disease Progression|15|||
124956277|NCT02030847|449466086|FG000|Overall Study|New Cancer Therapy|8|||
124956278|NCT02030847|449466086|FG000|Overall Study|Physician Decision|3|||
124956279|NCT02030847|449466086|FG000|Overall Study|Withdrawal by Subject|1|||
124956280|NCT06247488|449466089|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
124956281|NCT06247488|449466090|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
124956282|NCT06247488|449466091|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
124956283|NCT06247488|449466092|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
124956284|NCT06247488|449466093|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
124956285|NCT06247488|449466094|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
124956286|NCT06247488|449466089|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
124956287|NCT06247488|449466090|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
124956288|NCT06247488|449466091|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
124956289|NCT06247488|449466092|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
124956290|NCT06247488|449466093|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
124956291|NCT06247488|449466094|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
124956292|NCT06247488|449466089|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
124956293|NCT06247488|449466090|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
124956294|NCT06247488|449466091|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
124956295|NCT06247488|449466092|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
124956296|NCT06247488|449466093|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
124956297|NCT06247488|449466094|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
124956298|NCT06247488|449466089|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
124956299|NCT06247488|449466090|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
124956300|NCT06247488|449466091|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
124956301|NCT06247488|449466092|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
124956302|NCT06247488|449466093|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
124956303|NCT06247488|449466094|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
124956304|NCT06247488|449466089|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
124956305|NCT06247488|449466090|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
124956306|NCT06247488|449466091|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
124956307|NCT06247488|449466092|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
124956308|NCT06247488|449466093|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
124956309|NCT06247488|449466094|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
124956310|NCT06247488|449466089|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
124956311|NCT06247488|449466090|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
124956312|NCT06247488|449466091|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
124956313|NCT06247488|449466092|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
125125594|NCT01101022|450085763|FG000|Overall Study|Vacation|0|||
125125595|NCT01101022|450085764|FG001|Overall Study|Vacation|1|||
125125596|NCT01519661|450085765|FG000|Overall Study|Protocol deviation|6|||
125125597|NCT01519661|450085765|FG000|Overall Study|Lost to Follow-up|3|||
125125598|NCT01519661|450085765|FG000|Overall Study|Withdrawal by Subject|17|||
125125599|NCT01519661|450085765|FG000|Overall Study|Lack of Efficacy|6|||
125125600|NCT01519661|450085765|FG000|Overall Study|Adverse Event|29|||
125125601|NCT01139047|450085766|FG000|Overall Study|Withdrawal by Subject|1|||
125125602|NCT01941095|450085767|FG000|Overall Study|Insufficient therapeutic response|13|||
125125603|NCT01941095|450085767|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
125125604|NCT01941095|450085767|FG000|Overall Study|Adverse Event|11|||
125125605|NCT01941095|450085767|FG000|Overall Study|Physician Decision|3|||
125125606|NCT01941095|450085767|FG000|Overall Study|Withdrawal by Subject|17|||
125215301|NCT02559570|450414978|FG000|Overall Study|Other Miscellaneous Reasons|0|||
125215302|NCT02559570|450414979|FG001|Overall Study|Other Miscellaneous Reasons|0|||
125215303|NCT02559570|450414980|FG002|Overall Study|Other Miscellaneous Reasons|1|||
125215304|NCT02559570|450414981|FG003|Overall Study|Other Miscellaneous Reasons|0|||
125215305|NCT02559570|450414982|FG004|Overall Study|Other Miscellaneous Reasons|0|||
125215306|NCT00524680|450414988|FG000|Overall Study|progression|0|||
125215307|NCT00524680|450414989|FG001|Overall Study|progression|0|||
125215308|NCT00524680|450414990|FG002|Overall Study|progression|0|||
125215309|NCT00524680|450414991|FG003|Overall Study|progression|1|||
125215310|NCT00524680|450414988|FG000|Overall Study|Adverse Event|2|||
125215311|NCT00524680|450414989|FG001|Overall Study|Adverse Event|0|||
125215312|NCT00524680|450414990|FG002|Overall Study|Adverse Event|0|||
124956314|NCT06247488|449466093|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
125215313|NCT00524680|450414991|FG003|Overall Study|Adverse Event|1|||
124956315|NCT06247488|449466094|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
124956316|NCT06247488|449466089|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
125125607|NCT01941095|450085767|FG000|Overall Study|Lost to Follow-up|10|||
125125608|NCT02918877|450085770|FG000|Overall Study|Withdrawal by Subject|2|||
125125609|NCT02918877|450085771|FG001|Overall Study|Withdrawal by Subject|2|||
125125610|NCT02918877|450085770|FG000|Overall Study|Surgery cancelled|1|||
125215314|NCT00524680|450414988|FG000|Overall Study|Other|0|||
125215315|NCT00524680|450414989|FG001|Overall Study|Other|1|||
124956317|NCT06247488|449466090|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
124956318|NCT06247488|449466091|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
124956319|NCT06247488|449466092|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
124956320|NCT06247488|449466093|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
125125611|NCT02918877|450085771|FG001|Overall Study|Surgery cancelled|0|||
125125612|NCT02918877|450085770|FG000|Overall Study|Physician Decision|1|||
125125613|NCT02918877|450085771|FG001|Overall Study|Physician Decision|0|||
125125614|NCT02918877|450085770|FG000|Overall Study|Received intraoperative steroids|1|||
124956321|NCT06247488|449466094|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
124956322|NCT02720198|449466095|FG000|Overall Study|Withdrawal by Subject|0|||
124956323|NCT02720198|449466096|FG001|Overall Study|Withdrawal by Subject|1|||
124956324|NCT02023099|449466099|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
124956325|NCT02023099|449466100|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
124956326|NCT02023099|449466101|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
124956327|NCT02023099|449466099|FG000|Overall Study|Withdrawn Consent|3|||
124956328|NCT02023099|449466100|FG001|Overall Study|Withdrawn Consent|0|||
124956329|NCT02023099|449466101|FG002|Overall Study|Withdrawn Consent|1|||
124956330|NCT02023099|449466099|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
124956331|NCT02023099|449466100|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
125125615|NCT02918877|450085771|FG001|Overall Study|Received intraoperative steroids|0|||
124956332|NCT02023099|449466101|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
124956333|NCT02592434|449466102|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
124956334|NCT02592434|449466103|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
124956335|NCT02592434|449466104|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
124956336|NCT02592434|449466102|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
124956337|NCT02592434|449466103|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
124956338|NCT02592434|449466104|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
124956339|NCT02592434|449466102|FG000|Open-Label Phase (18 Weeks)|Other|3|||
124956340|NCT02592434|449466103|FG001|Open-Label Phase (18 Weeks)|Other|0|||
124956341|NCT02592434|449466104|FG002|Open-Label Phase (18 Weeks)|Other|0|||
124956342|NCT02592434|449466102|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
124956343|NCT02592434|449466103|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
124956344|NCT02592434|449466104|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
124956345|NCT02592434|449466102|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
124956346|NCT02592434|449466103|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
125125616|NCT02918877|450085770|FG000|Overall Study|Unable to obtain lab samples|1|||
125125617|NCT02918877|450085771|FG001|Overall Study|Unable to obtain lab samples|0|||
125125618|NCT02918877|450085770|FG000|Overall Study|Unsafe to perform BAL|0|||
124956347|NCT02592434|449466104|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
124956348|NCT02592434|449466102|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
124956349|NCT02592434|449466103|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
124956350|NCT02592434|449466104|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
124956351|NCT02592434|449466102|FG000|Double Blind Phase (26 Weeks)|Other|0|||
124956352|NCT02592434|449466103|FG001|Double Blind Phase (26 Weeks)|Other|1|||
124956353|NCT02592434|449466104|FG002|Double Blind Phase (26 Weeks)|Other|0|||
124956354|NCT02592434|449466102|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
124956355|NCT02592434|449466103|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
124956356|NCT02592434|449466104|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
125125619|NCT02918877|450085771|FG001|Overall Study|Unsafe to perform BAL|1|||
124956357|NCT02592434|449466102|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
124956358|NCT02592434|449466103|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
125125620|NCT03527745|450085772|FG000|Overall Study|Lost to Follow-up|3|||
125125621|NCT03527745|450085773|FG001|Overall Study|Lost to Follow-up|6|||
125030804|NCT01850615|449735052|FG001|Overall Study|Lost to Follow-up|1|||
125030805|NCT01850615|449735051|FG000|Overall Study|Unclassified|0|||
125030806|NCT01850615|449735052|FG001|Overall Study|Unclassified|1|||
125030807|NCT01227967|449735053|FG000|Overall Study|Protocol Violation|3|||
125030808|NCT01227967|449735054|FG001|Overall Study|Protocol Violation|1|||
125030809|NCT01227967|449735053|FG000|Overall Study|Death|0|||
125030810|NCT01227967|449735054|FG001|Overall Study|Death|1|||
125215316|NCT00524680|450414990|FG002|Overall Study|Other|2|||
125215317|NCT00524680|450414991|FG003|Overall Study|Other|3|||
125215318|NCT00524680|450414988|FG000|Overall Study|Withdrawal by Subject|1|||
125215319|NCT00524680|450414989|FG001|Overall Study|Withdrawal by Subject|0|||
125215320|NCT00524680|450414990|FG002|Overall Study|Withdrawal by Subject|1|||
125215321|NCT00524680|450414991|FG003|Overall Study|Withdrawal by Subject|1|||
125215322|NCT01607346|450414992|FG000|Overall Study|Adverse Event|3|||
125215323|NCT01098162|450414993|FG000|Overall Study|Adverse Event|37|||
125215324|NCT01098162|450414993|FG000|Overall Study|Lack of Efficacy|4|||
125215325|NCT01098162|450414993|FG000|Overall Study|Wish of Patient|7|||
125215326|NCT01098162|450414993|FG000|Overall Study|Lost to Follow-up|9|||
125215327|NCT01098162|450414993|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
125215328|NCT01098162|450414993|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
125215329|NCT01098162|450414993|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
125215330|NCT01098162|450414993|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
125215331|NCT01098162|450414993|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
125215332|NCT01098162|450414993|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
125215333|NCT01098162|450414993|FG000|Overall Study|Other Reason|1|||
125215334|NCT01098162|450414993|FG000|Overall Study|Reason Unknown|26|||
125215335|NCT00625183|450414994|FG000|Overall Study|Disease Progression|1|||
125215336|NCT01451554|450414995|FG000|Overall Study|Withdrawal by Subject|14|||
125215337|NCT01451554|450414996|FG001|Overall Study|Withdrawal by Subject|9|||
125215338|NCT01402986|450414997|FG000|Overall Study|Withdrawal by Subject|7|||
125215339|NCT01402986|450414998|FG001|Overall Study|Withdrawal by Subject|10|||
125215340|NCT01402986|450414999|FG002|Overall Study|Withdrawal by Subject|7|||
125215341|NCT01402986|450415000|FG003|Overall Study|Withdrawal by Subject|13|||
125215342|NCT01402986|450414997|FG000|Overall Study|Death|0|||
125215343|NCT01402986|450414998|FG001|Overall Study|Death|0|||
125215344|NCT01402986|450414999|FG002|Overall Study|Death|0|||
125215345|NCT01402986|450415000|FG003|Overall Study|Death|2|||
125215346|NCT01402986|450414997|FG000|Overall Study|Lost to Follow-up|0|||
124956359|NCT02592434|449466104|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
124956360|NCT02592434|449466102|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
124956361|NCT02592434|449466103|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
124956362|NCT02592434|449466104|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
124956363|NCT01469819|449466105|FG000|Overall Study|Withdrawal by Subject|1|||
124956364|NCT01469819|449466105|FG000|Overall Study|Did not meet inclusionary criteria|2|||
124956365|NCT01469819|449466105|FG000|Overall Study|Could not swallow SmartPill|2|||
124956366|NCT01469819|449466105|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
124956367|NCT02029521|449466106|FG000|Overall Study|Protocol Violation|1|||
124956368|NCT02029521|449466107|FG001|Overall Study|Protocol Violation|0|||
124956369|NCT02029521|449466106|FG000|Overall Study|Withdrawal by Subject|1|||
124956370|NCT02029521|449466107|FG001|Overall Study|Withdrawal by Subject|1|||
124956371|NCT00428441|449466110|FG000|Overall Study|Lost to Follow-up|1|||
124956372|NCT00510783|449466115|FG000|Overall Study|Lost to Follow-up|29|||
124956373|NCT00510783|449466116|FG001|Overall Study|Lost to Follow-up|25|||
124956374|NCT00510783|449466115|FG000|Overall Study|Withdrawal by Subject|2|||
124956375|NCT00510783|449466116|FG001|Overall Study|Withdrawal by Subject|3|||
124956376|NCT00510783|449466115|FG000|Overall Study|Protocol Violation|0|||
124956377|NCT00510783|449466116|FG001|Overall Study|Protocol Violation|1|||
124956378|NCT02744898|449466117|FG000|Overall Study|Progressive Disease|2|||
124956379|NCT02744898|449466117|FG000|Overall Study|Physician Decision|1|||
124956380|NCT02744898|449466117|FG000|Overall Study|Toxicity|1|||
124956381|NCT01348763|449466120|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
124956382|NCT01348763|449466120|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
124956383|NCT01078571|449466121|FG000|Overall Study|Adverse Event|36|||
124956384|NCT01078571|449466121|FG000|Overall Study|Lack of effectiveness|36|||
124956385|NCT01078571|449466121|FG000|Overall Study|Reason not reported|21|||
124956386|NCT01078571|449466121|FG000|Overall Study|Withdrawal by Subject|12|||
124956387|NCT01078571|449466121|FG000|Overall Study|Lost to Follow-up|8|||
124956388|NCT01078571|449466121|FG000|Overall Study|Protocol Violation|2|||
124956389|NCT03647709|449466123|FG000|Overall Study|Lost to Follow-up|5|||
124956390|NCT03647709|449466123|FG000|Overall Study|Physician Decision|6|||
124956391|NCT03647709|449466123|FG000|Overall Study|Withdrawal by Subject|3|||
125030811|NCT01227967|449735053|FG000|Overall Study|Lost to Follow-up|8|||
125215347|NCT01402986|450414998|FG001|Overall Study|Lost to Follow-up|0|||
125215348|NCT01402986|450414999|FG002|Overall Study|Lost to Follow-up|0|||
125030812|NCT01227967|449735054|FG001|Overall Study|Lost to Follow-up|3|||
125030813|NCT01227967|449735053|FG000|Overall Study|Withdrawal by Subject|4|||
125215349|NCT01402986|450415000|FG003|Overall Study|Lost to Follow-up|1|||
124956392|NCT03802513|449466125|FG000|Overall Study|Lost to Follow-up|1|||
124956393|NCT03045302|449466141|FG000|Overall Study|Pre-treatment adverse event|1|||
124956394|NCT05287178|449466142|FG000|Overall Study|Lost to Follow-up|2|||
124956395|NCT00603278|449466143|FG000|Overall Study|Lack of Efficacy|35|||
124956396|NCT00603278|449466144|FG001|Overall Study|Lack of Efficacy|10|||
124956397|NCT00603278|449466145|FG002|Overall Study|Lack of Efficacy|11|||
124956398|NCT00603278|449466146|FG003|Overall Study|Lack of Efficacy|8|||
124956399|NCT00603278|449466147|FG004|Overall Study|Lack of Efficacy|7|||
124956400|NCT00603278|449466148|FG005|Overall Study|Lack of Efficacy|14|||
124956401|NCT00603278|449466143|FG000|Overall Study|Adverse Event|0|||
124956402|NCT00603278|449466144|FG001|Overall Study|Adverse Event|3|||
124956403|NCT00603278|449466145|FG002|Overall Study|Adverse Event|1|||
124956404|NCT00603278|449466146|FG003|Overall Study|Adverse Event|0|||
124956405|NCT00603278|449466147|FG004|Overall Study|Adverse Event|2|||
124956406|NCT00603278|449466148|FG005|Overall Study|Adverse Event|1|||
124956407|NCT00603278|449466143|FG000|Overall Study|Withdrawal by Subject|2|||
124956408|NCT00603278|449466144|FG001|Overall Study|Withdrawal by Subject|3|||
124956409|NCT00603278|449466145|FG002|Overall Study|Withdrawal by Subject|1|||
124956410|NCT00603278|449466146|FG003|Overall Study|Withdrawal by Subject|2|||
124956411|NCT00603278|449466147|FG004|Overall Study|Withdrawal by Subject|1|||
124956412|NCT00603278|449466148|FG005|Overall Study|Withdrawal by Subject|2|||
124956413|NCT00603278|449466143|FG000|Overall Study|Protocol Violation|3|||
124956414|NCT00603278|449466144|FG001|Overall Study|Protocol Violation|0|||
124956415|NCT00603278|449466145|FG002|Overall Study|Protocol Violation|1|||
124956416|NCT00603278|449466146|FG003|Overall Study|Protocol Violation|1|||
124956417|NCT00603278|449466147|FG004|Overall Study|Protocol Violation|0|||
124956418|NCT00603278|449466148|FG005|Overall Study|Protocol Violation|1|||
124956419|NCT00603278|449466143|FG000|Overall Study|Physician Decision|0|||
124956420|NCT00603278|449466144|FG001|Overall Study|Physician Decision|1|||
124956421|NCT00603278|449466145|FG002|Overall Study|Physician Decision|0|||
124956422|NCT00603278|449466146|FG003|Overall Study|Physician Decision|0|||
124956423|NCT00603278|449466147|FG004|Overall Study|Physician Decision|2|||
124956424|NCT00603278|449466148|FG005|Overall Study|Physician Decision|1|||
124956425|NCT00603278|449466143|FG000|Overall Study|Lost to Follow-up|1|||
124956426|NCT00603278|449466144|FG001|Overall Study|Lost to Follow-up|0|||
124956427|NCT00603278|449466145|FG002|Overall Study|Lost to Follow-up|0|||
124956428|NCT00603278|449466146|FG003|Overall Study|Lost to Follow-up|0|||
124956429|NCT00603278|449466147|FG004|Overall Study|Lost to Follow-up|1|||
124956430|NCT00603278|449466148|FG005|Overall Study|Lost to Follow-up|0|||
124956431|NCT04374253|449466152|FG000|Overall Study|Adverse Event|0|||
124956432|NCT04374253|449466153|FG001|Overall Study|Adverse Event|26|||
124956433|NCT04374253|449466154|FG002|Overall Study|Adverse Event|2|||
124956434|NCT04374253|449466155|FG003|Overall Study|Adverse Event|12|||
124956435|NCT04374253|449466152|FG000|Overall Study|Study terminated by sponsor|13|||
124956436|NCT04374253|449466153|FG001|Overall Study|Study terminated by sponsor|593|||
124956437|NCT04374253|449466154|FG002|Overall Study|Study terminated by sponsor|21|||
124956438|NCT04374253|449466155|FG003|Overall Study|Study terminated by sponsor|567|||
124956439|NCT04374253|449466152|FG000|Overall Study|Withdrawal by Subject|0|||
124956440|NCT04374253|449466153|FG001|Overall Study|Withdrawal by Subject|55|||
124956441|NCT04374253|449466154|FG002|Overall Study|Withdrawal by Subject|3|||
124956442|NCT04374253|449466155|FG003|Overall Study|Withdrawal by Subject|40|||
124956443|NCT04374253|449466152|FG000|Overall Study|Physician Decision|1|||
124956444|NCT04374253|449466153|FG001|Overall Study|Physician Decision|10|||
124956445|NCT04374253|449466154|FG002|Overall Study|Physician Decision|1|||
124956446|NCT04374253|449466155|FG003|Overall Study|Physician Decision|10|||
124956447|NCT04374253|449466152|FG000|Overall Study|Protocol Violation|0|||
124956448|NCT04374253|449466153|FG001|Overall Study|Protocol Violation|0|||
125030814|NCT01227967|449735054|FG001|Overall Study|Withdrawal by Subject|3|||
125030815|NCT01227967|449735053|FG000|Overall Study|Physician Decision|0|||
124956449|NCT04374253|449466154|FG002|Overall Study|Protocol Violation|0|||
124956450|NCT04374253|449466155|FG003|Overall Study|Protocol Violation|2|||
124956451|NCT04374253|449466152|FG000|Overall Study|Death|0|||
124956452|NCT04374253|449466153|FG001|Overall Study|Death|3|||
124956453|NCT04374253|449466154|FG002|Overall Study|Death|1|||
124956454|NCT04374253|449466155|FG003|Overall Study|Death|1|||
124956455|NCT04374253|449466152|FG000|Overall Study|Lack of Efficacy|0|||
124956456|NCT04374253|449466153|FG001|Overall Study|Lack of Efficacy|0|||
124956457|NCT04374253|449466154|FG002|Overall Study|Lack of Efficacy|0|||
124956458|NCT04374253|449466155|FG003|Overall Study|Lack of Efficacy|1|||
124956459|NCT04374253|449466152|FG000|Overall Study|Lost to Follow-up|1|||
125030816|NCT01227967|449735054|FG001|Overall Study|Physician Decision|1|||
124956460|NCT04374253|449466153|FG001|Overall Study|Lost to Follow-up|1|||
124956461|NCT04374253|449466154|FG002|Overall Study|Lost to Follow-up|0|||
124956462|NCT04374253|449466155|FG003|Overall Study|Lost to Follow-up|2|||
124956463|NCT04374253|449466152|FG000|Overall Study|Reason Not Specified|0|||
124956464|NCT04374253|449466153|FG001|Overall Study|Reason Not Specified|8|||
124956465|NCT04374253|449466154|FG002|Overall Study|Reason Not Specified|0|||
124956466|NCT04374253|449466155|FG003|Overall Study|Reason Not Specified|8|||
124956467|NCT01207453|449466156|FG000|First Intervention|Adverse Event|2|||
124956468|NCT01207453|449466157|FG001|First Intervention|Adverse Event|1|||
124956469|NCT01207453|449466156|FG000|Washout|Adverse Event|1|||
124956470|NCT01207453|449466157|FG001|Washout|Adverse Event|0|||
124956471|NCT01207453|449466156|FG000|Washout|Lost to Follow-up|1|||
125125622|NCT03527745|450085774|FG002|Overall Study|Lost to Follow-up|7|||
125125623|NCT03527745|450085775|FG003|Overall Study|Lost to Follow-up|9|||
125125624|NCT03527745|450085776|FG004|Overall Study|Lost to Follow-up|0|||
124956472|NCT01207453|449466157|FG001|Washout|Lost to Follow-up|0|||
124956473|NCT01207453|449466156|FG000|2nd Intervention|Adverse Event|1|||
124956474|NCT01207453|449466157|FG001|2nd Intervention|Adverse Event|2|||
124956475|NCT01207453|449466156|FG000|2nd Intervention|Lost to Follow-up|1|||
124956476|NCT01207453|449466157|FG001|2nd Intervention|Lost to Follow-up|0|||
124956477|NCT00990821|449466158|FG000|Overall Study|Withdrawal by Subject|0|||
124956478|NCT00990821|449466159|FG001|Overall Study|Withdrawal by Subject|2|||
124956479|NCT00990821|449466160|FG002|Overall Study|Withdrawal by Subject|0|||
124956480|NCT00990821|449466161|FG003|Overall Study|Withdrawal by Subject|0|||
124956481|NCT00990821|449466162|FG004|Overall Study|Withdrawal by Subject|3|||
124956482|NCT00990821|449466163|FG005|Overall Study|Withdrawal by Subject|3|||
124956483|NCT00990821|449466164|FG006|Overall Study|Withdrawal by Subject|1|||
124956484|NCT00990821|449466165|FG007|Overall Study|Withdrawal by Subject|0|||
124956485|NCT00990821|449466166|FG008|Overall Study|Withdrawal by Subject|0|||
124956486|NCT00990821|449466167|FG009|Overall Study|Withdrawal by Subject|1|||
124956487|NCT00990821|449466168|FG010|Overall Study|Withdrawal by Subject|3|||
124956488|NCT00990821|449466169|FG011|Overall Study|Withdrawal by Subject|5|||
124956489|NCT00990821|449466170|FG012|Overall Study|Withdrawal by Subject|2|||
124956490|NCT00990821|449466171|FG013|Overall Study|Withdrawal by Subject|1|||
124956491|NCT00308113|449466172|FG000|Overall Study|Protocol closure|0|||
124956492|NCT00308113|449466173|FG001|Overall Study|Protocol closure|0|||
124956493|NCT00308113|449466174|FG002|Overall Study|Protocol closure|0|||
124956494|NCT00308113|449466175|FG003|Overall Study|Protocol closure|1|||
124956495|NCT01123642|449467821|FG000|Overall Study|Lost to Follow-up|23|||
124956496|NCT01123642|449467821|FG000|Overall Study|Withdrawal by Subject|9|||
124956497|NCT01123642|449467821|FG000|Overall Study|ineligible at baseline assessment|36|||
124956498|NCT00925288|449467822|FG000|Overall Study|Lost to Follow-up|9|||
124956499|NCT00925288|449467823|FG001|Overall Study|Lost to Follow-up|7|||
124956500|NCT03322514|449467824|FG000|Overall Study|Withdrawal by Subject|1|||
124956501|NCT03322514|449467825|FG001|Overall Study|Withdrawal by Subject|1|||
124956502|NCT01184859|449467826|FG000|Period 1: Single Dose|Insufficient urine production|0|||
124956503|NCT01184859|449467827|FG001|Period 1: Single Dose|Insufficient urine production|1|||
124956504|NCT01184859|449467828|FG002|Period 1: Single Dose|Insufficient urine production|0|||
124956505|NCT01184859|449467829|FG003|Period 1: Single Dose|Insufficient urine production|0|||
124956506|NCT01184859|449467830|FG004|Period 1: Single Dose|Insufficient urine production|0|||
125125625|NCT03527745|450085777|FG005|Overall Study|Lost to Follow-up|2|||
125125626|NCT03527745|450085778|FG006|Overall Study|Lost to Follow-up|3|||
125125627|NCT03527745|450085779|FG007|Overall Study|Lost to Follow-up|2|||
125125628|NCT03527745|450085780|FG008|Overall Study|Lost to Follow-up|3|||
125125629|NCT03527745|450085781|FG009|Overall Study|Lost to Follow-up|2|||
125125630|NCT03527745|450085782|FG010|Overall Study|Lost to Follow-up|1|||
125125631|NCT03527745|450085783|FG011|Overall Study|Lost to Follow-up|1|||
125125632|NCT03527745|450085784|FG012|Overall Study|Lost to Follow-up|0|||
125125633|NCT03527745|450085785|FG013|Overall Study|Lost to Follow-up|0|||
125125634|NCT03527745|450085786|FG014|Overall Study|Lost to Follow-up|0|||
125125635|NCT03527745|450085787|FG015|Overall Study|Lost to Follow-up|0|||
125125636|NCT03527745|450085788|FG016|Overall Study|Lost to Follow-up|1|||
125125637|NCT03527745|450085789|FG017|Overall Study|Lost to Follow-up|0|||
124956507|NCT01184859|449467826|FG000|Period 1: Single Dose|Protocol Violation|0|||
124956508|NCT01184859|449467827|FG001|Period 1: Single Dose|Protocol Violation|1|||
124956509|NCT01184859|449467828|FG002|Period 1: Single Dose|Protocol Violation|0|||
124956510|NCT01184859|449467829|FG003|Period 1: Single Dose|Protocol Violation|0|||
124956511|NCT01184859|449467830|FG004|Period 1: Single Dose|Protocol Violation|0|||
124956512|NCT01184859|449467826|FG000|Period 1: Single Dose|Adverse Event|0|||
124956513|NCT01184859|449467827|FG001|Period 1: Single Dose|Adverse Event|0|||
124956514|NCT01184859|449467828|FG002|Period 1: Single Dose|Adverse Event|0|||
125125638|NCT03527745|450085790|FG018|Overall Study|Lost to Follow-up|0|||
125125639|NCT03527745|450085791|FG019|Overall Study|Lost to Follow-up|1|||
125125640|NCT03527745|450085792|FG020|Overall Study|Lost to Follow-up|1|||
124956515|NCT01184859|449467829|FG003|Period 1: Single Dose|Adverse Event|0|||
124956516|NCT01184859|449467830|FG004|Period 1: Single Dose|Adverse Event|1|||
124956517|NCT01184859|449467826|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
124956518|NCT01184859|449467827|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
124956519|NCT01184859|449467828|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
124956520|NCT01184859|449467829|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
125125641|NCT03527745|450085793|FG021|Overall Study|Lost to Follow-up|5|||
125125642|NCT03527745|450085794|FG022|Overall Study|Lost to Follow-up|6|||
125125643|NCT03527745|450085795|FG023|Overall Study|Lost to Follow-up|8|||
125125644|NCT03527745|450085796|FG024|Overall Study|Lost to Follow-up|1|||
125125645|NCT03527745|450085797|FG025|Overall Study|Lost to Follow-up|3|||
125125646|NCT01604850|450085798|FG000|Overall Study|Enrolled but never treated|0|||
124956521|NCT01184859|449467830|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
124956522|NCT01184859|449467826|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
124956523|NCT01184859|449467827|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
124956524|NCT01184859|449467828|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
124956525|NCT01184859|449467829|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
124956526|NCT01184859|449467830|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
124956527|NCT00961298|449467831|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
124956528|NCT00961298|449467831|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
124956529|NCT00961298|449467831|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
124956530|NCT01904019|449467833|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
124956531|NCT01904019|449467833|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
124956532|NCT01904019|449467833|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
124956533|NCT01904019|449467833|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
124956534|NCT01904019|449467833|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
124956535|NCT01904019|449467833|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
124956536|NCT01537120|449467834|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
124956537|NCT01537120|449467834|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
124956538|NCT01503515|449467839|FG000|Overall Study|Adverse Event|4|||
124956539|NCT01503515|449467840|FG001|Overall Study|Adverse Event|5|||
124956540|NCT01503515|449467839|FG000|Overall Study|Death|0|||
124956541|NCT01503515|449467840|FG001|Overall Study|Death|1|||
124956542|NCT01503515|449467839|FG000|Overall Study|Physician Decision|14|||
124956543|NCT01503515|449467840|FG001|Overall Study|Physician Decision|23|||
124956544|NCT01503515|449467839|FG000|Overall Study|Withdrawal by Subject|0|||
124956545|NCT01503515|449467840|FG001|Overall Study|Withdrawal by Subject|1|||
124956546|NCT01503515|449467839|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
124956547|NCT01503515|449467840|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
124956548|NCT01503515|449467839|FG000|Overall Study|Ineligible|1|||
124956549|NCT01503515|449467840|FG001|Overall Study|Ineligible|1|||
124956550|NCT03087851|449467842|FG000|Overall Study|Withdraw on medical grounds|0|||
124956551|NCT03087851|449467843|FG001|Overall Study|Withdraw on medical grounds|1|||
124956552|NCT03087851|449467844|FG002|Overall Study|Withdraw on medical grounds|2|||
124956553|NCT02123797|449467847|FG000|Baseline Intervention|Death|9|||
124956554|NCT02123797|449467848|FG001|Baseline Intervention|Death|16|||
124956555|NCT02123797|449467849|FG002|Baseline Intervention|Death|0|||
124956556|NCT02123797|449467850|FG003|Baseline Intervention|Death|0|||
124956557|NCT02123797|449467851|FG004|Baseline Intervention|Death|0|||
124956558|NCT02123797|449467847|FG000|Baseline Intervention|Withdrawal by Subject|2|||
124956559|NCT02123797|449467848|FG001|Baseline Intervention|Withdrawal by Subject|8|||
124956560|NCT02123797|449467849|FG002|Baseline Intervention|Withdrawal by Subject|0|||
124956561|NCT02123797|449467850|FG003|Baseline Intervention|Withdrawal by Subject|0|||
124956562|NCT02123797|449467851|FG004|Baseline Intervention|Withdrawal by Subject|0|||
124956563|NCT02123797|449467847|FG000|Baseline Intervention|Relocation|2|||
124956564|NCT02123797|449467848|FG001|Baseline Intervention|Relocation|0|||
124956565|NCT02123797|449467849|FG002|Baseline Intervention|Relocation|0|||
124956566|NCT02123797|449467850|FG003|Baseline Intervention|Relocation|0|||
124956567|NCT02123797|449467851|FG004|Baseline Intervention|Relocation|0|||
124956568|NCT02123797|449467847|FG000|Baseline Intervention|Out of window for initial survey|6|||
124956569|NCT02123797|449467848|FG001|Baseline Intervention|Out of window for initial survey|13|||
125125647|NCT01604850|450085799|FG001|Overall Study|Enrolled but never treated|1|||
124956570|NCT02123797|449467849|FG002|Baseline Intervention|Out of window for initial survey|0|||
124956571|NCT02123797|449467850|FG003|Baseline Intervention|Out of window for initial survey|0|||
124956572|NCT02123797|449467851|FG004|Baseline Intervention|Out of window for initial survey|0|||
124956573|NCT02123797|449467847|FG000|Baseline Intervention|Lost to Follow-up|0|||
124956574|NCT02123797|449467848|FG001|Baseline Intervention|Lost to Follow-up|5|||
124956575|NCT02123797|449467849|FG002|Baseline Intervention|Lost to Follow-up|0|||
124956576|NCT02123797|449467850|FG003|Baseline Intervention|Lost to Follow-up|0|||
125125648|NCT01604850|450085798|FG000|Overall Study|Efficacy Failure|50|||
124956577|NCT02123797|449467851|FG004|Baseline Intervention|Lost to Follow-up|0|||
124956578|NCT02123797|449467847|FG000|Baseline Intervention|Other Disease|3|||
124956579|NCT02123797|449467848|FG001|Baseline Intervention|Other Disease|0|||
124956580|NCT02123797|449467849|FG002|Baseline Intervention|Other Disease|0|||
124956581|NCT02123797|449467850|FG003|Baseline Intervention|Other Disease|0|||
124956582|NCT02123797|449467851|FG004|Baseline Intervention|Other Disease|0|||
124956583|NCT02123797|449467847|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
124956584|NCT02123797|449467848|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
125125649|NCT01604850|450085799|FG001|Overall Study|Efficacy Failure|29|||
125125650|NCT01604850|450085798|FG000|Overall Study|Lost to Follow-up|1|||
125125651|NCT01604850|450085799|FG001|Overall Study|Lost to Follow-up|0|||
125125652|NCT01604850|450085798|FG000|Overall Study|Subject withdrew consent|1|||
125125653|NCT01604850|450085799|FG001|Overall Study|Subject withdrew consent|0|||
125125654|NCT00243932|450085800|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
125125655|NCT00243932|450085801|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
125125656|NCT00243932|450085802|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
125125657|NCT00880568|450085804|FG000|Overall Study|Disease progression|3|||
125125658|NCT00880568|450085805|FG001|Overall Study|Disease progression|3|||
125125659|NCT00880568|450085806|FG002|Overall Study|Disease progression|3|||
125125660|NCT00880568|450085807|FG003|Overall Study|Disease progression|1|||
125125661|NCT00880568|450085808|FG004|Overall Study|Disease progression|3|||
125125662|NCT00880568|450085809|FG005|Overall Study|Disease progression|3|||
125125663|NCT00880568|450085810|FG006|Overall Study|Disease progression|5|||
125125664|NCT00880568|450085811|FG007|Overall Study|Disease progression|0|||
125125665|NCT00880568|450085812|FG008|Overall Study|Disease progression|3|||
125125666|NCT00880568|450085804|FG000|Overall Study|Adverse Event|0|||
125125667|NCT00880568|450085805|FG001|Overall Study|Adverse Event|0|||
125125668|NCT00880568|450085806|FG002|Overall Study|Adverse Event|0|||
125125669|NCT00880568|450085807|FG003|Overall Study|Adverse Event|0|||
125125670|NCT00880568|450085808|FG004|Overall Study|Adverse Event|0|||
125125671|NCT00880568|450085809|FG005|Overall Study|Adverse Event|0|||
125125672|NCT00880568|450085810|FG006|Overall Study|Adverse Event|1|||
125125673|NCT00880568|450085811|FG007|Overall Study|Adverse Event|1|||
125125674|NCT00880568|450085812|FG008|Overall Study|Adverse Event|0|||
125125675|NCT00880568|450085804|FG000|Overall Study|Withdrawal by Subject|0|||
125125676|NCT00880568|450085805|FG001|Overall Study|Withdrawal by Subject|0|||
125125677|NCT00880568|450085806|FG002|Overall Study|Withdrawal by Subject|0|||
125125678|NCT00880568|450085807|FG003|Overall Study|Withdrawal by Subject|0|||
125125679|NCT00880568|450085808|FG004|Overall Study|Withdrawal by Subject|0|||
125125680|NCT00880568|450085809|FG005|Overall Study|Withdrawal by Subject|0|||
125125681|NCT00880568|450085810|FG006|Overall Study|Withdrawal by Subject|0|||
125125682|NCT00880568|450085811|FG007|Overall Study|Withdrawal by Subject|1|||
125125683|NCT00880568|450085812|FG008|Overall Study|Withdrawal by Subject|0|||
125125684|NCT00849901|450085813|FG000|Acute Treatment Phase|Adverse Event|9|||
125125685|NCT00849901|450085814|FG001|Acute Treatment Phase|Adverse Event|1|||
125125686|NCT00849901|450085815|FG002|Acute Treatment Phase|Adverse Event|3|||
125125687|NCT00849901|450085813|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
125125688|NCT00849901|450085814|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
125125689|NCT00849901|450085815|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
125125690|NCT00849901|450085813|FG000|Acute Treatment Phase|Protocol Violation|0|||
125125691|NCT00849901|450085814|FG001|Acute Treatment Phase|Protocol Violation|2|||
125125692|NCT00849901|450085815|FG002|Acute Treatment Phase|Protocol Violation|1|||
125125693|NCT00849901|450085813|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
125125694|NCT00849901|450085814|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
125125695|NCT00849901|450085815|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
125125696|NCT00849901|450085813|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
125125697|NCT00849901|450085814|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
125125698|NCT00849901|450085815|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
125125699|NCT00849901|450085813|FG000|Acute Treatment Phase|Physician Decision|1|||
125125700|NCT00849901|450085814|FG001|Acute Treatment Phase|Physician Decision|1|||
125125701|NCT00849901|450085815|FG002|Acute Treatment Phase|Physician Decision|1|||
125125702|NCT00849901|450085813|FG000|Acute Treatment Phase|Sponsor Decision|1|||
125125703|NCT00849901|450085814|FG001|Acute Treatment Phase|Sponsor Decision|0|||
125125704|NCT00849901|450085815|FG002|Acute Treatment Phase|Sponsor Decision|0|||
125125705|NCT00849901|450085813|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
125125706|NCT00849901|450085814|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
125125707|NCT00849901|450085815|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
125125708|NCT00849901|450085813|FG000|Extension Phase|Adverse Event|2|||
125125709|NCT00849901|450085814|FG001|Extension Phase|Adverse Event|8|||
125125710|NCT00849901|450085815|FG002|Extension Phase|Adverse Event|4|||
125125711|NCT00849901|450085813|FG000|Extension Phase|Lost to Follow-up|3|||
125125712|NCT00849901|450085814|FG001|Extension Phase|Lost to Follow-up|0|||
125125713|NCT00849901|450085815|FG002|Extension Phase|Lost to Follow-up|1|||
125125714|NCT00849901|450085813|FG000|Extension Phase|Protocol Violation|2|||
125125715|NCT00849901|450085814|FG001|Extension Phase|Protocol Violation|2|||
125125716|NCT00849901|450085815|FG002|Extension Phase|Protocol Violation|4|||
125125717|NCT00849901|450085813|FG000|Extension Phase|Withdrawal by Subject|7|||
125125718|NCT00849901|450085814|FG001|Extension Phase|Withdrawal by Subject|6|||
125125719|NCT00849901|450085815|FG002|Extension Phase|Withdrawal by Subject|3|||
125125720|NCT00849901|450085813|FG000|Extension Phase|Parent or Caregiver Decision|10|||
125125721|NCT00849901|450085814|FG001|Extension Phase|Parent or Caregiver Decision|4|||
125125722|NCT00849901|450085815|FG002|Extension Phase|Parent or Caregiver Decision|4|||
125125723|NCT00849901|450085813|FG000|Extension Phase|Physician Decision|1|||
125125724|NCT00849901|450085814|FG001|Extension Phase|Physician Decision|2|||
125125725|NCT00849901|450085815|FG002|Extension Phase|Physician Decision|0|||
125125726|NCT00849901|450085813|FG000|Extension Phase|Lack of Efficacy|2|||
125125727|NCT00849901|450085814|FG001|Extension Phase|Lack of Efficacy|4|||
125125728|NCT00849901|450085815|FG002|Extension Phase|Lack of Efficacy|1|||
125125729|NCT00437658|450085816|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
125125730|NCT00437658|450085817|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
125125731|NCT00437658|450085818|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
125125732|NCT00437658|450085816|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
125125733|NCT00437658|450085817|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
125125734|NCT00437658|450085818|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
124956585|NCT02123797|449467849|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
124956586|NCT02123797|449467850|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
124956587|NCT02123797|449467851|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
124956588|NCT02123797|449467847|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
124956589|NCT02123797|449467848|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
124956590|NCT02123797|449467849|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
124956591|NCT02123797|449467850|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
124956592|NCT02123797|449467851|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
124956593|NCT02123797|449467847|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
124956594|NCT02123797|449467848|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
124956595|NCT02123797|449467849|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
124956596|NCT02123797|449467850|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
124956597|NCT02123797|449467851|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
124956598|NCT02123797|449467847|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
124956599|NCT02123797|449467848|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
124956600|NCT02123797|449467849|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
124956601|NCT02123797|449467850|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
124956602|NCT02123797|449467851|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
124956603|NCT02123797|449467847|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
124956604|NCT02123797|449467848|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
124956605|NCT02123797|449467849|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
124956606|NCT02123797|449467850|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
124956607|NCT02123797|449467851|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
124956608|NCT02123797|449467847|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
124956609|NCT02123797|449467848|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
124956610|NCT02123797|449467849|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
124956611|NCT02123797|449467850|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
124956612|NCT02123797|449467851|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
124956613|NCT02123797|449467847|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
124956614|NCT02123797|449467848|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
124956615|NCT02123797|449467849|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
124956616|NCT02123797|449467850|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
124956617|NCT02123797|449467851|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
124956618|NCT02123797|449467847|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
124956619|NCT02123797|449467848|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
124956620|NCT02123797|449467849|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
124956621|NCT02123797|449467850|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
124956622|NCT02123797|449467851|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
124956623|NCT02123797|449467847|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
124956624|NCT02123797|449467848|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
124956625|NCT02123797|449467849|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
124956626|NCT02123797|449467850|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
124956627|NCT02123797|449467851|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
124956628|NCT03997409|449467854|FG000|Overall Study|Protocol Violation|1|||
124956629|NCT03997409|449467855|FG001|Overall Study|Protocol Violation|1|||
124956630|NCT03997409|449467856|FG002|Overall Study|Protocol Violation|0|||
124956631|NCT03997409|449467854|FG000|Overall Study|Withdrawal by Subject|3|||
124956632|NCT03997409|449467855|FG001|Overall Study|Withdrawal by Subject|0|||
124956633|NCT03997409|449467856|FG002|Overall Study|Withdrawal by Subject|0|||
124956634|NCT03997409|449467854|FG000|Overall Study|Lost to Follow-up|0|||
125125735|NCT00437658|450085816|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
125125736|NCT00437658|450085817|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
125125737|NCT00437658|450085818|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
125125738|NCT00437658|450085816|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
125125739|NCT00437658|450085817|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
125125740|NCT00437658|450085818|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
124956635|NCT03997409|449467855|FG001|Overall Study|Lost to Follow-up|0|||
125215350|NCT01402986|450414997|FG000|Overall Study|Other|2|||
124956636|NCT03997409|449467856|FG002|Overall Study|Lost to Follow-up|1|||
125125741|NCT00437658|450085816|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
125125742|NCT00437658|450085817|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
125125743|NCT00437658|450085818|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
125125744|NCT00437658|450085816|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
125125745|NCT00437658|450085817|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
125125746|NCT00437658|450085818|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
125125747|NCT00437658|450085816|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
125125748|NCT00437658|450085817|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
125125749|NCT00437658|450085818|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
125125750|NCT00437658|450085816|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
125125751|NCT00437658|450085817|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
125125752|NCT00437658|450085818|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
125125753|NCT00437658|450085816|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
125125754|NCT00437658|450085817|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
125125755|NCT00437658|450085818|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
124956637|NCT01753323|449467857|FG000|Overall Study|Lack of Efficacy|0|||
124956638|NCT01753323|449467858|FG001|Overall Study|Lack of Efficacy|0|||
124956639|NCT01753323|449467859|FG002|Overall Study|Lack of Efficacy|8|||
124956640|NCT01753323|449467857|FG000|Overall Study|Protocol deviation|1|||
124956641|NCT01753323|449467858|FG001|Overall Study|Protocol deviation|0|||
124956642|NCT01753323|449467859|FG002|Overall Study|Protocol deviation|0|||
124956643|NCT01753323|449467857|FG000|Overall Study|Adverse Event|0|||
124956644|NCT01753323|449467858|FG001|Overall Study|Adverse Event|0|||
124956645|NCT01753323|449467859|FG002|Overall Study|Adverse Event|1|||
124956646|NCT01498445|449467861|FG000|Overall Study|Lack of Efficacy|0|||
124956647|NCT01498445|449467862|FG001|Overall Study|Lack of Efficacy|0|||
124956648|NCT01498445|449467863|FG002|Overall Study|Lack of Efficacy|1|||
124956649|NCT01498445|449467864|FG003|Overall Study|Lack of Efficacy|2|||
124956650|NCT01498445|449467865|FG004|Overall Study|Lack of Efficacy|0|||
124956651|NCT01498445|449467866|FG005|Overall Study|Lack of Efficacy|0|||
124956652|NCT01498445|449467861|FG000|Overall Study|Screen Failure|0|||
124956653|NCT01498445|449467862|FG001|Overall Study|Screen Failure|0|||
124956654|NCT01498445|449467863|FG002|Overall Study|Screen Failure|0|||
124956655|NCT01498445|449467864|FG003|Overall Study|Screen Failure|0|||
124956656|NCT01498445|449467865|FG004|Overall Study|Screen Failure|1|||
124956657|NCT01498445|449467866|FG005|Overall Study|Screen Failure|1|||
124956658|NCT00730925|449467869|FG000|Overall Study|Progressive Disease|21|||
124956659|NCT00730925|449467869|FG000|Overall Study|Dose reducing Event|2|||
124956660|NCT00730925|449467869|FG000|Overall Study|Other Averse Event|7|||
124956661|NCT00730925|449467869|FG000|Overall Study|Protocol Violation|1|||
125125756|NCT00437658|450085816|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
125125757|NCT00437658|450085817|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
125125758|NCT00437658|450085818|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
124956662|NCT00730925|449467869|FG000|Overall Study|Withdrawal by Subject|1|||
124956663|NCT00730925|449467869|FG000|Overall Study|Switch to combination therapy|8|||
125125759|NCT00437658|450085816|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
125125760|NCT00437658|450085817|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
125125761|NCT00437658|450085818|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
125125762|NCT00437658|450085816|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
125125763|NCT00437658|450085817|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
125125764|NCT00437658|450085818|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
125125765|NCT04407806|450085820|FG000|Overall Study|Withdrawal by Subject|1|||
125125766|NCT04407806|450085821|FG001|Overall Study|Withdrawal by Subject|2|||
125125767|NCT02731157|450085822|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
125125768|NCT00832377|450085823|FG000|Overall Study|Protocol Violation|1|||
125125769|NCT01449630|450085824|FG000|Period 1|Physician Decision|1|||
125125770|NCT01449630|450085825|FG001|Period 1|Physician Decision|0|||
125125771|NCT01449630|450085826|FG002|Period 1|Physician Decision|0|||
124956664|NCT00730925|449467869|FG000|Overall Study|Other|1|||
124956665|NCT00561678|449467870|FG000|Overall Study|Withdrawal by Subject|4|||
125125772|NCT01449630|450085827|FG003|Period 1|Physician Decision|1|||
125125773|NCT01449630|450085828|FG004|Period 1|Physician Decision|0|||
125125774|NCT01449630|450085829|FG005|Period 1|Physician Decision|0|||
125125775|NCT01449630|450085830|FG006|Period 1|Physician Decision|0|||
125125776|NCT01449630|450085831|FG007|Period 1|Physician Decision|0|||
125215351|NCT01402986|450414998|FG001|Overall Study|Other|5|||
124956666|NCT00561678|449467871|FG001|Overall Study|Withdrawal by Subject|3|||
124956667|NCT00561678|449467870|FG000|Overall Study|surgery cancelled|1|||
124956668|NCT00561678|449467871|FG001|Overall Study|surgery cancelled|1|||
124956669|NCT00561678|449467870|FG000|Overall Study|surgery rescheduled to different site|2|||
124956670|NCT00561678|449467871|FG001|Overall Study|surgery rescheduled to different site|2|||
124956671|NCT00561678|449467870|FG000|Overall Study|anesthesia provider refusal|1|||
125125777|NCT01449630|450085832|FG008|Period 1|Physician Decision|0|||
125125778|NCT01449630|450085824|FG000|Period 1|Sponsor Decision|0|||
125125779|NCT01449630|450085825|FG001|Period 1|Sponsor Decision|0|||
125215352|NCT01402986|450414999|FG002|Overall Study|Other|1|||
125215353|NCT01402986|450415000|FG003|Overall Study|Other|6|||
124956672|NCT00561678|449467871|FG001|Overall Study|anesthesia provider refusal|0|||
124956673|NCT01732627|449467872|FG000|Overall Study|Withdrawal by Subject|1|||
124956674|NCT01732627|449467873|FG001|Overall Study|Withdrawal by Subject|0|||
124956675|NCT01072396|449467874|FG000|Period One|Adverse Event|1|||
124956676|NCT01072396|449467875|FG001|Period One|Adverse Event|1|||
124956677|NCT01072396|449467874|FG000|Period One|Protocol Violation|2|||
124956678|NCT01072396|449467875|FG001|Period One|Protocol Violation|1|||
124956679|NCT01072396|449467874|FG000|Period One|Withdrawal by Subject|2|||
124956680|NCT01072396|449467875|FG001|Period One|Withdrawal by Subject|0|||
124956681|NCT01072396|449467874|FG000|Washout Period|Missing termination information|0|||
124956682|NCT01072396|449467875|FG001|Washout Period|Missing termination information|1|||
124956683|NCT01072396|449467874|FG000|Period Two|Adverse Event|0|||
124956684|NCT01072396|449467875|FG001|Period Two|Adverse Event|3|||
124956685|NCT01072396|449467874|FG000|Period Two|Lost to Follow-up|1|||
124956686|NCT01072396|449467875|FG001|Period Two|Lost to Follow-up|0|||
124956687|NCT00005908|449467876|FG000|Overall Study|Withdrawal by Subject|1|||
124956688|NCT00005908|449467877|FG001|Overall Study|Withdrawal by Subject|0|||
124956689|NCT01106586|449467880|FG000|Overall Study|Adverse Event|9|||
124956690|NCT01106586|449467881|FG001|Overall Study|Adverse Event|15|||
124956691|NCT01106586|449467880|FG000|Overall Study|Death|1|||
124956692|NCT01106586|449467881|FG001|Overall Study|Death|3|||
124956693|NCT01106586|449467880|FG000|Overall Study|Pregnancy|2|||
124956694|NCT01106586|449467881|FG001|Overall Study|Pregnancy|2|||
124956695|NCT01106586|449467880|FG000|Overall Study|Lack of Efficacy|1|||
124956696|NCT01106586|449467881|FG001|Overall Study|Lack of Efficacy|0|||
124956697|NCT01106586|449467880|FG000|Overall Study|Investigator's Discretion|5|||
125030817|NCT01227967|449735053|FG000|Overall Study|Never Started Treatment|0|||
124956698|NCT01106586|449467881|FG001|Overall Study|Investigator's Discretion|8|||
124956699|NCT01106586|449467880|FG000|Overall Study|Withdrew Consent|18|||
125030818|NCT01227967|449735054|FG001|Overall Study|Never Started Treatment|4|||
125030819|NCT01227967|449735053|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
125030820|NCT01227967|449735054|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
125030821|NCT01763164|449735055|FG000|Treatment Phase|Participant/Guardian decision|26|||
125030822|NCT01763164|449735056|FG001|Treatment Phase|Participant/Guardian decision|14|||
125030823|NCT01763164|449735055|FG000|Treatment Phase|Protocol Violation|1|||
125030824|NCT01763164|449735056|FG001|Treatment Phase|Protocol Violation|1|||
125215354|NCT01085084|450415001|FG000|Overall Study|Withdrawal by Subject|1|||
124956700|NCT01106586|449467881|FG001|Overall Study|Withdrew Consent|30|||
124956701|NCT01106586|449467880|FG000|Overall Study|Lost to Follow-up|24|||
124956702|NCT01106586|449467881|FG001|Overall Study|Lost to Follow-up|20|||
124956703|NCT01106586|449467880|FG000|Overall Study|Participant Noncompliance|12|||
124956704|NCT01106586|449467881|FG001|Overall Study|Participant Noncompliance|10|||
124956705|NCT01106586|449467880|FG000|Overall Study|Protocol Violation|1|||
124956706|NCT01106586|449467881|FG001|Overall Study|Protocol Violation|0|||
124956707|NCT01106586|449467880|FG000|Overall Study|Participant Transferred to Another Study|212|||
125030825|NCT01763164|449735055|FG000|Treatment Phase|Progressive Disease|142|||
125030826|NCT01763164|449735056|FG001|Treatment Phase|Progressive Disease|76|||
125030827|NCT01763164|449735055|FG000|Treatment Phase|Physician Decision|24|||
124956708|NCT01106586|449467881|FG001|Overall Study|Participant Transferred to Another Study|197|||
124956709|NCT01379521|449467882|FG000|Overall Study -Treatment Period|Adverse Event|3|||
124956710|NCT01379521|449467883|FG001|Overall Study -Treatment Period|Adverse Event|0|||
124956711|NCT01379521|449467882|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
124956712|NCT01379521|449467883|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
124956713|NCT01379521|449467882|FG000|Overall Study -Treatment Period|Disease Progression|23|||
124956714|NCT01379521|449467883|FG001|Overall Study -Treatment Period|Disease Progression|22|||
124956715|NCT01379521|449467882|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
124956716|NCT01379521|449467883|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
124956717|NCT01379521|449467882|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
124956718|NCT01379521|449467883|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
124956719|NCT01379521|449467882|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
124956720|NCT01379521|449467883|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
124956721|NCT01379521|449467882|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
124956722|NCT01379521|449467883|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
124956723|NCT01379521|449467882|FG000|Overall Study -Treatment Period|Death|2|||
124956724|NCT01379521|449467883|FG001|Overall Study -Treatment Period|Death|1|||
124956725|NCT01379521|449467882|FG000|Post-Treatment Evaluations|Disease Progression|22|||
124956726|NCT01379521|449467883|FG001|Post-Treatment Evaluations|Disease Progression|20|||
124956727|NCT01379521|449467882|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
124956728|NCT01379521|449467883|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
124956729|NCT01379521|449467882|FG000|Post-Treatment Evaluations|Death|1|||
124956730|NCT01379521|449467883|FG001|Post-Treatment Evaluations|Death|0|||
124956731|NCT00938041|449467884|FG000|Overall Study|Lost to Follow-up|6|||
124956732|NCT00938041|449467884|FG000|Overall Study|Received Alternative Therapy|1|||
124956733|NCT00938041|449467884|FG000|Overall Study|Progressive Disease|5|||
124956734|NCT00938041|449467884|FG000|Overall Study|Death|12|||
124956735|NCT00938041|449467884|FG000|Overall Study|Adrenal Insufficiency|3|||
124956736|NCT01026103|449467885|FG000|Overall Study|Physician Decision|1|||
124956737|NCT01026103|449467885|FG000|Overall Study|did not receive study device bc of error|1|||
124956738|NCT00105521|449467886|FG000|Overall Study|Other|1|||
124956739|NCT00105521|449467887|FG001|Overall Study|Other|1|||
124956740|NCT00105521|449467888|FG002|Overall Study|Other|2|||
124956741|NCT00105521|449467889|FG003|Overall Study|Other|0|||
124956742|NCT00105521|449467886|FG000|Overall Study|Adverse Event|10|||
124956743|NCT00105521|449467887|FG001|Overall Study|Adverse Event|4|||
124956744|NCT00105521|449467888|FG002|Overall Study|Adverse Event|10|||
124956745|NCT00105521|449467889|FG003|Overall Study|Adverse Event|8|||
124956746|NCT00105521|449467886|FG000|Overall Study|Withdrawal by Subject|1|||
124956747|NCT00105521|449467887|FG001|Overall Study|Withdrawal by Subject|0|||
124956748|NCT00105521|449467888|FG002|Overall Study|Withdrawal by Subject|1|||
124956749|NCT00105521|449467889|FG003|Overall Study|Withdrawal by Subject|4|||
124956750|NCT00105521|449467886|FG000|Overall Study|Lack of Efficacy|0|||
125125780|NCT01449630|450085826|FG002|Period 1|Sponsor Decision|0|||
125125781|NCT01449630|450085827|FG003|Period 1|Sponsor Decision|0|||
125125782|NCT01449630|450085828|FG004|Period 1|Sponsor Decision|0|||
125125783|NCT01449630|450085829|FG005|Period 1|Sponsor Decision|1|||
125125784|NCT01449630|450085830|FG006|Period 1|Sponsor Decision|0|||
125125785|NCT01449630|450085831|FG007|Period 1|Sponsor Decision|0|||
125125786|NCT01449630|450085832|FG008|Period 1|Sponsor Decision|0|||
125125787|NCT01449630|450085824|FG000|Period 2|Sponsor Decision|0|||
125125788|NCT01449630|450085825|FG001|Period 2|Sponsor Decision|0|||
125125789|NCT01449630|450085826|FG002|Period 2|Sponsor Decision|0|||
125125790|NCT01449630|450085827|FG003|Period 2|Sponsor Decision|0|||
125125791|NCT01449630|450085828|FG004|Period 2|Sponsor Decision|0|||
125125792|NCT01449630|450085829|FG005|Period 2|Sponsor Decision|0|||
125125793|NCT01449630|450085830|FG006|Period 2|Sponsor Decision|1|||
125125794|NCT01449630|450085831|FG007|Period 2|Sponsor Decision|0|||
125125795|NCT01449630|450085832|FG008|Period 2|Sponsor Decision|0|||
125125796|NCT01735630|450085837|FG000|Overall Study|Adverse Event|8|||
125125797|NCT01735630|450085838|FG001|Overall Study|Adverse Event|7|||
125125798|NCT01735630|450085837|FG000|Overall Study|Lost to Follow-up|1|||
125125799|NCT01735630|450085838|FG001|Overall Study|Lost to Follow-up|0|||
125125800|NCT01735630|450085837|FG000|Overall Study|Physician Decision|0|||
125125801|NCT01735630|450085838|FG001|Overall Study|Physician Decision|1|||
125125802|NCT01735630|450085837|FG000|Overall Study|Sponsor Decision|2|||
124956751|NCT00105521|449467887|FG001|Overall Study|Lack of Efficacy|0|||
124956752|NCT00105521|449467888|FG002|Overall Study|Lack of Efficacy|0|||
124956753|NCT00105521|449467889|FG003|Overall Study|Lack of Efficacy|1|||
124956754|NCT00105521|449467886|FG000|Overall Study|Protocol Violation|3|||
124956755|NCT00105521|449467887|FG001|Overall Study|Protocol Violation|5|||
124956756|NCT00105521|449467888|FG002|Overall Study|Protocol Violation|4|||
124956757|NCT00105521|449467889|FG003|Overall Study|Protocol Violation|4|||
125125803|NCT01735630|450085838|FG001|Overall Study|Sponsor Decision|1|||
125125804|NCT01735630|450085837|FG000|Overall Study|Withdrawal by Subject|7|||
125125805|NCT01735630|450085838|FG001|Overall Study|Withdrawal by Subject|9|||
125125806|NCT03099538|450085839|FG000|Overall Study|Lack of Efficacy|3|||
125125807|NCT01941030|450085852|FG000|Overall Study|Death|3|||
125125808|NCT01941030|450085853|FG001|Overall Study|Death|2|||
125125809|NCT01941030|450085852|FG000|Overall Study|Lost to Follow-up|6|||
125125810|NCT01941030|450085853|FG001|Overall Study|Lost to Follow-up|5|||
125125811|NCT01941030|450085852|FG000|Overall Study|Withdrawal by Subject|4|||
125125812|NCT01941030|450085853|FG001|Overall Study|Withdrawal by Subject|6|||
125125813|NCT02930005|450085854|FG000|Overall Study|Lost to Follow-up|1|||
125125814|NCT02930005|450085855|FG001|Overall Study|Lost to Follow-up|5|||
125125815|NCT00822926|450085858|FG000|Second Injection Visit|Lost to Follow-up|1|||
125125816|NCT00822926|450085859|FG001|Second Injection Visit|Lost to Follow-up|0|||
125125817|NCT00822926|450085858|FG000|Second Injection Visit|Withdrawal by Subject|0|||
125125818|NCT00822926|450085859|FG001|Second Injection Visit|Withdrawal by Subject|1|||
125125819|NCT02534493|450085873|FG000|Overall Study|Lost to Follow-up|1|||
125125820|NCT02534493|450085873|FG000|Overall Study|Withdrawal by Subject|1|||
125125821|NCT03125200|450085877|FG000|Overall Study|Study Termination|0|||
125125822|NCT03125200|450085878|FG001|Overall Study|Study Termination|0|||
125125823|NCT03125200|450085879|FG002|Overall Study|Study Termination|0|||
125125824|NCT03125200|450085880|FG003|Overall Study|Study Termination|1|||
125125825|NCT03125200|450085881|FG004|Overall Study|Study Termination|1|||
125125826|NCT03125200|450085882|FG005|Overall Study|Study Termination|2|||
125125827|NCT03125200|450085883|FG006|Overall Study|Study Termination|1|||
125125828|NCT03125200|450085877|FG000|Overall Study|Clinical Progression|0|||
125125829|NCT03125200|450085878|FG001|Overall Study|Clinical Progression|0|||
125125830|NCT03125200|450085879|FG002|Overall Study|Clinical Progression|0|||
125125831|NCT03125200|450085880|FG003|Overall Study|Clinical Progression|1|||
125125832|NCT03125200|450085881|FG004|Overall Study|Clinical Progression|0|||
125125833|NCT03125200|450085882|FG005|Overall Study|Clinical Progression|1|||
125125834|NCT03125200|450085883|FG006|Overall Study|Clinical Progression|0|||
125125835|NCT03125200|450085877|FG000|Overall Study|Progressive Disease|2|||
125125836|NCT03125200|450085878|FG001|Overall Study|Progressive Disease|1|||
125125837|NCT03125200|450085879|FG002|Overall Study|Progressive Disease|2|||
124956758|NCT00105521|449467886|FG000|Overall Study|Lost to Follow-up|0|||
124956759|NCT00105521|449467887|FG001|Overall Study|Lost to Follow-up|1|||
125125838|NCT03125200|450085880|FG003|Overall Study|Progressive Disease|1|||
125125839|NCT03125200|450085881|FG004|Overall Study|Progressive Disease|2|||
125125840|NCT03125200|450085882|FG005|Overall Study|Progressive Disease|0|||
125125841|NCT03125200|450085883|FG006|Overall Study|Progressive Disease|1|||
124956760|NCT00105521|449467888|FG002|Overall Study|Lost to Follow-up|0|||
125125842|NCT03125200|450085877|FG000|Overall Study|Lack of Efficacy|0|||
125125843|NCT03125200|450085878|FG001|Overall Study|Lack of Efficacy|0|||
125125844|NCT03125200|450085879|FG002|Overall Study|Lack of Efficacy|0|||
125125845|NCT03125200|450085880|FG003|Overall Study|Lack of Efficacy|1|||
125125846|NCT03125200|450085881|FG004|Overall Study|Lack of Efficacy|0|||
125125847|NCT03125200|450085882|FG005|Overall Study|Lack of Efficacy|0|||
125125848|NCT03125200|450085883|FG006|Overall Study|Lack of Efficacy|0|||
125125849|NCT03125200|450085877|FG000|Overall Study|Toxicity|0|||
125125850|NCT03125200|450085878|FG001|Overall Study|Toxicity|0|||
125125851|NCT03125200|450085879|FG002|Overall Study|Toxicity|0|||
125125852|NCT03125200|450085880|FG003|Overall Study|Toxicity|1|||
125125853|NCT03125200|450085881|FG004|Overall Study|Toxicity|0|||
125125854|NCT03125200|450085882|FG005|Overall Study|Toxicity|0|||
125125855|NCT03125200|450085883|FG006|Overall Study|Toxicity|0|||
125125856|NCT03125200|450085877|FG000|Overall Study|Consent Withdrawn by Subject|0|||
125125857|NCT03125200|450085878|FG001|Overall Study|Consent Withdrawn by Subject|1|||
125125858|NCT03125200|450085879|FG002|Overall Study|Consent Withdrawn by Subject|0|||
125215355|NCT01085084|450415002|FG001|Overall Study|Withdrawal by Subject|0|||
125215356|NCT01085084|450415003|FG002|Overall Study|Withdrawal by Subject|0|||
125215357|NCT01085084|450415001|FG000|Overall Study|Lost to Follow-up|2|||
125215358|NCT01085084|450415002|FG001|Overall Study|Lost to Follow-up|1|||
125215359|NCT01085084|450415003|FG002|Overall Study|Lost to Follow-up|1|||
125215360|NCT01085084|450415001|FG000|Overall Study|Adverse Event|4|||
125215361|NCT01085084|450415002|FG001|Overall Study|Adverse Event|3|||
125125859|NCT03125200|450085880|FG003|Overall Study|Consent Withdrawn by Subject|0|||
125125860|NCT03125200|450085881|FG004|Overall Study|Consent Withdrawn by Subject|1|||
125125861|NCT03125200|450085882|FG005|Overall Study|Consent Withdrawn by Subject|0|||
125125862|NCT03125200|450085883|FG006|Overall Study|Consent Withdrawn by Subject|1|||
125125863|NCT00119379|450085884|FG000|Overall Study|Adverse Event|4|||
125125864|NCT00119379|450085885|FG001|Overall Study|Adverse Event|1|||
125125865|NCT01706536|450085888|FG000|Overall Study|Withdrawal by Subject|1|||
125125866|NCT01706536|450085889|FG001|Overall Study|Withdrawal by Subject|0|||
125125867|NCT01706536|450085890|FG002|Overall Study|Withdrawal by Subject|1|||
125125868|NCT01706536|450085891|FG003|Overall Study|Withdrawal by Subject|0|||
125125869|NCT01706536|450085892|FG004|Overall Study|Withdrawal by Subject|0|||
125125870|NCT01706536|450085888|FG000|Overall Study|Adverse Event|2|||
125125871|NCT01706536|450085889|FG001|Overall Study|Adverse Event|3|||
125125872|NCT01706536|450085890|FG002|Overall Study|Adverse Event|4|||
125125873|NCT01706536|450085891|FG003|Overall Study|Adverse Event|3|||
125125874|NCT01706536|450085892|FG004|Overall Study|Adverse Event|2|||
125125875|NCT01706536|450085888|FG000|Overall Study|Lack of Efficacy|1|||
125125876|NCT01706536|450085889|FG001|Overall Study|Lack of Efficacy|0|||
125125877|NCT01706536|450085890|FG002|Overall Study|Lack of Efficacy|0|||
125125878|NCT01706536|450085891|FG003|Overall Study|Lack of Efficacy|1|||
125125879|NCT01706536|450085892|FG004|Overall Study|Lack of Efficacy|0|||
125125880|NCT01706536|450085888|FG000|Overall Study|non compliance|0|||
125125881|NCT01706536|450085889|FG001|Overall Study|non compliance|1|||
125125882|NCT01706536|450085890|FG002|Overall Study|non compliance|0|||
125125883|NCT01706536|450085891|FG003|Overall Study|non compliance|0|||
124956761|NCT00105521|449467889|FG003|Overall Study|Lost to Follow-up|0|||
124956762|NCT02475733|449467890|FG000|Overall Study|Withdrawal by Subject|1|||
124956763|NCT02475733|449467891|FG001|Overall Study|Withdrawal by Subject|0|||
124956764|NCT02475733|449467890|FG000|Overall Study|Physician Decision|1|||
124956765|NCT02475733|449467891|FG001|Overall Study|Physician Decision|0|||
124956766|NCT00404547|449467892|FG000|Overall Study|Adverse Event|39|||
124956767|NCT00404547|449467893|FG001|Overall Study|Adverse Event|6|||
124956768|NCT00404547|449467892|FG000|Overall Study|Withdrawal by Subject|19|||
124956769|NCT00404547|449467893|FG001|Overall Study|Withdrawal by Subject|2|||
124956770|NCT00404547|449467892|FG000|Overall Study|Protocol Violation|0|||
124956771|NCT00404547|449467893|FG001|Overall Study|Protocol Violation|1|||
124956772|NCT00404547|449467892|FG000|Overall Study|Lost to Follow-up|20|||
124956773|NCT00404547|449467893|FG001|Overall Study|Lost to Follow-up|9|||
124956774|NCT00404547|449467892|FG000|Overall Study|Lack of compliance|5|||
124956775|NCT00404547|449467893|FG001|Overall Study|Lack of compliance|1|||
124956776|NCT00404547|449467892|FG000|Overall Study|Other|4|||
124956777|NCT00404547|449467893|FG001|Overall Study|Other|0|||
125125884|NCT01706536|450085892|FG004|Overall Study|non compliance|0|||
125125885|NCT00683293|450085904|FG000|Overall Study|Withdrawal by Subject|2|||
125125886|NCT00683293|450085905|FG001|Overall Study|Withdrawal by Subject|3|||
125125887|NCT03262012|450085906|FG000|Overall Study|Withdrawal by Subject|15|||
125125888|NCT03262012|450085907|FG001|Overall Study|Withdrawal by Subject|13|||
125215362|NCT01085084|450415003|FG002|Overall Study|Adverse Event|6|||
125215363|NCT01085084|450415001|FG000|Overall Study|Treatment Failure|0|||
125215364|NCT01085084|450415002|FG001|Overall Study|Treatment Failure|1|||
125125889|NCT03262012|450085908|FG002|Overall Study|Withdrawal by Subject|8|||
125125890|NCT03262012|450085909|FG003|Overall Study|Withdrawal by Subject|7|||
125125891|NCT03262012|450085906|FG000|Overall Study|Adverse Event|10|||
125125892|NCT03262012|450085907|FG001|Overall Study|Adverse Event|12|||
125125893|NCT03262012|450085908|FG002|Overall Study|Adverse Event|4|||
125125894|NCT03262012|450085909|FG003|Overall Study|Adverse Event|6|||
125125895|NCT03262012|450085906|FG000|Overall Study|Physician Decision|2|||
125215365|NCT01085084|450415003|FG002|Overall Study|Treatment Failure|2|||
124956778|NCT00404547|449467892|FG000|Overall Study|Reason not stated|3|||
124956779|NCT00404547|449467893|FG001|Overall Study|Reason not stated|6|||
124956780|NCT02131155|449467896|FG000|Overall Study|Adverse Event|1|||
124956781|NCT02131155|449467897|FG001|Overall Study|Adverse Event|0|||
125125896|NCT03262012|450085907|FG001|Overall Study|Physician Decision|5|||
125125897|NCT03262012|450085908|FG002|Overall Study|Physician Decision|1|||
125125898|NCT03262012|450085909|FG003|Overall Study|Physician Decision|0|||
125125899|NCT03262012|450085906|FG000|Overall Study|Lack of Efficacy|0|||
125125900|NCT03262012|450085907|FG001|Overall Study|Lack of Efficacy|5|||
125125901|NCT03262012|450085908|FG002|Overall Study|Lack of Efficacy|1|||
125125902|NCT03262012|450085909|FG003|Overall Study|Lack of Efficacy|2|||
125125903|NCT03262012|450085906|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
125125904|NCT03262012|450085907|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
125125905|NCT03262012|450085908|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
125125906|NCT03262012|450085909|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
125125907|NCT01469546|450085910|FG000|Received 5 mg Dose|Adverse Event|13|||
125125908|NCT01469546|450085910|FG000|Received 5 mg Dose|Death|2|||
125125909|NCT01469546|450085910|FG000|Received 5 mg Dose|Protocol Violation|2|||
125125910|NCT01469546|450085910|FG000|Received 5 mg Dose|Progressive Disease|3|||
125125911|NCT01469546|450085910|FG000|Received 5 mg Dose|Physician Decision|3|||
125125912|NCT02079532|450085913|FG000|Overall Study|Adverse Event|7|||
125125913|NCT02079532|450085913|FG000|Overall Study|Additional or changed therapy|2|||
125125914|NCT02079532|450085913|FG000|Overall Study|Lack of Efficacy|9|||
125125915|NCT02079532|450085913|FG000|Overall Study|Protocol Violation|3|||
125125916|NCT02079532|450085913|FG000|Overall Study|Withdrawal by Subject|1|||
125125917|NCT02079532|450085913|FG000|Overall Study|Administrative problems|1|||
125125918|NCT02079532|450085913|FG000|Overall Study|Inclusion into ReFIRST|3|||
125125919|NCT02079532|450085913|FG000|Overall Study|Other|3|||
125125920|NCT01085045|450087226|FG000|Part A|Withdrawal by Subject|4|||
125125921|NCT01085045|450087226|FG000|Part A|Adverse Event|6|||
125125922|NCT01085045|450087226|FG000|Part A|Protocol Violation|1|||
125125923|NCT01085045|450087226|FG000|Part A|Protocol Specified Criteria|7|||
125125924|NCT01085045|450087226|FG000|Part B|Withdrawal by Subject|2|||
125125925|NCT01085045|450087226|FG000|Part B|Protocol Specified Criteria|6|||
125125926|NCT01085045|450087226|FG000|Part B|Lost to Follow-up|1|||
125125927|NCT01085045|450087226|FG000|Part B|Adverse Event|6|||
125125928|NCT04455633|450087234|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
125125929|NCT04455633|450087235|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
125125930|NCT04455633|450087236|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
125125931|NCT04455633|450087234|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
125125932|NCT04455633|450087235|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
125125933|NCT04455633|450087236|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
125125934|NCT04455633|450087234|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
125125935|NCT04455633|450087235|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
125125936|NCT04455633|450087236|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
125125937|NCT04455633|450087234|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
125125938|NCT04455633|450087235|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
125125939|NCT04455633|450087236|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
125125940|NCT02532764|450087237|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
125125941|NCT02532764|450087238|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
125125942|NCT02532764|450087239|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
125125943|NCT02532764|450087240|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
124956782|NCT02131155|449467896|FG000|Overall Study|Treatment completed|1|||
124956783|NCT02131155|449467897|FG001|Overall Study|Treatment completed|0|||
124956784|NCT02131155|449467896|FG000|Overall Study|Primary tumour recurrence|2|||
124956785|NCT02131155|449467897|FG001|Overall Study|Primary tumour recurrence|1|||
124956786|NCT02131155|449467896|FG000|Overall Study|Refused to continue study medication|1|||
124956787|NCT02131155|449467897|FG001|Overall Study|Refused to continue study medication|0|||
124956788|NCT02131155|449467896|FG000|Overall Study|Study early termination|20|||
124956789|NCT02131155|449467897|FG001|Overall Study|Study early termination|10|||
124956790|NCT01887418|449467898|FG000|Overall Study|Travelling difficulties|0|||
124956791|NCT01887418|449467899|FG001|Overall Study|Travelling difficulties|0|||
125125944|NCT02532764|450087241|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
125125945|NCT02532764|450087242|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
125125946|NCT02532764|450087243|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
125125947|NCT02532764|450087244|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
125125948|NCT02532764|450087245|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
125125949|NCT02532764|450087246|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
124956792|NCT01887418|449467900|FG002|Overall Study|Travelling difficulties|1|||
125125950|NCT01717976|450087247|FG000|Overall Study|Protocol Violation|0|||
125125951|NCT01717976|450087248|FG001|Overall Study|Protocol Violation|1|||
125125952|NCT00727571|450087253|FG000|Overall Study|Ineligibility determined|1|||
125125953|NCT00727571|450087254|FG001|Overall Study|Ineligibility determined|1|||
124956793|NCT02350127|449467904|FG000|4-Month Assessment|Withdrawal by Subject|10|||
124956794|NCT02350127|449467905|FG001|4-Month Assessment|Withdrawal by Subject|9|||
125125954|NCT00727571|450087255|FG002|Overall Study|Ineligibility determined|1|||
125125955|NCT00727571|450087256|FG003|Overall Study|Ineligibility determined|0|||
125125956|NCT00727571|450087253|FG000|Overall Study|Death|0|||
125125957|NCT00727571|450087254|FG001|Overall Study|Death|19|||
125125958|NCT00727571|450087255|FG002|Overall Study|Death|5|||
125125959|NCT00727571|450087256|FG003|Overall Study|Death|1|||
125125960|NCT00727571|450087253|FG000|Overall Study|Physician Decision|0|||
125125961|NCT00727571|450087254|FG001|Overall Study|Physician Decision|5|||
125125962|NCT00727571|450087255|FG002|Overall Study|Physician Decision|0|||
125125963|NCT00727571|450087256|FG003|Overall Study|Physician Decision|0|||
125125964|NCT00727571|450087253|FG000|Overall Study|Withdrawal by Subject|0|||
125125965|NCT00727571|450087254|FG001|Overall Study|Withdrawal by Subject|10|||
125125966|NCT00727571|450087255|FG002|Overall Study|Withdrawal by Subject|11|||
125125967|NCT00727571|450087256|FG003|Overall Study|Withdrawal by Subject|0|||
125125968|NCT00727571|450087253|FG000|Overall Study|Subject Non Compliance|0|||
125125969|NCT00727571|450087254|FG001|Overall Study|Subject Non Compliance|6|||
125125970|NCT00727571|450087255|FG002|Overall Study|Subject Non Compliance|0|||
125125971|NCT00727571|450087256|FG003|Overall Study|Subject Non Compliance|4|||
125125972|NCT00727571|450087253|FG000|Overall Study|Dismissed from nursing home|0|||
125125973|NCT00727571|450087254|FG001|Overall Study|Dismissed from nursing home|9|||
125125974|NCT00727571|450087255|FG002|Overall Study|Dismissed from nursing home|5|||
125125975|NCT00727571|450087256|FG003|Overall Study|Dismissed from nursing home|0|||
125125976|NCT00727571|450087253|FG000|Overall Study|Hospitalization|0|||
125125977|NCT00727571|450087254|FG001|Overall Study|Hospitalization|1|||
125125978|NCT00727571|450087255|FG002|Overall Study|Hospitalization|0|||
125125979|NCT00727571|450087256|FG003|Overall Study|Hospitalization|1|||
125125980|NCT00727571|450087253|FG000|Overall Study|AE not leading to hospitalization|0|||
125125981|NCT00727571|450087254|FG001|Overall Study|AE not leading to hospitalization|0|||
125125982|NCT00727571|450087255|FG002|Overall Study|AE not leading to hospitalization|2|||
125125983|NCT00727571|450087256|FG003|Overall Study|AE not leading to hospitalization|0|||
125125984|NCT00727571|450087253|FG000|Overall Study|Other|0|||
125125985|NCT00727571|450087254|FG001|Overall Study|Other|4|||
125125986|NCT00727571|450087255|FG002|Overall Study|Other|6|||
125125987|NCT00727571|450087256|FG003|Overall Study|Other|0|||
125125988|NCT03164772|450087258|FG000|Overall Study|Death|4|||
125125989|NCT03164772|450087259|FG001|Overall Study|Death|2|||
125125990|NCT03164772|450087258|FG000|Overall Study|Adverse Event|1|||
125125991|NCT03164772|450087259|FG001|Overall Study|Adverse Event|4|||
125125992|NCT03164772|450087258|FG000|Overall Study|Progressive Disease|11|||
125125993|NCT03164772|450087259|FG001|Overall Study|Progressive Disease|21|||
125125994|NCT03164772|450087258|FG000|Overall Study|Physician Decision|2|||
125125995|NCT03164772|450087259|FG001|Overall Study|Physician Decision|0|||
125125996|NCT03164772|450087258|FG000|Overall Study|Withdrawal by Subject|0|||
125125997|NCT03164772|450087259|FG001|Overall Study|Withdrawal by Subject|4|||
125125998|NCT04099888|450087262|FG000|Overall Study|Study terminated by sponsor|9|||
125125999|NCT04099888|450087263|FG001|Overall Study|Study terminated by sponsor|11|||
125126000|NCT04099888|450087262|FG000|Overall Study|Lost to Follow-up|1|||
125126001|NCT04099888|450087263|FG001|Overall Study|Lost to Follow-up|1|||
125126002|NCT04099888|450087262|FG000|Overall Study|Withdrawal by Subject|5|||
125126003|NCT04099888|450087263|FG001|Overall Study|Withdrawal by Subject|6|||
125126004|NCT04099888|450087262|FG000|Overall Study|Death|5|||
125126005|NCT04099888|450087263|FG001|Overall Study|Death|2|||
125126006|NCT04099888|450087262|FG000|Overall Study|Other|1|||
125126007|NCT04099888|450087263|FG001|Overall Study|Other|0|||
125126008|NCT04538170|450087264|FG000|Overall Study|Withdrawal by Subject|104|||
124956795|NCT02350127|449467904|FG000|4-Month Assessment|Death|1|||
124956796|NCT02350127|449467905|FG001|4-Month Assessment|Death|0|||
124956797|NCT02350127|449467904|FG000|8-Month Assessment|Death|1|||
125126009|NCT04538170|450087265|FG001|Overall Study|Withdrawal by Subject|210|||
125126010|NCT00051025|450087269|FG000|Overall Study|Progressive Disease|1|||
125126011|NCT00051025|450087270|FG001|Overall Study|Progressive Disease|1|||
125126012|NCT00051025|450087269|FG000|Overall Study|Adverse Event|1|||
124956798|NCT02350127|449467905|FG001|8-Month Assessment|Death|1|||
124956799|NCT02350127|449467904|FG000|8-Month Assessment|Withdrawal by Subject|5|||
125126013|NCT00051025|450087270|FG001|Overall Study|Adverse Event|1|||
125126014|NCT00051025|450087269|FG000|Overall Study|Withdrawal by Subject|0|||
125126015|NCT00051025|450087270|FG001|Overall Study|Withdrawal by Subject|1|||
125126016|NCT00051025|450087269|FG000|Overall Study|Death|0|||
125126017|NCT00051025|450087270|FG001|Overall Study|Death|1|||
125126018|NCT00274937|450087271|FG000|Overall Study|Physician Decision|10|||
125126019|NCT00274937|450087271|FG000|Overall Study|Withdrawal by Subject|6|||
125126020|NCT00274937|450087271|FG000|Overall Study|Progressive Disease|4|||
125126021|NCT02189941|450087272|FG000|Overall Study|Non-compliance|0|||
125126022|NCT02189941|450087273|FG001|Overall Study|Non-compliance|0|||
125126023|NCT02189941|450087274|FG002|Overall Study|Non-compliance|1|||
124956800|NCT02350127|449467905|FG001|8-Month Assessment|Withdrawal by Subject|8|||
125126024|NCT00445003|450087275|FG000|Overall Study|Death|1|||
125126025|NCT00445003|450087276|FG001|Overall Study|Death|2|||
125126026|NCT00445003|450087277|FG002|Overall Study|Death|1|||
124956801|NCT01446042|449467906|FG000|Overall Study|Withdrawal by Subject|12|||
124956802|NCT01446042|449467907|FG001|Overall Study|Withdrawal by Subject|2|||
124956803|NCT01446042|449467908|FG002|Overall Study|Withdrawal by Subject|4|||
124956804|NCT01446042|449467906|FG000|Overall Study|Adverse Event|1|||
124956805|NCT01446042|449467907|FG001|Overall Study|Adverse Event|0|||
124956806|NCT01446042|449467908|FG002|Overall Study|Adverse Event|4|||
125215366|NCT02427802|450415004|FG000|Overall Study|Adverse Event|11|||
125215367|NCT02427802|450415005|FG001|Overall Study|Adverse Event|3|||
125215368|NCT02427802|450415006|FG002|Overall Study|Adverse Event|7|||
125215369|NCT02427802|450415004|FG000|Overall Study|Death|0|||
125215370|NCT02427802|450415005|FG001|Overall Study|Death|4|||
125215371|NCT02427802|450415006|FG002|Overall Study|Death|1|||
125215372|NCT02427802|450415004|FG000|Overall Study|Lost to Follow-up|13|||
125215373|NCT02427802|450415005|FG001|Overall Study|Lost to Follow-up|8|||
125215374|NCT02427802|450415006|FG002|Overall Study|Lost to Follow-up|8|||
125215375|NCT02427802|450415004|FG000|Overall Study|Physician Decision|4|||
125215376|NCT02427802|450415005|FG001|Overall Study|Physician Decision|2|||
125215377|NCT02427802|450415006|FG002|Overall Study|Physician Decision|4|||
125215378|NCT02427802|450415004|FG000|Overall Study|Withdrawal by Subject|10|||
125215379|NCT02427802|450415005|FG001|Overall Study|Withdrawal by Subject|5|||
125215380|NCT02427802|450415006|FG002|Overall Study|Withdrawal by Subject|11|||
125215381|NCT02427802|450415004|FG000|Overall Study|Protocol Violation|3|||
125215382|NCT02427802|450415005|FG001|Overall Study|Protocol Violation|1|||
125215383|NCT02427802|450415006|FG002|Overall Study|Protocol Violation|1|||
125215384|NCT02427802|450415004|FG000|Overall Study|protocol specific treatment unrelated|18|||
125215385|NCT02427802|450415005|FG001|Overall Study|protocol specific treatment unrelated|11|||
125215386|NCT02427802|450415006|FG002|Overall Study|protocol specific treatment unrelated|11|||
125215387|NCT02749799|450415007|FG000|Overall Study|Adverse Event|2|||
125215388|NCT02749799|450415007|FG000|Overall Study|Lost to Follow-up|4|||
125215389|NCT02749799|450415007|FG000|Overall Study|Protocol Violation|1|||
125215390|NCT02749799|450415007|FG000|Overall Study|Withdrawal by Subject|1|||
125215391|NCT02634983|450415008|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
125215392|NCT02634983|450415009|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
125215393|NCT02070978|450415010|FG000|Overall Study|Adverse Event|6|||
124956807|NCT01446042|449467906|FG000|Overall Study|Lost to Follow-up|5|||
124956808|NCT01446042|449467907|FG001|Overall Study|Lost to Follow-up|0|||
125030828|NCT01763164|449735056|FG001|Treatment Phase|Physician Decision|13|||
125030829|NCT01763164|449735055|FG000|Treatment Phase|Death|10|||
125030830|NCT01763164|449735056|FG001|Treatment Phase|Death|1|||
125030831|NCT01763164|449735055|FG000|Treatment Phase|Adverse Event|66|||
125030832|NCT01763164|449735056|FG001|Treatment Phase|Adverse Event|8|||
125030833|NCT01763164|449735055|FG000|Treatment Phase|Randomized but not Treated|0|||
125030834|NCT01763164|449735056|FG001|Treatment Phase|Randomized but not Treated|19|||
125030835|NCT01763164|449735055|FG000|Treatment Phase|Other|0|||
125030836|NCT01763164|449735056|FG001|Treatment Phase|Other|1|||
125030837|NCT01763164|449735055|FG000|Follow up Phase|New therapy for study indication|12|||
125030838|NCT01763164|449735056|FG001|Follow up Phase|New therapy for study indication|3|||
125030839|NCT01763164|449735055|FG000|Follow up Phase|Death|21|||
125030840|NCT01763164|449735056|FG001|Follow up Phase|Death|4|||
125030841|NCT01763164|449735055|FG000|Follow up Phase|Subject/guardian decision|9|||
125030842|NCT01763164|449735056|FG001|Follow up Phase|Subject/guardian decision|2|||
125030843|NCT01763164|449735055|FG000|Follow up Phase|Progressive disease|127|||
125030844|NCT01763164|449735056|FG001|Follow up Phase|Progressive disease|62|||
125030845|NCT01763164|449735055|FG000|Follow up Phase|Physician Decision|10|||
125030846|NCT01763164|449735056|FG001|Follow up Phase|Physician Decision|3|||
125030847|NCT01763164|449735055|FG000|Follow up Phase|Lost to Follow-up|1|||
125030848|NCT01763164|449735056|FG001|Follow up Phase|Lost to Follow-up|0|||
125030849|NCT01763164|449735055|FG000|Follow up Phase|Adverse Event|17|||
125030850|NCT01763164|449735056|FG001|Follow up Phase|Adverse Event|1|||
125030851|NCT01375764|449735067|FG000|Overall Study|Lost to Follow-up|0|||
125030852|NCT01375764|449735068|FG001|Overall Study|Lost to Follow-up|1|||
125030853|NCT01375764|449735069|FG002|Overall Study|Lost to Follow-up|0|||
125030854|NCT01375764|449735070|FG003|Overall Study|Lost to Follow-up|0|||
125215394|NCT02070978|450415011|FG001|Overall Study|Adverse Event|2|||
125030855|NCT01375764|449735071|FG004|Overall Study|Lost to Follow-up|0|||
125030856|NCT01375764|449735067|FG000|Overall Study|Withdrawal by Subject|2|||
125030857|NCT01375764|449735068|FG001|Overall Study|Withdrawal by Subject|0|||
125030858|NCT01375764|449735069|FG002|Overall Study|Withdrawal by Subject|0|||
125030859|NCT01375764|449735070|FG003|Overall Study|Withdrawal by Subject|0|||
125030860|NCT01375764|449735071|FG004|Overall Study|Withdrawal by Subject|1|||
125215395|NCT02070978|450415012|FG002|Overall Study|Adverse Event|0|||
124956809|NCT01446042|449467908|FG002|Overall Study|Lost to Follow-up|0|||
124956810|NCT01446042|449467906|FG000|Overall Study|Other reasons|2|||
125030861|NCT01375764|449735067|FG000|Overall Study|Other|0|||
125215396|NCT02070978|450415010|FG000|Overall Study|Lost to Follow-up|1|||
125215397|NCT02070978|450415011|FG001|Overall Study|Lost to Follow-up|3|||
125215398|NCT02070978|450415012|FG002|Overall Study|Lost to Follow-up|4|||
124956811|NCT01446042|449467907|FG001|Overall Study|Other reasons|1|||
124956812|NCT01446042|449467908|FG002|Overall Study|Other reasons|1|||
125126027|NCT00445003|450087275|FG000|Overall Study|Missed Visit|3|||
125126028|NCT00445003|450087276|FG001|Overall Study|Missed Visit|5|||
125126029|NCT00445003|450087277|FG002|Overall Study|Missed Visit|1|||
125126030|NCT00445003|450087275|FG000|Overall Study|Dropped|1|||
125126031|NCT00445003|450087276|FG001|Overall Study|Dropped|3|||
125126032|NCT00445003|450087277|FG002|Overall Study|Dropped|2|||
125126033|NCT01471093|450087278|FG000|Overall Study|Adverse Event|1|||
125126034|NCT01471093|450087279|FG001|Overall Study|Adverse Event|0|||
125126035|NCT01471093|450087280|FG002|Overall Study|Adverse Event|0|||
125126036|NCT01471093|450087281|FG003|Overall Study|Adverse Event|0|||
124956813|NCT03906240|449467909|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
124956814|NCT03906240|449467910|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
124956815|NCT03906240|449467909|FG000|Overall Study|Lost to Follow-up|1|||
124956816|NCT03906240|449467910|FG001|Overall Study|Lost to Follow-up|0|||
124956817|NCT03906240|449467909|FG000|Overall Study|Withdrawal by Subject|0|||
124956818|NCT03906240|449467910|FG001|Overall Study|Withdrawal by Subject|1|||
124956819|NCT00296504|449467915|FG000|Interim Analysis|Withdrawal by Subject|8|||
124956820|NCT00296504|449467916|FG001|Interim Analysis|Withdrawal by Subject|0|||
124956821|NCT00296504|449467917|FG002|Interim Analysis|Withdrawal by Subject|12|||
124956822|NCT00296504|449467918|FG003|Interim Analysis|Withdrawal by Subject|0|||
124956823|NCT00296504|449467919|FG004|Interim Analysis|Withdrawal by Subject|5|||
124956824|NCT00296504|449467920|FG005|Interim Analysis|Withdrawal by Subject|5|||
124956825|NCT00296504|449467921|FG006|Interim Analysis|Withdrawal by Subject|9|||
124956826|NCT00296504|449467922|FG007|Interim Analysis|Withdrawal by Subject|3|||
124956827|NCT00296504|449467923|FG008|Interim Analysis|Withdrawal by Subject|0|||
125126037|NCT02475954|450087282|FG000|Overall Study|Withdrawal by Subject|2|||
125126038|NCT02475954|450087283|FG001|Overall Study|Withdrawal by Subject|2|||
125126039|NCT02475954|450087282|FG000|Overall Study|Lost to Follow-up|11|||
124956828|NCT00296504|449467915|FG000|Interim Analysis|Lost to Follow-up|13|||
124956829|NCT00296504|449467916|FG001|Interim Analysis|Lost to Follow-up|3|||
124956830|NCT00296504|449467917|FG002|Interim Analysis|Lost to Follow-up|26|||
124956831|NCT00296504|449467918|FG003|Interim Analysis|Lost to Follow-up|8|||
124956832|NCT00296504|449467919|FG004|Interim Analysis|Lost to Follow-up|14|||
124956833|NCT00296504|449467920|FG005|Interim Analysis|Lost to Follow-up|4|||
124956834|NCT00296504|449467921|FG006|Interim Analysis|Lost to Follow-up|11|||
124956835|NCT00296504|449467922|FG007|Interim Analysis|Lost to Follow-up|4|||
124956836|NCT00296504|449467923|FG008|Interim Analysis|Lost to Follow-up|0|||
124956837|NCT00296504|449467915|FG000|Interim Analysis|Clinical Progression|1|||
124956838|NCT00296504|449467916|FG001|Interim Analysis|Clinical Progression|0|||
124956839|NCT00296504|449467917|FG002|Interim Analysis|Clinical Progression|1|||
124956840|NCT00296504|449467918|FG003|Interim Analysis|Clinical Progression|1|||
124956841|NCT00296504|449467919|FG004|Interim Analysis|Clinical Progression|0|||
124956842|NCT00296504|449467920|FG005|Interim Analysis|Clinical Progression|2|||
124956843|NCT00296504|449467921|FG006|Interim Analysis|Clinical Progression|1|||
124956844|NCT00296504|449467922|FG007|Interim Analysis|Clinical Progression|2|||
124956845|NCT00296504|449467923|FG008|Interim Analysis|Clinical Progression|0|||
124956846|NCT00296504|449467915|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
124956847|NCT00296504|449467916|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
124956848|NCT00296504|449467917|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
124956849|NCT00296504|449467918|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
124956850|NCT00296504|449467919|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
124956851|NCT00296504|449467920|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
124956852|NCT00296504|449467921|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
124956853|NCT00296504|449467922|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
124956854|NCT00296504|449467923|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
124956855|NCT00296504|449467915|FG000|Interim Analysis|Adverse Event|0|||
125126040|NCT02475954|450087283|FG001|Overall Study|Lost to Follow-up|9|||
125126041|NCT02475954|450087282|FG000|Overall Study|Death|1|||
125126042|NCT02475954|450087283|FG001|Overall Study|Death|1|||
125126043|NCT02932878|450087284|FG000|Overall Study|Due to Lab Results|2|||
125126044|NCT02932878|450087285|FG001|Overall Study|Due to Lab Results|1|||
125126045|NCT01918397|450087288|FG000|Overall Study|Never started treatment|2|||
125126046|NCT01918397|450087289|FG001|Overall Study|Never started treatment|1|||
125126047|NCT01918397|450087290|FG002|Overall Study|Never started treatment|0|||
124956856|NCT00296504|449467916|FG001|Interim Analysis|Adverse Event|0|||
124956857|NCT00296504|449467917|FG002|Interim Analysis|Adverse Event|13|||
124956858|NCT00296504|449467918|FG003|Interim Analysis|Adverse Event|4|||
124956859|NCT00296504|449467919|FG004|Interim Analysis|Adverse Event|6|||
124956860|NCT00296504|449467920|FG005|Interim Analysis|Adverse Event|3|||
124956861|NCT00296504|449467921|FG006|Interim Analysis|Adverse Event|4|||
124956862|NCT00296504|449467922|FG007|Interim Analysis|Adverse Event|5|||
125126048|NCT01918397|450087291|FG003|Overall Study|Never started treatment|0|||
125126049|NCT01918397|450087288|FG000|Overall Study|Adverse Event|1|||
125126050|NCT01918397|450087289|FG001|Overall Study|Adverse Event|1|||
125126051|NCT01918397|450087290|FG002|Overall Study|Adverse Event|1|||
125126052|NCT01918397|450087291|FG003|Overall Study|Adverse Event|0|||
125126053|NCT01918397|450087288|FG000|Overall Study|Lack of compliance|2|||
125126054|NCT01918397|450087289|FG001|Overall Study|Lack of compliance|2|||
125126055|NCT01918397|450087290|FG002|Overall Study|Lack of compliance|3|||
125126056|NCT01918397|450087291|FG003|Overall Study|Lack of compliance|0|||
125126057|NCT01918397|450087288|FG000|Overall Study|Pregnancy|0|||
125126058|NCT01918397|450087289|FG001|Overall Study|Pregnancy|1|||
125126059|NCT01918397|450087290|FG002|Overall Study|Pregnancy|0|||
125126060|NCT01918397|450087291|FG003|Overall Study|Pregnancy|0|||
125126061|NCT01918397|450087288|FG000|Overall Study|Rifampin susceptible|0|||
125126062|NCT01918397|450087289|FG001|Overall Study|Rifampin susceptible|0|||
125126063|NCT01918397|450087290|FG002|Overall Study|Rifampin susceptible|0|||
125126064|NCT01918397|450087291|FG003|Overall Study|Rifampin susceptible|2|||
125126065|NCT01918397|450087288|FG000|Overall Study|Treatment failure|0|||
125126066|NCT01918397|450087289|FG001|Overall Study|Treatment failure|0|||
125126067|NCT01918397|450087290|FG002|Overall Study|Treatment failure|0|||
125126068|NCT01918397|450087291|FG003|Overall Study|Treatment failure|1|||
125126069|NCT01918397|450087288|FG000|Overall Study|Withdrawal by Subject|3|||
125126070|NCT01918397|450087289|FG001|Overall Study|Withdrawal by Subject|2|||
125126071|NCT01918397|450087290|FG002|Overall Study|Withdrawal by Subject|1|||
125126072|NCT01918397|450087291|FG003|Overall Study|Withdrawal by Subject|1|||
125126073|NCT01918397|450087288|FG000|Overall Study|XDR at baseline|0|||
125126074|NCT01918397|450087289|FG001|Overall Study|XDR at baseline|0|||
125126075|NCT01918397|450087290|FG002|Overall Study|XDR at baseline|1|||
125126076|NCT01918397|450087291|FG003|Overall Study|XDR at baseline|0|||
125126077|NCT01918397|450087288|FG000|Overall Study|Lost to Follow-up|2|||
125126078|NCT01918397|450087289|FG001|Overall Study|Lost to Follow-up|1|||
124956863|NCT00296504|449467923|FG008|Interim Analysis|Adverse Event|0|||
124956864|NCT00296504|449467915|FG000|Interim Analysis|Protocol Violation|0|||
125126079|NCT01918397|450087290|FG002|Overall Study|Lost to Follow-up|1|||
125126080|NCT01918397|450087291|FG003|Overall Study|Lost to Follow-up|1|||
124956865|NCT00296504|449467916|FG001|Interim Analysis|Protocol Violation|0|||
125126081|NCT01918397|450087288|FG000|Overall Study|Increased QTc|1|||
125126082|NCT01918397|450087289|FG001|Overall Study|Increased QTc|0|||
125126083|NCT01918397|450087290|FG002|Overall Study|Increased QTc|0|||
125126084|NCT01918397|450087291|FG003|Overall Study|Increased QTc|1|||
125126085|NCT01918397|450087288|FG000|Overall Study|Death|0|||
125126086|NCT01918397|450087289|FG001|Overall Study|Death|0|||
125126087|NCT01918397|450087290|FG002|Overall Study|Death|1|||
124956866|NCT00296504|449467917|FG002|Interim Analysis|Protocol Violation|2|||
125126088|NCT01918397|450087291|FG003|Overall Study|Death|0|||
125126089|NCT01918397|450087288|FG000|Overall Study|Involved in another investigative trial|0|||
125126090|NCT01918397|450087289|FG001|Overall Study|Involved in another investigative trial|0|||
125126091|NCT01918397|450087290|FG002|Overall Study|Involved in another investigative trial|0|||
125126092|NCT01918397|450087291|FG003|Overall Study|Involved in another investigative trial|1|||
125126093|NCT00864097|450087292|FG000|Overall Study|Death|0|||
125126094|NCT00864097|450087293|FG001|Overall Study|Death|1|||
125126095|NCT00864097|450087294|FG002|Overall Study|Death|0|||
125126096|NCT00864097|450087295|FG003|Overall Study|Death|0|||
125126097|NCT00864097|450087292|FG000|Overall Study|Adverse Event|6|||
125126098|NCT00864097|450087293|FG001|Overall Study|Adverse Event|8|||
125126099|NCT00864097|450087294|FG002|Overall Study|Adverse Event|11|||
125126100|NCT00864097|450087295|FG003|Overall Study|Adverse Event|9|||
125126101|NCT00864097|450087292|FG000|Overall Study|Lack of Efficacy|9|||
125126102|NCT00864097|450087293|FG001|Overall Study|Lack of Efficacy|3|||
125126103|NCT00864097|450087294|FG002|Overall Study|Lack of Efficacy|7|||
125126104|NCT00864097|450087295|FG003|Overall Study|Lack of Efficacy|2|||
125126105|NCT00864097|450087292|FG000|Overall Study|Lost to Follow-up|0|||
125126106|NCT00864097|450087293|FG001|Overall Study|Lost to Follow-up|1|||
125126107|NCT00864097|450087294|FG002|Overall Study|Lost to Follow-up|0|||
125126108|NCT00864097|450087295|FG003|Overall Study|Lost to Follow-up|1|||
125126109|NCT00864097|450087292|FG000|Overall Study|Withdrawal by Subject|15|||
125126110|NCT00864097|450087293|FG001|Overall Study|Withdrawal by Subject|11|||
125126111|NCT00864097|450087294|FG002|Overall Study|Withdrawal by Subject|11|||
125126112|NCT00864097|450087295|FG003|Overall Study|Withdrawal by Subject|12|||
125126113|NCT00864097|450087292|FG000|Overall Study|Protocol Violation|2|||
125126114|NCT00864097|450087293|FG001|Overall Study|Protocol Violation|1|||
125126115|NCT00864097|450087294|FG002|Overall Study|Protocol Violation|0|||
125126116|NCT00864097|450087295|FG003|Overall Study|Protocol Violation|1|||
125126117|NCT00864097|450087292|FG000|Overall Study|Terminated by sponsor|105|||
125126118|NCT00864097|450087293|FG001|Overall Study|Terminated by sponsor|112|||
125126119|NCT00864097|450087294|FG002|Overall Study|Terminated by sponsor|102|||
125126120|NCT00864097|450087295|FG003|Overall Study|Terminated by sponsor|99|||
125126121|NCT00864097|450087292|FG000|Overall Study|Randomized but not treated|2|||
125126122|NCT00864097|450087293|FG001|Overall Study|Randomized but not treated|0|||
125126123|NCT00864097|450087294|FG002|Overall Study|Randomized but not treated|1|||
125126124|NCT00864097|450087295|FG003|Overall Study|Randomized but not treated|0|||
125126125|NCT00864097|450087292|FG000|Overall Study|Other|0|||
125126126|NCT00864097|450087293|FG001|Overall Study|Other|0|||
125126127|NCT00864097|450087294|FG002|Overall Study|Other|0|||
125126128|NCT00864097|450087295|FG003|Overall Study|Other|1|||
125126129|NCT00620022|450087296|FG000|Treatment Period 1|Adverse Event|4|||
125126130|NCT00620022|450087297|FG001|Treatment Period 1|Adverse Event|6|||
125126131|NCT00620022|450087296|FG000|Treatment Period 1|Subject withdrew consent|1|||
125126132|NCT00620022|450087297|FG001|Treatment Period 1|Subject withdrew consent|0|||
125126133|NCT00620022|450087296|FG000|Treatment Period 2|Adverse Event|2|||
125126134|NCT00620022|450087297|FG001|Treatment Period 2|Adverse Event|2|||
125126135|NCT00262223|450087301|FG000|Treatment Phase|Withdrawal by Subject|3|||
125126136|NCT00262223|450087302|FG001|Treatment Phase|Withdrawal by Subject|6|||
125126137|NCT00262223|450087301|FG000|Treatment Phase|Adverse Event|1|||
125126138|NCT00262223|450087302|FG001|Treatment Phase|Adverse Event|2|||
125126139|NCT00262223|450087301|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
125126140|NCT00262223|450087302|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
125126141|NCT00262223|450087301|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
125126142|NCT00262223|450087302|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
125215399|NCT02070978|450415010|FG000|Overall Study|Withdrawal by Subject|3|||
124956867|NCT00296504|449467918|FG003|Interim Analysis|Protocol Violation|0|||
124956868|NCT00296504|449467919|FG004|Interim Analysis|Protocol Violation|1|||
124956869|NCT00296504|449467920|FG005|Interim Analysis|Protocol Violation|0|||
124956870|NCT00296504|449467921|FG006|Interim Analysis|Protocol Violation|0|||
124956871|NCT00296504|449467922|FG007|Interim Analysis|Protocol Violation|1|||
124956872|NCT00296504|449467923|FG008|Interim Analysis|Protocol Violation|0|||
124956873|NCT00296504|449467915|FG000|Interim Analysis|Insufficient CD4 Response|0|||
124956874|NCT00296504|449467916|FG001|Interim Analysis|Insufficient CD4 Response|0|||
124956875|NCT00296504|449467917|FG002|Interim Analysis|Insufficient CD4 Response|0|||
124956876|NCT00296504|449467918|FG003|Interim Analysis|Insufficient CD4 Response|0|||
125126143|NCT00262223|450087301|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
125126144|NCT00262223|450087302|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
125126145|NCT01804270|450087305|FG000|Overall Study|Withdrawal by Subject|1|||
125126146|NCT01804270|450087306|FG001|Overall Study|Withdrawal by Subject|1|||
125126147|NCT01328093|450087310|FG000|Double-Blind Phase|Adverse Event|78|||
125126148|NCT01328093|450087311|FG001|Double-Blind Phase|Adverse Event|15|||
125126149|NCT01328093|450087310|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
125126150|NCT01328093|450087311|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
125126151|NCT01328093|450087310|FG000|Double-Blind Phase|Lost to Follow-up|39|||
124956877|NCT00296504|449467919|FG004|Interim Analysis|Insufficient CD4 Response|1|||
124956878|NCT00296504|449467920|FG005|Interim Analysis|Insufficient CD4 Response|1|||
125126152|NCT01328093|450087311|FG001|Double-Blind Phase|Lost to Follow-up|14|||
125126153|NCT01328093|450087310|FG000|Double-Blind Phase|Protocol Violation|30|||
125126154|NCT01328093|450087311|FG001|Double-Blind Phase|Protocol Violation|10|||
125126155|NCT01328093|450087310|FG000|Double-Blind Phase|Lack of Efficacy|55|||
125126156|NCT01328093|450087311|FG001|Double-Blind Phase|Lack of Efficacy|13|||
125126157|NCT01328093|450087310|FG000|Double-Blind Phase|Sponsor Decision|17|||
125126158|NCT01328093|450087311|FG001|Double-Blind Phase|Sponsor Decision|3|||
125126159|NCT01328093|450087310|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
125126160|NCT01328093|450087311|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
125126161|NCT01328093|450087310|FG000|Double-Blind Phase|Scheduling conflict|8|||
125126162|NCT01328093|450087311|FG001|Double-Blind Phase|Scheduling conflict|3|||
125126163|NCT01328093|450087310|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
125126164|NCT01328093|450087311|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
125126165|NCT01328093|450087310|FG000|Double-Blind Phase|Death|1|||
125126166|NCT01328093|450087311|FG001|Double-Blind Phase|Death|0|||
125126167|NCT01328093|450087310|FG000|Open-Label Phase|Sponsor Decision|98|||
125126168|NCT01328093|450087311|FG001|Open-Label Phase|Sponsor Decision|34|||
125126169|NCT01328093|450087310|FG000|Open-Label Phase|Protocol Violation|8|||
125126170|NCT01328093|450087311|FG001|Open-Label Phase|Protocol Violation|3|||
125126171|NCT01328093|450087310|FG000|Open-Label Phase|Lost to Follow-up|10|||
125126172|NCT01328093|450087311|FG001|Open-Label Phase|Lost to Follow-up|1|||
125126173|NCT01328093|450087310|FG000|Open-Label Phase|Adverse Event|10|||
125126174|NCT01328093|450087311|FG001|Open-Label Phase|Adverse Event|4|||
125126175|NCT01328093|450087310|FG000|Open-Label Phase|Lack of Efficacy|5|||
125126176|NCT01328093|450087311|FG001|Open-Label Phase|Lack of Efficacy|6|||
125126177|NCT01328093|450087310|FG000|Open-Label Phase|Withdrawal by Subject|4|||
125126178|NCT01328093|450087311|FG001|Open-Label Phase|Withdrawal by Subject|1|||
125126179|NCT01328093|450087310|FG000|Open-Label Phase|Scheduling conflict|2|||
125126180|NCT01328093|450087311|FG001|Open-Label Phase|Scheduling conflict|1|||
125126181|NCT01328093|450087310|FG000|Open-Label Phase|Subject is moving or has moved|2|||
124956879|NCT00296504|449467921|FG006|Interim Analysis|Insufficient CD4 Response|0|||
124956880|NCT00296504|449467922|FG007|Interim Analysis|Insufficient CD4 Response|0|||
124956881|NCT00296504|449467923|FG008|Interim Analysis|Insufficient CD4 Response|0|||
124956882|NCT00296504|449467915|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
124956883|NCT00296504|449467916|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
124956884|NCT00296504|449467917|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
124956885|NCT00296504|449467918|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
124956886|NCT00296504|449467919|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
124956887|NCT00296504|449467920|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
125126182|NCT01328093|450087311|FG001|Open-Label Phase|Subject is moving or has moved|0|||
125215400|NCT02070978|450415011|FG001|Overall Study|Withdrawal by Subject|5|||
124956888|NCT00296504|449467921|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
124956889|NCT00296504|449467922|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
124956890|NCT00296504|449467923|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
125126183|NCT01328093|450087310|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
125126184|NCT01328093|450087311|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
125126185|NCT05150964|450087314|FG000|Overall Study|Lost to Follow-up|2|||
124956891|NCT00296504|449467915|FG000|Interim Analysis|Pregnancy|4|||
125126186|NCT03661528|450087315|FG000|Overall Study|Death|1|||
125126187|NCT03661528|450087316|FG001|Overall Study|Death|0|||
125126188|NCT03661528|450087315|FG000|Overall Study|Physician Decision|3|||
125126189|NCT03661528|450087316|FG001|Overall Study|Physician Decision|1|||
125126190|NCT03661528|450087315|FG000|Overall Study|Other than Specified|5|||
125126191|NCT03661528|450087316|FG001|Overall Study|Other than Specified|2|||
125126192|NCT03661528|450087315|FG000|Overall Study|Withdrawal by Subject|5|||
125126193|NCT03661528|450087316|FG001|Overall Study|Withdrawal by Subject|3|||
124956892|NCT00296504|449467916|FG001|Interim Analysis|Pregnancy|1|||
124956893|NCT00296504|449467917|FG002|Interim Analysis|Pregnancy|4|||
124956894|NCT00296504|449467918|FG003|Interim Analysis|Pregnancy|2|||
124956895|NCT00296504|449467919|FG004|Interim Analysis|Pregnancy|0|||
124956896|NCT00296504|449467920|FG005|Interim Analysis|Pregnancy|1|||
124956897|NCT00296504|449467921|FG006|Interim Analysis|Pregnancy|1|||
124956898|NCT00296504|449467922|FG007|Interim Analysis|Pregnancy|1|||
124956899|NCT00296504|449467923|FG008|Interim Analysis|Pregnancy|0|||
124956900|NCT00296504|449467915|FG000|Interim Analysis|Death|1|||
124956901|NCT00296504|449467916|FG001|Interim Analysis|Death|0|||
124956902|NCT00296504|449467917|FG002|Interim Analysis|Death|3|||
124956903|NCT00296504|449467918|FG003|Interim Analysis|Death|0|||
124956904|NCT00296504|449467919|FG004|Interim Analysis|Death|0|||
124956905|NCT00296504|449467920|FG005|Interim Analysis|Death|0|||
124956906|NCT00296504|449467921|FG006|Interim Analysis|Death|0|||
124956907|NCT00296504|449467922|FG007|Interim Analysis|Death|0|||
125126194|NCT03661528|450087315|FG000|Overall Study|Disease Progression|8|||
125126195|NCT03661528|450087316|FG001|Overall Study|Disease Progression|13|||
125126196|NCT03661528|450087315|FG000|Overall Study|Adverse Event|61|||
125126197|NCT03661528|450087316|FG001|Overall Study|Adverse Event|55|||
125126198|NCT02178722|450087317|FG000|Overall Study|Withdrawal by Subject|0|||
125126199|NCT02178722|450087318|FG001|Overall Study|Withdrawal by Subject|0|||
125126200|NCT02178722|450087319|FG002|Overall Study|Withdrawal by Subject|0|||
125126201|NCT02178722|450087320|FG003|Overall Study|Withdrawal by Subject|2|||
125126202|NCT02178722|450087321|FG004|Overall Study|Withdrawal by Subject|33|||
125126203|NCT02178722|450087317|FG000|Overall Study|Death|2|||
125126204|NCT02178722|450087318|FG001|Overall Study|Death|13|||
125126205|NCT02178722|450087319|FG002|Overall Study|Death|12|||
125126206|NCT02178722|450087320|FG003|Overall Study|Death|12|||
125126207|NCT02178722|450087321|FG004|Overall Study|Death|205|||
125126208|NCT02178722|450087317|FG000|Overall Study|Lost to Follow-up|0|||
125126209|NCT02178722|450087318|FG001|Overall Study|Lost to Follow-up|0|||
125126210|NCT02178722|450087319|FG002|Overall Study|Lost to Follow-up|0|||
125126211|NCT02178722|450087320|FG003|Overall Study|Lost to Follow-up|2|||
125126212|NCT02178722|450087321|FG004|Overall Study|Lost to Follow-up|11|||
124956908|NCT00296504|449467923|FG008|Interim Analysis|Death|0|||
124956909|NCT00296504|449467915|FG000|Interim Analysis|Participant Non-compliant|0|||
124956910|NCT00296504|449467916|FG001|Interim Analysis|Participant Non-compliant|1|||
124956911|NCT00296504|449467917|FG002|Interim Analysis|Participant Non-compliant|2|||
124956912|NCT00296504|449467918|FG003|Interim Analysis|Participant Non-compliant|1|||
125126213|NCT02178722|450087317|FG000|Overall Study|Study terminated by Sponsor|2|||
125126214|NCT02178722|450087318|FG001|Overall Study|Study terminated by Sponsor|7|||
125126215|NCT02178722|450087319|FG002|Overall Study|Study terminated by Sponsor|6|||
125126216|NCT02178722|450087320|FG003|Overall Study|Study terminated by Sponsor|4|||
125126217|NCT02178722|450087321|FG004|Overall Study|Study terminated by Sponsor|128|||
125126218|NCT02178722|450087317|FG000|Overall Study|Physician Decision|0|||
125126219|NCT02178722|450087318|FG001|Overall Study|Physician Decision|0|||
125126220|NCT02178722|450087319|FG002|Overall Study|Physician Decision|0|||
125126221|NCT02178722|450087320|FG003|Overall Study|Physician Decision|0|||
125126222|NCT02178722|450087321|FG004|Overall Study|Physician Decision|3|||
125126223|NCT02178722|450087317|FG000|Overall Study|Other|0|||
125126224|NCT02178722|450087318|FG001|Overall Study|Other|0|||
125126225|NCT02178722|450087319|FG002|Overall Study|Other|0|||
125126226|NCT02178722|450087320|FG003|Overall Study|Other|0|||
125126227|NCT02178722|450087321|FG004|Overall Study|Other|2|||
125126228|NCT03553823|450087322|FG000|Overall Study|Physician Decision|0|||
125126229|NCT03553823|450087323|FG001|Overall Study|Physician Decision|1|||
125126230|NCT03340727|450087324|FG000|Overall Study|Death|1|||
125126231|NCT03340727|450087325|FG001|Overall Study|Death|0|||
125126232|NCT03340727|450087324|FG000|Overall Study|Lost to Follow-up|31|||
125126233|NCT03340727|450087325|FG001|Overall Study|Lost to Follow-up|35|||
125126234|NCT03340727|450087324|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
125126235|NCT03340727|450087325|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
125126236|NCT03340727|450087324|FG000|Overall Study|Transferred to another facility|10|||
125126237|NCT03340727|450087325|FG001|Overall Study|Transferred to another facility|7|||
125126238|NCT03340727|450087324|FG000|Overall Study|Withdrawal by Subject|28|||
125126239|NCT03340727|450087325|FG001|Overall Study|Withdrawal by Subject|17|||
125126240|NCT03991494|450087332|FG000|Overall Study|Progressive Disease|4|||
125126241|NCT01937390|450087336|FG000|Overall Study|Death|2|||
125126242|NCT01937390|450087336|FG000|Overall Study|Lost to Follow-up|7|||
125126243|NCT01937390|450087336|FG000|Overall Study|Withdrawal by Subject|5|||
125126244|NCT01937390|450087336|FG000|Overall Study|Fail to return|21|||
125126245|NCT01569152|450087339|FG000|Phase IIa, Period 1|Early Escape|5|||
125126246|NCT01569152|450087340|FG001|Phase IIa, Period 1|Early Escape|22|||
125126247|NCT01569152|450087341|FG002|Phase IIa, Period 1|Early Escape|0|||
125126248|NCT01569152|450087339|FG000|Phase IIa, Period 1|Adverse Event|4|||
125126249|NCT01569152|450087340|FG001|Phase IIa, Period 1|Adverse Event|0|||
125126250|NCT01569152|450087341|FG002|Phase IIa, Period 1|Adverse Event|0|||
125126251|NCT01569152|450087339|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
125126252|NCT01569152|450087340|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
125126253|NCT01569152|450087341|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
125126254|NCT01569152|450087339|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
125126255|NCT01569152|450087340|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
125126256|NCT01569152|450087341|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
125126257|NCT01569152|450087339|FG000|Phase IIa, Period 1|Protocol Violation|0|||
125126258|NCT01569152|450087340|FG001|Phase IIa, Period 1|Protocol Violation|1|||
125126259|NCT01569152|450087341|FG002|Phase IIa, Period 1|Protocol Violation|0|||
125126260|NCT01569152|450087339|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
125126261|NCT01569152|450087340|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
125126262|NCT01569152|450087341|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
125126263|NCT01569152|450087339|FG000|Safety Extension, Period 3|Adverse Event|0|||
125126264|NCT01569152|450087340|FG001|Safety Extension, Period 3|Adverse Event|0|||
125126265|NCT01569152|450087341|FG002|Safety Extension, Period 3|Adverse Event|4|||
125126266|NCT01569152|450087339|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
125215401|NCT02070978|450415012|FG002|Overall Study|Withdrawal by Subject|3|||
125215402|NCT02070978|450415010|FG000|Overall Study|Protocol Violation|1|||
125126267|NCT01569152|450087340|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
125126268|NCT01569152|450087341|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
125215403|NCT02070978|450415011|FG001|Overall Study|Protocol Violation|0|||
125215404|NCT02070978|450415012|FG002|Overall Study|Protocol Violation|3|||
125126269|NCT01569152|450087339|FG000|Safety Extension, Period 3|Physician Decision|0|||
125126270|NCT01569152|450087340|FG001|Safety Extension, Period 3|Physician Decision|0|||
125126271|NCT01569152|450087341|FG002|Safety Extension, Period 3|Physician Decision|2|||
125126272|NCT01569152|450087339|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
125126273|NCT01569152|450087340|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
125126274|NCT01569152|450087341|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
125215405|NCT02070978|450415010|FG000|Overall Study|Lack of Efficacy|0|||
125126275|NCT02920996|450087346|FG000|Overall Study|Adverse Event|8|||
125126276|NCT02920996|450087347|FG001|Overall Study|Adverse Event|0|||
125126277|NCT02920996|450087346|FG000|Overall Study|Physician Decision|1|||
125126278|NCT02920996|450087347|FG001|Overall Study|Physician Decision|0|||
125126279|NCT02920996|450087346|FG000|Overall Study|Death|1|||
125126280|NCT02920996|450087347|FG001|Overall Study|Death|0|||
125126281|NCT02920996|450087346|FG000|Overall Study|Missing|1|||
125126282|NCT02920996|450087347|FG001|Overall Study|Missing|0|||
125126283|NCT02920996|450087346|FG000|Overall Study|Subject Non-Compliance|1|||
125126284|NCT02920996|450087347|FG001|Overall Study|Subject Non-Compliance|0|||
125126285|NCT00154102|450087348|FG000|Overall Study|investigational study phase ongoing|7|||
125126286|NCT00154102|450087349|FG001|Overall Study|investigational study phase ongoing|2|||
125126287|NCT00463606|450087350|FG000|Overall Study|Adverse Event|21|||
124956913|NCT00296504|449467919|FG004|Interim Analysis|Participant Non-compliant|1|||
124956914|NCT00296504|449467920|FG005|Interim Analysis|Participant Non-compliant|3|||
124956915|NCT00296504|449467921|FG006|Interim Analysis|Participant Non-compliant|6|||
124956916|NCT00296504|449467922|FG007|Interim Analysis|Participant Non-compliant|2|||
124956917|NCT00296504|449467923|FG008|Interim Analysis|Participant Non-compliant|0|||
124956918|NCT00296504|449467915|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
125126288|NCT00463606|450087351|FG001|Overall Study|Adverse Event|18|||
125126289|NCT00463606|450087352|FG002|Overall Study|Adverse Event|11|||
125126290|NCT00463606|450087350|FG000|Overall Study|Withdrawal by Subject|11|||
125126291|NCT00463606|450087351|FG001|Overall Study|Withdrawal by Subject|11|||
125126292|NCT00463606|450087352|FG002|Overall Study|Withdrawal by Subject|5|||
125126293|NCT00463606|450087350|FG000|Overall Study|Lost to Follow-up|2|||
125126294|NCT00463606|450087351|FG001|Overall Study|Lost to Follow-up|2|||
125126295|NCT00463606|450087352|FG002|Overall Study|Lost to Follow-up|3|||
125126296|NCT00463606|450087350|FG000|Overall Study|Subject noncompliance|1|||
125126297|NCT00463606|450087351|FG001|Overall Study|Subject noncompliance|1|||
125126298|NCT00463606|450087352|FG002|Overall Study|Subject noncompliance|0|||
125126299|NCT00463606|450087350|FG000|Overall Study|Subject moved out of town|1|||
125126300|NCT00463606|450087351|FG001|Overall Study|Subject moved out of town|0|||
125126301|NCT00463606|450087352|FG002|Overall Study|Subject moved out of town|0|||
125126302|NCT00463606|450087350|FG000|Overall Study|Physician Decision|0|||
125126303|NCT00463606|450087351|FG001|Overall Study|Physician Decision|1|||
125126304|NCT00463606|450087352|FG002|Overall Study|Physician Decision|0|||
125126305|NCT00463606|450087350|FG000|Overall Study|Sponsor request|0|||
125126306|NCT00463606|450087351|FG001|Overall Study|Sponsor request|1|||
125126307|NCT00463606|450087352|FG002|Overall Study|Sponsor request|0|||
125126308|NCT00463606|450087350|FG000|Overall Study|Exclusion criteria violation|2|||
125126309|NCT00463606|450087351|FG001|Overall Study|Exclusion criteria violation|0|||
125126310|NCT00463606|450087352|FG002|Overall Study|Exclusion criteria violation|0|||
125126311|NCT00463606|450087350|FG000|Overall Study|Coordinator error|1|||
125126312|NCT00463606|450087351|FG001|Overall Study|Coordinator error|0|||
125126313|NCT00463606|450087352|FG002|Overall Study|Coordinator error|0|||
125126314|NCT00463606|450087350|FG000|Overall Study|Patient randomized in error|1|||
125126315|NCT00463606|450087351|FG001|Overall Study|Patient randomized in error|0|||
125126316|NCT00463606|450087352|FG002|Overall Study|Patient randomized in error|0|||
125126317|NCT00463606|450087350|FG000|Overall Study|Participation in another ABT-335 trial|1|||
125126318|NCT00463606|450087351|FG001|Overall Study|Participation in another ABT-335 trial|0|||
125126319|NCT00463606|450087352|FG002|Overall Study|Participation in another ABT-335 trial|0|||
125126320|NCT00463606|450087350|FG000|Overall Study|Protocol Violation|0|||
125126321|NCT00463606|450087351|FG001|Overall Study|Protocol Violation|0|||
125126322|NCT00463606|450087352|FG002|Overall Study|Protocol Violation|1|||
125126323|NCT02682602|450087354|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
125126324|NCT02682602|450087355|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
125126325|NCT02682602|450087354|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
125126326|NCT02682602|450087355|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
125126327|NCT01432171|450087359|FG000|Overall Study|Death|1|||
125126328|NCT01432171|450087360|FG001|Overall Study|Death|2|||
125126329|NCT01432171|450087359|FG000|Overall Study|Lost to Follow-up|6|||
125126330|NCT01432171|450087360|FG001|Overall Study|Lost to Follow-up|5|||
124956919|NCT00296504|449467916|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
124956920|NCT00296504|449467917|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
125126331|NCT01432171|450087359|FG000|Overall Study|Withdrawal by Subject|3|||
125126332|NCT01432171|450087360|FG001|Overall Study|Withdrawal by Subject|1|||
125126333|NCT01432171|450087359|FG000|Overall Study|Noncompliance|2|||
125126334|NCT01432171|450087360|FG001|Overall Study|Noncompliance|3|||
125126335|NCT01432171|450087359|FG000|Overall Study|Insurance denial trial coverage|1|||
125126336|NCT01432171|450087360|FG001|Overall Study|Insurance denial trial coverage|0|||
125126337|NCT01432171|450087359|FG000|Overall Study|Patient moved to palliative care|1|||
125126338|NCT01432171|450087360|FG001|Overall Study|Patient moved to palliative care|0|||
125126339|NCT00416520|450088579|FG000|Open-label Period|Adverse Event|28|||
125126340|NCT00416520|450088580|FG001|Open-label Period|Adverse Event|10|||
125126341|NCT00416520|450088581|FG002|Open-label Period|Adverse Event|0|||
125126342|NCT00416520|450088582|FG003|Open-label Period|Adverse Event|0|||
125126343|NCT00416520|450088579|FG000|Open-label Period|Death|2|||
125126344|NCT00416520|450088580|FG001|Open-label Period|Death|1|||
125126345|NCT00416520|450088581|FG002|Open-label Period|Death|0|||
125126346|NCT00416520|450088582|FG003|Open-label Period|Death|0|||
125126347|NCT00416520|450088579|FG000|Open-label Period|Lack of Efficacy|8|||
125126348|NCT00416520|450088580|FG001|Open-label Period|Lack of Efficacy|1|||
125126349|NCT00416520|450088581|FG002|Open-label Period|Lack of Efficacy|0|||
125126350|NCT00416520|450088582|FG003|Open-label Period|Lack of Efficacy|0|||
125126351|NCT00416520|450088579|FG000|Open-label Period|Protocol Violation|3|||
125126352|NCT00416520|450088580|FG001|Open-label Period|Protocol Violation|3|||
125126353|NCT00416520|450088581|FG002|Open-label Period|Protocol Violation|0|||
125126354|NCT00416520|450088582|FG003|Open-label Period|Protocol Violation|0|||
125126355|NCT00416520|450088579|FG000|Open-label Period|Withdrawal by Subject|16|||
125126356|NCT00416520|450088580|FG001|Open-label Period|Withdrawal by Subject|5|||
125126357|NCT00416520|450088581|FG002|Open-label Period|Withdrawal by Subject|0|||
125126358|NCT00416520|450088582|FG003|Open-label Period|Withdrawal by Subject|0|||
125126359|NCT00416520|450088579|FG000|Open-label Period|Other Reasons|3|||
125126360|NCT00416520|450088580|FG001|Open-label Period|Other Reasons|12|||
125126361|NCT00416520|450088581|FG002|Open-label Period|Other Reasons|0|||
125126362|NCT00416520|450088582|FG003|Open-label Period|Other Reasons|0|||
125126363|NCT00416520|450088579|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
125126364|NCT00416520|450088580|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
125126365|NCT00416520|450088581|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
125126366|NCT00416520|450088582|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
125126367|NCT00416520|450088579|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
125126368|NCT00416520|450088580|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
125126369|NCT00416520|450088581|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
125126370|NCT00416520|450088582|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
125126371|NCT00416520|450088579|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
125126372|NCT00416520|450088580|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
125126373|NCT00416520|450088581|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
125126374|NCT00416520|450088582|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
125126375|NCT04015232|450088593|FG000|Overall Study|Withdrawal by Subject|7|||
125126376|NCT04015232|450088594|FG001|Overall Study|Withdrawal by Subject|4|||
125126377|NCT04015232|450088593|FG000|Overall Study|Protocol Violation|1|||
125126378|NCT04015232|450088594|FG001|Overall Study|Protocol Violation|0|||
125126379|NCT04015232|450088593|FG000|Overall Study|Medical Grounds|3|||
125126380|NCT04015232|450088594|FG001|Overall Study|Medical Grounds|3|||
125126381|NCT02152566|450088595|FG000|Overall Study|Lost to Follow-up|1|||
125126382|NCT02152566|450088595|FG000|Overall Study|Withdrawal by Subject|2|||
125126383|NCT02334722|450088600|FG000|Overall Study|Lost to Follow-up|4|||
125126384|NCT02334722|450088601|FG001|Overall Study|Lost to Follow-up|0|||
125126385|NCT02334722|450088600|FG000|Overall Study|6 week questionnaire not completed|2|||
125126386|NCT02334722|450088601|FG001|Overall Study|6 week questionnaire not completed|0|||
125126387|NCT02334722|450088600|FG000|Overall Study|Unable to obtain medication|1|||
125126388|NCT02334722|450088601|FG001|Overall Study|Unable to obtain medication|1|||
125126389|NCT02334722|450088600|FG000|Overall Study|Withdrawal by Subject|0|||
125126390|NCT02334722|450088601|FG001|Overall Study|Withdrawal by Subject|3|||
125126391|NCT02334722|450088600|FG000|Overall Study|Adverse Event|0|||
125126392|NCT02334722|450088601|FG001|Overall Study|Adverse Event|2|||
125126393|NCT02334722|450088600|FG000|Overall Study|Physician Decision|0|||
125126394|NCT02334722|450088601|FG001|Overall Study|Physician Decision|1|||
125126395|NCT00856388|450088602|FG000|Overall Study|Other|1|||
125126396|NCT01617668|450088605|FG000|Overall Study|Adverse Event|7|||
125126397|NCT01617668|450088606|FG001|Overall Study|Adverse Event|0|||
125126398|NCT01617668|450088607|FG002|Overall Study|Adverse Event|12|||
125126399|NCT01617668|450088608|FG003|Overall Study|Adverse Event|5|||
125126400|NCT01617668|450088605|FG000|Overall Study|Physician Decision|1|||
125126401|NCT01617668|450088606|FG001|Overall Study|Physician Decision|2|||
125126402|NCT01617668|450088607|FG002|Overall Study|Physician Decision|3|||
125126403|NCT01617668|450088608|FG003|Overall Study|Physician Decision|0|||
125126404|NCT01617668|450088605|FG000|Overall Study|Progressive Disease|4|||
125126405|NCT01617668|450088606|FG001|Overall Study|Progressive Disease|4|||
125126406|NCT01617668|450088607|FG002|Overall Study|Progressive Disease|6|||
124956921|NCT00296504|449467918|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
124956922|NCT00296504|449467919|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
124956923|NCT00296504|449467920|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
125126407|NCT01617668|450088608|FG003|Overall Study|Progressive Disease|9|||
125126408|NCT01617668|450088605|FG000|Overall Study|Subject/guardian decision|1|||
125126409|NCT01617668|450088606|FG001|Overall Study|Subject/guardian decision|3|||
125126410|NCT01617668|450088607|FG002|Overall Study|Subject/guardian decision|2|||
125126411|NCT01617668|450088608|FG003|Overall Study|Subject/guardian decision|1|||
125126412|NCT02017964|450088609|FG000|Overall Study|Patient deemed ineligible|1|||
125126413|NCT00925769|450088610|FG000|Overall Study|Major toxicity|1|||
125126414|NCT00925769|450088611|FG001|Overall Study|Major toxicity|0|||
125126415|NCT00925769|450088612|FG002|Overall Study|Major toxicity|1|||
125126416|NCT00925769|450088613|FG003|Overall Study|Major toxicity|1|||
125126417|NCT00925769|450088614|FG004|Overall Study|Major toxicity|0|||
125126418|NCT00925769|450088615|FG005|Overall Study|Major toxicity|0|||
125126419|NCT00925769|450088610|FG000|Overall Study|Disease progression|4|||
125126420|NCT00925769|450088611|FG001|Overall Study|Disease progression|5|||
125126421|NCT00925769|450088612|FG002|Overall Study|Disease progression|3|||
125215406|NCT02070978|450415011|FG001|Overall Study|Lack of Efficacy|1|||
125215407|NCT02070978|450415012|FG002|Overall Study|Lack of Efficacy|0|||
125215408|NCT02070978|450415010|FG000|Overall Study|Death|0|||
125215409|NCT02070978|450415011|FG001|Overall Study|Death|0|||
125215410|NCT02070978|450415012|FG002|Overall Study|Death|2|||
125215411|NCT02070978|450415010|FG000|Overall Study|Un-specified|3|||
125215412|NCT02070978|450415011|FG001|Overall Study|Un-specified|2|||
125215413|NCT02070978|450415012|FG002|Overall Study|Un-specified|2|||
125215414|NCT02070978|450415010|FG000|Overall Study|Terminated by Sponsor|33|||
125215415|NCT02070978|450415011|FG001|Overall Study|Terminated by Sponsor|40|||
125215416|NCT02070978|450415012|FG002|Overall Study|Terminated by Sponsor|39|||
125215417|NCT03749109|450415013|FG000|Overall Study|Adverse Event|2|||
125215418|NCT03749109|450415014|FG001|Overall Study|Adverse Event|0|||
125215419|NCT03178851|450415015|FG000|Overall Study|Death|48|||
125215420|NCT03178851|450415016|FG001|Overall Study|Death|2|||
125215421|NCT03178851|450415017|FG002|Overall Study|Death|25|||
125215422|NCT03178851|450415015|FG000|Overall Study|Withdrawal by Subject|8|||
125215423|NCT03178851|450415016|FG001|Overall Study|Withdrawal by Subject|0|||
125215424|NCT03178851|450415017|FG002|Overall Study|Withdrawal by Subject|0|||
125215425|NCT03178851|450415015|FG000|Overall Study|Lost to Follow-up|5|||
125215426|NCT03178851|450415016|FG001|Overall Study|Lost to Follow-up|2|||
125215427|NCT03178851|450415017|FG002|Overall Study|Lost to Follow-up|0|||
125215428|NCT03178851|450415015|FG000|Overall Study|Adverse Event|0|||
125215429|NCT03178851|450415016|FG001|Overall Study|Adverse Event|0|||
125215430|NCT03178851|450415017|FG002|Overall Study|Adverse Event|1|||
125215431|NCT03178851|450415015|FG000|Overall Study|Study Termination by Sponsor|31|||
125215432|NCT03178851|450415016|FG001|Overall Study|Study Termination by Sponsor|7|||
125215433|NCT03178851|450415017|FG002|Overall Study|Study Termination by Sponsor|26|||
125215434|NCT03951753|450415018|FG000|Overall Study|Adverse Event|1|||
125215435|NCT03951753|450415019|FG001|Overall Study|Adverse Event|0|||
125126422|NCT00925769|450088613|FG003|Overall Study|Disease progression|4|||
124956924|NCT00296504|449467921|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
124956925|NCT00296504|449467922|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
124956926|NCT00296504|449467923|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
124956927|NCT00296504|449467915|FG000|Interim Analysis|To Simplify Treatment|0|||
124956928|NCT00296504|449467916|FG001|Interim Analysis|To Simplify Treatment|0|||
124956929|NCT00296504|449467917|FG002|Interim Analysis|To Simplify Treatment|1|||
124956930|NCT00296504|449467918|FG003|Interim Analysis|To Simplify Treatment|0|||
124956931|NCT00296504|449467919|FG004|Interim Analysis|To Simplify Treatment|0|||
124956932|NCT00296504|449467920|FG005|Interim Analysis|To Simplify Treatment|0|||
125126423|NCT00925769|450088614|FG004|Overall Study|Disease progression|2|||
125126424|NCT00925769|450088615|FG005|Overall Study|Disease progression|3|||
125126425|NCT00925769|450088610|FG000|Overall Study|Death|0|||
125126426|NCT00925769|450088611|FG001|Overall Study|Death|0|||
125126427|NCT00925769|450088612|FG002|Overall Study|Death|1|||
125126428|NCT00925769|450088613|FG003|Overall Study|Death|0|||
124956933|NCT00296504|449467921|FG006|Interim Analysis|To Simplify Treatment|2|||
124956934|NCT00296504|449467922|FG007|Interim Analysis|To Simplify Treatment|0|||
124956935|NCT00296504|449467923|FG008|Interim Analysis|To Simplify Treatment|0|||
124956936|NCT00296504|449467915|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
124956937|NCT00296504|449467916|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
124956938|NCT00296504|449467917|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
125126429|NCT00925769|450088614|FG004|Overall Study|Death|0|||
125126430|NCT00925769|450088615|FG005|Overall Study|Death|0|||
125126431|NCT00925769|450088610|FG000|Overall Study|Physician Decision|1|||
125126432|NCT00925769|450088611|FG001|Overall Study|Physician Decision|0|||
125126433|NCT00925769|450088612|FG002|Overall Study|Physician Decision|0|||
125126434|NCT00925769|450088613|FG003|Overall Study|Physician Decision|0|||
125126435|NCT00925769|450088614|FG004|Overall Study|Physician Decision|0|||
125215436|NCT03951753|450415020|FG002|Overall Study|Adverse Event|3|||
125215437|NCT03951753|450415018|FG000|Overall Study|Withdrawal by Subject|3|||
125215438|NCT03951753|450415019|FG001|Overall Study|Withdrawal by Subject|1|||
124956939|NCT00296504|449467918|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
124956940|NCT00296504|449467919|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
124956941|NCT00296504|449467920|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
125126436|NCT00925769|450088615|FG005|Overall Study|Physician Decision|0|||
125215439|NCT03951753|450415020|FG002|Overall Study|Withdrawal by Subject|0|||
125126437|NCT00925769|450088610|FG000|Overall Study|Missing documentation|0|||
125126438|NCT00925769|450088611|FG001|Overall Study|Missing documentation|1|||
125126439|NCT00925769|450088612|FG002|Overall Study|Missing documentation|0|||
125126440|NCT00925769|450088613|FG003|Overall Study|Missing documentation|0|||
125126441|NCT00925769|450088614|FG004|Overall Study|Missing documentation|0|||
125126442|NCT00925769|450088615|FG005|Overall Study|Missing documentation|0|||
125126443|NCT00925769|450088610|FG000|Overall Study|End of study visit not done|0|||
125126444|NCT00925769|450088611|FG001|Overall Study|End of study visit not done|0|||
125126445|NCT00925769|450088612|FG002|Overall Study|End of study visit not done|1|||
125126446|NCT00925769|450088613|FG003|Overall Study|End of study visit not done|0|||
125126447|NCT00925769|450088614|FG004|Overall Study|End of study visit not done|0|||
125126448|NCT00925769|450088615|FG005|Overall Study|End of study visit not done|0|||
125126449|NCT00925769|450088610|FG000|Overall Study|Participant is unable to swallow drug|0|||
125126450|NCT00925769|450088611|FG001|Overall Study|Participant is unable to swallow drug|0|||
125126451|NCT00925769|450088612|FG002|Overall Study|Participant is unable to swallow drug|0|||
125126452|NCT00925769|450088613|FG003|Overall Study|Participant is unable to swallow drug|1|||
125126453|NCT00925769|450088614|FG004|Overall Study|Participant is unable to swallow drug|0|||
125126454|NCT00925769|450088615|FG005|Overall Study|Participant is unable to swallow drug|0|||
125126455|NCT00925769|450088610|FG000|Overall Study|Adverse Event|0|||
125126456|NCT00925769|450088611|FG001|Overall Study|Adverse Event|0|||
125126457|NCT00925769|450088612|FG002|Overall Study|Adverse Event|0|||
125126458|NCT00925769|450088613|FG003|Overall Study|Adverse Event|0|||
125126459|NCT00925769|450088614|FG004|Overall Study|Adverse Event|1|||
125126460|NCT00925769|450088615|FG005|Overall Study|Adverse Event|0|||
125126461|NCT00686959|450088617|FG000|Overall Study|Participants censored (no death events)|124|||
125126462|NCT00686959|450088618|FG001|Overall Study|Participants censored (no death events)|117|||
125126463|NCT00150462|450088619|FG000|Overall Study|Disease Progression or Relapse|3|||
125126464|NCT00150462|450088620|FG001|Overall Study|Disease Progression or Relapse|1|||
125126465|NCT00150462|450088621|FG002|Overall Study|Disease Progression or Relapse|2|||
125126466|NCT00150462|450088622|FG003|Overall Study|Disease Progression or Relapse|1|||
125126467|NCT00150462|450088623|FG004|Overall Study|Disease Progression or Relapse|2|||
125126468|NCT00150462|450088624|FG005|Overall Study|Disease Progression or Relapse|2|||
125126469|NCT00150462|450088625|FG006|Overall Study|Disease Progression or Relapse|3|||
125126470|NCT00150462|450088626|FG007|Overall Study|Disease Progression or Relapse|5|||
125126471|NCT00150462|450088627|FG008|Overall Study|Disease Progression or Relapse|5|||
125126472|NCT00150462|450088628|FG009|Overall Study|Disease Progression or Relapse|3|||
125126473|NCT00150462|450088629|FG010|Overall Study|Disease Progression or Relapse|2|||
125126474|NCT00150462|450088619|FG000|Overall Study|Withdrawal by Subject|0|||
125126475|NCT00150462|450088620|FG001|Overall Study|Withdrawal by Subject|1|||
125126476|NCT00150462|450088621|FG002|Overall Study|Withdrawal by Subject|1|||
125126477|NCT00150462|450088622|FG003|Overall Study|Withdrawal by Subject|0|||
125126478|NCT00150462|450088623|FG004|Overall Study|Withdrawal by Subject|1|||
125126479|NCT00150462|450088624|FG005|Overall Study|Withdrawal by Subject|2|||
125126480|NCT00150462|450088625|FG006|Overall Study|Withdrawal by Subject|0|||
125126481|NCT00150462|450088626|FG007|Overall Study|Withdrawal by Subject|1|||
125126482|NCT00150462|450088627|FG008|Overall Study|Withdrawal by Subject|0|||
125126483|NCT00150462|450088628|FG009|Overall Study|Withdrawal by Subject|1|||
125126484|NCT00150462|450088629|FG010|Overall Study|Withdrawal by Subject|0|||
125126485|NCT00150462|450088619|FG000|Overall Study|Death|0|||
125126486|NCT00150462|450088620|FG001|Overall Study|Death|1|||
125126487|NCT00150462|450088621|FG002|Overall Study|Death|0|||
125126488|NCT00150462|450088622|FG003|Overall Study|Death|0|||
125126489|NCT00150462|450088623|FG004|Overall Study|Death|0|||
125126490|NCT00150462|450088624|FG005|Overall Study|Death|0|||
125126491|NCT00150462|450088625|FG006|Overall Study|Death|0|||
125126492|NCT00150462|450088626|FG007|Overall Study|Death|0|||
125126493|NCT00150462|450088627|FG008|Overall Study|Death|1|||
125126494|NCT00150462|450088628|FG009|Overall Study|Death|0|||
125126495|NCT00150462|450088629|FG010|Overall Study|Death|0|||
125126496|NCT00150462|450088619|FG000|Overall Study|Adverse Event|0|||
125126497|NCT00150462|450088620|FG001|Overall Study|Adverse Event|0|||
125126498|NCT00150462|450088621|FG002|Overall Study|Adverse Event|0|||
125126499|NCT00150462|450088622|FG003|Overall Study|Adverse Event|1|||
125126500|NCT00150462|450088623|FG004|Overall Study|Adverse Event|0|||
125126501|NCT00150462|450088624|FG005|Overall Study|Adverse Event|0|||
125126502|NCT00150462|450088625|FG006|Overall Study|Adverse Event|0|||
125126503|NCT00150462|450088626|FG007|Overall Study|Adverse Event|2|||
125126504|NCT00150462|450088627|FG008|Overall Study|Adverse Event|0|||
125126505|NCT00150462|450088628|FG009|Overall Study|Adverse Event|1|||
125126506|NCT00150462|450088629|FG010|Overall Study|Adverse Event|0|||
125126507|NCT00150462|450088619|FG000|Overall Study|Physician Decision|0|||
125126508|NCT00150462|450088620|FG001|Overall Study|Physician Decision|0|||
125126509|NCT00150462|450088621|FG002|Overall Study|Physician Decision|1|||
125126510|NCT00150462|450088622|FG003|Overall Study|Physician Decision|1|||
125126511|NCT00150462|450088623|FG004|Overall Study|Physician Decision|0|||
125126512|NCT00150462|450088624|FG005|Overall Study|Physician Decision|0|||
125126513|NCT00150462|450088625|FG006|Overall Study|Physician Decision|0|||
125126514|NCT00150462|450088626|FG007|Overall Study|Physician Decision|0|||
125126515|NCT00150462|450088627|FG008|Overall Study|Physician Decision|0|||
125126516|NCT00150462|450088628|FG009|Overall Study|Physician Decision|0|||
125126517|NCT00150462|450088629|FG010|Overall Study|Physician Decision|0|||
125126518|NCT00150462|450088619|FG000|Overall Study|Other|0|||
125126519|NCT00150462|450088620|FG001|Overall Study|Other|0|||
125126520|NCT00150462|450088621|FG002|Overall Study|Other|0|||
125126521|NCT00150462|450088622|FG003|Overall Study|Other|0|||
125126522|NCT00150462|450088623|FG004|Overall Study|Other|0|||
125126523|NCT00150462|450088624|FG005|Overall Study|Other|0|||
125126524|NCT00150462|450088625|FG006|Overall Study|Other|0|||
125126525|NCT00150462|450088626|FG007|Overall Study|Other|0|||
125030862|NCT01375764|449735068|FG001|Overall Study|Other|0|||
125030863|NCT01375764|449735069|FG002|Overall Study|Other|0|||
125030864|NCT01375764|449735070|FG003|Overall Study|Other|1|||
125030865|NCT01375764|449735071|FG004|Overall Study|Other|0|||
125030866|NCT03595280|449735072|FG000|Overall Study|Lost to Follow-up|6|||
125030867|NCT03595280|449735073|FG001|Overall Study|Lost to Follow-up|9|||
125030868|NCT03595280|449735074|FG002|Overall Study|Lost to Follow-up|15|||
125030869|NCT02658812|449735075|FG000|Overall Study|Disease Progression|7|||
125030870|NCT02658812|449735075|FG000|Overall Study|Unrelated to study treatment|1|||
125030871|NCT02658812|449735075|FG000|Overall Study|Adverse Event|1|||
125030872|NCT01512264|449735076|FG000|Overall Study|Lost to Follow-up|0|||
125030873|NCT01512264|449735077|FG001|Overall Study|Lost to Follow-up|0|||
125030874|NCT01512264|449735078|FG002|Overall Study|Lost to Follow-up|0|||
125030875|NCT01512264|449735079|FG003|Overall Study|Lost to Follow-up|1|||
125030876|NCT01194440|449735080|FG000|Baseline (First Dose)|Reason not specified|4|||
125030877|NCT01194440|449735080|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
125030878|NCT01194440|449735080|FG000|Baseline (First Dose)|Change in therapy|1|||
125030879|NCT01194440|449735080|FG000|Baseline (First Dose)|Adverse Event|1|||
125030880|NCT01194440|449735080|FG000|6-months (2nd Dose)|Change in therapy|4|||
125030881|NCT00584870|449735081|FG000|Overall Study|Adverse Event|4|||
125126526|NCT00150462|450088627|FG008|Overall Study|Other|0|||
125126527|NCT00150462|450088628|FG009|Overall Study|Other|1|||
125126528|NCT00150462|450088629|FG010|Overall Study|Other|1|||
125126529|NCT01196052|450088632|FG000|Overall Study|Adverse Event|9|||
125126530|NCT01196052|450088632|FG000|Overall Study|Lost to Follow-up|1|||
125126531|NCT01196052|450088632|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
125126532|NCT01196052|450088632|FG000|Overall Study|Reason not Specified|5|||
125126533|NCT01196052|450088632|FG000|Overall Study|Withdrawal by Subject|6|||
125126534|NCT01572948|450088633|FG000|Overall Study|Lost to Follow-up|1|||
125126535|NCT01572948|450088634|FG001|Overall Study|Lost to Follow-up|0|||
125126536|NCT01572948|450088633|FG000|Overall Study|unable to contact|0|||
125126537|NCT01572948|450088634|FG001|Overall Study|unable to contact|1|||
125126538|NCT03603314|450088635|FG000|Overall Study|Lost to Follow-up|0|||
125126539|NCT03603314|450088636|FG001|Overall Study|Lost to Follow-up|3|||
125126540|NCT03603314|450088637|FG002|Overall Study|Lost to Follow-up|0|||
125126541|NCT03603314|450088635|FG000|Overall Study|Protocol Violation|0|||
125126542|NCT03603314|450088636|FG001|Overall Study|Protocol Violation|1|||
125126543|NCT03603314|450088637|FG002|Overall Study|Protocol Violation|0|||
125126544|NCT03603314|450088635|FG000|Overall Study|Adverse Event|2|||
125126545|NCT03603314|450088636|FG001|Overall Study|Adverse Event|0|||
125126546|NCT03603314|450088637|FG002|Overall Study|Adverse Event|0|||
125126547|NCT03603314|450088635|FG000|Overall Study|Physician Decision|1|||
125126548|NCT03603314|450088636|FG001|Overall Study|Physician Decision|1|||
125126549|NCT03603314|450088637|FG002|Overall Study|Physician Decision|0|||
125126550|NCT03603314|450088635|FG000|Overall Study|Withdrawal by Subject|4|||
125126551|NCT03603314|450088636|FG001|Overall Study|Withdrawal by Subject|5|||
125126552|NCT03603314|450088637|FG002|Overall Study|Withdrawal by Subject|3|||
125126553|NCT03603314|450088635|FG000|Overall Study|Other|0|||
125126554|NCT03603314|450088636|FG001|Overall Study|Other|1|||
125126555|NCT03603314|450088637|FG002|Overall Study|Other|0|||
125126556|NCT03450070|450088638|FG000|Overall Study|Withdrawal by Subject|8|||
125126557|NCT01720264|450088641|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
125126558|NCT01720264|450088641|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
125126559|NCT01720264|450088641|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
125126560|NCT00877032|450088642|FG000|Overall Study|Did not meet entrance criteria|0|||
125126561|NCT00877032|450088643|FG001|Overall Study|Did not meet entrance criteria|0|||
125126562|NCT00877032|450088644|FG002|Overall Study|Did not meet entrance criteria|0|||
125126563|NCT00877032|450088645|FG003|Overall Study|Did not meet entrance criteria|1|||
125126564|NCT00877032|450088646|FG004|Overall Study|Did not meet entrance criteria|0|||
125126565|NCT00877032|450088647|FG005|Overall Study|Did not meet entrance criteria|0|||
125030882|NCT00584870|449735082|FG001|Overall Study|Adverse Event|3|||
125030883|NCT00584870|449735083|FG002|Overall Study|Adverse Event|2|||
125126566|NCT00877032|450088648|FG006|Overall Study|Did not meet entrance criteria|2|||
125126567|NCT00615069|450088658|FG000|Overall Study|Death|10|||
125030884|NCT00584870|449735081|FG000|Overall Study|Lost to Follow-up|4|||
125030885|NCT00584870|449735082|FG001|Overall Study|Lost to Follow-up|1|||
125126568|NCT00615069|450088658|FG000|Overall Study|Physician Decision|2|||
125126569|NCT00615069|450088658|FG000|Overall Study|Withdrawal by Subject|4|||
125126570|NCT00669942|450088659|FG000|Parts 2 and 3|Adverse Event|0|||
125126571|NCT00669942|450088660|FG001|Parts 2 and 3|Adverse Event|0|||
125126572|NCT00669942|450088661|FG002|Parts 2 and 3|Adverse Event|0|||
125126573|NCT00669942|450088662|FG003|Parts 2 and 3|Adverse Event|0|||
125126574|NCT00669942|450088663|FG004|Parts 2 and 3|Adverse Event|0|||
125126575|NCT00669942|450088664|FG005|Parts 2 and 3|Adverse Event|0|||
125126576|NCT00669942|450088665|FG006|Parts 2 and 3|Adverse Event|0|||
125126577|NCT00669942|450088666|FG007|Parts 2 and 3|Adverse Event|2|||
124956942|NCT00296504|449467921|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
124956943|NCT00296504|449467922|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
124956944|NCT00296504|449467923|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
124956945|NCT00296504|449467915|FG000|Interim Analysis|Participant Moved|1|||
124956946|NCT00296504|449467916|FG001|Interim Analysis|Participant Moved|0|||
124956947|NCT00296504|449467917|FG002|Interim Analysis|Participant Moved|1|||
124956948|NCT00296504|449467918|FG003|Interim Analysis|Participant Moved|0|||
124956949|NCT00296504|449467919|FG004|Interim Analysis|Participant Moved|0|||
124956950|NCT00296504|449467920|FG005|Interim Analysis|Participant Moved|1|||
124956951|NCT00296504|449467921|FG006|Interim Analysis|Participant Moved|1|||
124956952|NCT00296504|449467922|FG007|Interim Analysis|Participant Moved|0|||
124956953|NCT00296504|449467923|FG008|Interim Analysis|Participant Moved|0|||
124956954|NCT00296504|449467915|FG000|Interim Analysis|Participant Was Incarcerated|2|||
124956955|NCT00296504|449467916|FG001|Interim Analysis|Participant Was Incarcerated|0|||
124956956|NCT00296504|449467917|FG002|Interim Analysis|Participant Was Incarcerated|1|||
124956957|NCT00296504|449467918|FG003|Interim Analysis|Participant Was Incarcerated|0|||
124956958|NCT00296504|449467919|FG004|Interim Analysis|Participant Was Incarcerated|0|||
124956959|NCT00296504|449467920|FG005|Interim Analysis|Participant Was Incarcerated|0|||
124956960|NCT00296504|449467921|FG006|Interim Analysis|Participant Was Incarcerated|0|||
124956961|NCT00296504|449467922|FG007|Interim Analysis|Participant Was Incarcerated|0|||
124956962|NCT00296504|449467923|FG008|Interim Analysis|Participant Was Incarcerated|0|||
124956963|NCT00296504|449467915|FG000|Interim Analysis|Resistance to FPV|0|||
124956964|NCT00296504|449467916|FG001|Interim Analysis|Resistance to FPV|0|||
124956965|NCT00296504|449467917|FG002|Interim Analysis|Resistance to FPV|1|||
125126578|NCT00669942|450088667|FG008|Parts 2 and 3|Adverse Event|1|||
125126579|NCT00669942|450088668|FG009|Parts 2 and 3|Adverse Event|0|||
125126580|NCT00669942|450088669|FG010|Parts 2 and 3|Adverse Event|0|||
125126581|NCT00669942|450088670|FG011|Parts 2 and 3|Adverse Event|0|||
125126582|NCT00669942|450088659|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
125126583|NCT00669942|450088660|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
125126584|NCT00669942|450088661|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
125126585|NCT00669942|450088662|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
125126586|NCT00669942|450088663|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
125126587|NCT00669942|450088664|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
125126588|NCT00669942|450088665|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
125126589|NCT00669942|450088666|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
125126590|NCT00669942|450088667|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
125126591|NCT00669942|450088668|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
125126592|NCT00669942|450088669|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
125126593|NCT00669942|450088670|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
125126594|NCT00669942|450088659|FG000|Parts 2 and 3|Protocol Violation|0|||
125126595|NCT00669942|450088660|FG001|Parts 2 and 3|Protocol Violation|0|||
125126596|NCT00669942|450088661|FG002|Parts 2 and 3|Protocol Violation|0|||
125126597|NCT00669942|450088662|FG003|Parts 2 and 3|Protocol Violation|0|||
125126598|NCT00669942|450088663|FG004|Parts 2 and 3|Protocol Violation|0|||
125126599|NCT00669942|450088664|FG005|Parts 2 and 3|Protocol Violation|1|||
125126600|NCT00669942|450088665|FG006|Parts 2 and 3|Protocol Violation|0|||
125126601|NCT00669942|450088666|FG007|Parts 2 and 3|Protocol Violation|0|||
125126602|NCT00669942|450088667|FG008|Parts 2 and 3|Protocol Violation|0|||
125126603|NCT00669942|450088668|FG009|Parts 2 and 3|Protocol Violation|0|||
125126604|NCT00669942|450088669|FG010|Parts 2 and 3|Protocol Violation|0|||
125126605|NCT00669942|450088670|FG011|Parts 2 and 3|Protocol Violation|0|||
125126606|NCT00259012|450088673|FG000|Overall Study|Adverse Event|0|||
124956966|NCT00296504|449467918|FG003|Interim Analysis|Resistance to FPV|0|||
124956967|NCT00296504|449467919|FG004|Interim Analysis|Resistance to FPV|0|||
124956968|NCT00296504|449467920|FG005|Interim Analysis|Resistance to FPV|0|||
124956969|NCT00296504|449467921|FG006|Interim Analysis|Resistance to FPV|0|||
124956970|NCT00296504|449467922|FG007|Interim Analysis|Resistance to FPV|0|||
124956971|NCT00296504|449467923|FG008|Interim Analysis|Resistance to FPV|0|||
124956972|NCT00296504|449467915|FG000|Interim Analysis|Physician Decision|0|||
125126607|NCT00259012|450088674|FG001|Overall Study|Adverse Event|1|||
125126608|NCT00259012|450088673|FG000|Overall Study|Withdrawal by Subject|1|||
125126609|NCT00259012|450088674|FG001|Overall Study|Withdrawal by Subject|0|||
125126610|NCT00259012|450088673|FG000|Overall Study|Physician Decision|0|||
125126611|NCT00259012|450088674|FG001|Overall Study|Physician Decision|1|||
125126612|NCT00259012|450088673|FG000|Overall Study|Lost to Follow-up|0|||
125126613|NCT00259012|450088674|FG001|Overall Study|Lost to Follow-up|1|||
125126614|NCT00259012|450088673|FG000|Overall Study|Protocol Violation|1|||
125126615|NCT00259012|450088674|FG001|Overall Study|Protocol Violation|1|||
125126616|NCT01496183|450088681|FG000|Overall Study|Physician Decision|3|||
125126617|NCT01496183|450088682|FG001|Overall Study|Physician Decision|1|||
125126618|NCT01496183|450088681|FG000|Overall Study|Withdrawal by Subject|0|||
125126619|NCT01496183|450088682|FG001|Overall Study|Withdrawal by Subject|1|||
125126620|NCT03002077|450088683|FG000|Overall Study|Non-compliance with Study Drug|4|||
125126621|NCT03002077|450088683|FG000|Overall Study|Non-compliance w/Background ADT|1|||
125126622|NCT03002077|450088683|FG000|Overall Study|Study Terminated by Sponsor|257|||
125126623|NCT03002077|450088683|FG000|Overall Study|Site Terminated by Sponsor|5|||
125126624|NCT03002077|450088683|FG000|Overall Study|Miscellaneous Reasons|10|||
125126625|NCT03002077|450088683|FG000|Overall Study|Adverse Event|23|||
125126626|NCT03002077|450088683|FG000|Overall Study|Lack of Efficacy|20|||
125126627|NCT03002077|450088683|FG000|Overall Study|Withdrawal by Subject|72|||
125126628|NCT03002077|450088683|FG000|Overall Study|Lost to Follow-up|21|||
125126629|NCT03002077|450088683|FG000|Overall Study|Pregnancy|4|||
125126630|NCT03002077|450088683|FG000|Overall Study|Protocol Violation|21|||
125126631|NCT04625114|450088686|FG000|Overall Study|Adverse Event|3|||
125126632|NCT04625114|450088687|FG001|Overall Study|Adverse Event|1|||
125126633|NCT04625114|450088686|FG000|Overall Study|Withdrawal by Subject|2|||
125126634|NCT04625114|450088687|FG001|Overall Study|Withdrawal by Subject|0|||
125126635|NCT00336479|450088698|FG000|Overall Study|Adverse Event|8|||
125126636|NCT00336479|450088699|FG001|Overall Study|Adverse Event|11|||
125126637|NCT00336479|450088700|FG002|Overall Study|Adverse Event|18|||
125126638|NCT00336479|450088701|FG003|Overall Study|Adverse Event|4|||
125126639|NCT00336479|450088698|FG000|Overall Study|Noncompliant|1|||
125126640|NCT00336479|450088699|FG001|Overall Study|Noncompliant|7|||
125126641|NCT00336479|450088700|FG002|Overall Study|Noncompliant|3|||
125126642|NCT00336479|450088701|FG003|Overall Study|Noncompliant|0|||
125126643|NCT00336479|450088698|FG000|Overall Study|Physician Decision|2|||
125126644|NCT00336479|450088699|FG001|Overall Study|Physician Decision|3|||
125126645|NCT00336479|450088700|FG002|Overall Study|Physician Decision|1|||
125126646|NCT00336479|450088701|FG003|Overall Study|Physician Decision|0|||
125126647|NCT00336479|450088698|FG000|Overall Study|Lost to Follow-up|3|||
125126648|NCT00336479|450088699|FG001|Overall Study|Lost to Follow-up|2|||
125126649|NCT00336479|450088700|FG002|Overall Study|Lost to Follow-up|0|||
125126650|NCT00336479|450088701|FG003|Overall Study|Lost to Follow-up|0|||
125126651|NCT00336479|450088698|FG000|Overall Study|Withdrawal by Subject|3|||
125126652|NCT00336479|450088699|FG001|Overall Study|Withdrawal by Subject|2|||
125126653|NCT00336479|450088700|FG002|Overall Study|Withdrawal by Subject|3|||
125126654|NCT00336479|450088701|FG003|Overall Study|Withdrawal by Subject|0|||
125126655|NCT00336479|450088698|FG000|Overall Study|Other|0|||
125126656|NCT00336479|450088699|FG001|Overall Study|Other|0|||
125126657|NCT00336479|450088700|FG002|Overall Study|Other|1|||
125126658|NCT00336479|450088701|FG003|Overall Study|Other|0|||
124956973|NCT00296504|449467916|FG001|Interim Analysis|Physician Decision|0|||
124956974|NCT00296504|449467917|FG002|Interim Analysis|Physician Decision|1|||
124956975|NCT00296504|449467918|FG003|Interim Analysis|Physician Decision|0|||
124956976|NCT00296504|449467919|FG004|Interim Analysis|Physician Decision|0|||
124956977|NCT00296504|449467920|FG005|Interim Analysis|Physician Decision|0|||
124956978|NCT00296504|449467921|FG006|Interim Analysis|Physician Decision|0|||
124956979|NCT00296504|449467922|FG007|Interim Analysis|Physician Decision|0|||
124956980|NCT00296504|449467923|FG008|Interim Analysis|Physician Decision|0|||
124956981|NCT00296504|449467915|FG000|Interim Analysis|Principle Investigator Discretion|2|||
124956982|NCT00296504|449467916|FG001|Interim Analysis|Principle Investigator Discretion|0|||
124956983|NCT00296504|449467917|FG002|Interim Analysis|Principle Investigator Discretion|1|||
124956984|NCT00296504|449467918|FG003|Interim Analysis|Principle Investigator Discretion|1|||
124956985|NCT00296504|449467919|FG004|Interim Analysis|Principle Investigator Discretion|0|||
124956986|NCT00296504|449467920|FG005|Interim Analysis|Principle Investigator Discretion|0|||
124956987|NCT00296504|449467921|FG006|Interim Analysis|Principle Investigator Discretion|0|||
124956988|NCT00296504|449467922|FG007|Interim Analysis|Principle Investigator Discretion|0|||
124956989|NCT00296504|449467923|FG008|Interim Analysis|Principle Investigator Discretion|0|||
124956990|NCT00296504|449467915|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
124956991|NCT00296504|449467916|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
124956992|NCT00296504|449467917|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
124956993|NCT00296504|449467918|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
124956994|NCT00296504|449467919|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
124956995|NCT00296504|449467920|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
124956996|NCT00296504|449467921|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
124956997|NCT00296504|449467922|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
124956998|NCT00296504|449467923|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
124956999|NCT00296504|449467915|FG000|Interim Analysis|Non-adherence|2|||
125126659|NCT00336479|450088698|FG000|Overall Study|Virologic Stopping Rule|20|||
125126660|NCT00336479|450088699|FG001|Overall Study|Virologic Stopping Rule|0|||
125126661|NCT00336479|450088700|FG002|Overall Study|Virologic Stopping Rule|0|||
125126662|NCT00336479|450088701|FG003|Overall Study|Virologic Stopping Rule|0|||
125126663|NCT01479439|450088702|FG000|Overall Study|Adverse Event|1|||
125126664|NCT01479439|450088703|FG001|Overall Study|Adverse Event|0|||
125126665|NCT01479439|450088704|FG002|Overall Study|Adverse Event|0|||
125126666|NCT01479439|450088702|FG000|Overall Study|Lost to Follow-up|0|||
125126667|NCT01479439|450088703|FG001|Overall Study|Lost to Follow-up|1|||
125126668|NCT01479439|450088704|FG002|Overall Study|Lost to Follow-up|0|||
125126669|NCT01479439|450088702|FG000|Overall Study|Protocol Violation|0|||
125126670|NCT01479439|450088703|FG001|Overall Study|Protocol Violation|0|||
125126671|NCT01479439|450088704|FG002|Overall Study|Protocol Violation|2|||
125126672|NCT02365207|450088705|FG000|Overall Study|Withdrawal by Subject|1|||
125126673|NCT02365207|450088705|FG000|Overall Study|Physician Decision|1|||
125126674|NCT01722877|450088706|FG000|Overall Study|Death|1|||
125126675|NCT01722877|450088706|FG000|Overall Study|Lost to Follow-up|1|||
125126676|NCT01395030|450088707|FG000|Overall Study|Did not complete FCH PET/CT|7|||
125126677|NCT02079766|450088708|FG000|Overall Study|Physician Decision|1|||
125126678|NCT02079766|450088709|FG001|Overall Study|Physician Decision|0|||
125126679|NCT02079766|450088708|FG000|Overall Study|Withdrawal by Subject|1|||
125126680|NCT02079766|450088709|FG001|Overall Study|Withdrawal by Subject|0|||
125126681|NCT05067647|450088713|FG000|Overall Study|Lost to Follow-up|1|||
125126682|NCT00857623|450088715|FG000|Overall Study|Adverse Event|5|||
125126683|NCT00857623|450088716|FG001|Overall Study|Adverse Event|2|||
125126684|NCT00857623|450088715|FG000|Overall Study|Study-specific discontinuation criteria|5|||
125126685|NCT00857623|450088716|FG001|Overall Study|Study-specific discontinuation criteria|3|||
125126686|NCT00857623|450088715|FG000|Overall Study|Withdrawal by Subject|2|||
125126687|NCT00857623|450088716|FG001|Overall Study|Withdrawal by Subject|1|||
125126688|NCT00857623|450088715|FG000|Overall Study|Lack of Efficacy|1|||
125126689|NCT00857623|450088716|FG001|Overall Study|Lack of Efficacy|1|||
125126690|NCT00857623|450088715|FG000|Overall Study|Severe non-compliance to protocol|1|||
125126691|NCT00857623|450088716|FG001|Overall Study|Severe non-compliance to protocol|1|||
125126692|NCT00857623|450088715|FG000|Overall Study|Intake of prohibited medication|0|||
125126693|NCT00857623|450088716|FG001|Overall Study|Intake of prohibited medication|1|||
125126694|NCT00857623|450088715|FG000|Overall Study|Positive for HEP C|0|||
125126695|NCT00857623|450088716|FG001|Overall Study|Positive for HEP C|1|||
125126696|NCT00870870|450088719|FG000|Overall Study|Withdrawal by Subject|0|||
125126697|NCT00870870|450088720|FG001|Overall Study|Withdrawal by Subject|1|||
125126698|NCT00870870|450088721|FG002|Overall Study|Withdrawal by Subject|1|||
125126699|NCT00870870|450088722|FG003|Overall Study|Withdrawal by Subject|3|||
125126700|NCT00870870|450088719|FG000|Overall Study|Adverse Event|0|||
125126701|NCT00870870|450088720|FG001|Overall Study|Adverse Event|0|||
125126702|NCT00870870|450088721|FG002|Overall Study|Adverse Event|2|||
125126703|NCT00870870|450088722|FG003|Overall Study|Adverse Event|2|||
125126704|NCT00694551|450088725|FG000|Overall Study|Disease Progression|1|||
125126705|NCT00694551|450088726|FG001|Overall Study|Disease Progression|0|||
125126706|NCT00694551|450088727|FG002|Overall Study|Disease Progression|1|||
125126707|NCT00385684|450088732|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
125126708|NCT00385684|450088733|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
125126709|NCT00385684|450088732|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
125126710|NCT00385684|450088733|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
125126711|NCT00385684|450088732|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
125126712|NCT00385684|450088733|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
125126713|NCT02801877|450088734|FG000|Overall Study|Lost to Follow-up|1|||
125126714|NCT02801877|450088735|FG001|Overall Study|Lost to Follow-up|1|||
125126715|NCT02801877|450088736|FG002|Overall Study|Lost to Follow-up|2|||
125126716|NCT02801877|450088737|FG003|Overall Study|Lost to Follow-up|0|||
125126717|NCT02801877|450088734|FG000|Overall Study|Never Started Treatment|2|||
125126718|NCT02801877|450088735|FG001|Overall Study|Never Started Treatment|0|||
125126719|NCT02801877|450088736|FG002|Overall Study|Never Started Treatment|4|||
125126720|NCT02801877|450088737|FG003|Overall Study|Never Started Treatment|0|||
125126721|NCT00591630|450088738|FG000|Overall Study|Death|0|||
125126722|NCT00591630|450088739|FG001|Overall Study|Death|0|||
125126723|NCT00591630|450088740|FG002|Overall Study|Death|1|||
125126724|NCT00591630|450088741|FG003|Overall Study|Death|0|||
125126725|NCT02924038|450090300|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
125126726|NCT02924038|450090301|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
125126727|NCT03601637|450090302|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
125126728|NCT03601637|450090303|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
125126729|NCT03601637|450090302|FG000|Overall Study|Adverse Event|1|||
125126730|NCT03601637|450090303|FG001|Overall Study|Adverse Event|1|||
125126731|NCT03601637|450090302|FG000|Overall Study|Other|0|||
125126732|NCT03601637|450090303|FG001|Overall Study|Other|1|||
125126733|NCT00420303|450090306|FG000|Overall Study|Serious Adverse Event|1|||
125126734|NCT00420303|450090307|FG001|Overall Study|Serious Adverse Event|0|||
125126735|NCT00420303|450090306|FG000|Overall Study|Lack of Efficacy|0|||
125126736|NCT00420303|450090307|FG001|Overall Study|Lack of Efficacy|3|||
125126737|NCT00420303|450090306|FG000|Overall Study|Physician Decision|0|||
125126738|NCT00420303|450090307|FG001|Overall Study|Physician Decision|1|||
125126739|NCT01029353|450090309|FG000|Overall Study|Lost to Follow-up|4|||
125126740|NCT01029353|450090310|FG001|Overall Study|Lost to Follow-up|5|||
125126741|NCT01029353|450090311|FG002|Overall Study|Lost to Follow-up|5|||
125126742|NCT01029353|450090312|FG003|Overall Study|Lost to Follow-up|4|||
125126743|NCT01029353|450090309|FG000|Overall Study|Consent Withdrawn|2|||
125126744|NCT01029353|450090310|FG001|Overall Study|Consent Withdrawn|0|||
125126745|NCT01029353|450090311|FG002|Overall Study|Consent Withdrawn|0|||
125126746|NCT01029353|450090312|FG003|Overall Study|Consent Withdrawn|0|||
125126747|NCT01029353|450090309|FG000|Overall Study|Primary Outcome Indeterminate|1|||
125126748|NCT01029353|450090310|FG001|Overall Study|Primary Outcome Indeterminate|3|||
125126749|NCT01029353|450090311|FG002|Overall Study|Primary Outcome Indeterminate|2|||
125126750|NCT01029353|450090312|FG003|Overall Study|Primary Outcome Indeterminate|0|||
125126751|NCT01900730|450090313|FG000|Overall Study|Withdrawal by Subject|1|||
125126752|NCT01900730|450090314|FG001|Overall Study|Withdrawal by Subject|0|||
125126753|NCT01900730|450090313|FG000|Overall Study|Screen Failure|1|||
125126754|NCT01900730|450090314|FG001|Overall Study|Screen Failure|0|||
125126755|NCT01520909|450090315|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
125126756|NCT01520909|450090316|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
125126757|NCT01520909|450090317|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
125126758|NCT01520909|450090315|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
125126759|NCT01520909|450090316|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
125126760|NCT01520909|450090317|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
125126761|NCT01520909|450090315|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
125126762|NCT01520909|450090316|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
125126763|NCT01520909|450090317|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
125126764|NCT01520909|450090315|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
125126765|NCT01520909|450090316|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
125126766|NCT01520909|450090317|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
125126767|NCT02942264|450090318|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
125126768|NCT02942264|450090319|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
125126769|NCT02942264|450090320|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
125126770|NCT02942264|450090321|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
125126771|NCT02942264|450090322|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
125126772|NCT02942264|450090323|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
125126773|NCT02942264|450090324|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
125126774|NCT02942264|450090325|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
125126775|NCT02942264|450090326|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
125126776|NCT02942264|450090318|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
125126777|NCT02942264|450090319|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
125126778|NCT02942264|450090320|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
125126779|NCT02942264|450090321|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
125126780|NCT02942264|450090322|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
125126781|NCT02942264|450090323|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
125126782|NCT02942264|450090324|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
125126783|NCT02942264|450090325|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
125126784|NCT02942264|450090326|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
125126785|NCT00569374|450090329|FG000|Overall Study|Withdrawal by Subject|4|||
125126786|NCT00064753|450090330|FG000|Overall Study|Death|251|||
125126787|NCT00064753|450090331|FG001|Overall Study|Death|242|||
125126788|NCT00064753|450090330|FG000|Overall Study|Withdrawal by Subject|198|||
125126789|NCT00064753|450090331|FG001|Overall Study|Withdrawal by Subject|171|||
125126790|NCT00064753|450090330|FG000|Overall Study|Lost to Follow-up|225|||
124957000|NCT00296504|449467916|FG001|Interim Analysis|Non-adherence|0|||
125126791|NCT00064753|450090331|FG001|Overall Study|Lost to Follow-up|235|||
125126792|NCT01544127|450090337|FG000|Overall Study|Lost to Follow-up|4|||
125126793|NCT01544127|450090338|FG001|Overall Study|Lost to Follow-up|2|||
125126794|NCT01544127|450090339|FG002|Overall Study|Lost to Follow-up|9|||
125126795|NCT01544127|450090337|FG000|Overall Study|Withdrawal by Subject|2|||
125126796|NCT01544127|450090338|FG001|Overall Study|Withdrawal by Subject|2|||
125126797|NCT01544127|450090339|FG002|Overall Study|Withdrawal by Subject|1|||
125126798|NCT01544127|450090337|FG000|Overall Study|Discharged out of catchment area|1|||
125215440|NCT03951753|450415018|FG000|Overall Study|Lost to Follow-up|0|||
125126799|NCT01544127|450090338|FG001|Overall Study|Discharged out of catchment area|1|||
125126800|NCT01544127|450090339|FG002|Overall Study|Discharged out of catchment area|1|||
125126801|NCT01544127|450090337|FG000|Overall Study|Death|1|||
125126802|NCT01544127|450090338|FG001|Overall Study|Death|0|||
125126803|NCT01544127|450090339|FG002|Overall Study|Death|0|||
125126804|NCT01544127|450090337|FG000|Overall Study|Jail or Prison|1|||
125126805|NCT01544127|450090338|FG001|Overall Study|Jail or Prison|1|||
125126806|NCT01544127|450090339|FG002|Overall Study|Jail or Prison|2|||
125126807|NCT01544127|450090337|FG000|Overall Study|Became Psychotic|1|||
125126808|NCT01544127|450090338|FG001|Overall Study|Became Psychotic|0|||
125126809|NCT01544127|450090339|FG002|Overall Study|Became Psychotic|0|||
125126810|NCT01544127|450090337|FG000|Overall Study|Researcher withdrew|1|||
125126811|NCT01544127|450090338|FG001|Overall Study|Researcher withdrew|0|||
125126812|NCT01544127|450090339|FG002|Overall Study|Researcher withdrew|0|||
125126813|NCT01544127|450090337|FG000|Overall Study|Went active duty|0|||
125126814|NCT01544127|450090338|FG001|Overall Study|Went active duty|0|||
125126815|NCT01544127|450090339|FG002|Overall Study|Went active duty|1|||
125126816|NCT00533273|450090342|FG000|Double-blind|Withdrew consent|0|||
125126817|NCT00533273|450090343|FG001|Double-blind|Withdrew consent|2|||
125126818|NCT00533273|450090342|FG000|Open-label|Withdrawal by Subject|6|||
125126819|NCT00533273|450090343|FG001|Open-label|Withdrawal by Subject|0|||
125126820|NCT02914600|450090344|FG000|Overall Study|Adverse Event|298|||
125126821|NCT02914600|450090345|FG001|Overall Study|Adverse Event|35|||
125126822|NCT02914600|450090346|FG002|Overall Study|Adverse Event|25|||
125126823|NCT02914600|450090344|FG000|Overall Study|Sponsors decision|287|||
125126824|NCT02914600|450090345|FG001|Overall Study|Sponsors decision|41|||
125126825|NCT02914600|450090346|FG002|Overall Study|Sponsors decision|12|||
125126826|NCT02914600|450090344|FG000|Overall Study|Withdrawal by Subject|158|||
125126827|NCT02914600|450090345|FG001|Overall Study|Withdrawal by Subject|20|||
125126828|NCT02914600|450090346|FG002|Overall Study|Withdrawal by Subject|18|||
125126829|NCT02914600|450090344|FG000|Overall Study|Investigators discretion|169|||
125126830|NCT02914600|450090345|FG001|Overall Study|Investigators discretion|14|||
125126831|NCT02914600|450090346|FG002|Overall Study|Investigators discretion|13|||
125126832|NCT02914600|450090344|FG000|Overall Study|Lost to Follow-up|10|||
125126833|NCT02914600|450090345|FG001|Overall Study|Lost to Follow-up|4|||
125126834|NCT02914600|450090346|FG002|Overall Study|Lost to Follow-up|0|||
125126835|NCT02914600|450090344|FG000|Overall Study|Pregnancy|8|||
125126836|NCT02914600|450090345|FG001|Overall Study|Pregnancy|0|||
125126837|NCT02914600|450090346|FG002|Overall Study|Pregnancy|0|||
125126838|NCT02914600|450090344|FG000|Overall Study|Protocol Violation|5|||
125126839|NCT02914600|450090345|FG001|Overall Study|Protocol Violation|3|||
125126840|NCT02914600|450090346|FG002|Overall Study|Protocol Violation|0|||
125126841|NCT02914600|450090344|FG000|Overall Study|Non-compliance with study drug|6|||
125126842|NCT02914600|450090345|FG001|Overall Study|Non-compliance with study drug|1|||
125126843|NCT02914600|450090346|FG002|Overall Study|Non-compliance with study drug|0|||
125126844|NCT02914600|450090344|FG000|Overall Study|Death|3|||
125126845|NCT02914600|450090345|FG001|Overall Study|Death|1|||
125126846|NCT02914600|450090346|FG002|Overall Study|Death|1|||
125126847|NCT02914600|450090344|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
125126848|NCT02914600|450090345|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
125126849|NCT02914600|450090346|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
125126850|NCT02914600|450090344|FG000|Overall Study|Enrolled but not treated|1|||
125126851|NCT02914600|450090345|FG001|Overall Study|Enrolled but not treated|0|||
125126852|NCT02914600|450090346|FG002|Overall Study|Enrolled but not treated|0|||
125126853|NCT00454909|450090347|FG000|Overall Study|Withdrawal by Subject|1|||
125126854|NCT00454909|450090348|FG001|Overall Study|Withdrawal by Subject|0|||
125126855|NCT00454909|450090349|FG002|Overall Study|Withdrawal by Subject|0|||
125126856|NCT00454909|450090347|FG000|Overall Study|Migrated/moved from study area|0|||
125126857|NCT00454909|450090348|FG001|Overall Study|Migrated/moved from study area|0|||
125126858|NCT00454909|450090349|FG002|Overall Study|Migrated/moved from study area|1|||
125126859|NCT00454909|450090347|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
125126860|NCT00454909|450090348|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
125126861|NCT00454909|450090349|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
125126862|NCT00454909|450090347|FG000|Overall Study|Others|1|||
125126863|NCT00454909|450090348|FG001|Overall Study|Others|0|||
125126864|NCT00454909|450090349|FG002|Overall Study|Others|0|||
125126865|NCT02457520|450090350|FG000|Active Treatment Phase|Adverse Event|10|||
125126866|NCT02457520|450090350|FG000|Active Treatment Phase|Lost to Follow-up|8|||
125126867|NCT02457520|450090350|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
125126868|NCT02457520|450090350|FG000|Active Treatment Phase|other|4|||
125126869|NCT02457520|450090350|FG000|Active Treatment Phase|Physician Decision|1|||
125126870|NCT02457520|450090350|FG000|Active Treatment Phase|Protocol Violation|1|||
125126871|NCT02457520|450090350|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
125126872|NCT02457520|450090350|FG000|Post-treatment Period|Other: Retreatment Required|7|||
125126873|NCT02457520|450090350|FG000|Post-treatment Period|Lost to Follow-up|23|||
125126874|NCT02457520|450090350|FG000|Post-treatment Period|Other|3|||
125126875|NCT02457520|450090350|FG000|Post-treatment Period|Physician Decision|1|||
125126876|NCT02457520|450090350|FG000|Post-treatment Period|Withdrawal by Subject|14|||
125126877|NCT02107092|450090351|FG000|Overall Study|Miscellaneous|3|||
125126878|NCT02107092|450090351|FG000|Overall Study|Subject compliance|3|||
125126879|NCT02107092|450090351|FG000|Overall Study|Hypo-or hyperkalemia|2|||
125126880|NCT02107092|450090351|FG000|Overall Study|Met ECG withdrawal criteria|3|||
125126881|NCT02107092|450090351|FG000|Overall Study|Physician Decision|3|||
125126882|NCT02107092|450090351|FG000|Overall Study|Lost to Follow-up|2|||
125126883|NCT02107092|450090351|FG000|Overall Study|Withdrawal by Subject|9|||
125126884|NCT02107092|450090351|FG000|Overall Study|Adverse Event|7|||
125126885|NCT02107092|450090351|FG000|Overall Study|Expected progression of CKD|12|||
125126886|NCT03522675|450090353|FG000|Overall Study|Screen fail|1|||
125126887|NCT03522675|450090353|FG000|Overall Study|Non-reactive to histamine|1|||
125126888|NCT00707161|450090354|FG000|Overall Study|Physician Decision|6|||
125126889|NCT02076022|450090357|FG000|Overall Study|Withdrawal by Subject|2|||
125126890|NCT02076022|450090358|FG001|Overall Study|Withdrawal by Subject|0|||
125126891|NCT00312663|450090359|FG000|Immunization Phase|Adverse Event|0|||
125126892|NCT00312663|450090360|FG001|Immunization Phase|Adverse Event|1|||
125126893|NCT00312663|450090361|FG002|Immunization Phase|Adverse Event|0|||
125126894|NCT02661295|450090366|FG000|Overall Study|Death|1|||
125126895|NCT02661295|450090366|FG000|Overall Study|Transferred Out|1|||
125126896|NCT02661295|450090366|FG000|Overall Study|Kidney Transplant|1|||
125126897|NCT02661295|450090366|FG000|Overall Study|Withdrawn due to side effects|8|||
125126898|NCT02661295|450090366|FG000|Overall Study|Withdrawn due to access type|1|||
125126899|NCT02661295|450090366|FG000|Overall Study|Withdrawn due to allergies|1|||
125126900|NCT02661295|450090366|FG000|Overall Study|Withdrawn due to non-compliance|1|||
125126901|NCT02661295|450090366|FG000|Overall Study|Withdrawal by Subject|3|||
125126902|NCT02661295|450090366|FG000|Overall Study|Failed screening|2|||
125126903|NCT01376167|450090367|FG000|Overall Study|Lost to Follow-up|2|||
125126904|NCT01376167|450090368|FG001|Overall Study|Lost to Follow-up|4|||
125126905|NCT01376167|450090369|FG002|Overall Study|Lost to Follow-up|2|||
125126906|NCT01376167|450090367|FG000|Overall Study|Physician Decision|1|||
125126907|NCT01376167|450090368|FG001|Overall Study|Physician Decision|1|||
125126908|NCT01376167|450090369|FG002|Overall Study|Physician Decision|0|||
125126909|NCT01376167|450090367|FG000|Overall Study|Withdrawal by Subject|1|||
125126910|NCT01376167|450090368|FG001|Overall Study|Withdrawal by Subject|5|||
125126911|NCT01376167|450090369|FG002|Overall Study|Withdrawal by Subject|4|||
125126912|NCT02849652|450090378|FG000|Overall Study|Lost to Follow-up|104|||
125126913|NCT02849652|450090379|FG001|Overall Study|Lost to Follow-up|35|||
125126914|NCT02849652|450090380|FG002|Overall Study|Lost to Follow-up|116|||
125126915|NCT02849652|450090381|FG003|Overall Study|Lost to Follow-up|22|||
125126916|NCT02849652|450090378|FG000|Overall Study|Withdrawal by Subject|10|||
125126917|NCT02849652|450090379|FG001|Overall Study|Withdrawal by Subject|2|||
125126918|NCT02849652|450090380|FG002|Overall Study|Withdrawal by Subject|8|||
125126919|NCT02849652|450090381|FG003|Overall Study|Withdrawal by Subject|4|||
125126920|NCT00565448|450090382|FG000|Overall Study|Adverse Event|1|||
125126921|NCT00565448|450090383|FG001|Overall Study|Adverse Event|2|||
125126922|NCT00565448|450090382|FG000|Overall Study|Disease progression|1|||
125126923|NCT00565448|450090383|FG001|Overall Study|Disease progression|0|||
125126924|NCT00565448|450090382|FG000|Overall Study|Withdrawal by Subject|1|||
125126925|NCT00565448|450090383|FG001|Overall Study|Withdrawal by Subject|0|||
125126926|NCT00472290|450090384|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
125126927|NCT00472290|450090384|FG000|Overall Study|Protocol Specified Criteria|7|||
125126928|NCT00472290|450090384|FG000|Overall Study|Administrative Decision|37|||
125126929|NCT00472290|450090384|FG000|Overall Study|Death|3|||
125126930|NCT00472290|450090384|FG000|Overall Study|Lost to Follow-up|1|||
125126931|NCT00472290|450090384|FG000|Overall Study|Lack of Efficacy|1|||
125126932|NCT00472290|450090384|FG000|Overall Study|Disease Progression|4|||
125126933|NCT00472290|450090384|FG000|Overall Study|Withdrawal by Subject|5|||
125126934|NCT00472290|450090384|FG000|Overall Study|Adverse Event|6|||
125126935|NCT00472290|450090384|FG000|Overall Study|Requirement for alternative therapy|7|||
125126936|NCT00777829|450090385|FG000|Overall Study|Withdrawal by Subject|0|||
125126937|NCT00777829|450090386|FG001|Overall Study|Withdrawal by Subject|2|||
125126938|NCT02016170|450090390|FG000|Overall Study|Adverse Event|1|||
125126939|NCT02016170|450090391|FG001|Overall Study|Adverse Event|1|||
125126940|NCT02016170|450090392|FG002|Overall Study|Adverse Event|0|||
125126941|NCT02016170|450090390|FG000|Overall Study|Protocol Violation|1|||
125126942|NCT02016170|450090391|FG001|Overall Study|Protocol Violation|0|||
125126943|NCT02016170|450090392|FG002|Overall Study|Protocol Violation|0|||
125126944|NCT00302952|450090393|FG000|Overall Study|Physician Decision|1|||
125126945|NCT00302952|450090394|FG001|Overall Study|Physician Decision|1|||
125126946|NCT00302952|450090393|FG000|Overall Study|Withdrawal by Subject|2|||
125126947|NCT00302952|450090394|FG001|Overall Study|Withdrawal by Subject|3|||
125126948|NCT00302952|450090393|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
125126949|NCT00302952|450090394|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
125126950|NCT02373098|450090398|FG000|Overall Study|Lost to Follow-up|1|||
125126951|NCT02373098|450090399|FG001|Overall Study|Lost to Follow-up|0|||
125126952|NCT02373098|450090398|FG000|Overall Study|Protocol Violation|3|||
125126953|NCT02373098|450090399|FG001|Overall Study|Protocol Violation|0|||
125126954|NCT02373098|450090398|FG000|Overall Study|Withdrawal by Subject|5|||
125126955|NCT02373098|450090399|FG001|Overall Study|Withdrawal by Subject|0|||
125126956|NCT02373098|450090398|FG000|Overall Study|Adverse Event|3|||
125126957|NCT02373098|450090399|FG001|Overall Study|Adverse Event|0|||
125126958|NCT02008565|450090401|FG000|Overall Study|Protocol Violation|1|||
125126959|NCT02008565|450090402|FG001|Overall Study|Protocol Violation|1|||
125126960|NCT02008565|450090403|FG002|Overall Study|Protocol Violation|2|||
125126961|NCT02008565|450090404|FG003|Overall Study|Protocol Violation|0|||
125126962|NCT02193178|450090405|FG000|Overall Study|Lost to Follow-up|1|||
125126963|NCT02193178|450090405|FG000|Overall Study|Dry eyes|1|||
125126964|NCT03435081|450090406|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
125126965|NCT03435081|450090407|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
125126966|NCT03435081|450090408|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
125126967|NCT03435081|450090406|FG000|Week 0 to Week 16|Adverse Event|2|||
125126968|NCT03435081|450090407|FG001|Week 0 to Week 16|Adverse Event|2|||
125126969|NCT03435081|450090408|FG002|Week 0 to Week 16|Adverse Event|2|||
125126970|NCT03435081|450090406|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
125126971|NCT03435081|450090407|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
125126972|NCT03435081|450090408|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
125126973|NCT03435081|450090406|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
125126974|NCT03435081|450090407|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
125126975|NCT03435081|450090408|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
125126976|NCT03435081|450090406|FG000|Week 0 to Week 16|Pregnancy|1|||
125126977|NCT03435081|450090407|FG001|Week 0 to Week 16|Pregnancy|0|||
125126978|NCT03435081|450090408|FG002|Week 0 to Week 16|Pregnancy|0|||
125126979|NCT03435081|450090406|FG000|Week 0 to Week 16|Non-compliance|1|||
125126980|NCT03435081|450090407|FG001|Week 0 to Week 16|Non-compliance|0|||
125126981|NCT03435081|450090408|FG002|Week 0 to Week 16|Non-compliance|2|||
125126982|NCT03435081|450090406|FG000|Week 0 to Week 16|Inadequate Response|0|||
125126983|NCT03435081|450090407|FG001|Week 0 to Week 16|Inadequate Response|1|||
125126984|NCT03435081|450090408|FG002|Week 0 to Week 16|Inadequate Response|0|||
124957001|NCT00296504|449467917|FG002|Interim Analysis|Non-adherence|0|||
124957002|NCT00296504|449467918|FG003|Interim Analysis|Non-adherence|0|||
124957003|NCT00296504|449467919|FG004|Interim Analysis|Non-adherence|1|||
125126985|NCT03435081|450090406|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
125126986|NCT03435081|450090407|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
125126987|NCT03435081|450090408|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
125126988|NCT03435081|450090406|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
125126989|NCT03435081|450090407|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
125126990|NCT03435081|450090408|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
125126991|NCT03435081|450090406|FG000|Week 16 to Week 104|Adverse Event|1|||
125126992|NCT03435081|450090407|FG001|Week 16 to Week 104|Adverse Event|0|||
125126993|NCT03435081|450090408|FG002|Week 16 to Week 104|Adverse Event|2|||
125126994|NCT03435081|450090406|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
125126995|NCT03435081|450090407|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
125126996|NCT03435081|450090408|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
125126997|NCT03435081|450090406|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
125126998|NCT03435081|450090407|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
125126999|NCT03435081|450090408|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
125127000|NCT03435081|450090406|FG000|Week 16 to Week 104|Non--Compliance|0|||
125127001|NCT03435081|450090407|FG001|Week 16 to Week 104|Non--Compliance|0|||
125127002|NCT03435081|450090408|FG002|Week 16 to Week 104|Non--Compliance|1|||
125127003|NCT00420238|450090409|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
125127004|NCT00420238|450090410|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
125127005|NCT00420238|450090409|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
125127006|NCT00420238|450090410|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
125127007|NCT00420238|450090409|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
125127008|NCT00420238|450090410|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
125127009|NCT00420238|450090409|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
125127010|NCT00420238|450090410|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
125127011|NCT00420238|450090409|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
125127012|NCT00420238|450090410|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
125127013|NCT00420238|450090409|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
125127014|NCT00420238|450090410|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
125127015|NCT05214560|450090411|FG000|Overall Study|Screening Failure|1|||
124957004|NCT00296504|449467920|FG005|Interim Analysis|Non-adherence|0|||
125215441|NCT03951753|450415019|FG001|Overall Study|Lost to Follow-up|0|||
125215442|NCT03951753|450415020|FG002|Overall Study|Lost to Follow-up|1|||
125215443|NCT02226120|450415023|FG000|Overall Study|Adverse Event|60|||
125215444|NCT02226120|450415023|FG000|Overall Study|Death|172|||
125215445|NCT02226120|450415023|FG000|Overall Study|Study terminated by sponsor|1|||
125215446|NCT02226120|450415023|FG000|Overall Study|Technical problems|4|||
125215447|NCT02226120|450415023|FG000|Overall Study|Lost to Follow-up|13|||
125215448|NCT02226120|450415023|FG000|Overall Study|Physician Decision|21|||
125215449|NCT02226120|450415023|FG000|Overall Study|Withdrawal by parent/guardian|36|||
125030886|NCT00584870|449735083|FG002|Overall Study|Lost to Follow-up|1|||
125030887|NCT00584870|449735081|FG000|Overall Study|Lack of Efficacy|7|||
125030888|NCT00584870|449735082|FG001|Overall Study|Lack of Efficacy|14|||
125030889|NCT00584870|449735083|FG002|Overall Study|Lack of Efficacy|8|||
125215450|NCT02226120|450415023|FG000|Overall Study|Non-compliance with study drug|10|||
125215451|NCT02226120|450415023|FG000|Overall Study|Protocol deviation|1|||
125215452|NCT02226120|450415023|FG000|Overall Study|missing treatment disposition pages|2|||
125215453|NCT02669043|450415024|FG000|Overall Study|Didn't meet I/E criteria|4|||
125215454|NCT01133704|450417377|FG000|Overall Study|Death|44|||
125215455|NCT01133704|450417378|FG001|Overall Study|Death|26|||
125215456|NCT01133704|450417377|FG000|Overall Study|Patient refused to continue|4|||
125215457|NCT01133704|450417378|FG001|Overall Study|Patient refused to continue|0|||
125215458|NCT01133704|450417377|FG000|Overall Study|Study Closure|1|||
125215459|NCT01133704|450417378|FG001|Overall Study|Study Closure|0|||
125215460|NCT04985942|450417381|FG000|Overall Study|Adverse Event|14|||
125215461|NCT04985942|450417382|FG001|Overall Study|Adverse Event|2|||
125215462|NCT04985942|450417381|FG000|Overall Study|Lack of Efficacy|0|||
125215463|NCT04985942|450417382|FG001|Overall Study|Lack of Efficacy|3|||
125215464|NCT04985942|450417381|FG000|Overall Study|Lost to Follow-up|1|||
125215465|NCT04985942|450417382|FG001|Overall Study|Lost to Follow-up|1|||
125215466|NCT04985942|450417381|FG000|Overall Study|Protocol Violation|1|||
125215467|NCT04985942|450417382|FG001|Overall Study|Protocol Violation|1|||
125215468|NCT04985942|450417381|FG000|Overall Study|Withdrawal by Subject|5|||
125215469|NCT04985942|450417382|FG001|Overall Study|Withdrawal by Subject|4|||
125215470|NCT02849704|450417384|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
125215471|NCT02849704|450417385|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
125215472|NCT02849704|450417384|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
125215473|NCT02849704|450417385|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
125215474|NCT02849704|450417384|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
125215475|NCT02849704|450417385|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
125215476|NCT01128400|450417388|FG000|Overall Study|Lost to Follow-up|1|||
125215477|NCT01128400|450417389|FG001|Overall Study|Lost to Follow-up|0|||
125215478|NCT01128400|450417390|FG002|Overall Study|Lost to Follow-up|1|||
125215479|NCT01128400|450417388|FG000|Overall Study|Screening failure|1|||
125215480|NCT01128400|450417389|FG001|Overall Study|Screening failure|0|||
125215481|NCT01128400|450417390|FG002|Overall Study|Screening failure|0|||
125215482|NCT01128400|450417388|FG000|Overall Study|were not invited to participate on taste|0|||
125215483|NCT01128400|450417389|FG001|Overall Study|were not invited to participate on taste|0|||
125215484|NCT01128400|450417390|FG002|Overall Study|were not invited to participate on taste|15|||
125215485|NCT01128400|450417388|FG000|Overall Study|Excluded due to sinus problems|0|||
125215486|NCT01128400|450417389|FG001|Overall Study|Excluded due to sinus problems|1|||
125215487|NCT01128400|450417390|FG002|Overall Study|Excluded due to sinus problems|0|||
125030890|NCT00584870|449735081|FG000|Overall Study|Withdrawal by Subject|10|||
125030891|NCT00584870|449735082|FG001|Overall Study|Withdrawal by Subject|5|||
125030892|NCT00584870|449735083|FG002|Overall Study|Withdrawal by Subject|3|||
125030893|NCT00584870|449735081|FG000|Overall Study|Protocol Violation|1|||
125030894|NCT00584870|449735082|FG001|Overall Study|Protocol Violation|1|||
125030895|NCT00584870|449735083|FG002|Overall Study|Protocol Violation|2|||
125030896|NCT00584870|449735081|FG000|Overall Study|Did not met entrance criteria|1|||
125030897|NCT00584870|449735082|FG001|Overall Study|Did not met entrance criteria|0|||
125030898|NCT00584870|449735083|FG002|Overall Study|Did not met entrance criteria|0|||
125030899|NCT00584870|449735081|FG000|Overall Study|Other|2|||
125030900|NCT00584870|449735082|FG001|Overall Study|Other|0|||
125030901|NCT00584870|449735083|FG002|Overall Study|Other|0|||
125030902|NCT00584870|449735081|FG000|Overall Study|Randomized but not treated|0|||
125030903|NCT00584870|449735082|FG001|Overall Study|Randomized but not treated|1|||
125030904|NCT00584870|449735083|FG002|Overall Study|Randomized but not treated|2|||
125030905|NCT00854828|449735084|FG000|Overall Study|Death|1|||
125030906|NCT00854828|449735085|FG001|Overall Study|Death|0|||
125030907|NCT00854828|449735086|FG002|Overall Study|Death|0|||
125030908|NCT00854828|449735087|FG003|Overall Study|Death|0|||
125215488|NCT04076319|450417402|FG000|Overall Study|Withdrawal by Subject|2|||
125215489|NCT04076319|450417403|FG001|Overall Study|Withdrawal by Subject|0|||
125215490|NCT04076319|450417402|FG000|Overall Study|Death|1|||
125127016|NCT05214560|450090411|FG000|Overall Study|Physician Decision|4|||
125127017|NCT05214560|450090411|FG000|Overall Study|Withdrawal by Subject|1|||
125127018|NCT05214560|450090411|FG000|Overall Study|Lost to Follow-up|2|||
125127019|NCT05214560|450090411|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
125127020|NCT05214560|450090411|FG000|Overall Study|Study physician not available for the anesthesia|3|||
125127021|NCT05214560|450090411|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
125127022|NCT05214560|450090411|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
125127023|NCT05214560|450090411|FG000|Overall Study|Surgery not performed|3|||
125127024|NCT03639311|450090412|FG000|Maintenance Phase|Lost to Follow-up|1|||
125127025|NCT03639311|450090413|FG001|Maintenance Phase|Lost to Follow-up|0|||
125127026|NCT03639311|450090414|FG002|Maintenance Phase|Lost to Follow-up|0|||
125127027|NCT03639311|450090412|FG000|Maintenance Phase|Adverse Event|1|||
125127028|NCT03639311|450090413|FG001|Maintenance Phase|Adverse Event|0|||
125127029|NCT03639311|450090414|FG002|Maintenance Phase|Adverse Event|0|||
125127030|NCT03639311|450090412|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
125127031|NCT03639311|450090413|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
125127032|NCT03639311|450090414|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
125127033|NCT03639311|450090412|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
125127034|NCT03639311|450090413|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
125127035|NCT03639311|450090414|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
125127036|NCT03639311|450090412|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
125127037|NCT03639311|450090413|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
125127038|NCT03639311|450090414|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
125127039|NCT03639311|450090412|FG000|Maintenance Phase|Lack of Efficacy|1|||
125127040|NCT03639311|450090413|FG001|Maintenance Phase|Lack of Efficacy|0|||
125127041|NCT03639311|450090414|FG002|Maintenance Phase|Lack of Efficacy|0|||
125127042|NCT04320849|450090417|FG000|Overall Study|Withdrawal by Subject|4|||
125127043|NCT04320849|450090417|FG000|Overall Study|Imaging data unavailable|2|||
125127044|NCT04320849|450090417|FG000|Overall Study|Incomplete imaging|2|||
125127045|NCT03018249|450090424|FG000|Overall Study|Withdrawal by Subject|2|||
125127046|NCT03018249|450090425|FG001|Overall Study|Withdrawal by Subject|2|||
125127047|NCT00304083|450090427|FG000|Overall Study|Withdrawal by Subject|4|||
125127048|NCT00304083|450090428|FG001|Overall Study|Withdrawal by Subject|2|||
125127049|NCT00304083|450090427|FG000|Overall Study|Physician Decision|8|||
125127050|NCT00304083|450090428|FG001|Overall Study|Physician Decision|3|||
125127051|NCT00304083|450090427|FG000|Overall Study|Disease Progression|5|||
125127052|NCT00304083|450090428|FG001|Overall Study|Disease Progression|1|||
125127053|NCT00304083|450090427|FG000|Overall Study|Other|5|||
125127054|NCT00304083|450090428|FG001|Overall Study|Other|2|||
125127055|NCT03966365|450090431|FG000|Overall Study|Protocol Violation|1|||
125127056|NCT03966365|450090432|FG001|Overall Study|Protocol Violation|0|||
125127057|NCT01044732|450090433|FG000|Overall Study|Lost to Follow-up|2|||
125127058|NCT01044732|450090434|FG001|Overall Study|Lost to Follow-up|1|||
125127059|NCT01044732|450090433|FG000|Overall Study|Physician Decision|5|||
125127060|NCT01044732|450090434|FG001|Overall Study|Physician Decision|3|||
125127061|NCT01044732|450090433|FG000|Overall Study|Protocol Violation|11|||
125127062|NCT01044732|450090434|FG001|Overall Study|Protocol Violation|12|||
125127063|NCT01044732|450090433|FG000|Overall Study|Withdrawal by Subject|0|||
125127064|NCT01044732|450090434|FG001|Overall Study|Withdrawal by Subject|1|||
125127065|NCT01044732|450090433|FG000|Overall Study|Inadequate bowel preparation|11|||
125127066|NCT01044732|450090434|FG001|Overall Study|Inadequate bowel preparation|17|||
125127067|NCT01044732|450090433|FG000|Overall Study|Inability to reach cecum|5|||
125127068|NCT01044732|450090434|FG001|Overall Study|Inability to reach cecum|2|||
125127069|NCT01044732|450090433|FG000|Overall Study|Technical error or malfunction|15|||
125127070|NCT01044732|450090434|FG001|Overall Study|Technical error or malfunction|14|||
125127071|NCT00824265|450090437|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
125127072|NCT00824265|450090438|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
125127073|NCT00824265|450090437|FG000|Treatment Phase|Protocol Violation|1|||
125127074|NCT00824265|450090438|FG001|Treatment Phase|Protocol Violation|0|||
125127075|NCT00824265|450090437|FG000|Treatment Phase|Lost to Follow-up|1|||
125127076|NCT00824265|450090438|FG001|Treatment Phase|Lost to Follow-up|1|||
125127077|NCT00824265|450090437|FG000|Treatment Phase|Physician Decision|6|||
125127078|NCT00824265|450090438|FG001|Treatment Phase|Physician Decision|12|||
125127079|NCT00824265|450090437|FG000|Treatment Phase|Withdrawal by Subject|6|||
125127080|NCT00824265|450090438|FG001|Treatment Phase|Withdrawal by Subject|15|||
125127081|NCT00824265|450090437|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
125127082|NCT00824265|450090438|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
125127083|NCT00824265|450090437|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
125127084|NCT00824265|450090438|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
125127085|NCT01402947|450090439|FG000|First Intervention|Adverse Event|0|||
125127086|NCT01402947|450090440|FG001|First Intervention|Adverse Event|1|||
125127087|NCT01248247|450092165|FG000|Overall Study|Adverse Event|2|||
125127088|NCT01248247|450092166|FG001|Overall Study|Adverse Event|4|||
125127089|NCT01248247|450092167|FG002|Overall Study|Adverse Event|4|||
125127090|NCT01248247|450092168|FG003|Overall Study|Adverse Event|2|||
125127091|NCT01248247|450092165|FG000|Overall Study|Death|0|||
125127092|NCT01248247|450092166|FG001|Overall Study|Death|1|||
125127093|NCT01248247|450092167|FG002|Overall Study|Death|4|||
125127094|NCT01248247|450092168|FG003|Overall Study|Death|7|||
125127095|NCT01248247|450092165|FG000|Overall Study|Lost to Follow-up|0|||
125127096|NCT01248247|450092166|FG001|Overall Study|Lost to Follow-up|1|||
125127097|NCT01248247|450092167|FG002|Overall Study|Lost to Follow-up|1|||
125127098|NCT01248247|450092168|FG003|Overall Study|Lost to Follow-up|0|||
125127099|NCT01248247|450092165|FG000|Overall Study|Alternative treatment|0|||
125127100|NCT01248247|450092166|FG001|Overall Study|Alternative treatment|1|||
125127101|NCT01248247|450092167|FG002|Overall Study|Alternative treatment|0|||
125127102|NCT01248247|450092168|FG003|Overall Study|Alternative treatment|0|||
125127103|NCT01248247|450092165|FG000|Overall Study|Other|2|||
125127104|NCT01248247|450092166|FG001|Overall Study|Other|8|||
125127105|NCT01248247|450092167|FG002|Overall Study|Other|8|||
125127106|NCT01248247|450092168|FG003|Overall Study|Other|5|||
125127107|NCT01248247|450092165|FG000|Overall Study|Progression|18|||
125127108|NCT01248247|450092166|FG001|Overall Study|Progression|27|||
125127109|NCT01248247|450092167|FG002|Overall Study|Progression|56|||
125127110|NCT01248247|450092168|FG003|Overall Study|Progression|44|||
125127111|NCT01248247|450092165|FG000|Overall Study|Refuse further treatment|0|||
125127112|NCT01248247|450092166|FG001|Overall Study|Refuse further treatment|0|||
125127113|NCT01248247|450092167|FG002|Overall Study|Refuse further treatment|1|||
125127114|NCT01248247|450092168|FG003|Overall Study|Refuse further treatment|2|||
125127115|NCT01248247|450092165|FG000|Overall Study|Complicating disease|0|||
125127116|NCT01248247|450092166|FG001|Overall Study|Complicating disease|0|||
125127117|NCT01248247|450092167|FG002|Overall Study|Complicating disease|1|||
125127118|NCT01248247|450092168|FG003|Overall Study|Complicating disease|1|||
125127119|NCT01108094|450092169|FG000|Overall Study|Adverse Event|2|||
125127120|NCT01108094|450092170|FG001|Overall Study|Adverse Event|0|||
125127121|NCT01108094|450092171|FG002|Overall Study|Adverse Event|0|||
125127122|NCT01108094|450092172|FG003|Overall Study|Adverse Event|0|||
125127123|NCT01108094|450092169|FG000|Overall Study|Withdrawal by Subject|1|||
125127124|NCT01108094|450092170|FG001|Overall Study|Withdrawal by Subject|0|||
125127125|NCT01108094|450092171|FG002|Overall Study|Withdrawal by Subject|0|||
125127126|NCT01108094|450092172|FG003|Overall Study|Withdrawal by Subject|0|||
125127127|NCT04349917|450092173|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
125127128|NCT04349917|450092174|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
125127129|NCT04349917|450092173|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
125127130|NCT04349917|450092174|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
125127131|NCT00705536|450092175|FG000|Start Period 1|Withdrawal by Subject|0|||
125127132|NCT00705536|450092176|FG001|Start Period 1|Withdrawal by Subject|0|||
125127133|NCT00705536|450092177|FG002|Start Period 1|Withdrawal by Subject|0|||
125127134|NCT00705536|450092178|FG003|Start Period 1|Withdrawal by Subject|1|||
125127135|NCT04188106|450092179|FG000|Overall Study|Lost to Follow-up|5|||
125127136|NCT04188106|450092179|FG000|Overall Study|Non-Compliance|1|||
125127137|NCT00441467|450092180|FG000|Overall Study|Adverse Event|6|||
125127138|NCT00441467|450092180|FG000|Overall Study|Withdrawal by Subject|3|||
125127139|NCT00441467|450092180|FG000|Overall Study|Progressive disease|9|||
125127140|NCT02289963|450092181|FG000|Overall Study|Adverse Event|1|||
125127141|NCT02289963|450092182|FG001|Overall Study|Adverse Event|2|||
125127142|NCT02289963|450092181|FG000|Overall Study|Poor compliance to protocol|1|||
125127143|NCT02289963|450092182|FG001|Overall Study|Poor compliance to protocol|0|||
125127144|NCT02289963|450092181|FG000|Overall Study|Withdrawal by Subject|1|||
125127145|NCT02289963|450092182|FG001|Overall Study|Withdrawal by Subject|0|||
125127146|NCT02289963|450092181|FG000|Overall Study|Last injection missed|2|||
125127147|NCT02289963|450092182|FG001|Overall Study|Last injection missed|2|||
125127148|NCT02289963|450092181|FG000|Overall Study|End treatment visit outside visit window|0|||
125127149|NCT02289963|450092182|FG001|Overall Study|End treatment visit outside visit window|4|||
125127150|NCT02289963|450092181|FG000|Overall Study|Other than specified above|0|||
125127151|NCT02289963|450092182|FG001|Overall Study|Other than specified above|2|||
125127152|NCT01042522|450092184|FG000|Overall Study|Adverse Event|1|||
124957005|NCT00296504|449467921|FG006|Interim Analysis|Non-adherence|0|||
124957006|NCT00296504|449467922|FG007|Interim Analysis|Non-adherence|1|||
124957007|NCT00296504|449467923|FG008|Interim Analysis|Non-adherence|0|||
124957008|NCT00296504|449467915|FG000|Interim Analysis|Site Closing|1|||
124957009|NCT00296504|449467916|FG001|Interim Analysis|Site Closing|0|||
124957010|NCT00296504|449467917|FG002|Interim Analysis|Site Closing|0|||
124957011|NCT00296504|449467918|FG003|Interim Analysis|Site Closing|0|||
124957012|NCT00296504|449467919|FG004|Interim Analysis|Site Closing|0|||
124957013|NCT00296504|449467920|FG005|Interim Analysis|Site Closing|1|||
124957014|NCT00296504|449467921|FG006|Interim Analysis|Site Closing|2|||
124957015|NCT00296504|449467922|FG007|Interim Analysis|Site Closing|0|||
124957016|NCT00296504|449467923|FG008|Interim Analysis|Site Closing|0|||
124957017|NCT00296504|449467915|FG000|Interim Analysis|Lack of Personnel at Site|1|||
124957018|NCT00296504|449467916|FG001|Interim Analysis|Lack of Personnel at Site|0|||
124957019|NCT00296504|449467917|FG002|Interim Analysis|Lack of Personnel at Site|0|||
124957020|NCT00296504|449467918|FG003|Interim Analysis|Lack of Personnel at Site|0|||
124957021|NCT00296504|449467919|FG004|Interim Analysis|Lack of Personnel at Site|0|||
124957022|NCT00296504|449467920|FG005|Interim Analysis|Lack of Personnel at Site|0|||
124957023|NCT00296504|449467921|FG006|Interim Analysis|Lack of Personnel at Site|0|||
124957024|NCT00296504|449467922|FG007|Interim Analysis|Lack of Personnel at Site|0|||
124957025|NCT00296504|449467923|FG008|Interim Analysis|Lack of Personnel at Site|0|||
124957026|NCT00296504|449467915|FG000|Interim Analysis|Missed Schedule Date|1|||
124957027|NCT00296504|449467916|FG001|Interim Analysis|Missed Schedule Date|0|||
124957028|NCT00296504|449467917|FG002|Interim Analysis|Missed Schedule Date|0|||
124957029|NCT00296504|449467918|FG003|Interim Analysis|Missed Schedule Date|0|||
124957030|NCT00296504|449467919|FG004|Interim Analysis|Missed Schedule Date|0|||
124957031|NCT00296504|449467920|FG005|Interim Analysis|Missed Schedule Date|0|||
125030909|NCT00854828|449735084|FG000|Overall Study|Withdrawal by Subject|1|||
125030910|NCT00854828|449735085|FG001|Overall Study|Withdrawal by Subject|1|||
125030911|NCT00854828|449735086|FG002|Overall Study|Withdrawal by Subject|0|||
125030912|NCT00854828|449735087|FG003|Overall Study|Withdrawal by Subject|9|||
125030913|NCT00854828|449735084|FG000|Overall Study|Missed 24mo visit|1|||
125030914|NCT00854828|449735085|FG001|Overall Study|Missed 24mo visit|1|||
125030915|NCT00854828|449735086|FG002|Overall Study|Missed 24mo visit|8|||
125030916|NCT00854828|449735087|FG003|Overall Study|Missed 24mo visit|8|||
125030917|NCT02675075|449735089|FG000|Overall Study|Lost to Follow-up|3|||
125030918|NCT02675075|449735090|FG001|Overall Study|Lost to Follow-up|0|||
125030919|NCT02292212|449735091|FG000|ViE Phase|Withdrawal by Subject|1|||
125030920|NCT02292212|449735091|FG000|ViE Phase|Protocol Violation|2|||
125030921|NCT04957290|449735092|FG000|Overall Study|Progressive disease|3|||
125030922|NCT04957290|449735093|FG001|Overall Study|Progressive disease|3|||
125030923|NCT04957290|449735094|FG002|Overall Study|Progressive disease|2|||
125030924|NCT04957290|449735095|FG003|Overall Study|Progressive disease|0|||
125030925|NCT04957290|449735096|FG004|Overall Study|Progressive disease|0|||
125030926|NCT04957290|449735097|FG005|Overall Study|Progressive disease|0|||
125030927|NCT04957290|449735092|FG000|Overall Study|Withdrawal by Subject|1|||
125030928|NCT04957290|449735093|FG001|Overall Study|Withdrawal by Subject|0|||
125030929|NCT04957290|449735094|FG002|Overall Study|Withdrawal by Subject|1|||
125030930|NCT04957290|449735095|FG003|Overall Study|Withdrawal by Subject|0|||
125030931|NCT04957290|449735096|FG004|Overall Study|Withdrawal by Subject|0|||
125030932|NCT04957290|449735097|FG005|Overall Study|Withdrawal by Subject|0|||
125030933|NCT04957290|449735092|FG000|Overall Study|Death|0|||
125030934|NCT04957290|449735093|FG001|Overall Study|Death|2|||
125030935|NCT04957290|449735094|FG002|Overall Study|Death|1|||
125030936|NCT04957290|449735095|FG003|Overall Study|Death|0|||
125030937|NCT04957290|449735096|FG004|Overall Study|Death|0|||
125030938|NCT04957290|449735097|FG005|Overall Study|Death|0|||
125030939|NCT04957290|449735092|FG000|Overall Study|non compliance with study drug|0|||
125030940|NCT04957290|449735093|FG001|Overall Study|non compliance with study drug|1|||
125030941|NCT04957290|449735094|FG002|Overall Study|non compliance with study drug|0|||
125030942|NCT04957290|449735095|FG003|Overall Study|non compliance with study drug|0|||
125030943|NCT04957290|449735096|FG004|Overall Study|non compliance with study drug|0|||
124957032|NCT00296504|449467921|FG006|Interim Analysis|Missed Schedule Date|0|||
124957033|NCT00296504|449467922|FG007|Interim Analysis|Missed Schedule Date|0|||
124957034|NCT00296504|449467923|FG008|Interim Analysis|Missed Schedule Date|0|||
124957035|NCT00296504|449467915|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
124957036|NCT00296504|449467916|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
124957037|NCT00296504|449467917|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
124957038|NCT00296504|449467918|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
125030944|NCT04957290|449735097|FG005|Overall Study|non compliance with study drug|0|||
125030945|NCT04957290|449735092|FG000|Overall Study|none specified.|0|||
125030946|NCT04957290|449735093|FG001|Overall Study|none specified.|1|||
125030947|NCT04957290|449735094|FG002|Overall Study|none specified.|2|||
125030948|NCT04957290|449735095|FG003|Overall Study|none specified.|0|||
125030949|NCT04957290|449735096|FG004|Overall Study|none specified.|0|||
125030950|NCT04957290|449735097|FG005|Overall Study|none specified.|0|||
125030951|NCT04957290|449735092|FG000|Overall Study|unacceptable toxicity|0|||
125127153|NCT01042522|450092185|FG001|Overall Study|Adverse Event|2|||
125127154|NCT01042522|450092184|FG000|Overall Study|Disease Progression|5|||
125127155|NCT01042522|450092185|FG001|Overall Study|Disease Progression|0|||
125127156|NCT01042522|450092184|FG000|Overall Study|Death|1|||
125127157|NCT01042522|450092185|FG001|Overall Study|Death|0|||
125127158|NCT01042522|450092184|FG000|Overall Study|Patient Refused|0|||
125127159|NCT01042522|450092185|FG001|Overall Study|Patient Refused|3|||
125127160|NCT01042522|450092184|FG000|Overall Study|Withdrawal by Subject|1|||
125127161|NCT01042522|450092185|FG001|Overall Study|Withdrawal by Subject|1|||
125127162|NCT00549718|450092186|FG000|Overall Study|Insufficient clinical response|20|||
125127163|NCT00549718|450092187|FG001|Overall Study|Insufficient clinical response|7|||
125127164|NCT00549718|450092188|FG002|Overall Study|Insufficient clinical response|18|||
125127165|NCT00549718|450092189|FG003|Overall Study|Insufficient clinical response|32|||
125127166|NCT00549718|450092186|FG000|Overall Study|Adverse Event|6|||
125127167|NCT00549718|450092187|FG001|Overall Study|Adverse Event|8|||
125127168|NCT00549718|450092188|FG002|Overall Study|Adverse Event|7|||
125127169|NCT00549718|450092189|FG003|Overall Study|Adverse Event|3|||
125127170|NCT00549718|450092186|FG000|Overall Study|Lost to Follow-up|4|||
125127171|NCT00549718|450092187|FG001|Overall Study|Lost to Follow-up|2|||
125127172|NCT00549718|450092188|FG002|Overall Study|Lost to Follow-up|0|||
125127173|NCT00549718|450092189|FG003|Overall Study|Lost to Follow-up|6|||
125127174|NCT00549718|450092186|FG000|Overall Study|Withdrawal by Subject|9|||
125127175|NCT00549718|450092187|FG001|Overall Study|Withdrawal by Subject|18|||
125127176|NCT00549718|450092188|FG002|Overall Study|Withdrawal by Subject|12|||
125127177|NCT00549718|450092189|FG003|Overall Study|Withdrawal by Subject|13|||
125127178|NCT00549718|450092186|FG000|Overall Study|Administrative|2|||
124957039|NCT00296504|449467919|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
124957040|NCT00296504|449467920|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
124957041|NCT00296504|449467921|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
124957042|NCT00296504|449467922|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
124957043|NCT00296504|449467923|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
124957044|NCT00296504|449467915|FG000|Interim Analysis|Participant Stopped|0|||
124957045|NCT00296504|449467916|FG001|Interim Analysis|Participant Stopped|0|||
124957046|NCT00296504|449467917|FG002|Interim Analysis|Participant Stopped|0|||
124957047|NCT00296504|449467918|FG003|Interim Analysis|Participant Stopped|0|||
124957048|NCT00296504|449467919|FG004|Interim Analysis|Participant Stopped|1|||
124957049|NCT00296504|449467920|FG005|Interim Analysis|Participant Stopped|0|||
124957050|NCT00296504|449467921|FG006|Interim Analysis|Participant Stopped|0|||
124957051|NCT00296504|449467922|FG007|Interim Analysis|Participant Stopped|0|||
124957052|NCT00296504|449467923|FG008|Interim Analysis|Participant Stopped|0|||
124957053|NCT00296504|449467915|FG000|Interim Analysis|Physician and Participant Decision|0|||
124957054|NCT00296504|449467916|FG001|Interim Analysis|Physician and Participant Decision|0|||
124957055|NCT00296504|449467917|FG002|Interim Analysis|Physician and Participant Decision|0|||
124957056|NCT00296504|449467918|FG003|Interim Analysis|Physician and Participant Decision|0|||
124957057|NCT00296504|449467919|FG004|Interim Analysis|Physician and Participant Decision|0|||
125127179|NCT00549718|450092187|FG001|Overall Study|Administrative|2|||
125127180|NCT00549718|450092188|FG002|Overall Study|Administrative|2|||
125127181|NCT00549718|450092189|FG003|Overall Study|Administrative|1|||
125127182|NCT01507051|450092192|FG000|Overall Study|Withdrawal by Subject|1|||
125127183|NCT01507051|450092193|FG001|Overall Study|Withdrawal by Subject|3|||
125127184|NCT01507051|450092194|FG002|Overall Study|Withdrawal by Subject|1|||
125127185|NCT01507051|450092195|FG003|Overall Study|Withdrawal by Subject|6|||
125127186|NCT01507051|450092192|FG000|Overall Study|Physician Decision|0|||
125127187|NCT01507051|450092193|FG001|Overall Study|Physician Decision|0|||
125127188|NCT01507051|450092194|FG002|Overall Study|Physician Decision|0|||
125127189|NCT01507051|450092195|FG003|Overall Study|Physician Decision|1|||
125127190|NCT01507051|450092192|FG000|Overall Study|Adverse Event|1|||
125127191|NCT01507051|450092193|FG001|Overall Study|Adverse Event|0|||
125127192|NCT01507051|450092194|FG002|Overall Study|Adverse Event|0|||
125127193|NCT01507051|450092195|FG003|Overall Study|Adverse Event|0|||
125127194|NCT01675622|450092196|FG000|Overall Study|Withdrawal by Subject|2|||
125127195|NCT01675622|450092197|FG001|Overall Study|Withdrawal by Subject|2|||
125127196|NCT01675622|450092196|FG000|Overall Study|Adverse Event|12|||
125127197|NCT01675622|450092197|FG001|Overall Study|Adverse Event|10|||
125127198|NCT01675622|450092196|FG000|Overall Study|Protocol Violation|4|||
125127199|NCT01675622|450092197|FG001|Overall Study|Protocol Violation|1|||
124957058|NCT00296504|449467920|FG005|Interim Analysis|Physician and Participant Decision|1|||
124957059|NCT00296504|449467921|FG006|Interim Analysis|Physician and Participant Decision|0|||
124957060|NCT00296504|449467922|FG007|Interim Analysis|Physician and Participant Decision|0|||
124957061|NCT00296504|449467923|FG008|Interim Analysis|Physician and Participant Decision|0|||
125127200|NCT01675622|450092196|FG000|Overall Study|Lack of Efficacy|2|||
125127201|NCT01675622|450092197|FG001|Overall Study|Lack of Efficacy|4|||
125127202|NCT01675622|450092196|FG000|Overall Study|Lost to Follow-up|1|||
125127203|NCT01675622|450092197|FG001|Overall Study|Lost to Follow-up|3|||
125127204|NCT01675622|450092196|FG000|Overall Study|Other|5|||
124957062|NCT00296504|449467915|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
125127205|NCT01675622|450092197|FG001|Overall Study|Other|4|||
125127206|NCT04032977|450092198|FG000|Overall Study|Withdrawal by Subject|6|||
125127207|NCT04032977|450092199|FG001|Overall Study|Withdrawal by Subject|1|||
125127208|NCT04032977|450092198|FG000|Overall Study|Lost to Follow-up|2|||
125127209|NCT04032977|450092199|FG001|Overall Study|Lost to Follow-up|7|||
125127210|NCT04032977|450092198|FG000|Overall Study|Pregnancy|1|||
125127211|NCT04032977|450092199|FG001|Overall Study|Pregnancy|0|||
125127212|NCT02880761|450092200|FG000|Overall Study|Death|6|||
125127213|NCT02880761|450092201|FG001|Overall Study|Death|8|||
125127214|NCT02880761|450092200|FG000|Overall Study|Withdrawal by Subject|3|||
125127215|NCT02880761|450092201|FG001|Overall Study|Withdrawal by Subject|6|||
125127216|NCT02880761|450092200|FG000|Overall Study|Protocol Violation|4|||
125127217|NCT02880761|450092201|FG001|Overall Study|Protocol Violation|3|||
125127218|NCT02880761|450092200|FG000|Overall Study|Lost to Follow-up|3|||
125127219|NCT02880761|450092201|FG001|Overall Study|Lost to Follow-up|4|||
125127220|NCT03597256|450092202|FG000|Overall Study|Lost to Follow-up|3|||
125127221|NCT03597256|450092203|FG001|Overall Study|Lost to Follow-up|1|||
125127222|NCT03597256|450092202|FG000|Overall Study|Withdrawal by Subject|0|||
125127223|NCT03597256|450092203|FG001|Overall Study|Withdrawal by Subject|1|||
125127224|NCT03597256|450092202|FG000|Overall Study|Could not return for treatment|0|||
125127225|NCT03597256|450092203|FG001|Overall Study|Could not return for treatment|1|||
125127226|NCT03597256|450092202|FG000|Overall Study|Moved from location|0|||
125127227|NCT03597256|450092203|FG001|Overall Study|Moved from location|1|||
125127228|NCT03597256|450092202|FG000|Overall Study|Not accepted the treatment|0|||
125127229|NCT03597256|450092203|FG001|Overall Study|Not accepted the treatment|1|||
124957063|NCT00296504|449467916|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
125127230|NCT02943447|450092204|FG000|Blinded Study Phase|Withdrew Consent|1|||
125127231|NCT02943447|450092205|FG001|Blinded Study Phase|Withdrew Consent|2|||
125127232|NCT02943447|450092206|FG002|Blinded Study Phase|Withdrew Consent|1|||
125127233|NCT02943447|450092204|FG000|Blinded Study Phase|Adverse Event|3|||
125127234|NCT02943447|450092205|FG001|Blinded Study Phase|Adverse Event|0|||
125127235|NCT02943447|450092206|FG002|Blinded Study Phase|Adverse Event|0|||
125127236|NCT02943447|450092204|FG000|Blinded Study Phase|Investigator's discretion|1|||
125127237|NCT02943447|450092205|FG001|Blinded Study Phase|Investigator's discretion|0|||
125127238|NCT02943447|450092206|FG002|Blinded Study Phase|Investigator's discretion|0|||
125127239|NCT02943447|450092204|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
125127240|NCT02943447|450092205|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
125127241|NCT02943447|450092206|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
125127242|NCT02943447|450092204|FG000|Open-Label Extension Phase|Adverse Event|4|||
125127243|NCT02943447|450092205|FG001|Open-Label Extension Phase|Adverse Event|7|||
125127244|NCT02943447|450092206|FG002|Open-Label Extension Phase|Adverse Event|3|||
125127245|NCT02943447|450092204|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
125127246|NCT02943447|450092205|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
125127247|NCT02943447|450092206|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
125127248|NCT02943447|450092204|FG000|Open-Label Extension Phase|Withdrew consent|1|||
125127249|NCT02943447|450092205|FG001|Open-Label Extension Phase|Withdrew consent|1|||
125127250|NCT02943447|450092206|FG002|Open-Label Extension Phase|Withdrew consent|1|||
125127251|NCT02943447|450092204|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
125127252|NCT02943447|450092205|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
125127253|NCT02943447|450092206|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
125127254|NCT02106156|450092207|FG000|Overall Study|Patient Died|19|||
125127255|NCT02106156|450092208|FG001|Overall Study|Patient Died|0|||
125127256|NCT02106156|450092209|FG002|Overall Study|Patient Died|0|||
125127257|NCT02106156|450092207|FG000|Overall Study|Lack of Tolerability|305|||
125127258|NCT02106156|450092208|FG001|Overall Study|Lack of Tolerability|3|||
125127259|NCT02106156|450092209|FG002|Overall Study|Lack of Tolerability|0|||
125127260|NCT02106156|450092207|FG000|Overall Study|Lack of Virological Response|1044|||
125127261|NCT02106156|450092208|FG001|Overall Study|Lack of Virological Response|8|||
125127262|NCT02106156|450092209|FG002|Overall Study|Lack of Virological Response|0|||
125127263|NCT02106156|450092207|FG000|Overall Study|Concomitant Disease|74|||
125127264|NCT02106156|450092208|FG001|Overall Study|Concomitant Disease|2|||
125127265|NCT02106156|450092209|FG002|Overall Study|Concomitant Disease|0|||
124957064|NCT00296504|449467917|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
124957065|NCT00296504|449467918|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
125127266|NCT02106156|450092207|FG000|Overall Study|Lack of Compliance|211|||
125127267|NCT02106156|450092208|FG001|Overall Study|Lack of Compliance|7|||
125127268|NCT02106156|450092209|FG002|Overall Study|Lack of Compliance|0|||
125127269|NCT02106156|450092207|FG000|Overall Study|Patients Request|307|||
125127270|NCT02106156|450092208|FG001|Overall Study|Patients Request|9|||
125127271|NCT02106156|450092209|FG002|Overall Study|Patients Request|0|||
125127272|NCT02106156|450092207|FG000|Overall Study|Lost to Follow-up|451|||
125127273|NCT02106156|450092208|FG001|Overall Study|Lost to Follow-up|8|||
125127274|NCT02106156|450092209|FG002|Overall Study|Lost to Follow-up|0|||
125127275|NCT02106156|450092207|FG000|Overall Study|Unplanned Event|82|||
125127276|NCT02106156|450092208|FG001|Overall Study|Unplanned Event|2|||
125127277|NCT02106156|450092209|FG002|Overall Study|Unplanned Event|0|||
124957066|NCT00296504|449467919|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
124957067|NCT00296504|449467920|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
124957068|NCT00296504|449467921|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
124957069|NCT00296504|449467922|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
124957070|NCT00296504|449467923|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
124957071|NCT00296504|449467915|FG000|Interim Analysis|Study Ended|0|||
124957072|NCT00296504|449467916|FG001|Interim Analysis|Study Ended|0|||
124957073|NCT00296504|449467917|FG002|Interim Analysis|Study Ended|0|||
124957074|NCT00296504|449467918|FG003|Interim Analysis|Study Ended|0|||
124957075|NCT00296504|449467919|FG004|Interim Analysis|Study Ended|0|||
124957076|NCT00296504|449467920|FG005|Interim Analysis|Study Ended|0|||
124957077|NCT00296504|449467921|FG006|Interim Analysis|Study Ended|1|||
124957078|NCT00296504|449467922|FG007|Interim Analysis|Study Ended|0|||
124957079|NCT00296504|449467923|FG008|Interim Analysis|Study Ended|0|||
124957080|NCT00296504|449467915|FG000|Interim Analysis|Participant Needed Interferon|0|||
124957081|NCT00296504|449467916|FG001|Interim Analysis|Participant Needed Interferon|0|||
124957082|NCT00296504|449467917|FG002|Interim Analysis|Participant Needed Interferon|0|||
124957083|NCT00296504|449467918|FG003|Interim Analysis|Participant Needed Interferon|0|||
124957084|NCT00296504|449467919|FG004|Interim Analysis|Participant Needed Interferon|0|||
124957085|NCT00296504|449467920|FG005|Interim Analysis|Participant Needed Interferon|0|||
124957086|NCT00296504|449467921|FG006|Interim Analysis|Participant Needed Interferon|0|||
124957087|NCT00296504|449467922|FG007|Interim Analysis|Participant Needed Interferon|1|||
124957088|NCT00296504|449467923|FG008|Interim Analysis|Participant Needed Interferon|0|||
124957089|NCT00296504|449467915|FG000|Interim Analysis|Ongoing|32|||
124957090|NCT00296504|449467916|FG001|Interim Analysis|Ongoing|12|||
124957091|NCT00296504|449467917|FG002|Interim Analysis|Ongoing|16|||
124957092|NCT00296504|449467918|FG003|Interim Analysis|Ongoing|22|||
124957093|NCT00296504|449467919|FG004|Interim Analysis|Ongoing|0|||
124957094|NCT00296504|449467920|FG005|Interim Analysis|Ongoing|0|||
124957095|NCT00296504|449467921|FG006|Interim Analysis|Ongoing|30|||
124957096|NCT00296504|449467922|FG007|Interim Analysis|Ongoing|1|||
124957097|NCT00296504|449467923|FG008|Interim Analysis|Ongoing|0|||
125127278|NCT02106156|450092207|FG000|Overall Study|Change of Laboratory Parameter|10|||
124957098|NCT00296504|449467915|FG000|Final Analysis|Withdrawal by Subject|0|||
124957099|NCT00296504|449467916|FG001|Final Analysis|Withdrawal by Subject|0|||
124957100|NCT00296504|449467917|FG002|Final Analysis|Withdrawal by Subject|0|||
124957101|NCT00296504|449467918|FG003|Final Analysis|Withdrawal by Subject|0|||
124957102|NCT00296504|449467919|FG004|Final Analysis|Withdrawal by Subject|0|||
124957103|NCT00296504|449467920|FG005|Final Analysis|Withdrawal by Subject|0|||
124957104|NCT00296504|449467921|FG006|Final Analysis|Withdrawal by Subject|0|||
124957105|NCT00296504|449467922|FG007|Final Analysis|Withdrawal by Subject|0|||
124957106|NCT00296504|449467923|FG008|Final Analysis|Withdrawal by Subject|1|||
124957107|NCT00296504|449467915|FG000|Final Analysis|Lost to Follow-up|0|||
124957108|NCT00296504|449467916|FG001|Final Analysis|Lost to Follow-up|0|||
124957109|NCT00296504|449467917|FG002|Final Analysis|Lost to Follow-up|0|||
124957110|NCT00296504|449467918|FG003|Final Analysis|Lost to Follow-up|0|||
124957111|NCT00296504|449467919|FG004|Final Analysis|Lost to Follow-up|0|||
124957112|NCT00296504|449467920|FG005|Final Analysis|Lost to Follow-up|0|||
124957113|NCT00296504|449467921|FG006|Final Analysis|Lost to Follow-up|0|||
124957114|NCT00296504|449467922|FG007|Final Analysis|Lost to Follow-up|0|||
124957115|NCT00296504|449467923|FG008|Final Analysis|Lost to Follow-up|5|||
124957116|NCT00296504|449467915|FG000|Final Analysis|Insufficient Viral Load Response|0|||
124957117|NCT00296504|449467916|FG001|Final Analysis|Insufficient Viral Load Response|0|||
124957118|NCT00296504|449467917|FG002|Final Analysis|Insufficient Viral Load Response|0|||
124957119|NCT00296504|449467918|FG003|Final Analysis|Insufficient Viral Load Response|0|||
124957120|NCT00296504|449467919|FG004|Final Analysis|Insufficient Viral Load Response|0|||
124957121|NCT00296504|449467920|FG005|Final Analysis|Insufficient Viral Load Response|0|||
124957122|NCT00296504|449467921|FG006|Final Analysis|Insufficient Viral Load Response|0|||
124957123|NCT00296504|449467922|FG007|Final Analysis|Insufficient Viral Load Response|0|||
124957124|NCT00296504|449467923|FG008|Final Analysis|Insufficient Viral Load Response|6|||
124957125|NCT00296504|449467915|FG000|Final Analysis|Adverse Event|0|||
124957126|NCT00296504|449467916|FG001|Final Analysis|Adverse Event|0|||
124957127|NCT00296504|449467917|FG002|Final Analysis|Adverse Event|0|||
124957128|NCT00296504|449467918|FG003|Final Analysis|Adverse Event|0|||
124957129|NCT00296504|449467919|FG004|Final Analysis|Adverse Event|0|||
124957130|NCT00296504|449467920|FG005|Final Analysis|Adverse Event|0|||
124957131|NCT00296504|449467921|FG006|Final Analysis|Adverse Event|0|||
124957132|NCT00296504|449467922|FG007|Final Analysis|Adverse Event|0|||
124957133|NCT00296504|449467923|FG008|Final Analysis|Adverse Event|2|||
124957134|NCT00296504|449467915|FG000|Final Analysis|Pregnancy|0|||
124957135|NCT00296504|449467916|FG001|Final Analysis|Pregnancy|0|||
124957136|NCT00296504|449467917|FG002|Final Analysis|Pregnancy|0|||
124957137|NCT00296504|449467918|FG003|Final Analysis|Pregnancy|0|||
124957138|NCT00296504|449467919|FG004|Final Analysis|Pregnancy|0|||
125127279|NCT02106156|450092208|FG001|Overall Study|Change of Laboratory Parameter|0|||
125127280|NCT02106156|450092209|FG002|Overall Study|Change of Laboratory Parameter|0|||
125127281|NCT02106156|450092207|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
125127282|NCT02106156|450092208|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
125127283|NCT02106156|450092209|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
125127284|NCT02106156|450092207|FG000|Overall Study|Relocation/Change of Physician|40|||
125127285|NCT02106156|450092208|FG001|Overall Study|Relocation/Change of Physician|1|||
125127286|NCT02106156|450092209|FG002|Overall Study|Relocation/Change of Physician|0|||
125127287|NCT05017480|450092216|FG000|Stage 1 Study|Withdrawal by Subject|8|||
125127288|NCT05017480|450092217|FG001|Stage 1 Study|Withdrawal by Subject|6|||
124957139|NCT00296504|449467920|FG005|Final Analysis|Pregnancy|0|||
124957140|NCT00296504|449467921|FG006|Final Analysis|Pregnancy|0|||
124957141|NCT00296504|449467922|FG007|Final Analysis|Pregnancy|0|||
124957142|NCT00296504|449467923|FG008|Final Analysis|Pregnancy|4|||
124957143|NCT00296504|449467915|FG000|Final Analysis|Tuberculosis|0|||
125127289|NCT05017480|450092218|FG002|Stage 1 Study|Withdrawal by Subject|0|||
125127290|NCT05017480|450092219|FG003|Stage 1 Study|Withdrawal by Subject|0|||
125127291|NCT05017480|450092220|FG004|Stage 1 Study|Withdrawal by Subject|0|||
124957144|NCT00296504|449467916|FG001|Final Analysis|Tuberculosis|0|||
124957145|NCT00296504|449467917|FG002|Final Analysis|Tuberculosis|0|||
124957146|NCT00296504|449467918|FG003|Final Analysis|Tuberculosis|0|||
124957147|NCT00296504|449467919|FG004|Final Analysis|Tuberculosis|0|||
124957148|NCT00296504|449467920|FG005|Final Analysis|Tuberculosis|0|||
124957149|NCT00296504|449467921|FG006|Final Analysis|Tuberculosis|0|||
124957150|NCT00296504|449467922|FG007|Final Analysis|Tuberculosis|0|||
124957151|NCT00296504|449467923|FG008|Final Analysis|Tuberculosis|1|||
125215491|NCT04076319|450417403|FG001|Overall Study|Death|0|||
125215492|NCT01054222|450417404|FG000|Overall Study|Lack of Efficacy|1|||
125215493|NCT01054222|450417404|FG000|Overall Study|Lost to Follow-up|4|||
125215494|NCT01054222|450417404|FG000|Overall Study|Withdrawal by Subject|6|||
125215495|NCT00824655|450417405|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
125215496|NCT00824655|450417406|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
124957152|NCT00296504|449467915|FG000|Final Analysis|Participant Moved to Another Country|0|||
124957153|NCT00296504|449467916|FG001|Final Analysis|Participant Moved to Another Country|0|||
124957154|NCT00296504|449467917|FG002|Final Analysis|Participant Moved to Another Country|0|||
124957155|NCT00296504|449467918|FG003|Final Analysis|Participant Moved to Another Country|0|||
124957156|NCT00296504|449467919|FG004|Final Analysis|Participant Moved to Another Country|0|||
124957157|NCT00296504|449467920|FG005|Final Analysis|Participant Moved to Another Country|0|||
124957158|NCT00296504|449467921|FG006|Final Analysis|Participant Moved to Another Country|0|||
124957159|NCT00296504|449467922|FG007|Final Analysis|Participant Moved to Another Country|0|||
125127292|NCT05017480|450092216|FG000|Stage 1 Study|Adverse Event|1|||
125127293|NCT05017480|450092217|FG001|Stage 1 Study|Adverse Event|1|||
125127294|NCT05017480|450092218|FG002|Stage 1 Study|Adverse Event|0|||
125127295|NCT05017480|450092219|FG003|Stage 1 Study|Adverse Event|0|||
125127296|NCT05017480|450092220|FG004|Stage 1 Study|Adverse Event|0|||
125127297|NCT05017480|450092216|FG000|Stage 1 Study|Poor Compliance|1|||
125127298|NCT05017480|450092217|FG001|Stage 1 Study|Poor Compliance|1|||
125127299|NCT05017480|450092218|FG002|Stage 1 Study|Poor Compliance|0|||
125127300|NCT05017480|450092219|FG003|Stage 1 Study|Poor Compliance|0|||
125127301|NCT05017480|450092220|FG004|Stage 1 Study|Poor Compliance|0|||
125127302|NCT05017480|450092216|FG000|Stage 1 Study|Physician Decision|0|||
125127303|NCT05017480|450092217|FG001|Stage 1 Study|Physician Decision|1|||
125127304|NCT05017480|450092218|FG002|Stage 1 Study|Physician Decision|0|||
125127305|NCT05017480|450092219|FG003|Stage 1 Study|Physician Decision|0|||
125127306|NCT05017480|450092220|FG004|Stage 1 Study|Physician Decision|0|||
125127307|NCT05017480|450092216|FG000|Stage 2 Study|Withdrawal by Subject|0|||
125127308|NCT05017480|450092217|FG001|Stage 2 Study|Withdrawal by Subject|0|||
125127309|NCT05017480|450092218|FG002|Stage 2 Study|Withdrawal by Subject|6|||
125127310|NCT05017480|450092219|FG003|Stage 2 Study|Withdrawal by Subject|9|||
125215497|NCT00824655|450417405|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
125215498|NCT00824655|450417406|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
124957160|NCT00296504|449467923|FG008|Final Analysis|Participant Moved to Another Country|1|||
124957161|NCT00296504|449467915|FG000|Final Analysis|Poor Adherence|0|||
124957162|NCT00296504|449467916|FG001|Final Analysis|Poor Adherence|0|||
124957163|NCT00296504|449467917|FG002|Final Analysis|Poor Adherence|0|||
125215499|NCT03504189|450417407|FG000|Overall Study|Withdrawal by Subject|1|||
124957164|NCT00296504|449467918|FG003|Final Analysis|Poor Adherence|0|||
124957165|NCT00296504|449467919|FG004|Final Analysis|Poor Adherence|0|||
125127311|NCT05017480|450092220|FG004|Stage 2 Study|Withdrawal by Subject|11|||
124957166|NCT00296504|449467920|FG005|Final Analysis|Poor Adherence|0|||
124957167|NCT00296504|449467921|FG006|Final Analysis|Poor Adherence|0|||
124957168|NCT00296504|449467922|FG007|Final Analysis|Poor Adherence|0|||
124957169|NCT00296504|449467923|FG008|Final Analysis|Poor Adherence|1|||
125127312|NCT05017480|450092216|FG000|Stage 2 Study|Lost to Follow-up|0|||
125127313|NCT05017480|450092217|FG001|Stage 2 Study|Lost to Follow-up|0|||
125127314|NCT05017480|450092218|FG002|Stage 2 Study|Lost to Follow-up|0|||
124957170|NCT02162771|449467930|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
124957171|NCT02162771|449467931|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
124957172|NCT02162771|449467930|FG000|Core Study Period (Part 2)|Adverse Event|4|||
124957173|NCT02162771|449467931|FG001|Core Study Period (Part 2)|Adverse Event|1|||
124957174|NCT02162771|449467930|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
124957175|NCT02162771|449467931|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
124957176|NCT02162771|449467930|FG000|Core Study Period (Part 2)|Physician Decision|0|||
124957177|NCT02162771|449467931|FG001|Core Study Period (Part 2)|Physician Decision|2|||
124957178|NCT02162771|449467930|FG000|Core Study Period (Part 2)|Death|1|||
124957179|NCT02162771|449467931|FG001|Core Study Period (Part 2)|Death|0|||
124957180|NCT02162771|449467930|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
124957181|NCT02162771|449467931|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
124957182|NCT02162771|449467930|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
124957183|NCT02162771|449467931|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
124957184|NCT02162771|449467930|FG000|Maintenance Study Period (Part 2)|Death|2|||
124957185|NCT02162771|449467931|FG001|Maintenance Study Period (Part 2)|Death|1|||
124957186|NCT02162771|449467930|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
124957187|NCT02162771|449467931|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
124957188|NCT02162771|449467930|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
124957189|NCT02162771|449467931|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
124957190|NCT02162771|449467930|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
124957191|NCT02162771|449467931|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
124957192|NCT00449033|449467945|FG000|Treatment Period|Adverse Event|117|||
124957193|NCT00449033|449467946|FG001|Treatment Period|Adverse Event|83|||
124957194|NCT00449033|449467945|FG000|Treatment Period|Death|21|||
124957195|NCT00449033|449467946|FG001|Treatment Period|Death|12|||
124957196|NCT00449033|449467945|FG000|Treatment Period|Lost to Follow-up|0|||
124957197|NCT00449033|449467946|FG001|Treatment Period|Lost to Follow-up|2|||
124957198|NCT00449033|449467945|FG000|Treatment Period|Physician Decision|4|||
124957199|NCT00449033|449467946|FG001|Treatment Period|Physician Decision|5|||
124957200|NCT00449033|449467945|FG000|Treatment Period|Protocol Violation|8|||
124957201|NCT00449033|449467946|FG001|Treatment Period|Protocol Violation|7|||
124957202|NCT00449033|449467945|FG000|Treatment Period|Disease Progression|231|||
124957203|NCT00449033|449467946|FG001|Treatment Period|Disease Progression|288|||
124957204|NCT00449033|449467945|FG000|Treatment Period|Consent Withdrawn|36|||
124957205|NCT00449033|449467946|FG001|Treatment Period|Consent Withdrawn|20|||
124957206|NCT00449033|449467945|FG000|Treatment Period|Amended Protocol Criteria|22|||
124957207|NCT00449033|449467946|FG001|Treatment Period|Amended Protocol Criteria|18|||
124957208|NCT00449033|449467945|FG000|Treatment Period|Non-compliance|7|||
124957209|NCT00449033|449467946|FG001|Treatment Period|Non-compliance|8|||
124957210|NCT00449033|449467945|FG000|Treatment Period|Second Malignancy|0|||
124957211|NCT00449033|449467946|FG001|Treatment Period|Second Malignancy|1|||
124957212|NCT00449033|449467945|FG000|Treatment Period|Reason Missing|0|||
124957213|NCT00449033|449467946|FG001|Treatment Period|Reason Missing|4|||
124957214|NCT00449033|449467945|FG000|Treatment Period|Treatment Ongoing|6|||
124957215|NCT00449033|449467946|FG001|Treatment Period|Treatment Ongoing|4|||
124957216|NCT00449033|449467945|FG000|Follow-up Period|Death|299|||
124957217|NCT00449033|449467946|FG001|Follow-up Period|Death|311|||
124957218|NCT00449033|449467945|FG000|Follow-up Period|Lost to Follow-up|6|||
124957219|NCT00449033|449467946|FG001|Follow-up Period|Lost to Follow-up|10|||
124957220|NCT00449033|449467945|FG000|Follow-up Period|Reason Missing|120|||
124957221|NCT00449033|449467946|FG001|Follow-up Period|Reason Missing|113|||
124957222|NCT04393779|449467947|FG000|Overall Study|Death|1|||
124957223|NCT04393779|449467947|FG000|Overall Study|Device reintervention or explant|4|||
124957224|NCT01190228|449467948|FG000|Overall Study|Protocol Violation|4|||
124957225|NCT01190228|449467949|FG001|Overall Study|Protocol Violation|0|||
124957226|NCT01190228|449467950|FG002|Overall Study|Protocol Violation|0|||
124957227|NCT01190228|449467948|FG000|Overall Study|Withdrawal by Subject|1|||
124957228|NCT01190228|449467949|FG001|Overall Study|Withdrawal by Subject|0|||
124957229|NCT01190228|449467950|FG002|Overall Study|Withdrawal by Subject|0|||
124957230|NCT01770509|449467952|FG000|Overall Study|Injury|0|||
124957231|NCT01770509|449467953|FG001|Overall Study|Injury|1|||
124957232|NCT01770509|449467952|FG000|Overall Study|Lost to Follow-up|1|||
124957233|NCT01770509|449467953|FG001|Overall Study|Lost to Follow-up|2|||
124957234|NCT00905255|449467958|FG000|Overall Study|Adverse Event|7|||
124957235|NCT00905255|449467959|FG001|Overall Study|Adverse Event|5|||
124957236|NCT00905255|449467958|FG000|Overall Study|Withdrawal by Subject|5|||
124957237|NCT00905255|449467959|FG001|Overall Study|Withdrawal by Subject|4|||
124957238|NCT00905255|449467958|FG000|Overall Study|Familial and Personal Reasons|1|||
124957239|NCT00905255|449467959|FG001|Overall Study|Familial and Personal Reasons|0|||
124957240|NCT00390806|449467962|FG000|Overall Study|Lost to Follow-up|7|||
124957241|NCT00390806|449467963|FG001|Overall Study|Lost to Follow-up|6|||
124957242|NCT00390806|449467962|FG000|Overall Study|Protocol Violation|2|||
124957243|NCT00390806|449467963|FG001|Overall Study|Protocol Violation|2|||
124957244|NCT00390806|449467962|FG000|Overall Study|Withdrawal by Subject|12|||
124957245|NCT00390806|449467963|FG001|Overall Study|Withdrawal by Subject|15|||
124957246|NCT00390806|449467962|FG000|Overall Study|Investigator Decision|4|||
124957247|NCT00390806|449467963|FG001|Overall Study|Investigator Decision|6|||
124957248|NCT00390806|449467962|FG000|Overall Study|Death|1|||
124957249|NCT00390806|449467963|FG001|Overall Study|Death|0|||
124957250|NCT00390806|449467962|FG000|Overall Study|Physician Decision|0|||
124957251|NCT00390806|449467963|FG001|Overall Study|Physician Decision|1|||
124957252|NCT00390806|449467962|FG000|Overall Study|Ongoing|4|||
124957253|NCT00390806|449467963|FG001|Overall Study|Ongoing|2|||
124957254|NCT04150250|449467966|FG000|Overall Study|Lost to Follow-up|0|||
124957255|NCT04150250|449467967|FG001|Overall Study|Lost to Follow-up|2|||
124957256|NCT01786551|449467968|FG000|Overall Study|Participant withdrew consent|2|||
124957257|NCT00170950|449467970|FG000|Overall Study|Death|236|||
124957258|NCT00170950|449467971|FG001|Overall Study|Death|274|||
124957259|NCT00170950|449467970|FG000|Overall Study|Withdrawal by Subject|496|||
124957260|NCT00170950|449467971|FG001|Overall Study|Withdrawal by Subject|498|||
124957261|NCT00170950|449467970|FG000|Overall Study|Lost to Follow-up|134|||
124957262|NCT00170950|449467971|FG001|Overall Study|Lost to Follow-up|115|||
124957263|NCT00170950|449467970|FG000|Overall Study|Missing|2|||
125030952|NCT04957290|449735093|FG001|Overall Study|unacceptable toxicity|0|||
125030953|NCT04957290|449735094|FG002|Overall Study|unacceptable toxicity|1|||
125030954|NCT04957290|449735095|FG003|Overall Study|unacceptable toxicity|0|||
125030955|NCT04957290|449735096|FG004|Overall Study|unacceptable toxicity|0|||
125030956|NCT04957290|449735097|FG005|Overall Study|unacceptable toxicity|0|||
125030957|NCT04957290|449735092|FG000|Overall Study|Adverse Event|0|||
125030958|NCT04957290|449735093|FG001|Overall Study|Adverse Event|0|||
125030959|NCT04957290|449735094|FG002|Overall Study|Adverse Event|1|||
125030960|NCT04957290|449735095|FG003|Overall Study|Adverse Event|0|||
125030961|NCT04957290|449735096|FG004|Overall Study|Adverse Event|0|||
125030962|NCT04957290|449735097|FG005|Overall Study|Adverse Event|0|||
125030963|NCT04957290|449735092|FG000|Overall Study|study terminated by sponsor|0|||
125030964|NCT04957290|449735093|FG001|Overall Study|study terminated by sponsor|0|||
125030965|NCT04957290|449735094|FG002|Overall Study|study terminated by sponsor|2|||
125030966|NCT04957290|449735095|FG003|Overall Study|study terminated by sponsor|0|||
125030967|NCT04957290|449735096|FG004|Overall Study|study terminated by sponsor|0|||
125030968|NCT04957290|449735097|FG005|Overall Study|study terminated by sponsor|0|||
125030969|NCT00896532|449735098|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125030970|NCT00896532|449735099|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125030971|NCT00896532|449735100|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125030972|NCT00896532|449735101|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
125030973|NCT00896532|449735102|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125030974|NCT00896532|449735103|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
125030975|NCT00896532|449735104|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125030976|NCT00896532|449735105|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125030977|NCT00896532|449735106|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125030978|NCT00896532|449735107|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125030979|NCT00896532|449735108|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125030980|NCT00896532|449735109|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125030981|NCT00896532|449735110|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125030982|NCT00896532|449735111|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125030983|NCT00896532|449735112|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125030984|NCT00896532|449735113|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125030985|NCT00896532|449735114|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125030986|NCT00896532|449735115|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125030987|NCT00896532|449735116|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125030988|NCT00896532|449735117|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125030989|NCT00896532|449735118|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125030990|NCT00896532|449735119|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125030991|NCT00896532|449735120|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125030992|NCT00896532|449735098|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
125030993|NCT00896532|449735099|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
125030994|NCT00896532|449735100|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
125030995|NCT00896532|449735101|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
125030996|NCT00896532|449735102|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
125030997|NCT00896532|449735103|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
125030998|NCT00896532|449735104|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
125127315|NCT05017480|450092219|FG003|Stage 2 Study|Lost to Follow-up|2|||
125127316|NCT05017480|450092220|FG004|Stage 2 Study|Lost to Follow-up|1|||
124957264|NCT00170950|449467971|FG001|Overall Study|Missing|1|||
124957265|NCT00170950|449467970|FG000|Overall Study|Termination Data Not Recorded|17|||
124957266|NCT00170950|449467971|FG001|Overall Study|Termination Data Not Recorded|22|||
124957267|NCT00748098|449467972|FG000|First Treatment Intervention Period|Adverse Event|1|||
125127317|NCT05017480|450092216|FG000|Stage 2 Study|Adverse Event|0|||
125127318|NCT05017480|450092217|FG001|Stage 2 Study|Adverse Event|0|||
125127319|NCT05017480|450092218|FG002|Stage 2 Study|Adverse Event|0|||
125127320|NCT05017480|450092219|FG003|Stage 2 Study|Adverse Event|1|||
125127321|NCT05017480|450092220|FG004|Stage 2 Study|Adverse Event|0|||
125127322|NCT05017480|450092216|FG000|Stage 2 Study|COVID-19|0|||
125127323|NCT05017480|450092217|FG001|Stage 2 Study|COVID-19|0|||
125127324|NCT05017480|450092218|FG002|Stage 2 Study|COVID-19|0|||
125127325|NCT05017480|450092219|FG003|Stage 2 Study|COVID-19|1|||
125127326|NCT05017480|450092220|FG004|Stage 2 Study|COVID-19|0|||
125127327|NCT05017480|450092216|FG000|Stage 2 Study|Pregnancy|0|||
125127328|NCT05017480|450092217|FG001|Stage 2 Study|Pregnancy|0|||
125127329|NCT05017480|450092218|FG002|Stage 2 Study|Pregnancy|0|||
125127330|NCT05017480|450092219|FG003|Stage 2 Study|Pregnancy|0|||
125127331|NCT05017480|450092220|FG004|Stage 2 Study|Pregnancy|1|||
125127332|NCT01136382|450092221|FG000|Overall Study|Other|8|||
125127333|NCT01136382|450092222|FG001|Overall Study|Other|3|||
125127334|NCT01136382|450092221|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
125127335|NCT01136382|450092222|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
125127336|NCT01136382|450092221|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
125127337|NCT01136382|450092222|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
125127338|NCT01136382|450092221|FG000|Overall Study|Withdrawal by Subject|4|||
125127339|NCT01136382|450092222|FG001|Overall Study|Withdrawal by Subject|1|||
125127340|NCT00485472|450092227|FG000|Overall Study|Adverse Event|8|||
125127341|NCT00485472|450092228|FG001|Overall Study|Adverse Event|5|||
125127342|NCT00485472|450092227|FG000|Overall Study|Lack of Efficacy|5|||
125127343|NCT00485472|450092228|FG001|Overall Study|Lack of Efficacy|4|||
125127344|NCT00485472|450092227|FG000|Overall Study|Withdrawal by Subject|1|||
125127345|NCT00485472|450092228|FG001|Overall Study|Withdrawal by Subject|0|||
125127346|NCT00485472|450092227|FG000|Overall Study|Protocol Violation|0|||
125127347|NCT00485472|450092228|FG001|Overall Study|Protocol Violation|1|||
125127348|NCT00485472|450092227|FG000|Overall Study|Other|2|||
125127349|NCT00485472|450092228|FG001|Overall Study|Other|1|||
125127350|NCT00485472|450092227|FG000|Overall Study|Lost to Follow-up|0|||
125127351|NCT00485472|450092228|FG001|Overall Study|Lost to Follow-up|1|||
125127352|NCT00088829|450092230|FG000|Overall Study|PI left institution and study was close|22|||
124957268|NCT00748098|449467973|FG001|First Treatment Intervention Period|Adverse Event|1|||
124957269|NCT00748098|449467972|FG000|First Treatment Intervention Period|Protocol Violation|1|||
124957270|NCT00748098|449467973|FG001|First Treatment Intervention Period|Protocol Violation|0|||
124957271|NCT00748098|449467972|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
124957272|NCT00748098|449467973|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
124957273|NCT00748098|449467972|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
124957274|NCT00748098|449467973|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
124957275|NCT00748098|449467972|FG000|First Taper Period|Protocol Violation|1|||
125127353|NCT00633594|450092231|FG000|Overall Study|Adverse Event|0|||
125127354|NCT00633594|450092232|FG001|Overall Study|Adverse Event|4|||
125127355|NCT00633594|450092233|FG002|Overall Study|Adverse Event|7|||
124957276|NCT00748098|449467973|FG001|First Taper Period|Protocol Violation|0|||
124957277|NCT00748098|449467972|FG000|First Taper Period|Withdrawal by Subject|2|||
124957278|NCT00748098|449467973|FG001|First Taper Period|Withdrawal by Subject|0|||
124957279|NCT00748098|449467972|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
124957280|NCT00748098|449467973|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
124957281|NCT00748098|449467972|FG000|1-Week Washout Period|Adverse Event|0|||
124957282|NCT00748098|449467973|FG001|1-Week Washout Period|Adverse Event|1|||
124957283|NCT00748098|449467972|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
125127356|NCT00633594|450092231|FG000|Overall Study|Death|0|||
125127357|NCT00633594|450092232|FG001|Overall Study|Death|1|||
124957284|NCT00748098|449467973|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
125127358|NCT00633594|450092233|FG002|Overall Study|Death|2|||
125127359|NCT00633594|450092231|FG000|Overall Study|Disease Progression|0|||
125127360|NCT00633594|450092232|FG001|Overall Study|Disease Progression|0|||
125127361|NCT00633594|450092233|FG002|Overall Study|Disease Progression|1|||
125127362|NCT00365300|450092238|FG000|Open-label Phase|Adverse Event|4|||
125127363|NCT00365300|450092239|FG001|Open-label Phase|Adverse Event|0|||
125127364|NCT00365300|450092238|FG000|Open-label Phase|Failed to Return|1|||
125127365|NCT00365300|450092239|FG001|Open-label Phase|Failed to Return|0|||
125127366|NCT00365300|450092238|FG000|Open-label Phase|Physician Decision|1|||
125127367|NCT00365300|450092239|FG001|Open-label Phase|Physician Decision|0|||
125127368|NCT00365300|450092238|FG000|Open-label Phase|Noncompliance|9|||
125127369|NCT00365300|450092239|FG001|Open-label Phase|Noncompliance|0|||
125127370|NCT00365300|450092238|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
125127371|NCT00365300|450092239|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
125127372|NCT00365300|450092238|FG000|Open-label Phase|Protocol Violation|1|||
125127373|NCT00365300|450092239|FG001|Open-label Phase|Protocol Violation|0|||
124957285|NCT00748098|449467972|FG000|Second Treatment Intervention Period|Adverse Event|4|||
124957286|NCT00748098|449467973|FG001|Second Treatment Intervention Period|Adverse Event|1|||
125127374|NCT00365300|450092238|FG000|Open-label Phase|Lack of Efficacy|1|||
125127375|NCT00365300|450092239|FG001|Open-label Phase|Lack of Efficacy|0|||
125127376|NCT00365300|450092238|FG000|Open-label Phase|Patient skipped open label phase|1|||
125127377|NCT00365300|450092239|FG001|Open-label Phase|Patient skipped open label phase|0|||
125127378|NCT00365300|450092238|FG000|Double-blind Phase|Failed to return|1|||
125127379|NCT00365300|450092239|FG001|Double-blind Phase|Failed to return|0|||
125127380|NCT00365300|450092238|FG000|Double-blind Phase|Noncompliance|1|||
125127381|NCT00365300|450092239|FG001|Double-blind Phase|Noncompliance|1|||
125127382|NCT00365300|450092238|FG000|Double-blind Phase|Withdrawal by Subject|0|||
125127383|NCT00365300|450092239|FG001|Double-blind Phase|Withdrawal by Subject|1|||
125127384|NCT00365300|450092238|FG000|Double-blind Phase|Protocol Violation|3|||
125127385|NCT00365300|450092239|FG001|Double-blind Phase|Protocol Violation|1|||
125127386|NCT00365300|450092238|FG000|Double-blind Phase|Lack of Efficacy|6|||
125127387|NCT00365300|450092239|FG001|Double-blind Phase|Lack of Efficacy|6|||
125127388|NCT02896361|450092240|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
125127389|NCT02896361|450092241|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
125127390|NCT02896361|450092242|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
125127391|NCT02896361|450092240|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
125127392|NCT02896361|450092241|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
125127393|NCT02896361|450092242|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
125127394|NCT01287013|450092245|FG000|Overall Study|Non-evaluable|3|||
125127395|NCT01287013|450092246|FG001|Overall Study|Non-evaluable|5|||
124957287|NCT00748098|449467972|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
124957288|NCT00748098|449467973|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
124957289|NCT00748098|449467972|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
124957290|NCT00748098|449467973|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
124957291|NCT02442622|449467974|FG000|Overall Study|Withdrawal by Subject|3|||
124957292|NCT02442622|449467975|FG001|Overall Study|Withdrawal by Subject|1|||
124957293|NCT01232569|449469690|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
124957294|NCT01232569|449469691|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
124957295|NCT01232569|449469692|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
124957296|NCT01232569|449469693|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
124957297|NCT01232569|449469690|FG000|Double-blind Treatment Period|Escape|2|||
124957298|NCT01232569|449469691|FG001|Double-blind Treatment Period|Escape|2|||
124957299|NCT01232569|449469692|FG002|Double-blind Treatment Period|Escape|0|||
124957300|NCT01232569|449469693|FG003|Double-blind Treatment Period|Escape|0|||
124957301|NCT01232569|449469690|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
124957302|NCT01232569|449469691|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
124957303|NCT01232569|449469692|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
124957304|NCT01232569|449469693|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
124957305|NCT01232569|449469690|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
124957306|NCT01232569|449469691|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
124957307|NCT01232569|449469692|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
124957308|NCT01232569|449469693|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
124957309|NCT01232569|449469690|FG000|Double-blind Treatment Period|Physician Decision|1|||
124957310|NCT01232569|449469691|FG001|Double-blind Treatment Period|Physician Decision|0|||
124957311|NCT01232569|449469692|FG002|Double-blind Treatment Period|Physician Decision|0|||
124957312|NCT01232569|449469693|FG003|Double-blind Treatment Period|Physician Decision|0|||
124957313|NCT01232569|449469690|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
124957314|NCT01232569|449469691|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
124957315|NCT01232569|449469692|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
124957316|NCT01232569|449469693|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
124957317|NCT01232569|449469690|FG000|Double-blind Treatment Period|Death|2|||
124957318|NCT01232569|449469691|FG001|Double-blind Treatment Period|Death|0|||
124957319|NCT01232569|449469692|FG002|Double-blind Treatment Period|Death|0|||
124957320|NCT01232569|449469693|FG003|Double-blind Treatment Period|Death|0|||
124957321|NCT04044352|449469694|FG000|Overall Study|Lost to Follow-up|9|||
124957322|NCT04044352|449469694|FG000|Overall Study|Withdrawal by Subject|2|||
124957323|NCT00651937|449469695|FG000|Overall Study|Withdrawal by Subject|4|||
124957324|NCT00651937|449469696|FG001|Overall Study|Withdrawal by Subject|1|||
124957325|NCT00511147|449469697|FG000|Overall Study|Withdrawal by Subject|1|||
124957326|NCT00511147|449469697|FG000|Overall Study|Disease progression|5|||
125127396|NCT01287013|450092247|FG002|Overall Study|Non-evaluable|21|||
125127397|NCT01045096|450092248|FG000|Overall Study|Withdrawal by Subject|2|||
125127398|NCT01045096|450092249|FG001|Overall Study|Withdrawal by Subject|0|||
125127399|NCT01045096|450092250|FG002|Overall Study|Withdrawal by Subject|0|||
125127400|NCT01045096|450092248|FG000|Overall Study|Other|1|||
124957327|NCT00511147|449469697|FG000|Overall Study|Required platelet transfusion|1|||
124957328|NCT00396097|449469699|FG000|Overall Study|Withdrawal by Subject|17|||
124957329|NCT00396097|449469700|FG001|Overall Study|Withdrawal by Subject|17|||
124957330|NCT00396097|449469699|FG000|Overall Study|Lost to Follow-up|4|||
124957331|NCT00396097|449469700|FG001|Overall Study|Lost to Follow-up|9|||
124957332|NCT00396097|449469699|FG000|Overall Study|Other|3|||
124957333|NCT00396097|449469700|FG001|Overall Study|Other|5|||
125215500|NCT03504189|450417407|FG000|Overall Study|Screening Failure|1|||
125215501|NCT03504189|450417407|FG000|Overall Study|Device Failure|2|||
125215502|NCT04336475|450417408|FG000|Overall Study|pain|1|||
125215503|NCT04336475|450417409|FG001|Overall Study|pain|0|||
125215504|NCT04336475|450417408|FG000|Overall Study|upper respiratory infection|1|||
125215505|NCT04336475|450417409|FG001|Overall Study|upper respiratory infection|0|||
125215506|NCT04336475|450417408|FG000|Overall Study|Lost to Follow-up|0|||
125215507|NCT04336475|450417409|FG001|Overall Study|Lost to Follow-up|2|||
124957334|NCT00396097|449469699|FG000|Overall Study|Protocol Violation|0|||
124957335|NCT00396097|449469700|FG001|Overall Study|Protocol Violation|6|||
124957336|NCT00396097|449469699|FG000|Overall Study|Adverse Event|1|||
124957337|NCT00396097|449469700|FG001|Overall Study|Adverse Event|5|||
124957338|NCT00396097|449469699|FG000|Overall Study|Insufficient Clinical Response|1|||
124957339|NCT00396097|449469700|FG001|Overall Study|Insufficient Clinical Response|4|||
124957340|NCT03461211|449469701|FG000|Overall Study|Adverse Event|1|||
124957341|NCT03461211|449469702|FG001|Overall Study|Adverse Event|1|||
124957342|NCT03461211|449469701|FG000|Overall Study|Lack of Efficacy|0|||
124957343|NCT03461211|449469702|FG001|Overall Study|Lack of Efficacy|1|||
124957344|NCT04736602|449469709|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
124957345|NCT04736602|449469709|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
125030999|NCT00896532|449735105|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125031000|NCT00896532|449735106|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125031001|NCT00896532|449735107|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125031002|NCT00896532|449735108|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125031003|NCT00896532|449735109|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125031004|NCT00896532|449735110|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125031005|NCT00896532|449735111|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125031006|NCT00896532|449735112|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125031007|NCT00896532|449735113|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125031008|NCT00896532|449735114|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125031009|NCT00896532|449735115|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125031010|NCT00896532|449735116|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125031011|NCT00896532|449735117|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125031012|NCT00896532|449735118|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125031013|NCT00896532|449735119|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125031014|NCT00896532|449735120|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125031015|NCT00896532|449735098|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
125031016|NCT00896532|449735099|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
125031017|NCT00896532|449735100|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
125031018|NCT00896532|449735101|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
125031019|NCT00896532|449735102|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
125031020|NCT00896532|449735103|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
125031021|NCT00896532|449735104|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
125031022|NCT00896532|449735105|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
125031023|NCT00896532|449735106|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125031024|NCT00896532|449735107|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125031025|NCT00896532|449735108|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125031026|NCT00896532|449735109|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125031027|NCT00896532|449735110|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125031028|NCT00896532|449735111|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125031029|NCT00896532|449735112|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125031030|NCT00896532|449735113|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125031031|NCT00896532|449735114|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125215508|NCT02171429|450417421|FG000|Overall Study|Other|0|||
125215509|NCT02171429|450417422|FG001|Overall Study|Other|1|||
125215510|NCT02171429|450417423|FG002|Overall Study|Other|1|||
124957346|NCT00475735|449469711|FG000|Treatment Period 1|Adverse Event|2|||
124957347|NCT00475735|449469712|FG001|Treatment Period 1|Adverse Event|0|||
124957348|NCT00475735|449469713|FG002|Treatment Period 1|Adverse Event|0|||
124957349|NCT00475735|449469714|FG003|Treatment Period 1|Adverse Event|0|||
125127401|NCT01045096|450092249|FG001|Overall Study|Other|0|||
125127402|NCT01045096|450092250|FG002|Overall Study|Other|0|||
125127403|NCT01179048|450092251|FG000|Overall Study|Withdrawn - does not allow contact|4|||
125127404|NCT01179048|450092252|FG001|Overall Study|Withdrawn - does not allow contact|8|||
125127405|NCT01179048|450092251|FG000|Overall Study|Lost to Follow-up|8|||
125127406|NCT01179048|450092252|FG001|Overall Study|Lost to Follow-up|9|||
125127407|NCT01179048|450092251|FG000|Overall Study|Alive|127|||
125127408|NCT01179048|450092252|FG001|Overall Study|Alive|142|||
125127409|NCT02109042|450092253|FG000|Overall Study|Sponsor Decision|15|||
125127410|NCT01511939|450092254|FG000|Overall Study|Withdrawal by Subject|2|||
125127411|NCT01511939|450092255|FG001|Overall Study|Withdrawal by Subject|1|||
125127412|NCT01511939|450092256|FG002|Overall Study|Withdrawal by Subject|0|||
125127413|NCT03203447|450092257|FG000|Overall Study|Withdrawal by Subject|2|||
125127414|NCT03203447|450092258|FG001|Overall Study|Withdrawal by Subject|1|||
125127415|NCT03203447|450092257|FG000|Overall Study|Lost to Follow-up|1|||
125127416|NCT03203447|450092258|FG001|Overall Study|Lost to Follow-up|10|||
125127417|NCT03203447|450092257|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
125127418|NCT03203447|450092258|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
125127419|NCT00324168|450092259|FG000|Overall Study|Lost to Follow-up|19|||
125127420|NCT00324168|450092260|FG001|Overall Study|Lost to Follow-up|18|||
125127421|NCT00324168|450092259|FG000|Overall Study|Death|3|||
125127422|NCT00324168|450092260|FG001|Overall Study|Death|3|||
125127423|NCT00324168|450092259|FG000|Overall Study|Patient did not visit in f/u window|6|||
125127424|NCT00324168|450092260|FG001|Overall Study|Patient did not visit in f/u window|9|||
125127425|NCT03497897|450092264|FG000|Overall Study|Adverse Event|1|||
125127426|NCT03497897|450092265|FG001|Overall Study|Adverse Event|1|||
125127427|NCT03497897|450092266|FG002|Overall Study|Adverse Event|1|||
125127428|NCT03497897|450092264|FG000|Overall Study|Lost to Follow-up|2|||
125127429|NCT03497897|450092265|FG001|Overall Study|Lost to Follow-up|0|||
125127430|NCT03497897|450092266|FG002|Overall Study|Lost to Follow-up|2|||
125127431|NCT03497897|450092264|FG000|Overall Study|Physician Decision|1|||
125127432|NCT03497897|450092265|FG001|Overall Study|Physician Decision|0|||
125127433|NCT03497897|450092266|FG002|Overall Study|Physician Decision|0|||
125127434|NCT03497897|450092264|FG000|Overall Study|Subject/Guardian Decision|2|||
125127435|NCT03497897|450092265|FG001|Overall Study|Subject/Guardian Decision|1|||
125127436|NCT03497897|450092266|FG002|Overall Study|Subject/Guardian Decision|3|||
125127437|NCT00528606|450092272|FG000|Overall Study|Withdrew consent|4|||
125127438|NCT00528606|450092273|FG001|Overall Study|Withdrew consent|3|||
125127439|NCT00528606|450092272|FG000|Overall Study|Lost to Follow-up|4|||
125127440|NCT00528606|450092273|FG001|Overall Study|Lost to Follow-up|1|||
125127441|NCT00528606|450092272|FG000|Overall Study|Adverse Event|3|||
125127442|NCT00528606|450092273|FG001|Overall Study|Adverse Event|0|||
125127443|NCT00528606|450092272|FG000|Overall Study|Other|2|||
125127444|NCT00528606|450092273|FG001|Overall Study|Other|0|||
125127445|NCT03478397|450092280|FG000|Overall Study|Refused to participate|31|||
125127446|NCT03478397|450092281|FG001|Overall Study|Refused to participate|7|||
125127447|NCT02188303|450092282|FG000|Overall Study|Adverse Event|0|||
125127448|NCT02188303|450092283|FG001|Overall Study|Adverse Event|0|||
125127449|NCT02188303|450092284|FG002|Overall Study|Adverse Event|0|||
125127450|NCT02188303|450092285|FG003|Overall Study|Adverse Event|0|||
125127451|NCT02188303|450092286|FG004|Overall Study|Adverse Event|0|||
125127452|NCT02188303|450092287|FG005|Overall Study|Adverse Event|2|||
125127453|NCT02188303|450092288|FG006|Overall Study|Adverse Event|0|||
125127454|NCT02188303|450092289|FG007|Overall Study|Adverse Event|2|||
125127455|NCT02188303|450092282|FG000|Overall Study|Dose Termination Criteria Met|0|||
125127456|NCT02188303|450092283|FG001|Overall Study|Dose Termination Criteria Met|0|||
125127457|NCT02188303|450092284|FG002|Overall Study|Dose Termination Criteria Met|0|||
125127458|NCT02188303|450092285|FG003|Overall Study|Dose Termination Criteria Met|0|||
125127459|NCT02188303|450092286|FG004|Overall Study|Dose Termination Criteria Met|0|||
125127460|NCT02188303|450092287|FG005|Overall Study|Dose Termination Criteria Met|0|||
125127461|NCT02188303|450092288|FG006|Overall Study|Dose Termination Criteria Met|2|||
125127462|NCT02188303|450092289|FG007|Overall Study|Dose Termination Criteria Met|4|||
125127463|NCT04206332|450092290|FG000|Part A|Lost to Follow-up|0|||
125215511|NCT02171429|450417421|FG000|Overall Study|Non-Compliance|0|||
125215512|NCT02171429|450417422|FG001|Overall Study|Non-Compliance|0|||
125127464|NCT04206332|450092291|FG001|Part A|Lost to Follow-up|1|||
125127465|NCT04206332|450092292|FG002|Part A|Lost to Follow-up|0|||
125127466|NCT04206332|450092293|FG003|Part A|Lost to Follow-up|0|||
125127467|NCT04206332|450092294|FG004|Part A|Lost to Follow-up|0|||
125127468|NCT04206332|450092295|FG005|Part A|Lost to Follow-up|0|||
125127469|NCT04206332|450092296|FG006|Part A|Lost to Follow-up|0|||
125127470|NCT04206332|450092297|FG007|Part A|Lost to Follow-up|0|||
125127471|NCT04206332|450092298|FG008|Part A|Lost to Follow-up|0|||
125127472|NCT04206332|450092299|FG009|Part A|Lost to Follow-up|0|||
125127473|NCT04206332|450092300|FG010|Part A|Lost to Follow-up|0|||
125127474|NCT04206332|450092301|FG011|Part A|Lost to Follow-up|0|||
125127475|NCT04206332|450092302|FG012|Part A|Lost to Follow-up|0|||
125215513|NCT02171429|450417423|FG002|Overall Study|Non-Compliance|1|||
125127476|NCT04206332|450092303|FG013|Part A|Lost to Follow-up|0|||
124957350|NCT00475735|449469715|FG004|Treatment Period 1|Adverse Event|0|||
124957351|NCT00475735|449469716|FG005|Treatment Period 1|Adverse Event|0|||
124957352|NCT00475735|449469711|FG000|Treatment Period 1|Lack of Efficacy|1|||
124957353|NCT00475735|449469712|FG001|Treatment Period 1|Lack of Efficacy|0|||
124957354|NCT00475735|449469713|FG002|Treatment Period 1|Lack of Efficacy|0|||
124957355|NCT00475735|449469714|FG003|Treatment Period 1|Lack of Efficacy|0|||
124957356|NCT00475735|449469715|FG004|Treatment Period 1|Lack of Efficacy|0|||
124957357|NCT00475735|449469716|FG005|Treatment Period 1|Lack of Efficacy|0|||
124957358|NCT00475735|449469711|FG000|Treatment Period 1|Lost to Follow-up|0|||
124957359|NCT00475735|449469712|FG001|Treatment Period 1|Lost to Follow-up|0|||
124957360|NCT00475735|449469713|FG002|Treatment Period 1|Lost to Follow-up|0|||
124957361|NCT00475735|449469714|FG003|Treatment Period 1|Lost to Follow-up|0|||
124957362|NCT00475735|449469715|FG004|Treatment Period 1|Lost to Follow-up|0|||
124957363|NCT00475735|449469716|FG005|Treatment Period 1|Lost to Follow-up|1|||
124957364|NCT00475735|449469711|FG000|Treatment Period 1|Protocol Violation|0|||
125031032|NCT00896532|449735115|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125031033|NCT00896532|449735116|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125031034|NCT00896532|449735117|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125031035|NCT00896532|449735118|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125031036|NCT00896532|449735119|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125031037|NCT00896532|449735120|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125031038|NCT00896532|449735098|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125031039|NCT00896532|449735099|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125031040|NCT00896532|449735100|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
125031041|NCT00896532|449735101|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125031042|NCT00896532|449735102|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
125031043|NCT00896532|449735103|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125031044|NCT00896532|449735104|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125031045|NCT00896532|449735105|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125031046|NCT00896532|449735106|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125031047|NCT00896532|449735107|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125031048|NCT00896532|449735108|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125031049|NCT00896532|449735109|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125031050|NCT00896532|449735110|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125031051|NCT00896532|449735111|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125031052|NCT00896532|449735112|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125031053|NCT00896532|449735113|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125031054|NCT00896532|449735114|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125031055|NCT00896532|449735115|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125031056|NCT00896532|449735116|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125031057|NCT00896532|449735117|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125031058|NCT00896532|449735118|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125031059|NCT00896532|449735119|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125031060|NCT00896532|449735120|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125031061|NCT00896532|449735098|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
125031062|NCT00896532|449735099|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125031063|NCT00896532|449735100|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125031064|NCT00896532|449735101|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
125031065|NCT00896532|449735102|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125031066|NCT00896532|449735103|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125031067|NCT00896532|449735104|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125031068|NCT00896532|449735105|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125031069|NCT00896532|449735106|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125031070|NCT00896532|449735107|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125031071|NCT00896532|449735108|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125031072|NCT00896532|449735109|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125031073|NCT00896532|449735110|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125031074|NCT00896532|449735111|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125031075|NCT00896532|449735112|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125031076|NCT00896532|449735113|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125031077|NCT00896532|449735114|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125031078|NCT00896532|449735115|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125031079|NCT00896532|449735116|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125031080|NCT00896532|449735117|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125031081|NCT00896532|449735118|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125031082|NCT00896532|449735119|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124957365|NCT00475735|449469712|FG001|Treatment Period 1|Protocol Violation|0|||
125127477|NCT04206332|450092304|FG014|Part A|Lost to Follow-up|0|||
125127478|NCT04206332|450092305|FG015|Part A|Lost to Follow-up|0|||
125127479|NCT04206332|450092306|FG016|Part A|Lost to Follow-up|0|||
125127480|NCT04206332|450092290|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127481|NCT04206332|450092291|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127482|NCT04206332|450092292|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127483|NCT04206332|450092293|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127484|NCT04206332|450092294|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127485|NCT04206332|450092295|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
125127486|NCT04206332|450092296|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127487|NCT04206332|450092297|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127488|NCT04206332|450092298|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127489|NCT04206332|450092299|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127490|NCT04206332|450092300|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127491|NCT04206332|450092301|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127492|NCT04206332|450092302|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127493|NCT04206332|450092303|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127494|NCT04206332|450092304|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127495|NCT04206332|450092305|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127496|NCT04206332|450092306|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127497|NCT04206332|450092290|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127498|NCT04206332|450092291|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127499|NCT04206332|450092292|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127500|NCT04206332|450092293|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127501|NCT04206332|450092294|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125215514|NCT02171429|450417421|FG000|Overall Study|Physician Decision|0|||
125215515|NCT02171429|450417422|FG001|Overall Study|Physician Decision|0|||
125215516|NCT02171429|450417423|FG002|Overall Study|Physician Decision|1|||
125215517|NCT02171429|450417421|FG000|Overall Study|Withdrawal by Subject|1|||
125215518|NCT02171429|450417422|FG001|Overall Study|Withdrawal by Subject|1|||
125215519|NCT02171429|450417423|FG002|Overall Study|Withdrawal by Subject|1|||
125215520|NCT02171429|450417421|FG000|Overall Study|Lost to Follow-up|0|||
125215521|NCT02171429|450417422|FG001|Overall Study|Lost to Follow-up|1|||
125215522|NCT02171429|450417423|FG002|Overall Study|Lost to Follow-up|0|||
125215523|NCT02171429|450417421|FG000|Overall Study|Death|0|||
125215524|NCT02171429|450417422|FG001|Overall Study|Death|0|||
125215525|NCT02171429|450417423|FG002|Overall Study|Death|1|||
125215526|NCT01763203|450417424|FG000|Overall Study|Death|4|||
125215527|NCT01763203|450417425|FG001|Overall Study|Death|7|||
125215528|NCT01763203|450417424|FG000|Overall Study|Lost to Follow-up|12|||
125215529|NCT01763203|450417425|FG001|Overall Study|Lost to Follow-up|12|||
125215530|NCT01763203|450417424|FG000|Overall Study|Withdrawal by Subject|8|||
125215531|NCT01763203|450417425|FG001|Overall Study|Withdrawal by Subject|12|||
125215532|NCT01763203|450417424|FG000|Overall Study|Moved out of study region|7|||
125215533|NCT01763203|450417425|FG001|Overall Study|Moved out of study region|10|||
125215534|NCT01763203|450417424|FG000|Overall Study|Physician Decision|2|||
125215535|NCT01763203|450417425|FG001|Overall Study|Physician Decision|1|||
125215536|NCT02187861|450417426|FG000|Overall Study|Adverse Event|2|||
125215537|NCT02187861|450417427|FG001|Overall Study|Adverse Event|1|||
125215538|NCT02187861|450417428|FG002|Overall Study|Adverse Event|2|||
125215539|NCT02187861|450417429|FG003|Overall Study|Adverse Event|1|||
125215540|NCT02187861|450417426|FG000|Overall Study|Death|0|||
125215541|NCT02187861|450417427|FG001|Overall Study|Death|3|||
125215542|NCT02187861|450417428|FG002|Overall Study|Death|1|||
125215543|NCT02187861|450417429|FG003|Overall Study|Death|2|||
125215544|NCT02187861|450417426|FG000|Overall Study|Physician Decision|0|||
125215545|NCT02187861|450417427|FG001|Overall Study|Physician Decision|1|||
125215546|NCT02187861|450417428|FG002|Overall Study|Physician Decision|0|||
125215547|NCT02187861|450417429|FG003|Overall Study|Physician Decision|3|||
125215548|NCT02187861|450417426|FG000|Overall Study|Progressive Disease|4|||
125215549|NCT02187861|450417427|FG001|Overall Study|Progressive Disease|42|||
125215550|NCT02187861|450417428|FG002|Overall Study|Progressive Disease|19|||
125215551|NCT02187861|450417429|FG003|Overall Study|Progressive Disease|22|||
125215552|NCT02187861|450417426|FG000|Overall Study|Withdrawal by Subject|0|||
125215553|NCT02187861|450417427|FG001|Overall Study|Withdrawal by Subject|0|||
124957366|NCT00475735|449469713|FG002|Treatment Period 1|Protocol Violation|0|||
125215554|NCT02187861|450417428|FG002|Overall Study|Withdrawal by Subject|3|||
125127502|NCT04206332|450092295|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127503|NCT04206332|450092296|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127504|NCT04206332|450092297|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
125127505|NCT04206332|450092298|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127506|NCT04206332|450092299|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127507|NCT04206332|450092300|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
125127508|NCT04206332|450092301|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127509|NCT04206332|450092302|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127510|NCT04206332|450092303|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127511|NCT04206332|450092304|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127512|NCT04206332|450092305|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127513|NCT04206332|450092306|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127514|NCT04206332|450092290|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127515|NCT04206332|450092291|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127516|NCT04206332|450092292|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127517|NCT04206332|450092293|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127518|NCT04206332|450092294|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127519|NCT04206332|450092295|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127520|NCT04206332|450092296|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127521|NCT04206332|450092297|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127522|NCT04206332|450092298|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127523|NCT04206332|450092299|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127524|NCT04206332|450092300|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127525|NCT04206332|450092301|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127526|NCT04206332|450092302|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127527|NCT04206332|450092303|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127528|NCT04206332|450092304|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127529|NCT04206332|450092305|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127530|NCT04206332|450092306|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
125127531|NCT04206332|450092290|FG000|Part C|Withdrawal by Subject|0|||
125127532|NCT04206332|450092291|FG001|Part C|Withdrawal by Subject|0|||
125127533|NCT04206332|450092292|FG002|Part C|Withdrawal by Subject|0|||
125127534|NCT04206332|450092293|FG003|Part C|Withdrawal by Subject|0|||
125127535|NCT04206332|450092294|FG004|Part C|Withdrawal by Subject|0|||
125127536|NCT04206332|450092295|FG005|Part C|Withdrawal by Subject|0|||
125127537|NCT04206332|450092296|FG006|Part C|Withdrawal by Subject|0|||
125127538|NCT04206332|450092297|FG007|Part C|Withdrawal by Subject|0|||
125127539|NCT04206332|450092298|FG008|Part C|Withdrawal by Subject|0|||
125127540|NCT04206332|450092299|FG009|Part C|Withdrawal by Subject|0|||
125127541|NCT04206332|450092300|FG010|Part C|Withdrawal by Subject|0|||
125127542|NCT04206332|450092301|FG011|Part C|Withdrawal by Subject|0|||
125127543|NCT04206332|450092302|FG012|Part C|Withdrawal by Subject|0|||
125127544|NCT04206332|450092303|FG013|Part C|Withdrawal by Subject|0|||
125127545|NCT04206332|450092304|FG014|Part C|Withdrawal by Subject|2|||
125127546|NCT04206332|450092305|FG015|Part C|Withdrawal by Subject|0|||
125127547|NCT04206332|450092306|FG016|Part C|Withdrawal by Subject|0|||
125127548|NCT00912288|450092309|FG000|Overall Study|Death|0|||
125127549|NCT00912288|450092310|FG001|Overall Study|Death|1|||
125127550|NCT00912288|450092309|FG000|Overall Study|Adverse Event|1|||
125127551|NCT00912288|450092310|FG001|Overall Study|Adverse Event|1|||
125127552|NCT00912288|450092309|FG000|Overall Study|Lost to Follow-up|1|||
125127553|NCT00912288|450092310|FG001|Overall Study|Lost to Follow-up|0|||
125127554|NCT00912288|450092309|FG000|Overall Study|Protocol Violation|1|||
125127555|NCT00912288|450092310|FG001|Overall Study|Protocol Violation|0|||
125127556|NCT00912288|450092309|FG000|Overall Study|Withdrawal by Subject|3|||
125127557|NCT00912288|450092310|FG001|Overall Study|Withdrawal by Subject|3|||
125127558|NCT00912288|450092309|FG000|Overall Study|Study terminated by sponsor|34|||
125127559|NCT00912288|450092310|FG001|Overall Study|Study terminated by sponsor|35|||
125127560|NCT00912288|450092309|FG000|Overall Study|Other|1|||
125127561|NCT00912288|450092310|FG001|Overall Study|Other|0|||
125127562|NCT00893464|450092315|FG000|Overall Study|Did not complete therapy/experience PD|0|||
125127563|NCT00893464|450092316|FG001|Overall Study|Did not complete therapy/experience PD|0|||
125127564|NCT00893464|450092317|FG002|Overall Study|Did not complete therapy/experience PD|0|||
125127565|NCT00893464|450092318|FG003|Overall Study|Did not complete therapy/experience PD|0|||
125127566|NCT00893464|450092319|FG004|Overall Study|Did not complete therapy/experience PD|0|||
125127567|NCT00893464|450092320|FG005|Overall Study|Did not complete therapy/experience PD|0|||
125127568|NCT00893464|450092321|FG006|Overall Study|Did not complete therapy/experience PD|2|||
125127569|NCT00893464|450092322|FG007|Overall Study|Did not complete therapy/experience PD|2|||
125127570|NCT00050778|450092323|FG000|Overall Study|Adverse Event|13|||
125127571|NCT00050778|450092324|FG001|Overall Study|Adverse Event|3|||
125127572|NCT00050778|450092325|FG002|Overall Study|Adverse Event|2|||
125127573|NCT00050778|450092323|FG000|Overall Study|Death|0|||
125127574|NCT00050778|450092324|FG001|Overall Study|Death|1|||
125127575|NCT00050778|450092325|FG002|Overall Study|Death|1|||
125127576|NCT00050778|450092323|FG000|Overall Study|Lack of Efficacy|16|||
125127577|NCT00050778|450092324|FG001|Overall Study|Lack of Efficacy|2|||
125127578|NCT00050778|450092325|FG002|Overall Study|Lack of Efficacy|2|||
125127579|NCT00050778|450092323|FG000|Overall Study|Lost to Follow-up|0|||
125127580|NCT00050778|450092324|FG001|Overall Study|Lost to Follow-up|2|||
125127581|NCT00050778|450092325|FG002|Overall Study|Lost to Follow-up|4|||
125127582|NCT00050778|450092323|FG000|Overall Study|Physician Decision|3|||
125127583|NCT00050778|450092324|FG001|Overall Study|Physician Decision|0|||
125127584|NCT00050778|450092325|FG002|Overall Study|Physician Decision|2|||
125127585|NCT00050778|450092323|FG000|Overall Study|Protocol Violation|2|||
125127586|NCT00050778|450092324|FG001|Overall Study|Protocol Violation|0|||
125127587|NCT00050778|450092325|FG002|Overall Study|Protocol Violation|1|||
125127588|NCT00050778|450092323|FG000|Overall Study|Withdrawal by Subject|6|||
125127589|NCT00050778|450092324|FG001|Overall Study|Withdrawal by Subject|8|||
125127590|NCT00050778|450092325|FG002|Overall Study|Withdrawal by Subject|4|||
125127591|NCT00050778|450092323|FG000|Overall Study|Randomized but not treated|4|||
125127592|NCT00050778|450092324|FG001|Overall Study|Randomized but not treated|5|||
125127593|NCT00050778|450092325|FG002|Overall Study|Randomized but not treated|2|||
125127594|NCT00050778|450092323|FG000|Overall Study|Familial and personal reasons|1|||
125127595|NCT00050778|450092324|FG001|Overall Study|Familial and personal reasons|0|||
125127596|NCT00050778|450092325|FG002|Overall Study|Familial and personal reasons|0|||
125127597|NCT01126736|450092329|FG000|Overall Study|Death|2|||
125127598|NCT01126736|450092330|FG001|Overall Study|Death|2|||
125127599|NCT01126736|450092331|FG002|Overall Study|Death|1|||
125127600|NCT01126736|450092332|FG003|Overall Study|Death|19|||
125127601|NCT01126736|450092333|FG004|Overall Study|Death|19|||
125127602|NCT01126736|450092329|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
125127603|NCT01126736|450092330|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
125127604|NCT01126736|450092331|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
125127605|NCT01126736|450092332|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
125127606|NCT01126736|450092333|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
125127607|NCT01126736|450092329|FG000|Overall Study|Lost to Follow-up|0|||
125127608|NCT01126736|450092330|FG001|Overall Study|Lost to Follow-up|0|||
125127609|NCT01126736|450092331|FG002|Overall Study|Lost to Follow-up|0|||
125127610|NCT01126736|450092332|FG003|Overall Study|Lost to Follow-up|1|||
125127611|NCT01126736|450092333|FG004|Overall Study|Lost to Follow-up|1|||
125127612|NCT01126736|450092329|FG000|Overall Study|Administrative reasons|0|||
125127613|NCT01126736|450092330|FG001|Overall Study|Administrative reasons|0|||
125127614|NCT01126736|450092331|FG002|Overall Study|Administrative reasons|0|||
125127615|NCT01126736|450092332|FG003|Overall Study|Administrative reasons|0|||
125127616|NCT01126736|450092333|FG004|Overall Study|Administrative reasons|1|||
125127617|NCT01126736|450092329|FG000|Overall Study|Progressive disease|0|||
124957367|NCT00475735|449469714|FG003|Treatment Period 1|Protocol Violation|1|||
124957368|NCT00475735|449469715|FG004|Treatment Period 1|Protocol Violation|0|||
124957369|NCT00475735|449469716|FG005|Treatment Period 1|Protocol Violation|0|||
125127618|NCT01126736|450092330|FG001|Overall Study|Progressive disease|0|||
125127619|NCT01126736|450092331|FG002|Overall Study|Progressive disease|0|||
125127620|NCT01126736|450092332|FG003|Overall Study|Progressive disease|2|||
125127621|NCT01126736|450092333|FG004|Overall Study|Progressive disease|1|||
125127622|NCT01126736|450092329|FG000|Overall Study|Withdrawal by Subject|0|||
125127623|NCT01126736|450092330|FG001|Overall Study|Withdrawal by Subject|0|||
125127624|NCT01126736|450092331|FG002|Overall Study|Withdrawal by Subject|0|||
124957370|NCT00475735|449469711|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125127625|NCT01126736|450092332|FG003|Overall Study|Withdrawal by Subject|1|||
125127626|NCT01126736|450092333|FG004|Overall Study|Withdrawal by Subject|1|||
125127627|NCT01126736|450092329|FG000|Overall Study|Other|2|||
124957371|NCT00475735|449469712|FG001|Treatment Period 1|Withdrawal by Subject|1|||
124957372|NCT00475735|449469713|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124957373|NCT00475735|449469714|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124957374|NCT00475735|449469715|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125127628|NCT01126736|450092330|FG001|Overall Study|Other|4|||
124957375|NCT00475735|449469716|FG005|Treatment Period 1|Withdrawal by Subject|0|||
124957376|NCT00475735|449469711|FG000|Treatment Period 1|DC due to AE but continuing|0|||
124957377|NCT00475735|449469712|FG001|Treatment Period 1|DC due to AE but continuing|0|||
124957378|NCT00475735|449469713|FG002|Treatment Period 1|DC due to AE but continuing|0|||
124957379|NCT00475735|449469714|FG003|Treatment Period 1|DC due to AE but continuing|1|||
124957380|NCT00475735|449469715|FG004|Treatment Period 1|DC due to AE but continuing|2|||
124957381|NCT00475735|449469716|FG005|Treatment Period 1|DC due to AE but continuing|2|||
124957382|NCT00475735|449469711|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
124957383|NCT00475735|449469712|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
124957384|NCT00475735|449469713|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
124957385|NCT00475735|449469714|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
124957386|NCT00475735|449469715|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
124957387|NCT00475735|449469716|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
125127629|NCT01126736|450092331|FG002|Overall Study|Other|4|||
125127630|NCT01126736|450092332|FG003|Overall Study|Other|16|||
125127631|NCT01126736|450092333|FG004|Overall Study|Other|15|||
125127632|NCT04869787|450092335|FG000|Screening|Physician Decision|1|||
125127633|NCT04869787|450092335|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
125127634|NCT00813293|450092336|FG000|Overall Study|Intercurrent illness|1|||
125127635|NCT00813293|450092337|FG001|Overall Study|Intercurrent illness|0|||
125127636|NCT00813293|450092336|FG000|Overall Study|Adverse Event|0|||
125127637|NCT00813293|450092337|FG001|Overall Study|Adverse Event|1|||
125127638|NCT00282048|450092339|FG000|Overall Study|Lack of Efficacy|30|||
125127639|NCT00282048|450092339|FG000|Overall Study|Adverse Event|22|||
125127640|NCT00282048|450092339|FG000|Overall Study|Withdrawal by Subject|1|||
125127641|NCT00282048|450092339|FG000|Overall Study|Other|8|||
125127642|NCT00282048|450092339|FG000|Overall Study|Ongoing|1|||
125127643|NCT01536405|450092340|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
125127644|NCT01536405|450092341|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
125127645|NCT01536405|450092340|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
125127646|NCT01536405|450092341|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
125127647|NCT01536405|450092340|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
125127648|NCT01536405|450092341|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
125127649|NCT01536405|450092340|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
125127650|NCT01536405|450092341|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
125127651|NCT01536405|450092340|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
125127652|NCT01536405|450092341|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
125127653|NCT01536405|450092340|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
125127654|NCT01536405|450092341|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
125127655|NCT01536405|450092340|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
125127656|NCT01536405|450092341|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
125127657|NCT01536405|450092340|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
125127658|NCT01536405|450092341|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
125127659|NCT01536405|450092340|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
125127660|NCT01536405|450092341|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
125127661|NCT01536405|450092340|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
125127662|NCT01536405|450092341|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
125127663|NCT01536405|450092340|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
125127664|NCT01536405|450092341|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
125127665|NCT01536405|450092340|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
125127666|NCT01536405|450092341|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
125127667|NCT01536405|450092340|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
125127668|NCT01536405|450092341|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
125127669|NCT00301366|450092342|FG000|Overall Study|Adverse Event|1|||
124957388|NCT00475735|449469711|FG000|Treatment Washout|Lost to Follow-up|0|||
124957389|NCT00475735|449469712|FG001|Treatment Washout|Lost to Follow-up|1|||
125127670|NCT04213326|450092343|FG000|Overall Study|Consent withdrawn|51|||
125127671|NCT04213326|450092344|FG001|Overall Study|Consent withdrawn|241|||
125127672|NCT04213326|450092343|FG000|Overall Study|Lost to Follow-up|50|||
125127673|NCT04213326|450092344|FG001|Overall Study|Lost to Follow-up|902|||
124957390|NCT00475735|449469713|FG002|Treatment Washout|Lost to Follow-up|0|||
124957391|NCT00475735|449469714|FG003|Treatment Washout|Lost to Follow-up|0|||
124957392|NCT00475735|449469715|FG004|Treatment Washout|Lost to Follow-up|0|||
124957393|NCT00475735|449469716|FG005|Treatment Washout|Lost to Follow-up|0|||
124957394|NCT00475735|449469711|FG000|Treatment Washout|Protocol Violation|0|||
125127674|NCT04213326|450092343|FG000|Overall Study|Protocol Violation|3|||
125127675|NCT04213326|450092344|FG001|Overall Study|Protocol Violation|25|||
125127676|NCT04213326|450092343|FG000|Overall Study|Participant eligibility changed|106|||
124957395|NCT00475735|449469712|FG001|Treatment Washout|Protocol Violation|1|||
124957396|NCT00475735|449469713|FG002|Treatment Washout|Protocol Violation|0|||
125127677|NCT04213326|450092344|FG001|Overall Study|Participant eligibility changed|19|||
125127678|NCT04213326|450092343|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
125127679|NCT04213326|450092344|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
125127680|NCT04213326|450092343|FG000|Overall Study|Incomplete study visit|0|||
125127681|NCT04213326|450092344|FG001|Overall Study|Incomplete study visit|367|||
125127682|NCT02549092|450092347|FG000|Treatment Period|Adverse Event|2|||
125127683|NCT02549092|450092348|FG001|Treatment Period|Adverse Event|2|||
125127684|NCT02549092|450092347|FG000|Treatment Period|Withdrawal by Subject|1|||
125127685|NCT02549092|450092348|FG001|Treatment Period|Withdrawal by Subject|3|||
125127686|NCT02549092|450092347|FG000|Treatment Period|Lack of Efficacy|0|||
125127687|NCT02549092|450092348|FG001|Treatment Period|Lack of Efficacy|2|||
125127688|NCT02549092|450092347|FG000|Extension/Transition Period|Adverse Event|1|||
125127689|NCT02549092|450092348|FG001|Extension/Transition Period|Adverse Event|1|||
125127690|NCT02549092|450092347|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
125127691|NCT02549092|450092348|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
125127692|NCT02549092|450092347|FG000|Extension/Transition Period|Other, Not Specified|4|||
125127693|NCT02549092|450092348|FG001|Extension/Transition Period|Other, Not Specified|2|||
125127694|NCT02511782|450092349|FG000|Overall Study|Withdrawal by Subject|1|||
125127695|NCT02511782|450092350|FG001|Overall Study|Withdrawal by Subject|0|||
125127696|NCT02511782|450092351|FG002|Overall Study|Withdrawal by Subject|0|||
125127697|NCT03627091|450092352|FG000|Overall Study|Adverse Event|0|||
125127698|NCT03627091|450092353|FG001|Overall Study|Adverse Event|0|||
125127699|NCT03627091|450092354|FG002|Overall Study|Adverse Event|2|||
125127700|NCT03627091|450092352|FG000|Overall Study|Withdrawal by Subject|2|||
125127701|NCT03627091|450092353|FG001|Overall Study|Withdrawal by Subject|0|||
125127702|NCT03627091|450092354|FG002|Overall Study|Withdrawal by Subject|2|||
125127703|NCT03627091|450092352|FG000|Overall Study|Physician Decision|2|||
125127704|NCT03627091|450092353|FG001|Overall Study|Physician Decision|0|||
125127705|NCT03627091|450092354|FG002|Overall Study|Physician Decision|0|||
125127706|NCT03627091|450092352|FG000|Overall Study|Site terminated by sponsor|0|||
125127707|NCT03627091|450092353|FG001|Overall Study|Site terminated by sponsor|1|||
125127708|NCT03627091|450092354|FG002|Overall Study|Site terminated by sponsor|0|||
125127709|NCT03627091|450092352|FG000|Overall Study|Disease relapse|7|||
125127710|NCT03627091|450092353|FG001|Overall Study|Disease relapse|5|||
125127711|NCT03627091|450092354|FG002|Overall Study|Disease relapse|1|||
125127712|NCT03627091|450092352|FG000|Overall Study|Other|1|||
125127713|NCT03627091|450092353|FG001|Overall Study|Other|0|||
125127714|NCT03627091|450092354|FG002|Overall Study|Other|0|||
125127715|NCT00450190|450092355|FG000|Overall Study|Withdrawal by Subject|2|||
125127716|NCT04149964|450092367|FG000|Overall Study|Lost to Follow-up|19|||
125215555|NCT02187861|450417429|FG003|Overall Study|Withdrawal by Subject|3|||
125215556|NCT02187861|450417426|FG000|Overall Study|Other|0|||
125127717|NCT04149964|450092368|FG001|Overall Study|Lost to Follow-up|18|||
125127718|NCT04753437|450092369|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
125127719|NCT04753437|450092370|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
125127720|NCT04753437|450092369|FG000|Overall Study|Liver Function Test Abnormalities|2|||
125127721|NCT04753437|450092370|FG001|Overall Study|Liver Function Test Abnormalities|4|||
125127722|NCT02424097|450094005|FG000|Overall Study|Lost to Follow-up|1|||
125127723|NCT02424097|450094006|FG001|Overall Study|Lost to Follow-up|2|||
125127724|NCT02311361|450094007|FG000|Overall Study|Did not receive treatment|0|||
125127725|NCT02311361|450094008|FG001|Overall Study|Did not receive treatment|1|||
125127726|NCT02311361|450094009|FG002|Overall Study|Did not receive treatment|0|||
125127727|NCT02311361|450094010|FG003|Overall Study|Did not receive treatment|1|||
125127728|NCT00745420|450094012|FG000|Overall Study|Ineligible|1|||
125127729|NCT02653664|450094013|FG000|Post-Treatment|Withdrawal by Subject|6|||
125127730|NCT02653664|450094014|FG001|Post-Treatment|Withdrawal by Subject|5|||
125127731|NCT02653664|450094015|FG002|Post-Treatment|Withdrawal by Subject|7|||
125127732|NCT02653664|450094013|FG000|Post-Treatment|Lost to Follow-up|8|||
125127733|NCT02653664|450094014|FG001|Post-Treatment|Lost to Follow-up|1|||
125127734|NCT02653664|450094015|FG002|Post-Treatment|Lost to Follow-up|7|||
125127735|NCT02653664|450094013|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
125127736|NCT02653664|450094014|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
125127737|NCT02653664|450094015|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
125127738|NCT02653664|450094013|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
125127739|NCT02653664|450094014|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
125127740|NCT02653664|450094015|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
125127741|NCT02653664|450094013|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
125127742|NCT02653664|450094014|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
125127743|NCT02653664|450094015|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
125127744|NCT02653664|450094013|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
125127745|NCT02653664|450094014|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
125127746|NCT02653664|450094015|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
125127747|NCT02653664|450094013|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
125127748|NCT02653664|450094014|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
125127749|NCT02653664|450094015|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
125127750|NCT02653664|450094013|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
125127751|NCT02653664|450094014|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
125127752|NCT02653664|450094015|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
125127753|NCT02653664|450094013|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
125127754|NCT02653664|450094014|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
125127755|NCT02653664|450094015|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
125127756|NCT02653664|450094013|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
125127757|NCT02653664|450094014|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
125127758|NCT02653664|450094015|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
125127759|NCT04657770|450094016|FG000|Overall Study|Withdrawal by Subject|3|||
125127760|NCT04657770|450094016|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
125127761|NCT00746798|450094017|FG000|Overall Study|Protocol Violation|0|||
125127762|NCT00746798|450094018|FG001|Overall Study|Protocol Violation|1|||
125127763|NCT00746798|450094019|FG002|Overall Study|Protocol Violation|0|||
125127764|NCT00746798|450094020|FG003|Overall Study|Protocol Violation|0|||
125127765|NCT00746798|450094017|FG000|Overall Study|Withdrawal by Subject|0|||
125127766|NCT00746798|450094018|FG001|Overall Study|Withdrawal by Subject|1|||
125127767|NCT00746798|450094019|FG002|Overall Study|Withdrawal by Subject|1|||
125127768|NCT00746798|450094020|FG003|Overall Study|Withdrawal by Subject|0|||
125127769|NCT00746798|450094017|FG000|Overall Study|Death|0|||
125127770|NCT00746798|450094018|FG001|Overall Study|Death|0|||
125127771|NCT00746798|450094019|FG002|Overall Study|Death|2|||
125127772|NCT00746798|450094020|FG003|Overall Study|Death|0|||
125127773|NCT00746798|450094017|FG000|Overall Study|Participant unable to return for visit|1|||
125127774|NCT00746798|450094018|FG001|Overall Study|Participant unable to return for visit|0|||
125127775|NCT00746798|450094019|FG002|Overall Study|Participant unable to return for visit|0|||
124957397|NCT00475735|449469714|FG003|Treatment Washout|Protocol Violation|0|||
124957398|NCT00475735|449469715|FG004|Treatment Washout|Protocol Violation|0|||
124957399|NCT00475735|449469716|FG005|Treatment Washout|Protocol Violation|0|||
125127776|NCT00746798|450094020|FG003|Overall Study|Participant unable to return for visit|0|||
125127777|NCT03655106|450094021|FG000|Overall Study|Withdrawal by Subject|3|||
124957400|NCT00475735|449469711|FG000|Treatment Period 2|Adverse Event|0|||
124957401|NCT00475735|449469712|FG001|Treatment Period 2|Adverse Event|1|||
124957402|NCT00475735|449469713|FG002|Treatment Period 2|Adverse Event|0|||
125127778|NCT03655106|450094022|FG001|Overall Study|Withdrawal by Subject|2|||
125127779|NCT03655106|450094021|FG000|Overall Study|Lost to Follow-up|2|||
125127780|NCT03655106|450094022|FG001|Overall Study|Lost to Follow-up|1|||
125127781|NCT03655106|450094021|FG000|Overall Study|Duplicate Enrollment|1|||
125127782|NCT03655106|450094022|FG001|Overall Study|Duplicate Enrollment|1|||
125127783|NCT03655106|450094021|FG000|Overall Study|Protocol Violation|3|||
124957403|NCT00475735|449469714|FG003|Treatment Period 2|Adverse Event|2|||
124957404|NCT00475735|449469715|FG004|Treatment Period 2|Adverse Event|0|||
124957405|NCT00475735|449469716|FG005|Treatment Period 2|Adverse Event|0|||
125127784|NCT03655106|450094022|FG001|Overall Study|Protocol Violation|0|||
125127785|NCT01367457|450094032|FG000|Overall Study|Death|2|||
125127786|NCT01367457|450094033|FG001|Overall Study|Death|0|||
125127787|NCT01367457|450094034|FG002|Overall Study|Death|0|||
125127788|NCT01367457|450094032|FG000|Overall Study|Investigator's decision|2|||
125127789|NCT01367457|450094033|FG001|Overall Study|Investigator's decision|0|||
125127790|NCT01367457|450094034|FG002|Overall Study|Investigator's decision|0|||
125127791|NCT01367457|450094032|FG000|Overall Study|Clinical decline (CD)|2|||
125127792|NCT01367457|450094033|FG001|Overall Study|Clinical decline (CD)|0|||
125127793|NCT01367457|450094034|FG002|Overall Study|Clinical decline (CD)|0|||
125127794|NCT01367457|450094032|FG000|Overall Study|Progression and death|8|||
125127795|NCT01367457|450094033|FG001|Overall Study|Progression and death|0|||
125127796|NCT01367457|450094034|FG002|Overall Study|Progression and death|0|||
125127797|NCT01367457|450094032|FG000|Overall Study|Toxicity|16|||
125127798|NCT01367457|450094033|FG001|Overall Study|Toxicity|0|||
125127799|NCT01367457|450094034|FG002|Overall Study|Toxicity|0|||
125127800|NCT01367457|450094032|FG000|Overall Study|Progression|137|||
124957406|NCT00475735|449469711|FG000|Treatment Period 2|Lack of Efficacy|0|||
124957407|NCT00475735|449469712|FG001|Treatment Period 2|Lack of Efficacy|0|||
124957408|NCT00475735|449469713|FG002|Treatment Period 2|Lack of Efficacy|0|||
125127801|NCT01367457|450094033|FG001|Overall Study|Progression|0|||
125127802|NCT01367457|450094034|FG002|Overall Study|Progression|0|||
125127803|NCT01367457|450094032|FG000|Overall Study|Patient asks for rest + slow progression|1|||
125127804|NCT01367457|450094033|FG001|Overall Study|Patient asks for rest + slow progression|0|||
125127805|NCT01367457|450094034|FG002|Overall Study|Patient asks for rest + slow progression|0|||
125127806|NCT01367457|450094032|FG000|Overall Study|Investigator's opinion, stable disease|1|||
125127807|NCT01367457|450094033|FG001|Overall Study|Investigator's opinion, stable disease|0|||
125127808|NCT01367457|450094034|FG002|Overall Study|Investigator's opinion, stable disease|0|||
125215557|NCT02187861|450417427|FG001|Overall Study|Other|1|||
125215558|NCT02187861|450417428|FG002|Overall Study|Other|7|||
124957409|NCT00475735|449469714|FG003|Treatment Period 2|Lack of Efficacy|0|||
125127809|NCT01367457|450094032|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
124957410|NCT00475735|449469715|FG004|Treatment Period 2|Lack of Efficacy|0|||
125127810|NCT01367457|450094033|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
124957411|NCT00475735|449469716|FG005|Treatment Period 2|Lack of Efficacy|1|||
125127811|NCT01367457|450094034|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
124957412|NCT00475735|449469711|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124957413|NCT00475735|449469712|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124957414|NCT00475735|449469713|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124957415|NCT00475735|449469714|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124957416|NCT00475735|449469715|FG004|Treatment Period 2|Withdrawal by Subject|1|||
124957417|NCT00475735|449469716|FG005|Treatment Period 2|Withdrawal by Subject|0|||
124957418|NCT03132753|449469717|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
124957419|NCT03132753|449469718|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
124957420|NCT03132753|449469717|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
125031083|NCT00896532|449735120|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125031084|NCT00896532|449735098|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031085|NCT00896532|449735099|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031086|NCT00896532|449735100|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
125031087|NCT00896532|449735101|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031088|NCT00896532|449735102|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031089|NCT00896532|449735103|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031090|NCT00896532|449735104|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031091|NCT00896532|449735105|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031092|NCT00896532|449735106|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031093|NCT00896532|449735107|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031094|NCT00896532|449735108|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031095|NCT00896532|449735109|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031096|NCT00896532|449735110|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031097|NCT00896532|449735111|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031098|NCT00896532|449735112|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031099|NCT00896532|449735113|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031100|NCT00896532|449735114|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031101|NCT00896532|449735115|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031102|NCT00896532|449735116|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031103|NCT00896532|449735117|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031104|NCT00896532|449735118|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031105|NCT00896532|449735119|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031106|NCT00896532|449735120|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125031107|NCT00896532|449735098|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031108|NCT00896532|449735099|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031109|NCT00896532|449735100|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
125031110|NCT00896532|449735101|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031111|NCT00896532|449735102|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031112|NCT00896532|449735103|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031113|NCT00896532|449735104|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031114|NCT00896532|449735105|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031115|NCT00896532|449735106|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031116|NCT00896532|449735107|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031117|NCT00896532|449735108|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031118|NCT00896532|449735109|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031119|NCT00896532|449735110|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031120|NCT00896532|449735111|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031121|NCT00896532|449735112|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031122|NCT00896532|449735113|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031123|NCT00896532|449735114|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031124|NCT00896532|449735115|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031125|NCT00896532|449735116|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031126|NCT00896532|449735117|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031127|NCT00896532|449735118|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031128|NCT00896532|449735119|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031129|NCT00896532|449735120|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125031130|NCT00896532|449735098|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125033626|NCT01701258|449743825|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
125033627|NCT01701258|449743826|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
124957421|NCT03132753|449469718|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
125127812|NCT01367457|450094032|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
125127813|NCT01367457|450094033|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
125127814|NCT01367457|450094034|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
125127815|NCT01367457|450094032|FG000|Overall Study|low grade toxicities + stable disease|1|||
125127816|NCT01367457|450094033|FG001|Overall Study|low grade toxicities + stable disease|0|||
125127817|NCT01367457|450094034|FG002|Overall Study|low grade toxicities + stable disease|0|||
125127818|NCT01367457|450094032|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
125127819|NCT01367457|450094033|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
125127820|NCT01367457|450094034|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
125127821|NCT01367457|450094032|FG000|Overall Study|Withdrawal by Subject|1|||
125127822|NCT01367457|450094033|FG001|Overall Study|Withdrawal by Subject|0|||
125127823|NCT01367457|450094034|FG002|Overall Study|Withdrawal by Subject|0|||
125127824|NCT01367457|450094032|FG000|Overall Study|CD, associated leukaemia|1|||
125127825|NCT01367457|450094033|FG001|Overall Study|CD, associated leukaemia|0|||
125127826|NCT01367457|450094034|FG002|Overall Study|CD, associated leukaemia|0|||
125127827|NCT01367457|450094032|FG000|Overall Study|Uncontrolled pain|1|||
125127828|NCT01367457|450094033|FG001|Overall Study|Uncontrolled pain|0|||
125127829|NCT01367457|450094034|FG002|Overall Study|Uncontrolled pain|0|||
125127830|NCT01367457|450094032|FG000|Overall Study|Overall status worsens to grade 4|1|||
125127831|NCT01367457|450094033|FG001|Overall Study|Overall status worsens to grade 4|0|||
125127832|NCT01367457|450094034|FG002|Overall Study|Overall status worsens to grade 4|0|||
125127833|NCT01367457|450094032|FG000|Overall Study|Stabilisation + frequent infections|1|||
125127834|NCT01367457|450094033|FG001|Overall Study|Stabilisation + frequent infections|0|||
125127835|NCT01367457|450094034|FG002|Overall Study|Stabilisation + frequent infections|0|||
125127836|NCT01367457|450094032|FG000|Overall Study|No clinical benefit|1|||
125127837|NCT01367457|450094033|FG001|Overall Study|No clinical benefit|0|||
125127838|NCT01367457|450094034|FG002|Overall Study|No clinical benefit|0|||
125127839|NCT01367457|450094032|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
125127840|NCT01367457|450094033|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
125127841|NCT01367457|450094034|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
125127842|NCT01367457|450094032|FG000|Overall Study|Overall decline|1|||
125127843|NCT01367457|450094033|FG001|Overall Study|Overall decline|0|||
125127844|NCT01367457|450094034|FG002|Overall Study|Overall decline|0|||
125127845|NCT01367457|450094032|FG000|Overall Study|Rejection of treatment|1|||
125127846|NCT01367457|450094033|FG001|Overall Study|Rejection of treatment|0|||
125127847|NCT01367457|450094034|FG002|Overall Study|Rejection of treatment|0|||
125127848|NCT01367457|450094032|FG000|Overall Study|Lost to Follow-up|1|||
125127849|NCT01367457|450094033|FG001|Overall Study|Lost to Follow-up|0|||
125127850|NCT01367457|450094034|FG002|Overall Study|Lost to Follow-up|0|||
125127851|NCT01367457|450094032|FG000|Overall Study|Death from septic shock|1|||
125127852|NCT01367457|450094033|FG001|Overall Study|Death from septic shock|0|||
125127853|NCT01367457|450094034|FG002|Overall Study|Death from septic shock|0|||
125127854|NCT01367457|450094032|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
125127855|NCT01367457|450094033|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
125127856|NCT01367457|450094034|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
125127857|NCT01367457|450094032|FG000|Overall Study|Patient's Wish|1|||
125127858|NCT01367457|450094033|FG001|Overall Study|Patient's Wish|0|||
125127859|NCT01367457|450094034|FG002|Overall Study|Patient's Wish|0|||
125127860|NCT01367457|450094032|FG000|Overall Study|Palliative. Overall decline|1|||
125127861|NCT01367457|450094033|FG001|Overall Study|Palliative. Overall decline|0|||
125127862|NCT01367457|450094034|FG002|Overall Study|Palliative. Overall decline|0|||
125127863|NCT01367457|450094032|FG000|Overall Study|Suspected DP/suspected active infection|1|||
125127864|NCT01367457|450094033|FG001|Overall Study|Suspected DP/suspected active infection|0|||
125215559|NCT02187861|450417429|FG003|Overall Study|Other|1|||
125127865|NCT01367457|450094034|FG002|Overall Study|Suspected DP/suspected active infection|0|||
124957422|NCT00125853|449469719|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
125127866|NCT01882257|450094037|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
125127867|NCT01882257|450094038|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
125127868|NCT01882257|450094039|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
125127869|NCT01882257|450094037|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
125127870|NCT01882257|450094038|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
125127871|NCT01882257|450094039|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
125127872|NCT02058498|450094040|FG000|Overall Study|Withdrawal by Subject|4|||
125127873|NCT01391793|450094044|FG000|Overall Study|Ineligible|3|||
125127874|NCT01391793|450094045|FG001|Overall Study|Ineligible|0|||
125127875|NCT01391793|450094044|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
125127876|NCT01391793|450094045|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
125127877|NCT01391793|450094044|FG000|Overall Study|No DMSA|73|||
125127878|NCT01391793|450094045|FG001|Overall Study|No DMSA|57|||
125127879|NCT01666730|450094046|FG000|Overall Study|Adverse Event|16|||
125127880|NCT01666730|450094046|FG000|Overall Study|Death|2|||
125127881|NCT01666730|450094046|FG000|Overall Study|Physician Decision|5|||
125127882|NCT01666730|450094046|FG000|Overall Study|Withdrawal by Subject|9|||
125127883|NCT01666730|450094046|FG000|Overall Study|Disease progression/relapse|18|||
125127884|NCT02087904|450094047|FG000|Overall Study|Did Not Receive Study Drug|0|||
125127885|NCT02087904|450094048|FG001|Overall Study|Did Not Receive Study Drug|0|||
125127886|NCT02087904|450094049|FG002|Overall Study|Did Not Receive Study Drug|2|||
125127887|NCT02087904|450094050|FG003|Overall Study|Did Not Receive Study Drug|1|||
125127888|NCT02087904|450094047|FG000|Overall Study|Adverse Event|8|||
125127889|NCT02087904|450094048|FG001|Overall Study|Adverse Event|4|||
125127890|NCT02087904|450094049|FG002|Overall Study|Adverse Event|4|||
125127891|NCT02087904|450094050|FG003|Overall Study|Adverse Event|12|||
125127892|NCT02087904|450094047|FG000|Overall Study|Lack of Efficacy|3|||
125127893|NCT02087904|450094048|FG001|Overall Study|Lack of Efficacy|6|||
125127894|NCT02087904|450094049|FG002|Overall Study|Lack of Efficacy|3|||
125127895|NCT02087904|450094050|FG003|Overall Study|Lack of Efficacy|2|||
125127896|NCT02087904|450094047|FG000|Overall Study|Other|6|||
125127897|NCT02087904|450094048|FG001|Overall Study|Other|2|||
125127898|NCT02087904|450094049|FG002|Overall Study|Other|4|||
125127899|NCT02087904|450094050|FG003|Overall Study|Other|4|||
125127900|NCT02087904|450094047|FG000|Overall Study|Withdrawal by Subject|8|||
125127901|NCT02087904|450094048|FG001|Overall Study|Withdrawal by Subject|3|||
125127902|NCT02087904|450094049|FG002|Overall Study|Withdrawal by Subject|7|||
125127903|NCT02087904|450094050|FG003|Overall Study|Withdrawal by Subject|4|||
125127904|NCT02087904|450094047|FG000|Overall Study|Lost to Follow-up|0|||
125127905|NCT02087904|450094048|FG001|Overall Study|Lost to Follow-up|4|||
125127906|NCT02087904|450094049|FG002|Overall Study|Lost to Follow-up|2|||
125127907|NCT02087904|450094050|FG003|Overall Study|Lost to Follow-up|2|||
125127908|NCT01389102|450094052|FG000|Overall Study|Adverse Event|1|||
125127909|NCT01389102|450094053|FG001|Overall Study|Adverse Event|3|||
125127910|NCT01389102|450094054|FG002|Overall Study|Adverse Event|2|||
125127911|NCT01389102|450094055|FG003|Overall Study|Adverse Event|2|||
125127912|NCT01389102|450094056|FG004|Overall Study|Adverse Event|2|||
125127913|NCT01389102|450094057|FG005|Overall Study|Adverse Event|2|||
125127914|NCT01389102|450094052|FG000|Overall Study|Hurricane Katrina|4|||
125127915|NCT01389102|450094053|FG001|Overall Study|Hurricane Katrina|2|||
125127916|NCT01389102|450094054|FG002|Overall Study|Hurricane Katrina|3|||
125127917|NCT01389102|450094055|FG003|Overall Study|Hurricane Katrina|0|||
125127918|NCT01389102|450094056|FG004|Overall Study|Hurricane Katrina|3|||
125127919|NCT01389102|450094057|FG005|Overall Study|Hurricane Katrina|1|||
125127920|NCT01389102|450094052|FG000|Overall Study|Lost to Follow-up|4|||
125215560|NCT02768792|450417433|FG000|Overall Study|Adverse Event|1|||
125215561|NCT05980013|450417434|FG000|Overall Study|Withdrawal by Subject|0|||
125127921|NCT01389102|450094053|FG001|Overall Study|Lost to Follow-up|1|||
125127922|NCT01389102|450094054|FG002|Overall Study|Lost to Follow-up|1|||
125215562|NCT05980013|450417435|FG001|Overall Study|Withdrawal by Subject|1|||
124957423|NCT00125853|449469720|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
124957424|NCT03575572|449469724|FG000|Overall Study|Withdrawal by Subject|2|||
124957425|NCT03575572|449469724|FG000|Overall Study|Physician Decision|2|||
125127923|NCT01389102|450094055|FG003|Overall Study|Lost to Follow-up|2|||
125127924|NCT01389102|450094056|FG004|Overall Study|Lost to Follow-up|4|||
125215563|NCT05980013|450417434|FG000|Overall Study|Device Error|0|||
125127925|NCT01389102|450094057|FG005|Overall Study|Lost to Follow-up|1|||
125127926|NCT01389102|450094052|FG000|Overall Study|Protocol Violation|0|||
125215564|NCT05980013|450417435|FG001|Overall Study|Device Error|1|||
124957426|NCT00157209|449469729|FG000|Overall Study|Ongoing at data cut-off|10|||
124957427|NCT00157209|449469730|FG001|Overall Study|Ongoing at data cut-off|0|||
124957428|NCT03751280|449469731|FG000|Overall Study|Adverse Event|0|||
124957429|NCT03751280|449469732|FG001|Overall Study|Adverse Event|1|||
124957430|NCT03751280|449469731|FG000|Overall Study|Lost to Follow-up|3|||
124957431|NCT03751280|449469732|FG001|Overall Study|Lost to Follow-up|5|||
124957432|NCT03751280|449469731|FG000|Overall Study|Physician Decision|0|||
124957433|NCT03751280|449469732|FG001|Overall Study|Physician Decision|2|||
124957434|NCT03751280|449469731|FG000|Overall Study|Protocol Violation|0|||
124957435|NCT03751280|449469732|FG001|Overall Study|Protocol Violation|2|||
124957436|NCT03751280|449469731|FG000|Overall Study|Withdrawal by Subject|5|||
124957437|NCT03751280|449469732|FG001|Overall Study|Withdrawal by Subject|2|||
124957438|NCT01257698|449469742|FG000|Overall Study|Protocol Violation|4|||
124957439|NCT01257698|449469743|FG001|Overall Study|Protocol Violation|0|||
124957440|NCT03023878|449469753|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
124957441|NCT03023878|449469753|FG000|Pre-Study Run-In Period|Death|1|||
124957442|NCT03023878|449469753|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
124957443|NCT03023878|449469753|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
124957444|NCT03023878|449469753|FG000|Treatment Period|Disease Progression|1|||
124957445|NCT03023878|449469753|FG000|Treatment Period|Withdrawal by Subject|1|||
124957446|NCT03023878|449469753|FG000|Treatment Period|Adverse Event|1|||
124957447|NCT03023878|449469753|FG000|Long Term Follow-Up Period|Death|2|||
124957448|NCT01247922|449469754|FG000|Overall Study|Disease progression|4|||
124957449|NCT01876823|449469757|FG000|Overall Study|Withdrawal by Subject|5|||
124957450|NCT01876823|449469757|FG000|Overall Study|Physician Decision|2|||
124957451|NCT01876823|449469757|FG000|Overall Study|Patients moved|2|||
124957452|NCT00577096|449469758|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
124957453|NCT00577096|449469759|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
124957454|NCT00577096|449469758|FG000|Short Term Participation|Withdrawal by Subject|3|||
124957455|NCT00577096|449469759|FG001|Short Term Participation|Withdrawal by Subject|5|||
124957456|NCT00577096|449469758|FG000|Short Term Participation|Death|1|||
124957457|NCT00577096|449469759|FG001|Short Term Participation|Death|1|||
124957458|NCT00794573|449469764|FG000|Overall Study|Death|3|||
124957459|NCT00794573|449469765|FG001|Overall Study|Death|0|||
124957460|NCT00794573|449469764|FG000|Overall Study|Withdrawal by Subject|9|||
124957461|NCT00794573|449469765|FG001|Overall Study|Withdrawal by Subject|12|||
125127927|NCT01389102|450094053|FG001|Overall Study|Protocol Violation|0|||
125127928|NCT01389102|450094054|FG002|Overall Study|Protocol Violation|3|||
125127929|NCT01389102|450094055|FG003|Overall Study|Protocol Violation|0|||
125127930|NCT01389102|450094056|FG004|Overall Study|Protocol Violation|1|||
125127931|NCT01389102|450094057|FG005|Overall Study|Protocol Violation|1|||
125127932|NCT01389102|450094052|FG000|Overall Study|Withdrawal by Subject|7|||
125127933|NCT01389102|450094053|FG001|Overall Study|Withdrawal by Subject|4|||
125127934|NCT01389102|450094054|FG002|Overall Study|Withdrawal by Subject|9|||
125127935|NCT01389102|450094055|FG003|Overall Study|Withdrawal by Subject|2|||
125127936|NCT01389102|450094056|FG004|Overall Study|Withdrawal by Subject|3|||
125127937|NCT01389102|450094057|FG005|Overall Study|Withdrawal by Subject|3|||
125127938|NCT01389102|450094052|FG000|Overall Study|Subject Traveling Out of Country|0|||
125127939|NCT01389102|450094053|FG001|Overall Study|Subject Traveling Out of Country|0|||
125127940|NCT01389102|450094054|FG002|Overall Study|Subject Traveling Out of Country|0|||
125127941|NCT01389102|450094055|FG003|Overall Study|Subject Traveling Out of Country|1|||
125127942|NCT01389102|450094056|FG004|Overall Study|Subject Traveling Out of Country|0|||
125127943|NCT01389102|450094057|FG005|Overall Study|Subject Traveling Out of Country|0|||
125127944|NCT01389102|450094052|FG000|Overall Study|Subject Moved|2|||
125127945|NCT01389102|450094053|FG001|Overall Study|Subject Moved|0|||
125127946|NCT01389102|450094054|FG002|Overall Study|Subject Moved|1|||
124957462|NCT00794573|449469764|FG000|Overall Study|Lost to Follow-up|26|||
124957463|NCT00794573|449469765|FG001|Overall Study|Lost to Follow-up|33|||
124957464|NCT03928821|449469766|FG000|Overall Study|Death|0|||
124957465|NCT03928821|449469767|FG001|Overall Study|Death|1|||
124957466|NCT03928821|449469768|FG002|Overall Study|Death|0|||
124957467|NCT03928821|449469769|FG003|Overall Study|Death|0|||
124957468|NCT03928821|449469766|FG000|Overall Study|Lost to Follow-up|0|||
124957469|NCT03928821|449469767|FG001|Overall Study|Lost to Follow-up|2|||
125127947|NCT01389102|450094055|FG003|Overall Study|Subject Moved|0|||
125127948|NCT01389102|450094056|FG004|Overall Study|Subject Moved|0|||
125127949|NCT01389102|450094057|FG005|Overall Study|Subject Moved|0|||
125127950|NCT01389102|450094052|FG000|Overall Study|Unavailable due to husband's illness|0|||
124957470|NCT03928821|449469768|FG002|Overall Study|Lost to Follow-up|3|||
124957471|NCT03928821|449469769|FG003|Overall Study|Lost to Follow-up|0|||
125127951|NCT01389102|450094053|FG001|Overall Study|Unavailable due to husband's illness|1|||
125127952|NCT01389102|450094054|FG002|Overall Study|Unavailable due to husband's illness|0|||
125127953|NCT01389102|450094055|FG003|Overall Study|Unavailable due to husband's illness|0|||
124957472|NCT03928821|449469766|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
124957473|NCT03928821|449469767|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
124957474|NCT03928821|449469768|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
124957475|NCT03928821|449469769|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
124957476|NCT02784535|449469770|FG000|Overall Study|Adverse Event|1|||
124957477|NCT02784535|449469771|FG001|Overall Study|Adverse Event|0|||
124957478|NCT02784535|449469770|FG000|Overall Study|Withdrawal by Subject|0|||
124957479|NCT02784535|449469771|FG001|Overall Study|Withdrawal by Subject|1|||
124957480|NCT02784535|449469770|FG000|Overall Study|Physician Decision|0|||
124957481|NCT02784535|449469771|FG001|Overall Study|Physician Decision|1|||
124957482|NCT00985621|449469773|FG000|Overall Study|Adverse Event|2|||
124957483|NCT00985621|449469774|FG001|Overall Study|Adverse Event|3|||
124957484|NCT00985621|449469775|FG002|Overall Study|Adverse Event|4|||
124957485|NCT00985621|449469776|FG003|Overall Study|Adverse Event|16|||
124957486|NCT00985621|449469773|FG000|Overall Study|Lack of Efficacy|10|||
124957487|NCT00985621|449469774|FG001|Overall Study|Lack of Efficacy|6|||
124957488|NCT00985621|449469775|FG002|Overall Study|Lack of Efficacy|5|||
124957489|NCT00985621|449469776|FG003|Overall Study|Lack of Efficacy|12|||
124957490|NCT00985621|449469773|FG000|Overall Study|Lost to Follow-up|2|||
124957491|NCT00985621|449469774|FG001|Overall Study|Lost to Follow-up|3|||
124957492|NCT00985621|449469775|FG002|Overall Study|Lost to Follow-up|4|||
124957493|NCT00985621|449469776|FG003|Overall Study|Lost to Follow-up|4|||
124957494|NCT00985621|449469773|FG000|Overall Study|Study Terminated by Sponsor|89|||
124957495|NCT00985621|449469774|FG001|Overall Study|Study Terminated by Sponsor|108|||
124957496|NCT00985621|449469775|FG002|Overall Study|Study Terminated by Sponsor|99|||
124957497|NCT00985621|449469776|FG003|Overall Study|Study Terminated by Sponsor|92|||
124957498|NCT00985621|449469773|FG000|Overall Study|Protocol Violation|1|||
124957499|NCT00985621|449469774|FG001|Overall Study|Protocol Violation|1|||
124957500|NCT00985621|449469775|FG002|Overall Study|Protocol Violation|1|||
124957501|NCT00985621|449469776|FG003|Overall Study|Protocol Violation|0|||
124957502|NCT00985621|449469773|FG000|Overall Study|Withdrawal by Subject|8|||
124957503|NCT00985621|449469774|FG001|Overall Study|Withdrawal by Subject|10|||
124957504|NCT00985621|449469775|FG002|Overall Study|Withdrawal by Subject|8|||
124957505|NCT00985621|449469776|FG003|Overall Study|Withdrawal by Subject|12|||
124957506|NCT00985621|449469773|FG000|Overall Study|Other|1|||
124957507|NCT00985621|449469774|FG001|Overall Study|Other|0|||
124957508|NCT00985621|449469775|FG002|Overall Study|Other|0|||
124957509|NCT00985621|449469776|FG003|Overall Study|Other|0|||
124957510|NCT00985621|449469773|FG000|Overall Study|Randomized but not Treated|1|||
124957511|NCT00985621|449469774|FG001|Overall Study|Randomized but not Treated|0|||
124957512|NCT00985621|449469775|FG002|Overall Study|Randomized but not Treated|2|||
124957513|NCT00985621|449469776|FG003|Overall Study|Randomized but not Treated|1|||
124957514|NCT01911819|449469777|FG000|Overall Study|Adverse Event|0|||
124957515|NCT01911819|449469778|FG001|Overall Study|Adverse Event|1|||
124957516|NCT01911819|449469779|FG002|Overall Study|Adverse Event|0|||
124957517|NCT01911819|449469777|FG000|Overall Study|Withdrawal by Subject|1|||
124957518|NCT01911819|449469778|FG001|Overall Study|Withdrawal by Subject|1|||
124957519|NCT01911819|449469779|FG002|Overall Study|Withdrawal by Subject|0|||
124957520|NCT03849300|449469783|FG000|Overall Study|move out to different area|1|||
124957521|NCT03849300|449469784|FG001|Overall Study|move out to different area|3|||
124957522|NCT03849300|449469785|FG002|Overall Study|move out to different area|1|||
124957523|NCT03849300|449469786|FG003|Overall Study|move out to different area|4|||
124957524|NCT03849300|449469783|FG000|Overall Study|scheduling/transportation conflict|4|||
124957525|NCT03849300|449469784|FG001|Overall Study|scheduling/transportation conflict|4|||
124957526|NCT03849300|449469785|FG002|Overall Study|scheduling/transportation conflict|3|||
124957527|NCT03849300|449469786|FG003|Overall Study|scheduling/transportation conflict|2|||
124957528|NCT00464737|449469789|FG000|Overall Study|Adverse Event|12|||
124957529|NCT00464737|449469790|FG001|Overall Study|Adverse Event|17|||
124957530|NCT00464737|449469791|FG002|Overall Study|Adverse Event|33|||
124957531|NCT00464737|449469789|FG000|Overall Study|Lack of Efficacy|7|||
124957532|NCT00464737|449469790|FG001|Overall Study|Lack of Efficacy|7|||
124957533|NCT00464737|449469791|FG002|Overall Study|Lack of Efficacy|4|||
124957534|NCT00464737|449469789|FG000|Overall Study|Withdrawal by Subject|5|||
124957535|NCT00464737|449469790|FG001|Overall Study|Withdrawal by Subject|3|||
124957536|NCT00464737|449469791|FG002|Overall Study|Withdrawal by Subject|5|||
124957537|NCT00464737|449469789|FG000|Overall Study|Protocol Violation|1|||
124957538|NCT00464737|449469790|FG001|Overall Study|Protocol Violation|1|||
124957539|NCT00464737|449469791|FG002|Overall Study|Protocol Violation|5|||
124957540|NCT00464737|449469789|FG000|Overall Study|Non-compliance|0|||
124957541|NCT00464737|449469790|FG001|Overall Study|Non-compliance|1|||
124957542|NCT00464737|449469791|FG002|Overall Study|Non-compliance|1|||
124957543|NCT00464737|449469789|FG000|Overall Study|Lost to Follow-up|5|||
124957544|NCT00464737|449469790|FG001|Overall Study|Lost to Follow-up|2|||
124957545|NCT00464737|449469791|FG002|Overall Study|Lost to Follow-up|5|||
124957546|NCT00464737|449469789|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
124957547|NCT00464737|449469790|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
124957548|NCT00464737|449469791|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
125127954|NCT01389102|450094056|FG004|Overall Study|Unavailable due to husband's illness|0|||
125127955|NCT01389102|450094057|FG005|Overall Study|Unavailable due to husband's illness|0|||
125127956|NCT01389102|450094052|FG000|Overall Study|Investigator Judgement|0|||
125127957|NCT01389102|450094053|FG001|Overall Study|Investigator Judgement|1|||
125127958|NCT01389102|450094054|FG002|Overall Study|Investigator Judgement|0|||
125127959|NCT01389102|450094055|FG003|Overall Study|Investigator Judgement|0|||
124957549|NCT00464737|449469789|FG000|Overall Study|Other: Subject left town; family illness|1|||
124957550|NCT00464737|449469790|FG001|Overall Study|Other: Subject left town; family illness|0|||
124957551|NCT00464737|449469791|FG002|Overall Study|Other: Subject left town; family illness|0|||
124957552|NCT00464737|449469789|FG000|Overall Study|Other: Study demands too great|0|||
124957553|NCT00464737|449469790|FG001|Overall Study|Other: Study demands too great|1|||
124957554|NCT00464737|449469791|FG002|Overall Study|Other: Study demands too great|0|||
124957555|NCT00464737|449469789|FG000|Overall Study|Other: Personal family reasons|0|||
124957556|NCT00464737|449469790|FG001|Overall Study|Other: Personal family reasons|0|||
124957557|NCT00464737|449469791|FG002|Overall Study|Other: Personal family reasons|1|||
124957558|NCT00464737|449469789|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
124957559|NCT00464737|449469790|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
124957560|NCT00464737|449469791|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
124957561|NCT00676663|449469794|FG000|Overall Study|Death|43|||
124957562|NCT00676663|449469795|FG001|Overall Study|Death|27|||
124957563|NCT00676663|449469794|FG000|Overall Study|Withdrew Consent|1|||
124957564|NCT00676663|449469795|FG001|Overall Study|Withdrew Consent|8|||
124957565|NCT00676663|449469794|FG000|Overall Study|Lost to Follow-up|1|||
124957566|NCT00676663|449469795|FG001|Overall Study|Lost to Follow-up|3|||
124957567|NCT00580047|449469796|FG000|Overall Study|Lost to Follow-up|1|||
125127960|NCT01389102|450094056|FG004|Overall Study|Investigator Judgement|0|||
125127961|NCT01389102|450094057|FG005|Overall Study|Investigator Judgement|0|||
125127962|NCT02910037|450094058|FG000|Overall Study|Withdrawal by Subject|4|||
125127963|NCT02910037|450094058|FG000|Overall Study|Lost to Follow-up|6|||
125127964|NCT00436553|450094059|FG000|Overall Study|Adverse Event|4|||
125127965|NCT00436553|450094060|FG001|Overall Study|Adverse Event|3|||
125127966|NCT00436553|450094061|FG002|Overall Study|Adverse Event|4|||
125127967|NCT00436553|450094059|FG000|Overall Study|Death|3|||
125127968|NCT00436553|450094060|FG001|Overall Study|Death|1|||
125127969|NCT00436553|450094061|FG002|Overall Study|Death|3|||
125127970|NCT00436553|450094059|FG000|Overall Study|Lost to Follow-up|0|||
125127971|NCT00436553|450094060|FG001|Overall Study|Lost to Follow-up|2|||
125127972|NCT00436553|450094061|FG002|Overall Study|Lost to Follow-up|0|||
125127973|NCT00436553|450094059|FG000|Overall Study|Protocol Violation|1|||
125127974|NCT00436553|450094060|FG001|Overall Study|Protocol Violation|0|||
125127975|NCT00436553|450094061|FG002|Overall Study|Protocol Violation|0|||
125127976|NCT00436553|450094059|FG000|Overall Study|Withdrawal by Subject|5|||
125127977|NCT00436553|450094060|FG001|Overall Study|Withdrawal by Subject|6|||
125127978|NCT00436553|450094061|FG002|Overall Study|Withdrawal by Subject|3|||
125127979|NCT01661686|450094070|FG000|Overall Study|Lost to Follow-up|2|||
125127980|NCT01661686|450094071|FG001|Overall Study|Lost to Follow-up|1|||
125127981|NCT01661686|450094070|FG000|Overall Study|did not receive allocated intervention|0|||
125127982|NCT01661686|450094071|FG001|Overall Study|did not receive allocated intervention|1|||
125127983|NCT01873586|450094072|FG000|Overall Study|Lost to Follow-up|3|||
125127984|NCT00624065|450094073|FG000|Overall Study|Adverse Event|5|||
125127985|NCT00624065|450094074|FG001|Overall Study|Adverse Event|6|||
125127986|NCT00624065|450094073|FG000|Overall Study|Lost to Follow-up|4|||
125127987|NCT00624065|450094074|FG001|Overall Study|Lost to Follow-up|1|||
125127988|NCT00624065|450094073|FG000|Overall Study|Consent withdrawn|6|||
125127989|NCT00624065|450094074|FG001|Overall Study|Consent withdrawn|5|||
125127990|NCT00624065|450094073|FG000|Overall Study|Lack of Efficacy|0|||
125127991|NCT00624065|450094074|FG001|Overall Study|Lack of Efficacy|3|||
125127992|NCT00624065|450094073|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
124957568|NCT00580047|449469797|FG001|Overall Study|Lost to Follow-up|1|||
124957569|NCT00580047|449469798|FG002|Overall Study|Lost to Follow-up|0|||
124957570|NCT00580047|449469796|FG000|Overall Study|Withdrawal by Subject|1|||
124957571|NCT00580047|449469797|FG001|Overall Study|Withdrawal by Subject|1|||
124957572|NCT00580047|449469798|FG002|Overall Study|Withdrawal by Subject|2|||
124957573|NCT00580047|449469796|FG000|Overall Study|Withdrawal by Subject|1|||
125127993|NCT00624065|450094074|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
125127994|NCT00696020|450094075|FG000|Overall Study|Adverse Event|3|||
125127995|NCT00696020|450094076|FG001|Overall Study|Adverse Event|1|||
125127996|NCT00696020|450094077|FG002|Overall Study|Adverse Event|2|||
125127997|NCT00696020|450094078|FG003|Overall Study|Adverse Event|1|||
125127998|NCT00696020|450094075|FG000|Overall Study|Lack of Efficacy|1|||
124957574|NCT00580047|449469797|FG001|Overall Study|Withdrawal by Subject|0|||
125127999|NCT00696020|450094076|FG001|Overall Study|Lack of Efficacy|0|||
125128000|NCT00696020|450094077|FG002|Overall Study|Lack of Efficacy|0|||
125128001|NCT00696020|450094078|FG003|Overall Study|Lack of Efficacy|0|||
125128002|NCT00696020|450094075|FG000|Overall Study|Protocol Violation|0|||
125128003|NCT00696020|450094076|FG001|Overall Study|Protocol Violation|0|||
125128004|NCT00696020|450094077|FG002|Overall Study|Protocol Violation|0|||
125128005|NCT00696020|450094078|FG003|Overall Study|Protocol Violation|1|||
125128006|NCT00696020|450094075|FG000|Overall Study|Withdrawal by Subject|0|||
125128007|NCT00696020|450094076|FG001|Overall Study|Withdrawal by Subject|1|||
125128008|NCT00696020|450094077|FG002|Overall Study|Withdrawal by Subject|0|||
125128009|NCT00696020|450094078|FG003|Overall Study|Withdrawal by Subject|1|||
125128010|NCT00696020|450094075|FG000|Overall Study|Other not stated above|0|||
125128011|NCT00696020|450094076|FG001|Overall Study|Other not stated above|0|||
125128012|NCT00696020|450094077|FG002|Overall Study|Other not stated above|1|||
125128013|NCT00696020|450094078|FG003|Overall Study|Other not stated above|1|||
125128014|NCT01387022|450094079|FG000|Overall Study|Death|1|||
125128015|NCT01387022|450094080|FG001|Overall Study|Death|1|||
125128016|NCT01387022|450094079|FG000|Overall Study|Lost to Follow-up|0|||
125128017|NCT01387022|450094080|FG001|Overall Study|Lost to Follow-up|3|||
125128018|NCT01536574|450094090|FG000|Overall Study|Adverse Event|4|||
125128019|NCT01536574|450094091|FG001|Overall Study|Adverse Event|5|||
125128020|NCT01536574|450094090|FG000|Overall Study|Withdrawal by Subject|1|||
125128021|NCT01536574|450094091|FG001|Overall Study|Withdrawal by Subject|2|||
125128022|NCT01536574|450094090|FG000|Overall Study|Lack of Efficacy|1|||
125128023|NCT01536574|450094091|FG001|Overall Study|Lack of Efficacy|0|||
125128024|NCT02193165|450094094|FG000|4 Week Product Use|Lost to Follow-up|1|||
125128025|NCT02193165|450094095|FG001|4 Week Product Use|Lost to Follow-up|1|||
125128026|NCT02193165|450094096|FG002|4 Week Product Use|Lost to Follow-up|1|||
125128027|NCT02193165|450094094|FG000|6 Week Product Use|Lost to Follow-up|0|||
125128028|NCT02193165|450094095|FG001|6 Week Product Use|Lost to Follow-up|1|||
125128029|NCT02193165|450094096|FG002|6 Week Product Use|Lost to Follow-up|0|||
125128030|NCT01498120|450094097|FG000|Overall Study|Lost to Follow-up|1|||
125128031|NCT01498120|450094097|FG000|Overall Study|Withdrawal by Subject|5|||
125128032|NCT01498120|450094097|FG000|Overall Study|AE, non-serious non-fatal|3|||
125128033|NCT01498120|450094097|FG000|Overall Study|Other|4|||
125128034|NCT01173692|450094098|FG000|Overall Study|Adverse Event|1|||
125128035|NCT01173692|450094099|FG001|Overall Study|Adverse Event|2|||
125128036|NCT01173692|450094098|FG000|Overall Study|Withdrawal by Subject|1|||
125128037|NCT01173692|450094099|FG001|Overall Study|Withdrawal by Subject|3|||
125128038|NCT00678639|450094100|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
125128039|NCT00678639|450094101|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
125128040|NCT00986245|450094102|FG000|First Intervention|Poor compliance|8|||
125128041|NCT00986245|450094103|FG001|First Intervention|Poor compliance|4|||
125128042|NCT00986245|450094102|FG000|First Intervention|Lack of Efficacy|1|||
125128043|NCT00986245|450094103|FG001|First Intervention|Lack of Efficacy|2|||
124957575|NCT00580047|449469798|FG002|Overall Study|Withdrawal by Subject|0|||
125128044|NCT00986245|450094102|FG000|First Intervention|Withdrawal by Subject|0|||
125128045|NCT00986245|450094103|FG001|First Intervention|Withdrawal by Subject|1|||
125128046|NCT00986245|450094102|FG000|First Intervention|Protocol Violation|0|||
125128047|NCT00986245|450094103|FG001|First Intervention|Protocol Violation|1|||
125128048|NCT00986245|450094102|FG000|First Intervention|Out of indication|1|||
125128049|NCT00986245|450094103|FG001|First Intervention|Out of indication|0|||
125128050|NCT00986245|450094102|FG000|Second Intervention|Poor compliance|1|||
125128051|NCT00986245|450094103|FG001|Second Intervention|Poor compliance|0|||
125128052|NCT00986245|450094102|FG000|Second Intervention|Lost to Follow-up|1|||
124957576|NCT04382053|449469804|FG000|Overall Study|Death|6|||
124957577|NCT04382053|449469805|FG001|Overall Study|Death|8|||
124957578|NCT04382053|449469804|FG000|Overall Study|Lost to Follow-up|0|||
124957579|NCT04382053|449469805|FG001|Overall Study|Lost to Follow-up|2|||
124957580|NCT04382053|449469804|FG000|Overall Study|Protocol Deviation|1|||
124957581|NCT04382053|449469805|FG001|Overall Study|Protocol Deviation|2|||
124957582|NCT04382053|449469804|FG000|Overall Study|Withdrawal by Subject|2|||
124957583|NCT04382053|449469805|FG001|Overall Study|Withdrawal by Subject|1|||
124957584|NCT00417989|449469811|FG000|Overall Study|Withdrawal by Subject|13|||
125128053|NCT00986245|450094103|FG001|Second Intervention|Lost to Follow-up|0|||
124957585|NCT00417989|449469812|FG001|Overall Study|Withdrawal by Subject|13|||
124957586|NCT00417989|449469811|FG000|Overall Study|Lost to Follow-up|1|||
124957587|NCT00417989|449469812|FG001|Overall Study|Lost to Follow-up|6|||
124957588|NCT00417989|449469811|FG000|Overall Study|Protocol Violation|1|||
125215565|NCT01768559|450417438|FG000|Overall Study|Randomized but not treated|0|||
125128054|NCT00986245|450094102|FG000|Second Intervention|Protocol Violation|0|||
125128055|NCT00986245|450094103|FG001|Second Intervention|Protocol Violation|1|||
124957589|NCT00417989|449469812|FG001|Overall Study|Protocol Violation|0|||
125128056|NCT01629381|450094104|FG000|Overall Study|Withdrawal by Subject|2|||
125128057|NCT01629381|450094105|FG001|Overall Study|Withdrawal by Subject|5|||
125128058|NCT01214850|450094106|FG000|Overall Study|Withdrawal by Subject|38|||
124957590|NCT00417989|449469811|FG000|Overall Study|Death|0|||
125128059|NCT01214850|450094107|FG001|Overall Study|Withdrawal by Subject|31|||
125128060|NCT01214850|450094108|FG002|Overall Study|Withdrawal by Subject|28|||
125128061|NCT01214850|450094106|FG000|Overall Study|Lost to Follow-up|124|||
125128062|NCT01214850|450094107|FG001|Overall Study|Lost to Follow-up|98|||
125128063|NCT01214850|450094108|FG002|Overall Study|Lost to Follow-up|123|||
125128064|NCT01214850|450094106|FG000|Overall Study|Protocol Violation|5|||
125128065|NCT01214850|450094107|FG001|Overall Study|Protocol Violation|5|||
125128066|NCT01214850|450094108|FG002|Overall Study|Protocol Violation|6|||
125128067|NCT01214850|450094106|FG000|Overall Study|Adverse event or death|11|||
125128068|NCT01214850|450094107|FG001|Overall Study|Adverse event or death|8|||
125128069|NCT01214850|450094108|FG002|Overall Study|Adverse event or death|3|||
125128070|NCT01214850|450094106|FG000|Overall Study|Inappropriate enrollment|2|||
125128071|NCT01214850|450094107|FG001|Overall Study|Inappropriate enrollment|1|||
125128072|NCT01214850|450094108|FG002|Overall Study|Inappropriate enrollment|0|||
125128073|NCT01214850|450094106|FG000|Overall Study|Administrative reason|1|||
125128074|NCT01214850|450094107|FG001|Overall Study|Administrative reason|0|||
125128075|NCT01214850|450094108|FG002|Overall Study|Administrative reason|0|||
125128076|NCT01214850|450094106|FG000|Overall Study|Unable to classify|2|||
125128077|NCT01214850|450094107|FG001|Overall Study|Unable to classify|1|||
125128078|NCT01214850|450094108|FG002|Overall Study|Unable to classify|1|||
125128079|NCT01863745|450094109|FG000|Overall Study|Disease Progression|9|||
125128080|NCT01863745|450094109|FG000|Overall Study|Adverse Event|2|||
125128081|NCT01863745|450094109|FG000|Overall Study|Death|1|||
125128082|NCT01863745|450094109|FG000|Overall Study|Withdrawal by Subject|1|||
125128083|NCT00193609|450094110|FG000|Overall Study|Lack of Efficacy|2|||
125128084|NCT00193609|450094110|FG000|Overall Study|Adverse Event|2|||
125128085|NCT00854308|450094111|FG000|Overall Study|Disease progression|42|||
125128086|NCT00854308|450094112|FG001|Overall Study|Disease progression|50|||
125128087|NCT00854308|450094111|FG000|Overall Study|Adverse Event|8|||
125128088|NCT00854308|450094112|FG001|Overall Study|Adverse Event|3|||
125128089|NCT00854308|450094111|FG000|Overall Study|Death|2|||
125128090|NCT00854308|450094112|FG001|Overall Study|Death|5|||
125128091|NCT00854308|450094111|FG000|Overall Study|Physician Decision|6|||
125128092|NCT00854308|450094112|FG001|Overall Study|Physician Decision|6|||
125128093|NCT00854308|450094111|FG000|Overall Study|Withdrawal by Subject|4|||
125128094|NCT00854308|450094112|FG001|Overall Study|Withdrawal by Subject|2|||
125128095|NCT00854308|450094111|FG000|Overall Study|Sponsor's decision to terminate study|0|||
125128096|NCT00854308|450094112|FG001|Overall Study|Sponsor's decision to terminate study|1|||
125128097|NCT00610363|450094115|FG000|Overall Study|Non-compliance with protocol|0|||
125128098|NCT00610363|450094116|FG001|Overall Study|Non-compliance with protocol|1|||
125128099|NCT00610363|450094115|FG000|Overall Study|Adverse Event|3|||
125128100|NCT00610363|450094116|FG001|Overall Study|Adverse Event|1|||
125128101|NCT00610363|450094115|FG000|Overall Study|Lack of Efficacy|2|||
125128102|NCT00610363|450094116|FG001|Overall Study|Lack of Efficacy|0|||
125128103|NCT00610363|450094115|FG000|Overall Study|Lost to Follow-up|4|||
125128104|NCT00610363|450094116|FG001|Overall Study|Lost to Follow-up|0|||
125128105|NCT00610363|450094115|FG000|Overall Study|Withdrawal by Subject|1|||
125128106|NCT00610363|450094116|FG001|Overall Study|Withdrawal by Subject|0|||
125128107|NCT00610363|450094115|FG000|Overall Study|Other than specified above|1|||
125128108|NCT00610363|450094116|FG001|Overall Study|Other than specified above|1|||
125128109|NCT03048500|450094117|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
125128110|NCT03048500|450094117|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
125128111|NCT03048500|450094117|FG000|Reached 1st Response/Continued Treatment|Death|1|||
125128112|NCT03048500|450094117|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
125128113|NCT03048500|450094117|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
125128114|NCT03048500|450094117|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
125128115|NCT03048500|450094117|FG000|Follow up for 3 Years|Death|12|||
125128116|NCT01171963|450094118|FG000|Overall Study|Adverse Event|10|||
125128117|NCT01171963|450094119|FG001|Overall Study|Adverse Event|15|||
125128118|NCT01171963|450094118|FG000|Overall Study|Lost to Follow-up|23|||
125128119|NCT01171963|450094119|FG001|Overall Study|Lost to Follow-up|24|||
124957591|NCT00417989|449469812|FG001|Overall Study|Death|1|||
124957592|NCT00417989|449469811|FG000|Overall Study|Physician Decision|5|||
125128120|NCT01171963|450094118|FG000|Overall Study|Other - diarrhoea|1|||
125128121|NCT01171963|450094119|FG001|Overall Study|Other - diarrhoea|0|||
125128122|NCT01171963|450094118|FG000|Overall Study|Withdrawal by Subject|114|||
125128123|NCT01171963|450094119|FG001|Overall Study|Withdrawal by Subject|129|||
125128124|NCT00626548|450094122|FG000|Overall Study|Adverse Event|164|||
125128125|NCT00626548|450094123|FG001|Overall Study|Adverse Event|44|||
125128126|NCT00626548|450094122|FG000|Overall Study|Withdrawal by Subject|42|||
125128127|NCT00626548|450094123|FG001|Overall Study|Withdrawal by Subject|46|||
124957593|NCT00417989|449469812|FG001|Overall Study|Physician Decision|2|||
125128128|NCT00626548|450094122|FG000|Overall Study|Protocol Violation|4|||
125128129|NCT00626548|450094123|FG001|Overall Study|Protocol Violation|11|||
125128130|NCT00626548|450094122|FG000|Overall Study|Lost to Follow-up|2|||
125128131|NCT00626548|450094123|FG001|Overall Study|Lost to Follow-up|2|||
124957594|NCT00497198|449469820|FG000|Overall Study|Adverse Event|4|||
124957595|NCT00497198|449469821|FG001|Overall Study|Adverse Event|2|||
124957596|NCT00497198|449469820|FG000|Overall Study|Physician Decision|1|||
124957597|NCT00497198|449469821|FG001|Overall Study|Physician Decision|2|||
124957598|NCT00497198|449469820|FG000|Overall Study|Withdrawal by Subject|0|||
125128132|NCT00626548|450094122|FG000|Overall Study|Other termination reason|493|||
125128133|NCT00626548|450094123|FG001|Overall Study|Other termination reason|613|||
125128134|NCT00048581|450094124|FG000|Double-Blind Period|Adverse Event|9|||
125128135|NCT00048581|450094125|FG001|Double-Blind Period|Adverse Event|5|||
124957599|NCT00497198|449469821|FG001|Overall Study|Withdrawal by Subject|1|||
124957600|NCT02799745|449469822|FG000|Overall Study|Participant moved out of state|1|||
124957601|NCT02799745|449469823|FG001|Overall Study|Participant moved out of state|0|||
124957602|NCT02799745|449469822|FG000|Overall Study|Discontinued due to planned surgery|1|||
124957603|NCT02799745|449469823|FG001|Overall Study|Discontinued due to planned surgery|0|||
124957604|NCT02799745|449469822|FG000|Overall Study|Withdrawal by Subject|16|||
124957605|NCT02799745|449469823|FG001|Overall Study|Withdrawal by Subject|25|||
124957606|NCT02799745|449469822|FG000|Overall Study|Protocol Deviation|4|||
125128136|NCT00048581|450094126|FG002|Double-Blind Period|Adverse Event|0|||
125128137|NCT00048581|450094124|FG000|Double-Blind Period|Lack of Efficacy|14|||
125128138|NCT00048581|450094125|FG001|Double-Blind Period|Lack of Efficacy|27|||
125128139|NCT00048581|450094126|FG002|Double-Blind Period|Lack of Efficacy|0|||
124957607|NCT02799745|449469823|FG001|Overall Study|Protocol Deviation|5|||
124957608|NCT02799745|449469822|FG000|Overall Study|Progressive Disease|28|||
124957609|NCT02799745|449469823|FG001|Overall Study|Progressive Disease|38|||
124957610|NCT02799745|449469822|FG000|Overall Study|Lost to Follow-up|3|||
124957611|NCT02799745|449469823|FG001|Overall Study|Lost to Follow-up|2|||
124957612|NCT02799745|449469822|FG000|Overall Study|Death|3|||
124957613|NCT02799745|449469823|FG001|Overall Study|Death|0|||
124957614|NCT02799745|449469822|FG000|Overall Study|Adverse Event|0|||
124957615|NCT02799745|449469823|FG001|Overall Study|Adverse Event|1|||
124957616|NCT00814632|449471152|FG000|Overall Study|Lack of Efficacy|2|||
124957617|NCT00635570|449471154|FG000|Overall Study|Lost to Follow-up|8|||
124957618|NCT00635570|449471155|FG001|Overall Study|Lost to Follow-up|8|||
125128140|NCT00048581|450094124|FG000|Double-Blind Period|Lost to Follow-up|5|||
125128141|NCT00048581|450094125|FG001|Double-Blind Period|Lost to Follow-up|0|||
125128142|NCT00048581|450094126|FG002|Double-Blind Period|Lost to Follow-up|0|||
125128143|NCT00048581|450094124|FG000|Double-Blind Period|Withdrawal by Subject|5|||
125128144|NCT00048581|450094125|FG001|Double-Blind Period|Withdrawal by Subject|2|||
124957619|NCT00635570|449471154|FG000|Overall Study|Withdrawal by Subject|1|||
124957620|NCT00635570|449471155|FG001|Overall Study|Withdrawal by Subject|1|||
124957621|NCT00635570|449471154|FG000|Overall Study|Adverse Event|2|||
124957622|NCT00635570|449471155|FG001|Overall Study|Adverse Event|0|||
124957623|NCT00635570|449471154|FG000|Overall Study|Physician Decision|1|||
125128145|NCT00048581|450094126|FG002|Double-Blind Period|Withdrawal by Subject|0|||
125128146|NCT00048581|450094124|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
125128147|NCT00048581|450094125|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
125128148|NCT00048581|450094126|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
125128149|NCT00048581|450094124|FG000|Double-Blind Period|Investigator Decision|1|||
125128150|NCT00048581|450094125|FG001|Double-Blind Period|Investigator Decision|0|||
125128151|NCT00048581|450094126|FG002|Double-Blind Period|Investigator Decision|0|||
125128152|NCT00048581|450094124|FG000|Open-Label Period|Death|0|||
125128153|NCT00048581|450094125|FG001|Open-Label Period|Death|0|||
125128154|NCT00048581|450094126|FG002|Open-Label Period|Death|4|||
125128155|NCT00048581|450094124|FG000|Open-Label Period|Adverse Event|0|||
125128156|NCT00048581|450094125|FG001|Open-Label Period|Adverse Event|0|||
125128157|NCT00048581|450094126|FG002|Open-Label Period|Adverse Event|37|||
125128158|NCT00048581|450094124|FG000|Open-Label Period|Lack of Efficacy|0|||
124957624|NCT00635570|449471155|FG001|Overall Study|Physician Decision|0|||
124957625|NCT00635570|449471154|FG000|Overall Study|Did not complete survey|2|||
124957626|NCT00635570|449471155|FG001|Overall Study|Did not complete survey|1|||
124957627|NCT00635570|449471154|FG000|Overall Study|Early termination(No sexual activity)|1|||
124957628|NCT00635570|449471155|FG001|Overall Study|Early termination(No sexual activity)|1|||
124957629|NCT02514577|449471166|FG000|Overall Study|Lost to Follow-up|6|||
125128159|NCT00048581|450094125|FG001|Open-Label Period|Lack of Efficacy|0|||
125128160|NCT00048581|450094126|FG002|Open-Label Period|Lack of Efficacy|69|||
125128161|NCT00048581|450094124|FG000|Open-Label Period|Lost to Follow-up|0|||
125128162|NCT00048581|450094125|FG001|Open-Label Period|Lost to Follow-up|0|||
124957630|NCT02514577|449471167|FG001|Overall Study|Lost to Follow-up|6|||
125128163|NCT00048581|450094126|FG002|Open-Label Period|Lost to Follow-up|14|||
125128164|NCT00048581|450094124|FG000|Open-Label Period|Withdrawal by Subject|0|||
125128165|NCT00048581|450094125|FG001|Open-Label Period|Withdrawal by Subject|0|||
125128166|NCT00048581|450094126|FG002|Open-Label Period|Withdrawal by Subject|20|||
124957631|NCT02514577|449471166|FG000|Overall Study|Protocol Violation|1|||
124957632|NCT02514577|449471167|FG001|Overall Study|Protocol Violation|0|||
124957633|NCT02514577|449471166|FG000|Overall Study|Withdrawal by Subject|6|||
125128167|NCT00048581|450094124|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
125128168|NCT00048581|450094125|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
125128169|NCT00048581|450094126|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
125128170|NCT00048581|450094124|FG000|Open-Label Period|Poor/Non-compliance|0|||
125128171|NCT00048581|450094125|FG001|Open-Label Period|Poor/Non-compliance|0|||
125128172|NCT00048581|450094126|FG002|Open-Label Period|Poor/Non-compliance|5|||
125128173|NCT00048581|450094124|FG000|Open-Label Period|Pregnancy|0|||
125128174|NCT00048581|450094125|FG001|Open-Label Period|Pregnancy|0|||
125128175|NCT00048581|450094126|FG002|Open-Label Period|Pregnancy|7|||
125128176|NCT00048581|450094124|FG000|Open-Label Period|Study Site Closure|0|||
125128177|NCT00048581|450094125|FG001|Open-Label Period|Study Site Closure|0|||
125128178|NCT00048581|450094126|FG002|Open-Label Period|Study Site Closure|2|||
125128179|NCT00048581|450094124|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
125128180|NCT00048581|450094125|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
125128181|NCT00048581|450094126|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
125128182|NCT00048581|450094124|FG000|Open-Label Period|Problem With Transportation To Site|0|||
125128183|NCT00048581|450094125|FG001|Open-Label Period|Problem With Transportation To Site|0|||
125128184|NCT00048581|450094126|FG002|Open-Label Period|Problem With Transportation To Site|1|||
125128185|NCT00048581|450094124|FG000|Open-Label Period|Primary Investigator Retired|0|||
125128186|NCT00048581|450094125|FG001|Open-Label Period|Primary Investigator Retired|0|||
125128187|NCT00048581|450094126|FG002|Open-Label Period|Primary Investigator Retired|2|||
125128188|NCT00048581|450094124|FG000|Open-Label Period|Study Ended By Sponsor|0|||
125128189|NCT00048581|450094125|FG001|Open-Label Period|Study Ended By Sponsor|0|||
125128190|NCT00048581|450094126|FG002|Open-Label Period|Study Ended By Sponsor|1|||
125128191|NCT01059903|450094127|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
125128192|NCT01059903|450094128|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
125128193|NCT00385593|450094129|FG000|Overall Study|Adverse Event|3|||
125128194|NCT00385593|450094130|FG001|Overall Study|Adverse Event|2|||
125128195|NCT00385593|450094129|FG000|Overall Study|Withdrawal by Subject|17|||
125128196|NCT00385593|450094130|FG001|Overall Study|Withdrawal by Subject|7|||
125128197|NCT00385593|450094129|FG000|Overall Study|Lost to Follow-up|12|||
125128198|NCT00385593|450094130|FG001|Overall Study|Lost to Follow-up|8|||
125128199|NCT00385593|450094129|FG000|Overall Study|Protocol Violation|7|||
125128200|NCT00385593|450094130|FG001|Overall Study|Protocol Violation|4|||
125128201|NCT00385593|450094129|FG000|Overall Study|Several reasons|17|||
125128202|NCT00385593|450094130|FG001|Overall Study|Several reasons|15|||
125128203|NCT00385593|450094129|FG000|Overall Study|Incorrect inclusion|2|||
125128204|NCT00385593|450094130|FG001|Overall Study|Incorrect inclusion|0|||
125128205|NCT00385593|450094129|FG000|Overall Study|Incorrect randomization|0|||
125128206|NCT00385593|450094130|FG001|Overall Study|Incorrect randomization|1|||
125128207|NCT00214422|450094131|FG000|Overall Study|Physician Decision|2|||
125128208|NCT00214422|450094132|FG001|Overall Study|Physician Decision|0|||
125128209|NCT00214422|450094133|FG002|Overall Study|Physician Decision|0|||
125128210|NCT00214422|450094131|FG000|Overall Study|Developed esophageal ca|1|||
124957634|NCT02514577|449471167|FG001|Overall Study|Withdrawal by Subject|6|||
124957635|NCT02514577|449471166|FG000|Overall Study|Adverse Event|1|||
125128211|NCT00214422|450094132|FG001|Overall Study|Developed esophageal ca|0|||
125128212|NCT00214422|450094133|FG002|Overall Study|Developed esophageal ca|0|||
125128213|NCT00214422|450094131|FG000|Overall Study|Pt taken off study|1|||
125128214|NCT00214422|450094132|FG001|Overall Study|Pt taken off study|1|||
125128215|NCT00214422|450094133|FG002|Overall Study|Pt taken off study|0|||
125128216|NCT00214422|450094131|FG000|Overall Study|Disease progression on study|1|||
125128217|NCT00214422|450094132|FG001|Overall Study|Disease progression on study|0|||
125128218|NCT00214422|450094133|FG002|Overall Study|Disease progression on study|0|||
125128219|NCT00214422|450094131|FG000|Overall Study|Unable to make a radiation treatment|0|||
125128220|NCT00214422|450094132|FG001|Overall Study|Unable to make a radiation treatment|0|||
125128221|NCT00214422|450094133|FG002|Overall Study|Unable to make a radiation treatment|1|||
125128222|NCT00319735|450094134|FG000|Overall Study|Death|2|||
125128223|NCT03929393|450094135|FG000|Overall Study|Death|1|||
125128224|NCT03929393|450094136|FG001|Overall Study|Death|0|||
125128225|NCT03929393|450094135|FG000|Overall Study|Time Commitment|2|||
125128226|NCT03929393|450094136|FG001|Overall Study|Time Commitment|5|||
125128227|NCT03929393|450094135|FG000|Overall Study|Motor Vehicle Accident|0|||
124957636|NCT02514577|449471167|FG001|Overall Study|Adverse Event|1|||
125128228|NCT03929393|450094136|FG001|Overall Study|Motor Vehicle Accident|1|||
125128229|NCT03929393|450094135|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
125128230|NCT03929393|450094136|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
125128231|NCT03929393|450094135|FG000|Overall Study|Other|1|||
125128232|NCT03929393|450094136|FG001|Overall Study|Other|3|||
125128233|NCT03420300|450094137|FG000|Overall Study|Death|2|||
125128234|NCT02421952|450094138|FG000|Overall Study|Diary Not Returned|93|||
125128235|NCT02421952|450094138|FG000|Overall Study|Failed seriation task|13|||
125128236|NCT02421952|450094138|FG000|Overall Study|Subject uncooperative for baseline test|2|||
125128237|NCT02421952|450094138|FG000|Overall Study|Surgery cancelled|1|||
125128238|NCT02140060|450094139|FG000|Overall Study|Adverse Event|0|||
125128239|NCT02140060|450094140|FG001|Overall Study|Adverse Event|0|||
125128240|NCT02140060|450094141|FG002|Overall Study|Adverse Event|0|||
125128241|NCT02140060|450094142|FG003|Overall Study|Adverse Event|1|||
125128242|NCT02140060|450094143|FG004|Overall Study|Adverse Event|1|||
125128243|NCT02140060|450094144|FG005|Overall Study|Adverse Event|1|||
125128244|NCT02140060|450094139|FG000|Overall Study|Lack of Efficacy|0|||
125128245|NCT02140060|450094140|FG001|Overall Study|Lack of Efficacy|0|||
125128246|NCT02140060|450094141|FG002|Overall Study|Lack of Efficacy|0|||
125128247|NCT02140060|450094142|FG003|Overall Study|Lack of Efficacy|1|||
125128248|NCT02140060|450094143|FG004|Overall Study|Lack of Efficacy|0|||
125128249|NCT02140060|450094144|FG005|Overall Study|Lack of Efficacy|0|||
125128250|NCT01038856|450096013|FG000|Overall Study|Adverse Event|2|||
125128251|NCT04466111|450096015|FG000|Prior to Trial Phase|Physician Decision|1|||
125128252|NCT00105196|450096016|FG000|Overall Study|Lack of Efficacy|2|||
125128253|NCT00105196|450096017|FG001|Overall Study|Lack of Efficacy|3|||
125128254|NCT00105196|450096016|FG000|Overall Study|Adverse Event|11|||
125128255|NCT00105196|450096017|FG001|Overall Study|Adverse Event|3|||
125128256|NCT00105196|450096016|FG000|Overall Study|Withdrawal by Subject|6|||
125128257|NCT00105196|450096017|FG001|Overall Study|Withdrawal by Subject|6|||
125128258|NCT00105196|450096016|FG000|Overall Study|Lost to Follow-up|3|||
125128259|NCT00105196|450096017|FG001|Overall Study|Lost to Follow-up|2|||
125128260|NCT00105196|450096016|FG000|Overall Study|Poor/noncompliance|3|||
125128261|NCT00105196|450096017|FG001|Overall Study|Poor/noncompliance|4|||
125128262|NCT00105196|450096016|FG000|Overall Study|Protocol Violation|5|||
125128263|NCT00105196|450096017|FG001|Overall Study|Protocol Violation|2|||
125215566|NCT01768559|450417439|FG001|Overall Study|Randomized but not treated|0|||
125215567|NCT01768559|450417440|FG002|Overall Study|Randomized but not treated|1|||
125215568|NCT01768559|450417438|FG000|Overall Study|Adverse Event|15|||
125215569|NCT01768559|450417439|FG001|Overall Study|Adverse Event|2|||
125215570|NCT01768559|450417440|FG002|Overall Study|Adverse Event|5|||
125128264|NCT00105196|450096016|FG000|Overall Study|pending surgery|0|||
125215571|NCT01768559|450417438|FG000|Overall Study|Lack of Efficacy|6|||
125215572|NCT01768559|450417439|FG001|Overall Study|Lack of Efficacy|4|||
125215573|NCT01768559|450417440|FG002|Overall Study|Lack of Efficacy|0|||
125128265|NCT00105196|450096017|FG001|Overall Study|pending surgery|1|||
125128266|NCT00105196|450096016|FG000|Overall Study|marijuana use|0|||
125128267|NCT00105196|450096017|FG001|Overall Study|marijuana use|1|||
125128268|NCT00105196|450096016|FG000|Overall Study|Subject became unblinded|0|||
125128269|NCT00105196|450096017|FG001|Overall Study|Subject became unblinded|1|||
125215574|NCT01768559|450417438|FG000|Overall Study|Poor compliance to protocol|0|||
125128270|NCT03025880|450096018|FG000|Overall Study|Adverse Event|1|||
125128271|NCT03025880|450096019|FG001|Overall Study|Adverse Event|0|||
125128272|NCT03025880|450096018|FG000|Overall Study|Death|1|||
125128273|NCT03025880|450096019|FG001|Overall Study|Death|1|||
125128274|NCT03025880|450096018|FG000|Overall Study|Withdrawal by Subject|0|||
125128275|NCT03025880|450096019|FG001|Overall Study|Withdrawal by Subject|1|||
125128276|NCT03025880|450096018|FG000|Overall Study|Physician Decision|0|||
125128277|NCT03025880|450096019|FG001|Overall Study|Physician Decision|1|||
125128278|NCT03025880|450096018|FG000|Overall Study|Progressive Disease|12|||
125128279|NCT03025880|450096019|FG001|Overall Study|Progressive Disease|19|||
125128280|NCT01035060|450096020|FG000|Overall Study|Lost to Follow-up|0|||
125128281|NCT01035060|450096021|FG001|Overall Study|Lost to Follow-up|7|||
125128282|NCT01035060|450096020|FG000|Overall Study|Did not quality after 2nd screening|14|||
125128283|NCT01035060|450096021|FG001|Overall Study|Did not quality after 2nd screening|1|||
125128284|NCT01035060|450096020|FG000|Overall Study|Withdrawal by Subject|8|||
125128285|NCT01035060|450096021|FG001|Overall Study|Withdrawal by Subject|6|||
125128286|NCT01035060|450096020|FG000|Overall Study|Physician Decision|2|||
125128287|NCT01035060|450096021|FG001|Overall Study|Physician Decision|0|||
125128288|NCT02015390|450096026|FG000|Overall Study|Lost to Follow-up|1|||
125128289|NCT02015390|450096027|FG001|Overall Study|Lost to Follow-up|0|||
125128290|NCT02015390|450096026|FG000|Overall Study|Adverse Event|0|||
125128291|NCT02015390|450096027|FG001|Overall Study|Adverse Event|3|||
125128292|NCT02015390|450096026|FG000|Overall Study|Physician Decision|0|||
125128293|NCT02015390|450096027|FG001|Overall Study|Physician Decision|1|||
125128294|NCT02193880|450096028|FG000|Overall Study|patients did not collect enough HPC|3|||
125128295|NCT03136380|450096029|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
125128296|NCT03136380|450096030|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
125128297|NCT03136380|450096031|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
125128298|NCT03136380|450096032|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
125128299|NCT03136380|450096033|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
125128300|NCT00553280|450096037|FG000|Overall Study|Adverse Event|19|||
125128301|NCT00553280|450096037|FG000|Overall Study|Lack of Efficacy|3|||
125128302|NCT00553280|450096037|FG000|Overall Study|Withdrawal by Subject|3|||
125128303|NCT00553280|450096037|FG000|Overall Study|Physician Decision|1|||
125128304|NCT02794974|450096038|FG000|Overall Study|Physician Decision|0|||
125128305|NCT02794974|450096039|FG001|Overall Study|Physician Decision|1|||
125128306|NCT02202850|450096040|FG000|Overall Study|Other|2|||
125128307|NCT02202850|450096041|FG001|Overall Study|Other|2|||
125128308|NCT02202850|450096040|FG000|Overall Study|Enbrel treatment discontinued|15|||
125128309|NCT02202850|450096041|FG001|Overall Study|Enbrel treatment discontinued|3|||
125128310|NCT02202850|450096040|FG000|Overall Study|Lost to Follow-up|7|||
125128311|NCT02202850|450096041|FG001|Overall Study|Lost to Follow-up|1|||
125128312|NCT02996682|450096042|FG000|Overall Study|Death|0|||
125128313|NCT02996682|450096043|FG001|Overall Study|Death|3|||
125128314|NCT02587962|450096044|FG000|Overall Study|Adverse Event|0|||
125128315|NCT02587962|450096045|FG001|Overall Study|Adverse Event|0|||
125128316|NCT02587962|450096046|FG002|Overall Study|Adverse Event|1|||
125128317|NCT02587962|450096047|FG003|Overall Study|Adverse Event|0|||
125128318|NCT02587962|450096048|FG004|Overall Study|Adverse Event|0|||
125128319|NCT02587962|450096044|FG000|Overall Study|Withdrawal by Subject|0|||
125128320|NCT02587962|450096045|FG001|Overall Study|Withdrawal by Subject|0|||
124957637|NCT04816708|449471170|FG000|Overall Study|Lost to Follow-up|10|||
124957638|NCT04816708|449471171|FG001|Overall Study|Lost to Follow-up|4|||
124957639|NCT02388932|449471172|FG000|Overall Study|Death|1|||
125128321|NCT02587962|450096046|FG002|Overall Study|Withdrawal by Subject|1|||
125128322|NCT02587962|450096047|FG003|Overall Study|Withdrawal by Subject|1|||
125128323|NCT02587962|450096048|FG004|Overall Study|Withdrawal by Subject|4|||
125128324|NCT02587962|450096044|FG000|Overall Study|Radiological progression|2|||
125128325|NCT02587962|450096045|FG001|Overall Study|Radiological progression|2|||
125128326|NCT02587962|450096046|FG002|Overall Study|Radiological progression|2|||
125128327|NCT02587962|450096047|FG003|Overall Study|Radiological progression|5|||
125128328|NCT02587962|450096048|FG004|Overall Study|Radiological progression|10|||
125128329|NCT02587962|450096044|FG000|Overall Study|Clinical progression|0|||
125128330|NCT02587962|450096045|FG001|Overall Study|Clinical progression|1|||
125128331|NCT02587962|450096046|FG002|Overall Study|Clinical progression|2|||
124957640|NCT03568708|449471175|FG000|Overall Study|Withdrawal by Subject|1|||
125128332|NCT02587962|450096047|FG003|Overall Study|Clinical progression|0|||
125128333|NCT02587962|450096048|FG004|Overall Study|Clinical progression|1|||
125128334|NCT00086996|450096050|FG000|Overall Study|Adverse Event|29|||
125128335|NCT00086996|450096050|FG000|Overall Study|Death|4|||
125128336|NCT00086996|450096050|FG000|Overall Study|progression/relapse|7|||
125128337|NCT00086996|450096050|FG000|Overall Study|Withdrawal by Subject|13|||
125128338|NCT00086996|450096050|FG000|Overall Study|Other|6|||
125128339|NCT00086996|450096050|FG000|Overall Study|not eligible|5|||
125128340|NCT00184600|450096051|FG000|Overall Study|Adverse Event|9|||
124957641|NCT03568708|449471176|FG001|Overall Study|Withdrawal by Subject|1|||
124957642|NCT03568708|449471175|FG000|Overall Study|Lost to Follow-up|0|||
124957643|NCT03568708|449471176|FG001|Overall Study|Lost to Follow-up|1|||
124957644|NCT00809783|449471177|FG000|Overall Study|Death|1|||
124957645|NCT00809783|449471178|FG001|Overall Study|Death|0|||
124957646|NCT00809783|449471179|FG002|Overall Study|Death|0|||
125128341|NCT00184600|450096052|FG001|Overall Study|Adverse Event|0|||
125128342|NCT00184600|450096053|FG002|Overall Study|Adverse Event|5|||
125128343|NCT00184600|450096051|FG000|Overall Study|Death|3|||
125128344|NCT00184600|450096052|FG001|Overall Study|Death|9|||
125128345|NCT00184600|450096053|FG002|Overall Study|Death|7|||
125128346|NCT00184600|450096051|FG000|Overall Study|Lack of Efficacy|3|||
125128347|NCT00184600|450096052|FG001|Overall Study|Lack of Efficacy|1|||
125128348|NCT00184600|450096053|FG002|Overall Study|Lack of Efficacy|3|||
125128349|NCT00184600|450096051|FG000|Overall Study|Lost to Follow-up|4|||
125128350|NCT00184600|450096052|FG001|Overall Study|Lost to Follow-up|6|||
125128351|NCT00184600|450096053|FG002|Overall Study|Lost to Follow-up|1|||
125128352|NCT00184600|450096051|FG000|Overall Study|Protocol Violation|2|||
125128353|NCT00184600|450096052|FG001|Overall Study|Protocol Violation|2|||
125128354|NCT00184600|450096053|FG002|Overall Study|Protocol Violation|3|||
125128355|NCT00184600|450096051|FG000|Overall Study|Withdrawal by Subject|20|||
125128356|NCT00184600|450096052|FG001|Overall Study|Withdrawal by Subject|28|||
125128357|NCT00184600|450096053|FG002|Overall Study|Withdrawal by Subject|12|||
125128358|NCT00184600|450096051|FG000|Overall Study|Unclassified|4|||
125128359|NCT00184600|450096052|FG001|Overall Study|Unclassified|5|||
125128360|NCT00184600|450096053|FG002|Overall Study|Unclassified|3|||
125128361|NCT04274686|450096055|FG000|Overall Study|Physician Decision|1|||
125128362|NCT04274686|450096056|FG001|Overall Study|Physician Decision|0|||
125128363|NCT00376623|450096057|FG000|Overall Study|Progressive disease|35|||
125128364|NCT00376623|450096058|FG001|Overall Study|Progressive disease|22|||
125128365|NCT00376623|450096059|FG002|Overall Study|Progressive disease|17|||
125128366|NCT00376623|450096057|FG000|Overall Study|Lost to Follow-up|0|||
125128367|NCT00376623|450096058|FG001|Overall Study|Lost to Follow-up|1|||
125128368|NCT00376623|450096059|FG002|Overall Study|Lost to Follow-up|0|||
125128369|NCT00376623|450096057|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
125128370|NCT00376623|450096058|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
125128371|NCT00376623|450096059|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
125128372|NCT00376623|450096057|FG000|Overall Study|Not treated with BI 2536|1|||
125128373|NCT00376623|450096058|FG001|Overall Study|Not treated with BI 2536|0|||
125128374|NCT00376623|450096059|FG002|Overall Study|Not treated with BI 2536|0|||
125128375|NCT00376623|450096057|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
125128376|NCT00376623|450096058|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
125128377|NCT00376623|450096059|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
125128378|NCT00376623|450096057|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
125128379|NCT00376623|450096058|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
124957647|NCT00809783|449471177|FG000|Overall Study|Adverse Event|34|||
124957648|NCT00809783|449471178|FG001|Overall Study|Adverse Event|52|||
124957649|NCT00809783|449471179|FG002|Overall Study|Adverse Event|71|||
124957650|NCT00809783|449471177|FG000|Overall Study|Lack of Efficacy|39|||
124957651|NCT00809783|449471178|FG001|Overall Study|Lack of Efficacy|52|||
124957652|NCT00809783|449471179|FG002|Overall Study|Lack of Efficacy|63|||
124957653|NCT00809783|449471177|FG000|Overall Study|Lost to Follow-up|0|||
124957654|NCT00809783|449471178|FG001|Overall Study|Lost to Follow-up|3|||
124957655|NCT00809783|449471179|FG002|Overall Study|Lost to Follow-up|4|||
124957656|NCT00809783|449471177|FG000|Overall Study|Withdrawal by Subject|47|||
124957657|NCT00809783|449471178|FG001|Overall Study|Withdrawal by Subject|72|||
124957658|NCT00809783|449471179|FG002|Overall Study|Withdrawal by Subject|64|||
124957659|NCT00809783|449471177|FG000|Overall Study|Protocol Violation|2|||
124957660|NCT00809783|449471178|FG001|Overall Study|Protocol Violation|6|||
124957661|NCT00809783|449471179|FG002|Overall Study|Protocol Violation|5|||
124957662|NCT00809783|449471177|FG000|Overall Study|Randomized, but not treated|3|||
124957663|NCT00809783|449471178|FG001|Overall Study|Randomized, but not treated|0|||
124957664|NCT00809783|449471179|FG002|Overall Study|Randomized, but not treated|2|||
124957665|NCT00809783|449471177|FG000|Overall Study|Study Terminated by Sponsor|378|||
125128380|NCT00376623|450096059|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
125128381|NCT00376623|450096057|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
125128382|NCT00376623|450096058|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
125128383|NCT00376623|450096059|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
125128384|NCT00376623|450096057|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
124957666|NCT00809783|449471178|FG001|Overall Study|Study Terminated by Sponsor|626|||
124957667|NCT00809783|449471179|FG002|Overall Study|Study Terminated by Sponsor|565|||
124957668|NCT00809783|449471177|FG000|Overall Study|Other|21|||
124957669|NCT00809783|449471178|FG001|Overall Study|Other|21|||
124957670|NCT00809783|449471179|FG002|Overall Study|Other|16|||
124957671|NCT00126555|449471180|FG000|Overall Study|Withdrawal by Subject|1|||
124957672|NCT00126555|449471180|FG000|Overall Study|Adverse Event|2|||
124957673|NCT00126555|449471180|FG000|Overall Study|Progressive Disease|3|||
124957674|NCT01284634|449471192|FG000|Overall Study|Adverse Event|1|||
124957675|NCT01284634|449471193|FG001|Overall Study|Adverse Event|0|||
124957676|NCT01284634|449471194|FG002|Overall Study|Adverse Event|2|||
124957677|NCT01284634|449471195|FG003|Overall Study|Adverse Event|1|||
124957678|NCT01059526|449471196|FG000|Overall Study|Patient enrolled but not treated|20|||
124957679|NCT01059526|449471197|FG001|Overall Study|Patient enrolled but not treated|17|||
124957680|NCT01059526|449471196|FG000|Overall Study|Adverse Event|2|||
124957681|NCT01059526|449471197|FG001|Overall Study|Adverse Event|2|||
124957682|NCT01059526|449471196|FG000|Overall Study|Protocol Violation|0|||
124957683|NCT01059526|449471197|FG001|Overall Study|Protocol Violation|1|||
124957684|NCT01059526|449471196|FG000|Overall Study|Withdrawal by Subject|3|||
124957685|NCT01059526|449471197|FG001|Overall Study|Withdrawal by Subject|1|||
124957686|NCT01059526|449471196|FG000|Overall Study|Lost to Follow-up|4|||
124957687|NCT01059526|449471197|FG001|Overall Study|Lost to Follow-up|1|||
124957688|NCT01059526|449471196|FG000|Overall Study|Patient found to be dermatographic|1|||
124957689|NCT01059526|449471197|FG001|Overall Study|Patient found to be dermatographic|0|||
124957690|NCT02720081|449471198|FG000|Overall Study|Adverse Event|0|||
124957691|NCT02720081|449471199|FG001|Overall Study|Adverse Event|3|||
124957692|NCT02720081|449471198|FG000|Overall Study|Protocol Violation|4|||
124957693|NCT02720081|449471199|FG001|Overall Study|Protocol Violation|1|||
124957694|NCT01732588|449471200|FG000|First Intervention (7 Days)|Adverse Event|0|||
124957695|NCT01732588|449471201|FG001|First Intervention (7 Days)|Adverse Event|1|||
124957696|NCT01732588|449471202|FG002|First Intervention (7 Days)|Adverse Event|0|||
124957697|NCT05012397|449471206|FG000|Overall Study|Death|10|||
124957698|NCT05012397|449471206|FG000|Overall Study|Physician Decision|9|||
124957699|NCT05012397|449471206|FG000|Overall Study|Withdrawal by Subject|5|||
124957700|NCT05012397|449471206|FG000|Overall Study|Lost to Follow-up|2|||
124957701|NCT03334747|449471207|FG000|Treatment Phase|Technical problems|0|||
124957702|NCT03334747|449471208|FG001|Treatment Phase|Technical problems|0|||
124957703|NCT03334747|449471209|FG002|Treatment Phase|Technical problems|0|||
124957704|NCT03334747|449471210|FG003|Treatment Phase|Technical problems|0|||
124957705|NCT03334747|449471211|FG004|Treatment Phase|Technical problems|1|||
124957706|NCT03334747|449471212|FG005|Treatment Phase|Technical problems|0|||
124957707|NCT03334747|449471213|FG006|Treatment Phase|Technical problems|0|||
124957708|NCT03334747|449471214|FG007|Treatment Phase|Technical problems|0|||
124957709|NCT03334747|449471215|FG008|Treatment Phase|Technical problems|0|||
124957710|NCT03334747|449471207|FG000|Treatment Phase|Subject/guardian decision|1|||
124957711|NCT03334747|449471208|FG001|Treatment Phase|Subject/guardian decision|0|||
124957712|NCT03334747|449471209|FG002|Treatment Phase|Subject/guardian decision|0|||
124957713|NCT03334747|449471210|FG003|Treatment Phase|Subject/guardian decision|0|||
124957714|NCT03334747|449471211|FG004|Treatment Phase|Subject/guardian decision|0|||
124957715|NCT03334747|449471212|FG005|Treatment Phase|Subject/guardian decision|1|||
124957716|NCT03334747|449471213|FG006|Treatment Phase|Subject/guardian decision|0|||
124957717|NCT03334747|449471214|FG007|Treatment Phase|Subject/guardian decision|0|||
124957718|NCT03334747|449471215|FG008|Treatment Phase|Subject/guardian decision|0|||
124957719|NCT03334747|449471207|FG000|Follow-Up Phase|Subject/guardian decision|0|||
124957720|NCT03334747|449471208|FG001|Follow-Up Phase|Subject/guardian decision|0|||
124957721|NCT03334747|449471209|FG002|Follow-Up Phase|Subject/guardian decision|0|||
124957722|NCT03334747|449471210|FG003|Follow-Up Phase|Subject/guardian decision|0|||
124957723|NCT03334747|449471211|FG004|Follow-Up Phase|Subject/guardian decision|0|||
124957724|NCT03334747|449471212|FG005|Follow-Up Phase|Subject/guardian decision|0|||
124957725|NCT03334747|449471213|FG006|Follow-Up Phase|Subject/guardian decision|1|||
124957726|NCT03334747|449471214|FG007|Follow-Up Phase|Subject/guardian decision|0|||
124957727|NCT03334747|449471215|FG008|Follow-Up Phase|Subject/guardian decision|1|||
124957728|NCT02567227|449471216|FG000|9 Weeks|Adverse Event|5|||
124957729|NCT02567227|449471217|FG001|9 Weeks|Adverse Event|5|||
124957730|NCT02567227|449471216|FG000|9 Weeks|Withdrawal by Subject|18|||
124957731|NCT02567227|449471217|FG001|9 Weeks|Withdrawal by Subject|8|||
124957732|NCT02567227|449471216|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
124957733|NCT02567227|449471217|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
124957734|NCT02567227|449471216|FG000|6 Month|Death|2|||
124957735|NCT02567227|449471217|FG001|6 Month|Death|0|||
124957736|NCT02567227|449471216|FG000|6 Month|Lost to Follow-up|43|||
124957737|NCT02567227|449471217|FG001|6 Month|Lost to Follow-up|40|||
124957738|NCT02567227|449471216|FG000|12 Months|Lost to Follow-up|31|||
124957739|NCT02567227|449471217|FG001|12 Months|Lost to Follow-up|32|||
124957740|NCT02567227|449471216|FG000|12 Months|Death|0|||
124957741|NCT02567227|449471217|FG001|12 Months|Death|2|||
124957742|NCT02498418|449471221|FG000|Overall Study|Lack of Efficacy|0|||
124957743|NCT02498418|449471222|FG001|Overall Study|Lack of Efficacy|0|||
124957744|NCT02498418|449471223|FG002|Overall Study|Lack of Efficacy|1|||
124957745|NCT02498418|449471221|FG000|Overall Study|Withdrawal by Subject|2|||
124957746|NCT02498418|449471222|FG001|Overall Study|Withdrawal by Subject|0|||
124957747|NCT02498418|449471223|FG002|Overall Study|Withdrawal by Subject|3|||
124957748|NCT02498418|449471221|FG000|Overall Study|Lost to Follow-up|0|||
124957749|NCT02498418|449471222|FG001|Overall Study|Lost to Follow-up|1|||
124957750|NCT02498418|449471223|FG002|Overall Study|Lost to Follow-up|1|||
124957751|NCT02498418|449471221|FG000|Overall Study|Participant taken prohibited medication|0|||
124957752|NCT02498418|449471222|FG001|Overall Study|Participant taken prohibited medication|1|||
124957753|NCT02498418|449471223|FG002|Overall Study|Participant taken prohibited medication|1|||
124957754|NCT00762502|449471224|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
124957755|NCT00762502|449471225|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
124957756|NCT00762502|449471226|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
124957757|NCT00762502|449471224|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
124957758|NCT00762502|449471225|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
124957759|NCT00762502|449471226|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
124957760|NCT00762502|449471224|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
124957761|NCT00762502|449471225|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
124957762|NCT00762502|449471226|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
124957763|NCT03042559|449471227|FG000|Overall Study|drop out|1|||
124957764|NCT03042559|449471228|FG001|Overall Study|drop out|1|||
124957765|NCT01485991|449471229|FG000|Overall Study|Adverse Event|0|||
124957766|NCT01485991|449471230|FG001|Overall Study|Adverse Event|4|||
124957767|NCT01485991|449471229|FG000|Overall Study|Lost to Follow-up|13|||
124957768|NCT01485991|449471230|FG001|Overall Study|Lost to Follow-up|10|||
124957769|NCT01485991|449471229|FG000|Overall Study|Withdrawal by Subject|13|||
124957770|NCT01485991|449471230|FG001|Overall Study|Withdrawal by Subject|20|||
124957771|NCT01485991|449471229|FG000|Overall Study|randomized but not treated|6|||
124957772|NCT01485991|449471230|FG001|Overall Study|randomized but not treated|2|||
124957773|NCT01475370|449471231|FG000|Overall Study|Exacerbation of primary disease|2|||
124957774|NCT01475370|449471232|FG001|Overall Study|Exacerbation of primary disease|2|||
124957775|NCT01475370|449471233|FG002|Overall Study|Exacerbation of primary disease|2|||
124957776|NCT01475370|449471231|FG000|Overall Study|Study drug administration difficult|0|||
124957777|NCT01475370|449471232|FG001|Overall Study|Study drug administration difficult|1|||
124957778|NCT01475370|449471233|FG002|Overall Study|Study drug administration difficult|1|||
124957779|NCT01475370|449471231|FG000|Overall Study|Other than specified|1|||
124957780|NCT01475370|449471232|FG001|Overall Study|Other than specified|0|||
124957781|NCT01475370|449471233|FG002|Overall Study|Other than specified|0|||
124957782|NCT01675050|449471236|FG000|Period One Treatment|Withdrawal by Subject|1|||
124957783|NCT01675050|449471237|FG001|Period One Treatment|Withdrawal by Subject|0|||
124957784|NCT04474691|449471238|FG000|Overall Study|Withdrawal by Subject|9|||
124957785|NCT02625922|449471239|FG000|Overall Study|Non-availability of IMP|1|||
124957786|NCT02625922|449471240|FG001|Overall Study|Non-availability of IMP|1|||
124957787|NCT02625922|449471239|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
124957788|NCT02625922|449471240|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
124957789|NCT01261793|449471247|FG000|Overall Study|Lack of Efficacy|44|||
124957790|NCT01261793|449471248|FG001|Overall Study|Lack of Efficacy|37|||
124957791|NCT01261793|449471249|FG002|Overall Study|Lack of Efficacy|32|||
124957792|NCT01261793|449471247|FG000|Overall Study|Protocol Violation|3|||
124957793|NCT01261793|449471248|FG001|Overall Study|Protocol Violation|5|||
124957794|NCT01261793|449471249|FG002|Overall Study|Protocol Violation|6|||
124957795|NCT01261793|449471247|FG000|Overall Study|Lost to Follow-up|10|||
124957796|NCT01261793|449471248|FG001|Overall Study|Lost to Follow-up|3|||
124957797|NCT01261793|449471249|FG002|Overall Study|Lost to Follow-up|7|||
124957798|NCT01261793|449471247|FG000|Overall Study|Withdrawal by Subject|12|||
124957799|NCT01261793|449471248|FG001|Overall Study|Withdrawal by Subject|14|||
124957800|NCT01261793|449471249|FG002|Overall Study|Withdrawal by Subject|14|||
124957801|NCT01261793|449471247|FG000|Overall Study|Death|3|||
124957802|NCT01261793|449471248|FG001|Overall Study|Death|1|||
124957803|NCT01261793|449471249|FG002|Overall Study|Death|0|||
124957804|NCT01261793|449471247|FG000|Overall Study|Adverse Event|9|||
124957805|NCT01261793|449471248|FG001|Overall Study|Adverse Event|24|||
124957806|NCT01261793|449471249|FG002|Overall Study|Adverse Event|19|||
124957807|NCT01261793|449471247|FG000|Overall Study|Patient non-availability|1|||
124957808|NCT01261793|449471248|FG001|Overall Study|Patient non-availability|1|||
124957809|NCT01261793|449471249|FG002|Overall Study|Patient non-availability|1|||
124957810|NCT01261793|449471247|FG000|Overall Study|Suspected pregnancy|1|||
124957811|NCT01261793|449471248|FG001|Overall Study|Suspected pregnancy|1|||
124957812|NCT01261793|449471249|FG002|Overall Study|Suspected pregnancy|0|||
124957813|NCT01261793|449471247|FG000|Overall Study|Patient non-compliance|1|||
124957814|NCT01261793|449471248|FG001|Overall Study|Patient non-compliance|0|||
124957815|NCT01261793|449471249|FG002|Overall Study|Patient non-compliance|1|||
124957816|NCT01261793|449471247|FG000|Overall Study|Patient pregnant|1|||
124957817|NCT01261793|449471248|FG001|Overall Study|Patient pregnant|0|||
125215575|NCT01768559|450417439|FG001|Overall Study|Poor compliance to protocol|3|||
124957818|NCT01261793|449471249|FG002|Overall Study|Patient pregnant|0|||
125215576|NCT01768559|450417440|FG002|Overall Study|Poor compliance to protocol|2|||
124957819|NCT01261793|449471247|FG000|Overall Study|Outside the study area|0|||
124957820|NCT01261793|449471248|FG001|Overall Study|Outside the study area|2|||
124957821|NCT01261793|449471249|FG002|Overall Study|Outside the study area|1|||
124957822|NCT01261793|449471247|FG000|Overall Study|Lack of efficacy & patient not available|0|||
124957823|NCT01261793|449471248|FG001|Overall Study|Lack of efficacy & patient not available|1|||
124957824|NCT01261793|449471249|FG002|Overall Study|Lack of efficacy & patient not available|0|||
124957825|NCT01261793|449471247|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
124957826|NCT01261793|449471248|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
124957827|NCT01261793|449471249|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
124957828|NCT01261793|449471247|FG000|Overall Study|Randomization error|0|||
124957829|NCT01261793|449471248|FG001|Overall Study|Randomization error|1|||
124957830|NCT01261793|449471249|FG002|Overall Study|Randomization error|0|||
124957831|NCT01261793|449471247|FG000|Overall Study|Patient unable to start IV line|0|||
124957832|NCT01261793|449471248|FG001|Overall Study|Patient unable to start IV line|0|||
124957833|NCT01261793|449471249|FG002|Overall Study|Patient unable to start IV line|1|||
124957834|NCT00832650|449471253|FG000|Overall Study|Randomized but not treated|0|||
124957835|NCT00832650|449471254|FG001|Overall Study|Randomized but not treated|0|||
124957836|NCT00832650|449471255|FG002|Overall Study|Randomized but not treated|1|||
124957837|NCT02335242|449471259|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
124957838|NCT02335242|449471260|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
124957839|NCT02335242|449471259|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
124957840|NCT02335242|449471260|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
124957841|NCT02335242|449471259|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
124957842|NCT02335242|449471260|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
124957843|NCT00257556|449471263|FG000|Overall Study|Adverse Event|1|||
124957844|NCT00257556|449471264|FG001|Overall Study|Adverse Event|4|||
124957845|NCT00257556|449471263|FG000|Overall Study|Physician Decision|6|||
124957846|NCT00257556|449471264|FG001|Overall Study|Physician Decision|0|||
124957847|NCT00257556|449471263|FG000|Overall Study|Did not meet hCG criterion|3|||
124957848|NCT00257556|449471264|FG001|Overall Study|Did not meet hCG criterion|0|||
124957849|NCT00257556|449471263|FG000|Overall Study|other reason|4|||
124957850|NCT00257556|449471264|FG001|Overall Study|other reason|6|||
124957851|NCT04839289|449471265|FG000|Overall Study|Withdrawal by Subject|1|||
124957852|NCT04839289|449471266|FG001|Overall Study|Withdrawal by Subject|0|||
124957853|NCT02418819|449471268|FG000|Overall Study|Adverse Event|0|||
124957854|NCT02418819|449471269|FG001|Overall Study|Adverse Event|0|||
124957855|NCT02418819|449471270|FG002|Overall Study|Adverse Event|1|||
124957856|NCT02418819|449471271|FG003|Overall Study|Adverse Event|0|||
124957857|NCT02418819|449471268|FG000|Overall Study|Lost to Follow-up|1|||
124957858|NCT02418819|449471269|FG001|Overall Study|Lost to Follow-up|0|||
124957859|NCT02418819|449471270|FG002|Overall Study|Lost to Follow-up|0|||
124957860|NCT02418819|449471271|FG003|Overall Study|Lost to Follow-up|0|||
124957861|NCT02418819|449471268|FG000|Overall Study|No longer meets eligibility criteria|0|||
124957862|NCT02418819|449471269|FG001|Overall Study|No longer meets eligibility criteria|0|||
124957863|NCT02418819|449471270|FG002|Overall Study|No longer meets eligibility criteria|1|||
124957864|NCT02418819|449471271|FG003|Overall Study|No longer meets eligibility criteria|0|||
124957865|NCT02418819|449471268|FG000|Overall Study|No longer willing to participate|0|||
124957866|NCT02418819|449471269|FG001|Overall Study|No longer willing to participate|0|||
124957867|NCT02418819|449471270|FG002|Overall Study|No longer willing to participate|2|||
124957868|NCT02418819|449471271|FG003|Overall Study|No longer willing to participate|1|||
124957869|NCT04743999|449471272|FG000|3-month Questionnaire|Death|1|||
124957870|NCT04743999|449471272|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
124957871|NCT04743999|449471272|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
124957872|NCT04743999|449471272|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
124957873|NCT01721759|449471273|FG000|Treatment Period|Disease Progression|85|||
124957874|NCT01721759|449471273|FG000|Treatment Period|Study drug toxicity|14|||
124957875|NCT01721759|449471273|FG000|Treatment Period|Death|1|||
124957876|NCT01721759|449471273|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
124957877|NCT01721759|449471273|FG000|Treatment Period|Participant request to withdraw|3|||
124957878|NCT01721759|449471273|FG000|Treatment Period|Other Reasons|3|||
124957879|NCT01721759|449471273|FG000|End of Study Period|Participant Withdrew Consent|5|||
124957880|NCT01721759|449471273|FG000|End of Study Period|Death|101|||
124957881|NCT01721759|449471273|FG000|End of Study Period|Lost to Follow-up|1|||
124957882|NCT01721759|449471273|FG000|End of Study Period|Other Reasons|10|||
124957883|NCT01399905|449471274|FG000|Overall Study|Withdrawal by Subject|1|||
124957884|NCT01399905|449471275|FG001|Overall Study|Withdrawal by Subject|1|||
124957885|NCT01804140|449471281|FG000|Overall Study|No sampling or biopsy procedures done|114|||
124957886|NCT02785900|449471282|FG000|Overall Study|Study Termination by Sponsor|64|||
124957887|NCT02785900|449471283|FG001|Overall Study|Study Termination by Sponsor|81|||
124957888|NCT02785900|449471282|FG000|Overall Study|Death|46|||
124957889|NCT02785900|449471283|FG001|Overall Study|Death|32|||
124957890|NCT02785900|449471282|FG000|Overall Study|Withdrawal by Subject|4|||
124957891|NCT02785900|449471283|FG001|Overall Study|Withdrawal by Subject|8|||
124957892|NCT02785900|449471282|FG000|Overall Study|Physician Decision|3|||
124957893|NCT02785900|449471283|FG001|Overall Study|Physician Decision|2|||
124957894|NCT01808144|449471284|FG000|Overall Study|Death|1|||
124957895|NCT01808144|449471285|FG001|Overall Study|Death|0|||
124957896|NCT01808144|449471284|FG000|Overall Study|Withdrawal by Subject|16|||
124957897|NCT01808144|449471285|FG001|Overall Study|Withdrawal by Subject|23|||
124957898|NCT01808144|449471284|FG000|Overall Study|Lost to Follow-up|6|||
124957899|NCT01808144|449471285|FG001|Overall Study|Lost to Follow-up|3|||
124957900|NCT01808144|449471284|FG000|Overall Study|Protocol Violation|6|||
124957901|NCT01808144|449471285|FG001|Overall Study|Protocol Violation|6|||
124957902|NCT01808144|449471284|FG000|Overall Study|Gout flare|0|||
124957903|NCT01808144|449471285|FG001|Overall Study|Gout flare|1|||
124957904|NCT01808144|449471284|FG000|Overall Study|Adverse Event|11|||
124957905|NCT01808144|449471285|FG001|Overall Study|Adverse Event|15|||
124957906|NCT00383500|449471286|FG000|Overall Study|Withdrawal by Subject|8|||
124957907|NCT00383500|449471287|FG001|Overall Study|Withdrawal by Subject|3|||
124957908|NCT00383500|449471288|FG002|Overall Study|Withdrawal by Subject|0|||
124957909|NCT00383500|449471286|FG000|Overall Study|Lost to Follow-up|0|||
124957910|NCT00383500|449471287|FG001|Overall Study|Lost to Follow-up|0|||
124957911|NCT00383500|449471288|FG002|Overall Study|Lost to Follow-up|2|||
124957912|NCT04341584|449471292|FG000|Overall Study|Withdrew consent|0|||
124957913|NCT04341584|449471293|FG001|Overall Study|Withdrew consent|2|||
124957914|NCT04341584|449471294|FG002|Overall Study|Withdrew consent|2|||
124957915|NCT04341584|449471295|FG003|Overall Study|Withdrew consent|1|||
124957916|NCT04853238|449471297|FG000|Overall Study|Death|4|||
124957917|NCT04853238|449471298|FG001|Overall Study|Death|0|||
124957918|NCT04853238|449471299|FG002|Overall Study|Death|2|||
124957919|NCT04853238|449471297|FG000|Overall Study|Lost to Follow-up|16|||
124957920|NCT04853238|449471298|FG001|Overall Study|Lost to Follow-up|2|||
124957921|NCT04853238|449471299|FG002|Overall Study|Lost to Follow-up|37|||
124957922|NCT04853238|449471297|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
124957923|NCT04853238|449471298|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
124957924|NCT04853238|449471299|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
124957925|NCT04853238|449471297|FG000|Overall Study|Withdrawal by Subject|6|||
124957926|NCT04853238|449471298|FG001|Overall Study|Withdrawal by Subject|0|||
124957927|NCT04853238|449471299|FG002|Overall Study|Withdrawal by Subject|21|||
124957928|NCT04853238|449471297|FG000|Overall Study|Physician Decision|0|||
124957929|NCT04853238|449471298|FG001|Overall Study|Physician Decision|0|||
124957930|NCT04853238|449471299|FG002|Overall Study|Physician Decision|2|||
124957931|NCT04853238|449471297|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
124957932|NCT04853238|449471298|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
124957933|NCT04853238|449471299|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
124957934|NCT02176356|449472667|FG000|Overall Study|Screen Failure|14|||
124957935|NCT02176356|449472667|FG000|Overall Study|Lost to Follow-up|4|||
124957936|NCT02176356|449472667|FG000|Overall Study|Personal Reasons|3|||
124957937|NCT02176356|449472667|FG000|Overall Study|Other Miscellaneous Reasons|2|||
124957938|NCT00792259|449472668|FG000|Overall Study|Poor Quality Scans|1|||
124957939|NCT00792259|449472669|FG001|Overall Study|Poor Quality Scans|0|||
124957940|NCT00792259|449472670|FG002|Overall Study|Poor Quality Scans|0|||
124957941|NCT00332488|449472671|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
124957942|NCT00332488|449472672|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
124957943|NCT00332488|449472673|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
124957944|NCT00332488|449472671|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
124957945|NCT00332488|449472672|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
124957946|NCT00332488|449472673|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
124957947|NCT00332488|449472671|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
124957948|NCT00332488|449472672|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
124957949|NCT00332488|449472673|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
124957950|NCT00332488|449472671|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
124957951|NCT00332488|449472672|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
124957952|NCT00332488|449472673|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
124957953|NCT00332488|449472671|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
124957954|NCT00332488|449472672|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
124957955|NCT00332488|449472673|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
124957956|NCT00332488|449472671|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
124957957|NCT00332488|449472672|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
124957958|NCT00332488|449472673|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
124957959|NCT00332488|449472671|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
124957960|NCT00332488|449472672|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
124957961|NCT00332488|449472673|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
124957962|NCT00332488|449472671|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
124957963|NCT00332488|449472672|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
124957964|NCT00332488|449472673|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
124957965|NCT00332488|449472671|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
124957966|NCT00332488|449472672|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
124957967|NCT00332488|449472673|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
124957968|NCT00332488|449472671|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
124957969|NCT00332488|449472672|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
124957970|NCT00332488|449472673|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
124957971|NCT00332488|449472671|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
124957972|NCT00332488|449472672|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
124957973|NCT00332488|449472673|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
124957974|NCT00332488|449472671|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
124957975|NCT00332488|449472672|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
124957976|NCT00332488|449472673|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
124957977|NCT00371462|449472674|FG000|Overall Study|Withdrawal by Subject|1|||
124957978|NCT00371462|449472675|FG001|Overall Study|Withdrawal by Subject|0|||
124957979|NCT00371462|449472674|FG000|Overall Study|Other|7|||
124957980|NCT00371462|449472675|FG001|Overall Study|Other|8|||
124957981|NCT03721978|449472677|FG000|Overall Study|Withdrawal by Subject|6|||
124957982|NCT03721978|449472678|FG001|Overall Study|Withdrawal by Subject|1|||
124957983|NCT03721978|449472677|FG000|Overall Study|Adverse Event|1|||
124957984|NCT03721978|449472678|FG001|Overall Study|Adverse Event|1|||
124957985|NCT03721978|449472677|FG000|Overall Study|Progressive Disease|1|||
124957986|NCT03721978|449472678|FG001|Overall Study|Progressive Disease|0|||
124957987|NCT03721978|449472677|FG000|Overall Study|Lost to Follow-up|5|||
124957988|NCT03721978|449472678|FG001|Overall Study|Lost to Follow-up|1|||
124957989|NCT03721978|449472677|FG000|Overall Study|Reason not Specified|0|||
124957990|NCT03721978|449472678|FG001|Overall Study|Reason not Specified|2|||
124957991|NCT05244226|449472679|FG000|Overall Study|Adverse Event|1|||
124957992|NCT05244226|449472680|FG001|Overall Study|Adverse Event|0|||
124957993|NCT05244226|449472681|FG002|Overall Study|Adverse Event|0|||
124957994|NCT05244226|449472679|FG000|Overall Study|Lost to Follow-up|0|||
124957995|NCT05244226|449472680|FG001|Overall Study|Lost to Follow-up|0|||
124957996|NCT05244226|449472681|FG002|Overall Study|Lost to Follow-up|1|||
124957997|NCT05244226|449472679|FG000|Overall Study|Protocol Violation|0|||
124957998|NCT05244226|449472680|FG001|Overall Study|Protocol Violation|2|||
124957999|NCT05244226|449472681|FG002|Overall Study|Protocol Violation|2|||
124958000|NCT00733226|449472682|FG000|Overall Study|Withdrawal by Subject|1|||
124958001|NCT00733226|449472683|FG001|Overall Study|Withdrawal by Subject|0|||
124958002|NCT00733226|449472682|FG000|Overall Study|Lost to Follow-up|2|||
124958003|NCT00733226|449472683|FG001|Overall Study|Lost to Follow-up|0|||
124958004|NCT00733226|449472682|FG000|Overall Study|moved to another place|2|||
124958005|NCT00733226|449472683|FG001|Overall Study|moved to another place|0|||
124958006|NCT03722485|449472684|FG000|Overall Study|Withdrawal by Subject|1|||
124958007|NCT03722485|449472685|FG001|Overall Study|Withdrawal by Subject|0|||
124958008|NCT03722485|449472684|FG000|Overall Study|Adverse Event|0|||
124958009|NCT03722485|449472685|FG001|Overall Study|Adverse Event|2|||
124958010|NCT03722485|449472684|FG000|Overall Study|subject discharged prior to study completion|1|||
124958011|NCT03722485|449472685|FG001|Overall Study|subject discharged prior to study completion|5|||
124958012|NCT03722485|449472684|FG000|Overall Study|eligibility criteria not met|2|||
124958013|NCT03722485|449472685|FG001|Overall Study|eligibility criteria not met|0|||
124958014|NCT00349622|449472686|FG000|Overall Study|Death|168|||
124958015|NCT00349622|449472687|FG001|Overall Study|Death|86|||
124958016|NCT00349622|449472686|FG000|Overall Study|Lost to Follow-up|5|||
124958017|NCT00349622|449472687|FG001|Overall Study|Lost to Follow-up|1|||
124958018|NCT00349622|449472686|FG000|Overall Study|Withdrawal by Subject|5|||
124958019|NCT00349622|449472687|FG001|Overall Study|Withdrawal by Subject|9|||
124958020|NCT01902381|449472688|FG000|Overall Study|Withdrawal by Subject|1|||
124958021|NCT00755716|449472689|FG000|Overall Study|Adverse Event|1|||
124958022|NCT00755716|449472690|FG001|Overall Study|Adverse Event|4|||
124958023|NCT00755716|449472691|FG002|Overall Study|Adverse Event|1|||
124958024|NCT00755716|449472689|FG000|Overall Study|Lack of Efficacy|2|||
124958025|NCT00755716|449472690|FG001|Overall Study|Lack of Efficacy|0|||
124958026|NCT00755716|449472691|FG002|Overall Study|Lack of Efficacy|0|||
124958027|NCT00755716|449472689|FG000|Overall Study|Lost to Follow-up|5|||
124958028|NCT00755716|449472690|FG001|Overall Study|Lost to Follow-up|3|||
124958029|NCT00755716|449472691|FG002|Overall Study|Lost to Follow-up|1|||
124958030|NCT00755716|449472689|FG000|Overall Study|work schedule issues|0|||
124958031|NCT00755716|449472690|FG001|Overall Study|work schedule issues|1|||
124958032|NCT00755716|449472691|FG002|Overall Study|work schedule issues|1|||
124958033|NCT02762500|449472692|FG000|Overall Study|Lack of Efficacy|1|||
124958034|NCT02762500|449472693|FG001|Overall Study|Lack of Efficacy|0|||
124958035|NCT02762500|449472692|FG000|Overall Study|Withdrawal by Subject|1|||
124958036|NCT02762500|449472693|FG001|Overall Study|Withdrawal by Subject|1|||
124958037|NCT02762500|449472692|FG000|Overall Study|Adverse Event|0|||
124958038|NCT02762500|449472693|FG001|Overall Study|Adverse Event|2|||
124958039|NCT02229396|449472694|FG000|Overall Study|Adverse Event|6|||
124958040|NCT02229396|449472695|FG001|Overall Study|Adverse Event|12|||
124958041|NCT02229396|449472696|FG002|Overall Study|Adverse Event|12|||
124958042|NCT02229396|449472694|FG000|Overall Study|Death|2|||
124958043|NCT02229396|449472695|FG001|Overall Study|Death|3|||
124958044|NCT02229396|449472696|FG002|Overall Study|Death|1|||
124958045|NCT02229396|449472694|FG000|Overall Study|Lost to Follow-up|14|||
124958046|NCT02229396|449472695|FG001|Overall Study|Lost to Follow-up|14|||
124958047|NCT02229396|449472696|FG002|Overall Study|Lost to Follow-up|21|||
124958048|NCT02229396|449472694|FG000|Overall Study|Protocol Violation|2|||
124958049|NCT02229396|449472695|FG001|Overall Study|Protocol Violation|1|||
124958050|NCT02229396|449472696|FG002|Overall Study|Protocol Violation|0|||
124958051|NCT02229396|449472694|FG000|Overall Study|Patient Incorrectly Randomized|0|||
124958052|NCT02229396|449472695|FG001|Overall Study|Patient Incorrectly Randomized|0|||
124958053|NCT02229396|449472696|FG002|Overall Study|Patient Incorrectly Randomized|1|||
124958054|NCT02229396|449472694|FG000|Overall Study|Other|10|||
124958055|NCT02229396|449472695|FG001|Overall Study|Other|18|||
124958056|NCT02229396|449472696|FG002|Overall Study|Other|15|||
124958057|NCT02229396|449472694|FG000|Overall Study|Withdrawal by Subject|42|||
124958058|NCT02229396|449472695|FG001|Overall Study|Withdrawal by Subject|28|||
124958059|NCT02229396|449472696|FG002|Overall Study|Withdrawal by Subject|41|||
124958060|NCT02229396|449472694|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
124958061|NCT02229396|449472695|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
124958062|NCT02229396|449472696|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
124958063|NCT02229396|449472694|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
124958064|NCT02229396|449472695|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
124958065|NCT02229396|449472696|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
124958066|NCT03275402|449472698|FG000|Overall Study|Death|17|||
124958067|NCT03275402|449472698|FG000|Overall Study|Study terminated by sponsor|21|||
124958068|NCT03275402|449472698|FG000|Overall Study|Withdrawal by Subject|1|||
124958069|NCT05135156|449472702|FG000|Overall Study|Lost to Follow-up|0|||
124958070|NCT05135156|449472703|FG001|Overall Study|Lost to Follow-up|0|||
124958071|NCT05135156|449472704|FG002|Overall Study|Lost to Follow-up|2|||
124958072|NCT02402465|449472710|FG000|Overall Study|Withdrawal by Subject|0|||
124958073|NCT02402465|449472711|FG001|Overall Study|Withdrawal by Subject|0|||
124958074|NCT02402465|449472712|FG002|Overall Study|Withdrawal by Subject|0|||
124958075|NCT02402465|449472713|FG003|Overall Study|Withdrawal by Subject|0|||
125215577|NCT01768559|450417438|FG000|Overall Study|Other than specified|9|||
124958076|NCT02402465|449472714|FG004|Overall Study|Withdrawal by Subject|0|||
124958077|NCT02402465|449472715|FG005|Overall Study|Withdrawal by Subject|1|||
124958078|NCT02402465|449472710|FG000|Overall Study|Lost to Follow-up|0|||
124958079|NCT02402465|449472711|FG001|Overall Study|Lost to Follow-up|1|||
124958080|NCT02402465|449472712|FG002|Overall Study|Lost to Follow-up|0|||
124958081|NCT02402465|449472713|FG003|Overall Study|Lost to Follow-up|0|||
124958082|NCT02402465|449472714|FG004|Overall Study|Lost to Follow-up|1|||
124958083|NCT02402465|449472715|FG005|Overall Study|Lost to Follow-up|0|||
124958084|NCT03807700|449472716|FG000|Overall Study|Withdrawal by Subject|2|||
124958085|NCT03807700|449472717|FG001|Overall Study|Withdrawal by Subject|1|||
124958086|NCT02005029|449472719|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
124958087|NCT02005029|449472720|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
124958088|NCT02316847|449472721|FG000|Overall Study|Adverse Event|0|||
124958089|NCT02316847|449472722|FG001|Overall Study|Adverse Event|3|||
124958090|NCT02316847|449472721|FG000|Overall Study|Lost to Follow-up|0|||
124958091|NCT02316847|449472722|FG001|Overall Study|Lost to Follow-up|2|||
124958092|NCT02316847|449472721|FG000|Overall Study|Physician Decision|0|||
124958093|NCT02316847|449472722|FG001|Overall Study|Physician Decision|1|||
124958094|NCT02316847|449472721|FG000|Overall Study|Pregnancy|0|||
124958095|NCT02316847|449472722|FG001|Overall Study|Pregnancy|1|||
124958096|NCT02316847|449472721|FG000|Overall Study|Withdrawal by Subject|2|||
125031131|NCT00896532|449735099|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125031132|NCT00896532|449735100|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125031133|NCT00896532|449735101|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
125031134|NCT00896532|449735102|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125031135|NCT00896532|449735103|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125031136|NCT00896532|449735104|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125031137|NCT00896532|449735105|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125031138|NCT00896532|449735106|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125031139|NCT00896532|449735107|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125031140|NCT00896532|449735108|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125031141|NCT00896532|449735109|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125031142|NCT00896532|449735110|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125031143|NCT00896532|449735111|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125031144|NCT00896532|449735112|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125031145|NCT00896532|449735113|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125031146|NCT00896532|449735114|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125031147|NCT00896532|449735115|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125031148|NCT00896532|449735116|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125031149|NCT00896532|449735117|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125031150|NCT00896532|449735118|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125031151|NCT00896532|449735119|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125031152|NCT00896532|449735120|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125031153|NCT00896532|449735098|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125031154|NCT00896532|449735099|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
124958097|NCT02316847|449472722|FG001|Overall Study|Withdrawal by Subject|9|||
124958098|NCT02316847|449472721|FG000|Overall Study|Noncompliance with study drug|0|||
124958099|NCT02316847|449472722|FG001|Overall Study|Noncompliance with study drug|3|||
124958100|NCT02316847|449472721|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
124958101|NCT02316847|449472722|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
124958102|NCT01370018|449472723|FG000|Overall Study|Did not meet criteria for analysis|1|||
124958103|NCT01525641|449472724|FG000|Overall Study|Case report form not collected|25|||
124958104|NCT01525641|449472724|FG000|Overall Study|No visit since the first visit|16|||
124958105|NCT01525641|449472724|FG000|Overall Study|Adverse Event|73|||
124958106|NCT01525641|449472724|FG000|Overall Study|Lack of Efficacy|24|||
124958107|NCT01525641|449472724|FG000|Overall Study|Improvement|5|||
124958108|NCT01525641|449472724|FG000|Overall Study|Lost to follow-up (relocation)|1|||
124958109|NCT01525641|449472724|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
124958110|NCT01525641|449472724|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
124958111|NCT01525641|449472724|FG000|Overall Study|Other than stated above|7|||
125031155|NCT00896532|449735100|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125031156|NCT00896532|449735101|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
125031157|NCT00896532|449735102|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
125031158|NCT00896532|449735103|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125031159|NCT00896532|449735104|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125031160|NCT00896532|449735105|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125031161|NCT00896532|449735106|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125031162|NCT00896532|449735107|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125031163|NCT00896532|449735108|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125031164|NCT00896532|449735109|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125031165|NCT00896532|449735110|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125031166|NCT00896532|449735111|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125031167|NCT00896532|449735112|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125031168|NCT00896532|449735113|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125031169|NCT00896532|449735114|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125031170|NCT00896532|449735115|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125031171|NCT00896532|449735116|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125031172|NCT00896532|449735117|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125031173|NCT00896532|449735118|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125031174|NCT00896532|449735119|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125031175|NCT00896532|449735120|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125031176|NCT00896532|449735098|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125031177|NCT00896532|449735099|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125031178|NCT00896532|449735100|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125031179|NCT00896532|449735101|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125031180|NCT00896532|449735102|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125031181|NCT00896532|449735103|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125031182|NCT00896532|449735104|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125031183|NCT00896532|449735105|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125031184|NCT00896532|449735106|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
125031185|NCT00896532|449735107|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125031186|NCT00896532|449735108|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125031187|NCT00896532|449735109|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125031188|NCT00896532|449735110|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125031189|NCT00896532|449735111|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125031190|NCT00896532|449735112|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125031191|NCT00896532|449735113|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125031192|NCT00896532|449735114|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125031193|NCT00896532|449735115|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125031194|NCT00896532|449735116|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125031195|NCT00896532|449735117|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125031196|NCT00896532|449735118|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125031197|NCT00896532|449735119|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125128385|NCT00376623|450096058|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
125128386|NCT00376623|450096059|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
124958112|NCT03772041|449472725|FG000|Overall Study|Adverse Event|8|||
124958113|NCT03772041|449472726|FG001|Overall Study|Adverse Event|3|||
124958114|NCT03772041|449472725|FG000|Overall Study|Withdrawal by Subject|0|||
124958115|NCT03772041|449472726|FG001|Overall Study|Withdrawal by Subject|2|||
124958116|NCT03772041|449472725|FG000|Overall Study|Protocol Violation|4|||
124958117|NCT03772041|449472726|FG001|Overall Study|Protocol Violation|2|||
124958118|NCT03772041|449472725|FG000|Overall Study|Physician Decision|2|||
124958119|NCT03772041|449472726|FG001|Overall Study|Physician Decision|3|||
124958120|NCT04748445|449472736|FG000|Overall Study|No longer met eligibility criteria|12|||
124958121|NCT04748445|449472736|FG000|Overall Study|Other|36|||
124958122|NCT04748445|449472736|FG000|Overall Study|Withdrawal by Subject|553|||
124958123|NCT04748445|449472736|FG000|Overall Study|Lost to Follow-up|30|||
124958124|NCT01536535|449472740|FG000|Overall Study|Withdrawal by Subject|10|||
124958125|NCT01536535|449472741|FG001|Overall Study|Withdrawal by Subject|5|||
124958126|NCT01536535|449472740|FG000|Overall Study|Lost to Follow-up|4|||
124958127|NCT01536535|449472741|FG001|Overall Study|Lost to Follow-up|6|||
124958128|NCT01536535|449472740|FG000|Overall Study|Physician Decision|1|||
125128387|NCT00376623|450096057|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
125031198|NCT00896532|449735120|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125031199|NCT00896532|449735098|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124958129|NCT01536535|449472741|FG001|Overall Study|Physician Decision|1|||
124958130|NCT01536535|449472740|FG000|Overall Study|Participant moved|0|||
124958131|NCT01536535|449472741|FG001|Overall Study|Participant moved|1|||
124958132|NCT00385697|449472744|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
124958133|NCT00385697|449472745|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
124958134|NCT00385697|449472746|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
124958135|NCT00385697|449472747|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
124958136|NCT00385697|449472748|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
124958137|NCT00385697|449472744|FG000|Open-label Segment 1|Lost to Follow-up|1|||
124958138|NCT00385697|449472745|FG001|Open-label Segment 1|Lost to Follow-up|0|||
124958139|NCT00385697|449472746|FG002|Open-label Segment 1|Lost to Follow-up|0|||
124958140|NCT00385697|449472747|FG003|Open-label Segment 1|Lost to Follow-up|0|||
124958141|NCT00385697|449472748|FG004|Open-label Segment 1|Lost to Follow-up|0|||
124958142|NCT00385697|449472744|FG000|Double-blind Segment 2|Adverse Event|0|||
124958143|NCT00385697|449472745|FG001|Double-blind Segment 2|Adverse Event|3|||
124958144|NCT00385697|449472746|FG002|Double-blind Segment 2|Adverse Event|1|||
124958145|NCT00385697|449472747|FG003|Double-blind Segment 2|Adverse Event|0|||
124958146|NCT00385697|449472748|FG004|Double-blind Segment 2|Adverse Event|0|||
124958147|NCT00385697|449472744|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
124958148|NCT00385697|449472745|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
124958149|NCT00385697|449472746|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
124958150|NCT00385697|449472747|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
124958151|NCT00385697|449472748|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
124958152|NCT00385697|449472744|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
124958153|NCT00385697|449472745|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
124958154|NCT00385697|449472746|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
124958155|NCT00385697|449472747|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
124958156|NCT00385697|449472748|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
124958157|NCT00385697|449472744|FG000|Double-blind Segment 2|Other|0|||
124958158|NCT00385697|449472745|FG001|Double-blind Segment 2|Other|2|||
124958159|NCT00385697|449472746|FG002|Double-blind Segment 2|Other|0|||
124958160|NCT00385697|449472747|FG003|Double-blind Segment 2|Other|0|||
124958161|NCT00385697|449472748|FG004|Double-blind Segment 2|Other|0|||
124958162|NCT02538471|449472750|FG000|Overall Study|Progression of disease|2|||
124958163|NCT00084747|449472751|FG000|Overall Study|Relapsed|8|||
124958164|NCT00084747|449472751|FG000|Overall Study|Death|3|||
124958165|NCT00084747|449472751|FG000|Overall Study|Withdrawal by Subject|2|||
124958166|NCT02382406|449472756|FG000|Study Treatment|Disease Progression|8|||
124958167|NCT02382406|449472757|FG001|Study Treatment|Disease Progression|0|||
124958168|NCT02382406|449472758|FG002|Study Treatment|Disease Progression|20|||
124958169|NCT02382406|449472756|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
124958170|NCT02382406|449472757|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
124958171|NCT02382406|449472758|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
124958172|NCT02382406|449472756|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
124958173|NCT02382406|449472757|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
124958174|NCT02382406|449472758|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
124958175|NCT02382406|449472756|FG000|Study Treatment|symptomatic deterioration|1|||
124958176|NCT02382406|449472757|FG001|Study Treatment|symptomatic deterioration|0|||
124958177|NCT02382406|449472758|FG002|Study Treatment|symptomatic deterioration|1|||
124958178|NCT02382406|449472756|FG000|Study Treatment|Death|0|||
124958179|NCT02382406|449472757|FG001|Study Treatment|Death|0|||
124958180|NCT02382406|449472758|FG002|Study Treatment|Death|2|||
124958181|NCT02382406|449472756|FG000|Follow up|Death|11|||
124958182|NCT02382406|449472757|FG001|Follow up|Death|0|||
124958183|NCT02382406|449472758|FG002|Follow up|Death|19|||
124958184|NCT02382406|449472756|FG000|Follow up|Symptomatic deterioration|1|||
124958185|NCT02382406|449472757|FG001|Follow up|Symptomatic deterioration|0|||
124958186|NCT02382406|449472758|FG002|Follow up|Symptomatic deterioration|1|||
124958187|NCT02382406|449472756|FG000|Follow up|Patient Refused Follow-up|1|||
124958188|NCT02382406|449472757|FG001|Follow up|Patient Refused Follow-up|0|||
124958189|NCT02382406|449472758|FG002|Follow up|Patient Refused Follow-up|0|||
124958190|NCT02382406|449472756|FG000|Follow up|Study Terminated|1|||
124958191|NCT02382406|449472757|FG001|Follow up|Study Terminated|0|||
124958192|NCT02382406|449472758|FG002|Follow up|Study Terminated|8|||
124958193|NCT02382406|449472756|FG000|Follow up|Withdrawal by Subject|0|||
124958194|NCT02382406|449472757|FG001|Follow up|Withdrawal by Subject|0|||
124958195|NCT02382406|449472758|FG002|Follow up|Withdrawal by Subject|2|||
124958196|NCT03794609|449472761|FG000|Overall Study|Other|10|||
124958197|NCT03794609|449472761|FG000|Overall Study|Withdrawal by Subject|66|||
124958198|NCT03794609|449472761|FG000|Overall Study|The child is enrolled in an interventional study|70|||
124958199|NCT03794609|449472761|FG000|Overall Study|Inclusion/exclusion criteria|8|||
124958200|NCT03794609|449472761|FG000|Overall Study|At sponsor's request|151|||
124958201|NCT03794609|449472761|FG000|Overall Study|Physician Decision|1|||
124958202|NCT03794609|449472761|FG000|Overall Study|Lost to Follow-up|5|||
124958203|NCT04543942|449472762|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
124958204|NCT04543942|449472763|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
124958205|NCT04543942|449472762|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
124958206|NCT04543942|449472763|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
124958207|NCT02097056|449472768|FG000|Overall Study|Protocol Violation|2|||
124958208|NCT02097056|449472768|FG000|Overall Study|Withdrawal by Subject|15|||
124958209|NCT02097056|449472768|FG000|Overall Study|Lost to Follow-up|2|||
124958210|NCT02097056|449472768|FG000|Overall Study|Adverse Event|37|||
124958211|NCT02097056|449472768|FG000|Overall Study|Other|2|||
124958212|NCT01323309|449472769|FG000|Overall Study|Death|9|||
124958213|NCT01323309|449472770|FG001|Overall Study|Death|15|||
124958214|NCT01323309|449472771|FG002|Overall Study|Death|5|||
124958215|NCT01323309|449472769|FG000|Overall Study|Lost to Follow-up|11|||
124958216|NCT01323309|449472770|FG001|Overall Study|Lost to Follow-up|14|||
124958217|NCT01323309|449472771|FG002|Overall Study|Lost to Follow-up|24|||
124958218|NCT01323309|449472769|FG000|Overall Study|Withdrawal by Subject|14|||
124958219|NCT01323309|449472770|FG001|Overall Study|Withdrawal by Subject|14|||
124958220|NCT01323309|449472771|FG002|Overall Study|Withdrawal by Subject|18|||
124958221|NCT01323309|449472769|FG000|Overall Study|Disease progression|5|||
124958222|NCT01323309|449472770|FG001|Overall Study|Disease progression|11|||
124958223|NCT01323309|449472771|FG002|Overall Study|Disease progression|4|||
124958224|NCT02133131|449472776|FG000|Overall Study|Adverse Event|0|||
124958225|NCT02133131|449472777|FG001|Overall Study|Adverse Event|0|||
124958226|NCT02133131|449472778|FG002|Overall Study|Adverse Event|0|||
124958227|NCT02133131|449472779|FG003|Overall Study|Adverse Event|1|||
124958228|NCT02133131|449472780|FG004|Overall Study|Adverse Event|0|||
124958229|NCT02133131|449472781|FG005|Overall Study|Adverse Event|0|||
124958230|NCT02133131|449472782|FG006|Overall Study|Adverse Event|0|||
124958231|NCT02133131|449472776|FG000|Overall Study|Lost to Follow-up|1|||
124958232|NCT02133131|449472777|FG001|Overall Study|Lost to Follow-up|0|||
124958233|NCT02133131|449472778|FG002|Overall Study|Lost to Follow-up|0|||
124958234|NCT02133131|449472779|FG003|Overall Study|Lost to Follow-up|1|||
124958235|NCT02133131|449472780|FG004|Overall Study|Lost to Follow-up|0|||
124958236|NCT02133131|449472781|FG005|Overall Study|Lost to Follow-up|0|||
124958237|NCT02133131|449472782|FG006|Overall Study|Lost to Follow-up|0|||
124958238|NCT02133131|449472776|FG000|Overall Study|Status not recorded|4|||
124958239|NCT02133131|449472777|FG001|Overall Study|Status not recorded|5|||
124958240|NCT02133131|449472778|FG002|Overall Study|Status not recorded|1|||
124958241|NCT02133131|449472779|FG003|Overall Study|Status not recorded|4|||
124958242|NCT02133131|449472780|FG004|Overall Study|Status not recorded|0|||
124958243|NCT02133131|449472781|FG005|Overall Study|Status not recorded|0|||
124958244|NCT02133131|449472782|FG006|Overall Study|Status not recorded|0|||
124958245|NCT02133131|449472776|FG000|Overall Study|Ongoing in study|0|||
124958246|NCT02133131|449472777|FG001|Overall Study|Ongoing in study|0|||
124958247|NCT02133131|449472778|FG002|Overall Study|Ongoing in study|0|||
124958248|NCT02133131|449472779|FG003|Overall Study|Ongoing in study|0|||
124958249|NCT02133131|449472780|FG004|Overall Study|Ongoing in study|15|||
124958250|NCT02133131|449472781|FG005|Overall Study|Ongoing in study|14|||
124958251|NCT02133131|449472782|FG006|Overall Study|Ongoing in study|11|||
124958252|NCT02133131|449472776|FG000|Overall Study|Protocol Violation|0|||
124958253|NCT02133131|449472777|FG001|Overall Study|Protocol Violation|0|||
124958254|NCT02133131|449472778|FG002|Overall Study|Protocol Violation|0|||
124958255|NCT02133131|449472779|FG003|Overall Study|Protocol Violation|0|||
124958256|NCT02133131|449472780|FG004|Overall Study|Protocol Violation|0|||
124958257|NCT02133131|449472781|FG005|Overall Study|Protocol Violation|0|||
124958258|NCT02133131|449472782|FG006|Overall Study|Protocol Violation|1|||
124958259|NCT01544153|449472783|FG000|Overall Study|Under 18|0|||
124958260|NCT01544153|449472784|FG001|Overall Study|Under 18|1|||
124958261|NCT01544153|449472785|FG002|Overall Study|Under 18|0|||
124958262|NCT01544153|449472786|FG003|Overall Study|Under 18|0|||
124958263|NCT01544153|449472783|FG000|Overall Study|Non-smoker|0|||
124958264|NCT01544153|449472784|FG001|Overall Study|Non-smoker|0|||
124958265|NCT01544153|449472785|FG002|Overall Study|Non-smoker|1|||
124958266|NCT01544153|449472786|FG003|Overall Study|Non-smoker|0|||
124958267|NCT00884793|449472791|FG000|Overall Study|Withdrawal by Subject|1|||
124958268|NCT03169530|449472792|FG000|Overall Study|Study ended by NIH|15|||
124958269|NCT03169530|449472793|FG001|Overall Study|Study ended by NIH|17|||
124958270|NCT01032200|449472794|FG000|Overall Study|Death|1|||
124958271|NCT01032200|449472795|FG001|Overall Study|Death|1|||
124958272|NCT01032200|449472794|FG000|Overall Study|Withdrawal by Subject|1|||
124958273|NCT01032200|449472795|FG001|Overall Study|Withdrawal by Subject|3|||
125031200|NCT00896532|449735099|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124958274|NCT01032200|449472794|FG000|Overall Study|Toxicity|0|||
124958275|NCT01032200|449472795|FG001|Overall Study|Toxicity|2|||
124958276|NCT01032200|449472794|FG000|Overall Study|Progression|1|||
124958277|NCT01032200|449472795|FG001|Overall Study|Progression|0|||
124958278|NCT01032200|449472794|FG000|Overall Study|Multiple|1|||
124958279|NCT01032200|449472795|FG001|Overall Study|Multiple|1|||
124958280|NCT00714688|449472799|FG000|Overall Study|Lack of Efficacy|14|||
124958281|NCT00714688|449472800|FG001|Overall Study|Lack of Efficacy|1|||
124958282|NCT00714688|449472801|FG002|Overall Study|Lack of Efficacy|4|||
124958283|NCT00714688|449472799|FG000|Overall Study|Withdrawal by Subject|4|||
124958284|NCT00714688|449472800|FG001|Overall Study|Withdrawal by Subject|3|||
124958285|NCT00714688|449472801|FG002|Overall Study|Withdrawal by Subject|3|||
124958286|NCT00714688|449472799|FG000|Overall Study|Lost to Follow-up|5|||
124958287|NCT00714688|449472800|FG001|Overall Study|Lost to Follow-up|2|||
124958288|NCT00714688|449472801|FG002|Overall Study|Lost to Follow-up|0|||
124958289|NCT00714688|449472799|FG000|Overall Study|Adverse Event|2|||
124958290|NCT00714688|449472800|FG001|Overall Study|Adverse Event|15|||
124958291|NCT00714688|449472801|FG002|Overall Study|Adverse Event|19|||
124958292|NCT00714688|449472799|FG000|Overall Study|Subject Non-compliant|3|||
124958293|NCT00714688|449472800|FG001|Overall Study|Subject Non-compliant|5|||
124958294|NCT00714688|449472801|FG002|Overall Study|Subject Non-compliant|5|||
124958295|NCT00714688|449472799|FG000|Overall Study|Ineligible to Continue the Study|0|||
124958296|NCT00714688|449472800|FG001|Overall Study|Ineligible to Continue the Study|1|||
124958297|NCT00714688|449472801|FG002|Overall Study|Ineligible to Continue the Study|1|||
124958298|NCT00714688|449472799|FG000|Overall Study|Sponsor's Decision|0|||
124958299|NCT00714688|449472800|FG001|Overall Study|Sponsor's Decision|2|||
124958300|NCT00714688|449472801|FG002|Overall Study|Sponsor's Decision|0|||
124958301|NCT00714688|449472799|FG000|Overall Study|Other|1|||
124958302|NCT00714688|449472800|FG001|Overall Study|Other|6|||
124958303|NCT00714688|449472801|FG002|Overall Study|Other|5|||
124958304|NCT00500539|449472802|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
124958305|NCT00500539|449472802|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
124958306|NCT00500539|449472802|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
124958307|NCT00500539|449472802|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
124958308|NCT00500539|449472802|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
124958309|NCT00500539|449472802|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
124958310|NCT00500539|449472802|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
124958311|NCT00500539|449472802|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
124958312|NCT00500539|449472802|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
124958313|NCT00500539|449472802|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
124958314|NCT00500539|449472802|FG000|Follow-up Period (16 Weeks)|Death|1|||
124958315|NCT00500539|449472802|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
124958316|NCT00500539|449472802|FG000|Follow-up Period (16 Weeks)|Missing|3|||
124958317|NCT02316171|449472803|FG000|Overall Study|difficulties with urinary catheter|1|||
124958318|NCT02316171|449472804|FG001|Overall Study|difficulties with urinary catheter|0|||
124958319|NCT02316171|449472805|FG002|Overall Study|difficulties with urinary catheter|0|||
124958320|NCT02316171|449472806|FG003|Overall Study|difficulties with urinary catheter|0|||
124958321|NCT01524887|449472808|FG000|Overall Study|Withdrawal by Subject|6|||
124958322|NCT01524887|449472809|FG001|Overall Study|Withdrawal by Subject|2|||
124958323|NCT01524887|449472810|FG002|Overall Study|Withdrawal by Subject|3|||
124958324|NCT01524887|449472808|FG000|Overall Study|Adverse Event|5|||
124958325|NCT01524887|449472809|FG001|Overall Study|Adverse Event|1|||
124958326|NCT01524887|449472810|FG002|Overall Study|Adverse Event|1|||
124958327|NCT01524887|449472808|FG000|Overall Study|Protocol Violation|0|||
124958328|NCT01524887|449472809|FG001|Overall Study|Protocol Violation|0|||
124958329|NCT01524887|449472810|FG002|Overall Study|Protocol Violation|1|||
124958330|NCT01524887|449472808|FG000|Overall Study|Study termination|73|||
124958331|NCT01524887|449472809|FG001|Overall Study|Study termination|87|||
124958332|NCT01524887|449472810|FG002|Overall Study|Study termination|79|||
124958333|NCT01524887|449472808|FG000|Overall Study|Withdrawal by Caregiver|0|||
124958334|NCT01524887|449472809|FG001|Overall Study|Withdrawal by Caregiver|0|||
124958335|NCT01524887|449472810|FG002|Overall Study|Withdrawal by Caregiver|2|||
124958336|NCT01524887|449472808|FG000|Overall Study|Use of prohibited medication|1|||
124958337|NCT01524887|449472809|FG001|Overall Study|Use of prohibited medication|0|||
124958338|NCT01524887|449472810|FG002|Overall Study|Use of prohibited medication|0|||
124958339|NCT00547300|449472811|FG000|Overall Study|Study was Administratively Terminated|25|||
124958340|NCT00547300|449472812|FG001|Overall Study|Study was Administratively Terminated|24|||
124958341|NCT00547300|449472811|FG000|Overall Study|Did not Meet Entry Criteria|0|||
124958342|NCT00547300|449472812|FG001|Overall Study|Did not Meet Entry Criteria|2|||
124958343|NCT04380688|449472815|FG000|Overall Study|Death|2|||
124958344|NCT04380688|449472816|FG001|Overall Study|Death|2|||
124958345|NCT04380688|449472815|FG000|Overall Study|Lost to Follow-up|2|||
124958346|NCT04380688|449472816|FG001|Overall Study|Lost to Follow-up|4|||
124958347|NCT04380688|449472815|FG000|Overall Study|Withdrawal by Subject|3|||
124958348|NCT04380688|449472816|FG001|Overall Study|Withdrawal by Subject|3|||
124958349|NCT03993054|449472817|FG000|Overall Study|PI Decision|1|||
124958350|NCT04267393|449472820|FG000|Randomization|Adverse Event|1|||
124958351|NCT04267393|449472821|FG001|Randomization|Adverse Event|0|||
124958352|NCT04267393|449472822|FG002|Randomization|Adverse Event|0|||
124958353|NCT04267393|449472820|FG000|Randomization|Administrative Reasons by Sponsor|0|||
124958354|NCT04267393|449472821|FG001|Randomization|Administrative Reasons by Sponsor|1|||
124958355|NCT04267393|449472822|FG002|Randomization|Administrative Reasons by Sponsor|0|||
124958356|NCT04267393|449472820|FG000|Treatment Period|Adverse Event|0|||
124958357|NCT04267393|449472821|FG001|Treatment Period|Adverse Event|2|||
124958358|NCT04267393|449472822|FG002|Treatment Period|Adverse Event|3|||
124958359|NCT04267393|449472820|FG000|Treatment Period|Participant Withdrew Consent|0|||
124958360|NCT04267393|449472821|FG001|Treatment Period|Participant Withdrew Consent|0|||
124958361|NCT04267393|449472822|FG002|Treatment Period|Participant Withdrew Consent|1|||
124958362|NCT04267393|449472820|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
124958363|NCT04267393|449472821|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
124958364|NCT04267393|449472822|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
124958365|NCT02093897|449474503|FG000|Overall Study|Physician Decision|1|||
124958366|NCT02093897|449474503|FG000|Overall Study|Planned age group closure - no's reached|17|||
124958367|NCT02093897|449474503|FG000|Overall Study|Adverse event, non-fatal|1|||
124958368|NCT00088452|449474504|FG000|Overall Study|Did not receive intervention|1|||
124958369|NCT00088452|449474505|FG001|Overall Study|Did not receive intervention|0|||
124958370|NCT00088452|449474506|FG002|Overall Study|Did not receive intervention|1|||
124958371|NCT02081196|449474508|FG000|Overall Study|Lost to Follow-up|1|||
124958372|NCT03098797|449474511|FG000|Part 2 Open Label Extension|Adverse Event|2|||
124958373|NCT03098797|449474512|FG001|Part 2 Open Label Extension|Adverse Event|0|||
124958374|NCT00381888|449474515|FG000|Overall Study|Death|1|||
124958375|NCT00381888|449474515|FG000|Overall Study|Withdrawal by Subject|1|||
124958376|NCT00381888|449474515|FG000|Overall Study|Physician Decision|1|||
124958377|NCT00381888|449474515|FG000|Overall Study|Protocol Violation|9|||
124958378|NCT00381888|449474515|FG000|Overall Study|Had laparoscopic surgery|2|||
124958379|NCT00381888|449474515|FG000|Overall Study|Surgery was cancelled|2|||
124958380|NCT00381888|449474515|FG000|Overall Study|Adverse Event|1|||
124958381|NCT01231464|449474516|FG000|Overall Study|Adverse Event|0|||
124958382|NCT01231464|449474517|FG001|Overall Study|Adverse Event|1|||
124958383|NCT01231464|449474516|FG000|Overall Study|Protocol Violation|1|||
124958384|NCT01231464|449474517|FG001|Overall Study|Protocol Violation|2|||
124958385|NCT01231464|449474516|FG000|Overall Study|Lost to Follow-up|1|||
124958386|NCT01231464|449474517|FG001|Overall Study|Lost to Follow-up|2|||
124958387|NCT01231464|449474516|FG000|Overall Study|Withdrawal by Subject|3|||
124958388|NCT01231464|449474517|FG001|Overall Study|Withdrawal by Subject|2|||
124958389|NCT01589523|449474526|FG000|Overall Study|Withdrawal by Subject|1|||
124958390|NCT00961896|449474527|FG000|Overall Study|Abnormal laboratory value|0|||
124958391|NCT00961896|449474528|FG001|Overall Study|Abnormal laboratory value|0|||
124958392|NCT00961896|449474529|FG002|Overall Study|Abnormal laboratory value|1|||
124958393|NCT02507687|449474538|FG000|Overall Study|Adverse Event|3|||
124958394|NCT02507687|449474539|FG001|Overall Study|Adverse Event|2|||
124958395|NCT02507687|449474540|FG002|Overall Study|Adverse Event|2|||
124958396|NCT02507687|449474541|FG003|Overall Study|Adverse Event|2|||
124958397|NCT02507687|449474538|FG000|Overall Study|Withdrawal by Subject|1|||
124958398|NCT02507687|449474539|FG001|Overall Study|Withdrawal by Subject|4|||
124958399|NCT02507687|449474540|FG002|Overall Study|Withdrawal by Subject|6|||
124958400|NCT02507687|449474541|FG003|Overall Study|Withdrawal by Subject|6|||
124958401|NCT02507687|449474538|FG000|Overall Study|Protocol Violation|1|||
124958402|NCT02507687|449474539|FG001|Overall Study|Protocol Violation|0|||
124958403|NCT02507687|449474540|FG002|Overall Study|Protocol Violation|2|||
124958404|NCT02507687|449474541|FG003|Overall Study|Protocol Violation|0|||
124958405|NCT02507687|449474538|FG000|Overall Study|Lost to Follow-up|0|||
124958406|NCT02507687|449474539|FG001|Overall Study|Lost to Follow-up|0|||
124958407|NCT02507687|449474540|FG002|Overall Study|Lost to Follow-up|2|||
124958408|NCT02507687|449474541|FG003|Overall Study|Lost to Follow-up|1|||
124958409|NCT02507687|449474538|FG000|Overall Study|Screen Failure|0|||
124958410|NCT02507687|449474539|FG001|Overall Study|Screen Failure|0|||
124958411|NCT02507687|449474540|FG002|Overall Study|Screen Failure|1|||
124958412|NCT02507687|449474541|FG003|Overall Study|Screen Failure|0|||
124958413|NCT02507687|449474538|FG000|Overall Study|Other, Not Specified|0|||
124958414|NCT02507687|449474539|FG001|Overall Study|Other, Not Specified|0|||
124958415|NCT02507687|449474540|FG002|Overall Study|Other, Not Specified|2|||
124958416|NCT02507687|449474541|FG003|Overall Study|Other, Not Specified|4|||
124958417|NCT02675998|449474542|FG000|8-Week Treatment Period|Adverse Event|6|||
124958418|NCT02675998|449474543|FG001|8-Week Treatment Period|Adverse Event|5|||
124958419|NCT02675998|449474544|FG002|8-Week Treatment Period|Adverse Event|6|||
124958420|NCT02675998|449474545|FG003|8-Week Treatment Period|Adverse Event|0|||
124958421|NCT02675998|449474542|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
124958422|NCT02675998|449474543|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
124958423|NCT02675998|449474544|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
124958424|NCT02675998|449474545|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
124958425|NCT02675998|449474542|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
124958426|NCT02675998|449474543|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
124958427|NCT02675998|449474544|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
124958428|NCT02675998|449474545|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
124958429|NCT02675998|449474542|FG000|8-Week Treatment Period|Physician Decision|1|||
124958430|NCT02675998|449474543|FG001|8-Week Treatment Period|Physician Decision|0|||
124958431|NCT02675998|449474544|FG002|8-Week Treatment Period|Physician Decision|2|||
124958432|NCT02675998|449474545|FG003|8-Week Treatment Period|Physician Decision|0|||
124958433|NCT02675998|449474542|FG000|8-Week Treatment Period|GI side Effects|1|||
124958434|NCT02675998|449474543|FG001|8-Week Treatment Period|GI side Effects|4|||
124958435|NCT02675998|449474544|FG002|8-Week Treatment Period|GI side Effects|2|||
124958436|NCT02675998|449474545|FG003|8-Week Treatment Period|GI side Effects|0|||
124958437|NCT02675998|449474542|FG000|8-Week Treatment Period|Protocol Violation|1|||
124958438|NCT02675998|449474543|FG001|8-Week Treatment Period|Protocol Violation|1|||
124958439|NCT02675998|449474544|FG002|8-Week Treatment Period|Protocol Violation|1|||
124958440|NCT02675998|449474545|FG003|8-Week Treatment Period|Protocol Violation|0|||
124958441|NCT02675998|449474542|FG000|8-Week Treatment Period|Other|3|||
124958442|NCT02675998|449474543|FG001|8-Week Treatment Period|Other|1|||
124958443|NCT02675998|449474544|FG002|8-Week Treatment Period|Other|2|||
124958444|NCT02675998|449474545|FG003|8-Week Treatment Period|Other|0|||
124958445|NCT02675998|449474542|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
124958446|NCT02675998|449474543|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
124958447|NCT02675998|449474544|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
124958448|NCT02675998|449474545|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
124958449|NCT02675998|449474542|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
124958450|NCT02675998|449474543|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
124958451|NCT02675998|449474544|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
124958452|NCT02675998|449474545|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
124958453|NCT02675998|449474542|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
124958454|NCT02675998|449474543|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
124958455|NCT02675998|449474544|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
124958456|NCT02675998|449474545|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
124958457|NCT02675998|449474542|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
124958458|NCT02675998|449474543|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
124958459|NCT02675998|449474544|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
124958460|NCT02675998|449474545|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
124958461|NCT02675998|449474542|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
124958462|NCT02675998|449474543|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
124958463|NCT02675998|449474544|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
124958464|NCT02675998|449474545|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
124958465|NCT02916706|449474546|FG000|Overall Study|Adverse Event|0|||
124958466|NCT02916706|449474547|FG001|Overall Study|Adverse Event|1|||
124958467|NCT02916706|449474546|FG000|Overall Study|Lost to Follow-up|0|||
124958468|NCT02916706|449474547|FG001|Overall Study|Lost to Follow-up|1|||
124958469|NCT02916706|449474546|FG000|Overall Study|Physician Decision|1|||
124958470|NCT02916706|449474547|FG001|Overall Study|Physician Decision|0|||
124958471|NCT02916706|449474546|FG000|Overall Study|Protocol Violation|3|||
124958472|NCT02916706|449474547|FG001|Overall Study|Protocol Violation|1|||
124958473|NCT02916706|449474546|FG000|Overall Study|Withdrawal by Subject|6|||
124958474|NCT02916706|449474547|FG001|Overall Study|Withdrawal by Subject|9|||
124958475|NCT02916706|449474546|FG000|Overall Study|Other|5|||
124958476|NCT02916706|449474547|FG001|Overall Study|Other|19|||
124958477|NCT04357964|449474548|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
124958478|NCT04357964|449474549|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
124958479|NCT04357964|449474548|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
124958480|NCT04357964|449474549|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
124958481|NCT04357964|449474548|FG000|Overall Study|Adipose sample was insufficient quality|0|||
125128388|NCT00376623|450096058|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
125128389|NCT00376623|450096059|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
125128390|NCT00376623|450096057|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
125128391|NCT00376623|450096058|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
125128392|NCT00376623|450096059|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
125128393|NCT00376623|450096057|FG000|Overall Study|Increase of tumour markers|0|||
124958482|NCT04357964|449474549|FG001|Overall Study|Adipose sample was insufficient quality|1|||
124958483|NCT01194271|449474552|FG000|Overall Study|Withdrawal by Subject|1|||
124958484|NCT01194271|449474552|FG000|Overall Study|Ineligible, Screen Failure|1|||
124958485|NCT01194271|449474552|FG000|Overall Study|Death|1|||
124958486|NCT00381797|449474555|FG000|Overall Study|Withdrawal by Subject|1|||
124958487|NCT00381797|449474556|FG001|Overall Study|Withdrawal by Subject|1|||
124958488|NCT00381797|449474557|FG002|Overall Study|Withdrawal by Subject|0|||
124958489|NCT00381797|449474558|FG003|Overall Study|Withdrawal by Subject|0|||
124958490|NCT00381797|449474559|FG004|Overall Study|Withdrawal by Subject|2|||
124958491|NCT00381797|449474555|FG000|Overall Study|Ineligible|0|||
124958492|NCT00381797|449474556|FG001|Overall Study|Ineligible|0|||
124958493|NCT00381797|449474557|FG002|Overall Study|Ineligible|0|||
124958494|NCT00381797|449474558|FG003|Overall Study|Ineligible|1|||
124958495|NCT00381797|449474559|FG004|Overall Study|Ineligible|0|||
124958496|NCT00443898|449474562|FG000|Overall Study|Adverse Event|0|||
124958497|NCT00443898|449474563|FG001|Overall Study|Adverse Event|0|||
124958498|NCT00443898|449474564|FG002|Overall Study|Adverse Event|1|||
124958499|NCT00443898|449474565|FG003|Overall Study|Adverse Event|1|||
124958500|NCT00443898|449474562|FG000|Overall Study|Lack of Efficacy|2|||
124958501|NCT00443898|449474563|FG001|Overall Study|Lack of Efficacy|3|||
124958502|NCT00443898|449474564|FG002|Overall Study|Lack of Efficacy|3|||
124958503|NCT00443898|449474565|FG003|Overall Study|Lack of Efficacy|1|||
124958504|NCT00443898|449474562|FG000|Overall Study|Protocol Violation|1|||
124958505|NCT00443898|449474563|FG001|Overall Study|Protocol Violation|1|||
124958506|NCT00443898|449474564|FG002|Overall Study|Protocol Violation|1|||
124958507|NCT00443898|449474565|FG003|Overall Study|Protocol Violation|0|||
124958508|NCT00443898|449474562|FG000|Overall Study|Withdrawal by Subject|11|||
124958509|NCT00443898|449474563|FG001|Overall Study|Withdrawal by Subject|10|||
124958510|NCT00443898|449474564|FG002|Overall Study|Withdrawal by Subject|10|||
124958511|NCT00443898|449474565|FG003|Overall Study|Withdrawal by Subject|6|||
124958512|NCT00443898|449474562|FG000|Overall Study|Lost to Follow-up|10|||
124958513|NCT00443898|449474563|FG001|Overall Study|Lost to Follow-up|10|||
124958514|NCT00443898|449474564|FG002|Overall Study|Lost to Follow-up|14|||
124958515|NCT00443898|449474565|FG003|Overall Study|Lost to Follow-up|10|||
124958516|NCT00443898|449474562|FG000|Overall Study|Death|0|||
124958517|NCT00443898|449474563|FG001|Overall Study|Death|1|||
124958518|NCT00443898|449474564|FG002|Overall Study|Death|0|||
124958519|NCT00443898|449474565|FG003|Overall Study|Death|0|||
124958520|NCT00043186|449474566|FG000|Overall Study|Physician Decision|0|||
124958521|NCT00043186|449474567|FG001|Overall Study|Physician Decision|0|||
124958522|NCT00043186|449474568|FG002|Overall Study|Physician Decision|3|||
124958523|NCT00043186|449474569|FG003|Overall Study|Physician Decision|0|||
124958524|NCT00043186|449474570|FG004|Overall Study|Physician Decision|1|||
124958525|NCT00043186|449474571|FG005|Overall Study|Physician Decision|0|||
124958526|NCT00043186|449474572|FG006|Overall Study|Physician Decision|0|||
124958527|NCT00043186|449474573|FG007|Overall Study|Physician Decision|1|||
124958528|NCT00043186|449474574|FG008|Overall Study|Physician Decision|1|||
124958529|NCT00043186|449474566|FG000|Overall Study|Adverse Event|2|||
124958530|NCT00043186|449474567|FG001|Overall Study|Adverse Event|2|||
124958531|NCT00043186|449474568|FG002|Overall Study|Adverse Event|2|||
124958532|NCT00043186|449474569|FG003|Overall Study|Adverse Event|3|||
124958533|NCT00043186|449474570|FG004|Overall Study|Adverse Event|2|||
124958534|NCT00043186|449474571|FG005|Overall Study|Adverse Event|1|||
124958535|NCT00043186|449474572|FG006|Overall Study|Adverse Event|2|||
124958536|NCT00043186|449474573|FG007|Overall Study|Adverse Event|1|||
124958537|NCT00043186|449474574|FG008|Overall Study|Adverse Event|3|||
124958538|NCT00043186|449474566|FG000|Overall Study|Withdrawal by Subject|11|||
124958539|NCT00043186|449474567|FG001|Overall Study|Withdrawal by Subject|8|||
124958540|NCT00043186|449474568|FG002|Overall Study|Withdrawal by Subject|11|||
124958541|NCT00043186|449474569|FG003|Overall Study|Withdrawal by Subject|13|||
124958542|NCT00043186|449474570|FG004|Overall Study|Withdrawal by Subject|14|||
124958543|NCT00043186|449474571|FG005|Overall Study|Withdrawal by Subject|6|||
124958544|NCT00043186|449474572|FG006|Overall Study|Withdrawal by Subject|12|||
124958545|NCT00043186|449474573|FG007|Overall Study|Withdrawal by Subject|9|||
124958546|NCT00043186|449474574|FG008|Overall Study|Withdrawal by Subject|10|||
124958547|NCT00043186|449474566|FG000|Overall Study|Death|0|||
124958548|NCT00043186|449474567|FG001|Overall Study|Death|0|||
124958549|NCT00043186|449474568|FG002|Overall Study|Death|1|||
124958550|NCT00043186|449474569|FG003|Overall Study|Death|0|||
124958551|NCT00043186|449474570|FG004|Overall Study|Death|0|||
124958552|NCT00043186|449474571|FG005|Overall Study|Death|0|||
124958553|NCT00043186|449474572|FG006|Overall Study|Death|2|||
124958554|NCT00043186|449474573|FG007|Overall Study|Death|0|||
124958555|NCT00043186|449474574|FG008|Overall Study|Death|0|||
124958556|NCT00043186|449474566|FG000|Overall Study|Disease progression|1|||
124958557|NCT00043186|449474567|FG001|Overall Study|Disease progression|0|||
124958558|NCT00043186|449474568|FG002|Overall Study|Disease progression|0|||
124958559|NCT00043186|449474569|FG003|Overall Study|Disease progression|3|||
124958560|NCT00043186|449474570|FG004|Overall Study|Disease progression|0|||
124958561|NCT00043186|449474571|FG005|Overall Study|Disease progression|0|||
124958562|NCT00043186|449474572|FG006|Overall Study|Disease progression|0|||
124958563|NCT00043186|449474573|FG007|Overall Study|Disease progression|4|||
124958564|NCT00043186|449474574|FG008|Overall Study|Disease progression|0|||
124958565|NCT00043186|449474566|FG000|Overall Study|Ineligibility determined|0|||
124958566|NCT00043186|449474567|FG001|Overall Study|Ineligibility determined|0|||
124958567|NCT00043186|449474568|FG002|Overall Study|Ineligibility determined|0|||
124958568|NCT00043186|449474569|FG003|Overall Study|Ineligibility determined|0|||
124958569|NCT00043186|449474570|FG004|Overall Study|Ineligibility determined|0|||
125031201|NCT00896532|449735100|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125031202|NCT00896532|449735101|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125031203|NCT00896532|449735102|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125031204|NCT00896532|449735103|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125031205|NCT00896532|449735104|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125031206|NCT00896532|449735105|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125031207|NCT00896532|449735106|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125031208|NCT00896532|449735107|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124958570|NCT00043186|449474571|FG005|Overall Study|Ineligibility determined|0|||
124958571|NCT00043186|449474572|FG006|Overall Study|Ineligibility determined|0|||
124958572|NCT00043186|449474573|FG007|Overall Study|Ineligibility determined|0|||
124958573|NCT00043186|449474574|FG008|Overall Study|Ineligibility determined|1|||
124958574|NCT00043186|449474566|FG000|Overall Study|Lost to Follow-up|3|||
124958575|NCT00043186|449474567|FG001|Overall Study|Lost to Follow-up|5|||
124958576|NCT00043186|449474568|FG002|Overall Study|Lost to Follow-up|1|||
124958577|NCT00043186|449474569|FG003|Overall Study|Lost to Follow-up|1|||
124958578|NCT00043186|449474570|FG004|Overall Study|Lost to Follow-up|1|||
124958579|NCT00043186|449474571|FG005|Overall Study|Lost to Follow-up|1|||
124958580|NCT00043186|449474572|FG006|Overall Study|Lost to Follow-up|1|||
125031209|NCT00896532|449735108|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124958581|NCT00043186|449474573|FG007|Overall Study|Lost to Follow-up|1|||
124958582|NCT00043186|449474574|FG008|Overall Study|Lost to Follow-up|2|||
124958583|NCT00043186|449474566|FG000|Overall Study|Noncompliance|0|||
124958584|NCT00043186|449474567|FG001|Overall Study|Noncompliance|0|||
124958585|NCT00043186|449474568|FG002|Overall Study|Noncompliance|1|||
124958586|NCT00043186|449474569|FG003|Overall Study|Noncompliance|1|||
124958587|NCT00043186|449474570|FG004|Overall Study|Noncompliance|0|||
124958588|NCT00043186|449474571|FG005|Overall Study|Noncompliance|0|||
124958589|NCT00043186|449474572|FG006|Overall Study|Noncompliance|0|||
124958590|NCT00043186|449474573|FG007|Overall Study|Noncompliance|0|||
124958591|NCT00043186|449474574|FG008|Overall Study|Noncompliance|0|||
124958592|NCT00043186|449474566|FG000|Overall Study|Other|0|||
124958593|NCT00043186|449474567|FG001|Overall Study|Other|0|||
125031210|NCT00896532|449735109|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125031211|NCT00896532|449735110|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
125031212|NCT00896532|449735111|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125031213|NCT00896532|449735112|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125031214|NCT00896532|449735113|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125031215|NCT00896532|449735114|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125031216|NCT00896532|449735115|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125031217|NCT00896532|449735116|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125031218|NCT00896532|449735117|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125031219|NCT00896532|449735118|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125031220|NCT00896532|449735119|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125215578|NCT01768559|450417439|FG001|Overall Study|Other than specified|8|||
125215579|NCT01768559|450417440|FG002|Overall Study|Other than specified|5|||
124958594|NCT00043186|449474568|FG002|Overall Study|Other|1|||
124958595|NCT00043186|449474569|FG003|Overall Study|Other|1|||
124958596|NCT00043186|449474570|FG004|Overall Study|Other|0|||
124958597|NCT00043186|449474571|FG005|Overall Study|Other|0|||
124958598|NCT00043186|449474572|FG006|Overall Study|Other|0|||
124958599|NCT00043186|449474573|FG007|Overall Study|Other|0|||
124958600|NCT00043186|449474574|FG008|Overall Study|Other|0|||
124958601|NCT00958711|449474575|FG000|Overall Study|Withdrawal by Subject|0|||
124958602|NCT00958711|449474576|FG001|Overall Study|Withdrawal by Subject|4|||
124958603|NCT00958711|449474575|FG000|Overall Study|Physician Decision|5|||
124958604|NCT00958711|449474576|FG001|Overall Study|Physician Decision|7|||
124958605|NCT00958711|449474575|FG000|Overall Study|Lost to Follow-up|4|||
124958606|NCT00958711|449474576|FG001|Overall Study|Lost to Follow-up|1|||
124958607|NCT00958711|449474575|FG000|Overall Study|Other|2|||
124958608|NCT00958711|449474576|FG001|Overall Study|Other|5|||
124958609|NCT00958711|449474575|FG000|Overall Study|Death|1|||
124958610|NCT00958711|449474576|FG001|Overall Study|Death|2|||
124958611|NCT00958711|449474575|FG000|Overall Study|Adverse Event|1|||
124958612|NCT00958711|449474576|FG001|Overall Study|Adverse Event|2|||
125031221|NCT00896532|449735120|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124958613|NCT00550771|449474583|FG000|Overall Study|Adverse Event|11|||
124958614|NCT00550771|449474584|FG001|Overall Study|Adverse Event|3|||
124958615|NCT00550771|449474583|FG000|Overall Study|Discontinued for study-related reasons|0|||
125215580|NCT02782377|450417441|FG000|Overall Study|Physician Decision|5|||
124958616|NCT00550771|449474584|FG001|Overall Study|Discontinued for study-related reasons|1|||
124958617|NCT00550771|449474583|FG000|Overall Study|Physician Decision|2|||
124958618|NCT00550771|449474584|FG001|Overall Study|Physician Decision|0|||
124958619|NCT00550771|449474583|FG000|Overall Study|Withdrawal by Subject|0|||
124958620|NCT00550771|449474584|FG001|Overall Study|Withdrawal by Subject|1|||
124958621|NCT00550771|449474583|FG000|Overall Study|Protocol Violation|4|||
124958622|NCT00550771|449474584|FG001|Overall Study|Protocol Violation|5|||
124958623|NCT00730847|449474585|FG000|Overall Study|Adverse Event|1|||
124958624|NCT00730847|449474585|FG000|Overall Study|Protocol Violation|2|||
124958625|NCT00730847|449474585|FG000|Overall Study|Withdrawal by Subject|16|||
124958626|NCT00730847|449474585|FG000|Overall Study|Lost to Follow-up|67|||
124958627|NCT00730847|449474585|FG000|Overall Study|Unknown completion status|21|||
124958628|NCT00730847|449474585|FG000|Overall Study|Other|24|||
124958629|NCT03022578|449474586|FG000|Overall Study|Adverse Event|1|||
124958630|NCT03022578|449474586|FG000|Overall Study|Lack of Efficacy|2|||
124958631|NCT03022578|449474586|FG000|Overall Study|Withdrawal by Subject|1|||
124958632|NCT03681353|449474592|FG000|Overall Study|Lost to Follow-up|2|||
124958633|NCT03681353|449474592|FG000|Overall Study|Withdrawal by Subject|3|||
124958634|NCT03681353|449474592|FG000|Overall Study|withdrawn by PI|2|||
124958635|NCT00726388|449474598|FG000|Overall Study|Withdrawal by Subject|5|||
124958636|NCT00726388|449474598|FG000|Overall Study|Adverse Event|3|||
124958637|NCT00726388|449474598|FG000|Overall Study|Lost to Follow-up|10|||
124958638|NCT00726388|449474598|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
124958639|NCT00726388|449474598|FG000|Overall Study|Other|5|||
124958640|NCT00726388|449474598|FG000|Overall Study|Enrolled, Not Treated|79|||
124958641|NCT00111839|449474599|FG000|Overall Study|Disease Progression|30|||
124958642|NCT00111839|449474600|FG001|Overall Study|Disease Progression|33|||
124958643|NCT00111839|449474601|FG002|Overall Study|Disease Progression|33|||
124958644|NCT00111839|449474599|FG000|Overall Study|Adverse Event|5|||
124958645|NCT00111839|449474600|FG001|Overall Study|Adverse Event|3|||
124958646|NCT00111839|449474601|FG002|Overall Study|Adverse Event|1|||
124958647|NCT00111839|449474599|FG000|Overall Study|Protocol Violation|2|||
124958648|NCT00111839|449474600|FG001|Overall Study|Protocol Violation|4|||
124958649|NCT00111839|449474601|FG002|Overall Study|Protocol Violation|2|||
124958650|NCT00111839|449474599|FG000|Overall Study|Death|1|||
124958651|NCT00111839|449474600|FG001|Overall Study|Death|1|||
124958652|NCT00111839|449474601|FG002|Overall Study|Death|6|||
124958653|NCT00111839|449474599|FG000|Overall Study|Withdrawal by Subject|2|||
124958654|NCT00111839|449474600|FG001|Overall Study|Withdrawal by Subject|2|||
124958655|NCT00111839|449474601|FG002|Overall Study|Withdrawal by Subject|2|||
124958656|NCT00111839|449474599|FG000|Overall Study|Lost to Follow-up|1|||
124958657|NCT00111839|449474600|FG001|Overall Study|Lost to Follow-up|0|||
124958658|NCT00111839|449474601|FG002|Overall Study|Lost to Follow-up|0|||
124958659|NCT00111839|449474599|FG000|Overall Study|Logistical Constraint|1|||
124958660|NCT00111839|449474600|FG001|Overall Study|Logistical Constraint|0|||
124958661|NCT00111839|449474601|FG002|Overall Study|Logistical Constraint|0|||
124958662|NCT00111839|449474599|FG000|Overall Study|Other|6|||
124958663|NCT00111839|449474600|FG001|Overall Study|Other|3|||
124958664|NCT00111839|449474601|FG002|Overall Study|Other|3|||
124958665|NCT00111839|449474599|FG000|Overall Study|Randomized but Not Treated|0|||
124958666|NCT00111839|449474600|FG001|Overall Study|Randomized but Not Treated|0|||
124958667|NCT00111839|449474601|FG002|Overall Study|Randomized but Not Treated|2|||
124958668|NCT00377312|449474604|FG000|Overall Study|Adverse Event|1|||
124958669|NCT00377312|449474605|FG001|Overall Study|Adverse Event|1|||
124958670|NCT02775214|449474606|FG000|Overall Study|Withdrawal by Subject|2|||
124958671|NCT02775214|449474607|FG001|Overall Study|Withdrawal by Subject|0|||
124958672|NCT00762723|449474608|FG000|Overall Study|Study Terminated slow enrollement|5|||
124958673|NCT00762723|449474609|FG001|Overall Study|Study Terminated slow enrollement|5|||
124958674|NCT00762723|449474610|FG002|Overall Study|Study Terminated slow enrollement|3|||
124958675|NCT00382408|449474611|FG000|Overall Study|Did not meet protocol requirement|3|||
124958676|NCT00382408|449474612|FG001|Overall Study|Did not meet protocol requirement|3|||
124958677|NCT00382408|449474611|FG000|Overall Study|Protocol Violation|2|||
124958678|NCT00382408|449474612|FG001|Overall Study|Protocol Violation|2|||
124958679|NCT00382408|449474611|FG000|Overall Study|Physician Decision|1|||
124958680|NCT00382408|449474612|FG001|Overall Study|Physician Decision|0|||
124958681|NCT00382408|449474611|FG000|Overall Study|Withdrawal by Subject|17|||
124958682|NCT00382408|449474612|FG001|Overall Study|Withdrawal by Subject|6|||
124958683|NCT00382408|449474611|FG000|Overall Study|Pregnancy|2|||
124958684|NCT00382408|449474612|FG001|Overall Study|Pregnancy|0|||
124958685|NCT00382408|449474611|FG000|Overall Study|Lost to Follow-up|19|||
124958686|NCT00382408|449474612|FG001|Overall Study|Lost to Follow-up|8|||
124958687|NCT00382408|449474611|FG000|Overall Study|Other|100|||
124958688|NCT00382408|449474612|FG001|Overall Study|Other|35|||
124958689|NCT01145417|449474613|FG000|Overall Study|Death|1|||
124958690|NCT01145417|449474614|FG001|Overall Study|Death|0|||
124958691|NCT01145417|449474613|FG000|Overall Study|Lost to Follow-up|2|||
124958692|NCT01145417|449474614|FG001|Overall Study|Lost to Follow-up|1|||
124958693|NCT01145417|449474613|FG000|Overall Study|Withdrawal by Subject|1|||
124958694|NCT01145417|449474614|FG001|Overall Study|Withdrawal by Subject|2|||
124958695|NCT01145417|449474613|FG000|Overall Study|Pregnancy|1|||
124958696|NCT01145417|449474614|FG001|Overall Study|Pregnancy|0|||
124958697|NCT01145417|449474613|FG000|Overall Study|Adverse Event|0|||
124958698|NCT01145417|449474614|FG001|Overall Study|Adverse Event|1|||
124958699|NCT01145417|449474613|FG000|Overall Study|Study terminated by sponsor|35|||
124958700|NCT01145417|449474614|FG001|Overall Study|Study terminated by sponsor|43|||
124958701|NCT01145417|449474613|FG000|Overall Study|Other|1|||
124958702|NCT01145417|449474614|FG001|Overall Study|Other|0|||
124958703|NCT02435381|449474615|FG000|Overall Study|Lost to Follow-up|2|||
124958704|NCT02435381|449474616|FG001|Overall Study|Lost to Follow-up|1|||
124958705|NCT01191697|449474617|FG000|Overall Study|Death|1|||
124958706|NCT01191697|449474617|FG000|Overall Study|Physician Decision|2|||
124958707|NCT01191697|449474617|FG000|Overall Study|Pursue chemoradiation|2|||
124958708|NCT01191697|449474617|FG000|Overall Study|Break from chemotherapy|2|||
124958709|NCT01191697|449474617|FG000|Overall Study|Withdrawal by Subject|1|||
124958710|NCT01191697|449474617|FG000|Overall Study|Surveillance|1|||
124958711|NCT01191697|449474617|FG000|Overall Study|Adverse Event|2|||
124958712|NCT01191697|449474617|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
124958713|NCT01191697|449474617|FG000|Overall Study|Not completed but analyzed|25|||
124958714|NCT01066897|449474621|FG000|Overall Study|Withdrawal by Subject|1|||
124958715|NCT01066897|449474622|FG001|Overall Study|Withdrawal by Subject|0|||
124958716|NCT01066897|449474621|FG000|Overall Study|stopped study after developing the flu.|1|||
124958717|NCT01066897|449474622|FG001|Overall Study|stopped study after developing the flu.|0|||
124958718|NCT05372913|449474628|FG000|Overall Study|Withdrawal by Subject|0|||
124958719|NCT05372913|449474629|FG001|Overall Study|Withdrawal by Subject|2|||
124958720|NCT05372913|449474628|FG000|Overall Study|Protocol Violation|2|||
124958721|NCT05372913|449474629|FG001|Overall Study|Protocol Violation|2|||
124958722|NCT05372913|449474628|FG000|Overall Study|Adverse Event|0|||
124958723|NCT05372913|449474629|FG001|Overall Study|Adverse Event|1|||
124958724|NCT02986659|449474630|FG000|First Intervention Period|Adverse Event|3|||
124958725|NCT02986659|449474631|FG001|First Intervention Period|Adverse Event|1|||
124958726|NCT02986659|449474630|FG000|First Intervention Period|Lost to Follow-up|1|||
124958727|NCT02986659|449474631|FG001|First Intervention Period|Lost to Follow-up|0|||
124958728|NCT02986659|449474630|FG000|First Intervention Period|Withdrawal by Subject|0|||
124958729|NCT02986659|449474631|FG001|First Intervention Period|Withdrawal by Subject|1|||
124958730|NCT02986659|449474630|FG000|Second Intervention Period|Adverse Event|0|||
124958731|NCT02986659|449474631|FG001|Second Intervention Period|Adverse Event|6|||
124958732|NCT00191984|449474638|FG000|Overall Study|Disease Progression|21|||
124958733|NCT00191984|449474638|FG000|Overall Study|Adverse Event|4|||
124958734|NCT00191984|449474638|FG000|Overall Study|Death|2|||
124958735|NCT00191984|449474638|FG000|Overall Study|Entry Criteria Exclusion|1|||
124958736|NCT00191984|449474638|FG000|Overall Study|Withdrawal by Subject|7|||
124958737|NCT00191984|449474638|FG000|Overall Study|Physician Decision|4|||
124958738|NCT02137239|449474639|FG000|Overall Study|Discontinued Study Treatment|0|||
124958739|NCT02137239|449474640|FG001|Overall Study|Discontinued Study Treatment|3|||
124958740|NCT02137239|449474639|FG000|Overall Study|Withdrew Consent|1|||
124958741|NCT02137239|449474640|FG001|Overall Study|Withdrew Consent|1|||
124958742|NCT02137239|449474639|FG000|Overall Study|Adverse Event|2|||
124958743|NCT02137239|449474640|FG001|Overall Study|Adverse Event|2|||
124958744|NCT00139659|449474641|FG000|Overall Study|Adverse Event|12|||
124958745|NCT00139659|449474642|FG001|Overall Study|Adverse Event|1|||
124958746|NCT00139659|449474641|FG000|Overall Study|Lack of Efficacy|1|||
124958747|NCT00139659|449474642|FG001|Overall Study|Lack of Efficacy|1|||
124958748|NCT00139659|449474641|FG000|Overall Study|Lost to Follow-up|7|||
124958749|NCT00139659|449474642|FG001|Overall Study|Lost to Follow-up|3|||
124958750|NCT00139659|449474641|FG000|Overall Study|Reason not Specified|6|||
124958751|NCT00139659|449474642|FG001|Overall Study|Reason not Specified|3|||
124958752|NCT00139659|449474641|FG000|Overall Study|Withdrawal by Subject|14|||
124958753|NCT00139659|449474642|FG001|Overall Study|Withdrawal by Subject|10|||
124958754|NCT03048058|449474643|FG000|Overall Study|Lost to Follow-up|4|||
124958755|NCT03048058|449474644|FG001|Overall Study|Lost to Follow-up|0|||
124958756|NCT03048058|449474643|FG000|Overall Study|Withdrawal by Subject|0|||
124958757|NCT03048058|449474644|FG001|Overall Study|Withdrawal by Subject|4|||
124958758|NCT02359552|449474646|FG000|Overall Study|Lost to Follow-up|3|||
124958759|NCT02359552|449474647|FG001|Overall Study|Lost to Follow-up|4|||
124958760|NCT02391116|449474648|FG000|Treatment|Withdrawal by Subject|1|||
124958761|NCT02391116|449474648|FG000|Treatment|Protocol Violation|1|||
124958762|NCT02391116|449474648|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
124958763|NCT02391116|449474648|FG000|Treatment|AE with Clinical PD|3|||
124958764|NCT02391116|449474648|FG000|Safety Follow-up|Adverse Event|1|||
124958765|NCT02391116|449474648|FG000|Safety Follow-up|Withdrawal by Subject|4|||
124958766|NCT02391116|449474648|FG000|Safety Follow-up|Switching to Other Therapy|4|||
124958767|NCT02391116|449474648|FG000|Safety Follow-up|No Follow Up|1|||
124958768|NCT02391116|449474648|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
124958769|NCT02391116|449474648|FG000|Active Follow-up|Withdrawal by Subject|1|||
124958770|NCT02391116|449474648|FG000|Active Follow-up|Switching to Other Therapy|2|||
124958771|NCT02391116|449474648|FG000|Survival Follow-up|Withdrawal by Subject|3|||
124958772|NCT02391116|449474648|FG000|Survival Follow-up|Switching to Other Therapy|1|||
124958773|NCT02282917|449474650|FG000|Overall Study|Withdrawal by Subject|1|||
124958774|NCT02282917|449474650|FG000|Overall Study|Screen Failure/Not Eligible|1|||
124958775|NCT01747629|449474651|FG000|Overall Study|Adverse Event|1|||
124958776|NCT01747629|449474652|FG001|Overall Study|Adverse Event|2|||
124958777|NCT01747629|449474651|FG000|Overall Study|Withdrawal by Subject|2|||
124958778|NCT01747629|449474652|FG001|Overall Study|Withdrawal by Subject|2|||
124958779|NCT01747629|449474651|FG000|Overall Study|Noncompliance|1|||
124958780|NCT01747629|449474652|FG001|Overall Study|Noncompliance|1|||
124958781|NCT01747629|449474651|FG000|Overall Study|Inclusion criteria not met|1|||
124958782|NCT01747629|449474652|FG001|Overall Study|Inclusion criteria not met|0|||
124958783|NCT01747629|449474651|FG000|Overall Study|Not treated|1|||
124958784|NCT01747629|449474652|FG001|Overall Study|Not treated|0|||
124958785|NCT01747629|449474651|FG000|Overall Study|Other|2|||
124958786|NCT01747629|449474652|FG001|Overall Study|Other|1|||
124958787|NCT01395914|449474653|FG000|Overall Study|Unrelated to study drug AE|6|||
124958788|NCT01395914|449474654|FG001|Overall Study|Unrelated to study drug AE|1|||
124958789|NCT01395914|449474653|FG000|Overall Study|Death|23|||
124958790|NCT01395914|449474654|FG001|Overall Study|Death|17|||
124958791|NCT01395914|449474653|FG000|Overall Study|Other|9|||
124958792|NCT01395914|449474654|FG001|Overall Study|Other|3|||
124958793|NCT01395914|449474653|FG000|Overall Study|Withdrawal by patient|27|||
124958794|NCT01395914|449474654|FG001|Overall Study|Withdrawal by patient|14|||
124958795|NCT01395914|449474653|FG000|Overall Study|Study drug-related AE|1|||
124958796|NCT01395914|449474654|FG001|Overall Study|Study drug-related AE|0|||
124958797|NCT01395914|449474653|FG000|Overall Study|Lost to Follow-up|6|||
124958798|NCT01395914|449474654|FG001|Overall Study|Lost to Follow-up|2|||
124958799|NCT04414397|449474655|FG000|Control Period|Withdrawal by Subject|2|||
124958800|NCT04414397|449474656|FG001|Control Period|Withdrawal by Subject|2|||
124958801|NCT04414397|449474655|FG000|Control Period|Lost to Follow-up|0|||
124958802|NCT04414397|449474656|FG001|Control Period|Lost to Follow-up|4|||
124958803|NCT04414397|449474655|FG000|Control Period|Protocol deviation|0|||
124958804|NCT04414397|449474656|FG001|Control Period|Protocol deviation|1|||
124958805|NCT04414397|449474655|FG000|Post-Control Period|Withdrawal by Subject|3|||
124958806|NCT04414397|449474656|FG001|Post-Control Period|Withdrawal by Subject|6|||
124958807|NCT04414397|449474655|FG000|Post-Control Period|Lost to Follow-up|4|||
124958808|NCT04414397|449474656|FG001|Post-Control Period|Lost to Follow-up|9|||
124958809|NCT04414397|449474655|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
124958810|NCT04414397|449474656|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
124958811|NCT04414397|449474655|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
124958812|NCT04414397|449474656|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
124958813|NCT01920178|449474661|FG000|Overall Study|Lost to Follow-up|2|||
124958814|NCT01920178|449474662|FG001|Overall Study|Lost to Follow-up|1|||
124958815|NCT02391545|449474663|FG000|Overall Study|Death|0|||
124958816|NCT02391545|449474664|FG001|Overall Study|Death|2|||
124958817|NCT02391545|449474663|FG000|Overall Study|Lost to Follow-up|0|||
124958818|NCT02391545|449474664|FG001|Overall Study|Lost to Follow-up|1|||
124958819|NCT02391545|449474663|FG000|Overall Study|Termination of study by sponsor|20|||
124958820|NCT02391545|449474664|FG001|Overall Study|Termination of study by sponsor|20|||
124958821|NCT02391545|449474663|FG000|Overall Study|Withdrawal by Subject|0|||
124958822|NCT02391545|449474664|FG001|Overall Study|Withdrawal by Subject|1|||
124958823|NCT02391545|449474663|FG000|Overall Study|Other Reasons|6|||
124958824|NCT02391545|449474664|FG001|Overall Study|Other Reasons|4|||
124958825|NCT01002547|449477346|FG000|Overall Study|Withdrawal by Subject|4|||
124958826|NCT01002547|449477347|FG001|Overall Study|Withdrawal by Subject|0|||
124958827|NCT01002547|449477348|FG002|Overall Study|Withdrawal by Subject|5|||
124958828|NCT01002547|449477346|FG000|Overall Study|Lost to Follow-up|2|||
124958829|NCT01002547|449477347|FG001|Overall Study|Lost to Follow-up|1|||
124958830|NCT01002547|449477348|FG002|Overall Study|Lost to Follow-up|1|||
124958831|NCT01002547|449477346|FG000|Overall Study|Physician Decision|1|||
124958832|NCT01002547|449477347|FG001|Overall Study|Physician Decision|0|||
124958833|NCT01002547|449477348|FG002|Overall Study|Physician Decision|0|||
124958834|NCT01002547|449477346|FG000|Overall Study|Death|0|||
124958835|NCT01002547|449477347|FG001|Overall Study|Death|2|||
124958836|NCT01002547|449477348|FG002|Overall Study|Death|2|||
124958837|NCT01002547|449477346|FG000|Overall Study|Adverse Event|1|||
124958838|NCT01002547|449477347|FG001|Overall Study|Adverse Event|0|||
124958839|NCT01002547|449477348|FG002|Overall Study|Adverse Event|0|||
124958840|NCT00434577|449477351|FG000|Months 0-3|Serious Adverse Event|0|||
124958841|NCT00434577|449477352|FG001|Months 0-3|Serious Adverse Event|0|||
124958842|NCT00434577|449477353|FG002|Months 0-3|Serious Adverse Event|1|||
124958843|NCT00434577|449477354|FG003|Months 0-3|Serious Adverse Event|0|||
124958844|NCT00434577|449477355|FG004|Months 0-3|Serious Adverse Event|0|||
124958845|NCT00434577|449477351|FG000|Months 0-3|Adverse Event|0|||
124958846|NCT00434577|449477352|FG001|Months 0-3|Adverse Event|1|||
124958847|NCT00434577|449477353|FG002|Months 0-3|Adverse Event|1|||
124958848|NCT00434577|449477354|FG003|Months 0-3|Adverse Event|0|||
124958849|NCT00434577|449477355|FG004|Months 0-3|Adverse Event|0|||
124958850|NCT00434577|449477351|FG000|Months 0-3|Lost to Follow-up|0|||
124958851|NCT00434577|449477352|FG001|Months 0-3|Lost to Follow-up|0|||
124958852|NCT00434577|449477353|FG002|Months 0-3|Lost to Follow-up|0|||
124958853|NCT00434577|449477354|FG003|Months 0-3|Lost to Follow-up|0|||
124958854|NCT00434577|449477355|FG004|Months 0-3|Lost to Follow-up|2|||
124958855|NCT00434577|449477351|FG000|Months 0-3|Protocol Violation|1|||
124958856|NCT00434577|449477352|FG001|Months 0-3|Protocol Violation|0|||
124958857|NCT00434577|449477353|FG002|Months 0-3|Protocol Violation|1|||
124958858|NCT00434577|449477354|FG003|Months 0-3|Protocol Violation|0|||
124958859|NCT00434577|449477355|FG004|Months 0-3|Protocol Violation|0|||
124958860|NCT00434577|449477351|FG000|Months 0-3|Withdrawal by Subject|2|||
124958861|NCT00434577|449477352|FG001|Months 0-3|Withdrawal by Subject|1|||
124958862|NCT00434577|449477353|FG002|Months 0-3|Withdrawal by Subject|1|||
124958863|NCT00434577|449477354|FG003|Months 0-3|Withdrawal by Subject|1|||
124958864|NCT00434577|449477355|FG004|Months 0-3|Withdrawal by Subject|1|||
124958865|NCT01967719|449477356|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
124958866|NCT01967719|449477357|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
124958867|NCT01967719|449477358|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
124958868|NCT01967719|449477359|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
124958869|NCT01967719|449477356|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
124958870|NCT01967719|449477357|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
124958871|NCT01967719|449477358|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
124958872|NCT01967719|449477359|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
124958873|NCT02329223|449477360|FG000|Overall Study|Withdrawal by Subject|1|||
124958874|NCT02329223|449477361|FG001|Overall Study|Withdrawal by Subject|2|||
124958875|NCT02329223|449477362|FG002|Overall Study|Withdrawal by Subject|5|||
124958876|NCT02329223|449477360|FG000|Overall Study|Physician Decision|0|||
124958877|NCT02329223|449477361|FG001|Overall Study|Physician Decision|0|||
124958878|NCT02329223|449477362|FG002|Overall Study|Physician Decision|1|||
124958879|NCT02329223|449477360|FG000|Overall Study|Adverse Event|0|||
124958880|NCT02329223|449477361|FG001|Overall Study|Adverse Event|1|||
124958881|NCT02329223|449477362|FG002|Overall Study|Adverse Event|0|||
124958882|NCT00506922|449477368|FG000|Overall Study|Physician Decision|0|||
124958883|NCT00506922|449477369|FG001|Overall Study|Physician Decision|0|||
124958884|NCT00506922|449477370|FG002|Overall Study|Physician Decision|0|||
124958885|NCT00506922|449477371|FG003|Overall Study|Physician Decision|2|||
124958886|NCT00506922|449477372|FG004|Overall Study|Physician Decision|0|||
124958887|NCT00506922|449477368|FG000|Overall Study|Withdrawal by Subject|0|||
124958888|NCT00506922|449477369|FG001|Overall Study|Withdrawal by Subject|0|||
124958889|NCT00506922|449477370|FG002|Overall Study|Withdrawal by Subject|0|||
124958890|NCT00506922|449477371|FG003|Overall Study|Withdrawal by Subject|0|||
124958891|NCT00506922|449477372|FG004|Overall Study|Withdrawal by Subject|1|||
124958892|NCT00848393|449477380|FG000|Overall Study|Protocol Violation|0|||
124958893|NCT00848393|449477381|FG001|Overall Study|Protocol Violation|0|||
124958894|NCT00848393|449477382|FG002|Overall Study|Protocol Violation|1|||
124958895|NCT00848393|449477380|FG000|Overall Study|surgical complications unrelated to stud|0|||
124958896|NCT00848393|449477381|FG001|Overall Study|surgical complications unrelated to stud|0|||
124958897|NCT00848393|449477382|FG002|Overall Study|surgical complications unrelated to stud|2|||
124958898|NCT01011049|449477383|FG000|Overall Study|Protocol Violation|0|||
124958899|NCT01011049|449477384|FG001|Overall Study|Protocol Violation|0|||
124958900|NCT01011049|449477385|FG002|Overall Study|Protocol Violation|2|||
124958901|NCT01011049|449477386|FG003|Overall Study|Protocol Violation|0|||
124958902|NCT01011049|449477383|FG000|Overall Study|Lost to Follow-up|1|||
124958903|NCT01011049|449477384|FG001|Overall Study|Lost to Follow-up|2|||
124958904|NCT01011049|449477385|FG002|Overall Study|Lost to Follow-up|1|||
124958905|NCT01011049|449477386|FG003|Overall Study|Lost to Follow-up|0|||
124958906|NCT01011049|449477383|FG000|Overall Study|Withdrawal by Subject|0|||
124958907|NCT01011049|449477384|FG001|Overall Study|Withdrawal by Subject|0|||
124958908|NCT01011049|449477385|FG002|Overall Study|Withdrawal by Subject|1|||
124958909|NCT01011049|449477386|FG003|Overall Study|Withdrawal by Subject|0|||
124958910|NCT00352053|449477392|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
124958911|NCT00352053|449477393|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
124958912|NCT00352053|449477392|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
124958913|NCT00352053|449477393|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
124958914|NCT00352053|449477392|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
124958915|NCT00352053|449477393|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
124958916|NCT00352053|449477392|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
124958917|NCT00352053|449477393|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
124958918|NCT00352053|449477392|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
124958919|NCT00352053|449477393|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
124958920|NCT00352053|449477392|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
124958921|NCT00352053|449477393|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
124958922|NCT00352053|449477392|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
124958923|NCT00352053|449477393|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
124958924|NCT00352053|449477392|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
124958925|NCT00352053|449477393|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
124958926|NCT00352053|449477392|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
124958927|NCT00352053|449477393|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
124958928|NCT00352053|449477392|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
124958929|NCT00352053|449477393|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
125215581|NCT00398047|450417443|FG000|Overall Study|all patient progressed before completion|3|||
124958930|NCT00352053|449477392|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
124958931|NCT00352053|449477393|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
124958932|NCT00352053|449477392|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
124958933|NCT00352053|449477393|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
124958934|NCT00352053|449477392|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
124958935|NCT00352053|449477393|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
124958936|NCT00520403|449477394|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
124958937|NCT00520403|449477394|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
124958938|NCT00520403|449477394|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
124958939|NCT00520403|449477394|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
124958940|NCT00520403|449477394|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
124958941|NCT00520403|449477394|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
124958942|NCT00520403|449477394|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
124958943|NCT00520403|449477394|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
124958944|NCT00405912|449477397|FG000|Overall Study|Withdrawal by Subject|12|||
124958945|NCT00405912|449477398|FG001|Overall Study|Withdrawal by Subject|11|||
124958946|NCT00405912|449477399|FG002|Overall Study|Withdrawal by Subject|12|||
124958947|NCT00405912|449477397|FG000|Overall Study|Lost to Follow-up|4|||
124958948|NCT00405912|449477398|FG001|Overall Study|Lost to Follow-up|8|||
124958949|NCT00405912|449477399|FG002|Overall Study|Lost to Follow-up|4|||
124958950|NCT03730662|449477400|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
124958951|NCT03730662|449477401|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
124958952|NCT03730662|449477402|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
124958953|NCT03730662|449477403|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
124958954|NCT03730662|449477400|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
124958955|NCT03730662|449477401|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
124958956|NCT03730662|449477402|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
124958957|NCT03730662|449477403|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
124958958|NCT03730662|449477400|FG000|Treatment Period (52 Weeks)|Death|6|||
124958959|NCT03730662|449477401|FG001|Treatment Period (52 Weeks)|Death|2|||
124958960|NCT03730662|449477402|FG002|Treatment Period (52 Weeks)|Death|2|||
124958961|NCT03730662|449477403|FG003|Treatment Period (52 Weeks)|Death|9|||
124958962|NCT03730662|449477400|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
124958963|NCT03730662|449477401|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
124958964|NCT03730662|449477402|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
124958965|NCT03730662|449477403|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
124958966|NCT03730662|449477400|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
124958967|NCT03730662|449477401|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
124958968|NCT03730662|449477402|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
124958969|NCT03730662|449477403|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
124958970|NCT03730662|449477400|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
124958971|NCT03730662|449477401|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
124958972|NCT03730662|449477402|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
124958973|NCT03730662|449477403|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
124958974|NCT03730662|449477400|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
124958975|NCT03730662|449477401|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
124958976|NCT03730662|449477402|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
124958977|NCT03730662|449477403|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
124958978|NCT03730662|449477400|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
124958979|NCT03730662|449477401|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
124958980|NCT03730662|449477402|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
124958981|NCT03730662|449477403|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
125215582|NCT01188668|450417444|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
124958982|NCT03730662|449477400|FG000|Variable Treatment Period|Adverse Event|1|||
124958983|NCT03730662|449477401|FG001|Variable Treatment Period|Adverse Event|2|||
124958984|NCT03730662|449477402|FG002|Variable Treatment Period|Adverse Event|0|||
124958985|NCT03730662|449477403|FG003|Variable Treatment Period|Adverse Event|7|||
124958986|NCT03730662|449477400|FG000|Variable Treatment Period|Death|9|||
124958987|NCT03730662|449477401|FG001|Variable Treatment Period|Death|0|||
124958988|NCT03730662|449477402|FG002|Variable Treatment Period|Death|6|||
124958989|NCT03730662|449477403|FG003|Variable Treatment Period|Death|26|||
124958990|NCT03730662|449477400|FG000|Variable Treatment Period|Lost to Follow-up|2|||
124958991|NCT03730662|449477401|FG001|Variable Treatment Period|Lost to Follow-up|1|||
124958992|NCT03730662|449477402|FG002|Variable Treatment Period|Lost to Follow-up|4|||
124958993|NCT03730662|449477403|FG003|Variable Treatment Period|Lost to Follow-up|11|||
124958994|NCT03730662|449477400|FG000|Variable Treatment Period|Personal Reason|0|||
124958995|NCT03730662|449477401|FG001|Variable Treatment Period|Personal Reason|2|||
124958996|NCT03730662|449477402|FG002|Variable Treatment Period|Personal Reason|1|||
124958997|NCT03730662|449477403|FG003|Variable Treatment Period|Personal Reason|6|||
124958998|NCT03730662|449477400|FG000|Variable Treatment Period|Physician Decision|0|||
124958999|NCT03730662|449477401|FG001|Variable Treatment Period|Physician Decision|0|||
124959000|NCT03730662|449477402|FG002|Variable Treatment Period|Physician Decision|0|||
124959001|NCT03730662|449477403|FG003|Variable Treatment Period|Physician Decision|3|||
124959002|NCT03730662|449477400|FG000|Variable Treatment Period|Protocol Violation|0|||
124959003|NCT03730662|449477401|FG001|Variable Treatment Period|Protocol Violation|1|||
124959004|NCT03730662|449477402|FG002|Variable Treatment Period|Protocol Violation|1|||
124959005|NCT03730662|449477403|FG003|Variable Treatment Period|Protocol Violation|1|||
124959006|NCT03730662|449477400|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
124959007|NCT03730662|449477401|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
124959008|NCT03730662|449477402|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
124959009|NCT03730662|449477403|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
124959010|NCT01797562|449477404|FG000|Overall Study|Protocol Violation|5|||
124959011|NCT01309243|449477405|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
124959012|NCT01309243|449477406|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
124959013|NCT01309243|449477405|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
124959014|NCT01309243|449477406|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
124959015|NCT01309243|449477405|FG000|Randomized Phase Through Week 96|Death|0|||
124959016|NCT01309243|449477406|FG001|Randomized Phase Through Week 96|Death|1|||
124959017|NCT01309243|449477405|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
124959018|NCT01309243|449477406|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
124959019|NCT01309243|449477405|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
124959020|NCT01309243|449477406|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
124959021|NCT01309243|449477405|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
124959022|NCT01309243|449477406|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
124959023|NCT01309243|449477405|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
124959024|NCT01309243|449477406|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
124959025|NCT01309243|449477405|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
124959026|NCT01309243|449477406|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
124959027|NCT01309243|449477405|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
124959028|NCT01309243|449477406|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
124959029|NCT01309243|449477405|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
124959030|NCT01309243|449477406|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
124959031|NCT01309243|449477405|FG000|Extension Phase|Lost to Follow-up|6|||
124959032|NCT01309243|449477406|FG001|Extension Phase|Lost to Follow-up|0|||
124959033|NCT00632931|449477409|FG000|Part 1, Period 1|Protocol Violation|1|||
124959034|NCT00632931|449477410|FG001|Part 1, Period 1|Protocol Violation|0|||
124959035|NCT00632931|449477411|FG002|Part 1, Period 1|Protocol Violation|0|||
124959036|NCT00632931|449477409|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
124959037|NCT00632931|449477410|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
124959038|NCT00632931|449477411|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
124959039|NCT00632931|449477409|FG000|Part 2|Adverse Event|0|||
124959040|NCT00632931|449477410|FG001|Part 2|Adverse Event|0|||
124959041|NCT00632931|449477411|FG002|Part 2|Adverse Event|3|||
124959042|NCT00632931|449477409|FG000|Part 2|Death|0|||
124959043|NCT00632931|449477410|FG001|Part 2|Death|0|||
124959044|NCT00632931|449477411|FG002|Part 2|Death|1|||
124959045|NCT00632931|449477409|FG000|Part 2|Lack of Efficacy|0|||
124959046|NCT00632931|449477410|FG001|Part 2|Lack of Efficacy|0|||
125031222|NCT00896532|449735098|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124959047|NCT00632931|449477411|FG002|Part 2|Lack of Efficacy|17|||
124959048|NCT00632931|449477409|FG000|Part 2|Withdrawal by Subject|0|||
124959049|NCT00632931|449477410|FG001|Part 2|Withdrawal by Subject|0|||
124959050|NCT00632931|449477411|FG002|Part 2|Withdrawal by Subject|3|||
124959051|NCT01441583|449477414|FG000|Overall Study|Withdrawal by Subject|1|||
124959052|NCT01441583|449477415|FG001|Overall Study|Withdrawal by Subject|1|||
124959053|NCT01441583|449477416|FG002|Overall Study|Withdrawal by Subject|1|||
124959054|NCT01441583|449477414|FG000|Overall Study|Death|1|||
124959055|NCT01441583|449477415|FG001|Overall Study|Death|0|||
124959056|NCT01441583|449477416|FG002|Overall Study|Death|4|||
124959057|NCT01441583|449477414|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
124959058|NCT01441583|449477415|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
124959059|NCT01441583|449477416|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
124959060|NCT03341312|449477417|FG000|Period 1|Withdrawal by Subject|0|||
124959061|NCT03341312|449477418|FG001|Period 1|Withdrawal by Subject|1|||
124959062|NCT03341312|449477419|FG002|Period 1|Withdrawal by Subject|0|||
124959063|NCT03341312|449477420|FG003|Period 1|Withdrawal by Subject|0|||
124959064|NCT00839306|449477421|FG000|Overall Study|Adverse Event|3|||
124959065|NCT00839306|449477422|FG001|Overall Study|Adverse Event|5|||
124959066|NCT00839306|449477421|FG000|Overall Study|Lost to Follow-up|6|||
124959067|NCT00839306|449477422|FG001|Overall Study|Lost to Follow-up|9|||
124959068|NCT00839306|449477421|FG000|Overall Study|Withdrawal by Subject|5|||
124959069|NCT00839306|449477422|FG001|Overall Study|Withdrawal by Subject|7|||
124959070|NCT00839306|449477421|FG000|Overall Study|Lack of Efficacy|5|||
124959071|NCT00839306|449477422|FG001|Overall Study|Lack of Efficacy|4|||
124959072|NCT00839306|449477421|FG000|Overall Study|Other|6|||
124959073|NCT00839306|449477422|FG001|Overall Study|Other|18|||
124959074|NCT01812707|449477423|FG000|Overall Study|Adverse Event|0|||
124959075|NCT01812707|449477424|FG001|Overall Study|Adverse Event|0|||
124959076|NCT01812707|449477425|FG002|Overall Study|Adverse Event|0|||
124959077|NCT01812707|449477426|FG003|Overall Study|Adverse Event|2|||
124959078|NCT01812707|449477423|FG000|Overall Study|Poor compliance to protocol|1|||
124959079|NCT01812707|449477424|FG001|Overall Study|Poor compliance to protocol|0|||
124959080|NCT01812707|449477425|FG002|Overall Study|Poor compliance to protocol|0|||
124959081|NCT01812707|449477426|FG003|Overall Study|Poor compliance to protocol|0|||
124959082|NCT01812707|449477423|FG000|Overall Study|Consent withdrawn by participant|1|||
124959083|NCT01812707|449477424|FG001|Overall Study|Consent withdrawn by participant|0|||
124959084|NCT01812707|449477425|FG002|Overall Study|Consent withdrawn by participant|0|||
124959085|NCT01812707|449477426|FG003|Overall Study|Consent withdrawn by participant|0|||
124959086|NCT05060237|449477427|FG000|Overall Study|Withdrawal by Subject|4|||
124959087|NCT05060237|449477427|FG000|Overall Study|Screening failure|8|||
124959088|NCT01697592|449477428|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
124959089|NCT01697592|449477429|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
124959090|NCT01697592|449477430|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
124959091|NCT01697592|449477431|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
124959092|NCT01697592|449477432|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
124959093|NCT01697592|449477433|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
124959094|NCT01697592|449477434|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
124959095|NCT01697592|449477435|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
124959096|NCT01697592|449477436|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
124959097|NCT01697592|449477437|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
124959098|NCT01697592|449477428|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
124959099|NCT01697592|449477429|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
125031223|NCT00896532|449735099|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125031224|NCT00896532|449735100|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125031225|NCT00896532|449735101|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125031226|NCT00896532|449735102|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124959100|NCT01697592|449477430|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
124959101|NCT01697592|449477431|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
124959102|NCT01697592|449477432|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
124959103|NCT01697592|449477433|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
125031227|NCT00896532|449735103|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125031228|NCT00896532|449735104|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125031229|NCT00896532|449735105|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125031230|NCT00896532|449735106|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125031231|NCT00896532|449735107|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125215583|NCT01188668|450417444|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
124959104|NCT01697592|449477434|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
125031232|NCT00896532|449735108|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
125031233|NCT00896532|449735109|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125031234|NCT00896532|449735110|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
125215584|NCT01188668|450417444|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
124959105|NCT01697592|449477435|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
124959106|NCT01697592|449477436|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
124959107|NCT01697592|449477437|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
124959108|NCT01697592|449477428|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
124959109|NCT01697592|449477429|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
124959110|NCT01697592|449477430|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
124959111|NCT01697592|449477431|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
124959112|NCT01697592|449477432|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
124959113|NCT01697592|449477433|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
124959114|NCT01697592|449477434|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
124959115|NCT01697592|449477435|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
124959116|NCT01697592|449477436|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
124959117|NCT01697592|449477437|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
124959118|NCT01697592|449477428|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
124959119|NCT01697592|449477429|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
124959120|NCT01697592|449477430|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
124959121|NCT01697592|449477431|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
124959122|NCT01697592|449477432|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
124959123|NCT01697592|449477433|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
124959124|NCT01697592|449477434|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
124959125|NCT01697592|449477435|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
124959126|NCT01697592|449477436|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
124959127|NCT01697592|449477437|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
124959128|NCT01697592|449477428|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
124959129|NCT01697592|449477429|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
124959130|NCT01697592|449477430|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
124959131|NCT01697592|449477431|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
124959132|NCT01697592|449477432|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
124959133|NCT01697592|449477433|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
124959134|NCT01697592|449477434|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
124959135|NCT01697592|449477435|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
124959136|NCT01697592|449477436|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
124959137|NCT01697592|449477437|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
124959138|NCT01697592|449477428|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
124959139|NCT01697592|449477429|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
124959140|NCT01697592|449477430|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
124959141|NCT01697592|449477431|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
124959142|NCT01697592|449477432|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
124959143|NCT01697592|449477433|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
124959144|NCT01697592|449477434|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
124959145|NCT01697592|449477435|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
124959146|NCT01697592|449477436|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
124959147|NCT01697592|449477437|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
124959148|NCT01697592|449477428|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
124959149|NCT01697592|449477429|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
124959150|NCT01697592|449477430|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
124959151|NCT01697592|449477431|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
124959152|NCT01697592|449477432|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
124959153|NCT01697592|449477433|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
124959154|NCT01697592|449477434|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
124959155|NCT01697592|449477435|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
124959156|NCT01697592|449477436|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
124959157|NCT01697592|449477437|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
124959158|NCT01697592|449477428|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
124959159|NCT01697592|449477429|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
124959160|NCT01697592|449477430|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
124959161|NCT01697592|449477431|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
124959162|NCT01697592|449477432|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
124959163|NCT01697592|449477433|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
124959164|NCT01697592|449477434|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
124959165|NCT01697592|449477435|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
124959166|NCT01697592|449477436|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
124959167|NCT01697592|449477437|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
124959168|NCT02396758|449477438|FG000|Overall Study|Withdrawal by Subject|2|||
124959169|NCT02396758|449477439|FG001|Overall Study|Withdrawal by Subject|0|||
124959170|NCT02396758|449477440|FG002|Overall Study|Withdrawal by Subject|0|||
124959171|NCT02396758|449477441|FG003|Overall Study|Withdrawal by Subject|1|||
124959172|NCT02396758|449477438|FG000|Overall Study|Lost to Follow-up|8|||
124959173|NCT02396758|449477439|FG001|Overall Study|Lost to Follow-up|5|||
124959174|NCT02396758|449477440|FG002|Overall Study|Lost to Follow-up|3|||
124959175|NCT02396758|449477441|FG003|Overall Study|Lost to Follow-up|3|||
124959176|NCT02396758|449477438|FG000|Overall Study|Death|1|||
124959177|NCT02396758|449477439|FG001|Overall Study|Death|1|||
124959178|NCT02396758|449477440|FG002|Overall Study|Death|0|||
124959179|NCT02396758|449477441|FG003|Overall Study|Death|1|||
124959180|NCT02396758|449477438|FG000|Overall Study|Randomized but not treated|1|||
124959181|NCT02396758|449477439|FG001|Overall Study|Randomized but not treated|0|||
124959182|NCT02396758|449477440|FG002|Overall Study|Randomized but not treated|1|||
124959183|NCT02396758|449477441|FG003|Overall Study|Randomized but not treated|0|||
124959184|NCT00265096|449477442|FG000|Overall Study|Adverse Event|14|||
124959185|NCT00265096|449477443|FG001|Overall Study|Adverse Event|18|||
125031235|NCT00896532|449735111|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125031236|NCT00896532|449735112|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124959186|NCT00265096|449477444|FG002|Overall Study|Adverse Event|18|||
124959187|NCT00265096|449477442|FG000|Overall Study|Lost to Follow-up|2|||
124959188|NCT00265096|449477443|FG001|Overall Study|Lost to Follow-up|5|||
124959189|NCT00265096|449477444|FG002|Overall Study|Lost to Follow-up|3|||
124959190|NCT00265096|449477442|FG000|Overall Study|Death|0|||
124959191|NCT00265096|449477443|FG001|Overall Study|Death|1|||
124959192|NCT00265096|449477444|FG002|Overall Study|Death|2|||
124959193|NCT00265096|449477442|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
124959194|NCT00265096|449477443|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
124959195|NCT00265096|449477444|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
124959196|NCT00265096|449477442|FG000|Overall Study|Other|11|||
124959197|NCT00265096|449477443|FG001|Overall Study|Other|19|||
124959198|NCT00265096|449477444|FG002|Overall Study|Other|10|||
124959199|NCT00774306|449477445|FG000|Overall Study|Adverse Event|3|||
125031237|NCT00896532|449735113|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125031238|NCT00896532|449735114|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124959200|NCT00774306|449477446|FG001|Overall Study|Adverse Event|0|||
124959201|NCT00774306|449477447|FG002|Overall Study|Adverse Event|0|||
124959202|NCT00774306|449477448|FG003|Overall Study|Adverse Event|0|||
124959203|NCT00774306|449477445|FG000|Overall Study|Protocol Violation|2|||
124959204|NCT00774306|449477446|FG001|Overall Study|Protocol Violation|0|||
124959205|NCT00774306|449477447|FG002|Overall Study|Protocol Violation|3|||
124959206|NCT00774306|449477448|FG003|Overall Study|Protocol Violation|0|||
124959207|NCT00774306|449477445|FG000|Overall Study|Withdrawal by Subject|6|||
124959208|NCT00774306|449477446|FG001|Overall Study|Withdrawal by Subject|1|||
124959209|NCT00774306|449477447|FG002|Overall Study|Withdrawal by Subject|1|||
124959210|NCT00774306|449477448|FG003|Overall Study|Withdrawal by Subject|0|||
124959211|NCT00774306|449477445|FG000|Overall Study|Lost to Follow-up|6|||
124959212|NCT00774306|449477446|FG001|Overall Study|Lost to Follow-up|0|||
124959213|NCT00774306|449477447|FG002|Overall Study|Lost to Follow-up|4|||
124959214|NCT00774306|449477448|FG003|Overall Study|Lost to Follow-up|5|||
124959215|NCT00774306|449477445|FG000|Overall Study|Death|1|||
124959216|NCT00774306|449477446|FG001|Overall Study|Death|1|||
124959217|NCT00774306|449477447|FG002|Overall Study|Death|0|||
124959218|NCT00774306|449477448|FG003|Overall Study|Death|0|||
124959219|NCT00666835|449477451|FG000|Overall Study|Withdrawal by Subject|5|||
124959220|NCT00666835|449477452|FG001|Overall Study|Withdrawal by Subject|2|||
124959221|NCT00666835|449477451|FG000|Overall Study|Lack of Efficacy|0|||
124959222|NCT00666835|449477452|FG001|Overall Study|Lack of Efficacy|1|||
124959223|NCT00666835|449477451|FG000|Overall Study|Incl./excl. not fulfilled|7|||
124959224|NCT00666835|449477452|FG001|Overall Study|Incl./excl. not fulfilled|2|||
124959225|NCT00666835|449477451|FG000|Overall Study|Adverse Event|7|||
124959226|NCT00666835|449477452|FG001|Overall Study|Adverse Event|6|||
124959227|NCT00666835|449477451|FG000|Overall Study|Protocol Violation|2|||
124959228|NCT00666835|449477452|FG001|Overall Study|Protocol Violation|0|||
124959229|NCT00666835|449477451|FG000|Overall Study|Death|15|||
124959230|NCT00666835|449477452|FG001|Overall Study|Death|4|||
124959231|NCT00666835|449477451|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
124959232|NCT00666835|449477452|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
124959233|NCT00666835|449477451|FG000|Overall Study|Hemoglobulin concentration|4|||
124959234|NCT00666835|449477452|FG001|Overall Study|Hemoglobulin concentration|3|||
124959235|NCT00666835|449477451|FG000|Overall Study|Planned operation|2|||
124959236|NCT00666835|449477452|FG001|Overall Study|Planned operation|0|||
124959237|NCT00666835|449477451|FG000|Overall Study|Physician Decision|1|||
124959238|NCT00666835|449477452|FG001|Overall Study|Physician Decision|2|||
124959239|NCT01126879|449477453|FG000|Overall Study|Progressive Disease|3|||
124959240|NCT01126879|449477454|FG001|Overall Study|Progressive Disease|1|||
124959241|NCT01126879|449477453|FG000|Overall Study|Withdrawal by Subject|1|||
124959242|NCT01126879|449477454|FG001|Overall Study|Withdrawal by Subject|0|||
124959243|NCT01126879|449477453|FG000|Overall Study|Adverse Event|0|||
124959244|NCT01126879|449477454|FG001|Overall Study|Adverse Event|1|||
124959245|NCT01126879|449477453|FG000|Overall Study|Physician Decision|1|||
124959246|NCT01126879|449477454|FG001|Overall Study|Physician Decision|0|||
124959247|NCT03319719|449477455|FG000|Overall Study|Lost to Follow-up|1|||
124959248|NCT03193216|449477459|FG000|Overall Study|Lost to Follow-up|1|||
124959249|NCT03193216|449477460|FG001|Overall Study|Lost to Follow-up|0|||
124959250|NCT03193216|449477459|FG000|Overall Study|Withdrawal by Subject|5|||
124959251|NCT03193216|449477460|FG001|Overall Study|Withdrawal by Subject|0|||
124959252|NCT03193216|449477459|FG000|Overall Study|Physician Decision|4|||
124959253|NCT03193216|449477460|FG001|Overall Study|Physician Decision|0|||
124959254|NCT02236598|449477464|FG000|Overall Study|Adverse Event|0|||
124959255|NCT02236598|449477465|FG001|Overall Study|Adverse Event|1|||
124959256|NCT02236598|449477464|FG000|Overall Study|Withdrawal by Subject|0|||
124959257|NCT02236598|449477465|FG001|Overall Study|Withdrawal by Subject|1|||
124959258|NCT01264887|449477467|FG000|Overall Study|Adverse Event|5|||
124959259|NCT01264887|449477467|FG000|Overall Study|Death|7|||
124959260|NCT01264887|449477467|FG000|Overall Study|Lack of Efficacy|5|||
124959261|NCT01264887|449477467|FG000|Overall Study|Physician Decision|4|||
124959262|NCT01264887|449477467|FG000|Overall Study|Withdrawal by Subject|6|||
124959263|NCT01264887|449477467|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
124959264|NCT01264887|449477467|FG000|Overall Study|Other|2|||
125031239|NCT00896532|449735115|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125031240|NCT00896532|449735116|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125031241|NCT00896532|449735117|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125215585|NCT00902746|450417445|FG000|Overall Study|Protocol Violation|7|||
124959265|NCT02959177|449477468|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
124959266|NCT02959177|449477469|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
124959267|NCT02959177|449477470|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
124959268|NCT02959177|449477468|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
124959269|NCT02959177|449477469|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
124959270|NCT02959177|449477470|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
124959271|NCT02959177|449477468|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
124959272|NCT02959177|449477469|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
124959273|NCT02959177|449477470|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
124959274|NCT02959177|449477468|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
124959275|NCT02959177|449477469|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
124959276|NCT02959177|449477470|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
124959277|NCT02959177|449477468|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
124959278|NCT02959177|449477469|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
124959279|NCT02959177|449477470|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
124959280|NCT02959177|449477468|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
124959281|NCT02959177|449477469|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
124959282|NCT02959177|449477470|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
124959283|NCT02959177|449477468|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
124959284|NCT02959177|449477469|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
124959285|NCT02959177|449477470|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
124959286|NCT01061775|449477473|FG000|Overall Study|Physician Decision|2|||
124959287|NCT01061775|449477473|FG000|Overall Study|Lost to Follow-up|1|||
124959288|NCT01313299|449477478|FG000|Overall Study|Adverse Event|3|||
124959289|NCT01313299|449477479|FG001|Overall Study|Adverse Event|1|||
124959290|NCT01313299|449477480|FG002|Overall Study|Adverse Event|1|||
124959291|NCT01313299|449477478|FG000|Overall Study|Lost to Follow-up|1|||
124959292|NCT01313299|449477479|FG001|Overall Study|Lost to Follow-up|0|||
124959293|NCT01313299|449477480|FG002|Overall Study|Lost to Follow-up|0|||
124959294|NCT01313299|449477478|FG000|Overall Study|Protocol Violation|2|||
124959295|NCT01313299|449477479|FG001|Overall Study|Protocol Violation|0|||
124959296|NCT01313299|449477480|FG002|Overall Study|Protocol Violation|0|||
124959297|NCT01313299|449477478|FG000|Overall Study|Withdrawal by Subject|1|||
124959298|NCT01313299|449477479|FG001|Overall Study|Withdrawal by Subject|0|||
124959299|NCT01313299|449477480|FG002|Overall Study|Withdrawal by Subject|2|||
124959300|NCT01313299|449477478|FG000|Overall Study|Family reason and moved out of state|0|||
124959301|NCT01313299|449477479|FG001|Overall Study|Family reason and moved out of state|2|||
124959302|NCT01313299|449477480|FG002|Overall Study|Family reason and moved out of state|0|||
124959303|NCT01313299|449477478|FG000|Overall Study|Lack of subject compliance|0|||
124959304|NCT01313299|449477479|FG001|Overall Study|Lack of subject compliance|0|||
124959305|NCT01313299|449477480|FG002|Overall Study|Lack of subject compliance|1|||
124959306|NCT04089332|449477484|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
124959307|NCT04089332|449477484|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
124959308|NCT04089332|449477484|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
124959309|NCT00050167|449477485|FG000|Overall Study|not eligible not invasive|1|||
124959310|NCT00050167|449477486|FG001|Overall Study|not eligible not invasive|1|||
124959311|NCT04754594|449477490|FG000|Blinded Period|Withdrawal by Subject|4|||
124959312|NCT04754594|449477491|FG001|Blinded Period|Withdrawal by Subject|9|||
124959313|NCT04754594|449477492|FG002|Blinded Period|Withdrawal by Subject|0|||
124959314|NCT04754594|449477493|FG003|Blinded Period|Withdrawal by Subject|0|||
124959315|NCT04754594|449477490|FG000|Blinded Period|Protocol Violation|2|||
124959316|NCT04754594|449477491|FG001|Blinded Period|Protocol Violation|2|||
124959317|NCT04754594|449477492|FG002|Blinded Period|Protocol Violation|0|||
124959318|NCT04754594|449477493|FG003|Blinded Period|Protocol Violation|0|||
124959319|NCT04754594|449477490|FG000|Blinded Period|Lost to Follow-up|1|||
124959320|NCT04754594|449477491|FG001|Blinded Period|Lost to Follow-up|1|||
124959321|NCT04754594|449477492|FG002|Blinded Period|Lost to Follow-up|0|||
124959322|NCT04754594|449477493|FG003|Blinded Period|Lost to Follow-up|0|||
124959323|NCT04754594|449477490|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
124959324|NCT04754594|449477491|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
124959325|NCT04754594|449477492|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
124959326|NCT04754594|449477493|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
124959327|NCT04754594|449477490|FG000|Unblinded Period|Withdrawal by Subject|6|||
124959328|NCT04754594|449477491|FG001|Unblinded Period|Withdrawal by Subject|8|||
124959329|NCT04754594|449477492|FG002|Unblinded Period|Withdrawal by Subject|0|||
124959330|NCT04754594|449477493|FG003|Unblinded Period|Withdrawal by Subject|0|||
124959331|NCT04754594|449477490|FG000|Unblinded Period|Lost to Follow-up|5|||
124959332|NCT04754594|449477491|FG001|Unblinded Period|Lost to Follow-up|3|||
124959333|NCT04754594|449477492|FG002|Unblinded Period|Lost to Follow-up|0|||
124959334|NCT04754594|449477493|FG003|Unblinded Period|Lost to Follow-up|0|||
124959335|NCT04754594|449477490|FG000|Unblinded Period|Protocol Violation|2|||
124959336|NCT04754594|449477491|FG001|Unblinded Period|Protocol Violation|4|||
124959337|NCT04754594|449477492|FG002|Unblinded Period|Protocol Violation|0|||
124959338|NCT04754594|449477493|FG003|Unblinded Period|Protocol Violation|0|||
124959339|NCT04754594|449477490|FG000|Unblinded Period|Other|3|||
124959340|NCT04754594|449477491|FG001|Unblinded Period|Other|0|||
124959341|NCT04754594|449477492|FG002|Unblinded Period|Other|0|||
124959342|NCT04754594|449477493|FG003|Unblinded Period|Other|0|||
124959343|NCT04754594|449477490|FG000|Infant Participants|Withdrawal by Subject|0|||
124959344|NCT04754594|449477491|FG001|Infant Participants|Withdrawal by Subject|0|||
124959345|NCT04754594|449477492|FG002|Infant Participants|Withdrawal by Subject|9|||
124959346|NCT04754594|449477493|FG003|Infant Participants|Withdrawal by Subject|17|||
124959347|NCT04754594|449477490|FG000|Infant Participants|Lost to Follow-up|0|||
124959348|NCT04754594|449477491|FG001|Infant Participants|Lost to Follow-up|0|||
124959349|NCT04754594|449477492|FG002|Infant Participants|Lost to Follow-up|4|||
124959350|NCT04754594|449477493|FG003|Infant Participants|Lost to Follow-up|10|||
124959351|NCT04754594|449477490|FG000|Infant Participants|Death|0|||
124959352|NCT04754594|449477491|FG001|Infant Participants|Death|0|||
124959353|NCT04754594|449477492|FG002|Infant Participants|Death|1|||
124959354|NCT04754594|449477493|FG003|Infant Participants|Death|1|||
124959355|NCT04754594|449477490|FG000|Infant Participants|Other|0|||
124959356|NCT04754594|449477491|FG001|Infant Participants|Other|0|||
124959357|NCT04754594|449477492|FG002|Infant Participants|Other|1|||
124959358|NCT04754594|449477493|FG003|Infant Participants|Other|1|||
124959359|NCT03340766|449477496|FG000|Overall Study|Withdrawal by Subject|2|||
124959360|NCT03340766|449477497|FG001|Overall Study|Withdrawal by Subject|1|||
124959361|NCT03340766|449477498|FG002|Overall Study|Withdrawal by Subject|3|||
124959362|NCT03340766|449477496|FG000|Overall Study|Lost to Follow-up|0|||
124959363|NCT03340766|449477497|FG001|Overall Study|Lost to Follow-up|0|||
124959364|NCT03340766|449477498|FG002|Overall Study|Lost to Follow-up|1|||
124959365|NCT03340766|449477496|FG000|Overall Study|Death|6|||
124959366|NCT03340766|449477497|FG001|Overall Study|Death|7|||
124959367|NCT03340766|449477498|FG002|Overall Study|Death|4|||
124959368|NCT02849509|449477501|FG000|Overall Study|Worsening of disease under study|1|||
124959369|NCT02849509|449477502|FG001|Overall Study|Worsening of disease under study|1|||
124959370|NCT02849509|449477503|FG002|Overall Study|Worsening of disease under study|1|||
124959371|NCT02849509|449477501|FG000|Overall Study|Worsening of other pre-existing disease|0|||
124959372|NCT02849509|449477502|FG001|Overall Study|Worsening of other pre-existing disease|1|||
124959373|NCT02849509|449477503|FG002|Overall Study|Worsening of other pre-existing disease|2|||
124959374|NCT02849509|449477501|FG000|Overall Study|Other adverse event|36|||
124959375|NCT02849509|449477502|FG001|Overall Study|Other adverse event|41|||
124959376|NCT02849509|449477503|FG002|Overall Study|Other adverse event|8|||
124959377|NCT02849509|449477501|FG000|Overall Study|Withdrawal by Subject|6|||
124959378|NCT02849509|449477502|FG001|Overall Study|Withdrawal by Subject|17|||
124959379|NCT02849509|449477503|FG002|Overall Study|Withdrawal by Subject|12|||
124959380|NCT02849509|449477501|FG000|Overall Study|Lost to Follow-up|27|||
124959381|NCT02849509|449477502|FG001|Overall Study|Lost to Follow-up|67|||
124959382|NCT02849509|449477503|FG002|Overall Study|Lost to Follow-up|36|||
124959383|NCT02849509|449477501|FG000|Overall Study|Other, reason not specified|14|||
124959384|NCT02849509|449477502|FG001|Overall Study|Other, reason not specified|29|||
124959385|NCT02849509|449477503|FG002|Overall Study|Other, reason not specified|25|||
124959386|NCT02849509|449477501|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
124959387|NCT02849509|449477502|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
124959388|NCT02849509|449477503|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
124959389|NCT02256488|449477504|FG000|Overall Study|Lost to Follow-up|6|||
124959390|NCT02256488|449477505|FG001|Overall Study|Lost to Follow-up|6|||
124959391|NCT02256488|449477506|FG002|Overall Study|Lost to Follow-up|9|||
124959392|NCT02256488|449477507|FG003|Overall Study|Lost to Follow-up|3|||
124959393|NCT02256488|449477504|FG000|Overall Study|OTHER|1|||
124959394|NCT02256488|449477505|FG001|Overall Study|OTHER|0|||
124959395|NCT02256488|449477506|FG002|Overall Study|OTHER|1|||
124959396|NCT02256488|449477507|FG003|Overall Study|OTHER|1|||
124959397|NCT02256488|449477504|FG000|Overall Study|Withdrawal by Subject|1|||
124959398|NCT02256488|449477505|FG001|Overall Study|Withdrawal by Subject|0|||
124959399|NCT02256488|449477506|FG002|Overall Study|Withdrawal by Subject|0|||
124959400|NCT02256488|449477507|FG003|Overall Study|Withdrawal by Subject|2|||
124959401|NCT02864147|449477511|FG000|Overall Study|Withdrawal by Subject|3|||
124959402|NCT02864147|449477512|FG001|Overall Study|Withdrawal by Subject|2|||
124959403|NCT02864147|449477513|FG002|Overall Study|Withdrawal by Subject|1|||
124959404|NCT02864147|449477511|FG000|Overall Study|Lost to Follow-up|0|||
124959405|NCT02864147|449477512|FG001|Overall Study|Lost to Follow-up|4|||
124959406|NCT02864147|449477513|FG002|Overall Study|Lost to Follow-up|0|||
124959407|NCT02864147|449477511|FG000|Overall Study|Adverse Event|0|||
124959408|NCT02864147|449477512|FG001|Overall Study|Adverse Event|1|||
124959409|NCT02864147|449477513|FG002|Overall Study|Adverse Event|0|||
124959410|NCT02864147|449477511|FG000|Overall Study|Pregnancy|4|||
124959411|NCT02864147|449477512|FG001|Overall Study|Pregnancy|0|||
124959412|NCT02864147|449477513|FG002|Overall Study|Pregnancy|0|||
124959413|NCT02864147|449477511|FG000|Overall Study|Physician Decision|0|||
124959414|NCT02864147|449477512|FG001|Overall Study|Physician Decision|0|||
124959415|NCT02864147|449477513|FG002|Overall Study|Physician Decision|1|||
124959416|NCT02864147|449477511|FG000|Overall Study|Opted for excisional procedures|0|||
124959417|NCT02864147|449477512|FG001|Overall Study|Opted for excisional procedures|0|||
124959418|NCT02864147|449477513|FG002|Overall Study|Opted for excisional procedures|3|||
125128394|NCT00376623|450096058|FG001|Overall Study|Increase of tumour markers|1|||
124959419|NCT00975130|449477514|FG000|Study Part 1|Adverse Event|150|||
124959420|NCT00975130|449477515|FG001|Study Part 1|Adverse Event|0|||
124959421|NCT00975130|449477516|FG002|Study Part 1|Adverse Event|0|||
124959422|NCT00975130|449477514|FG000|Study Part 1|Lost to Follow-up|19|||
124959423|NCT00975130|449477515|FG001|Study Part 1|Lost to Follow-up|0|||
124959424|NCT00975130|449477516|FG002|Study Part 1|Lost to Follow-up|0|||
124959425|NCT00975130|449477514|FG000|Study Part 1|Withdrawal by Subject|61|||
124959426|NCT00975130|449477515|FG001|Study Part 1|Withdrawal by Subject|0|||
124959427|NCT00975130|449477516|FG002|Study Part 1|Withdrawal by Subject|0|||
124959428|NCT00975130|449477514|FG000|Study Part 1|Protocol Violation|13|||
124959429|NCT00975130|449477515|FG001|Study Part 1|Protocol Violation|0|||
124959430|NCT00975130|449477516|FG002|Study Part 1|Protocol Violation|0|||
124959431|NCT00975130|449477514|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
124959432|NCT00975130|449477515|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
124959433|NCT00975130|449477516|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
125031242|NCT00896532|449735118|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124959434|NCT00975130|449477514|FG000|Study Part 1|Administrative|4|||
124959435|NCT00975130|449477515|FG001|Study Part 1|Administrative|0|||
124959436|NCT00975130|449477516|FG002|Study Part 1|Administrative|0|||
124959437|NCT00975130|449477514|FG000|Study Part 1|Withdrew Consent|24|||
124959438|NCT00975130|449477515|FG001|Study Part 1|Withdrew Consent|0|||
125031243|NCT00896532|449735119|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124959439|NCT00975130|449477516|FG002|Study Part 1|Withdrew Consent|0|||
124959440|NCT00975130|449477514|FG000|Study Part 2|Adverse Event|0|||
124959441|NCT00975130|449477515|FG001|Study Part 2|Adverse Event|14|||
125031244|NCT00896532|449735120|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124959442|NCT00975130|449477516|FG002|Study Part 2|Adverse Event|7|||
124959443|NCT00975130|449477514|FG000|Study Part 2|Lost to Follow-up|0|||
124959444|NCT00975130|449477515|FG001|Study Part 2|Lost to Follow-up|0|||
124959445|NCT00975130|449477516|FG002|Study Part 2|Lost to Follow-up|1|||
124959446|NCT00975130|449477514|FG000|Study Part 2|Withdrawal by Subject|0|||
124959447|NCT00975130|449477515|FG001|Study Part 2|Withdrawal by Subject|13|||
124959448|NCT00975130|449477516|FG002|Study Part 2|Withdrawal by Subject|5|||
124959449|NCT00975130|449477514|FG000|Study Part 2|Withdrew Consent|0|||
124959450|NCT00975130|449477515|FG001|Study Part 2|Withdrew Consent|6|||
124959451|NCT00975130|449477516|FG002|Study Part 2|Withdrew Consent|2|||
124959452|NCT00975130|449477514|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
124959453|NCT00975130|449477515|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
124959454|NCT00975130|449477516|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
124959455|NCT00975130|449477514|FG000|Study Part 2|Administrative|0|||
124959456|NCT00975130|449477515|FG001|Study Part 2|Administrative|1|||
124959457|NCT00975130|449477516|FG002|Study Part 2|Administrative|0|||
124959458|NCT00975130|449477514|FG000|Study Part 2|Protocol Violation|0|||
124959459|NCT00975130|449477515|FG001|Study Part 2|Protocol Violation|0|||
124959460|NCT00975130|449477516|FG002|Study Part 2|Protocol Violation|1|||
124959461|NCT00240097|449477517|FG000|Part I|Adverse Event|1|||
124959462|NCT00240097|449477517|FG000|Part I|Death|1|||
124959463|NCT00240097|449477517|FG000|Part I|histology|1|||
124959464|NCT00240097|449477517|FG000|Part I|unevaluable|1|||
124959465|NCT00240097|449477517|FG000|Part II|did not continue from Part I|23|||
124959466|NCT02383927|449477518|FG000|Overall Study|Disease Progression|8|||
124959467|NCT02383927|449477519|FG001|Overall Study|Disease Progression|8|||
124959468|NCT02383927|449477520|FG002|Overall Study|Disease Progression|15|||
124959469|NCT02383927|449477521|FG003|Overall Study|Disease Progression|4|||
124959470|NCT02383927|449477518|FG000|Overall Study|Physician Decision|0|||
124959471|NCT02383927|449477519|FG001|Overall Study|Physician Decision|0|||
124959472|NCT02383927|449477520|FG002|Overall Study|Physician Decision|2|||
124959473|NCT02383927|449477521|FG003|Overall Study|Physician Decision|0|||
124959474|NCT02383927|449477518|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
124959475|NCT02383927|449477519|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
124959476|NCT02383927|449477520|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
124959477|NCT02383927|449477521|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
124959478|NCT02383927|449477518|FG000|Overall Study|Adverse Event|4|||
124959479|NCT02383927|449477519|FG001|Overall Study|Adverse Event|1|||
124959480|NCT02383927|449477520|FG002|Overall Study|Adverse Event|3|||
124959481|NCT02383927|449477521|FG003|Overall Study|Adverse Event|5|||
124959482|NCT02383927|449477518|FG000|Overall Study|Miscellaneous|1|||
124959483|NCT02383927|449477519|FG001|Overall Study|Miscellaneous|0|||
124959484|NCT02383927|449477520|FG002|Overall Study|Miscellaneous|0|||
124959485|NCT02383927|449477521|FG003|Overall Study|Miscellaneous|1|||
124959486|NCT02383927|449477518|FG000|Overall Study|Withdrawal by Subject|0|||
124959487|NCT02383927|449477519|FG001|Overall Study|Withdrawal by Subject|1|||
124959488|NCT02383927|449477520|FG002|Overall Study|Withdrawal by Subject|4|||
124959489|NCT02383927|449477521|FG003|Overall Study|Withdrawal by Subject|0|||
124959490|NCT00734851|449477522|FG000|Overall Study|Withdrawal by Subject|2|||
124959491|NCT00734851|449477522|FG000|Overall Study|Lost to Follow-up|1|||
125031245|NCT00896532|449735098|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124959492|NCT00734851|449477522|FG000|Overall Study|Physician Decision|18|||
124959493|NCT03562117|449477525|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
124959494|NCT03562117|449477526|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
124959495|NCT03562117|449477527|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
124959496|NCT01294358|449477528|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
124959497|NCT01294358|449477529|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
124959498|NCT01294358|449477530|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
124959499|NCT01294358|449477531|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
124959500|NCT01294358|449477532|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
124959501|NCT01294358|449477528|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
124959502|NCT01294358|449477529|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
124959503|NCT01294358|449477530|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
124959504|NCT01294358|449477531|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
124959505|NCT01294358|449477532|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
124959506|NCT01294358|449477528|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
124959507|NCT01294358|449477529|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
124959508|NCT01294358|449477530|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
124959509|NCT01294358|449477531|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
125128395|NCT00376623|450096059|FG002|Overall Study|Increase of tumour markers|0|||
125031246|NCT00896532|449735099|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125031247|NCT00896532|449735100|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124959510|NCT01294358|449477532|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
124959511|NCT01294358|449477528|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
124959512|NCT01294358|449477529|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
124959513|NCT01294358|449477530|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
124959514|NCT01294358|449477531|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
124959515|NCT01294358|449477532|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
124959516|NCT03356145|449477533|FG000|Overall Study|Withdrawal by Subject|2|||
124959517|NCT03356145|449477534|FG001|Overall Study|Withdrawal by Subject|1|||
124959518|NCT03356145|449477533|FG000|Overall Study|Did not meet inclusion criteria|1|||
124959519|NCT03356145|449477534|FG001|Overall Study|Did not meet inclusion criteria|0|||
124959520|NCT03613454|449477535|FG000|Overall Study|Protocol Violation|1|||
124959521|NCT03613454|449477536|FG001|Overall Study|Protocol Violation|0|||
124959522|NCT03613454|449477535|FG000|Overall Study|Protocol Violation|0|||
124959523|NCT03613454|449477536|FG001|Overall Study|Protocol Violation|1|||
124959524|NCT02963922|449477537|FG000|Overall Study|Adverse Event|15|||
124959525|NCT02963922|449477538|FG001|Overall Study|Adverse Event|6|||
124959526|NCT02963922|449477537|FG000|Overall Study|Protocol deviation|6|||
124959527|NCT02963922|449477538|FG001|Overall Study|Protocol deviation|6|||
124959528|NCT02963922|449477537|FG000|Overall Study|Lack of Efficacy|1|||
124959529|NCT02963922|449477538|FG001|Overall Study|Lack of Efficacy|1|||
124959530|NCT02963922|449477537|FG000|Overall Study|Lost to Follow-up|2|||
124959531|NCT02963922|449477538|FG001|Overall Study|Lost to Follow-up|3|||
124959532|NCT02963922|449477537|FG000|Overall Study|Other|8|||
124959533|NCT02963922|449477538|FG001|Overall Study|Other|14|||
125128396|NCT00376623|450096057|FG000|Overall Study|Bone metastasis|1|||
125128397|NCT00376623|450096058|FG001|Overall Study|Bone metastasis|0|||
125128398|NCT00376623|450096059|FG002|Overall Study|Bone metastasis|0|||
125128399|NCT00286754|450096060|FG000|Overall Study|Adverse Event|2|||
125128400|NCT00286754|450096061|FG001|Overall Study|Adverse Event|2|||
125128401|NCT00286754|450096062|FG002|Overall Study|Adverse Event|3|||
125128402|NCT00286754|450096060|FG000|Overall Study|Withdrawal by Subject|6|||
125128403|NCT00286754|450096061|FG001|Overall Study|Withdrawal by Subject|2|||
125128404|NCT00286754|450096062|FG002|Overall Study|Withdrawal by Subject|0|||
125128405|NCT00286754|450096060|FG000|Overall Study|Lost to Follow-up|12|||
125128406|NCT00286754|450096061|FG001|Overall Study|Lost to Follow-up|14|||
125128407|NCT00286754|450096062|FG002|Overall Study|Lost to Follow-up|6|||
125128408|NCT00286754|450096060|FG000|Overall Study|Moved out of state|0|||
125128409|NCT00286754|450096061|FG001|Overall Study|Moved out of state|0|||
125128410|NCT00286754|450096062|FG002|Overall Study|Moved out of state|1|||
125128411|NCT00910663|450096063|FG000|Period 1|Withdrawal by Subject|0|||
125128412|NCT00910663|450096064|FG001|Period 1|Withdrawal by Subject|1|||
125128413|NCT02865850|450096065|FG000|Overall Study|Death|15|||
125128414|NCT02865850|450096066|FG001|Overall Study|Death|19|||
125128415|NCT02865850|450096065|FG000|Overall Study|Withdrawal by Subject|3|||
125128416|NCT02865850|450096066|FG001|Overall Study|Withdrawal by Subject|2|||
125128417|NCT02865850|450096065|FG000|Overall Study|Lost to Follow-up|3|||
125128418|NCT02865850|450096066|FG001|Overall Study|Lost to Follow-up|2|||
125128419|NCT02726581|450096067|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
125128420|NCT02726581|450096068|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
125128421|NCT02726581|450096069|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
125128422|NCT02726581|450096067|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
125128423|NCT02726581|450096068|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
125128424|NCT02726581|450096069|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
125128425|NCT02726581|450096067|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
125128426|NCT02726581|450096068|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125128427|NCT02726581|450096069|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125128428|NCT02726581|450096067|FG000|Treatment Period|Disease progression|47|||
125128429|NCT02726581|450096068|FG001|Treatment Period|Disease progression|50|||
125128430|NCT02726581|450096069|FG002|Treatment Period|Disease progression|16|||
125128431|NCT02726581|450096067|FG000|Treatment Period|Other reasons|9|||
124959534|NCT00655668|449477551|FG000|Overall Study|Adverse Event|6|||
125128432|NCT02726581|450096068|FG001|Treatment Period|Other reasons|8|||
124959535|NCT00655668|449477551|FG000|Overall Study|Death|5|||
124959536|NCT00655668|449477551|FG000|Overall Study|Disease Progression|27|||
124959537|NCT00655668|449477551|FG000|Overall Study|Study Terminated|9|||
124959538|NCT00655668|449477551|FG000|Overall Study|Other|1|||
124959539|NCT00655668|449477551|FG000|Overall Study|New Lymphoma Treatment Started|4|||
124959540|NCT00655668|449477551|FG000|Overall Study|Withdrawal by Subject|2|||
124959541|NCT03873038|449477554|FG000|Part 2|Withdrawal by Subject|0|||
124959542|NCT03873038|449477555|FG001|Part 2|Withdrawal by Subject|0|||
124959543|NCT03873038|449477556|FG002|Part 2|Withdrawal by Subject|0|||
124959544|NCT03873038|449477557|FG003|Part 2|Withdrawal by Subject|0|||
124959545|NCT03873038|449477558|FG004|Part 2|Withdrawal by Subject|0|||
124959546|NCT03873038|449477559|FG005|Part 2|Withdrawal by Subject|1|||
124959547|NCT03873038|449477554|FG000|Part 2|Unknon|0|||
124959548|NCT03873038|449477555|FG001|Part 2|Unknon|0|||
124959549|NCT03873038|449477556|FG002|Part 2|Unknon|0|||
124959550|NCT03873038|449477557|FG003|Part 2|Unknon|0|||
124959551|NCT03873038|449477558|FG004|Part 2|Unknon|1|||
124959552|NCT03873038|449477559|FG005|Part 2|Unknon|0|||
124959553|NCT04222088|449477561|FG000|Overall Study|Lost to Follow-up|5|||
124959554|NCT04222088|449477562|FG001|Overall Study|Lost to Follow-up|1|||
124959555|NCT04222088|449477561|FG000|Overall Study|Withdrawal by Subject|4|||
124959556|NCT04222088|449477562|FG001|Overall Study|Withdrawal by Subject|0|||
124959557|NCT00595764|449477563|FG000|Overall Study|Protocol Violation|24|||
124959558|NCT00595764|449477564|FG001|Overall Study|Protocol Violation|19|||
124959559|NCT00595764|449477563|FG000|Overall Study|Missed Medication >1 week|10|||
124959560|NCT00595764|449477564|FG001|Overall Study|Missed Medication >1 week|17|||
124959561|NCT00595764|449477563|FG000|Overall Study|Missed 3 PM visits|1|||
124959562|NCT00595764|449477564|FG001|Overall Study|Missed 3 PM visits|7|||
124959563|NCT00595764|449477563|FG000|Overall Study|Withdrawal by Subject|4|||
124959564|NCT00595764|449477564|FG001|Overall Study|Withdrawal by Subject|0|||
124959565|NCT01071317|449477565|FG000|Overall Study|Lost to Follow-up|2|||
124959566|NCT01071317|449477566|FG001|Overall Study|Lost to Follow-up|2|||
124959567|NCT01332318|449477568|FG000|Overall Study|Adverse Event|0|||
124959568|NCT01332318|449477569|FG001|Overall Study|Adverse Event|3|||
124959569|NCT01332318|449477570|FG002|Overall Study|Adverse Event|0|||
124959570|NCT01332318|449477571|FG003|Overall Study|Adverse Event|0|||
124959571|NCT01332318|449477568|FG000|Overall Study|Withdrawal by Subject|1|||
124959572|NCT01332318|449477569|FG001|Overall Study|Withdrawal by Subject|1|||
124959573|NCT01332318|449477570|FG002|Overall Study|Withdrawal by Subject|0|||
124959574|NCT01332318|449477571|FG003|Overall Study|Withdrawal by Subject|1|||
124959575|NCT01332318|449477568|FG000|Overall Study|Protocol Violation|1|||
124959576|NCT01332318|449477569|FG001|Overall Study|Protocol Violation|0|||
124959577|NCT01332318|449477570|FG002|Overall Study|Protocol Violation|1|||
124959578|NCT01332318|449477571|FG003|Overall Study|Protocol Violation|1|||
124959579|NCT02040532|449477572|FG000|Overall Study|Lost to Follow-up|1|||
124959580|NCT02040532|449477572|FG000|Overall Study|Physician Decision|4|||
124959581|NCT02040532|449477572|FG000|Overall Study|Adverse Event|4|||
124959582|NCT02040532|449477572|FG000|Overall Study|Withdrawal by Subject|3|||
124959583|NCT02820298|449477577|FG000|Overall Study|Withdrawal by Subject|0|||
124959584|NCT02820298|449477578|FG001|Overall Study|Withdrawal by Subject|1|||
124959585|NCT02820298|449477577|FG000|Overall Study|Physician Decision|1|||
124959586|NCT02820298|449477578|FG001|Overall Study|Physician Decision|0|||
124959587|NCT02820298|449477577|FG000|Overall Study|Protocol Violation|0|||
124959588|NCT02820298|449477578|FG001|Overall Study|Protocol Violation|1|||
124959589|NCT01894256|449477579|FG000|Part A|Adverse Event|0|||
124959590|NCT01894256|449477580|FG001|Part A|Adverse Event|1|||
124959591|NCT01894256|449477581|FG002|Part A|Adverse Event|0|||
124959592|NCT01894256|449477579|FG000|Part B|Death|0|||
124959593|NCT01894256|449477580|FG001|Part B|Death|1|||
124959594|NCT01894256|449477581|FG002|Part B|Death|1|||
124959595|NCT01894256|449477579|FG000|Part B|Withdrawal by Subject|0|||
124959596|NCT01894256|449477580|FG001|Part B|Withdrawal by Subject|1|||
124959597|NCT01894256|449477581|FG002|Part B|Withdrawal by Subject|0|||
124959598|NCT01894256|449477579|FG000|Part B|Lack of Efficacy|15|||
124959599|NCT01894256|449477580|FG001|Part B|Lack of Efficacy|12|||
124959600|NCT01894256|449477581|FG002|Part B|Lack of Efficacy|13|||
124959601|NCT01780584|449477582|FG000|Overall Study|Death|1|||
124959602|NCT01780584|449477583|FG001|Overall Study|Death|0|||
124959603|NCT01780584|449477584|FG002|Overall Study|Death|1|||
124959604|NCT01780584|449477582|FG000|Overall Study|Adverse Event|0|||
124959605|NCT01780584|449477583|FG001|Overall Study|Adverse Event|1|||
124959606|NCT01780584|449477584|FG002|Overall Study|Adverse Event|0|||
124959607|NCT01780584|449477582|FG000|Overall Study|Protocol Violation|0|||
124959608|NCT01780584|449477583|FG001|Overall Study|Protocol Violation|0|||
124959609|NCT01780584|449477584|FG002|Overall Study|Protocol Violation|1|||
124959610|NCT01772147|449479126|FG000|Overall Study|Adverse Event|13|||
124959611|NCT01772147|449479127|FG001|Overall Study|Adverse Event|10|||
124959612|NCT01772147|449479128|FG002|Overall Study|Adverse Event|6|||
124959613|NCT01772147|449479126|FG000|Overall Study|Withdrew Consent|7|||
124959614|NCT01772147|449479127|FG001|Overall Study|Withdrew Consent|8|||
124959615|NCT01772147|449479128|FG002|Overall Study|Withdrew Consent|4|||
124959616|NCT01772147|449479126|FG000|Overall Study|Lost to Follow-up|1|||
124959617|NCT01772147|449479127|FG001|Overall Study|Lost to Follow-up|0|||
124959618|NCT01772147|449479128|FG002|Overall Study|Lost to Follow-up|1|||
124959619|NCT01772147|449479126|FG000|Overall Study|Protocol Deviation|2|||
124959620|NCT01772147|449479127|FG001|Overall Study|Protocol Deviation|1|||
124959621|NCT01772147|449479128|FG002|Overall Study|Protocol Deviation|1|||
124959622|NCT01772147|449479126|FG000|Overall Study|Lack of Efficacy|8|||
124959623|NCT01772147|449479127|FG001|Overall Study|Lack of Efficacy|6|||
125215586|NCT00902746|450417445|FG000|Overall Study|Withdrawal by Subject|16|||
124959624|NCT01772147|449479128|FG002|Overall Study|Lack of Efficacy|6|||
124959625|NCT00796614|449479133|FG000|Overall Study|Adverse Event|1|||
124959626|NCT00796614|449479134|FG001|Overall Study|Adverse Event|2|||
124959627|NCT00796614|449479135|FG002|Overall Study|Adverse Event|0|||
124959628|NCT00796614|449479136|FG003|Overall Study|Adverse Event|0|||
124959629|NCT00796614|449479133|FG000|Overall Study|Protocol Violation|0|||
124959630|NCT00796614|449479134|FG001|Overall Study|Protocol Violation|0|||
124959631|NCT00796614|449479135|FG002|Overall Study|Protocol Violation|2|||
124959632|NCT00796614|449479136|FG003|Overall Study|Protocol Violation|0|||
124959633|NCT00796614|449479133|FG000|Overall Study|Lost to Follow-up|2|||
124959634|NCT00796614|449479134|FG001|Overall Study|Lost to Follow-up|2|||
124959635|NCT00796614|449479135|FG002|Overall Study|Lost to Follow-up|1|||
124959636|NCT00796614|449479136|FG003|Overall Study|Lost to Follow-up|0|||
124959637|NCT00796614|449479133|FG000|Overall Study|Withdrawal by Subject|1|||
124959638|NCT00796614|449479134|FG001|Overall Study|Withdrawal by Subject|0|||
124959639|NCT00796614|449479135|FG002|Overall Study|Withdrawal by Subject|0|||
124959640|NCT00796614|449479136|FG003|Overall Study|Withdrawal by Subject|1|||
124959641|NCT00796614|449479133|FG000|Overall Study|Other than stated|1|||
124959642|NCT00796614|449479134|FG001|Overall Study|Other than stated|0|||
124959643|NCT00796614|449479135|FG002|Overall Study|Other than stated|0|||
124959644|NCT00796614|449479136|FG003|Overall Study|Other than stated|0|||
124959645|NCT00509821|449479137|FG000|Study Period 1 (Induction)|Death|0|||
124959646|NCT00509821|449479138|FG001|Study Period 1 (Induction)|Death|1|||
124959647|NCT00509821|449479137|FG000|Study Period 1 (Induction)|Adverse Event|0|||
124959648|NCT00509821|449479138|FG001|Study Period 1 (Induction)|Adverse Event|2|||
124959649|NCT00509821|449479137|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
124959650|NCT00509821|449479138|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
124959651|NCT01816685|449479139|FG000|Overall Study|Lost to Follow-up|7|||
124959652|NCT01816685|449479140|FG001|Overall Study|Lost to Follow-up|9|||
124959653|NCT01816685|449479139|FG000|Overall Study|Surgery Cancelled|3|||
124959654|NCT01816685|449479140|FG001|Overall Study|Surgery Cancelled|2|||
124959655|NCT03449134|449479141|FG000|52-Week Treatment Period|Death|2|||
124959656|NCT03449134|449479142|FG001|52-Week Treatment Period|Death|1|||
124959657|NCT03449134|449479143|FG002|52-Week Treatment Period|Death|0|||
124959658|NCT03449134|449479141|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
124959659|NCT03449134|449479142|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
124959660|NCT03449134|449479143|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
124959661|NCT03449134|449479141|FG000|52-Week Treatment Period|Physician Decision|2|||
124959662|NCT03449134|449479142|FG001|52-Week Treatment Period|Physician Decision|3|||
124959663|NCT03449134|449479143|FG002|52-Week Treatment Period|Physician Decision|3|||
124959664|NCT03449134|449479141|FG000|52-Week Treatment Period|Screen Failure|1|||
124959665|NCT03449134|449479142|FG001|52-Week Treatment Period|Screen Failure|0|||
125128433|NCT02726581|450096069|FG002|Treatment Period|Other reasons|2|||
125128434|NCT02726581|450096067|FG000|Treatment Period|Study drug toxicity|6|||
125128435|NCT02726581|450096068|FG001|Treatment Period|Study drug toxicity|3|||
125128436|NCT02726581|450096069|FG002|Treatment Period|Study drug toxicity|2|||
125128437|NCT02726581|450096067|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
125128438|NCT02726581|450096068|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
125128439|NCT02726581|450096069|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
125128440|NCT02726581|450096067|FG000|Treatment Period|Participant withdrew consent|3|||
125128441|NCT02726581|450096068|FG001|Treatment Period|Participant withdrew consent|1|||
125128442|NCT02726581|450096069|FG002|Treatment Period|Participant withdrew consent|1|||
125128443|NCT02726581|450096067|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
125128444|NCT02726581|450096068|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
125128445|NCT02726581|450096069|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
125128446|NCT02726581|450096067|FG000|Treatment Period|Maximum clinical benefit|0|||
125128447|NCT02726581|450096068|FG001|Treatment Period|Maximum clinical benefit|2|||
125128448|NCT02726581|450096069|FG002|Treatment Period|Maximum clinical benefit|0|||
125128449|NCT02726581|450096067|FG000|Treatment Period|Death|1|||
125128450|NCT02726581|450096068|FG001|Treatment Period|Death|0|||
125128451|NCT02726581|450096069|FG002|Treatment Period|Death|0|||
125128452|NCT02726581|450096067|FG000|Treatment Period|Poor/non-compliance|1|||
125128453|NCT02726581|450096068|FG001|Treatment Period|Poor/non-compliance|0|||
125128454|NCT02726581|450096069|FG002|Treatment Period|Poor/non-compliance|0|||
125128455|NCT02726581|450096067|FG000|Treatment Period|Participant no longer meets study criteria|0|||
125128456|NCT02726581|450096068|FG001|Treatment Period|Participant no longer meets study criteria|1|||
125128457|NCT02726581|450096069|FG002|Treatment Period|Participant no longer meets study criteria|0|||
125128458|NCT00552669|450096073|FG000|Overall Study|Death|3|||
125128459|NCT00552669|450096074|FG001|Overall Study|Death|7|||
125128460|NCT01844375|450096075|FG000|Overall Study|Protocol Violation|1|||
125128461|NCT01844375|450096076|FG001|Overall Study|Protocol Violation|1|||
125128462|NCT01772537|450096078|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
125128463|NCT01772537|450096079|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
125128464|NCT01772537|450096080|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
125128465|NCT01263704|450096081|FG000|Overall Study|Progressive disease|18|||
124959666|NCT03449134|449479143|FG002|52-Week Treatment Period|Screen Failure|1|||
124959667|NCT03449134|449479141|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
124959668|NCT03449134|449479142|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
124959669|NCT03449134|449479143|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
124959670|NCT03449134|449479141|FG000|52-Week Treatment Period|Site Closure|1|||
124959671|NCT03449134|449479142|FG001|52-Week Treatment Period|Site Closure|0|||
124959672|NCT03449134|449479143|FG002|52-Week Treatment Period|Site Closure|0|||
124959673|NCT00957996|449479144|FG000|Overall Study|Death|4|||
124959674|NCT00957996|449479145|FG001|Overall Study|Death|10|||
124959675|NCT00957996|449479144|FG000|Overall Study|Lost to Follow-up|4|||
124959676|NCT00957996|449479145|FG001|Overall Study|Lost to Follow-up|7|||
124959677|NCT00957996|449479144|FG000|Overall Study|Withdrawal by Subject|9|||
124959678|NCT00957996|449479145|FG001|Overall Study|Withdrawal by Subject|2|||
124959679|NCT00957996|449479144|FG000|Overall Study|Adverse Event|2|||
124959680|NCT00957996|449479145|FG001|Overall Study|Adverse Event|1|||
124959681|NCT00957996|449479144|FG000|Overall Study|Physician Decision|1|||
124959682|NCT00957996|449479145|FG001|Overall Study|Physician Decision|1|||
124959683|NCT00957996|449479144|FG000|Overall Study|Influenza-related complication|0|||
124959684|NCT00957996|449479145|FG001|Overall Study|Influenza-related complication|1|||
124959685|NCT00957996|449479144|FG000|Overall Study|Missing|1|||
124959686|NCT00957996|449479145|FG001|Overall Study|Missing|0|||
124959687|NCT00957996|449479144|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
124959688|NCT00957996|449479145|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
124959689|NCT00275301|449479148|FG000|Overall Study|Adverse Event|5|||
124959690|NCT02561078|449479151|FG000|Overall Study|Adverse Event|5|||
124959691|NCT02561078|449479152|FG001|Overall Study|Adverse Event|2|||
124959692|NCT02561078|449479151|FG000|Overall Study|Death|2|||
124959693|NCT02561078|449479152|FG001|Overall Study|Death|1|||
124959694|NCT02561078|449479151|FG000|Overall Study|Lost to Follow-up|2|||
124959695|NCT02561078|449479152|FG001|Overall Study|Lost to Follow-up|6|||
124959696|NCT02561078|449479151|FG000|Overall Study|Non-Compliance with Study Drug|6|||
125128466|NCT01263704|450096081|FG000|Overall Study|Adverse Event|3|||
124959697|NCT02561078|449479152|FG001|Overall Study|Non-Compliance with Study Drug|3|||
124959698|NCT02561078|449479151|FG000|Overall Study|Physician Decision|2|||
124959699|NCT02561078|449479152|FG001|Overall Study|Physician Decision|3|||
124959700|NCT02561078|449479151|FG000|Overall Study|Withdrawal by Subject|13|||
124959701|NCT02561078|449479152|FG001|Overall Study|Withdrawal by Subject|10|||
124959702|NCT01983462|449479153|FG000|Overall Study|Adverse Event|1|||
124959703|NCT01983462|449479154|FG001|Overall Study|Adverse Event|0|||
124959704|NCT01983462|449479155|FG002|Overall Study|Adverse Event|0|||
124959705|NCT00684203|449479156|FG000|Overall Study|Adverse Event|6|||
124959706|NCT00684203|449479157|FG001|Overall Study|Adverse Event|4|||
125215587|NCT00902746|450417445|FG000|Overall Study|Adverse Event|8|||
125215588|NCT00902746|450417445|FG000|Overall Study|Lost to Follow-up|3|||
124959707|NCT00684203|449479158|FG002|Overall Study|Adverse Event|8|||
124959708|NCT00684203|449479159|FG003|Overall Study|Adverse Event|0|||
124959709|NCT00684203|449479160|FG004|Overall Study|Adverse Event|0|||
124959710|NCT00684203|449479161|FG005|Overall Study|Adverse Event|0|||
124959711|NCT00684203|449479156|FG000|Overall Study|Protocol-defined clinical event|3|||
124959712|NCT00684203|449479157|FG001|Overall Study|Protocol-defined clinical event|1|||
124959713|NCT00684203|449479158|FG002|Overall Study|Protocol-defined clinical event|0|||
124959714|NCT00684203|449479159|FG003|Overall Study|Protocol-defined clinical event|0|||
124959715|NCT00684203|449479160|FG004|Overall Study|Protocol-defined clinical event|0|||
124959716|NCT00684203|449479161|FG005|Overall Study|Protocol-defined clinical event|0|||
124959717|NCT00684203|449479156|FG000|Overall Study|Withdrawal by Subject|0|||
124959718|NCT00684203|449479157|FG001|Overall Study|Withdrawal by Subject|2|||
124959719|NCT00684203|449479158|FG002|Overall Study|Withdrawal by Subject|1|||
124959720|NCT00684203|449479159|FG003|Overall Study|Withdrawal by Subject|0|||
124959721|NCT00684203|449479160|FG004|Overall Study|Withdrawal by Subject|0|||
124959722|NCT00684203|449479161|FG005|Overall Study|Withdrawal by Subject|0|||
124959723|NCT00684203|449479156|FG000|Overall Study|Did not meet protocol eligibility|0|||
124959724|NCT00684203|449479157|FG001|Overall Study|Did not meet protocol eligibility|1|||
124959725|NCT00684203|449479158|FG002|Overall Study|Did not meet protocol eligibility|0|||
124959726|NCT00684203|449479159|FG003|Overall Study|Did not meet protocol eligibility|0|||
124959727|NCT00684203|449479160|FG004|Overall Study|Did not meet protocol eligibility|0|||
125215589|NCT00902746|450417445|FG000|Overall Study|Physician Decision|2|||
124959728|NCT00684203|449479161|FG005|Overall Study|Did not meet protocol eligibility|0|||
124959729|NCT00719212|449479162|FG000|Overall Study|Death|41|||
124959730|NCT00719212|449479162|FG000|Overall Study|Lost to Follow-up|2|||
124959731|NCT00719212|449479162|FG000|Overall Study|Withdrawal by Subject|1|||
124959732|NCT00508274|449479163|FG000|Overall Study|Adverse Event|5|||
124959733|NCT00508274|449479163|FG000|Overall Study|Death|7|||
124959734|NCT00508274|449479163|FG000|Overall Study|Disease progression|32|||
124959735|NCT00508274|449479163|FG000|Overall Study|Withdrawal by Subject|1|||
124959736|NCT00508274|449479163|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
124959737|NCT00508274|449479163|FG000|Overall Study|Missing|3|||
124959738|NCT03296566|449479164|FG000|Overall Study|Lost to Follow-up|19|||
124959739|NCT03296566|449479165|FG001|Overall Study|Lost to Follow-up|46|||
124959740|NCT03296566|449479164|FG000|Overall Study|Withdrawal by Subject|0|||
124959741|NCT03296566|449479165|FG001|Overall Study|Withdrawal by Subject|3|||
124959742|NCT03924947|449479170|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
124959743|NCT03924947|449479171|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
124959744|NCT03924947|449479172|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
124959745|NCT03924947|449479173|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
124959746|NCT03924947|449479174|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
124959747|NCT03924947|449479175|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
124959748|NCT01631825|449479176|FG000|Overall Study|Adverse Event|42|||
124959749|NCT01631825|449479176|FG000|Overall Study|Lack of Efficacy|7|||
124959750|NCT01631825|449479176|FG000|Overall Study|Withdrawal by Subject|9|||
124959751|NCT01631825|449479176|FG000|Overall Study|Protocol Violation|4|||
124959752|NCT01631825|449479176|FG000|Overall Study|Discontinuation criteria|1|||
124959753|NCT01631825|449479176|FG000|Overall Study|Physician Decision|2|||
124959754|NCT02499835|449479177|FG000|Overall Study|Withdrawal by Subject|1|||
124959755|NCT02499835|449479178|FG001|Overall Study|Withdrawal by Subject|0|||
124959756|NCT02499835|449479179|FG002|Overall Study|Withdrawal by Subject|0|||
124959757|NCT02499835|449479180|FG003|Overall Study|Withdrawal by Subject|1|||
124959758|NCT02499835|449479177|FG000|Overall Study|Physician Decision|0|||
124959759|NCT02499835|449479178|FG001|Overall Study|Physician Decision|3|||
124959760|NCT02499835|449479179|FG002|Overall Study|Physician Decision|18|||
124959761|NCT02499835|449479180|FG003|Overall Study|Physician Decision|7|||
124959762|NCT02499835|449479177|FG000|Overall Study|Adverse Event|0|||
124959763|NCT02499835|449479178|FG001|Overall Study|Adverse Event|0|||
124959764|NCT02499835|449479179|FG002|Overall Study|Adverse Event|0|||
124959765|NCT02499835|449479180|FG003|Overall Study|Adverse Event|1|||
124959766|NCT02499835|449479177|FG000|Overall Study|Disease progression|2|||
124959767|NCT02499835|449479178|FG001|Overall Study|Disease progression|1|||
124959768|NCT02499835|449479179|FG002|Overall Study|Disease progression|0|||
124959769|NCT02499835|449479180|FG003|Overall Study|Disease progression|7|||
124959770|NCT03226353|449479181|FG000|Overall Study|Withdrawal by Subject|1|||
124959771|NCT03226353|449479181|FG000|Overall Study|Screen Failure|5|||
124959772|NCT00498433|449479183|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
124959773|NCT00498433|449479184|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
124959774|NCT00498433|449479185|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
124959775|NCT00498433|449479183|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
124959776|NCT00498433|449479184|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
124959777|NCT00498433|449479185|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
124959778|NCT00498433|449479183|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
124959779|NCT00498433|449479184|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
124959780|NCT00498433|449479185|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
124959781|NCT00498433|449479183|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
124959782|NCT00498433|449479184|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
124959783|NCT00498433|449479185|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
124959784|NCT04491006|449479186|FG000|Overall Study|Adverse Event|0|||
124959785|NCT04491006|449479187|FG001|Overall Study|Adverse Event|3|||
124959786|NCT04491006|449479188|FG002|Overall Study|Adverse Event|5|||
124959787|NCT04491006|449479186|FG000|Overall Study|Withdrawal by Subject|1|||
124959788|NCT04491006|449479187|FG001|Overall Study|Withdrawal by Subject|0|||
124959789|NCT04491006|449479188|FG002|Overall Study|Withdrawal by Subject|2|||
124959790|NCT00744796|449479190|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
124959791|NCT02581189|449479195|FG000|Overall Study|Failure to return|36|||
124959792|NCT02581189|449479195|FG000|Overall Study|Withdrew consent|5|||
124959793|NCT02581189|449479195|FG000|Overall Study|Death|3|||
124959794|NCT02581189|449479195|FG000|Overall Study|Insufficient virological response|2|||
124959795|NCT02581189|449479195|FG000|Overall Study|Other, not specified|7|||
124959796|NCT01514864|449479196|FG000|Overall Study|Disease progression|7|||
124959797|NCT01514864|449479197|FG001|Overall Study|Disease progression|5|||
124959798|NCT01514864|449479196|FG000|Overall Study|Study drug toxicity|2|||
124959799|NCT01514864|449479197|FG001|Overall Study|Study drug toxicity|0|||
124959800|NCT02253147|449479198|FG000|Overall Study|Protocol Violation|30|||
124959801|NCT02253147|449479198|FG000|Overall Study|Did not consent to study extension|9|||
124959802|NCT02253147|449479198|FG000|Overall Study|Conditional re-treatment at W52|5|||
124959803|NCT02253147|449479198|FG000|Overall Study|Lost to Follow-up|2|||
124959804|NCT02253147|449479198|FG000|Overall Study|Withdrawal by Subject|1|||
124959805|NCT02254681|449479200|FG000|Overall Study|Lack of Efficacy|6|||
124959806|NCT00797511|449479201|FG000|Overall Study|Withdrawal by Subject|1|||
124959807|NCT00843115|449479202|FG000|Overall Study|Death|4|||
124959808|NCT00843115|449479202|FG000|Overall Study|Adverse Event|30|||
124959809|NCT00843115|449479202|FG000|Overall Study|Lost to Follow-up|4|||
124959810|NCT00843115|449479202|FG000|Overall Study|Withdrawal by Subject|17|||
124959811|NCT00843115|449479202|FG000|Overall Study|Family wanted meds stopped|1|||
124959812|NCT00843115|449479202|FG000|Overall Study|Family does not want continuation|1|||
124959813|NCT00843115|449479202|FG000|Overall Study|Patient forgot to take meds|1|||
124959814|NCT00843115|449479202|FG000|Overall Study|Does not meet entrance criteria|1|||
124959815|NCT00843115|449479202|FG000|Overall Study|Physician Decision|1|||
124959816|NCT00843115|449479202|FG000|Overall Study|Family discontinued meds|1|||
124959817|NCT00843115|449479202|FG000|Overall Study|patient took for 2 days then stopped|1|||
124959818|NCT00843115|449479202|FG000|Overall Study|patient never took the medication|1|||
124959819|NCT00843115|449479202|FG000|Overall Study|hospitalized due to deterioration|1|||
124959820|NCT00843115|449479202|FG000|Overall Study|week 12 not done|1|||
124959821|NCT00843115|449479202|FG000|Overall Study|Syndrome De Glissement|1|||
124959822|NCT02621047|449479203|FG000|Overall Study|Adverse Event|0|||
124959823|NCT02621047|449479204|FG001|Overall Study|Adverse Event|0|||
124959824|NCT02621047|449479205|FG002|Overall Study|Adverse Event|1|||
124959825|NCT01951261|449479206|FG000|Overall Study|Death|1|||
124959826|NCT01951261|449479207|FG001|Overall Study|Death|0|||
124959827|NCT01951261|449479206|FG000|Overall Study|Lost to Follow-up|4|||
124959828|NCT01951261|449479207|FG001|Overall Study|Lost to Follow-up|3|||
124959829|NCT01951261|449479206|FG000|Overall Study|Protocol Violation|4|||
124959830|NCT01951261|449479207|FG001|Overall Study|Protocol Violation|3|||
124959831|NCT00495612|449479208|FG000|Overall Study|Lost to Follow-up|1|||
124959832|NCT00495612|449479209|FG001|Overall Study|Lost to Follow-up|0|||
124959833|NCT00495612|449479208|FG000|Overall Study|Subject's Decision to Withdraw|3|||
124959834|NCT00495612|449479209|FG001|Overall Study|Subject's Decision to Withdraw|0|||
124959835|NCT00818519|449479212|FG000|Overall Study|Adverse Event|2|||
124959836|NCT00818519|449479213|FG001|Overall Study|Adverse Event|2|||
124959837|NCT00818519|449479212|FG000|Overall Study|Lost to Follow-up|4|||
124959838|NCT00818519|449479213|FG001|Overall Study|Lost to Follow-up|6|||
124959839|NCT00818519|449479212|FG000|Overall Study|Protocol Violation|2|||
124959840|NCT00818519|449479213|FG001|Overall Study|Protocol Violation|1|||
124959841|NCT00818519|449479212|FG000|Overall Study|Pregnancy|0|||
124959842|NCT00818519|449479213|FG001|Overall Study|Pregnancy|1|||
124959843|NCT00818519|449479212|FG000|Overall Study|Withdrawal by Subject|4|||
124959844|NCT00818519|449479213|FG001|Overall Study|Withdrawal by Subject|9|||
124959845|NCT00818519|449479212|FG000|Overall Study|participant recovered completely|1|||
124959846|NCT00818519|449479213|FG001|Overall Study|participant recovered completely|0|||
124959847|NCT00818519|449479212|FG000|Overall Study|participant will leave for long tme|1|||
124959848|NCT00818519|449479213|FG001|Overall Study|participant will leave for long tme|0|||
124959849|NCT03740919|449479215|FG000|Lead-in Period|Lost to Follow-up|1|||
124959850|NCT03740919|449479216|FG001|Lead-in Period|Lost to Follow-up|0|||
124959851|NCT03740919|449479217|FG002|Lead-in Period|Lost to Follow-up|0|||
124959852|NCT03740919|449479218|FG003|Lead-in Period|Lost to Follow-up|0|||
124959853|NCT03740919|449479215|FG000|Lead-in Period|Physician Decision|2|||
124959854|NCT03740919|449479216|FG001|Lead-in Period|Physician Decision|0|||
124959855|NCT03740919|449479217|FG002|Lead-in Period|Physician Decision|0|||
124959856|NCT03740919|449479218|FG003|Lead-in Period|Physician Decision|0|||
124959857|NCT03740919|449479215|FG000|Lead-in Period|Protocol Violation|1|||
124959858|NCT03740919|449479216|FG001|Lead-in Period|Protocol Violation|0|||
124959859|NCT03740919|449479217|FG002|Lead-in Period|Protocol Violation|0|||
124959860|NCT03740919|449479218|FG003|Lead-in Period|Protocol Violation|0|||
124959861|NCT03740919|449479215|FG000|Lead-in Period|Withdrawal by Subject|10|||
124959862|NCT03740919|449479216|FG001|Lead-in Period|Withdrawal by Subject|0|||
124959863|NCT03740919|449479217|FG002|Lead-in Period|Withdrawal by Subject|0|||
124959864|NCT03740919|449479218|FG003|Lead-in Period|Withdrawal by Subject|0|||
124959865|NCT03740919|449479215|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
124959866|NCT03740919|449479216|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
124959867|NCT03740919|449479217|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
124959868|NCT03740919|449479218|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
124959869|NCT03740919|449479215|FG000|Lead-in Period|Study Task Too Burdensome|1|||
124959870|NCT03740919|449479216|FG001|Lead-in Period|Study Task Too Burdensome|0|||
124959871|NCT03740919|449479217|FG002|Lead-in Period|Study Task Too Burdensome|0|||
124959872|NCT03740919|449479218|FG003|Lead-in Period|Study Task Too Burdensome|0|||
124959873|NCT03740919|449479215|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
125128467|NCT01263704|450096081|FG000|Overall Study|Death|2|||
124959874|NCT03740919|449479216|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
124959875|NCT03740919|449479217|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
124959876|NCT03740919|449479218|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
124959877|NCT03740919|449479215|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
124959878|NCT03740919|449479216|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
124959879|NCT03740919|449479217|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
124959880|NCT03740919|449479218|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
124959881|NCT03740919|449479215|FG000|Treatment Period|Adverse Event|0|||
124959882|NCT03740919|449479216|FG001|Treatment Period|Adverse Event|0|||
124959883|NCT03740919|449479217|FG002|Treatment Period|Adverse Event|2|||
124959884|NCT03740919|449479218|FG003|Treatment Period|Adverse Event|0|||
124959885|NCT03740919|449479215|FG000|Treatment Period|Protocol Violation|0|||
124959886|NCT03740919|449479216|FG001|Treatment Period|Protocol Violation|1|||
124959887|NCT03740919|449479217|FG002|Treatment Period|Protocol Violation|0|||
125215590|NCT00303472|450417446|FG000|Treatment Period|Adverse Event|0|||
125215591|NCT00303472|450417447|FG001|Treatment Period|Adverse Event|0|||
124959888|NCT03740919|449479218|FG003|Treatment Period|Protocol Violation|0|||
124959889|NCT03740919|449479215|FG000|Treatment Period|Withdrawal by Subject|0|||
125215592|NCT00303472|450417448|FG002|Treatment Period|Adverse Event|0|||
125215593|NCT00303472|450417449|FG003|Treatment Period|Adverse Event|0|||
125215594|NCT00303472|450417450|FG004|Treatment Period|Adverse Event|1|||
125215595|NCT00303472|450417451|FG005|Treatment Period|Adverse Event|0|||
125215596|NCT00303472|450417452|FG006|Treatment Period|Adverse Event|0|||
125128468|NCT01263704|450096081|FG000|Overall Study|Patient withdrew consent|2|||
124959890|NCT03740919|449479216|FG001|Treatment Period|Withdrawal by Subject|7|||
124959891|NCT03740919|449479217|FG002|Treatment Period|Withdrawal by Subject|6|||
125215597|NCT00303472|450417446|FG000|Treatment Period|Death|0|||
125215598|NCT00303472|450417447|FG001|Treatment Period|Death|0|||
125215599|NCT00303472|450417448|FG002|Treatment Period|Death|0|||
125215600|NCT00303472|450417449|FG003|Treatment Period|Death|1|||
125215601|NCT00303472|450417450|FG004|Treatment Period|Death|0|||
125215602|NCT00303472|450417451|FG005|Treatment Period|Death|0|||
125215603|NCT00303472|450417452|FG006|Treatment Period|Death|1|||
125215604|NCT00303472|450417446|FG000|Treatment Period|Withdrawal by Subject|0|||
125215605|NCT00303472|450417447|FG001|Treatment Period|Withdrawal by Subject|0|||
125215606|NCT00303472|450417448|FG002|Treatment Period|Withdrawal by Subject|0|||
125215607|NCT00303472|450417449|FG003|Treatment Period|Withdrawal by Subject|1|||
125215608|NCT00303472|450417450|FG004|Treatment Period|Withdrawal by Subject|0|||
125215609|NCT00303472|450417451|FG005|Treatment Period|Withdrawal by Subject|1|||
125215610|NCT00303472|450417452|FG006|Treatment Period|Withdrawal by Subject|0|||
125215611|NCT00303472|450417446|FG000|Treatment Period|Other|0|||
125215612|NCT00303472|450417447|FG001|Treatment Period|Other|0|||
125215613|NCT00303472|450417448|FG002|Treatment Period|Other|0|||
125215614|NCT00303472|450417449|FG003|Treatment Period|Other|0|||
125215615|NCT00303472|450417450|FG004|Treatment Period|Other|1|||
125215616|NCT00303472|450417451|FG005|Treatment Period|Other|0|||
125215617|NCT00303472|450417452|FG006|Treatment Period|Other|1|||
125215618|NCT00303472|450417446|FG000|Treatment Period|Disease Progression (to AML)|0|||
125215619|NCT00303472|450417447|FG001|Treatment Period|Disease Progression (to AML)|0|||
125215620|NCT00303472|450417448|FG002|Treatment Period|Disease Progression (to AML)|0|||
125215621|NCT00303472|450417449|FG003|Treatment Period|Disease Progression (to AML)|0|||
125215622|NCT00303472|450417450|FG004|Treatment Period|Disease Progression (to AML)|1|||
125215623|NCT00303472|450417451|FG005|Treatment Period|Disease Progression (to AML)|0|||
125215624|NCT00303472|450417452|FG006|Treatment Period|Disease Progression (to AML)|0|||
125215625|NCT00303472|450417446|FG000|Treatment Extension (Optional)|Adverse Event|1|||
125215626|NCT00303472|450417447|FG001|Treatment Extension (Optional)|Adverse Event|0|||
125215627|NCT00303472|450417448|FG002|Treatment Extension (Optional)|Adverse Event|1|||
125215628|NCT00303472|450417449|FG003|Treatment Extension (Optional)|Adverse Event|0|||
125215629|NCT00303472|450417450|FG004|Treatment Extension (Optional)|Adverse Event|0|||
125215630|NCT00303472|450417451|FG005|Treatment Extension (Optional)|Adverse Event|0|||
125215631|NCT00303472|450417452|FG006|Treatment Extension (Optional)|Adverse Event|0|||
125215632|NCT00303472|450417446|FG000|Treatment Extension (Optional)|Death|2|||
125215633|NCT00303472|450417447|FG001|Treatment Extension (Optional)|Death|0|||
125215634|NCT00303472|450417448|FG002|Treatment Extension (Optional)|Death|1|||
125215635|NCT00303472|450417449|FG003|Treatment Extension (Optional)|Death|0|||
125215636|NCT00303472|450417450|FG004|Treatment Extension (Optional)|Death|0|||
125215637|NCT00303472|450417451|FG005|Treatment Extension (Optional)|Death|0|||
125215638|NCT00303472|450417452|FG006|Treatment Extension (Optional)|Death|0|||
125215639|NCT00303472|450417446|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
125215640|NCT00303472|450417447|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
125215641|NCT00303472|450417448|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
125215642|NCT00303472|450417449|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
125215643|NCT00303472|450417450|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
125215644|NCT00303472|450417451|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
124959892|NCT03740919|449479218|FG003|Treatment Period|Withdrawal by Subject|2|||
124959893|NCT03740919|449479215|FG000|Treatment Period|Terminated by Sponsor|0|||
124959894|NCT03740919|449479216|FG001|Treatment Period|Terminated by Sponsor|1|||
124959895|NCT03740919|449479217|FG002|Treatment Period|Terminated by Sponsor|0|||
124959896|NCT03740919|449479218|FG003|Treatment Period|Terminated by Sponsor|0|||
124959897|NCT03740919|449479215|FG000|Treatment Period|Issue with Insulin Pump|0|||
124959898|NCT03740919|449479216|FG001|Treatment Period|Issue with Insulin Pump|1|||
124959899|NCT03740919|449479217|FG002|Treatment Period|Issue with Insulin Pump|0|||
124959900|NCT03740919|449479218|FG003|Treatment Period|Issue with Insulin Pump|0|||
124959901|NCT03740919|449479215|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
124959902|NCT03740919|449479216|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
124959903|NCT03740919|449479217|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
124959904|NCT03740919|449479218|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
124959905|NCT03740919|449479215|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
124959906|NCT03740919|449479216|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
124959907|NCT03740919|449479217|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
124959908|NCT03740919|449479218|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
124959909|NCT03740919|449479215|FG000|Treatment Period|Not Completing Diary|0|||
124959910|NCT03740919|449479216|FG001|Treatment Period|Not Completing Diary|0|||
124959911|NCT03740919|449479217|FG002|Treatment Period|Not Completing Diary|1|||
124959912|NCT03740919|449479218|FG003|Treatment Period|Not Completing Diary|0|||
124959913|NCT03740919|449479215|FG000|Treatment Period|Insulin Painful to Participant|0|||
124959914|NCT03740919|449479216|FG001|Treatment Period|Insulin Painful to Participant|0|||
124959915|NCT03740919|449479217|FG002|Treatment Period|Insulin Painful to Participant|1|||
124959916|NCT03740919|449479218|FG003|Treatment Period|Insulin Painful to Participant|0|||
124959917|NCT03640754|449479219|FG000|Overall Study|Withdrawal by Subject|1|||
124959918|NCT03640754|449479220|FG001|Overall Study|Withdrawal by Subject|0|||
124959919|NCT03640754|449479219|FG000|Overall Study|Lost to Follow-up|0|||
124959920|NCT03640754|449479220|FG001|Overall Study|Lost to Follow-up|1|||
124959921|NCT01679613|449479226|FG000|Overall Study|other than stated above|0|||
124959922|NCT01679613|449479227|FG001|Overall Study|other than stated above|1|||
124959923|NCT01679613|449479228|FG002|Overall Study|other than stated above|2|||
124959924|NCT01679613|449479229|FG003|Overall Study|other than stated above|2|||
124959925|NCT04783519|449479230|FG000|Overall Study|Withdrawal by Subject|2|||
124959926|NCT04783519|449479231|FG001|Overall Study|Withdrawal by Subject|7|||
124959927|NCT04783519|449479232|FG002|Overall Study|Withdrawal by Subject|3|||
124959928|NCT04783519|449479230|FG000|Overall Study|Lost to Follow-up|9|||
124959929|NCT04783519|449479231|FG001|Overall Study|Lost to Follow-up|7|||
124959930|NCT04783519|449479232|FG002|Overall Study|Lost to Follow-up|6|||
124959931|NCT00727259|449479233|FG000|Overall Study|Not all questionnaires completed|1055|||
124959932|NCT01021683|449479234|FG000|Overall Study|Lack of Efficacy|12|||
124959933|NCT01021683|449479234|FG000|Overall Study|Recovery of neutrophil count|51|||
124959934|NCT01021683|449479234|FG000|Overall Study|Other|8|||
124959935|NCT00645099|449479235|FG000|Overall Study|Lack of Efficacy|15|||
124959936|NCT00645099|449479236|FG001|Overall Study|Lack of Efficacy|6|||
124959937|NCT00645099|449479235|FG000|Overall Study|Withdrawal by Subject|30|||
125215645|NCT00303472|450417452|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
125215646|NCT00303472|450417446|FG000|Treatment Extension (Optional)|Physician Decision|0|||
125215647|NCT00303472|450417447|FG001|Treatment Extension (Optional)|Physician Decision|4|||
124959938|NCT00645099|449479236|FG001|Overall Study|Withdrawal by Subject|22|||
124959939|NCT00645099|449479235|FG000|Overall Study|Lost to Follow-up|6|||
124959940|NCT00645099|449479236|FG001|Overall Study|Lost to Follow-up|4|||
124959941|NCT00645099|449479235|FG000|Overall Study|Adverse Event|11|||
124959942|NCT00645099|449479236|FG001|Overall Study|Adverse Event|5|||
124959943|NCT00645099|449479235|FG000|Overall Study|Other|9|||
124959944|NCT00645099|449479236|FG001|Overall Study|Other|5|||
124959945|NCT01201915|449479237|FG000|Overall Study|Adverse Event|2|||
124959946|NCT01201915|449479238|FG001|Overall Study|Adverse Event|1|||
124959947|NCT01201915|449479239|FG002|Overall Study|Adverse Event|1|||
124959948|NCT01201915|449479237|FG000|Overall Study|Lost to Follow-up|0|||
124959949|NCT01201915|449479238|FG001|Overall Study|Lost to Follow-up|4|||
124959950|NCT01201915|449479239|FG002|Overall Study|Lost to Follow-up|0|||
125215648|NCT00303472|450417448|FG002|Treatment Extension (Optional)|Physician Decision|2|||
125215649|NCT00303472|450417449|FG003|Treatment Extension (Optional)|Physician Decision|3|||
125215650|NCT00303472|450417450|FG004|Treatment Extension (Optional)|Physician Decision|2|||
125215651|NCT00303472|450417451|FG005|Treatment Extension (Optional)|Physician Decision|0|||
125215652|NCT00303472|450417452|FG006|Treatment Extension (Optional)|Physician Decision|0|||
124959951|NCT01201915|449479237|FG000|Overall Study|Physician Decision|3|||
124959952|NCT01201915|449479238|FG001|Overall Study|Physician Decision|0|||
124959953|NCT01201915|449479239|FG002|Overall Study|Physician Decision|0|||
124959954|NCT01201915|449479237|FG000|Overall Study|Subject Decision|3|||
124959955|NCT01201915|449479238|FG001|Overall Study|Subject Decision|3|||
124959956|NCT01201915|449479239|FG002|Overall Study|Subject Decision|5|||
124959957|NCT01201915|449479237|FG000|Overall Study|Target Lesion Progression|0|||
124959958|NCT01201915|449479238|FG001|Overall Study|Target Lesion Progression|3|||
124959959|NCT01201915|449479239|FG002|Overall Study|Target Lesion Progression|0|||
124959960|NCT02154516|449479240|FG000|Overall Study|Withdrawal by Subject|0|||
124959961|NCT02154516|449479241|FG001|Overall Study|Withdrawal by Subject|1|||
124959962|NCT02154516|449479240|FG000|Overall Study|Lost to Follow-up|1|||
124959963|NCT02154516|449479241|FG001|Overall Study|Lost to Follow-up|0|||
124959964|NCT02154516|449479240|FG000|Overall Study|Removal/revision of device|1|||
124959965|NCT02154516|449479241|FG001|Overall Study|Removal/revision of device|0|||
125031248|NCT00896532|449735101|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125215653|NCT00303472|450417446|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
125215654|NCT00303472|450417447|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
125215655|NCT00303472|450417448|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
125215656|NCT00303472|450417449|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
125215657|NCT00303472|450417450|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
125215658|NCT00303472|450417451|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
125215659|NCT00303472|450417452|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
125215660|NCT00303472|450417446|FG000|Treatment Extension (Optional)|Other|0|||
125215661|NCT00303472|450417447|FG001|Treatment Extension (Optional)|Other|2|||
125215662|NCT00303472|450417448|FG002|Treatment Extension (Optional)|Other|4|||
125215663|NCT00303472|450417449|FG003|Treatment Extension (Optional)|Other|2|||
125215664|NCT00303472|450417450|FG004|Treatment Extension (Optional)|Other|1|||
125215665|NCT00303472|450417451|FG005|Treatment Extension (Optional)|Other|0|||
125215666|NCT00303472|450417452|FG006|Treatment Extension (Optional)|Other|0|||
125215667|NCT00303472|450417446|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
125215668|NCT00303472|450417447|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
125215669|NCT00303472|450417448|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
125215670|NCT00303472|450417449|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
125215671|NCT00303472|450417450|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
125215672|NCT00303472|450417451|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
125215673|NCT00303472|450417452|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
125215674|NCT02081001|450417453|FG000|Overall Study|Adverse Event|0|||
125215675|NCT02081001|450417454|FG001|Overall Study|Adverse Event|0|||
125215676|NCT02081001|450417455|FG002|Overall Study|Adverse Event|0|||
125215677|NCT02081001|450417456|FG003|Overall Study|Adverse Event|0|||
125215678|NCT02081001|450417457|FG004|Overall Study|Adverse Event|1|||
125215679|NCT02081001|450417458|FG005|Overall Study|Adverse Event|0|||
125215680|NCT02081001|450417459|FG006|Overall Study|Adverse Event|0|||
125215681|NCT02081001|450417460|FG007|Overall Study|Adverse Event|0|||
125215682|NCT02081001|450417461|FG008|Overall Study|Adverse Event|0|||
125215683|NCT02081001|450417462|FG009|Overall Study|Adverse Event|0|||
125215684|NCT02081001|450417463|FG010|Overall Study|Adverse Event|0|||
125215685|NCT02081001|450417464|FG011|Overall Study|Adverse Event|0|||
125215686|NCT02347072|450417467|FG000|Overall Study|Adverse Event|2|||
124959966|NCT02154516|449479240|FG000|Overall Study|Death|2|||
124959967|NCT02154516|449479241|FG001|Overall Study|Death|1|||
124959968|NCT03406507|449479242|FG000|Extension Period|Lack of Efficacy|0|||
124959969|NCT03406507|449479243|FG001|Extension Period|Lack of Efficacy|1|||
124959970|NCT00663923|449479244|FG000|Overall Study|Lost to Follow-up|2|||
124959971|NCT02965599|449479245|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
124959972|NCT02965599|449479246|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
124959973|NCT00230971|449479247|FG000|Randomization|No study drug administered|3|||
124959974|NCT00230971|449479248|FG001|Randomization|No study drug administered|3|||
124959975|NCT00230971|449479247|FG000|Baseline Participants|Lost to Follow-up|5|||
124959976|NCT00230971|449479248|FG001|Baseline Participants|Lost to Follow-up|12|||
124959977|NCT00230971|449479247|FG000|Baseline Participants|Death|6|||
124959978|NCT00230971|449479248|FG001|Baseline Participants|Death|5|||
124959979|NCT00230971|449479247|FG000|Baseline Participants|Withdrawal by Subject|7|||
124959980|NCT00230971|449479248|FG001|Baseline Participants|Withdrawal by Subject|1|||
124959981|NCT00230971|449479247|FG000|Baseline Participants|Adverse Event|1|||
124959982|NCT00230971|449479248|FG001|Baseline Participants|Adverse Event|0|||
124959983|NCT00230971|449479247|FG000|Baseline Participants|No bacteria observed|1|||
124959984|NCT00230971|449479248|FG001|Baseline Participants|No bacteria observed|0|||
124959985|NCT00230971|449479247|FG000|Baseline Participants|Failure to return|1|||
124959986|NCT00230971|449479248|FG001|Baseline Participants|Failure to return|1|||
124959987|NCT00230971|449479247|FG000|Baseline Participants|Reintervention|1|||
124959988|NCT00230971|449479248|FG001|Baseline Participants|Reintervention|0|||
124959989|NCT01960348|449480358|FG000|Overall Study|Adverse event, not serious|2|||
124959990|NCT01960348|449480359|FG001|Overall Study|Adverse event, not serious|2|||
124959991|NCT01960348|449480358|FG000|Overall Study|Adverse event, serious fatal|6|||
124959992|NCT01960348|449480359|FG001|Overall Study|Adverse event, serious fatal|5|||
124959993|NCT01960348|449480358|FG000|Overall Study|Adverse event, serious non-fatal|0|||
124959994|NCT01960348|449480359|FG001|Overall Study|Adverse event, serious non-fatal|3|||
124959995|NCT01960348|449480358|FG000|Overall Study|Withdrawal by Subject|1|||
124959996|NCT01960348|449480359|FG001|Overall Study|Withdrawal by Subject|11|||
124959997|NCT01960348|449480358|FG000|Overall Study|Physician Decision|0|||
124959998|NCT01960348|449480359|FG001|Overall Study|Physician Decision|1|||
124959999|NCT01960348|449480358|FG000|Overall Study|Protocol Violation|1|||
124960000|NCT01960348|449480359|FG001|Overall Study|Protocol Violation|0|||
124960001|NCT01580995|449480360|FG000|Overall Study|Lost to Follow-up|2|||
124960002|NCT01580995|449480361|FG001|Overall Study|Lost to Follow-up|2|||
124960003|NCT05109117|449480362|FG000|Overall Study|Lost to Follow-up|1|||
124960004|NCT05109117|449480362|FG000|Overall Study|Discontinued for non-compliance|1|||
124960005|NCT03371485|449480368|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
124960006|NCT03371485|449480368|FG000|2-year Follow-up|Death|5|||
124960007|NCT02204319|449480369|FG000|Overall Study|Pregnancy|1|||
124960008|NCT02204319|449480369|FG000|Overall Study|Withdrawal by Subject|2|||
124960009|NCT02171130|449480378|FG000|Overall Study|Death|1|||
124960010|NCT02171130|449480378|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
124960011|NCT02171130|449480378|FG000|Overall Study|Discontinued; Site Termination|5|||
124960012|NCT02171130|449480378|FG000|Overall Study|Withdrawal by Subject|3|||
124960013|NCT02171130|449480378|FG000|Overall Study|Physician Decision|1|||
124960014|NCT02171130|449480378|FG000|Overall Study|Lost to Follow-up|1|||
124960015|NCT02171130|449480378|FG000|Overall Study|Met Exclusion Criteria|1|||
124960016|NCT04531813|449480379|FG000|Overall Study|Protocol Violation|1|||
124960017|NCT04531813|449480379|FG000|Overall Study|Withdrawal by Subject|1|||
124960018|NCT02853305|449480380|FG000|Overall Study|Death|287|||
124960019|NCT02853305|449480381|FG001|Overall Study|Death|249|||
124960020|NCT02853305|449480382|FG002|Overall Study|Death|300|||
124960021|NCT02853305|449480380|FG000|Overall Study|Withdrawal by Subject|2|||
124960022|NCT02853305|449480381|FG001|Overall Study|Withdrawal by Subject|8|||
124960023|NCT02853305|449480382|FG002|Overall Study|Withdrawal by Subject|3|||
124960024|NCT02853305|449480380|FG000|Overall Study|Transferred to Extension Study|46|||
124960025|NCT02853305|449480381|FG001|Overall Study|Transferred to Extension Study|30|||
124960026|NCT02853305|449480382|FG002|Overall Study|Transferred to Extension Study|25|||
124960027|NCT02853305|449480380|FG000|Overall Study|Did Not Continue on Extension Study|16|||
124960028|NCT02853305|449480381|FG001|Overall Study|Did Not Continue on Extension Study|20|||
124960029|NCT02853305|449480382|FG002|Overall Study|Did Not Continue on Extension Study|24|||
124960030|NCT02381652|449480387|FG000|Overall Study|Withdrawal by Subject|0|||
124960031|NCT02381652|449480388|FG001|Overall Study|Withdrawal by Subject|0|||
124960032|NCT02381652|449480389|FG002|Overall Study|Withdrawal by Subject|1|||
124960033|NCT01340300|449480390|FG000|Overall Study|Lost to Follow-up|3|||
124960034|NCT01340300|449480391|FG001|Overall Study|Lost to Follow-up|0|||
124960035|NCT01340300|449480392|FG002|Overall Study|Lost to Follow-up|5|||
124960036|NCT01340300|449480393|FG003|Overall Study|Lost to Follow-up|10|||
124960037|NCT01340300|449480390|FG000|Overall Study|Withdrawal by Subject|5|||
124960038|NCT01340300|449480391|FG001|Overall Study|Withdrawal by Subject|6|||
124960039|NCT01340300|449480392|FG002|Overall Study|Withdrawal by Subject|6|||
124960040|NCT01340300|449480393|FG003|Overall Study|Withdrawal by Subject|3|||
124960041|NCT01340300|449480390|FG000|Overall Study|Adverse Event|1|||
124960042|NCT01340300|449480391|FG001|Overall Study|Adverse Event|0|||
124960043|NCT01340300|449480392|FG002|Overall Study|Adverse Event|4|||
124960044|NCT01340300|449480393|FG003|Overall Study|Adverse Event|0|||
124960045|NCT01340300|449480390|FG000|Overall Study|Physician Decision|0|||
124960046|NCT01340300|449480391|FG001|Overall Study|Physician Decision|1|||
124960047|NCT01340300|449480392|FG002|Overall Study|Physician Decision|0|||
124960048|NCT01340300|449480393|FG003|Overall Study|Physician Decision|0|||
124960049|NCT01340300|449480390|FG000|Overall Study|Unrelated sickness|0|||
124960050|NCT01340300|449480391|FG001|Overall Study|Unrelated sickness|2|||
124960051|NCT01340300|449480392|FG002|Overall Study|Unrelated sickness|0|||
124960052|NCT01340300|449480393|FG003|Overall Study|Unrelated sickness|1|||
124960053|NCT03544229|449480394|FG000|Overall Study|Adverse Event|1|||
124960054|NCT03544229|449480395|FG001|Overall Study|Adverse Event|0|||
124960055|NCT03544229|449480396|FG002|Overall Study|Adverse Event|1|||
124960056|NCT03544229|449480397|FG003|Overall Study|Adverse Event|0|||
124960057|NCT03544229|449480394|FG000|Overall Study|Protocol Deviation|0|||
124960058|NCT03544229|449480395|FG001|Overall Study|Protocol Deviation|0|||
124960059|NCT03544229|449480396|FG002|Overall Study|Protocol Deviation|1|||
124960060|NCT03544229|449480397|FG003|Overall Study|Protocol Deviation|0|||
124960061|NCT03544229|449480394|FG000|Overall Study|Lost to Follow-up|3|||
124960062|NCT03544229|449480395|FG001|Overall Study|Lost to Follow-up|0|||
124960063|NCT03544229|449480396|FG002|Overall Study|Lost to Follow-up|0|||
124960064|NCT03544229|449480397|FG003|Overall Study|Lost to Follow-up|2|||
124960065|NCT03544229|449480394|FG000|Overall Study|Voluntary Withdrawal|2|||
124960066|NCT03544229|449480395|FG001|Overall Study|Voluntary Withdrawal|1|||
124960067|NCT03544229|449480396|FG002|Overall Study|Voluntary Withdrawal|3|||
124960068|NCT03544229|449480397|FG003|Overall Study|Voluntary Withdrawal|0|||
124960069|NCT03544229|449480394|FG000|Overall Study|Lack of Efficacy|0|||
124960070|NCT03544229|449480395|FG001|Overall Study|Lack of Efficacy|1|||
124960071|NCT03544229|449480396|FG002|Overall Study|Lack of Efficacy|0|||
124960072|NCT03544229|449480397|FG003|Overall Study|Lack of Efficacy|0|||
124960073|NCT04772313|449480398|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
124960074|NCT04772313|449480398|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
124960075|NCT01836198|449480400|FG000|Part A, Period 2|Protocol Violation|0|||
124960076|NCT01836198|449480401|FG001|Part A, Period 2|Protocol Violation|1|||
124960077|NCT01836198|449480402|FG002|Part A, Period 2|Protocol Violation|0|||
124960078|NCT03187353|449480403|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
124960079|NCT03187353|449480404|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
124960080|NCT03187353|449480403|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
124960081|NCT03187353|449480404|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
124960082|NCT03187353|449480403|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
124960083|NCT03187353|449480404|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
124960084|NCT03187353|449480403|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
124960085|NCT03187353|449480404|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
124960086|NCT03187353|449480403|FG000|Washout (2 Weeks)|Adverse Event|2|||
124960087|NCT03187353|449480404|FG001|Washout (2 Weeks)|Adverse Event|0|||
124960088|NCT03187353|449480403|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
124960089|NCT03187353|449480404|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
124960090|NCT02215954|449480405|FG000|Overall Study|Adverse Event|0|||
124960091|NCT02215954|449480406|FG001|Overall Study|Adverse Event|0|||
124960092|NCT02215954|449480407|FG002|Overall Study|Adverse Event|1|||
124960093|NCT02215954|449480405|FG000|Overall Study|Withdrawal by Subject|0|||
124960094|NCT02215954|449480406|FG001|Overall Study|Withdrawal by Subject|0|||
124960095|NCT02215954|449480407|FG002|Overall Study|Withdrawal by Subject|2|||
124960096|NCT02215954|449480405|FG000|Overall Study|Not exposed|1|||
124960097|NCT02215954|449480406|FG001|Overall Study|Not exposed|1|||
124960098|NCT02215954|449480407|FG002|Overall Study|Not exposed|3|||
124960099|NCT02460562|449480409|FG000|Overall Study|Lost to Follow-up|15|||
124960100|NCT02460562|449480410|FG001|Overall Study|Lost to Follow-up|16|||
124960101|NCT03303521|449480411|FG000|Overall Study|Withdrawal by Subject|2|||
124960102|NCT03303521|449480412|FG001|Overall Study|Withdrawal by Subject|0|||
124960103|NCT03303521|449480411|FG000|Overall Study|Death|1|||
124960104|NCT03303521|449480412|FG001|Overall Study|Death|0|||
124960105|NCT03303521|449480411|FG000|Overall Study|Kidney transplantation|0|||
124960106|NCT03303521|449480412|FG001|Overall Study|Kidney transplantation|1|||
124960107|NCT03303521|449480411|FG000|Overall Study|Investigational product discontinuation|0|||
124960108|NCT03303521|449480412|FG001|Overall Study|Investigational product discontinuation|1|||
124960109|NCT03303521|449480411|FG000|Overall Study|Transferred to non-study dialysis center|1|||
124960110|NCT03303521|449480412|FG001|Overall Study|Transferred to non-study dialysis center|0|||
124960111|NCT03303521|449480411|FG000|Overall Study|Non-comliance to study protocol|0|||
124960112|NCT03303521|449480412|FG001|Overall Study|Non-comliance to study protocol|1|||
124960113|NCT03303521|449480411|FG000|Overall Study|Adverse Event|1|||
124960114|NCT03303521|449480412|FG001|Overall Study|Adverse Event|0|||
124960115|NCT01654289|449480413|FG000|Overall Study|Withdrawal by Subject|10|||
124960116|NCT01654289|449480414|FG001|Overall Study|Withdrawal by Subject|8|||
124960117|NCT01654289|449480415|FG002|Overall Study|Withdrawal by Subject|5|||
124960118|NCT01654289|449480413|FG000|Overall Study|Withdrew from intervention only|17|||
124960119|NCT01654289|449480414|FG001|Overall Study|Withdrew from intervention only|20|||
124960120|NCT01654289|449480415|FG002|Overall Study|Withdrew from intervention only|0|||
124960121|NCT02642159|449480416|FG000|Overall Study|Randomized but not treated|1|||
124960122|NCT02642159|449480417|FG001|Overall Study|Randomized but not treated|0|||
124960123|NCT02642159|449480416|FG000|Overall Study|Adverse Event|10|||
125215687|NCT02347072|450417467|FG000|Overall Study|Withdrawal by Subject|6|||
125215688|NCT02347072|450417467|FG000|Overall Study|Physician Decision|1|||
124960124|NCT02642159|449480417|FG001|Overall Study|Adverse Event|4|||
124960125|NCT02642159|449480416|FG000|Overall Study|Withdrawal by Subject|9|||
124960126|NCT02642159|449480417|FG001|Overall Study|Withdrawal by Subject|1|||
124960127|NCT02642159|449480416|FG000|Overall Study|Poor compliance to study protocol|1|||
124960128|NCT02642159|449480417|FG001|Overall Study|Poor compliance to study protocol|0|||
124960129|NCT02642159|449480416|FG000|Overall Study|Other than specified above|10|||
124960130|NCT02642159|449480417|FG001|Overall Study|Other than specified above|3|||
124960131|NCT04194541|449480418|FG000|Day 1 Through 13|Lost to Follow-up|3|||
124960132|NCT04194541|449480418|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
124960133|NCT04194541|449480418|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
124960134|NCT03746483|449480419|FG000|Overall Study|Adverse Event|0|||
124960135|NCT03746483|449480420|FG001|Overall Study|Adverse Event|1|||
125215689|NCT02347072|450417467|FG000|Overall Study|Lost to Follow-up|2|||
124960136|NCT03746483|449480419|FG000|Overall Study|Lack of Efficacy|3|||
124960137|NCT03746483|449480420|FG001|Overall Study|Lack of Efficacy|2|||
124960138|NCT03746483|449480419|FG000|Overall Study|Lost to Follow-up|1|||
124960139|NCT03746483|449480420|FG001|Overall Study|Lost to Follow-up|0|||
124960140|NCT03746483|449480419|FG000|Overall Study|Protocol Violation|2|||
124960141|NCT03746483|449480420|FG001|Overall Study|Protocol Violation|0|||
124960142|NCT00187135|449480421|FG000|Visit One|Withdrawal by Subject|1|||
124960143|NCT00187135|449480422|FG001|Visit One|Withdrawal by Subject|0|||
124960144|NCT00187135|449480423|FG002|Visit One|Withdrawal by Subject|0|||
124960145|NCT00187135|449480424|FG003|Visit One|Withdrawal by Subject|0|||
124960146|NCT00187135|449480425|FG004|Visit One|Withdrawal by Subject|0|||
124960147|NCT00187135|449480426|FG005|Visit One|Withdrawal by Subject|1|||
124960148|NCT00187135|449480421|FG000|Visit One|Physician Decision|3|||
124960149|NCT00187135|449480422|FG001|Visit One|Physician Decision|1|||
124960150|NCT00187135|449480423|FG002|Visit One|Physician Decision|0|||
124960151|NCT00187135|449480424|FG003|Visit One|Physician Decision|0|||
124960152|NCT00187135|449480425|FG004|Visit One|Physician Decision|0|||
124960153|NCT00187135|449480426|FG005|Visit One|Physician Decision|1|||
124960154|NCT00187135|449480421|FG000|Visit Two|Death|0|||
124960155|NCT00187135|449480422|FG001|Visit Two|Death|0|||
124960156|NCT00187135|449480423|FG002|Visit Two|Death|0|||
124960157|NCT00187135|449480424|FG003|Visit Two|Death|1|||
124960158|NCT00187135|449480425|FG004|Visit Two|Death|0|||
124960159|NCT00187135|449480426|FG005|Visit Two|Death|1|||
124960160|NCT00187135|449480421|FG000|Visit Two|Physician Decision|1|||
125215690|NCT02347072|450417467|FG000|Overall Study|Protocol Violation|1|||
125215691|NCT02347072|450417467|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
125215692|NCT03124537|450417469|FG000|Overall Study|Lost to Follow-up|3|||
125215693|NCT03124537|450417470|FG001|Overall Study|Lost to Follow-up|5|||
125215694|NCT03124537|450417469|FG000|Overall Study|App Crash, Incomplete Data|7|||
125215695|NCT03124537|450417470|FG001|Overall Study|App Crash, Incomplete Data|8|||
125215696|NCT03681184|450417473|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
125215697|NCT03681184|450417474|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
125215698|NCT00396383|450417477|FG000|Overall Study|Death|2|||
125215699|NCT00396383|450417477|FG000|Overall Study|Lost to Follow-up|1|||
124960161|NCT00187135|449480422|FG001|Visit Two|Physician Decision|0|||
124960162|NCT00187135|449480423|FG002|Visit Two|Physician Decision|0|||
124960163|NCT00187135|449480424|FG003|Visit Two|Physician Decision|0|||
124960164|NCT00187135|449480425|FG004|Visit Two|Physician Decision|0|||
124960165|NCT00187135|449480426|FG005|Visit Two|Physician Decision|0|||
124960166|NCT00187135|449480421|FG000|Visit Two|Withdrawal by Subject|1|||
124960167|NCT00187135|449480422|FG001|Visit Two|Withdrawal by Subject|1|||
124960168|NCT00187135|449480423|FG002|Visit Two|Withdrawal by Subject|1|||
124960169|NCT00187135|449480424|FG003|Visit Two|Withdrawal by Subject|0|||
124960170|NCT00187135|449480425|FG004|Visit Two|Withdrawal by Subject|1|||
124960171|NCT00187135|449480426|FG005|Visit Two|Withdrawal by Subject|1|||
124960172|NCT00187135|449480421|FG000|Visit Two|Study Discontinued|3|||
124960173|NCT00187135|449480422|FG001|Visit Two|Study Discontinued|2|||
124960174|NCT00187135|449480423|FG002|Visit Two|Study Discontinued|1|||
124960175|NCT00187135|449480424|FG003|Visit Two|Study Discontinued|7|||
124960176|NCT00187135|449480425|FG004|Visit Two|Study Discontinued|5|||
124960177|NCT00187135|449480426|FG005|Visit Two|Study Discontinued|6|||
124960178|NCT00187135|449480421|FG000|Visit Three|Death|0|||
124960179|NCT00187135|449480422|FG001|Visit Three|Death|0|||
124960180|NCT00187135|449480423|FG002|Visit Three|Death|1|||
124960181|NCT00187135|449480424|FG003|Visit Three|Death|0|||
124960182|NCT00187135|449480425|FG004|Visit Three|Death|1|||
124960183|NCT00187135|449480426|FG005|Visit Three|Death|0|||
124960184|NCT00187135|449480421|FG000|Visit Three|Withdrawal by Subject|0|||
124960185|NCT00187135|449480422|FG001|Visit Three|Withdrawal by Subject|1|||
124960186|NCT00187135|449480423|FG002|Visit Three|Withdrawal by Subject|1|||
124960187|NCT00187135|449480424|FG003|Visit Three|Withdrawal by Subject|2|||
124960188|NCT00187135|449480425|FG004|Visit Three|Withdrawal by Subject|0|||
124960189|NCT00187135|449480426|FG005|Visit Three|Withdrawal by Subject|0|||
124960190|NCT00187135|449480421|FG000|Visit Three|Study Discontinued|7|||
124960191|NCT00187135|449480422|FG001|Visit Three|Study Discontinued|6|||
124960192|NCT00187135|449480423|FG002|Visit Three|Study Discontinued|7|||
124960193|NCT00187135|449480424|FG003|Visit Three|Study Discontinued|7|||
124960194|NCT00187135|449480425|FG004|Visit Three|Study Discontinued|7|||
124960195|NCT00187135|449480426|FG005|Visit Three|Study Discontinued|6|||
124960196|NCT01924806|449480427|FG000|Overall Study|Physician Decision|2|||
124960197|NCT01924806|449480428|FG001|Overall Study|Physician Decision|1|||
124960198|NCT01954771|449480429|FG000|Overall Study|Missing HbA1c of end-point|1|||
124960199|NCT01954771|449480430|FG001|Overall Study|Missing HbA1c of end-point|1|||
124960200|NCT01954771|449480431|FG002|Overall Study|Missing HbA1c of end-point|0|||
124960201|NCT01954771|449480429|FG000|Overall Study|Missing CGMS of end-point|1|||
124960202|NCT01954771|449480430|FG001|Overall Study|Missing CGMS of end-point|1|||
125215700|NCT04318132|450417480|FG000|Overall Study|Protocol Violation|0|||
125215701|NCT04318132|450417481|FG001|Overall Study|Protocol Violation|0|||
125215702|NCT04318132|450417482|FG002|Overall Study|Protocol Violation|3|||
125215703|NCT04318132|450417483|FG003|Overall Study|Protocol Violation|0|||
125215704|NCT00585325|450417484|FG000|Overall Study|Withdrawal by Subject|1|||
125215705|NCT00585325|450417485|FG001|Overall Study|Withdrawal by Subject|1|||
125215706|NCT04424914|450417486|FG000|Overall Study|Other|0|||
125215707|NCT04424914|450417487|FG001|Overall Study|Other|0|||
125215708|NCT04424914|450417488|FG002|Overall Study|Other|28|||
124960203|NCT01954771|449480431|FG002|Overall Study|Missing CGMS of end-point|0|||
124960204|NCT01954771|449480429|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
124960205|NCT01954771|449480430|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
124960206|NCT01954771|449480431|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
124960207|NCT03635775|449480434|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
124960208|NCT03635775|449480435|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
124960209|NCT03635775|449480436|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
124960210|NCT03635775|449480437|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
124960211|NCT00297778|449480440|FG000|Overall Study|Adverse Event|16|||
124960212|NCT00297778|449480441|FG001|Overall Study|Adverse Event|10|||
124960213|NCT00297778|449480440|FG000|Overall Study|Withdrawal by Subject|1|||
124960214|NCT00297778|449480441|FG001|Overall Study|Withdrawal by Subject|5|||
124960215|NCT00297778|449480440|FG000|Overall Study|Lack of Efficacy|2|||
124960216|NCT00297778|449480441|FG001|Overall Study|Lack of Efficacy|1|||
124960217|NCT00297778|449480440|FG000|Overall Study|Non-compliant with trial protocol|0|||
124960218|NCT00297778|449480441|FG001|Overall Study|Non-compliant with trial protocol|3|||
124960219|NCT00297778|449480440|FG000|Overall Study|Other|0|||
124960220|NCT00297778|449480441|FG001|Overall Study|Other|1|||
124960221|NCT00679549|449480442|FG000|Overall Study|dropout|2|||
124960222|NCT00679549|449480443|FG001|Overall Study|dropout|4|||
124960223|NCT00679549|449480442|FG000|Overall Study|missing outcome echocardiograms|4|||
124960224|NCT00679549|449480443|FG001|Overall Study|missing outcome echocardiograms|5|||
124960225|NCT03280108|449480444|FG000|Overall Study|Lost to Follow-up|2|||
124960226|NCT03280108|449480445|FG001|Overall Study|Lost to Follow-up|0|||
124960227|NCT02996097|449480446|FG000|Overall Study|Lost to Follow-up|11|||
124960228|NCT02996097|449480447|FG001|Overall Study|Lost to Follow-up|11|||
124960229|NCT02201771|449480448|FG000|Overall Study|Death|3|||
124960230|NCT02201771|449480449|FG001|Overall Study|Death|2|||
124960231|NCT02201771|449480450|FG002|Overall Study|Death|0|||
124960232|NCT02201771|449480448|FG000|Overall Study|Protocol Violation|10|||
124960233|NCT02201771|449480449|FG001|Overall Study|Protocol Violation|8|||
124960234|NCT02201771|449480450|FG002|Overall Study|Protocol Violation|10|||
124960235|NCT01820637|449480451|FG000|Overall Study|Death|2|||
124960236|NCT01820637|449480451|FG000|Overall Study|Withdrawal by Subject|1|||
124960237|NCT00264498|449480452|FG000|Randomized Treatment|Death|0|||
124960238|NCT00264498|449480453|FG001|Randomized Treatment|Death|3|||
124960239|NCT00264498|449480452|FG000|Randomized Treatment|Withdrawal by Subject|0|||
124960240|NCT00264498|449480453|FG001|Randomized Treatment|Withdrawal by Subject|1|||
124960241|NCT00264498|449480452|FG000|Randomized Treatment|Objective disease Progression|13|||
124960242|NCT00264498|449480453|FG001|Randomized Treatment|Objective disease Progression|14|||
124960243|NCT00264498|449480452|FG000|Randomized Treatment|Physician Decision|1|||
124960244|NCT00264498|449480453|FG001|Randomized Treatment|Physician Decision|0|||
124960245|NCT00264498|449480452|FG000|Randomized Treatment|Incorrectly randomized|1|||
125128469|NCT01263704|450096081|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
125128470|NCT01263704|450096081|FG000|Overall Study|Lost to Follow-up|1|||
124960246|NCT00264498|449480453|FG001|Randomized Treatment|Incorrectly randomized|0|||
124960247|NCT00264498|449480452|FG000|Randomized Treatment|Study Closure|1|||
124960248|NCT00264498|449480453|FG001|Randomized Treatment|Study Closure|0|||
124960249|NCT00264498|449480452|FG000|Randomized Treatment|Protocol Violation|1|||
124960250|NCT00264498|449480453|FG001|Randomized Treatment|Protocol Violation|0|||
124960251|NCT00264498|449480452|FG000|Crossover Treatment|Death|1|||
124960252|NCT00264498|449480453|FG001|Crossover Treatment|Death|3|||
124960253|NCT00264498|449480452|FG000|Crossover Treatment|Objective disease progression|4|||
124960254|NCT00264498|449480453|FG001|Crossover Treatment|Objective disease progression|5|||
124960255|NCT00264498|449480452|FG000|Crossover Treatment|Study closure|0|||
124960256|NCT00264498|449480453|FG001|Crossover Treatment|Study closure|1|||
124960257|NCT00264498|449480452|FG000|Crossover Treatment|Withdrawal by Subject|1|||
124960258|NCT00264498|449480453|FG001|Crossover Treatment|Withdrawal by Subject|0|||
124960259|NCT00583115|449480454|FG000|Overall Study|Death|1|||
124960260|NCT02205476|449480455|FG000|Overall Study|Study termination by Sponsor|7|||
125031249|NCT00896532|449735102|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124960261|NCT02205476|449480456|FG001|Overall Study|Study termination by Sponsor|3|||
124960262|NCT02109107|449480457|FG000|Overall Study|Lost to Follow-up|2|||
124960263|NCT00607789|449480463|FG000|Overall Study|Adverse Event|3|||
124960264|NCT00607789|449480464|FG001|Overall Study|Adverse Event|0|||
124960265|NCT00607789|449480463|FG000|Overall Study|Lack of Efficacy|0|||
124960266|NCT00607789|449480464|FG001|Overall Study|Lack of Efficacy|1|||
124960267|NCT00607789|449480463|FG000|Overall Study|Inadequate adherence|3|||
124960268|NCT00607789|449480464|FG001|Overall Study|Inadequate adherence|0|||
124960269|NCT00607789|449480463|FG000|Overall Study|Lost to Follow-up|0|||
124960270|NCT00607789|449480464|FG001|Overall Study|Lost to Follow-up|5|||
125128471|NCT01263704|450096081|FG000|Overall Study|Colon metastases|1|||
124960271|NCT00607789|449480463|FG000|Overall Study|Withdrawal by Subject|1|||
124960272|NCT00607789|449480464|FG001|Overall Study|Withdrawal by Subject|0|||
124960273|NCT01919398|449480465|FG000|Overall Study|Progressive Disease|0|||
124960274|NCT01919398|449480466|FG001|Overall Study|Progressive Disease|0|||
124960275|NCT01919398|449480467|FG002|Overall Study|Progressive Disease|4|||
124960276|NCT02016690|449480469|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
124960277|NCT02016690|449480469|FG000|Overall Study|Excluded from SAS: Duplication|2|||
124960278|NCT02016690|449480469|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
124960279|NCT02016690|449480469|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
124960280|NCT02016690|449480469|FG000|Overall Study|Did not meet inclusion criteria|13|||
124960281|NCT02016690|449480469|FG000|Overall Study|Hospitalized for RSV at study start|3|||
125128472|NCT01263704|450096081|FG000|Overall Study|Principal Investigator (PI) decision|1|||
124960282|NCT02865135|449480474|FG000|Overall Study|Death|0|||
124960283|NCT02865135|449480475|FG001|Overall Study|Death|1|||
124960284|NCT02865135|449480476|FG002|Overall Study|Death|0|||
124960285|NCT02865135|449480474|FG000|Overall Study|Progression|6|||
124960286|NCT02865135|449480475|FG001|Overall Study|Progression|2|||
124960287|NCT02865135|449480476|FG002|Overall Study|Progression|2|||
124960288|NCT01196741|449480479|FG000|Overall Study|Disease progression|34|||
124960289|NCT01196741|449480480|FG001|Overall Study|Disease progression|14|||
124960290|NCT01196741|449480479|FG000|Overall Study|Adverse Event|10|||
124960291|NCT01196741|449480480|FG001|Overall Study|Adverse Event|6|||
124960292|NCT01196741|449480479|FG000|Overall Study|Serious Adverse Event|3|||
124960293|NCT01196741|449480480|FG001|Overall Study|Serious Adverse Event|1|||
124960294|NCT01196741|449480479|FG000|Overall Study|Dose limiting Adverse Event|2|||
124960295|NCT01196741|449480480|FG001|Overall Study|Dose limiting Adverse Event|1|||
124960296|NCT01196741|449480479|FG000|Overall Study|Withdrawal by Subject|3|||
124960297|NCT01196741|449480480|FG001|Overall Study|Withdrawal by Subject|0|||
124960298|NCT01196741|449480479|FG000|Overall Study|Other reason|3|||
124960299|NCT01196741|449480480|FG001|Overall Study|Other reason|3|||
124960300|NCT01196741|449480479|FG000|Overall Study|Other|3|||
124960301|NCT01196741|449480480|FG001|Overall Study|Other|2|||
124960302|NCT01196741|449480479|FG000|Overall Study|Protocol Violation|2|||
124960303|NCT01196741|449480480|FG001|Overall Study|Protocol Violation|1|||
124960304|NCT02273180|449480481|FG000|Overall Study|Adverse Event|2|||
124960305|NCT02273180|449480482|FG001|Overall Study|Adverse Event|2|||
124960306|NCT02273180|449480481|FG000|Overall Study|Lack of Efficacy|1|||
124960307|NCT02273180|449480482|FG001|Overall Study|Lack of Efficacy|0|||
124960308|NCT02273180|449480481|FG000|Overall Study|Protocol Violation|1|||
124960309|NCT02273180|449480482|FG001|Overall Study|Protocol Violation|7|||
124960310|NCT02273180|449480481|FG000|Overall Study|Randomized but not treated|1|||
124960311|NCT02273180|449480482|FG001|Overall Study|Randomized but not treated|0|||
124960312|NCT02273180|449480481|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
124960313|NCT02273180|449480482|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
124960314|NCT02273180|449480481|FG000|Overall Study|Other than specified above|21|||
124960315|NCT02273180|449480482|FG001|Overall Study|Other than specified above|10|||
124960316|NCT00509925|449480483|FG000|Overall Study|Personal reasons|0|||
124960317|NCT00509925|449480484|FG001|Overall Study|Personal reasons|1|||
124960318|NCT03302559|449480487|FG000|Overall Study|Adverse Event|2|||
124960319|NCT03302559|449480487|FG000|Overall Study|Lost to Follow-up|1|||
124960320|NCT03302559|449480487|FG000|Overall Study|Withdrew Consent|3|||
124960321|NCT00598871|449482425|FG000|Overall Study|Adverse Event|0|||
124960322|NCT00598871|449482426|FG001|Overall Study|Adverse Event|1|||
124960323|NCT02151643|449482431|FG000|Overall Study|Adverse Event|2|||
124960324|NCT02151643|449482432|FG001|Overall Study|Adverse Event|0|||
124960325|NCT02151643|449482433|FG002|Overall Study|Adverse Event|1|||
124960326|NCT02151643|449482434|FG003|Overall Study|Adverse Event|4|||
124960327|NCT02151643|449482435|FG004|Overall Study|Adverse Event|0|||
124960328|NCT02151643|449482431|FG000|Overall Study|Withdrawal by Subject|0|||
124960329|NCT02151643|449482432|FG001|Overall Study|Withdrawal by Subject|1|||
124960330|NCT02151643|449482433|FG002|Overall Study|Withdrawal by Subject|1|||
124960331|NCT02151643|449482434|FG003|Overall Study|Withdrawal by Subject|1|||
124960332|NCT02151643|449482435|FG004|Overall Study|Withdrawal by Subject|1|||
124960333|NCT02151643|449482431|FG000|Overall Study|Hyperphosphataemia|1|||
124960334|NCT02151643|449482432|FG001|Overall Study|Hyperphosphataemia|0|||
124960335|NCT02151643|449482433|FG002|Overall Study|Hyperphosphataemia|0|||
124960336|NCT02151643|449482434|FG003|Overall Study|Hyperphosphataemia|0|||
124960337|NCT02151643|449482435|FG004|Overall Study|Hyperphosphataemia|1|||
125128473|NCT03020615|450096082|FG000|Overall Study|Physician Decision|3|||
124960338|NCT02151643|449482431|FG000|Overall Study|High Ferritin levels|3|||
124960339|NCT02151643|449482432|FG001|Overall Study|High Ferritin levels|3|||
124960340|NCT02151643|449482433|FG002|Overall Study|High Ferritin levels|2|||
124960341|NCT02151643|449482434|FG003|Overall Study|High Ferritin levels|2|||
124960342|NCT02151643|449482435|FG004|Overall Study|High Ferritin levels|1|||
124960343|NCT01084239|449482440|FG000|28-Day Follow-up|Lost to Follow-up|4|||
124960344|NCT01084239|449482441|FG001|28-Day Follow-up|Lost to Follow-up|9|||
124960345|NCT02396953|449482442|FG000|Overall Study|Withdrawal by Subject|0|||
124960346|NCT02396953|449482443|FG001|Overall Study|Withdrawal by Subject|0|||
124960347|NCT02396953|449482444|FG002|Overall Study|Withdrawal by Subject|1|||
124960348|NCT02396953|449482442|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
124960349|NCT02396953|449482443|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
124960350|NCT02396953|449482444|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
124960351|NCT02396953|449482442|FG000|Overall Study|Personal Reasons|1|||
124960352|NCT02396953|449482443|FG001|Overall Study|Personal Reasons|1|||
124960353|NCT02396953|449482444|FG002|Overall Study|Personal Reasons|0|||
124960354|NCT02679079|449482445|FG000|Overall Study|Adverse Event|2|||
124960355|NCT02679079|449482446|FG001|Overall Study|Adverse Event|0|||
124960356|NCT02679079|449482447|FG002|Overall Study|Adverse Event|2|||
124960357|NCT02679079|449482445|FG000|Overall Study|Protocol Violation|0|||
124960358|NCT02679079|449482446|FG001|Overall Study|Protocol Violation|1|||
124960359|NCT02679079|449482447|FG002|Overall Study|Protocol Violation|0|||
124960360|NCT02679079|449482445|FG000|Overall Study|Withdrawal by Subject|2|||
124960361|NCT02679079|449482446|FG001|Overall Study|Withdrawal by Subject|1|||
124960362|NCT02679079|449482447|FG002|Overall Study|Withdrawal by Subject|0|||
124960363|NCT04150341|449482448|FG000|Overall Study|Physician Decision|0|||
124960364|NCT04150341|449482449|FG001|Overall Study|Physician Decision|0|||
124960365|NCT04150341|449482450|FG002|Overall Study|Physician Decision|1|||
124960366|NCT04150341|449482451|FG003|Overall Study|Physician Decision|0|||
125128474|NCT03020615|450096083|FG001|Overall Study|Physician Decision|1|||
124960367|NCT04150341|449482452|FG004|Overall Study|Physician Decision|0|||
124960368|NCT04150341|449482453|FG005|Overall Study|Physician Decision|0|||
124960369|NCT04150341|449482448|FG000|Overall Study|Adverse Event|0|||
124960370|NCT04150341|449482449|FG001|Overall Study|Adverse Event|0|||
124960371|NCT04150341|449482450|FG002|Overall Study|Adverse Event|0|||
124960372|NCT04150341|449482451|FG003|Overall Study|Adverse Event|0|||
124960373|NCT04150341|449482452|FG004|Overall Study|Adverse Event|1|||
124960374|NCT04150341|449482453|FG005|Overall Study|Adverse Event|0|||
124960375|NCT00833898|449482460|FG000|Overall Study|Withdrawal by Subject|33|||
124960376|NCT00833898|449482461|FG001|Overall Study|Withdrawal by Subject|27|||
124960377|NCT00833898|449482460|FG000|Overall Study|Lost to Follow-up|7|||
124960378|NCT00833898|449482461|FG001|Overall Study|Lost to Follow-up|7|||
124960379|NCT00833898|449482460|FG000|Overall Study|Patient did not receive transplant|0|||
124960380|NCT00833898|449482461|FG001|Overall Study|Patient did not receive transplant|2|||
124960381|NCT00805285|449482462|FG000|Overall Study|Lack of Efficacy|1|||
124960382|NCT00917462|449482463|FG000|Overall Study|Clinical Deterioration|1|||
124960383|NCT01402063|449482464|FG000|Overall Study|Withdrawal by Subject|3|||
124960384|NCT01402063|449482465|FG001|Overall Study|Withdrawal by Subject|3|||
124960385|NCT02110225|449482469|FG000|Overall Study|Lost to Follow-up|0|||
124960386|NCT02110225|449482470|FG001|Overall Study|Lost to Follow-up|1|||
124960387|NCT02110225|449482471|FG002|Overall Study|Lost to Follow-up|0|||
124960388|NCT02176018|449482472|FG000|Overall Study|Adverse Event|0|||
124960389|NCT02176018|449482473|FG001|Overall Study|Adverse Event|2|||
124960390|NCT02176018|449482472|FG000|Overall Study|Lost to Follow-up|3|||
124960391|NCT02176018|449482473|FG001|Overall Study|Lost to Follow-up|1|||
124960392|NCT02176018|449482472|FG000|Overall Study|Protocol Violation|1|||
124960393|NCT02176018|449482473|FG001|Overall Study|Protocol Violation|1|||
124960394|NCT02176018|449482472|FG000|Overall Study|Withdrawal by Subject|1|||
124960395|NCT02176018|449482473|FG001|Overall Study|Withdrawal by Subject|2|||
124960396|NCT03022045|449482474|FG000|Overall Study|Adverse Event|0|||
124960397|NCT03022045|449482475|FG001|Overall Study|Adverse Event|1|||
124960398|NCT03022045|449482474|FG000|Overall Study|Withdrawal by Subject|1|||
124960399|NCT03022045|449482475|FG001|Overall Study|Withdrawal by Subject|1|||
124960400|NCT03972137|449482482|FG000|Overall Study|Lost to Follow-up|2|||
124960401|NCT03972137|449482482|FG000|Overall Study|Withdrawal by Subject|4|||
124960402|NCT00899379|449482483|FG000|Overall Study|Adverse Event|2|||
124960403|NCT00899379|449482484|FG001|Overall Study|Adverse Event|2|||
124960404|NCT00899379|449482485|FG002|Overall Study|Adverse Event|1|||
124960405|NCT00899379|449482486|FG003|Overall Study|Adverse Event|1|||
124960406|NCT00899379|449482487|FG004|Overall Study|Adverse Event|2|||
124960407|NCT00899379|449482483|FG000|Overall Study|Lack of Efficacy|0|||
124960408|NCT00899379|449482484|FG001|Overall Study|Lack of Efficacy|4|||
124960409|NCT00899379|449482485|FG002|Overall Study|Lack of Efficacy|3|||
124960410|NCT00899379|449482486|FG003|Overall Study|Lack of Efficacy|0|||
124960411|NCT00899379|449482487|FG004|Overall Study|Lack of Efficacy|1|||
124960412|NCT00899379|449482483|FG000|Overall Study|Lost to Follow-up|9|||
124960413|NCT00899379|449482484|FG001|Overall Study|Lost to Follow-up|3|||
124960414|NCT00899379|449482485|FG002|Overall Study|Lost to Follow-up|0|||
125215709|NCT04424914|450417486|FG000|Overall Study|Withdrawal by Subject|3|||
124960415|NCT00899379|449482486|FG003|Overall Study|Lost to Follow-up|6|||
124960416|NCT00899379|449482487|FG004|Overall Study|Lost to Follow-up|2|||
124960417|NCT00899379|449482483|FG000|Overall Study|Protocol Violation|0|||
124960418|NCT00899379|449482484|FG001|Overall Study|Protocol Violation|0|||
124960419|NCT00899379|449482485|FG002|Overall Study|Protocol Violation|1|||
124960420|NCT00899379|449482486|FG003|Overall Study|Protocol Violation|1|||
124960421|NCT00899379|449482487|FG004|Overall Study|Protocol Violation|0|||
124960422|NCT00899379|449482483|FG000|Overall Study|Withdrawal by Subject|2|||
124960423|NCT00899379|449482484|FG001|Overall Study|Withdrawal by Subject|4|||
124960424|NCT00899379|449482485|FG002|Overall Study|Withdrawal by Subject|2|||
124960425|NCT00899379|449482486|FG003|Overall Study|Withdrawal by Subject|3|||
124960426|NCT00899379|449482487|FG004|Overall Study|Withdrawal by Subject|6|||
124960427|NCT00899379|449482483|FG000|Overall Study|Pregnancy|0|||
125215710|NCT04424914|450417487|FG001|Overall Study|Withdrawal by Subject|0|||
124960428|NCT00899379|449482484|FG001|Overall Study|Pregnancy|0|||
124960429|NCT00899379|449482485|FG002|Overall Study|Pregnancy|1|||
124960430|NCT00899379|449482486|FG003|Overall Study|Pregnancy|0|||
124960431|NCT00899379|449482487|FG004|Overall Study|Pregnancy|1|||
124960432|NCT00899379|449482483|FG000|Overall Study|Patient Uncooperative|0|||
124960433|NCT00899379|449482484|FG001|Overall Study|Patient Uncooperative|1|||
124960434|NCT00899379|449482485|FG002|Overall Study|Patient Uncooperative|0|||
124960435|NCT00899379|449482486|FG003|Overall Study|Patient Uncooperative|1|||
124960436|NCT00899379|449482487|FG004|Overall Study|Patient Uncooperative|2|||
124960437|NCT00899379|449482483|FG000|Overall Study|Abnormal Baseline ECG|0|||
124960438|NCT00899379|449482484|FG001|Overall Study|Abnormal Baseline ECG|0|||
124960439|NCT00899379|449482485|FG002|Overall Study|Abnormal Baseline ECG|0|||
124960440|NCT00899379|449482486|FG003|Overall Study|Abnormal Baseline ECG|1|||
124960441|NCT00899379|449482487|FG004|Overall Study|Abnormal Baseline ECG|0|||
124960442|NCT00899379|449482483|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
124960443|NCT00899379|449482484|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
124960444|NCT00899379|449482485|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
124960445|NCT00899379|449482486|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
124960446|NCT00899379|449482487|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
124960447|NCT00899379|449482483|FG000|Overall Study|Not Completed/Entered Extn|5|||
124960448|NCT00899379|449482484|FG001|Overall Study|Not Completed/Entered Extn|1|||
124960449|NCT00899379|449482485|FG002|Overall Study|Not Completed/Entered Extn|6|||
124960450|NCT00899379|449482486|FG003|Overall Study|Not Completed/Entered Extn|4|||
124960451|NCT00899379|449482487|FG004|Overall Study|Not Completed/Entered Extn|3|||
124960452|NCT00899379|449482483|FG000|Overall Study|Study Terminated|3|||
124960453|NCT00899379|449482484|FG001|Overall Study|Study Terminated|0|||
124960454|NCT00899379|449482485|FG002|Overall Study|Study Terminated|3|||
124960455|NCT00899379|449482486|FG003|Overall Study|Study Terminated|3|||
124960456|NCT00899379|449482487|FG004|Overall Study|Study Terminated|1|||
124960457|NCT00899379|449482483|FG000|Overall Study|Lost to Follow-up|3|||
124960458|NCT00899379|449482484|FG001|Overall Study|Lost to Follow-up|1|||
124960459|NCT00899379|449482485|FG002|Overall Study|Lost to Follow-up|0|||
124960460|NCT00899379|449482486|FG003|Overall Study|Lost to Follow-up|2|||
124960461|NCT00899379|449482487|FG004|Overall Study|Lost to Follow-up|5|||
124960462|NCT00899379|449482483|FG000|Overall Study|Withdrawal by Subject|4|||
124960463|NCT00899379|449482484|FG001|Overall Study|Withdrawal by Subject|7|||
124960464|NCT00899379|449482485|FG002|Overall Study|Withdrawal by Subject|4|||
124960465|NCT00899379|449482486|FG003|Overall Study|Withdrawal by Subject|7|||
124960466|NCT00899379|449482487|FG004|Overall Study|Withdrawal by Subject|2|||
124960467|NCT00899379|449482483|FG000|Overall Study|Pregnancy|1|||
124960468|NCT00899379|449482484|FG001|Overall Study|Pregnancy|0|||
124960469|NCT00899379|449482485|FG002|Overall Study|Pregnancy|0|||
124960470|NCT00899379|449482486|FG003|Overall Study|Pregnancy|0|||
124960471|NCT00899379|449482487|FG004|Overall Study|Pregnancy|0|||
124960472|NCT00899379|449482483|FG000|Overall Study|Patient Uncooperative|0|||
124960473|NCT00899379|449482484|FG001|Overall Study|Patient Uncooperative|0|||
124960474|NCT00899379|449482485|FG002|Overall Study|Patient Uncooperative|0|||
124960475|NCT00899379|449482486|FG003|Overall Study|Patient Uncooperative|1|||
124960476|NCT00899379|449482487|FG004|Overall Study|Patient Uncooperative|0|||
124960477|NCT00899379|449482483|FG000|Overall Study|Abnormal Prestudy Labs|0|||
124960478|NCT00899379|449482484|FG001|Overall Study|Abnormal Prestudy Labs|0|||
124960479|NCT00899379|449482485|FG002|Overall Study|Abnormal Prestudy Labs|0|||
124960480|NCT00899379|449482486|FG003|Overall Study|Abnormal Prestudy Labs|0|||
124960481|NCT00899379|449482487|FG004|Overall Study|Abnormal Prestudy Labs|2|||
124960482|NCT00899379|449482483|FG000|Overall Study|Abnormal Baseline ECG|0|||
125215711|NCT04424914|450417488|FG002|Overall Study|Withdrawal by Subject|0|||
124960483|NCT00899379|449482484|FG001|Overall Study|Abnormal Baseline ECG|0|||
124960484|NCT00899379|449482485|FG002|Overall Study|Abnormal Baseline ECG|1|||
124960485|NCT00899379|449482486|FG003|Overall Study|Abnormal Baseline ECG|1|||
124960486|NCT00899379|449482487|FG004|Overall Study|Abnormal Baseline ECG|0|||
124960487|NCT00899379|449482483|FG000|Overall Study|No Attack Pretreatment|3|||
124960488|NCT00899379|449482484|FG001|Overall Study|No Attack Pretreatment|5|||
124960489|NCT00899379|449482485|FG002|Overall Study|No Attack Pretreatment|5|||
124960490|NCT00899379|449482486|FG003|Overall Study|No Attack Pretreatment|6|||
124960491|NCT00899379|449482487|FG004|Overall Study|No Attack Pretreatment|4|||
124960492|NCT00899379|449482483|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
124960493|NCT00899379|449482484|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
124960494|NCT00899379|449482485|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
124960495|NCT00899379|449482486|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
124960496|NCT00899379|449482487|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
124960497|NCT00899379|449482483|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
124960498|NCT00899379|449482484|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
124960499|NCT00899379|449482485|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
124960500|NCT00899379|449482486|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
124960501|NCT00899379|449482487|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
124960502|NCT03220776|449482492|FG000|Overall Study|Claustrophobia|0|||
124960503|NCT03220776|449482493|FG001|Overall Study|Claustrophobia|1|||
124960504|NCT03220776|449482494|FG002|Overall Study|Claustrophobia|1|||
124960505|NCT03220776|449482495|FG003|Overall Study|Claustrophobia|0|||
124960506|NCT03220776|449482496|FG004|Overall Study|Claustrophobia|1|||
124960507|NCT03220776|449482497|FG005|Overall Study|Claustrophobia|0|||
124960508|NCT03220776|449482492|FG000|Overall Study|MRI Equipment Failure|1|||
124960509|NCT03220776|449482493|FG001|Overall Study|MRI Equipment Failure|0|||
124960510|NCT03220776|449482494|FG002|Overall Study|MRI Equipment Failure|0|||
124960511|NCT03220776|449482495|FG003|Overall Study|MRI Equipment Failure|0|||
124960512|NCT03220776|449482496|FG004|Overall Study|MRI Equipment Failure|0|||
124960513|NCT03220776|449482497|FG005|Overall Study|MRI Equipment Failure|0|||
124960514|NCT03220776|449482492|FG000|Overall Study|Inclimate Weather|0|||
124960515|NCT03220776|449482493|FG001|Overall Study|Inclimate Weather|0|||
124960516|NCT03220776|449482494|FG002|Overall Study|Inclimate Weather|0|||
124960517|NCT03220776|449482495|FG003|Overall Study|Inclimate Weather|0|||
124960518|NCT03220776|449482496|FG004|Overall Study|Inclimate Weather|0|||
124960519|NCT03220776|449482497|FG005|Overall Study|Inclimate Weather|1|||
124960520|NCT03220776|449482492|FG000|Overall Study|Physician Decision|0|||
124960521|NCT03220776|449482493|FG001|Overall Study|Physician Decision|0|||
124960522|NCT03220776|449482494|FG002|Overall Study|Physician Decision|0|||
124960523|NCT03220776|449482495|FG003|Overall Study|Physician Decision|1|||
124960524|NCT03220776|449482496|FG004|Overall Study|Physician Decision|0|||
124960525|NCT03220776|449482497|FG005|Overall Study|Physician Decision|0|||
124960526|NCT03220776|449482492|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
124960527|NCT03220776|449482493|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
124960528|NCT03220776|449482494|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
124960529|NCT03220776|449482495|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
124960530|NCT03220776|449482496|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
124960531|NCT03220776|449482497|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
124960532|NCT03220776|449482492|FG000|Overall Study|Protocol Violation|0|||
124960533|NCT03220776|449482493|FG001|Overall Study|Protocol Violation|0|||
124960534|NCT03220776|449482494|FG002|Overall Study|Protocol Violation|0|||
124960535|NCT03220776|449482495|FG003|Overall Study|Protocol Violation|2|||
124960536|NCT03220776|449482496|FG004|Overall Study|Protocol Violation|0|||
124960537|NCT03220776|449482497|FG005|Overall Study|Protocol Violation|1|||
124960538|NCT03220776|449482492|FG000|Overall Study|Withdrawal by Subject|1|||
124960539|NCT03220776|449482493|FG001|Overall Study|Withdrawal by Subject|0|||
124960540|NCT03220776|449482494|FG002|Overall Study|Withdrawal by Subject|0|||
124960541|NCT03220776|449482495|FG003|Overall Study|Withdrawal by Subject|0|||
124960542|NCT03220776|449482496|FG004|Overall Study|Withdrawal by Subject|0|||
124960543|NCT03220776|449482497|FG005|Overall Study|Withdrawal by Subject|0|||
124960544|NCT03441789|449482498|FG000|Overall Study|Withdrawal by Subject|1|||
124960545|NCT03441789|449482499|FG001|Overall Study|Withdrawal by Subject|1|||
124960546|NCT03441789|449482498|FG000|Overall Study|Adverse Event|0|||
124960547|NCT03441789|449482499|FG001|Overall Study|Adverse Event|1|||
124960548|NCT03441789|449482498|FG000|Overall Study|Protocol Violation|0|||
124960549|NCT03441789|449482499|FG001|Overall Study|Protocol Violation|1|||
124960550|NCT03441789|449482498|FG000|Overall Study|Lost to Follow-up|0|||
124960551|NCT03441789|449482499|FG001|Overall Study|Lost to Follow-up|1|||
124960552|NCT01780545|449482500|FG000|Overall Study|Withdrawal by Subject|3|||
124960553|NCT01780545|449482501|FG001|Overall Study|Withdrawal by Subject|1|||
124960554|NCT01780545|449482500|FG000|Overall Study|Lost to Follow-up|1|||
124960555|NCT01780545|449482501|FG001|Overall Study|Lost to Follow-up|1|||
124960556|NCT03168425|449482502|FG000|Overall Study|Lost to Follow-up|5|||
124960557|NCT03168425|449482503|FG001|Overall Study|Lost to Follow-up|8|||
124960558|NCT03168425|449482502|FG000|Overall Study|unable to confirm post op opioids|2|||
124960559|NCT03168425|449482503|FG001|Overall Study|unable to confirm post op opioids|3|||
124960560|NCT03029234|449482506|FG000|Overall Study|Sponsor Decision|1|||
124960561|NCT03029234|449482506|FG000|Overall Study|Withdrawal by Subject|5|||
124960562|NCT03029234|449482506|FG000|Overall Study|Death|91|||
124960563|NCT03029234|449482506|FG000|Overall Study|Lost to Follow-up|2|||
124960564|NCT02166047|449482510|FG000|Overall Study|Withdrawal by Participant|0|||
124960565|NCT02166047|449482511|FG001|Overall Study|Withdrawal by Participant|1|||
124960566|NCT02166047|449482512|FG002|Overall Study|Withdrawal by Participant|2|||
124960567|NCT02166047|449482513|FG003|Overall Study|Withdrawal by Participant|0|||
124960568|NCT02166047|449482514|FG004|Overall Study|Withdrawal by Participant|0|||
124960569|NCT02166047|449482515|FG005|Overall Study|Withdrawal by Participant|0|||
124960570|NCT02166047|449482516|FG006|Overall Study|Withdrawal by Participant|1|||
124960571|NCT02166047|449482517|FG007|Overall Study|Withdrawal by Participant|0|||
124960572|NCT02166047|449482518|FG008|Overall Study|Withdrawal by Participant|0|||
124960573|NCT02166047|449482519|FG009|Overall Study|Withdrawal by Participant|0|||
124960574|NCT02166047|449482520|FG010|Overall Study|Withdrawal by Participant|0|||
124960575|NCT02166047|449482521|FG011|Overall Study|Withdrawal by Participant|0|||
124960576|NCT02166047|449482510|FG000|Overall Study|Adverse Event|0|||
124960577|NCT02166047|449482511|FG001|Overall Study|Adverse Event|0|||
124960578|NCT02166047|449482512|FG002|Overall Study|Adverse Event|0|||
124960579|NCT02166047|449482513|FG003|Overall Study|Adverse Event|0|||
124960580|NCT02166047|449482514|FG004|Overall Study|Adverse Event|1|||
124960581|NCT02166047|449482515|FG005|Overall Study|Adverse Event|0|||
124960582|NCT02166047|449482516|FG006|Overall Study|Adverse Event|1|||
124960583|NCT02166047|449482517|FG007|Overall Study|Adverse Event|0|||
124960584|NCT02166047|449482518|FG008|Overall Study|Adverse Event|0|||
124960585|NCT02166047|449482519|FG009|Overall Study|Adverse Event|0|||
124960586|NCT02166047|449482520|FG010|Overall Study|Adverse Event|2|||
124960587|NCT02166047|449482521|FG011|Overall Study|Adverse Event|0|||
124960588|NCT01960114|449482522|FG000|Overall Study|Adverse Event|1|||
124960589|NCT01960114|449482523|FG001|Overall Study|Adverse Event|0|||
124960590|NCT01960114|449482522|FG000|Overall Study|Could not swallow study medication|0|||
124960591|NCT01960114|449482523|FG001|Overall Study|Could not swallow study medication|1|||
124960592|NCT02469077|449482524|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
124960593|NCT02469077|449482525|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
124960594|NCT02469077|449482524|FG000|Post Randomization/Intervention Period|Relocated|1|||
124960595|NCT02469077|449482525|FG001|Post Randomization/Intervention Period|Relocated|1|||
124960596|NCT02469077|449482524|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
124960597|NCT02469077|449482525|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
124960598|NCT02469077|449482524|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
124960599|NCT02469077|449482525|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
124960600|NCT00053352|449482531|FG000|Overall Study|Lost to Follow-up|0|||
124960601|NCT00053352|449482532|FG001|Overall Study|Lost to Follow-up|1|||
124960602|NCT00053352|449482531|FG000|Overall Study|Physician Decision|11|||
124960603|NCT00053352|449482532|FG001|Overall Study|Physician Decision|1|||
124960604|NCT00053352|449482531|FG000|Overall Study|Withdrawal by Subject|1|||
124960605|NCT00053352|449482532|FG001|Overall Study|Withdrawal by Subject|0|||
124960606|NCT00053352|449482531|FG000|Overall Study|Ineligible|8|||
124960607|NCT00053352|449482532|FG001|Overall Study|Ineligible|8|||
124960608|NCT00053352|449482531|FG000|Overall Study|Disease at new site|1|||
124960609|NCT00053352|449482532|FG001|Overall Study|Disease at new site|0|||
124960610|NCT00439647|449482533|FG000|Overall Study|Withdrawal by Subject|25|||
124960611|NCT00439647|449482534|FG001|Overall Study|Withdrawal by Subject|22|||
124960612|NCT00439647|449482533|FG000|Overall Study|Death|15|||
124960613|NCT00439647|449482534|FG001|Overall Study|Death|18|||
124960614|NCT00439647|449482533|FG000|Overall Study|Adverse Event|11|||
124960615|NCT00439647|449482534|FG001|Overall Study|Adverse Event|11|||
124960616|NCT00439647|449482533|FG000|Overall Study|Lost to Follow-up|4|||
124960617|NCT00439647|449482534|FG001|Overall Study|Lost to Follow-up|12|||
124960618|NCT00439647|449482533|FG000|Overall Study|Protocol Violation|3|||
124960619|NCT00439647|449482534|FG001|Overall Study|Protocol Violation|4|||
124960620|NCT00439647|449482533|FG000|Overall Study|Lack of Efficacy|0|||
124960621|NCT00439647|449482534|FG001|Overall Study|Lack of Efficacy|4|||
124960622|NCT02845375|449482535|FG000|Overall Study|upper airway obstruction|1|||
124960623|NCT02845375|449482536|FG001|Overall Study|upper airway obstruction|2|||
124960624|NCT02845375|449482537|FG002|Overall Study|upper airway obstruction|1|||
125215712|NCT04424914|450417486|FG000|Overall Study|Study terminated by sponsor|23|||
125215713|NCT04424914|450417487|FG001|Overall Study|Study terminated by sponsor|7|||
125215714|NCT04424914|450417488|FG002|Overall Study|Study terminated by sponsor|0|||
124960625|NCT01177137|449482541|FG000|Overall Study|Withdrawal by Subject|10|||
124960626|NCT01177137|449482542|FG001|Overall Study|Withdrawal by Subject|10|||
124960627|NCT01177137|449482543|FG002|Overall Study|Withdrawal by Subject|2|||
124960628|NCT01287416|449482544|FG000|Pre-post Training|Withdrawal by Subject|17|||
124960629|NCT01287416|449482545|FG001|Pre-post Training|Withdrawal by Subject|24|||
124960630|NCT01287416|449482544|FG000|Pre-post Training|Lost to Follow-up|5|||
124960631|NCT01287416|449482545|FG001|Pre-post Training|Lost to Follow-up|1|||
124960632|NCT01287416|449482544|FG000|6 Month Follow-up|Lost to Follow-up|3|||
124960633|NCT01287416|449482545|FG001|6 Month Follow-up|Lost to Follow-up|2|||
124960634|NCT02506881|449482547|FG000|First Intervention (Day 1)|Protocol Violation|0|||
124960635|NCT02506881|449482548|FG001|First Intervention (Day 1)|Protocol Violation|0|||
124960636|NCT02506881|449482549|FG002|First Intervention (Day 1)|Protocol Violation|1|||
124960637|NCT02506881|449482550|FG003|First Intervention (Day 1)|Protocol Violation|0|||
124960638|NCT02506881|449482547|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
124960639|NCT02506881|449482548|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
124960640|NCT02506881|449482549|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
124960641|NCT02506881|449482550|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
124960642|NCT02506881|449482547|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
124960643|NCT02506881|449482548|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
124960644|NCT02506881|449482549|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
124960645|NCT02506881|449482550|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
124960646|NCT01363297|449482554|FG000|Overall Study|Other|0|||
124960647|NCT01363297|449482555|FG001|Overall Study|Other|0|||
124960648|NCT01363297|449482556|FG002|Overall Study|Other|0|||
124960649|NCT01363297|449482557|FG003|Overall Study|Other|0|||
124960650|NCT01363297|449482558|FG004|Overall Study|Other|1|||
124960651|NCT01363297|449482554|FG000|Overall Study|Death|3|||
124960652|NCT01363297|449482555|FG001|Overall Study|Death|6|||
124960653|NCT01363297|449482556|FG002|Overall Study|Death|6|||
124960654|NCT01363297|449482557|FG003|Overall Study|Death|10|||
124960655|NCT01363297|449482558|FG004|Overall Study|Death|30|||
124960656|NCT02515097|449482559|FG000|Overall Study|Lost to Follow-up|4|||
124960657|NCT02515097|449482560|FG001|Overall Study|Lost to Follow-up|2|||
124960658|NCT02515097|449482559|FG000|Overall Study|Withdrawal by Subject|1|||
124960659|NCT02515097|449482560|FG001|Overall Study|Withdrawal by Subject|3|||
124960660|NCT02515097|449482559|FG000|Overall Study|Adverse Event|2|||
124960661|NCT02515097|449482560|FG001|Overall Study|Adverse Event|1|||
124960662|NCT06016127|449482563|FG000|Overall Study|Withdrawal by Subject|4|||
124960663|NCT06016127|449482564|FG001|Overall Study|Withdrawal by Subject|3|||
124960664|NCT03915951|449482565|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
124960665|NCT03915951|449482566|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
124960666|NCT03915951|449482565|FG000|Overall Study|Adverse Event|12|||
124960667|NCT03915951|449482566|FG001|Overall Study|Adverse Event|6|||
124960668|NCT03915951|449482565|FG000|Overall Study|Disease progression (radiological)|17|||
124960669|NCT03915951|449482566|FG001|Overall Study|Disease progression (radiological)|15|||
124960670|NCT03915951|449482565|FG000|Overall Study|Disease progression (clinical)|4|||
124960671|NCT03915951|449482566|FG001|Overall Study|Disease progression (clinical)|1|||
124960672|NCT03915951|449482565|FG000|Overall Study|Patient decision|0|||
124960673|NCT03915951|449482566|FG001|Overall Study|Patient decision|4|||
124960674|NCT03915951|449482565|FG000|Overall Study|Investigator decision|0|||
124960675|NCT03915951|449482566|FG001|Overall Study|Investigator decision|1|||
124960676|NCT03915951|449482565|FG000|Overall Study|Consent withdrawn|1|||
124960677|NCT03915951|449482566|FG001|Overall Study|Consent withdrawn|1|||
124960678|NCT03915951|449482565|FG000|Overall Study|Death|0|||
124960679|NCT03915951|449482566|FG001|Overall Study|Death|3|||
124960680|NCT02269917|449482568|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
124960681|NCT02269917|449482569|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
124960682|NCT02269917|449482570|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
124960683|NCT02269917|449482568|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
124960684|NCT02269917|449482569|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
124960685|NCT02269917|449482570|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
124960686|NCT02269917|449482568|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
124960687|NCT02269917|449482569|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
124960688|NCT02269917|449482570|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
124960689|NCT02269917|449482568|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
124960690|NCT02269917|449482569|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
124960691|NCT02269917|449482570|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
124960692|NCT02269917|449482568|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
124960693|NCT02269917|449482569|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
124960694|NCT02269917|449482570|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
124960695|NCT02269917|449482568|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
124960696|NCT02269917|449482569|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
124960697|NCT02269917|449482570|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
124960698|NCT02269917|449482568|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
124960699|NCT02269917|449482569|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
124960700|NCT02269917|449482570|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
124960701|NCT02269917|449482568|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
124960702|NCT02269917|449482569|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
124960703|NCT02269917|449482570|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
124960704|NCT02269917|449482568|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
124960705|NCT02269917|449482569|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
124960706|NCT02269917|449482570|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
124960707|NCT02269917|449482568|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
124960708|NCT02269917|449482569|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
124960709|NCT02269917|449482570|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
124960710|NCT02269917|449482568|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
124960711|NCT02269917|449482569|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
124960712|NCT02269917|449482570|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
124960713|NCT02269917|449482568|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
124960714|NCT02269917|449482569|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
124960715|NCT02269917|449482570|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
124960716|NCT02269917|449482568|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
124960717|NCT02269917|449482569|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
124960718|NCT02269917|449482570|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
124960719|NCT02269917|449482568|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
124960720|NCT02269917|449482569|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
124960721|NCT02269917|449482570|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
124960722|NCT02269917|449482568|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
124960723|NCT02269917|449482569|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
124960724|NCT02269917|449482570|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
124960725|NCT02269917|449482568|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
124960726|NCT02269917|449482569|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
124960727|NCT02269917|449482570|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
124960728|NCT01121185|449482577|FG000|Overall Study|Not infused|0|||
124960729|NCT01121185|449482578|FG001|Overall Study|Not infused|1|||
124960730|NCT01121185|449482577|FG000|Overall Study|Not transplanted|1|||
124960731|NCT01121185|449482578|FG001|Overall Study|Not transplanted|0|||
124960732|NCT03015181|449482579|FG000|Overall Study|Enrolled, but product never administered|1|||
124960733|NCT03015181|449482580|FG001|Overall Study|Enrolled, but product never administered|0|||
124960734|NCT03015181|449482581|FG002|Overall Study|Enrolled, but product never administered|0|||
124960735|NCT03015181|449482582|FG003|Overall Study|Enrolled, but product never administered|0|||
124960736|NCT03015181|449482583|FG004|Overall Study|Enrolled, but product never administered|0|||
124960737|NCT03015181|449482584|FG005|Overall Study|Enrolled, but product never administered|0|||
124960738|NCT03015181|449482585|FG006|Overall Study|Enrolled, but product never administered|0|||
124960739|NCT03015181|449482579|FG000|Overall Study|Withdrawal by Subject|0|||
124960740|NCT03015181|449482580|FG001|Overall Study|Withdrawal by Subject|0|||
124960741|NCT03015181|449482581|FG002|Overall Study|Withdrawal by Subject|0|||
124960742|NCT03015181|449482582|FG003|Overall Study|Withdrawal by Subject|0|||
124960743|NCT03015181|449482583|FG004|Overall Study|Withdrawal by Subject|0|||
124960744|NCT03015181|449482584|FG005|Overall Study|Withdrawal by Subject|1|||
124960745|NCT03015181|449482585|FG006|Overall Study|Withdrawal by Subject|0|||
124960746|NCT03015181|449482579|FG000|Overall Study|Physician Decision|0|||
124960747|NCT03015181|449482580|FG001|Overall Study|Physician Decision|0|||
124960748|NCT03015181|449482581|FG002|Overall Study|Physician Decision|0|||
124960749|NCT03015181|449482582|FG003|Overall Study|Physician Decision|0|||
124960750|NCT03015181|449482583|FG004|Overall Study|Physician Decision|0|||
124960751|NCT03015181|449482584|FG005|Overall Study|Physician Decision|0|||
124960752|NCT03015181|449482585|FG006|Overall Study|Physician Decision|1|||
124960753|NCT01064856|449482591|FG000|Double-blind (DB) Period|Adverse Event|1|||
124960754|NCT01064856|449482592|FG001|Double-blind (DB) Period|Adverse Event|0|||
124960755|NCT01064856|449482593|FG002|Double-blind (DB) Period|Adverse Event|0|||
124960756|NCT01064856|449482594|FG003|Double-blind (DB) Period|Adverse Event|0|||
124960757|NCT01064856|449482591|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
124960758|NCT01064856|449482592|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
124960759|NCT01064856|449482593|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
124960760|NCT01064856|449482594|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
124960761|NCT01064856|449482591|FG000|Open-label (OL) Period|Adverse Event|0|||
124960762|NCT01064856|449482592|FG001|Open-label (OL) Period|Adverse Event|0|||
124960763|NCT01064856|449482593|FG002|Open-label (OL) Period|Adverse Event|12|||
124960764|NCT01064856|449482594|FG003|Open-label (OL) Period|Adverse Event|6|||
124960765|NCT01064856|449482591|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
124960766|NCT01064856|449482592|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
124960767|NCT01064856|449482593|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
124960768|NCT01064856|449482594|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
124960769|NCT01064856|449482591|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
124960770|NCT01064856|449482592|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
124960771|NCT01064856|449482593|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
124960772|NCT01064856|449482594|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
124960773|NCT01064856|449482591|FG000|Open-label (OL) Period|Other|0|||
124960774|NCT01064856|449482592|FG001|Open-label (OL) Period|Other|0|||
124960775|NCT01064856|449482593|FG002|Open-label (OL) Period|Other|7|||
124960776|NCT01064856|449482594|FG003|Open-label (OL) Period|Other|7|||
124960777|NCT01204775|449482597|FG000|Overall Study|Poor/non-compliance|0|||
124960778|NCT01204775|449482598|FG001|Overall Study|Poor/non-compliance|1|||
124960779|NCT01204775|449482597|FG000|Overall Study|Withdrawal by Subject|1|||
124960780|NCT01204775|449482598|FG001|Overall Study|Withdrawal by Subject|0|||
124960781|NCT01374971|449482599|FG000|Overall Study|Withdrawal by Subject|1|||
124960782|NCT03749616|449482602|FG000|Overall Study|Lost to Follow-up|4|||
124960783|NCT03749616|449482603|FG001|Overall Study|Lost to Follow-up|7|||
124960784|NCT03749616|449482602|FG000|Overall Study|Screen Failure|1|||
124960785|NCT03749616|449482603|FG001|Overall Study|Screen Failure|1|||
124960786|NCT03749616|449482602|FG000|Overall Study|Withdrawal by Subject|2|||
124960787|NCT03749616|449482603|FG001|Overall Study|Withdrawal by Subject|0|||
124960788|NCT04435522|449482604|FG000|Overall Study|Withdrawal by Subject|2|||
124960789|NCT00951171|449482605|FG000|Overall Study|Adverse Event|2|||
124960790|NCT00951171|449482606|FG001|Overall Study|Adverse Event|0|||
124960791|NCT00919061|449482607|FG000|Overall Study|Adverse Event|1|||
124960792|NCT00919061|449482607|FG000|Overall Study|Withdrawal by Subject|1|||
124960793|NCT05294328|449482616|FG000|Overall Study|Adverse Event|1|||
124960794|NCT05294328|449482617|FG001|Overall Study|Adverse Event|0|||
124960795|NCT05294328|449482618|FG002|Overall Study|Adverse Event|0|||
124960796|NCT05294328|449482616|FG000|Overall Study|Physician Decision|1|||
124960797|NCT05294328|449482617|FG001|Overall Study|Physician Decision|1|||
124960798|NCT05294328|449482618|FG002|Overall Study|Physician Decision|0|||
124960799|NCT05294328|449482616|FG000|Overall Study|Withdrawal by Subject|0|||
124960800|NCT05294328|449482617|FG001|Overall Study|Withdrawal by Subject|2|||
124960801|NCT05294328|449482618|FG002|Overall Study|Withdrawal by Subject|1|||
124960802|NCT05294328|449482616|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
124960803|NCT05294328|449482617|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
124960804|NCT05294328|449482618|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
124960805|NCT02056873|449482619|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
124960806|NCT02972242|449485048|FG000|Overall Study|Withdrawal by Subject|1|||
124960807|NCT02972242|449485049|FG001|Overall Study|Withdrawal by Subject|0|||
124960808|NCT04572997|449485050|FG000|Overall Study|Adverse Event|1|||
124960809|NCT02956278|449485051|FG000|Overall Study|Withdrawal by Subject|6|||
124960810|NCT02956278|449485052|FG001|Overall Study|Withdrawal by Subject|2|||
124960811|NCT02956278|449485053|FG002|Overall Study|Withdrawal by Subject|0|||
124960812|NCT00740597|449485062|FG000|Overall Study|insurance would not cover treatment|1|||
124960813|NCT00552513|449485066|FG000|Overall Study|Lost to Follow-up|5|||
124960814|NCT00552513|449485067|FG001|Overall Study|Lost to Follow-up|1|||
124960815|NCT02720185|449485068|FG000|Overall Study|Lost to Follow-up|1|||
124960816|NCT01157351|449485069|FG000|Overall Study|Adverse Event|5|||
124960817|NCT01157351|449485070|FG001|Overall Study|Adverse Event|4|||
124960818|NCT01157351|449485069|FG000|Overall Study|Death|1|||
124960819|NCT01157351|449485070|FG001|Overall Study|Death|0|||
124960820|NCT01157351|449485069|FG000|Overall Study|Lost to Follow-up|53|||
124960821|NCT01157351|449485070|FG001|Overall Study|Lost to Follow-up|55|||
124960822|NCT01157351|449485069|FG000|Overall Study|Withdrawal by Subject|37|||
124960823|NCT01157351|449485070|FG001|Overall Study|Withdrawal by Subject|27|||
124960824|NCT01157351|449485069|FG000|Overall Study|Physician Decision|5|||
124960825|NCT01157351|449485070|FG001|Overall Study|Physician Decision|4|||
124960826|NCT01157351|449485069|FG000|Overall Study|Protocol Violation|0|||
124960827|NCT01157351|449485070|FG001|Overall Study|Protocol Violation|1|||
124960828|NCT01157351|449485069|FG000|Overall Study|Other|32|||
124960829|NCT01157351|449485070|FG001|Overall Study|Other|36|||
124960830|NCT01157351|449485069|FG000|Overall Study|Noncompliance with Study Drug|0|||
124960831|NCT01157351|449485070|FG001|Overall Study|Noncompliance with Study Drug|3|||
124960832|NCT01157351|449485069|FG000|Overall Study|Randomized but not Treated|4|||
124960833|NCT01157351|449485070|FG001|Overall Study|Randomized but not Treated|2|||
124960834|NCT03418493|449485071|FG000|Overall Study|Adverse Event|1|||
124960835|NCT03418493|449485072|FG001|Overall Study|Adverse Event|0|||
124960836|NCT03418493|449485073|FG002|Overall Study|Adverse Event|0|||
124960837|NCT03418493|449485074|FG003|Overall Study|Adverse Event|0|||
124960838|NCT03418493|449485075|FG004|Overall Study|Adverse Event|0|||
124960839|NCT03418493|449485076|FG005|Overall Study|Adverse Event|0|||
124960840|NCT03418493|449485077|FG006|Overall Study|Adverse Event|0|||
124960841|NCT03418493|449485078|FG007|Overall Study|Adverse Event|0|||
124960842|NCT03418493|449485079|FG008|Overall Study|Adverse Event|0|||
124960843|NCT03418493|449485080|FG009|Overall Study|Adverse Event|0|||
124960844|NCT03418493|449485081|FG010|Overall Study|Adverse Event|0|||
124960845|NCT03418493|449485071|FG000|Overall Study|Protocol Violation|0|||
124960846|NCT03418493|449485072|FG001|Overall Study|Protocol Violation|0|||
124960847|NCT03418493|449485073|FG002|Overall Study|Protocol Violation|0|||
124960848|NCT03418493|449485074|FG003|Overall Study|Protocol Violation|0|||
124960849|NCT03418493|449485075|FG004|Overall Study|Protocol Violation|0|||
124960850|NCT03418493|449485076|FG005|Overall Study|Protocol Violation|0|||
124960851|NCT03418493|449485077|FG006|Overall Study|Protocol Violation|0|||
124960852|NCT03418493|449485078|FG007|Overall Study|Protocol Violation|0|||
124960853|NCT03418493|449485079|FG008|Overall Study|Protocol Violation|0|||
124960854|NCT03418493|449485080|FG009|Overall Study|Protocol Violation|1|||
124960855|NCT03418493|449485081|FG010|Overall Study|Protocol Violation|0|||
124960856|NCT05446714|449485085|FG000|Overall Study|Lost to Follow-up|1|||
124960857|NCT05446714|449485086|FG001|Overall Study|Lost to Follow-up|3|||
124960858|NCT05446714|449485087|FG002|Overall Study|Lost to Follow-up|2|||
124960859|NCT05446714|449485085|FG000|Overall Study|Protocol Violation|2|||
124960860|NCT05446714|449485086|FG001|Overall Study|Protocol Violation|0|||
124960861|NCT05446714|449485087|FG002|Overall Study|Protocol Violation|0|||
124960862|NCT00197106|449485090|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
124960863|NCT00197106|449485091|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
124960864|NCT00197106|449485092|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
124960865|NCT00197106|449485090|FG000|Overall Treatment Period|Lack of Efficacy|0|||
124960866|NCT00197106|449485091|FG001|Overall Treatment Period|Lack of Efficacy|1|||
124960867|NCT00197106|449485092|FG002|Overall Treatment Period|Lack of Efficacy|0|||
124960868|NCT00197106|449485090|FG000|Overall Treatment Period|Lost to Follow-up|0|||
124960869|NCT00197106|449485091|FG001|Overall Treatment Period|Lost to Follow-up|0|||
124960870|NCT00197106|449485092|FG002|Overall Treatment Period|Lost to Follow-up|2|||
124960871|NCT00197106|449485090|FG000|Overall Treatment Period|Protocol Violation|0|||
124960872|NCT00197106|449485091|FG001|Overall Treatment Period|Protocol Violation|0|||
124960873|NCT00197106|449485092|FG002|Overall Treatment Period|Protocol Violation|2|||
124960874|NCT00197106|449485090|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
124960875|NCT00197106|449485091|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
124960876|NCT00197106|449485092|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
124960877|NCT00329550|449485095|FG000|Overall Study|Adverse Event|3|||
124960878|NCT00329550|449485096|FG001|Overall Study|Adverse Event|4|||
124960879|NCT00329550|449485097|FG002|Overall Study|Adverse Event|2|||
124960880|NCT00329550|449485095|FG000|Overall Study|Withdrawal of Consent|1|||
124960881|NCT00329550|449485096|FG001|Overall Study|Withdrawal of Consent|0|||
124960882|NCT00329550|449485097|FG002|Overall Study|Withdrawal of Consent|1|||
124960883|NCT00329550|449485095|FG000|Overall Study|Due to Relocation|0|||
124960884|NCT00329550|449485096|FG001|Overall Study|Due to Relocation|0|||
124960885|NCT00329550|449485097|FG002|Overall Study|Due to Relocation|1|||
124960886|NCT01649557|449485104|FG000|Overall Study|Lost to Follow-up|5|||
124960887|NCT01649557|449485105|FG001|Overall Study|Lost to Follow-up|0|||
124960888|NCT01649557|449485106|FG002|Overall Study|Lost to Follow-up|3|||
124960889|NCT01649557|449485104|FG000|Overall Study|Adverse Event|7|||
124960890|NCT01649557|449485105|FG001|Overall Study|Adverse Event|5|||
124960891|NCT01649557|449485106|FG002|Overall Study|Adverse Event|1|||
124960892|NCT01649557|449485104|FG000|Overall Study|Met withdrawal criteria|4|||
124960893|NCT01649557|449485105|FG001|Overall Study|Met withdrawal criteria|0|||
124960894|NCT01649557|449485106|FG002|Overall Study|Met withdrawal criteria|0|||
124960895|NCT01649557|449485104|FG000|Overall Study|Physician Decision|8|||
124960896|NCT01649557|449485105|FG001|Overall Study|Physician Decision|2|||
124960897|NCT01649557|449485106|FG002|Overall Study|Physician Decision|1|||
124960898|NCT01649557|449485104|FG000|Overall Study|Withdrawal by Subject|15|||
124960899|NCT01649557|449485105|FG001|Overall Study|Withdrawal by Subject|5|||
124960900|NCT01649557|449485106|FG002|Overall Study|Withdrawal by Subject|4|||
124960901|NCT01649557|449485104|FG000|Overall Study|Protocol deviation|0|||
124960902|NCT01649557|449485105|FG001|Overall Study|Protocol deviation|2|||
124960903|NCT01649557|449485106|FG002|Overall Study|Protocol deviation|0|||
124960904|NCT01649557|449485104|FG000|Overall Study|Lack of Efficacy|5|||
124960905|NCT01649557|449485105|FG001|Overall Study|Lack of Efficacy|0|||
124960906|NCT01649557|449485106|FG002|Overall Study|Lack of Efficacy|0|||
124960907|NCT00666198|449485109|FG000|Overall Study|Protocol Violation|10|||
124960908|NCT00666198|449485109|FG000|Overall Study|No Visit After First Day of Treatment|13|||
124960909|NCT00666198|449485109|FG000|Overall Study|Safety Not Assessable|6|||
124960910|NCT00666198|449485109|FG000|Overall Study|No Drug Administration|4|||
124960911|NCT00922441|449485110|FG000|Overall Study|Protocol Violation|0|||
124960912|NCT00922441|449485111|FG001|Overall Study|Protocol Violation|0|||
124960913|NCT00922441|449485112|FG002|Overall Study|Protocol Violation|2|||
124960914|NCT00922441|449485110|FG000|Overall Study|Withdrawal by Subject|0|||
124960915|NCT00922441|449485111|FG001|Overall Study|Withdrawal by Subject|0|||
124960916|NCT00922441|449485112|FG002|Overall Study|Withdrawal by Subject|1|||
124960917|NCT01040403|449485115|FG000|Overall Study|Adverse Event|10|||
124960918|NCT01040403|449485115|FG000|Overall Study|Protocol Violation|2|||
124960919|NCT01040403|449485115|FG000|Overall Study|Lost to Follow-up|1|||
124960920|NCT01040403|449485115|FG000|Overall Study|Not treated|1|||
124960921|NCT01040403|449485115|FG000|Overall Study|Other reason not defined above|6|||
124960922|NCT02973477|449485116|FG000|First Intervention|Lost to Follow-up|0|||
124960923|NCT02973477|449485117|FG001|First Intervention|Lost to Follow-up|2|||
124960924|NCT02973477|449485116|FG000|Washout|Withdrawal by Subject|1|||
124960925|NCT02973477|449485117|FG001|Washout|Withdrawal by Subject|0|||
124960926|NCT02973477|449485116|FG000|Second Intervention|Lost to Follow-up|1|||
124960927|NCT02973477|449485117|FG001|Second Intervention|Lost to Follow-up|0|||
124960928|NCT01885936|449485118|FG000|Overall Study|Withdrawal by Subject|1|||
124960929|NCT01885936|449485119|FG001|Overall Study|Withdrawal by Subject|0|||
124960930|NCT03036150|449485120|FG000|Overall Study|Withdrawal by Subject|8|||
124960931|NCT03036150|449485121|FG001|Overall Study|Withdrawal by Subject|3|||
124960932|NCT03036150|449485120|FG000|Overall Study|Lost to Follow-up|2|||
124960933|NCT03036150|449485121|FG001|Overall Study|Lost to Follow-up|2|||
124960934|NCT00317603|449485122|FG000|Overall Study|Progressive Disease|3|||
124960935|NCT00523549|449485123|FG000|Overall Study|Adverse Event|6|||
124960936|NCT00523549|449485124|FG001|Overall Study|Adverse Event|3|||
124960937|NCT00523549|449485123|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124960938|NCT00523549|449485124|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
124960939|NCT00523549|449485123|FG000|Overall Study|Protocol Deviation|3|||
125215715|NCT04424914|450417486|FG000|Overall Study|Lost to Follow-up|0|||
124960940|NCT00523549|449485124|FG001|Overall Study|Protocol Deviation|1|||
124960941|NCT00523549|449485123|FG000|Overall Study|Patient withdrew consent|7|||
124960942|NCT00523549|449485124|FG001|Overall Study|Patient withdrew consent|6|||
124960943|NCT00523549|449485123|FG000|Overall Study|Lost to Follow-up|3|||
124960944|NCT00523549|449485124|FG001|Overall Study|Lost to Follow-up|5|||
124960945|NCT00427778|449485129|FG000|First Intervention (4 Weeks)|no longer interested|1|||
125215716|NCT04424914|450417487|FG001|Overall Study|Lost to Follow-up|0|||
124960946|NCT00427778|449485130|FG001|First Intervention (4 Weeks)|no longer interested|0|||
125215717|NCT04424914|450417488|FG002|Overall Study|Lost to Follow-up|1|||
124960947|NCT00427778|449485129|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
124960948|NCT00427778|449485130|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
124960949|NCT00427778|449485129|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
124960950|NCT00427778|449485130|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
124960951|NCT00427778|449485129|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
124960952|NCT00427778|449485130|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
124960953|NCT01388478|449485131|FG000|Overall Study|Adverse Event|4|||
124960954|NCT01388478|449485131|FG000|Overall Study|Withdrawal by Subject|1|||
124960955|NCT01990664|449485132|FG000|Overall Study|Lost to Follow-up|2|||
124960956|NCT01990664|449485133|FG001|Overall Study|Lost to Follow-up|6|||
124960957|NCT01990664|449485132|FG000|Overall Study|Withdrawal by Subject|2|||
124960958|NCT01990664|449485133|FG001|Overall Study|Withdrawal by Subject|3|||
124960959|NCT01990664|449485132|FG000|Overall Study|Protocol Violation|1|||
124960960|NCT01990664|449485133|FG001|Overall Study|Protocol Violation|0|||
124960961|NCT01990664|449485132|FG000|Overall Study|Lens Discomfort|1|||
124960962|NCT01990664|449485133|FG001|Overall Study|Lens Discomfort|1|||
124960963|NCT01990664|449485132|FG000|Overall Study|Lens Handling Difficulties|1|||
124960964|NCT01990664|449485133|FG001|Overall Study|Lens Handling Difficulties|0|||
124960965|NCT01990664|449485132|FG000|Overall Study|Unsatisfactory Visual Response|0|||
124960966|NCT01990664|449485133|FG001|Overall Study|Unsatisfactory Visual Response|1|||
124960967|NCT01037413|449485134|FG000|Part A: Skin Testing|Adverse Event|1|||
124960968|NCT01037413|449485135|FG001|Part A: Skin Testing|Adverse Event|0|||
124960969|NCT01037413|449485134|FG000|Part A: Skin Testing|Protocol Violation|1|||
124960970|NCT01037413|449485135|FG001|Part A: Skin Testing|Protocol Violation|0|||
124960971|NCT01037413|449485134|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
124960972|NCT01037413|449485135|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
124960973|NCT01037413|449485134|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
124960974|NCT01037413|449485135|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
124960975|NCT00619983|449485136|FG000|Test Drug Alone|Withdrawal by Subject|1|||
124960976|NCT00619983|449485137|FG001|Test Drug Alone|Withdrawal by Subject|0|||
124960977|NCT00619983|449485138|FG002|Test Drug Alone|Withdrawal by Subject|0|||
124960978|NCT00619983|449485139|FG003|Test Drug Alone|Withdrawal by Subject|1|||
124960979|NCT00619983|449485136|FG000|Test Drug Alone|Failure of daily diary device|1|||
124960980|NCT00619983|449485137|FG001|Test Drug Alone|Failure of daily diary device|1|||
124960981|NCT00619983|449485138|FG002|Test Drug Alone|Failure of daily diary device|2|||
124960982|NCT00619983|449485139|FG003|Test Drug Alone|Failure of daily diary device|2|||
124960983|NCT00931918|449485140|FG000|Overall Study|Adverse Event|4|||
124960984|NCT00931918|449485141|FG001|Overall Study|Adverse Event|6|||
124960985|NCT00931918|449485140|FG000|Overall Study|Progressive Disease|2|||
124960986|NCT00931918|449485141|FG001|Overall Study|Progressive Disease|1|||
124960987|NCT00931918|449485140|FG000|Overall Study|Symptomatic Deterioration|1|||
124960988|NCT00931918|449485141|FG001|Overall Study|Symptomatic Deterioration|0|||
124960989|NCT00931918|449485140|FG000|Overall Study|Withdrawal by Patient|3|||
124960990|NCT00931918|449485141|FG001|Overall Study|Withdrawal by Patient|4|||
124960991|NCT00931918|449485140|FG000|Overall Study|Other Reason not Specified|4|||
124960992|NCT00931918|449485141|FG001|Overall Study|Other Reason not Specified|4|||
124960993|NCT00931918|449485140|FG000|Overall Study|Did not receive study drug|3|||
124960994|NCT00931918|449485141|FG001|Overall Study|Did not receive study drug|2|||
124960995|NCT00570921|449485142|FG000|Overall Study|Protocol Violation|1|||
124960996|NCT00570921|449485142|FG000|Overall Study|Physician Decision|1|||
124960997|NCT00784277|449485144|FG000|IR Treatment|Adverse Event|4|||
124960998|NCT00784277|449485145|FG001|IR Treatment|Adverse Event|8|||
124960999|NCT00784277|449485146|FG002|IR Treatment|Adverse Event|19|||
124961000|NCT00784277|449485147|FG003|IR Treatment|Adverse Event|35|||
124961001|NCT00784277|449485148|FG004|IR Treatment|Adverse Event|0|||
124961002|NCT00784277|449485149|FG005|IR Treatment|Adverse Event|0|||
124961003|NCT00784277|449485150|FG006|IR Treatment|Adverse Event|0|||
124961004|NCT00784277|449485144|FG000|IR Treatment|Lack of Efficacy|4|||
124961005|NCT00784277|449485145|FG001|IR Treatment|Lack of Efficacy|4|||
124961006|NCT00784277|449485146|FG002|IR Treatment|Lack of Efficacy|1|||
124961007|NCT00784277|449485147|FG003|IR Treatment|Lack of Efficacy|0|||
124961008|NCT00784277|449485148|FG004|IR Treatment|Lack of Efficacy|0|||
124961009|NCT00784277|449485149|FG005|IR Treatment|Lack of Efficacy|0|||
124961010|NCT00784277|449485150|FG006|IR Treatment|Lack of Efficacy|0|||
124961011|NCT00784277|449485144|FG000|IR Treatment|Lost to Follow-up|1|||
124961012|NCT00784277|449485145|FG001|IR Treatment|Lost to Follow-up|0|||
124961013|NCT00784277|449485146|FG002|IR Treatment|Lost to Follow-up|1|||
124961014|NCT00784277|449485147|FG003|IR Treatment|Lost to Follow-up|0|||
124961015|NCT00784277|449485148|FG004|IR Treatment|Lost to Follow-up|0|||
124961016|NCT00784277|449485149|FG005|IR Treatment|Lost to Follow-up|0|||
124961017|NCT00784277|449485150|FG006|IR Treatment|Lost to Follow-up|0|||
124961018|NCT00784277|449485144|FG000|IR Treatment|Withdrawal by Subject|5|||
124961019|NCT00784277|449485145|FG001|IR Treatment|Withdrawal by Subject|1|||
124961020|NCT00784277|449485146|FG002|IR Treatment|Withdrawal by Subject|4|||
124961021|NCT00784277|449485147|FG003|IR Treatment|Withdrawal by Subject|6|||
124961022|NCT00784277|449485148|FG004|IR Treatment|Withdrawal by Subject|0|||
125215718|NCT04424914|450417486|FG000|Overall Study|Death|3|||
124961023|NCT00784277|449485149|FG005|IR Treatment|Withdrawal by Subject|0|||
125031250|NCT00896532|449735103|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125031251|NCT00896532|449735104|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125031252|NCT00896532|449735105|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125215719|NCT04424914|450417487|FG001|Overall Study|Death|1|||
124961024|NCT00784277|449485150|FG006|IR Treatment|Withdrawal by Subject|0|||
124961025|NCT00784277|449485144|FG000|IR Treatment|Resolution Of Pain|0|||
124961026|NCT00784277|449485145|FG001|IR Treatment|Resolution Of Pain|1|||
124961027|NCT00784277|449485146|FG002|IR Treatment|Resolution Of Pain|0|||
124961028|NCT00784277|449485147|FG003|IR Treatment|Resolution Of Pain|0|||
124961029|NCT00784277|449485148|FG004|IR Treatment|Resolution Of Pain|0|||
124961030|NCT00784277|449485149|FG005|IR Treatment|Resolution Of Pain|0|||
124961031|NCT00784277|449485150|FG006|IR Treatment|Resolution Of Pain|0|||
124961032|NCT00784277|449485144|FG000|IR Treatment|Other|2|||
124961033|NCT00784277|449485145|FG001|IR Treatment|Other|3|||
124961034|NCT00784277|449485146|FG002|IR Treatment|Other|3|||
124961035|NCT00784277|449485147|FG003|IR Treatment|Other|2|||
124961036|NCT00784277|449485148|FG004|IR Treatment|Other|0|||
124961037|NCT00784277|449485149|FG005|IR Treatment|Other|0|||
124961038|NCT00784277|449485150|FG006|IR Treatment|Other|0|||
124961039|NCT00784277|449485144|FG000|ER Treatment|Adverse Event|0|||
124961040|NCT00784277|449485145|FG001|ER Treatment|Adverse Event|0|||
124961041|NCT00784277|449485146|FG002|ER Treatment|Adverse Event|0|||
124961042|NCT00784277|449485147|FG003|ER Treatment|Adverse Event|0|||
124961043|NCT00784277|449485148|FG004|ER Treatment|Adverse Event|1|||
124961044|NCT00784277|449485149|FG005|ER Treatment|Adverse Event|7|||
124961045|NCT00784277|449485150|FG006|ER Treatment|Adverse Event|7|||
124961046|NCT00784277|449485144|FG000|ER Treatment|Lack of Efficacy|0|||
124961047|NCT00784277|449485145|FG001|ER Treatment|Lack of Efficacy|0|||
124961048|NCT00784277|449485146|FG002|ER Treatment|Lack of Efficacy|0|||
124961049|NCT00784277|449485147|FG003|ER Treatment|Lack of Efficacy|0|||
124961050|NCT00784277|449485148|FG004|ER Treatment|Lack of Efficacy|3|||
124961051|NCT00784277|449485149|FG005|ER Treatment|Lack of Efficacy|4|||
124961052|NCT00784277|449485150|FG006|ER Treatment|Lack of Efficacy|0|||
124961053|NCT00784277|449485144|FG000|ER Treatment|Lost to Follow-up|0|||
124961054|NCT00784277|449485145|FG001|ER Treatment|Lost to Follow-up|0|||
124961055|NCT00784277|449485146|FG002|ER Treatment|Lost to Follow-up|0|||
124961056|NCT00784277|449485147|FG003|ER Treatment|Lost to Follow-up|0|||
124961057|NCT00784277|449485148|FG004|ER Treatment|Lost to Follow-up|0|||
124961058|NCT00784277|449485149|FG005|ER Treatment|Lost to Follow-up|2|||
124961059|NCT00784277|449485150|FG006|ER Treatment|Lost to Follow-up|0|||
124961060|NCT00784277|449485144|FG000|ER Treatment|Withdrawal by Subject|0|||
124961061|NCT00784277|449485145|FG001|ER Treatment|Withdrawal by Subject|0|||
124961062|NCT00784277|449485146|FG002|ER Treatment|Withdrawal by Subject|0|||
124961063|NCT00784277|449485147|FG003|ER Treatment|Withdrawal by Subject|0|||
124961064|NCT00784277|449485148|FG004|ER Treatment|Withdrawal by Subject|2|||
124961065|NCT00784277|449485149|FG005|ER Treatment|Withdrawal by Subject|5|||
124961066|NCT00784277|449485150|FG006|ER Treatment|Withdrawal by Subject|3|||
124961067|NCT00784277|449485144|FG000|ER Treatment|Study Medication Non-Compliant|0|||
124961068|NCT00784277|449485145|FG001|ER Treatment|Study Medication Non-Compliant|0|||
124961069|NCT00784277|449485146|FG002|ER Treatment|Study Medication Non-Compliant|0|||
124961070|NCT00784277|449485147|FG003|ER Treatment|Study Medication Non-Compliant|0|||
124961071|NCT00784277|449485148|FG004|ER Treatment|Study Medication Non-Compliant|2|||
124961072|NCT00784277|449485149|FG005|ER Treatment|Study Medication Non-Compliant|3|||
124961073|NCT00784277|449485150|FG006|ER Treatment|Study Medication Non-Compliant|3|||
124961074|NCT00784277|449485144|FG000|ER Treatment|Other|0|||
124961075|NCT00784277|449485145|FG001|ER Treatment|Other|0|||
124961076|NCT00784277|449485146|FG002|ER Treatment|Other|0|||
124961077|NCT00784277|449485147|FG003|ER Treatment|Other|0|||
124961078|NCT00784277|449485148|FG004|ER Treatment|Other|1|||
124961079|NCT00784277|449485149|FG005|ER Treatment|Other|3|||
124961080|NCT00784277|449485150|FG006|ER Treatment|Other|2|||
124961081|NCT02025985|449485159|FG000|Overall Study|Consent withdrawn|0|||
124961082|NCT02025985|449485160|FG001|Overall Study|Consent withdrawn|0|||
124961083|NCT02025985|449485161|FG002|Overall Study|Consent withdrawn|1|||
124961084|NCT02025985|449485162|FG003|Overall Study|Consent withdrawn|0|||
124961085|NCT02025985|449485163|FG004|Overall Study|Consent withdrawn|0|||
124961086|NCT02025985|449485159|FG000|Overall Study|Termination of study by Sponsor|4|||
124961087|NCT02025985|449485160|FG001|Overall Study|Termination of study by Sponsor|3|||
124961088|NCT02025985|449485161|FG002|Overall Study|Termination of study by Sponsor|1|||
124961089|NCT02025985|449485162|FG003|Overall Study|Termination of study by Sponsor|1|||
124961090|NCT02025985|449485163|FG004|Overall Study|Termination of study by Sponsor|3|||
124961091|NCT02025985|449485159|FG000|Overall Study|Death|21|||
124961092|NCT02025985|449485160|FG001|Overall Study|Death|20|||
124961093|NCT02025985|449485161|FG002|Overall Study|Death|23|||
124961094|NCT02025985|449485162|FG003|Overall Study|Death|20|||
124961095|NCT02025985|449485163|FG004|Overall Study|Death|17|||
124961096|NCT03041701|449485164|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
124961097|NCT03041701|449485165|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
124961098|NCT03041701|449485166|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
124961099|NCT03041701|449485164|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
124961100|NCT03041701|449485165|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
124961101|NCT03041701|449485166|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
124961102|NCT00745121|449485167|FG000|Overall Study|Death|3|||
124961103|NCT00745121|449485168|FG001|Overall Study|Death|0|||
124961104|NCT00745121|449485167|FG000|Overall Study|Adverse Event|1|||
124961105|NCT00745121|449485168|FG001|Overall Study|Adverse Event|0|||
124961106|NCT00745121|449485167|FG000|Overall Study|Lost to Follow-up|1|||
124961107|NCT00745121|449485168|FG001|Overall Study|Lost to Follow-up|0|||
124961108|NCT00745121|449485167|FG000|Overall Study|Withdrawal by Subject|4|||
124961109|NCT00745121|449485168|FG001|Overall Study|Withdrawal by Subject|2|||
125215720|NCT04424914|450417488|FG002|Overall Study|Death|0|||
125215721|NCT00334295|450417493|FG000|Overall Study|Patients received fewer than 3 injection|5|||
124961110|NCT01713998|449485169|FG000|Overall Study|Lost to Follow-up|2|||
124961111|NCT01713998|449485170|FG001|Overall Study|Lost to Follow-up|0|||
124961112|NCT01713998|449485171|FG002|Overall Study|Lost to Follow-up|2|||
124961113|NCT01713998|449485169|FG000|Overall Study|Withdrawal by Subject|1|||
124961114|NCT01713998|449485170|FG001|Overall Study|Withdrawal by Subject|0|||
124961115|NCT01713998|449485171|FG002|Overall Study|Withdrawal by Subject|0|||
124961116|NCT02101268|449485172|FG000|Randomized Treatment Phase|Subject Decision|8|||
124961117|NCT02101268|449485173|FG001|Randomized Treatment Phase|Subject Decision|4|||
124961118|NCT02101268|449485174|FG002|Randomized Treatment Phase|Subject Decision|0|||
124961119|NCT02101268|449485175|FG003|Randomized Treatment Phase|Subject Decision|0|||
124961120|NCT02101268|449485172|FG000|Randomized Treatment Phase|Physician Decision|4|||
124961121|NCT02101268|449485173|FG001|Randomized Treatment Phase|Physician Decision|1|||
124961122|NCT02101268|449485174|FG002|Randomized Treatment Phase|Physician Decision|0|||
124961123|NCT02101268|449485175|FG003|Randomized Treatment Phase|Physician Decision|0|||
124961124|NCT02101268|449485172|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
124961125|NCT02101268|449485173|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
124961126|NCT02101268|449485174|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
124961127|NCT02101268|449485175|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
124961128|NCT02101268|449485172|FG000|Randomized Treatment Phase|Adverse Event|6|||
124961129|NCT02101268|449485173|FG001|Randomized Treatment Phase|Adverse Event|0|||
124961130|NCT02101268|449485174|FG002|Randomized Treatment Phase|Adverse Event|0|||
124961131|NCT02101268|449485175|FG003|Randomized Treatment Phase|Adverse Event|0|||
124961132|NCT02101268|449485172|FG000|Randomized Treatment Phase|Death|5|||
124961133|NCT02101268|449485173|FG001|Randomized Treatment Phase|Death|4|||
124961134|NCT02101268|449485174|FG002|Randomized Treatment Phase|Death|0|||
124961135|NCT02101268|449485175|FG003|Randomized Treatment Phase|Death|0|||
124961136|NCT02101268|449485172|FG000|Randomized Treatment Phase|Disease Progression|4|||
124961137|NCT02101268|449485173|FG001|Randomized Treatment Phase|Disease Progression|1|||
124961138|NCT02101268|449485174|FG002|Randomized Treatment Phase|Disease Progression|0|||
124961139|NCT02101268|449485175|FG003|Randomized Treatment Phase|Disease Progression|0|||
124961140|NCT02101268|449485172|FG000|Extended Treatment Phase|Subject Decision|0|||
124961141|NCT02101268|449485173|FG001|Extended Treatment Phase|Subject Decision|0|||
124961142|NCT02101268|449485174|FG002|Extended Treatment Phase|Subject Decision|3|||
124961143|NCT02101268|449485175|FG003|Extended Treatment Phase|Subject Decision|2|||
124961144|NCT02101268|449485172|FG000|Extended Treatment Phase|Physician Decision|0|||
124961145|NCT02101268|449485173|FG001|Extended Treatment Phase|Physician Decision|0|||
124961146|NCT02101268|449485174|FG002|Extended Treatment Phase|Physician Decision|5|||
124961147|NCT02101268|449485175|FG003|Extended Treatment Phase|Physician Decision|2|||
124961148|NCT02101268|449485172|FG000|Extended Treatment Phase|Adverse Event|0|||
124961149|NCT02101268|449485173|FG001|Extended Treatment Phase|Adverse Event|0|||
124961150|NCT02101268|449485174|FG002|Extended Treatment Phase|Adverse Event|14|||
124961151|NCT02101268|449485175|FG003|Extended Treatment Phase|Adverse Event|18|||
124961152|NCT02101268|449485172|FG000|Extended Treatment Phase|Death|0|||
124961153|NCT02101268|449485173|FG001|Extended Treatment Phase|Death|0|||
124961154|NCT02101268|449485174|FG002|Extended Treatment Phase|Death|5|||
124961155|NCT02101268|449485175|FG003|Extended Treatment Phase|Death|1|||
124961156|NCT02101268|449485172|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
124961157|NCT02101268|449485173|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
124961158|NCT02101268|449485174|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
124961159|NCT02101268|449485175|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
124961160|NCT02101268|449485172|FG000|Extended Treatment Phase|Disease Progression|0|||
124961161|NCT02101268|449485173|FG001|Extended Treatment Phase|Disease Progression|0|||
124961162|NCT02101268|449485174|FG002|Extended Treatment Phase|Disease Progression|13|||
124961163|NCT02101268|449485175|FG003|Extended Treatment Phase|Disease Progression|6|||
124961164|NCT02101268|449485172|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
124961165|NCT02101268|449485173|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
124961166|NCT02101268|449485174|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
124961167|NCT02101268|449485175|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
124961168|NCT00740870|449485176|FG000|Overall Study|Not Catheterized|4|||
124961169|NCT00740870|449485176|FG000|Overall Study|Further testing contraindicated implant|17|||
124961170|NCT00839332|449485178|FG000|Phase 1|Disease Progression|38|||
124961171|NCT00839332|449485179|FG001|Phase 1|Disease Progression|0|||
124961172|NCT00839332|449485180|FG002|Phase 1|Disease Progression|0|||
124961173|NCT00839332|449485178|FG000|Phase 1|Adverse Event|6|||
124961174|NCT00839332|449485179|FG001|Phase 1|Adverse Event|0|||
125128475|NCT03020615|450096084|FG002|Overall Study|Physician Decision|2|||
125128476|NCT03020615|450096082|FG000|Overall Study|Parent/guardian/patient choice|3|||
125128477|NCT03020615|450096083|FG001|Overall Study|Parent/guardian/patient choice|0|||
125128478|NCT03020615|450096084|FG002|Overall Study|Parent/guardian/patient choice|4|||
125128479|NCT03020615|450096082|FG000|Overall Study|Screen failure|0|||
125128480|NCT03020615|450096083|FG001|Overall Study|Screen failure|0|||
125128481|NCT03020615|450096084|FG002|Overall Study|Screen failure|1|||
125128482|NCT03020615|450096082|FG000|Overall Study|Death|1|||
125128483|NCT03020615|450096083|FG001|Overall Study|Death|0|||
125128484|NCT03020615|450096084|FG002|Overall Study|Death|0|||
125128485|NCT03020615|450096082|FG000|Overall Study|Lost to Follow-up|0|||
125128486|NCT03020615|450096083|FG001|Overall Study|Lost to Follow-up|1|||
125128487|NCT03020615|450096084|FG002|Overall Study|Lost to Follow-up|0|||
124961175|NCT00839332|449485180|FG002|Phase 1|Adverse Event|0|||
124961176|NCT00839332|449485178|FG000|Phase 1|Withdrawal by Subject|4|||
124961177|NCT00839332|449485179|FG001|Phase 1|Withdrawal by Subject|0|||
124961178|NCT00839332|449485180|FG002|Phase 1|Withdrawal by Subject|0|||
124961179|NCT00839332|449485178|FG000|Phase 1|Physician Decision|2|||
124961180|NCT00839332|449485179|FG001|Phase 1|Physician Decision|0|||
124961181|NCT00839332|449485180|FG002|Phase 1|Physician Decision|0|||
124961182|NCT00839332|449485178|FG000|Phase 2|Protocol Violation|0|||
124961183|NCT00839332|449485179|FG001|Phase 2|Protocol Violation|1|||
124961184|NCT00839332|449485180|FG002|Phase 2|Protocol Violation|0|||
124961185|NCT00839332|449485178|FG000|Phase 2|Disease Progression|0|||
124961186|NCT00839332|449485179|FG001|Phase 2|Disease Progression|46|||
124961187|NCT00839332|449485180|FG002|Phase 2|Disease Progression|21|||
124961188|NCT00839332|449485178|FG000|Phase 2|Adverse Event|0|||
124961189|NCT00839332|449485179|FG001|Phase 2|Adverse Event|8|||
124961190|NCT00839332|449485180|FG002|Phase 2|Adverse Event|6|||
124961191|NCT00839332|449485178|FG000|Phase 2|Death|0|||
124961192|NCT00839332|449485179|FG001|Phase 2|Death|4|||
124961193|NCT00839332|449485180|FG002|Phase 2|Death|2|||
124961194|NCT00839332|449485178|FG000|Phase 2|Withdrawal by Subject|0|||
124961195|NCT00839332|449485179|FG001|Phase 2|Withdrawal by Subject|5|||
124961196|NCT00839332|449485180|FG002|Phase 2|Withdrawal by Subject|8|||
124961197|NCT00839332|449485178|FG000|Phase 2|Physician Decision|0|||
124961198|NCT00839332|449485179|FG001|Phase 2|Physician Decision|4|||
124961199|NCT00839332|449485180|FG002|Phase 2|Physician Decision|1|||
124961200|NCT00839332|449485178|FG000|Phase 2|Lost to Follow-up|0|||
124961201|NCT00839332|449485179|FG001|Phase 2|Lost to Follow-up|0|||
124961202|NCT00839332|449485180|FG002|Phase 2|Lost to Follow-up|1|||
124961203|NCT01200485|449485181|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
124961204|NCT01200485|449485182|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
124961205|NCT01200485|449485183|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
124961206|NCT01200485|449485181|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
124961207|NCT01200485|449485182|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
124961208|NCT01200485|449485183|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
124961209|NCT06080438|449485184|FG000|Overall Study|Lost to Follow-up|2|||
124961210|NCT03569475|449485185|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
124961211|NCT03569475|449485186|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
124961212|NCT03569475|449485187|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
124961213|NCT03569475|449485185|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
125128488|NCT00252720|450096086|FG000|Overall Study|Withdrawal by Subject|95|||
125128489|NCT00252720|450096087|FG001|Overall Study|Withdrawal by Subject|97|||
124961214|NCT03569475|449485186|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
124961215|NCT03569475|449485187|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
124961216|NCT03569475|449485185|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
124961217|NCT03569475|449485186|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
124961218|NCT03569475|449485187|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
124961219|NCT03569475|449485185|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
124961220|NCT03569475|449485186|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
124961221|NCT03569475|449485187|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
124961222|NCT03569475|449485185|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
124961223|NCT03569475|449485186|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
124961224|NCT03569475|449485187|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
125128490|NCT00252720|450096086|FG000|Overall Study|Death|7|||
125128491|NCT00252720|450096087|FG001|Overall Study|Death|8|||
125128492|NCT00252720|450096086|FG000|Overall Study|Moving|23|||
125128493|NCT00252720|450096087|FG001|Overall Study|Moving|42|||
125128494|NCT00252720|450096086|FG000|Overall Study|Mainly patients lost to follow-up|7|||
125031253|NCT00896532|449735106|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125031254|NCT00896532|449735107|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125031255|NCT00896532|449735108|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125031256|NCT00896532|449735109|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125031257|NCT00896532|449735110|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
125031258|NCT00896532|449735111|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
125031259|NCT00896532|449735112|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125128495|NCT00252720|450096087|FG001|Overall Study|Mainly patients lost to follow-up|18|||
125128496|NCT02514122|450096092|FG000|Overall Study|Withdrawal by Subject|2|||
125128497|NCT02514122|450096093|FG001|Overall Study|Withdrawal by Subject|0|||
125128498|NCT00112463|450096094|FG000|Overall Study|Physician Decision|1|||
125128499|NCT00112463|450096094|FG000|Overall Study|Progression|30|||
125128500|NCT00112463|450096094|FG000|Overall Study|Second Primary|1|||
125128501|NCT00112463|450096094|FG000|Overall Study|Toxicity|3|||
125128502|NCT00112463|450096094|FG000|Overall Study|Withdrawal by Subject|2|||
125128503|NCT00112463|450096094|FG000|Overall Study|Never started treatment|2|||
125128504|NCT01118312|450096101|FG000|Overall Study|Lost to Follow-up|33|||
125128505|NCT01118312|450096102|FG001|Overall Study|Lost to Follow-up|32|||
125128506|NCT01118312|450096101|FG000|Overall Study|Withdrawal by Subject|1|||
125128507|NCT01118312|450096102|FG001|Overall Study|Withdrawal by Subject|3|||
125128508|NCT01546545|450096106|FG000|Overall Study|Withdrawal by Subject|1|||
124961225|NCT03569475|449485185|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
124961226|NCT03569475|449485186|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
124961227|NCT03569475|449485187|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
124961228|NCT03569475|449485185|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
124961229|NCT03569475|449485186|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
124961230|NCT03569475|449485187|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
124961231|NCT03569475|449485185|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
124961232|NCT03569475|449485186|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
124961233|NCT03569475|449485187|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
124961234|NCT03569475|449485185|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
124961235|NCT03569475|449485186|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
124961236|NCT03569475|449485187|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
124961237|NCT03638258|449485188|FG000|Overall Study|Adverse Event|1|||
124961238|NCT03638258|449485189|FG001|Overall Study|Adverse Event|0|||
124961239|NCT03638258|449485190|FG002|Overall Study|Adverse Event|2|||
124961240|NCT03638258|449485188|FG000|Overall Study|Lost to Follow-up|2|||
124961241|NCT03638258|449485189|FG001|Overall Study|Lost to Follow-up|4|||
124961242|NCT03638258|449485190|FG002|Overall Study|Lost to Follow-up|5|||
124961243|NCT03638258|449485188|FG000|Overall Study|Pregnancy|0|||
124961244|NCT03638258|449485189|FG001|Overall Study|Pregnancy|0|||
124961245|NCT03638258|449485190|FG002|Overall Study|Pregnancy|1|||
124961246|NCT03638258|449485188|FG000|Overall Study|Protocol Violation|0|||
124961247|NCT03638258|449485189|FG001|Overall Study|Protocol Violation|0|||
124961248|NCT03638258|449485190|FG002|Overall Study|Protocol Violation|1|||
124961249|NCT03638258|449485188|FG000|Overall Study|Withdrawal by Subject|4|||
124961250|NCT03638258|449485189|FG001|Overall Study|Withdrawal by Subject|5|||
124961251|NCT03638258|449485190|FG002|Overall Study|Withdrawal by Subject|12|||
124961252|NCT03638258|449485188|FG000|Overall Study|Lack of Efficacy|0|||
124961253|NCT03638258|449485189|FG001|Overall Study|Lack of Efficacy|0|||
124961254|NCT03638258|449485190|FG002|Overall Study|Lack of Efficacy|2|||
124961255|NCT02630706|449485192|FG000|Overall Study|Adverse Event|2|||
124961256|NCT02630706|449485193|FG001|Overall Study|Adverse Event|1|||
124961257|NCT02630706|449485194|FG002|Overall Study|Adverse Event|1|||
124961258|NCT02630706|449485192|FG000|Overall Study|Lost to Follow-up|0|||
124961259|NCT02630706|449485193|FG001|Overall Study|Lost to Follow-up|1|||
124961260|NCT02630706|449485194|FG002|Overall Study|Lost to Follow-up|2|||
124961261|NCT02630706|449485192|FG000|Overall Study|Physician Decision|1|||
124961262|NCT02630706|449485193|FG001|Overall Study|Physician Decision|1|||
124961263|NCT02630706|449485194|FG002|Overall Study|Physician Decision|0|||
124961264|NCT02630706|449485192|FG000|Overall Study|Pregnancy|0|||
124961265|NCT02630706|449485193|FG001|Overall Study|Pregnancy|1|||
124961266|NCT02630706|449485194|FG002|Overall Study|Pregnancy|0|||
124961267|NCT02630706|449485192|FG000|Overall Study|Withdrawal by Subject|4|||
124961268|NCT02630706|449485193|FG001|Overall Study|Withdrawal by Subject|5|||
124961269|NCT02630706|449485194|FG002|Overall Study|Withdrawal by Subject|7|||
124961270|NCT01678898|449485195|FG000|PB-102-F01|Adverse Event|0|||
124961271|NCT01678898|449485196|FG001|PB-102-F01|Adverse Event|1|||
124961272|NCT01678898|449485197|FG002|PB-102-F01|Adverse Event|0|||
124961273|NCT01678898|449485195|FG000|PB-102-F01|Physician Decision|0|||
125128509|NCT00735904|450096107|FG000|Overall Study|Adverse Event|3|||
125128510|NCT00735904|450096107|FG000|Overall Study|Death|20|||
124961274|NCT01678898|449485196|FG001|PB-102-F01|Physician Decision|1|||
124961275|NCT01678898|449485197|FG002|PB-102-F01|Physician Decision|0|||
124961276|NCT01527500|449485200|FG000|Part A|Administrative|11|||
124961277|NCT01527500|449485201|FG001|Part A|Administrative|7|||
124961278|NCT01527500|449485200|FG000|Part A|Adverse Event|4|||
124961279|NCT01527500|449485201|FG001|Part A|Adverse Event|2|||
124961280|NCT01527500|449485200|FG000|Part A|Death|4|||
124961281|NCT01527500|449485201|FG001|Part A|Death|1|||
124961282|NCT01527500|449485200|FG000|Part A|Lost to Follow-up|0|||
124961283|NCT01527500|449485201|FG001|Part A|Lost to Follow-up|1|||
124961284|NCT01527500|449485200|FG000|Part A|Protocol Deviation|9|||
125128511|NCT00735904|450096107|FG000|Overall Study|Protocol Violation|1|||
124961285|NCT01527500|449485201|FG001|Part A|Protocol Deviation|2|||
124961286|NCT01527500|449485200|FG000|Part A|Withdrawal by Subject|2|||
124961287|NCT01527500|449485201|FG001|Part A|Withdrawal by Subject|0|||
124961288|NCT01527500|449485200|FG000|Part B|Adverse Event|1|||
124961289|NCT01527500|449485201|FG001|Part B|Adverse Event|0|||
124961290|NCT03078751|449485209|FG000|Overall Study|Adverse Event|4|||
124961291|NCT03078751|449485210|FG001|Overall Study|Adverse Event|0|||
124961292|NCT03078751|449485209|FG000|Overall Study|Physician Decision|1|||
124961293|NCT03078751|449485210|FG001|Overall Study|Physician Decision|0|||
124961294|NCT03078751|449485209|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
124961295|NCT03078751|449485210|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
124961296|NCT03078751|449485209|FG000|Overall Study|Subject/guardian decision|8|||
125128512|NCT00735904|450096107|FG000|Overall Study|Withdrawal by Subject|1|||
125128513|NCT00735904|450096107|FG000|Overall Study|Study Terminated by Sponsor|5|||
125128514|NCT00735904|450096107|FG000|Overall Study|Other|8|||
125128515|NCT01390844|450096108|FG000|Treatment Phase|Adverse Event|12|||
125128516|NCT01390844|450096109|FG001|Treatment Phase|Adverse Event|2|||
125128517|NCT01390844|450096110|FG002|Treatment Phase|Adverse Event|3|||
125128518|NCT01390844|450096111|FG003|Treatment Phase|Adverse Event|2|||
125128519|NCT01390844|450096108|FG000|Treatment Phase|Treatment Failure|23|||
125128520|NCT01390844|450096109|FG001|Treatment Phase|Treatment Failure|25|||
125128521|NCT01390844|450096110|FG002|Treatment Phase|Treatment Failure|10|||
125128522|NCT01390844|450096111|FG003|Treatment Phase|Treatment Failure|13|||
125128523|NCT01390844|450096108|FG000|Treatment Phase|Non-Medical Reasons|5|||
125128524|NCT01390844|450096109|FG001|Treatment Phase|Non-Medical Reasons|1|||
125128525|NCT01390844|450096110|FG002|Treatment Phase|Non-Medical Reasons|8|||
125128526|NCT01390844|450096111|FG003|Treatment Phase|Non-Medical Reasons|1|||
125128527|NCT01390844|450096108|FG000|Treatment Phase|Non-GCP Compliant|0|||
125128528|NCT01390844|450096109|FG001|Treatment Phase|Non-GCP Compliant|0|||
125128529|NCT01390844|450096110|FG002|Treatment Phase|Non-GCP Compliant|10|||
125128530|NCT01390844|450096111|FG003|Treatment Phase|Non-GCP Compliant|3|||
125128531|NCT01390844|450096108|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
125128532|NCT01390844|450096109|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
125128533|NCT01390844|450096110|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
125128534|NCT01390844|450096111|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
125128535|NCT03204539|450096114|FG000|Overall Study|Loss of funding|0|||
125128536|NCT03204539|450096115|FG001|Overall Study|Loss of funding|1|||
125128537|NCT05093205|450096116|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
125128538|NCT05093205|450096117|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
125128539|NCT05093205|450096118|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
125128540|NCT05093205|450096119|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
125128541|NCT05093205|450096120|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
125128542|NCT05093205|450096121|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
125128543|NCT05093205|450096122|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
125128544|NCT05093205|450096123|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
125128545|NCT05093205|450096124|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
125128546|NCT05093205|450096125|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
125128547|NCT05093205|450096126|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
125128548|NCT05093205|450096127|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
125128549|NCT05093205|450096128|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
125128550|NCT05093205|450096116|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
124961297|NCT03078751|449485210|FG001|Overall Study|Subject/guardian decision|1|||
124961298|NCT03078751|449485209|FG000|Overall Study|Untreated|0|||
124961299|NCT03078751|449485210|FG001|Overall Study|Untreated|4|||
124961300|NCT01209286|449485211|FG000|Overall Study|Adverse Event|4|||
124961301|NCT01209286|449485212|FG001|Overall Study|Adverse Event|3|||
124961302|NCT01209286|449485213|FG002|Overall Study|Adverse Event|1|||
124961303|NCT01209286|449485211|FG000|Overall Study|Hematological Relapse After Remission|0|||
124961304|NCT01209286|449485212|FG001|Overall Study|Hematological Relapse After Remission|1|||
124961305|NCT01209286|449485213|FG002|Overall Study|Hematological Relapse After Remission|1|||
124961306|NCT01209286|449485211|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
124961307|NCT01209286|449485212|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
124961308|NCT01209286|449485213|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
124961309|NCT01209286|449485211|FG000|Overall Study|Physician Decision|0|||
124961310|NCT01209286|449485212|FG001|Overall Study|Physician Decision|2|||
124961311|NCT01209286|449485213|FG002|Overall Study|Physician Decision|0|||
124961312|NCT01209286|449485211|FG000|Overall Study|Other|0|||
124961313|NCT01209286|449485212|FG001|Overall Study|Other|1|||
124961314|NCT01209286|449485213|FG002|Overall Study|Other|0|||
125128551|NCT05093205|450096117|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125128552|NCT05093205|450096118|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
125128553|NCT05093205|450096119|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125128554|NCT05093205|450096120|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125128555|NCT05093205|450096121|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125128556|NCT05093205|450096122|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125215722|NCT03383692|450417498|FG000|Overall Study|Progressive disease as per RECIST|3|||
125215723|NCT03383692|450417499|FG001|Overall Study|Progressive disease as per RECIST|3|||
124961315|NCT00981578|449485214|FG000|Overall Study|Death|1|||
124961316|NCT00981578|449485214|FG000|Overall Study|Withdrawal by Subject|2|||
125128557|NCT05093205|450096123|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125128558|NCT05093205|450096124|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125128559|NCT05093205|450096125|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125128560|NCT05093205|450096126|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
124961317|NCT03030599|449485215|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
124961318|NCT03030599|449485216|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
124961319|NCT03030599|449485217|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
124961320|NCT03030599|449485215|FG000|Open Label Treatment and Titration|Other|1|||
124961321|NCT03030599|449485216|FG001|Open Label Treatment and Titration|Other|0|||
124961322|NCT03030599|449485217|FG002|Open Label Treatment and Titration|Other|0|||
124961323|NCT03030599|449485215|FG000|Open Label Treatment and Titration|Physician Decision|3|||
124961324|NCT03030599|449485216|FG001|Open Label Treatment and Titration|Physician Decision|0|||
124961325|NCT03030599|449485217|FG002|Open Label Treatment and Titration|Physician Decision|0|||
124961326|NCT03030599|449485215|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
124961327|NCT03030599|449485216|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
124961328|NCT03030599|449485217|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
124961329|NCT03030599|449485215|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
124961330|NCT03030599|449485216|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
124961331|NCT03030599|449485217|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
124961332|NCT03030599|449485215|FG000|Open Label Treatment and Titration|Adverse Event|18|||
124961333|NCT03030599|449485216|FG001|Open Label Treatment and Titration|Adverse Event|0|||
124961334|NCT03030599|449485217|FG002|Open Label Treatment and Titration|Adverse Event|0|||
124961335|NCT03030599|449485215|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
124961336|NCT03030599|449485216|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
124961337|NCT03030599|449485217|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
124961338|NCT03030599|449485215|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
124961339|NCT03030599|449485216|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
124961340|NCT03030599|449485217|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
124961341|NCT03030599|449485215|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
124961342|NCT03030599|449485216|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
124961343|NCT03030599|449485217|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
124961344|NCT03030599|449485215|FG000|Stable Dose|Protocol deviation|3|||
124961345|NCT03030599|449485216|FG001|Stable Dose|Protocol deviation|0|||
124961346|NCT03030599|449485217|FG002|Stable Dose|Protocol deviation|0|||
124961347|NCT03030599|449485215|FG000|Stable Dose|Adverse Event|1|||
124961348|NCT03030599|449485216|FG001|Stable Dose|Adverse Event|0|||
124961349|NCT03030599|449485217|FG002|Stable Dose|Adverse Event|0|||
124961350|NCT03030599|449485215|FG000|Stable Dose|Lost to Follow-up|1|||
124961351|NCT03030599|449485216|FG001|Stable Dose|Lost to Follow-up|0|||
124961352|NCT03030599|449485217|FG002|Stable Dose|Lost to Follow-up|0|||
124961353|NCT03030599|449485215|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
124961354|NCT03030599|449485216|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
124961355|NCT03030599|449485217|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
124961356|NCT03030599|449485215|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
124961357|NCT03030599|449485216|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
124961358|NCT03030599|449485217|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
124961359|NCT03030599|449485215|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
124961360|NCT03030599|449485216|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
124961361|NCT03030599|449485217|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
124961362|NCT03030599|449485215|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
124961363|NCT03030599|449485216|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
124961364|NCT03030599|449485217|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
124961365|NCT03030599|449485215|FG000|Open-label Extension|Adverse Event|3|||
124961366|NCT03030599|449485216|FG001|Open-label Extension|Adverse Event|0|||
124961367|NCT03030599|449485217|FG002|Open-label Extension|Adverse Event|0|||
124961368|NCT03030599|449485215|FG000|Open-label Extension|Lost to Follow-up|2|||
124961369|NCT03030599|449485216|FG001|Open-label Extension|Lost to Follow-up|0|||
124961370|NCT03030599|449485217|FG002|Open-label Extension|Lost to Follow-up|0|||
124961371|NCT03030599|449485215|FG000|Open-label Extension|Lack of Efficacy|1|||
124961372|NCT03030599|449485216|FG001|Open-label Extension|Lack of Efficacy|0|||
124961373|NCT03030599|449485217|FG002|Open-label Extension|Lack of Efficacy|0|||
124961374|NCT03030599|449485215|FG000|Open-label Extension|Other Reason|1|||
125128561|NCT05093205|450096127|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125128562|NCT05093205|450096128|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125128563|NCT05093205|450096116|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
124961375|NCT03030599|449485216|FG001|Open-label Extension|Other Reason|0|||
124961376|NCT03030599|449485217|FG002|Open-label Extension|Other Reason|0|||
124961377|NCT01180790|449485218|FG000|Overall Study|Adverse Event|1|||
124961378|NCT01180790|449485219|FG001|Overall Study|Adverse Event|1|||
124961379|NCT01180790|449485220|FG002|Overall Study|Adverse Event|2|||
124961380|NCT01180790|449485221|FG003|Overall Study|Adverse Event|0|||
124961381|NCT01180790|449485222|FG004|Overall Study|Adverse Event|1|||
124961382|NCT01180790|449485223|FG005|Overall Study|Adverse Event|3|||
124961383|NCT01180790|449485224|FG006|Overall Study|Adverse Event|0|||
124961384|NCT01180790|449485218|FG000|Overall Study|Withdrawal by Subject|3|||
125128564|NCT05093205|450096117|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
125128565|NCT05093205|450096118|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
125128566|NCT05093205|450096119|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
125128567|NCT05093205|450096120|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
125128568|NCT05093205|450096121|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
125128569|NCT05093205|450096122|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
125128570|NCT05093205|450096123|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
125128571|NCT05093205|450096124|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
125128572|NCT05093205|450096125|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
125128573|NCT05093205|450096126|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
125128574|NCT05093205|450096127|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
125128575|NCT05093205|450096128|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
125128576|NCT05093205|450096116|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
125128577|NCT05093205|450096117|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
125128578|NCT05093205|450096118|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
125128579|NCT05093205|450096119|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
125128580|NCT05093205|450096120|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
125128581|NCT05093205|450096121|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
125128582|NCT05093205|450096122|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
125128583|NCT05093205|450096123|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
125128584|NCT05093205|450096124|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
125128585|NCT05093205|450096125|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
125128586|NCT05093205|450096126|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
125128587|NCT05093205|450096127|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
125128588|NCT05093205|450096128|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
125128589|NCT05093205|450096116|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
125128590|NCT05093205|450096117|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
125128591|NCT05093205|450096118|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
125128592|NCT05093205|450096119|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
125128593|NCT05093205|450096120|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
125128594|NCT05093205|450096121|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
125128595|NCT05093205|450096122|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
125128596|NCT05093205|450096123|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
125128597|NCT05093205|450096124|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
125128598|NCT05093205|450096125|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
124961385|NCT01180790|449485219|FG001|Overall Study|Withdrawal by Subject|0|||
124961386|NCT01180790|449485220|FG002|Overall Study|Withdrawal by Subject|5|||
124961387|NCT01180790|449485221|FG003|Overall Study|Withdrawal by Subject|0|||
124961388|NCT01180790|449485222|FG004|Overall Study|Withdrawal by Subject|2|||
124961389|NCT01180790|449485223|FG005|Overall Study|Withdrawal by Subject|1|||
124961390|NCT01180790|449485224|FG006|Overall Study|Withdrawal by Subject|0|||
124961391|NCT01180790|449485218|FG000|Overall Study|Lost to Follow-up|3|||
124961392|NCT01180790|449485219|FG001|Overall Study|Lost to Follow-up|1|||
124961393|NCT01180790|449485220|FG002|Overall Study|Lost to Follow-up|0|||
124961394|NCT01180790|449485221|FG003|Overall Study|Lost to Follow-up|2|||
124961395|NCT01180790|449485222|FG004|Overall Study|Lost to Follow-up|1|||
124961396|NCT01180790|449485223|FG005|Overall Study|Lost to Follow-up|0|||
124961397|NCT01180790|449485224|FG006|Overall Study|Lost to Follow-up|1|||
124961398|NCT01180790|449485218|FG000|Overall Study|Physician Decision|1|||
124961399|NCT01180790|449485219|FG001|Overall Study|Physician Decision|0|||
124961400|NCT01180790|449485220|FG002|Overall Study|Physician Decision|0|||
124961401|NCT01180790|449485221|FG003|Overall Study|Physician Decision|1|||
124961402|NCT01180790|449485222|FG004|Overall Study|Physician Decision|0|||
124961403|NCT01180790|449485223|FG005|Overall Study|Physician Decision|0|||
124961404|NCT01180790|449485224|FG006|Overall Study|Physician Decision|0|||
124961405|NCT01180790|449485218|FG000|Overall Study|Lack of Efficacy|1|||
124961406|NCT01180790|449485219|FG001|Overall Study|Lack of Efficacy|2|||
124961407|NCT01180790|449485220|FG002|Overall Study|Lack of Efficacy|5|||
125128599|NCT05093205|450096126|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
125128600|NCT05093205|450096127|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
124961408|NCT01180790|449485221|FG003|Overall Study|Lack of Efficacy|6|||
124961409|NCT01180790|449485222|FG004|Overall Study|Lack of Efficacy|1|||
124961410|NCT01180790|449485223|FG005|Overall Study|Lack of Efficacy|3|||
125128601|NCT05093205|450096128|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
125128602|NCT05093205|450096116|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
125128603|NCT05093205|450096117|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
125215724|NCT03383692|450417498|FG000|Overall Study|Clinical progression|0|||
124961411|NCT01180790|449485224|FG006|Overall Study|Lack of Efficacy|0|||
124961412|NCT01180790|449485218|FG000|Overall Study|compliance|0|||
124961413|NCT01180790|449485219|FG001|Overall Study|compliance|1|||
124961414|NCT01180790|449485220|FG002|Overall Study|compliance|0|||
124961415|NCT01180790|449485221|FG003|Overall Study|compliance|0|||
124961416|NCT01180790|449485222|FG004|Overall Study|compliance|0|||
124961417|NCT01180790|449485223|FG005|Overall Study|compliance|0|||
124961418|NCT01180790|449485224|FG006|Overall Study|compliance|0|||
125128604|NCT05093205|450096118|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
125128605|NCT05093205|450096119|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
125128606|NCT05093205|450096120|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
125128607|NCT05093205|450096121|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
125128608|NCT05093205|450096122|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
125128609|NCT05093205|450096123|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
124961419|NCT01180790|449485218|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
124961420|NCT01180790|449485219|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
124961421|NCT01180790|449485220|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
124961422|NCT01180790|449485221|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
124961423|NCT01180790|449485222|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
124961424|NCT01180790|449485223|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
124961425|NCT01180790|449485224|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
124961426|NCT04582864|449485225|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
124961427|NCT04582864|449485225|FG000|Overall Study|Death|1|||
124961428|NCT00316589|449485226|FG000|Overall Study|Withdrawal by Subject|0|||
124961429|NCT00316589|449485227|FG001|Overall Study|Withdrawal by Subject|5|||
124961430|NCT00316589|449485228|FG002|Overall Study|Withdrawal by Subject|0|||
124961431|NCT00316589|449485229|FG003|Overall Study|Withdrawal by Subject|1|||
124961432|NCT00316589|449485226|FG000|Overall Study|Subject unwilling/unable to comply|0|||
124961433|NCT00316589|449485227|FG001|Overall Study|Subject unwilling/unable to comply|6|||
124961434|NCT00316589|449485228|FG002|Overall Study|Subject unwilling/unable to comply|0|||
124961435|NCT00316589|449485229|FG003|Overall Study|Subject unwilling/unable to comply|2|||
124961436|NCT00316589|449485226|FG000|Overall Study|Adverse Event|1|||
124961437|NCT00316589|449485227|FG001|Overall Study|Adverse Event|0|||
124961438|NCT00316589|449485228|FG002|Overall Study|Adverse Event|0|||
124961439|NCT00316589|449485229|FG003|Overall Study|Adverse Event|1|||
124961440|NCT00316589|449485226|FG000|Overall Study|Physician Decision|0|||
124961441|NCT00316589|449485227|FG001|Overall Study|Physician Decision|1|||
124961442|NCT00316589|449485228|FG002|Overall Study|Physician Decision|0|||
124961443|NCT00316589|449485229|FG003|Overall Study|Physician Decision|0|||
124961444|NCT00316589|449485226|FG000|Overall Study|Other reason|0|||
124961445|NCT00316589|449485227|FG001|Overall Study|Other reason|12|||
124961446|NCT00316589|449485228|FG002|Overall Study|Other reason|1|||
124961447|NCT00316589|449485229|FG003|Overall Study|Other reason|1|||
124961448|NCT01482819|449485230|FG000|Overall Study|Lost to Follow-up|2|||
124961449|NCT00562484|449485231|FG000|Overall Study|Adverse Event|6|||
124961450|NCT00562484|449485232|FG001|Overall Study|Adverse Event|1|||
124961451|NCT00562484|449485231|FG000|Overall Study|Protocol Violation|11|||
124961452|NCT00562484|449485232|FG001|Overall Study|Protocol Violation|2|||
124961453|NCT00562484|449485231|FG000|Overall Study|Withdrawal by Subject|12|||
124961454|NCT00562484|449485232|FG001|Overall Study|Withdrawal by Subject|9|||
124961455|NCT00562484|449485231|FG000|Overall Study|Moved away from the study area|20|||
124961456|NCT00562484|449485232|FG001|Overall Study|Moved away from the study area|9|||
124961457|NCT00562484|449485231|FG000|Overall Study|Lost to Follow-up|132|||
124961458|NCT00562484|449485232|FG001|Overall Study|Lost to Follow-up|71|||
124961459|NCT00562484|449485231|FG000|Overall Study|Reason not provided or not specified|25|||
124961460|NCT00562484|449485232|FG001|Overall Study|Reason not provided or not specified|12|||
124961461|NCT00702520|449485234|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
124961462|NCT00702520|449485235|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
124961463|NCT00702520|449485236|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
124961464|NCT00702520|449485237|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
124961465|NCT00702520|449485234|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
124961466|NCT00702520|449485235|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
124961467|NCT00702520|449485236|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
124961468|NCT00702520|449485237|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
124961469|NCT00702520|449485234|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
124961470|NCT00702520|449485235|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
124961471|NCT00702520|449485236|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
124961472|NCT00702520|449485237|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
124961473|NCT02481934|449485238|FG000|Overall Study|Death|2|||
124961474|NCT04130061|449485246|FG000|Overall Study|OR team forgot to request membrane|1|||
124961475|NCT04130061|449485247|FG001|Overall Study|OR team forgot to request membrane|0|||
124961476|NCT01568112|449485248|FG000|Overall Study|Randomized But Not Treated|0|||
124961477|NCT01568112|449485249|FG001|Overall Study|Randomized But Not Treated|1|||
124961478|NCT01568112|449485250|FG002|Overall Study|Randomized But Not Treated|0|||
124961479|NCT01568112|449485251|FG003|Overall Study|Randomized But Not Treated|0|||
124961480|NCT01568112|449485248|FG000|Overall Study|Withdrew due to Adverse Event|2|||
124961481|NCT01568112|449485249|FG001|Overall Study|Withdrew due to Adverse Event|4|||
125128610|NCT05093205|450096124|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
125128611|NCT05093205|450096125|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
125128612|NCT05093205|450096126|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
125128613|NCT05093205|450096127|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
125128614|NCT05093205|450096128|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
125128615|NCT05093205|450096116|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
125128616|NCT05093205|450096117|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
125128617|NCT05093205|450096118|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
125128618|NCT05093205|450096119|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
125128619|NCT05093205|450096120|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
125128620|NCT05093205|450096121|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
125128621|NCT05093205|450096122|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
125128622|NCT05093205|450096123|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
125128623|NCT05093205|450096124|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
125128624|NCT05093205|450096125|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
125128625|NCT05093205|450096126|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
125128626|NCT05093205|450096127|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
125128627|NCT05093205|450096128|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
125128628|NCT05093205|450096116|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
125128629|NCT05093205|450096117|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
125128630|NCT05093205|450096118|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
125128631|NCT05093205|450096119|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
125128632|NCT05093205|450096120|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
125128633|NCT05093205|450096121|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
125128634|NCT05093205|450096122|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
125128635|NCT05093205|450096123|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
125128636|NCT05093205|450096124|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
125128637|NCT05093205|450096125|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
125128638|NCT05093205|450096126|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
125128639|NCT05093205|450096127|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
125128640|NCT05093205|450096128|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
125128641|NCT05093205|450096116|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128642|NCT05093205|450096117|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128643|NCT05093205|450096118|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128644|NCT05093205|450096119|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128645|NCT05093205|450096120|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128646|NCT05093205|450096121|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128647|NCT05093205|450096122|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128648|NCT05093205|450096123|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128649|NCT05093205|450096124|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128650|NCT05093205|450096125|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
125128651|NCT05093205|450096126|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128652|NCT05093205|450096127|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128653|NCT05093205|450096128|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128654|NCT05093205|450096116|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
125128655|NCT05093205|450096117|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
125128656|NCT05093205|450096118|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
125128657|NCT05093205|450096119|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
125128658|NCT05093205|450096120|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
125128659|NCT05093205|450096121|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
125128660|NCT05093205|450096122|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
125128661|NCT05093205|450096123|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
125128662|NCT05093205|450096124|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
125128663|NCT05093205|450096125|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
125128664|NCT05093205|450096126|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
125128665|NCT05093205|450096127|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
125128666|NCT05093205|450096128|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
125128667|NCT05093205|450096116|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128668|NCT05093205|450096117|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128669|NCT05093205|450096118|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128670|NCT05093205|450096119|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128671|NCT05093205|450096120|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128672|NCT05093205|450096121|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128673|NCT05093205|450096122|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128674|NCT05093205|450096123|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128675|NCT05093205|450096124|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128676|NCT05093205|450096125|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128677|NCT05093205|450096126|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
125128678|NCT05093205|450096127|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128679|NCT05093205|450096128|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128680|NCT05093205|450096116|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128681|NCT05093205|450096117|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128682|NCT05093205|450096118|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128683|NCT05093205|450096119|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128684|NCT05093205|450096120|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128685|NCT05093205|450096121|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128686|NCT05093205|450096122|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128687|NCT05093205|450096123|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128688|NCT05093205|450096124|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128689|NCT05093205|450096125|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128690|NCT05093205|450096126|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128691|NCT05093205|450096127|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
125128692|NCT05093205|450096128|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128693|NCT05093205|450096116|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
125128694|NCT05093205|450096117|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
125128695|NCT05093205|450096118|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
125128696|NCT05093205|450096119|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
125128697|NCT05093205|450096120|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
124961482|NCT01568112|449485250|FG002|Overall Study|Withdrew due to Adverse Event|6|||
124961483|NCT01568112|449485251|FG003|Overall Study|Withdrew due to Adverse Event|3|||
124961484|NCT01568112|449485248|FG000|Overall Study|Lost to Follow-up|0|||
124961485|NCT01568112|449485249|FG001|Overall Study|Lost to Follow-up|0|||
124961486|NCT01568112|449485250|FG002|Overall Study|Lost to Follow-up|0|||
124961487|NCT01568112|449485251|FG003|Overall Study|Lost to Follow-up|1|||
124961488|NCT01568112|449485248|FG000|Overall Study|Withdrawal by Subject|2|||
124961489|NCT01568112|449485249|FG001|Overall Study|Withdrawal by Subject|3|||
124961490|NCT01568112|449485250|FG002|Overall Study|Withdrawal by Subject|0|||
124961491|NCT01568112|449485251|FG003|Overall Study|Withdrawal by Subject|7|||
125128698|NCT05093205|450096121|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
124961492|NCT01568112|449485248|FG000|Overall Study|Withdrawal by Physician|1|||
124961493|NCT01568112|449485249|FG001|Overall Study|Withdrawal by Physician|0|||
125128699|NCT05093205|450096122|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
125128700|NCT05093205|450096123|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
125128701|NCT05093205|450096124|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
125128702|NCT05093205|450096125|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
125128703|NCT05093205|450096126|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
124961494|NCT01568112|449485250|FG002|Overall Study|Withdrawal by Physician|1|||
124961495|NCT01568112|449485251|FG003|Overall Study|Withdrawal by Physician|1|||
124961496|NCT00560313|449486474|FG000|Overall Study|Adverse Events or Death|2|||
125128704|NCT05093205|450096127|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
125128705|NCT05093205|450096128|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
125128706|NCT05093205|450096116|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128707|NCT05093205|450096117|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128708|NCT05093205|450096118|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128709|NCT05093205|450096119|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128710|NCT05093205|450096120|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128711|NCT05093205|450096121|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128712|NCT05093205|450096122|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128713|NCT05093205|450096123|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128714|NCT05093205|450096124|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128715|NCT05093205|450096125|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128716|NCT05093205|450096126|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128717|NCT05093205|450096127|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
125128718|NCT05093205|450096128|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128719|NCT03361228|450096130|FG000|Overall Study|Other|1|||
125128720|NCT03361228|450096131|FG001|Overall Study|Other|1|||
125128721|NCT03361228|450096130|FG000|Overall Study|Death|3|||
125128722|NCT03361228|450096131|FG001|Overall Study|Death|0|||
125128723|NCT03693430|450096139|FG000|Overall Study|Lost to Follow-up|3|||
125128724|NCT03693430|450096140|FG001|Overall Study|Lost to Follow-up|14|||
125128725|NCT03693430|450096139|FG000|Overall Study|Death|1|||
125128726|NCT03693430|450096140|FG001|Overall Study|Death|0|||
125128727|NCT03693430|450096139|FG000|Overall Study|Withdrawal by Subject|0|||
125128728|NCT03693430|450096140|FG001|Overall Study|Withdrawal by Subject|4|||
125128729|NCT04185909|450096141|FG000|Overall Study|Lost to Follow-up|1|||
125128730|NCT01417078|450096142|FG000|Overall Study|Withdrawal by Subject|1|||
125128731|NCT01223365|450096151|FG000|Open-label Titration Period|Enrolled but not treated|1|||
125128732|NCT01223365|450096151|FG000|Open-label Titration Period|Adverse Event|23|||
125128733|NCT01223365|450096151|FG000|Open-label Titration Period|Lack of Efficacy|3|||
125128734|NCT01223365|450096151|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
125128735|NCT01223365|450096151|FG000|Open-label Titration Period|Protocol Violation|1|||
125128736|NCT01223365|450096151|FG000|Open-label Titration Period|Lost to Follow-up|2|||
125128737|NCT01223365|450096151|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
125128738|NCT01223365|450096151|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
125128739|NCT01223365|450096151|FG000|Open-label Titration Period|Starting physical therapy|1|||
125128740|NCT01223365|450096151|FG000|Open-label Treatment Period|Adverse Event|39|||
125128741|NCT01223365|450096151|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
125215725|NCT03383692|450417499|FG001|Overall Study|Clinical progression|1|||
125128742|NCT01223365|450096151|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
125128743|NCT01223365|450096151|FG000|Open-label Treatment Period|Protocol Violation|15|||
125128744|NCT01223365|450096151|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
125128745|NCT01223365|450096151|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
125215726|NCT03383692|450417498|FG000|Overall Study|Adverse Event|3|||
124961497|NCT00560313|449486474|FG000|Overall Study|Withdrawal by Subject|2|||
125215727|NCT03383692|450417499|FG001|Overall Study|Adverse Event|0|||
125031260|NCT00896532|449735113|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125031261|NCT00896532|449735114|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125031262|NCT00896532|449735115|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125031263|NCT00896532|449735116|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125031264|NCT00896532|449735117|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125031265|NCT00896532|449735118|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125031266|NCT00896532|449735119|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125031267|NCT00896532|449735120|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125031268|NCT00896532|449735098|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
125031269|NCT00896532|449735099|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
125031270|NCT00896532|449735100|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
125031271|NCT00896532|449735101|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
125031272|NCT00896532|449735102|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
125031273|NCT00896532|449735103|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
125031274|NCT00896532|449735104|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
125128746|NCT01223365|450096151|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
125128747|NCT01223365|450096151|FG000|Open-label Treatment Period|Moved out of area|2|||
125128748|NCT01223365|450096151|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
125128749|NCT01223365|450096151|FG000|Open-label Treatment Period|"Out of window"|1|||
125128750|NCT01223365|450096151|FG000|Open-label Treatment Period|Starting physical therapy|1|||
125031275|NCT00896532|449735105|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
125031276|NCT00896532|449735106|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
125128751|NCT01223365|450096151|FG000|Open-label Treatment Period|Physician Decision|2|||
125128752|NCT03567174|450096152|FG000|Overall Study|Death|24|||
125128753|NCT03567174|450096153|FG001|Overall Study|Death|31|||
125031277|NCT00896532|449735107|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
125031278|NCT00896532|449735108|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
125031279|NCT00896532|449735109|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
125031280|NCT00896532|449735110|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
125031281|NCT00896532|449735111|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
125031282|NCT00896532|449735112|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
125031283|NCT00896532|449735113|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
125031284|NCT00896532|449735114|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
125031285|NCT00896532|449735115|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
125031286|NCT00896532|449735116|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
125031287|NCT00896532|449735117|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
125031288|NCT00896532|449735118|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
125031289|NCT00896532|449735119|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
125031290|NCT00896532|449735120|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
125031291|NCT00896532|449735098|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125031292|NCT00896532|449735099|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125031293|NCT00896532|449735100|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125031294|NCT00896532|449735101|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125031295|NCT00896532|449735102|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125031296|NCT00896532|449735103|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125031297|NCT00896532|449735104|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125031298|NCT00896532|449735105|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125031299|NCT00896532|449735106|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125031300|NCT00896532|449735107|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125031301|NCT00896532|449735108|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125031302|NCT00896532|449735109|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125031303|NCT00896532|449735110|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125031304|NCT00896532|449735111|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125031305|NCT00896532|449735112|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125031306|NCT00896532|449735113|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
125031307|NCT00896532|449735114|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
125031308|NCT00896532|449735115|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125031309|NCT00896532|449735116|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125031310|NCT00896532|449735117|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125031311|NCT00896532|449735118|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125031312|NCT00896532|449735119|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125031313|NCT00896532|449735120|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125031314|NCT00896532|449735098|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125031315|NCT00896532|449735099|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125031316|NCT00896532|449735100|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125031317|NCT00896532|449735101|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125031318|NCT00896532|449735102|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125031319|NCT00896532|449735103|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125128754|NCT03567174|450096152|FG000|Overall Study|Lost to Follow-up|165|||
125128755|NCT03567174|450096153|FG001|Overall Study|Lost to Follow-up|174|||
125128756|NCT03243630|450096154|FG000|Overall Study|Protocol Violation|1|||
125128757|NCT03243630|450096154|FG000|Overall Study|Physician Decision|1|||
125128758|NCT01387737|450097629|FG000|Overall Study|Adverse Event|20|||
125128759|NCT01387737|450097630|FG001|Overall Study|Adverse Event|30|||
125128760|NCT01387737|450097629|FG000|Overall Study|Lack of Efficacy|1|||
125128761|NCT01387737|450097630|FG001|Overall Study|Lack of Efficacy|0|||
125128762|NCT01387737|450097629|FG000|Overall Study|Physician Decision|3|||
125128763|NCT01387737|450097630|FG001|Overall Study|Physician Decision|10|||
125128764|NCT01387737|450097629|FG000|Overall Study|Withdrawal by Subject|27|||
125128765|NCT01387737|450097630|FG001|Overall Study|Withdrawal by Subject|31|||
125128766|NCT01387737|450097629|FG000|Overall Study|Clearly not eligible for the study|1|||
125128767|NCT01387737|450097630|FG001|Overall Study|Clearly not eligible for the study|3|||
125128768|NCT02817841|450097632|FG000|Overall Study|Lost to Follow-up|287|||
124961498|NCT00560313|449486474|FG000|Overall Study|Lost to Follow-up|1|||
125128769|NCT02817841|450097632|FG000|Overall Study|Withdrawal by Subject|183|||
125128770|NCT02817841|450097632|FG000|Overall Study|Adverse event not related to bleeding|131|||
125128771|NCT02817841|450097632|FG000|Overall Study|Adverse event related to bleeding|51|||
125128772|NCT02817841|450097632|FG000|Overall Study|Pregnancy|32|||
125128773|NCT02817841|450097632|FG000|Overall Study|Pregnancy wish|17|||
125128774|NCT02817841|450097632|FG000|Overall Study|Other reasons|53|||
125128775|NCT02817841|450097632|FG000|Overall Study|Protocol Violation|94|||
125128776|NCT01746017|450097641|FG000|Period 1|Withdrawal by Subject|0|||
125128777|NCT01746017|450097642|FG001|Period 1|Withdrawal by Subject|0|||
125128778|NCT01746017|450097643|FG002|Period 1|Withdrawal by Subject|0|||
125128779|NCT01746017|450097644|FG003|Period 1|Withdrawal by Subject|0|||
125128780|NCT01746017|450097645|FG004|Period 1|Withdrawal by Subject|0|||
125128781|NCT01746017|450097646|FG005|Period 1|Withdrawal by Subject|0|||
125128782|NCT01746017|450097647|FG006|Period 1|Withdrawal by Subject|1|||
125128783|NCT01746017|450097648|FG007|Period 1|Withdrawal by Subject|0|||
125128784|NCT01746017|450097649|FG008|Period 1|Withdrawal by Subject|0|||
125128785|NCT01746017|450097650|FG009|Period 1|Withdrawal by Subject|0|||
125128786|NCT01746017|450097651|FG010|Period 1|Withdrawal by Subject|0|||
125128787|NCT01746017|450097641|FG000|Period 3|Withdrawal by Subject|0|||
125128788|NCT01746017|450097642|FG001|Period 3|Withdrawal by Subject|0|||
124961499|NCT00560313|449486474|FG000|Overall Study|Protocol Violation|1|||
124961500|NCT00746785|449486475|FG000|Overall Study|Lost to Follow-up|29|||
124961501|NCT00746785|449486476|FG001|Overall Study|Lost to Follow-up|25|||
124961502|NCT00746785|449486477|FG002|Overall Study|Lost to Follow-up|27|||
124961503|NCT00966979|449486479|FG000|Overall Study|Death|1|||
124961504|NCT00966979|449486479|FG000|Overall Study|Lost to Follow-up|6|||
124961505|NCT00966979|449486479|FG000|Overall Study|Withdrawal by Subject|14|||
124961506|NCT00966979|449486479|FG000|Overall Study|Adverse Event|5|||
124961507|NCT00966979|449486479|FG000|Overall Study|Sponsor terminated early|49|||
124961508|NCT00966979|449486479|FG000|Overall Study|Censored because surgery not done|2|||
124961509|NCT00966979|449486479|FG000|Overall Study|Censored because study device was not implanted|14|||
124961510|NCT00966979|449486479|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
124961511|NCT04140266|449486480|FG000|Overall Study|Physician Decision|2|||
124961512|NCT04140266|449486481|FG001|Overall Study|Physician Decision|0|||
124961513|NCT04140266|449486480|FG000|Overall Study|Withdrawal by Subject|4|||
124961514|NCT04140266|449486481|FG001|Overall Study|Withdrawal by Subject|2|||
124961515|NCT01990313|449486482|FG000|Overall Study|Lost to Follow-up|1|||
124961516|NCT03511378|449486483|FG000|Overall Study|Withdrawal by Subject|2|||
124961517|NCT03511378|449486484|FG001|Overall Study|Withdrawal by Subject|2|||
124961518|NCT03511378|449486483|FG000|Overall Study|Patient not coming or schedule visit|1|||
124961519|NCT03511378|449486484|FG001|Overall Study|Patient not coming or schedule visit|0|||
124961520|NCT00837096|449486485|FG000|Overall Study|Physician Decision|1|||
124961521|NCT00837096|449486486|FG001|Overall Study|Physician Decision|1|||
124961522|NCT00837096|449486485|FG000|Overall Study|Not reported|9|||
125128789|NCT01746017|450097643|FG002|Period 3|Withdrawal by Subject|0|||
125128790|NCT01746017|450097644|FG003|Period 3|Withdrawal by Subject|0|||
125128791|NCT01746017|450097645|FG004|Period 3|Withdrawal by Subject|0|||
125128792|NCT01746017|450097646|FG005|Period 3|Withdrawal by Subject|1|||
125128793|NCT01746017|450097647|FG006|Period 3|Withdrawal by Subject|0|||
125128794|NCT01746017|450097648|FG007|Period 3|Withdrawal by Subject|0|||
125128795|NCT01746017|450097649|FG008|Period 3|Withdrawal by Subject|0|||
125128796|NCT01746017|450097650|FG009|Period 3|Withdrawal by Subject|0|||
125128797|NCT01746017|450097651|FG010|Period 3|Withdrawal by Subject|0|||
125215728|NCT00893971|450417500|FG000|Overall Study|Physician Decision|3|||
125128798|NCT00397488|450097652|FG000|Overall Study|Withdrawal by Subject|3|||
125128799|NCT00397488|450097652|FG000|Overall Study|Adverse Event|3|||
125128800|NCT00397488|450097652|FG000|Overall Study|Death|1|||
125128801|NCT01215981|450097655|FG000|Overall Study|Physician Decision|0|||
125128802|NCT01215981|450097656|FG001|Overall Study|Physician Decision|1|||
125128803|NCT01215981|450097655|FG000|Overall Study|Protocol Violation|1|||
125128804|NCT01215981|450097656|FG001|Overall Study|Protocol Violation|0|||
125128805|NCT01215981|450097655|FG000|Overall Study|Withdrawal by Subject|1|||
125128806|NCT01215981|450097656|FG001|Overall Study|Withdrawal by Subject|0|||
125128807|NCT03075761|450097657|FG000|Overall Study|Lost to Follow-up|1|||
125128808|NCT03075761|450097658|FG001|Overall Study|Lost to Follow-up|6|||
125128809|NCT00840632|450097662|FG000|First Intervention|Withdrawal by Subject|0|||
125128810|NCT00840632|450097663|FG001|First Intervention|Withdrawal by Subject|1|||
125128811|NCT00840632|450097662|FG000|Washout|Withdrawal by Subject|1|||
125128812|NCT00840632|450097663|FG001|Washout|Withdrawal by Subject|1|||
125128813|NCT01294787|450097664|FG000|Period 1|Adverse Event|0|||
125128814|NCT01294787|450097665|FG001|Period 1|Adverse Event|0|||
125128815|NCT01294787|450097666|FG002|Period 1|Adverse Event|0|||
125128816|NCT01294787|450097667|FG003|Period 1|Adverse Event|0|||
124961523|NCT00837096|449486486|FG001|Overall Study|Not reported|8|||
124961524|NCT05006417|449486487|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
124961525|NCT00280683|449486488|FG000|Overall Study|Withdrawal by Subject|1|||
124961526|NCT00280683|449486489|FG001|Overall Study|Withdrawal by Subject|2|||
124961527|NCT00280683|449486488|FG000|Overall Study|Adverse Event|1|||
124961528|NCT00280683|449486489|FG001|Overall Study|Adverse Event|1|||
124961529|NCT01243411|449486490|FG000|Overall Study|Withdrawal by Subject|18|||
124961530|NCT01243411|449486490|FG000|Overall Study|Lost to Follow-up|10|||
124961531|NCT01243411|449486490|FG000|Overall Study|Adverse Event|5|||
124961532|NCT01243411|449486490|FG000|Overall Study|Other|8|||
124961533|NCT00510198|449486493|FG000|Overall Study|Withdrawal by Subject|5|||
124961534|NCT00510198|449486494|FG001|Overall Study|Withdrawal by Subject|4|||
124961535|NCT03712449|449486501|FG000|Overall Study|Withdraw Consent|0|||
124961536|NCT03712449|449486502|FG001|Overall Study|Withdraw Consent|1|||
124961537|NCT05153499|449486506|FG000|Overall Study|Withdrawal by Subject|1|||
124961538|NCT05153499|449486507|FG001|Overall Study|Withdrawal by Subject|0|||
124961539|NCT05153499|449486506|FG000|Overall Study|Clinical Hold|1|||
124961540|NCT05153499|449486507|FG001|Overall Study|Clinical Hold|0|||
124961541|NCT05153499|449486506|FG000|Overall Study|Study Termination|6|||
124961542|NCT05153499|449486507|FG001|Overall Study|Study Termination|5|||
124961543|NCT01649297|449486509|FG000|Overall Study|Adverse Event|5|||
124961544|NCT01649297|449486510|FG001|Overall Study|Adverse Event|5|||
124961545|NCT01649297|449486511|FG002|Overall Study|Adverse Event|4|||
124961546|NCT01649297|449486512|FG003|Overall Study|Adverse Event|13|||
124961547|NCT01649297|449486513|FG004|Overall Study|Adverse Event|1|||
125128817|NCT01294787|450097668|FG004|Period 1|Adverse Event|1|||
125128818|NCT01294787|450097669|FG005|Period 1|Adverse Event|0|||
125128819|NCT01294787|450097664|FG000|Period 1|Withdrawal by Subject|0|||
124961548|NCT01649297|449486509|FG000|Overall Study|Lack of Efficacy|0|||
124961549|NCT01649297|449486510|FG001|Overall Study|Lack of Efficacy|0|||
124961550|NCT01649297|449486511|FG002|Overall Study|Lack of Efficacy|0|||
124961551|NCT01649297|449486512|FG003|Overall Study|Lack of Efficacy|0|||
124961552|NCT01649297|449486513|FG004|Overall Study|Lack of Efficacy|1|||
124961553|NCT01649297|449486509|FG000|Overall Study|Non compliant with Protocol|1|||
124961554|NCT01649297|449486510|FG001|Overall Study|Non compliant with Protocol|0|||
124961555|NCT01649297|449486511|FG002|Overall Study|Non compliant with Protocol|3|||
124961556|NCT01649297|449486512|FG003|Overall Study|Non compliant with Protocol|2|||
124961557|NCT01649297|449486513|FG004|Overall Study|Non compliant with Protocol|1|||
124961558|NCT01649297|449486509|FG000|Overall Study|Lost to Follow-up|1|||
125128820|NCT01294787|450097665|FG001|Period 1|Withdrawal by Subject|0|||
125128821|NCT01294787|450097666|FG002|Period 1|Withdrawal by Subject|0|||
125128822|NCT01294787|450097667|FG003|Period 1|Withdrawal by Subject|1|||
125128823|NCT01294787|450097668|FG004|Period 1|Withdrawal by Subject|1|||
124961559|NCT01649297|449486510|FG001|Overall Study|Lost to Follow-up|1|||
124961560|NCT01649297|449486511|FG002|Overall Study|Lost to Follow-up|4|||
124961561|NCT01649297|449486512|FG003|Overall Study|Lost to Follow-up|3|||
124961562|NCT01649297|449486513|FG004|Overall Study|Lost to Follow-up|0|||
124961563|NCT01649297|449486509|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
124961564|NCT01649297|449486510|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
124961565|NCT01649297|449486511|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
124961566|NCT01649297|449486512|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
124961567|NCT01649297|449486513|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
124961568|NCT01649297|449486509|FG000|Overall Study|For other reason|4|||
124961569|NCT01649297|449486510|FG001|Overall Study|For other reason|1|||
124961570|NCT01649297|449486511|FG002|Overall Study|For other reason|2|||
124961571|NCT01649297|449486512|FG003|Overall Study|For other reason|0|||
124961572|NCT01649297|449486513|FG004|Overall Study|For other reason|0|||
124961573|NCT01685047|449486514|FG000|Overall Study|Withdrawal by Subject|20|||
124961574|NCT01685047|449486514|FG000|Overall Study|Death|26|||
124961575|NCT01685047|449486514|FG000|Overall Study|Lost to Follow-up|8|||
124961576|NCT01685047|449486514|FG000|Overall Study|Physician Decision|25|||
124961577|NCT01685047|449486514|FG000|Overall Study|Adverse Event|5|||
124961578|NCT01685047|449486514|FG000|Overall Study|patient withdrawn by sponsor|1|||
124961579|NCT02490878|449486521|FG000|Overall Study|deemed ineligible|0|||
124961580|NCT02490878|449486522|FG001|Overall Study|deemed ineligible|1|||
124961581|NCT02490878|449486521|FG000|Overall Study|progression prior to treatment|0|||
124961582|NCT02490878|449486522|FG001|Overall Study|progression prior to treatment|1|||
124961583|NCT02490878|449486521|FG000|Overall Study|only submitted baseline QOL|0|||
124961584|NCT02490878|449486522|FG001|Overall Study|only submitted baseline QOL|1|||
124961585|NCT02544113|449486523|FG000|Overall Study|Death|3|||
124961586|NCT02544113|449486524|FG001|Overall Study|Death|4|||
124961587|NCT00451555|449486525|FG000|Overall Study|Protocol Violation|2|||
124961588|NCT00451555|449486526|FG001|Overall Study|Protocol Violation|2|||
124961589|NCT00451555|449486525|FG000|Overall Study|Adverse Event|3|||
124961590|NCT00451555|449486526|FG001|Overall Study|Adverse Event|1|||
124961591|NCT00451555|449486525|FG000|Overall Study|Withdrawal by Subject|6|||
124961592|NCT00451555|449486526|FG001|Overall Study|Withdrawal by Subject|0|||
124961593|NCT00451555|449486525|FG000|Overall Study|Physician Decision|2|||
124961594|NCT00451555|449486526|FG001|Overall Study|Physician Decision|1|||
124961595|NCT02847637|449486527|FG000|Overall Study|Withdrawal by Subject|0|||
124961596|NCT02847637|449486528|FG001|Overall Study|Withdrawal by Subject|1|||
124961597|NCT02847637|449486529|FG002|Overall Study|Withdrawal by Subject|1|||
124961598|NCT02847637|449486530|FG003|Overall Study|Withdrawal by Subject|0|||
124961599|NCT02847637|449486527|FG000|Overall Study|Lost to Follow-up|1|||
124961600|NCT02847637|449486528|FG001|Overall Study|Lost to Follow-up|1|||
124961601|NCT02847637|449486529|FG002|Overall Study|Lost to Follow-up|0|||
124961602|NCT02847637|449486530|FG003|Overall Study|Lost to Follow-up|0|||
124961603|NCT02741713|449486538|FG000|Overall Study|Surgery type changed intra-operatively|2|||
124961604|NCT02741713|449486539|FG001|Overall Study|Surgery type changed intra-operatively|1|||
124961605|NCT01093222|449486540|FG000|Overall Study|Ineligible|6|||
124961606|NCT01093222|449486540|FG000|Overall Study|Adverse Event|7|||
124961607|NCT01093222|449486540|FG000|Overall Study|Progression/relapse|24|||
124961608|NCT01093222|449486540|FG000|Overall Study|Death|2|||
124961609|NCT01093222|449486540|FG000|Overall Study|Not protocol specified|1|||
124961610|NCT00588341|449486541|FG000|Overall Study|Withdrawal by Subject|3|||
124961611|NCT00588341|449486541|FG000|Overall Study|Not treated due to metastatic disease|1|||
124961612|NCT00588341|449486541|FG000|Overall Study|Patient ineligible|1|||
124961613|NCT01670188|449486542|FG000|Overall Study|Death|0|||
124961614|NCT01670188|449486543|FG001|Overall Study|Death|1|||
124961615|NCT01281917|449486551|FG000|Overall Study|Withdrawal by Subject|1|||
124961616|NCT01187407|449486553|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
124961617|NCT01187407|449486554|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
124961618|NCT01187407|449486555|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
124961619|NCT01187407|449486556|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
124961620|NCT01187407|449486557|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
124961621|NCT01187407|449486553|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
124961622|NCT01187407|449486554|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
124961623|NCT01187407|449486555|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
124961624|NCT01187407|449486556|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
124961625|NCT01187407|449486557|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
124961626|NCT01187407|449486553|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
124961627|NCT01187407|449486554|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
124961628|NCT01187407|449486555|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
124961629|NCT01187407|449486556|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
124961630|NCT01187407|449486557|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
124961631|NCT01187407|449486553|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
125128824|NCT01294787|450097669|FG005|Period 1|Withdrawal by Subject|1|||
125128825|NCT01294787|450097664|FG000|Period 1|Administrative problem|0|||
125128826|NCT01294787|450097665|FG001|Period 1|Administrative problem|0|||
125128827|NCT01294787|450097666|FG002|Period 1|Administrative problem|1|||
125128828|NCT01294787|450097667|FG003|Period 1|Administrative problem|0|||
125128829|NCT01294787|450097668|FG004|Period 1|Administrative problem|0|||
125128830|NCT01294787|450097669|FG005|Period 1|Administrative problem|1|||
125128831|NCT01294787|450097664|FG000|Period 2|Adverse Event|0|||
125128832|NCT01294787|450097665|FG001|Period 2|Adverse Event|3|||
125128833|NCT01294787|450097666|FG002|Period 2|Adverse Event|0|||
125128834|NCT01294787|450097667|FG003|Period 2|Adverse Event|1|||
125128835|NCT01294787|450097668|FG004|Period 2|Adverse Event|0|||
125128836|NCT01294787|450097669|FG005|Period 2|Adverse Event|0|||
125128837|NCT01294787|450097664|FG000|Period 2|No longer needs study drug|0|||
125128838|NCT01294787|450097665|FG001|Period 2|No longer needs study drug|0|||
125128839|NCT01294787|450097666|FG002|Period 2|No longer needs study drug|0|||
125128840|NCT01294787|450097667|FG003|Period 2|No longer needs study drug|1|||
125128841|NCT01294787|450097668|FG004|Period 2|No longer needs study drug|0|||
125128842|NCT01294787|450097669|FG005|Period 2|No longer needs study drug|0|||
125128843|NCT01294787|450097664|FG000|Period 3|Adverse Event|0|||
125128844|NCT01294787|450097665|FG001|Period 3|Adverse Event|0|||
125128845|NCT01294787|450097666|FG002|Period 3|Adverse Event|0|||
125128846|NCT01294787|450097667|FG003|Period 3|Adverse Event|0|||
125128847|NCT01294787|450097668|FG004|Period 3|Adverse Event|1|||
125128848|NCT01294787|450097669|FG005|Period 3|Adverse Event|0|||
125128849|NCT01725529|450097670|FG000|Overall Study|Adverse Event|1|||
125128850|NCT01725529|450097671|FG001|Overall Study|Adverse Event|0|||
125128851|NCT01725529|450097672|FG002|Overall Study|Adverse Event|0|||
124961632|NCT01187407|449486554|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
124961633|NCT01187407|449486555|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
124961634|NCT01187407|449486556|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
124961635|NCT01187407|449486557|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
124961636|NCT01187407|449486553|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
124961637|NCT01187407|449486554|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
124961638|NCT01187407|449486555|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
124961639|NCT01187407|449486556|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
124961640|NCT01187407|449486557|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
124961641|NCT01187407|449486553|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
124961642|NCT01187407|449486554|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
124961643|NCT01187407|449486555|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
124961644|NCT01187407|449486556|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
124961645|NCT01187407|449486557|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
124961646|NCT01187407|449486553|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
124961647|NCT01187407|449486554|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
124961648|NCT01187407|449486555|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
124961649|NCT01187407|449486556|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
124961650|NCT01187407|449486557|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
124961651|NCT01187407|449486553|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
124961652|NCT01187407|449486554|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
124961653|NCT01187407|449486555|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
124961654|NCT01187407|449486556|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
124961655|NCT01187407|449486557|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
124961656|NCT01187407|449486553|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
124961657|NCT01187407|449486554|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
124961658|NCT01187407|449486555|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
124961659|NCT01187407|449486556|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
124961660|NCT01187407|449486557|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
124961661|NCT01187407|449486553|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
124961662|NCT01187407|449486554|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
124961663|NCT01187407|449486555|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
124961664|NCT01187407|449486556|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
125128852|NCT01725529|450097670|FG000|Overall Study|Lost to Follow-up|2|||
125128853|NCT01725529|450097671|FG001|Overall Study|Lost to Follow-up|1|||
125128854|NCT01725529|450097672|FG002|Overall Study|Lost to Follow-up|1|||
125128855|NCT01725529|450097670|FG000|Overall Study|Protocol Violation|0|||
125128856|NCT01725529|450097671|FG001|Overall Study|Protocol Violation|1|||
125128857|NCT01725529|450097672|FG002|Overall Study|Protocol Violation|1|||
125128858|NCT01725529|450097670|FG000|Overall Study|Withdrawal by Subject|12|||
125128859|NCT01725529|450097671|FG001|Overall Study|Withdrawal by Subject|14|||
125128860|NCT01725529|450097672|FG002|Overall Study|Withdrawal by Subject|8|||
125128861|NCT01948258|450097677|FG000|Overall Study|Pregnancy|41|||
125128862|NCT01948258|450097677|FG000|Overall Study|Did not complete by cut-off date|35|||
125128863|NCT01948258|450097677|FG000|Overall Study|Lost to Follow-up|27|||
125128864|NCT01948258|450097677|FG000|Overall Study|Withdrawal by SPD|8|||
125128865|NCT01948258|450097677|FG000|Overall Study|Withdrawal by Subject|6|||
125128866|NCT01948258|450097677|FG000|Overall Study|Health Care Professional|43|||
125128867|NCT01948258|450097677|FG000|Overall Study|Removed from statistical analysis|2|||
125128868|NCT02262377|450097678|FG000|Overall Study|Lost to Follow-up|5|||
125128869|NCT02262377|450097679|FG001|Overall Study|Lost to Follow-up|6|||
125128870|NCT02262377|450097678|FG000|Overall Study|Found ineligible after enrollment|3|||
125128871|NCT02262377|450097679|FG001|Overall Study|Found ineligible after enrollment|0|||
125128872|NCT02262377|450097678|FG000|Overall Study|Withdrawal by Subject|4|||
125128873|NCT02262377|450097679|FG001|Overall Study|Withdrawal by Subject|0|||
125128874|NCT00723528|450097683|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
124961665|NCT01187407|449486557|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
124961666|NCT01187407|449486553|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
124961667|NCT01187407|449486554|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
124961668|NCT01187407|449486555|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
124961669|NCT01187407|449486556|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
124961670|NCT01187407|449486557|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
124961671|NCT01187407|449486553|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
124961672|NCT01187407|449486554|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
124961673|NCT01187407|449486555|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
124961674|NCT01187407|449486556|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
124961675|NCT01187407|449486557|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
124961676|NCT01187407|449486553|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
124961677|NCT01187407|449486554|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
124961678|NCT01187407|449486555|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
124961679|NCT01187407|449486556|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
124961680|NCT01187407|449486557|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
124961681|NCT01187407|449486553|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
124961682|NCT01187407|449486554|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
124961683|NCT01187407|449486555|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
124961684|NCT01187407|449486556|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
124961685|NCT01187407|449486557|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
124961686|NCT00776984|449486560|FG000|Overall Study|Adverse Event|8|||
124961687|NCT00776984|449486561|FG001|Overall Study|Adverse Event|2|||
124961688|NCT00776984|449486560|FG000|Overall Study|Protocol Violation|4|||
124961689|NCT00776984|449486561|FG001|Overall Study|Protocol Violation|2|||
124961690|NCT00776984|449486560|FG000|Overall Study|Lost to Follow-up|2|||
124961691|NCT00776984|449486561|FG001|Overall Study|Lost to Follow-up|0|||
124961692|NCT00776984|449486560|FG000|Overall Study|Withdrawal by Subject|12|||
124961693|NCT00776984|449486561|FG001|Overall Study|Withdrawal by Subject|7|||
124961694|NCT00776984|449486560|FG000|Overall Study|Lack of Efficacy|0|||
124961695|NCT00776984|449486561|FG001|Overall Study|Lack of Efficacy|1|||
124961696|NCT00776984|449486560|FG000|Overall Study|Other|5|||
124961697|NCT00776984|449486561|FG001|Overall Study|Other|9|||
124961698|NCT02573883|449486569|FG000|Six Month Follow Up|Lost to Follow-up|1|||
124961699|NCT02573883|449486570|FG001|Six Month Follow Up|Lost to Follow-up|0|||
124961700|NCT02573883|449486571|FG002|Six Month Follow Up|Lost to Follow-up|0|||
124961701|NCT02573883|449486572|FG003|Six Month Follow Up|Lost to Follow-up|0|||
124961702|NCT02573883|449486569|FG000|One Year Follow Up|Lost to Follow-up|2|||
124961703|NCT02573883|449486570|FG001|One Year Follow Up|Lost to Follow-up|1|||
124961704|NCT02573883|449486571|FG002|One Year Follow Up|Lost to Follow-up|0|||
124961705|NCT02573883|449486572|FG003|One Year Follow Up|Lost to Follow-up|0|||
124961706|NCT01544309|449486573|FG000|Overall Study|Withdrawal by Subject|12|||
124961707|NCT01544309|449486574|FG001|Overall Study|Withdrawal by Subject|7|||
124961708|NCT01544309|449486573|FG000|Overall Study|Protocol Violation|2|||
124961709|NCT01544309|449486574|FG001|Overall Study|Protocol Violation|1|||
124961710|NCT01544309|449486573|FG000|Overall Study|Physician Decision|4|||
124961711|NCT01544309|449486574|FG001|Overall Study|Physician Decision|1|||
124961712|NCT01544309|449486573|FG000|Overall Study|Not performed pre-dose examination|1|||
124961713|NCT01544309|449486574|FG001|Overall Study|Not performed pre-dose examination|2|||
124961714|NCT01544309|449486573|FG000|Overall Study|Administered prohibit prior medication|1|||
124961715|NCT01544309|449486574|FG001|Overall Study|Administered prohibit prior medication|0|||
124961716|NCT00118703|449486575|FG000|Overall Study|Protocol Violation|1|||
124961717|NCT00118703|449486576|FG001|Overall Study|Protocol Violation|0|||
124961718|NCT00118703|449486575|FG000|Overall Study|Adverse Event|1|||
124961719|NCT00118703|449486576|FG001|Overall Study|Adverse Event|1|||
125128875|NCT00723528|450097684|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
125128876|NCT00723528|450097685|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
124961720|NCT00118703|449486575|FG000|Overall Study|Participant took two different treatment|0|||
124961721|NCT00118703|449486576|FG001|Overall Study|Participant took two different treatment|1|||
124961722|NCT00118703|449486575|FG000|Overall Study|Withdrawal by Subject|2|||
124961723|NCT00118703|449486576|FG001|Overall Study|Withdrawal by Subject|5|||
124961724|NCT00118703|449486575|FG000|Overall Study|Lost to Follow-up|1|||
124961725|NCT00118703|449486576|FG001|Overall Study|Lost to Follow-up|2|||
124961726|NCT03796208|449486581|FG000|Overall Study|Withdrawal by Subject|3|||
124961727|NCT03796208|449486582|FG001|Overall Study|Withdrawal by Subject|0|||
124961728|NCT03796208|449486581|FG000|Overall Study|Loss of pregnancy|1|||
124961729|NCT03796208|449486582|FG001|Overall Study|Loss of pregnancy|1|||
124961730|NCT03796208|449486581|FG000|Overall Study|Changed prenatal clinics|0|||
124961731|NCT03796208|449486582|FG001|Overall Study|Changed prenatal clinics|5|||
124961732|NCT03796208|449486581|FG000|Overall Study|Lost to Follow-up|20|||
124961733|NCT03796208|449486582|FG001|Overall Study|Lost to Follow-up|16|||
124961734|NCT01560585|449486583|FG000|Overall Study|Physician Decision|3|||
124961735|NCT02175745|449486584|FG000|Overall Study|Not Eligible|1|||
124961736|NCT04688086|449486585|FG000|Overall Study|Lost to Follow-up|164|||
124961737|NCT04688086|449486585|FG000|Overall Study|Imaging error;|64|||
124961738|NCT04206384|449486586|FG000|Overall Study|Withdrawal by Subject|8|||
124961739|NCT04206384|449486586|FG000|Overall Study|Adverse Event|2|||
124961740|NCT00006436|449486587|FG000|Overall Study|Refused further treatment|2|||
124961741|NCT00006436|449486587|FG000|Overall Study|Declined to participate (before treatment started)|1|||
124961742|NCT00942188|449486590|FG000|Overall Study|Adverse Event|0|||
124961743|NCT00942188|449486591|FG001|Overall Study|Adverse Event|3|||
124961744|NCT00942188|449486592|FG002|Overall Study|Adverse Event|2|||
124961745|NCT00942188|449486593|FG003|Overall Study|Adverse Event|0|||
124961746|NCT00942188|449486590|FG000|Overall Study|Lack of Efficacy|0|||
124961747|NCT00942188|449486591|FG001|Overall Study|Lack of Efficacy|0|||
124961748|NCT00942188|449486592|FG002|Overall Study|Lack of Efficacy|0|||
124961749|NCT00942188|449486593|FG003|Overall Study|Lack of Efficacy|1|||
124961750|NCT00942188|449486590|FG000|Overall Study|Protocol Violation|1|||
124961751|NCT00942188|449486591|FG001|Overall Study|Protocol Violation|1|||
124961752|NCT00942188|449486592|FG002|Overall Study|Protocol Violation|0|||
124961753|NCT00942188|449486593|FG003|Overall Study|Protocol Violation|0|||
124961754|NCT00942188|449486590|FG000|Overall Study|Lost to Follow-up|2|||
124961755|NCT00942188|449486591|FG001|Overall Study|Lost to Follow-up|1|||
124961756|NCT00942188|449486592|FG002|Overall Study|Lost to Follow-up|2|||
124961757|NCT00942188|449486593|FG003|Overall Study|Lost to Follow-up|0|||
124961758|NCT00942188|449486590|FG000|Overall Study|Withdrawal by Subject|1|||
124961759|NCT00942188|449486591|FG001|Overall Study|Withdrawal by Subject|3|||
124961760|NCT00942188|449486592|FG002|Overall Study|Withdrawal by Subject|4|||
124961761|NCT00942188|449486593|FG003|Overall Study|Withdrawal by Subject|2|||
124961762|NCT00942188|449486590|FG000|Overall Study|Physician Decision|0|||
124961763|NCT00942188|449486591|FG001|Overall Study|Physician Decision|0|||
124961764|NCT00942188|449486592|FG002|Overall Study|Physician Decision|1|||
124961765|NCT00942188|449486593|FG003|Overall Study|Physician Decision|0|||
124961766|NCT00942188|449486590|FG000|Overall Study|Sponsor Decision|0|||
124961767|NCT00942188|449486591|FG001|Overall Study|Sponsor Decision|2|||
124961768|NCT00942188|449486592|FG002|Overall Study|Sponsor Decision|0|||
124961769|NCT00942188|449486593|FG003|Overall Study|Sponsor Decision|1|||
124961770|NCT00276016|449486594|FG000|Intervention 1|Withdrawal by Subject|0|||
124961771|NCT00276016|449486595|FG001|Intervention 1|Withdrawal by Subject|1|||
124961772|NCT00276016|449486596|FG002|Intervention 1|Withdrawal by Subject|0|||
124961773|NCT00276016|449486597|FG003|Intervention 1|Withdrawal by Subject|0|||
124961774|NCT00276016|449486598|FG004|Intervention 1|Withdrawal by Subject|0|||
124961775|NCT00276016|449486599|FG005|Intervention 1|Withdrawal by Subject|0|||
124961776|NCT05041439|449486600|FG000|Overall Study|Withdrawal by Subject|1|||
124961777|NCT05041439|449486601|FG001|Overall Study|Withdrawal by Subject|1|||
124961778|NCT05041439|449486600|FG000|Overall Study|Death|1|||
124961779|NCT05041439|449486601|FG001|Overall Study|Death|0|||
124961780|NCT00113269|449488080|FG000|Overall Study|Not transplanted, donor issues|4|||
124961781|NCT00113269|449488081|FG001|Overall Study|Not transplanted, donor issues|0|||
124961782|NCT00113269|449488082|FG002|Overall Study|Not transplanted, donor issues|2|||
125215729|NCT00492232|450417501|FG000|Placebo Run-in|Adverse Event|0|||
124961783|NCT00113269|449488083|FG003|Overall Study|Not transplanted, donor issues|2|||
124961784|NCT00113269|449488080|FG000|Overall Study|Not transplanted, recipient issues|2|||
124961785|NCT00113269|449488081|FG001|Overall Study|Not transplanted, recipient issues|1|||
124961786|NCT00113269|449488082|FG002|Overall Study|Not transplanted, recipient issues|7|||
124961787|NCT00113269|449488083|FG003|Overall Study|Not transplanted, recipient issues|4|||
124961788|NCT00113269|449488080|FG000|Overall Study|Early graft loss, technical|0|||
124961789|NCT00113269|449488081|FG001|Overall Study|Early graft loss, technical|0|||
124961790|NCT00113269|449488082|FG002|Overall Study|Early graft loss, technical|2|||
124961791|NCT00113269|449488083|FG003|Overall Study|Early graft loss, technical|0|||
124961792|NCT00113269|449488080|FG000|Overall Study|Death in operating room|0|||
124961793|NCT00113269|449488081|FG001|Overall Study|Death in operating room|0|||
124961794|NCT00113269|449488082|FG002|Overall Study|Death in operating room|0|||
124961795|NCT00113269|449488083|FG003|Overall Study|Death in operating room|1|||
125128877|NCT00723528|450097686|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
125128878|NCT00723528|450097687|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
125128879|NCT00723528|450097688|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
125128880|NCT00723528|450097689|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
125128881|NCT00723528|450097683|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
125128882|NCT00723528|450097684|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
125128883|NCT00723528|450097685|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
125128884|NCT00723528|450097686|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
125128885|NCT00723528|450097687|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
124961796|NCT00113269|449488080|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
124961797|NCT00113269|449488081|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
124961798|NCT00113269|449488082|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
124961799|NCT00113269|449488083|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
124961800|NCT00113269|449488080|FG000|Overall Study|Adverse Event|2|||
124961801|NCT00113269|449488081|FG001|Overall Study|Adverse Event|7|||
124961802|NCT00113269|449488082|FG002|Overall Study|Adverse Event|11|||
124961803|NCT00113269|449488083|FG003|Overall Study|Adverse Event|7|||
124961804|NCT00113269|449488080|FG000|Overall Study|Withdrawal by Subject|4|||
124961805|NCT00113269|449488081|FG001|Overall Study|Withdrawal by Subject|3|||
124961806|NCT00113269|449488082|FG002|Overall Study|Withdrawal by Subject|4|||
124961807|NCT00113269|449488083|FG003|Overall Study|Withdrawal by Subject|2|||
124961808|NCT00113269|449488080|FG000|Overall Study|Graft loss|6|||
124961809|NCT00113269|449488081|FG001|Overall Study|Graft loss|6|||
124961810|NCT00113269|449488082|FG002|Overall Study|Graft loss|4|||
124961811|NCT00113269|449488083|FG003|Overall Study|Graft loss|9|||
124961812|NCT00113269|449488080|FG000|Overall Study|Protocol Violation|1|||
124961813|NCT00113269|449488081|FG001|Overall Study|Protocol Violation|0|||
124961814|NCT00113269|449488082|FG002|Overall Study|Protocol Violation|4|||
124961815|NCT00113269|449488083|FG003|Overall Study|Protocol Violation|2|||
124961816|NCT00113269|449488080|FG000|Overall Study|Lost to Follow-up|2|||
124961817|NCT00113269|449488081|FG001|Overall Study|Lost to Follow-up|3|||
124961818|NCT00113269|449488082|FG002|Overall Study|Lost to Follow-up|6|||
124961819|NCT00113269|449488083|FG003|Overall Study|Lost to Follow-up|3|||
124961820|NCT00113269|449488080|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
124961821|NCT00113269|449488081|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
124961822|NCT00113269|449488082|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
124961823|NCT00113269|449488083|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
124961824|NCT00113269|449488080|FG000|Overall Study|Discontinued due to rejection|0|||
124961825|NCT00113269|449488081|FG001|Overall Study|Discontinued due to rejection|0|||
124961826|NCT00113269|449488082|FG002|Overall Study|Discontinued due to rejection|1|||
124961827|NCT00113269|449488083|FG003|Overall Study|Discontinued due to rejection|0|||
124961828|NCT00113269|449488080|FG000|Overall Study|Moved|0|||
124961829|NCT00113269|449488081|FG001|Overall Study|Moved|1|||
124961830|NCT00113269|449488082|FG002|Overall Study|Moved|0|||
124961831|NCT00113269|449488083|FG003|Overall Study|Moved|3|||
124961832|NCT00113269|449488080|FG000|Overall Study|Received pancreas transplant|0|||
124961833|NCT00113269|449488081|FG001|Overall Study|Received pancreas transplant|0|||
124961834|NCT00113269|449488082|FG002|Overall Study|Received pancreas transplant|0|||
124961835|NCT00113269|449488083|FG003|Overall Study|Received pancreas transplant|2|||
124961836|NCT00113269|449488080|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
124961837|NCT00113269|449488081|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
124961838|NCT00113269|449488082|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
124961839|NCT00113269|449488083|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
124961840|NCT00113269|449488080|FG000|Overall Study|Did not meet eligibility criteria|1|||
124961841|NCT00113269|449488081|FG001|Overall Study|Did not meet eligibility criteria|0|||
124961842|NCT00113269|449488082|FG002|Overall Study|Did not meet eligibility criteria|0|||
124961843|NCT00113269|449488083|FG003|Overall Study|Did not meet eligibility criteria|1|||
124961844|NCT00113269|449488080|FG000|Overall Study|Unable to return for follow up|2|||
124961845|NCT00113269|449488081|FG001|Overall Study|Unable to return for follow up|1|||
124961846|NCT00113269|449488082|FG002|Overall Study|Unable to return for follow up|0|||
125128886|NCT00723528|450097688|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
125128887|NCT00723528|450097689|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
124961847|NCT00113269|449488083|FG003|Overall Study|Unable to return for follow up|0|||
124961848|NCT03119688|449488089|FG000|Overall Study|Adverse Event|4|||
124961849|NCT03226106|449488090|FG000|Overall Study|Withdrawal by Subject|2|||
124961850|NCT03226106|449488091|FG001|Overall Study|Withdrawal by Subject|0|||
124961851|NCT03226106|449488090|FG000|Overall Study|Adverse Event|1|||
124961852|NCT03226106|449488091|FG001|Overall Study|Adverse Event|0|||
124961853|NCT03226106|449488090|FG000|Overall Study|Lost to Follow-up|2|||
124961854|NCT03226106|449488091|FG001|Overall Study|Lost to Follow-up|0|||
124961855|NCT00721214|449488092|FG000|Overall Study|Chose another center for transplant|1|||
124961856|NCT00721214|449488092|FG000|Overall Study|Death|3|||
124961857|NCT00488319|449488095|FG000|Overall Study|Adverse Event|1|||
125215730|NCT00492232|450417502|FG001|Placebo Run-in|Adverse Event|2|||
124961858|NCT00488319|449488096|FG001|Overall Study|Adverse Event|2|||
124961859|NCT00488319|449488097|FG002|Overall Study|Adverse Event|23|||
124961860|NCT00488319|449488095|FG000|Overall Study|Lack of Efficacy|6|||
124961861|NCT00488319|449488096|FG001|Overall Study|Lack of Efficacy|12|||
124961862|NCT00488319|449488097|FG002|Overall Study|Lack of Efficacy|27|||
124961863|NCT00488319|449488095|FG000|Overall Study|Lost to Follow-up|3|||
124961864|NCT00488319|449488096|FG001|Overall Study|Lost to Follow-up|5|||
124961865|NCT00488319|449488097|FG002|Overall Study|Lost to Follow-up|16|||
124961866|NCT00488319|449488095|FG000|Overall Study|Withdrawal by Subject|5|||
124961867|NCT00488319|449488096|FG001|Overall Study|Withdrawal by Subject|20|||
124961868|NCT00488319|449488097|FG002|Overall Study|Withdrawal by Subject|44|||
124961869|NCT00488319|449488095|FG000|Overall Study|Other reasons for withdrawal|0|||
124961870|NCT00488319|449488096|FG001|Overall Study|Other reasons for withdrawal|4|||
124961871|NCT00488319|449488097|FG002|Overall Study|Other reasons for withdrawal|12|||
124961872|NCT02158247|449488098|FG000|Overall Study|Invisible vocal cords|5|||
124961873|NCT00875615|449488105|FG000|Overall Study|Withdrawal by Subject|1|||
124961874|NCT01772823|449488106|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
124961875|NCT01772823|449488107|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
124961876|NCT01772823|449488106|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
124961877|NCT01772823|449488107|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
124961878|NCT01772823|449488106|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
124961879|NCT01772823|449488107|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
124961880|NCT01772823|449488106|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
124961881|NCT01772823|449488107|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
124961882|NCT01772823|449488106|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
124961883|NCT01772823|449488107|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
124961884|NCT01772823|449488106|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
124961885|NCT01772823|449488107|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
124961886|NCT01772823|449488106|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
124961887|NCT01772823|449488107|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
124961888|NCT01772823|449488106|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
124961889|NCT01772823|449488107|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
124961890|NCT01772823|449488106|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
124961891|NCT01772823|449488107|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
124961892|NCT01772823|449488106|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
124961893|NCT01772823|449488107|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
124961894|NCT01772823|449488106|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
124961895|NCT01772823|449488107|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
124961896|NCT01772823|449488106|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
124961897|NCT01772823|449488107|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
124961898|NCT01772823|449488106|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
124961899|NCT01772823|449488107|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
124961900|NCT01772823|449488106|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
124961901|NCT01772823|449488107|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
124961902|NCT01772823|449488106|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
124961903|NCT01772823|449488107|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
124961904|NCT01772823|449488106|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
125031320|NCT00896532|449735104|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125031321|NCT00896532|449735105|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125031322|NCT00896532|449735106|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125031323|NCT00896532|449735107|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125031324|NCT00896532|449735108|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125031325|NCT00896532|449735109|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125031326|NCT00896532|449735110|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125031327|NCT00896532|449735111|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125031328|NCT00896532|449735112|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125031329|NCT00896532|449735113|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
125031330|NCT00896532|449735114|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
125031331|NCT00896532|449735115|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
125031332|NCT00896532|449735116|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125031333|NCT00896532|449735117|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125031334|NCT00896532|449735118|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125031335|NCT00896532|449735119|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
124961905|NCT01772823|449488107|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
124961906|NCT01732926|449488109|FG000|Overall Study|Study Terminated by Sponsor|168|||
124961907|NCT01732926|449488110|FG001|Overall Study|Study Terminated by Sponsor|80|||
124961908|NCT01732926|449488109|FG000|Overall Study|Withdrawal by Subject|46|||
124961909|NCT01732926|449488110|FG001|Overall Study|Withdrawal by Subject|8|||
124961910|NCT01732926|449488109|FG000|Overall Study|Physician Decision|24|||
124961911|NCT01732926|449488110|FG001|Overall Study|Physician Decision|11|||
124961912|NCT01732926|449488109|FG000|Overall Study|Other Reason|21|||
124961913|NCT01732926|449488110|FG001|Overall Study|Other Reason|4|||
124961914|NCT01732926|449488109|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
124961915|NCT01732926|449488110|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
124961916|NCT01732926|449488109|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
124961917|NCT01732926|449488110|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
124961918|NCT02262364|449488114|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
124961919|NCT01049984|449488116|FG000|Overall Study|Withdrawal by Subject|1|||
124961920|NCT01049984|449488117|FG001|Overall Study|Withdrawal by Subject|5|||
124961921|NCT01049984|449488116|FG000|Overall Study|Protocol Violation|3|||
124961922|NCT01049984|449488117|FG001|Overall Study|Protocol Violation|4|||
124961923|NCT01049984|449488116|FG000|Overall Study|Lost to Follow-up|2|||
124961924|NCT01049984|449488117|FG001|Overall Study|Lost to Follow-up|1|||
124961925|NCT01049984|449488116|FG000|Overall Study|Adverse Event|13|||
124961926|NCT01049984|449488117|FG001|Overall Study|Adverse Event|7|||
124961927|NCT01049984|449488116|FG000|Overall Study|Treatment failure|0|||
124961928|NCT01049984|449488117|FG001|Overall Study|Treatment failure|2|||
124961929|NCT03503162|449488123|FG000|Overall Study|did not meet eligibility|1|||
124961930|NCT03891641|449488126|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
124961931|NCT03891641|449488127|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
124961932|NCT00920699|449488129|FG000|Overall Study|Withdrawal by Subject|2|||
124961933|NCT00920699|449488130|FG001|Overall Study|Withdrawal by Subject|0|||
124961934|NCT00920699|449488131|FG002|Overall Study|Withdrawal by Subject|2|||
124961935|NCT00920699|449488129|FG000|Overall Study|no longer met eligibility|0|||
124961936|NCT00920699|449488130|FG001|Overall Study|no longer met eligibility|1|||
124961937|NCT00920699|449488131|FG002|Overall Study|no longer met eligibility|0|||
124961938|NCT00920699|449488129|FG000|Overall Study|Lost to Follow-up|0|||
124961939|NCT00920699|449488130|FG001|Overall Study|Lost to Follow-up|0|||
124961940|NCT00920699|449488131|FG002|Overall Study|Lost to Follow-up|2|||
124961941|NCT03723915|449488135|FG000|Screening|Failed to meet screening requirements.|2|||
124961942|NCT03723915|449488135|FG000|On Treatment|Failed to meet treatment requirements|2|||
124961943|NCT01978236|449488138|FG000|Overall Study|Discontinued due to study close|2|||
124961944|NCT00634920|449488140|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
124961945|NCT00634920|449488141|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
124961946|NCT00634920|449488142|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
124961947|NCT00634920|449488140|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
124961948|NCT00634920|449488141|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
124961949|NCT00634920|449488142|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
124961950|NCT00634920|449488140|FG000|Period 1 - Pre-Randomization|Rejections|0|||
124961951|NCT00634920|449488141|FG001|Period 1 - Pre-Randomization|Rejections|0|||
124961952|NCT00634920|449488142|FG002|Period 1 - Pre-Randomization|Rejections|55|||
124961953|NCT00634920|449488140|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
124961954|NCT00634920|449488141|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
124961955|NCT00634920|449488142|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
124961956|NCT00634920|449488140|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
124961957|NCT00634920|449488141|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
124961958|NCT00634920|449488142|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
124961959|NCT00634920|449488140|FG000|Period 1 - Pre-Randomization|Other issues|0|||
124961960|NCT00634920|449488141|FG001|Period 1 - Pre-Randomization|Other issues|0|||
124961961|NCT00634920|449488142|FG002|Period 1 - Pre-Randomization|Other issues|6|||
124961962|NCT00634920|449488140|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
124961963|NCT00634920|449488141|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
124961964|NCT00634920|449488142|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
124961965|NCT00634920|449488140|FG000|Period 2 - Post-Randomization|Rejection|11|||
124961966|NCT00634920|449488141|FG001|Period 2 - Post-Randomization|Rejection|5|||
124961967|NCT00634920|449488142|FG002|Period 2 - Post-Randomization|Rejection|0|||
124961968|NCT00634920|449488140|FG000|Period 2 - Post-Randomization|Death|2|||
124961969|NCT00634920|449488141|FG001|Period 2 - Post-Randomization|Death|5|||
124961970|NCT00634920|449488142|FG002|Period 2 - Post-Randomization|Death|0|||
124961971|NCT00634920|449488140|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
124961972|NCT00634920|449488141|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
125128888|NCT00723528|450097683|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
125128889|NCT00723528|450097684|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
125128890|NCT00723528|450097685|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
124961973|NCT00634920|449488142|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
124961974|NCT00634920|449488140|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
124961975|NCT00634920|449488141|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
124961976|NCT00634920|449488142|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
124961977|NCT00819013|449488143|FG000|Overall Study|Not meeting continuing study eligibility|2|||
124961978|NCT00819013|449488144|FG001|Overall Study|Not meeting continuing study eligibility|1|||
124961979|NCT00819013|449488145|FG002|Overall Study|Not meeting continuing study eligibility|2|||
124961980|NCT00819013|449488146|FG003|Overall Study|Not meeting continuing study eligibility|1|||
124961981|NCT00819013|449488143|FG000|Overall Study|Adverse Event|0|||
124961982|NCT00819013|449488144|FG001|Overall Study|Adverse Event|0|||
124961983|NCT00819013|449488145|FG002|Overall Study|Adverse Event|1|||
124961984|NCT00819013|449488146|FG003|Overall Study|Adverse Event|0|||
124961985|NCT00819013|449488143|FG000|Overall Study|Withdrawal by Subject|1|||
124961986|NCT00819013|449488144|FG001|Overall Study|Withdrawal by Subject|0|||
124961987|NCT00819013|449488145|FG002|Overall Study|Withdrawal by Subject|1|||
124961988|NCT00819013|449488146|FG003|Overall Study|Withdrawal by Subject|0|||
124961989|NCT00819013|449488143|FG000|Overall Study|Lost to Follow-up|0|||
124961990|NCT00819013|449488144|FG001|Overall Study|Lost to Follow-up|0|||
124961991|NCT00819013|449488145|FG002|Overall Study|Lost to Follow-up|1|||
124961992|NCT00819013|449488146|FG003|Overall Study|Lost to Follow-up|2|||
124961993|NCT00819013|449488143|FG000|Overall Study|Death|0|||
124961994|NCT00819013|449488144|FG001|Overall Study|Death|0|||
124961995|NCT00819013|449488145|FG002|Overall Study|Death|0|||
124961996|NCT00819013|449488146|FG003|Overall Study|Death|1|||
124961997|NCT00363649|449488147|FG000|Overall Study|Withdrawal by Subject|1|||
124961998|NCT00363649|449488148|FG001|Overall Study|Withdrawal by Subject|1|||
124961999|NCT00363649|449488147|FG000|Overall Study|Adverse Event|6|||
124962000|NCT00363649|449488148|FG001|Overall Study|Adverse Event|0|||
124962001|NCT00607997|449488151|FG000|Overall Study|Lack of Efficacy|6|||
124962002|NCT00607997|449488152|FG001|Overall Study|Lack of Efficacy|20|||
124962003|NCT00607997|449488153|FG002|Overall Study|Lack of Efficacy|14|||
124962004|NCT00607997|449488154|FG003|Overall Study|Lack of Efficacy|10|||
124962005|NCT00607997|449488151|FG000|Overall Study|Death|8|||
124962006|NCT00607997|449488152|FG001|Overall Study|Death|5|||
124962007|NCT00607997|449488153|FG002|Overall Study|Death|2|||
124962008|NCT00607997|449488154|FG003|Overall Study|Death|5|||
124962009|NCT00607997|449488151|FG000|Overall Study|Adverse Event|3|||
124962010|NCT00607997|449488152|FG001|Overall Study|Adverse Event|1|||
124962011|NCT00607997|449488153|FG002|Overall Study|Adverse Event|2|||
124962012|NCT00607997|449488154|FG003|Overall Study|Adverse Event|0|||
124962013|NCT00607997|449488151|FG000|Overall Study|Physician Decision|4|||
124962014|NCT00607997|449488152|FG001|Overall Study|Physician Decision|1|||
124962015|NCT00607997|449488153|FG002|Overall Study|Physician Decision|0|||
124962016|NCT00607997|449488154|FG003|Overall Study|Physician Decision|0|||
124962017|NCT00607997|449488151|FG000|Overall Study|Relapse, recurrent illness|4|||
124962018|NCT00607997|449488152|FG001|Overall Study|Relapse, recurrent illness|0|||
124962019|NCT00607997|449488153|FG002|Overall Study|Relapse, recurrent illness|2|||
124962020|NCT00607997|449488154|FG003|Overall Study|Relapse, recurrent illness|0|||
124962021|NCT00607997|449488151|FG000|Overall Study|Other without explanation|2|||
124962022|NCT00607997|449488152|FG001|Overall Study|Other without explanation|0|||
124962023|NCT00607997|449488153|FG002|Overall Study|Other without explanation|4|||
124962024|NCT00607997|449488154|FG003|Overall Study|Other without explanation|1|||
124962025|NCT00576823|449488155|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
124962026|NCT00576823|449488156|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
124962027|NCT00576823|449488157|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
124962028|NCT00576823|449488155|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
124962029|NCT00576823|449488156|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
124962030|NCT00576823|449488157|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
124962031|NCT00510146|449488163|FG000|Double-Blind Treatment|Adverse Event|30|||
124962032|NCT00510146|449488164|FG001|Double-Blind Treatment|Adverse Event|13|||
124962033|NCT00510146|449488163|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
124962034|NCT00510146|449488164|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
124962035|NCT00510146|449488163|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
124962036|NCT00510146|449488164|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
124962037|NCT00510146|449488163|FG000|Double-Blind Treatment|Physician Decision|6|||
124962038|NCT00510146|449488164|FG001|Double-Blind Treatment|Physician Decision|0|||
124962039|NCT00510146|449488163|FG000|Double-Blind Treatment|Protocol Violation|1|||
124962040|NCT00510146|449488164|FG001|Double-Blind Treatment|Protocol Violation|2|||
124962041|NCT00510146|449488163|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
124962042|NCT00510146|449488164|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
124962043|NCT00510146|449488163|FG000|Double-Blind Treatment|Clinical Relapse|0|||
125215731|NCT00492232|450417501|FG000|Placebo Run-in|Protocol Violation|0|||
124962044|NCT00510146|449488164|FG001|Double-Blind Treatment|Clinical Relapse|1|||
124962045|NCT00510146|449488163|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
124962046|NCT00510146|449488164|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
124962047|NCT00510146|449488163|FG000|Open-Label Treatment|Adverse Event|22|||
124962048|NCT00510146|449488164|FG001|Open-Label Treatment|Adverse Event|8|||
124962049|NCT00510146|449488163|FG000|Open-Label Treatment|Death|1|||
124962050|NCT00510146|449488164|FG001|Open-Label Treatment|Death|1|||
124962051|NCT00510146|449488163|FG000|Open-Label Treatment|Lack of Efficacy|4|||
124962052|NCT00510146|449488164|FG001|Open-Label Treatment|Lack of Efficacy|0|||
124962053|NCT00510146|449488163|FG000|Open-Label Treatment|Lost to Follow-up|10|||
124962054|NCT00510146|449488164|FG001|Open-Label Treatment|Lost to Follow-up|1|||
124962055|NCT00510146|449488163|FG000|Open-Label Treatment|Physician Decision|3|||
124962056|NCT00510146|449488164|FG001|Open-Label Treatment|Physician Decision|1|||
124962057|NCT00510146|449488163|FG000|Open-Label Treatment|Protocol Violation|4|||
124962058|NCT00510146|449488164|FG001|Open-Label Treatment|Protocol Violation|2|||
124962059|NCT00510146|449488163|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
124962060|NCT00510146|449488164|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
124962061|NCT00510146|449488163|FG000|Open-Label Treatment|Clinical Relapse|1|||
124962062|NCT00510146|449488164|FG001|Open-Label Treatment|Clinical Relapse|1|||
124962063|NCT00510146|449488163|FG000|Open-Label Treatment|Sponsor Decision|2|||
124962064|NCT00510146|449488164|FG001|Open-Label Treatment|Sponsor Decision|0|||
124962065|NCT01930214|449488166|FG000|Overall Study|Death|4|||
124962066|NCT01930214|449488167|FG001|Overall Study|Death|4|||
124962067|NCT01930214|449488168|FG002|Overall Study|Death|11|||
124962068|NCT01930214|449488166|FG000|Overall Study|Lost to Follow-up|12|||
124962069|NCT01930214|449488167|FG001|Overall Study|Lost to Follow-up|13|||
124962070|NCT01930214|449488168|FG002|Overall Study|Lost to Follow-up|12|||
124962071|NCT01930214|449488166|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
124962072|NCT01930214|449488167|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
124962073|NCT01930214|449488168|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
124962074|NCT01930214|449488166|FG000|Overall Study|Physician Decision|2|||
124962075|NCT01930214|449488167|FG001|Overall Study|Physician Decision|0|||
124962076|NCT01930214|449488168|FG002|Overall Study|Physician Decision|0|||
124962077|NCT02132117|449488169|FG000|Overall Study|Adverse Event|6|||
124962078|NCT02132117|449488170|FG001|Overall Study|Adverse Event|1|||
124962079|NCT02132117|449488169|FG000|Overall Study|Lost to Follow-up|2|||
124962080|NCT02132117|449488170|FG001|Overall Study|Lost to Follow-up|2|||
124962081|NCT02132117|449488169|FG000|Overall Study|Personal Reasons|1|||
124962082|NCT02132117|449488170|FG001|Overall Study|Personal Reasons|2|||
124962083|NCT02132117|449488169|FG000|Overall Study|Other Miscellaneous Reasons|2|||
124962084|NCT02132117|449488170|FG001|Overall Study|Other Miscellaneous Reasons|0|||
124962085|NCT03589300|449488171|FG000|Overall Study|Adverse Event|2|||
124962086|NCT03589300|449488171|FG000|Overall Study|Death|4|||
124962087|NCT03589300|449488171|FG000|Overall Study|Lost to Follow-up|12|||
124962088|NCT03589300|449488171|FG000|Overall Study|Withdrawal by Subject|5|||
124962089|NCT02864342|449488177|FG000|Overall Study|Eligibility Criteria Deviation|2|||
124962090|NCT02864342|449488178|FG001|Overall Study|Eligibility Criteria Deviation|3|||
124962091|NCT02864342|449488177|FG000|Overall Study|Withdrawal by Subject|4|||
124962092|NCT02864342|449488178|FG001|Overall Study|Withdrawal by Subject|2|||
124962093|NCT02864342|449488177|FG000|Overall Study|Device Technology Issue|6|||
124962094|NCT02864342|449488178|FG001|Overall Study|Device Technology Issue|7|||
124962095|NCT02864342|449488177|FG000|Overall Study|Death|0|||
124962096|NCT02864342|449488178|FG001|Overall Study|Death|1|||
124962097|NCT02864342|449488177|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
124962098|NCT02864342|449488178|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
124962099|NCT02864342|449488177|FG000|Overall Study|Lost to Follow-up|1|||
124962100|NCT02864342|449488178|FG001|Overall Study|Lost to Follow-up|5|||
125128891|NCT00723528|450097686|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
125128892|NCT00723528|450097687|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
125128893|NCT00723528|450097688|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
125128894|NCT00723528|450097689|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
125128895|NCT00723528|450097683|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
125128896|NCT00723528|450097684|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
124962101|NCT02864342|449488177|FG000|Overall Study|Lost Device|1|||
124962102|NCT02864342|449488178|FG001|Overall Study|Lost Device|0|||
124962103|NCT02864342|449488177|FG000|Overall Study|Adverse Event|1|||
124962104|NCT02864342|449488178|FG001|Overall Study|Adverse Event|0|||
124962105|NCT02725008|449488183|FG000|Overall Study|Lost to Follow-up|7|||
124962106|NCT02725008|449488184|FG001|Overall Study|Lost to Follow-up|9|||
124962107|NCT02725008|449488183|FG000|Overall Study|Withdrawal by Subject|2|||
124962108|NCT02725008|449488184|FG001|Overall Study|Withdrawal by Subject|2|||
124962109|NCT02725008|449488183|FG000|Overall Study|Admitted to hospital|0|||
124962110|NCT02725008|449488184|FG001|Overall Study|Admitted to hospital|1|||
124962111|NCT00853021|449488191|FG000|Overall Study|Adverse Event|2|||
124962112|NCT00853021|449488191|FG000|Overall Study|Withdrawal by Subject|2|||
125128897|NCT00723528|450097685|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
125128898|NCT00723528|450097686|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
125128899|NCT00723528|450097687|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
124962113|NCT00853021|449488191|FG000|Overall Study|Death|1|||
124962114|NCT01329419|449488192|FG000|Overall Study|Protocol Violation|235|||
124962115|NCT02212197|449488198|FG000|Overall Study|Need for radiotherapy|1|||
124962116|NCT02212197|449488199|FG001|Overall Study|Need for radiotherapy|0|||
124962117|NCT02212197|449488200|FG002|Overall Study|Need for radiotherapy|0|||
124962118|NCT02551692|449488202|FG000|Overall Study|Lost to Follow-up|0|||
124962119|NCT02551692|449488203|FG001|Overall Study|Lost to Follow-up|1|||
124962120|NCT02551692|449488204|FG002|Overall Study|Lost to Follow-up|4|||
124962121|NCT02551692|449488202|FG000|Overall Study|Withdrawal by Subject|1|||
124962122|NCT02551692|449488203|FG001|Overall Study|Withdrawal by Subject|0|||
124962123|NCT02551692|449488204|FG002|Overall Study|Withdrawal by Subject|1|||
124962124|NCT01091519|449488205|FG000|Overall Study|Adverse Event|12|||
124962125|NCT01091519|449488206|FG001|Overall Study|Adverse Event|16|||
124962126|NCT01091519|449488205|FG000|Overall Study|Death|1|||
124962127|NCT01091519|449488206|FG001|Overall Study|Death|0|||
124962128|NCT01091519|449488205|FG000|Overall Study|Lack of Efficacy|16|||
124962129|NCT01091519|449488206|FG001|Overall Study|Lack of Efficacy|19|||
124962130|NCT01091519|449488205|FG000|Overall Study|Lost to Follow-up|14|||
124962131|NCT01091519|449488206|FG001|Overall Study|Lost to Follow-up|24|||
124962132|NCT01091519|449488205|FG000|Overall Study|Withdrawal by Subject|2|||
124962133|NCT01091519|449488206|FG001|Overall Study|Withdrawal by Subject|2|||
124962134|NCT01091519|449488205|FG000|Overall Study|Other|6|||
124962135|NCT01091519|449488206|FG001|Overall Study|Other|8|||
124962136|NCT01091519|449488205|FG000|Overall Study|Randomized not treated|4|||
124962137|NCT01091519|449488206|FG001|Overall Study|Randomized not treated|4|||
124962138|NCT01177228|449488209|FG000|Overall Study|Positive tuberculosis test|0|||
124962139|NCT01177228|449488210|FG001|Overall Study|Positive tuberculosis test|1|||
124962140|NCT01177228|449488211|FG002|Overall Study|Positive tuberculosis test|0|||
124962141|NCT01177228|449488212|FG003|Overall Study|Positive tuberculosis test|0|||
124962142|NCT01177228|449488209|FG000|Overall Study|Worsening disease activity|1|||
124962143|NCT01177228|449488210|FG001|Overall Study|Worsening disease activity|0|||
124962144|NCT01177228|449488211|FG002|Overall Study|Worsening disease activity|0|||
124962145|NCT01177228|449488212|FG003|Overall Study|Worsening disease activity|0|||
124962146|NCT01177228|449488209|FG000|Overall Study|Withdrawal by Subject|0|||
124962147|NCT01177228|449488210|FG001|Overall Study|Withdrawal by Subject|1|||
124962148|NCT01177228|449488211|FG002|Overall Study|Withdrawal by Subject|0|||
124962149|NCT01177228|449488212|FG003|Overall Study|Withdrawal by Subject|0|||
124962150|NCT01592383|449488213|FG000|Overall Study|Adverse Event|1|||
124962151|NCT04159805|449488214|FG000|Overall Study|Withdrawal by Subject|0|||
124962152|NCT04159805|449488215|FG001|Overall Study|Withdrawal by Subject|2|||
124962153|NCT04159805|449488216|FG002|Overall Study|Withdrawal by Subject|2|||
124962154|NCT04167085|449488217|FG000|Baseline|Withdrawal by Subject|2|||
124962155|NCT04167085|449488218|FG001|Baseline|Withdrawal by Subject|1|||
124962156|NCT04167085|449488217|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
124962157|NCT04167085|449488218|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
124962158|NCT01171183|449490206|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
124962159|NCT01171183|449490207|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
124962160|NCT01171183|449490206|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
124962161|NCT01171183|449490207|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
124962162|NCT01171183|449490206|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
124962163|NCT01171183|449490207|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
124962164|NCT01171183|449490206|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
124962165|NCT01171183|449490207|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
124962166|NCT01171183|449490206|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
124962167|NCT01171183|449490207|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
124962168|NCT01171183|449490206|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
124962169|NCT01171183|449490207|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
124962170|NCT01904136|449490211|FG000|Overall Study|Physician Decision|0|||
124962171|NCT01904136|449490212|FG001|Overall Study|Physician Decision|0|||
124962172|NCT01904136|449490213|FG002|Overall Study|Physician Decision|0|||
124962173|NCT01904136|449490214|FG003|Overall Study|Physician Decision|0|||
124962174|NCT01904136|449490215|FG004|Overall Study|Physician Decision|0|||
124962175|NCT01904136|449490216|FG005|Overall Study|Physician Decision|1|||
124962176|NCT01904136|449490217|FG006|Overall Study|Physician Decision|0|||
124962177|NCT01904136|449490218|FG007|Overall Study|Physician Decision|0|||
124962178|NCT01904136|449490219|FG008|Overall Study|Physician Decision|0|||
124962179|NCT00853372|449490220|FG000|Overall Study|Death|30|||
124962180|NCT00853372|449490221|FG001|Overall Study|Death|26|||
124962181|NCT00853372|449490220|FG000|Overall Study|Lost to Follow-up|1|||
124962182|NCT00853372|449490221|FG001|Overall Study|Lost to Follow-up|2|||
125031336|NCT00896532|449735120|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125031337|NCT00896532|449735098|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031338|NCT00896532|449735099|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031339|NCT00896532|449735100|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031340|NCT00896532|449735101|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031341|NCT00896532|449735102|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031342|NCT00896532|449735103|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031343|NCT00896532|449735104|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031344|NCT00896532|449735105|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031345|NCT00896532|449735106|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031346|NCT00896532|449735107|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031347|NCT00896532|449735108|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031348|NCT00896532|449735109|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031349|NCT00896532|449735110|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031350|NCT00896532|449735111|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031351|NCT00896532|449735112|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031352|NCT00896532|449735113|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031353|NCT00896532|449735114|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
125031354|NCT00896532|449735115|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031355|NCT00896532|449735116|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031356|NCT00896532|449735117|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031357|NCT00896532|449735118|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031358|NCT00896532|449735119|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031359|NCT00896532|449735120|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125031360|NCT00896532|449735098|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
125031361|NCT00896532|449735099|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
125031362|NCT00896532|449735100|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
125031363|NCT00896532|449735101|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
125031364|NCT00896532|449735102|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
125031365|NCT00896532|449735103|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
125031366|NCT00896532|449735104|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
125031367|NCT00896532|449735105|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
125031368|NCT00896532|449735106|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
125031369|NCT00896532|449735107|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
125031370|NCT00896532|449735108|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
125031371|NCT00896532|449735109|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
125031372|NCT00896532|449735110|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
125031373|NCT00896532|449735111|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
125031374|NCT00896532|449735112|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
125031375|NCT00896532|449735113|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
125031376|NCT00896532|449735114|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
125031377|NCT00896532|449735115|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
125031378|NCT00896532|449735116|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
125031379|NCT00896532|449735117|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
125031380|NCT00896532|449735118|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
125031381|NCT00896532|449735119|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
125031382|NCT00896532|449735120|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
125031383|NCT00896532|449735098|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031384|NCT00896532|449735099|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031385|NCT00896532|449735100|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031386|NCT00896532|449735101|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031387|NCT00896532|449735102|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031388|NCT00896532|449735103|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031389|NCT00896532|449735104|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031390|NCT00896532|449735105|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031391|NCT00896532|449735106|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031392|NCT00896532|449735107|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031393|NCT00896532|449735108|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031394|NCT00896532|449735109|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031395|NCT00896532|449735110|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031396|NCT00896532|449735111|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031397|NCT00896532|449735112|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031398|NCT00896532|449735113|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031399|NCT00896532|449735114|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
125033628|NCT01701258|449743827|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
125128900|NCT00723528|450097688|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
124962183|NCT00853372|449490220|FG000|Overall Study|Full Consent Withdrawn|1|||
124962184|NCT00853372|449490221|FG001|Overall Study|Full Consent Withdrawn|1|||
124962185|NCT01821729|449490222|FG000|Overall Study|Withdrawal by Subject|1|||
124962186|NCT02517528|449490223|FG000|Overall Study|Withdrawal by Subject|1|||
124962187|NCT03713281|449490226|FG000|Overall Study|Lens handling difficuluties|2|||
124962188|NCT03713281|449490226|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
124962189|NCT00320398|449490227|FG000|Overall Study|Adverse Event|1|||
124962190|NCT00320398|449490228|FG001|Overall Study|Adverse Event|4|||
124962191|NCT00320398|449490227|FG000|Overall Study|Other|1|||
124962192|NCT00320398|449490228|FG001|Overall Study|Other|0|||
124962193|NCT02815735|449490231|FG000|First Intervention (4 Weeks)|Discomfort|1|||
124962194|NCT02815735|449490232|FG001|First Intervention (4 Weeks)|Discomfort|0|||
124962195|NCT02815735|449490231|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
124962196|NCT02815735|449490232|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
124962197|NCT02815735|449490231|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
124962198|NCT02815735|449490232|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
124962199|NCT02815735|449490231|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
124962200|NCT02815735|449490232|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
124962201|NCT01746108|449490235|FG000|Overall Study|Migrated /moved from study area|0|||
124962202|NCT01746108|449490236|FG001|Overall Study|Migrated /moved from study area|1|||
124962203|NCT01746108|449490237|FG002|Overall Study|Migrated /moved from study area|0|||
124962204|NCT01746108|449490235|FG000|Overall Study|Adverse event, non-fatal|0|||
124962205|NCT01746108|449490236|FG001|Overall Study|Adverse event, non-fatal|1|||
124962206|NCT01746108|449490237|FG002|Overall Study|Adverse event, non-fatal|0|||
124962207|NCT01746108|449490235|FG000|Overall Study|Withdrawal by Subject|0|||
124962208|NCT01746108|449490236|FG001|Overall Study|Withdrawal by Subject|1|||
124962209|NCT01746108|449490237|FG002|Overall Study|Withdrawal by Subject|0|||
124962210|NCT01746108|449490235|FG000|Overall Study|Lost to Follow-up|0|||
124962211|NCT01746108|449490236|FG001|Overall Study|Lost to Follow-up|1|||
124962212|NCT01746108|449490237|FG002|Overall Study|Lost to Follow-up|0|||
124962213|NCT00468858|449490239|FG000|Overall Study|Adverse Event|0|||
124962214|NCT00468858|449490240|FG001|Overall Study|Adverse Event|1|||
124962215|NCT00468858|449490241|FG002|Overall Study|Adverse Event|0|||
124962216|NCT00468858|449490239|FG000|Overall Study|Withdrawal by Subject|7|||
124962217|NCT00468858|449490240|FG001|Overall Study|Withdrawal by Subject|4|||
124962218|NCT00468858|449490241|FG002|Overall Study|Withdrawal by Subject|5|||
124962219|NCT00468858|449490239|FG000|Overall Study|Relocation|1|||
124962220|NCT00468858|449490240|FG001|Overall Study|Relocation|3|||
124962221|NCT00468858|449490241|FG002|Overall Study|Relocation|3|||
124962222|NCT00468858|449490239|FG000|Overall Study|Lost to Follow-up|1|||
124962223|NCT00468858|449490240|FG001|Overall Study|Lost to Follow-up|2|||
124962224|NCT00468858|449490241|FG002|Overall Study|Lost to Follow-up|5|||
124962225|NCT00468858|449490239|FG000|Overall Study|Other|0|||
124962226|NCT00468858|449490240|FG001|Overall Study|Other|0|||
124962227|NCT00468858|449490241|FG002|Overall Study|Other|1|||
124962228|NCT00809341|449490244|FG000|Overall Study|Physician Decision|0|||
124962229|NCT00809341|449490245|FG001|Overall Study|Physician Decision|1|||
124962230|NCT00225277|449490253|FG000|Overall Study|Adverse Event|30|||
124962231|NCT00225277|449490254|FG001|Overall Study|Adverse Event|34|||
124962232|NCT00225277|449490253|FG000|Overall Study|Lack of Efficacy|4|||
124962233|NCT00225277|449490254|FG001|Overall Study|Lack of Efficacy|1|||
124962234|NCT00225277|449490253|FG000|Overall Study|Lost to Follow-up|4|||
124962235|NCT00225277|449490254|FG001|Overall Study|Lost to Follow-up|6|||
124962236|NCT00225277|449490253|FG000|Overall Study|Physician Decision|6|||
124962237|NCT00225277|449490254|FG001|Overall Study|Physician Decision|8|||
124962238|NCT00225277|449490253|FG000|Overall Study|Protocol Violation|6|||
124962239|NCT00225277|449490254|FG001|Overall Study|Protocol Violation|3|||
124962240|NCT00225277|449490253|FG000|Overall Study|Withdrawal by Subject|40|||
124962241|NCT00225277|449490254|FG001|Overall Study|Withdrawal by Subject|34|||
124962242|NCT00225277|449490253|FG000|Overall Study|Other|7|||
124962243|NCT00225277|449490254|FG001|Overall Study|Other|9|||
124962244|NCT04582669|449490261|FG000|Overall Study|Subject missed appointment(s).|1|||
124962245|NCT04582669|449490262|FG001|Overall Study|Subject missed appointment(s).|0|||
124962246|NCT04582669|449490263|FG002|Overall Study|Subject missed appointment(s).|1|||
124962247|NCT04582669|449490264|FG003|Overall Study|Subject missed appointment(s).|2|||
124962248|NCT04582669|449490261|FG000|Overall Study|Protocol Violation|0|||
124962249|NCT04582669|449490262|FG001|Overall Study|Protocol Violation|1|||
124962250|NCT04582669|449490263|FG002|Overall Study|Protocol Violation|1|||
124962251|NCT04582669|449490264|FG003|Overall Study|Protocol Violation|0|||
125128901|NCT00723528|450097689|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
125128902|NCT00723528|450097683|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
124962252|NCT00591409|449490265|FG000|Overall Study|Not Treated|0|||
124962253|NCT00591409|449490266|FG001|Overall Study|Not Treated|0|||
124962254|NCT00591409|449490267|FG002|Overall Study|Not Treated|0|||
124962255|NCT00591409|449490268|FG003|Overall Study|Not Treated|0|||
124962256|NCT00591409|449490269|FG004|Overall Study|Not Treated|1|||
125128903|NCT00723528|450097684|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
125128904|NCT00723528|450097685|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
125128905|NCT00723528|450097686|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
125128906|NCT00723528|450097687|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
125128907|NCT00723528|450097688|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
125128908|NCT00723528|450097689|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
125128909|NCT00723528|450097683|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
125215732|NCT00492232|450417502|FG001|Placebo Run-in|Protocol Violation|3|||
124962257|NCT00591409|449490270|FG005|Overall Study|Not Treated|0|||
124962258|NCT00591409|449490271|FG006|Overall Study|Not Treated|0|||
124962259|NCT00591409|449490272|FG007|Overall Study|Not Treated|0|||
124962260|NCT00591409|449490273|FG008|Overall Study|Not Treated|0|||
124962261|NCT00591409|449490274|FG009|Overall Study|Not Treated|1|||
124962262|NCT00677092|449490275|FG000|Overall Study|Adverse Event|1|||
124962263|NCT00677092|449490275|FG000|Overall Study|Lost to Follow-up|1|||
124962264|NCT00677092|449490275|FG000|Overall Study|Withdrawal by Subject|3|||
124962265|NCT00677092|449490275|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
124962266|NCT02716298|449490276|FG000|First Intervention (1 Month)|Lens discomfort|1|||
124962267|NCT02716298|449490277|FG001|First Intervention (1 Month)|Lens discomfort|1|||
124962268|NCT00550446|449490278|FG000|Up To Week 12|Adverse Event|2|||
124962269|NCT00550446|449490279|FG001|Up To Week 12|Adverse Event|2|||
124962270|NCT00550446|449490280|FG002|Up To Week 12|Adverse Event|0|||
124962271|NCT00550446|449490281|FG003|Up To Week 12|Adverse Event|0|||
124962272|NCT00550446|449490282|FG004|Up To Week 12|Adverse Event|2|||
124962273|NCT00550446|449490283|FG005|Up To Week 12|Adverse Event|2|||
124962274|NCT00550446|449490284|FG006|Up To Week 12|Adverse Event|1|||
124962275|NCT00550446|449490285|FG007|Up To Week 12|Adverse Event|0|||
124962276|NCT00550446|449490286|FG008|Up To Week 12|Adverse Event|0|||
124962277|NCT00550446|449490287|FG009|Up To Week 12|Adverse Event|0|||
124962278|NCT00550446|449490288|FG010|Up To Week 12|Adverse Event|0|||
124962279|NCT00550446|449490278|FG000|Up To Week 12|Lack of Efficacy|3|||
124962280|NCT00550446|449490279|FG001|Up To Week 12|Lack of Efficacy|1|||
124962281|NCT00550446|449490280|FG002|Up To Week 12|Lack of Efficacy|0|||
124962282|NCT00550446|449490281|FG003|Up To Week 12|Lack of Efficacy|1|||
124962283|NCT00550446|449490282|FG004|Up To Week 12|Lack of Efficacy|0|||
124962284|NCT00550446|449490283|FG005|Up To Week 12|Lack of Efficacy|3|||
124962285|NCT00550446|449490284|FG006|Up To Week 12|Lack of Efficacy|3|||
124962286|NCT00550446|449490285|FG007|Up To Week 12|Lack of Efficacy|0|||
124962287|NCT00550446|449490286|FG008|Up To Week 12|Lack of Efficacy|0|||
124962288|NCT00550446|449490287|FG009|Up To Week 12|Lack of Efficacy|0|||
124962289|NCT00550446|449490288|FG010|Up To Week 12|Lack of Efficacy|0|||
124962290|NCT00550446|449490278|FG000|Up To Week 12|Lost to Follow-up|0|||
124962291|NCT00550446|449490279|FG001|Up To Week 12|Lost to Follow-up|1|||
124962292|NCT00550446|449490280|FG002|Up To Week 12|Lost to Follow-up|0|||
124962293|NCT00550446|449490281|FG003|Up To Week 12|Lost to Follow-up|0|||
124962294|NCT00550446|449490282|FG004|Up To Week 12|Lost to Follow-up|1|||
124962295|NCT00550446|449490283|FG005|Up To Week 12|Lost to Follow-up|1|||
124962296|NCT00550446|449490284|FG006|Up To Week 12|Lost to Follow-up|2|||
124962297|NCT00550446|449490285|FG007|Up To Week 12|Lost to Follow-up|0|||
124962298|NCT00550446|449490286|FG008|Up To Week 12|Lost to Follow-up|0|||
124962299|NCT00550446|449490287|FG009|Up To Week 12|Lost to Follow-up|0|||
124962300|NCT00550446|449490288|FG010|Up To Week 12|Lost to Follow-up|0|||
124962301|NCT00550446|449490278|FG000|Up To Week 12|Withdrawal by Subject|2|||
124962302|NCT00550446|449490279|FG001|Up To Week 12|Withdrawal by Subject|0|||
124962303|NCT00550446|449490280|FG002|Up To Week 12|Withdrawal by Subject|3|||
124962304|NCT00550446|449490281|FG003|Up To Week 12|Withdrawal by Subject|2|||
124962305|NCT00550446|449490282|FG004|Up To Week 12|Withdrawal by Subject|0|||
125128910|NCT00723528|450097684|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
125128911|NCT00723528|450097685|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
125128912|NCT00723528|450097686|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
125215733|NCT00492232|450417501|FG000|Placebo Run-in|Lost to Follow-up|0|||
124962306|NCT00550446|449490283|FG005|Up To Week 12|Withdrawal by Subject|1|||
124962307|NCT00550446|449490284|FG006|Up To Week 12|Withdrawal by Subject|3|||
124962308|NCT00550446|449490285|FG007|Up To Week 12|Withdrawal by Subject|0|||
125128913|NCT00723528|450097687|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
124962309|NCT00550446|449490286|FG008|Up To Week 12|Withdrawal by Subject|0|||
124962310|NCT00550446|449490287|FG009|Up To Week 12|Withdrawal by Subject|0|||
124962311|NCT00550446|449490288|FG010|Up To Week 12|Withdrawal by Subject|0|||
124962312|NCT00550446|449490278|FG000|Up To Week 12|Other|3|||
125128914|NCT00723528|450097688|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
125128915|NCT00723528|450097689|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
124962313|NCT00550446|449490279|FG001|Up To Week 12|Other|0|||
124962314|NCT00550446|449490280|FG002|Up To Week 12|Other|0|||
124962315|NCT00550446|449490281|FG003|Up To Week 12|Other|0|||
124962316|NCT00550446|449490282|FG004|Up To Week 12|Other|0|||
125031400|NCT00896532|449735115|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031401|NCT00896532|449735116|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031402|NCT00896532|449735117|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031403|NCT00896532|449735118|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031404|NCT00896532|449735119|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031405|NCT00896532|449735120|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125031406|NCT00896532|449735098|FG000|Months 48-72: Follow-on Phase|Death|0|||
125031407|NCT00896532|449735099|FG001|Months 48-72: Follow-on Phase|Death|0|||
125031408|NCT00896532|449735100|FG002|Months 48-72: Follow-on Phase|Death|0|||
125031409|NCT00896532|449735101|FG003|Months 48-72: Follow-on Phase|Death|0|||
125031410|NCT00896532|449735102|FG004|Months 48-72: Follow-on Phase|Death|0|||
125031411|NCT00896532|449735103|FG005|Months 48-72: Follow-on Phase|Death|0|||
125031412|NCT00896532|449735104|FG006|Months 48-72: Follow-on Phase|Death|0|||
125031413|NCT00896532|449735105|FG007|Months 48-72: Follow-on Phase|Death|0|||
125031414|NCT00896532|449735106|FG008|Months 48-72: Follow-on Phase|Death|0|||
125031415|NCT00896532|449735107|FG009|Months 48-72: Follow-on Phase|Death|0|||
125031416|NCT00896532|449735108|FG010|Months 48-72: Follow-on Phase|Death|0|||
125031417|NCT00896532|449735109|FG011|Months 48-72: Follow-on Phase|Death|0|||
125031418|NCT00896532|449735110|FG012|Months 48-72: Follow-on Phase|Death|0|||
125031419|NCT00896532|449735111|FG013|Months 48-72: Follow-on Phase|Death|0|||
125031420|NCT00896532|449735112|FG014|Months 48-72: Follow-on Phase|Death|0|||
125031421|NCT00896532|449735113|FG015|Months 48-72: Follow-on Phase|Death|0|||
125031422|NCT00896532|449735114|FG016|Months 48-72: Follow-on Phase|Death|0|||
125031423|NCT00896532|449735115|FG017|Months 48-72: Follow-on Phase|Death|0|||
125031424|NCT00896532|449735116|FG018|Months 48-72: Follow-on Phase|Death|1|||
125031425|NCT00896532|449735117|FG019|Months 48-72: Follow-on Phase|Death|0|||
125031426|NCT00896532|449735118|FG020|Months 48-72: Follow-on Phase|Death|0|||
125031427|NCT00896532|449735119|FG021|Months 48-72: Follow-on Phase|Death|0|||
125031428|NCT00896532|449735120|FG022|Months 48-72: Follow-on Phase|Death|0|||
125031429|NCT00896532|449735098|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125031430|NCT00896532|449735099|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125031431|NCT00896532|449735100|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125031432|NCT00896532|449735101|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125031433|NCT00896532|449735102|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124962317|NCT00550446|449490283|FG005|Up To Week 12|Other|1|||
124962318|NCT00550446|449490284|FG006|Up To Week 12|Other|4|||
124962319|NCT00550446|449490285|FG007|Up To Week 12|Other|0|||
125128916|NCT00723528|450097683|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
125128917|NCT00723528|450097684|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
125128918|NCT00723528|450097685|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
125128919|NCT00723528|450097686|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
125128920|NCT00723528|450097687|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
125128921|NCT00723528|450097688|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
125128922|NCT00723528|450097689|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
125128923|NCT00723528|450097683|FG000|Period 2: After Controlled Period|Other|0|||
125128924|NCT00723528|450097684|FG001|Period 2: After Controlled Period|Other|0|||
125128925|NCT00723528|450097685|FG002|Period 2: After Controlled Period|Other|0|||
124962320|NCT00550446|449490286|FG008|Up To Week 12|Other|0|||
124962321|NCT00550446|449490287|FG009|Up To Week 12|Other|0|||
124962322|NCT00550446|449490288|FG010|Up To Week 12|Other|0|||
124962323|NCT00550446|449490278|FG000|Up To Week 12|Randomized not treated|0|||
124962324|NCT00550446|449490279|FG001|Up To Week 12|Randomized not treated|1|||
124962325|NCT00550446|449490280|FG002|Up To Week 12|Randomized not treated|1|||
124962326|NCT00550446|449490281|FG003|Up To Week 12|Randomized not treated|0|||
124962327|NCT00550446|449490282|FG004|Up To Week 12|Randomized not treated|0|||
124962328|NCT00550446|449490283|FG005|Up To Week 12|Randomized not treated|0|||
124962329|NCT00550446|449490284|FG006|Up To Week 12|Randomized not treated|0|||
124962330|NCT00550446|449490285|FG007|Up To Week 12|Randomized not treated|0|||
124962331|NCT00550446|449490286|FG008|Up To Week 12|Randomized not treated|0|||
124962332|NCT00550446|449490287|FG009|Up To Week 12|Randomized not treated|0|||
124962333|NCT00550446|449490288|FG010|Up To Week 12|Randomized not treated|0|||
124962334|NCT00550446|449490278|FG000|Post Week 12|Adverse Event|2|||
124962335|NCT00550446|449490279|FG001|Post Week 12|Adverse Event|1|||
124962336|NCT00550446|449490280|FG002|Post Week 12|Adverse Event|1|||
125128926|NCT00723528|450097686|FG003|Period 2: After Controlled Period|Other|0|||
125128927|NCT00723528|450097687|FG004|Period 2: After Controlled Period|Other|1|||
125128928|NCT00723528|450097688|FG005|Period 2: After Controlled Period|Other|4|||
125215734|NCT00492232|450417502|FG001|Placebo Run-in|Lost to Follow-up|3|||
125215735|NCT00492232|450417501|FG000|Placebo Run-in|Withdrawal by Subject|0|||
125215736|NCT00492232|450417502|FG001|Placebo Run-in|Withdrawal by Subject|8|||
125215737|NCT00492232|450417501|FG000|Placebo Run-in|Pregnancy|0|||
125215738|NCT00492232|450417502|FG001|Placebo Run-in|Pregnancy|1|||
125215739|NCT00492232|450417501|FG000|Placebo Run-in|Entrance criteria not met|0|||
125128929|NCT00723528|450097689|FG006|Period 2: After Controlled Period|Other|0|||
125128930|NCT00723528|450097683|FG000|Period 2: After Controlled Period|Adverse Event|0|||
125215740|NCT00492232|450417502|FG001|Placebo Run-in|Entrance criteria not met|45|||
125215741|NCT00492232|450417501|FG000|Placebo Run-in|Other|0|||
124962337|NCT00550446|449490281|FG003|Post Week 12|Adverse Event|1|||
124962338|NCT00550446|449490282|FG004|Post Week 12|Adverse Event|1|||
124962339|NCT00550446|449490283|FG005|Post Week 12|Adverse Event|1|||
124962340|NCT00550446|449490284|FG006|Post Week 12|Adverse Event|0|||
125128931|NCT00723528|450097684|FG001|Period 2: After Controlled Period|Adverse Event|0|||
125128932|NCT00723528|450097685|FG002|Period 2: After Controlled Period|Adverse Event|0|||
125128933|NCT00723528|450097686|FG003|Period 2: After Controlled Period|Adverse Event|0|||
125128934|NCT00723528|450097687|FG004|Period 2: After Controlled Period|Adverse Event|1|||
125128935|NCT00723528|450097688|FG005|Period 2: After Controlled Period|Adverse Event|0|||
125215742|NCT00492232|450417502|FG001|Placebo Run-in|Other|6|||
125031434|NCT00896532|449735103|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125031435|NCT00896532|449735104|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125031436|NCT00896532|449735105|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125031437|NCT00896532|449735106|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125031438|NCT00896532|449735107|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125031439|NCT00896532|449735108|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125031440|NCT00896532|449735109|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125031441|NCT00896532|449735110|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125031442|NCT00896532|449735111|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125031443|NCT00896532|449735112|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125031444|NCT00896532|449735113|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125031445|NCT00896532|449735114|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125031446|NCT00896532|449735115|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125031447|NCT00896532|449735116|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125031448|NCT00896532|449735117|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125031449|NCT00896532|449735118|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125031450|NCT00896532|449735119|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
125031451|NCT00896532|449735120|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125031452|NCT00896532|449735098|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125031453|NCT00896532|449735099|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125031454|NCT00896532|449735100|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125031455|NCT00896532|449735101|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125031456|NCT00896532|449735102|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125031457|NCT00896532|449735103|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125031458|NCT00896532|449735104|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125031459|NCT00896532|449735105|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125031460|NCT00896532|449735106|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125031461|NCT00896532|449735107|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125031462|NCT00896532|449735108|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125031463|NCT00896532|449735109|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125031464|NCT00896532|449735110|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125128936|NCT00723528|450097689|FG006|Period 2: After Controlled Period|Adverse Event|1|||
125128937|NCT00723528|450097683|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
125128938|NCT00723528|450097684|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
125128939|NCT00723528|450097685|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
125128940|NCT00723528|450097686|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
125128941|NCT00723528|450097687|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
125128942|NCT00723528|450097688|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
125128943|NCT00723528|450097689|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
125128944|NCT00723528|450097683|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
125128945|NCT00723528|450097684|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
125128946|NCT00723528|450097685|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
125128947|NCT00723528|450097686|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
125128948|NCT00723528|450097687|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
125128949|NCT00723528|450097688|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
125128950|NCT00723528|450097689|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
125128951|NCT01993030|450097690|FG000|Overall Study|Adverse Event|0|||
125128952|NCT01993030|450097691|FG001|Overall Study|Adverse Event|4|||
125128953|NCT03785548|450097692|FG000|Overall Study|age > 80|1|||
125128954|NCT03785548|450097693|FG001|Overall Study|age > 80|0|||
125128955|NCT03785548|450097692|FG000|Overall Study|no Postop queries|1|||
125128956|NCT03785548|450097693|FG001|Overall Study|no Postop queries|0|||
125128957|NCT01710657|450097694|FG000|Overall Study|Lost to Follow-up|2|||
125128958|NCT01710657|450097695|FG001|Overall Study|Lost to Follow-up|0|||
125128959|NCT01710657|450097696|FG002|Overall Study|Lost to Follow-up|1|||
125128960|NCT01710657|450097694|FG000|Overall Study|Protocol Violation|2|||
125128961|NCT01710657|450097695|FG001|Overall Study|Protocol Violation|2|||
125128962|NCT01710657|450097696|FG002|Overall Study|Protocol Violation|0|||
125128963|NCT01710657|450097694|FG000|Overall Study|Adverse Event|14|||
125128964|NCT01710657|450097695|FG001|Overall Study|Adverse Event|8|||
125128965|NCT01710657|450097696|FG002|Overall Study|Adverse Event|28|||
125128966|NCT01710657|450097694|FG000|Overall Study|Withdrawal by Subject|0|||
125128967|NCT01710657|450097695|FG001|Overall Study|Withdrawal by Subject|1|||
125128968|NCT01710657|450097696|FG002|Overall Study|Withdrawal by Subject|2|||
125128969|NCT01710657|450097694|FG000|Overall Study|Lack of Efficacy|0|||
125128970|NCT01710657|450097695|FG001|Overall Study|Lack of Efficacy|1|||
125128971|NCT01710657|450097696|FG002|Overall Study|Lack of Efficacy|1|||
125128972|NCT01591785|450097699|FG000|Overall Study|worsening condition|1|||
125128973|NCT01591785|450097700|FG001|Overall Study|worsening condition|2|||
125128974|NCT01591785|450097699|FG000|Overall Study|Protocol Violation|2|||
125128975|NCT01591785|450097700|FG001|Overall Study|Protocol Violation|0|||
125128976|NCT01591785|450097699|FG000|Overall Study|Lost to Follow-up|1|||
125128977|NCT01591785|450097700|FG001|Overall Study|Lost to Follow-up|0|||
125128978|NCT00358449|450097701|FG000|Overall Study|Adverse Event|1|||
125128979|NCT00358449|450097702|FG001|Overall Study|Adverse Event|0|||
125128980|NCT00358449|450097703|FG002|Overall Study|Adverse Event|1|||
125128981|NCT00358449|450097701|FG000|Overall Study|Lost to Follow-up|1|||
124962341|NCT00550446|449490285|FG007|Post Week 12|Adverse Event|0|||
124962342|NCT00550446|449490286|FG008|Post Week 12|Adverse Event|0|||
124962343|NCT00550446|449490287|FG009|Post Week 12|Adverse Event|4|||
124962344|NCT00550446|449490288|FG010|Post Week 12|Adverse Event|0|||
124962345|NCT00550446|449490278|FG000|Post Week 12|Lack of Efficacy|0|||
124962346|NCT00550446|449490279|FG001|Post Week 12|Lack of Efficacy|0|||
124962347|NCT00550446|449490280|FG002|Post Week 12|Lack of Efficacy|1|||
124962348|NCT00550446|449490281|FG003|Post Week 12|Lack of Efficacy|0|||
124962349|NCT00550446|449490282|FG004|Post Week 12|Lack of Efficacy|0|||
124962350|NCT00550446|449490283|FG005|Post Week 12|Lack of Efficacy|0|||
124962351|NCT00550446|449490284|FG006|Post Week 12|Lack of Efficacy|0|||
124962352|NCT00550446|449490285|FG007|Post Week 12|Lack of Efficacy|1|||
124962353|NCT00550446|449490286|FG008|Post Week 12|Lack of Efficacy|1|||
124962354|NCT00550446|449490287|FG009|Post Week 12|Lack of Efficacy|2|||
124962355|NCT00550446|449490288|FG010|Post Week 12|Lack of Efficacy|1|||
124962356|NCT00550446|449490278|FG000|Post Week 12|Lost to Follow-up|0|||
124962357|NCT00550446|449490279|FG001|Post Week 12|Lost to Follow-up|0|||
124962358|NCT00550446|449490280|FG002|Post Week 12|Lost to Follow-up|1|||
124962359|NCT00550446|449490281|FG003|Post Week 12|Lost to Follow-up|1|||
124962360|NCT00550446|449490282|FG004|Post Week 12|Lost to Follow-up|0|||
124962361|NCT00550446|449490283|FG005|Post Week 12|Lost to Follow-up|0|||
124962362|NCT00550446|449490284|FG006|Post Week 12|Lost to Follow-up|1|||
124962363|NCT00550446|449490285|FG007|Post Week 12|Lost to Follow-up|0|||
124962364|NCT00550446|449490286|FG008|Post Week 12|Lost to Follow-up|0|||
124962365|NCT00550446|449490287|FG009|Post Week 12|Lost to Follow-up|0|||
124962366|NCT00550446|449490288|FG010|Post Week 12|Lost to Follow-up|0|||
124962367|NCT00550446|449490278|FG000|Post Week 12|Withdrawal by Subject|0|||
124962368|NCT00550446|449490279|FG001|Post Week 12|Withdrawal by Subject|0|||
124962369|NCT00550446|449490280|FG002|Post Week 12|Withdrawal by Subject|0|||
124962370|NCT00550446|449490281|FG003|Post Week 12|Withdrawal by Subject|0|||
124962371|NCT00550446|449490282|FG004|Post Week 12|Withdrawal by Subject|1|||
124962372|NCT00550446|449490283|FG005|Post Week 12|Withdrawal by Subject|0|||
124962373|NCT00550446|449490284|FG006|Post Week 12|Withdrawal by Subject|0|||
124962374|NCT00550446|449490285|FG007|Post Week 12|Withdrawal by Subject|0|||
124962375|NCT00550446|449490286|FG008|Post Week 12|Withdrawal by Subject|0|||
124962376|NCT00550446|449490287|FG009|Post Week 12|Withdrawal by Subject|0|||
124962377|NCT00550446|449490288|FG010|Post Week 12|Withdrawal by Subject|0|||
124962378|NCT00550446|449490278|FG000|Post Week 12|Other|1|||
124962379|NCT00550446|449490279|FG001|Post Week 12|Other|1|||
124962380|NCT00550446|449490280|FG002|Post Week 12|Other|0|||
124962381|NCT00550446|449490281|FG003|Post Week 12|Other|1|||
124962382|NCT00550446|449490282|FG004|Post Week 12|Other|0|||
124962383|NCT00550446|449490283|FG005|Post Week 12|Other|0|||
124962384|NCT00550446|449490284|FG006|Post Week 12|Other|1|||
124962385|NCT00550446|449490285|FG007|Post Week 12|Other|0|||
124962386|NCT00550446|449490286|FG008|Post Week 12|Other|1|||
124962387|NCT00550446|449490287|FG009|Post Week 12|Other|1|||
124962388|NCT00550446|449490288|FG010|Post Week 12|Other|0|||
124962389|NCT02246218|449490289|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124962390|NCT02246218|449490290|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
124962391|NCT02246218|449490289|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
124962392|NCT02246218|449490290|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
124962393|NCT02246218|449490289|FG000|Overall Study|Adverse Event|1|||
124962394|NCT02246218|449490290|FG001|Overall Study|Adverse Event|1|||
124962395|NCT02246218|449490289|FG000|Overall Study|Lost to Follow-up|1|||
124962396|NCT02246218|449490290|FG001|Overall Study|Lost to Follow-up|0|||
124962397|NCT04952701|449490291|FG000|Control Lens|Physician Decision|4|||
124962398|NCT04952701|449490291|FG000|Test Lens|Physician Decision|1|||
124962399|NCT02212301|449490292|FG000|Period 1|Lost to Follow-up|0|||
124962400|NCT02212301|449490293|FG001|Period 1|Lost to Follow-up|1|||
124962401|NCT03927222|449490294|FG000|Overall Study|Progression|3|||
124962402|NCT03927222|449490294|FG000|Overall Study|CMV testing results inconclusive|1|||
124962403|NCT03927222|449490294|FG000|Overall Study|Unable to generate enough vaccines|1|||
124962404|NCT03927222|449490294|FG000|Overall Study|Early study termination|1|||
124962405|NCT00578318|449490299|FG000|Overall Study|Lost to Follow-up|2|||
124962406|NCT00578318|449490300|FG001|Overall Study|Lost to Follow-up|0|||
124962407|NCT00578318|449490299|FG000|Overall Study|Physician Decision|1|||
124962408|NCT00578318|449490300|FG001|Overall Study|Physician Decision|0|||
124962409|NCT00866918|449490301|FG000|Overall Study|Death|1|||
124962410|NCT00866918|449490302|FG001|Overall Study|Death|5|||
124962411|NCT00866918|449490301|FG000|Overall Study|Lack of Efficacy|1|||
124962412|NCT00866918|449490302|FG001|Overall Study|Lack of Efficacy|1|||
124962413|NCT00866918|449490301|FG000|Overall Study|Physician Decision|10|||
124962414|NCT00866918|449490302|FG001|Overall Study|Physician Decision|2|||
124962415|NCT00866918|449490301|FG000|Overall Study|Ineligible|2|||
125031465|NCT00896532|449735111|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124962416|NCT00866918|449490302|FG001|Overall Study|Ineligible|4|||
124962417|NCT00866918|449490301|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
124962418|NCT00866918|449490302|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
125031466|NCT00896532|449735112|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125031467|NCT00896532|449735113|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125031468|NCT00896532|449735114|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125031469|NCT00896532|449735115|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125031470|NCT00896532|449735116|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125031471|NCT00896532|449735117|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125031472|NCT00896532|449735118|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125031473|NCT00896532|449735119|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
125031474|NCT00896532|449735120|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125031475|NCT02411747|449735121|FG000|Overall Study|Withdrawal by Subject|1|||
125031476|NCT02411747|449735122|FG001|Overall Study|Withdrawal by Subject|0|||
125031477|NCT02411747|449735121|FG000|Overall Study|Protocol Violation|2|||
124962419|NCT00866918|449490301|FG000|Overall Study|Secondary malignancy|1|||
125031478|NCT02411747|449735122|FG001|Overall Study|Protocol Violation|4|||
124962420|NCT00866918|449490302|FG001|Overall Study|Secondary malignancy|0|||
124962421|NCT00527514|449490304|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
124962422|NCT00527514|449490304|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
124962423|NCT00527514|449490304|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
124962424|NCT00527514|449490304|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
124962425|NCT00527514|449490304|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
124962426|NCT00527514|449490304|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
124962427|NCT00527514|449490304|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
124962428|NCT00001941|449490321|FG000|Overall Study|not treated- rapidly progressing disease|0|||
124962429|NCT00001941|449490322|FG001|Overall Study|not treated- rapidly progressing disease|0|||
124962430|NCT00001941|449490323|FG002|Overall Study|not treated- rapidly progressing disease|0|||
124962431|NCT00001941|449490324|FG003|Overall Study|not treated- rapidly progressing disease|0|||
124962432|NCT00001941|449490325|FG004|Overall Study|not treated- rapidly progressing disease|1|||
124962433|NCT00640042|449490329|FG000|Enrollment|Did not receive study drug|83|||
124962434|NCT00519285|449490330|FG000|Overall Study|Adverse Event|127|||
124962435|NCT00519285|449490331|FG001|Overall Study|Adverse Event|266|||
124962436|NCT00519285|449490330|FG000|Overall Study|Disease progression|334|||
124962437|NCT00519285|449490331|FG001|Overall Study|Disease progression|186|||
124962438|NCT00519285|449490330|FG000|Overall Study|Physician Decision|75|||
124962439|NCT00519285|449490331|FG001|Overall Study|Physician Decision|47|||
124962440|NCT00519285|449490330|FG000|Overall Study|Participant's request|53|||
124962441|NCT00519285|449490331|FG001|Overall Study|Participant's request|84|||
124962442|NCT00519285|449490330|FG000|Overall Study|Consent withdrawn|4|||
124962443|NCT00519285|449490331|FG001|Overall Study|Consent withdrawn|5|||
124962444|NCT00519285|449490330|FG000|Overall Study|Poor compliance to protocol|5|||
124962445|NCT00519285|449490331|FG001|Overall Study|Poor compliance to protocol|7|||
124962446|NCT00519285|449490330|FG000|Overall Study|Reason unspecified|5|||
124962447|NCT00519285|449490331|FG001|Overall Study|Reason unspecified|8|||
124962448|NCT00519285|449490330|FG000|Overall Study|Not treated|8|||
124962449|NCT00519285|449490331|FG001|Overall Study|Not treated|7|||
124962450|NCT00519285|449490330|FG000|Overall Study|Treatment ongoing|1|||
124962451|NCT00519285|449490331|FG001|Overall Study|Treatment ongoing|2|||
124962452|NCT01020747|449490332|FG000|Overall Study|Withdrawal by Subject|1|||
124962453|NCT01222078|449490333|FG000|Overall Study|Early termination of the study|1|||
124962454|NCT02970305|449490334|FG000|Overall Study|Adverse Event|10|||
124962455|NCT02970305|449490335|FG001|Overall Study|Adverse Event|6|||
124962456|NCT02970305|449490334|FG000|Overall Study|Lack of Efficacy|1|||
124962457|NCT02970305|449490335|FG001|Overall Study|Lack of Efficacy|1|||
124962458|NCT02970305|449490334|FG000|Overall Study|Noncompliance with study drug|2|||
124962459|NCT02970305|449490335|FG001|Overall Study|Noncompliance with study drug|4|||
124962460|NCT02970305|449490334|FG000|Overall Study|Protocol Violation|2|||
124962461|NCT02970305|449490335|FG001|Overall Study|Protocol Violation|2|||
124962462|NCT02970305|449490334|FG000|Overall Study|Withdrawal by Subject|12|||
124962463|NCT02970305|449490335|FG001|Overall Study|Withdrawal by Subject|11|||
124962464|NCT02970305|449490334|FG000|Overall Study|Not further specified|1|||
124962465|NCT02970305|449490335|FG001|Overall Study|Not further specified|2|||
124962466|NCT02970305|449490334|FG000|Overall Study|Lost to Follow-up|1|||
124962467|NCT02970305|449490335|FG001|Overall Study|Lost to Follow-up|2|||
124962468|NCT00983892|449490336|FG000|Overall Study|Withdrawal by Subject|10|||
124962469|NCT00983892|449490337|FG001|Overall Study|Withdrawal by Subject|12|||
124962470|NCT00808899|449490339|FG000|Overall Study|Death|1|||
124962471|NCT00808899|449490339|FG000|Overall Study|Physician Decision|3|||
124962472|NCT03120949|449490344|FG000|Overall Study|randomized in error|1|||
124962473|NCT03120949|449490345|FG001|Overall Study|randomized in error|0|||
124962474|NCT03120949|449490344|FG000|Overall Study|Death|13|||
124962475|NCT03120949|449490345|FG001|Overall Study|Death|13|||
124962476|NCT03120949|449490344|FG000|Overall Study|Lost to Follow-up|23|||
124962477|NCT03120949|449490345|FG001|Overall Study|Lost to Follow-up|13|||
124962478|NCT03120949|449490344|FG000|Overall Study|Withdrawal by Subject|139|||
124962479|NCT03120949|449490345|FG001|Overall Study|Withdrawal by Subject|124|||
124962480|NCT03120949|449490344|FG000|Overall Study|Covid-19|43|||
124962481|NCT03120949|449490345|FG001|Overall Study|Covid-19|34|||
124962482|NCT03120949|449490344|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
124962483|NCT03120949|449490345|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
124962484|NCT03120949|449490344|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
124962485|NCT03120949|449490345|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
124962486|NCT03120949|449490344|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
124962487|NCT03120949|449490345|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
124962488|NCT03120949|449490344|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
124969642|NCT01234883|449517432|FG000|Overall Study|Early treatment release|8|||
124969643|NCT01234883|449517433|FG001|Overall Study|Early treatment release|10|||
124969644|NCT01234883|449517432|FG000|Overall Study|Parent/guardian withdrew consent|1|||
124969645|NCT01234883|449517433|FG001|Overall Study|Parent/guardian withdrew consent|2|||
125128982|NCT00358449|450097702|FG001|Overall Study|Lost to Follow-up|0|||
125128983|NCT00358449|450097703|FG002|Overall Study|Lost to Follow-up|0|||
125128984|NCT00358449|450097701|FG000|Overall Study|Withdrawal by Subject|2|||
125128985|NCT00358449|450097702|FG001|Overall Study|Withdrawal by Subject|0|||
125128986|NCT00358449|450097703|FG002|Overall Study|Withdrawal by Subject|0|||
124962489|NCT03120949|449490345|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
124962490|NCT03120949|449490344|FG000|Overall Study|Site was closed|2|||
124962491|NCT03120949|449490345|FG001|Overall Study|Site was closed|3|||
124962492|NCT03120949|449490344|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
124962493|NCT03120949|449490345|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
124962494|NCT03120949|449490344|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
124962495|NCT03120949|449490345|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
124962496|NCT03120949|449490344|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
124962497|NCT03120949|449490345|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
124962498|NCT03120949|449490344|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
124962499|NCT03120949|449490345|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
124962500|NCT03120949|449490344|FG000|Overall Study|Other: Adverse Event|0|||
124962501|NCT03120949|449490345|FG001|Overall Study|Other: Adverse Event|1|||
125128987|NCT00358449|450097701|FG000|Overall Study|Lack of Efficacy|0|||
125128988|NCT00358449|450097702|FG001|Overall Study|Lack of Efficacy|1|||
125128989|NCT00358449|450097703|FG002|Overall Study|Lack of Efficacy|0|||
125215743|NCT00492232|450417501|FG000|Placebo Run-in|Missing|0|||
125128990|NCT00358449|450097701|FG000|Overall Study|Steriod Inhaler was Increased|0|||
125128991|NCT00358449|450097702|FG001|Overall Study|Steriod Inhaler was Increased|0|||
125128992|NCT00358449|450097703|FG002|Overall Study|Steriod Inhaler was Increased|1|||
125128993|NCT00496964|450097711|FG000|Overall Study|Withdrawal by Subject|0|||
125128994|NCT00496964|450097712|FG001|Overall Study|Withdrawal by Subject|1|||
124962502|NCT03120949|449490344|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
124962503|NCT03120949|449490345|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
124962504|NCT03120949|449490344|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
124962505|NCT03120949|449490345|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
124962506|NCT03120949|449490344|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
125128995|NCT00469417|450097713|FG000|Overall Study|Treatment failure all lesions|18|||
125128996|NCT00469417|450097714|FG001|Overall Study|Treatment failure all lesions|11|||
125128997|NCT00469417|450097713|FG000|Overall Study|Consent withdrawn|1|||
125128998|NCT00469417|450097714|FG001|Overall Study|Consent withdrawn|1|||
125128999|NCT00469417|450097713|FG000|Overall Study|Adverse Event|8|||
125129000|NCT00469417|450097714|FG001|Overall Study|Adverse Event|2|||
124962507|NCT03120949|449490345|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
124962508|NCT03120949|449490344|FG000|Overall Study|Personal Reasons|0|||
124962509|NCT03120949|449490345|FG001|Overall Study|Personal Reasons|1|||
124969646|NCT01234883|449517432|FG000|Overall Study|Technical difficulties with IV infusion|0|||
125129001|NCT00469417|450097713|FG000|Overall Study|Lost to Follow-up|1|||
125129002|NCT00469417|450097714|FG001|Overall Study|Lost to Follow-up|2|||
125129003|NCT00469417|450097713|FG000|Overall Study|Intercurrent disease|0|||
124962510|NCT03120949|449490344|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
124962511|NCT03120949|449490345|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
124962512|NCT03120949|449490344|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
124962513|NCT03120949|449490345|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
124962514|NCT03120949|449490344|FG000|Overall Study|Compliance With Medication|0|||
124962515|NCT03120949|449490345|FG001|Overall Study|Compliance With Medication|1|||
124962516|NCT03120949|449490344|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
124962517|NCT03120949|449490345|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
124962518|NCT03120949|449490344|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
124962519|NCT03120949|449490345|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
124962520|NCT03120949|449490344|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
124962521|NCT03120949|449490345|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
124962522|NCT00988117|449490346|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
124962523|NCT00988117|449490346|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
124962524|NCT04522778|449490349|FG000|Overall Study|Patient did not want to wear the device|1|||
124962525|NCT04522778|449490350|FG001|Overall Study|Patient did not want to wear the device|0|||
124962526|NCT04522778|449490349|FG000|Overall Study|Lost to Follow-up|0|||
124962527|NCT04522778|449490350|FG001|Overall Study|Lost to Follow-up|1|||
124962528|NCT01225159|449490351|FG000|Overall Study|Change operation|1|||
124962529|NCT01225159|449490352|FG001|Overall Study|Change operation|0|||
124962530|NCT00312845|449490353|FG000|Overall Study|Adverse Event|19|||
124962531|NCT00312845|449490354|FG001|Overall Study|Adverse Event|5|||
124962532|NCT00312845|449490353|FG000|Overall Study|Death|2|||
124962533|NCT00312845|449490354|FG001|Overall Study|Death|2|||
124962534|NCT00312845|449490353|FG000|Overall Study|Withdrawal by Subject|14|||
124962535|NCT00312845|449490354|FG001|Overall Study|Withdrawal by Subject|6|||
124962536|NCT00312845|449490353|FG000|Overall Study|Disease Progression|56|||
124962537|NCT00312845|449490354|FG001|Overall Study|Disease Progression|77|||
124962538|NCT00312845|449490353|FG000|Overall Study|Lost to Follow-up|2|||
124962539|NCT00312845|449490354|FG001|Overall Study|Lost to Follow-up|0|||
124962540|NCT00312845|449490353|FG000|Overall Study|Other|6|||
124962541|NCT00312845|449490354|FG001|Overall Study|Other|5|||
124962542|NCT01220856|449490355|FG000|Overall Study|graft loss|3|||
124962543|NCT01220856|449490356|FG001|Overall Study|graft loss|3|||
124962544|NCT01220856|449490355|FG000|Overall Study|Lost to Follow-up|1|||
124962545|NCT01220856|449490356|FG001|Overall Study|Lost to Follow-up|0|||
124962546|NCT04088500|449490357|FG000|Overall Study|Reason unknown|1|||
124962547|NCT04088500|449490357|FG000|Overall Study|Participant withdrew consent|1|||
124962548|NCT04088500|449490357|FG000|Overall Study|Disease progression|3|||
124962549|NCT03821064|449490358|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
124962550|NCT03325608|449490367|FG000|Overall Study|Lost to Follow-up|23|||
124962551|NCT03325608|449490368|FG001|Overall Study|Lost to Follow-up|23|||
124962552|NCT03325608|449490369|FG002|Overall Study|Lost to Follow-up|30|||
124962553|NCT03325608|449490370|FG003|Overall Study|Lost to Follow-up|30|||
124962554|NCT03325608|449490367|FG000|Overall Study|Death of Caregiver|0|||
124962555|NCT03325608|449490368|FG001|Overall Study|Death of Caregiver|0|||
124962556|NCT03325608|449490369|FG002|Overall Study|Death of Caregiver|2|||
124962557|NCT03325608|449490370|FG003|Overall Study|Death of Caregiver|2|||
124962558|NCT03325608|449490367|FG000|Overall Study|Death of Care Recipient|34|||
124962559|NCT03325608|449490368|FG001|Overall Study|Death of Care Recipient|34|||
124962560|NCT03325608|449490369|FG002|Overall Study|Death of Care Recipient|28|||
124962561|NCT03325608|449490370|FG003|Overall Study|Death of Care Recipient|28|||
124962562|NCT03325608|449490367|FG000|Overall Study|Withdrawal by Subject|49|||
124962563|NCT03325608|449490368|FG001|Overall Study|Withdrawal by Subject|49|||
124962564|NCT03325608|449490369|FG002|Overall Study|Withdrawal by Subject|35|||
124962565|NCT03325608|449490370|FG003|Overall Study|Withdrawal by Subject|35|||
124962566|NCT03325608|449490367|FG000|Overall Study|Ineligible|7|||
124962567|NCT03325608|449490368|FG001|Overall Study|Ineligible|7|||
124962568|NCT03325608|449490369|FG002|Overall Study|Ineligible|5|||
124962569|NCT03325608|449490370|FG003|Overall Study|Ineligible|5|||
124962570|NCT02188784|449490371|FG000|Overall Study|Death|3|||
124962571|NCT02188784|449490372|FG001|Overall Study|Death|1|||
124962572|NCT02188784|449490371|FG000|Overall Study|Lost to Follow-up|1|||
125129004|NCT00469417|450097714|FG001|Overall Study|Intercurrent disease|1|||
125129005|NCT00469417|450097713|FG000|Overall Study|Randomized but not treated|2|||
125129006|NCT00469417|450097714|FG001|Overall Study|Randomized but not treated|0|||
125129007|NCT00909610|450097715|FG000|Period: First Intervention|Adverse Event|0|||
124962573|NCT02188784|449490372|FG001|Overall Study|Lost to Follow-up|0|||
124962574|NCT02188784|449490371|FG000|Overall Study|Withdrawal by Subject|3|||
124962575|NCT02188784|449490372|FG001|Overall Study|Withdrawal by Subject|9|||
124962576|NCT02188784|449490371|FG000|Overall Study|Physician Decision|2|||
124962577|NCT02188784|449490372|FG001|Overall Study|Physician Decision|3|||
124962578|NCT01190449|449490373|FG000|Overall Study|Ineligible|0|||
124962579|NCT01190449|449490374|FG001|Overall Study|Ineligible|4|||
124962580|NCT01268098|449492086|FG000|Overall Study|Adverse Event|1|||
124962581|NCT01268098|449492087|FG001|Overall Study|Adverse Event|0|||
124962582|NCT01093599|449492094|FG000|Overall Study|Lost to Follow-up|32|||
124962583|NCT01093599|449492095|FG001|Overall Study|Lost to Follow-up|46|||
124962584|NCT01703845|449492096|FG000|Overall Study|Adverse Event|1|||
124962585|NCT01703845|449492097|FG001|Overall Study|Adverse Event|0|||
124962586|NCT01703845|449492096|FG000|Overall Study|Protocol Violation|1|||
124962587|NCT01703845|449492097|FG001|Overall Study|Protocol Violation|0|||
124962588|NCT01703845|449492096|FG000|Overall Study|other than stated above|1|||
124962589|NCT01703845|449492097|FG001|Overall Study|other than stated above|0|||
124962590|NCT01644188|449492098|FG000|Overall Study|Adverse Event|44|||
124962591|NCT01644188|449492099|FG001|Overall Study|Adverse Event|20|||
124962592|NCT01644188|449492098|FG000|Overall Study|Poor compliance to protocol|26|||
124962593|NCT01644188|449492099|FG001|Overall Study|Poor compliance to protocol|14|||
124962594|NCT01644188|449492098|FG000|Overall Study|Physician Decision|1|||
124962595|NCT01644188|449492099|FG001|Overall Study|Physician Decision|3|||
124962596|NCT01644188|449492098|FG000|Overall Study|Participant moved|7|||
124962597|NCT01644188|449492099|FG001|Overall Study|Participant moved|2|||
124962598|NCT01644188|449492098|FG000|Overall Study|Related to auto-injector administration|2|||
124962599|NCT01644188|449492099|FG001|Overall Study|Related to auto-injector administration|2|||
124962600|NCT01644188|449492098|FG000|Overall Study|Consent withdrawn by participant|14|||
124962601|NCT01644188|449492099|FG001|Overall Study|Consent withdrawn by participant|7|||
124962602|NCT01644188|449492098|FG000|Overall Study|Selection criteria finally not met|2|||
124962603|NCT01644188|449492099|FG001|Overall Study|Selection criteria finally not met|0|||
124962604|NCT01644188|449492098|FG000|Overall Study|Lost to Follow-up|1|||
124962605|NCT01644188|449492099|FG001|Overall Study|Lost to Follow-up|0|||
124962606|NCT01644188|449492098|FG000|Overall Study|Death|4|||
124962607|NCT01644188|449492099|FG001|Overall Study|Death|3|||
124962608|NCT01644188|449492098|FG000|Overall Study|Last visit outside protocol visit window|14|||
124962609|NCT01644188|449492099|FG001|Overall Study|Last visit outside protocol visit window|16|||
124962610|NCT01644188|449492098|FG000|Overall Study|Site closure|1|||
124962611|NCT01644188|449492099|FG001|Overall Study|Site closure|1|||
124962612|NCT01644188|449492098|FG000|Overall Study|Other than specified above|6|||
124962613|NCT01644188|449492099|FG001|Overall Study|Other than specified above|7|||
124962614|NCT01929876|449492101|FG000|Period 2|Non-Compliance|1|||
124962615|NCT01845649|449492102|FG000|Overall Study|Adverse Event|7|||
124962616|NCT01845649|449492103|FG001|Overall Study|Adverse Event|10|||
124962617|NCT01845649|449492102|FG000|Overall Study|Lack of Efficacy|1|||
124962618|NCT01845649|449492103|FG001|Overall Study|Lack of Efficacy|1|||
124962619|NCT01845649|449492102|FG000|Overall Study|Lost to Follow-up|2|||
124962620|NCT01845649|449492103|FG001|Overall Study|Lost to Follow-up|2|||
124962621|NCT01845649|449492102|FG000|Overall Study|Withdrew Consent|12|||
124962622|NCT01845649|449492103|FG001|Overall Study|Withdrew Consent|4|||
124962623|NCT01845649|449492102|FG000|Overall Study|Protocol Deviation|7|||
124962624|NCT01845649|449492103|FG001|Overall Study|Protocol Deviation|4|||
124962625|NCT01845649|449492102|FG000|Overall Study|Reason not Specified|2|||
124962626|NCT01845649|449492103|FG001|Overall Study|Reason not Specified|1|||
124962627|NCT03991988|449492104|FG000|Overall Study|Withdrawal by Subject|2|||
124962628|NCT03991988|449492105|FG001|Overall Study|Withdrawal by Subject|2|||
124962629|NCT01222533|449492107|FG000|Overall Study|Adverse Event|5|||
124962630|NCT01222533|449492107|FG000|Overall Study|Withdrawal by Subject|5|||
124962631|NCT01222533|449492107|FG000|Overall Study|Other|4|||
124962632|NCT01947517|449492108|FG000|Overall Study|Withdrawal by Subject|1|||
124962633|NCT01947517|449492109|FG001|Overall Study|Withdrawal by Subject|1|||
124962634|NCT02418845|449492113|FG000|Overall Study|Lost to Follow-up|7|||
124962635|NCT02418845|449492114|FG001|Overall Study|Lost to Follow-up|2|||
124962636|NCT02418845|449492113|FG000|Overall Study|Lack of Efficacy|0|||
124962637|NCT02418845|449492114|FG001|Overall Study|Lack of Efficacy|3|||
124962638|NCT02418845|449492113|FG000|Overall Study|Physician Decision|5|||
124962639|NCT02418845|449492114|FG001|Overall Study|Physician Decision|5|||
124962640|NCT02418845|449492113|FG000|Overall Study|Protocol Violation|1|||
124962641|NCT02418845|449492114|FG001|Overall Study|Protocol Violation|0|||
124962642|NCT02418845|449492113|FG000|Overall Study|Withdrawal by Subject|3|||
124962643|NCT02418845|449492114|FG001|Overall Study|Withdrawal by Subject|2|||
124962644|NCT00526097|449492115|FG000|Overall Study|Adverse Event|6|||
124962645|NCT00526097|449492116|FG001|Overall Study|Adverse Event|44|||
124962646|NCT00526097|449492115|FG000|Overall Study|Protocol Violation|4|||
124962647|NCT00526097|449492116|FG001|Overall Study|Protocol Violation|10|||
124962648|NCT00526097|449492115|FG000|Overall Study|Withdrawal by Subject|3|||
124962649|NCT00526097|449492116|FG001|Overall Study|Withdrawal by Subject|1|||
124962650|NCT00526097|449492115|FG000|Overall Study|Other|2|||
124962651|NCT00526097|449492116|FG001|Overall Study|Other|1|||
124962652|NCT00460564|449492117|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
124962653|NCT00460564|449492118|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
124962654|NCT00460564|449492119|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
124962655|NCT00460564|449492120|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
125129008|NCT00909610|450097716|FG001|Period: First Intervention|Adverse Event|1|||
125129009|NCT00909610|450097715|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
125129010|NCT00909610|450097716|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
125129011|NCT00909610|450097715|FG000|Period: Second Intervention|Adverse Event|1|||
124962656|NCT00460564|449492121|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
124962657|NCT00460564|449492122|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
124962658|NCT00460564|449492123|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
124962659|NCT00460564|449492124|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
124962660|NCT00460564|449492117|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
124962661|NCT00460564|449492118|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
124962662|NCT00460564|449492119|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
124962663|NCT00460564|449492120|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
124962664|NCT00460564|449492121|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
124962665|NCT00460564|449492122|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
124962666|NCT00460564|449492123|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
124962667|NCT00460564|449492124|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
124962668|NCT00460564|449492117|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
124962669|NCT00460564|449492118|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
124962670|NCT00460564|449492119|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
124962671|NCT00460564|449492120|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
124962672|NCT00460564|449492121|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
124962673|NCT00460564|449492122|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
124962674|NCT00460564|449492123|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
124962675|NCT00460564|449492124|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
124962676|NCT00460564|449492117|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
124962677|NCT00460564|449492118|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
124962678|NCT00460564|449492119|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
124962679|NCT00460564|449492120|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
124962680|NCT00460564|449492121|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
124962681|NCT00460564|449492122|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
124962682|NCT00460564|449492123|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
124962683|NCT00460564|449492124|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
124962684|NCT00460564|449492117|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
124962685|NCT00460564|449492118|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
124962686|NCT00460564|449492119|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
124962687|NCT00460564|449492120|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
124962688|NCT00460564|449492121|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
124962689|NCT00460564|449492122|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
125031479|NCT02149810|449735123|FG000|Overall Study|Physician Decision|1|||
125031480|NCT02149810|449735124|FG001|Overall Study|Physician Decision|2|||
125031481|NCT02149810|449735123|FG000|Overall Study|Lost to Follow-up|2|||
125031482|NCT02149810|449735124|FG001|Overall Study|Lost to Follow-up|1|||
125031483|NCT02149810|449735123|FG000|Overall Study|Withdrawal by Subject|5|||
125031484|NCT02149810|449735124|FG001|Overall Study|Withdrawal by Subject|1|||
125031485|NCT00675597|449735125|FG000|Overall Study|Withdrawal by Subject|3|||
125031486|NCT01015833|449735128|FG000|Overall Study|Death|1|||
125031487|NCT01015833|449735129|FG001|Overall Study|Death|0|||
125031488|NCT01015833|449735128|FG000|Overall Study|Withdrawal by Subject|3|||
125031489|NCT01015833|449735129|FG001|Overall Study|Withdrawal by Subject|2|||
125031490|NCT01015833|449735128|FG000|Overall Study|Adverse Event|0|||
125031491|NCT01015833|449735129|FG001|Overall Study|Adverse Event|1|||
125031492|NCT01015833|449735128|FG000|Overall Study|Physician Decision|2|||
125031493|NCT01015833|449735129|FG001|Overall Study|Physician Decision|0|||
125031494|NCT01015833|449735128|FG000|Overall Study|Symptomatic deterioration|0|||
125031495|NCT01015833|449735129|FG001|Overall Study|Symptomatic deterioration|1|||
125031496|NCT01015833|449735128|FG000|Overall Study|Other|5|||
125031497|NCT01015833|449735129|FG001|Overall Study|Other|1|||
125031498|NCT01015833|449735128|FG000|Overall Study|Motor Vehicle Accidents|1|||
125031499|NCT01015833|449735129|FG001|Overall Study|Motor Vehicle Accidents|0|||
125031500|NCT01015833|449735128|FG000|Overall Study|Did not start treatment|1|||
125031501|NCT01015833|449735129|FG001|Overall Study|Did not start treatment|0|||
125031502|NCT01671280|449735130|FG000|Overall Study|Withdrawal by Subject|2|||
125031503|NCT00996203|449735131|FG000|Overall Study|Adverse Event|3|||
125031504|NCT00996203|449735131|FG000|Overall Study|Lost to Follow-up|1|||
125031505|NCT00996203|449735131|FG000|Overall Study|Lack of Efficacy|1|||
125031506|NCT00996203|449735131|FG000|Overall Study|Protocol Violation|2|||
125031507|NCT01439945|449735132|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
125129012|NCT00909610|450097716|FG001|Period: Second Intervention|Adverse Event|0|||
125129013|NCT05327491|450097721|FG000|Periods 1 & 2|Miscellaneous|0|||
124962690|NCT00460564|449492123|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
124962691|NCT00460564|449492124|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
124962692|NCT00511836|449492125|FG000|Double-blind Period|Lost to Follow-up|1|||
124962693|NCT00511836|449492126|FG001|Double-blind Period|Lost to Follow-up|0|||
124962694|NCT00943618|449492130|FG000|Overall Study|Lost to Follow-up|38|||
124962695|NCT00943618|449492131|FG001|Overall Study|Lost to Follow-up|48|||
124962696|NCT00943618|449492132|FG002|Overall Study|Lost to Follow-up|20|||
124962697|NCT00943618|449492130|FG000|Overall Study|Discontinued Medication|17|||
124962698|NCT00943618|449492131|FG001|Overall Study|Discontinued Medication|29|||
124962699|NCT00943618|449492132|FG002|Overall Study|Discontinued Medication|11|||
124962700|NCT00487552|449492147|FG000|Overall Study|Unsuccessful magnet placements|3|||
124962701|NCT00487552|449492147|FG000|Overall Study|Death due to progressive malignancy|2|||
124962702|NCT00487552|449492147|FG000|Overall Study|Stent not placed|1|||
124962703|NCT02412111|449492148|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
124962704|NCT02412111|449492149|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
124962705|NCT02412111|449492150|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
124962706|NCT02412111|449492148|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
124962707|NCT02412111|449492149|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
124962708|NCT02412111|449492150|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
124962709|NCT02412111|449492148|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
124962710|NCT02412111|449492149|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
124962711|NCT02412111|449492150|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
124962712|NCT02412111|449492148|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
124962713|NCT02412111|449492149|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
124962714|NCT02412111|449492150|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
124962715|NCT02412111|449492148|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
124962716|NCT02412111|449492149|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
124962717|NCT02412111|449492150|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
124962718|NCT02412111|449492148|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
124962719|NCT02412111|449492149|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
124962720|NCT02412111|449492150|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
124962721|NCT02412111|449492148|FG000|Active Comparator Period (8 Weeks)|Other|0|||
124962722|NCT02412111|449492149|FG001|Active Comparator Period (8 Weeks)|Other|0|||
124962723|NCT02412111|449492150|FG002|Active Comparator Period (8 Weeks)|Other|2|||
124962724|NCT00630552|449492151|FG000|Overall Study|Adverse Event|0|||
124962725|NCT00630552|449492152|FG001|Overall Study|Adverse Event|1|||
124962726|NCT00630552|449492153|FG002|Overall Study|Adverse Event|5|||
124962727|NCT00630552|449492154|FG003|Overall Study|Adverse Event|4|||
124962728|NCT00630552|449492155|FG004|Overall Study|Adverse Event|2|||
124962729|NCT00630552|449492151|FG000|Overall Study|Disease progression|5|||
124962730|NCT00630552|449492152|FG001|Overall Study|Disease progression|6|||
124962731|NCT00630552|449492153|FG002|Overall Study|Disease progression|27|||
124962732|NCT00630552|449492154|FG003|Overall Study|Disease progression|22|||
124962733|NCT00630552|449492155|FG004|Overall Study|Disease progression|31|||
124962734|NCT00630552|449492151|FG000|Overall Study|Never received IP|0|||
124962735|NCT00630552|449492152|FG001|Overall Study|Never received IP|0|||
124962736|NCT00630552|449492153|FG002|Overall Study|Never received IP|0|||
124962737|NCT00630552|449492154|FG003|Overall Study|Never received IP|2|||
124962738|NCT00630552|449492155|FG004|Overall Study|Never received IP|2|||
124962739|NCT00630552|449492151|FG000|Overall Study|Ineligibility determined|0|||
125129014|NCT05327491|450097722|FG001|Periods 1 & 2|Miscellaneous|1|||
125129015|NCT05327491|450097723|FG002|Periods 1 & 2|Miscellaneous|0|||
125129016|NCT05327491|450097724|FG003|Periods 1 & 2|Miscellaneous|0|||
125129017|NCT05327491|450097721|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
125129018|NCT05327491|450097722|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
125129019|NCT05327491|450097723|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
125129020|NCT05327491|450097724|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
125129021|NCT05038293|450097725|FG000|Overall Study|device was not operating properly for one subject.|1|||
124962740|NCT00630552|449492152|FG001|Overall Study|Ineligibility determined|0|||
124962741|NCT00630552|449492153|FG002|Overall Study|Ineligibility determined|0|||
125129022|NCT05038293|450097726|FG001|Overall Study|device was not operating properly for one subject.|0|||
125129023|NCT05038293|450097725|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
125215744|NCT00492232|450417502|FG001|Placebo Run-in|Missing|2|||
125031508|NCT01439945|449735133|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
125031509|NCT01439945|449735134|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
125031510|NCT01439945|449735135|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
125031511|NCT01439945|449735132|FG000|Double-Blind Treatment Phase|Ineligible|1|||
125031512|NCT01439945|449735133|FG001|Double-Blind Treatment Phase|Ineligible|2|||
125031513|NCT01439945|449735134|FG002|Double-Blind Treatment Phase|Ineligible|0|||
125031514|NCT01439945|449735135|FG003|Double-Blind Treatment Phase|Ineligible|1|||
125031515|NCT01468987|449735138|FG000|Overall Study|Adverse Event|12|||
125031516|NCT01468987|449735139|FG001|Overall Study|Adverse Event|9|||
125031517|NCT01468987|449735138|FG000|Overall Study|Death|4|||
125031518|NCT01468987|449735139|FG001|Overall Study|Death|1|||
125031519|NCT01468987|449735138|FG000|Overall Study|Lost to Follow-up|10|||
125031520|NCT01468987|449735139|FG001|Overall Study|Lost to Follow-up|5|||
125031521|NCT01468987|449735138|FG000|Overall Study|Protocol Violation|8|||
125031522|NCT01468987|449735139|FG001|Overall Study|Protocol Violation|2|||
125031523|NCT01468987|449735138|FG000|Overall Study|Withdrawal by Subject|28|||
125031524|NCT01468987|449735139|FG001|Overall Study|Withdrawal by Subject|28|||
125031525|NCT01468987|449735138|FG000|Overall Study|Physician Decision|8|||
125031526|NCT01468987|449735139|FG001|Overall Study|Physician Decision|15|||
125031527|NCT01468987|449735138|FG000|Overall Study|Sponsor Decision|1|||
125031528|NCT01468987|449735139|FG001|Overall Study|Sponsor Decision|0|||
125031529|NCT05032950|449735140|FG000|Overall Study|Adverse Event|0|||
125031530|NCT05032950|449735141|FG001|Overall Study|Adverse Event|0|||
125031531|NCT05032950|449735142|FG002|Overall Study|Adverse Event|1|||
125031532|NCT05032950|449735143|FG003|Overall Study|Adverse Event|1|||
125031533|NCT05032950|449735144|FG004|Overall Study|Adverse Event|0|||
125031534|NCT05032950|449735145|FG005|Overall Study|Adverse Event|0|||
125031535|NCT02292771|449735149|FG000|Overall Study|Withdrawal by Subject|2|||
125031536|NCT02292771|449735150|FG001|Overall Study|Withdrawal by Subject|1|||
125031537|NCT02292771|449735149|FG000|Overall Study|Lost to Follow-up|2|||
125031538|NCT02292771|449735150|FG001|Overall Study|Lost to Follow-up|1|||
125031539|NCT01475734|449737353|FG000|Overall Study|Withdrawal by Subject|1|||
125031540|NCT01475734|449737354|FG001|Overall Study|Withdrawal by Subject|0|||
125031541|NCT01475734|449737353|FG000|Overall Study|Protocol Violation|1|||
125031542|NCT01475734|449737354|FG001|Overall Study|Protocol Violation|0|||
125031543|NCT01475734|449737353|FG000|Overall Study|Physician Decision|0|||
125031544|NCT01475734|449737354|FG001|Overall Study|Physician Decision|1|||
125031545|NCT00376961|449737358|FG000|Initial Registration|Adverse Event|1|||
125031546|NCT00376961|449737359|FG001|Initial Registration|Adverse Event|0|||
125031547|NCT00376961|449737358|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
125031548|NCT00376961|449737359|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
125031549|NCT00376961|449737358|FG000|Initial Registration|Progression/relapse|1|||
125031550|NCT00376961|449737359|FG001|Initial Registration|Progression/relapse|0|||
125031551|NCT00376961|449737358|FG000|Initial Registration|Ineligible|3|||
125031552|NCT00376961|449737359|FG001|Initial Registration|Ineligible|0|||
125031553|NCT00376961|449737358|FG000|Maintenance|Adverse Event|0|||
125031554|NCT00376961|449737359|FG001|Maintenance|Adverse Event|1|||
125031555|NCT00376961|449737358|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
125031556|NCT00376961|449737359|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
125031557|NCT00376961|449737358|FG000|Maintenance|Progression/relapse|0|||
125031558|NCT00376961|449737359|FG001|Maintenance|Progression/relapse|18|||
125031559|NCT00376961|449737358|FG000|Maintenance|Ineligible|0|||
125031560|NCT00376961|449737359|FG001|Maintenance|Ineligible|3|||
125031561|NCT01059448|449737360|FG000|Overall Study|Adverse Event|1|||
125031562|NCT01059448|449737361|FG001|Overall Study|Adverse Event|3|||
125031563|NCT01059448|449737362|FG002|Overall Study|Adverse Event|0|||
125031564|NCT01059448|449737363|FG003|Overall Study|Adverse Event|1|||
125031565|NCT01059448|449737360|FG000|Overall Study|Withdrawal by Subject|2|||
125031566|NCT01059448|449737361|FG001|Overall Study|Withdrawal by Subject|0|||
125031567|NCT01059448|449737362|FG002|Overall Study|Withdrawal by Subject|2|||
125031568|NCT01059448|449737363|FG003|Overall Study|Withdrawal by Subject|4|||
125031569|NCT01059448|449737360|FG000|Overall Study|Disease Progression|2|||
125031570|NCT01059448|449737361|FG001|Overall Study|Disease Progression|1|||
125031571|NCT01059448|449737362|FG002|Overall Study|Disease Progression|4|||
125031572|NCT01059448|449737363|FG003|Overall Study|Disease Progression|2|||
125031573|NCT01059448|449737360|FG000|Overall Study|Administrative Decision|43|||
125031574|NCT01059448|449737361|FG001|Overall Study|Administrative Decision|49|||
125031575|NCT01059448|449737362|FG002|Overall Study|Administrative Decision|45|||
125031576|NCT01059448|449737363|FG003|Overall Study|Administrative Decision|46|||
125031577|NCT01059448|449737360|FG000|Overall Study|Lost to Follow-up|0|||
125031578|NCT01059448|449737361|FG001|Overall Study|Lost to Follow-up|0|||
125031579|NCT01059448|449737362|FG002|Overall Study|Lost to Follow-up|2|||
125031580|NCT01059448|449737363|FG003|Overall Study|Lost to Follow-up|0|||
125031581|NCT01059448|449737360|FG000|Overall Study|Death|0|||
125031582|NCT01059448|449737361|FG001|Overall Study|Death|1|||
125031583|NCT01059448|449737362|FG002|Overall Study|Death|0|||
125031584|NCT01059448|449737363|FG003|Overall Study|Death|0|||
125031585|NCT01059448|449737360|FG000|Overall Study|Other|1|||
125031586|NCT01059448|449737361|FG001|Overall Study|Other|1|||
125031587|NCT01059448|449737362|FG002|Overall Study|Other|0|||
125031588|NCT01059448|449737363|FG003|Overall Study|Other|1|||
125031589|NCT02911688|449737364|FG000|Washout|Lost to Follow-up|1|||
125031590|NCT02911688|449737365|FG001|Washout|Lost to Follow-up|1|||
125031591|NCT02911688|449737364|FG000|Washout|Withdrawal by Subject|0|||
125031592|NCT02911688|449737365|FG001|Washout|Withdrawal by Subject|1|||
125031593|NCT00809328|449737366|FG000|Overall Study|Lack of Efficacy|18|||
125031594|NCT00809328|449737366|FG000|Overall Study|Adverse Event|6|||
125031595|NCT00809328|449737366|FG000|Overall Study|Protocol Violation|3|||
125031596|NCT00809328|449737366|FG000|Overall Study|Withdrawal by Subject|2|||
125031597|NCT05148884|449737375|FG000|Overall Study|Withdrawal by Subject|3|||
125031598|NCT05148884|449737376|FG001|Overall Study|Withdrawal by Subject|0|||
125031599|NCT05148884|449737375|FG000|Overall Study|Deep brain stimulation operation|0|||
125031600|NCT05148884|449737376|FG001|Overall Study|Deep brain stimulation operation|1|||
125129024|NCT05038293|450097726|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
125031601|NCT01993888|449737377|FG000|Overall Study|Death|1|||
125031602|NCT01993888|449737378|FG001|Overall Study|Death|1|||
125031603|NCT01993888|449737377|FG000|Overall Study|Lost to Follow-up|1|||
125129025|NCT01247701|450097730|FG000|Overall Study|Death|2|||
125129026|NCT01247701|450097730|FG000|Overall Study|Relapsed|8|||
125031604|NCT01993888|449737378|FG001|Overall Study|Lost to Follow-up|1|||
125129027|NCT04166630|450097731|FG000|Overall Study|Withdrawal by Subject|0|||
124962742|NCT00630552|449492154|FG003|Overall Study|Ineligibility determined|0|||
124962743|NCT00630552|449492155|FG004|Overall Study|Ineligibility determined|1|||
124962744|NCT00630552|449492151|FG000|Overall Study|Protocol Violation|0|||
124962745|NCT00630552|449492152|FG001|Overall Study|Protocol Violation|0|||
124962746|NCT00630552|449492153|FG002|Overall Study|Protocol Violation|0|||
124962747|NCT00630552|449492154|FG003|Overall Study|Protocol Violation|1|||
124962748|NCT00630552|449492155|FG004|Overall Study|Protocol Violation|0|||
124962749|NCT00630552|449492151|FG000|Overall Study|Physician Decision|0|||
125129028|NCT04166630|450097732|FG001|Overall Study|Withdrawal by Subject|1|||
125129029|NCT00096447|450097733|FG000|Overall Study|Never treated|1|||
124962750|NCT00630552|449492152|FG001|Overall Study|Physician Decision|0|||
124962751|NCT00630552|449492153|FG002|Overall Study|Physician Decision|0|||
124962752|NCT00630552|449492154|FG003|Overall Study|Physician Decision|0|||
124962753|NCT00630552|449492155|FG004|Overall Study|Physician Decision|1|||
124962754|NCT00630552|449492151|FG000|Overall Study|Death|0|||
124962755|NCT00630552|449492152|FG001|Overall Study|Death|0|||
124962756|NCT00630552|449492153|FG002|Overall Study|Death|1|||
124962757|NCT00630552|449492154|FG003|Overall Study|Death|2|||
124962758|NCT00630552|449492155|FG004|Overall Study|Death|2|||
124962759|NCT00630552|449492151|FG000|Overall Study|Withdrawal by Subject|0|||
124962760|NCT00630552|449492152|FG001|Overall Study|Withdrawal by Subject|0|||
124962761|NCT00630552|449492153|FG002|Overall Study|Withdrawal by Subject|0|||
124962762|NCT00630552|449492154|FG003|Overall Study|Withdrawal by Subject|1|||
124962763|NCT00630552|449492155|FG004|Overall Study|Withdrawal by Subject|0|||
124962764|NCT00630552|449492151|FG000|Overall Study|Other|0|||
124962765|NCT00630552|449492152|FG001|Overall Study|Other|0|||
124962766|NCT00630552|449492153|FG002|Overall Study|Other|4|||
124962767|NCT00630552|449492154|FG003|Overall Study|Other|2|||
124962768|NCT00630552|449492155|FG004|Overall Study|Other|0|||
124962769|NCT04349644|449492156|FG000|Allocation/Pretest|Lost to pretest|0|||
124962770|NCT04349644|449492157|FG001|Allocation/Pretest|Lost to pretest|3|||
124962771|NCT04349644|449492156|FG000|Posttest|Lost to posttest|0|||
124962772|NCT04349644|449492157|FG001|Posttest|Lost to posttest|8|||
124962773|NCT04349644|449492156|FG000|Posttest|Discontinued intervention|6|||
124962774|NCT04349644|449492157|FG001|Posttest|Discontinued intervention|0|||
124962775|NCT04349644|449492156|FG000|Follow-up|Lost to Follow-up|0|||
124962776|NCT04349644|449492157|FG001|Follow-up|Lost to Follow-up|2|||
124962777|NCT00983905|449492158|FG000|Theophylline Alone|Adverse Event|1|||
124962778|NCT00983905|449492158|FG000|Colchicine Alone|Adverse Event|2|||
124962779|NCT01114139|449492159|FG000|Overall Study|Adverse Event|3|||
124962780|NCT01114139|449492160|FG001|Overall Study|Adverse Event|2|||
124962781|NCT01114139|449492159|FG000|Overall Study|Lost to Follow-up|15|||
124962782|NCT01114139|449492160|FG001|Overall Study|Lost to Follow-up|3|||
124962783|NCT01114139|449492159|FG000|Overall Study|Withdrawal by Subject|17|||
124962784|NCT01114139|449492160|FG001|Overall Study|Withdrawal by Subject|6|||
124962785|NCT01114139|449492159|FG000|Overall Study|Other-Missed 1 visit|1|||
124962786|NCT01114139|449492160|FG001|Overall Study|Other-Missed 1 visit|0|||
124962787|NCT01114139|449492159|FG000|Overall Study|Other-Protocol Violation|1|||
124962788|NCT01114139|449492160|FG001|Overall Study|Other-Protocol Violation|0|||
124962789|NCT01114139|449492159|FG000|Overall Study|Other-Out of window for study drug dose|1|||
124962790|NCT01114139|449492160|FG001|Overall Study|Other-Out of window for study drug dose|0|||
125031605|NCT01993888|449737377|FG000|Overall Study|Withdrawal by Subject|0|||
124962791|NCT01114139|449492159|FG000|Overall Study|Other-Participant falsified records|0|||
124962792|NCT01114139|449492160|FG001|Overall Study|Other-Participant falsified records|1|||
124962793|NCT01114139|449492159|FG000|Overall Study|Other-Participant went on hospice|0|||
124962794|NCT01114139|449492160|FG001|Overall Study|Other-Participant went on hospice|1|||
124962795|NCT01114139|449492159|FG000|Overall Study|Other-Physician changed treatment|1|||
124962796|NCT01114139|449492160|FG001|Overall Study|Other-Physician changed treatment|0|||
124962797|NCT01114139|449492159|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
125031606|NCT01993888|449737378|FG001|Overall Study|Withdrawal by Subject|1|||
124962798|NCT01114139|449492160|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
124962799|NCT01169636|449492161|FG000|Overall Study|Adverse Event|0|||
125215745|NCT00492232|450417501|FG000|Double-Blind Treatment|Adverse Event|1|||
125215746|NCT00492232|450417502|FG001|Double-Blind Treatment|Adverse Event|2|||
125215747|NCT00492232|450417501|FG000|Double-Blind Treatment|Protocol Violation|3|||
125129030|NCT00834743|450097734|FG000|Second Intervention|Withdrawal by Subject|1|||
125129031|NCT00834743|450097735|FG001|Second Intervention|Withdrawal by Subject|0|||
125129032|NCT04088760|450097736|FG000|Overall Study|Physician Decision|1|||
125129033|NCT04091971|450097737|FG000|Overall Study|Withdrawal by Subject|1|||
125129034|NCT04091971|450097737|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
125129035|NCT04091971|450097737|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
125129036|NCT02472366|450097741|FG000|Overall Study|Lost to Follow-up|1|||
125129037|NCT02472366|450097742|FG001|Overall Study|Lost to Follow-up|0|||
125129038|NCT02728102|450097743|FG000|Overall Study|Death|3|||
125129039|NCT02728102|450097744|FG001|Overall Study|Death|0|||
125129040|NCT02728102|450097745|FG002|Overall Study|Death|1|||
125129041|NCT02728102|450097743|FG000|Overall Study|Withdrawal by Subject|0|||
125129042|NCT02728102|450097744|FG001|Overall Study|Withdrawal by Subject|2|||
125129043|NCT02728102|450097745|FG002|Overall Study|Withdrawal by Subject|3|||
125129044|NCT02728102|450097743|FG000|Overall Study|Physician Decision|1|||
125129045|NCT02728102|450097744|FG001|Overall Study|Physician Decision|1|||
125129046|NCT02728102|450097745|FG002|Overall Study|Physician Decision|0|||
125129047|NCT02728102|450097743|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
125129048|NCT02728102|450097744|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
125129049|NCT02728102|450097745|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
125129050|NCT02728102|450097743|FG000|Overall Study|Covid|0|||
125129051|NCT02728102|450097744|FG001|Overall Study|Covid|0|||
125129052|NCT02728102|450097745|FG002|Overall Study|Covid|1|||
125129053|NCT02419937|450097748|FG000|Overall Study|Lost to Follow-up|1|||
125129054|NCT02419937|450097749|FG001|Overall Study|Lost to Follow-up|0|||
125129055|NCT02924883|450097750|FG000|Overall Study|Death|39|||
125129056|NCT02924883|450097751|FG001|Overall Study|Death|20|||
125129057|NCT02924883|450097750|FG000|Overall Study|Lost to Follow-up|1|||
125129058|NCT02924883|450097751|FG001|Overall Study|Lost to Follow-up|0|||
125129059|NCT02924883|450097750|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
125129060|NCT02924883|450097751|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
125129061|NCT02924883|450097750|FG000|Overall Study|Protocol Violation|1|||
125129062|NCT02924883|450097751|FG001|Overall Study|Protocol Violation|0|||
125129063|NCT02924883|450097750|FG000|Overall Study|Withdrawal by Subject|22|||
125129064|NCT02924883|450097751|FG001|Overall Study|Withdrawal by Subject|16|||
125129065|NCT02924883|450097750|FG000|Overall Study|Progressive Disease|1|||
125129066|NCT02924883|450097751|FG001|Overall Study|Progressive Disease|0|||
125129067|NCT02924883|450097750|FG000|Overall Study|Study Terminated by Sponsor|69|||
125129068|NCT02924883|450097751|FG001|Overall Study|Study Terminated by Sponsor|32|||
125129069|NCT01182415|450097752|FG000|Overall Study|Lost to Follow-up|1|||
125129070|NCT01981720|450097753|FG000|Overall Study|Adverse Event|1|||
125129071|NCT01981720|450097753|FG000|Overall Study|Withdrawal by Subject|3|||
125129072|NCT01981720|450097753|FG000|Overall Study|Pregnancy|1|||
125129073|NCT00004562|450097756|FG000|Overall Study|Lost to Follow-up|102|||
125129074|NCT00004562|450097757|FG001|Overall Study|Lost to Follow-up|91|||
125129075|NCT02770820|450097758|FG000|Overall Study|Death|1|||
125129076|NCT02770820|450097758|FG000|Overall Study|Physician Decision|2|||
125129077|NCT02336165|450097759|FG000|Overall Study|Death|3|||
125129078|NCT02336165|450097760|FG001|Overall Study|Death|0|||
125129079|NCT02336165|450097761|FG002|Overall Study|Death|0|||
124962800|NCT01169636|449492162|FG001|Overall Study|Adverse Event|0|||
124962801|NCT01169636|449492163|FG002|Overall Study|Adverse Event|1|||
124962802|NCT01169636|449492164|FG003|Overall Study|Adverse Event|1|||
124962803|NCT01169636|449492165|FG004|Overall Study|Adverse Event|0|||
124962804|NCT01169636|449492161|FG000|Overall Study|Screen failure|0|||
124962805|NCT01169636|449492162|FG001|Overall Study|Screen failure|0|||
124962806|NCT01169636|449492163|FG002|Overall Study|Screen failure|2|||
124962807|NCT01169636|449492164|FG003|Overall Study|Screen failure|0|||
124962808|NCT01169636|449492165|FG004|Overall Study|Screen failure|0|||
124962809|NCT01169636|449492161|FG000|Overall Study|Withdrawal by Subject|0|||
124962810|NCT01169636|449492162|FG001|Overall Study|Withdrawal by Subject|0|||
124962811|NCT01169636|449492163|FG002|Overall Study|Withdrawal by Subject|0|||
124962812|NCT01169636|449492164|FG003|Overall Study|Withdrawal by Subject|0|||
124962813|NCT01169636|449492165|FG004|Overall Study|Withdrawal by Subject|3|||
125129080|NCT02336165|450097762|FG003|Overall Study|Death|0|||
125129081|NCT02336165|450097763|FG004|Overall Study|Death|1|||
125129082|NCT02336165|450097759|FG000|Overall Study|Physician Decision|2|||
125129083|NCT02336165|450097760|FG001|Overall Study|Physician Decision|2|||
124962814|NCT02705625|449492166|FG000|Overall Study|Protocol Violation|1|||
124962815|NCT02705625|449492167|FG001|Overall Study|Protocol Violation|0|||
124962816|NCT02705625|449492168|FG002|Overall Study|Protocol Violation|0|||
124962817|NCT02705625|449492166|FG000|Overall Study|Adverse Event|6|||
124962818|NCT02705625|449492167|FG001|Overall Study|Adverse Event|5|||
124962819|NCT02705625|449492168|FG002|Overall Study|Adverse Event|2|||
124962820|NCT02705625|449492166|FG000|Overall Study|Death|0|||
124962821|NCT02705625|449492167|FG001|Overall Study|Death|0|||
124962822|NCT02705625|449492168|FG002|Overall Study|Death|1|||
124962823|NCT02705625|449492166|FG000|Overall Study|Withdrawal by Subject|1|||
124962824|NCT02705625|449492167|FG001|Overall Study|Withdrawal by Subject|4|||
124962825|NCT02705625|449492168|FG002|Overall Study|Withdrawal by Subject|5|||
124962826|NCT02705625|449492166|FG000|Overall Study|Lost to Follow-up|0|||
124962827|NCT02705625|449492167|FG001|Overall Study|Lost to Follow-up|0|||
124962828|NCT02705625|449492168|FG002|Overall Study|Lost to Follow-up|1|||
124962829|NCT02705625|449492166|FG000|Overall Study|Non-compliance|0|||
124962830|NCT02705625|449492167|FG001|Overall Study|Non-compliance|1|||
124962831|NCT02705625|449492168|FG002|Overall Study|Non-compliance|1|||
124962832|NCT02705625|449492166|FG000|Overall Study|Overdosing|0|||
124962833|NCT02705625|449492167|FG001|Overall Study|Overdosing|0|||
124962834|NCT02705625|449492168|FG002|Overall Study|Overdosing|1|||
124962835|NCT00494026|449492169|FG000|Overall Study|Sponsor Decision|4|||
124962836|NCT01057251|449492171|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
124962837|NCT01057251|449492172|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
124962838|NCT01057251|449492171|FG000|Overall Study|Adverse Event|4|||
124962839|NCT01057251|449492172|FG001|Overall Study|Adverse Event|2|||
124962840|NCT01057251|449492171|FG000|Overall Study|Lack of Efficacy|2|||
124962841|NCT01057251|449492172|FG001|Overall Study|Lack of Efficacy|11|||
124962842|NCT01057251|449492171|FG000|Overall Study|Protocol Violation|6|||
124962843|NCT01057251|449492172|FG001|Overall Study|Protocol Violation|2|||
124962844|NCT01057251|449492171|FG000|Overall Study|Withdrawal by Subject|4|||
124962845|NCT01057251|449492172|FG001|Overall Study|Withdrawal by Subject|5|||
124962846|NCT01057251|449492171|FG000|Overall Study|Lost to Follow-up|7|||
124962847|NCT01057251|449492172|FG001|Overall Study|Lost to Follow-up|6|||
124962848|NCT01057251|449492171|FG000|Overall Study|Other Reason|1|||
124962849|NCT01057251|449492172|FG001|Overall Study|Other Reason|1|||
124962850|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
124962851|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
124962852|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
124962853|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
124962854|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
124962855|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
124962856|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
124962857|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
124962858|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
124962859|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
124962860|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
124962861|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
124962862|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
124962863|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
124962864|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
124962865|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
124962866|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
124962867|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
124962868|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
124962869|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
124962870|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
124962871|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
124962872|NCT02637856|449492173|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
124962873|NCT02637856|449492174|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
124962874|NCT02637856|449492173|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
124962875|NCT02637856|449492174|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
124962876|NCT00784147|449492175|FG000|Overall Study|Lost to Follow-up|2|||
124962877|NCT00784147|449492176|FG001|Overall Study|Lost to Follow-up|4|||
124962878|NCT00784147|449492175|FG000|Overall Study|Withdrawal by Subject|1|||
124962879|NCT00784147|449492176|FG001|Overall Study|Withdrawal by Subject|3|||
124962880|NCT00784147|449492175|FG000|Overall Study|Physician Decision|2|||
124962881|NCT00784147|449492176|FG001|Overall Study|Physician Decision|1|||
124962882|NCT00784147|449492175|FG000|Overall Study|Protocol Violation|1|||
124962883|NCT00784147|449492176|FG001|Overall Study|Protocol Violation|1|||
124962884|NCT00784147|449492175|FG000|Overall Study|Death|2|||
125129084|NCT02336165|450097761|FG002|Overall Study|Physician Decision|1|||
125129085|NCT02336165|450097762|FG003|Overall Study|Physician Decision|1|||
125129086|NCT02336165|450097763|FG004|Overall Study|Physician Decision|0|||
125129087|NCT02336165|450097759|FG000|Overall Study|Withdrawal by Subject|0|||
125129088|NCT02336165|450097760|FG001|Overall Study|Withdrawal by Subject|0|||
125129089|NCT02336165|450097761|FG002|Overall Study|Withdrawal by Subject|1|||
125129090|NCT02336165|450097762|FG003|Overall Study|Withdrawal by Subject|0|||
125129091|NCT02336165|450097763|FG004|Overall Study|Withdrawal by Subject|1|||
125129092|NCT02336165|450097759|FG000|Overall Study|Adverse Event|4|||
125129093|NCT02336165|450097760|FG001|Overall Study|Adverse Event|1|||
124962885|NCT00784147|449492176|FG001|Overall Study|Death|0|||
124962886|NCT04544865|449492180|FG000|Overall Study|Death|0|||
124962887|NCT04544865|449492181|FG001|Overall Study|Death|2|||
124962888|NCT04544865|449492180|FG000|Overall Study|Lost to Follow-up|11|||
124962889|NCT04544865|449492181|FG001|Overall Study|Lost to Follow-up|7|||
124962890|NCT04544865|449492180|FG000|Overall Study|Withdrawal by Subject|0|||
124962891|NCT04544865|449492181|FG001|Overall Study|Withdrawal by Subject|1|||
124962892|NCT04544865|449492180|FG000|Overall Study|Other|0|||
124962893|NCT04544865|449492181|FG001|Overall Study|Other|1|||
124962894|NCT02287883|449492182|FG000|Overall Study|Death|8|||
124962895|NCT02287883|449492183|FG001|Overall Study|Death|7|||
124962896|NCT02287883|449492182|FG000|Overall Study|No longer eligible|222|||
124962897|NCT02287883|449492183|FG001|Overall Study|No longer eligible|182|||
124962898|NCT02287883|449492182|FG000|Overall Study|Non-response to survey|229|||
124962899|NCT02287883|449492183|FG001|Overall Study|Non-response to survey|237|||
124962900|NCT00802438|449492184|FG000|Overall Study|Screen Failure|20|||
124962901|NCT00802438|449492184|FG000|Overall Study|Withdrawal by Subject|7|||
124962902|NCT00802438|449492184|FG000|Overall Study|Physician Decision|1|||
124962903|NCT04016805|449492185|FG000|Overall Study|Sponsor's Discretion|30|||
124962904|NCT04016805|449492186|FG001|Overall Study|Sponsor's Discretion|6|||
124962905|NCT04016805|449492187|FG002|Overall Study|Sponsor's Discretion|5|||
124962906|NCT03175198|449492188|FG000|Overall Study|Adverse Event|480|||
124962907|NCT03175198|449492188|FG000|Overall Study|No actual visit|120|||
124962908|NCT03175198|449492188|FG000|Overall Study|Registration rule not followed|4|||
124962909|NCT03175198|449492188|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
124962910|NCT03175198|449492188|FG000|Overall Study|Other personal reason|509|||
124962911|NCT03175198|449492188|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
124962912|NCT03175198|449492188|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
124962913|NCT03175198|449492188|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
124962914|NCT03175198|449492188|FG000|Overall Study|To conduct invasive treatment of operation|53|||
124962915|NCT03175198|449492188|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
124962916|NCT01193218|449492190|FG000|0-12 Weeks|Adverse Event|6|||
124962917|NCT01193218|449492191|FG001|0-12 Weeks|Adverse Event|0|||
124962918|NCT01193218|449492192|FG002|0-12 Weeks|Adverse Event|1|||
124962919|NCT01193218|449492193|FG003|0-12 Weeks|Adverse Event|0|||
124962920|NCT01193218|449492194|FG004|0-12 Weeks|Adverse Event|0|||
124962921|NCT01193218|449492195|FG005|0-12 Weeks|Adverse Event|2|||
124962922|NCT01193218|449492196|FG006|0-12 Weeks|Adverse Event|2|||
124962923|NCT01193218|449492197|FG007|0-12 Weeks|Adverse Event|0|||
124962924|NCT01193218|449492190|FG000|0-12 Weeks|Protocol Violation|0|||
124962925|NCT01193218|449492191|FG001|0-12 Weeks|Protocol Violation|0|||
124962926|NCT01193218|449492192|FG002|0-12 Weeks|Protocol Violation|0|||
124962927|NCT01193218|449492193|FG003|0-12 Weeks|Protocol Violation|0|||
124962928|NCT01193218|449492194|FG004|0-12 Weeks|Protocol Violation|1|||
124962929|NCT01193218|449492195|FG005|0-12 Weeks|Protocol Violation|1|||
124962930|NCT01193218|449492196|FG006|0-12 Weeks|Protocol Violation|0|||
124962931|NCT01193218|449492197|FG007|0-12 Weeks|Protocol Violation|0|||
124962932|NCT01193218|449492190|FG000|0-12 Weeks|Withdrawal by Subject|3|||
124962933|NCT01193218|449492191|FG001|0-12 Weeks|Withdrawal by Subject|0|||
124962934|NCT01193218|449492192|FG002|0-12 Weeks|Withdrawal by Subject|2|||
124962935|NCT01193218|449492193|FG003|0-12 Weeks|Withdrawal by Subject|0|||
124962936|NCT01193218|449492194|FG004|0-12 Weeks|Withdrawal by Subject|0|||
124962937|NCT01193218|449492195|FG005|0-12 Weeks|Withdrawal by Subject|0|||
124962938|NCT01193218|449492196|FG006|0-12 Weeks|Withdrawal by Subject|1|||
124962939|NCT01193218|449492197|FG007|0-12 Weeks|Withdrawal by Subject|0|||
124962940|NCT01193218|449492190|FG000|12-52 Weeks|Adverse Event|1|||
124962941|NCT01193218|449492191|FG001|12-52 Weeks|Adverse Event|0|||
124962942|NCT01193218|449492192|FG002|12-52 Weeks|Adverse Event|1|||
124962943|NCT01193218|449492193|FG003|12-52 Weeks|Adverse Event|2|||
124962944|NCT01193218|449492194|FG004|12-52 Weeks|Adverse Event|3|||
124962945|NCT01193218|449492195|FG005|12-52 Weeks|Adverse Event|3|||
124962946|NCT01193218|449492196|FG006|12-52 Weeks|Adverse Event|1|||
124962947|NCT01193218|449492197|FG007|12-52 Weeks|Adverse Event|2|||
124962948|NCT01193218|449492190|FG000|12-52 Weeks|Lack of Efficacy|0|||
124962949|NCT01193218|449492191|FG001|12-52 Weeks|Lack of Efficacy|0|||
125129094|NCT02336165|450097761|FG002|Overall Study|Adverse Event|2|||
125129095|NCT02336165|450097762|FG003|Overall Study|Adverse Event|4|||
125129096|NCT02336165|450097763|FG004|Overall Study|Adverse Event|1|||
125129097|NCT02336165|450097759|FG000|Overall Study|Progressive disease|23|||
124962950|NCT01193218|449492192|FG002|12-52 Weeks|Lack of Efficacy|0|||
124962951|NCT01193218|449492193|FG003|12-52 Weeks|Lack of Efficacy|0|||
124962952|NCT01193218|449492194|FG004|12-52 Weeks|Lack of Efficacy|0|||
124962953|NCT01193218|449492195|FG005|12-52 Weeks|Lack of Efficacy|0|||
124962954|NCT01193218|449492196|FG006|12-52 Weeks|Lack of Efficacy|1|||
124962955|NCT01193218|449492197|FG007|12-52 Weeks|Lack of Efficacy|0|||
124962956|NCT01193218|449492190|FG000|12-52 Weeks|Withdrawal by Subject|3|||
124962957|NCT01193218|449492191|FG001|12-52 Weeks|Withdrawal by Subject|0|||
124962958|NCT01193218|449492192|FG002|12-52 Weeks|Withdrawal by Subject|3|||
124962959|NCT01193218|449492193|FG003|12-52 Weeks|Withdrawal by Subject|0|||
124962960|NCT01193218|449492194|FG004|12-52 Weeks|Withdrawal by Subject|0|||
124962961|NCT01193218|449492195|FG005|12-52 Weeks|Withdrawal by Subject|2|||
124962962|NCT01193218|449492196|FG006|12-52 Weeks|Withdrawal by Subject|1|||
124962963|NCT01193218|449492197|FG007|12-52 Weeks|Withdrawal by Subject|2|||
124962964|NCT01193218|449492190|FG000|12-52 Weeks|Other reason than above|1|||
124962965|NCT01193218|449492191|FG001|12-52 Weeks|Other reason than above|0|||
124962966|NCT01193218|449492192|FG002|12-52 Weeks|Other reason than above|0|||
124962967|NCT01193218|449492193|FG003|12-52 Weeks|Other reason than above|1|||
124962968|NCT01193218|449492194|FG004|12-52 Weeks|Other reason than above|1|||
124962969|NCT01193218|449492195|FG005|12-52 Weeks|Other reason than above|0|||
125129098|NCT02336165|450097760|FG001|Overall Study|Progressive disease|22|||
125129099|NCT02336165|450097761|FG002|Overall Study|Progressive disease|27|||
125129100|NCT02336165|450097762|FG003|Overall Study|Progressive disease|24|||
125129101|NCT02336165|450097763|FG004|Overall Study|Progressive disease|19|||
125129102|NCT02336165|450097759|FG000|Overall Study|Non-compliance|1|||
124962970|NCT01193218|449492196|FG006|12-52 Weeks|Other reason than above|0|||
124962971|NCT01193218|449492197|FG007|12-52 Weeks|Other reason than above|0|||
124962972|NCT03811834|449492198|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
124962973|NCT01242371|449492199|FG000|Overall Study|Withdrawal by Subject|2|||
124962974|NCT01242371|449492200|FG001|Overall Study|Withdrawal by Subject|2|||
124962975|NCT01242371|449492199|FG000|Overall Study|Protocol Violation|0|||
125129103|NCT02336165|450097760|FG001|Overall Study|Non-compliance|0|||
124962976|NCT01242371|449492200|FG001|Overall Study|Protocol Violation|3|||
125129104|NCT02336165|450097761|FG002|Overall Study|Non-compliance|0|||
125129105|NCT02336165|450097762|FG003|Overall Study|Non-compliance|1|||
124962977|NCT03188536|449492201|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
124962978|NCT03188536|449492201|FG000|Overall Study|Not participated/met inclusion criteria|1|||
124962979|NCT04947436|449492204|FG000|Overall Study|Lost to Follow-up|3|||
124962980|NCT04947436|449492205|FG001|Overall Study|Lost to Follow-up|7|||
124962981|NCT04947436|449492206|FG002|Overall Study|Lost to Follow-up|5|||
124962982|NCT04947436|449492204|FG000|Overall Study|Death|1|||
124962983|NCT04947436|449492205|FG001|Overall Study|Death|1|||
124962984|NCT04947436|449492206|FG002|Overall Study|Death|1|||
124962985|NCT02161185|449492210|FG000|Treatment Phase|Administrative/Other|7|||
125129106|NCT02336165|450097763|FG004|Overall Study|Non-compliance|0|||
125129107|NCT02336165|450097759|FG000|Overall Study|Other|1|||
125129108|NCT02336165|450097760|FG001|Overall Study|Other|0|||
125129109|NCT02336165|450097761|FG002|Overall Study|Other|0|||
125129110|NCT02336165|450097762|FG003|Overall Study|Other|1|||
125129111|NCT02336165|450097763|FG004|Overall Study|Other|0|||
125129112|NCT03195491|450097769|FG000|Overall Study|Study drug toxicity|25|||
125129113|NCT03195491|450097770|FG001|Overall Study|Study drug toxicity|3|||
125129114|NCT03195491|450097769|FG000|Overall Study|Maximum clinical benefit|5|||
125129115|NCT03195491|450097770|FG001|Overall Study|Maximum clinical benefit|0|||
125129116|NCT03195491|450097769|FG000|Overall Study|Lost to Follow-up|1|||
125129117|NCT03195491|450097770|FG001|Overall Study|Lost to Follow-up|0|||
125129118|NCT03195491|450097769|FG000|Overall Study|Death|3|||
125129119|NCT03195491|450097770|FG001|Overall Study|Death|0|||
125129120|NCT03195491|450097769|FG000|Overall Study|Adverse event unrelated to study drug|19|||
125129121|NCT03195491|450097770|FG001|Overall Study|Adverse event unrelated to study drug|2|||
125129122|NCT03195491|450097769|FG000|Overall Study|Disease progression|266|||
125129123|NCT03195491|450097770|FG001|Overall Study|Disease progression|8|||
125129124|NCT03195491|450097769|FG000|Overall Study|Other reasons|10|||
125129125|NCT03195491|450097770|FG001|Overall Study|Other reasons|0|||
125129126|NCT03195491|450097769|FG000|Overall Study|Participant withdrew consent|8|||
125129127|NCT03195491|450097770|FG001|Overall Study|Participant withdrew consent|1|||
125129128|NCT03195491|450097769|FG000|Overall Study|Participant no longer meets study criteria|0|||
125129129|NCT03195491|450097770|FG001|Overall Study|Participant no longer meets study criteria|1|||
125129130|NCT03195491|450097769|FG000|Overall Study|Participant request to discontinue study treatment|10|||
125215748|NCT00492232|450417502|FG001|Double-Blind Treatment|Protocol Violation|7|||
125215749|NCT00492232|450417501|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
124962986|NCT00372255|449492211|FG000|Overall Study|Withdrawn for other reasons|2|||
124962987|NCT00372255|449492212|FG001|Overall Study|Withdrawn for other reasons|1|||
124962988|NCT01215032|449492218|FG000|Overall Study|Adverse Event|3|||
124962989|NCT01215032|449492218|FG000|Overall Study|Lack of Efficacy|17|||
124962990|NCT01424189|449492219|FG000|Overall Study|Adverse Event|1|||
124962991|NCT01424189|449492220|FG001|Overall Study|Adverse Event|0|||
124962992|NCT01424189|449492219|FG000|Overall Study|Lost to Follow-up|4|||
124962993|NCT01424189|449492220|FG001|Overall Study|Lost to Follow-up|1|||
124962994|NCT01424189|449492219|FG000|Overall Study|Withdrawal by Subject|4|||
124962995|NCT01424189|449492220|FG001|Overall Study|Withdrawal by Subject|4|||
124962996|NCT01424189|449492219|FG000|Overall Study|Subject moved|1|||
124962997|NCT01424189|449492220|FG001|Overall Study|Subject moved|0|||
124962998|NCT01424189|449492219|FG000|Overall Study|Death|3|||
124962999|NCT01424189|449492220|FG001|Overall Study|Death|1|||
124963000|NCT01078584|449492223|FG000|Overall Study|Final Status Unknown|1073|||
124963001|NCT01078584|449492223|FG000|Overall Study|Lost to Follow-up|670|||
124963002|NCT01078584|449492223|FG000|Overall Study|Non-serious Adverse Event|577|||
124963003|NCT01078584|449492223|FG000|Overall Study|Withdrawal of Consent|244|||
124963004|NCT01078584|449492223|FG000|Overall Study|Physician Withdrew from Study|90|||
124963005|NCT01078584|449492223|FG000|Overall Study|Non-compliance|67|||
124963006|NCT01078584|449492223|FG000|Overall Study|Blood Pressure Controlled|49|||
124963007|NCT01078584|449492223|FG000|Overall Study|Physician Switched Medication|26|||
124963008|NCT01078584|449492223|FG000|Overall Study|Physician Discontinued Patient|12|||
124963009|NCT01078584|449492223|FG000|Overall Study|Lack of Efficacy|98|||
124963010|NCT01078584|449492223|FG000|Overall Study|Protocol Violation|75|||
124963011|NCT01078584|449492223|FG000|Overall Study|Serious Adverse Event|27|||
124963012|NCT01078584|449492223|FG000|Overall Study|Multiple Reasons|2|||
124963013|NCT01208870|449492224|FG000|Overall Study|Lost to Follow-up|2|||
124963014|NCT01208870|449492225|FG001|Overall Study|Lost to Follow-up|8|||
125129131|NCT03195491|450097770|FG001|Overall Study|Participant request to discontinue study treatment|0|||
125129132|NCT04239872|450097772|FG000|Overall Study|Lost to Follow-up|0|||
125129133|NCT04239872|450097773|FG001|Overall Study|Lost to Follow-up|1|||
125129134|NCT01185821|450097781|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125129135|NCT01185821|450097782|FG001|Overall Study|Abnormal laboratory value(s)|2|||
125129136|NCT01185821|450097783|FG002|Overall Study|Abnormal laboratory value(s)|1|||
125129137|NCT01185821|450097784|FG003|Overall Study|Abnormal laboratory value(s)|0|||
125129138|NCT01185821|450097785|FG004|Overall Study|Abnormal laboratory value(s)|0|||
125129139|NCT01185821|450097781|FG000|Overall Study|Protocol Violation|0|||
125129140|NCT01185821|450097782|FG001|Overall Study|Protocol Violation|0|||
124963015|NCT01077622|449492226|FG000|Overall Study|Physician Decision|2|||
124963016|NCT01077622|449492226|FG000|Overall Study|Withdrawal by Subject|1|||
124963017|NCT00424177|449492227|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
124963018|NCT00424177|449492227|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
124963019|NCT00424177|449492227|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
124963020|NCT00424177|449492227|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
124963021|NCT00424177|449492227|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
125129141|NCT01185821|450097783|FG002|Overall Study|Protocol Violation|0|||
125129142|NCT01185821|450097784|FG003|Overall Study|Protocol Violation|1|||
125129143|NCT01185821|450097785|FG004|Overall Study|Protocol Violation|1|||
125129144|NCT01185821|450097781|FG000|Overall Study|Abnormal test procedure result|0|||
125129145|NCT01185821|450097782|FG001|Overall Study|Abnormal test procedure result|0|||
125129146|NCT01185821|450097783|FG002|Overall Study|Abnormal test procedure result|0|||
125129147|NCT01185821|450097784|FG003|Overall Study|Abnormal test procedure result|0|||
125129148|NCT01185821|450097785|FG004|Overall Study|Abnormal test procedure result|1|||
125129149|NCT01185821|450097781|FG000|Overall Study|Death|0|||
125129150|NCT01185821|450097782|FG001|Overall Study|Death|1|||
125129151|NCT01185821|450097783|FG002|Overall Study|Death|0|||
125129152|NCT01185821|450097784|FG003|Overall Study|Death|0|||
125129153|NCT01185821|450097785|FG004|Overall Study|Death|0|||
125129154|NCT01185821|450097781|FG000|Overall Study|Condition no longer required study drug|0|||
125129155|NCT01185821|450097782|FG001|Overall Study|Condition no longer required study drug|0|||
125129156|NCT01185821|450097783|FG002|Overall Study|Condition no longer required study drug|0|||
125129157|NCT01185821|450097784|FG003|Overall Study|Condition no longer required study drug|0|||
125129158|NCT01185821|450097785|FG004|Overall Study|Condition no longer required study drug|1|||
125129159|NCT01185821|450097781|FG000|Overall Study|Adverse Event|2|||
125129160|NCT01185821|450097782|FG001|Overall Study|Adverse Event|3|||
125129161|NCT01185821|450097783|FG002|Overall Study|Adverse Event|1|||
125129162|NCT01185821|450097784|FG003|Overall Study|Adverse Event|2|||
125129163|NCT01185821|450097785|FG004|Overall Study|Adverse Event|5|||
125129164|NCT01185821|450097781|FG000|Overall Study|Lack of Efficacy|0|||
125129165|NCT01185821|450097782|FG001|Overall Study|Lack of Efficacy|0|||
125129166|NCT01185821|450097783|FG002|Overall Study|Lack of Efficacy|3|||
125129167|NCT01185821|450097784|FG003|Overall Study|Lack of Efficacy|0|||
125129168|NCT01185821|450097785|FG004|Overall Study|Lack of Efficacy|9|||
125129169|NCT01185821|450097781|FG000|Overall Study|Withdrawal by Subject|3|||
125129170|NCT01185821|450097782|FG001|Overall Study|Withdrawal by Subject|2|||
125129171|NCT01185821|450097783|FG002|Overall Study|Withdrawal by Subject|2|||
125129172|NCT01185821|450097784|FG003|Overall Study|Withdrawal by Subject|1|||
125129173|NCT01185821|450097785|FG004|Overall Study|Withdrawal by Subject|3|||
125129174|NCT01185821|450097781|FG000|Overall Study|Lost to Follow-up|1|||
125129175|NCT01185821|450097782|FG001|Overall Study|Lost to Follow-up|1|||
125129176|NCT01185821|450097783|FG002|Overall Study|Lost to Follow-up|2|||
124963022|NCT00424177|449492227|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
124963023|NCT00424177|449492227|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
124963024|NCT00424177|449492227|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
124963025|NCT00424177|449492227|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
124963026|NCT00424177|449492227|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
124963027|NCT00496834|449492233|FG000|Overall Study|Withdrawal by Subject|4|||
124963028|NCT00496834|449492234|FG001|Overall Study|Withdrawal by Subject|6|||
124963029|NCT00496834|449492233|FG000|Overall Study|Contraindicated medication administered|0|||
124963030|NCT00496834|449492234|FG001|Overall Study|Contraindicated medication administered|1|||
124963031|NCT00496834|449492233|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
124963032|NCT00496834|449492234|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
124963033|NCT00496834|449492233|FG000|Overall Study|Adverse Event|5|||
124963034|NCT00496834|449492234|FG001|Overall Study|Adverse Event|3|||
124963035|NCT00496834|449492233|FG000|Overall Study|IP administration violation|2|||
124963036|NCT00496834|449492234|FG001|Overall Study|IP administration violation|0|||
124963037|NCT00496834|449492233|FG000|Overall Study|Lost to Follow-up|2|||
124963038|NCT00496834|449492234|FG001|Overall Study|Lost to Follow-up|0|||
124963039|NCT00496834|449492233|FG000|Overall Study|Blood Pressure control failure|2|||
124963040|NCT00496834|449492234|FG001|Overall Study|Blood Pressure control failure|1|||
124963041|NCT04944784|449492237|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
124963042|NCT04944784|449492238|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
124963043|NCT04944784|449492239|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
124963044|NCT04944784|449492240|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
124963045|NCT04944784|449492237|FG000|Double-blind Period|Adverse Event|20|||
124963046|NCT04944784|449492238|FG001|Double-blind Period|Adverse Event|4|||
124963047|NCT04944784|449492239|FG002|Double-blind Period|Adverse Event|0|||
124963048|NCT04944784|449492240|FG003|Double-blind Period|Adverse Event|0|||
124963049|NCT04944784|449492237|FG000|Double-blind Period|Withdrawal by Subject|15|||
124963050|NCT04944784|449492238|FG001|Double-blind Period|Withdrawal by Subject|4|||
124963051|NCT04944784|449492239|FG002|Double-blind Period|Withdrawal by Subject|0|||
124963052|NCT04944784|449492240|FG003|Double-blind Period|Withdrawal by Subject|0|||
124963053|NCT04944784|449492237|FG000|Double-blind Period|Death|7|||
124963054|NCT04944784|449492238|FG001|Double-blind Period|Death|2|||
124963055|NCT04944784|449492239|FG002|Double-blind Period|Death|0|||
124963056|NCT04944784|449492240|FG003|Double-blind Period|Death|0|||
124963057|NCT04944784|449492237|FG000|Double-blind Period|Physician Decision|2|||
125129177|NCT01185821|450097784|FG003|Overall Study|Lost to Follow-up|1|||
125129178|NCT01185821|450097785|FG004|Overall Study|Lost to Follow-up|2|||
125215750|NCT00492232|450417502|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
124963058|NCT04944784|449492238|FG001|Double-blind Period|Physician Decision|1|||
124963059|NCT04944784|449492239|FG002|Double-blind Period|Physician Decision|0|||
124963060|NCT04944784|449492240|FG003|Double-blind Period|Physician Decision|0|||
124963061|NCT04944784|449492237|FG000|Double-blind Period|Lack of Efficacy|0|||
124963062|NCT04944784|449492238|FG001|Double-blind Period|Lack of Efficacy|1|||
124963063|NCT04944784|449492239|FG002|Double-blind Period|Lack of Efficacy|0|||
124963064|NCT04944784|449492240|FG003|Double-blind Period|Lack of Efficacy|0|||
125129179|NCT01185821|450097781|FG000|Overall Study|Administrative problems|0|||
125129180|NCT01185821|450097782|FG001|Overall Study|Administrative problems|0|||
125129181|NCT01185821|450097783|FG002|Overall Study|Administrative problems|1|||
125215751|NCT00492232|450417501|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
124963065|NCT04944784|449492237|FG000|Double-blind Period|Sponsor Request|2|||
125129182|NCT01185821|450097784|FG003|Overall Study|Administrative problems|1|||
125129183|NCT01185821|450097785|FG004|Overall Study|Administrative problems|2|||
125129184|NCT00296647|450097786|FG000|Overall Study|Death|4|||
125129185|NCT00296647|450097787|FG001|Overall Study|Death|1|||
125129186|NCT00296647|450097788|FG002|Overall Study|Death|2|||
125129187|NCT00296647|450097789|FG003|Overall Study|Death|1|||
125129188|NCT00296647|450097790|FG004|Overall Study|Death|1|||
125129189|NCT00296647|450097786|FG000|Overall Study|Withdrawal by Subject|28|||
125129190|NCT00296647|450097787|FG001|Overall Study|Withdrawal by Subject|27|||
125129191|NCT00296647|450097788|FG002|Overall Study|Withdrawal by Subject|32|||
125129192|NCT00296647|450097789|FG003|Overall Study|Withdrawal by Subject|16|||
125129193|NCT00296647|450097790|FG004|Overall Study|Withdrawal by Subject|19|||
125129194|NCT00854100|450097795|FG000|Overall Study|Inability to complete the study visits|0|||
125129195|NCT00854100|450097796|FG001|Overall Study|Inability to complete the study visits|0|||
125129196|NCT00854100|450097797|FG002|Overall Study|Inability to complete the study visits|1|||
125129197|NCT00854100|450097795|FG000|Overall Study|Lost to Follow-up|2|||
125129198|NCT00854100|450097796|FG001|Overall Study|Lost to Follow-up|0|||
125129199|NCT00854100|450097797|FG002|Overall Study|Lost to Follow-up|3|||
125129200|NCT00854100|450097795|FG000|Overall Study|Withdrawal by Subject|3|||
124963066|NCT04944784|449492238|FG001|Double-blind Period|Sponsor Request|1|||
124963067|NCT04944784|449492239|FG002|Double-blind Period|Sponsor Request|0|||
124963068|NCT04944784|449492240|FG003|Double-blind Period|Sponsor Request|0|||
124963069|NCT04944784|449492237|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
124963070|NCT04944784|449492238|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
124963071|NCT04944784|449492239|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
124963072|NCT04944784|449492240|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
124963073|NCT04944784|449492237|FG000|Double-blind Period|Participant Choice|1|||
124963074|NCT04944784|449492238|FG001|Double-blind Period|Participant Choice|1|||
124963075|NCT04944784|449492239|FG002|Double-blind Period|Participant Choice|0|||
124963076|NCT04944784|449492240|FG003|Double-blind Period|Participant Choice|0|||
124963077|NCT04944784|449492237|FG000|Double-blind Period|Progressive Disease|2|||
124963078|NCT04944784|449492238|FG001|Double-blind Period|Progressive Disease|2|||
124963079|NCT04944784|449492239|FG002|Double-blind Period|Progressive Disease|0|||
124963080|NCT04944784|449492240|FG003|Double-blind Period|Progressive Disease|0|||
124963081|NCT04944784|449492237|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
124963082|NCT04944784|449492238|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
124963083|NCT04944784|449492239|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
124963084|NCT04944784|449492240|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
124963085|NCT04944784|449492237|FG000|Active Drug Period|Adverse Event|0|||
124963086|NCT04944784|449492238|FG001|Active Drug Period|Adverse Event|0|||
124963087|NCT04944784|449492239|FG002|Active Drug Period|Adverse Event|3|||
124963088|NCT04944784|449492240|FG003|Active Drug Period|Adverse Event|6|||
124963089|NCT04944784|449492237|FG000|Active Drug Period|Withdrawal by Subject|0|||
124963090|NCT04944784|449492238|FG001|Active Drug Period|Withdrawal by Subject|0|||
124963091|NCT04944784|449492239|FG002|Active Drug Period|Withdrawal by Subject|4|||
124963092|NCT04944784|449492240|FG003|Active Drug Period|Withdrawal by Subject|7|||
124963093|NCT04944784|449492237|FG000|Active Drug Period|Death|0|||
124963094|NCT04944784|449492238|FG001|Active Drug Period|Death|0|||
124963095|NCT04944784|449492239|FG002|Active Drug Period|Death|3|||
124963096|NCT04944784|449492240|FG003|Active Drug Period|Death|4|||
124963097|NCT04944784|449492237|FG000|Active Drug Period|Lack of Efficacy|0|||
124963098|NCT04944784|449492238|FG001|Active Drug Period|Lack of Efficacy|0|||
124963099|NCT04944784|449492239|FG002|Active Drug Period|Lack of Efficacy|2|||
124963100|NCT04944784|449492240|FG003|Active Drug Period|Lack of Efficacy|2|||
124963101|NCT04944784|449492237|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
124963102|NCT04944784|449492238|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
124963103|NCT04944784|449492239|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
124963104|NCT04944784|449492240|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
124963105|NCT04944784|449492237|FG000|Active Drug Period|Participant Choice|0|||
124963106|NCT04944784|449492238|FG001|Active Drug Period|Participant Choice|0|||
124963107|NCT04944784|449492239|FG002|Active Drug Period|Participant Choice|0|||
124963108|NCT04944784|449492240|FG003|Active Drug Period|Participant Choice|1|||
124963109|NCT04944784|449492237|FG000|Active Drug Period|Progressive Disease|0|||
124963110|NCT04944784|449492238|FG001|Active Drug Period|Progressive Disease|0|||
124963111|NCT04944784|449492239|FG002|Active Drug Period|Progressive Disease|4|||
124963112|NCT04944784|449492240|FG003|Active Drug Period|Progressive Disease|4|||
124963113|NCT04944784|449492237|FG000|Active Drug Period|Lost to Follow-up|0|||
125129201|NCT00854100|450097796|FG001|Overall Study|Withdrawal by Subject|1|||
125129202|NCT00854100|450097797|FG002|Overall Study|Withdrawal by Subject|2|||
124963114|NCT04944784|449492238|FG001|Active Drug Period|Lost to Follow-up|0|||
125129203|NCT00854100|450097795|FG000|Overall Study|Protocol Violation|2|||
125129204|NCT00854100|450097796|FG001|Overall Study|Protocol Violation|4|||
124963115|NCT04944784|449492239|FG002|Active Drug Period|Lost to Follow-up|0|||
124963116|NCT04944784|449492240|FG003|Active Drug Period|Lost to Follow-up|1|||
124963117|NCT02210208|449494026|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
125129205|NCT00854100|450097797|FG002|Overall Study|Protocol Violation|3|||
125129206|NCT00854100|450097795|FG000|Overall Study|Adverse Event|2|||
125129207|NCT00854100|450097796|FG001|Overall Study|Adverse Event|1|||
125129208|NCT00854100|450097797|FG002|Overall Study|Adverse Event|2|||
125031607|NCT00832819|449737380|FG000|Overall Study|Adverse Event|0|||
125031608|NCT00832819|449737381|FG001|Overall Study|Adverse Event|1|||
125215752|NCT00492232|450417502|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
125031609|NCT00832819|449737382|FG002|Overall Study|Adverse Event|0|||
125031610|NCT00832819|449737380|FG000|Overall Study|Protocol Violation|0|||
125031611|NCT00832819|449737381|FG001|Overall Study|Protocol Violation|0|||
125031612|NCT00832819|449737382|FG002|Overall Study|Protocol Violation|1|||
125031613|NCT00851903|449737383|FG000|Overall Study|Withdrawal by Subject|2|||
125031614|NCT00317044|449737384|FG000|Overall Study|Protocol Violation|28|||
125031615|NCT00317044|449737385|FG001|Overall Study|Protocol Violation|22|||
125031616|NCT00317044|449737386|FG002|Overall Study|Protocol Violation|20|||
125031617|NCT00317044|449737384|FG000|Overall Study|Adverse Event|4|||
125031618|NCT00317044|449737385|FG001|Overall Study|Adverse Event|7|||
125031619|NCT00317044|449737386|FG002|Overall Study|Adverse Event|4|||
125031620|NCT00317044|449737384|FG000|Overall Study|Withdrawal by Subject|10|||
125215753|NCT00492232|450417501|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
125031621|NCT00317044|449737385|FG001|Overall Study|Withdrawal by Subject|7|||
124963118|NCT02210208|449494026|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
124963119|NCT02210208|449494026|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
124963120|NCT01066936|449494027|FG000|Overall Study|Death|2|||
124963121|NCT01066936|449494027|FG000|Overall Study|Device revised/removed|1|||
124963122|NCT01066936|449494027|FG000|Overall Study|Lost to Follow-up|3|||
124963123|NCT01066936|449494027|FG000|Overall Study|Withdrawal by Subject|4|||
124963124|NCT04984239|449494030|FG000|Overall Study|Lost to Follow-up|1|||
124963125|NCT04190225|449494031|FG000|Overall Study|Lost to Follow-up|2|||
124963126|NCT04190225|449494032|FG001|Overall Study|Lost to Follow-up|3|||
124963127|NCT04190225|449494031|FG000|Overall Study|Withdrawal by Subject|3|||
124963128|NCT04190225|449494032|FG001|Overall Study|Withdrawal by Subject|2|||
125129209|NCT02883452|450099256|FG000|Overall Study|Withdrawal by Subject|1|||
125129210|NCT02883452|450099257|FG001|Overall Study|Withdrawal by Subject|1|||
125129211|NCT02883452|450099258|FG002|Overall Study|Withdrawal by Subject|3|||
125129212|NCT02883452|450099259|FG003|Overall Study|Withdrawal by Subject|0|||
125129213|NCT02883452|450099260|FG004|Overall Study|Withdrawal by Subject|2|||
125129214|NCT02883452|450099261|FG005|Overall Study|Withdrawal by Subject|5|||
125129215|NCT02883452|450099256|FG000|Overall Study|Disease progression|1|||
125129216|NCT02883452|450099257|FG001|Overall Study|Disease progression|0|||
125129217|NCT02883452|450099258|FG002|Overall Study|Disease progression|0|||
124963129|NCT04190225|449494031|FG000|Overall Study|Unrelated health condition|2|||
124963130|NCT04190225|449494032|FG001|Overall Study|Unrelated health condition|0|||
124963131|NCT02994784|449494033|FG000|6 Months Follow-up|Lost to Follow-up|3|||
124963132|NCT02466243|449494035|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
124963133|NCT02466243|449494036|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
124963134|NCT02466243|449494035|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
124963135|NCT02466243|449494036|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
124963136|NCT02466243|449494035|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
124963137|NCT02466243|449494036|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
124963138|NCT02466243|449494035|FG000|Part B Open-label Treatment Period|Missing|2|||
124963139|NCT02466243|449494036|FG001|Part B Open-label Treatment Period|Missing|2|||
124963140|NCT00477464|449494037|FG000|Overall Study|Lost to Follow-up|1|||
124963141|NCT00477464|449494037|FG000|Overall Study|Death|36|||
124963142|NCT00477464|449494037|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
125129218|NCT02883452|450099259|FG003|Overall Study|Disease progression|1|||
125129219|NCT02883452|450099260|FG004|Overall Study|Disease progression|4|||
125129220|NCT02883452|450099261|FG005|Overall Study|Disease progression|5|||
125129221|NCT02883452|450099256|FG000|Overall Study|Adverse Event|2|||
125129222|NCT02883452|450099257|FG001|Overall Study|Adverse Event|1|||
125129223|NCT02883452|450099258|FG002|Overall Study|Adverse Event|1|||
125129224|NCT02883452|450099259|FG003|Overall Study|Adverse Event|1|||
125215754|NCT00492232|450417502|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
125215755|NCT00492232|450417501|FG000|Double-Blind Treatment|Other|6|||
125129225|NCT02883452|450099260|FG004|Overall Study|Adverse Event|1|||
125215756|NCT00492232|450417502|FG001|Double-Blind Treatment|Other|5|||
125215757|NCT00492232|450417501|FG000|Double-Blind Treatment|Randomized not treated|1|||
124963143|NCT00639769|449494038|FG000|Overall Study|Death|2|||
124963144|NCT00639769|449494038|FG000|Overall Study|Adverse Event|7|||
124963145|NCT00639769|449494038|FG000|Overall Study|Lack of Efficacy|1|||
124963146|NCT00639769|449494038|FG000|Overall Study|Disease progression|26|||
124963147|NCT00639769|449494038|FG000|Overall Study|Withdrawal by Subject|4|||
124963148|NCT00863798|449494039|FG000|Overall Study|Adverse Event|5|||
124963149|NCT00863798|449494040|FG001|Overall Study|Adverse Event|2|||
124963150|NCT00863798|449494041|FG002|Overall Study|Adverse Event|4|||
124963151|NCT00863798|449494039|FG000|Overall Study|Participant failed to return|2|||
124963152|NCT00863798|449494040|FG001|Overall Study|Participant failed to return|1|||
124963153|NCT00863798|449494041|FG002|Overall Study|Participant failed to return|0|||
124963154|NCT00863798|449494039|FG000|Overall Study|Investigator request|1|||
124963155|NCT00863798|449494040|FG001|Overall Study|Investigator request|2|||
125129226|NCT02883452|450099261|FG005|Overall Study|Adverse Event|3|||
125215758|NCT00492232|450417502|FG001|Double-Blind Treatment|Randomized not treated|0|||
125129227|NCT02883452|450099256|FG000|Overall Study|Physician Decision|0|||
125129228|NCT02883452|450099257|FG001|Overall Study|Physician Decision|0|||
125129229|NCT02883452|450099258|FG002|Overall Study|Physician Decision|0|||
125129230|NCT02883452|450099259|FG003|Overall Study|Physician Decision|0|||
125129231|NCT02883452|450099260|FG004|Overall Study|Physician Decision|4|||
125129232|NCT02883452|450099261|FG005|Overall Study|Physician Decision|1|||
125129233|NCT02883452|450099256|FG000|Overall Study|Death|1|||
125129234|NCT02883452|450099257|FG001|Overall Study|Death|0|||
124963156|NCT00863798|449494041|FG002|Overall Study|Investigator request|1|||
124963157|NCT00863798|449494039|FG000|Overall Study|Lack of Efficacy|4|||
124963158|NCT00863798|449494040|FG001|Overall Study|Lack of Efficacy|3|||
125129235|NCT02883452|450099258|FG002|Overall Study|Death|1|||
125215759|NCT00492232|450417501|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
125129236|NCT02883452|450099259|FG003|Overall Study|Death|0|||
125215760|NCT00492232|450417502|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
125215761|NCT02453256|450417503|FG000|Double Blind Period|Death|1|||
125215762|NCT02453256|450417504|FG001|Double Blind Period|Death|1|||
125215763|NCT02453256|450417503|FG000|Double Blind Period|Adverse Event|3|||
125215764|NCT02453256|450417504|FG001|Double Blind Period|Adverse Event|2|||
125215765|NCT02453256|450417503|FG000|Double Blind Period|Withdrawal by Subject|9|||
125215766|NCT02453256|450417504|FG001|Double Blind Period|Withdrawal by Subject|5|||
124963159|NCT00863798|449494041|FG002|Overall Study|Lack of Efficacy|6|||
124963160|NCT00863798|449494039|FG000|Overall Study|Lost to Follow-up|6|||
124963161|NCT00863798|449494040|FG001|Overall Study|Lost to Follow-up|9|||
124963162|NCT00863798|449494041|FG002|Overall Study|Lost to Follow-up|5|||
124963163|NCT00863798|449494039|FG000|Overall Study|Other|2|||
124963164|NCT00863798|449494040|FG001|Overall Study|Other|3|||
124963165|NCT00863798|449494041|FG002|Overall Study|Other|1|||
124963166|NCT00863798|449494039|FG000|Overall Study|Protocol Violation|0|||
124963167|NCT00863798|449494040|FG001|Overall Study|Protocol Violation|1|||
124963168|NCT00863798|449494041|FG002|Overall Study|Protocol Violation|1|||
124963169|NCT00863798|449494039|FG000|Overall Study|Withdrawal by Subject|8|||
124963170|NCT00863798|449494040|FG001|Overall Study|Withdrawal by Subject|7|||
124963171|NCT00863798|449494041|FG002|Overall Study|Withdrawal by Subject|4|||
124963172|NCT00863798|449494039|FG000|Overall Study|Randomized not treated|4|||
124963173|NCT00863798|449494040|FG001|Overall Study|Randomized not treated|2|||
124963174|NCT00863798|449494041|FG002|Overall Study|Randomized not treated|3|||
124963175|NCT04238520|449494042|FG000|Overall Study|Withdrawal by Subject|1|||
124963176|NCT04238520|449494043|FG001|Overall Study|Withdrawal by Subject|1|||
124963177|NCT04238520|449494042|FG000|Overall Study|Lost to Follow-up|1|||
124963178|NCT04238520|449494043|FG001|Overall Study|Lost to Follow-up|2|||
124963179|NCT04238520|449494042|FG000|Overall Study|Death|0|||
124963180|NCT04238520|449494043|FG001|Overall Study|Death|2|||
124963181|NCT04238520|449494042|FG000|Overall Study|Unsafe home environment for research staff|0|||
124963182|NCT04238520|449494043|FG001|Overall Study|Unsafe home environment for research staff|1|||
124963183|NCT01470599|449494044|FG000|Overall Study|Did not meet entrance criteria|1|||
124963184|NCT01470599|449494045|FG001|Overall Study|Did not meet entrance criteria|0|||
124963185|NCT01470599|449494044|FG000|Overall Study|Lost to Follow-up|2|||
124963186|NCT01470599|449494045|FG001|Overall Study|Lost to Follow-up|1|||
124963187|NCT01470599|449494044|FG000|Overall Study|Withdrawal by Subject|3|||
124963188|NCT01470599|449494045|FG001|Overall Study|Withdrawal by Subject|4|||
124963189|NCT01470599|449494044|FG000|Overall Study|Other|1|||
124963190|NCT01470599|449494045|FG001|Overall Study|Other|0|||
124963191|NCT01470599|449494044|FG000|Overall Study|Protocol Violation|3|||
124963192|NCT01470599|449494045|FG001|Overall Study|Protocol Violation|1|||
124963193|NCT01470599|449494044|FG000|Overall Study|Adverse event related to study drug|2|||
124963194|NCT01470599|449494045|FG001|Overall Study|Adverse event related to study drug|5|||
124963195|NCT01470599|449494044|FG000|Overall Study|Insufficient clinical response|6|||
124963196|NCT01470599|449494045|FG001|Overall Study|Insufficient clinical response|27|||
124963197|NCT01470599|449494044|FG000|Overall Study|Adverse event not related to study drug|1|||
124963198|NCT01470599|449494045|FG001|Overall Study|Adverse event not related to study drug|5|||
124963199|NCT00195442|449494046|FG000|Overall Study|Less than expected therapeutic effect|38|||
124963200|NCT00195442|449494046|FG000|Overall Study|Lost to Follow-up|27|||
124963201|NCT00195442|449494046|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
124963202|NCT00195442|449494046|FG000|Overall Study|Intermittent product shortage|21|||
124963203|NCT00195442|449494046|FG000|Overall Study|Death|7|||
124963204|NCT00195442|449494046|FG000|Overall Study|No reason specified|4|||
124963205|NCT00195442|449494046|FG000|Overall Study|Poor cooperation|2|||
124963206|NCT00195442|449494046|FG000|Overall Study|Other|14|||
124963207|NCT01917006|449494047|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
124963208|NCT01917006|449494048|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
124963209|NCT01917006|449494049|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
124963210|NCT01917006|449494050|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
124963211|NCT01917006|449494051|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
124963212|NCT01917006|449494052|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
124963213|NCT01917006|449494053|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
124963214|NCT01917006|449494054|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
124963215|NCT01917006|449494047|FG000|Randomized-treatment Period|Personal Reasons|0|||
124963216|NCT01917006|449494048|FG001|Randomized-treatment Period|Personal Reasons|0|||
124963217|NCT01917006|449494049|FG002|Randomized-treatment Period|Personal Reasons|0|||
124963218|NCT01917006|449494050|FG003|Randomized-treatment Period|Personal Reasons|0|||
125215767|NCT02453256|450417503|FG000|Double Blind Period|Other|0|||
124963219|NCT01917006|449494051|FG004|Randomized-treatment Period|Personal Reasons|0|||
124963220|NCT01917006|449494052|FG005|Randomized-treatment Period|Personal Reasons|1|||
124963221|NCT01917006|449494053|FG006|Randomized-treatment Period|Personal Reasons|0|||
124963222|NCT01917006|449494054|FG007|Randomized-treatment Period|Personal Reasons|0|||
124963223|NCT01917006|449494047|FG000|Randomized-treatment Period|Protocol Violation|1|||
124963224|NCT01917006|449494048|FG001|Randomized-treatment Period|Protocol Violation|0|||
124963225|NCT01917006|449494049|FG002|Randomized-treatment Period|Protocol Violation|0|||
124963226|NCT01917006|449494050|FG003|Randomized-treatment Period|Protocol Violation|0|||
124963227|NCT01917006|449494051|FG004|Randomized-treatment Period|Protocol Violation|0|||
124963228|NCT01917006|449494052|FG005|Randomized-treatment Period|Protocol Violation|0|||
124963229|NCT01917006|449494053|FG006|Randomized-treatment Period|Protocol Violation|0|||
124963230|NCT01917006|449494054|FG007|Randomized-treatment Period|Protocol Violation|0|||
124963231|NCT01917006|449494047|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
125129237|NCT02883452|450099260|FG004|Overall Study|Death|0|||
125129238|NCT02883452|450099261|FG005|Overall Study|Death|0|||
125129239|NCT02883452|450099256|FG000|Overall Study|Other|0|||
125129240|NCT02883452|450099257|FG001|Overall Study|Other|0|||
125129241|NCT02883452|450099258|FG002|Overall Study|Other|0|||
125129242|NCT02883452|450099259|FG003|Overall Study|Other|0|||
125129243|NCT02883452|450099260|FG004|Overall Study|Other|0|||
125129244|NCT02883452|450099261|FG005|Overall Study|Other|1|||
125129245|NCT03447262|450099262|FG000|Overall Study|Adverse Event|7|||
125129246|NCT03447262|450099262|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
125129247|NCT03447262|450099262|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
125129248|NCT03447262|450099262|FG000|Overall Study|Death|2|||
125129249|NCT03447262|450099262|FG000|Overall Study|Study Termination by Sponsor|455|||
124963232|NCT01917006|449494048|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
125129250|NCT03447262|450099262|FG000|Overall Study|Other|4|||
125129251|NCT00830206|450099263|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
125129252|NCT00830206|450099264|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
125129253|NCT00328926|450099265|FG000|Overall Study|Pregnancy|2|||
125129254|NCT00328926|450099266|FG001|Overall Study|Pregnancy|1|||
125129255|NCT00328926|450099267|FG002|Overall Study|Pregnancy|0|||
125129256|NCT00328926|450099265|FG000|Overall Study|Lost to Follow-up|0|||
125129257|NCT00328926|450099266|FG001|Overall Study|Lost to Follow-up|1|||
125129258|NCT00328926|450099267|FG002|Overall Study|Lost to Follow-up|0|||
125129259|NCT00328926|450099265|FG000|Overall Study|Death|0|||
125129260|NCT00328926|450099266|FG001|Overall Study|Death|0|||
125129261|NCT00328926|450099267|FG002|Overall Study|Death|1|||
125129262|NCT00328926|450099265|FG000|Overall Study|In vitro fertilization treatment|0|||
125129263|NCT00328926|450099266|FG001|Overall Study|In vitro fertilization treatment|0|||
125129264|NCT00328926|450099267|FG002|Overall Study|In vitro fertilization treatment|1|||
125129265|NCT00328926|450099265|FG000|Overall Study|Lack of ovarian response|0|||
125129266|NCT00328926|450099266|FG001|Overall Study|Lack of ovarian response|1|||
125129267|NCT00328926|450099267|FG002|Overall Study|Lack of ovarian response|0|||
124963233|NCT01917006|449494049|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
124963234|NCT01917006|449494050|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
124963235|NCT01917006|449494051|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
124963236|NCT01917006|449494052|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
124963237|NCT01917006|449494053|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
125129268|NCT04123548|450099268|FG000|Overall Study|Withdrawal by Subject|1|||
125129269|NCT04123548|450099268|FG000|Overall Study|Lost to Follow-up|8|||
125129270|NCT04123548|450099268|FG000|Overall Study|Death|4|||
125129271|NCT04123548|450099268|FG000|Overall Study|Reason Not Specified|1|||
125129272|NCT01171989|450099269|FG000|Overall Study|Lost to Follow-up|0|||
125129273|NCT01171989|450099270|FG001|Overall Study|Lost to Follow-up|0|||
125129274|NCT01171989|450099271|FG002|Overall Study|Lost to Follow-up|1|||
125129275|NCT00418184|450099272|FG000|Double-blind Phase|Withdrawal by Subject|22|||
125129276|NCT00418184|450099273|FG001|Double-blind Phase|Withdrawal by Subject|9|||
125129277|NCT00418184|450099272|FG000|Double-blind Phase|Adverse Event|2|||
125129278|NCT00418184|450099273|FG001|Double-blind Phase|Adverse Event|1|||
125129279|NCT00418184|450099272|FG000|Double-blind Phase|Poor compliance|3|||
125129280|NCT00418184|450099273|FG001|Double-blind Phase|Poor compliance|1|||
125129281|NCT02300103|450099274|FG000|Overall Study|Lack of Efficacy|3|||
125129282|NCT02300103|450099274|FG000|Overall Study|Protocol Violation|1|||
125129283|NCT02300103|450099274|FG000|Overall Study|Withdrew Consent|2|||
125129284|NCT01015625|450099275|FG000|Overall Study|Lost to Follow-up|3|||
125129285|NCT01015625|450099276|FG001|Overall Study|Lost to Follow-up|1|||
125129286|NCT01015625|450099275|FG000|Overall Study|Withdrawal by Subject|2|||
124963238|NCT01917006|449494054|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
125129287|NCT01015625|450099276|FG001|Overall Study|Withdrawal by Subject|3|||
125129288|NCT01015625|450099275|FG000|Overall Study|Physician Decision|2|||
124963239|NCT01917006|449494047|FG000|Open-label Period|Adverse Event|0|||
125129289|NCT01015625|450099276|FG001|Overall Study|Physician Decision|0|||
125129290|NCT01015625|450099275|FG000|Overall Study|Death|30|||
125129291|NCT01015625|450099276|FG001|Overall Study|Death|22|||
125129292|NCT01256684|450099277|FG000|Overall Study|Adverse Event|1|||
125129293|NCT01256684|450099278|FG001|Overall Study|Adverse Event|4|||
125129294|NCT01256684|450099279|FG002|Overall Study|Adverse Event|2|||
124963240|NCT01917006|449494048|FG001|Open-label Period|Adverse Event|0|||
124963241|NCT01917006|449494049|FG002|Open-label Period|Adverse Event|0|||
124963242|NCT01917006|449494050|FG003|Open-label Period|Adverse Event|0|||
124963243|NCT01917006|449494051|FG004|Open-label Period|Adverse Event|0|||
124963244|NCT01917006|449494052|FG005|Open-label Period|Adverse Event|0|||
124963245|NCT01917006|449494053|FG006|Open-label Period|Adverse Event|0|||
124963246|NCT01917006|449494054|FG007|Open-label Period|Adverse Event|1|||
124963247|NCT01917006|449494047|FG000|Open-label Period|Lost to Follow-up|0|||
124963248|NCT01917006|449494048|FG001|Open-label Period|Lost to Follow-up|0|||
124963249|NCT01917006|449494049|FG002|Open-label Period|Lost to Follow-up|0|||
124963250|NCT01917006|449494050|FG003|Open-label Period|Lost to Follow-up|0|||
124963251|NCT01917006|449494051|FG004|Open-label Period|Lost to Follow-up|0|||
124963252|NCT01917006|449494052|FG005|Open-label Period|Lost to Follow-up|0|||
124963253|NCT01917006|449494053|FG006|Open-label Period|Lost to Follow-up|0|||
124963254|NCT01917006|449494054|FG007|Open-label Period|Lost to Follow-up|1|||
124963255|NCT00847132|449494057|FG000|Overall Study|Death|1|||
124963256|NCT00847132|449494058|FG001|Overall Study|Death|1|||
124963257|NCT03357471|449494064|FG000|Overall Study|Adverse Event|1|||
125129295|NCT01256684|450099277|FG000|Overall Study|Withdrawal by Subject|4|||
125129296|NCT01256684|450099278|FG001|Overall Study|Withdrawal by Subject|0|||
125129297|NCT01256684|450099279|FG002|Overall Study|Withdrawal by Subject|2|||
125129298|NCT01256684|450099277|FG000|Overall Study|Physician Decision|0|||
125129299|NCT01256684|450099278|FG001|Overall Study|Physician Decision|1|||
125129300|NCT01256684|450099279|FG002|Overall Study|Physician Decision|0|||
125129301|NCT01256684|450099277|FG000|Overall Study|Lack of Efficacy|0|||
125129302|NCT01256684|450099278|FG001|Overall Study|Lack of Efficacy|1|||
125129303|NCT01256684|450099279|FG002|Overall Study|Lack of Efficacy|1|||
125129304|NCT01256684|450099277|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
125129305|NCT01256684|450099278|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
125129306|NCT01256684|450099279|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
125129307|NCT02674477|450099281|FG000|Overall Study|Protocol Violation|8|||
125129308|NCT02674477|450099282|FG001|Overall Study|Protocol Violation|2|||
125129309|NCT02098876|450099286|FG000|Overall Study|Withdrawal by Subject|5|||
125129310|NCT02098876|450099287|FG001|Overall Study|Withdrawal by Subject|5|||
125129311|NCT01061866|450099288|FG000|Overall Study|Adverse Event|2|||
125129312|NCT00772941|450099289|FG000|Overall Study|CRFs not available|195|||
125129313|NCT00772941|450099289|FG000|Overall Study|Study not completed|16|||
125129314|NCT00772941|450099289|FG000|Overall Study|Missed Visits|374|||
125129315|NCT00772941|450099289|FG000|Overall Study|Poor Compliance|7|||
125129316|NCT00772941|450099289|FG000|Overall Study|GPSP Violation|90|||
124963258|NCT03357471|449494065|FG001|Overall Study|Adverse Event|0|||
125129317|NCT04786184|450099290|FG000|Overall Study|Adverse Event|4|||
125129318|NCT04786184|450099291|FG001|Overall Study|Adverse Event|0|||
125129319|NCT04786184|450099290|FG000|Overall Study|Withdrawal by Subject|3|||
125129320|NCT04786184|450099291|FG001|Overall Study|Withdrawal by Subject|1|||
125129321|NCT04786184|450099290|FG000|Overall Study|Lost to Follow-up|4|||
125129322|NCT04786184|450099291|FG001|Overall Study|Lost to Follow-up|2|||
124963259|NCT03357471|449494064|FG000|Overall Study|Lost to Follow-up|1|||
124963260|NCT03357471|449494065|FG001|Overall Study|Lost to Follow-up|0|||
124963261|NCT02973802|449494066|FG000|Overall Study|Lost to Follow-up|1|||
124963262|NCT02973802|449494066|FG000|Overall Study|Withdrawal by Subject|1|||
125031622|NCT00317044|449737386|FG002|Overall Study|Withdrawal by Subject|12|||
125031623|NCT00317044|449737384|FG000|Overall Study|Lost to Follow-up|0|||
125031624|NCT00317044|449737385|FG001|Overall Study|Lost to Follow-up|2|||
125031625|NCT00317044|449737386|FG002|Overall Study|Lost to Follow-up|3|||
125031626|NCT00317044|449737384|FG000|Overall Study|Multiple Reasons|6|||
125031627|NCT00317044|449737385|FG001|Overall Study|Multiple Reasons|2|||
125031628|NCT00317044|449737386|FG002|Overall Study|Multiple Reasons|6|||
125031629|NCT02357420|449737387|FG000|Overall Study|Adverse Event|3|||
125031630|NCT02357420|449737388|FG001|Overall Study|Adverse Event|3|||
125031631|NCT02357420|449737389|FG002|Overall Study|Adverse Event|8|||
125031632|NCT02357420|449737390|FG003|Overall Study|Adverse Event|9|||
125031633|NCT02357420|449737387|FG000|Overall Study|Investigator Decision|1|||
125031634|NCT02357420|449737388|FG001|Overall Study|Investigator Decision|0|||
125031635|NCT02357420|449737389|FG002|Overall Study|Investigator Decision|0|||
125031636|NCT02357420|449737390|FG003|Overall Study|Investigator Decision|0|||
125031637|NCT02357420|449737387|FG000|Overall Study|Prohibited Medication|1|||
124963263|NCT00706914|449494067|FG000|Overall Study|Lack of Efficacy|0|||
124963264|NCT00706914|449494068|FG001|Overall Study|Lack of Efficacy|1|||
124963265|NCT00706914|449494069|FG002|Overall Study|Lack of Efficacy|0|||
125031638|NCT02357420|449737388|FG001|Overall Study|Prohibited Medication|1|||
125129323|NCT00834756|450099292|FG000|First Intervention|Adverse Event|1|||
125129324|NCT00834756|450099293|FG001|First Intervention|Adverse Event|0|||
125129325|NCT00834756|450099292|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
125129326|NCT00834756|450099293|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
125129327|NCT01472341|450099294|FG000|Overall Study|Started insulin therapy|55|||
125215768|NCT02453256|450417504|FG001|Double Blind Period|Other|1|||
124963266|NCT00706914|449494067|FG000|Overall Study|Lost to Follow-up|1|||
124963267|NCT00706914|449494068|FG001|Overall Study|Lost to Follow-up|0|||
124963268|NCT00706914|449494069|FG002|Overall Study|Lost to Follow-up|0|||
124963269|NCT00706914|449494067|FG000|Overall Study|Adverse Event|2|||
124963270|NCT00706914|449494068|FG001|Overall Study|Adverse Event|2|||
124963271|NCT00706914|449494069|FG002|Overall Study|Adverse Event|0|||
124963272|NCT00706914|449494067|FG000|Overall Study|Protocol Violation|3|||
124963273|NCT00706914|449494068|FG001|Overall Study|Protocol Violation|1|||
124963274|NCT00706914|449494069|FG002|Overall Study|Protocol Violation|1|||
124963275|NCT03927690|449494074|FG000|Overall Study|Withdrawal by Subject|3|||
124963276|NCT03927690|449494075|FG001|Overall Study|Withdrawal by Subject|1|||
124963277|NCT03927690|449494076|FG002|Overall Study|Withdrawal by Subject|1|||
124963278|NCT03927690|449494074|FG000|Overall Study|Adverse Event|1|||
124963279|NCT03927690|449494075|FG001|Overall Study|Adverse Event|0|||
124963280|NCT03927690|449494076|FG002|Overall Study|Adverse Event|0|||
124963281|NCT03927690|449494074|FG000|Overall Study|Death|1|||
124963282|NCT03927690|449494075|FG001|Overall Study|Death|0|||
124963283|NCT03927690|449494076|FG002|Overall Study|Death|0|||
124963284|NCT03927690|449494074|FG000|Overall Study|Lost to Follow-up|2|||
124963285|NCT03927690|449494075|FG001|Overall Study|Lost to Follow-up|2|||
124963286|NCT03927690|449494076|FG002|Overall Study|Lost to Follow-up|1|||
124963287|NCT01850823|449494077|FG000|Overall Study|Early Visit Window|0|||
124963288|NCT01850823|449494078|FG001|Overall Study|Early Visit Window|1|||
124963289|NCT01850823|449494079|FG002|Overall Study|Early Visit Window|4|||
124963290|NCT01850823|449494077|FG000|Overall Study|Enrolled in Error|0|||
124963291|NCT01850823|449494078|FG001|Overall Study|Enrolled in Error|1|||
124963292|NCT01850823|449494079|FG002|Overall Study|Enrolled in Error|2|||
124963293|NCT01850823|449494077|FG000|Overall Study|Lack of Efficacy|1|||
124963294|NCT01850823|449494078|FG001|Overall Study|Lack of Efficacy|0|||
124963295|NCT01850823|449494079|FG002|Overall Study|Lack of Efficacy|0|||
124963296|NCT01850823|449494077|FG000|Overall Study|Lost to Follow-up|0|||
124963297|NCT01850823|449494078|FG001|Overall Study|Lost to Follow-up|0|||
124963298|NCT01850823|449494079|FG002|Overall Study|Lost to Follow-up|1|||
124963299|NCT01850823|449494077|FG000|Overall Study|Restricted Medication|0|||
124963300|NCT01850823|449494078|FG001|Overall Study|Restricted Medication|0|||
124963301|NCT01850823|449494079|FG002|Overall Study|Restricted Medication|2|||
124963302|NCT01850823|449494077|FG000|Overall Study|Significant worstening of SAR|0|||
124963303|NCT01850823|449494078|FG001|Overall Study|Significant worstening of SAR|1|||
124963304|NCT01850823|449494079|FG002|Overall Study|Significant worstening of SAR|0|||
124963305|NCT01850823|449494077|FG000|Overall Study|Withdrawal by Subject|2|||
124963306|NCT01850823|449494078|FG001|Overall Study|Withdrawal by Subject|0|||
124963307|NCT01850823|449494079|FG002|Overall Study|Withdrawal by Subject|1|||
124963308|NCT01751165|449494080|FG000|Overall Study|Adverse event, serious fatal|1|||
124963309|NCT01751165|449494081|FG001|Overall Study|Adverse event, serious fatal|0|||
124963310|NCT01751165|449494082|FG002|Overall Study|Adverse event, serious fatal|1|||
124963311|NCT01751165|449494080|FG000|Overall Study|Withdrawal by Subject|0|||
124963312|NCT01751165|449494081|FG001|Overall Study|Withdrawal by Subject|0|||
124963313|NCT01751165|449494082|FG002|Overall Study|Withdrawal by Subject|1|||
124963314|NCT01751165|449494080|FG000|Overall Study|Serious adverse event|0|||
124963315|NCT01751165|449494081|FG001|Overall Study|Serious adverse event|2|||
124963316|NCT01751165|449494082|FG002|Overall Study|Serious adverse event|0|||
124963317|NCT01751165|449494080|FG000|Overall Study|Lost to Follow-up|1|||
125031639|NCT02357420|449737389|FG002|Overall Study|Prohibited Medication|0|||
125031640|NCT02357420|449737390|FG003|Overall Study|Prohibited Medication|0|||
124963318|NCT01751165|449494081|FG001|Overall Study|Lost to Follow-up|1|||
124963319|NCT01751165|449494082|FG002|Overall Study|Lost to Follow-up|1|||
124963320|NCT00988533|449494087|FG000|Overall Study|Lost to Follow-up|3|||
125031641|NCT02357420|449737387|FG000|Overall Study|Protocol Non-compliance|0|||
124963321|NCT00943722|449494093|FG000|Base Study|Adverse Event|0|||
124963322|NCT00943722|449494094|FG001|Base Study|Adverse Event|0|||
124963323|NCT00943722|449494095|FG002|Base Study|Adverse Event|0|||
124963324|NCT00943722|449494096|FG003|Base Study|Adverse Event|1|||
124963325|NCT00943722|449494097|FG004|Base Study|Adverse Event|0|||
124963326|NCT00943722|449494098|FG005|Base Study|Adverse Event|0|||
124963327|NCT00943722|449494099|FG006|Base Study|Adverse Event|0|||
124963328|NCT00943722|449494093|FG000|Base Study|Lost to Follow-up|12|||
124963329|NCT00943722|449494094|FG001|Base Study|Lost to Follow-up|8|||
124963330|NCT00943722|449494095|FG002|Base Study|Lost to Follow-up|10|||
124963331|NCT00943722|449494096|FG003|Base Study|Lost to Follow-up|8|||
124963332|NCT00943722|449494097|FG004|Base Study|Lost to Follow-up|11|||
124963333|NCT00943722|449494098|FG005|Base Study|Lost to Follow-up|0|||
124963334|NCT00943722|449494099|FG006|Base Study|Lost to Follow-up|0|||
124963335|NCT00943722|449494093|FG000|Base Study|Physician Decision|1|||
124963336|NCT00943722|449494094|FG001|Base Study|Physician Decision|0|||
124963337|NCT00943722|449494095|FG002|Base Study|Physician Decision|0|||
124963338|NCT00943722|449494096|FG003|Base Study|Physician Decision|0|||
124963339|NCT00943722|449494097|FG004|Base Study|Physician Decision|1|||
124963340|NCT00943722|449494098|FG005|Base Study|Physician Decision|0|||
124963341|NCT00943722|449494099|FG006|Base Study|Physician Decision|0|||
124963342|NCT00943722|449494093|FG000|Base Study|Pregnancy|0|||
124963343|NCT00943722|449494094|FG001|Base Study|Pregnancy|0|||
124963344|NCT00943722|449494095|FG002|Base Study|Pregnancy|1|||
124963345|NCT00943722|449494096|FG003|Base Study|Pregnancy|0|||
124963346|NCT00943722|449494097|FG004|Base Study|Pregnancy|2|||
124963347|NCT00943722|449494098|FG005|Base Study|Pregnancy|0|||
125215769|NCT02453256|450417503|FG000|Open Label Period|Adverse Event|1|||
124963348|NCT00943722|449494099|FG006|Base Study|Pregnancy|0|||
124963349|NCT00943722|449494093|FG000|Base Study|Protocol Violation|0|||
124963350|NCT00943722|449494094|FG001|Base Study|Protocol Violation|1|||
124963351|NCT00943722|449494095|FG002|Base Study|Protocol Violation|0|||
125215770|NCT02453256|450417504|FG001|Open Label Period|Adverse Event|3|||
125129328|NCT01472341|450099294|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
125129329|NCT01472341|450099294|FG000|Overall Study|Withdrawal by Subject|39|||
125129330|NCT01472341|450099294|FG000|Overall Study|Lost to Follow-up|52|||
125129331|NCT01472341|450099294|FG000|Overall Study|Laboratory parameters unavailable|25|||
125031642|NCT02357420|449737388|FG001|Overall Study|Protocol Non-compliance|0|||
125031643|NCT02357420|449737389|FG002|Overall Study|Protocol Non-compliance|0|||
125215771|NCT02453256|450417503|FG000|Open Label Period|Death|0|||
125215772|NCT02453256|450417504|FG001|Open Label Period|Death|1|||
125215773|NCT02453256|450417503|FG000|Open Label Period|Lost to Follow-up|1|||
125215774|NCT02453256|450417504|FG001|Open Label Period|Lost to Follow-up|0|||
125215775|NCT02453256|450417503|FG000|Open Label Period|Other|0|||
125215776|NCT02453256|450417504|FG001|Open Label Period|Other|2|||
125215777|NCT02453256|450417503|FG000|Open Label Period|Withdrawal by Subject|5|||
125215778|NCT02453256|450417504|FG001|Open Label Period|Withdrawal by Subject|1|||
125215779|NCT01216332|450417505|FG000|Overall Study|Withdrawal by Subject|4|||
125215780|NCT01216332|450417506|FG001|Overall Study|Withdrawal by Subject|0|||
125215781|NCT00636636|450417507|FG000|Overall Study|Other reason|4|||
125215782|NCT00636636|450417508|FG001|Overall Study|Other reason|6|||
125215783|NCT00636636|450417507|FG000|Overall Study|Adverse Event|19|||
125215784|NCT00636636|450417508|FG001|Overall Study|Adverse Event|8|||
125215785|NCT00636636|450417507|FG000|Overall Study|Lack of Efficacy|7|||
125215786|NCT00636636|450417508|FG001|Overall Study|Lack of Efficacy|12|||
125215787|NCT00636636|450417507|FG000|Overall Study|Protocol Violation|2|||
125215788|NCT00636636|450417508|FG001|Overall Study|Protocol Violation|2|||
125215789|NCT00636636|450417507|FG000|Overall Study|Lost to Follow-up|0|||
125215790|NCT00636636|450417508|FG001|Overall Study|Lost to Follow-up|1|||
125215791|NCT00636636|450417507|FG000|Overall Study|Death|0|||
125215792|NCT00636636|450417508|FG001|Overall Study|Death|1|||
125215793|NCT00636636|450417507|FG000|Overall Study|Withdrawal by Subject|4|||
125215794|NCT00636636|450417508|FG001|Overall Study|Withdrawal by Subject|9|||
125215795|NCT00524173|450417509|FG000|Overall Study|Lost to Follow-up|0|||
125215796|NCT00524173|450417510|FG001|Overall Study|Lost to Follow-up|1|||
125031644|NCT02357420|449737390|FG003|Overall Study|Protocol Non-compliance|1|||
125215797|NCT00524173|450417509|FG000|Overall Study|Death|1|||
125215798|NCT00524173|450417510|FG001|Overall Study|Death|0|||
125215799|NCT00524173|450417509|FG000|Overall Study|Had not reached endpoint at study close|4|||
125215800|NCT00524173|450417510|FG001|Overall Study|Had not reached endpoint at study close|1|||
125215801|NCT01237327|450417511|FG000|Overall Study|Protocol Violation: Core Study|1|||
124963352|NCT00943722|449494096|FG003|Base Study|Protocol Violation|0|||
124963353|NCT00943722|449494097|FG004|Base Study|Protocol Violation|2|||
124963354|NCT00943722|449494098|FG005|Base Study|Protocol Violation|0|||
124963355|NCT00943722|449494099|FG006|Base Study|Protocol Violation|0|||
124963356|NCT00943722|449494093|FG000|Base Study|Withdrawal by Subject|12|||
124963357|NCT00943722|449494094|FG001|Base Study|Withdrawal by Subject|13|||
124963358|NCT00943722|449494095|FG002|Base Study|Withdrawal by Subject|2|||
124963359|NCT00943722|449494096|FG003|Base Study|Withdrawal by Subject|13|||
124963360|NCT00943722|449494097|FG004|Base Study|Withdrawal by Subject|8|||
124963361|NCT00943722|449494098|FG005|Base Study|Withdrawal by Subject|0|||
124963362|NCT00943722|449494099|FG006|Base Study|Withdrawal by Subject|0|||
124963363|NCT00943722|449494093|FG000|Base Study|Month 12 visit not completed|0|||
124963364|NCT00943722|449494094|FG001|Base Study|Month 12 visit not completed|0|||
124963365|NCT00943722|449494095|FG002|Base Study|Month 12 visit not completed|0|||
124963366|NCT00943722|449494096|FG003|Base Study|Month 12 visit not completed|0|||
124963367|NCT00943722|449494097|FG004|Base Study|Month 12 visit not completed|2|||
124963368|NCT00943722|449494098|FG005|Base Study|Month 12 visit not completed|0|||
124963369|NCT00943722|449494099|FG006|Base Study|Month 12 visit not completed|0|||
124963370|NCT00943722|449494093|FG000|First Extension Study: EXT 1|Adverse Event|0|||
124963371|NCT00943722|449494094|FG001|First Extension Study: EXT 1|Adverse Event|0|||
124963372|NCT00943722|449494095|FG002|First Extension Study: EXT 1|Adverse Event|0|||
124963373|NCT00943722|449494096|FG003|First Extension Study: EXT 1|Adverse Event|0|||
124963374|NCT00943722|449494097|FG004|First Extension Study: EXT 1|Adverse Event|0|||
124963375|NCT00943722|449494098|FG005|First Extension Study: EXT 1|Adverse Event|1|||
124963376|NCT00943722|449494099|FG006|First Extension Study: EXT 1|Adverse Event|0|||
124963377|NCT00943722|449494093|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
124963378|NCT00943722|449494094|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
124963379|NCT00943722|449494095|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
125031645|NCT02357420|449737387|FG000|Overall Study|Withdrawn Consent|4|||
124963380|NCT00943722|449494096|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
124963381|NCT00943722|449494097|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
124963382|NCT00943722|449494098|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
124963383|NCT00943722|449494099|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
124963384|NCT00943722|449494093|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
124963385|NCT00943722|449494094|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
124963386|NCT00943722|449494095|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
124963387|NCT00943722|449494096|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
124963388|NCT00943722|449494097|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
124963389|NCT00943722|449494098|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
124963390|NCT00943722|449494099|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
124963391|NCT00943722|449494093|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
124963392|NCT00943722|449494094|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
124963393|NCT00943722|449494095|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
124963394|NCT00943722|449494096|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
124963395|NCT00943722|449494097|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
124963396|NCT00943722|449494098|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
124963397|NCT00943722|449494099|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
124963398|NCT00943722|449494093|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
124963399|NCT00943722|449494094|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
124963400|NCT00943722|449494095|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
124963401|NCT00943722|449494096|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
124963402|NCT00943722|449494097|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
124963403|NCT00943722|449494098|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
124963404|NCT00943722|449494099|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
124963405|NCT00943722|449494093|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
124963406|NCT00943722|449494094|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
124963407|NCT00943722|449494095|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
124963408|NCT00943722|449494096|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
124963409|NCT00943722|449494097|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
124963410|NCT00943722|449494098|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
124963411|NCT00943722|449494099|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
124963412|NCT00943722|449494093|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
124963413|NCT00943722|449494094|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
124963414|NCT00943722|449494095|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
124963415|NCT00943722|449494096|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
124963416|NCT00943722|449494097|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
124963417|NCT00943722|449494098|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
124963418|NCT00943722|449494099|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
124963419|NCT00943722|449494093|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
124963420|NCT00943722|449494094|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
124963421|NCT00943722|449494095|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
124963422|NCT00943722|449494096|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
124963423|NCT00943722|449494097|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
124963424|NCT00943722|449494098|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
124963425|NCT00943722|449494099|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
124963426|NCT00943722|449494093|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
124963427|NCT00943722|449494094|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
124963428|NCT00943722|449494095|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
124963429|NCT00943722|449494096|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
124963430|NCT00943722|449494097|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
124963431|NCT00943722|449494098|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
124963432|NCT00943722|449494099|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
124963433|NCT01036165|449494100|FG000|Overall Study|Adverse Event|6|||
124963434|NCT01036165|449494100|FG000|Overall Study|Lost to Follow-up|2|||
124963435|NCT01036165|449494100|FG000|Overall Study|Withdrawal by Subject|3|||
124963436|NCT01036165|449494100|FG000|Overall Study|Device Related Issues|3|||
124963437|NCT01036165|449494100|FG000|Overall Study|Problems finding proper area to inject|1|||
124963438|NCT00913523|449494106|FG000|Overall Study|Withdrawal by Subject|3|||
125031646|NCT02357420|449737388|FG001|Overall Study|Withdrawn Consent|8|||
125031647|NCT02357420|449737389|FG002|Overall Study|Withdrawn Consent|6|||
125031648|NCT02357420|449737390|FG003|Overall Study|Withdrawn Consent|6|||
125031649|NCT02357420|449737387|FG000|Overall Study|Lost to Follow-up|3|||
125031650|NCT02357420|449737388|FG001|Overall Study|Lost to Follow-up|0|||
125031651|NCT02357420|449737389|FG002|Overall Study|Lost to Follow-up|2|||
125031652|NCT02357420|449737390|FG003|Overall Study|Lost to Follow-up|3|||
125031653|NCT00928070|449737393|FG000|Overall Study|Lost to Follow-up|1|||
125031654|NCT00928070|449737394|FG001|Overall Study|Lost to Follow-up|2|||
125129332|NCT01472341|450099294|FG000|Overall Study|Death|9|||
125215802|NCT01237327|450417512|FG001|Overall Study|Protocol Violation: Core Study|0|||
125215803|NCT01237327|450417511|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
125215804|NCT01237327|450417512|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
125215805|NCT01237327|450417511|FG000|Overall Study|Progression of Disease: Core Study|18|||
125215806|NCT01237327|450417512|FG001|Overall Study|Progression of Disease: Core Study|22|||
125215807|NCT01237327|450417511|FG000|Overall Study|Progression of Disease: Extension Study|15|||
125215808|NCT01237327|450417512|FG001|Overall Study|Progression of Disease: Extension Study|13|||
125215809|NCT01237327|450417511|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
125215810|NCT01237327|450417512|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
124963439|NCT00913523|449494107|FG001|Overall Study|Withdrawal by Subject|2|||
124963440|NCT00913523|449494108|FG002|Overall Study|Withdrawal by Subject|2|||
124963441|NCT00913523|449494106|FG000|Overall Study|Lost to Follow-up|1|||
124963442|NCT00913523|449494107|FG001|Overall Study|Lost to Follow-up|1|||
124963443|NCT00913523|449494108|FG002|Overall Study|Lost to Follow-up|1|||
124963444|NCT00913523|449494106|FG000|Overall Study|Adverse Event|1|||
124963445|NCT00913523|449494107|FG001|Overall Study|Adverse Event|0|||
124963446|NCT00913523|449494108|FG002|Overall Study|Adverse Event|0|||
124963447|NCT00913523|449494106|FG000|Overall Study|Protocol Violation|5|||
124963448|NCT00913523|449494107|FG001|Overall Study|Protocol Violation|8|||
124963449|NCT00913523|449494108|FG002|Overall Study|Protocol Violation|8|||
124963450|NCT00913523|449494106|FG000|Overall Study|Pregnancy|1|||
124963451|NCT00913523|449494107|FG001|Overall Study|Pregnancy|3|||
124963452|NCT00913523|449494108|FG002|Overall Study|Pregnancy|0|||
124963453|NCT00913523|449494106|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
124963454|NCT00913523|449494107|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
124963455|NCT00913523|449494108|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
124963456|NCT02895360|449494109|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
124963457|NCT02895360|449494110|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
124963458|NCT02895360|449494111|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
124963459|NCT02895360|449494112|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
124963460|NCT02895360|449494113|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
124963461|NCT02895360|449494114|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
124963462|NCT02895360|449494109|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
124963463|NCT02895360|449494110|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
124963464|NCT02895360|449494111|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
124963465|NCT02895360|449494112|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
124963466|NCT02895360|449494113|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
124963467|NCT02895360|449494114|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
124963468|NCT02895360|449494109|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
124963469|NCT02895360|449494110|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
124963470|NCT02895360|449494111|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
124963471|NCT02895360|449494112|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
124963472|NCT02895360|449494113|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
124963473|NCT02895360|449494114|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
124963474|NCT02895360|449494109|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
124963475|NCT02895360|449494110|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
124963476|NCT02895360|449494111|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
124963477|NCT02895360|449494112|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
124963478|NCT02895360|449494113|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
124963479|NCT02895360|449494114|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
124963480|NCT02895360|449494109|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
124963481|NCT02895360|449494110|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
124963482|NCT02895360|449494111|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
124963483|NCT02895360|449494112|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
124963484|NCT02895360|449494113|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
124963485|NCT02895360|449494114|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
124963486|NCT02895360|449494109|FG000|Phase 2a|Adverse Event|0|||
124963487|NCT02895360|449494110|FG001|Phase 2a|Adverse Event|0|||
124963488|NCT02895360|449494111|FG002|Phase 2a|Adverse Event|0|||
124963489|NCT02895360|449494112|FG003|Phase 2a|Adverse Event|0|||
124963490|NCT02895360|449494113|FG004|Phase 2a|Adverse Event|0|||
124963491|NCT02895360|449494114|FG005|Phase 2a|Adverse Event|1|||
124963492|NCT02895360|449494109|FG000|Phase 2a|Progressive disease|0|||
124963493|NCT02895360|449494110|FG001|Phase 2a|Progressive disease|0|||
124963494|NCT02895360|449494111|FG002|Phase 2a|Progressive disease|0|||
125129333|NCT04060147|450099302|FG000|Overall Study|Withdrew consent|1|||
124963495|NCT02895360|449494112|FG003|Phase 2a|Progressive disease|0|||
124963496|NCT02895360|449494113|FG004|Phase 2a|Progressive disease|11|||
124963497|NCT02895360|449494114|FG005|Phase 2a|Progressive disease|11|||
124963498|NCT00916305|449494115|FG000|Overall Study|Lost to Follow-up|21|||
124963499|NCT00916305|449494116|FG001|Overall Study|Lost to Follow-up|27|||
124963500|NCT00916305|449494115|FG000|Overall Study|Withdrawal by Subject|0|||
124963501|NCT00916305|449494116|FG001|Overall Study|Withdrawal by Subject|1|||
124963502|NCT01844726|449494117|FG000|Overall Study|Withdrawal by Subject|0|||
124963503|NCT01844726|449494118|FG001|Overall Study|Withdrawal by Subject|1|||
125129334|NCT02057458|450099306|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
124963504|NCT01844726|449494117|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
124963505|NCT01844726|449494118|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
124963506|NCT00307164|449494121|FG000|Overall Study|Death|1|||
124963507|NCT00307164|449494122|FG001|Overall Study|Death|0|||
124963508|NCT00307164|449494121|FG000|Overall Study|Severe debilitation, unable to continue|1|||
124963509|NCT00307164|449494122|FG001|Overall Study|Severe debilitation, unable to continue|0|||
124963510|NCT00307164|449494121|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
125129335|NCT02057458|450099307|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
125129336|NCT02057458|450099308|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
125129337|NCT02057458|450099306|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
125129338|NCT02057458|450099307|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
124963511|NCT00307164|449494122|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
124963512|NCT00307164|449494121|FG000|Overall Study|Withdrawal by Subject|1|||
124963513|NCT00307164|449494122|FG001|Overall Study|Withdrawal by Subject|8|||
124963514|NCT00307164|449494121|FG000|Overall Study|Not compliant with requirements|4|||
124963515|NCT00307164|449494122|FG001|Overall Study|Not compliant with requirements|4|||
124963516|NCT00307164|449494121|FG000|Overall Study|Lost to Follow-up|6|||
124963517|NCT00307164|449494122|FG001|Overall Study|Lost to Follow-up|1|||
124963518|NCT01167192|449494128|FG000|Overall Study|Adverse Event|1|||
124963519|NCT01167192|449494128|FG000|Overall Study|Death|1|||
124963520|NCT01167192|449494128|FG000|Overall Study|Withdrawal by Subject|1|||
124963521|NCT01167192|449494128|FG000|Overall Study|Insurance denial|1|||
124963522|NCT02560389|449494129|FG000|Overall Study|Lost to Follow-up|1|||
124963523|NCT02560389|449494130|FG001|Overall Study|Lost to Follow-up|2|||
124963524|NCT02560389|449494131|FG002|Overall Study|Lost to Follow-up|2|||
124963525|NCT02560389|449494129|FG000|Overall Study|Tested positive for illicit substance|0|||
124963526|NCT02560389|449494130|FG001|Overall Study|Tested positive for illicit substance|1|||
124963527|NCT02560389|449494131|FG002|Overall Study|Tested positive for illicit substance|0|||
124963528|NCT01203956|449494142|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
124963529|NCT01203956|449494143|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
124963530|NCT00069277|449494144|FG000|Overall Study|Adverse Event|3|||
124963531|NCT00069277|449494144|FG000|Overall Study|Withdrawal by Subject|1|||
124963532|NCT00069277|449494144|FG000|Overall Study|Progressive Disease|15|||
124963533|NCT00069277|449494144|FG000|Overall Study|Physician Decision|2|||
124963534|NCT02230306|449494145|FG000|Overall Study|Did not receive study treatment|1|||
124963535|NCT00361842|449494152|FG000|Overall Study|Withdrawal by Subject|2|||
124963536|NCT00361842|449494153|FG001|Overall Study|Withdrawal by Subject|3|||
124963537|NCT00361842|449494152|FG000|Overall Study|Death|2|||
124963538|NCT00361842|449494153|FG001|Overall Study|Death|1|||
124963539|NCT00361842|449494152|FG000|Overall Study|Disease progression|19|||
124963540|NCT00361842|449494153|FG001|Overall Study|Disease progression|20|||
124963541|NCT00361842|449494152|FG000|Overall Study|Adverse Event|2|||
124963542|NCT00361842|449494153|FG001|Overall Study|Adverse Event|3|||
124963543|NCT00361842|449494152|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
124963544|NCT00361842|449494153|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
124963545|NCT00361842|449494152|FG000|Overall Study|Other|1|||
124963546|NCT00361842|449494153|FG001|Overall Study|Other|0|||
124963547|NCT00361842|449494152|FG000|Overall Study|Other|0|||
124963548|NCT00361842|449494153|FG001|Overall Study|Other|2|||
124963549|NCT03512288|449494154|FG000|Overall Study|Adverse Event|1|||
124963550|NCT03512288|449494155|FG001|Overall Study|Adverse Event|0|||
124963551|NCT03512288|449494154|FG000|Overall Study|Lost to Follow-up|12|||
124963552|NCT03512288|449494155|FG001|Overall Study|Lost to Follow-up|15|||
124963553|NCT03512288|449494154|FG000|Overall Study|Physician Decision|0|||
124963554|NCT03512288|449494155|FG001|Overall Study|Physician Decision|2|||
124963555|NCT03512288|449494154|FG000|Overall Study|Protocol Violation|6|||
124963556|NCT03512288|449494155|FG001|Overall Study|Protocol Violation|4|||
124963557|NCT03512288|449494154|FG000|Overall Study|Medication error without associated adverse event|1|||
124963558|NCT03512288|449494155|FG001|Overall Study|Medication error without associated adverse event|0|||
124963559|NCT03512288|449494154|FG000|Overall Study|No longer met eligibility criteria|5|||
124963560|NCT03512288|449494155|FG001|Overall Study|No longer met eligibility criteria|2|||
124963561|NCT03512288|449494154|FG000|Overall Study|Withdrawal by parent/guardian|14|||
124963562|NCT03512288|449494155|FG001|Overall Study|Withdrawal by parent/guardian|18|||
124963563|NCT03512288|449494154|FG000|Overall Study|Other|1|||
124963564|NCT03512288|449494155|FG001|Overall Study|Other|1|||
124963565|NCT03512288|449494154|FG000|Overall Study|Randomized but not treated|1|||
124963566|NCT03512288|449494155|FG001|Overall Study|Randomized but not treated|1|||
124963567|NCT04814992|449494156|FG000|Overall Study|Withdrawal by Subject|6|||
125129339|NCT02057458|450099308|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
124963568|NCT04814992|449494157|FG001|Overall Study|Withdrawal by Subject|3|||
124963569|NCT04814992|449494156|FG000|Overall Study|Lost to Follow-up|1|||
124963570|NCT04814992|449494157|FG001|Overall Study|Lost to Follow-up|4|||
124963571|NCT01260142|449494160|FG000|Treatment Period 1|Study on hold|1|||
124963572|NCT01260142|449494161|FG001|Treatment Period 1|Study on hold|1|||
124963573|NCT01260142|449494162|FG002|Treatment Period 1|Study on hold|0|||
124963574|NCT01260142|449494163|FG003|Treatment Period 1|Study on hold|0|||
124963575|NCT01260142|449494164|FG004|Treatment Period 1|Study on hold|1|||
124963576|NCT01260142|449494165|FG005|Treatment Period 1|Study on hold|2|||
124963577|NCT01260142|449494160|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
124963578|NCT01260142|449494161|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
124963579|NCT01260142|449494162|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
124963580|NCT01260142|449494163|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
125129340|NCT02057458|450099306|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
124963581|NCT01260142|449494164|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
124963582|NCT01260142|449494165|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
124963583|NCT01260142|449494160|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124963584|NCT01260142|449494161|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124963585|NCT01260142|449494162|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124963586|NCT01260142|449494163|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124963587|NCT01260142|449494164|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124963588|NCT01260142|449494165|FG005|Treatment Period 1|Withdrawal by Subject|1|||
124963589|NCT00691678|449494166|FG000|Overall Study|Adverse Event|5|||
124963590|NCT00691678|449494166|FG000|Overall Study|life events, pain|11|||
124963591|NCT01227928|449494167|FG000|Overall Study|Lost to Follow-up|4|||
124963592|NCT01227928|449494168|FG001|Overall Study|Lost to Follow-up|2|||
124963593|NCT01227928|449494167|FG000|Overall Study|Withdrawal by Subject|4|||
124963594|NCT01227928|449494168|FG001|Overall Study|Withdrawal by Subject|3|||
124963595|NCT01227928|449494167|FG000|Overall Study|Death|14|||
124963596|NCT01227928|449494168|FG001|Overall Study|Death|12|||
124963597|NCT00934700|449494171|FG000|Overall Study|missing scan|5|||
124963598|NCT00934700|449494172|FG001|Overall Study|missing scan|9|||
124963599|NCT00934700|449494171|FG000|Overall Study|Death|8|||
124963600|NCT00934700|449494172|FG001|Overall Study|Death|3|||
124963601|NCT01494298|449494173|FG000|Overall Study|Protocol Violation|2|||
124963602|NCT01494298|449494174|FG001|Overall Study|Protocol Violation|8|||
124963603|NCT02930837|449494175|FG000|Overall Study|Adverse Event|6|||
124963604|NCT02930837|449494175|FG000|Overall Study|Lost to Follow-up|5|||
124963605|NCT02930837|449494175|FG000|Overall Study|Withdrawal by Subject|1|||
124963606|NCT01393613|449494178|FG000|Overall Study|Adverse Event|11|||
124963607|NCT01393613|449494179|FG001|Overall Study|Adverse Event|11|||
124963608|NCT01393613|449494180|FG002|Overall Study|Adverse Event|13|||
124963609|NCT01393613|449494181|FG003|Overall Study|Adverse Event|22|||
124963610|NCT01393613|449494178|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
124963611|NCT01393613|449494179|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
124963612|NCT01393613|449494180|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
124963613|NCT01393613|449494181|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
124963614|NCT01393613|449494178|FG000|Overall Study|Physician Decision|2|||
124963615|NCT01393613|449494179|FG001|Overall Study|Physician Decision|0|||
124963616|NCT01393613|449494180|FG002|Overall Study|Physician Decision|0|||
124963617|NCT01393613|449494181|FG003|Overall Study|Physician Decision|1|||
124963618|NCT01393613|449494178|FG000|Overall Study|Withdrawal by Subject|15|||
124963619|NCT01393613|449494179|FG001|Overall Study|Withdrawal by Subject|25|||
124963620|NCT01393613|449494180|FG002|Overall Study|Withdrawal by Subject|23|||
124963621|NCT01393613|449494181|FG003|Overall Study|Withdrawal by Subject|21|||
124963622|NCT01393613|449494178|FG000|Overall Study|Protocol Deviation|2|||
124963623|NCT01393613|449494179|FG001|Overall Study|Protocol Deviation|1|||
124963624|NCT01393613|449494180|FG002|Overall Study|Protocol Deviation|0|||
124963625|NCT01393613|449494181|FG003|Overall Study|Protocol Deviation|0|||
124963626|NCT01393613|449494178|FG000|Overall Study|Lack of Efficacy|9|||
124963627|NCT01393613|449494179|FG001|Overall Study|Lack of Efficacy|20|||
124963628|NCT01393613|449494180|FG002|Overall Study|Lack of Efficacy|16|||
124963629|NCT01393613|449494181|FG003|Overall Study|Lack of Efficacy|21|||
124963630|NCT01831726|449494182|FG000|Overall Study|Adverse Event|16|||
124963631|NCT01831726|449494182|FG000|Overall Study|Death|7|||
124963632|NCT01831726|449494182|FG000|Overall Study|Disease Progression|49|||
124963633|NCT01831726|449494182|FG000|Overall Study|Physician Decision|1|||
124963634|NCT01831726|449494182|FG000|Overall Study|Subject/guardian decision|7|||
124963635|NCT01283971|449494189|FG000|Overall Study|Adverse Event|3|||
124963636|NCT01283971|449494190|FG001|Overall Study|Adverse Event|5|||
124963637|NCT01283971|449494189|FG000|Overall Study|Insufficient therapeutic responses|3|||
124963638|NCT01283971|449494190|FG001|Overall Study|Insufficient therapeutic responses|3|||
124963639|NCT01283971|449494189|FG000|Overall Study|Protocol Violation|5|||
124963640|NCT01283971|449494190|FG001|Overall Study|Protocol Violation|1|||
124963641|NCT01283971|449494189|FG000|Overall Study|Refused treatment|3|||
124963642|NCT01283971|449494190|FG001|Overall Study|Refused treatment|1|||
124963643|NCT01283971|449494189|FG000|Overall Study|Failure to return|0|||
124963644|NCT01283971|449494190|FG001|Overall Study|Failure to return|1|||
124963645|NCT01283971|449494189|FG000|Overall Study|Administrative reasons|1|||
124963646|NCT01283971|449494190|FG001|Overall Study|Administrative reasons|1|||
124963647|NCT01502371|449494191|FG000|Overall Study|Withdrawal by Subject|1|||
124963648|NCT01502371|449494192|FG001|Overall Study|Withdrawal by Subject|2|||
124963649|NCT01502371|449494193|FG002|Overall Study|Withdrawal by Subject|1|||
124963650|NCT01502371|449494194|FG003|Overall Study|Withdrawal by Subject|1|||
124963651|NCT01502371|449494195|FG004|Overall Study|Withdrawal by Subject|1|||
124963652|NCT01502371|449494191|FG000|Overall Study|Adverse Event|2|||
124963653|NCT01502371|449494192|FG001|Overall Study|Adverse Event|1|||
124963654|NCT01502371|449494193|FG002|Overall Study|Adverse Event|0|||
124963655|NCT01502371|449494194|FG003|Overall Study|Adverse Event|4|||
124963656|NCT01502371|449494195|FG004|Overall Study|Adverse Event|3|||
124963657|NCT01502371|449494191|FG000|Overall Study|Treatment Failure|22|||
124963658|NCT01502371|449494192|FG001|Overall Study|Treatment Failure|20|||
124963659|NCT01502371|449494193|FG002|Overall Study|Treatment Failure|12|||
125215811|NCT01237327|450417511|FG000|Overall Study|Withdrawal by Subject|1|||
125215812|NCT01237327|450417512|FG001|Overall Study|Withdrawal by Subject|3|||
125215813|NCT01237327|450417511|FG000|Overall Study|Lost to Follow-up|3|||
125215814|NCT01237327|450417512|FG001|Overall Study|Lost to Follow-up|0|||
125215815|NCT02483572|450417515|FG000|Overall Study|Withdrawal by Subject|1|||
125215816|NCT02483572|450417516|FG001|Overall Study|Withdrawal by Subject|0|||
125215817|NCT02483572|450417515|FG000|Overall Study|Lost to Follow-up|1|||
125215818|NCT02483572|450417516|FG001|Overall Study|Lost to Follow-up|0|||
125215819|NCT02483572|450417515|FG000|Overall Study|Physician Decision|0|||
125215820|NCT02483572|450417516|FG001|Overall Study|Physician Decision|1|||
125215821|NCT04811664|450417517|FG000|Overall Study|Lost to Follow-up|78|||
125215822|NCT04811664|450417518|FG001|Overall Study|Lost to Follow-up|125|||
125215823|NCT04811664|450417519|FG002|Overall Study|Lost to Follow-up|46|||
125215824|NCT04811664|450417517|FG000|Overall Study|Withdrawal by Subject|39|||
125215825|NCT04811664|450417518|FG001|Overall Study|Withdrawal by Subject|76|||
125215826|NCT04811664|450417519|FG002|Overall Study|Withdrawal by Subject|12|||
125215827|NCT04811664|450417517|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
125215828|NCT04811664|450417518|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
125215829|NCT04811664|450417519|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
125215830|NCT04811664|450417517|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
125215831|NCT04811664|450417518|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
125215832|NCT04811664|450417519|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
125215833|NCT04811664|450417517|FG000|Overall Study|Protocol Violation|0|||
125215834|NCT04811664|450417518|FG001|Overall Study|Protocol Violation|5|||
125215835|NCT04811664|450417519|FG002|Overall Study|Protocol Violation|11|||
125215836|NCT04811664|450417517|FG000|Overall Study|Study Terminated by Sponsor|4|||
125215837|NCT04811664|450417518|FG001|Overall Study|Study Terminated by Sponsor|3|||
125215838|NCT04811664|450417519|FG002|Overall Study|Study Terminated by Sponsor|34|||
125215839|NCT04811664|450417517|FG000|Overall Study|Early Study Closure|3|||
125215840|NCT04811664|450417518|FG001|Overall Study|Early Study Closure|7|||
125215841|NCT04811664|450417519|FG002|Overall Study|Early Study Closure|79|||
125215842|NCT04811664|450417517|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
125215843|NCT04811664|450417518|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
125215844|NCT04811664|450417519|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
125215845|NCT05052697|450417520|FG000|Substudy A|Lost to Follow-up|0|||
125215846|NCT05052697|450417521|FG001|Substudy A|Lost to Follow-up|0|||
125215847|NCT05052697|450417522|FG002|Substudy A|Lost to Follow-up|0|||
125215848|NCT05052697|450417523|FG003|Substudy A|Lost to Follow-up|0|||
125215849|NCT05052697|450417524|FG004|Substudy A|Lost to Follow-up|0|||
125215850|NCT05052697|450417525|FG005|Substudy A|Lost to Follow-up|1|||
125215851|NCT05052697|450417526|FG006|Substudy A|Lost to Follow-up|0|||
125215852|NCT05052697|450417527|FG007|Substudy A|Lost to Follow-up|0|||
125215853|NCT05052697|450417528|FG008|Substudy A|Lost to Follow-up|0|||
125215854|NCT05052697|450417529|FG009|Substudy A|Lost to Follow-up|0|||
125215855|NCT05052697|450417530|FG010|Substudy A|Lost to Follow-up|0|||
125215856|NCT05052697|450417531|FG011|Substudy A|Lost to Follow-up|0|||
125215857|NCT05052697|450417532|FG012|Substudy A|Lost to Follow-up|0|||
125215858|NCT05052697|450417533|FG013|Substudy A|Lost to Follow-up|0|||
125215859|NCT05052697|450417534|FG014|Substudy A|Lost to Follow-up|0|||
125215860|NCT05052697|450417535|FG015|Substudy A|Lost to Follow-up|2|||
125215861|NCT05052697|450417536|FG016|Substudy A|Lost to Follow-up|0|||
125215862|NCT05052697|450417537|FG017|Substudy A|Lost to Follow-up|0|||
125215863|NCT05052697|450417538|FG018|Substudy A|Lost to Follow-up|0|||
125215864|NCT05052697|450417539|FG019|Substudy A|Lost to Follow-up|0|||
125215865|NCT05052697|450417540|FG020|Substudy A|Lost to Follow-up|0|||
125215866|NCT05052697|450417541|FG021|Substudy A|Lost to Follow-up|0|||
125215867|NCT05052697|450417542|FG022|Substudy A|Lost to Follow-up|0|||
125215868|NCT05052697|450417543|FG023|Substudy A|Lost to Follow-up|0|||
125215869|NCT05052697|450417544|FG024|Substudy A|Lost to Follow-up|0|||
125215870|NCT05052697|450417545|FG025|Substudy A|Lost to Follow-up|0|||
125215871|NCT05052697|450417546|FG026|Substudy A|Lost to Follow-up|0|||
125215872|NCT05052697|450417547|FG027|Substudy A|Lost to Follow-up|0|||
125215873|NCT05052697|450417548|FG028|Substudy A|Lost to Follow-up|0|||
125215874|NCT05052697|450417549|FG029|Substudy A|Lost to Follow-up|0|||
125215875|NCT05052697|450417550|FG030|Substudy A|Lost to Follow-up|0|||
125215876|NCT05052697|450417551|FG031|Substudy A|Lost to Follow-up|0|||
125215877|NCT05052697|450417552|FG032|Substudy A|Lost to Follow-up|0|||
125215878|NCT05052697|450417553|FG033|Substudy A|Lost to Follow-up|0|||
125215879|NCT05052697|450417520|FG000|Substudy A|No longer met eligibility criteria|0|||
125215880|NCT05052697|450417521|FG001|Substudy A|No longer met eligibility criteria|0|||
125215881|NCT05052697|450417522|FG002|Substudy A|No longer met eligibility criteria|0|||
125215882|NCT05052697|450417523|FG003|Substudy A|No longer met eligibility criteria|0|||
125215883|NCT05052697|450417524|FG004|Substudy A|No longer met eligibility criteria|0|||
125215884|NCT05052697|450417525|FG005|Substudy A|No longer met eligibility criteria|0|||
125215885|NCT05052697|450417526|FG006|Substudy A|No longer met eligibility criteria|0|||
125215886|NCT05052697|450417527|FG007|Substudy A|No longer met eligibility criteria|0|||
125215887|NCT05052697|450417528|FG008|Substudy A|No longer met eligibility criteria|0|||
125215888|NCT05052697|450417529|FG009|Substudy A|No longer met eligibility criteria|0|||
125215889|NCT05052697|450417530|FG010|Substudy A|No longer met eligibility criteria|0|||
125215890|NCT05052697|450417531|FG011|Substudy A|No longer met eligibility criteria|0|||
125215891|NCT05052697|450417532|FG012|Substudy A|No longer met eligibility criteria|0|||
125215892|NCT05052697|450417533|FG013|Substudy A|No longer met eligibility criteria|1|||
125215893|NCT05052697|450417534|FG014|Substudy A|No longer met eligibility criteria|0|||
125129341|NCT02057458|450099307|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
125129342|NCT02057458|450099308|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
125129343|NCT01534520|450099309|FG000|Overall Study|Adverse Event|0|||
125129344|NCT01534520|450099310|FG001|Overall Study|Adverse Event|1|||
125129345|NCT02979353|450099313|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
125129346|NCT02979353|450099314|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
125129347|NCT02979353|450099313|FG000|Overall Study|Withdrawal by Subject|16|||
125129348|NCT02979353|450099314|FG001|Overall Study|Withdrawal by Subject|12|||
125129349|NCT02979353|450099313|FG000|Overall Study|Death|10|||
125129350|NCT02979353|450099314|FG001|Overall Study|Death|11|||
125129351|NCT02979353|450099313|FG000|Overall Study|Transfer to Hospice Care|19|||
125129352|NCT02979353|450099314|FG001|Overall Study|Transfer to Hospice Care|14|||
125129353|NCT02979353|450099313|FG000|Overall Study|Lost to Follow-up|1|||
125129354|NCT02979353|450099314|FG001|Overall Study|Lost to Follow-up|5|||
125129355|NCT01079988|450099315|FG000|Overall Study|Lost to Follow-up|0|||
125215894|NCT05052697|450417535|FG015|Substudy A|No longer met eligibility criteria|0|||
125215895|NCT05052697|450417536|FG016|Substudy A|No longer met eligibility criteria|0|||
125129356|NCT01079988|450099316|FG001|Overall Study|Lost to Follow-up|0|||
125129357|NCT01079988|450099317|FG002|Overall Study|Lost to Follow-up|0|||
125129358|NCT01079988|450099318|FG003|Overall Study|Lost to Follow-up|1|||
125031655|NCT00928070|449737393|FG000|Overall Study|Withdrawal by Subject|10|||
125031656|NCT00928070|449737394|FG001|Overall Study|Withdrawal by Subject|3|||
125031657|NCT00928070|449737393|FG000|Overall Study|Adverse Event|14|||
125031658|NCT00928070|449737394|FG001|Overall Study|Adverse Event|26|||
125031659|NCT00928070|449737393|FG000|Overall Study|Lack of Efficacy|9|||
125031660|NCT00928070|449737394|FG001|Overall Study|Lack of Efficacy|5|||
125031661|NCT00928070|449737393|FG000|Overall Study|Did not meet entrance criteria|16|||
125031662|NCT00928070|449737394|FG001|Overall Study|Did not meet entrance criteria|9|||
125031663|NCT00928070|449737393|FG000|Overall Study|Protocol Violation|6|||
125031664|NCT00928070|449737394|FG001|Overall Study|Protocol Violation|5|||
125031665|NCT00928070|449737393|FG000|Overall Study|Randomized but not treated|2|||
125031666|NCT00928070|449737394|FG001|Overall Study|Randomized but not treated|2|||
125031667|NCT00928070|449737393|FG000|Overall Study|Other|5|||
125031668|NCT00928070|449737394|FG001|Overall Study|Other|5|||
125129359|NCT01079988|450099319|FG004|Overall Study|Lost to Follow-up|0|||
125129360|NCT01079988|450099315|FG000|Overall Study|Lack of Efficacy|1|||
125129361|NCT01079988|450099316|FG001|Overall Study|Lack of Efficacy|0|||
125129362|NCT01079988|450099317|FG002|Overall Study|Lack of Efficacy|0|||
125129363|NCT01079988|450099318|FG003|Overall Study|Lack of Efficacy|0|||
125129364|NCT01079988|450099319|FG004|Overall Study|Lack of Efficacy|0|||
125129365|NCT01079988|450099315|FG000|Overall Study|Other|0|||
125129366|NCT01079988|450099316|FG001|Overall Study|Other|0|||
125129367|NCT01079988|450099317|FG002|Overall Study|Other|0|||
125129368|NCT01079988|450099318|FG003|Overall Study|Other|2|||
125129369|NCT01079988|450099319|FG004|Overall Study|Other|1|||
125129370|NCT00585689|450099320|FG000|Overall Study|Received different ABI-007 schedule|3|||
125129371|NCT00585689|450099320|FG000|Overall Study|Adverse Event|1|||
125129372|NCT00585689|450099320|FG000|Overall Study|Patient Declined Surgery|1|||
125129373|NCT00585689|450099320|FG000|Overall Study|Patient had unresectable disease|1|||
125129374|NCT00585689|450099320|FG000|Overall Study|Death|1|||
125129375|NCT00550537|450099321|FG000|Overall Study|Death|18|||
125129376|NCT00550537|450099321|FG000|Overall Study|Adverse Event|20|||
125129377|NCT00550537|450099321|FG000|Overall Study|Disease progression before|46|||
125129378|NCT00550537|450099321|FG000|Overall Study|Withdrawal by Subject|7|||
125129379|NCT00550537|450099321|FG000|Overall Study|Change in treatment plan|4|||
125129380|NCT00550537|450099321|FG000|Overall Study|Other complicating ilness|3|||
125129381|NCT00550537|450099321|FG000|Overall Study|Declining performance status|2|||
125129382|NCT00550537|450099321|FG000|Overall Study|Treated closer to home|4|||
125129383|NCT00268905|450099322|FG000|Overall Study|Adverse Event|3|||
125129384|NCT00268905|450099323|FG001|Overall Study|Adverse Event|0|||
125129385|NCT00268905|450099324|FG002|Overall Study|Adverse Event|4|||
125129386|NCT00268905|450099322|FG000|Overall Study|Lost to Follow-up|0|||
125129387|NCT00268905|450099323|FG001|Overall Study|Lost to Follow-up|1|||
125129388|NCT00268905|450099324|FG002|Overall Study|Lost to Follow-up|0|||
125129389|NCT00268905|450099322|FG000|Overall Study|Withdrawal by Subject|0|||
125129390|NCT00268905|450099323|FG001|Overall Study|Withdrawal by Subject|0|||
125129391|NCT00268905|450099324|FG002|Overall Study|Withdrawal by Subject|3|||
125129392|NCT00268905|450099322|FG000|Overall Study|Progressive Disease|28|||
125129393|NCT00268905|450099323|FG001|Overall Study|Progressive Disease|4|||
125129394|NCT00268905|450099324|FG002|Overall Study|Progressive Disease|3|||
125129395|NCT00268905|450099322|FG000|Overall Study|Physician Decision|3|||
125129396|NCT00268905|450099323|FG001|Overall Study|Physician Decision|0|||
125129397|NCT00268905|450099324|FG002|Overall Study|Physician Decision|1|||
125129398|NCT00268905|450099322|FG000|Overall Study|Clinical Progression|9|||
125129399|NCT00268905|450099323|FG001|Overall Study|Clinical Progression|4|||
125129400|NCT00268905|450099324|FG002|Overall Study|Clinical Progression|1|||
125129401|NCT00617305|450099325|FG000|Overall Study|Adverse Event|4|||
125129402|NCT00617305|450099326|FG001|Overall Study|Adverse Event|0|||
125129403|NCT00617305|450099327|FG002|Overall Study|Adverse Event|0|||
125129404|NCT00617305|450099325|FG000|Overall Study|Death|1|||
125129405|NCT00617305|450099326|FG001|Overall Study|Death|0|||
125129406|NCT00617305|450099327|FG002|Overall Study|Death|0|||
125129407|NCT00617305|450099325|FG000|Overall Study|Physician Decision|1|||
125129408|NCT00617305|450099326|FG001|Overall Study|Physician Decision|0|||
125129409|NCT00617305|450099327|FG002|Overall Study|Physician Decision|0|||
125129410|NCT00617305|450099325|FG000|Overall Study|Protocol Violation|1|||
125129411|NCT00617305|450099326|FG001|Overall Study|Protocol Violation|0|||
125129412|NCT00617305|450099327|FG002|Overall Study|Protocol Violation|1|||
125129413|NCT00617305|450099325|FG000|Overall Study|Withdrawal by Subject|1|||
125129414|NCT00617305|450099326|FG001|Overall Study|Withdrawal by Subject|0|||
125031669|NCT02054702|449737398|FG000|Overall Study|Lost to Follow-up|3|||
125129415|NCT00617305|450099327|FG002|Overall Study|Withdrawal by Subject|0|||
125129416|NCT03459807|450099329|FG000|Overall Study|Withdrawal due to transplant|0|||
125129417|NCT03459807|450099330|FG001|Overall Study|Withdrawal due to transplant|1|||
125129418|NCT04510285|450099331|FG000|Overall Study|Death|1|||
125129419|NCT01406795|450099332|FG000|Overall Study|Withdrawal by Subject|1|||
125129420|NCT03897088|450099335|FG000|Overall Study|Withdrawal by Subject|12|||
125129421|NCT03897088|450099336|FG001|Overall Study|Withdrawal by Subject|12|||
124963660|NCT01502371|449494194|FG003|Overall Study|Treatment Failure|19|||
124963661|NCT01502371|449494195|FG004|Overall Study|Treatment Failure|30|||
124963662|NCT01502371|449494191|FG000|Overall Study|Lack of Efficacy|3|||
124963663|NCT01502371|449494192|FG001|Overall Study|Lack of Efficacy|3|||
124963664|NCT01502371|449494193|FG002|Overall Study|Lack of Efficacy|2|||
124963665|NCT01502371|449494194|FG003|Overall Study|Lack of Efficacy|2|||
124963666|NCT01502371|449494195|FG004|Overall Study|Lack of Efficacy|4|||
124963667|NCT01502371|449494191|FG000|Overall Study|Physician Decision|3|||
124963668|NCT01502371|449494192|FG001|Overall Study|Physician Decision|0|||
124963669|NCT01502371|449494193|FG002|Overall Study|Physician Decision|0|||
124963670|NCT01502371|449494194|FG003|Overall Study|Physician Decision|0|||
124963671|NCT01502371|449494195|FG004|Overall Study|Physician Decision|1|||
124963672|NCT01502371|449494191|FG000|Overall Study|Noncompliance with Study Drug|0|||
124963673|NCT01502371|449494192|FG001|Overall Study|Noncompliance with Study Drug|0|||
124963674|NCT01502371|449494193|FG002|Overall Study|Noncompliance with Study Drug|1|||
124963675|NCT01502371|449494194|FG003|Overall Study|Noncompliance with Study Drug|2|||
124963676|NCT01502371|449494195|FG004|Overall Study|Noncompliance with Study Drug|1|||
124963677|NCT01502371|449494191|FG000|Overall Study|Technical Problems|1|||
124963678|NCT01502371|449494192|FG001|Overall Study|Technical Problems|0|||
124963679|NCT01502371|449494193|FG002|Overall Study|Technical Problems|2|||
124963680|NCT01502371|449494194|FG003|Overall Study|Technical Problems|4|||
124963681|NCT01502371|449494195|FG004|Overall Study|Technical Problems|1|||
124963682|NCT01502371|449494191|FG000|Overall Study|Protocol Violation|9|||
124963683|NCT01502371|449494192|FG001|Overall Study|Protocol Violation|5|||
124963684|NCT01502371|449494193|FG002|Overall Study|Protocol Violation|6|||
124963685|NCT01502371|449494194|FG003|Overall Study|Protocol Violation|5|||
124963686|NCT01502371|449494195|FG004|Overall Study|Protocol Violation|10|||
124963687|NCT01502371|449494191|FG000|Overall Study|Excluded Medication|0|||
124963688|NCT01502371|449494192|FG001|Overall Study|Excluded Medication|1|||
124963689|NCT01502371|449494193|FG002|Overall Study|Excluded Medication|1|||
124963690|NCT01502371|449494194|FG003|Overall Study|Excluded Medication|0|||
124963691|NCT01502371|449494195|FG004|Overall Study|Excluded Medication|1|||
124963692|NCT02598934|449494196|FG000|Overall Study|Adverse Event|11|||
124963693|NCT02598934|449494197|FG001|Overall Study|Adverse Event|13|||
124963694|NCT02598934|449494196|FG000|Overall Study|Failure to Return|3|||
124963695|NCT02598934|449494197|FG001|Overall Study|Failure to Return|3|||
124963696|NCT02598934|449494196|FG000|Overall Study|Withdrawal by Subject|2|||
124963697|NCT02598934|449494197|FG001|Overall Study|Withdrawal by Subject|3|||
124963698|NCT02598934|449494196|FG000|Overall Study|Administrative|2|||
124963699|NCT02598934|449494197|FG001|Overall Study|Administrative|1|||
124963700|NCT02598934|449494196|FG000|Overall Study|Protocol Violation|1|||
124963701|NCT02598934|449494197|FG001|Overall Study|Protocol Violation|2|||
124963702|NCT03049306|449494200|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
124963703|NCT03049306|449494201|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
124963704|NCT02154347|449494202|FG000|Double-blind Period|Adverse Event|1|||
124963705|NCT02154347|449494203|FG001|Double-blind Period|Adverse Event|2|||
124963706|NCT02154347|449494202|FG000|Double-blind Period|Lack of Efficacy|1|||
124963707|NCT02154347|449494203|FG001|Double-blind Period|Lack of Efficacy|0|||
124963708|NCT02154347|449494202|FG000|Double-blind Period|Physician Decision|0|||
124963709|NCT02154347|449494203|FG001|Double-blind Period|Physician Decision|1|||
124963710|NCT02154347|449494202|FG000|Double-blind Period|Withdrawal by Subject|1|||
124963711|NCT02154347|449494203|FG001|Double-blind Period|Withdrawal by Subject|1|||
124963712|NCT02154347|449494202|FG000|Open-label Period|Adverse Event|3|||
124963713|NCT02154347|449494203|FG001|Open-label Period|Adverse Event|4|||
124963714|NCT02154347|449494202|FG000|Open-label Period|Lack of Efficacy|4|||
125031670|NCT02054702|449737399|FG001|Overall Study|Lost to Follow-up|5|||
125031671|NCT02054702|449737398|FG000|Overall Study|Adverse Event|3|||
125031672|NCT02054702|449737399|FG001|Overall Study|Adverse Event|1|||
125031673|NCT02054702|449737398|FG000|Overall Study|Met Withdrawal Criteria|4|||
125031674|NCT02054702|449737399|FG001|Overall Study|Met Withdrawal Criteria|1|||
124963715|NCT02154347|449494203|FG001|Open-label Period|Lack of Efficacy|19|||
124963716|NCT02154347|449494202|FG000|Open-label Period|Protocol Violation|0|||
124963717|NCT02154347|449494203|FG001|Open-label Period|Protocol Violation|1|||
124963718|NCT02154347|449494202|FG000|Open-label Period|Withdrawal by Subject|0|||
124963719|NCT02154347|449494203|FG001|Open-label Period|Withdrawal by Subject|1|||
124963720|NCT02473913|449494205|FG000|Overall Study|Lost to Follow-up|3|||
125031675|NCT02054702|449737398|FG000|Overall Study|Physician Decision|0|||
124963721|NCT02473913|449494206|FG001|Overall Study|Lost to Follow-up|3|||
124963722|NCT00605566|449495740|FG000|Overall Study|Adverse Event|1|||
124963723|NCT00605566|449495740|FG000|Overall Study|Clinical deterioration|1|||
124963724|NCT00605566|449495740|FG000|Overall Study|Poor compliance in run-in period|1|||
124963725|NCT04156399|449495741|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
124963726|NCT04156399|449495741|FG000|Overall Study|study suspension due to COVID pandemic|3|||
124963727|NCT03440047|449495742|FG000|Overall Study|Withdrawal by Subject|2|||
124963728|NCT01181609|449495743|FG000|Overall Study|Adverse Event|1|||
124963729|NCT01181609|449495743|FG000|Overall Study|Withdrawal by Subject|1|||
124963730|NCT01181609|449495743|FG000|Overall Study|Lost to Follow-up|1|||
125215896|NCT05052697|450417537|FG017|Substudy A|No longer met eligibility criteria|0|||
124963731|NCT01181609|449495743|FG000|Overall Study|Death|50|||
124963732|NCT01333111|449495744|FG000|Overall Study|patient undergoing major surgery|0|||
124963733|NCT01333111|449495745|FG001|Overall Study|patient undergoing major surgery|2|||
124963734|NCT01333111|449495746|FG002|Overall Study|patient undergoing major surgery|0|||
124963735|NCT01333111|449495744|FG000|Overall Study|personal reasons|0|||
124963736|NCT01333111|449495745|FG001|Overall Study|personal reasons|0|||
124963737|NCT01333111|449495746|FG002|Overall Study|personal reasons|1|||
124963738|NCT01333111|449495744|FG000|Overall Study|unclassified|1|||
124963739|NCT01333111|449495745|FG001|Overall Study|unclassified|0|||
124963740|NCT01333111|449495746|FG002|Overall Study|unclassified|0|||
124963741|NCT01333111|449495744|FG000|Overall Study|withdrawal criteria|0|||
124963742|NCT01333111|449495745|FG001|Overall Study|withdrawal criteria|1|||
124963743|NCT01333111|449495746|FG002|Overall Study|withdrawal criteria|0|||
124963744|NCT01333111|449495744|FG000|Overall Study|Non-compliance|1|||
124963745|NCT01333111|449495745|FG001|Overall Study|Non-compliance|0|||
124963746|NCT01333111|449495746|FG002|Overall Study|Non-compliance|0|||
124963747|NCT01333111|449495744|FG000|Overall Study|Ineffective therapy|0|||
124963748|NCT01333111|449495745|FG001|Overall Study|Ineffective therapy|0|||
124963749|NCT01333111|449495746|FG002|Overall Study|Ineffective therapy|1|||
124963750|NCT04732871|449495747|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
124963751|NCT04732871|449495748|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
124963752|NCT04732871|449495749|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
124963753|NCT04732871|449495747|FG000|Overall Study|Lost to Follow-up|7|||
124963754|NCT04732871|449495748|FG001|Overall Study|Lost to Follow-up|4|||
124963755|NCT04732871|449495749|FG002|Overall Study|Lost to Follow-up|3|||
124963756|NCT04732871|449495747|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
124963757|NCT04732871|449495748|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
124963758|NCT04732871|449495749|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
124963759|NCT04732871|449495747|FG000|Overall Study|Migrated / moved from the study area|5|||
124963760|NCT04732871|449495748|FG001|Overall Study|Migrated / moved from the study area|0|||
124963761|NCT04732871|449495749|FG002|Overall Study|Migrated / moved from the study area|0|||
124963762|NCT04732871|449495747|FG000|Overall Study|Other|1|||
124963763|NCT04732871|449495748|FG001|Overall Study|Other|0|||
124963764|NCT04732871|449495749|FG002|Overall Study|Other|1|||
124963765|NCT04732871|449495747|FG000|Overall Study|Ongoing|6|||
124963766|NCT04732871|449495748|FG001|Overall Study|Ongoing|0|||
124963767|NCT04732871|449495749|FG002|Overall Study|Ongoing|1|||
124963768|NCT04732871|449495747|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
124963769|NCT04732871|449495748|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
125215897|NCT05052697|450417538|FG018|Substudy A|No longer met eligibility criteria|0|||
125215898|NCT05052697|450417539|FG019|Substudy A|No longer met eligibility criteria|0|||
125215899|NCT05052697|450417540|FG020|Substudy A|No longer met eligibility criteria|0|||
125215900|NCT05052697|450417541|FG021|Substudy A|No longer met eligibility criteria|0|||
125215901|NCT05052697|450417542|FG022|Substudy A|No longer met eligibility criteria|0|||
125215902|NCT05052697|450417543|FG023|Substudy A|No longer met eligibility criteria|0|||
125215903|NCT05052697|450417544|FG024|Substudy A|No longer met eligibility criteria|0|||
125215904|NCT05052697|450417545|FG025|Substudy A|No longer met eligibility criteria|0|||
125215905|NCT05052697|450417546|FG026|Substudy A|No longer met eligibility criteria|0|||
125215906|NCT05052697|450417547|FG027|Substudy A|No longer met eligibility criteria|0|||
125215907|NCT05052697|450417548|FG028|Substudy A|No longer met eligibility criteria|0|||
125215908|NCT05052697|450417549|FG029|Substudy A|No longer met eligibility criteria|0|||
125215909|NCT05052697|450417550|FG030|Substudy A|No longer met eligibility criteria|0|||
124963770|NCT04732871|449495749|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
124963771|NCT03294941|449495754|FG000|Overall Study|Withdrawal by Subject|0|||
124963772|NCT03294941|449495755|FG001|Overall Study|Withdrawal by Subject|2|||
124963773|NCT00702650|449495756|FG000|Overall Study|Withdrawal by Subject|9|||
124963774|NCT00702650|449495756|FG000|Overall Study|Non-Compliance of Study Drug|3|||
124963775|NCT00702650|449495756|FG000|Overall Study|Lost to Follow-up|2|||
124963776|NCT00702650|449495756|FG000|Overall Study|Non-Compliance with Site Directives|1|||
124963777|NCT00702650|449495756|FG000|Overall Study|Sponsor Request|1|||
124963778|NCT00702650|449495756|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
124963779|NCT00702650|449495756|FG000|Overall Study|Adverse Event|3|||
124963780|NCT01475461|449495762|FG000|Run-in Period|Not meet eligibility criteria|16|||
124963781|NCT01475461|449495763|FG001|Run-in Period|Not meet eligibility criteria|0|||
124963782|NCT01475461|449495764|FG002|Run-in Period|Not meet eligibility criteria|0|||
124963783|NCT01475461|449495765|FG003|Run-in Period|Not meet eligibility criteria|0|||
124963784|NCT01475461|449495766|FG004|Run-in Period|Not meet eligibility criteria|0|||
124963785|NCT01475461|449495767|FG005|Run-in Period|Not meet eligibility criteria|0|||
124963786|NCT01475461|449495768|FG006|Run-in Period|Not meet eligibility criteria|0|||
124963787|NCT01475461|449495762|FG000|Run-in Period|Lost to Follow-up|7|||
124963788|NCT01475461|449495763|FG001|Run-in Period|Lost to Follow-up|0|||
124963789|NCT01475461|449495764|FG002|Run-in Period|Lost to Follow-up|0|||
124963790|NCT01475461|449495765|FG003|Run-in Period|Lost to Follow-up|0|||
124963791|NCT01475461|449495766|FG004|Run-in Period|Lost to Follow-up|0|||
124963792|NCT01475461|449495767|FG005|Run-in Period|Lost to Follow-up|0|||
124963793|NCT01475461|449495768|FG006|Run-in Period|Lost to Follow-up|0|||
124963794|NCT01475461|449495762|FG000|Run-in Period|Withdrawal by Subject|11|||
124963795|NCT01475461|449495763|FG001|Run-in Period|Withdrawal by Subject|0|||
124963796|NCT01475461|449495764|FG002|Run-in Period|Withdrawal by Subject|0|||
124963797|NCT01475461|449495765|FG003|Run-in Period|Withdrawal by Subject|0|||
124963798|NCT01475461|449495766|FG004|Run-in Period|Withdrawal by Subject|0|||
124963799|NCT01475461|449495767|FG005|Run-in Period|Withdrawal by Subject|0|||
124963800|NCT01475461|449495768|FG006|Run-in Period|Withdrawal by Subject|0|||
124963801|NCT01475461|449495762|FG000|Run-in Period|Other|3|||
124963802|NCT01475461|449495763|FG001|Run-in Period|Other|0|||
124963803|NCT01475461|449495764|FG002|Run-in Period|Other|0|||
124963804|NCT01475461|449495765|FG003|Run-in Period|Other|0|||
124963805|NCT01475461|449495766|FG004|Run-in Period|Other|0|||
124963806|NCT01475461|449495767|FG005|Run-in Period|Other|0|||
124963807|NCT01475461|449495768|FG006|Run-in Period|Other|0|||
124963808|NCT01475461|449495762|FG000|Run-in Period|Protocol Violation|4|||
124963809|NCT01475461|449495763|FG001|Run-in Period|Protocol Violation|0|||
124963810|NCT01475461|449495764|FG002|Run-in Period|Protocol Violation|0|||
124963811|NCT01475461|449495765|FG003|Run-in Period|Protocol Violation|0|||
124963812|NCT01475461|449495766|FG004|Run-in Period|Protocol Violation|0|||
124963813|NCT01475461|449495767|FG005|Run-in Period|Protocol Violation|0|||
124963814|NCT01475461|449495768|FG006|Run-in Period|Protocol Violation|0|||
124963815|NCT01475461|449495762|FG000|Treatment Period|Death|0|||
124963816|NCT01475461|449495763|FG001|Treatment Period|Death|0|||
124963817|NCT01475461|449495764|FG002|Treatment Period|Death|0|||
125215910|NCT05052697|450417551|FG031|Substudy A|No longer met eligibility criteria|0|||
125215911|NCT05052697|450417552|FG032|Substudy A|No longer met eligibility criteria|0|||
125215912|NCT05052697|450417553|FG033|Substudy A|No longer met eligibility criteria|0|||
124963818|NCT01475461|449495765|FG003|Treatment Period|Death|1|||
124963819|NCT01475461|449495766|FG004|Treatment Period|Death|0|||
124963820|NCT01475461|449495767|FG005|Treatment Period|Death|0|||
124963821|NCT01475461|449495768|FG006|Treatment Period|Death|0|||
124963822|NCT01475461|449495762|FG000|Treatment Period|Lost to Follow-up|0|||
124963823|NCT01475461|449495763|FG001|Treatment Period|Lost to Follow-up|3|||
124963824|NCT01475461|449495764|FG002|Treatment Period|Lost to Follow-up|2|||
124963825|NCT01475461|449495765|FG003|Treatment Period|Lost to Follow-up|3|||
125215913|NCT05052697|450417520|FG000|Substudy A|Not vaccinated|0|||
125215914|NCT05052697|450417521|FG001|Substudy A|Not vaccinated|0|||
125215915|NCT05052697|450417522|FG002|Substudy A|Not vaccinated|0|||
124963826|NCT01475461|449495766|FG004|Treatment Period|Lost to Follow-up|1|||
124963827|NCT01475461|449495767|FG005|Treatment Period|Lost to Follow-up|2|||
124963828|NCT01475461|449495768|FG006|Treatment Period|Lost to Follow-up|1|||
124963829|NCT01475461|449495762|FG000|Treatment Period|Withdrawal by Subject|0|||
124963830|NCT01475461|449495763|FG001|Treatment Period|Withdrawal by Subject|2|||
124963831|NCT01475461|449495764|FG002|Treatment Period|Withdrawal by Subject|2|||
124963832|NCT01475461|449495765|FG003|Treatment Period|Withdrawal by Subject|0|||
124963833|NCT01475461|449495766|FG004|Treatment Period|Withdrawal by Subject|2|||
124963834|NCT01475461|449495767|FG005|Treatment Period|Withdrawal by Subject|2|||
124963835|NCT01475461|449495768|FG006|Treatment Period|Withdrawal by Subject|0|||
124963836|NCT01475461|449495762|FG000|Treatment Period|Other|0|||
124963837|NCT01475461|449495763|FG001|Treatment Period|Other|1|||
124963838|NCT01475461|449495764|FG002|Treatment Period|Other|0|||
124963839|NCT01475461|449495765|FG003|Treatment Period|Other|0|||
124963840|NCT01475461|449495766|FG004|Treatment Period|Other|0|||
124963841|NCT01475461|449495767|FG005|Treatment Period|Other|0|||
124963842|NCT01475461|449495768|FG006|Treatment Period|Other|0|||
124963843|NCT01475461|449495762|FG000|Treatment Period|Protocol Violation|0|||
124963844|NCT01475461|449495763|FG001|Treatment Period|Protocol Violation|1|||
124963845|NCT01475461|449495764|FG002|Treatment Period|Protocol Violation|0|||
124963846|NCT01475461|449495765|FG003|Treatment Period|Protocol Violation|0|||
124963847|NCT01475461|449495766|FG004|Treatment Period|Protocol Violation|0|||
124963848|NCT01475461|449495767|FG005|Treatment Period|Protocol Violation|0|||
124963849|NCT01475461|449495768|FG006|Treatment Period|Protocol Violation|1|||
124963850|NCT01475461|449495762|FG000|Treatment Period|Lack of Efficacy|0|||
124963851|NCT01475461|449495763|FG001|Treatment Period|Lack of Efficacy|2|||
124963852|NCT01475461|449495764|FG002|Treatment Period|Lack of Efficacy|0|||
124963853|NCT01475461|449495765|FG003|Treatment Period|Lack of Efficacy|2|||
124963854|NCT01475461|449495766|FG004|Treatment Period|Lack of Efficacy|1|||
124963855|NCT01475461|449495767|FG005|Treatment Period|Lack of Efficacy|1|||
124963856|NCT01475461|449495768|FG006|Treatment Period|Lack of Efficacy|0|||
124963857|NCT01475461|449495762|FG000|Treatment Period|Medication Error|0|||
124963858|NCT01475461|449495763|FG001|Treatment Period|Medication Error|0|||
124963859|NCT01475461|449495764|FG002|Treatment Period|Medication Error|0|||
124963860|NCT01475461|449495765|FG003|Treatment Period|Medication Error|1|||
124963861|NCT01475461|449495766|FG004|Treatment Period|Medication Error|0|||
124963862|NCT01475461|449495767|FG005|Treatment Period|Medication Error|0|||
124963863|NCT01475461|449495768|FG006|Treatment Period|Medication Error|0|||
124963864|NCT01475461|449495762|FG000|Treatment Period|Adverse Event|0|||
124963865|NCT01475461|449495763|FG001|Treatment Period|Adverse Event|0|||
124963866|NCT01475461|449495764|FG002|Treatment Period|Adverse Event|0|||
124963867|NCT01475461|449495765|FG003|Treatment Period|Adverse Event|1|||
124963868|NCT01475461|449495766|FG004|Treatment Period|Adverse Event|0|||
124963869|NCT01475461|449495767|FG005|Treatment Period|Adverse Event|0|||
124963870|NCT01475461|449495768|FG006|Treatment Period|Adverse Event|0|||
124963871|NCT02512861|449495771|FG000|Overall Study|Protocol Violation|3|||
124963872|NCT02512861|449495772|FG001|Overall Study|Protocol Violation|7|||
124963873|NCT02512861|449495771|FG000|Overall Study|Physician Decision|3|||
124963874|NCT02512861|449495772|FG001|Overall Study|Physician Decision|1|||
124963875|NCT02512861|449495771|FG000|Overall Study|Withdrawal by Subject|0|||
124963876|NCT02512861|449495772|FG001|Overall Study|Withdrawal by Subject|1|||
124963877|NCT01774019|449495773|FG000|Overall Study|No longer meets protocol criteria|2|||
124963878|NCT01774019|449495774|FG001|Overall Study|No longer meets protocol criteria|0|||
124963879|NCT01774019|449495773|FG000|Overall Study|Withdrawal by Subject|1|||
124963880|NCT01774019|449495774|FG001|Overall Study|Withdrawal by Subject|0|||
124963881|NCT01774019|449495773|FG000|Overall Study|Surgery delayed > 120 days|1|||
124963882|NCT01774019|449495774|FG001|Overall Study|Surgery delayed > 120 days|0|||
124963883|NCT01774019|449495773|FG000|Overall Study|Patient refused surgery|1|||
124963884|NCT01774019|449495774|FG001|Overall Study|Patient refused surgery|1|||
124963885|NCT01774019|449495773|FG000|Overall Study|Unable to implant study device|1|||
124963886|NCT01774019|449495774|FG001|Overall Study|Unable to implant study device|0|||
124963887|NCT01774019|449495773|FG000|Overall Study|Lost to Follow-up|0|||
124963888|NCT01774019|449495774|FG001|Overall Study|Lost to Follow-up|3|||
124963889|NCT03214250|449495777|FG000|Overall Study|Death|5|||
124963890|NCT03214250|449495778|FG001|Overall Study|Death|5|||
124963891|NCT03214250|449495779|FG002|Overall Study|Death|7|||
124963892|NCT03214250|449495780|FG003|Overall Study|Death|4|||
124963893|NCT03214250|449495781|FG004|Overall Study|Death|23|||
124963894|NCT03214250|449495782|FG005|Overall Study|Death|23|||
124963895|NCT03214250|449495783|FG006|Overall Study|Death|24|||
124963896|NCT03214250|449495777|FG000|Overall Study|Lost to Follow-up|0|||
124963897|NCT03214250|449495778|FG001|Overall Study|Lost to Follow-up|0|||
124963898|NCT03214250|449495779|FG002|Overall Study|Lost to Follow-up|0|||
124963899|NCT03214250|449495780|FG003|Overall Study|Lost to Follow-up|1|||
124963900|NCT03214250|449495781|FG004|Overall Study|Lost to Follow-up|1|||
124963901|NCT03214250|449495782|FG005|Overall Study|Lost to Follow-up|2|||
125215916|NCT05052697|450417523|FG003|Substudy A|Not vaccinated|1|||
124963902|NCT03214250|449495783|FG006|Overall Study|Lost to Follow-up|0|||
124963903|NCT03214250|449495777|FG000|Overall Study|Other|0|||
124963904|NCT03214250|449495778|FG001|Overall Study|Other|0|||
124963905|NCT03214250|449495779|FG002|Overall Study|Other|0|||
124963906|NCT03214250|449495780|FG003|Overall Study|Other|0|||
124963907|NCT03214250|449495781|FG004|Overall Study|Other|1|||
124963908|NCT03214250|449495782|FG005|Overall Study|Other|1|||
124963909|NCT03214250|449495783|FG006|Overall Study|Other|2|||
124963910|NCT03214250|449495777|FG000|Overall Study|Remains on Study|2|||
124963911|NCT03214250|449495778|FG001|Overall Study|Remains on Study|2|||
124963912|NCT03214250|449495779|FG002|Overall Study|Remains on Study|0|||
124963913|NCT03214250|449495780|FG003|Overall Study|Remains on Study|1|||
124963914|NCT03214250|449495781|FG004|Overall Study|Remains on Study|7|||
124963915|NCT03214250|449495782|FG005|Overall Study|Remains on Study|5|||
124963916|NCT03214250|449495783|FG006|Overall Study|Remains on Study|3|||
124963917|NCT03214250|449495777|FG000|Overall Study|Withdrawal by Subject|0|||
124963918|NCT03214250|449495778|FG001|Overall Study|Withdrawal by Subject|0|||
124963919|NCT03214250|449495779|FG002|Overall Study|Withdrawal by Subject|1|||
124963920|NCT03214250|449495780|FG003|Overall Study|Withdrawal by Subject|2|||
124963921|NCT03214250|449495781|FG004|Overall Study|Withdrawal by Subject|5|||
124963922|NCT03214250|449495782|FG005|Overall Study|Withdrawal by Subject|0|||
124963923|NCT03214250|449495783|FG006|Overall Study|Withdrawal by Subject|2|||
124963924|NCT03463577|449495789|FG000|Overall Study|Lost to Follow-up|238|||
124963925|NCT03463577|449495790|FG001|Overall Study|Lost to Follow-up|435|||
124963926|NCT03463577|449495791|FG002|Overall Study|Lost to Follow-up|0|||
124963927|NCT03463577|449495792|FG003|Overall Study|Lost to Follow-up|0|||
124963928|NCT03463577|449495793|FG004|Overall Study|Lost to Follow-up|0|||
124963929|NCT03463577|449495794|FG005|Overall Study|Lost to Follow-up|0|||
124963930|NCT03463577|449495789|FG000|Overall Study|With unknown pregnancy outcome|0|||
124963931|NCT03463577|449495790|FG001|Overall Study|With unknown pregnancy outcome|5|||
124963932|NCT03463577|449495791|FG002|Overall Study|With unknown pregnancy outcome|0|||
124963933|NCT03463577|449495792|FG003|Overall Study|With unknown pregnancy outcome|0|||
124963934|NCT03463577|449495793|FG004|Overall Study|With unknown pregnancy outcome|0|||
124963935|NCT03463577|449495794|FG005|Overall Study|With unknown pregnancy outcome|0|||
124963936|NCT03463577|449495789|FG000|Overall Study|Maternal death|2|||
124963937|NCT03463577|449495790|FG001|Overall Study|Maternal death|0|||
124963938|NCT03463577|449495791|FG002|Overall Study|Maternal death|0|||
124963939|NCT03463577|449495792|FG003|Overall Study|Maternal death|0|||
124963940|NCT03463577|449495793|FG004|Overall Study|Maternal death|0|||
124963941|NCT03463577|449495794|FG005|Overall Study|Maternal death|0|||
124963942|NCT03463577|449495789|FG000|Overall Study|Neonatal death|0|||
124963943|NCT03463577|449495790|FG001|Overall Study|Neonatal death|0|||
124963944|NCT03463577|449495791|FG002|Overall Study|Neonatal death|0|||
124963945|NCT03463577|449495792|FG003|Overall Study|Neonatal death|15|||
124963946|NCT03463577|449495793|FG004|Overall Study|Neonatal death|17|||
124963947|NCT03463577|449495794|FG005|Overall Study|Neonatal death|0|||
124963948|NCT00292981|449495796|FG000|Overall Study|Adverse Event|1|||
124963949|NCT00292981|449495796|FG000|Overall Study|Lost to Follow-up|13|||
124963950|NCT00292981|449495796|FG000|Overall Study|Withdrawal by Subject|22|||
124963951|NCT00292981|449495796|FG000|Overall Study|Other|3|||
124963952|NCT00594178|449495797|FG000|Overall Study|Physician Decision|5|||
124963953|NCT02172950|449495798|FG000|Overall Study|Physician Decision|3|||
124963954|NCT02172950|449495799|FG001|Overall Study|Physician Decision|3|||
124963955|NCT02172950|449495798|FG000|Overall Study|Lack of Efficacy|1|||
124963956|NCT02172950|449495799|FG001|Overall Study|Lack of Efficacy|0|||
124963957|NCT02172950|449495798|FG000|Overall Study|Adverse Event|4|||
124963958|NCT02172950|449495799|FG001|Overall Study|Adverse Event|1|||
124963959|NCT02172950|449495798|FG000|Overall Study|Withdrawal by Subject|10|||
124963960|NCT02172950|449495799|FG001|Overall Study|Withdrawal by Subject|0|||
124963961|NCT02172950|449495798|FG000|Overall Study|Protocol Violation|1|||
124963962|NCT02172950|449495799|FG001|Overall Study|Protocol Violation|0|||
124963963|NCT02172950|449495798|FG000|Overall Study|Lost to Follow-up|1|||
124963964|NCT02172950|449495799|FG001|Overall Study|Lost to Follow-up|0|||
124963965|NCT02172950|449495798|FG000|Overall Study|Death|1|||
124963966|NCT02172950|449495799|FG001|Overall Study|Death|0|||
124963967|NCT02172950|449495798|FG000|Overall Study|Patient traveling|1|||
124963968|NCT02172950|449495799|FG001|Overall Study|Patient traveling|0|||
124963969|NCT02172950|449495798|FG000|Overall Study|Patient went to other country|1|||
125215917|NCT05052697|450417524|FG004|Substudy A|Not vaccinated|0|||
125215918|NCT05052697|450417525|FG005|Substudy A|Not vaccinated|0|||
125215919|NCT05052697|450417526|FG006|Substudy A|Not vaccinated|0|||
124963970|NCT02172950|449495799|FG001|Overall Study|Patient went to other country|0|||
125215920|NCT05052697|450417527|FG007|Substudy A|Not vaccinated|0|||
124963971|NCT02172950|449495798|FG000|Overall Study|Patient relocated overseas|1|||
124963972|NCT02172950|449495799|FG001|Overall Study|Patient relocated overseas|1|||
124963973|NCT02172950|449495798|FG000|Overall Study|Patient moving|1|||
124963974|NCT02172950|449495799|FG001|Overall Study|Patient moving|0|||
124963975|NCT00496626|449495800|FG000|Overall Study|Lost to Follow-up|0|||
125215921|NCT05052697|450417528|FG008|Substudy A|Not vaccinated|1|||
125215922|NCT05052697|450417529|FG009|Substudy A|Not vaccinated|0|||
125215923|NCT05052697|450417530|FG010|Substudy A|Not vaccinated|0|||
124963976|NCT00496626|449495801|FG001|Overall Study|Lost to Follow-up|1|||
124963977|NCT00496626|449495800|FG000|Overall Study|Protocol Violation|1|||
124963978|NCT00496626|449495801|FG001|Overall Study|Protocol Violation|0|||
125215924|NCT05052697|450417531|FG011|Substudy A|Not vaccinated|0|||
124963979|NCT00496626|449495800|FG000|Overall Study|Withdrawal by Subject|5|||
124963980|NCT00496626|449495801|FG001|Overall Study|Withdrawal by Subject|4|||
124963981|NCT00496626|449495800|FG000|Overall Study|Relocated|0|||
124963982|NCT00496626|449495801|FG001|Overall Study|Relocated|1|||
124963983|NCT00611715|449495802|FG000|Overall Study|Disease Progression|24|||
124963984|NCT00611715|449495803|FG001|Overall Study|Disease Progression|4|||
124963985|NCT00611715|449495802|FG000|Overall Study|Withdrawal by Subject|5|||
124963986|NCT00611715|449495803|FG001|Overall Study|Withdrawal by Subject|1|||
124963987|NCT00611715|449495802|FG000|Overall Study|Adverse Event|9|||
124963988|NCT00611715|449495803|FG001|Overall Study|Adverse Event|1|||
124963989|NCT00611715|449495802|FG000|Overall Study|Death|1|||
124963990|NCT00611715|449495803|FG001|Overall Study|Death|0|||
124963991|NCT00611715|449495802|FG000|Overall Study|two patients are still on treatment|2|||
124963992|NCT00611715|449495803|FG001|Overall Study|two patients are still on treatment|0|||
124963993|NCT00107978|449495804|FG000|Overall Study|Adverse Event|1|||
124963994|NCT00107978|449495805|FG001|Overall Study|Adverse Event|5|||
124963995|NCT00107978|449495804|FG000|Overall Study|Death|3|||
124963996|NCT00107978|449495805|FG001|Overall Study|Death|3|||
124963997|NCT00107978|449495804|FG000|Overall Study|Lost to Follow-up|20|||
124963998|NCT00107978|449495805|FG001|Overall Study|Lost to Follow-up|28|||
124963999|NCT00107978|449495804|FG000|Overall Study|Withdrawal by Subject|4|||
124964000|NCT00107978|449495805|FG001|Overall Study|Withdrawal by Subject|9|||
124964001|NCT00107978|449495804|FG000|Overall Study|Protocol Violation|0|||
124964002|NCT00107978|449495805|FG001|Overall Study|Protocol Violation|1|||
124964003|NCT00107978|449495804|FG000|Overall Study|Other|5|||
124964004|NCT00107978|449495805|FG001|Overall Study|Other|4|||
124964005|NCT00727415|449495806|FG000|Phase I|Dose Limiting Toxicity|2|||
124964006|NCT04191148|449495808|FG000|Overall Study|Withdrawal by Subject|1|||
124964007|NCT04191148|449495809|FG001|Overall Study|Withdrawal by Subject|0|||
124964008|NCT04191148|449495808|FG000|Overall Study|Adverse Event|1|||
124964009|NCT04191148|449495809|FG001|Overall Study|Adverse Event|0|||
124964010|NCT01274559|449495814|FG000|Overall Study|Adverse Event|57|||
124964011|NCT01274559|449495815|FG001|Overall Study|Adverse Event|13|||
124964012|NCT01274559|449495814|FG000|Overall Study|Death|1|||
124964013|NCT01274559|449495815|FG001|Overall Study|Death|1|||
124964014|NCT01274559|449495814|FG000|Overall Study|Lost to Follow-up|3|||
124964015|NCT01274559|449495815|FG001|Overall Study|Lost to Follow-up|3|||
124964016|NCT01274559|449495814|FG000|Overall Study|Non-compliance with Study Drug|2|||
124964017|NCT01274559|449495815|FG001|Overall Study|Non-compliance with Study Drug|4|||
124964018|NCT01274559|449495814|FG000|Overall Study|Physician Decision|2|||
124964019|NCT01274559|449495815|FG001|Overall Study|Physician Decision|1|||
124964020|NCT01274559|449495814|FG000|Overall Study|Protocol Violation|28|||
124964021|NCT01274559|449495815|FG001|Overall Study|Protocol Violation|23|||
124964022|NCT01274559|449495814|FG000|Overall Study|Study Terminated by Sponsor|79|||
124964023|NCT01274559|449495815|FG001|Overall Study|Study Terminated by Sponsor|87|||
124964024|NCT01274559|449495814|FG000|Overall Study|Withdrawal by Subject|25|||
124964025|NCT01274559|449495815|FG001|Overall Study|Withdrawal by Subject|13|||
124964026|NCT02971228|449495816|FG000|Overall Study|Withdrawal by Subject|1|||
124964027|NCT02971228|449495817|FG001|Overall Study|Withdrawal by Subject|1|||
124964028|NCT02971228|449495818|FG002|Overall Study|Withdrawal by Subject|0|||
124964029|NCT02971228|449495819|FG003|Overall Study|Withdrawal by Subject|0|||
124964030|NCT02971228|449495820|FG004|Overall Study|Withdrawal by Subject|0|||
124964031|NCT02971228|449495816|FG000|Overall Study|Logistical challenges|0|||
124964032|NCT02971228|449495817|FG001|Overall Study|Logistical challenges|1|||
124964033|NCT02971228|449495818|FG002|Overall Study|Logistical challenges|0|||
124964034|NCT02971228|449495819|FG003|Overall Study|Logistical challenges|0|||
124964035|NCT02971228|449495820|FG004|Overall Study|Logistical challenges|0|||
124964036|NCT01664923|449495821|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
124964037|NCT01664923|449495822|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
124964038|NCT01664923|449495821|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
124964039|NCT01664923|449495822|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
124964040|NCT01664923|449495821|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
125129422|NCT03897088|450099335|FG000|Overall Study|Lost to Follow-up|7|||
125129423|NCT03897088|450099336|FG001|Overall Study|Lost to Follow-up|15|||
124964041|NCT01664923|449495822|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
124964042|NCT01664923|449495821|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
124964043|NCT01664923|449495822|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
124964044|NCT01664923|449495821|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
124964045|NCT01664923|449495822|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
124964046|NCT01664923|449495821|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
124964047|NCT01664923|449495822|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
124964048|NCT01664923|449495821|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
124964049|NCT01664923|449495822|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
124964050|NCT01664923|449495821|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
124964051|NCT01664923|449495822|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
124964052|NCT01664923|449495821|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
124964053|NCT01664923|449495822|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
124964054|NCT01664923|449495821|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
124964055|NCT01664923|449495822|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
124964056|NCT01664923|449495821|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
125129424|NCT03897088|450099335|FG000|Overall Study|Sponsor Decision|1|||
125129425|NCT03897088|450099336|FG001|Overall Study|Sponsor Decision|2|||
125129426|NCT03897088|450099335|FG000|Overall Study|COVID-19|2|||
125129427|NCT03897088|450099336|FG001|Overall Study|COVID-19|0|||
125129428|NCT03897088|450099335|FG000|Overall Study|Other|3|||
124964057|NCT01664923|449495822|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
124964058|NCT01664923|449495821|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
124964059|NCT01664923|449495822|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
124964060|NCT01664923|449495821|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
124964061|NCT01664923|449495822|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
124964062|NCT01664923|449495821|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
124964063|NCT01664923|449495822|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
124964064|NCT03409731|449495827|FG000|Overall Study|Withdrawal by Subject|17|||
124964065|NCT03409731|449495827|FG000|Overall Study|Death|4|||
124964066|NCT00827775|449495832|FG000|Overall Study|Withdrawal by Subject|0|||
124964067|NCT00827775|449495833|FG001|Overall Study|Withdrawal by Subject|5|||
124964068|NCT02427958|449495834|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
124964069|NCT02427958|449495834|FG000|Overall Study|Lost to Follow-up|6|||
124964070|NCT02427958|449495834|FG000|Overall Study|Withdrawal by Subject|14|||
124964071|NCT02427958|449495834|FG000|Overall Study|Lack of Efficacy|1|||
124964072|NCT03410108|449495835|FG000|Overall Study|Ongoing|41|||
124964073|NCT03410108|449495835|FG000|Overall Study|Adverse Event|4|||
124964074|NCT03410108|449495835|FG000|Overall Study|Progressive Disease|58|||
124964075|NCT03410108|449495835|FG000|Overall Study|Withdrawal by Subject|1|||
124964076|NCT01013740|449495838|FG000|Overall Study|Lost to Follow-up|3|||
124964077|NCT01013740|449495839|FG001|Overall Study|Lost to Follow-up|5|||
124964078|NCT01013740|449495838|FG000|Overall Study|Physician Decision|2|||
124964079|NCT01013740|449495839|FG001|Overall Study|Physician Decision|0|||
124964080|NCT01013740|449495838|FG000|Overall Study|Withdrawal by Subject|2|||
124964081|NCT01013740|449495839|FG001|Overall Study|Withdrawal by Subject|10|||
124964082|NCT01013740|449495838|FG000|Overall Study|study close / terminated : done in error|2|||
124964083|NCT01013740|449495839|FG001|Overall Study|study close / terminated : done in error|1|||
124964084|NCT01013740|449495838|FG000|Overall Study|Missing|2|||
124964085|NCT01013740|449495839|FG001|Overall Study|Missing|1|||
125129429|NCT03897088|450099336|FG001|Overall Study|Other|0|||
125129430|NCT03897088|450099335|FG000|Overall Study|Non-compliance with Study Drug|1|||
125129431|NCT03897088|450099336|FG001|Overall Study|Non-compliance with Study Drug|1|||
125129432|NCT03897088|450099335|FG000|Overall Study|Pregnancy|0|||
125129433|NCT03897088|450099336|FG001|Overall Study|Pregnancy|1|||
125129434|NCT00855738|450099337|FG000|Overall Study|Lost to Follow-up|2|||
125129435|NCT00855738|450099337|FG000|Overall Study|Adverse Event|1|||
125129436|NCT00855738|450099337|FG000|Overall Study|Subject Defaulted|1|||
125129437|NCT00855738|450099337|FG000|Overall Study|Death|1|||
125129438|NCT02392000|450099340|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
125129439|NCT02392000|450099340|FG000|Overall Study|Withdrawal by Subject|1|||
125129440|NCT02392000|450099340|FG000|Overall Study|Lost to Follow-up|8|||
125215925|NCT05052697|450417532|FG012|Substudy A|Not vaccinated|0|||
124964086|NCT01013740|449495838|FG000|Overall Study|Ongoing: Study records not completed|0|||
125129441|NCT04384978|450099341|FG000|Overall Study|Withdrawal by Subject|4|||
125129442|NCT04384978|450099342|FG001|Overall Study|Withdrawal by Subject|0|||
124964087|NCT01013740|449495839|FG001|Overall Study|Ongoing: Study records not completed|2|||
124964088|NCT00338949|449495840|FG000|Subject Screening|Screen failures|11|||
124964089|NCT00338949|449495841|FG001|Subject Screening|Screen failures|11|||
124964090|NCT00338949|449495840|FG000|Randomization|Withdrawal by Subject|1|||
124964091|NCT00338949|449495841|FG001|Randomization|Withdrawal by Subject|0|||
124964092|NCT00338949|449495840|FG000|Randomization|Adverse Event|0|||
124964093|NCT00338949|449495841|FG001|Randomization|Adverse Event|5|||
124964094|NCT00025662|449495842|FG000|Overall Study|Withdrawal by Subject|2|||
124964095|NCT00025662|449495842|FG000|Overall Study|Technical failure of manipulation|1|||
124964096|NCT00582114|449495843|FG000|Overall Study|Death|4|||
124964097|NCT00582114|449495844|FG001|Overall Study|Death|4|||
124964098|NCT00582114|449495843|FG000|Overall Study|Kidney Transplant|3|||
124964099|NCT00582114|449495844|FG001|Overall Study|Kidney Transplant|1|||
124964100|NCT00582114|449495843|FG000|Overall Study|Lost to Follow-up|7|||
124964101|NCT00582114|449495844|FG001|Overall Study|Lost to Follow-up|6|||
124964102|NCT00582114|449495843|FG000|Overall Study|Withdrawal by Subject|8|||
124964103|NCT00582114|449495844|FG001|Overall Study|Withdrawal by Subject|16|||
124964104|NCT00582114|449495843|FG000|Overall Study|Adverse Event|1|||
124964105|NCT00582114|449495844|FG001|Overall Study|Adverse Event|1|||
124964106|NCT00582114|449495843|FG000|Overall Study|Physician Decision|0|||
124964107|NCT00582114|449495844|FG001|Overall Study|Physician Decision|6|||
124964108|NCT00582114|449495843|FG000|Overall Study|Stopped by data safety monitoring board|19|||
124964109|NCT00582114|449495844|FG001|Overall Study|Stopped by data safety monitoring board|20|||
124964110|NCT02604342|449495845|FG000|Overall Study|Death|32|||
124964111|NCT02604342|449495846|FG001|Overall Study|Death|16|||
124964112|NCT02604342|449495845|FG000|Overall Study|Progression of disease|1|||
124964113|NCT02604342|449495846|FG001|Overall Study|Progression of disease|0|||
124964114|NCT02604342|449495845|FG000|Overall Study|Withdrawal by Subject|5|||
124964115|NCT02604342|449495846|FG001|Overall Study|Withdrawal by Subject|6|||
124964116|NCT02604342|449495845|FG000|Overall Study|Other|1|||
124964117|NCT02604342|449495846|FG001|Overall Study|Other|0|||
124964118|NCT02604342|449495845|FG000|Overall Study|Study Termination by Sponsor|1|||
124964119|NCT02604342|449495846|FG001|Overall Study|Study Termination by Sponsor|0|||
124964120|NCT02604342|449495845|FG000|Overall Study|Lost to Follow-up|1|||
124964121|NCT02604342|449495846|FG001|Overall Study|Lost to Follow-up|1|||
124964122|NCT02604342|449495845|FG000|Overall Study|Physician Decision|2|||
124964123|NCT02604342|449495846|FG001|Overall Study|Physician Decision|0|||
124964124|NCT00130728|449495847|FG000|Overall Study|Death|258|||
124964125|NCT00130728|449495848|FG001|Overall Study|Death|258|||
124964126|NCT00130728|449495847|FG000|Overall Study|Lost to Follow-up|4|||
124964127|NCT00130728|449495848|FG001|Overall Study|Lost to Follow-up|0|||
124964128|NCT00130728|449495847|FG000|Overall Study|Withdrawal by Subject|0|||
124964129|NCT00130728|449495848|FG001|Overall Study|Withdrawal by Subject|2|||
124964130|NCT02881047|449495851|FG000|Overall Study|Adverse Event|1|||
124964131|NCT02881047|449495851|FG000|Overall Study|Withdrawal by Subject|1|||
124964132|NCT03028012|449495852|FG000|Overall Study|Lost to Follow-up|2|||
124964133|NCT03028012|449495853|FG001|Overall Study|Lost to Follow-up|3|||
124964134|NCT03028012|449495854|FG002|Overall Study|Lost to Follow-up|3|||
124964135|NCT02484547|449495863|FG000|Placebo-Controlled Period|Adverse Event|10|||
124964136|NCT02484547|449495864|FG001|Placebo-Controlled Period|Adverse Event|13|||
124964137|NCT02484547|449495865|FG002|Placebo-Controlled Period|Adverse Event|20|||
124964138|NCT02484547|449495866|FG003|Placebo-Controlled Period|Adverse Event|0|||
124964139|NCT02484547|449495867|FG004|Placebo-Controlled Period|Adverse Event|0|||
124964140|NCT02484547|449495868|FG005|Placebo-Controlled Period|Adverse Event|0|||
124964141|NCT02484547|449495869|FG006|Placebo-Controlled Period|Adverse Event|0|||
124964142|NCT02484547|449495863|FG000|Placebo-Controlled Period|Change of Treatment|0|||
124964143|NCT02484547|449495864|FG001|Placebo-Controlled Period|Change of Treatment|0|||
124964144|NCT02484547|449495865|FG002|Placebo-Controlled Period|Change of Treatment|1|||
124964145|NCT02484547|449495866|FG003|Placebo-Controlled Period|Change of Treatment|0|||
124964146|NCT02484547|449495867|FG004|Placebo-Controlled Period|Change of Treatment|0|||
124964147|NCT02484547|449495868|FG005|Placebo-Controlled Period|Change of Treatment|0|||
124964148|NCT02484547|449495869|FG006|Placebo-Controlled Period|Change of Treatment|0|||
124964149|NCT02484547|449495863|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
124964150|NCT02484547|449495864|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
124964151|NCT02484547|449495865|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
124964152|NCT02484547|449495866|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
124964153|NCT02484547|449495867|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
124964154|NCT02484547|449495868|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
124964155|NCT02484547|449495869|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
124964156|NCT02484547|449495863|FG000|Placebo-Controlled Period|Death|5|||
124964157|NCT02484547|449495864|FG001|Placebo-Controlled Period|Death|0|||
124964158|NCT02484547|449495865|FG002|Placebo-Controlled Period|Death|6|||
124964159|NCT02484547|449495866|FG003|Placebo-Controlled Period|Death|0|||
125129443|NCT03725605|450099343|FG000|Overall Study|Unsuccessful TIL expansion|2|||
125129444|NCT03555305|450099344|FG000|Period 1|Physician Decision|0|||
125129445|NCT03555305|450099345|FG001|Period 1|Physician Decision|1|||
125129446|NCT03555305|450099344|FG000|Period 1|Adverse Event|0|||
124964160|NCT02484547|449495867|FG004|Placebo-Controlled Period|Death|0|||
124964161|NCT02484547|449495868|FG005|Placebo-Controlled Period|Death|0|||
124964162|NCT02484547|449495869|FG006|Placebo-Controlled Period|Death|0|||
124964163|NCT02484547|449495863|FG000|Placebo-Controlled Period|Disease Progression|2|||
124964164|NCT02484547|449495864|FG001|Placebo-Controlled Period|Disease Progression|0|||
124964165|NCT02484547|449495865|FG002|Placebo-Controlled Period|Disease Progression|1|||
124964166|NCT02484547|449495866|FG003|Placebo-Controlled Period|Disease Progression|0|||
124964167|NCT02484547|449495867|FG004|Placebo-Controlled Period|Disease Progression|0|||
124964168|NCT02484547|449495868|FG005|Placebo-Controlled Period|Disease Progression|0|||
124964169|NCT02484547|449495869|FG006|Placebo-Controlled Period|Disease Progression|0|||
124964170|NCT02484547|449495863|FG000|Placebo-Controlled Period|Investigator Decision|2|||
124964171|NCT02484547|449495864|FG001|Placebo-Controlled Period|Investigator Decision|2|||
124964172|NCT02484547|449495865|FG002|Placebo-Controlled Period|Investigator Decision|5|||
124964173|NCT02484547|449495866|FG003|Placebo-Controlled Period|Investigator Decision|0|||
124964174|NCT02484547|449495867|FG004|Placebo-Controlled Period|Investigator Decision|0|||
124964175|NCT02484547|449495868|FG005|Placebo-Controlled Period|Investigator Decision|0|||
124964176|NCT02484547|449495869|FG006|Placebo-Controlled Period|Investigator Decision|0|||
124964177|NCT02484547|449495863|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
124964178|NCT02484547|449495864|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
124964179|NCT02484547|449495865|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
124964180|NCT02484547|449495866|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
124964181|NCT02484547|449495867|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
124964182|NCT02484547|449495868|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
124964183|NCT02484547|449495869|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
124964184|NCT02484547|449495863|FG000|Placebo-Controlled Period|Relocation|1|||
125129447|NCT03555305|450099345|FG001|Period 1|Adverse Event|1|||
125129448|NCT03586726|450099353|FG000|Overall Study|Withdrawal by Subject|1|||
125129449|NCT00965185|450099354|FG000|Overall Study|Lost to Follow-up|2|||
125129450|NCT00965185|450099355|FG001|Overall Study|Lost to Follow-up|0|||
125129451|NCT00965185|450099354|FG000|Overall Study|Withdrawal by Subject|0|||
125129452|NCT00965185|450099355|FG001|Overall Study|Withdrawal by Subject|1|||
125129453|NCT02100228|450099358|FG000|Overall Study|Other|19|||
125129454|NCT02100228|450099359|FG001|Overall Study|Other|19|||
125129455|NCT02100228|450099358|FG000|Overall Study|Administrative reason|0|||
125129456|NCT02100228|450099359|FG001|Overall Study|Administrative reason|1|||
125129457|NCT02100228|450099358|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
125129458|NCT02100228|450099359|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
125129459|NCT02100228|450099358|FG000|Overall Study|Non-compliance|0|||
125129460|NCT02100228|450099359|FG001|Overall Study|Non-compliance|3|||
125129461|NCT02100228|450099358|FG000|Overall Study|Lost to Follow-up|0|||
125129462|NCT02100228|450099359|FG001|Overall Study|Lost to Follow-up|1|||
125129463|NCT02100228|450099358|FG000|Overall Study|Withdrawal by Subject|27|||
125129464|NCT02100228|450099359|FG001|Overall Study|Withdrawal by Subject|37|||
125129465|NCT02100228|450099358|FG000|Overall Study|Adverse Event|16|||
125129466|NCT02100228|450099359|FG001|Overall Study|Adverse Event|12|||
125129467|NCT02100228|450099358|FG000|Overall Study|Death|1|||
125129468|NCT02100228|450099359|FG001|Overall Study|Death|1|||
125129469|NCT02216071|450099384|FG000|Overall Study|Withdrawal by Subject|7|||
125129470|NCT02216071|450099385|FG001|Overall Study|Withdrawal by Subject|2|||
125129471|NCT02216071|450099384|FG000|Overall Study|Lost to Follow-up|3|||
125129472|NCT02216071|450099385|FG001|Overall Study|Lost to Follow-up|3|||
125129473|NCT02216071|450099384|FG000|Overall Study|Protocol Violation|3|||
125129474|NCT02216071|450099385|FG001|Overall Study|Protocol Violation|5|||
125129475|NCT02216071|450099384|FG000|Overall Study|Other|2|||
125129476|NCT02216071|450099385|FG001|Overall Study|Other|2|||
125129477|NCT00389064|450099386|FG000|Overall Study|Adverse Event|11|||
125129478|NCT00389064|450099387|FG001|Overall Study|Adverse Event|3|||
125129479|NCT00389064|450099386|FG000|Overall Study|Lack of Efficacy|3|||
125129480|NCT00389064|450099387|FG001|Overall Study|Lack of Efficacy|14|||
125129481|NCT00389064|450099386|FG000|Overall Study|Withdrawal by Subject|17|||
125129482|NCT00389064|450099387|FG001|Overall Study|Withdrawal by Subject|27|||
125129483|NCT00389064|450099386|FG000|Overall Study|Physician Decision|2|||
125129484|NCT00389064|450099387|FG001|Overall Study|Physician Decision|2|||
125129485|NCT00389064|450099386|FG000|Overall Study|Lost to Follow-up|1|||
125129486|NCT00389064|450099387|FG001|Overall Study|Lost to Follow-up|2|||
125129487|NCT00389064|450099386|FG000|Overall Study|Protocol Violation|2|||
125129488|NCT00389064|450099387|FG001|Overall Study|Protocol Violation|0|||
125129489|NCT00389064|450099386|FG000|Overall Study|Multiple Reasons|9|||
125129490|NCT00389064|450099387|FG001|Overall Study|Multiple Reasons|11|||
125129491|NCT03707912|450099396|FG000|Overall Study|Violation of inclusion criteria|1|||
125129492|NCT03707912|450099397|FG001|Overall Study|Violation of inclusion criteria|0|||
125129493|NCT01811953|450100959|FG000|Overall Study|Adverse Event|0|||
125129494|NCT01811953|450100960|FG001|Overall Study|Adverse Event|0|||
125129495|NCT01811953|450100961|FG002|Overall Study|Adverse Event|0|||
125129496|NCT01811953|450100962|FG003|Overall Study|Adverse Event|1|||
125129497|NCT01811953|450100963|FG004|Overall Study|Adverse Event|0|||
125129498|NCT01811953|450100964|FG005|Overall Study|Adverse Event|1|||
125129499|NCT01811953|450100959|FG000|Overall Study|Protocol Violation|0|||
125129500|NCT01811953|450100960|FG001|Overall Study|Protocol Violation|0|||
125129501|NCT01811953|450100961|FG002|Overall Study|Protocol Violation|0|||
124964185|NCT02484547|449495864|FG001|Placebo-Controlled Period|Relocation|1|||
124964186|NCT02484547|449495865|FG002|Placebo-Controlled Period|Relocation|1|||
124964187|NCT02484547|449495866|FG003|Placebo-Controlled Period|Relocation|0|||
124964188|NCT02484547|449495867|FG004|Placebo-Controlled Period|Relocation|0|||
124964189|NCT02484547|449495868|FG005|Placebo-Controlled Period|Relocation|0|||
124964190|NCT02484547|449495869|FG006|Placebo-Controlled Period|Relocation|0|||
124964191|NCT02484547|449495863|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
124964192|NCT02484547|449495864|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
124964193|NCT02484547|449495865|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
124964194|NCT02484547|449495866|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
124964195|NCT02484547|449495867|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
124964196|NCT02484547|449495868|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
124964197|NCT02484547|449495869|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
124964198|NCT02484547|449495863|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
124964199|NCT02484547|449495864|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
124964200|NCT02484547|449495865|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
124964201|NCT02484547|449495866|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
124964202|NCT02484547|449495867|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
124964203|NCT02484547|449495868|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
124964204|NCT02484547|449495869|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
124964205|NCT02484547|449495863|FG000|Placebo-Controlled Period|Reason not Specified|216|||
124964206|NCT02484547|449495864|FG001|Placebo-Controlled Period|Reason not Specified|194|||
124964207|NCT02484547|449495865|FG002|Placebo-Controlled Period|Reason not Specified|183|||
124964208|NCT02484547|449495866|FG003|Placebo-Controlled Period|Reason not Specified|0|||
124964209|NCT02484547|449495867|FG004|Placebo-Controlled Period|Reason not Specified|0|||
124964210|NCT02484547|449495868|FG005|Placebo-Controlled Period|Reason not Specified|0|||
124964211|NCT02484547|449495869|FG006|Placebo-Controlled Period|Reason not Specified|0|||
124964212|NCT02484547|449495863|FG000|Long-Term Extension Period|Adverse Event|0|||
124964213|NCT02484547|449495864|FG001|Long-Term Extension Period|Adverse Event|0|||
124964214|NCT02484547|449495865|FG002|Long-Term Extension Period|Adverse Event|0|||
124964215|NCT02484547|449495866|FG003|Long-Term Extension Period|Adverse Event|0|||
124964216|NCT02484547|449495867|FG004|Long-Term Extension Period|Adverse Event|1|||
124964217|NCT02484547|449495868|FG005|Long-Term Extension Period|Adverse Event|3|||
124964218|NCT02484547|449495869|FG006|Long-Term Extension Period|Adverse Event|2|||
124964219|NCT02484547|449495863|FG000|Long-Term Extension Period|Death|0|||
124964220|NCT02484547|449495864|FG001|Long-Term Extension Period|Death|0|||
124964221|NCT02484547|449495865|FG002|Long-Term Extension Period|Death|0|||
124964222|NCT02484547|449495866|FG003|Long-Term Extension Period|Death|0|||
124964223|NCT02484547|449495867|FG004|Long-Term Extension Period|Death|0|||
124964224|NCT02484547|449495868|FG005|Long-Term Extension Period|Death|3|||
124964225|NCT02484547|449495869|FG006|Long-Term Extension Period|Death|0|||
124964226|NCT02484547|449495863|FG000|Long-Term Extension Period|Disease Progression|0|||
124964227|NCT02484547|449495864|FG001|Long-Term Extension Period|Disease Progression|0|||
124964228|NCT02484547|449495865|FG002|Long-Term Extension Period|Disease Progression|0|||
124964229|NCT02484547|449495866|FG003|Long-Term Extension Period|Disease Progression|0|||
124964230|NCT02484547|449495867|FG004|Long-Term Extension Period|Disease Progression|2|||
124964231|NCT02484547|449495868|FG005|Long-Term Extension Period|Disease Progression|4|||
124964232|NCT02484547|449495869|FG006|Long-Term Extension Period|Disease Progression|0|||
124964233|NCT02484547|449495863|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
124964234|NCT02484547|449495864|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
124964235|NCT02484547|449495865|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
124964236|NCT02484547|449495866|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
124964237|NCT02484547|449495867|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
124964238|NCT02484547|449495868|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
124964239|NCT02484547|449495869|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
124964240|NCT02484547|449495863|FG000|Long-Term Extension Period|Loss of Capacity|0|||
124964241|NCT02484547|449495864|FG001|Long-Term Extension Period|Loss of Capacity|0|||
124964242|NCT02484547|449495865|FG002|Long-Term Extension Period|Loss of Capacity|0|||
124964243|NCT02484547|449495866|FG003|Long-Term Extension Period|Loss of Capacity|0|||
124964244|NCT02484547|449495867|FG004|Long-Term Extension Period|Loss of Capacity|1|||
124964245|NCT02484547|449495868|FG005|Long-Term Extension Period|Loss of Capacity|0|||
124964246|NCT02484547|449495869|FG006|Long-Term Extension Period|Loss of Capacity|0|||
125129502|NCT01811953|450100962|FG003|Overall Study|Protocol Violation|0|||
124964247|NCT02484547|449495863|FG000|Long-Term Extension Period|Change of Treatment|0|||
125129503|NCT01811953|450100963|FG004|Overall Study|Protocol Violation|1|||
125129504|NCT01811953|450100964|FG005|Overall Study|Protocol Violation|0|||
125129505|NCT00371839|450100965|FG000|Overall Study|Death|4|||
124964248|NCT02484547|449495864|FG001|Long-Term Extension Period|Change of Treatment|0|||
125129506|NCT00371839|450100966|FG001|Overall Study|Death|0|||
125215926|NCT05052697|450417533|FG013|Substudy A|Not vaccinated|0|||
125215927|NCT05052697|450417534|FG014|Substudy A|Not vaccinated|0|||
125215928|NCT05052697|450417535|FG015|Substudy A|Not vaccinated|0|||
125215929|NCT05052697|450417536|FG016|Substudy A|Not vaccinated|0|||
125215930|NCT05052697|450417537|FG017|Substudy A|Not vaccinated|0|||
125215931|NCT05052697|450417538|FG018|Substudy A|Not vaccinated|0|||
125215932|NCT05052697|450417539|FG019|Substudy A|Not vaccinated|0|||
125215933|NCT05052697|450417540|FG020|Substudy A|Not vaccinated|0|||
125215934|NCT05052697|450417541|FG021|Substudy A|Not vaccinated|0|||
125215935|NCT05052697|450417542|FG022|Substudy A|Not vaccinated|0|||
125215936|NCT05052697|450417543|FG023|Substudy A|Not vaccinated|0|||
125215937|NCT05052697|450417544|FG024|Substudy A|Not vaccinated|0|||
125215938|NCT05052697|450417545|FG025|Substudy A|Not vaccinated|0|||
125215939|NCT05052697|450417546|FG026|Substudy A|Not vaccinated|0|||
125215940|NCT05052697|450417547|FG027|Substudy A|Not vaccinated|0|||
125215941|NCT05052697|450417548|FG028|Substudy A|Not vaccinated|0|||
125215942|NCT05052697|450417549|FG029|Substudy A|Not vaccinated|0|||
125215943|NCT05052697|450417550|FG030|Substudy A|Not vaccinated|0|||
125215944|NCT05052697|450417551|FG031|Substudy A|Not vaccinated|0|||
125215945|NCT05052697|450417552|FG032|Substudy A|Not vaccinated|0|||
125215946|NCT05052697|450417553|FG033|Substudy A|Not vaccinated|0|||
125215947|NCT05052697|450417520|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215948|NCT05052697|450417521|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215949|NCT05052697|450417522|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215950|NCT05052697|450417523|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215951|NCT05052697|450417524|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215952|NCT05052697|450417525|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125129507|NCT00371839|450100967|FG002|Overall Study|Death|0|||
125129508|NCT00371839|450100965|FG000|Overall Study|Withdrawal by Subject|7|||
125129509|NCT00371839|450100966|FG001|Overall Study|Withdrawal by Subject|4|||
125129510|NCT00371839|450100967|FG002|Overall Study|Withdrawal by Subject|0|||
125129511|NCT00371839|450100965|FG000|Overall Study|Lost to Follow-up|6|||
125129512|NCT00371839|450100966|FG001|Overall Study|Lost to Follow-up|3|||
125129513|NCT00371839|450100967|FG002|Overall Study|Lost to Follow-up|2|||
125129514|NCT01049334|450100968|FG000|Overall Study|Withdrawal by Subject|5|||
125129515|NCT01049334|450100969|FG001|Overall Study|Withdrawal by Subject|3|||
125129516|NCT01049334|450100968|FG000|Overall Study|Adverse Event|2|||
125215953|NCT05052697|450417526|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215954|NCT05052697|450417527|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215955|NCT05052697|450417528|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215956|NCT05052697|450417529|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215957|NCT05052697|450417530|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215958|NCT05052697|450417531|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215959|NCT05052697|450417532|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215960|NCT05052697|450417533|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215961|NCT05052697|450417534|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215962|NCT05052697|450417535|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215963|NCT05052697|450417536|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215964|NCT05052697|450417537|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215965|NCT05052697|450417538|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
125215966|NCT05052697|450417539|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
125215967|NCT05052697|450417540|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215968|NCT05052697|450417541|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
125215969|NCT05052697|450417542|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
125215970|NCT05052697|450417543|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124964249|NCT02484547|449495865|FG002|Long-Term Extension Period|Change of Treatment|0|||
124964250|NCT02484547|449495866|FG003|Long-Term Extension Period|Change of Treatment|0|||
124964251|NCT02484547|449495867|FG004|Long-Term Extension Period|Change of Treatment|0|||
124964252|NCT02484547|449495868|FG005|Long-Term Extension Period|Change of Treatment|0|||
125129517|NCT01049334|450100969|FG001|Overall Study|Adverse Event|3|||
125215971|NCT05052697|450417544|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215972|NCT05052697|450417545|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215973|NCT05052697|450417546|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215974|NCT05052697|450417547|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215975|NCT05052697|450417548|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124964253|NCT02484547|449495869|FG006|Long-Term Extension Period|Change of Treatment|1|||
125215976|NCT05052697|450417549|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124964254|NCT02484547|449495863|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
124964255|NCT02484547|449495864|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
124964256|NCT02484547|449495865|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
124964257|NCT02484547|449495866|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
124964258|NCT02484547|449495867|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
125129518|NCT01049334|450100968|FG000|Overall Study|Physician Decision|2|||
124964259|NCT02484547|449495868|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
124964260|NCT02484547|449495869|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
124964261|NCT02484547|449495863|FG000|Long-Term Extension Period|Investigator Decision|0|||
124964262|NCT02484547|449495864|FG001|Long-Term Extension Period|Investigator Decision|0|||
124964263|NCT02484547|449495865|FG002|Long-Term Extension Period|Investigator Decision|0|||
124964264|NCT02484547|449495866|FG003|Long-Term Extension Period|Investigator Decision|2|||
124964265|NCT02484547|449495867|FG004|Long-Term Extension Period|Investigator Decision|1|||
124964266|NCT02484547|449495868|FG005|Long-Term Extension Period|Investigator Decision|0|||
124964267|NCT02484547|449495869|FG006|Long-Term Extension Period|Investigator Decision|1|||
124964268|NCT02484547|449495863|FG000|Long-Term Extension Period|Relocation|0|||
124964269|NCT02484547|449495864|FG001|Long-Term Extension Period|Relocation|0|||
124964270|NCT02484547|449495865|FG002|Long-Term Extension Period|Relocation|0|||
124964271|NCT02484547|449495866|FG003|Long-Term Extension Period|Relocation|1|||
124964272|NCT02484547|449495867|FG004|Long-Term Extension Period|Relocation|1|||
124964273|NCT02484547|449495868|FG005|Long-Term Extension Period|Relocation|0|||
124964274|NCT02484547|449495869|FG006|Long-Term Extension Period|Relocation|0|||
124964275|NCT02484547|449495863|FG000|Long-Term Extension Period|Study Visit Burden|0|||
124964276|NCT02484547|449495864|FG001|Long-Term Extension Period|Study Visit Burden|0|||
124964277|NCT02484547|449495865|FG002|Long-Term Extension Period|Study Visit Burden|0|||
124964278|NCT02484547|449495866|FG003|Long-Term Extension Period|Study Visit Burden|2|||
124964279|NCT02484547|449495867|FG004|Long-Term Extension Period|Study Visit Burden|0|||
124964280|NCT02484547|449495868|FG005|Long-Term Extension Period|Study Visit Burden|0|||
124964281|NCT02484547|449495869|FG006|Long-Term Extension Period|Study Visit Burden|3|||
124964282|NCT02484547|449495863|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
124964283|NCT02484547|449495864|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
124964284|NCT02484547|449495865|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
124964285|NCT02484547|449495866|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
124964286|NCT02484547|449495867|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
124964287|NCT02484547|449495868|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
124964288|NCT02484547|449495869|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
124964289|NCT02484547|449495863|FG000|Long-Term Extension Period|Reason not Specified|0|||
124964290|NCT02484547|449495864|FG001|Long-Term Extension Period|Reason not Specified|0|||
124964291|NCT02484547|449495865|FG002|Long-Term Extension Period|Reason not Specified|0|||
124964292|NCT02484547|449495866|FG003|Long-Term Extension Period|Reason not Specified|119|||
124964293|NCT02484547|449495867|FG004|Long-Term Extension Period|Reason not Specified|117|||
124964294|NCT02484547|449495868|FG005|Long-Term Extension Period|Reason not Specified|223|||
124964295|NCT02484547|449495869|FG006|Long-Term Extension Period|Reason not Specified|231|||
124964296|NCT01813305|449495870|FG000|Overall Study|Withdrawal by Subject|12|||
124964297|NCT01813305|449495871|FG001|Overall Study|Withdrawal by Subject|5|||
124964298|NCT01813305|449495870|FG000|Overall Study|Safety Concern|4|||
124964299|NCT01813305|449495871|FG001|Overall Study|Safety Concern|0|||
124964300|NCT01813305|449495870|FG000|Overall Study|Ulcer became worse|4|||
124964301|NCT01813305|449495871|FG001|Overall Study|Ulcer became worse|0|||
124964302|NCT01813305|449495870|FG000|Overall Study|Physician Decision|4|||
124964303|NCT01813305|449495871|FG001|Overall Study|Physician Decision|0|||
124964304|NCT01813305|449495870|FG000|Overall Study|Lost to Follow-up|3|||
124964305|NCT01813305|449495871|FG001|Overall Study|Lost to Follow-up|1|||
124964306|NCT01813305|449495870|FG000|Overall Study|Protocol Violation|1|||
124964307|NCT01813305|449495871|FG001|Overall Study|Protocol Violation|0|||
124964308|NCT01813305|449495870|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
124964309|NCT01813305|449495871|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
124964310|NCT01665599|449495875|FG000|Overall Study|Adverse Event|1|||
124964311|NCT01665599|449495875|FG000|Overall Study|Consent Withdrawn|1|||
124964312|NCT01665599|449495875|FG000|Overall Study|Investigator/Sponsor decision|1|||
124964313|NCT01665599|449495875|FG000|Overall Study|Death|1|||
124964314|NCT01665599|449495875|FG000|Overall Study|Lost to Follow-up|2|||
124964315|NCT01665599|449495875|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
124964316|NCT01665599|449495875|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
124964317|NCT01837797|449495876|FG000|Period 1|Adverse Event|9|||
124964318|NCT01837797|449495877|FG001|Period 1|Adverse Event|0|||
124964319|NCT01837797|449495878|FG002|Period 1|Adverse Event|0|||
124964320|NCT01837797|449495879|FG003|Period 1|Adverse Event|0|||
124964321|NCT01837797|449495880|FG004|Period 1|Adverse Event|0|||
124964322|NCT01837797|449495876|FG000|Period 1|Withdrawal by Subject|6|||
124964323|NCT01837797|449495877|FG001|Period 1|Withdrawal by Subject|0|||
124964324|NCT01837797|449495878|FG002|Period 1|Withdrawal by Subject|0|||
124964325|NCT01837797|449495879|FG003|Period 1|Withdrawal by Subject|0|||
124964326|NCT01837797|449495880|FG004|Period 1|Withdrawal by Subject|0|||
124964327|NCT01837797|449495876|FG000|Period 1|Administrative reasons|76|||
124964328|NCT01837797|449495877|FG001|Period 1|Administrative reasons|0|||
124964329|NCT01837797|449495878|FG002|Period 1|Administrative reasons|0|||
124964330|NCT01837797|449495879|FG003|Period 1|Administrative reasons|0|||
124964331|NCT01837797|449495880|FG004|Period 1|Administrative reasons|0|||
124964332|NCT01837797|449495876|FG000|Period 1|Withdrawal of consent before treatment|1|||
125129519|NCT01049334|450100969|FG001|Overall Study|Physician Decision|0|||
125129520|NCT01049334|450100968|FG000|Overall Study|Protocol Violation|0|||
125129521|NCT01049334|450100969|FG001|Overall Study|Protocol Violation|1|||
125129522|NCT00396279|450100970|FG000|Overall Study|Ongoing in study|26|||
125129523|NCT00396279|450100970|FG000|Overall Study|Disease progression|2|||
125129524|NCT00396279|450100970|FG000|Overall Study|Withdrawal by Subject|1|||
125129525|NCT00396279|450100970|FG000|Overall Study|Physician Decision|1|||
125129526|NCT00667095|450100978|FG000|Overall Study|Withdrawal by Subject|0|||
125129527|NCT00667095|450100979|FG001|Overall Study|Withdrawal by Subject|1|||
125129528|NCT00905346|450100983|FG000|Period 1|Withdrawal by Subject|1|||
125129529|NCT00905346|450100984|FG001|Period 1|Withdrawal by Subject|0|||
125129530|NCT03351335|450100985|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
125129531|NCT03351335|450100986|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
125129532|NCT03351335|450100987|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
125129533|NCT05612724|450100992|FG000|Overall Study|Lost to Follow-up|4|||
125129534|NCT04000815|450100995|FG000|Overall Study|Lost to Follow-up|9|||
125129535|NCT04000815|450100996|FG001|Overall Study|Lost to Follow-up|2|||
125129536|NCT04000815|450100997|FG002|Overall Study|Lost to Follow-up|3|||
125129537|NCT04000815|450100995|FG000|Overall Study|Withdrawal by Subject|4|||
124964333|NCT01837797|449495877|FG001|Period 1|Withdrawal of consent before treatment|0|||
124964334|NCT01837797|449495878|FG002|Period 1|Withdrawal of consent before treatment|0|||
124964335|NCT01837797|449495879|FG003|Period 1|Withdrawal of consent before treatment|0|||
124964336|NCT01837797|449495880|FG004|Period 1|Withdrawal of consent before treatment|0|||
124964337|NCT01837797|449495876|FG000|Period 1|Other|10|||
124964338|NCT01837797|449495877|FG001|Period 1|Other|0|||
124964339|NCT01837797|449495878|FG002|Period 1|Other|0|||
124964340|NCT01837797|449495879|FG003|Period 1|Other|0|||
124964341|NCT01837797|449495880|FG004|Period 1|Other|0|||
124964342|NCT01837797|449495876|FG000|Period 2|Administrative or other reasons|0|||
124964343|NCT01837797|449495877|FG001|Period 2|Administrative or other reasons|5|||
124964344|NCT01837797|449495878|FG002|Period 2|Administrative or other reasons|2|||
124964345|NCT01837797|449495879|FG003|Period 2|Administrative or other reasons|4|||
124964346|NCT01837797|449495880|FG004|Period 2|Administrative or other reasons|0|||
124964347|NCT01837797|449495876|FG000|Period 2|Adverse Event|0|||
124964348|NCT01837797|449495877|FG001|Period 2|Adverse Event|0|||
124964349|NCT01837797|449495878|FG002|Period 2|Adverse Event|0|||
124964350|NCT01837797|449495879|FG003|Period 2|Adverse Event|1|||
124964351|NCT01837797|449495880|FG004|Period 2|Adverse Event|0|||
124964352|NCT01837797|449495876|FG000|Period 3|Adverse Event|0|||
124964353|NCT01837797|449495877|FG001|Period 3|Adverse Event|0|||
124964354|NCT01837797|449495878|FG002|Period 3|Adverse Event|0|||
124964355|NCT01837797|449495879|FG003|Period 3|Adverse Event|0|||
124964356|NCT01837797|449495880|FG004|Period 3|Adverse Event|1|||
124964357|NCT01837797|449495876|FG000|Period 3|Administrative reasons|0|||
124964358|NCT01837797|449495877|FG001|Period 3|Administrative reasons|0|||
124964359|NCT01837797|449495878|FG002|Period 3|Administrative reasons|0|||
124964360|NCT01837797|449495879|FG003|Period 3|Administrative reasons|0|||
124964361|NCT01837797|449495880|FG004|Period 3|Administrative reasons|20|||
124964362|NCT01837797|449495876|FG000|Period 3|Other|0|||
124964363|NCT01837797|449495877|FG001|Period 3|Other|0|||
124964364|NCT01837797|449495878|FG002|Period 3|Other|0|||
124964365|NCT01837797|449495879|FG003|Period 3|Other|0|||
124964366|NCT01837797|449495880|FG004|Period 3|Other|2|||
124964367|NCT01705145|449495881|FG000|Part B|Adverse Event|1|||
124964368|NCT01503164|449495890|FG000|Overall Study|Withdrawal by Subject|2|||
124964369|NCT01503164|449495891|FG001|Overall Study|Withdrawal by Subject|1|||
124964370|NCT04088136|449495892|FG000|Overall Study|Withdrawal by Subject|5|||
124964371|NCT04088136|449495893|FG001|Overall Study|Withdrawal by Subject|0|||
124964372|NCT04088136|449495892|FG000|Overall Study|Lack of Efficacy|0|||
124964373|NCT04088136|449495893|FG001|Overall Study|Lack of Efficacy|1|||
125129538|NCT04000815|450100996|FG001|Overall Study|Withdrawal by Subject|3|||
125129539|NCT04000815|450100997|FG002|Overall Study|Withdrawal by Subject|2|||
124964374|NCT00143598|449495902|FG000|Overall Study|Lost to Follow-up|23|||
124964375|NCT00143598|449495903|FG001|Overall Study|Lost to Follow-up|21|||
124964376|NCT00143598|449495902|FG000|Overall Study|Withdrawal by Subject|33|||
124964377|NCT00143598|449495903|FG001|Overall Study|Withdrawal by Subject|37|||
124964378|NCT00143598|449495902|FG000|Overall Study|Death|36|||
124964379|NCT00143598|449495903|FG001|Overall Study|Death|36|||
125129540|NCT04000815|450100995|FG000|Overall Study|Right ovarian cyst occured|1|||
125129541|NCT04000815|450100996|FG001|Overall Study|Right ovarian cyst occured|0|||
125129542|NCT04000815|450100997|FG002|Overall Study|Right ovarian cyst occured|0|||
124964380|NCT03900715|449495906|FG000|Overall Study|Protocol Deviation|1|||
124964381|NCT03900715|449495906|FG000|Overall Study|Lack of Efficacy|1|||
124964382|NCT03900715|449495906|FG000|Overall Study|Progressive Disease|6|||
124964383|NCT03900715|449495906|FG000|Overall Study|Adverse Event|2|||
124964384|NCT03900715|449495906|FG000|Overall Study|Other reasons|11|||
124964385|NCT01878383|449497670|FG000|Overall Study|Lost to Follow-up|0|||
124964386|NCT01878383|449497671|FG001|Overall Study|Lost to Follow-up|1499|||
124964387|NCT03464383|449497672|FG000|Overall Study|Lost to Follow-up|1|||
125215977|NCT05052697|450417550|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215978|NCT05052697|450417551|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215979|NCT05052697|450417552|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215980|NCT05052697|450417553|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215981|NCT05052697|450417520|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215982|NCT05052697|450417521|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215983|NCT05052697|450417522|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215984|NCT05052697|450417523|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215985|NCT05052697|450417524|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215986|NCT05052697|450417525|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215987|NCT05052697|450417526|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215988|NCT05052697|450417527|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215989|NCT05052697|450417528|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215990|NCT05052697|450417529|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215991|NCT05052697|450417530|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215992|NCT05052697|450417531|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215993|NCT05052697|450417532|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215994|NCT05052697|450417533|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215995|NCT05052697|450417534|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215996|NCT05052697|450417535|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215997|NCT05052697|450417536|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215998|NCT05052697|450417537|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
125215999|NCT05052697|450417538|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216000|NCT05052697|450417539|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216001|NCT05052697|450417540|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216002|NCT05052697|450417541|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216003|NCT05052697|450417542|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216004|NCT05052697|450417543|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216005|NCT05052697|450417544|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216006|NCT05052697|450417545|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216007|NCT05052697|450417546|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216008|NCT05052697|450417547|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216009|NCT05052697|450417548|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216010|NCT05052697|450417549|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216011|NCT05052697|450417550|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216012|NCT05052697|450417551|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216013|NCT05052697|450417552|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216014|NCT05052697|450417553|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216015|NCT05052697|450417520|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216016|NCT05052697|450417521|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216017|NCT05052697|450417522|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216018|NCT05052697|450417523|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216019|NCT05052697|450417524|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216020|NCT05052697|450417525|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216021|NCT05052697|450417526|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216022|NCT05052697|450417527|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216023|NCT05052697|450417528|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216024|NCT05052697|450417529|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216025|NCT05052697|450417530|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216026|NCT05052697|450417531|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216027|NCT05052697|450417532|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216028|NCT05052697|450417533|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216029|NCT05052697|450417534|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216030|NCT05052697|450417535|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216031|NCT05052697|450417536|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216032|NCT05052697|450417537|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216033|NCT05052697|450417538|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216034|NCT05052697|450417539|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
125129543|NCT04000815|450100995|FG000|Overall Study|Hypertension occured on follow up|0|||
125129544|NCT04000815|450100996|FG001|Overall Study|Hypertension occured on follow up|0|||
125129545|NCT04000815|450100997|FG002|Overall Study|Hypertension occured on follow up|2|||
125129546|NCT00239577|450100998|FG000|Primary Phase|Adverse Event|0|||
125129547|NCT00239577|450100999|FG001|Primary Phase|Adverse Event|0|||
125129548|NCT00239577|450101000|FG002|Primary Phase|Adverse Event|1|||
125129549|NCT00239577|450101001|FG003|Primary Phase|Adverse Event|0|||
125129550|NCT00239577|450100998|FG000|Primary Phase|Other|5|||
125129551|NCT00239577|450100999|FG001|Primary Phase|Other|3|||
125129552|NCT00239577|450101000|FG002|Primary Phase|Other|2|||
125129553|NCT00239577|450101001|FG003|Primary Phase|Other|0|||
125129554|NCT03988803|450101004|FG000|Period 2|Prematurely discontinued from medication|2|||
125129555|NCT03988803|450101004|FG000|Period 2|Adverse Event|1|||
125216035|NCT05052697|450417540|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216036|NCT05052697|450417541|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216037|NCT05052697|450417542|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216038|NCT05052697|450417543|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216039|NCT05052697|450417544|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216040|NCT05052697|450417545|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216041|NCT05052697|450417546|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216042|NCT05052697|450417547|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216043|NCT05052697|450417548|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216044|NCT05052697|450417549|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216045|NCT05052697|450417550|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216046|NCT05052697|450417551|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216047|NCT05052697|450417552|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216048|NCT05052697|450417553|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216049|NCT05052697|450417520|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216050|NCT05052697|450417521|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216051|NCT05052697|450417522|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216052|NCT05052697|450417523|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216053|NCT05052697|450417524|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216054|NCT05052697|450417525|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216055|NCT05052697|450417526|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216056|NCT05052697|450417527|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216057|NCT05052697|450417528|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216058|NCT05052697|450417529|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216059|NCT05052697|450417530|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216060|NCT05052697|450417531|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216061|NCT05052697|450417532|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216062|NCT05052697|450417533|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216063|NCT05052697|450417534|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216064|NCT05052697|450417535|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216065|NCT05052697|450417536|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216066|NCT05052697|450417537|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
125216067|NCT05052697|450417538|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125129556|NCT02736721|450101005|FG000|Overall Study|Adverse Event|8|||
125129557|NCT02736721|450101005|FG000|Overall Study|Lost to Follow-up|3|||
125129558|NCT02736721|450101005|FG000|Overall Study|Other|5|||
125129559|NCT03021018|450101008|FG000|Overall Study|Adverse Event|1|||
125129560|NCT03021018|450101009|FG001|Overall Study|Adverse Event|0|||
125129561|NCT03021018|450101010|FG002|Overall Study|Adverse Event|0|||
125129562|NCT03021018|450101008|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
125129563|NCT03021018|450101009|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
125129564|NCT03021018|450101010|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
125129565|NCT02269657|450101021|FG000|Overall Study|Protocol Violation|3|||
125129566|NCT00620074|450101024|FG000|Overall Study|Adverse Event|1|||
125129567|NCT03450057|450101025|FG000|Overall Study|Death|17|||
125129568|NCT03450057|450101025|FG000|Overall Study|ICF withdrawal|4|||
125129569|NCT03450057|450101025|FG000|Overall Study|Lost to Follow-up|2|||
125129570|NCT01838941|450101026|FG000|Overall Study|Adverse Event|1|||
125216068|NCT05052697|450417539|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216069|NCT05052697|450417540|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216070|NCT05052697|450417541|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216071|NCT05052697|450417542|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216072|NCT05052697|450417543|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125129571|NCT01838941|450101026|FG000|Overall Study|Withdrawal by Subject|1|||
125129572|NCT02822235|450101027|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
125129573|NCT02822235|450101028|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
125129574|NCT02822235|450101027|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
125129575|NCT02822235|450101028|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
125216073|NCT05052697|450417544|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216074|NCT05052697|450417545|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
125129576|NCT02822235|450101027|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
125129577|NCT02822235|450101028|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
125216075|NCT05052697|450417546|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216076|NCT05052697|450417547|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
125216077|NCT05052697|450417548|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216078|NCT05052697|450417549|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216079|NCT05052697|450417550|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216080|NCT05052697|450417551|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216081|NCT05052697|450417552|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216082|NCT05052697|450417553|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216083|NCT05052697|450417520|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124964388|NCT03464383|449497673|FG001|Overall Study|Lost to Follow-up|0|||
124964389|NCT03464383|449497674|FG002|Overall Study|Lost to Follow-up|0|||
124964390|NCT03464383|449497672|FG000|Overall Study|Withdrawal by Subject|0|||
124964391|NCT03464383|449497673|FG001|Overall Study|Withdrawal by Subject|1|||
124964392|NCT03464383|449497674|FG002|Overall Study|Withdrawal by Subject|0|||
124964393|NCT00695136|449497679|FG000|Overall Study|Withdrawal by Subject|1|||
124964394|NCT00695136|449497679|FG000|Overall Study|unrelated adverse event|1|||
124964395|NCT01726049|449497681|FG000|Overall Study|Death|1|||
124964396|NCT01726049|449497682|FG001|Overall Study|Death|1|||
124964397|NCT01726049|449497681|FG000|Overall Study|Adverse Event|4|||
124964398|NCT01726049|449497682|FG001|Overall Study|Adverse Event|1|||
124964399|NCT01726049|449497681|FG000|Overall Study|refused second HC|0|||
124964400|NCT01726049|449497682|FG001|Overall Study|refused second HC|2|||
124964401|NCT02806505|449497684|FG000|Overall Study|Adverse event/intercurrent illness|1|||
124964402|NCT02806505|449497685|FG001|Overall Study|Adverse event/intercurrent illness|3|||
124964403|NCT02806505|449497684|FG000|Overall Study|Death|4|||
124964404|NCT02806505|449497685|FG001|Overall Study|Death|0|||
124964405|NCT02806505|449497684|FG000|Overall Study|Did not cooperate/refused treatment|3|||
124964406|NCT02806505|449497685|FG001|Overall Study|Did not cooperate/refused treatment|3|||
124964407|NCT02806505|449497684|FG000|Overall Study|Failure to return|0|||
124964408|NCT02806505|449497685|FG001|Overall Study|Failure to return|1|||
124964409|NCT02806505|449497684|FG000|Overall Study|Insufficient therapeutic response|2|||
124964410|NCT02806505|449497685|FG001|Overall Study|Insufficient therapeutic response|4|||
124964411|NCT01722045|449497692|FG000|Overall Study|Adverse Event|8|||
124964412|NCT01722045|449497692|FG000|Overall Study|Death|3|||
124964413|NCT01722045|449497692|FG000|Overall Study|Withdrawal by Subject|8|||
124964414|NCT01722045|449497692|FG000|Overall Study|Lost to Follow-up|4|||
124964415|NCT01722045|449497692|FG000|Overall Study|Protocol Deviation|1|||
124964416|NCT01722045|449497692|FG000|Overall Study|Physician Decision|3|||
124964417|NCT01722045|449497692|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
124964418|NCT00263211|449497697|FG000|Overall Study|Death|1|||
124964419|NCT00263211|449497698|FG001|Overall Study|Death|0|||
124964420|NCT00263211|449497697|FG000|Overall Study|Withdrawal by Subject|3|||
124964421|NCT00263211|449497698|FG001|Overall Study|Withdrawal by Subject|0|||
124964422|NCT00263211|449497697|FG000|Overall Study|Protocol Violation|1|||
124964423|NCT00263211|449497698|FG001|Overall Study|Protocol Violation|0|||
124964424|NCT00263211|449497697|FG000|Overall Study|Disease Progression|0|||
124964425|NCT00263211|449497698|FG001|Overall Study|Disease Progression|1|||
124964426|NCT00760513|449497699|FG000|Overall Study|Withdrawal by Subject|5|||
124964427|NCT00760513|449497700|FG001|Overall Study|Withdrawal by Subject|7|||
124964428|NCT00908349|449497703|FG000|Overall Study|Adverse Event|10|||
124964429|NCT00908349|449497703|FG000|Overall Study|Withdrawal by Subject|9|||
124964430|NCT00908349|449497703|FG000|Overall Study|Physician Decision|5|||
124964431|NCT00908349|449497703|FG000|Overall Study|Lost to Follow-up|5|||
124964432|NCT00908349|449497703|FG000|Overall Study|Various|6|||
124964433|NCT03834623|449497707|FG000|Overall Study|Progression|0|||
124964434|NCT03834623|449497708|FG001|Overall Study|Progression|1|||
124964435|NCT00478647|449497709|FG000|Overall Study|Adverse Event|1|||
124964436|NCT00478647|449497709|FG000|Overall Study|Withdrawal by Subject|1|||
124964437|NCT01755546|449497712|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
124964438|NCT01755546|449497712|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
124964439|NCT01755546|449497712|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
124964440|NCT01755546|449497712|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
124964441|NCT01755546|449497712|FG000|Titration Phase|Adverse Event|11|||
124964442|NCT01755546|449497712|FG000|Titration Phase|Lack of Efficacy|18|||
124964443|NCT01755546|449497712|FG000|Titration Phase|Protocol Violation|9|||
124964444|NCT01755546|449497712|FG000|Titration Phase|Lost to Follow-up|2|||
124964445|NCT01755546|449497712|FG000|Titration Phase|Other and Continuing|22|||
124964446|NCT01755546|449497712|FG000|Titration Phase|Withdrawal by Subject|8|||
124964447|NCT01755546|449497712|FG000|Long Term Treatment|Adverse Event|12|||
124964448|NCT01755546|449497712|FG000|Long Term Treatment|Lack of Efficacy|6|||
124964449|NCT01755546|449497712|FG000|Long Term Treatment|Protocol Violation|10|||
124964450|NCT01755546|449497712|FG000|Long Term Treatment|Withdrawal by Subject|35|||
124964451|NCT01755546|449497712|FG000|Long Term Treatment|Lost to Follow-up|17|||
124964452|NCT01755546|449497712|FG000|Long Term Treatment|other and ongoing|41|||
124964453|NCT00362375|449497713|FG000|Overall Study|Lost to Follow-up|40|||
124964454|NCT00362375|449497714|FG001|Overall Study|Lost to Follow-up|35|||
124964455|NCT04606199|449497715|FG000|Overall Study|Withdrawal by Subject|2|||
124964456|NCT02624869|449497720|FG000|Overall Study|Lost to Follow-up|0|||
124964457|NCT02624869|449497721|FG001|Overall Study|Lost to Follow-up|0|||
124964458|NCT02624869|449497722|FG002|Overall Study|Lost to Follow-up|1|||
124964459|NCT02624869|449497720|FG000|Overall Study|Withdrawal by Subject|1|||
124964460|NCT02624869|449497721|FG001|Overall Study|Withdrawal by Subject|3|||
125129578|NCT02822235|450101027|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
124964461|NCT02624869|449497722|FG002|Overall Study|Withdrawal by Subject|1|||
124964462|NCT03596242|449497725|FG000|Overall Study|Lost to Follow-up|2|||
124964463|NCT03596242|449497726|FG001|Overall Study|Lost to Follow-up|2|||
124964464|NCT02509312|449497727|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
124964465|NCT02509312|449497728|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
124964466|NCT02509312|449497727|FG000|Overall Study|Obstetrician refusal|0|||
124964467|NCT02509312|449497728|FG001|Overall Study|Obstetrician refusal|1|||
124964468|NCT02509312|449497727|FG000|Overall Study|Patient elected for TOLAC|1|||
124964469|NCT02509312|449497728|FG001|Overall Study|Patient elected for TOLAC|0|||
124964470|NCT02509312|449497727|FG000|Overall Study|Cesarean deemed stat|1|||
124964471|NCT02509312|449497728|FG001|Overall Study|Cesarean deemed stat|0|||
124964472|NCT02509312|449497727|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
124964473|NCT02509312|449497728|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
124964474|NCT04051242|449497731|FG000|Overall Study|Withdrawal by Subject|1|||
124964475|NCT04051242|449497731|FG000|Overall Study|Physician Decision|1|||
124964476|NCT00704171|449497732|FG000|Overall Study|Withdrawal by Subject|1|||
124964477|NCT00704171|449497733|FG001|Overall Study|Withdrawal by Subject|0|||
124964478|NCT01874665|449497734|FG000|Overall Study|Adverse Event|6|||
124964479|NCT01874665|449497735|FG001|Overall Study|Adverse Event|2|||
124964480|NCT01874665|449497734|FG000|Overall Study|Withdrawal by Subject|4|||
124964481|NCT01874665|449497735|FG001|Overall Study|Withdrawal by Subject|1|||
124964482|NCT01874665|449497734|FG000|Overall Study|Physician Decision|3|||
124964483|NCT01874665|449497735|FG001|Overall Study|Physician Decision|0|||
124964484|NCT01874665|449497734|FG000|Overall Study|Clinical Progressive Disease|4|||
124964485|NCT01874665|449497735|FG001|Overall Study|Clinical Progressive Disease|3|||
124964486|NCT01874665|449497734|FG000|Overall Study|Study Terminated by Sponsor|0|||
124964487|NCT01874665|449497735|FG001|Overall Study|Study Terminated by Sponsor|2|||
124964488|NCT01874665|449497734|FG000|Overall Study|Documented Progressive Disease|11|||
124964489|NCT01874665|449497735|FG001|Overall Study|Documented Progressive Disease|7|||
124964490|NCT01874665|449497734|FG000|Overall Study|Other|2|||
124964491|NCT01874665|449497735|FG001|Overall Study|Other|0|||
124964492|NCT04962698|449497740|FG000|Motor Imagery|Technical difficulty|1|||
124964493|NCT04962698|449497741|FG001|Motor Imagery|Technical difficulty|0|||
124964494|NCT04962698|449497740|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
124964495|NCT04962698|449497741|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
124964496|NCT04962698|449497740|FG000|Kinesthetic MI|Technical difficulty|1|||
124964497|NCT04962698|449497741|FG001|Kinesthetic MI|Technical difficulty|0|||
124964498|NCT04962698|449497740|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
124964499|NCT04962698|449497741|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
124964500|NCT04962698|449497740|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
124964501|NCT04962698|449497741|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
124964502|NCT04962698|449497740|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
124964503|NCT04962698|449497741|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
124964504|NCT04962698|449497740|FG000|Virtual-hand Interaction|Technical difficulty|1|||
124964505|NCT04962698|449497741|FG001|Virtual-hand Interaction|Technical difficulty|0|||
124964506|NCT04962698|449497740|FG000|Robotic Action Observation|Technical difficulty|1|||
124964507|NCT04962698|449497741|FG001|Robotic Action Observation|Technical difficulty|0|||
124964508|NCT04962698|449497740|FG000|Rest|Technical difficulty|1|||
124964509|NCT04962698|449497741|FG001|Rest|Technical difficulty|0|||
124964510|NCT04962698|449497740|FG000|Rest|Exclusion criteria met after enrollment|0|||
124964511|NCT04962698|449497741|FG001|Rest|Exclusion criteria met after enrollment|2|||
124964512|NCT00853229|449497742|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
124964513|NCT00853229|449497743|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
124964514|NCT03201900|449497747|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
124964515|NCT03201900|449497747|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
124964516|NCT03201900|449497747|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
124964517|NCT03201900|449497747|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
124964518|NCT03201900|449497747|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
124964519|NCT03201900|449497747|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
124964520|NCT03201900|449497747|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
124964521|NCT03201900|449497747|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
124964522|NCT03201900|449497747|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
124964523|NCT03201900|449497747|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
124964524|NCT03201900|449497747|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
124964525|NCT03201900|449497747|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
124964526|NCT03201900|449497747|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
124964527|NCT00776659|449497766|FG000|Overall Study|Lost to Follow-up|15|||
124964528|NCT00776659|449497766|FG000|Overall Study|Withdrawal by Subject|10|||
125031676|NCT02054702|449737399|FG001|Overall Study|Physician Decision|1|||
125031677|NCT02054702|449737398|FG000|Overall Study|Withdrawal by Subject|14|||
125031678|NCT02054702|449737399|FG001|Overall Study|Withdrawal by Subject|4|||
125031679|NCT00501228|449737402|FG000|Overall Study|Withdrawal by Subject|1|||
125031680|NCT02304926|449737403|FG000|Overall Study|Lost to Follow-up|2|||
125216084|NCT05052697|450417521|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216085|NCT05052697|450417522|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216086|NCT05052697|450417523|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216087|NCT05052697|450417524|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216088|NCT05052697|450417525|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216089|NCT05052697|450417526|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216090|NCT05052697|450417527|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216091|NCT05052697|450417528|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216092|NCT05052697|450417529|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216093|NCT05052697|450417530|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216094|NCT05052697|450417531|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216095|NCT05052697|450417532|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216096|NCT05052697|450417533|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124964529|NCT00776659|449497766|FG000|Overall Study|Study Terminated by Sponsor|1|||
124964530|NCT02835092|449497772|FG000|Overall Study|Withdrawal by Subject|3|||
124964531|NCT02835092|449497773|FG001|Overall Study|Withdrawal by Subject|6|||
124964532|NCT02835092|449497774|FG002|Overall Study|Withdrawal by Subject|3|||
124964533|NCT02835092|449497772|FG000|Overall Study|Lost to Follow-up|0|||
124964534|NCT02835092|449497773|FG001|Overall Study|Lost to Follow-up|2|||
124964535|NCT02835092|449497774|FG002|Overall Study|Lost to Follow-up|0|||
124964536|NCT00025506|449497776|FG000|Overall Study|Ineligible: clerical error|1|||
124964537|NCT00025506|449497776|FG000|Overall Study|Ineligible: wrong cell type|5|||
124964538|NCT00025506|449497776|FG000|Overall Study|Ineligible: inadequate pathology|2|||
124964539|NCT00025506|449497776|FG000|Overall Study|Never Treated|2|||
124964540|NCT01321723|449497777|FG000|Overall Study|Adverse Event|3|||
124964541|NCT01321723|449497778|FG001|Overall Study|Adverse Event|5|||
124964542|NCT01321723|449497779|FG002|Overall Study|Adverse Event|2|||
124964543|NCT01321723|449497777|FG000|Overall Study|Withdrawal by Subject|2|||
124964544|NCT01321723|449497778|FG001|Overall Study|Withdrawal by Subject|0|||
124964545|NCT01321723|449497779|FG002|Overall Study|Withdrawal by Subject|2|||
124964546|NCT00713206|449497780|FG000|Overall Study|Lost to Follow-up|4|||
124964547|NCT00713206|449497781|FG001|Overall Study|Lost to Follow-up|4|||
124964548|NCT00713206|449497780|FG000|Overall Study|Death|1|||
124964549|NCT00713206|449497781|FG001|Overall Study|Death|0|||
124964550|NCT02561806|449497782|FG000|Induction Period|Adverse Event|0|||
124964551|NCT02561806|449497783|FG001|Induction Period|Adverse Event|2|||
124964552|NCT02561806|449497782|FG000|Induction Period|Lack of Efficacy|1|||
124964553|NCT02561806|449497783|FG001|Induction Period|Lack of Efficacy|0|||
124964554|NCT02561806|449497782|FG000|Induction Period|Withdrawal by Subject|0|||
124964555|NCT02561806|449497783|FG001|Induction Period|Withdrawal by Subject|2|||
124964556|NCT02561806|449497782|FG000|Induction Period|Site staff became unblinded|1|||
124964557|NCT02561806|449497783|FG001|Induction Period|Site staff became unblinded|0|||
124964558|NCT02561806|449497782|FG000|Induction Period|Randomized but not treated|0|||
124964559|NCT02561806|449497783|FG001|Induction Period|Randomized but not treated|1|||
124964560|NCT02561806|449497782|FG000|Maintenance Period|Adverse Event|2|||
124964561|NCT02561806|449497783|FG001|Maintenance Period|Adverse Event|1|||
124964562|NCT02561806|449497782|FG000|Maintenance Period|Lack of Efficacy|3|||
124964563|NCT02561806|449497783|FG001|Maintenance Period|Lack of Efficacy|1|||
124964564|NCT02561806|449497782|FG000|Maintenance Period|Lost to Follow-up|2|||
124964565|NCT02561806|449497783|FG001|Maintenance Period|Lost to Follow-up|2|||
124964566|NCT02561806|449497782|FG000|Maintenance Period|Protocol Violation|1|||
124964567|NCT02561806|449497783|FG001|Maintenance Period|Protocol Violation|0|||
124964568|NCT02561806|449497782|FG000|Maintenance Period|Withdrawal by Subject|5|||
124964569|NCT02561806|449497783|FG001|Maintenance Period|Withdrawal by Subject|3|||
124964570|NCT02561806|449497782|FG000|Maintenance Period|Site staff became unblinded|0|||
124964571|NCT02561806|449497783|FG001|Maintenance Period|Site staff became unblinded|1|||
124964572|NCT02561806|449497782|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
124964573|NCT02561806|449497783|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
124964574|NCT02561806|449497782|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
124964575|NCT02561806|449497783|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
124964576|NCT02547441|449497784|FG000|Double-Blind Study Period|Adverse Event|4|||
125216097|NCT05052697|450417534|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216098|NCT05052697|450417535|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216099|NCT05052697|450417536|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124964577|NCT02547441|449497785|FG001|Double-Blind Study Period|Adverse Event|9|||
124964578|NCT02547441|449497784|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
124964579|NCT02547441|449497785|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
124964580|NCT02547441|449497784|FG000|Double-Blind Study Period|Physician Decision|1|||
124964581|NCT02547441|449497785|FG001|Double-Blind Study Period|Physician Decision|0|||
124964582|NCT02547441|449497784|FG000|Double-Blind Study Period|Protocol Violation|1|||
124964583|NCT02547441|449497785|FG001|Double-Blind Study Period|Protocol Violation|2|||
124964584|NCT02547441|449497784|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
124964585|NCT02547441|449497785|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
124964586|NCT02547441|449497784|FG000|Double-Blind Study Period|Sponsor Decision|1|||
124964587|NCT02547441|449497785|FG001|Double-Blind Study Period|Sponsor Decision|0|||
124964588|NCT02547441|449497784|FG000|Open-Label Study Period|Adverse Event|10|||
124964589|NCT02547441|449497785|FG001|Open-Label Study Period|Adverse Event|11|||
124964590|NCT02547441|449497784|FG000|Open-Label Study Period|Lack of Efficacy|3|||
124964591|NCT02547441|449497785|FG001|Open-Label Study Period|Lack of Efficacy|2|||
124964592|NCT02547441|449497784|FG000|Open-Label Study Period|Lost to Follow-up|7|||
124964593|NCT02547441|449497785|FG001|Open-Label Study Period|Lost to Follow-up|8|||
124964594|NCT02547441|449497784|FG000|Open-Label Study Period|Physician Decision|1|||
124964595|NCT02547441|449497785|FG001|Open-Label Study Period|Physician Decision|0|||
124964596|NCT02547441|449497784|FG000|Open-Label Study Period|Protocol Violation|2|||
124964597|NCT02547441|449497785|FG001|Open-Label Study Period|Protocol Violation|0|||
124964598|NCT02547441|449497784|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
124964599|NCT02547441|449497785|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
124964600|NCT02547441|449497784|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
124964601|NCT02547441|449497785|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
124964602|NCT01322009|449497787|FG000|Overall Study|Death|0|||
124964603|NCT01322009|449497788|FG001|Overall Study|Death|1|||
124964604|NCT01322009|449497787|FG000|Overall Study|Adverse Event|0|||
124964605|NCT01322009|449497788|FG001|Overall Study|Adverse Event|1|||
124964606|NCT01322009|449497787|FG000|Overall Study|ng tube discontinued|0|||
124964607|NCT01322009|449497788|FG001|Overall Study|ng tube discontinued|1|||
124964608|NCT01657877|449497789|FG000|Overall Study|Withdrawal by Subject|4|||
124964609|NCT01657877|449497789|FG000|Overall Study|Protocol Violation|6|||
124964610|NCT01657877|449497789|FG000|Overall Study|Adverse Event|2|||
124964611|NCT01657877|449497789|FG000|Overall Study|Other Reason|2|||
124964612|NCT02872311|449497793|FG000|Overall Study|Death|2|||
124964613|NCT02872311|449497794|FG001|Overall Study|Death|0|||
124964614|NCT02872311|449497795|FG002|Overall Study|Death|0|||
124964615|NCT02872311|449497796|FG003|Overall Study|Death|0|||
124964616|NCT02872311|449497797|FG004|Overall Study|Death|0|||
124964617|NCT02872311|449497793|FG000|Overall Study|Lost to Follow-up|2|||
124964618|NCT02872311|449497794|FG001|Overall Study|Lost to Follow-up|0|||
124964619|NCT02872311|449497795|FG002|Overall Study|Lost to Follow-up|0|||
124964620|NCT02872311|449497796|FG003|Overall Study|Lost to Follow-up|0|||
124964621|NCT02872311|449497797|FG004|Overall Study|Lost to Follow-up|0|||
124964622|NCT02872311|449497793|FG000|Overall Study|Protocol Violation|0|||
124964623|NCT02872311|449497794|FG001|Overall Study|Protocol Violation|2|||
124964624|NCT02872311|449497795|FG002|Overall Study|Protocol Violation|1|||
124964625|NCT02872311|449497796|FG003|Overall Study|Protocol Violation|0|||
124964626|NCT02872311|449497797|FG004|Overall Study|Protocol Violation|0|||
124964627|NCT00511797|449497798|FG000|Overall Study|Adverse Event|1|||
124964628|NCT00511797|449497799|FG001|Overall Study|Adverse Event|2|||
124964629|NCT00511797|449497800|FG002|Overall Study|Adverse Event|2|||
124964630|NCT00511797|449497801|FG003|Overall Study|Adverse Event|2|||
124964631|NCT00511797|449497798|FG000|Overall Study|Lost to Follow-up|1|||
124964632|NCT00511797|449497799|FG001|Overall Study|Lost to Follow-up|0|||
124964633|NCT00511797|449497800|FG002|Overall Study|Lost to Follow-up|0|||
124964634|NCT00511797|449497801|FG003|Overall Study|Lost to Follow-up|1|||
124964635|NCT00511797|449497798|FG000|Overall Study|Pregnancy|0|||
124964636|NCT00511797|449497799|FG001|Overall Study|Pregnancy|0|||
124964637|NCT00511797|449497800|FG002|Overall Study|Pregnancy|0|||
124964638|NCT00511797|449497801|FG003|Overall Study|Pregnancy|1|||
124964639|NCT00511797|449497798|FG000|Overall Study|Protocol Violation|0|||
124964640|NCT00511797|449497799|FG001|Overall Study|Protocol Violation|2|||
124964641|NCT00511797|449497800|FG002|Overall Study|Protocol Violation|2|||
124964642|NCT00511797|449497801|FG003|Overall Study|Protocol Violation|3|||
124964643|NCT00511797|449497798|FG000|Overall Study|Withdrawal by Subject|3|||
124964644|NCT00511797|449497799|FG001|Overall Study|Withdrawal by Subject|3|||
124964645|NCT00511797|449497800|FG002|Overall Study|Withdrawal by Subject|4|||
124964646|NCT00511797|449497801|FG003|Overall Study|Withdrawal by Subject|2|||
124964647|NCT00511797|449497798|FG000|Overall Study|Never dispensed|1|||
124964648|NCT00511797|449497799|FG001|Overall Study|Never dispensed|0|||
124964649|NCT00511797|449497800|FG002|Overall Study|Never dispensed|1|||
124964650|NCT00511797|449497801|FG003|Overall Study|Never dispensed|3|||
124964651|NCT00511797|449497798|FG000|Overall Study|Study drug not taken|0|||
124964652|NCT00511797|449497799|FG001|Overall Study|Study drug not taken|1|||
124964653|NCT00511797|449497800|FG002|Overall Study|Study drug not taken|0|||
124964654|NCT00511797|449497801|FG003|Overall Study|Study drug not taken|1|||
124964655|NCT00511797|449497798|FG000|Overall Study|Partially missing diary|0|||
124964656|NCT00511797|449497799|FG001|Overall Study|Partially missing diary|0|||
124964657|NCT00511797|449497800|FG002|Overall Study|Partially missing diary|1|||
124964658|NCT00511797|449497801|FG003|Overall Study|Partially missing diary|0|||
124964659|NCT00511797|449497798|FG000|Overall Study|Other (moving etc)|1|||
124964660|NCT00511797|449497799|FG001|Overall Study|Other (moving etc)|0|||
124964661|NCT00511797|449497800|FG002|Overall Study|Other (moving etc)|1|||
124964662|NCT00511797|449497801|FG003|Overall Study|Other (moving etc)|2|||
125031681|NCT02304926|449737404|FG001|Overall Study|Lost to Follow-up|1|||
125031682|NCT03157531|449737406|FG000|Overall Study|Death|2|||
124964663|NCT03974100|449497802|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
124964664|NCT03974100|449497803|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
124964665|NCT03974100|449497804|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
124964666|NCT03974100|449497805|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
124964667|NCT03974100|449497806|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
124964668|NCT03974100|449497802|FG000|TP1 - Day 1 to Week 52|Death|1|||
124964669|NCT03974100|449497803|FG001|TP1 - Day 1 to Week 52|Death|0|||
124964670|NCT03974100|449497804|FG002|TP1 - Day 1 to Week 52|Death|0|||
124964671|NCT03974100|449497805|FG003|TP1 - Day 1 to Week 52|Death|0|||
124964672|NCT03974100|449497806|FG004|TP1 - Day 1 to Week 52|Death|0|||
124964673|NCT03974100|449497802|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
124964674|NCT03974100|449497803|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
125129579|NCT02822235|450101028|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
125129580|NCT02822235|450101027|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
125129581|NCT02822235|450101028|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
125129582|NCT02822235|450101027|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
125129583|NCT02822235|450101028|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
125129584|NCT03214952|450101029|FG000|Overall Study|Protocol Deviation|45|||
125129585|NCT03214952|450101029|FG000|Overall Study|Case Report Forms Uncollected|13|||
125129586|NCT02246166|450101032|FG000|Overall Study|Protocol Violation|1|||
125129587|NCT02246166|450101033|FG001|Overall Study|Protocol Violation|0|||
125129588|NCT03769896|450101034|FG000|Open-label Phase|Lack of Efficacy|5|||
125129589|NCT03769896|450101035|FG001|Open-label Phase|Lack of Efficacy|0|||
125129590|NCT03769896|450101034|FG000|Open-label Phase|Adverse Event|3|||
125129591|NCT03769896|450101035|FG001|Open-label Phase|Adverse Event|0|||
125129592|NCT03769896|450101034|FG000|Open-label Phase|Withdrawal by Subject|1|||
125129593|NCT03769896|450101035|FG001|Open-label Phase|Withdrawal by Subject|0|||
125129594|NCT00377260|450101036|FG000|Overall Study|Lost to Follow-up|0|||
125129595|NCT00377260|450101037|FG001|Overall Study|Lost to Follow-up|1|||
125129596|NCT00377260|450101036|FG000|Overall Study|Withdrawal by Subject|2|||
125129597|NCT00377260|450101037|FG001|Overall Study|Withdrawal by Subject|4|||
125129598|NCT00829530|450101038|FG000|First Intervention|Adverse Event|0|||
125129599|NCT00829530|450101039|FG001|First Intervention|Adverse Event|1|||
125129600|NCT00829530|450101038|FG000|First Intervention|Intolerance to Venopuncture|0|||
125129601|NCT00829530|450101039|FG001|First Intervention|Intolerance to Venopuncture|1|||
125129602|NCT00829530|450101038|FG000|Second Intervention|Intolerance to Venopuncture|1|||
125129603|NCT00829530|450101039|FG001|Second Intervention|Intolerance to Venopuncture|0|||
124964675|NCT03974100|449497804|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
124964676|NCT03974100|449497805|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
124964677|NCT03974100|449497806|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
125031683|NCT03157531|449737406|FG000|Overall Study|Lost to Follow-up|4|||
125031684|NCT00331006|449737407|FG000|Screening Phase|Withdrawal by Subject|1|||
125031685|NCT00331006|449737407|FG000|Screening Phase|enrollment halted|1|||
125031686|NCT00331006|449737407|FG000|Screening Phase|Lost to Follow-up|1|||
125031687|NCT00331006|449737407|FG000|Screening Phase|Ineligible for treatment phase|4|||
125031688|NCT00331006|449737407|FG000|Treatment Phase|Withdrawal by Subject|1|||
125031689|NCT00331006|449737407|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
125031690|NCT00331006|449737407|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
125031691|NCT03804684|449737408|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
125031692|NCT03804684|449737409|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
124964678|NCT03974100|449497802|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
124964679|NCT03974100|449497803|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
124964680|NCT03974100|449497804|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
124964681|NCT03974100|449497805|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
124964682|NCT03974100|449497806|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
124964683|NCT03974100|449497802|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
124964684|NCT03974100|449497803|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
124964685|NCT03974100|449497804|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
124964686|NCT03974100|449497805|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
124964687|NCT03974100|449497806|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
124964688|NCT03974100|449497802|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
124964689|NCT03974100|449497803|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
124964690|NCT03974100|449497804|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
124964691|NCT03974100|449497805|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
124964692|NCT03974100|449497806|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
124964693|NCT03974100|449497802|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
124964694|NCT03974100|449497803|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
124964695|NCT03974100|449497804|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
124964696|NCT03974100|449497805|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
124964697|NCT03974100|449497806|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
124964698|NCT02019641|449497807|FG000|10-Week Follow up|Withdrawal by investigator|2|||
124964699|NCT02019641|449497808|FG001|10-Week Follow up|Withdrawal by investigator|0|||
124964700|NCT02019641|449497809|FG002|10-Week Follow up|Withdrawal by investigator|0|||
124964701|NCT02019641|449497807|FG000|10-Week Follow up|Withdrawal by Subject|1|||
124964702|NCT02019641|449497808|FG001|10-Week Follow up|Withdrawal by Subject|1|||
124964703|NCT02019641|449497809|FG002|10-Week Follow up|Withdrawal by Subject|0|||
124964704|NCT02019641|449497807|FG000|20-Week Follow up|Withdrawal by investigator|0|||
124964705|NCT02019641|449497808|FG001|20-Week Follow up|Withdrawal by investigator|0|||
124964706|NCT02019641|449497809|FG002|20-Week Follow up|Withdrawal by investigator|1|||
124964707|NCT00545571|449497812|FG000|Overall Study|Administrative Reasons|1|||
124964708|NCT00545571|449497812|FG000|Overall Study|Adverse Event|2|||
124964709|NCT00545571|449497812|FG000|Overall Study|Death|5|||
124964710|NCT00545571|449497812|FG000|Overall Study|Lack of Efficacy|1|||
124964711|NCT00545571|449497812|FG000|Overall Study|Protocol Violation|2|||
124964712|NCT00545571|449497812|FG000|Overall Study|Refused Treatment|1|||
124964713|NCT00545571|449497812|FG000|Overall Study|Screen Failure|16|||
124964714|NCT00545571|449497812|FG000|Overall Study|Transfusion|12|||
124964715|NCT00545571|449497812|FG000|Overall Study|Early Termination of Study|24|||
124964716|NCT00545571|449497812|FG000|Overall Study|Kidney Transplantation|3|||
124964717|NCT03269695|449497813|FG000|Overall Study|Adverse Event|2|||
124964718|NCT03269695|449497814|FG001|Overall Study|Adverse Event|1|||
124964719|NCT03269695|449497813|FG000|Overall Study|Lack of Efficacy|0|||
124964720|NCT03269695|449497814|FG001|Overall Study|Lack of Efficacy|1|||
124964721|NCT03269695|449497813|FG000|Overall Study|Withdrawal by Subject|0|||
124964722|NCT03269695|449497814|FG001|Overall Study|Withdrawal by Subject|1|||
124964723|NCT02024750|449497815|FG000|Overall Study|Withdrawal by Subject|2|||
124964724|NCT02024750|449497816|FG001|Overall Study|Withdrawal by Subject|1|||
124964725|NCT01349036|449497817|FG000|Overall Study|Disease progression|13|||
124964726|NCT01349036|449497818|FG001|Overall Study|Disease progression|22|||
124964727|NCT01349036|449497817|FG000|Overall Study|Other|1|||
124964728|NCT01349036|449497818|FG001|Overall Study|Other|0|||
124964729|NCT01349036|449497817|FG000|Overall Study|Withdrawal by Subject|0|||
124964730|NCT01349036|449497818|FG001|Overall Study|Withdrawal by Subject|2|||
124964731|NCT00746356|449497819|FG000|Overall Study|Withdrawal by Subject|2|||
124964732|NCT00746356|449497820|FG001|Overall Study|Withdrawal by Subject|3|||
124964733|NCT00746356|449497819|FG000|Overall Study|Death|7|||
125216100|NCT05052697|450417537|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216101|NCT05052697|450417538|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216102|NCT05052697|450417539|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124964734|NCT00746356|449497820|FG001|Overall Study|Death|3|||
124964735|NCT00746356|449497819|FG000|Overall Study|Lost to Follow-up|1|||
124964736|NCT00746356|449497820|FG001|Overall Study|Lost to Follow-up|0|||
124964737|NCT00746356|449497819|FG000|Overall Study|Removal of Device|0|||
124964738|NCT00746356|449497820|FG001|Overall Study|Removal of Device|1|||
124964739|NCT00746356|449497819|FG000|Overall Study|Patient relocated|1|||
124964740|NCT00746356|449497820|FG001|Overall Study|Patient relocated|0|||
124964741|NCT03605368|449497823|FG000|Overall Study|Lost to Follow-up|2|||
124964742|NCT03605368|449497824|FG001|Overall Study|Lost to Follow-up|1|||
125031693|NCT00238264|449737412|FG000|Overall Study|Death|7|||
124964743|NCT03605368|449497825|FG002|Overall Study|Lost to Follow-up|3|||
124964744|NCT03605368|449497826|FG003|Overall Study|Lost to Follow-up|2|||
124964745|NCT03605368|449497823|FG000|Overall Study|Withdrawal by Subject|0|||
124964746|NCT03605368|449497824|FG001|Overall Study|Withdrawal by Subject|0|||
124964747|NCT03605368|449497825|FG002|Overall Study|Withdrawal by Subject|4|||
124964748|NCT03605368|449497826|FG003|Overall Study|Withdrawal by Subject|3|||
124964749|NCT01125566|449497827|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
124964750|NCT01125566|449497828|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
124964751|NCT01125566|449497829|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
124964752|NCT01125566|449497827|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
124964753|NCT01125566|449497828|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
124964754|NCT01125566|449497829|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
124964755|NCT01125566|449497827|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
124964756|NCT01125566|449497828|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
124964757|NCT01125566|449497829|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
124964758|NCT01125566|449497827|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
124964759|NCT01125566|449497828|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
124964760|NCT01125566|449497829|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
124964761|NCT01125566|449497827|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
124964762|NCT01125566|449497828|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
124969647|NCT01234883|449517433|FG001|Overall Study|Technical difficulties with IV infusion|1|||
125129604|NCT04112823|450101042|FG000|Overall Study|Lost to Follow-up|2|||
125129605|NCT04112823|450101043|FG001|Overall Study|Lost to Follow-up|3|||
125129606|NCT00625443|450101044|FG000|Overall Study|Adverse Event|1|||
125129607|NCT00625443|450101045|FG001|Overall Study|Adverse Event|4|||
125129608|NCT00625443|450101046|FG002|Overall Study|Adverse Event|0|||
125129609|NCT00625443|450101044|FG000|Overall Study|Non-compliance with protocol|0|||
125129610|NCT00625443|450101045|FG001|Overall Study|Non-compliance with protocol|1|||
125129611|NCT00625443|450101046|FG002|Overall Study|Non-compliance with protocol|0|||
125129612|NCT00625443|450101044|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
125129613|NCT00625443|450101045|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
125129614|NCT00625443|450101046|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
125129615|NCT00625443|450101044|FG000|Overall Study|Withdrawal by Subject|0|||
125129616|NCT00625443|450101045|FG001|Overall Study|Withdrawal by Subject|1|||
125129617|NCT00625443|450101046|FG002|Overall Study|Withdrawal by Subject|2|||
125129618|NCT00625443|450101044|FG000|Overall Study|Physician Decision|0|||
125129619|NCT00625443|450101045|FG001|Overall Study|Physician Decision|4|||
125129620|NCT00625443|450101046|FG002|Overall Study|Physician Decision|2|||
125129621|NCT00625443|450101044|FG000|Overall Study|Other|0|||
125129622|NCT00625443|450101045|FG001|Overall Study|Other|1|||
125129623|NCT00625443|450101046|FG002|Overall Study|Other|1|||
125129624|NCT02678286|450101051|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
125129625|NCT02678286|450101052|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
125129626|NCT02678286|450101051|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
125129627|NCT02678286|450101052|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
125129628|NCT02678286|450101051|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
125129629|NCT02678286|450101052|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
125129630|NCT02678286|450101051|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
125129631|NCT02678286|450101052|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
125129632|NCT02678286|450101051|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
125129633|NCT02678286|450101052|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
125129634|NCT01422538|450101055|FG000|Overall Study|Lost to Follow-up|0|||
125129635|NCT01422538|450101056|FG001|Overall Study|Lost to Follow-up|1|||
125129636|NCT01422538|450101057|FG002|Overall Study|Lost to Follow-up|1|||
125129637|NCT01422538|450101055|FG000|Overall Study|Missed visit|0|||
125129638|NCT01422538|450101056|FG001|Overall Study|Missed visit|1|||
125129639|NCT01422538|450101057|FG002|Overall Study|Missed visit|1|||
125129640|NCT01270503|450101058|FG000|Overall Study|Lost to Follow-up|1|||
125129641|NCT02481830|450101062|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
125129642|NCT02481830|450101063|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
125129643|NCT02481830|450101062|FG000|Pre-treatment|Withdrawal by Subject|0|||
125129644|NCT02481830|450101063|FG001|Pre-treatment|Withdrawal by Subject|10|||
125129645|NCT02481830|450101062|FG000|Pre-treatment|Disease Progression|1|||
125129646|NCT02481830|450101063|FG001|Pre-treatment|Disease Progression|1|||
125129647|NCT02481830|450101062|FG000|Pre-treatment|Other reasons|0|||
125129648|NCT02481830|450101063|FG001|Pre-treatment|Other reasons|1|||
125129649|NCT02481830|450101062|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
125129650|NCT02481830|450101063|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
125129651|NCT02481830|450101062|FG000|Treatment|Disease Progression|233|||
125129652|NCT02481830|450101063|FG001|Treatment|Disease Progression|171|||
125129653|NCT02481830|450101062|FG000|Treatment|Study drug toxicity|18|||
125129654|NCT02481830|450101063|FG001|Treatment|Study drug toxicity|38|||
125129655|NCT02481830|450101062|FG000|Treatment|Death|1|||
125129656|NCT02481830|450101063|FG001|Treatment|Death|1|||
125129657|NCT02481830|450101062|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
125129658|NCT02481830|450101063|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
125129659|NCT02481830|450101062|FG000|Treatment|Participants request to discontinue Study treatment|6|||
125129660|NCT02481830|450101063|FG001|Treatment|Participants request to discontinue Study treatment|34|||
125129661|NCT02481830|450101062|FG000|Treatment|Withdrawal by Subject|2|||
125129662|NCT02481830|450101063|FG001|Treatment|Withdrawal by Subject|3|||
125129663|NCT02481830|450101062|FG000|Treatment|Lost to Follow-up|1|||
125031694|NCT00238264|449737412|FG000|Overall Study|Lost to Follow-up|18|||
125031695|NCT00238264|449737412|FG000|Overall Study|Withdrawal by Subject|4|||
125031696|NCT00238264|449737412|FG000|Overall Study|Ineligible|7|||
125031697|NCT02706938|449737413|FG000|First Period, 6 Weeks|Adverse Event|8|||
125031698|NCT02706938|449737414|FG001|First Period, 6 Weeks|Adverse Event|0|||
125031699|NCT02706938|449737413|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
125031700|NCT02706938|449737414|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
125031701|NCT02706938|449737413|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
125031702|NCT02706938|449737414|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
125031703|NCT02706938|449737413|FG000|Second Period, 6 Weeks|Adverse Event|0|||
125031704|NCT02706938|449737414|FG001|Second Period, 6 Weeks|Adverse Event|7|||
125031705|NCT02706938|449737413|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
125031706|NCT02706938|449737414|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
125031707|NCT01838044|449737415|FG000|Overall Study|Adverse Event|4|||
125031708|NCT01838044|449737416|FG001|Overall Study|Adverse Event|6|||
125031709|NCT01838044|449737415|FG000|Overall Study|Protocol Violation|3|||
125031710|NCT01838044|449737416|FG001|Overall Study|Protocol Violation|3|||
125031711|NCT01838044|449737415|FG000|Overall Study|Withdrawal by Subject|0|||
125031712|NCT01838044|449737416|FG001|Overall Study|Withdrawal by Subject|2|||
125031713|NCT01838044|449737415|FG000|Overall Study|Insufficient clinical response|1|||
125031714|NCT01838044|449737416|FG001|Overall Study|Insufficient clinical response|2|||
125031715|NCT01838044|449737415|FG000|Overall Study|Medication error without associated AE|0|||
125031716|NCT01838044|449737416|FG001|Overall Study|Medication error without associated AE|1|||
125031717|NCT01838044|449737415|FG000|Overall Study|Lost to Follow-up|0|||
125031718|NCT01838044|449737416|FG001|Overall Study|Lost to Follow-up|2|||
125031719|NCT00860470|449737420|FG000|Overall Study|Death|6|||
125031720|NCT00860470|449737421|FG001|Overall Study|Death|10|||
125031721|NCT00860470|449737420|FG000|Overall Study|Moved away|8|||
125031722|NCT00860470|449737421|FG001|Overall Study|Moved away|10|||
125031723|NCT00860470|449737420|FG000|Overall Study|Lost to Follow-up|34|||
125031724|NCT00860470|449737421|FG001|Overall Study|Lost to Follow-up|39|||
125031725|NCT01662648|449737423|FG000|Overall Study|Death|1|||
125031726|NCT01662648|449737424|FG001|Overall Study|Death|3|||
125031727|NCT01662648|449737423|FG000|Overall Study|Adverse Event|40|||
125031728|NCT01662648|449737424|FG001|Overall Study|Adverse Event|37|||
125031729|NCT01662648|449737423|FG000|Overall Study|Lack of Efficacy|17|||
125031730|NCT01662648|449737424|FG001|Overall Study|Lack of Efficacy|16|||
125031731|NCT01662648|449737423|FG000|Overall Study|Participant ineligible to continue trial|1|||
125031732|NCT01662648|449737424|FG001|Overall Study|Participant ineligible to continue trial|1|||
125129664|NCT02481830|450101063|FG001|Treatment|Lost to Follow-up|0|||
125129665|NCT02481830|450101062|FG000|Treatment|Maximum Clinical Benefit|0|||
125129666|NCT02481830|450101063|FG001|Treatment|Maximum Clinical Benefit|5|||
125129667|NCT02481830|450101062|FG000|Treatment|Administrative reason by sponsor|1|||
125129668|NCT02481830|450101063|FG001|Treatment|Administrative reason by sponsor|1|||
125129669|NCT02481830|450101062|FG000|Treatment|Other reasons|6|||
125129670|NCT02481830|450101063|FG001|Treatment|Other reasons|1|||
124964763|NCT01125566|449497829|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
124964764|NCT01125566|449497827|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
124964765|NCT01125566|449497828|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
124964766|NCT01125566|449497829|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
124964767|NCT01125566|449497827|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
124964768|NCT01125566|449497828|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
124964769|NCT01125566|449497829|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
124964770|NCT01125566|449497827|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
124964771|NCT01125566|449497828|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
124964772|NCT01125566|449497829|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
124964773|NCT01125566|449497827|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
124964774|NCT01125566|449497828|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
124964775|NCT01125566|449497829|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
124964776|NCT01125566|449497827|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
124964777|NCT01125566|449497828|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
124964778|NCT01125566|449497829|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
124964779|NCT01125566|449497827|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
124964780|NCT01125566|449497828|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
124964781|NCT01125566|449497829|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
124964782|NCT01125566|449497827|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
124964783|NCT01125566|449497828|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
124964784|NCT01125566|449497829|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
124964785|NCT03151551|449497830|FG000|Open-Label Treatment Period|Adverse Event|0|||
124964786|NCT03151551|449497831|FG001|Open-Label Treatment Period|Adverse Event|2|||
124964787|NCT03151551|449497830|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
124964788|NCT03151551|449497831|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
124964789|NCT03151551|449497830|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
124964790|NCT03151551|449497831|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
124964791|NCT03151551|449497830|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
124964792|NCT03151551|449497831|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
124964793|NCT03151551|449497830|FG000|Open-Label Treatment Period|Physician Decision|3|||
124964794|NCT03151551|449497831|FG001|Open-Label Treatment Period|Physician Decision|0|||
124964795|NCT03151551|449497830|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
124964796|NCT03151551|449497831|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
124964797|NCT03151551|449497830|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
124964798|NCT03151551|449497831|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
124964799|NCT03151551|449497830|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
124964800|NCT03151551|449497831|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
124964801|NCT03151551|449497830|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
124964802|NCT03151551|449497831|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
124964803|NCT03151551|449497830|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
124964804|NCT03151551|449497831|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
124964805|NCT00514813|449497832|FG000|Overall Study|Study terminated|14|||
124964806|NCT00514813|449497833|FG001|Overall Study|Study terminated|74|||
124964807|NCT00514813|449497834|FG002|Overall Study|Study terminated|40|||
124964808|NCT00514813|449497835|FG003|Overall Study|Study terminated|2|||
124964809|NCT00514813|449497832|FG000|Overall Study|Adverse Event|0|||
124964810|NCT00514813|449497833|FG001|Overall Study|Adverse Event|2|||
124964811|NCT00514813|449497834|FG002|Overall Study|Adverse Event|2|||
124964812|NCT00514813|449497835|FG003|Overall Study|Adverse Event|0|||
124964813|NCT00514813|449497832|FG000|Overall Study|Protocol Violation|1|||
124964814|NCT00514813|449497833|FG001|Overall Study|Protocol Violation|0|||
124964815|NCT00514813|449497834|FG002|Overall Study|Protocol Violation|0|||
124964816|NCT00514813|449497835|FG003|Overall Study|Protocol Violation|0|||
124964817|NCT00514813|449497832|FG000|Overall Study|Withdrawal by Subject|0|||
124964818|NCT00514813|449497833|FG001|Overall Study|Withdrawal by Subject|1|||
124964819|NCT00514813|449497834|FG002|Overall Study|Withdrawal by Subject|0|||
124964820|NCT00514813|449497835|FG003|Overall Study|Withdrawal by Subject|0|||
124964821|NCT00514813|449497832|FG000|Overall Study|Lack of Efficacy|0|||
124964822|NCT00514813|449497833|FG001|Overall Study|Lack of Efficacy|1|||
124964823|NCT00514813|449497834|FG002|Overall Study|Lack of Efficacy|0|||
124964824|NCT00514813|449497835|FG003|Overall Study|Lack of Efficacy|0|||
124964825|NCT00514813|449497832|FG000|Overall Study|Kidney transplant|0|||
124964826|NCT00514813|449497833|FG001|Overall Study|Kidney transplant|6|||
124964827|NCT00514813|449497834|FG002|Overall Study|Kidney transplant|2|||
124964828|NCT00514813|449497835|FG003|Overall Study|Kidney transplant|0|||
124964829|NCT00514813|449497832|FG000|Overall Study|Death|0|||
124964830|NCT00514813|449497833|FG001|Overall Study|Death|2|||
124964831|NCT00514813|449497834|FG002|Overall Study|Death|3|||
124964832|NCT00514813|449497835|FG003|Overall Study|Death|2|||
125216103|NCT05052697|450417540|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216104|NCT05052697|450417541|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216105|NCT05052697|450417542|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216106|NCT05052697|450417543|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216107|NCT05052697|450417544|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216108|NCT05052697|450417545|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216109|NCT05052697|450417546|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216110|NCT05052697|450417547|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216111|NCT05052697|450417548|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
125216112|NCT05052697|450417549|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216113|NCT05052697|450417550|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
125216114|NCT05052697|450417551|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
125216115|NCT05052697|450417552|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
125216116|NCT05052697|450417553|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216117|NCT05052697|450417520|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216118|NCT05052697|450417521|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216119|NCT05052697|450417522|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216120|NCT05052697|450417523|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216121|NCT05052697|450417524|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216122|NCT05052697|450417525|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216123|NCT05052697|450417526|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216124|NCT05052697|450417527|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216125|NCT05052697|450417528|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216126|NCT05052697|450417529|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216127|NCT05052697|450417530|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124964833|NCT02979613|449497836|FG000|Double-Blind Phase|Withdrew Consent|2|||
124964834|NCT02979613|449497837|FG001|Double-Blind Phase|Withdrew Consent|4|||
124964835|NCT02979613|449497836|FG000|Double-Blind Phase|Pregnancy|2|||
124964836|NCT02979613|449497837|FG001|Double-Blind Phase|Pregnancy|2|||
124964837|NCT02979613|449497836|FG000|Double-Blind Phase|Adverse Event|2|||
124964838|NCT02979613|449497837|FG001|Double-Blind Phase|Adverse Event|0|||
124964839|NCT02979613|449497836|FG000|Double-Blind Phase|Lost to Follow-up|1|||
124964840|NCT02979613|449497837|FG001|Double-Blind Phase|Lost to Follow-up|1|||
124964841|NCT02979613|449497836|FG000|Double-Blind Phase|Protocol Violation|1|||
124964842|NCT02979613|449497837|FG001|Double-Blind Phase|Protocol Violation|1|||
124964843|NCT02979613|449497836|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
124964844|NCT02979613|449497837|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
124964845|NCT02979613|449497836|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
124964846|NCT02979613|449497837|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
124964847|NCT02979613|449497836|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
124964848|NCT02979613|449497837|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
124964849|NCT02979613|449497836|FG000|Open-Label Extension (OLE) Phase|Death|0|||
124964850|NCT02979613|449497837|FG001|Open-Label Extension (OLE) Phase|Death|1|||
124964851|NCT02979613|449497836|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
124964852|NCT02979613|449497837|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
124964853|NCT01075100|449497840|FG000|Overall Study|Adverse Event|15|||
124964854|NCT01075100|449497841|FG001|Overall Study|Adverse Event|18|||
124964855|NCT01075100|449497840|FG000|Overall Study|Patient Request|4|||
124964856|NCT01075100|449497841|FG001|Overall Study|Patient Request|4|||
124964857|NCT01075100|449497840|FG000|Overall Study|Investigator Request|2|||
124964858|NCT01075100|449497841|FG001|Overall Study|Investigator Request|1|||
124964859|NCT01075100|449497840|FG000|Overall Study|Disease Progression|25|||
124964860|NCT01075100|449497841|FG001|Overall Study|Disease Progression|29|||
124964861|NCT01075100|449497840|FG000|Overall Study|Other|3|||
124964862|NCT01075100|449497841|FG001|Overall Study|Other|1|||
124964863|NCT02250183|449497842|FG000|Overall Study|Withdrawal by Subject|2|||
124964864|NCT02250183|449497842|FG000|Overall Study|Adverse Event|5|||
124964865|NCT02250183|449497842|FG000|Overall Study|Lost to Follow-up|1|||
124964866|NCT03282799|449497843|FG000|Overall Study|Pregnancy|1|||
124964867|NCT03282799|449497844|FG001|Overall Study|Pregnancy|0|||
124964868|NCT03282799|449497843|FG000|Overall Study|Physician Decision|1|||
124964869|NCT03282799|449497844|FG001|Overall Study|Physician Decision|0|||
124964870|NCT00092521|449499213|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
125216128|NCT05052697|450417531|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216129|NCT05052697|450417532|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216130|NCT05052697|450417533|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124964871|NCT00092521|449499214|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
124964872|NCT00092521|449499215|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
124964873|NCT00092521|449499216|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
124964874|NCT00092521|449499213|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
124964875|NCT00092521|449499214|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
125129671|NCT04627038|450101064|FG000|Overall Study|Adverse Event|36|||
125129672|NCT04627038|450101065|FG001|Overall Study|Adverse Event|8|||
125129673|NCT04627038|450101064|FG000|Overall Study|Lost to Follow-up|1|||
125129674|NCT04627038|450101065|FG001|Overall Study|Lost to Follow-up|0|||
125129675|NCT04627038|450101064|FG000|Overall Study|Physician Decision|0|||
125129676|NCT04627038|450101065|FG001|Overall Study|Physician Decision|1|||
125129677|NCT04627038|450101064|FG000|Overall Study|Protocol Violation|3|||
125129678|NCT04627038|450101065|FG001|Overall Study|Protocol Violation|1|||
125129679|NCT04627038|450101064|FG000|Overall Study|Withdrawal by Subject|13|||
125129680|NCT04627038|450101065|FG001|Overall Study|Withdrawal by Subject|3|||
125129681|NCT04627038|450101064|FG000|Overall Study|Non-compliance with study drug|0|||
124964876|NCT00092521|449499215|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
124964877|NCT00092521|449499216|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
124964878|NCT00092521|449499213|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
124964879|NCT00092521|449499214|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
124964880|NCT00092521|449499215|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
124964881|NCT00092521|449499216|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
124964882|NCT00092521|449499213|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
124964883|NCT00092521|449499214|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
124964884|NCT00092521|449499215|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
124964885|NCT00092521|449499216|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
124964886|NCT00092521|449499213|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
124964887|NCT00092521|449499214|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
124964888|NCT00092521|449499215|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
124964889|NCT00092521|449499216|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
124964890|NCT00092521|449499213|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
124964891|NCT00092521|449499214|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
124964892|NCT00092521|449499215|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
124964893|NCT00092521|449499216|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
124964894|NCT00092521|449499213|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
124964895|NCT00092521|449499214|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
124964896|NCT00092521|449499215|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
124964897|NCT00092521|449499216|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
124964898|NCT00092521|449499213|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
124964899|NCT00092521|449499214|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
124964900|NCT00092521|449499215|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
124964901|NCT00092521|449499216|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
124964902|NCT00092521|449499213|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
124964903|NCT00092521|449499214|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
124964904|NCT00092521|449499215|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
124964905|NCT00092521|449499216|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
124964906|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
124964907|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
124964908|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
124964909|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
124964910|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
124964911|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
124964912|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
124964913|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
124964914|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
124964915|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
124964916|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
124964917|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
124964918|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Death|2|||
124964919|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Death|0|||
124964920|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Death|1|||
124964921|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Death|0|||
124964922|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
124964923|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
124964924|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
124964925|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
124964926|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
124964927|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
125129682|NCT04627038|450101065|FG001|Overall Study|Non-compliance with study drug|1|||
125129683|NCT04627038|450101064|FG000|Overall Study|Prohibited Concomitant Medication|1|||
125129684|NCT04627038|450101065|FG001|Overall Study|Prohibited Concomitant Medication|0|||
125129685|NCT03956862|450101070|FG000|Overall Study|Lost to Follow-up|1|||
124964928|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
124964929|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
124964930|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
124964931|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
124964932|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
124964933|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
124964934|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Moved|32|||
124964935|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Moved|2|||
124964936|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Moved|28|||
124964937|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Moved|0|||
124964938|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
124964939|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
124964940|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
124964941|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
124964942|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Travel|2|||
124964943|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Travel|0|||
124964944|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Travel|0|||
124964945|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Travel|0|||
124964946|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
124964947|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
124964948|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
124964949|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
124964950|NCT00092521|449499213|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
124964951|NCT00092521|449499214|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
124964952|NCT00092521|449499215|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
124964953|NCT00092521|449499216|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
124964954|NCT00092521|449499213|FG000|Extension Study (Group 4)|Adverse Event|0|||
124964955|NCT00092521|449499214|FG001|Extension Study (Group 4)|Adverse Event|0|||
124964956|NCT00092521|449499215|FG002|Extension Study (Group 4)|Adverse Event|0|||
124964957|NCT00092521|449499216|FG003|Extension Study (Group 4)|Adverse Event|2|||
124964958|NCT00092521|449499213|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
124964959|NCT00092521|449499214|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
124964960|NCT00092521|449499215|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
124964961|NCT00092521|449499216|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
124964962|NCT00092521|449499213|FG000|Extension Study (Group 4)|Pregnancy|0|||
124964963|NCT00092521|449499214|FG001|Extension Study (Group 4)|Pregnancy|0|||
124964964|NCT00092521|449499215|FG002|Extension Study (Group 4)|Pregnancy|0|||
124964965|NCT00092521|449499216|FG003|Extension Study (Group 4)|Pregnancy|4|||
124964966|NCT00092521|449499213|FG000|Extension Study (Group 4)|Protocol Violation|0|||
124964967|NCT00092521|449499214|FG001|Extension Study (Group 4)|Protocol Violation|0|||
124964968|NCT00092521|449499215|FG002|Extension Study (Group 4)|Protocol Violation|0|||
124964969|NCT00092521|449499216|FG003|Extension Study (Group 4)|Protocol Violation|2|||
124964970|NCT00092521|449499213|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
124964971|NCT00092521|449499214|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
124964972|NCT00092521|449499215|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
124964973|NCT00092521|449499216|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
124964974|NCT00092521|449499213|FG000|Extension Study (Group 4)|Moved|0|||
124964975|NCT00092521|449499214|FG001|Extension Study (Group 4)|Moved|0|||
124964976|NCT00092521|449499215|FG002|Extension Study (Group 4)|Moved|0|||
124964977|NCT00092521|449499216|FG003|Extension Study (Group 4)|Moved|16|||
125031733|NCT01662648|449737423|FG000|Overall Study|Lost to Follow-up|24|||
125031734|NCT01662648|449737424|FG001|Overall Study|Lost to Follow-up|36|||
125031735|NCT01662648|449737423|FG000|Overall Study|Withdrawal by Subject|36|||
125031736|NCT01662648|449737424|FG001|Overall Study|Withdrawal by Subject|53|||
125031737|NCT01662648|449737423|FG000|Overall Study|Participant non-compliant|16|||
125031738|NCT01662648|449737424|FG001|Overall Study|Participant non-compliant|20|||
125031739|NCT01662648|449737423|FG000|Overall Study|Other|8|||
125031740|NCT01662648|449737424|FG001|Overall Study|Other|11|||
125031741|NCT01662648|449737423|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
125031742|NCT01662648|449737424|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
125031743|NCT01662648|449737423|FG000|Overall Study|LOE and other reason unspecified|1|||
125031744|NCT01662648|449737424|FG001|Overall Study|LOE and other reason unspecified|0|||
125031745|NCT01662648|449737423|FG000|Overall Study|LOE and Participant non-compliant|0|||
125031746|NCT01662648|449737424|FG001|Overall Study|LOE and Participant non-compliant|1|||
125031747|NCT02928952|449737425|FG000|Overall Study|Lost to Follow-up|5|||
125031748|NCT02928952|449737426|FG001|Overall Study|Lost to Follow-up|5|||
125031749|NCT02928952|449737425|FG000|Overall Study|Withdrawal by Subject|5|||
125031750|NCT02928952|449737426|FG001|Overall Study|Withdrawal by Subject|1|||
125031751|NCT02928952|449737425|FG000|Overall Study|Physician Decision|0|||
125031752|NCT02928952|449737426|FG001|Overall Study|Physician Decision|1|||
125031753|NCT03751111|449737427|FG000|Overall Study|Lack of Efficacy|9|||
125031754|NCT03751111|449737428|FG001|Overall Study|Lack of Efficacy|30|||
125031755|NCT03751111|449737427|FG000|Overall Study|Adverse Event|3|||
125031756|NCT03751111|449737428|FG001|Overall Study|Adverse Event|2|||
125031757|NCT00723957|449737429|FG000|Overall Study|Adverse event unrelated to study drug|1|||
125031758|NCT00723957|449737430|FG001|Overall Study|Adverse event unrelated to study drug|4|||
125031759|NCT00723957|449737429|FG000|Overall Study|Death|3|||
125031760|NCT00723957|449737430|FG001|Overall Study|Death|4|||
125031761|NCT00723957|449737429|FG000|Overall Study|Disease progression|27|||
125031762|NCT00723957|449737430|FG001|Overall Study|Disease progression|25|||
125031763|NCT00723957|449737429|FG000|Overall Study|Maximum clinical benefit|4|||
125031764|NCT00723957|449737430|FG001|Overall Study|Maximum clinical benefit|5|||
125031765|NCT00723957|449737429|FG000|Overall Study|Investigator decision|1|||
125031766|NCT00723957|449737430|FG001|Overall Study|Investigator decision|1|||
125031767|NCT00723957|449737429|FG000|Overall Study|Study drug toxicity|4|||
125031768|NCT00723957|449737430|FG001|Overall Study|Study drug toxicity|6|||
125031769|NCT00723957|449737429|FG000|Overall Study|Withdrawal by Subject|7|||
125031770|NCT00723957|449737430|FG001|Overall Study|Withdrawal by Subject|5|||
125031771|NCT00723957|449737429|FG000|Overall Study|Reason not analyzed|1|||
125031772|NCT00723957|449737430|FG001|Overall Study|Reason not analyzed|0|||
125031773|NCT00723957|449737429|FG000|Overall Study|Never received treatment|3|||
125031774|NCT00723957|449737430|FG001|Overall Study|Never received treatment|3|||
125031775|NCT00706628|449737432|FG000|Overall Study|Other Adverse Event|16|||
125216131|NCT05052697|450417534|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216132|NCT05052697|450417535|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216133|NCT05052697|450417536|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216134|NCT05052697|450417537|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216135|NCT05052697|450417538|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216136|NCT05052697|450417539|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216137|NCT05052697|450417540|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216138|NCT05052697|450417541|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216139|NCT05052697|450417542|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216140|NCT05052697|450417543|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216141|NCT05052697|450417544|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216142|NCT05052697|450417545|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216143|NCT05052697|450417546|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216144|NCT05052697|450417547|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216145|NCT05052697|450417548|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
125216146|NCT05052697|450417549|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
125216147|NCT05052697|450417550|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
125216148|NCT05052697|450417551|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
125216149|NCT05052697|450417552|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
125216150|NCT05052697|450417553|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125031776|NCT00706628|449737433|FG001|Overall Study|Other Adverse Event|5|||
125031777|NCT00706628|449737434|FG002|Overall Study|Other Adverse Event|5|||
125031778|NCT00706628|449737435|FG003|Overall Study|Other Adverse Event|2|||
125031779|NCT00706628|449737432|FG000|Overall Study|Non compliant with protocol|0|||
125031780|NCT00706628|449737433|FG001|Overall Study|Non compliant with protocol|1|||
125031781|NCT00706628|449737434|FG002|Overall Study|Non compliant with protocol|0|||
125216151|NCT05052697|450417520|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216152|NCT05052697|450417521|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216153|NCT05052697|450417522|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216154|NCT05052697|450417523|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216155|NCT05052697|450417524|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216156|NCT05052697|450417525|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216157|NCT05052697|450417526|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125031782|NCT00706628|449737435|FG003|Overall Study|Non compliant with protocol|0|||
125031783|NCT00706628|449737432|FG000|Overall Study|Consent withdrawn|6|||
125031784|NCT00706628|449737433|FG001|Overall Study|Consent withdrawn|1|||
125031785|NCT00706628|449737434|FG002|Overall Study|Consent withdrawn|3|||
125031786|NCT00706628|449737435|FG003|Overall Study|Consent withdrawn|0|||
125031787|NCT00706628|449737432|FG000|Overall Study|Progressive disease|20|||
125031788|NCT00706628|449737433|FG001|Overall Study|Progressive disease|13|||
125031789|NCT00706628|449737434|FG002|Overall Study|Progressive disease|8|||
125031790|NCT00706628|449737435|FG003|Overall Study|Progressive disease|1|||
125031791|NCT00706628|449737432|FG000|Overall Study|Other than those stated above|4|||
125031792|NCT00706628|449737433|FG001|Overall Study|Other than those stated above|0|||
125031793|NCT00706628|449737434|FG002|Overall Study|Other than those stated above|0|||
125031794|NCT00706628|449737435|FG003|Overall Study|Other than those stated above|0|||
125031795|NCT00706628|449737432|FG000|Overall Study|Not treated|1|||
125031796|NCT00706628|449737433|FG001|Overall Study|Not treated|1|||
125031797|NCT00706628|449737434|FG002|Overall Study|Not treated|0|||
125031798|NCT00706628|449737435|FG003|Overall Study|Not treated|0|||
125031799|NCT01264939|449737436|FG000|Overall Study|Adverse Event|1|||
125031800|NCT01264939|449737437|FG001|Overall Study|Adverse Event|3|||
125031801|NCT01264939|449737436|FG000|Overall Study|Lost to Follow-up|0|||
125031802|NCT01264939|449737437|FG001|Overall Study|Lost to Follow-up|3|||
125031803|NCT01264939|449737436|FG000|Overall Study|Physician Decision|1|||
125031804|NCT01264939|449737437|FG001|Overall Study|Physician Decision|1|||
125031805|NCT01264939|449737436|FG000|Overall Study|Patient/Guardian Decision|8|||
125031806|NCT01264939|449737437|FG001|Overall Study|Patient/Guardian Decision|10|||
125031807|NCT01264939|449737436|FG000|Overall Study|Disease Progression|8|||
125031808|NCT01264939|449737437|FG001|Overall Study|Disease Progression|11|||
124964978|NCT00092521|449499213|FG000|Extension Study (Group 4)|Site Terminated|0|||
124964979|NCT00092521|449499214|FG001|Extension Study (Group 4)|Site Terminated|0|||
124964980|NCT00092521|449499215|FG002|Extension Study (Group 4)|Site Terminated|0|||
124964981|NCT00092521|449499216|FG003|Extension Study (Group 4)|Site Terminated|4|||
124964982|NCT00092521|449499213|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
124964983|NCT00092521|449499214|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
124964984|NCT00092521|449499215|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
124964985|NCT00092521|449499216|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
124964986|NCT03475056|449499217|FG000|Overall Study|Lost to Follow-up|0|||
124964987|NCT03475056|449499218|FG001|Overall Study|Lost to Follow-up|1|||
124964988|NCT03475056|449499217|FG000|Overall Study|Moved from Area|0|||
124964989|NCT03475056|449499218|FG001|Overall Study|Moved from Area|2|||
124964990|NCT01932762|449499219|FG000|Overall Study|Withdrawal by Subject|1|||
124964991|NCT01932762|449499220|FG001|Overall Study|Withdrawal by Subject|2|||
124964992|NCT01932762|449499221|FG002|Overall Study|Withdrawal by Subject|0|||
124964993|NCT01932762|449499222|FG003|Overall Study|Withdrawal by Subject|0|||
124964994|NCT01932762|449499219|FG000|Overall Study|Lost to Follow-up|4|||
124964995|NCT01932762|449499220|FG001|Overall Study|Lost to Follow-up|0|||
124964996|NCT01932762|449499221|FG002|Overall Study|Lost to Follow-up|0|||
124964997|NCT01932762|449499222|FG003|Overall Study|Lost to Follow-up|1|||
124964998|NCT01932762|449499219|FG000|Overall Study|Physician Decision|1|||
124964999|NCT01932762|449499220|FG001|Overall Study|Physician Decision|0|||
124965000|NCT01932762|449499221|FG002|Overall Study|Physician Decision|0|||
124965001|NCT01932762|449499222|FG003|Overall Study|Physician Decision|0|||
124965002|NCT01101334|449499226|FG000|Overall Study|Adverse Event|9|||
124965003|NCT01101334|449499227|FG001|Overall Study|Adverse Event|4|||
124965004|NCT01101334|449499226|FG000|Overall Study|Death|7|||
124965005|NCT01101334|449499227|FG001|Overall Study|Death|1|||
124965006|NCT01101334|449499226|FG000|Overall Study|Withdrawal by Subject|4|||
124965007|NCT01101334|449499227|FG001|Overall Study|Withdrawal by Subject|3|||
124965008|NCT01101334|449499226|FG000|Overall Study|Withdrawal by Sponsor|1|||
124965009|NCT01101334|449499227|FG001|Overall Study|Withdrawal by Sponsor|1|||
124965010|NCT01101334|449499226|FG000|Overall Study|Progressive Disease|22|||
124965011|NCT01101334|449499227|FG001|Overall Study|Progressive Disease|35|||
124965012|NCT01101334|449499226|FG000|Overall Study|Other|2|||
124965013|NCT01101334|449499227|FG001|Overall Study|Other|1|||
124965014|NCT03864341|449499230|FG000|Overall Study|Withdrawal by Subject|1|||
124965015|NCT00612352|449499233|FG000|Overall Study|Adverse Event|1|||
124965016|NCT00612352|449499234|FG001|Overall Study|Adverse Event|0|||
124965017|NCT00612352|449499233|FG000|Overall Study|Withdrawal by Subject|3|||
124965018|NCT00612352|449499234|FG001|Overall Study|Withdrawal by Subject|5|||
124965019|NCT00612352|449499233|FG000|Overall Study|moved out of state|1|||
124965020|NCT00612352|449499234|FG001|Overall Study|moved out of state|0|||
124965021|NCT00612352|449499233|FG000|Overall Study|didn't return calls/show up on test date|4|||
124965022|NCT00612352|449499234|FG001|Overall Study|didn't return calls/show up on test date|1|||
124965023|NCT02161406|449499235|FG000|Overall Study|Death|2|||
124965024|NCT02161406|449499236|FG001|Overall Study|Death|1|||
124965025|NCT02161406|449499235|FG000|Overall Study|Lost to Follow-up|2|||
124965026|NCT02161406|449499236|FG001|Overall Study|Lost to Follow-up|1|||
124965027|NCT02161406|449499235|FG000|Overall Study|Withdrawal by Subject|2|||
124965028|NCT02161406|449499236|FG001|Overall Study|Withdrawal by Subject|4|||
124965029|NCT02161406|449499235|FG000|Overall Study|investigator withdrew subject|3|||
124965030|NCT02161406|449499236|FG001|Overall Study|investigator withdrew subject|1|||
124965031|NCT02161406|449499235|FG000|Overall Study|Lack of Efficacy|1|||
124965032|NCT02161406|449499236|FG001|Overall Study|Lack of Efficacy|1|||
124965033|NCT02161406|449499235|FG000|Overall Study|relocation|0|||
124965034|NCT02161406|449499236|FG001|Overall Study|relocation|1|||
124965035|NCT02034162|449499237|FG000|Double-blind|Lost to Follow-up|3|||
124965036|NCT02034162|449499238|FG001|Double-blind|Lost to Follow-up|0|||
124965037|NCT02034162|449499239|FG002|Double-blind|Lost to Follow-up|0|||
124965038|NCT02034162|449499237|FG000|Double-blind|Physician Decision|1|||
124965039|NCT02034162|449499238|FG001|Double-blind|Physician Decision|0|||
124965040|NCT02034162|449499239|FG002|Double-blind|Physician Decision|0|||
124965041|NCT02034162|449499237|FG000|Double-blind|Protocol Violation|0|||
124965042|NCT02034162|449499238|FG001|Double-blind|Protocol Violation|1|||
124965043|NCT02034162|449499239|FG002|Double-blind|Protocol Violation|0|||
124965044|NCT02034162|449499237|FG000|Double-blind|Withdrawal by Subject|5|||
124965045|NCT02034162|449499238|FG001|Double-blind|Withdrawal by Subject|7|||
124965046|NCT02034162|449499239|FG002|Double-blind|Withdrawal by Subject|0|||
124965047|NCT03458728|449499241|FG000|Overall Study|Adverse Event|1|||
124965048|NCT03458728|449499242|FG001|Overall Study|Adverse Event|0|||
124965049|NCT03458728|449499241|FG000|Overall Study|Physician Decision|1|||
124965050|NCT03458728|449499242|FG001|Overall Study|Physician Decision|0|||
124965051|NCT03458728|449499241|FG000|Overall Study|Progressive disease - clinical assessment|1|||
124965052|NCT03458728|449499242|FG001|Overall Study|Progressive disease - clinical assessment|0|||
124965053|NCT03458728|449499241|FG000|Overall Study|Progressive disease - radiological progression|21|||
125031809|NCT02266433|449737442|FG000|Overall Study|Lost to Follow-up|54|||
125031810|NCT02266433|449737443|FG001|Overall Study|Lost to Follow-up|46|||
125031811|NCT02266433|449737442|FG000|Overall Study|Withdrawal by Subject|5|||
125031812|NCT02266433|449737443|FG001|Overall Study|Withdrawal by Subject|7|||
125031813|NCT04525703|449737444|FG000|Overall Study|Lost to Follow-up|6|||
125031814|NCT04525703|449737445|FG001|Overall Study|Lost to Follow-up|15|||
125031815|NCT04525703|449737446|FG002|Overall Study|Lost to Follow-up|8|||
125031816|NCT01285349|449737447|FG000|Overall Study|Lost to Follow-up|27|||
125031817|NCT01285349|449737448|FG001|Overall Study|Lost to Follow-up|20|||
125031818|NCT01285349|449737449|FG002|Overall Study|Lost to Follow-up|27|||
125031819|NCT01145560|449737450|FG000|Overall Study|Withdrawal by Subject|2|||
125031820|NCT01145560|449737451|FG001|Overall Study|Withdrawal by Subject|1|||
125031821|NCT01145560|449737452|FG002|Overall Study|Withdrawal by Subject|0|||
125031822|NCT01145560|449737450|FG000|Overall Study|Lost to Follow-up|1|||
125031823|NCT01145560|449737451|FG001|Overall Study|Lost to Follow-up|1|||
125031824|NCT01145560|449737452|FG002|Overall Study|Lost to Follow-up|1|||
125031825|NCT01145560|449737450|FG000|Overall Study|No study drug by 24h after organ failure|1|||
125031826|NCT01145560|449737451|FG001|Overall Study|No study drug by 24h after organ failure|0|||
125031827|NCT01145560|449737452|FG002|Overall Study|No study drug by 24h after organ failure|0|||
125031828|NCT01145560|449737450|FG000|Overall Study|Accidental unblinding of study treatment|0|||
125031829|NCT01145560|449737451|FG001|Overall Study|Accidental unblinding of study treatment|1|||
125129686|NCT03956862|450101071|FG001|Overall Study|Lost to Follow-up|1|||
125216158|NCT05052697|450417527|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216159|NCT05052697|450417528|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216160|NCT05052697|450417529|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216161|NCT05052697|450417530|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216162|NCT05052697|450417531|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216163|NCT05052697|450417532|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216164|NCT05052697|450417533|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216165|NCT05052697|450417534|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216166|NCT05052697|450417535|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216167|NCT05052697|450417536|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216168|NCT05052697|450417537|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216169|NCT05052697|450417538|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216170|NCT05052697|450417539|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216171|NCT05052697|450417540|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216172|NCT05052697|450417541|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216173|NCT05052697|450417542|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216174|NCT05052697|450417543|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216175|NCT05052697|450417544|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216176|NCT05052697|450417545|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216177|NCT05052697|450417546|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216178|NCT05052697|450417547|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216179|NCT05052697|450417548|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216180|NCT05052697|450417549|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216181|NCT05052697|450417550|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216182|NCT05052697|450417551|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216183|NCT05052697|450417552|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
125216184|NCT05052697|450417553|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216185|NCT05052697|450417520|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216186|NCT05052697|450417521|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216187|NCT05052697|450417522|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216188|NCT05052697|450417523|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216189|NCT05052697|450417524|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216190|NCT05052697|450417525|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216191|NCT05052697|450417526|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216192|NCT05052697|450417527|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216193|NCT05052697|450417528|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216194|NCT05052697|450417529|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125129687|NCT03956862|450101070|FG000|Overall Study|Withdrawal by Subject|1|||
125129688|NCT03956862|450101071|FG001|Overall Study|Withdrawal by Subject|1|||
125129689|NCT01363765|450101072|FG000|Overall Study|non-diagnostic|2621|||
125129690|NCT01363765|450101073|FG001|Overall Study|non-diagnostic|1124|||
125129691|NCT01363765|450101072|FG000|Overall Study|duplicate records|736|||
125129692|NCT01363765|450101073|FG001|Overall Study|duplicate records|3177|||
125129693|NCT01363765|450101072|FG000|Overall Study|non-resident|156|||
125129694|NCT01363765|450101073|FG001|Overall Study|non-resident|76|||
125129695|NCT01363765|450101072|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
125129696|NCT01363765|450101073|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
125129697|NCT01363765|450101072|FG000|Overall Study|smear during intervention|2170|||
125216195|NCT05052697|450417530|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216196|NCT05052697|450417531|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216197|NCT05052697|450417532|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125129698|NCT01363765|450101073|FG001|Overall Study|smear during intervention|0|||
125129699|NCT02601560|450101076|FG000|Overall Study|Other|0|||
125129700|NCT02601560|450101077|FG001|Overall Study|Other|0|||
125129701|NCT02601560|450101078|FG002|Overall Study|Other|0|||
125129702|NCT02601560|450101079|FG003|Overall Study|Other|0|||
125129703|NCT02601560|450101080|FG004|Overall Study|Other|0|||
125129704|NCT02601560|450101081|FG005|Overall Study|Other|0|||
125216198|NCT05052697|450417533|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124965054|NCT03458728|449499242|FG001|Overall Study|Progressive disease - radiological progression|6|||
124965055|NCT03458728|449499241|FG000|Overall Study|Withdrawal by Subject|0|||
124965056|NCT03458728|449499242|FG001|Overall Study|Withdrawal by Subject|1|||
124965057|NCT00858247|449499244|FG000|Baseline Assessment|Withdrawal by Subject|1|||
124965058|NCT00858247|449499245|FG001|Baseline Assessment|Withdrawal by Subject|1|||
124965059|NCT00858247|449499244|FG000|Baseline Assessment|Poor IV access|1|||
124965060|NCT00858247|449499245|FG001|Baseline Assessment|Poor IV access|0|||
124965061|NCT00858247|449499244|FG000|Baseline Assessment|Protocol Violation|0|||
124965062|NCT00858247|449499245|FG001|Baseline Assessment|Protocol Violation|1|||
124965063|NCT00858247|449499244|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
124965064|NCT00858247|449499245|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
124965065|NCT00337285|449499246|FG000|Overall Study|Withdrawal by Subject|42|||
124965066|NCT00337285|449499246|FG000|Overall Study|Lost to Follow-up|41|||
124965067|NCT00337285|449499246|FG000|Overall Study|Adverse Event|28|||
124965068|NCT00337285|449499246|FG000|Overall Study|Protocol Violation|27|||
124965069|NCT00337285|449499246|FG000|Overall Study|Lack of Efficacy|11|||
124965070|NCT00337285|449499246|FG000|Overall Study|Death|1|||
124965071|NCT00337285|449499246|FG000|Overall Study|Physician Decision|1|||
124965072|NCT00337285|449499246|FG000|Overall Study|Lack of protocol compliance|7|||
124965073|NCT00553605|449499247|FG000|Overall Study|Did not meet entrance criteria|1|||
124965074|NCT00553605|449499248|FG001|Overall Study|Did not meet entrance criteria|3|||
124965075|NCT00553605|449499247|FG000|Overall Study|Did not receive full dose|1|||
124965076|NCT00553605|449499248|FG001|Overall Study|Did not receive full dose|0|||
124965077|NCT00553605|449499247|FG000|Overall Study|Randomized but not treated|2|||
124965078|NCT00553605|449499248|FG001|Overall Study|Randomized but not treated|0|||
124965079|NCT03481556|449499249|FG000|Overall Study|Adverse Event|1|||
124965080|NCT03481556|449499250|FG001|Overall Study|Adverse Event|0|||
124965081|NCT03481556|449499251|FG002|Overall Study|Adverse Event|0|||
124965082|NCT03481556|449499252|FG003|Overall Study|Adverse Event|0|||
124965083|NCT03481556|449499249|FG000|Overall Study|Death|4|||
124965084|NCT03481556|449499250|FG001|Overall Study|Death|2|||
124965085|NCT03481556|449499251|FG002|Overall Study|Death|3|||
124965086|NCT03481556|449499252|FG003|Overall Study|Death|16|||
124965087|NCT03481556|449499249|FG000|Overall Study|Study Terminated by Sponsor|10|||
124965088|NCT03481556|449499250|FG001|Overall Study|Study Terminated by Sponsor|5|||
124965089|NCT03481556|449499251|FG002|Overall Study|Study Terminated by Sponsor|2|||
124965090|NCT03481556|449499252|FG003|Overall Study|Study Terminated by Sponsor|9|||
124965091|NCT01085812|449499253|FG000|Open-Label Period|Adverse Event|0|||
124965092|NCT01085812|449499254|FG001|Open-Label Period|Adverse Event|80|||
124965093|NCT01085812|449499253|FG000|Open-Label Period|Lack of Efficacy|0|||
124965094|NCT01085812|449499254|FG001|Open-Label Period|Lack of Efficacy|26|||
124965095|NCT01085812|449499253|FG000|Open-Label Period|Protocol Violation|0|||
124965096|NCT01085812|449499254|FG001|Open-Label Period|Protocol Violation|39|||
124965097|NCT01085812|449499253|FG000|Open-Label Period|Withdrawal by Subject|0|||
124965098|NCT01085812|449499254|FG001|Open-Label Period|Withdrawal by Subject|53|||
124965099|NCT01085812|449499253|FG000|Open-Label Period|Lost to Follow-up|0|||
124965100|NCT01085812|449499254|FG001|Open-Label Period|Lost to Follow-up|42|||
124965101|NCT01085812|449499253|FG000|Double-Blind Period|Adverse Event|3|||
124965102|NCT01085812|449499254|FG001|Double-Blind Period|Adverse Event|8|||
124965103|NCT01085812|449499253|FG000|Double-Blind Period|Protocol Violation|2|||
124965104|NCT01085812|449499254|FG001|Double-Blind Period|Protocol Violation|7|||
124965105|NCT01085812|449499253|FG000|Double-Blind Period|Withdrawal by Subject|11|||
124965106|NCT01085812|449499254|FG001|Double-Blind Period|Withdrawal by Subject|24|||
124965107|NCT01085812|449499253|FG000|Double-Blind Period|Lost to Follow-up|5|||
124965108|NCT01085812|449499254|FG001|Double-Blind Period|Lost to Follow-up|17|||
124965109|NCT01085812|449499253|FG000|Double-Blind Period|Other Reasons|0|||
124965110|NCT01085812|449499254|FG001|Double-Blind Period|Other Reasons|2|||
124965111|NCT01085812|449499253|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
124965112|NCT01085812|449499254|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
124965113|NCT01085812|449499253|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
124965114|NCT01085812|449499254|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
124965115|NCT01085812|449499253|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
124965116|NCT01085812|449499254|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
124965117|NCT01085812|449499253|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
124965118|NCT01085812|449499254|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
124965119|NCT01085812|449499253|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
124965120|NCT01085812|449499254|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
124965121|NCT01101997|449499255|FG000|Overall Study|Withdrawal by Subject|2|||
124965122|NCT02669407|449499258|FG000|Overall Study|Physician Decision|3|||
124965123|NCT03634839|449499259|FG000|First Intervention (2 Hours)|Adverse Event|0|||
124965124|NCT03634839|449499260|FG001|First Intervention (2 Hours)|Adverse Event|2|||
124965125|NCT00350298|449499261|FG000|Overall Study|Death|7|||
124965126|NCT00350298|449499262|FG001|Overall Study|Death|8|||
124965127|NCT00350298|449499261|FG000|Overall Study|Lost to Follow-up|1|||
124965128|NCT00350298|449499262|FG001|Overall Study|Lost to Follow-up|2|||
124965129|NCT00350298|449499261|FG000|Overall Study|Withdrawal by Subject|1|||
124965130|NCT00350298|449499262|FG001|Overall Study|Withdrawal by Subject|3|||
124965131|NCT02447432|449499263|FG000|Epoch 001|Adverse Event|1|||
124965132|NCT02447432|449499264|FG001|Epoch 001|Adverse Event|1|||
124965133|NCT02447432|449499263|FG000|Epoch 001|Withdrawal by Subject|0|||
124965134|NCT02447432|449499264|FG001|Epoch 001|Withdrawal by Subject|4|||
124965135|NCT02447432|449499263|FG000|Epoch 001|Migrated/moved from study area|3|||
124965136|NCT02447432|449499264|FG001|Epoch 001|Migrated/moved from study area|5|||
124965137|NCT02447432|449499263|FG000|Epoch 001|Lost to Follow-up|1|||
124965138|NCT02447432|449499264|FG001|Epoch 001|Lost to Follow-up|3|||
124965139|NCT02647788|449499265|FG000|Overall Study|Lost to Follow-up|13|||
124965140|NCT02647788|449499266|FG001|Overall Study|Lost to Follow-up|11|||
124965141|NCT02647788|449499265|FG000|Overall Study|Did not want opiate|0|||
124965142|NCT02647788|449499266|FG001|Overall Study|Did not want opiate|1|||
124965143|NCT02647788|449499265|FG000|Overall Study|Withdrawal by Subject|1|||
124965144|NCT02647788|449499266|FG001|Overall Study|Withdrawal by Subject|0|||
124965145|NCT02647788|449499265|FG000|Overall Study|Felt itchy with assigned medication|1|||
124965146|NCT02647788|449499266|FG001|Overall Study|Felt itchy with assigned medication|0|||
124965147|NCT02647788|449499265|FG000|Overall Study|Felt nauseous with assigned medication|1|||
124965148|NCT02647788|449499266|FG001|Overall Study|Felt nauseous with assigned medication|1|||
124965149|NCT00233389|449499269|FG000|Overall Study|Adverse Event|5|||
124965150|NCT00233389|449499270|FG001|Overall Study|Adverse Event|5|||
124965151|NCT00233389|449499269|FG000|Overall Study|Lack of Efficacy|11|||
124965152|NCT00233389|449499270|FG001|Overall Study|Lack of Efficacy|8|||
124965153|NCT00233389|449499269|FG000|Overall Study|Lost to Follow-up|1|||
124965154|NCT00233389|449499270|FG001|Overall Study|Lost to Follow-up|1|||
124965155|NCT00233389|449499269|FG000|Overall Study|Physician Decision|1|||
124965156|NCT00233389|449499270|FG001|Overall Study|Physician Decision|0|||
124965157|NCT00233389|449499269|FG000|Overall Study|Protocol Violation|0|||
124965158|NCT00233389|449499270|FG001|Overall Study|Protocol Violation|1|||
124965159|NCT00233389|449499269|FG000|Overall Study|Withdrawal by Subject|0|||
124965160|NCT00233389|449499270|FG001|Overall Study|Withdrawal by Subject|1|||
124965161|NCT00302159|449499273|FG000|Overall Study|pt declined before treatment started|1|||
124965162|NCT00302159|449499273|FG000|Overall Study|pt started Avastin|1|||
124965163|NCT01233999|449499276|FG000|Overall Study|Withdrawal by Subject|1|||
124965164|NCT01233999|449499276|FG000|Overall Study|Lost to Follow-up|1|||
124965165|NCT00129649|449499283|FG000|Overall Study|Withdrawal by Subject|76|||
124965166|NCT00129649|449499284|FG001|Overall Study|Withdrawal by Subject|65|||
124965167|NCT00905034|449499286|FG000|Overall Study|Withdrawal by Subject|1|||
124965168|NCT00394589|449499287|FG000|Overall Study|Adverse Event|2|||
124965169|NCT00394589|449499288|FG001|Overall Study|Adverse Event|1|||
124965170|NCT00394589|449499289|FG002|Overall Study|Adverse Event|2|||
124965171|NCT00394589|449499287|FG000|Overall Study|Lack of Efficacy|2|||
124965172|NCT00394589|449499288|FG001|Overall Study|Lack of Efficacy|2|||
124965173|NCT00394589|449499289|FG002|Overall Study|Lack of Efficacy|3|||
124965174|NCT00394589|449499287|FG000|Overall Study|Protocol Violation|4|||
124965175|NCT00394589|449499288|FG001|Overall Study|Protocol Violation|0|||
124965176|NCT00394589|449499289|FG002|Overall Study|Protocol Violation|2|||
124965177|NCT04081389|449499290|FG000|Overall Study|Withdrawal by Subject|0|||
124965178|NCT04081389|449499291|FG001|Overall Study|Withdrawal by Subject|0|||
124965179|NCT04081389|449499292|FG002|Overall Study|Withdrawal by Subject|1|||
124965180|NCT04081389|449499293|FG003|Overall Study|Withdrawal by Subject|0|||
124965181|NCT01114672|449499294|FG000|Overall Study|Death|0|||
124965182|NCT01114672|449499295|FG001|Overall Study|Death|1|||
124965183|NCT01114672|449499294|FG000|Overall Study|Withdrawal by Subject|2|||
124965184|NCT01114672|449499295|FG001|Overall Study|Withdrawal by Subject|1|||
124965185|NCT01114672|449499294|FG000|Overall Study|Lost to Follow-up|1|||
124965186|NCT01114672|449499295|FG001|Overall Study|Lost to Follow-up|0|||
124965187|NCT01114672|449499294|FG000|Overall Study|transplanted|1|||
124965188|NCT01114672|449499295|FG001|Overall Study|transplanted|0|||
124965189|NCT01710800|449499298|FG000|Overall Study|Withdrawal by Subject|21|||
124965190|NCT01710800|449499298|FG000|Overall Study|Protocol Violation|1|||
124965191|NCT02586415|449499299|FG000|Overall Study|Death|13|||
124965192|NCT02586415|449499300|FG001|Overall Study|Death|23|||
124965193|NCT02586415|449499299|FG000|Overall Study|Lost to Follow-up|1|||
124965194|NCT02586415|449499300|FG001|Overall Study|Lost to Follow-up|2|||
124965195|NCT01585298|449499301|FG000|Overall Study|Study completion was not documented.|1|||
124965196|NCT01585298|449499301|FG000|Overall Study|Protocol deviation|1|||
125031830|NCT01145560|449737452|FG002|Overall Study|Accidental unblinding of study treatment|0|||
125031831|NCT01145560|449737450|FG000|Overall Study|False insurance information|0|||
125031832|NCT01145560|449737451|FG001|Overall Study|False insurance information|1|||
125031833|NCT01145560|449737452|FG002|Overall Study|False insurance information|0|||
125031834|NCT01145560|449737450|FG000|Overall Study|Withdrawal of therapy|0|||
125031835|NCT01145560|449737451|FG001|Overall Study|Withdrawal of therapy|0|||
125031836|NCT01145560|449737452|FG002|Overall Study|Withdrawal of therapy|1|||
124965197|NCT01585298|449499301|FG000|Overall Study|Administrative problems|4|||
124965198|NCT01585298|449499301|FG000|Overall Study|Lost to Follow-up|2|||
124965199|NCT01585298|449499301|FG000|Overall Study|Withdrawal by Subject|4|||
124965200|NCT01585298|449499301|FG000|Overall Study|Abnormal test procedure results|1|||
124965201|NCT01585298|449499301|FG000|Overall Study|Adverse Event|24|||
124965202|NCT04545476|449499302|FG000|Overall Study|Lost to Follow-up|1|||
124965203|NCT04545476|449499303|FG001|Overall Study|Lost to Follow-up|1|||
124965204|NCT04545476|449499304|FG002|Overall Study|Lost to Follow-up|0|||
124965205|NCT04545476|449499305|FG003|Overall Study|Lost to Follow-up|0|||
124965206|NCT03318783|449499308|FG000|Overall Study|Withdrawal by Subject|0|||
124965207|NCT03318783|449499309|FG001|Overall Study|Withdrawal by Subject|1|||
124965208|NCT03318783|449499308|FG000|Overall Study|Death|0|||
124965209|NCT03318783|449499309|FG001|Overall Study|Death|1|||
124965210|NCT04035577|449499312|FG000|Overall Study|Lost to Follow-up|1|||
124965211|NCT04035577|449499312|FG000|Overall Study|Withdrawal by Subject|1|||
124965212|NCT01313624|449499314|FG000|Double-Blind Phase|Adverse Event|27|||
124965213|NCT01313624|449499315|FG001|Double-Blind Phase|Adverse Event|4|||
124965214|NCT01313624|449499314|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
124965215|NCT01313624|449499315|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
124965216|NCT01313624|449499314|FG000|Double-Blind Phase|Lost to Follow-up|0|||
124965217|NCT01313624|449499315|FG001|Double-Blind Phase|Lost to Follow-up|2|||
124965218|NCT01313624|449499314|FG000|Double-Blind Phase|Physician Decision|1|||
124965219|NCT01313624|449499315|FG001|Double-Blind Phase|Physician Decision|0|||
124965220|NCT01313624|449499314|FG000|Double-Blind Phase|Lack of Efficacy|1|||
124965221|NCT01313624|449499315|FG001|Double-Blind Phase|Lack of Efficacy|0|||
124965222|NCT01313624|449499314|FG000|Open-Label Phase|Adverse Event|1|||
124965223|NCT01313624|449499315|FG001|Open-Label Phase|Adverse Event|10|||
124965224|NCT01313624|449499314|FG000|Open-Label Phase|Withdrawal by Subject|2|||
124965225|NCT01313624|449499315|FG001|Open-Label Phase|Withdrawal by Subject|2|||
124965226|NCT01313624|449499314|FG000|Open-Label Phase|Lost to Follow-up|1|||
124965227|NCT01313624|449499315|FG001|Open-Label Phase|Lost to Follow-up|1|||
124965228|NCT00104637|449499316|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
124965229|NCT00104637|449499317|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
124965230|NCT00505414|449499318|FG000|Titration Phase|Adverse Event|0|||
124965231|NCT00505414|449499319|FG001|Titration Phase|Adverse Event|0|||
124965232|NCT00505414|449499320|FG002|Titration Phase|Adverse Event|0|||
124965233|NCT00505414|449499321|FG003|Titration Phase|Adverse Event|8|||
124965234|NCT00505414|449499322|FG004|Titration Phase|Adverse Event|3|||
124965235|NCT00505414|449499318|FG000|Titration Phase|Death|0|||
124965236|NCT00505414|449499319|FG001|Titration Phase|Death|0|||
124965237|NCT00505414|449499320|FG002|Titration Phase|Death|0|||
124965238|NCT00505414|449499321|FG003|Titration Phase|Death|2|||
124965239|NCT00505414|449499322|FG004|Titration Phase|Death|0|||
124965240|NCT00505414|449499318|FG000|Titration Phase|Lack of Efficacy|0|||
124965241|NCT00505414|449499319|FG001|Titration Phase|Lack of Efficacy|0|||
124965242|NCT00505414|449499320|FG002|Titration Phase|Lack of Efficacy|0|||
124965243|NCT00505414|449499321|FG003|Titration Phase|Lack of Efficacy|10|||
124965244|NCT00505414|449499322|FG004|Titration Phase|Lack of Efficacy|1|||
124965245|NCT00505414|449499318|FG000|Titration Phase|Protocol Violation|0|||
124965246|NCT00505414|449499319|FG001|Titration Phase|Protocol Violation|0|||
124965247|NCT00505414|449499320|FG002|Titration Phase|Protocol Violation|0|||
124965248|NCT00505414|449499321|FG003|Titration Phase|Protocol Violation|0|||
124965249|NCT00505414|449499322|FG004|Titration Phase|Protocol Violation|1|||
124965250|NCT00505414|449499318|FG000|Titration Phase|Withdrawal by Subject|0|||
124965251|NCT00505414|449499319|FG001|Titration Phase|Withdrawal by Subject|0|||
124965252|NCT00505414|449499320|FG002|Titration Phase|Withdrawal by Subject|0|||
124965253|NCT00505414|449499321|FG003|Titration Phase|Withdrawal by Subject|3|||
124965254|NCT00505414|449499322|FG004|Titration Phase|Withdrawal by Subject|4|||
124965255|NCT00505414|449499318|FG000|Titration Phase|Underlying disease and therapy required|0|||
124965256|NCT00505414|449499319|FG001|Titration Phase|Underlying disease and therapy required|0|||
124965257|NCT00505414|449499320|FG002|Titration Phase|Underlying disease and therapy required|0|||
124965258|NCT00505414|449499321|FG003|Titration Phase|Underlying disease and therapy required|7|||
124965259|NCT00505414|449499322|FG004|Titration Phase|Underlying disease and therapy required|3|||
124965260|NCT00505414|449499318|FG000|Maintenance Phase|Adverse Event|2|||
124965261|NCT00505414|449499319|FG001|Maintenance Phase|Adverse Event|2|||
124965262|NCT00505414|449499320|FG002|Maintenance Phase|Adverse Event|3|||
124965263|NCT00505414|449499321|FG003|Maintenance Phase|Adverse Event|0|||
124965264|NCT00505414|449499322|FG004|Maintenance Phase|Adverse Event|0|||
124965265|NCT00505414|449499318|FG000|Maintenance Phase|Death|2|||
124965266|NCT00505414|449499319|FG001|Maintenance Phase|Death|0|||
124965267|NCT00505414|449499320|FG002|Maintenance Phase|Death|1|||
124965268|NCT00505414|449499321|FG003|Maintenance Phase|Death|0|||
124965269|NCT00505414|449499322|FG004|Maintenance Phase|Death|0|||
124965270|NCT00505414|449499318|FG000|Maintenance Phase|Lack of Efficacy|2|||
124965271|NCT00505414|449499319|FG001|Maintenance Phase|Lack of Efficacy|1|||
124965272|NCT00505414|449499320|FG002|Maintenance Phase|Lack of Efficacy|1|||
124965273|NCT00505414|449499321|FG003|Maintenance Phase|Lack of Efficacy|0|||
124965274|NCT00505414|449499322|FG004|Maintenance Phase|Lack of Efficacy|0|||
124965275|NCT00505414|449499318|FG000|Maintenance Phase|Withdrawal by Subject|0|||
124965276|NCT00505414|449499319|FG001|Maintenance Phase|Withdrawal by Subject|0|||
124965277|NCT00505414|449499320|FG002|Maintenance Phase|Withdrawal by Subject|1|||
124965278|NCT00505414|449499321|FG003|Maintenance Phase|Withdrawal by Subject|0|||
124965279|NCT00505414|449499322|FG004|Maintenance Phase|Withdrawal by Subject|0|||
124965280|NCT00505414|449499318|FG000|Maintenance Phase|underlying disease and therapy required|0|||
124965281|NCT00505414|449499319|FG001|Maintenance Phase|underlying disease and therapy required|2|||
124965282|NCT00505414|449499320|FG002|Maintenance Phase|underlying disease and therapy required|2|||
124965283|NCT00505414|449499321|FG003|Maintenance Phase|underlying disease and therapy required|0|||
124965284|NCT00505414|449499322|FG004|Maintenance Phase|underlying disease and therapy required|0|||
124965285|NCT01560871|449499323|FG000|Overall Study|transportation issues|2|||
124965286|NCT01560871|449499324|FG001|Overall Study|transportation issues|1|||
124965287|NCT01560871|449499323|FG000|Overall Study|relocation|1|||
124965288|NCT01560871|449499324|FG001|Overall Study|relocation|0|||
124965289|NCT01560871|449499323|FG000|Overall Study|readmission to a hospital|2|||
124965290|NCT01560871|449499324|FG001|Overall Study|readmission to a hospital|1|||
124965291|NCT01560871|449499323|FG000|Overall Study|Lost to Follow-up|1|||
124965292|NCT01560871|449499324|FG001|Overall Study|Lost to Follow-up|0|||
124965293|NCT00644878|449499325|FG000|Overall Study|Adverse Event|2|||
124965294|NCT00644878|449499325|FG000|Overall Study|Abnormal laboratory value|3|||
124965295|NCT00644878|449499325|FG000|Overall Study|Protocol deviation|2|||
124965296|NCT00644878|449499325|FG000|Overall Study|Treatment duration completed as per protocol|11|||
124965297|NCT00591591|449499328|FG000|Overall Study|Withdrawal by Subject|1|||
124965298|NCT00591591|449499329|FG001|Overall Study|Withdrawal by Subject|37|||
124965299|NCT00591591|449499328|FG000|Overall Study|Lack of Efficacy|10|||
124965300|NCT00591591|449499329|FG001|Overall Study|Lack of Efficacy|2|||
124965301|NCT01841112|449499335|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
124965302|NCT01841112|449499336|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
124965303|NCT01841112|449499337|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
124965304|NCT01841112|449499338|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
124965305|NCT01841112|449499339|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
124965306|NCT00878553|449499340|FG000|Sleep Study|Withdrawal by Subject|2|||
124965307|NCT00878553|449499341|FG001|Sleep Study|Withdrawal by Subject|0|||
124965308|NCT00878553|449499342|FG002|Sleep Study|Withdrawal by Subject|0|||
124965309|NCT00878553|449499343|FG003|Sleep Study|Withdrawal by Subject|0|||
124965310|NCT00878553|449499344|FG004|Sleep Study|Withdrawal by Subject|0|||
124965311|NCT00878553|449499340|FG000|Sleep Study|Lost to Follow-up|1|||
124965312|NCT00878553|449499341|FG001|Sleep Study|Lost to Follow-up|0|||
124965313|NCT00878553|449499342|FG002|Sleep Study|Lost to Follow-up|0|||
124965314|NCT00878553|449499343|FG003|Sleep Study|Lost to Follow-up|0|||
124965315|NCT00878553|449499344|FG004|Sleep Study|Lost to Follow-up|0|||
124965316|NCT00878553|449499340|FG000|Sleep Study|car accident|1|||
124965317|NCT00878553|449499341|FG001|Sleep Study|car accident|0|||
124965318|NCT00878553|449499342|FG002|Sleep Study|car accident|0|||
124965319|NCT00878553|449499343|FG003|Sleep Study|car accident|0|||
124965320|NCT00878553|449499344|FG004|Sleep Study|car accident|0|||
124965321|NCT00878553|449499340|FG000|Sleep Study|family emergency|1|||
124965322|NCT00878553|449499341|FG001|Sleep Study|family emergency|0|||
124965323|NCT00878553|449499342|FG002|Sleep Study|family emergency|0|||
124965324|NCT00878553|449499343|FG003|Sleep Study|family emergency|0|||
124965325|NCT00878553|449499344|FG004|Sleep Study|family emergency|0|||
124965326|NCT00878553|449499340|FG000|PK Study|Withdrawal by Subject|0|||
124965327|NCT00878553|449499341|FG001|PK Study|Withdrawal by Subject|0|||
124965328|NCT00878553|449499342|FG002|PK Study|Withdrawal by Subject|0|||
124965329|NCT00878553|449499343|FG003|PK Study|Withdrawal by Subject|1|||
124965330|NCT00878553|449499344|FG004|PK Study|Withdrawal by Subject|0|||
124965331|NCT00461123|449499345|FG000|Overall Study|Adverse Event|1|||
124965332|NCT00461123|449499346|FG001|Overall Study|Adverse Event|0|||
124965333|NCT00461123|449499345|FG000|Overall Study|Lost to Follow-up|1|||
124965334|NCT00461123|449499346|FG001|Overall Study|Lost to Follow-up|1|||
124965335|NCT00461123|449499345|FG000|Overall Study|Protocol Violation|3|||
124965336|NCT00461123|449499346|FG001|Overall Study|Protocol Violation|2|||
124965337|NCT00461123|449499345|FG000|Overall Study|Withdrawal by Subject|1|||
124965338|NCT00461123|449499346|FG001|Overall Study|Withdrawal by Subject|3|||
124965339|NCT05896696|449499351|FG000|Overall Study|Screening Failure|7|||
124965340|NCT05896696|449499351|FG000|Overall Study|Withdrawal by Subject|2|||
124965341|NCT02080403|449501785|FG000|Overall Study|Adverse Event|5|||
124965342|NCT02080403|449501786|FG001|Overall Study|Adverse Event|1|||
124965343|NCT02080403|449501785|FG000|Overall Study|Death|0|||
124965344|NCT02080403|449501786|FG001|Overall Study|Death|2|||
124965345|NCT02080403|449501785|FG000|Overall Study|Lost to Follow-up|2|||
124965346|NCT02080403|449501786|FG001|Overall Study|Lost to Follow-up|0|||
124965347|NCT02080403|449501785|FG000|Overall Study|Pregnancy|0|||
124965348|NCT02080403|449501786|FG001|Overall Study|Pregnancy|1|||
124965349|NCT02080403|449501785|FG000|Overall Study|Protocol Violation|3|||
124965350|NCT02080403|449501786|FG001|Overall Study|Protocol Violation|7|||
124965351|NCT02080403|449501785|FG000|Overall Study|Withdrawal by Subject|5|||
124965352|NCT02080403|449501786|FG001|Overall Study|Withdrawal by Subject|1|||
124965353|NCT01999972|449501787|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
124965354|NCT01999972|449501788|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
125216199|NCT05052697|450417534|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216200|NCT05052697|450417535|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216201|NCT05052697|450417536|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216202|NCT05052697|450417537|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216203|NCT05052697|450417538|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216204|NCT05052697|450417539|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216205|NCT05052697|450417540|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216206|NCT05052697|450417541|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216207|NCT05052697|450417542|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216208|NCT05052697|450417543|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216209|NCT05052697|450417544|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125031837|NCT00712348|449737453|FG000|Overall Study|Withdrawal by Subject|1|||
125031838|NCT02452762|449737455|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
125031839|NCT02452762|449737456|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
125031840|NCT02452762|449737455|FG000|Overall Study|Withdrawal by Subject|1|||
125031841|NCT02452762|449737456|FG001|Overall Study|Withdrawal by Subject|0|||
125031842|NCT00631137|449737457|FG000|Overall Study|Withdrawal by Subject|1|||
125031843|NCT00631137|449737458|FG001|Overall Study|Withdrawal by Subject|0|||
124965355|NCT01999972|449501789|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
124965356|NCT01999972|449501790|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
124965357|NCT01999972|449501791|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
124965358|NCT01999972|449501792|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
124965359|NCT01999972|449501787|FG000|Dose Escalation Part|Death|0|||
124965360|NCT01999972|449501788|FG001|Dose Escalation Part|Death|1|||
124965361|NCT01999972|449501789|FG002|Dose Escalation Part|Death|0|||
124965362|NCT01999972|449501790|FG003|Dose Escalation Part|Death|0|||
124965363|NCT01999972|449501791|FG004|Dose Escalation Part|Death|0|||
124965364|NCT01999972|449501792|FG005|Dose Escalation Part|Death|0|||
124965365|NCT01999972|449501787|FG000|Dose Escalation Part|Enrolled but not treated|0|||
124965366|NCT01999972|449501788|FG001|Dose Escalation Part|Enrolled but not treated|0|||
124965367|NCT01999972|449501789|FG002|Dose Escalation Part|Enrolled but not treated|1|||
124965368|NCT01999972|449501790|FG003|Dose Escalation Part|Enrolled but not treated|1|||
124965369|NCT01999972|449501791|FG004|Dose Escalation Part|Enrolled but not treated|0|||
124965370|NCT01999972|449501792|FG005|Dose Escalation Part|Enrolled but not treated|0|||
124965371|NCT01999972|449501787|FG000|Dose Escalation Part|Disease progression|3|||
124965372|NCT01999972|449501788|FG001|Dose Escalation Part|Disease progression|2|||
124965373|NCT01999972|449501789|FG002|Dose Escalation Part|Disease progression|3|||
124965374|NCT01999972|449501790|FG003|Dose Escalation Part|Disease progression|6|||
124965375|NCT01999972|449501791|FG004|Dose Escalation Part|Disease progression|0|||
124965376|NCT01999972|449501792|FG005|Dose Escalation Part|Disease progression|0|||
125031844|NCT03682120|449737459|FG000|Overall Study|Lost to Follow-up|11|||
125031845|NCT03682120|449737460|FG001|Overall Study|Lost to Follow-up|4|||
125031846|NCT03682120|449737461|FG002|Overall Study|Lost to Follow-up|5|||
125031847|NCT03682120|449737462|FG003|Overall Study|Lost to Follow-up|2|||
124965377|NCT01999972|449501787|FG000|Dose Escalation Part|Adverse Event|0|||
124965378|NCT01999972|449501788|FG001|Dose Escalation Part|Adverse Event|0|||
124965379|NCT01999972|449501789|FG002|Dose Escalation Part|Adverse Event|0|||
124965380|NCT01999972|449501790|FG003|Dose Escalation Part|Adverse Event|2|||
124965381|NCT01999972|449501791|FG004|Dose Escalation Part|Adverse Event|0|||
125031848|NCT03682120|449737459|FG000|Overall Study|Physician Decision|1|||
125216210|NCT05052697|450417545|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216211|NCT05052697|450417546|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125129705|NCT02601560|450101082|FG006|Overall Study|Other|1|||
125129706|NCT02601560|450101083|FG007|Overall Study|Other|0|||
125129707|NCT03500692|450101084|FG000|Overall Study|Death|163|||
125129708|NCT03500692|450101084|FG000|Overall Study|Lost to Follow-up|75|||
124965382|NCT01999972|449501792|FG005|Dose Escalation Part|Adverse Event|0|||
124965383|NCT01999972|449501787|FG000|Dose Escalation Part|Global deterioration of health status|1|||
124965384|NCT01999972|449501788|FG001|Dose Escalation Part|Global deterioration of health status|0|||
124965385|NCT01999972|449501789|FG002|Dose Escalation Part|Global deterioration of health status|0|||
124965386|NCT01999972|449501790|FG003|Dose Escalation Part|Global deterioration of health status|1|||
124965387|NCT01999972|449501791|FG004|Dose Escalation Part|Global deterioration of health status|0|||
124965388|NCT01999972|449501792|FG005|Dose Escalation Part|Global deterioration of health status|0|||
124965389|NCT01999972|449501787|FG000|Dose Expansion Part|Death|0|||
124965390|NCT01999972|449501788|FG001|Dose Expansion Part|Death|0|||
124965391|NCT01999972|449501789|FG002|Dose Expansion Part|Death|0|||
124965392|NCT01999972|449501790|FG003|Dose Expansion Part|Death|0|||
124965393|NCT01999972|449501791|FG004|Dose Expansion Part|Death|2|||
124965394|NCT01999972|449501792|FG005|Dose Expansion Part|Death|1|||
124965395|NCT01999972|449501787|FG000|Dose Expansion Part|Disease progression|0|||
124965396|NCT01999972|449501788|FG001|Dose Expansion Part|Disease progression|0|||
124965397|NCT01999972|449501789|FG002|Dose Expansion Part|Disease progression|0|||
124965398|NCT01999972|449501790|FG003|Dose Expansion Part|Disease progression|0|||
124965399|NCT01999972|449501791|FG004|Dose Expansion Part|Disease progression|9|||
124965400|NCT01999972|449501792|FG005|Dose Expansion Part|Disease progression|3|||
124965401|NCT01999972|449501787|FG000|Dose Expansion Part|Sponsor decision|0|||
124965402|NCT01999972|449501788|FG001|Dose Expansion Part|Sponsor decision|0|||
124965403|NCT01999972|449501789|FG002|Dose Expansion Part|Sponsor decision|0|||
124965404|NCT01999972|449501790|FG003|Dose Expansion Part|Sponsor decision|0|||
124965405|NCT01999972|449501791|FG004|Dose Expansion Part|Sponsor decision|1|||
124965406|NCT01999972|449501792|FG005|Dose Expansion Part|Sponsor decision|0|||
124965407|NCT01999972|449501787|FG000|Dose Expansion Part|Adverse Event|0|||
124965408|NCT01999972|449501788|FG001|Dose Expansion Part|Adverse Event|0|||
124965409|NCT01999972|449501789|FG002|Dose Expansion Part|Adverse Event|0|||
124965410|NCT01999972|449501790|FG003|Dose Expansion Part|Adverse Event|0|||
124965411|NCT01999972|449501791|FG004|Dose Expansion Part|Adverse Event|4|||
124965412|NCT01999972|449501792|FG005|Dose Expansion Part|Adverse Event|2|||
124965413|NCT01999972|449501787|FG000|Dose Expansion Part|Participant's non-compliance|0|||
124965414|NCT01999972|449501788|FG001|Dose Expansion Part|Participant's non-compliance|0|||
124965415|NCT01999972|449501789|FG002|Dose Expansion Part|Participant's non-compliance|0|||
124965416|NCT01999972|449501790|FG003|Dose Expansion Part|Participant's non-compliance|0|||
124965417|NCT01999972|449501791|FG004|Dose Expansion Part|Participant's non-compliance|0|||
124965418|NCT01999972|449501792|FG005|Dose Expansion Part|Participant's non-compliance|1|||
124965419|NCT01999972|449501787|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
124965420|NCT01999972|449501788|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
124965421|NCT01999972|449501789|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
124965422|NCT01999972|449501790|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
124965423|NCT01999972|449501791|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
124965424|NCT01999972|449501792|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
124965425|NCT01999972|449501787|FG000|Dose Expansion Part|Changed to standard of care|0|||
125129709|NCT03500692|450101084|FG000|Overall Study|Termination Reasons|3|||
125129710|NCT01880593|450101085|FG000|Overall Study|Adverse Event|1|||
125129711|NCT01880593|450101086|FG001|Overall Study|Adverse Event|0|||
125129712|NCT01880593|450101085|FG000|Overall Study|Lack of Efficacy|1|||
125129713|NCT01880593|450101086|FG001|Overall Study|Lack of Efficacy|5|||
124965426|NCT01999972|449501788|FG001|Dose Expansion Part|Changed to standard of care|0|||
124965427|NCT01999972|449501789|FG002|Dose Expansion Part|Changed to standard of care|0|||
124965428|NCT01999972|449501790|FG003|Dose Expansion Part|Changed to standard of care|0|||
124965429|NCT01999972|449501791|FG004|Dose Expansion Part|Changed to standard of care|1|||
124965430|NCT01999972|449501792|FG005|Dose Expansion Part|Changed to standard of care|0|||
124965431|NCT02826798|449501794|FG000|Overall Study|Withdrawal by Subject|0|||
124965432|NCT02826798|449501795|FG001|Overall Study|Withdrawal by Subject|1|||
124965433|NCT02826798|449501796|FG002|Overall Study|Withdrawal by Subject|0|||
124965434|NCT02826798|449501797|FG003|Overall Study|Withdrawal by Subject|1|||
124965435|NCT02826798|449501798|FG004|Overall Study|Withdrawal by Subject|0|||
124965436|NCT01986114|449501802|FG000|Overall Study|Adverse Event|59|||
124965437|NCT01986114|449501802|FG000|Overall Study|Lack of Efficacy|23|||
124965438|NCT01986114|449501802|FG000|Overall Study|Withdrawal by Subject|58|||
124965439|NCT01986114|449501802|FG000|Overall Study|Noncompliance|3|||
124965440|NCT01986114|449501802|FG000|Overall Study|Protocol Violation|1|||
124965441|NCT01986114|449501802|FG000|Overall Study|Lost to Follow-up|5|||
125129714|NCT01880593|450101085|FG000|Overall Study|Withdrawal by Subject|6|||
125129715|NCT01880593|450101086|FG001|Overall Study|Withdrawal by Subject|1|||
125129716|NCT02272777|450101087|FG000|Overall Study|Adverse Event|0|||
124965442|NCT01986114|449501802|FG000|Overall Study|Other reason|7|||
124965443|NCT00664105|449501803|FG000|Overall Study|Death|3|||
124965444|NCT00664105|449501803|FG000|Overall Study|Withdrawal by Subject|5|||
124965445|NCT00664105|449501803|FG000|Overall Study|Adverse Event|9|||
124965446|NCT00664105|449501803|FG000|Overall Study|Disease progression|7|||
124965447|NCT04702893|449501804|FG000|Overall Study|Other reasons than listed|11|||
124965448|NCT04702893|449501804|FG000|Overall Study|Withdrawal by Subject|3|||
124965449|NCT04702893|449501804|FG000|Overall Study|Lost to Follow-up|7|||
124965450|NCT04702893|449501804|FG000|Overall Study|Death|10|||
124965451|NCT04702893|449501804|FG000|Overall Study|Not treated|6|||
124965452|NCT04469465|449501805|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
124965453|NCT04469465|449501806|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
124965454|NCT04469465|449501805|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
124965455|NCT04469465|449501806|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
124965456|NCT04469465|449501805|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
124965457|NCT04469465|449501806|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
124965458|NCT04469465|449501805|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
124965459|NCT04469465|449501806|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
124965460|NCT04469465|449501805|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
124965461|NCT04469465|449501806|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
124965462|NCT04469465|449501805|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
124965463|NCT04469465|449501806|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
124965464|NCT04469465|449501805|FG000|Long-Term Extension (LTE)|Death|0|||
124965465|NCT04469465|449501806|FG001|Long-Term Extension (LTE)|Death|1|||
124965466|NCT04469465|449501805|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
124965467|NCT04469465|449501806|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
124965468|NCT01951378|449501807|FG000|Overall Study|Study Terminated-Not completed|23|||
124965469|NCT01951378|449501808|FG001|Overall Study|Study Terminated-Not completed|17|||
124965470|NCT01660256|449501809|FG000|Overall Study|Adverse Event|4|||
124965471|NCT01660256|449501810|FG001|Overall Study|Adverse Event|0|||
124965472|NCT01660256|449501811|FG002|Overall Study|Adverse Event|2|||
124965473|NCT01660256|449501809|FG000|Overall Study|Withdrawal by Subject|1|||
124965474|NCT01660256|449501810|FG001|Overall Study|Withdrawal by Subject|0|||
124965475|NCT01660256|449501811|FG002|Overall Study|Withdrawal by Subject|2|||
124965476|NCT03491215|449501812|FG000|Overall Study|Death|6|||
124965477|NCT03491215|449501813|FG001|Overall Study|Death|2|||
124965478|NCT03491215|449501814|FG002|Overall Study|Death|1|||
124965479|NCT03491215|449501815|FG003|Overall Study|Death|0|||
124965480|NCT03491215|449501812|FG000|Overall Study|Physician Decision|1|||
124965481|NCT03491215|449501813|FG001|Overall Study|Physician Decision|0|||
124965482|NCT03491215|449501814|FG002|Overall Study|Physician Decision|0|||
124965483|NCT03491215|449501815|FG003|Overall Study|Physician Decision|0|||
124965484|NCT00551135|449501821|FG000|Overall Study|Adverse Event|1|||
124965485|NCT00551135|449501822|FG001|Overall Study|Adverse Event|0|||
124965486|NCT00551135|449501823|FG002|Overall Study|Adverse Event|1|||
124965487|NCT00551135|449501824|FG003|Overall Study|Adverse Event|1|||
124965488|NCT00551135|449501821|FG000|Overall Study|Lost to Follow-up|0|||
124965489|NCT00551135|449501822|FG001|Overall Study|Lost to Follow-up|0|||
124965490|NCT00551135|449501823|FG002|Overall Study|Lost to Follow-up|0|||
124965491|NCT00551135|449501824|FG003|Overall Study|Lost to Follow-up|1|||
124965492|NCT00551135|449501821|FG000|Overall Study|Other|3|||
124965493|NCT00551135|449501822|FG001|Overall Study|Other|2|||
124965494|NCT00551135|449501823|FG002|Overall Study|Other|1|||
124965495|NCT00551135|449501824|FG003|Overall Study|Other|2|||
124965496|NCT00551135|449501821|FG000|Overall Study|Withdrawal by Subject|1|||
124965497|NCT00551135|449501822|FG001|Overall Study|Withdrawal by Subject|0|||
124965498|NCT00551135|449501823|FG002|Overall Study|Withdrawal by Subject|3|||
124965499|NCT00551135|449501824|FG003|Overall Study|Withdrawal by Subject|1|||
124965500|NCT01202409|449501825|FG000|Overall Study|Adverse Event|1|||
124965501|NCT01202409|449501825|FG000|Overall Study|Ineligible - KRAS mutants|7|||
124965502|NCT01004185|449501826|FG000|Overall Study|Adverse Event|1|||
124965503|NCT01004185|449501827|FG001|Overall Study|Adverse Event|1|||
124965504|NCT01004185|449501826|FG000|Overall Study|Lost to Follow-up|0|||
124965505|NCT01004185|449501827|FG001|Overall Study|Lost to Follow-up|1|||
125129717|NCT02272777|450101088|FG001|Overall Study|Adverse Event|1|||
125129718|NCT02272777|450101087|FG000|Overall Study|Withdrawal by Subject|0|||
124965506|NCT01004185|449501826|FG000|Overall Study|Lack of Efficacy|2|||
124965507|NCT01004185|449501827|FG001|Overall Study|Lack of Efficacy|1|||
124965508|NCT01004185|449501826|FG000|Overall Study|Sponsor Terminated Study|4|||
124965509|NCT01004185|449501827|FG001|Overall Study|Sponsor Terminated Study|5|||
124965510|NCT01004185|449501826|FG000|Overall Study|Withdrawal by Subject|2|||
124965511|NCT01004185|449501827|FG001|Overall Study|Withdrawal by Subject|1|||
124965512|NCT01172639|449501832|FG000|Overall Study|Death|1|||
124965513|NCT01172639|449501833|FG001|Overall Study|Death|1|||
124965514|NCT01172639|449501834|FG002|Overall Study|Death|0|||
125129719|NCT02272777|450101088|FG001|Overall Study|Withdrawal by Subject|3|||
124965515|NCT01172639|449501835|FG003|Overall Study|Death|0|||
124965516|NCT01172639|449501836|FG004|Overall Study|Death|0|||
124965517|NCT01172639|449501832|FG000|Overall Study|Lost to Follow-up|9|||
124965518|NCT01172639|449501833|FG001|Overall Study|Lost to Follow-up|7|||
124965519|NCT01172639|449501834|FG002|Overall Study|Lost to Follow-up|11|||
124965520|NCT01172639|449501835|FG003|Overall Study|Lost to Follow-up|6|||
124965521|NCT01172639|449501836|FG004|Overall Study|Lost to Follow-up|6|||
124965522|NCT01172639|449501832|FG000|Overall Study|Withdrawal by Subject|3|||
124965523|NCT01172639|449501833|FG001|Overall Study|Withdrawal by Subject|3|||
124965524|NCT01172639|449501834|FG002|Overall Study|Withdrawal by Subject|5|||
124965525|NCT01172639|449501835|FG003|Overall Study|Withdrawal by Subject|5|||
124965526|NCT01172639|449501836|FG004|Overall Study|Withdrawal by Subject|0|||
124965527|NCT00469456|449501839|FG000|Overall Study|Adverse Event|4|||
124965528|NCT00469456|449501840|FG001|Overall Study|Adverse Event|3|||
124965529|NCT00469456|449501839|FG000|Overall Study|Protocol Violation|1|||
124965530|NCT00469456|449501840|FG001|Overall Study|Protocol Violation|0|||
124965531|NCT00469456|449501839|FG000|Overall Study|Withdrawal by Subject|4|||
124965532|NCT00469456|449501840|FG001|Overall Study|Withdrawal by Subject|1|||
124965533|NCT00719043|449501853|FG000|Overall Study|Adverse Event|5|||
124965534|NCT00719043|449501854|FG001|Overall Study|Adverse Event|1|||
124965535|NCT00719043|449501855|FG002|Overall Study|Adverse Event|2|||
124965536|NCT00719043|449501856|FG003|Overall Study|Adverse Event|2|||
124965537|NCT00719043|449501857|FG004|Overall Study|Adverse Event|1|||
124965538|NCT00719043|449501858|FG005|Overall Study|Adverse Event|4|||
124965539|NCT00719043|449501859|FG006|Overall Study|Adverse Event|4|||
124965540|NCT00719043|449501853|FG000|Overall Study|Lost to Follow-up|14|||
124965541|NCT00719043|449501854|FG001|Overall Study|Lost to Follow-up|10|||
124965542|NCT00719043|449501855|FG002|Overall Study|Lost to Follow-up|8|||
124965543|NCT00719043|449501856|FG003|Overall Study|Lost to Follow-up|9|||
124965544|NCT00719043|449501857|FG004|Overall Study|Lost to Follow-up|10|||
124965545|NCT00719043|449501858|FG005|Overall Study|Lost to Follow-up|9|||
124965546|NCT00719043|449501859|FG006|Overall Study|Lost to Follow-up|9|||
124965547|NCT00719043|449501853|FG000|Overall Study|Protocol Violation|0|||
124965548|NCT00719043|449501854|FG001|Overall Study|Protocol Violation|0|||
124965549|NCT00719043|449501855|FG002|Overall Study|Protocol Violation|0|||
124965550|NCT00719043|449501856|FG003|Overall Study|Protocol Violation|0|||
124965551|NCT00719043|449501857|FG004|Overall Study|Protocol Violation|0|||
124965552|NCT00719043|449501858|FG005|Overall Study|Protocol Violation|1|||
124965553|NCT00719043|449501859|FG006|Overall Study|Protocol Violation|0|||
124965554|NCT00719043|449501853|FG000|Overall Study|Other|1|||
124965555|NCT00719043|449501854|FG001|Overall Study|Other|0|||
124965556|NCT00719043|449501855|FG002|Overall Study|Other|1|||
124965557|NCT00719043|449501856|FG003|Overall Study|Other|2|||
124965558|NCT00719043|449501857|FG004|Overall Study|Other|0|||
124965559|NCT00719043|449501858|FG005|Overall Study|Other|2|||
124965560|NCT00719043|449501859|FG006|Overall Study|Other|1|||
124965561|NCT00719043|449501853|FG000|Overall Study|Withdrawal by Subject|12|||
124965562|NCT00719043|449501854|FG001|Overall Study|Withdrawal by Subject|14|||
124965563|NCT00719043|449501855|FG002|Overall Study|Withdrawal by Subject|9|||
124965564|NCT00719043|449501856|FG003|Overall Study|Withdrawal by Subject|10|||
124965565|NCT00719043|449501857|FG004|Overall Study|Withdrawal by Subject|16|||
124965566|NCT00719043|449501858|FG005|Overall Study|Withdrawal by Subject|18|||
124965567|NCT00719043|449501859|FG006|Overall Study|Withdrawal by Subject|14|||
124965568|NCT01588366|449501860|FG000|Overall Study|Adverse Event|0|||
124965569|NCT01588366|449501861|FG001|Overall Study|Adverse Event|1|||
124965570|NCT01588366|449501862|FG002|Overall Study|Adverse Event|0|||
124965571|NCT01588366|449501863|FG003|Overall Study|Adverse Event|1|||
124965572|NCT01588366|449501864|FG004|Overall Study|Adverse Event|0|||
125031849|NCT03682120|449737460|FG001|Overall Study|Physician Decision|0|||
125031850|NCT03682120|449737461|FG002|Overall Study|Physician Decision|0|||
125031851|NCT03682120|449737462|FG003|Overall Study|Physician Decision|0|||
125031852|NCT03682120|449737459|FG000|Overall Study|Withdrawal by Subject|1|||
125031853|NCT03682120|449737460|FG001|Overall Study|Withdrawal by Subject|2|||
125031854|NCT03682120|449737461|FG002|Overall Study|Withdrawal by Subject|3|||
125031855|NCT03682120|449737462|FG003|Overall Study|Withdrawal by Subject|0|||
125031856|NCT03682120|449737459|FG000|Overall Study|Death|0|||
125031857|NCT03682120|449737460|FG001|Overall Study|Death|1|||
124965573|NCT01588366|449501865|FG005|Overall Study|Adverse Event|2|||
124965574|NCT03245619|449501866|FG000|Part A (Up to Day 22)|Physician Decision|4|||
124965575|NCT03245619|449501867|FG001|Part A (Up to Day 22)|Physician Decision|6|||
124965576|NCT03245619|449501868|FG002|Part A (Up to Day 22)|Physician Decision|6|||
124965577|NCT03245619|449501869|FG003|Part A (Up to Day 22)|Physician Decision|0|||
124965578|NCT03245619|449501870|FG004|Part A (Up to Day 22)|Physician Decision|0|||
124965579|NCT03245619|449501871|FG005|Part A (Up to Day 22)|Physician Decision|0|||
124965580|NCT03245619|449501872|FG006|Part A (Up to Day 22)|Physician Decision|0|||
124965581|NCT03245619|449501873|FG007|Part A (Up to Day 22)|Physician Decision|0|||
124965582|NCT03245619|449501874|FG008|Part A (Up to Day 22)|Physician Decision|0|||
124965583|NCT03245619|449501875|FG009|Part A (Up to Day 22)|Physician Decision|0|||
124965584|NCT03245619|449501876|FG010|Part A (Up to Day 22)|Physician Decision|0|||
124965585|NCT03245619|449501877|FG011|Part A (Up to Day 22)|Physician Decision|0|||
125031858|NCT03682120|449737461|FG002|Overall Study|Death|0|||
125031859|NCT03682120|449737462|FG003|Overall Study|Death|0|||
125129720|NCT02272777|450101087|FG000|Overall Study|Lost to Follow-up|2|||
125129721|NCT02272777|450101088|FG001|Overall Study|Lost to Follow-up|0|||
125129722|NCT02272777|450101087|FG000|Overall Study|Other|2|||
124965586|NCT03245619|449501878|FG012|Part A (Up to Day 22)|Physician Decision|0|||
124965587|NCT03245619|449501879|FG013|Part A (Up to Day 22)|Physician Decision|0|||
124965588|NCT03245619|449501880|FG014|Part A (Up to Day 22)|Physician Decision|0|||
124965589|NCT03245619|449501881|FG015|Part A (Up to Day 22)|Physician Decision|0|||
124965590|NCT03245619|449501882|FG016|Part A (Up to Day 22)|Physician Decision|0|||
124965591|NCT01704547|449501883|FG000|Overall Study|Physician Decision|4|||
124965592|NCT01704547|449501883|FG000|Overall Study|Withdrawal by Subject|1|||
124965593|NCT00690378|449501890|FG000|Overall Study|Adverse Event|1|||
124965594|NCT00690378|449501891|FG001|Overall Study|Adverse Event|0|||
124965595|NCT00690378|449501890|FG000|Overall Study|Withdrawal by Subject|2|||
124965596|NCT00690378|449501891|FG001|Overall Study|Withdrawal by Subject|0|||
124965597|NCT00690378|449501890|FG000|Overall Study|Protocol Violation|1|||
124965598|NCT00690378|449501891|FG001|Overall Study|Protocol Violation|0|||
124965599|NCT00690378|449501890|FG000|Overall Study|Lost to Follow-up|2|||
124965600|NCT00690378|449501891|FG001|Overall Study|Lost to Follow-up|3|||
124965601|NCT00690378|449501890|FG000|Overall Study|Did not meet inc/exc criteria|13|||
124965602|NCT00690378|449501891|FG001|Overall Study|Did not meet inc/exc criteria|11|||
124965603|NCT00690378|449501890|FG000|Overall Study|Social problem|1|||
124965604|NCT00690378|449501891|FG001|Overall Study|Social problem|0|||
124965605|NCT00846768|449501893|FG000|Overall Study|Adverse Event|0|||
124965606|NCT00846768|449501894|FG001|Overall Study|Adverse Event|1|||
124965607|NCT00846768|449501895|FG002|Overall Study|Adverse Event|0|||
124965608|NCT00846768|449501896|FG003|Overall Study|Adverse Event|0|||
124965609|NCT00912223|449501901|FG000|Overall Study|Withdrawal by Subject|1|||
124965610|NCT00912223|449501901|FG000|Overall Study|Not transplanted|1|||
124965611|NCT00912223|449501901|FG000|Overall Study|Transformed disease|1|||
124965612|NCT01099579|449501902|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
124965613|NCT01099579|449501903|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
124965614|NCT01099579|449501904|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
124965615|NCT01099579|449501902|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
124965616|NCT01099579|449501903|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
124965617|NCT01099579|449501904|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
124965618|NCT01099579|449501902|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
124965619|NCT01099579|449501903|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
124965620|NCT01099579|449501904|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
124965621|NCT01099579|449501902|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
124965622|NCT01099579|449501903|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
124965623|NCT01099579|449501904|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
124965624|NCT01099579|449501902|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
124965625|NCT01099579|449501903|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
124965626|NCT01099579|449501904|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
124965627|NCT01099579|449501902|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
124965628|NCT01099579|449501903|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
124965629|NCT01099579|449501904|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
124965630|NCT01099579|449501902|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
124965631|NCT01099579|449501903|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
124965632|NCT01099579|449501904|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
124965633|NCT01099579|449501902|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
124965634|NCT01099579|449501903|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
124965635|NCT01099579|449501904|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
124965636|NCT01099579|449501902|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
124965637|NCT01099579|449501903|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
124965638|NCT01099579|449501904|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
124965639|NCT01099579|449501902|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
124965640|NCT01099579|449501903|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
124965641|NCT01099579|449501904|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
124965642|NCT00909532|449501905|FG000|Overall Study|Adverse Event|4|||
124965643|NCT00909532|449501906|FG001|Overall Study|Adverse Event|1|||
124965644|NCT00909532|449501905|FG000|Overall Study|Pregnancy|0|||
124965645|NCT00909532|449501906|FG001|Overall Study|Pregnancy|1|||
124965646|NCT00909532|449501905|FG000|Overall Study|Prohibited Medication|2|||
124965647|NCT00909532|449501906|FG001|Overall Study|Prohibited Medication|1|||
124965648|NCT00909532|449501905|FG000|Overall Study|Withdrawal of Consent|1|||
124965649|NCT00909532|449501906|FG001|Overall Study|Withdrawal of Consent|1|||
124965650|NCT00909532|449501905|FG000|Overall Study|Noncompliance with Study Requirements|0|||
124965651|NCT00909532|449501906|FG001|Overall Study|Noncompliance with Study Requirements|2|||
124965652|NCT00909532|449501905|FG000|Overall Study|Physician Decision|1|||
124965653|NCT00909532|449501906|FG001|Overall Study|Physician Decision|0|||
124965654|NCT00909532|449501905|FG000|Overall Study|Wrong Genotype|1|||
124965655|NCT00909532|449501906|FG001|Overall Study|Wrong Genotype|0|||
124965656|NCT00909532|449501905|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
125129723|NCT02272777|450101088|FG001|Overall Study|Other|0|||
125129724|NCT02066922|450101089|FG000|Overall Study|Adverse Event|1|||
125129725|NCT05275205|450101090|FG000|Overall Study|Adverse Event|1|||
125129726|NCT05275205|450101091|FG001|Overall Study|Adverse Event|2|||
125129727|NCT05275205|450101090|FG000|Overall Study|Physician Decision|1|||
124965657|NCT00909532|449501906|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
124965658|NCT01157377|449501909|FG000|Overall Study|Lost to Follow-up|0|||
124965659|NCT01157377|449501910|FG001|Overall Study|Lost to Follow-up|0|||
124965660|NCT01157377|449501911|FG002|Overall Study|Lost to Follow-up|1|||
124965661|NCT01157377|449501912|FG003|Overall Study|Lost to Follow-up|0|||
124965662|NCT01157377|449501913|FG004|Overall Study|Lost to Follow-up|1|||
124965663|NCT01157377|449501914|FG005|Overall Study|Lost to Follow-up|1|||
124965664|NCT01157377|449501915|FG006|Overall Study|Lost to Follow-up|0|||
124965665|NCT01157377|449501909|FG000|Overall Study|Personal Reasons|2|||
124965666|NCT01157377|449501910|FG001|Overall Study|Personal Reasons|1|||
124965667|NCT01157377|449501911|FG002|Overall Study|Personal Reasons|0|||
124965668|NCT01157377|449501912|FG003|Overall Study|Personal Reasons|1|||
124965669|NCT01157377|449501913|FG004|Overall Study|Personal Reasons|0|||
124965670|NCT01157377|449501914|FG005|Overall Study|Personal Reasons|0|||
124965671|NCT01157377|449501915|FG006|Overall Study|Personal Reasons|0|||
124965672|NCT01157377|449501909|FG000|Overall Study|Protocol Violation|0|||
124965673|NCT01157377|449501910|FG001|Overall Study|Protocol Violation|0|||
124965674|NCT01157377|449501911|FG002|Overall Study|Protocol Violation|0|||
124965675|NCT01157377|449501912|FG003|Overall Study|Protocol Violation|0|||
124965676|NCT01157377|449501913|FG004|Overall Study|Protocol Violation|0|||
124965677|NCT01157377|449501914|FG005|Overall Study|Protocol Violation|1|||
124965678|NCT01157377|449501915|FG006|Overall Study|Protocol Violation|0|||
124965679|NCT01157377|449501909|FG000|Overall Study|Lack of Efficacy|0|||
124965680|NCT01157377|449501910|FG001|Overall Study|Lack of Efficacy|0|||
124965681|NCT01157377|449501911|FG002|Overall Study|Lack of Efficacy|0|||
124965682|NCT01157377|449501912|FG003|Overall Study|Lack of Efficacy|0|||
124965683|NCT01157377|449501913|FG004|Overall Study|Lack of Efficacy|0|||
124965684|NCT01157377|449501914|FG005|Overall Study|Lack of Efficacy|0|||
124965685|NCT01157377|449501915|FG006|Overall Study|Lack of Efficacy|1|||
124965686|NCT01157377|449501909|FG000|Overall Study|Other Miscellaneous Reasons|0|||
124965687|NCT01157377|449501910|FG001|Overall Study|Other Miscellaneous Reasons|2|||
124965688|NCT01157377|449501911|FG002|Overall Study|Other Miscellaneous Reasons|0|||
124965689|NCT01157377|449501912|FG003|Overall Study|Other Miscellaneous Reasons|0|||
124965690|NCT01157377|449501913|FG004|Overall Study|Other Miscellaneous Reasons|1|||
124965691|NCT01157377|449501914|FG005|Overall Study|Other Miscellaneous Reasons|1|||
124965692|NCT01157377|449501915|FG006|Overall Study|Other Miscellaneous Reasons|1|||
124965693|NCT00927901|449501916|FG000|Treatment Period 1|Subject withdrew consent|0|||
124965694|NCT00927901|449501917|FG001|Treatment Period 1|Subject withdrew consent|0|||
124965695|NCT00927901|449501918|FG002|Treatment Period 1|Subject withdrew consent|1|||
124965696|NCT00927901|449501919|FG003|Treatment Period 1|Subject withdrew consent|0|||
124965697|NCT00927901|449501916|FG000|Treatment Period 4|Adverse Event|0|||
124965698|NCT00927901|449501917|FG001|Treatment Period 4|Adverse Event|0|||
124965699|NCT00927901|449501918|FG002|Treatment Period 4|Adverse Event|0|||
124965700|NCT00927901|449501919|FG003|Treatment Period 4|Adverse Event|1|||
124965701|NCT00927901|449501916|FG000|Treatment Period 4|Subject withdrew consent|0|||
124965702|NCT00927901|449501917|FG001|Treatment Period 4|Subject withdrew consent|0|||
124965703|NCT00927901|449501918|FG002|Treatment Period 4|Subject withdrew consent|1|||
124965704|NCT00927901|449501919|FG003|Treatment Period 4|Subject withdrew consent|0|||
124965705|NCT01263925|449501924|FG000|Overall Study|Protocol Violation|1|||
124965706|NCT01263925|449501925|FG001|Overall Study|Protocol Violation|0|||
124965707|NCT01263925|449501924|FG000|Overall Study|Lack of Efficacy|0|||
124965708|NCT01263925|449501925|FG001|Overall Study|Lack of Efficacy|1|||
124965709|NCT01263925|449501924|FG000|Overall Study|Adverse Event|23|||
125129728|NCT05275205|450101091|FG001|Overall Study|Physician Decision|1|||
125129729|NCT05275205|450101090|FG000|Overall Study|Withdrawal by Subject|2|||
124965710|NCT01263925|449501925|FG001|Overall Study|Adverse Event|22|||
124965711|NCT01263925|449501924|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
125129730|NCT05275205|450101091|FG001|Overall Study|Withdrawal by Subject|3|||
124965712|NCT01263925|449501925|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
124965713|NCT01263925|449501924|FG000|Overall Study|Withdrawal by Subject|6|||
124965714|NCT01263925|449501925|FG001|Overall Study|Withdrawal by Subject|8|||
124965715|NCT01263925|449501924|FG000|Overall Study|Other|4|||
124965716|NCT01263925|449501925|FG001|Overall Study|Other|4|||
124965717|NCT01263925|449501924|FG000|Overall Study|Lost to Follow-up|3|||
124965718|NCT01263925|449501925|FG001|Overall Study|Lost to Follow-up|1|||
125129731|NCT05275205|450101090|FG000|Overall Study|Death|1|||
125129732|NCT05275205|450101091|FG001|Overall Study|Death|0|||
124965719|NCT01263925|449501924|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
124965720|NCT01263925|449501925|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
124965721|NCT01263925|449501924|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
124965722|NCT01263925|449501925|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
124965723|NCT01263925|449501924|FG000|Overall Study|AE/ Withdrawal|1|||
124965724|NCT01263925|449501925|FG001|Overall Study|AE/ Withdrawal|4|||
124965725|NCT01263925|449501924|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
124965726|NCT01263925|449501925|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
124965727|NCT01263925|449501924|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
124965728|NCT01263925|449501925|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
124965729|NCT01263925|449501924|FG000|Overall Study|Withdrawal/ Not specified|0|||
124965730|NCT01263925|449501925|FG001|Overall Study|Withdrawal/ Not specified|1|||
124965731|NCT03029819|449501926|FG000|Overall Study|Lost to Follow-up|3|||
124965732|NCT03029819|449501927|FG001|Overall Study|Lost to Follow-up|5|||
124965733|NCT03029819|449501926|FG000|Overall Study|Removed due to disruptive behavior|0|||
124965734|NCT03029819|449501927|FG001|Overall Study|Removed due to disruptive behavior|1|||
124965735|NCT02650466|449501934|FG000|Overall Study|Physician Decision|1|||
124965736|NCT02650466|449501934|FG000|Overall Study|Withdrawal by Subject|5|||
124965737|NCT02650466|449501934|FG000|Overall Study|Lost to Follow-up|1|||
124965738|NCT01726517|449501935|FG000|Overall Study|Withdrawal by Subject|0|||
124965739|NCT01726517|449501936|FG001|Overall Study|Withdrawal by Subject|0|||
124965740|NCT01726517|449501937|FG002|Overall Study|Withdrawal by Subject|1|||
124965741|NCT01726517|449501938|FG003|Overall Study|Withdrawal by Subject|0|||
124965742|NCT01726517|449501939|FG004|Overall Study|Withdrawal by Subject|0|||
124965743|NCT00573651|449501940|FG000|Overall Study|Lost to Follow-up|3|||
124965744|NCT00573651|449501940|FG000|Overall Study|Withdrawal by Subject|1|||
124965745|NCT03765164|449501941|FG000|Pre-intervention|Withdrawal by Subject|5|||
124965746|NCT03765164|449501942|FG001|Pre-intervention|Withdrawal by Subject|6|||
124965747|NCT03797989|449501964|FG000|VAC069A|Withdrawal by Subject|0|||
124965748|NCT03797989|449501965|FG001|VAC069A|Withdrawal by Subject|0|||
124965749|NCT03797989|449501966|FG002|VAC069A|Withdrawal by Subject|1|||
124965750|NCT03797989|449501967|FG003|VAC069A|Withdrawal by Subject|0|||
124965751|NCT03797989|449501968|FG004|VAC069A|Withdrawal by Subject|0|||
124965752|NCT03797989|449501969|FG005|VAC069A|Withdrawal by Subject|0|||
124965753|NCT03797989|449501970|FG006|VAC069A|Withdrawal by Subject|0|||
124965754|NCT03797989|449501971|FG007|VAC069A|Withdrawal by Subject|0|||
124965755|NCT03797989|449501972|FG008|VAC069A|Withdrawal by Subject|0|||
124965756|NCT03797989|449501973|FG009|VAC069A|Withdrawal by Subject|0|||
124965757|NCT03797989|449501974|FG010|VAC069A|Withdrawal by Subject|0|||
124965758|NCT03797989|449501975|FG011|VAC069A|Withdrawal by Subject|0|||
124965759|NCT04052997|449501976|FG000|Overall Study|Withdrawal by Subject|17|||
124965760|NCT04052997|449501976|FG000|Overall Study|Physician Decision|50|||
124965761|NCT04052997|449501976|FG000|Overall Study|Death|43|||
124965762|NCT04052997|449501976|FG000|Overall Study|Lost to Follow-up|5|||
124965763|NCT04052997|449501976|FG000|Overall Study|Progression of Disease|1|||
124965764|NCT01024036|449501977|FG000|Blinded Treatment|Adverse Event|1|||
124965765|NCT01024036|449501978|FG001|Blinded Treatment|Adverse Event|1|||
124965766|NCT01024036|449501977|FG000|Blinded Treatment|Lack of Efficacy|16|||
124965767|NCT01024036|449501978|FG001|Blinded Treatment|Lack of Efficacy|14|||
124965768|NCT01024036|449501977|FG000|Blinded Treatment|Physician Decision|1|||
124965769|NCT01024036|449501978|FG001|Blinded Treatment|Physician Decision|0|||
124965770|NCT01024036|449501977|FG000|Blinded Treatment|Death|0|||
124965771|NCT01024036|449501978|FG001|Blinded Treatment|Death|2|||
124965772|NCT01024036|449501977|FG000|Blinded Treatment|Withdrawal by Subject|4|||
124965773|NCT01024036|449501978|FG001|Blinded Treatment|Withdrawal by Subject|3|||
124965774|NCT01024036|449501977|FG000|Unblinded Treatment|Adverse Event|0|||
124965775|NCT01024036|449501978|FG001|Unblinded Treatment|Adverse Event|1|||
124965776|NCT01024036|449501977|FG000|Unblinded Treatment|Lack of Efficacy|0|||
124965777|NCT01024036|449501978|FG001|Unblinded Treatment|Lack of Efficacy|2|||
124965778|NCT01024036|449501977|FG000|Follow-Up Period|Lost to Follow-up|1|||
124965779|NCT01024036|449501978|FG001|Follow-Up Period|Lost to Follow-up|1|||
124965780|NCT01024036|449501977|FG000|Follow-Up Period|Withdrawal by Subject|0|||
124965781|NCT01024036|449501978|FG001|Follow-Up Period|Withdrawal by Subject|1|||
124965782|NCT01024036|449501977|FG000|Follow-Up Period|Adverse Event|4|||
124965783|NCT01024036|449501978|FG001|Follow-Up Period|Adverse Event|1|||
124965784|NCT00604188|449501983|FG000|Overall Study|Adverse Event|1|||
125031860|NCT03682120|449737459|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
125031861|NCT03682120|449737460|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
125031862|NCT03682120|449737461|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
125031863|NCT03682120|449737462|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
125031864|NCT03308188|449737463|FG000|Overall Study|Withdrawal by Subject|0|||
125031865|NCT03308188|449737464|FG001|Overall Study|Withdrawal by Subject|3|||
125031866|NCT03308188|449737463|FG000|Overall Study|Death|0|||
125031867|NCT03308188|449737464|FG001|Overall Study|Death|1|||
125031868|NCT01791855|449737465|FG000|Overall Study|Adverse Event|0|||
125031869|NCT01791855|449737466|FG001|Overall Study|Adverse Event|0|||
125031870|NCT01791855|449737467|FG002|Overall Study|Adverse Event|0|||
124965785|NCT00604188|449501984|FG001|Overall Study|Adverse Event|4|||
124965786|NCT00604188|449501983|FG000|Overall Study|Lost to Follow-up|17|||
124965787|NCT00604188|449501984|FG001|Overall Study|Lost to Follow-up|15|||
124965788|NCT00604188|449501983|FG000|Overall Study|Withdrawal by Subject|5|||
125031871|NCT01791855|449737468|FG003|Overall Study|Adverse Event|1|||
124965789|NCT00604188|449501984|FG001|Overall Study|Withdrawal by Subject|1|||
124965790|NCT00604188|449501983|FG000|Overall Study|Non-compliance with protocol|4|||
124965791|NCT00604188|449501984|FG001|Overall Study|Non-compliance with protocol|4|||
124965792|NCT00604188|449501983|FG000|Overall Study|Did not receive study drug|0|||
124965793|NCT00604188|449501984|FG001|Overall Study|Did not receive study drug|1|||
124965794|NCT00356759|449501989|FG000|Overall Study|Death|5|||
124965795|NCT00356759|449501990|FG001|Overall Study|Death|2|||
124965796|NCT00356759|449501989|FG000|Overall Study|Withdrawal by Subject|2|||
124965797|NCT00356759|449501990|FG001|Overall Study|Withdrawal by Subject|2|||
124965798|NCT00356759|449501989|FG000|Overall Study|Adverse Event|1|||
124965799|NCT00356759|449501990|FG001|Overall Study|Adverse Event|3|||
124965800|NCT00356759|449501989|FG000|Overall Study|Lost to Follow-up|1|||
124965801|NCT00356759|449501990|FG001|Overall Study|Lost to Follow-up|1|||
124965802|NCT00356759|449501989|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
124965803|NCT00356759|449501990|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
124965804|NCT00474383|449501992|FG000|Main Study|Adverse Event|11|||
124965805|NCT00474383|449501993|FG001|Main Study|Adverse Event|0|||
124965806|NCT00474383|449501992|FG000|Main Study|Symptomatic Deterioration|1|||
124965807|NCT00474383|449501993|FG001|Main Study|Symptomatic Deterioration|0|||
124965808|NCT00474383|449501992|FG000|Main Study|Progressive Disease|23|||
124965809|NCT00474383|449501993|FG001|Main Study|Progressive Disease|0|||
124965810|NCT00474383|449501992|FG000|Main Study|Other|1|||
124965811|NCT00474383|449501993|FG001|Main Study|Other|0|||
124965812|NCT00474383|449501992|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
124965813|NCT00474383|449501993|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
124965814|NCT00474383|449501992|FG000|Extension|Progressive Disease|0|||
124965815|NCT00474383|449501993|FG001|Extension|Progressive Disease|5|||
124965816|NCT02998918|449501994|FG000|Overall Study|Withdrawal by Subject|1|||
124965817|NCT02998918|449501995|FG001|Overall Study|Withdrawal by Subject|0|||
124965818|NCT00443599|449502001|FG000|Overall Study|Physician Decision|2|||
124965819|NCT00443599|449502002|FG001|Overall Study|Physician Decision|1|||
124965820|NCT00443599|449502001|FG000|Overall Study|Death|1|||
124965821|NCT00443599|449502002|FG001|Overall Study|Death|1|||
124965822|NCT00443599|449502001|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
124965823|NCT00443599|449502002|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
124965824|NCT02202109|449503904|FG000|Overall Study|Lost to Follow-up|88|||
124965825|NCT02202109|449503905|FG001|Overall Study|Lost to Follow-up|87|||
124965826|NCT02202109|449503904|FG000|Overall Study|Withdrawal by Subject|2|||
124965827|NCT02202109|449503905|FG001|Overall Study|Withdrawal by Subject|0|||
124965828|NCT01256671|449503907|FG000|Overall Study|Adverse Event|29|||
124965829|NCT01256671|449503907|FG000|Overall Study|Lost to Follow-up|16|||
124965830|NCT01256671|449503907|FG000|Overall Study|Withdrawal by Subject|31|||
124965831|NCT01256671|449503907|FG000|Overall Study|Physician Decision|3|||
124965832|NCT01256671|449503907|FG000|Overall Study|Lack of Efficacy|4|||
124965833|NCT01256671|449503907|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
124965834|NCT01468077|449503914|FG000|Overall Study|Adverse Event|2|||
124965835|NCT01468077|449503915|FG001|Overall Study|Adverse Event|2|||
124965836|NCT01468077|449503914|FG000|Overall Study|Lack of Efficacy|1|||
124965837|NCT01468077|449503915|FG001|Overall Study|Lack of Efficacy|1|||
124965838|NCT01468077|449503914|FG000|Overall Study|Physician Decision|1|||
124965839|NCT01468077|449503915|FG001|Overall Study|Physician Decision|0|||
124965840|NCT00761956|449503916|FG000|Overall Study|Lost to Follow-up|6|||
124965841|NCT00761956|449503917|FG001|Overall Study|Lost to Follow-up|11|||
124965842|NCT00761956|449503916|FG000|Overall Study|Withdrawal by Subject|3|||
124965843|NCT00761956|449503917|FG001|Overall Study|Withdrawal by Subject|8|||
124965844|NCT00761956|449503916|FG000|Overall Study|Death|0|||
124965845|NCT00761956|449503917|FG001|Overall Study|Death|1|||
124965846|NCT00761956|449503916|FG000|Overall Study|Adverse Event|26|||
124965847|NCT00761956|449503917|FG001|Overall Study|Adverse Event|34|||
124965848|NCT03024996|449503918|FG000|Overall Study|Death|57|||
124965849|NCT03024996|449503919|FG001|Overall Study|Death|55|||
124965850|NCT03024996|449503918|FG000|Overall Study|Disease relapse|1|||
124965851|NCT03024996|449503919|FG001|Overall Study|Disease relapse|0|||
124965852|NCT03024996|449503918|FG000|Overall Study|Lost to Follow-up|5|||
124965853|NCT03024996|449503919|FG001|Overall Study|Lost to Follow-up|10|||
124965854|NCT03024996|449503918|FG000|Overall Study|Other|3|||
124965855|NCT03024996|449503919|FG001|Overall Study|Other|3|||
124965856|NCT03024996|449503918|FG000|Overall Study|Physician Decision|0|||
124965857|NCT03024996|449503919|FG001|Overall Study|Physician Decision|1|||
124965858|NCT03024996|449503918|FG000|Overall Study|Study terminated by sponsor|303|||
124965859|NCT03024996|449503919|FG001|Overall Study|Study terminated by sponsor|283|||
124965860|NCT03024996|449503918|FG000|Overall Study|Withdrawal by Subject|21|||
124965861|NCT03024996|449503919|FG001|Overall Study|Withdrawal by Subject|36|||
124965862|NCT00030823|449503924|FG000|Overall Study|Withdrawal by Subject|1|||
124965863|NCT04333147|449503926|FG000|Overall Study|Adverse Event|43|||
124965864|NCT04333147|449503927|FG001|Overall Study|Adverse Event|40|||
124965865|NCT04333147|449503926|FG000|Overall Study|Lack of Efficacy|49|||
125129733|NCT05275205|450101090|FG000|Overall Study|Patient unable to attend visits|1|||
125129734|NCT05275205|450101091|FG001|Overall Study|Patient unable to attend visits|0|||
125129735|NCT00440297|450101092|FG000|Overall Study|Adverse Event|8|||
124965866|NCT04333147|449503927|FG001|Overall Study|Lack of Efficacy|48|||
124965867|NCT04333147|449503926|FG000|Overall Study|Lost to Follow-up|19|||
124965868|NCT04333147|449503927|FG001|Overall Study|Lost to Follow-up|16|||
124965869|NCT04333147|449503926|FG000|Overall Study|Physician Decision|17|||
124965870|NCT04333147|449503927|FG001|Overall Study|Physician Decision|20|||
124965871|NCT04333147|449503926|FG000|Overall Study|Withdrawal by Subject|65|||
124965872|NCT04333147|449503927|FG001|Overall Study|Withdrawal by Subject|68|||
124965873|NCT04333147|449503926|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
124965874|NCT04333147|449503927|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
124965875|NCT04333147|449503926|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
124965876|NCT04333147|449503927|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
124965877|NCT04333147|449503926|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
124965878|NCT04333147|449503927|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
124965879|NCT02106195|449503928|FG000|Overall Study|Adverse Event|2|||
124965880|NCT02106195|449503928|FG000|Overall Study|Protocol Violation|1|||
124965881|NCT00408928|449503929|FG000|Overall Study|Withdrawal by Subject|1|||
124965882|NCT00408928|449503929|FG000|Overall Study|Death|1|||
124965883|NCT00408928|449503929|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
124965884|NCT03194867|449503930|FG000|Overall Study|Incorrect completion of end of study form|0|||
124965885|NCT03194867|449503931|FG001|Overall Study|Incorrect completion of end of study form|0|||
124965886|NCT03194867|449503932|FG002|Overall Study|Incorrect completion of end of study form|1|||
124965887|NCT03194867|449503933|FG003|Overall Study|Incorrect completion of end of study form|0|||
124965888|NCT00464945|449503934|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
124965889|NCT00464945|449503935|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
124965890|NCT00464945|449503934|FG000|Infant Series|Protocol Violation|1|||
124965891|NCT00464945|449503935|FG001|Infant Series|Protocol Violation|0|||
124965892|NCT00464945|449503934|FG000|Infant Series|Lost to Follow-up|1|||
124965893|NCT00464945|449503935|FG001|Infant Series|Lost to Follow-up|0|||
124965894|NCT00464945|449503934|FG000|After Infant Series|Withdrawal by Subject|0|||
124965895|NCT00464945|449503935|FG001|After Infant Series|Withdrawal by Subject|2|||
124965896|NCT00464945|449503934|FG000|Toddler Dose|Lost to Follow-up|0|||
124965897|NCT00464945|449503935|FG001|Toddler Dose|Lost to Follow-up|1|||
124965898|NCT03305809|449503938|FG000|Overall Study|Adverse Event|2|||
124965899|NCT03305809|449503939|FG001|Overall Study|Adverse Event|2|||
124965900|NCT03305809|449503940|FG002|Overall Study|Adverse Event|6|||
124965901|NCT03305809|449503941|FG003|Overall Study|Adverse Event|6|||
124965902|NCT03305809|449503938|FG000|Overall Study|Death|0|||
124965903|NCT03305809|449503939|FG001|Overall Study|Death|0|||
124965904|NCT03305809|449503940|FG002|Overall Study|Death|1|||
124965905|NCT03305809|449503941|FG003|Overall Study|Death|1|||
124965906|NCT03305809|449503938|FG000|Overall Study|Lost to Follow-up|1|||
124965907|NCT03305809|449503939|FG001|Overall Study|Lost to Follow-up|2|||
124965908|NCT03305809|449503940|FG002|Overall Study|Lost to Follow-up|0|||
124965909|NCT03305809|449503941|FG003|Overall Study|Lost to Follow-up|0|||
124965910|NCT03305809|449503938|FG000|Overall Study|Sponsor Decision|1|||
124965911|NCT03305809|449503939|FG001|Overall Study|Sponsor Decision|0|||
124965912|NCT03305809|449503940|FG002|Overall Study|Sponsor Decision|1|||
124965913|NCT03305809|449503941|FG003|Overall Study|Sponsor Decision|8|||
124965914|NCT03305809|449503938|FG000|Overall Study|Physician Decision|0|||
124965915|NCT03305809|449503939|FG001|Overall Study|Physician Decision|0|||
124965916|NCT03305809|449503940|FG002|Overall Study|Physician Decision|2|||
124965917|NCT03305809|449503941|FG003|Overall Study|Physician Decision|4|||
124965918|NCT03305809|449503938|FG000|Overall Study|Progressive Disease|0|||
124965919|NCT03305809|449503939|FG001|Overall Study|Progressive Disease|0|||
124965920|NCT03305809|449503940|FG002|Overall Study|Progressive Disease|1|||
124965921|NCT03305809|449503941|FG003|Overall Study|Progressive Disease|0|||
124965922|NCT03305809|449503938|FG000|Overall Study|Protocol Violation|1|||
124965923|NCT03305809|449503939|FG001|Overall Study|Protocol Violation|0|||
124965924|NCT03305809|449503940|FG002|Overall Study|Protocol Violation|2|||
125129736|NCT00440297|450101093|FG001|Overall Study|Adverse Event|5|||
125129737|NCT00440297|450101092|FG000|Overall Study|Lost to Follow-up|1|||
125129738|NCT00440297|450101093|FG001|Overall Study|Lost to Follow-up|0|||
125129739|NCT00440297|450101092|FG000|Overall Study|Physician Decision|1|||
125129740|NCT00440297|450101093|FG001|Overall Study|Physician Decision|0|||
124965925|NCT03305809|449503941|FG003|Overall Study|Protocol Violation|3|||
124965926|NCT03305809|449503938|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
124965927|NCT03305809|449503939|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
124965928|NCT03305809|449503940|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
124965929|NCT03305809|449503941|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
124965930|NCT03305809|449503938|FG000|Overall Study|Withdrawal by Subject|2|||
124965931|NCT03305809|449503939|FG001|Overall Study|Withdrawal by Subject|4|||
124965932|NCT03305809|449503940|FG002|Overall Study|Withdrawal by Subject|5|||
125129741|NCT00440297|450101092|FG000|Overall Study|Protocol Violation|11|||
125129742|NCT00440297|450101093|FG001|Overall Study|Protocol Violation|7|||
124965933|NCT03305809|449503941|FG003|Overall Study|Withdrawal by Subject|2|||
124965934|NCT03305809|449503938|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
124965935|NCT03305809|449503939|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
124965936|NCT03305809|449503940|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
124965937|NCT03305809|449503941|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
124965938|NCT00816556|449503942|FG000|Overall Study|Adverse Event|1|||
124965939|NCT00816556|449503943|FG001|Overall Study|Adverse Event|1|||
124965940|NCT00816556|449503944|FG002|Overall Study|Adverse Event|1|||
124965941|NCT00816556|449503942|FG000|Overall Study|Withdrawal by Subject|1|||
124965942|NCT00816556|449503943|FG001|Overall Study|Withdrawal by Subject|1|||
124965943|NCT00816556|449503944|FG002|Overall Study|Withdrawal by Subject|1|||
124965944|NCT00816556|449503942|FG000|Overall Study|Lost to Follow-up|0|||
124965945|NCT00816556|449503943|FG001|Overall Study|Lost to Follow-up|0|||
124965946|NCT00816556|449503944|FG002|Overall Study|Lost to Follow-up|1|||
124965947|NCT02438371|449503945|FG000|Overall Study|Lost to Follow-up|3|||
124965948|NCT02438371|449503946|FG001|Overall Study|Lost to Follow-up|2|||
124965949|NCT02438371|449503945|FG000|Overall Study|Withdrawal by Subject|1|||
124965950|NCT02438371|449503946|FG001|Overall Study|Withdrawal by Subject|1|||
124965951|NCT03546816|449503947|FG000|Overall Study|Adverse Event|5|||
124965952|NCT03546816|449503948|FG001|Overall Study|Adverse Event|3|||
124965953|NCT03546816|449503947|FG000|Overall Study|Lack of Efficacy|2|||
124965954|NCT03546816|449503948|FG001|Overall Study|Lack of Efficacy|4|||
124965955|NCT03546816|449503947|FG000|Overall Study|Pregnancy|1|||
124965956|NCT03546816|449503948|FG001|Overall Study|Pregnancy|0|||
124965957|NCT03546816|449503947|FG000|Overall Study|Physician Decision|2|||
124965958|NCT03546816|449503948|FG001|Overall Study|Physician Decision|0|||
124965959|NCT03546816|449503947|FG000|Overall Study|Withdrawal by Subject|8|||
124965960|NCT03546816|449503948|FG001|Overall Study|Withdrawal by Subject|10|||
124965961|NCT03546816|449503947|FG000|Overall Study|Lost to Follow-up|3|||
124965962|NCT03546816|449503948|FG001|Overall Study|Lost to Follow-up|2|||
124965963|NCT01161446|449503949|FG000|Overall Study|Lost to Follow-up|18|||
124965964|NCT01161446|449503950|FG001|Overall Study|Lost to Follow-up|14|||
124965965|NCT01161446|449503949|FG000|Overall Study|Withdrawal by Subject|0|||
124965966|NCT01161446|449503950|FG001|Overall Study|Withdrawal by Subject|1|||
124965967|NCT03065933|449503951|FG000|Overall Study|study terminated|5|||
124965968|NCT02330562|449503952|FG000|Overall Study|Adverse Event|0|||
124965969|NCT02330562|449503953|FG001|Overall Study|Adverse Event|0|||
124965970|NCT02330562|449503954|FG002|Overall Study|Adverse Event|3|||
124965971|NCT02330562|449503955|FG003|Overall Study|Adverse Event|0|||
124965972|NCT02330562|449503956|FG004|Overall Study|Adverse Event|3|||
124965973|NCT02330562|449503957|FG005|Overall Study|Adverse Event|1|||
124965974|NCT02330562|449503958|FG006|Overall Study|Adverse Event|0|||
124965975|NCT02330562|449503959|FG007|Overall Study|Adverse Event|0|||
124965976|NCT02330562|449503960|FG008|Overall Study|Adverse Event|0|||
124965977|NCT02330562|449503961|FG009|Overall Study|Adverse Event|1|||
124965978|NCT02330562|449503962|FG010|Overall Study|Adverse Event|1|||
124965979|NCT02330562|449503952|FG000|Overall Study|Participant decision|1|||
124965980|NCT02330562|449503953|FG001|Overall Study|Participant decision|0|||
124965981|NCT02330562|449503954|FG002|Overall Study|Participant decision|4|||
124965982|NCT02330562|449503955|FG003|Overall Study|Participant decision|1|||
124965983|NCT02330562|449503956|FG004|Overall Study|Participant decision|5|||
124965984|NCT02330562|449503957|FG005|Overall Study|Participant decision|2|||
124965985|NCT02330562|449503958|FG006|Overall Study|Participant decision|0|||
124965986|NCT02330562|449503959|FG007|Overall Study|Participant decision|0|||
124965987|NCT02330562|449503960|FG008|Overall Study|Participant decision|0|||
124965988|NCT02330562|449503961|FG009|Overall Study|Participant decision|3|||
124965989|NCT02330562|449503962|FG010|Overall Study|Participant decision|0|||
124965990|NCT02330562|449503952|FG000|Overall Study|Disease progression|5|||
124965991|NCT02330562|449503953|FG001|Overall Study|Disease progression|3|||
124965992|NCT02330562|449503954|FG002|Overall Study|Disease progression|20|||
124965993|NCT02330562|449503955|FG003|Overall Study|Disease progression|28|||
124965994|NCT02330562|449503956|FG004|Overall Study|Disease progression|23|||
124965995|NCT02330562|449503957|FG005|Overall Study|Disease progression|7|||
124965996|NCT02330562|449503958|FG006|Overall Study|Disease progression|1|||
124965997|NCT02330562|449503959|FG007|Overall Study|Disease progression|1|||
124965998|NCT02330562|449503960|FG008|Overall Study|Disease progression|1|||
124965999|NCT02330562|449503961|FG009|Overall Study|Disease progression|0|||
124966000|NCT02330562|449503962|FG010|Overall Study|Disease progression|5|||
124966001|NCT02330562|449503952|FG000|Overall Study|Other reasons|0|||
124966002|NCT02330562|449503953|FG001|Overall Study|Other reasons|0|||
124966003|NCT02330562|449503954|FG002|Overall Study|Other reasons|0|||
124966004|NCT02330562|449503955|FG003|Overall Study|Other reasons|1|||
124966005|NCT02330562|449503956|FG004|Overall Study|Other reasons|0|||
124966006|NCT02330562|449503957|FG005|Overall Study|Other reasons|0|||
124966007|NCT02330562|449503958|FG006|Overall Study|Other reasons|0|||
124966008|NCT02330562|449503959|FG007|Overall Study|Other reasons|0|||
124966009|NCT02330562|449503960|FG008|Overall Study|Other reasons|0|||
124966010|NCT02330562|449503961|FG009|Overall Study|Other reasons|0|||
124966011|NCT02330562|449503962|FG010|Overall Study|Other reasons|0|||
125031872|NCT01791855|449737465|FG000|Overall Study|Randomized, not treated|0|||
125031873|NCT01791855|449737466|FG001|Overall Study|Randomized, not treated|1|||
125031874|NCT01791855|449737467|FG002|Overall Study|Randomized, not treated|0|||
125031875|NCT01791855|449737468|FG003|Overall Study|Randomized, not treated|0|||
125031876|NCT00772447|449737469|FG000|Overall Study|Withdrawal by Subject|9|||
125031877|NCT00772447|449737470|FG001|Overall Study|Withdrawal by Subject|5|||
125031878|NCT00772447|449737469|FG000|Overall Study|Physician Decision|4|||
125031879|NCT00772447|449737470|FG001|Overall Study|Physician Decision|8|||
125031880|NCT00772447|449737469|FG000|Overall Study|Lost to Follow-up|2|||
125031881|NCT00772447|449737470|FG001|Overall Study|Lost to Follow-up|4|||
125031882|NCT00772447|449737469|FG000|Overall Study|incorrect enrolment|3|||
125031883|NCT00772447|449737470|FG001|Overall Study|incorrect enrolment|4|||
125031884|NCT00772447|449737469|FG000|Overall Study|Protocol Violation|0|||
125031885|NCT00772447|449737470|FG001|Overall Study|Protocol Violation|1|||
125031886|NCT00772447|449737469|FG000|Overall Study|all others|2|||
125031887|NCT00772447|449737470|FG001|Overall Study|all others|2|||
125031888|NCT01957137|449737471|FG000|Randomized Portion|Adverse Event|1|||
125031889|NCT01957137|449737471|FG000|Randomized Portion|Withdrawal by Subject|1|||
125031890|NCT01497262|449737472|FG000|Overall Study|Abnormal Lab Values|4|||
125031891|NCT01497262|449737472|FG000|Overall Study|Abnormal Test Procedure Result|1|||
125031892|NCT01497262|449737472|FG000|Overall Study|Physician Decision|1|||
125031893|NCT01497262|449737472|FG000|Overall Study|Withdrawal by Subject|2|||
125031894|NCT01497262|449737472|FG000|Overall Study|Adverse Event|2|||
125031895|NCT01497262|449737472|FG000|Overall Study|Protocol Violation|1|||
125031896|NCT02497001|449737475|FG000|Overall Study|Lost to Follow-up|10|||
125129743|NCT00440297|450101092|FG000|Overall Study|Withdrawal by Subject|1|||
125129744|NCT00440297|450101093|FG001|Overall Study|Withdrawal by Subject|6|||
125129745|NCT00440297|450101092|FG000|Overall Study|Randomized by mistake|1|||
125129746|NCT00440297|450101093|FG001|Overall Study|Randomized by mistake|0|||
125129747|NCT02039908|450101096|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
125129748|NCT02039908|450101097|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
125129749|NCT02039908|450101098|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
125031897|NCT02497001|449737476|FG001|Overall Study|Lost to Follow-up|2|||
125129750|NCT02039908|450101099|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
125129751|NCT02039908|450101096|FG000|Phase 1-Summer|Protocol Violation|6|||
125031898|NCT02497001|449737477|FG002|Overall Study|Lost to Follow-up|0|||
125031899|NCT02497001|449737478|FG003|Overall Study|Lost to Follow-up|2|||
125031900|NCT02497001|449737475|FG000|Overall Study|Adverse Event|28|||
125031901|NCT02497001|449737476|FG001|Overall Study|Adverse Event|30|||
125031902|NCT02497001|449737477|FG002|Overall Study|Adverse Event|11|||
125129752|NCT02039908|450101097|FG001|Phase 1-Summer|Protocol Violation|0|||
125129753|NCT02039908|450101098|FG002|Phase 1-Summer|Protocol Violation|0|||
125129754|NCT02039908|450101099|FG003|Phase 1-Summer|Protocol Violation|0|||
125031903|NCT02497001|449737478|FG003|Overall Study|Adverse Event|11|||
125031904|NCT02497001|449737475|FG000|Overall Study|Withdrawal by Subject|14|||
125031905|NCT02497001|449737476|FG001|Overall Study|Withdrawal by Subject|37|||
125031906|NCT02497001|449737477|FG002|Overall Study|Withdrawal by Subject|19|||
125031907|NCT02497001|449737478|FG003|Overall Study|Withdrawal by Subject|15|||
125129755|NCT02039908|450101096|FG000|Phase 2-School Year|Lost to Follow-up|0|||
125129756|NCT02039908|450101097|FG001|Phase 2-School Year|Lost to Follow-up|0|||
124966012|NCT02330562|449503952|FG000|Overall Study|Withdrawal by Subject|0|||
124966013|NCT02330562|449503953|FG001|Overall Study|Withdrawal by Subject|0|||
124966014|NCT02330562|449503954|FG002|Overall Study|Withdrawal by Subject|0|||
124966015|NCT02330562|449503955|FG003|Overall Study|Withdrawal by Subject|0|||
124966016|NCT02330562|449503956|FG004|Overall Study|Withdrawal by Subject|0|||
124966017|NCT02330562|449503957|FG005|Overall Study|Withdrawal by Subject|0|||
124966018|NCT02330562|449503958|FG006|Overall Study|Withdrawal by Subject|0|||
124966019|NCT02330562|449503959|FG007|Overall Study|Withdrawal by Subject|0|||
124966020|NCT02330562|449503960|FG008|Overall Study|Withdrawal by Subject|0|||
124966021|NCT02330562|449503961|FG009|Overall Study|Withdrawal by Subject|1|||
124966022|NCT02330562|449503962|FG010|Overall Study|Withdrawal by Subject|0|||
125031908|NCT02497001|449737475|FG000|Overall Study|Physician Decision|5|||
125129757|NCT02039908|450101098|FG002|Phase 2-School Year|Lost to Follow-up|1|||
125129758|NCT02039908|450101099|FG003|Phase 2-School Year|Lost to Follow-up|3|||
125129759|NCT02039908|450101096|FG000|Phase 2-School Year|Protocol Violation|0|||
124966023|NCT01162135|449503966|FG000|Overall Study|Withdrawal by Subject|1|||
124966024|NCT01162135|449503966|FG000|Overall Study|Severe back pain|1|||
125129760|NCT02039908|450101097|FG001|Phase 2-School Year|Protocol Violation|0|||
125129761|NCT02039908|450101098|FG002|Phase 2-School Year|Protocol Violation|3|||
124966025|NCT01162135|449503966|FG000|Overall Study|Ineligible|1|||
124966026|NCT01379703|449503967|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
124966027|NCT01379703|449503968|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
125031909|NCT02497001|449737476|FG001|Overall Study|Physician Decision|11|||
125031910|NCT02497001|449737477|FG002|Overall Study|Physician Decision|5|||
125031911|NCT02497001|449737478|FG003|Overall Study|Physician Decision|1|||
125031912|NCT02497001|449737475|FG000|Overall Study|subjects that were not treated|1|||
125031913|NCT02497001|449737476|FG001|Overall Study|subjects that were not treated|2|||
124966028|NCT01379703|449503969|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
124966029|NCT01379703|449503967|FG000|Study Start Through 9 Months|Adverse Event|0|||
124966030|NCT01379703|449503968|FG001|Study Start Through 9 Months|Adverse Event|14|||
124966031|NCT01379703|449503969|FG002|Study Start Through 9 Months|Adverse Event|10|||
124966032|NCT01379703|449503967|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
124966033|NCT01379703|449503968|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
124966034|NCT01379703|449503969|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
124966035|NCT01379703|449503967|FG000|Study Start Through 9 Months|Treatment Failure|0|||
124966036|NCT01379703|449503968|FG001|Study Start Through 9 Months|Treatment Failure|2|||
124966037|NCT01379703|449503969|FG002|Study Start Through 9 Months|Treatment Failure|2|||
124966038|NCT01379703|449503967|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
124966039|NCT01379703|449503968|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
124966040|NCT01379703|449503969|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
124966041|NCT01379703|449503967|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
124966042|NCT01379703|449503968|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
124966043|NCT01379703|449503969|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
124966044|NCT01379703|449503967|FG000|Study Start Through 9 Months|Medication not available|0|||
124966045|NCT01379703|449503968|FG001|Study Start Through 9 Months|Medication not available|2|||
124966046|NCT01379703|449503969|FG002|Study Start Through 9 Months|Medication not available|1|||
124966047|NCT01379703|449503967|FG000|Study Start Through 9 Months|Poor general condition|0|||
124966048|NCT01379703|449503968|FG001|Study Start Through 9 Months|Poor general condition|1|||
124966049|NCT01379703|449503969|FG002|Study Start Through 9 Months|Poor general condition|0|||
124966050|NCT01379703|449503967|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
124966051|NCT01379703|449503968|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
124966052|NCT01379703|449503969|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
124966053|NCT01379703|449503967|FG000|Study Start Through 9 Months|Reason unknown|2|||
124966054|NCT01379703|449503968|FG001|Study Start Through 9 Months|Reason unknown|31|||
124966055|NCT01379703|449503969|FG002|Study Start Through 9 Months|Reason unknown|24|||
124966056|NCT01379703|449503967|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
124966057|NCT01379703|449503968|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
124966058|NCT01379703|449503969|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
124966059|NCT01379703|449503967|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
124966060|NCT01379703|449503968|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
124966061|NCT01379703|449503969|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
124966062|NCT01379703|449503967|FG000|9 Months Through 18 Months|Adverse Event|0|||
124966063|NCT01379703|449503968|FG001|9 Months Through 18 Months|Adverse Event|6|||
124966064|NCT01379703|449503969|FG002|9 Months Through 18 Months|Adverse Event|0|||
124966065|NCT01379703|449503967|FG000|9 Months Through 18 Months|Treatment failure|0|||
124966066|NCT01379703|449503968|FG001|9 Months Through 18 Months|Treatment failure|5|||
124966067|NCT01379703|449503969|FG002|9 Months Through 18 Months|Treatment failure|0|||
124966068|NCT01379703|449503967|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
124966069|NCT01379703|449503968|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
124966070|NCT01379703|449503969|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
124966071|NCT01379703|449503967|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
124966072|NCT01379703|449503968|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
124966073|NCT01379703|449503969|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
124966074|NCT01379703|449503967|FG000|9 Months Through 18 Months|Fatigue|0|||
124966075|NCT01379703|449503968|FG001|9 Months Through 18 Months|Fatigue|1|||
124966076|NCT01379703|449503969|FG002|9 Months Through 18 Months|Fatigue|0|||
124966077|NCT01379703|449503967|FG000|9 Months Through 18 Months|Reason Unknown|0|||
124966078|NCT01379703|449503968|FG001|9 Months Through 18 Months|Reason Unknown|23|||
124966079|NCT01379703|449503969|FG002|9 Months Through 18 Months|Reason Unknown|0|||
124966080|NCT01316887|449503970|FG000|Overall Study|Adverse Event|13|||
124966081|NCT01316887|449503971|FG001|Overall Study|Adverse Event|21|||
124966082|NCT01316887|449503972|FG002|Overall Study|Adverse Event|17|||
124966083|NCT01316887|449503970|FG000|Overall Study|Lack of Efficacy|9|||
124966084|NCT01316887|449503971|FG001|Overall Study|Lack of Efficacy|3|||
124966085|NCT01316887|449503972|FG002|Overall Study|Lack of Efficacy|1|||
124966086|NCT01316887|449503970|FG000|Overall Study|Protocol Violation|2|||
124966087|NCT01316887|449503971|FG001|Overall Study|Protocol Violation|6|||
124966088|NCT01316887|449503972|FG002|Overall Study|Protocol Violation|6|||
124966089|NCT01316887|449503970|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
124966090|NCT01316887|449503971|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
124966091|NCT01316887|449503972|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
124966092|NCT01316887|449503970|FG000|Overall Study|Study Closed/Terminated|2|||
124966093|NCT01316887|449503971|FG001|Overall Study|Study Closed/Terminated|4|||
124966094|NCT01316887|449503972|FG002|Overall Study|Study Closed/Terminated|3|||
124966095|NCT01316887|449503970|FG000|Overall Study|Lost to Follow-up|1|||
124966096|NCT01316887|449503971|FG001|Overall Study|Lost to Follow-up|7|||
125129762|NCT02039908|450101099|FG003|Phase 2-School Year|Protocol Violation|0|||
125129763|NCT02039908|450101096|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
124966097|NCT01316887|449503972|FG002|Overall Study|Lost to Follow-up|5|||
124966098|NCT01316887|449503970|FG000|Overall Study|Withdrawal by Subject|8|||
124966099|NCT01316887|449503971|FG001|Overall Study|Withdrawal by Subject|16|||
124966100|NCT01316887|449503972|FG002|Overall Study|Withdrawal by Subject|15|||
124966101|NCT00813098|449503973|FG000|Overall Study|Adverse Event|2|||
124966102|NCT00813098|449503974|FG001|Overall Study|Adverse Event|4|||
124966103|NCT00813098|449503975|FG002|Overall Study|Adverse Event|1|||
124966104|NCT00813098|449503973|FG000|Overall Study|Withdrawal by Subject|0|||
124966105|NCT00813098|449503974|FG001|Overall Study|Withdrawal by Subject|1|||
124966106|NCT00813098|449503975|FG002|Overall Study|Withdrawal by Subject|0|||
124966107|NCT00813098|449503973|FG000|Overall Study|Inability to complete study procedures|1|||
124966108|NCT00813098|449503974|FG001|Overall Study|Inability to complete study procedures|0|||
124966109|NCT00813098|449503975|FG002|Overall Study|Inability to complete study procedures|0|||
124966110|NCT00813098|449503973|FG000|Overall Study|Lost to Follow-up|0|||
124966111|NCT00813098|449503974|FG001|Overall Study|Lost to Follow-up|1|||
124966112|NCT00813098|449503975|FG002|Overall Study|Lost to Follow-up|0|||
124966113|NCT00813098|449503973|FG000|Overall Study|Protocol Violation|0|||
124966114|NCT00813098|449503974|FG001|Overall Study|Protocol Violation|0|||
124966115|NCT00813098|449503975|FG002|Overall Study|Protocol Violation|1|||
124966116|NCT00813098|449503973|FG000|Overall Study|Principal Investigator decision|0|||
124966117|NCT00813098|449503974|FG001|Overall Study|Principal Investigator decision|1|||
124966118|NCT00813098|449503975|FG002|Overall Study|Principal Investigator decision|0|||
124966119|NCT00813098|449503973|FG000|Overall Study|Withdrew Consent|0|||
124966120|NCT00813098|449503974|FG001|Overall Study|Withdrew Consent|1|||
124966121|NCT00813098|449503975|FG002|Overall Study|Withdrew Consent|0|||
124966122|NCT03470545|449503978|FG000|Overall Study|Death|0|||
124966123|NCT03470545|449503979|FG001|Overall Study|Death|1|||
124966124|NCT03470545|449503978|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
124966125|NCT03470545|449503979|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
124966126|NCT03470545|449503978|FG000|Overall Study|Adverse Event|2|||
124966127|NCT03470545|449503979|FG001|Overall Study|Adverse Event|0|||
124966128|NCT03470545|449503978|FG000|Overall Study|Withdrawal by Subject|1|||
124966129|NCT03470545|449503979|FG001|Overall Study|Withdrawal by Subject|1|||
124966130|NCT03470545|449503978|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
124966131|NCT03470545|449503979|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
124966132|NCT02312206|449503980|FG000|Overall Study|Adverse Event|3|||
124966133|NCT02312206|449503981|FG001|Overall Study|Adverse Event|6|||
124966134|NCT02312206|449503980|FG000|Overall Study|Withdrawal by Subject|6|||
124966135|NCT02312206|449503981|FG001|Overall Study|Withdrawal by Subject|6|||
124966136|NCT02312206|449503980|FG000|Overall Study|Physician Decision|7|||
124966137|NCT02312206|449503981|FG001|Overall Study|Physician Decision|6|||
124966138|NCT02312206|449503980|FG000|Overall Study|Death|31|||
124966139|NCT02312206|449503981|FG001|Overall Study|Death|36|||
124966140|NCT02312206|449503980|FG000|Overall Study|Study Terminated by Sponsor|81|||
124966141|NCT02312206|449503981|FG001|Overall Study|Study Terminated by Sponsor|74|||
124966142|NCT02312206|449503980|FG000|Overall Study|Patient transferred to hospice|0|||
124966143|NCT02312206|449503981|FG001|Overall Study|Patient transferred to hospice|1|||
124966144|NCT02312206|449503980|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
124966145|NCT02312206|449503981|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
124966146|NCT02312206|449503980|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
124966147|NCT02312206|449503981|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
124966148|NCT02312206|449503980|FG000|Overall Study|Disease Progression|1|||
124966149|NCT02312206|449503981|FG001|Overall Study|Disease Progression|0|||
124966150|NCT00585975|449503982|FG000|Overall Study|Withdrawal by Subject|3|||
124966151|NCT00585975|449503983|FG001|Overall Study|Withdrawal by Subject|3|||
124966152|NCT00585975|449503982|FG000|Overall Study|Lost to Follow-up|2|||
124966153|NCT00585975|449503983|FG001|Overall Study|Lost to Follow-up|1|||
124966154|NCT00585975|449503982|FG000|Overall Study|Enrollment met/over-enrolled|10|||
124966155|NCT00585975|449503983|FG001|Overall Study|Enrollment met/over-enrolled|9|||
124966156|NCT03082612|449503984|FG000|Overall Study|Lost to Follow-up|2|||
124966157|NCT03082612|449503985|FG001|Overall Study|Lost to Follow-up|0|||
124966158|NCT01336205|449503986|FG000|Overall Study|Other|22|||
124966159|NCT01336205|449503987|FG001|Overall Study|Other|9|||
124966160|NCT01336205|449503986|FG000|Overall Study|Lost to Follow-up|40|||
124966161|NCT01336205|449503987|FG001|Overall Study|Lost to Follow-up|20|||
124966162|NCT01336205|449503986|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
124966163|NCT01336205|449503987|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
124966164|NCT01336205|449503986|FG000|Overall Study|Lack of Efficacy|4|||
124966165|NCT01336205|449503987|FG001|Overall Study|Lack of Efficacy|0|||
125216212|NCT05052697|450417547|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216213|NCT05052697|450417548|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
124966166|NCT01336205|449503986|FG000|Overall Study|Severe noncompliance with protocol|9|||
125216214|NCT05052697|450417549|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
125216215|NCT05052697|450417550|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
125216216|NCT05052697|450417551|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216217|NCT05052697|450417552|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216218|NCT05052697|450417553|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216219|NCT01289574|450417554|FG000|Overall Study|Lack of Efficacy|4|||
125216220|NCT01289574|450417555|FG001|Overall Study|Lack of Efficacy|0|||
125216221|NCT01289574|450417556|FG002|Overall Study|Lack of Efficacy|1|||
125216222|NCT01289574|450417554|FG000|Overall Study|Lost to Follow-up|2|||
125216223|NCT01289574|450417555|FG001|Overall Study|Lost to Follow-up|0|||
125216224|NCT01289574|450417556|FG002|Overall Study|Lost to Follow-up|1|||
125216225|NCT01289574|450417554|FG000|Overall Study|Withdrawal by Subject|1|||
125216226|NCT01289574|450417555|FG001|Overall Study|Withdrawal by Subject|1|||
125216227|NCT01289574|450417556|FG002|Overall Study|Withdrawal by Subject|1|||
125216228|NCT01289574|450417554|FG000|Overall Study|Adverse Event|0|||
125216229|NCT01289574|450417555|FG001|Overall Study|Adverse Event|1|||
125216230|NCT01289574|450417556|FG002|Overall Study|Adverse Event|0|||
125216231|NCT01289574|450417554|FG000|Overall Study|Subject wanted alternate treatment|0|||
125216232|NCT01289574|450417555|FG001|Overall Study|Subject wanted alternate treatment|1|||
125216233|NCT01289574|450417556|FG002|Overall Study|Subject wanted alternate treatment|0|||
125216234|NCT00262002|450417557|FG000|Overall Study|Adverse Event|2|||
125216235|NCT00262002|450417558|FG001|Overall Study|Adverse Event|1|||
125216236|NCT00262002|450417559|FG002|Overall Study|Adverse Event|0|||
125216237|NCT00262002|450417560|FG003|Overall Study|Adverse Event|0|||
125216238|NCT00262002|450417561|FG004|Overall Study|Adverse Event|0|||
125216239|NCT00262002|450417562|FG005|Overall Study|Adverse Event|1|||
125216240|NCT00262002|450417563|FG006|Overall Study|Adverse Event|0|||
125216241|NCT00262002|450417557|FG000|Overall Study|Withdrawal by Subject|4|||
125216242|NCT00262002|450417558|FG001|Overall Study|Withdrawal by Subject|2|||
125216243|NCT00262002|450417559|FG002|Overall Study|Withdrawal by Subject|0|||
125216244|NCT00262002|450417560|FG003|Overall Study|Withdrawal by Subject|1|||
125216245|NCT00262002|450417561|FG004|Overall Study|Withdrawal by Subject|2|||
125216246|NCT00262002|450417562|FG005|Overall Study|Withdrawal by Subject|2|||
125216247|NCT00262002|450417563|FG006|Overall Study|Withdrawal by Subject|2|||
125216248|NCT00262002|450417557|FG000|Overall Study|Lost to Follow-up|2|||
125216249|NCT00262002|450417558|FG001|Overall Study|Lost to Follow-up|0|||
125216250|NCT00262002|450417559|FG002|Overall Study|Lost to Follow-up|0|||
125216251|NCT00262002|450417560|FG003|Overall Study|Lost to Follow-up|2|||
125216252|NCT00262002|450417561|FG004|Overall Study|Lost to Follow-up|0|||
125216253|NCT00262002|450417562|FG005|Overall Study|Lost to Follow-up|1|||
125216254|NCT00262002|450417563|FG006|Overall Study|Lost to Follow-up|0|||
125216255|NCT00262002|450417557|FG000|Overall Study|Inapropriate enrollment|0|||
125216256|NCT00262002|450417558|FG001|Overall Study|Inapropriate enrollment|1|||
125216257|NCT00262002|450417559|FG002|Overall Study|Inapropriate enrollment|0|||
125216258|NCT00262002|450417560|FG003|Overall Study|Inapropriate enrollment|0|||
125216259|NCT00262002|450417561|FG004|Overall Study|Inapropriate enrollment|0|||
125216260|NCT00262002|450417562|FG005|Overall Study|Inapropriate enrollment|0|||
125216261|NCT00262002|450417563|FG006|Overall Study|Inapropriate enrollment|0|||
125216262|NCT00262002|450417557|FG000|Overall Study|Protocol Violation|3|||
125216263|NCT00262002|450417558|FG001|Overall Study|Protocol Violation|2|||
125216264|NCT00262002|450417559|FG002|Overall Study|Protocol Violation|0|||
125216265|NCT00262002|450417560|FG003|Overall Study|Protocol Violation|2|||
125216266|NCT00262002|450417561|FG004|Overall Study|Protocol Violation|5|||
125031914|NCT02497001|449737477|FG002|Overall Study|subjects that were not treated|2|||
125031915|NCT02497001|449737478|FG003|Overall Study|subjects that were not treated|1|||
125031916|NCT02497001|449737475|FG000|Overall Study|Major Protocol Deviation|3|||
125031917|NCT02497001|449737476|FG001|Overall Study|Major Protocol Deviation|4|||
125031918|NCT02497001|449737477|FG002|Overall Study|Major Protocol Deviation|4|||
125031919|NCT02497001|449737478|FG003|Overall Study|Major Protocol Deviation|4|||
125031920|NCT02497001|449737475|FG000|Overall Study|Lack of Efficacy|10|||
125031921|NCT02497001|449737476|FG001|Overall Study|Lack of Efficacy|16|||
125031922|NCT02497001|449737477|FG002|Overall Study|Lack of Efficacy|6|||
125031923|NCT02497001|449737478|FG003|Overall Study|Lack of Efficacy|6|||
125216267|NCT00262002|450417562|FG005|Overall Study|Protocol Violation|3|||
125216268|NCT00262002|450417563|FG006|Overall Study|Protocol Violation|2|||
125216269|NCT00262002|450417557|FG000|Overall Study|Unable to classify|0|||
125216270|NCT00262002|450417558|FG001|Overall Study|Unable to classify|0|||
125216271|NCT00262002|450417559|FG002|Overall Study|Unable to classify|0|||
125216272|NCT00262002|450417560|FG003|Overall Study|Unable to classify|0|||
125216273|NCT00262002|450417561|FG004|Overall Study|Unable to classify|0|||
125216274|NCT00262002|450417562|FG005|Overall Study|Unable to classify|0|||
125216275|NCT00262002|450417563|FG006|Overall Study|Unable to classify|2|||
125216276|NCT01790516|450417564|FG000|Overall Study|Physician Decision|1|||
125216277|NCT01790516|450417565|FG001|Overall Study|Physician Decision|0|||
125216278|NCT01554163|450417566|FG000|Overall Study|Adverse Event|3|||
125216279|NCT01554163|450417567|FG001|Overall Study|Adverse Event|0|||
125216280|NCT01554163|450417566|FG000|Overall Study|Lack of Efficacy|1|||
125216281|NCT01554163|450417567|FG001|Overall Study|Lack of Efficacy|0|||
125031924|NCT02497001|449737475|FG000|Overall Study|Protocol Violation|3|||
125031925|NCT02497001|449737476|FG001|Overall Study|Protocol Violation|1|||
125031926|NCT02497001|449737477|FG002|Overall Study|Protocol Violation|3|||
125216282|NCT01554163|450417566|FG000|Overall Study|Lost to Follow-up|1|||
125216283|NCT01554163|450417567|FG001|Overall Study|Lost to Follow-up|0|||
125216284|NCT01554163|450417566|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125216285|NCT01554163|450417567|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125216286|NCT01554163|450417566|FG000|Overall Study|Protocol Violation|0|||
125031927|NCT02497001|449737478|FG003|Overall Study|Protocol Violation|1|||
125031928|NCT03898063|449737481|FG000|Overall Study|Withdrawal by Subject|10|||
125031929|NCT03898063|449737482|FG001|Overall Study|Withdrawal by Subject|8|||
125031930|NCT02949830|449737483|FG000|Overall Study|Adverse Event|1|||
125031931|NCT02949830|449737483|FG000|Overall Study|Withdrawal by Subject|1|||
125031932|NCT00054132|449737484|FG000|Overall Study|Not Treated|1|||
125031933|NCT01290887|449737485|FG000|Overall Study|Adverse Event|6|||
125031934|NCT01290887|449737486|FG001|Overall Study|Adverse Event|11|||
125031935|NCT01290887|449737485|FG000|Overall Study|Lack of Efficacy|4|||
125031936|NCT01290887|449737486|FG001|Overall Study|Lack of Efficacy|5|||
125031937|NCT01290887|449737485|FG000|Overall Study|Withdrawal by Subject|26|||
125129764|NCT02039908|450101097|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
125129765|NCT02039908|450101098|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
125031938|NCT01290887|449737486|FG001|Overall Study|Withdrawal by Subject|32|||
125129766|NCT02039908|450101099|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
125129767|NCT01802320|450101100|FG000|Overall Study|Death|1|||
125129768|NCT01802320|450101100|FG000|Overall Study|Withdrawal by Subject|1|||
125129769|NCT01066143|450102422|FG000|Overall Study|ineligible for the study|8|||
125129770|NCT05376319|450102423|FG000|Overall Study|Funding termination|2|||
125129771|NCT05376319|450102424|FG001|Overall Study|Funding termination|4|||
125129772|NCT00942968|450102425|FG000|Overall Study|Adverse Event|60|||
125129773|NCT00942968|450102425|FG000|Overall Study|Death|76|||
125129774|NCT00942968|450102425|FG000|Overall Study|Protocol Violation|9|||
125129775|NCT00942968|450102425|FG000|Overall Study|Lost to Follow-up|4|||
125129776|NCT00942968|450102425|FG000|Overall Study|Withdrawal by Subject|44|||
125129777|NCT00942968|450102425|FG000|Overall Study|Sponsor request|5|||
125129778|NCT00942968|450102425|FG000|Overall Study|Physician Decision|11|||
125129779|NCT00942968|450102425|FG000|Overall Study|Progression of disease|12|||
125129780|NCT00942968|450102425|FG000|Overall Study|Inferior vena cava filter placement|4|||
125129781|NCT00942968|450102425|FG000|Overall Study|Pulmonary embolism (PE)|1|||
125129782|NCT00942968|450102425|FG000|Overall Study|Participant required pancreatic biopsy|1|||
125129783|NCT00942968|450102425|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
125129784|NCT01466166|450102428|FG000|Overall Study|Death|1|||
125129785|NCT01466166|450102428|FG000|Overall Study|Lost to Follow-up|7|||
125129786|NCT01466166|450102428|FG000|Overall Study|Infusion Reaction (IR)|27|||
125129787|NCT01466166|450102428|FG000|Overall Study|Adverse Event (Other than IR)|11|||
125129788|NCT01466166|450102428|FG000|Overall Study|Elevated Serum Uric Acid|78|||
125129789|NCT01466166|450102428|FG000|Overall Study|Withdrawal by Subject|13|||
125129790|NCT01466166|450102428|FG000|Overall Study|Sponsor Decision|4|||
125129791|NCT01466166|450102428|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
125129792|NCT01466166|450102428|FG000|Overall Study|Other|20|||
125129793|NCT01340495|450102431|FG000|Overall Study|Withdrawal by Subject|1|||
125129794|NCT00667862|450102434|FG000|Overall Study|Adverse Event|9|||
125129795|NCT00667862|450102434|FG000|Overall Study|Death|1|||
125129796|NCT00667862|450102434|FG000|Overall Study|Disease Progression|22|||
125129797|NCT00667862|450102434|FG000|Overall Study|Withdrawal by Subject|3|||
125129798|NCT02495857|450102436|FG000|Overall Study|Adverse Event|5|||
125129799|NCT02495857|450102437|FG001|Overall Study|Adverse Event|0|||
125129800|NCT02495857|450102438|FG002|Overall Study|Adverse Event|1|||
125129801|NCT02495857|450102436|FG000|Overall Study|Withdrawal by Subject|9|||
125129802|NCT02495857|450102437|FG001|Overall Study|Withdrawal by Subject|6|||
125129803|NCT02495857|450102438|FG002|Overall Study|Withdrawal by Subject|10|||
125129804|NCT02495857|450102436|FG000|Overall Study|Physician Decision|0|||
125129805|NCT02495857|450102437|FG001|Overall Study|Physician Decision|1|||
125129806|NCT02495857|450102438|FG002|Overall Study|Physician Decision|0|||
125129807|NCT02495857|450102436|FG000|Overall Study|Protocol Violation|1|||
125129808|NCT02495857|450102437|FG001|Overall Study|Protocol Violation|1|||
125129809|NCT02495857|450102438|FG002|Overall Study|Protocol Violation|2|||
125129810|NCT02495857|450102436|FG000|Overall Study|Lost to Follow-up|4|||
125129811|NCT02495857|450102437|FG001|Overall Study|Lost to Follow-up|5|||
125129812|NCT02495857|450102438|FG002|Overall Study|Lost to Follow-up|3|||
125129813|NCT02495857|450102436|FG000|Overall Study|Other|3|||
125031939|NCT01290887|449737485|FG000|Overall Study|Protocol Violation|2|||
125031940|NCT01290887|449737486|FG001|Overall Study|Protocol Violation|1|||
125129814|NCT02495857|450102437|FG001|Overall Study|Other|3|||
125129815|NCT02495857|450102438|FG002|Overall Study|Other|2|||
125129816|NCT01435265|450102440|FG000|Overall Study|Lost to Follow-up|0|||
125129817|NCT01435265|450102441|FG001|Overall Study|Lost to Follow-up|1|||
125129818|NCT04605094|450102442|FG000|Overall Study|Adverse Event|2|||
125129819|NCT04605094|450102443|FG001|Overall Study|Adverse Event|2|||
125216287|NCT01554163|450417567|FG001|Overall Study|Protocol Violation|4|||
125031941|NCT01290887|449737485|FG000|Overall Study|Lost to Follow-up|4|||
125031942|NCT01290887|449737486|FG001|Overall Study|Lost to Follow-up|4|||
125216288|NCT01554163|450417566|FG000|Overall Study|Withdrawal by Subject|1|||
125216289|NCT01554163|450417567|FG001|Overall Study|Withdrawal by Subject|5|||
125216290|NCT01554163|450417566|FG000|Overall Study|Not Treated|1|||
125216291|NCT01554163|450417567|FG001|Overall Study|Not Treated|0|||
125216292|NCT03034135|450417568|FG000|Overall Study|Withdrawal by Subject|2|||
125216293|NCT01972464|450417569|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
125216294|NCT01972464|450417570|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
125216295|NCT01972464|450417569|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
125216296|NCT01972464|450417570|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
125216297|NCT01972464|450417569|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
125216298|NCT01972464|450417570|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
125216299|NCT01972464|450417569|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
125216300|NCT01972464|450417570|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
125216301|NCT02526160|450419426|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
125216302|NCT02526160|450419427|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
125216303|NCT02526160|450419426|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
125216304|NCT02526160|450419427|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
125216305|NCT02526160|450419426|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
125216306|NCT02526160|450419427|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
125216307|NCT02526160|450419426|FG000|Open-Label Treatment Extension Period I|Death|0|||
125216308|NCT02526160|450419427|FG001|Open-Label Treatment Extension Period I|Death|1|||
125216309|NCT02526160|450419426|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
125216310|NCT02526160|450419427|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
125216311|NCT02526160|450419426|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
125216312|NCT02526160|450419427|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
125216313|NCT02526160|450419426|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
125216314|NCT02526160|450419427|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
125216315|NCT02526160|450419426|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
125216316|NCT02526160|450419427|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
125216317|NCT02576977|450419428|FG000|Overall Study|Adverse Event|13|||
125216318|NCT02576977|450419429|FG001|Overall Study|Adverse Event|2|||
125216319|NCT02576977|450419428|FG000|Overall Study|Death|73|||
125216320|NCT02576977|450419429|FG001|Overall Study|Death|60|||
125216321|NCT02576977|450419428|FG000|Overall Study|Screen failure|1|||
125216322|NCT02576977|450419429|FG001|Overall Study|Screen failure|0|||
125216323|NCT02576977|450419428|FG000|Overall Study|Study Terminated at Selected Sites|27|||
125216324|NCT02576977|450419429|FG001|Overall Study|Study Terminated at Selected Sites|50|||
125216325|NCT02576977|450419428|FG000|Overall Study|Withdrawal by Subject|11|||
125216326|NCT02576977|450419429|FG001|Overall Study|Withdrawal by Subject|11|||
125216327|NCT02576977|450419428|FG000|Overall Study|Final Disposition Unknown|0|||
125216328|NCT02576977|450419429|FG001|Overall Study|Final Disposition Unknown|1|||
125216329|NCT02576977|450419428|FG000|Overall Study|Lost to Follow-up|1|||
125216330|NCT02576977|450419429|FG001|Overall Study|Lost to Follow-up|0|||
125216331|NCT02576977|450419428|FG000|Overall Study|Progressive Disease|0|||
125216332|NCT02576977|450419429|FG001|Overall Study|Progressive Disease|1|||
125216333|NCT00314808|450419435|FG000|Overall Study|Disease Progression without AE|4|||
125216334|NCT00314808|450419435|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
125216335|NCT04304508|450419436|FG000|Overall Study|Subject Decision|29|||
125216336|NCT04304508|450419437|FG001|Overall Study|Subject Decision|39|||
125216337|NCT04304508|450419438|FG002|Overall Study|Subject Decision|37|||
125216338|NCT04304508|450419439|FG003|Overall Study|Subject Decision|48|||
125216339|NCT04304508|450419436|FG000|Overall Study|Death|6|||
125216340|NCT04304508|450419437|FG001|Overall Study|Death|1|||
125216341|NCT04304508|450419438|FG002|Overall Study|Death|8|||
125216342|NCT04304508|450419439|FG003|Overall Study|Death|5|||
125216343|NCT04304508|450419436|FG000|Overall Study|Non-compliance With Study Drug|3|||
125216344|NCT04304508|450419437|FG001|Overall Study|Non-compliance With Study Drug|1|||
125216345|NCT04304508|450419438|FG002|Overall Study|Non-compliance With Study Drug|2|||
125031943|NCT01290887|449737485|FG000|Overall Study|Non-compliance to study procedures|0|||
125031944|NCT01290887|449737486|FG001|Overall Study|Non-compliance to study procedures|1|||
125031945|NCT01290887|449737485|FG000|Overall Study|Non-compliance to study medications|1|||
125031946|NCT01290887|449737486|FG001|Overall Study|Non-compliance to study medications|0|||
125031947|NCT01290887|449737485|FG000|Overall Study|Sponsor closure of study|420|||
125031948|NCT01290887|449737486|FG001|Overall Study|Sponsor closure of study|476|||
125031949|NCT01290887|449737485|FG000|Overall Study|Other|3|||
125031950|NCT01290887|449737486|FG001|Overall Study|Other|6|||
125216346|NCT04304508|450419439|FG003|Overall Study|Non-compliance With Study Drug|0|||
125216347|NCT04304508|450419436|FG000|Overall Study|Switching To Other Therapy|1|||
125216348|NCT04304508|450419437|FG001|Overall Study|Switching To Other Therapy|1|||
125216349|NCT04304508|450419438|FG002|Overall Study|Switching To Other Therapy|1|||
124966167|NCT01336205|449503987|FG001|Overall Study|Severe noncompliance with protocol|2|||
124966168|NCT01336205|449503986|FG000|Overall Study|Adverse Event|56|||
124966169|NCT01336205|449503987|FG001|Overall Study|Adverse Event|6|||
124966170|NCT01336205|449503986|FG000|Overall Study|Death|1|||
124966171|NCT01336205|449503987|FG001|Overall Study|Death|1|||
124966172|NCT01336205|449503986|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
124966173|NCT01336205|449503987|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
124966174|NCT01336205|449503986|FG000|Overall Study|Withdrawal by Subject|72|||
124966175|NCT01336205|449503987|FG001|Overall Study|Withdrawal by Subject|38|||
124966176|NCT01336205|449503986|FG000|Overall Study|Did not receive treatment|4|||
124966177|NCT01336205|449503987|FG001|Overall Study|Did not receive treatment|0|||
124966178|NCT01006616|449503988|FG000|Period 1 (6 Months)|Adverse Event|10|||
124966179|NCT01006616|449503989|FG001|Period 1 (6 Months)|Adverse Event|31|||
124966180|NCT01006616|449503990|FG002|Period 1 (6 Months)|Adverse Event|37|||
124966181|NCT01006616|449503991|FG003|Period 1 (6 Months)|Adverse Event|9|||
124966182|NCT01006616|449503988|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
124966183|NCT01006616|449503989|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
124966184|NCT01006616|449503990|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
124966185|NCT01006616|449503991|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
124966186|NCT01006616|449503988|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
124966187|NCT01006616|449503989|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
124966188|NCT01006616|449503990|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
124966189|NCT01006616|449503991|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
124966190|NCT01006616|449503988|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
124966191|NCT01006616|449503989|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
124966192|NCT01006616|449503990|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
124966193|NCT01006616|449503991|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
124966194|NCT01006616|449503988|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
124966195|NCT01006616|449503989|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
124966196|NCT01006616|449503990|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
124966197|NCT01006616|449503991|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
124966198|NCT01006616|449503988|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
124966199|NCT01006616|449503989|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
124966200|NCT01006616|449503990|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
124966201|NCT01006616|449503991|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
124966202|NCT01006616|449503988|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
124966203|NCT01006616|449503989|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
124966204|NCT01006616|449503990|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
124966205|NCT01006616|449503991|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
124966206|NCT01006616|449503988|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
124966207|NCT01006616|449503989|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
124966208|NCT01006616|449503990|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
124966209|NCT01006616|449503991|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
124966210|NCT01006616|449503988|FG000|Period 1 (6 Months)|Not Treated|0|||
124966211|NCT01006616|449503989|FG001|Period 1 (6 Months)|Not Treated|0|||
124966212|NCT01006616|449503990|FG002|Period 1 (6 Months)|Not Treated|1|||
124966213|NCT01006616|449503991|FG003|Period 1 (6 Months)|Not Treated|1|||
124966214|NCT01006616|449503988|FG000|Period 2 (18 Months)|Adverse Event|6|||
124966215|NCT01006616|449503989|FG001|Period 2 (18 Months)|Adverse Event|6|||
124966216|NCT01006616|449503990|FG002|Period 2 (18 Months)|Adverse Event|6|||
124966217|NCT01006616|449503991|FG003|Period 2 (18 Months)|Adverse Event|4|||
124966218|NCT01006616|449503988|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
124966219|NCT01006616|449503989|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
124966220|NCT01006616|449503990|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
124966221|NCT01006616|449503991|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
124966222|NCT01006616|449503988|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
124966223|NCT01006616|449503989|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
124966224|NCT01006616|449503990|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
124966225|NCT01006616|449503991|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
124966226|NCT01006616|449503988|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
124966227|NCT01006616|449503989|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
124966228|NCT01006616|449503990|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
124966229|NCT01006616|449503991|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
124966230|NCT01006616|449503988|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
124966231|NCT01006616|449503989|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
124966232|NCT01006616|449503990|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
124966233|NCT01006616|449503991|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
124966234|NCT01006616|449503988|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
124966235|NCT01006616|449503989|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
124966236|NCT01006616|449503990|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
125031951|NCT01795547|449737487|FG000|Overall Study|Adverse Event|16|||
124966237|NCT01006616|449503991|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
124966238|NCT01006616|449503988|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
124966239|NCT01006616|449503989|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
124966240|NCT01006616|449503990|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
124966241|NCT01006616|449503991|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
124966242|NCT01006616|449503988|FG000|Period 2 (18 Months)|Study Terminated|63|||
124966243|NCT01006616|449503989|FG001|Period 2 (18 Months)|Study Terminated|46|||
124966244|NCT01006616|449503990|FG002|Period 2 (18 Months)|Study Terminated|44|||
124966245|NCT01006616|449503991|FG003|Period 2 (18 Months)|Study Terminated|70|||
124966246|NCT03672175|449503994|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
124966247|NCT03672175|449503995|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
124966248|NCT03672175|449503996|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
124966249|NCT03672175|449503994|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
124966250|NCT03672175|449503995|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
124966251|NCT03672175|449503996|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
124966252|NCT03672175|449503994|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
124966253|NCT03672175|449503995|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
124966254|NCT03672175|449503996|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
124966255|NCT03672175|449503994|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
124966256|NCT03672175|449503995|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
124966257|NCT03672175|449503996|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
124966258|NCT03672175|449503994|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
124966259|NCT03672175|449503995|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
124966260|NCT03672175|449503996|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
124966261|NCT03672175|449503994|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
124966262|NCT03672175|449503995|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
124966263|NCT03672175|449503996|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
124966264|NCT03672175|449503994|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
124966265|NCT03672175|449503995|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
124966266|NCT03672175|449503996|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
124966267|NCT03672175|449503994|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
124966268|NCT03672175|449503995|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
124966269|NCT03672175|449503996|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
124966270|NCT03672175|449503994|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
124966271|NCT03672175|449503995|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
124966272|NCT03672175|449503996|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
124966273|NCT03672175|449503994|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
124966274|NCT03672175|449503995|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
124966275|NCT03672175|449503996|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
124966276|NCT03672175|449503994|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
124966277|NCT03672175|449503995|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
124966278|NCT03672175|449503996|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
124966279|NCT03672175|449503994|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
124966280|NCT03672175|449503995|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
124966281|NCT03672175|449503996|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
124966282|NCT02482935|449503997|FG000|Period 1|Withdrawal by Subject|1|||
124966283|NCT02482935|449503998|FG001|Period 1|Withdrawal by Subject|0|||
124966284|NCT03414047|449503999|FG000|Overall Study|Adverse Event|0|||
124966285|NCT03414047|449504000|FG001|Overall Study|Adverse Event|0|||
124966286|NCT03414047|449504001|FG002|Overall Study|Adverse Event|1|||
124966287|NCT03414047|449504002|FG003|Overall Study|Adverse Event|1|||
124966288|NCT03414047|449503999|FG000|Overall Study|Physician Decision|1|||
124966289|NCT03414047|449504000|FG001|Overall Study|Physician Decision|0|||
124966290|NCT03414047|449504001|FG002|Overall Study|Physician Decision|0|||
124966291|NCT03414047|449504002|FG003|Overall Study|Physician Decision|1|||
124966292|NCT03414047|449503999|FG000|Overall Study|Withdrawal by Subject|1|||
124966293|NCT03414047|449504000|FG001|Overall Study|Withdrawal by Subject|0|||
124966294|NCT03414047|449504001|FG002|Overall Study|Withdrawal by Subject|2|||
124966295|NCT03414047|449504002|FG003|Overall Study|Withdrawal by Subject|0|||
124966296|NCT00217022|449504010|FG000|Overall Study|Withdrawal by Subject|1|||
124966297|NCT00217022|449504011|FG001|Overall Study|Withdrawal by Subject|1|||
124966298|NCT02777242|449504015|FG000|Overall Study|Other|2|||
124966299|NCT02777242|449504015|FG000|Overall Study|Lost to Follow-up|1|||
124966300|NCT02777242|449504015|FG000|Overall Study|Multiple|1|||
124966301|NCT02777242|449504015|FG000|Overall Study|Sponsor's request|1|||
124966302|NCT02777242|449504015|FG000|Overall Study|Withdrawal by Subject|1|||
124966303|NCT01898442|449504016|FG000|Overall Study|Hemolysis/technical problems|1|||
124966304|NCT01898442|449504017|FG001|Overall Study|Hemolysis/technical problems|2|||
124966305|NCT01898442|449504018|FG002|Overall Study|Hemolysis/technical problems|2|||
124966306|NCT01898442|449504016|FG000|Overall Study|Patient vomited pills|0|||
124966307|NCT01898442|449504017|FG001|Overall Study|Patient vomited pills|0|||
124966308|NCT01898442|449504018|FG002|Overall Study|Patient vomited pills|1|||
124966309|NCT05178979|449504019|FG000|Overall Study|Death|0|||
124966310|NCT05178979|449504020|FG001|Overall Study|Death|5|||
124966311|NCT05178979|449504021|FG002|Overall Study|Death|0|||
124966312|NCT05178979|449504022|FG003|Overall Study|Death|3|||
124966313|NCT05178979|449504019|FG000|Overall Study|Adverse Event|0|||
124966314|NCT05178979|449504020|FG001|Overall Study|Adverse Event|1|||
124966315|NCT05178979|449504021|FG002|Overall Study|Adverse Event|0|||
124966316|NCT05178979|449504022|FG003|Overall Study|Adverse Event|0|||
124966317|NCT05178979|449504019|FG000|Overall Study|Lost to Follow-up|1|||
124966318|NCT05178979|449504020|FG001|Overall Study|Lost to Follow-up|8|||
124966319|NCT05178979|449504021|FG002|Overall Study|Lost to Follow-up|3|||
124966320|NCT05178979|449504022|FG003|Overall Study|Lost to Follow-up|8|||
124966321|NCT02980705|449504029|FG000|Overall Study|Adverse Event|0|||
124966322|NCT02980705|449504030|FG001|Overall Study|Adverse Event|1|||
124966323|NCT02980705|449504029|FG000|Overall Study|Withdrawal by Subject|6|||
124966324|NCT02980705|449504030|FG001|Overall Study|Withdrawal by Subject|9|||
124966325|NCT02980705|449504029|FG000|Overall Study|withdrew participation|0|||
124966326|NCT02980705|449504030|FG001|Overall Study|withdrew participation|1|||
124966327|NCT02980705|449504029|FG000|Overall Study|Lost to Follow-up|2|||
124966328|NCT02980705|449504030|FG001|Overall Study|Lost to Follow-up|0|||
124966329|NCT01721746|449504031|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
124966330|NCT01721746|449504032|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
124966331|NCT01721746|449504031|FG000|Pre-Treatment|Withdrawal by Subject|1|||
124966332|NCT01721746|449504032|FG001|Pre-Treatment|Withdrawal by Subject|16|||
124966333|NCT01721746|449504031|FG000|Pre-Treatment|Poor/Non-compliance|1|||
124966334|NCT01721746|449504032|FG001|Pre-Treatment|Poor/Non-compliance|0|||
124966335|NCT01721746|449504031|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
124966336|NCT01721746|449504032|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
124966337|NCT01721746|449504031|FG000|Treatment|Disease Progression|192|||
124966338|NCT01721746|449504032|FG001|Treatment|Disease Progression|74|||
124966339|NCT01721746|449504031|FG000|Treatment|Study Drug Toxicity|19|||
124966340|NCT01721746|449504032|FG001|Treatment|Study Drug Toxicity|11|||
124966341|NCT01721746|449504031|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
124966342|NCT01721746|449504032|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
124966343|NCT01721746|449504031|FG000|Treatment|Participant request to discontinue Study treatment|26|||
124966344|NCT01721746|449504032|FG001|Treatment|Participant request to discontinue Study treatment|7|||
124966345|NCT01721746|449504031|FG000|Treatment|Participant withdrew consent|4|||
124966346|NCT01721746|449504032|FG001|Treatment|Participant withdrew consent|2|||
124966347|NCT01721746|449504031|FG000|Treatment|Maximum Clinical Benefit|9|||
124966348|NCT01721746|449504032|FG001|Treatment|Maximum Clinical Benefit|3|||
124966349|NCT01721746|449504031|FG000|Treatment|Poor/Non-compliance|2|||
124966350|NCT01721746|449504032|FG001|Treatment|Poor/Non-compliance|0|||
125216350|NCT04304508|450419439|FG003|Overall Study|Switching To Other Therapy|2|||
125216351|NCT04304508|450419436|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
125216352|NCT04304508|450419437|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
125216353|NCT04304508|450419438|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
125216354|NCT04304508|450419439|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
125216355|NCT04304508|450419436|FG000|Overall Study|Withdrawal by Subject|7|||
125216356|NCT04304508|450419437|FG001|Overall Study|Withdrawal by Subject|5|||
125216357|NCT04304508|450419438|FG002|Overall Study|Withdrawal by Subject|11|||
125216358|NCT04304508|450419439|FG003|Overall Study|Withdrawal by Subject|6|||
125216359|NCT04304508|450419436|FG000|Overall Study|Logistical Difficulties|2|||
125216360|NCT04304508|450419437|FG001|Overall Study|Logistical Difficulties|2|||
125216361|NCT04304508|450419438|FG002|Overall Study|Logistical Difficulties|3|||
125031952|NCT01795547|449737488|FG001|Overall Study|Adverse Event|27|||
125031953|NCT01795547|449737487|FG000|Overall Study|Lack of Efficacy|8|||
125031954|NCT01795547|449737488|FG001|Overall Study|Lack of Efficacy|3|||
125031955|NCT01795547|449737487|FG000|Overall Study|Protocol Violation|6|||
125031956|NCT01795547|449737488|FG001|Overall Study|Protocol Violation|4|||
125031957|NCT01795547|449737487|FG000|Overall Study|Lost to Follow-up|2|||
125031958|NCT01795547|449737488|FG001|Overall Study|Lost to Follow-up|5|||
125031959|NCT01795547|449737487|FG000|Overall Study|Withdrawal of consent|7|||
125031960|NCT01795547|449737488|FG001|Overall Study|Withdrawal of consent|12|||
125031961|NCT01795547|449737487|FG000|Overall Study|Not Treated|4|||
125031962|NCT01795547|449737488|FG001|Overall Study|Not Treated|10|||
125031963|NCT01795547|449737487|FG000|Overall Study|Non-compliance with IMP|1|||
125031964|NCT01795547|449737488|FG001|Overall Study|Non-compliance with IMP|1|||
125031965|NCT01795547|449737487|FG000|Overall Study|Others|4|||
125031966|NCT01795547|449737488|FG001|Overall Study|Others|1|||
125031967|NCT01795547|449737487|FG000|Overall Study|Not stated|0|||
125216362|NCT04304508|450419439|FG003|Overall Study|Logistical Difficulties|2|||
125216363|NCT04304508|450419436|FG000|Overall Study|Missing Information|1|||
125216364|NCT04304508|450419437|FG001|Overall Study|Missing Information|2|||
125216365|NCT04304508|450419438|FG002|Overall Study|Missing Information|1|||
125216366|NCT04304508|450419439|FG003|Overall Study|Missing Information|3|||
125031968|NCT01795547|449737488|FG001|Overall Study|Not stated|1|||
125031969|NCT02959814|449737490|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
125216367|NCT04304508|450419436|FG000|Overall Study|Other|7|||
125216368|NCT04304508|450419437|FG001|Overall Study|Other|6|||
125216369|NCT04304508|450419438|FG002|Overall Study|Other|5|||
125216370|NCT04304508|450419439|FG003|Overall Study|Other|4|||
125031970|NCT02959814|449737490|FG000|Overall Study|Excluded based on anatomical criteria|2|||
125031971|NCT02959814|449737490|FG000|Overall Study|Protocol Violation|7|||
125031972|NCT02959814|449737490|FG000|Overall Study|FFR not measured|2|||
125031973|NCT02959814|449737490|FG000|Overall Study|In-procedure QFR not computed|6|||
125216371|NCT04304508|450419436|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
125216372|NCT04304508|450419437|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
125216373|NCT04304508|450419438|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
125216374|NCT04304508|450419439|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
125216375|NCT04304508|450419436|FG000|Overall Study|Physician Decision|3|||
125216376|NCT04304508|450419437|FG001|Overall Study|Physician Decision|4|||
125216377|NCT04304508|450419438|FG002|Overall Study|Physician Decision|9|||
125216378|NCT04304508|450419439|FG003|Overall Study|Physician Decision|7|||
125216379|NCT04304508|450419436|FG000|Overall Study|Study drug never administered|10|||
125216380|NCT04304508|450419437|FG001|Overall Study|Study drug never administered|4|||
125216381|NCT04304508|450419438|FG002|Overall Study|Study drug never administered|4|||
125216382|NCT04304508|450419439|FG003|Overall Study|Study drug never administered|4|||
125216383|NCT04304508|450419436|FG000|Overall Study|Adverse Event|49|||
125216384|NCT04304508|450419437|FG001|Overall Study|Adverse Event|50|||
125216385|NCT04304508|450419438|FG002|Overall Study|Adverse Event|51|||
125216386|NCT04304508|450419439|FG003|Overall Study|Adverse Event|56|||
125216387|NCT04304508|450419436|FG000|Overall Study|Lost to Follow-up|1|||
125216388|NCT04304508|450419437|FG001|Overall Study|Lost to Follow-up|5|||
125216389|NCT04304508|450419438|FG002|Overall Study|Lost to Follow-up|2|||
125216390|NCT04304508|450419439|FG003|Overall Study|Lost to Follow-up|3|||
125031974|NCT02959814|449737490|FG000|Overall Study|Excluded by FFR core-lab|24|||
125031975|NCT02116621|449737491|FG000|Baseline|Withdrawal by Subject|0|||
125031976|NCT02116621|449737492|FG001|Baseline|Withdrawal by Subject|4|||
125031977|NCT02116621|449737491|FG000|Three Month Follow-up|Death|1|||
125031978|NCT02116621|449737492|FG001|Three Month Follow-up|Death|1|||
125031979|NCT02116621|449737491|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
125216391|NCT02688764|450419440|FG000|Overall Study|Adverse Event|3|||
125216392|NCT02688764|450419441|FG001|Overall Study|Adverse Event|3|||
125216393|NCT02688764|450419440|FG000|Overall Study|AE/Kidney transplant|1|||
125216394|NCT02688764|450419441|FG001|Overall Study|AE/Kidney transplant|0|||
125216395|NCT02688764|450419440|FG000|Overall Study|AE/Lack of efficacy|1|||
125216396|NCT02688764|450419441|FG001|Overall Study|AE/Lack of efficacy|0|||
125216397|NCT02688764|450419440|FG000|Overall Study|AE/Non-compl.|1|||
125216398|NCT02688764|450419441|FG001|Overall Study|AE/Non-compl.|0|||
125216399|NCT02688764|450419440|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
125216400|NCT02688764|450419441|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
125216401|NCT02688764|450419440|FG000|Overall Study|AE/Other|0|||
125216402|NCT02688764|450419441|FG001|Overall Study|AE/Other|1|||
125216403|NCT02688764|450419440|FG000|Overall Study|AE/Physician decision|1|||
125216404|NCT02688764|450419441|FG001|Overall Study|AE/Physician decision|0|||
125216405|NCT02688764|450419440|FG000|Overall Study|AE/Withd. parent|3|||
125216406|NCT02688764|450419441|FG001|Overall Study|AE/Withd. parent|0|||
125216407|NCT02688764|450419440|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
125216408|NCT02688764|450419441|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
125216409|NCT02688764|450419440|FG000|Overall Study|AE/Withd. subject|1|||
125216410|NCT02688764|450419441|FG001|Overall Study|AE/Withd. subject|0|||
125216411|NCT02688764|450419440|FG000|Overall Study|Kidney transplant|10|||
125216412|NCT02688764|450419441|FG001|Overall Study|Kidney transplant|4|||
125216413|NCT02688764|450419440|FG000|Overall Study|Lack of Efficacy|3|||
125216414|NCT02688764|450419441|FG001|Overall Study|Lack of Efficacy|2|||
125216415|NCT02688764|450419440|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
125216416|NCT02688764|450419441|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
125216417|NCT02688764|450419440|FG000|Overall Study|Non-compliance with study drug|4|||
125216418|NCT02688764|450419441|FG001|Overall Study|Non-compliance with study drug|0|||
125216419|NCT02688764|450419440|FG000|Overall Study|Non-compl./Physician decision|2|||
125216420|NCT02688764|450419441|FG001|Overall Study|Non-compl./Physician decision|0|||
125216421|NCT02688764|450419440|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
125216422|NCT02688764|450419441|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
125216423|NCT02688764|450419440|FG000|Overall Study|Non-compl./Withd. subject|0|||
125216424|NCT02688764|450419441|FG001|Overall Study|Non-compl./Withd. subject|2|||
125216425|NCT02688764|450419440|FG000|Overall Study|Phosphorus level outside safe range|0|||
125129820|NCT04605094|450102442|FG000|Overall Study|Lost to Follow-up|1|||
125129821|NCT04605094|450102443|FG001|Overall Study|Lost to Follow-up|4|||
125129822|NCT04605094|450102442|FG000|Overall Study|Physician Decision|2|||
125129823|NCT04605094|450102443|FG001|Overall Study|Physician Decision|2|||
125129824|NCT04605094|450102442|FG000|Overall Study|Study terminated by Sponsor|31|||
124966351|NCT01721746|449504031|FG000|Treatment|Participant no longer met Study criteria|4|||
124966352|NCT01721746|449504032|FG001|Treatment|Participant no longer met Study criteria|0|||
124966353|NCT01721746|449504031|FG000|Treatment|Other reasons|6|||
124966354|NCT01721746|449504032|FG001|Treatment|Other reasons|2|||
124966355|NCT04358068|449504033|FG000|Overall Study|Did not initiate study treatment|2|||
124966356|NCT04358068|449504034|FG001|Overall Study|Did not initiate study treatment|2|||
124966357|NCT00239681|449504035|FG000|Overall Study|Adverse Event|100|||
125129825|NCT04605094|450102443|FG001|Overall Study|Study terminated by Sponsor|33|||
125129826|NCT04605094|450102442|FG000|Overall Study|Withdrawal by Subject|22|||
125129827|NCT04605094|450102443|FG001|Overall Study|Withdrawal by Subject|19|||
125129828|NCT04605094|450102442|FG000|Overall Study|Other|1|||
125129829|NCT04605094|450102443|FG001|Overall Study|Other|1|||
125129830|NCT02724462|450102444|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
125129831|NCT02724462|450102445|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
125129832|NCT02724462|450102444|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
125129833|NCT02724462|450102445|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
125129834|NCT02724462|450102444|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
125129835|NCT02724462|450102445|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
125129836|NCT02724462|450102444|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
125129837|NCT02724462|450102445|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
125129838|NCT02724462|450102444|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
125129839|NCT02724462|450102445|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
125129840|NCT02724462|450102444|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
125129841|NCT02724462|450102445|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
125129842|NCT01900691|450102446|FG000|Overall Study|Death|7|||
125129843|NCT01900691|450102446|FG000|Overall Study|Lost to Follow-up|4|||
125129844|NCT01900691|450102446|FG000|Overall Study|Study Device Not Placed|3|||
125129845|NCT01900691|450102446|FG000|Overall Study|Non study stent placed|2|||
125129846|NCT01900691|450102446|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
125129847|NCT01900691|450102446|FG000|Overall Study|Complete stent migration through digestive tract|1|||
125129848|NCT02128997|450102454|FG000|Overall Study|Lost to Follow-up|6|||
125129849|NCT02128997|450102455|FG001|Overall Study|Lost to Follow-up|11|||
125129850|NCT02422264|450102464|FG000|Overall Study|Serious Adverse Event|1|||
125129851|NCT02422264|450102465|FG001|Overall Study|Serious Adverse Event|0|||
125129852|NCT02422264|450102464|FG000|Overall Study|Withdrawal by Subject|1|||
125129853|NCT02422264|450102465|FG001|Overall Study|Withdrawal by Subject|2|||
125129854|NCT02422264|450102464|FG000|Overall Study|Migrated/moved from study area|3|||
125216426|NCT02688764|450419441|FG001|Overall Study|Phosphorus level outside safe range|1|||
125216427|NCT02688764|450419440|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
125216428|NCT02688764|450419441|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
125216429|NCT02688764|450419440|FG000|Overall Study|Study drug taste/Withd. parent|1|||
125216430|NCT02688764|450419441|FG001|Overall Study|Study drug taste/Withd. parent|0|||
125216431|NCT02688764|450419440|FG000|Overall Study|Subject moving out|2|||
125216432|NCT02688764|450419441|FG001|Overall Study|Subject moving out|0|||
125216433|NCT02688764|450419440|FG000|Overall Study|Subject taken off dialysis|1|||
125216434|NCT02688764|450419441|FG001|Overall Study|Subject taken off dialysis|0|||
125216435|NCT02688764|450419440|FG000|Overall Study|Withdrawal by parent|3|||
125216436|NCT02688764|450419441|FG001|Overall Study|Withdrawal by parent|0|||
125216437|NCT02113007|450419442|FG000|Overall Study|Progressive disease|2|||
125216438|NCT00885378|450419443|FG000|Overall Study|Lack of Efficacy|2|||
125216439|NCT00885378|450419444|FG001|Overall Study|Lack of Efficacy|2|||
125129855|NCT02422264|450102465|FG001|Overall Study|Migrated/moved from study area|1|||
125129856|NCT02422264|450102464|FG000|Overall Study|Subject vaccinated outside of the study|0|||
125216440|NCT00885378|450419443|FG000|Overall Study|Withdrawal by Subject|1|||
125216441|NCT00885378|450419444|FG001|Overall Study|Withdrawal by Subject|2|||
125216442|NCT00885378|450419443|FG000|Overall Study|Lost to Follow-up|1|||
125216443|NCT00885378|450419444|FG001|Overall Study|Lost to Follow-up|2|||
125216444|NCT00885378|450419443|FG000|Overall Study|Poor/Noncompliance|2|||
125129857|NCT02422264|450102465|FG001|Overall Study|Subject vaccinated outside of the study|1|||
125129858|NCT03874715|450102467|FG000|Overall Study|Adverse Event|2|||
125216445|NCT00885378|450419444|FG001|Overall Study|Poor/Noncompliance|2|||
125216446|NCT00885378|450419443|FG000|Overall Study|Protocol Violation|2|||
125216447|NCT00885378|450419444|FG001|Overall Study|Protocol Violation|0|||
125216448|NCT04750278|450419445|FG000|Overall Study|Death|9|||
125216449|NCT04750278|450419446|FG001|Overall Study|Death|10|||
125216450|NCT04750278|450419447|FG002|Overall Study|Death|10|||
125216451|NCT04750278|450419445|FG000|Overall Study|Withdrawal by Subject|4|||
125216452|NCT04750278|450419446|FG001|Overall Study|Withdrawal by Subject|1|||
125216453|NCT04750278|450419447|FG002|Overall Study|Withdrawal by Subject|2|||
125216454|NCT04750278|450419445|FG000|Overall Study|Lost to Follow-up|1|||
125216455|NCT04750278|450419446|FG001|Overall Study|Lost to Follow-up|1|||
125216456|NCT04750278|450419447|FG002|Overall Study|Lost to Follow-up|1|||
125216457|NCT04750278|450419445|FG000|Overall Study|Pregnancy|1|||
125216458|NCT04750278|450419446|FG001|Overall Study|Pregnancy|0|||
125216459|NCT04750278|450419447|FG002|Overall Study|Pregnancy|0|||
125216460|NCT04750278|450419445|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
125216461|NCT04750278|450419446|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
125216462|NCT04750278|450419447|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
125216463|NCT04750278|450419445|FG000|Overall Study|Non-compliance|0|||
125216464|NCT04750278|450419446|FG001|Overall Study|Non-compliance|0|||
125216465|NCT04750278|450419447|FG002|Overall Study|Non-compliance|1|||
125216466|NCT04750278|450419445|FG000|Overall Study|Transfer to Outside Facility|0|||
125216467|NCT04750278|450419446|FG001|Overall Study|Transfer to Outside Facility|2|||
125216468|NCT04750278|450419447|FG002|Overall Study|Transfer to Outside Facility|1|||
125216469|NCT04750278|450419445|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
125216470|NCT04750278|450419446|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
125031980|NCT02116621|449737492|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
125031981|NCT02116621|449737491|FG000|Three Month Follow-up|Lost to Follow-up|0|||
125031982|NCT02116621|449737492|FG001|Three Month Follow-up|Lost to Follow-up|1|||
125031983|NCT02116621|449737491|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
125031984|NCT02116621|449737492|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
125031985|NCT02116621|449737491|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
125129859|NCT03874715|450102468|FG001|Overall Study|Adverse Event|0|||
125129860|NCT03874715|450102467|FG000|Overall Study|Poor compliance to protocol|5|||
125129861|NCT03874715|450102468|FG001|Overall Study|Poor compliance to protocol|1|||
125129862|NCT03874715|450102467|FG000|Overall Study|Withdrawal by Subject|1|||
125129863|NCT03874715|450102468|FG001|Overall Study|Withdrawal by Subject|0|||
125129864|NCT03874715|450102467|FG000|Overall Study|Other-unspecified|1|||
125129865|NCT03874715|450102468|FG001|Overall Study|Other-unspecified|0|||
125129866|NCT00851877|450102471|FG000|Phase I-1|Death|1|||
125129867|NCT00851877|450102472|FG001|Phase I-1|Death|0|||
125031986|NCT02116621|449737492|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
125031987|NCT02116621|449737491|FG000|Six Month Follow-up|Lost to Follow-up|2|||
125031988|NCT02116621|449737492|FG001|Six Month Follow-up|Lost to Follow-up|1|||
125031989|NCT02116621|449737491|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
125031990|NCT02116621|449737492|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
125031991|NCT02116621|449737491|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
125031992|NCT02116621|449737492|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
125129868|NCT00851877|450102473|FG002|Phase I-1|Death|0|||
125129869|NCT00851877|450102471|FG000|Phase II|Withdrawal by Subject|0|||
125129870|NCT00851877|450102472|FG001|Phase II|Withdrawal by Subject|0|||
125129871|NCT00851877|450102473|FG002|Phase II|Withdrawal by Subject|3|||
125216471|NCT04750278|450419447|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
125216472|NCT04750278|450419445|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
125216473|NCT04750278|450419446|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
125129872|NCT00829673|450102474|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
125129873|NCT00829673|450102475|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
125129874|NCT00573066|450102476|FG000|Overall Study|Exclusion criteria|18|||
125129875|NCT00573066|450102476|FG000|Overall Study|IV malfunction|1|||
125129876|NCT00573066|450102476|FG000|Overall Study|Postoperative bleeding|1|||
125129877|NCT01034358|450102477|FG000|Overall Study|Withdrawal by Subject|1|||
125129878|NCT01034358|450102477|FG000|Overall Study|Protocol Violation|1|||
125129879|NCT00829790|450102480|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
125129880|NCT00829790|450102481|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
125129881|NCT01534663|450102482|FG000|Overall Study|Lost to Follow-up|0|||
125129882|NCT01534663|450102483|FG001|Overall Study|Lost to Follow-up|2|||
125129883|NCT01534663|450102482|FG000|Overall Study|Adverse Event|2|||
125129884|NCT01534663|450102483|FG001|Overall Study|Adverse Event|1|||
124966358|NCT00239681|449504036|FG001|Overall Study|Adverse Event|99|||
124966359|NCT00239681|449504035|FG000|Overall Study|Withdrawal by Subject|458|||
124966360|NCT00239681|449504036|FG001|Overall Study|Withdrawal by Subject|489|||
124966361|NCT00239681|449504035|FG000|Overall Study|Lost to Follow-up|28|||
124966362|NCT00239681|449504036|FG001|Overall Study|Lost to Follow-up|22|||
124966363|NCT00239681|449504035|FG000|Overall Study|Protocol Violation|4|||
124966364|NCT00239681|449504036|FG001|Overall Study|Protocol Violation|4|||
124966365|NCT00239681|449504035|FG000|Overall Study|Physician Decision|13|||
124966366|NCT00239681|449504036|FG001|Overall Study|Physician Decision|17|||
124966367|NCT00239681|449504035|FG000|Overall Study|No information chacked on CaseReportForm|90|||
124966368|NCT00239681|449504036|FG001|Overall Study|No information chacked on CaseReportForm|84|||
124966369|NCT02447718|449504037|FG000|Overall Study|Lost to Follow-up|8|||
124966370|NCT02447718|449504038|FG001|Overall Study|Lost to Follow-up|0|||
124966371|NCT02447718|449504037|FG000|Overall Study|Withdrawal by Subject|3|||
124966372|NCT02447718|449504038|FG001|Overall Study|Withdrawal by Subject|0|||
124966373|NCT02447718|449504037|FG000|Overall Study|Screen Failure|1|||
124966374|NCT02447718|449504038|FG001|Overall Study|Screen Failure|0|||
124966375|NCT03599622|449504039|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
124966376|NCT03599622|449504040|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
124966377|NCT03599622|449504041|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
124966378|NCT03599622|449504042|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
124966379|NCT03599622|449504039|FG000|Pre-Treatment Period|Other reasons|1|||
124966380|NCT03599622|449504040|FG001|Pre-Treatment Period|Other reasons|1|||
124966381|NCT03599622|449504041|FG002|Pre-Treatment Period|Other reasons|1|||
124966382|NCT03599622|449504042|FG003|Pre-Treatment Period|Other reasons|0|||
124966383|NCT03599622|449504039|FG000|Treatment Period|Adverse Event|11|||
124966384|NCT03599622|449504040|FG001|Treatment Period|Adverse Event|20|||
124966385|NCT03599622|449504041|FG002|Treatment Period|Adverse Event|18|||
124966386|NCT03599622|449504042|FG003|Treatment Period|Adverse Event|2|||
124966387|NCT03599622|449504039|FG000|Treatment Period|Lack of Efficacy|18|||
124966388|NCT03599622|449504040|FG001|Treatment Period|Lack of Efficacy|12|||
124966389|NCT03599622|449504041|FG002|Treatment Period|Lack of Efficacy|13|||
124966390|NCT03599622|449504042|FG003|Treatment Period|Lack of Efficacy|2|||
124966391|NCT03599622|449504039|FG000|Treatment Period|Withdrawal by Subject|5|||
124966392|NCT03599622|449504040|FG001|Treatment Period|Withdrawal by Subject|11|||
124966393|NCT03599622|449504041|FG002|Treatment Period|Withdrawal by Subject|16|||
124966394|NCT03599622|449504042|FG003|Treatment Period|Withdrawal by Subject|1|||
125031993|NCT02116621|449737491|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
125031994|NCT02116621|449737492|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
125031995|NCT02116621|449737491|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
125031996|NCT02116621|449737492|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
125031997|NCT02116621|449737491|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
125031998|NCT02116621|449737492|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
125031999|NCT00961961|449737493|FG000|Phase I|Withdrawal by Subject|7|||
125032000|NCT00961961|449737494|FG001|Phase I|Withdrawal by Subject|0|||
125032001|NCT00961961|449737495|FG002|Phase I|Withdrawal by Subject|0|||
125032002|NCT00961961|449737496|FG003|Phase I|Withdrawal by Subject|0|||
125032003|NCT00961961|449737493|FG000|Phase I|Lost to Follow-up|10|||
125032004|NCT00961961|449737494|FG001|Phase I|Lost to Follow-up|0|||
125032005|NCT00961961|449737495|FG002|Phase I|Lost to Follow-up|0|||
125032006|NCT00961961|449737496|FG003|Phase I|Lost to Follow-up|0|||
125032007|NCT00961961|449737493|FG000|Phase I|Lack of Efficacy|94|||
125129885|NCT00627016|450102484|FG000|Overall Study|Adverse Event|1|||
125129886|NCT00627016|450102485|FG001|Overall Study|Adverse Event|1|||
125032008|NCT00961961|449737494|FG001|Phase I|Lack of Efficacy|0|||
125032009|NCT00961961|449737495|FG002|Phase I|Lack of Efficacy|0|||
125032010|NCT00961961|449737496|FG003|Phase I|Lack of Efficacy|0|||
125129887|NCT00627016|450102484|FG000|Overall Study|Protocol Violation|0|||
125129888|NCT00627016|450102485|FG001|Overall Study|Protocol Violation|2|||
125129889|NCT00627016|450102484|FG000|Overall Study|Lost to Follow-up|0|||
125129890|NCT00627016|450102485|FG001|Overall Study|Lost to Follow-up|1|||
125032011|NCT00961961|449737493|FG000|Phase I|Adverse Event|7|||
125032012|NCT00961961|449737494|FG001|Phase I|Adverse Event|0|||
125032013|NCT00961961|449737495|FG002|Phase I|Adverse Event|0|||
125032014|NCT00961961|449737496|FG003|Phase I|Adverse Event|0|||
125032015|NCT00961961|449737493|FG000|Phase I|Physician Decision|8|||
125032016|NCT00961961|449737494|FG001|Phase I|Physician Decision|0|||
125032017|NCT00961961|449737495|FG002|Phase I|Physician Decision|0|||
125032018|NCT00961961|449737496|FG003|Phase I|Physician Decision|0|||
125032019|NCT00961961|449737493|FG000|Phase II|Lost to Follow-up|0|||
125032020|NCT00961961|449737494|FG001|Phase II|Lost to Follow-up|0|||
125032021|NCT00961961|449737495|FG002|Phase II|Lost to Follow-up|10|||
125032022|NCT00961961|449737496|FG003|Phase II|Lost to Follow-up|7|||
125032023|NCT00961961|449737493|FG000|Phase II|Adverse Event|0|||
125032024|NCT00961961|449737494|FG001|Phase II|Adverse Event|0|||
125032025|NCT00961961|449737495|FG002|Phase II|Adverse Event|0|||
125032026|NCT00961961|449737496|FG003|Phase II|Adverse Event|1|||
125032027|NCT00961961|449737493|FG000|Phase II|Physician Decision|0|||
125032028|NCT00961961|449737494|FG001|Phase II|Physician Decision|0|||
125032029|NCT00961961|449737495|FG002|Phase II|Physician Decision|1|||
125032030|NCT00961961|449737496|FG003|Phase II|Physician Decision|0|||
125032031|NCT00961961|449737493|FG000|Phase II|Withdrawal by Subject|0|||
125032032|NCT00961961|449737494|FG001|Phase II|Withdrawal by Subject|0|||
125032033|NCT00961961|449737495|FG002|Phase II|Withdrawal by Subject|1|||
125032034|NCT00961961|449737496|FG003|Phase II|Withdrawal by Subject|0|||
125032035|NCT03437447|449737497|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125032036|NCT03437447|449737498|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125032037|NCT03437447|449737499|FG002|Treatment Period 1|Withdrawal by Subject|1|||
125032038|NCT02764541|449737500|FG000|Overall Study|Withdrawal by Subject|0|||
125032039|NCT02764541|449737501|FG001|Overall Study|Withdrawal by Subject|0|||
125032040|NCT02764541|449737502|FG002|Overall Study|Withdrawal by Subject|0|||
125032041|NCT02764541|449737503|FG003|Overall Study|Withdrawal by Subject|0|||
125129891|NCT00627016|450102484|FG000|Overall Study|Withdrawal by Subject|2|||
125129892|NCT00627016|450102485|FG001|Overall Study|Withdrawal by Subject|1|||
125129893|NCT00627016|450102484|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
125129894|NCT00627016|450102485|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
125129895|NCT00627016|450102484|FG000|Overall Study|Lack of Efficacy|1|||
125129896|NCT00627016|450102485|FG001|Overall Study|Lack of Efficacy|0|||
125129897|NCT00627016|450102484|FG000|Overall Study|Placed on Excluded Drugs|1|||
125129898|NCT00627016|450102485|FG001|Overall Study|Placed on Excluded Drugs|0|||
125129899|NCT00627016|450102484|FG000|Overall Study|Pregnancy|1|||
125129900|NCT00627016|450102485|FG001|Overall Study|Pregnancy|0|||
125129901|NCT03107091|450102486|FG000|Overall Study|Physician Decision|1|||
125032042|NCT02764541|449737504|FG004|Overall Study|Withdrawal by Subject|1|||
125032043|NCT02764541|449737505|FG005|Overall Study|Withdrawal by Subject|1|||
125032044|NCT02764541|449737506|FG006|Overall Study|Withdrawal by Subject|0|||
125032045|NCT02764541|449737507|FG007|Overall Study|Withdrawal by Subject|1|||
125032046|NCT02764541|449737500|FG000|Overall Study|Adverse Event|1|||
125032047|NCT02764541|449737501|FG001|Overall Study|Adverse Event|0|||
125032048|NCT02764541|449737502|FG002|Overall Study|Adverse Event|0|||
125032049|NCT02764541|449737503|FG003|Overall Study|Adverse Event|0|||
125032050|NCT02764541|449737504|FG004|Overall Study|Adverse Event|0|||
125032051|NCT02764541|449737505|FG005|Overall Study|Adverse Event|0|||
125032052|NCT02764541|449737506|FG006|Overall Study|Adverse Event|1|||
125032053|NCT02764541|449737507|FG007|Overall Study|Adverse Event|0|||
125032054|NCT02764541|449737500|FG000|Overall Study|Metastasis|1|||
125032055|NCT02764541|449737501|FG001|Overall Study|Metastasis|0|||
125129902|NCT04567186|450102487|FG000|Period 1|COVID-19 related|1|||
125129903|NCT04567186|450102488|FG001|Period 1|COVID-19 related|0|||
125216474|NCT04750278|450419447|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
125216475|NCT01775787|450419448|FG000|First 7-10 Days|Adverse Event|0|||
125216476|NCT01775787|450419449|FG001|First 7-10 Days|Adverse Event|1|||
125216477|NCT01775787|450419448|FG000|First 7-10 Days|family emergency|0|||
125032056|NCT02764541|449737502|FG002|Overall Study|Metastasis|0|||
125032057|NCT02764541|449737503|FG003|Overall Study|Metastasis|0|||
125032058|NCT02764541|449737504|FG004|Overall Study|Metastasis|0|||
125032059|NCT02764541|449737505|FG005|Overall Study|Metastasis|0|||
125032060|NCT02764541|449737506|FG006|Overall Study|Metastasis|0|||
125032061|NCT02764541|449737507|FG007|Overall Study|Metastasis|0|||
125032062|NCT02764541|449737500|FG000|Overall Study|Disease progression|1|||
125032063|NCT02764541|449737501|FG001|Overall Study|Disease progression|1|||
125032064|NCT02764541|449737502|FG002|Overall Study|Disease progression|0|||
125032065|NCT02764541|449737503|FG003|Overall Study|Disease progression|0|||
125032066|NCT02764541|449737504|FG004|Overall Study|Disease progression|0|||
125032067|NCT02764541|449737505|FG005|Overall Study|Disease progression|0|||
125032068|NCT02764541|449737506|FG006|Overall Study|Disease progression|0|||
125032069|NCT02764541|449737507|FG007|Overall Study|Disease progression|1|||
125032070|NCT02764541|449737500|FG000|Overall Study|Protocol Violation|0|||
125032071|NCT02764541|449737501|FG001|Overall Study|Protocol Violation|0|||
125129904|NCT04567186|450102487|FG000|Period 1|Protocol Violation|0|||
125129905|NCT04567186|450102488|FG001|Period 1|Protocol Violation|1|||
125129906|NCT04567186|450102487|FG000|Period 1|Adverse Event|0|||
124966395|NCT03599622|449504039|FG000|Treatment Period|Other reasons|4|||
124966396|NCT03599622|449504040|FG001|Treatment Period|Other reasons|6|||
124966397|NCT03599622|449504041|FG002|Treatment Period|Other reasons|7|||
124966398|NCT03599622|449504042|FG003|Treatment Period|Other reasons|0|||
124966399|NCT03599622|449504039|FG000|Treatment Period|Lost to Follow-up|1|||
124966400|NCT03599622|449504040|FG001|Treatment Period|Lost to Follow-up|0|||
124966401|NCT03599622|449504041|FG002|Treatment Period|Lost to Follow-up|0|||
124966402|NCT03599622|449504042|FG003|Treatment Period|Lost to Follow-up|0|||
124966403|NCT03599622|449504039|FG000|Treatment Period|Study terminated by sponsor|7|||
124966404|NCT03599622|449504040|FG001|Treatment Period|Study terminated by sponsor|20|||
124966405|NCT03599622|449504041|FG002|Treatment Period|Study terminated by sponsor|15|||
124966406|NCT03599622|449504042|FG003|Treatment Period|Study terminated by sponsor|0|||
124966407|NCT03599622|449504039|FG000|Treatment Period|Site terminated by sponsor|0|||
124966408|NCT03599622|449504040|FG001|Treatment Period|Site terminated by sponsor|1|||
124966409|NCT03599622|449504041|FG002|Treatment Period|Site terminated by sponsor|0|||
124966410|NCT03599622|449504042|FG003|Treatment Period|Site terminated by sponsor|0|||
124966411|NCT00468130|449504044|FG000|Overall Study|Adverse Event|2|||
124966412|NCT00468130|449504045|FG001|Overall Study|Adverse Event|1|||
124966413|NCT00468130|449504044|FG000|Overall Study|Withdrawal by Subject|0|||
124966414|NCT00468130|449504045|FG001|Overall Study|Withdrawal by Subject|1|||
124966415|NCT00436956|449504046|FG000|Overall Study|Not evaluable|1|||
124966416|NCT00436956|449504047|FG001|Overall Study|Not evaluable|0|||
124966417|NCT01006889|449504048|FG000|Overall Study|Withdrawal by Subject|3|||
124966418|NCT01130168|449504049|FG000|Period 1|Withdrawal by Subject|0|||
124966419|NCT01130168|449504050|FG001|Period 1|Withdrawal by Subject|1|||
124966420|NCT01130168|449504051|FG002|Period 1|Withdrawal by Subject|0|||
124966421|NCT01130168|449504052|FG003|Period 1|Withdrawal by Subject|1|||
124966422|NCT01130168|449504053|FG004|Period 1|Withdrawal by Subject|0|||
124966423|NCT01130168|449504054|FG005|Period 1|Withdrawal by Subject|0|||
124966424|NCT01130168|449504049|FG000|Period 1|Discontinued For Other Reason|0|||
124966425|NCT01130168|449504050|FG001|Period 1|Discontinued For Other Reason|0|||
124966426|NCT01130168|449504051|FG002|Period 1|Discontinued For Other Reason|1|||
124966427|NCT01130168|449504052|FG003|Period 1|Discontinued For Other Reason|1|||
125129907|NCT04567186|450102488|FG001|Period 1|Adverse Event|2|||
125129908|NCT04567186|450102487|FG000|Period 2|COVID-19 Related|0|||
125129909|NCT04567186|450102488|FG001|Period 2|COVID-19 Related|1|||
125129910|NCT04567186|450102487|FG000|Period 2|Protocol Violation|0|||
125129911|NCT04567186|450102488|FG001|Period 2|Protocol Violation|1|||
125129912|NCT04567186|450102487|FG000|Period 2|Lost to Follow-up|0|||
125129913|NCT04567186|450102488|FG001|Period 2|Lost to Follow-up|1|||
125129914|NCT04567186|450102487|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
125129915|NCT04567186|450102488|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
125129916|NCT01185548|450102491|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
125129917|NCT02331394|450102492|FG000|Overall Study|Disease progression|1|||
125129918|NCT01313273|450102493|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
125129919|NCT01313273|450102494|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
125129920|NCT01313273|450102493|FG000|Overall Study|Withdrawal by Subject|1|||
125129921|NCT01313273|450102494|FG001|Overall Study|Withdrawal by Subject|0|||
125129922|NCT01313273|450102493|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
125129923|NCT01313273|450102494|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
125129924|NCT03687736|450102495|FG000|Overall Study|Lost to Follow-up|7|||
125129925|NCT03687736|450102495|FG000|Overall Study|Withdrawal by Subject|3|||
125129926|NCT02459951|450102496|FG000|Overall Study|Unable to meet holding requirement|1|||
125129927|NCT00102440|450102497|FG000|Overall Study|Lost to Follow-up|25|||
125129928|NCT00102440|450102498|FG001|Overall Study|Lost to Follow-up|18|||
125129929|NCT00102440|450102499|FG002|Overall Study|Lost to Follow-up|21|||
125129930|NCT00102440|450102497|FG000|Overall Study|Adverse Event|16|||
125129931|NCT00102440|450102498|FG001|Overall Study|Adverse Event|23|||
125129932|NCT00102440|450102499|FG002|Overall Study|Adverse Event|8|||
125129933|NCT00102440|450102497|FG000|Overall Study|Gout Flare|10|||
125129934|NCT00102440|450102498|FG001|Overall Study|Gout Flare|28|||
124966428|NCT01130168|449504053|FG004|Period 1|Discontinued For Other Reason|0|||
125129935|NCT00102440|450102499|FG002|Overall Study|Gout Flare|9|||
125129936|NCT00102440|450102497|FG000|Overall Study|Personal Reason(s)|19|||
125129937|NCT00102440|450102498|FG001|Overall Study|Personal Reason(s)|13|||
125129938|NCT00102440|450102499|FG002|Overall Study|Personal Reason(s)|13|||
125129939|NCT00102440|450102497|FG000|Overall Study|Other|11|||
125129940|NCT00102440|450102498|FG001|Overall Study|Other|14|||
125129941|NCT00102440|450102499|FG002|Overall Study|Other|14|||
125129942|NCT00102440|450102497|FG000|Overall Study|Protocol Violation|7|||
124966429|NCT01130168|449504054|FG005|Period 1|Discontinued For Other Reason|0|||
124966430|NCT01130168|449504049|FG000|Period 1|Adverse Event|0|||
125129943|NCT00102440|450102498|FG001|Overall Study|Protocol Violation|2|||
125129944|NCT00102440|450102499|FG002|Overall Study|Protocol Violation|1|||
125129945|NCT02255097|450102500|FG000|Overall Study|Death|151|||
125129946|NCT02255097|450102500|FG000|Overall Study|Lost to Follow-up|5|||
125129947|NCT02255097|450102500|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
125216478|NCT01775787|450419449|FG001|First 7-10 Days|family emergency|1|||
125129948|NCT02255097|450102500|FG000|Overall Study|Withdrawal by Subject|7|||
125129949|NCT02255097|450102500|FG000|Overall Study|Allocated but not treated|1|||
124966431|NCT01130168|449504050|FG001|Period 1|Adverse Event|0|||
124966432|NCT01130168|449504051|FG002|Period 1|Adverse Event|0|||
124966433|NCT01130168|449504052|FG003|Period 1|Adverse Event|1|||
124966434|NCT01130168|449504053|FG004|Period 1|Adverse Event|0|||
124966435|NCT01130168|449504054|FG005|Period 1|Adverse Event|0|||
124966436|NCT01702519|449504055|FG000|Washout Period|Lost to Follow-up|1|||
124966437|NCT01702519|449504056|FG001|Washout Period|Lost to Follow-up|0|||
124966438|NCT01702519|449504055|FG000|Washout Period|Withdrawal by Subject|0|||
124966439|NCT01702519|449504056|FG001|Washout Period|Withdrawal by Subject|2|||
124966440|NCT03738397|449504059|FG000|Overall Study|Adverse Event|3|||
124966441|NCT03738397|449504060|FG001|Overall Study|Adverse Event|7|||
124966442|NCT03738397|449504059|FG000|Overall Study|Withdrawal by Subject|8|||
124966443|NCT03738397|449504060|FG001|Overall Study|Withdrawal by Subject|11|||
124966444|NCT03738397|449504059|FG000|Overall Study|Lost to Follow-up|7|||
124966445|NCT03738397|449504060|FG001|Overall Study|Lost to Follow-up|5|||
124966446|NCT03738397|449504059|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
124966447|NCT03738397|449504060|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
124966448|NCT03738397|449504059|FG000|Overall Study|Other|4|||
124966449|NCT03738397|449504060|FG001|Overall Study|Other|6|||
124966450|NCT00904722|449504061|FG000|Overall Study|Physician Decision|1|||
124966451|NCT01891890|449504062|FG000|Overall Study|Lost to Follow-up|0|||
124966452|NCT01891890|449504063|FG001|Overall Study|Lost to Follow-up|0|||
124966453|NCT01891890|449504064|FG002|Overall Study|Lost to Follow-up|1|||
124966454|NCT01891890|449504062|FG000|Overall Study|Study ended before endpoint reached|7|||
124966455|NCT01891890|449504063|FG001|Overall Study|Study ended before endpoint reached|3|||
124966456|NCT01891890|449504064|FG002|Overall Study|Study ended before endpoint reached|6|||
124966457|NCT03448536|449504071|FG000|Overall Study|Protocol Violation|2|||
124966458|NCT03448536|449504072|FG001|Overall Study|Protocol Violation|0|||
124966459|NCT03448536|449504071|FG000|Overall Study|Pregnancy|1|||
124966460|NCT03448536|449504072|FG001|Overall Study|Pregnancy|0|||
124966461|NCT03448536|449504071|FG000|Overall Study|Withdrawal by Subject|1|||
124966462|NCT03448536|449504072|FG001|Overall Study|Withdrawal by Subject|2|||
124966463|NCT03448536|449504071|FG000|Overall Study|Lost to Follow-up|3|||
124966464|NCT03448536|449504072|FG001|Overall Study|Lost to Follow-up|2|||
125129950|NCT01010542|450102504|FG000|Overall Study|Adverse Event|0|||
125129951|NCT01010542|450102505|FG001|Overall Study|Adverse Event|1|||
125129952|NCT01010542|450102506|FG002|Overall Study|Adverse Event|0|||
125129953|NCT01010542|450102504|FG000|Overall Study|Lost to Follow-up|0|||
124966465|NCT03448536|449504071|FG000|Overall Study|Inadequate pain reporter|1|||
124966466|NCT03448536|449504072|FG001|Overall Study|Inadequate pain reporter|0|||
124966467|NCT03448536|449504071|FG000|Overall Study|Other|3|||
124966468|NCT03448536|449504072|FG001|Overall Study|Other|0|||
125129954|NCT01010542|450102505|FG001|Overall Study|Lost to Follow-up|1|||
124966469|NCT03448536|449504071|FG000|Overall Study|Physician Decision|1|||
124966470|NCT03448536|449504072|FG001|Overall Study|Physician Decision|0|||
124966471|NCT04811339|449504077|FG000|Overall Study|lack of transportation not wanting to return|4|||
124966472|NCT04811339|449504078|FG001|Overall Study|lack of transportation not wanting to return|8|||
124966473|NCT04811339|449504079|FG002|Overall Study|lack of transportation not wanting to return|0|||
124966474|NCT04811339|449504077|FG000|Overall Study|Adverse Event|3|||
124966475|NCT04811339|449504078|FG001|Overall Study|Adverse Event|0|||
124966476|NCT04811339|449504079|FG002|Overall Study|Adverse Event|0|||
124966477|NCT04811339|449504077|FG000|Overall Study|Lost to Follow-up|1|||
124966478|NCT04811339|449504078|FG001|Overall Study|Lost to Follow-up|0|||
124966479|NCT04811339|449504079|FG002|Overall Study|Lost to Follow-up|0|||
124966480|NCT04811339|449504077|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
124966481|NCT04811339|449504078|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
124966482|NCT04811339|449504079|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
124966483|NCT04811339|449504077|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
124966484|NCT04811339|449504078|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
124966485|NCT04811339|449504079|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
124966486|NCT04811339|449504077|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
124966487|NCT04811339|449504078|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
124966488|NCT04811339|449504079|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
124966489|NCT04811339|449504077|FG000|Overall Study|Withdrawal by Subject|0|||
124966490|NCT04811339|449504078|FG001|Overall Study|Withdrawal by Subject|3|||
124966491|NCT04811339|449504079|FG002|Overall Study|Withdrawal by Subject|0|||
124966492|NCT04811339|449504077|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
124966493|NCT04811339|449504078|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
124966494|NCT04811339|449504079|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
124966495|NCT04811339|449504077|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
124966496|NCT04811339|449504078|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
124966497|NCT04811339|449504079|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
124966498|NCT02536742|449505638|FG000|Overall Study|Did not start protocol therapy|1|||
124966499|NCT02536742|449505638|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
124966500|NCT04629443|449505639|FG000|Overall Study|Adverse Event|2|||
124966501|NCT04629443|449505640|FG001|Overall Study|Adverse Event|1|||
124966502|NCT04629443|449505641|FG002|Overall Study|Adverse Event|2|||
124966503|NCT04629443|449505639|FG000|Overall Study|Progressive Disease|2|||
124966504|NCT04629443|449505640|FG001|Overall Study|Progressive Disease|3|||
124966505|NCT04629443|449505641|FG002|Overall Study|Progressive Disease|3|||
124966506|NCT04629443|449505639|FG000|Overall Study|Physician Decision|1|||
124966507|NCT04629443|449505640|FG001|Overall Study|Physician Decision|3|||
124966508|NCT04629443|449505641|FG002|Overall Study|Physician Decision|0|||
124966509|NCT01547117|449505642|FG000|Overall Study|Physician Decision|0|||
124966510|NCT01547117|449505643|FG001|Overall Study|Physician Decision|1|||
124966511|NCT01547117|449505644|FG002|Overall Study|Physician Decision|1|||
124966512|NCT01547117|449505645|FG003|Overall Study|Physician Decision|3|||
124966513|NCT01547117|449505642|FG000|Overall Study|Withdrawal by Subject|1|||
124966514|NCT01547117|449505643|FG001|Overall Study|Withdrawal by Subject|2|||
124966515|NCT01547117|449505644|FG002|Overall Study|Withdrawal by Subject|1|||
124966516|NCT01547117|449505645|FG003|Overall Study|Withdrawal by Subject|2|||
124966517|NCT03021551|449505646|FG000|Overall Study|Equipment Issues|2|||
124966518|NCT03021551|449505646|FG000|Overall Study|Protocol Violation|1|||
124966519|NCT02088554|449505650|FG000|Overall Study|Exited before procedure|130|||
124966520|NCT02088554|449505650|FG000|Overall Study|Attempted but not implanted|31|||
124966521|NCT02088554|449505650|FG000|Overall Study|Implant not attempted|19|||
124966522|NCT02088554|449505650|FG000|Overall Study|Pending next visit|532|||
124966523|NCT02088554|449505650|FG000|Overall Study|Death|170|||
124966524|NCT02088554|449505650|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
124966525|NCT02088554|449505650|FG000|Overall Study|Lost to Follow-up|23|||
124966526|NCT02088554|449505650|FG000|Overall Study|Explanted|32|||
124966527|NCT02088554|449505650|FG000|Overall Study|Any other reason not covered by previous categories|11|||
124966528|NCT03898960|449505653|FG000|Overall Study|Death|10|||
124966529|NCT00548847|449505654|FG000|Overall Study|Disease progression|7|||
125129955|NCT01010542|450102506|FG002|Overall Study|Lost to Follow-up|0|||
125129956|NCT01010542|450102504|FG000|Overall Study|Withdrawal by Subject|0|||
125129957|NCT01010542|450102505|FG001|Overall Study|Withdrawal by Subject|3|||
125129958|NCT01010542|450102506|FG002|Overall Study|Withdrawal by Subject|2|||
125129959|NCT01745120|450102507|FG000|Overall Study|Investigator decision|1|||
125129960|NCT01745120|450102508|FG001|Overall Study|Investigator decision|0|||
124966530|NCT01086384|449505655|FG000|2-week Run-in Period|Adverse Event|1|||
125129961|NCT00579670|450102511|FG000|Overall Study|Death|1|||
125129962|NCT00579670|450102512|FG001|Overall Study|Death|0|||
125129963|NCT00579670|450102513|FG002|Overall Study|Death|0|||
125129964|NCT00579670|450102514|FG003|Overall Study|Death|0|||
125129965|NCT00579670|450102515|FG004|Overall Study|Death|0|||
125129966|NCT00579670|450102511|FG000|Overall Study|Adverse Event|1|||
125032072|NCT02764541|449737502|FG002|Overall Study|Protocol Violation|0|||
125032073|NCT02764541|449737503|FG003|Overall Study|Protocol Violation|1|||
125032074|NCT02764541|449737504|FG004|Overall Study|Protocol Violation|0|||
125032075|NCT02764541|449737505|FG005|Overall Study|Protocol Violation|1|||
125032076|NCT02764541|449737506|FG006|Overall Study|Protocol Violation|0|||
125032077|NCT02764541|449737507|FG007|Overall Study|Protocol Violation|0|||
125032078|NCT02764541|449737500|FG000|Overall Study|Physician Decision|0|||
125032079|NCT02764541|449737501|FG001|Overall Study|Physician Decision|0|||
125032080|NCT02764541|449737502|FG002|Overall Study|Physician Decision|0|||
125032081|NCT02764541|449737503|FG003|Overall Study|Physician Decision|1|||
125032082|NCT02764541|449737504|FG004|Overall Study|Physician Decision|0|||
125032083|NCT02764541|449737505|FG005|Overall Study|Physician Decision|0|||
125032084|NCT02764541|449737506|FG006|Overall Study|Physician Decision|0|||
125032085|NCT02764541|449737507|FG007|Overall Study|Physician Decision|1|||
125032086|NCT02764541|449737500|FG000|Overall Study|Three Cycles completed before surgery|0|||
125032087|NCT02764541|449737501|FG001|Overall Study|Three Cycles completed before surgery|0|||
125032088|NCT02764541|449737502|FG002|Overall Study|Three Cycles completed before surgery|0|||
125032089|NCT02764541|449737503|FG003|Overall Study|Three Cycles completed before surgery|1|||
125032090|NCT02764541|449737504|FG004|Overall Study|Three Cycles completed before surgery|0|||
125032091|NCT02764541|449737505|FG005|Overall Study|Three Cycles completed before surgery|0|||
125032092|NCT02764541|449737506|FG006|Overall Study|Three Cycles completed before surgery|0|||
125032093|NCT02764541|449737507|FG007|Overall Study|Three Cycles completed before surgery|0|||
125032094|NCT02764541|449737500|FG000|Overall Study|Patient Compliance|0|||
125032095|NCT02764541|449737501|FG001|Overall Study|Patient Compliance|0|||
125032096|NCT02764541|449737502|FG002|Overall Study|Patient Compliance|1|||
124966531|NCT01086384|449505656|FG001|2-week Run-in Period|Adverse Event|0|||
124966532|NCT01086384|449505657|FG002|2-week Run-in Period|Adverse Event|0|||
124966533|NCT01086384|449505655|FG000|2-week Run-in Period|Protocol Violation|1|||
124966534|NCT01086384|449505656|FG001|2-week Run-in Period|Protocol Violation|0|||
124966535|NCT01086384|449505657|FG002|2-week Run-in Period|Protocol Violation|0|||
124966536|NCT01086384|449505655|FG000|2-week Run-in Period|Lost to Follow-up|1|||
124966537|NCT01086384|449505656|FG001|2-week Run-in Period|Lost to Follow-up|0|||
124966538|NCT01086384|449505657|FG002|2-week Run-in Period|Lost to Follow-up|0|||
124966539|NCT01086384|449505655|FG000|2-week Run-in Period|Physician Decision|6|||
124966540|NCT01086384|449505656|FG001|2-week Run-in Period|Physician Decision|0|||
124966541|NCT01086384|449505657|FG002|2-week Run-in Period|Physician Decision|0|||
124966542|NCT01086384|449505655|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
124966543|NCT01086384|449505656|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
124966544|NCT01086384|449505657|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
124966545|NCT01086384|449505655|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
124966546|NCT01086384|449505656|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
124966547|NCT01086384|449505657|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
124966548|NCT01086384|449505655|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
124966549|NCT01086384|449505656|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
124966550|NCT01086384|449505657|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
124966551|NCT01086384|449505655|FG000|2-week Run-in Period|Randomized in Error|1|||
124966552|NCT01086384|449505656|FG001|2-week Run-in Period|Randomized in Error|0|||
124966553|NCT01086384|449505657|FG002|2-week Run-in Period|Randomized in Error|0|||
124966554|NCT01086384|449505655|FG000|Treatment Period|Withdrawal by Subject|0|||
124966555|NCT01086384|449505656|FG001|Treatment Period|Withdrawal by Subject|53|||
124966556|NCT01086384|449505657|FG002|Treatment Period|Withdrawal by Subject|55|||
124966557|NCT01086384|449505655|FG000|Treatment Period|Protocol Violation|0|||
124966558|NCT01086384|449505656|FG001|Treatment Period|Protocol Violation|26|||
124966559|NCT01086384|449505657|FG002|Treatment Period|Protocol Violation|17|||
124966560|NCT01086384|449505655|FG000|Treatment Period|Lack of Efficacy|0|||
124966561|NCT01086384|449505656|FG001|Treatment Period|Lack of Efficacy|22|||
125032097|NCT02764541|449737503|FG003|Overall Study|Patient Compliance|0|||
125032098|NCT02764541|449737504|FG004|Overall Study|Patient Compliance|0|||
125032099|NCT02764541|449737505|FG005|Overall Study|Patient Compliance|0|||
125032100|NCT02764541|449737506|FG006|Overall Study|Patient Compliance|0|||
125032101|NCT02764541|449737507|FG007|Overall Study|Patient Compliance|0|||
124966562|NCT01086384|449505657|FG002|Treatment Period|Lack of Efficacy|13|||
124966563|NCT01086384|449505655|FG000|Treatment Period|Adverse Event|0|||
124966564|NCT01086384|449505656|FG001|Treatment Period|Adverse Event|19|||
125032102|NCT02764541|449737500|FG000|Overall Study|Death|0|||
125032103|NCT02764541|449737501|FG001|Overall Study|Death|0|||
125032104|NCT02764541|449737502|FG002|Overall Study|Death|0|||
125032105|NCT02764541|449737503|FG003|Overall Study|Death|0|||
125032106|NCT02764541|449737504|FG004|Overall Study|Death|0|||
125032107|NCT02764541|449737505|FG005|Overall Study|Death|0|||
124966565|NCT01086384|449505657|FG002|Treatment Period|Adverse Event|15|||
124966566|NCT01086384|449505655|FG000|Treatment Period|Lost to Follow-up|0|||
124966567|NCT01086384|449505656|FG001|Treatment Period|Lost to Follow-up|11|||
124966568|NCT01086384|449505657|FG002|Treatment Period|Lost to Follow-up|9|||
124966569|NCT01086384|449505655|FG000|Treatment Period|Physician Decision|0|||
124966570|NCT01086384|449505656|FG001|Treatment Period|Physician Decision|9|||
124966571|NCT01086384|449505657|FG002|Treatment Period|Physician Decision|6|||
124966572|NCT01086384|449505655|FG000|Treatment Period|Study Closed/Terminated|0|||
124966573|NCT01086384|449505656|FG001|Treatment Period|Study Closed/Terminated|7|||
124966574|NCT01086384|449505657|FG002|Treatment Period|Study Closed/Terminated|8|||
124966575|NCT01086384|449505655|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
124966576|NCT01086384|449505656|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
124966577|NCT01086384|449505657|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
124966578|NCT01086384|449505655|FG000|Treatment Period|Received Treatment in Error|0|||
124966579|NCT01086384|449505656|FG001|Treatment Period|Received Treatment in Error|1|||
124966580|NCT01086384|449505657|FG002|Treatment Period|Received Treatment in Error|0|||
124966581|NCT02250534|449505660|FG000|Overall Study|Lost to Follow-up|18|||
124966582|NCT02250534|449505661|FG001|Overall Study|Lost to Follow-up|28|||
124966583|NCT02250534|449505662|FG002|Overall Study|Lost to Follow-up|33|||
124966584|NCT02250534|449505660|FG000|Overall Study|Personal reasons|7|||
124966585|NCT02250534|449505661|FG001|Overall Study|Personal reasons|8|||
124966586|NCT02250534|449505662|FG002|Overall Study|Personal reasons|14|||
124966587|NCT02250534|449505660|FG000|Overall Study|Adverse Event|6|||
124966588|NCT02250534|449505661|FG001|Overall Study|Adverse Event|3|||
124966589|NCT02250534|449505662|FG002|Overall Study|Adverse Event|8|||
124966590|NCT02250534|449505660|FG000|Overall Study|incarcerated|2|||
124966591|NCT02250534|449505661|FG001|Overall Study|incarcerated|1|||
124966592|NCT02250534|449505662|FG002|Overall Study|incarcerated|2|||
124966593|NCT02250534|449505660|FG000|Overall Study|Withdrawal by Subject|0|||
124966594|NCT02250534|449505661|FG001|Overall Study|Withdrawal by Subject|1|||
124966595|NCT02250534|449505662|FG002|Overall Study|Withdrawal by Subject|2|||
124966596|NCT02250534|449505660|FG000|Overall Study|Death|0|||
124966597|NCT02250534|449505661|FG001|Overall Study|Death|1|||
124966598|NCT02250534|449505662|FG002|Overall Study|Death|1|||
124966599|NCT02250534|449505660|FG000|Overall Study|Physician Decision|1|||
124966600|NCT02250534|449505661|FG001|Overall Study|Physician Decision|3|||
124966601|NCT02250534|449505662|FG002|Overall Study|Physician Decision|1|||
124966602|NCT02250534|449505660|FG000|Overall Study|Protocol Violation|1|||
124966603|NCT02250534|449505661|FG001|Overall Study|Protocol Violation|0|||
124966604|NCT02250534|449505662|FG002|Overall Study|Protocol Violation|1|||
124966605|NCT02250534|449505660|FG000|Overall Study|Reason unknown|1|||
124966606|NCT02250534|449505661|FG001|Overall Study|Reason unknown|0|||
124966607|NCT02250534|449505662|FG002|Overall Study|Reason unknown|0|||
124966608|NCT02725567|449505664|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
124966609|NCT02725567|449505665|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
124966610|NCT02725567|449505664|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
124966611|NCT02725567|449505665|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
124966612|NCT02725567|449505664|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
124966613|NCT02725567|449505665|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
124966614|NCT00255944|449505666|FG000|Overall Study|Lost to Follow-up|797|||
124966615|NCT00255944|449505667|FG001|Overall Study|Lost to Follow-up|834|||
124966616|NCT01129115|449505669|FG000|Overall Study|Adverse Event|1|||
124966617|NCT01129115|449505670|FG001|Overall Study|Adverse Event|2|||
124966618|NCT01129115|449505671|FG002|Overall Study|Adverse Event|3|||
124966619|NCT01129115|449505672|FG003|Overall Study|Adverse Event|3|||
124966620|NCT01129115|449505669|FG000|Overall Study|Withdrawal by Subject|1|||
124966621|NCT01129115|449505670|FG001|Overall Study|Withdrawal by Subject|3|||
124966622|NCT01129115|449505671|FG002|Overall Study|Withdrawal by Subject|1|||
124966623|NCT01129115|449505672|FG003|Overall Study|Withdrawal by Subject|4|||
124966624|NCT01129115|449505669|FG000|Overall Study|Protocol Violation|0|||
124966625|NCT01129115|449505670|FG001|Overall Study|Protocol Violation|2|||
124966626|NCT01129115|449505671|FG002|Overall Study|Protocol Violation|2|||
124966627|NCT01129115|449505672|FG003|Overall Study|Protocol Violation|2|||
124966628|NCT01747837|449505674|FG000|Overall Study|Lost to Follow-up|5|||
124966629|NCT01747837|449505675|FG001|Overall Study|Lost to Follow-up|2|||
124966630|NCT01747837|449505674|FG000|Overall Study|Death|4|||
124966631|NCT01747837|449505675|FG001|Overall Study|Death|4|||
124966632|NCT01435798|449505677|FG000|Overall Study|Withdrawal by Subject|1|||
124966633|NCT01253447|449505678|FG000|Overall Study|Adverse Event|2|||
124966634|NCT00817336|449505679|FG000|Overall Study|Withdrawal by Subject|1|||
124966635|NCT00817336|449505680|FG001|Overall Study|Withdrawal by Subject|1|||
124966636|NCT02299427|449505681|FG000|Overall Study|Withdrawal by Subject|1|||
125032108|NCT02764541|449737506|FG006|Overall Study|Death|1|||
125032109|NCT02764541|449737507|FG007|Overall Study|Death|0|||
125032110|NCT02764541|449737500|FG000|Overall Study|Insurance reasons|0|||
125032111|NCT02764541|449737501|FG001|Overall Study|Insurance reasons|0|||
124966637|NCT02299427|449505682|FG001|Overall Study|Withdrawal by Subject|0|||
124966638|NCT02299427|449505681|FG000|Overall Study|Lost to Follow-up|1|||
124966639|NCT02299427|449505682|FG001|Overall Study|Lost to Follow-up|3|||
124966640|NCT02299427|449505681|FG000|Overall Study|not adherent to dog website use|21|||
124966641|NCT02299427|449505682|FG001|Overall Study|not adherent to dog website use|0|||
124966642|NCT02108652|449505683|FG000|Overall Study|Death|253|||
124966643|NCT02108652|449505683|FG000|Overall Study|Lost to Follow-up|2|||
124966644|NCT02108652|449505683|FG000|Overall Study|Withdrawal by Subject|16|||
124966645|NCT02108652|449505683|FG000|Overall Study|Study Terminated By Sponsor|31|||
124966646|NCT02108652|449505683|FG000|Overall Study|Non-Compliance|1|||
124966647|NCT02108652|449505683|FG000|Overall Study|Physician Decision|6|||
124966648|NCT02108652|449505683|FG000|Overall Study|Progression Of Disease|1|||
124966649|NCT01182181|449505686|FG000|First Intervention|Adverse Event|1|||
124966650|NCT01182181|449505687|FG001|First Intervention|Adverse Event|0|||
124966651|NCT01182181|449505686|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
124966652|NCT01182181|449505687|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
124966653|NCT01121913|449505688|FG000|First Intervention Period|Adverse Event|0|||
124966654|NCT01121913|449505689|FG001|First Intervention Period|Adverse Event|0|||
124966655|NCT01121913|449505690|FG002|First Intervention Period|Adverse Event|1|||
124966656|NCT01121913|449505691|FG003|First Intervention Period|Adverse Event|0|||
124966657|NCT01121913|449505688|FG000|First Washout Period|Withdrawal by Subject|1|||
124966658|NCT01121913|449505689|FG001|First Washout Period|Withdrawal by Subject|0|||
124966659|NCT01121913|449505690|FG002|First Washout Period|Withdrawal by Subject|0|||
124966660|NCT01121913|449505691|FG003|First Washout Period|Withdrawal by Subject|0|||
124966661|NCT01121913|449505688|FG000|Second Intervention Period|Adverse Event|0|||
124966662|NCT01121913|449505689|FG001|Second Intervention Period|Adverse Event|0|||
124966663|NCT01121913|449505690|FG002|Second Intervention Period|Adverse Event|1|||
124966664|NCT01121913|449505691|FG003|Second Intervention Period|Adverse Event|0|||
124966665|NCT01121913|449505688|FG000|Second Washout Period|Withdrawal by Subject|0|||
124966666|NCT01121913|449505689|FG001|Second Washout Period|Withdrawal by Subject|0|||
124966667|NCT01121913|449505690|FG002|Second Washout Period|Withdrawal by Subject|1|||
124966668|NCT01121913|449505691|FG003|Second Washout Period|Withdrawal by Subject|0|||
124966669|NCT01121913|449505688|FG000|Third Washout Period|Adverse Event|1|||
124966670|NCT01121913|449505689|FG001|Third Washout Period|Adverse Event|0|||
124966671|NCT01121913|449505690|FG002|Third Washout Period|Adverse Event|0|||
124966672|NCT01121913|449505691|FG003|Third Washout Period|Adverse Event|0|||
124966673|NCT02564718|449505694|FG000|Overall Study|Withdrew from treatment|0|||
124966674|NCT02564718|449505695|FG001|Overall Study|Withdrew from treatment|1|||
124966675|NCT00937521|449505696|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
124966676|NCT00937521|449505697|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
124966677|NCT00937521|449505698|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
124966678|NCT00937521|449505699|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
124966679|NCT00937521|449505700|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
124966680|NCT00937521|449505701|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
124966681|NCT00937521|449505702|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
124966682|NCT00937521|449505703|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
124966683|NCT00937521|449505696|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
124966684|NCT00937521|449505697|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
124966685|NCT00937521|449505698|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
124966686|NCT00937521|449505699|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
124966687|NCT00937521|449505700|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
124966688|NCT00937521|449505701|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
124966689|NCT00937521|449505702|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
124966690|NCT00937521|449505703|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
124966691|NCT00937521|449505696|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
124966692|NCT00937521|449505697|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
125032112|NCT02764541|449737502|FG002|Overall Study|Insurance reasons|0|||
125032113|NCT02764541|449737503|FG003|Overall Study|Insurance reasons|0|||
125032114|NCT02764541|449737504|FG004|Overall Study|Insurance reasons|0|||
125032115|NCT02764541|449737505|FG005|Overall Study|Insurance reasons|0|||
124966693|NCT00937521|449505698|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
124966694|NCT00937521|449505699|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
124966695|NCT00937521|449505700|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
124966696|NCT00937521|449505701|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
124966697|NCT00937521|449505702|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
124966698|NCT00937521|449505703|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
124966699|NCT00937521|449505696|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
124966700|NCT00937521|449505697|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
124966701|NCT00937521|449505698|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
125032116|NCT02764541|449737506|FG006|Overall Study|Insurance reasons|1|||
125032117|NCT02764541|449737507|FG007|Overall Study|Insurance reasons|0|||
125032118|NCT00749190|449737508|FG000|Overall Study|Adverse Event|0|||
125032119|NCT00749190|449737509|FG001|Overall Study|Adverse Event|2|||
125032120|NCT00749190|449737510|FG002|Overall Study|Adverse Event|0|||
125032121|NCT00749190|449737511|FG003|Overall Study|Adverse Event|4|||
125032122|NCT00749190|449737512|FG004|Overall Study|Adverse Event|0|||
125032123|NCT00749190|449737513|FG005|Overall Study|Adverse Event|3|||
125032124|NCT00749190|449737514|FG006|Overall Study|Adverse Event|0|||
125032125|NCT00749190|449737508|FG000|Overall Study|Lack of Efficacy|3|||
125032126|NCT00749190|449737509|FG001|Overall Study|Lack of Efficacy|1|||
125032127|NCT00749190|449737510|FG002|Overall Study|Lack of Efficacy|1|||
125032128|NCT00749190|449737511|FG003|Overall Study|Lack of Efficacy|0|||
125032129|NCT00749190|449737512|FG004|Overall Study|Lack of Efficacy|0|||
125032130|NCT00749190|449737513|FG005|Overall Study|Lack of Efficacy|1|||
125032131|NCT00749190|449737514|FG006|Overall Study|Lack of Efficacy|0|||
125032132|NCT00749190|449737508|FG000|Overall Study|Withdrawal by Subject|2|||
125032133|NCT00749190|449737509|FG001|Overall Study|Withdrawal by Subject|1|||
125032134|NCT00749190|449737510|FG002|Overall Study|Withdrawal by Subject|0|||
125032135|NCT00749190|449737511|FG003|Overall Study|Withdrawal by Subject|0|||
125032136|NCT00749190|449737512|FG004|Overall Study|Withdrawal by Subject|0|||
125032137|NCT00749190|449737513|FG005|Overall Study|Withdrawal by Subject|1|||
125032138|NCT00749190|449737514|FG006|Overall Study|Withdrawal by Subject|0|||
125032139|NCT00749190|449737508|FG000|Overall Study|Protocol Violation|0|||
125032140|NCT00749190|449737509|FG001|Overall Study|Protocol Violation|1|||
125032141|NCT00749190|449737510|FG002|Overall Study|Protocol Violation|0|||
125032142|NCT00749190|449737511|FG003|Overall Study|Protocol Violation|0|||
125032143|NCT00749190|449737512|FG004|Overall Study|Protocol Violation|0|||
125032144|NCT00749190|449737513|FG005|Overall Study|Protocol Violation|0|||
125032145|NCT00749190|449737514|FG006|Overall Study|Protocol Violation|1|||
125032146|NCT00749190|449737508|FG000|Overall Study|Other reason not defined above|0|||
125032147|NCT00749190|449737509|FG001|Overall Study|Other reason not defined above|0|||
125032148|NCT00749190|449737510|FG002|Overall Study|Other reason not defined above|0|||
125032149|NCT00749190|449737511|FG003|Overall Study|Other reason not defined above|1|||
125032150|NCT00749190|449737512|FG004|Overall Study|Other reason not defined above|0|||
125032151|NCT00749190|449737513|FG005|Overall Study|Other reason not defined above|0|||
125032152|NCT00749190|449737514|FG006|Overall Study|Other reason not defined above|0|||
125032153|NCT01245673|449737515|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
125032154|NCT00355121|449737517|FG000|Overall Study|Did not receive study vaccine|1|||
125032155|NCT00355121|449737518|FG001|Overall Study|Did not receive study vaccine|0|||
125032156|NCT00355121|449737519|FG002|Overall Study|Did not receive study vaccine|1|||
125032157|NCT00355121|449737517|FG000|Overall Study|Adverse Event|0|||
125032158|NCT00355121|449737518|FG001|Overall Study|Adverse Event|1|||
125032159|NCT00355121|449737519|FG002|Overall Study|Adverse Event|0|||
125032160|NCT00355121|449737517|FG000|Overall Study|Protocol Violation|7|||
125032161|NCT00355121|449737518|FG001|Overall Study|Protocol Violation|9|||
125032162|NCT00355121|449737519|FG002|Overall Study|Protocol Violation|1|||
125032163|NCT00355121|449737517|FG000|Overall Study|Lost to Follow-up|4|||
125032164|NCT00355121|449737518|FG001|Overall Study|Lost to Follow-up|7|||
125032165|NCT00355121|449737519|FG002|Overall Study|Lost to Follow-up|1|||
125032166|NCT00355121|449737517|FG000|Overall Study|Withdrawal by Subject|9|||
125032167|NCT00355121|449737518|FG001|Overall Study|Withdrawal by Subject|10|||
125032168|NCT00355121|449737519|FG002|Overall Study|Withdrawal by Subject|2|||
125032169|NCT00355121|449737517|FG000|Overall Study|Serious adverse events|0|||
125032170|NCT00355121|449737518|FG001|Overall Study|Serious adverse events|2|||
125032171|NCT00355121|449737519|FG002|Overall Study|Serious adverse events|0|||
125032172|NCT00630331|449737521|FG000|Overall Study|Death|2|||
125032173|NCT00630331|449737522|FG001|Overall Study|Death|1|||
125032174|NCT00630331|449737523|FG002|Overall Study|Death|1|||
125032175|NCT00630331|449737521|FG000|Overall Study|Adverse Event|1|||
125032176|NCT00630331|449737522|FG001|Overall Study|Adverse Event|0|||
125032177|NCT00630331|449737523|FG002|Overall Study|Adverse Event|0|||
125032178|NCT00630331|449737521|FG000|Overall Study|Withdrawal by Subject|12|||
125032179|NCT00630331|449737522|FG001|Overall Study|Withdrawal by Subject|7|||
125032180|NCT00630331|449737523|FG002|Overall Study|Withdrawal by Subject|5|||
125032181|NCT00630331|449737521|FG000|Overall Study|Lost to Follow-up|175|||
125032182|NCT00630331|449737522|FG001|Overall Study|Lost to Follow-up|143|||
125032183|NCT00630331|449737523|FG002|Overall Study|Lost to Follow-up|170|||
125032184|NCT00630331|449737521|FG000|Overall Study|Inappropriate enrollment|3|||
125032185|NCT00630331|449737522|FG001|Overall Study|Inappropriate enrollment|6|||
125032186|NCT00630331|449737523|FG002|Overall Study|Inappropriate enrollment|3|||
125032187|NCT00630331|449737521|FG000|Overall Study|Unable to classify|9|||
125032188|NCT00630331|449737522|FG001|Overall Study|Unable to classify|4|||
125032189|NCT00630331|449737523|FG002|Overall Study|Unable to classify|3|||
125032190|NCT00630331|449737521|FG000|Overall Study|Protocol Violation|4|||
125032191|NCT00630331|449737522|FG001|Overall Study|Protocol Violation|5|||
125032192|NCT00630331|449737523|FG002|Overall Study|Protocol Violation|6|||
125032193|NCT04640766|449737524|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
125032194|NCT01565980|449737526|FG000|Overall Study|Death|1|||
124966702|NCT00937521|449505699|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
124966703|NCT00937521|449505700|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
124966704|NCT00937521|449505701|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
124966705|NCT00937521|449505702|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
124966706|NCT00937521|449505703|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
124966707|NCT00937521|449505696|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
124966708|NCT00937521|449505697|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
124966709|NCT00937521|449505698|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
124966710|NCT00937521|449505699|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
124966711|NCT00937521|449505700|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
124966712|NCT00937521|449505701|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
124966713|NCT00937521|449505702|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
124966714|NCT00937521|449505703|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
124966715|NCT00937521|449505696|FG000|Booster Phase|Adverse Event|0|||
124966716|NCT00937521|449505697|FG001|Booster Phase|Adverse Event|0|||
124966717|NCT00937521|449505698|FG002|Booster Phase|Adverse Event|0|||
124966718|NCT00937521|449505699|FG003|Booster Phase|Adverse Event|0|||
124966719|NCT00937521|449505700|FG004|Booster Phase|Adverse Event|0|||
124966720|NCT00937521|449505701|FG005|Booster Phase|Adverse Event|0|||
124966721|NCT00937521|449505702|FG006|Booster Phase|Adverse Event|1|||
124966722|NCT00937521|449505703|FG007|Booster Phase|Adverse Event|0|||
124966723|NCT00937521|449505696|FG000|Booster Phase|Withdrawal by Subject|1|||
124966724|NCT00937521|449505697|FG001|Booster Phase|Withdrawal by Subject|0|||
124966725|NCT00937521|449505698|FG002|Booster Phase|Withdrawal by Subject|0|||
124966726|NCT00937521|449505699|FG003|Booster Phase|Withdrawal by Subject|1|||
124966727|NCT00937521|449505700|FG004|Booster Phase|Withdrawal by Subject|0|||
124966728|NCT00937521|449505701|FG005|Booster Phase|Withdrawal by Subject|0|||
124966729|NCT00937521|449505702|FG006|Booster Phase|Withdrawal by Subject|0|||
124966730|NCT00937521|449505703|FG007|Booster Phase|Withdrawal by Subject|2|||
124966731|NCT00937521|449505696|FG000|Booster Phase|Lost to Follow-up|2|||
124966732|NCT00937521|449505697|FG001|Booster Phase|Lost to Follow-up|2|||
124966733|NCT00937521|449505698|FG002|Booster Phase|Lost to Follow-up|4|||
124966734|NCT00937521|449505699|FG003|Booster Phase|Lost to Follow-up|2|||
124966735|NCT00937521|449505700|FG004|Booster Phase|Lost to Follow-up|4|||
124966736|NCT00937521|449505701|FG005|Booster Phase|Lost to Follow-up|4|||
124966737|NCT00937521|449505702|FG006|Booster Phase|Lost to Follow-up|3|||
124966738|NCT00937521|449505703|FG007|Booster Phase|Lost to Follow-up|0|||
124966739|NCT00937521|449505696|FG000|Booster Phase|Administrative Reason|0|||
124966740|NCT00937521|449505697|FG001|Booster Phase|Administrative Reason|0|||
124966741|NCT00937521|449505698|FG002|Booster Phase|Administrative Reason|1|||
124966742|NCT00937521|449505699|FG003|Booster Phase|Administrative Reason|0|||
124966743|NCT00937521|449505700|FG004|Booster Phase|Administrative Reason|1|||
124966744|NCT00937521|449505701|FG005|Booster Phase|Administrative Reason|1|||
124966745|NCT00937521|449505702|FG006|Booster Phase|Administrative Reason|0|||
124966746|NCT00937521|449505703|FG007|Booster Phase|Administrative Reason|0|||
124966747|NCT00937521|449505696|FG000|Booster Phase|Protocol Deviation|0|||
124966748|NCT00937521|449505697|FG001|Booster Phase|Protocol Deviation|0|||
124966749|NCT00937521|449505698|FG002|Booster Phase|Protocol Deviation|0|||
124966750|NCT00937521|449505699|FG003|Booster Phase|Protocol Deviation|0|||
124966751|NCT00937521|449505700|FG004|Booster Phase|Protocol Deviation|0|||
124966752|NCT00937521|449505701|FG005|Booster Phase|Protocol Deviation|0|||
124966753|NCT00937521|449505702|FG006|Booster Phase|Protocol Deviation|1|||
124966754|NCT00937521|449505703|FG007|Booster Phase|Protocol Deviation|0|||
124966755|NCT04353817|449505704|FG000|Overall Study|Adverse Event|0|||
124966756|NCT04353817|449505705|FG001|Overall Study|Adverse Event|1|||
124966757|NCT00770588|449505706|FG000|Overall Study|Adverse Event|9|||
124966758|NCT00770588|449505707|FG001|Overall Study|Adverse Event|2|||
124966759|NCT00770588|449505706|FG000|Overall Study|Death caused by progression of disease|70|||
124966760|NCT00770588|449505707|FG001|Overall Study|Death caused by progression of disease|91|||
124966761|NCT00770588|449505706|FG000|Overall Study|Lost to Follow-up|1|||
124966762|NCT00770588|449505707|FG001|Overall Study|Lost to Follow-up|1|||
124966763|NCT00770588|449505706|FG000|Overall Study|Withdrawal by Subject|1|||
124966764|NCT00770588|449505707|FG001|Overall Study|Withdrawal by Subject|1|||
124966765|NCT00002597|449505708|FG000|Overall Study|Protocol Violation|19|||
124966766|NCT00002597|449505709|FG001|Overall Study|Protocol Violation|17|||
124966767|NCT00002597|449505708|FG000|Overall Study|Withdrawal by Subject|7|||
124966768|NCT00002597|449505709|FG001|Overall Study|Withdrawal by Subject|6|||
124966769|NCT02485899|449505711|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
124966770|NCT02485899|449505712|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
124966771|NCT02485899|449505711|FG000|Overall Study|Withdrawal by Subject|1|||
124966772|NCT02485899|449505712|FG001|Overall Study|Withdrawal by Subject|0|||
124966773|NCT02485899|449505711|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
124966774|NCT02485899|449505712|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
124966775|NCT01918371|449505713|FG000|Overall Study|Missing Data|1|||
124966776|NCT01918371|449505714|FG001|Overall Study|Missing Data|1|||
124966777|NCT02143063|449505715|FG000|Overall Study|Lost to Follow-up|16|||
124966778|NCT02143063|449505716|FG001|Overall Study|Lost to Follow-up|28|||
124966779|NCT02143063|449505717|FG002|Overall Study|Lost to Follow-up|29|||
124966780|NCT02143063|449505715|FG000|Overall Study|Withdrawal by Subject|0|||
124966781|NCT02143063|449505716|FG001|Overall Study|Withdrawal by Subject|1|||
124966782|NCT02143063|449505717|FG002|Overall Study|Withdrawal by Subject|0|||
124966783|NCT02143063|449505715|FG000|Overall Study|Death|0|||
124966784|NCT02143063|449505716|FG001|Overall Study|Death|1|||
124966785|NCT02143063|449505717|FG002|Overall Study|Death|1|||
124966786|NCT00623363|449505720|FG000|Overall Study|Adverse Event|2|||
124966787|NCT00623363|449505721|FG001|Overall Study|Adverse Event|2|||
124966788|NCT01880437|449505723|FG000|Overall Study|Death|12|||
124966789|NCT01880437|449505724|FG001|Overall Study|Death|4|||
124966790|NCT01880437|449505725|FG002|Overall Study|Death|17|||
124966791|NCT01880437|449505723|FG000|Overall Study|Study terminated by Sponsor|3|||
124966792|NCT01880437|449505724|FG001|Overall Study|Study terminated by Sponsor|0|||
124966793|NCT01880437|449505725|FG002|Overall Study|Study terminated by Sponsor|2|||
124966794|NCT00823836|449505726|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
124966795|NCT00823836|449505727|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
124966796|NCT00823836|449505726|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
124966797|NCT00823836|449505727|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
124966798|NCT00823836|449505726|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
124966799|NCT00823836|449505727|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
124966800|NCT00823836|449505726|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
124966801|NCT00823836|449505727|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
124966802|NCT00823836|449505726|FG000|Long-term Phase|Adverse Event|3|||
124966803|NCT00823836|449505727|FG001|Long-term Phase|Adverse Event|2|||
124966804|NCT00823836|449505726|FG000|Long-term Phase|Physician Decision|1|||
124966805|NCT00823836|449505727|FG001|Long-term Phase|Physician Decision|2|||
124966806|NCT00823836|449505726|FG000|Long-term Phase|Withdrawal by Subject|1|||
124966807|NCT00823836|449505727|FG001|Long-term Phase|Withdrawal by Subject|1|||
124966808|NCT03713320|449505728|FG000|Randomized Period|Adverse Event|1|||
124966809|NCT03713320|449505729|FG001|Randomized Period|Adverse Event|5|||
124966810|NCT03713320|449505730|FG002|Randomized Period|Adverse Event|0|||
124966811|NCT03713320|449505728|FG000|Randomized Period|Physician Decision|1|||
124966812|NCT03713320|449505729|FG001|Randomized Period|Physician Decision|1|||
124966813|NCT03713320|449505730|FG002|Randomized Period|Physician Decision|0|||
124966814|NCT03713320|449505728|FG000|Randomized Period|Withdrawal by Subject|4|||
124966815|NCT03713320|449505729|FG001|Randomized Period|Withdrawal by Subject|0|||
124966816|NCT03713320|449505730|FG002|Randomized Period|Withdrawal by Subject|0|||
124966817|NCT03713320|449505728|FG000|Randomized Period|Participant decision|3|||
124966818|NCT03713320|449505729|FG001|Randomized Period|Participant decision|1|||
124966819|NCT03713320|449505730|FG002|Randomized Period|Participant decision|0|||
124966820|NCT03713320|449505728|FG000|Randomized Period|Study terminated by sponsor|6|||
124966821|NCT03713320|449505729|FG001|Randomized Period|Study terminated by sponsor|3|||
124966822|NCT03713320|449505730|FG002|Randomized Period|Study terminated by sponsor|0|||
124966823|NCT03713320|449505728|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
124966824|NCT03713320|449505729|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
124966825|NCT03713320|449505730|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
124966826|NCT03713320|449505728|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
124966827|NCT03713320|449505729|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
124966828|NCT03713320|449505730|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
124966829|NCT04354168|449505735|FG000|Overall Study|Lost to Follow-up|22|||
124966830|NCT01438840|449505738|FG000|Core Study|Adverse Event|0|||
124966831|NCT01438840|449505739|FG001|Core Study|Adverse Event|3|||
124966832|NCT01438840|449505740|FG002|Core Study|Adverse Event|0|||
124966833|NCT01438840|449505738|FG000|Core Study|Lack of Efficacy|15|||
124966834|NCT01438840|449505739|FG001|Core Study|Lack of Efficacy|7|||
124966835|NCT01438840|449505740|FG002|Core Study|Lack of Efficacy|0|||
124966836|NCT01438840|449505738|FG000|Core Study|Withdrawal of consent|1|||
124966837|NCT01438840|449505739|FG001|Core Study|Withdrawal of consent|0|||
124966838|NCT01438840|449505740|FG002|Core Study|Withdrawal of consent|0|||
124966839|NCT01438840|449505738|FG000|Extension Phase|Adverse Event|0|||
125032195|NCT01565980|449737527|FG001|Overall Study|Death|0|||
125032196|NCT01565980|449737526|FG000|Overall Study|Lost to Follow-up|1|||
125032197|NCT01565980|449737527|FG001|Overall Study|Lost to Follow-up|0|||
125032198|NCT01565980|449737526|FG000|Overall Study|health complications|1|||
125032199|NCT01565980|449737527|FG001|Overall Study|health complications|1|||
125032200|NCT01565980|449737526|FG000|Overall Study|stopped medical treatment|1|||
125032201|NCT01565980|449737527|FG001|Overall Study|stopped medical treatment|0|||
125032202|NCT01565980|449737526|FG000|Overall Study|Withdrawal by Subject|0|||
125032203|NCT01565980|449737527|FG001|Overall Study|Withdrawal by Subject|3|||
124966840|NCT01438840|449505739|FG001|Extension Phase|Adverse Event|0|||
124966841|NCT01438840|449505740|FG002|Extension Phase|Adverse Event|3|||
125032204|NCT01929135|449737531|FG000|Overall Study|Lost to Follow-up|1|||
125032205|NCT01929135|449737532|FG001|Overall Study|Lost to Follow-up|1|||
125032206|NCT02425098|449737533|FG000|Overall Study|Lost to Follow-up|7|||
124966842|NCT01438840|449505738|FG000|Extension Phase|Lost to Follow-up|0|||
124966843|NCT01438840|449505739|FG001|Extension Phase|Lost to Follow-up|0|||
124966844|NCT01438840|449505740|FG002|Extension Phase|Lost to Follow-up|1|||
124966845|NCT01438840|449505738|FG000|Extension Phase|Withdrawal by Subject|0|||
124966846|NCT01438840|449505739|FG001|Extension Phase|Withdrawal by Subject|0|||
124966847|NCT01438840|449505740|FG002|Extension Phase|Withdrawal by Subject|3|||
124966848|NCT01438840|449505738|FG000|Extension Phase|Lack of Efficacy|0|||
124966849|NCT01438840|449505739|FG001|Extension Phase|Lack of Efficacy|0|||
124966850|NCT01438840|449505740|FG002|Extension Phase|Lack of Efficacy|2|||
124966851|NCT01438840|449505738|FG000|Extension Phase|Other|0|||
124966852|NCT01438840|449505739|FG001|Extension Phase|Other|0|||
124966853|NCT01438840|449505740|FG002|Extension Phase|Other|1|||
124966854|NCT02062645|449505743|FG000|Overall Study|Adverse Event|2|||
124966855|NCT02062645|449505743|FG000|Overall Study|Protocol Violation|8|||
124966856|NCT02062645|449505743|FG000|Overall Study|Lost to Follow-up|5|||
124966857|NCT02804399|449505744|FG000|Period 2|Adverse Event|0|||
124966858|NCT02804399|449505745|FG001|Period 2|Adverse Event|1|||
124966859|NCT01774305|449505746|FG000|Overall Study|Physician Decision|1|||
124966860|NCT01774305|449505747|FG001|Overall Study|Physician Decision|0|||
124966861|NCT04211389|449505748|FG000|Overall Study|Adverse Event|1|||
124966862|NCT04211389|449505749|FG001|Overall Study|Adverse Event|2|||
124966863|NCT04211389|449505748|FG000|Overall Study|Lost to Follow-up|15|||
124966864|NCT04211389|449505749|FG001|Overall Study|Lost to Follow-up|7|||
124966865|NCT04211389|449505748|FG000|Overall Study|Protocol Violation|0|||
124966866|NCT04211389|449505749|FG001|Overall Study|Protocol Violation|1|||
124966867|NCT04211389|449505748|FG000|Overall Study|Withdrawal by Subject|10|||
124966868|NCT04211389|449505749|FG001|Overall Study|Withdrawal by Subject|11|||
124966869|NCT00087555|449505753|FG000|Overall Study|Adverse Event|3|||
124966870|NCT00087555|449505754|FG001|Overall Study|Adverse Event|6|||
124966871|NCT00087555|449505755|FG002|Overall Study|Adverse Event|14|||
124966872|NCT00087555|449505753|FG000|Overall Study|Lost to Follow-up|0|||
124966873|NCT00087555|449505754|FG001|Overall Study|Lost to Follow-up|1|||
124966874|NCT00087555|449505755|FG002|Overall Study|Lost to Follow-up|1|||
124966875|NCT00087555|449505753|FG000|Overall Study|Non - Compliance|1|||
124966876|NCT00087555|449505754|FG001|Overall Study|Non - Compliance|0|||
124966877|NCT00087555|449505755|FG002|Overall Study|Non - Compliance|0|||
124966878|NCT00087555|449505753|FG000|Overall Study|Protocol Violation|0|||
124966879|NCT00087555|449505754|FG001|Overall Study|Protocol Violation|0|||
124966880|NCT00087555|449505755|FG002|Overall Study|Protocol Violation|2|||
124966881|NCT00087555|449505753|FG000|Overall Study|Screen Failure|1|||
124966882|NCT00087555|449505754|FG001|Overall Study|Screen Failure|1|||
124966883|NCT00087555|449505755|FG002|Overall Study|Screen Failure|0|||
124966884|NCT00087555|449505753|FG000|Overall Study|Pregnancy|0|||
124966885|NCT00087555|449505754|FG001|Overall Study|Pregnancy|1|||
124966886|NCT00087555|449505755|FG002|Overall Study|Pregnancy|1|||
124966887|NCT00087555|449505753|FG000|Overall Study|Withdrawal by Subject|3|||
124966888|NCT00087555|449505754|FG001|Overall Study|Withdrawal by Subject|2|||
124966889|NCT00087555|449505755|FG002|Overall Study|Withdrawal by Subject|1|||
124966890|NCT00087555|449505753|FG000|Overall Study|Lack of Efficacy|2|||
124966891|NCT00087555|449505754|FG001|Overall Study|Lack of Efficacy|0|||
124966892|NCT00087555|449505755|FG002|Overall Study|Lack of Efficacy|1|||
124966893|NCT00087555|449505753|FG000|Overall Study|Non Compliance|0|||
124966894|NCT00087555|449505754|FG001|Overall Study|Non Compliance|0|||
124966895|NCT00087555|449505755|FG002|Overall Study|Non Compliance|1|||
125032207|NCT02425098|449737534|FG001|Overall Study|Lost to Follow-up|7|||
125032208|NCT02425098|449737533|FG000|Overall Study|Withdrawal by Subject|4|||
125032209|NCT02425098|449737534|FG001|Overall Study|Withdrawal by Subject|8|||
125032210|NCT02425098|449737533|FG000|Overall Study|Pregnancy|2|||
125032211|NCT02425098|449737534|FG001|Overall Study|Pregnancy|0|||
125032212|NCT02425098|449737533|FG000|Overall Study|Reason not Specified|0|||
125032213|NCT02425098|449737534|FG001|Overall Study|Reason not Specified|1|||
125032214|NCT02078219|449737540|FG000|Overall Study|Other|2|||
125032215|NCT02078219|449737541|FG001|Overall Study|Other|2|||
125032216|NCT02078219|449737542|FG002|Overall Study|Other|3|||
125032217|NCT02078219|449737543|FG003|Overall Study|Other|0|||
124966896|NCT00087555|449505753|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
124966897|NCT00087555|449505754|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
125032218|NCT02078219|449737544|FG004|Overall Study|Other|1|||
125032219|NCT02078219|449737540|FG000|Overall Study|Withdrawal by Subject|0|||
124966898|NCT00087555|449505755|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
124966899|NCT00087555|449505753|FG000|Overall Study|Patient wanted to go back on Med|1|||
124966900|NCT00087555|449505754|FG001|Overall Study|Patient wanted to go back on Med|0|||
124966901|NCT00087555|449505755|FG002|Overall Study|Patient wanted to go back on Med|0|||
124966902|NCT01062971|449505758|FG000|Overall Study|Protocol Violation|1|||
124966903|NCT01062971|449505759|FG001|Overall Study|Protocol Violation|3|||
124966904|NCT01062971|449505758|FG000|Overall Study|Lost to Follow-up|3|||
124966905|NCT01062971|449505759|FG001|Overall Study|Lost to Follow-up|4|||
125032220|NCT02078219|449737541|FG001|Overall Study|Withdrawal by Subject|1|||
125032221|NCT02078219|449737542|FG002|Overall Study|Withdrawal by Subject|0|||
125032222|NCT02078219|449737543|FG003|Overall Study|Withdrawal by Subject|1|||
124966906|NCT05523219|449505760|FG000|Overall Study|Wrong inclusion|1|||
124966907|NCT05523219|449505760|FG000|Overall Study|Lost to Follow-up|7|||
124966908|NCT02261285|449505761|FG000|Overall Study|Disease progression|0|||
124966909|NCT02261285|449505762|FG001|Overall Study|Disease progression|0|||
124966910|NCT02261285|449505763|FG002|Overall Study|Disease progression|1|||
124966911|NCT02760485|449505764|FG000|Phase 1|Death|3|||
124966912|NCT02760485|449505765|FG001|Phase 1|Death|6|||
124966913|NCT02760485|449505766|FG002|Phase 1|Death|0|||
124966914|NCT02760485|449505764|FG000|Phase 1|Withdrawal by Subject|2|||
124966915|NCT02760485|449505765|FG001|Phase 1|Withdrawal by Subject|0|||
124966916|NCT02760485|449505766|FG002|Phase 1|Withdrawal by Subject|0|||
124966917|NCT02760485|449505764|FG000|Phase 1|Progressive Disease|1|||
124966918|NCT02760485|449505765|FG001|Phase 1|Progressive Disease|0|||
124966919|NCT02760485|449505766|FG002|Phase 1|Progressive Disease|0|||
124966920|NCT02760485|449505764|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
124966921|NCT02760485|449505765|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
124966922|NCT02760485|449505766|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
124966923|NCT02760485|449505764|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
124966924|NCT02760485|449505765|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
124966925|NCT02760485|449505766|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
124966926|NCT02760485|449505764|FG000|Phase 2|Death|0|||
124966927|NCT02760485|449505765|FG001|Phase 2|Death|0|||
124966928|NCT02760485|449505766|FG002|Phase 2|Death|12|||
124966929|NCT02760485|449505764|FG000|Phase 2|Withdrawal by Subject|0|||
124966930|NCT02760485|449505765|FG001|Phase 2|Withdrawal by Subject|0|||
124966931|NCT02760485|449505766|FG002|Phase 2|Withdrawal by Subject|3|||
124966932|NCT02760485|449505764|FG000|Phase 2|Progressive Disease|0|||
124966933|NCT02760485|449505765|FG001|Phase 2|Progressive Disease|0|||
124966934|NCT02760485|449505766|FG002|Phase 2|Progressive Disease|1|||
124966935|NCT02760485|449505764|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
124966936|NCT02760485|449505765|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
124966937|NCT02760485|449505766|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
124966938|NCT01182207|449505767|FG000|First Intervention|Positive Hepatitis Results|0|||
124966939|NCT01182207|449505768|FG001|First Intervention|Positive Hepatitis Results|1|||
124966940|NCT01182207|449505767|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
124966941|NCT01182207|449505768|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
124966942|NCT01087814|449505769|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
124966943|NCT01087814|449505770|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
124966944|NCT01087814|449505769|FG000|Second Intervention (5 Days)|Physician Decision|1|||
124966945|NCT01087814|449505770|FG001|Second Intervention (5 Days)|Physician Decision|0|||
124966946|NCT01161628|449505771|FG000|Overall Study|Death|6|||
124966947|NCT01161628|449505771|FG000|Overall Study|Lack of Efficacy|2|||
124966948|NCT00715117|449505772|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
124966949|NCT00715117|449505773|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
124966950|NCT01482429|449505774|FG000|Care Usual|Protocol Violation|0|||
124966951|NCT01482429|449505775|FG001|Care Usual|Protocol Violation|172|||
124966952|NCT01482429|449505774|FG000|Care Usual|Lost to Follow-up|0|||
124966953|NCT01482429|449505775|FG001|Care Usual|Lost to Follow-up|1|||
124966954|NCT01482429|449505774|FG000|Protocol|Protocol Violation|275|||
124966955|NCT01482429|449505775|FG001|Protocol|Protocol Violation|0|||
124966956|NCT04680637|449505776|FG000|Overall Study|Lost to Follow-up|0|||
124966957|NCT04680637|449505777|FG001|Overall Study|Lost to Follow-up|1|||
124966958|NCT04680637|449505778|FG002|Overall Study|Lost to Follow-up|0|||
124966959|NCT04680637|449505779|FG003|Overall Study|Lost to Follow-up|1|||
124966960|NCT04680637|449505776|FG000|Overall Study|Death|1|||
124966961|NCT04680637|449505777|FG001|Overall Study|Death|0|||
124966962|NCT04680637|449505778|FG002|Overall Study|Death|0|||
124966963|NCT04680637|449505779|FG003|Overall Study|Death|0|||
124966964|NCT04680637|449505776|FG000|Overall Study|Withdrawal by Subject|7|||
125216479|NCT01775787|450419448|FG000|First 7-10 Days|time commitment|0|||
125216480|NCT01775787|450419449|FG001|First 7-10 Days|time commitment|2|||
125216481|NCT01775787|450419448|FG000|First 7-10 Days|concerns with using IV|1|||
125216482|NCT01775787|450419449|FG001|First 7-10 Days|concerns with using IV|2|||
125216483|NCT01775787|450419448|FG000|Second 7-10 Days|time commitment|0|||
125216484|NCT01775787|450419449|FG001|Second 7-10 Days|time commitment|1|||
125216485|NCT01775787|450419448|FG000|Second 7-10 Days|concerns with using IV|0|||
124966965|NCT04680637|449505777|FG001|Overall Study|Withdrawal by Subject|10|||
124966966|NCT04680637|449505778|FG002|Overall Study|Withdrawal by Subject|17|||
124966967|NCT04680637|449505779|FG003|Overall Study|Withdrawal by Subject|15|||
124966968|NCT04680637|449505776|FG000|Overall Study|Decision by Sponsor|21|||
124966969|NCT04680637|449505777|FG001|Overall Study|Decision by Sponsor|15|||
124966970|NCT04680637|449505778|FG002|Overall Study|Decision by Sponsor|7|||
124966971|NCT04680637|449505779|FG003|Overall Study|Decision by Sponsor|32|||
124966972|NCT02037256|449505780|FG000|Overall Study|Protocol Violation|0|||
124966973|NCT02037256|449505781|FG001|Overall Study|Protocol Violation|1|||
124966974|NCT02037256|449505780|FG000|Overall Study|Withdrawn prior to Velcade|0|||
124966975|NCT02037256|449505781|FG001|Overall Study|Withdrawn prior to Velcade|2|||
125216486|NCT01775787|450419449|FG001|Second 7-10 Days|concerns with using IV|1|||
124966976|NCT00497874|449507335|FG000|Overall Study|Withdrawal by Subject|48|||
124966977|NCT00497874|449507336|FG001|Overall Study|Withdrawal by Subject|17|||
124966978|NCT00497874|449507335|FG000|Overall Study|Illness|8|||
124966979|NCT00497874|449507336|FG001|Overall Study|Illness|4|||
124966980|NCT00497874|449507335|FG000|Overall Study|Death|2|||
124966981|NCT00497874|449507336|FG001|Overall Study|Death|4|||
124966982|NCT00497874|449507335|FG000|Overall Study|Unable to contact|52|||
124966983|NCT00497874|449507336|FG001|Overall Study|Unable to contact|67|||
124966984|NCT00497874|449507335|FG000|Overall Study|Unable to schedule|37|||
124966985|NCT00497874|449507336|FG001|Overall Study|Unable to schedule|24|||
124966986|NCT04843579|449507340|FG000|Overall Study|Adverse Event|1|||
124966987|NCT04843579|449507340|FG000|Overall Study|Disease Progression|1|||
124966988|NCT04009629|449507341|FG000|Overall Study|Withdrawal by Subject|2|||
124966989|NCT04009629|449507342|FG001|Overall Study|Withdrawal by Subject|0|||
124966990|NCT04398368|449507343|FG000|Overall Study|Withdrawal by Subject|2|||
124966991|NCT02808975|449507345|FG000|Overall Study|Adverse Event|3|||
124966992|NCT02808975|449507346|FG001|Overall Study|Adverse Event|4|||
124966993|NCT02808975|449507345|FG000|Overall Study|Withdrew consent|9|||
124966994|NCT02808975|449507346|FG001|Overall Study|Withdrew consent|8|||
124966995|NCT02808975|449507345|FG000|Overall Study|Lost to Follow-up|4|||
124966996|NCT02808975|449507346|FG001|Overall Study|Lost to Follow-up|6|||
124966997|NCT02808975|449507345|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
124966998|NCT02808975|449507346|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
124966999|NCT02808975|449507345|FG000|Overall Study|Other, not specified|5|||
124967000|NCT02808975|449507346|FG001|Overall Study|Other, not specified|1|||
124967001|NCT03602586|449507347|FG000|Overall Study|Withdrawal by Subject|3|||
124967002|NCT00891046|449507354|FG000|Overall Study|Protocol Violation|1|||
124967003|NCT00891046|449507355|FG001|Overall Study|Protocol Violation|1|||
124967004|NCT00891046|449507356|FG002|Overall Study|Protocol Violation|0|||
124967005|NCT00891046|449507357|FG003|Overall Study|Protocol Violation|0|||
124967006|NCT00891046|449507358|FG004|Overall Study|Protocol Violation|1|||
124967007|NCT00891046|449507354|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
124967008|NCT00891046|449507355|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124967009|NCT00891046|449507356|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
124967010|NCT00891046|449507357|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
125129967|NCT00579670|450102512|FG001|Overall Study|Adverse Event|0|||
125129968|NCT00579670|450102513|FG002|Overall Study|Adverse Event|1|||
124967011|NCT00891046|449507358|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
124967012|NCT00891046|449507354|FG000|Overall Study|Administrative problems|0|||
124967013|NCT00891046|449507355|FG001|Overall Study|Administrative problems|0|||
124967014|NCT00891046|449507356|FG002|Overall Study|Administrative problems|0|||
124967015|NCT00891046|449507357|FG003|Overall Study|Administrative problems|0|||
125032223|NCT02078219|449737544|FG004|Overall Study|Withdrawal by Subject|1|||
125032224|NCT02078219|449737540|FG000|Overall Study|Protocol Violation|0|||
125032225|NCT02078219|449737541|FG001|Overall Study|Protocol Violation|0|||
125032226|NCT02078219|449737542|FG002|Overall Study|Protocol Violation|0|||
125032227|NCT02078219|449737543|FG003|Overall Study|Protocol Violation|1|||
125032228|NCT02078219|449737544|FG004|Overall Study|Protocol Violation|0|||
125032229|NCT02078219|449737540|FG000|Overall Study|Death|0|||
125032230|NCT02078219|449737541|FG001|Overall Study|Death|0|||
125129969|NCT00579670|450102514|FG003|Overall Study|Adverse Event|2|||
125129970|NCT00579670|450102515|FG004|Overall Study|Adverse Event|0|||
125129971|NCT00579670|450102511|FG000|Overall Study|Lack of Efficacy|0|||
125129972|NCT00579670|450102512|FG001|Overall Study|Lack of Efficacy|0|||
125129973|NCT00579670|450102513|FG002|Overall Study|Lack of Efficacy|1|||
125129974|NCT00579670|450102514|FG003|Overall Study|Lack of Efficacy|14|||
125129975|NCT00579670|450102515|FG004|Overall Study|Lack of Efficacy|0|||
125129976|NCT00579670|450102511|FG000|Overall Study|Lost to Follow-up|0|||
125129977|NCT00579670|450102512|FG001|Overall Study|Lost to Follow-up|1|||
125129978|NCT00579670|450102513|FG002|Overall Study|Lost to Follow-up|0|||
125129979|NCT00579670|450102514|FG003|Overall Study|Lost to Follow-up|4|||
124967016|NCT00891046|449507358|FG004|Overall Study|Administrative problems|1|||
124967017|NCT00891046|449507354|FG000|Overall Study|Participant no longer required drug|0|||
124967018|NCT00891046|449507355|FG001|Overall Study|Participant no longer required drug|2|||
124967019|NCT00891046|449507356|FG002|Overall Study|Participant no longer required drug|0|||
124967020|NCT00891046|449507357|FG003|Overall Study|Participant no longer required drug|0|||
124967021|NCT00891046|449507358|FG004|Overall Study|Participant no longer required drug|1|||
124967022|NCT00891046|449507354|FG000|Overall Study|Adverse Event|4|||
124967023|NCT00891046|449507355|FG001|Overall Study|Adverse Event|3|||
124967024|NCT00891046|449507356|FG002|Overall Study|Adverse Event|2|||
124967025|NCT00891046|449507357|FG003|Overall Study|Adverse Event|0|||
124967026|NCT00891046|449507358|FG004|Overall Study|Adverse Event|14|||
124967027|NCT00891046|449507354|FG000|Overall Study|Withdrawal by Subject|2|||
124967028|NCT00891046|449507355|FG001|Overall Study|Withdrawal by Subject|1|||
124967029|NCT00891046|449507356|FG002|Overall Study|Withdrawal by Subject|2|||
124967030|NCT00891046|449507357|FG003|Overall Study|Withdrawal by Subject|1|||
124967031|NCT00891046|449507358|FG004|Overall Study|Withdrawal by Subject|1|||
124967032|NCT00891046|449507354|FG000|Overall Study|Lost to Follow-up|0|||
124967033|NCT00891046|449507355|FG001|Overall Study|Lost to Follow-up|0|||
124967034|NCT00891046|449507356|FG002|Overall Study|Lost to Follow-up|0|||
124967035|NCT00891046|449507357|FG003|Overall Study|Lost to Follow-up|0|||
124967036|NCT00891046|449507358|FG004|Overall Study|Lost to Follow-up|1|||
124967037|NCT02166476|449507359|FG000|Overall Study|Withdrawal by Subject|5|||
124967038|NCT02166476|449507360|FG001|Overall Study|Withdrawal by Subject|7|||
124967039|NCT02166476|449507359|FG000|Overall Study|Adverse Event|3|||
124967040|NCT02166476|449507360|FG001|Overall Study|Adverse Event|3|||
124967041|NCT02166476|449507359|FG000|Overall Study|Lost to Follow-up|5|||
124967042|NCT02166476|449507360|FG001|Overall Study|Lost to Follow-up|10|||
124967043|NCT02166476|449507359|FG000|Overall Study|Physician Decision|1|||
124967044|NCT02166476|449507360|FG001|Overall Study|Physician Decision|0|||
124967045|NCT02166476|449507359|FG000|Overall Study|Unable to Come for Visit|0|||
124967046|NCT02166476|449507360|FG001|Overall Study|Unable to Come for Visit|3|||
124967047|NCT04523207|449507364|FG000|Overall Study|Adverse Event|5|||
124967048|NCT04523207|449507365|FG001|Overall Study|Adverse Event|1|||
124967049|NCT04523207|449507364|FG000|Overall Study|Lost to Follow-up|2|||
124967050|NCT04523207|449507365|FG001|Overall Study|Lost to Follow-up|0|||
124967051|NCT04523207|449507364|FG000|Overall Study|Withdrawal by Subject|2|||
124967052|NCT04523207|449507365|FG001|Overall Study|Withdrawal by Subject|0|||
125032231|NCT02078219|449737542|FG002|Overall Study|Death|0|||
125032232|NCT02078219|449737543|FG003|Overall Study|Death|1|||
125032233|NCT02078219|449737544|FG004|Overall Study|Death|0|||
125129980|NCT00579670|450102515|FG004|Overall Study|Lost to Follow-up|0|||
125129981|NCT00579670|450102511|FG000|Overall Study|Other|0|||
125129982|NCT00579670|450102512|FG001|Overall Study|Other|0|||
125129983|NCT00579670|450102513|FG002|Overall Study|Other|1|||
125129984|NCT00579670|450102514|FG003|Overall Study|Other|2|||
125129985|NCT00579670|450102515|FG004|Overall Study|Other|0|||
124967053|NCT04523207|449507364|FG000|Overall Study|Progressive Disease|2|||
124967054|NCT04523207|449507365|FG001|Overall Study|Progressive Disease|1|||
124967055|NCT04523207|449507364|FG000|Overall Study|Other|7|||
124967056|NCT04523207|449507365|FG001|Overall Study|Other|1|||
124967057|NCT03113383|449507366|FG000|Overall Study|Death|4|||
124967058|NCT03113383|449507367|FG001|Overall Study|Death|0|||
124967059|NCT03062449|449507369|FG000|Overall Study|Withdrawal by Subject|7|||
125129986|NCT00579670|450102511|FG000|Overall Study|Withdrawal by Subject|0|||
124967060|NCT03062449|449507370|FG001|Overall Study|Withdrawal by Subject|1|||
124967061|NCT02053610|449507372|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
124967062|NCT02053610|449507373|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
124967063|NCT02053610|449507372|FG000|Overall Study|Withdrew Consent|2|||
125032234|NCT02078219|449737540|FG000|Overall Study|Adverse Event|1|||
125032235|NCT02078219|449737541|FG001|Overall Study|Adverse Event|1|||
125032236|NCT02078219|449737542|FG002|Overall Study|Adverse Event|3|||
124967064|NCT02053610|449507373|FG001|Overall Study|Withdrew Consent|9|||
124967065|NCT02053610|449507372|FG000|Overall Study|Death|5|||
124967066|NCT02053610|449507373|FG001|Overall Study|Death|5|||
124967067|NCT02053610|449507372|FG000|Overall Study|Administrative/Other|1|||
124967068|NCT02053610|449507373|FG001|Overall Study|Administrative/Other|1|||
124967069|NCT02053610|449507372|FG000|Overall Study|Disease Progression|2|||
124967070|NCT02053610|449507373|FG001|Overall Study|Disease Progression|3|||
124967071|NCT02053610|449507372|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
124967072|NCT02053610|449507373|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
124967073|NCT02053610|449507372|FG000|Overall Study|Did not Receive Treatment|4|||
124967074|NCT02053610|449507373|FG001|Overall Study|Did not Receive Treatment|2|||
124967075|NCT02053610|449507372|FG000|Overall Study|Insufficient Therapeutic Response|1|||
124967076|NCT02053610|449507373|FG001|Overall Study|Insufficient Therapeutic Response|1|||
124967077|NCT02053610|449507372|FG000|Overall Study|Violation of Selection Criteria|1|||
124967078|NCT02053610|449507373|FG001|Overall Study|Violation of Selection Criteria|0|||
124967079|NCT03568812|449507374|FG000|Overall Study|Physician Decision|0|||
124967080|NCT03568812|449507375|FG001|Overall Study|Physician Decision|1|||
124967081|NCT00543062|449507379|FG000|Overall Study|Withdrawal by Subject|1|||
124967082|NCT00543062|449507380|FG001|Overall Study|Withdrawal by Subject|0|||
124967083|NCT00543062|449507381|FG002|Overall Study|Withdrawal by Subject|2|||
124967084|NCT00543062|449507382|FG003|Overall Study|Withdrawal by Subject|0|||
124967085|NCT00543062|449507379|FG000|Overall Study|Adverse Event|0|||
124967086|NCT00543062|449507380|FG001|Overall Study|Adverse Event|1|||
124967087|NCT00543062|449507381|FG002|Overall Study|Adverse Event|1|||
124967088|NCT00543062|449507382|FG003|Overall Study|Adverse Event|1|||
124967089|NCT00543062|449507379|FG000|Overall Study|Protocol Violation|1|||
124967090|NCT00543062|449507380|FG001|Overall Study|Protocol Violation|0|||
124967091|NCT00543062|449507381|FG002|Overall Study|Protocol Violation|0|||
124967092|NCT00543062|449507382|FG003|Overall Study|Protocol Violation|0|||
124967093|NCT00328562|449507385|FG000|Overall Study|Disease progression|1|||
124967094|NCT04014790|449507386|FG000|Overall Study|Death|4|||
124967095|NCT04014790|449507386|FG000|Overall Study|Adverse Event|1|||
124967096|NCT04014790|449507386|FG000|Overall Study|Withdrawal by Subject|1|||
124967097|NCT01010204|449507389|FG000|Overall Study|Lost to Follow-up|2|||
124967098|NCT01010204|449507390|FG001|Overall Study|Lost to Follow-up|2|||
124967099|NCT01010204|449507389|FG000|Overall Study|Adverse Event|1|||
124967100|NCT01010204|449507390|FG001|Overall Study|Adverse Event|3|||
124967101|NCT01010204|449507389|FG000|Overall Study|Withdrawal by Subject|2|||
124967102|NCT01010204|449507390|FG001|Overall Study|Withdrawal by Subject|3|||
124967103|NCT01010204|449507389|FG000|Overall Study|psychiatric hospitalization|2|||
124967104|NCT01010204|449507390|FG001|Overall Study|psychiatric hospitalization|1|||
124967105|NCT01513330|449507391|FG000|SenSura Mio First,|Adverse Event|2|||
124967106|NCT01513330|449507392|FG001|SenSura Mio First,|Adverse Event|0|||
124967107|NCT01513330|449507391|FG000|SenSura Mio First,|Lack of Efficacy|0|||
124967108|NCT01513330|449507392|FG001|SenSura Mio First,|Lack of Efficacy|1|||
124967109|NCT01513330|449507391|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
124967110|NCT01513330|449507392|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
124967111|NCT01513330|449507391|FG000|SenSura Mio First,|Other|1|||
124967112|NCT01513330|449507392|FG001|SenSura Mio First,|Other|0|||
124967113|NCT01513330|449507391|FG000|Standard Care First,|Lack of Efficacy|2|||
124967114|NCT01513330|449507392|FG001|Standard Care First,|Lack of Efficacy|2|||
124967115|NCT01513330|449507391|FG000|Standard Care First,|Withdrawal by Subject|1|||
124967116|NCT01513330|449507392|FG001|Standard Care First,|Withdrawal by Subject|2|||
124967117|NCT01513330|449507391|FG000|Standard Care First,|Other|1|||
124967118|NCT01513330|449507392|FG001|Standard Care First,|Other|0|||
124967119|NCT01519778|449507393|FG000|Overall Study|Withdrawal by Subject|3|||
124967120|NCT01519778|449507393|FG000|Overall Study|Lost to Follow-up|10|||
124967121|NCT01519778|449507393|FG000|Overall Study|Physician Decision|1|||
124967122|NCT01657799|449507394|FG000|Overall Study|Adverse Event Related to progression|6|||
124967123|NCT01657799|449507395|FG001|Overall Study|Adverse Event Related to progression|8|||
124967124|NCT01657799|449507396|FG002|Overall Study|Adverse Event Related to progression|12|||
124967125|NCT01657799|449507394|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
124967126|NCT01657799|449507395|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
124967127|NCT01657799|449507396|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
124967128|NCT01657799|449507394|FG000|Overall Study|Withdrawal by Subject|13|||
124967129|NCT01657799|449507395|FG001|Overall Study|Withdrawal by Subject|10|||
124967130|NCT01657799|449507396|FG002|Overall Study|Withdrawal by Subject|10|||
124967131|NCT01657799|449507394|FG000|Overall Study|Lost to Follow-up|1|||
124967132|NCT01657799|449507395|FG001|Overall Study|Lost to Follow-up|0|||
124967133|NCT01657799|449507396|FG002|Overall Study|Lost to Follow-up|1|||
124967134|NCT01657799|449507394|FG000|Overall Study|Disease Progression|2|||
124967135|NCT01657799|449507395|FG001|Overall Study|Disease Progression|4|||
124967136|NCT01657799|449507396|FG002|Overall Study|Disease Progression|4|||
124967137|NCT01657799|449507394|FG000|Overall Study|Progressive Disease Clinical|7|||
124967138|NCT01657799|449507395|FG001|Overall Study|Progressive Disease Clinical|4|||
125032237|NCT02078219|449737543|FG003|Overall Study|Adverse Event|1|||
125032238|NCT02078219|449737544|FG004|Overall Study|Adverse Event|0|||
125032239|NCT03283085|449737551|FG000|Overall Study|Adverse Event|18|||
125032240|NCT03283085|449737552|FG001|Overall Study|Adverse Event|3|||
125032241|NCT03283085|449737553|FG002|Overall Study|Adverse Event|13|||
125032242|NCT03283085|449737554|FG003|Overall Study|Adverse Event|0|||
125032243|NCT03283085|449737555|FG004|Overall Study|Adverse Event|0|||
125032244|NCT03283085|449737556|FG005|Overall Study|Adverse Event|5|||
125032245|NCT03283085|449737551|FG000|Overall Study|Death|0|||
125032246|NCT03283085|449737552|FG001|Overall Study|Death|0|||
125032247|NCT03283085|449737553|FG002|Overall Study|Death|3|||
125032248|NCT03283085|449737554|FG003|Overall Study|Death|1|||
125032249|NCT03283085|449737555|FG004|Overall Study|Death|0|||
125032250|NCT03283085|449737556|FG005|Overall Study|Death|0|||
125032251|NCT03283085|449737551|FG000|Overall Study|Withdrawal by Subject|42|||
125032252|NCT03283085|449737552|FG001|Overall Study|Withdrawal by Subject|21|||
125032253|NCT03283085|449737553|FG002|Overall Study|Withdrawal by Subject|66|||
125032254|NCT03283085|449737554|FG003|Overall Study|Withdrawal by Subject|3|||
125032255|NCT03283085|449737555|FG004|Overall Study|Withdrawal by Subject|3|||
125032256|NCT03283085|449737556|FG005|Overall Study|Withdrawal by Subject|5|||
125032257|NCT03283085|449737551|FG000|Overall Study|Physician Decision|14|||
125032258|NCT03283085|449737552|FG001|Overall Study|Physician Decision|8|||
125032259|NCT03283085|449737553|FG002|Overall Study|Physician Decision|19|||
125032260|NCT03283085|449737554|FG003|Overall Study|Physician Decision|0|||
125032261|NCT03283085|449737555|FG004|Overall Study|Physician Decision|0|||
125032262|NCT03283085|449737556|FG005|Overall Study|Physician Decision|2|||
125032263|NCT03283085|449737551|FG000|Overall Study|Site Terminated by Sponsor|1|||
125032264|NCT03283085|449737552|FG001|Overall Study|Site Terminated by Sponsor|0|||
125032265|NCT03283085|449737553|FG002|Overall Study|Site Terminated by Sponsor|3|||
125032266|NCT03283085|449737554|FG003|Overall Study|Site Terminated by Sponsor|0|||
125032267|NCT03283085|449737555|FG004|Overall Study|Site Terminated by Sponsor|0|||
125032268|NCT03283085|449737556|FG005|Overall Study|Site Terminated by Sponsor|0|||
125032269|NCT03283085|449737551|FG000|Overall Study|Lost to Follow-up|2|||
125032270|NCT03283085|449737552|FG001|Overall Study|Lost to Follow-up|0|||
125032271|NCT03283085|449737553|FG002|Overall Study|Lost to Follow-up|2|||
125032272|NCT03283085|449737554|FG003|Overall Study|Lost to Follow-up|0|||
125032273|NCT03283085|449737555|FG004|Overall Study|Lost to Follow-up|0|||
125032274|NCT03283085|449737556|FG005|Overall Study|Lost to Follow-up|1|||
125032275|NCT03283085|449737551|FG000|Overall Study|Pregnancy|0|||
125032276|NCT03283085|449737552|FG001|Overall Study|Pregnancy|0|||
125032277|NCT03283085|449737553|FG002|Overall Study|Pregnancy|1|||
125032278|NCT03283085|449737554|FG003|Overall Study|Pregnancy|0|||
125032279|NCT03283085|449737555|FG004|Overall Study|Pregnancy|0|||
125032280|NCT03283085|449737556|FG005|Overall Study|Pregnancy|0|||
125032281|NCT03283085|449737551|FG000|Overall Study|Lack of Efficacy|12|||
125032282|NCT03283085|449737552|FG001|Overall Study|Lack of Efficacy|6|||
125032283|NCT03283085|449737553|FG002|Overall Study|Lack of Efficacy|24|||
125032284|NCT03283085|449737554|FG003|Overall Study|Lack of Efficacy|1|||
125032285|NCT03283085|449737555|FG004|Overall Study|Lack of Efficacy|1|||
125032286|NCT03283085|449737556|FG005|Overall Study|Lack of Efficacy|0|||
125032287|NCT03283085|449737551|FG000|Overall Study|Reason not Specified|0|||
125032288|NCT03283085|449737552|FG001|Overall Study|Reason not Specified|4|||
125216487|NCT01616758|450419454|FG000|Overall Study|Adverse Event|1|||
125032289|NCT03283085|449737553|FG002|Overall Study|Reason not Specified|8|||
125032290|NCT03283085|449737554|FG003|Overall Study|Reason not Specified|0|||
125032291|NCT03283085|449737555|FG004|Overall Study|Reason not Specified|0|||
125032292|NCT03283085|449737556|FG005|Overall Study|Reason not Specified|1|||
125032293|NCT03136107|449737557|FG000|Overall Study|Other (Not specified)|1|||
125032294|NCT02300129|449739450|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
125032295|NCT02300129|449739451|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
125032296|NCT02300129|449739452|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
125032297|NCT02300129|449739453|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
125032298|NCT02300129|449739450|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
125032299|NCT02300129|449739451|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
125032300|NCT02300129|449739452|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
125032301|NCT02300129|449739453|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
125032302|NCT02300129|449739450|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
125032303|NCT02300129|449739451|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
125032304|NCT02300129|449739452|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
125032305|NCT02300129|449739453|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
125032306|NCT00522392|449739456|FG000|Overall Study|Disease progression|0|||
125032307|NCT00522392|449739457|FG001|Overall Study|Disease progression|3|||
125032308|NCT00522392|449739456|FG000|Overall Study|Adverse Event|7|||
125032309|NCT00522392|449739457|FG001|Overall Study|Adverse Event|7|||
125032310|NCT00522392|449739456|FG000|Overall Study|Withdrawal by Subject|1|||
125032311|NCT00522392|449739457|FG001|Overall Study|Withdrawal by Subject|1|||
125032312|NCT00522392|449739456|FG000|Overall Study|Physician Decision|0|||
125032313|NCT00522392|449739457|FG001|Overall Study|Physician Decision|1|||
125032314|NCT00522392|449739456|FG000|Overall Study|Non-compliance|0|||
125032315|NCT00522392|449739457|FG001|Overall Study|Non-compliance|1|||
125129987|NCT00579670|450102512|FG001|Overall Study|Withdrawal by Subject|0|||
125129988|NCT00579670|450102513|FG002|Overall Study|Withdrawal by Subject|1|||
125129989|NCT00579670|450102514|FG003|Overall Study|Withdrawal by Subject|0|||
125129990|NCT00579670|450102515|FG004|Overall Study|Withdrawal by Subject|0|||
124967139|NCT01657799|449507396|FG002|Overall Study|Progressive Disease Clinical|7|||
124967140|NCT01657799|449507394|FG000|Overall Study|Radiographic & Clinical Progression|16|||
124967141|NCT01657799|449507395|FG001|Overall Study|Radiographic & Clinical Progression|11|||
124967142|NCT01657799|449507396|FG002|Overall Study|Radiographic & Clinical Progression|15|||
124967143|NCT01657799|449507394|FG000|Overall Study|Other|52|||
124967144|NCT01657799|449507395|FG001|Overall Study|Other|62|||
124967145|NCT01657799|449507396|FG002|Overall Study|Other|49|||
124967146|NCT00412880|449507397|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
124967147|NCT00412880|449507397|FG000|Overall Study|Consent withdrawn|1|||
124967148|NCT00412880|449507397|FG000|Overall Study|Adverse Event|1|||
124967149|NCT00412880|449507397|FG000|Overall Study|Progressive disease|20|||
124967150|NCT03297398|449507398|FG000|Overall Study|Sponsor's decision|6|||
124967151|NCT03297398|449507399|FG001|Overall Study|Sponsor's decision|9|||
124967152|NCT03297398|449507400|FG002|Overall Study|Sponsor's decision|7|||
124967153|NCT03297398|449507398|FG000|Overall Study|Adverse Event|1|||
124967154|NCT03297398|449507399|FG001|Overall Study|Adverse Event|4|||
124967155|NCT03297398|449507400|FG002|Overall Study|Adverse Event|4|||
124967156|NCT03297398|449507398|FG000|Overall Study|Withdrawal by Subject|1|||
124967157|NCT03297398|449507399|FG001|Overall Study|Withdrawal by Subject|2|||
124967158|NCT03297398|449507400|FG002|Overall Study|Withdrawal by Subject|2|||
124967159|NCT03297398|449507398|FG000|Overall Study|Protocol Violation|0|||
124967160|NCT03297398|449507399|FG001|Overall Study|Protocol Violation|2|||
124967161|NCT03297398|449507400|FG002|Overall Study|Protocol Violation|0|||
124967162|NCT03297398|449507398|FG000|Overall Study|Physician Decision|0|||
124967163|NCT03297398|449507399|FG001|Overall Study|Physician Decision|0|||
124967164|NCT03297398|449507400|FG002|Overall Study|Physician Decision|1|||
124967165|NCT03297398|449507398|FG000|Overall Study|Lost to Follow-up|0|||
124967166|NCT03297398|449507399|FG001|Overall Study|Lost to Follow-up|0|||
124967167|NCT03297398|449507400|FG002|Overall Study|Lost to Follow-up|1|||
124967168|NCT01772563|449507403|FG000|Cycle 1|Dose limiting toxicity|2|||
124967169|NCT01772563|449507403|FG000|Cycle 1|Progressive disease|2|||
124967170|NCT01772563|449507403|FG000|Cycle 2 and Beyond|Progressive disease|17|||
124967171|NCT01772563|449507403|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
124967172|NCT01772563|449507403|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
124967173|NCT01192776|449507405|FG000|Overall Study|Death|8|||
124967174|NCT01192776|449507406|FG001|Overall Study|Death|15|||
124967175|NCT01192776|449507407|FG002|Overall Study|Death|18|||
124967176|NCT01192776|449507408|FG003|Overall Study|Death|15|||
124967177|NCT01192776|449507405|FG000|Overall Study|Lost to Follow-up|3|||
124967178|NCT01192776|449507406|FG001|Overall Study|Lost to Follow-up|6|||
124967179|NCT01192776|449507407|FG002|Overall Study|Lost to Follow-up|3|||
124967180|NCT01192776|449507408|FG003|Overall Study|Lost to Follow-up|5|||
124967181|NCT03732820|449507416|FG000|Overall Study|Death|168|||
125129991|NCT00850174|450102519|FG000|Washout: One Week|Withdrawal by Subject|0|||
125129992|NCT00850174|450102520|FG001|Washout: One Week|Withdrawal by Subject|2|||
125129993|NCT00850174|450102519|FG000|Second Intervention|Withdrawal by Subject|1|||
125129994|NCT00850174|450102520|FG001|Second Intervention|Withdrawal by Subject|0|||
125129995|NCT00635492|450102521|FG000|Overall Study|Death|12|||
125129996|NCT00635492|450102522|FG001|Overall Study|Death|40|||
125129997|NCT00635492|450102521|FG000|Overall Study|Lost to Follow-up|151|||
125129998|NCT00635492|450102522|FG001|Overall Study|Lost to Follow-up|172|||
125129999|NCT00635492|450102521|FG000|Overall Study|Physician Decision|32|||
125130000|NCT00635492|450102522|FG001|Overall Study|Physician Decision|22|||
125130001|NCT00635492|450102521|FG000|Overall Study|Sponsor decision|2|||
124967182|NCT03732820|449507417|FG001|Overall Study|Death|203|||
124967183|NCT03732820|449507416|FG000|Overall Study|Other|2|||
124967184|NCT03732820|449507417|FG001|Overall Study|Other|2|||
124967185|NCT03732820|449507416|FG000|Overall Study|Failure to meet randomisation criteria|1|||
124967186|NCT03732820|449507417|FG001|Overall Study|Failure to meet randomisation criteria|1|||
124967187|NCT03732820|449507416|FG000|Overall Study|Patient decision|14|||
124967188|NCT03732820|449507417|FG001|Overall Study|Patient decision|10|||
124967189|NCT03732820|449507416|FG000|Overall Study|Screen failure|0|||
124967190|NCT03732820|449507417|FG001|Overall Study|Screen failure|1|||
124967191|NCT03732820|449507416|FG000|Overall Study|Patients ongoing study at data cut off|210|||
124967192|NCT03732820|449507417|FG001|Overall Study|Patients ongoing study at data cut off|178|||
124967193|NCT03732820|449507416|FG000|Overall Study|Lost to Follow-up|4|||
124967194|NCT03732820|449507417|FG001|Overall Study|Lost to Follow-up|2|||
124967195|NCT00992992|449507418|FG000|Overall Study|Lost to Follow-up|3|||
125130002|NCT00635492|450102522|FG001|Overall Study|Sponsor decision|3|||
125130003|NCT00635492|450102521|FG000|Overall Study|Withdrawal by Subject|82|||
125130004|NCT00635492|450102522|FG001|Overall Study|Withdrawal by Subject|45|||
124967196|NCT00992992|449507418|FG000|Overall Study|Death|16|||
124967197|NCT00992992|449507418|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
124967198|NCT00992992|449507418|FG000|Overall Study|Sponsor Closed the Study|4|||
124967199|NCT00832000|449507419|FG000|Overall Study|Adverse Event|2|||
124967200|NCT00832000|449507420|FG001|Overall Study|Adverse Event|0|||
124967201|NCT00832000|449507419|FG000|Overall Study|Withdrawal by Subject|1|||
124967202|NCT00832000|449507420|FG001|Overall Study|Withdrawal by Subject|0|||
124967203|NCT00832000|449507419|FG000|Overall Study|No calls to IVR in either period|1|||
124967204|NCT00832000|449507420|FG001|Overall Study|No calls to IVR in either period|1|||
124967205|NCT00832000|449507419|FG000|Overall Study|No calls to IVR in period 2|2|||
124967206|NCT00832000|449507420|FG001|Overall Study|No calls to IVR in period 2|0|||
124967207|NCT03845075|449507421|FG000|Part 1 - DB|Withdrawal by Subject|1|||
124967208|NCT03845075|449507422|FG001|Part 1 - DB|Withdrawal by Subject|1|||
124967209|NCT03845075|449507423|FG002|Part 1 - DB|Withdrawal by Subject|0|||
124967210|NCT03845075|449507424|FG003|Part 1 - DB|Withdrawal by Subject|0|||
124967211|NCT03845075|449507421|FG000|Part 1 - DB|Adverse Event|0|||
124967212|NCT03845075|449507422|FG001|Part 1 - DB|Adverse Event|1|||
124967213|NCT03845075|449507423|FG002|Part 1 - DB|Adverse Event|0|||
124967214|NCT03845075|449507424|FG003|Part 1 - DB|Adverse Event|0|||
124967215|NCT03845075|449507421|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
124967216|NCT03845075|449507422|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
124967217|NCT03845075|449507423|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
124967218|NCT03845075|449507424|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
124967219|NCT00935259|449507425|FG000|Period 1|Administrative (scheduling conflict)|1|||
124967220|NCT00935259|449507426|FG001|Period 1|Administrative (scheduling conflict)|1|||
124967221|NCT03856047|449507427|FG000|Overall Study|Withdrawal by Subject|0|||
124967222|NCT03856047|449507428|FG001|Overall Study|Withdrawal by Subject|1|||
124967223|NCT03856047|449507429|FG002|Overall Study|Withdrawal by Subject|1|||
124967224|NCT03856047|449507430|FG003|Overall Study|Withdrawal by Subject|0|||
124967225|NCT03856047|449507431|FG004|Overall Study|Withdrawal by Subject|3|||
124967226|NCT03856047|449507432|FG005|Overall Study|Withdrawal by Subject|0|||
124967227|NCT03856047|449507433|FG006|Overall Study|Withdrawal by Subject|2|||
124967228|NCT03856047|449507427|FG000|Overall Study|Lost to Follow-up|4|||
124967229|NCT03856047|449507428|FG001|Overall Study|Lost to Follow-up|2|||
124967230|NCT03856047|449507429|FG002|Overall Study|Lost to Follow-up|3|||
124967231|NCT03856047|449507430|FG003|Overall Study|Lost to Follow-up|1|||
125130005|NCT01900626|450102523|FG000|Overall Study|study was closed due to low enrollment|1|||
125130006|NCT01900626|450102524|FG001|Overall Study|study was closed due to low enrollment|1|||
125130007|NCT01702987|450102525|FG000|Overall Study|Withdrawal by Subject|1|||
125130008|NCT01702987|450102526|FG001|Overall Study|Withdrawal by Subject|0|||
125130009|NCT02017223|450102527|FG000|Overall Study|Algorithm problems|2|||
125130010|NCT04263649|450102528|FG000|Overall Study|Adverse Event|53|||
125130011|NCT04263649|450102528|FG000|Overall Study|Lost to Follow-up|3|||
125130012|NCT04263649|450102528|FG000|Overall Study|Death|29|||
125130013|NCT04263649|450102528|FG000|Overall Study|Device deficiency|19|||
125130014|NCT04263649|450102528|FG000|Overall Study|other reasons|11|||
125130015|NCT05169710|450102530|FG000|Overall Study|Adverse Event|1|||
125130016|NCT05169710|450102531|FG001|Overall Study|Adverse Event|2|||
125130017|NCT05169710|450102532|FG002|Overall Study|Adverse Event|2|||
125130018|NCT05169710|450102530|FG000|Overall Study|Lost to Follow-up|0|||
125130019|NCT05169710|450102531|FG001|Overall Study|Lost to Follow-up|0|||
125130020|NCT05169710|450102532|FG002|Overall Study|Lost to Follow-up|1|||
125130021|NCT05169710|450102530|FG000|Overall Study|Withdrawal by Subject|2|||
125130022|NCT05169710|450102531|FG001|Overall Study|Withdrawal by Subject|1|||
125130023|NCT05169710|450102532|FG002|Overall Study|Withdrawal by Subject|0|||
125130024|NCT05169710|450102530|FG000|Overall Study|Other Study Discontinuation Reason|0|||
125130025|NCT05169710|450102531|FG001|Overall Study|Other Study Discontinuation Reason|2|||
125130026|NCT05169710|450102532|FG002|Overall Study|Other Study Discontinuation Reason|0|||
125130027|NCT00846495|450102541|FG000|Overall Study|Lost to Follow-up|1|||
125130028|NCT00846495|450102542|FG001|Overall Study|Lost to Follow-up|0|||
125130029|NCT00846495|450102541|FG000|Overall Study|Adverse Event|5|||
124967232|NCT03856047|449507431|FG004|Overall Study|Lost to Follow-up|4|||
124967233|NCT03856047|449507432|FG005|Overall Study|Lost to Follow-up|4|||
124967234|NCT03856047|449507433|FG006|Overall Study|Lost to Follow-up|4|||
124967235|NCT00874497|449507437|FG000|Overall Study|Lost to Follow-up|2|||
124967236|NCT00874497|449507438|FG001|Overall Study|Lost to Follow-up|4|||
124967237|NCT00874497|449507437|FG000|Overall Study|Adverse Event|9|||
124967238|NCT00874497|449507438|FG001|Overall Study|Adverse Event|4|||
124967239|NCT00874497|449507437|FG000|Overall Study|Sponsor Discontinued Trial|7|||
124967240|NCT00874497|449507438|FG001|Overall Study|Sponsor Discontinued Trial|3|||
124967241|NCT00874497|449507437|FG000|Overall Study|Met Withdrawal Criteria|4|||
124967242|NCT00874497|449507438|FG001|Overall Study|Met Withdrawal Criteria|2|||
125130030|NCT00846495|450102542|FG001|Overall Study|Adverse Event|1|||
125130031|NCT00846495|450102541|FG000|Overall Study|Lack of Efficacy|1|||
125130032|NCT00846495|450102542|FG001|Overall Study|Lack of Efficacy|2|||
125130033|NCT00846495|450102541|FG000|Overall Study|Physician Decision|1|||
125130034|NCT00846495|450102542|FG001|Overall Study|Physician Decision|0|||
124967243|NCT00874497|449507437|FG000|Overall Study|Physician Decision|1|||
125130035|NCT01686438|450102543|FG000|Overall Study|Lost to Follow-up|8|||
125130036|NCT01686438|450102544|FG001|Overall Study|Lost to Follow-up|9|||
125130037|NCT01686438|450102545|FG002|Overall Study|Lost to Follow-up|10|||
125130038|NCT01686438|450102543|FG000|Overall Study|Adverse Event|0|||
125130039|NCT01686438|450102544|FG001|Overall Study|Adverse Event|0|||
125130040|NCT01686438|450102545|FG002|Overall Study|Adverse Event|1|||
125130041|NCT01686438|450102543|FG000|Overall Study|Protocol Violation|0|||
125130042|NCT01686438|450102544|FG001|Overall Study|Protocol Violation|0|||
125130043|NCT01686438|450102545|FG002|Overall Study|Protocol Violation|1|||
125130044|NCT01686438|450102543|FG000|Overall Study|Withdrawal by Subject|0|||
125130045|NCT01686438|450102544|FG001|Overall Study|Withdrawal by Subject|0|||
125130046|NCT01686438|450102545|FG002|Overall Study|Withdrawal by Subject|1|||
125130047|NCT06358820|450104408|FG000|Overall Study|Adverse Event|11|||
125130048|NCT06358820|450104408|FG000|Overall Study|kidney transplantation|3|||
125130049|NCT06358820|450104408|FG000|Overall Study|patient voluntary withdrawal|6|||
125130050|NCT06358820|450104408|FG000|Overall Study|Physician Decision|1|||
125130051|NCT01124175|450104409|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
125130052|NCT01124175|450104410|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
125130053|NCT00218257|450104416|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
125130054|NCT00218257|450104417|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
125130055|NCT00462345|450104420|FG000|Overall Study|Withdrawal by Subject|2|||
125130056|NCT00462345|450104420|FG000|Overall Study|Did not complete second course|1|||
125130057|NCT00070291|450104423|FG000|Step 1|Withdrawal by Subject|1|||
125130058|NCT00070291|450104423|FG000|Step 1|Adverse Event|1|||
125130059|NCT00070291|450104423|FG000|Step 2|Adverse Event|1|||
125130060|NCT00520130|450104426|FG000|Overall Study|Disease progression on study|4|||
125130061|NCT00520130|450104427|FG001|Overall Study|Disease progression on study|0|||
125130062|NCT00520130|450104426|FG000|Overall Study|Physician Decision|1|||
125130063|NCT00520130|450104427|FG001|Overall Study|Physician Decision|1|||
125130064|NCT02028715|450104428|FG000|Overall Study|Adverse Event|2|||
125130065|NCT02028715|450104429|FG001|Overall Study|Adverse Event|2|||
125130066|NCT02028715|450104428|FG000|Overall Study|Physician Decision|1|||
125130067|NCT02028715|450104429|FG001|Overall Study|Physician Decision|0|||
125130068|NCT02028715|450104428|FG000|Overall Study|Did not complete satisfaction surveys|2|||
125130069|NCT02028715|450104429|FG001|Overall Study|Did not complete satisfaction surveys|2|||
125130070|NCT04915755|450104430|FG000|Overall Study|Physician Decision|3|||
125130071|NCT04915755|450104431|FG001|Overall Study|Physician Decision|2|||
125130072|NCT04915755|450104430|FG000|Overall Study|Withdrawal by Subject|1|||
125130073|NCT04915755|450104431|FG001|Overall Study|Withdrawal by Subject|1|||
125130074|NCT04915755|450104430|FG000|Overall Study|Ongoing for PACT|3|||
125130075|NCT04915755|450104431|FG001|Overall Study|Ongoing for PACT|2|||
125130076|NCT04915755|450104430|FG000|Overall Study|Other|7|||
125130077|NCT04915755|450104431|FG001|Overall Study|Other|11|||
125130078|NCT02533258|450104432|FG000|Overall Study|Adverse Event|1|||
125130079|NCT02533258|450104432|FG000|Overall Study|Death|2|||
124967244|NCT00874497|449507438|FG001|Overall Study|Physician Decision|1|||
124967245|NCT00874497|449507437|FG000|Overall Study|Withdrawal by Subject|5|||
125130080|NCT02533258|450104432|FG000|Overall Study|Other|1|||
125130081|NCT02533258|450104432|FG000|Overall Study|Economic factor|1|||
125130082|NCT02533258|450104432|FG000|Overall Study|Progression of pleural effusion|1|||
125130083|NCT02533258|450104432|FG000|Overall Study|Lack of Efficacy|2|||
125130084|NCT01149473|450104433|FG000|First Intervention|Adverse Event|1|||
125130085|NCT01149473|450104434|FG001|First Intervention|Adverse Event|1|||
125130086|NCT01149473|450104433|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
125130087|NCT01149473|450104434|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
125130088|NCT01954394|450104437|FG000|Overall Study|Enrolled but not treated|1|||
125130089|NCT01954394|450104438|FG001|Overall Study|Enrolled but not treated|0|||
125130090|NCT01954394|450104437|FG000|Overall Study|Adverse Event|10|||
125130091|NCT01954394|450104438|FG001|Overall Study|Adverse Event|23|||
125130092|NCT01954394|450104437|FG000|Overall Study|Poor compliance to protocol|7|||
125130093|NCT01954394|450104438|FG001|Overall Study|Poor compliance to protocol|7|||
125130094|NCT01954394|450104437|FG000|Overall Study|Participant Moved|0|||
125130095|NCT01954394|450104438|FG001|Overall Study|Participant Moved|4|||
125130096|NCT01954394|450104437|FG000|Overall Study|Related to Study Drug administration|2|||
125130097|NCT01954394|450104438|FG001|Overall Study|Related to Study Drug administration|2|||
125130098|NCT01954394|450104437|FG000|Overall Study|Other than specified above|10|||
125130099|NCT01954394|450104438|FG001|Overall Study|Other than specified above|21|||
125130100|NCT04089735|450104439|FG000|Overall Study|Adverse Event|1|||
125130101|NCT04089735|450104440|FG001|Overall Study|Adverse Event|0|||
125130102|NCT04089735|450104441|FG002|Overall Study|Adverse Event|1|||
125130103|NCT04089735|450104442|FG003|Overall Study|Adverse Event|1|||
125130104|NCT04089735|450104443|FG004|Overall Study|Adverse Event|0|||
125130105|NCT04089735|450104444|FG005|Overall Study|Adverse Event|0|||
125130106|NCT04089735|450104439|FG000|Overall Study|Physician Decision|0|||
125130107|NCT04089735|450104440|FG001|Overall Study|Physician Decision|3|||
125130108|NCT04089735|450104441|FG002|Overall Study|Physician Decision|0|||
125130109|NCT04089735|450104442|FG003|Overall Study|Physician Decision|0|||
125130110|NCT04089735|450104443|FG004|Overall Study|Physician Decision|0|||
125130111|NCT04089735|450104444|FG005|Overall Study|Physician Decision|0|||
125130112|NCT04089735|450104439|FG000|Overall Study|Withdrawal by Subject|0|||
125130113|NCT04089735|450104440|FG001|Overall Study|Withdrawal by Subject|0|||
125130114|NCT04089735|450104441|FG002|Overall Study|Withdrawal by Subject|1|||
125130115|NCT04089735|450104442|FG003|Overall Study|Withdrawal by Subject|0|||
125130116|NCT04089735|450104443|FG004|Overall Study|Withdrawal by Subject|0|||
125130117|NCT04089735|450104444|FG005|Overall Study|Withdrawal by Subject|0|||
125130118|NCT04089735|450104439|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
125130119|NCT04089735|450104440|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
125130120|NCT04089735|450104441|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
125130121|NCT04089735|450104442|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
125130122|NCT04089735|450104443|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
125130123|NCT04089735|450104444|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
125130124|NCT01439880|450104445|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
125130125|NCT01439880|450104446|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
125130126|NCT01439880|450104445|FG000|SOC-controlled Period (Year 1)|Death|2|||
125130127|NCT01439880|450104446|FG001|SOC-controlled Period (Year 1)|Death|1|||
125130128|NCT01439880|450104445|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
125130129|NCT01439880|450104446|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
125130130|NCT01439880|450104445|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
125130131|NCT01439880|450104446|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
125130132|NCT01439880|450104445|FG000|SOC-controlled Period (Year 1)|Other|8|||
125130133|NCT01439880|450104446|FG001|SOC-controlled Period (Year 1)|Other|13|||
125130134|NCT01439880|450104445|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
125130135|NCT01439880|450104446|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
125130136|NCT01439880|450104445|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
125130137|NCT01439880|450104446|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
125130138|NCT01439880|450104445|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
125130139|NCT01439880|450104446|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
125130140|NCT01439880|450104445|FG000|All-IP Period (Years 2 to 5)|Death|3|||
125130141|NCT01439880|450104446|FG001|All-IP Period (Years 2 to 5)|Death|13|||
125130142|NCT01439880|450104445|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
125130143|NCT01439880|450104446|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
125130144|NCT01439880|450104445|FG000|All-IP Period (Years 2 to 5)|Other|14|||
125130145|NCT01439880|450104446|FG001|All-IP Period (Years 2 to 5)|Other|31|||
125130146|NCT01439880|450104445|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
125130147|NCT01439880|450104446|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
125130148|NCT02956460|450104447|FG000|Lens 1|Lost to Follow-up|1|||
125130149|NCT02956460|450104448|FG001|Lens 1|Lost to Follow-up|0|||
125130150|NCT00834067|450104451|FG000|Washout of 21 Days|Protocol Violation|0|||
125130151|NCT00834067|450104452|FG001|Washout of 21 Days|Protocol Violation|1|||
125130152|NCT04129346|450104453|FG000|Overall Study|Death|1|||
125130153|NCT04129346|450104454|FG001|Overall Study|Death|0|||
125130154|NCT01083693|450104455|FG000|Overall Study|Adverse Event|1|||
125130155|NCT01083693|450104456|FG001|Overall Study|Adverse Event|1|||
125130156|NCT01083693|450104457|FG002|Overall Study|Adverse Event|0|||
125130157|NCT01083693|450104455|FG000|Overall Study|Lost to Follow-up|2|||
125130158|NCT01083693|450104456|FG001|Overall Study|Lost to Follow-up|0|||
125130159|NCT01083693|450104457|FG002|Overall Study|Lost to Follow-up|2|||
125130160|NCT01083693|450104455|FG000|Overall Study|Lack of effectiveness|13|||
125130161|NCT01083693|450104456|FG001|Overall Study|Lack of effectiveness|2|||
125130162|NCT01083693|450104457|FG002|Overall Study|Lack of effectiveness|2|||
125130163|NCT01083693|450104455|FG000|Overall Study|Patient Moved|0|||
125130164|NCT01083693|450104456|FG001|Overall Study|Patient Moved|1|||
125130165|NCT01083693|450104457|FG002|Overall Study|Patient Moved|0|||
125130166|NCT01083693|450104455|FG000|Overall Study|Complete remission|0|||
125130167|NCT01083693|450104456|FG001|Overall Study|Complete remission|1|||
125130168|NCT01083693|450104457|FG002|Overall Study|Complete remission|0|||
125130169|NCT01083693|450104455|FG000|Overall Study|Other medical condition/surgery|1|||
125130170|NCT01083693|450104456|FG001|Overall Study|Other medical condition/surgery|1|||
125130171|NCT01083693|450104457|FG002|Overall Study|Other medical condition/surgery|0|||
125130172|NCT01083693|450104455|FG000|Overall Study|Withdrawal by Subject|3|||
125130173|NCT01083693|450104456|FG001|Overall Study|Withdrawal by Subject|0|||
125130174|NCT01083693|450104457|FG002|Overall Study|Withdrawal by Subject|2|||
125130175|NCT01083693|450104455|FG000|Overall Study|Reason unknown|0|||
125130176|NCT01083693|450104456|FG001|Overall Study|Reason unknown|0|||
125130177|NCT01083693|450104457|FG002|Overall Study|Reason unknown|1|||
125130178|NCT00836056|450104465|FG000|First Intervention|Adverse Event|1|||
125130179|NCT00836056|450104466|FG001|First Intervention|Adverse Event|0|||
125130180|NCT01029340|450104468|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
125130181|NCT01029340|450104469|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
125130182|NCT01029340|450104470|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
125130183|NCT01029340|450104471|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
125130184|NCT01029340|450104472|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
124967246|NCT00874497|449507438|FG001|Overall Study|Withdrawal by Subject|4|||
124967247|NCT01017263|449507439|FG000|Overall Study|not eligible|12|||
124967248|NCT00665223|449507444|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
124967249|NCT00665223|449507445|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
124967250|NCT00665223|449507446|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
125130185|NCT01029340|450104473|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
125130186|NCT01029340|450104468|FG000|Part B Treatment Period|Protocol Violation|0|||
125130187|NCT01029340|450104469|FG001|Part B Treatment Period|Protocol Violation|0|||
125130188|NCT01029340|450104470|FG002|Part B Treatment Period|Protocol Violation|1|||
125130189|NCT01029340|450104471|FG003|Part B Treatment Period|Protocol Violation|0|||
125130190|NCT01029340|450104472|FG004|Part B Treatment Period|Protocol Violation|0|||
125130191|NCT01029340|450104473|FG005|Part B Treatment Period|Protocol Violation|0|||
125130192|NCT01029340|450104468|FG000|Extension Period|Adverse Event|0|||
125130193|NCT01029340|450104469|FG001|Extension Period|Adverse Event|0|||
125130194|NCT01029340|450104470|FG002|Extension Period|Adverse Event|0|||
125130195|NCT01029340|450104471|FG003|Extension Period|Adverse Event|0|||
125130196|NCT01029340|450104472|FG004|Extension Period|Adverse Event|0|||
125130197|NCT01029340|450104473|FG005|Extension Period|Adverse Event|1|||
125130198|NCT01029340|450104468|FG000|Extension Period|starting another study|0|||
125130199|NCT01029340|450104469|FG001|Extension Period|starting another study|0|||
125130200|NCT01029340|450104470|FG002|Extension Period|starting another study|0|||
125130201|NCT01029340|450104471|FG003|Extension Period|starting another study|0|||
125130202|NCT01029340|450104472|FG004|Extension Period|starting another study|0|||
125130203|NCT01029340|450104473|FG005|Extension Period|starting another study|8|||
125130204|NCT01029340|450104468|FG000|Extension Period|non-compliance|0|||
125130205|NCT01029340|450104469|FG001|Extension Period|non-compliance|0|||
125130206|NCT01029340|450104470|FG002|Extension Period|non-compliance|0|||
125130207|NCT01029340|450104471|FG003|Extension Period|non-compliance|0|||
125130208|NCT01029340|450104472|FG004|Extension Period|non-compliance|0|||
125130209|NCT01029340|450104473|FG005|Extension Period|non-compliance|1|||
125130210|NCT01029340|450104468|FG000|Extension Period|Withdrawal by Subject|0|||
125130211|NCT01029340|450104469|FG001|Extension Period|Withdrawal by Subject|0|||
125130212|NCT01029340|450104470|FG002|Extension Period|Withdrawal by Subject|0|||
125130213|NCT01029340|450104471|FG003|Extension Period|Withdrawal by Subject|0|||
125130214|NCT01029340|450104472|FG004|Extension Period|Withdrawal by Subject|0|||
125130215|NCT01029340|450104473|FG005|Extension Period|Withdrawal by Subject|1|||
125130216|NCT01029340|450104468|FG000|Extension Period|Physician Decision|0|||
125130217|NCT01029340|450104469|FG001|Extension Period|Physician Decision|0|||
125130218|NCT01029340|450104470|FG002|Extension Period|Physician Decision|0|||
125130219|NCT01029340|450104471|FG003|Extension Period|Physician Decision|0|||
125130220|NCT01029340|450104472|FG004|Extension Period|Physician Decision|0|||
125130221|NCT01029340|450104473|FG005|Extension Period|Physician Decision|1|||
125130222|NCT02648347|450104474|FG000|Overall Study|Death|174|||
125130223|NCT02648347|450104475|FG001|Overall Study|Death|167|||
125130224|NCT02648347|450104474|FG000|Overall Study|Withdrawal by Subject|16|||
125130225|NCT02648347|450104475|FG001|Overall Study|Withdrawal by Subject|9|||
125130226|NCT02648347|450104474|FG000|Overall Study|Lost to Follow-up|18|||
124967251|NCT00665223|449507444|FG000|Randomized Phase (26 Weeks)|Death|0|||
125130227|NCT02648347|450104475|FG001|Overall Study|Lost to Follow-up|21|||
125130228|NCT02648347|450104474|FG000|Overall Study|Missing|1|||
125130229|NCT02648347|450104475|FG001|Overall Study|Missing|0|||
125130230|NCT03546842|450104477|FG000|Overall Study|Protocol Violation|1|||
125130231|NCT03546842|450104477|FG000|Overall Study|Withdrawal by Subject|2|||
125130232|NCT01265056|450104486|FG000|Initial Study Period|Withdrawal by Subject|1|||
125130233|NCT01265056|450104487|FG001|Initial Study Period|Withdrawal by Subject|1|||
125130234|NCT01265056|450104486|FG000|Initial Study Period|Withdrawal by Subject|1|||
125130235|NCT01265056|450104487|FG001|Initial Study Period|Withdrawal by Subject|1|||
125130236|NCT01265056|450104486|FG000|Follow up|Lost to Follow-up|7|||
125130237|NCT01265056|450104487|FG001|Follow up|Lost to Follow-up|3|||
125130238|NCT00833937|450104496|FG000|Washout|Withdrawal by Subject|1|||
125130239|NCT00833937|450104497|FG001|Washout|Withdrawal by Subject|0|||
125130240|NCT04419311|450104499|FG000|Overall Study|Lost to Follow-up|1|||
125130241|NCT04419311|450104500|FG001|Overall Study|Lost to Follow-up|0|||
125130242|NCT00465270|450104501|FG000|Overall Study|Death|7|||
125130243|NCT00465270|450104502|FG001|Overall Study|Death|11|||
125130244|NCT00465270|450104501|FG000|Overall Study|Withdrawal by Subject|34|||
125130245|NCT00465270|450104502|FG001|Overall Study|Withdrawal by Subject|78|||
125130246|NCT00465270|450104501|FG000|Overall Study|Lost to Follow-up|60|||
125130247|NCT00465270|450104502|FG001|Overall Study|Lost to Follow-up|67|||
125130248|NCT00465270|450104501|FG000|Overall Study|Investigator request|3|||
125130249|NCT00465270|450104502|FG001|Overall Study|Investigator request|4|||
125130250|NCT03233724|450104503|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
125130251|NCT03233724|450104504|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
125130252|NCT03233724|450104505|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
125130253|NCT03233724|450104506|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
125130254|NCT03233724|450104507|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
125130255|NCT03233724|450104503|FG000|Phase I Dose Escalation|Best interest of participant|1|||
125130256|NCT03233724|450104504|FG001|Phase I Dose Escalation|Best interest of participant|1|||
125130257|NCT03233724|450104505|FG002|Phase I Dose Escalation|Best interest of participant|1|||
125130258|NCT03233724|450104506|FG003|Phase I Dose Escalation|Best interest of participant|0|||
125130259|NCT03233724|450104507|FG004|Phase I Dose Escalation|Best interest of participant|0|||
125130260|NCT03233724|450104503|FG000|Phase I Dose Escalation|Physician Decision|0|||
125130261|NCT03233724|450104504|FG001|Phase I Dose Escalation|Physician Decision|0|||
125130262|NCT03233724|450104505|FG002|Phase I Dose Escalation|Physician Decision|1|||
125130263|NCT03233724|450104506|FG003|Phase I Dose Escalation|Physician Decision|0|||
125130264|NCT03233724|450104507|FG004|Phase I Dose Escalation|Physician Decision|0|||
125130265|NCT03233724|450104503|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
125130266|NCT03233724|450104504|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
125130267|NCT03233724|450104505|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
125130268|NCT03233724|450104506|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
125130269|NCT03233724|450104507|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
125130270|NCT03135834|450104508|FG000|Stage 1|Adverse Event|1|||
125130271|NCT03135834|450104509|FG001|Stage 1|Adverse Event|2|||
125130272|NCT03135834|450104510|FG002|Stage 1|Adverse Event|2|||
125130273|NCT03135834|450104511|FG003|Stage 1|Adverse Event|1|||
125130274|NCT03135834|450104508|FG000|Stage 1|Death|1|||
125130275|NCT03135834|450104509|FG001|Stage 1|Death|0|||
125130276|NCT03135834|450104510|FG002|Stage 1|Death|0|||
125130277|NCT03135834|450104511|FG003|Stage 1|Death|0|||
125130278|NCT03135834|450104508|FG000|Stage 1|Lost to Follow-up|17|||
125130279|NCT03135834|450104509|FG001|Stage 1|Lost to Follow-up|24|||
125130280|NCT03135834|450104510|FG002|Stage 1|Lost to Follow-up|21|||
125130281|NCT03135834|450104511|FG003|Stage 1|Lost to Follow-up|38|||
125130282|NCT03135834|450104508|FG000|Stage 1|No longer met eligibility criteria|1|||
125130283|NCT03135834|450104509|FG001|Stage 1|No longer met eligibility criteria|6|||
125130284|NCT03135834|450104510|FG002|Stage 1|No longer met eligibility criteria|2|||
125130285|NCT03135834|450104511|FG003|Stage 1|No longer met eligibility criteria|5|||
124967252|NCT00665223|449507445|FG001|Randomized Phase (26 Weeks)|Death|0|||
124967253|NCT00665223|449507446|FG002|Randomized Phase (26 Weeks)|Death|1|||
124967254|NCT00665223|449507444|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
124967255|NCT00665223|449507445|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
125130286|NCT03135834|450104508|FG000|Stage 1|Other|0|||
125130287|NCT03135834|450104509|FG001|Stage 1|Other|2|||
124967256|NCT00665223|449507446|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
125130288|NCT03135834|450104510|FG002|Stage 1|Other|1|||
125130289|NCT03135834|450104511|FG003|Stage 1|Other|0|||
125130290|NCT03135834|450104508|FG000|Stage 1|Physician Decision|0|||
125130291|NCT03135834|450104509|FG001|Stage 1|Physician Decision|1|||
125130292|NCT03135834|450104510|FG002|Stage 1|Physician Decision|0|||
125130293|NCT03135834|450104511|FG003|Stage 1|Physician Decision|0|||
125130294|NCT03135834|450104508|FG000|Stage 1|Pregnancy|0|||
125130295|NCT03135834|450104509|FG001|Stage 1|Pregnancy|4|||
125130296|NCT03135834|450104510|FG002|Stage 1|Pregnancy|2|||
125130297|NCT03135834|450104511|FG003|Stage 1|Pregnancy|4|||
125130298|NCT03135834|450104508|FG000|Stage 1|Protocol Violation|1|||
125130299|NCT03135834|450104509|FG001|Stage 1|Protocol Violation|1|||
125130300|NCT03135834|450104510|FG002|Stage 1|Protocol Violation|2|||
125130301|NCT03135834|450104511|FG003|Stage 1|Protocol Violation|1|||
125130302|NCT03135834|450104508|FG000|Stage 1|Withdrawal by parent/guardian|2|||
125130303|NCT03135834|450104509|FG001|Stage 1|Withdrawal by parent/guardian|10|||
125130304|NCT03135834|450104510|FG002|Stage 1|Withdrawal by parent/guardian|2|||
125130305|NCT03135834|450104511|FG003|Stage 1|Withdrawal by parent/guardian|1|||
125130306|NCT03135834|450104508|FG000|Stage 1|Withdrawal by Subject|16|||
125130307|NCT03135834|450104509|FG001|Stage 1|Withdrawal by Subject|22|||
125130308|NCT03135834|450104510|FG002|Stage 1|Withdrawal by Subject|7|||
125130309|NCT03135834|450104511|FG003|Stage 1|Withdrawal by Subject|10|||
125130310|NCT03135834|450104508|FG000|Stage 1|Randomized but not Vaccinated|0|||
125130311|NCT03135834|450104509|FG001|Stage 1|Randomized but not Vaccinated|3|||
125130312|NCT03135834|450104510|FG002|Stage 1|Randomized but not Vaccinated|1|||
125130313|NCT03135834|450104511|FG003|Stage 1|Randomized but not Vaccinated|6|||
125130314|NCT03135834|450104508|FG000|Stage 2|Lost to Follow-up|0|||
125130315|NCT03135834|450104509|FG001|Stage 2|Lost to Follow-up|1|||
125130316|NCT03135834|450104510|FG002|Stage 2|Lost to Follow-up|0|||
125130317|NCT03135834|450104511|FG003|Stage 2|Lost to Follow-up|0|||
125130318|NCT03135834|450104508|FG000|Stage 2|Withdrawal by Subject|0|||
125130319|NCT03135834|450104509|FG001|Stage 2|Withdrawal by Subject|1|||
125130320|NCT03135834|450104510|FG002|Stage 2|Withdrawal by Subject|0|||
125130321|NCT03135834|450104511|FG003|Stage 2|Withdrawal by Subject|0|||
125130322|NCT03135834|450104508|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
125130323|NCT03135834|450104509|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
125130324|NCT03135834|450104510|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
125130325|NCT03135834|450104511|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
125130326|NCT03135834|450104508|FG000|Stage 2|Did not receive Booster Vaccination|1|||
125130327|NCT03135834|450104509|FG001|Stage 2|Did not receive Booster Vaccination|1|||
125130328|NCT03135834|450104510|FG002|Stage 2|Did not receive Booster Vaccination|0|||
125130329|NCT03135834|450104511|FG003|Stage 2|Did not receive Booster Vaccination|0|||
125130330|NCT01045161|450104512|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
125130331|NCT01045161|450104513|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
125130332|NCT01045161|450104514|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
125130333|NCT01045161|450104512|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
125130334|NCT01045161|450104513|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
125130335|NCT01045161|450104514|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
125130336|NCT01045161|450104512|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
125130337|NCT01045161|450104513|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
125130338|NCT01045161|450104514|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
125130339|NCT01045161|450104512|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
125130340|NCT01045161|450104513|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
125130341|NCT01045161|450104514|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
125130342|NCT01045161|450104512|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
125130343|NCT01045161|450104513|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
125130344|NCT01045161|450104514|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
125130345|NCT01045161|450104512|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
125130346|NCT01045161|450104513|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
125130347|NCT01045161|450104514|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
125130348|NCT01045161|450104512|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
125130349|NCT01045161|450104513|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
125130350|NCT01045161|450104514|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
125130351|NCT01045161|450104512|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
125130352|NCT01045161|450104513|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
125130353|NCT01045161|450104514|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
125130354|NCT01045161|450104512|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
125130355|NCT01045161|450104513|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
125130356|NCT01045161|450104514|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
125130357|NCT01045161|450104512|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
125130358|NCT01045161|450104513|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
125130359|NCT01045161|450104514|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
125130360|NCT01045161|450104512|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
125130361|NCT01045161|450104513|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
125130362|NCT01045161|450104514|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
125130363|NCT01045161|450104512|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
125130364|NCT01045161|450104513|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
125130365|NCT01045161|450104514|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
125130366|NCT01045161|450104512|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
125130367|NCT01045161|450104513|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
125130368|NCT01045161|450104514|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
125130369|NCT01045161|450104512|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
125130370|NCT01045161|450104513|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
125130371|NCT01045161|450104514|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
125130372|NCT02605928|450104517|FG000|Overall Study|Model tuning phase|28|||
125130373|NCT02605928|450104517|FG000|Overall Study|Lack of Efficacy|5|||
125130374|NCT02612337|450104520|FG000|Overall Study|Lack of Efficacy|1|||
125130375|NCT02612337|450104521|FG001|Overall Study|Lack of Efficacy|0|||
125130376|NCT02612337|450104520|FG000|Overall Study|Withdrawal by Subject|2|||
125130377|NCT02612337|450104521|FG001|Overall Study|Withdrawal by Subject|2|||
125130378|NCT02612337|450104520|FG000|Overall Study|Did not receive study drug|0|||
125130379|NCT02612337|450104521|FG001|Overall Study|Did not receive study drug|1|||
125130380|NCT02242201|450104524|FG000|Overall Study|preoperative identified neuropathy|2|||
125130381|NCT02242201|450104525|FG001|Overall Study|preoperative identified neuropathy|0|||
125130382|NCT02242201|450104526|FG002|Overall Study|preoperative identified neuropathy|0|||
125130383|NCT02242201|450104524|FG000|Overall Study|planned post-op anticoagulation|1|||
125130384|NCT02242201|450104525|FG001|Overall Study|planned post-op anticoagulation|0|||
125130385|NCT02242201|450104526|FG002|Overall Study|planned post-op anticoagulation|0|||
125130386|NCT02242201|450104524|FG000|Overall Study|changed surgical procedure|1|||
125130387|NCT02242201|450104525|FG001|Overall Study|changed surgical procedure|0|||
125130388|NCT02242201|450104526|FG002|Overall Study|changed surgical procedure|0|||
125130389|NCT02242201|450104524|FG000|Overall Study|postponed surgery|0|||
125130390|NCT02242201|450104525|FG001|Overall Study|postponed surgery|0|||
125130391|NCT02242201|450104526|FG002|Overall Study|postponed surgery|1|||
125130392|NCT02242201|450104524|FG000|Overall Study|preoperative opioid consumption|0|||
125130393|NCT02242201|450104525|FG001|Overall Study|preoperative opioid consumption|1|||
125130394|NCT02242201|450104526|FG002|Overall Study|preoperative opioid consumption|0|||
125130395|NCT02374853|450104529|FG000|Overall Study|Surgery Cancelled|5|||
125130396|NCT02374853|450104530|FG001|Overall Study|Surgery Cancelled|11|||
125130397|NCT02281084|450104533|FG000|Overall Study|Death|21|||
125130398|NCT02281084|450104534|FG001|Overall Study|Death|18|||
125130399|NCT02281084|450104535|FG002|Overall Study|Death|3|||
125130400|NCT02281084|450104536|FG003|Overall Study|Death|5|||
125130401|NCT02281084|450104533|FG000|Overall Study|Adverse Event|1|||
125130402|NCT02281084|450104534|FG001|Overall Study|Adverse Event|0|||
125130403|NCT02281084|450104535|FG002|Overall Study|Adverse Event|0|||
125130404|NCT02281084|450104536|FG003|Overall Study|Adverse Event|0|||
125130405|NCT02281084|450104533|FG000|Overall Study|Withdrawal by Subject|2|||
125130406|NCT02281084|450104534|FG001|Overall Study|Withdrawal by Subject|2|||
125130407|NCT02281084|450104535|FG002|Overall Study|Withdrawal by Subject|0|||
125130408|NCT02281084|450104536|FG003|Overall Study|Withdrawal by Subject|0|||
125130409|NCT02281084|450104533|FG000|Overall Study|Site Closure by Sponsor|5|||
125130410|NCT02281084|450104534|FG001|Overall Study|Site Closure by Sponsor|1|||
125130411|NCT02281084|450104535|FG002|Overall Study|Site Closure by Sponsor|2|||
125130412|NCT02281084|450104536|FG003|Overall Study|Site Closure by Sponsor|0|||
125130413|NCT01697696|450104537|FG000|Overall Study|Study terminated by sponsor|0|||
125130414|NCT01697696|450104538|FG001|Overall Study|Study terminated by sponsor|3|||
125130415|NCT01697696|450104537|FG000|Overall Study|Protocol deviation|1|||
125130416|NCT01697696|450104538|FG001|Overall Study|Protocol deviation|0|||
125130417|NCT01697696|450104537|FG000|Overall Study|Physician Decision|1|||
125130418|NCT01697696|450104538|FG001|Overall Study|Physician Decision|0|||
125130419|NCT01697696|450104537|FG000|Overall Study|Death|4|||
125130420|NCT01697696|450104538|FG001|Overall Study|Death|2|||
125130421|NCT01697696|450104537|FG000|Overall Study|Lost to Follow-up|10|||
125130422|NCT01697696|450104538|FG001|Overall Study|Lost to Follow-up|7|||
125130423|NCT01697696|450104537|FG000|Overall Study|Subject/guardian decision|31|||
125130424|NCT01697696|450104538|FG001|Overall Study|Subject/guardian decision|35|||
125130425|NCT01424644|450104539|FG000|Overall Study|Adverse Event|2|||
125130426|NCT01424644|450104540|FG001|Overall Study|Adverse Event|0|||
125130427|NCT01424644|450104539|FG000|Overall Study|Withdrawal by Subject|9|||
125130428|NCT01424644|450104540|FG001|Overall Study|Withdrawal by Subject|12|||
125130429|NCT01424644|450104539|FG000|Overall Study|Lost to Follow-up|16|||
125130430|NCT01424644|450104540|FG001|Overall Study|Lost to Follow-up|12|||
125130431|NCT01424644|450104539|FG000|Overall Study|Protocol Violation|4|||
125130432|NCT01424644|450104540|FG001|Overall Study|Protocol Violation|3|||
125130433|NCT01424644|450104539|FG000|Overall Study|Administrative Reason|1|||
125216488|NCT01616758|450419454|FG000|Overall Study|Withdrawal by Subject|2|||
125130434|NCT01424644|450104540|FG001|Overall Study|Administrative Reason|0|||
125130435|NCT01424644|450104539|FG000|Overall Study|Unable to Classify|1|||
125130436|NCT01424644|450104540|FG001|Overall Study|Unable to Classify|0|||
125130437|NCT05593965|450104541|FG000|1st Intervention (1 Day)|Technical error|1|||
125130438|NCT05593965|450104542|FG001|1st Intervention (1 Day)|Technical error|0|||
125216489|NCT01616758|450419454|FG000|Overall Study|Disease progression|18|||
125130439|NCT02024932|450104561|FG000|Overall Study|Adverse Event|2|||
125130440|NCT02024932|450104562|FG001|Overall Study|Adverse Event|3|||
125130441|NCT02024932|450104563|FG002|Overall Study|Adverse Event|0|||
125130442|NCT02024932|450104564|FG003|Overall Study|Adverse Event|0|||
125130443|NCT02024932|450104565|FG004|Overall Study|Adverse Event|2|||
125130444|NCT02024932|450104566|FG005|Overall Study|Adverse Event|0|||
125130445|NCT02024932|450104561|FG000|Overall Study|Abnormal laboratory value|0|||
125130446|NCT02024932|450104562|FG001|Overall Study|Abnormal laboratory value|0|||
125130447|NCT02024932|450104563|FG002|Overall Study|Abnormal laboratory value|0|||
125130448|NCT02024932|450104564|FG003|Overall Study|Abnormal laboratory value|2|||
125130449|NCT02024932|450104565|FG004|Overall Study|Abnormal laboratory value|0|||
125130450|NCT02024932|450104566|FG005|Overall Study|Abnormal laboratory value|0|||
125130451|NCT02445339|450104567|FG000|Overall Study|Physician Decision|1|||
125130452|NCT02445339|450104568|FG001|Overall Study|Physician Decision|0|||
125130453|NCT02445339|450104567|FG000|Overall Study|Lost to Follow-up|11|||
125130454|NCT02445339|450104568|FG001|Overall Study|Lost to Follow-up|15|||
125130455|NCT03020641|450104569|FG000|Overall Study|Lost to Follow-up|0|||
125130456|NCT03020641|450104570|FG001|Overall Study|Lost to Follow-up|1|||
125130457|NCT03020641|450104569|FG000|Overall Study|Converted to open surgery|2|||
125130458|NCT03020641|450104570|FG001|Overall Study|Converted to open surgery|1|||
125130459|NCT03020641|450104569|FG000|Overall Study|for surgery not performed|0|||
125130460|NCT03020641|450104570|FG001|Overall Study|for surgery not performed|1|||
125130461|NCT03041025|450104571|FG000|Overall Study|Adverse Event|0|||
125130462|NCT03041025|450104572|FG001|Overall Study|Adverse Event|0|||
125130463|NCT03041025|450104573|FG002|Overall Study|Adverse Event|1|||
125130464|NCT03041025|450104571|FG000|Overall Study|Lost to Follow-up|1|||
125130465|NCT03041025|450104572|FG001|Overall Study|Lost to Follow-up|0|||
125130466|NCT03041025|450104573|FG002|Overall Study|Lost to Follow-up|0|||
125130467|NCT03041025|450104571|FG000|Overall Study|Withdrawal by Subject|0|||
125130468|NCT03041025|450104572|FG001|Overall Study|Withdrawal by Subject|0|||
125130469|NCT03041025|450104573|FG002|Overall Study|Withdrawal by Subject|1|||
125130470|NCT02963259|450104575|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
125130471|NCT02963259|450104575|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
125130472|NCT02963259|450104575|FG000|Overall Study|Death|1|||
125130473|NCT02963259|450104575|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
125130474|NCT00939003|450104576|FG000|Double-blind Treatment Period|Adverse Event|1|||
125130475|NCT00939003|450104577|FG001|Double-blind Treatment Period|Adverse Event|1|||
125130476|NCT00939003|450104576|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
125130477|NCT00939003|450104577|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
125130478|NCT00939003|450104576|FG000|Double-blind Treatment Period|Pregnancy|0|||
125130479|NCT00939003|450104577|FG001|Double-blind Treatment Period|Pregnancy|1|||
125130480|NCT00939003|450104576|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
125130481|NCT00939003|450104577|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
125130482|NCT00939003|450104576|FG000|Open-label Treatment Period|Adverse Event|4|||
125130483|NCT00939003|450104577|FG001|Open-label Treatment Period|Adverse Event|8|||
125130484|NCT00939003|450104576|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
125130485|NCT00939003|450104577|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
125130486|NCT00939003|450104576|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
124967257|NCT00665223|449507444|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
124967258|NCT00665223|449507445|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
124967259|NCT00665223|449507446|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
124967260|NCT00665223|449507444|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
124967261|NCT00665223|449507445|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
124967262|NCT00665223|449507446|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
124967263|NCT00665223|449507444|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
124967264|NCT00665223|449507445|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
124967265|NCT00665223|449507446|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
124967266|NCT00665223|449507444|FG000|Open-Label Period (26 Weeks)|Death|0|||
124967267|NCT00665223|449507445|FG001|Open-Label Period (26 Weeks)|Death|1|||
124967268|NCT00665223|449507446|FG002|Open-Label Period (26 Weeks)|Death|0|||
124967269|NCT00665223|449507444|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
124967270|NCT00665223|449507445|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
124967271|NCT00665223|449507446|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
124967272|NCT00665223|449507444|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
124967273|NCT00665223|449507445|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
124967274|NCT00665223|449507446|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
124967275|NCT00665223|449507444|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
124967276|NCT00665223|449507445|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
125130487|NCT00939003|450104577|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
125130488|NCT00939003|450104576|FG000|Open-label Treatment Period|Pregnancy|1|||
125130489|NCT00939003|450104577|FG001|Open-label Treatment Period|Pregnancy|1|||
125130490|NCT00939003|450104576|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
125130491|NCT00939003|450104577|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
125130492|NCT00939003|450104576|FG000|Open-label Treatment Period|Site Closure|3|||
125130493|NCT00939003|450104577|FG001|Open-label Treatment Period|Site Closure|4|||
125130494|NCT02131129|450104578|FG000|Overall Study|Withdrawal by Subject|1|||
125130495|NCT02131129|450104579|FG001|Overall Study|Withdrawal by Subject|0|||
125130496|NCT00727961|450104580|FG000|Overall Study|Lost to Follow-up|1|||
125130497|NCT00727961|450104580|FG000|Overall Study|Adverse Event|4|||
125130498|NCT00727961|450104580|FG000|Overall Study|Patient's refusal|2|||
125130499|NCT00727961|450104580|FG000|Overall Study|Progression|30|||
125130500|NCT02865122|450104581|FG000|Overall Study|Adverse Event|1|||
125130501|NCT02865122|450104582|FG001|Overall Study|Adverse Event|0|||
125130502|NCT02865122|450104583|FG002|Overall Study|Adverse Event|0|||
125130503|NCT01421277|450104585|FG000|Overall Study|Lack of qualifying event|0|||
125130504|NCT01421277|450104586|FG001|Overall Study|Lack of qualifying event|61|||
125130505|NCT01421277|450104585|FG000|Overall Study|Incomplete baseline data|0|||
125130506|NCT01421277|450104586|FG001|Overall Study|Incomplete baseline data|31|||
125130507|NCT01015703|450106299|FG000|Overall Study|Withdrawal by Subject|0|||
125130508|NCT01015703|450106300|FG001|Overall Study|Withdrawal by Subject|1|||
125130509|NCT01015703|450106301|FG002|Overall Study|Withdrawal by Subject|0|||
125130510|NCT01015703|450106302|FG003|Overall Study|Withdrawal by Subject|0|||
125130511|NCT01015703|450106303|FG004|Overall Study|Withdrawal by Subject|0|||
125130512|NCT01015703|450106299|FG000|Overall Study|Adverse Event|1|||
125130513|NCT01015703|450106300|FG001|Overall Study|Adverse Event|0|||
125130514|NCT01015703|450106301|FG002|Overall Study|Adverse Event|0|||
125130515|NCT01015703|450106302|FG003|Overall Study|Adverse Event|0|||
125130516|NCT01015703|450106303|FG004|Overall Study|Adverse Event|0|||
124967277|NCT00665223|449507446|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
124967278|NCT00665223|449507444|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
124967279|NCT00665223|449507445|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
124967280|NCT00665223|449507446|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
124967281|NCT01278615|449507447|FG000|Overall Study|Withdrawal by Subject|2|||
124967282|NCT00905359|449507448|FG000|Overall Study|Lost to Follow-up|17|||
124967283|NCT00905359|449507449|FG001|Overall Study|Lost to Follow-up|10|||
124967284|NCT00905359|449507448|FG000|Overall Study|Death|2|||
124967285|NCT00905359|449507449|FG001|Overall Study|Death|0|||
124967286|NCT00905359|449507448|FG000|Overall Study|Withdrawal consent|5|||
124967287|NCT00905359|449507449|FG001|Overall Study|Withdrawal consent|6|||
124967288|NCT02654132|449507450|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
124967289|NCT02654132|449507451|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
124967290|NCT02654132|449507450|FG000|Treatment Period|Disease progression|43|||
124967291|NCT02654132|449507451|FG001|Treatment Period|Disease progression|38|||
124967292|NCT02654132|449507450|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
124967293|NCT02654132|449507451|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
125130517|NCT01015703|450106299|FG000|Overall Study|Protocol Violation|1|||
125130518|NCT01015703|450106300|FG001|Overall Study|Protocol Violation|0|||
125130519|NCT01015703|450106301|FG002|Overall Study|Protocol Violation|0|||
125130520|NCT01015703|450106302|FG003|Overall Study|Protocol Violation|0|||
125130521|NCT01015703|450106303|FG004|Overall Study|Protocol Violation|0|||
125130522|NCT00834418|450106304|FG000|Overall Study|Adverse Event|0|||
125130523|NCT00834418|450106305|FG001|Overall Study|Adverse Event|2|||
125130524|NCT01705574|450106306|FG000|Double-Blind Phase|Lost to Follow-up|12|||
125130525|NCT01705574|450106307|FG001|Double-Blind Phase|Lost to Follow-up|16|||
125130526|NCT01705574|450106308|FG002|Double-Blind Phase|Lost to Follow-up|0|||
125130527|NCT01705574|450106309|FG003|Double-Blind Phase|Lost to Follow-up|0|||
125130528|NCT01705574|450106306|FG000|Double-Blind Phase|Adverse Event|3|||
125130529|NCT01705574|450106307|FG001|Double-Blind Phase|Adverse Event|10|||
125130530|NCT01705574|450106308|FG002|Double-Blind Phase|Adverse Event|0|||
125130531|NCT01705574|450106309|FG003|Double-Blind Phase|Adverse Event|0|||
125130532|NCT01705574|450106306|FG000|Double-Blind Phase|Withdrew Consent|8|||
125130533|NCT01705574|450106307|FG001|Double-Blind Phase|Withdrew Consent|5|||
125130534|NCT01705574|450106308|FG002|Double-Blind Phase|Withdrew Consent|0|||
125130535|NCT01705574|450106309|FG003|Double-Blind Phase|Withdrew Consent|0|||
125130536|NCT01705574|450106306|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
125130537|NCT01705574|450106307|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
125130538|NCT01705574|450106308|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
125130539|NCT01705574|450106309|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
125130540|NCT01705574|450106306|FG000|Double-Blind Phase|Pregnancy|1|||
125130541|NCT01705574|450106307|FG001|Double-Blind Phase|Pregnancy|1|||
125130542|NCT01705574|450106308|FG002|Double-Blind Phase|Pregnancy|0|||
125130543|NCT01705574|450106309|FG003|Double-Blind Phase|Pregnancy|0|||
125130544|NCT01705574|450106306|FG000|Double-Blind Phase|Protocol Violation|1|||
125130545|NCT01705574|450106307|FG001|Double-Blind Phase|Protocol Violation|0|||
125130546|NCT01705574|450106308|FG002|Double-Blind Phase|Protocol Violation|0|||
125130547|NCT01705574|450106309|FG003|Double-Blind Phase|Protocol Violation|0|||
125130548|NCT01705574|450106306|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
125130549|NCT01705574|450106307|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
125216490|NCT01616758|450419454|FG000|Overall Study|Study termination by Sponsor|1|||
125216491|NCT03252145|450419455|FG000|Overall Study|Withdrawal by Subject|1|||
125216492|NCT03252145|450419456|FG001|Overall Study|Withdrawal by Subject|0|||
125216493|NCT03252145|450419455|FG000|Overall Study|Complicating Disease|1|||
125216494|NCT03252145|450419456|FG001|Overall Study|Complicating Disease|2|||
125216495|NCT03091738|450419457|FG000|Overall Study|Adverse Event|1|||
124967294|NCT02654132|449507450|FG000|Treatment Period|Other reasons|4|||
125130550|NCT01705574|450106308|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
125130551|NCT01705574|450106309|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
124967295|NCT02654132|449507451|FG001|Treatment Period|Other reasons|2|||
124967296|NCT02654132|449507450|FG000|Treatment Period|Study drug toxicity|2|||
124967297|NCT02654132|449507451|FG001|Treatment Period|Study drug toxicity|2|||
124967298|NCT02654132|449507450|FG000|Treatment Period|Withdrawal by Subject|2|||
124967299|NCT02654132|449507451|FG001|Treatment Period|Withdrawal by Subject|1|||
124967300|NCT02654132|449507450|FG000|Treatment Period|Maximum Clinical Benefit|0|||
125130552|NCT01705574|450106306|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
125130553|NCT01705574|450106307|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
125216496|NCT03091738|450419457|FG000|Overall Study|Lost to Follow-up|1|||
125216497|NCT00199849|450419466|FG000|Overall Study|Unrelated illness or complication|0|||
124967301|NCT02654132|449507451|FG001|Treatment Period|Maximum Clinical Benefit|2|||
125130554|NCT01705574|450106308|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
125130555|NCT01705574|450106309|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
124967302|NCT02654132|449507450|FG000|Treatment Period|Participant request to discontinue|2|||
124967303|NCT02654132|449507451|FG001|Treatment Period|Participant request to discontinue|0|||
124967304|NCT02654132|449507450|FG000|Treatment Period|Administrative reasons by sponsor|0|||
124967305|NCT02654132|449507451|FG001|Treatment Period|Administrative reasons by sponsor|1|||
125130556|NCT01705574|450106306|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
125130557|NCT01705574|450106307|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
125130558|NCT01705574|450106308|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
125130559|NCT01705574|450106309|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
125130560|NCT01705574|450106306|FG000|Open-Label Extension Phase|Adverse Event|3|||
125130561|NCT01705574|450106307|FG001|Open-Label Extension Phase|Adverse Event|0|||
125130562|NCT01705574|450106308|FG002|Open-Label Extension Phase|Adverse Event|0|||
125130563|NCT01705574|450106309|FG003|Open-Label Extension Phase|Adverse Event|1|||
125130564|NCT01705574|450106306|FG000|Open-Label Extension Phase|Death|2|||
125130565|NCT01705574|450106307|FG001|Open-Label Extension Phase|Death|0|||
125130566|NCT01705574|450106308|FG002|Open-Label Extension Phase|Death|1|||
125130567|NCT01705574|450106309|FG003|Open-Label Extension Phase|Death|0|||
125130568|NCT01705574|450106306|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
125130569|NCT01705574|450106307|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
125130570|NCT01705574|450106308|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
125130571|NCT01705574|450106309|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
125130572|NCT01705574|450106306|FG000|Open-Label Extension Phase|Physician Decision|0|||
125130573|NCT01705574|450106307|FG001|Open-Label Extension Phase|Physician Decision|0|||
125130574|NCT01705574|450106308|FG002|Open-Label Extension Phase|Physician Decision|2|||
125130575|NCT01705574|450106309|FG003|Open-Label Extension Phase|Physician Decision|0|||
125130576|NCT01705574|450106306|FG000|Open-Label Extension Phase|Pregnancy|0|||
125130577|NCT01705574|450106307|FG001|Open-Label Extension Phase|Pregnancy|0|||
125130578|NCT01705574|450106308|FG002|Open-Label Extension Phase|Pregnancy|1|||
124967306|NCT02654132|449507450|FG000|Treatment Period|Death|1|||
124967307|NCT02654132|449507451|FG001|Treatment Period|Death|0|||
124967308|NCT00621192|449507452|FG000|Overall Study|Withdrawal by Subject|0|||
124967309|NCT00621192|449507453|FG001|Overall Study|Withdrawal by Subject|0|||
124967310|NCT00621192|449507454|FG002|Overall Study|Withdrawal by Subject|2|||
124967311|NCT00621192|449507455|FG003|Overall Study|Withdrawal by Subject|0|||
124967312|NCT00621192|449507452|FG000|Overall Study|Physician Decision|1|||
124967313|NCT00621192|449507453|FG001|Overall Study|Physician Decision|3|||
124967314|NCT00621192|449507454|FG002|Overall Study|Physician Decision|0|||
124967315|NCT00621192|449507455|FG003|Overall Study|Physician Decision|0|||
124967316|NCT00621192|449507452|FG000|Overall Study|Protocol Violation|1|||
124967317|NCT00621192|449507453|FG001|Overall Study|Protocol Violation|0|||
124967318|NCT00621192|449507454|FG002|Overall Study|Protocol Violation|0|||
124967319|NCT00621192|449507455|FG003|Overall Study|Protocol Violation|1|||
124967320|NCT00621192|449507452|FG000|Overall Study|Adverse Event|0|||
124967321|NCT00621192|449507453|FG001|Overall Study|Adverse Event|1|||
124967322|NCT00621192|449507454|FG002|Overall Study|Adverse Event|0|||
124967323|NCT00621192|449507455|FG003|Overall Study|Adverse Event|1|||
124967324|NCT00621192|449507452|FG000|Overall Study|Death|2|||
124967325|NCT00621192|449507453|FG001|Overall Study|Death|5|||
124967326|NCT00621192|449507454|FG002|Overall Study|Death|0|||
124967327|NCT00621192|449507455|FG003|Overall Study|Death|0|||
124967328|NCT00621192|449507452|FG000|Overall Study|Final Assessments not Completed|0|||
124967329|NCT00621192|449507453|FG001|Overall Study|Final Assessments not Completed|0|||
124967330|NCT00621192|449507454|FG002|Overall Study|Final Assessments not Completed|3|||
124967331|NCT00621192|449507455|FG003|Overall Study|Final Assessments not Completed|1|||
125130579|NCT01705574|450106309|FG003|Open-Label Extension Phase|Pregnancy|1|||
125130580|NCT00089661|450106314|FG000|Overall Study|Adverse Event|0|||
125130581|NCT00089661|450106315|FG001|Overall Study|Adverse Event|2|||
125130582|NCT00089661|450106314|FG000|Overall Study|Death|1|||
125130583|NCT00089661|450106315|FG001|Overall Study|Death|0|||
125130584|NCT00089661|450106314|FG000|Overall Study|Lost to Follow-up|0|||
125130585|NCT00089661|450106315|FG001|Overall Study|Lost to Follow-up|3|||
125130586|NCT00089661|450106314|FG000|Overall Study|Withdrawal by Subject|11|||
125130587|NCT00089661|450106315|FG001|Overall Study|Withdrawal by Subject|9|||
125130588|NCT00089661|450106314|FG000|Overall Study|Disease progression|1|||
125130589|NCT00089661|450106315|FG001|Overall Study|Disease progression|3|||
124967332|NCT04706793|449507456|FG000|Treatment|Disease worsening|10|||
124967333|NCT04706793|449507457|FG001|Treatment|Disease worsening|10|||
124967334|NCT04706793|449507456|FG000|Follow-up|Lack of Efficacy|1|||
124967335|NCT04706793|449507457|FG001|Follow-up|Lack of Efficacy|0|||
124967336|NCT04706793|449507456|FG000|Follow-up|Disease worsening|8|||
124967337|NCT04706793|449507457|FG001|Follow-up|Disease worsening|10|||
124967338|NCT04706793|449507456|FG000|Follow-up|Adverse Event|1|||
124967339|NCT04706793|449507457|FG001|Follow-up|Adverse Event|0|||
124967340|NCT02601209|449507459|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
124967341|NCT02601209|449507460|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
124967342|NCT02601209|449507461|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
124967343|NCT02601209|449507462|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
124967344|NCT02601209|449507463|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
124967345|NCT02601209|449507464|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
124967346|NCT02601209|449507465|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
124967347|NCT02601209|449507466|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
124967348|NCT02601209|449507467|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
124967349|NCT02601209|449507459|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
124967350|NCT02601209|449507460|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
124967351|NCT02601209|449507461|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
124967352|NCT02601209|449507462|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
124967353|NCT02601209|449507463|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
124967354|NCT02601209|449507464|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
124967355|NCT02601209|449507465|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
124967356|NCT02601209|449507466|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
124967357|NCT02601209|449507467|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
124967358|NCT03636373|449507468|FG000|Overall Study|Study closure due to Covid-19|1|||
124967359|NCT03636373|449507469|FG001|Overall Study|Study closure due to Covid-19|0|||
124967360|NCT00572533|449507470|FG000|Overall Study|Death|4|||
124967361|NCT00572533|449507471|FG001|Overall Study|Death|1|||
124967362|NCT00572533|449507470|FG000|Overall Study|Received Kidney Transplant|2|||
124967363|NCT00572533|449507471|FG001|Overall Study|Received Kidney Transplant|1|||
124967364|NCT00572533|449507470|FG000|Overall Study|Social Issues|1|||
124967365|NCT00572533|449507471|FG001|Overall Study|Social Issues|0|||
124967366|NCT00572533|449507470|FG000|Overall Study|Transfer out of Facility|0|||
124967367|NCT00572533|449507471|FG001|Overall Study|Transfer out of Facility|1|||
124967368|NCT01530087|449507475|FG000|Overall Study|Physician Decision|2|||
124967369|NCT02344173|449507480|FG000|Procedure|Ablation Procedure Not Performed|7|||
124967370|NCT02344173|449507480|FG000|12-month Visit|Death|8|||
124967371|NCT02344173|449507480|FG000|12-month Visit|Withdrawal by Subject|30|||
124967372|NCT02344173|449507480|FG000|12-month Visit|Lost to Follow-up|58|||
124967373|NCT00661713|449507481|FG000|Overall Study|Death|1|||
124967374|NCT00661713|449507482|FG001|Overall Study|Death|0|||
124967375|NCT00661713|449507483|FG002|Overall Study|Death|0|||
124967376|NCT00661713|449507484|FG003|Overall Study|Death|0|||
124967377|NCT00661713|449507485|FG004|Overall Study|Death|1|||
124967378|NCT00661713|449507486|FG005|Overall Study|Death|0|||
124967379|NCT00661713|449507487|FG006|Overall Study|Death|0|||
124967380|NCT00661713|449507488|FG007|Overall Study|Death|0|||
124967381|NCT00661713|449507481|FG000|Overall Study|Unable to Classify|1|||
124967382|NCT00661713|449507482|FG001|Overall Study|Unable to Classify|0|||
124967383|NCT00661713|449507483|FG002|Overall Study|Unable to Classify|0|||
124967384|NCT00661713|449507484|FG003|Overall Study|Unable to Classify|0|||
124967385|NCT00661713|449507485|FG004|Overall Study|Unable to Classify|0|||
124967386|NCT00661713|449507486|FG005|Overall Study|Unable to Classify|0|||
124967387|NCT00661713|449507487|FG006|Overall Study|Unable to Classify|0|||
124967388|NCT00661713|449507488|FG007|Overall Study|Unable to Classify|0|||
124967389|NCT00661713|449507481|FG000|Overall Study|Protocol Violation|1|||
124967390|NCT00661713|449507482|FG001|Overall Study|Protocol Violation|6|||
124967391|NCT00661713|449507483|FG002|Overall Study|Protocol Violation|3|||
124967392|NCT00661713|449507484|FG003|Overall Study|Protocol Violation|3|||
124967393|NCT00661713|449507485|FG004|Overall Study|Protocol Violation|0|||
124967394|NCT00661713|449507486|FG005|Overall Study|Protocol Violation|2|||
124967395|NCT00661713|449507487|FG006|Overall Study|Protocol Violation|2|||
124967396|NCT00661713|449507488|FG007|Overall Study|Protocol Violation|1|||
124967397|NCT00661713|449507481|FG000|Overall Study|Withdrawal by Subject|11|||
124967398|NCT00661713|449507482|FG001|Overall Study|Withdrawal by Subject|25|||
124967399|NCT00661713|449507483|FG002|Overall Study|Withdrawal by Subject|12|||
124967400|NCT00661713|449507484|FG003|Overall Study|Withdrawal by Subject|21|||
124967401|NCT00661713|449507485|FG004|Overall Study|Withdrawal by Subject|12|||
124967402|NCT00661713|449507486|FG005|Overall Study|Withdrawal by Subject|26|||
124967403|NCT00661713|449507487|FG006|Overall Study|Withdrawal by Subject|45|||
124967404|NCT00661713|449507488|FG007|Overall Study|Withdrawal by Subject|9|||
124967405|NCT00661713|449507481|FG000|Overall Study|Lost to Follow-up|2|||
124967406|NCT00661713|449507482|FG001|Overall Study|Lost to Follow-up|7|||
124967407|NCT00661713|449507483|FG002|Overall Study|Lost to Follow-up|2|||
124967408|NCT00661713|449507484|FG003|Overall Study|Lost to Follow-up|2|||
124967409|NCT00661713|449507485|FG004|Overall Study|Lost to Follow-up|5|||
124967410|NCT00661713|449507486|FG005|Overall Study|Lost to Follow-up|7|||
124967411|NCT00661713|449507487|FG006|Overall Study|Lost to Follow-up|14|||
124967412|NCT00661713|449507488|FG007|Overall Study|Lost to Follow-up|1|||
124967413|NCT00661713|449507481|FG000|Overall Study|Administrative Reason|0|||
124967414|NCT00661713|449507482|FG001|Overall Study|Administrative Reason|1|||
124967415|NCT00661713|449507483|FG002|Overall Study|Administrative Reason|0|||
124967416|NCT00661713|449507484|FG003|Overall Study|Administrative Reason|2|||
124967417|NCT00661713|449507485|FG004|Overall Study|Administrative Reason|2|||
124967418|NCT00661713|449507486|FG005|Overall Study|Administrative Reason|2|||
124967419|NCT00661713|449507487|FG006|Overall Study|Administrative Reason|1|||
124967420|NCT00661713|449507488|FG007|Overall Study|Administrative Reason|0|||
124967421|NCT00661713|449507481|FG000|Overall Study|Adverse Event|0|||
124967422|NCT00661713|449507482|FG001|Overall Study|Adverse Event|0|||
124967423|NCT00661713|449507483|FG002|Overall Study|Adverse Event|0|||
124967424|NCT00661713|449507484|FG003|Overall Study|Adverse Event|0|||
124967425|NCT00661713|449507485|FG004|Overall Study|Adverse Event|0|||
124967426|NCT00661713|449507486|FG005|Overall Study|Adverse Event|0|||
124967427|NCT00661713|449507487|FG006|Overall Study|Adverse Event|1|||
124967428|NCT00661713|449507488|FG007|Overall Study|Adverse Event|0|||
124967429|NCT00661713|449507481|FG000|Overall Study|Inappropriate Enrollment|0|||
124967430|NCT00661713|449507482|FG001|Overall Study|Inappropriate Enrollment|0|||
124967431|NCT00661713|449507483|FG002|Overall Study|Inappropriate Enrollment|0|||
124967432|NCT00661713|449507484|FG003|Overall Study|Inappropriate Enrollment|0|||
124967433|NCT00661713|449507485|FG004|Overall Study|Inappropriate Enrollment|0|||
124967434|NCT00661713|449507486|FG005|Overall Study|Inappropriate Enrollment|0|||
124967435|NCT00661713|449507487|FG006|Overall Study|Inappropriate Enrollment|1|||
124967436|NCT00661713|449507488|FG007|Overall Study|Inappropriate Enrollment|0|||
124967437|NCT00416598|449509479|FG000|Induction & Intensification|Adverse Event|38|||
124967438|NCT00416598|449509479|FG000|Induction & Intensification|Death|32|||
124967439|NCT00416598|449509479|FG000|Induction & Intensification|Withdrawal by Subject|46|||
124967440|NCT00416598|449509479|FG000|Induction & Intensification|Alternative Treatment|135|||
124967441|NCT00416598|449509479|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
124967442|NCT00416598|449509479|FG000|Induction & Intensification|Relapse/progression|29|||
124967443|NCT00416598|449509479|FG000|Induction & Intensification|Failed induction|87|||
124967444|NCT00416598|449509479|FG000|Decitabine Maintenance|Adverse Event|5|||
124967445|NCT00416598|449509479|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
124967446|NCT00416598|449509479|FG000|Decitabine Maintenance|Progression/relapse|38|||
124967447|NCT00416598|449509479|FG000|Decitabine Maintenance|Alternative treatment|2|||
124967448|NCT00416598|449509479|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
124967449|NCT00810342|449509484|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
124967450|NCT00810342|449509485|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
124967451|NCT00810342|449509484|FG000|Month 1 Follow-up|Pregnancy|1|||
124967452|NCT00810342|449509485|FG001|Month 1 Follow-up|Pregnancy|0|||
124967453|NCT00810342|449509484|FG000|6-month Follow-up|Lost to Follow-up|18|||
124967454|NCT00810342|449509485|FG001|6-month Follow-up|Lost to Follow-up|6|||
124967455|NCT00810342|449509484|FG000|6-month Follow-up|Pregnancy|6|||
124967456|NCT00810342|449509485|FG001|6-month Follow-up|Pregnancy|2|||
125032316|NCT05211336|449739464|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
125130590|NCT00089661|450106314|FG000|Overall Study|Ineligibility determined|4|||
124967457|NCT00810342|449509484|FG000|12-month Followup|Pregnancy|9|||
124967458|NCT00810342|449509485|FG001|12-month Followup|Pregnancy|10|||
124967459|NCT00810342|449509484|FG000|12-month Followup|Lost to Follow-up|3|||
124967460|NCT00810342|449509485|FG001|12-month Followup|Lost to Follow-up|1|||
125032317|NCT05211336|449739465|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
125032318|NCT05211336|449739464|FG000|Overall Study|Progressive disease|0|||
125032319|NCT05211336|449739465|FG001|Overall Study|Progressive disease|4|||
125032320|NCT05211336|449739464|FG000|Overall Study|Death due to myocardial infarction|0|||
125032321|NCT05211336|449739465|FG001|Overall Study|Death due to myocardial infarction|1|||
125032322|NCT05211336|449739464|FG000|Overall Study|Death due to unknown cause|0|||
125032323|NCT05211336|449739465|FG001|Overall Study|Death due to unknown cause|1|||
125032324|NCT05211336|449739464|FG000|Overall Study|Worsening kidney function and quality of response|0|||
125032325|NCT05211336|449739465|FG001|Overall Study|Worsening kidney function and quality of response|1|||
125032326|NCT00332709|449739471|FG000|Overall Study|Adverse Event|11|||
125032327|NCT00332709|449739472|FG001|Overall Study|Adverse Event|14|||
125032328|NCT00332709|449739471|FG000|Overall Study|Withdrawal by Subject|2|||
125032329|NCT00332709|449739472|FG001|Overall Study|Withdrawal by Subject|3|||
125032330|NCT00332709|449739471|FG000|Overall Study|Lost to Follow-up|2|||
125032331|NCT00332709|449739472|FG001|Overall Study|Lost to Follow-up|0|||
125032332|NCT00332709|449739471|FG000|Overall Study|Administrative Problems|0|||
125032333|NCT00332709|449739472|FG001|Overall Study|Administrative Problems|3|||
125032334|NCT00332709|449739471|FG000|Overall Study|Abnormal test procedure result|1|||
125032335|NCT00332709|449739472|FG001|Overall Study|Abnormal test procedure result|0|||
125032336|NCT03575104|449739473|FG000|Overall Study|Adverse Event|4|||
125032337|NCT03575104|449739474|FG001|Overall Study|Adverse Event|3|||
125032338|NCT03575104|449739475|FG002|Overall Study|Adverse Event|4|||
125032339|NCT03575104|449739473|FG000|Overall Study|Withdrawal by Subject|13|||
125032340|NCT03575104|449739474|FG001|Overall Study|Withdrawal by Subject|16|||
125032341|NCT03575104|449739475|FG002|Overall Study|Withdrawal by Subject|11|||
125032342|NCT03575104|449739473|FG000|Overall Study|Other reasons|6|||
125032343|NCT03575104|449739474|FG001|Overall Study|Other reasons|8|||
125032344|NCT03575104|449739475|FG002|Overall Study|Other reasons|6|||
124967461|NCT04504630|449509486|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
124967462|NCT04504630|449509487|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
124967463|NCT04504630|449509486|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
124967464|NCT04504630|449509487|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
124967465|NCT04486313|449509488|FG000|Overall Study|Lost to Follow-up|7|||
124967466|NCT04486313|449509489|FG001|Overall Study|Lost to Follow-up|9|||
124967467|NCT04486313|449509488|FG000|Overall Study|Withdrawal by Subject|8|||
124967468|NCT04486313|449509489|FG001|Overall Study|Withdrawal by Subject|6|||
125130591|NCT00089661|450106315|FG001|Overall Study|Ineligibility determined|4|||
125130592|NCT00089661|450106314|FG000|Overall Study|Noncompliance|2|||
125130593|NCT00089661|450106315|FG001|Overall Study|Noncompliance|4|||
125130594|NCT00089661|450106314|FG000|Overall Study|Other|2|||
125130595|NCT00089661|450106315|FG001|Overall Study|Other|1|||
125130596|NCT01273805|450106316|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
125130597|NCT01273805|450106317|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
125130598|NCT02647944|450106318|FG000|Overall Study|Withdrawal by Subject|0|||
125130599|NCT02647944|450106319|FG001|Overall Study|Withdrawal by Subject|3|||
125130600|NCT02647944|450106318|FG000|Overall Study|Adverse Event|2|||
125130601|NCT02647944|450106319|FG001|Overall Study|Adverse Event|0|||
125130602|NCT02760368|450106321|FG000|Overall Study|Withdrawal by Subject|8|||
125130603|NCT02760368|450106322|FG001|Overall Study|Withdrawal by Subject|12|||
125130604|NCT02760368|450106323|FG002|Overall Study|Withdrawal by Subject|9|||
125130605|NCT02760368|450106321|FG000|Overall Study|Screen Failure|0|||
124967469|NCT04486313|449509488|FG000|Overall Study|Physician Decision|1|||
124967470|NCT04486313|449509489|FG001|Overall Study|Physician Decision|1|||
124967471|NCT04486313|449509488|FG000|Overall Study|Death|2|||
124967472|NCT04486313|449509489|FG001|Overall Study|Death|0|||
124967473|NCT04486313|449509488|FG000|Overall Study|Protocol Violation|1|||
124967474|NCT04486313|449509489|FG001|Overall Study|Protocol Violation|1|||
124967475|NCT01496365|449509490|FG000|Overall Study|Adverse Event|2|||
124967476|NCT01496365|449509491|FG001|Overall Study|Adverse Event|3|||
124967477|NCT01496365|449509492|FG002|Overall Study|Adverse Event|3|||
124967478|NCT01496365|449509493|FG003|Overall Study|Adverse Event|2|||
124967479|NCT01496365|449509494|FG004|Overall Study|Adverse Event|5|||
124967480|NCT01496365|449509495|FG005|Overall Study|Adverse Event|6|||
124967481|NCT01496365|449509496|FG006|Overall Study|Adverse Event|4|||
124967482|NCT01496365|449509490|FG000|Overall Study|Withdrawal by Subject|6|||
124967483|NCT01496365|449509491|FG001|Overall Study|Withdrawal by Subject|6|||
124967484|NCT01496365|449509492|FG002|Overall Study|Withdrawal by Subject|0|||
124967485|NCT01496365|449509493|FG003|Overall Study|Withdrawal by Subject|1|||
124967486|NCT01496365|449509494|FG004|Overall Study|Withdrawal by Subject|3|||
124967487|NCT01496365|449509495|FG005|Overall Study|Withdrawal by Subject|2|||
124967488|NCT01496365|449509496|FG006|Overall Study|Withdrawal by Subject|1|||
124967489|NCT01496365|449509490|FG000|Overall Study|Protocol Violation|2|||
124967490|NCT01496365|449509491|FG001|Overall Study|Protocol Violation|1|||
124967491|NCT01496365|449509492|FG002|Overall Study|Protocol Violation|1|||
124967492|NCT01496365|449509493|FG003|Overall Study|Protocol Violation|0|||
124967493|NCT01496365|449509494|FG004|Overall Study|Protocol Violation|0|||
125216498|NCT00199849|450419467|FG001|Overall Study|Unrelated illness or complication|1|||
125216499|NCT00199849|450419468|FG002|Overall Study|Unrelated illness or complication|0|||
125216500|NCT00199849|450419466|FG000|Overall Study|Progressive disease requiring intervention|0|||
125216501|NCT00199849|450419467|FG001|Overall Study|Progressive disease requiring intervention|0|||
125216502|NCT00199849|450419468|FG002|Overall Study|Progressive disease requiring intervention|1|||
125216503|NCT00199849|450419466|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
125216504|NCT00199849|450419467|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
125216505|NCT00199849|450419468|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
125216506|NCT03746405|450419476|FG000|Overall Study|Withdrawal by Subject|3|||
125216507|NCT03746405|450419477|FG001|Overall Study|Withdrawal by Subject|0|||
125216508|NCT03746405|450419476|FG000|Overall Study|technical difficulties|0|||
125216509|NCT03746405|450419477|FG001|Overall Study|technical difficulties|2|||
125216510|NCT01465230|450419479|FG000|Overall Study|Withdrawal by Subject|2|||
124967494|NCT01496365|449509495|FG005|Overall Study|Protocol Violation|1|||
124967495|NCT01496365|449509496|FG006|Overall Study|Protocol Violation|0|||
125130606|NCT02760368|450106322|FG001|Overall Study|Screen Failure|0|||
125130607|NCT02760368|450106323|FG002|Overall Study|Screen Failure|1|||
125130608|NCT02760368|450106321|FG000|Overall Study|Death|0|||
125130609|NCT02760368|450106322|FG001|Overall Study|Death|1|||
124967496|NCT01496365|449509490|FG000|Overall Study|Lack of Efficacy|1|||
124967497|NCT01496365|449509491|FG001|Overall Study|Lack of Efficacy|0|||
124967498|NCT01496365|449509492|FG002|Overall Study|Lack of Efficacy|0|||
124967499|NCT01496365|449509493|FG003|Overall Study|Lack of Efficacy|0|||
124967500|NCT01496365|449509494|FG004|Overall Study|Lack of Efficacy|0|||
124967501|NCT01496365|449509495|FG005|Overall Study|Lack of Efficacy|1|||
124967502|NCT01496365|449509496|FG006|Overall Study|Lack of Efficacy|0|||
124967503|NCT01496365|449509490|FG000|Overall Study|Lost to Follow-up|0|||
124967504|NCT01496365|449509491|FG001|Overall Study|Lost to Follow-up|1|||
125130610|NCT02760368|450106323|FG002|Overall Study|Death|0|||
124967505|NCT01496365|449509492|FG002|Overall Study|Lost to Follow-up|0|||
124967506|NCT01496365|449509493|FG003|Overall Study|Lost to Follow-up|0|||
124967507|NCT01496365|449509494|FG004|Overall Study|Lost to Follow-up|2|||
124967508|NCT01496365|449509495|FG005|Overall Study|Lost to Follow-up|0|||
124967509|NCT01496365|449509496|FG006|Overall Study|Lost to Follow-up|0|||
124967510|NCT01496365|449509490|FG000|Overall Study|Other|4|||
124967511|NCT01496365|449509491|FG001|Overall Study|Other|4|||
124967512|NCT01496365|449509492|FG002|Overall Study|Other|2|||
124967513|NCT01496365|449509493|FG003|Overall Study|Other|1|||
124967514|NCT01496365|449509494|FG004|Overall Study|Other|3|||
124967515|NCT01496365|449509495|FG005|Overall Study|Other|0|||
124967516|NCT01496365|449509496|FG006|Overall Study|Other|1|||
124967517|NCT02706951|449509498|FG000|Period 1|Adverse Event|1|||
125216511|NCT02372383|450419484|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
125216512|NCT02372383|450419485|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
125216513|NCT02372383|450419486|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
125216514|NCT01704755|450419490|FG000|Overall Study|Adverse Event|4|||
125216515|NCT01704755|450419491|FG001|Overall Study|Adverse Event|1|||
125216516|NCT01704755|450419490|FG000|Overall Study|Lost to Follow-up|3|||
125216517|NCT01704755|450419491|FG001|Overall Study|Lost to Follow-up|4|||
125216518|NCT01704755|450419490|FG000|Overall Study|Withdrew consent|1|||
125216519|NCT01704755|450419491|FG001|Overall Study|Withdrew consent|1|||
125216520|NCT01704755|450419490|FG000|Overall Study|Other (not specified)|3|||
124967518|NCT02706951|449509499|FG001|Period 1|Adverse Event|5|||
124967519|NCT02706951|449509500|FG002|Period 1|Adverse Event|3|||
124967520|NCT02706951|449509501|FG003|Period 1|Adverse Event|0|||
124967521|NCT02706951|449509502|FG004|Period 1|Adverse Event|0|||
124967522|NCT02706951|449509498|FG000|Period 1|Withdrawal by Subject|10|||
124967523|NCT02706951|449509499|FG001|Period 1|Withdrawal by Subject|6|||
124967524|NCT02706951|449509500|FG002|Period 1|Withdrawal by Subject|6|||
124967525|NCT02706951|449509501|FG003|Period 1|Withdrawal by Subject|0|||
124967526|NCT02706951|449509502|FG004|Period 1|Withdrawal by Subject|0|||
124967527|NCT02706951|449509498|FG000|Period 1|Lost to Follow-up|0|||
124967528|NCT02706951|449509499|FG001|Period 1|Lost to Follow-up|4|||
124967529|NCT02706951|449509500|FG002|Period 1|Lost to Follow-up|1|||
124967530|NCT02706951|449509501|FG003|Period 1|Lost to Follow-up|0|||
124967531|NCT02706951|449509502|FG004|Period 1|Lost to Follow-up|0|||
124967532|NCT02706951|449509498|FG000|Period 1|Other|2|||
124967533|NCT02706951|449509499|FG001|Period 1|Other|1|||
124967534|NCT02706951|449509500|FG002|Period 1|Other|0|||
124967535|NCT02706951|449509501|FG003|Period 1|Other|0|||
124967536|NCT02706951|449509502|FG004|Period 1|Other|0|||
124967537|NCT02706951|449509498|FG000|Period 2|Adverse Event|0|||
124967538|NCT02706951|449509499|FG001|Period 2|Adverse Event|0|||
124967539|NCT02706951|449509500|FG002|Period 2|Adverse Event|0|||
125216521|NCT01704755|450419491|FG001|Overall Study|Other (not specified)|1|||
125216522|NCT01704755|450419490|FG000|Overall Study|Withdrew consent and personal issues|1|||
125216523|NCT01704755|450419491|FG001|Overall Study|Withdrew consent and personal issues|0|||
125216524|NCT04105842|450419492|FG000|Overall Study|Withdrawal by Subject|2|||
124967540|NCT02706951|449509501|FG003|Period 2|Adverse Event|25|||
124967541|NCT02706951|449509502|FG004|Period 2|Adverse Event|34|||
124967542|NCT02706951|449509498|FG000|Period 2|Withdrawal by Subject|0|||
124967543|NCT02706951|449509499|FG001|Period 2|Withdrawal by Subject|0|||
125032345|NCT03575104|449739473|FG000|Overall Study|Lost to Follow-up|1|||
125032346|NCT03575104|449739474|FG001|Overall Study|Lost to Follow-up|2|||
125032347|NCT03575104|449739475|FG002|Overall Study|Lost to Follow-up|1|||
125032348|NCT01409928|449739477|FG000|Overall Study|Physician Decision|12|||
125032349|NCT00432237|449739480|FG000|Overall Study|Adverse Event|0|||
125032350|NCT00432237|449739481|FG001|Overall Study|Adverse Event|0|||
125032351|NCT00432237|449739482|FG002|Overall Study|Adverse Event|0|||
125032352|NCT00432237|449739483|FG003|Overall Study|Adverse Event|1|||
125032353|NCT00432237|449739480|FG000|Overall Study|Lack of Efficacy|0|||
125032354|NCT00432237|449739481|FG001|Overall Study|Lack of Efficacy|0|||
125032355|NCT00432237|449739482|FG002|Overall Study|Lack of Efficacy|0|||
125032356|NCT00432237|449739483|FG003|Overall Study|Lack of Efficacy|1|||
125032357|NCT00432237|449739480|FG000|Overall Study|Lost to Follow-up|10|||
125032358|NCT00432237|449739481|FG001|Overall Study|Lost to Follow-up|10|||
125032359|NCT00432237|449739482|FG002|Overall Study|Lost to Follow-up|18|||
125032360|NCT00432237|449739483|FG003|Overall Study|Lost to Follow-up|18|||
125032361|NCT00432237|449739480|FG000|Overall Study|Physician Decision|1|||
125032362|NCT00432237|449739481|FG001|Overall Study|Physician Decision|3|||
125032363|NCT00432237|449739482|FG002|Overall Study|Physician Decision|2|||
125216525|NCT02087670|450419493|FG000|Overall Study|Withdrawal by Subject|3|||
124967544|NCT02706951|449509500|FG002|Period 2|Withdrawal by Subject|0|||
124967545|NCT02706951|449509501|FG003|Period 2|Withdrawal by Subject|38|||
124967546|NCT02706951|449509502|FG004|Period 2|Withdrawal by Subject|44|||
124967547|NCT02706951|449509498|FG000|Period 2|Lost to Follow-up|0|||
124967548|NCT02706951|449509499|FG001|Period 2|Lost to Follow-up|0|||
124967549|NCT02706951|449509500|FG002|Period 2|Lost to Follow-up|0|||
124967550|NCT02706951|449509501|FG003|Period 2|Lost to Follow-up|17|||
125032364|NCT00432237|449739483|FG003|Overall Study|Physician Decision|1|||
124967551|NCT02706951|449509502|FG004|Period 2|Lost to Follow-up|9|||
124967552|NCT02706951|449509498|FG000|Period 2|COVID-19 Related|0|||
124967553|NCT02706951|449509499|FG001|Period 2|COVID-19 Related|0|||
124967554|NCT02706951|449509500|FG002|Period 2|COVID-19 Related|0|||
124967555|NCT02706951|449509501|FG003|Period 2|COVID-19 Related|1|||
124967556|NCT02706951|449509502|FG004|Period 2|COVID-19 Related|2|||
124967557|NCT02706951|449509498|FG000|Period 2|Other|0|||
124967558|NCT02706951|449509499|FG001|Period 2|Other|0|||
124967559|NCT02706951|449509500|FG002|Period 2|Other|0|||
124967560|NCT02706951|449509501|FG003|Period 2|Other|37|||
124967561|NCT02706951|449509502|FG004|Period 2|Other|31|||
124967562|NCT01843777|449509503|FG000|Overall Study|Withdrawal by Subject|1|||
124967563|NCT01843777|449509504|FG001|Overall Study|Withdrawal by Subject|0|||
124967564|NCT01777334|449509509|FG000|Overall Study|Adverse Event|18|||
124967565|NCT01777334|449509510|FG001|Overall Study|Adverse Event|14|||
124967566|NCT01777334|449509509|FG000|Overall Study|Lack of Efficacy|15|||
124967567|NCT01777334|449509510|FG001|Overall Study|Lack of Efficacy|29|||
124967568|NCT01777334|449509509|FG000|Overall Study|Protocol Violation|3|||
124967569|NCT01777334|449509510|FG001|Overall Study|Protocol Violation|7|||
124967570|NCT01777334|449509509|FG000|Overall Study|Lost to Follow-up|3|||
124967571|NCT01777334|449509510|FG001|Overall Study|Lost to Follow-up|2|||
124967572|NCT01777334|449509509|FG000|Overall Study|Withdrawal by Subject|14|||
124967573|NCT01777334|449509510|FG001|Overall Study|Withdrawal by Subject|11|||
124967574|NCT04599855|449509517|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
124967575|NCT04599855|449509518|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
124967576|NCT04599855|449509519|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
124967577|NCT04599855|449509517|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
124967578|NCT04599855|449509518|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
124967579|NCT04599855|449509519|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
124967580|NCT04599855|449509517|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
124967581|NCT04599855|449509518|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
124967582|NCT04599855|449509519|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
124967583|NCT04599855|449509517|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
124967584|NCT04599855|449509518|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
124967585|NCT04599855|449509519|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
124967586|NCT04599855|449509517|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
124967587|NCT04599855|449509518|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
124967588|NCT04599855|449509519|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
124967589|NCT04599855|449509517|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
124967590|NCT04599855|449509518|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
124967591|NCT04599855|449509519|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
124967592|NCT04599855|449509517|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
124967593|NCT04599855|449509518|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
124967594|NCT04599855|449509519|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
124967595|NCT04599855|449509517|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
124967596|NCT04599855|449509518|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
124967597|NCT04599855|449509519|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
124967598|NCT04599855|449509517|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
124967599|NCT04599855|449509518|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
124967600|NCT04599855|449509519|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
124967601|NCT04599855|449509517|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
124967602|NCT04599855|449509518|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
124967603|NCT04599855|449509519|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
124967604|NCT04599855|449509517|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
124967605|NCT04599855|449509518|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
124967606|NCT04599855|449509519|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
125130611|NCT02760368|450106321|FG000|Overall Study|Withdrawal by Sponsor|0|||
125130612|NCT02760368|450106322|FG001|Overall Study|Withdrawal by Sponsor|0|||
124967607|NCT04599855|449509517|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
124967608|NCT04599855|449509518|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
124967609|NCT04599855|449509519|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
124967610|NCT04599855|449509517|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
124967611|NCT04599855|449509518|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
125032365|NCT00432237|449739480|FG000|Overall Study|Pregnancy|0|||
125032366|NCT00432237|449739481|FG001|Overall Study|Pregnancy|1|||
125032367|NCT00432237|449739482|FG002|Overall Study|Pregnancy|0|||
125032368|NCT00432237|449739483|FG003|Overall Study|Pregnancy|0|||
125032369|NCT00432237|449739480|FG000|Overall Study|Protocol Violation|13|||
125032370|NCT00432237|449739481|FG001|Overall Study|Protocol Violation|10|||
125032371|NCT00432237|449739482|FG002|Overall Study|Protocol Violation|11|||
125032372|NCT00432237|449739483|FG003|Overall Study|Protocol Violation|8|||
125032373|NCT00432237|449739480|FG000|Overall Study|Withdrawal by Subject|5|||
125032374|NCT00432237|449739481|FG001|Overall Study|Withdrawal by Subject|6|||
124967612|NCT04599855|449509519|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
124967613|NCT04599855|449509517|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
124967614|NCT04599855|449509518|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
124967615|NCT04599855|449509519|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
124967616|NCT02165397|449509520|FG000|Overall Study|Death|7|||
124967617|NCT02165397|449509521|FG001|Overall Study|Death|10|||
124967618|NCT02165397|449509522|FG002|Overall Study|Death|8|||
124967619|NCT02165397|449509520|FG000|Overall Study|Lost to Follow-up|1|||
124967620|NCT02165397|449509521|FG001|Overall Study|Lost to Follow-up|3|||
124967621|NCT02165397|449509522|FG002|Overall Study|Lost to Follow-up|0|||
124967622|NCT02165397|449509520|FG000|Overall Study|Withdrawal by Subject|6|||
124967623|NCT02165397|449509521|FG001|Overall Study|Withdrawal by Subject|6|||
124967624|NCT02165397|449509522|FG002|Overall Study|Withdrawal by Subject|1|||
124967625|NCT02165397|449509520|FG000|Overall Study|Other, Not Specified|0|||
124967626|NCT02165397|449509521|FG001|Overall Study|Other, Not Specified|0|||
124967627|NCT02165397|449509522|FG002|Overall Study|Other, Not Specified|1|||
124967628|NCT00236184|449509525|FG000|Overall Study|Adverse Event|5|||
124967629|NCT00236184|449509526|FG001|Overall Study|Adverse Event|2|||
124967630|NCT00236184|449509525|FG000|Overall Study|Lack of Efficacy|0|||
124967631|NCT00236184|449509526|FG001|Overall Study|Lack of Efficacy|1|||
124967632|NCT00236184|449509525|FG000|Overall Study|Lost to Follow-up|3|||
124967633|NCT00236184|449509526|FG001|Overall Study|Lost to Follow-up|4|||
124967634|NCT00236184|449509525|FG000|Overall Study|Physician Decision|1|||
124967635|NCT00236184|449509526|FG001|Overall Study|Physician Decision|1|||
124967636|NCT00236184|449509525|FG000|Overall Study|Withdrawal by Subject|3|||
124967637|NCT00236184|449509526|FG001|Overall Study|Withdrawal by Subject|0|||
124967638|NCT00236184|449509525|FG000|Overall Study|Protocol Violation|3|||
124967639|NCT00236184|449509526|FG001|Overall Study|Protocol Violation|0|||
124967640|NCT00236184|449509525|FG000|Overall Study|non-compliance with study drug|2|||
124967641|NCT00236184|449509526|FG001|Overall Study|non-compliance with study drug|1|||
124967642|NCT00236184|449509525|FG000|Overall Study|other|1|||
124967643|NCT00236184|449509526|FG001|Overall Study|other|2|||
124967644|NCT02599688|449509527|FG000|Overall Study|Lack of Efficacy|1|||
124967645|NCT02599688|449509527|FG000|Overall Study|Withdrawal by Subject|1|||
124967646|NCT02599688|449509527|FG000|Overall Study|Termination by Sponsor|2|||
124967647|NCT01841697|449509528|FG000|Overall Study|Death|0|||
124967648|NCT01841697|449509529|FG001|Overall Study|Death|1|||
124967649|NCT01841697|449509528|FG000|Overall Study|Lost to Follow-up|4|||
124967650|NCT01841697|449509529|FG001|Overall Study|Lost to Follow-up|1|||
124967651|NCT01841697|449509528|FG000|Overall Study|Withdrawal by Subject|16|||
124967652|NCT01841697|449509529|FG001|Overall Study|Withdrawal by Subject|16|||
124967653|NCT00756457|449509530|FG000|Overall Study|Lost to Follow-up|1|||
124967654|NCT00756457|449509531|FG001|Overall Study|Lost to Follow-up|2|||
124967655|NCT01777490|449509535|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
124967656|NCT01777490|449509536|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
124967657|NCT01777490|449509537|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
124967658|NCT01777490|449509538|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
124967659|NCT00822770|449509543|FG000|Overall Study|Not treated|1|||
124967660|NCT00822770|449509544|FG001|Overall Study|Not treated|0|||
124967661|NCT00822770|449509543|FG000|Overall Study|Complication/Incomplete treatment|1|||
124967662|NCT00822770|449509544|FG001|Overall Study|Complication/Incomplete treatment|0|||
124967663|NCT00822770|449509543|FG000|Overall Study|Death|1|||
124967664|NCT00822770|449509544|FG001|Overall Study|Death|1|||
125130613|NCT02760368|450106323|FG002|Overall Study|Withdrawal by Sponsor|1|||
125130614|NCT03375463|450106324|FG000|Period 1|Lost to Follow-up|0|||
125130615|NCT03375463|450106325|FG001|Period 1|Lost to Follow-up|0|||
125130616|NCT03375463|450106326|FG002|Period 1|Lost to Follow-up|1|||
125130617|NCT03375463|450106327|FG003|Period 1|Lost to Follow-up|0|||
125130618|NCT03375463|450106328|FG004|Period 1|Lost to Follow-up|0|||
125130619|NCT03375463|450106329|FG005|Period 1|Lost to Follow-up|0|||
125130620|NCT03375463|450106324|FG000|Period 1|Adverse Event|0|||
124967665|NCT02818998|449509545|FG000|Overall Study|Adverse Event|3|||
124967666|NCT02818998|449509546|FG001|Overall Study|Adverse Event|2|||
124967667|NCT02818998|449509547|FG002|Overall Study|Adverse Event|1|||
125130621|NCT03375463|450106325|FG001|Period 1|Adverse Event|0|||
125130622|NCT03375463|450106326|FG002|Period 1|Adverse Event|0|||
124967668|NCT02818998|449509545|FG000|Overall Study|Lost to Follow-up|4|||
124967669|NCT02818998|449509546|FG001|Overall Study|Lost to Follow-up|1|||
124967670|NCT02818998|449509547|FG002|Overall Study|Lost to Follow-up|2|||
124967671|NCT02818998|449509545|FG000|Overall Study|Withdrawal by sponsor|0|||
124967672|NCT02818998|449509546|FG001|Overall Study|Withdrawal by sponsor|1|||
124967673|NCT02818998|449509547|FG002|Overall Study|Withdrawal by sponsor|1|||
124967674|NCT02818998|449509545|FG000|Overall Study|Death|3|||
124967675|NCT02818998|449509546|FG001|Overall Study|Death|6|||
125130623|NCT03375463|450106327|FG003|Period 1|Adverse Event|0|||
124967676|NCT02818998|449509547|FG002|Overall Study|Death|8|||
124967677|NCT02818998|449509545|FG000|Overall Study|Withdrawal by Subject|7|||
124967678|NCT02818998|449509546|FG001|Overall Study|Withdrawal by Subject|6|||
124967679|NCT02818998|449509547|FG002|Overall Study|Withdrawal by Subject|6|||
124967680|NCT02818998|449509545|FG000|Overall Study|Physician Decision|1|||
124967681|NCT02818998|449509546|FG001|Overall Study|Physician Decision|0|||
124967682|NCT02818998|449509547|FG002|Overall Study|Physician Decision|0|||
124967683|NCT00632021|449509551|FG000|Overall Study|Withdrawal/death|4|||
124967684|NCT00632021|449509552|FG001|Overall Study|Withdrawal/death|7|||
124967685|NCT00458393|449509553|FG000|Overall Study|Withdrawal by Subject|67|||
124967686|NCT00458393|449509554|FG001|Overall Study|Withdrawal by Subject|80|||
124967687|NCT00458393|449509553|FG000|Overall Study|Physician Decision|31|||
124967688|NCT00458393|449509554|FG001|Overall Study|Physician Decision|22|||
124967689|NCT00458393|449509553|FG000|Overall Study|Relocated|77|||
124967690|NCT00458393|449509554|FG001|Overall Study|Relocated|81|||
124967691|NCT00458393|449509553|FG000|Overall Study|Lost to Follow-up|115|||
124967692|NCT00458393|449509554|FG001|Overall Study|Lost to Follow-up|92|||
124967693|NCT00458393|449509553|FG000|Overall Study|Sites marked other on the form.|19|||
124967694|NCT00458393|449509554|FG001|Overall Study|Sites marked other on the form.|20|||
124967695|NCT01101061|449509557|FG000|Overall Study|Adverse Event|0|||
124967696|NCT01101061|449509558|FG001|Overall Study|Adverse Event|0|||
124967697|NCT01101061|449509559|FG002|Overall Study|Adverse Event|1|||
124967698|NCT01101061|449509560|FG003|Overall Study|Adverse Event|0|||
124967699|NCT01101061|449509561|FG004|Overall Study|Adverse Event|0|||
124967700|NCT01101061|449509562|FG005|Overall Study|Adverse Event|0|||
124967701|NCT00857233|449509563|FG000|Overall Study|Adverse Event|24|||
124967702|NCT00857233|449509563|FG000|Overall Study|Lack of Efficacy|1|||
124967703|NCT00857233|449509563|FG000|Overall Study|Non-compliance|1|||
124967704|NCT00857233|449509563|FG000|Overall Study|Withdrawal of Consent|9|||
124967705|NCT00857233|449509563|FG000|Overall Study|Lost to Follow-up|4|||
124967706|NCT00857233|449509563|FG000|Overall Study|Nursing Home Placement|14|||
124967707|NCT00857233|449509563|FG000|Overall Study|Other Reasons|2|||
124967708|NCT05043883|449509564|FG000|Overall Study|Minimum required measurements could not be taken|4|||
124967709|NCT01587118|449509565|FG000|Overall Study|Adverse Event|3|||
124967710|NCT01587118|449509565|FG000|Overall Study|Lost to Follow-up|2|||
124967711|NCT01587118|449509565|FG000|Overall Study|Relocation|1|||
124967712|NCT01587118|449509565|FG000|Overall Study|nonresponse|1|||
124967713|NCT00263575|449509566|FG000|Titration Period|Adverse Event|14|||
124967714|NCT00263575|449509566|FG000|Titration Period|Withdrawal by Subject|10|||
124967715|NCT00263575|449509566|FG000|Titration Period|Protocol Violation|9|||
124967716|NCT00263575|449509566|FG000|Titration Period|Sponsor Decision|2|||
124967717|NCT00263575|449509566|FG000|Titration Period|Other|2|||
124967718|NCT00263575|449509566|FG000|Titration Period|Lack of Efficacy|6|||
124967719|NCT00263575|449509566|FG000|Maintence Period|Adverse Event|23|||
124967720|NCT00263575|449509566|FG000|Maintence Period|Withdrawal by Subject|8|||
124967721|NCT00263575|449509566|FG000|Maintence Period|Protocol Violation|4|||
124967722|NCT00263575|449509566|FG000|Maintence Period|Lack of Efficacy|4|||
124967723|NCT00263575|449509566|FG000|Maintence Period|Physician Decision|6|||
124967724|NCT00263575|449509566|FG000|Maintence Period|Lost to Follow-up|1|||
124967725|NCT00263575|449509566|FG000|Maintence Period|Sponsor Decision|24|||
124967726|NCT00263575|449509566|FG000|Maintence Period|Other|7|||
124967727|NCT01728623|449509570|FG000|Overall Study|Disease progression|26|||
124967728|NCT01728623|449509570|FG000|Overall Study|Adverse Event|1|||
124967729|NCT01728623|449509570|FG000|Overall Study|Withdrawal by Subject|1|||
124967730|NCT00243022|449509571|FG000|Overall Study|Withdrawal by Subject|1|||
124967731|NCT00243022|449509572|FG001|Overall Study|Withdrawal by Subject|0|||
124967732|NCT00243022|449509571|FG000|Overall Study|Death|1|||
124967733|NCT00243022|449509572|FG001|Overall Study|Death|0|||
124967734|NCT00243022|449509571|FG000|Overall Study|Difficult Travel Distance|0|||
124967735|NCT00243022|449509572|FG001|Overall Study|Difficult Travel Distance|1|||
124967736|NCT01390441|449509573|FG000|Treatment Period|Protocol Violation|0|||
124967737|NCT01390441|449509574|FG001|Treatment Period|Protocol Violation|1|||
124967738|NCT01390441|449509575|FG002|Treatment Period|Protocol Violation|0|||
124967739|NCT01390441|449509576|FG003|Treatment Period|Protocol Violation|0|||
124967740|NCT01390441|449509577|FG004|Treatment Period|Protocol Violation|0|||
124967741|NCT01390441|449509573|FG000|Treatment Period|Physician Decision|0|||
124967742|NCT01390441|449509574|FG001|Treatment Period|Physician Decision|0|||
124967743|NCT01390441|449509575|FG002|Treatment Period|Physician Decision|0|||
124967744|NCT01390441|449509576|FG003|Treatment Period|Physician Decision|1|||
124967745|NCT01390441|449509577|FG004|Treatment Period|Physician Decision|0|||
124967746|NCT01390441|449509573|FG000|Treatment Period|Lack of Efficacy|0|||
124967747|NCT01390441|449509574|FG001|Treatment Period|Lack of Efficacy|0|||
124967748|NCT01390441|449509575|FG002|Treatment Period|Lack of Efficacy|0|||
124967749|NCT01390441|449509576|FG003|Treatment Period|Lack of Efficacy|0|||
124967750|NCT01390441|449509577|FG004|Treatment Period|Lack of Efficacy|1|||
124967751|NCT01390441|449509573|FG000|Treatment Period|Unknown due to early stopping of study|0|||
124967752|NCT01390441|449509574|FG001|Treatment Period|Unknown due to early stopping of study|0|||
124967753|NCT01390441|449509575|FG002|Treatment Period|Unknown due to early stopping of study|8|||
125216526|NCT02087670|450419494|FG001|Overall Study|Withdrawal by Subject|2|||
125216527|NCT01639703|450419495|FG000|Overall Study|Withdrawal by Subject|5|||
125216528|NCT01639703|450419495|FG000|Overall Study|Other reason|7|||
125216529|NCT01042392|450419496|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
125216530|NCT01042392|450419497|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
125216531|NCT01042392|450419498|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
125216532|NCT01042392|450419499|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
125216533|NCT01042392|450419496|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
125216534|NCT01042392|450419497|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
125216535|NCT01042392|450419498|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
125216536|NCT01042392|450419499|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
125216537|NCT01042392|450419496|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
125216538|NCT01042392|450419497|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
125216539|NCT01042392|450419498|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
125216540|NCT01042392|450419499|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
125216541|NCT01042392|450419496|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
125216542|NCT01042392|450419497|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
125216543|NCT01042392|450419498|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
125216544|NCT01042392|450419499|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
125216545|NCT01042392|450419496|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
125216546|NCT01042392|450419497|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
125216547|NCT01042392|450419498|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
125216548|NCT01042392|450419499|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
125216549|NCT01042392|450419496|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
125216550|NCT01042392|450419497|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
125216551|NCT01042392|450419498|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
125216552|NCT01042392|450419499|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
125216553|NCT01042392|450419496|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
125216554|NCT01042392|450419497|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
125216555|NCT01042392|450419498|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
125216556|NCT01042392|450419499|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
125216557|NCT01042392|450419496|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
125216558|NCT01042392|450419497|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
125216559|NCT01042392|450419498|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
125216560|NCT01042392|450419499|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
125216561|NCT01042392|450419496|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
125216562|NCT01042392|450419497|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
125216563|NCT01042392|450419498|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
125216564|NCT01042392|450419499|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
125216565|NCT02869893|450419502|FG000|Overall Study|participant aversion to IV|5|||
125216566|NCT02869893|450419502|FG000|Overall Study|participant fear of MRI scanner|2|||
125216567|NCT02588092|450419515|FG000|Overall Study|Death|4|||
124967754|NCT01390441|449509576|FG003|Treatment Period|Unknown due to early stopping of study|11|||
124967755|NCT01390441|449509577|FG004|Treatment Period|Unknown due to early stopping of study|7|||
124967756|NCT01390441|449509573|FG000|Treatment Period|Adverse Event|0|||
124967757|NCT01390441|449509574|FG001|Treatment Period|Adverse Event|0|||
124967758|NCT01390441|449509575|FG002|Treatment Period|Adverse Event|1|||
124967759|NCT01390441|449509576|FG003|Treatment Period|Adverse Event|1|||
124967760|NCT01390441|449509577|FG004|Treatment Period|Adverse Event|2|||
124967761|NCT01390441|449509573|FG000|Treatment Period|Withdrawal by Subject|0|||
124967762|NCT01390441|449509574|FG001|Treatment Period|Withdrawal by Subject|0|||
124967763|NCT01390441|449509575|FG002|Treatment Period|Withdrawal by Subject|1|||
124967764|NCT01390441|449509576|FG003|Treatment Period|Withdrawal by Subject|0|||
124967765|NCT01390441|449509577|FG004|Treatment Period|Withdrawal by Subject|1|||
125216568|NCT02588092|450419516|FG001|Overall Study|Death|3|||
124967766|NCT01390441|449509573|FG000|Treatment Period|Lost to Follow-up|1|||
125216569|NCT02588092|450419517|FG002|Overall Study|Death|3|||
125216570|NCT02588092|450419518|FG003|Overall Study|Death|3|||
125216571|NCT02588092|450419519|FG004|Overall Study|Death|2|||
125216572|NCT02588092|450419520|FG005|Overall Study|Death|2|||
125216573|NCT02588092|450419521|FG006|Overall Study|Death|2|||
125216574|NCT02588092|450419522|FG007|Overall Study|Death|1|||
125216575|NCT02588092|450419523|FG008|Overall Study|Death|5|||
125216576|NCT02588092|450419524|FG009|Overall Study|Death|2|||
124967767|NCT01390441|449509574|FG001|Treatment Period|Lost to Follow-up|0|||
124967768|NCT01390441|449509575|FG002|Treatment Period|Lost to Follow-up|0|||
124967769|NCT01390441|449509576|FG003|Treatment Period|Lost to Follow-up|0|||
124967770|NCT01390441|449509577|FG004|Treatment Period|Lost to Follow-up|0|||
124967771|NCT01390441|449509573|FG000|Extension Period|Protocol Violation|3|||
124967772|NCT01390441|449509574|FG001|Extension Period|Protocol Violation|1|||
124967773|NCT01390441|449509575|FG002|Extension Period|Protocol Violation|0|||
124967774|NCT01390441|449509576|FG003|Extension Period|Protocol Violation|1|||
124967775|NCT01390441|449509577|FG004|Extension Period|Protocol Violation|0|||
124967776|NCT03517111|449509578|FG000|Enrolled|Withdrawal by Subject|0|||
124967777|NCT03517111|449509579|FG001|Enrolled|Withdrawal by Subject|1|||
124967778|NCT03517111|449509580|FG002|Enrolled|Withdrawal by Subject|0|||
124967779|NCT03517111|449509578|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
124967780|NCT03517111|449509579|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
124967781|NCT03517111|449509580|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
124967782|NCT03517111|449509578|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
124967783|NCT03517111|449509579|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
124967784|NCT03517111|449509580|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
124967785|NCT03517111|449509578|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
124967786|NCT03517111|449509579|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
124967787|NCT03517111|449509580|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
125032375|NCT00432237|449739482|FG002|Overall Study|Withdrawal by Subject|9|||
125032376|NCT00432237|449739483|FG003|Overall Study|Withdrawal by Subject|11|||
125032377|NCT00432237|449739480|FG000|Overall Study|Lack of Qualifying Event|38|||
125032378|NCT00432237|449739481|FG001|Overall Study|Lack of Qualifying Event|71|||
125032379|NCT00432237|449739482|FG002|Overall Study|Lack of Qualifying Event|69|||
124967788|NCT03517111|449509578|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
124967789|NCT03517111|449509579|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
124967790|NCT03517111|449509580|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
125032380|NCT00432237|449739483|FG003|Overall Study|Lack of Qualifying Event|84|||
125032381|NCT00603239|449739484|FG000|Overall Study|Adverse Event|4|||
125032382|NCT00603239|449739485|FG001|Overall Study|Adverse Event|1|||
125032383|NCT00603239|449739484|FG000|Overall Study|Entry criteria not met|0|||
125032384|NCT00603239|449739485|FG001|Overall Study|Entry criteria not met|1|||
125032385|NCT00603239|449739484|FG000|Overall Study|Loss of glucose control|3|||
125032386|NCT00603239|449739485|FG001|Overall Study|Loss of glucose control|0|||
125032387|NCT00603239|449739484|FG000|Overall Study|Lost to Follow-up|2|||
125032388|NCT00603239|449739485|FG001|Overall Study|Lost to Follow-up|1|||
125032389|NCT00603239|449739484|FG000|Overall Study|Physician Decision|2|||
125032390|NCT00603239|449739485|FG001|Overall Study|Physician Decision|0|||
125032391|NCT00603239|449739484|FG000|Overall Study|Protocol Violation|2|||
125032392|NCT00603239|449739485|FG001|Overall Study|Protocol Violation|0|||
125032393|NCT00603239|449739484|FG000|Overall Study|Subject decision|2|||
125032394|NCT00603239|449739485|FG001|Overall Study|Subject decision|1|||
125032395|NCT01354132|449739486|FG000|Randomization|Physician Decision|1|||
125032396|NCT01354132|449739487|FG001|Randomization|Physician Decision|0|||
125032397|NCT01354132|449739486|FG000|Randomization|Withdrawal by Subject|0|||
125032398|NCT01354132|449739487|FG001|Randomization|Withdrawal by Subject|1|||
125032399|NCT01354132|449739486|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
125032400|NCT01354132|449739487|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
125032401|NCT01354132|449739486|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
125032402|NCT01354132|449739487|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
125032403|NCT01354132|449739486|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
125032404|NCT01354132|449739487|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
125032405|NCT00191854|449739488|FG000|Overall Study|Death|26|||
125032406|NCT00191854|449739489|FG001|Overall Study|Death|23|||
124967791|NCT01781832|449509583|FG000|Overall Study|Withdrawal by Subject|1|||
124967792|NCT01163474|449509584|FG000|Overall Study|Withdrawal by Subject|1|||
125130624|NCT03375463|450106328|FG004|Period 1|Adverse Event|1|||
125130625|NCT03375463|450106329|FG005|Period 1|Adverse Event|0|||
124967793|NCT01163474|449509584|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
124967794|NCT01163474|449509584|FG000|Overall Study|Lost to Follow-up|3|||
124967795|NCT03432390|449509587|FG000|Apnea Period|Protocol Violation|2|||
124967796|NCT03432390|449509588|FG001|Apnea Period|Protocol Violation|2|||
124967797|NCT00798304|449509591|FG000|Overall Study|Adverse Event|0|||
124967798|NCT00798304|449509592|FG001|Overall Study|Adverse Event|1|||
124967799|NCT00798304|449509593|FG002|Overall Study|Adverse Event|1|||
124967800|NCT00798304|449509591|FG000|Overall Study|Discontinuation by Sponsor|14|||
124967801|NCT00798304|449509592|FG001|Overall Study|Discontinuation by Sponsor|21|||
124967802|NCT00798304|449509593|FG002|Overall Study|Discontinuation by Sponsor|9|||
124967803|NCT02689453|449509604|FG000|Overall Study|Progressive disease|0|||
124967804|NCT02689453|449509605|FG001|Overall Study|Progressive disease|1|||
124967805|NCT02689453|449509606|FG002|Overall Study|Progressive disease|1|||
124967806|NCT04206085|449509607|FG000|Overall Study|Lost to Follow-up|0|||
124967807|NCT04206085|449509608|FG001|Overall Study|Lost to Follow-up|1|||
124967808|NCT04206085|449509609|FG002|Overall Study|Lost to Follow-up|0|||
124967809|NCT04206085|449509607|FG000|Overall Study|Lost to Follow-up|0|||
124967810|NCT04206085|449509608|FG001|Overall Study|Lost to Follow-up|0|||
124967811|NCT04206085|449509609|FG002|Overall Study|Lost to Follow-up|1|||
124967812|NCT00763451|449509610|FG000|Overall Study|Adverse Event|4|||
125130626|NCT03375463|450106324|FG000|Period 2|Lost to Follow-up|1|||
125130627|NCT03375463|450106325|FG001|Period 2|Lost to Follow-up|1|||
125130628|NCT03375463|450106326|FG002|Period 2|Lost to Follow-up|0|||
125130629|NCT03375463|450106327|FG003|Period 2|Lost to Follow-up|0|||
125130630|NCT03375463|450106328|FG004|Period 2|Lost to Follow-up|0|||
125130631|NCT03375463|450106329|FG005|Period 2|Lost to Follow-up|0|||
125130632|NCT01602419|450106330|FG000|Overall Study|Not treated with Wilate|9|||
124967813|NCT00763451|449509611|FG001|Overall Study|Adverse Event|6|||
124967814|NCT00763451|449509612|FG002|Overall Study|Adverse Event|19|||
124967815|NCT00763451|449509613|FG003|Overall Study|Adverse Event|14|||
124967816|NCT00763451|449509610|FG000|Overall Study|Lack of Efficacy|1|||
124967817|NCT00763451|449509611|FG001|Overall Study|Lack of Efficacy|4|||
124967818|NCT00763451|449509612|FG002|Overall Study|Lack of Efficacy|3|||
124967819|NCT00763451|449509613|FG003|Overall Study|Lack of Efficacy|2|||
124967820|NCT00763451|449509610|FG000|Overall Study|Withdrawal by Subject|1|||
124967821|NCT00763451|449509611|FG001|Overall Study|Withdrawal by Subject|6|||
125130633|NCT01602419|450106330|FG000|Overall Study|Adverse Drug Reaction|4|||
125130634|NCT01602419|450106330|FG000|Overall Study|Insurance issues|3|||
124967822|NCT00763451|449509612|FG002|Overall Study|Withdrawal by Subject|9|||
124967823|NCT00763451|449509613|FG003|Overall Study|Withdrawal by Subject|7|||
124967824|NCT00763451|449509610|FG000|Overall Study|Protocol Violation|0|||
124967825|NCT00763451|449509611|FG001|Overall Study|Protocol Violation|0|||
125130635|NCT01602419|450106330|FG000|Overall Study|Changed treatment centre|1|||
125130636|NCT01602419|450106330|FG000|Overall Study|Treatment centre closed|1|||
125130637|NCT01602419|450106330|FG000|Overall Study|Withdrawal by Subject|5|||
124967826|NCT00763451|449509612|FG002|Overall Study|Protocol Violation|1|||
124967827|NCT00763451|449509613|FG003|Overall Study|Protocol Violation|0|||
124967828|NCT00763451|449509610|FG000|Overall Study|Poor Compliance to Protocol|1|||
125130638|NCT01602419|450106330|FG000|Overall Study|Lost to Follow-up|6|||
125130639|NCT01792635|450106331|FG000|Part B|Adverse Event|0|||
124967829|NCT00763451|449509611|FG001|Overall Study|Poor Compliance to Protocol|1|||
125130640|NCT01792635|450106332|FG001|Part B|Adverse Event|0|||
125216577|NCT02588092|450419515|FG000|Overall Study|Withdrawal by Subject|0|||
125216578|NCT02588092|450419516|FG001|Overall Study|Withdrawal by Subject|0|||
125216579|NCT02588092|450419517|FG002|Overall Study|Withdrawal by Subject|0|||
125216580|NCT02588092|450419518|FG003|Overall Study|Withdrawal by Subject|0|||
125216581|NCT02588092|450419519|FG004|Overall Study|Withdrawal by Subject|0|||
124967830|NCT00763451|449509612|FG002|Overall Study|Poor Compliance to Protocol|2|||
124967831|NCT00763451|449509613|FG003|Overall Study|Poor Compliance to Protocol|2|||
124967832|NCT00763451|449509610|FG000|Overall Study|Familial and Personal Reasons|5|||
124967833|NCT00763451|449509611|FG001|Overall Study|Familial and Personal Reasons|3|||
124967834|NCT00763451|449509612|FG002|Overall Study|Familial and Personal Reasons|5|||
124967835|NCT00763451|449509613|FG003|Overall Study|Familial and Personal Reasons|4|||
124967836|NCT00763451|449509610|FG000|Overall Study|Randomized but not Treated|1|||
124967837|NCT00763451|449509611|FG001|Overall Study|Randomized but not Treated|1|||
125216582|NCT02588092|450419520|FG005|Overall Study|Withdrawal by Subject|1|||
125216583|NCT02588092|450419521|FG006|Overall Study|Withdrawal by Subject|1|||
125216584|NCT02588092|450419522|FG007|Overall Study|Withdrawal by Subject|2|||
125216585|NCT02588092|450419523|FG008|Overall Study|Withdrawal by Subject|0|||
125216586|NCT02588092|450419524|FG009|Overall Study|Withdrawal by Subject|0|||
125216587|NCT02588092|450419515|FG000|Overall Study|Started Another Treatment|0|||
125216588|NCT02588092|450419516|FG001|Overall Study|Started Another Treatment|0|||
125216589|NCT02588092|450419517|FG002|Overall Study|Started Another Treatment|0|||
125216590|NCT02588092|450419518|FG003|Overall Study|Started Another Treatment|0|||
125216591|NCT02588092|450419519|FG004|Overall Study|Started Another Treatment|1|||
125216592|NCT02588092|450419520|FG005|Overall Study|Started Another Treatment|0|||
125216593|NCT02588092|450419521|FG006|Overall Study|Started Another Treatment|0|||
125216594|NCT02588092|450419522|FG007|Overall Study|Started Another Treatment|1|||
125216595|NCT02588092|450419523|FG008|Overall Study|Started Another Treatment|0|||
125216596|NCT02588092|450419524|FG009|Overall Study|Started Another Treatment|0|||
125216597|NCT02588092|450419515|FG000|Overall Study|Sponsor Decision|0|||
125216598|NCT02588092|450419516|FG001|Overall Study|Sponsor Decision|0|||
125216599|NCT02588092|450419517|FG002|Overall Study|Sponsor Decision|0|||
125216600|NCT02588092|450419518|FG003|Overall Study|Sponsor Decision|0|||
125216601|NCT02588092|450419519|FG004|Overall Study|Sponsor Decision|0|||
124967838|NCT00763451|449509612|FG002|Overall Study|Randomized but not Treated|0|||
124967839|NCT00763451|449509613|FG003|Overall Study|Randomized but not Treated|0|||
125216602|NCT02588092|450419520|FG005|Overall Study|Sponsor Decision|0|||
125216603|NCT02588092|450419521|FG006|Overall Study|Sponsor Decision|0|||
125216604|NCT02588092|450419522|FG007|Overall Study|Sponsor Decision|0|||
125216605|NCT02588092|450419523|FG008|Overall Study|Sponsor Decision|1|||
125216606|NCT02588092|450419524|FG009|Overall Study|Sponsor Decision|1|||
125216607|NCT01030718|450419527|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
125216608|NCT01030718|450419528|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
125216609|NCT01030718|450419529|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
125216610|NCT01030718|450419527|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
125216611|NCT01030718|450419528|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
125216612|NCT01030718|450419529|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
125216613|NCT01030718|450419527|FG000|Studies CA180-031 and -036 Combined|Death|0|||
125216614|NCT01030718|450419528|FG001|Studies CA180-031 and -036 Combined|Death|1|||
125216615|NCT01030718|450419529|FG002|Studies CA180-031 and -036 Combined|Death|0|||
125216616|NCT01030718|450419527|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
125216617|NCT01030718|450419528|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
125216618|NCT01030718|450419529|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
125216619|NCT01030718|450419527|FG000|Study CA180-036 Only|insufficient effect|1|||
125216620|NCT01030718|450419528|FG001|Study CA180-036 Only|insufficient effect|1|||
125216621|NCT01030718|450419529|FG002|Study CA180-036 Only|insufficient effect|5|||
125216622|NCT01030718|450419527|FG000|Study CA180-036 Only|Adverse Event|2|||
125216623|NCT01030718|450419528|FG001|Study CA180-036 Only|Adverse Event|3|||
125216624|NCT01030718|450419529|FG002|Study CA180-036 Only|Adverse Event|0|||
125216625|NCT01030718|450419527|FG000|Study CA180-036 Only|Death|0|||
124967840|NCT00763451|449509610|FG000|Overall Study|Study Site Reason|0|||
124967841|NCT00763451|449509611|FG001|Overall Study|Study Site Reason|1|||
124967842|NCT00763451|449509612|FG002|Overall Study|Study Site Reason|1|||
125216626|NCT01030718|450419528|FG001|Study CA180-036 Only|Death|1|||
124967843|NCT00763451|449509613|FG003|Overall Study|Study Site Reason|1|||
124967844|NCT00725543|449509617|FG000|Overall Study|Adverse Event|10|||
124967845|NCT00725543|449509617|FG000|Overall Study|Lack of Efficacy|3|||
124967846|NCT00725543|449509617|FG000|Overall Study|Withdrawal by Subject|10|||
124967847|NCT00725543|449509617|FG000|Overall Study|Physician Decision|5|||
124967848|NCT00725543|449509617|FG000|Overall Study|Lost to Follow-up|4|||
124967849|NCT00725543|449509617|FG000|Overall Study|Non-compliance|2|||
124967850|NCT00725543|449509617|FG000|Overall Study|Other|119|||
124967851|NCT05594589|449509618|FG000|Overall Study|Other|0|||
125216627|NCT01030718|450419529|FG002|Study CA180-036 Only|Death|0|||
125216628|NCT01030718|450419527|FG000|Study CA180-036 Only|Other Reasons|0|||
125216629|NCT01030718|450419528|FG001|Study CA180-036 Only|Other Reasons|2|||
125216630|NCT01030718|450419529|FG002|Study CA180-036 Only|Other Reasons|0|||
125216631|NCT00423813|450419530|FG000|Overall Study|Adverse Event|11|||
125216632|NCT00423813|450419531|FG001|Overall Study|Adverse Event|30|||
125216633|NCT00423813|450419532|FG002|Overall Study|Adverse Event|40|||
125216634|NCT00423813|450419530|FG000|Overall Study|Withdrawal by Subject|6|||
125216635|NCT00423813|450419531|FG001|Overall Study|Withdrawal by Subject|8|||
125216636|NCT00423813|450419532|FG002|Overall Study|Withdrawal by Subject|5|||
125216637|NCT00423813|450419530|FG000|Overall Study|Lost to Follow-up|5|||
125216638|NCT00423813|450419531|FG001|Overall Study|Lost to Follow-up|4|||
125216639|NCT00423813|450419532|FG002|Overall Study|Lost to Follow-up|4|||
125216640|NCT00423813|450419530|FG000|Overall Study|Lack of Efficacy|23|||
125216641|NCT00423813|450419531|FG001|Overall Study|Lack of Efficacy|18|||
125216642|NCT00423813|450419532|FG002|Overall Study|Lack of Efficacy|19|||
125216643|NCT00423813|450419530|FG000|Overall Study|Physician Decision|2|||
125216644|NCT00423813|450419531|FG001|Overall Study|Physician Decision|0|||
125216645|NCT00423813|450419532|FG002|Overall Study|Physician Decision|0|||
125216646|NCT00423813|450419530|FG000|Overall Study|Sponsor Decision|0|||
125216647|NCT00423813|450419531|FG001|Overall Study|Sponsor Decision|1|||
125216648|NCT00423813|450419532|FG002|Overall Study|Sponsor Decision|0|||
125216649|NCT00423813|450419530|FG000|Overall Study|Protocol Violation|9|||
125216650|NCT00423813|450419531|FG001|Overall Study|Protocol Violation|4|||
125216651|NCT00423813|450419532|FG002|Overall Study|Protocol Violation|4|||
124967852|NCT05594589|449509619|FG001|Overall Study|Other|1|||
124967853|NCT05594589|449509620|FG002|Overall Study|Other|0|||
124967854|NCT02168478|449509627|FG000|Overall Study|Withdrawal by Subject|1|||
124967855|NCT02168478|449509627|FG000|Overall Study|Did Not Consent to Participation|2|||
124967856|NCT02168478|449509627|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
124967857|NCT03845023|449509632|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
124967858|NCT03845023|449509633|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
124967859|NCT03845023|449509634|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
124967860|NCT03845023|449509635|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
125216652|NCT00423813|450419530|FG000|Overall Study|Pregnancy|0|||
125216653|NCT00423813|450419531|FG001|Overall Study|Pregnancy|0|||
125216654|NCT00423813|450419532|FG002|Overall Study|Pregnancy|1|||
125216655|NCT00423813|450419530|FG000|Overall Study|Subject started night shift work|1|||
125216656|NCT00423813|450419531|FG001|Overall Study|Subject started night shift work|0|||
125216657|NCT00423813|450419532|FG002|Overall Study|Subject started night shift work|0|||
125216658|NCT00423813|450419530|FG000|Overall Study|Will start exclusionary medications|0|||
125216659|NCT00423813|450419531|FG001|Overall Study|Will start exclusionary medications|1|||
125216660|NCT00423813|450419532|FG002|Overall Study|Will start exclusionary medications|0|||
125216661|NCT00423813|450419530|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
125216662|NCT00423813|450419531|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
125216663|NCT00423813|450419532|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
125216664|NCT01386944|450419533|FG000|Overall Study|Adverse Event|26|||
125216665|NCT01386944|450419533|FG000|Overall Study|Lack of Efficacy|14|||
124967861|NCT03845023|449509632|FG000|Follow-Up (14 Days)|Adverse Event|0|||
124967862|NCT03845023|449509633|FG001|Follow-Up (14 Days)|Adverse Event|0|||
124967863|NCT03845023|449509634|FG002|Follow-Up (14 Days)|Adverse Event|1|||
124967864|NCT03845023|449509635|FG003|Follow-Up (14 Days)|Adverse Event|1|||
125216666|NCT01386944|450419533|FG000|Overall Study|Lost to Follow-up|8|||
125216667|NCT01386944|450419533|FG000|Overall Study|Unspecified reason|8|||
125216668|NCT03883477|450419534|FG000|Overall Study|Death|1|||
125216669|NCT03883477|450419535|FG001|Overall Study|Death|0|||
125216670|NCT03883477|450419534|FG000|Overall Study|Protocol Violation|0|||
125216671|NCT03883477|450419535|FG001|Overall Study|Protocol Violation|1|||
125216672|NCT03853291|450419536|FG000|Overall Study|Lost to Follow-up|1|||
125216673|NCT03853291|450419537|FG001|Overall Study|Lost to Follow-up|2|||
125216674|NCT03853291|450419538|FG002|Overall Study|Lost to Follow-up|0|||
124967865|NCT02554383|449509639|FG000|Overall Study|Ineligible|3|||
124967866|NCT02554383|449509640|FG001|Overall Study|Ineligible|2|||
124967867|NCT02554383|449509639|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
124967868|NCT02554383|449509640|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
124967869|NCT02554383|449509639|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
124967870|NCT02554383|449509640|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
124967871|NCT02554383|449509639|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
125216675|NCT03853291|450419539|FG003|Overall Study|Lost to Follow-up|0|||
125216676|NCT03853291|450419540|FG004|Overall Study|Lost to Follow-up|0|||
125032407|NCT00191854|449739490|FG002|Overall Study|Death|29|||
125032408|NCT00191854|449739488|FG000|Overall Study|Lost to Follow-up|7|||
125032409|NCT00191854|449739489|FG001|Overall Study|Lost to Follow-up|5|||
125032410|NCT00191854|449739490|FG002|Overall Study|Lost to Follow-up|5|||
125032411|NCT00191854|449739488|FG000|Overall Study|Withdrawal by Subject|4|||
125032412|NCT00191854|449739489|FG001|Overall Study|Withdrawal by Subject|2|||
125032413|NCT00191854|449739490|FG002|Overall Study|Withdrawal by Subject|3|||
125032414|NCT00191854|449739488|FG000|Overall Study|Sponsor Decision|0|||
125032415|NCT00191854|449739489|FG001|Overall Study|Sponsor Decision|0|||
125032416|NCT00191854|449739490|FG002|Overall Study|Sponsor Decision|1|||
125032417|NCT00191854|449739488|FG000|Overall Study|Screen Failure|0|||
125032418|NCT00191854|449739489|FG001|Overall Study|Screen Failure|0|||
125032419|NCT00191854|449739490|FG002|Overall Study|Screen Failure|1|||
125032420|NCT00862251|449739492|FG000|Overall Study|Adverse Event|8|||
125032421|NCT00862251|449739493|FG001|Overall Study|Adverse Event|3|||
125032422|NCT00862251|449739494|FG002|Overall Study|Adverse Event|1|||
125032423|NCT00862251|449739492|FG000|Overall Study|Lost to Follow-up|0|||
125032424|NCT00862251|449739493|FG001|Overall Study|Lost to Follow-up|0|||
125032425|NCT00862251|449739494|FG002|Overall Study|Lost to Follow-up|1|||
125032426|NCT00862251|449739492|FG000|Overall Study|Protocol Violation|2|||
125032427|NCT00862251|449739493|FG001|Overall Study|Protocol Violation|0|||
125032428|NCT00862251|449739494|FG002|Overall Study|Protocol Violation|1|||
125032429|NCT00862251|449739492|FG000|Overall Study|Withdrawal by Subject|9|||
125032430|NCT00862251|449739493|FG001|Overall Study|Withdrawal by Subject|2|||
125032431|NCT00862251|449739494|FG002|Overall Study|Withdrawal by Subject|6|||
125032432|NCT01756274|449739501|FG000|Overall Study|Protocol Violation|2|||
125032433|NCT01756274|449739501|FG000|Overall Study|Laboratory error|1|||
125032434|NCT01147926|449739502|FG000|Overall Study|Subject Withdrew Consent|9|||
125032435|NCT01147926|449739503|FG001|Overall Study|Subject Withdrew Consent|10|||
125032436|NCT01147926|449739502|FG000|Overall Study|Adverse Event|7|||
125032437|NCT01147926|449739503|FG001|Overall Study|Adverse Event|6|||
125032438|NCT01147926|449739502|FG000|Overall Study|Subject Non-Compliant|5|||
125032439|NCT01147926|449739503|FG001|Overall Study|Subject Non-Compliant|4|||
125032440|NCT01147926|449739502|FG000|Overall Study|Principal investigator left hospital|1|||
125032441|NCT01147926|449739503|FG001|Overall Study|Principal investigator left hospital|3|||
125032442|NCT01147926|449739502|FG000|Overall Study|Selection criteria not met|3|||
125032443|NCT01147926|449739503|FG001|Overall Study|Selection criteria not met|1|||
125032444|NCT01147926|449739502|FG000|Overall Study|Lost to Follow-up|0|||
125032445|NCT01147926|449739503|FG001|Overall Study|Lost to Follow-up|2|||
125032446|NCT01147926|449739502|FG000|Overall Study|Sponsor's Decision|0|||
125032447|NCT01147926|449739503|FG001|Overall Study|Sponsor's Decision|1|||
125032448|NCT01147926|449739502|FG000|Overall Study|Lack of Efficacy|1|||
125032449|NCT01147926|449739503|FG001|Overall Study|Lack of Efficacy|0|||
125032450|NCT01147926|449739502|FG000|Overall Study|Too busy, no time for study|1|||
125130641|NCT01792635|450106333|FG002|Part B|Adverse Event|1|||
125130642|NCT01792635|450106331|FG000|Part B|Study terminated|0|||
125130643|NCT01792635|450106332|FG001|Part B|Study terminated|4|||
125130644|NCT01792635|450106333|FG002|Part B|Study terminated|3|||
125130645|NCT02902211|450106337|FG000|First Three Months|Withdrawal by Subject|7|||
125130646|NCT02902211|450106338|FG001|First Three Months|Withdrawal by Subject|3|||
125130647|NCT01513174|450106341|FG000|Overall Study|Inclusion Error|1|||
125130648|NCT01513174|450106342|FG001|Overall Study|Inclusion Error|7|||
125130649|NCT01513174|450106341|FG000|Overall Study|Not receive study treatment|3|||
125130650|NCT01513174|450106342|FG001|Overall Study|Not receive study treatment|1|||
125130651|NCT02682784|450106350|FG000|Overall Study|Withdrawal by Subject|0|||
125130652|NCT02682784|450106351|FG001|Overall Study|Withdrawal by Subject|2|||
125130653|NCT02682784|450106352|FG002|Overall Study|Withdrawal by Subject|1|||
125130654|NCT02682784|450106353|FG003|Overall Study|Withdrawal by Subject|2|||
125130655|NCT02682784|450106350|FG000|Overall Study|Physician Decision|1|||
125130656|NCT02682784|450106351|FG001|Overall Study|Physician Decision|0|||
125130657|NCT02682784|450106352|FG002|Overall Study|Physician Decision|1|||
125130658|NCT02682784|450106353|FG003|Overall Study|Physician Decision|1|||
125130659|NCT00467363|450106354|FG000|Overall Study|Lost to Follow-up|80|||
125130660|NCT00467363|450106355|FG001|Overall Study|Lost to Follow-up|70|||
125130661|NCT04533594|450106356|FG000|Overall Study|Death|26|||
125130662|NCT01401647|450106359|FG000|Overall Study|Withdrawal by Subject|1|||
125130663|NCT01401647|450106360|FG001|Overall Study|Withdrawal by Subject|5|||
125130664|NCT01401647|450106361|FG002|Overall Study|Withdrawal by Subject|2|||
125130665|NCT01401647|450106359|FG000|Overall Study|Lost to Follow-up|3|||
125130666|NCT01401647|450106360|FG001|Overall Study|Lost to Follow-up|3|||
125130667|NCT01401647|450106361|FG002|Overall Study|Lost to Follow-up|1|||
125130668|NCT00473330|450106366|FG000|Core Study|Adverse Event|4|||
125130669|NCT00473330|450106367|FG001|Core Study|Adverse Event|4|||
125130670|NCT00473330|450106368|FG002|Core Study|Adverse Event|1|||
125130671|NCT00473330|450106366|FG000|Core Study|Death|6|||
125130672|NCT00473330|450106367|FG001|Core Study|Death|4|||
125130673|NCT00473330|450106368|FG002|Core Study|Death|4|||
125130674|NCT00473330|450106366|FG000|Core Study|Lost to Follow-up|5|||
125130675|NCT00473330|450106367|FG001|Core Study|Lost to Follow-up|5|||
125130676|NCT00473330|450106368|FG002|Core Study|Lost to Follow-up|10|||
125130677|NCT00473330|450106366|FG000|Core Study|Physician Decision|2|||
125130678|NCT00473330|450106367|FG001|Core Study|Physician Decision|1|||
125130679|NCT00473330|450106368|FG002|Core Study|Physician Decision|3|||
125130680|NCT00473330|450106366|FG000|Core Study|Subject Non-compliance|1|||
125130681|NCT00473330|450106367|FG001|Core Study|Subject Non-compliance|2|||
125130682|NCT00473330|450106368|FG002|Core Study|Subject Non-compliance|1|||
125130683|NCT00473330|450106366|FG000|Core Study|Subject Required Other Therapy|0|||
125130684|NCT00473330|450106367|FG001|Core Study|Subject Required Other Therapy|1|||
125130685|NCT00473330|450106368|FG002|Core Study|Subject Required Other Therapy|3|||
125130686|NCT00473330|450106366|FG000|Core Study|Subject's Decision|9|||
125130687|NCT00473330|450106367|FG001|Core Study|Subject's Decision|8|||
125130688|NCT00473330|450106368|FG002|Core Study|Subject's Decision|19|||
125130689|NCT00473330|450106366|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
125130690|NCT00473330|450106367|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
125130691|NCT00473330|450106368|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
125130692|NCT00473330|450106366|FG000|Open-label Extension Through Month 48|Death|2|||
125130693|NCT00473330|450106367|FG001|Open-label Extension Through Month 48|Death|0|||
125130694|NCT00473330|450106368|FG002|Open-label Extension Through Month 48|Death|0|||
125130695|NCT00473330|450106366|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
125130696|NCT00473330|450106367|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
125130697|NCT00473330|450106368|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
125130698|NCT00473330|450106366|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
125130699|NCT00473330|450106367|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
125032451|NCT01147926|449739503|FG001|Overall Study|Too busy, no time for study|0|||
125032452|NCT01147926|449739502|FG000|Overall Study|Went on holiday|0|||
125032453|NCT01147926|449739503|FG001|Overall Study|Went on holiday|1|||
125130700|NCT00473330|450106368|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
125130701|NCT00473330|450106366|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
125130702|NCT00473330|450106367|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
125130703|NCT00473330|450106368|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
125130704|NCT00473330|450106366|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
125130705|NCT00473330|450106367|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
125032454|NCT01147926|449739502|FG000|Overall Study|Colonoscopy result|0|||
125130706|NCT00473330|450106368|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
125216677|NCT03853291|450419541|FG005|Overall Study|Lost to Follow-up|0|||
125216678|NCT03853291|450419536|FG000|Overall Study|Determined to be ineligible|1|||
125216679|NCT03853291|450419537|FG001|Overall Study|Determined to be ineligible|1|||
125216680|NCT03853291|450419538|FG002|Overall Study|Determined to be ineligible|0|||
125216681|NCT03853291|450419539|FG003|Overall Study|Determined to be ineligible|0|||
125216682|NCT03853291|450419540|FG004|Overall Study|Determined to be ineligible|0|||
125216683|NCT03853291|450419541|FG005|Overall Study|Determined to be ineligible|0|||
125216684|NCT03762681|450419547|FG000|Part 1|Withdrawal by Subject|0|||
125216685|NCT03762681|450419548|FG001|Part 1|Withdrawal by Subject|0|||
125216686|NCT03762681|450419549|FG002|Part 1|Withdrawal by Subject|0|||
125216687|NCT03762681|450419550|FG003|Part 1|Withdrawal by Subject|1|||
125216688|NCT03762681|450419551|FG004|Part 1|Withdrawal by Subject|0|||
125216689|NCT03762681|450419552|FG005|Part 1|Withdrawal by Subject|0|||
125216690|NCT03762681|450419553|FG006|Part 1|Withdrawal by Subject|0|||
125216691|NCT03762681|450419554|FG007|Part 1|Withdrawal by Subject|0|||
125216692|NCT03762681|450419547|FG000|Part 2a|Pandemic Travel Restrictions|0|||
125216693|NCT03762681|450419548|FG001|Part 2a|Pandemic Travel Restrictions|0|||
125216694|NCT03762681|450419549|FG002|Part 2a|Pandemic Travel Restrictions|0|||
125216695|NCT03762681|450419550|FG003|Part 2a|Pandemic Travel Restrictions|0|||
125216696|NCT03762681|450419551|FG004|Part 2a|Pandemic Travel Restrictions|0|||
125216697|NCT03762681|450419552|FG005|Part 2a|Pandemic Travel Restrictions|0|||
125216698|NCT03762681|450419553|FG006|Part 2a|Pandemic Travel Restrictions|0|||
125216699|NCT03762681|450419554|FG007|Part 2a|Pandemic Travel Restrictions|1|||
124967872|NCT02554383|449509640|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
124967873|NCT02918292|449509641|FG000|Study Enrollment Prior to Transplant|Death|1|||
124967874|NCT02918292|449509641|FG000|Study Follow up After Transplant|Death|6|||
125216700|NCT02137226|450419555|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
125216701|NCT02137226|450419556|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
125216702|NCT02137226|450419557|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
124967875|NCT01801982|449509642|FG000|Overall Study|Lost to Follow-up|1|||
124967876|NCT01185171|449509645|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
124967877|NCT01185171|449509645|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
125216703|NCT02137226|450419558|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
125216704|NCT02137226|450419559|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
125216705|NCT02137226|450419555|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
125216706|NCT02137226|450419556|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
125216707|NCT02137226|450419557|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
124967878|NCT01185171|449509645|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
125032455|NCT01147926|449739503|FG001|Overall Study|Colonoscopy result|1|||
125032456|NCT03417440|449739507|FG000|Overall Study|Lost to Follow-up|0|||
125032457|NCT03417440|449739508|FG001|Overall Study|Lost to Follow-up|1|||
125032458|NCT03417440|449739509|FG002|Overall Study|Lost to Follow-up|0|||
125032459|NCT03417440|449739510|FG003|Overall Study|Lost to Follow-up|0|||
125032460|NCT03417440|449739511|FG004|Overall Study|Lost to Follow-up|1|||
125032461|NCT03417440|449739512|FG005|Overall Study|Lost to Follow-up|0|||
125032462|NCT03417440|449739513|FG006|Overall Study|Lost to Follow-up|0|||
125032463|NCT03417440|449739514|FG007|Overall Study|Lost to Follow-up|0|||
125032464|NCT03417440|449739507|FG000|Overall Study|Withdrawal by Subject|2|||
125032465|NCT03417440|449739508|FG001|Overall Study|Withdrawal by Subject|0|||
125032466|NCT03417440|449739509|FG002|Overall Study|Withdrawal by Subject|2|||
125032467|NCT03417440|449739510|FG003|Overall Study|Withdrawal by Subject|1|||
125032468|NCT03417440|449739511|FG004|Overall Study|Withdrawal by Subject|1|||
125032469|NCT03417440|449739512|FG005|Overall Study|Withdrawal by Subject|0|||
125032470|NCT03417440|449739513|FG006|Overall Study|Withdrawal by Subject|0|||
125032471|NCT03417440|449739514|FG007|Overall Study|Withdrawal by Subject|1|||
125032472|NCT03304522|449739517|FG000|Overall Study|Adverse Event|0|||
125032473|NCT03304522|449739518|FG001|Overall Study|Adverse Event|4|||
125032474|NCT03304522|449739517|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
125032475|NCT03304522|449739518|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
125032476|NCT03304522|449739517|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
125032477|NCT03304522|449739518|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
125032478|NCT03304522|449739517|FG000|Overall Study|Other|0|||
125032479|NCT03304522|449739518|FG001|Overall Study|Other|1|||
125032480|NCT00486603|449739519|FG000|Overall Study|Withdrawal by Subject|1|||
125032481|NCT00486603|449739520|FG001|Overall Study|Withdrawal by Subject|0|||
125032482|NCT00486603|449739521|FG002|Overall Study|Withdrawal by Subject|0|||
125032483|NCT00486603|449739522|FG003|Overall Study|Withdrawal by Subject|0|||
125032484|NCT00486603|449739523|FG004|Overall Study|Withdrawal by Subject|0|||
125216708|NCT02137226|450419558|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
125032485|NCT00486603|449739519|FG000|Overall Study|Physician Decision|0|||
125032486|NCT00486603|449739520|FG001|Overall Study|Physician Decision|1|||
125032487|NCT00486603|449739521|FG002|Overall Study|Physician Decision|0|||
125216709|NCT02137226|450419559|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
125032488|NCT00486603|449739522|FG003|Overall Study|Physician Decision|0|||
124967879|NCT01185171|449509645|FG000|Maintenance|Elevated liver transaminases|3|||
124967880|NCT01185171|449509645|FG000|Maintenance|Rush|2|||
124967881|NCT01185171|449509645|FG000|Maintenance|Diarrhea|1|||
124967882|NCT01185171|449509645|FG000|Maintenance|Xerostomia|1|||
124967883|NCT01185171|449509645|FG000|Maintenance|Nausea|1|||
124967884|NCT01185171|449509645|FG000|Maintenance|Comorbid Illness|2|||
124967885|NCT01185171|449509645|FG000|Maintenance|Withdrawal by Subject|1|||
124967886|NCT01185171|449509645|FG000|Maintenance|Disease Recurrence|1|||
125130707|NCT00473330|450106366|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
125130708|NCT00473330|450106367|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
125130709|NCT00473330|450106368|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
125130710|NCT00473330|450106366|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
125130711|NCT00473330|450106367|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
125130712|NCT00473330|450106368|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
125130713|NCT00473330|450106366|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
125130714|NCT00473330|450106367|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
125130715|NCT00473330|450106368|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
125130716|NCT00473330|450106366|FG000|Open-label Extension Through Month 60|Death|2|||
125130717|NCT00473330|450106367|FG001|Open-label Extension Through Month 60|Death|2|||
125130718|NCT00473330|450106368|FG002|Open-label Extension Through Month 60|Death|1|||
125130719|NCT00473330|450106366|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
125130720|NCT00473330|450106367|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
125130721|NCT00473330|450106368|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
125130722|NCT00473330|450106366|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
125130723|NCT00473330|450106367|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
125130724|NCT00473330|450106368|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
125130725|NCT00473330|450106366|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
125130726|NCT00473330|450106367|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
125130727|NCT00473330|450106368|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
125130728|NCT00473330|450106366|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
125130729|NCT00473330|450106367|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
125130730|NCT00473330|450106368|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
125130731|NCT00473330|450106366|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
125130732|NCT00473330|450106367|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
125130733|NCT00473330|450106368|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
125130734|NCT00473330|450106366|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
125130735|NCT00473330|450106367|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
125130736|NCT00473330|450106368|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
125130737|NCT01975948|450106369|FG000|Overall Study|Withdrawal by Subject|17|||
125130738|NCT01975948|450106370|FG001|Overall Study|Withdrawal by Subject|21|||
124967887|NCT00727506|449509646|FG000|Overall Study|Adverse Event|0|||
125130739|NCT01975948|450106371|FG002|Overall Study|Withdrawal by Subject|7|||
125130740|NCT01975948|450106372|FG003|Overall Study|Withdrawal by Subject|6|||
125130741|NCT01675765|450106373|FG000|Overall Study|Progressive disease|4|||
125130742|NCT01675765|450106374|FG001|Overall Study|Progressive disease|4|||
125130743|NCT01675765|450106373|FG000|Overall Study|Adverse Event|1|||
125130744|NCT01675765|450106374|FG001|Overall Study|Adverse Event|2|||
125130745|NCT01675765|450106373|FG000|Overall Study|Withdrawal by Subject|2|||
125130746|NCT01675765|450106374|FG001|Overall Study|Withdrawal by Subject|0|||
125130747|NCT01675765|450106373|FG000|Overall Study|Death|1|||
125130748|NCT01675765|450106374|FG001|Overall Study|Death|0|||
125130749|NCT01675765|450106373|FG000|Overall Study|Clinical progression|3|||
125130750|NCT01675765|450106374|FG001|Overall Study|Clinical progression|2|||
125130751|NCT01723397|450106379|FG000|Study Period 1|Protocol Violation|0|||
125130752|NCT01723397|450106380|FG001|Study Period 1|Protocol Violation|1|||
125130753|NCT01723397|450106379|FG000|Study Period 2|Protocol Violation|0|||
125130754|NCT01723397|450106380|FG001|Study Period 2|Protocol Violation|1|||
125130755|NCT02196675|450106381|FG000|Overall Study|Withdrawal by Subject|1|||
125130756|NCT02196675|450106382|FG001|Overall Study|Withdrawal by Subject|0|||
125130757|NCT02196675|450106383|FG002|Overall Study|Withdrawal by Subject|0|||
125130758|NCT02196675|450106381|FG000|Overall Study|Intra-operative surgical exclusion|1|||
125130759|NCT02196675|450106382|FG001|Overall Study|Intra-operative surgical exclusion|1|||
125130760|NCT02196675|450106383|FG002|Overall Study|Intra-operative surgical exclusion|0|||
124967888|NCT00727506|449509647|FG001|Overall Study|Adverse Event|0|||
124967889|NCT00727506|449509648|FG002|Overall Study|Adverse Event|4|||
124967890|NCT00727506|449509649|FG003|Overall Study|Adverse Event|4|||
124967891|NCT00727506|449509650|FG004|Overall Study|Adverse Event|1|||
124967892|NCT00727506|449509651|FG005|Overall Study|Adverse Event|8|||
124967893|NCT00727506|449509646|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
124967894|NCT00727506|449509647|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125216710|NCT02137226|450419555|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
125216711|NCT02137226|450419556|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
125216712|NCT02137226|450419557|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
125216713|NCT02137226|450419558|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
125216714|NCT02137226|450419559|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
125216715|NCT02137226|450419555|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
125216716|NCT02137226|450419556|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
125216717|NCT02137226|450419557|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
125216718|NCT02137226|450419558|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
125216719|NCT02137226|450419559|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
125216720|NCT02137226|450419555|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
125216721|NCT02137226|450419556|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
125216722|NCT02137226|450419557|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
125216723|NCT02137226|450419558|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
125216724|NCT02137226|450419559|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
125216725|NCT02137226|450419555|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
125216726|NCT02137226|450419556|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
125216727|NCT02137226|450419557|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
125216728|NCT02137226|450419558|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
125216729|NCT02137226|450419559|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
125216730|NCT02137226|450419555|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
125216731|NCT02137226|450419556|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
125216732|NCT02137226|450419557|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
125216733|NCT02137226|450419558|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
125216734|NCT02137226|450419559|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
125216735|NCT02137226|450419555|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
125216736|NCT02137226|450419556|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
125216737|NCT02137226|450419557|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
125216738|NCT02137226|450419558|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
125216739|NCT02137226|450419559|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
125216740|NCT02137226|450419555|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
125216741|NCT02137226|450419556|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
125216742|NCT02137226|450419557|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
125216743|NCT02137226|450419558|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
125216744|NCT02137226|450419559|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
125216745|NCT02137226|450419555|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
125216746|NCT02137226|450419556|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
125216747|NCT02137226|450419557|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
125216748|NCT02137226|450419558|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
125216749|NCT02137226|450419559|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
125216750|NCT02137226|450419555|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
125216751|NCT02137226|450419556|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
125216752|NCT02137226|450419557|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
125216753|NCT02137226|450419558|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
124967895|NCT00727506|449509648|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
124967896|NCT00727506|449509649|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124967897|NCT00727506|449509650|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124967898|NCT00727506|449509651|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124967899|NCT00727506|449509646|FG000|Overall Study|Progressive disease|4|||
125130761|NCT02196675|450106381|FG000|Overall Study|Protocol Violation|0|||
125130762|NCT02196675|450106382|FG001|Overall Study|Protocol Violation|1|||
125130763|NCT02196675|450106383|FG002|Overall Study|Protocol Violation|0|||
125130764|NCT02196675|450106381|FG000|Overall Study|Death|0|||
125130765|NCT02196675|450106382|FG001|Overall Study|Death|0|||
125130766|NCT02196675|450106383|FG002|Overall Study|Death|1|||
125130767|NCT02711852|450106384|FG000|Overall Study|Death|5|||
125130768|NCT02711852|450106384|FG000|Overall Study|Lost to Follow-up|1|||
125130769|NCT02711852|450106384|FG000|Overall Study|Completed follow-up|3|||
125130770|NCT02711852|450106384|FG000|Overall Study|Withdrawal by Subject|1|||
125130771|NCT00537979|450106385|FG000|Overall Study|Adverse Event|2|||
125130772|NCT00537979|450106386|FG001|Overall Study|Adverse Event|2|||
125130773|NCT00537979|450106385|FG000|Overall Study|Withdrawal by Subject|1|||
125130774|NCT00537979|450106386|FG001|Overall Study|Withdrawal by Subject|4|||
125130775|NCT00537979|450106385|FG000|Overall Study|Lost to Follow-up|1|||
125130776|NCT00537979|450106386|FG001|Overall Study|Lost to Follow-up|4|||
125130777|NCT00537979|450106385|FG000|Overall Study|Lack of Efficacy|0|||
125130778|NCT00537979|450106386|FG001|Overall Study|Lack of Efficacy|1|||
125130779|NCT00537979|450106385|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
125130780|NCT00537979|450106386|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
125130781|NCT00537979|450106385|FG000|Overall Study|Death|0|||
125216754|NCT02137226|450419559|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
125216755|NCT02137226|450419555|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
125216756|NCT02137226|450419556|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
125216757|NCT02137226|450419557|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
125216758|NCT02137226|450419558|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
125216759|NCT02137226|450419559|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
125216760|NCT00003896|450419564|FG000|Overall Study|Adverse Event|16|||
125216761|NCT00003896|450419564|FG000|Overall Study|Withdrawal by Subject|1|||
125216762|NCT00003896|450419564|FG000|Overall Study|Lack of Efficacy|1|||
125216763|NCT00003896|450419564|FG000|Overall Study|Death|3|||
125216764|NCT00003896|450419564|FG000|Overall Study|not protocol specified|3|||
125216765|NCT00003896|450419564|FG000|Overall Study|ineligible|5|||
125216766|NCT00985686|450419567|FG000|Overall Study|Lost to Follow-up|1|||
125216767|NCT00985686|450419568|FG001|Overall Study|Lost to Follow-up|1|||
125216768|NCT00985686|450419569|FG002|Overall Study|Lost to Follow-up|0|||
125216769|NCT00985686|450419570|FG003|Overall Study|Lost to Follow-up|2|||
125216770|NCT01670045|450419571|FG000|Overall Study|Withdrawal by Subject|3|||
125216771|NCT01670045|450419571|FG000|Overall Study|Adverse Event|1|||
125216772|NCT01670045|450419571|FG000|Overall Study|Death|1|||
125216773|NCT01670045|450419571|FG000|Overall Study|Lost to Follow-up|11|||
125216774|NCT02787083|450419577|FG000|Overall Study|Adverse Event|1|||
125216775|NCT02787083|450419578|FG001|Overall Study|Adverse Event|0|||
125216776|NCT02787083|450419577|FG000|Overall Study|Withdrawal by Subject|2|||
125216777|NCT02787083|450419578|FG001|Overall Study|Withdrawal by Subject|2|||
125216778|NCT02710084|450419579|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
125216779|NCT02710084|450419580|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
125216780|NCT03162328|450419581|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
125216781|NCT03162328|450419582|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
125216782|NCT03162328|450419583|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
125216783|NCT03162328|450419581|FG000|Screening Period|Withdrawal by Subject|1|||
125216784|NCT03162328|450419582|FG001|Screening Period|Withdrawal by Subject|0|||
125216785|NCT03162328|450419583|FG002|Screening Period|Withdrawal by Subject|0|||
125216786|NCT03162328|450419581|FG000|Study Period|Withdrawal by Subject|0|||
125216787|NCT03162328|450419582|FG001|Study Period|Withdrawal by Subject|0|||
125216788|NCT03162328|450419583|FG002|Study Period|Withdrawal by Subject|1|||
125216789|NCT00282152|450419584|FG000|Overall Study|Withdrawal by Subject|1|||
125216790|NCT00282152|450419585|FG001|Overall Study|Withdrawal by Subject|0|||
125216791|NCT03301831|450419586|FG000|Overall Study|Lost to Follow-up|5|||
125216792|NCT03301831|450419587|FG001|Overall Study|Lost to Follow-up|3|||
125216793|NCT03301831|450419586|FG000|Overall Study|Protocol Violation|4|||
125216794|NCT03301831|450419587|FG001|Overall Study|Protocol Violation|0|||
125216795|NCT03301831|450419586|FG000|Overall Study|Withdrawal by Subject|11|||
125216796|NCT03301831|450419587|FG001|Overall Study|Withdrawal by Subject|0|||
125216797|NCT03268005|450419589|FG000|Overall Study|Death|2|||
125216798|NCT03268005|450419590|FG001|Overall Study|Death|1|||
125216799|NCT03268005|450419589|FG000|Overall Study|Lost to Follow-up|2|||
125216800|NCT03268005|450419590|FG001|Overall Study|Lost to Follow-up|2|||
125216801|NCT03268005|450419589|FG000|Overall Study|Withdrawal by Subject|11|||
125216802|NCT03268005|450419590|FG001|Overall Study|Withdrawal by Subject|11|||
125216803|NCT00845676|450419593|FG000|Overall Study|Virologic breakthrough at week 20|1|||
125216804|NCT00845676|450419593|FG000|Overall Study|Adverse Event|1|||
125216805|NCT00481767|450419594|FG000|Overall Study|Withdrawal by Subject|16|||
125216806|NCT00481767|450419595|FG001|Overall Study|Withdrawal by Subject|11|||
125216807|NCT00481767|450419594|FG000|Overall Study|Lost to Follow-up|16|||
125216808|NCT00481767|450419595|FG001|Overall Study|Lost to Follow-up|10|||
125216809|NCT04378569|450421926|FG000|Overall Study|Adverse Event|0|||
125216810|NCT04378569|450421927|FG001|Overall Study|Adverse Event|0|||
125216811|NCT04378569|450421928|FG002|Overall Study|Adverse Event|2|||
125216812|NCT04378569|450421929|FG003|Overall Study|Adverse Event|0|||
125216813|NCT04378569|450421930|FG004|Overall Study|Adverse Event|3|||
125216814|NCT04378569|450421931|FG005|Overall Study|Adverse Event|3|||
125216815|NCT04378569|450421926|FG000|Overall Study|Lost to Follow-up|0|||
125216816|NCT04378569|450421927|FG001|Overall Study|Lost to Follow-up|3|||
125216817|NCT04378569|450421928|FG002|Overall Study|Lost to Follow-up|1|||
125216818|NCT04378569|450421929|FG003|Overall Study|Lost to Follow-up|0|||
125216819|NCT04378569|450421930|FG004|Overall Study|Lost to Follow-up|1|||
125216820|NCT04378569|450421931|FG005|Overall Study|Lost to Follow-up|1|||
125216821|NCT04378569|450421926|FG000|Overall Study|Protocol Violation|0|||
125216822|NCT04378569|450421927|FG001|Overall Study|Protocol Violation|0|||
125216823|NCT04378569|450421928|FG002|Overall Study|Protocol Violation|0|||
125216824|NCT04378569|450421929|FG003|Overall Study|Protocol Violation|0|||
125216825|NCT04378569|450421930|FG004|Overall Study|Protocol Violation|0|||
125216826|NCT04378569|450421931|FG005|Overall Study|Protocol Violation|1|||
125216827|NCT04378569|450421926|FG000|Overall Study|Withdrawal by Subject|0|||
125216828|NCT04378569|450421927|FG001|Overall Study|Withdrawal by Subject|6|||
125216829|NCT04378569|450421928|FG002|Overall Study|Withdrawal by Subject|7|||
125216830|NCT04378569|450421929|FG003|Overall Study|Withdrawal by Subject|4|||
125216831|NCT04378569|450421930|FG004|Overall Study|Withdrawal by Subject|5|||
125216832|NCT04378569|450421931|FG005|Overall Study|Withdrawal by Subject|4|||
125130782|NCT00537979|450106386|FG001|Overall Study|Death|3|||
125130783|NCT00537979|450106385|FG000|Overall Study|Kidney transplant|0|||
125130784|NCT00537979|450106386|FG001|Overall Study|Kidney transplant|3|||
125130785|NCT00537979|450106385|FG000|Overall Study|Heart failure|0|||
125130786|NCT00537979|450106386|FG001|Overall Study|Heart failure|1|||
125130787|NCT02009163|450106387|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
125130788|NCT02009163|450106388|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
125130789|NCT02009163|450106389|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
125130790|NCT02009163|450106387|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
125130791|NCT02009163|450106388|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
125130792|NCT02009163|450106389|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
125130793|NCT02009163|450106387|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
125130794|NCT02009163|450106388|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
125130795|NCT02009163|450106389|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
125130796|NCT02009163|450106387|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
125130797|NCT02009163|450106388|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
125130798|NCT02009163|450106389|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
125130799|NCT02009163|450106387|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
125130800|NCT02009163|450106388|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
125130801|NCT02009163|450106389|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
125130802|NCT02009163|450106387|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
125130803|NCT02009163|450106388|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
125130804|NCT02009163|450106389|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
125130805|NCT02009163|450106387|FG000|Open-label Period (Non-randomized)|Other|13|||
125130806|NCT02009163|450106388|FG001|Open-label Period (Non-randomized)|Other|0|||
125130807|NCT02009163|450106389|FG002|Open-label Period (Non-randomized)|Other|0|||
125130808|NCT02009163|450106387|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
125130809|NCT02009163|450106388|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
125130810|NCT02009163|450106389|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
125130811|NCT02009163|450106387|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
125130812|NCT02009163|450106388|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
125130813|NCT02009163|450106389|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
125130814|NCT02009163|450106387|FG000|Randomized-withdrawal Period|Adverse Event|0|||
125130815|NCT02009163|450106388|FG001|Randomized-withdrawal Period|Adverse Event|0|||
125130816|NCT02009163|450106389|FG002|Randomized-withdrawal Period|Adverse Event|6|||
125130817|NCT02009163|450106387|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
125130818|NCT02009163|450106388|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
125130819|NCT02009163|450106389|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
125130820|NCT02009163|450106387|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
125130821|NCT02009163|450106388|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
125130822|NCT02009163|450106389|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
125130823|NCT02009163|450106387|FG000|Randomized-withdrawal Period|Pregnancy|0|||
125130824|NCT02009163|450106388|FG001|Randomized-withdrawal Period|Pregnancy|0|||
125130825|NCT02009163|450106389|FG002|Randomized-withdrawal Period|Pregnancy|2|||
125130826|NCT02009163|450106387|FG000|Randomized-withdrawal Period|Other|0|||
125130827|NCT02009163|450106388|FG001|Randomized-withdrawal Period|Other|9|||
125130828|NCT02009163|450106389|FG002|Randomized-withdrawal Period|Other|5|||
125130829|NCT02453386|450106390|FG000|Overall Study|Adverse Event|22|||
125130830|NCT02453386|450106391|FG001|Overall Study|Adverse Event|30|||
125130831|NCT02453386|450106392|FG002|Overall Study|Adverse Event|15|||
125130832|NCT02453386|450106390|FG000|Overall Study|Protocol Violation|1|||
125130833|NCT02453386|450106391|FG001|Overall Study|Protocol Violation|0|||
125130834|NCT02453386|450106392|FG002|Overall Study|Protocol Violation|1|||
125130835|NCT02453386|450106390|FG000|Overall Study|Withdrawal by Subject|10|||
125130836|NCT02453386|450106391|FG001|Overall Study|Withdrawal by Subject|9|||
125130837|NCT02453386|450106392|FG002|Overall Study|Withdrawal by Subject|9|||
125130838|NCT02453386|450106390|FG000|Overall Study|Sponsor Terminated Study|14|||
125130839|NCT02453386|450106391|FG001|Overall Study|Sponsor Terminated Study|8|||
125130840|NCT02453386|450106392|FG002|Overall Study|Sponsor Terminated Study|11|||
125130841|NCT02453386|450106390|FG000|Overall Study|Subject Terminated by Sponsor|1|||
125130842|NCT02453386|450106391|FG001|Overall Study|Subject Terminated by Sponsor|1|||
125130843|NCT02453386|450106392|FG002|Overall Study|Subject Terminated by Sponsor|1|||
125130844|NCT02453386|450106390|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
125130845|NCT02453386|450106391|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
125130846|NCT02453386|450106392|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
125130847|NCT02453386|450106390|FG000|Overall Study|Lost to Follow-up|0|||
125130848|NCT02453386|450106391|FG001|Overall Study|Lost to Follow-up|0|||
125130849|NCT02453386|450106392|FG002|Overall Study|Lost to Follow-up|1|||
125130850|NCT02453386|450106390|FG000|Overall Study|Other|1|||
125130851|NCT02453386|450106391|FG001|Overall Study|Other|0|||
125130852|NCT02453386|450106392|FG002|Overall Study|Other|1|||
124967900|NCT00727506|449509647|FG001|Overall Study|Progressive disease|7|||
124967901|NCT00727506|449509648|FG002|Overall Study|Progressive disease|9|||
124967902|NCT00727506|449509649|FG003|Overall Study|Progressive disease|28|||
124967903|NCT00727506|449509650|FG004|Overall Study|Progressive disease|38|||
124967904|NCT00727506|449509651|FG005|Overall Study|Progressive disease|28|||
124967905|NCT00727506|449509646|FG000|Overall Study|Refused to continue medication|0|||
124967906|NCT00727506|449509647|FG001|Overall Study|Refused to continue medication|1|||
124967907|NCT00727506|449509648|FG002|Overall Study|Refused to continue medication|2|||
124967908|NCT00727506|449509649|FG003|Overall Study|Refused to continue medication|3|||
124967909|NCT00727506|449509650|FG004|Overall Study|Refused to continue medication|1|||
124967910|NCT00727506|449509651|FG005|Overall Study|Refused to continue medication|2|||
124967911|NCT00727506|449509646|FG000|Overall Study|Other reason not described above|0|||
124967912|NCT00727506|449509647|FG001|Overall Study|Other reason not described above|0|||
124967913|NCT00727506|449509648|FG002|Overall Study|Other reason not described above|1|||
124967914|NCT00727506|449509649|FG003|Overall Study|Other reason not described above|4|||
124967915|NCT00727506|449509650|FG004|Overall Study|Other reason not described above|1|||
124967916|NCT00727506|449509651|FG005|Overall Study|Other reason not described above|1|||
124967917|NCT03561597|449509652|FG000|Overall Study|Lost to Follow-up|20|||
124967918|NCT03783689|449509654|FG000|Overall Study|Adverse Event|2|||
124967919|NCT03783689|449509655|FG001|Overall Study|Adverse Event|0|||
124967920|NCT03783689|449509654|FG000|Overall Study|Lost to Follow-up|2|||
124967921|NCT03783689|449509655|FG001|Overall Study|Lost to Follow-up|1|||
124967922|NCT03783689|449509654|FG000|Overall Study|Physician Decision|2|||
124967923|NCT03783689|449509655|FG001|Overall Study|Physician Decision|1|||
124967924|NCT03783689|449509654|FG000|Overall Study|Withdrawal by Subject|3|||
124967925|NCT03783689|449509655|FG001|Overall Study|Withdrawal by Subject|3|||
124967926|NCT01255761|449509658|FG000|Overall Study|Adverse Event|29|||
124967927|NCT01255761|449509659|FG001|Overall Study|Adverse Event|43|||
124967928|NCT01255761|449509658|FG000|Overall Study|Lack of Efficacy|86|||
124967929|NCT01255761|449509659|FG001|Overall Study|Lack of Efficacy|74|||
124967930|NCT01255761|449509658|FG000|Overall Study|Protocol Violation|9|||
124967931|NCT01255761|449509659|FG001|Overall Study|Protocol Violation|5|||
124967932|NCT01255761|449509658|FG000|Overall Study|Lost to Follow-up|10|||
124967933|NCT01255761|449509659|FG001|Overall Study|Lost to Follow-up|8|||
124967934|NCT01255761|449509658|FG000|Overall Study|Withdrawal by Subject|11|||
124967935|NCT01255761|449509659|FG001|Overall Study|Withdrawal by Subject|27|||
124967936|NCT01255761|449509658|FG000|Overall Study|Other Reasons|37|||
124967937|NCT01255761|449509659|FG001|Overall Study|Other Reasons|18|||
124967938|NCT03783871|449509665|FG000|Overall Study|Withdrawal by Subject|15|||
124967939|NCT03783871|449509665|FG000|Overall Study|Death|13|||
124967940|NCT03783871|449509665|FG000|Overall Study|Lost to Follow-up|2|||
124967941|NCT04594733|449509667|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
124967942|NCT04594733|449509668|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
124967943|NCT04594733|449509667|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
124967944|NCT04594733|449509668|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
124967945|NCT04594733|449509667|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
124967946|NCT04594733|449509668|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
124967947|NCT02647645|449509671|FG000|Overall Study|Lost to Follow-up|2|||
124967948|NCT02647645|449509672|FG001|Overall Study|Lost to Follow-up|1|||
124967949|NCT00356811|449509673|FG000|Overall Study|Death|35|||
124967950|NCT00356811|449509673|FG000|Overall Study|Lost to Follow-up|2|||
124967951|NCT00356811|449509673|FG000|Overall Study|Withdrawal by Subject|6|||
124967952|NCT00356811|449509673|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
124967953|NCT00356811|449509673|FG000|Overall Study|Study Is Terminating|3|||
124967954|NCT00356811|449509673|FG000|Overall Study|Site Closed during Follow-up|2|||
124967955|NCT02386839|449509674|FG000|Overall Study|Death|1|||
124967956|NCT02386839|449509675|FG001|Overall Study|Death|0|||
124967957|NCT02386839|449509674|FG000|Overall Study|Withdrawal by Subject|9|||
124967958|NCT02386839|449509675|FG001|Overall Study|Withdrawal by Subject|10|||
124967959|NCT02386839|449509674|FG000|Overall Study|Lost to Follow-up|4|||
124967960|NCT02386839|449509675|FG001|Overall Study|Lost to Follow-up|4|||
124967961|NCT02386839|449509674|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
124967962|NCT02386839|449509675|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
124967963|NCT02386839|449509674|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
124967964|NCT02386839|449509675|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
124967965|NCT02386839|449509674|FG000|Overall Study|Other (unspecified)|1|||
124967966|NCT02386839|449509675|FG001|Overall Study|Other (unspecified)|0|||
124967967|NCT02101983|449509676|FG000|Overall Study|Physician Decision|1|||
124967968|NCT02101983|449509677|FG001|Overall Study|Physician Decision|0|||
124967969|NCT00826228|449511262|FG000|Overall Study|Withdrawal by Subject|1|||
124967970|NCT00903760|449511263|FG000|Overall Study|Disease Progression/Death|8|||
124967971|NCT00903760|449511264|FG001|Overall Study|Disease Progression/Death|6|||
124967972|NCT00903760|449511263|FG000|Overall Study|Stem Cell Transplant|8|||
124967973|NCT00903760|449511264|FG001|Overall Study|Stem Cell Transplant|4|||
124967974|NCT00903760|449511263|FG000|Overall Study|Physician Decision|1|||
125130853|NCT02388191|450106415|FG000|Overall Study|Patient did not receive IUD|1|||
125130854|NCT02388191|450106416|FG001|Overall Study|Patient did not receive IUD|0|||
125130855|NCT03686033|450106417|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
125130856|NCT03686033|450106418|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
124967975|NCT00903760|449511264|FG001|Overall Study|Physician Decision|2|||
124967976|NCT00903760|449511263|FG000|Overall Study|Death|0|||
124967977|NCT00903760|449511264|FG001|Overall Study|Death|1|||
124967978|NCT00903760|449511263|FG000|Overall Study|Lost to Follow-up|1|||
124967979|NCT00903760|449511264|FG001|Overall Study|Lost to Follow-up|0|||
124967980|NCT00903760|449511263|FG000|Overall Study|Withdrawal by Subject|1|||
124967981|NCT00903760|449511264|FG001|Overall Study|Withdrawal by Subject|2|||
124967982|NCT00903760|449511263|FG000|Overall Study|Off treatment for long period|0|||
124967983|NCT00903760|449511264|FG001|Overall Study|Off treatment for long period|1|||
124967984|NCT01845805|449511266|FG000|Overall Study|Withdrawal by Subject|1|||
124967985|NCT01845805|449511267|FG001|Overall Study|Withdrawal by Subject|2|||
124967986|NCT01845805|449511266|FG000|Overall Study|Disease Progression|13|||
124967987|NCT01845805|449511267|FG001|Overall Study|Disease Progression|14|||
124967988|NCT01845805|449511266|FG000|Overall Study|Drug-related Toxicity|4|||
124967989|NCT01845805|449511267|FG001|Overall Study|Drug-related Toxicity|0|||
124967990|NCT00589303|449511274|FG000|Overall Study|Withdrawal by Subject|2|||
124967991|NCT00589303|449511275|FG001|Overall Study|Withdrawal by Subject|1|||
124967992|NCT04367480|449511276|FG000|Overall Study|Adverse Event|1|||
124967993|NCT04367480|449511277|FG001|Overall Study|Adverse Event|1|||
125130857|NCT03686033|450106419|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
125130858|NCT03686033|450106420|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
125130859|NCT03686033|450106421|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
125130860|NCT03686033|450106422|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
125130861|NCT03197883|450106423|FG000|Overall Study|Adverse Event|1|||
125130862|NCT03197883|450106424|FG001|Overall Study|Adverse Event|1|||
125130863|NCT03197883|450106423|FG000|Overall Study|Lost to Follow-up|1|||
125130864|NCT03197883|450106424|FG001|Overall Study|Lost to Follow-up|0|||
125130865|NCT03197883|450106423|FG000|Overall Study|Protocol Violation|1|||
125130866|NCT03197883|450106424|FG001|Overall Study|Protocol Violation|0|||
125130867|NCT03197883|450106423|FG000|Overall Study|Other (Not Specified)|0|||
125130868|NCT03197883|450106424|FG001|Overall Study|Other (Not Specified)|5|||
125130869|NCT00858845|450106425|FG000|Overall Study|Patient underwent heart transplant.|0|||
125130870|NCT00858845|450106426|FG001|Overall Study|Patient underwent heart transplant.|1|||
125130871|NCT03031847|450106428|FG000|Overall Study|Death|1|||
125130872|NCT03031847|450106429|FG001|Overall Study|Death|1|||
125130873|NCT03031847|450106430|FG002|Overall Study|Death|2|||
125130874|NCT03031847|450106431|FG003|Overall Study|Death|3|||
125130875|NCT03031847|450106428|FG000|Overall Study|Lost to Follow-up|1|||
125130876|NCT03031847|450106429|FG001|Overall Study|Lost to Follow-up|1|||
125130877|NCT03031847|450106430|FG002|Overall Study|Lost to Follow-up|2|||
125130878|NCT03031847|450106431|FG003|Overall Study|Lost to Follow-up|3|||
125130879|NCT01353664|450106433|FG000|Overall Study|Other|3|||
125130880|NCT01353664|450106433|FG000|Overall Study|Disease Progression|16|||
125130881|NCT02089997|450106441|FG000|Overall Study|Case report forms uncollected|99|||
125130882|NCT02089997|450106441|FG000|Overall Study|Protocol Violation|147|||
125130883|NCT02441309|450106442|FG000|Overall Study|Disease progression|2|||
125130884|NCT02441309|450106443|FG001|Overall Study|Disease progression|1|||
125130885|NCT02441309|450106444|FG002|Overall Study|Disease progression|2|||
125130886|NCT02441309|450106442|FG000|Overall Study|Adverse Event|0|||
125130887|NCT02441309|450106443|FG001|Overall Study|Adverse Event|1|||
125130888|NCT02441309|450106444|FG002|Overall Study|Adverse Event|0|||
125130889|NCT02441309|450106442|FG000|Overall Study|Withdrawal by Subject|1|||
125130890|NCT02441309|450106443|FG001|Overall Study|Withdrawal by Subject|0|||
124967994|NCT04367480|449511276|FG000|Overall Study|Death|1|||
124967995|NCT04367480|449511277|FG001|Overall Study|Death|0|||
124967996|NCT04367480|449511276|FG000|Overall Study|Lost to Follow-up|1|||
124967997|NCT04367480|449511277|FG001|Overall Study|Lost to Follow-up|1|||
124967998|NCT04367480|449511276|FG000|Overall Study|Withdrawal by Subject|0|||
124967999|NCT04367480|449511277|FG001|Overall Study|Withdrawal by Subject|3|||
124968000|NCT04367480|449511276|FG000|Overall Study|App glitch during the study|1|||
124968001|NCT04367480|449511277|FG001|Overall Study|App glitch during the study|0|||
124968002|NCT04367480|449511276|FG000|Overall Study|Device Distribution Error|0|||
125130891|NCT02441309|450106444|FG002|Overall Study|Withdrawal by Subject|1|||
125130892|NCT00415363|450106445|FG000|Overall Study|Withdrawal by Subject|4|||
124968003|NCT04367480|449511277|FG001|Overall Study|Device Distribution Error|2|||
124968004|NCT04367480|449511276|FG000|Overall Study|Ineligible after Randomization|0|||
124968005|NCT04367480|449511277|FG001|Overall Study|Ineligible after Randomization|1|||
124968006|NCT04367480|449511276|FG000|Overall Study|Other Medical Reasons|0|||
125130893|NCT00415363|450106446|FG001|Overall Study|Withdrawal by Subject|4|||
125130894|NCT00415363|450106445|FG000|Overall Study|Adverse Event|4|||
125130895|NCT00415363|450106446|FG001|Overall Study|Adverse Event|4|||
125130896|NCT00415363|450106445|FG000|Overall Study|Lost to Follow-up|2|||
125130897|NCT00415363|450106446|FG001|Overall Study|Lost to Follow-up|1|||
125130898|NCT00415363|450106445|FG000|Overall Study|Physician Decision|3|||
125130899|NCT00415363|450106446|FG001|Overall Study|Physician Decision|1|||
125130900|NCT00415363|450106445|FG000|Overall Study|Death|16|||
125130901|NCT00415363|450106446|FG001|Overall Study|Death|12|||
125130902|NCT00415363|450106445|FG000|Overall Study|Progressive disease|26|||
125130903|NCT00415363|450106446|FG001|Overall Study|Progressive disease|32|||
125130904|NCT00095212|450106451|FG000|Overall Study|Withdrawal by Subject|1|||
125130905|NCT00095212|450106452|FG001|Overall Study|Withdrawal by Subject|3|||
125130906|NCT02335658|450106453|FG000|Overall Study|Adverse Event|18|||
125130907|NCT02335658|450106454|FG001|Overall Study|Adverse Event|12|||
125130908|NCT02335658|450106453|FG000|Overall Study|Lack of Efficacy|4|||
125130909|NCT02335658|450106454|FG001|Overall Study|Lack of Efficacy|5|||
125216833|NCT04378569|450421926|FG000|Overall Study|Lack of response|0|||
125216834|NCT04378569|450421927|FG001|Overall Study|Lack of response|0|||
125130910|NCT02335658|450106453|FG000|Overall Study|Pregnancy|1|||
125130911|NCT02335658|450106454|FG001|Overall Study|Pregnancy|0|||
125130912|NCT02335658|450106453|FG000|Overall Study|Withdrawal by Subject|13|||
125216835|NCT04378569|450421928|FG002|Overall Study|Lack of response|1|||
125216836|NCT04378569|450421929|FG003|Overall Study|Lack of response|0|||
124968007|NCT04367480|449511277|FG001|Overall Study|Other Medical Reasons|2|||
124968008|NCT00730015|449511279|FG000|Overall Study|Adverse Event|11|||
124968009|NCT00730015|449511280|FG001|Overall Study|Adverse Event|10|||
124968010|NCT00730015|449511281|FG002|Overall Study|Adverse Event|8|||
124968011|NCT00730015|449511279|FG000|Overall Study|Protocol Violation|2|||
124968012|NCT00730015|449511280|FG001|Overall Study|Protocol Violation|6|||
124968013|NCT00730015|449511281|FG002|Overall Study|Protocol Violation|4|||
125130913|NCT02335658|450106454|FG001|Overall Study|Withdrawal by Subject|21|||
125130914|NCT02335658|450106453|FG000|Overall Study|non-compliance|2|||
125130915|NCT02335658|450106454|FG001|Overall Study|non-compliance|3|||
125130916|NCT02335658|450106453|FG000|Overall Study|other reason|2|||
125130917|NCT02335658|450106454|FG001|Overall Study|other reason|3|||
125130918|NCT05341622|450106455|FG000|Overall Study|Death|0|||
125130919|NCT05341622|450106456|FG001|Overall Study|Death|0|||
125130920|NCT05341622|450106457|FG002|Overall Study|Death|0|||
125130921|NCT05341622|450106458|FG003|Overall Study|Death|0|||
125130922|NCT05341622|450106459|FG004|Overall Study|Death|1|||
125130923|NCT05341622|450106460|FG005|Overall Study|Death|0|||
125130924|NCT05341622|450106461|FG006|Overall Study|Death|0|||
125130925|NCT05341622|450106462|FG007|Overall Study|Death|1|||
125130926|NCT05341622|450106455|FG000|Overall Study|Invalid Address|0|||
125130927|NCT05341622|450106456|FG001|Overall Study|Invalid Address|1|||
125130928|NCT05341622|450106457|FG002|Overall Study|Invalid Address|0|||
125130929|NCT05341622|450106458|FG003|Overall Study|Invalid Address|0|||
125130930|NCT05341622|450106459|FG004|Overall Study|Invalid Address|0|||
125130931|NCT05341622|450106460|FG005|Overall Study|Invalid Address|0|||
125130932|NCT05341622|450106461|FG006|Overall Study|Invalid Address|0|||
125130933|NCT05341622|450106462|FG007|Overall Study|Invalid Address|0|||
125130934|NCT05341622|450106455|FG000|Overall Study|Ineligible|26|||
125130935|NCT05341622|450106456|FG001|Overall Study|Ineligible|21|||
125130936|NCT05341622|450106457|FG002|Overall Study|Ineligible|28|||
125130937|NCT05341622|450106458|FG003|Overall Study|Ineligible|24|||
125130938|NCT05341622|450106459|FG004|Overall Study|Ineligible|29|||
125130939|NCT05341622|450106460|FG005|Overall Study|Ineligible|31|||
125130940|NCT05341622|450106461|FG006|Overall Study|Ineligible|28|||
125130941|NCT05341622|450106462|FG007|Overall Study|Ineligible|26|||
125130942|NCT02658084|450106463|FG000|Overall Study|Withdrawal by Subject|1|||
125130943|NCT02658084|450106464|FG001|Overall Study|Withdrawal by Subject|0|||
125130944|NCT02658084|450106463|FG000|Overall Study|Study Termination|1|||
125130945|NCT02658084|450106464|FG001|Overall Study|Study Termination|0|||
125130946|NCT02305758|450106465|FG000|Overall Study|Death|27|||
125130947|NCT02305758|450106466|FG001|Overall Study|Death|27|||
125130948|NCT02305758|450106465|FG000|Overall Study|Withdrew consent|9|||
124968014|NCT00730015|449511279|FG000|Overall Study|Withdrawal by Subject|12|||
124968015|NCT00730015|449511280|FG001|Overall Study|Withdrawal by Subject|12|||
124968016|NCT00730015|449511281|FG002|Overall Study|Withdrawal by Subject|8|||
124968017|NCT00730015|449511279|FG000|Overall Study|Lost to Follow-up|4|||
124968018|NCT00730015|449511280|FG001|Overall Study|Lost to Follow-up|10|||
124968019|NCT00730015|449511281|FG002|Overall Study|Lost to Follow-up|3|||
124968020|NCT00730015|449511279|FG000|Overall Study|Lack of Efficacy|1|||
124968021|NCT00730015|449511280|FG001|Overall Study|Lack of Efficacy|2|||
124968022|NCT00730015|449511281|FG002|Overall Study|Lack of Efficacy|8|||
124968023|NCT00730015|449511279|FG000|Overall Study|Other Reason|1|||
124968024|NCT00730015|449511280|FG001|Overall Study|Other Reason|0|||
124968025|NCT00730015|449511281|FG002|Overall Study|Other Reason|1|||
124968026|NCT04120376|449511282|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
124968027|NCT04120376|449511283|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
124968028|NCT00634842|449511284|FG000|Overall Study|Adverse Event|2|||
124968029|NCT00634842|449511285|FG001|Overall Study|Adverse Event|3|||
124968030|NCT00634842|449511284|FG000|Overall Study|Protocol Violation|8|||
124968031|NCT00634842|449511285|FG001|Overall Study|Protocol Violation|4|||
124968032|NCT00634842|449511284|FG000|Overall Study|Move to another state|1|||
124968033|NCT00634842|449511285|FG001|Overall Study|Move to another state|0|||
124968034|NCT00634842|449511284|FG000|Overall Study|Inclusion criteria were not met|1|||
124968035|NCT00634842|449511285|FG001|Overall Study|Inclusion criteria were not met|0|||
124968036|NCT00634842|449511284|FG000|Overall Study|Lost to Follow-up|1|||
124968037|NCT00634842|449511285|FG001|Overall Study|Lost to Follow-up|2|||
124968038|NCT00634842|449511284|FG000|Overall Study|Physician Decision|1|||
124968039|NCT00634842|449511285|FG001|Overall Study|Physician Decision|0|||
124968040|NCT00634842|449511284|FG000|Overall Study|Withdrawal by Subject|1|||
124968041|NCT00634842|449511285|FG001|Overall Study|Withdrawal by Subject|3|||
124968042|NCT00634842|449511284|FG000|Overall Study|Lack of time and intolerance to drug|0|||
124968043|NCT00634842|449511285|FG001|Overall Study|Lack of time and intolerance to drug|1|||
124968044|NCT00634842|449511284|FG000|Overall Study|Discontinued due to injection|0|||
124968045|NCT00634842|449511285|FG001|Overall Study|Discontinued due to injection|2|||
124968046|NCT00634842|449511284|FG000|Overall Study|No need of study drug to treat diabetes|0|||
124968047|NCT00634842|449511285|FG001|Overall Study|No need of study drug to treat diabetes|1|||
124968048|NCT00634842|449511284|FG000|Overall Study|No wish to keep taking Avandia|0|||
124968049|NCT00634842|449511285|FG001|Overall Study|No wish to keep taking Avandia|1|||
124968050|NCT00634842|449511284|FG000|Overall Study|Subject off study drug for too long|0|||
124968051|NCT00634842|449511285|FG001|Overall Study|Subject off study drug for too long|1|||
124968052|NCT00943787|449511309|FG000|Overall Study|Physician Decision|4|||
124968053|NCT00943787|449511309|FG000|Overall Study|Withdrawal by Subject|3|||
124968054|NCT01288209|449511311|FG000|Overall Study|Withdrawal by Subject|1|||
124968055|NCT01288209|449511312|FG001|Overall Study|Withdrawal by Subject|3|||
124968056|NCT01288209|449511311|FG000|Overall Study|Other|1|||
124968057|NCT01288209|449511312|FG001|Overall Study|Other|0|||
124968058|NCT01015677|449511313|FG000|Overall Study|Adverse Event|0|||
124968059|NCT01015677|449511314|FG001|Overall Study|Adverse Event|1|||
125032489|NCT00486603|449739523|FG004|Overall Study|Physician Decision|0|||
125032490|NCT01670994|449739524|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
124968060|NCT01015677|449511315|FG002|Overall Study|Adverse Event|0|||
124968061|NCT01015677|449511313|FG000|Overall Study|Lack of Efficacy|0|||
124968062|NCT01015677|449511314|FG001|Overall Study|Lack of Efficacy|1|||
124968063|NCT01015677|449511315|FG002|Overall Study|Lack of Efficacy|0|||
124968064|NCT01015677|449511313|FG000|Overall Study|Protocol Violation|0|||
124968065|NCT01015677|449511314|FG001|Overall Study|Protocol Violation|1|||
124968066|NCT01015677|449511315|FG002|Overall Study|Protocol Violation|0|||
124968067|NCT01015677|449511313|FG000|Overall Study|Withdrawal by Subject|1|||
124968068|NCT01015677|449511314|FG001|Overall Study|Withdrawal by Subject|1|||
124968069|NCT01015677|449511315|FG002|Overall Study|Withdrawal by Subject|0|||
124968070|NCT02232399|449511316|FG000|Overall Study|Adverse Event|1|||
124968071|NCT02232399|449511317|FG001|Overall Study|Adverse Event|0|||
124968072|NCT02232399|449511316|FG000|Overall Study|Withdrawal by Subject|0|||
124968073|NCT02232399|449511317|FG001|Overall Study|Withdrawal by Subject|1|||
124968074|NCT01646385|449511320|FG000|Overall Study|Death|202|||
124968075|NCT01646385|449511321|FG001|Overall Study|Death|222|||
124968076|NCT01646385|449511320|FG000|Overall Study|Switched to alternate biologic|636|||
124968077|NCT01646385|449511321|FG001|Overall Study|Switched to alternate biologic|649|||
124968078|NCT01216072|449511322|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
124968079|NCT01216072|449511323|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
124968080|NCT01216072|449511322|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
124968081|NCT01216072|449511323|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
124968082|NCT01216072|449511322|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
124968083|NCT01216072|449511323|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
124968084|NCT01216072|449511322|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
124968085|NCT01216072|449511323|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
124968086|NCT01216072|449511322|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
124968087|NCT01216072|449511323|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
124968088|NCT01216072|449511322|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
124968089|NCT01216072|449511323|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
124968090|NCT01216072|449511322|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
124968091|NCT01216072|449511323|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
124968092|NCT01216072|449511322|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
124968093|NCT01216072|449511323|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
124968094|NCT01216072|449511322|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
124968095|NCT01216072|449511323|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
124968096|NCT01216072|449511322|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
125130949|NCT02305758|450106466|FG001|Overall Study|Withdrew consent|2|||
125130950|NCT02305758|450106465|FG000|Overall Study|Lost to Follow-up|6|||
125130951|NCT02305758|450106466|FG001|Overall Study|Lost to Follow-up|1|||
125130952|NCT02305758|450106465|FG000|Overall Study|Study Terminated by Sponsor|21|||
125130953|NCT02305758|450106466|FG001|Overall Study|Study Terminated by Sponsor|34|||
125130954|NCT02305758|450106465|FG000|Overall Study|Other, not specified|2|||
125130955|NCT02305758|450106466|FG001|Overall Study|Other, not specified|1|||
125130956|NCT02032888|450106469|FG000|Treatment Period|Poor compliance/noncompliance|1|||
124968097|NCT01216072|449511323|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
124968098|NCT04294667|449511325|FG000|Overall Study|Lack of Efficacy|4|||
124968099|NCT04294667|449511326|FG001|Overall Study|Lack of Efficacy|4|||
124968100|NCT04294667|449511325|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
124968101|NCT04294667|449511326|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
124968102|NCT04294667|449511325|FG000|Overall Study|Patient has a Renal Flare|1|||
124968103|NCT04294667|449511326|FG001|Overall Study|Patient has a Renal Flare|0|||
124968104|NCT04294667|449511325|FG000|Overall Study|SLE Worsening|0|||
124968105|NCT04294667|449511326|FG001|Overall Study|SLE Worsening|1|||
124968106|NCT04294667|449511325|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
124968107|NCT04294667|449511326|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
124968108|NCT04294667|449511325|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
124968109|NCT04294667|449511326|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
124968110|NCT04294667|449511325|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
124968111|NCT04294667|449511326|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
124968112|NCT04294667|449511325|FG000|Overall Study|Subject Moved to Another State|0|||
124968113|NCT04294667|449511326|FG001|Overall Study|Subject Moved to Another State|1|||
124968114|NCT04294667|449511325|FG000|Overall Study|Adverse event, serious fatal|0|||
124968115|NCT04294667|449511326|FG001|Overall Study|Adverse event, serious fatal|1|||
124968116|NCT04294667|449511325|FG000|Overall Study|Adverse event, non-fatal|3|||
124968117|NCT04294667|449511326|FG001|Overall Study|Adverse event, non-fatal|4|||
124968118|NCT04799418|449511327|FG000|Overall Study|Death|1|||
124968119|NCT04799418|449511328|FG001|Overall Study|Death|1|||
125130957|NCT02032888|450106470|FG001|Treatment Period|Poor compliance/noncompliance|1|||
125130958|NCT02032888|450106471|FG002|Treatment Period|Poor compliance/noncompliance|0|||
124968120|NCT04799418|449511327|FG000|Overall Study|Lack of Efficacy|14|||
124968121|NCT04799418|449511328|FG001|Overall Study|Lack of Efficacy|14|||
124968122|NCT04799418|449511327|FG000|Overall Study|Withdrawal by Subject|10|||
124968123|NCT04799418|449511328|FG001|Overall Study|Withdrawal by Subject|7|||
124968124|NCT04799418|449511327|FG000|Overall Study|Adverse Event|3|||
124968125|NCT04799418|449511328|FG001|Overall Study|Adverse Event|2|||
124968126|NCT00952848|449511331|FG000|Overall Study|Withdrawal by Subject|4|||
125130959|NCT02032888|450106469|FG000|Treatment Period|Other|1|||
125216837|NCT04378569|450421930|FG004|Overall Study|Lack of response|1|||
125216838|NCT04378569|450421931|FG005|Overall Study|Lack of response|1|||
124968127|NCT00537329|449511332|FG000|Overall Study|Death|10|||
124968128|NCT00537329|449511332|FG000|Overall Study|Adverse Event|3|||
124968129|NCT00537329|449511332|FG000|Overall Study|Lack of Efficacy|2|||
124968130|NCT00537329|449511332|FG000|Overall Study|Lost to Follow-up|6|||
124968131|NCT00537329|449511332|FG000|Overall Study|Withdrawal by Subject|4|||
124968132|NCT00537329|449511332|FG000|Overall Study|Other|1|||
125216839|NCT01962948|450421932|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
125216840|NCT01962948|450421933|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
125216841|NCT01962948|450421934|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
125216842|NCT01962948|450421935|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
125216843|NCT03630705|450421936|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
125216844|NCT03630705|450421937|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
125216845|NCT03630705|450421938|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
125216846|NCT03630705|450421939|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
124968133|NCT02049515|449511333|FG000|Overall Study|Adverse Event|46|||
124968134|NCT02049515|449511334|FG001|Overall Study|Adverse Event|2|||
124968135|NCT02049515|449511333|FG000|Overall Study|Protocol-specified Disease Progression|23|||
124968136|NCT02049515|449511334|FG001|Overall Study|Protocol-specified Disease Progression|2|||
124968137|NCT02049515|449511333|FG000|Overall Study|Death|6|||
124968138|NCT02049515|449511334|FG001|Overall Study|Death|0|||
124968139|NCT02049515|449511333|FG000|Overall Study|Physician Decision|5|||
124968140|NCT02049515|449511334|FG001|Overall Study|Physician Decision|1|||
124968141|NCT02049515|449511333|FG000|Overall Study|Withdrawal by Subject|3|||
124968142|NCT02049515|449511334|FG001|Overall Study|Withdrawal by Subject|0|||
124968143|NCT02049515|449511333|FG000|Overall Study|Termination of the Study by Sponsor|2|||
124968144|NCT02049515|449511334|FG001|Overall Study|Termination of the Study by Sponsor|0|||
124968145|NCT02049515|449511333|FG000|Overall Study|Protocol Violation|1|||
124968146|NCT02049515|449511334|FG001|Overall Study|Protocol Violation|1|||
124968147|NCT02049515|449511333|FG000|Overall Study|Clinical Deterioration|1|||
124968148|NCT02049515|449511334|FG001|Overall Study|Clinical Deterioration|0|||
124968149|NCT02049515|449511333|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
124968150|NCT02049515|449511334|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
124968151|NCT02049515|449511333|FG000|Overall Study|Treatment Interruption >42 Days|1|||
125033629|NCT01701258|449743828|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
125216847|NCT03630705|450421936|FG000|Overall Study|Lost to Follow-up|1|||
124968152|NCT02049515|449511334|FG001|Overall Study|Treatment Interruption >42 Days|0|||
124968153|NCT02049515|449511333|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
124968154|NCT02049515|449511334|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
124968155|NCT02138253|449511336|FG000|Overall Study|Adverse Event|3|||
124968156|NCT02138253|449511337|FG001|Overall Study|Adverse Event|3|||
124968157|NCT02138253|449511336|FG000|Overall Study|Lost to Follow-up|2|||
124968158|NCT02138253|449511337|FG001|Overall Study|Lost to Follow-up|1|||
124968159|NCT02138253|449511336|FG000|Overall Study|Physician Decision|2|||
124968160|NCT02138253|449511337|FG001|Overall Study|Physician Decision|0|||
124968161|NCT02138253|449511336|FG000|Overall Study|Non compliance|1|||
124968162|NCT02138253|449511337|FG001|Overall Study|Non compliance|0|||
124968163|NCT02138253|449511336|FG000|Overall Study|Withdrawal by Subject|1|||
124968164|NCT02138253|449511337|FG001|Overall Study|Withdrawal by Subject|0|||
124968165|NCT01426113|449511338|FG000|Overall Study|Study Discontinued|1|||
124968166|NCT01426113|449511339|FG001|Overall Study|Study Discontinued|1|||
124968167|NCT01426113|449511338|FG000|Overall Study|Adverse Event|0|||
124968168|NCT01426113|449511339|FG001|Overall Study|Adverse Event|1|||
124968169|NCT00224029|449511340|FG000|Overall Study|Lost to Follow-up|1|||
124968170|NCT00224029|449511340|FG000|Overall Study|Withdrawal by Subject|4|||
124968171|NCT00224029|449511340|FG000|Overall Study|Other|1|||
124968172|NCT02872012|449511341|FG000|Overall Study|Withdrawal by Subject|1|||
124968173|NCT02872012|449511342|FG001|Overall Study|Withdrawal by Subject|0|||
124968174|NCT02872012|449511343|FG002|Overall Study|Withdrawal by Subject|0|||
124968175|NCT02872012|449511344|FG003|Overall Study|Withdrawal by Subject|0|||
124968176|NCT02872012|449511345|FG004|Overall Study|Withdrawal by Subject|0|||
124968177|NCT02725528|449511348|FG000|Overall Study|Lost to Follow-up|1|||
124968178|NCT02725528|449511349|FG001|Overall Study|Lost to Follow-up|4|||
124968179|NCT02725528|449511348|FG000|Overall Study|Withdrawal by Subject|0|||
124968180|NCT02725528|449511349|FG001|Overall Study|Withdrawal by Subject|1|||
124968181|NCT02569957|449511350|FG000|Overall Study|Withdrawal by Subject|0|||
124968182|NCT02569957|449511351|FG001|Overall Study|Withdrawal by Subject|1|||
124968183|NCT02635386|449511352|FG000|Overall Study|Pregnancy|2|||
124968184|NCT02635386|449511353|FG001|Overall Study|Pregnancy|0|||
124968185|NCT02635386|449511354|FG002|Overall Study|Pregnancy|0|||
124968186|NCT02635386|449511355|FG003|Overall Study|Pregnancy|0|||
124968187|NCT02635386|449511356|FG004|Overall Study|Pregnancy|2|||
124968188|NCT02635386|449511352|FG000|Overall Study|Withdrawal by Subject|1|||
124968189|NCT02635386|449511353|FG001|Overall Study|Withdrawal by Subject|1|||
124968190|NCT02635386|449511354|FG002|Overall Study|Withdrawal by Subject|0|||
124968191|NCT02635386|449511355|FG003|Overall Study|Withdrawal by Subject|1|||
124968192|NCT02635386|449511356|FG004|Overall Study|Withdrawal by Subject|0|||
124968193|NCT02635386|449511352|FG000|Overall Study|Physician Decision|0|||
124968194|NCT02635386|449511353|FG001|Overall Study|Physician Decision|1|||
124968195|NCT02635386|449511354|FG002|Overall Study|Physician Decision|0|||
125130960|NCT02032888|450106470|FG001|Treatment Period|Other|1|||
125130961|NCT02032888|450106471|FG002|Treatment Period|Other|0|||
125130962|NCT02032888|450106469|FG000|Follow-up Period|Lost to Follow-up|1|||
125130963|NCT02032888|450106470|FG001|Follow-up Period|Lost to Follow-up|1|||
125130964|NCT02032888|450106471|FG002|Follow-up Period|Lost to Follow-up|0|||
125130965|NCT02032888|450106469|FG000|Follow-up Period|Death|1|||
125130966|NCT02032888|450106470|FG001|Follow-up Period|Death|1|||
125130967|NCT02032888|450106471|FG002|Follow-up Period|Death|0|||
125130968|NCT02032888|450106469|FG000|Follow-up Period|Other|1|||
125130969|NCT02032888|450106470|FG001|Follow-up Period|Other|0|||
125130970|NCT02032888|450106471|FG002|Follow-up Period|Other|0|||
125130971|NCT03616106|450106474|FG000|Overall Study|Removed by PI|6|||
125130972|NCT03616106|450106475|FG001|Overall Study|Removed by PI|0|||
125130973|NCT03616106|450106474|FG000|Overall Study|Withdrawal by Subject|1|||
125130974|NCT03616106|450106475|FG001|Overall Study|Withdrawal by Subject|1|||
125130975|NCT03616106|450106474|FG000|Overall Study|Lost to Follow-up|7|||
125130976|NCT03616106|450106475|FG001|Overall Study|Lost to Follow-up|0|||
125130977|NCT03206177|450106477|FG000|Overall Study|Withdrawal by Subject|1|||
125130978|NCT04611789|450106479|FG000|Overall Study|Lost to Follow-up|1|||
125130979|NCT04611789|450106480|FG001|Overall Study|Lost to Follow-up|0|||
125130980|NCT04611789|450106481|FG002|Overall Study|Lost to Follow-up|0|||
125130981|NCT03880266|450106482|FG000|Overall Study|Withdrawal by Subject|0|||
125130982|NCT03880266|450106483|FG001|Overall Study|Withdrawal by Subject|1|||
125130983|NCT03880266|450106484|FG002|Overall Study|Withdrawal by Subject|1|||
125130984|NCT03880266|450106485|FG003|Overall Study|Withdrawal by Subject|0|||
125130985|NCT03880266|450106486|FG004|Overall Study|Withdrawal by Subject|0|||
125130986|NCT03880266|450106487|FG005|Overall Study|Withdrawal by Subject|0|||
125130987|NCT03880266|450106488|FG006|Overall Study|Withdrawal by Subject|0|||
125130988|NCT03880266|450106489|FG007|Overall Study|Withdrawal by Subject|0|||
125130989|NCT03161405|450106490|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
125130990|NCT00837486|450106491|FG000|Blinded-treatment Phase|Physician Decision|1|||
125130991|NCT00837486|450106492|FG001|Blinded-treatment Phase|Physician Decision|0|||
125130992|NCT00837486|450106491|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
125130993|NCT00837486|450106492|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
125130994|NCT00837486|450106491|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
125130995|NCT00837486|450106492|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
125130996|NCT00837486|450106491|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
125130997|NCT00837486|450106492|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
125130998|NCT02655679|450106493|FG000|Overall Study|Adverse Event|0|||
125130999|NCT02655679|450106494|FG001|Overall Study|Adverse Event|1|||
124968196|NCT02635386|449511355|FG003|Overall Study|Physician Decision|0|||
124968197|NCT02635386|449511356|FG004|Overall Study|Physician Decision|0|||
124968198|NCT02635386|449511352|FG000|Overall Study|Moved Out of State|0|||
124968199|NCT02635386|449511353|FG001|Overall Study|Moved Out of State|1|||
124968200|NCT02635386|449511354|FG002|Overall Study|Moved Out of State|0|||
124968201|NCT02635386|449511355|FG003|Overall Study|Moved Out of State|0|||
124968202|NCT02635386|449511356|FG004|Overall Study|Moved Out of State|0|||
124968203|NCT02635386|449511352|FG000|Overall Study|Noncompliant|0|||
124968204|NCT02635386|449511353|FG001|Overall Study|Noncompliant|2|||
124968205|NCT02635386|449511354|FG002|Overall Study|Noncompliant|1|||
124968206|NCT02635386|449511355|FG003|Overall Study|Noncompliant|1|||
124968207|NCT02635386|449511356|FG004|Overall Study|Noncompliant|1|||
124968208|NCT02635386|449511352|FG000|Overall Study|side effects|0|||
124968209|NCT02635386|449511353|FG001|Overall Study|side effects|0|||
124968210|NCT02635386|449511354|FG002|Overall Study|side effects|1|||
124968211|NCT02635386|449511355|FG003|Overall Study|side effects|4|||
124968212|NCT02635386|449511356|FG004|Overall Study|side effects|6|||
124968213|NCT02635386|449511352|FG000|Overall Study|needed other major surgery|0|||
125032491|NCT01670994|449739525|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
125032492|NCT01670994|449739524|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
125032493|NCT01670994|449739525|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
125032494|NCT01670994|449739524|FG000|Overall Study|Patient experienced DLT|0|||
125032495|NCT01670994|449739525|FG001|Overall Study|Patient experienced DLT|1|||
125032496|NCT02013544|449739526|FG000|Overall Study|Adverse Event|5|||
125032497|NCT02013544|449739527|FG001|Overall Study|Adverse Event|5|||
125032498|NCT02013544|449739526|FG000|Overall Study|Lost to Follow-up|2|||
125032499|NCT02013544|449739527|FG001|Overall Study|Lost to Follow-up|3|||
125032500|NCT02013544|449739526|FG000|Overall Study|Withdrawal by Subject|2|||
125032501|NCT02013544|449739527|FG001|Overall Study|Withdrawal by Subject|8|||
125032502|NCT02013544|449739526|FG000|Overall Study|Physician Decision|0|||
125032503|NCT02013544|449739527|FG001|Overall Study|Physician Decision|1|||
125032504|NCT02013544|449739526|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
125032505|NCT02013544|449739527|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
125032506|NCT01295125|449739528|FG000|Overall Study|Study stopped prematurely|9|||
125032507|NCT00885365|449739531|FG000|4 Weeks ON Treatment|Adverse Event|2|||
125032508|NCT00885365|449739532|FG001|4 Weeks ON Treatment|Adverse Event|4|||
125032509|NCT00885365|449739531|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
125032510|NCT00885365|449739532|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
125032511|NCT00885365|449739531|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
125032512|NCT00885365|449739532|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
125032513|NCT01824979|449739533|FG000|Overall Study|Withdrawal by Subject|5|||
125032514|NCT01824979|449739534|FG001|Overall Study|Withdrawal by Subject|0|||
125032515|NCT01824979|449739533|FG000|Overall Study|Physician Decision|2|||
125032516|NCT01824979|449739534|FG001|Overall Study|Physician Decision|0|||
125032517|NCT01824979|449739533|FG000|Overall Study|Protocol Violation|6|||
125032518|NCT01824979|449739534|FG001|Overall Study|Protocol Violation|13|||
125032519|NCT02507349|449739536|FG000|Overall Study|Death|12|||
125032520|NCT02507349|449739537|FG001|Overall Study|Death|16|||
125032521|NCT02507349|449739536|FG000|Overall Study|Withdrawal by Subject|1|||
124968214|NCT02635386|449511353|FG001|Overall Study|needed other major surgery|1|||
124968215|NCT02635386|449511354|FG002|Overall Study|needed other major surgery|0|||
124968216|NCT02635386|449511355|FG003|Overall Study|needed other major surgery|0|||
124968217|NCT02635386|449511356|FG004|Overall Study|needed other major surgery|0|||
124968218|NCT02635386|449511352|FG000|Overall Study|Other medical problems not drug related|0|||
124968219|NCT02635386|449511353|FG001|Overall Study|Other medical problems not drug related|0|||
124968220|NCT02635386|449511354|FG002|Overall Study|Other medical problems not drug related|0|||
124968221|NCT02635386|449511355|FG003|Overall Study|Other medical problems not drug related|1|||
124968222|NCT02635386|449511356|FG004|Overall Study|Other medical problems not drug related|0|||
125216848|NCT03630705|450421937|FG001|Overall Study|Lost to Follow-up|2|||
125216849|NCT03630705|450421938|FG002|Overall Study|Lost to Follow-up|0|||
125216850|NCT03630705|450421939|FG003|Overall Study|Lost to Follow-up|0|||
125216851|NCT04727528|450421942|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
125216852|NCT04727528|450421943|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
125216853|NCT04727528|450421942|FG000|Open-label Period|Randomized who did not receive treatment|1|||
125216854|NCT04727528|450421943|FG001|Open-label Period|Randomized who did not receive treatment|0|||
125216855|NCT04727528|450421942|FG000|Double-blind Treatment Phase|Adverse Event|0|||
125216856|NCT04727528|450421943|FG001|Double-blind Treatment Phase|Adverse Event|1|||
125216857|NCT04727528|450421942|FG000|Double-blind Treatment Phase|Death|0|||
125216858|NCT04727528|450421943|FG001|Double-blind Treatment Phase|Death|1|||
125216859|NCT04727528|450421942|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
125216860|NCT04727528|450421943|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
125216861|NCT04727528|450421942|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
125216862|NCT04727528|450421943|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
125216863|NCT04727528|450421942|FG000|Double-blind Treatment Phase|Physician Decision|0|||
125216864|NCT04727528|450421943|FG001|Double-blind Treatment Phase|Physician Decision|1|||
125216865|NCT04727528|450421942|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
125216866|NCT04727528|450421943|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125216867|NCT01763827|450421944|FG000|Overall Study|Withdrawal by Subject|1|||
125216868|NCT01763827|450421945|FG001|Overall Study|Withdrawal by Subject|0|||
125216869|NCT01763827|450421946|FG002|Overall Study|Withdrawal by Subject|0|||
125216870|NCT01763827|450421947|FG003|Overall Study|Withdrawal by Subject|0|||
125216871|NCT01763827|450421948|FG004|Overall Study|Withdrawal by Subject|2|||
125216872|NCT01763827|450421949|FG005|Overall Study|Withdrawal by Subject|0|||
125216873|NCT01763827|450421944|FG000|Overall Study|Decision by sponsor|2|||
125216874|NCT01763827|450421945|FG001|Overall Study|Decision by sponsor|0|||
125216875|NCT01763827|450421946|FG002|Overall Study|Decision by sponsor|3|||
125216876|NCT01763827|450421947|FG003|Overall Study|Decision by sponsor|0|||
125216877|NCT01763827|450421948|FG004|Overall Study|Decision by sponsor|2|||
124968223|NCT01209598|449511357|FG000|Overall Study|Withdrawal by Subject|1|||
124968224|NCT01209598|449511358|FG001|Overall Study|Withdrawal by Subject|0|||
124968225|NCT02719743|449511359|FG000|Overall Study|Consent withdrawal|0|||
124968226|NCT02719743|449511360|FG001|Overall Study|Consent withdrawal|2|||
124968227|NCT02719743|449511361|FG002|Overall Study|Consent withdrawal|0|||
125216878|NCT01763827|450421949|FG005|Overall Study|Decision by sponsor|1|||
125216879|NCT01763827|450421944|FG000|Overall Study|Lost to Follow-up|0|||
125216880|NCT01763827|450421945|FG001|Overall Study|Lost to Follow-up|1|||
125216881|NCT01763827|450421946|FG002|Overall Study|Lost to Follow-up|1|||
124968228|NCT02719743|449511362|FG003|Overall Study|Consent withdrawal|1|||
125216882|NCT01763827|450421947|FG003|Overall Study|Lost to Follow-up|1|||
125216883|NCT01763827|450421948|FG004|Overall Study|Lost to Follow-up|2|||
125216884|NCT01763827|450421949|FG005|Overall Study|Lost to Follow-up|1|||
125216885|NCT02906579|450421950|FG000|Overall Study|Adverse Event|1|||
125216886|NCT02906579|450421950|FG000|Overall Study|Physician Decision|1|||
125216887|NCT01826981|450421953|FG000|Overall Study|Lack of Efficacy|0|||
125216888|NCT01826981|450421954|FG001|Overall Study|Lack of Efficacy|1|||
125216889|NCT01826981|450421955|FG002|Overall Study|Lack of Efficacy|0|||
125216890|NCT01826981|450421956|FG003|Overall Study|Lack of Efficacy|0|||
125216891|NCT01826981|450421957|FG004|Overall Study|Lack of Efficacy|5|||
125216892|NCT01826981|450421958|FG005|Overall Study|Lack of Efficacy|0|||
125216893|NCT01826981|450421959|FG006|Overall Study|Lack of Efficacy|0|||
125216894|NCT01826981|450421960|FG007|Overall Study|Lack of Efficacy|8|||
125216895|NCT01826981|450421961|FG008|Overall Study|Lack of Efficacy|7|||
125216896|NCT01826981|450421962|FG009|Overall Study|Lack of Efficacy|0|||
125216897|NCT01826981|450421963|FG010|Overall Study|Lack of Efficacy|1|||
125216898|NCT01826981|450421964|FG011|Overall Study|Lack of Efficacy|0|||
125216899|NCT01826981|450421965|FG012|Overall Study|Lack of Efficacy|0|||
125216900|NCT01826981|450421966|FG013|Overall Study|Lack of Efficacy|3|||
125216901|NCT01826981|450421967|FG014|Overall Study|Lack of Efficacy|0|||
125216902|NCT01826981|450421953|FG000|Overall Study|Lost to Follow-up|0|||
125216903|NCT01826981|450421954|FG001|Overall Study|Lost to Follow-up|0|||
125216904|NCT01826981|450421955|FG002|Overall Study|Lost to Follow-up|0|||
125216905|NCT01826981|450421956|FG003|Overall Study|Lost to Follow-up|0|||
125216906|NCT01826981|450421957|FG004|Overall Study|Lost to Follow-up|1|||
125216907|NCT01826981|450421958|FG005|Overall Study|Lost to Follow-up|1|||
125216908|NCT01826981|450421959|FG006|Overall Study|Lost to Follow-up|0|||
125216909|NCT01826981|450421960|FG007|Overall Study|Lost to Follow-up|1|||
125216910|NCT01826981|450421961|FG008|Overall Study|Lost to Follow-up|0|||
125216911|NCT01826981|450421962|FG009|Overall Study|Lost to Follow-up|1|||
125216912|NCT01826981|450421963|FG010|Overall Study|Lost to Follow-up|1|||
125216913|NCT01826981|450421964|FG011|Overall Study|Lost to Follow-up|1|||
125216914|NCT01826981|450421965|FG012|Overall Study|Lost to Follow-up|1|||
125216915|NCT01826981|450421966|FG013|Overall Study|Lost to Follow-up|0|||
125216916|NCT01826981|450421967|FG014|Overall Study|Lost to Follow-up|0|||
125216917|NCT01826981|450421953|FG000|Overall Study|Withdrew Consent|0|||
125216918|NCT01826981|450421954|FG001|Overall Study|Withdrew Consent|0|||
125216919|NCT01826981|450421955|FG002|Overall Study|Withdrew Consent|0|||
125216920|NCT01826981|450421956|FG003|Overall Study|Withdrew Consent|0|||
125216921|NCT01826981|450421957|FG004|Overall Study|Withdrew Consent|0|||
125216922|NCT01826981|450421958|FG005|Overall Study|Withdrew Consent|0|||
125216923|NCT01826981|450421959|FG006|Overall Study|Withdrew Consent|1|||
125216924|NCT01826981|450421960|FG007|Overall Study|Withdrew Consent|1|||
124968229|NCT02719743|449511363|FG004|Overall Study|Consent withdrawal|0|||
124968230|NCT02719743|449511359|FG000|Overall Study|Migrated/moved from study area|0|||
124968231|NCT02719743|449511360|FG001|Overall Study|Migrated/moved from study area|0|||
125216925|NCT01826981|450421961|FG008|Overall Study|Withdrew Consent|0|||
125216926|NCT01826981|450421962|FG009|Overall Study|Withdrew Consent|0|||
125216927|NCT01826981|450421963|FG010|Overall Study|Withdrew Consent|0|||
125216928|NCT01826981|450421964|FG011|Overall Study|Withdrew Consent|1|||
125216929|NCT01826981|450421965|FG012|Overall Study|Withdrew Consent|0|||
125216930|NCT01826981|450421966|FG013|Overall Study|Withdrew Consent|1|||
125216931|NCT01826981|450421967|FG014|Overall Study|Withdrew Consent|0|||
125216932|NCT01826981|450421953|FG000|Overall Study|Adverse Event|0|||
125216933|NCT01826981|450421954|FG001|Overall Study|Adverse Event|0|||
124968232|NCT02719743|449511361|FG002|Overall Study|Migrated/moved from study area|0|||
125216934|NCT01826981|450421955|FG002|Overall Study|Adverse Event|0|||
125216935|NCT01826981|450421956|FG003|Overall Study|Adverse Event|0|||
125216936|NCT01826981|450421957|FG004|Overall Study|Adverse Event|1|||
125216937|NCT01826981|450421958|FG005|Overall Study|Adverse Event|0|||
125032522|NCT02507349|449739537|FG001|Overall Study|Withdrawal by Subject|1|||
125032523|NCT02507349|449739536|FG000|Overall Study|Lost to Follow-up|174|||
125032524|NCT02507349|449739537|FG001|Overall Study|Lost to Follow-up|144|||
125032525|NCT00888238|449739538|FG000|Washout Period After Period 2|Adverse Event|0|||
125032526|NCT00888238|449739539|FG001|Washout Period After Period 2|Adverse Event|0|||
125032527|NCT00888238|449739540|FG002|Washout Period After Period 2|Adverse Event|1|||
125032528|NCT03371355|449739551|FG000|Overall Study|Investigator judgment|0|||
125032529|NCT03371355|449739552|FG001|Overall Study|Investigator judgment|0|||
125032530|NCT03371355|449739553|FG002|Overall Study|Investigator judgment|1|||
125032531|NCT03371355|449739554|FG003|Overall Study|Investigator judgment|1|||
125032532|NCT03371355|449739551|FG000|Overall Study|Voluntary withdrawal|1|||
125032533|NCT03371355|449739552|FG001|Overall Study|Voluntary withdrawal|0|||
125032534|NCT03371355|449739553|FG002|Overall Study|Voluntary withdrawal|1|||
125032535|NCT03371355|449739554|FG003|Overall Study|Voluntary withdrawal|2|||
125032536|NCT03371355|449739551|FG000|Overall Study|Adverse Event|0|||
125032537|NCT03371355|449739552|FG001|Overall Study|Adverse Event|1|||
125032538|NCT03371355|449739553|FG002|Overall Study|Adverse Event|2|||
125032539|NCT03371355|449739554|FG003|Overall Study|Adverse Event|3|||
125032540|NCT03371355|449739551|FG000|Overall Study|Reason not Specified|0|||
125032541|NCT03371355|449739552|FG001|Overall Study|Reason not Specified|1|||
125032542|NCT03371355|449739553|FG002|Overall Study|Reason not Specified|0|||
125032543|NCT03371355|449739554|FG003|Overall Study|Reason not Specified|1|||
125032544|NCT00977470|449739557|FG000|Overall Study|Lack of Efficacy|32|||
125032545|NCT00977470|449739558|FG001|Overall Study|Lack of Efficacy|30|||
125032546|NCT00977470|449739557|FG000|Overall Study|Physician Decision|2|||
125032547|NCT00977470|449739558|FG001|Overall Study|Physician Decision|0|||
125032548|NCT00977470|449739557|FG000|Overall Study|Adverse Event|1|||
125032549|NCT00977470|449739558|FG001|Overall Study|Adverse Event|2|||
125032550|NCT00977470|449739557|FG000|Overall Study|Protocol Violation|1|||
125032551|NCT00977470|449739558|FG001|Overall Study|Protocol Violation|0|||
125032552|NCT00977470|449739557|FG000|Overall Study|Withdrawal by Subject|0|||
125032553|NCT00977470|449739558|FG001|Overall Study|Withdrawal by Subject|2|||
125032554|NCT00977470|449739557|FG000|Overall Study|Death|0|||
125032555|NCT00977470|449739558|FG001|Overall Study|Death|2|||
125032556|NCT00977470|449739557|FG000|Overall Study|clinical decline|0|||
125032557|NCT00977470|449739558|FG001|Overall Study|clinical decline|1|||
125032558|NCT00977470|449739557|FG000|Overall Study|prolonged recovery post-surgery|0|||
125032559|NCT00977470|449739558|FG001|Overall Study|prolonged recovery post-surgery|1|||
125032560|NCT00977470|449739557|FG000|Overall Study|Still on-study|2|||
125032561|NCT00977470|449739558|FG001|Overall Study|Still on-study|0|||
125032562|NCT03529409|449739564|FG000|Randomized|Lost to Follow-up|0|||
125032563|NCT03529409|449739565|FG001|Randomized|Lost to Follow-up|0|||
125032564|NCT03529409|449739566|FG002|Randomized|Lost to Follow-up|4|||
125032565|NCT03529409|449739564|FG000|Randomized|Excluded|0|||
125032566|NCT03529409|449739565|FG001|Randomized|Excluded|0|||
125032567|NCT03529409|449739566|FG002|Randomized|Excluded|1|||
125032568|NCT03529409|449739564|FG000|Post-treatment Assessment|Death|1|||
125032569|NCT03529409|449739565|FG001|Post-treatment Assessment|Death|0|||
125032570|NCT03529409|449739566|FG002|Post-treatment Assessment|Death|0|||
125032571|NCT03529409|449739564|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
125032572|NCT03529409|449739565|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
125032573|NCT03529409|449739566|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
125032574|NCT03529409|449739564|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
125032575|NCT03529409|449739565|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
125032576|NCT03529409|449739566|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
125032577|NCT03529409|449739564|FG000|Follow-up Assessment|Death|1|||
125032578|NCT03529409|449739565|FG001|Follow-up Assessment|Death|0|||
125032579|NCT03529409|449739566|FG002|Follow-up Assessment|Death|0|||
125032580|NCT03529409|449739564|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
125032581|NCT03529409|449739565|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
125032582|NCT03529409|449739566|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
125032583|NCT02040142|449739567|FG000|Overall Study|Lost to Follow-up|5|||
125032584|NCT02040142|449739567|FG000|Overall Study|Death|17|||
125131000|NCT02655679|450106495|FG002|Overall Study|Adverse Event|0|||
125216938|NCT01826981|450421959|FG006|Overall Study|Adverse Event|0|||
125216939|NCT01826981|450421960|FG007|Overall Study|Adverse Event|0|||
125216940|NCT01826981|450421961|FG008|Overall Study|Adverse Event|0|||
125216941|NCT01826981|450421962|FG009|Overall Study|Adverse Event|0|||
125216942|NCT01826981|450421963|FG010|Overall Study|Adverse Event|0|||
125216943|NCT01826981|450421964|FG011|Overall Study|Adverse Event|0|||
125216944|NCT01826981|450421965|FG012|Overall Study|Adverse Event|0|||
125216945|NCT01826981|450421966|FG013|Overall Study|Adverse Event|0|||
125216946|NCT01826981|450421967|FG014|Overall Study|Adverse Event|0|||
125216947|NCT01826981|450421953|FG000|Overall Study|Upper G-I Haemorrhage|0|||
125216948|NCT01826981|450421954|FG001|Overall Study|Upper G-I Haemorrhage|0|||
125216949|NCT01826981|450421955|FG002|Overall Study|Upper G-I Haemorrhage|0|||
125216950|NCT01826981|450421956|FG003|Overall Study|Upper G-I Haemorrhage|0|||
125216951|NCT01826981|450421957|FG004|Overall Study|Upper G-I Haemorrhage|0|||
125216952|NCT01826981|450421958|FG005|Overall Study|Upper G-I Haemorrhage|0|||
125216953|NCT01826981|450421959|FG006|Overall Study|Upper G-I Haemorrhage|0|||
125216954|NCT01826981|450421960|FG007|Overall Study|Upper G-I Haemorrhage|0|||
125216955|NCT01826981|450421961|FG008|Overall Study|Upper G-I Haemorrhage|0|||
125216956|NCT01826981|450421962|FG009|Overall Study|Upper G-I Haemorrhage|0|||
125216957|NCT01826981|450421963|FG010|Overall Study|Upper G-I Haemorrhage|0|||
125216958|NCT01826981|450421964|FG011|Overall Study|Upper G-I Haemorrhage|0|||
125216959|NCT01826981|450421965|FG012|Overall Study|Upper G-I Haemorrhage|0|||
125216960|NCT01826981|450421966|FG013|Overall Study|Upper G-I Haemorrhage|1|||
125216961|NCT01826981|450421967|FG014|Overall Study|Upper G-I Haemorrhage|0|||
125216962|NCT01826981|450421953|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216963|NCT01826981|450421954|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216964|NCT01826981|450421955|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216965|NCT01826981|450421956|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216966|NCT01826981|450421957|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216967|NCT01826981|450421958|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216968|NCT01826981|450421959|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216969|NCT01826981|450421960|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
125216970|NCT01826981|450421961|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216971|NCT01826981|450421962|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216972|NCT01826981|450421963|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216973|NCT01826981|450421964|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216974|NCT01826981|450421965|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216975|NCT01826981|450421966|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216976|NCT01826981|450421967|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216977|NCT02030119|450421970|FG000|Overall Study|Withdrawal by Subject|3|||
125216978|NCT02030119|450421971|FG001|Overall Study|Withdrawal by Subject|1|||
125216979|NCT02030119|450421972|FG002|Overall Study|Withdrawal by Subject|5|||
125216980|NCT02030119|450421973|FG003|Overall Study|Withdrawal by Subject|3|||
125216981|NCT02030119|450421970|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
125216982|NCT02030119|450421971|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
125216983|NCT02030119|450421972|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
125216984|NCT02030119|450421973|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
125216985|NCT00759655|450421974|FG000|Overall Study|Termination of the study by sponsor|1|||
125216986|NCT02793947|450421975|FG000|Overall Study|Death|1|||
125216987|NCT02793947|450421976|FG001|Overall Study|Death|0|||
125216988|NCT02793947|450421975|FG000|Overall Study|Physician Decision|1|||
125216989|NCT02793947|450421976|FG001|Overall Study|Physician Decision|5|||
125216990|NCT03479008|450421983|FG000|Overall Study|Withdrawal by Subject|3|||
125216991|NCT01310127|450421984|FG000|Overall Study|Protocol Violation|1|||
125131001|NCT02655679|450106496|FG003|Overall Study|Adverse Event|0|||
125131002|NCT02655679|450106497|FG004|Overall Study|Adverse Event|0|||
125131003|NCT02655679|450106493|FG000|Overall Study|Withdrawal by Subject|1|||
125131004|NCT02655679|450106494|FG001|Overall Study|Withdrawal by Subject|1|||
125131005|NCT02655679|450106495|FG002|Overall Study|Withdrawal by Subject|0|||
125131006|NCT02655679|450106496|FG003|Overall Study|Withdrawal by Subject|3|||
125131007|NCT02655679|450106497|FG004|Overall Study|Withdrawal by Subject|1|||
125131008|NCT02655679|450106493|FG000|Overall Study|Inability to Comply with the Protocol|1|||
125131009|NCT02655679|450106494|FG001|Overall Study|Inability to Comply with the Protocol|0|||
125216992|NCT01310127|450421985|FG001|Overall Study|Protocol Violation|1|||
125216993|NCT01310127|450421984|FG000|Overall Study|advanced psc cataract outlier|1|||
125216994|NCT01310127|450421985|FG001|Overall Study|advanced psc cataract outlier|0|||
125216995|NCT00412932|450421986|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
125216996|NCT00412932|450421986|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
125216997|NCT00412932|450421986|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
125216998|NCT00412932|450421986|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
125216999|NCT00412932|450421986|FG000|Olmesartan (Olm) 20 mg|Other|1|||
125217000|NCT00412932|450421986|FG000|Olmesartan 40 mg|Adverse Event|4|||
124968233|NCT02719743|449511362|FG003|Overall Study|Migrated/moved from study area|0|||
124968234|NCT02719743|449511363|FG004|Overall Study|Migrated/moved from study area|2|||
124968235|NCT02719743|449511359|FG000|Overall Study|Lost to Follow-up|1|||
124968236|NCT02719743|449511360|FG001|Overall Study|Lost to Follow-up|1|||
124968237|NCT02719743|449511361|FG002|Overall Study|Lost to Follow-up|0|||
124968238|NCT02719743|449511362|FG003|Overall Study|Lost to Follow-up|0|||
125131010|NCT02655679|450106495|FG002|Overall Study|Inability to Comply with the Protocol|0|||
125131011|NCT02655679|450106496|FG003|Overall Study|Inability to Comply with the Protocol|0|||
125131012|NCT02655679|450106497|FG004|Overall Study|Inability to Comply with the Protocol|0|||
125131013|NCT02655679|450106493|FG000|Overall Study|Lost to Follow-up|0|||
125131014|NCT02655679|450106494|FG001|Overall Study|Lost to Follow-up|1|||
125131015|NCT02655679|450106495|FG002|Overall Study|Lost to Follow-up|1|||
125131016|NCT02655679|450106496|FG003|Overall Study|Lost to Follow-up|1|||
125131017|NCT02655679|450106497|FG004|Overall Study|Lost to Follow-up|0|||
125131018|NCT02655679|450106493|FG000|Overall Study|Other Miscellaneous Reasons|1|||
125131019|NCT02655679|450106494|FG001|Overall Study|Other Miscellaneous Reasons|0|||
125131020|NCT02655679|450106495|FG002|Overall Study|Other Miscellaneous Reasons|0|||
124968239|NCT02719743|449511363|FG004|Overall Study|Lost to Follow-up|0|||
125131021|NCT02655679|450106496|FG003|Overall Study|Other Miscellaneous Reasons|0|||
125131022|NCT02655679|450106497|FG004|Overall Study|Other Miscellaneous Reasons|0|||
125131023|NCT01577381|450106498|FG000|Overall Study|Discontinued|2|||
125131024|NCT01577381|450106499|FG001|Overall Study|Discontinued|1|||
125217001|NCT00412932|450421986|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
125217002|NCT00412932|450421986|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
124968240|NCT02287233|449511364|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
125131025|NCT01577381|450106500|FG002|Overall Study|Discontinued|2|||
125217003|NCT00412932|450421986|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
125217004|NCT00412932|450421986|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
125217005|NCT00412932|450421986|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
125217006|NCT00412932|450421986|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
125217007|NCT01490840|450421990|FG000|Phase 1|Lost to Follow-up|1|||
125217008|NCT01490840|450421991|FG001|Phase 1|Lost to Follow-up|0|||
125217009|NCT01490840|450421990|FG000|Phase 1|Adverse Event|2|||
125217010|NCT01490840|450421991|FG001|Phase 1|Adverse Event|1|||
125217011|NCT01490840|450421990|FG000|Phase 1|Withdrawal by Subject|6|||
125217012|NCT01490840|450421991|FG001|Phase 1|Withdrawal by Subject|5|||
125217013|NCT01490840|450421990|FG000|Phase 1|Visit 6a omitted|1|||
125217014|NCT01490840|450421991|FG001|Phase 1|Visit 6a omitted|0|||
125217015|NCT01490840|450421990|FG000|Phase 2|Withdrawal by Subject|4|||
125217016|NCT01490840|450421991|FG001|Phase 2|Withdrawal by Subject|3|||
125217017|NCT01490840|450421990|FG000|Phase 2|Permanent interruption of fingolimod|0|||
125217018|NCT01490840|450421991|FG001|Phase 2|Permanent interruption of fingolimod|1|||
125217019|NCT01490840|450421990|FG000|Phase 2|Lost to Follow-up|1|||
125217020|NCT01490840|450421991|FG001|Phase 2|Lost to Follow-up|1|||
125217021|NCT01490840|450421990|FG000|Phase 2|Adverse Event|1|||
125217022|NCT01490840|450421991|FG001|Phase 2|Adverse Event|1|||
125217023|NCT01025284|450421996|FG000|Overall Study|Investigator Decision|0|||
125217024|NCT01025284|450421997|FG001|Overall Study|Investigator Decision|1|||
125217025|NCT01025284|450421998|FG002|Overall Study|Investigator Decision|0|||
125217026|NCT01025284|450421996|FG000|Overall Study|Withdrawal by Subject|0|||
125217027|NCT01025284|450421997|FG001|Overall Study|Withdrawal by Subject|1|||
125217028|NCT01025284|450421998|FG002|Overall Study|Withdrawal by Subject|0|||
125217029|NCT00905567|450421999|FG000|Washout|Withdrawal by Subject|0|||
125217030|NCT00905567|450422000|FG001|Washout|Withdrawal by Subject|1|||
125217031|NCT02753816|450422001|FG000|Overall Study|Protocol Violation|0|||
125217032|NCT02753816|450422002|FG001|Overall Study|Protocol Violation|1|||
125217033|NCT02753816|450422003|FG002|Overall Study|Protocol Violation|0|||
125217034|NCT02542397|450422004|FG000|Overall Study|Death|2|||
125217035|NCT02542397|450422004|FG000|Overall Study|Physician Decision|6|||
125217036|NCT02542397|450422004|FG000|Overall Study|Withdrawal by Subject|6|||
125217037|NCT02542397|450422004|FG000|Overall Study|Lost to Follow-up|2|||
125217038|NCT01738919|450422010|FG000|Overall Study|Lost to Follow-up|1|||
125217039|NCT01738919|450422011|FG001|Overall Study|Lost to Follow-up|0|||
125217040|NCT01738919|450422010|FG000|Overall Study|Immigrated|0|||
125217041|NCT01738919|450422011|FG001|Overall Study|Immigrated|1|||
125217042|NCT01738919|450422010|FG000|Overall Study|Withdrawal by Subject|0|||
125217043|NCT01738919|450422011|FG001|Overall Study|Withdrawal by Subject|1|||
125217044|NCT01738919|450422010|FG000|Overall Study|Not treated in accordance to guidelines|0|||
125217045|NCT01738919|450422011|FG001|Overall Study|Not treated in accordance to guidelines|1|||
125217046|NCT01473940|450422012|FG000|Induction Therapy|Death|0|||
125217047|NCT01473940|450422013|FG001|Induction Therapy|Death|0|||
125217048|NCT01473940|450422014|FG002|Induction Therapy|Death|1|||
125217049|NCT01473940|450422015|FG003|Induction Therapy|Death|1|||
125217050|NCT01473940|450422012|FG000|Induction Therapy|Progressive Disease|0|||
125217051|NCT01473940|450422013|FG001|Induction Therapy|Progressive Disease|1|||
125217052|NCT01473940|450422014|FG002|Induction Therapy|Progressive Disease|1|||
125217053|NCT01473940|450422015|FG003|Induction Therapy|Progressive Disease|0|||
125217054|NCT01473940|450422012|FG000|Maintenance Therapy|Progressive Disease|1|||
125217055|NCT01473940|450422013|FG001|Maintenance Therapy|Progressive Disease|2|||
125217056|NCT01473940|450422014|FG002|Maintenance Therapy|Progressive Disease|1|||
125217057|NCT01473940|450422015|FG003|Maintenance Therapy|Progressive Disease|4|||
125217058|NCT00547248|450422016|FG000|Overall Study|Protocol Violation|0|||
125217059|NCT00547248|450422017|FG001|Overall Study|Protocol Violation|0|||
125217060|NCT00547248|450422018|FG002|Overall Study|Protocol Violation|1|||
125217061|NCT00547248|450422019|FG003|Overall Study|Protocol Violation|1|||
125217062|NCT00547248|450422016|FG000|Overall Study|Migrated/moved from study area|0|||
125217063|NCT00547248|450422017|FG001|Overall Study|Migrated/moved from study area|0|||
125217064|NCT00547248|450422018|FG002|Overall Study|Migrated/moved from study area|2|||
125217065|NCT00547248|450422019|FG003|Overall Study|Migrated/moved from study area|0|||
125217066|NCT00547248|450422016|FG000|Overall Study|Withdrawal by Subject|0|||
125217067|NCT00547248|450422017|FG001|Overall Study|Withdrawal by Subject|0|||
125217068|NCT00547248|450422018|FG002|Overall Study|Withdrawal by Subject|7|||
125217069|NCT00547248|450422019|FG003|Overall Study|Withdrawal by Subject|1|||
125217070|NCT00534248|450422022|FG000|Overall Study|Adverse Event|19|||
125217071|NCT00534248|450422023|FG001|Overall Study|Adverse Event|29|||
125217072|NCT00534248|450422022|FG000|Overall Study|Lost to Follow-up|353|||
125217073|NCT00534248|450422023|FG001|Overall Study|Lost to Follow-up|375|||
125217074|NCT00534248|450422022|FG000|Overall Study|Other protocol specified criteria|13|||
125217075|NCT00534248|450422023|FG001|Overall Study|Other protocol specified criteria|3|||
125217076|NCT00534248|450422022|FG000|Overall Study|Physician Decision|10|||
125217077|NCT00534248|450422023|FG001|Overall Study|Physician Decision|7|||
125217078|NCT00534248|450422022|FG000|Overall Study|Protocol Violation|3|||
125217079|NCT00534248|450422023|FG001|Overall Study|Protocol Violation|4|||
125217080|NCT00534248|450422022|FG000|Overall Study|Withdrawal by Subject|263|||
125217081|NCT00534248|450422023|FG001|Overall Study|Withdrawal by Subject|255|||
125217082|NCT02532257|450422024|FG000|Overall Study|Adverse Event|2|||
125217083|NCT02532257|450422024|FG000|Overall Study|Physician Decision|4|||
125217084|NCT02532257|450422024|FG000|Overall Study|Withdrawal by Subject|3|||
125217085|NCT02532257|450422024|FG000|Overall Study|Progressive Disease|10|||
125217086|NCT02849171|450422025|FG000|Overall Study|Withdrawal by Subject|1|||
125217087|NCT02849171|450422025|FG000|Overall Study|Not treated|1|||
125217088|NCT02259400|450422028|FG000|Overall Study|Death|0|||
125217089|NCT02259400|450422029|FG001|Overall Study|Death|2|||
125217090|NCT00697593|450422031|FG000|Overall Study|Adverse Event|3|||
125217091|NCT00697593|450422031|FG000|Overall Study|Protocol Violation|1|||
125217092|NCT00697593|450422031|FG000|Overall Study|Lack of Efficacy|3|||
125217093|NCT00697593|450422031|FG000|Overall Study|Suspension of the study by sponsor|12|||
125217094|NCT02964338|450422032|FG000|Overall Study|Sponsor terminated study for futility|12|||
125217095|NCT02964338|450422033|FG001|Overall Study|Sponsor terminated study for futility|15|||
125217096|NCT02964338|450422034|FG002|Overall Study|Sponsor terminated study for futility|14|||
125217097|NCT02964338|450422032|FG000|Overall Study|Lack of Efficacy|0|||
125217098|NCT02964338|450422033|FG001|Overall Study|Lack of Efficacy|3|||
125217099|NCT02964338|450422034|FG002|Overall Study|Lack of Efficacy|0|||
125217100|NCT02964338|450422032|FG000|Overall Study|Lost to Follow-up|1|||
125217101|NCT02964338|450422033|FG001|Overall Study|Lost to Follow-up|0|||
125217102|NCT02964338|450422034|FG002|Overall Study|Lost to Follow-up|3|||
124968241|NCT02287233|449511365|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
124968242|NCT02287233|449511366|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
125217103|NCT02964338|450422032|FG000|Overall Study|Protocol Violation|0|||
125217104|NCT02964338|450422033|FG001|Overall Study|Protocol Violation|1|||
125217105|NCT02964338|450422034|FG002|Overall Study|Protocol Violation|0|||
125217106|NCT02964338|450422032|FG000|Overall Study|Withdrawal by Subject|1|||
125217107|NCT02964338|450422033|FG001|Overall Study|Withdrawal by Subject|3|||
125217108|NCT02964338|450422034|FG002|Overall Study|Withdrawal by Subject|1|||
125217109|NCT02964338|450422032|FG000|Overall Study|Adverse Event|2|||
125217110|NCT02964338|450422033|FG001|Overall Study|Adverse Event|1|||
125217111|NCT02964338|450422034|FG002|Overall Study|Adverse Event|1|||
125217112|NCT02964338|450422032|FG000|Overall Study|Non-compliant with e-diary|0|||
125217113|NCT02964338|450422033|FG001|Overall Study|Non-compliant with e-diary|1|||
125217114|NCT02964338|450422034|FG002|Overall Study|Non-compliant with e-diary|0|||
125217115|NCT02964338|450422032|FG000|Overall Study|Did not meet criteria|1|||
125131026|NCT01577381|450106501|FG003|Overall Study|Discontinued|2|||
124968243|NCT02287233|449511364|FG000|Overall Study|Adverse Event Related to Progression|0|||
124968244|NCT02287233|449511365|FG001|Overall Study|Adverse Event Related to Progression|2|||
124968245|NCT02287233|449511366|FG002|Overall Study|Adverse Event Related to Progression|8|||
124968246|NCT02287233|449511364|FG000|Overall Study|Physician Decision|1|||
124968247|NCT02287233|449511365|FG001|Overall Study|Physician Decision|2|||
124968248|NCT02287233|449511366|FG002|Overall Study|Physician Decision|4|||
124968249|NCT02287233|449511364|FG000|Overall Study|Progressive Disease with Death|0|||
124968250|NCT02287233|449511365|FG001|Overall Study|Progressive Disease with Death|0|||
124968251|NCT02287233|449511366|FG002|Overall Study|Progressive Disease with Death|10|||
124968252|NCT02287233|449511364|FG000|Overall Study|Progressive Disease Without Death|2|||
124968253|NCT02287233|449511365|FG001|Overall Study|Progressive Disease Without Death|3|||
124968254|NCT02287233|449511366|FG002|Overall Study|Progressive Disease Without Death|20|||
124968255|NCT02287233|449511364|FG000|Overall Study|Withdrawal by Subject|1|||
124968256|NCT02287233|449511365|FG001|Overall Study|Withdrawal by Subject|1|||
124968257|NCT02287233|449511366|FG002|Overall Study|Withdrawal by Subject|7|||
124968258|NCT02287233|449511364|FG000|Overall Study|Other|3|||
124968259|NCT02287233|449511365|FG001|Overall Study|Other|0|||
124968260|NCT02287233|449511366|FG002|Overall Study|Other|15|||
124968261|NCT02287233|449511364|FG000|Overall Study|Did Not Receive Treatment|0|||
124968262|NCT02287233|449511365|FG001|Overall Study|Did Not Receive Treatment|0|||
124968263|NCT02287233|449511366|FG002|Overall Study|Did Not Receive Treatment|2|||
124968264|NCT03772613|449511367|FG000|Overall Study|Lost to Follow-up|0|||
124968265|NCT03772613|449511368|FG001|Overall Study|Lost to Follow-up|1|||
124968266|NCT03772613|449511369|FG002|Overall Study|Lost to Follow-up|1|||
124968267|NCT01427738|449511370|FG000|Overall Study|Death|12|||
124968268|NCT01427738|449511371|FG001|Overall Study|Death|9|||
124968269|NCT01427738|449511370|FG000|Overall Study|Severe debilitation, unable to continue|0|||
124968270|NCT01427738|449511371|FG001|Overall Study|Severe debilitation, unable to continue|1|||
124968271|NCT01427738|449511370|FG000|Overall Study|Subject unable to get to clinic|5|||
124968272|NCT01427738|449511371|FG001|Overall Study|Subject unable to get to clinic|2|||
124968273|NCT01427738|449511370|FG000|Overall Study|Withdrawal by Subject|0|||
124968274|NCT01427738|449511371|FG001|Overall Study|Withdrawal by Subject|2|||
124968275|NCT01427738|449511370|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
125032585|NCT02040142|449739567|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
125032586|NCT02330419|449739569|FG000|Overall Study|Lost to Follow-up|3|||
124968276|NCT01427738|449511371|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
124968277|NCT01427738|449511370|FG000|Overall Study|Lost to Follow-up|1|||
124968278|NCT01427738|449511371|FG001|Overall Study|Lost to Follow-up|5|||
124968279|NCT05314374|449511372|FG000|Overall Study|Adverse Event|2|||
124968280|NCT05314374|449511373|FG001|Overall Study|Adverse Event|2|||
125032587|NCT02330419|449739570|FG001|Overall Study|Lost to Follow-up|7|||
125032588|NCT01813890|449739573|FG000|Overall Study|Adverse Event|0|||
125032589|NCT01813890|449739574|FG001|Overall Study|Adverse Event|3|||
125032590|NCT01813890|449739575|FG002|Overall Study|Adverse Event|4|||
125032591|NCT01813890|449739573|FG000|Overall Study|Lack of Efficacy|9|||
125032592|NCT01813890|449739574|FG001|Overall Study|Lack of Efficacy|1|||
125032593|NCT01813890|449739575|FG002|Overall Study|Lack of Efficacy|2|||
125032594|NCT03952559|449739576|FG000|Double Blind Treatment Period|Adverse Event|0|||
125032595|NCT03952559|449739577|FG001|Double Blind Treatment Period|Adverse Event|2|||
125032596|NCT03952559|449739578|FG002|Double Blind Treatment Period|Adverse Event|1|||
125032597|NCT03952559|449739579|FG003|Double Blind Treatment Period|Adverse Event|0|||
125032598|NCT03952559|449739580|FG004|Double Blind Treatment Period|Adverse Event|1|||
125032599|NCT03952559|449739576|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
125032600|NCT03952559|449739577|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
125032601|NCT03952559|449739578|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
125032602|NCT03952559|449739579|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
125032603|NCT03952559|449739580|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
125032604|NCT03952559|449739576|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
125032605|NCT03952559|449739577|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
125032606|NCT03952559|449739578|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
125032607|NCT03952559|449739579|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
125032608|NCT03952559|449739580|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
125032609|NCT03952559|449739576|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
125032610|NCT03952559|449739577|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
125032611|NCT03952559|449739578|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
125032612|NCT03952559|449739579|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
125032613|NCT03952559|449739580|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
125032614|NCT01870739|449739583|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
125032615|NCT01870739|449739584|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
125032616|NCT01870739|449739583|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
125032617|NCT01870739|449739584|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
125032618|NCT01870739|449739583|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
125032619|NCT01870739|449739584|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
125032620|NCT01870739|449739583|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
125032621|NCT01870739|449739584|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
125032622|NCT01870739|449739583|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
125032623|NCT01870739|449739584|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
125032624|NCT01870739|449739583|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
125032625|NCT01870739|449739584|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
125032626|NCT01870739|449739583|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
125032627|NCT01870739|449739584|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
125032628|NCT01986062|449739585|FG000|Overall Study|Lost to Follow-up|1|||
125032629|NCT01986062|449739586|FG001|Overall Study|Lost to Follow-up|0|||
125032630|NCT01986062|449739585|FG000|Overall Study|Withdrawal by Subject|0|||
125032631|NCT01986062|449739586|FG001|Overall Study|Withdrawal by Subject|1|||
125032632|NCT03538743|449739587|FG000|Overall Study|Adverse Event|0|||
125032633|NCT03538743|449739588|FG001|Overall Study|Adverse Event|0|||
125032634|NCT03538743|449739589|FG002|Overall Study|Adverse Event|1|||
125032635|NCT03538743|449739590|FG003|Overall Study|Adverse Event|1|||
125032636|NCT03538743|449739591|FG004|Overall Study|Adverse Event|0|||
125032637|NCT03538743|449739592|FG005|Overall Study|Adverse Event|0|||
125217116|NCT02964338|450422033|FG001|Overall Study|Did not meet criteria|0|||
125217117|NCT02964338|450422034|FG002|Overall Study|Did not meet criteria|0|||
125217118|NCT00741598|450422038|FG000|Overall Study|Lost to Follow-up|3|||
125217119|NCT00741598|450422039|FG001|Overall Study|Lost to Follow-up|4|||
125217120|NCT00741598|450422038|FG000|Overall Study|Lack of Efficacy|1|||
125217121|NCT00741598|450422039|FG001|Overall Study|Lack of Efficacy|2|||
125217122|NCT00741598|450422038|FG000|Overall Study|Physician Decision|1|||
125217123|NCT00741598|450422039|FG001|Overall Study|Physician Decision|1|||
125032638|NCT03538743|449739593|FG006|Overall Study|Adverse Event|0|||
125032639|NCT03538743|449739594|FG007|Overall Study|Adverse Event|0|||
125032640|NCT03538743|449739595|FG008|Overall Study|Adverse Event|0|||
125032641|NCT03538743|449739587|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
125032642|NCT03538743|449739588|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
125032643|NCT03538743|449739589|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
125032644|NCT03538743|449739590|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
125032645|NCT03538743|449739591|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
125032646|NCT03538743|449739592|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
125032647|NCT03538743|449739593|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
125032648|NCT03538743|449739594|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
125032649|NCT03538743|449739595|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
125032650|NCT03538743|449739587|FG000|Overall Study|Withdrawal by Subject|0|||
125032651|NCT03538743|449739588|FG001|Overall Study|Withdrawal by Subject|0|||
125217124|NCT00741598|450422038|FG000|Overall Study|Pregnancy|1|||
125217125|NCT00741598|450422039|FG001|Overall Study|Pregnancy|0|||
125032652|NCT03538743|449739589|FG002|Overall Study|Withdrawal by Subject|0|||
125032653|NCT03538743|449739590|FG003|Overall Study|Withdrawal by Subject|1|||
125032654|NCT03538743|449739591|FG004|Overall Study|Withdrawal by Subject|0|||
125032655|NCT03538743|449739592|FG005|Overall Study|Withdrawal by Subject|0|||
125032656|NCT03538743|449739593|FG006|Overall Study|Withdrawal by Subject|0|||
125032657|NCT03538743|449739594|FG007|Overall Study|Withdrawal by Subject|0|||
125032658|NCT03538743|449739595|FG008|Overall Study|Withdrawal by Subject|0|||
125032659|NCT01827384|449739597|FG000|Overall Study|Switched to alternative treatment|0|||
125032660|NCT01827384|449739598|FG001|Overall Study|Switched to alternative treatment|0|||
125032661|NCT01827384|449739599|FG002|Overall Study|Switched to alternative treatment|0|||
125032662|NCT01827384|449739600|FG003|Overall Study|Switched to alternative treatment|0|||
125217126|NCT00741598|450422038|FG000|Overall Study|Withdrawal by Subject|3|||
125217127|NCT00741598|450422039|FG001|Overall Study|Withdrawal by Subject|2|||
125217128|NCT00587795|450422040|FG000|Overall Study|Withdrawal by Subject|1|||
125217129|NCT00587795|450422041|FG001|Overall Study|Withdrawal by Subject|0|||
125217130|NCT00435461|450422048|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
125217131|NCT00435461|450422049|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
125217132|NCT00435461|450422050|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
125217133|NCT00435461|450422048|FG000|Overall Study|Protocol Violation|6|||
125217134|NCT00435461|450422049|FG001|Overall Study|Protocol Violation|9|||
125217135|NCT00435461|450422050|FG002|Overall Study|Protocol Violation|10|||
125217136|NCT00435461|450422048|FG000|Overall Study|Participant randomized(inadequate score)|1|||
125217137|NCT00435461|450422049|FG001|Overall Study|Participant randomized(inadequate score)|0|||
125217138|NCT00435461|450422050|FG002|Overall Study|Participant randomized(inadequate score)|0|||
125217139|NCT00435461|450422048|FG000|Overall Study|Compliance less than 80 percent|1|||
125217140|NCT00435461|450422049|FG001|Overall Study|Compliance less than 80 percent|0|||
125217141|NCT00435461|450422050|FG002|Overall Study|Compliance less than 80 percent|0|||
125217142|NCT00435461|450422048|FG000|Overall Study|In error, two study medications switched|1|||
125217143|NCT00435461|450422049|FG001|Overall Study|In error, two study medications switched|0|||
125217144|NCT00435461|450422050|FG002|Overall Study|In error, two study medications switched|0|||
125217145|NCT00435461|450422048|FG000|Overall Study|Lack of Efficacy|2|||
125032663|NCT01827384|449739601|FG004|Overall Study|Switched to alternative treatment|0|||
125032664|NCT01827384|449739602|FG005|Overall Study|Switched to alternative treatment|0|||
125032665|NCT01827384|449739603|FG006|Overall Study|Switched to alternative treatment|0|||
125032666|NCT01827384|449739604|FG007|Overall Study|Switched to alternative treatment|0|||
125032667|NCT01827384|449739605|FG008|Overall Study|Switched to alternative treatment|0|||
125032668|NCT01827384|449739606|FG009|Overall Study|Switched to alternative treatment|0|||
125032669|NCT01827384|449739607|FG010|Overall Study|Switched to alternative treatment|0|||
125032670|NCT01827384|449739608|FG011|Overall Study|Switched to alternative treatment|0|||
125131027|NCT01577381|450106498|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
125131028|NCT01577381|450106499|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
125131029|NCT01577381|450106500|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
125131030|NCT01577381|450106501|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
125131031|NCT02186821|450106502|FG000|Overall Study|Adverse Event|9|||
125131032|NCT02186821|450106502|FG000|Overall Study|Death|2|||
125131033|NCT02186821|450106502|FG000|Overall Study|Disease progression|32|||
125131034|NCT02186821|450106502|FG000|Overall Study|Protocol Violation|1|||
125131035|NCT02186821|450106502|FG000|Overall Study|Physician Decision|1|||
125131036|NCT02186821|450106502|FG000|Overall Study|Study terminated by sponsor|2|||
125131037|NCT00819741|450106507|FG000|Overall Study|Adverse Event|5|||
125131038|NCT00819741|450106508|FG001|Overall Study|Adverse Event|2|||
125131039|NCT00819741|450106507|FG000|Overall Study|Lack of Efficacy|0|||
125131040|NCT00819741|450106508|FG001|Overall Study|Lack of Efficacy|2|||
125131041|NCT00819741|450106507|FG000|Overall Study|Lost to Follow-up|3|||
125131042|NCT00819741|450106508|FG001|Overall Study|Lost to Follow-up|1|||
125131043|NCT00819741|450106507|FG000|Overall Study|Protocol Violation|3|||
125131044|NCT00819741|450106508|FG001|Overall Study|Protocol Violation|4|||
125131045|NCT00819741|450106507|FG000|Overall Study|Withdrawal by Subject|2|||
125032671|NCT01827384|449739609|FG012|Overall Study|Switched to alternative treatment|0|||
125032672|NCT01827384|449739610|FG013|Overall Study|Switched to alternative treatment|2|||
125032673|NCT01827384|449739597|FG000|Overall Study|Disease progression before treatment|0|||
125032674|NCT01827384|449739598|FG001|Overall Study|Disease progression before treatment|0|||
125032675|NCT01827384|449739599|FG002|Overall Study|Disease progression before treatment|0|||
125131046|NCT00819741|450106508|FG001|Overall Study|Withdrawal by Subject|2|||
125131047|NCT00819741|450106507|FG000|Overall Study|Unclassified|6|||
125131048|NCT00819741|450106508|FG001|Overall Study|Unclassified|0|||
125131049|NCT00819741|450106507|FG000|Overall Study|Reasons unknown|3|||
125131050|NCT00819741|450106508|FG001|Overall Study|Reasons unknown|3|||
125217146|NCT00435461|450422049|FG001|Overall Study|Lack of Efficacy|1|||
125217147|NCT00435461|450422050|FG002|Overall Study|Lack of Efficacy|0|||
125032676|NCT01827384|449739600|FG003|Overall Study|Disease progression before treatment|0|||
125032677|NCT01827384|449739601|FG004|Overall Study|Disease progression before treatment|0|||
125131051|NCT00119015|450106509|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
125217148|NCT00435461|450422048|FG000|Overall Study|Withdrawal by Subject|1|||
125217149|NCT00435461|450422049|FG001|Overall Study|Withdrawal by Subject|0|||
125217150|NCT00435461|450422050|FG002|Overall Study|Withdrawal by Subject|2|||
125217151|NCT00435461|450422048|FG000|Overall Study|Randomized in error|1|||
125217152|NCT00435461|450422049|FG001|Overall Study|Randomized in error|0|||
125217153|NCT00435461|450422050|FG002|Overall Study|Randomized in error|0|||
125217154|NCT00435461|450422048|FG000|Overall Study|Participant could not tolerate symptoms|0|||
125217155|NCT00435461|450422049|FG001|Overall Study|Participant could not tolerate symptoms|0|||
125217156|NCT00435461|450422050|FG002|Overall Study|Participant could not tolerate symptoms|1|||
125217157|NCT00435461|450422048|FG000|Overall Study|Participant could not swallow capsule|0|||
125217158|NCT00435461|450422049|FG001|Overall Study|Participant could not swallow capsule|0|||
125217159|NCT00435461|450422050|FG002|Overall Study|Participant could not swallow capsule|1|||
125217160|NCT00435461|450422048|FG000|Overall Study|Pregnancy|2|||
125217161|NCT00435461|450422049|FG001|Overall Study|Pregnancy|0|||
125217162|NCT00435461|450422050|FG002|Overall Study|Pregnancy|0|||
125217163|NCT00435461|450422048|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
125217164|NCT00435461|450422049|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
125217165|NCT00435461|450422050|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
125217166|NCT00435461|450422048|FG000|Overall Study|Participant ended study one day early|1|||
125217167|NCT00435461|450422049|FG001|Overall Study|Participant ended study one day early|0|||
125217168|NCT00435461|450422050|FG002|Overall Study|Participant ended study one day early|0|||
125217169|NCT00435461|450422048|FG000|Overall Study|Noncompliance with study requirements|1|||
125217170|NCT00435461|450422049|FG001|Overall Study|Noncompliance with study requirements|1|||
125217171|NCT00435461|450422050|FG002|Overall Study|Noncompliance with study requirements|1|||
125217172|NCT00435461|450422048|FG000|Overall Study|Adverse Event|1|||
125217173|NCT00435461|450422049|FG001|Overall Study|Adverse Event|2|||
125217174|NCT00435461|450422050|FG002|Overall Study|Adverse Event|6|||
125217175|NCT00435461|450422048|FG000|Overall Study|Non-Compliance of diary|2|||
125217176|NCT00435461|450422049|FG001|Overall Study|Non-Compliance of diary|0|||
125217177|NCT00435461|450422050|FG002|Overall Study|Non-Compliance of diary|1|||
125217178|NCT00435461|450422048|FG000|Overall Study|Lost to Follow-up|1|||
125217179|NCT00435461|450422049|FG001|Overall Study|Lost to Follow-up|1|||
125217180|NCT00435461|450422050|FG002|Overall Study|Lost to Follow-up|2|||
125217181|NCT00837967|450422051|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
125217182|NCT00837967|450422052|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
125217183|NCT00551525|450422055|FG000|Overall Study|Protocol Violation|5|||
125217184|NCT04676724|450422056|FG000|Overall Study|Adverse Event|2|||
125217185|NCT04676724|450422057|FG001|Overall Study|Adverse Event|0|||
125217186|NCT04676724|450422056|FG000|Overall Study|Lost to Follow-up|1|||
125217187|NCT04676724|450422057|FG001|Overall Study|Lost to Follow-up|0|||
125217188|NCT04676724|450422056|FG000|Overall Study|Physician Decision|0|||
125217189|NCT04676724|450422057|FG001|Overall Study|Physician Decision|1|||
125217190|NCT04676724|450422056|FG000|Overall Study|Withdrawal by Subject|3|||
125217191|NCT04676724|450422057|FG001|Overall Study|Withdrawal by Subject|2|||
125217192|NCT05446142|450422068|FG000|Period 2|Adverse Event|1|||
125217193|NCT05446142|450422069|FG001|Period 2|Adverse Event|0|||
125217194|NCT05446142|450422070|FG002|Period 2|Adverse Event|0|||
125217195|NCT05446142|450422071|FG003|Period 2|Adverse Event|0|||
125217196|NCT05446142|450422072|FG004|Period 2|Adverse Event|0|||
125217197|NCT05446142|450422073|FG005|Period 2|Adverse Event|0|||
124968281|NCT02658175|449511374|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
125131052|NCT00119015|450106510|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
125131053|NCT00119015|450106511|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
125131054|NCT01313780|450106512|FG000|Overall Study|Lack of Efficacy|4|||
125131055|NCT01313780|450106513|FG001|Overall Study|Lack of Efficacy|2|||
125131056|NCT01313780|450106512|FG000|Overall Study|Adverse Event|6|||
125131057|NCT01313780|450106513|FG001|Overall Study|Adverse Event|11|||
125131058|NCT01313780|450106512|FG000|Overall Study|Withdrawal by Subject|2|||
125217198|NCT02098395|450422074|FG000|Overall Study|Protocol Violation|2|||
125217199|NCT02098395|450422075|FG001|Overall Study|Protocol Violation|2|||
125217200|NCT02098395|450422076|FG002|Overall Study|Protocol Violation|0|||
125217201|NCT02098395|450422077|FG003|Overall Study|Protocol Violation|7|||
125217202|NCT02098395|450422074|FG000|Overall Study|Withdrawal by Subject|10|||
125217203|NCT02098395|450422075|FG001|Overall Study|Withdrawal by Subject|10|||
124968282|NCT02658175|449511375|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
125217204|NCT02098395|450422076|FG002|Overall Study|Withdrawal by Subject|5|||
125217205|NCT02098395|450422077|FG003|Overall Study|Withdrawal by Subject|13|||
125217206|NCT02098395|450422074|FG000|Overall Study|Adverse Event|12|||
124968283|NCT02658175|449511376|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
125217207|NCT02098395|450422075|FG001|Overall Study|Adverse Event|19|||
125217208|NCT02098395|450422076|FG002|Overall Study|Adverse Event|34|||
125217209|NCT02098395|450422077|FG003|Overall Study|Adverse Event|2|||
125217210|NCT02098395|450422074|FG000|Overall Study|Lost to Follow-up|2|||
125217211|NCT02098395|450422075|FG001|Overall Study|Lost to Follow-up|1|||
125217212|NCT02098395|450422076|FG002|Overall Study|Lost to Follow-up|0|||
125217213|NCT02098395|450422077|FG003|Overall Study|Lost to Follow-up|3|||
125217214|NCT02098395|450422074|FG000|Overall Study|Unclassified|0|||
125217215|NCT02098395|450422075|FG001|Overall Study|Unclassified|0|||
125217216|NCT02098395|450422076|FG002|Overall Study|Unclassified|3|||
125217217|NCT02098395|450422077|FG003|Overall Study|Unclassified|2|||
125217218|NCT00547157|450422080|FG000|Overall Study|Other|1|||
125217219|NCT00547157|450422081|FG001|Overall Study|Other|0|||
125217220|NCT00547157|450422080|FG000|Overall Study|Death|38|||
125217221|NCT00547157|450422081|FG001|Overall Study|Death|18|||
125217222|NCT00547157|450422080|FG000|Overall Study|Withdrawal by Subject|3|||
125217223|NCT00547157|450422081|FG001|Overall Study|Withdrawal by Subject|1|||
125217224|NCT00547157|450422080|FG000|Overall Study|Administrative decision|3|||
125217225|NCT00547157|450422081|FG001|Overall Study|Administrative decision|2|||
125217226|NCT00547157|450422080|FG000|Overall Study|Lost to Follow-up|4|||
125217227|NCT00547157|450422081|FG001|Overall Study|Lost to Follow-up|2|||
125217228|NCT00110357|450422082|FG000|Overall Study|Deterioration without progression|2|||
125217229|NCT00110357|450422083|FG001|Overall Study|Deterioration without progression|0|||
125217230|NCT00110357|450422082|FG000|Overall Study|Disease progression/relapse|20|||
125217231|NCT00110357|450422083|FG001|Overall Study|Disease progression/relapse|15|||
125217232|NCT00110357|450422082|FG000|Overall Study|Study Closure|1|||
125131059|NCT01313780|450106513|FG001|Overall Study|Withdrawal by Subject|8|||
125131060|NCT01313780|450106512|FG000|Overall Study|Protocol Violation|10|||
125131061|NCT01313780|450106513|FG001|Overall Study|Protocol Violation|4|||
125131062|NCT01313780|450106512|FG000|Overall Study|missing data|3|||
125131063|NCT01313780|450106513|FG001|Overall Study|missing data|3|||
125131064|NCT03235739|450107973|FG000|Overall Study|Withdrawal by Subject|2|||
125131065|NCT03235739|450107974|FG001|Overall Study|Withdrawal by Subject|2|||
125131066|NCT03235739|450107973|FG000|Overall Study|Physician Decision|0|||
125131067|NCT03235739|450107974|FG001|Overall Study|Physician Decision|1|||
125131068|NCT00834522|450107977|FG000|Washout|Adverse Event|1|||
125131069|NCT00834522|450107978|FG001|Washout|Adverse Event|0|||
125131070|NCT00834522|450107977|FG000|Washout|Withdrawal by Subject|2|||
125131071|NCT00834522|450107978|FG001|Washout|Withdrawal by Subject|1|||
125131072|NCT00834249|450107979|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
125131073|NCT00834249|450107980|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
125131074|NCT00834249|450107979|FG000|Second Intervention|Adverse Event|1|||
125131075|NCT00834249|450107980|FG001|Second Intervention|Adverse Event|0|||
125131076|NCT02146105|450107983|FG000|Overall Study|Adverse Event|1|||
125131077|NCT02146105|450107983|FG000|Overall Study|Withdrawal by Subject|5|||
125131078|NCT05755282|450107984|FG000|Overall Study|Protocol Violation|0|||
125131079|NCT05755282|450107985|FG001|Overall Study|Protocol Violation|1|||
125131080|NCT02476994|450107987|FG000|Overall Study|Based on feedback from FDA|1|||
125131081|NCT02476994|450107988|FG001|Overall Study|Based on feedback from FDA|0|||
125131082|NCT01558635|450107991|FG000|Overall Study|Death|1|||
125131083|NCT01558635|450107991|FG000|Overall Study|Withdrawal by Subject|2|||
125131084|NCT01558635|450107991|FG000|Overall Study|Physician Decision|1|||
125131085|NCT01558635|450107991|FG000|Overall Study|Subject received other treatment|1|||
125131086|NCT01558635|450107991|FG000|Overall Study|Reveal XT was explanted|1|||
125131087|NCT03699020|450107992|FG000|Overall Study|Withdrawal by Subject|3|||
125131088|NCT03699020|450107993|FG001|Overall Study|Withdrawal by Subject|2|||
125131089|NCT02246920|450107994|FG000|Overall Study|Adverse Event|3|||
125131090|NCT02246920|450107995|FG001|Overall Study|Adverse Event|1|||
125131091|NCT02246920|450107996|FG002|Overall Study|Adverse Event|1|||
125131092|NCT02246920|450107994|FG000|Overall Study|Lost to Follow-up|2|||
125131093|NCT02246920|450107995|FG001|Overall Study|Lost to Follow-up|1|||
125131094|NCT02246920|450107996|FG002|Overall Study|Lost to Follow-up|0|||
125217233|NCT00110357|450422083|FG001|Overall Study|Study Closure|0|||
124968284|NCT02658175|449511374|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
124968285|NCT02658175|449511375|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
124968286|NCT02658175|449511376|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
125131095|NCT02246920|450107994|FG000|Overall Study|Protocol Violation|2|||
125131096|NCT02246920|450107995|FG001|Overall Study|Protocol Violation|5|||
125131097|NCT02246920|450107996|FG002|Overall Study|Protocol Violation|1|||
125131098|NCT02246920|450107994|FG000|Overall Study|Withdrawal by Subject|0|||
125217234|NCT00110357|450422082|FG000|Overall Study|Study Drug Toxicity|1|||
125217235|NCT00110357|450422083|FG001|Overall Study|Study Drug Toxicity|3|||
125131099|NCT02246920|450107995|FG001|Overall Study|Withdrawal by Subject|0|||
125131100|NCT02246920|450107996|FG002|Overall Study|Withdrawal by Subject|1|||
125131101|NCT00448019|450107999|FG000|Overall Study|Withdrawal by Subject|3|||
125131102|NCT00448019|450107999|FG000|Overall Study|Disease progression|1|||
125217236|NCT00110357|450422082|FG000|Overall Study|Withdrawal by Subject|3|||
125131103|NCT00448019|450107999|FG000|Overall Study|Death|2|||
125131104|NCT00448019|450107999|FG000|Overall Study|Insurance Issues|1|||
125131105|NCT02543203|450108000|FG000|Overall Study|Unpalatable Fragrance|2|||
125131106|NCT02543203|450108001|FG001|Overall Study|Unpalatable Fragrance|2|||
125217237|NCT00110357|450422083|FG001|Overall Study|Withdrawal by Subject|1|||
125217238|NCT03382418|450422084|FG000|Overall Study|Withdrawal by Subject|1|||
124968287|NCT02658175|449511374|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
124969648|NCT01234883|449517432|FG000|Overall Study|Inclusion/exclusion failure|1|||
125131107|NCT02543203|450108000|FG000|Overall Study|Lost to Follow-up|1|||
125131108|NCT02543203|450108001|FG001|Overall Study|Lost to Follow-up|0|||
125131109|NCT02543203|450108000|FG000|Overall Study|Increased Irritability|1|||
124968288|NCT02658175|449511375|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
124968289|NCT02658175|449511376|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
124968290|NCT02658175|449511374|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
124968291|NCT02658175|449511375|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
124968292|NCT02658175|449511376|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
124968293|NCT02658175|449511374|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
124968294|NCT02658175|449511375|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
124968295|NCT02658175|449511376|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
124968296|NCT02658175|449511374|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
124968297|NCT02658175|449511375|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
124968298|NCT02658175|449511376|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
124968299|NCT02658175|449511374|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
124968300|NCT02658175|449511375|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
124968301|NCT02658175|449511376|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
124968302|NCT02658175|449511374|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
124968303|NCT02658175|449511375|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
124968304|NCT02658175|449511376|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
124968305|NCT02658175|449511374|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
124968306|NCT02658175|449511375|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
124968307|NCT02658175|449511376|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
125032678|NCT01827384|449739602|FG005|Overall Study|Disease progression before treatment|0|||
125032679|NCT01827384|449739603|FG006|Overall Study|Disease progression before treatment|0|||
125032680|NCT01827384|449739604|FG007|Overall Study|Disease progression before treatment|0|||
125032681|NCT01827384|449739605|FG008|Overall Study|Disease progression before treatment|0|||
125032682|NCT01827384|449739606|FG009|Overall Study|Disease progression before treatment|0|||
125032683|NCT01827384|449739607|FG010|Overall Study|Disease progression before treatment|0|||
125032684|NCT01827384|449739608|FG011|Overall Study|Disease progression before treatment|0|||
125032685|NCT01827384|449739609|FG012|Overall Study|Disease progression before treatment|0|||
125032686|NCT01827384|449739610|FG013|Overall Study|Disease progression before treatment|4|||
125032687|NCT01827384|449739597|FG000|Overall Study|Ineligible|0|||
125032688|NCT01827384|449739598|FG001|Overall Study|Ineligible|0|||
125032689|NCT01827384|449739599|FG002|Overall Study|Ineligible|0|||
125032690|NCT01827384|449739600|FG003|Overall Study|Ineligible|0|||
125032691|NCT01827384|449739601|FG004|Overall Study|Ineligible|0|||
125032692|NCT01827384|449739602|FG005|Overall Study|Ineligible|0|||
125032693|NCT01827384|449739603|FG006|Overall Study|Ineligible|0|||
125032694|NCT01827384|449739604|FG007|Overall Study|Ineligible|0|||
125032695|NCT01827384|449739605|FG008|Overall Study|Ineligible|0|||
125032696|NCT01827384|449739606|FG009|Overall Study|Ineligible|0|||
125032697|NCT01827384|449739607|FG010|Overall Study|Ineligible|0|||
125032698|NCT01827384|449739608|FG011|Overall Study|Ineligible|0|||
125032699|NCT01827384|449739609|FG012|Overall Study|Ineligible|0|||
125032700|NCT01827384|449739610|FG013|Overall Study|Ineligible|19|||
125032701|NCT01827384|449739597|FG000|Overall Study|Participant died before treatment|0|||
125032702|NCT01827384|449739598|FG001|Overall Study|Participant died before treatment|0|||
125032703|NCT01827384|449739599|FG002|Overall Study|Participant died before treatment|0|||
125032704|NCT01827384|449739600|FG003|Overall Study|Participant died before treatment|0|||
125032705|NCT01827384|449739601|FG004|Overall Study|Participant died before treatment|0|||
125032706|NCT01827384|449739602|FG005|Overall Study|Participant died before treatment|0|||
125032707|NCT01827384|449739603|FG006|Overall Study|Participant died before treatment|0|||
125032708|NCT01827384|449739604|FG007|Overall Study|Participant died before treatment|0|||
125032709|NCT01827384|449739605|FG008|Overall Study|Participant died before treatment|0|||
125032710|NCT01827384|449739606|FG009|Overall Study|Participant died before treatment|0|||
125032711|NCT01827384|449739607|FG010|Overall Study|Participant died before treatment|0|||
125032712|NCT01827384|449739608|FG011|Overall Study|Participant died before treatment|0|||
125032713|NCT01827384|449739609|FG012|Overall Study|Participant died before treatment|0|||
125032714|NCT01827384|449739610|FG013|Overall Study|Participant died before treatment|5|||
125032715|NCT01827384|449739597|FG000|Overall Study|Insufficient tumor cells|0|||
125032716|NCT01827384|449739598|FG001|Overall Study|Insufficient tumor cells|0|||
125032717|NCT01827384|449739599|FG002|Overall Study|Insufficient tumor cells|0|||
125032718|NCT01827384|449739600|FG003|Overall Study|Insufficient tumor cells|0|||
125032719|NCT01827384|449739601|FG004|Overall Study|Insufficient tumor cells|0|||
125032720|NCT01827384|449739602|FG005|Overall Study|Insufficient tumor cells|0|||
125032721|NCT01827384|449739603|FG006|Overall Study|Insufficient tumor cells|0|||
125032722|NCT01827384|449739604|FG007|Overall Study|Insufficient tumor cells|0|||
125032723|NCT01827384|449739605|FG008|Overall Study|Insufficient tumor cells|0|||
125032724|NCT01827384|449739606|FG009|Overall Study|Insufficient tumor cells|0|||
125032725|NCT01827384|449739607|FG010|Overall Study|Insufficient tumor cells|0|||
125032726|NCT01827384|449739608|FG011|Overall Study|Insufficient tumor cells|0|||
125032727|NCT01827384|449739609|FG012|Overall Study|Insufficient tumor cells|0|||
125032728|NCT01827384|449739610|FG013|Overall Study|Insufficient tumor cells|13|||
125032729|NCT01827384|449739597|FG000|Overall Study|No actionable mutation|0|||
125131110|NCT02543203|450108001|FG001|Overall Study|Increased Irritability|0|||
125131111|NCT02543203|450108000|FG000|Overall Study|Family|1|||
125032730|NCT01827384|449739598|FG001|Overall Study|No actionable mutation|0|||
125131112|NCT02543203|450108001|FG001|Overall Study|Family|2|||
125032731|NCT01827384|449739599|FG002|Overall Study|No actionable mutation|0|||
125032732|NCT01827384|449739600|FG003|Overall Study|No actionable mutation|0|||
125032733|NCT01827384|449739601|FG004|Overall Study|No actionable mutation|0|||
125032734|NCT01827384|449739602|FG005|Overall Study|No actionable mutation|0|||
125032735|NCT01827384|449739603|FG006|Overall Study|No actionable mutation|0|||
125032736|NCT01827384|449739604|FG007|Overall Study|No actionable mutation|0|||
125032737|NCT01827384|449739605|FG008|Overall Study|No actionable mutation|0|||
125032738|NCT01827384|449739606|FG009|Overall Study|No actionable mutation|0|||
125032739|NCT01827384|449739607|FG010|Overall Study|No actionable mutation|0|||
125032740|NCT01827384|449739608|FG011|Overall Study|No actionable mutation|0|||
125032741|NCT01827384|449739609|FG012|Overall Study|No actionable mutation|0|||
125032742|NCT01827384|449739610|FG013|Overall Study|No actionable mutation|73|||
125032743|NCT01827384|449739597|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
125032744|NCT01827384|449739598|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
125032745|NCT01827384|449739599|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
125032746|NCT01827384|449739600|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
125032747|NCT01827384|449739601|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
125032748|NCT01827384|449739602|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
125032749|NCT01827384|449739603|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
125032750|NCT01827384|449739604|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
125032751|NCT01827384|449739605|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
125032752|NCT01827384|449739606|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
125032753|NCT01827384|449739607|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
125032754|NCT01827384|449739608|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
125032755|NCT01827384|449739609|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
125032756|NCT01827384|449739610|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
125032757|NCT03636906|449739617|FG000|Overall Study|Adverse Event|0|||
125032758|NCT03636906|449739618|FG001|Overall Study|Adverse Event|0|||
125032759|NCT03636906|449739619|FG002|Overall Study|Adverse Event|1|||
125032760|NCT03636906|449739617|FG000|Overall Study|Lost to Follow-up|1|||
125032761|NCT03636906|449739618|FG001|Overall Study|Lost to Follow-up|0|||
125032762|NCT03636906|449739619|FG002|Overall Study|Lost to Follow-up|0|||
125032763|NCT03636906|449739617|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
125032764|NCT03636906|449739618|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
125032765|NCT03636906|449739619|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
125032766|NCT03636906|449739617|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
125032767|NCT03636906|449739618|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
125032768|NCT03636906|449739619|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
125032769|NCT03636906|449739617|FG000|Overall Study|Other|0|||
125032770|NCT03636906|449739618|FG001|Overall Study|Other|0|||
125032771|NCT03636906|449739619|FG002|Overall Study|Other|1|||
125032772|NCT01291017|449739620|FG000|Overall Study|Lost to Follow-up|2|||
125032773|NCT01291017|449739620|FG000|Overall Study|Withdrawal by Subject|3|||
125032774|NCT03690869|449739622|FG000|Overall Study|Adverse Event|0|||
125032775|NCT03690869|449739623|FG001|Overall Study|Adverse Event|0|||
125032776|NCT03690869|449739624|FG002|Overall Study|Adverse Event|0|||
125032777|NCT03690869|449739625|FG003|Overall Study|Adverse Event|1|||
125032778|NCT03690869|449739626|FG004|Overall Study|Adverse Event|0|||
125032779|NCT03690869|449739627|FG005|Overall Study|Adverse Event|0|||
125032780|NCT03690869|449739628|FG006|Overall Study|Adverse Event|0|||
125032781|NCT03690869|449739629|FG007|Overall Study|Adverse Event|1|||
125032782|NCT03690869|449739630|FG008|Overall Study|Adverse Event|0|||
125032783|NCT03690869|449739631|FG009|Overall Study|Adverse Event|1|||
125032784|NCT03690869|449739622|FG000|Overall Study|Death|1|||
125032785|NCT03690869|449739623|FG001|Overall Study|Death|1|||
125032786|NCT03690869|449739624|FG002|Overall Study|Death|1|||
125032787|NCT03690869|449739625|FG003|Overall Study|Death|4|||
125032788|NCT03690869|449739626|FG004|Overall Study|Death|2|||
125032789|NCT03690869|449739627|FG005|Overall Study|Death|5|||
125032790|NCT03690869|449739628|FG006|Overall Study|Death|3|||
125032791|NCT03690869|449739629|FG007|Overall Study|Death|2|||
125032792|NCT03690869|449739630|FG008|Overall Study|Death|0|||
125032793|NCT03690869|449739631|FG009|Overall Study|Death|3|||
125032794|NCT03690869|449739622|FG000|Overall Study|Lost to Follow-up|0|||
125032795|NCT03690869|449739623|FG001|Overall Study|Lost to Follow-up|0|||
125032796|NCT03690869|449739624|FG002|Overall Study|Lost to Follow-up|1|||
125032797|NCT03690869|449739625|FG003|Overall Study|Lost to Follow-up|0|||
125032798|NCT03690869|449739626|FG004|Overall Study|Lost to Follow-up|0|||
125032799|NCT03690869|449739627|FG005|Overall Study|Lost to Follow-up|0|||
125032800|NCT03690869|449739628|FG006|Overall Study|Lost to Follow-up|0|||
125032801|NCT03690869|449739629|FG007|Overall Study|Lost to Follow-up|0|||
125032802|NCT03690869|449739630|FG008|Overall Study|Lost to Follow-up|0|||
125032803|NCT03690869|449739631|FG009|Overall Study|Lost to Follow-up|0|||
125032804|NCT03690869|449739622|FG000|Overall Study|Other Treatment|1|||
125032805|NCT03690869|449739623|FG001|Overall Study|Other Treatment|1|||
125032806|NCT03690869|449739624|FG002|Overall Study|Other Treatment|1|||
125032807|NCT03690869|449739625|FG003|Overall Study|Other Treatment|2|||
125032808|NCT03690869|449739626|FG004|Overall Study|Other Treatment|3|||
125032809|NCT03690869|449739627|FG005|Overall Study|Other Treatment|1|||
125032810|NCT03690869|449739628|FG006|Overall Study|Other Treatment|2|||
125032811|NCT03690869|449739629|FG007|Overall Study|Other Treatment|7|||
125032812|NCT03690869|449739630|FG008|Overall Study|Other Treatment|0|||
125032813|NCT03690869|449739631|FG009|Overall Study|Other Treatment|3|||
125032814|NCT03690869|449739622|FG000|Overall Study|Physician Decision|0|||
125032815|NCT03690869|449739623|FG001|Overall Study|Physician Decision|1|||
125032816|NCT03690869|449739624|FG002|Overall Study|Physician Decision|0|||
125032817|NCT03690869|449739625|FG003|Overall Study|Physician Decision|0|||
125032818|NCT03690869|449739626|FG004|Overall Study|Physician Decision|0|||
125032819|NCT03690869|449739627|FG005|Overall Study|Physician Decision|0|||
125032820|NCT03690869|449739628|FG006|Overall Study|Physician Decision|0|||
125032821|NCT03690869|449739629|FG007|Overall Study|Physician Decision|0|||
125032822|NCT03690869|449739630|FG008|Overall Study|Physician Decision|0|||
125032823|NCT03690869|449739631|FG009|Overall Study|Physician Decision|0|||
125032824|NCT03690869|449739622|FG000|Overall Study|Progressive Disease|1|||
125032825|NCT03690869|449739623|FG001|Overall Study|Progressive Disease|2|||
125032826|NCT03690869|449739624|FG002|Overall Study|Progressive Disease|0|||
125032827|NCT03690869|449739625|FG003|Overall Study|Progressive Disease|1|||
125032828|NCT03690869|449739626|FG004|Overall Study|Progressive Disease|0|||
125032829|NCT03690869|449739627|FG005|Overall Study|Progressive Disease|0|||
125032830|NCT03690869|449739628|FG006|Overall Study|Progressive Disease|0|||
125217239|NCT03382418|450422085|FG001|Overall Study|Withdrawal by Subject|0|||
125217240|NCT03382418|450422086|FG002|Overall Study|Withdrawal by Subject|0|||
125217241|NCT03382418|450422084|FG000|Overall Study|Lost to Follow-up|2|||
125217242|NCT03382418|450422085|FG001|Overall Study|Lost to Follow-up|3|||
125217243|NCT03382418|450422086|FG002|Overall Study|Lost to Follow-up|0|||
125217244|NCT04633226|450422087|FG000|Overall Study|Withdrawal by parent/guardian|4|||
125217245|NCT04633226|450422087|FG000|Overall Study|Randomized by mistake without study treatment|1|||
125217246|NCT01151345|450422088|FG000|First Intervention Period|Protocol Violation|0|||
125032831|NCT03690869|449739629|FG007|Overall Study|Progressive Disease|0|||
125032832|NCT03690869|449739630|FG008|Overall Study|Progressive Disease|1|||
125032833|NCT03690869|449739631|FG009|Overall Study|Progressive Disease|1|||
125032834|NCT03690869|449739622|FG000|Overall Study|Subject Decision|0|||
125032835|NCT03690869|449739623|FG001|Overall Study|Subject Decision|0|||
125032836|NCT03690869|449739624|FG002|Overall Study|Subject Decision|0|||
125032837|NCT03690869|449739625|FG003|Overall Study|Subject Decision|1|||
125032838|NCT03690869|449739626|FG004|Overall Study|Subject Decision|0|||
125032839|NCT03690869|449739627|FG005|Overall Study|Subject Decision|0|||
125032840|NCT03690869|449739628|FG006|Overall Study|Subject Decision|0|||
125032841|NCT03690869|449739629|FG007|Overall Study|Subject Decision|1|||
125032842|NCT03690869|449739630|FG008|Overall Study|Subject Decision|0|||
125032843|NCT03690869|449739631|FG009|Overall Study|Subject Decision|0|||
125033630|NCT01701258|449743829|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
125033631|NCT01701258|449743830|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
125033632|NCT01701258|449743831|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
125033633|NCT01701258|449743832|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
125033634|NCT01701258|449743820|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
125033635|NCT01701258|449743821|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
125033636|NCT01701258|449743822|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
125033637|NCT01701258|449743823|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
125033638|NCT01701258|449743824|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
125033639|NCT01701258|449743825|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
125033640|NCT01701258|449743826|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
125033641|NCT01701258|449743827|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
125217247|NCT01151345|450422089|FG001|First Intervention Period|Protocol Violation|1|||
125217248|NCT00099632|450422092|FG000|Overall Study|Lost to Follow-up|1|||
125217249|NCT00099632|450422093|FG001|Overall Study|Lost to Follow-up|0|||
125217250|NCT00099632|450422094|FG002|Overall Study|Lost to Follow-up|3|||
125217251|NCT00099632|450422095|FG003|Overall Study|Lost to Follow-up|1|||
125033642|NCT01701258|449743828|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
125033643|NCT01701258|449743829|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
125033644|NCT01701258|449743830|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
125033645|NCT01701258|449743831|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
125033646|NCT01701258|449743832|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
125033647|NCT01701258|449743820|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
125033648|NCT01701258|449743821|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
125217252|NCT00099632|450422096|FG004|Overall Study|Lost to Follow-up|1|||
125217253|NCT00099632|450422097|FG005|Overall Study|Lost to Follow-up|0|||
125217254|NCT00099632|450422092|FG000|Overall Study|Withdrawal by Subject|0|||
125217255|NCT00099632|450422093|FG001|Overall Study|Withdrawal by Subject|1|||
125033649|NCT01701258|449743822|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
125033650|NCT01701258|449743823|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
125032844|NCT03219164|449741387|FG000|Overall Study|Study Terminated by Sponsor|16|||
125032845|NCT03219164|449741388|FG001|Overall Study|Study Terminated by Sponsor|12|||
125032846|NCT03219164|449741387|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
125032847|NCT03219164|449741388|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
125032848|NCT03219164|449741387|FG000|Overall Study|Lost to Follow-up|1|||
125032849|NCT03219164|449741388|FG001|Overall Study|Lost to Follow-up|1|||
125032850|NCT03219164|449741387|FG000|Overall Study|Adverse Event|1|||
125032851|NCT03219164|449741388|FG001|Overall Study|Adverse Event|0|||
125032852|NCT03219164|449741387|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125032853|NCT03219164|449741388|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125032854|NCT03219164|449741387|FG000|Overall Study|Protocol Violation|0|||
125032855|NCT03219164|449741388|FG001|Overall Study|Protocol Violation|1|||
125032856|NCT03219164|449741387|FG000|Overall Study|Withdrew Assent|1|||
125032857|NCT03219164|449741388|FG001|Overall Study|Withdrew Assent|0|||
125032858|NCT02689492|449741389|FG000|Overall Study|Lost to Follow-up|61|||
125032859|NCT02689492|449741389|FG000|Overall Study|Withdrawal by Subject|11|||
125032860|NCT02689492|449741389|FG000|Overall Study|Death|9|||
125032861|NCT02689492|449741389|FG000|Overall Study|Physician Decision|2|||
125032862|NCT02689492|449741389|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
125032863|NCT02689492|449741389|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
125032864|NCT02689492|449741389|FG000|Overall Study|Other than listed|1|||
125032865|NCT02029976|449741390|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
125032866|NCT02029976|449741391|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
125032867|NCT02029976|449741390|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
125032868|NCT02029976|449741391|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
125032869|NCT02029976|449741390|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
125032870|NCT02029976|449741391|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
125032871|NCT02029976|449741390|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
125032872|NCT02029976|449741391|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
125032873|NCT04025632|449741392|FG000|Overall Study|Adverse Event|1|||
125032874|NCT04025632|449741393|FG001|Overall Study|Adverse Event|1|||
125032875|NCT04025632|449741392|FG000|Overall Study|Withdrawal by Subject|1|||
125032876|NCT04025632|449741393|FG001|Overall Study|Withdrawal by Subject|1|||
125032877|NCT04025632|449741392|FG000|Overall Study|Study Terminated by Sponsor|10|||
125032878|NCT04025632|449741393|FG001|Overall Study|Study Terminated by Sponsor|9|||
125032879|NCT04025632|449741392|FG000|Overall Study|Physician Decision|3|||
125032880|NCT04025632|449741393|FG001|Overall Study|Physician Decision|1|||
125032881|NCT00127127|449741394|FG000|Overall Study|Adverse Event|0|||
125032882|NCT00127127|449741395|FG001|Overall Study|Adverse Event|2|||
125032883|NCT00127127|449741396|FG002|Overall Study|Adverse Event|0|||
125032884|NCT00127127|449741397|FG003|Overall Study|Adverse Event|1|||
125032885|NCT00127127|449741394|FG000|Overall Study|Lack of Efficacy|1|||
125032886|NCT00127127|449741395|FG001|Overall Study|Lack of Efficacy|3|||
125032887|NCT00127127|449741396|FG002|Overall Study|Lack of Efficacy|0|||
125032888|NCT00127127|449741397|FG003|Overall Study|Lack of Efficacy|2|||
125032889|NCT01524991|449741400|FG000|Overall Study|Adverse Event|12|||
125032890|NCT01524991|449741400|FG000|Overall Study|Death|1|||
125032891|NCT01524991|449741400|FG000|Overall Study|Disease ProgressionDu|17|||
125032892|NCT01524991|449741400|FG000|Overall Study|Other complicating disease|1|||
125032893|NCT01524991|449741400|FG000|Overall Study|Withdrawal by Subject|2|||
125032894|NCT01524991|449741400|FG000|Overall Study|Symptomatic Deterioration|1|||
125032895|NCT01805180|449741403|FG000|Lead-in Donor Phase|screen failure|1|||
125032896|NCT01805180|449741404|FG001|Lead-in Donor Phase|screen failure|0|||
125032897|NCT01805180|449741405|FG002|Lead-in Donor Phase|screen failure|0|||
125032898|NCT00582556|449741409|FG000|Overall Study|Withdrawal by Subject|0|||
125032899|NCT00582556|449741410|FG001|Overall Study|Withdrawal by Subject|1|||
125032900|NCT00582556|449741411|FG002|Overall Study|Withdrawal by Subject|1|||
125032901|NCT00582556|449741409|FG000|Overall Study|Physician Decision|0|||
125032902|NCT00582556|449741410|FG001|Overall Study|Physician Decision|0|||
125032903|NCT00582556|449741411|FG002|Overall Study|Physician Decision|1|||
125217256|NCT00099632|450422094|FG002|Overall Study|Withdrawal by Subject|0|||
125032904|NCT01341457|449741412|FG000|Overall Study|Adverse Event|2|||
125032905|NCT01341457|449741413|FG001|Overall Study|Adverse Event|0|||
125032906|NCT03124459|449741414|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
125032907|NCT03124459|449741415|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
125032908|NCT03124459|449741416|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
125032909|NCT03124459|449741417|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
125032910|NCT03124459|449741418|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
125032911|NCT03124459|449741419|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
125032912|NCT03124459|449741414|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
125032913|NCT03124459|449741415|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
125032914|NCT03124459|449741416|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
125032915|NCT03124459|449741417|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
125032916|NCT03124459|449741418|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
125032917|NCT03124459|449741419|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
125032918|NCT03124459|449741414|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
125032919|NCT03124459|449741415|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
125032920|NCT03124459|449741416|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
125032921|NCT03124459|449741417|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
125032922|NCT03124459|449741418|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
125032923|NCT03124459|449741419|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
125032924|NCT03124459|449741414|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
125032925|NCT03124459|449741415|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
125032926|NCT03124459|449741416|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
125032927|NCT03124459|449741417|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
125032928|NCT03124459|449741418|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
125032929|NCT03124459|449741419|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
125032930|NCT03124459|449741414|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
125032931|NCT03124459|449741415|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
125032932|NCT03124459|449741416|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
125032933|NCT03124459|449741417|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
125032934|NCT03124459|449741418|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
125032935|NCT03124459|449741419|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
125032936|NCT03124459|449741414|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
125032937|NCT03124459|449741415|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
125032938|NCT03124459|449741416|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
125032939|NCT03124459|449741417|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
125032940|NCT03124459|449741418|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
125032941|NCT03124459|449741419|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
125032942|NCT00496366|449741420|FG000|Overall Study|Death|1|||
125032943|NCT01717638|449741423|FG000|Overall Study|Lost to Follow-up|0|||
125032944|NCT01717638|449741424|FG001|Overall Study|Lost to Follow-up|0|||
125032945|NCT01717638|449741425|FG002|Overall Study|Lost to Follow-up|0|||
125032946|NCT01717638|449741426|FG003|Overall Study|Lost to Follow-up|0|||
125032947|NCT01717638|449741427|FG004|Overall Study|Lost to Follow-up|0|||
125032948|NCT01717638|449741428|FG005|Overall Study|Lost to Follow-up|1|||
125032949|NCT01717638|449741429|FG006|Overall Study|Lost to Follow-up|0|||
125032950|NCT01717638|449741430|FG007|Overall Study|Lost to Follow-up|0|||
125131113|NCT02543203|450108000|FG000|Overall Study|Negative Behavior|1|||
125131114|NCT02543203|450108001|FG001|Overall Study|Negative Behavior|0|||
125131115|NCT02543203|450108000|FG000|Overall Study|Withdrawal by Subject|0|||
125131116|NCT02543203|450108001|FG001|Overall Study|Withdrawal by Subject|1|||
125131117|NCT02077465|450108002|FG000|Overall Study|Withdrew Consent|0|||
125131118|NCT02077465|450108003|FG001|Overall Study|Withdrew Consent|1|||
125131119|NCT02077465|450108002|FG000|Overall Study|Lost to Follow-up|1|||
125131120|NCT02077465|450108003|FG001|Overall Study|Lost to Follow-up|0|||
125131121|NCT01827163|450108004|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
125131122|NCT01827163|450108004|FG000|Overall Study|Adverse Event|9|||
125131123|NCT03620747|450108006|FG000|Overall Study|Participant decision|7|||
125131124|NCT03620747|450108006|FG000|Overall Study|Adverse Event|6|||
125032951|NCT01717638|449741431|FG008|Overall Study|Lost to Follow-up|0|||
125032952|NCT01717638|449741432|FG009|Overall Study|Lost to Follow-up|0|||
125032953|NCT01717638|449741433|FG010|Overall Study|Lost to Follow-up|0|||
125032954|NCT01717638|449741434|FG011|Overall Study|Lost to Follow-up|0|||
125032955|NCT01717638|449741435|FG012|Overall Study|Lost to Follow-up|0|||
125032956|NCT01717638|449741423|FG000|Overall Study|Father in hospital|0|||
125032957|NCT01717638|449741424|FG001|Overall Study|Father in hospital|0|||
125032958|NCT01717638|449741425|FG002|Overall Study|Father in hospital|0|||
125032959|NCT01717638|449741426|FG003|Overall Study|Father in hospital|0|||
125131125|NCT03620747|450108006|FG000|Overall Study|Lack of Efficacy|1|||
125032960|NCT01717638|449741427|FG004|Overall Study|Father in hospital|0|||
125032961|NCT01717638|449741428|FG005|Overall Study|Father in hospital|0|||
125032962|NCT01717638|449741429|FG006|Overall Study|Father in hospital|0|||
125032963|NCT01717638|449741430|FG007|Overall Study|Father in hospital|0|||
125032964|NCT01717638|449741431|FG008|Overall Study|Father in hospital|0|||
125032965|NCT01717638|449741432|FG009|Overall Study|Father in hospital|0|||
125131126|NCT03620747|450108006|FG000|Overall Study|Poor compliance to protocol|2|||
125217257|NCT00099632|450422095|FG003|Overall Study|Withdrawal by Subject|0|||
125217258|NCT00099632|450422096|FG004|Overall Study|Withdrawal by Subject|0|||
125217259|NCT00099632|450422097|FG005|Overall Study|Withdrawal by Subject|1|||
125217260|NCT00099632|450422092|FG000|Overall Study|Protocol Violation|0|||
125217261|NCT00099632|450422093|FG001|Overall Study|Protocol Violation|0|||
125217262|NCT00099632|450422094|FG002|Overall Study|Protocol Violation|0|||
125217263|NCT00099632|450422095|FG003|Overall Study|Protocol Violation|0|||
125217264|NCT00099632|450422096|FG004|Overall Study|Protocol Violation|0|||
125217265|NCT00099632|450422097|FG005|Overall Study|Protocol Violation|1|||
125217266|NCT03134911|450422104|FG000|Overall Study|Screen failure|31|||
125217267|NCT03134911|450422104|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
125217268|NCT01087203|450422105|FG000|Overall Study|Lost to Follow-up|2|||
125217269|NCT01087203|450422106|FG001|Overall Study|Lost to Follow-up|0|||
125217270|NCT01087203|450422105|FG000|Overall Study|Withdrawal by Subject|2|||
125217271|NCT01087203|450422106|FG001|Overall Study|Withdrawal by Subject|6|||
125217272|NCT01087203|450422105|FG000|Overall Study|Lack of Efficacy|1|||
125217273|NCT01087203|450422106|FG001|Overall Study|Lack of Efficacy|2|||
125217274|NCT01087203|450422105|FG000|Overall Study|Study terminated by sponsor|27|||
125217275|NCT01087203|450422106|FG001|Overall Study|Study terminated by sponsor|27|||
125217276|NCT05305989|450422108|FG000|Overall Study|Other|3|||
125217277|NCT05305989|450422109|FG001|Overall Study|Other|2|||
125217278|NCT05305989|450422110|FG002|Overall Study|Other|0|||
125217279|NCT05305989|450422108|FG000|Overall Study|Sponsor decision|2|||
125217280|NCT05305989|450422109|FG001|Overall Study|Sponsor decision|1|||
125217281|NCT05305989|450422110|FG002|Overall Study|Sponsor decision|0|||
125217282|NCT05305989|450422108|FG000|Overall Study|Protocol Violation|0|||
125217283|NCT05305989|450422109|FG001|Overall Study|Protocol Violation|1|||
125217284|NCT05305989|450422110|FG002|Overall Study|Protocol Violation|0|||
125217285|NCT05305989|450422108|FG000|Overall Study|Investigator decision|1|||
125217286|NCT05305989|450422109|FG001|Overall Study|Investigator decision|2|||
125217287|NCT05305989|450422110|FG002|Overall Study|Investigator decision|0|||
125217288|NCT05305989|450422108|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
125217289|NCT05305989|450422109|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
125217290|NCT05305989|450422110|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
125217291|NCT05305989|450422108|FG000|Overall Study|Adverse Event|1|||
125217292|NCT05305989|450422109|FG001|Overall Study|Adverse Event|1|||
125217293|NCT05305989|450422110|FG002|Overall Study|Adverse Event|0|||
125217294|NCT05305989|450422108|FG000|Overall Study|Enrolled but never dosed|3|||
125217295|NCT05305989|450422109|FG001|Overall Study|Enrolled but never dosed|2|||
125217296|NCT05305989|450422110|FG002|Overall Study|Enrolled but never dosed|1|||
125217297|NCT02182830|450422111|FG000|Overall Study|Not Treated|1|||
125217298|NCT02182830|450422112|FG001|Overall Study|Not Treated|1|||
125217299|NCT02182830|450422111|FG000|Overall Study|Trial stopped, reason missing|3|||
125217300|NCT02182830|450422112|FG001|Overall Study|Trial stopped, reason missing|3|||
125217301|NCT02182830|450422111|FG000|Overall Study|Consent withdrawn|8|||
125217302|NCT02182830|450422112|FG001|Overall Study|Consent withdrawn|8|||
125217303|NCT02182830|450422111|FG000|Overall Study|Lost to Follow-up|3|||
125217304|NCT02182830|450422112|FG001|Overall Study|Lost to Follow-up|3|||
125217305|NCT00154375|450422113|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
125217306|NCT00154375|450422114|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
125217307|NCT00154375|450422113|FG000|Overall Study|Adverse Event|18|||
125217308|NCT00154375|450422114|FG001|Overall Study|Adverse Event|20|||
125217309|NCT00154375|450422113|FG000|Overall Study|Withdrawal by Subject|14|||
125217310|NCT00154375|450422114|FG001|Overall Study|Withdrawal by Subject|10|||
125217311|NCT00154375|450422113|FG000|Overall Study|Death|5|||
125217312|NCT00154375|450422114|FG001|Overall Study|Death|13|||
125217313|NCT00154375|450422113|FG000|Overall Study|Study drug no longer required|5|||
125217314|NCT00154375|450422114|FG001|Overall Study|Study drug no longer required|3|||
125217315|NCT00154375|450422113|FG000|Overall Study|Lost to Follow-up|2|||
125217316|NCT00154375|450422114|FG001|Overall Study|Lost to Follow-up|1|||
125217317|NCT00154375|450422113|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125217318|NCT00154375|450422114|FG001|Overall Study|Abnormal laboratory value(s)|2|||
125217319|NCT00154375|450422113|FG000|Overall Study|Protocol Violation|0|||
125217320|NCT00154375|450422114|FG001|Overall Study|Protocol Violation|1|||
125217321|NCT00154375|450422113|FG000|Overall Study|Suspected progression of disease|44|||
125217322|NCT00154375|450422114|FG001|Overall Study|Suspected progression of disease|30|||
125217323|NCT02348008|450422115|FG000|Overall Study|Adverse Event|2|||
125217324|NCT02348008|450422116|FG001|Overall Study|Adverse Event|3|||
125217325|NCT02348008|450422117|FG002|Overall Study|Adverse Event|3|||
125217326|NCT02348008|450422115|FG000|Overall Study|Disease Progression|1|||
125217327|NCT02348008|450422116|FG001|Overall Study|Disease Progression|5|||
125217328|NCT02348008|450422117|FG002|Overall Study|Disease Progression|16|||
125217329|NCT02348008|450422115|FG000|Overall Study|Withdrawal by Subject|0|||
125217330|NCT02348008|450422116|FG001|Overall Study|Withdrawal by Subject|1|||
125217331|NCT02348008|450422117|FG002|Overall Study|Withdrawal by Subject|0|||
125217332|NCT02348008|450422115|FG000|Overall Study|Symptomatic Deterioration|0|||
125032966|NCT01717638|449741433|FG010|Overall Study|Father in hospital|0|||
125032967|NCT01717638|449741434|FG011|Overall Study|Father in hospital|0|||
125032968|NCT01717638|449741435|FG012|Overall Study|Father in hospital|1|||
125032969|NCT01717638|449741423|FG000|Overall Study|Withdrawal by Subject|0|||
125032970|NCT01717638|449741424|FG001|Overall Study|Withdrawal by Subject|1|||
125032971|NCT01717638|449741425|FG002|Overall Study|Withdrawal by Subject|1|||
125032972|NCT01717638|449741426|FG003|Overall Study|Withdrawal by Subject|0|||
125032973|NCT01717638|449741427|FG004|Overall Study|Withdrawal by Subject|1|||
125032974|NCT01717638|449741428|FG005|Overall Study|Withdrawal by Subject|0|||
125032975|NCT01717638|449741429|FG006|Overall Study|Withdrawal by Subject|2|||
125032976|NCT01717638|449741430|FG007|Overall Study|Withdrawal by Subject|1|||
125032977|NCT01717638|449741431|FG008|Overall Study|Withdrawal by Subject|2|||
125032978|NCT01717638|449741432|FG009|Overall Study|Withdrawal by Subject|1|||
125032979|NCT01717638|449741433|FG010|Overall Study|Withdrawal by Subject|0|||
125032980|NCT01717638|449741434|FG011|Overall Study|Withdrawal by Subject|0|||
125032981|NCT01717638|449741435|FG012|Overall Study|Withdrawal by Subject|18|||
125032982|NCT00434967|449741443|FG000|Overall Study|Adverse Event|2|||
125032983|NCT00434967|449741444|FG001|Overall Study|Adverse Event|4|||
125032984|NCT00434967|449741445|FG002|Overall Study|Adverse Event|3|||
125032985|NCT00434967|449741446|FG003|Overall Study|Adverse Event|3|||
125032986|NCT00434967|449741443|FG000|Overall Study|Lost to Follow-up|0|||
125032987|NCT00434967|449741444|FG001|Overall Study|Lost to Follow-up|0|||
125032988|NCT00434967|449741445|FG002|Overall Study|Lost to Follow-up|1|||
125032989|NCT00434967|449741446|FG003|Overall Study|Lost to Follow-up|0|||
125032990|NCT00434967|449741443|FG000|Overall Study|Withdrawal by Subject|2|||
125032991|NCT00434967|449741444|FG001|Overall Study|Withdrawal by Subject|2|||
125032992|NCT00434967|449741445|FG002|Overall Study|Withdrawal by Subject|4|||
125032993|NCT00434967|449741446|FG003|Overall Study|Withdrawal by Subject|6|||
125032994|NCT00434967|449741443|FG000|Overall Study|Randomized in error|0|||
125032995|NCT00434967|449741444|FG001|Overall Study|Randomized in error|0|||
125032996|NCT00434967|449741445|FG002|Overall Study|Randomized in error|0|||
125032997|NCT00434967|449741446|FG003|Overall Study|Randomized in error|1|||
125032998|NCT00434967|449741443|FG000|Overall Study|Protocol Violation|0|||
125032999|NCT00434967|449741444|FG001|Overall Study|Protocol Violation|1|||
125033000|NCT00434967|449741445|FG002|Overall Study|Protocol Violation|0|||
125033001|NCT00434967|449741446|FG003|Overall Study|Protocol Violation|1|||
125033002|NCT00434967|449741443|FG000|Overall Study|Physician Decision|1|||
125033003|NCT00434967|449741444|FG001|Overall Study|Physician Decision|1|||
125033004|NCT00434967|449741445|FG002|Overall Study|Physician Decision|1|||
125033005|NCT00434967|449741446|FG003|Overall Study|Physician Decision|0|||
125033006|NCT00434967|449741443|FG000|Overall Study|Patient Disposition Challenges|2|||
125033007|NCT00434967|449741444|FG001|Overall Study|Patient Disposition Challenges|0|||
125033008|NCT00434967|449741445|FG002|Overall Study|Patient Disposition Challenges|0|||
125033009|NCT00434967|449741446|FG003|Overall Study|Patient Disposition Challenges|3|||
125033010|NCT01848145|449741447|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
125033011|NCT01848145|449741447|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
125033012|NCT01848145|449741447|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
125033013|NCT01848145|449741447|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
125033014|NCT01848145|449741447|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
125033015|NCT01848145|449741447|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
125033016|NCT01848145|449741447|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
125033017|NCT02886702|449741450|FG000|Overall Study|Other|4|||
125033018|NCT02886702|449741451|FG001|Overall Study|Other|3|||
125033019|NCT02886702|449741452|FG002|Overall Study|Other|9|||
125033020|NCT02886702|449741450|FG000|Overall Study|Withdrawal by Subject|24|||
125033021|NCT02886702|449741451|FG001|Overall Study|Withdrawal by Subject|18|||
125033022|NCT02886702|449741452|FG002|Overall Study|Withdrawal by Subject|22|||
125033023|NCT02886702|449741450|FG000|Overall Study|Significant Worsening of Condition|0|||
125033024|NCT02886702|449741451|FG001|Overall Study|Significant Worsening of Condition|1|||
125033025|NCT02886702|449741452|FG002|Overall Study|Significant Worsening of Condition|0|||
125033026|NCT02886702|449741450|FG000|Overall Study|Protocol Violation|2|||
125033027|NCT02886702|449741451|FG001|Overall Study|Protocol Violation|2|||
125033028|NCT02886702|449741452|FG002|Overall Study|Protocol Violation|1|||
125131127|NCT03620747|450108006|FG000|Overall Study|Other-unspecified|3|||
125131128|NCT02714062|450108007|FG000|Overall Study|Adverse Event|0|||
125033029|NCT02886702|449741450|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125033030|NCT02886702|449741451|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125033031|NCT02886702|449741452|FG002|Overall Study|Non-Compliance With Study Drug|4|||
125033032|NCT02886702|449741450|FG000|Overall Study|Lost to Follow-up|11|||
125033033|NCT02886702|449741451|FG001|Overall Study|Lost to Follow-up|13|||
125033034|NCT02886702|449741452|FG002|Overall Study|Lost to Follow-up|8|||
125033035|NCT02886702|449741450|FG000|Overall Study|Lack of Efficacy|3|||
125033036|NCT02886702|449741451|FG001|Overall Study|Lack of Efficacy|4|||
125033037|NCT02886702|449741452|FG002|Overall Study|Lack of Efficacy|5|||
125033038|NCT02886702|449741450|FG000|Overall Study|Adverse Event|4|||
125033039|NCT02886702|449741451|FG001|Overall Study|Adverse Event|9|||
125033040|NCT02886702|449741452|FG002|Overall Study|Adverse Event|3|||
124968308|NCT02658175|449511374|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
124968309|NCT02658175|449511375|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
124968310|NCT02658175|449511376|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
124968311|NCT01214421|449511377|FG000|Overall Study|Lost to Follow-up|7|||
124968312|NCT01214421|449511378|FG001|Overall Study|Lost to Follow-up|3|||
124968313|NCT01214421|449511379|FG002|Overall Study|Lost to Follow-up|7|||
124968314|NCT01214421|449511380|FG003|Overall Study|Lost to Follow-up|3|||
124968315|NCT01214421|449511377|FG000|Overall Study|Adverse Event|16|||
124968316|NCT01214421|449511378|FG001|Overall Study|Adverse Event|35|||
125131129|NCT02714062|450108008|FG001|Overall Study|Adverse Event|0|||
125131130|NCT02714062|450108009|FG002|Overall Study|Adverse Event|2|||
125131131|NCT02714062|450108007|FG000|Overall Study|Withdrawal by Subject|1|||
125131132|NCT02714062|450108008|FG001|Overall Study|Withdrawal by Subject|0|||
125131133|NCT02714062|450108009|FG002|Overall Study|Withdrawal by Subject|1|||
125131134|NCT02714062|450108007|FG000|Overall Study|Protocol Violation|0|||
125131135|NCT02714062|450108008|FG001|Overall Study|Protocol Violation|1|||
125131136|NCT02714062|450108009|FG002|Overall Study|Protocol Violation|0|||
125217333|NCT02348008|450422116|FG001|Overall Study|Symptomatic Deterioration|1|||
125217334|NCT02348008|450422117|FG002|Overall Study|Symptomatic Deterioration|0|||
124968317|NCT01214421|449511379|FG002|Overall Study|Adverse Event|14|||
124968318|NCT01214421|449511380|FG003|Overall Study|Adverse Event|3|||
124968319|NCT01214421|449511377|FG000|Overall Study|Sponsor Discontinued Site|1|||
124968320|NCT01214421|449511378|FG001|Overall Study|Sponsor Discontinued Site|2|||
124968321|NCT01214421|449511379|FG002|Overall Study|Sponsor Discontinued Site|0|||
124968322|NCT01214421|449511380|FG003|Overall Study|Sponsor Discontinued Site|0|||
124968323|NCT01214421|449511377|FG000|Overall Study|Withdrawal Criteria Met|3|||
124968324|NCT01214421|449511378|FG001|Overall Study|Withdrawal Criteria Met|0|||
124968325|NCT01214421|449511379|FG002|Overall Study|Withdrawal Criteria Met|2|||
124968326|NCT01214421|449511380|FG003|Overall Study|Withdrawal Criteria Met|1|||
124968327|NCT01214421|449511377|FG000|Overall Study|Physician Decision|2|||
124968328|NCT01214421|449511378|FG001|Overall Study|Physician Decision|0|||
124968329|NCT01214421|449511379|FG002|Overall Study|Physician Decision|4|||
124968330|NCT01214421|449511380|FG003|Overall Study|Physician Decision|0|||
124968331|NCT01214421|449511377|FG000|Overall Study|Withdrawal by Subject|21|||
124968332|NCT01214421|449511378|FG001|Overall Study|Withdrawal by Subject|18|||
124968333|NCT01214421|449511379|FG002|Overall Study|Withdrawal by Subject|11|||
124968334|NCT01214421|449511380|FG003|Overall Study|Withdrawal by Subject|2|||
124968335|NCT02581059|449511385|FG000|Study Treatment|Disease Progression|1|||
124968336|NCT02581059|449511386|FG001|Study Treatment|Disease Progression|1|||
124968337|NCT02581059|449511385|FG000|Study Treatment|Adverse Event|2|||
124968338|NCT02581059|449511386|FG001|Study Treatment|Adverse Event|1|||
124968339|NCT02581059|449511385|FG000|Study Treatment|Death|1|||
124968340|NCT02581059|449511386|FG001|Study Treatment|Death|1|||
124968341|NCT02581059|449511385|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
124968342|NCT02581059|449511386|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
124968343|NCT02581059|449511385|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
124968344|NCT02581059|449511386|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
124968345|NCT02581059|449511385|FG000|Follow up|Death|1|||
124968346|NCT02581059|449511386|FG001|Follow up|Death|3|||
124968347|NCT02581059|449511385|FG000|Follow up|study terminated|1|||
124968348|NCT02581059|449511386|FG001|Follow up|study terminated|1|||
124968349|NCT02581059|449511385|FG000|Follow up|screen failure|0|||
124968350|NCT02581059|449511386|FG001|Follow up|screen failure|1|||
124968351|NCT02581059|449511385|FG000|Follow up|Patient started new clinical trial|1|||
124968352|NCT02581059|449511386|FG001|Follow up|Patient started new clinical trial|0|||
124968353|NCT02392104|449511387|FG000|Overall Study|discontinuation of warfarin|3|||
124968354|NCT02392104|449511387|FG000|Overall Study|bleeding event|1|||
124968355|NCT02392104|449511387|FG000|Overall Study|transferred care to another doctor|2|||
124968356|NCT02392104|449511387|FG000|Overall Study|INR goal range changed|1|||
124968357|NCT02392104|449511387|FG000|Overall Study|admitted to skilled nursing facility|3|||
124968358|NCT02392104|449511387|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
124968359|NCT04887506|449511388|FG000|Overall Study|Death|1|||
124968360|NCT04887506|449511389|FG001|Overall Study|Death|1|||
124968361|NCT04887506|449511388|FG000|Overall Study|Withdrawal by Subject|0|||
124968362|NCT04887506|449511389|FG001|Overall Study|Withdrawal by Subject|3|||
125131137|NCT02294604|450108010|FG000|Overall Study|Did not provide samples for culture|0|||
125131138|NCT02294604|450108011|FG001|Overall Study|Did not provide samples for culture|1|||
125131139|NCT02294604|450108012|FG002|Overall Study|Did not provide samples for culture|0|||
125131140|NCT02294604|450108010|FG000|Overall Study|Culture contamination|1|||
125131141|NCT02294604|450108011|FG001|Overall Study|Culture contamination|2|||
125131142|NCT02294604|450108012|FG002|Overall Study|Culture contamination|0|||
125131143|NCT01200810|450108017|FG000|Overall Study|Physician Decision|1|||
125131144|NCT01200810|450108018|FG001|Overall Study|Physician Decision|0|||
125131145|NCT01200810|450108017|FG000|Overall Study|Withdrawal by Subject|1|||
125131146|NCT01200810|450108018|FG001|Overall Study|Withdrawal by Subject|2|||
125131147|NCT01200810|450108017|FG000|Overall Study|Sponsor stopped making study drug|3|||
125131148|NCT01200810|450108018|FG001|Overall Study|Sponsor stopped making study drug|3|||
125131149|NCT00365846|450108019|FG000|Overall Study|Lost to Follow-up|1|||
124968363|NCT04887506|449511388|FG000|Overall Study|Adverse Event|4|||
124968364|NCT04887506|449511389|FG001|Overall Study|Adverse Event|3|||
124968365|NCT04887506|449511388|FG000|Overall Study|Other - Not Reported|1|||
124968366|NCT04887506|449511389|FG001|Overall Study|Other - Not Reported|1|||
124968367|NCT02394665|449511392|FG000|Overall Study|Physician Decision|1|||
124968368|NCT02394665|449511393|FG001|Overall Study|Physician Decision|0|||
125217335|NCT00792116|450422124|FG000|Overall Study|Lost to Follow-up|0|||
125217336|NCT00792116|450422125|FG001|Overall Study|Lost to Follow-up|1|||
124968369|NCT02394665|449511394|FG002|Overall Study|Physician Decision|0|||
124968370|NCT02636608|449511395|FG000|Overall Study|Failure to Return|4|||
124968371|NCT02636608|449511395|FG000|Overall Study|Insufficient Virological Response|1|||
124968372|NCT02636608|449511395|FG000|Overall Study|Death|3|||
124968373|NCT02636608|449511395|FG000|Overall Study|Other|2|||
124968374|NCT02636608|449511395|FG000|Overall Study|Did Not Receive Treatment|1|||
125033041|NCT02886702|449741450|FG000|Overall Study|Administrative Reasons|0|||
125033042|NCT02886702|449741451|FG001|Overall Study|Administrative Reasons|0|||
125033043|NCT02886702|449741452|FG002|Overall Study|Administrative Reasons|1|||
125033044|NCT02429856|449741453|FG000|Overall Study|Death|12|||
125033045|NCT02429856|449741454|FG001|Overall Study|Death|13|||
125033046|NCT02429856|449741453|FG000|Overall Study|Lost to Follow-up|6|||
125033047|NCT02429856|449741454|FG001|Overall Study|Lost to Follow-up|5|||
125033048|NCT02429856|449741453|FG000|Overall Study|Withdrawal by Subject|1|||
125033049|NCT02429856|449741454|FG001|Overall Study|Withdrawal by Subject|1|||
125033050|NCT03514914|449741456|FG000|Overall Study|Death|3|||
125033051|NCT03514914|449741457|FG001|Overall Study|Death|3|||
125033052|NCT03514914|449741456|FG000|Overall Study|Lost to Follow-up|117|||
125033053|NCT03514914|449741457|FG001|Overall Study|Lost to Follow-up|89|||
125033054|NCT01355289|449741459|FG000|Core Study|Adverse Event, Non-Fatal|1|||
125033055|NCT01355289|449741460|FG001|Core Study|Adverse Event, Non-Fatal|0|||
125033056|NCT01355289|449741461|FG002|Core Study|Adverse Event, Non-Fatal|0|||
125033057|NCT01355289|449741462|FG003|Core Study|Adverse Event, Non-Fatal|0|||
125033058|NCT01355289|449741463|FG004|Core Study|Adverse Event, Non-Fatal|0|||
125033059|NCT01355289|449741459|FG000|Core Study|Inadequate Therapeutic Effect|0|||
125033060|NCT01355289|449741460|FG001|Core Study|Inadequate Therapeutic Effect|0|||
125033061|NCT01355289|449741461|FG002|Core Study|Inadequate Therapeutic Effect|0|||
125033062|NCT01355289|449741462|FG003|Core Study|Inadequate Therapeutic Effect|1|||
125033063|NCT01355289|449741463|FG004|Core Study|Inadequate Therapeutic Effect|0|||
125033064|NCT01355289|449741459|FG000|Core Study|Other|0|||
125033065|NCT01355289|449741460|FG001|Core Study|Other|0|||
125033066|NCT01355289|449741461|FG002|Core Study|Other|0|||
125033067|NCT01355289|449741462|FG003|Core Study|Other|1|||
125033068|NCT01355289|449741463|FG004|Core Study|Other|0|||
125033069|NCT01355289|449741459|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
125033070|NCT01355289|449741460|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
125033071|NCT01355289|449741461|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
125033072|NCT01355289|449741462|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
125033073|NCT01355289|449741463|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
125033074|NCT01355289|449741459|FG000|Open Label Extension|Lost to Follow-up|0|||
125033075|NCT01355289|449741460|FG001|Open Label Extension|Lost to Follow-up|0|||
125033076|NCT01355289|449741461|FG002|Open Label Extension|Lost to Follow-up|0|||
125033077|NCT01355289|449741462|FG003|Open Label Extension|Lost to Follow-up|0|||
125033078|NCT01355289|449741463|FG004|Open Label Extension|Lost to Follow-up|1|||
125033079|NCT01355289|449741459|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
125033080|NCT01355289|449741460|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
125033081|NCT01355289|449741461|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
125033082|NCT01355289|449741462|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
125033083|NCT01355289|449741463|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
125033084|NCT01355289|449741459|FG000|Open Label Extension|Other|0|||
125033085|NCT01355289|449741460|FG001|Open Label Extension|Other|0|||
125033086|NCT01355289|449741461|FG002|Open Label Extension|Other|0|||
125033087|NCT01355289|449741462|FG003|Open Label Extension|Other|0|||
125033088|NCT01355289|449741463|FG004|Open Label Extension|Other|3|||
125033089|NCT04336163|449741464|FG000|Overall Study|Lost to Follow-up|55|||
125033090|NCT04336163|449741465|FG001|Overall Study|Lost to Follow-up|0|||
125033091|NCT01085682|449741466|FG000|Overall Study|Withdrawal by Subject|25|||
125033092|NCT01085682|449741467|FG001|Overall Study|Withdrawal by Subject|25|||
125033093|NCT01451645|449741468|FG000|Overall Study|Protocol Violation|1|||
125033094|NCT01451645|449741469|FG001|Overall Study|Protocol Violation|0|||
125033095|NCT01451645|449741468|FG000|Overall Study|Adverse Event|0|||
125033096|NCT01451645|449741469|FG001|Overall Study|Adverse Event|3|||
125033097|NCT01451645|449741468|FG000|Overall Study|Withdrawal by Subject|4|||
125033098|NCT01451645|449741469|FG001|Overall Study|Withdrawal by Subject|2|||
125033099|NCT01451645|449741468|FG000|Overall Study|Lost to Follow-up|4|||
125033100|NCT01451645|449741469|FG001|Overall Study|Lost to Follow-up|3|||
125033101|NCT00813995|449741476|FG000|Overall Study|Clinical adverse event|9|||
125033102|NCT00813995|449741477|FG001|Overall Study|Clinical adverse event|3|||
125033103|NCT00813995|449741476|FG000|Overall Study|Laboratory adverse event|0|||
125033104|NCT00813995|449741477|FG001|Overall Study|Laboratory adverse event|2|||
125033105|NCT00813995|449741476|FG000|Overall Study|Lack of Efficacy|1|||
125033106|NCT00813995|449741477|FG001|Overall Study|Lack of Efficacy|0|||
125033107|NCT00813995|449741476|FG000|Overall Study|Lost to Follow-up|4|||
125033108|NCT00813995|449741477|FG001|Overall Study|Lost to Follow-up|2|||
125033109|NCT00813995|449741476|FG000|Overall Study|Other reason|2|||
125033110|NCT00813995|449741477|FG001|Overall Study|Other reason|2|||
125033111|NCT00813995|449741476|FG000|Overall Study|Protocol Violation|3|||
125033112|NCT00813995|449741477|FG001|Overall Study|Protocol Violation|2|||
125033113|NCT00813995|449741476|FG000|Overall Study|Subject moved|4|||
125033114|NCT00813995|449741477|FG001|Overall Study|Subject moved|0|||
125033115|NCT00813995|449741476|FG000|Overall Study|Withdrawal by Subject|0|||
125033116|NCT00813995|449741477|FG001|Overall Study|Withdrawal by Subject|5|||
125033117|NCT01614964|449741478|FG000|Overall Study|Withdrawal by Subject|2|||
125033118|NCT01614964|449741479|FG001|Overall Study|Withdrawal by Subject|0|||
125217337|NCT00792116|450422124|FG000|Overall Study|Discontnued intervention|1|||
125217338|NCT00792116|450422125|FG001|Overall Study|Discontnued intervention|0|||
125217339|NCT04865419|450423503|FG000|Overall Study|Other|1|||
125217340|NCT04865419|450423504|FG001|Overall Study|Other|2|||
125217341|NCT04865419|450423505|FG002|Overall Study|Other|2|||
125217342|NCT04865419|450423506|FG003|Overall Study|Other|1|||
125217343|NCT04865419|450423507|FG004|Overall Study|Other|3|||
125217344|NCT04865419|450423508|FG005|Overall Study|Other|0|||
125217345|NCT04865419|450423509|FG006|Overall Study|Other|0|||
125217346|NCT04865419|450423510|FG007|Overall Study|Other|1|||
125217347|NCT04865419|450423511|FG008|Overall Study|Other|0|||
125217348|NCT04865419|450423512|FG009|Overall Study|Other|0|||
125217349|NCT04865419|450423513|FG010|Overall Study|Other|0|||
124968375|NCT05613088|449511398|FG000|Treatment|Ongoing Study Treatment|9|||
124968376|NCT05613088|449511399|FG001|Treatment|Ongoing Study Treatment|2|||
124968377|NCT05613088|449511398|FG000|Treatment|Adverse Event|3|||
124968378|NCT05613088|449511399|FG001|Treatment|Adverse Event|1|||
124968379|NCT05613088|449511398|FG000|Treatment|Other Reasons|0|||
124968380|NCT05613088|449511399|FG001|Treatment|Other Reasons|1|||
124968381|NCT05613088|449511398|FG000|Treatment|Progressive Disease|58|||
124968382|NCT05613088|449511399|FG001|Treatment|Progressive Disease|26|||
124968383|NCT05613088|449511398|FG000|Treatment|Withdrawal by Subject|0|||
124968384|NCT05613088|449511399|FG001|Treatment|Withdrawal by Subject|4|||
124968385|NCT03912532|449511400|FG000|Overall Study|Adverse Event|3|||
124968386|NCT03912532|449511401|FG001|Overall Study|Adverse Event|3|||
124968387|NCT03912532|449511402|FG002|Overall Study|Adverse Event|2|||
124968388|NCT03912532|449511403|FG003|Overall Study|Adverse Event|2|||
124968389|NCT03912532|449511400|FG000|Overall Study|Lost to Follow-up|3|||
124968390|NCT03912532|449511401|FG001|Overall Study|Lost to Follow-up|2|||
124968391|NCT03912532|449511402|FG002|Overall Study|Lost to Follow-up|1|||
124968392|NCT03912532|449511403|FG003|Overall Study|Lost to Follow-up|2|||
124968393|NCT03912532|449511400|FG000|Overall Study|Withdrawal by Subject|1|||
125033119|NCT01614964|449741478|FG000|Overall Study|Lost to Follow-up|3|||
125033120|NCT01614964|449741479|FG001|Overall Study|Lost to Follow-up|0|||
125033121|NCT02700984|449741490|FG000|Overall Study|Death|2|||
125033122|NCT02700984|449741491|FG001|Overall Study|Death|1|||
125217350|NCT04865419|450423503|FG000|Overall Study|Withdrawal by Subject|0|||
125217351|NCT04865419|450423504|FG001|Overall Study|Withdrawal by Subject|1|||
124968394|NCT03912532|449511401|FG001|Overall Study|Withdrawal by Subject|1|||
124968395|NCT03912532|449511402|FG002|Overall Study|Withdrawal by Subject|2|||
124968396|NCT03912532|449511403|FG003|Overall Study|Withdrawal by Subject|0|||
124968397|NCT03912532|449511400|FG000|Overall Study|Physician Decision|1|||
124968398|NCT03912532|449511401|FG001|Overall Study|Physician Decision|0|||
125033123|NCT02700984|449741490|FG000|Overall Study|Lost to Follow-up|2|||
125033124|NCT02700984|449741491|FG001|Overall Study|Lost to Follow-up|1|||
125217352|NCT04865419|450423505|FG002|Overall Study|Withdrawal by Subject|1|||
125217353|NCT04865419|450423506|FG003|Overall Study|Withdrawal by Subject|0|||
125217354|NCT04865419|450423507|FG004|Overall Study|Withdrawal by Subject|0|||
125217355|NCT04865419|450423508|FG005|Overall Study|Withdrawal by Subject|0|||
125217356|NCT04865419|450423509|FG006|Overall Study|Withdrawal by Subject|0|||
125217357|NCT04865419|450423510|FG007|Overall Study|Withdrawal by Subject|1|||
125217358|NCT04865419|450423511|FG008|Overall Study|Withdrawal by Subject|2|||
125217359|NCT04865419|450423512|FG009|Overall Study|Withdrawal by Subject|1|||
125217360|NCT04865419|450423513|FG010|Overall Study|Withdrawal by Subject|0|||
125217361|NCT04865419|450423503|FG000|Overall Study|Study terminated by Sponsor|0|||
125217362|NCT04865419|450423504|FG001|Overall Study|Study terminated by Sponsor|0|||
125217363|NCT04865419|450423505|FG002|Overall Study|Study terminated by Sponsor|0|||
125217364|NCT04865419|450423506|FG003|Overall Study|Study terminated by Sponsor|2|||
125217365|NCT04865419|450423507|FG004|Overall Study|Study terminated by Sponsor|2|||
125217366|NCT04865419|450423508|FG005|Overall Study|Study terminated by Sponsor|0|||
125217367|NCT04865419|450423509|FG006|Overall Study|Study terminated by Sponsor|0|||
125217368|NCT04865419|450423510|FG007|Overall Study|Study terminated by Sponsor|0|||
125217369|NCT04865419|450423511|FG008|Overall Study|Study terminated by Sponsor|0|||
125217370|NCT04865419|450423512|FG009|Overall Study|Study terminated by Sponsor|0|||
125217371|NCT04865419|450423513|FG010|Overall Study|Study terminated by Sponsor|1|||
125217372|NCT04865419|450423503|FG000|Overall Study|Death|3|||
125217373|NCT04865419|450423504|FG001|Overall Study|Death|1|||
125217374|NCT04865419|450423505|FG002|Overall Study|Death|4|||
124968399|NCT03912532|449511402|FG002|Overall Study|Physician Decision|0|||
124968400|NCT03912532|449511403|FG003|Overall Study|Physician Decision|3|||
124968401|NCT03912532|449511400|FG000|Overall Study|Other|0|||
124968402|NCT03912532|449511401|FG001|Overall Study|Other|1|||
124968403|NCT03912532|449511402|FG002|Overall Study|Other|1|||
124968404|NCT03912532|449511403|FG003|Overall Study|Other|0|||
124968405|NCT04199052|449511406|FG000|Overall Study|Lost to Follow-up|11|||
124968406|NCT04199052|449511407|FG001|Overall Study|Lost to Follow-up|18|||
124968407|NCT03569891|449511408|FG000|Lead-in|Ineligible during lead-in|8|||
124968408|NCT03569891|449511408|FG000|Lead-in|Withdrawal by Subject|3|||
124968409|NCT03569891|449511408|FG000|Lead-in|Risks related to COVID-19|2|||
124968410|NCT03569891|449511408|FG000|AMT-061|Adverse Event|1|||
124968411|NCT00815919|449511409|FG000|Overall Study|Unrelated Fungal Infection|1|||
124968412|NCT00815919|449511409|FG000|Overall Study|AML Relapse|1|||
124968413|NCT00815919|449511409|FG000|Overall Study|Lack of Efficacy|2|||
124968414|NCT03614676|449513346|FG000|Overall Study|Delivery before planned visit|2|||
124968415|NCT03614676|449513347|FG001|Overall Study|Delivery before planned visit|0|||
124968416|NCT03614676|449513346|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
124968417|NCT03614676|449513347|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
124968418|NCT03614676|449513346|FG000|Overall Study|Migrated / moved from the study area|30|||
124968419|NCT03614676|449513347|FG001|Overall Study|Migrated / moved from the study area|22|||
124968420|NCT03614676|449513346|FG000|Overall Study|Lost to Follow-up|17|||
124968421|NCT03614676|449513347|FG001|Overall Study|Lost to Follow-up|42|||
124968422|NCT03614676|449513346|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
124968423|NCT03614676|449513347|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
124968424|NCT03614676|449513346|FG000|Overall Study|Other|16|||
124968425|NCT03614676|449513347|FG001|Overall Study|Other|47|||
124968426|NCT03614676|449513346|FG000|Overall Study|Protocol Violation|0|||
124968427|NCT03614676|449513347|FG001|Overall Study|Protocol Violation|2|||
124968428|NCT03614676|449513346|FG000|Overall Study|Neonatal event of interest|0|||
124968429|NCT03614676|449513347|FG001|Overall Study|Neonatal event of interest|6|||
124968430|NCT03614676|449513346|FG000|Overall Study|Death in infant greater than 28 days old|0|||
124968431|NCT03614676|449513347|FG001|Overall Study|Death in infant greater than 28 days old|12|||
124968432|NCT03614676|449513346|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
124968433|NCT03614676|449513347|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
124968434|NCT02825251|449513350|FG000|Overall Study|Adverse Event|0|||
124968435|NCT02825251|449513351|FG001|Overall Study|Adverse Event|1|||
124968436|NCT02825251|449513350|FG000|Overall Study|Lost to Follow-up|0|||
124968437|NCT02825251|449513351|FG001|Overall Study|Lost to Follow-up|1|||
125033125|NCT02700984|449741490|FG000|Overall Study|Physician Decision|0|||
125217375|NCT04865419|450423506|FG003|Overall Study|Death|2|||
125217376|NCT04865419|450423507|FG004|Overall Study|Death|5|||
124968438|NCT02825251|449513350|FG000|Overall Study|Withdrawal by Subject|1|||
124968439|NCT02825251|449513351|FG001|Overall Study|Withdrawal by Subject|4|||
124968440|NCT02825251|449513350|FG000|Overall Study|Unclassified|2|||
124968441|NCT02825251|449513351|FG001|Overall Study|Unclassified|0|||
124968442|NCT00487825|449513352|FG000|Overall Study|Adverse Event|2|||
124968443|NCT00487825|449513353|FG001|Overall Study|Adverse Event|2|||
125131150|NCT00904215|450108021|FG000|Overall Study|Adverse Event|25|||
125131151|NCT00904215|450108021|FG000|Overall Study|Protocol Violation|10|||
125131152|NCT00904215|450108021|FG000|Overall Study|Lost to Follow-up|63|||
125131153|NCT00904215|450108021|FG000|Overall Study|Withdrawal by Subject|9|||
125131154|NCT00904215|450108021|FG000|Overall Study|Other|28|||
125131155|NCT00960297|450108022|FG000|Overall Study|Physician Decision|1|||
125131156|NCT00960297|450108022|FG000|Overall Study|Venous port infection|1|||
125131157|NCT00960297|450108022|FG000|Overall Study|Disease progression|1|||
125131158|NCT03965091|450108030|FG000|Overall Study|Adverse Event|0|||
125131159|NCT03965091|450108031|FG001|Overall Study|Adverse Event|2|||
125131160|NCT03965091|450108032|FG002|Overall Study|Adverse Event|3|||
124968444|NCT00487825|449513352|FG000|Overall Study|Lack of Efficacy|1|||
124968445|NCT00487825|449513353|FG001|Overall Study|Lack of Efficacy|1|||
124968446|NCT00487825|449513352|FG000|Overall Study|Other|3|||
124968447|NCT00487825|449513353|FG001|Overall Study|Other|2|||
124968448|NCT01639742|449513356|FG000|Overall Study|Study Ongoing|17|||
124968449|NCT01639742|449513356|FG000|Overall Study|Lost to Follow-up|1|||
124968450|NCT01190644|449513358|FG000|Overall Study|Death|2|||
124968451|NCT01190644|449513358|FG000|Overall Study|Disease progression|1|||
124968452|NCT02366143|449513359|FG000|Overall Study|Death|307|||
124968453|NCT02366143|449513360|FG001|Overall Study|Death|278|||
124968454|NCT02366143|449513361|FG002|Overall Study|Death|280|||
124968455|NCT02366143|449513359|FG000|Overall Study|Lost to Follow-up|2|||
124968456|NCT02366143|449513360|FG001|Overall Study|Lost to Follow-up|4|||
124968457|NCT02366143|449513361|FG002|Overall Study|Lost to Follow-up|2|||
124968458|NCT02366143|449513359|FG000|Overall Study|Physician Decision|1|||
124968459|NCT02366143|449513360|FG001|Overall Study|Physician Decision|2|||
124968460|NCT02366143|449513361|FG002|Overall Study|Physician Decision|1|||
124968461|NCT02366143|449513359|FG000|Overall Study|Protocol Violation|0|||
124968462|NCT02366143|449513360|FG001|Overall Study|Protocol Violation|0|||
124968463|NCT02366143|449513361|FG002|Overall Study|Protocol Violation|2|||
124968464|NCT02366143|449513359|FG000|Overall Study|Withdrawal by Subject|16|||
124968465|NCT02366143|449513360|FG001|Overall Study|Withdrawal by Subject|17|||
124968466|NCT02366143|449513361|FG002|Overall Study|Withdrawal by Subject|22|||
124968467|NCT02366143|449513359|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
124968468|NCT02366143|449513360|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
124968469|NCT02366143|449513361|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
124968470|NCT02366143|449513359|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
124968471|NCT02366143|449513360|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
124968472|NCT02366143|449513361|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
124968473|NCT02366143|449513359|FG000|Overall Study|Randomization Error|1|||
124968474|NCT02366143|449513360|FG001|Overall Study|Randomization Error|0|||
124968475|NCT02366143|449513361|FG002|Overall Study|Randomization Error|0|||
124968476|NCT02366143|449513359|FG000|Overall Study|PI Move and Site Closure|1|||
124968477|NCT02366143|449513360|FG001|Overall Study|PI Move and Site Closure|0|||
124968478|NCT02366143|449513361|FG002|Overall Study|PI Move and Site Closure|1|||
125131161|NCT03965091|450108030|FG000|Overall Study|Withdrawal by Subject|11|||
124968479|NCT02366143|449513359|FG000|Overall Study|Study Terminated By Sponsor|0|||
124968480|NCT02366143|449513360|FG001|Overall Study|Study Terminated By Sponsor|0|||
124968481|NCT02366143|449513361|FG002|Overall Study|Study Terminated By Sponsor|2|||
124968482|NCT02366143|449513359|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
124968483|NCT02366143|449513360|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
125033126|NCT02700984|449741491|FG001|Overall Study|Physician Decision|1|||
125033127|NCT02700984|449741490|FG000|Overall Study|Withdrawal by Subject|8|||
125033128|NCT02700984|449741491|FG001|Overall Study|Withdrawal by Subject|9|||
125033129|NCT02700984|449741490|FG000|Overall Study|Reason not specified|3|||
125033130|NCT02700984|449741491|FG001|Overall Study|Reason not specified|2|||
125033131|NCT00473876|449741493|FG000|Overall Study|Lost to Follow-up|3|||
125033132|NCT00473876|449741494|FG001|Overall Study|Lost to Follow-up|1|||
125033133|NCT00348140|449741495|FG000|Overall Study|Adverse Event|46|||
125033134|NCT00348140|449741496|FG001|Overall Study|Adverse Event|49|||
125131162|NCT03965091|450108031|FG001|Overall Study|Withdrawal by Subject|3|||
125131163|NCT03965091|450108032|FG002|Overall Study|Withdrawal by Subject|5|||
125131164|NCT03965091|450108030|FG000|Overall Study|Non-compliance with study drug|0|||
125131165|NCT03965091|450108031|FG001|Overall Study|Non-compliance with study drug|0|||
125131166|NCT03965091|450108032|FG002|Overall Study|Non-compliance with study drug|1|||
125131167|NCT03965091|450108030|FG000|Overall Study|Lost to Follow-up|1|||
125131168|NCT03965091|450108031|FG001|Overall Study|Lost to Follow-up|1|||
125131169|NCT03965091|450108032|FG002|Overall Study|Lost to Follow-up|1|||
125131170|NCT03965091|450108030|FG000|Overall Study|Lack of Efficacy|2|||
125131171|NCT03965091|450108031|FG001|Overall Study|Lack of Efficacy|0|||
125131172|NCT03965091|450108032|FG002|Overall Study|Lack of Efficacy|0|||
125033135|NCT00348140|449741497|FG002|Overall Study|Adverse Event|78|||
125033136|NCT00348140|449741495|FG000|Overall Study|Lost to Follow-up|4|||
125033137|NCT00348140|449741496|FG001|Overall Study|Lost to Follow-up|4|||
125033138|NCT00348140|449741497|FG002|Overall Study|Lost to Follow-up|4|||
125033139|NCT00348140|449741495|FG000|Overall Study|Protocol Violation|12|||
125033140|NCT00348140|449741496|FG001|Overall Study|Protocol Violation|13|||
125033141|NCT00348140|449741497|FG002|Overall Study|Protocol Violation|14|||
125033142|NCT00348140|449741495|FG000|Overall Study|Withdrawal by Subject|32|||
125033143|NCT00348140|449741496|FG001|Overall Study|Withdrawal by Subject|40|||
125033144|NCT00348140|449741497|FG002|Overall Study|Withdrawal by Subject|40|||
125033145|NCT00348140|449741495|FG000|Overall Study|Non-compliance|8|||
125033146|NCT00348140|449741496|FG001|Overall Study|Non-compliance|13|||
125033147|NCT00348140|449741497|FG002|Overall Study|Non-compliance|5|||
125033148|NCT00348140|449741495|FG000|Overall Study|Participant at risk due to study drug|2|||
125033149|NCT00348140|449741496|FG001|Overall Study|Participant at risk due to study drug|0|||
125033150|NCT00348140|449741497|FG002|Overall Study|Participant at risk due to study drug|0|||
125033151|NCT00348140|449741495|FG000|Overall Study|Conditional medication increased dose|1|||
125033152|NCT00348140|449741496|FG001|Overall Study|Conditional medication increased dose|0|||
125217377|NCT04865419|450423508|FG005|Overall Study|Death|2|||
124968484|NCT02366143|449513361|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
124968485|NCT02366143|449513359|FG000|Overall Study|Patient moved to roll-over study|1|||
124968486|NCT02366143|449513360|FG001|Overall Study|Patient moved to roll-over study|19|||
124968487|NCT02366143|449513361|FG002|Overall Study|Patient moved to roll-over study|28|||
124968488|NCT02366143|449513359|FG000|Overall Study|Patient moved to commercial stock|0|||
124968489|NCT02366143|449513360|FG001|Overall Study|Patient moved to commercial stock|0|||
124968490|NCT02366143|449513361|FG002|Overall Study|Patient moved to commercial stock|1|||
124968491|NCT02366143|449513359|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
124968492|NCT02366143|449513360|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
124968493|NCT02366143|449513361|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
124968494|NCT02366143|449513359|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
124968495|NCT02366143|449513360|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
124968496|NCT02366143|449513361|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
124968497|NCT02366143|449513359|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
124968498|NCT02366143|449513360|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
124968499|NCT02366143|449513361|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
124968500|NCT02366143|449513359|FG000|Overall Study|Requester's instructions|1|||
124968501|NCT02366143|449513360|FG001|Overall Study|Requester's instructions|1|||
124968502|NCT02366143|449513361|FG002|Overall Study|Requester's instructions|1|||
124968503|NCT02366143|449513359|FG000|Overall Study|Uneligible|0|||
124968504|NCT02366143|449513360|FG001|Overall Study|Uneligible|1|||
124968505|NCT02366143|449513361|FG002|Overall Study|Uneligible|0|||
124968506|NCT02366143|449513359|FG000|Overall Study|Post Trial Migration|0|||
124968507|NCT02366143|449513360|FG001|Overall Study|Post Trial Migration|1|||
124968508|NCT02366143|449513361|FG002|Overall Study|Post Trial Migration|0|||
124968509|NCT02366143|449513359|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
124968510|NCT02366143|449513360|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
124968511|NCT02366143|449513361|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
124968512|NCT02366143|449513359|FG000|Overall Study|Patient switched to PTAP|0|||
124968513|NCT02366143|449513360|FG001|Overall Study|Patient switched to PTAP|1|||
124968514|NCT02366143|449513361|FG002|Overall Study|Patient switched to PTAP|0|||
124968515|NCT02366143|449513359|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
124968516|NCT02366143|449513360|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
124968517|NCT02366143|449513361|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
124968518|NCT04411186|449513362|FG000|Overall Study|Withdrawn due to protocol violation|0|||
124968519|NCT04411186|449513363|FG001|Overall Study|Withdrawn due to protocol violation|1|||
125033153|NCT00348140|449741497|FG002|Overall Study|Conditional medication increased dose|0|||
125033154|NCT00348140|449741495|FG000|Overall Study|Caregiver related|4|||
125033155|NCT00348140|449741496|FG001|Overall Study|Caregiver related|7|||
125033156|NCT00348140|449741497|FG002|Overall Study|Caregiver related|3|||
125033157|NCT00348140|449741495|FG000|Overall Study|Participant hospitalised|3|||
125033158|NCT00348140|449741496|FG001|Overall Study|Participant hospitalised|0|||
125033159|NCT00348140|449741497|FG002|Overall Study|Participant hospitalised|0|||
125033160|NCT00348140|449741495|FG000|Overall Study|Efficacy related|1|||
125033161|NCT00348140|449741496|FG001|Overall Study|Efficacy related|1|||
125033162|NCT00348140|449741497|FG002|Overall Study|Efficacy related|0|||
125033163|NCT00348140|449741495|FG000|Overall Study|Administration related|3|||
125033164|NCT00348140|449741496|FG001|Overall Study|Administration related|1|||
125033165|NCT00348140|449741497|FG002|Overall Study|Administration related|1|||
125033166|NCT00348140|449741495|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
125217378|NCT04865419|450423509|FG006|Overall Study|Death|1|||
125217379|NCT04865419|450423510|FG007|Overall Study|Death|1|||
124968520|NCT00575042|449513364|FG000|Overall Study|Adverse Event|2|||
124968521|NCT00575042|449513364|FG000|Overall Study|Lost to Follow-up|1|||
124968522|NCT01053247|449513365|FG000|Overall Study|Withdrawal by Subject|9|||
124968523|NCT01053247|449513366|FG001|Overall Study|Withdrawal by Subject|4|||
124968524|NCT01053247|449513367|FG002|Overall Study|Withdrawal by Subject|15|||
124968525|NCT01053247|449513365|FG000|Overall Study|Lack of Efficacy|1|||
124968526|NCT01053247|449513366|FG001|Overall Study|Lack of Efficacy|0|||
124968527|NCT01053247|449513367|FG002|Overall Study|Lack of Efficacy|1|||
124968528|NCT01053247|449513365|FG000|Overall Study|Protocol Violation|2|||
124968529|NCT01053247|449513366|FG001|Overall Study|Protocol Violation|1|||
124968530|NCT01053247|449513367|FG002|Overall Study|Protocol Violation|2|||
124968531|NCT01053247|449513365|FG000|Overall Study|Lost to Follow-up|8|||
124968532|NCT01053247|449513366|FG001|Overall Study|Lost to Follow-up|5|||
124968533|NCT01053247|449513367|FG002|Overall Study|Lost to Follow-up|7|||
124968534|NCT01053247|449513365|FG000|Overall Study|Adverse Event|0|||
124968535|NCT01053247|449513366|FG001|Overall Study|Adverse Event|9|||
124968536|NCT01053247|449513367|FG002|Overall Study|Adverse Event|3|||
124968537|NCT04795336|449513368|FG000|Overall Study|Withdrawal by Subject|3|||
124968538|NCT04795336|449513369|FG001|Overall Study|Withdrawal by Subject|4|||
124968539|NCT04795336|449513370|FG002|Overall Study|Withdrawal by Subject|3|||
124968540|NCT04795336|449513371|FG003|Overall Study|Withdrawal by Subject|12|||
124968541|NCT04795336|449513368|FG000|Overall Study|Lost study logs|0|||
124968542|NCT04795336|449513369|FG001|Overall Study|Lost study logs|1|||
124968543|NCT04795336|449513370|FG002|Overall Study|Lost study logs|0|||
124968544|NCT04795336|449513371|FG003|Overall Study|Lost study logs|2|||
124968545|NCT04795336|449513368|FG000|Overall Study|Did not take study medication|2|||
124968546|NCT04795336|449513369|FG001|Overall Study|Did not take study medication|0|||
124968547|NCT04795336|449513370|FG002|Overall Study|Did not take study medication|0|||
124968548|NCT04795336|449513371|FG003|Overall Study|Did not take study medication|0|||
124968549|NCT03898700|449513372|FG000|Overall Study|Withdrawal by Subject|2|||
124968550|NCT03023722|449513373|FG000|Overall Study|No follow-up assessment|4|||
124968551|NCT03616964|449513374|FG000|Overall Study|Adverse Event|15|||
124968552|NCT03616964|449513375|FG001|Overall Study|Adverse Event|10|||
124968553|NCT03616964|449513376|FG002|Overall Study|Adverse Event|16|||
124968554|NCT03616964|449513374|FG000|Overall Study|Death|3|||
124968555|NCT03616964|449513375|FG001|Overall Study|Death|0|||
124968556|NCT03616964|449513376|FG002|Overall Study|Death|4|||
124968557|NCT03616964|449513374|FG000|Overall Study|Lack of Efficacy|4|||
124968558|NCT03616964|449513375|FG001|Overall Study|Lack of Efficacy|8|||
124968559|NCT03616964|449513376|FG002|Overall Study|Lack of Efficacy|8|||
124968560|NCT03616964|449513374|FG000|Overall Study|Lost to Follow-up|2|||
124968561|NCT03616964|449513375|FG001|Overall Study|Lost to Follow-up|1|||
124968562|NCT03616964|449513376|FG002|Overall Study|Lost to Follow-up|3|||
124968563|NCT03616964|449513374|FG000|Overall Study|Withdrawal by Subject|18|||
124968564|NCT03616964|449513375|FG001|Overall Study|Withdrawal by Subject|14|||
124968565|NCT03616964|449513376|FG002|Overall Study|Withdrawal by Subject|21|||
124968566|NCT03616964|449513374|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
124968567|NCT03616964|449513375|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
124968568|NCT03616964|449513376|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
124968569|NCT03616964|449513374|FG000|Overall Study|Sponsor's Decision|1|||
124968570|NCT03616964|449513375|FG001|Overall Study|Sponsor's Decision|0|||
124968571|NCT03616964|449513376|FG002|Overall Study|Sponsor's Decision|0|||
124968572|NCT03616964|449513374|FG000|Overall Study|Physician Decision|0|||
124968573|NCT03616964|449513375|FG001|Overall Study|Physician Decision|2|||
124968574|NCT03616964|449513376|FG002|Overall Study|Physician Decision|0|||
124968575|NCT03616964|449513374|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
125217380|NCT04865419|450423511|FG008|Overall Study|Death|2|||
124968576|NCT03616964|449513375|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
124968577|NCT03616964|449513376|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
124968578|NCT03616964|449513374|FG000|Overall Study|Protocol Violation|0|||
124968579|NCT03616964|449513375|FG001|Overall Study|Protocol Violation|1|||
124968580|NCT03616964|449513376|FG002|Overall Study|Protocol Violation|0|||
124968581|NCT03616964|449513374|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
124968582|NCT03616964|449513375|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
124968583|NCT03616964|449513376|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
124968584|NCT03616964|449513374|FG000|Overall Study|Randomized but Never Treated|1|||
124968585|NCT03616964|449513375|FG001|Overall Study|Randomized but Never Treated|1|||
124968586|NCT03616964|449513376|FG002|Overall Study|Randomized but Never Treated|1|||
124968587|NCT02641587|449513386|FG000|Confinement Period|Adverse Event|1|||
124968588|NCT02641587|449513387|FG001|Confinement Period|Adverse Event|0|||
124968589|NCT02641587|449513386|FG000|Confinement Period|Withdrawal by Subject|2|||
124968590|NCT02641587|449513387|FG001|Confinement Period|Withdrawal by Subject|1|||
124968591|NCT02641587|449513386|FG000|Ambulatory Period|Withdrawal by Subject|1|||
124968592|NCT02641587|449513387|FG001|Ambulatory Period|Withdrawal by Subject|0|||
124968593|NCT01165177|449513388|FG000|Overall Study|Serious Adverse Event|227|||
125217381|NCT04865419|450423512|FG009|Overall Study|Death|2|||
125033167|NCT00348140|449741496|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
125033168|NCT00348140|449741497|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
125033169|NCT00348140|449741495|FG000|Overall Study|Participant unwell|1|||
125033170|NCT00348140|449741496|FG001|Overall Study|Participant unwell|0|||
125033171|NCT00348140|449741497|FG002|Overall Study|Participant unwell|0|||
125033172|NCT00348140|449741495|FG000|Overall Study|Screen failure|1|||
125033173|NCT00348140|449741496|FG001|Overall Study|Screen failure|0|||
125033174|NCT00348140|449741497|FG002|Overall Study|Screen failure|0|||
125033175|NCT00348140|449741495|FG000|Overall Study|Investigator decided to discontinue|4|||
125033176|NCT00348140|449741496|FG001|Overall Study|Investigator decided to discontinue|1|||
125033177|NCT00348140|449741497|FG002|Overall Study|Investigator decided to discontinue|4|||
125033178|NCT00348140|449741495|FG000|Overall Study|Decided to discontinue on their own|1|||
125033179|NCT00348140|449741496|FG001|Overall Study|Decided to discontinue on their own|4|||
125033180|NCT00348140|449741497|FG002|Overall Study|Decided to discontinue on their own|1|||
125033181|NCT00348140|449741495|FG000|Overall Study|Use of prohibited drug|1|||
125033182|NCT00348140|449741496|FG001|Overall Study|Use of prohibited drug|0|||
125033183|NCT00348140|449741497|FG002|Overall Study|Use of prohibited drug|2|||
125033184|NCT00348140|449741495|FG000|Overall Study|Disease progression|1|||
125033185|NCT00348140|449741496|FG001|Overall Study|Disease progression|2|||
125033186|NCT00348140|449741497|FG002|Overall Study|Disease progression|5|||
125033187|NCT00348140|449741495|FG000|Overall Study|Increased risk of cardiac infarction|0|||
125033188|NCT00348140|449741496|FG001|Overall Study|Increased risk of cardiac infarction|1|||
125033189|NCT00348140|449741497|FG002|Overall Study|Increased risk of cardiac infarction|0|||
125033190|NCT00348140|449741495|FG000|Overall Study|Serious adverse event|0|||
125033191|NCT00348140|449741496|FG001|Overall Study|Serious adverse event|1|||
125033192|NCT00348140|449741497|FG002|Overall Study|Serious adverse event|0|||
125033193|NCT00348140|449741495|FG000|Overall Study|Abnormal ECG|0|||
125033194|NCT00348140|449741496|FG001|Overall Study|Abnormal ECG|1|||
125033195|NCT00348140|449741497|FG002|Overall Study|Abnormal ECG|3|||
125033196|NCT00348140|449741495|FG000|Overall Study|Participant died|0|||
125033197|NCT00348140|449741496|FG001|Overall Study|Participant died|1|||
125033198|NCT00348140|449741497|FG002|Overall Study|Participant died|0|||
125033199|NCT00348140|449741495|FG000|Overall Study|Exclusion criteria met|0|||
125033200|NCT00348140|449741496|FG001|Overall Study|Exclusion criteria met|0|||
125033201|NCT00348140|449741497|FG002|Overall Study|Exclusion criteria met|1|||
125033202|NCT00348140|449741495|FG000|Overall Study|Memory declined|0|||
125033203|NCT00348140|449741496|FG001|Overall Study|Memory declined|0|||
125033204|NCT00348140|449741497|FG002|Overall Study|Memory declined|1|||
125033205|NCT01032629|449741498|FG000|Overall Study|Closed Site|21|||
125033206|NCT01032629|449741499|FG001|Overall Study|Closed Site|18|||
125033207|NCT01032629|449741500|FG002|Overall Study|Closed Site|16|||
125033208|NCT01032629|449741498|FG000|Overall Study|Withdrawal by Subject|50|||
125033209|NCT01032629|449741499|FG001|Overall Study|Withdrawal by Subject|36|||
124968594|NCT01165177|449513389|FG001|Overall Study|Serious Adverse Event|235|||
124968595|NCT01165177|449513388|FG000|Overall Study|Withdrawal by Subject|368|||
124968596|NCT01165177|449513389|FG001|Overall Study|Withdrawal by Subject|354|||
124968597|NCT01165177|449513388|FG000|Overall Study|Protocol Violation|19|||
124968598|NCT01165177|449513389|FG001|Overall Study|Protocol Violation|21|||
124968599|NCT01165177|449513388|FG000|Overall Study|Non-serious adverse event|30|||
124968600|NCT01165177|449513389|FG001|Overall Study|Non-serious adverse event|18|||
124968601|NCT01165177|449513388|FG000|Overall Study|Other unspecified reasons|47|||
124968602|NCT01165177|449513389|FG001|Overall Study|Other unspecified reasons|35|||
124968603|NCT01165177|449513388|FG000|Overall Study|Suspected HZ episode|0|||
124968604|NCT01165177|449513389|FG001|Overall Study|Suspected HZ episode|2|||
124968605|NCT01165177|449513388|FG000|Overall Study|Lost to Follow-up|183|||
124968606|NCT01165177|449513389|FG001|Overall Study|Lost to Follow-up|194|||
124968607|NCT01165177|449513388|FG000|Overall Study|Migrated/ moved from study area|48|||
124968608|NCT01165177|449513389|FG001|Overall Study|Migrated/ moved from study area|43|||
124968609|NCT01663506|449513390|FG000|Overall Study|Lack of Efficacy|3|||
124968610|NCT01663506|449513390|FG000|Overall Study|Consent Withdrawal by Subject|1|||
124968611|NCT01663506|449513390|FG000|Overall Study|Lost to Follow-up|1|||
124968612|NCT01663506|449513390|FG000|Overall Study|Adverse Event|1|||
124968613|NCT01663506|449513390|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
124968614|NCT03210519|449513394|FG000|Overall Study|Adverse Event|2|||
124968615|NCT03210519|449513395|FG001|Overall Study|Adverse Event|0|||
124968616|NCT04351269|449513396|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
125033210|NCT01032629|449741500|FG002|Overall Study|Withdrawal by Subject|35|||
125033211|NCT01032629|449741498|FG000|Overall Study|Lost to Follow-up|74|||
124968617|NCT04351269|449513397|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
124968618|NCT04351269|449513398|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
124968619|NCT04351269|449513396|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
124968620|NCT04351269|449513397|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
124968621|NCT04351269|449513398|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
124968622|NCT04351269|449513396|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
124968623|NCT04351269|449513397|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
124968624|NCT04351269|449513398|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
124968625|NCT04351269|449513396|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
124968626|NCT04351269|449513397|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
124968627|NCT04351269|449513398|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
124968628|NCT04351269|449513396|FG000|Overall Study|Lost to Follow-up|1|||
124968629|NCT04351269|449513397|FG001|Overall Study|Lost to Follow-up|3|||
124968630|NCT04351269|449513398|FG002|Overall Study|Lost to Follow-up|0|||
124968631|NCT02229578|449513403|FG000|Overall Study|Withdrawal by Subject|1|||
124968632|NCT02229578|449513404|FG001|Overall Study|Withdrawal by Subject|3|||
124968633|NCT02229578|449513403|FG000|Overall Study|Protocol Violation|2|||
124968634|NCT02229578|449513404|FG001|Overall Study|Protocol Violation|0|||
124968635|NCT01407276|449513411|FG000|Overall Study|Withdrawal by Subject|0|||
124968636|NCT01407276|449513412|FG001|Overall Study|Withdrawal by Subject|0|||
124968637|NCT01407276|449513413|FG002|Overall Study|Withdrawal by Subject|0|||
124968638|NCT01407276|449513414|FG003|Overall Study|Withdrawal by Subject|0|||
124968639|NCT01407276|449513415|FG004|Overall Study|Withdrawal by Subject|0|||
124968640|NCT01407276|449513416|FG005|Overall Study|Withdrawal by Subject|0|||
124968641|NCT01407276|449513417|FG006|Overall Study|Withdrawal by Subject|0|||
124968642|NCT01407276|449513418|FG007|Overall Study|Withdrawal by Subject|1|||
124968643|NCT00085566|449513422|FG000|Overall Study|Adverse Event|0|||
124968644|NCT00085566|449513423|FG001|Overall Study|Adverse Event|0|||
124968645|NCT00085566|449513424|FG002|Overall Study|Adverse Event|10|||
124968646|NCT00085566|449513422|FG000|Overall Study|Patient Not treated|0|||
124968647|NCT00085566|449513423|FG001|Overall Study|Patient Not treated|0|||
124968648|NCT00085566|449513424|FG002|Overall Study|Patient Not treated|3|||
124968649|NCT00085566|449513422|FG000|Overall Study|Clinical progression|0|||
124968650|NCT00085566|449513423|FG001|Overall Study|Clinical progression|0|||
124968651|NCT00085566|449513424|FG002|Overall Study|Clinical progression|1|||
124968652|NCT00745498|449513425|FG000|Overall Study|Lost to Follow-up|1|||
124968653|NCT00745498|449513426|FG001|Overall Study|Lost to Follow-up|1|||
124968654|NCT00745498|449513427|FG002|Overall Study|Lost to Follow-up|3|||
124968655|NCT00745498|449513425|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
124968656|NCT00745498|449513426|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
124968657|NCT00745498|449513427|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
124968658|NCT00745498|449513425|FG000|Overall Study|Non-PDR related VH|0|||
124968659|NCT00745498|449513426|FG001|Overall Study|Non-PDR related VH|1|||
124968660|NCT00745498|449513427|FG002|Overall Study|Non-PDR related VH|1|||
124968661|NCT00745498|449513425|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
124968662|NCT00745498|449513426|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
124968663|NCT00745498|449513427|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
124968664|NCT03174782|449513428|FG000|Overall Study|Protocol Violation|1|||
124968665|NCT03174782|449513429|FG001|Overall Study|Protocol Violation|0|||
124968666|NCT03174782|449513428|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
124968667|NCT03174782|449513429|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
124968668|NCT00778921|449513430|FG000|Overall Study|Adverse Event|9|||
124968669|NCT00778921|449513431|FG001|Overall Study|Adverse Event|10|||
124968670|NCT00778921|449513432|FG002|Overall Study|Adverse Event|14|||
124968671|NCT00778921|449513430|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
124968672|NCT00778921|449513431|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
124968673|NCT00778921|449513432|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
124968674|NCT00778921|449513430|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
124968675|NCT00778921|449513431|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
124968676|NCT00778921|449513432|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
124968677|NCT00778921|449513430|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
124968678|NCT00778921|449513431|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
124968679|NCT00778921|449513432|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
124968680|NCT00778921|449513430|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
124968681|NCT00778921|449513431|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
124968682|NCT00778921|449513432|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
124968683|NCT00778921|449513430|FG000|Overall Study|Patient withdrew request|3|||
124968684|NCT00778921|449513431|FG001|Overall Study|Patient withdrew request|1|||
124968685|NCT00778921|449513432|FG002|Overall Study|Patient withdrew request|6|||
124968686|NCT00778921|449513430|FG000|Overall Study|Lost to Follow-up|0|||
124968687|NCT00778921|449513431|FG001|Overall Study|Lost to Follow-up|2|||
124968688|NCT00778921|449513432|FG002|Overall Study|Lost to Follow-up|1|||
124968689|NCT00778921|449513430|FG000|Overall Study|Administrative Problems|1|||
124968690|NCT00778921|449513431|FG001|Overall Study|Administrative Problems|2|||
124968691|NCT00778921|449513432|FG002|Overall Study|Administrative Problems|0|||
124968692|NCT00778921|449513430|FG000|Overall Study|Protocol Violation|3|||
124968693|NCT00778921|449513431|FG001|Overall Study|Protocol Violation|0|||
124968694|NCT00778921|449513432|FG002|Overall Study|Protocol Violation|2|||
124968695|NCT00778921|449513430|FG000|Overall Study|Not treated|0|||
124968696|NCT00778921|449513431|FG001|Overall Study|Not treated|2|||
124968697|NCT00778921|449513432|FG002|Overall Study|Not treated|2|||
124968698|NCT04805073|449513433|FG000|Overall Study|study personnel not available|2|||
124968699|NCT04805073|449513434|FG001|Overall Study|study personnel not available|0|||
124968700|NCT04805073|449513433|FG000|Overall Study|spinal anesthesia failure|0|||
124968701|NCT04805073|449513434|FG001|Overall Study|spinal anesthesia failure|1|||
124968702|NCT04805073|449513433|FG000|Overall Study|Lost to Follow-up|0|||
124968703|NCT04805073|449513434|FG001|Overall Study|Lost to Follow-up|2|||
124968704|NCT03178045|449513435|FG000|Overall Study|Withdrawal by Subject|5|||
124968705|NCT03178045|449513436|FG001|Overall Study|Withdrawal by Subject|7|||
124968706|NCT03178045|449513435|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
124968707|NCT03178045|449513436|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
124968708|NCT03178045|449513435|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
124968709|NCT03178045|449513436|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
124968710|NCT01078922|449513444|FG000|Overall Study|Adverse Event|1|||
124968711|NCT02706847|449513445|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
124968712|NCT02706847|449513446|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
124968713|NCT02706847|449513447|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
124968714|NCT02706847|449513448|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
124968715|NCT02706847|449513445|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
124968716|NCT02706847|449513446|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
124968717|NCT02706847|449513447|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
124968718|NCT02706847|449513448|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
124968719|NCT02706847|449513445|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
124968720|NCT02706847|449513446|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
124968721|NCT02706847|449513447|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
124968722|NCT02706847|449513448|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
124968723|NCT02706847|449513445|FG000|Period 1: Day 1 to Week 12|Other|4|||
124968724|NCT02706847|449513446|FG001|Period 1: Day 1 to Week 12|Other|4|||
124968725|NCT02706847|449513447|FG002|Period 1: Day 1 to Week 12|Other|2|||
124968726|NCT02706847|449513448|FG003|Period 1: Day 1 to Week 12|Other|2|||
124968727|NCT02706847|449513445|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
124968728|NCT02706847|449513446|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
124968729|NCT02706847|449513447|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
124968730|NCT02706847|449513448|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
124968731|NCT02706847|449513445|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
124968732|NCT02706847|449513446|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
124968733|NCT02706847|449513447|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
124968734|NCT02706847|449513448|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
124968735|NCT02706847|449513445|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
124968736|NCT02706847|449513446|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
124968737|NCT02706847|449513447|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
124968738|NCT02706847|449513448|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
124968739|NCT02706847|449513445|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
124968740|NCT02706847|449513446|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
124968741|NCT02706847|449513447|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
124968742|NCT02706847|449513448|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
124968743|NCT02706847|449513445|FG000|Period 1: Week 12 to Week 24|Other|1|||
124968744|NCT02706847|449513446|FG001|Period 1: Week 12 to Week 24|Other|0|||
125033212|NCT01032629|449741499|FG001|Overall Study|Lost to Follow-up|47|||
125033213|NCT01032629|449741500|FG002|Overall Study|Lost to Follow-up|37|||
125033214|NCT03545282|449741501|FG000|Overall Study|Lost to Follow-up|15|||
125033215|NCT03545282|449741502|FG001|Overall Study|Lost to Follow-up|10|||
124968745|NCT02706847|449513447|FG002|Period 1: Week 12 to Week 24|Other|1|||
125033216|NCT03545282|449741501|FG000|Overall Study|Withdrawal by Subject|2|||
125033217|NCT03545282|449741502|FG001|Overall Study|Withdrawal by Subject|2|||
125033218|NCT00755079|449741503|FG000|Overall Study|Lost to Follow-up|1|||
124968746|NCT02706847|449513448|FG003|Period 1: Week 12 to Week 24|Other|4|||
124968747|NCT02706847|449513445|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
124968748|NCT02706847|449513446|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
124968749|NCT02706847|449513447|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
124968750|NCT02706847|449513448|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
124968751|NCT02706847|449513445|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
124968752|NCT02706847|449513446|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
124968753|NCT02706847|449513447|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
125033219|NCT00755079|449741504|FG001|Overall Study|Lost to Follow-up|3|||
125131173|NCT03965091|450108030|FG000|Overall Study|Other than specified|9|||
125131174|NCT03965091|450108031|FG001|Overall Study|Other than specified|11|||
125131175|NCT03965091|450108032|FG002|Overall Study|Other than specified|8|||
125131176|NCT02159950|450108042|FG000|Overall Study|Adverse Event|0|||
125131177|NCT02159950|450108043|FG001|Overall Study|Adverse Event|1|||
125131178|NCT02159950|450108042|FG000|Overall Study|Progression|0|||
125131179|NCT02159950|450108043|FG001|Overall Study|Progression|1|||
124968754|NCT02706847|449513448|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
124968755|NCT02706847|449513445|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
124968756|NCT02706847|449513446|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
124968757|NCT02706847|449513447|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
124968758|NCT02706847|449513448|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
124968759|NCT02706847|449513445|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
124968760|NCT02706847|449513446|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
124968761|NCT02706847|449513447|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
124968762|NCT02706847|449513448|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
124968763|NCT02706847|449513445|FG000|Period 2: Week 24 to Week 260|Other|8|||
124968764|NCT02706847|449513446|FG001|Period 2: Week 24 to Week 260|Other|5|||
124968765|NCT02706847|449513447|FG002|Period 2: Week 24 to Week 260|Other|15|||
124968766|NCT02706847|449513448|FG003|Period 2: Week 24 to Week 260|Other|15|||
124968767|NCT01174264|449513451|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
124968768|NCT01174264|449513452|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
124968769|NCT01174264|449513453|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
124968770|NCT01174264|449513451|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
124968771|NCT01174264|449513452|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
124968772|NCT01174264|449513453|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
124968773|NCT01174264|449513451|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
124968774|NCT01174264|449513452|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
124968775|NCT01174264|449513453|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
124968776|NCT02058836|449513455|FG000|Overall Study|Withdrawal by Subject|1|||
124968777|NCT02058836|449513456|FG001|Overall Study|Withdrawal by Subject|1|||
124968778|NCT00267098|449513457|FG000|Overall Study|Death|0|||
124968779|NCT00267098|449513458|FG001|Overall Study|Death|0|||
124968780|NCT00267098|449513459|FG002|Overall Study|Death|57|||
124968781|NCT00267098|449513460|FG003|Overall Study|Death|66|||
124968782|NCT00267098|449513461|FG004|Overall Study|Death|14|||
124968783|NCT00267098|449513462|FG005|Overall Study|Death|23|||
124968784|NCT00267098|449513463|FG006|Overall Study|Death|28|||
124968785|NCT00267098|449513464|FG007|Overall Study|Death|9|||
124968786|NCT00267098|449513457|FG000|Overall Study|Lost to Follow-up|0|||
124968787|NCT00267098|449513458|FG001|Overall Study|Lost to Follow-up|0|||
124968788|NCT00267098|449513459|FG002|Overall Study|Lost to Follow-up|6|||
124968789|NCT00267098|449513460|FG003|Overall Study|Lost to Follow-up|5|||
124968790|NCT00267098|449513461|FG004|Overall Study|Lost to Follow-up|2|||
124968791|NCT00267098|449513462|FG005|Overall Study|Lost to Follow-up|3|||
124968792|NCT00267098|449513463|FG006|Overall Study|Lost to Follow-up|1|||
124968793|NCT00267098|449513464|FG007|Overall Study|Lost to Follow-up|1|||
124968794|NCT00267098|449513457|FG000|Overall Study|Withdrawal by Subject|8|||
124968795|NCT00267098|449513458|FG001|Overall Study|Withdrawal by Subject|0|||
124968796|NCT00267098|449513459|FG002|Overall Study|Withdrawal by Subject|24|||
124968797|NCT00267098|449513460|FG003|Overall Study|Withdrawal by Subject|21|||
124968798|NCT00267098|449513461|FG004|Overall Study|Withdrawal by Subject|12|||
124968799|NCT00267098|449513462|FG005|Overall Study|Withdrawal by Subject|9|||
124968800|NCT00267098|449513463|FG006|Overall Study|Withdrawal by Subject|12|||
124968801|NCT00267098|449513464|FG007|Overall Study|Withdrawal by Subject|5|||
124968802|NCT00267098|449513457|FG000|Overall Study|Physician Decision|5|||
124968803|NCT00267098|449513458|FG001|Overall Study|Physician Decision|0|||
124968804|NCT00267098|449513459|FG002|Overall Study|Physician Decision|7|||
124968805|NCT00267098|449513460|FG003|Overall Study|Physician Decision|11|||
124968806|NCT00267098|449513461|FG004|Overall Study|Physician Decision|5|||
124968807|NCT00267098|449513462|FG005|Overall Study|Physician Decision|4|||
124968808|NCT00267098|449513463|FG006|Overall Study|Physician Decision|3|||
124968809|NCT00267098|449513464|FG007|Overall Study|Physician Decision|0|||
124968810|NCT00267098|449513457|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
124968811|NCT00267098|449513458|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124968812|NCT00267098|449513459|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124968813|NCT00267098|449513460|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124968814|NCT00267098|449513461|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
124968815|NCT00267098|449513462|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124968816|NCT00267098|449513463|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124968817|NCT00267098|449513464|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124968818|NCT00267098|449513457|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
124968819|NCT00267098|449513458|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
125131180|NCT00003659|450108044|FG000|Overall Study|Withdrawal by Subject|3|||
125131181|NCT02648438|450108047|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124968820|NCT00267098|449513459|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
124968821|NCT00267098|449513460|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
124968822|NCT00267098|449513461|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
124968823|NCT00267098|449513462|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
124968824|NCT00267098|449513463|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
124968825|NCT00267098|449513464|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
124968826|NCT00267098|449513457|FG000|Overall Study|Site closure|0|||
124968827|NCT00267098|449513458|FG001|Overall Study|Site closure|0|||
124968828|NCT00267098|449513459|FG002|Overall Study|Site closure|0|||
124968829|NCT00267098|449513460|FG003|Overall Study|Site closure|1|||
124968830|NCT00267098|449513461|FG004|Overall Study|Site closure|0|||
124968831|NCT00267098|449513462|FG005|Overall Study|Site closure|1|||
124968832|NCT00267098|449513463|FG006|Overall Study|Site closure|1|||
124968833|NCT00267098|449513464|FG007|Overall Study|Site closure|0|||
124968834|NCT00267098|449513457|FG000|Overall Study|Explanted Medtronic device|0|||
124968835|NCT00267098|449513458|FG001|Overall Study|Explanted Medtronic device|0|||
124968836|NCT00267098|449513459|FG002|Overall Study|Explanted Medtronic device|0|||
124968837|NCT00267098|449513460|FG003|Overall Study|Explanted Medtronic device|1|||
124968838|NCT00267098|449513461|FG004|Overall Study|Explanted Medtronic device|0|||
124968839|NCT00267098|449513462|FG005|Overall Study|Explanted Medtronic device|0|||
124968840|NCT00267098|449513463|FG006|Overall Study|Explanted Medtronic device|0|||
124968841|NCT00267098|449513464|FG007|Overall Study|Explanted Medtronic device|0|||
124968842|NCT00267098|449513457|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
124968843|NCT00267098|449513458|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
124968844|NCT00267098|449513459|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
124968845|NCT00267098|449513460|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
124968846|NCT00267098|449513461|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
124968847|NCT00267098|449513462|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
124968848|NCT00267098|449513463|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
124968849|NCT00267098|449513464|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
124968850|NCT00267098|449513457|FG000|Overall Study|Subject listed for heart transplant|0|||
124968851|NCT00267098|449513458|FG001|Overall Study|Subject listed for heart transplant|0|||
124968852|NCT00267098|449513459|FG002|Overall Study|Subject listed for heart transplant|0|||
124968853|NCT00267098|449513460|FG003|Overall Study|Subject listed for heart transplant|0|||
124968854|NCT00267098|449513461|FG004|Overall Study|Subject listed for heart transplant|0|||
124968855|NCT00267098|449513462|FG005|Overall Study|Subject listed for heart transplant|0|||
124968856|NCT00267098|449513463|FG006|Overall Study|Subject listed for heart transplant|1|||
124968857|NCT00267098|449513464|FG007|Overall Study|Subject listed for heart transplant|0|||
124968858|NCT00267098|449513457|FG000|Overall Study|Sponsor withdrew subject|0|||
124968859|NCT00267098|449513458|FG001|Overall Study|Sponsor withdrew subject|0|||
124968860|NCT00267098|449513459|FG002|Overall Study|Sponsor withdrew subject|0|||
124968861|NCT00267098|449513460|FG003|Overall Study|Sponsor withdrew subject|1|||
124968862|NCT00267098|449513461|FG004|Overall Study|Sponsor withdrew subject|0|||
124968863|NCT00267098|449513462|FG005|Overall Study|Sponsor withdrew subject|0|||
124968864|NCT00267098|449513463|FG006|Overall Study|Sponsor withdrew subject|0|||
124968865|NCT00267098|449513464|FG007|Overall Study|Sponsor withdrew subject|0|||
124968866|NCT00547534|449513465|FG000|Overall Study|Adverse Event|7|||
124968867|NCT00547534|449513465|FG000|Overall Study|Disease Progression|4|||
124968868|NCT02688530|449513467|FG000|Overall Study|Withdrawal by Subject|0|||
124968869|NCT02688530|449513468|FG001|Overall Study|Withdrawal by Subject|1|||
124968870|NCT02688530|449513469|FG002|Overall Study|Withdrawal by Subject|0|||
124968871|NCT02688530|449513470|FG003|Overall Study|Withdrawal by Subject|0|||
124968872|NCT02688530|449513467|FG000|Overall Study|Lost to Follow-up|0|||
124968873|NCT02688530|449513468|FG001|Overall Study|Lost to Follow-up|0|||
124968874|NCT02688530|449513469|FG002|Overall Study|Lost to Follow-up|2|||
124968875|NCT02688530|449513470|FG003|Overall Study|Lost to Follow-up|0|||
124968876|NCT01658020|449513471|FG000|Overall Study|Adverse Event|3|||
124968877|NCT01658020|449513472|FG001|Overall Study|Adverse Event|3|||
125033220|NCT00755079|449741503|FG000|Overall Study|Adverse Event|0|||
125033221|NCT00755079|449741504|FG001|Overall Study|Adverse Event|1|||
125033222|NCT00755079|449741503|FG000|Overall Study|Withdrawal by Subject|0|||
125033223|NCT00755079|449741504|FG001|Overall Study|Withdrawal by Subject|2|||
125033224|NCT03377634|449741508|FG000|Study Period|Adverse Event|1|||
124968878|NCT01658020|449513471|FG000|Overall Study|Lost to Follow-up|1|||
124968879|NCT01658020|449513472|FG001|Overall Study|Lost to Follow-up|0|||
124968880|NCT01658020|449513471|FG000|Overall Study|Withdrawal by Subject|4|||
124968881|NCT01658020|449513472|FG001|Overall Study|Withdrawal by Subject|5|||
124968882|NCT01658020|449513471|FG000|Overall Study|Protocol Violation|0|||
124968883|NCT01658020|449513472|FG001|Overall Study|Protocol Violation|1|||
124968884|NCT02353871|449513473|FG000|Overall Study|Protocol deviation|0|||
124968885|NCT02353871|449513474|FG001|Overall Study|Protocol deviation|1|||
124968886|NCT02353871|449513473|FG000|Overall Study|Consent withdrawn|1|||
124968887|NCT02353871|449513474|FG001|Overall Study|Consent withdrawn|8|||
124968888|NCT02353871|449513473|FG000|Overall Study|Lost to Follow-up|2|||
124968889|NCT02353871|449513474|FG001|Overall Study|Lost to Follow-up|0|||
124968890|NCT00115336|449513475|FG000|Overall Study|Hospital discharge before study drug|0|||
124968891|NCT00115336|449513476|FG001|Overall Study|Hospital discharge before study drug|1|||
124968892|NCT04599907|449513483|FG000|Overall Study|Withdrawal by Subject|1|||
124968893|NCT04599907|449513484|FG001|Overall Study|Withdrawal by Subject|7|||
124968894|NCT04599907|449513485|FG002|Overall Study|Withdrawal by Subject|6|||
124968895|NCT04599907|449513483|FG000|Overall Study|Lost to Follow-up|0|||
124968896|NCT04599907|449513484|FG001|Overall Study|Lost to Follow-up|1|||
124968897|NCT04599907|449513485|FG002|Overall Study|Lost to Follow-up|0|||
124968898|NCT01466790|449513488|FG000|Overall Study|Adverse Event|1|||
124968899|NCT01466790|449513489|FG001|Overall Study|Adverse Event|0|||
125217382|NCT04865419|450423513|FG010|Overall Study|Death|1|||
125217383|NCT04865419|450423503|FG000|Overall Study|Lost to Follow-up|0|||
124968900|NCT01466790|449513490|FG002|Overall Study|Adverse Event|0|||
124968901|NCT01466790|449513491|FG003|Overall Study|Adverse Event|0|||
124968902|NCT01466790|449513492|FG004|Overall Study|Adverse Event|2|||
124968903|NCT01466790|449513493|FG005|Overall Study|Adverse Event|0|||
124968904|NCT01466790|449513494|FG006|Overall Study|Adverse Event|0|||
124968905|NCT01466790|449513495|FG007|Overall Study|Adverse Event|0|||
124968906|NCT01466790|449513488|FG000|Overall Study|Lost to Follow-up|2|||
124968907|NCT01466790|449513489|FG001|Overall Study|Lost to Follow-up|0|||
124968908|NCT01466790|449513490|FG002|Overall Study|Lost to Follow-up|0|||
124968909|NCT01466790|449513491|FG003|Overall Study|Lost to Follow-up|0|||
124968910|NCT01466790|449513492|FG004|Overall Study|Lost to Follow-up|0|||
124968911|NCT01466790|449513493|FG005|Overall Study|Lost to Follow-up|0|||
124968912|NCT01466790|449513494|FG006|Overall Study|Lost to Follow-up|0|||
124968913|NCT01466790|449513495|FG007|Overall Study|Lost to Follow-up|0|||
124968914|NCT01466790|449513488|FG000|Overall Study|Withdrawal by Subject|1|||
124968915|NCT01466790|449513489|FG001|Overall Study|Withdrawal by Subject|1|||
124968916|NCT01466790|449513490|FG002|Overall Study|Withdrawal by Subject|0|||
124968917|NCT01466790|449513491|FG003|Overall Study|Withdrawal by Subject|0|||
124968918|NCT01466790|449513492|FG004|Overall Study|Withdrawal by Subject|1|||
124968919|NCT01466790|449513493|FG005|Overall Study|Withdrawal by Subject|0|||
124968920|NCT01466790|449513494|FG006|Overall Study|Withdrawal by Subject|1|||
124968921|NCT01466790|449513495|FG007|Overall Study|Withdrawal by Subject|1|||
124968922|NCT02242643|449513497|FG000|Overall Study|Protocol Violation|1|||
124968923|NCT02242643|449513498|FG001|Overall Study|Protocol Violation|2|||
124968924|NCT02242643|449513497|FG000|Overall Study|Withdrawal by Subject|15|||
124968925|NCT02242643|449513498|FG001|Overall Study|Withdrawal by Subject|10|||
124968926|NCT02242643|449513497|FG000|Overall Study|Migrated/moved from study area|1|||
124968927|NCT02242643|449513498|FG001|Overall Study|Migrated/moved from study area|3|||
124968928|NCT02242643|449513497|FG000|Overall Study|Lost to Follow-up|54|||
124968929|NCT02242643|449513498|FG001|Overall Study|Lost to Follow-up|61|||
124968930|NCT02242643|449513497|FG000|Overall Study|Child placed in foster care by family|0|||
124968931|NCT02242643|449513498|FG001|Overall Study|Child placed in foster care by family|1|||
124968932|NCT02242643|449513497|FG000|Overall Study|Non-compliance|1|||
124968933|NCT02242643|449513498|FG001|Overall Study|Non-compliance|0|||
124968934|NCT02242643|449513497|FG000|Overall Study|Consent withdrawal by parent|1|||
124968935|NCT02242643|449513498|FG001|Overall Study|Consent withdrawal by parent|0|||
124968936|NCT02242643|449513497|FG000|Overall Study|Protocol requirements not followed|1|||
124968937|NCT02242643|449513498|FG001|Overall Study|Protocol requirements not followed|0|||
124968938|NCT02242643|449513497|FG000|Overall Study|Language barrier|1|||
124968939|NCT02242643|449513498|FG001|Overall Study|Language barrier|0|||
124968940|NCT02242643|449513497|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
124968941|NCT02242643|449513498|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
124968942|NCT01251887|449513499|FG000|Overall Study|Scheduling conflict|1|||
124968943|NCT01251887|449513500|FG001|Overall Study|Scheduling conflict|2|||
125217384|NCT04865419|450423504|FG001|Overall Study|Lost to Follow-up|0|||
125033225|NCT03377634|449741509|FG001|Study Period|Adverse Event|0|||
125033226|NCT03377634|449741508|FG000|Study Period|Withdrawal by Subject|1|||
125033227|NCT03377634|449741509|FG001|Study Period|Withdrawal by Subject|0|||
125033228|NCT00737529|449741514|FG000|Overall Study|Disease Progression|95|||
125033229|NCT00737529|449741514|FG000|Overall Study|Adverse Event|24|||
125033230|NCT00737529|449741514|FG000|Overall Study|Withdrawal by Subject|5|||
125033231|NCT00737529|449741514|FG000|Overall Study|Death|4|||
125033232|NCT00737529|449741514|FG000|Overall Study|Protocol Violation|1|||
125033233|NCT00737529|449741514|FG000|Overall Study|Other|4|||
125033234|NCT01818297|449741522|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
125033235|NCT01818297|449741523|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
125033236|NCT01818297|449741522|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
125033237|NCT01818297|449741523|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
125033238|NCT01818297|449741522|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
125033239|NCT01818297|449741523|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
125033240|NCT01412229|449741524|FG000|Overall Study|Physician Decision|1|||
125033241|NCT01889602|449741525|FG000|First Intervention|Adverse Event|1|||
125033242|NCT01889602|449741526|FG001|First Intervention|Adverse Event|1|||
125033243|NCT01889602|449741527|FG002|First Intervention|Adverse Event|1|||
125033244|NCT01889602|449741525|FG000|First Intervention|Protocol Violation|0|||
125033245|NCT01889602|449741526|FG001|First Intervention|Protocol Violation|1|||
125033246|NCT01889602|449741527|FG002|First Intervention|Protocol Violation|1|||
125033247|NCT01889602|449741525|FG000|First Intervention|Study ending|0|||
125033248|NCT01889602|449741526|FG001|First Intervention|Study ending|1|||
125033249|NCT01889602|449741527|FG002|First Intervention|Study ending|0|||
125033250|NCT01889602|449741525|FG000|Second Intervention|Adverse Event|0|||
125033251|NCT01889602|449741526|FG001|Second Intervention|Adverse Event|0|||
125033252|NCT01889602|449741527|FG002|Second Intervention|Adverse Event|1|||
125033253|NCT01889602|449741525|FG000|Second Intervention|Study ending|1|||
125033254|NCT01889602|449741526|FG001|Second Intervention|Study ending|0|||
125033255|NCT01889602|449741527|FG002|Second Intervention|Study ending|0|||
125033256|NCT01889602|449741525|FG000|Second Intervention|Withdrawal by Subject|0|||
125033257|NCT01889602|449741526|FG001|Second Intervention|Withdrawal by Subject|0|||
125033258|NCT01889602|449741527|FG002|Second Intervention|Withdrawal by Subject|1|||
125033259|NCT01889602|449741525|FG000|Third Intervention|Protocol Violation|1|||
125033260|NCT01889602|449741526|FG001|Third Intervention|Protocol Violation|0|||
125033261|NCT01889602|449741527|FG002|Third Intervention|Protocol Violation|0|||
125033262|NCT01889602|449741525|FG000|Third Intervention|Withdrawal by Subject|2|||
125033263|NCT01889602|449741526|FG001|Third Intervention|Withdrawal by Subject|2|||
125033264|NCT01889602|449741527|FG002|Third Intervention|Withdrawal by Subject|0|||
125033265|NCT00404092|449741528|FG000|Overall Study|Death|1|||
125033266|NCT00404092|449741529|FG001|Overall Study|Death|0|||
125033267|NCT00404092|449741530|FG002|Overall Study|Death|0|||
125033268|NCT00404092|449741531|FG003|Overall Study|Death|0|||
125033269|NCT00404092|449741528|FG000|Overall Study|Adverse Event|0|||
125033270|NCT00404092|449741529|FG001|Overall Study|Adverse Event|0|||
125033271|NCT00404092|449741530|FG002|Overall Study|Adverse Event|1|||
125033272|NCT00404092|449741531|FG003|Overall Study|Adverse Event|0|||
125033273|NCT00591734|449741534|FG000|Overall Study|Lack of Efficacy|35|||
125033274|NCT00591734|449741534|FG000|Overall Study|Adverse Event|5|||
125033275|NCT00591734|449741534|FG000|Overall Study|Physician Decision|5|||
125033276|NCT00591734|449741534|FG000|Overall Study|Intercurrent Illness|8|||
125033277|NCT04752384|449741535|FG000|Overall Study|Withdrawal by Subject|1|||
125033278|NCT04752384|449741535|FG000|Overall Study|Death|1|||
125033279|NCT01955707|449741537|FG000|Overall Study|Adverse Event|1|||
125033280|NCT01955707|449741538|FG001|Overall Study|Adverse Event|2|||
125033281|NCT01955707|449741537|FG000|Overall Study|Lost to Follow-up|2|||
125033282|NCT01955707|449741538|FG001|Overall Study|Lost to Follow-up|1|||
125033283|NCT01955707|449741537|FG000|Overall Study|Withdrawal by Subject|0|||
125033284|NCT01955707|449741538|FG001|Overall Study|Withdrawal by Subject|3|||
125033285|NCT01955707|449741537|FG000|Overall Study|Death|13|||
125033286|NCT01955707|449741538|FG001|Overall Study|Death|14|||
125033287|NCT01955707|449741537|FG000|Overall Study|Other|4|||
125033288|NCT01955707|449741538|FG001|Overall Study|Other|2|||
125033289|NCT01817790|449741541|FG000|Overall Study|Adverse Event|0|||
125033290|NCT01817790|449741542|FG001|Overall Study|Adverse Event|2|||
125033291|NCT01817790|449741541|FG000|Overall Study|Lost to Follow-up|0|||
125033292|NCT01817790|449741542|FG001|Overall Study|Lost to Follow-up|1|||
125033293|NCT01817790|449741541|FG000|Overall Study|Protocol Violation|2|||
125033294|NCT01817790|449741542|FG001|Overall Study|Protocol Violation|1|||
125033295|NCT01817790|449741541|FG000|Overall Study|Withdrawal by Subject|1|||
125033296|NCT01817790|449741542|FG001|Overall Study|Withdrawal by Subject|3|||
125033297|NCT01817790|449741541|FG000|Overall Study|Other: Could not attend appointment|1|||
125033298|NCT01817790|449741542|FG001|Overall Study|Other: Could not attend appointment|1|||
125033299|NCT01671345|449741543|FG000|Overall Study|Lost to Follow-up|10|||
125033300|NCT01671345|449741544|FG001|Overall Study|Lost to Follow-up|6|||
125033301|NCT01671345|449741543|FG000|Overall Study|visit with non-participating physician|3|||
125033302|NCT01671345|449741544|FG001|Overall Study|visit with non-participating physician|3|||
124968944|NCT01251887|449513501|FG002|Overall Study|Scheduling conflict|2|||
124968945|NCT01251887|449513499|FG000|Overall Study|Physician Decision|0|||
124968946|NCT01251887|449513500|FG001|Overall Study|Physician Decision|1|||
124968947|NCT01251887|449513501|FG002|Overall Study|Physician Decision|0|||
124968948|NCT02633397|449513502|FG000|Overall Study|Adverse Event|8|||
124968949|NCT02633397|449513503|FG001|Overall Study|Adverse Event|8|||
124968950|NCT02633397|449513502|FG000|Overall Study|Study Burden|4|||
124968951|NCT02633397|449513503|FG001|Overall Study|Study Burden|1|||
124968952|NCT02633397|449513502|FG000|Overall Study|Treatment interruption|2|||
124968953|NCT02633397|449513503|FG001|Overall Study|Treatment interruption|5|||
124968954|NCT02633397|449513502|FG000|Overall Study|Death|2|||
124968955|NCT02633397|449513503|FG001|Overall Study|Death|2|||
124968956|NCT02633397|449513502|FG000|Overall Study|Physician Decision|0|||
124968957|NCT02633397|449513503|FG001|Overall Study|Physician Decision|1|||
124968958|NCT03595878|449513504|FG000|Overall Study|Death|2|||
124968959|NCT03595878|449513505|FG001|Overall Study|Death|1|||
124968960|NCT03595878|449513506|FG002|Overall Study|Death|0|||
124968961|NCT03595878|449513504|FG000|Overall Study|Disease progression|2|||
124968962|NCT03595878|449513505|FG001|Overall Study|Disease progression|1|||
124968963|NCT03595878|449513506|FG002|Overall Study|Disease progression|2|||
124968964|NCT03668223|449513507|FG000|Overall Study|Death|10|||
124968965|NCT03668223|449513508|FG001|Overall Study|Death|5|||
124968966|NCT03668223|449513507|FG000|Overall Study|Lost to Follow-up|12|||
124968967|NCT03668223|449513508|FG001|Overall Study|Lost to Follow-up|12|||
125131182|NCT02648438|450108048|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
125217385|NCT04865419|450423505|FG002|Overall Study|Lost to Follow-up|0|||
124968968|NCT03668223|449513507|FG000|Overall Study|Withdrawal by Subject|8|||
124968969|NCT03668223|449513508|FG001|Overall Study|Withdrawal by Subject|3|||
124968970|NCT01103232|449513509|FG000|Overall Study|Withdrawal by Subject|1|||
124968971|NCT01103232|449513510|FG001|Overall Study|Withdrawal by Subject|1|||
124968972|NCT01103232|449513509|FG000|Overall Study|Protocol Violation|0|||
124968973|NCT01103232|449513510|FG001|Overall Study|Protocol Violation|1|||
124968974|NCT03036124|449513511|FG000|Overall Study|Lost to Follow-up|0|||
124968975|NCT03036124|449513512|FG001|Overall Study|Lost to Follow-up|2|||
124968976|NCT03036124|449513511|FG000|Overall Study|Withdrawal by Subject|5|||
125217386|NCT04865419|450423506|FG003|Overall Study|Lost to Follow-up|0|||
125033303|NCT04980391|449741545|FG000|Overall Study|Death|0|||
125033304|NCT04980391|449741546|FG001|Overall Study|Death|0|||
125033305|NCT04980391|449741547|FG002|Overall Study|Death|1|||
125033306|NCT04980391|449741548|FG003|Overall Study|Death|1|||
125033307|NCT04980391|449741545|FG000|Overall Study|Lost to Follow-up|3|||
125033308|NCT04980391|449741546|FG001|Overall Study|Lost to Follow-up|3|||
125033309|NCT04980391|449741547|FG002|Overall Study|Lost to Follow-up|2|||
125033310|NCT04980391|449741548|FG003|Overall Study|Lost to Follow-up|3|||
125033311|NCT04980391|449741545|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
125033312|NCT04980391|449741546|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
125033313|NCT04980391|449741547|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
125033314|NCT04980391|449741548|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
125033315|NCT04980391|449741545|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125033316|NCT04980391|449741546|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125033317|NCT04980391|449741547|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
125033318|NCT04980391|449741548|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125033319|NCT04980391|449741545|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
125033320|NCT04980391|449741546|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
125033321|NCT04980391|449741547|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
125033322|NCT04980391|449741548|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
125033323|NCT04280081|449741550|FG000|Overall Study|Adverse Event|4|||
125033324|NCT04280081|449741550|FG000|Overall Study|Death|2|||
125033325|NCT04280081|449741550|FG000|Overall Study|Progressive Disease|6|||
125033326|NCT01468311|449741551|FG000|Overall Study|mobilization failure|1|||
125033327|NCT01468311|449741551|FG000|Overall Study|Withdrawal by Subject|1|||
125033328|NCT01750918|449743775|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
125033329|NCT01750918|449743776|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
125033330|NCT01750918|449743777|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
125033331|NCT01750918|449743778|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
125033332|NCT01750918|449743779|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
125033333|NCT01750918|449743780|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
125033334|NCT01750918|449743781|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
125033335|NCT01750918|449743782|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
125033336|NCT01750918|449743775|FG000|Overall Study|Lost to Follow-up|0|||
125033337|NCT01750918|449743776|FG001|Overall Study|Lost to Follow-up|0|||
125033338|NCT01750918|449743777|FG002|Overall Study|Lost to Follow-up|2|||
125033339|NCT01750918|449743778|FG003|Overall Study|Lost to Follow-up|2|||
125033340|NCT01750918|449743779|FG004|Overall Study|Lost to Follow-up|0|||
125033341|NCT01750918|449743780|FG005|Overall Study|Lost to Follow-up|0|||
125033342|NCT01750918|449743781|FG006|Overall Study|Lost to Follow-up|0|||
125033343|NCT01750918|449743782|FG007|Overall Study|Lost to Follow-up|1|||
125033344|NCT01750918|449743775|FG000|Overall Study|Withdrawal by Subject|0|||
125033345|NCT01750918|449743776|FG001|Overall Study|Withdrawal by Subject|0|||
125033346|NCT01750918|449743777|FG002|Overall Study|Withdrawal by Subject|1|||
125033347|NCT01750918|449743778|FG003|Overall Study|Withdrawal by Subject|2|||
125033348|NCT01750918|449743779|FG004|Overall Study|Withdrawal by Subject|1|||
125033349|NCT01750918|449743780|FG005|Overall Study|Withdrawal by Subject|1|||
125033350|NCT01750918|449743781|FG006|Overall Study|Withdrawal by Subject|2|||
125033351|NCT01750918|449743782|FG007|Overall Study|Withdrawal by Subject|2|||
125033352|NCT02338843|449743789|FG000|Overall Study|Adverse Event|2|||
125033353|NCT02338843|449743790|FG001|Overall Study|Adverse Event|1|||
125033354|NCT02338843|449743789|FG000|Overall Study|Death|40|||
125033355|NCT02338843|449743790|FG001|Overall Study|Death|53|||
125033356|NCT02338843|449743789|FG000|Overall Study|Physician Decision|1|||
125033357|NCT02338843|449743790|FG001|Overall Study|Physician Decision|0|||
125033358|NCT02338843|449743789|FG000|Overall Study|Withdrawal by Subject|0|||
125033359|NCT02338843|449743790|FG001|Overall Study|Withdrawal by Subject|2|||
125033360|NCT02338843|449743789|FG000|Overall Study|Subject Recovered|0|||
125217387|NCT04865419|450423507|FG004|Overall Study|Lost to Follow-up|0|||
125217388|NCT04865419|450423508|FG005|Overall Study|Lost to Follow-up|0|||
125217389|NCT04865419|450423509|FG006|Overall Study|Lost to Follow-up|0|||
125217390|NCT04865419|450423510|FG007|Overall Study|Lost to Follow-up|0|||
125217391|NCT04865419|450423511|FG008|Overall Study|Lost to Follow-up|0|||
125217392|NCT04865419|450423512|FG009|Overall Study|Lost to Follow-up|1|||
125217393|NCT04865419|450423513|FG010|Overall Study|Lost to Follow-up|0|||
125033361|NCT02338843|449743790|FG001|Overall Study|Subject Recovered|2|||
125033362|NCT02338843|449743789|FG000|Overall Study|Discontinued prior to randomizat|1|||
125033363|NCT02338843|449743790|FG001|Overall Study|Discontinued prior to randomizat|0|||
125033364|NCT00023322|449743791|FG000|Overall Study|Lost to Follow-up|1|||
125033365|NCT01793792|449743796|FG000|Overall Study|Death|5|||
125033366|NCT01793792|449743796|FG000|Overall Study|Lost to Follow-up|5|||
125033367|NCT01793792|449743796|FG000|Overall Study|Withdrawal by Subject|1|||
125033368|NCT01793792|449743796|FG000|Overall Study|Device Not Implanted|1|||
125033369|NCT02185521|449743797|FG000|Overall Study|Withdrawal by Subject|1|||
125033370|NCT02185521|449743797|FG000|Overall Study|Protocol Violation|1|||
125033371|NCT03902080|449743805|FG000|Overall Study|Adverse Event|17|||
125033372|NCT03902080|449743806|FG001|Overall Study|Adverse Event|15|||
125033373|NCT03902080|449743805|FG000|Overall Study|Withdrawal by Subject|28|||
125033374|NCT03902080|449743806|FG001|Overall Study|Withdrawal by Subject|35|||
125033375|NCT03902080|449743805|FG000|Overall Study|Lost to Follow-up|6|||
125033376|NCT03902080|449743806|FG001|Overall Study|Lost to Follow-up|7|||
125033377|NCT03902080|449743805|FG000|Overall Study|Other|3|||
125033378|NCT03902080|449743806|FG001|Overall Study|Other|5|||
125033379|NCT03902080|449743805|FG000|Overall Study|Non compliance|4|||
125033380|NCT03902080|449743806|FG001|Overall Study|Non compliance|3|||
125033381|NCT03902080|449743805|FG000|Overall Study|Physician Decision|5|||
125033382|NCT03902080|449743806|FG001|Overall Study|Physician Decision|1|||
125033383|NCT03902080|449743805|FG000|Overall Study|Protocol Violation|3|||
125033384|NCT03902080|449743806|FG001|Overall Study|Protocol Violation|3|||
125033385|NCT03902080|449743805|FG000|Overall Study|Lack of Efficacy|1|||
125033386|NCT03902080|449743806|FG001|Overall Study|Lack of Efficacy|3|||
125033387|NCT03902080|449743805|FG000|Overall Study|Withdrawn prior to dosing|0|||
125033388|NCT03902080|449743806|FG001|Overall Study|Withdrawn prior to dosing|1|||
125033389|NCT00408005|449743811|FG000|Induction|Adverse Event|19|||
125033390|NCT00408005|449743812|FG001|Induction|Adverse Event|3|||
125033391|NCT00408005|449743813|FG002|Induction|Adverse Event|0|||
125033392|NCT00408005|449743814|FG003|Induction|Adverse Event|0|||
125033393|NCT00408005|449743815|FG004|Induction|Adverse Event|0|||
125033394|NCT00408005|449743816|FG005|Induction|Adverse Event|0|||
125033395|NCT00408005|449743817|FG006|Induction|Adverse Event|0|||
125033396|NCT00408005|449743818|FG007|Induction|Adverse Event|0|||
125033397|NCT00408005|449743811|FG000|Induction|Death|6|||
125033398|NCT00408005|449743812|FG001|Induction|Death|0|||
125033399|NCT00408005|449743813|FG002|Induction|Death|0|||
125033400|NCT00408005|449743814|FG003|Induction|Death|0|||
125033401|NCT00408005|449743815|FG004|Induction|Death|0|||
125033402|NCT00408005|449743816|FG005|Induction|Death|0|||
125033403|NCT00408005|449743817|FG006|Induction|Death|0|||
125033404|NCT00408005|449743818|FG007|Induction|Death|0|||
125033405|NCT00408005|449743811|FG000|Induction|Physician Decision|83|||
125033406|NCT00408005|449743812|FG001|Induction|Physician Decision|9|||
125033407|NCT00408005|449743813|FG002|Induction|Physician Decision|0|||
125033408|NCT00408005|449743814|FG003|Induction|Physician Decision|0|||
125033409|NCT00408005|449743815|FG004|Induction|Physician Decision|0|||
125033410|NCT00408005|449743816|FG005|Induction|Physician Decision|0|||
125033411|NCT00408005|449743817|FG006|Induction|Physician Decision|0|||
125033412|NCT00408005|449743818|FG007|Induction|Physician Decision|0|||
125033413|NCT00408005|449743811|FG000|Induction|Withdrawal by Subject|2|||
125033414|NCT00408005|449743812|FG001|Induction|Withdrawal by Subject|4|||
125033415|NCT00408005|449743813|FG002|Induction|Withdrawal by Subject|0|||
125033416|NCT00408005|449743814|FG003|Induction|Withdrawal by Subject|0|||
125033417|NCT00408005|449743815|FG004|Induction|Withdrawal by Subject|0|||
125033418|NCT00408005|449743816|FG005|Induction|Withdrawal by Subject|0|||
125033419|NCT00408005|449743817|FG006|Induction|Withdrawal by Subject|0|||
125033420|NCT00408005|449743818|FG007|Induction|Withdrawal by Subject|0|||
125033421|NCT00408005|449743811|FG000|Induction|Ineligible|33|||
125033422|NCT00408005|449743812|FG001|Induction|Ineligible|14|||
125131183|NCT02648438|450108049|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
125131184|NCT02648438|450108047|FG000|Overall Study|Protocol Violation|2|||
125131185|NCT02648438|450108048|FG001|Overall Study|Protocol Violation|0|||
125131186|NCT02648438|450108049|FG002|Overall Study|Protocol Violation|0|||
124968977|NCT03036124|449513512|FG001|Overall Study|Withdrawal by Subject|4|||
124968978|NCT04650698|449515226|FG000|Overall Study|Protocol Violation|2|||
124968979|NCT04650698|449515227|FG001|Overall Study|Protocol Violation|1|||
124968980|NCT04650698|449515226|FG000|Overall Study|Withdrawal by Subject|0|||
124968981|NCT04650698|449515227|FG001|Overall Study|Withdrawal by Subject|1|||
124968982|NCT01090011|449515228|FG000|Overall Study|Progressive disease|128|||
124968983|NCT01090011|449515228|FG000|Overall Study|Adverse Event|32|||
124968984|NCT01090011|449515228|FG000|Overall Study|Protocol Violation|1|||
124968985|NCT01090011|449515228|FG000|Overall Study|Refusal to start/continue medication|5|||
124968986|NCT01090011|449515228|FG000|Overall Study|Other reason not defined above|5|||
124968987|NCT00307047|449515229|FG000|Overall Study|Lost to Follow-up|35|||
124968988|NCT00307047|449515230|FG001|Overall Study|Lost to Follow-up|24|||
124968989|NCT00307047|449515229|FG000|Overall Study|Withdrawal by Subject|6|||
124968990|NCT00307047|449515230|FG001|Overall Study|Withdrawal by Subject|6|||
124968991|NCT00307047|449515229|FG000|Overall Study|Physician Decision|1|||
124968992|NCT00307047|449515230|FG001|Overall Study|Physician Decision|2|||
124968993|NCT00307047|449515229|FG000|Overall Study|Lost to follow-up for other reasons|0|||
124968994|NCT00307047|449515230|FG001|Overall Study|Lost to follow-up for other reasons|1|||
124968995|NCT00307047|449515229|FG000|Overall Study|All death, all MI, all Revascularization|27|||
124968996|NCT00307047|449515230|FG001|Overall Study|All death, all MI, all Revascularization|16|||
124968997|NCT00379769|449515231|FG000|Main Study|Death|57|||
124968998|NCT00379769|449515232|FG001|Main Study|Death|67|||
124968999|NCT00379769|449515233|FG002|Main Study|Death|54|||
124969000|NCT00379769|449515234|FG003|Main Study|Death|72|||
124969001|NCT00379769|449515235|FG004|Main Study|Death|0|||
124969002|NCT00379769|449515236|FG005|Main Study|Death|0|||
124969003|NCT00379769|449515231|FG000|Main Study|Adverse Event|5|||
124969004|NCT00379769|449515232|FG001|Main Study|Adverse Event|8|||
124969005|NCT00379769|449515233|FG002|Main Study|Adverse Event|10|||
124969006|NCT00379769|449515234|FG003|Main Study|Adverse Event|11|||
124969007|NCT00379769|449515235|FG004|Main Study|Adverse Event|0|||
124969008|NCT00379769|449515236|FG005|Main Study|Adverse Event|0|||
124969009|NCT00379769|449515231|FG000|Main Study|Lost to Follow-up|29|||
124969010|NCT00379769|449515232|FG001|Main Study|Lost to Follow-up|29|||
124969011|NCT00379769|449515233|FG002|Main Study|Lost to Follow-up|25|||
124969012|NCT00379769|449515234|FG003|Main Study|Lost to Follow-up|26|||
124969013|NCT00379769|449515235|FG004|Main Study|Lost to Follow-up|0|||
124969014|NCT00379769|449515236|FG005|Main Study|Lost to Follow-up|0|||
124969015|NCT00379769|449515231|FG000|Main Study|Withdrawal by Subject|46|||
124969016|NCT00379769|449515232|FG001|Main Study|Withdrawal by Subject|56|||
124969017|NCT00379769|449515233|FG002|Main Study|Withdrawal by Subject|72|||
124969018|NCT00379769|449515234|FG003|Main Study|Withdrawal by Subject|70|||
124969019|NCT00379769|449515235|FG004|Main Study|Withdrawal by Subject|0|||
124969020|NCT00379769|449515236|FG005|Main Study|Withdrawal by Subject|0|||
124969021|NCT00379769|449515231|FG000|Main Study|Moved to survival status follow-up only|27|||
124969022|NCT00379769|449515232|FG001|Main Study|Moved to survival status follow-up only|25|||
124969023|NCT00379769|449515233|FG002|Main Study|Moved to survival status follow-up only|32|||
124969024|NCT00379769|449515234|FG003|Main Study|Moved to survival status follow-up only|36|||
124969025|NCT00379769|449515235|FG004|Main Study|Moved to survival status follow-up only|0|||
124969026|NCT00379769|449515236|FG005|Main Study|Moved to survival status follow-up only|0|||
124969027|NCT00379769|449515231|FG000|Main Study|Participant moved|3|||
124969028|NCT00379769|449515232|FG001|Main Study|Participant moved|2|||
124969029|NCT00379769|449515233|FG002|Main Study|Participant moved|3|||
124969030|NCT00379769|449515234|FG003|Main Study|Participant moved|3|||
124969031|NCT00379769|449515235|FG004|Main Study|Participant moved|0|||
124969032|NCT00379769|449515236|FG005|Main Study|Participant moved|0|||
124969033|NCT00379769|449515231|FG000|Main Study|Poor compliance|3|||
124969034|NCT00379769|449515232|FG001|Main Study|Poor compliance|2|||
124969035|NCT00379769|449515233|FG002|Main Study|Poor compliance|2|||
124969036|NCT00379769|449515234|FG003|Main Study|Poor compliance|1|||
124969037|NCT00379769|449515235|FG004|Main Study|Poor compliance|0|||
124969038|NCT00379769|449515236|FG005|Main Study|Poor compliance|0|||
124969039|NCT00379769|449515231|FG000|Main Study|Prohibited glucose lowering medication|0|||
124969040|NCT00379769|449515232|FG001|Main Study|Prohibited glucose lowering medication|3|||
124969041|NCT00379769|449515233|FG002|Main Study|Prohibited glucose lowering medication|0|||
124969042|NCT00379769|449515234|FG003|Main Study|Prohibited glucose lowering medication|1|||
124969043|NCT00379769|449515235|FG004|Main Study|Prohibited glucose lowering medication|0|||
124969044|NCT00379769|449515236|FG005|Main Study|Prohibited glucose lowering medication|0|||
124969045|NCT00379769|449515231|FG000|Main Study|Site closed|4|||
124969046|NCT00379769|449515232|FG001|Main Study|Site closed|4|||
124969047|NCT00379769|449515233|FG002|Main Study|Site closed|4|||
124969048|NCT00379769|449515234|FG003|Main Study|Site closed|8|||
124969049|NCT00379769|449515235|FG004|Main Study|Site closed|0|||
124969050|NCT00379769|449515236|FG005|Main Study|Site closed|0|||
124969051|NCT00379769|449515231|FG000|Main Study|Entry criteria violation|0|||
124969052|NCT00379769|449515232|FG001|Main Study|Entry criteria violation|0|||
124969053|NCT00379769|449515233|FG002|Main Study|Entry criteria violation|1|||
124969054|NCT00379769|449515234|FG003|Main Study|Entry criteria violation|1|||
124969055|NCT00379769|449515235|FG004|Main Study|Entry criteria violation|0|||
124969056|NCT00379769|449515236|FG005|Main Study|Entry criteria violation|0|||
124969057|NCT00379769|449515231|FG000|Main Study|Participant did not take study drug|0|||
124969058|NCT00379769|449515232|FG001|Main Study|Participant did not take study drug|0|||
124969059|NCT00379769|449515233|FG002|Main Study|Participant did not take study drug|1|||
124969060|NCT00379769|449515234|FG003|Main Study|Participant did not take study drug|0|||
124969061|NCT00379769|449515235|FG004|Main Study|Participant did not take study drug|0|||
124969062|NCT00379769|449515236|FG005|Main Study|Participant did not take study drug|0|||
124969063|NCT00379769|449515231|FG000|Main Study|Physician Decision|2|||
124969064|NCT00379769|449515232|FG001|Main Study|Physician Decision|2|||
124969065|NCT00379769|449515233|FG002|Main Study|Physician Decision|1|||
124969066|NCT00379769|449515234|FG003|Main Study|Physician Decision|1|||
124969067|NCT00379769|449515235|FG004|Main Study|Physician Decision|0|||
124969068|NCT00379769|449515236|FG005|Main Study|Physician Decision|0|||
124969069|NCT00379769|449515231|FG000|Main Study|Participant completed study at visit 27|1|||
124969070|NCT00379769|449515232|FG001|Main Study|Participant completed study at visit 27|0|||
124969071|NCT00379769|449515233|FG002|Main Study|Participant completed study at visit 27|0|||
124969072|NCT00379769|449515234|FG003|Main Study|Participant completed study at visit 27|0|||
124969073|NCT00379769|449515235|FG004|Main Study|Participant completed study at visit 27|0|||
124969074|NCT00379769|449515236|FG005|Main Study|Participant completed study at visit 27|0|||
124969075|NCT00379769|449515231|FG000|Main Study|Personal reasons|1|||
124969076|NCT00379769|449515232|FG001|Main Study|Personal reasons|0|||
124969077|NCT00379769|449515233|FG002|Main Study|Personal reasons|0|||
124969078|NCT00379769|449515234|FG003|Main Study|Personal reasons|0|||
124969079|NCT00379769|449515235|FG004|Main Study|Personal reasons|0|||
124969080|NCT00379769|449515236|FG005|Main Study|Personal reasons|0|||
124969081|NCT00379769|449515231|FG000|Main Study|Risk of heart failure|0|||
124969082|NCT00379769|449515232|FG001|Main Study|Risk of heart failure|1|||
124969083|NCT00379769|449515233|FG002|Main Study|Risk of heart failure|0|||
124969084|NCT00379769|449515234|FG003|Main Study|Risk of heart failure|0|||
124969085|NCT00379769|449515235|FG004|Main Study|Risk of heart failure|0|||
124969086|NCT00379769|449515236|FG005|Main Study|Risk of heart failure|0|||
124969087|NCT00379769|449515231|FG000|Main Study|Investigator refused to log temperature|0|||
124969088|NCT00379769|449515232|FG001|Main Study|Investigator refused to log temperature|0|||
124969089|NCT00379769|449515233|FG002|Main Study|Investigator refused to log temperature|1|||
124969090|NCT00379769|449515234|FG003|Main Study|Investigator refused to log temperature|0|||
124969091|NCT00379769|449515235|FG004|Main Study|Investigator refused to log temperature|0|||
124969092|NCT00379769|449515236|FG005|Main Study|Investigator refused to log temperature|0|||
124969093|NCT00379769|449515231|FG000|Main Study|Reason unspecified|0|||
124969094|NCT00379769|449515232|FG001|Main Study|Reason unspecified|0|||
124969095|NCT00379769|449515233|FG002|Main Study|Reason unspecified|1|||
124969096|NCT00379769|449515234|FG003|Main Study|Reason unspecified|0|||
124969097|NCT00379769|449515235|FG004|Main Study|Reason unspecified|0|||
124969098|NCT00379769|449515236|FG005|Main Study|Reason unspecified|0|||
124969099|NCT00379769|449515231|FG000|Observational Follow-up|Death|0|||
124969100|NCT00379769|449515232|FG001|Observational Follow-up|Death|0|||
124969101|NCT00379769|449515233|FG002|Observational Follow-up|Death|0|||
124969102|NCT00379769|449515234|FG003|Observational Follow-up|Death|0|||
124969103|NCT00379769|449515235|FG004|Observational Follow-up|Death|78|||
124969104|NCT00379769|449515236|FG005|Observational Follow-up|Death|70|||
124969105|NCT00379769|449515231|FG000|Observational Follow-up|Adverse Event|0|||
124969106|NCT00379769|449515232|FG001|Observational Follow-up|Adverse Event|0|||
124969107|NCT00379769|449515233|FG002|Observational Follow-up|Adverse Event|0|||
124969108|NCT00379769|449515234|FG003|Observational Follow-up|Adverse Event|0|||
124969109|NCT00379769|449515235|FG004|Observational Follow-up|Adverse Event|1|||
124969110|NCT00379769|449515236|FG005|Observational Follow-up|Adverse Event|0|||
124969111|NCT00379769|449515231|FG000|Observational Follow-up|Lost to Follow-up|0|||
124969112|NCT00379769|449515232|FG001|Observational Follow-up|Lost to Follow-up|0|||
124969113|NCT00379769|449515233|FG002|Observational Follow-up|Lost to Follow-up|0|||
124969114|NCT00379769|449515234|FG003|Observational Follow-up|Lost to Follow-up|0|||
124969115|NCT00379769|449515235|FG004|Observational Follow-up|Lost to Follow-up|25|||
124969116|NCT00379769|449515236|FG005|Observational Follow-up|Lost to Follow-up|27|||
124969117|NCT00379769|449515231|FG000|Observational Follow-up|Withdrawal by Subject|0|||
125033423|NCT00408005|449743813|FG002|Induction|Ineligible|0|||
125033424|NCT00408005|449743814|FG003|Induction|Ineligible|0|||
125033425|NCT00408005|449743815|FG004|Induction|Ineligible|0|||
125033426|NCT00408005|449743816|FG005|Induction|Ineligible|0|||
125033427|NCT00408005|449743817|FG006|Induction|Ineligible|0|||
125033428|NCT00408005|449743818|FG007|Induction|Ineligible|0|||
125033429|NCT00408005|449743811|FG000|Induction|Refusal of Further Protocol Therapy|225|||
125033430|NCT00408005|449743812|FG001|Induction|Refusal of Further Protocol Therapy|44|||
125033431|NCT00408005|449743813|FG002|Induction|Refusal of Further Protocol Therapy|0|||
124969118|NCT00379769|449515232|FG001|Observational Follow-up|Withdrawal by Subject|0|||
124969119|NCT00379769|449515233|FG002|Observational Follow-up|Withdrawal by Subject|0|||
124969120|NCT00379769|449515234|FG003|Observational Follow-up|Withdrawal by Subject|0|||
124969121|NCT00379769|449515235|FG004|Observational Follow-up|Withdrawal by Subject|12|||
124969122|NCT00379769|449515236|FG005|Observational Follow-up|Withdrawal by Subject|12|||
124969123|NCT00379769|449515231|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
124969124|NCT00379769|449515232|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
124969125|NCT00379769|449515233|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
124969126|NCT00379769|449515234|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
124969127|NCT00379769|449515235|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
124969128|NCT00379769|449515236|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
124969129|NCT00379769|449515231|FG000|Observational Follow-up|Physician Decision|0|||
124969130|NCT00379769|449515232|FG001|Observational Follow-up|Physician Decision|0|||
124969131|NCT00379769|449515233|FG002|Observational Follow-up|Physician Decision|0|||
124969132|NCT00379769|449515234|FG003|Observational Follow-up|Physician Decision|0|||
124969133|NCT00379769|449515235|FG004|Observational Follow-up|Physician Decision|8|||
124969134|NCT00379769|449515236|FG005|Observational Follow-up|Physician Decision|8|||
124969135|NCT00379769|449515231|FG000|Observational Follow-up|Site Closed Early|0|||
124969136|NCT00379769|449515232|FG001|Observational Follow-up|Site Closed Early|0|||
124969137|NCT00379769|449515233|FG002|Observational Follow-up|Site Closed Early|0|||
124969138|NCT00379769|449515234|FG003|Observational Follow-up|Site Closed Early|0|||
124969139|NCT00379769|449515235|FG004|Observational Follow-up|Site Closed Early|6|||
124969140|NCT00379769|449515236|FG005|Observational Follow-up|Site Closed Early|7|||
124969141|NCT00379769|449515231|FG000|Observational Follow-up|Participant Moved|0|||
124969142|NCT00379769|449515232|FG001|Observational Follow-up|Participant Moved|0|||
124969143|NCT00379769|449515233|FG002|Observational Follow-up|Participant Moved|0|||
124969144|NCT00379769|449515234|FG003|Observational Follow-up|Participant Moved|0|||
124969145|NCT00379769|449515235|FG004|Observational Follow-up|Participant Moved|0|||
124969146|NCT00379769|449515236|FG005|Observational Follow-up|Participant Moved|1|||
124969147|NCT00379769|449515231|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
124969148|NCT00379769|449515232|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
124969149|NCT00379769|449515233|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
124969150|NCT00379769|449515234|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
124969151|NCT00379769|449515235|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
124969152|NCT00379769|449515236|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
124969153|NCT03778294|449515237|FG000|Overall Study|Death|1|||
124969154|NCT03778294|449515237|FG000|Overall Study|Issues with insurance|1|||
124969155|NCT03778294|449515237|FG000|Overall Study|disease progression before treatment|2|||
124969156|NCT02388347|449515238|FG000|Overall Study|Withdrawal by Subject|0|||
124969157|NCT02388347|449515239|FG001|Overall Study|Withdrawal by Subject|0|||
124969158|NCT02388347|449515240|FG002|Overall Study|Withdrawal by Subject|1|||
124969159|NCT02388347|449515241|FG003|Overall Study|Withdrawal by Subject|0|||
124969160|NCT02388347|449515242|FG004|Overall Study|Withdrawal by Subject|0|||
124969161|NCT02820597|449515244|FG000|Overall Study|Lost to Follow-up|12|||
124969162|NCT00701909|449515247|FG000|Overall Study|Withdrawal by Subject|0|||
124969163|NCT00701909|449515248|FG001|Overall Study|Withdrawal by Subject|1|||
124969164|NCT02666664|449515255|FG000|Overall Study|Physician Decision|0|||
124969165|NCT02666664|449515256|FG001|Overall Study|Physician Decision|1|||
124969166|NCT02666664|449515255|FG000|Overall Study|Protocol Violation|0|||
124969167|NCT02666664|449515256|FG001|Overall Study|Protocol Violation|2|||
124969168|NCT02666664|449515255|FG000|Overall Study|Other|0|||
124969169|NCT02666664|449515256|FG001|Overall Study|Other|1|||
124969170|NCT02666664|449515255|FG000|Overall Study|Adverse Event|12|||
124969171|NCT02666664|449515256|FG001|Overall Study|Adverse Event|37|||
124969172|NCT02666664|449515255|FG000|Overall Study|Withdrawal by participant|23|||
124969173|NCT02666664|449515256|FG001|Overall Study|Withdrawal by participant|40|||
124969174|NCT02666664|449515255|FG000|Overall Study|Sponsor decision|0|||
124969175|NCT02666664|449515256|FG001|Overall Study|Sponsor decision|1|||
124969176|NCT02666664|449515255|FG000|Overall Study|Lost to Follow-up|1|||
124969177|NCT02666664|449515256|FG001|Overall Study|Lost to Follow-up|2|||
124969178|NCT00971997|449515257|FG000|Overall Study|Adverse Event|2|||
124969179|NCT00971997|449515257|FG000|Overall Study|Death|1|||
124969180|NCT00971997|449515257|FG000|Overall Study|Protocol Violation|4|||
124969181|NCT00971997|449515257|FG000|Overall Study|Withdrawal by Subject|5|||
124969182|NCT00971997|449515257|FG000|Overall Study|Physician Decision|7|||
124969183|NCT01385748|449515258|FG000|Overall Study|Withdrawal by Subject|7|||
124969184|NCT01385748|449515259|FG001|Overall Study|Withdrawal by Subject|4|||
125131187|NCT02648438|450108047|FG000|Overall Study|Withdrawal by Subject|1|||
124969185|NCT01385748|449515260|FG002|Overall Study|Withdrawal by Subject|5|||
124969186|NCT01385748|449515258|FG000|Overall Study|Noncompliance|3|||
124969187|NCT01385748|449515259|FG001|Overall Study|Noncompliance|1|||
124969188|NCT01385748|449515260|FG002|Overall Study|Noncompliance|6|||
124969189|NCT01385748|449515258|FG000|Overall Study|Other|1|||
124969190|NCT01385748|449515259|FG001|Overall Study|Other|7|||
124969191|NCT01385748|449515260|FG002|Overall Study|Other|1|||
124969192|NCT01385748|449515258|FG000|Overall Study|Adverse Event|4|||
124969193|NCT01385748|449515259|FG001|Overall Study|Adverse Event|2|||
124969194|NCT01385748|449515260|FG002|Overall Study|Adverse Event|1|||
124969195|NCT01266018|449515263|FG000|Overall Study|Physician Decision|1|||
124969196|NCT01266018|449515264|FG001|Overall Study|Physician Decision|0|||
124969197|NCT01266018|449515263|FG000|Overall Study|Progressive disease|0|||
124969198|NCT01266018|449515264|FG001|Overall Study|Progressive disease|1|||
124969199|NCT03167151|449515265|FG000|Overall Study|Withdrawal by Subject|1|||
124969200|NCT03167151|449515266|FG001|Overall Study|Withdrawal by Subject|0|||
124969201|NCT03167151|449515267|FG002|Overall Study|Withdrawal by Subject|0|||
124969202|NCT03167151|449515265|FG000|Overall Study|No evidence of tumour at surgery|0|||
124969203|NCT03167151|449515266|FG001|Overall Study|No evidence of tumour at surgery|1|||
124969204|NCT03167151|449515267|FG002|Overall Study|No evidence of tumour at surgery|1|||
124969205|NCT01458522|449515268|FG000|Overall Study|Withdrawal by Subject|2|||
124969206|NCT01458522|449515269|FG001|Overall Study|Withdrawal by Subject|2|||
124969207|NCT01458522|449515268|FG000|Overall Study|Physician Decision|1|||
124969208|NCT01458522|449515269|FG001|Overall Study|Physician Decision|9|||
124969209|NCT02684123|449515270|FG000|Phase 1|Lack of Efficacy|5|||
124969210|NCT02684123|449515271|FG001|Phase 1|Lack of Efficacy|0|||
124969211|NCT02684123|449515270|FG000|Phase 1|Adverse Event|3|||
124969212|NCT02684123|449515271|FG001|Phase 1|Adverse Event|0|||
124969213|NCT02684123|449515270|FG000|Phase 1|Lost to Follow-up|0|||
124969214|NCT02684123|449515271|FG001|Phase 1|Lost to Follow-up|1|||
124969215|NCT02684123|449515270|FG000|Phase 2|Lack of Efficacy|1|||
124969216|NCT02684123|449515271|FG001|Phase 2|Lack of Efficacy|8|||
124969217|NCT00516139|449515272|FG000|Overall Study|Adverse Event|27|||
124969218|NCT00516139|449515272|FG000|Overall Study|Lost to Follow-up|1|||
124969219|NCT00516139|449515272|FG000|Overall Study|Protocol Violation|1|||
124969220|NCT00516139|449515272|FG000|Overall Study|Withdrawal by Subject|8|||
124969221|NCT00516139|449515272|FG000|Overall Study|Lack of Efficacy|1|||
124969222|NCT03382561|449515273|FG000|Overall Study|Disease progression|47|||
124969223|NCT03382561|449515274|FG001|Overall Study|Disease progression|6|||
124969224|NCT03382561|449515273|FG000|Overall Study|Adverse Event|10|||
124969225|NCT03382561|449515274|FG001|Overall Study|Adverse Event|2|||
124969226|NCT03382561|449515273|FG000|Overall Study|Death|8|||
124969227|NCT03382561|449515274|FG001|Overall Study|Death|3|||
124969228|NCT03382561|449515273|FG000|Overall Study|Withdrawal by Subject|6|||
124969229|NCT03382561|449515274|FG001|Overall Study|Withdrawal by Subject|5|||
124969230|NCT03382561|449515273|FG000|Overall Study|Alternative therapy|2|||
124969231|NCT03382561|449515274|FG001|Overall Study|Alternative therapy|8|||
124969232|NCT03382561|449515273|FG000|Overall Study|Never started treatment|3|||
124969233|NCT03382561|449515274|FG001|Overall Study|Never started treatment|6|||
124969234|NCT03382561|449515273|FG000|Overall Study|Lack of Efficacy|0|||
124969235|NCT03382561|449515274|FG001|Overall Study|Lack of Efficacy|1|||
124969236|NCT03382561|449515273|FG000|Overall Study|Physician Decision|0|||
124969237|NCT03382561|449515274|FG001|Overall Study|Physician Decision|1|||
124969238|NCT03382561|449515273|FG000|Overall Study|Other complicating disease|0|||
124969239|NCT03382561|449515274|FG001|Overall Study|Other complicating disease|1|||
124969240|NCT01131104|449515275|FG000|Overall Study|Withdrawal by Subject|3|||
125217394|NCT04208412|450423514|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
124969241|NCT01131104|449515275|FG000|Overall Study|Physician Decision|4|||
124969242|NCT01131104|449515275|FG000|Overall Study|Information Not Available|5|||
124969243|NCT01131104|449515275|FG000|Overall Study|No Information on Index Date of Onset|1|||
124969244|NCT02370251|449515278|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
124969245|NCT02370251|449515278|FG000|Overall Study|Death|4|||
124969246|NCT02270671|449515279|FG000|Overall Study|Withdrawal by Subject|1|||
124969247|NCT02270671|449515280|FG001|Overall Study|Withdrawal by Subject|1|||
124969248|NCT02270671|449515279|FG000|Overall Study|Protocol Violation|0|||
124969249|NCT02270671|449515280|FG001|Overall Study|Protocol Violation|1|||
124969250|NCT02270671|449515279|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
124969251|NCT02270671|449515280|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
125217432|NCT01348100|450423526|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124969252|NCT02270671|449515279|FG000|Overall Study|Lost to Follow-up|2|||
124969253|NCT02270671|449515280|FG001|Overall Study|Lost to Follow-up|1|||
124969254|NCT02367352|449515292|FG000|Overall Study|Progressive disease|7|||
124969255|NCT02367352|449515293|FG001|Overall Study|Progressive disease|0|||
124969256|NCT02367352|449515294|FG002|Overall Study|Progressive disease|0|||
124969257|NCT02367352|449515292|FG000|Overall Study|Participant Received Alternative Therapy|1|||
124969258|NCT02367352|449515293|FG001|Overall Study|Participant Received Alternative Therapy|0|||
124969259|NCT02367352|449515294|FG002|Overall Study|Participant Received Alternative Therapy|0|||
124969260|NCT02367352|449515292|FG000|Overall Study|Adverse Event|1|||
124969261|NCT02367352|449515293|FG001|Overall Study|Adverse Event|0|||
124969262|NCT02367352|449515294|FG002|Overall Study|Adverse Event|0|||
124969263|NCT00174447|449515295|FG000|Overall Study|Adverse Event|19|||
124969264|NCT00174447|449515295|FG000|Overall Study|Withdrawal by Subject|15|||
124969265|NCT00174447|449515295|FG000|Overall Study|Protocol Violation|1|||
124969266|NCT00174447|449515295|FG000|Overall Study|Lack of Efficacy|1|||
124969267|NCT00174447|449515295|FG000|Overall Study|Administrative reason/Other|2|||
124969268|NCT01437423|449515296|FG000|Overall Study|Lost to Follow-up|12|||
124969269|NCT01437423|449515296|FG000|Overall Study|Off label usage|3|||
124969270|NCT05878873|449515297|FG000|Overall Study|Lost to Follow-up|2|||
124969271|NCT05878873|449515298|FG001|Overall Study|Lost to Follow-up|0|||
124969272|NCT00633945|449515300|FG000|Overall Study|Physician Decision|2|||
124969273|NCT03865953|449515301|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
124969274|NCT03865953|449515302|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
124969275|NCT03865953|449515301|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
124969276|NCT03865953|449515302|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
124969277|NCT03865953|449515301|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
124969278|NCT03865953|449515302|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
124969279|NCT00882115|449515303|FG000|Overall Study|Withdrawal by Subject|3|||
125217395|NCT04208412|450423515|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
125217396|NCT04208412|450423514|FG000|Overall Study|Withdrawal by Subject|1|||
125217397|NCT04208412|450423515|FG001|Overall Study|Withdrawal by Subject|0|||
125131188|NCT02648438|450108048|FG001|Overall Study|Withdrawal by Subject|1|||
125131189|NCT02648438|450108049|FG002|Overall Study|Withdrawal by Subject|0|||
125131190|NCT03138967|450108050|FG000|Overall Study|Death|0|||
125131191|NCT03138967|450108051|FG001|Overall Study|Death|1|||
125131192|NCT03138967|450108050|FG000|Overall Study|Physician Decision|1|||
125131193|NCT03138967|450108051|FG001|Overall Study|Physician Decision|3|||
125131194|NCT04400890|450108052|FG000|Overall Study|Withdrawal by Subject|3|||
125131195|NCT04400890|450108053|FG001|Overall Study|Withdrawal by Subject|2|||
125131196|NCT03925532|450108054|FG000|Overall Study|Lost to Follow-up|1|||
125131197|NCT02258074|450108055|FG000|Overall Study|Withdrawal by Subject|1|||
125131198|NCT02258074|450108056|FG001|Overall Study|Withdrawal by Subject|0|||
125131199|NCT02258074|450108057|FG002|Overall Study|Withdrawal by Subject|0|||
125131200|NCT02258074|450108058|FG003|Overall Study|Withdrawal by Subject|0|||
124969280|NCT00882115|449515303|FG000|Overall Study|did not respond to DEP challe|6|||
124969281|NCT01271504|449515304|FG000|Overall Study|Death|7|||
124969282|NCT01271504|449515305|FG001|Overall Study|Death|6|||
124969283|NCT01271504|449515306|FG002|Overall Study|Death|32|||
124969284|NCT01271504|449515307|FG003|Overall Study|Death|32|||
124969285|NCT01271504|449515304|FG000|Overall Study|Lost to Follow-up|0|||
124969286|NCT01271504|449515305|FG001|Overall Study|Lost to Follow-up|1|||
124969287|NCT01271504|449515306|FG002|Overall Study|Lost to Follow-up|3|||
124969288|NCT01271504|449515307|FG003|Overall Study|Lost to Follow-up|1|||
124969289|NCT01271504|449515304|FG000|Overall Study|Protocol Violation|0|||
124969290|NCT01271504|449515305|FG001|Overall Study|Protocol Violation|0|||
124969291|NCT01271504|449515306|FG002|Overall Study|Protocol Violation|0|||
124969292|NCT01271504|449515307|FG003|Overall Study|Protocol Violation|2|||
124969293|NCT01271504|449515304|FG000|Overall Study|Administrative Reasons|0|||
124969294|NCT01271504|449515305|FG001|Overall Study|Administrative Reasons|0|||
124969295|NCT01271504|449515306|FG002|Overall Study|Administrative Reasons|6|||
124969296|NCT01271504|449515307|FG003|Overall Study|Administrative Reasons|5|||
124969297|NCT01271504|449515304|FG000|Overall Study|Withdrawal by Subject|0|||
124969298|NCT01271504|449515305|FG001|Overall Study|Withdrawal by Subject|0|||
124969299|NCT01271504|449515306|FG002|Overall Study|Withdrawal by Subject|1|||
124969300|NCT01271504|449515307|FG003|Overall Study|Withdrawal by Subject|3|||
124969301|NCT01271504|449515304|FG000|Overall Study|Other|0|||
124969302|NCT01271504|449515305|FG001|Overall Study|Other|1|||
124969303|NCT01271504|449515306|FG002|Overall Study|Other|2|||
124969304|NCT01271504|449515307|FG003|Overall Study|Other|0|||
124969305|NCT02552147|449515308|FG000|First Intervention (7 Days)|Protocol Violation|1|||
124969306|NCT02552147|449515309|FG001|First Intervention (7 Days)|Protocol Violation|0|||
124969307|NCT02552147|449515308|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
124969308|NCT02552147|449515309|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
124969309|NCT02375347|449515310|FG000|Overall Study|Protocol Violation|1|||
124969310|NCT02031536|449515312|FG000|Overall Study|ineligible|1|||
124969311|NCT02031536|449515313|FG001|Overall Study|ineligible|0|||
124969312|NCT04147858|449515324|FG000|Overall Study|Adverse Event|6|||
124969313|NCT04147858|449515325|FG001|Overall Study|Adverse Event|6|||
124969314|NCT04147858|449515326|FG002|Overall Study|Adverse Event|6|||
124969315|NCT04147858|449515324|FG000|Overall Study|Lack of Efficacy|3|||
124969316|NCT04147858|449515325|FG001|Overall Study|Lack of Efficacy|3|||
124969317|NCT04147858|449515326|FG002|Overall Study|Lack of Efficacy|1|||
124969318|NCT04147858|449515324|FG000|Overall Study|Lost to Follow-up|1|||
124969319|NCT04147858|449515325|FG001|Overall Study|Lost to Follow-up|6|||
124969320|NCT04147858|449515326|FG002|Overall Study|Lost to Follow-up|2|||
124969321|NCT04147858|449515324|FG000|Overall Study|Withdrawal by Subject|3|||
124969322|NCT04147858|449515325|FG001|Overall Study|Withdrawal by Subject|4|||
124969323|NCT04147858|449515326|FG002|Overall Study|Withdrawal by Subject|10|||
124969324|NCT04147858|449515324|FG000|Overall Study|Subject Noncompliance, Other|4|||
124969325|NCT04147858|449515325|FG001|Overall Study|Subject Noncompliance, Other|3|||
124969326|NCT04147858|449515326|FG002|Overall Study|Subject Noncompliance, Other|1|||
124969327|NCT01191008|449515327|FG000|Overall Study|Protocol Violation|7|||
124969328|NCT01191008|449515327|FG000|Overall Study|Lost to Follow-up|8|||
124969329|NCT04905849|449515330|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
124969330|NCT04905849|449515331|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
124969331|NCT00838929|449515336|FG000|Overall Study|Protocol Violation|0|||
124969332|NCT00838929|449515337|FG001|Overall Study|Protocol Violation|1|||
125131201|NCT00723710|450108059|FG000|Overall Study|Disease progression|48|||
125131202|NCT00723710|450108059|FG000|Overall Study|Adverse Event|88|||
124969333|NCT00838929|449515338|FG002|Overall Study|Protocol Violation|0|||
124969334|NCT00838929|449515336|FG000|Overall Study|Disease progression|0|||
124969335|NCT00838929|449515337|FG001|Overall Study|Disease progression|2|||
124969336|NCT00838929|449515338|FG002|Overall Study|Disease progression|1|||
125217398|NCT04208412|450423514|FG000|Overall Study|Lost to Follow-up|0|||
124969337|NCT03522389|449515342|FG000|Overall Study|Lost to Follow-up|1|||
125131203|NCT00723710|450108059|FG000|Overall Study|Withdrawal by Subject|36|||
124969338|NCT03522389|449515343|FG001|Overall Study|Lost to Follow-up|1|||
125131204|NCT00723710|450108059|FG000|Overall Study|Physician Decision|2|||
125217399|NCT04208412|450423515|FG001|Overall Study|Lost to Follow-up|1|||
125131205|NCT04405570|450108060|FG000|Overall Study|Adverse Event|0|||
125131206|NCT04405570|450108061|FG001|Overall Study|Adverse Event|1|||
125131207|NCT04405570|450108062|FG002|Overall Study|Adverse Event|1|||
125131208|NCT04405570|450108063|FG003|Overall Study|Adverse Event|1|||
125131209|NCT04405570|450108060|FG000|Overall Study|Lost to Follow-up|0|||
125131210|NCT04405570|450108061|FG001|Overall Study|Lost to Follow-up|1|||
125131211|NCT04405570|450108062|FG002|Overall Study|Lost to Follow-up|0|||
125131212|NCT04405570|450108063|FG003|Overall Study|Lost to Follow-up|0|||
125131213|NCT04405570|450108060|FG000|Overall Study|Physician Decision|0|||
125131214|NCT04405570|450108061|FG001|Overall Study|Physician Decision|0|||
124969339|NCT03522389|449515344|FG002|Overall Study|Lost to Follow-up|2|||
124969340|NCT03522389|449515342|FG000|Overall Study|had herniated nucleus pulposus|0|||
124969341|NCT03522389|449515343|FG001|Overall Study|had herniated nucleus pulposus|1|||
124969342|NCT03522389|449515344|FG002|Overall Study|had herniated nucleus pulposus|0|||
124969343|NCT03522389|449515342|FG000|Overall Study|go to work in other province|1|||
124969344|NCT03522389|449515343|FG001|Overall Study|go to work in other province|0|||
124969345|NCT03522389|449515344|FG002|Overall Study|go to work in other province|0|||
124969346|NCT02257918|449515345|FG000|Overall Study|Lost to Follow-up|4|||
124969347|NCT02257918|449515346|FG001|Overall Study|Lost to Follow-up|1|||
124969348|NCT02257918|449515347|FG002|Overall Study|Lost to Follow-up|0|||
124969349|NCT02257918|449515345|FG000|Overall Study|Withdrawal by Subject|0|||
124969350|NCT02257918|449515346|FG001|Overall Study|Withdrawal by Subject|0|||
124969351|NCT02257918|449515347|FG002|Overall Study|Withdrawal by Subject|1|||
124969352|NCT02257918|449515345|FG000|Overall Study|Pregnancy|0|||
124969353|NCT02257918|449515346|FG001|Overall Study|Pregnancy|0|||
124969354|NCT02257918|449515347|FG002|Overall Study|Pregnancy|1|||
124969355|NCT03494985|449515356|FG000|Overall Study|Adverse Event|3|||
124969356|NCT03494985|449515357|FG001|Overall Study|Adverse Event|2|||
124969357|NCT03494985|449515358|FG002|Overall Study|Adverse Event|3|||
124969358|NCT03494985|449515359|FG003|Overall Study|Adverse Event|0|||
124969359|NCT03494985|449515356|FG000|Overall Study|Other (Withdrawal of consent)|2|||
124969360|NCT03494985|449515357|FG001|Overall Study|Other (Withdrawal of consent)|3|||
124969361|NCT03494985|449515358|FG002|Overall Study|Other (Withdrawal of consent)|2|||
124969362|NCT03494985|449515359|FG003|Overall Study|Other (Withdrawal of consent)|5|||
124969363|NCT03494985|449515356|FG000|Overall Study|Other (Not specified)|0|||
124969364|NCT03494985|449515357|FG001|Overall Study|Other (Not specified)|1|||
124969365|NCT03494985|449515358|FG002|Overall Study|Other (Not specified)|1|||
124969366|NCT03494985|449515359|FG003|Overall Study|Other (Not specified)|0|||
124969367|NCT02282059|449515360|FG000|Overall Study|Other|15|||
124969368|NCT02282059|449515361|FG001|Overall Study|Other|3|||
124969369|NCT02282059|449515360|FG000|Overall Study|Participant refused further follow-up|8|||
124969370|NCT02282059|449515361|FG001|Overall Study|Participant refused further follow-up|4|||
124969371|NCT02282059|449515360|FG000|Overall Study|Lost to Follow-up|19|||
124969372|NCT02282059|449515361|FG001|Overall Study|Lost to Follow-up|3|||
124969373|NCT02282059|449515360|FG000|Overall Study|Death|40|||
124969374|NCT02282059|449515361|FG001|Overall Study|Death|8|||
124969375|NCT05093504|449515362|FG000|Overall Study|Death|0|||
124969376|NCT05093504|449515363|FG001|Overall Study|Death|1|||
124969377|NCT02394925|449515364|FG000|Overall Study|Adverse Event|1|||
124969378|NCT02394925|449515364|FG000|Overall Study|Lens Discomfort|3|||
124969379|NCT02394925|449515364|FG000|Overall Study|Lens handling difficulities|5|||
124969380|NCT02394925|449515364|FG000|Overall Study|Lost to Follow-up|9|||
124969381|NCT02394925|449515364|FG000|Overall Study|Protocol Violation|5|||
124969382|NCT02394925|449515364|FG000|Overall Study|No longer meet eligibility criteria|1|||
124969383|NCT02394925|449515364|FG000|Overall Study|Unsatisfactory Visual Response|5|||
124969384|NCT05347485|449515373|FG000|Overall Study|Death|14|||
124969385|NCT05347485|449515373|FG000|Overall Study|Lost to Follow-up|2|||
124969386|NCT05347485|449515373|FG000|Overall Study|Withdrawal by Subject|13|||
124969387|NCT05347485|449515373|FG000|Overall Study|Progressive Disease|1|||
124969388|NCT05347485|449515373|FG000|Overall Study|Study Terminated by Sponsor|49|||
124969389|NCT05347485|449515373|FG000|Overall Study|Other|1|||
124969390|NCT05347485|449515373|FG000|Overall Study|Enrolled (consented) but not treated|4|||
124969391|NCT05347485|449515373|FG000|Overall Study|Disease Relapse|2|||
124969392|NCT04886518|449515374|FG000|Overall Study|Noncompliance with study drug|1|||
124969393|NCT04886518|449515375|FG001|Overall Study|Noncompliance with study drug|0|||
124969394|NCT04886518|449515376|FG002|Overall Study|Noncompliance with study drug|0|||
124969395|NCT04886518|449515374|FG000|Overall Study|Adverse Event|0|||
124969396|NCT04886518|449515375|FG001|Overall Study|Adverse Event|1|||
124969397|NCT04886518|449515376|FG002|Overall Study|Adverse Event|0|||
124969398|NCT04886518|449515374|FG000|Overall Study|Withdrawal by Subject|1|||
124969399|NCT04886518|449515375|FG001|Overall Study|Withdrawal by Subject|0|||
124969400|NCT04886518|449515376|FG002|Overall Study|Withdrawal by Subject|0|||
124969401|NCT03733899|449515377|FG000|Period 1|Protocol Violation|0|||
124969402|NCT03733899|449515378|FG001|Period 1|Protocol Violation|0|||
124969403|NCT03733899|449515379|FG002|Period 1|Protocol Violation|0|||
124969404|NCT03733899|449515380|FG003|Period 1|Protocol Violation|0|||
124969405|NCT03733899|449515381|FG004|Period 1|Protocol Violation|0|||
125131215|NCT04405570|450108062|FG002|Overall Study|Physician Decision|1|||
125033432|NCT00408005|449743814|FG003|Induction|Refusal of Further Protocol Therapy|0|||
125033433|NCT00408005|449743815|FG004|Induction|Refusal of Further Protocol Therapy|0|||
125033434|NCT00408005|449743816|FG005|Induction|Refusal of Further Protocol Therapy|0|||
125033435|NCT00408005|449743817|FG006|Induction|Refusal of Further Protocol Therapy|0|||
125033436|NCT00408005|449743818|FG007|Induction|Refusal of Further Protocol Therapy|0|||
125033437|NCT00408005|449743811|FG000|Induction|Entered another COG therapeutic protocol|4|||
125033438|NCT00408005|449743812|FG001|Induction|Entered another COG therapeutic protocol|0|||
125033439|NCT00408005|449743813|FG002|Induction|Entered another COG therapeutic protocol|0|||
125033440|NCT00408005|449743814|FG003|Induction|Entered another COG therapeutic protocol|0|||
125033441|NCT00408005|449743815|FG004|Induction|Entered another COG therapeutic protocol|0|||
125033442|NCT00408005|449743816|FG005|Induction|Entered another COG therapeutic protocol|0|||
125033443|NCT00408005|449743817|FG006|Induction|Entered another COG therapeutic protocol|0|||
125033444|NCT00408005|449743818|FG007|Induction|Entered another COG therapeutic protocol|0|||
125033445|NCT00408005|449743811|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
125033446|NCT00408005|449743812|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
125033447|NCT00408005|449743813|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
125033448|NCT00408005|449743814|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
125033449|NCT00408005|449743815|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
125033450|NCT00408005|449743816|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
125033451|NCT00408005|449743817|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
125033452|NCT00408005|449743818|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
125033453|NCT00408005|449743811|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
125033454|NCT00408005|449743812|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
125033455|NCT00408005|449743813|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
125033456|NCT00408005|449743814|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
125033457|NCT00408005|449743815|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
125033458|NCT00408005|449743816|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
125033459|NCT00408005|449743817|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
125033460|NCT00408005|449743818|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
125033461|NCT00408005|449743811|FG000|Induction|Progressive Disease|0|||
125033462|NCT00408005|449743812|FG001|Induction|Progressive Disease|1|||
125033463|NCT00408005|449743813|FG002|Induction|Progressive Disease|0|||
125033464|NCT00408005|449743814|FG003|Induction|Progressive Disease|0|||
125033465|NCT00408005|449743815|FG004|Induction|Progressive Disease|0|||
125033466|NCT00408005|449743816|FG005|Induction|Progressive Disease|0|||
125033467|NCT00408005|449743817|FG006|Induction|Progressive Disease|0|||
125033468|NCT00408005|449743818|FG007|Induction|Progressive Disease|0|||
125033469|NCT00408005|449743811|FG000|Induction|Inevaluable|18|||
125033470|NCT00408005|449743812|FG001|Induction|Inevaluable|14|||
125033471|NCT00408005|449743813|FG002|Induction|Inevaluable|0|||
125033472|NCT00408005|449743814|FG003|Induction|Inevaluable|0|||
125033473|NCT00408005|449743815|FG004|Induction|Inevaluable|0|||
125033474|NCT00408005|449743816|FG005|Induction|Inevaluable|0|||
125033475|NCT00408005|449743817|FG006|Induction|Inevaluable|0|||
125033476|NCT00408005|449743818|FG007|Induction|Inevaluable|0|||
125033477|NCT00408005|449743811|FG000|Induction|Failed to Complete Randomization|3|||
125033478|NCT00408005|449743812|FG001|Induction|Failed to Complete Randomization|2|||
125033479|NCT00408005|449743813|FG002|Induction|Failed to Complete Randomization|0|||
125033480|NCT00408005|449743814|FG003|Induction|Failed to Complete Randomization|0|||
125033481|NCT00408005|449743815|FG004|Induction|Failed to Complete Randomization|0|||
125033482|NCT00408005|449743816|FG005|Induction|Failed to Complete Randomization|0|||
125033483|NCT00408005|449743817|FG006|Induction|Failed to Complete Randomization|0|||
125033484|NCT00408005|449743818|FG007|Induction|Failed to Complete Randomization|0|||
125033485|NCT00408005|449743811|FG000|Induction|Protocol Deviation|3|||
125033486|NCT00408005|449743812|FG001|Induction|Protocol Deviation|1|||
125033487|NCT00408005|449743813|FG002|Induction|Protocol Deviation|0|||
125033488|NCT00408005|449743814|FG003|Induction|Protocol Deviation|0|||
125033489|NCT00408005|449743815|FG004|Induction|Protocol Deviation|0|||
125033490|NCT00408005|449743816|FG005|Induction|Protocol Deviation|0|||
125033491|NCT00408005|449743817|FG006|Induction|Protocol Deviation|0|||
125131216|NCT04405570|450108063|FG003|Overall Study|Physician Decision|0|||
125131217|NCT04405570|450108060|FG000|Overall Study|Withdrawal by Subject|0|||
125131218|NCT04405570|450108061|FG001|Overall Study|Withdrawal by Subject|1|||
125131219|NCT04405570|450108062|FG002|Overall Study|Withdrawal by Subject|1|||
125131220|NCT04405570|450108063|FG003|Overall Study|Withdrawal by Subject|0|||
125131221|NCT04405570|450108060|FG000|Overall Study|Randomized not dosed|0|||
125033492|NCT00408005|449743818|FG007|Induction|Protocol Deviation|0|||
125033493|NCT00408005|449743811|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
125033494|NCT00408005|449743812|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
125033495|NCT00408005|449743813|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
125033496|NCT00408005|449743814|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
125033497|NCT00408005|449743815|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
125033498|NCT00408005|449743816|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
124969406|NCT03733899|449515382|FG005|Period 1|Protocol Violation|1|||
124969407|NCT03733899|449515377|FG000|Period 2|Unscuccessful Treatment|0|||
124969408|NCT03733899|449515378|FG001|Period 2|Unscuccessful Treatment|1|||
124969409|NCT03733899|449515379|FG002|Period 2|Unscuccessful Treatment|0|||
124969410|NCT03733899|449515380|FG003|Period 2|Unscuccessful Treatment|0|||
124969411|NCT03733899|449515381|FG004|Period 2|Unscuccessful Treatment|0|||
124969412|NCT03733899|449515382|FG005|Period 2|Unscuccessful Treatment|0|||
124969413|NCT03733899|449515377|FG000|Period 3|Withdrawal by Subject|1|||
124969414|NCT03733899|449515378|FG001|Period 3|Withdrawal by Subject|0|||
124969415|NCT03733899|449515379|FG002|Period 3|Withdrawal by Subject|0|||
124969416|NCT03733899|449515380|FG003|Period 3|Withdrawal by Subject|0|||
124969417|NCT03733899|449515381|FG004|Period 3|Withdrawal by Subject|0|||
124969418|NCT03733899|449515382|FG005|Period 3|Withdrawal by Subject|0|||
124969419|NCT01689363|449517381|FG000|Overall Study|Protocol Violation|0|||
124969420|NCT01689363|449517382|FG001|Overall Study|Protocol Violation|1|||
124969421|NCT01689363|449517383|FG002|Overall Study|Protocol Violation|0|||
124969422|NCT01689363|449517384|FG003|Overall Study|Protocol Violation|0|||
124969423|NCT01689363|449517385|FG004|Overall Study|Protocol Violation|0|||
124969424|NCT01689363|449517386|FG005|Overall Study|Protocol Violation|0|||
124969425|NCT01689363|449517387|FG006|Overall Study|Protocol Violation|0|||
124969426|NCT01689363|449517388|FG007|Overall Study|Protocol Violation|0|||
124969427|NCT02104505|449517389|FG000|First Intervention (14 Days)|Adverse Event|2|||
124969428|NCT02104505|449517390|FG001|First Intervention (14 Days)|Adverse Event|0|||
124969429|NCT02104505|449517389|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
124969430|NCT02104505|449517390|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
124969431|NCT02104505|449517389|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
124969432|NCT02104505|449517390|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
124969433|NCT02104505|449517389|FG000|First Intervention (14 Days)|exclusionary condition|0|||
124969434|NCT02104505|449517390|FG001|First Intervention (14 Days)|exclusionary condition|1|||
124969435|NCT02104505|449517389|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
124969436|NCT02104505|449517390|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
124969437|NCT02104505|449517389|FG000|Second Intervention (14 Days)|Adverse Event|2|||
124969438|NCT02104505|449517390|FG001|Second Intervention (14 Days)|Adverse Event|0|||
124969439|NCT02859064|449517391|FG000|Overall Study|Progressive Disease|3|||
125033499|NCT00408005|449743817|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
125033500|NCT00408005|449743818|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
125033501|NCT00408005|449743811|FG000|Induction|Recurrent leukemia|1|||
125033502|NCT00408005|449743812|FG001|Induction|Recurrent leukemia|0|||
125033503|NCT00408005|449743813|FG002|Induction|Recurrent leukemia|0|||
125033504|NCT00408005|449743814|FG003|Induction|Recurrent leukemia|0|||
125033505|NCT00408005|449743815|FG004|Induction|Recurrent leukemia|0|||
125217400|NCT05415462|450423518|FG000|Overall Study|Death|18|||
124969440|NCT02859064|449517391|FG000|Overall Study|Physician Decision|1|||
124969441|NCT02859064|449517391|FG000|Overall Study|Withdrawal by Subject|1|||
124969442|NCT02859064|449517391|FG000|Overall Study|Death|1|||
124969443|NCT00321685|449517392|FG000|Overall Study|Adverse Event|18|||
125033506|NCT00408005|449743816|FG005|Induction|Recurrent leukemia|0|||
125033507|NCT00408005|449743817|FG006|Induction|Recurrent leukemia|0|||
125131222|NCT04405570|450108061|FG001|Overall Study|Randomized not dosed|2|||
125131223|NCT04405570|450108062|FG002|Overall Study|Randomized not dosed|0|||
125131224|NCT04405570|450108063|FG003|Overall Study|Randomized not dosed|0|||
125131225|NCT04499963|450108064|FG000|Overall Study|Adverse Event|3|||
125131226|NCT04499963|450108065|FG001|Overall Study|Adverse Event|0|||
125131227|NCT04499963|450108064|FG000|Overall Study|Death|3|||
125131228|NCT04499963|450108065|FG001|Overall Study|Death|0|||
125131229|NCT04499963|450108064|FG000|Overall Study|Lack of Efficacy|7|||
125131230|NCT04499963|450108065|FG001|Overall Study|Lack of Efficacy|0|||
125131231|NCT04499963|450108064|FG000|Overall Study|Lost to Follow-up|2|||
125131232|NCT04499963|450108065|FG001|Overall Study|Lost to Follow-up|0|||
125131233|NCT01208337|450108068|FG000|Overall Study|Death|3|||
125131234|NCT03663179|450108074|FG000|Overall Study|Withdrawal by Subject|2|||
125131235|NCT03663179|450108075|FG001|Overall Study|Withdrawal by Subject|0|||
125131236|NCT03663179|450108074|FG000|Overall Study|Lost to Follow-up|1|||
125131237|NCT03663179|450108075|FG001|Overall Study|Lost to Follow-up|1|||
125131238|NCT03663179|450108074|FG000|Overall Study|Revealed exclusionary condition|1|||
125131239|NCT03663179|450108075|FG001|Overall Study|Revealed exclusionary condition|0|||
125131240|NCT00984126|450108079|FG000|Overall Study|Protocol Violation|0|||
125131241|NCT00984126|450108080|FG001|Overall Study|Protocol Violation|0|||
125131242|NCT00984126|450108081|FG002|Overall Study|Protocol Violation|1|||
125131243|NCT00984126|450108082|FG003|Overall Study|Protocol Violation|2|||
125131244|NCT00984126|450108079|FG000|Overall Study|Adverse Event|0|||
125131245|NCT00984126|450108080|FG001|Overall Study|Adverse Event|0|||
125131246|NCT00984126|450108081|FG002|Overall Study|Adverse Event|0|||
125131247|NCT00984126|450108082|FG003|Overall Study|Adverse Event|2|||
125131248|NCT00984126|450108079|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
125131249|NCT00984126|450108080|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
125131250|NCT00984126|450108081|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
125131251|NCT00984126|450108082|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
125131252|NCT00984126|450108079|FG000|Overall Study|Withdrawal criteria|0|||
125131253|NCT00984126|450108080|FG001|Overall Study|Withdrawal criteria|1|||
125131254|NCT00984126|450108081|FG002|Overall Study|Withdrawal criteria|3|||
125131255|NCT00984126|450108082|FG003|Overall Study|Withdrawal criteria|9|||
125131256|NCT01001208|450108083|FG000|Overall Study|Adverse Event|10|||
125131257|NCT01001208|450108084|FG001|Overall Study|Adverse Event|5|||
125131258|NCT01001208|450108083|FG000|Overall Study|Lost to Follow-up|5|||
125131259|NCT01001208|450108084|FG001|Overall Study|Lost to Follow-up|9|||
125131260|NCT01001208|450108083|FG000|Overall Study|Physician Decision|1|||
125131261|NCT01001208|450108084|FG001|Overall Study|Physician Decision|0|||
124969444|NCT00321685|449517392|FG000|Overall Study|Death|2|||
124969445|NCT00321685|449517392|FG000|Overall Study|Withdrawal by Subject|8|||
124969446|NCT00321685|449517392|FG000|Overall Study|Alternative therapy|1|||
124969447|NCT00321685|449517392|FG000|Overall Study|Complicating disese|1|||
124969448|NCT00321685|449517392|FG000|Overall Study|Other|5|||
124969449|NCT00321685|449517392|FG000|Overall Study|Not start protocol therapy|2|||
124969450|NCT00321685|449517392|FG000|Overall Study|Ineligible|2|||
124969451|NCT00127842|449517393|FG000|Overall Study|Adverse Event|15|||
124969452|NCT00127842|449517393|FG000|Overall Study|Withdrawal by Subject|3|||
124969453|NCT00127842|449517393|FG000|Overall Study|Lost to Follow-up|1|||
124969454|NCT00127842|449517393|FG000|Overall Study|Lack of Efficacy|12|||
124969455|NCT00127842|449517393|FG000|Overall Study|Noncompliance|2|||
124969456|NCT00127842|449517393|FG000|Overall Study|Protocol Violation|1|||
125131262|NCT01001208|450108083|FG000|Overall Study|Withdrawal by Subject|4|||
125131263|NCT01001208|450108084|FG001|Overall Study|Withdrawal by Subject|5|||
125131264|NCT01001208|450108083|FG000|Overall Study|Ineligibility Determined|4|||
125131265|NCT01001208|450108084|FG001|Overall Study|Ineligibility Determined|2|||
125131266|NCT01001208|450108083|FG000|Overall Study|Noncompliance|4|||
125131267|NCT01001208|450108084|FG001|Overall Study|Noncompliance|7|||
125131268|NCT01001208|450108083|FG000|Overall Study|Disease Progression|0|||
125131269|NCT01001208|450108084|FG001|Overall Study|Disease Progression|3|||
124969457|NCT00127842|449517393|FG000|Overall Study|Other|5|||
124969458|NCT01638390|449517396|FG000|Overall Study|screening failures|21|||
124969459|NCT01377389|449517397|FG000|Overall Study|Withdrawal by Subject|1|||
125131270|NCT01001208|450108083|FG000|Overall Study|Other|0|||
125131271|NCT01001208|450108084|FG001|Overall Study|Other|2|||
125131272|NCT01864174|450108085|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
125217401|NCT05415462|450423519|FG001|Overall Study|Death|10|||
125033508|NCT00408005|449743818|FG007|Induction|Recurrent leukemia|0|||
125033509|NCT00408005|449743811|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
125033510|NCT00408005|449743812|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
125033511|NCT00408005|449743813|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
125033512|NCT00408005|449743814|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
125033513|NCT00408005|449743815|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
125033514|NCT00408005|449743816|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
125033515|NCT00408005|449743817|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
125033516|NCT00408005|449743818|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
125033517|NCT00408005|449743811|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
125033518|NCT00408005|449743812|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
125033519|NCT00408005|449743813|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
125033520|NCT00408005|449743814|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
125033521|NCT00408005|449743815|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
125033522|NCT00408005|449743816|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
125033523|NCT00408005|449743817|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
125033524|NCT00408005|449743818|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
125033525|NCT00408005|449743811|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
125033526|NCT00408005|449743812|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
125033527|NCT00408005|449743813|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
125033528|NCT00408005|449743814|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
125033529|NCT00408005|449743815|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
125033530|NCT00408005|449743816|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
125033531|NCT00408005|449743817|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
125033532|NCT00408005|449743818|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
125033533|NCT00408005|449743811|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
125033534|NCT00408005|449743812|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
125033535|NCT00408005|449743813|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
125033536|NCT00408005|449743814|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
125033537|NCT00408005|449743815|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
125033538|NCT00408005|449743816|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
125033539|NCT00408005|449743817|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
125033540|NCT00408005|449743818|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
125033541|NCT00408005|449743811|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
125033542|NCT00408005|449743812|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
125033543|NCT00408005|449743813|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
125033544|NCT00408005|449743814|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
125033545|NCT00408005|449743815|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
125033546|NCT00408005|449743816|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
125033547|NCT00408005|449743817|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
125033548|NCT00408005|449743818|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
125033549|NCT00408005|449743811|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
125033550|NCT00408005|449743812|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
125033551|NCT00408005|449743813|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
125033552|NCT00408005|449743814|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
125033553|NCT00408005|449743815|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
125033554|NCT00408005|449743816|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
125033555|NCT00408005|449743817|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
125033556|NCT00408005|449743818|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
125033557|NCT00408005|449743811|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
125033558|NCT00408005|449743812|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
125033559|NCT00408005|449743813|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
125033560|NCT00408005|449743814|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
125033561|NCT00408005|449743815|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
125033562|NCT00408005|449743816|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
125033563|NCT00408005|449743817|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
125033564|NCT00408005|449743818|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
125033565|NCT00408005|449743811|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
125131273|NCT01864174|450108086|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
125131274|NCT01864174|450108085|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
125131275|NCT01864174|450108086|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
125131276|NCT01864174|450108085|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
125131277|NCT01864174|450108086|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
125131278|NCT01864174|450108085|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
125217440|NCT01348100|450423520|FG000|Overall Study|Administrative Problems|0|||
125217441|NCT01348100|450423521|FG001|Overall Study|Administrative Problems|0|||
125217442|NCT01348100|450423522|FG002|Overall Study|Administrative Problems|0|||
125217443|NCT01348100|450423523|FG003|Overall Study|Administrative Problems|0|||
125217444|NCT01348100|450423524|FG004|Overall Study|Administrative Problems|0|||
125217445|NCT01348100|450423525|FG005|Overall Study|Administrative Problems|1|||
125217446|NCT01348100|450423526|FG006|Overall Study|Administrative Problems|1|||
125217447|NCT03882957|450423529|FG000|Overall Study|Did not complete all three arms|1|||
125217448|NCT04186221|450423534|FG000|Overall Study|Death|1|||
125217449|NCT01134393|450423535|FG000|Overall Study|Adverse Event|18|||
125217450|NCT01134393|450423535|FG000|Overall Study|Lack of Efficacy|2|||
125217451|NCT01134393|450423535|FG000|Overall Study|Protocol Violation|12|||
125217452|NCT01134393|450423535|FG000|Overall Study|Lost to Follow-up|3|||
125217453|NCT01134393|450423535|FG000|Overall Study|Withdrawal by Subject|11|||
125217454|NCT01134393|450423535|FG000|Overall Study|Other|6|||
125217455|NCT00531947|450423536|FG000|Overall Study|Adverse Event|5|||
125217456|NCT00531947|450423537|FG001|Overall Study|Adverse Event|10|||
125217457|NCT00531947|450423536|FG000|Overall Study|Lost to Follow-up|12|||
125217458|NCT00531947|450423537|FG001|Overall Study|Lost to Follow-up|9|||
125217459|NCT00531947|450423536|FG000|Overall Study|Withdrawal by Subject|14|||
125217460|NCT00531947|450423537|FG001|Overall Study|Withdrawal by Subject|19|||
125217461|NCT00531947|450423536|FG000|Overall Study|Protocol Violation|2|||
125217462|NCT00531947|450423537|FG001|Overall Study|Protocol Violation|1|||
125217463|NCT00531947|450423536|FG000|Overall Study|Non-Compliance|4|||
125217464|NCT00531947|450423537|FG001|Overall Study|Non-Compliance|7|||
125217465|NCT00531947|450423536|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
125217466|NCT00531947|450423537|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
125217467|NCT00420628|450423543|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
125217468|NCT00420628|450423544|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
124969649|NCT01234883|449517433|FG001|Overall Study|Inclusion/exclusion failure|0|||
124969650|NCT00126659|449517439|FG000|Overall Study|Adverse Event|0|||
124969651|NCT00126659|449517440|FG001|Overall Study|Adverse Event|0|||
124969652|NCT00126659|449517441|FG002|Overall Study|Adverse Event|2|||
124969653|NCT01013961|449517442|FG000|Overall Study|Adverse Event|2|||
124969654|NCT01013961|449517443|FG001|Overall Study|Adverse Event|2|||
124969655|NCT01013961|449517442|FG000|Overall Study|Withdrawal by Subject|1|||
124969656|NCT01013961|449517443|FG001|Overall Study|Withdrawal by Subject|0|||
124969657|NCT01013961|449517442|FG000|Overall Study|Physician Decision|0|||
124969658|NCT01013961|449517443|FG001|Overall Study|Physician Decision|1|||
124969659|NCT01375751|449517448|FG000|Overall Study|Other|0|||
124969660|NCT01375751|449517449|FG001|Overall Study|Other|1|||
124969661|NCT01375751|449517450|FG002|Overall Study|Other|0|||
124969662|NCT02980523|449517451|FG000|Overall Study|Lost to Follow-up|1|||
124969663|NCT02980523|449517452|FG001|Overall Study|Lost to Follow-up|4|||
124969664|NCT02980523|449517453|FG002|Overall Study|Lost to Follow-up|1|||
124969665|NCT02980523|449517454|FG003|Overall Study|Lost to Follow-up|2|||
124969666|NCT02980523|449517455|FG004|Overall Study|Lost to Follow-up|1|||
124969667|NCT02980523|449517451|FG000|Overall Study|Excluded from analysis|1|||
124969668|NCT02980523|449517452|FG001|Overall Study|Excluded from analysis|3|||
124969669|NCT02980523|449517453|FG002|Overall Study|Excluded from analysis|1|||
124969670|NCT02980523|449517454|FG003|Overall Study|Excluded from analysis|1|||
124969671|NCT02980523|449517455|FG004|Overall Study|Excluded from analysis|1|||
124969672|NCT02980523|449517451|FG000|Overall Study|Lack of Efficacy|1|||
124969673|NCT02980523|449517452|FG001|Overall Study|Lack of Efficacy|4|||
124969674|NCT02980523|449517453|FG002|Overall Study|Lack of Efficacy|4|||
124969675|NCT02980523|449517454|FG003|Overall Study|Lack of Efficacy|5|||
124969676|NCT02980523|449517455|FG004|Overall Study|Lack of Efficacy|8|||
124969677|NCT02980523|449517451|FG000|Overall Study|Did not receive intervention|0|||
124969678|NCT02980523|449517452|FG001|Overall Study|Did not receive intervention|0|||
124969679|NCT02980523|449517453|FG002|Overall Study|Did not receive intervention|0|||
124969680|NCT02980523|449517454|FG003|Overall Study|Did not receive intervention|1|||
124969681|NCT02980523|449517455|FG004|Overall Study|Did not receive intervention|0|||
124969682|NCT01547598|449517459|FG000|Overall Study|Withdrew consent|1|||
124969683|NCT01547598|449517460|FG001|Overall Study|Withdrew consent|1|||
124969684|NCT01547598|449517459|FG000|Overall Study|Lost to Follow-up|1|||
125217469|NCT00420628|450423543|FG000|Overall Study|Lost to Follow-up|3|||
124969685|NCT01547598|449517460|FG001|Overall Study|Lost to Follow-up|1|||
124969686|NCT01547598|449517459|FG000|Overall Study|Adverse Event|1|||
124969687|NCT01547598|449517460|FG001|Overall Study|Adverse Event|1|||
124969688|NCT01547598|449517459|FG000|Overall Study|Protocol Violation|1|||
124969689|NCT01547598|449517460|FG001|Overall Study|Protocol Violation|1|||
124969690|NCT01547598|449517459|FG000|Overall Study|Other Miscellaneous Reasons|2|||
125217470|NCT00420628|450423544|FG001|Overall Study|Lost to Follow-up|2|||
125217471|NCT00420628|450423543|FG000|Overall Study|Adverse Event|1|||
124969691|NCT01547598|449517460|FG001|Overall Study|Other Miscellaneous Reasons|1|||
124969692|NCT02229227|449517466|FG000|Overall Study|Adverse Event|14|||
124969693|NCT02229227|449517467|FG001|Overall Study|Adverse Event|9|||
124969694|NCT02229227|449517466|FG000|Overall Study|Lack of Efficacy|3|||
125033651|NCT01701258|449743824|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
125033652|NCT01701258|449743825|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
125033653|NCT01701258|449743826|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
125033654|NCT01701258|449743827|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
125033655|NCT01701258|449743828|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
125033656|NCT01701258|449743829|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
125033657|NCT01701258|449743830|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
125033658|NCT01701258|449743831|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
125033659|NCT01701258|449743832|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
125033660|NCT01701258|449743820|FG000|Assessment and Scheduling|Investigator Terminated|2|||
125033661|NCT01701258|449743821|FG001|Assessment and Scheduling|Investigator Terminated|0|||
125033662|NCT01701258|449743822|FG002|Assessment and Scheduling|Investigator Terminated|0|||
125033663|NCT01701258|449743823|FG003|Assessment and Scheduling|Investigator Terminated|0|||
125033664|NCT01701258|449743824|FG004|Assessment and Scheduling|Investigator Terminated|0|||
125033665|NCT01701258|449743825|FG005|Assessment and Scheduling|Investigator Terminated|0|||
125033666|NCT01701258|449743826|FG006|Assessment and Scheduling|Investigator Terminated|0|||
125033667|NCT01701258|449743827|FG007|Assessment and Scheduling|Investigator Terminated|0|||
125033668|NCT01701258|449743828|FG008|Assessment and Scheduling|Investigator Terminated|0|||
125033669|NCT01701258|449743829|FG009|Assessment and Scheduling|Investigator Terminated|0|||
125033670|NCT01701258|449743830|FG010|Assessment and Scheduling|Investigator Terminated|0|||
125033671|NCT01701258|449743831|FG011|Assessment and Scheduling|Investigator Terminated|0|||
125033672|NCT01701258|449743832|FG012|Assessment and Scheduling|Investigator Terminated|0|||
125033673|NCT03155997|449743833|FG000|Overall Study|Withdrawal by Subject|119|||
125033674|NCT03155997|449743834|FG001|Overall Study|Withdrawal by Subject|134|||
125033675|NCT03155997|449743833|FG000|Overall Study|Lost to Follow-up|12|||
125033676|NCT03155997|449743834|FG001|Overall Study|Lost to Follow-up|13|||
125033677|NCT03155997|449743833|FG000|Overall Study|Missing disposition data|0|||
125033678|NCT03155997|449743834|FG001|Overall Study|Missing disposition data|1|||
125033679|NCT03155997|449743833|FG000|Overall Study|On study treatment|2027|||
125033680|NCT03155997|449743834|FG001|Overall Study|On study treatment|2074|||
125033681|NCT03093402|449743835|FG000|Overall Study|Lost to Follow-up|1|||
125033682|NCT03093402|449743836|FG001|Overall Study|Lost to Follow-up|0|||
125033683|NCT03093402|449743837|FG002|Overall Study|Lost to Follow-up|0|||
125033684|NCT03093402|449743838|FG003|Overall Study|Lost to Follow-up|0|||
125033685|NCT03093402|449743835|FG000|Overall Study|Withdrawal by Subject|3|||
125033686|NCT03093402|449743836|FG001|Overall Study|Withdrawal by Subject|3|||
125033687|NCT03093402|449743837|FG002|Overall Study|Withdrawal by Subject|0|||
125033688|NCT03093402|449743838|FG003|Overall Study|Withdrawal by Subject|1|||
125033689|NCT03093402|449743835|FG000|Overall Study|Withdrew prior to dosing|2|||
125033690|NCT03093402|449743836|FG001|Overall Study|Withdrew prior to dosing|1|||
125033691|NCT03093402|449743837|FG002|Overall Study|Withdrew prior to dosing|2|||
125033692|NCT03093402|449743838|FG003|Overall Study|Withdrew prior to dosing|3|||
125033693|NCT03093402|449743835|FG000|Overall Study|Ineligible for study|1|||
125033694|NCT03093402|449743836|FG001|Overall Study|Ineligible for study|0|||
125033695|NCT03093402|449743837|FG002|Overall Study|Ineligible for study|0|||
125033696|NCT03093402|449743838|FG003|Overall Study|Ineligible for study|0|||
125033697|NCT03093402|449743835|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
125033698|NCT03093402|449743836|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
125033699|NCT03093402|449743837|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
125033700|NCT03093402|449743838|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
125033701|NCT02347631|449743839|FG000|First Intervention (2 Months)|Adverse Event|1|||
125217472|NCT00420628|450423544|FG001|Overall Study|Adverse Event|0|||
125033702|NCT02347631|449743840|FG001|First Intervention (2 Months)|Adverse Event|1|||
125033703|NCT02347631|449743839|FG000|First Intervention (2 Months)|Pregnancy|1|||
125033704|NCT02347631|449743840|FG001|First Intervention (2 Months)|Pregnancy|0|||
125033705|NCT02347631|449743839|FG000|First Intervention (2 Months)|Moved out of area|0|||
125033706|NCT02347631|449743840|FG001|First Intervention (2 Months)|Moved out of area|2|||
125033707|NCT02347631|449743839|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
125033708|NCT02347631|449743840|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
125033709|NCT02347631|449743839|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
125033710|NCT02347631|449743840|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
125033711|NCT02347631|449743839|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
125033712|NCT02347631|449743840|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
125033713|NCT02347631|449743839|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
125033714|NCT02347631|449743840|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
125033715|NCT02347631|449743839|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
125033716|NCT02347631|449743840|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
125033717|NCT05340504|449743854|FG000|Overall Study|Withdrawal by Subject|1|||
125033718|NCT05340504|449743855|FG001|Overall Study|Withdrawal by Subject|0|||
125033719|NCT00619957|449743856|FG000|Month 24 Double-Blind|Adverse Event|9|||
125033720|NCT00619957|449743857|FG001|Month 24 Double-Blind|Adverse Event|7|||
125033721|NCT00619957|449743856|FG000|Month 24 Double-Blind|Protocol Violation|1|||
125217473|NCT05095311|450423554|FG000|Overall Study|Lost to Follow-up|7|||
125217474|NCT05095311|450423555|FG001|Overall Study|Lost to Follow-up|0|||
125217475|NCT05095311|450423556|FG002|Overall Study|Lost to Follow-up|0|||
125217476|NCT02588664|450423559|FG000|Overall Study|Death|56|||
125217477|NCT02588664|450423560|FG001|Overall Study|Death|55|||
125217478|NCT02588664|450423559|FG000|Overall Study|Lost to Follow-up|1305|||
125217479|NCT02588664|450423560|FG001|Overall Study|Lost to Follow-up|990|||
125217480|NCT01429298|450423561|FG000|Overall Study|Protocol Violation|4|||
125217481|NCT01429298|450423562|FG001|Overall Study|Protocol Violation|6|||
125217482|NCT02903420|450423565|FG000|Overall Study|Death|3|||
125217483|NCT03092791|450423567|FG000|Overall Study|Lost to Follow-up|0|||
125217484|NCT03092791|450423568|FG001|Overall Study|Lost to Follow-up|0|||
125217485|NCT03092791|450423569|FG002|Overall Study|Lost to Follow-up|0|||
125217486|NCT03092791|450423570|FG003|Overall Study|Lost to Follow-up|0|||
125217487|NCT03092791|450423571|FG004|Overall Study|Lost to Follow-up|0|||
125217488|NCT03092791|450423572|FG005|Overall Study|Lost to Follow-up|0|||
125033722|NCT00619957|449743857|FG001|Month 24 Double-Blind|Protocol Violation|0|||
125033723|NCT00619957|449743856|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
125033724|NCT00619957|449743857|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
125033725|NCT00619957|449743856|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
125033726|NCT00619957|449743857|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
125033727|NCT00619957|449743856|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
125033728|NCT00619957|449743857|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
125033729|NCT00619957|449743856|FG000|Month 48 Open-Label|Adverse Event|4|||
125033730|NCT00619957|449743857|FG001|Month 48 Open-Label|Adverse Event|4|||
125033731|NCT00619957|449743856|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
125033732|NCT00619957|449743857|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
125033733|NCT00619957|449743856|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
125033734|NCT00619957|449743857|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
125033735|NCT00190775|449743858|FG000|Overall Study|Adverse Event|57|||
125033736|NCT00190775|449743859|FG001|Overall Study|Adverse Event|22|||
125033737|NCT00190775|449743858|FG000|Overall Study|Satisfactory Response|1|||
125033738|NCT00190775|449743859|FG001|Overall Study|Satisfactory Response|0|||
125131403|NCT03818581|450109962|FG002|Overall Study|Withdrawal by Subject|0|||
125131404|NCT03818581|450109963|FG003|Overall Study|Withdrawal by Subject|0|||
125131405|NCT03818581|450109964|FG004|Overall Study|Withdrawal by Subject|1|||
125131406|NCT03818581|450109960|FG000|Overall Study|No longer met study criteria|0|||
125131407|NCT03818581|450109961|FG001|Overall Study|No longer met study criteria|0|||
125131408|NCT03818581|450109962|FG002|Overall Study|No longer met study criteria|0|||
125131409|NCT03818581|450109963|FG003|Overall Study|No longer met study criteria|0|||
125131410|NCT03818581|450109964|FG004|Overall Study|No longer met study criteria|1|||
125131411|NCT02096211|450109967|FG000|Overall Study|Death|2|||
125131412|NCT02096211|450109967|FG000|Overall Study|Withdrawal by Subject|8|||
125131413|NCT02096211|450109967|FG000|Overall Study|Revision of implant|7|||
125131414|NCT02096211|450109967|FG000|Overall Study|Lost to Follow-up|43|||
125131415|NCT00519194|450109970|FG000|Overall Study|Withdrawal by Subject|9|||
125217489|NCT03092791|450423573|FG006|Overall Study|Lost to Follow-up|1|||
125217490|NCT03092791|450423574|FG007|Overall Study|Lost to Follow-up|0|||
125217491|NCT03092791|450423567|FG000|Overall Study|Withdrawal of Consent|0|||
125217492|NCT03092791|450423568|FG001|Overall Study|Withdrawal of Consent|0|||
125033739|NCT00190775|449743858|FG000|Overall Study|Lack of Efficacy|28|||
125033740|NCT00190775|449743859|FG001|Overall Study|Lack of Efficacy|32|||
125033741|NCT00190775|449743858|FG000|Overall Study|Lost to Follow-up|31|||
125033742|NCT00190775|449743859|FG001|Overall Study|Lost to Follow-up|23|||
125033743|NCT00190775|449743858|FG000|Overall Study|Participant Moved|0|||
125033744|NCT00190775|449743859|FG001|Overall Study|Participant Moved|1|||
125217493|NCT03092791|450423569|FG002|Overall Study|Withdrawal of Consent|0|||
125217494|NCT03092791|450423570|FG003|Overall Study|Withdrawal of Consent|0|||
125033745|NCT00190775|449743858|FG000|Overall Study|Withdrawal by Subject|24|||
125033746|NCT00190775|449743859|FG001|Overall Study|Withdrawal by Subject|13|||
125033747|NCT00190775|449743858|FG000|Overall Study|Sponsor Decision|1|||
125033748|NCT00190775|449743859|FG001|Overall Study|Sponsor Decision|0|||
125033749|NCT00190775|449743858|FG000|Overall Study|Physician Decision|3|||
125033750|NCT00190775|449743859|FG001|Overall Study|Physician Decision|0|||
125033751|NCT00190775|449743858|FG000|Overall Study|Noncompliance|3|||
125033752|NCT00190775|449743859|FG001|Overall Study|Noncompliance|5|||
125033753|NCT00190775|449743858|FG000|Overall Study|Protocol Violation|0|||
125033754|NCT00190775|449743859|FG001|Overall Study|Protocol Violation|1|||
125033755|NCT00190775|449743858|FG000|Overall Study|Exclusion Criteria Met|1|||
125033756|NCT00190775|449743859|FG001|Overall Study|Exclusion Criteria Met|3|||
125033757|NCT01526148|449743860|FG000|Overall Study|Adverse Event|6|||
125033758|NCT01526148|449743861|FG001|Overall Study|Adverse Event|5|||
125033759|NCT01526148|449743860|FG000|Overall Study|Lost to Follow-up|3|||
125033760|NCT01526148|449743861|FG001|Overall Study|Lost to Follow-up|6|||
125033761|NCT01526148|449743860|FG000|Overall Study|Withdrawal by Subject|2|||
125033762|NCT01526148|449743861|FG001|Overall Study|Withdrawal by Subject|0|||
125033763|NCT01526148|449743860|FG000|Overall Study|Unstable Medical Condition|1|||
125033764|NCT01526148|449743861|FG001|Overall Study|Unstable Medical Condition|0|||
125033765|NCT01526148|449743860|FG000|Overall Study|Unable to discontinue concomitant med|1|||
125033766|NCT01526148|449743861|FG001|Overall Study|Unable to discontinue concomitant med|0|||
125033767|NCT01526148|449743860|FG000|Overall Study|Moved out of state|1|||
125033768|NCT01526148|449743861|FG001|Overall Study|Moved out of state|0|||
125033769|NCT01526148|449743860|FG000|Overall Study|Incarcerated|0|||
125033770|NCT01526148|449743861|FG001|Overall Study|Incarcerated|2|||
125033771|NCT01173653|449743862|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
125033772|NCT01173653|449743863|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
125033773|NCT00481065|449743864|FG000|Overall Study|Adverse event or death|1|||
125033774|NCT00481065|449743865|FG001|Overall Study|Adverse event or death|1|||
125033775|NCT00481065|449743866|FG002|Overall Study|Adverse event or death|3|||
125033776|NCT00481065|449743867|FG003|Overall Study|Adverse event or death|0|||
125033777|NCT00481065|449743868|FG004|Overall Study|Adverse event or death|2|||
125033778|NCT00481065|449743869|FG005|Overall Study|Adverse event or death|0|||
125033779|NCT00481065|449743870|FG006|Overall Study|Adverse event or death|1|||
125033780|NCT00481065|449743871|FG007|Overall Study|Adverse event or death|1|||
125033781|NCT00481065|449743864|FG000|Overall Study|Withdrawal by Subject|11|||
125033782|NCT00481065|449743865|FG001|Overall Study|Withdrawal by Subject|12|||
125033783|NCT00481065|449743866|FG002|Overall Study|Withdrawal by Subject|7|||
125033784|NCT00481065|449743867|FG003|Overall Study|Withdrawal by Subject|11|||
125033785|NCT00481065|449743868|FG004|Overall Study|Withdrawal by Subject|13|||
125033786|NCT00481065|449743869|FG005|Overall Study|Withdrawal by Subject|12|||
125033787|NCT00481065|449743870|FG006|Overall Study|Withdrawal by Subject|9|||
125033788|NCT00481065|449743871|FG007|Overall Study|Withdrawal by Subject|10|||
125033789|NCT00481065|449743864|FG000|Overall Study|Lost to Follow-up|4|||
125033790|NCT00481065|449743865|FG001|Overall Study|Lost to Follow-up|2|||
125033791|NCT00481065|449743866|FG002|Overall Study|Lost to Follow-up|4|||
125033792|NCT00481065|449743867|FG003|Overall Study|Lost to Follow-up|3|||
125033793|NCT00481065|449743868|FG004|Overall Study|Lost to Follow-up|3|||
125033794|NCT00481065|449743869|FG005|Overall Study|Lost to Follow-up|3|||
125033795|NCT00481065|449743870|FG006|Overall Study|Lost to Follow-up|2|||
125033796|NCT00481065|449743871|FG007|Overall Study|Lost to Follow-up|5|||
125033797|NCT00481065|449743864|FG000|Overall Study|Inappropriate enrollment|4|||
125033798|NCT00481065|449743865|FG001|Overall Study|Inappropriate enrollment|0|||
125033799|NCT00481065|449743866|FG002|Overall Study|Inappropriate enrollment|2|||
125033800|NCT00481065|449743867|FG003|Overall Study|Inappropriate enrollment|0|||
125033801|NCT00481065|449743868|FG004|Overall Study|Inappropriate enrollment|2|||
125033802|NCT00481065|449743869|FG005|Overall Study|Inappropriate enrollment|1|||
125033803|NCT00481065|449743870|FG006|Overall Study|Inappropriate enrollment|0|||
125033804|NCT00481065|449743871|FG007|Overall Study|Inappropriate enrollment|1|||
125033805|NCT00481065|449743864|FG000|Overall Study|Administrative reason|0|||
125033806|NCT00481065|449743865|FG001|Overall Study|Administrative reason|0|||
125033807|NCT00481065|449743866|FG002|Overall Study|Administrative reason|0|||
125033808|NCT00481065|449743867|FG003|Overall Study|Administrative reason|0|||
125033809|NCT00481065|449743868|FG004|Overall Study|Administrative reason|0|||
125033810|NCT00481065|449743869|FG005|Overall Study|Administrative reason|2|||
125033811|NCT00481065|449743870|FG006|Overall Study|Administrative reason|1|||
125131416|NCT00519194|450109970|FG000|Overall Study|Death|9|||
125131417|NCT00519194|450109970|FG000|Overall Study|Lost to Follow-up|3|||
125131418|NCT03165994|450109971|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
125131419|NCT03165994|450109971|FG000|Overall Study|Death|2|||
125131420|NCT03165994|450109971|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
125131421|NCT03165994|450109971|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
125131422|NCT03165994|450109971|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
125131423|NCT03165994|450109971|FG000|Overall Study|Miscellaneous|1|||
125131424|NCT00461786|450109978|FG000|Overall Study|Entry Criteria Not Met|2|||
125131425|NCT00461786|450109978|FG000|Overall Study|Inevaluable (Never Treated)|1|||
125033812|NCT00481065|449743871|FG007|Overall Study|Administrative reason|0|||
125033813|NCT00481065|449743864|FG000|Overall Study|Protocol Violation|2|||
125033814|NCT00481065|449743865|FG001|Overall Study|Protocol Violation|1|||
125033815|NCT00481065|449743866|FG002|Overall Study|Protocol Violation|1|||
125033816|NCT00481065|449743867|FG003|Overall Study|Protocol Violation|1|||
125033817|NCT00481065|449743868|FG004|Overall Study|Protocol Violation|2|||
125033818|NCT00481065|449743869|FG005|Overall Study|Protocol Violation|6|||
125033819|NCT00481065|449743870|FG006|Overall Study|Protocol Violation|3|||
125033820|NCT00481065|449743871|FG007|Overall Study|Protocol Violation|2|||
125033821|NCT00481065|449743864|FG000|Overall Study|Unable to classify|0|||
125033822|NCT00481065|449743865|FG001|Overall Study|Unable to classify|1|||
125033823|NCT00481065|449743866|FG002|Overall Study|Unable to classify|2|||
125033824|NCT00481065|449743867|FG003|Overall Study|Unable to classify|0|||
125033825|NCT00481065|449743868|FG004|Overall Study|Unable to classify|1|||
125033826|NCT00481065|449743869|FG005|Overall Study|Unable to classify|0|||
125033827|NCT00481065|449743870|FG006|Overall Study|Unable to classify|0|||
125033828|NCT00481065|449743871|FG007|Overall Study|Unable to classify|0|||
125033829|NCT01709331|449743874|FG000|Overall Study|Adverse Event|1|||
125033830|NCT01651780|449743882|FG000|Overall Study|Physician decision: No 30-day visit|2|||
125033831|NCT01651780|449743883|FG001|Overall Study|Physician decision: No 30-day visit|1|||
125033832|NCT01651780|449743882|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
125033833|NCT01651780|449743883|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
125033834|NCT01651780|449743882|FG000|Overall Study|Withdrawal by Subject|2|||
125033835|NCT01651780|449743883|FG001|Overall Study|Withdrawal by Subject|0|||
125033836|NCT01651780|449743882|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
125033837|NCT01651780|449743883|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
125033838|NCT01651780|449743882|FG000|Overall Study|Lost to Follow-up|1|||
125033839|NCT01651780|449743883|FG001|Overall Study|Lost to Follow-up|2|||
125033840|NCT01651780|449743882|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
125033841|NCT01651780|449743883|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
125033842|NCT01628926|449743884|FG000|Overall Study|Adverse Event|13|||
125033843|NCT01628926|449743885|FG001|Overall Study|Adverse Event|11|||
125033844|NCT01628926|449743886|FG002|Overall Study|Adverse Event|9|||
125033845|NCT01628926|449743884|FG000|Overall Study|Lack of Efficacy|2|||
125033846|NCT01628926|449743885|FG001|Overall Study|Lack of Efficacy|1|||
125033847|NCT01628926|449743886|FG002|Overall Study|Lack of Efficacy|5|||
125033848|NCT01628926|449743884|FG000|Overall Study|Withdrawal by Subject|6|||
125033849|NCT01628926|449743885|FG001|Overall Study|Withdrawal by Subject|4|||
125033850|NCT01628926|449743886|FG002|Overall Study|Withdrawal by Subject|2|||
125033851|NCT01628926|449743884|FG000|Overall Study|Protocol Violation|0|||
125033852|NCT01628926|449743885|FG001|Overall Study|Protocol Violation|1|||
125033853|NCT01628926|449743886|FG002|Overall Study|Protocol Violation|0|||
125033854|NCT01628926|449743884|FG000|Overall Study|Discontinuation criteria|3|||
125033855|NCT01628926|449743885|FG001|Overall Study|Discontinuation criteria|4|||
125131426|NCT00934050|450109979|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
125131427|NCT00934050|450109980|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
125131428|NCT00934050|450109981|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
125131429|NCT00934050|450109982|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
125131430|NCT00934050|450109983|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
125131431|NCT00934050|450109984|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
125131432|NCT00934050|450109979|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
125131433|NCT00934050|450109980|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
125131434|NCT00934050|450109981|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
125131435|NCT00934050|450109982|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
125131436|NCT00934050|450109983|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
125131437|NCT00934050|450109984|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
125131438|NCT00934050|450109979|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
125131439|NCT00934050|450109980|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
125131440|NCT00934050|450109981|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
125131441|NCT00934050|450109982|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
125131442|NCT00934050|450109983|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
125131443|NCT00934050|450109984|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
125131444|NCT00934050|450109979|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
125131445|NCT00934050|450109980|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
125131446|NCT00934050|450109981|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
125131447|NCT00934050|450109982|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
125033856|NCT01628926|449743886|FG002|Overall Study|Discontinuation criteria|0|||
125131448|NCT00934050|450109983|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
125131449|NCT00934050|450109984|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
125217495|NCT03092791|450423571|FG004|Overall Study|Withdrawal of Consent|4|||
125217496|NCT03092791|450423572|FG005|Overall Study|Withdrawal of Consent|12|||
125033857|NCT01628926|449743884|FG000|Overall Study|Physician Decision|2|||
125033858|NCT01628926|449743885|FG001|Overall Study|Physician Decision|2|||
125033859|NCT01628926|449743886|FG002|Overall Study|Physician Decision|1|||
125131450|NCT00934050|450109979|FG000|Enrolled After 15 Dec 2009|Death|0|||
125217497|NCT03092791|450423573|FG006|Overall Study|Withdrawal of Consent|6|||
125217498|NCT03092791|450423574|FG007|Overall Study|Withdrawal of Consent|4|||
125033860|NCT03029832|449743887|FG000|Overall Study|Safety Follow-Up Completed|2|||
125033861|NCT03029832|449743888|FG001|Overall Study|Safety Follow-Up Completed|0|||
125033862|NCT03029832|449743887|FG000|Overall Study|Death due to Disease Progression|1|||
125033863|NCT03029832|449743888|FG001|Overall Study|Death due to Disease Progression|0|||
125033864|NCT03029832|449743887|FG000|Overall Study|Study Terminated By Sponsor|1|||
125033865|NCT03029832|449743888|FG001|Overall Study|Study Terminated By Sponsor|1|||
125033866|NCT00151892|449743895|FG000|Overall Study|Lack of Efficacy|50|||
125033867|NCT00151892|449743896|FG001|Overall Study|Lack of Efficacy|57|||
125033868|NCT00151892|449743895|FG000|Overall Study|Patient request|10|||
125033869|NCT00151892|449743896|FG001|Overall Study|Patient request|7|||
125033870|NCT00151892|449743895|FG000|Overall Study|Lost to Follow-up|5|||
125033871|NCT00151892|449743896|FG001|Overall Study|Lost to Follow-up|10|||
125033872|NCT00151892|449743895|FG000|Overall Study|Adverse Event|6|||
125033873|NCT00151892|449743896|FG001|Overall Study|Adverse Event|3|||
125033874|NCT00151892|449743895|FG000|Overall Study|Protocol Violation|3|||
125033875|NCT00151892|449743896|FG001|Overall Study|Protocol Violation|3|||
125033876|NCT00151892|449743895|FG000|Overall Study|Non-compliance|0|||
125033877|NCT00151892|449743896|FG001|Overall Study|Non-compliance|1|||
125033878|NCT00151892|449743895|FG000|Overall Study|Pregnancy|0|||
125033879|NCT00151892|449743896|FG001|Overall Study|Pregnancy|1|||
125033880|NCT00151892|449743895|FG000|Overall Study|Did not return for a visit|1|||
125033881|NCT00151892|449743896|FG001|Overall Study|Did not return for a visit|0|||
125033882|NCT00151892|449743895|FG000|Overall Study|Used prohibited corticosteroids|1|||
125033883|NCT00151892|449743896|FG001|Overall Study|Used prohibited corticosteroids|0|||
125033884|NCT00151892|449743895|FG000|Overall Study|Lack of study medication at center|0|||
125033885|NCT00151892|449743896|FG001|Overall Study|Lack of study medication at center|1|||
125033886|NCT02901431|449743897|FG000|PK Part|Adverse Event|0|||
125033887|NCT02901431|449743898|FG001|PK Part|Adverse Event|1|||
125033888|NCT02901431|449743899|FG002|PK Part|Adverse Event|0|||
125033889|NCT02901431|449743900|FG003|PK Part|Adverse Event|0|||
125033890|NCT02901431|449743901|FG004|PK Part|Adverse Event|0|||
125033891|NCT02901431|449743902|FG005|PK Part|Adverse Event|0|||
125033892|NCT02901431|449743903|FG006|PK Part|Adverse Event|0|||
125033893|NCT02901431|449743904|FG007|PK Part|Adverse Event|0|||
125033894|NCT02901431|449743905|FG008|PK Part|Adverse Event|0|||
125033895|NCT02901431|449743906|FG009|PK Part|Adverse Event|0|||
125217499|NCT03092791|450423567|FG000|Overall Study|Study Termination|0|||
125217500|NCT03092791|450423568|FG001|Overall Study|Study Termination|0|||
125033896|NCT02901431|449743907|FG010|PK Part|Adverse Event|0|||
125033897|NCT02901431|449743908|FG011|PK Part|Adverse Event|0|||
125033898|NCT02901431|449743909|FG012|PK Part|Adverse Event|0|||
125033899|NCT02901431|449743897|FG000|PK Part|Lost to Follow-up|0|||
125033900|NCT02901431|449743898|FG001|PK Part|Lost to Follow-up|0|||
125033901|NCT02901431|449743899|FG002|PK Part|Lost to Follow-up|1|||
125131451|NCT00934050|450109980|FG001|Enrolled After 15 Dec 2009|Death|0|||
125131452|NCT00934050|450109981|FG002|Enrolled After 15 Dec 2009|Death|0|||
125131453|NCT00934050|450109982|FG003|Enrolled After 15 Dec 2009|Death|0|||
125131454|NCT00934050|450109983|FG004|Enrolled After 15 Dec 2009|Death|0|||
125131455|NCT00934050|450109984|FG005|Enrolled After 15 Dec 2009|Death|1|||
125131456|NCT00934050|450109979|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
125131457|NCT00934050|450109980|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
125131458|NCT00934050|450109981|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
125131459|NCT00934050|450109982|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
125131460|NCT00934050|450109983|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
125131461|NCT00934050|450109984|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
125131462|NCT00934050|450109979|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
125131463|NCT00934050|450109980|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
125131464|NCT00934050|450109981|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
125131465|NCT00934050|450109982|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
125131466|NCT00934050|450109983|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
125131467|NCT00934050|450109984|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
125131468|NCT00835991|450109985|FG000|First Intervention|Adverse Event|0|||
125131469|NCT00835991|450109986|FG001|First Intervention|Adverse Event|1|||
125131470|NCT00835991|450109985|FG000|Washout|Protocol Violation|0|||
125131471|NCT00835991|450109986|FG001|Washout|Protocol Violation|2|||
125217501|NCT03092791|450423569|FG002|Overall Study|Study Termination|0|||
125033902|NCT02901431|449743900|FG003|PK Part|Lost to Follow-up|0|||
125217502|NCT03092791|450423570|FG003|Overall Study|Study Termination|0|||
125033903|NCT02901431|449743901|FG004|PK Part|Lost to Follow-up|0|||
125033904|NCT02901431|449743902|FG005|PK Part|Lost to Follow-up|0|||
125033905|NCT02901431|449743903|FG006|PK Part|Lost to Follow-up|0|||
125033906|NCT02901431|449743904|FG007|PK Part|Lost to Follow-up|0|||
125033907|NCT02901431|449743905|FG008|PK Part|Lost to Follow-up|0|||
125033908|NCT02901431|449743906|FG009|PK Part|Lost to Follow-up|0|||
125033909|NCT02901431|449743907|FG010|PK Part|Lost to Follow-up|0|||
125033910|NCT02901431|449743908|FG011|PK Part|Lost to Follow-up|0|||
125033911|NCT02901431|449743909|FG012|PK Part|Lost to Follow-up|0|||
125131472|NCT00835991|450109985|FG000|Washout|Withdrawal by Subject|3|||
125033912|NCT02901431|449743897|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
125033913|NCT02901431|449743898|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125033914|NCT02901431|449743899|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125033915|NCT02901431|449743900|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125033916|NCT02901431|449743901|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125033917|NCT02901431|449743902|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125033918|NCT02901431|449743903|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125033919|NCT02901431|449743904|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125033920|NCT02901431|449743905|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125033921|NCT02901431|449743906|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125033922|NCT02901431|449743907|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125033923|NCT02901431|449743908|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125033924|NCT02901431|449743909|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125033925|NCT02901431|449743897|FG000|PK Part|Pending dose confirmation|0|||
125033926|NCT02901431|449743898|FG001|PK Part|Pending dose confirmation|1|||
125033927|NCT02901431|449743899|FG002|PK Part|Pending dose confirmation|0|||
125033928|NCT02901431|449743900|FG003|PK Part|Pending dose confirmation|0|||
125033929|NCT02901431|449743901|FG004|PK Part|Pending dose confirmation|0|||
125033930|NCT02901431|449743902|FG005|PK Part|Pending dose confirmation|0|||
125033931|NCT02901431|449743903|FG006|PK Part|Pending dose confirmation|0|||
125033932|NCT02901431|449743904|FG007|PK Part|Pending dose confirmation|0|||
125033933|NCT02901431|449743905|FG008|PK Part|Pending dose confirmation|0|||
125033934|NCT02901431|449743906|FG009|PK Part|Pending dose confirmation|0|||
125033935|NCT02901431|449743907|FG010|PK Part|Pending dose confirmation|0|||
125033936|NCT02901431|449743908|FG011|PK Part|Pending dose confirmation|0|||
125033937|NCT02901431|449743909|FG012|PK Part|Pending dose confirmation|0|||
125033938|NCT02901431|449743897|FG000|PK Part|8 weeks of treatment ran out|2|||
125033939|NCT02901431|449743898|FG001|PK Part|8 weeks of treatment ran out|0|||
125033940|NCT02901431|449743899|FG002|PK Part|8 weeks of treatment ran out|0|||
125033941|NCT02901431|449743900|FG003|PK Part|8 weeks of treatment ran out|0|||
125033942|NCT02901431|449743901|FG004|PK Part|8 weeks of treatment ran out|0|||
125033943|NCT02901431|449743902|FG005|PK Part|8 weeks of treatment ran out|0|||
125033944|NCT02901431|449743903|FG006|PK Part|8 weeks of treatment ran out|0|||
125033945|NCT02901431|449743904|FG007|PK Part|8 weeks of treatment ran out|0|||
125033946|NCT02901431|449743905|FG008|PK Part|8 weeks of treatment ran out|0|||
125033947|NCT02901431|449743906|FG009|PK Part|8 weeks of treatment ran out|0|||
125033948|NCT02901431|449743907|FG010|PK Part|8 weeks of treatment ran out|0|||
125033949|NCT02901431|449743908|FG011|PK Part|8 weeks of treatment ran out|0|||
125033950|NCT02901431|449743909|FG012|PK Part|8 weeks of treatment ran out|0|||
125033951|NCT02901431|449743897|FG000|PK Part|Stopped treatment after 8 weeks|1|||
125033952|NCT02901431|449743898|FG001|PK Part|Stopped treatment after 8 weeks|0|||
125033953|NCT02901431|449743899|FG002|PK Part|Stopped treatment after 8 weeks|1|||
125033954|NCT02901431|449743900|FG003|PK Part|Stopped treatment after 8 weeks|0|||
125033955|NCT02901431|449743901|FG004|PK Part|Stopped treatment after 8 weeks|0|||
125033956|NCT02901431|449743902|FG005|PK Part|Stopped treatment after 8 weeks|0|||
125033957|NCT02901431|449743903|FG006|PK Part|Stopped treatment after 8 weeks|0|||
125033958|NCT02901431|449743904|FG007|PK Part|Stopped treatment after 8 weeks|0|||
125033959|NCT02901431|449743905|FG008|PK Part|Stopped treatment after 8 weeks|0|||
125033960|NCT02901431|449743906|FG009|PK Part|Stopped treatment after 8 weeks|0|||
125033961|NCT02901431|449743907|FG010|PK Part|Stopped treatment after 8 weeks|0|||
125033962|NCT02901431|449743908|FG011|PK Part|Stopped treatment after 8 weeks|0|||
125033963|NCT02901431|449743909|FG012|PK Part|Stopped treatment after 8 weeks|0|||
125033964|NCT02901431|449743897|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
125033965|NCT02901431|449743898|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
125033966|NCT02901431|449743899|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
125033967|NCT02901431|449743900|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
125033968|NCT02901431|449743901|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
125033969|NCT02901431|449743902|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
125033970|NCT02901431|449743903|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
125033971|NCT02901431|449743904|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
125033972|NCT02901431|449743905|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
125033973|NCT02901431|449743906|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
125033974|NCT02901431|449743907|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
124969695|NCT02229227|449517467|FG001|Overall Study|Lack of Efficacy|3|||
124969696|NCT02229227|449517466|FG000|Overall Study|Protocol Violation|6|||
124969697|NCT02229227|449517467|FG001|Overall Study|Protocol Violation|8|||
124969698|NCT02229227|449517466|FG000|Overall Study|Protocol defined stopping criteria|1|||
124969699|NCT02229227|449517467|FG001|Overall Study|Protocol defined stopping criteria|3|||
124969700|NCT02229227|449517466|FG000|Overall Study|Lost to Follow-up|3|||
124969701|NCT02229227|449517467|FG001|Overall Study|Lost to Follow-up|3|||
124969702|NCT02229227|449517466|FG000|Overall Study|Study terminated by sponsor|11|||
124969703|NCT02229227|449517467|FG001|Overall Study|Study terminated by sponsor|11|||
124969704|NCT02229227|449517466|FG000|Overall Study|Withdrawal by Subject|8|||
124969705|NCT02229227|449517467|FG001|Overall Study|Withdrawal by Subject|12|||
124969706|NCT02229227|449517466|FG000|Overall Study|Other|0|||
124969707|NCT02229227|449517467|FG001|Overall Study|Other|1|||
124969708|NCT02229227|449517466|FG000|Overall Study|Physician Decision|5|||
124969709|NCT02229227|449517467|FG001|Overall Study|Physician Decision|12|||
124969710|NCT04071301|449517468|FG000|Overall Study|Withdrawal by Subject|6|||
124969711|NCT04071301|449517468|FG000|Overall Study|Death|1|||
124969712|NCT05186311|449517469|FG000|Part A: Serum|Withdrawal by Subject|1|||
124969713|NCT02125279|449517470|FG000|Overall Study|Lack of Efficacy|2|||
124969714|NCT02125279|449517470|FG000|Overall Study|Withdrawal by Subject|6|||
124969715|NCT02125279|449517470|FG000|Overall Study|Protocol Violation|1|||
124969716|NCT02125279|449517470|FG000|Overall Study|Lost to Follow-up|4|||
124969717|NCT01850589|449517478|FG000|Overall Study|Withdrawal by Subject|8|||
124969718|NCT01850589|449517479|FG001|Overall Study|Withdrawal by Subject|0|||
124969719|NCT04468230|449517484|FG000|Overall Study|Adverse Event|2|||
124969720|NCT03721705|449517487|FG000|Overall Study|Adverse Event|2|||
124969721|NCT03721705|449517488|FG001|Overall Study|Adverse Event|0|||
124969722|NCT03721705|449517487|FG000|Overall Study|Withdrawal by Subject|4|||
124969723|NCT03721705|449517488|FG001|Overall Study|Withdrawal by Subject|10|||
124969724|NCT03721705|449517487|FG000|Overall Study|No Suitable Study Partner|1|||
124969725|NCT03721705|449517488|FG001|Overall Study|No Suitable Study Partner|0|||
124969726|NCT03721705|449517487|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
124969727|NCT03721705|449517488|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
124969728|NCT03721705|449517487|FG000|Overall Study|Death|0|||
124969729|NCT03721705|449517488|FG001|Overall Study|Death|1|||
124969730|NCT03721172|449517489|FG000|Placebo-controlled Phase|Adverse Event|7|||
124969731|NCT03721172|449517490|FG001|Placebo-controlled Phase|Adverse Event|7|||
124969732|NCT03721172|449517491|FG002|Placebo-controlled Phase|Adverse Event|0|||
124969733|NCT03721172|449517489|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
124969734|NCT03721172|449517490|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
124969735|NCT03721172|449517491|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
124969736|NCT03721172|449517489|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
124969737|NCT03721172|449517490|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
124969738|NCT03721172|449517491|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
124969739|NCT03721172|449517489|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
124969740|NCT03721172|449517490|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
124969741|NCT03721172|449517491|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
124969742|NCT03721172|449517489|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
124969743|NCT03721172|449517490|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
124969744|NCT03721172|449517491|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
124969745|NCT03721172|449517489|FG000|Placebo-controlled Phase|Other|3|||
124969746|NCT03721172|449517490|FG001|Placebo-controlled Phase|Other|0|||
124969747|NCT03721172|449517491|FG002|Placebo-controlled Phase|Other|0|||
124969748|NCT03721172|449517489|FG000|Apremilast Extension Phase|Adverse Event|0|||
125033975|NCT02901431|449743908|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
125217503|NCT03092791|450423571|FG004|Overall Study|Study Termination|55|||
125217504|NCT03092791|450423572|FG005|Overall Study|Study Termination|46|||
125217505|NCT03092791|450423573|FG006|Overall Study|Study Termination|53|||
125217506|NCT03092791|450423574|FG007|Overall Study|Study Termination|55|||
125217507|NCT03092791|450423567|FG000|Overall Study|Death|0|||
125217508|NCT03092791|450423568|FG001|Overall Study|Death|0|||
125217509|NCT03092791|450423569|FG002|Overall Study|Death|0|||
125217510|NCT03092791|450423570|FG003|Overall Study|Death|0|||
125217511|NCT03092791|450423571|FG004|Overall Study|Death|0|||
125217512|NCT03092791|450423572|FG005|Overall Study|Death|1|||
125217513|NCT03092791|450423573|FG006|Overall Study|Death|0|||
125217514|NCT03092791|450423574|FG007|Overall Study|Death|1|||
125217515|NCT03092791|450423567|FG000|Overall Study|Reason Not Specified|0|||
125217516|NCT03092791|450423568|FG001|Overall Study|Reason Not Specified|0|||
124969749|NCT03721172|449517490|FG001|Apremilast Extension Phase|Adverse Event|0|||
124969750|NCT03721172|449517491|FG002|Apremilast Extension Phase|Adverse Event|10|||
124969751|NCT03721172|449517489|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
124969752|NCT03721172|449517490|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
124969753|NCT03721172|449517491|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
124969754|NCT03721172|449517489|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
124969755|NCT03721172|449517490|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
125131473|NCT00835991|450109986|FG001|Washout|Withdrawal by Subject|1|||
125131474|NCT02149420|450109987|FG000|Core Study|Administrative problems|0|||
125131475|NCT02149420|450109988|FG001|Core Study|Administrative problems|1|||
125131476|NCT02149420|450109989|FG002|Core Study|Administrative problems|2|||
125131477|NCT02149420|450109987|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
125131478|NCT02149420|450109988|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
125131479|NCT02149420|450109989|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
125131480|NCT02378935|450109992|FG000|Overall Study|Lack of Efficacy|10|||
125131481|NCT02378935|450109993|FG001|Overall Study|Lack of Efficacy|0|||
125131482|NCT02378935|450109994|FG002|Overall Study|Lack of Efficacy|2|||
125131483|NCT02378935|450109995|FG003|Overall Study|Lack of Efficacy|6|||
125131484|NCT02378935|450109996|FG004|Overall Study|Lack of Efficacy|0|||
125131485|NCT02378935|450109997|FG005|Overall Study|Lack of Efficacy|0|||
125131486|NCT02378935|450109998|FG006|Overall Study|Lack of Efficacy|0|||
125033976|NCT02901431|449743909|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
125033977|NCT02901431|449743897|FG000|PK Part|Discontinued per Sponsor|0|||
125131487|NCT02378935|450109992|FG000|Overall Study|Death|0|||
125131488|NCT02378935|450109993|FG001|Overall Study|Death|0|||
125131489|NCT02378935|450109994|FG002|Overall Study|Death|1|||
125131490|NCT02378935|450109995|FG003|Overall Study|Death|0|||
125131491|NCT02378935|450109996|FG004|Overall Study|Death|0|||
125131492|NCT02378935|450109997|FG005|Overall Study|Death|0|||
125131493|NCT02378935|450109998|FG006|Overall Study|Death|0|||
125131494|NCT00272779|450109999|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
125131495|NCT00272779|450110000|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
125131496|NCT00272779|450109999|FG000|Baseline Through Week 48|Death before Week 48|4|||
125131497|NCT00272779|450110000|FG001|Baseline Through Week 48|Death before Week 48|4|||
125131498|NCT00272779|450109999|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
125131499|NCT00272779|450110000|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
125131500|NCT00272779|450109999|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
125131501|NCT00272779|450110000|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
125131502|NCT00272779|450109999|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
125131503|NCT00272779|450110000|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
125131504|NCT00272779|450109999|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
125131505|NCT00272779|450110000|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
125131506|NCT00272779|450109999|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
125131507|NCT00272779|450110000|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
125131508|NCT00272779|450109999|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
125131509|NCT00272779|450110000|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
125131510|NCT00272779|450109999|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
125033978|NCT02901431|449743898|FG001|PK Part|Discontinued per Sponsor|3|||
125033979|NCT02901431|449743899|FG002|PK Part|Discontinued per Sponsor|0|||
125033980|NCT02901431|449743900|FG003|PK Part|Discontinued per Sponsor|0|||
125033981|NCT02901431|449743901|FG004|PK Part|Discontinued per Sponsor|0|||
125033982|NCT02901431|449743902|FG005|PK Part|Discontinued per Sponsor|0|||
125033983|NCT02901431|449743903|FG006|PK Part|Discontinued per Sponsor|0|||
125033984|NCT02901431|449743904|FG007|PK Part|Discontinued per Sponsor|0|||
125033985|NCT02901431|449743905|FG008|PK Part|Discontinued per Sponsor|0|||
125033986|NCT02901431|449743906|FG009|PK Part|Discontinued per Sponsor|0|||
125131511|NCT00272779|450110000|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
125131512|NCT00272779|450109999|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
125131513|NCT00272779|450110000|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
125131514|NCT00272779|450109999|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
125131515|NCT00272779|450110000|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
125131516|NCT00272779|450109999|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
125131517|NCT00272779|450110000|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
125131518|NCT00272779|450109999|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
125131519|NCT00272779|450110000|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
125131520|NCT00272779|450109999|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
125131521|NCT00272779|450110000|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
125131522|NCT00272779|450109999|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
125131523|NCT00272779|450110000|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
125131524|NCT00272779|450109999|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
125131525|NCT00272779|450110000|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
125131526|NCT00272779|450109999|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
125131527|NCT00272779|450110000|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
125131528|NCT00272779|450109999|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
125217517|NCT03092791|450423569|FG002|Overall Study|Reason Not Specified|0|||
125217518|NCT03092791|450423570|FG003|Overall Study|Reason Not Specified|0|||
125217519|NCT03092791|450423571|FG004|Overall Study|Reason Not Specified|1|||
125033987|NCT02901431|449743907|FG010|PK Part|Discontinued per Sponsor|0|||
125033988|NCT02901431|449743908|FG011|PK Part|Discontinued per Sponsor|0|||
125033989|NCT02901431|449743909|FG012|PK Part|Discontinued per Sponsor|0|||
125033990|NCT02901431|449743897|FG000|PK Part|Withdrawal by Subject|1|||
124969756|NCT03721172|449517491|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
124969757|NCT03721172|449517489|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
124969758|NCT03721172|449517490|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
124969759|NCT03721172|449517491|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
124969760|NCT03721172|449517489|FG000|Apremilast Extension Phase|Protocol Violation|0|||
124969761|NCT03721172|449517490|FG001|Apremilast Extension Phase|Protocol Violation|0|||
124969762|NCT03721172|449517491|FG002|Apremilast Extension Phase|Protocol Violation|1|||
124969763|NCT03721172|449517489|FG000|Apremilast Extension Phase|Physician Decision|0|||
124969764|NCT03721172|449517490|FG001|Apremilast Extension Phase|Physician Decision|0|||
124969765|NCT03721172|449517491|FG002|Apremilast Extension Phase|Physician Decision|1|||
124969766|NCT03721172|449517489|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
124969767|NCT03721172|449517490|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
124969768|NCT03721172|449517491|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
124969769|NCT03721172|449517489|FG000|Apremilast Extension Phase|Other|0|||
124969770|NCT03721172|449517490|FG001|Apremilast Extension Phase|Other|0|||
124969771|NCT03721172|449517491|FG002|Apremilast Extension Phase|Other|3|||
124969772|NCT03721172|449517489|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
124969773|NCT03721172|449517490|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
124969774|NCT03721172|449517491|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
124969775|NCT02417441|449517494|FG000|Overall Study|Inconclusive due to missing data|52|||
124969776|NCT02417441|449517495|FG001|Overall Study|Inconclusive due to missing data|19|||
124969777|NCT00983853|449517500|FG000|Overall Study|Lost to Follow-up|1|||
124969778|NCT00983853|449517501|FG001|Overall Study|Lost to Follow-up|1|||
124969779|NCT00983853|449517502|FG002|Overall Study|Lost to Follow-up|2|||
124969780|NCT00983853|449517503|FG003|Overall Study|Lost to Follow-up|2|||
124969781|NCT00983853|449517504|FG004|Overall Study|Lost to Follow-up|2|||
124969782|NCT00983853|449517505|FG005|Overall Study|Lost to Follow-up|1|||
124969783|NCT00983853|449517500|FG000|Overall Study|Withdrawal by Subject|0|||
124969784|NCT00983853|449517501|FG001|Overall Study|Withdrawal by Subject|0|||
124969785|NCT00983853|449517502|FG002|Overall Study|Withdrawal by Subject|1|||
124969786|NCT00983853|449517503|FG003|Overall Study|Withdrawal by Subject|0|||
124969787|NCT00983853|449517504|FG004|Overall Study|Withdrawal by Subject|1|||
125033991|NCT02901431|449743898|FG001|PK Part|Withdrawal by Subject|1|||
125033992|NCT02901431|449743899|FG002|PK Part|Withdrawal by Subject|3|||
125033993|NCT02901431|449743900|FG003|PK Part|Withdrawal by Subject|0|||
125033994|NCT02901431|449743901|FG004|PK Part|Withdrawal by Subject|0|||
125033995|NCT02901431|449743902|FG005|PK Part|Withdrawal by Subject|0|||
125033996|NCT02901431|449743903|FG006|PK Part|Withdrawal by Subject|0|||
125033997|NCT02901431|449743904|FG007|PK Part|Withdrawal by Subject|0|||
125033998|NCT02901431|449743905|FG008|PK Part|Withdrawal by Subject|0|||
125033999|NCT02901431|449743906|FG009|PK Part|Withdrawal by Subject|0|||
125034000|NCT02901431|449743907|FG010|PK Part|Withdrawal by Subject|0|||
125034001|NCT02901431|449743908|FG011|PK Part|Withdrawal by Subject|0|||
125034002|NCT02901431|449743909|FG012|PK Part|Withdrawal by Subject|0|||
125034003|NCT02901431|449743897|FG000|Main Treatment Part|Adverse Event|0|||
125034004|NCT02901431|449743898|FG001|Main Treatment Part|Adverse Event|0|||
125034005|NCT02901431|449743899|FG002|Main Treatment Part|Adverse Event|0|||
125034006|NCT02901431|449743900|FG003|Main Treatment Part|Adverse Event|3|||
125034007|NCT02901431|449743901|FG004|Main Treatment Part|Adverse Event|3|||
125034008|NCT02901431|449743902|FG005|Main Treatment Part|Adverse Event|4|||
125217520|NCT03092791|450423572|FG005|Overall Study|Reason Not Specified|1|||
125217521|NCT03092791|450423573|FG006|Overall Study|Reason Not Specified|0|||
125217522|NCT03092791|450423574|FG007|Overall Study|Reason Not Specified|0|||
125217523|NCT00980655|450423576|FG000|Overall Study|Adverse Event|13|||
125217524|NCT00980655|450423577|FG001|Overall Study|Adverse Event|31|||
125217525|NCT00980655|450423576|FG000|Overall Study|Death|0|||
125217526|NCT00980655|450423577|FG001|Overall Study|Death|7|||
125217527|NCT00980655|450423576|FG000|Overall Study|Protocol Violation|2|||
125217528|NCT00980655|450423577|FG001|Overall Study|Protocol Violation|7|||
125217529|NCT00980655|450423576|FG000|Overall Study|Withdrawal by Subject|0|||
125217530|NCT00980655|450423577|FG001|Overall Study|Withdrawal by Subject|4|||
125217531|NCT00980655|450423576|FG000|Overall Study|Lost to Follow-up|0|||
124969788|NCT00983853|449517505|FG005|Overall Study|Withdrawal by Subject|0|||
124969789|NCT00983853|449517500|FG000|Overall Study|Unable to come to study follow-up visits|0|||
124969790|NCT00983853|449517501|FG001|Overall Study|Unable to come to study follow-up visits|1|||
124969791|NCT00983853|449517502|FG002|Overall Study|Unable to come to study follow-up visits|0|||
124969792|NCT00983853|449517503|FG003|Overall Study|Unable to come to study follow-up visits|0|||
125034009|NCT02901431|449743903|FG006|Main Treatment Part|Adverse Event|1|||
125034010|NCT02901431|449743904|FG007|Main Treatment Part|Adverse Event|0|||
125034011|NCT02901431|449743905|FG008|Main Treatment Part|Adverse Event|0|||
125034012|NCT02901431|449743906|FG009|Main Treatment Part|Adverse Event|0|||
125034013|NCT02901431|449743907|FG010|Main Treatment Part|Adverse Event|0|||
125034014|NCT02901431|449743908|FG011|Main Treatment Part|Adverse Event|0|||
125034015|NCT02901431|449743909|FG012|Main Treatment Part|Adverse Event|0|||
125034016|NCT02901431|449743897|FG000|Main Treatment Part|Lack of Efficacy|0|||
125034017|NCT02901431|449743898|FG001|Main Treatment Part|Lack of Efficacy|0|||
125034018|NCT02901431|449743899|FG002|Main Treatment Part|Lack of Efficacy|0|||
125217532|NCT00980655|450423577|FG001|Overall Study|Lost to Follow-up|1|||
125217533|NCT00980655|450423576|FG000|Overall Study|Parent/legal guardian request|1|||
125217534|NCT00980655|450423577|FG001|Overall Study|Parent/legal guardian request|0|||
125034019|NCT02901431|449743900|FG003|Main Treatment Part|Lack of Efficacy|1|||
125034020|NCT02901431|449743901|FG004|Main Treatment Part|Lack of Efficacy|0|||
125034021|NCT02901431|449743902|FG005|Main Treatment Part|Lack of Efficacy|0|||
125034022|NCT02901431|449743903|FG006|Main Treatment Part|Lack of Efficacy|0|||
125034023|NCT02901431|449743904|FG007|Main Treatment Part|Lack of Efficacy|0|||
125034024|NCT02901431|449743905|FG008|Main Treatment Part|Lack of Efficacy|0|||
125034025|NCT02901431|449743906|FG009|Main Treatment Part|Lack of Efficacy|0|||
125034026|NCT02901431|449743907|FG010|Main Treatment Part|Lack of Efficacy|0|||
125034027|NCT02901431|449743908|FG011|Main Treatment Part|Lack of Efficacy|0|||
125034028|NCT02901431|449743909|FG012|Main Treatment Part|Lack of Efficacy|0|||
125034029|NCT02901431|449743897|FG000|Main Treatment Part|Lost to Follow-up|0|||
125034030|NCT02901431|449743898|FG001|Main Treatment Part|Lost to Follow-up|0|||
125034031|NCT02901431|449743899|FG002|Main Treatment Part|Lost to Follow-up|0|||
125034032|NCT02901431|449743900|FG003|Main Treatment Part|Lost to Follow-up|3|||
125034033|NCT02901431|449743901|FG004|Main Treatment Part|Lost to Follow-up|1|||
125034034|NCT02901431|449743902|FG005|Main Treatment Part|Lost to Follow-up|2|||
125034035|NCT02901431|449743903|FG006|Main Treatment Part|Lost to Follow-up|3|||
125034036|NCT02901431|449743904|FG007|Main Treatment Part|Lost to Follow-up|0|||
125034037|NCT02901431|449743905|FG008|Main Treatment Part|Lost to Follow-up|0|||
125034038|NCT02901431|449743906|FG009|Main Treatment Part|Lost to Follow-up|0|||
125034039|NCT02901431|449743907|FG010|Main Treatment Part|Lost to Follow-up|0|||
125034040|NCT02901431|449743908|FG011|Main Treatment Part|Lost to Follow-up|0|||
125034041|NCT02901431|449743909|FG012|Main Treatment Part|Lost to Follow-up|0|||
125034042|NCT02901431|449743897|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
125034043|NCT02901431|449743898|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
125034044|NCT02901431|449743899|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
125034045|NCT02901431|449743900|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
125034046|NCT02901431|449743901|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
125034047|NCT02901431|449743902|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
125034048|NCT02901431|449743903|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
125034049|NCT02901431|449743904|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
125034050|NCT02901431|449743905|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
125034051|NCT02901431|449743906|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
125034052|NCT02901431|449743907|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
125034053|NCT02901431|449743908|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
125034054|NCT02901431|449743909|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
125034055|NCT02901431|449743897|FG000|Main Treatment Part|Physician Decision|0|||
125034056|NCT02901431|449743898|FG001|Main Treatment Part|Physician Decision|0|||
125034057|NCT02901431|449743899|FG002|Main Treatment Part|Physician Decision|0|||
125034058|NCT02901431|449743900|FG003|Main Treatment Part|Physician Decision|1|||
125034059|NCT02901431|449743901|FG004|Main Treatment Part|Physician Decision|0|||
125034060|NCT02901431|449743902|FG005|Main Treatment Part|Physician Decision|0|||
125034061|NCT02901431|449743903|FG006|Main Treatment Part|Physician Decision|1|||
125034062|NCT02901431|449743904|FG007|Main Treatment Part|Physician Decision|0|||
125034063|NCT02901431|449743905|FG008|Main Treatment Part|Physician Decision|0|||
125034064|NCT02901431|449743906|FG009|Main Treatment Part|Physician Decision|0|||
125034065|NCT02901431|449743907|FG010|Main Treatment Part|Physician Decision|0|||
125034066|NCT02901431|449743908|FG011|Main Treatment Part|Physician Decision|0|||
125034067|NCT02901431|449743909|FG012|Main Treatment Part|Physician Decision|0|||
125034068|NCT02901431|449743897|FG000|Main Treatment Part|Withdrawal by Subject|0|||
125034069|NCT02901431|449743898|FG001|Main Treatment Part|Withdrawal by Subject|0|||
125034070|NCT02901431|449743899|FG002|Main Treatment Part|Withdrawal by Subject|0|||
125034071|NCT02901431|449743900|FG003|Main Treatment Part|Withdrawal by Subject|18|||
125034072|NCT02901431|449743901|FG004|Main Treatment Part|Withdrawal by Subject|3|||
125034073|NCT02901431|449743902|FG005|Main Treatment Part|Withdrawal by Subject|5|||
125034074|NCT02901431|449743903|FG006|Main Treatment Part|Withdrawal by Subject|6|||
125034075|NCT02901431|449743904|FG007|Main Treatment Part|Withdrawal by Subject|0|||
125034076|NCT02901431|449743905|FG008|Main Treatment Part|Withdrawal by Subject|0|||
125034077|NCT02901431|449743906|FG009|Main Treatment Part|Withdrawal by Subject|0|||
125034078|NCT02901431|449743907|FG010|Main Treatment Part|Withdrawal by Subject|0|||
125034079|NCT02901431|449743908|FG011|Main Treatment Part|Withdrawal by Subject|0|||
125034080|NCT02901431|449743909|FG012|Main Treatment Part|Withdrawal by Subject|0|||
125034081|NCT02901431|449743897|FG000|Open Label Part|Adverse Event|0|||
125034082|NCT02901431|449743898|FG001|Open Label Part|Adverse Event|0|||
125034083|NCT02901431|449743899|FG002|Open Label Part|Adverse Event|0|||
125034084|NCT02901431|449743900|FG003|Open Label Part|Adverse Event|0|||
125034085|NCT02901431|449743901|FG004|Open Label Part|Adverse Event|0|||
125034086|NCT02901431|449743902|FG005|Open Label Part|Adverse Event|0|||
125034087|NCT02901431|449743903|FG006|Open Label Part|Adverse Event|0|||
125034088|NCT02901431|449743904|FG007|Open Label Part|Adverse Event|0|||
125034089|NCT02901431|449743905|FG008|Open Label Part|Adverse Event|4|||
125034090|NCT02901431|449743906|FG009|Open Label Part|Adverse Event|4|||
125034091|NCT02901431|449743907|FG010|Open Label Part|Adverse Event|0|||
125034092|NCT02901431|449743908|FG011|Open Label Part|Adverse Event|4|||
125034093|NCT02901431|449743909|FG012|Open Label Part|Adverse Event|1|||
125034094|NCT02901431|449743897|FG000|Open Label Part|Lost to Follow-up|0|||
125034095|NCT02901431|449743898|FG001|Open Label Part|Lost to Follow-up|0|||
125034096|NCT02901431|449743899|FG002|Open Label Part|Lost to Follow-up|0|||
125034097|NCT02901431|449743900|FG003|Open Label Part|Lost to Follow-up|0|||
125034098|NCT02901431|449743901|FG004|Open Label Part|Lost to Follow-up|0|||
125034099|NCT02901431|449743902|FG005|Open Label Part|Lost to Follow-up|0|||
125034100|NCT02901431|449743903|FG006|Open Label Part|Lost to Follow-up|0|||
125034101|NCT02901431|449743904|FG007|Open Label Part|Lost to Follow-up|0|||
125034102|NCT02901431|449743905|FG008|Open Label Part|Lost to Follow-up|2|||
125034103|NCT02901431|449743906|FG009|Open Label Part|Lost to Follow-up|2|||
125034104|NCT02901431|449743907|FG010|Open Label Part|Lost to Follow-up|1|||
125034105|NCT02901431|449743908|FG011|Open Label Part|Lost to Follow-up|1|||
125034106|NCT02901431|449743909|FG012|Open Label Part|Lost to Follow-up|1|||
125034107|NCT02901431|449743897|FG000|Open Label Part|Physician Decision|0|||
125034108|NCT02901431|449743898|FG001|Open Label Part|Physician Decision|0|||
125034109|NCT02901431|449743899|FG002|Open Label Part|Physician Decision|0|||
125034110|NCT02901431|449743900|FG003|Open Label Part|Physician Decision|0|||
125034111|NCT02901431|449743901|FG004|Open Label Part|Physician Decision|0|||
125034112|NCT02901431|449743902|FG005|Open Label Part|Physician Decision|0|||
125034113|NCT02901431|449743903|FG006|Open Label Part|Physician Decision|0|||
125034114|NCT02901431|449743904|FG007|Open Label Part|Physician Decision|0|||
125034115|NCT02901431|449743905|FG008|Open Label Part|Physician Decision|1|||
125034116|NCT02901431|449743906|FG009|Open Label Part|Physician Decision|1|||
125034117|NCT02901431|449743907|FG010|Open Label Part|Physician Decision|0|||
125034118|NCT02901431|449743908|FG011|Open Label Part|Physician Decision|0|||
125034119|NCT02901431|449743909|FG012|Open Label Part|Physician Decision|0|||
125034120|NCT02901431|449743897|FG000|Open Label Part|Study Terminated By Sponsor|0|||
125034121|NCT02901431|449743898|FG001|Open Label Part|Study Terminated By Sponsor|0|||
125034122|NCT02901431|449743899|FG002|Open Label Part|Study Terminated By Sponsor|0|||
125131529|NCT00272779|450110000|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
125131530|NCT00272779|450109999|FG000|Baseline Through Week 48|Continuing treatment|385|||
125131531|NCT00272779|450110000|FG001|Baseline Through Week 48|Continuing treatment|368|||
125131532|NCT00272779|450109999|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
125131533|NCT00272779|450110000|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
125131534|NCT00272779|450109999|FG000|Baseline Through Week 48|Never treated|2|||
125131535|NCT00272779|450110000|FG001|Baseline Through Week 48|Never treated|3|||
125034123|NCT02901431|449743900|FG003|Open Label Part|Study Terminated By Sponsor|0|||
125034124|NCT02901431|449743901|FG004|Open Label Part|Study Terminated By Sponsor|0|||
125034125|NCT02901431|449743902|FG005|Open Label Part|Study Terminated By Sponsor|0|||
125217535|NCT00980655|450423576|FG000|Overall Study|Other|0|||
125217536|NCT00980655|450423577|FG001|Overall Study|Other|1|||
125217537|NCT01124292|450423581|FG000|Overall Study|Lost to Follow-up|2|||
125217538|NCT01124292|450423582|FG001|Overall Study|Lost to Follow-up|4|||
125217539|NCT01124292|450423583|FG002|Overall Study|Lost to Follow-up|3|||
125217540|NCT01124292|450423581|FG000|Overall Study|Physician Decision|0|||
125217541|NCT01124292|450423582|FG001|Overall Study|Physician Decision|3|||
125217542|NCT01124292|450423583|FG002|Overall Study|Physician Decision|2|||
125217543|NCT01124292|450423581|FG000|Overall Study|Withdrawal by Subject|0|||
125217544|NCT01124292|450423582|FG001|Overall Study|Withdrawal by Subject|6|||
125217545|NCT01124292|450423583|FG002|Overall Study|Withdrawal by Subject|2|||
125217546|NCT01124292|450423581|FG000|Overall Study|medical issue unrelated to the study|0|||
125217547|NCT01124292|450423582|FG001|Overall Study|medical issue unrelated to the study|0|||
125217548|NCT01124292|450423583|FG002|Overall Study|medical issue unrelated to the study|2|||
125217549|NCT01124292|450423581|FG000|Overall Study|piercing track closed|0|||
125217550|NCT01124292|450423582|FG001|Overall Study|piercing track closed|2|||
125217551|NCT01124292|450423583|FG002|Overall Study|piercing track closed|1|||
125217552|NCT03373461|450423584|FG000|Part 2|Adverse Event|0|||
125217553|NCT03373461|450423585|FG001|Part 2|Adverse Event|1|||
125217554|NCT03373461|450423586|FG002|Part 2|Adverse Event|0|||
125217555|NCT03373461|450423587|FG003|Part 2|Adverse Event|0|||
125217556|NCT03373461|450423588|FG004|Part 2|Adverse Event|1|||
125217557|NCT03300180|450423589|FG000|Baseline|Withdrawal by Subject|4|||
125217558|NCT03300180|450423590|FG001|Baseline|Withdrawal by Subject|6|||
125217559|NCT03300180|450423591|FG002|Baseline|Withdrawal by Subject|4|||
125217560|NCT03300180|450423589|FG000|6 Month Outcome|Withdrawal by Subject|12|||
125217561|NCT03300180|450423590|FG001|6 Month Outcome|Withdrawal by Subject|12|||
125217562|NCT03300180|450423591|FG002|6 Month Outcome|Withdrawal by Subject|19|||
124969793|NCT00983853|449517504|FG004|Overall Study|Unable to come to study follow-up visits|0|||
124969794|NCT00983853|449517505|FG005|Overall Study|Unable to come to study follow-up visits|0|||
124969795|NCT02947100|449517510|FG000|Overall Study|study terminated early|3|||
124969796|NCT02947100|449517510|FG000|Overall Study|did not meet inclusion criteria|1|||
124969797|NCT02402322|449517511|FG000|Pretreatment|Withdrawal by Subject|3|||
124969798|NCT02402322|449517512|FG001|Pretreatment|Withdrawal by Subject|1|||
124969799|NCT02402322|449517513|FG002|Pretreatment|Withdrawal by Subject|1|||
124969800|NCT02402322|449517511|FG000|Follow-up|Withdrawal by Subject|6|||
124969801|NCT02402322|449517512|FG001|Follow-up|Withdrawal by Subject|3|||
124969802|NCT02402322|449517513|FG002|Follow-up|Withdrawal by Subject|24|||
124969803|NCT02472145|449517516|FG000|Overall Study|Death|10|||
124969804|NCT02472145|449517517|FG001|Overall Study|Death|101|||
124969805|NCT02472145|449517518|FG002|Overall Study|Death|99|||
124969806|NCT02472145|449517516|FG000|Overall Study|Lost to Follow-up|0|||
124969807|NCT02472145|449517517|FG001|Overall Study|Lost to Follow-up|1|||
124969808|NCT02472145|449517518|FG002|Overall Study|Lost to Follow-up|0|||
124969809|NCT02472145|449517516|FG000|Overall Study|Withdrawal by Subject|0|||
124969810|NCT02472145|449517517|FG001|Overall Study|Withdrawal by Subject|9|||
124969811|NCT02472145|449517518|FG002|Overall Study|Withdrawal by Subject|13|||
124969812|NCT02472145|449517516|FG000|Overall Study|Sponsor decision|0|||
124969813|NCT02472145|449517517|FG001|Overall Study|Sponsor decision|3|||
124969814|NCT02472145|449517518|FG002|Overall Study|Sponsor decision|2|||
124969815|NCT02472145|449517516|FG000|Overall Study|Other|0|||
124969816|NCT02472145|449517517|FG001|Overall Study|Other|45|||
124969817|NCT02472145|449517518|FG002|Overall Study|Other|43|||
124969818|NCT01080326|449517519|FG000|Overall Study|Patient deterioration prior to procedure|3|||
124969819|NCT01080326|449517519|FG000|Overall Study|Surgeon decision|1|||
124969820|NCT01318876|449517520|FG000|Day 8 Survey|email address invalid|96|||
124969821|NCT01318876|449517520|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
124969822|NCT01318876|449517520|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
124969823|NCT01296555|449517521|FG000|Overall Study|Adverse Event|0|||
124969824|NCT01296555|449517522|FG001|Overall Study|Adverse Event|0|||
124969825|NCT01296555|449517523|FG002|Overall Study|Adverse Event|1|||
124969826|NCT01296555|449517524|FG003|Overall Study|Adverse Event|1|||
125217563|NCT03300180|450423589|FG000|6 Month Outcome|Death|2|||
125217564|NCT03300180|450423590|FG001|6 Month Outcome|Death|4|||
124969827|NCT01296555|449517525|FG004|Overall Study|Adverse Event|2|||
124969828|NCT01296555|449517526|FG005|Overall Study|Adverse Event|4|||
124969829|NCT01296555|449517527|FG006|Overall Study|Adverse Event|1|||
124969830|NCT01296555|449517528|FG007|Overall Study|Adverse Event|4|||
125217565|NCT03300180|450423591|FG002|6 Month Outcome|Death|3|||
125217566|NCT03300180|450423589|FG000|6 Month Outcome|Missed Assessment|43|||
125217567|NCT03300180|450423590|FG001|6 Month Outcome|Missed Assessment|52|||
125217568|NCT03300180|450423591|FG002|6 Month Outcome|Missed Assessment|46|||
125217569|NCT03300180|450423589|FG000|12 Month Outcome|Withdrawal by Subject|3|||
125217570|NCT03300180|450423590|FG001|12 Month Outcome|Withdrawal by Subject|6|||
125217571|NCT03300180|450423591|FG002|12 Month Outcome|Withdrawal by Subject|6|||
124969831|NCT01296555|449517529|FG008|Overall Study|Adverse Event|3|||
124969832|NCT01296555|449517530|FG009|Overall Study|Adverse Event|1|||
124969833|NCT01296555|449517531|FG010|Overall Study|Adverse Event|0|||
124969834|NCT01296555|449517532|FG011|Overall Study|Adverse Event|4|||
125034126|NCT02901431|449743903|FG006|Open Label Part|Study Terminated By Sponsor|0|||
125034127|NCT02901431|449743904|FG007|Open Label Part|Study Terminated By Sponsor|0|||
125034128|NCT02901431|449743905|FG008|Open Label Part|Study Terminated By Sponsor|35|||
125034129|NCT02901431|449743906|FG009|Open Label Part|Study Terminated By Sponsor|12|||
125034130|NCT02901431|449743907|FG010|Open Label Part|Study Terminated By Sponsor|21|||
125034131|NCT02901431|449743908|FG011|Open Label Part|Study Terminated By Sponsor|31|||
125034132|NCT02901431|449743909|FG012|Open Label Part|Study Terminated By Sponsor|0|||
125034133|NCT02901431|449743897|FG000|Open Label Part|Withdrawal by Subject|0|||
125034134|NCT02901431|449743898|FG001|Open Label Part|Withdrawal by Subject|0|||
125034135|NCT02901431|449743899|FG002|Open Label Part|Withdrawal by Subject|0|||
125034136|NCT02901431|449743900|FG003|Open Label Part|Withdrawal by Subject|0|||
125034137|NCT02901431|449743901|FG004|Open Label Part|Withdrawal by Subject|0|||
125034138|NCT02901431|449743902|FG005|Open Label Part|Withdrawal by Subject|0|||
125034139|NCT02901431|449743903|FG006|Open Label Part|Withdrawal by Subject|0|||
125034140|NCT02901431|449743904|FG007|Open Label Part|Withdrawal by Subject|0|||
125034141|NCT02901431|449743905|FG008|Open Label Part|Withdrawal by Subject|6|||
125034142|NCT02901431|449743906|FG009|Open Label Part|Withdrawal by Subject|5|||
125034143|NCT02901431|449743907|FG010|Open Label Part|Withdrawal by Subject|7|||
125034144|NCT02901431|449743908|FG011|Open Label Part|Withdrawal by Subject|3|||
125034145|NCT02901431|449743909|FG012|Open Label Part|Withdrawal by Subject|1|||
125034146|NCT04223609|449743912|FG000|Overall Study|Adverse Event|0|||
125034147|NCT04223609|449743913|FG001|Overall Study|Adverse Event|1|||
125034148|NCT04223609|449743912|FG000|Overall Study|Missed last visit|0|||
125034149|NCT04223609|449743913|FG001|Overall Study|Missed last visit|1|||
125034150|NCT01275222|449743916|FG000|Phase l by Treatment|Adverse Event|1|||
125034151|NCT01275222|449743917|FG001|Phase l by Treatment|Adverse Event|4|||
125034152|NCT01275222|449743918|FG002|Phase l by Treatment|Adverse Event|2|||
125034153|NCT01275222|449743919|FG003|Phase l by Treatment|Adverse Event|3|||
125034154|NCT01275222|449743920|FG004|Phase l by Treatment|Adverse Event|0|||
125034155|NCT01275222|449743921|FG005|Phase l by Treatment|Adverse Event|0|||
125034156|NCT01275222|449743916|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
125034157|NCT01275222|449743917|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
125034158|NCT01275222|449743918|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
125034159|NCT01275222|449743919|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
125034160|NCT01275222|449743920|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
125034161|NCT01275222|449743921|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
125034162|NCT01275222|449743916|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
125034163|NCT01275222|449743917|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
125034164|NCT01275222|449743918|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
125034165|NCT01275222|449743919|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
125034166|NCT01275222|449743920|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
125034167|NCT01275222|449743921|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
125034168|NCT01275222|449743916|FG000|Phase l by Treatment|Disease progression|12|||
125034169|NCT01275222|449743917|FG001|Phase l by Treatment|Disease progression|8|||
125034170|NCT01275222|449743918|FG002|Phase l by Treatment|Disease progression|2|||
125034171|NCT01275222|449743919|FG003|Phase l by Treatment|Disease progression|5|||
125034172|NCT01275222|449743920|FG004|Phase l by Treatment|Disease progression|0|||
125034173|NCT01275222|449743921|FG005|Phase l by Treatment|Disease progression|0|||
125034174|NCT01275222|449743916|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
125034175|NCT01275222|449743917|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
125034176|NCT01275222|449743918|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
125034177|NCT01275222|449743919|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
125034178|NCT01275222|449743920|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
125034179|NCT01275222|449743921|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
125034180|NCT01275222|449743916|FG000|Phase l by Treatment|Death|0|||
125034181|NCT01275222|449743917|FG001|Phase l by Treatment|Death|1|||
125034182|NCT01275222|449743918|FG002|Phase l by Treatment|Death|0|||
125034183|NCT01275222|449743919|FG003|Phase l by Treatment|Death|1|||
125034184|NCT01275222|449743920|FG004|Phase l by Treatment|Death|0|||
125131536|NCT00272779|450109999|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
125131537|NCT00272779|450110000|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
125131538|NCT00272779|450109999|FG000|Baseline Through Week 96|Death before Week 96|6|||
125131539|NCT00272779|450110000|FG001|Baseline Through Week 96|Death before Week 96|5|||
125034185|NCT01275222|449743921|FG005|Phase l by Treatment|Death|0|||
125034186|NCT01275222|449743916|FG000|Phase ll by Stratum|Adverse Event|0|||
125034187|NCT01275222|449743917|FG001|Phase ll by Stratum|Adverse Event|0|||
125131540|NCT00272779|450109999|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
125034188|NCT01275222|449743918|FG002|Phase ll by Stratum|Adverse Event|0|||
125034189|NCT01275222|449743919|FG003|Phase ll by Stratum|Adverse Event|0|||
125034190|NCT01275222|449743920|FG004|Phase ll by Stratum|Adverse Event|2|||
125034191|NCT01275222|449743921|FG005|Phase ll by Stratum|Adverse Event|10|||
125034192|NCT01275222|449743916|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
125034193|NCT01275222|449743917|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
125034194|NCT01275222|449743918|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
125034195|NCT01275222|449743919|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
125034196|NCT01275222|449743920|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
125034197|NCT01275222|449743921|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
125034198|NCT01275222|449743916|FG000|Phase ll by Stratum|Disease progression|0|||
125034199|NCT01275222|449743917|FG001|Phase ll by Stratum|Disease progression|0|||
125034200|NCT01275222|449743918|FG002|Phase ll by Stratum|Disease progression|0|||
125034201|NCT01275222|449743919|FG003|Phase ll by Stratum|Disease progression|0|||
125034202|NCT01275222|449743920|FG004|Phase ll by Stratum|Disease progression|23|||
125034203|NCT01275222|449743921|FG005|Phase ll by Stratum|Disease progression|31|||
125034204|NCT01275222|449743916|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
125034205|NCT01275222|449743917|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
125034206|NCT01275222|449743918|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
125034207|NCT01275222|449743919|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
125034208|NCT01275222|449743920|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
125034209|NCT01275222|449743921|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
125034210|NCT01275222|449743916|FG000|Phase ll by Stratum|Death|0|||
125034211|NCT01275222|449743917|FG001|Phase ll by Stratum|Death|0|||
125034212|NCT01275222|449743918|FG002|Phase ll by Stratum|Death|0|||
125034213|NCT01275222|449743919|FG003|Phase ll by Stratum|Death|0|||
125034214|NCT01275222|449743920|FG004|Phase ll by Stratum|Death|1|||
125034215|NCT01275222|449743921|FG005|Phase ll by Stratum|Death|1|||
125034216|NCT03440944|449743922|FG000|Overall Study|Physician Decision|1|||
125034217|NCT03440944|449743923|FG001|Overall Study|Physician Decision|0|||
125034218|NCT03440944|449743922|FG000|Overall Study|No Acceptable Vasculature|0|||
125034219|NCT03440944|449743923|FG001|Overall Study|No Acceptable Vasculature|1|||
125034220|NCT00484315|449743924|FG000|12-Month Clinical Follow-up|Death|6|||
125034221|NCT00484315|449743925|FG001|12-Month Clinical Follow-up|Death|2|||
125034222|NCT00484315|449743924|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
125034223|NCT00484315|449743925|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
125034224|NCT00484315|449743924|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
125034225|NCT00484315|449743925|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
125034226|NCT00484315|449743924|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
125034227|NCT00484315|449743925|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
125034228|NCT00484315|449743924|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
125034229|NCT00484315|449743925|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
125034230|NCT00484315|449743924|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
125034231|NCT00484315|449743925|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
125034232|NCT00484315|449743924|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
125034233|NCT00484315|449743925|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
125034234|NCT00943683|449743926|FG000|Overall Study|Adverse Event|3|||
125034235|NCT00943683|449743927|FG001|Overall Study|Adverse Event|3|||
125034236|NCT00943683|449743926|FG000|Overall Study|Lost to Follow-up|1|||
125034237|NCT00943683|449743927|FG001|Overall Study|Lost to Follow-up|1|||
125034238|NCT00943683|449743926|FG000|Overall Study|Protocol Violation|1|||
125034239|NCT00943683|449743927|FG001|Overall Study|Protocol Violation|2|||
125034240|NCT00943683|449743926|FG000|Overall Study|Withdrawal by Subject|1|||
125034241|NCT00943683|449743927|FG001|Overall Study|Withdrawal by Subject|0|||
125034242|NCT00943683|449743926|FG000|Overall Study|Patient Moved|1|||
125034243|NCT00943683|449743927|FG001|Overall Study|Patient Moved|0|||
125034244|NCT04672083|449743928|FG000|Overall Study|Lost to Follow-up|1|||
125034245|NCT04672083|449743929|FG001|Overall Study|Lost to Follow-up|0|||
125034246|NCT04672083|449743930|FG002|Overall Study|Lost to Follow-up|0|||
125034247|NCT04672083|449743931|FG003|Overall Study|Lost to Follow-up|0|||
125034248|NCT04672083|449743932|FG004|Overall Study|Lost to Follow-up|0|||
125034249|NCT02500537|449743933|FG000|Overall Study|Death|2|||
125034250|NCT02500537|449743934|FG001|Overall Study|Death|0|||
125034251|NCT02500537|449743933|FG000|Overall Study|Lost to Follow-up|0|||
125034252|NCT02500537|449743934|FG001|Overall Study|Lost to Follow-up|1|||
125034253|NCT02500537|449743933|FG000|Overall Study|Withdrawal by Subject|1|||
125034254|NCT02500537|449743934|FG001|Overall Study|Withdrawal by Subject|0|||
125034255|NCT01551745|449743935|FG000|Overall Study|Withdrawal by Subject|1|||
125131541|NCT00272779|450110000|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
125131542|NCT00272779|450109999|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
125131543|NCT00272779|450110000|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
125034256|NCT01551745|449743935|FG000|Overall Study|Disease Progression|2|||
125034257|NCT01661790|449743936|FG000|Overall Study|Lost to Follow-up|0|||
125034258|NCT01661790|449743937|FG001|Overall Study|Lost to Follow-up|2|||
125034259|NCT02048904|449743940|FG000|Overall Study|Withdrawal by Subject|7|||
125034260|NCT02048904|449743940|FG000|Overall Study|Physician Decision|70|||
125034261|NCT00784758|449743950|FG000|Overall Study|Withdrawal by Subject|3|||
125034262|NCT00784758|449743951|FG001|Overall Study|Withdrawal by Subject|0|||
125034263|NCT00784758|449743950|FG000|Overall Study|Adverse Event|1|||
125034264|NCT00784758|449743951|FG001|Overall Study|Adverse Event|0|||
125217572|NCT03300180|450423589|FG000|12 Month Outcome|Death|9|||
125217573|NCT03300180|450423590|FG001|12 Month Outcome|Death|6|||
125217574|NCT03300180|450423591|FG002|12 Month Outcome|Death|6|||
125217575|NCT03300180|450423589|FG000|12 Month Outcome|Missed Assessment|62|||
125217576|NCT03300180|450423590|FG001|12 Month Outcome|Missed Assessment|59|||
125217577|NCT03300180|450423591|FG002|12 Month Outcome|Missed Assessment|58|||
125217578|NCT03300180|450423589|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
125217579|NCT03300180|450423590|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
125217580|NCT03300180|450423591|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
125217581|NCT03300180|450423589|FG000|18 Month Outcome Assessment|Death|8|||
125217582|NCT03300180|450423590|FG001|18 Month Outcome Assessment|Death|5|||
125217583|NCT03300180|450423591|FG002|18 Month Outcome Assessment|Death|5|||
125217584|NCT03300180|450423589|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
125217585|NCT03300180|450423590|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
125217586|NCT03300180|450423591|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
125217587|NCT03300180|450423589|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
125217588|NCT03300180|450423590|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
125217589|NCT03300180|450423591|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
125217590|NCT03300180|450423589|FG000|24 Month Outcome Assessment|Death|13|||
125217591|NCT03300180|450423590|FG001|24 Month Outcome Assessment|Death|13|||
125217592|NCT03300180|450423591|FG002|24 Month Outcome Assessment|Death|3|||
125217593|NCT03300180|450423589|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
125217594|NCT03300180|450423590|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
125217595|NCT03300180|450423591|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
125217596|NCT01941537|450423594|FG000|Overall Study|Lack of Efficacy|1|||
125217597|NCT01941537|450423595|FG001|Overall Study|Lack of Efficacy|2|||
125217598|NCT01941537|450423594|FG000|Overall Study|Lost to Follow-up|1|||
125217599|NCT01941537|450423595|FG001|Overall Study|Lost to Follow-up|0|||
125217600|NCT01941537|450423594|FG000|Overall Study|Pregnancy|1|||
125217601|NCT01941537|450423595|FG001|Overall Study|Pregnancy|0|||
125217602|NCT01941537|450423594|FG000|Overall Study|Adverse Event|1|||
125217603|NCT01941537|450423595|FG001|Overall Study|Adverse Event|0|||
125217604|NCT01941537|450423594|FG000|Overall Study|Withdrawal by Subject|0|||
125217605|NCT01941537|450423595|FG001|Overall Study|Withdrawal by Subject|1|||
125217606|NCT02557516|450423597|FG000|Overall Study|Adverse Event|1|||
125217607|NCT02557516|450423598|FG001|Overall Study|Adverse Event|0|||
125217608|NCT02557516|450423599|FG002|Overall Study|Adverse Event|2|||
124969835|NCT01296555|449517533|FG012|Overall Study|Adverse Event|1|||
124969836|NCT01296555|449517534|FG013|Overall Study|Adverse Event|4|||
124969837|NCT01296555|449517535|FG014|Overall Study|Adverse Event|0|||
124969838|NCT01296555|449517536|FG015|Overall Study|Adverse Event|0|||
124969839|NCT01296555|449517537|FG016|Overall Study|Adverse Event|0|||
124969840|NCT01296555|449517538|FG017|Overall Study|Adverse Event|0|||
124969841|NCT01296555|449517539|FG018|Overall Study|Adverse Event|0|||
124969842|NCT01296555|449517540|FG019|Overall Study|Adverse Event|1|||
124969843|NCT01296555|449517541|FG020|Overall Study|Adverse Event|0|||
124969844|NCT01296555|449517542|FG021|Overall Study|Adverse Event|0|||
124969845|NCT01296555|449517543|FG022|Overall Study|Adverse Event|0|||
124969846|NCT01296555|449517544|FG023|Overall Study|Adverse Event|0|||
124969847|NCT01296555|449517545|FG024|Overall Study|Adverse Event|0|||
124969848|NCT01296555|449517546|FG025|Overall Study|Adverse Event|0|||
124969849|NCT01296555|449517547|FG026|Overall Study|Adverse Event|0|||
124969850|NCT01296555|449517548|FG027|Overall Study|Adverse Event|0|||
124969851|NCT01296555|449517549|FG028|Overall Study|Adverse Event|0|||
124969852|NCT01296555|449517521|FG000|Overall Study|Reason Not Specified|0|||
124969853|NCT01296555|449517522|FG001|Overall Study|Reason Not Specified|0|||
124969854|NCT01296555|449517523|FG002|Overall Study|Reason Not Specified|0|||
124969855|NCT01296555|449517524|FG003|Overall Study|Reason Not Specified|0|||
124969856|NCT01296555|449517525|FG004|Overall Study|Reason Not Specified|0|||
124969857|NCT01296555|449517526|FG005|Overall Study|Reason Not Specified|0|||
124969858|NCT01296555|449517527|FG006|Overall Study|Reason Not Specified|0|||
124969859|NCT01296555|449517528|FG007|Overall Study|Reason Not Specified|0|||
124969860|NCT01296555|449517529|FG008|Overall Study|Reason Not Specified|0|||
124969861|NCT01296555|449517530|FG009|Overall Study|Reason Not Specified|0|||
124969862|NCT01296555|449517531|FG010|Overall Study|Reason Not Specified|0|||
124969863|NCT01296555|449517532|FG011|Overall Study|Reason Not Specified|0|||
124969864|NCT01296555|449517533|FG012|Overall Study|Reason Not Specified|0|||
124969865|NCT01296555|449517534|FG013|Overall Study|Reason Not Specified|1|||
124969866|NCT01296555|449517535|FG014|Overall Study|Reason Not Specified|2|||
124969867|NCT01296555|449517536|FG015|Overall Study|Reason Not Specified|3|||
124969868|NCT01296555|449517537|FG016|Overall Study|Reason Not Specified|7|||
124969869|NCT01296555|449517538|FG017|Overall Study|Reason Not Specified|4|||
124969870|NCT01296555|449517539|FG018|Overall Study|Reason Not Specified|3|||
124969871|NCT01296555|449517540|FG019|Overall Study|Reason Not Specified|7|||
124969872|NCT01296555|449517541|FG020|Overall Study|Reason Not Specified|11|||
124969873|NCT01296555|449517542|FG021|Overall Study|Reason Not Specified|5|||
124969874|NCT01296555|449517543|FG022|Overall Study|Reason Not Specified|5|||
124969875|NCT01296555|449517544|FG023|Overall Study|Reason Not Specified|7|||
124969876|NCT01296555|449517545|FG024|Overall Study|Reason Not Specified|2|||
124969877|NCT01296555|449517546|FG025|Overall Study|Reason Not Specified|2|||
124969878|NCT01296555|449517547|FG026|Overall Study|Reason Not Specified|19|||
124969879|NCT01296555|449517548|FG027|Overall Study|Reason Not Specified|11|||
124969880|NCT01296555|449517549|FG028|Overall Study|Reason Not Specified|9|||
124969881|NCT01296555|449517521|FG000|Overall Study|Physician Decision|0|||
124969882|NCT01296555|449517522|FG001|Overall Study|Physician Decision|0|||
124969883|NCT01296555|449517523|FG002|Overall Study|Physician Decision|0|||
124969884|NCT01296555|449517524|FG003|Overall Study|Physician Decision|0|||
124969885|NCT01296555|449517525|FG004|Overall Study|Physician Decision|1|||
124969886|NCT01296555|449517526|FG005|Overall Study|Physician Decision|0|||
124969887|NCT01296555|449517527|FG006|Overall Study|Physician Decision|0|||
124969888|NCT01296555|449517528|FG007|Overall Study|Physician Decision|0|||
124969889|NCT01296555|449517529|FG008|Overall Study|Physician Decision|0|||
124969890|NCT01296555|449517530|FG009|Overall Study|Physician Decision|0|||
124969891|NCT01296555|449517531|FG010|Overall Study|Physician Decision|0|||
124969892|NCT01296555|449517532|FG011|Overall Study|Physician Decision|0|||
124969893|NCT01296555|449517533|FG012|Overall Study|Physician Decision|0|||
124969894|NCT01296555|449517534|FG013|Overall Study|Physician Decision|1|||
124969895|NCT01296555|449517535|FG014|Overall Study|Physician Decision|0|||
124969896|NCT01296555|449517536|FG015|Overall Study|Physician Decision|0|||
124969897|NCT01296555|449517537|FG016|Overall Study|Physician Decision|0|||
124969898|NCT01296555|449517538|FG017|Overall Study|Physician Decision|0|||
124969899|NCT01296555|449517539|FG018|Overall Study|Physician Decision|0|||
124969900|NCT01296555|449517540|FG019|Overall Study|Physician Decision|1|||
124969901|NCT01296555|449517541|FG020|Overall Study|Physician Decision|0|||
124969902|NCT01296555|449517542|FG021|Overall Study|Physician Decision|0|||
124969903|NCT01296555|449517543|FG022|Overall Study|Physician Decision|0|||
124969904|NCT01296555|449517544|FG023|Overall Study|Physician Decision|0|||
124969905|NCT01296555|449517545|FG024|Overall Study|Physician Decision|0|||
124969906|NCT01296555|449517546|FG025|Overall Study|Physician Decision|0|||
124969907|NCT01296555|449517547|FG026|Overall Study|Physician Decision|0|||
124969908|NCT01296555|449517548|FG027|Overall Study|Physician Decision|0|||
124969909|NCT01296555|449517549|FG028|Overall Study|Physician Decision|0|||
124969910|NCT01296555|449517521|FG000|Overall Study|Progressive Disease|6|||
124969911|NCT01296555|449517522|FG001|Overall Study|Progressive Disease|3|||
124969912|NCT01296555|449517523|FG002|Overall Study|Progressive Disease|3|||
124969913|NCT01296555|449517524|FG003|Overall Study|Progressive Disease|7|||
124969914|NCT01296555|449517525|FG004|Overall Study|Progressive Disease|6|||
124969915|NCT01296555|449517526|FG005|Overall Study|Progressive Disease|16|||
124969916|NCT01296555|449517527|FG006|Overall Study|Progressive Disease|16|||
124969917|NCT01296555|449517528|FG007|Overall Study|Progressive Disease|8|||
124969918|NCT01296555|449517529|FG008|Overall Study|Progressive Disease|7|||
124969919|NCT01296555|449517530|FG009|Overall Study|Progressive Disease|18|||
124969920|NCT01296555|449517531|FG010|Overall Study|Progressive Disease|7|||
124969921|NCT01296555|449517532|FG011|Overall Study|Progressive Disease|14|||
124969922|NCT01296555|449517533|FG012|Overall Study|Progressive Disease|5|||
124969923|NCT01296555|449517534|FG013|Overall Study|Progressive Disease|12|||
124969924|NCT01296555|449517535|FG014|Overall Study|Progressive Disease|1|||
124969925|NCT01296555|449517536|FG015|Overall Study|Progressive Disease|1|||
124969926|NCT01296555|449517537|FG016|Overall Study|Progressive Disease|0|||
124969927|NCT01296555|449517538|FG017|Overall Study|Progressive Disease|0|||
124969928|NCT01296555|449517539|FG018|Overall Study|Progressive Disease|0|||
124969929|NCT01296555|449517540|FG019|Overall Study|Progressive Disease|1|||
124969930|NCT01296555|449517541|FG020|Overall Study|Progressive Disease|0|||
124969931|NCT01296555|449517542|FG021|Overall Study|Progressive Disease|0|||
124969932|NCT01296555|449517543|FG022|Overall Study|Progressive Disease|0|||
124969933|NCT01296555|449517544|FG023|Overall Study|Progressive Disease|0|||
124969934|NCT01296555|449517545|FG024|Overall Study|Progressive Disease|1|||
124969935|NCT01296555|449517546|FG025|Overall Study|Progressive Disease|0|||
124969936|NCT01296555|449517547|FG026|Overall Study|Progressive Disease|5|||
125217609|NCT02557516|450423600|FG003|Overall Study|Adverse Event|1|||
125217610|NCT02557516|450423597|FG000|Overall Study|Disease progression|0|||
125217611|NCT02557516|450423598|FG001|Overall Study|Disease progression|2|||
125217612|NCT02557516|450423599|FG002|Overall Study|Disease progression|0|||
125217613|NCT02557516|450423600|FG003|Overall Study|Disease progression|0|||
125217614|NCT02557516|450423597|FG000|Overall Study|Physician Decision|0|||
125217615|NCT02557516|450423598|FG001|Overall Study|Physician Decision|2|||
125217616|NCT02557516|450423599|FG002|Overall Study|Physician Decision|0|||
125217617|NCT02557516|450423600|FG003|Overall Study|Physician Decision|0|||
125217618|NCT02557516|450423597|FG000|Overall Study|Sponsor decision|0|||
124969937|NCT01296555|449517548|FG027|Overall Study|Progressive Disease|1|||
124969938|NCT01296555|449517549|FG028|Overall Study|Progressive Disease|0|||
124969939|NCT01296555|449517521|FG000|Overall Study|Protocol Violation|0|||
124969940|NCT01296555|449517522|FG001|Overall Study|Protocol Violation|0|||
124969941|NCT01296555|449517523|FG002|Overall Study|Protocol Violation|0|||
124969942|NCT01296555|449517524|FG003|Overall Study|Protocol Violation|0|||
125217619|NCT02557516|450423598|FG001|Overall Study|Sponsor decision|1|||
125217620|NCT02557516|450423599|FG002|Overall Study|Sponsor decision|2|||
125217621|NCT02557516|450423600|FG003|Overall Study|Sponsor decision|8|||
125217622|NCT00588146|450425216|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
125217623|NCT00588146|450425217|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
125217624|NCT02823470|450425218|FG000|Overall Study|Adverse Event|1|||
125217625|NCT02823470|450425219|FG001|Overall Study|Adverse Event|0|||
125217626|NCT02823470|450425218|FG000|Overall Study|Study terminated by sponsor|8|||
124969943|NCT01296555|449517525|FG004|Overall Study|Protocol Violation|0|||
124969944|NCT01296555|449517526|FG005|Overall Study|Protocol Violation|0|||
124969945|NCT01296555|449517527|FG006|Overall Study|Protocol Violation|0|||
124969946|NCT01296555|449517528|FG007|Overall Study|Protocol Violation|0|||
124969947|NCT01296555|449517529|FG008|Overall Study|Protocol Violation|0|||
124969948|NCT01296555|449517530|FG009|Overall Study|Protocol Violation|0|||
124969949|NCT01296555|449517531|FG010|Overall Study|Protocol Violation|0|||
124969950|NCT01296555|449517532|FG011|Overall Study|Protocol Violation|0|||
124969951|NCT01296555|449517533|FG012|Overall Study|Protocol Violation|0|||
124969952|NCT01296555|449517534|FG013|Overall Study|Protocol Violation|1|||
124969953|NCT01296555|449517535|FG014|Overall Study|Protocol Violation|0|||
124969954|NCT01296555|449517536|FG015|Overall Study|Protocol Violation|0|||
124969955|NCT01296555|449517537|FG016|Overall Study|Protocol Violation|0|||
124969956|NCT01296555|449517538|FG017|Overall Study|Protocol Violation|0|||
124969957|NCT01296555|449517539|FG018|Overall Study|Protocol Violation|0|||
124969958|NCT01296555|449517540|FG019|Overall Study|Protocol Violation|0|||
124969959|NCT01296555|449517541|FG020|Overall Study|Protocol Violation|0|||
124969960|NCT01296555|449517542|FG021|Overall Study|Protocol Violation|0|||
124969961|NCT01296555|449517543|FG022|Overall Study|Protocol Violation|0|||
124969962|NCT01296555|449517544|FG023|Overall Study|Protocol Violation|0|||
124969963|NCT01296555|449517545|FG024|Overall Study|Protocol Violation|0|||
124969964|NCT01296555|449517546|FG025|Overall Study|Protocol Violation|0|||
124969965|NCT01296555|449517547|FG026|Overall Study|Protocol Violation|0|||
124969966|NCT01296555|449517548|FG027|Overall Study|Protocol Violation|0|||
124969967|NCT01296555|449517549|FG028|Overall Study|Protocol Violation|0|||
125034265|NCT04439123|449743955|FG000|Overall Study|Adverse Event|11|||
125034266|NCT04439123|449743955|FG000|Overall Study|Death|1|||
125034267|NCT04439123|449743955|FG000|Overall Study|Disease progression|19|||
125034268|NCT04439123|449743955|FG000|Overall Study|Withdrawal by Subject|2|||
125034269|NCT04439123|449743955|FG000|Overall Study|Still on treatment|2|||
125034270|NCT02875223|449743956|FG000|Overall Study|Other reasons|0|||
125034271|NCT02875223|449743957|FG001|Overall Study|Other reasons|0|||
125034272|NCT02875223|449743958|FG002|Overall Study|Other reasons|1|||
125034273|NCT02875223|449743959|FG003|Overall Study|Other reasons|0|||
125034274|NCT02875223|449743960|FG004|Overall Study|Other reasons|1|||
125217627|NCT02823470|450425219|FG001|Overall Study|Study terminated by sponsor|15|||
125034275|NCT02875223|449743961|FG005|Overall Study|Other reasons|2|||
125034276|NCT02875223|449743962|FG006|Overall Study|Other reasons|0|||
125034277|NCT02875223|449743963|FG007|Overall Study|Other reasons|2|||
125034278|NCT02875223|449743964|FG008|Overall Study|Other reasons|0|||
125034279|NCT02875223|449743965|FG009|Overall Study|Other reasons|0|||
125034280|NCT02875223|449743966|FG010|Overall Study|Other reasons|0|||
125034281|NCT02875223|449743967|FG011|Overall Study|Other reasons|0|||
125034282|NCT02875223|449743968|FG012|Overall Study|Other reasons|0|||
125034283|NCT02875223|449743956|FG000|Overall Study|Withdrawal by Subject|0|||
125034284|NCT02875223|449743957|FG001|Overall Study|Withdrawal by Subject|0|||
125034285|NCT02875223|449743958|FG002|Overall Study|Withdrawal by Subject|0|||
125034286|NCT02875223|449743959|FG003|Overall Study|Withdrawal by Subject|0|||
125034287|NCT02875223|449743960|FG004|Overall Study|Withdrawal by Subject|1|||
125217628|NCT00463801|450425222|FG000|Overall Study|Protocol Violation|1|||
124969968|NCT01296555|449517521|FG000|Overall Study|Study Terminated By Sponsor|0|||
124969969|NCT01296555|449517522|FG001|Overall Study|Study Terminated By Sponsor|0|||
125217629|NCT00463801|450425222|FG000|Overall Study|Lack of Efficacy|2|||
124969970|NCT01296555|449517523|FG002|Overall Study|Study Terminated By Sponsor|0|||
124969971|NCT01296555|449517524|FG003|Overall Study|Study Terminated By Sponsor|0|||
124969972|NCT01296555|449517525|FG004|Overall Study|Study Terminated By Sponsor|0|||
124969973|NCT01296555|449517526|FG005|Overall Study|Study Terminated By Sponsor|0|||
124969974|NCT01296555|449517527|FG006|Overall Study|Study Terminated By Sponsor|0|||
124969975|NCT01296555|449517528|FG007|Overall Study|Study Terminated By Sponsor|0|||
124969976|NCT01296555|449517529|FG008|Overall Study|Study Terminated By Sponsor|0|||
124969977|NCT01296555|449517530|FG009|Overall Study|Study Terminated By Sponsor|0|||
124969978|NCT01296555|449517531|FG010|Overall Study|Study Terminated By Sponsor|0|||
124969979|NCT01296555|449517532|FG011|Overall Study|Study Terminated By Sponsor|0|||
124969980|NCT01296555|449517533|FG012|Overall Study|Study Terminated By Sponsor|0|||
124969981|NCT01296555|449517534|FG013|Overall Study|Study Terminated By Sponsor|0|||
124969982|NCT01296555|449517535|FG014|Overall Study|Study Terminated By Sponsor|0|||
124969983|NCT01296555|449517536|FG015|Overall Study|Study Terminated By Sponsor|0|||
124969984|NCT01296555|449517537|FG016|Overall Study|Study Terminated By Sponsor|0|||
124969985|NCT01296555|449517538|FG017|Overall Study|Study Terminated By Sponsor|0|||
124969986|NCT01296555|449517539|FG018|Overall Study|Study Terminated By Sponsor|0|||
124969987|NCT01296555|449517540|FG019|Overall Study|Study Terminated By Sponsor|0|||
124969988|NCT01296555|449517541|FG020|Overall Study|Study Terminated By Sponsor|0|||
124969989|NCT01296555|449517542|FG021|Overall Study|Study Terminated By Sponsor|0|||
124969990|NCT01296555|449517543|FG022|Overall Study|Study Terminated By Sponsor|0|||
124969991|NCT01296555|449517544|FG023|Overall Study|Study Terminated By Sponsor|0|||
124969992|NCT01296555|449517545|FG024|Overall Study|Study Terminated By Sponsor|0|||
124969993|NCT01296555|449517546|FG025|Overall Study|Study Terminated By Sponsor|1|||
124969994|NCT01296555|449517547|FG026|Overall Study|Study Terminated By Sponsor|0|||
124969995|NCT01296555|449517548|FG027|Overall Study|Study Terminated By Sponsor|0|||
124969996|NCT01296555|449517549|FG028|Overall Study|Study Terminated By Sponsor|0|||
124969997|NCT01296555|449517521|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124969998|NCT01296555|449517522|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124969999|NCT01296555|449517523|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970000|NCT01296555|449517524|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970001|NCT01296555|449517525|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970002|NCT01296555|449517526|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970003|NCT01296555|449517527|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970004|NCT01296555|449517528|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970005|NCT01296555|449517529|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970006|NCT01296555|449517530|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970007|NCT01296555|449517531|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970008|NCT01296555|449517532|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970009|NCT01296555|449517533|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970010|NCT01296555|449517534|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970011|NCT01296555|449517535|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970012|NCT01296555|449517536|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970013|NCT01296555|449517537|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970014|NCT01296555|449517538|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970015|NCT01296555|449517539|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970016|NCT01296555|449517540|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
124970017|NCT01296555|449517541|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970018|NCT01296555|449517542|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970019|NCT01296555|449517543|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970020|NCT01296555|449517544|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970021|NCT01296555|449517545|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970022|NCT01296555|449517546|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970023|NCT01296555|449517547|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125034288|NCT02875223|449743961|FG005|Overall Study|Withdrawal by Subject|1|||
124970024|NCT01296555|449517548|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970025|NCT01296555|449517549|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970026|NCT01296555|449517521|FG000|Overall Study|Death|0|||
124970027|NCT01296555|449517522|FG001|Overall Study|Death|0|||
124970028|NCT01296555|449517523|FG002|Overall Study|Death|0|||
124970029|NCT01296555|449517524|FG003|Overall Study|Death|2|||
124970030|NCT01296555|449517525|FG004|Overall Study|Death|1|||
124970031|NCT01296555|449517526|FG005|Overall Study|Death|0|||
124970032|NCT01296555|449517527|FG006|Overall Study|Death|2|||
124970033|NCT01296555|449517528|FG007|Overall Study|Death|0|||
125034289|NCT02875223|449743962|FG006|Overall Study|Withdrawal by Subject|0|||
125217630|NCT00463801|450425222|FG000|Overall Study|Adverse Event|4|||
124970034|NCT01296555|449517529|FG008|Overall Study|Death|0|||
125034290|NCT02875223|449743963|FG007|Overall Study|Withdrawal by Subject|0|||
125034291|NCT02875223|449743964|FG008|Overall Study|Withdrawal by Subject|1|||
125034292|NCT02875223|449743965|FG009|Overall Study|Withdrawal by Subject|0|||
125034293|NCT02875223|449743966|FG010|Overall Study|Withdrawal by Subject|0|||
125034294|NCT02875223|449743967|FG011|Overall Study|Withdrawal by Subject|0|||
125034295|NCT02875223|449743968|FG012|Overall Study|Withdrawal by Subject|0|||
125034296|NCT02875223|449743956|FG000|Overall Study|Progressive disease|0|||
125034297|NCT02875223|449743957|FG001|Overall Study|Progressive disease|0|||
125034298|NCT02875223|449743958|FG002|Overall Study|Progressive disease|1|||
125034299|NCT02875223|449743959|FG003|Overall Study|Progressive disease|0|||
125034300|NCT02875223|449743960|FG004|Overall Study|Progressive disease|0|||
125034301|NCT02875223|449743961|FG005|Overall Study|Progressive disease|0|||
125034302|NCT02875223|449743962|FG006|Overall Study|Progressive disease|0|||
125034303|NCT02875223|449743963|FG007|Overall Study|Progressive disease|0|||
125034304|NCT02875223|449743964|FG008|Overall Study|Progressive disease|0|||
125034305|NCT02875223|449743965|FG009|Overall Study|Progressive disease|12|||
125034306|NCT02875223|449743966|FG010|Overall Study|Progressive disease|2|||
125034307|NCT02875223|449743967|FG011|Overall Study|Progressive disease|3|||
125034308|NCT02875223|449743968|FG012|Overall Study|Progressive disease|6|||
125034309|NCT02875223|449743956|FG000|Overall Study|Death|4|||
125034310|NCT02875223|449743957|FG001|Overall Study|Death|4|||
125034311|NCT02875223|449743958|FG002|Overall Study|Death|3|||
125034312|NCT02875223|449743959|FG003|Overall Study|Death|4|||
125034313|NCT02875223|449743960|FG004|Overall Study|Death|2|||
125034314|NCT02875223|449743961|FG005|Overall Study|Death|3|||
125034315|NCT02875223|449743962|FG006|Overall Study|Death|5|||
125034316|NCT02875223|449743963|FG007|Overall Study|Death|7|||
125131544|NCT00272779|450109999|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
125131545|NCT00272779|450110000|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
125131546|NCT00272779|450109999|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
125131547|NCT00272779|450110000|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
125131548|NCT00272779|450109999|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
125131549|NCT00272779|450110000|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
125131550|NCT00272779|450109999|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
125131551|NCT00272779|450110000|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
125131552|NCT00272779|450109999|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
125131553|NCT00272779|450110000|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
125131554|NCT00272779|450109999|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
125131555|NCT00272779|450110000|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
125131556|NCT00272779|450109999|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
125131557|NCT00272779|450110000|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
125131558|NCT00272779|450109999|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
125131559|NCT00272779|450110000|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
125131560|NCT00272779|450109999|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
125131561|NCT00272779|450110000|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
125131562|NCT00272779|450109999|FG000|Baseline Through Week 96|Never treated|2|||
125131563|NCT00272779|450110000|FG001|Baseline Through Week 96|Never treated|3|||
125131564|NCT00272779|450109999|FG000|Baseline Through Week 96|Continuing on treatment|61|||
125131565|NCT00272779|450110000|FG001|Baseline Through Week 96|Continuing on treatment|38|||
125131566|NCT00561015|450110001|FG000|Overall Study|Adverse Event|0|||
125131567|NCT00561015|450110002|FG001|Overall Study|Adverse Event|0|||
125131568|NCT00561015|450110003|FG002|Overall Study|Adverse Event|0|||
125131569|NCT00561015|450110004|FG003|Overall Study|Adverse Event|0|||
125131570|NCT00561015|450110005|FG004|Overall Study|Adverse Event|1|||
125131571|NCT00561015|450110006|FG005|Overall Study|Adverse Event|0|||
125131572|NCT00561015|450110001|FG000|Overall Study|Lost to Follow-up|2|||
125131573|NCT00561015|450110002|FG001|Overall Study|Lost to Follow-up|0|||
125131574|NCT00561015|450110003|FG002|Overall Study|Lost to Follow-up|0|||
125131575|NCT00561015|450110004|FG003|Overall Study|Lost to Follow-up|1|||
125131576|NCT00561015|450110005|FG004|Overall Study|Lost to Follow-up|0|||
125131577|NCT00561015|450110006|FG005|Overall Study|Lost to Follow-up|3|||
125034317|NCT02875223|449743964|FG008|Overall Study|Death|3|||
125034318|NCT02875223|449743965|FG009|Overall Study|Death|2|||
125034319|NCT02875223|449743966|FG010|Overall Study|Death|0|||
125034320|NCT02875223|449743967|FG011|Overall Study|Death|0|||
125034321|NCT02875223|449743968|FG012|Overall Study|Death|0|||
125034322|NCT02875223|449743956|FG000|Overall Study|Lost to Follow-up|0|||
125034323|NCT02875223|449743957|FG001|Overall Study|Lost to Follow-up|1|||
125034324|NCT02875223|449743958|FG002|Overall Study|Lost to Follow-up|1|||
125034325|NCT02875223|449743959|FG003|Overall Study|Lost to Follow-up|0|||
125034326|NCT02875223|449743960|FG004|Overall Study|Lost to Follow-up|1|||
125034327|NCT02875223|449743961|FG005|Overall Study|Lost to Follow-up|0|||
125034328|NCT02875223|449743962|FG006|Overall Study|Lost to Follow-up|1|||
125034329|NCT02875223|449743963|FG007|Overall Study|Lost to Follow-up|1|||
125034330|NCT02875223|449743964|FG008|Overall Study|Lost to Follow-up|0|||
125034331|NCT02875223|449743965|FG009|Overall Study|Lost to Follow-up|0|||
125034332|NCT02875223|449743966|FG010|Overall Study|Lost to Follow-up|0|||
125034333|NCT02875223|449743967|FG011|Overall Study|Lost to Follow-up|0|||
125034334|NCT02875223|449743968|FG012|Overall Study|Lost to Follow-up|0|||
125034335|NCT04211337|449743972|FG000|Overall Study|On Treatment|175|||
125034336|NCT04211337|449743973|FG001|Overall Study|On Treatment|40|||
125034337|NCT04211337|449743972|FG000|Overall Study|Withdrawal by Subject|0|||
125034338|NCT04211337|449743973|FG001|Overall Study|Withdrawal by Subject|2|||
125034339|NCT06119191|449743978|FG000|Overall Study|Adverse Event|0|||
125034340|NCT06119191|449743979|FG001|Overall Study|Adverse Event|1|||
125034341|NCT06119191|449743978|FG000|Overall Study|Protocol Violation|1|||
125034342|NCT06119191|449743979|FG001|Overall Study|Protocol Violation|0|||
125034343|NCT02732951|449745918|FG000|Overall Study|Other than listed|1|||
125034344|NCT02732951|449745919|FG001|Overall Study|Other than listed|0|||
125034345|NCT02732951|449745918|FG000|Overall Study|Lost to Follow-up|0|||
125034346|NCT02732951|449745919|FG001|Overall Study|Lost to Follow-up|1|||
125034347|NCT02732951|449745918|FG000|Overall Study|Adverse Event|4|||
125034348|NCT02732951|449745919|FG001|Overall Study|Adverse Event|4|||
125034349|NCT02732951|449745918|FG000|Overall Study|Protocol Violation|0|||
125034350|NCT02732951|449745919|FG001|Overall Study|Protocol Violation|1|||
125034351|NCT03263806|449745920|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
125034352|NCT03263806|449745921|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
125034353|NCT03263806|449745920|FG000|Overall Study|Withdrawal by Subject|0|||
125131578|NCT00561015|450110001|FG000|Overall Study|Participant non-compliance|2|||
125131579|NCT00561015|450110002|FG001|Overall Study|Participant non-compliance|0|||
125131580|NCT00561015|450110003|FG002|Overall Study|Participant non-compliance|0|||
125131581|NCT00561015|450110004|FG003|Overall Study|Participant non-compliance|0|||
125131582|NCT00561015|450110005|FG004|Overall Study|Participant non-compliance|0|||
125131583|NCT00561015|450110006|FG005|Overall Study|Participant non-compliance|0|||
125131584|NCT03616535|450110007|FG000|Overall Study|Death|2|||
125131585|NCT03616535|450110008|FG001|Overall Study|Death|0|||
125131586|NCT03616535|450110009|FG002|Overall Study|Death|0|||
125131587|NCT03616535|450110010|FG003|Overall Study|Death|1|||
125131588|NCT03616535|450110007|FG000|Overall Study|Lost to Follow-up|2|||
125131589|NCT03616535|450110008|FG001|Overall Study|Lost to Follow-up|1|||
125131590|NCT03616535|450110009|FG002|Overall Study|Lost to Follow-up|0|||
125131591|NCT03616535|450110010|FG003|Overall Study|Lost to Follow-up|2|||
125131592|NCT03616535|450110007|FG000|Overall Study|Withdrawal by Subject|1|||
125131593|NCT03616535|450110008|FG001|Overall Study|Withdrawal by Subject|2|||
125131594|NCT03616535|450110009|FG002|Overall Study|Withdrawal by Subject|5|||
125131595|NCT03616535|450110010|FG003|Overall Study|Withdrawal by Subject|1|||
125131596|NCT03616535|450110007|FG000|Overall Study|Not specified or change in eligibility|2|||
125131597|NCT03616535|450110008|FG001|Overall Study|Not specified or change in eligibility|3|||
125131598|NCT03616535|450110009|FG002|Overall Study|Not specified or change in eligibility|3|||
125131599|NCT03616535|450110010|FG003|Overall Study|Not specified or change in eligibility|1|||
125131600|NCT02440711|450110011|FG000|Second Intervention|Lost to Follow-up|1|||
125131601|NCT02440711|450110012|FG001|Second Intervention|Lost to Follow-up|0|||
125131602|NCT00163657|450110017|FG000|Overall Study|Death|12|||
125131603|NCT00163657|450110018|FG001|Overall Study|Death|14|||
125131604|NCT00163657|450110019|FG002|Overall Study|Death|19|||
125131605|NCT00163657|450110017|FG000|Overall Study|graft loss|4|||
125131606|NCT00163657|450110018|FG001|Overall Study|graft loss|1|||
125131607|NCT00163657|450110019|FG002|Overall Study|graft loss|2|||
125131608|NCT00163657|450110017|FG000|Overall Study|Withdrawal by Subject|2|||
125034354|NCT03263806|449745921|FG001|Overall Study|Withdrawal by Subject|1|||
125131609|NCT00163657|450110018|FG001|Overall Study|Withdrawal by Subject|3|||
125131610|NCT00163657|450110019|FG002|Overall Study|Withdrawal by Subject|2|||
125131611|NCT00163657|450110017|FG000|Overall Study|Physician Decision|0|||
125131612|NCT00163657|450110018|FG001|Overall Study|Physician Decision|1|||
125131613|NCT00163657|450110019|FG002|Overall Study|Physician Decision|1|||
125131614|NCT00163657|450110017|FG000|Overall Study|Non Compliance|1|||
125034355|NCT03263806|449745920|FG000|Overall Study|Study Termination|5|||
125034356|NCT03263806|449745921|FG001|Overall Study|Study Termination|6|||
125034357|NCT01412879|449745922|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
125034358|NCT01412879|449745923|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
125034359|NCT01412879|449745924|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
125131615|NCT00163657|450110018|FG001|Overall Study|Non Compliance|0|||
124970035|NCT01296555|449517530|FG009|Overall Study|Death|1|||
124970036|NCT01296555|449517531|FG010|Overall Study|Death|0|||
124970037|NCT01296555|449517532|FG011|Overall Study|Death|1|||
124970038|NCT01296555|449517533|FG012|Overall Study|Death|0|||
124970039|NCT01296555|449517534|FG013|Overall Study|Death|2|||
124970040|NCT01296555|449517535|FG014|Overall Study|Death|27|||
124970041|NCT01296555|449517536|FG015|Overall Study|Death|15|||
124970042|NCT01296555|449517537|FG016|Overall Study|Death|11|||
124970043|NCT01296555|449517538|FG017|Overall Study|Death|11|||
124970044|NCT01296555|449517539|FG018|Overall Study|Death|17|||
124970045|NCT01296555|449517540|FG019|Overall Study|Death|12|||
124970046|NCT01296555|449517541|FG020|Overall Study|Death|13|||
124970047|NCT01296555|449517542|FG021|Overall Study|Death|12|||
124970048|NCT01296555|449517543|FG022|Overall Study|Death|12|||
124970049|NCT01296555|449517544|FG023|Overall Study|Death|13|||
124970050|NCT01296555|449517545|FG024|Overall Study|Death|7|||
124970051|NCT01296555|449517546|FG025|Overall Study|Death|7|||
124970052|NCT01296555|449517547|FG026|Overall Study|Death|35|||
124970053|NCT01296555|449517548|FG027|Overall Study|Death|92|||
124970054|NCT01296555|449517549|FG028|Overall Study|Death|44|||
124970055|NCT01296555|449517521|FG000|Overall Study|Lost to Follow-up|0|||
124970056|NCT01296555|449517522|FG001|Overall Study|Lost to Follow-up|0|||
124970057|NCT01296555|449517523|FG002|Overall Study|Lost to Follow-up|0|||
124970058|NCT01296555|449517524|FG003|Overall Study|Lost to Follow-up|0|||
124970059|NCT01296555|449517525|FG004|Overall Study|Lost to Follow-up|0|||
124970060|NCT01296555|449517526|FG005|Overall Study|Lost to Follow-up|0|||
124970061|NCT01296555|449517527|FG006|Overall Study|Lost to Follow-up|0|||
124970062|NCT01296555|449517528|FG007|Overall Study|Lost to Follow-up|0|||
124970063|NCT01296555|449517529|FG008|Overall Study|Lost to Follow-up|0|||
124970064|NCT01296555|449517530|FG009|Overall Study|Lost to Follow-up|0|||
124970065|NCT01296555|449517531|FG010|Overall Study|Lost to Follow-up|0|||
124970066|NCT01296555|449517532|FG011|Overall Study|Lost to Follow-up|0|||
124970067|NCT01296555|449517533|FG012|Overall Study|Lost to Follow-up|0|||
124970068|NCT01296555|449517534|FG013|Overall Study|Lost to Follow-up|0|||
124970069|NCT01296555|449517535|FG014|Overall Study|Lost to Follow-up|2|||
124970070|NCT01296555|449517536|FG015|Overall Study|Lost to Follow-up|1|||
124970071|NCT01296555|449517537|FG016|Overall Study|Lost to Follow-up|0|||
124970072|NCT01296555|449517538|FG017|Overall Study|Lost to Follow-up|2|||
124970073|NCT01296555|449517539|FG018|Overall Study|Lost to Follow-up|0|||
124970074|NCT01296555|449517540|FG019|Overall Study|Lost to Follow-up|2|||
124970075|NCT01296555|449517541|FG020|Overall Study|Lost to Follow-up|3|||
124970076|NCT01296555|449517542|FG021|Overall Study|Lost to Follow-up|2|||
124970077|NCT01296555|449517543|FG022|Overall Study|Lost to Follow-up|0|||
124970078|NCT01296555|449517544|FG023|Overall Study|Lost to Follow-up|0|||
124970079|NCT01296555|449517545|FG024|Overall Study|Lost to Follow-up|0|||
124970080|NCT01296555|449517546|FG025|Overall Study|Lost to Follow-up|0|||
124970081|NCT01296555|449517547|FG026|Overall Study|Lost to Follow-up|3|||
124970082|NCT01296555|449517548|FG027|Overall Study|Lost to Follow-up|13|||
124970083|NCT01296555|449517549|FG028|Overall Study|Lost to Follow-up|5|||
124970084|NCT01296555|449517521|FG000|Overall Study|Non-Compliance With Study Drug|0|||
124970085|NCT01296555|449517522|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124970086|NCT01296555|449517523|FG002|Overall Study|Non-Compliance With Study Drug|0|||
124970087|NCT01296555|449517524|FG003|Overall Study|Non-Compliance With Study Drug|0|||
124970088|NCT01296555|449517525|FG004|Overall Study|Non-Compliance With Study Drug|0|||
124970089|NCT01296555|449517526|FG005|Overall Study|Non-Compliance With Study Drug|0|||
124970090|NCT01296555|449517527|FG006|Overall Study|Non-Compliance With Study Drug|0|||
124970091|NCT01296555|449517528|FG007|Overall Study|Non-Compliance With Study Drug|1|||
124970092|NCT01296555|449517529|FG008|Overall Study|Non-Compliance With Study Drug|0|||
124970093|NCT01296555|449517530|FG009|Overall Study|Non-Compliance With Study Drug|0|||
124970094|NCT01296555|449517531|FG010|Overall Study|Non-Compliance With Study Drug|0|||
124970095|NCT01296555|449517532|FG011|Overall Study|Non-Compliance With Study Drug|0|||
124970096|NCT01296555|449517533|FG012|Overall Study|Non-Compliance With Study Drug|0|||
124970097|NCT01296555|449517534|FG013|Overall Study|Non-Compliance With Study Drug|0|||
124970098|NCT01296555|449517535|FG014|Overall Study|Non-Compliance With Study Drug|0|||
125034360|NCT01412879|449745922|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
125034361|NCT01412879|449745923|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
125034362|NCT01412879|449745924|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
125034363|NCT01412879|449745922|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
125034364|NCT01412879|449745923|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
125034365|NCT01412879|449745924|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
125034366|NCT01412879|449745922|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
125131616|NCT00163657|450110019|FG002|Overall Study|Non Compliance|0|||
124970099|NCT01296555|449517536|FG015|Overall Study|Non-Compliance With Study Drug|0|||
124970100|NCT01296555|449517537|FG016|Overall Study|Non-Compliance With Study Drug|0|||
124970101|NCT01296555|449517538|FG017|Overall Study|Non-Compliance With Study Drug|0|||
124970102|NCT01296555|449517539|FG018|Overall Study|Non-Compliance With Study Drug|0|||
124970103|NCT01296555|449517540|FG019|Overall Study|Non-Compliance With Study Drug|0|||
124970104|NCT01296555|449517541|FG020|Overall Study|Non-Compliance With Study Drug|0|||
124970105|NCT01296555|449517542|FG021|Overall Study|Non-Compliance With Study Drug|0|||
124970106|NCT01296555|449517543|FG022|Overall Study|Non-Compliance With Study Drug|0|||
124970107|NCT01296555|449517544|FG023|Overall Study|Non-Compliance With Study Drug|0|||
124970108|NCT01296555|449517545|FG024|Overall Study|Non-Compliance With Study Drug|0|||
124970109|NCT01296555|449517546|FG025|Overall Study|Non-Compliance With Study Drug|0|||
124970110|NCT01296555|449517547|FG026|Overall Study|Non-Compliance With Study Drug|0|||
124970111|NCT01296555|449517548|FG027|Overall Study|Non-Compliance With Study Drug|0|||
124970112|NCT01296555|449517549|FG028|Overall Study|Non-Compliance With Study Drug|0|||
124970113|NCT01296555|449517521|FG000|Overall Study|Withdrawal by Subject|0|||
124970114|NCT01296555|449517522|FG001|Overall Study|Withdrawal by Subject|0|||
124970115|NCT01296555|449517523|FG002|Overall Study|Withdrawal by Subject|0|||
124970116|NCT01296555|449517524|FG003|Overall Study|Withdrawal by Subject|0|||
124970117|NCT01296555|449517525|FG004|Overall Study|Withdrawal by Subject|1|||
124970118|NCT01296555|449517526|FG005|Overall Study|Withdrawal by Subject|0|||
124970119|NCT01296555|449517527|FG006|Overall Study|Withdrawal by Subject|1|||
124970120|NCT01296555|449517528|FG007|Overall Study|Withdrawal by Subject|0|||
124970121|NCT01296555|449517529|FG008|Overall Study|Withdrawal by Subject|0|||
124970122|NCT01296555|449517530|FG009|Overall Study|Withdrawal by Subject|0|||
124970123|NCT01296555|449517531|FG010|Overall Study|Withdrawal by Subject|1|||
124970124|NCT01296555|449517532|FG011|Overall Study|Withdrawal by Subject|1|||
124970125|NCT01296555|449517533|FG012|Overall Study|Withdrawal by Subject|0|||
124970126|NCT01296555|449517534|FG013|Overall Study|Withdrawal by Subject|0|||
124970127|NCT01296555|449517535|FG014|Overall Study|Withdrawal by Subject|3|||
124970128|NCT01296555|449517536|FG015|Overall Study|Withdrawal by Subject|0|||
124970129|NCT01296555|449517537|FG016|Overall Study|Withdrawal by Subject|2|||
124970130|NCT01296555|449517538|FG017|Overall Study|Withdrawal by Subject|1|||
124970131|NCT01296555|449517539|FG018|Overall Study|Withdrawal by Subject|0|||
124970132|NCT01296555|449517540|FG019|Overall Study|Withdrawal by Subject|1|||
124970133|NCT01296555|449517541|FG020|Overall Study|Withdrawal by Subject|1|||
124970134|NCT01296555|449517542|FG021|Overall Study|Withdrawal by Subject|1|||
124970135|NCT01296555|449517543|FG022|Overall Study|Withdrawal by Subject|3|||
124970136|NCT01296555|449517544|FG023|Overall Study|Withdrawal by Subject|0|||
124970137|NCT01296555|449517545|FG024|Overall Study|Withdrawal by Subject|0|||
124970138|NCT01296555|449517546|FG025|Overall Study|Withdrawal by Subject|0|||
124970139|NCT01296555|449517547|FG026|Overall Study|Withdrawal by Subject|8|||
124970140|NCT01296555|449517548|FG027|Overall Study|Withdrawal by Subject|4|||
124970141|NCT01296555|449517549|FG028|Overall Study|Withdrawal by Subject|2|||
124970142|NCT00409409|449517550|FG000|Overall Study|Adverse Event|7|||
124970143|NCT00409409|449517551|FG001|Overall Study|Adverse Event|2|||
124970144|NCT00409409|449517550|FG000|Overall Study|Withdrawal by Subject|1|||
124970145|NCT00409409|449517551|FG001|Overall Study|Withdrawal by Subject|1|||
124970146|NCT00409409|449517550|FG000|Overall Study|Any other reason not above-mentioned|0|||
124970147|NCT00409409|449517551|FG001|Overall Study|Any other reason not above-mentioned|1|||
124970148|NCT03635086|449517556|FG000|Overall Study|Withdrawal of consent|0|||
124970149|NCT03635086|449517557|FG001|Overall Study|Withdrawal of consent|0|||
124970150|NCT03635086|449517558|FG002|Overall Study|Withdrawal of consent|1|||
124970151|NCT03635086|449517559|FG003|Overall Study|Withdrawal of consent|0|||
124970152|NCT03635086|449517560|FG004|Overall Study|Withdrawal of consent|0|||
124970153|NCT03635086|449517556|FG000|Overall Study|Adverse Event|0|||
124970154|NCT03635086|449517557|FG001|Overall Study|Adverse Event|1|||
124970155|NCT03635086|449517558|FG002|Overall Study|Adverse Event|0|||
124970156|NCT03635086|449517559|FG003|Overall Study|Adverse Event|0|||
124970157|NCT03635086|449517560|FG004|Overall Study|Adverse Event|0|||
124970158|NCT03635086|449517556|FG000|Overall Study|Lost to Follow-up|1|||
124970159|NCT03635086|449517557|FG001|Overall Study|Lost to Follow-up|0|||
124970160|NCT03635086|449517558|FG002|Overall Study|Lost to Follow-up|0|||
124970161|NCT03635086|449517559|FG003|Overall Study|Lost to Follow-up|0|||
124970162|NCT03635086|449517560|FG004|Overall Study|Lost to Follow-up|0|||
124970163|NCT03000348|449517561|FG000|Overall Study|Adverse Event|1|||
124970164|NCT03000348|449517562|FG001|Overall Study|Adverse Event|1|||
124970165|NCT03000348|449517563|FG002|Overall Study|Adverse Event|1|||
124970166|NCT03000348|449517564|FG003|Overall Study|Adverse Event|1|||
124970167|NCT03000348|449517565|FG004|Overall Study|Adverse Event|1|||
124970168|NCT03000348|449517566|FG005|Overall Study|Adverse Event|1|||
124970169|NCT03000348|449517561|FG000|Overall Study|Lost to Follow-up|0|||
124970170|NCT03000348|449517562|FG001|Overall Study|Lost to Follow-up|0|||
124970171|NCT03000348|449517563|FG002|Overall Study|Lost to Follow-up|1|||
124970172|NCT03000348|449517564|FG003|Overall Study|Lost to Follow-up|0|||
124970173|NCT03000348|449517565|FG004|Overall Study|Lost to Follow-up|0|||
124970174|NCT03000348|449517566|FG005|Overall Study|Lost to Follow-up|0|||
124970175|NCT03000348|449517561|FG000|Overall Study|Withdrawal by Subject|0|||
124970176|NCT03000348|449517562|FG001|Overall Study|Withdrawal by Subject|1|||
124970177|NCT03000348|449517563|FG002|Overall Study|Withdrawal by Subject|0|||
124970178|NCT03000348|449517564|FG003|Overall Study|Withdrawal by Subject|0|||
124970179|NCT03000348|449517565|FG004|Overall Study|Withdrawal by Subject|0|||
125034367|NCT01412879|449745923|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
125034368|NCT01412879|449745924|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
125034369|NCT01412879|449745922|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
125034370|NCT01412879|449745923|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
125034371|NCT01412879|449745924|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
125034372|NCT04840667|449745925|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
125034373|NCT01445171|449745926|FG000|Overall Study|Lost to Follow-up|11|||
125034374|NCT01445171|449745926|FG000|Overall Study|Withdrawal by Subject|16|||
125034375|NCT01445171|449745926|FG000|Overall Study|Death|51|||
125034376|NCT01445171|449745926|FG000|Overall Study|Subjects declined to return for followup|9|||
125034377|NCT01445171|449745926|FG000|Overall Study|Consented but did not receive device|8|||
125034378|NCT03195894|449745933|FG000|Overall Study|"An example is Started other treatment."|4|||
125034379|NCT03195894|449745934|FG001|Overall Study|"An example is Started other treatment."|5|||
125034380|NCT03195894|449745933|FG000|Overall Study|Withdrawal by Subject|15|||
125034381|NCT03195894|449745934|FG001|Overall Study|Withdrawal by Subject|4|||
125034382|NCT03195894|449745933|FG000|Overall Study|Lost to Follow-up|14|||
125034383|NCT03195894|449745934|FG001|Overall Study|Lost to Follow-up|19|||
125034384|NCT00162773|449745935|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
125034385|NCT01903876|449745939|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
125034386|NCT01903876|449745940|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
125034387|NCT01903876|449745939|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
125034388|NCT01903876|449745940|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
125034389|NCT02612909|449745941|FG000|Phase 2|Withdrawal by Subject|2|||
125034390|NCT02612909|449745942|FG001|Phase 2|Withdrawal by Subject|5|||
125034391|NCT02612909|449745943|FG002|Phase 2|Withdrawal by Subject|0|||
125034392|NCT02612909|449745944|FG003|Phase 2|Withdrawal by Subject|0|||
125034393|NCT02612909|449745945|FG004|Phase 2|Withdrawal by Subject|0|||
125034394|NCT02612909|449745941|FG000|Phase 2|Pregnancy|0|||
125034395|NCT02612909|449745942|FG001|Phase 2|Pregnancy|0|||
125034396|NCT02612909|449745943|FG002|Phase 2|Pregnancy|1|||
125034397|NCT02612909|449745944|FG003|Phase 2|Pregnancy|0|||
125034398|NCT02612909|449745945|FG004|Phase 2|Pregnancy|0|||
125034399|NCT02612909|449745941|FG000|Phase 3|Withdrawal by Subject|0|||
125034400|NCT02612909|449745942|FG001|Phase 3|Withdrawal by Subject|0|||
125034401|NCT02612909|449745943|FG002|Phase 3|Withdrawal by Subject|0|||
125034402|NCT02612909|449745944|FG003|Phase 3|Withdrawal by Subject|1|||
125034403|NCT02612909|449745945|FG004|Phase 3|Withdrawal by Subject|0|||
125034404|NCT00450580|449745947|FG000|Overall Study|Adverse Event|5|||
125034405|NCT00450580|449745948|FG001|Overall Study|Adverse Event|7|||
125034406|NCT00450580|449745947|FG000|Overall Study|Lost to Follow-up|4|||
125034407|NCT00450580|449745948|FG001|Overall Study|Lost to Follow-up|5|||
125034408|NCT00450580|449745947|FG000|Overall Study|Withdrawal by Subject|2|||
125034409|NCT00450580|449745948|FG001|Overall Study|Withdrawal by Subject|2|||
125034410|NCT00450580|449745947|FG000|Overall Study|Protocol Violation|1|||
125034411|NCT00450580|449745948|FG001|Overall Study|Protocol Violation|1|||
125034412|NCT00450580|449745947|FG000|Overall Study|Protocol-defined virologic failure|1|||
125034413|NCT00450580|449745948|FG001|Overall Study|Protocol-defined virologic failure|0|||
125034414|NCT00450580|449745947|FG000|Overall Study|Could not comply with scheduled visits|1|||
125034415|NCT00450580|449745948|FG001|Overall Study|Could not comply with scheduled visits|0|||
125034416|NCT00450580|449745947|FG000|Overall Study|Patient went to Brazil|1|||
125034417|NCT00450580|449745948|FG001|Overall Study|Patient went to Brazil|0|||
125034418|NCT00450580|449745947|FG000|Overall Study|Patient could not swallow Norvir|1|||
125034419|NCT00450580|449745948|FG001|Overall Study|Patient could not swallow Norvir|0|||
125034420|NCT00450580|449745947|FG000|Overall Study|Withdrawal due to pregnancy|0|||
125034421|NCT00450580|449745948|FG001|Overall Study|Withdrawal due to pregnancy|1|||
125034422|NCT00393718|449745949|FG000|Overall Study|Adverse Event|20|||
125034423|NCT00393718|449745950|FG001|Overall Study|Adverse Event|8|||
125034424|NCT00393718|449745949|FG000|Overall Study|Protocol Violation|1|||
125034425|NCT00393718|449745950|FG001|Overall Study|Protocol Violation|2|||
125034426|NCT00393718|449745949|FG000|Overall Study|Lack of Efficacy|10|||
125034427|NCT00393718|449745950|FG001|Overall Study|Lack of Efficacy|9|||
125034428|NCT00393718|449745949|FG000|Overall Study|Hypoglycaemia|3|||
125131617|NCT00163657|450110017|FG000|Overall Study|Lost to Follow-up|1|||
125131618|NCT00163657|450110018|FG001|Overall Study|Lost to Follow-up|3|||
125131619|NCT00163657|450110019|FG002|Overall Study|Lost to Follow-up|10|||
125131620|NCT00163657|450110017|FG000|Overall Study|Other reason|0|||
125131621|NCT00163657|450110018|FG001|Overall Study|Other reason|1|||
125131622|NCT00163657|450110019|FG002|Overall Study|Other reason|3|||
125131623|NCT03935880|450110020|FG000|Overall Study|Lost to Follow-up|0|||
125131624|NCT03935880|450110021|FG001|Overall Study|Lost to Follow-up|1|||
125131625|NCT02563561|450110022|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
125131626|NCT02563561|450110023|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
125131627|NCT02563561|450110024|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
125131628|NCT02563561|450110022|FG000|Overall Study|Withdrew of Consent|1|||
125131629|NCT02563561|450110023|FG001|Overall Study|Withdrew of Consent|1|||
125131630|NCT02563561|450110024|FG002|Overall Study|Withdrew of Consent|2|||
125131631|NCT02563561|450110022|FG000|Overall Study|Lost to Follow-up|1|||
125131632|NCT02563561|450110023|FG001|Overall Study|Lost to Follow-up|1|||
125131633|NCT02563561|450110024|FG002|Overall Study|Lost to Follow-up|0|||
125131634|NCT02563561|450110022|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
125131635|NCT02563561|450110023|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
125131636|NCT02563561|450110024|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
125131637|NCT02563561|450110022|FG000|Overall Study|Investigator Decision|3|||
125131638|NCT02563561|450110023|FG001|Overall Study|Investigator Decision|4|||
125131639|NCT02563561|450110024|FG002|Overall Study|Investigator Decision|2|||
125131640|NCT02563561|450110022|FG000|Overall Study|Sponsor Decision|5|||
125131641|NCT02563561|450110023|FG001|Overall Study|Sponsor Decision|2|||
125131642|NCT02563561|450110024|FG002|Overall Study|Sponsor Decision|4|||
125131643|NCT02563561|450110022|FG000|Overall Study|Other|1|||
125131644|NCT02563561|450110023|FG001|Overall Study|Other|5|||
125131645|NCT02563561|450110024|FG002|Overall Study|Other|2|||
125131646|NCT03122535|450110027|FG000|Overall Study|Lost to Follow-up|68|||
125131647|NCT03122535|450110028|FG001|Overall Study|Lost to Follow-up|68|||
125131648|NCT03122535|450110027|FG000|Overall Study|Physician Decision|3|||
125131649|NCT03122535|450110028|FG001|Overall Study|Physician Decision|3|||
125131650|NCT03122535|450110027|FG000|Overall Study|Withdrawal by Subject|2|||
125131651|NCT03122535|450110028|FG001|Overall Study|Withdrawal by Subject|2|||
125131652|NCT02718326|450110029|FG000|Overall Study|Adverse Event|4|||
125131653|NCT02718326|450110030|FG001|Overall Study|Adverse Event|9|||
125131654|NCT02718326|450110031|FG002|Overall Study|Adverse Event|0|||
125131655|NCT02718326|450110029|FG000|Overall Study|Death|8|||
125131656|NCT02718326|450110030|FG001|Overall Study|Death|1|||
125217631|NCT00463801|450425222|FG000|Overall Study|Lost to Follow-up|5|||
125217632|NCT00463801|450425222|FG000|Overall Study|No longer require therapy|1|||
125217633|NCT02315664|450425223|FG000|Overall Study|Lost to Follow-up|1|||
125217634|NCT02315664|450425224|FG001|Overall Study|Lost to Follow-up|1|||
125217635|NCT02315664|450425223|FG000|Overall Study|Withdrawal by Subject|0|||
125217636|NCT02315664|450425224|FG001|Overall Study|Withdrawal by Subject|3|||
125217637|NCT02501161|450425225|FG000|Overall Study|Adverse Event|2|||
125217638|NCT02501161|450425226|FG001|Overall Study|Adverse Event|6|||
125217639|NCT02501161|450425225|FG000|Overall Study|Lost to Follow-up|7|||
125217640|NCT02501161|450425226|FG001|Overall Study|Lost to Follow-up|4|||
125217641|NCT02501161|450425225|FG000|Overall Study|Withdrawal by Subject|10|||
125217642|NCT02501161|450425226|FG001|Overall Study|Withdrawal by Subject|15|||
125217643|NCT02501161|450425225|FG000|Overall Study|Other|3|||
125217644|NCT02501161|450425226|FG001|Overall Study|Other|0|||
125217645|NCT01990573|450425229|FG000|Overall Study|Physician Decision|0|||
125217646|NCT01990573|450425230|FG001|Overall Study|Physician Decision|0|||
125131657|NCT02718326|450110031|FG002|Overall Study|Death|2|||
125131658|NCT02718326|450110029|FG000|Overall Study|Withdrawal by Subject|4|||
125131659|NCT02718326|450110030|FG001|Overall Study|Withdrawal by Subject|9|||
125131660|NCT02718326|450110031|FG002|Overall Study|Withdrawal by Subject|6|||
125131661|NCT02718326|450110029|FG000|Overall Study|Lost to Follow-up|18|||
125131662|NCT02718326|450110030|FG001|Overall Study|Lost to Follow-up|5|||
125217647|NCT01990573|450425231|FG002|Overall Study|Physician Decision|1|||
125217648|NCT03335813|450425233|FG000|Overall Study|Withdrawal by Subject|1|||
125034429|NCT00393718|449745950|FG001|Overall Study|Hypoglycaemia|2|||
125034430|NCT00393718|449745949|FG000|Overall Study|Subject decision|5|||
125034431|NCT00393718|449745950|FG001|Overall Study|Subject decision|0|||
125034432|NCT00393718|449745949|FG000|Overall Study|Withdrawal of consent|2|||
125034433|NCT00393718|449745950|FG001|Overall Study|Withdrawal of consent|1|||
125034434|NCT00393718|449745949|FG000|Overall Study|Missed measurement|1|||
125034435|NCT00393718|449745950|FG001|Overall Study|Missed measurement|0|||
125034436|NCT00393718|449745949|FG000|Overall Study|Move|1|||
125034437|NCT00393718|449745950|FG001|Overall Study|Move|0|||
125034438|NCT04938648|449745951|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
125034439|NCT04938648|449745952|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
125034440|NCT04938648|449745951|FG000|Overall Study|Patient too ill|0|||
125034441|NCT04938648|449745952|FG001|Overall Study|Patient too ill|1|||
125034442|NCT04938648|449745951|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
125034443|NCT04938648|449745952|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
125034444|NCT04938648|449745951|FG000|Overall Study|Patient did not have memory problems|1|||
125034445|NCT04938648|449745952|FG001|Overall Study|Patient did not have memory problems|1|||
125034446|NCT04938648|449745951|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
125034447|NCT04938648|449745952|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
125034448|NCT04938648|449745951|FG000|Overall Study|Care partner could not be reached|0|||
125034449|NCT04938648|449745952|FG001|Overall Study|Care partner could not be reached|1|||
125034450|NCT04938648|449745951|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
125034451|NCT04938648|449745952|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
125034452|NCT04938648|449745951|FG000|Overall Study|Withdrawal by Subject|2|||
125034453|NCT04938648|449745952|FG001|Overall Study|Withdrawal by Subject|1|||
125034454|NCT03293654|449745953|FG000|Overall Study|Lost to Follow-up|0|||
125034455|NCT03293654|449745954|FG001|Overall Study|Lost to Follow-up|1|||
125034456|NCT03293654|449745955|FG002|Overall Study|Lost to Follow-up|0|||
125034457|NCT01919307|449745956|FG000|Overall Study|Withdrawal by Subject|9|||
125034458|NCT00763009|449745959|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
125034459|NCT00891735|449745960|FG000|Overall Study|Adverse Event|2|||
125034460|NCT00891735|449745961|FG001|Overall Study|Adverse Event|0|||
125034461|NCT00891735|449745962|FG002|Overall Study|Adverse Event|2|||
125034462|NCT00891735|449745963|FG003|Overall Study|Adverse Event|0|||
125034463|NCT00891735|449745960|FG000|Overall Study|Death|8|||
125034464|NCT00891735|449745961|FG001|Overall Study|Death|5|||
125034465|NCT00891735|449745962|FG002|Overall Study|Death|4|||
125034466|NCT00891735|449745963|FG003|Overall Study|Death|5|||
125034467|NCT00891735|449745960|FG000|Overall Study|Lost to Follow-up|2|||
125034468|NCT00891735|449745961|FG001|Overall Study|Lost to Follow-up|2|||
125034469|NCT00891735|449745962|FG002|Overall Study|Lost to Follow-up|2|||
125034470|NCT00891735|449745963|FG003|Overall Study|Lost to Follow-up|2|||
125034471|NCT00891735|449745960|FG000|Overall Study|Physician's decision to withdraw patient|1|||
125034472|NCT00891735|449745961|FG001|Overall Study|Physician's decision to withdraw patient|0|||
125034473|NCT00891735|449745962|FG002|Overall Study|Physician's decision to withdraw patient|0|||
125034474|NCT00891735|449745963|FG003|Overall Study|Physician's decision to withdraw patient|0|||
125034475|NCT00891735|449745960|FG000|Overall Study|Patient's decision to withdraw|4|||
125034476|NCT00891735|449745961|FG001|Overall Study|Patient's decision to withdraw|9|||
125034477|NCT00891735|449745962|FG002|Overall Study|Patient's decision to withdraw|4|||
125034478|NCT00891735|449745963|FG003|Overall Study|Patient's decision to withdraw|8|||
125034479|NCT03663166|449745968|FG000|Overall Study|Withdrawal by Subject|1|||
125034480|NCT02978222|449745969|FG000|Overall Study|Withdrawal by Subject|2|||
125034481|NCT02978222|449745970|FG001|Overall Study|Withdrawal by Subject|2|||
125034482|NCT02978222|449745969|FG000|Overall Study|Physician Decision|2|||
125034483|NCT02978222|449745970|FG001|Overall Study|Physician Decision|0|||
125034484|NCT02978222|449745969|FG000|Overall Study|Adverse Event|0|||
125034485|NCT02978222|449745970|FG001|Overall Study|Adverse Event|1|||
125034486|NCT02978222|449745969|FG000|Overall Study|Death|1|||
125034487|NCT02978222|449745970|FG001|Overall Study|Death|0|||
125034488|NCT02978222|449745969|FG000|Overall Study|Disease Progression|32|||
125034489|NCT02978222|449745970|FG001|Overall Study|Disease Progression|32|||
125034490|NCT02978222|449745969|FG000|Overall Study|Early Study Termination|24|||
125034491|NCT02978222|449745970|FG001|Overall Study|Early Study Termination|21|||
125034492|NCT01686568|449745971|FG000|Main Study|Withdrawal by Subject|1|||
125034493|NCT01686568|449745972|FG001|Main Study|Withdrawal by Subject|3|||
125034494|NCT01686568|449745971|FG000|Main Study|Noncompliance with protocol|0|||
125034495|NCT01686568|449745972|FG001|Main Study|Noncompliance with protocol|1|||
125034496|NCT01686568|449745971|FG000|Main Study|Liver enzymes above range of exclusion|1|||
125034497|NCT01686568|449745972|FG001|Main Study|Liver enzymes above range of exclusion|0|||
125034498|NCT01686568|449745971|FG000|Sub-Study|Not consented for sub-study|2|||
124970180|NCT03000348|449517566|FG005|Overall Study|Withdrawal by Subject|0|||
124970181|NCT03000348|449517561|FG000|Overall Study|Consent|0|||
124970182|NCT03000348|449517562|FG001|Overall Study|Consent|0|||
124970183|NCT03000348|449517563|FG002|Overall Study|Consent|0|||
124970184|NCT03000348|449517564|FG003|Overall Study|Consent|0|||
124970185|NCT03000348|449517565|FG004|Overall Study|Consent|1|||
124970186|NCT03000348|449517566|FG005|Overall Study|Consent|0|||
124970187|NCT03000348|449517561|FG000|Overall Study|Failure to expectorate sputum|1|||
124970188|NCT03000348|449517562|FG001|Overall Study|Failure to expectorate sputum|0|||
124970189|NCT03000348|449517563|FG002|Overall Study|Failure to expectorate sputum|1|||
124970190|NCT03000348|449517564|FG003|Overall Study|Failure to expectorate sputum|0|||
124970191|NCT03000348|449517565|FG004|Overall Study|Failure to expectorate sputum|1|||
124970192|NCT03000348|449517566|FG005|Overall Study|Failure to expectorate sputum|0|||
124970193|NCT03000348|449517561|FG000|Overall Study|No gram negative|1|||
124970194|NCT03000348|449517562|FG001|Overall Study|No gram negative|2|||
124970195|NCT03000348|449517563|FG002|Overall Study|No gram negative|1|||
124970196|NCT03000348|449517564|FG003|Overall Study|No gram negative|1|||
124970197|NCT03000348|449517565|FG004|Overall Study|No gram negative|1|||
124970198|NCT03000348|449517566|FG005|Overall Study|No gram negative|1|||
124970199|NCT03000348|449517561|FG000|Overall Study|Patient had no transport|0|||
124970200|NCT03000348|449517562|FG001|Overall Study|Patient had no transport|0|||
124970201|NCT03000348|449517563|FG002|Overall Study|Patient had no transport|0|||
124970202|NCT03000348|449517564|FG003|Overall Study|Patient had no transport|1|||
124970203|NCT03000348|449517565|FG004|Overall Study|Patient had no transport|0|||
124970204|NCT03000348|449517566|FG005|Overall Study|Patient had no transport|0|||
124970205|NCT03000348|449517561|FG000|Overall Study|Dosing|0|||
124970206|NCT03000348|449517562|FG001|Overall Study|Dosing|0|||
124970207|NCT03000348|449517563|FG002|Overall Study|Dosing|0|||
124970208|NCT03000348|449517564|FG003|Overall Study|Dosing|0|||
124970209|NCT03000348|449517565|FG004|Overall Study|Dosing|1|||
124970210|NCT03000348|449517566|FG005|Overall Study|Dosing|0|||
124970211|NCT04042077|449517567|FG000|Overall Study|Adverse Event|0|||
124970212|NCT04042077|449517568|FG001|Overall Study|Adverse Event|1|||
124970213|NCT04042077|449517567|FG000|Overall Study|Death|2|||
124970214|NCT04042077|449517568|FG001|Overall Study|Death|1|||
124970215|NCT04042077|449517567|FG000|Overall Study|Physician Decision|2|||
124970216|NCT04042077|449517568|FG001|Overall Study|Physician Decision|0|||
124970217|NCT04042077|449517567|FG000|Overall Study|Withdrawal by Subject|3|||
124970218|NCT04042077|449517568|FG001|Overall Study|Withdrawal by Subject|2|||
124970219|NCT04042077|449517567|FG000|Overall Study|Lack of Efficacy|0|||
124970220|NCT04042077|449517568|FG001|Overall Study|Lack of Efficacy|1|||
124970221|NCT01236352|449517582|FG000|Overall Study|Death|0|||
124970222|NCT01236352|449517583|FG001|Overall Study|Death|0|||
124970223|NCT01236352|449517584|FG002|Overall Study|Death|0|||
124970224|NCT01236352|449517585|FG003|Overall Study|Death|0|||
124970225|NCT01236352|449517586|FG004|Overall Study|Death|0|||
124970226|NCT01236352|449517587|FG005|Overall Study|Death|0|||
124970227|NCT01236352|449517588|FG006|Overall Study|Death|0|||
124970228|NCT01236352|449517589|FG007|Overall Study|Death|1|||
124970229|NCT01236352|449517590|FG008|Overall Study|Death|0|||
124970230|NCT01236352|449517591|FG009|Overall Study|Death|0|||
124970231|NCT01236352|449517592|FG010|Overall Study|Death|0|||
124970232|NCT01236352|449517582|FG000|Overall Study|Withdrawal by Subject|0|||
124970233|NCT01236352|449517583|FG001|Overall Study|Withdrawal by Subject|0|||
124970234|NCT01236352|449517584|FG002|Overall Study|Withdrawal by Subject|0|||
124970235|NCT01236352|449517585|FG003|Overall Study|Withdrawal by Subject|0|||
124970236|NCT01236352|449517586|FG004|Overall Study|Withdrawal by Subject|0|||
124970237|NCT01236352|449517587|FG005|Overall Study|Withdrawal by Subject|0|||
124970238|NCT01236352|449517588|FG006|Overall Study|Withdrawal by Subject|0|||
124970239|NCT01236352|449517589|FG007|Overall Study|Withdrawal by Subject|0|||
124970240|NCT01236352|449517590|FG008|Overall Study|Withdrawal by Subject|0|||
124970241|NCT01236352|449517591|FG009|Overall Study|Withdrawal by Subject|2|||
124970242|NCT01236352|449517592|FG010|Overall Study|Withdrawal by Subject|1|||
124970243|NCT01236352|449517582|FG000|Overall Study|Adverse Event|0|||
124970244|NCT01236352|449517583|FG001|Overall Study|Adverse Event|0|||
124970245|NCT01236352|449517584|FG002|Overall Study|Adverse Event|0|||
124970246|NCT01236352|449517585|FG003|Overall Study|Adverse Event|0|||
125034499|NCT01686568|449745972|FG001|Sub-Study|Not consented for sub-study|2|||
125034500|NCT03838484|449745973|FG000|Overall Study|Lost to Follow-up|0|||
125034501|NCT03838484|449745974|FG001|Overall Study|Lost to Follow-up|1|||
125034502|NCT03838484|449745975|FG002|Overall Study|Lost to Follow-up|0|||
124970247|NCT01236352|449517586|FG004|Overall Study|Adverse Event|0|||
124970248|NCT01236352|449517587|FG005|Overall Study|Adverse Event|0|||
124970249|NCT01236352|449517588|FG006|Overall Study|Adverse Event|2|||
124970250|NCT01236352|449517589|FG007|Overall Study|Adverse Event|0|||
124970251|NCT01236352|449517590|FG008|Overall Study|Adverse Event|0|||
124970252|NCT01236352|449517591|FG009|Overall Study|Adverse Event|4|||
124970253|NCT01236352|449517592|FG010|Overall Study|Adverse Event|1|||
124970254|NCT01236352|449517582|FG000|Overall Study|Study drug toxicity|0|||
124970255|NCT01236352|449517583|FG001|Overall Study|Study drug toxicity|0|||
124970256|NCT01236352|449517584|FG002|Overall Study|Study drug toxicity|0|||
125034503|NCT03838484|449745976|FG003|Overall Study|Lost to Follow-up|0|||
125034504|NCT00158184|449745977|FG000|Overall Study|personal issues|3|||
125034505|NCT00158184|449745978|FG001|Overall Study|personal issues|1|||
125034506|NCT00158184|449745977|FG000|Overall Study|failed for follow unit/study rules|2|||
125034507|NCT00158184|449745978|FG001|Overall Study|failed for follow unit/study rules|0|||
125034508|NCT00158184|449745977|FG000|Overall Study|Adverse Event|1|||
125034509|NCT00158184|449745978|FG001|Overall Study|Adverse Event|1|||
125034510|NCT02868892|449745981|FG000|Overall Study|Investigator left site and no follow-up|6|||
125034511|NCT02393209|449745985|FG000|Overall Study|Study Terminated by Sponsor|1|||
125034512|NCT02393209|449745986|FG001|Overall Study|Study Terminated by Sponsor|1|||
125034513|NCT02393209|449745987|FG002|Overall Study|Study Terminated by Sponsor|0|||
125034514|NCT02393209|449745988|FG003|Overall Study|Study Terminated by Sponsor|0|||
125034515|NCT02393209|449745985|FG000|Overall Study|Withdrawal by Patient|1|||
125034516|NCT02393209|449745986|FG001|Overall Study|Withdrawal by Patient|0|||
125034517|NCT02393209|449745987|FG002|Overall Study|Withdrawal by Patient|0|||
125034518|NCT02393209|449745988|FG003|Overall Study|Withdrawal by Patient|0|||
125034519|NCT02393209|449745985|FG000|Overall Study|Death|2|||
125034520|NCT02393209|449745986|FG001|Overall Study|Death|2|||
125034521|NCT02393209|449745987|FG002|Overall Study|Death|0|||
125034522|NCT02393209|449745988|FG003|Overall Study|Death|0|||
125034523|NCT02393209|449745985|FG000|Overall Study|Death due to Disease Progression|2|||
125034524|NCT02393209|449745986|FG001|Overall Study|Death due to Disease Progression|2|||
125034525|NCT02393209|449745987|FG002|Overall Study|Death due to Disease Progression|0|||
125034526|NCT02393209|449745988|FG003|Overall Study|Death due to Disease Progression|0|||
125034527|NCT02393209|449745985|FG000|Overall Study|Death from Legionella Infection|0|||
125034528|NCT02393209|449745986|FG001|Overall Study|Death from Legionella Infection|1|||
125034529|NCT02393209|449745987|FG002|Overall Study|Death from Legionella Infection|0|||
125034530|NCT02393209|449745988|FG003|Overall Study|Death from Legionella Infection|0|||
125034531|NCT02393209|449745985|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
125034532|NCT02393209|449745986|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
125034533|NCT02393209|449745987|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
125034534|NCT02393209|449745988|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
125034535|NCT02393209|449745985|FG000|Overall Study|Lost to Follow-up|0|||
125034536|NCT02393209|449745986|FG001|Overall Study|Lost to Follow-up|1|||
125034537|NCT02393209|449745987|FG002|Overall Study|Lost to Follow-up|0|||
125034538|NCT02393209|449745988|FG003|Overall Study|Lost to Follow-up|0|||
125034539|NCT00868790|449745989|FG000|Period 1|Adverse Event|1|||
125034540|NCT00868790|449745990|FG001|Period 1|Adverse Event|0|||
125034541|NCT00868790|449745991|FG002|Period 1|Adverse Event|0|||
125034542|NCT00868790|449745992|FG003|Period 1|Adverse Event|0|||
125034543|NCT00868790|449745993|FG004|Period 1|Adverse Event|0|||
125034544|NCT00868790|449745994|FG005|Period 1|Adverse Event|0|||
125034545|NCT00868790|449745995|FG006|Period 1|Adverse Event|0|||
125034546|NCT00868790|449745996|FG007|Period 1|Adverse Event|3|||
125034547|NCT00868790|449745997|FG008|Period 1|Adverse Event|1|||
125034548|NCT00868790|449745998|FG009|Period 1|Adverse Event|0|||
125034549|NCT00868790|449745999|FG010|Period 1|Adverse Event|0|||
125034550|NCT00868790|449746000|FG011|Period 1|Adverse Event|0|||
125034551|NCT00868790|449746001|FG012|Period 1|Adverse Event|0|||
125034552|NCT00868790|449746002|FG013|Period 1|Adverse Event|1|||
125034553|NCT00868790|449745989|FG000|Period 1|Protocol Violation|1|||
125034554|NCT00868790|449745990|FG001|Period 1|Protocol Violation|0|||
125034555|NCT00868790|449745991|FG002|Period 1|Protocol Violation|0|||
125034556|NCT00868790|449745992|FG003|Period 1|Protocol Violation|0|||
125034557|NCT00868790|449745993|FG004|Period 1|Protocol Violation|0|||
125034558|NCT00868790|449745994|FG005|Period 1|Protocol Violation|0|||
125034559|NCT00868790|449745995|FG006|Period 1|Protocol Violation|0|||
125034560|NCT00868790|449745996|FG007|Period 1|Protocol Violation|0|||
125034561|NCT00868790|449745997|FG008|Period 1|Protocol Violation|0|||
125034562|NCT00868790|449745998|FG009|Period 1|Protocol Violation|0|||
125034563|NCT00868790|449745999|FG010|Period 1|Protocol Violation|0|||
125034564|NCT00868790|449746000|FG011|Period 1|Protocol Violation|0|||
125034565|NCT00868790|449746001|FG012|Period 1|Protocol Violation|0|||
125034566|NCT00868790|449746002|FG013|Period 1|Protocol Violation|0|||
125034567|NCT00868790|449745989|FG000|Period 1|Withdrawal by Subject|0|||
125034568|NCT00868790|449745990|FG001|Period 1|Withdrawal by Subject|1|||
125034569|NCT00868790|449745991|FG002|Period 1|Withdrawal by Subject|0|||
125034570|NCT00868790|449745992|FG003|Period 1|Withdrawal by Subject|0|||
125034571|NCT00868790|449745993|FG004|Period 1|Withdrawal by Subject|0|||
125034572|NCT00868790|449745994|FG005|Period 1|Withdrawal by Subject|0|||
125217649|NCT01957579|450425234|FG000|Overall Study|Withdrawal of concent|0|||
125217650|NCT01957579|450425235|FG001|Overall Study|Withdrawal of concent|1|||
125034573|NCT00868790|449745995|FG006|Period 1|Withdrawal by Subject|0|||
125034574|NCT00868790|449745996|FG007|Period 1|Withdrawal by Subject|0|||
125034575|NCT00868790|449745997|FG008|Period 1|Withdrawal by Subject|0|||
125131663|NCT02718326|450110031|FG002|Overall Study|Lost to Follow-up|14|||
124970257|NCT01236352|449517585|FG003|Overall Study|Study drug toxicity|0|||
124970258|NCT01236352|449517586|FG004|Overall Study|Study drug toxicity|0|||
124970259|NCT01236352|449517587|FG005|Overall Study|Study drug toxicity|1|||
124970260|NCT01236352|449517588|FG006|Overall Study|Study drug toxicity|1|||
124970261|NCT01236352|449517589|FG007|Overall Study|Study drug toxicity|0|||
124970262|NCT01236352|449517590|FG008|Overall Study|Study drug toxicity|0|||
124970263|NCT01236352|449517591|FG009|Overall Study|Study drug toxicity|2|||
124970264|NCT01236352|449517592|FG010|Overall Study|Study drug toxicity|2|||
124970265|NCT01236352|449517582|FG000|Overall Study|Disease progression|1|||
124970266|NCT01236352|449517583|FG001|Overall Study|Disease progression|2|||
124970267|NCT01236352|449517584|FG002|Overall Study|Disease progression|1|||
124970268|NCT01236352|449517585|FG003|Overall Study|Disease progression|2|||
124970269|NCT01236352|449517586|FG004|Overall Study|Disease progression|2|||
124970270|NCT01236352|449517587|FG005|Overall Study|Disease progression|2|||
124970271|NCT01236352|449517588|FG006|Overall Study|Disease progression|1|||
124970272|NCT01236352|449517589|FG007|Overall Study|Disease progression|3|||
124970273|NCT01236352|449517590|FG008|Overall Study|Disease progression|2|||
124970274|NCT01236352|449517591|FG009|Overall Study|Disease progression|2|||
124970275|NCT01236352|449517592|FG010|Overall Study|Disease progression|2|||
124970276|NCT01236352|449517582|FG000|Overall Study|Poor/Non-compliance|1|||
124970277|NCT01236352|449517583|FG001|Overall Study|Poor/Non-compliance|0|||
124970278|NCT01236352|449517584|FG002|Overall Study|Poor/Non-compliance|0|||
124970279|NCT01236352|449517585|FG003|Overall Study|Poor/Non-compliance|0|||
124970280|NCT01236352|449517586|FG004|Overall Study|Poor/Non-compliance|0|||
124970281|NCT01236352|449517587|FG005|Overall Study|Poor/Non-compliance|0|||
124970282|NCT01236352|449517588|FG006|Overall Study|Poor/Non-compliance|0|||
124970283|NCT01236352|449517589|FG007|Overall Study|Poor/Non-compliance|0|||
124970284|NCT01236352|449517590|FG008|Overall Study|Poor/Non-compliance|0|||
124970285|NCT01236352|449517591|FG009|Overall Study|Poor/Non-compliance|0|||
124970286|NCT01236352|449517592|FG010|Overall Study|Poor/Non-compliance|0|||
124970287|NCT01236352|449517582|FG000|Overall Study|Maximum clinical benefit|1|||
124970288|NCT01236352|449517583|FG001|Overall Study|Maximum clinical benefit|1|||
124970289|NCT01236352|449517584|FG002|Overall Study|Maximum clinical benefit|1|||
124970290|NCT01236352|449517585|FG003|Overall Study|Maximum clinical benefit|0|||
124970291|NCT01236352|449517586|FG004|Overall Study|Maximum clinical benefit|2|||
124970292|NCT01236352|449517587|FG005|Overall Study|Maximum clinical benefit|0|||
124970293|NCT01236352|449517588|FG006|Overall Study|Maximum clinical benefit|3|||
124970294|NCT01236352|449517589|FG007|Overall Study|Maximum clinical benefit|1|||
124970295|NCT01236352|449517590|FG008|Overall Study|Maximum clinical benefit|1|||
124970296|NCT01236352|449517591|FG009|Overall Study|Maximum clinical benefit|4|||
124970297|NCT01236352|449517592|FG010|Overall Study|Maximum clinical benefit|2|||
124970298|NCT01236352|449517582|FG000|Overall Study|Subject request to discontinue treatment|0|||
124970299|NCT01236352|449517583|FG001|Overall Study|Subject request to discontinue treatment|0|||
124970300|NCT01236352|449517584|FG002|Overall Study|Subject request to discontinue treatment|1|||
124970301|NCT01236352|449517585|FG003|Overall Study|Subject request to discontinue treatment|1|||
124970302|NCT01236352|449517586|FG004|Overall Study|Subject request to discontinue treatment|0|||
124970303|NCT01236352|449517587|FG005|Overall Study|Subject request to discontinue treatment|1|||
124970304|NCT01236352|449517588|FG006|Overall Study|Subject request to discontinue treatment|0|||
124970305|NCT01236352|449517589|FG007|Overall Study|Subject request to discontinue treatment|0|||
124970306|NCT01236352|449517590|FG008|Overall Study|Subject request to discontinue treatment|0|||
124970307|NCT01236352|449517591|FG009|Overall Study|Subject request to discontinue treatment|1|||
124970308|NCT01236352|449517592|FG010|Overall Study|Subject request to discontinue treatment|4|||
124970309|NCT01236352|449517582|FG000|Overall Study|Subject to receive drug via EAP|1|||
124970310|NCT01236352|449517583|FG001|Overall Study|Subject to receive drug via EAP|1|||
124970311|NCT01236352|449517584|FG002|Overall Study|Subject to receive drug via EAP|1|||
124970312|NCT01236352|449517585|FG003|Overall Study|Subject to receive drug via EAP|0|||
124970313|NCT01236352|449517586|FG004|Overall Study|Subject to receive drug via EAP|0|||
124970314|NCT01236352|449517587|FG005|Overall Study|Subject to receive drug via EAP|0|||
124970315|NCT01236352|449517588|FG006|Overall Study|Subject to receive drug via EAP|0|||
124970316|NCT01236352|449517589|FG007|Overall Study|Subject to receive drug via EAP|2|||
124970317|NCT01236352|449517590|FG008|Overall Study|Subject to receive drug via EAP|0|||
124970318|NCT01236352|449517591|FG009|Overall Study|Subject to receive drug via EAP|4|||
124970319|NCT01236352|449517592|FG010|Overall Study|Subject to receive drug via EAP|0|||
124970320|NCT01236352|449517582|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
124970321|NCT01236352|449517583|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
124970322|NCT01236352|449517584|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
124970323|NCT01236352|449517585|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
124970324|NCT01236352|449517586|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
124970325|NCT01236352|449517587|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
124970326|NCT01236352|449517588|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
124970327|NCT01236352|449517589|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
124970328|NCT01236352|449517590|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
124970329|NCT01236352|449517591|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
124970330|NCT01236352|449517592|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
124970331|NCT01236352|449517582|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
124970332|NCT01236352|449517583|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
124970333|NCT01236352|449517584|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
125034576|NCT00868790|449745998|FG009|Period 1|Withdrawal by Subject|0|||
124970334|NCT01236352|449517585|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
124970335|NCT01236352|449517586|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
124970336|NCT01236352|449517587|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
125034577|NCT00868790|449745999|FG010|Period 1|Withdrawal by Subject|0|||
125034578|NCT00868790|449746000|FG011|Period 1|Withdrawal by Subject|0|||
125034579|NCT00868790|449746001|FG012|Period 1|Withdrawal by Subject|0|||
125034580|NCT00868790|449746002|FG013|Period 1|Withdrawal by Subject|1|||
125034581|NCT00868790|449745989|FG000|Period 1|Abnormal Triglycerides|0|||
125034582|NCT00868790|449745990|FG001|Period 1|Abnormal Triglycerides|0|||
125034583|NCT00868790|449745991|FG002|Period 1|Abnormal Triglycerides|0|||
125034584|NCT00868790|449745992|FG003|Period 1|Abnormal Triglycerides|0|||
125034585|NCT00868790|449745993|FG004|Period 1|Abnormal Triglycerides|1|||
125034586|NCT00868790|449745994|FG005|Period 1|Abnormal Triglycerides|0|||
125034587|NCT00868790|449745995|FG006|Period 1|Abnormal Triglycerides|0|||
125034588|NCT00868790|449745996|FG007|Period 1|Abnormal Triglycerides|0|||
125034589|NCT00868790|449745997|FG008|Period 1|Abnormal Triglycerides|0|||
125034590|NCT00868790|449745998|FG009|Period 1|Abnormal Triglycerides|0|||
125034591|NCT00868790|449745999|FG010|Period 1|Abnormal Triglycerides|0|||
125034592|NCT00868790|449746000|FG011|Period 1|Abnormal Triglycerides|0|||
125034593|NCT00868790|449746001|FG012|Period 1|Abnormal Triglycerides|0|||
125034594|NCT00868790|449746002|FG013|Period 1|Abnormal Triglycerides|0|||
125034595|NCT00868790|449745989|FG000|Period 1|Lost to Follow-up|0|||
125034596|NCT00868790|449745990|FG001|Period 1|Lost to Follow-up|0|||
125034597|NCT00868790|449745991|FG002|Period 1|Lost to Follow-up|0|||
125034598|NCT00868790|449745992|FG003|Period 1|Lost to Follow-up|0|||
125034599|NCT00868790|449745993|FG004|Period 1|Lost to Follow-up|0|||
124970337|NCT01236352|449517588|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
124970338|NCT01236352|449517589|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
124970339|NCT01236352|449517590|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
124970340|NCT01236352|449517591|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
124970341|NCT01236352|449517592|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
124970342|NCT01236352|449517582|FG000|Overall Study|Lack of response to drug|0|||
124970343|NCT01236352|449517583|FG001|Overall Study|Lack of response to drug|0|||
124970344|NCT01236352|449517584|FG002|Overall Study|Lack of response to drug|0|||
125131664|NCT02718326|450110029|FG000|Overall Study|Protocol Deviation|1|||
125131665|NCT02718326|450110030|FG001|Overall Study|Protocol Deviation|0|||
125131666|NCT02718326|450110031|FG002|Overall Study|Protocol Deviation|0|||
125131667|NCT02718326|450110029|FG000|Overall Study|Pregnancy|1|||
125131668|NCT02718326|450110030|FG001|Overall Study|Pregnancy|0|||
125131669|NCT02718326|450110031|FG002|Overall Study|Pregnancy|0|||
125131670|NCT02646124|450110032|FG000|Overall Study|Lost to Follow-up|0|||
125131671|NCT02646124|450110033|FG001|Overall Study|Lost to Follow-up|2|||
125131672|NCT03154047|450110035|FG000|Overall Study|Death|1|||
125131673|NCT03154047|450110035|FG000|Overall Study|Study terminated by sponsor|76|||
125131674|NCT03154047|450110035|FG000|Overall Study|Withdrawal by Subject|3|||
125131675|NCT00857454|450110036|FG000|Overall Study|Withdrawal by Subject|2|||
125131676|NCT00857454|450110036|FG000|Overall Study|Lost to Follow-up|1|||
125131677|NCT00857454|450110036|FG000|Overall Study|Adverse Event|2|||
125131678|NCT00857454|450110036|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
125131679|NCT00857454|450110036|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
125131680|NCT00857454|450110036|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
125131681|NCT02436005|450110037|FG000|Second Intervention|Adverse Event|0|||
125131682|NCT02436005|450110038|FG001|Second Intervention|Adverse Event|1|||
125131683|NCT00573443|450110039|FG000|Double-Blind Phase|Lost to Follow-up|1|||
125131684|NCT00573443|450110040|FG001|Double-Blind Phase|Lost to Follow-up|3|||
125131685|NCT00573443|450110041|FG002|Double-Blind Phase|Lost to Follow-up|2|||
125131686|NCT00573443|450110039|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
125131687|NCT00573443|450110040|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
125131688|NCT00573443|450110041|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
125131689|NCT00573443|450110039|FG000|Double-Blind Phase|Adverse Event|1|||
125217651|NCT01957579|450425236|FG002|Overall Study|Withdrawal of concent|0|||
125217652|NCT01957579|450425237|FG003|Overall Study|Withdrawal of concent|0|||
125217653|NCT01957579|450425234|FG000|Overall Study|Death|0|||
125217654|NCT01957579|450425235|FG001|Overall Study|Death|0|||
125217655|NCT01957579|450425236|FG002|Overall Study|Death|2|||
125131690|NCT00573443|450110040|FG001|Double-Blind Phase|Adverse Event|5|||
125131691|NCT00573443|450110041|FG002|Double-Blind Phase|Adverse Event|0|||
125131692|NCT00573443|450110039|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
125131693|NCT00573443|450110040|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
125131694|NCT00573443|450110041|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
125217656|NCT01957579|450425237|FG003|Overall Study|Death|0|||
125217657|NCT01639144|450425240|FG000|Overall Study|Withdrawal by Subject|4|||
125217658|NCT01639144|450425241|FG001|Overall Study|Withdrawal by Subject|2|||
125217659|NCT01639144|450425240|FG000|Overall Study|Physician Decision|2|||
125217660|NCT01639144|450425241|FG001|Overall Study|Physician Decision|0|||
125217661|NCT01639144|450425240|FG000|Overall Study|Met postoperative exclusion criteria|4|||
125217662|NCT01639144|450425241|FG001|Overall Study|Met postoperative exclusion criteria|3|||
125217663|NCT02239640|450425250|FG000|Overall Study|Withdrawal by Subject|3|||
125217664|NCT02239640|450425250|FG000|Overall Study|Lost to Follow-up|72|||
125217665|NCT02239640|450425250|FG000|Overall Study|Death|142|||
125217666|NCT02630563|450425251|FG000|Overall Study|Administrative|1|||
125217667|NCT02485483|450425252|FG000|Overall Study|Depression at baseline|15|||
125217668|NCT02485483|450425253|FG001|Overall Study|Depression at baseline|0|||
125217669|NCT02485483|450425252|FG000|Overall Study|Discontinued after baseline|39|||
125217670|NCT02485483|450425253|FG001|Overall Study|Discontinued after baseline|0|||
125217671|NCT02061813|450425254|FG000|Overall Study|Withdrawal by Subject|1|||
125217672|NCT02061813|450425254|FG000|Overall Study|Protocol Violation|2|||
125217673|NCT01724177|450425258|FG000|Overall Study|Adverse Event|8|||
125217674|NCT01724177|450425258|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
125217675|NCT01724177|450425258|FG000|Overall Study|Nervous participant|1|||
125217676|NCT01724177|450425258|FG000|Overall Study|Serious Adverse Event Related|1|||
125217677|NCT01705080|450425261|FG000|Overall Study|Missed visit|10|||
125217678|NCT01705080|450425262|FG001|Overall Study|Missed visit|4|||
125217679|NCT01705080|450425263|FG002|Overall Study|Missed visit|1|||
125217680|NCT01705080|450425261|FG000|Overall Study|Death|4|||
125217681|NCT01705080|450425262|FG001|Overall Study|Death|4|||
125217682|NCT01705080|450425263|FG002|Overall Study|Death|6|||
125217683|NCT01705080|450425261|FG000|Overall Study|Withdrawal by Subject|61|||
125217684|NCT01705080|450425262|FG001|Overall Study|Withdrawal by Subject|44|||
125217685|NCT01705080|450425263|FG002|Overall Study|Withdrawal by Subject|9|||
125217686|NCT00206427|450425266|FG000|Overall Study|Adverse Event|2|||
125217687|NCT00281697|450425270|FG000|Overall Study|> 60 days since last dose of study drug|4|||
125034600|NCT00868790|449745994|FG005|Period 1|Lost to Follow-up|1|||
125034601|NCT00868790|449745995|FG006|Period 1|Lost to Follow-up|0|||
125034602|NCT00868790|449745996|FG007|Period 1|Lost to Follow-up|0|||
125034603|NCT00868790|449745997|FG008|Period 1|Lost to Follow-up|0|||
125034604|NCT00868790|449745998|FG009|Period 1|Lost to Follow-up|0|||
125034605|NCT00868790|449745999|FG010|Period 1|Lost to Follow-up|0|||
125034606|NCT00868790|449746000|FG011|Period 1|Lost to Follow-up|0|||
125034607|NCT00868790|449746001|FG012|Period 1|Lost to Follow-up|0|||
125034608|NCT00868790|449746002|FG013|Period 1|Lost to Follow-up|0|||
125034609|NCT00868790|449745989|FG000|Period 2|Adverse Event|0|||
125034610|NCT00868790|449745990|FG001|Period 2|Adverse Event|0|||
125034611|NCT00868790|449745991|FG002|Period 2|Adverse Event|0|||
125034612|NCT00868790|449745992|FG003|Period 2|Adverse Event|0|||
125034613|NCT00868790|449745993|FG004|Period 2|Adverse Event|0|||
125034614|NCT00868790|449745994|FG005|Period 2|Adverse Event|0|||
125034615|NCT00868790|449745995|FG006|Period 2|Adverse Event|0|||
125217688|NCT00281697|450425271|FG001|Overall Study|> 60 days since last dose of study drug|4|||
125217689|NCT00281697|450425270|FG000|Overall Study|Adverse Event|54|||
125217690|NCT00281697|450425271|FG001|Overall Study|Adverse Event|15|||
125217691|NCT00281697|450425270|FG000|Overall Study|Death|8|||
125217692|NCT00281697|450425271|FG001|Overall Study|Death|3|||
125217693|NCT00281697|450425270|FG000|Overall Study|Disease progression|279|||
125217694|NCT00281697|450425271|FG001|Overall Study|Disease progression|149|||
125217695|NCT00281697|450425270|FG000|Overall Study|Other|5|||
125217696|NCT00281697|450425271|FG001|Overall Study|Other|6|||
125217697|NCT00281697|450425270|FG000|Overall Study|Physician's decision to withdraw|15|||
125217698|NCT00281697|450425271|FG001|Overall Study|Physician's decision to withdraw|12|||
125217699|NCT00281697|450425270|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
125217700|NCT00281697|450425271|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
125217701|NCT00281697|450425270|FG000|Overall Study|Did not receive study drug|3|||
125217702|NCT00281697|450425271|FG001|Overall Study|Did not receive study drug|2|||
125217703|NCT03130959|450425284|FG000|Overall Study|Disease progression|19|||
125217704|NCT03130959|450425285|FG001|Overall Study|Disease progression|7|||
125217705|NCT03130959|450425286|FG002|Overall Study|Disease progression|12|||
125217706|NCT03130959|450425287|FG003|Overall Study|Disease progression|7|||
125217707|NCT03130959|450425288|FG004|Overall Study|Disease progression|12|||
125217708|NCT03130959|450425289|FG005|Overall Study|Disease progression|3|||
125217709|NCT03130959|450425290|FG006|Overall Study|Disease progression|6|||
125217710|NCT03130959|450425291|FG007|Overall Study|Disease progression|3|||
125217711|NCT03130959|450425292|FG008|Overall Study|Disease progression|15|||
125217712|NCT03130959|450425293|FG009|Overall Study|Disease progression|8|||
125217713|NCT03130959|450425284|FG000|Overall Study|Study drug toxicity|2|||
125217714|NCT03130959|450425285|FG001|Overall Study|Study drug toxicity|2|||
125217715|NCT03130959|450425286|FG002|Overall Study|Study drug toxicity|1|||
125217716|NCT03130959|450425287|FG003|Overall Study|Study drug toxicity|2|||
125217717|NCT03130959|450425288|FG004|Overall Study|Study drug toxicity|1|||
125217718|NCT03130959|450425289|FG005|Overall Study|Study drug toxicity|1|||
125217719|NCT03130959|450425290|FG006|Overall Study|Study drug toxicity|3|||
125217720|NCT03130959|450425291|FG007|Overall Study|Study drug toxicity|0|||
125217721|NCT03130959|450425292|FG008|Overall Study|Study drug toxicity|3|||
125217722|NCT03130959|450425293|FG009|Overall Study|Study drug toxicity|3|||
125217723|NCT03130959|450425284|FG000|Overall Study|Other reasons|0|||
125217724|NCT03130959|450425285|FG001|Overall Study|Other reasons|0|||
125217725|NCT03130959|450425286|FG002|Overall Study|Other reasons|0|||
125217726|NCT03130959|450425287|FG003|Overall Study|Other reasons|0|||
125217727|NCT03130959|450425288|FG004|Overall Study|Other reasons|0|||
125217728|NCT03130959|450425289|FG005|Overall Study|Other reasons|1|||
125217729|NCT03130959|450425290|FG006|Overall Study|Other reasons|1|||
125217730|NCT03130959|450425291|FG007|Overall Study|Other reasons|0|||
125217731|NCT03130959|450425292|FG008|Overall Study|Other reasons|0|||
125217732|NCT03130959|450425293|FG009|Overall Study|Other reasons|0|||
125217733|NCT03130959|450425284|FG000|Overall Study|Subject request to discontinue therapy|0|||
125217734|NCT03130959|450425285|FG001|Overall Study|Subject request to discontinue therapy|0|||
125217735|NCT03130959|450425286|FG002|Overall Study|Subject request to discontinue therapy|1|||
125217736|NCT03130959|450425287|FG003|Overall Study|Subject request to discontinue therapy|1|||
125217737|NCT03130959|450425288|FG004|Overall Study|Subject request to discontinue therapy|0|||
125217738|NCT03130959|450425289|FG005|Overall Study|Subject request to discontinue therapy|0|||
125217739|NCT03130959|450425290|FG006|Overall Study|Subject request to discontinue therapy|1|||
125217740|NCT03130959|450425291|FG007|Overall Study|Subject request to discontinue therapy|1|||
125217741|NCT03130959|450425292|FG008|Overall Study|Subject request to discontinue therapy|0|||
125217742|NCT03130959|450425293|FG009|Overall Study|Subject request to discontinue therapy|0|||
125217743|NCT03130959|450425284|FG000|Overall Study|Not reported|0|||
125217744|NCT03130959|450425285|FG001|Overall Study|Not reported|0|||
125217745|NCT03130959|450425286|FG002|Overall Study|Not reported|0|||
125217746|NCT03130959|450425287|FG003|Overall Study|Not reported|1|||
125217747|NCT03130959|450425288|FG004|Overall Study|Not reported|0|||
125217748|NCT03130959|450425289|FG005|Overall Study|Not reported|1|||
125217749|NCT03130959|450425290|FG006|Overall Study|Not reported|0|||
125034616|NCT00868790|449745996|FG007|Period 2|Adverse Event|0|||
125034617|NCT00868790|449745997|FG008|Period 2|Adverse Event|1|||
125034618|NCT00868790|449745998|FG009|Period 2|Adverse Event|0|||
125034619|NCT00868790|449745999|FG010|Period 2|Adverse Event|0|||
125034620|NCT00868790|449746000|FG011|Period 2|Adverse Event|0|||
125034621|NCT00868790|449746001|FG012|Period 2|Adverse Event|0|||
125034622|NCT00868790|449746002|FG013|Period 2|Adverse Event|0|||
125131695|NCT00573443|450110039|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
125131696|NCT00573443|450110040|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
125131697|NCT00573443|450110041|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
125131698|NCT00573443|450110039|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
125131699|NCT00573443|450110040|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
125131700|NCT00573443|450110041|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
125131701|NCT00573443|450110039|FG000|Double-Blind Phase|Protocol Violation|0|||
125034623|NCT00868790|449745989|FG000|Period 2|Lost to Follow-up|0|||
125034624|NCT00868790|449745990|FG001|Period 2|Lost to Follow-up|1|||
125131702|NCT00573443|450110040|FG001|Double-Blind Phase|Protocol Violation|2|||
125131703|NCT00573443|450110041|FG002|Double-Blind Phase|Protocol Violation|1|||
125034625|NCT00868790|449745991|FG002|Period 2|Lost to Follow-up|0|||
125034626|NCT00868790|449745992|FG003|Period 2|Lost to Follow-up|0|||
125034627|NCT00868790|449745993|FG004|Period 2|Lost to Follow-up|0|||
125034628|NCT00868790|449745994|FG005|Period 2|Lost to Follow-up|1|||
125034629|NCT00868790|449745995|FG006|Period 2|Lost to Follow-up|0|||
125034630|NCT00868790|449745996|FG007|Period 2|Lost to Follow-up|0|||
125131704|NCT00573443|450110039|FG000|Double-Blind Phase|Other|0|||
125131705|NCT00573443|450110040|FG001|Double-Blind Phase|Other|2|||
125131706|NCT00573443|450110041|FG002|Double-Blind Phase|Other|3|||
125131707|NCT00573443|450110039|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
125131708|NCT00573443|450110040|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
125131709|NCT00573443|450110041|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
125131710|NCT00573443|450110039|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
125131711|NCT00573443|450110040|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
125131712|NCT00573443|450110041|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
125131713|NCT00573443|450110039|FG000|Open-Label Extension Phase|Adverse Event|3|||
125131714|NCT00573443|450110040|FG001|Open-Label Extension Phase|Adverse Event|0|||
125131715|NCT00573443|450110041|FG002|Open-Label Extension Phase|Adverse Event|0|||
125034631|NCT00868790|449745997|FG008|Period 2|Lost to Follow-up|0|||
125034632|NCT00868790|449745998|FG009|Period 2|Lost to Follow-up|0|||
125034633|NCT00868790|449745999|FG010|Period 2|Lost to Follow-up|0|||
125131716|NCT00573443|450110039|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
125131717|NCT00573443|450110040|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
124970345|NCT01236352|449517585|FG003|Overall Study|Lack of response to drug|0|||
124970346|NCT01236352|449517586|FG004|Overall Study|Lack of response to drug|0|||
124970347|NCT01236352|449517587|FG005|Overall Study|Lack of response to drug|0|||
124970348|NCT01236352|449517588|FG006|Overall Study|Lack of response to drug|0|||
124970349|NCT01236352|449517589|FG007|Overall Study|Lack of response to drug|0|||
124970350|NCT01236352|449517590|FG008|Overall Study|Lack of response to drug|0|||
124970351|NCT01236352|449517591|FG009|Overall Study|Lack of response to drug|1|||
124970352|NCT01236352|449517592|FG010|Overall Study|Lack of response to drug|1|||
124970353|NCT01236352|449517582|FG000|Overall Study|Patient transferred to IST|0|||
124970354|NCT01236352|449517583|FG001|Overall Study|Patient transferred to IST|0|||
124970355|NCT01236352|449517584|FG002|Overall Study|Patient transferred to IST|0|||
124970356|NCT01236352|449517585|FG003|Overall Study|Patient transferred to IST|0|||
124970357|NCT01236352|449517586|FG004|Overall Study|Patient transferred to IST|0|||
124970358|NCT01236352|449517587|FG005|Overall Study|Patient transferred to IST|0|||
124970359|NCT01236352|449517588|FG006|Overall Study|Patient transferred to IST|0|||
124970360|NCT01236352|449517589|FG007|Overall Study|Patient transferred to IST|0|||
124970361|NCT01236352|449517590|FG008|Overall Study|Patient transferred to IST|0|||
124970362|NCT01236352|449517591|FG009|Overall Study|Patient transferred to IST|2|||
124970363|NCT01236352|449517592|FG010|Overall Study|Patient transferred to IST|6|||
124970364|NCT04913948|449517599|FG000|Overall Study|Withdrawal by Subject|2|||
124970365|NCT04913948|449517599|FG000|Overall Study|Sample processing issues|1|||
124970366|NCT04913948|449517599|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
124970367|NCT01068210|449517602|FG000|Overall Study|Lost to Follow-up|1|||
124970368|NCT01068210|449517603|FG001|Overall Study|Lost to Follow-up|2|||
124970369|NCT01068210|449517604|FG002|Overall Study|Lost to Follow-up|2|||
124970370|NCT01068210|449517605|FG003|Overall Study|Lost to Follow-up|1|||
124970371|NCT01068210|449517602|FG000|Overall Study|Second cancer|0|||
124970372|NCT01068210|449517603|FG001|Overall Study|Second cancer|1|||
124970373|NCT01068210|449517604|FG002|Overall Study|Second cancer|0|||
124970374|NCT01068210|449517605|FG003|Overall Study|Second cancer|0|||
124970375|NCT01068210|449517602|FG000|Overall Study|Disease progression|0|||
124970376|NCT01068210|449517603|FG001|Overall Study|Disease progression|0|||
124970377|NCT01068210|449517604|FG002|Overall Study|Disease progression|0|||
124970378|NCT01068210|449517605|FG003|Overall Study|Disease progression|2|||
124970379|NCT05990387|449517606|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
124970380|NCT05990387|449517607|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
124970381|NCT04750577|449517608|FG000|Overall Study|Adverse Event|2|||
124970382|NCT04750577|449517609|FG001|Overall Study|Adverse Event|10|||
124970383|NCT04750577|449517610|FG002|Overall Study|Adverse Event|8|||
124970384|NCT04750577|449517611|FG003|Overall Study|Adverse Event|1|||
124970385|NCT04750577|449517608|FG000|Overall Study|Change of residence|0|||
124970386|NCT04750577|449517609|FG001|Overall Study|Change of residence|0|||
124970387|NCT04750577|449517610|FG002|Overall Study|Change of residence|1|||
125034634|NCT00868790|449746000|FG011|Period 2|Lost to Follow-up|0|||
125034635|NCT00868790|449746001|FG012|Period 2|Lost to Follow-up|0|||
125034636|NCT00868790|449746002|FG013|Period 2|Lost to Follow-up|0|||
125034637|NCT00868790|449745989|FG000|Period 2|Withdrawal by Subject|0|||
125034638|NCT00868790|449745990|FG001|Period 2|Withdrawal by Subject|0|||
125034639|NCT00868790|449745991|FG002|Period 2|Withdrawal by Subject|0|||
124970388|NCT04750577|449517611|FG003|Overall Study|Change of residence|0|||
124970389|NCT04750577|449517608|FG000|Overall Study|Burden of study procedures|0|||
124970390|NCT04750577|449517609|FG001|Overall Study|Burden of study procedures|2|||
124970391|NCT04750577|449517610|FG002|Overall Study|Burden of study procedures|2|||
124970392|NCT04750577|449517611|FG003|Overall Study|Burden of study procedures|0|||
124970393|NCT04750577|449517608|FG000|Overall Study|Prematurely discontinued|0|||
124970394|NCT04750577|449517609|FG001|Overall Study|Prematurely discontinued|0|||
124970395|NCT04750577|449517610|FG002|Overall Study|Prematurely discontinued|0|||
124970396|NCT04750577|449517611|FG003|Overall Study|Prematurely discontinued|2|||
124970397|NCT04750577|449517608|FG000|Overall Study|Protocol deviation|1|||
124970398|NCT04750577|449517609|FG001|Overall Study|Protocol deviation|1|||
124970399|NCT04750577|449517610|FG002|Overall Study|Protocol deviation|1|||
124970400|NCT04750577|449517611|FG003|Overall Study|Protocol deviation|1|||
124970401|NCT04750577|449517608|FG000|Overall Study|Other than listed|3|||
124970402|NCT04750577|449517609|FG001|Overall Study|Other than listed|2|||
124970403|NCT04750577|449517610|FG002|Overall Study|Other than listed|2|||
124970404|NCT04750577|449517611|FG003|Overall Study|Other than listed|1|||
124970405|NCT04750577|449517608|FG000|Overall Study|Not treated|0|||
124970406|NCT04750577|449517609|FG001|Overall Study|Not treated|0|||
124970407|NCT04750577|449517610|FG002|Overall Study|Not treated|0|||
124970408|NCT04750577|449517611|FG003|Overall Study|Not treated|2|||
124970409|NCT03371823|449517614|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
124970410|NCT03371823|449517615|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
124970411|NCT01263054|449517617|FG000|Overall Study|Death|1|||
124970412|NCT01263054|449517618|FG001|Overall Study|Death|0|||
124970413|NCT01263054|449517617|FG000|Overall Study|Lost to Follow-up|2|||
124970414|NCT01263054|449517618|FG001|Overall Study|Lost to Follow-up|2|||
124970415|NCT01263054|449517617|FG000|Overall Study|Withdrawal by Subject|1|||
124970416|NCT01263054|449517618|FG001|Overall Study|Withdrawal by Subject|3|||
124970417|NCT01263054|449517617|FG000|Overall Study|Qualification Violation|1|||
124970418|NCT01263054|449517618|FG001|Overall Study|Qualification Violation|0|||
124970419|NCT01263054|449517617|FG000|Overall Study|Other|0|||
124970420|NCT01263054|449517618|FG001|Overall Study|Other|1|||
124970421|NCT02035696|449519267|FG000|Overall Study|Lost to Follow-up|0|||
124970422|NCT02035696|449519268|FG001|Overall Study|Lost to Follow-up|3|||
124970423|NCT02035696|449519269|FG002|Overall Study|Lost to Follow-up|1|||
124970424|NCT02035696|449519270|FG003|Overall Study|Lost to Follow-up|2|||
124970425|NCT02035696|449519267|FG000|Overall Study|Withdrawal by Subject|3|||
124970426|NCT02035696|449519268|FG001|Overall Study|Withdrawal by Subject|0|||
124970427|NCT02035696|449519269|FG002|Overall Study|Withdrawal by Subject|2|||
124970428|NCT02035696|449519270|FG003|Overall Study|Withdrawal by Subject|1|||
124970429|NCT00966264|449519271|FG000|Overall Study|Lost to Follow-up|4|||
124970430|NCT00966264|449519272|FG001|Overall Study|Lost to Follow-up|3|||
124970431|NCT01246999|449519273|FG000|Overall Study|Lost to Follow-up|0|||
124970432|NCT01246999|449519274|FG001|Overall Study|Lost to Follow-up|1|||
124970433|NCT01246999|449519275|FG002|Overall Study|Lost to Follow-up|0|||
124970434|NCT01246999|449519276|FG003|Overall Study|Lost to Follow-up|0|||
124970435|NCT01246999|449519273|FG000|Overall Study|Withdrawal by Subject|0|||
124970436|NCT01246999|449519274|FG001|Overall Study|Withdrawal by Subject|0|||
124970437|NCT01246999|449519275|FG002|Overall Study|Withdrawal by Subject|0|||
124970438|NCT01246999|449519276|FG003|Overall Study|Withdrawal by Subject|2|||
124970439|NCT01867047|449519277|FG000|Overall Study|Lost to Follow-up|3|||
124970440|NCT01867047|449519278|FG001|Overall Study|Lost to Follow-up|3|||
124970441|NCT01867047|449519277|FG000|Overall Study|Withdrawal by Subject|2|||
124970442|NCT01867047|449519278|FG001|Overall Study|Withdrawal by Subject|0|||
124970443|NCT01867047|449519277|FG000|Overall Study|Physician Decision|2|||
124970444|NCT01867047|449519278|FG001|Overall Study|Physician Decision|0|||
124970445|NCT01867047|449519277|FG000|Overall Study|surgery not indicated in protocol|1|||
124970446|NCT01867047|449519278|FG001|Overall Study|surgery not indicated in protocol|2|||
124970447|NCT01536587|449519281|FG000|Overall Study|Adverse Event|2|||
124970448|NCT02354651|449519282|FG000|Overall Study|Withdrawal by Subject|2|||
124970449|NCT02354651|449519282|FG000|Overall Study|Physician Decision|1|||
124970450|NCT01245140|449519289|FG000|Overall Study|Adverse Event|1|||
124970451|NCT01245140|449519290|FG001|Overall Study|Adverse Event|3|||
124970452|NCT01245140|449519289|FG000|Overall Study|Lack of Efficacy|2|||
124970453|NCT01245140|449519290|FG001|Overall Study|Lack of Efficacy|4|||
124970454|NCT01245140|449519289|FG000|Overall Study|Protocol Violation|0|||
125034640|NCT00868790|449745992|FG003|Period 2|Withdrawal by Subject|0|||
125034641|NCT00868790|449745993|FG004|Period 2|Withdrawal by Subject|0|||
125034642|NCT00868790|449745994|FG005|Period 2|Withdrawal by Subject|0|||
124970455|NCT01245140|449519290|FG001|Overall Study|Protocol Violation|1|||
125034643|NCT00868790|449745995|FG006|Period 2|Withdrawal by Subject|0|||
125034644|NCT00868790|449745996|FG007|Period 2|Withdrawal by Subject|0|||
125034645|NCT00868790|449745997|FG008|Period 2|Withdrawal by Subject|1|||
125034646|NCT00868790|449745998|FG009|Period 2|Withdrawal by Subject|0|||
125034647|NCT00868790|449745999|FG010|Period 2|Withdrawal by Subject|0|||
125034648|NCT00868790|449746000|FG011|Period 2|Withdrawal by Subject|0|||
125034649|NCT00868790|449746001|FG012|Period 2|Withdrawal by Subject|0|||
125034650|NCT00868790|449746002|FG013|Period 2|Withdrawal by Subject|1|||
125131718|NCT00573443|450110041|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
124970456|NCT01245140|449519289|FG000|Overall Study|Withdrawal by Subject|0|||
124970457|NCT01245140|449519290|FG001|Overall Study|Withdrawal by Subject|1|||
124970458|NCT01245140|449519289|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
124970459|NCT01245140|449519290|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
124970460|NCT04836559|449519291|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
124970461|NCT04836559|449519292|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
124970462|NCT04836559|449519293|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
124970463|NCT04836559|449519294|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
124970464|NCT04836559|449519295|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
124970465|NCT04836559|449519296|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
124970466|NCT04836559|449519297|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
124970467|NCT04836559|449519298|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
124970468|NCT04836559|449519291|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
124970469|NCT04836559|449519292|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
124970470|NCT04836559|449519293|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
124970471|NCT04836559|449519294|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
124970472|NCT04836559|449519295|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
124970473|NCT04836559|449519296|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
124970474|NCT04836559|449519297|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
125034651|NCT00868790|449745989|FG000|Period 3|Adverse Event|0|||
125034652|NCT00868790|449745990|FG001|Period 3|Adverse Event|0|||
125034653|NCT00868790|449745991|FG002|Period 3|Adverse Event|0|||
125034654|NCT00868790|449745992|FG003|Period 3|Adverse Event|0|||
125034655|NCT00868790|449745993|FG004|Period 3|Adverse Event|0|||
125131719|NCT00573443|450110039|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
125131720|NCT00573443|450110040|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
125131721|NCT00573443|450110041|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
125131722|NCT00573443|450110039|FG000|Open-Label Extension Phase|Protocol Violation|2|||
125131723|NCT00573443|450110040|FG001|Open-Label Extension Phase|Protocol Violation|0|||
125131724|NCT00573443|450110041|FG002|Open-Label Extension Phase|Protocol Violation|0|||
125131725|NCT00573443|450110039|FG000|Open-Label Extension Phase|Other|2|||
125131726|NCT00573443|450110040|FG001|Open-Label Extension Phase|Other|0|||
125131727|NCT00573443|450110041|FG002|Open-Label Extension Phase|Other|0|||
125131728|NCT00804856|450110042|FG000|Overall Study|Progressive Disease|3|||
125131729|NCT00804856|450110043|FG001|Overall Study|Progressive Disease|2|||
125131730|NCT00804856|450110044|FG002|Overall Study|Progressive Disease|4|||
125131731|NCT00804856|450110045|FG003|Overall Study|Progressive Disease|6|||
125131732|NCT00804856|450110046|FG004|Overall Study|Progressive Disease|4|||
125131733|NCT00804856|450110047|FG005|Overall Study|Progressive Disease|1|||
125131734|NCT00804856|450110048|FG006|Overall Study|Progressive Disease|8|||
125131735|NCT00804856|450110049|FG007|Overall Study|Progressive Disease|2|||
125131736|NCT00804856|450110050|FG008|Overall Study|Progressive Disease|4|||
125131737|NCT00804856|450110051|FG009|Overall Study|Progressive Disease|5|||
125131738|NCT00804856|450110052|FG010|Overall Study|Progressive Disease|12|||
125131739|NCT00804856|450110053|FG011|Overall Study|Progressive Disease|2|||
125131740|NCT00804856|450110054|FG012|Overall Study|Progressive Disease|2|||
125131741|NCT00804856|450110055|FG013|Overall Study|Progressive Disease|26|||
125131742|NCT00804856|450110056|FG014|Overall Study|Progressive Disease|20|||
125217750|NCT03130959|450425291|FG007|Overall Study|Not reported|0|||
125034656|NCT00868790|449745994|FG005|Period 3|Adverse Event|0|||
125034657|NCT00868790|449745995|FG006|Period 3|Adverse Event|0|||
125034658|NCT00868790|449745996|FG007|Period 3|Adverse Event|0|||
125034659|NCT00868790|449745997|FG008|Period 3|Adverse Event|0|||
125034660|NCT00868790|449745998|FG009|Period 3|Adverse Event|1|||
125034661|NCT00868790|449745999|FG010|Period 3|Adverse Event|0|||
125034662|NCT00868790|449746000|FG011|Period 3|Adverse Event|0|||
125034663|NCT00868790|449746001|FG012|Period 3|Adverse Event|0|||
125034664|NCT00868790|449746002|FG013|Period 3|Adverse Event|0|||
125034665|NCT00868790|449745989|FG000|Period 3|Protocol Violation|0|||
125034666|NCT00868790|449745990|FG001|Period 3|Protocol Violation|0|||
125131743|NCT00804856|450110042|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125131744|NCT00804856|450110043|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125034667|NCT00868790|449745991|FG002|Period 3|Protocol Violation|0|||
125034668|NCT00868790|449745992|FG003|Period 3|Protocol Violation|0|||
125034669|NCT00868790|449745993|FG004|Period 3|Protocol Violation|0|||
125034670|NCT00868790|449745994|FG005|Period 3|Protocol Violation|0|||
125034671|NCT00868790|449745995|FG006|Period 3|Protocol Violation|0|||
125034672|NCT00868790|449745996|FG007|Period 3|Protocol Violation|0|||
125034673|NCT00868790|449745997|FG008|Period 3|Protocol Violation|0|||
125034674|NCT00868790|449745998|FG009|Period 3|Protocol Violation|0|||
125034675|NCT00868790|449745999|FG010|Period 3|Protocol Violation|1|||
124970475|NCT04836559|449519298|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
124970476|NCT04836559|449519291|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
124970477|NCT04836559|449519292|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
124970478|NCT04836559|449519293|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
124970479|NCT04836559|449519294|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
124970480|NCT04836559|449519295|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
124970481|NCT04836559|449519296|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
124970482|NCT04836559|449519297|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
124970483|NCT04836559|449519298|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
124970484|NCT04836559|449519291|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
124970485|NCT04836559|449519292|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
124970486|NCT04836559|449519293|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
124970487|NCT04836559|449519294|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
124970488|NCT04836559|449519295|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
124970489|NCT04836559|449519296|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
124970490|NCT04836559|449519297|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
124970491|NCT04836559|449519298|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
124970492|NCT04836559|449519291|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
124970493|NCT04836559|449519292|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
124970494|NCT04836559|449519293|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
124970495|NCT04836559|449519294|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
124970496|NCT04836559|449519295|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
124970497|NCT04836559|449519296|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
124970498|NCT04836559|449519297|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
124970499|NCT04836559|449519298|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
124970500|NCT04836559|449519291|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
124970501|NCT04836559|449519292|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
124970502|NCT04836559|449519293|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
124970503|NCT04836559|449519294|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
124970504|NCT04836559|449519295|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
124970505|NCT04836559|449519296|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
124970506|NCT04836559|449519297|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
124970507|NCT04836559|449519298|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
124970508|NCT04836559|449519291|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
124970509|NCT04836559|449519292|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
124970510|NCT04836559|449519293|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
124970511|NCT04836559|449519294|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
124970512|NCT04836559|449519295|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
125034676|NCT00868790|449746000|FG011|Period 3|Protocol Violation|0|||
124970513|NCT04836559|449519296|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
125034677|NCT00868790|449746001|FG012|Period 3|Protocol Violation|0|||
125131745|NCT00804856|450110044|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125131746|NCT00804856|450110045|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125034678|NCT00868790|449746002|FG013|Period 3|Protocol Violation|0|||
125034679|NCT00868790|449745989|FG000|Period 3|Study Terminated by Sponsor|0|||
125131747|NCT00804856|450110046|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
125131748|NCT00804856|450110047|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125131749|NCT00804856|450110048|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125131750|NCT00804856|450110049|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125131751|NCT00804856|450110050|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125131752|NCT00804856|450110051|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125131753|NCT00804856|450110052|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125131754|NCT00804856|450110053|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125131755|NCT00804856|450110054|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125131756|NCT00804856|450110055|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125131757|NCT00804856|450110056|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
125131758|NCT00804856|450110042|FG000|Overall Study|Other Adverse Event|1|||
125131759|NCT00804856|450110043|FG001|Overall Study|Other Adverse Event|1|||
125131760|NCT00804856|450110044|FG002|Overall Study|Other Adverse Event|1|||
125131761|NCT00804856|450110045|FG003|Overall Study|Other Adverse Event|2|||
125131762|NCT00804856|450110046|FG004|Overall Study|Other Adverse Event|2|||
125131763|NCT00804856|450110047|FG005|Overall Study|Other Adverse Event|1|||
125131764|NCT00804856|450110048|FG006|Overall Study|Other Adverse Event|3|||
125131765|NCT00804856|450110049|FG007|Overall Study|Other Adverse Event|0|||
125131766|NCT00804856|450110050|FG008|Overall Study|Other Adverse Event|0|||
125131767|NCT00804856|450110051|FG009|Overall Study|Other Adverse Event|1|||
125131768|NCT00804856|450110052|FG010|Overall Study|Other Adverse Event|5|||
125131769|NCT00804856|450110053|FG011|Overall Study|Other Adverse Event|2|||
125131770|NCT00804856|450110054|FG012|Overall Study|Other Adverse Event|0|||
125131771|NCT00804856|450110055|FG013|Overall Study|Other Adverse Event|6|||
125131772|NCT00804856|450110056|FG014|Overall Study|Other Adverse Event|13|||
125131773|NCT00804856|450110042|FG000|Overall Study|Non compliance with protocol|0|||
125131774|NCT00804856|450110043|FG001|Overall Study|Non compliance with protocol|0|||
125131775|NCT00804856|450110044|FG002|Overall Study|Non compliance with protocol|0|||
125131776|NCT00804856|450110045|FG003|Overall Study|Non compliance with protocol|0|||
125131777|NCT00804856|450110046|FG004|Overall Study|Non compliance with protocol|0|||
125131778|NCT00804856|450110047|FG005|Overall Study|Non compliance with protocol|0|||
125131779|NCT00804856|450110048|FG006|Overall Study|Non compliance with protocol|0|||
125131780|NCT00804856|450110049|FG007|Overall Study|Non compliance with protocol|0|||
125131781|NCT00804856|450110050|FG008|Overall Study|Non compliance with protocol|0|||
125131782|NCT00804856|450110051|FG009|Overall Study|Non compliance with protocol|0|||
125131783|NCT00804856|450110052|FG010|Overall Study|Non compliance with protocol|0|||
125131784|NCT00804856|450110053|FG011|Overall Study|Non compliance with protocol|0|||
125131785|NCT00804856|450110054|FG012|Overall Study|Non compliance with protocol|0|||
125131786|NCT00804856|450110055|FG013|Overall Study|Non compliance with protocol|2|||
125131787|NCT00804856|450110056|FG014|Overall Study|Non compliance with protocol|0|||
125131788|NCT00804856|450110042|FG000|Overall Study|Refused to continue medication|0|||
125131789|NCT00804856|450110043|FG001|Overall Study|Refused to continue medication|0|||
125131790|NCT00804856|450110044|FG002|Overall Study|Refused to continue medication|0|||
125131791|NCT00804856|450110045|FG003|Overall Study|Refused to continue medication|1|||
125131792|NCT00804856|450110046|FG004|Overall Study|Refused to continue medication|1|||
125131793|NCT00804856|450110047|FG005|Overall Study|Refused to continue medication|0|||
125131794|NCT00804856|450110048|FG006|Overall Study|Refused to continue medication|0|||
125131795|NCT00804856|450110049|FG007|Overall Study|Refused to continue medication|0|||
125131796|NCT00804856|450110050|FG008|Overall Study|Refused to continue medication|0|||
125131797|NCT00804856|450110051|FG009|Overall Study|Refused to continue medication|0|||
125217751|NCT03130959|450425292|FG008|Overall Study|Not reported|0|||
125217752|NCT03130959|450425293|FG009|Overall Study|Not reported|1|||
125131798|NCT00804856|450110052|FG010|Overall Study|Refused to continue medication|3|||
125131799|NCT00804856|450110053|FG011|Overall Study|Refused to continue medication|0|||
125131800|NCT00804856|450110054|FG012|Overall Study|Refused to continue medication|1|||
125131801|NCT00804856|450110055|FG013|Overall Study|Refused to continue medication|1|||
125131802|NCT00804856|450110056|FG014|Overall Study|Refused to continue medication|5|||
125131803|NCT00804856|450110042|FG000|Overall Study|Other reason than listed above|0|||
125131804|NCT00804856|450110043|FG001|Overall Study|Other reason than listed above|0|||
125131805|NCT00804856|450110044|FG002|Overall Study|Other reason than listed above|0|||
125131806|NCT00804856|450110045|FG003|Overall Study|Other reason than listed above|0|||
125131807|NCT00804856|450110046|FG004|Overall Study|Other reason than listed above|0|||
125131808|NCT00804856|450110047|FG005|Overall Study|Other reason than listed above|1|||
125131809|NCT00804856|450110048|FG006|Overall Study|Other reason than listed above|0|||
125131810|NCT00804856|450110049|FG007|Overall Study|Other reason than listed above|0|||
125131811|NCT00804856|450110050|FG008|Overall Study|Other reason than listed above|1|||
125217753|NCT03130959|450425284|FG000|Overall Study|Adverse Event unrelated to drug|0|||
124970514|NCT04836559|449519297|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
124970515|NCT04836559|449519298|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
124970516|NCT04836559|449519291|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
124970517|NCT04836559|449519292|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
124970518|NCT04836559|449519293|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
124970519|NCT04836559|449519294|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
124970520|NCT04836559|449519295|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
124970521|NCT04836559|449519296|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
124970522|NCT04836559|449519297|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
124970523|NCT04836559|449519298|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
124970524|NCT04836559|449519291|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
124970525|NCT04836559|449519292|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
124970526|NCT04836559|449519293|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
124970527|NCT04836559|449519294|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
124970528|NCT04836559|449519295|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
124970529|NCT04836559|449519296|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
124970530|NCT04836559|449519297|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
124970531|NCT04836559|449519298|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
124970532|NCT02635360|449519299|FG000|Overall Study|Adverse Event|0|||
124970533|NCT02635360|449519300|FG001|Overall Study|Adverse Event|3|||
124970534|NCT02635360|449519299|FG000|Overall Study|Withdrawal by Subject|2|||
124970535|NCT02635360|449519300|FG001|Overall Study|Withdrawal by Subject|0|||
124970536|NCT02635360|449519299|FG000|Overall Study|Non-Compliance|3|||
124970537|NCT02635360|449519300|FG001|Overall Study|Non-Compliance|1|||
124970538|NCT02635360|449519299|FG000|Overall Study|Disease Progression|0|||
124970539|NCT02635360|449519300|FG001|Overall Study|Disease Progression|2|||
124970540|NCT02635360|449519299|FG000|Overall Study|Lost to Follow-up|1|||
124970541|NCT02635360|449519300|FG001|Overall Study|Lost to Follow-up|1|||
124970542|NCT04978350|449519301|FG000|Overall Study|Lost to Follow-up|6|||
124970543|NCT05765435|449519304|FG000|Overall Study|Lost to Follow-up|0|||
124970544|NCT05765435|449519305|FG001|Overall Study|Lost to Follow-up|1|||
124970545|NCT05765435|449519306|FG002|Overall Study|Lost to Follow-up|0|||
124970546|NCT05765435|449519304|FG000|Overall Study|Withdrawal by Subject|0|||
125131812|NCT00804856|450110051|FG009|Overall Study|Other reason than listed above|0|||
125131813|NCT00804856|450110052|FG010|Overall Study|Other reason than listed above|3|||
125131814|NCT00804856|450110053|FG011|Overall Study|Other reason than listed above|1|||
125131815|NCT00804856|450110054|FG012|Overall Study|Other reason than listed above|1|||
125131816|NCT00804856|450110055|FG013|Overall Study|Other reason than listed above|10|||
125131817|NCT00804856|450110056|FG014|Overall Study|Other reason than listed above|3|||
125131818|NCT00418561|450110057|FG000|Overall Study|Participant's (guardian's) decision|0|||
125131819|NCT00418561|450110058|FG001|Overall Study|Participant's (guardian's) decision|1|||
125131820|NCT00418561|450110059|FG002|Overall Study|Participant's (guardian's) decision|0|||
125131821|NCT01796171|450110060|FG000|Enrolled|Death|0|||
125131822|NCT01796171|450110061|FG001|Enrolled|Death|0|||
125131823|NCT01796171|450110062|FG002|Enrolled|Death|0|||
125131824|NCT01796171|450110063|FG003|Enrolled|Death|0|||
125131825|NCT01796171|450110064|FG004|Enrolled|Death|0|||
125131826|NCT01796171|450110065|FG005|Enrolled|Death|0|||
124970547|NCT05765435|449519305|FG001|Overall Study|Withdrawal by Subject|0|||
125131827|NCT01796171|450110066|FG006|Enrolled|Death|0|||
124970548|NCT05765435|449519306|FG002|Overall Study|Withdrawal by Subject|1|||
124970549|NCT00781937|449519315|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
124970550|NCT00781937|449519316|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
124970551|NCT00781937|449519315|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
124970552|NCT00781937|449519316|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
124970553|NCT00781937|449519315|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
124970554|NCT00781937|449519316|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
125131828|NCT01796171|450110067|FG007|Enrolled|Death|0|||
125131829|NCT01796171|450110068|FG008|Enrolled|Death|0|||
125131830|NCT01796171|450110069|FG009|Enrolled|Death|0|||
125131831|NCT01796171|450110070|FG010|Enrolled|Death|0|||
125131832|NCT01796171|450110071|FG011|Enrolled|Death|0|||
125131833|NCT01796171|450110072|FG012|Enrolled|Death|0|||
125131834|NCT01796171|450110073|FG013|Enrolled|Death|0|||
125131835|NCT01796171|450110074|FG014|Enrolled|Death|1|||
125131836|NCT01796171|450110060|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
125131837|NCT01796171|450110061|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
125131838|NCT01796171|450110062|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
125131839|NCT01796171|450110063|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
125131840|NCT01796171|450110064|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
125131841|NCT01796171|450110065|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
125131842|NCT01796171|450110066|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
125131843|NCT01796171|450110067|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
125131844|NCT01796171|450110068|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
125131845|NCT01796171|450110069|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
125131846|NCT01796171|450110070|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
125131847|NCT01796171|450110071|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
125131848|NCT01796171|450110072|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
125131849|NCT01796171|450110073|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
125131850|NCT01796171|450110074|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
124970555|NCT00781937|449519315|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
124970556|NCT00781937|449519316|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
124970557|NCT00781937|449519315|FG000|Main Trial Period Through Week 56|Unclassified|10|||
124970558|NCT00781937|449519316|FG001|Main Trial Period Through Week 56|Unclassified|15|||
124970559|NCT00781937|449519315|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
124970560|NCT00781937|449519316|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
125131851|NCT01796171|450110060|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131852|NCT01796171|450110061|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
124970561|NCT00781937|449519315|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
124970562|NCT00781937|449519316|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
124970563|NCT04698915|449519317|FG000|Overall Study|Adverse Event|2|||
124970564|NCT04698915|449519318|FG001|Overall Study|Adverse Event|0|||
124970565|NCT04698915|449519317|FG000|Overall Study|Death|23|||
124970566|NCT04698915|449519318|FG001|Overall Study|Death|20|||
124970567|NCT04698915|449519317|FG000|Overall Study|Physician Decision|1|||
125034680|NCT00868790|449745990|FG001|Period 3|Study Terminated by Sponsor|0|||
125034681|NCT00868790|449745991|FG002|Period 3|Study Terminated by Sponsor|0|||
125034682|NCT00868790|449745992|FG003|Period 3|Study Terminated by Sponsor|1|||
125034683|NCT00868790|449745993|FG004|Period 3|Study Terminated by Sponsor|0|||
125034684|NCT00868790|449745994|FG005|Period 3|Study Terminated by Sponsor|0|||
125034685|NCT00868790|449745995|FG006|Period 3|Study Terminated by Sponsor|0|||
125034686|NCT00868790|449745996|FG007|Period 3|Study Terminated by Sponsor|0|||
125034687|NCT00868790|449745997|FG008|Period 3|Study Terminated by Sponsor|0|||
125131853|NCT01796171|450110062|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131854|NCT01796171|450110063|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131855|NCT01796171|450110064|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131856|NCT01796171|450110065|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131857|NCT01796171|450110066|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131858|NCT01796171|450110067|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131859|NCT01796171|450110068|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131860|NCT01796171|450110069|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131861|NCT01796171|450110070|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131862|NCT01796171|450110071|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131863|NCT01796171|450110072|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131864|NCT01796171|450110073|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
125131865|NCT01796171|450110074|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125034688|NCT00868790|449745998|FG009|Period 3|Study Terminated by Sponsor|0|||
125034689|NCT00868790|449745999|FG010|Period 3|Study Terminated by Sponsor|0|||
125034690|NCT00868790|449746000|FG011|Period 3|Study Terminated by Sponsor|0|||
125034691|NCT00868790|449746001|FG012|Period 3|Study Terminated by Sponsor|0|||
125034692|NCT00868790|449746002|FG013|Period 3|Study Terminated by Sponsor|0|||
125034693|NCT00868790|449745989|FG000|Period 4|Adverse Event|0|||
125034694|NCT00868790|449745990|FG001|Period 4|Adverse Event|0|||
125034695|NCT00868790|449745991|FG002|Period 4|Adverse Event|0|||
125034696|NCT00868790|449745992|FG003|Period 4|Adverse Event|0|||
125131866|NCT01796171|450110060|FG000|Treatment Period With Betalutin|Progressive disease|0|||
124970568|NCT04698915|449519318|FG001|Overall Study|Physician Decision|1|||
124970569|NCT04698915|449519317|FG000|Overall Study|Lost to Follow-up|1|||
125034697|NCT00868790|449745993|FG004|Period 4|Adverse Event|0|||
125034698|NCT00868790|449745994|FG005|Period 4|Adverse Event|0|||
125034699|NCT00868790|449745995|FG006|Period 4|Adverse Event|0|||
125034700|NCT00868790|449745996|FG007|Period 4|Adverse Event|1|||
125034701|NCT00868790|449745997|FG008|Period 4|Adverse Event|0|||
125034702|NCT00868790|449745998|FG009|Period 4|Adverse Event|0|||
125034703|NCT00868790|449745999|FG010|Period 4|Adverse Event|1|||
125034704|NCT00868790|449746000|FG011|Period 4|Adverse Event|0|||
125034705|NCT00868790|449746001|FG012|Period 4|Adverse Event|1|||
125034706|NCT00868790|449746002|FG013|Period 4|Adverse Event|0|||
125034707|NCT00868790|449745989|FG000|Period 4|Lost to Follow-up|0|||
125034708|NCT00868790|449745990|FG001|Period 4|Lost to Follow-up|0|||
125034709|NCT00868790|449745991|FG002|Period 4|Lost to Follow-up|0|||
125034710|NCT00868790|449745992|FG003|Period 4|Lost to Follow-up|0|||
125034711|NCT00868790|449745993|FG004|Period 4|Lost to Follow-up|0|||
125034712|NCT00868790|449745994|FG005|Period 4|Lost to Follow-up|0|||
125034713|NCT00868790|449745995|FG006|Period 4|Lost to Follow-up|0|||
125034714|NCT00868790|449745996|FG007|Period 4|Lost to Follow-up|1|||
125034715|NCT00868790|449745997|FG008|Period 4|Lost to Follow-up|0|||
125034716|NCT00868790|449745998|FG009|Period 4|Lost to Follow-up|0|||
125034717|NCT00868790|449745999|FG010|Period 4|Lost to Follow-up|0|||
125034718|NCT00868790|449746000|FG011|Period 4|Lost to Follow-up|0|||
125034719|NCT00868790|449746001|FG012|Period 4|Lost to Follow-up|0|||
125034720|NCT00868790|449746002|FG013|Period 4|Lost to Follow-up|0|||
125034721|NCT00868790|449745989|FG000|Period 4|Study Terminated by Sponsor|2|||
125034722|NCT00868790|449745990|FG001|Period 4|Study Terminated by Sponsor|0|||
125034723|NCT00868790|449745991|FG002|Period 4|Study Terminated by Sponsor|0|||
125034724|NCT00868790|449745992|FG003|Period 4|Study Terminated by Sponsor|0|||
125034725|NCT00868790|449745993|FG004|Period 4|Study Terminated by Sponsor|0|||
125034726|NCT00868790|449745994|FG005|Period 4|Study Terminated by Sponsor|0|||
125034727|NCT00868790|449745995|FG006|Period 4|Study Terminated by Sponsor|0|||
125034728|NCT00868790|449745996|FG007|Period 4|Study Terminated by Sponsor|1|||
125034729|NCT00868790|449745997|FG008|Period 4|Study Terminated by Sponsor|2|||
125034730|NCT00868790|449745998|FG009|Period 4|Study Terminated by Sponsor|0|||
125034731|NCT00868790|449745999|FG010|Period 4|Study Terminated by Sponsor|2|||
125034732|NCT00868790|449746000|FG011|Period 4|Study Terminated by Sponsor|1|||
125034733|NCT00868790|449746001|FG012|Period 4|Study Terminated by Sponsor|0|||
125034734|NCT00868790|449746002|FG013|Period 4|Study Terminated by Sponsor|1|||
125034735|NCT00868790|449745989|FG000|Period 4|Abnormal ALT/AST|0|||
125034736|NCT00868790|449745990|FG001|Period 4|Abnormal ALT/AST|0|||
125034737|NCT00868790|449745991|FG002|Period 4|Abnormal ALT/AST|1|||
124970570|NCT04698915|449519318|FG001|Overall Study|Lost to Follow-up|0|||
124970571|NCT04698915|449519317|FG000|Overall Study|Study Terminated by Sponsor|55|||
124970572|NCT04698915|449519318|FG001|Overall Study|Study Terminated by Sponsor|60|||
124970573|NCT04698915|449519317|FG000|Overall Study|Withdrawal by Subject|2|||
124970574|NCT04698915|449519318|FG001|Overall Study|Withdrawal by Subject|3|||
124970575|NCT01150045|449519319|FG000|Overall Study|Protocol Violation|0|||
124970576|NCT01150045|449519320|FG001|Overall Study|Protocol Violation|1|||
124970577|NCT01150045|449519321|FG002|Overall Study|Protocol Violation|0|||
124970578|NCT01150045|449519322|FG003|Overall Study|Protocol Violation|1|||
124970579|NCT01790295|449519324|FG000|Overall Study|Adverse Event|1|||
124970580|NCT01790295|449519324|FG000|Overall Study|Death|4|||
124970581|NCT01790295|449519324|FG000|Overall Study|Lack of Efficacy|2|||
124970582|NCT01790295|449519324|FG000|Overall Study|Study closure|4|||
124970583|NCT00420784|449519331|FG000|Overall Study|Adverse Event|11|||
124970584|NCT00420784|449519332|FG001|Overall Study|Adverse Event|29|||
124970585|NCT00420784|449519333|FG002|Overall Study|Adverse Event|10|||
124970586|NCT00420784|449519334|FG003|Overall Study|Adverse Event|5|||
124970587|NCT00420784|449519331|FG000|Overall Study|Withdrawal by Subject|0|||
124970588|NCT00420784|449519332|FG001|Overall Study|Withdrawal by Subject|1|||
124970589|NCT00420784|449519333|FG002|Overall Study|Withdrawal by Subject|0|||
124970590|NCT00420784|449519334|FG003|Overall Study|Withdrawal by Subject|0|||
124970591|NCT00420784|449519331|FG000|Overall Study|Lost to Follow-up|0|||
124970592|NCT00420784|449519332|FG001|Overall Study|Lost to Follow-up|0|||
124970593|NCT00420784|449519333|FG002|Overall Study|Lost to Follow-up|2|||
125034738|NCT00868790|449745992|FG003|Period 4|Abnormal ALT/AST|0|||
125217754|NCT03130959|450425285|FG001|Overall Study|Adverse Event unrelated to drug|0|||
124970594|NCT00420784|449519334|FG003|Overall Study|Lost to Follow-up|1|||
124970595|NCT00420784|449519331|FG000|Overall Study|Virologic Stopping Rule|17|||
124970596|NCT00420784|449519332|FG001|Overall Study|Virologic Stopping Rule|26|||
124970597|NCT00420784|449519333|FG002|Overall Study|Virologic Stopping Rule|41|||
124970598|NCT00420784|449519334|FG003|Overall Study|Virologic Stopping Rule|67|||
125034739|NCT00868790|449745993|FG004|Period 4|Abnormal ALT/AST|0|||
124970599|NCT00420784|449519331|FG000|Overall Study|Other|1|||
124970600|NCT00420784|449519332|FG001|Overall Study|Other|2|||
124970601|NCT00420784|449519333|FG002|Overall Study|Other|0|||
124970602|NCT00420784|449519334|FG003|Overall Study|Other|5|||
124970603|NCT03603639|449519335|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
124970604|NCT03603639|449519336|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
124970605|NCT03603639|449519337|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
124970606|NCT03603639|449519338|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
124970607|NCT03603639|449519339|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
124970608|NCT03603639|449519340|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
124970609|NCT03603639|449519335|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
124970610|NCT03603639|449519336|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
124970611|NCT03603639|449519337|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
124970612|NCT03603639|449519338|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
124970613|NCT03603639|449519339|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
124970614|NCT03603639|449519340|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
124970615|NCT03016598|449519344|FG000|Overall Study|Lost to Follow-up|0|||
124970616|NCT03016598|449519345|FG001|Overall Study|Lost to Follow-up|2|||
124970617|NCT04593823|449519347|FG000|Overall Study|Withdrawal by Subject|1|||
124970618|NCT04593823|449519348|FG001|Overall Study|Withdrawal by Subject|1|||
124970619|NCT04593823|449519347|FG000|Overall Study|Lost to Follow-up|0|||
124970620|NCT04593823|449519348|FG001|Overall Study|Lost to Follow-up|1|||
124970621|NCT00742326|449519349|FG000|Overall Study|Physician Decision|0|||
124970622|NCT00742326|449519350|FG001|Overall Study|Physician Decision|1|||
124970623|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
124970624|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
124970625|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
124970626|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
124970627|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
124970628|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
124970629|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
124970630|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
124970631|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
125034740|NCT00868790|449745994|FG005|Period 4|Abnormal ALT/AST|0|||
124970632|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
124970633|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
124970634|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
124970635|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
124970636|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
124970637|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
124970638|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
124970639|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
124970640|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
124970641|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Missing|2|||
124970642|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Missing|1|||
125217755|NCT03130959|450425286|FG002|Overall Study|Adverse Event unrelated to drug|1|||
125217756|NCT03130959|450425287|FG003|Overall Study|Adverse Event unrelated to drug|1|||
125217757|NCT03130959|450425288|FG004|Overall Study|Adverse Event unrelated to drug|1|||
125217758|NCT03130959|450425289|FG005|Overall Study|Adverse Event unrelated to drug|0|||
125217759|NCT03130959|450425290|FG006|Overall Study|Adverse Event unrelated to drug|1|||
125217760|NCT03130959|450425291|FG007|Overall Study|Adverse Event unrelated to drug|0|||
125217761|NCT03130959|450425292|FG008|Overall Study|Adverse Event unrelated to drug|1|||
125217762|NCT03130959|450425293|FG009|Overall Study|Adverse Event unrelated to drug|1|||
125217763|NCT03130959|450425284|FG000|Overall Study|Participant withdrew consent|0|||
125217764|NCT03130959|450425285|FG001|Overall Study|Participant withdrew consent|1|||
125217765|NCT03130959|450425286|FG002|Overall Study|Participant withdrew consent|0|||
125217766|NCT03130959|450425287|FG003|Overall Study|Participant withdrew consent|2|||
125217767|NCT03130959|450425288|FG004|Overall Study|Participant withdrew consent|1|||
125217768|NCT03130959|450425289|FG005|Overall Study|Participant withdrew consent|0|||
124970643|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
124970644|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
124970645|NCT00443209|449519352|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
124970646|NCT00443209|449519353|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
124970647|NCT00443209|449519352|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
124970648|NCT00443209|449519353|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
124970649|NCT00443209|449519352|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
124970650|NCT00443209|449519353|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
124970651|NCT00443209|449519352|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
124970652|NCT00443209|449519353|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
124970653|NCT00443209|449519352|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
124970654|NCT00443209|449519353|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
124970655|NCT00443209|449519352|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
124970656|NCT00443209|449519353|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
124970657|NCT01628692|449519354|FG000|Overall Study|Lack of Efficacy|4|||
124970658|NCT01628692|449519355|FG001|Overall Study|Lack of Efficacy|4|||
124970659|NCT01628692|449519356|FG002|Overall Study|Lack of Efficacy|5|||
124970660|NCT01628692|449519357|FG003|Overall Study|Lack of Efficacy|1|||
124970661|NCT01628692|449519358|FG004|Overall Study|Lack of Efficacy|4|||
124970662|NCT01628692|449519359|FG005|Overall Study|Lack of Efficacy|7|||
124970663|NCT01628692|449519354|FG000|Overall Study|Adverse Event|2|||
124970664|NCT01628692|449519355|FG001|Overall Study|Adverse Event|0|||
124970665|NCT01628692|449519356|FG002|Overall Study|Adverse Event|2|||
124970666|NCT01628692|449519357|FG003|Overall Study|Adverse Event|0|||
124970667|NCT01628692|449519358|FG004|Overall Study|Adverse Event|0|||
124970668|NCT01628692|449519359|FG005|Overall Study|Adverse Event|0|||
124970669|NCT01628692|449519354|FG000|Overall Study|Withdrawal by Subject|0|||
124970670|NCT01628692|449519355|FG001|Overall Study|Withdrawal by Subject|1|||
124970671|NCT01628692|449519356|FG002|Overall Study|Withdrawal by Subject|1|||
124970672|NCT01628692|449519357|FG003|Overall Study|Withdrawal by Subject|0|||
124970673|NCT01628692|449519358|FG004|Overall Study|Withdrawal by Subject|0|||
124970674|NCT01628692|449519359|FG005|Overall Study|Withdrawal by Subject|0|||
125034741|NCT00868790|449745995|FG006|Period 4|Abnormal ALT/AST|0|||
125034742|NCT00868790|449745996|FG007|Period 4|Abnormal ALT/AST|0|||
124970675|NCT01628692|449519354|FG000|Overall Study|Death|0|||
124970676|NCT01628692|449519355|FG001|Overall Study|Death|1|||
125034743|NCT00868790|449745997|FG008|Period 4|Abnormal ALT/AST|0|||
125034744|NCT00868790|449745998|FG009|Period 4|Abnormal ALT/AST|0|||
125034745|NCT00868790|449745999|FG010|Period 4|Abnormal ALT/AST|0|||
125034746|NCT00868790|449746000|FG011|Period 4|Abnormal ALT/AST|0|||
124970677|NCT01628692|449519356|FG002|Overall Study|Death|0|||
124970678|NCT01628692|449519357|FG003|Overall Study|Death|0|||
125034747|NCT00868790|449746001|FG012|Period 4|Abnormal ALT/AST|0|||
125034748|NCT00868790|449746002|FG013|Period 4|Abnormal ALT/AST|0|||
125034749|NCT00868790|449745989|FG000|Post-study|Withdrawal by Subject|0|||
125034750|NCT00868790|449745990|FG001|Post-study|Withdrawal by Subject|0|||
125034751|NCT00868790|449745991|FG002|Post-study|Withdrawal by Subject|0|||
125034752|NCT00868790|449745992|FG003|Post-study|Withdrawal by Subject|0|||
125034753|NCT00868790|449745993|FG004|Post-study|Withdrawal by Subject|1|||
125034754|NCT00868790|449745994|FG005|Post-study|Withdrawal by Subject|0|||
125034755|NCT00868790|449745995|FG006|Post-study|Withdrawal by Subject|0|||
125034756|NCT00868790|449745996|FG007|Post-study|Withdrawal by Subject|0|||
125034757|NCT00868790|449745997|FG008|Post-study|Withdrawal by Subject|0|||
125034758|NCT00868790|449745998|FG009|Post-study|Withdrawal by Subject|0|||
125034759|NCT00868790|449745999|FG010|Post-study|Withdrawal by Subject|0|||
125034760|NCT00868790|449746000|FG011|Post-study|Withdrawal by Subject|0|||
125034761|NCT00868790|449746001|FG012|Post-study|Withdrawal by Subject|0|||
125034762|NCT00868790|449746002|FG013|Post-study|Withdrawal by Subject|0|||
125034763|NCT00868790|449745989|FG000|Post-study|Excluded Medication|0|||
125034764|NCT00868790|449745990|FG001|Post-study|Excluded Medication|0|||
125034765|NCT00868790|449745991|FG002|Post-study|Excluded Medication|0|||
125034766|NCT00868790|449745992|FG003|Post-study|Excluded Medication|0|||
125034767|NCT00868790|449745993|FG004|Post-study|Excluded Medication|0|||
125034768|NCT00868790|449745994|FG005|Post-study|Excluded Medication|0|||
125034769|NCT00868790|449745995|FG006|Post-study|Excluded Medication|0|||
125034770|NCT00868790|449745996|FG007|Post-study|Excluded Medication|2|||
125034771|NCT00868790|449745997|FG008|Post-study|Excluded Medication|0|||
124970679|NCT01628692|449519358|FG004|Overall Study|Death|0|||
124970680|NCT01628692|449519359|FG005|Overall Study|Death|0|||
124970681|NCT01628692|449519354|FG000|Overall Study|Poor compliance/noncompliance|1|||
124970682|NCT01628692|449519355|FG001|Overall Study|Poor compliance/noncompliance|0|||
124970683|NCT01628692|449519356|FG002|Overall Study|Poor compliance/noncompliance|0|||
124970684|NCT01628692|449519357|FG003|Overall Study|Poor compliance/noncompliance|0|||
124970685|NCT01628692|449519358|FG004|Overall Study|Poor compliance/noncompliance|0|||
124970686|NCT01628692|449519359|FG005|Overall Study|Poor compliance/noncompliance|0|||
124970687|NCT01628692|449519354|FG000|Overall Study|Administrative reason by sponsor|0|||
124970688|NCT01628692|449519355|FG001|Overall Study|Administrative reason by sponsor|0|||
124970689|NCT01628692|449519356|FG002|Overall Study|Administrative reason by sponsor|0|||
124970690|NCT01628692|449519357|FG003|Overall Study|Administrative reason by sponsor|0|||
124970691|NCT01628692|449519358|FG004|Overall Study|Administrative reason by sponsor|0|||
124970692|NCT01628692|449519359|FG005|Overall Study|Administrative reason by sponsor|1|||
124970693|NCT01628692|449519354|FG000|Overall Study|Completed 12 Week only|0|||
124970694|NCT01628692|449519355|FG001|Overall Study|Completed 12 Week only|0|||
124970695|NCT01628692|449519356|FG002|Overall Study|Completed 12 Week only|0|||
124970696|NCT01628692|449519357|FG003|Overall Study|Completed 12 Week only|0|||
124970697|NCT01628692|449519358|FG004|Overall Study|Completed 12 Week only|0|||
124970698|NCT01628692|449519359|FG005|Overall Study|Completed 12 Week only|1|||
124970699|NCT02196077|449519361|FG000|Overall Study|Adverse Event|4|||
124970700|NCT02196077|449519361|FG000|Overall Study|Lack of Efficacy|1|||
124970701|NCT02196077|449519361|FG000|Overall Study|Withdrawal by Subject|14|||
124970702|NCT02196077|449519361|FG000|Overall Study|Physician Decision|1|||
124970703|NCT02196077|449519361|FG000|Overall Study|Lost to Follow-up|3|||
124970704|NCT02196077|449519361|FG000|Overall Study|Protocol Violation|24|||
124970705|NCT02781311|449519366|FG000|Overall Study|Adverse Event|2|||
124970706|NCT02781311|449519367|FG001|Overall Study|Adverse Event|6|||
124970707|NCT02781311|449519368|FG002|Overall Study|Adverse Event|1|||
124970708|NCT02781311|449519366|FG000|Overall Study|Withdrawal of Consent|11|||
124970709|NCT02781311|449519367|FG001|Overall Study|Withdrawal of Consent|12|||
124970710|NCT02781311|449519368|FG002|Overall Study|Withdrawal of Consent|2|||
124970711|NCT02781311|449519366|FG000|Overall Study|Lost to Follow-up|11|||
124970712|NCT02781311|449519367|FG001|Overall Study|Lost to Follow-up|8|||
124970713|NCT02781311|449519368|FG002|Overall Study|Lost to Follow-up|1|||
124970714|NCT02781311|449519366|FG000|Overall Study|Non-Compliance with Study Drug|2|||
125034772|NCT00868790|449745998|FG009|Post-study|Excluded Medication|1|||
125034773|NCT00868790|449745999|FG010|Post-study|Excluded Medication|0|||
125034774|NCT00868790|449746000|FG011|Post-study|Excluded Medication|0|||
125034775|NCT00868790|449746001|FG012|Post-study|Excluded Medication|0|||
125034776|NCT00868790|449746002|FG013|Post-study|Excluded Medication|0|||
125034777|NCT02582671|449746003|FG000|Overall Study|Failure to return|1|||
125034778|NCT02582671|449746003|FG000|Overall Study|Other, not specified|1|||
125217769|NCT03130959|450425290|FG006|Overall Study|Participant withdrew consent|0|||
124970715|NCT02781311|449519367|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124970716|NCT02781311|449519368|FG002|Overall Study|Non-Compliance with Study Drug|0|||
124970717|NCT01056263|449519369|FG000|Overall Study|Adverse Event|12|||
124970718|NCT01056263|449519369|FG000|Overall Study|Death|1|||
124970719|NCT01056263|449519369|FG000|Overall Study|Withdrawal by Subject|1|||
124970720|NCT01056263|449519369|FG000|Overall Study|Lack of Efficacy|29|||
124970721|NCT01056263|449519369|FG000|Overall Study|Progressive disease|2|||
125034779|NCT03068715|449746004|FG000|Overall Study|No longer met inclusion criteria|1|||
125034780|NCT03068715|449746005|FG001|Overall Study|No longer met inclusion criteria|0|||
125034781|NCT01276288|449746006|FG000|Overall Study|Adverse Event|1|||
125034782|NCT01276288|449746007|FG001|Overall Study|Adverse Event|1|||
125034783|NCT01276288|449746008|FG002|Overall Study|Adverse Event|0|||
125034784|NCT01276288|449746009|FG003|Overall Study|Adverse Event|0|||
125034785|NCT01276288|449746006|FG000|Overall Study|not treated|1|||
125034786|NCT01276288|449746007|FG001|Overall Study|not treated|0|||
125034787|NCT01276288|449746008|FG002|Overall Study|not treated|0|||
125034788|NCT01276288|449746009|FG003|Overall Study|not treated|0|||
125034789|NCT03168867|449746011|FG000|Overall Study|Withdrawal by Subject|1|||
125034790|NCT03168867|449746012|FG001|Overall Study|Withdrawal by Subject|5|||
125034791|NCT04348851|449746013|FG000|Post-Test 1|Withdrawal by Subject|0|||
125034792|NCT04348851|449746014|FG001|Post-Test 1|Withdrawal by Subject|1|||
125034793|NCT04348851|449746015|FG002|Post-Test 1|Withdrawal by Subject|0|||
125217770|NCT03130959|450425291|FG007|Overall Study|Participant withdrew consent|0|||
125217771|NCT03130959|450425292|FG008|Overall Study|Participant withdrew consent|0|||
125034794|NCT04348851|449746016|FG003|Post-Test 1|Withdrawal by Subject|0|||
125034795|NCT04348851|449746013|FG000|Post-Test 1|Lost to Follow-up|0|||
125034796|NCT04348851|449746014|FG001|Post-Test 1|Lost to Follow-up|1|||
125034797|NCT04348851|449746015|FG002|Post-Test 1|Lost to Follow-up|0|||
125034798|NCT04348851|449746016|FG003|Post-Test 1|Lost to Follow-up|0|||
125034799|NCT04348851|449746013|FG000|Post-Test 2|Stroke survivor death|0|||
125034800|NCT04348851|449746014|FG001|Post-Test 2|Stroke survivor death|1|||
125034801|NCT04348851|449746015|FG002|Post-Test 2|Stroke survivor death|0|||
125034802|NCT04348851|449746016|FG003|Post-Test 2|Stroke survivor death|1|||
125034803|NCT03401749|449746017|FG000|Overall Study|Lost to Follow-up|20|||
125034804|NCT03401749|449746018|FG001|Overall Study|Lost to Follow-up|16|||
125034805|NCT03401749|449746019|FG002|Overall Study|Lost to Follow-up|26|||
125034806|NCT03040024|449746022|FG000|Overall Study|Adverse Event|0|||
125034807|NCT03040024|449746023|FG001|Overall Study|Adverse Event|1|||
125034808|NCT03040024|449746024|FG002|Overall Study|Adverse Event|0|||
125034809|NCT03040024|449746022|FG000|Overall Study|Death|0|||
125034810|NCT03040024|449746023|FG001|Overall Study|Death|1|||
125034811|NCT03040024|449746024|FG002|Overall Study|Death|0|||
125034812|NCT03040024|449746022|FG000|Overall Study|Physician Decision|0|||
125034813|NCT03040024|449746023|FG001|Overall Study|Physician Decision|0|||
125034814|NCT03040024|449746024|FG002|Overall Study|Physician Decision|1|||
125034815|NCT00519077|449746025|FG000|Overall Study|Death|6|||
125131867|NCT01796171|450110061|FG001|Treatment Period With Betalutin|Progressive disease|1|||
125131868|NCT01796171|450110062|FG002|Treatment Period With Betalutin|Progressive disease|0|||
125131869|NCT01796171|450110063|FG003|Treatment Period With Betalutin|Progressive disease|0|||
125131870|NCT01796171|450110064|FG004|Treatment Period With Betalutin|Progressive disease|0|||
125131871|NCT01796171|450110065|FG005|Treatment Period With Betalutin|Progressive disease|0|||
125131872|NCT01796171|450110066|FG006|Treatment Period With Betalutin|Progressive disease|0|||
125131873|NCT01796171|450110067|FG007|Treatment Period With Betalutin|Progressive disease|0|||
125131874|NCT01796171|450110068|FG008|Treatment Period With Betalutin|Progressive disease|0|||
125131875|NCT01796171|450110069|FG009|Treatment Period With Betalutin|Progressive disease|0|||
125131876|NCT01796171|450110070|FG010|Treatment Period With Betalutin|Progressive disease|0|||
125131877|NCT01796171|450110071|FG011|Treatment Period With Betalutin|Progressive disease|0|||
125131878|NCT01796171|450110072|FG012|Treatment Period With Betalutin|Progressive disease|0|||
125131879|NCT01796171|450110073|FG013|Treatment Period With Betalutin|Progressive disease|0|||
125131880|NCT01796171|450110074|FG014|Treatment Period With Betalutin|Progressive disease|0|||
125131881|NCT01796171|450110060|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125131882|NCT01796171|450110061|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125131883|NCT01796171|450110062|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125131884|NCT01796171|450110063|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125131885|NCT01796171|450110064|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125131886|NCT01796171|450110065|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125131887|NCT01796171|450110066|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125217772|NCT03130959|450425293|FG009|Overall Study|Participant withdrew consent|2|||
125034816|NCT00519077|449746025|FG000|Overall Study|Other|2|||
125034817|NCT01967225|449746026|FG000|Overall Study|Adverse Event|3|||
125034818|NCT01967225|449746027|FG001|Overall Study|Adverse Event|1|||
125034819|NCT01967225|449746026|FG000|Overall Study|Withdrawal by Subject|2|||
125034820|NCT01967225|449746027|FG001|Overall Study|Withdrawal by Subject|1|||
125034821|NCT01967225|449746026|FG000|Overall Study|Lack of Efficacy|1|||
125217773|NCT03130959|450425284|FG000|Overall Study|Administrative reason by sponsor|1|||
125034822|NCT01967225|449746027|FG001|Overall Study|Lack of Efficacy|1|||
125034823|NCT01967225|449746026|FG000|Overall Study|Switching to other therapy|2|||
125034824|NCT01967225|449746027|FG001|Overall Study|Switching to other therapy|0|||
125034825|NCT01967225|449746026|FG000|Overall Study|Protocol driven decision point|1|||
125034826|NCT01967225|449746027|FG001|Overall Study|Protocol driven decision point|0|||
125034827|NCT01967225|449746026|FG000|Overall Study|Logistical difficulties|1|||
125034828|NCT01967225|449746027|FG001|Overall Study|Logistical difficulties|0|||
125034829|NCT01967225|449746026|FG000|Overall Study|Protocol Violation|2|||
125034830|NCT01967225|449746027|FG001|Overall Study|Protocol Violation|0|||
124970722|NCT01056263|449519369|FG000|Overall Study|Neoplasm progression|1|||
124970723|NCT01056263|449519369|FG000|Overall Study|Objective progression or relapse|1|||
124970724|NCT01056263|449519369|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
124970725|NCT01262092|449519370|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
124970726|NCT01262092|449519371|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
124970727|NCT01262092|449519370|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
124970728|NCT01262092|449519371|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
124970729|NCT01262092|449519370|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
124970730|NCT01262092|449519371|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
124970731|NCT01262092|449519370|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
124970732|NCT01262092|449519371|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
124970733|NCT00699842|449519374|FG000|Overall Study|Death|0|||
124970734|NCT00699842|449519375|FG001|Overall Study|Death|1|||
124970735|NCT00699842|449519376|FG002|Overall Study|Death|0|||
124970736|NCT03023423|449519377|FG000|Overall Study|Death|5|||
124970737|NCT03023423|449519378|FG001|Overall Study|Death|12|||
124970738|NCT03023423|449519379|FG002|Overall Study|Death|20|||
124970739|NCT03023423|449519377|FG000|Overall Study|Other|0|||
124970740|NCT03023423|449519378|FG001|Overall Study|Other|2|||
124970741|NCT03023423|449519379|FG002|Overall Study|Other|2|||
124970742|NCT03023423|449519377|FG000|Overall Study|Ongoing|2|||
124970743|NCT03023423|449519378|FG001|Overall Study|Ongoing|32|||
124970744|NCT03023423|449519379|FG002|Overall Study|Ongoing|24|||
124970745|NCT03512197|449519380|FG000|Overall Study|Guardian decision|1|||
124970746|NCT03512197|449519381|FG001|Overall Study|Guardian decision|1|||
124970747|NCT03512197|449519380|FG000|Overall Study|Lack of Efficacy|19|||
124970748|NCT03512197|449519381|FG001|Overall Study|Lack of Efficacy|11|||
124970749|NCT03512197|449519380|FG000|Overall Study|New Therapy for Study Indication|16|||
124970750|NCT03512197|449519381|FG001|Overall Study|New Therapy for Study Indication|16|||
124970751|NCT03512197|449519380|FG000|Overall Study|Physician Decision|60|||
124970752|NCT03512197|449519381|FG001|Overall Study|Physician Decision|60|||
124970753|NCT03512197|449519380|FG000|Overall Study|Protocol Violation|0|||
124970754|NCT03512197|449519381|FG001|Overall Study|Protocol Violation|2|||
124970755|NCT03512197|449519380|FG000|Overall Study|Terminated by Sponsored|46|||
124970756|NCT03512197|449519381|FG001|Overall Study|Terminated by Sponsored|50|||
124970757|NCT03512197|449519380|FG000|Overall Study|Subject Decision|15|||
124970758|NCT03512197|449519381|FG001|Overall Study|Subject Decision|12|||
124970759|NCT03512197|449519380|FG000|Overall Study|Withdrawal of informed consent|20|||
124970760|NCT03512197|449519381|FG001|Overall Study|Withdrawal of informed consent|14|||
124970761|NCT03512197|449519380|FG000|Overall Study|Adverse Event|30|||
124970762|NCT03512197|449519381|FG001|Overall Study|Adverse Event|34|||
124970763|NCT03512197|449519380|FG000|Overall Study|Death|14|||
124970764|NCT03512197|449519381|FG001|Overall Study|Death|9|||
124970765|NCT03512197|449519380|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
124970766|NCT03512197|449519381|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
124970767|NCT03512197|449519380|FG000|Overall Study|Missing|3|||
124970768|NCT03512197|449519381|FG001|Overall Study|Missing|13|||
124970769|NCT03842436|449519382|FG000|Overall Study|Lost to Follow-up|1|||
124970770|NCT01806389|449519383|FG000|Overall Study|Withdrawal by Subject|4|||
124970771|NCT01310699|449519386|FG000|Overall Study|Patients did not complete tandem.|4|||
124970772|NCT01310699|449519387|FG001|Overall Study|Patients did not complete tandem.|6|||
124970773|NCT00936598|449519388|FG000|Overall Study|Withdrawal by Subject|1|||
124970774|NCT00936598|449519389|FG001|Overall Study|Withdrawal by Subject|0|||
124970775|NCT00936598|449519388|FG000|Overall Study|Ineligible after consent|1|||
124970776|NCT00936598|449519389|FG001|Overall Study|Ineligible after consent|0|||
125034831|NCT04696861|449746029|FG000|Overall Study|Death|1|||
125034832|NCT04696861|449746030|FG001|Overall Study|Death|0|||
125034833|NCT04696861|449746029|FG000|Overall Study|Lost to Follow-up|3|||
124970777|NCT00926575|449519390|FG000|Overall Study|Adverse Event|1|||
124970778|NCT00926575|449519391|FG001|Overall Study|Adverse Event|1|||
124970779|NCT00926575|449519390|FG000|Overall Study|Death|4|||
124970780|NCT00926575|449519391|FG001|Overall Study|Death|4|||
124970781|NCT00926575|449519390|FG000|Overall Study|Lost to Follow-up|1|||
124970782|NCT00926575|449519391|FG001|Overall Study|Lost to Follow-up|1|||
124970783|NCT00926575|449519390|FG000|Overall Study|Physician Decision|1|||
124970784|NCT00926575|449519391|FG001|Overall Study|Physician Decision|2|||
124970785|NCT00926575|449519390|FG000|Overall Study|Protocol Violation|1|||
124970786|NCT00926575|449519391|FG001|Overall Study|Protocol Violation|0|||
124970787|NCT00926575|449519390|FG000|Overall Study|Withdrawal by Subject|8|||
124970788|NCT00926575|449519391|FG001|Overall Study|Withdrawal by Subject|9|||
124970789|NCT00490698|449519394|FG000|Overall Study|Withdrawal by Subject|1|||
124970790|NCT00490698|449519394|FG000|Overall Study|Disease Progression|7|||
124970791|NCT00490698|449519394|FG000|Overall Study|Physician Decision|2|||
124970792|NCT02201901|449519395|FG000|Overall Study|Randomized but never treated|0|||
124970793|NCT02201901|449519396|FG001|Overall Study|Randomized but never treated|1|||
124970794|NCT02201901|449519397|FG002|Overall Study|Randomized but never treated|0|||
124970795|NCT02201901|449519395|FG000|Overall Study|Lack of Efficacy|7|||
124970796|NCT02201901|449519396|FG001|Overall Study|Lack of Efficacy|1|||
125217774|NCT03130959|450425285|FG001|Overall Study|Administrative reason by sponsor|0|||
125034834|NCT04696861|449746030|FG001|Overall Study|Lost to Follow-up|0|||
125034835|NCT02382133|449746033|FG000|Overall Study|Death|22|||
125034836|NCT02382133|449746033|FG000|Overall Study|transfer out of ICU|4|||
125034837|NCT02382133|449746033|FG000|Overall Study|Physician Decision|2|||
125034838|NCT02382133|449746033|FG000|Overall Study|arterial catheter loss|4|||
125034839|NCT02382133|449746033|FG000|Overall Study|pressure injury both sites|1|||
125034840|NCT00655928|449746034|FG000|Overall Study|Withdrawal by Subject|2|||
125034841|NCT00655928|449746035|FG001|Overall Study|Withdrawal by Subject|1|||
125034842|NCT00655928|449746034|FG000|Overall Study|Physician Decision|1|||
125034843|NCT00655928|449746035|FG001|Overall Study|Physician Decision|1|||
125034844|NCT04906707|449746036|FG000|Overall Study|Withdrawal by Subject|2|||
125034845|NCT04906707|449746037|FG001|Overall Study|Withdrawal by Subject|0|||
125034846|NCT04906707|449746036|FG000|Overall Study|Withdrawal due to PI decision|1|||
125034847|NCT04906707|449746037|FG001|Overall Study|Withdrawal due to PI decision|0|||
125034848|NCT04906707|449746036|FG000|Overall Study|Lost to Follow-up|0|||
125034849|NCT04906707|449746037|FG001|Overall Study|Lost to Follow-up|1|||
125034850|NCT01707992|449746038|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
125034851|NCT01707992|449746039|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
125034852|NCT01707992|449746040|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
125034853|NCT01707992|449746041|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
125034854|NCT01707992|449746042|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
125034855|NCT01707992|449746043|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
125034856|NCT01707992|449746038|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
125034857|NCT01707992|449746039|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
125217775|NCT03130959|450425286|FG002|Overall Study|Administrative reason by sponsor|1|||
125034858|NCT01707992|449746040|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
125034859|NCT01707992|449746041|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
125034860|NCT01707992|449746042|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
125217776|NCT03130959|450425287|FG003|Overall Study|Administrative reason by sponsor|0|||
124970797|NCT02201901|449519397|FG002|Overall Study|Lack of Efficacy|6|||
124970798|NCT02201901|449519395|FG000|Overall Study|Death|3|||
124970799|NCT02201901|449519396|FG001|Overall Study|Death|3|||
124970800|NCT02201901|449519397|FG002|Overall Study|Death|3|||
124970801|NCT02201901|449519395|FG000|Overall Study|Lost to Follow-up|2|||
124970802|NCT02201901|449519396|FG001|Overall Study|Lost to Follow-up|3|||
124970803|NCT02201901|449519397|FG002|Overall Study|Lost to Follow-up|2|||
124970804|NCT02201901|449519395|FG000|Overall Study|Withdrew Consent|2|||
124970805|NCT02201901|449519396|FG001|Overall Study|Withdrew Consent|0|||
124970806|NCT02201901|449519397|FG002|Overall Study|Withdrew Consent|2|||
124970807|NCT02201901|449519395|FG000|Overall Study|Adverse Event|1|||
124970808|NCT02201901|449519396|FG001|Overall Study|Adverse Event|1|||
124970809|NCT02201901|449519397|FG002|Overall Study|Adverse Event|0|||
124970810|NCT03358238|449519401|FG000|Overall Study|Withdrawal by Subject|0|||
124970811|NCT03358238|449519402|FG001|Overall Study|Withdrawal by Subject|1|||
124970812|NCT04277507|449519405|FG000|Overall Study|Lost to Follow-up|17|||
124970813|NCT04277507|449519405|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
124970814|NCT04277507|449519405|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
124970815|NCT04277507|449519405|FG000|Overall Study|Withdrawal by Subject|3|||
124970816|NCT04277507|449519405|FG000|Overall Study|Death due to COVID-19|1|||
124970817|NCT04277507|449519405|FG000|Overall Study|Data missing for full evaluation|5|||
124970818|NCT01431950|449519406|FG000|Overall Study|Study Site Closed/Terminated|7|||
124970819|NCT01431950|449519407|FG001|Overall Study|Study Site Closed/Terminated|3|||
124970820|NCT01431950|449519406|FG000|Overall Study|Withdrawal by Subject|4|||
124970821|NCT01431950|449519407|FG001|Overall Study|Withdrawal by Subject|3|||
124970822|NCT01431950|449519406|FG000|Overall Study|Protocol Violation|2|||
124970823|NCT01431950|449519407|FG001|Overall Study|Protocol Violation|3|||
124970824|NCT01431950|449519406|FG000|Overall Study|Adverse Event|2|||
124970825|NCT01431950|449519407|FG001|Overall Study|Adverse Event|2|||
124970826|NCT01431950|449519406|FG000|Overall Study|Physician Decision|2|||
124970827|NCT01431950|449519407|FG001|Overall Study|Physician Decision|1|||
124970828|NCT01431950|449519406|FG000|Overall Study|Lack of Efficacy|2|||
124970829|NCT01431950|449519407|FG001|Overall Study|Lack of Efficacy|1|||
124970830|NCT01431950|449519406|FG000|Overall Study|Lost to Follow-up|0|||
124970831|NCT01431950|449519407|FG001|Overall Study|Lost to Follow-up|1|||
124970832|NCT01431950|449519406|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
124970833|NCT01431950|449519407|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
124970834|NCT04577573|449519410|FG000|Overall Study|Technical - invalid protocol|0|||
124970835|NCT04577573|449519411|FG001|Overall Study|Technical - invalid protocol|2|||
124970836|NCT04577573|449519412|FG002|Overall Study|Technical - invalid protocol|0|||
124970837|NCT06719986|449519413|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
124970838|NCT06719986|449519414|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
124970839|NCT06719986|449519415|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
124970840|NCT06719986|449519413|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
124970841|NCT06719986|449519414|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
124970842|NCT06719986|449519415|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
124970843|NCT05992922|449519417|FG000|Overall Study|Adverse Event|6|||
124970844|NCT05992922|449519418|FG001|Overall Study|Adverse Event|0|||
124970845|NCT05992922|449519417|FG000|Overall Study|Sponsor Termination of Study|14|||
124970846|NCT05992922|449519418|FG001|Overall Study|Sponsor Termination of Study|20|||
124970847|NCT04596995|449521056|FG000|Overall Study|Lack of Efficacy|8|||
124970848|NCT04596995|449521056|FG000|Overall Study|Lost to Follow-up|3|||
124970849|NCT04596995|449521056|FG000|Overall Study|Withdrawal by Subject|12|||
124970850|NCT04596995|449521056|FG000|Overall Study|Sponsor decision|3|||
124970851|NCT04596995|449521056|FG000|Overall Study|Enrolled in managed access program|3|||
124970852|NCT00590564|449521058|FG000|Overall Study|Withdrawal by Subject|4|||
124970853|NCT00590564|449521058|FG000|Overall Study|Lost to Follow-up|6|||
124970854|NCT00590564|449521058|FG000|Overall Study|Protocol Violation|1|||
125034861|NCT01707992|449746043|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
124970855|NCT00590564|449521058|FG000|Overall Study|Patient Found to be Ineligible|1|||
124970856|NCT00590564|449521058|FG000|Overall Study|Patient Non-compliance|6|||
124970857|NCT01434680|449521059|FG000|Overall Study|Withdrawal by Subject|1|||
124970858|NCT01434680|449521060|FG001|Overall Study|Withdrawal by Subject|0|||
124970859|NCT01434680|449521061|FG002|Overall Study|Withdrawal by Subject|2|||
124970860|NCT01434680|449521062|FG003|Overall Study|Withdrawal by Subject|0|||
124970861|NCT01434680|449521059|FG000|Overall Study|Lost to Follow-up|1|||
124970862|NCT01434680|449521060|FG001|Overall Study|Lost to Follow-up|1|||
124970863|NCT01434680|449521061|FG002|Overall Study|Lost to Follow-up|0|||
124970864|NCT01434680|449521062|FG003|Overall Study|Lost to Follow-up|0|||
124970865|NCT01434680|449521059|FG000|Overall Study|Protocol Violation|1|||
124970866|NCT01434680|449521060|FG001|Overall Study|Protocol Violation|1|||
124970867|NCT01434680|449521061|FG002|Overall Study|Protocol Violation|0|||
124970868|NCT01434680|449521062|FG003|Overall Study|Protocol Violation|0|||
124970869|NCT00983749|449521064|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
124970870|NCT00983749|449521065|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
124970871|NCT01952847|449521066|FG000|Overall Study|Ineligible|1|||
124970872|NCT01952847|449521067|FG001|Overall Study|Ineligible|0|||
124970873|NCT01952847|449521068|FG002|Overall Study|Ineligible|0|||
124970874|NCT01952847|449521069|FG003|Overall Study|Ineligible|0|||
124970875|NCT01952847|449521066|FG000|Overall Study|Lack of Insurance Coverage|0|||
124970876|NCT01952847|449521067|FG001|Overall Study|Lack of Insurance Coverage|1|||
124970877|NCT01952847|449521068|FG002|Overall Study|Lack of Insurance Coverage|0|||
124970878|NCT01952847|449521069|FG003|Overall Study|Lack of Insurance Coverage|0|||
124970879|NCT01952847|449521066|FG000|Overall Study|Withdrawal by Subject|1|||
124970880|NCT01952847|449521067|FG001|Overall Study|Withdrawal by Subject|1|||
124970881|NCT01952847|449521068|FG002|Overall Study|Withdrawal by Subject|0|||
124970882|NCT01952847|449521069|FG003|Overall Study|Withdrawal by Subject|1|||
124970883|NCT01907906|449521070|FG000|Overall Study|Withdrawal by Subject|1|||
124970884|NCT01907906|449521071|FG001|Overall Study|Withdrawal by Subject|0|||
124970885|NCT01907906|449521070|FG000|Overall Study|Physician Decision|3|||
124970886|NCT01907906|449521071|FG001|Overall Study|Physician Decision|1|||
124970887|NCT00121667|449521073|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
124970888|NCT00121667|449521074|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
124970889|NCT00121667|449521075|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
124970890|NCT00121667|449521076|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
124970891|NCT00121667|449521073|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
124970892|NCT00121667|449521074|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
124970893|NCT00121667|449521075|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
124970894|NCT00121667|449521076|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
124970895|NCT00121667|449521073|FG000|Short Term (ST) Period|Adverse Event|5|||
124970896|NCT00121667|449521074|FG001|Short Term (ST) Period|Adverse Event|6|||
124970897|NCT00121667|449521075|FG002|Short Term (ST) Period|Adverse Event|5|||
124970898|NCT00121667|449521076|FG003|Short Term (ST) Period|Adverse Event|3|||
124970899|NCT00121667|449521073|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
124970900|NCT00121667|449521074|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
124970901|NCT00121667|449521075|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
124970902|NCT00121667|449521076|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
124970903|NCT00121667|449521073|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
124970904|NCT00121667|449521074|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
124970905|NCT00121667|449521075|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
124970906|NCT00121667|449521076|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
124970907|NCT00121667|449521073|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
124970908|NCT00121667|449521074|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
124970909|NCT00121667|449521075|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
124970910|NCT00121667|449521076|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
124970911|NCT00121667|449521073|FG000|Short Term (ST) Period|Other Reason|3|||
124970912|NCT00121667|449521074|FG001|Short Term (ST) Period|Other Reason|0|||
124970913|NCT00121667|449521075|FG002|Short Term (ST) Period|Other Reason|0|||
124970914|NCT00121667|449521076|FG003|Short Term (ST) Period|Other Reason|0|||
124970915|NCT00121667|449521073|FG000|Short Term (ST) Period|Death|0|||
124970916|NCT00121667|449521074|FG001|Short Term (ST) Period|Death|0|||
124970917|NCT00121667|449521075|FG002|Short Term (ST) Period|Death|0|||
124970918|NCT00121667|449521076|FG003|Short Term (ST) Period|Death|1|||
124970919|NCT00121667|449521073|FG000|Short Term (ST) Period|Pregnancy|0|||
124970920|NCT00121667|449521074|FG001|Short Term (ST) Period|Pregnancy|0|||
124970921|NCT00121667|449521075|FG002|Short Term (ST) Period|Pregnancy|0|||
124970922|NCT00121667|449521076|FG003|Short Term (ST) Period|Pregnancy|1|||
124970923|NCT00121667|449521073|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
124970924|NCT00121667|449521074|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
124970925|NCT00121667|449521075|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
124970926|NCT00121667|449521076|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
124970927|NCT00121667|449521073|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
124970928|NCT00121667|449521074|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
124970929|NCT00121667|449521075|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
124970930|NCT00121667|449521076|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
124970931|NCT00121667|449521073|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
124970932|NCT00121667|449521074|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
124970933|NCT00121667|449521075|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
124970934|NCT00121667|449521076|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
124970935|NCT00121667|449521073|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
125034862|NCT01707992|449746038|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
125034863|NCT01707992|449746039|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
124970936|NCT00121667|449521074|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
124970937|NCT00121667|449521075|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
124970938|NCT00121667|449521076|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
124970939|NCT00121667|449521073|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
124970940|NCT00121667|449521074|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
124970941|NCT00121667|449521075|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
124970942|NCT00121667|449521076|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
124970943|NCT00121667|449521073|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
124970944|NCT00121667|449521074|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
124970945|NCT00121667|449521075|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
124970946|NCT00121667|449521076|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
124970947|NCT00121667|449521073|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
124970948|NCT00121667|449521074|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
124970949|NCT00121667|449521075|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
124970950|NCT00121667|449521076|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
124970951|NCT00121667|449521073|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
124970952|NCT00121667|449521074|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
124970953|NCT00121667|449521075|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
124970954|NCT00121667|449521076|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
124970955|NCT00121667|449521073|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
124970956|NCT00121667|449521074|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
124970957|NCT00121667|449521075|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
124970958|NCT00121667|449521076|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
124970959|NCT01453023|449521077|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
124970960|NCT01453023|449521078|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
124970961|NCT01453023|449521077|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
124970962|NCT01453023|449521078|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
124970963|NCT01453023|449521077|FG000|Treatment Period 2|Protocol Violation|0|||
124970964|NCT01453023|449521078|FG001|Treatment Period 2|Protocol Violation|1|||
124970965|NCT02879383|449521079|FG000|First 24 Weeks|Physician Decision|0|||
124970966|NCT02879383|449521080|FG001|First 24 Weeks|Physician Decision|1|||
124970967|NCT02879383|449521081|FG002|First 24 Weeks|Physician Decision|0|||
124970968|NCT02879383|449521082|FG003|First 24 Weeks|Physician Decision|0|||
124970969|NCT02413593|449521094|FG000|Overall Study|Lost to Follow-up|3|||
124970970|NCT02413593|449521094|FG000|Overall Study|Adverse Event|1|||
124970971|NCT00723125|449521095|FG000|Overall Study|Met Dx|1|||
124970972|NCT00723125|449521096|FG001|Overall Study|Met Dx|0|||
124970973|NCT00723125|449521095|FG000|Overall Study|Withdrawal by Subject|15|||
124970974|NCT00723125|449521096|FG001|Overall Study|Withdrawal by Subject|6|||
124970975|NCT00723125|449521095|FG000|Overall Study|Adverse Event|2|||
124970976|NCT00723125|449521096|FG001|Overall Study|Adverse Event|0|||
124970977|NCT03482752|449521100|FG000|Overall Study|Withdrawal by Subject|2|||
124970978|NCT03482752|449521100|FG000|Overall Study|Lost to Follow-up|1|||
124970979|NCT03482752|449521100|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
124970980|NCT01080300|449521102|FG000|Overall Study|Adverse Event|49|||
125034864|NCT01707992|449746040|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
125034865|NCT01707992|449746041|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
125034866|NCT01707992|449746042|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
125034867|NCT01707992|449746043|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
125034868|NCT01707992|449746038|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
125034869|NCT01707992|449746039|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
125131888|NCT01796171|450110067|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125034870|NCT01707992|449746040|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
125034871|NCT01707992|449746041|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
125034872|NCT01707992|449746042|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
125034873|NCT01707992|449746043|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
125034874|NCT01707992|449746038|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
125034875|NCT01707992|449746039|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
125034876|NCT01707992|449746040|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
125034877|NCT01707992|449746041|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
125034878|NCT01707992|449746042|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
125034879|NCT01707992|449746043|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
125034880|NCT01707992|449746038|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
125034881|NCT01707992|449746039|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
125034882|NCT01707992|449746040|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
125034883|NCT01707992|449746041|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
125034884|NCT01707992|449746042|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
125034885|NCT01707992|449746043|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
125034886|NCT01707992|449746038|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
125034887|NCT01707992|449746039|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
125034888|NCT01707992|449746040|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
125034889|NCT01707992|449746041|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
125034890|NCT01707992|449746042|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
125034891|NCT01707992|449746043|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
125034892|NCT01707992|449746038|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
125034893|NCT01707992|449746039|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
125034894|NCT01707992|449746040|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
125034895|NCT01707992|449746041|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
125034896|NCT01707992|449746042|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
125034897|NCT01707992|449746043|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
125034898|NCT01707992|449746038|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
125034899|NCT01707992|449746039|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
125034900|NCT01707992|449746040|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
125034901|NCT01707992|449746041|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
125034902|NCT01707992|449746042|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
125034903|NCT01707992|449746043|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
125034904|NCT01707992|449746038|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
125034905|NCT01707992|449746039|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
125034906|NCT01707992|449746040|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
125034907|NCT01707992|449746041|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
125034908|NCT01707992|449746042|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
125034909|NCT01707992|449746043|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
125034910|NCT01707992|449746038|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
125034911|NCT01707992|449746039|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
125034912|NCT01707992|449746040|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
125034913|NCT01707992|449746041|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
125217777|NCT03130959|450425288|FG004|Overall Study|Administrative reason by sponsor|0|||
125131889|NCT01796171|450110068|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
125131890|NCT01796171|450110069|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125131891|NCT01796171|450110070|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
125131892|NCT01796171|450110071|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
125131893|NCT01796171|450110072|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125131894|NCT01796171|450110073|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125131895|NCT01796171|450110074|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125131896|NCT01796171|450110060|FG000|Treatment Period With Betalutin|Physician Decision|0|||
125131897|NCT01796171|450110061|FG001|Treatment Period With Betalutin|Physician Decision|0|||
125131898|NCT01796171|450110062|FG002|Treatment Period With Betalutin|Physician Decision|0|||
125131899|NCT01796171|450110063|FG003|Treatment Period With Betalutin|Physician Decision|0|||
125131900|NCT01796171|450110064|FG004|Treatment Period With Betalutin|Physician Decision|0|||
125131901|NCT01796171|450110065|FG005|Treatment Period With Betalutin|Physician Decision|0|||
125131902|NCT01796171|450110066|FG006|Treatment Period With Betalutin|Physician Decision|0|||
125131903|NCT01796171|450110067|FG007|Treatment Period With Betalutin|Physician Decision|0|||
125131904|NCT01796171|450110068|FG008|Treatment Period With Betalutin|Physician Decision|0|||
125131905|NCT01796171|450110069|FG009|Treatment Period With Betalutin|Physician Decision|0|||
125131906|NCT01796171|450110070|FG010|Treatment Period With Betalutin|Physician Decision|5|||
125131907|NCT01796171|450110071|FG011|Treatment Period With Betalutin|Physician Decision|1|||
125131908|NCT01796171|450110072|FG012|Treatment Period With Betalutin|Physician Decision|1|||
125131909|NCT01796171|450110073|FG013|Treatment Period With Betalutin|Physician Decision|0|||
125131910|NCT01796171|450110074|FG014|Treatment Period With Betalutin|Physician Decision|0|||
125131911|NCT01796171|450110060|FG000|Treatment Period With Betalutin|Death|0|||
124970981|NCT01080300|449521103|FG001|Overall Study|Adverse Event|35|||
124970982|NCT01080300|449521102|FG000|Overall Study|Lack of Efficacy|12|||
124970983|NCT01080300|449521103|FG001|Overall Study|Lack of Efficacy|15|||
124970984|NCT01080300|449521102|FG000|Overall Study|Protocol Violation|7|||
124970985|NCT01080300|449521103|FG001|Overall Study|Protocol Violation|13|||
124970986|NCT01080300|449521102|FG000|Overall Study|Lost to Follow-up|10|||
124970987|NCT01080300|449521103|FG001|Overall Study|Lost to Follow-up|6|||
124970988|NCT01080300|449521102|FG000|Overall Study|Death|0|||
124970989|NCT01080300|449521103|FG001|Overall Study|Death|1|||
124970990|NCT01080300|449521102|FG000|Overall Study|Withdrawal by Subject|12|||
124970991|NCT01080300|449521103|FG001|Overall Study|Withdrawal by Subject|28|||
124970992|NCT01080300|449521102|FG000|Overall Study|Reasons not specified|4|||
124970993|NCT01080300|449521103|FG001|Overall Study|Reasons not specified|6|||
124970994|NCT01807182|449521104|FG000|Overall Study|Death|1|||
124970995|NCT01807182|449521104|FG000|Overall Study|New therapy|1|||
124970996|NCT01807182|449521104|FG000|Overall Study|Moved to hospice care|1|||
124970997|NCT01776008|449521105|FG000|Overall Study|ineligible|2|||
124970998|NCT03513068|449521108|FG000|Overall Study|Death|1|||
124970999|NCT03513068|449521109|FG001|Overall Study|Death|0|||
124971000|NCT03513068|449521108|FG000|Overall Study|Withdrawal by Subject|4|||
124971001|NCT03513068|449521109|FG001|Overall Study|Withdrawal by Subject|6|||
124971002|NCT00478205|449521110|FG000|Overall Study|Adverse Event|182|||
124971003|NCT00478205|449521111|FG001|Overall Study|Adverse Event|39|||
124971004|NCT00478205|449521110|FG000|Overall Study|Medication Non-compliance|9|||
124971005|NCT00478205|449521111|FG001|Overall Study|Medication Non-compliance|4|||
124971006|NCT00478205|449521110|FG000|Overall Study|Protocol Violation|15|||
124971007|NCT00478205|449521111|FG001|Overall Study|Protocol Violation|5|||
124971008|NCT00478205|449521110|FG000|Overall Study|Request of Investigator or Sponsor|4|||
124971009|NCT00478205|449521111|FG001|Overall Study|Request of Investigator or Sponsor|5|||
125131912|NCT01796171|450110061|FG001|Treatment Period With Betalutin|Death|0|||
125131913|NCT01796171|450110062|FG002|Treatment Period With Betalutin|Death|0|||
124971010|NCT00478205|449521110|FG000|Overall Study|Withdrawal by Subject|61|||
124971011|NCT00478205|449521111|FG001|Overall Study|Withdrawal by Subject|22|||
124971012|NCT00478205|449521110|FG000|Overall Study|Lack of Efficacy|1|||
124971013|NCT00478205|449521111|FG001|Overall Study|Lack of Efficacy|0|||
124971014|NCT00478205|449521110|FG000|Overall Study|Other|24|||
125034914|NCT01707992|449746042|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
125034915|NCT01707992|449746043|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
125034916|NCT01707992|449746038|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
125034917|NCT01707992|449746039|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
125034918|NCT01707992|449746040|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
125034919|NCT01707992|449746041|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
125034920|NCT01707992|449746042|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
125034921|NCT01707992|449746043|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
125034922|NCT01707992|449746038|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
125034923|NCT01707992|449746039|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
125034924|NCT01707992|449746040|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
124971015|NCT00478205|449521111|FG001|Overall Study|Other|12|||
124971016|NCT00003477|449521114|FG000|Overall Study|Not evalauable|4|||
124971017|NCT01575873|449521115|FG000|Overall Study|Withdrawal by Subject|15|||
124971018|NCT01575873|449521116|FG001|Overall Study|Withdrawal by Subject|20|||
124971019|NCT01575873|449521117|FG002|Overall Study|Withdrawal by Subject|34|||
124971020|NCT01575873|449521118|FG003|Overall Study|Withdrawal by Subject|34|||
124971021|NCT01575873|449521115|FG000|Overall Study|Adverse Event|7|||
124971022|NCT01575873|449521116|FG001|Overall Study|Adverse Event|7|||
124971023|NCT01575873|449521117|FG002|Overall Study|Adverse Event|9|||
124971024|NCT01575873|449521118|FG003|Overall Study|Adverse Event|12|||
124971025|NCT01575873|449521115|FG000|Overall Study|Lost to Follow-up|1|||
124971026|NCT01575873|449521116|FG001|Overall Study|Lost to Follow-up|3|||
124971027|NCT01575873|449521117|FG002|Overall Study|Lost to Follow-up|13|||
124971028|NCT01575873|449521118|FG003|Overall Study|Lost to Follow-up|5|||
124971029|NCT01575873|449521115|FG000|Overall Study|Death|3|||
124971030|NCT01575873|449521116|FG001|Overall Study|Death|2|||
124971031|NCT01575873|449521117|FG002|Overall Study|Death|8|||
124971032|NCT01575873|449521118|FG003|Overall Study|Death|9|||
124971033|NCT01575873|449521115|FG000|Overall Study|Noncompliance|1|||
124971034|NCT01575873|449521116|FG001|Overall Study|Noncompliance|2|||
124971035|NCT01575873|449521117|FG002|Overall Study|Noncompliance|4|||
124971036|NCT01575873|449521118|FG003|Overall Study|Noncompliance|3|||
124971037|NCT01575873|449521115|FG000|Overall Study|Administrative decision|1|||
124971038|NCT01575873|449521116|FG001|Overall Study|Administrative decision|1|||
124971039|NCT01575873|449521117|FG002|Overall Study|Administrative decision|1|||
124971040|NCT01575873|449521118|FG003|Overall Study|Administrative decision|0|||
124971041|NCT01575873|449521115|FG000|Overall Study|Protocol deviation|0|||
124971042|NCT01575873|449521116|FG001|Overall Study|Protocol deviation|1|||
124971043|NCT01575873|449521117|FG002|Overall Study|Protocol deviation|0|||
124971044|NCT01575873|449521118|FG003|Overall Study|Protocol deviation|1|||
124971045|NCT01575873|449521115|FG000|Overall Study|Requirement for Alternative Therapy|0|||
124971046|NCT01575873|449521116|FG001|Overall Study|Requirement for Alternative Therapy|0|||
124971047|NCT01575873|449521117|FG002|Overall Study|Requirement for Alternative Therapy|1|||
124971048|NCT01575873|449521118|FG003|Overall Study|Requirement for Alternative Therapy|1|||
124971049|NCT01575873|449521115|FG000|Overall Study|Other|0|||
125034925|NCT01707992|449746041|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
125034926|NCT01707992|449746042|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
125034927|NCT01707992|449746043|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
125034928|NCT01707992|449746038|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
125034929|NCT01707992|449746039|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
125034930|NCT01707992|449746040|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
125034931|NCT01707992|449746041|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
125034932|NCT01707992|449746042|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
125034933|NCT01707992|449746043|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
125034934|NCT01707992|449746038|FG000|Active Treatment Phase (24 Months)|Death|0|||
125034935|NCT01707992|449746039|FG001|Active Treatment Phase (24 Months)|Death|0|||
125034936|NCT01707992|449746040|FG002|Active Treatment Phase (24 Months)|Death|0|||
125034937|NCT01707992|449746041|FG003|Active Treatment Phase (24 Months)|Death|2|||
125034938|NCT01707992|449746042|FG004|Active Treatment Phase (24 Months)|Death|0|||
125034939|NCT01707992|449746043|FG005|Active Treatment Phase (24 Months)|Death|0|||
125034940|NCT01707992|449746038|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
125034941|NCT01707992|449746039|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
125034942|NCT01707992|449746040|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
125034943|NCT01707992|449746041|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
125034944|NCT01707992|449746042|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
125034945|NCT01707992|449746043|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
125034946|NCT01707992|449746038|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
125034947|NCT01707992|449746039|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
125034948|NCT01707992|449746040|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
124971050|NCT01575873|449521116|FG001|Overall Study|Other|0|||
124971051|NCT01575873|449521117|FG002|Overall Study|Other|4|||
124971052|NCT01575873|449521118|FG003|Overall Study|Other|2|||
125217778|NCT03130959|450425289|FG005|Overall Study|Administrative reason by sponsor|0|||
125217779|NCT03130959|450425290|FG006|Overall Study|Administrative reason by sponsor|0|||
125217780|NCT03130959|450425291|FG007|Overall Study|Administrative reason by sponsor|0|||
125217781|NCT03130959|450425292|FG008|Overall Study|Administrative reason by sponsor|0|||
125217782|NCT03130959|450425293|FG009|Overall Study|Administrative reason by sponsor|0|||
125217783|NCT03130959|450425284|FG000|Overall Study|Lost to Follow-up|1|||
125217784|NCT03130959|450425285|FG001|Overall Study|Lost to Follow-up|0|||
125217785|NCT03130959|450425286|FG002|Overall Study|Lost to Follow-up|0|||
125217786|NCT03130959|450425287|FG003|Overall Study|Lost to Follow-up|0|||
125217787|NCT03130959|450425288|FG004|Overall Study|Lost to Follow-up|0|||
125217788|NCT03130959|450425289|FG005|Overall Study|Lost to Follow-up|0|||
125217789|NCT03130959|450425290|FG006|Overall Study|Lost to Follow-up|0|||
125217790|NCT03130959|450425291|FG007|Overall Study|Lost to Follow-up|0|||
125217791|NCT03130959|450425292|FG008|Overall Study|Lost to Follow-up|0|||
125217792|NCT03130959|450425293|FG009|Overall Study|Lost to Follow-up|0|||
125217793|NCT02384538|450425294|FG000|Overall Study|Adverse Event|1|||
125217794|NCT02384538|450425295|FG001|Overall Study|Adverse Event|4|||
125217795|NCT02384538|450425294|FG000|Overall Study|Lack of Efficacy|4|||
124971053|NCT01850030|449521119|FG000|Overall Study|Adverse Event|64|||
125034949|NCT01707992|449746041|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
125034950|NCT01707992|449746042|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
125034951|NCT01707992|449746043|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
125034952|NCT01707992|449746038|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
125034953|NCT01707992|449746039|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
125034954|NCT01707992|449746040|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
125034955|NCT01707992|449746041|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
125034956|NCT01707992|449746042|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
125034957|NCT01707992|449746043|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
125034958|NCT01707992|449746038|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
125034959|NCT01707992|449746039|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
125034960|NCT01707992|449746040|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
125034961|NCT01707992|449746041|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
125034962|NCT01707992|449746042|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
125034963|NCT01707992|449746043|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
125034964|NCT01976806|449746044|FG000|Overall Study|Lost to Follow-up|1|||
125034965|NCT01976806|449746045|FG001|Overall Study|Lost to Follow-up|4|||
125034966|NCT01976806|449746044|FG000|Overall Study|Adverse Event|1|||
125034967|NCT01976806|449746045|FG001|Overall Study|Adverse Event|1|||
125034968|NCT01976806|449746044|FG000|Overall Study|Withdrawal by Subject|1|||
125034969|NCT01976806|449746045|FG001|Overall Study|Withdrawal by Subject|1|||
125034970|NCT01523873|449746053|FG000|Overall Study|Protocol Violation|422|||
125034971|NCT02654002|449746054|FG000|Overall Study|Adverse Event|0|||
125034972|NCT02654002|449746055|FG001|Overall Study|Adverse Event|0|||
125034973|NCT02654002|449746056|FG002|Overall Study|Adverse Event|0|||
125034974|NCT02654002|449746057|FG003|Overall Study|Adverse Event|0|||
125034975|NCT02654002|449746058|FG004|Overall Study|Adverse Event|0|||
125034976|NCT02654002|449746059|FG005|Overall Study|Adverse Event|0|||
125217796|NCT02384538|450425295|FG001|Overall Study|Lack of Efficacy|4|||
125217797|NCT02384538|450425294|FG000|Overall Study|Withdrew Consent|0|||
124971054|NCT01850030|449521120|FG001|Overall Study|Adverse Event|82|||
124971055|NCT01850030|449521119|FG000|Overall Study|Lack of Efficacy|3|||
124971056|NCT01850030|449521120|FG001|Overall Study|Lack of Efficacy|1|||
124971057|NCT01850030|449521119|FG000|Overall Study|Lost to Follow-up|5|||
124971058|NCT01850030|449521120|FG001|Overall Study|Lost to Follow-up|5|||
124971059|NCT01850030|449521119|FG000|Overall Study|Withdrawal by Subject|3|||
124971060|NCT01850030|449521120|FG001|Overall Study|Withdrawal by Subject|4|||
124971061|NCT01850030|449521119|FG000|Overall Study|Protocol Violation|24|||
124971062|NCT01850030|449521120|FG001|Overall Study|Protocol Violation|28|||
124971063|NCT01850030|449521119|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
124971064|NCT01850030|449521120|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
124971065|NCT00762476|449521121|FG000|Overall Study|Adverse Event|7|||
124971066|NCT00762476|449521122|FG001|Overall Study|Adverse Event|1|||
124971067|NCT00762476|449521121|FG000|Overall Study|Lost to Follow-up|2|||
124971068|NCT00762476|449521122|FG001|Overall Study|Lost to Follow-up|0|||
124971069|NCT00762476|449521121|FG000|Overall Study|Protocol Violation|5|||
125034977|NCT02654002|449746060|FG006|Overall Study|Adverse Event|1|||
125034978|NCT02654002|449746061|FG007|Overall Study|Adverse Event|0|||
125034979|NCT02654002|449746062|FG008|Overall Study|Adverse Event|0|||
125217798|NCT02384538|450425295|FG001|Overall Study|Withdrew Consent|4|||
125217799|NCT02384538|450425294|FG000|Overall Study|Other|1|||
125217800|NCT02384538|450425295|FG001|Overall Study|Other|3|||
125217801|NCT04446429|450425296|FG000|Overall Study|Lost to Follow-up|6|||
125217802|NCT04446429|450425297|FG001|Overall Study|Lost to Follow-up|0|||
124971070|NCT00762476|449521122|FG001|Overall Study|Protocol Violation|6|||
124971071|NCT00762476|449521121|FG000|Overall Study|Physician Decision|2|||
125217803|NCT02256917|450425298|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
125217804|NCT02256917|450425298|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
125217805|NCT02256917|450425298|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
125217806|NCT02256917|450425298|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
125217807|NCT02256917|450425298|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
125217808|NCT00313586|450425299|FG000|Overall Study|Disease progression|14|||
125217809|NCT00313586|450425300|FG001|Overall Study|Disease progression|19|||
125217810|NCT00313586|450425301|FG002|Overall Study|Disease progression|10|||
125217811|NCT00313586|450425302|FG003|Overall Study|Disease progression|3|||
125217812|NCT00313586|450425299|FG000|Overall Study|Adverse Event|12|||
125217813|NCT00313586|450425300|FG001|Overall Study|Adverse Event|18|||
125217814|NCT00313586|450425301|FG002|Overall Study|Adverse Event|3|||
125217815|NCT00313586|450425302|FG003|Overall Study|Adverse Event|10|||
125217816|NCT00313586|450425299|FG000|Overall Study|Death|11|||
125217817|NCT00313586|450425300|FG001|Overall Study|Death|8|||
125217818|NCT00313586|450425301|FG002|Overall Study|Death|1|||
125217819|NCT00313586|450425302|FG003|Overall Study|Death|7|||
125217820|NCT00313586|450425299|FG000|Overall Study|Withdrawal by Subject|13|||
125217821|NCT00313586|450425300|FG001|Overall Study|Withdrawal by Subject|6|||
125217822|NCT00313586|450425301|FG002|Overall Study|Withdrawal by Subject|6|||
124971072|NCT00762476|449521122|FG001|Overall Study|Physician Decision|14|||
124971073|NCT00762476|449521121|FG000|Overall Study|Withdrawal by Subject|6|||
124971074|NCT00762476|449521122|FG001|Overall Study|Withdrawal by Subject|12|||
124971075|NCT00762476|449521121|FG000|Overall Study|antibiotic use|0|||
124971076|NCT00762476|449521122|FG001|Overall Study|antibiotic use|1|||
124971077|NCT00762476|449521121|FG000|Overall Study|non-compliance with study visits|0|||
124971078|NCT00762476|449521122|FG001|Overall Study|non-compliance with study visits|2|||
124971079|NCT00762476|449521121|FG000|Overall Study|Seasonal allergies|1|||
124971080|NCT00762476|449521122|FG001|Overall Study|Seasonal allergies|0|||
124971081|NCT00965497|449521124|FG000|Overall Study|Physician Decision|1|||
124971082|NCT02638103|449521126|FG000|Overall Study|Adverse Event|13|||
124971083|NCT02638103|449521127|FG001|Overall Study|Adverse Event|12|||
124971084|NCT02638103|449521128|FG002|Overall Study|Adverse Event|19|||
124971085|NCT02638103|449521129|FG003|Overall Study|Adverse Event|12|||
124971086|NCT02638103|449521126|FG000|Overall Study|Withdrawal by Subject|43|||
124971087|NCT02638103|449521127|FG001|Overall Study|Withdrawal by Subject|53|||
124971088|NCT02638103|449521128|FG002|Overall Study|Withdrawal by Subject|30|||
124971089|NCT02638103|449521129|FG003|Overall Study|Withdrawal by Subject|61|||
124971090|NCT02638103|449521126|FG000|Overall Study|Protocol Violation|1|||
124971091|NCT02638103|449521127|FG001|Overall Study|Protocol Violation|2|||
124971092|NCT02638103|449521128|FG002|Overall Study|Protocol Violation|1|||
124971093|NCT02638103|449521129|FG003|Overall Study|Protocol Violation|4|||
124971094|NCT02638103|449521126|FG000|Overall Study|Pregnancy|2|||
124971095|NCT02638103|449521127|FG001|Overall Study|Pregnancy|3|||
124971096|NCT02638103|449521128|FG002|Overall Study|Pregnancy|0|||
124971097|NCT02638103|449521129|FG003|Overall Study|Pregnancy|1|||
124971098|NCT02638103|449521126|FG000|Overall Study|Non-compliance to Study Procedures|2|||
124971099|NCT02638103|449521127|FG001|Overall Study|Non-compliance to Study Procedures|1|||
124971100|NCT02638103|449521128|FG002|Overall Study|Non-compliance to Study Procedures|1|||
124971101|NCT02638103|449521129|FG003|Overall Study|Non-compliance to Study Procedures|1|||
124971102|NCT02638103|449521126|FG000|Overall Study|Lost to Follow-up|26|||
124971103|NCT02638103|449521127|FG001|Overall Study|Lost to Follow-up|33|||
124971104|NCT02638103|449521128|FG002|Overall Study|Lost to Follow-up|20|||
124971105|NCT02638103|449521129|FG003|Overall Study|Lost to Follow-up|37|||
124971106|NCT02638103|449521126|FG000|Overall Study|Lack of Efficacy|14|||
124971107|NCT02638103|449521127|FG001|Overall Study|Lack of Efficacy|10|||
124971108|NCT02638103|449521128|FG002|Overall Study|Lack of Efficacy|12|||
125217823|NCT00313586|450425302|FG003|Overall Study|Withdrawal by Subject|2|||
125217824|NCT00313586|450425299|FG000|Overall Study|Alternative therapy|3|||
125217825|NCT00313586|450425300|FG001|Overall Study|Alternative therapy|6|||
125217826|NCT00313586|450425301|FG002|Overall Study|Alternative therapy|2|||
125217827|NCT00313586|450425302|FG003|Overall Study|Alternative therapy|0|||
125217828|NCT00313586|450425299|FG000|Overall Study|Other complicating disease|2|||
125217829|NCT00313586|450425300|FG001|Overall Study|Other complicating disease|2|||
125217830|NCT00313586|450425301|FG002|Overall Study|Other complicating disease|0|||
125217831|NCT00313586|450425302|FG003|Overall Study|Other complicating disease|0|||
125217832|NCT00313586|450425299|FG000|Overall Study|Did not achieve HI-major/better response|10|||
125217833|NCT00313586|450425300|FG001|Overall Study|Did not achieve HI-major/better response|7|||
125217834|NCT00313586|450425301|FG002|Overall Study|Did not achieve HI-major/better response|2|||
125217835|NCT00313586|450425302|FG003|Overall Study|Did not achieve HI-major/better response|1|||
125217836|NCT00313586|450425299|FG000|Overall Study|Physician Decision|2|||
124971109|NCT02638103|449521129|FG003|Overall Study|Lack of Efficacy|22|||
124971110|NCT02638103|449521126|FG000|Overall Study|Other than specified|5|||
124971111|NCT02638103|449521127|FG001|Overall Study|Other than specified|4|||
124971112|NCT02638103|449521128|FG002|Overall Study|Other than specified|2|||
124971113|NCT02638103|449521129|FG003|Overall Study|Other than specified|4|||
124971114|NCT01827046|449521134|FG000|Overall Study|Lost to Follow-up|1|||
124971115|NCT01827046|449521135|FG001|Overall Study|Lost to Follow-up|5|||
124971116|NCT01827046|449521134|FG000|Overall Study|Withdrawal by Subject|0|||
124971117|NCT01827046|449521135|FG001|Overall Study|Withdrawal by Subject|4|||
125131914|NCT01796171|450110063|FG003|Treatment Period With Betalutin|Death|0|||
125131915|NCT01796171|450110064|FG004|Treatment Period With Betalutin|Death|0|||
125131916|NCT01796171|450110065|FG005|Treatment Period With Betalutin|Death|0|||
125131917|NCT01796171|450110066|FG006|Treatment Period With Betalutin|Death|0|||
125131918|NCT01796171|450110067|FG007|Treatment Period With Betalutin|Death|0|||
125131919|NCT01796171|450110068|FG008|Treatment Period With Betalutin|Death|0|||
125131920|NCT01796171|450110069|FG009|Treatment Period With Betalutin|Death|0|||
125131921|NCT01796171|450110070|FG010|Treatment Period With Betalutin|Death|2|||
124971118|NCT02734004|449521136|FG000|Overall Study|Death|36|||
125131922|NCT01796171|450110071|FG011|Treatment Period With Betalutin|Death|0|||
124971119|NCT02734004|449521137|FG001|Overall Study|Death|24|||
124971120|NCT02734004|449521138|FG002|Overall Study|Death|26|||
124971121|NCT02734004|449521139|FG003|Overall Study|Death|35|||
124971122|NCT02734004|449521140|FG004|Overall Study|Death|13|||
125131923|NCT01796171|450110072|FG012|Treatment Period With Betalutin|Death|0|||
125131924|NCT01796171|450110073|FG013|Treatment Period With Betalutin|Death|0|||
125131925|NCT01796171|450110074|FG014|Treatment Period With Betalutin|Death|0|||
124971123|NCT02734004|449521141|FG005|Overall Study|Death|17|||
124971124|NCT02734004|449521142|FG006|Overall Study|Death|20|||
124971125|NCT02734004|449521136|FG000|Overall Study|Lost to Follow-up|1|||
124971126|NCT02734004|449521137|FG001|Overall Study|Lost to Follow-up|1|||
124971127|NCT02734004|449521138|FG002|Overall Study|Lost to Follow-up|0|||
124971128|NCT02734004|449521139|FG003|Overall Study|Lost to Follow-up|0|||
124971129|NCT02734004|449521140|FG004|Overall Study|Lost to Follow-up|1|||
124971130|NCT02734004|449521141|FG005|Overall Study|Lost to Follow-up|0|||
124971131|NCT02734004|449521142|FG006|Overall Study|Lost to Follow-up|0|||
124971132|NCT02734004|449521136|FG000|Overall Study|Withdrawal by Subject|3|||
124971133|NCT02734004|449521137|FG001|Overall Study|Withdrawal by Subject|1|||
124971134|NCT02734004|449521138|FG002|Overall Study|Withdrawal by Subject|1|||
124971135|NCT02734004|449521139|FG003|Overall Study|Withdrawal by Subject|1|||
124971136|NCT02734004|449521140|FG004|Overall Study|Withdrawal by Subject|3|||
124971137|NCT02734004|449521141|FG005|Overall Study|Withdrawal by Subject|0|||
124971138|NCT02734004|449521142|FG006|Overall Study|Withdrawal by Subject|2|||
124971139|NCT02734004|449521136|FG000|Overall Study|Other|0|||
124971140|NCT02734004|449521137|FG001|Overall Study|Other|8|||
124971141|NCT02734004|449521138|FG002|Overall Study|Other|7|||
124971142|NCT02734004|449521139|FG003|Overall Study|Other|4|||
124971143|NCT02734004|449521140|FG004|Overall Study|Other|34|||
124971144|NCT02734004|449521141|FG005|Overall Study|Other|14|||
124971145|NCT02734004|449521142|FG006|Overall Study|Other|10|||
124971146|NCT01294436|449521143|FG000|Overall Study|Adverse Event|10|||
124971147|NCT01294436|449521144|FG001|Overall Study|Adverse Event|17|||
124971148|NCT01294436|449521143|FG000|Overall Study|Withdrawal by Subject|11|||
124971149|NCT01294436|449521144|FG001|Overall Study|Withdrawal by Subject|28|||
124971150|NCT01294436|449521143|FG000|Overall Study|subject no longer meets study criteria|5|||
124971151|NCT01294436|449521144|FG001|Overall Study|subject no longer meets study criteria|20|||
124971152|NCT01294436|449521143|FG000|Overall Study|poor/non-compliance|2|||
124971153|NCT01294436|449521144|FG001|Overall Study|poor/non-compliance|5|||
124971154|NCT02296892|449521151|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
124971155|NCT02296892|449521152|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
124971156|NCT02296892|449521153|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
124971157|NCT02296892|449521151|FG000|Overall Study|Lost to Follow-up|5|||
124971158|NCT02296892|449521152|FG001|Overall Study|Lost to Follow-up|0|||
124971159|NCT02296892|449521153|FG002|Overall Study|Lost to Follow-up|1|||
124971160|NCT00585078|449521154|FG000|Overall Study|Withdrawal by Subject|4|||
124971161|NCT00585078|449521154|FG000|Overall Study|Poor performance status|1|||
124971162|NCT00585078|449521154|FG000|Overall Study|Disease Progression|24|||
125131926|NCT01796171|450110060|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
124971163|NCT00585078|449521154|FG000|Overall Study|Adverse Event|10|||
124971164|NCT00585078|449521154|FG000|Overall Study|Death|1|||
124971165|NCT01018732|449521155|FG000|Overall Study|Lost to Follow-up|0|||
125034980|NCT02654002|449746054|FG000|Overall Study|Withdrew Consent|0|||
125034981|NCT02654002|449746055|FG001|Overall Study|Withdrew Consent|0|||
125034982|NCT02654002|449746056|FG002|Overall Study|Withdrew Consent|0|||
125034983|NCT02654002|449746057|FG003|Overall Study|Withdrew Consent|0|||
125034984|NCT02654002|449746058|FG004|Overall Study|Withdrew Consent|0|||
125034985|NCT02654002|449746059|FG005|Overall Study|Withdrew Consent|1|||
125034986|NCT02654002|449746060|FG006|Overall Study|Withdrew Consent|0|||
125034987|NCT02654002|449746061|FG007|Overall Study|Withdrew Consent|1|||
125034988|NCT02654002|449746062|FG008|Overall Study|Withdrew Consent|0|||
125034989|NCT00891202|449746063|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
125034990|NCT00891202|449746064|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
125034991|NCT00891202|449746065|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
125034992|NCT00891202|449746066|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
125034993|NCT00891202|449746063|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
125034994|NCT00891202|449746064|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
125034995|NCT00891202|449746065|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
125034996|NCT00891202|449746066|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
125034997|NCT00891202|449746063|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
125034998|NCT00891202|449746064|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
125034999|NCT00891202|449746065|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
125035000|NCT00891202|449746066|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
125035001|NCT00891202|449746063|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
125035002|NCT00891202|449746064|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
125035003|NCT00891202|449746065|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
125035004|NCT00891202|449746066|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
125035005|NCT03313050|449746070|FG000|Stage 2: 12 Months|Adverse Event|0|||
125035006|NCT03313050|449746071|FG001|Stage 2: 12 Months|Adverse Event|0|||
125035007|NCT03313050|449746072|FG002|Stage 2: 12 Months|Adverse Event|0|||
125035008|NCT03313050|449746073|FG003|Stage 2: 12 Months|Adverse Event|1|||
125035009|NCT03313050|449746070|FG000|Stage 2: 12 Months|Death|0|||
125035010|NCT03313050|449746071|FG001|Stage 2: 12 Months|Death|0|||
125035011|NCT03313050|449746072|FG002|Stage 2: 12 Months|Death|3|||
125035012|NCT03313050|449746073|FG003|Stage 2: 12 Months|Death|0|||
125035013|NCT03313050|449746070|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
125035014|NCT03313050|449746071|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
125035015|NCT03313050|449746072|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
125035016|NCT03313050|449746073|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
125035017|NCT03313050|449746070|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
125035018|NCT03313050|449746071|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
125035019|NCT03313050|449746072|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
125035020|NCT03313050|449746073|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
125035021|NCT03313050|449746070|FG000|Stage 2: 12 Months|Protocol deviation|0|||
125035022|NCT03313050|449746071|FG001|Stage 2: 12 Months|Protocol deviation|0|||
125035023|NCT03313050|449746072|FG002|Stage 2: 12 Months|Protocol deviation|7|||
125035024|NCT03313050|449746073|FG003|Stage 2: 12 Months|Protocol deviation|7|||
125035025|NCT03313050|449746070|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
125035026|NCT03313050|449746071|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
125035027|NCT03313050|449746072|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
125035028|NCT03313050|449746073|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
125035029|NCT03313050|449746070|FG000|Stage 2: 12 Months|Other|0|||
125035030|NCT03313050|449746071|FG001|Stage 2: 12 Months|Other|0|||
125035031|NCT03313050|449746072|FG002|Stage 2: 12 Months|Other|0|||
125035032|NCT03313050|449746073|FG003|Stage 2: 12 Months|Other|1|||
125035033|NCT02848833|449746082|FG000|Overall Study|subject who are duplicated|1|||
125035034|NCT02848833|449746082|FG000|Overall Study|have not taken the study drug|11|||
125035035|NCT02848833|449746082|FG000|Overall Study|follow-up failure|6|||
125035036|NCT02848833|449746082|FG000|Overall Study|Protocol Violation|119|||
125035037|NCT02847598|449746083|FG000|Overall Study|Adverse Event|0|||
125035038|NCT02847598|449746084|FG001|Overall Study|Adverse Event|0|||
125131927|NCT01796171|450110061|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
125131928|NCT01796171|450110062|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
125131929|NCT01796171|450110063|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
125035039|NCT02847598|449746085|FG002|Overall Study|Adverse Event|0|||
125131930|NCT01796171|450110064|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
125131931|NCT01796171|450110065|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
125131932|NCT01796171|450110066|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
125035040|NCT02847598|449746086|FG003|Overall Study|Adverse Event|0|||
125035041|NCT02847598|449746087|FG004|Overall Study|Adverse Event|0|||
125035042|NCT02847598|449746088|FG005|Overall Study|Adverse Event|0|||
125035043|NCT02847598|449746089|FG006|Overall Study|Adverse Event|0|||
125035044|NCT02847598|449746090|FG007|Overall Study|Adverse Event|1|||
125035045|NCT02847598|449746083|FG000|Overall Study|Consent withdrawn|2|||
125035046|NCT02847598|449746084|FG001|Overall Study|Consent withdrawn|0|||
125035047|NCT02847598|449746085|FG002|Overall Study|Consent withdrawn|0|||
125035048|NCT02847598|449746086|FG003|Overall Study|Consent withdrawn|4|||
125131933|NCT01796171|450110067|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
125131934|NCT01796171|450110068|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
125131935|NCT01796171|450110069|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
125131936|NCT01796171|450110070|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
125131937|NCT01796171|450110071|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
125131938|NCT01796171|450110072|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
125131939|NCT01796171|450110073|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
125131940|NCT01796171|450110074|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
125131941|NCT01796171|450110060|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131942|NCT01796171|450110061|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131943|NCT01796171|450110062|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131944|NCT01796171|450110063|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131945|NCT01796171|450110064|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131946|NCT01796171|450110065|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131947|NCT01796171|450110066|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131948|NCT01796171|450110067|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131949|NCT01796171|450110068|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131950|NCT01796171|450110069|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131951|NCT01796171|450110070|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
125131952|NCT01796171|450110071|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
125131953|NCT01796171|450110072|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131954|NCT01796171|450110073|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125035049|NCT02847598|449746087|FG004|Overall Study|Consent withdrawn|3|||
125035050|NCT02847598|449746088|FG005|Overall Study|Consent withdrawn|2|||
125035051|NCT02847598|449746089|FG006|Overall Study|Consent withdrawn|1|||
125035052|NCT02847598|449746090|FG007|Overall Study|Consent withdrawn|3|||
125035053|NCT02847598|449746083|FG000|Overall Study|Death|3|||
125035054|NCT02847598|449746084|FG001|Overall Study|Death|0|||
125035055|NCT02847598|449746085|FG002|Overall Study|Death|0|||
125035056|NCT02847598|449746086|FG003|Overall Study|Death|0|||
125035057|NCT02847598|449746087|FG004|Overall Study|Death|0|||
125035058|NCT02847598|449746088|FG005|Overall Study|Death|0|||
125035059|NCT02847598|449746089|FG006|Overall Study|Death|0|||
125035060|NCT02847598|449746090|FG007|Overall Study|Death|0|||
125035061|NCT02847598|449746083|FG000|Overall Study|Lost to Follow-up|0|||
125035062|NCT02847598|449746084|FG001|Overall Study|Lost to Follow-up|0|||
125035063|NCT02847598|449746085|FG002|Overall Study|Lost to Follow-up|0|||
125035064|NCT02847598|449746086|FG003|Overall Study|Lost to Follow-up|0|||
125131955|NCT01796171|450110074|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131956|NCT01796171|450110060|FG000|Follow-up Period|Start of further anticancer therapy|4|||
125131957|NCT01796171|450110061|FG001|Follow-up Period|Start of further anticancer therapy|25|||
125131958|NCT01796171|450110062|FG002|Follow-up Period|Start of further anticancer therapy|2|||
125131959|NCT01796171|450110063|FG003|Follow-up Period|Start of further anticancer therapy|1|||
125131960|NCT01796171|450110064|FG004|Follow-up Period|Start of further anticancer therapy|2|||
125131961|NCT01796171|450110065|FG005|Follow-up Period|Start of further anticancer therapy|2|||
125131962|NCT01796171|450110066|FG006|Follow-up Period|Start of further anticancer therapy|1|||
125131963|NCT01796171|450110067|FG007|Follow-up Period|Start of further anticancer therapy|15|||
125131964|NCT01796171|450110068|FG008|Follow-up Period|Start of further anticancer therapy|2|||
125131965|NCT01796171|450110069|FG009|Follow-up Period|Start of further anticancer therapy|0|||
125131966|NCT01796171|450110070|FG010|Follow-up Period|Start of further anticancer therapy|0|||
125131967|NCT01796171|450110071|FG011|Follow-up Period|Start of further anticancer therapy|0|||
125131968|NCT01796171|450110072|FG012|Follow-up Period|Start of further anticancer therapy|0|||
125131969|NCT01796171|450110073|FG013|Follow-up Period|Start of further anticancer therapy|0|||
125131970|NCT01796171|450110074|FG014|Follow-up Period|Start of further anticancer therapy|0|||
125131971|NCT01796171|450110060|FG000|Follow-up Period|Progressive disease|0|||
125131972|NCT01796171|450110061|FG001|Follow-up Period|Progressive disease|1|||
125131973|NCT01796171|450110062|FG002|Follow-up Period|Progressive disease|0|||
125131974|NCT01796171|450110063|FG003|Follow-up Period|Progressive disease|0|||
125131975|NCT01796171|450110064|FG004|Follow-up Period|Progressive disease|0|||
125131976|NCT01796171|450110065|FG005|Follow-up Period|Progressive disease|0|||
125131977|NCT01796171|450110066|FG006|Follow-up Period|Progressive disease|0|||
125131978|NCT01796171|450110067|FG007|Follow-up Period|Progressive disease|3|||
125131979|NCT01796171|450110068|FG008|Follow-up Period|Progressive disease|0|||
125131980|NCT01796171|450110069|FG009|Follow-up Period|Progressive disease|0|||
125131981|NCT01796171|450110070|FG010|Follow-up Period|Progressive disease|0|||
125131982|NCT01796171|450110071|FG011|Follow-up Period|Progressive disease|0|||
125035065|NCT02847598|449746087|FG004|Overall Study|Lost to Follow-up|0|||
125035066|NCT02847598|449746088|FG005|Overall Study|Lost to Follow-up|1|||
125035067|NCT02847598|449746089|FG006|Overall Study|Lost to Follow-up|1|||
125035068|NCT02847598|449746090|FG007|Overall Study|Lost to Follow-up|0|||
125035069|NCT04167345|449746091|FG000|Overall Study|Other|1|||
125035070|NCT04167345|449746092|FG001|Overall Study|Other|1|||
125035071|NCT04167345|449746093|FG002|Overall Study|Other|0|||
125035072|NCT04167345|449746094|FG003|Overall Study|Other|0|||
125035073|NCT04167345|449746095|FG004|Overall Study|Other|0|||
125035074|NCT05047523|449747859|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
125035075|NCT05047523|449747860|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
125035076|NCT05047523|449747861|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
125035077|NCT05047523|449747862|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
125035078|NCT05047523|449747863|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
125035079|NCT05047523|449747864|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
125035080|NCT05047523|449747859|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
125035081|NCT05047523|449747860|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
125035082|NCT05047523|449747861|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
125035083|NCT05047523|449747862|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
125035084|NCT05047523|449747863|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
125035085|NCT05047523|449747864|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
125035086|NCT05047523|449747859|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
125035087|NCT05047523|449747860|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
125035088|NCT05047523|449747861|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
125035089|NCT05047523|449747862|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
125035090|NCT05047523|449747863|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
125035091|NCT05047523|449747864|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
125035092|NCT05047523|449747859|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
125035093|NCT05047523|449747860|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
125035094|NCT05047523|449747861|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
125035095|NCT05047523|449747862|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
125035096|NCT05047523|449747863|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
125035097|NCT05047523|449747864|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
125035098|NCT05047523|449747859|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
125035099|NCT05047523|449747860|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
125035100|NCT05047523|449747861|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
125035101|NCT05047523|449747862|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
125035102|NCT05047523|449747863|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
125035103|NCT05047523|449747864|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
125035104|NCT05047523|449747859|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
125035105|NCT05047523|449747860|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
125035106|NCT05047523|449747861|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
125035107|NCT05047523|449747862|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
125035108|NCT05047523|449747863|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
125035109|NCT05047523|449747864|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
125035110|NCT03658889|449747865|FG000|Overall Study|Protocol Violation|2|||
125035111|NCT03658889|449747866|FG001|Overall Study|Protocol Violation|0|||
125035112|NCT04317690|449747876|FG000|Overall Study|did not have complete information for primary outcome|0|||
125035113|NCT04317690|449747877|FG001|Overall Study|did not have complete information for primary outcome|4|||
125035114|NCT04317690|449747878|FG002|Overall Study|did not have complete information for primary outcome|0|||
125035115|NCT04317690|449747879|FG003|Overall Study|did not have complete information for primary outcome|2|||
125035116|NCT04317690|449747880|FG004|Overall Study|did not have complete information for primary outcome|0|||
125035117|NCT03323749|449747881|FG000|Double-blind Period|Lost to Follow-up|4|||
125035118|NCT03323749|449747882|FG001|Double-blind Period|Lost to Follow-up|5|||
125035119|NCT03323749|449747881|FG000|Double-blind Period|Adverse Event|3|||
125035120|NCT03323749|449747882|FG001|Double-blind Period|Adverse Event|1|||
125035121|NCT03323749|449747881|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
125035122|NCT03323749|449747882|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
125035123|NCT03323749|449747881|FG000|Open-Label Period|Adverse Event|3|||
125035124|NCT03323749|449747882|FG001|Open-Label Period|Adverse Event|10|||
125035125|NCT03323749|449747881|FG000|Open-Label Period|Withdrawal by Subject|7|||
125035126|NCT03323749|449747882|FG001|Open-Label Period|Withdrawal by Subject|5|||
125035127|NCT01719757|449747883|FG000|Overall Study|Adverse Event|38|||
125035128|NCT01719757|449747883|FG000|Overall Study|Withdrawal by Subject|15|||
125035129|NCT01719757|449747883|FG000|Overall Study|Lost to Follow-up|20|||
125035130|NCT01719757|449747883|FG000|Overall Study|Protocol Violation|1|||
125131983|NCT01796171|450110072|FG012|Follow-up Period|Progressive disease|0|||
125131984|NCT01796171|450110073|FG013|Follow-up Period|Progressive disease|0|||
125131985|NCT01796171|450110074|FG014|Follow-up Period|Progressive disease|0|||
125035131|NCT01719757|449747883|FG000|Overall Study|well controlled pain|27|||
125131986|NCT01796171|450110060|FG000|Follow-up Period|Physician Decision|0|||
124971166|NCT01018732|449521156|FG001|Overall Study|Lost to Follow-up|0|||
124971167|NCT01018732|449521157|FG002|Overall Study|Lost to Follow-up|3|||
124971168|NCT01018732|449521155|FG000|Overall Study|Protocol Violation|1|||
124971169|NCT01018732|449521156|FG001|Overall Study|Protocol Violation|1|||
124971170|NCT01018732|449521157|FG002|Overall Study|Protocol Violation|0|||
124971171|NCT01018732|449521155|FG000|Overall Study|Inappropriate Enrollment|0|||
124971172|NCT01018732|449521156|FG001|Overall Study|Inappropriate Enrollment|1|||
124971173|NCT01018732|449521157|FG002|Overall Study|Inappropriate Enrollment|0|||
124971174|NCT01018732|449521155|FG000|Overall Study|Unable to Classify|0|||
124971175|NCT01018732|449521156|FG001|Overall Study|Unable to Classify|0|||
124971176|NCT01018732|449521157|FG002|Overall Study|Unable to Classify|1|||
124971177|NCT01536171|449521158|FG000|Overall Study|Withdrawal by Subject|1|||
124971178|NCT02165826|449521162|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
124971179|NCT02165826|449521163|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
124971180|NCT02165826|449521164|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
124971181|NCT02165826|449521162|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
124971182|NCT02165826|449521163|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
124971183|NCT02165826|449521164|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
124971184|NCT02165826|449521162|FG000|Main Treatment Period|Lost to Follow-up|4|||
124971185|NCT02165826|449521163|FG001|Main Treatment Period|Lost to Follow-up|2|||
124971186|NCT02165826|449521164|FG002|Main Treatment Period|Lost to Follow-up|1|||
124971187|NCT02165826|449521162|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
124971188|NCT02165826|449521163|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
124971189|NCT02165826|449521164|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
124971190|NCT02165826|449521162|FG000|Main Treatment Period|Lack of Efficacy|2|||
124971191|NCT02165826|449521163|FG001|Main Treatment Period|Lack of Efficacy|0|||
124971192|NCT02165826|449521164|FG002|Main Treatment Period|Lack of Efficacy|0|||
124971193|NCT02165826|449521162|FG000|Main Treatment Period|Reason Not Specified|8|||
124971194|NCT02165826|449521163|FG001|Main Treatment Period|Reason Not Specified|5|||
124971195|NCT02165826|449521164|FG002|Main Treatment Period|Reason Not Specified|16|||
124971196|NCT02165826|449521162|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
124971197|NCT02165826|449521163|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
124971198|NCT02165826|449521164|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
124971199|NCT02165826|449521162|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
124971200|NCT02165826|449521163|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
124971201|NCT02165826|449521164|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
124971202|NCT02165826|449521162|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
124971203|NCT02165826|449521163|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
124971204|NCT02165826|449521164|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
124971205|NCT02165826|449521162|FG000|Down-Titration Period|Reason Not Specified|1|||
124971206|NCT02165826|449521163|FG001|Down-Titration Period|Reason Not Specified|0|||
124971207|NCT02165826|449521164|FG002|Down-Titration Period|Reason Not Specified|2|||
124971208|NCT04547023|449521171|FG000|Overall Study|Did Not Receive Intervention|3|||
124971209|NCT04547023|449521172|FG001|Overall Study|Did Not Receive Intervention|2|||
124971210|NCT04547023|449521171|FG000|Overall Study|Lost to Follow-up|1|||
124971211|NCT04547023|449521172|FG001|Overall Study|Lost to Follow-up|1|||
124971212|NCT00250432|449521173|FG000|Overall Study|Adverse Event|25|||
124971213|NCT00250432|449521174|FG001|Overall Study|Adverse Event|29|||
124971214|NCT00250432|449521173|FG000|Overall Study|Lack of Efficacy|2|||
124971215|NCT00250432|449521174|FG001|Overall Study|Lack of Efficacy|1|||
124971216|NCT00250432|449521173|FG000|Overall Study|Lost to Follow-up|6|||
124971217|NCT00250432|449521174|FG001|Overall Study|Lost to Follow-up|5|||
124971218|NCT00250432|449521173|FG000|Overall Study|Patient Moved|0|||
124971219|NCT00250432|449521174|FG001|Overall Study|Patient Moved|1|||
124971220|NCT00250432|449521173|FG000|Overall Study|Protocol Violation|0|||
124971221|NCT00250432|449521174|FG001|Overall Study|Protocol Violation|3|||
124971222|NCT00250432|449521173|FG000|Overall Study|Withdrawal by Subject|6|||
124971223|NCT00250432|449521174|FG001|Overall Study|Withdrawal by Subject|2|||
124971224|NCT00250432|449521173|FG000|Overall Study|Pt died out of posttherapy report period|6|||
124971225|NCT00250432|449521174|FG001|Overall Study|Pt died out of posttherapy report period|5|||
124971226|NCT00250432|449521173|FG000|Overall Study|Pt was considered untreatable|0|||
124971227|NCT00250432|449521174|FG001|Overall Study|Pt was considered untreatable|1|||
124971228|NCT01011868|449521175|FG000|After Week 18 Follow-up|Adverse Event|8|||
125217837|NCT00313586|450425300|FG001|Overall Study|Physician Decision|1|||
125217838|NCT00313586|450425301|FG002|Overall Study|Physician Decision|0|||
124971229|NCT01011868|449521176|FG001|After Week 18 Follow-up|Adverse Event|6|||
124971230|NCT01011868|449521177|FG002|After Week 18 Follow-up|Adverse Event|13|||
124971231|NCT01011868|449521175|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
124971232|NCT01011868|449521176|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
124971233|NCT01011868|449521177|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
124971234|NCT01011868|449521175|FG000|After Week 18 Follow-up|Protocol Violation|1|||
124971235|NCT01011868|449521176|FG001|After Week 18 Follow-up|Protocol Violation|1|||
124971236|NCT01011868|449521177|FG002|After Week 18 Follow-up|Protocol Violation|1|||
125131987|NCT01796171|450110061|FG001|Follow-up Period|Physician Decision|2|||
125131988|NCT01796171|450110062|FG002|Follow-up Period|Physician Decision|0|||
125131989|NCT01796171|450110063|FG003|Follow-up Period|Physician Decision|0|||
125131990|NCT01796171|450110064|FG004|Follow-up Period|Physician Decision|0|||
125131991|NCT01796171|450110065|FG005|Follow-up Period|Physician Decision|0|||
125131992|NCT01796171|450110066|FG006|Follow-up Period|Physician Decision|0|||
125131993|NCT01796171|450110067|FG007|Follow-up Period|Physician Decision|0|||
125131994|NCT01796171|450110068|FG008|Follow-up Period|Physician Decision|0|||
125131995|NCT01796171|450110069|FG009|Follow-up Period|Physician Decision|0|||
125131996|NCT01796171|450110070|FG010|Follow-up Period|Physician Decision|5|||
125131997|NCT01796171|450110071|FG011|Follow-up Period|Physician Decision|0|||
125131998|NCT01796171|450110072|FG012|Follow-up Period|Physician Decision|0|||
125131999|NCT01796171|450110073|FG013|Follow-up Period|Physician Decision|0|||
125132000|NCT01796171|450110074|FG014|Follow-up Period|Physician Decision|0|||
125132001|NCT01796171|450110060|FG000|Follow-up Period|Withdrawal by Subject|0|||
125132002|NCT01796171|450110061|FG001|Follow-up Period|Withdrawal by Subject|1|||
125132003|NCT01796171|450110062|FG002|Follow-up Period|Withdrawal by Subject|0|||
125132004|NCT01796171|450110063|FG003|Follow-up Period|Withdrawal by Subject|0|||
125132005|NCT01796171|450110064|FG004|Follow-up Period|Withdrawal by Subject|0|||
125132006|NCT01796171|450110065|FG005|Follow-up Period|Withdrawal by Subject|1|||
125132007|NCT01796171|450110066|FG006|Follow-up Period|Withdrawal by Subject|0|||
125132008|NCT01796171|450110067|FG007|Follow-up Period|Withdrawal by Subject|0|||
125132009|NCT01796171|450110068|FG008|Follow-up Period|Withdrawal by Subject|0|||
125132010|NCT01796171|450110069|FG009|Follow-up Period|Withdrawal by Subject|0|||
125132011|NCT01796171|450110070|FG010|Follow-up Period|Withdrawal by Subject|3|||
125132012|NCT01796171|450110071|FG011|Follow-up Period|Withdrawal by Subject|1|||
125132013|NCT01796171|450110072|FG012|Follow-up Period|Withdrawal by Subject|0|||
125132014|NCT01796171|450110073|FG013|Follow-up Period|Withdrawal by Subject|0|||
125132015|NCT01796171|450110074|FG014|Follow-up Period|Withdrawal by Subject|0|||
125132016|NCT01796171|450110060|FG000|Follow-up Period|Death|0|||
125132017|NCT01796171|450110061|FG001|Follow-up Period|Death|0|||
125132018|NCT01796171|450110062|FG002|Follow-up Period|Death|0|||
125217839|NCT00313586|450425302|FG003|Overall Study|Physician Decision|0|||
125217840|NCT00313586|450425299|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
125217841|NCT00313586|450425300|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
125217842|NCT00313586|450425301|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
124971237|NCT01011868|449521175|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
124971238|NCT01011868|449521176|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
124971239|NCT01011868|449521177|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
124971240|NCT01011868|449521175|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
124971241|NCT01011868|449521176|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
124971242|NCT01011868|449521177|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
124971243|NCT01011868|449521175|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
124971244|NCT01011868|449521176|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
124971245|NCT01011868|449521177|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
124971246|NCT01011868|449521175|FG000|After Week 78 Follow-up|Adverse Event|14|||
124971247|NCT01011868|449521176|FG001|After Week 78 Follow-up|Adverse Event|18|||
124971248|NCT01011868|449521177|FG002|After Week 78 Follow-up|Adverse Event|21|||
124971249|NCT01011868|449521175|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
124971250|NCT01011868|449521176|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
125132019|NCT01796171|450110063|FG003|Follow-up Period|Death|0|||
124971251|NCT01011868|449521177|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
125132020|NCT01796171|450110064|FG004|Follow-up Period|Death|0|||
125217843|NCT00313586|450425302|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
125217844|NCT00313586|450425299|FG000|Overall Study|Lost insurance|0|||
124971252|NCT01011868|449521175|FG000|After Week 78 Follow-up|Protocol Violation|9|||
124971253|NCT01011868|449521176|FG001|After Week 78 Follow-up|Protocol Violation|1|||
124971254|NCT01011868|449521177|FG002|After Week 78 Follow-up|Protocol Violation|2|||
124971255|NCT01011868|449521175|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
124971256|NCT01011868|449521176|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
124971257|NCT01011868|449521177|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
125217845|NCT00313586|450425300|FG001|Overall Study|Lost insurance|1|||
125132021|NCT01796171|450110065|FG005|Follow-up Period|Death|0|||
125132022|NCT01796171|450110066|FG006|Follow-up Period|Death|1|||
125132023|NCT01796171|450110067|FG007|Follow-up Period|Death|0|||
125132024|NCT01796171|450110068|FG008|Follow-up Period|Death|0|||
125132025|NCT01796171|450110069|FG009|Follow-up Period|Death|0|||
125132026|NCT01796171|450110070|FG010|Follow-up Period|Death|17|||
125132027|NCT01796171|450110071|FG011|Follow-up Period|Death|9|||
124971258|NCT01011868|449521175|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
124971259|NCT01011868|449521176|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
124971260|NCT01011868|449521177|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
124971261|NCT01011868|449521175|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
124971262|NCT01011868|449521176|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
124971263|NCT01011868|449521177|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
124971264|NCT03784820|449521178|FG000|Overall Study|Lost to Follow-up|5|||
124971265|NCT03784820|449521179|FG001|Overall Study|Lost to Follow-up|5|||
124971266|NCT03784820|449521180|FG002|Overall Study|Lost to Follow-up|3|||
124971267|NCT03784820|449521181|FG003|Overall Study|Lost to Follow-up|3|||
124971268|NCT00658606|449521184|FG000|Overall Study|Adverse Event|2|||
124971269|NCT00658606|449521185|FG001|Overall Study|Adverse Event|1|||
124971270|NCT00658606|449521184|FG000|Overall Study|Lack of Efficacy|6|||
124971271|NCT00658606|449521185|FG001|Overall Study|Lack of Efficacy|3|||
124971272|NCT00658606|449521184|FG000|Overall Study|Lost to Follow-up|1|||
124971273|NCT00658606|449521185|FG001|Overall Study|Lost to Follow-up|0|||
124971274|NCT00658606|449521184|FG000|Overall Study|Withdrawal by Subject|7|||
124971275|NCT00658606|449521185|FG001|Overall Study|Withdrawal by Subject|16|||
124971276|NCT00658606|449521184|FG000|Overall Study|Lack of Compliance|0|||
124971277|NCT00658606|449521185|FG001|Overall Study|Lack of Compliance|3|||
124971278|NCT00365547|449521188|FG000|Overall Study|Insurance did not cover Avastin|1|||
124971279|NCT00365547|449521188|FG000|Overall Study|Screen failure|1|||
124971280|NCT00365547|449521188|FG000|Overall Study|Withdrawal by Subject|1|||
124971281|NCT03170518|449521189|FG000|Overall Study|Lost to Follow-up|4|||
124971282|NCT03170518|449521190|FG001|Overall Study|Lost to Follow-up|1|||
124971283|NCT03170518|449521191|FG002|Overall Study|Lost to Follow-up|0|||
124971284|NCT03170518|449521189|FG000|Overall Study|Physician Decision|1|||
124971285|NCT03170518|449521190|FG001|Overall Study|Physician Decision|0|||
124971286|NCT03170518|449521191|FG002|Overall Study|Physician Decision|0|||
124971287|NCT03170518|449521189|FG000|Overall Study|Withdrawal by Subject|4|||
124971288|NCT03170518|449521190|FG001|Overall Study|Withdrawal by Subject|5|||
124971289|NCT03170518|449521191|FG002|Overall Study|Withdrawal by Subject|2|||
124971290|NCT03170518|449521189|FG000|Overall Study|Site terminated by sponsor|0|||
124971291|NCT03170518|449521190|FG001|Overall Study|Site terminated by sponsor|1|||
124971292|NCT03170518|449521191|FG002|Overall Study|Site terminated by sponsor|0|||
124971293|NCT03170518|449521189|FG000|Overall Study|Non-compliance with study drug|1|||
124971294|NCT03170518|449521190|FG001|Overall Study|Non-compliance with study drug|0|||
124971295|NCT03170518|449521191|FG002|Overall Study|Non-compliance with study drug|1|||
124971296|NCT03170518|449521189|FG000|Overall Study|Withdrawal by parent/guardian|2|||
124971297|NCT03170518|449521190|FG001|Overall Study|Withdrawal by parent/guardian|0|||
124971298|NCT03170518|449521191|FG002|Overall Study|Withdrawal by parent/guardian|0|||
124971299|NCT04428476|449521192|FG000|Overall Study|Withdrawal by Subject|1|||
124971300|NCT04428476|449521192|FG000|Overall Study|Still on treatment|12|||
124971301|NCT00546078|449521193|FG000|Overall Study|Lost to Follow-up|1|||
124971302|NCT00546078|449521194|FG001|Overall Study|Lost to Follow-up|3|||
124971303|NCT00546078|449521193|FG000|Overall Study|Withdrawal by Subject|2|||
124971304|NCT00546078|449521194|FG001|Overall Study|Withdrawal by Subject|3|||
124971305|NCT00546078|449521193|FG000|Overall Study|Other reason|1|||
124971306|NCT00546078|449521194|FG001|Overall Study|Other reason|1|||
124971307|NCT01261247|449521198|FG000|Overall Study|Ineligible|2|||
124971308|NCT02559310|449521199|FG000|Overall Study|Death|4|||
124971309|NCT02559310|449521200|FG001|Overall Study|Death|3|||
124971310|NCT02559310|449521199|FG000|Overall Study|Lost to Follow-up|5|||
124971311|NCT02559310|449521200|FG001|Overall Study|Lost to Follow-up|3|||
124971312|NCT02559310|449521199|FG000|Overall Study|Physician Decision|2|||
124971313|NCT02559310|449521200|FG001|Overall Study|Physician Decision|1|||
124971314|NCT02559310|449521199|FG000|Overall Study|Withdrawal by Subject|13|||
124971315|NCT02559310|449521200|FG001|Overall Study|Withdrawal by Subject|9|||
124971316|NCT02559310|449521199|FG000|Overall Study|Sponsor Decision|0|||
124971317|NCT02559310|449521200|FG001|Overall Study|Sponsor Decision|1|||
124971318|NCT02559310|449521199|FG000|Overall Study|Randomized but not treated|3|||
124971319|NCT02559310|449521200|FG001|Overall Study|Randomized but not treated|2|||
124971320|NCT01740154|449521201|FG000|Overall Study|Adverse Event|1|||
124971321|NCT02737826|449523238|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
124971322|NCT02737826|449523239|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
124971323|NCT02737826|449523240|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
124971324|NCT00129935|449523241|FG000|Overall Study|Adverse Event|18|||
124971325|NCT00129935|449523242|FG001|Overall Study|Adverse Event|56|||
125035132|NCT02626338|449747884|FG000|Overall Study|Lack of Efficacy|3|||
125035133|NCT02626338|449747885|FG001|Overall Study|Lack of Efficacy|2|||
124971326|NCT00129935|449523241|FG000|Overall Study|Death|1|||
124971327|NCT00129935|449523242|FG001|Overall Study|Death|1|||
124971328|NCT00129935|449523241|FG000|Overall Study|Withdrawal by Subject|7|||
124971329|NCT00129935|449523242|FG001|Overall Study|Withdrawal by Subject|20|||
124971330|NCT00129935|449523241|FG000|Overall Study|Protocol Violation|0|||
124971331|NCT00129935|449523242|FG001|Overall Study|Protocol Violation|4|||
124971332|NCT00129935|449523241|FG000|Overall Study|Physician Decision|3|||
125132028|NCT01796171|450110072|FG012|Follow-up Period|Death|1|||
125132029|NCT01796171|450110073|FG013|Follow-up Period|Death|0|||
125132030|NCT01796171|450110074|FG014|Follow-up Period|Death|0|||
125132031|NCT01796171|450110060|FG000|Follow-up Period|Patient transferred to other hospital|0|||
125132032|NCT01796171|450110061|FG001|Follow-up Period|Patient transferred to other hospital|1|||
125132033|NCT01796171|450110062|FG002|Follow-up Period|Patient transferred to other hospital|0|||
125132034|NCT01796171|450110063|FG003|Follow-up Period|Patient transferred to other hospital|0|||
125132035|NCT01796171|450110064|FG004|Follow-up Period|Patient transferred to other hospital|0|||
125132036|NCT01796171|450110065|FG005|Follow-up Period|Patient transferred to other hospital|0|||
125132037|NCT01796171|450110066|FG006|Follow-up Period|Patient transferred to other hospital|0|||
125132038|NCT01796171|450110067|FG007|Follow-up Period|Patient transferred to other hospital|0|||
125132039|NCT01796171|450110068|FG008|Follow-up Period|Patient transferred to other hospital|0|||
125132040|NCT01796171|450110069|FG009|Follow-up Period|Patient transferred to other hospital|0|||
125132041|NCT01796171|450110070|FG010|Follow-up Period|Patient transferred to other hospital|0|||
125132042|NCT01796171|450110071|FG011|Follow-up Period|Patient transferred to other hospital|0|||
125132043|NCT01796171|450110072|FG012|Follow-up Period|Patient transferred to other hospital|0|||
125132044|NCT01796171|450110073|FG013|Follow-up Period|Patient transferred to other hospital|0|||
125132045|NCT01796171|450110074|FG014|Follow-up Period|Patient transferred to other hospital|0|||
125132046|NCT01796171|450110060|FG000|Follow-up Period|Sponsor Decision|0|||
125132047|NCT01796171|450110061|FG001|Follow-up Period|Sponsor Decision|0|||
125132048|NCT01796171|450110062|FG002|Follow-up Period|Sponsor Decision|0|||
124971333|NCT00129935|449523242|FG001|Overall Study|Physician Decision|4|||
124971334|NCT00129935|449523241|FG000|Overall Study|Recurrence|1|||
124971335|NCT00129935|449523242|FG001|Overall Study|Recurrence|3|||
124971336|NCT00129935|449523241|FG000|Overall Study|Second primary|0|||
124971337|NCT00129935|449523242|FG001|Overall Study|Second primary|1|||
124971338|NCT00129935|449523241|FG000|Overall Study|Other|3|||
124971339|NCT00129935|449523242|FG001|Overall Study|Other|2|||
124971340|NCT00129935|449523241|FG000|Overall Study|Crossed to the other arm|2|||
124971341|NCT00129935|449523242|FG001|Overall Study|Crossed to the other arm|1|||
124971342|NCT00129935|449523241|FG000|Overall Study|Incorrect study treatment|1|||
124971343|NCT00129935|449523242|FG001|Overall Study|Incorrect study treatment|0|||
124971344|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
124971345|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
124971346|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
124971347|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Death|4|||
124971348|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Death|2|||
124971349|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Death|3|||
124971350|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
124971351|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
124971352|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
124971353|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
124971354|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
124971355|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
124971356|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
124971357|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
124971358|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
124971359|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
124971360|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
124971361|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
124971362|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
124971363|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
124971364|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
124971365|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
124971366|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
124971367|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
124971368|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
124971369|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
124971370|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
125132049|NCT01796171|450110063|FG003|Follow-up Period|Sponsor Decision|0|||
125132050|NCT01796171|450110064|FG004|Follow-up Period|Sponsor Decision|0|||
125132051|NCT01796171|450110065|FG005|Follow-up Period|Sponsor Decision|0|||
125132052|NCT01796171|450110066|FG006|Follow-up Period|Sponsor Decision|0|||
124971371|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
124971372|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
125132053|NCT01796171|450110067|FG007|Follow-up Period|Sponsor Decision|0|||
125132054|NCT01796171|450110068|FG008|Follow-up Period|Sponsor Decision|0|||
125132055|NCT01796171|450110069|FG009|Follow-up Period|Sponsor Decision|0|||
125217846|NCT00313586|450425301|FG002|Overall Study|Lost insurance|0|||
125035134|NCT02626338|449747886|FG002|Overall Study|Lack of Efficacy|0|||
125035135|NCT01901224|449747887|FG000|Overall Study|study was not funded and terminated|2|||
125035136|NCT04125680|449747889|FG000|Overall Study|Lost to Follow-up|15|||
125035137|NCT00391976|449747890|FG000|Overall Study|Adverse Event|0|||
125035138|NCT00391976|449747891|FG001|Overall Study|Adverse Event|0|||
125035139|NCT00391976|449747892|FG002|Overall Study|Adverse Event|1|||
125035140|NCT00391976|449747890|FG000|Overall Study|Withdrawal of consent|0|||
125035141|NCT00391976|449747891|FG001|Overall Study|Withdrawal of consent|1|||
125035142|NCT00391976|449747892|FG002|Overall Study|Withdrawal of consent|1|||
125035143|NCT00391976|449747890|FG000|Overall Study|Lost to Follow-up|1|||
125035144|NCT00391976|449747891|FG001|Overall Study|Lost to Follow-up|2|||
125035145|NCT00391976|449747892|FG002|Overall Study|Lost to Follow-up|0|||
125035146|NCT00391976|449747890|FG000|Overall Study|Inappropriate enrollment|1|||
125132056|NCT01796171|450110070|FG010|Follow-up Period|Sponsor Decision|40|||
125132057|NCT01796171|450110071|FG011|Follow-up Period|Sponsor Decision|15|||
125132058|NCT01796171|450110072|FG012|Follow-up Period|Sponsor Decision|7|||
125132059|NCT01796171|450110073|FG013|Follow-up Period|Sponsor Decision|0|||
125035147|NCT00391976|449747891|FG001|Overall Study|Inappropriate enrollment|1|||
125132060|NCT01796171|450110074|FG014|Follow-up Period|Sponsor Decision|0|||
125132061|NCT00829309|450110077|FG000|Washout: 7 Days|Protocol Violation|1|||
125132062|NCT00829309|450110078|FG001|Washout: 7 Days|Protocol Violation|0|||
125132063|NCT00455312|450110081|FG000|Overall Study|Death|0|||
125132064|NCT00455312|450110082|FG001|Overall Study|Death|1|||
125132065|NCT01693523|450110083|FG000|Overall Study|Adverse Event|2|||
125132066|NCT01693523|450110084|FG001|Overall Study|Adverse Event|1|||
125132067|NCT01693523|450110085|FG002|Overall Study|Adverse Event|0|||
125132068|NCT01693523|450110083|FG000|Overall Study|Death|0|||
125132069|NCT01693523|450110084|FG001|Overall Study|Death|1|||
125132070|NCT01693523|450110085|FG002|Overall Study|Death|1|||
125132071|NCT01693523|450110083|FG000|Overall Study|Lost to Follow-up|0|||
125132072|NCT01693523|450110084|FG001|Overall Study|Lost to Follow-up|0|||
125132073|NCT01693523|450110085|FG002|Overall Study|Lost to Follow-up|4|||
125132074|NCT01693523|450110083|FG000|Overall Study|Physician Decision|0|||
125132075|NCT01693523|450110084|FG001|Overall Study|Physician Decision|0|||
125132076|NCT01693523|450110085|FG002|Overall Study|Physician Decision|1|||
125132077|NCT01693523|450110083|FG000|Overall Study|Withdrawal by Subject|1|||
125132078|NCT01693523|450110084|FG001|Overall Study|Withdrawal by Subject|2|||
125132079|NCT01693523|450110085|FG002|Overall Study|Withdrawal by Subject|2|||
125132080|NCT01693523|450110083|FG000|Overall Study|Lack of compliance study medication|1|||
125132081|NCT01693523|450110084|FG001|Overall Study|Lack of compliance study medication|2|||
125132082|NCT01693523|450110085|FG002|Overall Study|Lack of compliance study medication|0|||
125132083|NCT01693523|450110083|FG000|Overall Study|Chemotherapy was held|1|||
125132084|NCT01693523|450110084|FG001|Overall Study|Chemotherapy was held|2|||
125132085|NCT01693523|450110085|FG002|Overall Study|Chemotherapy was held|0|||
125132086|NCT03343535|450110086|FG000|Overall Study|Lost to Follow-up|1|||
125132087|NCT03343535|450110086|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
125132088|NCT03343535|450110086|FG000|Overall Study|Death|12|||
125132089|NCT02659150|450110088|FG000|Subject Enrollment|Physician Decision|3|||
125132090|NCT02659150|450110088|FG000|Subject Enrollment|Withdrawal by Subject|2|||
125132091|NCT02659150|450110088|FG000|Baseline Imaging|Withdrawal by Subject|1|||
125132092|NCT02659150|450110088|FG000|Baseline Imaging|Physician Decision|1|||
125132093|NCT02659150|450110088|FG000|Study Drug Dosing|Adverse Event|1|||
125132094|NCT02576938|450110099|FG000|Overall Study|Adverse Event|5|||
125132095|NCT02576938|450110100|FG001|Overall Study|Adverse Event|3|||
125132096|NCT02576938|450110101|FG002|Overall Study|Adverse Event|6|||
125132097|NCT02576938|450110099|FG000|Overall Study|Protocol Violation|1|||
125132098|NCT02576938|450110100|FG001|Overall Study|Protocol Violation|1|||
125132099|NCT02576938|450110101|FG002|Overall Study|Protocol Violation|1|||
125132100|NCT02576938|450110099|FG000|Overall Study|Withdrawal by Subject|3|||
125132101|NCT02576938|450110100|FG001|Overall Study|Withdrawal by Subject|2|||
125132102|NCT02576938|450110101|FG002|Overall Study|Withdrawal by Subject|4|||
125035148|NCT00391976|449747892|FG002|Overall Study|Inappropriate enrollment|0|||
125035149|NCT00391976|449747890|FG000|Overall Study|Protocol deviation/violation|4|||
125035150|NCT00391976|449747891|FG001|Overall Study|Protocol deviation/violation|2|||
125132103|NCT02576938|450110099|FG000|Overall Study|Lack of Efficacy|9|||
125132104|NCT02576938|450110100|FG001|Overall Study|Lack of Efficacy|4|||
125132105|NCT02576938|450110101|FG002|Overall Study|Lack of Efficacy|0|||
125132106|NCT02576938|450110099|FG000|Overall Study|Lost to Follow-up|2|||
125132107|NCT02576938|450110100|FG001|Overall Study|Lost to Follow-up|0|||
125132108|NCT02576938|450110101|FG002|Overall Study|Lost to Follow-up|1|||
125132109|NCT02576938|450110099|FG000|Overall Study|Physician Decision|0|||
125132110|NCT02576938|450110100|FG001|Overall Study|Physician Decision|1|||
125132111|NCT02576938|450110101|FG002|Overall Study|Physician Decision|0|||
125132112|NCT02576938|450110099|FG000|Overall Study|Met Exclusion Criteria|0|||
125132113|NCT02576938|450110100|FG001|Overall Study|Met Exclusion Criteria|1|||
125217847|NCT00313586|450425302|FG003|Overall Study|Lost insurance|0|||
125217848|NCT00313586|450425299|FG000|Overall Study|Moved|0|||
125217849|NCT00313586|450425300|FG001|Overall Study|Moved|1|||
125035151|NCT00391976|449747892|FG002|Overall Study|Protocol deviation/violation|1|||
125035152|NCT00391976|449747890|FG000|Overall Study|Recurrence/no eradication of infection|21|||
125035153|NCT00391976|449747891|FG001|Overall Study|Recurrence/no eradication of infection|19|||
125035154|NCT00391976|449747892|FG002|Overall Study|Recurrence/no eradication of infection|0|||
125035155|NCT00391976|449747890|FG000|Overall Study|Unable to classify|0|||
125035156|NCT00391976|449747891|FG001|Overall Study|Unable to classify|0|||
125035157|NCT00391976|449747892|FG002|Overall Study|Unable to classify|1|||
125035158|NCT00391976|449747890|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
125035159|NCT00391976|449747891|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
125035160|NCT00391976|449747892|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
125035161|NCT02601950|449747896|FG000|Overall Study|Participant enrolled in rollover study|0|||
125035162|NCT02601950|449747897|FG001|Overall Study|Participant enrolled in rollover study|0|||
125035163|NCT02601950|449747898|FG002|Overall Study|Participant enrolled in rollover study|1|||
125035164|NCT02601950|449747899|FG003|Overall Study|Participant enrolled in rollover study|0|||
125035165|NCT02601950|449747900|FG004|Overall Study|Participant enrolled in rollover study|1|||
125035166|NCT02601950|449747901|FG005|Overall Study|Participant enrolled in rollover study|1|||
125035167|NCT02601950|449747902|FG006|Overall Study|Participant enrolled in rollover study|1|||
125035168|NCT02601950|449747903|FG007|Overall Study|Participant enrolled in rollover study|0|||
125035169|NCT02601950|449747896|FG000|Overall Study|Disease progression - radiological|21|||
125035170|NCT02601950|449747897|FG001|Overall Study|Disease progression - radiological|26|||
125035171|NCT02601950|449747898|FG002|Overall Study|Disease progression - radiological|22|||
125035172|NCT02601950|449747899|FG003|Overall Study|Disease progression - radiological|11|||
125035173|NCT02601950|449747900|FG004|Overall Study|Disease progression - radiological|46|||
125035174|NCT02601950|449747901|FG005|Overall Study|Disease progression - radiological|52|||
125035175|NCT02601950|449747902|FG006|Overall Study|Disease progression - radiological|7|||
125035176|NCT02601950|449747903|FG007|Overall Study|Disease progression - radiological|5|||
125035177|NCT02601950|449747896|FG000|Overall Study|Disease progression - clinical|3|||
125035178|NCT02601950|449747897|FG001|Overall Study|Disease progression - clinical|5|||
125035179|NCT02601950|449747898|FG002|Overall Study|Disease progression - clinical|4|||
125035180|NCT02601950|449747899|FG003|Overall Study|Disease progression - clinical|2|||
125035181|NCT02601950|449747900|FG004|Overall Study|Disease progression - clinical|6|||
125035182|NCT02601950|449747901|FG005|Overall Study|Disease progression - clinical|6|||
125035183|NCT02601950|449747902|FG006|Overall Study|Disease progression - clinical|5|||
125035184|NCT02601950|449747903|FG007|Overall Study|Disease progression - clinical|1|||
125035185|NCT02601950|449747896|FG000|Overall Study|Death|6|||
125035186|NCT02601950|449747897|FG001|Overall Study|Death|0|||
125035187|NCT02601950|449747898|FG002|Overall Study|Death|3|||
125035188|NCT02601950|449747899|FG003|Overall Study|Death|1|||
125035189|NCT02601950|449747900|FG004|Overall Study|Death|4|||
125035190|NCT02601950|449747901|FG005|Overall Study|Death|1|||
125035191|NCT02601950|449747902|FG006|Overall Study|Death|0|||
125035192|NCT02601950|449747903|FG007|Overall Study|Death|0|||
125035193|NCT02601950|449747896|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
125035194|NCT02601950|449747897|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
125035195|NCT02601950|449747898|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
125035196|NCT02601950|449747899|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
125035197|NCT02601950|449747900|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
125035198|NCT02601950|449747901|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
125035199|NCT02601950|449747902|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
125035200|NCT02601950|449747903|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
125035201|NCT02601950|449747896|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
125217850|NCT00313586|450425301|FG002|Overall Study|Moved|0|||
125217851|NCT00313586|450425302|FG003|Overall Study|Moved|0|||
125035202|NCT02601950|449747897|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
125035203|NCT02601950|449747898|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
125217852|NCT00313586|450425299|FG000|Overall Study|Death before starting treatment|1|||
125132114|NCT02576938|450110101|FG002|Overall Study|Met Exclusion Criteria|0|||
124971373|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
124971374|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
124971375|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
124971376|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
124971377|NCT02783573|449523243|FG000|Delayed-Start Period|Sponsor Decision|0|||
124971378|NCT02783573|449523244|FG001|Delayed-Start Period|Sponsor Decision|17|||
124971379|NCT02783573|449523245|FG002|Delayed-Start Period|Sponsor Decision|12|||
124971380|NCT02797522|449523253|FG000|Overall Study|Study Terminated by Sponsor|0|||
124971381|NCT02797522|449523254|FG001|Overall Study|Study Terminated by Sponsor|0|||
124971382|NCT02797522|449523255|FG002|Overall Study|Study Terminated by Sponsor|0|||
124971383|NCT02797522|449523256|FG003|Overall Study|Study Terminated by Sponsor|0|||
124971384|NCT02797522|449523257|FG004|Overall Study|Study Terminated by Sponsor|0|||
124971385|NCT02797522|449523258|FG005|Overall Study|Study Terminated by Sponsor|0|||
124971386|NCT02797522|449523259|FG006|Overall Study|Study Terminated by Sponsor|0|||
124971387|NCT02797522|449523260|FG007|Overall Study|Study Terminated by Sponsor|4|||
124971388|NCT02797522|449523261|FG008|Overall Study|Study Terminated by Sponsor|2|||
124971389|NCT02797522|449523262|FG009|Overall Study|Study Terminated by Sponsor|4|||
124971390|NCT02797522|449523263|FG010|Overall Study|Study Terminated by Sponsor|1|||
124971391|NCT00725712|449523264|FG000|Overall Study|Withdrawal by Subject|2|||
124971392|NCT00725712|449523265|FG001|Overall Study|Withdrawal by Subject|1|||
124971393|NCT00725712|449523264|FG000|Overall Study|Protocol Violation|1|||
124971394|NCT00725712|449523265|FG001|Overall Study|Protocol Violation|0|||
124971395|NCT00725712|449523264|FG000|Overall Study|Progressive disease|37|||
124971396|NCT00725712|449523265|FG001|Overall Study|Progressive disease|16|||
124971397|NCT00725712|449523264|FG000|Overall Study|Clinical progression not based on RECIST|0|||
124971398|NCT00725712|449523265|FG001|Overall Study|Clinical progression not based on RECIST|3|||
124971399|NCT00725712|449523264|FG000|Overall Study|Adverse Event|5|||
124971400|NCT00725712|449523265|FG001|Overall Study|Adverse Event|5|||
124971401|NCT00725712|449523264|FG000|Overall Study|Death|2|||
124971402|NCT00725712|449523265|FG001|Overall Study|Death|0|||
124971403|NCT00725712|449523264|FG000|Overall Study|Other: Death|1|||
124971404|NCT00725712|449523265|FG001|Overall Study|Other: Death|0|||
124971405|NCT00725712|449523264|FG000|Overall Study|Hospitalized, unable to continue|0|||
124971406|NCT00725712|449523265|FG001|Overall Study|Hospitalized, unable to continue|1|||
124971407|NCT03020069|449523266|FG000|Overall Study|Lost to Follow-up|0|||
124971408|NCT03020069|449523267|FG001|Overall Study|Lost to Follow-up|1|||
124971409|NCT00132678|449523270|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
124971410|NCT00132678|449523271|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
124971411|NCT00132678|449523272|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
124971412|NCT00132678|449523270|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
124971413|NCT00132678|449523271|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
124971414|NCT00132678|449523272|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
124971415|NCT00132678|449523270|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
124971416|NCT00132678|449523271|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
124971417|NCT00132678|449523272|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
124971418|NCT00132678|449523270|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
124971419|NCT00132678|449523271|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
124971420|NCT00132678|449523272|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
124971421|NCT00132678|449523270|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
124971422|NCT00132678|449523271|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
124971423|NCT00132678|449523272|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
124971424|NCT00132678|449523270|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
124971425|NCT00132678|449523271|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
124971426|NCT00132678|449523272|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
124971427|NCT00132678|449523270|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
124971428|NCT00132678|449523271|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
124971429|NCT00132678|449523272|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
124971430|NCT00132678|449523270|FG000|Period III (Open-Label Stabilization)|Death|2|||
124971431|NCT00132678|449523271|FG001|Period III (Open-Label Stabilization)|Death|0|||
124971432|NCT00132678|449523272|FG002|Period III (Open-Label Stabilization)|Death|0|||
124971433|NCT00132678|449523270|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
124971434|NCT00132678|449523271|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
124971435|NCT00132678|449523272|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
124971436|NCT00132678|449523270|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
124971437|NCT00132678|449523271|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
124971438|NCT00132678|449523272|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
124971439|NCT00132678|449523270|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
125035204|NCT02601950|449747899|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
125035205|NCT02601950|449747900|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
125035206|NCT02601950|449747901|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
125035207|NCT02601950|449747902|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
125035208|NCT02601950|449747903|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
125035209|NCT02601950|449747896|FG000|Overall Study|Non-compliance|0|||
125035210|NCT02601950|449747897|FG001|Overall Study|Non-compliance|1|||
125035211|NCT02601950|449747898|FG002|Overall Study|Non-compliance|0|||
125035212|NCT02601950|449747899|FG003|Overall Study|Non-compliance|0|||
125035213|NCT02601950|449747900|FG004|Overall Study|Non-compliance|0|||
125035214|NCT02601950|449747901|FG005|Overall Study|Non-compliance|1|||
125035215|NCT02601950|449747902|FG006|Overall Study|Non-compliance|1|||
125035216|NCT02601950|449747903|FG007|Overall Study|Non-compliance|0|||
125035217|NCT02601950|449747896|FG000|Overall Study|Participant refused further study treatment|0|||
125035218|NCT02601950|449747897|FG001|Overall Study|Participant refused further study treatment|1|||
125035219|NCT02601950|449747898|FG002|Overall Study|Participant refused further study treatment|1|||
125035220|NCT02601950|449747899|FG003|Overall Study|Participant refused further study treatment|0|||
125035221|NCT02601950|449747900|FG004|Overall Study|Participant refused further study treatment|2|||
125035222|NCT02601950|449747901|FG005|Overall Study|Participant refused further study treatment|2|||
125035223|NCT02601950|449747902|FG006|Overall Study|Participant refused further study treatment|2|||
125035224|NCT02601950|449747903|FG007|Overall Study|Participant refused further study treatment|1|||
125035225|NCT02601950|449747896|FG000|Overall Study|Investigator discretion|1|||
125035226|NCT02601950|449747897|FG001|Overall Study|Investigator discretion|0|||
125035227|NCT02601950|449747898|FG002|Overall Study|Investigator discretion|1|||
125035228|NCT02601950|449747899|FG003|Overall Study|Investigator discretion|0|||
125035229|NCT02601950|449747900|FG004|Overall Study|Investigator discretion|1|||
125035230|NCT02601950|449747901|FG005|Overall Study|Investigator discretion|1|||
125035231|NCT02601950|449747902|FG006|Overall Study|Investigator discretion|1|||
125035232|NCT02601950|449747903|FG007|Overall Study|Investigator discretion|0|||
125035233|NCT02601950|449747896|FG000|Overall Study|Other|0|||
125035234|NCT02601950|449747897|FG001|Overall Study|Other|0|||
125035235|NCT02601950|449747898|FG002|Overall Study|Other|0|||
125035236|NCT02601950|449747899|FG003|Overall Study|Other|0|||
125035237|NCT02601950|449747900|FG004|Overall Study|Other|2|||
125035238|NCT02601950|449747901|FG005|Overall Study|Other|2|||
125035239|NCT02601950|449747902|FG006|Overall Study|Other|1|||
125035240|NCT02601950|449747903|FG007|Overall Study|Other|0|||
125035241|NCT05817045|449747908|FG000|Overall Study|Protocol Violation|0|||
125035242|NCT05817045|449747909|FG001|Overall Study|Protocol Violation|3|||
125035243|NCT05817045|449747908|FG000|Overall Study|Withdrawal by Subject|10|||
125035244|NCT05817045|449747909|FG001|Overall Study|Withdrawal by Subject|7|||
125035245|NCT05817045|449747908|FG000|Overall Study|Physician Decision|3|||
125035246|NCT05817045|449747909|FG001|Overall Study|Physician Decision|0|||
125035247|NCT05817045|449747908|FG000|Overall Study|Lost to Follow-up|0|||
125035248|NCT05817045|449747909|FG001|Overall Study|Lost to Follow-up|1|||
125035249|NCT05817045|449747908|FG000|Overall Study|Device Deficiency|1|||
125035250|NCT05817045|449747909|FG001|Overall Study|Device Deficiency|0|||
125035251|NCT05817045|449747908|FG000|Overall Study|System Error|1|||
125035252|NCT05817045|449747909|FG001|Overall Study|System Error|0|||
125035253|NCT01147497|449747917|FG000|Overall Study|failed insertion|2|||
125035254|NCT01147497|449747918|FG001|Overall Study|failed insertion|0|||
125132115|NCT03500341|450110102|FG000|Overall Study|Withdrawn prior to Completion|2|||
125132116|NCT00838630|450110104|FG000|First Intervention|Adverse Event|1|||
125132117|NCT00838630|450110105|FG001|First Intervention|Adverse Event|0|||
125035255|NCT02731742|449747921|FG000|Overall Study|Death|1|||
125035256|NCT02731742|449747922|FG001|Overall Study|Death|2|||
125035257|NCT02731742|449747923|FG002|Overall Study|Death|5|||
125035258|NCT02731742|449747924|FG003|Overall Study|Death|0|||
125035259|NCT02731742|449747921|FG000|Overall Study|Physician Decision|0|||
125035260|NCT02731742|449747922|FG001|Overall Study|Physician Decision|0|||
125035261|NCT02731742|449747923|FG002|Overall Study|Physician Decision|0|||
125035262|NCT02731742|449747924|FG003|Overall Study|Physician Decision|1|||
125132118|NCT00838630|450110104|FG000|Washout: 7 Days|Protocol Violation|1|||
125132119|NCT00838630|450110105|FG001|Washout: 7 Days|Protocol Violation|0|||
125035263|NCT02731742|449747921|FG000|Overall Study|Study Terminated by Sponsor|2|||
125035264|NCT02731742|449747922|FG001|Overall Study|Study Terminated by Sponsor|1|||
125035265|NCT02731742|449747923|FG002|Overall Study|Study Terminated by Sponsor|1|||
125035266|NCT02731742|449747924|FG003|Overall Study|Study Terminated by Sponsor|1|||
125035267|NCT00619229|449747925|FG000|Overall Study|Withdrawal by Subject|1|||
125035268|NCT00619229|449747926|FG001|Overall Study|Withdrawal by Subject|1|||
125035269|NCT00619229|449747925|FG000|Overall Study|Lost to Follow-up|1|||
125035270|NCT00619229|449747926|FG001|Overall Study|Lost to Follow-up|0|||
125035271|NCT00619229|449747925|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
125035272|NCT00619229|449747926|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
125132120|NCT00448591|450110106|FG000|Overall Study|Withdrawal by Subject|178|||
125217853|NCT00313586|450425300|FG001|Overall Study|Death before starting treatment|0|||
125217854|NCT00313586|450425301|FG002|Overall Study|Death before starting treatment|0|||
125217855|NCT00313586|450425302|FG003|Overall Study|Death before starting treatment|0|||
125217856|NCT03076996|450425303|FG000|Overall Study|Withdrawal by Subject|2|||
125217857|NCT03076996|450425303|FG000|Overall Study|Lost to Follow-up|3|||
125217858|NCT03076996|450425303|FG000|Overall Study|Literacy precluded participation|1|||
125217859|NCT03117361|450425305|FG000|Overall Study|Progressive disease|5|||
125217860|NCT03117361|450425305|FG000|Overall Study|Death|1|||
125217861|NCT03117361|450425305|FG000|Overall Study|Physician Decision|2|||
125217862|NCT03117361|450425305|FG000|Overall Study|On study treatment at the end of study|1|||
125217863|NCT03117361|450425305|FG000|Overall Study|Treatment-related adverse event|1|||
125217864|NCT03280056|450425309|FG000|Overall Study|Withdrawal by Subject|12|||
125217865|NCT03280056|450425310|FG001|Overall Study|Withdrawal by Subject|14|||
125217866|NCT03280056|450425309|FG000|Overall Study|Death|9|||
125217867|NCT03280056|450425310|FG001|Overall Study|Death|2|||
125217868|NCT03280056|450425309|FG000|Overall Study|Adverse Event|1|||
125217869|NCT03280056|450425310|FG001|Overall Study|Adverse Event|3|||
125217870|NCT03280056|450425309|FG000|Overall Study|Lost to Follow-up|1|||
125217871|NCT03280056|450425310|FG001|Overall Study|Lost to Follow-up|1|||
125217872|NCT03280056|450425309|FG000|Overall Study|Physician Decision|0|||
125217873|NCT03280056|450425310|FG001|Overall Study|Physician Decision|1|||
125217874|NCT03280056|450425309|FG000|Overall Study|Early Discontinuation|1|||
125217875|NCT03280056|450425310|FG001|Overall Study|Early Discontinuation|0|||
125217876|NCT02144077|450425311|FG000|Overall Study|Withdrawal by Subject|3|||
125217877|NCT02144077|450425312|FG001|Overall Study|Withdrawal by Subject|3|||
125217878|NCT02144077|450425311|FG000|Overall Study|Adverse Event|2|||
125217879|NCT02144077|450425312|FG001|Overall Study|Adverse Event|3|||
125217880|NCT02144077|450425311|FG000|Overall Study|Lost to Follow-up|2|||
125217881|NCT02144077|450425312|FG001|Overall Study|Lost to Follow-up|2|||
125217882|NCT02144077|450425311|FG000|Overall Study|Protocol Violation|1|||
125217883|NCT02144077|450425312|FG001|Overall Study|Protocol Violation|2|||
125217884|NCT02144077|450425311|FG000|Overall Study|Death|0|||
125217885|NCT02144077|450425312|FG001|Overall Study|Death|1|||
125217886|NCT02144077|450425311|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
125217887|NCT02144077|450425312|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
125217888|NCT00610168|450425313|FG000|Overall Study|Withdrawal by Subject|2|||
125217889|NCT00610168|450425314|FG001|Overall Study|Withdrawal by Subject|0|||
125217890|NCT00943592|450425315|FG000|Overall Study|Death|3|||
125217891|NCT01247350|450425316|FG000|Overall Study|Adverse Event|0|||
125217892|NCT01247350|450425317|FG001|Overall Study|Adverse Event|0|||
125217893|NCT01247350|450425318|FG002|Overall Study|Adverse Event|1|||
125217894|NCT01247350|450425319|FG003|Overall Study|Adverse Event|0|||
125217895|NCT01247350|450425320|FG004|Overall Study|Adverse Event|0|||
125217896|NCT01247350|450425316|FG000|Overall Study|Withdrawal by Subject|0|||
125217897|NCT01247350|450425317|FG001|Overall Study|Withdrawal by Subject|0|||
125217898|NCT01247350|450425318|FG002|Overall Study|Withdrawal by Subject|0|||
125217899|NCT01247350|450425319|FG003|Overall Study|Withdrawal by Subject|1|||
125217900|NCT01247350|450425320|FG004|Overall Study|Withdrawal by Subject|0|||
125217901|NCT01247350|450425316|FG000|Overall Study|Entry criteria not met|0|||
125217902|NCT01247350|450425317|FG001|Overall Study|Entry criteria not met|0|||
125217903|NCT01247350|450425318|FG002|Overall Study|Entry criteria not met|0|||
125217904|NCT01247350|450425319|FG003|Overall Study|Entry criteria not met|0|||
124971440|NCT00132678|449523271|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
124971441|NCT00132678|449523272|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
124971442|NCT00132678|449523270|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
124971443|NCT00132678|449523271|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
124971444|NCT00132678|449523272|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
124971445|NCT00132678|449523270|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
124971446|NCT00132678|449523271|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
124971447|NCT00132678|449523272|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
124971448|NCT00132678|449523270|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
124971449|NCT00132678|449523271|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
124971450|NCT00132678|449523272|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
124971451|NCT00132678|449523270|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
124971452|NCT00132678|449523271|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
124971453|NCT00132678|449523272|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
124971454|NCT00132678|449523270|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
124971455|NCT00132678|449523271|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
124971456|NCT00132678|449523272|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
124971457|NCT00132678|449523270|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
124971458|NCT00132678|449523271|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
125035273|NCT00619229|449747925|FG000|Overall Study|Investigator planned Cataract Operation|1|||
125035274|NCT00619229|449747926|FG001|Overall Study|Investigator planned Cataract Operation|0|||
125035275|NCT02786901|449747927|FG000|Overall Study|Adverse Event|1|||
125035276|NCT02786901|449747928|FG001|Overall Study|Adverse Event|1|||
125035277|NCT02786901|449747929|FG002|Overall Study|Adverse Event|2|||
125035278|NCT02786901|449747927|FG000|Overall Study|Physician Decision|1|||
125035279|NCT02786901|449747928|FG001|Overall Study|Physician Decision|0|||
125035280|NCT02786901|449747929|FG002|Overall Study|Physician Decision|0|||
125035281|NCT02786901|449747927|FG000|Overall Study|Rescue Therapy Use|71|||
125035282|NCT02786901|449747928|FG001|Overall Study|Rescue Therapy Use|49|||
125035283|NCT02786901|449747929|FG002|Overall Study|Rescue Therapy Use|33|||
125035284|NCT02786901|449747927|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
125035285|NCT02786901|449747928|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
125035286|NCT02786901|449747929|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
125035287|NCT02786901|449747927|FG000|Overall Study|Disallowed medication|1|||
125035288|NCT02786901|449747928|FG001|Overall Study|Disallowed medication|1|||
125035289|NCT02786901|449747929|FG002|Overall Study|Disallowed medication|0|||
125035290|NCT02786901|449747927|FG000|Overall Study|Randomized in error|2|||
125035291|NCT02786901|449747928|FG001|Overall Study|Randomized in error|0|||
125132121|NCT00448591|450110106|FG000|Overall Study|Progressive Disease|1382|||
125035292|NCT02786901|449747929|FG002|Overall Study|Randomized in error|1|||
125132122|NCT00448591|450110106|FG000|Overall Study|Adverse Event|382|||
125132123|NCT00448591|450110106|FG000|Overall Study|Protocol Violation|41|||
125132124|NCT00448591|450110106|FG000|Overall Study|Lost to Follow-up|19|||
125132125|NCT00448591|450110106|FG000|Overall Study|Treatment Regimen Completed|70|||
125132126|NCT00448591|450110106|FG000|Overall Study|Other|154|||
125132127|NCT00448591|450110106|FG000|Overall Study|Termination of Study|70|||
125132128|NCT03017885|450110107|FG000|Overall Study|Adverse Event|2|||
125132129|NCT03017885|450110108|FG001|Overall Study|Adverse Event|0|||
125132130|NCT03017885|450110109|FG002|Overall Study|Adverse Event|0|||
125132131|NCT03017885|450110110|FG003|Overall Study|Adverse Event|0|||
125132132|NCT03017885|450110111|FG004|Overall Study|Adverse Event|0|||
125132133|NCT03017885|450110112|FG005|Overall Study|Adverse Event|0|||
125132134|NCT03017885|450110107|FG000|Overall Study|Progression of disease|4|||
125132135|NCT03017885|450110108|FG001|Overall Study|Progression of disease|3|||
125132136|NCT03017885|450110109|FG002|Overall Study|Progression of disease|4|||
125132137|NCT03017885|450110110|FG003|Overall Study|Progression of disease|0|||
125132138|NCT03017885|450110111|FG004|Overall Study|Progression of disease|0|||
125132139|NCT03017885|450110112|FG005|Overall Study|Progression of disease|0|||
125132140|NCT03017885|450110107|FG000|Overall Study|Other than listed|1|||
125132141|NCT03017885|450110108|FG001|Overall Study|Other than listed|2|||
125132142|NCT03017885|450110109|FG002|Overall Study|Other than listed|1|||
125132143|NCT03017885|450110110|FG003|Overall Study|Other than listed|0|||
125132144|NCT03017885|450110111|FG004|Overall Study|Other than listed|0|||
125035293|NCT03367871|449747930|FG000|Overall Study|Lost to Follow-up|1|||
125035294|NCT01157117|449747931|FG000|Overall Study|Dosing Symptoms|0|||
125035295|NCT01157117|449747932|FG001|Overall Study|Dosing Symptoms|4|||
125035296|NCT01157117|449747933|FG002|Overall Study|Dosing Symptoms|0|||
125132145|NCT03017885|450110112|FG005|Overall Study|Other than listed|0|||
125035297|NCT01157117|449747931|FG000|Overall Study|Withdrawal by Subject|4|||
124971459|NCT00132678|449523272|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
124971460|NCT00132678|449523270|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
124971461|NCT00132678|449523271|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
124971462|NCT00132678|449523272|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
124971463|NCT00132678|449523270|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
124971464|NCT00132678|449523271|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
124971465|NCT00132678|449523272|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
124971466|NCT00132678|449523270|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
124971467|NCT00132678|449523271|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
124971468|NCT00132678|449523272|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
124971469|NCT00132678|449523270|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
124971470|NCT00132678|449523271|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
124971471|NCT00132678|449523272|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
124971472|NCT00132678|449523270|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
124971473|NCT00132678|449523271|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
124971474|NCT00132678|449523272|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
124971475|NCT00132678|449523270|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
124971476|NCT00132678|449523271|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
124971477|NCT00132678|449523272|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
124971478|NCT00953147|449523273|FG000|Overall Study|Adverse Event|8|||
124971479|NCT00953147|449523274|FG001|Overall Study|Adverse Event|16|||
124971480|NCT00953147|449523275|FG002|Overall Study|Adverse Event|6|||
124971481|NCT00953147|449523273|FG000|Overall Study|Protocol Violation|2|||
124971482|NCT00953147|449523274|FG001|Overall Study|Protocol Violation|8|||
124971483|NCT00953147|449523275|FG002|Overall Study|Protocol Violation|4|||
124971484|NCT00953147|449523273|FG000|Overall Study|Withdrawal by Subject|13|||
124971485|NCT00953147|449523274|FG001|Overall Study|Withdrawal by Subject|15|||
124971486|NCT00953147|449523275|FG002|Overall Study|Withdrawal by Subject|12|||
124971487|NCT00953147|449523273|FG000|Overall Study|Lost to Follow-up|8|||
124971488|NCT00953147|449523274|FG001|Overall Study|Lost to Follow-up|9|||
124971489|NCT00953147|449523275|FG002|Overall Study|Lost to Follow-up|4|||
124971490|NCT00953147|449523273|FG000|Overall Study|Physician Decision|2|||
124971491|NCT00953147|449523274|FG001|Overall Study|Physician Decision|7|||
124971492|NCT00953147|449523275|FG002|Overall Study|Physician Decision|3|||
124971493|NCT00953147|449523273|FG000|Overall Study|Other|4|||
124971494|NCT00953147|449523274|FG001|Overall Study|Other|11|||
124971495|NCT00953147|449523275|FG002|Overall Study|Other|13|||
124971496|NCT01367847|449523276|FG000|Overall Study|Withdrawal by Subject|2|||
124971497|NCT01367847|449523277|FG001|Overall Study|Withdrawal by Subject|2|||
124971498|NCT02056626|449523278|FG000|Overall Study|patient did not follow directions|3|||
124971499|NCT02056626|449523279|FG001|Overall Study|patient did not follow directions|1|||
124971500|NCT02056626|449523280|FG002|Overall Study|patient did not follow directions|0|||
124971501|NCT02056626|449523281|FG003|Overall Study|patient did not follow directions|0|||
124971502|NCT00863512|449523282|FG000|Overall Study|Adverse Event|2|||
124971503|NCT00863512|449523283|FG001|Overall Study|Adverse Event|0|||
124971504|NCT00863512|449523282|FG000|Overall Study|Withdrawal by Subject|11|||
124971505|NCT00863512|449523283|FG001|Overall Study|Withdrawal by Subject|0|||
124971506|NCT00863512|449523282|FG000|Overall Study|Physician Decision|1|||
124971507|NCT00863512|449523283|FG001|Overall Study|Physician Decision|0|||
124971508|NCT00078338|449523284|FG000|Overall Study|Adverse Event|31|||
124971509|NCT00078338|449523285|FG001|Overall Study|Adverse Event|24|||
124971510|NCT00078338|449523284|FG000|Overall Study|Lost to Follow-up|17|||
124971511|NCT00078338|449523285|FG001|Overall Study|Lost to Follow-up|2|||
124971512|NCT00078338|449523284|FG000|Overall Study|Protocol Violation|2|||
124971513|NCT00078338|449523285|FG001|Overall Study|Protocol Violation|2|||
124971514|NCT00078338|449523284|FG000|Overall Study|Disease Progression|4|||
124971515|NCT00078338|449523285|FG001|Overall Study|Disease Progression|7|||
124971516|NCT00078338|449523284|FG000|Overall Study|Other|28|||
124971517|NCT00078338|449523285|FG001|Overall Study|Other|16|||
124971518|NCT00078338|449523284|FG000|Overall Study|Subjects randomized, but not treated|3|||
124971519|NCT00078338|449523285|FG001|Overall Study|Subjects randomized, but not treated|3|||
124971520|NCT02037477|449523286|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
124971521|NCT02037477|449523287|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
124971522|NCT02037477|449523288|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
124971523|NCT02037477|449523289|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
125132146|NCT03017885|450110107|FG000|Overall Study|Lost to Follow-up|2|||
125132147|NCT03017885|450110108|FG001|Overall Study|Lost to Follow-up|0|||
125132148|NCT03017885|450110109|FG002|Overall Study|Lost to Follow-up|3|||
125132149|NCT03017885|450110110|FG003|Overall Study|Lost to Follow-up|0|||
125132150|NCT03017885|450110111|FG004|Overall Study|Lost to Follow-up|0|||
125132151|NCT03017885|450110112|FG005|Overall Study|Lost to Follow-up|0|||
125132152|NCT03017885|450110107|FG000|Overall Study|Change to other anti-cancer therapy|0|||
125132153|NCT03017885|450110108|FG001|Overall Study|Change to other anti-cancer therapy|0|||
125132154|NCT03017885|450110109|FG002|Overall Study|Change to other anti-cancer therapy|1|||
125132155|NCT03017885|450110110|FG003|Overall Study|Change to other anti-cancer therapy|0|||
125132156|NCT03017885|450110111|FG004|Overall Study|Change to other anti-cancer therapy|0|||
125132157|NCT03017885|450110112|FG005|Overall Study|Change to other anti-cancer therapy|0|||
125132158|NCT01289262|450110113|FG000|Overall Study|Lost to Follow-up|29|||
124971524|NCT01454739|449523291|FG000|Overall Study|Protocol Violation|2|||
124971525|NCT01454739|449523292|FG001|Overall Study|Protocol Violation|3|||
124971526|NCT01454739|449523291|FG000|Overall Study|Withdrawal by Subject|2|||
124971527|NCT01454739|449523292|FG001|Overall Study|Withdrawal by Subject|6|||
124971528|NCT01454739|449523291|FG000|Overall Study|Other|3|||
124971529|NCT01454739|449523292|FG001|Overall Study|Other|5|||
124971530|NCT01454739|449523291|FG000|Overall Study|Physician Decision|0|||
124971531|NCT01454739|449523292|FG001|Overall Study|Physician Decision|5|||
124971532|NCT01454739|449523291|FG000|Overall Study|Lost to Follow-up|0|||
124971533|NCT01454739|449523292|FG001|Overall Study|Lost to Follow-up|1|||
124971534|NCT01454739|449523291|FG000|Overall Study|Adverse Event|0|||
124971535|NCT01454739|449523292|FG001|Overall Study|Adverse Event|1|||
124971536|NCT01784523|449523293|FG000|Overall Study|Study closed early|7|||
124971537|NCT01784523|449523294|FG001|Overall Study|Study closed early|4|||
124971538|NCT02577003|449523297|FG000|Overall Study|Adverse Event|2|||
124971539|NCT02577003|449523298|FG001|Overall Study|Adverse Event|4|||
124971540|NCT02577003|449523297|FG000|Overall Study|Withdrawal by Subject|0|||
124971541|NCT02577003|449523298|FG001|Overall Study|Withdrawal by Subject|1|||
124971542|NCT02786004|449523299|FG000|Overall Study|Withdrawal by Subject|0|||
124971543|NCT02786004|449523300|FG001|Overall Study|Withdrawal by Subject|1|||
124971544|NCT01677299|449523301|FG000|Overall Study|Adverse Event|0|||
124971545|NCT01677299|449523302|FG001|Overall Study|Adverse Event|2|||
124971546|NCT01677299|449523303|FG002|Overall Study|Adverse Event|1|||
124971547|NCT01677299|449523304|FG003|Overall Study|Adverse Event|0|||
124971548|NCT01677299|449523301|FG000|Overall Study|Withdrawal by Subject|0|||
124971549|NCT01677299|449523302|FG001|Overall Study|Withdrawal by Subject|1|||
124971550|NCT01677299|449523303|FG002|Overall Study|Withdrawal by Subject|0|||
124971551|NCT01677299|449523304|FG003|Overall Study|Withdrawal by Subject|1|||
124971552|NCT00559377|449523306|FG000|Overall Study|Withdrawal by Subject|9|||
124971553|NCT00940875|449523307|FG000|Treatment Phase|Adverse Event|9|||
124971554|NCT00940875|449523308|FG001|Treatment Phase|Adverse Event|3|||
124971555|NCT00940875|449523307|FG000|Treatment Phase|Death|3|||
124971556|NCT00940875|449523308|FG001|Treatment Phase|Death|5|||
124971557|NCT00940875|449523307|FG000|Treatment Phase|Lack of Efficacy|1|||
124971558|NCT00940875|449523308|FG001|Treatment Phase|Lack of Efficacy|0|||
124971559|NCT00940875|449523307|FG000|Treatment Phase|Withdrawal by Subject|3|||
124971560|NCT00940875|449523308|FG001|Treatment Phase|Withdrawal by Subject|0|||
124971561|NCT00940875|449523307|FG000|Treatment Phase|Disease progression|9|||
124971562|NCT00940875|449523308|FG001|Treatment Phase|Disease progression|11|||
124971563|NCT00940875|449523307|FG000|Treatment Phase|Physician Decision|1|||
124971564|NCT00940875|449523308|FG001|Treatment Phase|Physician Decision|0|||
124971565|NCT00940875|449523307|FG000|Post-Study Treatment|Death|0|||
124971566|NCT00940875|449523308|FG001|Post-Study Treatment|Death|1|||
124971567|NCT00940875|449523307|FG000|Post-Study Treatment|Disease Progression|0|||
124971568|NCT00940875|449523308|FG001|Post-Study Treatment|Disease Progression|2|||
124971569|NCT00490945|449523309|FG000|Overall Study|Adverse Event|0|||
124971570|NCT00490945|449523310|FG001|Overall Study|Adverse Event|1|||
124971571|NCT00490945|449523311|FG002|Overall Study|Adverse Event|0|||
124971572|NCT00490945|449523312|FG003|Overall Study|Adverse Event|0|||
124971573|NCT00490945|449523313|FG004|Overall Study|Adverse Event|0|||
124971574|NCT03334253|449523314|FG000|Overall Study|Withdrawal by Subject|1|||
124971575|NCT03334253|449523315|FG001|Overall Study|Withdrawal by Subject|0|||
124971576|NCT03334253|449523314|FG000|Overall Study|Lost to Follow-up|4|||
125132159|NCT01289262|450110114|FG001|Overall Study|Lost to Follow-up|16|||
124971577|NCT03334253|449523315|FG001|Overall Study|Lost to Follow-up|3|||
124971578|NCT03334253|449523314|FG000|Overall Study|Moved residence|2|||
124971579|NCT03334253|449523315|FG001|Overall Study|Moved residence|2|||
124971580|NCT00203047|449523316|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
124971581|NCT00203047|449523317|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
124971582|NCT00203047|449523316|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
124971583|NCT00203047|449523317|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
124971584|NCT00203047|449523316|FG000|Overall Study|Withdrawal by Subject|13|||
124971585|NCT00203047|449523317|FG001|Overall Study|Withdrawal by Subject|47|||
125132160|NCT01289262|450110113|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
124971586|NCT00203047|449523316|FG000|Overall Study|Teva requested participant withdrawal|1|||
124971587|NCT00203047|449523317|FG001|Overall Study|Teva requested participant withdrawal|1|||
124971588|NCT00203047|449523316|FG000|Overall Study|Physician Decision|8|||
124971589|NCT00203047|449523317|FG001|Overall Study|Physician Decision|7|||
124971590|NCT00203047|449523316|FG000|Overall Study|Non-compliance|4|||
124971591|NCT00203047|449523317|FG001|Overall Study|Non-compliance|8|||
124971592|NCT00203047|449523316|FG000|Overall Study|Protocol Violation|1|||
125132161|NCT01289262|450110114|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
124971593|NCT00203047|449523317|FG001|Overall Study|Protocol Violation|0|||
124971594|NCT00203047|449523316|FG000|Overall Study|Lost to Follow-up|11|||
124971595|NCT00203047|449523317|FG001|Overall Study|Lost to Follow-up|5|||
124971596|NCT00203047|449523316|FG000|Overall Study|Adverse Event|8|||
124971597|NCT00203047|449523317|FG001|Overall Study|Adverse Event|18|||
124971598|NCT00203047|449523316|FG000|Overall Study|Death|1|||
124971599|NCT00203047|449523317|FG001|Overall Study|Death|2|||
124971600|NCT00203047|449523316|FG000|Overall Study|Pregnancy|3|||
124971601|NCT00203047|449523317|FG001|Overall Study|Pregnancy|0|||
124971602|NCT00203047|449523316|FG000|Overall Study|Other|5|||
124971603|NCT00203047|449523317|FG001|Overall Study|Other|5|||
124971604|NCT00872001|449523320|FG000|Overall Study|Adverse Event|34|||
124971605|NCT00872001|449523321|FG001|Overall Study|Adverse Event|23|||
124971606|NCT00872001|449523320|FG000|Overall Study|Protocol Defined Clinical Event|5|||
124971607|NCT00872001|449523321|FG001|Overall Study|Protocol Defined Clinical Event|7|||
124971608|NCT00872001|449523320|FG000|Overall Study|Lost to Follow-up|13|||
124971609|NCT00872001|449523321|FG001|Overall Study|Lost to Follow-up|12|||
124971610|NCT00872001|449523320|FG000|Overall Study|Withdrawal by Subject|18|||
124971611|NCT00872001|449523321|FG001|Overall Study|Withdrawal by Subject|30|||
124971612|NCT00872001|449523320|FG000|Overall Study|Protocol Violation|5|||
124971613|NCT00872001|449523321|FG001|Overall Study|Protocol Violation|8|||
124971614|NCT00872001|449523320|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
124971615|NCT00872001|449523321|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
124971616|NCT00872001|449523320|FG000|Overall Study|Administrative|23|||
124971617|NCT00872001|449523321|FG001|Overall Study|Administrative|15|||
124971618|NCT00340704|449523322|FG000|PK Study|Adverse Event|0|||
124971619|NCT00340704|449523323|FG001|PK Study|Adverse Event|1|||
124971620|NCT00340704|449523324|FG002|PK Study|Adverse Event|0|||
124971621|NCT00340704|449523325|FG003|PK Study|Adverse Event|0|||
124971622|NCT00340704|449523326|FG004|PK Study|Adverse Event|0|||
124971623|NCT00340704|449523327|FG005|PK Study|Adverse Event|0|||
124971624|NCT00340704|449523328|FG006|PK Study|Adverse Event|0|||
124971625|NCT00340704|449523329|FG007|PK Study|Adverse Event|0|||
124971626|NCT00340704|449523330|FG008|PK Study|Adverse Event|0|||
124971627|NCT00340704|449523322|FG000|PK Study|Not treated|0|||
124971628|NCT00340704|449523323|FG001|PK Study|Not treated|0|||
124971629|NCT00340704|449523324|FG002|PK Study|Not treated|1|||
124971630|NCT00340704|449523325|FG003|PK Study|Not treated|0|||
124971631|NCT00340704|449523326|FG004|PK Study|Not treated|0|||
124971632|NCT00340704|449523327|FG005|PK Study|Not treated|0|||
124971633|NCT00340704|449523328|FG006|PK Study|Not treated|0|||
124971634|NCT00340704|449523329|FG007|PK Study|Not treated|0|||
124971635|NCT00340704|449523330|FG008|PK Study|Not treated|0|||
124971636|NCT00340704|449523322|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
124971637|NCT00340704|449523323|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
124971638|NCT00340704|449523324|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
124971639|NCT00340704|449523325|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
124971640|NCT00340704|449523326|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
124971641|NCT00340704|449523327|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
124971642|NCT00340704|449523328|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
124971643|NCT00340704|449523329|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
124971644|NCT00340704|449523330|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
124971645|NCT00340704|449523322|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
124971646|NCT00340704|449523323|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
124971647|NCT00340704|449523324|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
124971648|NCT00340704|449523325|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
124971649|NCT00340704|449523326|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
124971650|NCT00340704|449523327|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
124971651|NCT00340704|449523328|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
124971652|NCT00340704|449523329|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
124971653|NCT00340704|449523330|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
125132162|NCT00838279|450110115|FG000|Washout|Protocol Violation|1|||
125132163|NCT00838279|450110116|FG001|Washout|Protocol Violation|0|||
125132164|NCT00838279|450110115|FG000|Washout|Withdrawal by Subject|0|||
125132165|NCT00838279|450110116|FG001|Washout|Withdrawal by Subject|1|||
125132166|NCT01250912|450110120|FG000|Overall Study|Lost to Follow-up|1|||
124971654|NCT00340704|449523322|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
124971655|NCT00340704|449523323|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
124971656|NCT00340704|449523324|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
124971657|NCT00340704|449523325|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
124971658|NCT00340704|449523326|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
124971659|NCT00340704|449523327|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
125217905|NCT01247350|450425320|FG004|Overall Study|Entry criteria not met|1|||
125217906|NCT00169104|450425321|FG000|Overall Study|Withdrawal by Subject|2|||
125217907|NCT00169104|450425322|FG001|Overall Study|Withdrawal by Subject|0|||
125217908|NCT00169104|450425321|FG000|Overall Study|Protocol Violation|0|||
125217909|NCT00169104|450425322|FG001|Overall Study|Protocol Violation|1|||
125217910|NCT00169104|450425321|FG000|Overall Study|Physician Decision|0|||
125217911|NCT00169104|450425322|FG001|Overall Study|Physician Decision|1|||
125217912|NCT01540981|450425328|FG000|Overall Study|Withdrawal by Subject|1|||
125217913|NCT01540981|450425329|FG001|Overall Study|Withdrawal by Subject|0|||
125217914|NCT00141518|450425332|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
125217915|NCT00141518|450425333|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
125217916|NCT00141518|450425334|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
125217917|NCT00141518|450425332|FG000|Overall Study|Adverse Event|7|||
125217918|NCT00141518|450425333|FG001|Overall Study|Adverse Event|5|||
125217919|NCT00141518|450425334|FG002|Overall Study|Adverse Event|2|||
125217920|NCT00141518|450425332|FG000|Overall Study|Withdrawal by Subject|2|||
125217921|NCT00141518|450425333|FG001|Overall Study|Withdrawal by Subject|0|||
125217922|NCT00141518|450425334|FG002|Overall Study|Withdrawal by Subject|2|||
125217923|NCT00141518|450425332|FG000|Overall Study|Protocol Violation|1|||
125217924|NCT00141518|450425333|FG001|Overall Study|Protocol Violation|1|||
125217925|NCT00141518|450425334|FG002|Overall Study|Protocol Violation|2|||
125217926|NCT00141518|450425332|FG000|Overall Study|Lack of Efficacy|5|||
125217927|NCT00141518|450425333|FG001|Overall Study|Lack of Efficacy|0|||
125217928|NCT00141518|450425334|FG002|Overall Study|Lack of Efficacy|0|||
125217929|NCT01806168|450425336|FG000|Overall Study|Adverse Event|1|||
125217930|NCT01806168|450425337|FG001|Overall Study|Adverse Event|0|||
125217931|NCT01806168|450425338|FG002|Overall Study|Adverse Event|0|||
125217932|NCT01806168|450425336|FG000|Overall Study|Withdrawal by Subject|0|||
125217933|NCT01806168|450425337|FG001|Overall Study|Withdrawal by Subject|1|||
125217934|NCT01806168|450425338|FG002|Overall Study|Withdrawal by Subject|2|||
125217935|NCT01806168|450425336|FG000|Overall Study|Protocol Violation|0|||
125217936|NCT01806168|450425337|FG001|Overall Study|Protocol Violation|0|||
125217937|NCT01806168|450425338|FG002|Overall Study|Protocol Violation|1|||
125217938|NCT02438280|450425343|FG000|Overall Study|Physician Decision|1|||
125217939|NCT02438280|450425344|FG001|Overall Study|Physician Decision|0|||
125217940|NCT03066778|450425347|FG000|Overall Study|Death|195|||
125217941|NCT03066778|450425348|FG001|Overall Study|Death|205|||
125217942|NCT03066778|450425347|FG000|Overall Study|Withdrawal by Subject|5|||
125217943|NCT03066778|450425348|FG001|Overall Study|Withdrawal by Subject|7|||
125217944|NCT02328937|450425349|FG000|Period 1|Lost to Follow-up|0|||
125217945|NCT02328937|450425350|FG001|Period 1|Lost to Follow-up|0|||
125217946|NCT02328937|450425351|FG002|Period 1|Lost to Follow-up|0|||
125217947|NCT02328937|450425352|FG003|Period 1|Lost to Follow-up|1|||
125217948|NCT02328937|450425353|FG004|Period 1|Lost to Follow-up|0|||
125217949|NCT02328937|450425354|FG005|Period 1|Lost to Follow-up|0|||
125217950|NCT02328937|450425349|FG000|Period 2|Adverse Event|0|||
125217951|NCT02328937|450425350|FG001|Period 2|Adverse Event|0|||
125217952|NCT02328937|450425351|FG002|Period 2|Adverse Event|1|||
125217953|NCT02328937|450425352|FG003|Period 2|Adverse Event|0|||
125217954|NCT02328937|450425353|FG004|Period 2|Adverse Event|0|||
125217955|NCT02328937|450425354|FG005|Period 2|Adverse Event|0|||
125217956|NCT02091414|450425355|FG000|Overall Study|Withdrawal by Subject|2|||
125217957|NCT02091414|450425355|FG000|Overall Study|Death|2|||
125217958|NCT03665077|450425358|FG000|Overall Study|Lost to Follow-up|2|||
125217959|NCT03665077|450425358|FG000|Overall Study|Physician Decision|2|||
125217960|NCT02959918|450425359|FG000|Overall Study|Adverse Event|1|||
125217961|NCT02959918|450425360|FG001|Overall Study|Adverse Event|1|||
125217962|NCT02959918|450425361|FG002|Overall Study|Adverse Event|2|||
125217963|NCT02959918|450425362|FG003|Overall Study|Adverse Event|0|||
125217964|NCT02959918|450425363|FG004|Overall Study|Adverse Event|0|||
124971660|NCT00340704|449523328|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
124971661|NCT00340704|449523329|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
125217965|NCT02959918|450425364|FG005|Overall Study|Adverse Event|2|||
125217966|NCT02959918|450425365|FG006|Overall Study|Adverse Event|2|||
125217967|NCT02959918|450425366|FG007|Overall Study|Adverse Event|1|||
125217968|NCT02959918|450425367|FG008|Overall Study|Adverse Event|2|||
125217969|NCT02959918|450425368|FG009|Overall Study|Adverse Event|1|||
125217970|NCT02959918|450425369|FG010|Overall Study|Adverse Event|1|||
125217971|NCT02959918|450425370|FG011|Overall Study|Adverse Event|3|||
125217972|NCT02959918|450425371|FG012|Overall Study|Adverse Event|2|||
125217973|NCT02959918|450425372|FG013|Overall Study|Adverse Event|4|||
125217974|NCT02959918|450425359|FG000|Overall Study|Lost to Follow-up|0|||
125217975|NCT02959918|450425360|FG001|Overall Study|Lost to Follow-up|0|||
125217976|NCT02959918|450425361|FG002|Overall Study|Lost to Follow-up|0|||
125217977|NCT02959918|450425362|FG003|Overall Study|Lost to Follow-up|0|||
125217978|NCT02959918|450425363|FG004|Overall Study|Lost to Follow-up|0|||
124971662|NCT00340704|449523330|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
124971663|NCT00340704|449523322|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
124971664|NCT00340704|449523323|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
124971665|NCT00340704|449523324|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
124971666|NCT00340704|449523325|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
124971667|NCT00340704|449523326|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
124971668|NCT00340704|449523327|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
124971669|NCT00340704|449523328|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
124971670|NCT00340704|449523329|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
124971671|NCT00340704|449523330|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
124971672|NCT00246090|449523337|FG000|Overall Study|Adverse Event|25|||
124971673|NCT00246090|449523337|FG000|Overall Study|Withdrawal by Subject|7|||
125035298|NCT01157117|449747932|FG001|Overall Study|Withdrawal by Subject|1|||
125035299|NCT01157117|449747933|FG002|Overall Study|Withdrawal by Subject|1|||
125035300|NCT01157117|449747931|FG000|Overall Study|Lack of Efficacy|1|||
125035301|NCT01157117|449747932|FG001|Overall Study|Lack of Efficacy|1|||
125035302|NCT01157117|449747933|FG002|Overall Study|Lack of Efficacy|0|||
125035303|NCT01157117|449747931|FG000|Overall Study|Lost to Follow-up|0|||
125035304|NCT01157117|449747932|FG001|Overall Study|Lost to Follow-up|0|||
125035305|NCT01157117|449747933|FG002|Overall Study|Lost to Follow-up|1|||
125035306|NCT01157117|449747931|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
125035307|NCT01157117|449747932|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
125035308|NCT01157117|449747933|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
125035309|NCT01071070|449747939|FG000|Overall Study|Adverse Event|0|||
125035310|NCT01071070|449747940|FG001|Overall Study|Adverse Event|3|||
125035311|NCT01071070|449747939|FG000|Overall Study|Withdrawal by Subject|1|||
125035312|NCT01071070|449747940|FG001|Overall Study|Withdrawal by Subject|0|||
125035313|NCT01071070|449747939|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
125035314|NCT01071070|449747940|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
125035315|NCT01071070|449747939|FG000|Overall Study|Hypercalcemia|1|||
125035316|NCT01071070|449747940|FG001|Overall Study|Hypercalcemia|0|||
125035317|NCT02207907|449747941|FG000|Overall Study|Lost to Follow-up|3|||
125035318|NCT02207907|449747942|FG001|Overall Study|Lost to Follow-up|1|||
125035319|NCT02207907|449747941|FG000|Overall Study|Withdrawal by Subject|5|||
125035320|NCT02207907|449747942|FG001|Overall Study|Withdrawal by Subject|6|||
125035321|NCT02207907|449747941|FG000|Overall Study|Did not meet study criteria|3|||
125035322|NCT02207907|449747942|FG001|Overall Study|Did not meet study criteria|0|||
125035323|NCT02207907|449747941|FG000|Overall Study|Pregnancy|0|||
125035324|NCT02207907|449747942|FG001|Overall Study|Pregnancy|1|||
125035325|NCT02620020|449747943|FG000|Overall Study|Adverse Event|8|||
125035326|NCT02620020|449747944|FG001|Overall Study|Adverse Event|4|||
125035327|NCT02620020|449747945|FG002|Overall Study|Adverse Event|3|||
125035328|NCT02620020|449747946|FG003|Overall Study|Adverse Event|5|||
125035329|NCT02620020|449747943|FG000|Overall Study|Lost to Follow-up|4|||
125035330|NCT02620020|449747944|FG001|Overall Study|Lost to Follow-up|8|||
125035331|NCT02620020|449747945|FG002|Overall Study|Lost to Follow-up|1|||
125035332|NCT02620020|449747946|FG003|Overall Study|Lost to Follow-up|4|||
124971674|NCT00246090|449523337|FG000|Overall Study|Progressive Disease|212|||
124971675|NCT00246090|449523337|FG000|Overall Study|Clinical Progression|30|||
124971676|NCT00246090|449523337|FG000|Overall Study|Physician Decision|11|||
125035333|NCT02620020|449747943|FG000|Overall Study|Physician Decision|7|||
125035334|NCT02620020|449747944|FG001|Overall Study|Physician Decision|4|||
125035335|NCT02620020|449747945|FG002|Overall Study|Physician Decision|3|||
125035336|NCT02620020|449747946|FG003|Overall Study|Physician Decision|4|||
125035337|NCT02620020|449747943|FG000|Overall Study|Protocol Violation|5|||
125035338|NCT02620020|449747944|FG001|Overall Study|Protocol Violation|2|||
125035339|NCT02620020|449747945|FG002|Overall Study|Protocol Violation|1|||
125035340|NCT02620020|449747946|FG003|Overall Study|Protocol Violation|1|||
125132167|NCT01218867|450110123|FG000|Overall Study|Death during treatment|0|||
125132168|NCT01218867|450110124|FG001|Overall Study|Death during treatment|0|||
125132169|NCT01218867|450110125|FG002|Overall Study|Death during treatment|0|||
125132170|NCT01218867|450110126|FG003|Overall Study|Death during treatment|0|||
125132171|NCT01218867|450110127|FG004|Overall Study|Death during treatment|0|||
125132172|NCT01218867|450110128|FG005|Overall Study|Death during treatment|0|||
125132173|NCT01218867|450110129|FG006|Overall Study|Death during treatment|1|||
125132174|NCT01218867|450110130|FG007|Overall Study|Death during treatment|0|||
125132175|NCT01218867|450110131|FG008|Overall Study|Death during treatment|0|||
125035341|NCT02620020|449747943|FG000|Overall Study|Withdrawal by Subject|20|||
125035342|NCT02620020|449747944|FG001|Overall Study|Withdrawal by Subject|16|||
125035343|NCT02620020|449747945|FG002|Overall Study|Withdrawal by Subject|17|||
125132176|NCT01218867|450110132|FG009|Overall Study|Death during treatment|0|||
125132177|NCT01218867|450110133|FG010|Overall Study|Death during treatment|0|||
125132178|NCT01474551|450110134|FG000|Overall Study|Death|1|||
125035344|NCT02620020|449747946|FG003|Overall Study|Withdrawal by Subject|12|||
124971677|NCT00246090|449523337|FG000|Overall Study|Not Otherwise Specified|10|||
124971678|NCT02595372|449523338|FG000|Overall Study|Adverse Event|6|||
124971679|NCT02595372|449523338|FG000|Overall Study|Physician Decision|2|||
124971680|NCT02595372|449523338|FG000|Overall Study|Disease Progression|1|||
124971681|NCT00953615|449523339|FG000|Overall Study|Adverse Event|1|||
124971682|NCT01299480|449523340|FG000|Overall Study|No longer willing to participate|19|||
124971683|NCT01299480|449523341|FG001|Overall Study|No longer willing to participate|17|||
124971684|NCT01299480|449523342|FG002|Overall Study|No longer willing to participate|14|||
124971685|NCT01299480|449523343|FG003|Overall Study|No longer willing to participate|13|||
124971686|NCT01299480|449523344|FG004|Overall Study|No longer willing to participate|10|||
124971687|NCT01299480|449523340|FG000|Overall Study|Protocol Violation|7|||
124971688|NCT01299480|449523341|FG001|Overall Study|Protocol Violation|5|||
124971689|NCT01299480|449523342|FG002|Overall Study|Protocol Violation|8|||
124971690|NCT01299480|449523343|FG003|Overall Study|Protocol Violation|1|||
124971691|NCT01299480|449523344|FG004|Overall Study|Protocol Violation|1|||
124971692|NCT01299480|449523340|FG000|Overall Study|Withdrawal by Subject|3|||
124971693|NCT01299480|449523341|FG001|Overall Study|Withdrawal by Subject|4|||
124971694|NCT01299480|449523342|FG002|Overall Study|Withdrawal by Subject|7|||
124971695|NCT01299480|449523343|FG003|Overall Study|Withdrawal by Subject|3|||
124971696|NCT01299480|449523344|FG004|Overall Study|Withdrawal by Subject|4|||
124971697|NCT01299480|449523340|FG000|Overall Study|Adverse Event|6|||
124971698|NCT01299480|449523341|FG001|Overall Study|Adverse Event|4|||
124971699|NCT01299480|449523342|FG002|Overall Study|Adverse Event|5|||
124971700|NCT01299480|449523343|FG003|Overall Study|Adverse Event|4|||
124971701|NCT01299480|449523344|FG004|Overall Study|Adverse Event|0|||
124971702|NCT01299480|449523340|FG000|Overall Study|Withdrawal due to pregnancy|0|||
124971703|NCT01299480|449523341|FG001|Overall Study|Withdrawal due to pregnancy|1|||
124971704|NCT01299480|449523342|FG002|Overall Study|Withdrawal due to pregnancy|1|||
124971705|NCT01299480|449523343|FG003|Overall Study|Withdrawal due to pregnancy|0|||
124971706|NCT01299480|449523344|FG004|Overall Study|Withdrawal due to pregnancy|0|||
124971707|NCT01299480|449523340|FG000|Overall Study|Physician Decision|1|||
124971708|NCT01299480|449523341|FG001|Overall Study|Physician Decision|1|||
124971709|NCT01299480|449523342|FG002|Overall Study|Physician Decision|0|||
124971710|NCT01299480|449523343|FG003|Overall Study|Physician Decision|2|||
124971711|NCT01299480|449523344|FG004|Overall Study|Physician Decision|0|||
124971712|NCT01299480|449523340|FG000|Overall Study|Lost to Follow-up|3|||
124971713|NCT01299480|449523341|FG001|Overall Study|Lost to Follow-up|1|||
124971714|NCT01299480|449523342|FG002|Overall Study|Lost to Follow-up|2|||
124971715|NCT01299480|449523343|FG003|Overall Study|Lost to Follow-up|1|||
124971716|NCT01299480|449523344|FG004|Overall Study|Lost to Follow-up|2|||
124971717|NCT01299480|449523340|FG000|Overall Study|Other|3|||
124971718|NCT01299480|449523341|FG001|Overall Study|Other|2|||
124971719|NCT01299480|449523342|FG002|Overall Study|Other|3|||
124971720|NCT01299480|449523343|FG003|Overall Study|Other|0|||
124971721|NCT01299480|449523344|FG004|Overall Study|Other|3|||
124971722|NCT01299480|449523340|FG000|Overall Study|Started, but not vaccinated|0|||
124971723|NCT01299480|449523341|FG001|Overall Study|Started, but not vaccinated|0|||
124971724|NCT01299480|449523342|FG002|Overall Study|Started, but not vaccinated|1|||
124971725|NCT01299480|449523343|FG003|Overall Study|Started, but not vaccinated|1|||
124971726|NCT01299480|449523344|FG004|Overall Study|Started, but not vaccinated|0|||
124971727|NCT02389764|449523345|FG000|Overall Study|Lack of Efficacy|9|||
124971728|NCT00583947|449523346|FG000|Cross-over Period|Adverse Event|2|||
125035345|NCT02620020|449747943|FG000|Overall Study|Death|0|||
125035346|NCT02620020|449747944|FG001|Overall Study|Death|1|||
125035347|NCT02620020|449747945|FG002|Overall Study|Death|0|||
125035348|NCT02620020|449747946|FG003|Overall Study|Death|0|||
125035349|NCT02209506|449747948|FG000|Overall Study|Withdrawal by Subject|0|||
125035350|NCT02209506|449747949|FG001|Overall Study|Withdrawal by Subject|0|||
125035351|NCT02209506|449747950|FG002|Overall Study|Withdrawal by Subject|0|||
125035352|NCT02209506|449747951|FG003|Overall Study|Withdrawal by Subject|0|||
125035353|NCT02209506|449747952|FG004|Overall Study|Withdrawal by Subject|1|||
125035354|NCT01287104|449747957|FG000|Overall Study|Patient developed progressive disease|1|||
125035355|NCT01287104|449747958|FG001|Overall Study|Patient developed progressive disease|1|||
125035356|NCT01287104|449747959|FG002|Overall Study|Patient developed progressive disease|3|||
125035357|NCT01287104|449747960|FG003|Overall Study|Patient developed progressive disease|2|||
124971729|NCT00583947|449523347|FG001|Cross-over Period|Adverse Event|0|||
124971730|NCT00583947|449523346|FG000|Cross-over Period|Withdrawal by Subject|2|||
124971731|NCT00583947|449523347|FG001|Cross-over Period|Withdrawal by Subject|0|||
124971732|NCT00583947|449523346|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
124971733|NCT00583947|449523347|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
124971734|NCT00583947|449523346|FG000|Cross-over Period|Other|1|||
124971735|NCT00583947|449523347|FG001|Cross-over Period|Other|1|||
124971736|NCT00738283|449523348|FG000|Overall Study|Death|1|||
125035358|NCT01287104|449747957|FG000|Overall Study|Donor anaphylaxis|0|||
125035359|NCT01287104|449747958|FG001|Overall Study|Donor anaphylaxis|1|||
125035360|NCT01287104|449747959|FG002|Overall Study|Donor anaphylaxis|0|||
125035361|NCT01287104|449747960|FG003|Overall Study|Donor anaphylaxis|1|||
125035362|NCT01287104|449747957|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
125035363|NCT01287104|449747958|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
125035364|NCT01287104|449747959|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
125035365|NCT01287104|449747960|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
125035366|NCT01287104|449747957|FG000|Overall Study|Low donor chimerism|0|||
125035367|NCT01287104|449747958|FG001|Overall Study|Low donor chimerism|1|||
125035368|NCT01287104|449747959|FG002|Overall Study|Low donor chimerism|0|||
125035369|NCT01287104|449747960|FG003|Overall Study|Low donor chimerism|0|||
125035370|NCT01287104|449747957|FG000|Overall Study|NK cells did not meet release criteria|0|||
125035371|NCT01287104|449747958|FG001|Overall Study|NK cells did not meet release criteria|1|||
125035372|NCT01287104|449747959|FG002|Overall Study|NK cells did not meet release criteria|0|||
125035373|NCT01287104|449747960|FG003|Overall Study|NK cells did not meet release criteria|0|||
125035374|NCT02537678|449747961|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
125035375|NCT02537678|449747962|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
125035376|NCT02537678|449747961|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
125035377|NCT02537678|449747962|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
125035378|NCT02537678|449747961|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
125035379|NCT02537678|449747962|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
125035380|NCT02537678|449747961|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
125035381|NCT02537678|449747962|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
125035382|NCT02537678|449747961|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
125035383|NCT02537678|449747962|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
125035384|NCT02537678|449747961|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
125035385|NCT02537678|449747962|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
125035386|NCT02537678|449747961|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
125035387|NCT02537678|449747962|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
125035388|NCT02965378|449747963|FG000|Overall Study|Progression|16|||
125035389|NCT02965378|449747964|FG001|Overall Study|Progression|4|||
125035390|NCT02965378|449747963|FG000|Overall Study|Adverse Event|5|||
125035391|NCT02965378|449747964|FG001|Overall Study|Adverse Event|2|||
125035392|NCT02965378|449747963|FG000|Overall Study|Death|2|||
125035393|NCT02965378|449747964|FG001|Overall Study|Death|0|||
125035394|NCT02965378|449747963|FG000|Overall Study|Refusal|2|||
125035395|NCT02965378|449747964|FG001|Overall Study|Refusal|1|||
125035396|NCT02965378|449747963|FG000|Overall Study|Not protocol specified|0|||
125035397|NCT02965378|449747964|FG001|Overall Study|Not protocol specified|2|||
125035398|NCT00629083|449747969|FG000|Overall Study|Adverse Event|0|||
125035399|NCT00629083|449747970|FG001|Overall Study|Adverse Event|2|||
125035400|NCT00629083|449747969|FG000|Overall Study|Lack of Efficacy|3|||
125035401|NCT00629083|449747970|FG001|Overall Study|Lack of Efficacy|1|||
125035402|NCT00629083|449747969|FG000|Overall Study|Withdrawal by Subject|10|||
125035403|NCT00629083|449747970|FG001|Overall Study|Withdrawal by Subject|2|||
125035404|NCT00629083|449747969|FG000|Overall Study|Lost to Follow-up|12|||
125035405|NCT00629083|449747970|FG001|Overall Study|Lost to Follow-up|8|||
125035406|NCT00629083|449747969|FG000|Overall Study|Moved out of country/state|2|||
125035407|NCT00629083|449747970|FG001|Overall Study|Moved out of country/state|1|||
125035408|NCT00629083|449747969|FG000|Overall Study|Refused to return for 12 month visit|1|||
125035409|NCT00629083|449747970|FG001|Overall Study|Refused to return for 12 month visit|0|||
125035410|NCT02909153|449747971|FG000|Overall Study|Withdrawal by Subject|0|||
125035411|NCT02909153|449747972|FG001|Overall Study|Withdrawal by Subject|1|||
125035412|NCT02909153|449747973|FG002|Overall Study|Withdrawal by Subject|0|||
125035413|NCT02909153|449747974|FG003|Overall Study|Withdrawal by Subject|0|||
125035414|NCT02909153|449747975|FG004|Overall Study|Withdrawal by Subject|0|||
125035415|NCT01193686|449747976|FG000|Overall Study|Withdrawal by Subject|4|||
125035416|NCT01193686|449747977|FG001|Overall Study|Withdrawal by Subject|1|||
125035417|NCT01193686|449747976|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
125035418|NCT01193686|449747977|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
125035419|NCT01147809|449747978|FG000|Phase I (168 Days)|Adverse Event|0|||
125035420|NCT01147809|449747979|FG001|Phase I (168 Days)|Adverse Event|0|||
125035421|NCT01147809|449747980|FG002|Phase I (168 Days)|Adverse Event|0|||
125035422|NCT01147809|449747981|FG003|Phase I (168 Days)|Adverse Event|1|||
125035423|NCT01147809|449747982|FG004|Phase I (168 Days)|Adverse Event|0|||
124971737|NCT00738283|449523348|FG000|Overall Study|Transfer to another facility|2|||
124971738|NCT00738283|449523348|FG000|Overall Study|Discharge home prior to end of study|1|||
124971739|NCT00486252|449523351|FG000|Overall Study|Adverse Event|7|||
124971740|NCT00486252|449523351|FG000|Overall Study|Lack of Efficacy|9|||
124971741|NCT00486252|449523351|FG000|Overall Study|Lost to Follow-up|24|||
124971742|NCT00486252|449523351|FG000|Overall Study|Other|18|||
124971743|NCT01210651|449523352|FG000|Overall Study|Lost to Follow-up|1|||
124971744|NCT01210651|449523353|FG001|Overall Study|Lost to Follow-up|1|||
124971745|NCT01210651|449523352|FG000|Overall Study|schedule conflicts|1|||
124971746|NCT01210651|449523353|FG001|Overall Study|schedule conflicts|5|||
124971747|NCT01210651|449523352|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
124971748|NCT01210651|449523353|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
124971749|NCT01210651|449523352|FG000|Overall Study|Withdrawal by Subject|1|||
124971750|NCT01210651|449523353|FG001|Overall Study|Withdrawal by Subject|1|||
124971751|NCT01210651|449523352|FG000|Overall Study|Injury outside study|2|||
124971752|NCT01210651|449523353|FG001|Overall Study|Injury outside study|0|||
124971753|NCT02592707|449523357|FG000|Overall Study|Consent Withdrawn|0|||
124971754|NCT02592707|449523358|FG001|Overall Study|Consent Withdrawn|1|||
124971755|NCT02592707|449523359|FG002|Overall Study|Consent Withdrawn|2|||
124971756|NCT02592707|449523360|FG003|Overall Study|Consent Withdrawn|0|||
124971757|NCT02592707|449523357|FG000|Overall Study|Death|1|||
124971758|NCT02592707|449523358|FG001|Overall Study|Death|0|||
124971759|NCT02592707|449523359|FG002|Overall Study|Death|0|||
124971760|NCT02592707|449523360|FG003|Overall Study|Death|0|||
124971761|NCT02592707|449523357|FG000|Overall Study|Progressive Disease|4|||
124971762|NCT02592707|449523358|FG001|Overall Study|Progressive Disease|4|||
124971763|NCT02592707|449523359|FG002|Overall Study|Progressive Disease|3|||
124971764|NCT02592707|449523360|FG003|Overall Study|Progressive Disease|3|||
124971765|NCT02592707|449523357|FG000|Overall Study|Other|0|||
124971766|NCT02592707|449523358|FG001|Overall Study|Other|0|||
124971767|NCT02592707|449523359|FG002|Overall Study|Other|1|||
124971768|NCT02592707|449523360|FG003|Overall Study|Other|2|||
124971769|NCT02592707|449523357|FG000|Overall Study|Never entered LTFU period|1|||
124971770|NCT02592707|449523358|FG001|Overall Study|Never entered LTFU period|0|||
124971771|NCT02592707|449523359|FG002|Overall Study|Never entered LTFU period|0|||
124971772|NCT02592707|449523360|FG003|Overall Study|Never entered LTFU period|2|||
124971773|NCT00469859|449523361|FG000|Overall Study|Inevaluable|0|||
124971774|NCT00469859|449523362|FG001|Overall Study|Inevaluable|2|||
125132179|NCT01921062|450110135|FG000|Overall Study|Withdrawal by Subject|0|||
125132180|NCT01921062|450110136|FG001|Overall Study|Withdrawal by Subject|7|||
125132181|NCT01921062|450110135|FG000|Overall Study|Adverse Event|5|||
125132182|NCT01921062|450110136|FG001|Overall Study|Adverse Event|6|||
125132183|NCT01921062|450110135|FG000|Overall Study|Protocol Violation|0|||
125217979|NCT02959918|450425364|FG005|Overall Study|Lost to Follow-up|0|||
125217980|NCT02959918|450425365|FG006|Overall Study|Lost to Follow-up|0|||
125217981|NCT02959918|450425366|FG007|Overall Study|Lost to Follow-up|0|||
125217982|NCT02959918|450425367|FG008|Overall Study|Lost to Follow-up|0|||
125132184|NCT01921062|450110136|FG001|Overall Study|Protocol Violation|1|||
125132185|NCT01921062|450110135|FG000|Overall Study|VMIQ score > 72|4|||
125132186|NCT01921062|450110136|FG001|Overall Study|VMIQ score > 72|1|||
125132187|NCT01921062|450110135|FG000|Overall Study|Logistic error|0|||
125132188|NCT01921062|450110136|FG001|Overall Study|Logistic error|1|||
125217983|NCT02959918|450425368|FG009|Overall Study|Lost to Follow-up|1|||
125217984|NCT02959918|450425369|FG010|Overall Study|Lost to Follow-up|0|||
125217985|NCT02959918|450425370|FG011|Overall Study|Lost to Follow-up|0|||
125217986|NCT02959918|450425371|FG012|Overall Study|Lost to Follow-up|1|||
125217987|NCT02959918|450425372|FG013|Overall Study|Lost to Follow-up|0|||
125217988|NCT02959918|450425359|FG000|Overall Study|Withdrawal by Subject|0|||
125217989|NCT02959918|450425360|FG001|Overall Study|Withdrawal by Subject|0|||
125217990|NCT02959918|450425361|FG002|Overall Study|Withdrawal by Subject|1|||
125217991|NCT02959918|450425362|FG003|Overall Study|Withdrawal by Subject|2|||
124971775|NCT04855734|449523363|FG000|Overall Study|Lost to Follow-up|2|||
124971776|NCT04855734|449523364|FG001|Overall Study|Lost to Follow-up|2|||
124971777|NCT02520310|449523365|FG000|At 6 Months Clinical Follow-up|Death|1|||
124971778|NCT02520310|449523365|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
124971779|NCT02520310|449523365|FG000|AT 3 Year Clinical Follow-up|Death|2|||
125217992|NCT02959918|450425363|FG004|Overall Study|Withdrawal by Subject|0|||
124971780|NCT02520310|449523365|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
124971781|NCT02520310|449523365|FG000|AT 4 Year Clinical Follow-up|Death|1|||
125132189|NCT05323396|450110137|FG000|Overall Study|Lost to Follow-up|1|||
125132190|NCT05323396|450110138|FG001|Overall Study|Lost to Follow-up|35|||
125217993|NCT02959918|450425364|FG005|Overall Study|Withdrawal by Subject|0|||
124971782|NCT02520310|449523365|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
124971783|NCT01340014|449523366|FG000|Period 1, First 7 Days|Adverse Event|1|||
124971784|NCT01340014|449523367|FG001|Period 1, First 7 Days|Adverse Event|0|||
124971785|NCT01340014|449523366|FG000|Period 1, First 7 Days|Personal Reasons|1|||
125132191|NCT05323396|450110137|FG000|Overall Study|Pregnancy|1|||
125217994|NCT02959918|450425365|FG006|Overall Study|Withdrawal by Subject|1|||
125217995|NCT02959918|450425366|FG007|Overall Study|Withdrawal by Subject|0|||
124971786|NCT01340014|449523367|FG001|Period 1, First 7 Days|Personal Reasons|0|||
124971787|NCT01340014|449523366|FG000|Period 2, Second 7 Days|Adverse Event|0|||
124971788|NCT01340014|449523367|FG001|Period 2, Second 7 Days|Adverse Event|1|||
124971789|NCT04535544|449523370|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
124971790|NCT04535544|449523371|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
124971791|NCT04535544|449523372|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
124971792|NCT04535544|449523373|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
124971793|NCT04535544|449523370|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
124971794|NCT04535544|449523371|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
124971795|NCT04535544|449523372|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
124971796|NCT04535544|449523373|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
124971797|NCT04535544|449523370|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
124971798|NCT04535544|449523371|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
124971799|NCT04535544|449523372|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
124971800|NCT04535544|449523373|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
124971801|NCT04535544|449523370|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
124971802|NCT04535544|449523371|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
124971803|NCT04535544|449523372|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
124971804|NCT04535544|449523373|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
124971805|NCT04535544|449523370|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
124971806|NCT04535544|449523371|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
124971807|NCT04535544|449523372|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
124971808|NCT04535544|449523373|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
124971809|NCT04535544|449523370|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
124971810|NCT04535544|449523371|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
124971811|NCT04535544|449523372|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
124971812|NCT04535544|449523373|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
124971813|NCT04535544|449523370|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
124971814|NCT04535544|449523371|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
124971815|NCT04535544|449523372|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
124971816|NCT04535544|449523373|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
124971817|NCT04535544|449523370|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
124971818|NCT04535544|449523371|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
124971819|NCT04535544|449523372|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
124971820|NCT04535544|449523373|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
124971821|NCT05131477|449523376|FG000|PART 1|Withdrawal by Subject|2|||
124971822|NCT05131477|449523377|FG001|PART 1|Withdrawal by Subject|9|||
124971823|NCT05131477|449523378|FG002|PART 1|Withdrawal by Subject|6|||
124971824|NCT05131477|449523379|FG003|PART 1|Withdrawal by Subject|2|||
124971825|NCT05131477|449523380|FG004|PART 1|Withdrawal by Subject|8|||
124971826|NCT05131477|449523381|FG005|PART 1|Withdrawal by Subject|0|||
124971827|NCT05131477|449523382|FG006|PART 1|Withdrawal by Subject|0|||
124971828|NCT05131477|449523383|FG007|PART 1|Withdrawal by Subject|0|||
124971829|NCT05131477|449523384|FG008|PART 1|Withdrawal by Subject|0|||
124971830|NCT05131477|449523385|FG009|PART 1|Withdrawal by Subject|0|||
124971831|NCT05131477|449523386|FG010|PART 1|Withdrawal by Subject|0|||
124971832|NCT05131477|449523387|FG011|PART 1|Withdrawal by Subject|0|||
124971833|NCT05131477|449523388|FG012|PART 1|Withdrawal by Subject|0|||
124971834|NCT05131477|449523389|FG013|PART 1|Withdrawal by Subject|0|||
124971835|NCT05131477|449523376|FG000|PART 1|Physician Decision|1|||
124971836|NCT05131477|449523377|FG001|PART 1|Physician Decision|0|||
124971837|NCT05131477|449523378|FG002|PART 1|Physician Decision|0|||
124971838|NCT05131477|449523379|FG003|PART 1|Physician Decision|0|||
124971839|NCT05131477|449523380|FG004|PART 1|Physician Decision|0|||
124971840|NCT05131477|449523381|FG005|PART 1|Physician Decision|0|||
124971841|NCT05131477|449523382|FG006|PART 1|Physician Decision|0|||
124971842|NCT05131477|449523383|FG007|PART 1|Physician Decision|0|||
124971843|NCT05131477|449523384|FG008|PART 1|Physician Decision|0|||
124971844|NCT05131477|449523385|FG009|PART 1|Physician Decision|0|||
124971845|NCT05131477|449523386|FG010|PART 1|Physician Decision|0|||
124971846|NCT05131477|449523387|FG011|PART 1|Physician Decision|0|||
124971847|NCT05131477|449523388|FG012|PART 1|Physician Decision|0|||
124971848|NCT05131477|449523389|FG013|PART 1|Physician Decision|0|||
124971849|NCT05131477|449523376|FG000|PART 1|Adverse Event|3|||
124971850|NCT05131477|449523377|FG001|PART 1|Adverse Event|5|||
124971851|NCT05131477|449523378|FG002|PART 1|Adverse Event|1|||
124971852|NCT05131477|449523379|FG003|PART 1|Adverse Event|6|||
124971853|NCT05131477|449523380|FG004|PART 1|Adverse Event|4|||
124971854|NCT05131477|449523381|FG005|PART 1|Adverse Event|0|||
124971855|NCT05131477|449523382|FG006|PART 1|Adverse Event|0|||
124971856|NCT05131477|449523383|FG007|PART 1|Adverse Event|0|||
124971857|NCT05131477|449523384|FG008|PART 1|Adverse Event|0|||
125217996|NCT02959918|450425367|FG008|Overall Study|Withdrawal by Subject|1|||
125217997|NCT02959918|450425368|FG009|Overall Study|Withdrawal by Subject|1|||
125217998|NCT02959918|450425369|FG010|Overall Study|Withdrawal by Subject|2|||
125217999|NCT02959918|450425370|FG011|Overall Study|Withdrawal by Subject|3|||
125218000|NCT02959918|450425371|FG012|Overall Study|Withdrawal by Subject|1|||
125218001|NCT02959918|450425372|FG013|Overall Study|Withdrawal by Subject|1|||
125218002|NCT02959918|450425359|FG000|Overall Study|Protocol Violation|0|||
125218003|NCT02959918|450425360|FG001|Overall Study|Protocol Violation|0|||
125218004|NCT02959918|450425361|FG002|Overall Study|Protocol Violation|1|||
125218005|NCT02959918|450425362|FG003|Overall Study|Protocol Violation|0|||
125218006|NCT02959918|450425363|FG004|Overall Study|Protocol Violation|0|||
125218007|NCT02959918|450425364|FG005|Overall Study|Protocol Violation|1|||
125218008|NCT02959918|450425365|FG006|Overall Study|Protocol Violation|0|||
125218009|NCT02959918|450425366|FG007|Overall Study|Protocol Violation|0|||
125218010|NCT02959918|450425367|FG008|Overall Study|Protocol Violation|2|||
125218011|NCT02959918|450425368|FG009|Overall Study|Protocol Violation|1|||
125218012|NCT02959918|450425369|FG010|Overall Study|Protocol Violation|0|||
125218013|NCT02959918|450425370|FG011|Overall Study|Protocol Violation|1|||
125218014|NCT02959918|450425371|FG012|Overall Study|Protocol Violation|1|||
125218015|NCT02959918|450425372|FG013|Overall Study|Protocol Violation|0|||
125218016|NCT02959918|450425359|FG000|Overall Study|Stopping Rule Met|1|||
125218017|NCT02959918|450425360|FG001|Overall Study|Stopping Rule Met|0|||
125218018|NCT02959918|450425361|FG002|Overall Study|Stopping Rule Met|3|||
125218019|NCT02959918|450425362|FG003|Overall Study|Stopping Rule Met|4|||
125218020|NCT02959918|450425363|FG004|Overall Study|Stopping Rule Met|5|||
125218021|NCT02959918|450425364|FG005|Overall Study|Stopping Rule Met|3|||
125218022|NCT02959918|450425365|FG006|Overall Study|Stopping Rule Met|2|||
125218023|NCT02959918|450425366|FG007|Overall Study|Stopping Rule Met|4|||
125218024|NCT02959918|450425367|FG008|Overall Study|Stopping Rule Met|1|||
125218025|NCT02959918|450425368|FG009|Overall Study|Stopping Rule Met|1|||
125218026|NCT02959918|450425369|FG010|Overall Study|Stopping Rule Met|3|||
125218027|NCT02959918|450425370|FG011|Overall Study|Stopping Rule Met|5|||
125218028|NCT02959918|450425371|FG012|Overall Study|Stopping Rule Met|2|||
125218029|NCT02959918|450425372|FG013|Overall Study|Stopping Rule Met|1|||
125218030|NCT02959918|450425359|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
125218031|NCT02959918|450425360|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
125218032|NCT02959918|450425361|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
125218033|NCT02959918|450425362|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
125218034|NCT02959918|450425363|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
125218035|NCT02959918|450425364|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
125218036|NCT02959918|450425365|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
125218037|NCT02959918|450425366|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
125218038|NCT02959918|450425367|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
125218039|NCT02959918|450425368|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
125218040|NCT02959918|450425369|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
125218041|NCT02959918|450425370|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
125218042|NCT02959918|450425371|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
125218043|NCT02959918|450425372|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
124971858|NCT05131477|449523385|FG009|PART 1|Adverse Event|0|||
124971859|NCT05131477|449523386|FG010|PART 1|Adverse Event|0|||
124971860|NCT05131477|449523387|FG011|PART 1|Adverse Event|0|||
124971861|NCT05131477|449523388|FG012|PART 1|Adverse Event|0|||
124971862|NCT05131477|449523389|FG013|PART 1|Adverse Event|0|||
125218044|NCT02959918|450425359|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125218045|NCT02959918|450425360|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
124971863|NCT05131477|449523376|FG000|PART 1|unclassified|1|||
125218046|NCT02959918|450425361|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125218047|NCT02959918|450425362|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125218048|NCT02959918|450425363|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125218049|NCT02959918|450425364|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125218050|NCT02959918|450425365|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125218051|NCT02959918|450425366|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
124971864|NCT05131477|449523377|FG001|PART 1|unclassified|1|||
125218052|NCT02959918|450425367|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
124971865|NCT05131477|449523378|FG002|PART 1|unclassified|0|||
124971866|NCT05131477|449523379|FG003|PART 1|unclassified|0|||
124971867|NCT05131477|449523380|FG004|PART 1|unclassified|4|||
124971868|NCT05131477|449523381|FG005|PART 1|unclassified|0|||
124971869|NCT05131477|449523382|FG006|PART 1|unclassified|0|||
124971870|NCT05131477|449523383|FG007|PART 1|unclassified|0|||
124971871|NCT05131477|449523384|FG008|PART 1|unclassified|0|||
124971872|NCT05131477|449523385|FG009|PART 1|unclassified|0|||
124971873|NCT05131477|449523386|FG010|PART 1|unclassified|0|||
124971874|NCT05131477|449523387|FG011|PART 1|unclassified|0|||
124971875|NCT05131477|449523388|FG012|PART 1|unclassified|0|||
124971876|NCT05131477|449523389|FG013|PART 1|unclassified|0|||
124971877|NCT05131477|449523376|FG000|PART 1|Randomized and not treated|0|||
124971878|NCT05131477|449523377|FG001|PART 1|Randomized and not treated|0|||
124971879|NCT05131477|449523378|FG002|PART 1|Randomized and not treated|0|||
124971880|NCT05131477|449523379|FG003|PART 1|Randomized and not treated|1|||
124971881|NCT05131477|449523380|FG004|PART 1|Randomized and not treated|1|||
124971882|NCT05131477|449523381|FG005|PART 1|Randomized and not treated|0|||
124971883|NCT05131477|449523382|FG006|PART 1|Randomized and not treated|0|||
124971884|NCT05131477|449523383|FG007|PART 1|Randomized and not treated|0|||
124971885|NCT05131477|449523384|FG008|PART 1|Randomized and not treated|0|||
124971886|NCT05131477|449523385|FG009|PART 1|Randomized and not treated|0|||
124971887|NCT05131477|449523386|FG010|PART 1|Randomized and not treated|0|||
124971888|NCT05131477|449523387|FG011|PART 1|Randomized and not treated|0|||
124971889|NCT05131477|449523388|FG012|PART 1|Randomized and not treated|0|||
124971890|NCT05131477|449523389|FG013|PART 1|Randomized and not treated|0|||
124971891|NCT05131477|449523376|FG000|PART 1|Protocol Violation|2|||
124971892|NCT05131477|449523377|FG001|PART 1|Protocol Violation|0|||
124971893|NCT05131477|449523378|FG002|PART 1|Protocol Violation|0|||
124971894|NCT05131477|449523379|FG003|PART 1|Protocol Violation|1|||
124971895|NCT05131477|449523380|FG004|PART 1|Protocol Violation|0|||
124971896|NCT05131477|449523381|FG005|PART 1|Protocol Violation|0|||
124971897|NCT05131477|449523382|FG006|PART 1|Protocol Violation|0|||
124971898|NCT05131477|449523383|FG007|PART 1|Protocol Violation|0|||
124971899|NCT05131477|449523384|FG008|PART 1|Protocol Violation|0|||
124971900|NCT05131477|449523385|FG009|PART 1|Protocol Violation|0|||
124971901|NCT05131477|449523386|FG010|PART 1|Protocol Violation|0|||
124971902|NCT05131477|449523387|FG011|PART 1|Protocol Violation|0|||
124971903|NCT05131477|449523388|FG012|PART 1|Protocol Violation|0|||
124971904|NCT05131477|449523389|FG013|PART 1|Protocol Violation|0|||
124971905|NCT05131477|449523376|FG000|PART 1|Lack of Efficacy|0|||
124971906|NCT05131477|449523377|FG001|PART 1|Lack of Efficacy|1|||
124971907|NCT05131477|449523378|FG002|PART 1|Lack of Efficacy|1|||
124971908|NCT05131477|449523379|FG003|PART 1|Lack of Efficacy|2|||
124971909|NCT05131477|449523380|FG004|PART 1|Lack of Efficacy|5|||
124971910|NCT05131477|449523381|FG005|PART 1|Lack of Efficacy|0|||
124971911|NCT05131477|449523382|FG006|PART 1|Lack of Efficacy|0|||
124971912|NCT05131477|449523383|FG007|PART 1|Lack of Efficacy|0|||
124971913|NCT05131477|449523384|FG008|PART 1|Lack of Efficacy|0|||
124971914|NCT05131477|449523385|FG009|PART 1|Lack of Efficacy|0|||
124971915|NCT05131477|449523386|FG010|PART 1|Lack of Efficacy|0|||
124971916|NCT05131477|449523387|FG011|PART 1|Lack of Efficacy|0|||
124971917|NCT05131477|449523388|FG012|PART 1|Lack of Efficacy|0|||
124971918|NCT05131477|449523389|FG013|PART 1|Lack of Efficacy|0|||
124971919|NCT05131477|449523376|FG000|PART 2|Withdrawal by Subject|0|||
124971920|NCT05131477|449523377|FG001|PART 2|Withdrawal by Subject|0|||
124971921|NCT05131477|449523378|FG002|PART 2|Withdrawal by Subject|0|||
124971922|NCT05131477|449523379|FG003|PART 2|Withdrawal by Subject|0|||
124971923|NCT05131477|449523380|FG004|PART 2|Withdrawal by Subject|0|||
124971924|NCT05131477|449523381|FG005|PART 2|Withdrawal by Subject|0|||
124971925|NCT05131477|449523382|FG006|PART 2|Withdrawal by Subject|2|||
124971926|NCT05131477|449523383|FG007|PART 2|Withdrawal by Subject|0|||
124971927|NCT05131477|449523384|FG008|PART 2|Withdrawal by Subject|0|||
124971928|NCT05131477|449523385|FG009|PART 2|Withdrawal by Subject|0|||
124971929|NCT05131477|449523386|FG010|PART 2|Withdrawal by Subject|2|||
124971930|NCT05131477|449523387|FG011|PART 2|Withdrawal by Subject|0|||
124971931|NCT05131477|449523388|FG012|PART 2|Withdrawal by Subject|2|||
124971932|NCT05131477|449523389|FG013|PART 2|Withdrawal by Subject|2|||
124971933|NCT05131477|449523376|FG000|PART 2|Other|0|||
124971934|NCT05131477|449523377|FG001|PART 2|Other|0|||
124971935|NCT05131477|449523378|FG002|PART 2|Other|0|||
124971936|NCT05131477|449523379|FG003|PART 2|Other|0|||
124971937|NCT05131477|449523380|FG004|PART 2|Other|0|||
124971938|NCT05131477|449523381|FG005|PART 2|Other|0|||
124971939|NCT05131477|449523382|FG006|PART 2|Other|0|||
124971940|NCT05131477|449523383|FG007|PART 2|Other|0|||
124971941|NCT05131477|449523384|FG008|PART 2|Other|1|||
124971942|NCT05131477|449523385|FG009|PART 2|Other|1|||
124971943|NCT05131477|449523386|FG010|PART 2|Other|0|||
124971944|NCT05131477|449523387|FG011|PART 2|Other|0|||
124971945|NCT05131477|449523388|FG012|PART 2|Other|1|||
124971946|NCT05131477|449523389|FG013|PART 2|Other|0|||
124971947|NCT05131477|449523376|FG000|PART 2|Lack of Efficacy|0|||
125035424|NCT01147809|449747983|FG005|Phase I (168 Days)|Adverse Event|0|||
125035425|NCT01147809|449747978|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
125035426|NCT01147809|449747979|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
125035427|NCT01147809|449747980|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
125035428|NCT01147809|449747981|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
125035429|NCT01147809|449747982|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
125035430|NCT01147809|449747983|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
125035431|NCT01147809|449747978|FG000|Phase I (168 Days)|Physician Decision|0|||
125035432|NCT01147809|449747979|FG001|Phase I (168 Days)|Physician Decision|1|||
125132192|NCT05323396|450110138|FG001|Overall Study|Pregnancy|0|||
125132193|NCT01110005|450110139|FG000|Overall Study|ineligible|1|||
125132194|NCT01110005|450110140|FG001|Overall Study|ineligible|2|||
125132195|NCT01110005|450110139|FG000|Overall Study|missing consent|3|||
125132196|NCT01110005|450110140|FG001|Overall Study|missing consent|2|||
125132197|NCT01110005|450110139|FG000|Overall Study|Withdrawal by Subject|0|||
125132198|NCT01110005|450110140|FG001|Overall Study|Withdrawal by Subject|1|||
125132199|NCT04646213|450110141|FG000|Overall Study|Physician Decision|3|||
125132200|NCT04646213|450110141|FG000|Overall Study|Withdrawal by Subject|2|||
125132201|NCT00731783|450110148|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
125132202|NCT00731783|450110149|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
125132203|NCT00731783|450110148|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
125132204|NCT00731783|450110149|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
125132205|NCT00731783|450110148|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
125132206|NCT00731783|450110149|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
125132207|NCT00731783|450110148|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
125132208|NCT00731783|450110149|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
125132209|NCT00467896|450111704|FG000|Overall Study|Consent Withdrawal|18|||
125132210|NCT00467896|450111704|FG000|Overall Study|Adverse Event|7|||
125132211|NCT00467896|450111704|FG000|Overall Study|Serious Adverse Event|13|||
125132212|NCT00467896|450111704|FG000|Overall Study|Non-compliance|3|||
125132213|NCT00467896|450111704|FG000|Overall Study|Changed therapy|2|||
125132214|NCT00467896|450111704|FG000|Overall Study|Patient received transplant|2|||
125132215|NCT00467896|450111704|FG000|Overall Study|Patient had atrial septostomy|1|||
125132216|NCT00467896|450111704|FG000|Overall Study|Patient weaned off iloprost|1|||
125132217|NCT00467896|450111704|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
125132218|NCT00467896|450111704|FG000|Overall Study|Started intravenous prostacyclin|1|||
125132219|NCT00467896|450111704|FG000|Overall Study|Started inhaled Remodulin|1|||
125132220|NCT00467896|450111704|FG000|Overall Study|Patient had no improvement|1|||
125132221|NCT03772522|450111705|FG000|Pre-intervention|Withdrawal by Subject|3|||
125132222|NCT03772522|450111706|FG001|Pre-intervention|Withdrawal by Subject|4|||
125132223|NCT03772522|450111705|FG000|Intervention|Withdrawal by Subject|1|||
125132224|NCT03772522|450111706|FG001|Intervention|Withdrawal by Subject|0|||
125132225|NCT03772522|450111705|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
125132226|NCT03772522|450111706|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
125132227|NCT00834795|450111707|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
125132228|NCT00834795|450111708|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
125132229|NCT00834795|450111707|FG000|Second Intervention|Adverse Event|1|||
125132230|NCT00834795|450111708|FG001|Second Intervention|Adverse Event|0|||
125132231|NCT00579345|450111709|FG000|Overall Study|Withdrawal by Subject|2|||
125132232|NCT00579345|450111710|FG001|Overall Study|Withdrawal by Subject|0|||
125132233|NCT00579345|450111711|FG002|Overall Study|Withdrawal by Subject|0|||
125132234|NCT00579345|450111712|FG003|Overall Study|Withdrawal by Subject|0|||
125132235|NCT00579345|450111713|FG004|Overall Study|Withdrawal by Subject|0|||
125132236|NCT00579345|450111714|FG005|Overall Study|Withdrawal by Subject|0|||
125132237|NCT00579345|450111715|FG006|Overall Study|Withdrawal by Subject|0|||
125132238|NCT00579345|450111716|FG007|Overall Study|Withdrawal by Subject|1|||
125132239|NCT00579345|450111709|FG000|Overall Study|Lost to Follow-up|1|||
125132240|NCT00579345|450111710|FG001|Overall Study|Lost to Follow-up|0|||
125132241|NCT00579345|450111711|FG002|Overall Study|Lost to Follow-up|0|||
125132242|NCT00579345|450111712|FG003|Overall Study|Lost to Follow-up|0|||
125132243|NCT00579345|450111713|FG004|Overall Study|Lost to Follow-up|0|||
125132244|NCT00579345|450111714|FG005|Overall Study|Lost to Follow-up|0|||
125132245|NCT00579345|450111715|FG006|Overall Study|Lost to Follow-up|0|||
125132246|NCT00579345|450111716|FG007|Overall Study|Lost to Follow-up|0|||
125132247|NCT00579345|450111709|FG000|Overall Study|Adverse Event|0|||
125132248|NCT00579345|450111710|FG001|Overall Study|Adverse Event|0|||
125132249|NCT00579345|450111711|FG002|Overall Study|Adverse Event|1|||
125132250|NCT00579345|450111712|FG003|Overall Study|Adverse Event|0|||
125132251|NCT00579345|450111713|FG004|Overall Study|Adverse Event|0|||
125132252|NCT00579345|450111714|FG005|Overall Study|Adverse Event|0|||
125132253|NCT00579345|450111715|FG006|Overall Study|Adverse Event|0|||
125035433|NCT01147809|449747980|FG002|Phase I (168 Days)|Physician Decision|2|||
125132254|NCT00579345|450111716|FG007|Overall Study|Adverse Event|0|||
125132255|NCT00579345|450111709|FG000|Overall Study|Protocol Violation|1|||
125132256|NCT00579345|450111710|FG001|Overall Study|Protocol Violation|0|||
125132257|NCT00579345|450111711|FG002|Overall Study|Protocol Violation|0|||
125132258|NCT00579345|450111712|FG003|Overall Study|Protocol Violation|0|||
125218053|NCT02959918|450425368|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125218054|NCT02959918|450425369|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
124971948|NCT05131477|449523377|FG001|PART 2|Lack of Efficacy|0|||
124971949|NCT05131477|449523378|FG002|PART 2|Lack of Efficacy|0|||
124971950|NCT05131477|449523379|FG003|PART 2|Lack of Efficacy|0|||
124971951|NCT05131477|449523380|FG004|PART 2|Lack of Efficacy|0|||
124971952|NCT05131477|449523381|FG005|PART 2|Lack of Efficacy|1|||
124971953|NCT05131477|449523382|FG006|PART 2|Lack of Efficacy|1|||
124971954|NCT05131477|449523383|FG007|PART 2|Lack of Efficacy|0|||
124971955|NCT05131477|449523384|FG008|PART 2|Lack of Efficacy|3|||
124971956|NCT05131477|449523385|FG009|PART 2|Lack of Efficacy|0|||
124971957|NCT05131477|449523386|FG010|PART 2|Lack of Efficacy|1|||
124971958|NCT05131477|449523387|FG011|PART 2|Lack of Efficacy|0|||
124971959|NCT05131477|449523388|FG012|PART 2|Lack of Efficacy|2|||
124971960|NCT05131477|449523389|FG013|PART 2|Lack of Efficacy|0|||
124971961|NCT05131477|449523376|FG000|PART 2|Unclassified|0|||
124971962|NCT05131477|449523377|FG001|PART 2|Unclassified|0|||
124971963|NCT05131477|449523378|FG002|PART 2|Unclassified|0|||
124971964|NCT05131477|449523379|FG003|PART 2|Unclassified|0|||
124971965|NCT05131477|449523380|FG004|PART 2|Unclassified|0|||
124971966|NCT05131477|449523381|FG005|PART 2|Unclassified|0|||
124971967|NCT05131477|449523382|FG006|PART 2|Unclassified|0|||
124971968|NCT05131477|449523383|FG007|PART 2|Unclassified|0|||
124971969|NCT05131477|449523384|FG008|PART 2|Unclassified|0|||
124971970|NCT05131477|449523385|FG009|PART 2|Unclassified|0|||
124971971|NCT05131477|449523386|FG010|PART 2|Unclassified|1|||
124971972|NCT05131477|449523387|FG011|PART 2|Unclassified|0|||
124971973|NCT05131477|449523388|FG012|PART 2|Unclassified|0|||
124971974|NCT05131477|449523389|FG013|PART 2|Unclassified|0|||
124971975|NCT05131477|449523376|FG000|PART 2|Re-randomized and not treated|0|||
124971976|NCT05131477|449523377|FG001|PART 2|Re-randomized and not treated|0|||
124971977|NCT05131477|449523378|FG002|PART 2|Re-randomized and not treated|0|||
124971978|NCT05131477|449523379|FG003|PART 2|Re-randomized and not treated|0|||
124971979|NCT05131477|449523380|FG004|PART 2|Re-randomized and not treated|0|||
124971980|NCT05131477|449523381|FG005|PART 2|Re-randomized and not treated|0|||
124971981|NCT05131477|449523382|FG006|PART 2|Re-randomized and not treated|0|||
124971982|NCT05131477|449523383|FG007|PART 2|Re-randomized and not treated|1|||
124971983|NCT05131477|449523384|FG008|PART 2|Re-randomized and not treated|0|||
124971984|NCT05131477|449523385|FG009|PART 2|Re-randomized and not treated|0|||
124971985|NCT05131477|449523386|FG010|PART 2|Re-randomized and not treated|1|||
124971986|NCT05131477|449523387|FG011|PART 2|Re-randomized and not treated|0|||
124971987|NCT05131477|449523388|FG012|PART 2|Re-randomized and not treated|1|||
124971988|NCT05131477|449523389|FG013|PART 2|Re-randomized and not treated|1|||
124971989|NCT02194829|449523390|FG000|Overall Study|Adverse Event|2|||
124971990|NCT02194829|449523391|FG001|Overall Study|Adverse Event|2|||
124971991|NCT02194829|449523390|FG000|Overall Study|Death|0|||
124971992|NCT02194829|449523391|FG001|Overall Study|Death|1|||
124971993|NCT02194829|449523390|FG000|Overall Study|Disease progression|0|||
124971994|NCT02194829|449523391|FG001|Overall Study|Disease progression|1|||
124971995|NCT02194829|449523390|FG000|Overall Study|Withdrawal by Subject|0|||
124971996|NCT02194829|449523391|FG001|Overall Study|Withdrawal by Subject|1|||
124971997|NCT02194829|449523390|FG000|Overall Study|Never started protocol therapy|0|||
124971998|NCT02194829|449523391|FG001|Overall Study|Never started protocol therapy|1|||
124971999|NCT01124838|449523392|FG000|Overall Study|Miscellaneous|4|||
124972000|NCT01124838|449523393|FG001|Overall Study|Miscellaneous|2|||
124972001|NCT01124838|449523392|FG000|Overall Study|Adverse Event|7|||
124972002|NCT01124838|449523393|FG001|Overall Study|Adverse Event|11|||
124972003|NCT01124838|449523392|FG000|Overall Study|Lack of Efficacy|2|||
124972004|NCT01124838|449523393|FG001|Overall Study|Lack of Efficacy|0|||
124972005|NCT01124838|449523392|FG000|Overall Study|Withdrawal by Subject|3|||
124972006|NCT01124838|449523393|FG001|Overall Study|Withdrawal by Subject|2|||
124972007|NCT01124838|449523392|FG000|Overall Study|Lost to Follow-up|2|||
124972008|NCT01124838|449523393|FG001|Overall Study|Lost to Follow-up|0|||
124972009|NCT04297618|449523394|FG000|Overall Study|Adverse Event|1|||
124972010|NCT04297618|449523394|FG000|Overall Study|Withdrawal by Subject|1|||
124972011|NCT02726945|449523396|FG000|Overall Study|Withdrawal by Subject|0|||
124972012|NCT02726945|449523397|FG001|Overall Study|Withdrawal by Subject|0|||
124972013|NCT02726945|449523398|FG002|Overall Study|Withdrawal by Subject|1|||
124972014|NCT02726945|449523396|FG000|Overall Study|Elected to have total knee replacement|0|||
124972015|NCT02726945|449523397|FG001|Overall Study|Elected to have total knee replacement|1|||
124972016|NCT02726945|449523398|FG002|Overall Study|Elected to have total knee replacement|0|||
124972017|NCT02172911|449525499|FG000|Overall Study|Serious Adverse Event|0|||
125218055|NCT02959918|450425370|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
124972018|NCT02172911|449525500|FG001|Overall Study|Serious Adverse Event|1|||
124972019|NCT02172911|449525499|FG000|Overall Study|Progression of Disease|0|||
124972020|NCT02172911|449525500|FG001|Overall Study|Progression of Disease|1|||
124972021|NCT02172911|449525499|FG000|Overall Study|Loss of insurance coverage|1|||
124972022|NCT02172911|449525500|FG001|Overall Study|Loss of insurance coverage|0|||
124972023|NCT01606319|449525503|FG000|Overall Study|Lost to Follow-up|17|||
125035434|NCT01147809|449747981|FG003|Phase I (168 Days)|Physician Decision|0|||
125035435|NCT01147809|449747982|FG004|Phase I (168 Days)|Physician Decision|0|||
125035436|NCT01147809|449747983|FG005|Phase I (168 Days)|Physician Decision|0|||
125035437|NCT01147809|449747978|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
125035438|NCT01147809|449747979|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
125035439|NCT01147809|449747980|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
125035440|NCT01147809|449747981|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
125035441|NCT01147809|449747982|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
125035442|NCT01147809|449747983|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
125035443|NCT01147809|449747978|FG000|Phase II (168 Days)|Adverse Event|0|||
125035444|NCT01147809|449747979|FG001|Phase II (168 Days)|Adverse Event|0|||
125035445|NCT01147809|449747980|FG002|Phase II (168 Days)|Adverse Event|0|||
125035446|NCT01147809|449747981|FG003|Phase II (168 Days)|Adverse Event|0|||
125035447|NCT01147809|449747982|FG004|Phase II (168 Days)|Adverse Event|3|||
125035448|NCT01147809|449747983|FG005|Phase II (168 Days)|Adverse Event|6|||
125035449|NCT01147809|449747978|FG000|Phase II (168 Days)|Protocol Violation|0|||
125035450|NCT01147809|449747979|FG001|Phase II (168 Days)|Protocol Violation|0|||
125035451|NCT01147809|449747980|FG002|Phase II (168 Days)|Protocol Violation|0|||
125035452|NCT01147809|449747981|FG003|Phase II (168 Days)|Protocol Violation|0|||
125035453|NCT01147809|449747982|FG004|Phase II (168 Days)|Protocol Violation|0|||
125035454|NCT01147809|449747983|FG005|Phase II (168 Days)|Protocol Violation|1|||
125035455|NCT01147809|449747978|FG000|Phase II (168 Days)|Physician Decision|0|||
125035456|NCT01147809|449747979|FG001|Phase II (168 Days)|Physician Decision|0|||
125035457|NCT01147809|449747980|FG002|Phase II (168 Days)|Physician Decision|0|||
125218056|NCT02959918|450425371|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125218057|NCT02959918|450425372|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125218058|NCT02959918|450425359|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125035458|NCT01147809|449747981|FG003|Phase II (168 Days)|Physician Decision|0|||
125035459|NCT01147809|449747982|FG004|Phase II (168 Days)|Physician Decision|5|||
125035460|NCT01147809|449747983|FG005|Phase II (168 Days)|Physician Decision|11|||
125035461|NCT01147809|449747978|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
125035462|NCT01147809|449747979|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
125035463|NCT01147809|449747980|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
125218059|NCT02959918|450425360|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125218060|NCT02959918|450425361|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125035464|NCT01147809|449747981|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
125035465|NCT01147809|449747982|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
125035466|NCT01147809|449747983|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
125035467|NCT01147809|449747978|FG000|Phase II (168 Days)|Ongoing|0|||
125035468|NCT01147809|449747979|FG001|Phase II (168 Days)|Ongoing|0|||
125035469|NCT01147809|449747980|FG002|Phase II (168 Days)|Ongoing|0|||
125035470|NCT01147809|449747981|FG003|Phase II (168 Days)|Ongoing|0|||
125035471|NCT01147809|449747982|FG004|Phase II (168 Days)|Ongoing|1|||
125035472|NCT01147809|449747983|FG005|Phase II (168 Days)|Ongoing|0|||
125035473|NCT01307423|449747984|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
125035474|NCT01307423|449747985|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
125132259|NCT00579345|450111713|FG004|Overall Study|Protocol Violation|0|||
125132260|NCT00579345|450111714|FG005|Overall Study|Protocol Violation|0|||
125132261|NCT00579345|450111715|FG006|Overall Study|Protocol Violation|0|||
125132262|NCT00579345|450111716|FG007|Overall Study|Protocol Violation|1|||
125132263|NCT00579345|450111709|FG000|Overall Study|Death|1|||
125132264|NCT00579345|450111710|FG001|Overall Study|Death|1|||
125132265|NCT00579345|450111711|FG002|Overall Study|Death|1|||
125132266|NCT00579345|450111712|FG003|Overall Study|Death|1|||
125132267|NCT00579345|450111713|FG004|Overall Study|Death|0|||
125132268|NCT00579345|450111714|FG005|Overall Study|Death|0|||
125132269|NCT00579345|450111715|FG006|Overall Study|Death|0|||
125132270|NCT00579345|450111716|FG007|Overall Study|Death|0|||
125132271|NCT02175095|450111717|FG000|Overall Study|Withdrawal by Subject|3|||
125132272|NCT03697109|450111718|FG000|Open-label (OL) Phase|Adverse Event|24|||
125132273|NCT03697109|450111719|FG001|Open-label (OL) Phase|Adverse Event|0|||
125132274|NCT03697109|450111720|FG002|Open-label (OL) Phase|Adverse Event|0|||
125132275|NCT03697109|450111718|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
125132276|NCT03697109|450111719|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
125132277|NCT03697109|450111720|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
125132278|NCT03697109|450111718|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
125132279|NCT03697109|450111719|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
125132280|NCT03697109|450111720|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
125132281|NCT03697109|450111718|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
125035475|NCT01307423|449747986|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
125035476|NCT01307423|449747987|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125035477|NCT01307423|449747988|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125035478|NCT01307423|449747989|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125035479|NCT01307423|449747990|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125035480|NCT01307423|449747991|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125035481|NCT01307423|449747992|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125035482|NCT01307423|449747984|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
125035483|NCT01307423|449747985|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
125035484|NCT01307423|449747986|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
125035485|NCT01307423|449747987|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125035486|NCT01307423|449747988|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125035487|NCT01307423|449747989|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125035488|NCT01307423|449747990|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125035489|NCT01307423|449747991|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125035490|NCT01307423|449747992|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125035491|NCT01307423|449747984|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
125035492|NCT01307423|449747985|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
125035493|NCT01307423|449747986|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
125035494|NCT01307423|449747987|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125035495|NCT01307423|449747988|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125035496|NCT01307423|449747989|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125035497|NCT01307423|449747990|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125035498|NCT01307423|449747991|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125035499|NCT01307423|449747992|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125035500|NCT01307423|449747984|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125035501|NCT01307423|449747985|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125035502|NCT01307423|449747986|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
125035503|NCT01307423|449747987|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125035504|NCT01307423|449747988|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125035505|NCT01307423|449747989|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125035506|NCT01307423|449747990|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125035507|NCT01307423|449747991|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125035508|NCT01307423|449747992|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125035509|NCT01307423|449747984|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
125035510|NCT01307423|449747985|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
125035511|NCT01307423|449747986|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
125035512|NCT01307423|449747987|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125035513|NCT01307423|449747988|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125035514|NCT01307423|449747989|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125035515|NCT01307423|449747990|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125035516|NCT01307423|449747991|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125035517|NCT01307423|449747992|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125035518|NCT01307423|449747984|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
125035519|NCT01307423|449747985|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125035520|NCT01307423|449747986|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125035521|NCT01307423|449747987|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125035522|NCT01307423|449747988|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125035523|NCT01307423|449747989|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125035524|NCT01307423|449747990|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125035525|NCT01307423|449747991|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125035526|NCT01307423|449747992|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125035527|NCT01307423|449747984|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
125035528|NCT01307423|449747985|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
125035529|NCT01307423|449747986|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
125132282|NCT03697109|450111719|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
125132283|NCT03697109|450111720|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
125132284|NCT03697109|450111718|FG000|Open-label (OL) Phase|Physician Decision|2|||
125132285|NCT03697109|450111719|FG001|Open-label (OL) Phase|Physician Decision|0|||
125132286|NCT03697109|450111720|FG002|Open-label (OL) Phase|Physician Decision|0|||
125132287|NCT03697109|450111718|FG000|Open-label (OL) Phase|Death|2|||
125132288|NCT03697109|450111719|FG001|Open-label (OL) Phase|Death|0|||
125132289|NCT03697109|450111720|FG002|Open-label (OL) Phase|Death|0|||
125132290|NCT03697109|450111718|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
125218061|NCT02959918|450425362|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125218062|NCT02959918|450425363|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
124972024|NCT01606319|449525504|FG001|Overall Study|Lost to Follow-up|14|||
124972025|NCT01606319|449525503|FG000|Overall Study|Withdrawal by Subject|9|||
124972026|NCT01606319|449525504|FG001|Overall Study|Withdrawal by Subject|12|||
124972027|NCT01606319|449525503|FG000|Overall Study|Physician Decision|1|||
124972028|NCT01606319|449525504|FG001|Overall Study|Physician Decision|2|||
124972029|NCT01606319|449525503|FG000|Overall Study|Lack of Efficacy|6|||
124972030|NCT01606319|449525504|FG001|Overall Study|Lack of Efficacy|8|||
124972031|NCT01606319|449525503|FG000|Overall Study|Adverse Event|1|||
124972032|NCT01606319|449525504|FG001|Overall Study|Adverse Event|4|||
124972033|NCT01124097|449525508|FG000|Overall Study|Withdrawal by Subject|4|||
124972034|NCT01124097|449525509|FG001|Overall Study|Withdrawal by Subject|3|||
124972035|NCT01124097|449525510|FG002|Overall Study|Withdrawal by Subject|2|||
124972036|NCT01124097|449525511|FG003|Overall Study|Withdrawal by Subject|3|||
124972037|NCT01124097|449525508|FG000|Overall Study|Lack of Efficacy|2|||
124972038|NCT01124097|449525509|FG001|Overall Study|Lack of Efficacy|3|||
124972039|NCT01124097|449525510|FG002|Overall Study|Lack of Efficacy|1|||
124972040|NCT01124097|449525511|FG003|Overall Study|Lack of Efficacy|3|||
124972041|NCT01124097|449525508|FG000|Overall Study|Adverse Event|24|||
124972042|NCT01124097|449525509|FG001|Overall Study|Adverse Event|15|||
124972043|NCT01124097|449525510|FG002|Overall Study|Adverse Event|15|||
124972044|NCT01124097|449525511|FG003|Overall Study|Adverse Event|7|||
124972045|NCT01124097|449525508|FG000|Overall Study|Protocol Violation|2|||
124972046|NCT01124097|449525509|FG001|Overall Study|Protocol Violation|0|||
124972047|NCT01124097|449525510|FG002|Overall Study|Protocol Violation|2|||
124972048|NCT01124097|449525511|FG003|Overall Study|Protocol Violation|1|||
124972049|NCT01124097|449525508|FG000|Overall Study|Physician Decision|2|||
124972050|NCT01124097|449525509|FG001|Overall Study|Physician Decision|1|||
124972051|NCT01124097|449525510|FG002|Overall Study|Physician Decision|0|||
124972052|NCT01124097|449525511|FG003|Overall Study|Physician Decision|0|||
124972053|NCT01821937|449525512|FG000|Overall Study|Adverse Event|0|||
124972054|NCT01821937|449525513|FG001|Overall Study|Adverse Event|3|||
124972055|NCT02153905|449525514|FG000|Overall Study|Death|1|||
124972056|NCT02153905|449525515|FG001|Overall Study|Death|0|||
124972057|NCT00193479|449525516|FG000|Induction Chemotherapy|Adverse Event|2|||
124972058|NCT00193479|449525516|FG000|Induction Chemotherapy|Disease Progression|1|||
124972059|NCT00193479|449525516|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
124972060|NCT00193479|449525516|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
124972061|NCT01304498|449525517|FG000|Overall Study|Adverse Event|1|||
124972062|NCT01304498|449525518|FG001|Overall Study|Adverse Event|1|||
124972063|NCT01304498|449525517|FG000|Overall Study|Withdrawal by Subject|2|||
124972064|NCT01304498|449525518|FG001|Overall Study|Withdrawal by Subject|3|||
124972065|NCT01304498|449525517|FG000|Overall Study|Protocol Violation|1|||
124972066|NCT01304498|449525518|FG001|Overall Study|Protocol Violation|0|||
124972067|NCT01304498|449525517|FG000|Overall Study|Lost to Follow-up|2|||
124972068|NCT01304498|449525518|FG001|Overall Study|Lost to Follow-up|1|||
124972069|NCT01834586|449525520|FG000|Overall Study|Adverse Event|1|||
124972070|NCT01667549|449525521|FG000|Overall Study|Withdrawal by Subject|3|||
124972071|NCT01667549|449525522|FG001|Overall Study|Withdrawal by Subject|5|||
124972072|NCT01667549|449525523|FG002|Overall Study|Withdrawal by Subject|7|||
124972073|NCT01667549|449525524|FG003|Overall Study|Withdrawal by Subject|6|||
124972074|NCT01667549|449525525|FG004|Overall Study|Withdrawal by Subject|1|||
124972075|NCT04210843|449525526|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
124972076|NCT04210843|449525527|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
124972077|NCT04210843|449525526|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
124972078|NCT04210843|449525527|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
124972079|NCT04210843|449525526|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
124972080|NCT04210843|449525527|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
124972081|NCT04210843|449525526|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
124972082|NCT04210843|449525527|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
124972083|NCT04210843|449525526|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
124972084|NCT04210843|449525527|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
124972085|NCT04210843|449525526|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
125218063|NCT02959918|450425364|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
124972086|NCT04210843|449525527|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
124972087|NCT04210843|449525526|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
124972088|NCT04210843|449525527|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
124972089|NCT04210843|449525526|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
124972090|NCT04210843|449525527|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
124972091|NCT04210843|449525526|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
124972092|NCT04210843|449525527|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
124972093|NCT04210843|449525526|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
125035530|NCT01307423|449747987|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
125035531|NCT01307423|449747988|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
125035532|NCT01307423|449747989|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
125035533|NCT01307423|449747990|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
125035534|NCT01307423|449747991|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
125035535|NCT01307423|449747992|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
125035536|NCT01307423|449747984|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
125035537|NCT01307423|449747985|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
125035538|NCT01307423|449747986|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
125035539|NCT01307423|449747987|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
125035540|NCT01307423|449747988|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
125035541|NCT01307423|449747989|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
125035542|NCT01307423|449747990|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
125035543|NCT01307423|449747991|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
125035544|NCT01307423|449747992|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
125035545|NCT01307423|449747984|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
125035546|NCT01307423|449747985|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
125035547|NCT01307423|449747986|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
125035548|NCT01307423|449747987|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
125035549|NCT01307423|449747988|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
125035550|NCT01307423|449747989|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
125035551|NCT01307423|449747990|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
125035552|NCT01307423|449747991|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
125035553|NCT01307423|449747992|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
125035554|NCT01307423|449747984|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
125035555|NCT01307423|449747985|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
125035556|NCT01307423|449747986|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
125035557|NCT01307423|449747987|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
125035558|NCT01307423|449747988|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
125035559|NCT01307423|449747989|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
125035560|NCT01307423|449747990|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
125035561|NCT01307423|449747991|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
125035562|NCT01307423|449747992|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
125035563|NCT01307423|449747984|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
125035564|NCT01307423|449747985|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
125035565|NCT01307423|449747986|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
125035566|NCT01307423|449747987|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
125035567|NCT01307423|449747988|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
125035568|NCT01307423|449747989|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
125035569|NCT01307423|449747990|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
125035570|NCT01307423|449747991|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
125035571|NCT01307423|449747992|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
125035572|NCT01307423|449747984|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
125035573|NCT01307423|449747985|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
125035574|NCT01307423|449747986|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
125035575|NCT01307423|449747987|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
125035576|NCT01307423|449747988|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
125035577|NCT01307423|449747989|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
125035578|NCT01307423|449747990|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
125035579|NCT01307423|449747991|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
125132291|NCT03697109|450111719|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
125132292|NCT03697109|450111720|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
125132293|NCT03697109|450111718|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
125132294|NCT03697109|450111719|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
125132295|NCT03697109|450111720|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
125132296|NCT03697109|450111718|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
125132297|NCT03697109|450111719|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
125132298|NCT03697109|450111720|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
125132299|NCT01111461|450111721|FG000|Overall Study|Adverse Event|32|||
125132300|NCT01111461|450111721|FG000|Overall Study|Participant choice|11|||
125132301|NCT01111461|450111721|FG000|Overall Study|Lost to Follow-up|1|||
125132302|NCT01111461|450111721|FG000|Overall Study|Withdrawal by Subject|1|||
125035580|NCT01307423|449747992|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
124972094|NCT04210843|449525527|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
124972095|NCT04210843|449525526|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
124972096|NCT04210843|449525527|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
124972097|NCT04210843|449525526|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
124972098|NCT04210843|449525527|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
124972099|NCT04210843|449525526|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
124972100|NCT04210843|449525527|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
124972101|NCT04210843|449525526|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
124972102|NCT04210843|449525527|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
124972103|NCT04210843|449525526|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
124972104|NCT04210843|449525527|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
124972105|NCT04210843|449525526|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
124972106|NCT04210843|449525527|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
124972107|NCT04210843|449525526|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
124972108|NCT04210843|449525527|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
124972109|NCT04210843|449525526|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
124972110|NCT04210843|449525527|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
124972111|NCT04210843|449525526|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
124972112|NCT04210843|449525527|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
124972113|NCT04210843|449525526|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
124972114|NCT04210843|449525527|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
124972115|NCT04210843|449525526|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
124972116|NCT04210843|449525527|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
124972117|NCT04210843|449525526|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
124972118|NCT04210843|449525527|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
124972119|NCT04210843|449525526|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
124972120|NCT04210843|449525527|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
124972121|NCT04210843|449525526|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
124972122|NCT04210843|449525527|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
124972123|NCT02844777|449525528|FG000|Overall Study|Withdrawal by Subject|2|||
124972124|NCT02844777|449525529|FG001|Overall Study|Withdrawal by Subject|0|||
124972125|NCT02844777|449525530|FG002|Overall Study|Withdrawal by Subject|0|||
124972126|NCT00150618|449525531|FG000|Overall Study|Adverse Event|2|||
124972127|NCT00150618|449525532|FG001|Overall Study|Adverse Event|2|||
124972128|NCT00150618|449525533|FG002|Overall Study|Adverse Event|6|||
124972129|NCT00150618|449525534|FG003|Overall Study|Adverse Event|9|||
124972130|NCT00150618|449525535|FG004|Overall Study|Adverse Event|5|||
124972131|NCT00150618|449525531|FG000|Overall Study|Withdrawal by Subject|6|||
124972132|NCT00150618|449525532|FG001|Overall Study|Withdrawal by Subject|8|||
124972133|NCT00150618|449525533|FG002|Overall Study|Withdrawal by Subject|8|||
124972134|NCT00150618|449525534|FG003|Overall Study|Withdrawal by Subject|4|||
124972135|NCT00150618|449525535|FG004|Overall Study|Withdrawal by Subject|5|||
124972136|NCT00150618|449525531|FG000|Overall Study|Lost to Follow-up|4|||
124972137|NCT00150618|449525532|FG001|Overall Study|Lost to Follow-up|1|||
124972138|NCT00150618|449525533|FG002|Overall Study|Lost to Follow-up|5|||
124972139|NCT00150618|449525534|FG003|Overall Study|Lost to Follow-up|8|||
124972140|NCT00150618|449525535|FG004|Overall Study|Lost to Follow-up|4|||
124972141|NCT00150618|449525531|FG000|Overall Study|Protocol Violation|1|||
124972142|NCT00150618|449525532|FG001|Overall Study|Protocol Violation|0|||
124972143|NCT00150618|449525533|FG002|Overall Study|Protocol Violation|0|||
124972144|NCT00150618|449525534|FG003|Overall Study|Protocol Violation|0|||
124972145|NCT00150618|449525535|FG004|Overall Study|Protocol Violation|1|||
124972146|NCT00150618|449525531|FG000|Overall Study|Lack of Efficacy|1|||
124972147|NCT00150618|449525532|FG001|Overall Study|Lack of Efficacy|4|||
124972148|NCT00150618|449525533|FG002|Overall Study|Lack of Efficacy|7|||
124972149|NCT00150618|449525534|FG003|Overall Study|Lack of Efficacy|4|||
125035581|NCT01307423|449747984|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
125035582|NCT01307423|449747985|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
124972150|NCT00150618|449525535|FG004|Overall Study|Lack of Efficacy|6|||
124972151|NCT00150618|449525531|FG000|Overall Study|No study meds|0|||
125035583|NCT01307423|449747986|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
125035584|NCT01307423|449747987|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
125132303|NCT01111461|450111721|FG000|Overall Study|Other|6|||
124972152|NCT00150618|449525532|FG001|Overall Study|No study meds|0|||
124972153|NCT00150618|449525533|FG002|Overall Study|No study meds|0|||
125035585|NCT01307423|449747988|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
125035586|NCT01307423|449747989|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
125035587|NCT01307423|449747990|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
125035588|NCT01307423|449747991|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
125035589|NCT01307423|449747992|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
125035590|NCT01307423|449747984|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
125035591|NCT01307423|449747985|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
125035592|NCT01307423|449747986|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
125035593|NCT01307423|449747987|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
125035594|NCT01307423|449747988|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
125035595|NCT01307423|449747989|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
125035596|NCT01307423|449747990|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
125035597|NCT01307423|449747991|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
125035598|NCT01307423|449747992|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
125035599|NCT01307423|449747984|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
125035600|NCT01307423|449747985|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
125035601|NCT01307423|449747986|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
125035602|NCT01307423|449747987|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
125035603|NCT01307423|449747988|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
125035604|NCT01307423|449747989|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
125035605|NCT01307423|449747990|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
125035606|NCT01307423|449747991|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
125035607|NCT01307423|449747992|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
125035608|NCT01307423|449747984|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125035609|NCT01307423|449747985|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
125035610|NCT01307423|449747986|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
125035611|NCT01307423|449747987|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125035612|NCT01307423|449747988|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125035613|NCT01307423|449747989|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125035614|NCT01307423|449747990|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125035615|NCT01307423|449747991|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
125035616|NCT01307423|449747992|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
125035617|NCT01307423|449747984|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
125035618|NCT01307423|449747985|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
125035619|NCT01307423|449747986|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
125035620|NCT01307423|449747987|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
125035621|NCT01307423|449747988|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
125035622|NCT01307423|449747989|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
125035623|NCT01307423|449747990|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
125035624|NCT01307423|449747991|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
125035625|NCT01307423|449747992|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
125035626|NCT01307423|449747984|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
125035627|NCT01307423|449747985|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
125035628|NCT01307423|449747986|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
125035629|NCT01307423|449747987|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
125035630|NCT01307423|449747988|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
125035631|NCT01307423|449747989|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
125035632|NCT01307423|449747990|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
125035633|NCT01307423|449747991|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
125035634|NCT01307423|449747992|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
125035635|NCT01307423|449747984|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125035636|NCT01307423|449747985|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
125035637|NCT01307423|449747986|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
125035638|NCT01307423|449747987|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125035639|NCT01307423|449747988|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125035640|NCT01307423|449747989|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125035641|NCT01307423|449747990|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125035642|NCT01307423|449747991|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
125035643|NCT01307423|449747992|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
125035644|NCT01307423|449747984|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125035645|NCT01307423|449747985|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
125035646|NCT01307423|449747986|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125218064|NCT02959918|450425365|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125035647|NCT01307423|449747987|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125035648|NCT01307423|449747988|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125035649|NCT01307423|449747989|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
124972154|NCT00150618|449525534|FG003|Overall Study|No study meds|0|||
124972155|NCT00150618|449525535|FG004|Overall Study|No study meds|2|||
124972156|NCT00150618|449525531|FG000|Overall Study|Physician Decision|0|||
124972157|NCT00150618|449525532|FG001|Overall Study|Physician Decision|2|||
124972158|NCT00150618|449525533|FG002|Overall Study|Physician Decision|0|||
124972159|NCT00150618|449525534|FG003|Overall Study|Physician Decision|0|||
124972160|NCT00150618|449525535|FG004|Overall Study|Physician Decision|1|||
124972161|NCT00150618|449525531|FG000|Overall Study|Lack of compliance|2|||
124972162|NCT00150618|449525532|FG001|Overall Study|Lack of compliance|1|||
124972163|NCT00150618|449525533|FG002|Overall Study|Lack of compliance|1|||
124972164|NCT00150618|449525534|FG003|Overall Study|Lack of compliance|0|||
124972165|NCT00150618|449525535|FG004|Overall Study|Lack of compliance|1|||
124972166|NCT00150618|449525531|FG000|Overall Study|Abnormal ECG|1|||
124972167|NCT00150618|449525532|FG001|Overall Study|Abnormal ECG|0|||
124972168|NCT00150618|449525533|FG002|Overall Study|Abnormal ECG|0|||
124972169|NCT00150618|449525534|FG003|Overall Study|Abnormal ECG|0|||
124972170|NCT00150618|449525535|FG004|Overall Study|Abnormal ECG|0|||
124972171|NCT00150618|449525531|FG000|Overall Study|Sponsor's decision|0|||
124972172|NCT00150618|449525532|FG001|Overall Study|Sponsor's decision|0|||
124972173|NCT00150618|449525533|FG002|Overall Study|Sponsor's decision|0|||
124972174|NCT00150618|449525534|FG003|Overall Study|Sponsor's decision|1|||
124972175|NCT00150618|449525535|FG004|Overall Study|Sponsor's decision|0|||
124972176|NCT01012947|449525536|FG000|Overall Study|Lost to Follow-up|131|||
124972177|NCT01012947|449525537|FG001|Overall Study|Lost to Follow-up|135|||
124972178|NCT01012947|449525538|FG002|Overall Study|Lost to Follow-up|130|||
124972179|NCT01012947|449525539|FG003|Overall Study|Lost to Follow-up|118|||
124972180|NCT01012947|449525540|FG004|Overall Study|Lost to Follow-up|142|||
124972181|NCT01791413|449525541|FG000|Overall Study|Lost to Follow-up|5|||
124972182|NCT01791413|449525542|FG001|Overall Study|Lost to Follow-up|1|||
124972183|NCT00825305|449525544|FG000|Overall Study|Adverse Event|1|||
124972184|NCT00825305|449525545|FG001|Overall Study|Adverse Event|1|||
124972185|NCT00825305|449525544|FG000|Overall Study|Withdrawal by Subject|6|||
124972186|NCT00825305|449525545|FG001|Overall Study|Withdrawal by Subject|12|||
124972187|NCT00825305|449525544|FG000|Overall Study|Inappropriate inclusion|1|||
124972188|NCT00825305|449525545|FG001|Overall Study|Inappropriate inclusion|0|||
124972189|NCT00825305|449525544|FG000|Overall Study|Protocol Violation|9|||
124972190|NCT00825305|449525545|FG001|Overall Study|Protocol Violation|9|||
124972191|NCT00825305|449525544|FG000|Overall Study|Can not be classified|0|||
124972192|NCT00825305|449525545|FG001|Overall Study|Can not be classified|1|||
124972193|NCT04016272|449525546|FG000|Overall Study|Withdrawal by Subject|1|||
124972194|NCT04016272|449525547|FG001|Overall Study|Withdrawal by Subject|2|||
124972195|NCT02493946|449525550|FG000|DB Period|Withdrawal by Subject|8|||
124972196|NCT02493946|449525551|FG001|DB Period|Withdrawal by Subject|5|||
124972197|NCT02493946|449525552|FG002|DB Period|Withdrawal by Subject|0|||
124972198|NCT02493946|449525550|FG000|Open Label Period|Withdrawal by Subject|0|||
124972199|NCT02493946|449525551|FG001|Open Label Period|Withdrawal by Subject|0|||
124972200|NCT02493946|449525552|FG002|Open Label Period|Withdrawal by Subject|74|||
124972201|NCT02493946|449525550|FG000|Open Label Period|Adverse Event|0|||
124972202|NCT02493946|449525551|FG001|Open Label Period|Adverse Event|0|||
124972203|NCT02493946|449525552|FG002|Open Label Period|Adverse Event|4|||
124972204|NCT02493946|449525550|FG000|Open Label Period|Lost to Follow-up|0|||
124972205|NCT02493946|449525551|FG001|Open Label Period|Lost to Follow-up|0|||
124972206|NCT02493946|449525552|FG002|Open Label Period|Lost to Follow-up|1|||
124972207|NCT02493946|449525550|FG000|Open Label Period|Investigator decision, non-compliance|0|||
124972208|NCT02493946|449525551|FG001|Open Label Period|Investigator decision, non-compliance|0|||
124972209|NCT02493946|449525552|FG002|Open Label Period|Investigator decision, non-compliance|2|||
124972210|NCT02493946|449525550|FG000|Open Label Period|Investigator decision, non-availability|0|||
124972211|NCT02493946|449525551|FG001|Open Label Period|Investigator decision, non-availability|0|||
124972212|NCT02493946|449525552|FG002|Open Label Period|Investigator decision, non-availability|1|||
124972213|NCT02493946|449525550|FG000|Open Label Period|Pregnancy|0|||
124972214|NCT02493946|449525551|FG001|Open Label Period|Pregnancy|0|||
124972215|NCT02493946|449525552|FG002|Open Label Period|Pregnancy|3|||
124972216|NCT02493946|449525550|FG000|Open Label Period|Site error|0|||
124972217|NCT02493946|449525551|FG001|Open Label Period|Site error|0|||
124972218|NCT02493946|449525552|FG002|Open Label Period|Site error|1|||
124972219|NCT03355209|449525553|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
124972220|NCT03355209|449525554|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
124972221|NCT03355209|449525555|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
124972222|NCT03355209|449525556|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
124972223|NCT03355209|449525557|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
124972224|NCT03355209|449525558|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
124972225|NCT03355209|449525553|FG000|Part 1: Double-Blind Period|Death|0|||
124972226|NCT03355209|449525554|FG001|Part 1: Double-Blind Period|Death|0|||
124972227|NCT03355209|449525555|FG002|Part 1: Double-Blind Period|Death|1|||
124972228|NCT03355209|449525556|FG003|Part 1: Double-Blind Period|Death|0|||
124972229|NCT03355209|449525557|FG004|Part 1: Double-Blind Period|Death|0|||
125035650|NCT01307423|449747990|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
124972230|NCT03355209|449525558|FG005|Part 1: Double-Blind Period|Death|0|||
124972231|NCT03355209|449525553|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
124972232|NCT03355209|449525554|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
124972233|NCT03355209|449525555|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
124972234|NCT03355209|449525556|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
124972235|NCT03355209|449525557|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
124972236|NCT03355209|449525558|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
124972237|NCT03355209|449525553|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
124972238|NCT03355209|449525554|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
124972239|NCT03355209|449525555|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
124972240|NCT03355209|449525556|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
124972241|NCT03355209|449525557|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
124972242|NCT03355209|449525558|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
124972243|NCT03355209|449525553|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
124972244|NCT03355209|449525554|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
124972245|NCT03355209|449525555|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
124972246|NCT03355209|449525556|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
124972247|NCT03355209|449525557|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
124972248|NCT03355209|449525558|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
124972249|NCT03355209|449525553|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
124972250|NCT03355209|449525554|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
124972251|NCT03355209|449525555|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
124972252|NCT03355209|449525556|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
124972253|NCT03355209|449525557|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
124972254|NCT03355209|449525558|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
124972255|NCT03355209|449525553|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
124972256|NCT03355209|449525554|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
124972257|NCT03355209|449525555|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
124972258|NCT03355209|449525556|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
124972259|NCT03355209|449525557|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
124972260|NCT03355209|449525558|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
124972261|NCT03355209|449525553|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
124972262|NCT03355209|449525554|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
124972263|NCT03355209|449525555|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
124972264|NCT03355209|449525556|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
124972265|NCT03355209|449525557|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
124972266|NCT03355209|449525558|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
124972267|NCT03355209|449525553|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
124972268|NCT03355209|449525554|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
125132304|NCT00440518|450111723|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
125132305|NCT00440518|450111724|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
125132306|NCT00440518|450111725|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
125132307|NCT00440518|450111723|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
125132308|NCT00440518|450111724|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
125132309|NCT00440518|450111725|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
125132310|NCT00440518|450111723|FG000|Randomized /Titration Period|Protocol Deviation|1|||
125132311|NCT00440518|450111724|FG001|Randomized /Titration Period|Protocol Deviation|0|||
125132312|NCT00440518|450111725|FG002|Randomized /Titration Period|Protocol Deviation|0|||
125132313|NCT00440518|450111723|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
125132314|NCT00440518|450111724|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
125132315|NCT00440518|450111725|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
125132316|NCT00440518|450111723|FG000|Randomized /Titration Period|Other|1|||
125132317|NCT00440518|450111724|FG001|Randomized /Titration Period|Other|0|||
125132318|NCT00440518|450111725|FG002|Randomized /Titration Period|Other|0|||
125132319|NCT00440518|450111723|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
125132320|NCT00440518|450111724|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
125132321|NCT00440518|450111725|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
125132322|NCT00440518|450111723|FG000|Randomized /Titration Period|Adverse Event|2|||
125132323|NCT00440518|450111724|FG001|Randomized /Titration Period|Adverse Event|3|||
124972269|NCT03355209|449525555|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
124972270|NCT03355209|449525556|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
124972271|NCT03355209|449525557|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
125132324|NCT00440518|450111725|FG002|Randomized /Titration Period|Adverse Event|0|||
125132325|NCT00440518|450111723|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
125132326|NCT00440518|450111724|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
125132327|NCT00440518|450111725|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
125132328|NCT00440518|450111723|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
125132329|NCT00440518|450111724|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
125132330|NCT00440518|450111725|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
125132331|NCT00440518|450111723|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
125132332|NCT00440518|450111724|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
125132333|NCT00440518|450111725|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
125132334|NCT00440518|450111723|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
125132335|NCT00440518|450111724|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
125132336|NCT00440518|450111725|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
125132337|NCT00440518|450111723|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
125132338|NCT00440518|450111724|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
125132339|NCT00440518|450111725|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
125132340|NCT00440518|450111723|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
125132341|NCT00440518|450111724|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
125132342|NCT00440518|450111725|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
125132343|NCT00365365|450111726|FG000|Overall Study|Randomized but not treated|0|||
125132344|NCT00365365|450111727|FG001|Overall Study|Randomized but not treated|2|||
125132345|NCT00365365|450111728|FG002|Overall Study|Randomized but not treated|0|||
125132346|NCT00365365|450111726|FG000|Overall Study|Poor compliance to protocol|0|||
125132347|NCT00365365|450111727|FG001|Overall Study|Poor compliance to protocol|1|||
125132348|NCT00365365|450111728|FG002|Overall Study|Poor compliance to protocol|0|||
125132349|NCT00365365|450111726|FG000|Overall Study|Lost to Follow-up|3|||
125132350|NCT00365365|450111727|FG001|Overall Study|Lost to Follow-up|3|||
125132351|NCT00365365|450111728|FG002|Overall Study|Lost to Follow-up|3|||
125132352|NCT00365365|450111726|FG000|Overall Study|Death|1|||
125132353|NCT00365365|450111727|FG001|Overall Study|Death|3|||
125132354|NCT00365365|450111728|FG002|Overall Study|Death|0|||
125132355|NCT00365365|450111726|FG000|Overall Study|Subject's request|11|||
125132356|NCT00365365|450111727|FG001|Overall Study|Subject's request|13|||
125132357|NCT00365365|450111728|FG002|Overall Study|Subject's request|1|||
125132358|NCT00365365|450111726|FG000|Overall Study|Disease progression/relapse|9|||
125132359|NCT00365365|450111727|FG001|Overall Study|Disease progression/relapse|6|||
125132360|NCT00365365|450111728|FG002|Overall Study|Disease progression/relapse|7|||
125132361|NCT00365365|450111726|FG000|Overall Study|Adverse Event|6|||
125132362|NCT00365365|450111727|FG001|Overall Study|Adverse Event|6|||
125132363|NCT00365365|450111728|FG002|Overall Study|Adverse Event|3|||
125132364|NCT00365365|450111726|FG000|Overall Study|Moved|2|||
125132365|NCT00365365|450111727|FG001|Overall Study|Moved|0|||
125132366|NCT00365365|450111728|FG002|Overall Study|Moved|0|||
125132367|NCT00365365|450111726|FG000|Overall Study|New cancer|1|||
125132368|NCT00365365|450111727|FG001|Overall Study|New cancer|0|||
125132369|NCT00365365|450111728|FG002|Overall Study|New cancer|0|||
125132370|NCT00365365|450111726|FG000|Overall Study|Withdrew consent|1|||
125132371|NCT00365365|450111727|FG001|Overall Study|Withdrew consent|1|||
125132372|NCT00365365|450111728|FG002|Overall Study|Withdrew consent|0|||
125132373|NCT00365365|450111726|FG000|Overall Study|Second malignancy|0|||
125132374|NCT00365365|450111727|FG001|Overall Study|Second malignancy|1|||
125132375|NCT00365365|450111728|FG002|Overall Study|Second malignancy|0|||
125132376|NCT00365365|450111726|FG000|Overall Study|Patient/physician decision|0|||
125132377|NCT00365365|450111727|FG001|Overall Study|Patient/physician decision|0|||
125132378|NCT00365365|450111728|FG002|Overall Study|Patient/physician decision|1|||
125132379|NCT00984022|450111729|FG000|Overall Study|Lost to Follow-up|10|||
125132380|NCT00984022|450111730|FG001|Overall Study|Lost to Follow-up|14|||
125132381|NCT00905606|450111734|FG000|Period 1|Adverse Event|0|||
125132382|NCT00905606|450111735|FG001|Period 1|Adverse Event|1|||
125132383|NCT00905606|450111734|FG000|Washout|Withdrawal by Subject|1|||
125132384|NCT00905606|450111735|FG001|Washout|Withdrawal by Subject|0|||
125132385|NCT03868891|450111742|FG000|Overall Study|Adverse Event|1|||
125132386|NCT03868891|450111743|FG001|Overall Study|Adverse Event|0|||
125132387|NCT03868891|450111742|FG000|Overall Study|Lost to Follow-up|2|||
125132388|NCT03868891|450111743|FG001|Overall Study|Lost to Follow-up|1|||
125132389|NCT03868891|450111742|FG000|Overall Study|COVID-19 Restrictions|1|||
125132390|NCT03868891|450111743|FG001|Overall Study|COVID-19 Restrictions|2|||
125132391|NCT00777023|450111744|FG000|Overall Study|Adverse Event|15|||
125132392|NCT00777023|450111745|FG001|Overall Study|Adverse Event|21|||
125132393|NCT00777023|450111746|FG002|Overall Study|Adverse Event|8|||
125035651|NCT01307423|449747991|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
125035652|NCT01307423|449747992|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
125035653|NCT01307423|449747984|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
125035654|NCT01307423|449747985|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
125035655|NCT01307423|449747986|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
125035656|NCT01307423|449747987|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
125035657|NCT01307423|449747988|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
125035658|NCT01307423|449747989|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
125035659|NCT01307423|449747990|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
125035660|NCT01307423|449747991|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
125035661|NCT01307423|449747992|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
125035662|NCT01307423|449747984|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
125035663|NCT01307423|449747985|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
125035664|NCT01307423|449747986|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
125035665|NCT01307423|449747987|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
125035666|NCT01307423|449747988|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
125035667|NCT01307423|449747989|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
125035668|NCT01307423|449747990|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
125035669|NCT01307423|449747991|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
125035670|NCT01307423|449747992|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
125035671|NCT01307423|449747984|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
125035672|NCT01307423|449747985|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
125035673|NCT01307423|449747986|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
125035674|NCT01307423|449747987|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
125035675|NCT01307423|449747988|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
125035676|NCT01307423|449747989|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
125035677|NCT01307423|449747990|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
125035678|NCT01307423|449747991|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
125035679|NCT01307423|449747992|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
125035680|NCT01307423|449747984|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125035681|NCT01307423|449747985|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
125035682|NCT01307423|449747986|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
125035683|NCT01307423|449747987|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125035684|NCT01307423|449747988|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125035685|NCT01307423|449747989|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125035686|NCT01307423|449747990|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125035687|NCT01307423|449747991|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
125035688|NCT01307423|449747992|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
125035689|NCT01307423|449747984|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125035690|NCT01307423|449747985|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
125035691|NCT01307423|449747986|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
125035692|NCT01307423|449747987|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125035693|NCT01307423|449747988|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125035694|NCT01307423|449747989|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125035695|NCT01307423|449747990|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125035696|NCT01307423|449747991|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
125035697|NCT01307423|449747992|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
125035698|NCT01307423|449747984|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125035699|NCT01307423|449747985|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
125035700|NCT01307423|449747986|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125035701|NCT01307423|449747987|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125035702|NCT01307423|449747988|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125035703|NCT01307423|449747989|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125035704|NCT01307423|449747990|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125035705|NCT01307423|449747991|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
125035706|NCT01307423|449747992|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125035707|NCT01307423|449747984|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125035708|NCT01307423|449747985|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
125035709|NCT01307423|449747986|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125035710|NCT01307423|449747987|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125035711|NCT01307423|449747988|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125035712|NCT01307423|449747989|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125035713|NCT01307423|449747990|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125035714|NCT01307423|449747991|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125035715|NCT01307423|449747992|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125035716|NCT01307423|449747984|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125035717|NCT01307423|449747985|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
125218065|NCT02959918|450425366|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125035718|NCT01307423|449747986|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125035719|NCT01307423|449747987|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125035720|NCT01307423|449747988|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125035721|NCT01307423|449747989|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125035722|NCT01307423|449747990|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125035723|NCT01307423|449747991|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125035724|NCT01307423|449747992|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
125035725|NCT01307423|449747984|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125035726|NCT01307423|449747985|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
125035727|NCT01307423|449747986|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
125035728|NCT01307423|449747987|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125035729|NCT01307423|449747988|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125035730|NCT01307423|449747989|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125035731|NCT01307423|449747990|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125035732|NCT01307423|449747991|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
125035733|NCT01307423|449747992|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
125035734|NCT01307423|449747984|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125035735|NCT01307423|449747985|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125035736|NCT01307423|449747986|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
125035737|NCT01307423|449747987|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125035738|NCT01307423|449747988|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125035739|NCT01307423|449747989|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125035740|NCT01307423|449747990|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125035741|NCT01307423|449747991|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125035742|NCT01307423|449747992|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125035743|NCT01307423|449747984|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125035744|NCT01307423|449747985|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125035745|NCT01307423|449747986|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125035746|NCT01307423|449747987|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125035747|NCT01307423|449747988|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125035748|NCT01307423|449747989|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125035749|NCT01307423|449747990|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125035750|NCT01307423|449747991|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
125035751|NCT01307423|449747992|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125035752|NCT01307423|449747984|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125035753|NCT01307423|449747985|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
125035754|NCT01307423|449747986|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
125035755|NCT01307423|449747987|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125035756|NCT01307423|449747988|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125035757|NCT01307423|449747989|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125035758|NCT01307423|449747990|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125035759|NCT01307423|449747991|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125035760|NCT01307423|449747992|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
125035761|NCT01307423|449747984|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125035762|NCT01307423|449747985|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
125035763|NCT01307423|449747986|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
125035764|NCT01307423|449747987|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125035765|NCT01307423|449747988|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125035766|NCT01307423|449747989|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125035767|NCT01307423|449747990|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125035768|NCT01307423|449747991|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125035769|NCT01307423|449747992|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125035770|NCT01307423|449747984|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125035771|NCT01307423|449747985|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
125035772|NCT01307423|449747986|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
125035773|NCT01307423|449747987|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125035774|NCT01307423|449747988|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125035775|NCT01307423|449747989|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125035776|NCT01307423|449747990|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125035777|NCT01307423|449747991|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125035778|NCT01307423|449747992|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
125035779|NCT01307423|449747984|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
125035780|NCT01307423|449747985|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
125035781|NCT01307423|449747986|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
125035782|NCT01307423|449747987|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
125035783|NCT01307423|449747988|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
125035784|NCT01307423|449747989|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
125035785|NCT01307423|449747990|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
125218066|NCT02959918|450425367|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
125218067|NCT02959918|450425368|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125218068|NCT02959918|450425369|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125035786|NCT01307423|449747991|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
125035787|NCT01307423|449747992|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
125035788|NCT01307423|449747984|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125035789|NCT01307423|449747985|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125035790|NCT01307423|449747986|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
125035791|NCT01307423|449747987|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125218069|NCT02959918|450425370|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125218070|NCT02959918|450425371|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125218071|NCT02959918|450425372|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125218072|NCT02959918|450425359|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125218073|NCT02959918|450425360|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125218074|NCT02959918|450425361|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125218075|NCT02959918|450425362|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125218076|NCT02959918|450425363|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125218077|NCT02959918|450425364|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
124972272|NCT03355209|449525558|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
125035792|NCT01307423|449747988|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125035793|NCT01307423|449747989|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125035794|NCT01307423|449747990|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125035795|NCT01307423|449747991|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
125035796|NCT01307423|449747992|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
124972273|NCT03355209|449525553|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
124972274|NCT03355209|449525554|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
124972275|NCT03355209|449525555|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
124972276|NCT03355209|449525556|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
124972277|NCT03355209|449525557|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
124972278|NCT03355209|449525558|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
124972279|NCT03355209|449525553|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
124972280|NCT03355209|449525554|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
124972281|NCT03355209|449525555|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
124972282|NCT03355209|449525556|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
124972283|NCT03355209|449525557|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
124972284|NCT03355209|449525558|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
124972285|NCT01727505|449525560|FG000|First 24 Hours|Adverse Event|0|||
124972286|NCT01727505|449525561|FG001|First 24 Hours|Adverse Event|1|||
124972287|NCT01727505|449525560|FG000|Second 24 Hours|Missing data|0|||
124972288|NCT01727505|449525561|FG001|Second 24 Hours|Missing data|1|||
124972289|NCT02878603|449525562|FG000|Overall Study|Lost to Follow-up|4|||
124972290|NCT02878603|449525563|FG001|Overall Study|Lost to Follow-up|1|||
124972291|NCT02878603|449525562|FG000|Overall Study|Withdrawal by Subject|1|||
124972292|NCT02878603|449525563|FG001|Overall Study|Withdrawal by Subject|1|||
124972293|NCT02878603|449525562|FG000|Overall Study|Death|1|||
124972294|NCT02878603|449525563|FG001|Overall Study|Death|0|||
124972295|NCT02878603|449525562|FG000|Overall Study|Physician Decision|0|||
124972296|NCT02878603|449525563|FG001|Overall Study|Physician Decision|3|||
124972297|NCT00358644|449525564|FG000|Overall Study|Progressive Disease|21|||
124972298|NCT00358644|449525564|FG000|Overall Study|Adverse Event|7|||
125035797|NCT03075839|449747993|FG000|Overall Study|Lost to Follow-up|4|||
125035798|NCT01499290|449747994|FG000|Overall Study|Withdrawal by Subject|22|||
125035799|NCT01499290|449747995|FG001|Overall Study|Withdrawal by Subject|15|||
125035800|NCT01499290|449747994|FG000|Overall Study|Not specified in study report|11|||
125035801|NCT01499290|449747995|FG001|Overall Study|Not specified in study report|5|||
125035802|NCT01499290|449747994|FG000|Overall Study|Condition improved/subject recovered|1|||
125035803|NCT01499290|449747995|FG001|Overall Study|Condition improved/subject recovered|0|||
125035804|NCT01499290|449747994|FG000|Overall Study|Lack of Efficacy|7|||
125035805|NCT01499290|449747995|FG001|Overall Study|Lack of Efficacy|8|||
125035806|NCT01499290|449747994|FG000|Overall Study|Adverse Event|14|||
125035807|NCT01499290|449747995|FG001|Overall Study|Adverse Event|7|||
125035808|NCT04052139|449747996|FG000|Overall Study|Lost to Follow-up|2|||
125035809|NCT04052139|449747997|FG001|Overall Study|Lost to Follow-up|0|||
125035810|NCT04052139|449747998|FG002|Overall Study|Lost to Follow-up|0|||
125035811|NCT04052139|449747996|FG000|Overall Study|Withdrawal by Subject|1|||
125035812|NCT04052139|449747997|FG001|Overall Study|Withdrawal by Subject|0|||
125218078|NCT02959918|450425365|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
124972299|NCT00358644|449525564|FG000|Overall Study|Death|11|||
125132394|NCT00777023|450111744|FG000|Overall Study|Lack of Efficacy|1|||
125132395|NCT00777023|450111745|FG001|Overall Study|Lack of Efficacy|0|||
125132396|NCT00777023|450111746|FG002|Overall Study|Lack of Efficacy|14|||
125132397|NCT00777023|450111744|FG000|Overall Study|Protocol Violation|2|||
125132398|NCT00777023|450111745|FG001|Overall Study|Protocol Violation|1|||
125132399|NCT00777023|450111746|FG002|Overall Study|Protocol Violation|1|||
125132400|NCT00777023|450111744|FG000|Overall Study|Lost to Follow-up|2|||
125132401|NCT00777023|450111745|FG001|Overall Study|Lost to Follow-up|3|||
125132402|NCT00777023|450111746|FG002|Overall Study|Lost to Follow-up|3|||
125132403|NCT00777023|450111744|FG000|Overall Study|Death|0|||
125132404|NCT00777023|450111745|FG001|Overall Study|Death|1|||
125132405|NCT00777023|450111746|FG002|Overall Study|Death|0|||
125132406|NCT00777023|450111744|FG000|Overall Study|Withdrawal by Subject|7|||
125132407|NCT00777023|450111745|FG001|Overall Study|Withdrawal by Subject|7|||
124972300|NCT00358644|449525564|FG000|Overall Study|Withdrawal by Subject|4|||
124972301|NCT00358644|449525564|FG000|Overall Study|Physician Decision|6|||
124972302|NCT00358644|449525564|FG000|Overall Study|Patient not eligible for study|1|||
124972303|NCT03327831|449525565|FG000|Overall Study|Lost to Follow-up|2|||
124972304|NCT02838134|449525566|FG000|Overall Study|Lost to Follow-up|1|||
124972305|NCT02838134|449525567|FG001|Overall Study|Lost to Follow-up|2|||
125132408|NCT00777023|450111746|FG002|Overall Study|Withdrawal by Subject|8|||
125132409|NCT00777023|450111744|FG000|Overall Study|Missing data|1|||
125132410|NCT00777023|450111745|FG001|Overall Study|Missing data|1|||
125132411|NCT00777023|450111746|FG002|Overall Study|Missing data|0|||
125132412|NCT00777023|450111744|FG000|Overall Study|Reasons not specified|4|||
125132413|NCT00777023|450111745|FG001|Overall Study|Reasons not specified|4|||
125132414|NCT00777023|450111746|FG002|Overall Study|Reasons not specified|2|||
125132415|NCT00777023|450111744|FG000|Overall Study|Last dose date unknown|3|||
125132416|NCT00777023|450111745|FG001|Overall Study|Last dose date unknown|3|||
125132417|NCT00777023|450111746|FG002|Overall Study|Last dose date unknown|1|||
125132418|NCT03123094|450111747|FG000|Overall Study|Withdrawal by Subject|0|||
125218079|NCT02959918|450425366|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
124972306|NCT02838134|449525566|FG000|Overall Study|logistic problems|1|||
124972307|NCT02838134|449525567|FG001|Overall Study|logistic problems|1|||
124972308|NCT04674189|449525568|FG000|Overall Study|Adverse Event|0|||
124972309|NCT04674189|449525569|FG001|Overall Study|Adverse Event|0|||
124972310|NCT04674189|449525570|FG002|Overall Study|Adverse Event|1|||
124972311|NCT04674189|449525568|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
124972312|NCT04674189|449525569|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
124972313|NCT04674189|449525570|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
124972314|NCT04674189|449525568|FG000|Overall Study|Physician Decision|1|||
124972315|NCT04674189|449525569|FG001|Overall Study|Physician Decision|0|||
124972316|NCT04674189|449525570|FG002|Overall Study|Physician Decision|0|||
124972317|NCT04674189|449525568|FG000|Overall Study|Withdrawal by Participant|83|||
124972318|NCT04674189|449525569|FG001|Overall Study|Withdrawal by Participant|71|||
124972319|NCT04674189|449525570|FG002|Overall Study|Withdrawal by Participant|142|||
124972320|NCT04674189|449525568|FG000|Overall Study|Lost to Follow-up|55|||
124972321|NCT04674189|449525569|FG001|Overall Study|Lost to Follow-up|53|||
124972322|NCT04674189|449525570|FG002|Overall Study|Lost to Follow-up|44|||
124972323|NCT04674189|449525568|FG000|Overall Study|Miscellaneous|27|||
124972324|NCT04674189|449525569|FG001|Overall Study|Miscellaneous|23|||
124972325|NCT04674189|449525570|FG002|Overall Study|Miscellaneous|207|||
124972326|NCT04674189|449525568|FG000|Overall Study|Did Not Receive Treatment|3|||
124972327|NCT04674189|449525569|FG001|Overall Study|Did Not Receive Treatment|1|||
124972328|NCT04674189|449525570|FG002|Overall Study|Did Not Receive Treatment|2|||
124972329|NCT01564277|449525574|FG000|Overall Study|Protocol Violation|0|||
124972330|NCT01564277|449525575|FG001|Overall Study|Protocol Violation|1|||
124972331|NCT01564277|449525574|FG000|Overall Study|Physician Decision|1|||
124972332|NCT01564277|449525575|FG001|Overall Study|Physician Decision|0|||
124972333|NCT01637077|449525576|FG000|Overall Study|Cancel|1|||
124972334|NCT01637077|449525577|FG001|Overall Study|Cancel|1|||
124972335|NCT01637077|449525576|FG000|Overall Study|Withdrawal by Subject|1|||
124972336|NCT01637077|449525577|FG001|Overall Study|Withdrawal by Subject|0|||
125132419|NCT03123094|450111748|FG001|Overall Study|Withdrawal by Subject|2|||
125132420|NCT03123094|450111749|FG002|Overall Study|Withdrawal by Subject|1|||
125132421|NCT03123094|450111750|FG003|Overall Study|Withdrawal by Subject|0|||
125132422|NCT03123094|450111751|FG004|Overall Study|Withdrawal by Subject|1|||
125132423|NCT04247282|450111752|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
124972337|NCT01637077|449525576|FG000|Overall Study|No cycle 1 questionnaire data|2|||
124972338|NCT01637077|449525577|FG001|Overall Study|No cycle 1 questionnaire data|0|||
124972339|NCT00794924|449525578|FG000|Overall Study|Lost to Follow-up|6|||
125132424|NCT04247282|450111753|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
124972340|NCT00794924|449525579|FG001|Overall Study|Lost to Follow-up|8|||
124972341|NCT00794924|449525578|FG000|Overall Study|Withdrawal by Subject|48|||
124972342|NCT00794924|449525579|FG001|Overall Study|Withdrawal by Subject|60|||
125035813|NCT04052139|449747998|FG002|Overall Study|Withdrawal by Subject|0|||
125035814|NCT03896295|449747999|FG000|Overall Study|Adverse Event|0|||
125035815|NCT03896295|449748000|FG001|Overall Study|Adverse Event|1|||
125035816|NCT03896295|449747999|FG000|Overall Study|COVID-19|7|||
125035817|NCT03896295|449748000|FG001|Overall Study|COVID-19|29|||
125035818|NCT00700804|449748001|FG000|Overall Study|Withdrawal by Subject|1|||
125035819|NCT00700804|449748002|FG001|Overall Study|Withdrawal by Subject|2|||
125035820|NCT00700804|449748001|FG000|Overall Study|Protocol Violation|1|||
125035821|NCT00700804|449748002|FG001|Overall Study|Protocol Violation|1|||
125035822|NCT00700804|449748001|FG000|Overall Study|Loose Stools|1|||
125035823|NCT00700804|449748002|FG001|Overall Study|Loose Stools|1|||
125035824|NCT01511445|449748003|FG000|Overall Study|Lost to Follow-up|3|||
125035825|NCT01511445|449748004|FG001|Overall Study|Lost to Follow-up|1|||
125035826|NCT01511445|449748003|FG000|Overall Study|Protocol Violation|1|||
125035827|NCT01511445|449748004|FG001|Overall Study|Protocol Violation|3|||
125035828|NCT01511445|449748003|FG000|Overall Study|Protocol Violation|1|||
125035829|NCT01511445|449748004|FG001|Overall Study|Protocol Violation|0|||
125035830|NCT00998738|449748007|FG000|Overall Study|Uknown|1|||
125035831|NCT03946449|449748008|FG000|Treatment Extension II|Rolled over to another study|0|||
125035832|NCT03946449|449748009|FG001|Treatment Extension II|Rolled over to another study|0|||
125035833|NCT03946449|449748010|FG002|Treatment Extension II|Rolled over to another study|2|||
125035834|NCT03946449|449748008|FG000|Treatment Extension II|Withdrawal by Subject|0|||
125035835|NCT03946449|449748009|FG001|Treatment Extension II|Withdrawal by Subject|0|||
125035836|NCT03946449|449748010|FG002|Treatment Extension II|Withdrawal by Subject|1|||
125035837|NCT01609933|449750815|FG000|Overall Study|Adverse Event|1|||
125035838|NCT01609933|449750815|FG000|Overall Study|Withdrawal by Subject|3|||
125035839|NCT00224016|449750816|FG000|Titration Period|Withdrawal by Subject|0|||
125132425|NCT04247282|450111754|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
125132426|NCT04247282|450111755|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
125132427|NCT04247282|450111752|FG000|Overall Study|Refused further treatment|0|||
125132428|NCT04247282|450111753|FG001|Overall Study|Refused further treatment|1|||
125132429|NCT04247282|450111754|FG002|Overall Study|Refused further treatment|0|||
125132430|NCT04247282|450111755|FG003|Overall Study|Refused further treatment|0|||
125132431|NCT03496623|450111760|FG000|Run-In Period (2 Weeks)|Death|1|||
125132432|NCT03496623|450111761|FG001|Run-In Period (2 Weeks)|Death|0|||
125132433|NCT03496623|450111762|FG002|Run-In Period (2 Weeks)|Death|0|||
125132434|NCT03496623|450111763|FG003|Run-In Period (2 Weeks)|Death|0|||
125132435|NCT03496623|450111764|FG004|Run-In Period (2 Weeks)|Death|0|||
125132436|NCT03496623|450111760|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
125132437|NCT03496623|450111761|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
125132438|NCT03496623|450111762|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
125132439|NCT03496623|450111763|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
125132440|NCT03496623|450111764|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
125132441|NCT03496623|450111760|FG000|Period 1 (12 Weeks)|Death|0|||
125132442|NCT03496623|450111761|FG001|Period 1 (12 Weeks)|Death|3|||
125132443|NCT03496623|450111762|FG002|Period 1 (12 Weeks)|Death|0|||
125132444|NCT03496623|450111763|FG003|Period 1 (12 Weeks)|Death|0|||
125132445|NCT03496623|450111764|FG004|Period 1 (12 Weeks)|Death|0|||
125132446|NCT03496623|450111760|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
125132447|NCT03496623|450111761|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
125132448|NCT03496623|450111762|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
125132449|NCT03496623|450111763|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
125132450|NCT03496623|450111764|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
125132451|NCT03496623|450111760|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
125132452|NCT03496623|450111761|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
125132453|NCT03496623|450111762|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
125132454|NCT03496623|450111763|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
125132455|NCT03496623|450111764|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
125132456|NCT03496623|450111760|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
125218080|NCT02959918|450425367|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125218081|NCT02959918|450425368|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
125132457|NCT03496623|450111761|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
125132458|NCT03496623|450111762|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
125132459|NCT03496623|450111763|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
125132460|NCT03496623|450111764|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
125035840|NCT00224016|449750817|FG001|Titration Period|Withdrawal by Subject|1|||
125035841|NCT00224016|449750816|FG000|Titration Period|Lost to Follow-up|1|||
125035842|NCT00224016|449750817|FG001|Titration Period|Lost to Follow-up|0|||
125035843|NCT00224016|449750816|FG000|Maintenance Period|Withdrawal by Subject|2|||
125035844|NCT00224016|449750817|FG001|Maintenance Period|Withdrawal by Subject|0|||
125035845|NCT00224016|449750816|FG000|Maintenance Period|Lost to Follow-up|0|||
125035846|NCT00224016|449750817|FG001|Maintenance Period|Lost to Follow-up|1|||
125035847|NCT01252966|449750818|FG000|Overall Study|Lost to Follow-up|16|||
125035848|NCT01252966|449750819|FG001|Overall Study|Lost to Follow-up|10|||
125035849|NCT01252966|449750818|FG000|Overall Study|Withdrawal by Subject|7|||
125035850|NCT01252966|449750819|FG001|Overall Study|Withdrawal by Subject|3|||
125035851|NCT00206726|449750826|FG000|Overall Study|Delayed recovery of blood counts|1|||
125035852|NCT00206726|449750826|FG000|Overall Study|Progressive disease or relapsed disease|18|||
125035853|NCT00206726|449750826|FG000|Overall Study|Placed on new protocol|1|||
125035854|NCT00206726|449750826|FG000|Overall Study|Bone marrow transplant|1|||
125035855|NCT00206726|449750826|FG000|Overall Study|Adverse Event|17|||
125035856|NCT00206726|449750826|FG000|Overall Study|Death|4|||
125035857|NCT00206726|449750826|FG000|Overall Study|Protocol Violation|1|||
125035858|NCT00206726|449750826|FG000|Overall Study|Withdrawal by Subject|8|||
125035859|NCT01028352|449750829|FG000|Overall Study|Ineligible due to baseline average pain|5|||
125035860|NCT01028352|449750829|FG000|Overall Study|Withdrawal by Subject|1|||
125035861|NCT02091440|449750831|FG000|Overall Study|Death|2|||
125035862|NCT00768222|449750832|FG000|Overall Study|Lost to Follow-up|1|||
125035863|NCT00768222|449750833|FG001|Overall Study|Lost to Follow-up|1|||
125035864|NCT00768222|449750832|FG000|Overall Study|Withdrawal by Subject|3|||
125035865|NCT00768222|449750833|FG001|Overall Study|Withdrawal by Subject|1|||
125035866|NCT00768222|449750832|FG000|Overall Study|Protocol Violation|0|||
125035867|NCT00768222|449750833|FG001|Overall Study|Protocol Violation|2|||
125035868|NCT00278629|449750840|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
125035869|NCT03263091|449750842|FG000|OL Component|Withdrawal by Subject|1|||
125035870|NCT03263091|449750843|FG001|OL Component|Withdrawal by Subject|1|||
125035871|NCT03263091|449750844|FG002|OL Component|Withdrawal by Subject|0|||
125035872|NCT03263091|449750845|FG003|OL Component|Withdrawal by Subject|0|||
125035873|NCT03263091|449750846|FG004|OL Component|Withdrawal by Subject|0|||
125035874|NCT03263091|449750847|FG005|OL Component|Withdrawal by Subject|0|||
125035875|NCT03263091|449750842|FG000|OL Component|Physician Decision|0|||
125035876|NCT03263091|449750843|FG001|OL Component|Physician Decision|1|||
125035877|NCT03263091|449750844|FG002|OL Component|Physician Decision|2|||
125035878|NCT03263091|449750845|FG003|OL Component|Physician Decision|0|||
125035879|NCT03263091|449750846|FG004|OL Component|Physician Decision|0|||
125035880|NCT03263091|449750847|FG005|OL Component|Physician Decision|0|||
125035881|NCT03263091|449750842|FG000|OL Component|Death|1|||
125035882|NCT03263091|449750843|FG001|OL Component|Death|0|||
125035883|NCT03263091|449750844|FG002|OL Component|Death|0|||
125035884|NCT03263091|449750845|FG003|OL Component|Death|0|||
125035885|NCT03263091|449750846|FG004|OL Component|Death|0|||
125035886|NCT03263091|449750847|FG005|OL Component|Death|0|||
125035887|NCT03263091|449750842|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
125035888|NCT03263091|449750843|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
125035889|NCT03263091|449750844|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
125035890|NCT03263091|449750845|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
125035891|NCT03263091|449750846|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
125035892|NCT03263091|449750847|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
125035893|NCT03263091|449750842|FG000|OL High-EPO Component|Physician Decision|0|||
125035894|NCT03263091|449750843|FG001|OL High-EPO Component|Physician Decision|0|||
125132461|NCT03496623|450111760|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
125132462|NCT03496623|450111761|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
125132463|NCT03496623|450111762|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
125132464|NCT03496623|450111763|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
125132465|NCT03496623|450111764|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
125132466|NCT03496623|450111760|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
125132467|NCT03496623|450111761|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
125132468|NCT03496623|450111762|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
125132469|NCT03496623|450111763|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
125132470|NCT03496623|450111764|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
125132471|NCT03496623|450111760|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125132472|NCT03496623|450111761|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
125132473|NCT03496623|450111762|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
125132474|NCT03496623|450111763|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125132475|NCT03496623|450111764|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125035895|NCT03263091|449750844|FG002|OL High-EPO Component|Physician Decision|0|||
125035896|NCT03263091|449750845|FG003|OL High-EPO Component|Physician Decision|1|||
125035897|NCT03263091|449750846|FG004|OL High-EPO Component|Physician Decision|0|||
125035898|NCT03263091|449750847|FG005|OL High-EPO Component|Physician Decision|0|||
125035899|NCT03263091|449750842|FG000|OL High-EPO Component|Death|0|||
125035900|NCT03263091|449750843|FG001|OL High-EPO Component|Death|0|||
125035901|NCT03263091|449750844|FG002|OL High-EPO Component|Death|0|||
125132476|NCT01037114|450111765|FG000|Year 20|Others|1|||
125132477|NCT03181594|450111773|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
125035902|NCT03263091|449750845|FG003|OL High-EPO Component|Death|3|||
125035903|NCT03263091|449750846|FG004|OL High-EPO Component|Death|0|||
125035904|NCT03263091|449750847|FG005|OL High-EPO Component|Death|0|||
125035905|NCT03263091|449750842|FG000|DB Component|Withdrawal by Subject|0|||
125035906|NCT03263091|449750843|FG001|DB Component|Withdrawal by Subject|0|||
125035907|NCT03263091|449750844|FG002|DB Component|Withdrawal by Subject|0|||
125035908|NCT03263091|449750845|FG003|DB Component|Withdrawal by Subject|0|||
125035909|NCT03263091|449750846|FG004|DB Component|Withdrawal by Subject|22|||
125035910|NCT03263091|449750847|FG005|DB Component|Withdrawal by Subject|8|||
125035911|NCT03263091|449750842|FG000|DB Component|Physician Decision|0|||
125035912|NCT03263091|449750843|FG001|DB Component|Physician Decision|0|||
125035913|NCT03263091|449750844|FG002|DB Component|Physician Decision|0|||
125035914|NCT03263091|449750845|FG003|DB Component|Physician Decision|0|||
125035915|NCT03263091|449750846|FG004|DB Component|Physician Decision|3|||
125035916|NCT03263091|449750847|FG005|DB Component|Physician Decision|1|||
125035917|NCT03263091|449750842|FG000|DB Component|Adverse Event|0|||
125035918|NCT03263091|449750843|FG001|DB Component|Adverse Event|0|||
125035919|NCT03263091|449750844|FG002|DB Component|Adverse Event|0|||
125035920|NCT03263091|449750845|FG003|DB Component|Adverse Event|0|||
125035921|NCT03263091|449750846|FG004|DB Component|Adverse Event|2|||
125035922|NCT03263091|449750847|FG005|DB Component|Adverse Event|1|||
125035923|NCT03263091|449750842|FG000|DB Component|Lost to Follow-up|0|||
125035924|NCT03263091|449750843|FG001|DB Component|Lost to Follow-up|0|||
125035925|NCT03263091|449750844|FG002|DB Component|Lost to Follow-up|0|||
125035926|NCT03263091|449750845|FG003|DB Component|Lost to Follow-up|0|||
125035927|NCT03263091|449750846|FG004|DB Component|Lost to Follow-up|2|||
125035928|NCT03263091|449750847|FG005|DB Component|Lost to Follow-up|1|||
125035929|NCT03263091|449750842|FG000|DB Component|Death|0|||
125035930|NCT03263091|449750843|FG001|DB Component|Death|0|||
125035931|NCT03263091|449750844|FG002|DB Component|Death|0|||
125035932|NCT03263091|449750845|FG003|DB Component|Death|0|||
125035933|NCT03263091|449750846|FG004|DB Component|Death|7|||
125035934|NCT03263091|449750847|FG005|DB Component|Death|4|||
125035935|NCT03263091|449750842|FG000|DB Component|Other than specified|0|||
125035936|NCT03263091|449750843|FG001|DB Component|Other than specified|0|||
125035937|NCT03263091|449750844|FG002|DB Component|Other than specified|0|||
125035938|NCT03263091|449750845|FG003|DB Component|Other than specified|0|||
125035939|NCT03263091|449750846|FG004|DB Component|Other than specified|8|||
125035940|NCT03263091|449750847|FG005|DB Component|Other than specified|6|||
125035941|NCT02468193|449750848|FG000|Overall Study|Adverse Event|4|||
125035942|NCT02468193|449750848|FG000|Overall Study|Subject/ Guardian decision|2|||
125035943|NCT00742781|449750849|FG000|Overall Study|Withdrawal by Subject|3|||
125035944|NCT00826748|449750850|FG000|Overall Study|Withdrawal by Subject|0|||
125035945|NCT00826748|449750851|FG001|Overall Study|Withdrawal by Subject|0|||
125035946|NCT00826748|449750852|FG002|Overall Study|Withdrawal by Subject|2|||
125035947|NCT00826748|449750850|FG000|Overall Study|Physician Decision|0|||
125035948|NCT00826748|449750851|FG001|Overall Study|Physician Decision|0|||
125035949|NCT00826748|449750852|FG002|Overall Study|Physician Decision|1|||
125035950|NCT00826748|449750850|FG000|Overall Study|Samples Did Not pass QC|0|||
125035951|NCT00826748|449750851|FG001|Overall Study|Samples Did Not pass QC|0|||
125035952|NCT00826748|449750852|FG002|Overall Study|Samples Did Not pass QC|1|||
125035953|NCT03312218|449750855|FG000|Overall Study|Never signed in to access the app|54|||
125035954|NCT03312218|449750856|FG001|Overall Study|Never signed in to access the app|58|||
125035955|NCT01887912|449750858|FG000|Overall Study|Serious adverse event|400|||
125035956|NCT01887912|449750859|FG001|Overall Study|Serious adverse event|198|||
125035957|NCT01887912|449750858|FG000|Overall Study|Other Adverse Event|34|||
125035958|NCT01887912|449750859|FG001|Overall Study|Other Adverse Event|15|||
125035959|NCT01887912|449750858|FG000|Overall Study|Protocol Violation|67|||
125035960|NCT01887912|449750859|FG001|Overall Study|Protocol Violation|37|||
125035961|NCT01887912|449750858|FG000|Overall Study|Lost to Follow-up|163|||
125035962|NCT01887912|449750859|FG001|Overall Study|Lost to Follow-up|74|||
125035963|NCT01887912|449750858|FG000|Overall Study|Withdrawal by Subject|606|||
125035964|NCT01887912|449750859|FG001|Overall Study|Withdrawal by Subject|349|||
125035965|NCT01887912|449750858|FG000|Overall Study|Other|122|||
125035966|NCT01887912|449750859|FG001|Overall Study|Other|58|||
125035967|NCT05067127|449750862|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
125035968|NCT05067127|449750863|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
125035969|NCT05067127|449750864|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
125035970|NCT05067127|449750865|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
125035971|NCT05067127|449750862|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
125035972|NCT05067127|449750863|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
125035973|NCT05067127|449750864|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
125035974|NCT05067127|449750865|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
125035975|NCT05067127|449750862|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
125035976|NCT05067127|449750863|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
124972343|NCT00794924|449525578|FG000|Overall Study|Adverse Event|6|||
124972344|NCT00794924|449525579|FG001|Overall Study|Adverse Event|2|||
124972345|NCT01594970|449525580|FG000|Overall Study|Non-Adverse Event Related|4|||
124972346|NCT01594970|449525581|FG001|Overall Study|Non-Adverse Event Related|5|||
124972347|NCT01594970|449525582|FG002|Overall Study|Non-Adverse Event Related|6|||
124972348|NCT01594970|449525580|FG000|Overall Study|Adverse Event|17|||
124972349|NCT01594970|449525581|FG001|Overall Study|Adverse Event|23|||
124972350|NCT01594970|449525582|FG002|Overall Study|Adverse Event|23|||
124972351|NCT01594970|449525580|FG000|Overall Study|Lost to Follow-up|54|||
124972352|NCT01594970|449525581|FG001|Overall Study|Lost to Follow-up|54|||
124972353|NCT01594970|449525582|FG002|Overall Study|Lost to Follow-up|37|||
124972354|NCT03332784|449525585|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972355|NCT03332784|449525586|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
124972356|NCT03332784|449525587|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972357|NCT03332784|449525588|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972358|NCT03332784|449525589|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972359|NCT03332784|449525590|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972360|NCT03332784|449525591|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972361|NCT03332784|449525592|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
125132478|NCT03181594|450111773|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
125132479|NCT03181594|450111773|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
125132480|NCT03181594|450111773|FG000|Initial Study Protocol (12-month FU)|Death|1|||
125132481|NCT03181594|450111773|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
125132482|NCT03181594|450111773|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
125132483|NCT03247972|450111775|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
125132484|NCT03247972|450111775|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
125132485|NCT00968812|450111776|FG000|Overall Study|Adverse Event|30|||
125132486|NCT00968812|450111777|FG001|Overall Study|Adverse Event|46|||
125132487|NCT00968812|450111778|FG002|Overall Study|Adverse Event|33|||
124972362|NCT03332784|449525593|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972363|NCT03332784|449525594|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972364|NCT03332784|449525595|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972365|NCT03332784|449525596|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972366|NCT03332784|449525597|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972367|NCT03332784|449525598|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972368|NCT03332784|449525599|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
124972369|NCT03332784|449525600|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972370|NCT03332784|449525601|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972371|NCT03332784|449525602|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972372|NCT03332784|449525603|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972373|NCT03332784|449525604|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972374|NCT02498236|449525610|FG000|Overall Study|Did not show for testing|1|||
124972375|NCT02498236|449525611|FG001|Overall Study|Did not show for testing|0|||
124972376|NCT02498236|449525612|FG002|Overall Study|Did not show for testing|0|||
124972377|NCT02498236|449525613|FG003|Overall Study|Did not show for testing|0|||
124972378|NCT02498236|449525614|FG004|Overall Study|Did not show for testing|0|||
124972379|NCT02498236|449525615|FG005|Overall Study|Did not show for testing|0|||
124972380|NCT02498236|449525616|FG006|Overall Study|Did not show for testing|0|||
124972381|NCT02498236|449525617|FG007|Overall Study|Did not show for testing|1|||
125132488|NCT00968812|450111776|FG000|Overall Study|Death|2|||
125132489|NCT00968812|450111777|FG001|Overall Study|Death|2|||
125132490|NCT00968812|450111778|FG002|Overall Study|Death|1|||
125132491|NCT00968812|450111776|FG000|Overall Study|Lack of Efficacy|9|||
125132492|NCT00968812|450111777|FG001|Overall Study|Lack of Efficacy|7|||
125132493|NCT00968812|450111778|FG002|Overall Study|Lack of Efficacy|16|||
125132494|NCT00968812|450111776|FG000|Overall Study|Lost to Follow-up|17|||
125132495|NCT00968812|450111777|FG001|Overall Study|Lost to Follow-up|12|||
125132496|NCT00968812|450111778|FG002|Overall Study|Lost to Follow-up|11|||
125132497|NCT00968812|450111776|FG000|Overall Study|Physician Decision|8|||
125132498|NCT00968812|450111777|FG001|Overall Study|Physician Decision|5|||
125132499|NCT00968812|450111778|FG002|Overall Study|Physician Decision|9|||
125132500|NCT00968812|450111776|FG000|Overall Study|Protocol Violation|7|||
125132501|NCT00968812|450111777|FG001|Overall Study|Protocol Violation|4|||
125132502|NCT00968812|450111778|FG002|Overall Study|Protocol Violation|3|||
125132503|NCT00968812|450111776|FG000|Overall Study|Withdrawal by Subject|17|||
125132504|NCT00968812|450111777|FG001|Overall Study|Withdrawal by Subject|23|||
125132505|NCT00968812|450111778|FG002|Overall Study|Withdrawal by Subject|25|||
125132506|NCT00968812|450111776|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
125132507|NCT00968812|450111777|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
125132508|NCT00968812|450111778|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
125132509|NCT00968812|450111776|FG000|Overall Study|Noncompliance with study drug|4|||
125132510|NCT00968812|450111777|FG001|Overall Study|Noncompliance with study drug|1|||
125132511|NCT00968812|450111778|FG002|Overall Study|Noncompliance with study drug|6|||
125035977|NCT05067127|449750864|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
125035978|NCT05067127|449750865|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
125035979|NCT05067127|449750862|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
125035980|NCT05067127|449750863|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
125035981|NCT05067127|449750864|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
125035982|NCT05067127|449750865|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
125035983|NCT05067127|449750862|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
125035984|NCT05067127|449750863|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
125035985|NCT05067127|449750864|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
125035986|NCT05067127|449750865|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
125035987|NCT05067127|449750862|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
125035988|NCT05067127|449750863|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
125035989|NCT05067127|449750864|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
125035990|NCT05067127|449750865|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
125035991|NCT05067127|449750862|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
125035992|NCT05067127|449750863|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
125035993|NCT05067127|449750864|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
125035994|NCT05067127|449750865|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
125035995|NCT04462536|449750866|FG000|Overall Study|Withdrawal by Subject|3|||
125035996|NCT04462536|449750867|FG001|Overall Study|Withdrawal by Subject|9|||
125035997|NCT04462536|449750866|FG000|Overall Study|Lost to Follow-up|2|||
125035998|NCT04462536|449750867|FG001|Overall Study|Lost to Follow-up|4|||
125035999|NCT01154101|449750873|FG000|Overall Study|Adverse Event|0|||
125036000|NCT01154101|449750874|FG001|Overall Study|Adverse Event|2|||
125132512|NCT00968812|450111776|FG000|Overall Study|Unable to take rescue therapy|12|||
125132513|NCT00968812|450111777|FG001|Overall Study|Unable to take rescue therapy|12|||
125132514|NCT00968812|450111778|FG002|Overall Study|Unable to take rescue therapy|17|||
125132515|NCT00968812|450111776|FG000|Overall Study|Other|25|||
125132516|NCT00968812|450111777|FG001|Overall Study|Other|37|||
125132517|NCT00968812|450111778|FG002|Overall Study|Other|40|||
125132518|NCT00123734|450111783|FG000|Overall Study|Death|3|||
125132519|NCT00123734|450111783|FG000|Overall Study|Lost to Follow-up|3|||
125132520|NCT00123734|450111783|FG000|Overall Study|Dropout|1|||
125132521|NCT00123734|450111783|FG000|Overall Study|Withdrawal by Subject|1|||
125132522|NCT00113386|450111784|FG000|Overall Study|Withdrawal by Subject|1|||
125132523|NCT00113386|450111785|FG001|Overall Study|Withdrawal by Subject|0|||
125132524|NCT00113386|450111784|FG000|Overall Study|Physician Decision|0|||
125132525|NCT00113386|450111785|FG001|Overall Study|Physician Decision|1|||
125132526|NCT00113386|450111784|FG000|Overall Study|Toxicity|3|||
125132527|NCT00113386|450111785|FG001|Overall Study|Toxicity|0|||
125132528|NCT00113386|450111784|FG000|Overall Study|Ineligible|1|||
125132529|NCT00113386|450111785|FG001|Overall Study|Ineligible|2|||
125132530|NCT00113386|450111784|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
125132531|NCT00113386|450111785|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
125132532|NCT00640562|450111786|FG000|Overall Study|Adverse Event|8|||
125132533|NCT00640562|450111787|FG001|Overall Study|Adverse Event|5|||
125132534|NCT00640562|450111786|FG000|Overall Study|Lack of Efficacy|1|||
125132535|NCT00640562|450111787|FG001|Overall Study|Lack of Efficacy|4|||
125132536|NCT00640562|450111786|FG000|Overall Study|Protocol Violation|2|||
125132537|NCT00640562|450111787|FG001|Overall Study|Protocol Violation|4|||
125132538|NCT00640562|450111786|FG000|Overall Study|Withdrawal by Subject|6|||
125132539|NCT00640562|450111787|FG001|Overall Study|Withdrawal by Subject|10|||
125132540|NCT00640562|450111786|FG000|Overall Study|Known risperidone intolerance|0|||
125132541|NCT00640562|450111787|FG001|Overall Study|Known risperidone intolerance|1|||
125132542|NCT00640562|450111786|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
125132543|NCT00640562|450111787|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
125132544|NCT00640562|450111786|FG000|Overall Study|Low study drug dose|0|||
125036001|NCT01154101|449750875|FG002|Overall Study|Adverse Event|1|||
125036002|NCT01154101|449750876|FG003|Overall Study|Adverse Event|1|||
125036003|NCT01154101|449750877|FG004|Overall Study|Adverse Event|0|||
125132545|NCT00640562|450111787|FG001|Overall Study|Low study drug dose|1|||
125132546|NCT00640562|450111786|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
125132547|NCT00640562|450111787|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
125132548|NCT02937870|450111788|FG000|Overall Study|Adverse Event|1|||
125132549|NCT02937870|450111788|FG000|Overall Study|Protocol Deviation|2|||
125132550|NCT00609674|450111792|FG000|Overall Study|Adverse Event|1|||
125132551|NCT00609674|450111793|FG001|Overall Study|Adverse Event|1|||
125132552|NCT00609674|450111792|FG000|Overall Study|Protocol Violation|3|||
125132553|NCT00609674|450111793|FG001|Overall Study|Protocol Violation|5|||
124972382|NCT02498236|449525610|FG000|Overall Study|Equipment failure|0|||
124972383|NCT02498236|449525611|FG001|Overall Study|Equipment failure|0|||
124972384|NCT02498236|449525612|FG002|Overall Study|Equipment failure|0|||
124972385|NCT02498236|449525613|FG003|Overall Study|Equipment failure|0|||
124972386|NCT02498236|449525614|FG004|Overall Study|Equipment failure|0|||
124972387|NCT02498236|449525615|FG005|Overall Study|Equipment failure|0|||
124972388|NCT02498236|449525616|FG006|Overall Study|Equipment failure|1|||
124972389|NCT02498236|449525617|FG007|Overall Study|Equipment failure|0|||
124972390|NCT02498236|449525610|FG000|Overall Study|Withdrawal by Subject|0|||
124972391|NCT02498236|449525611|FG001|Overall Study|Withdrawal by Subject|0|||
124972392|NCT02498236|449525612|FG002|Overall Study|Withdrawal by Subject|0|||
124972393|NCT02498236|449525613|FG003|Overall Study|Withdrawal by Subject|0|||
124972394|NCT02498236|449525614|FG004|Overall Study|Withdrawal by Subject|1|||
124972395|NCT02498236|449525615|FG005|Overall Study|Withdrawal by Subject|0|||
124972396|NCT02498236|449525616|FG006|Overall Study|Withdrawal by Subject|0|||
124972397|NCT02498236|449525617|FG007|Overall Study|Withdrawal by Subject|0|||
124972398|NCT00383123|449525618|FG000|Overall Study|Adverse Event|1|||
124972399|NCT00383123|449525619|FG001|Overall Study|Adverse Event|0|||
124972400|NCT00383123|449525618|FG000|Overall Study|Lost to Follow-up|68|||
124972401|NCT00383123|449525619|FG001|Overall Study|Lost to Follow-up|61|||
124972402|NCT00383123|449525618|FG000|Overall Study|Protocol Violation|5|||
124972403|NCT00383123|449525619|FG001|Overall Study|Protocol Violation|1|||
125036004|NCT01154101|449750873|FG000|Overall Study|Lost to Follow-up|0|||
125036005|NCT01154101|449750874|FG001|Overall Study|Lost to Follow-up|1|||
125036006|NCT01154101|449750875|FG002|Overall Study|Lost to Follow-up|0|||
125036007|NCT01154101|449750876|FG003|Overall Study|Lost to Follow-up|1|||
125036008|NCT01154101|449750877|FG004|Overall Study|Lost to Follow-up|0|||
125036009|NCT01154101|449750873|FG000|Overall Study|Withdrawal by Subject|0|||
125036010|NCT01154101|449750874|FG001|Overall Study|Withdrawal by Subject|1|||
125036011|NCT01154101|449750875|FG002|Overall Study|Withdrawal by Subject|2|||
125036012|NCT01154101|449750876|FG003|Overall Study|Withdrawal by Subject|0|||
125036013|NCT01154101|449750877|FG004|Overall Study|Withdrawal by Subject|1|||
125036014|NCT01562028|449750878|FG000|Overall Study|Withdrawal by Subject|1|||
125036015|NCT01562028|449750879|FG001|Overall Study|Withdrawal by Subject|1|||
125036016|NCT01562028|449750878|FG000|Overall Study|Lost to Follow-up|2|||
125036017|NCT01562028|449750879|FG001|Overall Study|Lost to Follow-up|1|||
125036018|NCT02360098|449750880|FG000|Overall Study|Physician Decision|7|||
125036019|NCT04439266|449750891|FG000|Overall Study|Ineligible|1|||
125036020|NCT04439266|449750891|FG000|Overall Study|Adverse Event|1|||
125036021|NCT04439266|449750891|FG000|Overall Study|Death|1|||
125036022|NCT04439266|449750891|FG000|Overall Study|Disease progression|1|||
125036023|NCT04439266|449750891|FG000|Overall Study|Still on treatment|1|||
125036024|NCT05040971|449750894|FG000|Overall Study|Withdrawal by Subject|0|||
125036025|NCT05040971|449750895|FG001|Overall Study|Withdrawal by Subject|2|||
125036026|NCT05040971|449750894|FG000|Overall Study|Lost to Follow-up|8|||
125036027|NCT05040971|449750895|FG001|Overall Study|Lost to Follow-up|3|||
125036028|NCT05040971|449750894|FG000|Overall Study|Death|2|||
125036029|NCT05040971|449750895|FG001|Overall Study|Death|0|||
125036030|NCT06161012|449750896|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
125036031|NCT06161012|449750897|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
125036032|NCT04889209|449750900|FG000|All Cohorts Except 15E|Adverse Event|0|||
125036033|NCT04889209|449750901|FG001|All Cohorts Except 15E|Adverse Event|0|||
125036034|NCT04889209|449750902|FG002|All Cohorts Except 15E|Adverse Event|0|||
125036035|NCT04889209|449750903|FG003|All Cohorts Except 15E|Adverse Event|0|||
125036036|NCT04889209|449750904|FG004|All Cohorts Except 15E|Adverse Event|0|||
125036037|NCT04889209|449750905|FG005|All Cohorts Except 15E|Adverse Event|0|||
125036038|NCT04889209|449750906|FG006|All Cohorts Except 15E|Adverse Event|1|||
125036039|NCT04889209|449750907|FG007|All Cohorts Except 15E|Adverse Event|0|||
125036040|NCT04889209|449750908|FG008|All Cohorts Except 15E|Adverse Event|0|||
125036041|NCT04889209|449750909|FG009|All Cohorts Except 15E|Adverse Event|0|||
125036042|NCT04889209|449750910|FG010|All Cohorts Except 15E|Adverse Event|0|||
125036043|NCT04889209|449750911|FG011|All Cohorts Except 15E|Adverse Event|0|||
125036044|NCT04889209|449750912|FG012|All Cohorts Except 15E|Adverse Event|0|||
125036045|NCT04889209|449750913|FG013|All Cohorts Except 15E|Adverse Event|0|||
125218082|NCT02959918|450425369|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125218083|NCT02959918|450425370|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125218084|NCT02959918|450425371|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125218085|NCT02959918|450425372|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125218086|NCT03231306|450425373|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
125218087|NCT03231306|450425373|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
125218088|NCT03231306|450425373|FG000|Overall Study|Treatment delay > 21 days|2|||
125218089|NCT03231306|450425373|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
125218090|NCT03231306|450425373|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
125218091|NCT03231306|450425373|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
124972404|NCT00383123|449525618|FG000|Overall Study|Withdrawal by Subject|27|||
124972405|NCT00383123|449525619|FG001|Overall Study|Withdrawal by Subject|18|||
124972406|NCT00383123|449525618|FG000|Overall Study|Other reason|10|||
124972407|NCT00383123|449525619|FG001|Overall Study|Other reason|6|||
124972408|NCT01814072|449525620|FG000|Overall Study|Lost to Follow-up|2|||
124972409|NCT01814072|449525621|FG001|Overall Study|Lost to Follow-up|2|||
124972410|NCT01814072|449525622|FG002|Overall Study|Lost to Follow-up|2|||
124972411|NCT01814072|449525623|FG003|Overall Study|Lost to Follow-up|0|||
124972412|NCT01814072|449525624|FG004|Overall Study|Lost to Follow-up|2|||
124972413|NCT01814072|449525625|FG005|Overall Study|Lost to Follow-up|3|||
124972414|NCT01814072|449525626|FG006|Overall Study|Lost to Follow-up|3|||
124972415|NCT01814072|449525627|FG007|Overall Study|Lost to Follow-up|1|||
124972416|NCT01814072|449525628|FG008|Overall Study|Lost to Follow-up|2|||
124972417|NCT01814072|449525629|FG009|Overall Study|Lost to Follow-up|3|||
125036046|NCT04889209|449750914|FG014|All Cohorts Except 15E|Adverse Event|0|||
125036047|NCT04889209|449750915|FG015|All Cohorts Except 15E|Adverse Event|0|||
125036048|NCT04889209|449750916|FG016|All Cohorts Except 15E|Adverse Event|0|||
125036049|NCT04889209|449750917|FG017|All Cohorts Except 15E|Adverse Event|0|||
125036050|NCT04889209|449750900|FG000|All Cohorts Except 15E|Death|0|||
125036051|NCT04889209|449750901|FG001|All Cohorts Except 15E|Death|1|||
125036052|NCT04889209|449750902|FG002|All Cohorts Except 15E|Death|0|||
125036053|NCT04889209|449750903|FG003|All Cohorts Except 15E|Death|0|||
125036054|NCT04889209|449750904|FG004|All Cohorts Except 15E|Death|0|||
125036055|NCT04889209|449750905|FG005|All Cohorts Except 15E|Death|0|||
125036056|NCT04889209|449750906|FG006|All Cohorts Except 15E|Death|0|||
125036057|NCT04889209|449750907|FG007|All Cohorts Except 15E|Death|0|||
125036058|NCT04889209|449750908|FG008|All Cohorts Except 15E|Death|0|||
125036059|NCT04889209|449750909|FG009|All Cohorts Except 15E|Death|0|||
125036060|NCT04889209|449750910|FG010|All Cohorts Except 15E|Death|0|||
125036061|NCT04889209|449750911|FG011|All Cohorts Except 15E|Death|0|||
125036062|NCT04889209|449750912|FG012|All Cohorts Except 15E|Death|0|||
125036063|NCT04889209|449750913|FG013|All Cohorts Except 15E|Death|0|||
125036064|NCT04889209|449750914|FG014|All Cohorts Except 15E|Death|0|||
125036065|NCT04889209|449750915|FG015|All Cohorts Except 15E|Death|0|||
125036066|NCT04889209|449750916|FG016|All Cohorts Except 15E|Death|0|||
125036067|NCT04889209|449750917|FG017|All Cohorts Except 15E|Death|0|||
125036068|NCT04889209|449750900|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
125036069|NCT04889209|449750901|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
125036070|NCT04889209|449750902|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
125036071|NCT04889209|449750903|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
125036072|NCT04889209|449750904|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
125036073|NCT04889209|449750905|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
125036074|NCT04889209|449750906|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
125036075|NCT04889209|449750907|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
125036076|NCT04889209|449750908|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
125036077|NCT04889209|449750909|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
125036078|NCT04889209|449750910|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
125036079|NCT04889209|449750911|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
125036080|NCT04889209|449750912|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
125036081|NCT04889209|449750913|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
125036082|NCT04889209|449750914|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
125036083|NCT04889209|449750915|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
125036084|NCT04889209|449750916|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
125036085|NCT04889209|449750917|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
125036086|NCT04889209|449750900|FG000|All Cohorts Except 15E|Physician Decision|0|||
125036087|NCT04889209|449750901|FG001|All Cohorts Except 15E|Physician Decision|0|||
125036088|NCT04889209|449750902|FG002|All Cohorts Except 15E|Physician Decision|0|||
125036089|NCT04889209|449750903|FG003|All Cohorts Except 15E|Physician Decision|0|||
125036090|NCT04889209|449750904|FG004|All Cohorts Except 15E|Physician Decision|1|||
125036091|NCT04889209|449750905|FG005|All Cohorts Except 15E|Physician Decision|0|||
125036092|NCT04889209|449750906|FG006|All Cohorts Except 15E|Physician Decision|0|||
125036093|NCT04889209|449750907|FG007|All Cohorts Except 15E|Physician Decision|1|||
125036094|NCT04889209|449750908|FG008|All Cohorts Except 15E|Physician Decision|0|||
125036095|NCT04889209|449750909|FG009|All Cohorts Except 15E|Physician Decision|1|||
125036096|NCT04889209|449750910|FG010|All Cohorts Except 15E|Physician Decision|0|||
125036097|NCT04889209|449750911|FG011|All Cohorts Except 15E|Physician Decision|1|||
125036098|NCT04889209|449750912|FG012|All Cohorts Except 15E|Physician Decision|1|||
125036099|NCT04889209|449750913|FG013|All Cohorts Except 15E|Physician Decision|0|||
125036100|NCT04889209|449750914|FG014|All Cohorts Except 15E|Physician Decision|0|||
125036101|NCT04889209|449750915|FG015|All Cohorts Except 15E|Physician Decision|0|||
125036102|NCT04889209|449750916|FG016|All Cohorts Except 15E|Physician Decision|0|||
125036103|NCT04889209|449750917|FG017|All Cohorts Except 15E|Physician Decision|0|||
124972418|NCT01814072|449525630|FG010|Overall Study|Lost to Follow-up|1|||
124972419|NCT01814072|449525631|FG011|Overall Study|Lost to Follow-up|2|||
124972420|NCT01814072|449525632|FG012|Overall Study|Lost to Follow-up|2|||
125036104|NCT04889209|449750900|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
125036105|NCT04889209|449750901|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
125132554|NCT00609674|450111792|FG000|Overall Study|Lost to Follow-up|1|||
125132555|NCT00609674|450111793|FG001|Overall Study|Lost to Follow-up|0|||
125132556|NCT00609674|450111792|FG000|Overall Study|Withdrew consent|2|||
125132557|NCT00609674|450111793|FG001|Overall Study|Withdrew consent|1|||
125132558|NCT03098394|450111794|FG000|Overall Study|Pregnancy|0|||
125132559|NCT03098394|450111795|FG001|Overall Study|Pregnancy|1|||
125132560|NCT00571064|450111797|FG000|Overall Study|Adverse Event|13|||
125132561|NCT00571064|450111797|FG000|Overall Study|Protocol Violation|4|||
125036106|NCT04889209|449750902|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
125036107|NCT04889209|449750903|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
125036108|NCT04889209|449750904|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
125036109|NCT04889209|449750905|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
125036110|NCT04889209|449750906|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
125036111|NCT04889209|449750907|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
125036112|NCT04889209|449750908|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
125036113|NCT04889209|449750909|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
125036114|NCT04889209|449750910|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
125036115|NCT04889209|449750911|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
125132562|NCT00571064|450111797|FG000|Overall Study|Withdrawal by Subject|2|||
125036116|NCT04889209|449750912|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
125036117|NCT04889209|449750913|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
125036118|NCT04889209|449750914|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
125036119|NCT04889209|449750915|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
125036120|NCT04889209|449750916|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
125036121|NCT04889209|449750917|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
125036122|NCT04889209|449750900|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
125036123|NCT04889209|449750901|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
125036124|NCT04889209|449750902|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125036125|NCT04889209|449750903|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125036126|NCT04889209|449750904|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125036127|NCT04889209|449750905|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
125036128|NCT04889209|449750906|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125036129|NCT04889209|449750907|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
125036130|NCT04889209|449750908|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125036131|NCT04889209|449750909|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
125036132|NCT04889209|449750910|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125036133|NCT04889209|449750911|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125036134|NCT04889209|449750912|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125036135|NCT04889209|449750913|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125036136|NCT04889209|449750914|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125036137|NCT04889209|449750915|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125036138|NCT04889209|449750916|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125036139|NCT04889209|449750917|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
125036140|NCT04889209|449750900|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125036141|NCT04889209|449750901|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125036142|NCT04889209|449750902|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125036143|NCT04889209|449750903|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
125036144|NCT04889209|449750904|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125036145|NCT04889209|449750905|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125036146|NCT04889209|449750906|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125036147|NCT04889209|449750907|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125132563|NCT00571064|450111797|FG000|Overall Study|Other|2|||
125132564|NCT00244764|450111798|FG000|Overall Study|Adverse Event|37|||
125132565|NCT00244764|450111798|FG000|Overall Study|Lost to Follow-up|23|||
125132566|NCT00244764|450111798|FG000|Overall Study|Withdrawal by Subject|12|||
125132567|NCT00244764|450111798|FG000|Overall Study|Disease Progression|13|||
124972421|NCT01814072|449525633|FG013|Overall Study|Lost to Follow-up|1|||
124972422|NCT01814072|449525634|FG014|Overall Study|Lost to Follow-up|2|||
124972423|NCT01814072|449525635|FG015|Overall Study|Lost to Follow-up|1|||
124972424|NCT01814072|449525636|FG016|Overall Study|Lost to Follow-up|3|||
124972425|NCT01814072|449525637|FG017|Overall Study|Lost to Follow-up|1|||
124972426|NCT01814072|449525638|FG018|Overall Study|Lost to Follow-up|3|||
124972427|NCT01814072|449525639|FG019|Overall Study|Lost to Follow-up|3|||
124972428|NCT01814072|449525640|FG020|Overall Study|Lost to Follow-up|2|||
124972429|NCT01814072|449525641|FG021|Overall Study|Lost to Follow-up|1|||
124972430|NCT01814072|449525642|FG022|Overall Study|Lost to Follow-up|3|||
124972431|NCT01814072|449525643|FG023|Overall Study|Lost to Follow-up|1|||
124972432|NCT01814072|449525644|FG024|Overall Study|Lost to Follow-up|4|||
124972433|NCT01814072|449525645|FG025|Overall Study|Lost to Follow-up|1|||
124972434|NCT01814072|449525646|FG026|Overall Study|Lost to Follow-up|1|||
124972435|NCT01814072|449525647|FG027|Overall Study|Lost to Follow-up|2|||
124972436|NCT01814072|449525648|FG028|Overall Study|Lost to Follow-up|3|||
124972437|NCT01814072|449525649|FG029|Overall Study|Lost to Follow-up|3|||
124972438|NCT01814072|449525650|FG030|Overall Study|Lost to Follow-up|2|||
124972439|NCT01814072|449525651|FG031|Overall Study|Lost to Follow-up|0|||
124972440|NCT01814072|449525620|FG000|Overall Study|Withdrawal by Subject|2|||
124972441|NCT01814072|449525621|FG001|Overall Study|Withdrawal by Subject|0|||
124972442|NCT01814072|449525622|FG002|Overall Study|Withdrawal by Subject|1|||
124972443|NCT01814072|449525623|FG003|Overall Study|Withdrawal by Subject|0|||
124972444|NCT01814072|449525624|FG004|Overall Study|Withdrawal by Subject|2|||
124972445|NCT01814072|449525625|FG005|Overall Study|Withdrawal by Subject|3|||
124972446|NCT01814072|449525626|FG006|Overall Study|Withdrawal by Subject|1|||
124972447|NCT01814072|449525627|FG007|Overall Study|Withdrawal by Subject|0|||
124972448|NCT01814072|449525628|FG008|Overall Study|Withdrawal by Subject|1|||
124972449|NCT01814072|449525629|FG009|Overall Study|Withdrawal by Subject|2|||
124972450|NCT01814072|449525630|FG010|Overall Study|Withdrawal by Subject|0|||
124972451|NCT01814072|449525631|FG011|Overall Study|Withdrawal by Subject|0|||
124972452|NCT01814072|449525632|FG012|Overall Study|Withdrawal by Subject|1|||
124972453|NCT01814072|449525633|FG013|Overall Study|Withdrawal by Subject|1|||
124972454|NCT01814072|449525634|FG014|Overall Study|Withdrawal by Subject|1|||
124972455|NCT01814072|449525635|FG015|Overall Study|Withdrawal by Subject|1|||
124972456|NCT01814072|449525636|FG016|Overall Study|Withdrawal by Subject|0|||
124972457|NCT01814072|449525637|FG017|Overall Study|Withdrawal by Subject|0|||
124972458|NCT01814072|449525638|FG018|Overall Study|Withdrawal by Subject|0|||
124972459|NCT01814072|449525639|FG019|Overall Study|Withdrawal by Subject|2|||
124972460|NCT01814072|449525640|FG020|Overall Study|Withdrawal by Subject|0|||
124972461|NCT01814072|449525641|FG021|Overall Study|Withdrawal by Subject|0|||
124972462|NCT01814072|449525642|FG022|Overall Study|Withdrawal by Subject|1|||
124972463|NCT01814072|449525643|FG023|Overall Study|Withdrawal by Subject|0|||
124972464|NCT01814072|449525644|FG024|Overall Study|Withdrawal by Subject|2|||
124972465|NCT01814072|449525645|FG025|Overall Study|Withdrawal by Subject|1|||
124972466|NCT01814072|449525646|FG026|Overall Study|Withdrawal by Subject|1|||
124972467|NCT01814072|449525647|FG027|Overall Study|Withdrawal by Subject|2|||
124972468|NCT01814072|449525648|FG028|Overall Study|Withdrawal by Subject|1|||
124972469|NCT01814072|449525649|FG029|Overall Study|Withdrawal by Subject|0|||
124972470|NCT01814072|449525650|FG030|Overall Study|Withdrawal by Subject|0|||
124972471|NCT01814072|449525651|FG031|Overall Study|Withdrawal by Subject|0|||
124972472|NCT02336425|449525652|FG000|Overall Study|Study terminated.|2|||
124972473|NCT02336425|449525653|FG001|Overall Study|Study terminated.|2|||
124972474|NCT02336425|449525654|FG002|Overall Study|Study terminated.|3|||
124972475|NCT02336425|449525655|FG003|Overall Study|Study terminated.|3|||
125036148|NCT04889209|449750908|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
124972476|NCT00978562|449525656|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
124972477|NCT01782690|449525657|FG000|Overall Study|Not reported|7|||
124972478|NCT01782690|449525657|FG000|Overall Study|Toxicity of gemcitabine|1|||
125036149|NCT04889209|449750909|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125036150|NCT04889209|449750910|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125036151|NCT04889209|449750911|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125036152|NCT04889209|449750912|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125036153|NCT04889209|449750913|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125036154|NCT04889209|449750914|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125036155|NCT04889209|449750915|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
124972479|NCT01782690|449525657|FG000|Overall Study|Toxicity of erlotinib|1|||
124972480|NCT01782690|449525657|FG000|Overall Study|Lost to Follow-up|31|||
124972481|NCT01782690|449525657|FG000|Overall Study|Withdrawal of informed consent|2|||
124972482|NCT01782690|449525657|FG000|Overall Study|Absent rash|9|||
124972483|NCT01782690|449525657|FG000|Overall Study|Physician Decision|13|||
124972484|NCT01782690|449525657|FG000|Overall Study|Patient's wish|21|||
124972485|NCT01782690|449525657|FG000|Overall Study|Tumor progression|74|||
125036156|NCT04889209|449750916|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125036157|NCT04889209|449750917|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125036158|NCT04889209|449750900|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125036159|NCT04889209|449750901|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125036160|NCT04889209|449750902|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125036161|NCT04889209|449750903|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125036162|NCT04889209|449750904|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
125036163|NCT04889209|449750905|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125036164|NCT04889209|449750906|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
125036165|NCT04889209|449750907|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
125132568|NCT00244764|450111798|FG000|Overall Study|Protocol Violation|2|||
125132569|NCT00244764|450111798|FG000|Overall Study|Death|1|||
125132570|NCT00244764|450111798|FG000|Overall Study|Off Study Medication for >21 Days|1|||
125132571|NCT00244764|450111798|FG000|Overall Study|Declining Performance Status|1|||
125132572|NCT00244764|450111798|FG000|Overall Study|Participant was Hospitalized until Death|1|||
125132573|NCT00244764|450111798|FG000|Overall Study|Primary Investigator Discretion|2|||
125132574|NCT00244764|450111798|FG000|Overall Study|Sponsor Terminated Study|2|||
125132575|NCT00244764|450111798|FG000|Overall Study|Developed Secondary Malignancy|1|||
125132576|NCT00840073|450111811|FG000|Second Intervention|Missed 72 hour blood draw|1|||
125132577|NCT00840073|450111812|FG001|Second Intervention|Missed 72 hour blood draw|1|||
125132578|NCT03285594|450111813|FG000|Overall Study|At the Participant's Own Request|10|||
125132579|NCT03285594|450111814|FG001|Overall Study|At the Participant's Own Request|5|||
125132580|NCT03285594|450111815|FG002|Overall Study|At the Participant's Own Request|21|||
125132581|NCT03285594|450111813|FG000|Overall Study|Adverse Event|2|||
125132582|NCT03285594|450111814|FG001|Overall Study|Adverse Event|2|||
125132583|NCT03285594|450111815|FG002|Overall Study|Adverse Event|6|||
125132584|NCT03285594|450111813|FG000|Overall Study|Poor Compliance to Protocol|0|||
125132585|NCT03285594|450111814|FG001|Overall Study|Poor Compliance to Protocol|0|||
125132586|NCT03285594|450111815|FG002|Overall Study|Poor Compliance to Protocol|1|||
125132587|NCT03285594|450111813|FG000|Overall Study|Lost to Follow-up|0|||
125132588|NCT03285594|450111814|FG001|Overall Study|Lost to Follow-up|0|||
125132589|NCT03285594|450111815|FG002|Overall Study|Lost to Follow-up|1|||
125132590|NCT03285594|450111813|FG000|Overall Study|Reason Not Specified|3|||
125132591|NCT03285594|450111814|FG001|Overall Study|Reason Not Specified|4|||
125132592|NCT03285594|450111815|FG002|Overall Study|Reason Not Specified|8|||
125132593|NCT01615198|450111821|FG000|Overall Study|Withdrawal by Subject|5|||
125132594|NCT01615198|450111822|FG001|Overall Study|Withdrawal by Subject|5|||
125132595|NCT01615198|450111821|FG000|Overall Study|Protocol deviation|1|||
125132596|NCT01615198|450111822|FG001|Overall Study|Protocol deviation|1|||
125132597|NCT01615198|450111821|FG000|Overall Study|Physician Decision|5|||
125132598|NCT01615198|450111822|FG001|Overall Study|Physician Decision|1|||
125132599|NCT01615198|450111821|FG000|Overall Study|Lost to Follow-up|1|||
125132600|NCT01615198|450111822|FG001|Overall Study|Lost to Follow-up|1|||
125132601|NCT01615198|450111821|FG000|Overall Study|Lack of Efficacy|1|||
125132602|NCT01615198|450111822|FG001|Overall Study|Lack of Efficacy|6|||
125132603|NCT01615198|450111821|FG000|Overall Study|Adverse Event|11|||
125132604|NCT01615198|450111822|FG001|Overall Study|Adverse Event|5|||
125132605|NCT04608188|450111824|FG000|Overall Study|Withdrawal by Subject|4|||
125132606|NCT04608188|450111825|FG001|Overall Study|Withdrawal by Subject|8|||
125132607|NCT03122457|450111826|FG000|Overall Study|Withdrawal by Subject|6|||
125132608|NCT03273153|450111830|FG000|Overall Study|Adverse Event|1|||
125132609|NCT03273153|450111831|FG001|Overall Study|Adverse Event|2|||
125132610|NCT03273153|450111830|FG000|Overall Study|Missing|0|||
125132611|NCT03273153|450111831|FG001|Overall Study|Missing|2|||
125132612|NCT03273153|450111830|FG000|Overall Study|Other|3|||
125132613|NCT03273153|450111831|FG001|Overall Study|Other|2|||
125132614|NCT03273153|450111830|FG000|Overall Study|Symptomatic Deterioration|0|||
125132615|NCT03273153|450111831|FG001|Overall Study|Symptomatic Deterioration|1|||
125218092|NCT03231306|450425373|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
125218093|NCT03231306|450425373|FG000|Overall Study|More than 1 Reason|2|||
125218094|NCT02306850|450425374|FG000|Overall Study|Lack of Efficacy|2|||
125036166|NCT04889209|449750908|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125132616|NCT03273153|450111830|FG000|Overall Study|Progressive Disease|6|||
125132617|NCT03273153|450111831|FG001|Overall Study|Progressive Disease|5|||
125218095|NCT00237692|450425375|FG000|Overall Study|Lost to Follow-up|9|||
125132618|NCT03273153|450111830|FG000|Overall Study|Physician Decision|1|||
125132619|NCT03273153|450111831|FG001|Overall Study|Physician Decision|3|||
125132620|NCT03273153|450111830|FG000|Overall Study|Study Terminated by Sponsor|112|||
125132621|NCT03273153|450111831|FG001|Overall Study|Study Terminated by Sponsor|102|||
125132622|NCT03273153|450111830|FG000|Overall Study|Withdrawal by Subject|26|||
125132623|NCT03273153|450111831|FG001|Overall Study|Withdrawal by Subject|25|||
125132624|NCT03273153|450111830|FG000|Overall Study|Protocol Deviation|3|||
125218096|NCT00237692|450425376|FG001|Overall Study|Lost to Follow-up|3|||
125132625|NCT03273153|450111831|FG001|Overall Study|Protocol Deviation|0|||
125132626|NCT03273153|450111830|FG000|Overall Study|Lost to Follow-up|6|||
125132627|NCT03273153|450111831|FG001|Overall Study|Lost to Follow-up|11|||
125132628|NCT03273153|450111830|FG000|Overall Study|Death|66|||
125132629|NCT03273153|450111831|FG001|Overall Study|Death|69|||
125132630|NCT01908205|450111832|FG000|Overall Study|Lost to Follow-up|2|||
125132631|NCT01908205|450111833|FG001|Overall Study|Lost to Follow-up|0|||
125132632|NCT01908205|450111832|FG000|Overall Study|Withdrawal by Subject|3|||
125132633|NCT01908205|450111833|FG001|Overall Study|Withdrawal by Subject|1|||
125132634|NCT03134222|450111838|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
125132635|NCT03134222|450111839|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
125132636|NCT03134222|450111840|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
125132637|NCT03134222|450111841|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
125132638|NCT03134222|450111842|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
125132639|NCT03134222|450111838|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
125132640|NCT03134222|450111839|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
125132641|NCT03134222|450111840|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
125132642|NCT03134222|450111841|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
125132643|NCT03134222|450111842|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
125132644|NCT03134222|450111838|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
125132645|NCT03134222|450111839|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
125218097|NCT00237692|450425377|FG002|Overall Study|Lost to Follow-up|5|||
125218098|NCT00237692|450425378|FG003|Overall Study|Lost to Follow-up|3|||
125218099|NCT00237692|450425375|FG000|Overall Study|Death|1|||
125036167|NCT04889209|449750909|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
125036168|NCT04889209|449750910|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
125036169|NCT04889209|449750911|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125036170|NCT04889209|449750912|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
125036171|NCT04889209|449750913|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125036172|NCT04889209|449750914|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125036173|NCT04889209|449750915|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125036174|NCT04889209|449750916|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
125036175|NCT04889209|449750917|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125036176|NCT04889209|449750900|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125036177|NCT04889209|449750901|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125036178|NCT04889209|449750902|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125036179|NCT04889209|449750903|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125036180|NCT04889209|449750904|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125036181|NCT04889209|449750905|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125036182|NCT04889209|449750906|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125036183|NCT04889209|449750907|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125036184|NCT04889209|449750908|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125036185|NCT04889209|449750909|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125036186|NCT04889209|449750910|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125036187|NCT04889209|449750911|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125036188|NCT04889209|449750912|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125036189|NCT04889209|449750913|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125036190|NCT04889209|449750914|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125036191|NCT04889209|449750915|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125036192|NCT04889209|449750916|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125036193|NCT04889209|449750917|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
125036194|NCT04889209|449750900|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125036195|NCT04889209|449750901|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125036196|NCT04889209|449750902|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125036197|NCT04889209|449750903|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125036198|NCT04889209|449750904|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125036199|NCT04889209|449750905|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125036200|NCT04889209|449750906|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125036201|NCT04889209|449750907|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125036202|NCT04889209|449750908|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125218100|NCT00237692|450425376|FG001|Overall Study|Death|2|||
125218101|NCT00237692|450425377|FG002|Overall Study|Death|2|||
125036203|NCT04889209|449750909|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125036204|NCT04889209|449750910|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125036205|NCT04889209|449750911|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125132646|NCT03134222|450111840|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
125132647|NCT03134222|450111841|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
125218102|NCT00237692|450425378|FG003|Overall Study|Death|3|||
125036206|NCT04889209|449750912|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125036207|NCT04889209|449750913|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125036208|NCT04889209|449750914|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125036209|NCT04889209|449750915|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125036210|NCT04889209|449750916|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125036211|NCT04889209|449750917|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
125036212|NCT04889209|449750900|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125036213|NCT04889209|449750901|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125036214|NCT04889209|449750902|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125036215|NCT04889209|449750903|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125036216|NCT04889209|449750904|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125036217|NCT04889209|449750905|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125036218|NCT04889209|449750906|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125036219|NCT04889209|449750907|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125036220|NCT04889209|449750908|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125036221|NCT04889209|449750909|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125036222|NCT04889209|449750910|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125036223|NCT04889209|449750911|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125036224|NCT04889209|449750912|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125036225|NCT04889209|449750913|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125036226|NCT04889209|449750914|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
125036227|NCT04889209|449750915|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125036228|NCT04889209|449750916|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125036229|NCT04889209|449750917|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125036230|NCT01725165|449750924|FG000|Overall Study|Death|11|||
125036231|NCT01725165|449750925|FG001|Overall Study|Death|18|||
125036232|NCT05113940|449750928|FG000|Part A (18 Days)|Adverse Event|0|||
125036233|NCT05113940|449750929|FG001|Part A (18 Days)|Adverse Event|0|||
125036234|NCT05113940|449750930|FG002|Part A (18 Days)|Adverse Event|1|||
125036235|NCT05113940|449750931|FG003|Part A (18 Days)|Adverse Event|1|||
125036236|NCT05113940|449750932|FG004|Part A (18 Days)|Adverse Event|1|||
125132648|NCT03134222|450111842|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
125132649|NCT03134222|450111838|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
125132650|NCT03134222|450111839|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
125132651|NCT03134222|450111840|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
125132652|NCT03134222|450111841|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
125132653|NCT03134222|450111842|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
125132654|NCT03134222|450111838|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
125132655|NCT03134222|450111839|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
125132656|NCT03134222|450111840|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
125132657|NCT03134222|450111841|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
125132658|NCT03134222|450111842|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
125132659|NCT03134222|450111838|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
125132660|NCT03134222|450111839|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
125132661|NCT03134222|450111840|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
125132662|NCT03134222|450111841|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
125132663|NCT03134222|450111842|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
125132664|NCT03134222|450111838|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
125132665|NCT03134222|450111839|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
125132666|NCT03134222|450111840|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
125132667|NCT03134222|450111841|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
125132668|NCT03134222|450111842|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
125132669|NCT03134222|450111838|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
125132670|NCT03134222|450111839|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
125132671|NCT03134222|450111840|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
125132672|NCT03134222|450111841|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
125132673|NCT03134222|450111842|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
125132674|NCT03681470|450111845|FG000|Overall Study|Lack of Efficacy|3|||
125132675|NCT03681470|450111845|FG000|Overall Study|Lost to Follow-up|1|||
125132676|NCT03681470|450111845|FG000|Overall Study|Protocol Violation|3|||
125132677|NCT03681470|450111845|FG000|Overall Study|Withdrawal by Subject|1|||
125132678|NCT01686477|450111846|FG000|Feeding Intervention|Death|1|||
125132679|NCT01686477|450111847|FG001|Feeding Intervention|Death|0|||
125132680|NCT01686477|450111848|FG002|Feeding Intervention|Death|1|||
125132681|NCT01686477|450111846|FG000|Feeding Intervention|Withdrawal by Subject|0|||
125132682|NCT01686477|450111847|FG001|Feeding Intervention|Withdrawal by Subject|6|||
125218103|NCT00237692|450425375|FG000|Overall Study|Excluded - did not meet criteria|4|||
125036237|NCT05113940|449750933|FG005|Part A (18 Days)|Adverse Event|0|||
125036238|NCT05113940|449750934|FG006|Part A (18 Days)|Adverse Event|0|||
125036239|NCT05113940|449750935|FG007|Part A (18 Days)|Adverse Event|0|||
125036240|NCT05113940|449750936|FG008|Part A (18 Days)|Adverse Event|0|||
125036241|NCT05113940|449750937|FG009|Part A (18 Days)|Adverse Event|0|||
125036242|NCT05113940|449750938|FG010|Part A (18 Days)|Adverse Event|0|||
125036243|NCT05113940|449750939|FG011|Part A (18 Days)|Adverse Event|2|||
125036244|NCT05113940|449750940|FG012|Part A (18 Days)|Adverse Event|0|||
125036245|NCT05113940|449750941|FG013|Part A (18 Days)|Adverse Event|0|||
125036246|NCT05113940|449750942|FG014|Part A (18 Days)|Adverse Event|0|||
125036247|NCT05113940|449750928|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
125036248|NCT05113940|449750929|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
125036249|NCT05113940|449750930|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
125036250|NCT05113940|449750931|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
125036251|NCT05113940|449750932|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
125036252|NCT05113940|449750933|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
125036253|NCT05113940|449750934|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
125036254|NCT05113940|449750935|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
125036255|NCT05113940|449750936|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
125036256|NCT05113940|449750937|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
125036257|NCT05113940|449750938|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
125036258|NCT05113940|449750939|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
125036259|NCT05113940|449750940|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
125036260|NCT05113940|449750941|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
125036261|NCT05113940|449750942|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
125036262|NCT02688647|449750943|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
125036263|NCT02688647|449750944|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
125036264|NCT02688647|449750943|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
125036265|NCT02688647|449750944|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
125036266|NCT02688647|449750943|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
125036267|NCT02688647|449750944|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
125036268|NCT02688647|449750943|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
125036269|NCT02688647|449750944|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
125036270|NCT02688647|449750943|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
125036271|NCT02688647|449750944|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
125036272|NCT02688647|449750943|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
125036273|NCT02688647|449750944|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
125036274|NCT02688647|449750943|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
125036275|NCT02688647|449750944|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
125036276|NCT03619213|449750945|FG000|Overall Study|Lost to Follow-up|2|||
125036277|NCT03619213|449750946|FG001|Overall Study|Lost to Follow-up|1|||
125036278|NCT03619213|449750945|FG000|Overall Study|Withdrawal by Subject|8|||
125036279|NCT03619213|449750946|FG001|Overall Study|Withdrawal by Subject|10|||
125036280|NCT00382967|449750947|FG000|Overall Study|Protocol Violation|1|||
125036281|NCT00382967|449750948|FG001|Overall Study|Protocol Violation|1|||
125036282|NCT02542267|449750949|FG000|Overall Study|Withdrawal by Subject|10|||
125036283|NCT02542267|449750949|FG000|Overall Study|Physician Decision|6|||
125036284|NCT02542267|449750949|FG000|Overall Study|Lost to Follow-up|4|||
125036285|NCT02542267|449750949|FG000|Overall Study|Death|13|||
125036286|NCT02542267|449750949|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
125036287|NCT02542267|449750949|FG000|Overall Study|Other|9|||
125036288|NCT03049449|449750950|FG000|Overall Study|Did not receive treatment.|0|||
125132683|NCT01686477|450111848|FG002|Feeding Intervention|Withdrawal by Subject|0|||
125132684|NCT01686477|450111846|FG000|Feeding Intervention|Physician Decision|1|||
125132685|NCT01686477|450111847|FG001|Feeding Intervention|Physician Decision|2|||
125132686|NCT01686477|450111848|FG002|Feeding Intervention|Physician Decision|0|||
125132687|NCT01686477|450111846|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
125132688|NCT01686477|450111847|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
125132689|NCT01686477|450111848|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
125036289|NCT03049449|449750951|FG001|Overall Study|Did not receive treatment.|0|||
125036290|NCT03049449|449750952|FG002|Overall Study|Did not receive treatment.|0|||
125218104|NCT00237692|450425376|FG001|Overall Study|Excluded - did not meet criteria|3|||
125036291|NCT03049449|449750953|FG003|Overall Study|Did not receive treatment.|0|||
125036292|NCT03049449|449750954|FG004|Overall Study|Did not receive treatment.|0|||
125036293|NCT03049449|449750955|FG005|Overall Study|Did not receive treatment.|0|||
125036294|NCT03049449|449750956|FG006|Overall Study|Did not receive treatment.|0|||
125036295|NCT03049449|449750957|FG007|Overall Study|Did not receive treatment.|0|||
125036296|NCT03049449|449750958|FG008|Overall Study|Did not receive treatment.|1|||
125036297|NCT03049449|449750959|FG009|Overall Study|Did not receive treatment.|0|||
125036298|NCT03049449|449750950|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
125132690|NCT01686477|450111846|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
125218105|NCT00237692|450425377|FG002|Overall Study|Excluded - did not meet criteria|5|||
125132691|NCT01686477|450111847|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
125132692|NCT01686477|450111848|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
125132693|NCT01686477|450111846|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
125132694|NCT01686477|450111847|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
125132695|NCT01686477|450111848|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
125132696|NCT01686477|450111846|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
125132697|NCT01686477|450111847|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
125132698|NCT01686477|450111848|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
125132699|NCT01686477|450111846|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
125132700|NCT01686477|450111847|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
125132701|NCT01686477|450111848|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
125132702|NCT01686477|450111846|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
125132703|NCT01686477|450111847|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
125132704|NCT01686477|450111848|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
125132705|NCT01686477|450111846|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
125132706|NCT01686477|450111847|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
125132707|NCT01686477|450111848|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
125132708|NCT03290781|450111850|FG000|Overall Study|Adverse Event|5|||
125132709|NCT03290781|450111851|FG001|Overall Study|Adverse Event|7|||
125132710|NCT03290781|450111852|FG002|Overall Study|Adverse Event|4|||
125132711|NCT03290781|450111853|FG003|Overall Study|Adverse Event|1|||
125132712|NCT03290781|450111854|FG004|Overall Study|Adverse Event|0|||
125132713|NCT03290781|450111855|FG005|Overall Study|Adverse Event|0|||
125132714|NCT03290781|450111856|FG006|Overall Study|Adverse Event|0|||
125132715|NCT03290781|450111850|FG000|Overall Study|Death|0|||
125218106|NCT00237692|450425378|FG003|Overall Study|Excluded - did not meet criteria|9|||
125218107|NCT00237692|450425375|FG000|Overall Study|Withdrawal by Subject|4|||
125218108|NCT00237692|450425376|FG001|Overall Study|Withdrawal by Subject|6|||
124972486|NCT01782690|449525657|FG000|Overall Study|Death|133|||
124972487|NCT01782690|449525657|FG000|Overall Study|Study completion unknown|7|||
124972488|NCT04946942|449525659|FG000|Overall Study|Lost to Follow-up|6|||
124972489|NCT04946942|449525660|FG001|Overall Study|Lost to Follow-up|2|||
124972490|NCT04946942|449525661|FG002|Overall Study|Lost to Follow-up|0|||
124972491|NCT04907357|449525662|FG000|Overall Study|Death|0|||
124972492|NCT04907357|449525663|FG001|Overall Study|Death|1|||
124972493|NCT04907357|449525662|FG000|Overall Study|Lost to Follow-up|9|||
124972494|NCT04907357|449525663|FG001|Overall Study|Lost to Follow-up|18|||
124972495|NCT04907357|449525662|FG000|Overall Study|Physician Decision|1|||
124972496|NCT04907357|449525663|FG001|Overall Study|Physician Decision|0|||
124972497|NCT04907357|449525662|FG000|Overall Study|Withdrawal by Subject|0|||
124972498|NCT04907357|449525663|FG001|Overall Study|Withdrawal by Subject|1|||
124972499|NCT04907357|449525662|FG000|Overall Study|Unable to attend visits|1|||
124972500|NCT04907357|449525663|FG001|Overall Study|Unable to attend visits|0|||
124972501|NCT04907357|449525662|FG000|Overall Study|Incarcerated|1|||
124972502|NCT04907357|449525663|FG001|Overall Study|Incarcerated|1|||
124972503|NCT01948076|449525664|FG000|Overall Study|Withdrawal by Subject|0|||
124972504|NCT01948076|449525665|FG001|Overall Study|Withdrawal by Subject|1|||
124972505|NCT04124471|449525672|FG000|Overall Study|screen failure|1|||
124972506|NCT05226130|449525673|FG000|Overall Study|Lost to Follow-up|0|||
124972507|NCT05226130|449525674|FG001|Overall Study|Lost to Follow-up|1|||
124972508|NCT05226130|449525673|FG000|Overall Study|Not treatment adherent|0|||
124972509|NCT05226130|449525674|FG001|Overall Study|Not treatment adherent|2|||
124972510|NCT03358472|449525675|FG000|Overall Study|Death|6|||
124972511|NCT03358472|449525676|FG001|Overall Study|Death|3|||
124972512|NCT03358472|449525677|FG002|Overall Study|Death|10|||
124972513|NCT03358472|449525675|FG000|Overall Study|Physician Decision|0|||
124972514|NCT03358472|449525676|FG001|Overall Study|Physician Decision|1|||
124972515|NCT03358472|449525677|FG002|Overall Study|Physician Decision|0|||
124972516|NCT03358472|449525675|FG000|Overall Study|Withdrawal by Subject|0|||
124972517|NCT03358472|449525676|FG001|Overall Study|Withdrawal by Subject|0|||
124972518|NCT03358472|449525677|FG002|Overall Study|Withdrawal by Subject|1|||
124972519|NCT03358472|449525675|FG000|Overall Study|On-going at clinical cut off date|9|||
124972520|NCT03358472|449525676|FG001|Overall Study|On-going at clinical cut off date|6|||
124972521|NCT03358472|449525677|FG002|Overall Study|On-going at clinical cut off date|5|||
124972522|NCT03732677|449525678|FG000|Overall Study|Terminated the study|154|||
124972523|NCT03732677|449525679|FG001|Overall Study|Terminated the study|197|||
124972524|NCT03732677|449525678|FG000|Overall Study|Continuing study off treatment|379|||
124972525|NCT03732677|449525679|FG001|Overall Study|Continuing study off treatment|333|||
124972526|NCT04013971|449525680|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
124972527|NCT04013971|449525681|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
124972528|NCT04013971|449525680|FG000|Overall Study|Missing biomechanical data|0|||
125132716|NCT03290781|450111851|FG001|Overall Study|Death|0|||
125132717|NCT03290781|450111852|FG002|Overall Study|Death|1|||
125132718|NCT03290781|450111853|FG003|Overall Study|Death|0|||
125132719|NCT03290781|450111854|FG004|Overall Study|Death|1|||
125132720|NCT03290781|450111855|FG005|Overall Study|Death|0|||
125132721|NCT03290781|450111856|FG006|Overall Study|Death|0|||
125132722|NCT03290781|450111850|FG000|Overall Study|Withdrawal by Subject|6|||
125132723|NCT03290781|450111851|FG001|Overall Study|Withdrawal by Subject|5|||
125132724|NCT03290781|450111852|FG002|Overall Study|Withdrawal by Subject|9|||
125132725|NCT03290781|450111853|FG003|Overall Study|Withdrawal by Subject|10|||
125132726|NCT03290781|450111854|FG004|Overall Study|Withdrawal by Subject|1|||
125132727|NCT03290781|450111855|FG005|Overall Study|Withdrawal by Subject|2|||
125132728|NCT03290781|450111856|FG006|Overall Study|Withdrawal by Subject|0|||
125132729|NCT03290781|450111850|FG000|Overall Study|Physician Decision|0|||
125132730|NCT03290781|450111851|FG001|Overall Study|Physician Decision|1|||
125132731|NCT03290781|450111852|FG002|Overall Study|Physician Decision|0|||
125132732|NCT03290781|450111853|FG003|Overall Study|Physician Decision|0|||
125132733|NCT03290781|450111854|FG004|Overall Study|Physician Decision|0|||
125132734|NCT03290781|450111855|FG005|Overall Study|Physician Decision|0|||
125132735|NCT03290781|450111856|FG006|Overall Study|Physician Decision|0|||
125132736|NCT03290781|450111850|FG000|Overall Study|Site Terminated by Sponsor|1|||
125132737|NCT03290781|450111851|FG001|Overall Study|Site Terminated by Sponsor|0|||
125132738|NCT03290781|450111852|FG002|Overall Study|Site Terminated by Sponsor|2|||
125132739|NCT03290781|450111853|FG003|Overall Study|Site Terminated by Sponsor|1|||
125132740|NCT03290781|450111854|FG004|Overall Study|Site Terminated by Sponsor|0|||
125132741|NCT03290781|450111855|FG005|Overall Study|Site Terminated by Sponsor|0|||
125132742|NCT03290781|450111856|FG006|Overall Study|Site Terminated by Sponsor|0|||
125132743|NCT03290781|450111850|FG000|Overall Study|Lost to Follow-up|0|||
125132744|NCT03290781|450111851|FG001|Overall Study|Lost to Follow-up|0|||
125132745|NCT03290781|450111852|FG002|Overall Study|Lost to Follow-up|0|||
125132746|NCT03290781|450111853|FG003|Overall Study|Lost to Follow-up|1|||
125132747|NCT03290781|450111854|FG004|Overall Study|Lost to Follow-up|0|||
125132748|NCT03290781|450111855|FG005|Overall Study|Lost to Follow-up|0|||
125132749|NCT03290781|450111856|FG006|Overall Study|Lost to Follow-up|0|||
125132750|NCT03290781|450111850|FG000|Overall Study|Protocol Deviation|2|||
125132751|NCT03290781|450111851|FG001|Overall Study|Protocol Deviation|0|||
125132752|NCT03290781|450111852|FG002|Overall Study|Protocol Deviation|0|||
125132753|NCT03290781|450111853|FG003|Overall Study|Protocol Deviation|1|||
125132754|NCT03290781|450111854|FG004|Overall Study|Protocol Deviation|0|||
125132755|NCT03290781|450111855|FG005|Overall Study|Protocol Deviation|0|||
125132756|NCT03290781|450111856|FG006|Overall Study|Protocol Deviation|0|||
125132757|NCT03290781|450111850|FG000|Overall Study|Disease Relapse|32|||
125132758|NCT03290781|450111851|FG001|Overall Study|Disease Relapse|5|||
125132759|NCT03290781|450111852|FG002|Overall Study|Disease Relapse|38|||
125132760|NCT03290781|450111853|FG003|Overall Study|Disease Relapse|7|||
125132761|NCT03290781|450111854|FG004|Overall Study|Disease Relapse|3|||
125132762|NCT03290781|450111855|FG005|Overall Study|Disease Relapse|1|||
125132763|NCT03290781|450111856|FG006|Overall Study|Disease Relapse|4|||
125132764|NCT03290781|450111850|FG000|Overall Study|Other|3|||
125132765|NCT03290781|450111851|FG001|Overall Study|Other|0|||
125132766|NCT03290781|450111852|FG002|Overall Study|Other|2|||
125132767|NCT03290781|450111853|FG003|Overall Study|Other|2|||
125132768|NCT03290781|450111854|FG004|Overall Study|Other|0|||
125132769|NCT03290781|450111855|FG005|Overall Study|Other|0|||
125132770|NCT03290781|450111856|FG006|Overall Study|Other|0|||
125132771|NCT01136174|450111857|FG000|Overall Study|Adverse Event|0|||
125132772|NCT01136174|450111858|FG001|Overall Study|Adverse Event|0|||
125132773|NCT01136174|450111859|FG002|Overall Study|Adverse Event|0|||
125132774|NCT01136174|450111860|FG003|Overall Study|Adverse Event|4|||
125132775|NCT02820350|450111870|FG000|Overall Study|Withdrawal by Subject|3|||
125132776|NCT02820350|450111870|FG000|Overall Study|Death|4|||
125132777|NCT01597245|450111871|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
125132778|NCT01597245|450111872|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
125132779|NCT01597245|450111873|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
125132780|NCT01597245|450111874|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
125132781|NCT01597245|450111875|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132782|NCT01597245|450111876|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132783|NCT01597245|450111877|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132784|NCT01597245|450111878|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132785|NCT01597245|450111879|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132786|NCT01597245|450111880|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132787|NCT01597245|450111881|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132788|NCT01597245|450111882|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132789|NCT01597245|450111883|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132790|NCT01597245|450111884|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125036299|NCT03049449|449750951|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
125036300|NCT03049449|449750952|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
125036301|NCT03049449|449750953|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
125036302|NCT03049449|449750954|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
125036303|NCT03049449|449750955|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
125036304|NCT03049449|449750956|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
125036305|NCT03049449|449750957|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
125036306|NCT03049449|449750958|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
125036307|NCT03049449|449750959|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
125036308|NCT03049449|449750950|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
125036309|NCT03049449|449750951|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
125036310|NCT03049449|449750952|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
125036311|NCT03049449|449750953|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
125036312|NCT03049449|449750954|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
125036313|NCT03049449|449750955|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
125036314|NCT03049449|449750956|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
125036315|NCT03049449|449750957|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
125036316|NCT03049449|449750958|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
125036317|NCT03049449|449750959|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
125036318|NCT00474240|449750960|FG000|Overall Study|Withdrawal by Subject|1|||
125036319|NCT00474240|449750961|FG001|Overall Study|Withdrawal by Subject|1|||
125036320|NCT00474240|449750962|FG002|Overall Study|Withdrawal by Subject|0|||
125036321|NCT00474240|449750963|FG003|Overall Study|Withdrawal by Subject|2|||
125036322|NCT00474240|449750964|FG004|Overall Study|Withdrawal by Subject|3|||
125036323|NCT00474240|449750965|FG005|Overall Study|Withdrawal by Subject|1|||
125036324|NCT00474240|449750960|FG000|Overall Study|Adverse Event|0|||
125036325|NCT00474240|449750961|FG001|Overall Study|Adverse Event|0|||
125036326|NCT00474240|449750962|FG002|Overall Study|Adverse Event|9|||
125036327|NCT00474240|449750963|FG003|Overall Study|Adverse Event|14|||
125036328|NCT00474240|449750964|FG004|Overall Study|Adverse Event|5|||
125036329|NCT00474240|449750965|FG005|Overall Study|Adverse Event|16|||
125036330|NCT00474240|449750960|FG000|Overall Study|Removed due to lab value|0|||
125036331|NCT00474240|449750961|FG001|Overall Study|Removed due to lab value|0|||
125036332|NCT00474240|449750962|FG002|Overall Study|Removed due to lab value|0|||
125036333|NCT00474240|449750963|FG003|Overall Study|Removed due to lab value|0|||
125036334|NCT00474240|449750964|FG004|Overall Study|Removed due to lab value|0|||
125036335|NCT00474240|449750965|FG005|Overall Study|Removed due to lab value|1|||
125036336|NCT01974323|449750971|FG000|Overall Study|Other Reasons|25|||
125036337|NCT01974323|449750972|FG001|Overall Study|Other Reasons|28|||
125036338|NCT01974323|449750971|FG000|Overall Study|Protocol Violation|2|||
125036339|NCT01974323|449750972|FG001|Overall Study|Protocol Violation|2|||
125036340|NCT01974323|449750971|FG000|Overall Study|Personal Reasons|15|||
125036341|NCT01974323|449750972|FG001|Overall Study|Personal Reasons|19|||
125036342|NCT01974323|449750971|FG000|Overall Study|Lost to Follow-up|45|||
125036343|NCT01974323|449750972|FG001|Overall Study|Lost to Follow-up|40|||
125036344|NCT01974323|449750971|FG000|Overall Study|Pregnancy|2|||
125036345|NCT01974323|449750972|FG001|Overall Study|Pregnancy|1|||
125036346|NCT01974323|449750971|FG000|Overall Study|Lack of Efficacy|1|||
125036347|NCT01974323|449750972|FG001|Overall Study|Lack of Efficacy|1|||
125036348|NCT01974323|449750971|FG000|Overall Study|Adverse Event|2|||
125036349|NCT01974323|449750972|FG001|Overall Study|Adverse Event|2|||
125036350|NCT00331760|449750973|FG000|Overall Study|Ineligible / no protocol treatment|15|||
125036351|NCT00331760|449750974|FG001|Overall Study|Ineligible / no protocol treatment|8|||
125036352|NCT03093155|449750976|FG000|Overall Study|Not Eligible|1|||
125036353|NCT03093155|449750977|FG001|Overall Study|Not Eligible|0|||
125036354|NCT03093155|449750976|FG000|Overall Study|Withdrawal by Subject|0|||
125036355|NCT03093155|449750977|FG001|Overall Study|Withdrawal by Subject|1|||
125036356|NCT01075178|449750978|FG000|Subject Matching|eligible but not matched|130|||
125036357|NCT01075178|449750979|FG001|Subject Matching|eligible but not matched|403|||
125036358|NCT01075178|449750978|FG000|Subject Chart Review|died before chart review period|0|||
125036359|NCT01075178|449750979|FG001|Subject Chart Review|died before chart review period|2|||
125036360|NCT01075178|449750978|FG000|Subject Chart Review|no data collected due to site closure|3|||
125036361|NCT01075178|449750979|FG001|Subject Chart Review|no data collected due to site closure|4|||
125036362|NCT01075178|449750978|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
125036363|NCT01075178|449750979|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
125132791|NCT01597245|450111885|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132792|NCT01597245|450111886|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132793|NCT01597245|450111887|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132794|NCT01597245|450111888|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132795|NCT01597245|450111889|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132796|NCT01597245|450111890|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132797|NCT01597245|450111891|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132798|NCT01597245|450111871|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
125132799|NCT01597245|450111872|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
125132800|NCT01597245|450111873|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
125132801|NCT01597245|450111874|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
125132802|NCT01597245|450111875|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132803|NCT01597245|450111876|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132804|NCT01597245|450111877|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132805|NCT01597245|450111878|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132806|NCT01597245|450111879|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132807|NCT01597245|450111880|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132808|NCT01597245|450111881|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132809|NCT01597245|450111882|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132810|NCT01597245|450111883|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132811|NCT01597245|450111884|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132812|NCT01597245|450111885|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132813|NCT01597245|450111886|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132814|NCT01597245|450111887|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132815|NCT01597245|450111888|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132816|NCT01597245|450111889|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132817|NCT01597245|450111890|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132818|NCT01597245|450111891|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125036364|NCT02983604|449750980|FG000|Overall Study|Enrolled but not Treated|0|||
125036365|NCT02983604|449750981|FG001|Overall Study|Enrolled but not Treated|0|||
125036366|NCT02983604|449750982|FG002|Overall Study|Enrolled but not Treated|1|||
125036367|NCT02983604|449750983|FG003|Overall Study|Enrolled but not Treated|0|||
125036368|NCT01111604|449750984|FG000|Overall Study|Lost to Follow-up|0|||
125036369|NCT01111604|449750985|FG001|Overall Study|Lost to Follow-up|0|||
125036370|NCT01111604|449750986|FG002|Overall Study|Lost to Follow-up|1|||
125036371|NCT01111604|449750984|FG000|Overall Study|Withdrew Consent|3|||
125036372|NCT01111604|449750985|FG001|Overall Study|Withdrew Consent|0|||
125036373|NCT01111604|449750986|FG002|Overall Study|Withdrew Consent|2|||
125036374|NCT01111604|449750984|FG000|Overall Study|Withdrawal by Subject|2|||
125036375|NCT01111604|449750985|FG001|Overall Study|Withdrawal by Subject|0|||
125036376|NCT01111604|449750986|FG002|Overall Study|Withdrawal by Subject|0|||
125036377|NCT01111604|449750984|FG000|Overall Study|Death|1|||
125036378|NCT01111604|449750985|FG001|Overall Study|Death|0|||
125036379|NCT01111604|449750986|FG002|Overall Study|Death|0|||
125036380|NCT01111604|449750984|FG000|Overall Study|Met Exclusion Criteria|2|||
125036381|NCT01111604|449750985|FG001|Overall Study|Met Exclusion Criteria|0|||
125036382|NCT01111604|449750986|FG002|Overall Study|Met Exclusion Criteria|0|||
125132819|NCT01597245|450111871|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
125132820|NCT01597245|450111872|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
125132821|NCT01597245|450111873|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
125132822|NCT01597245|450111874|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
125132823|NCT01597245|450111875|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132824|NCT01597245|450111876|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132825|NCT01597245|450111877|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132826|NCT01597245|450111878|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132827|NCT01597245|450111879|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132828|NCT01597245|450111880|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132829|NCT01597245|450111881|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132830|NCT01597245|450111882|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132831|NCT01597245|450111883|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125218109|NCT00237692|450425377|FG002|Overall Study|Withdrawal by Subject|10|||
125036383|NCT00607048|449750988|FG000|Overall Study|Adverse Event|0|||
125036384|NCT00607048|449750989|FG001|Overall Study|Adverse Event|1|||
125036385|NCT00607048|449750990|FG002|Overall Study|Adverse Event|0|||
125036386|NCT00607048|449750991|FG003|Overall Study|Adverse Event|0|||
125036387|NCT00607048|449750992|FG004|Overall Study|Adverse Event|4|||
125036388|NCT00607048|449750993|FG005|Overall Study|Adverse Event|0|||
125036389|NCT00607048|449750988|FG000|Overall Study|Global deterioration of health|1|||
125036390|NCT00607048|449750989|FG001|Overall Study|Global deterioration of health|0|||
125132832|NCT01597245|450111884|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125036391|NCT00607048|449750990|FG002|Overall Study|Global deterioration of health|0|||
125132833|NCT01597245|450111885|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132834|NCT01597245|450111886|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132835|NCT01597245|450111887|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132836|NCT01597245|450111888|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132837|NCT01597245|450111889|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132838|NCT01597245|450111890|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132839|NCT01597245|450111891|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132840|NCT01597245|450111871|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
125132841|NCT01597245|450111872|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
125132842|NCT01597245|450111873|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
125132843|NCT01597245|450111874|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132844|NCT01597245|450111875|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132845|NCT01597245|450111876|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132846|NCT01597245|450111877|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132847|NCT01597245|450111878|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132848|NCT01597245|450111879|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132849|NCT01597245|450111880|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132850|NCT01597245|450111881|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132851|NCT01597245|450111882|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132852|NCT01597245|450111883|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132853|NCT01597245|450111884|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132854|NCT01597245|450111885|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132855|NCT01597245|450111886|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125218110|NCT00237692|450425378|FG003|Overall Study|Withdrawal by Subject|4|||
125132856|NCT01597245|450111887|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132857|NCT01597245|450111888|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132858|NCT01597245|450111889|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132859|NCT01597245|450111890|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132860|NCT01597245|450111891|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132861|NCT01597245|450111871|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
125132862|NCT01597245|450111872|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132863|NCT01597245|450111873|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132864|NCT01597245|450111874|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
125132865|NCT01597245|450111875|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132866|NCT01597245|450111876|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132867|NCT01597245|450111877|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132868|NCT01597245|450111878|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132869|NCT01597245|450111879|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132870|NCT01597245|450111880|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125218111|NCT00685360|450425381|FG000|Overall Study|Lost to Follow-up|0|||
125218112|NCT00685360|450425382|FG001|Overall Study|Lost to Follow-up|1|||
125218113|NCT00685360|450425383|FG002|Overall Study|Lost to Follow-up|2|||
125218114|NCT00685360|450425381|FG000|Overall Study|Adverse Event|4|||
125218115|NCT00685360|450425382|FG001|Overall Study|Adverse Event|6|||
125218116|NCT00685360|450425383|FG002|Overall Study|Adverse Event|4|||
125218117|NCT00685360|450425381|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
125218118|NCT00685360|450425382|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
125218119|NCT00685360|450425383|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
125218120|NCT00685360|450425381|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
125218121|NCT00685360|450425382|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
125218122|NCT00685360|450425383|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
125218123|NCT00685360|450425381|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
125218124|NCT00685360|450425382|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
125218125|NCT00685360|450425383|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
125218126|NCT00685360|450425381|FG000|Overall Study|Protocol Deviation|0|||
125218127|NCT00685360|450425382|FG001|Overall Study|Protocol Deviation|1|||
125218128|NCT00685360|450425383|FG002|Overall Study|Protocol Deviation|1|||
125218129|NCT03654729|450427276|FG000|Overall Study|Death|9|||
125218130|NCT03654729|450427277|FG001|Overall Study|Death|9|||
125218131|NCT03654729|450427278|FG002|Overall Study|Death|16|||
125132871|NCT01597245|450111881|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132872|NCT01597245|450111882|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132873|NCT01597245|450111883|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132874|NCT01597245|450111884|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125218132|NCT03654729|450427276|FG000|Overall Study|Withdrawal by Subject|8|||
125218133|NCT03654729|450427277|FG001|Overall Study|Withdrawal by Subject|6|||
125218134|NCT03654729|450427278|FG002|Overall Study|Withdrawal by Subject|4|||
125218135|NCT03654729|450427276|FG000|Overall Study|Study terminated by Sponsor|3|||
125036392|NCT00607048|449750991|FG003|Overall Study|Global deterioration of health|0|||
125036393|NCT00607048|449750992|FG004|Overall Study|Global deterioration of health|0|||
125036394|NCT00607048|449750993|FG005|Overall Study|Global deterioration of health|0|||
125036395|NCT00607048|449750988|FG000|Overall Study|Objective disease progression - relapse|1|||
125036396|NCT00607048|449750989|FG001|Overall Study|Objective disease progression - relapse|2|||
125036397|NCT00607048|449750990|FG002|Overall Study|Objective disease progression - relapse|4|||
125036398|NCT00607048|449750991|FG003|Overall Study|Objective disease progression - relapse|2|||
125036399|NCT00607048|449750992|FG004|Overall Study|Objective disease progression - relapse|2|||
125036400|NCT00607048|449750993|FG005|Overall Study|Objective disease progression - relapse|2|||
125132875|NCT01597245|450111885|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132876|NCT01597245|450111886|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132877|NCT01597245|450111887|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132878|NCT01597245|450111888|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132879|NCT01597245|450111889|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132880|NCT01597245|450111890|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132881|NCT01597245|450111891|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132882|NCT01597245|450111871|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
125132883|NCT01597245|450111872|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
125132884|NCT01597245|450111873|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
125132885|NCT01597245|450111874|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132886|NCT01597245|450111875|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132887|NCT01597245|450111876|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132888|NCT01597245|450111877|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132889|NCT01597245|450111878|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132890|NCT01597245|450111879|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132891|NCT01597245|450111880|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132892|NCT01597245|450111881|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132893|NCT01597245|450111882|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132894|NCT01597245|450111883|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132895|NCT01597245|450111884|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132896|NCT01597245|450111885|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132897|NCT01597245|450111886|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132898|NCT01597245|450111887|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132899|NCT01597245|450111888|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132900|NCT01597245|450111889|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132901|NCT01597245|450111890|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132902|NCT01597245|450111891|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132903|NCT01597245|450111871|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132904|NCT01597245|450111872|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132905|NCT01597245|450111873|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132906|NCT01597245|450111874|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132907|NCT01597245|450111875|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132908|NCT01597245|450111876|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
125132909|NCT01597245|450111877|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
125132910|NCT01597245|450111878|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132911|NCT01597245|450111879|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132912|NCT01597245|450111880|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132913|NCT01597245|450111881|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132914|NCT01597245|450111882|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132915|NCT01597245|450111883|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132916|NCT01597245|450111884|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132917|NCT01597245|450111885|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132918|NCT01597245|450111886|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132919|NCT01597245|450111887|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132920|NCT01597245|450111888|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132921|NCT01597245|450111889|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132922|NCT01597245|450111890|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132923|NCT01597245|450111891|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132924|NCT01597245|450111871|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132925|NCT01597245|450111872|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132926|NCT01597245|450111873|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125036401|NCT00607048|449750988|FG000|Overall Study|Withdrawal by Subject|0|||
125132927|NCT01597245|450111874|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132928|NCT01597245|450111875|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
125132929|NCT01597245|450111876|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
124972529|NCT04013971|449525681|FG001|Overall Study|Missing biomechanical data|1|||
124972530|NCT00344032|449525686|FG000|Overall Study|Adverse Event|0|||
124972531|NCT00344032|449525687|FG001|Overall Study|Adverse Event|1|||
124972532|NCT00344032|449525686|FG000|Overall Study|Withdrawal by Subject|6|||
124972533|NCT00344032|449525687|FG001|Overall Study|Withdrawal by Subject|2|||
124972534|NCT00344032|449525686|FG000|Overall Study|Lost to Follow-up|4|||
124972535|NCT00344032|449525687|FG001|Overall Study|Lost to Follow-up|6|||
125132930|NCT01597245|450111877|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
125132931|NCT01597245|450111878|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
125132932|NCT01597245|450111879|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132933|NCT01597245|450111880|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
125132934|NCT01597245|450111881|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132935|NCT01597245|450111882|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132936|NCT01597245|450111883|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132937|NCT01597245|450111884|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132938|NCT01597245|450111885|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132939|NCT01597245|450111886|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132940|NCT01597245|450111887|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132941|NCT01597245|450111888|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132942|NCT01597245|450111889|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132943|NCT01597245|450111890|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132944|NCT01597245|450111891|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132945|NCT01597245|450111871|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132946|NCT01597245|450111872|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132947|NCT01597245|450111873|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132948|NCT01597245|450111874|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132949|NCT01597245|450111875|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132950|NCT01597245|450111876|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
125132951|NCT01597245|450111877|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132952|NCT01597245|450111878|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132953|NCT01597245|450111879|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
125132954|NCT01597245|450111880|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132955|NCT01597245|450111881|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
125132956|NCT01597245|450111882|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
125132957|NCT01597245|450111883|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
125132958|NCT01597245|450111884|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132959|NCT01597245|450111885|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132960|NCT01597245|450111886|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132961|NCT01597245|450111887|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132962|NCT01597245|450111888|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132963|NCT01597245|450111889|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132964|NCT01597245|450111890|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132965|NCT01597245|450111891|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132966|NCT01597245|450111871|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132967|NCT01597245|450111872|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132968|NCT01597245|450111873|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132969|NCT01597245|450111874|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132970|NCT01597245|450111875|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
125132971|NCT01597245|450111876|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
125132972|NCT01597245|450111877|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
125132973|NCT01597245|450111878|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
125132974|NCT01597245|450111879|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
125132975|NCT01597245|450111880|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
125132976|NCT01597245|450111881|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
125132977|NCT01597245|450111882|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
125132978|NCT01597245|450111883|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
125132979|NCT01597245|450111884|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132980|NCT01597245|450111885|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132981|NCT01597245|450111886|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132982|NCT01597245|450111887|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132983|NCT01597245|450111888|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132984|NCT01597245|450111889|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132985|NCT01597245|450111890|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132986|NCT01597245|450111891|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132987|NCT01597245|450111871|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125132988|NCT01597245|450111872|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
124972536|NCT00344032|449525686|FG000|Overall Study|Physician Decision|4|||
125036402|NCT00607048|449750989|FG001|Overall Study|Withdrawal by Subject|0|||
125036403|NCT00607048|449750990|FG002|Overall Study|Withdrawal by Subject|0|||
125036404|NCT00607048|449750991|FG003|Overall Study|Withdrawal by Subject|1|||
125036405|NCT00607048|449750992|FG004|Overall Study|Withdrawal by Subject|0|||
125036406|NCT00607048|449750993|FG005|Overall Study|Withdrawal by Subject|2|||
125132989|NCT01597245|450111873|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125132990|NCT01597245|450111874|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125132991|NCT01597245|450111875|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
125132992|NCT01597245|450111876|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
125132993|NCT01597245|450111877|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
125132994|NCT01597245|450111878|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125132995|NCT01597245|450111879|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
125132996|NCT01597245|450111880|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
124972537|NCT00344032|449525687|FG001|Overall Study|Physician Decision|1|||
124972538|NCT05101993|449525694|FG000|Overall Study|Withdrawal by Subject|1|||
124972539|NCT02065882|449525695|FG000|Part I: PK/PD|Screening failure|5|||
124972540|NCT02065882|449525695|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
124972541|NCT02065882|449525695|FG000|Part I: PK/PD|Adverse Event|1|||
124972542|NCT02065882|449525695|FG000|Part II: Clinical Efficacy|Screening failure|7|||
124972543|NCT02065882|449525695|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
124972544|NCT02065882|449525695|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
124972545|NCT02065882|449525695|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
124972546|NCT02065882|449525695|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
124972547|NCT02065882|449525695|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
124972548|NCT02600897|449525696|FG000|Overall Study|Death|1|||
124972549|NCT02600897|449525697|FG001|Overall Study|Death|2|||
124972550|NCT02600897|449525698|FG002|Overall Study|Death|1|||
124972551|NCT02600897|449525699|FG003|Overall Study|Death|2|||
124972552|NCT02600897|449525700|FG004|Overall Study|Death|3|||
124972553|NCT02600897|449525701|FG005|Overall Study|Death|2|||
124972554|NCT02600897|449525702|FG006|Overall Study|Death|10|||
124972555|NCT02600897|449525703|FG007|Overall Study|Death|7|||
124972556|NCT02600897|449525704|FG008|Overall Study|Death|20|||
124972557|NCT02600897|449525696|FG000|Overall Study|Lost to Follow-up|1|||
124972558|NCT02600897|449525697|FG001|Overall Study|Lost to Follow-up|0|||
124972559|NCT02600897|449525698|FG002|Overall Study|Lost to Follow-up|0|||
124972560|NCT02600897|449525699|FG003|Overall Study|Lost to Follow-up|0|||
124972561|NCT02600897|449525700|FG004|Overall Study|Lost to Follow-up|0|||
124972562|NCT02600897|449525701|FG005|Overall Study|Lost to Follow-up|0|||
124972563|NCT02600897|449525702|FG006|Overall Study|Lost to Follow-up|0|||
124972564|NCT02600897|449525703|FG007|Overall Study|Lost to Follow-up|1|||
124972565|NCT02600897|449525704|FG008|Overall Study|Lost to Follow-up|0|||
124972566|NCT02600897|449525696|FG000|Overall Study|Withdrawal by Subject|0|||
124972567|NCT02600897|449525697|FG001|Overall Study|Withdrawal by Subject|0|||
124972568|NCT02600897|449525698|FG002|Overall Study|Withdrawal by Subject|0|||
124972569|NCT02600897|449525699|FG003|Overall Study|Withdrawal by Subject|0|||
124972570|NCT02600897|449525700|FG004|Overall Study|Withdrawal by Subject|0|||
124972571|NCT02600897|449525701|FG005|Overall Study|Withdrawal by Subject|0|||
124972572|NCT02600897|449525702|FG006|Overall Study|Withdrawal by Subject|0|||
124972573|NCT02600897|449525703|FG007|Overall Study|Withdrawal by Subject|4|||
124972574|NCT02600897|449525704|FG008|Overall Study|Withdrawal by Subject|2|||
124972575|NCT02600897|449525696|FG000|Overall Study|Reason Not Specified|0|||
124972576|NCT02600897|449525697|FG001|Overall Study|Reason Not Specified|0|||
124972577|NCT02600897|449525698|FG002|Overall Study|Reason Not Specified|0|||
124972578|NCT02600897|449525699|FG003|Overall Study|Reason Not Specified|0|||
124972579|NCT02600897|449525700|FG004|Overall Study|Reason Not Specified|0|||
124972580|NCT02600897|449525701|FG005|Overall Study|Reason Not Specified|0|||
124972581|NCT02600897|449525702|FG006|Overall Study|Reason Not Specified|0|||
125036407|NCT00607048|449750988|FG000|Overall Study|Other|1|||
125036408|NCT00607048|449750989|FG001|Overall Study|Other|1|||
125036409|NCT00607048|449750990|FG002|Overall Study|Other|0|||
124972582|NCT02600897|449525703|FG007|Overall Study|Reason Not Specified|0|||
124972583|NCT02600897|449525704|FG008|Overall Study|Reason Not Specified|1|||
124972584|NCT06840769|449525705|FG000|Overall Study|Withdrawal by Subject|1|||
125036410|NCT00607048|449750991|FG003|Overall Study|Other|0|||
125132997|NCT01597245|450111881|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
125132998|NCT01597245|450111882|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
124972585|NCT06840769|449525706|FG001|Overall Study|Withdrawal by Subject|0|||
125218136|NCT03654729|450427277|FG001|Overall Study|Study terminated by Sponsor|5|||
125218137|NCT03654729|450427278|FG002|Overall Study|Study terminated by Sponsor|4|||
125218138|NCT03654729|450427276|FG000|Overall Study|Not reported|2|||
125218139|NCT03654729|450427277|FG001|Overall Study|Not reported|4|||
125218140|NCT03654729|450427278|FG002|Overall Study|Not reported|5|||
125218141|NCT03654729|450427276|FG000|Overall Study|Progressive disease|3|||
125218142|NCT03654729|450427277|FG001|Overall Study|Progressive disease|0|||
125218143|NCT03654729|450427278|FG002|Overall Study|Progressive disease|0|||
125218144|NCT03654729|450427276|FG000|Overall Study|Lost to Follow-up|2|||
125218145|NCT03654729|450427277|FG001|Overall Study|Lost to Follow-up|0|||
125218146|NCT03654729|450427278|FG002|Overall Study|Lost to Follow-up|0|||
125218147|NCT03654729|450427276|FG000|Overall Study|Physician Decision|2|||
125218148|NCT03654729|450427277|FG001|Overall Study|Physician Decision|0|||
125218149|NCT03654729|450427278|FG002|Overall Study|Physician Decision|0|||
125218150|NCT03654729|450427276|FG000|Overall Study|Protocol Violation|1|||
125218151|NCT03654729|450427277|FG001|Overall Study|Protocol Violation|1|||
125218152|NCT03654729|450427278|FG002|Overall Study|Protocol Violation|0|||
125218153|NCT03654729|450427276|FG000|Overall Study|Non-compliance with study drug|0|||
125036411|NCT00607048|449750992|FG004|Overall Study|Other|0|||
125036412|NCT00607048|449750993|FG005|Overall Study|Other|1|||
125036413|NCT00316264|449750994|FG000|Overall Study|Lost to Follow-up|0|||
125036414|NCT00316264|449750995|FG001|Overall Study|Lost to Follow-up|1|||
125036415|NCT00316264|449750996|FG002|Overall Study|Lost to Follow-up|0|||
125036416|NCT00316264|449750994|FG000|Overall Study|Withdrawal of Consent|3|||
125036417|NCT00316264|449750995|FG001|Overall Study|Withdrawal of Consent|5|||
125036418|NCT00316264|449750996|FG002|Overall Study|Withdrawal of Consent|6|||
125036419|NCT00316264|449750994|FG000|Overall Study|Death|2|||
125036420|NCT00316264|449750995|FG001|Overall Study|Death|0|||
125036421|NCT00316264|449750996|FG002|Overall Study|Death|0|||
125036422|NCT00316264|449750994|FG000|Overall Study|Other|1|||
125036423|NCT00316264|449750995|FG001|Overall Study|Other|1|||
125036424|NCT00316264|449750996|FG002|Overall Study|Other|0|||
125036425|NCT00355264|449750997|FG000|Extension (Variable Duration)|Adverse Event|1|||
125036426|NCT00355264|449750997|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
125036427|NCT00826514|449750998|FG000|Overall Study|Adverse Event|1|||
125036428|NCT00826514|449750999|FG001|Overall Study|Adverse Event|1|||
125036429|NCT00826514|449750998|FG000|Overall Study|Lack of Efficacy|0|||
125036430|NCT00826514|449750999|FG001|Overall Study|Lack of Efficacy|1|||
125036431|NCT00826514|449750998|FG000|Overall Study|Withdrawal by Subject|2|||
125036432|NCT00826514|449750999|FG001|Overall Study|Withdrawal by Subject|3|||
125036433|NCT03926143|449751001|FG000|Overall Study|Physician Decision|3|||
125036434|NCT03926143|449751001|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
125036435|NCT03926143|449751001|FG000|Overall Study|Adverse Event|2|||
125036436|NCT03926143|449751001|FG000|Overall Study|Progressive disease|3|||
125036437|NCT02561156|449751002|FG000|Part 2|Adverse Event|0|||
125036438|NCT02561156|449751003|FG001|Part 2|Adverse Event|0|||
125036439|NCT02561156|449751004|FG002|Part 2|Adverse Event|0|||
125036440|NCT02561156|449751005|FG003|Part 2|Adverse Event|0|||
125036441|NCT02561156|449751006|FG004|Part 2|Adverse Event|0|||
125036442|NCT02561156|449751007|FG005|Part 2|Adverse Event|0|||
125036443|NCT02561156|449751008|FG006|Part 2|Adverse Event|0|||
125036444|NCT02561156|449751009|FG007|Part 2|Adverse Event|0|||
125036445|NCT02561156|449751010|FG008|Part 2|Adverse Event|0|||
125036446|NCT02561156|449751011|FG009|Part 2|Adverse Event|0|||
125036447|NCT02561156|449751012|FG010|Part 2|Adverse Event|0|||
125036448|NCT02561156|449751013|FG011|Part 2|Adverse Event|1|||
125036449|NCT02561156|449751014|FG012|Part 2|Adverse Event|0|||
125036450|NCT00098787|449751022|FG000|Overall Study|Never started treatment|3|||
125036451|NCT00098787|449751023|FG001|Overall Study|Never started treatment|2|||
125036452|NCT00098787|449751024|FG002|Overall Study|Never started treatment|1|||
125036453|NCT00098787|449751022|FG000|Overall Study|Ineligible|9|||
125036454|NCT00098787|449751023|FG001|Overall Study|Ineligible|7|||
125036455|NCT00098787|449751024|FG002|Overall Study|Ineligible|3|||
125036456|NCT00098787|449751022|FG000|Overall Study|Disease progression|28|||
125036457|NCT00098787|449751023|FG001|Overall Study|Disease progression|17|||
125036458|NCT00098787|449751024|FG002|Overall Study|Disease progression|23|||
125036459|NCT00098787|449751022|FG000|Overall Study|Adverse Event|8|||
125036460|NCT00098787|449751023|FG001|Overall Study|Adverse Event|17|||
125036461|NCT00098787|449751024|FG002|Overall Study|Adverse Event|8|||
125036462|NCT00098787|449751022|FG000|Overall Study|Death|6|||
125036463|NCT00098787|449751023|FG001|Overall Study|Death|1|||
125036464|NCT00098787|449751024|FG002|Overall Study|Death|0|||
125036465|NCT00098787|449751022|FG000|Overall Study|Withdrawal by Subject|4|||
125036466|NCT00098787|449751023|FG001|Overall Study|Withdrawal by Subject|12|||
125218154|NCT03654729|450427277|FG001|Overall Study|Non-compliance with study drug|1|||
125218155|NCT03654729|450427278|FG002|Overall Study|Non-compliance with study drug|0|||
125218156|NCT03654729|450427276|FG000|Overall Study|Site terminated by Sponsor|1|||
125036467|NCT00098787|449751024|FG002|Overall Study|Withdrawal by Subject|6|||
125036468|NCT00098787|449751022|FG000|Overall Study|Alternative therapy|8|||
125036469|NCT00098787|449751023|FG001|Overall Study|Alternative therapy|13|||
125036470|NCT00098787|449751024|FG002|Overall Study|Alternative therapy|13|||
125036471|NCT00098787|449751022|FG000|Overall Study|Other|7|||
125036472|NCT00098787|449751023|FG001|Overall Study|Other|6|||
125036473|NCT00098787|449751024|FG002|Overall Study|Other|9|||
125036474|NCT02203149|449751027|FG000|Part 1|Adverse Event|0|||
125036475|NCT02203149|449751028|FG001|Part 1|Adverse Event|1|||
125036476|NCT02203149|449751029|FG002|Part 1|Adverse Event|0|||
125036477|NCT02203149|449751030|FG003|Part 1|Adverse Event|0|||
125036478|NCT02203149|449751031|FG004|Part 1|Adverse Event|0|||
125036479|NCT02203149|449751027|FG000|Part 2|Death|0|||
125036480|NCT02203149|449751028|FG001|Part 2|Death|0|||
125036481|NCT02203149|449751029|FG002|Part 2|Death|1|||
125036482|NCT02203149|449751030|FG003|Part 2|Death|1|||
125036483|NCT02203149|449751031|FG004|Part 2|Death|0|||
125036484|NCT02203149|449751027|FG000|Part 2|Withdrawal by Subject|0|||
125036485|NCT02203149|449751028|FG001|Part 2|Withdrawal by Subject|0|||
125036486|NCT02203149|449751029|FG002|Part 2|Withdrawal by Subject|0|||
125036487|NCT02203149|449751030|FG003|Part 2|Withdrawal by Subject|1|||
125036488|NCT02203149|449751031|FG004|Part 2|Withdrawal by Subject|0|||
125036489|NCT02203149|449751027|FG000|Part 2|Adverse Event|0|||
125036490|NCT02203149|449751028|FG001|Part 2|Adverse Event|0|||
125036491|NCT02203149|449751029|FG002|Part 2|Adverse Event|0|||
125036492|NCT02203149|449751030|FG003|Part 2|Adverse Event|1|||
125036493|NCT02203149|449751031|FG004|Part 2|Adverse Event|1|||
125036494|NCT01360996|449751032|FG000|Overall Study|Withdrawal by Subject|4|||
125036495|NCT01360996|449751033|FG001|Overall Study|Withdrawal by Subject|3|||
125036496|NCT01360996|449751034|FG002|Overall Study|Withdrawal by Subject|2|||
125036497|NCT01360996|449751032|FG000|Overall Study|Noncompliant|2|||
125036498|NCT01360996|449751033|FG001|Overall Study|Noncompliant|0|||
125036499|NCT01360996|449751034|FG002|Overall Study|Noncompliant|0|||
125036500|NCT01454076|449751035|FG000|Overall Study|Other|2|||
125036501|NCT01454076|449751036|FG001|Overall Study|Other|0|||
125036502|NCT01454076|449751037|FG002|Overall Study|Other|0|||
125036503|NCT01454076|449751038|FG003|Overall Study|Other|1|||
125036504|NCT01454076|449751039|FG004|Overall Study|Other|2|||
125036505|NCT01454076|449751035|FG000|Overall Study|Withdrawal by Subject|3|||
125036506|NCT01454076|449751036|FG001|Overall Study|Withdrawal by Subject|4|||
125036507|NCT01454076|449751037|FG002|Overall Study|Withdrawal by Subject|2|||
125036508|NCT01454076|449751038|FG003|Overall Study|Withdrawal by Subject|1|||
125036509|NCT01454076|449751039|FG004|Overall Study|Withdrawal by Subject|2|||
125036510|NCT01454076|449751035|FG000|Overall Study|Adverse Event|8|||
125036511|NCT01454076|449751036|FG001|Overall Study|Adverse Event|2|||
125036512|NCT01454076|449751037|FG002|Overall Study|Adverse Event|7|||
125218157|NCT03654729|450427277|FG001|Overall Study|Site terminated by Sponsor|0|||
125218158|NCT03654729|450427278|FG002|Overall Study|Site terminated by Sponsor|0|||
125218159|NCT01000974|450427282|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
125218160|NCT01000974|450427283|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
125218161|NCT01000974|450427284|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
125036513|NCT01454076|449751038|FG003|Overall Study|Adverse Event|0|||
125036514|NCT01454076|449751039|FG004|Overall Study|Adverse Event|2|||
125036515|NCT04964258|449751040|FG000|Overall Study|Lost to Follow-up|1|||
125036516|NCT04964258|449751041|FG001|Overall Study|Lost to Follow-up|0|||
125036517|NCT04964258|449751042|FG002|Overall Study|Lost to Follow-up|0|||
125036518|NCT04964258|449751043|FG003|Overall Study|Lost to Follow-up|0|||
125036519|NCT04964258|449751044|FG004|Overall Study|Lost to Follow-up|0|||
125036520|NCT04964258|449751045|FG005|Overall Study|Lost to Follow-up|1|||
125036521|NCT04964258|449751046|FG006|Overall Study|Lost to Follow-up|0|||
125036522|NCT04964258|449751047|FG007|Overall Study|Lost to Follow-up|0|||
125036523|NCT04964258|449751048|FG008|Overall Study|Lost to Follow-up|0|||
125036524|NCT04964258|449751049|FG009|Overall Study|Lost to Follow-up|0|||
125036525|NCT04964258|449751050|FG010|Overall Study|Lost to Follow-up|0|||
125036526|NCT01478958|449751051|FG000|Overall Study|Withdrawal by Subject|1|||
125036527|NCT01478958|449751052|FG001|Overall Study|Withdrawal by Subject|1|||
125036528|NCT01478958|449751053|FG002|Overall Study|Withdrawal by Subject|1|||
125036529|NCT01478958|449751051|FG000|Overall Study|Weight loss|1|||
125036530|NCT01478958|449751052|FG001|Overall Study|Weight loss|0|||
125036531|NCT01478958|449751053|FG002|Overall Study|Weight loss|0|||
125218162|NCT01000974|450427282|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
125218163|NCT01000974|450427283|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
125036532|NCT01478958|449751051|FG000|Overall Study|Re-located|0|||
125036533|NCT01478958|449751052|FG001|Overall Study|Re-located|1|||
125036534|NCT01478958|449751053|FG002|Overall Study|Re-located|0|||
125036535|NCT01478958|449751051|FG000|Overall Study|Unable to comply|0|||
125036536|NCT01478958|449751052|FG001|Overall Study|Unable to comply|0|||
125036537|NCT01478958|449751053|FG002|Overall Study|Unable to comply|2|||
125036538|NCT02305563|449751054|FG000|Treatment Period|Disease progression|0|||
125036539|NCT02305563|449751055|FG001|Treatment Period|Disease progression|0|||
125036540|NCT02305563|449751056|FG002|Treatment Period|Disease progression|15|||
125218164|NCT01000974|450427284|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
125218165|NCT01000974|450427282|FG000|Primary Vaccination Phase|Protocol Violation|40|||
125218166|NCT01000974|450427283|FG001|Primary Vaccination Phase|Protocol Violation|3|||
125218167|NCT01000974|450427284|FG002|Primary Vaccination Phase|Protocol Violation|2|||
125218168|NCT01000974|450427282|FG000|Primary Vaccination Phase|Adverse Event|14|||
125218169|NCT01000974|450427283|FG001|Primary Vaccination Phase|Adverse Event|2|||
125218170|NCT01000974|450427284|FG002|Primary Vaccination Phase|Adverse Event|2|||
125218171|NCT01000974|450427282|FG000|Primary Vaccination Phase|Other|4|||
125218172|NCT01000974|450427283|FG001|Primary Vaccination Phase|Other|9|||
125218173|NCT01000974|450427284|FG002|Primary Vaccination Phase|Other|12|||
125218174|NCT01000974|450427282|FG000|Booster Vaccination Phase|Protocol Violation|0|||
125218175|NCT01000974|450427283|FG001|Booster Vaccination Phase|Protocol Violation|0|||
125218176|NCT01000974|450427284|FG002|Booster Vaccination Phase|Protocol Violation|2|||
125218177|NCT01000974|450427282|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
125218178|NCT01000974|450427283|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
125218179|NCT01000974|450427284|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
125218180|NCT01000974|450427282|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
125218181|NCT01000974|450427283|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
125218182|NCT01000974|450427284|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
125218183|NCT01000974|450427282|FG000|Booster Vaccination Phase|Other|24|||
125218184|NCT01000974|450427283|FG001|Booster Vaccination Phase|Other|6|||
125218185|NCT01000974|450427284|FG002|Booster Vaccination Phase|Other|4|||
125218186|NCT02750332|450427285|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125218187|NCT02750332|450427286|FG001|Treatment Period 1|Withdrawal by Subject|1|||
125218188|NCT00621257|450427287|FG000|Overall Study|Lost to Follow-up|4|||
125218189|NCT00621257|450427288|FG001|Overall Study|Lost to Follow-up|0|||
125218190|NCT00621257|450427289|FG002|Overall Study|Lost to Follow-up|2|||
125218191|NCT00621257|450427290|FG003|Overall Study|Lost to Follow-up|4|||
125218192|NCT00621257|450427291|FG004|Overall Study|Lost to Follow-up|7|||
125218193|NCT00621257|450427287|FG000|Overall Study|Adverse Event|0|||
125218194|NCT00621257|450427288|FG001|Overall Study|Adverse Event|1|||
125218195|NCT00621257|450427289|FG002|Overall Study|Adverse Event|1|||
125132999|NCT01597245|450111883|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
125133000|NCT01597245|450111884|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125133001|NCT01597245|450111885|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125133002|NCT01597245|450111886|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125133003|NCT01597245|450111887|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125133004|NCT01597245|450111888|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125133005|NCT01597245|450111889|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125133006|NCT01597245|450111890|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125133007|NCT01597245|450111891|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125133008|NCT01597245|450111871|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133009|NCT01597245|450111872|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133010|NCT01597245|450111873|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133011|NCT01597245|450111874|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133012|NCT01597245|450111875|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
125133013|NCT01597245|450111876|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133014|NCT01597245|450111877|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133015|NCT01597245|450111878|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133016|NCT01597245|450111879|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
125133017|NCT01597245|450111880|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
125133018|NCT01597245|450111881|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
125133019|NCT01597245|450111882|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133020|NCT01597245|450111883|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
125133021|NCT01597245|450111884|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133022|NCT01597245|450111885|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125218196|NCT00621257|450427290|FG003|Overall Study|Adverse Event|0|||
125218197|NCT00621257|450427291|FG004|Overall Study|Adverse Event|0|||
125218198|NCT00621257|450427287|FG000|Overall Study|Physician Decision|0|||
125218199|NCT00621257|450427288|FG001|Overall Study|Physician Decision|2|||
125218200|NCT00621257|450427289|FG002|Overall Study|Physician Decision|0|||
125218201|NCT00621257|450427290|FG003|Overall Study|Physician Decision|1|||
125218202|NCT00621257|450427291|FG004|Overall Study|Physician Decision|1|||
125218203|NCT00621257|450427287|FG000|Overall Study|Withdrawal by Subject|0|||
125218204|NCT00621257|450427288|FG001|Overall Study|Withdrawal by Subject|0|||
125036541|NCT02305563|449751057|FG003|Treatment Period|Disease progression|6|||
125036542|NCT02305563|449751058|FG004|Treatment Period|Disease progression|6|||
125036543|NCT02305563|449751054|FG000|Treatment Period|Study drug toxicity|0|||
125036544|NCT02305563|449751055|FG001|Treatment Period|Study drug toxicity|0|||
125036545|NCT02305563|449751056|FG002|Treatment Period|Study drug toxicity|0|||
125036546|NCT02305563|449751057|FG003|Treatment Period|Study drug toxicity|1|||
125036547|NCT02305563|449751058|FG004|Treatment Period|Study drug toxicity|2|||
125036548|NCT02305563|449751054|FG000|Treatment Period|Death|0|||
125036549|NCT02305563|449751055|FG001|Treatment Period|Death|0|||
125036550|NCT02305563|449751056|FG002|Treatment Period|Death|1|||
125036551|NCT02305563|449751057|FG003|Treatment Period|Death|2|||
125036552|NCT02305563|449751058|FG004|Treatment Period|Death|1|||
125036553|NCT02305563|449751054|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
125036554|NCT02305563|449751055|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
125036555|NCT02305563|449751056|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
125036556|NCT02305563|449751057|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
125036557|NCT02305563|449751058|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
125036558|NCT02305563|449751054|FG000|Treatment Period|Participant request to stop therapy|0|||
125036559|NCT02305563|449751055|FG001|Treatment Period|Participant request to stop therapy|2|||
125036560|NCT02305563|449751056|FG002|Treatment Period|Participant request to stop therapy|0|||
125036561|NCT02305563|449751057|FG003|Treatment Period|Participant request to stop therapy|1|||
125036562|NCT02305563|449751058|FG004|Treatment Period|Participant request to stop therapy|0|||
125036563|NCT02305563|449751054|FG000|Treatment Period|Participant withdrew consent|0|||
125036564|NCT02305563|449751055|FG001|Treatment Period|Participant withdrew consent|0|||
125036565|NCT02305563|449751056|FG002|Treatment Period|Participant withdrew consent|1|||
125036566|NCT02305563|449751057|FG003|Treatment Period|Participant withdrew consent|1|||
125036567|NCT02305563|449751058|FG004|Treatment Period|Participant withdrew consent|1|||
125036568|NCT02305563|449751054|FG000|Treatment Period|Maximum clinical benefit|0|||
125036569|NCT02305563|449751055|FG001|Treatment Period|Maximum clinical benefit|0|||
125036570|NCT02305563|449751056|FG002|Treatment Period|Maximum clinical benefit|0|||
125036571|NCT02305563|449751057|FG003|Treatment Period|Maximum clinical benefit|0|||
125133023|NCT01597245|450111886|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133024|NCT01597245|450111887|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133025|NCT01597245|450111888|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133026|NCT01597245|450111889|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133027|NCT01597245|450111890|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133028|NCT01597245|450111891|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133029|NCT01597245|450111871|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133030|NCT01597245|450111872|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133031|NCT01597245|450111873|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133032|NCT01597245|450111874|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133033|NCT01597245|450111875|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
125133034|NCT01597245|450111876|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
125133035|NCT01597245|450111877|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
125133036|NCT01597245|450111878|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133037|NCT01597245|450111879|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
125133038|NCT01597245|450111880|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
125133039|NCT01597245|450111881|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
125133040|NCT01597245|450111882|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
125133041|NCT01597245|450111883|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
125036572|NCT02305563|449751058|FG004|Treatment Period|Maximum clinical benefit|1|||
125133042|NCT01597245|450111884|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125218205|NCT00621257|450427289|FG002|Overall Study|Withdrawal by Subject|0|||
125218206|NCT00621257|450427290|FG003|Overall Study|Withdrawal by Subject|1|||
125218207|NCT00621257|450427291|FG004|Overall Study|Withdrawal by Subject|1|||
125218208|NCT01255904|450427292|FG000|Overall Study|Physician Decision|1|||
124972586|NCT06840769|449525707|FG002|Overall Study|Withdrawal by Subject|0|||
124972587|NCT06840769|449525708|FG003|Overall Study|Withdrawal by Subject|0|||
124972588|NCT06840769|449525709|FG004|Overall Study|Withdrawal by Subject|0|||
124972589|NCT03258723|449527270|FG000|Overall Study|COVID Interruption of study|54|||
124972590|NCT03258723|449527270|FG000|Overall Study|Lost to Follow-up|8|||
124972591|NCT00592293|449527272|FG000|Overall Study|Withdrawal by Subject|1|||
124972592|NCT00944229|449527273|FG000|Overall Study|Withdrawal by Subject|11|||
124972593|NCT00944229|449527273|FG000|Overall Study|Physician Decision|14|||
124972594|NCT04292470|449527274|FG000|Overall Study|Withdrawal by Subject|0|||
124972595|NCT04292470|449527275|FG001|Overall Study|Withdrawal by Subject|1|||
124972596|NCT02906020|449527276|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
124972597|NCT02906020|449527277|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
124972598|NCT02906020|449527278|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
124972599|NCT02906020|449527279|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
124972600|NCT02906020|449527280|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
124972601|NCT02906020|449527281|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
124972602|NCT02906020|449527282|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
124972603|NCT02906020|449527283|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
124972604|NCT02906020|449527284|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
124972605|NCT02906020|449527285|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
124972606|NCT02906020|449527286|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
124972607|NCT02906020|449527287|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
124972608|NCT02906020|449527288|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
124972609|NCT02906020|449527289|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
124972610|NCT02906020|449527290|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
124972611|NCT02906020|449527291|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
124972612|NCT02906020|449527276|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972613|NCT02906020|449527277|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972614|NCT02906020|449527278|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972615|NCT02906020|449527279|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972616|NCT02906020|449527280|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972617|NCT02906020|449527281|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972618|NCT02906020|449527282|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972619|NCT02906020|449527283|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972620|NCT02906020|449527284|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
125133043|NCT01597245|450111885|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133044|NCT01597245|450111886|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133045|NCT01597245|450111887|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133046|NCT01597245|450111888|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133047|NCT01597245|450111889|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133048|NCT01597245|450111890|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133049|NCT01597245|450111891|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133050|NCT01597245|450111871|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133051|NCT01597245|450111872|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133052|NCT01597245|450111873|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133053|NCT01597245|450111874|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133054|NCT01597245|450111875|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133055|NCT01597245|450111876|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
125133056|NCT01597245|450111877|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133057|NCT01597245|450111878|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133058|NCT01597245|450111879|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
124972621|NCT02906020|449527285|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
125133059|NCT01597245|450111880|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
125218209|NCT01255904|450427293|FG001|Overall Study|Physician Decision|4|||
124972622|NCT02906020|449527286|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972623|NCT02906020|449527287|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
125218210|NCT00632125|450427295|FG000|Overall Study|Death|82|||
125218211|NCT00632125|450427295|FG000|Overall Study|Withdrawal by Subject|44|||
125133060|NCT01597245|450111881|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
125133061|NCT01597245|450111882|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
125133062|NCT01597245|450111883|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133063|NCT01597245|450111884|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133064|NCT01597245|450111885|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133065|NCT01597245|450111886|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133066|NCT01597245|450111887|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133067|NCT01597245|450111888|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133068|NCT01597245|450111889|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133069|NCT01597245|450111890|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133070|NCT01597245|450111891|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133071|NCT01597245|450111871|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133072|NCT01597245|450111872|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133073|NCT01597245|450111873|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133074|NCT01597245|450111874|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133075|NCT01597245|450111875|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133076|NCT01597245|450111876|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133077|NCT01597245|450111877|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133078|NCT01597245|450111878|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133079|NCT01597245|450111879|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133080|NCT01597245|450111880|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133081|NCT01597245|450111881|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
125133082|NCT01597245|450111882|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133083|NCT01597245|450111883|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133084|NCT01597245|450111884|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
124972624|NCT02906020|449527288|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972625|NCT02906020|449527289|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
125133085|NCT01597245|450111885|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133086|NCT01597245|450111886|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133087|NCT01597245|450111887|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133088|NCT01597245|450111888|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133089|NCT01597245|450111889|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133090|NCT01597245|450111890|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133091|NCT01597245|450111891|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133092|NCT01597245|450111871|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133093|NCT01597245|450111872|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
124972626|NCT02906020|449527290|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972627|NCT02906020|449527291|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972628|NCT02906020|449527276|FG000|Part 2: Double-blind Treatment Period|Other|0|||
124972629|NCT02906020|449527277|FG001|Part 2: Double-blind Treatment Period|Other|0|||
124972630|NCT02906020|449527278|FG002|Part 2: Double-blind Treatment Period|Other|0|||
124972631|NCT02906020|449527279|FG003|Part 2: Double-blind Treatment Period|Other|0|||
124972632|NCT02906020|449527280|FG004|Part 2: Double-blind Treatment Period|Other|0|||
124972633|NCT02906020|449527281|FG005|Part 2: Double-blind Treatment Period|Other|0|||
124972634|NCT02906020|449527282|FG006|Part 2: Double-blind Treatment Period|Other|0|||
124972635|NCT02906020|449527283|FG007|Part 2: Double-blind Treatment Period|Other|0|||
124972636|NCT02906020|449527284|FG008|Part 2: Double-blind Treatment Period|Other|6|||
124972637|NCT02906020|449527285|FG009|Part 2: Double-blind Treatment Period|Other|10|||
124972638|NCT02906020|449527286|FG010|Part 2: Double-blind Treatment Period|Other|0|||
124972639|NCT02906020|449527287|FG011|Part 2: Double-blind Treatment Period|Other|0|||
124972640|NCT02906020|449527288|FG012|Part 2: Double-blind Treatment Period|Other|0|||
124972641|NCT02906020|449527289|FG013|Part 2: Double-blind Treatment Period|Other|0|||
124972642|NCT02906020|449527290|FG014|Part 2: Double-blind Treatment Period|Other|0|||
124972643|NCT02906020|449527291|FG015|Part 2: Double-blind Treatment Period|Other|0|||
124972644|NCT02906020|449527276|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972645|NCT02906020|449527277|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972646|NCT02906020|449527278|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972647|NCT02906020|449527279|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972648|NCT02906020|449527280|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
125133094|NCT01597245|450111873|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133095|NCT01597245|450111874|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133096|NCT01597245|450111875|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
124972649|NCT02906020|449527281|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
125036573|NCT02305563|449751054|FG000|Treatment Period|Poor/non-compliance|0|||
125036574|NCT02305563|449751055|FG001|Treatment Period|Poor/non-compliance|0|||
125036575|NCT02305563|449751056|FG002|Treatment Period|Poor/non-compliance|0|||
125036576|NCT02305563|449751057|FG003|Treatment Period|Poor/non-compliance|0|||
125036577|NCT02305563|449751058|FG004|Treatment Period|Poor/non-compliance|1|||
125036578|NCT02305563|449751054|FG000|Treatment Period|Administrative reason by Sponsor|0|||
125036579|NCT02305563|449751055|FG001|Treatment Period|Administrative reason by Sponsor|0|||
125036580|NCT02305563|449751056|FG002|Treatment Period|Administrative reason by Sponsor|0|||
125036581|NCT02305563|449751057|FG003|Treatment Period|Administrative reason by Sponsor|0|||
125036582|NCT02305563|449751058|FG004|Treatment Period|Administrative reason by Sponsor|1|||
125036583|NCT02305563|449751054|FG000|Treatment Period|other reason|2|||
125036584|NCT02305563|449751055|FG001|Treatment Period|other reason|0|||
125036585|NCT02305563|449751056|FG002|Treatment Period|other reason|2|||
125036586|NCT02305563|449751057|FG003|Treatment Period|other reason|2|||
125036587|NCT02305563|449751058|FG004|Treatment Period|other reason|1|||
125036588|NCT02305563|449751054|FG000|Treatment Period|Randomized but not treated|0|||
125036589|NCT02305563|449751055|FG001|Treatment Period|Randomized but not treated|0|||
125036590|NCT02305563|449751056|FG002|Treatment Period|Randomized but not treated|0|||
125036591|NCT02305563|449751057|FG003|Treatment Period|Randomized but not treated|0|||
125036592|NCT02305563|449751058|FG004|Treatment Period|Randomized but not treated|2|||
125036593|NCT02305563|449751054|FG000|Treatment Period|added ULO, then disease progression|0|||
125036594|NCT02305563|449751055|FG001|Treatment Period|added ULO, then disease progression|0|||
125036595|NCT02305563|449751056|FG002|Treatment Period|added ULO, then disease progression|0|||
125036596|NCT02305563|449751057|FG003|Treatment Period|added ULO, then disease progression|0|||
125036597|NCT02305563|449751058|FG004|Treatment Period|added ULO, then disease progression|4|||
125036598|NCT02305563|449751054|FG000|Treatment Period|added ULO; then other reason|0|||
125036599|NCT02305563|449751055|FG001|Treatment Period|added ULO; then other reason|0|||
125036600|NCT02305563|449751056|FG002|Treatment Period|added ULO; then other reason|0|||
125036601|NCT02305563|449751057|FG003|Treatment Period|added ULO; then other reason|0|||
125036602|NCT02305563|449751058|FG004|Treatment Period|added ULO; then other reason|1|||
125036603|NCT02305563|449751054|FG000|Treatment Period|added ULO, then request to stop|0|||
125036604|NCT02305563|449751055|FG001|Treatment Period|added ULO, then request to stop|0|||
125036605|NCT02305563|449751056|FG002|Treatment Period|added ULO, then request to stop|0|||
125036606|NCT02305563|449751057|FG003|Treatment Period|added ULO, then request to stop|0|||
125036607|NCT02305563|449751058|FG004|Treatment Period|added ULO, then request to stop|1|||
125036608|NCT02305563|449751054|FG000|Follow-up Period|Death|0|||
125036609|NCT02305563|449751055|FG001|Follow-up Period|Death|0|||
125036610|NCT02305563|449751056|FG002|Follow-up Period|Death|5|||
125036611|NCT02305563|449751057|FG003|Follow-up Period|Death|4|||
125036612|NCT02305563|449751058|FG004|Follow-up Period|Death|7|||
125036613|NCT02305563|449751054|FG000|Follow-up Period|Participant withdrew consent|0|||
125036614|NCT02305563|449751055|FG001|Follow-up Period|Participant withdrew consent|0|||
125036615|NCT02305563|449751056|FG002|Follow-up Period|Participant withdrew consent|2|||
125036616|NCT02305563|449751057|FG003|Follow-up Period|Participant withdrew consent|1|||
125036617|NCT02305563|449751058|FG004|Follow-up Period|Participant withdrew consent|0|||
125036618|NCT02305563|449751054|FG000|Follow-up Period|other reason|0|||
125036619|NCT02305563|449751055|FG001|Follow-up Period|other reason|0|||
125036620|NCT02305563|449751056|FG002|Follow-up Period|other reason|0|||
125036621|NCT02305563|449751057|FG003|Follow-up Period|other reason|0|||
125036622|NCT02305563|449751058|FG004|Follow-up Period|other reason|1|||
125036623|NCT02305563|449751054|FG000|Follow-up Period|Followup no longer required per protocol|3|||
125036624|NCT02305563|449751055|FG001|Follow-up Period|Followup no longer required per protocol|3|||
125036625|NCT02305563|449751056|FG002|Follow-up Period|Followup no longer required per protocol|4|||
125036626|NCT02305563|449751057|FG003|Follow-up Period|Followup no longer required per protocol|1|||
125036627|NCT02305563|449751058|FG004|Follow-up Period|Followup no longer required per protocol|4|||
125036628|NCT01926626|449751059|FG000|Overall Study|Withdrawal by Subject|15|||
125036629|NCT01926626|449751059|FG000|Overall Study|Lost to Follow-up|7|||
125036630|NCT03896581|449753021|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
125036631|NCT03896581|449753022|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
125036632|NCT03896581|449753021|FG000|Overall Study|Withdrawal by Subject|4|||
125036633|NCT03896581|449753022|FG001|Overall Study|Withdrawal by Subject|1|||
125036634|NCT03896581|449753021|FG000|Overall Study|Lost to Follow-up|1|||
125036635|NCT03896581|449753022|FG001|Overall Study|Lost to Follow-up|0|||
125036636|NCT03896581|449753021|FG000|Overall Study|Lack of Efficacy|2|||
125036637|NCT03896581|449753022|FG001|Overall Study|Lack of Efficacy|1|||
125036638|NCT03896581|449753021|FG000|Overall Study|Adverse event, non-fatal|0|||
124972650|NCT02906020|449527282|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972651|NCT02906020|449527283|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972652|NCT02906020|449527284|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972653|NCT02906020|449527285|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972654|NCT02906020|449527286|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972655|NCT02906020|449527287|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972656|NCT02906020|449527288|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
124972657|NCT02906020|449527289|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
124972658|NCT02906020|449527290|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972659|NCT02906020|449527291|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972660|NCT02906020|449527276|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972661|NCT02906020|449527277|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972662|NCT02906020|449527278|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972663|NCT02906020|449527279|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972664|NCT02906020|449527280|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972665|NCT02906020|449527281|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972666|NCT02906020|449527282|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972667|NCT02906020|449527283|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972668|NCT02906020|449527284|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972669|NCT02906020|449527285|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972670|NCT02906020|449527286|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972671|NCT02906020|449527287|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972672|NCT02906020|449527288|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
124972673|NCT02906020|449527289|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
124972674|NCT02906020|449527290|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972675|NCT02906020|449527291|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
124972676|NCT02906020|449527276|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972677|NCT02906020|449527277|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972678|NCT02906020|449527278|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972679|NCT02906020|449527279|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972680|NCT02906020|449527280|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972681|NCT02906020|449527281|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972682|NCT02906020|449527282|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972683|NCT02906020|449527283|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972684|NCT02906020|449527284|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972685|NCT02906020|449527285|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972686|NCT02906020|449527286|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
125036639|NCT03896581|449753022|FG001|Overall Study|Adverse event, non-fatal|2|||
125036640|NCT04375761|449753023|FG000|Overall Study|Death|1|||
125036641|NCT04375761|449753024|FG001|Overall Study|Death|2|||
125036642|NCT04375761|449753023|FG000|Overall Study|Lost to Follow-up|203|||
125036643|NCT04375761|449753024|FG001|Overall Study|Lost to Follow-up|380|||
125036644|NCT04375761|449753023|FG000|Overall Study|Withdrawal by Subject|47|||
125036645|NCT04375761|449753024|FG001|Overall Study|Withdrawal by Subject|98|||
125036646|NCT04375761|449753023|FG000|Overall Study|Noncompliance with study procedure|121|||
125036647|NCT04375761|449753024|FG001|Overall Study|Noncompliance with study procedure|251|||
125133097|NCT01597245|450111876|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133098|NCT01597245|450111877|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133099|NCT01597245|450111878|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133100|NCT01597245|450111879|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125036648|NCT04375761|449753023|FG000|Overall Study|Reimbursement not enough|1|||
125036649|NCT04375761|449753024|FG001|Overall Study|Reimbursement not enough|2|||
125036650|NCT04375761|449753023|FG000|Overall Study|Unforeseen family circumstances|1|||
125036651|NCT04375761|449753024|FG001|Overall Study|Unforeseen family circumstances|3|||
125036652|NCT04375761|449753023|FG000|Overall Study|Test too painful|1|||
125036653|NCT04375761|449753024|FG001|Overall Study|Test too painful|1|||
125036654|NCT04375761|449753023|FG000|Overall Study|Moved|0|||
125036655|NCT04375761|449753024|FG001|Overall Study|Moved|2|||
125036656|NCT04375761|449753023|FG000|Overall Study|Nonresponsive|0|||
125036657|NCT04375761|449753024|FG001|Overall Study|Nonresponsive|5|||
125036658|NCT03797001|449753025|FG000|Overall Study|Withdrawn due to COVID19|4|||
125036659|NCT03797001|449753026|FG001|Overall Study|Withdrawn due to COVID19|0|||
125036660|NCT03797001|449753025|FG000|Overall Study|Withdrawal by Subject|7|||
125036661|NCT03797001|449753026|FG001|Overall Study|Withdrawal by Subject|6|||
125036662|NCT03797001|449753025|FG000|Overall Study|Adverse Event|0|||
125036663|NCT03797001|449753026|FG001|Overall Study|Adverse Event|1|||
124972687|NCT02906020|449527287|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972688|NCT02906020|449527288|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
124972689|NCT02906020|449527289|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
124972690|NCT02906020|449527290|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972691|NCT02906020|449527291|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972692|NCT02906020|449527276|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972693|NCT02906020|449527277|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972694|NCT02906020|449527278|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972695|NCT02906020|449527279|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972696|NCT02906020|449527280|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972697|NCT02906020|449527281|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972698|NCT02906020|449527282|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972699|NCT02906020|449527283|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972700|NCT02906020|449527284|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972701|NCT02906020|449527285|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972702|NCT02906020|449527286|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972703|NCT02906020|449527287|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972704|NCT02906020|449527288|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
124972705|NCT02906020|449527289|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
124972706|NCT02906020|449527290|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972707|NCT02906020|449527291|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972708|NCT02906020|449527276|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972709|NCT02906020|449527277|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972710|NCT02906020|449527278|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972711|NCT02906020|449527279|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972712|NCT02906020|449527280|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972713|NCT02906020|449527281|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972714|NCT02906020|449527282|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972715|NCT02906020|449527283|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972716|NCT02906020|449527284|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972717|NCT02906020|449527285|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972718|NCT02906020|449527286|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972719|NCT02906020|449527287|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972720|NCT02906020|449527288|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
124972721|NCT02906020|449527289|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
124972722|NCT02906020|449527290|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
124972723|NCT02906020|449527291|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
125036664|NCT05630846|449753029|FG000|Overall Study|Death|1|||
125036665|NCT05630846|449753030|FG001|Overall Study|Death|0|||
125036666|NCT05630846|449753031|FG002|Overall Study|Death|0|||
125036667|NCT05630846|449753032|FG003|Overall Study|Death|0|||
125036668|NCT05630846|449753029|FG000|Overall Study|Withdrawal by Subject|3|||
125036669|NCT05630846|449753030|FG001|Overall Study|Withdrawal by Subject|3|||
125036670|NCT05630846|449753031|FG002|Overall Study|Withdrawal by Subject|4|||
125036671|NCT05630846|449753032|FG003|Overall Study|Withdrawal by Subject|1|||
125036672|NCT05630846|449753029|FG000|Overall Study|Lost to Follow-up|6|||
125036673|NCT05630846|449753030|FG001|Overall Study|Lost to Follow-up|5|||
125036674|NCT05630846|449753031|FG002|Overall Study|Lost to Follow-up|2|||
125036675|NCT05630846|449753032|FG003|Overall Study|Lost to Follow-up|5|||
125036676|NCT05630846|449753029|FG000|Overall Study|Other|1|||
125036677|NCT05630846|449753030|FG001|Overall Study|Other|0|||
125036678|NCT05630846|449753031|FG002|Overall Study|Other|0|||
125036679|NCT05630846|449753032|FG003|Overall Study|Other|0|||
125036680|NCT00960076|449753044|FG000|Overall Study|Adverse Event|1|||
125036681|NCT00960076|449753045|FG001|Overall Study|Adverse Event|7|||
125036682|NCT00960076|449753044|FG000|Overall Study|No longer met study criteria|1|||
125036683|NCT00960076|449753045|FG001|Overall Study|No longer met study criteria|5|||
125036684|NCT00960076|449753044|FG000|Overall Study|Withdrawal by Subject|1|||
125036685|NCT00960076|449753045|FG001|Overall Study|Withdrawal by Subject|2|||
125036686|NCT00960076|449753044|FG000|Overall Study|Lost to Follow-up|3|||
125036687|NCT00960076|449753045|FG001|Overall Study|Lost to Follow-up|3|||
125036688|NCT00960076|449753044|FG000|Overall Study|Severe non-compliance to protocol|1|||
125036689|NCT00960076|449753045|FG001|Overall Study|Severe non-compliance to protocol|2|||
125036690|NCT00960076|449753044|FG000|Overall Study|Hyperglycemia|1|||
125218212|NCT00632125|450427295|FG000|Overall Study|Adverse Event|36|||
125218213|NCT00632125|450427295|FG000|Overall Study|Renal transplantation|17|||
125218214|NCT00632125|450427295|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
125218215|NCT00632125|450427295|FG000|Overall Study|Non-compliance|8|||
125218216|NCT00632125|450427295|FG000|Overall Study|Development of uncontrolled hypertension|5|||
125218217|NCT00632125|450427295|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
125218218|NCT00540644|450427298|FG000|Overall Study|Adverse Event|3|||
125218219|NCT00540644|450427299|FG001|Overall Study|Adverse Event|1|||
125218220|NCT00540644|450427298|FG000|Overall Study|Disease Progression|3|||
125218221|NCT00540644|450427299|FG001|Overall Study|Disease Progression|1|||
125218222|NCT00540644|450427298|FG000|Overall Study|Physician Decision|0|||
125218223|NCT00540644|450427299|FG001|Overall Study|Physician Decision|5|||
125218224|NCT00540644|450427298|FG000|Overall Study|Withdrawal by Subject|2|||
125218225|NCT00540644|450427299|FG001|Overall Study|Withdrawal by Subject|2|||
125218226|NCT00540644|450427298|FG000|Overall Study|Noncomplilance|1|||
125218227|NCT00540644|450427299|FG001|Overall Study|Noncomplilance|0|||
125218228|NCT00809094|450427300|FG000|Overall Study|Lost to Follow-up|0|||
125218229|NCT00809094|450427301|FG001|Overall Study|Lost to Follow-up|1|||
125218230|NCT00397189|450427303|FG000|3 Weeks Period|Lost to Follow-up|5|||
125218231|NCT00397189|450427304|FG001|3 Weeks Period|Lost to Follow-up|4|||
125218232|NCT00397189|450427303|FG000|3 Weeks Period|Adverse Event|3|||
125218233|NCT00397189|450427304|FG001|3 Weeks Period|Adverse Event|2|||
125218234|NCT00397189|450427303|FG000|3 Weeks Period|Withdrawal by Subject|13|||
125218235|NCT00397189|450427304|FG001|3 Weeks Period|Withdrawal by Subject|9|||
125218236|NCT00397189|450427303|FG000|3 Weeks Period|Physician Decision|0|||
125218237|NCT00397189|450427304|FG001|3 Weeks Period|Physician Decision|2|||
125218238|NCT00397189|450427303|FG000|3 Weeks Period|Protocol Violation|0|||
125218239|NCT00397189|450427304|FG001|3 Weeks Period|Protocol Violation|3|||
125218240|NCT00397189|450427303|FG000|3 Weeks Period|Other|0|||
125218241|NCT00397189|450427304|FG001|3 Weeks Period|Other|2|||
125218242|NCT01535443|450427307|FG000|Overall Study|Physician Decision|3|||
125036691|NCT00960076|449753045|FG001|Overall Study|Hyperglycemia|5|||
125036692|NCT00960076|449753044|FG000|Overall Study|Did not attend the termination visit|0|||
125036693|NCT00960076|449753045|FG001|Overall Study|Did not attend the termination visit|1|||
125036694|NCT00500266|449753046|FG000|Overall Study|Death|3|||
125036695|NCT00500266|449753046|FG000|Overall Study|Lost to Follow-up|3|||
125036696|NCT00500266|449753046|FG000|Overall Study|Withdrawal by Subject|3|||
125036697|NCT00500266|449753046|FG000|Overall Study|Assigned, not treated|4|||
125036698|NCT01431287|449753047|FG000|Overall Study|not treated|0|||
125036699|NCT01431287|449753048|FG001|Overall Study|not treated|0|||
125036700|NCT01431287|449753049|FG002|Overall Study|not treated|1|||
125036701|NCT01431287|449753050|FG003|Overall Study|not treated|0|||
125036702|NCT01431287|449753051|FG004|Overall Study|not treated|0|||
125036703|NCT01431287|449753047|FG000|Overall Study|Adverse Event|59|||
125036704|NCT01431287|449753048|FG001|Overall Study|Adverse Event|57|||
125036705|NCT01431287|449753049|FG002|Overall Study|Adverse Event|53|||
125133101|NCT01597245|450111880|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133102|NCT01597245|450111881|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133103|NCT01597245|450111882|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133104|NCT01597245|450111883|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133105|NCT01597245|450111884|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
125133106|NCT01597245|450111885|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
125133107|NCT01597245|450111886|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
125133108|NCT01597245|450111887|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133109|NCT01597245|450111888|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133110|NCT01597245|450111889|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133111|NCT01597245|450111890|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133112|NCT01597245|450111891|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133113|NCT01597245|450111871|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133114|NCT01597245|450111872|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125218243|NCT00232557|450427308|FG000|Overall Study|Lost to Follow-up|3|||
125218244|NCT00232557|450427309|FG001|Overall Study|Lost to Follow-up|5|||
125218245|NCT01059773|450427310|FG000|Overall Study|Adverse Event|2|||
125218246|NCT01059773|450427311|FG001|Overall Study|Adverse Event|2|||
125218247|NCT01059773|450427310|FG000|Overall Study|Withdrawal by Subject|1|||
125218248|NCT01059773|450427311|FG001|Overall Study|Withdrawal by Subject|5|||
125036706|NCT01431287|449753050|FG003|Overall Study|Adverse Event|33|||
125218249|NCT01059773|450427310|FG000|Overall Study|Lost to Follow-up|1|||
125218250|NCT01059773|450427311|FG001|Overall Study|Lost to Follow-up|1|||
125218251|NCT01059773|450427310|FG000|Overall Study|Pregnancy|1|||
125218252|NCT01059773|450427311|FG001|Overall Study|Pregnancy|1|||
125036707|NCT01431287|449753051|FG004|Overall Study|Adverse Event|41|||
125133115|NCT01597245|450111873|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133116|NCT01597245|450111874|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133117|NCT01597245|450111875|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133118|NCT01597245|450111876|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133119|NCT01597245|450111877|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133120|NCT01597245|450111878|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133121|NCT01597245|450111879|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133122|NCT01597245|450111880|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
124972724|NCT02906020|449527276|FG000|Part 2: Long-term Follow-up Period|Other|0|||
124972725|NCT02906020|449527277|FG001|Part 2: Long-term Follow-up Period|Other|0|||
124972726|NCT02906020|449527278|FG002|Part 2: Long-term Follow-up Period|Other|0|||
124972727|NCT02906020|449527279|FG003|Part 2: Long-term Follow-up Period|Other|0|||
124972728|NCT02906020|449527280|FG004|Part 2: Long-term Follow-up Period|Other|0|||
124972729|NCT02906020|449527281|FG005|Part 2: Long-term Follow-up Period|Other|0|||
124972730|NCT02906020|449527282|FG006|Part 2: Long-term Follow-up Period|Other|0|||
124972731|NCT02906020|449527283|FG007|Part 2: Long-term Follow-up Period|Other|0|||
124972732|NCT02906020|449527284|FG008|Part 2: Long-term Follow-up Period|Other|0|||
124972733|NCT02906020|449527285|FG009|Part 2: Long-term Follow-up Period|Other|0|||
124972734|NCT02906020|449527286|FG010|Part 2: Long-term Follow-up Period|Other|0|||
124972735|NCT02906020|449527287|FG011|Part 2: Long-term Follow-up Period|Other|0|||
124972736|NCT02906020|449527288|FG012|Part 2: Long-term Follow-up Period|Other|13|||
124972737|NCT02906020|449527289|FG013|Part 2: Long-term Follow-up Period|Other|8|||
124972738|NCT02906020|449527290|FG014|Part 2: Long-term Follow-up Period|Other|3|||
124972739|NCT02906020|449527291|FG015|Part 2: Long-term Follow-up Period|Other|2|||
124972740|NCT04340947|449527294|FG000|7-day Washout Period|Lost to Follow-up|5|||
124972741|NCT04340947|449527295|FG001|7-day Washout Period|Lost to Follow-up|4|||
124972742|NCT00884650|449527297|FG000|Overall Study|Did not return complete pain diaries|7|||
124972743|NCT00884650|449527298|FG001|Overall Study|Did not return complete pain diaries|7|||
124972744|NCT00884650|449527297|FG000|Overall Study|Admitted Post-Op|1|||
124972745|NCT00884650|449527298|FG001|Overall Study|Admitted Post-Op|0|||
124972746|NCT00884650|449527297|FG000|Overall Study|Femoral Stress Fracture|1|||
124972747|NCT00884650|449527298|FG001|Overall Study|Femoral Stress Fracture|0|||
124972748|NCT00884650|449527297|FG000|Overall Study|Pain Pump Complication|0|||
124972749|NCT00884650|449527298|FG001|Overall Study|Pain Pump Complication|1|||
124972750|NCT01594827|449527303|FG000|Overall Study|Adverse Event|1|||
124972751|NCT01594827|449527304|FG001|Overall Study|Adverse Event|0|||
124972752|NCT01594827|449527303|FG000|Overall Study|Physician Decision|3|||
124972753|NCT01594827|449527304|FG001|Overall Study|Physician Decision|0|||
124972754|NCT02030002|449527306|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
124972755|NCT02030002|449527306|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
124972756|NCT02030002|449527306|FG000|Follow-up|Lost to Follow-up|2|||
124972757|NCT01592045|449527307|FG000|Overall Study|Disease Progression|1|||
124972758|NCT01592045|449527308|FG001|Overall Study|Disease Progression|1|||
124972759|NCT01592045|449527307|FG000|Overall Study|Adverse Event|1|||
124972760|NCT01592045|449527308|FG001|Overall Study|Adverse Event|1|||
124972761|NCT01592045|449527307|FG000|Overall Study|Withdrawal by Subject|1|||
124972762|NCT01592045|449527308|FG001|Overall Study|Withdrawal by Subject|0|||
124972763|NCT01592045|449527307|FG000|Overall Study|Moved out of country|2|||
124972764|NCT01592045|449527308|FG001|Overall Study|Moved out of country|0|||
124972765|NCT03994731|449527309|FG000|Pegloticase + IMM Period|Death|2|||
124972766|NCT03994731|449527310|FG001|Pegloticase + IMM Period|Death|0|||
124972767|NCT03994731|449527309|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
124972768|NCT03994731|449527310|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
124972769|NCT03994731|449527309|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
124972770|NCT03994731|449527310|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
124972771|NCT00609947|449527311|FG000|Overall Study|Death|1|||
124972772|NCT03812029|449527317|FG000|Overall Study|Protocol Violation|1|||
124972773|NCT03812029|449527318|FG001|Overall Study|Protocol Violation|0|||
124972774|NCT03812029|449527319|FG002|Overall Study|Protocol Violation|0|||
124972775|NCT03812029|449527320|FG003|Overall Study|Protocol Violation|1|||
124972776|NCT03812029|449527321|FG004|Overall Study|Protocol Violation|0|||
124972777|NCT03812029|449527317|FG000|Overall Study|Withdrawal by Subject|1|||
124972778|NCT03812029|449527318|FG001|Overall Study|Withdrawal by Subject|0|||
124972779|NCT03812029|449527319|FG002|Overall Study|Withdrawal by Subject|0|||
124972780|NCT03812029|449527320|FG003|Overall Study|Withdrawal by Subject|2|||
125133123|NCT01597245|450111881|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133124|NCT01597245|450111882|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133125|NCT01597245|450111883|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133126|NCT01597245|450111884|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
125133127|NCT01597245|450111885|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
125133128|NCT01597245|450111886|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
125133129|NCT01597245|450111887|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133130|NCT01597245|450111888|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133131|NCT01597245|450111889|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133132|NCT01597245|450111890|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133133|NCT01597245|450111891|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133134|NCT01597245|450111871|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133135|NCT01597245|450111872|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133136|NCT01597245|450111873|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133137|NCT01597245|450111874|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133138|NCT01597245|450111875|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133139|NCT01597245|450111876|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133140|NCT01597245|450111877|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133141|NCT01597245|450111878|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133142|NCT01597245|450111879|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133143|NCT01597245|450111880|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133144|NCT01597245|450111881|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133145|NCT01597245|450111882|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133146|NCT01597245|450111883|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133147|NCT01597245|450111884|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133148|NCT01597245|450111885|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
125133149|NCT01597245|450111886|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
125133150|NCT01597245|450111887|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133151|NCT01597245|450111888|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133152|NCT01597245|450111889|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133153|NCT01597245|450111890|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133154|NCT01597245|450111891|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133155|NCT01597245|450111871|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133156|NCT01597245|450111872|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133157|NCT01597245|450111873|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133158|NCT01597245|450111874|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133159|NCT01597245|450111875|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133160|NCT01597245|450111876|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133161|NCT01597245|450111877|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133162|NCT01597245|450111878|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133163|NCT01597245|450111879|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133164|NCT01597245|450111880|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133165|NCT01597245|450111881|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133166|NCT01597245|450111882|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133167|NCT01597245|450111883|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133168|NCT01597245|450111884|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125218253|NCT01059773|450427310|FG000|Overall Study|Protocol Violation|6|||
125133169|NCT01597245|450111885|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
125133170|NCT01597245|450111886|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
125133171|NCT01597245|450111887|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133172|NCT01597245|450111888|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133173|NCT01597245|450111889|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133174|NCT01597245|450111890|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133175|NCT01597245|450111891|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133176|NCT01597245|450111871|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133177|NCT01597245|450111872|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133178|NCT01597245|450111873|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133179|NCT01597245|450111874|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133180|NCT01597245|450111875|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133181|NCT01597245|450111876|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133182|NCT01597245|450111877|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133183|NCT01597245|450111878|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133184|NCT01597245|450111879|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125036708|NCT01431287|449753047|FG000|Overall Study|Non compliant with protocol|6|||
125036709|NCT01431287|449753048|FG001|Overall Study|Non compliant with protocol|6|||
125036710|NCT01431287|449753049|FG002|Overall Study|Non compliant with protocol|5|||
125036711|NCT01431287|449753050|FG003|Overall Study|Non compliant with protocol|6|||
125036712|NCT01431287|449753051|FG004|Overall Study|Non compliant with protocol|5|||
125036713|NCT01431287|449753047|FG000|Overall Study|Lost to Follow-up|0|||
125036714|NCT01431287|449753048|FG001|Overall Study|Lost to Follow-up|3|||
125036715|NCT01431287|449753049|FG002|Overall Study|Lost to Follow-up|2|||
125036716|NCT01431287|449753050|FG003|Overall Study|Lost to Follow-up|3|||
125036717|NCT01431287|449753051|FG004|Overall Study|Lost to Follow-up|1|||
125036718|NCT01431287|449753047|FG000|Overall Study|Consent withdrawn not due to AE|29|||
125036719|NCT01431287|449753048|FG001|Overall Study|Consent withdrawn not due to AE|30|||
125036720|NCT01431287|449753049|FG002|Overall Study|Consent withdrawn not due to AE|34|||
125036721|NCT01431287|449753050|FG003|Overall Study|Consent withdrawn not due to AE|19|||
125036722|NCT01431287|449753051|FG004|Overall Study|Consent withdrawn not due to AE|29|||
125036723|NCT01431287|449753047|FG000|Overall Study|not stated above|4|||
125036724|NCT01431287|449753048|FG001|Overall Study|not stated above|2|||
125036725|NCT01431287|449753049|FG002|Overall Study|not stated above|2|||
125036726|NCT01431287|449753050|FG003|Overall Study|not stated above|2|||
125036727|NCT01431287|449753051|FG004|Overall Study|not stated above|1|||
125036728|NCT00075881|449753052|FG000|Overall Study|Lack of Efficacy|18|||
125036729|NCT00075881|449753052|FG000|Overall Study|Adverse Event|7|||
125036730|NCT00075881|449753052|FG000|Overall Study|Death|1|||
125036731|NCT00075881|449753052|FG000|Overall Study|Withdrawal by Subject|2|||
125036732|NCT00075881|449753052|FG000|Overall Study|Protocol Violation|4|||
125036733|NCT00075881|449753052|FG000|Overall Study|other complicating disease|3|||
125036734|NCT00075881|449753052|FG000|Overall Study|other|4|||
125036735|NCT00075881|449753052|FG000|Overall Study|missing data|2|||
125036736|NCT00075881|449753052|FG000|Overall Study|Ineligible|1|||
125036737|NCT00075881|449753052|FG000|Overall Study|never start protocol therapy|1|||
125036738|NCT02224664|449753053|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
125036739|NCT02224664|449753054|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
125036740|NCT02224664|449753055|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
125036741|NCT02224664|449753056|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
125036742|NCT02224664|449753057|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
125036743|NCT02224664|449753053|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
125036744|NCT02224664|449753054|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
125036745|NCT02224664|449753055|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
125036746|NCT02224664|449753056|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
125036747|NCT02224664|449753057|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
125036748|NCT02224664|449753053|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
125036749|NCT02224664|449753054|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
125218254|NCT01059773|450427311|FG001|Overall Study|Protocol Violation|2|||
125036750|NCT02224664|449753055|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
125036751|NCT02224664|449753056|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
125036752|NCT02224664|449753057|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
125036753|NCT03019549|449753058|FG000|Washout|DId not meet genotype criteria|11|||
125036754|NCT03019549|449753058|FG000|Period 2|Adverse Event|2|||
125036755|NCT03019549|449753058|FG000|Period 2|Physician Decision|2|||
125036756|NCT03019549|449753058|FG000|Period 2|Withdrawal by Subject|1|||
125036757|NCT02109029|449753061|FG000|Part B|Adverse Event|0|||
125036758|NCT02109029|449753062|FG001|Part B|Adverse Event|0|||
125036759|NCT02109029|449753063|FG002|Part B|Adverse Event|0|||
125036760|NCT02109029|449753064|FG003|Part B|Adverse Event|0|||
125036761|NCT02109029|449753065|FG004|Part B|Adverse Event|1|||
125036762|NCT02109029|449753066|FG005|Part B|Adverse Event|1|||
125036763|NCT00110305|449753067|FG000|Overall Study|Adverse Event|46|||
125036764|NCT00110305|449753068|FG001|Overall Study|Adverse Event|13|||
125036765|NCT00110305|449753067|FG000|Overall Study|Sponsors Decision|1|||
125036766|NCT00110305|449753068|FG001|Overall Study|Sponsors Decision|0|||
125036767|NCT00110305|449753067|FG000|Overall Study|Subject Non-Compliant|9|||
125036768|NCT00110305|449753068|FG001|Overall Study|Subject Non-Compliant|2|||
125036769|NCT00110305|449753067|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
125218255|NCT01059773|450427310|FG000|Overall Study|Physician Decision|5|||
125036770|NCT00110305|449753068|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
125036771|NCT00110305|449753067|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
125036772|NCT00110305|449753068|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
125036773|NCT00110305|449753067|FG000|Overall Study|Protocol Violation|0|||
125036774|NCT00110305|449753068|FG001|Overall Study|Protocol Violation|1|||
125036775|NCT00110305|449753067|FG000|Overall Study|Withdrawal by Subject|7|||
125036776|NCT00110305|449753068|FG001|Overall Study|Withdrawal by Subject|7|||
125036777|NCT00110305|449753067|FG000|Overall Study|Lost to Follow-up|20|||
125036778|NCT00110305|449753068|FG001|Overall Study|Lost to Follow-up|3|||
125036779|NCT00110305|449753067|FG000|Overall Study|Other|8|||
125036780|NCT00110305|449753068|FG001|Overall Study|Other|2|||
125036781|NCT00215150|449753074|FG000|Open Label Phase|Lost to Follow-up|7|||
125036782|NCT00215150|449753074|FG000|Open Label Phase|Withdrawal by Subject|1|||
125036783|NCT00215150|449753074|FG000|Open Label Phase|Did not complete a post base visit|13|||
125036784|NCT00215150|449753074|FG000|Open Label Phase|Did not meet randomization criteria|9|||
125036785|NCT00215150|449753074|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
125036786|NCT00215150|449753074|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
125036787|NCT00215150|449753074|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
125036788|NCT02251743|449753075|FG000|Overall Study|Withdrawal by Subject|1|||
125036789|NCT02251743|449753076|FG001|Overall Study|Withdrawal by Subject|1|||
125036790|NCT00260208|449753079|FG000|Overall Study|Subject withdrew consent|11|||
125036791|NCT00260208|449753080|FG001|Overall Study|Subject withdrew consent|7|||
125036792|NCT00260208|449753079|FG000|Overall Study|Lost to Follow-up|6|||
125036793|NCT00260208|449753080|FG001|Overall Study|Lost to Follow-up|1|||
125036794|NCT00260208|449753079|FG000|Overall Study|Death|12|||
125036795|NCT00260208|449753080|FG001|Overall Study|Death|10|||
125036796|NCT00260208|449753079|FG000|Overall Study|Missing|18|||
125036797|NCT00260208|449753080|FG001|Overall Study|Missing|16|||
125036798|NCT02443402|449753082|FG000|Overall Study|Withdrawal by Subject|3|||
125036799|NCT02443402|449753083|FG001|Overall Study|Withdrawal by Subject|1|||
125036800|NCT02443402|449753082|FG000|Overall Study|Screen Failure|1|||
125036801|NCT02443402|449753083|FG001|Overall Study|Screen Failure|2|||
125036802|NCT01552057|449753099|FG000|Overall Study|Adverse Event|14|||
125036803|NCT01552057|449753100|FG001|Overall Study|Adverse Event|15|||
125036804|NCT01552057|449753099|FG000|Overall Study|Lack of Efficacy|8|||
125036805|NCT01552057|449753100|FG001|Overall Study|Lack of Efficacy|23|||
125036806|NCT01552057|449753099|FG000|Overall Study|Withdrawal by Subject|5|||
125036807|NCT01552057|449753100|FG001|Overall Study|Withdrawal by Subject|8|||
125036808|NCT01552057|449753099|FG000|Overall Study|Entry Criteria Not Met|2|||
125036809|NCT01552057|449753100|FG001|Overall Study|Entry Criteria Not Met|2|||
125036810|NCT01552057|449753099|FG000|Overall Study|Physician Decision|1|||
125036811|NCT01552057|449753100|FG001|Overall Study|Physician Decision|0|||
125036812|NCT01389245|449753101|FG000|Overall Study|Protocol Violation|10|||
125036813|NCT01389245|449753101|FG000|Overall Study|Lost to Follow-up|3|||
125036814|NCT01389245|449753101|FG000|Overall Study|Withdrawal by Subject|2|||
125036815|NCT05127486|449753102|FG000|Overall Study|Adverse Event|2|||
125036816|NCT05127486|449753103|FG001|Overall Study|Adverse Event|4|||
125036817|NCT05127486|449753102|FG000|Overall Study|Lack of Efficacy|1|||
125036818|NCT05127486|449753103|FG001|Overall Study|Lack of Efficacy|0|||
125036819|NCT05127486|449753102|FG000|Overall Study|Pregnancy|0|||
125036820|NCT05127486|449753103|FG001|Overall Study|Pregnancy|1|||
125036821|NCT05127486|449753102|FG000|Overall Study|Physician Decision|4|||
125036822|NCT05127486|449753103|FG001|Overall Study|Physician Decision|1|||
125036823|NCT05127486|449753102|FG000|Overall Study|Withdrawal by Subject|14|||
125036824|NCT05127486|449753103|FG001|Overall Study|Withdrawal by Subject|13|||
125036825|NCT05127486|449753102|FG000|Overall Study|Lost to Follow-up|5|||
125036826|NCT05127486|449753103|FG001|Overall Study|Lost to Follow-up|8|||
125036827|NCT00870688|449753104|FG000|Overall Study|Lost to Follow-up|2|||
125133185|NCT01597245|450111880|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133186|NCT01597245|450111881|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133187|NCT01597245|450111882|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133188|NCT01597245|450111883|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133189|NCT01597245|450111884|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
125133190|NCT01597245|450111885|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
125133191|NCT01597245|450111886|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
125036828|NCT00870688|449753104|FG000|Overall Study|Death, Unrelated|1|||
125036829|NCT00870688|449753104|FG000|Overall Study|Granules in the Stools|1|||
125036830|NCT01287754|449753105|FG000|Overall Study|Death|2|||
125036831|NCT01287754|449753106|FG001|Overall Study|Death|12|||
125036832|NCT01287754|449753105|FG000|Overall Study|Lost to Follow-up|1|||
125036833|NCT01287754|449753106|FG001|Overall Study|Lost to Follow-up|6|||
125036834|NCT01287754|449753105|FG000|Overall Study|Protocol Violation|0|||
125036835|NCT01287754|449753106|FG001|Overall Study|Protocol Violation|3|||
125036836|NCT04971226|449753107|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
125036837|NCT04971226|449753108|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
125133192|NCT01597245|450111887|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133193|NCT01597245|450111888|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133194|NCT01597245|450111889|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125218256|NCT01059773|450427311|FG001|Overall Study|Physician Decision|4|||
125036838|NCT04971226|449753109|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
125036839|NCT04971226|449753110|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
125036840|NCT04971226|449753107|FG000|Overall Study|Adverse Event|6|||
125036841|NCT04971226|449753108|FG001|Overall Study|Adverse Event|5|||
125036842|NCT04971226|449753109|FG002|Overall Study|Adverse Event|11|||
125036843|NCT04971226|449753110|FG003|Overall Study|Adverse Event|10|||
125036844|NCT04971226|449753107|FG000|Overall Study|Progressive disease|2|||
125036845|NCT04971226|449753108|FG001|Overall Study|Progressive disease|0|||
125036846|NCT04971226|449753109|FG002|Overall Study|Progressive disease|3|||
125036847|NCT04971226|449753110|FG003|Overall Study|Progressive disease|1|||
125036848|NCT04971226|449753107|FG000|Overall Study|Protocol Deviation|1|||
125036849|NCT04971226|449753108|FG001|Overall Study|Protocol Deviation|0|||
125036850|NCT04971226|449753109|FG002|Overall Study|Protocol Deviation|1|||
125036851|NCT04971226|449753110|FG003|Overall Study|Protocol Deviation|1|||
125036852|NCT04971226|449753107|FG000|Overall Study|Subject Decision|0|||
125036853|NCT04971226|449753108|FG001|Overall Study|Subject Decision|1|||
125036854|NCT04971226|449753109|FG002|Overall Study|Subject Decision|1|||
125036855|NCT04971226|449753110|FG003|Overall Study|Subject Decision|1|||
125036856|NCT04971226|449753107|FG000|Overall Study|Pregnancy|0|||
125036857|NCT04971226|449753108|FG001|Overall Study|Pregnancy|0|||
125036858|NCT04971226|449753109|FG002|Overall Study|Pregnancy|0|||
125036859|NCT04971226|449753110|FG003|Overall Study|Pregnancy|1|||
125036860|NCT04971226|449753107|FG000|Overall Study|Participants not treated|1|||
125036861|NCT04971226|449753108|FG001|Overall Study|Participants not treated|0|||
125036862|NCT04971226|449753109|FG002|Overall Study|Participants not treated|2|||
125036863|NCT04971226|449753110|FG003|Overall Study|Participants not treated|1|||
125036864|NCT00001337|449753118|FG000|Overall Study|Switched to alternate treatment|2|||
125036865|NCT00001337|449753119|FG001|Overall Study|Switched to alternate treatment|2|||
125036866|NCT00001337|449753120|FG002|Overall Study|Switched to alternate treatment|0|||
125036867|NCT00001337|449753118|FG000|Overall Study|Refused further treatment|2|||
125036868|NCT00001337|449753119|FG001|Overall Study|Refused further treatment|1|||
125036869|NCT00001337|449753120|FG002|Overall Study|Refused further treatment|0|||
125036870|NCT00001337|449753118|FG000|Overall Study|Began other Tx|1|||
125036871|NCT00001337|449753119|FG001|Overall Study|Began other Tx|0|||
125036872|NCT00001337|449753120|FG002|Overall Study|Began other Tx|0|||
125036873|NCT00001337|449753118|FG000|Overall Study|Physician Decision|3|||
125036874|NCT00001337|449753119|FG001|Overall Study|Physician Decision|1|||
125036875|NCT00001337|449753120|FG002|Overall Study|Physician Decision|0|||
125036876|NCT00001337|449753118|FG000|Overall Study|Doesn't have NHL|0|||
125036877|NCT00001337|449753119|FG001|Overall Study|Doesn't have NHL|1|||
125036878|NCT00001337|449753120|FG002|Overall Study|Doesn't have NHL|0|||
125036879|NCT00001337|449753118|FG000|Overall Study|Non protocol tx needed|3|||
125036880|NCT00001337|449753119|FG001|Overall Study|Non protocol tx needed|1|||
125036881|NCT00001337|449753120|FG002|Overall Study|Non protocol tx needed|0|||
125036882|NCT00001337|449753118|FG000|Overall Study|Protocol change|1|||
125036883|NCT00001337|449753119|FG001|Overall Study|Protocol change|0|||
125036884|NCT00001337|449753120|FG002|Overall Study|Protocol change|0|||
125036885|NCT00001337|449753118|FG000|Overall Study|2nd primary disease|0|||
125036886|NCT00001337|449753119|FG001|Overall Study|2nd primary disease|0|||
125036887|NCT00001337|449753120|FG002|Overall Study|2nd primary disease|1|||
125036888|NCT00001337|449753118|FG000|Overall Study|Death during follow up period|9|||
125036889|NCT00001337|449753119|FG001|Overall Study|Death during follow up period|4|||
125036890|NCT00001337|449753120|FG002|Overall Study|Death during follow up period|0|||
125036891|NCT00001337|449753118|FG000|Overall Study|Death on study|19|||
125036892|NCT00001337|449753119|FG001|Overall Study|Death on study|9|||
125036893|NCT00001337|449753120|FG002|Overall Study|Death on study|0|||
125036894|NCT00001337|449753118|FG000|Overall Study|Disease progression during follow-up period|3|||
125036895|NCT00001337|449753119|FG001|Overall Study|Disease progression during follow-up period|1|||
125036896|NCT00001337|449753120|FG002|Overall Study|Disease progression during follow-up period|0|||
125036897|NCT00001337|449753118|FG000|Overall Study|Disease progression on study|33|||
125036898|NCT00001337|449753119|FG001|Overall Study|Disease progression on study|41|||
125036899|NCT00001337|449753120|FG002|Overall Study|Disease progression on study|0|||
125036900|NCT00001337|449753118|FG000|Overall Study|Lost to further follow-up|10|||
125036901|NCT00001337|449753119|FG001|Overall Study|Lost to further follow-up|6|||
125036902|NCT00001337|449753120|FG002|Overall Study|Lost to further follow-up|0|||
125036903|NCT00001337|449753118|FG000|Overall Study|2nd malignancy|1|||
125036904|NCT00001337|449753119|FG001|Overall Study|2nd malignancy|0|||
125036905|NCT00001337|449753120|FG002|Overall Study|2nd malignancy|0|||
125036906|NCT00001337|449753118|FG000|Overall Study|Treatment for second lymphoma|0|||
125036907|NCT00001337|449753119|FG001|Overall Study|Treatment for second lymphoma|1|||
125036908|NCT00001337|449753120|FG002|Overall Study|Treatment for second lymphoma|0|||
125036909|NCT00001337|449753118|FG000|Overall Study|Transfer to transplant|0|||
125036910|NCT00001337|449753119|FG001|Overall Study|Transfer to transplant|1|||
125036911|NCT00001337|449753120|FG002|Overall Study|Transfer to transplant|0|||
125036912|NCT05590377|449753121|FG000|Overall Study|Death|1|||
125036913|NCT05590377|449753122|FG001|Overall Study|Death|1|||
125036914|NCT05590377|449753123|FG002|Overall Study|Death|2|||
125036915|NCT05590377|449753124|FG003|Overall Study|Death|0|||
125036916|NCT05590377|449753125|FG004|Overall Study|Death|0|||
125036917|NCT05590377|449753121|FG000|Overall Study|Study Terminated by Sponsor|1|||
125036918|NCT05590377|449753122|FG001|Overall Study|Study Terminated by Sponsor|5|||
125036919|NCT05590377|449753123|FG002|Overall Study|Study Terminated by Sponsor|4|||
125036920|NCT05590377|449753124|FG003|Overall Study|Study Terminated by Sponsor|0|||
125036921|NCT05590377|449753125|FG004|Overall Study|Study Terminated by Sponsor|0|||
125036922|NCT05590377|449753121|FG000|Overall Study|Withdrawal by Subject|1|||
125036923|NCT05590377|449753122|FG001|Overall Study|Withdrawal by Subject|0|||
125133195|NCT01597245|450111890|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133196|NCT01597245|450111891|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133197|NCT01597245|450111871|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
125036924|NCT05590377|449753123|FG002|Overall Study|Withdrawal by Subject|0|||
125133198|NCT01597245|450111872|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133199|NCT01597245|450111873|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133200|NCT01597245|450111874|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133201|NCT01597245|450111875|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133202|NCT01597245|450111876|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133203|NCT01597245|450111877|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133204|NCT01597245|450111878|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133205|NCT01597245|450111879|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133206|NCT01597245|450111880|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133207|NCT01597245|450111881|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
125036925|NCT05590377|449753124|FG003|Overall Study|Withdrawal by Subject|0|||
125036926|NCT05590377|449753125|FG004|Overall Study|Withdrawal by Subject|0|||
125133208|NCT01597245|450111882|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133209|NCT01597245|450111883|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133210|NCT01597245|450111884|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
125218257|NCT01059773|450427310|FG000|Overall Study|Lack of Efficacy|3|||
125218258|NCT01059773|450427311|FG001|Overall Study|Lack of Efficacy|3|||
125218259|NCT01059773|450427310|FG000|Overall Study|Death|0|||
125036927|NCT00442598|449753126|FG000|Overall Study|Adverse Event|1|||
125036928|NCT00442598|449753127|FG001|Overall Study|Adverse Event|0|||
125133211|NCT01597245|450111885|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
125133212|NCT01597245|450111886|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
125218260|NCT01059773|450427311|FG001|Overall Study|Death|1|||
125036929|NCT00442598|449753128|FG002|Overall Study|Adverse Event|0|||
125036930|NCT00442598|449753126|FG000|Overall Study|Tumor progression|3|||
125218261|NCT01059773|450427310|FG000|Overall Study|Malignancy including squamous cell skin|0|||
125218262|NCT01059773|450427311|FG001|Overall Study|Malignancy including squamous cell skin|1|||
125218263|NCT01059773|450427310|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
125218264|NCT01059773|450427311|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
125218265|NCT01059773|450427310|FG000|Overall Study|Other|1|||
125218266|NCT01059773|450427311|FG001|Overall Study|Other|3|||
125218267|NCT01029262|450427313|FG000|Overall Study|Adverse Event|9|||
125218268|NCT01029262|450427314|FG001|Overall Study|Adverse Event|52|||
125218269|NCT01029262|450427313|FG000|Overall Study|Lack of therapeutic effect|57|||
125218270|NCT01029262|450427314|FG001|Overall Study|Lack of therapeutic effect|76|||
125218271|NCT01029262|450427313|FG000|Overall Study|Withdrawal by Subject|10|||
125218272|NCT01029262|450427314|FG001|Overall Study|Withdrawal by Subject|17|||
125218273|NCT01029262|450427313|FG000|Overall Study|Protocol Violation|2|||
125218274|NCT01029262|450427314|FG001|Overall Study|Protocol Violation|3|||
125218275|NCT01029262|450427313|FG000|Overall Study|Miscellaneous|1|||
125218276|NCT01029262|450427314|FG001|Overall Study|Miscellaneous|9|||
125218277|NCT01029262|450427313|FG000|Overall Study|Death|0|||
125218278|NCT01029262|450427314|FG001|Overall Study|Death|3|||
125218279|NCT03410992|450427315|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
125218280|NCT03410992|450427316|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
125218281|NCT03410992|450427317|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
125218282|NCT03410992|450427318|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
125218283|NCT03410992|450427319|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
125218284|NCT03410992|450427320|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
125218285|NCT03410992|450427321|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
125218286|NCT03410992|450427322|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
125218287|NCT03410992|450427323|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
125218288|NCT03410992|450427324|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
125218289|NCT03410992|450427325|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
125036931|NCT00442598|449753127|FG001|Overall Study|Tumor progression|4|||
125036932|NCT00442598|449753128|FG002|Overall Study|Tumor progression|0|||
125036933|NCT00442598|449753126|FG000|Overall Study|Clinical deterioration|1|||
125036934|NCT00442598|449753127|FG001|Overall Study|Clinical deterioration|2|||
125036935|NCT00442598|449753128|FG002|Overall Study|Clinical deterioration|0|||
125036936|NCT00442598|449753126|FG000|Overall Study|CA125 progression|0|||
125036937|NCT00442598|449753127|FG001|Overall Study|CA125 progression|1|||
125133213|NCT01597245|450111887|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133214|NCT01597245|450111888|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133215|NCT01597245|450111889|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133216|NCT01597245|450111890|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133217|NCT01597245|450111891|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133218|NCT01597245|450111871|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133219|NCT01597245|450111872|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133220|NCT01597245|450111873|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133221|NCT01597245|450111874|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133222|NCT01597245|450111875|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133223|NCT01597245|450111876|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133224|NCT01597245|450111877|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133225|NCT01597245|450111878|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133226|NCT01597245|450111879|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125218290|NCT03410992|450427315|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
125218291|NCT03410992|450427316|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
125218292|NCT03410992|450427317|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
125218293|NCT03410992|450427318|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
125218294|NCT03410992|450427319|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
125133227|NCT01597245|450111880|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133228|NCT01597245|450111881|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133229|NCT01597245|450111882|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133230|NCT01597245|450111883|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133231|NCT01597245|450111884|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133232|NCT01597245|450111885|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
125218295|NCT03410992|450427320|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
125218296|NCT03410992|450427321|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
125036938|NCT00442598|449753128|FG002|Overall Study|CA125 progression|0|||
125133233|NCT01597245|450111886|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
125133234|NCT01597245|450111887|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133235|NCT01597245|450111888|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133236|NCT01597245|450111889|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133237|NCT01597245|450111890|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133238|NCT01597245|450111891|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133239|NCT01597245|450111871|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133240|NCT01597245|450111872|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133241|NCT01597245|450111873|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133242|NCT01597245|450111874|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133243|NCT01597245|450111875|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133244|NCT01597245|450111876|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133245|NCT01597245|450111877|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133246|NCT01597245|450111878|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133247|NCT01597245|450111879|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133248|NCT01597245|450111880|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133249|NCT01597245|450111881|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133250|NCT01597245|450111882|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133251|NCT01597245|450111883|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133252|NCT01597245|450111884|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133253|NCT01597245|450111885|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
125133254|NCT01597245|450111886|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
125133255|NCT01597245|450111887|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133256|NCT01597245|450111888|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133257|NCT01597245|450111889|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133258|NCT01597245|450111890|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133259|NCT01597245|450111891|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133260|NCT01597245|450111871|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133261|NCT01597245|450111872|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133262|NCT01597245|450111873|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133263|NCT01597245|450111874|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133264|NCT01597245|450111875|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133265|NCT01597245|450111876|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133266|NCT01597245|450111877|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133267|NCT01597245|450111878|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133268|NCT01597245|450111879|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133269|NCT01597245|450111880|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133270|NCT01597245|450111881|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133271|NCT01597245|450111882|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133272|NCT01597245|450111883|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133273|NCT01597245|450111884|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133274|NCT01597245|450111885|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
125133275|NCT01597245|450111886|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
125133276|NCT01597245|450111887|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133277|NCT01597245|450111888|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133278|NCT01597245|450111889|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133279|NCT01597245|450111890|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133280|NCT01597245|450111891|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133281|NCT01597245|450111871|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133282|NCT01597245|450111872|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133283|NCT01597245|450111873|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125218297|NCT03410992|450427322|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
125218298|NCT03410992|450427323|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
125218299|NCT03410992|450427324|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
124972781|NCT03812029|449527321|FG004|Overall Study|Withdrawal by Subject|2|||
124972782|NCT03812029|449527317|FG000|Overall Study|Stopping rules|0|||
124972783|NCT03812029|449527318|FG001|Overall Study|Stopping rules|1|||
124972784|NCT03812029|449527319|FG002|Overall Study|Stopping rules|0|||
124972785|NCT03812029|449527320|FG003|Overall Study|Stopping rules|0|||
124972786|NCT03812029|449527321|FG004|Overall Study|Stopping rules|0|||
124972787|NCT03812029|449527317|FG000|Overall Study|Adverse Event|0|||
124972788|NCT03812029|449527318|FG001|Overall Study|Adverse Event|9|||
124972789|NCT03812029|449527319|FG002|Overall Study|Adverse Event|0|||
124972790|NCT03812029|449527320|FG003|Overall Study|Adverse Event|3|||
124972791|NCT03812029|449527321|FG004|Overall Study|Adverse Event|5|||
124972792|NCT03812029|449527317|FG000|Overall Study|Lost to Follow-up|0|||
124972793|NCT03812029|449527318|FG001|Overall Study|Lost to Follow-up|0|||
124972794|NCT03812029|449527319|FG002|Overall Study|Lost to Follow-up|0|||
124972795|NCT03812029|449527320|FG003|Overall Study|Lost to Follow-up|0|||
124972796|NCT03812029|449527321|FG004|Overall Study|Lost to Follow-up|3|||
124972797|NCT03149042|449527322|FG000|Overall Study|Invasive FFR not performed|21|||
124972798|NCT03149042|449527322|FG000|Overall Study|Poor CT Image Quality|1|||
124972799|NCT03149042|449527322|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
124972800|NCT00790205|449527323|FG000|Overall Study|Lost to Follow-up|61|||
124972801|NCT00790205|449527324|FG001|Overall Study|Lost to Follow-up|71|||
124972802|NCT00790205|449527323|FG000|Overall Study|Withdrawal by Subject|299|||
124972803|NCT00790205|449527324|FG001|Overall Study|Withdrawal by Subject|363|||
124972804|NCT04092452|449527340|FG000|Overall Study|Adverse Event|1|||
124972805|NCT04092452|449527341|FG001|Overall Study|Adverse Event|3|||
124972806|NCT04092452|449527342|FG002|Overall Study|Adverse Event|3|||
125218300|NCT03410992|450427325|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
124972807|NCT04092452|449527343|FG003|Overall Study|Adverse Event|7|||
124972808|NCT04092452|449527340|FG000|Overall Study|Lack of Efficacy|1|||
124972809|NCT04092452|449527341|FG001|Overall Study|Lack of Efficacy|1|||
124972810|NCT04092452|449527342|FG002|Overall Study|Lack of Efficacy|1|||
124972811|NCT04092452|449527343|FG003|Overall Study|Lack of Efficacy|0|||
124972812|NCT04092452|449527340|FG000|Overall Study|Lost to Follow-up|4|||
125133284|NCT01597245|450111874|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133285|NCT01597245|450111875|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133286|NCT01597245|450111876|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133287|NCT01597245|450111877|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133288|NCT01597245|450111878|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133289|NCT01597245|450111879|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133290|NCT01597245|450111880|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133291|NCT01597245|450111881|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133292|NCT01597245|450111882|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133293|NCT01597245|450111883|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133294|NCT01597245|450111884|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
125133295|NCT01597245|450111885|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133296|NCT01597245|450111886|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133297|NCT01597245|450111887|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133298|NCT01597245|450111888|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133299|NCT01597245|450111889|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133300|NCT01597245|450111890|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133301|NCT01597245|450111891|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133302|NCT01597245|450111871|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133303|NCT01597245|450111872|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133304|NCT01597245|450111873|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133305|NCT01597245|450111874|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133306|NCT01597245|450111875|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133307|NCT01597245|450111876|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133308|NCT01597245|450111877|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133309|NCT01597245|450111878|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133310|NCT01597245|450111879|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133311|NCT01597245|450111880|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133312|NCT01597245|450111881|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133313|NCT01597245|450111882|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133314|NCT01597245|450111883|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133315|NCT01597245|450111884|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133316|NCT01597245|450111885|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133317|NCT01597245|450111886|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133318|NCT01597245|450111887|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
125133319|NCT01597245|450111888|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
125133320|NCT01597245|450111889|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
125133321|NCT01597245|450111890|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
125133322|NCT01597245|450111891|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
125133323|NCT01597245|450111871|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133324|NCT01597245|450111872|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133325|NCT01597245|450111873|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133326|NCT01597245|450111874|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133327|NCT01597245|450111875|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133328|NCT01597245|450111876|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133329|NCT01597245|450111877|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133330|NCT01597245|450111878|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133331|NCT01597245|450111879|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133332|NCT01597245|450111880|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133333|NCT01597245|450111881|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133334|NCT01597245|450111882|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133335|NCT01597245|450111883|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133336|NCT01597245|450111884|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133337|NCT01597245|450111885|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133338|NCT01597245|450111886|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133339|NCT01597245|450111887|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133340|NCT01597245|450111888|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
125133341|NCT01597245|450111889|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
125133342|NCT01597245|450111890|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
125133343|NCT01597245|450111891|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
125133344|NCT01597245|450111871|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133345|NCT01597245|450111872|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133346|NCT01597245|450111873|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125218301|NCT03410992|450427315|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
125218302|NCT03410992|450427316|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
125218303|NCT03410992|450427317|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
125218304|NCT03410992|450427318|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
125218305|NCT03410992|450427319|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
125218306|NCT03410992|450427320|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
125218307|NCT03410992|450427321|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
125218308|NCT03410992|450427322|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
125218309|NCT03410992|450427323|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
125218310|NCT03410992|450427324|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
125218311|NCT03410992|450427325|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
125218312|NCT03410992|450427315|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
125218313|NCT03410992|450427316|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
125218314|NCT03410992|450427317|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
125218315|NCT03410992|450427318|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
125218316|NCT03410992|450427319|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
125218317|NCT03410992|450427320|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
125218318|NCT03410992|450427321|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
125218319|NCT03410992|450427322|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
125218320|NCT03410992|450427323|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
125218321|NCT03410992|450427324|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
125218322|NCT03410992|450427325|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
125218323|NCT03410992|450427315|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
125218324|NCT03410992|450427316|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
125218325|NCT03410992|450427317|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
125218326|NCT03410992|450427318|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
125218327|NCT03410992|450427319|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
125218328|NCT03410992|450427320|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
125218329|NCT03410992|450427321|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
125218330|NCT03410992|450427322|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
125218331|NCT03410992|450427323|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
124972813|NCT04092452|449527341|FG001|Overall Study|Lost to Follow-up|3|||
124972814|NCT04092452|449527342|FG002|Overall Study|Lost to Follow-up|5|||
124972815|NCT04092452|449527343|FG003|Overall Study|Lost to Follow-up|1|||
124972816|NCT04092452|449527340|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125133347|NCT01597245|450111874|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133348|NCT01597245|450111875|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133349|NCT01597245|450111876|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133350|NCT01597245|450111877|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133351|NCT01597245|450111878|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133352|NCT01597245|450111879|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133353|NCT01597245|450111880|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133354|NCT01597245|450111881|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133355|NCT01597245|450111882|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133356|NCT01597245|450111883|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133357|NCT01597245|450111884|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133358|NCT01597245|450111885|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133359|NCT01597245|450111886|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133360|NCT01597245|450111887|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
125133361|NCT01597245|450111888|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133362|NCT01597245|450111889|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133363|NCT01597245|450111890|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
125133364|NCT01597245|450111891|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
125133365|NCT01597245|450111871|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133366|NCT01597245|450111872|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133367|NCT01597245|450111873|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133368|NCT01597245|450111874|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133369|NCT01597245|450111875|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133370|NCT01597245|450111876|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133371|NCT01597245|450111877|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125218332|NCT03410992|450427324|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
125218333|NCT03410992|450427325|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
125133372|NCT01597245|450111878|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133373|NCT01597245|450111879|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133374|NCT01597245|450111880|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133375|NCT01597245|450111881|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133376|NCT01597245|450111882|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133377|NCT01597245|450111883|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133378|NCT01597245|450111884|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133379|NCT01597245|450111885|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133380|NCT01597245|450111886|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133381|NCT01597245|450111887|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133382|NCT01597245|450111888|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133383|NCT01597245|450111889|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
125133384|NCT01597245|450111890|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
125133385|NCT01597245|450111891|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
125133386|NCT01597245|450111871|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133387|NCT01597245|450111872|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133388|NCT01597245|450111873|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133389|NCT01597245|450111874|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133390|NCT01597245|450111875|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133391|NCT01597245|450111876|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133392|NCT01597245|450111877|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133393|NCT01597245|450111878|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133394|NCT01597245|450111879|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133395|NCT01597245|450111880|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133396|NCT01597245|450111881|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133397|NCT01597245|450111882|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133398|NCT01597245|450111883|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133399|NCT01597245|450111884|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133400|NCT01597245|450111885|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133401|NCT01597245|450111886|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133402|NCT01597245|450111887|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
125133403|NCT01597245|450111888|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133404|NCT01597245|450111889|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133405|NCT01597245|450111890|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
125133406|NCT01597245|450111891|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
125133407|NCT01597245|450111871|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133408|NCT01597245|450111872|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133409|NCT01597245|450111873|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133410|NCT01597245|450111874|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133411|NCT01597245|450111875|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133412|NCT01597245|450111876|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133413|NCT01597245|450111877|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133414|NCT01597245|450111878|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133415|NCT01597245|450111879|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133416|NCT01597245|450111880|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133417|NCT01597245|450111881|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
124972817|NCT04092452|449527341|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124972818|NCT04092452|449527342|FG002|Overall Study|Non-Compliance With Study Drug|1|||
124972819|NCT04092452|449527343|FG003|Overall Study|Non-Compliance With Study Drug|1|||
124972820|NCT04092452|449527340|FG000|Overall Study|Physician Decision|1|||
124972821|NCT04092452|449527341|FG001|Overall Study|Physician Decision|0|||
124972822|NCT04092452|449527342|FG002|Overall Study|Physician Decision|1|||
124972823|NCT04092452|449527343|FG003|Overall Study|Physician Decision|0|||
124972824|NCT04092452|449527340|FG000|Overall Study|Pregnancy|2|||
124972825|NCT04092452|449527341|FG001|Overall Study|Pregnancy|0|||
124972826|NCT04092452|449527342|FG002|Overall Study|Pregnancy|0|||
124972827|NCT04092452|449527343|FG003|Overall Study|Pregnancy|0|||
124972828|NCT04092452|449527340|FG000|Overall Study|Protocol Deviation|1|||
124972829|NCT04092452|449527341|FG001|Overall Study|Protocol Deviation|0|||
124972830|NCT04092452|449527342|FG002|Overall Study|Protocol Deviation|0|||
124972831|NCT04092452|449527343|FG003|Overall Study|Protocol Deviation|0|||
124972832|NCT04092452|449527340|FG000|Overall Study|Withdrawal by Subject|3|||
124972833|NCT04092452|449527341|FG001|Overall Study|Withdrawal by Subject|10|||
124972834|NCT04092452|449527342|FG002|Overall Study|Withdrawal by Subject|3|||
124972835|NCT04092452|449527343|FG003|Overall Study|Withdrawal by Subject|5|||
125218334|NCT03410992|450427315|FG000|Week 16 Assessment|Incorrect escapers|0|||
125218335|NCT03410992|450427316|FG001|Week 16 Assessment|Incorrect escapers|6|||
125218336|NCT03410992|450427317|FG002|Week 16 Assessment|Incorrect escapers|0|||
125218337|NCT03410992|450427318|FG003|Week 16 Assessment|Incorrect escapers|0|||
125218338|NCT03410992|450427319|FG004|Week 16 Assessment|Incorrect escapers|0|||
125218339|NCT03410992|450427320|FG005|Week 16 Assessment|Incorrect escapers|0|||
125218340|NCT03410992|450427321|FG006|Week 16 Assessment|Incorrect escapers|0|||
125218341|NCT03410992|450427322|FG007|Week 16 Assessment|Incorrect escapers|0|||
125218342|NCT03410992|450427323|FG008|Week 16 Assessment|Incorrect escapers|0|||
125218343|NCT03410992|450427324|FG009|Week 16 Assessment|Incorrect escapers|0|||
125218344|NCT03410992|450427325|FG010|Week 16 Assessment|Incorrect escapers|0|||
125218345|NCT03410992|450427315|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
125218346|NCT03410992|450427316|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
125218347|NCT03410992|450427317|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
125218348|NCT03410992|450427318|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
125218349|NCT03410992|450427319|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
124972836|NCT04092452|449527340|FG000|Overall Study|Other|0|||
124972837|NCT04092452|449527341|FG001|Overall Study|Other|0|||
124972838|NCT04092452|449527342|FG002|Overall Study|Other|1|||
124972839|NCT04092452|449527343|FG003|Overall Study|Other|2|||
124972840|NCT02127125|449527344|FG000|Overall Study|Lost to Follow-up|0|||
124972841|NCT02127125|449527345|FG001|Overall Study|Lost to Follow-up|0|||
124972842|NCT02127125|449527346|FG002|Overall Study|Lost to Follow-up|0|||
124972843|NCT02127125|449527347|FG003|Overall Study|Lost to Follow-up|0|||
124972844|NCT02127125|449527348|FG004|Overall Study|Lost to Follow-up|2|||
124972845|NCT02127125|449527349|FG005|Overall Study|Lost to Follow-up|1|||
124972846|NCT02127125|449527350|FG006|Overall Study|Lost to Follow-up|0|||
124972847|NCT02127125|449527351|FG007|Overall Study|Lost to Follow-up|0|||
124972848|NCT02127125|449527352|FG008|Overall Study|Lost to Follow-up|0|||
124972849|NCT02127125|449527344|FG000|Overall Study|Withdrawal by Subject|0|||
124972850|NCT02127125|449527345|FG001|Overall Study|Withdrawal by Subject|0|||
124972851|NCT02127125|449527346|FG002|Overall Study|Withdrawal by Subject|0|||
124972852|NCT02127125|449527347|FG003|Overall Study|Withdrawal by Subject|1|||
124972853|NCT02127125|449527348|FG004|Overall Study|Withdrawal by Subject|0|||
124972854|NCT02127125|449527349|FG005|Overall Study|Withdrawal by Subject|0|||
124972855|NCT02127125|449527350|FG006|Overall Study|Withdrawal by Subject|0|||
124972856|NCT02127125|449527351|FG007|Overall Study|Withdrawal by Subject|0|||
124972857|NCT02127125|449527352|FG008|Overall Study|Withdrawal by Subject|0|||
124972858|NCT02127125|449527344|FG000|Overall Study|Physician Decision|0|||
124972859|NCT02127125|449527345|FG001|Overall Study|Physician Decision|0|||
124972860|NCT02127125|449527346|FG002|Overall Study|Physician Decision|1|||
124972861|NCT02127125|449527347|FG003|Overall Study|Physician Decision|0|||
124972862|NCT02127125|449527348|FG004|Overall Study|Physician Decision|1|||
124972863|NCT02127125|449527349|FG005|Overall Study|Physician Decision|2|||
124972864|NCT02127125|449527350|FG006|Overall Study|Physician Decision|0|||
124972865|NCT02127125|449527351|FG007|Overall Study|Physician Decision|0|||
124972866|NCT02127125|449527352|FG008|Overall Study|Physician Decision|0|||
124972867|NCT02353468|449527353|FG000|Overall Study|Study terminated|3|||
124972868|NCT02344342|449527354|FG000|Overall Study|Industry partner dropped out|11|||
124972869|NCT02344342|449527355|FG001|Overall Study|Industry partner dropped out|9|||
124972870|NCT02344342|449527356|FG002|Overall Study|Industry partner dropped out|14|||
124972871|NCT02344342|449527357|FG003|Overall Study|Industry partner dropped out|10|||
124972872|NCT00848484|449527358|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
124972873|NCT00848484|449527359|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
124972874|NCT00848484|449527358|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
124972875|NCT00848484|449527359|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
124972876|NCT00848484|449527358|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
124972877|NCT00848484|449527359|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
124972878|NCT00848484|449527358|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
124972879|NCT00848484|449527359|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
124972880|NCT00848484|449527358|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
125218350|NCT03410992|450427320|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
125218351|NCT03410992|450427321|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
125218352|NCT03410992|450427322|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
124972881|NCT00848484|449527359|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
125218353|NCT03410992|450427323|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
124972882|NCT03017742|449527367|FG000|Overall Study|Protocol Violation|36|||
124972883|NCT03017742|449527367|FG000|Overall Study|Withdrawal by Subject|37|||
124972884|NCT02975102|449527368|FG000|Overall Study|Adverse Event|2|||
124972885|NCT02975102|449527369|FG001|Overall Study|Adverse Event|1|||
124972886|NCT01441635|449527374|FG000|Overall Study|Adverse Event|4|||
124972887|NCT01441635|449527375|FG001|Overall Study|Adverse Event|3|||
124972888|NCT01441635|449527376|FG002|Overall Study|Adverse Event|1|||
125218354|NCT03410992|450427324|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
125218355|NCT03410992|450427325|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
125218356|NCT03410992|450427315|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
125218357|NCT03410992|450427316|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
125218358|NCT03410992|450427317|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
125218359|NCT03410992|450427318|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
125218360|NCT03410992|450427319|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
125218361|NCT03410992|450427320|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
125218362|NCT03410992|450427321|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
125218363|NCT03410992|450427322|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
125218364|NCT03410992|450427323|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
125218365|NCT03410992|450427324|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
125218366|NCT03410992|450427325|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
125218367|NCT03410992|450427315|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
125218368|NCT03410992|450427316|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
125218369|NCT03410992|450427317|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
125218370|NCT03410992|450427318|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
125218371|NCT03410992|450427319|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
125218372|NCT03410992|450427320|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
125218373|NCT03410992|450427321|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
125218374|NCT03410992|450427322|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
125218375|NCT03410992|450427323|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
125218376|NCT03410992|450427324|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
125218377|NCT03410992|450427325|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
125218378|NCT03410992|450427315|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
125218379|NCT03410992|450427316|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
125218380|NCT03410992|450427317|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
125218381|NCT03410992|450427318|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
125218382|NCT03410992|450427319|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
125218383|NCT03410992|450427320|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
125218384|NCT03410992|450427321|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
125218385|NCT03410992|450427322|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
125218386|NCT03410992|450427323|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
125218387|NCT03410992|450427324|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
125218388|NCT03410992|450427325|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
125218389|NCT03410992|450427315|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
125218390|NCT03410992|450427316|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
125218391|NCT03410992|450427317|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
125218392|NCT03410992|450427318|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
125218393|NCT03410992|450427319|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
125218394|NCT03410992|450427320|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
125218395|NCT03410992|450427321|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
125218396|NCT03410992|450427322|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
125218397|NCT03410992|450427323|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
125218398|NCT03410992|450427324|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
125218399|NCT03410992|450427325|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
125218400|NCT03410992|450427315|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
125218401|NCT03410992|450427316|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
125218402|NCT03410992|450427317|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
125218403|NCT03410992|450427318|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
125218404|NCT03410992|450427319|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
125218405|NCT03410992|450427320|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
125218406|NCT03410992|450427321|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
125218407|NCT03410992|450427322|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
125218408|NCT03410992|450427323|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
124972889|NCT01441635|449527377|FG003|Overall Study|Adverse Event|5|||
124972890|NCT01441635|449527378|FG004|Overall Study|Adverse Event|1|||
124972891|NCT01441635|449527379|FG005|Overall Study|Adverse Event|2|||
124972892|NCT01441635|449527380|FG006|Overall Study|Adverse Event|2|||
124972893|NCT01441635|449527381|FG007|Overall Study|Adverse Event|2|||
124972894|NCT01441635|449527382|FG008|Overall Study|Adverse Event|1|||
124972895|NCT01441635|449527383|FG009|Overall Study|Adverse Event|0|||
124972896|NCT01441635|449527374|FG000|Overall Study|Withdrawal by Subject|1|||
124972897|NCT01441635|449527375|FG001|Overall Study|Withdrawal by Subject|1|||
124972898|NCT01441635|449527376|FG002|Overall Study|Withdrawal by Subject|0|||
125133418|NCT01597245|450111882|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133419|NCT01597245|450111883|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133420|NCT01597245|450111884|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133421|NCT01597245|450111885|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133422|NCT01597245|450111886|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133423|NCT01597245|450111887|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
125133424|NCT01597245|450111888|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133425|NCT01597245|450111889|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133426|NCT01597245|450111890|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
125133427|NCT01597245|450111891|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
125133428|NCT01597245|450111871|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133429|NCT01597245|450111872|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133430|NCT01597245|450111873|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133431|NCT01597245|450111874|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133432|NCT01597245|450111875|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133433|NCT01597245|450111876|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133434|NCT01597245|450111877|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133435|NCT01597245|450111878|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133436|NCT01597245|450111879|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133437|NCT01597245|450111880|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133438|NCT01597245|450111881|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133439|NCT01597245|450111882|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133440|NCT01597245|450111883|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133441|NCT01597245|450111884|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133442|NCT01597245|450111885|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133443|NCT01597245|450111886|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133444|NCT01597245|450111887|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
125133445|NCT01597245|450111888|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133446|NCT01597245|450111889|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133447|NCT01597245|450111890|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
125133448|NCT01597245|450111891|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133449|NCT01597245|450111871|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133450|NCT01597245|450111872|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133451|NCT01597245|450111873|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133452|NCT01597245|450111874|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133453|NCT01597245|450111875|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133454|NCT01597245|450111876|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133455|NCT01597245|450111877|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133456|NCT01597245|450111878|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133457|NCT01597245|450111879|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133458|NCT01597245|450111880|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133459|NCT01597245|450111881|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133460|NCT01597245|450111882|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133461|NCT01597245|450111883|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133462|NCT01597245|450111884|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133463|NCT01597245|450111885|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133464|NCT01597245|450111886|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133465|NCT01597245|450111887|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
125133466|NCT01597245|450111888|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133467|NCT01597245|450111889|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133468|NCT01597245|450111890|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
124972899|NCT01441635|449527377|FG003|Overall Study|Withdrawal by Subject|1|||
124972900|NCT01441635|449527378|FG004|Overall Study|Withdrawal by Subject|0|||
124972901|NCT01441635|449527379|FG005|Overall Study|Withdrawal by Subject|0|||
124972902|NCT01441635|449527380|FG006|Overall Study|Withdrawal by Subject|2|||
124972903|NCT01441635|449527381|FG007|Overall Study|Withdrawal by Subject|0|||
124972904|NCT01441635|449527382|FG008|Overall Study|Withdrawal by Subject|1|||
124972905|NCT01441635|449527383|FG009|Overall Study|Withdrawal by Subject|1|||
124972906|NCT01441635|449527374|FG000|Overall Study|Lost to Follow-up|0|||
124972907|NCT01441635|449527375|FG001|Overall Study|Lost to Follow-up|1|||
125218409|NCT03410992|450427324|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
125218410|NCT03410992|450427325|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
125218411|NCT02260817|450427326|FG000|Overall Study|Lost to Follow-up|0|||
124972908|NCT01441635|449527376|FG002|Overall Study|Lost to Follow-up|1|||
124972909|NCT01441635|449527377|FG003|Overall Study|Lost to Follow-up|1|||
124972910|NCT01441635|449527378|FG004|Overall Study|Lost to Follow-up|1|||
124972911|NCT01441635|449527379|FG005|Overall Study|Lost to Follow-up|3|||
124972912|NCT01441635|449527380|FG006|Overall Study|Lost to Follow-up|1|||
124972913|NCT01441635|449527381|FG007|Overall Study|Lost to Follow-up|1|||
124972914|NCT01441635|449527382|FG008|Overall Study|Lost to Follow-up|0|||
124972915|NCT01441635|449527383|FG009|Overall Study|Lost to Follow-up|1|||
124972916|NCT01441635|449527374|FG000|Overall Study|Noncompliance|0|||
124972917|NCT01441635|449527375|FG001|Overall Study|Noncompliance|1|||
124972918|NCT01441635|449527376|FG002|Overall Study|Noncompliance|0|||
124972919|NCT01441635|449527377|FG003|Overall Study|Noncompliance|0|||
124972920|NCT01441635|449527378|FG004|Overall Study|Noncompliance|0|||
124972921|NCT01441635|449527379|FG005|Overall Study|Noncompliance|0|||
124972922|NCT01441635|449527380|FG006|Overall Study|Noncompliance|1|||
124972923|NCT01441635|449527381|FG007|Overall Study|Noncompliance|0|||
124972924|NCT01441635|449527382|FG008|Overall Study|Noncompliance|0|||
124972925|NCT01441635|449527383|FG009|Overall Study|Noncompliance|0|||
124972926|NCT01441635|449527374|FG000|Overall Study|Surgery or Invasive Intervention|0|||
124972927|NCT01441635|449527375|FG001|Overall Study|Surgery or Invasive Intervention|0|||
124972928|NCT01441635|449527376|FG002|Overall Study|Surgery or Invasive Intervention|1|||
124972929|NCT01441635|449527377|FG003|Overall Study|Surgery or Invasive Intervention|0|||
124972930|NCT01441635|449527378|FG004|Overall Study|Surgery or Invasive Intervention|0|||
124972931|NCT01441635|449527379|FG005|Overall Study|Surgery or Invasive Intervention|0|||
124972932|NCT01441635|449527380|FG006|Overall Study|Surgery or Invasive Intervention|0|||
124972933|NCT01441635|449527381|FG007|Overall Study|Surgery or Invasive Intervention|0|||
124972934|NCT01441635|449527382|FG008|Overall Study|Surgery or Invasive Intervention|0|||
124972935|NCT01441635|449527383|FG009|Overall Study|Surgery or Invasive Intervention|0|||
124972936|NCT01441635|449527374|FG000|Overall Study|Received Exclusionary Medication|1|||
124972937|NCT01441635|449527375|FG001|Overall Study|Received Exclusionary Medication|0|||
124972938|NCT01441635|449527376|FG002|Overall Study|Received Exclusionary Medication|0|||
124972939|NCT01441635|449527377|FG003|Overall Study|Received Exclusionary Medication|0|||
124972940|NCT01441635|449527378|FG004|Overall Study|Received Exclusionary Medication|0|||
124972941|NCT01441635|449527379|FG005|Overall Study|Received Exclusionary Medication|0|||
124972942|NCT01441635|449527380|FG006|Overall Study|Received Exclusionary Medication|0|||
124972943|NCT01441635|449527381|FG007|Overall Study|Received Exclusionary Medication|0|||
124972944|NCT01441635|449527382|FG008|Overall Study|Received Exclusionary Medication|0|||
124972945|NCT01441635|449527383|FG009|Overall Study|Received Exclusionary Medication|0|||
124972946|NCT01441635|449527374|FG000|Overall Study|Other|0|||
124972947|NCT01441635|449527375|FG001|Overall Study|Other|0|||
124972948|NCT01441635|449527376|FG002|Overall Study|Other|0|||
124972949|NCT01441635|449527377|FG003|Overall Study|Other|0|||
124972950|NCT01441635|449527378|FG004|Overall Study|Other|0|||
124972951|NCT01441635|449527379|FG005|Overall Study|Other|0|||
124972952|NCT01441635|449527380|FG006|Overall Study|Other|0|||
124972953|NCT01441635|449527381|FG007|Overall Study|Other|1|||
124972954|NCT01441635|449527382|FG008|Overall Study|Other|0|||
125036939|NCT00442598|449753126|FG000|Overall Study|Reduced creatinine clearance|1|||
125036940|NCT00442598|449753127|FG001|Overall Study|Reduced creatinine clearance|0|||
125036941|NCT00442598|449753128|FG002|Overall Study|Reduced creatinine clearance|0|||
125036942|NCT00442598|449753126|FG000|Overall Study|Death|0|||
125036943|NCT00442598|449753127|FG001|Overall Study|Death|1|||
125036944|NCT00442598|449753128|FG002|Overall Study|Death|0|||
125036945|NCT01262898|449753129|FG000|Overall Study|Protocol Violation|1|||
125036946|NCT01262898|449753130|FG001|Overall Study|Protocol Violation|1|||
125036947|NCT01262898|449753131|FG002|Overall Study|Protocol Violation|0|||
125036948|NCT01262898|449753132|FG003|Overall Study|Protocol Violation|0|||
125036949|NCT01262898|449753129|FG000|Overall Study|Lost to Follow-up|1|||
125036950|NCT01262898|449753130|FG001|Overall Study|Lost to Follow-up|0|||
125036951|NCT01262898|449753131|FG002|Overall Study|Lost to Follow-up|0|||
125036952|NCT01262898|449753132|FG003|Overall Study|Lost to Follow-up|0|||
125036953|NCT01262898|449753129|FG000|Overall Study|Withdrawal by Subject|1|||
125036954|NCT01262898|449753130|FG001|Overall Study|Withdrawal by Subject|1|||
125036955|NCT01262898|449753131|FG002|Overall Study|Withdrawal by Subject|0|||
125036956|NCT01262898|449753132|FG003|Overall Study|Withdrawal by Subject|0|||
125036957|NCT04026568|449753133|FG000|Overall Study|study terminated|0|||
125036958|NCT04026568|449753134|FG001|Overall Study|study terminated|1|||
125036959|NCT02197377|449753135|FG000|Overall Study|Insertion Failure|0|||
125036960|NCT02197377|449753136|FG001|Overall Study|Insertion Failure|3|||
125036961|NCT00502840|449753137|FG000|Overall Study|Adverse Event|5|||
125218412|NCT02260817|450427327|FG001|Overall Study|Lost to Follow-up|14|||
125218413|NCT02260817|450427326|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
125218414|NCT02260817|450427327|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
125218415|NCT02260817|450427326|FG000|Overall Study|Observation, no biopsy|0|||
125218416|NCT02260817|450427327|FG001|Overall Study|Observation, no biopsy|1|||
125218417|NCT02260817|450427326|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
125218418|NCT02260817|450427327|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
125218419|NCT02260817|450427326|FG000|Overall Study|Protocol Violation|0|||
125218420|NCT02260817|450427327|FG001|Overall Study|Protocol Violation|14|||
125218421|NCT04435808|450427328|FG000|Overall Study|Study stopped by DSMB|0|||
125218422|NCT04435808|450427329|FG001|Overall Study|Study stopped by DSMB|1|||
125218423|NCT03299101|450427330|FG000|Overall Study|Lost to Follow-up|1|||
124972955|NCT01441635|449527383|FG009|Overall Study|Other|0|||
124972956|NCT01825577|449527384|FG000|Overall Study|Physician Decision|2|||
124972957|NCT01825577|449527384|FG000|Overall Study|Withdrawal by Subject|1|||
124972958|NCT01825577|449527384|FG000|Overall Study|Withdrawn by family members|2|||
124972959|NCT01825577|449527384|FG000|Overall Study|Lack of Efficacy|3|||
124972960|NCT01358331|449527385|FG000|Overall Study|Lost to Follow-up|0|||
124972961|NCT01358331|449527386|FG001|Overall Study|Lost to Follow-up|0|||
124972962|NCT01358331|449527387|FG002|Overall Study|Lost to Follow-up|0|||
124972963|NCT01358331|449527388|FG003|Overall Study|Lost to Follow-up|1|||
124972964|NCT01358331|449527389|FG004|Overall Study|Lost to Follow-up|0|||
124972965|NCT01358331|449527390|FG005|Overall Study|Lost to Follow-up|0|||
124972966|NCT01358331|449527385|FG000|Overall Study|Withdrawal by Subject|0|||
124972967|NCT01358331|449527386|FG001|Overall Study|Withdrawal by Subject|0|||
124972968|NCT01358331|449527387|FG002|Overall Study|Withdrawal by Subject|0|||
124972969|NCT01358331|449527388|FG003|Overall Study|Withdrawal by Subject|1|||
124972970|NCT01358331|449527389|FG004|Overall Study|Withdrawal by Subject|1|||
124972971|NCT01358331|449527390|FG005|Overall Study|Withdrawal by Subject|1|||
124972972|NCT01358331|449527385|FG000|Overall Study|Adverse Events|1|||
124972973|NCT01358331|449527386|FG001|Overall Study|Adverse Events|1|||
124972974|NCT01358331|449527387|FG002|Overall Study|Adverse Events|1|||
124972975|NCT01358331|449527388|FG003|Overall Study|Adverse Events|0|||
125036962|NCT00502840|449753137|FG000|Overall Study|Additional or changed therapy|48|||
125036963|NCT00502840|449753137|FG000|Overall Study|Lack of Efficacy|11|||
125036964|NCT00502840|449753137|FG000|Overall Study|Protocol Violation|4|||
125036965|NCT00502840|449753137|FG000|Overall Study|Withdrawal by Subject|5|||
125036966|NCT00502840|449753137|FG000|Overall Study|Lost to Follow-up|6|||
125036967|NCT00502840|449753137|FG000|Overall Study|Administrative problems|1|||
125036968|NCT00502840|449753137|FG000|Overall Study|Other|20|||
125036969|NCT00461175|449753138|FG000|Overall Study|Protocol Violation|522|||
125036970|NCT00461175|449753139|FG001|Overall Study|Protocol Violation|365|||
125036971|NCT01700829|449753140|FG000|Overall Study|Withdrawal by Subject|1|||
125036972|NCT01700829|449753141|FG001|Overall Study|Withdrawal by Subject|1|||
125036973|NCT03406962|449753142|FG000|Overall Study|Death|2|||
125036974|NCT03406962|449753142|FG000|Overall Study|Adverse Event|1|||
125036975|NCT00327444|449753143|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
125036976|NCT00327444|449753144|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
125036977|NCT00327444|449753143|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
125036978|NCT00327444|449753144|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
125036979|NCT00327444|449753143|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
125036980|NCT00327444|449753144|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
125036981|NCT00327444|449753143|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
125036982|NCT00327444|449753144|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
125036983|NCT00327444|449753143|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
125036984|NCT00327444|449753144|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
125036985|NCT00327444|449753143|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
125036986|NCT00327444|449753144|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
125036987|NCT00327444|449753143|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
125036988|NCT00327444|449753144|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
125036989|NCT00327444|449753143|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
125036990|NCT00327444|449753144|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
125036991|NCT04439344|449753145|FG000|Overall Study|Never started threapy|3|||
125036992|NCT04439344|449753145|FG000|Overall Study|Ineligible|3|||
125036993|NCT04439344|449753145|FG000|Overall Study|Adverse Event|13|||
125036994|NCT04439344|449753145|FG000|Overall Study|Death|2|||
125036995|NCT04439344|449753145|FG000|Overall Study|Disease progression|29|||
125036996|NCT04439344|449753145|FG000|Overall Study|Withdrawal by Subject|2|||
125036997|NCT04439344|449753145|FG000|Overall Study|Alternative therapy|1|||
125218424|NCT03299101|450427330|FG000|Overall Study|Withdrawal by Subject|5|||
125218425|NCT03299101|450427330|FG000|Overall Study|Surgery was changed|3|||
124972976|NCT01358331|449527389|FG004|Overall Study|Adverse Events|1|||
124972977|NCT01358331|449527390|FG005|Overall Study|Adverse Events|5|||
124972978|NCT01358331|449527385|FG000|Overall Study|Symptomatic Deterioration|0|||
124972979|NCT01358331|449527386|FG001|Overall Study|Symptomatic Deterioration|0|||
125133469|NCT01597245|450111891|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133470|NCT01597245|450111871|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133471|NCT01597245|450111872|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133472|NCT01597245|450111873|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133473|NCT01597245|450111874|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133474|NCT01597245|450111875|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133475|NCT01597245|450111876|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133476|NCT01597245|450111877|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133477|NCT01597245|450111878|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133478|NCT01597245|450111879|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133479|NCT01597245|450111880|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133480|NCT01597245|450111881|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133481|NCT01597245|450111882|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133482|NCT01597245|450111883|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133483|NCT01597245|450111884|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133484|NCT01597245|450111885|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133485|NCT01597245|450111886|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133486|NCT01597245|450111887|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
124972980|NCT01358331|449527387|FG002|Overall Study|Symptomatic Deterioration|0|||
124972981|NCT01358331|449527388|FG003|Overall Study|Symptomatic Deterioration|0|||
124972982|NCT01358331|449527389|FG004|Overall Study|Symptomatic Deterioration|1|||
124972983|NCT01358331|449527390|FG005|Overall Study|Symptomatic Deterioration|0|||
124972984|NCT01358331|449527385|FG000|Overall Study|Participants did not wish to continue|0|||
124972985|NCT01358331|449527386|FG001|Overall Study|Participants did not wish to continue|0|||
124972986|NCT01358331|449527387|FG002|Overall Study|Participants did not wish to continue|0|||
124972987|NCT01358331|449527388|FG003|Overall Study|Participants did not wish to continue|0|||
124972988|NCT01358331|449527389|FG004|Overall Study|Participants did not wish to continue|1|||
124972989|NCT01358331|449527390|FG005|Overall Study|Participants did not wish to continue|0|||
124972990|NCT01358331|449527385|FG000|Overall Study|Progress of disease under investigation|1|||
124972991|NCT01358331|449527386|FG001|Overall Study|Progress of disease under investigation|2|||
124972992|NCT01358331|449527387|FG002|Overall Study|Progress of disease under investigation|3|||
124972993|NCT01358331|449527388|FG003|Overall Study|Progress of disease under investigation|1|||
124972994|NCT01358331|449527389|FG004|Overall Study|Progress of disease under investigation|3|||
124972995|NCT01358331|449527390|FG005|Overall Study|Progress of disease under investigation|0|||
124972996|NCT01969851|449527395|FG000|Overall Study|Adverse Event|0|||
124972997|NCT01969851|449527396|FG001|Overall Study|Adverse Event|0|||
124972998|NCT01969851|449527397|FG002|Overall Study|Adverse Event|3|||
124972999|NCT01969851|449527395|FG000|Overall Study|Lack of Efficacy|0|||
124973000|NCT01969851|449527396|FG001|Overall Study|Lack of Efficacy|3|||
124973001|NCT01969851|449527397|FG002|Overall Study|Lack of Efficacy|1|||
125036998|NCT00552110|449753146|FG000|Overall Study|Serious or Life-Threatening AE|0|||
125036999|NCT00552110|449753147|FG001|Overall Study|Serious or Life-Threatening AE|0|||
125037000|NCT00552110|449753148|FG002|Overall Study|Serious or Life-Threatening AE|1|||
125037001|NCT00552110|449753149|FG003|Overall Study|Serious or Life-Threatening AE|0|||
125037002|NCT00552110|449753150|FG004|Overall Study|Serious or Life-Threatening AE|0|||
125037003|NCT00552110|449753146|FG000|Overall Study|Lack of Efficacy|1|||
125037004|NCT00552110|449753147|FG001|Overall Study|Lack of Efficacy|0|||
125037005|NCT00552110|449753148|FG002|Overall Study|Lack of Efficacy|0|||
125037006|NCT00552110|449753149|FG003|Overall Study|Lack of Efficacy|1|||
125037007|NCT00552110|449753150|FG004|Overall Study|Lack of Efficacy|4|||
125037008|NCT00552110|449753146|FG000|Overall Study|Withdrawal by Subject|0|||
125037009|NCT00552110|449753147|FG001|Overall Study|Withdrawal by Subject|2|||
125037010|NCT00552110|449753148|FG002|Overall Study|Withdrawal by Subject|0|||
125037011|NCT00552110|449753149|FG003|Overall Study|Withdrawal by Subject|3|||
125037012|NCT00552110|449753150|FG004|Overall Study|Withdrawal by Subject|2|||
125037013|NCT00552110|449753146|FG000|Overall Study|Lost to Follow-up|0|||
125037014|NCT00552110|449753147|FG001|Overall Study|Lost to Follow-up|0|||
125037015|NCT00552110|449753148|FG002|Overall Study|Lost to Follow-up|0|||
125037016|NCT00552110|449753149|FG003|Overall Study|Lost to Follow-up|1|||
125037017|NCT00552110|449753150|FG004|Overall Study|Lost to Follow-up|1|||
125037018|NCT00552110|449753146|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
125037019|NCT00552110|449753147|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
125037020|NCT00552110|449753148|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
125037021|NCT00552110|449753149|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
125037022|NCT00552110|449753150|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
125037023|NCT00552110|449753146|FG000|Overall Study|Withdrawn per Sponsor|0|||
125037024|NCT00552110|449753147|FG001|Overall Study|Withdrawn per Sponsor|1|||
125037025|NCT00552110|449753148|FG002|Overall Study|Withdrawn per Sponsor|0|||
125037026|NCT00552110|449753149|FG003|Overall Study|Withdrawn per Sponsor|0|||
125037027|NCT00552110|449753150|FG004|Overall Study|Withdrawn per Sponsor|1|||
125133487|NCT01597245|450111888|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133488|NCT01597245|450111889|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133489|NCT01597245|450111890|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
125133490|NCT01597245|450111891|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133491|NCT00583453|450113761|FG000|Overall Study|discontinued intervention|0|||
125133492|NCT00583453|450113762|FG001|Overall Study|discontinued intervention|2|||
125133493|NCT00794963|450113763|FG000|Overall Study|Withdrawal by Subject|1|||
125133494|NCT00794963|450113764|FG001|Overall Study|Withdrawal by Subject|4|||
125133495|NCT01527006|450113770|FG000|Core Study|Adverse Event|0|||
125133496|NCT01527006|450113771|FG001|Core Study|Adverse Event|2|||
125133497|NCT01527006|450113770|FG000|Core Study|Lost to Follow-up|0|||
125133498|NCT01527006|450113771|FG001|Core Study|Lost to Follow-up|1|||
125133499|NCT01527006|450113770|FG000|Core Study|Subject Choice|1|||
125133500|NCT01527006|450113771|FG001|Core Study|Subject Choice|0|||
125133501|NCT01527006|450113770|FG000|Core Study|Inadequate Therapeutic Effect|1|||
125133502|NCT01527006|450113771|FG001|Core Study|Inadequate Therapeutic Effect|0|||
125133503|NCT01527006|450113770|FG000|Core Study|Withdrawal by Subject|0|||
125133504|NCT01527006|450113771|FG001|Core Study|Withdrawal by Subject|1|||
125133505|NCT01527006|450113770|FG000|Core Study|Other|0|||
125133506|NCT01527006|450113771|FG001|Core Study|Other|2|||
125133507|NCT01527006|450113770|FG000|Extension Phase|Adverse Event|4|||
125133508|NCT01527006|450113771|FG001|Extension Phase|Adverse Event|2|||
125133509|NCT01527006|450113770|FG000|Extension Phase|Lost to Follow-up|0|||
125133510|NCT01527006|450113771|FG001|Extension Phase|Lost to Follow-up|1|||
125133511|NCT01527006|450113770|FG000|Extension Phase|Subject Choice|1|||
125133512|NCT01527006|450113771|FG001|Extension Phase|Subject Choice|1|||
125133513|NCT01527006|450113770|FG000|Extension Phase|Inadequate therapeutic effect|1|||
125133514|NCT01527006|450113771|FG001|Extension Phase|Inadequate therapeutic effect|1|||
125133515|NCT01527006|450113770|FG000|Extension Phase|Other|0|||
125133516|NCT01527006|450113771|FG001|Extension Phase|Other|3|||
125133517|NCT00834340|450113776|FG000|Washout|Adverse Event|1|||
125133518|NCT00834340|450113777|FG001|Washout|Adverse Event|0|||
125133519|NCT00834340|450113776|FG000|Washout|Withdrawal by Subject|1|||
125133520|NCT00834340|450113777|FG001|Washout|Withdrawal by Subject|0|||
125133521|NCT02849457|450113780|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
125133522|NCT02849457|450113781|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
125133523|NCT02849457|450113782|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
125133524|NCT02849457|450113783|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
125133525|NCT03673670|450113787|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
125133526|NCT03673670|450113788|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
125133527|NCT03673670|450113789|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
125133528|NCT03673670|450113790|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
125133529|NCT03673670|450113791|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
125133530|NCT03673670|450113792|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
125133531|NCT03673670|450113787|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
125133532|NCT03673670|450113788|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
125133533|NCT03673670|450113789|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
125133534|NCT03673670|450113790|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
125133535|NCT03673670|450113791|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
125133536|NCT03673670|450113792|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
125133537|NCT03673670|450113787|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
125133538|NCT03673670|450113788|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
125133539|NCT03673670|450113789|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
125133540|NCT03673670|450113790|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
125133541|NCT03673670|450113791|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
125133542|NCT03673670|450113792|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
125133543|NCT03673670|450113787|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
125133544|NCT03673670|450113788|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
125133545|NCT03673670|450113789|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
125133546|NCT03673670|450113790|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
125133547|NCT03673670|450113791|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
125133548|NCT03673670|450113792|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
125133549|NCT03673670|450113787|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
125133550|NCT03673670|450113788|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
125133551|NCT03673670|450113789|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
125133552|NCT03673670|450113790|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
125133553|NCT03673670|450113791|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
125133554|NCT03673670|450113792|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
125133555|NCT03673670|450113787|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
125133556|NCT03673670|450113788|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
125218426|NCT03299101|450427330|FG000|Overall Study|Not enough time to complete prehab|1|||
125218427|NCT02457195|450427331|FG000|Overall Study|Adverse Event|3|||
124973002|NCT01969851|449527395|FG000|Overall Study|Withdrawal by Subject|1|||
124973003|NCT01969851|449527396|FG001|Overall Study|Withdrawal by Subject|0|||
124973004|NCT01969851|449527397|FG002|Overall Study|Withdrawal by Subject|1|||
124973005|NCT01969851|449527395|FG000|Overall Study|No effective dose in Titration period|0|||
124973006|NCT01969851|449527396|FG001|Overall Study|No effective dose in Titration period|0|||
124973007|NCT01969851|449527397|FG002|Overall Study|No effective dose in Titration period|1|||
124973008|NCT01969851|449527395|FG000|Overall Study|Sponsor decision|0|||
124973009|NCT01969851|449527396|FG001|Overall Study|Sponsor decision|0|||
124973010|NCT01969851|449527397|FG002|Overall Study|Sponsor decision|1|||
124973011|NCT01430468|449527406|FG000|Overall Study|Physician Decision|2|||
124973012|NCT01430468|449527407|FG001|Overall Study|Physician Decision|1|||
124973013|NCT01430468|449527406|FG000|Overall Study|Withdrawal by Subject|5|||
124973014|NCT01430468|449527407|FG001|Overall Study|Withdrawal by Subject|5|||
124973015|NCT00617929|449527410|FG000|Overall Study|Physician Decision|1|||
124973016|NCT01426347|449527411|FG000|Overall Study|Lost to Follow-up|0|||
124973017|NCT01426347|449527412|FG001|Overall Study|Lost to Follow-up|3|||
124973018|NCT01426347|449527411|FG000|Overall Study|Protocol Violation|2|||
124973019|NCT01426347|449527412|FG001|Overall Study|Protocol Violation|0|||
124973020|NCT01426347|449527411|FG000|Overall Study|Withdrawal by Subject|5|||
124973021|NCT01426347|449527412|FG001|Overall Study|Withdrawal by Subject|0|||
124973022|NCT01151423|449527414|FG000|Overall Study|Study terminated by Sponsor|9|||
124973023|NCT01151423|449527415|FG001|Overall Study|Study terminated by Sponsor|10|||
124973024|NCT01151423|449527414|FG000|Overall Study|Protocol Violation|0|||
124973025|NCT01151423|449527415|FG001|Overall Study|Protocol Violation|1|||
124973026|NCT01151423|449527414|FG000|Overall Study|Physician Decision|1|||
124973027|NCT01151423|449527415|FG001|Overall Study|Physician Decision|1|||
124973028|NCT01151423|449527414|FG000|Overall Study|Pregnancy|0|||
124973029|NCT01151423|449527415|FG001|Overall Study|Pregnancy|1|||
124973030|NCT01151423|449527414|FG000|Overall Study|Death|0|||
124973031|NCT01151423|449527415|FG001|Overall Study|Death|1|||
124973032|NCT01151423|449527414|FG000|Overall Study|Adverse Event|3|||
124973033|NCT01151423|449527415|FG001|Overall Study|Adverse Event|0|||
124973034|NCT01151423|449527414|FG000|Overall Study|Withdrawal by Subject|1|||
124973035|NCT01151423|449527415|FG001|Overall Study|Withdrawal by Subject|3|||
124973036|NCT01151423|449527414|FG000|Overall Study|Lost to Follow-up|1|||
124973037|NCT01151423|449527415|FG001|Overall Study|Lost to Follow-up|0|||
124973038|NCT01151423|449527414|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
124973039|NCT01151423|449527415|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
124973040|NCT01151423|449527414|FG000|Overall Study|Participated in other clinical trial|1|||
124973041|NCT01151423|449527415|FG001|Overall Study|Participated in other clinical trial|0|||
124973042|NCT03192462|449529231|FG000|Overall Study|Death|13|||
124973043|NCT03192462|449529232|FG001|Overall Study|Death|11|||
124973044|NCT03192462|449529233|FG002|Overall Study|Death|9|||
125037028|NCT00552110|449753146|FG000|Overall Study|Use of Prohibited Medication|1|||
125037029|NCT00552110|449753147|FG001|Overall Study|Use of Prohibited Medication|1|||
125037030|NCT00552110|449753148|FG002|Overall Study|Use of Prohibited Medication|0|||
125037031|NCT00552110|449753149|FG003|Overall Study|Use of Prohibited Medication|0|||
125037032|NCT00552110|449753150|FG004|Overall Study|Use of Prohibited Medication|0|||
125037033|NCT00552110|449753146|FG000|Overall Study|Delay of Study due to Relabeling|0|||
125037034|NCT00552110|449753147|FG001|Overall Study|Delay of Study due to Relabeling|0|||
125037035|NCT00552110|449753148|FG002|Overall Study|Delay of Study due to Relabeling|0|||
125037036|NCT00552110|449753149|FG003|Overall Study|Delay of Study due to Relabeling|1|||
125037037|NCT00552110|449753150|FG004|Overall Study|Delay of Study due to Relabeling|0|||
125218428|NCT02457195|450427331|FG000|Overall Study|Protocol Violation|2|||
124973045|NCT03192462|449529231|FG000|Overall Study|Lost to Follow-up|0|||
124973046|NCT03192462|449529232|FG001|Overall Study|Lost to Follow-up|1|||
124973047|NCT03192462|449529233|FG002|Overall Study|Lost to Follow-up|0|||
124973048|NCT03192462|449529231|FG000|Overall Study|On follow up|0|||
124973049|NCT03192462|449529232|FG001|Overall Study|On follow up|0|||
124973050|NCT03192462|449529233|FG002|Overall Study|On follow up|3|||
124973051|NCT02419417|449529234|FG000|Overall Study|Disease progression|5|||
124973052|NCT02419417|449529235|FG001|Overall Study|Disease progression|4|||
124973053|NCT02419417|449529236|FG002|Overall Study|Disease progression|13|||
124973054|NCT02419417|449529237|FG003|Overall Study|Disease progression|10|||
124973055|NCT02419417|449529238|FG004|Overall Study|Disease progression|10|||
124973056|NCT02419417|449529239|FG005|Overall Study|Disease progression|3|||
124973057|NCT02419417|449529240|FG006|Overall Study|Disease progression|4|||
125037038|NCT00552110|449753146|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
125037039|NCT00552110|449753147|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
125037040|NCT00552110|449753148|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
125037041|NCT00552110|449753149|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
125037042|NCT00552110|449753150|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
125037043|NCT00552110|449753146|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
125037044|NCT00552110|449753147|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
125037045|NCT00552110|449753148|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
125037046|NCT00552110|449753149|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
125037047|NCT00552110|449753150|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
125037048|NCT00454207|449753151|FG000|Overall Study|Adverse Event|3|||
125037049|NCT00454207|449753152|FG001|Overall Study|Adverse Event|1|||
125037050|NCT00454207|449753151|FG000|Overall Study|Lack of Efficacy|1|||
125037051|NCT00454207|449753152|FG001|Overall Study|Lack of Efficacy|0|||
125037052|NCT00454207|449753151|FG000|Overall Study|Protocol Violation|0|||
125037053|NCT00454207|449753152|FG001|Overall Study|Protocol Violation|1|||
125037054|NCT02272790|449753155|FG000|Overall Study|Physician Decision|0|||
125037055|NCT02272790|449753156|FG001|Overall Study|Physician Decision|1|||
125037056|NCT02272790|449753157|FG002|Overall Study|Physician Decision|0|||
125037057|NCT02272790|449753158|FG003|Overall Study|Physician Decision|0|||
125037058|NCT02272790|449753159|FG004|Overall Study|Physician Decision|0|||
125037059|NCT02272790|449753160|FG005|Overall Study|Physician Decision|0|||
125037060|NCT00332202|449753161|FG000|Overall Study|Adverse Event|72|||
125037061|NCT00332202|449753162|FG001|Overall Study|Adverse Event|28|||
125037062|NCT00332202|449753161|FG000|Overall Study|Lost to Follow-up|2|||
125037063|NCT00332202|449753162|FG001|Overall Study|Lost to Follow-up|1|||
125037064|NCT00332202|449753161|FG000|Overall Study|Physician Decision|6|||
125037065|NCT00332202|449753162|FG001|Overall Study|Physician Decision|8|||
125037066|NCT00332202|449753161|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
125133557|NCT03673670|450113789|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
125133558|NCT03673670|450113790|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
125133559|NCT03673670|450113791|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
125133560|NCT03673670|450113792|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
125133561|NCT03673670|450113787|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
125133562|NCT03673670|450113788|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
125133563|NCT03673670|450113789|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
125133564|NCT03673670|450113790|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
125133565|NCT03673670|450113791|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
125133566|NCT03673670|450113792|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
125133567|NCT04408794|450113793|FG000|Overall Study|Adverse Event|43|||
125133568|NCT04408794|450113793|FG000|Overall Study|Infrequent study drug usage|43|||
125133569|NCT04408794|450113793|FG000|Overall Study|Lack of Efficacy|61|||
125133570|NCT04408794|450113793|FG000|Overall Study|Lost to Follow-up|33|||
125133571|NCT04408794|450113793|FG000|Overall Study|Non-compliance|6|||
125133572|NCT04408794|450113793|FG000|Overall Study|Physician Decision|1|||
125133573|NCT04408794|450113793|FG000|Overall Study|Pregnancy|6|||
125133574|NCT04408794|450113793|FG000|Overall Study|Protocol Deviation|9|||
125133575|NCT04408794|450113793|FG000|Overall Study|Sheehan-STS Result|1|||
125133576|NCT04408794|450113793|FG000|Overall Study|Withdrawal by Subject|57|||
125133577|NCT04408794|450113793|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
125133578|NCT04408794|450113793|FG000|Overall Study|Never Treated Migraine|5|||
125133579|NCT04238754|450113796|FG000|Washout - 1 Week|Lost to Follow-up|1|||
125133580|NCT04238754|450113797|FG001|Washout - 1 Week|Lost to Follow-up|0|||
125133581|NCT01518972|450113801|FG000|Overall Study|Lost to Follow-up|2|||
125133582|NCT01518972|450113802|FG001|Overall Study|Lost to Follow-up|1|||
125133583|NCT01518972|450113801|FG000|Overall Study|Withdrawal by Subject|1|||
125133584|NCT01518972|450113802|FG001|Overall Study|Withdrawal by Subject|0|||
125133585|NCT01518972|450113801|FG000|Overall Study|Moved from area|1|||
125133586|NCT01518972|450113802|FG001|Overall Study|Moved from area|0|||
125133587|NCT01518972|450113801|FG000|Overall Study|Transportation problems|1|||
125133588|NCT01518972|450113802|FG001|Overall Study|Transportation problems|0|||
125133589|NCT01518972|450113801|FG000|Overall Study|Exclusionary medical condition|1|||
125133590|NCT01518972|450113802|FG001|Overall Study|Exclusionary medical condition|0|||
125133591|NCT01518972|450113801|FG000|Overall Study|Missed safety visits|0|||
125133592|NCT01518972|450113802|FG001|Overall Study|Missed safety visits|1|||
125133593|NCT01518972|450113801|FG000|Overall Study|Exclusionary medication|0|||
125133594|NCT01518972|450113802|FG001|Overall Study|Exclusionary medication|1|||
125133595|NCT01518972|450113801|FG000|Overall Study|Declined medication starting on day 12|0|||
125133596|NCT01518972|450113802|FG001|Overall Study|Declined medication starting on day 12|1|||
125133597|NCT01175018|450113803|FG000|Overall Study|Adverse Event|3|||
125133598|NCT01175018|450113804|FG001|Overall Study|Adverse Event|1|||
125133599|NCT04022954|450113806|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
125037067|NCT00332202|449753162|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
125037068|NCT00332202|449753161|FG000|Overall Study|Protocol Violation|7|||
125133600|NCT04022954|450113806|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
125037069|NCT00332202|449753162|FG001|Overall Study|Protocol Violation|2|||
125037070|NCT00332202|449753161|FG000|Overall Study|Sponsor Decision|1|||
125037071|NCT00332202|449753162|FG001|Overall Study|Sponsor Decision|2|||
125037072|NCT00332202|449753161|FG000|Overall Study|Withdrawal by Subject|36|||
125037073|NCT00332202|449753162|FG001|Overall Study|Withdrawal by Subject|17|||
125037074|NCT00332202|449753161|FG000|Overall Study|Progressive Disease|106|||
125133601|NCT04022954|450113806|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
125133602|NCT03872128|450113809|FG000|Overall Study|Dropped out before treatment|1|||
125133603|NCT03872128|450113810|FG001|Overall Study|Dropped out before treatment|0|||
125133604|NCT03872128|450113811|FG002|Overall Study|Dropped out before treatment|4|||
125133605|NCT03872128|450113809|FG000|Overall Study|Lost to Follow-up|2|||
125133606|NCT03872128|450113810|FG001|Overall Study|Lost to Follow-up|5|||
125133607|NCT03872128|450113811|FG002|Overall Study|Lost to Follow-up|8|||
125133608|NCT00556322|450113812|FG000|Overall Study|Insufficient therapeutic response|158|||
125133609|NCT00556322|450113813|FG001|Overall Study|Insufficient therapeutic response|168|||
125133610|NCT00556322|450113812|FG000|Overall Study|Adverse Event|7|||
125133611|NCT00556322|450113813|FG001|Overall Study|Adverse Event|4|||
125133612|NCT00556322|450113812|FG000|Overall Study|Other|4|||
125133613|NCT00556322|450113813|FG001|Overall Study|Other|1|||
125133614|NCT00556322|450113812|FG000|Overall Study|Lost to Follow-up|5|||
125133615|NCT00556322|450113813|FG001|Overall Study|Lost to Follow-up|3|||
125133616|NCT00556322|450113812|FG000|Overall Study|Withdrawal by Subject|19|||
125133617|NCT00556322|450113813|FG001|Overall Study|Withdrawal by Subject|7|||
125133618|NCT00556322|450113812|FG000|Overall Study|Protocol Violation|5|||
125133619|NCT00556322|450113813|FG001|Overall Study|Protocol Violation|1|||
125133620|NCT00556322|450113812|FG000|Overall Study|Ongoing at data cutoff|3|||
125133621|NCT00556322|450113813|FG001|Overall Study|Ongoing at data cutoff|5|||
125133622|NCT00556322|450113812|FG000|Overall Study|Death|20|||
125133623|NCT00556322|450113813|FG001|Overall Study|Death|14|||
125133624|NCT03733444|450113814|FG000|Overall Study|Adverse Event|8|||
125133625|NCT03733444|450113815|FG001|Overall Study|Adverse Event|10|||
125037075|NCT00332202|449753162|FG001|Overall Study|Progressive Disease|60|||
125037076|NCT00332202|449753161|FG000|Overall Study|Death|5|||
125037077|NCT00332202|449753162|FG001|Overall Study|Death|2|||
125037078|NCT03871491|449753163|FG000|Overall Study|Withdrawal by Subject|14|||
125037079|NCT03871491|449753164|FG001|Overall Study|Withdrawal by Subject|14|||
125037080|NCT03871491|449753165|FG002|Overall Study|Withdrawal by Subject|14|||
125037081|NCT03871491|449753166|FG003|Overall Study|Withdrawal by Subject|14|||
125037082|NCT03871491|449753163|FG000|Overall Study|Physician Decision|0|||
125037083|NCT03871491|449753164|FG001|Overall Study|Physician Decision|0|||
125037084|NCT03871491|449753165|FG002|Overall Study|Physician Decision|1|||
125037085|NCT03871491|449753166|FG003|Overall Study|Physician Decision|1|||
125037086|NCT03871491|449753163|FG000|Overall Study|Lost to Follow-up|50|||
125037087|NCT03871491|449753164|FG001|Overall Study|Lost to Follow-up|15|||
125037088|NCT03871491|449753165|FG002|Overall Study|Lost to Follow-up|36|||
125037089|NCT03871491|449753166|FG003|Overall Study|Lost to Follow-up|11|||
125037090|NCT04439331|449753167|FG000|Overall Study|Never Start Protocol Therapy|2|||
125037091|NCT04439331|449753167|FG000|Overall Study|Ineligible|2|||
125037092|NCT04439331|449753167|FG000|Overall Study|Mutation Status Not Confirmed|1|||
125037093|NCT04439331|449753167|FG000|Overall Study|Adverse Event|1|||
125037094|NCT04439331|449753167|FG000|Overall Study|Death|1|||
125037095|NCT04439331|449753167|FG000|Overall Study|Disease Progression|20|||
125037096|NCT04439331|449753167|FG000|Overall Study|Withdrawal by Subject|6|||
125037097|NCT04439331|449753167|FG000|Overall Study|Physician Decision|1|||
125037098|NCT04439331|449753167|FG000|Overall Study|Other Complicating Disease|1|||
125133626|NCT03733444|450113816|FG002|Overall Study|Adverse Event|5|||
125133627|NCT03733444|450113814|FG000|Overall Study|Death|20|||
125133628|NCT03733444|450113815|FG001|Overall Study|Death|19|||
125133629|NCT03733444|450113816|FG002|Overall Study|Death|11|||
125133630|NCT03733444|450113814|FG000|Overall Study|Lost to Follow-up|3|||
125133631|NCT03733444|450113815|FG001|Overall Study|Lost to Follow-up|0|||
125133632|NCT03733444|450113816|FG002|Overall Study|Lost to Follow-up|1|||
125133633|NCT03733444|450113814|FG000|Overall Study|Lack of Efficacy|0|||
125133634|NCT03733444|450113815|FG001|Overall Study|Lack of Efficacy|1|||
125133635|NCT03733444|450113816|FG002|Overall Study|Lack of Efficacy|1|||
125133636|NCT03733444|450113814|FG000|Overall Study|Physician Decision|2|||
125133637|NCT03733444|450113815|FG001|Overall Study|Physician Decision|1|||
125133638|NCT03733444|450113816|FG002|Overall Study|Physician Decision|0|||
125133639|NCT03733444|450113814|FG000|Overall Study|Protocol Violation|2|||
125037099|NCT00490542|449753170|FG000|Overall Study|Lost to Follow-up|3|||
125037100|NCT00490542|449753171|FG001|Overall Study|Lost to Follow-up|0|||
125037101|NCT00490542|449753170|FG000|Overall Study|Adverse Event|3|||
125133640|NCT03733444|450113815|FG001|Overall Study|Protocol Violation|1|||
125133641|NCT03733444|450113816|FG002|Overall Study|Protocol Violation|0|||
125037102|NCT00490542|449753171|FG001|Overall Study|Adverse Event|3|||
125037103|NCT00490542|449753170|FG000|Overall Study|Lack of Efficacy|1|||
125037104|NCT00490542|449753171|FG001|Overall Study|Lack of Efficacy|1|||
125133642|NCT03733444|450113814|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
125133643|NCT03733444|450113815|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
124973058|NCT02419417|449529241|FG007|Overall Study|Disease progression|5|||
124973059|NCT02419417|449529242|FG008|Overall Study|Disease progression|13|||
124973060|NCT02419417|449529243|FG009|Overall Study|Disease progression|9|||
124973061|NCT02419417|449529244|FG010|Overall Study|Disease progression|0|||
124973062|NCT02419417|449529234|FG000|Overall Study|Study drug toxicity|0|||
124973063|NCT02419417|449529235|FG001|Overall Study|Study drug toxicity|0|||
124973064|NCT02419417|449529236|FG002|Overall Study|Study drug toxicity|0|||
125037105|NCT00818259|449753175|FG000|Part I|Withdrawal by Subject|1|||
125037106|NCT00818259|449753176|FG001|Part I|Withdrawal by Subject|0|||
125037107|NCT00818259|449753177|FG002|Part I|Withdrawal by Subject|0|||
125037108|NCT00818259|449753178|FG003|Part I|Withdrawal by Subject|0|||
125037109|NCT00818259|449753179|FG004|Part I|Withdrawal by Subject|0|||
125037110|NCT00818259|449753180|FG005|Part I|Withdrawal by Subject|0|||
125037111|NCT00818259|449753181|FG006|Part I|Withdrawal by Subject|0|||
125037112|NCT00818259|449753182|FG007|Part I|Withdrawal by Subject|0|||
125037113|NCT00818259|449753183|FG008|Part I|Withdrawal by Subject|0|||
125037114|NCT00818259|449753175|FG000|Part II|Physician Decision|0|||
125037115|NCT00818259|449753176|FG001|Part II|Physician Decision|0|||
125037116|NCT00818259|449753177|FG002|Part II|Physician Decision|1|||
125037117|NCT00818259|449753178|FG003|Part II|Physician Decision|0|||
125037118|NCT00818259|449753179|FG004|Part II|Physician Decision|0|||
125037119|NCT00818259|449753180|FG005|Part II|Physician Decision|0|||
125037120|NCT00818259|449753181|FG006|Part II|Physician Decision|0|||
125037121|NCT00818259|449753182|FG007|Part II|Physician Decision|0|||
125037122|NCT00818259|449753183|FG008|Part II|Physician Decision|0|||
125037123|NCT00818259|449753175|FG000|Part II|Lack of Efficacy|0|||
125037124|NCT00818259|449753176|FG001|Part II|Lack of Efficacy|0|||
125037125|NCT00818259|449753177|FG002|Part II|Lack of Efficacy|0|||
125133644|NCT03733444|450113816|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
125133645|NCT03733444|450113814|FG000|Overall Study|Study Terminated by Sponsor|203|||
125133646|NCT03733444|450113815|FG001|Overall Study|Study Terminated by Sponsor|209|||
125133647|NCT03733444|450113816|FG002|Overall Study|Study Terminated by Sponsor|221|||
125133648|NCT03733444|450113814|FG000|Overall Study|Withdrawal by Subject|19|||
124973065|NCT02419417|449529237|FG003|Overall Study|Study drug toxicity|0|||
124973066|NCT02419417|449529238|FG004|Overall Study|Study drug toxicity|1|||
124973067|NCT02419417|449529239|FG005|Overall Study|Study drug toxicity|0|||
124973068|NCT02419417|449529240|FG006|Overall Study|Study drug toxicity|0|||
124973069|NCT02419417|449529241|FG007|Overall Study|Study drug toxicity|0|||
124973070|NCT02419417|449529242|FG008|Overall Study|Study drug toxicity|0|||
124973071|NCT02419417|449529243|FG009|Overall Study|Study drug toxicity|0|||
124973072|NCT02419417|449529244|FG010|Overall Study|Study drug toxicity|0|||
124973073|NCT02419417|449529234|FG000|Overall Study|Adverse event unrelated to study drug|0|||
124973074|NCT02419417|449529235|FG001|Overall Study|Adverse event unrelated to study drug|0|||
124973075|NCT02419417|449529236|FG002|Overall Study|Adverse event unrelated to study drug|0|||
124973076|NCT02419417|449529237|FG003|Overall Study|Adverse event unrelated to study drug|0|||
124973077|NCT02419417|449529238|FG004|Overall Study|Adverse event unrelated to study drug|2|||
124973078|NCT02419417|449529239|FG005|Overall Study|Adverse event unrelated to study drug|1|||
124973079|NCT02419417|449529240|FG006|Overall Study|Adverse event unrelated to study drug|0|||
124973080|NCT02419417|449529241|FG007|Overall Study|Adverse event unrelated to study drug|1|||
124973081|NCT02419417|449529242|FG008|Overall Study|Adverse event unrelated to study drug|0|||
124973082|NCT02419417|449529243|FG009|Overall Study|Adverse event unrelated to study drug|0|||
124973083|NCT02419417|449529244|FG010|Overall Study|Adverse event unrelated to study drug|0|||
124973084|NCT02419417|449529234|FG000|Overall Study|Participant request to discontinue|0|||
124973085|NCT02419417|449529235|FG001|Overall Study|Participant request to discontinue|0|||
124973086|NCT02419417|449529236|FG002|Overall Study|Participant request to discontinue|0|||
124973087|NCT02419417|449529237|FG003|Overall Study|Participant request to discontinue|0|||
124973088|NCT02419417|449529238|FG004|Overall Study|Participant request to discontinue|0|||
124973089|NCT02419417|449529239|FG005|Overall Study|Participant request to discontinue|0|||
124973090|NCT02419417|449529240|FG006|Overall Study|Participant request to discontinue|0|||
124973091|NCT02419417|449529241|FG007|Overall Study|Participant request to discontinue|0|||
124973092|NCT02419417|449529242|FG008|Overall Study|Participant request to discontinue|0|||
125133649|NCT03733444|450113815|FG001|Overall Study|Withdrawal by Subject|18|||
125133650|NCT03733444|450113816|FG002|Overall Study|Withdrawal by Subject|16|||
125133651|NCT03733444|450113814|FG000|Overall Study|Miscellaneous|1|||
125133652|NCT03733444|450113815|FG001|Overall Study|Miscellaneous|0|||
125133653|NCT03733444|450113816|FG002|Overall Study|Miscellaneous|1|||
124973093|NCT02419417|449529243|FG009|Overall Study|Participant request to discontinue|1|||
125037126|NCT00818259|449753178|FG003|Part II|Lack of Efficacy|1|||
125037127|NCT00818259|449753179|FG004|Part II|Lack of Efficacy|0|||
125037128|NCT00818259|449753180|FG005|Part II|Lack of Efficacy|0|||
125037129|NCT00818259|449753181|FG006|Part II|Lack of Efficacy|0|||
125037130|NCT00818259|449753182|FG007|Part II|Lack of Efficacy|0|||
125037131|NCT00818259|449753183|FG008|Part II|Lack of Efficacy|0|||
125037132|NCT00818259|449753175|FG000|Part II|Not Treated|0|||
125037133|NCT00818259|449753176|FG001|Part II|Not Treated|0|||
125037134|NCT00818259|449753177|FG002|Part II|Not Treated|0|||
125037135|NCT00818259|449753178|FG003|Part II|Not Treated|1|||
124973094|NCT02419417|449529244|FG010|Overall Study|Participant request to discontinue|0|||
124973095|NCT02419417|449529234|FG000|Overall Study|Withdrawal by Subject|0|||
124973096|NCT02419417|449529235|FG001|Overall Study|Withdrawal by Subject|0|||
124973097|NCT02419417|449529236|FG002|Overall Study|Withdrawal by Subject|0|||
124973098|NCT02419417|449529237|FG003|Overall Study|Withdrawal by Subject|0|||
124973099|NCT02419417|449529238|FG004|Overall Study|Withdrawal by Subject|0|||
124973100|NCT02419417|449529239|FG005|Overall Study|Withdrawal by Subject|0|||
124973101|NCT02419417|449529240|FG006|Overall Study|Withdrawal by Subject|0|||
124973102|NCT02419417|449529241|FG007|Overall Study|Withdrawal by Subject|0|||
124973103|NCT02419417|449529242|FG008|Overall Study|Withdrawal by Subject|0|||
124973104|NCT02419417|449529243|FG009|Overall Study|Withdrawal by Subject|0|||
124973105|NCT02419417|449529244|FG010|Overall Study|Withdrawal by Subject|1|||
124973106|NCT00078377|449529245|FG000|Overall Study|Adverse Event|2|||
124973107|NCT00078377|449529246|FG001|Overall Study|Adverse Event|5|||
124973108|NCT00078377|449529247|FG002|Overall Study|Adverse Event|1|||
124973109|NCT00078377|449529245|FG000|Overall Study|Lack of Efficacy|2|||
124973110|NCT00078377|449529246|FG001|Overall Study|Lack of Efficacy|0|||
124973111|NCT00078377|449529247|FG002|Overall Study|Lack of Efficacy|2|||
124973112|NCT00078377|449529245|FG000|Overall Study|Lost to Follow-up|0|||
124973113|NCT00078377|449529246|FG001|Overall Study|Lost to Follow-up|1|||
124973114|NCT00078377|449529247|FG002|Overall Study|Lost to Follow-up|1|||
124973115|NCT00078377|449529245|FG000|Overall Study|Physician Decision|2|||
124973116|NCT00078377|449529246|FG001|Overall Study|Physician Decision|0|||
124973117|NCT00078377|449529247|FG002|Overall Study|Physician Decision|0|||
124973118|NCT00078377|449529245|FG000|Overall Study|Withdrawal by Subject|3|||
124973119|NCT00078377|449529246|FG001|Overall Study|Withdrawal by Subject|4|||
124973120|NCT00078377|449529247|FG002|Overall Study|Withdrawal by Subject|4|||
124973121|NCT00078377|449529245|FG000|Overall Study|Miscellaneous|2|||
124973122|NCT00078377|449529246|FG001|Overall Study|Miscellaneous|6|||
124973123|NCT00078377|449529247|FG002|Overall Study|Miscellaneous|1|||
124973124|NCT00233480|449529248|FG000|Overall Study|Underwent status II heart transplant|0|||
124973125|NCT00233480|449529249|FG001|Overall Study|Underwent status II heart transplant|1|||
124973126|NCT00581893|449529250|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
124973127|NCT00581893|449529251|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
124973128|NCT00790400|449529254|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
124973129|NCT00790400|449529255|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
124973130|NCT00790400|449529254|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
124973131|NCT00790400|449529255|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
124973132|NCT00790400|449529254|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
124973133|NCT00790400|449529255|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
124973134|NCT00790400|449529254|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
124973135|NCT00790400|449529255|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
124973136|NCT00790400|449529254|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
125037136|NCT00818259|449753179|FG004|Part II|Not Treated|0|||
125037137|NCT00818259|449753180|FG005|Part II|Not Treated|0|||
125037138|NCT00818259|449753181|FG006|Part II|Not Treated|0|||
125037139|NCT00818259|449753182|FG007|Part II|Not Treated|0|||
125037140|NCT00818259|449753183|FG008|Part II|Not Treated|0|||
125037141|NCT00818259|449753175|FG000|Part IV|Physician Decision|0|||
125037142|NCT00818259|449753176|FG001|Part IV|Physician Decision|0|||
125037143|NCT00818259|449753177|FG002|Part IV|Physician Decision|0|||
125037144|NCT00818259|449753178|FG003|Part IV|Physician Decision|0|||
125037145|NCT00818259|449753179|FG004|Part IV|Physician Decision|0|||
125037146|NCT00818259|449753180|FG005|Part IV|Physician Decision|1|||
125037147|NCT00818259|449753181|FG006|Part IV|Physician Decision|0|||
125037148|NCT00818259|449753182|FG007|Part IV|Physician Decision|0|||
125037149|NCT00818259|449753183|FG008|Part IV|Physician Decision|0|||
125037150|NCT00818259|449753175|FG000|Part V|Adverse Event|0|||
125037151|NCT00818259|449753176|FG001|Part V|Adverse Event|0|||
125037152|NCT00818259|449753177|FG002|Part V|Adverse Event|0|||
125037153|NCT00818259|449753178|FG003|Part V|Adverse Event|0|||
125037154|NCT00818259|449753179|FG004|Part V|Adverse Event|0|||
125037155|NCT00818259|449753180|FG005|Part V|Adverse Event|0|||
125037156|NCT00818259|449753181|FG006|Part V|Adverse Event|0|||
125037157|NCT00818259|449753182|FG007|Part V|Adverse Event|1|||
125037158|NCT00818259|449753183|FG008|Part V|Adverse Event|0|||
125037159|NCT01237951|449753187|FG000|Overall Study|Death|1|||
125037160|NCT00924703|449753190|FG000|Overall Study|Withdrawal by Subject|11|||
125037161|NCT00924703|449753190|FG000|Overall Study|Physician Decision|5|||
125037162|NCT00924703|449753190|FG000|Overall Study|Lost to Follow-up|3|||
125037163|NCT00924703|449753190|FG000|Overall Study|Adverse Event|2|||
125037164|NCT00924703|449753190|FG000|Overall Study|Withdrawal by Sponsor|1|||
125037165|NCT00666562|449753191|FG000|Overall Study|Withdrawal by Subject|0|||
125037166|NCT00666562|449753192|FG001|Overall Study|Withdrawal by Subject|1|||
125037167|NCT00666562|449753193|FG002|Overall Study|Withdrawal by Subject|0|||
125037168|NCT00666562|449753191|FG000|Overall Study|Concomitant Medication|0|||
125037169|NCT00666562|449753192|FG001|Overall Study|Concomitant Medication|1|||
125037170|NCT00666562|449753193|FG002|Overall Study|Concomitant Medication|0|||
125037171|NCT01587989|449753196|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
125037172|NCT01587989|449753197|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
125037173|NCT01587989|449753198|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
125037174|NCT01587989|449753196|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
125037175|NCT01587989|449753197|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
125037176|NCT01587989|449753198|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
125037177|NCT01587989|449753196|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
125037178|NCT01587989|449753197|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
125037179|NCT01587989|449753198|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
125037180|NCT01587989|449753196|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
125037181|NCT01587989|449753197|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
125037182|NCT01587989|449753198|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
125037183|NCT01587989|449753196|FG000|Randomized Study Treatment|Screening failure|0|||
125037184|NCT01587989|449753197|FG001|Randomized Study Treatment|Screening failure|1|||
125037185|NCT01587989|449753198|FG002|Randomized Study Treatment|Screening failure|0|||
125037186|NCT01587989|449753196|FG000|Randomized Study Treatment|Physician Decision|0|||
125037187|NCT01587989|449753197|FG001|Randomized Study Treatment|Physician Decision|0|||
125037188|NCT01587989|449753198|FG002|Randomized Study Treatment|Physician Decision|1|||
125037189|NCT04429022|449753199|FG000|Overall Study|Protocol Violation|18|||
125037190|NCT04429022|449753200|FG001|Overall Study|Protocol Violation|1|||
125037191|NCT02582658|449753205|FG000|Overall Study|Failure to Return|10|||
125037192|NCT02582658|449753205|FG000|Overall Study|Insufficient Virological Response|2|||
125037193|NCT02582658|449753205|FG000|Overall Study|Withdrawn Consent|1|||
125037194|NCT02582658|449753205|FG000|Overall Study|Death|1|||
125037195|NCT02582658|449753205|FG000|Overall Study|Not further specified|11|||
125037196|NCT03274687|449754849|FG000|Overall Study|Protocol Violation|1|||
125037197|NCT03274687|449754850|FG001|Overall Study|Protocol Violation|1|||
125037198|NCT05556616|449754851|FG000|Overall Study|Withdrawal by Subject|1|||
125037199|NCT05556616|449754852|FG001|Overall Study|Withdrawal by Subject|0|||
125037200|NCT05556616|449754853|FG002|Overall Study|Withdrawal by Subject|0|||
125037201|NCT05556616|449754854|FG003|Overall Study|Withdrawal by Subject|0|||
125037202|NCT05556616|449754855|FG004|Overall Study|Withdrawal by Subject|0|||
125037203|NCT05556616|449754856|FG005|Overall Study|Withdrawal by Subject|0|||
125037204|NCT05556616|449754857|FG006|Overall Study|Withdrawal by Subject|0|||
125037205|NCT05556616|449754851|FG000|Overall Study|Death|0|||
125037206|NCT05556616|449754852|FG001|Overall Study|Death|0|||
125037207|NCT05556616|449754853|FG002|Overall Study|Death|2|||
125037208|NCT05556616|449754854|FG003|Overall Study|Death|1|||
125037209|NCT05556616|449754855|FG004|Overall Study|Death|0|||
125037210|NCT05556616|449754856|FG005|Overall Study|Death|0|||
125037211|NCT05556616|449754857|FG006|Overall Study|Death|0|||
125037212|NCT05556616|449754851|FG000|Overall Study|Study Terminated by Sponsor|0|||
125037213|NCT05556616|449754852|FG001|Overall Study|Study Terminated by Sponsor|3|||
125037214|NCT05556616|449754853|FG002|Overall Study|Study Terminated by Sponsor|0|||
125037215|NCT05556616|449754854|FG003|Overall Study|Study Terminated by Sponsor|0|||
125037216|NCT05556616|449754855|FG004|Overall Study|Study Terminated by Sponsor|0|||
125037217|NCT05556616|449754856|FG005|Overall Study|Study Terminated by Sponsor|0|||
125037218|NCT05556616|449754857|FG006|Overall Study|Study Terminated by Sponsor|0|||
125037219|NCT03539432|449754862|FG000|Overall Study|Lost to Follow-up|0|||
125037220|NCT03539432|449754863|FG001|Overall Study|Lost to Follow-up|1|||
125037221|NCT00824564|449754866|FG000|Overall Study|Lost to Follow-up|5|||
125037222|NCT00824564|449754867|FG001|Overall Study|Lost to Follow-up|7|||
125037223|NCT00824564|449754866|FG000|Overall Study|Withdrawal by Subject|1|||
125037224|NCT00824564|449754867|FG001|Overall Study|Withdrawal by Subject|1|||
125037225|NCT00824564|449754866|FG000|Overall Study|Other|1|||
125037226|NCT00824564|449754867|FG001|Overall Study|Other|2|||
125037227|NCT00824564|449754866|FG000|Overall Study|Randomized, but not treated|1|||
125037228|NCT00824564|449754867|FG001|Overall Study|Randomized, but not treated|0|||
125037229|NCT00476086|449754868|FG000|Overall Study|Alternative therapy|1|||
125037230|NCT00476086|449754868|FG000|Overall Study|Progressive Disease|4|||
125037231|NCT04178590|449754869|FG000|Overall Study|Pregnancy|1|||
125037232|NCT04178590|449754869|FG000|Overall Study|Lost to Follow-up|1|||
125037233|NCT02292849|449754871|FG000|Overall Study|Lost to Follow-up|0|||
125037234|NCT02292849|449754872|FG001|Overall Study|Lost to Follow-up|2|||
125037235|NCT02292849|449754873|FG002|Overall Study|Lost to Follow-up|2|||
125037236|NCT02292849|449754871|FG000|Overall Study|Physician Decision|4|||
125037237|NCT02292849|449754872|FG001|Overall Study|Physician Decision|0|||
125037238|NCT02292849|449754873|FG002|Overall Study|Physician Decision|0|||
125037239|NCT00886938|449754874|FG000|Overall Study|Adverse Event|1|||
125037240|NCT00886938|449754874|FG000|Overall Study|Withdrawal by Subject|1|||
125037241|NCT00364793|449754875|FG000|Overall Study|Adverse Event|2|||
125037242|NCT00364793|449754876|FG001|Overall Study|Adverse Event|0|||
125037243|NCT00364793|449754877|FG002|Overall Study|Adverse Event|0|||
125037244|NCT00364793|449754878|FG003|Overall Study|Adverse Event|0|||
125037245|NCT00364793|449754875|FG000|Overall Study|Death|1|||
125037246|NCT00364793|449754876|FG001|Overall Study|Death|0|||
125037247|NCT00364793|449754877|FG002|Overall Study|Death|1|||
125037248|NCT00364793|449754878|FG003|Overall Study|Death|0|||
125037249|NCT00364793|449754875|FG000|Overall Study|Lack of Efficacy|3|||
125037250|NCT00364793|449754876|FG001|Overall Study|Lack of Efficacy|3|||
125037251|NCT00364793|449754877|FG002|Overall Study|Lack of Efficacy|1|||
125037252|NCT00364793|449754878|FG003|Overall Study|Lack of Efficacy|1|||
125037253|NCT00364793|449754875|FG000|Overall Study|Lost to Follow-up|1|||
125037254|NCT00364793|449754876|FG001|Overall Study|Lost to Follow-up|0|||
125037255|NCT00364793|449754877|FG002|Overall Study|Lost to Follow-up|2|||
125037256|NCT00364793|449754878|FG003|Overall Study|Lost to Follow-up|0|||
125037257|NCT00364793|449754875|FG000|Overall Study|Poor or non-compliance|1|||
125037258|NCT00364793|449754876|FG001|Overall Study|Poor or non-compliance|1|||
125037259|NCT00364793|449754877|FG002|Overall Study|Poor or non-compliance|0|||
125037260|NCT00364793|449754878|FG003|Overall Study|Poor or non-compliance|1|||
125037261|NCT00364793|449754875|FG000|Overall Study|No longer meets criteria|0|||
125037262|NCT00364793|449754876|FG001|Overall Study|No longer meets criteria|0|||
125037263|NCT00364793|449754877|FG002|Overall Study|No longer meets criteria|0|||
125037264|NCT00364793|449754878|FG003|Overall Study|No longer meets criteria|1|||
125037265|NCT00364793|449754875|FG000|Overall Study|Withdrawal by Subject|0|||
125037266|NCT00364793|449754876|FG001|Overall Study|Withdrawal by Subject|1|||
125037267|NCT00364793|449754877|FG002|Overall Study|Withdrawal by Subject|0|||
125037268|NCT00364793|449754878|FG003|Overall Study|Withdrawal by Subject|0|||
125037269|NCT00363415|449754881|FG000|Overall Study|Progressive Disease|196|||
125037270|NCT00363415|449754882|FG001|Overall Study|Progressive Disease|107|||
125037271|NCT00363415|449754881|FG000|Overall Study|Sponsor Decision|67|||
125037272|NCT00363415|449754882|FG001|Overall Study|Sponsor Decision|31|||
125037273|NCT00363415|449754881|FG000|Overall Study|Death|32|||
125037274|NCT00363415|449754882|FG001|Overall Study|Death|29|||
125037275|NCT00363415|449754881|FG000|Overall Study|Adverse Event|24|||
125037276|NCT00363415|449754882|FG001|Overall Study|Adverse Event|15|||
125037277|NCT00363415|449754881|FG000|Overall Study|Physician Decision|18|||
125037278|NCT00363415|449754882|FG001|Overall Study|Physician Decision|35|||
125037279|NCT00363415|449754881|FG000|Overall Study|Entry Criteria Not Met|11|||
125037280|NCT00363415|449754882|FG001|Overall Study|Entry Criteria Not Met|10|||
125037281|NCT00363415|449754881|FG000|Overall Study|Withdrawal by Subject|9|||
125037282|NCT00363415|449754882|FG001|Overall Study|Withdrawal by Subject|15|||
125037283|NCT00363415|449754881|FG000|Overall Study|Lost to Follow-up|3|||
125037284|NCT00363415|449754882|FG001|Overall Study|Lost to Follow-up|3|||
125037285|NCT00363415|449754881|FG000|Overall Study|Protocol Violation|1|||
125037286|NCT00363415|449754882|FG001|Overall Study|Protocol Violation|4|||
125037287|NCT05027802|449754885|FG000|Overall Study|Adverse Event|2|||
125037288|NCT05027802|449754885|FG000|Overall Study|Withdrawal by Subject|18|||
125037289|NCT05027802|449754885|FG000|Overall Study|Death|2|||
125037290|NCT05027802|449754885|FG000|Overall Study|Other|1|||
124973137|NCT00790400|449529255|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
124973138|NCT00790400|449529254|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
124973139|NCT00790400|449529255|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
124973140|NCT00790400|449529254|FG000|Double-blind Period (Core Phase)|Death|1|||
124973141|NCT00790400|449529255|FG001|Double-blind Period (Core Phase)|Death|0|||
124973142|NCT00790400|449529254|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
124973143|NCT00790400|449529255|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
124973144|NCT00790400|449529254|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
124973145|NCT00790400|449529255|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
124973146|NCT00790400|449529254|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
124973147|NCT00790400|449529255|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
124973148|NCT00790400|449529254|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
124973149|NCT00790400|449529255|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
124973150|NCT00790400|449529254|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
124973151|NCT00790400|449529255|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
124973152|NCT00790400|449529254|FG000|Everolimus Period (Core or Extension)|Death|1|||
124973153|NCT00790400|449529255|FG001|Everolimus Period (Core or Extension)|Death|0|||
124973154|NCT00790400|449529254|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
124973155|NCT00790400|449529255|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
124973156|NCT00790400|449529254|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
124973157|NCT00790400|449529255|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
124973158|NCT00790400|449529254|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
124973159|NCT00790400|449529255|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
124973160|NCT01107899|449529261|FG000|Overall Study|Physician Decision|5|||
124973161|NCT01107899|449529262|FG001|Overall Study|Physician Decision|0|||
124973162|NCT01107899|449529263|FG002|Overall Study|Physician Decision|3|||
124973163|NCT01107899|449529261|FG000|Overall Study|Withdrawal by Subject|0|||
124973164|NCT01107899|449529262|FG001|Overall Study|Withdrawal by Subject|0|||
124973165|NCT01107899|449529263|FG002|Overall Study|Withdrawal by Subject|1|||
124973166|NCT00974259|449529264|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
124973167|NCT00974259|449529265|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
124973168|NCT01810939|449529285|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
124973169|NCT01810939|449529286|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
124973170|NCT01810939|449529287|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
124973171|NCT01810939|449529285|FG000|Part A Treatment Period|Protocol Violation|2|||
124973172|NCT01810939|449529286|FG001|Part A Treatment Period|Protocol Violation|0|||
124973173|NCT01810939|449529287|FG002|Part A Treatment Period|Protocol Violation|0|||
124973174|NCT01810939|449529285|FG000|Part A Treatment Period|Adverse Event|10|||
124973175|NCT01810939|449529286|FG001|Part A Treatment Period|Adverse Event|0|||
124973176|NCT01810939|449529287|FG002|Part A Treatment Period|Adverse Event|0|||
124973177|NCT01810939|449529285|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
124973178|NCT01810939|449529286|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
124973179|NCT01810939|449529287|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
124973180|NCT01810939|449529285|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
124973181|NCT01810939|449529286|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
124973182|NCT01810939|449529287|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
124973183|NCT01810939|449529285|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
124973184|NCT01810939|449529286|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
124973185|NCT01810939|449529287|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
124973186|NCT01810939|449529285|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
124973187|NCT01810939|449529286|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
124973188|NCT01810939|449529287|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
124973189|NCT01810939|449529285|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
124973190|NCT01810939|449529286|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
124973191|NCT01810939|449529287|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
124973192|NCT01810939|449529285|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
124973193|NCT01810939|449529286|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
124973194|NCT01810939|449529287|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
124973195|NCT01810939|449529285|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
124973196|NCT01810939|449529286|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
125037291|NCT03872180|449754888|FG000|Overall Study|Adverse Event|4|||
125037292|NCT03872180|449754888|FG000|Overall Study|Lack of Efficacy|2|||
125037293|NCT01506141|449754889|FG000|Overall Study|Adverse Event|0|||
125037294|NCT01506141|449754890|FG001|Overall Study|Adverse Event|2|||
125037295|NCT01506141|449754889|FG000|Overall Study|Participation Terminated by Investigator|1|||
125037296|NCT01506141|449754890|FG001|Overall Study|Participation Terminated by Investigator|1|||
125037297|NCT01506141|449754889|FG000|Overall Study|Site Terminated by Sponsor|2|||
125037298|NCT01506141|449754890|FG001|Overall Study|Site Terminated by Sponsor|0|||
125037299|NCT01506141|449754889|FG000|Overall Study|Reason Not Specified|4|||
125037300|NCT01506141|449754890|FG001|Overall Study|Reason Not Specified|2|||
125037301|NCT04607408|449754891|FG000|Overall Study|Lost to Follow-up|0|||
125037302|NCT04607408|449754892|FG001|Overall Study|Lost to Follow-up|0|||
125037303|NCT04607408|449754893|FG002|Overall Study|Lost to Follow-up|0|||
125037304|NCT04607408|449754894|FG003|Overall Study|Lost to Follow-up|1|||
125037305|NCT04607408|449754895|FG004|Overall Study|Lost to Follow-up|0|||
125037306|NCT04607408|449754891|FG000|Overall Study|Withdrawal by Subject|0|||
125037307|NCT04607408|449754892|FG001|Overall Study|Withdrawal by Subject|1|||
125037308|NCT04607408|449754893|FG002|Overall Study|Withdrawal by Subject|0|||
125037309|NCT04607408|449754894|FG003|Overall Study|Withdrawal by Subject|1|||
125037310|NCT04607408|449754895|FG004|Overall Study|Withdrawal by Subject|0|||
125037311|NCT02725788|449754900|FG000|Overall Study|Lost to Follow-up|1|||
125037312|NCT02725788|449754901|FG001|Overall Study|Lost to Follow-up|1|||
125037313|NCT02725788|449754900|FG000|Overall Study|Protocol Violation|0|||
125037314|NCT02725788|449754901|FG001|Overall Study|Protocol Violation|1|||
125037315|NCT00828464|449754902|FG000|Overall Study|Withdrawal by Subject|1|||
125037316|NCT00809133|449754903|FG000|Overall Study|Progressive disease|2|||
125037317|NCT00809133|449754904|FG001|Overall Study|Progressive disease|5|||
125037318|NCT00809133|449754905|FG002|Overall Study|Progressive disease|5|||
125037319|NCT00809133|449754906|FG003|Overall Study|Progressive disease|3|||
125037320|NCT00809133|449754907|FG004|Overall Study|Progressive disease|4|||
125037321|NCT00809133|449754908|FG005|Overall Study|Progressive disease|1|||
125037322|NCT00809133|449754909|FG006|Overall Study|Progressive disease|3|||
125037323|NCT00809133|449754910|FG007|Overall Study|Progressive disease|3|||
125037324|NCT00809133|449754911|FG008|Overall Study|Progressive disease|3|||
125037325|NCT00809133|449754912|FG009|Overall Study|Progressive disease|9|||
125037326|NCT00809133|449754913|FG010|Overall Study|Progressive disease|5|||
125037327|NCT00809133|449754914|FG011|Overall Study|Progressive disease|7|||
125037328|NCT00809133|449754915|FG012|Overall Study|Progressive disease|5|||
125037329|NCT00809133|449754916|FG013|Overall Study|Progressive disease|4|||
125037330|NCT00809133|449754903|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125133654|NCT03733444|450113814|FG000|Overall Study|Not Treated|1|||
125133655|NCT03733444|450113815|FG001|Overall Study|Not Treated|2|||
125133656|NCT03733444|450113816|FG002|Overall Study|Not Treated|1|||
125133657|NCT01788423|450113817|FG000|Overall Study|See Comments in Completed (above)|0|||
125133658|NCT01788423|450113818|FG001|Overall Study|See Comments in Completed (above)|4|||
125133659|NCT01788423|450113819|FG002|Overall Study|See Comments in Completed (above)|5|||
125133660|NCT03637764|450113820|FG000|Overall Study|Adverse Event|2|||
125133661|NCT03637764|450113821|FG001|Overall Study|Adverse Event|0|||
125133662|NCT03637764|450113822|FG002|Overall Study|Adverse Event|0|||
125133663|NCT03637764|450113823|FG003|Overall Study|Adverse Event|1|||
125133664|NCT03637764|450113820|FG000|Overall Study|Progressive Disease|23|||
125133665|NCT03637764|450113821|FG001|Overall Study|Progressive Disease|23|||
125133666|NCT03637764|450113822|FG002|Overall Study|Progressive Disease|18|||
125133667|NCT03637764|450113823|FG003|Overall Study|Progressive Disease|31|||
125133668|NCT03637764|450113820|FG000|Overall Study|Withdrawal by Subject|1|||
125133669|NCT03637764|450113821|FG001|Overall Study|Withdrawal by Subject|3|||
125133670|NCT03637764|450113822|FG002|Overall Study|Withdrawal by Subject|0|||
125133671|NCT03637764|450113823|FG003|Overall Study|Withdrawal by Subject|1|||
125133672|NCT02760927|450113824|FG000|Overall Study|Tube Slippage from Device|1|||
125133673|NCT01940341|450113828|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
125037331|NCT00809133|449754904|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125037332|NCT00809133|449754905|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125133674|NCT01940341|450113829|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
125133675|NCT01940341|450113830|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
125133676|NCT01940341|450113831|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
125218429|NCT02457195|450427331|FG000|Overall Study|Withdrawal by Subject|4|||
125037333|NCT00809133|449754906|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125037334|NCT00809133|449754907|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125037335|NCT00809133|449754908|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
125037336|NCT00809133|449754909|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
125037337|NCT00809133|449754910|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
125037338|NCT00809133|449754911|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125133677|NCT01940341|450113828|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
125133678|NCT01940341|450113829|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
125133679|NCT01940341|450113830|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
125133680|NCT01940341|450113831|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
125133681|NCT01940341|450113828|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
125133682|NCT01940341|450113829|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
125133683|NCT01940341|450113830|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
125133684|NCT01940341|450113831|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
125133685|NCT01940341|450113828|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
124973197|NCT01810939|449529287|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
124973198|NCT01810939|449529285|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
124973199|NCT01810939|449529286|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
124973200|NCT01810939|449529287|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
124973201|NCT01810939|449529285|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
124973202|NCT01810939|449529286|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
124973203|NCT01810939|449529287|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
124973204|NCT01810939|449529285|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
124973205|NCT01810939|449529286|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
124973206|NCT01810939|449529287|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
124973207|NCT01810939|449529285|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
124973208|NCT01810939|449529286|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
124973209|NCT01810939|449529287|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
124973210|NCT01810939|449529285|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
124973211|NCT01810939|449529286|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
124973212|NCT01810939|449529287|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
124973213|NCT01810939|449529285|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
124973214|NCT01810939|449529286|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
124973215|NCT01810939|449529287|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
124973216|NCT01810939|449529285|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
124973217|NCT01810939|449529286|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
124973218|NCT01810939|449529287|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
125133686|NCT01940341|450113829|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
125133687|NCT01940341|450113830|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
125133688|NCT01940341|450113831|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
125133689|NCT01940341|450113828|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
125133690|NCT01940341|450113829|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
125133691|NCT01940341|450113830|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
125133692|NCT01940341|450113831|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
125133693|NCT01940341|450113828|FG000|Period 1: Double-blind Phase|Death|0|||
125133694|NCT01940341|450113829|FG001|Period 1: Double-blind Phase|Death|1|||
125133695|NCT01940341|450113830|FG002|Period 1: Double-blind Phase|Death|0|||
125133696|NCT01940341|450113831|FG003|Period 1: Double-blind Phase|Death|0|||
125133697|NCT01940341|450113828|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
125133698|NCT01940341|450113829|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
125133699|NCT01940341|450113830|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
125133700|NCT01940341|450113831|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
125133701|NCT01940341|450113828|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
125133702|NCT01940341|450113829|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
125133703|NCT01940341|450113830|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
125133704|NCT01940341|450113831|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
125133705|NCT01940341|450113828|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
125133706|NCT01940341|450113829|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
125133707|NCT01940341|450113830|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
125133708|NCT01940341|450113831|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
125133709|NCT01940341|450113828|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
125133710|NCT01940341|450113829|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
125133711|NCT01940341|450113830|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
125133712|NCT01940341|450113831|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
125133713|NCT01940341|450113828|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
125133714|NCT01940341|450113829|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
125133715|NCT01940341|450113830|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
125133716|NCT01940341|450113831|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
125133717|NCT01940341|450113828|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
125133718|NCT01940341|450113829|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
125218430|NCT01896193|450427333|FG000|Overall Study|Lack of Efficacy|20|||
125037339|NCT00809133|449754912|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125037340|NCT00809133|449754913|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125037341|NCT00809133|449754914|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125037342|NCT00809133|449754915|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125037343|NCT00809133|449754916|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
125037344|NCT00809133|449754903|FG000|Overall Study|Other adverse event|1|||
125037345|NCT00809133|449754904|FG001|Overall Study|Other adverse event|1|||
125037346|NCT00809133|449754905|FG002|Overall Study|Other adverse event|1|||
125037347|NCT00809133|449754906|FG003|Overall Study|Other adverse event|0|||
125037348|NCT00809133|449754907|FG004|Overall Study|Other adverse event|0|||
125037349|NCT00809133|449754908|FG005|Overall Study|Other adverse event|3|||
125037350|NCT00809133|449754909|FG006|Overall Study|Other adverse event|2|||
125037351|NCT00809133|449754910|FG007|Overall Study|Other adverse event|4|||
125037352|NCT00809133|449754911|FG008|Overall Study|Other adverse event|0|||
125037353|NCT00809133|449754912|FG009|Overall Study|Other adverse event|0|||
125037354|NCT00809133|449754913|FG010|Overall Study|Other adverse event|1|||
125037355|NCT00809133|449754914|FG011|Overall Study|Other adverse event|1|||
125037356|NCT00809133|449754915|FG012|Overall Study|Other adverse event|0|||
125037357|NCT00809133|449754916|FG013|Overall Study|Other adverse event|1|||
125037358|NCT00809133|449754903|FG000|Overall Study|Lost to Follow-up|0|||
125037359|NCT00809133|449754904|FG001|Overall Study|Lost to Follow-up|0|||
125037360|NCT00809133|449754905|FG002|Overall Study|Lost to Follow-up|0|||
125037361|NCT00809133|449754906|FG003|Overall Study|Lost to Follow-up|0|||
125037362|NCT00809133|449754907|FG004|Overall Study|Lost to Follow-up|0|||
125037363|NCT00809133|449754908|FG005|Overall Study|Lost to Follow-up|1|||
125037364|NCT00809133|449754909|FG006|Overall Study|Lost to Follow-up|0|||
125037365|NCT00809133|449754910|FG007|Overall Study|Lost to Follow-up|0|||
125037366|NCT00809133|449754911|FG008|Overall Study|Lost to Follow-up|0|||
125037367|NCT00809133|449754912|FG009|Overall Study|Lost to Follow-up|0|||
125037368|NCT00809133|449754913|FG010|Overall Study|Lost to Follow-up|0|||
125037369|NCT00809133|449754914|FG011|Overall Study|Lost to Follow-up|0|||
125037370|NCT00809133|449754915|FG012|Overall Study|Lost to Follow-up|0|||
125037371|NCT00809133|449754916|FG013|Overall Study|Lost to Follow-up|0|||
125037372|NCT00809133|449754903|FG000|Overall Study|Consent withdrawn|0|||
125037373|NCT00809133|449754904|FG001|Overall Study|Consent withdrawn|0|||
125037374|NCT00809133|449754905|FG002|Overall Study|Consent withdrawn|0|||
125037375|NCT00809133|449754906|FG003|Overall Study|Consent withdrawn|0|||
125037376|NCT00809133|449754907|FG004|Overall Study|Consent withdrawn|1|||
125037377|NCT00809133|449754908|FG005|Overall Study|Consent withdrawn|0|||
125037378|NCT00809133|449754909|FG006|Overall Study|Consent withdrawn|0|||
125037379|NCT00809133|449754910|FG007|Overall Study|Consent withdrawn|0|||
125037380|NCT00809133|449754911|FG008|Overall Study|Consent withdrawn|0|||
125037381|NCT00809133|449754912|FG009|Overall Study|Consent withdrawn|0|||
125037382|NCT00809133|449754913|FG010|Overall Study|Consent withdrawn|0|||
125037383|NCT00809133|449754914|FG011|Overall Study|Consent withdrawn|0|||
125037384|NCT00809133|449754915|FG012|Overall Study|Consent withdrawn|0|||
125037385|NCT00809133|449754916|FG013|Overall Study|Consent withdrawn|0|||
125037386|NCT00809133|449754903|FG000|Overall Study|Other not mentioned above|0|||
125037387|NCT00809133|449754904|FG001|Overall Study|Other not mentioned above|1|||
125037388|NCT00809133|449754905|FG002|Overall Study|Other not mentioned above|0|||
125037389|NCT00809133|449754906|FG003|Overall Study|Other not mentioned above|0|||
125037390|NCT00809133|449754907|FG004|Overall Study|Other not mentioned above|0|||
125037391|NCT00809133|449754908|FG005|Overall Study|Other not mentioned above|1|||
125037392|NCT00809133|449754909|FG006|Overall Study|Other not mentioned above|0|||
125037393|NCT00809133|449754910|FG007|Overall Study|Other not mentioned above|0|||
125037394|NCT00809133|449754911|FG008|Overall Study|Other not mentioned above|0|||
125037395|NCT00809133|449754912|FG009|Overall Study|Other not mentioned above|0|||
125037396|NCT00809133|449754913|FG010|Overall Study|Other not mentioned above|0|||
125037397|NCT00809133|449754914|FG011|Overall Study|Other not mentioned above|0|||
125037398|NCT00809133|449754915|FG012|Overall Study|Other not mentioned above|0|||
125037399|NCT00809133|449754916|FG013|Overall Study|Other not mentioned above|0|||
125037400|NCT01025635|449754920|FG000|Overall Study|Withdrawal by Subject|6|||
125037401|NCT01025635|449754921|FG001|Overall Study|Withdrawal by Subject|7|||
125037402|NCT01025635|449754920|FG000|Overall Study|Protocol Violation|4|||
125037403|NCT01025635|449754921|FG001|Overall Study|Protocol Violation|2|||
125037404|NCT01025635|449754920|FG000|Overall Study|Lack of Efficacy|0|||
125037405|NCT01025635|449754921|FG001|Overall Study|Lack of Efficacy|1|||
125037406|NCT01025635|449754920|FG000|Overall Study|Lost to Follow-up|9|||
125037407|NCT01025635|449754921|FG001|Overall Study|Lost to Follow-up|13|||
125037408|NCT01025635|449754920|FG000|Overall Study|Reason not known|4|||
125037409|NCT01025635|449754921|FG001|Overall Study|Reason not known|2|||
125037410|NCT00727402|449754922|FG000|Overall Study|Physician Decision|116|||
125037411|NCT05292755|449754923|FG000|Overall Study|Lost to Follow-up|5|||
125037412|NCT05292755|449754924|FG001|Overall Study|Lost to Follow-up|9|||
125037413|NCT00432809|449754926|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
125037414|NCT00432809|449754927|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
124973219|NCT02963090|449529288|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
124973220|NCT02963090|449529289|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
124973221|NCT01375673|449529290|FG000|Overall Study|Withdrawal by Subject|0|||
124973222|NCT01375673|449529291|FG001|Overall Study|Withdrawal by Subject|1|||
124973223|NCT00979953|449529294|FG000|Overall Study|Adverse Event|5|||
124973224|NCT00979953|449529295|FG001|Overall Study|Adverse Event|2|||
124973225|NCT00979953|449529296|FG002|Overall Study|Adverse Event|17|||
124973226|NCT00979953|449529297|FG003|Overall Study|Adverse Event|4|||
124973227|NCT00979953|449529294|FG000|Overall Study|Lack of Efficacy|1|||
124973228|NCT00979953|449529295|FG001|Overall Study|Lack of Efficacy|2|||
124973229|NCT00979953|449529296|FG002|Overall Study|Lack of Efficacy|0|||
124973230|NCT00979953|449529297|FG003|Overall Study|Lack of Efficacy|0|||
124973231|NCT00979953|449529294|FG000|Overall Study|Lost to Follow-up|1|||
124973232|NCT00979953|449529295|FG001|Overall Study|Lost to Follow-up|1|||
124973233|NCT00979953|449529296|FG002|Overall Study|Lost to Follow-up|1|||
124973234|NCT00979953|449529297|FG003|Overall Study|Lost to Follow-up|0|||
124973235|NCT00979953|449529294|FG000|Overall Study|Withdrawal by Subject|0|||
124973236|NCT00979953|449529295|FG001|Overall Study|Withdrawal by Subject|0|||
124973237|NCT00979953|449529296|FG002|Overall Study|Withdrawal by Subject|2|||
124973238|NCT00979953|449529297|FG003|Overall Study|Withdrawal by Subject|1|||
124973239|NCT00979953|449529294|FG000|Overall Study|Protocol Violation|1|||
124973240|NCT00979953|449529295|FG001|Overall Study|Protocol Violation|0|||
124973241|NCT00979953|449529296|FG002|Overall Study|Protocol Violation|2|||
124973242|NCT00979953|449529297|FG003|Overall Study|Protocol Violation|2|||
124973243|NCT01607879|449529303|FG000|Overall Study|Death|1|||
124973244|NCT01607879|449529304|FG001|Overall Study|Death|0|||
124973245|NCT02406248|449529307|FG000|Overall Study|Death|7|||
124973246|NCT02406248|449529307|FG000|Overall Study|Withdrawal by Subject|2|||
124973247|NCT02643628|449529308|FG000|Overall Study|Lost to Follow-up|1|||
124973248|NCT02643628|449529309|FG001|Overall Study|Lost to Follow-up|4|||
124973249|NCT02643628|449529308|FG000|Overall Study|Withdrawal by Subject|0|||
124973250|NCT02643628|449529309|FG001|Overall Study|Withdrawal by Subject|1|||
124973251|NCT02643628|449529308|FG000|Overall Study|Relocated out of state|0|||
124973252|NCT02643628|449529309|FG001|Overall Study|Relocated out of state|1|||
124973253|NCT00706654|449529310|FG000|Conversion Phase|Lost to Follow-up|4|||
124973254|NCT00706654|449529311|FG001|Conversion Phase|Lost to Follow-up|0|||
124973255|NCT00706654|449529312|FG002|Conversion Phase|Lost to Follow-up|0|||
124973256|NCT00706654|449529313|FG003|Conversion Phase|Lost to Follow-up|0|||
124973257|NCT00706654|449529310|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
124973258|NCT00706654|449529311|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
124973259|NCT00706654|449529312|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
124973260|NCT00706654|449529313|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
124973261|NCT00706654|449529310|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
124973262|NCT00706654|449529311|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
124973263|NCT00706654|449529312|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
124973264|NCT00706654|449529313|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
124973265|NCT00706654|449529310|FG000|Conversion Phase|Withdrawn by Investigator|14|||
124973266|NCT00706654|449529311|FG001|Conversion Phase|Withdrawn by Investigator|0|||
124973267|NCT00706654|449529312|FG002|Conversion Phase|Withdrawn by Investigator|0|||
124973268|NCT00706654|449529313|FG003|Conversion Phase|Withdrawn by Investigator|0|||
124973269|NCT00706654|449529310|FG000|Conversion Phase|Withdrew Consent|38|||
124973270|NCT00706654|449529311|FG001|Conversion Phase|Withdrew Consent|0|||
124973271|NCT00706654|449529312|FG002|Conversion Phase|Withdrew Consent|0|||
124973272|NCT00706654|449529313|FG003|Conversion Phase|Withdrew Consent|0|||
124973273|NCT00706654|449529310|FG000|Conversion Phase|Adverse Event|18|||
124973274|NCT00706654|449529311|FG001|Conversion Phase|Adverse Event|0|||
124973275|NCT00706654|449529312|FG002|Conversion Phase|Adverse Event|0|||
124973276|NCT00706654|449529313|FG003|Conversion Phase|Adverse Event|0|||
125037415|NCT00432809|449754928|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
124973277|NCT00706654|449529310|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
124973278|NCT00706654|449529311|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
124973279|NCT00706654|449529312|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
124973280|NCT00706654|449529313|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
124973281|NCT00706654|449529310|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
124973282|NCT00706654|449529311|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
124973283|NCT00706654|449529312|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
124973284|NCT00706654|449529313|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
124973285|NCT00706654|449529310|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
125218431|NCT01896193|450427334|FG001|Overall Study|Lack of Efficacy|11|||
125218432|NCT01896193|450427333|FG000|Overall Study|Protocol Violation|0|||
125218433|NCT01896193|450427334|FG001|Overall Study|Protocol Violation|1|||
125218434|NCT01896193|450427333|FG000|Overall Study|Withdrew Consent|1|||
125218435|NCT01896193|450427334|FG001|Overall Study|Withdrew Consent|0|||
125218436|NCT02028507|450427335|FG000|Overall Study|Progressive Disease|122|||
125218437|NCT02028507|450427336|FG001|Overall Study|Progressive Disease|90|||
125218438|NCT02028507|450427337|FG002|Overall Study|Progressive Disease|102|||
125218439|NCT02028507|450427338|FG003|Overall Study|Progressive Disease|89|||
125218440|NCT02028507|450427335|FG000|Overall Study|Adverse Event|8|||
125218441|NCT02028507|450427336|FG001|Overall Study|Adverse Event|25|||
125218442|NCT02028507|450427337|FG002|Overall Study|Adverse Event|3|||
125218443|NCT02028507|450427338|FG003|Overall Study|Adverse Event|16|||
124973286|NCT00706654|449529311|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
124973287|NCT00706654|449529312|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
124973288|NCT00706654|449529313|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
124973289|NCT00706654|449529310|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
124973290|NCT00706654|449529311|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
124973291|NCT00706654|449529312|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
124973292|NCT00706654|449529313|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
124973293|NCT00706654|449529310|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
124973294|NCT00706654|449529311|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
124973295|NCT00706654|449529312|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
124973296|NCT00706654|449529313|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
124973297|NCT00706654|449529310|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
124973298|NCT00706654|449529311|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
124973299|NCT00706654|449529312|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
124973300|NCT00706654|449529313|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
124973301|NCT00706654|449529310|FG000|Oral Stabilization Phase|Withdrew consent|55|||
124973302|NCT00706654|449529311|FG001|Oral Stabilization Phase|Withdrew consent|0|||
124973303|NCT00706654|449529312|FG002|Oral Stabilization Phase|Withdrew consent|0|||
124973304|NCT00706654|449529313|FG003|Oral Stabilization Phase|Withdrew consent|0|||
124973305|NCT00706654|449529310|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
124973306|NCT00706654|449529311|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
124973307|NCT00706654|449529312|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
124973308|NCT00706654|449529313|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
124973309|NCT00706654|449529310|FG000|Oral Stabilization Phase|Adverse Event|21|||
124973310|NCT00706654|449529311|FG001|Oral Stabilization Phase|Adverse Event|0|||
124973311|NCT00706654|449529312|FG002|Oral Stabilization Phase|Adverse Event|0|||
124973312|NCT00706654|449529313|FG003|Oral Stabilization Phase|Adverse Event|0|||
124973313|NCT00706654|449529310|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
124973314|NCT00706654|449529311|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
124973315|NCT00706654|449529312|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
124973316|NCT00706654|449529313|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
124973317|NCT00706654|449529310|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
124973318|NCT00706654|449529311|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
124973319|NCT00706654|449529312|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
124973320|NCT00706654|449529313|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
124973321|NCT00706654|449529310|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
124973322|NCT00706654|449529311|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
124973323|NCT00706654|449529312|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
124973324|NCT00706654|449529313|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
124973325|NCT00706654|449529310|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
124973326|NCT00706654|449529311|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
124973327|NCT00706654|449529312|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
124973328|NCT00706654|449529313|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
124973329|NCT00706654|449529310|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
124973330|NCT00706654|449529311|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
124973331|NCT00706654|449529312|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
124973332|NCT00706654|449529313|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
124973333|NCT00706654|449529310|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
125218444|NCT02028507|450427335|FG000|Overall Study|Withdrawal by Subject|6|||
124973334|NCT00706654|449529311|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
124973335|NCT00706654|449529312|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
124973336|NCT00706654|449529313|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
124973337|NCT00706654|449529310|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
124973338|NCT00706654|449529311|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
125218445|NCT02028507|450427336|FG001|Overall Study|Withdrawal by Subject|8|||
125218446|NCT02028507|450427337|FG002|Overall Study|Withdrawal by Subject|5|||
125218447|NCT02028507|450427338|FG003|Overall Study|Withdrawal by Subject|9|||
125218448|NCT02028507|450427335|FG000|Overall Study|Protocol Violation|2|||
125218449|NCT02028507|450427336|FG001|Overall Study|Protocol Violation|4|||
125218450|NCT02028507|450427337|FG002|Overall Study|Protocol Violation|1|||
125218451|NCT02028507|450427338|FG003|Overall Study|Protocol Violation|3|||
125218452|NCT02028507|450427335|FG000|Overall Study|Physician Decision|0|||
125218453|NCT02028507|450427336|FG001|Overall Study|Physician Decision|4|||
125218454|NCT02028507|450427337|FG002|Overall Study|Physician Decision|0|||
125218455|NCT02028507|450427338|FG003|Overall Study|Physician Decision|0|||
125218456|NCT02028507|450427335|FG000|Overall Study|Death|1|||
125218457|NCT02028507|450427336|FG001|Overall Study|Death|0|||
125218458|NCT02028507|450427337|FG002|Overall Study|Death|1|||
125218459|NCT02028507|450427338|FG003|Overall Study|Death|3|||
125218460|NCT02028507|450427335|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
125218461|NCT02028507|450427336|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
124973339|NCT00706654|449529312|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
124973340|NCT00706654|449529313|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
124973341|NCT00706654|449529310|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
124973342|NCT00706654|449529311|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
124973343|NCT00706654|449529312|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
124973344|NCT00706654|449529313|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
124973345|NCT00706654|449529310|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
124973346|NCT00706654|449529311|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
124973347|NCT00706654|449529312|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
124973348|NCT00706654|449529313|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
124973349|NCT00706654|449529310|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
124973350|NCT00706654|449529311|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
124973351|NCT00706654|449529312|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
124973352|NCT00706654|449529313|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
124973353|NCT01001390|449529317|FG000|Overall Study|Failure to wear AFO device|2|||
124973354|NCT01001390|449529318|FG001|Overall Study|Failure to wear AFO device|0|||
124973355|NCT03690427|449529319|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
124973356|NCT03690427|449529320|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
124973357|NCT01151215|449529324|FG000|Overall Study|Worsening of condition under study|1|||
124973358|NCT01151215|449529325|FG001|Overall Study|Worsening of condition under study|1|||
124973359|NCT01151215|449529326|FG002|Overall Study|Worsening of condition under study|1|||
124973360|NCT01151215|449529324|FG000|Overall Study|Death|16|||
124973361|NCT01151215|449529325|FG001|Overall Study|Death|20|||
124973362|NCT01151215|449529326|FG002|Overall Study|Death|11|||
124973363|NCT01151215|449529324|FG000|Overall Study|Lost to Follow-up|0|||
124973364|NCT01151215|449529325|FG001|Overall Study|Lost to Follow-up|0|||
124973365|NCT01151215|449529326|FG002|Overall Study|Lost to Follow-up|3|||
124973366|NCT01151215|449529324|FG000|Overall Study|Withdrawal by Subject|3|||
124973367|NCT01151215|449529325|FG001|Overall Study|Withdrawal by Subject|1|||
124973368|NCT01151215|449529326|FG002|Overall Study|Withdrawal by Subject|2|||
124973369|NCT01151215|449529324|FG000|Overall Study|Disease progression|0|||
124973370|NCT01151215|449529325|FG001|Overall Study|Disease progression|1|||
124973371|NCT01151215|449529326|FG002|Overall Study|Disease progression|1|||
124973372|NCT01151215|449529324|FG000|Overall Study|Safety as judged by the investigator|0|||
124973373|NCT01151215|449529325|FG001|Overall Study|Safety as judged by the investigator|0|||
124973374|NCT01151215|449529326|FG002|Overall Study|Safety as judged by the investigator|1|||
124973375|NCT01721954|449529327|FG000|Overall Study|Death|58|||
124973376|NCT01721954|449529328|FG001|Overall Study|Death|64|||
124973377|NCT01721954|449529327|FG000|Overall Study|Withdrawal by Subject|8|||
124973378|NCT01721954|449529328|FG001|Overall Study|Withdrawal by Subject|4|||
124973379|NCT01721954|449529327|FG000|Overall Study|Adverse Event|2|||
124973380|NCT01721954|449529328|FG001|Overall Study|Adverse Event|0|||
124973381|NCT01721954|449529327|FG000|Overall Study|Lost to Follow-up|2|||
124973382|NCT01721954|449529328|FG001|Overall Study|Lost to Follow-up|1|||
124973383|NCT02956837|449529332|FG000|Overall Study|Serious Adverse Events|0|||
124973384|NCT02956837|449529333|FG001|Overall Study|Serious Adverse Events|1|||
124973385|NCT02956837|449529334|FG002|Overall Study|Serious Adverse Events|0|||
125218462|NCT02028507|450427337|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
124973386|NCT02956837|449529335|FG003|Overall Study|Serious Adverse Events|0|||
124973387|NCT02956837|449529332|FG000|Overall Study|Withdrawal by Subject|0|||
124973388|NCT02956837|449529333|FG001|Overall Study|Withdrawal by Subject|1|||
124973389|NCT02956837|449529334|FG002|Overall Study|Withdrawal by Subject|0|||
124973390|NCT02956837|449529335|FG003|Overall Study|Withdrawal by Subject|3|||
124973391|NCT02956837|449529332|FG000|Overall Study|Lost to Follow-up|0|||
125218463|NCT02028507|450427338|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
125037416|NCT00432809|449754926|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
125037417|NCT00432809|449754927|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
125037418|NCT00432809|449754928|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
125037419|NCT04433117|449754929|FG000|Overall Study|Withdrawal by Subject|1|||
125037420|NCT04433117|449754930|FG001|Overall Study|Withdrawal by Subject|0|||
125037421|NCT01051739|449754931|FG000|Overall Study|Death|3|||
125037422|NCT01051739|449754932|FG001|Overall Study|Death|3|||
125037423|NCT01051739|449754931|FG000|Overall Study|Withdrawal by Subject|25|||
125037424|NCT01051739|449754932|FG001|Overall Study|Withdrawal by Subject|10|||
125037425|NCT00707577|449754933|FG000|Overall Study|Withdrawal by Subject|3|||
125133719|NCT01940341|450113830|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
125133720|NCT01940341|450113831|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
125133721|NCT01940341|450113828|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
125133722|NCT01940341|450113829|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
125133723|NCT01940341|450113830|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
125133724|NCT01940341|450113831|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
125133725|NCT01940341|450113828|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
125133726|NCT01940341|450113829|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
125133727|NCT01940341|450113830|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
125133728|NCT01940341|450113831|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
125133729|NCT01940341|450113828|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
125133730|NCT01940341|450113829|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
125133731|NCT01940341|450113830|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
125133732|NCT01940341|450113831|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
125133733|NCT01940341|450113828|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
125133734|NCT01940341|450113829|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
125133735|NCT01940341|450113830|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
125133736|NCT01940341|450113831|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
125133737|NCT01940341|450113828|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
125133738|NCT01940341|450113829|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
125133739|NCT01940341|450113830|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
125133740|NCT01940341|450113831|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
125133741|NCT01940341|450113828|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
125133742|NCT01940341|450113829|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
125133743|NCT01940341|450113830|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
125133744|NCT01940341|450113831|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
125133745|NCT01940341|450113828|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
125133746|NCT01940341|450113829|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
125133747|NCT01940341|450113830|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
125133748|NCT01940341|450113831|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
125133749|NCT00841698|450113836|FG000|First Intervention|Withdrawal by Subject|1|||
125133750|NCT00841698|450113837|FG001|First Intervention|Withdrawal by Subject|0|||
125133751|NCT00185458|450113838|FG000|Contraception Phase|Adverse Event|37|||
125133752|NCT00185458|450113838|FG000|Contraception Phase|Lost to Follow-up|10|||
125133753|NCT00185458|450113838|FG000|Contraception Phase|Protocol Violation|2|||
125133754|NCT00185458|450113838|FG000|Contraception Phase|Physician Decision|2|||
125133755|NCT00185458|450113838|FG000|Contraception Phase|Withdrawal by Subject|7|||
125133756|NCT00185458|450113838|FG000|HRT Phase|Adverse Event|18|||
125133757|NCT00185458|450113838|FG000|HRT Phase|Lost to Follow-up|4|||
125133758|NCT00185458|450113838|FG000|HRT Phase|Protocol Violation|2|||
125133759|NCT00185458|450113838|FG000|HRT Phase|Withdrawal by Subject|3|||
125133760|NCT00251979|450113839|FG000|Overall Study|Protocol Violation|3|||
125133761|NCT00251979|450113840|FG001|Overall Study|Protocol Violation|5|||
125133762|NCT00251979|450113839|FG000|Overall Study|Adverse Event|11|||
125133763|NCT00251979|450113840|FG001|Overall Study|Adverse Event|17|||
125133764|NCT00251979|450113839|FG000|Overall Study|Withdrawal by Subject|13|||
125133765|NCT00251979|450113840|FG001|Overall Study|Withdrawal by Subject|7|||
125133766|NCT00251979|450113839|FG000|Overall Study|Lost to Follow-up|8|||
125133767|NCT00251979|450113840|FG001|Overall Study|Lost to Follow-up|6|||
125133768|NCT00251979|450113839|FG000|Overall Study|Death|3|||
125133769|NCT00251979|450113840|FG001|Overall Study|Death|5|||
125133770|NCT01576042|450113841|FG000|Overall Study|Physician Decision|2|||
125133771|NCT01576042|450113842|FG001|Overall Study|Physician Decision|0|||
125133772|NCT00835536|450113849|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
125133773|NCT00835536|450113850|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
125037426|NCT00707577|449754934|FG001|Overall Study|Withdrawal by Subject|2|||
125037427|NCT00707577|449754933|FG000|Overall Study|Lost to Follow-up|34|||
125037428|NCT00707577|449754934|FG001|Overall Study|Lost to Follow-up|25|||
125037429|NCT00707577|449754933|FG000|Overall Study|Left employment|13|||
125037430|NCT00707577|449754934|FG001|Overall Study|Left employment|10|||
125037431|NCT00707577|449754933|FG000|Overall Study|Pregnancy|4|||
125037432|NCT00707577|449754934|FG001|Overall Study|Pregnancy|1|||
125037433|NCT03853694|449754935|FG000|Overall Study|Protocol Violation|3|||
125037434|NCT03853694|449754936|FG001|Overall Study|Protocol Violation|5|||
125037435|NCT03853694|449754937|FG002|Overall Study|Protocol Violation|3|||
125037436|NCT03853694|449754935|FG000|Overall Study|Delivered early|0|||
125037437|NCT03853694|449754936|FG001|Overall Study|Delivered early|1|||
125037438|NCT03853694|449754937|FG002|Overall Study|Delivered early|0|||
125037439|NCT03853694|449754935|FG000|Overall Study|not suitable to proceed|0|||
125037440|NCT03853694|449754936|FG001|Overall Study|not suitable to proceed|1|||
125037441|NCT03853694|449754937|FG002|Overall Study|not suitable to proceed|0|||
125037442|NCT03853694|449754935|FG000|Overall Study|difficult surgery|0|||
125037443|NCT03853694|449754936|FG001|Overall Study|difficult surgery|0|||
125037444|NCT03853694|449754937|FG002|Overall Study|difficult surgery|1|||
125037445|NCT03853694|449754935|FG000|Overall Study|Lost to Follow-up|0|||
125037446|NCT03853694|449754936|FG001|Overall Study|Lost to Follow-up|1|||
125037447|NCT03853694|449754937|FG002|Overall Study|Lost to Follow-up|0|||
125037448|NCT03853694|449754935|FG000|Overall Study|Withdrawal by Subject|0|||
125037449|NCT03853694|449754936|FG001|Overall Study|Withdrawal by Subject|1|||
125037450|NCT03853694|449754937|FG002|Overall Study|Withdrawal by Subject|0|||
124973392|NCT02956837|449529333|FG001|Overall Study|Lost to Follow-up|1|||
124973393|NCT02956837|449529334|FG002|Overall Study|Lost to Follow-up|2|||
124973394|NCT02956837|449529335|FG003|Overall Study|Lost to Follow-up|0|||
124973395|NCT02597712|449529336|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
124973396|NCT02597712|449529337|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
124973397|NCT02597712|449529336|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
124973398|NCT02597712|449529337|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
124973399|NCT02597712|449529336|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
124973400|NCT02597712|449529337|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
124973401|NCT02637323|449529338|FG000|Overall Study|Lost to Follow-up|2|||
124973402|NCT02637323|449529339|FG001|Overall Study|Lost to Follow-up|0|||
124973403|NCT02637323|449529338|FG000|Overall Study|Protocol Violation|0|||
124973404|NCT02637323|449529339|FG001|Overall Study|Protocol Violation|1|||
124973405|NCT00513708|449529340|FG000|Overall Study|Lost to Follow-up|4|||
124973406|NCT00513708|449529341|FG001|Overall Study|Lost to Follow-up|4|||
124973407|NCT00513708|449529342|FG002|Overall Study|Lost to Follow-up|4|||
124973408|NCT01162486|449529343|FG000|Overall Study|low ANC|1|||
124973409|NCT01162486|449529344|FG001|Overall Study|low ANC|0|||
124973410|NCT01162486|449529345|FG002|Overall Study|low ANC|0|||
124973411|NCT01162486|449529346|FG003|Overall Study|low ANC|0|||
124973412|NCT01162486|449529347|FG004|Overall Study|low ANC|0|||
124973413|NCT01162486|449529343|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
124973414|NCT01162486|449529344|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
124973415|NCT01162486|449529345|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
124973416|NCT01162486|449529346|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
124973417|NCT01162486|449529347|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
124973418|NCT01162486|449529343|FG000|Overall Study|elevated LFTs|0|||
124973419|NCT01162486|449529344|FG001|Overall Study|elevated LFTs|0|||
124973420|NCT01162486|449529345|FG002|Overall Study|elevated LFTs|1|||
124973421|NCT01162486|449529346|FG003|Overall Study|elevated LFTs|0|||
125037451|NCT02499952|449754938|FG000|Overall Study|Lost to Follow-up|1|||
125037452|NCT02499952|449754938|FG000|Overall Study|Death|9|||
125037453|NCT05089708|449754939|FG000|Overall Study|Lost to Follow-up|9|||
125037454|NCT05089708|449754940|FG001|Overall Study|Lost to Follow-up|7|||
125037455|NCT05089708|449754939|FG000|Overall Study|Withdrawal by Subject|3|||
125037456|NCT05089708|449754940|FG001|Overall Study|Withdrawal by Subject|1|||
124973422|NCT01162486|449529347|FG004|Overall Study|elevated LFTs|0|||
124973423|NCT01162486|449529343|FG000|Overall Study|Pregnancy|0|||
124973424|NCT01162486|449529344|FG001|Overall Study|Pregnancy|0|||
124973425|NCT01162486|449529345|FG002|Overall Study|Pregnancy|0|||
124973426|NCT01162486|449529346|FG003|Overall Study|Pregnancy|1|||
124973427|NCT01162486|449529347|FG004|Overall Study|Pregnancy|0|||
124973428|NCT03274895|449529353|FG000|Overall Study|Lack of Efficacy|1|||
125133774|NCT03173547|450113851|FG000|Overall Study|Adverse Event|2|||
125133775|NCT03173547|450113852|FG001|Overall Study|Adverse Event|0|||
125133776|NCT03173547|450113851|FG000|Overall Study|Withdrawal by Subject|2|||
125133777|NCT03173547|450113852|FG001|Overall Study|Withdrawal by Subject|2|||
125133778|NCT00657553|450113853|FG000|Overall Study|low accrual, no analysis run|5|||
125133779|NCT00657553|450113854|FG001|Overall Study|low accrual, no analysis run|5|||
125133780|NCT00446563|450113855|FG000|Overall Study|Adverse Event|4|||
125037457|NCT05089708|449754939|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
125037458|NCT05089708|449754940|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
125037459|NCT05089708|449754939|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
125037460|NCT05089708|449754940|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
125037461|NCT02209766|449754942|FG000|Overall Study|Withdrawal by Subject|0|||
125037462|NCT02209766|449754943|FG001|Overall Study|Withdrawal by Subject|0|||
125037463|NCT02209766|449754944|FG002|Overall Study|Withdrawal by Subject|0|||
125037464|NCT02209766|449754945|FG003|Overall Study|Withdrawal by Subject|1|||
125037465|NCT02209766|449754946|FG004|Overall Study|Withdrawal by Subject|0|||
125037466|NCT00064701|449754947|FG000|One Year Post-transplant|Did not receive study drug|7|||
125037467|NCT00064701|449754948|FG001|One Year Post-transplant|Did not receive study drug|12|||
125037468|NCT00064701|449754949|FG002|One Year Post-transplant|Did not receive study drug|11|||
125037469|NCT00064701|449754947|FG000|One Year Post-transplant|Adverse Event|23|||
125037470|NCT00064701|449754948|FG001|One Year Post-transplant|Adverse Event|19|||
125037471|NCT00064701|449754949|FG002|One Year Post-transplant|Adverse Event|37|||
125037472|NCT00064701|449754947|FG000|One Year Post-transplant|Rejection|0|||
125037473|NCT00064701|449754948|FG001|One Year Post-transplant|Rejection|1|||
125037474|NCT00064701|449754949|FG002|One Year Post-transplant|Rejection|16|||
125037475|NCT00064701|449754947|FG000|One Year Post-transplant|Non-compliance|4|||
125037476|NCT00064701|449754948|FG001|One Year Post-transplant|Non-compliance|2|||
125037477|NCT00064701|449754949|FG002|One Year Post-transplant|Non-compliance|5|||
125037478|NCT00064701|449754947|FG000|One Year Post-transplant|Graft Failure|3|||
125037479|NCT00064701|449754948|FG001|One Year Post-transplant|Graft Failure|2|||
125037480|NCT00064701|449754949|FG002|One Year Post-transplant|Graft Failure|1|||
125037481|NCT00064701|449754947|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
125037482|NCT00064701|449754948|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
125037483|NCT00064701|449754949|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
125037484|NCT00064701|449754947|FG000|One Year Post-transplant|Lost to Follow-up|1|||
125037485|NCT00064701|449754948|FG001|One Year Post-transplant|Lost to Follow-up|0|||
125037486|NCT00064701|449754949|FG002|One Year Post-transplant|Lost to Follow-up|0|||
125037487|NCT00064701|449754947|FG000|One Year Post-transplant|Converted to rapamycin|1|||
125037488|NCT00064701|449754948|FG001|One Year Post-transplant|Converted to rapamycin|0|||
125037489|NCT00064701|449754949|FG002|One Year Post-transplant|Converted to rapamycin|0|||
125037490|NCT00064701|449754947|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
125037491|NCT00064701|449754948|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
125037492|NCT00064701|449754949|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
125037493|NCT00064701|449754947|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
125037494|NCT00064701|449754948|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
125037495|NCT00064701|449754949|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
125037496|NCT00064701|449754947|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
125037497|NCT00064701|449754948|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
125037498|NCT00064701|449754949|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
125037499|NCT00064701|449754947|FG000|One Year Post-transplant|Poor absorption|0|||
125037500|NCT00064701|449754948|FG001|One Year Post-transplant|Poor absorption|1|||
125037501|NCT00064701|449754949|FG002|One Year Post-transplant|Poor absorption|0|||
125037502|NCT00064701|449754947|FG000|One Year Post-transplant|Pancreas transplant|0|||
125037503|NCT00064701|449754948|FG001|One Year Post-transplant|Pancreas transplant|0|||
125037504|NCT00064701|449754949|FG002|One Year Post-transplant|Pancreas transplant|1|||
125037505|NCT00064701|449754947|FG000|Clinical Continuation Phase|Adverse Event|12|||
125037506|NCT00064701|449754948|FG001|Clinical Continuation Phase|Adverse Event|21|||
125037507|NCT00064701|449754949|FG002|Clinical Continuation Phase|Adverse Event|14|||
125037508|NCT00064701|449754947|FG000|Clinical Continuation Phase|Non-compliance|8|||
125037509|NCT00064701|449754948|FG001|Clinical Continuation Phase|Non-compliance|6|||
125037510|NCT00064701|449754949|FG002|Clinical Continuation Phase|Non-compliance|7|||
125037511|NCT00064701|449754947|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
125037512|NCT00064701|449754948|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
125037513|NCT00064701|449754949|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
125133781|NCT00446563|450113856|FG001|Overall Study|Adverse Event|3|||
125133782|NCT00446563|450113855|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125037514|NCT00064701|449754947|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
125037515|NCT00064701|449754948|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
125037516|NCT00064701|449754949|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
125037517|NCT00064701|449754947|FG000|Clinical Continuation Phase|Graft Failure|5|||
125037518|NCT00064701|449754948|FG001|Clinical Continuation Phase|Graft Failure|5|||
125037519|NCT00064701|449754949|FG002|Clinical Continuation Phase|Graft Failure|2|||
125037520|NCT00064701|449754947|FG000|Clinical Continuation Phase|Rejection|1|||
125037521|NCT00064701|449754948|FG001|Clinical Continuation Phase|Rejection|2|||
125037522|NCT00064701|449754949|FG002|Clinical Continuation Phase|Rejection|2|||
125037523|NCT00064701|449754947|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
125133783|NCT00446563|450113856|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125133784|NCT00446563|450113855|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125133785|NCT00446563|450113856|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125133786|NCT00446563|450113855|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125133787|NCT00446563|450113856|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
125133788|NCT00446563|450113855|FG000|Overall Study|Withdrawal by Subject|2|||
125133789|NCT00446563|450113856|FG001|Overall Study|Withdrawal by Subject|1|||
125133790|NCT00446563|450113855|FG000|Overall Study|Administrative problems|0|||
125133791|NCT00446563|450113856|FG001|Overall Study|Administrative problems|1|||
125133792|NCT03769025|450113857|FG000|Overall Study|Withdrawal by Subject|1|||
125133793|NCT03769025|450113858|FG001|Overall Study|Withdrawal by Subject|1|||
125133794|NCT03769025|450113857|FG000|Overall Study|Lost to Follow-up|4|||
125133795|NCT03769025|450113858|FG001|Overall Study|Lost to Follow-up|3|||
125133796|NCT01169558|450113859|FG000|Overall Study|Disease progression|98|||
125133797|NCT01169558|450113859|FG000|Overall Study|Adverse Event|25|||
125133798|NCT01169558|450113859|FG000|Overall Study|Withdrawal of Consent|8|||
125133799|NCT01169558|450113859|FG000|Overall Study|Medical Decision|7|||
125133800|NCT01169558|450113859|FG000|Overall Study|Stable Disease|4|||
125133801|NCT01169558|450113859|FG000|Overall Study|Lost to Follow-up|4|||
124973429|NCT03274895|449529354|FG001|Overall Study|Lack of Efficacy|0|||
124973430|NCT03274895|449529353|FG000|Overall Study|Adverse Event|8|||
124973431|NCT03274895|449529354|FG001|Overall Study|Adverse Event|7|||
124973432|NCT03274895|449529353|FG000|Overall Study|Lost to Follow-up|1|||
124973433|NCT03274895|449529354|FG001|Overall Study|Lost to Follow-up|0|||
124973434|NCT03274895|449529353|FG000|Overall Study|Diagnosis not confirmed|3|||
124973435|NCT03274895|449529354|FG001|Overall Study|Diagnosis not confirmed|4|||
124973436|NCT03229486|449529360|FG000|Overall Study|Protocol Violation|0|||
124973437|NCT03229486|449529361|FG001|Overall Study|Protocol Violation|1|||
124973438|NCT01461005|449529362|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
124973439|NCT00760747|449529367|FG000|Study Period II|Adverse Event|3|||
124973440|NCT00760747|449529368|FG001|Study Period II|Adverse Event|4|||
124973441|NCT00760747|449529367|FG000|Study Period II|Lack of Efficacy|0|||
124973442|NCT00760747|449529368|FG001|Study Period II|Lack of Efficacy|6|||
124973443|NCT00760747|449529367|FG000|Study Period II|Parent/Caregiver Decision|3|||
124973444|NCT00760747|449529368|FG001|Study Period II|Parent/Caregiver Decision|0|||
124973445|NCT00760747|449529367|FG000|Study Period II|Protocol Violation|6|||
124973446|NCT00760747|449529368|FG001|Study Period II|Protocol Violation|3|||
124973447|NCT00760747|449529367|FG000|Study Period II|Withdrawal by Subject|1|||
124973448|NCT00760747|449529368|FG001|Study Period II|Withdrawal by Subject|0|||
124973449|NCT00760747|449529367|FG000|Study Period II|No drug administered|0|||
124973450|NCT00760747|449529368|FG001|Study Period II|No drug administered|1|||
124973451|NCT00760747|449529367|FG000|Study Period III|Adverse Event|1|||
124973452|NCT00760747|449529368|FG001|Study Period III|Adverse Event|0|||
124973453|NCT00760747|449529367|FG000|Study Period III|Lack of Efficacy|1|||
124973454|NCT00760747|449529368|FG001|Study Period III|Lack of Efficacy|0|||
124973455|NCT00760747|449529367|FG000|Study Period III|Parent/Caregiver Decision|0|||
124973456|NCT00760747|449529368|FG001|Study Period III|Parent/Caregiver Decision|1|||
124973457|NCT00760747|449529367|FG000|Study Period III|Protocol Violation|1|||
124973458|NCT00760747|449529368|FG001|Study Period III|Protocol Violation|1|||
125133802|NCT01169558|450113859|FG000|Overall Study|Need for Surgery|4|||
125133803|NCT01169558|450113859|FG000|Overall Study|Non-compliance|2|||
125133804|NCT01169558|450113859|FG000|Overall Study|Protocol Violation|2|||
125133805|NCT01169558|450113859|FG000|Overall Study|Partial response|2|||
125133806|NCT02409355|450113865|FG000|Overall Study|Withdrawal by Subject|1|||
125133807|NCT02409355|450113866|FG001|Overall Study|Withdrawal by Subject|0|||
125133808|NCT02409355|450113865|FG000|Overall Study|Death|1|||
125133809|NCT02409355|450113866|FG001|Overall Study|Death|1|||
125133810|NCT02409355|450113865|FG000|Overall Study|Study terminated by Sponsor|2|||
125133811|NCT02409355|450113866|FG001|Overall Study|Study terminated by Sponsor|3|||
125133812|NCT00838539|450113867|FG000|Overall Study|Disease Progression|2|||
125133813|NCT00838539|450113868|FG001|Overall Study|Disease Progression|4|||
124973459|NCT00760747|449529367|FG000|Study Period III|Physician Decision|0|||
125133814|NCT00838539|450113869|FG002|Overall Study|Disease Progression|3|||
125133815|NCT00838539|450113870|FG003|Overall Study|Disease Progression|2|||
125133816|NCT00838539|450113871|FG004|Overall Study|Disease Progression|4|||
125133817|NCT00838539|450113872|FG005|Overall Study|Disease Progression|2|||
125133818|NCT00838539|450113873|FG006|Overall Study|Disease Progression|3|||
124973460|NCT00760747|449529368|FG001|Study Period III|Physician Decision|1|||
124973461|NCT01443923|449529369|FG000|Overall Study|Adverse Event|1|||
124973462|NCT01443923|449529370|FG001|Overall Study|Adverse Event|0|||
124973463|NCT03566979|449529373|FG000|Overall Study|Withdrawal by Subject|2|||
124973464|NCT03566979|449529374|FG001|Overall Study|Withdrawal by Subject|0|||
124973465|NCT03566979|449529375|FG002|Overall Study|Withdrawal by Subject|1|||
125133819|NCT00838539|450113874|FG007|Overall Study|Disease Progression|4|||
125133820|NCT00838539|450113875|FG008|Overall Study|Disease Progression|4|||
125037524|NCT00064701|449754948|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
125037525|NCT00064701|449754949|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
125037526|NCT00064701|449754947|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
125037527|NCT00064701|449754948|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
125037528|NCT00064701|449754949|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
125037529|NCT00064701|449754947|FG000|Clinical Continuation Phase|Physician Decision|1|||
125037530|NCT00064701|449754948|FG001|Clinical Continuation Phase|Physician Decision|3|||
125037531|NCT00064701|449754949|FG002|Clinical Continuation Phase|Physician Decision|0|||
125037532|NCT00064701|449754947|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
125037533|NCT00064701|449754948|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
125037534|NCT00064701|449754949|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
125037535|NCT00064701|449754947|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
125037536|NCT00064701|449754948|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
125037537|NCT00064701|449754949|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
125037538|NCT00064701|449754947|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
125037539|NCT00064701|449754948|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
125037540|NCT00064701|449754949|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
125037541|NCT00064701|449754947|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
125037542|NCT00064701|449754948|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
125037543|NCT00064701|449754949|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
125037544|NCT00064701|449754947|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
125037545|NCT00064701|449754948|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
125037546|NCT00064701|449754949|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
125037547|NCT00064701|449754947|FG000|Clinical Continuation Phase|Patient opted out|0|||
125037548|NCT00064701|449754948|FG001|Clinical Continuation Phase|Patient opted out|0|||
125037549|NCT00064701|449754949|FG002|Clinical Continuation Phase|Patient opted out|1|||
125037550|NCT01491945|449754951|FG000|Overall Study|Death|30|||
125037551|NCT01491945|449754951|FG000|Overall Study|Withdrwan/LTF|16|||
125218464|NCT02028507|450427335|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
125218465|NCT02028507|450427336|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
125218466|NCT02028507|450427337|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
125218467|NCT02028507|450427338|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
125218468|NCT02028507|450427335|FG000|Overall Study|Randomized But Not Treated|3|||
125218469|NCT02028507|450427336|FG001|Overall Study|Randomized But Not Treated|6|||
125218470|NCT02028507|450427337|FG002|Overall Study|Randomized But Not Treated|0|||
125218471|NCT02028507|450427338|FG003|Overall Study|Randomized But Not Treated|4|||
125218472|NCT02028507|450427335|FG000|Overall Study|Enzyme defect|0|||
125218473|NCT02028507|450427336|FG001|Overall Study|Enzyme defect|0|||
125218474|NCT02028507|450427337|FG002|Overall Study|Enzyme defect|0|||
125218475|NCT02028507|450427338|FG003|Overall Study|Enzyme defect|1|||
125218476|NCT02028507|450427335|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
125218477|NCT02028507|450427336|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
125218478|NCT02028507|450427337|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
125218479|NCT02028507|450427338|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
125218480|NCT02028507|450427335|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
125218481|NCT02028507|450427336|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
125218482|NCT02028507|450427337|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
125218483|NCT02028507|450427338|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
125218484|NCT02420262|450427341|FG000|Overall Study|Adverse Event|1|||
124973466|NCT03566979|449529376|FG003|Overall Study|Withdrawal by Subject|1|||
124973467|NCT03566979|449529373|FG000|Overall Study|Lost to Follow-up|2|||
124973468|NCT03566979|449529374|FG001|Overall Study|Lost to Follow-up|7|||
124973469|NCT03566979|449529375|FG002|Overall Study|Lost to Follow-up|9|||
124973470|NCT03566979|449529376|FG003|Overall Study|Lost to Follow-up|5|||
124973471|NCT03566979|449529373|FG000|Overall Study|Adverse Event|1|||
124973472|NCT03566979|449529374|FG001|Overall Study|Adverse Event|0|||
124973473|NCT03566979|449529375|FG002|Overall Study|Adverse Event|0|||
124973474|NCT03566979|449529376|FG003|Overall Study|Adverse Event|0|||
124973475|NCT01889069|449529381|FG000|Overall Study|Death|18|||
124973476|NCT01889069|449529381|FG000|Overall Study|Progression of Disease|14|||
124973477|NCT01889069|449529381|FG000|Overall Study|Lost to Follow-up|6|||
125037552|NCT01491945|449754951|FG000|Overall Study|Conversion|4|||
125218485|NCT02420262|450427342|FG001|Overall Study|Adverse Event|0|||
125218486|NCT02420262|450427341|FG000|Overall Study|Withdrawal by Subject|1|||
125037553|NCT01491945|449754951|FG000|Overall Study|Missed Visit|1|||
125218487|NCT02420262|450427342|FG001|Overall Study|Withdrawal by Subject|4|||
125218488|NCT02420262|450427341|FG000|Overall Study|Unclassified|0|||
124973478|NCT01889069|449529381|FG000|Overall Study|Other|4|||
124973479|NCT01889069|449529381|FG000|Overall Study|Consent Withdrawal|3|||
124973480|NCT01228175|449529382|FG000|Overall Study|Lost to Follow-up|64|||
124973481|NCT01228175|449529383|FG001|Overall Study|Lost to Follow-up|50|||
124973482|NCT01228175|449529382|FG000|Overall Study|Withdrawal by Subject|1|||
124973483|NCT01228175|449529383|FG001|Overall Study|Withdrawal by Subject|2|||
124973484|NCT01228175|449529382|FG000|Overall Study|Physician Decision|1|||
124973485|NCT01228175|449529383|FG001|Overall Study|Physician Decision|1|||
124973486|NCT00108745|449529384|FG000|Overall Study|Withdrawal by Subject|19|||
124973487|NCT00108745|449529385|FG001|Overall Study|Withdrawal by Subject|12|||
124973488|NCT00108745|449529386|FG002|Overall Study|Withdrawal by Subject|12|||
124973489|NCT00108745|449529384|FG000|Overall Study|Never Treated|8|||
124973490|NCT00108745|449529385|FG001|Overall Study|Never Treated|10|||
124973491|NCT00108745|449529386|FG002|Overall Study|Never Treated|12|||
124973492|NCT00108745|449529384|FG000|Overall Study|Ineligible|7|||
124973493|NCT00108745|449529385|FG001|Overall Study|Ineligible|13|||
124973494|NCT00108745|449529386|FG002|Overall Study|Ineligible|13|||
124973495|NCT00455741|449529388|FG000|Overall Study|Physician Decision|0|||
124973496|NCT00455741|449529389|FG001|Overall Study|Physician Decision|1|||
124973497|NCT01245374|449529393|FG000|Overall Study|Protocol Violation|1|||
124973498|NCT01245374|449529393|FG000|Overall Study|Withdrawal by Subject|3|||
124973499|NCT00935532|449529396|FG000|Overall Study|Adverse Event|11|||
124973500|NCT00935532|449529397|FG001|Overall Study|Adverse Event|6|||
124973501|NCT00935532|449529396|FG000|Overall Study|Death|1|||
124973502|NCT00935532|449529397|FG001|Overall Study|Death|0|||
124973503|NCT00935532|449529396|FG000|Overall Study|Lost to Follow-up|1|||
124973504|NCT00935532|449529397|FG001|Overall Study|Lost to Follow-up|0|||
124973505|NCT00935532|449529396|FG000|Overall Study|Physician Decision|1|||
124973506|NCT00935532|449529397|FG001|Overall Study|Physician Decision|2|||
124973507|NCT00935532|449529396|FG000|Overall Study|Protocol Violation|2|||
124973508|NCT00935532|449529397|FG001|Overall Study|Protocol Violation|1|||
124973509|NCT00935532|449529396|FG000|Overall Study|Subject Decision|2|||
124973510|NCT00935532|449529397|FG001|Overall Study|Subject Decision|1|||
124973511|NCT00935532|449529396|FG000|Overall Study|Sponsor Decision|0|||
124973512|NCT00935532|449529397|FG001|Overall Study|Sponsor Decision|1|||
124973513|NCT00935532|449529396|FG000|Overall Study|Loss Glucose Control|4|||
124973514|NCT00935532|449529397|FG001|Overall Study|Loss Glucose Control|0|||
124973515|NCT02227992|449529398|FG000|Overall Study|Lost to Follow-up|1|||
124973516|NCT02227992|449529399|FG001|Overall Study|Lost to Follow-up|1|||
124973517|NCT04954326|449529400|FG000|Overall Study|Protocol Violation|0|||
124973518|NCT04954326|449529401|FG001|Overall Study|Protocol Violation|1|||
124973519|NCT04954326|449529400|FG000|Overall Study|Death|0|||
124973520|NCT04954326|449529401|FG001|Overall Study|Death|2|||
124973521|NCT04954326|449529400|FG000|Overall Study|Physician Decision|0|||
124973522|NCT04954326|449529401|FG001|Overall Study|Physician Decision|1|||
124973523|NCT04982575|449529402|FG000|Overall Study|Withdrawal by Subject|2|||
124973524|NCT04982575|449529403|FG001|Overall Study|Withdrawal by Subject|0|||
124973525|NCT04982575|449529404|FG002|Overall Study|Withdrawal by Subject|2|||
125133821|NCT00838539|450113876|FG009|Overall Study|Disease Progression|5|||
125133822|NCT00838539|450113877|FG010|Overall Study|Disease Progression|1|||
124973526|NCT00475228|449529405|FG000|Overall Study|Lost to Follow-up|17|||
124973527|NCT00475228|449529406|FG001|Overall Study|Lost to Follow-up|17|||
124973528|NCT04949802|449531544|FG000|Overall Study|Lost to Follow-up|3|||
124973529|NCT02473965|449531545|FG000|Overall Study|Adverse Event|6|||
124973530|NCT02473965|449531546|FG001|Overall Study|Adverse Event|4|||
124973531|NCT02473965|449531545|FG000|Overall Study|MG worsening|4|||
124973532|NCT02473965|449531546|FG001|Overall Study|MG worsening|1|||
124973533|NCT02473965|449531545|FG000|Overall Study|Withdrawal by Subject|2|||
124973534|NCT02473965|449531546|FG001|Overall Study|Withdrawal by Subject|3|||
124973535|NCT02473965|449531545|FG000|Overall Study|Physician Decision|0|||
124973536|NCT02473965|449531546|FG001|Overall Study|Physician Decision|2|||
124973537|NCT01183390|449531547|FG000|First Intervention|Adverse Event|0|||
124973538|NCT01183390|449531548|FG001|First Intervention|Adverse Event|1|||
124973539|NCT03816761|449531549|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
124973540|NCT03816761|449531550|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
124973541|NCT03816761|449531551|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
124973542|NCT03816761|449531552|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
124973543|NCT03816761|449531553|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
124973544|NCT03816761|449531554|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
124973545|NCT03816761|449531549|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
124973546|NCT03816761|449531550|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
124973547|NCT03816761|449531551|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
124973548|NCT03816761|449531552|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
124973549|NCT03816761|449531553|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
124973550|NCT03816761|449531554|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
124973551|NCT01240551|449531555|FG000|Overall Study|Refused further treatment|3|||
124973552|NCT01240551|449531556|FG001|Overall Study|Refused further treatment|2|||
124973553|NCT01240551|449531555|FG000|Overall Study|Lost to Follow-up|1|||
124973554|NCT01240551|449531556|FG001|Overall Study|Lost to Follow-up|1|||
124973555|NCT01730950|449531562|FG000|Overall Study|Protocol Violation|6|||
125037554|NCT03770403|449754952|FG000|Overall Study|Adverse Event|8|||
125037555|NCT03770403|449754952|FG000|Overall Study|Death|5|||
125037556|NCT03770403|449754952|FG000|Overall Study|Physician Decision|1|||
125037557|NCT03770403|449754952|FG000|Overall Study|Sponsor decision|1|||
125037558|NCT03770403|449754952|FG000|Overall Study|Study terminated by Sponsor|1|||
125037559|NCT03770403|449754952|FG000|Overall Study|Withdrawal by Subject|13|||
125037560|NCT03770403|449754952|FG000|Overall Study|Other|88|||
125037561|NCT02700451|449754957|FG000|Overall Study|Protocol Violation|2|||
125037562|NCT02700451|449754958|FG001|Overall Study|Protocol Violation|2|||
125037563|NCT02700451|449754959|FG002|Overall Study|Protocol Violation|3|||
125037564|NCT02700451|449754957|FG000|Overall Study|Discontinued intervention|14|||
125037565|NCT02700451|449754958|FG001|Overall Study|Discontinued intervention|15|||
125037566|NCT02700451|449754959|FG002|Overall Study|Discontinued intervention|14|||
125037567|NCT04373460|449754960|FG000|Overall Study|Did not receive tranfusion|18|||
125037568|NCT04373460|449754961|FG001|Overall Study|Did not receive tranfusion|26|||
125037569|NCT01672957|449754962|FG000|Overall Study|Protocol Violation|48|||
125037570|NCT01672957|449754962|FG000|Overall Study|Death|2|||
125037571|NCT01672957|449754962|FG000|Overall Study|ICF Signed After Transplantation|5|||
125037572|NCT02115308|449754965|FG000|Overall Study|Safety Screening|2|||
125037573|NCT02115308|449754966|FG001|Overall Study|Safety Screening|2|||
125037574|NCT00642642|449754967|FG000|Treatment & Follow Up|Adverse Event|2|||
125037575|NCT00642642|449754967|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
125037576|NCT00642642|449754967|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
125037577|NCT02344576|449754968|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
125037578|NCT02344576|449754969|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
125037579|NCT02344576|449754970|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
125037580|NCT02344576|449754971|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
125037581|NCT02344576|449754968|FG000|1-Month Follow-Up|Death|13|||
125037582|NCT02344576|449754969|FG001|1-Month Follow-Up|Death|8|||
125037583|NCT02344576|449754970|FG002|1-Month Follow-Up|Death|0|||
125037584|NCT02344576|449754971|FG003|1-Month Follow-Up|Death|0|||
125037585|NCT02344576|449754968|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
125037586|NCT02344576|449754969|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
125037587|NCT02344576|449754970|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
125037588|NCT02344576|449754971|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
125037589|NCT02344576|449754968|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
125037590|NCT02344576|449754969|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
125037591|NCT02344576|449754970|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
125037592|NCT02344576|449754971|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
125037593|NCT02344576|449754968|FG000|6-Month Follow-Up|Death|14|||
125037594|NCT02344576|449754969|FG001|6-Month Follow-Up|Death|14|||
125037595|NCT02344576|449754970|FG002|6-Month Follow-Up|Death|0|||
125037596|NCT02344576|449754971|FG003|6-Month Follow-Up|Death|0|||
125037597|NCT02344576|449754968|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
125037598|NCT02344576|449754969|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
125037599|NCT02344576|449754970|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
125037600|NCT02344576|449754971|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
125037601|NCT02344576|449754968|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
125037602|NCT02344576|449754969|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
125037603|NCT02344576|449754970|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
125037604|NCT02344576|449754971|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
125037605|NCT02337387|449754974|FG000|Overall Study|Adverse Event|0|||
125037606|NCT02337387|449754975|FG001|Overall Study|Adverse Event|1|||
125037607|NCT02337387|449754976|FG002|Overall Study|Adverse Event|0|||
125037608|NCT02337387|449754977|FG003|Overall Study|Adverse Event|0|||
125037609|NCT02337387|449754974|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
125037610|NCT02337387|449754975|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
125037611|NCT02337387|449754976|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
125037612|NCT02337387|449754977|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
125037613|NCT02747004|449754978|FG000|Overall Study|Withdrawal by Subject|8|||
125037614|NCT02747004|449754979|FG001|Overall Study|Withdrawal by Subject|5|||
124973556|NCT01730950|449531563|FG001|Overall Study|Protocol Violation|6|||
124973557|NCT00667459|449531564|FG000|Overall Study|Death|0|||
124973558|NCT00667459|449531565|FG001|Overall Study|Death|2|||
124973559|NCT00667459|449531564|FG000|Overall Study|Lost to Follow-up|8|||
124973560|NCT00667459|449531565|FG001|Overall Study|Lost to Follow-up|43|||
124973561|NCT02568397|449531566|FG000|Period 2|Withdrawal by Subject|0|||
124973562|NCT02568397|449531567|FG001|Period 2|Withdrawal by Subject|1|||
124973563|NCT02568397|449531566|FG000|Period 2|Physician Decision|0|||
124973564|NCT02568397|449531567|FG001|Period 2|Physician Decision|1|||
124973565|NCT01200342|449531568|FG000|Overall Study|Disease Progression|1|||
124973566|NCT04546217|449531571|FG000|Overall Study|Withdrawal by Subject|2|||
124973567|NCT04546217|449531572|FG001|Overall Study|Withdrawal by Subject|0|||
124973568|NCT04546217|449531571|FG000|Overall Study|Uncontrolled hypertension|1|||
124973569|NCT04546217|449531572|FG001|Overall Study|Uncontrolled hypertension|0|||
124973570|NCT02550938|449531573|FG000|Overall Study|Lost to Follow-up|8|||
124973571|NCT02550938|449531574|FG001|Overall Study|Lost to Follow-up|7|||
124973572|NCT02550938|449531575|FG002|Overall Study|Lost to Follow-up|12|||
124973573|NCT02550938|449531576|FG003|Overall Study|Lost to Follow-up|11|||
124973574|NCT01484431|449531577|FG000|Period 1: High Dose|Physician Decision|0|||
124973575|NCT01484431|449531578|FG001|Period 1: High Dose|Physician Decision|1|||
124973576|NCT01484431|449531579|FG002|Period 1: High Dose|Physician Decision|0|||
124973577|NCT01484431|449531577|FG000|Period 2|Death|0|||
124973578|NCT01484431|449531578|FG001|Period 2|Death|1|||
124973579|NCT01484431|449531579|FG002|Period 2|Death|1|||
124973580|NCT01484431|449531577|FG000|Period 2|Physician Decision|0|||
124973581|NCT01484431|449531578|FG001|Period 2|Physician Decision|0|||
124973582|NCT01484431|449531579|FG002|Period 2|Physician Decision|1|||
124973583|NCT01484431|449531577|FG000|Period 2|Non-Compliance with Study Drug|1|||
124973584|NCT01484431|449531578|FG001|Period 2|Non-Compliance with Study Drug|0|||
124973585|NCT01484431|449531579|FG002|Period 2|Non-Compliance with Study Drug|0|||
124973586|NCT01888874|449531583|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
124973587|NCT01888874|449531584|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
124973588|NCT01888874|449531585|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
124973589|NCT01888874|449531586|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
124973590|NCT01888874|449531587|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
124973591|NCT01888874|449531588|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
124973592|NCT01888874|449531589|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
124973593|NCT01888874|449531583|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
124973594|NCT01888874|449531584|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
124973595|NCT01888874|449531585|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
124973596|NCT01888874|449531586|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
124973597|NCT01888874|449531587|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
124973598|NCT01888874|449531588|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
124973599|NCT01888874|449531589|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
124973600|NCT01888874|449531583|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
124973601|NCT01888874|449531584|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
124973602|NCT01888874|449531585|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
124973603|NCT01888874|449531586|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
124973604|NCT01888874|449531587|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
124973605|NCT01888874|449531588|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
124973606|NCT01888874|449531589|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
124973607|NCT01888874|449531583|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
124973608|NCT01888874|449531584|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
124973609|NCT01888874|449531585|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
124973610|NCT01888874|449531586|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
124973611|NCT01888874|449531587|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
124973612|NCT01888874|449531588|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
124973613|NCT01888874|449531589|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
124973614|NCT01888874|449531583|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
124973615|NCT01888874|449531584|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
124973616|NCT01888874|449531585|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
124973617|NCT01888874|449531586|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
124973618|NCT01888874|449531587|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
124973619|NCT01888874|449531588|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
125037615|NCT02747004|449754980|FG002|Overall Study|Withdrawal by Subject|4|||
125037616|NCT02747004|449754978|FG000|Overall Study|Lost to Follow-up|1|||
125037617|NCT02747004|449754979|FG001|Overall Study|Lost to Follow-up|2|||
125037618|NCT02747004|449754980|FG002|Overall Study|Lost to Follow-up|2|||
125037619|NCT02747004|449754978|FG000|Overall Study|on study treatment/follow-up|48|||
125037620|NCT02747004|449754979|FG001|Overall Study|on study treatment/follow-up|42|||
125037621|NCT02747004|449754980|FG002|Overall Study|on study treatment/follow-up|41|||
125037622|NCT06218251|449754981|FG000|Overall Study|Lost to Follow-up|4|||
125037623|NCT05087030|449754982|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
125037624|NCT05087030|449754983|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
125037625|NCT05087030|449754984|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
125037626|NCT05087030|449754985|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
125037627|NCT05087030|449754986|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
125037628|NCT05087030|449754982|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
125037629|NCT05087030|449754983|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
125037630|NCT05087030|449754984|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
125037631|NCT05087030|449754985|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
125037632|NCT05087030|449754986|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
125037633|NCT05087030|449754982|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
125037634|NCT05087030|449754983|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
125037635|NCT05087030|449754984|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
125037636|NCT05087030|449754985|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
125037637|NCT05087030|449754986|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
125037638|NCT05087030|449754982|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
125037639|NCT05087030|449754983|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
125037640|NCT05087030|449754984|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
125037641|NCT05087030|449754985|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
125037642|NCT05087030|449754986|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
125037643|NCT05087030|449754982|FG000|Main Period (Week 0 to Week 52)|Death|0|||
125037644|NCT05087030|449754983|FG001|Main Period (Week 0 to Week 52)|Death|1|||
125037645|NCT05087030|449754984|FG002|Main Period (Week 0 to Week 52)|Death|0|||
125037646|NCT05087030|449754985|FG003|Main Period (Week 0 to Week 52)|Death|0|||
125037647|NCT05087030|449754986|FG004|Main Period (Week 0 to Week 52)|Death|0|||
125037648|NCT05087030|449754982|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
125037649|NCT05087030|449754983|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
125037650|NCT05087030|449754984|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
125037651|NCT05087030|449754985|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
125037652|NCT05087030|449754986|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
125037653|NCT05087030|449754982|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
125037654|NCT05087030|449754983|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
125037655|NCT05087030|449754984|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
125037656|NCT05087030|449754985|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
125037657|NCT05087030|449754986|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
125037658|NCT05087030|449754982|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
125037659|NCT05087030|449754983|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
125037660|NCT05087030|449754984|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
125037661|NCT05087030|449754985|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
125037662|NCT05087030|449754986|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
125037663|NCT05087030|449754982|FG000|Main Period (Week 0 to Week 52)|Other|1|||
125037664|NCT05087030|449754983|FG001|Main Period (Week 0 to Week 52)|Other|2|||
125037665|NCT05087030|449754984|FG002|Main Period (Week 0 to Week 52)|Other|0|||
125037666|NCT05087030|449754985|FG003|Main Period (Week 0 to Week 52)|Other|0|||
125037667|NCT05087030|449754986|FG004|Main Period (Week 0 to Week 52)|Other|0|||
125037668|NCT05087030|449754982|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
125037669|NCT05087030|449754983|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
125037670|NCT05087030|449754984|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
125037671|NCT05087030|449754985|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
125037672|NCT05087030|449754986|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
125037673|NCT01444300|449754987|FG000|Overall Study|Adverse Event|4|||
125037674|NCT01444300|449754988|FG001|Overall Study|Adverse Event|0|||
125037675|NCT01053429|449754989|FG000|Overall Study|Adverse Event|64|||
125037676|NCT01053429|449754989|FG000|Overall Study|Other|309|||
125133823|NCT00838539|450113878|FG011|Overall Study|Disease Progression|4|||
125133824|NCT00838539|450113867|FG000|Overall Study|Adverse Event|1|||
125133825|NCT00838539|450113868|FG001|Overall Study|Adverse Event|1|||
125133826|NCT00838539|450113869|FG002|Overall Study|Adverse Event|1|||
125133827|NCT00838539|450113870|FG003|Overall Study|Adverse Event|1|||
125133828|NCT00838539|450113871|FG004|Overall Study|Adverse Event|2|||
125133829|NCT00838539|450113872|FG005|Overall Study|Adverse Event|1|||
125133830|NCT00838539|450113873|FG006|Overall Study|Adverse Event|0|||
125133831|NCT00838539|450113874|FG007|Overall Study|Adverse Event|2|||
125133832|NCT00838539|450113875|FG008|Overall Study|Adverse Event|0|||
125133833|NCT00838539|450113876|FG009|Overall Study|Adverse Event|1|||
125133834|NCT00838539|450113877|FG010|Overall Study|Adverse Event|2|||
125037677|NCT00963807|449754990|FG000|Overall Study|Physician Decision|2|||
125037678|NCT00963807|449754990|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
125133835|NCT00838539|450113878|FG011|Overall Study|Adverse Event|0|||
125133836|NCT00838539|450113867|FG000|Overall Study|Withdrawal by Subject|0|||
125133837|NCT00838539|450113868|FG001|Overall Study|Withdrawal by Subject|1|||
125037679|NCT00963807|449754990|FG000|Overall Study|Disease progression|15|||
125037680|NCT00684177|449754991|FG000|Overall Study|Adverse Event|4|||
125037681|NCT00684177|449754992|FG001|Overall Study|Adverse Event|3|||
125037682|NCT00684177|449754991|FG000|Overall Study|Lack of Efficacy|10|||
125037683|NCT00684177|449754992|FG001|Overall Study|Lack of Efficacy|15|||
125037684|NCT00684177|449754991|FG000|Overall Study|Protocol Violation|1|||
125037685|NCT00684177|449754992|FG001|Overall Study|Protocol Violation|0|||
125037686|NCT00684177|449754991|FG000|Overall Study|Lost to Follow-up|2|||
125037687|NCT00684177|449754992|FG001|Overall Study|Lost to Follow-up|1|||
125037688|NCT00684177|449754991|FG000|Overall Study|Physician Decision|2|||
125037689|NCT00684177|449754992|FG001|Overall Study|Physician Decision|0|||
125037690|NCT00684177|449754991|FG000|Overall Study|Withdrawal by Subject|1|||
125037691|NCT00684177|449754992|FG001|Overall Study|Withdrawal by Subject|2|||
125037692|NCT00684177|449754991|FG000|Overall Study|Other|1|||
125037693|NCT00684177|449754992|FG001|Overall Study|Other|2|||
125037694|NCT03095703|449757892|FG000|Overall Study|Withdrawal by Subject|1|||
125037695|NCT01381094|449757893|FG000|Overall Study|Adverse Event|1|||
125037696|NCT01381094|449757894|FG001|Overall Study|Adverse Event|2|||
125037697|NCT01381094|449757895|FG002|Overall Study|Adverse Event|0|||
125037698|NCT01381094|449757896|FG003|Overall Study|Adverse Event|1|||
125037699|NCT01381094|449757897|FG004|Overall Study|Adverse Event|0|||
125037700|NCT01381094|449757893|FG000|Overall Study|Lost to Follow-up|0|||
125037701|NCT01381094|449757894|FG001|Overall Study|Lost to Follow-up|0|||
125037702|NCT01381094|449757895|FG002|Overall Study|Lost to Follow-up|0|||
125037703|NCT01381094|449757896|FG003|Overall Study|Lost to Follow-up|0|||
125037704|NCT01381094|449757897|FG004|Overall Study|Lost to Follow-up|1|||
125037705|NCT01381094|449757893|FG000|Overall Study|Withdrawal of informed consent|0|||
125037706|NCT01381094|449757894|FG001|Overall Study|Withdrawal of informed consent|1|||
125037707|NCT01381094|449757895|FG002|Overall Study|Withdrawal of informed consent|0|||
125037708|NCT01381094|449757896|FG003|Overall Study|Withdrawal of informed consent|0|||
125037709|NCT01381094|449757897|FG004|Overall Study|Withdrawal of informed consent|0|||
125037710|NCT01381094|449757893|FG000|Overall Study|Participant given Aranesp injection|1|||
125037711|NCT01381094|449757894|FG001|Overall Study|Participant given Aranesp injection|0|||
125037712|NCT01381094|449757895|FG002|Overall Study|Participant given Aranesp injection|0|||
125037713|NCT01381094|449757896|FG003|Overall Study|Participant given Aranesp injection|0|||
125037714|NCT01381094|449757897|FG004|Overall Study|Participant given Aranesp injection|0|||
125037715|NCT01934504|449757900|FG000|Overall Study|Protocol Deviation|0|||
125037716|NCT01934504|449757901|FG001|Overall Study|Protocol Deviation|0|||
125037717|NCT01934504|449757902|FG002|Overall Study|Protocol Deviation|0|||
125037718|NCT01934504|449757903|FG003|Overall Study|Protocol Deviation|2|||
125037719|NCT01934504|449757900|FG000|Overall Study|Study Terminated by Sponsor|1|||
125037720|NCT01934504|449757901|FG001|Overall Study|Study Terminated by Sponsor|0|||
125037721|NCT01934504|449757902|FG002|Overall Study|Study Terminated by Sponsor|5|||
125037722|NCT01934504|449757903|FG003|Overall Study|Study Terminated by Sponsor|5|||
125037723|NCT02665689|449757904|FG000|Overall Study|Adverse Event|1|||
125037724|NCT02665689|449757905|FG001|Overall Study|Adverse Event|0|||
125037725|NCT02665689|449757904|FG000|Overall Study|Trial termination|1|||
125037726|NCT02665689|449757905|FG001|Overall Study|Trial termination|1|||
125037727|NCT02665689|449757904|FG000|Overall Study|Lost to Follow-up|0|||
125037728|NCT02665689|449757905|FG001|Overall Study|Lost to Follow-up|1|||
125037729|NCT00541307|449757906|FG000|Overall Study|Death|5|||
125037730|NCT00541307|449757906|FG000|Overall Study|Physician Decision|3|||
125037731|NCT00541307|449757906|FG000|Overall Study|Withdrawal by Subject|6|||
125037732|NCT00541307|449757906|FG000|Overall Study|Lost to Follow-up|4|||
125037733|NCT00541307|449757906|FG000|Overall Study|Subject returned early (outside window)|1|||
125037734|NCT00541307|449757906|FG000|Overall Study|Surgical Bypass|5|||
125037735|NCT02455557|449757907|FG000|Overall Study|Withdrawal by Subject|2|||
125133838|NCT00838539|450113869|FG002|Overall Study|Withdrawal by Subject|0|||
125133839|NCT00838539|450113870|FG003|Overall Study|Withdrawal by Subject|0|||
125133840|NCT00838539|450113871|FG004|Overall Study|Withdrawal by Subject|0|||
125133841|NCT00838539|450113872|FG005|Overall Study|Withdrawal by Subject|0|||
125133842|NCT00838539|450113873|FG006|Overall Study|Withdrawal by Subject|0|||
125133843|NCT00838539|450113874|FG007|Overall Study|Withdrawal by Subject|0|||
125133844|NCT00838539|450113875|FG008|Overall Study|Withdrawal by Subject|0|||
125133845|NCT00838539|450113876|FG009|Overall Study|Withdrawal by Subject|1|||
125037736|NCT03615222|449757908|FG000|Overall Study|Ineligible|26|||
125037737|NCT03615222|449757908|FG000|Overall Study|Withdrawal by Subject|7|||
125037738|NCT03615222|449757908|FG000|Overall Study|Death|1|||
125037739|NCT02900092|449757909|FG000|Overall Study|Adverse Event|1|||
125037740|NCT03895203|449757910|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
125037741|NCT03895203|449757911|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
125037742|NCT03895203|449757912|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
125037743|NCT03895203|449757913|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
125037744|NCT03895203|449757914|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
125037745|NCT03895203|449757915|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
125133846|NCT00838539|450113877|FG010|Overall Study|Withdrawal by Subject|2|||
125133847|NCT00838539|450113878|FG011|Overall Study|Withdrawal by Subject|0|||
125133848|NCT00838539|450113867|FG000|Overall Study|Death|0|||
125133849|NCT00838539|450113868|FG001|Overall Study|Death|0|||
124973620|NCT01888874|449531589|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
124973621|NCT01888874|449531583|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
124973622|NCT01888874|449531584|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
124973623|NCT01888874|449531585|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
124973624|NCT01888874|449531586|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
124973625|NCT01888874|449531587|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
124973626|NCT01888874|449531588|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
124973627|NCT01888874|449531589|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
124973628|NCT01888874|449531583|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
124973629|NCT01888874|449531584|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
124973630|NCT01888874|449531585|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
124973631|NCT01888874|449531586|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
124973632|NCT01888874|449531587|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
124973633|NCT01888874|449531588|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
124973634|NCT01888874|449531589|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
124973635|NCT01888874|449531583|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
124973636|NCT01888874|449531584|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
124973637|NCT01888874|449531585|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
124973638|NCT01888874|449531586|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
124973639|NCT01888874|449531587|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
124973640|NCT01888874|449531588|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
124973641|NCT01888874|449531589|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
124973642|NCT01888874|449531583|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
124973643|NCT01888874|449531584|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
124973644|NCT01888874|449531585|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
124973645|NCT01888874|449531586|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
124973646|NCT01888874|449531587|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
124973647|NCT01888874|449531588|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
124973648|NCT01888874|449531589|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
124973649|NCT01888874|449531583|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
124973650|NCT01888874|449531584|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
124973651|NCT01888874|449531585|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
124973652|NCT01888874|449531586|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
124973653|NCT01888874|449531587|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
124973654|NCT01888874|449531588|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
124973655|NCT01888874|449531589|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
124973656|NCT01888874|449531583|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
124973657|NCT01888874|449531584|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
124973658|NCT01888874|449531585|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
124973659|NCT01888874|449531586|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
124973660|NCT01888874|449531587|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
124973661|NCT01888874|449531588|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
124973662|NCT01888874|449531589|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
124973663|NCT01888874|449531583|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
124973664|NCT01888874|449531584|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
124973665|NCT01888874|449531585|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
124973666|NCT01888874|449531586|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
124973667|NCT01888874|449531587|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
125133850|NCT00838539|450113869|FG002|Overall Study|Death|0|||
125133851|NCT00838539|450113870|FG003|Overall Study|Death|0|||
124973668|NCT01888874|449531588|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
124973669|NCT01888874|449531589|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
124973670|NCT01888874|449531583|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
124973671|NCT01888874|449531584|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
124973672|NCT01888874|449531585|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
124973673|NCT01888874|449531586|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
124973674|NCT01888874|449531587|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
124973675|NCT01888874|449531588|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
125133852|NCT00838539|450113871|FG004|Overall Study|Death|0|||
125133853|NCT00838539|450113872|FG005|Overall Study|Death|0|||
125133854|NCT00838539|450113873|FG006|Overall Study|Death|1|||
125133855|NCT00838539|450113874|FG007|Overall Study|Death|0|||
125133856|NCT00838539|450113875|FG008|Overall Study|Death|0|||
125133857|NCT00838539|450113876|FG009|Overall Study|Death|0|||
125133858|NCT00838539|450113877|FG010|Overall Study|Death|0|||
125037746|NCT03895203|449757910|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
125037747|NCT03895203|449757911|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
125037748|NCT03895203|449757912|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
125037749|NCT03895203|449757913|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
125037750|NCT03895203|449757914|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
125037751|NCT03895203|449757915|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
125037752|NCT03895203|449757910|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
125037753|NCT03895203|449757911|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
125037754|NCT03895203|449757912|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
125037755|NCT03895203|449757913|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
125037756|NCT03895203|449757914|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
125037757|NCT03895203|449757915|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
125037758|NCT03895203|449757910|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
125037759|NCT03895203|449757911|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
125037760|NCT03895203|449757912|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
125037761|NCT03895203|449757913|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
125037762|NCT03895203|449757914|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
125037763|NCT03895203|449757915|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
125037764|NCT03895203|449757910|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
125037765|NCT03895203|449757911|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
125037766|NCT03895203|449757912|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
125037767|NCT03895203|449757913|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
125037768|NCT03895203|449757914|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
125037769|NCT03895203|449757915|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
125037770|NCT03895203|449757910|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
125037771|NCT03895203|449757911|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
125037772|NCT03895203|449757912|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
125037773|NCT03895203|449757913|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
125037774|NCT03895203|449757914|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
125037775|NCT03895203|449757915|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
125037776|NCT03895203|449757910|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
125037777|NCT03895203|449757911|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
125037778|NCT03895203|449757912|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
125037779|NCT03895203|449757913|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
125037780|NCT03895203|449757914|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
125037781|NCT03895203|449757915|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
125037782|NCT03895203|449757910|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
125037783|NCT03895203|449757911|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
125037784|NCT03895203|449757912|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
125133859|NCT00838539|450113878|FG011|Overall Study|Death|0|||
125133860|NCT00838539|450113867|FG000|Overall Study|Physician Decision|0|||
125133861|NCT00838539|450113868|FG001|Overall Study|Physician Decision|0|||
125133862|NCT00838539|450113869|FG002|Overall Study|Physician Decision|0|||
125133863|NCT00838539|450113870|FG003|Overall Study|Physician Decision|0|||
125133864|NCT00838539|450113871|FG004|Overall Study|Physician Decision|0|||
125133865|NCT00838539|450113872|FG005|Overall Study|Physician Decision|0|||
125133866|NCT00838539|450113873|FG006|Overall Study|Physician Decision|0|||
125133867|NCT00838539|450113874|FG007|Overall Study|Physician Decision|0|||
125133868|NCT00838539|450113875|FG008|Overall Study|Physician Decision|1|||
125133869|NCT00838539|450113876|FG009|Overall Study|Physician Decision|0|||
125133870|NCT00838539|450113877|FG010|Overall Study|Physician Decision|0|||
125133871|NCT00838539|450113878|FG011|Overall Study|Physician Decision|0|||
125133872|NCT00838539|450113867|FG000|Overall Study|Clinical Progression|0|||
125133873|NCT00838539|450113868|FG001|Overall Study|Clinical Progression|0|||
125133874|NCT00838539|450113869|FG002|Overall Study|Clinical Progression|0|||
125133875|NCT00838539|450113870|FG003|Overall Study|Clinical Progression|0|||
125133876|NCT00838539|450113871|FG004|Overall Study|Clinical Progression|0|||
125133877|NCT00838539|450113872|FG005|Overall Study|Clinical Progression|0|||
125133878|NCT00838539|450113873|FG006|Overall Study|Clinical Progression|1|||
125133879|NCT00838539|450113874|FG007|Overall Study|Clinical Progression|0|||
125133880|NCT00838539|450113875|FG008|Overall Study|Clinical Progression|0|||
125133881|NCT00838539|450113876|FG009|Overall Study|Clinical Progression|0|||
125133882|NCT00838539|450113877|FG010|Overall Study|Clinical Progression|0|||
125133883|NCT00838539|450113878|FG011|Overall Study|Clinical Progression|0|||
125037785|NCT03895203|449757913|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
125133884|NCT00838539|450113867|FG000|Overall Study|Symptomatic Deterioration|0|||
125037786|NCT03895203|449757914|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
125133885|NCT00838539|450113868|FG001|Overall Study|Symptomatic Deterioration|0|||
125133886|NCT00838539|450113869|FG002|Overall Study|Symptomatic Deterioration|1|||
125133887|NCT00838539|450113870|FG003|Overall Study|Symptomatic Deterioration|1|||
125133888|NCT00838539|450113871|FG004|Overall Study|Symptomatic Deterioration|0|||
125133889|NCT00838539|450113872|FG005|Overall Study|Symptomatic Deterioration|1|||
125133890|NCT00838539|450113873|FG006|Overall Study|Symptomatic Deterioration|0|||
125133891|NCT00838539|450113874|FG007|Overall Study|Symptomatic Deterioration|0|||
125133892|NCT00838539|450113875|FG008|Overall Study|Symptomatic Deterioration|0|||
125133893|NCT00838539|450113876|FG009|Overall Study|Symptomatic Deterioration|1|||
125133894|NCT00838539|450113877|FG010|Overall Study|Symptomatic Deterioration|0|||
125133895|NCT00838539|450113878|FG011|Overall Study|Symptomatic Deterioration|0|||
125133896|NCT03482882|450113879|FG000|Overall Study|Adverse Event|3|||
125133897|NCT03482882|450113879|FG000|Overall Study|Lost to Follow-up|1|||
125133898|NCT03482882|450113879|FG000|Overall Study|Protocol Violation|2|||
125133899|NCT03482882|450113879|FG000|Overall Study|Not further specified|1|||
125133900|NCT03123471|450113884|FG000|Placebo-controlled Phase|Adverse Event|3|||
125133901|NCT03123471|450113885|FG001|Placebo-controlled Phase|Adverse Event|8|||
125133902|NCT03123471|450113884|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
125133903|NCT03123471|450113885|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
125133904|NCT03123471|450113884|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
125133905|NCT03123471|450113885|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
125133906|NCT03123471|450113884|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
125133907|NCT03123471|450113885|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
125133908|NCT03123471|450113884|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
125133909|NCT03123471|450113885|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
125133910|NCT03123471|450113884|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
125133911|NCT03123471|450113885|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
125133912|NCT03123471|450113884|FG000|Placebo-controlled Phase|Miscellaneous|0|||
125133913|NCT03123471|450113885|FG001|Placebo-controlled Phase|Miscellaneous|1|||
125133914|NCT03123471|450113884|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
125133915|NCT03123471|450113885|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
125133916|NCT03123471|450113884|FG000|Apremilast Extension Phase|Adverse Event|1|||
125133917|NCT03123471|450113885|FG001|Apremilast Extension Phase|Adverse Event|5|||
125133918|NCT03123471|450113884|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
125133919|NCT03123471|450113885|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
125133920|NCT03123471|450113884|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
125133921|NCT03123471|450113885|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
125133922|NCT02957942|450113888|FG000|Overall Study|Withdrawal by Subject|0|||
125133923|NCT02957942|450113889|FG001|Overall Study|Withdrawal by Subject|1|||
125133924|NCT02957942|450113888|FG000|Overall Study|Practicing experiment protocol|0|||
125133925|NCT02957942|450113889|FG001|Overall Study|Practicing experiment protocol|6|||
125133926|NCT03238781|450113890|FG000|Overall Study|Adverse Event|1|||
125133927|NCT03238781|450113891|FG001|Overall Study|Adverse Event|1|||
125133928|NCT03238781|450113892|FG002|Overall Study|Adverse Event|2|||
125133929|NCT03238781|450113890|FG000|Overall Study|Lost to Follow-up|2|||
125133930|NCT03238781|450113891|FG001|Overall Study|Lost to Follow-up|1|||
125133931|NCT03238781|450113892|FG002|Overall Study|Lost to Follow-up|2|||
125133932|NCT03238781|450113890|FG000|Overall Study|Withdrawal by Subject|23|||
124973676|NCT01888874|449531589|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
124973677|NCT02763215|449531590|FG000|Overall Study|Participants withdrew from study|3|||
124973678|NCT02763215|449531590|FG000|Overall Study|Missed visit|1|||
124973679|NCT02763215|449531590|FG000|Overall Study|Visit outside visit-window|1|||
124973680|NCT02763215|449531590|FG000|Overall Study|Death|1|||
124973681|NCT02763215|449531590|FG000|Overall Study|Lost to Follow-up|1|||
124973682|NCT00475644|449531592|FG000|Overall Study|Protocol Violation|13|||
124973683|NCT01411241|449531593|FG000|Overall Study|Protocol Violation|0|||
124973684|NCT01411241|449531594|FG001|Overall Study|Protocol Violation|5|||
124973685|NCT01411241|449531593|FG000|Overall Study|Withdrawal by Subject|9|||
124973686|NCT01411241|449531594|FG001|Overall Study|Withdrawal by Subject|10|||
124973687|NCT01411241|449531593|FG000|Overall Study|Serious Adverse Event|0|||
124973688|NCT01411241|449531594|FG001|Overall Study|Serious Adverse Event|3|||
124973689|NCT01411241|449531593|FG000|Overall Study|Lost to Follow-up|2|||
124973690|NCT01411241|449531594|FG001|Overall Study|Lost to Follow-up|4|||
124973691|NCT02980042|449531599|FG000|Overall Study|Lost to Follow-up|5|||
124973692|NCT02980042|449531600|FG001|Overall Study|Lost to Follow-up|0|||
124973693|NCT02980042|449531599|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
124973694|NCT02980042|449531600|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
124973695|NCT01483144|449531605|FG000|Overall Study|Adverse Event|9|||
124973696|NCT01483144|449531606|FG001|Overall Study|Adverse Event|4|||
124973697|NCT01483144|449531607|FG002|Overall Study|Adverse Event|6|||
125133933|NCT03238781|450113891|FG001|Overall Study|Withdrawal by Subject|14|||
125133934|NCT03238781|450113892|FG002|Overall Study|Withdrawal by Subject|16|||
125133935|NCT03238781|450113890|FG000|Overall Study|Decision by sponsor|0|||
125133936|NCT03238781|450113891|FG001|Overall Study|Decision by sponsor|1|||
125133937|NCT03238781|450113892|FG002|Overall Study|Decision by sponsor|0|||
124973698|NCT01483144|449531605|FG000|Overall Study|Withdrawal by Subject|0|||
124973699|NCT01483144|449531606|FG001|Overall Study|Withdrawal by Subject|2|||
124973700|NCT01483144|449531607|FG002|Overall Study|Withdrawal by Subject|5|||
124973701|NCT01483144|449531605|FG000|Overall Study|Physician Decision|1|||
124973702|NCT01483144|449531606|FG001|Overall Study|Physician Decision|0|||
124973703|NCT01483144|449531607|FG002|Overall Study|Physician Decision|0|||
124973704|NCT01483144|449531605|FG000|Overall Study|Lost to Follow-up|2|||
124973705|NCT01483144|449531606|FG001|Overall Study|Lost to Follow-up|4|||
124973706|NCT01483144|449531607|FG002|Overall Study|Lost to Follow-up|1|||
124973707|NCT01483144|449531605|FG000|Overall Study|Protocol Violation|3|||
124973708|NCT01483144|449531606|FG001|Overall Study|Protocol Violation|3|||
124973709|NCT01483144|449531607|FG002|Overall Study|Protocol Violation|3|||
124973710|NCT02460575|449531608|FG000|Overall Study|Lost to Follow-up|1|||
124973711|NCT02460575|449531609|FG001|Overall Study|Lost to Follow-up|0|||
124973712|NCT00425607|449531610|FG000|Overall Study|Death|1|||
124973713|NCT00425607|449531610|FG000|Overall Study|Withdrawal by Subject|1|||
124973714|NCT00079339|449531611|FG000|Overall Study|Adverse Event|1|||
124973715|NCT00079339|449531612|FG001|Overall Study|Adverse Event|7|||
124973716|NCT00079339|449531613|FG002|Overall Study|Adverse Event|2|||
124973717|NCT00079339|449531611|FG000|Overall Study|Death|1|||
124973718|NCT00079339|449531612|FG001|Overall Study|Death|0|||
124973719|NCT00079339|449531613|FG002|Overall Study|Death|0|||
124973720|NCT00079339|449531611|FG000|Overall Study|Non-compliance|0|||
124973721|NCT00079339|449531612|FG001|Overall Study|Non-compliance|0|||
124973722|NCT00079339|449531613|FG002|Overall Study|Non-compliance|1|||
124973723|NCT00079339|449531611|FG000|Overall Study|Withdrawal by Subject|0|||
124973724|NCT00079339|449531612|FG001|Overall Study|Withdrawal by Subject|4|||
124973725|NCT00079339|449531613|FG002|Overall Study|Withdrawal by Subject|1|||
124973726|NCT00079339|449531611|FG000|Overall Study|Disease progression|3|||
124973727|NCT00079339|449531612|FG001|Overall Study|Disease progression|28|||
124973728|NCT00079339|449531613|FG002|Overall Study|Disease progression|2|||
124973729|NCT02563548|449531614|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
124973730|NCT02563548|449531615|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
124973731|NCT02563548|449531616|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
124973732|NCT02563548|449531617|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
124973733|NCT02563548|449531618|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
124973734|NCT02563548|449531619|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
125037787|NCT03895203|449757915|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
125037788|NCT03895203|449757910|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
125037789|NCT03895203|449757911|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
125037790|NCT03895203|449757912|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
125037791|NCT03895203|449757913|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
125037792|NCT03895203|449757914|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
125037793|NCT03895203|449757915|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
124973735|NCT02563548|449531614|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
124973736|NCT02563548|449531615|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
124973737|NCT02563548|449531616|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
124973738|NCT02563548|449531617|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
124973739|NCT02563548|449531618|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
124973740|NCT02563548|449531619|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
124973741|NCT02563548|449531614|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
124973742|NCT02563548|449531615|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
125037794|NCT03895203|449757910|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
125037795|NCT03895203|449757911|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
124973743|NCT02563548|449531616|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
124973744|NCT02563548|449531617|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
124973745|NCT02563548|449531618|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
124973746|NCT02563548|449531619|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
124973747|NCT02563548|449531614|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
124973748|NCT02563548|449531615|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
124973749|NCT02563548|449531616|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
125133938|NCT01249651|450113894|FG000|Overall Study|Withdrawal by Subject|4|||
125133939|NCT01249651|450113894|FG000|Overall Study|Adverse Event|1|||
125133940|NCT01249651|450113894|FG000|Overall Study|Protocol Violation|1|||
125133941|NCT01249651|450113894|FG000|Overall Study|Sponsor Decision|1|||
125133942|NCT00813592|450113900|FG000|Overall Study|Disease assessment was not completed per|2|||
125133943|NCT00811655|450113901|FG000|Overall Study|Physician Decision|1|||
125133944|NCT03801707|450113906|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
124973750|NCT02563548|449531617|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
124973751|NCT02563548|449531618|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
124973752|NCT02563548|449531619|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
124973753|NCT02563548|449531614|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
125133945|NCT03873272|450113907|FG000|Overall Study|Withdrawal by Subject|2|||
125133946|NCT03873272|450113908|FG001|Overall Study|Withdrawal by Subject|0|||
125133947|NCT03873272|450113909|FG002|Overall Study|Withdrawal by Subject|1|||
125133948|NCT03873272|450113907|FG000|Overall Study|Death|0|||
125133949|NCT03873272|450113908|FG001|Overall Study|Death|2|||
125133950|NCT03873272|450113909|FG002|Overall Study|Death|1|||
125133951|NCT00787254|450113912|FG000|Overall Study|Adverse Event|24|||
125133952|NCT00787254|450113913|FG001|Overall Study|Adverse Event|23|||
125133953|NCT00787254|450113912|FG000|Overall Study|Protocol Violation|26|||
125133954|NCT00787254|450113913|FG001|Overall Study|Protocol Violation|23|||
125133955|NCT00787254|450113912|FG000|Overall Study|Withdrawal by Subject|16|||
125133956|NCT00787254|450113913|FG001|Overall Study|Withdrawal by Subject|11|||
125133957|NCT00787254|450113912|FG000|Overall Study|Lack of Efficacy|4|||
125133958|NCT00787254|450113913|FG001|Overall Study|Lack of Efficacy|15|||
125133959|NCT00787254|450113912|FG000|Overall Study|NSAIDs discontinuation|1|||
124973754|NCT02563548|449531615|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
124973755|NCT02563548|449531616|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
124973756|NCT02563548|449531617|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
124973757|NCT02563548|449531618|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
124973758|NCT02563548|449531619|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
124973759|NCT02563548|449531614|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
124973760|NCT02563548|449531615|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
124973761|NCT02563548|449531616|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
124973762|NCT02563548|449531617|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
124973763|NCT02563548|449531618|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
124973764|NCT02563548|449531619|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
124973765|NCT02563548|449531614|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
124973766|NCT02563548|449531615|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
124973767|NCT02563548|449531616|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
124973768|NCT02563548|449531617|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
124973769|NCT02563548|449531618|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
124973770|NCT02563548|449531619|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
124973771|NCT02563548|449531614|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
124973772|NCT02563548|449531615|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
124973773|NCT02563548|449531616|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
124973774|NCT02563548|449531617|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
124973775|NCT02563548|449531618|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
125133960|NCT00787254|450113913|FG001|Overall Study|NSAIDs discontinuation|2|||
125133961|NCT00787254|450113912|FG000|Overall Study|Institution closed|1|||
125133962|NCT00787254|450113913|FG001|Overall Study|Institution closed|0|||
125133963|NCT00787254|450113912|FG000|Overall Study|Physician Decision|4|||
125133964|NCT00787254|450113913|FG001|Overall Study|Physician Decision|8|||
125133965|NCT00316186|450113914|FG000|Overall Study|Adverse Event|6|||
125133966|NCT00316186|450113914|FG000|Overall Study|Disease Progression|4|||
125133967|NCT00316186|450113914|FG000|Overall Study|Lost to Follow-up|1|||
125133968|NCT00316186|450113914|FG000|Overall Study|Other|1|||
125133969|NCT03071575|450115499|FG000|Overall Study|Death|0|||
125133970|NCT03071575|450115500|FG001|Overall Study|Death|1|||
125037796|NCT03895203|449757912|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
125037797|NCT03895203|449757913|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
125037798|NCT03895203|449757914|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
125037799|NCT03895203|449757915|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
125037800|NCT03895203|449757910|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
125037801|NCT03895203|449757911|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
125037802|NCT03895203|449757912|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
125037803|NCT03895203|449757913|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
125037804|NCT03895203|449757914|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
125037805|NCT03895203|449757915|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
125037806|NCT03895203|449757910|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
125037807|NCT03895203|449757911|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
125037808|NCT03895203|449757912|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
125037809|NCT03895203|449757913|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
125037810|NCT03895203|449757914|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
125037811|NCT03895203|449757915|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
125037812|NCT03895203|449757910|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
125037813|NCT03895203|449757911|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
125037814|NCT03895203|449757912|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
125037815|NCT03895203|449757913|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
125037816|NCT03895203|449757914|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
125037817|NCT03895203|449757915|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
125037818|NCT03895203|449757910|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
125037819|NCT03895203|449757911|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
125037820|NCT03895203|449757912|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
125037821|NCT03895203|449757913|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
125037822|NCT03895203|449757914|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
125037823|NCT03895203|449757915|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
125037824|NCT00996840|449757916|FG000|Overall Study|Adverse Event|0|||
125037825|NCT00996840|449757917|FG001|Overall Study|Adverse Event|1|||
125037826|NCT00996840|449757918|FG002|Overall Study|Adverse Event|0|||
125037827|NCT00996840|449757919|FG003|Overall Study|Adverse Event|0|||
125037828|NCT00996840|449757920|FG004|Overall Study|Adverse Event|0|||
125037829|NCT00996840|449757916|FG000|Overall Study|Physician Decision|0|||
125037830|NCT00996840|449757917|FG001|Overall Study|Physician Decision|0|||
125037831|NCT00996840|449757918|FG002|Overall Study|Physician Decision|1|||
125037832|NCT00996840|449757919|FG003|Overall Study|Physician Decision|1|||
125037833|NCT00996840|449757920|FG004|Overall Study|Physician Decision|2|||
125037834|NCT00996840|449757916|FG000|Overall Study|Withdrawal by Subject|1|||
125037835|NCT00996840|449757917|FG001|Overall Study|Withdrawal by Subject|1|||
125037836|NCT00996840|449757918|FG002|Overall Study|Withdrawal by Subject|0|||
125037837|NCT00996840|449757919|FG003|Overall Study|Withdrawal by Subject|0|||
125037838|NCT00996840|449757920|FG004|Overall Study|Withdrawal by Subject|0|||
125037839|NCT01485614|449757922|FG000|Randomization|Not Treated|1|||
125037840|NCT01485614|449757923|FG001|Randomization|Not Treated|0|||
125037841|NCT01485614|449757924|FG002|Randomization|Not Treated|0|||
125037842|NCT01485614|449757925|FG003|Randomization|Not Treated|0|||
125037843|NCT01485614|449757922|FG000|Weeks 0-20|Lost to Follow-up|2|||
125037844|NCT01485614|449757923|FG001|Weeks 0-20|Lost to Follow-up|0|||
125037845|NCT01485614|449757924|FG002|Weeks 0-20|Lost to Follow-up|0|||
125037846|NCT01485614|449757925|FG003|Weeks 0-20|Lost to Follow-up|0|||
125037847|NCT01485614|449757922|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
125037848|NCT01485614|449757923|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
125037849|NCT01485614|449757924|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
125037850|NCT01485614|449757925|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
125037851|NCT01485614|449757922|FG000|Weeks 0-20|Withdrawal by Subject|3|||
125037852|NCT01485614|449757923|FG001|Weeks 0-20|Withdrawal by Subject|2|||
125037853|NCT01485614|449757924|FG002|Weeks 0-20|Withdrawal by Subject|1|||
125037854|NCT01485614|449757925|FG003|Weeks 0-20|Withdrawal by Subject|0|||
125037855|NCT01485614|449757922|FG000|Weeks 20-54|Lost to Follow-up|4|||
125037856|NCT01485614|449757923|FG001|Weeks 20-54|Lost to Follow-up|3|||
125037857|NCT01485614|449757924|FG002|Weeks 20-54|Lost to Follow-up|1|||
125037858|NCT01485614|449757925|FG003|Weeks 20-54|Lost to Follow-up|0|||
125037859|NCT01485614|449757922|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
125037860|NCT01485614|449757923|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
125037861|NCT01485614|449757924|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
125037862|NCT01485614|449757925|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
125037863|NCT01485614|449757922|FG000|Weeks 20-54|Withdrawal by Subject|5|||
125037864|NCT01485614|449757923|FG001|Weeks 20-54|Withdrawal by Subject|3|||
124973776|NCT02563548|449531619|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
124973777|NCT02563548|449531614|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
124973778|NCT02563548|449531615|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
124973779|NCT02563548|449531616|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
124973780|NCT02563548|449531617|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
124973781|NCT02563548|449531618|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
124973782|NCT02563548|449531619|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
124973783|NCT02563548|449531614|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
124973784|NCT02563548|449531615|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
125037865|NCT01485614|449757924|FG002|Weeks 20-54|Withdrawal by Subject|0|||
125037866|NCT01485614|449757925|FG003|Weeks 20-54|Withdrawal by Subject|0|||
125037867|NCT02210780|449757926|FG000|Overall Study|Adverse Event|0|||
125037868|NCT02210780|449757927|FG001|Overall Study|Adverse Event|5|||
125037869|NCT02210780|449757926|FG000|Overall Study|Lost to Follow-up|2|||
125037870|NCT02210780|449757927|FG001|Overall Study|Lost to Follow-up|1|||
125037871|NCT02210780|449757926|FG000|Overall Study|Withdrawal by Subject|1|||
125037872|NCT02210780|449757927|FG001|Overall Study|Withdrawal by Subject|1|||
125037873|NCT02210780|449757926|FG000|Overall Study|Physician Decision|1|||
125037874|NCT02210780|449757927|FG001|Overall Study|Physician Decision|0|||
125037875|NCT02210780|449757926|FG000|Overall Study|Protocol Violation|1|||
125037876|NCT02210780|449757927|FG001|Overall Study|Protocol Violation|0|||
125037877|NCT02210780|449757926|FG000|Overall Study|Other than specified above|0|||
125037878|NCT02210780|449757927|FG001|Overall Study|Other than specified above|1|||
125037879|NCT02582515|449757928|FG000|Overall Study|Withdrawal by Subject|0|||
125037880|NCT02582515|449757929|FG001|Overall Study|Withdrawal by Subject|1|||
125037881|NCT00775021|449757930|FG000|First Intervention|Lost to Follow-up|1|||
125037882|NCT00775021|449757931|FG001|First Intervention|Lost to Follow-up|0|||
125037883|NCT00775021|449757930|FG000|Second Intervention|Adverse Event|0|||
125037884|NCT00775021|449757931|FG001|Second Intervention|Adverse Event|1|||
125037885|NCT00929240|449757936|FG000|Initial Treatment Phase|Adverse Event|31|||
125037886|NCT00929240|449757937|FG001|Initial Treatment Phase|Adverse Event|0|||
125037887|NCT00929240|449757938|FG002|Initial Treatment Phase|Adverse Event|0|||
125037888|NCT00929240|449757936|FG000|Initial Treatment Phase|Disease progression|41|||
125037889|NCT00929240|449757937|FG001|Initial Treatment Phase|Disease progression|0|||
125037890|NCT00929240|449757938|FG002|Initial Treatment Phase|Disease progression|0|||
125037891|NCT00929240|449757936|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
125037892|NCT00929240|449757937|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
125037893|NCT00929240|449757938|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
125037894|NCT00929240|449757936|FG000|Initial Treatment Phase|Protocol Violation|5|||
125037895|NCT00929240|449757937|FG001|Initial Treatment Phase|Protocol Violation|0|||
125037896|NCT00929240|449757938|FG002|Initial Treatment Phase|Protocol Violation|0|||
125037897|NCT00929240|449757936|FG000|Initial Treatment Phase|Death|2|||
125037898|NCT00929240|449757937|FG001|Initial Treatment Phase|Death|0|||
125037899|NCT00929240|449757938|FG002|Initial Treatment Phase|Death|0|||
125037900|NCT00929240|449757936|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
125037901|NCT00929240|449757937|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
125133971|NCT03071575|450115499|FG000|Overall Study|Lost to Follow-up|5|||
125133972|NCT03071575|450115500|FG001|Overall Study|Lost to Follow-up|11|||
125133973|NCT03071575|450115499|FG000|Overall Study|Withdrawal by Subject|4|||
125133974|NCT03071575|450115500|FG001|Overall Study|Withdrawal by Subject|2|||
125133975|NCT03255733|450115504|FG000|Overall Study|Lost to Follow-up|4|||
125133976|NCT04299087|450115505|FG000|Overall Study|Lost to Follow-up|2|||
125133977|NCT04299087|450115506|FG001|Overall Study|Lost to Follow-up|1|||
125133978|NCT00594035|450115507|FG000|Overall Study|Lost to Follow-up|1|||
125133979|NCT00594035|450115508|FG001|Overall Study|Lost to Follow-up|1|||
125133980|NCT00594035|450115507|FG000|Overall Study|Withdrawal by Subject|1|||
125133981|NCT00594035|450115508|FG001|Overall Study|Withdrawal by Subject|0|||
125133982|NCT00594035|450115507|FG000|Overall Study|Subject transferred to nursing home|0|||
125133983|NCT00594035|450115508|FG001|Overall Study|Subject transferred to nursing home|1|||
125218489|NCT02420262|450427342|FG001|Overall Study|Unclassified|1|||
125037902|NCT00929240|449757938|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
125037903|NCT00929240|449757936|FG000|Initial Treatment Phase|Physician Decision|4|||
125037904|NCT00929240|449757937|FG001|Initial Treatment Phase|Physician Decision|0|||
125037905|NCT00929240|449757938|FG002|Initial Treatment Phase|Physician Decision|0|||
125037906|NCT00929240|449757936|FG000|Maintenance Phase|Disease progression|0|||
125133984|NCT00594035|450115507|FG000|Overall Study|Subject couldn't return due to job|0|||
125133985|NCT00594035|450115508|FG001|Overall Study|Subject couldn't return due to job|1|||
125133986|NCT00795821|450115509|FG000|Acute Treatment Phase|Adverse Event|23|||
125133987|NCT00795821|450115510|FG001|Acute Treatment Phase|Adverse Event|4|||
125133988|NCT00795821|450115509|FG000|Acute Treatment Phase|Death|1|||
125133989|NCT00795821|450115510|FG001|Acute Treatment Phase|Death|0|||
124973785|NCT02563548|449531616|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
124973786|NCT02563548|449531617|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
124973787|NCT02563548|449531618|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
124973788|NCT02563548|449531619|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
124973789|NCT02563548|449531614|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
124973790|NCT02563548|449531615|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
124973791|NCT02563548|449531616|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
124973792|NCT02563548|449531617|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
124973793|NCT02563548|449531618|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
124973794|NCT02563548|449531619|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
124973795|NCT02563548|449531614|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
124973796|NCT02563548|449531615|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
124973797|NCT02563548|449531616|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
124973798|NCT02563548|449531617|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
124973799|NCT02563548|449531618|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
124973800|NCT02563548|449531619|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
124973801|NCT00520845|449531620|FG000|Overall Study|Death|3|||
124973802|NCT00520845|449531620|FG000|Overall Study|Adverse Event|4|||
124973803|NCT00520845|449531620|FG000|Overall Study|Disease Progression, relapse|13|||
124973804|NCT00520845|449531620|FG000|Overall Study|Withdrawal by Subject|1|||
124973805|NCT00520845|449531620|FG000|Overall Study|Alternative Therapy|1|||
124973806|NCT03274453|449531623|FG000|Overall Study|Lost to Follow-up|2|||
124973807|NCT03274453|449531624|FG001|Overall Study|Lost to Follow-up|5|||
124973808|NCT03274453|449531625|FG002|Overall Study|Lost to Follow-up|4|||
124973809|NCT03274453|449531626|FG003|Overall Study|Lost to Follow-up|1|||
124973810|NCT03274453|449531623|FG000|Overall Study|Physician Decision|2|||
124973811|NCT03274453|449531624|FG001|Overall Study|Physician Decision|0|||
124973812|NCT03274453|449531625|FG002|Overall Study|Physician Decision|0|||
124973813|NCT03274453|449531626|FG003|Overall Study|Physician Decision|3|||
124973814|NCT03274453|449531623|FG000|Overall Study|Surgery Cancelled|0|||
124973815|NCT03274453|449531624|FG001|Overall Study|Surgery Cancelled|1|||
124973816|NCT03274453|449531625|FG002|Overall Study|Surgery Cancelled|0|||
124973817|NCT03274453|449531626|FG003|Overall Study|Surgery Cancelled|0|||
124973818|NCT01732549|449531628|FG000|Overall Study|Adverse Event|13|||
124973819|NCT01732549|449531629|FG001|Overall Study|Adverse Event|3|||
124973820|NCT01732549|449531628|FG000|Overall Study|Consent withdrawn|13|||
124973821|NCT01732549|449531629|FG001|Overall Study|Consent withdrawn|6|||
124973822|NCT01732549|449531628|FG000|Overall Study|Disease progression|37|||
124973823|NCT01732549|449531629|FG001|Overall Study|Disease progression|50|||
124973824|NCT01732549|449531628|FG000|Overall Study|Other|8|||
124973825|NCT01732549|449531629|FG001|Overall Study|Other|14|||
124973826|NCT01516749|449531630|FG000|Active Therapy|Lost to Follow-up|1|||
124973827|NCT01516749|449531630|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
124973828|NCT00351377|449531631|FG000|Overall Study|Adverse Event|5|||
124973829|NCT00351377|449531631|FG000|Overall Study|Death|1|||
124973830|NCT00351377|449531631|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124973831|NCT02493062|449531636|FG000|Overall Study|Physician Decision|12|||
124973832|NCT03845140|449531639|FG000|Overall Study|Participant travelled outside study area|0|||
124973833|NCT03845140|449531640|FG001|Overall Study|Participant travelled outside study area|1|||
124973834|NCT03845140|449531641|FG002|Overall Study|Participant travelled outside study area|0|||
124973835|NCT03845140|449531642|FG003|Overall Study|Participant travelled outside study area|0|||
124973836|NCT03845140|449531643|FG004|Overall Study|Participant travelled outside study area|0|||
124973837|NCT03845140|449531644|FG005|Overall Study|Participant travelled outside study area|0|||
124973838|NCT03054337|449531645|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
124973839|NCT03054337|449531646|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
124973840|NCT03054337|449531647|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
124973841|NCT03054337|449531648|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
124973842|NCT03054337|449531649|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
124973843|NCT03054337|449531650|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
124973844|NCT01681992|449531653|FG000|Overall Study|Adverse Event|3|||
124973845|NCT01681992|449531654|FG001|Overall Study|Adverse Event|2|||
124973846|NCT01681992|449531655|FG002|Overall Study|Adverse Event|3|||
124973847|NCT01681992|449531653|FG000|Overall Study|Lost to Follow-up|36|||
124973848|NCT01681992|449531654|FG001|Overall Study|Lost to Follow-up|38|||
124973849|NCT01681992|449531655|FG002|Overall Study|Lost to Follow-up|53|||
124973850|NCT01681992|449531653|FG000|Overall Study|As Per Sponsor Decision|0|||
124973851|NCT01681992|449531654|FG001|Overall Study|As Per Sponsor Decision|0|||
124973852|NCT01681992|449531655|FG002|Overall Study|As Per Sponsor Decision|1|||
124973853|NCT01681992|449531653|FG000|Overall Study|Protocol Violation|0|||
124973854|NCT01681992|449531654|FG001|Overall Study|Protocol Violation|0|||
124973855|NCT01681992|449531655|FG002|Overall Study|Protocol Violation|1|||
124973856|NCT01681992|449531653|FG000|Overall Study|Withdrawal by Subject|27|||
124973857|NCT01681992|449531654|FG001|Overall Study|Withdrawal by Subject|30|||
124973858|NCT01681992|449531655|FG002|Overall Study|Withdrawal by Subject|25|||
124973859|NCT01327612|449531656|FG000|Overall Study|Withdrawal by Subject|0|||
124973860|NCT01327612|449531657|FG001|Overall Study|Withdrawal by Subject|0|||
124973861|NCT01327612|449531658|FG002|Overall Study|Withdrawal by Subject|0|||
124973862|NCT01327612|449531659|FG003|Overall Study|Withdrawal by Subject|0|||
124973863|NCT01327612|449531660|FG004|Overall Study|Withdrawal by Subject|0|||
124973864|NCT01327612|449531661|FG005|Overall Study|Withdrawal by Subject|1|||
124973865|NCT01327612|449531662|FG006|Overall Study|Withdrawal by Subject|0|||
124973866|NCT01327612|449531656|FG000|Overall Study|Disease Progression|1|||
124973867|NCT01327612|449531657|FG001|Overall Study|Disease Progression|1|||
124973868|NCT01327612|449531658|FG002|Overall Study|Disease Progression|1|||
124973869|NCT01327612|449531659|FG003|Overall Study|Disease Progression|0|||
124973870|NCT01327612|449531660|FG004|Overall Study|Disease Progression|1|||
124973871|NCT01327612|449531661|FG005|Overall Study|Disease Progression|2|||
124973872|NCT01327612|449531662|FG006|Overall Study|Disease Progression|2|||
124973873|NCT01327612|449531656|FG000|Overall Study|Administrative Decision|0|||
124973874|NCT01327612|449531657|FG001|Overall Study|Administrative Decision|0|||
124973875|NCT01327612|449531658|FG002|Overall Study|Administrative Decision|0|||
124973876|NCT01327612|449531659|FG003|Overall Study|Administrative Decision|1|||
124973877|NCT01327612|449531660|FG004|Overall Study|Administrative Decision|0|||
124973878|NCT01327612|449531661|FG005|Overall Study|Administrative Decision|0|||
124973879|NCT01327612|449531662|FG006|Overall Study|Administrative Decision|0|||
124973880|NCT01327612|449531656|FG000|Overall Study|Death|0|||
124973881|NCT01327612|449531657|FG001|Overall Study|Death|0|||
124973882|NCT01327612|449531658|FG002|Overall Study|Death|0|||
124973883|NCT01327612|449531659|FG003|Overall Study|Death|0|||
124973884|NCT01327612|449531660|FG004|Overall Study|Death|1|||
124973885|NCT01327612|449531661|FG005|Overall Study|Death|0|||
124973886|NCT01327612|449531662|FG006|Overall Study|Death|0|||
124973887|NCT01967069|449531668|FG000|Overall Study|Adverse Event|2|||
124973888|NCT01967069|449531669|FG001|Overall Study|Adverse Event|2|||
124973889|NCT01967069|449531668|FG000|Overall Study|Lost to Follow-up|5|||
124973890|NCT01967069|449531669|FG001|Overall Study|Lost to Follow-up|2|||
124973891|NCT01967069|449531668|FG000|Overall Study|Withdrawal by Subject|1|||
124973892|NCT01967069|449531669|FG001|Overall Study|Withdrawal by Subject|3|||
124973893|NCT01967069|449531668|FG000|Overall Study|Lack of Efficacy|0|||
124973894|NCT01967069|449531669|FG001|Overall Study|Lack of Efficacy|1|||
124973895|NCT01661205|449531672|FG000|Overall Study|Physician Decision|2|||
124973896|NCT05569421|449531677|FG000|Overall Study|Withdrawal by Subject|1|||
125037907|NCT00929240|449757937|FG001|Maintenance Phase|Disease progression|73|||
125037908|NCT00929240|449757938|FG002|Maintenance Phase|Disease progression|60|||
125037909|NCT00929240|449757936|FG000|Maintenance Phase|Adverse Event|0|||
125037910|NCT00929240|449757937|FG001|Maintenance Phase|Adverse Event|9|||
125037911|NCT00929240|449757938|FG002|Maintenance Phase|Adverse Event|12|||
125037912|NCT00929240|449757936|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125037913|NCT00929240|449757937|FG001|Maintenance Phase|Withdrawal by Subject|2|||
125037914|NCT00929240|449757938|FG002|Maintenance Phase|Withdrawal by Subject|6|||
125037915|NCT00929240|449757936|FG000|Maintenance Phase|Protocol Violation|0|||
125037916|NCT00929240|449757937|FG001|Maintenance Phase|Protocol Violation|1|||
125037917|NCT00929240|449757938|FG002|Maintenance Phase|Protocol Violation|0|||
125037918|NCT00929240|449757936|FG000|Maintenance Phase|Health authority/Study termination|0|||
125037919|NCT00929240|449757937|FG001|Maintenance Phase|Health authority/Study termination|1|||
125037920|NCT00929240|449757938|FG002|Maintenance Phase|Health authority/Study termination|2|||
125037921|NCT00929240|449757936|FG000|Maintenance Phase|Physician Decision|0|||
125037922|NCT00929240|449757937|FG001|Maintenance Phase|Physician Decision|2|||
125037923|NCT00929240|449757938|FG002|Maintenance Phase|Physician Decision|1|||
125037924|NCT00929240|449757936|FG000|Maintenance Phase|Change of treatment|0|||
125037925|NCT00929240|449757937|FG001|Maintenance Phase|Change of treatment|4|||
125037926|NCT00929240|449757938|FG002|Maintenance Phase|Change of treatment|0|||
125037927|NCT00929240|449757936|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
125037928|NCT00929240|449757937|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
125037929|NCT00929240|449757938|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
125037930|NCT00929240|449757936|FG000|Maintenance Phase|Participant not treated|0|||
125037931|NCT00929240|449757937|FG001|Maintenance Phase|Participant not treated|2|||
125037932|NCT00929240|449757938|FG002|Maintenance Phase|Participant not treated|0|||
125037933|NCT02371629|449757939|FG000|Overall Study|Patient decision|14|||
125037934|NCT02371629|449757940|FG001|Overall Study|Patient decision|10|||
125037935|NCT02371629|449757939|FG000|Overall Study|Adverse Event|8|||
125037936|NCT02371629|449757940|FG001|Overall Study|Adverse Event|8|||
125037937|NCT02371629|449757939|FG000|Overall Study|Physician Decision|2|||
125037938|NCT02371629|449757940|FG001|Overall Study|Physician Decision|3|||
125037939|NCT02371629|449757939|FG000|Overall Study|Death|1|||
125037940|NCT02371629|449757940|FG001|Overall Study|Death|1|||
124973897|NCT05569421|449531678|FG001|Overall Study|Withdrawal by Subject|0|||
125133990|NCT00795821|450115509|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
125133991|NCT00795821|450115510|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
125133992|NCT00795821|450115509|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
125133993|NCT00795821|450115510|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
125133994|NCT00795821|450115509|FG000|Acute Treatment Phase|Physician Decision|1|||
125133995|NCT00795821|450115510|FG001|Acute Treatment Phase|Physician Decision|1|||
125133996|NCT00795821|450115509|FG000|Acute Treatment Phase|Protocol Violation|1|||
125133997|NCT00795821|450115510|FG001|Acute Treatment Phase|Protocol Violation|2|||
125133998|NCT00795821|450115509|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
125133999|NCT00795821|450115510|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
125134000|NCT00795821|450115509|FG000|Long-term Extension Phase|Adverse Event|25|||
125134001|NCT00795821|450115510|FG001|Long-term Extension Phase|Adverse Event|32|||
124973898|NCT05569421|449531679|FG002|Overall Study|Withdrawal by Subject|0|||
124973899|NCT03111095|449531680|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
124973900|NCT03111095|449531681|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
124973901|NCT03111095|449531680|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
124973902|NCT03111095|449531681|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
124973903|NCT00504075|449531682|FG000|Overall Study|Adverse Event|1|||
124973904|NCT00504075|449531682|FG000|Overall Study|Lost to Follow-up|5|||
124973905|NCT00504075|449531682|FG000|Overall Study|Withdrawal by Subject|1|||
124973906|NCT00504075|449531682|FG000|Overall Study|Required other therapeutic intervention|1|||
124973907|NCT03106753|449531686|FG000|Overall Study|Withdrawal by Subject|0|||
124973908|NCT03106753|449531687|FG001|Overall Study|Withdrawal by Subject|1|||
124973909|NCT04245345|449531690|FG000|Overall Study|Death|1|||
124973910|NCT04245345|449531690|FG000|Overall Study|Exited prior to implant|5|||
124973911|NCT04245345|449531690|FG000|Overall Study|Exited prior to 1-month|9|||
124973912|NCT04245345|449531690|FG000|Overall Study|Missed 1-month visit|3|||
124973913|NCT04245345|449531690|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
124973914|NCT04245345|449531690|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
124973915|NCT02609672|449531693|FG000|Overall Study|Lost to Follow-up|3|||
124973916|NCT02609672|449531694|FG001|Overall Study|Lost to Follow-up|1|||
124973917|NCT03392168|449531695|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
124973918|NCT03392168|449531696|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
124973919|NCT03392168|449531697|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
124973920|NCT03392168|449531698|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
124973921|NCT03392168|449531695|FG000|Period 2: Cohort 2|Other|0|||
124973922|NCT03392168|449531696|FG001|Period 2: Cohort 2|Other|1|||
124973923|NCT03392168|449531697|FG002|Period 2: Cohort 2|Other|0|||
124973924|NCT03392168|449531698|FG003|Period 2: Cohort 2|Other|0|||
124973925|NCT00401258|449531699|FG000|Overall Study|Adverse Event|7|||
124973926|NCT00844597|449531700|FG000|Overall Study|Adverse Event|0|||
124973927|NCT00844597|449531701|FG001|Overall Study|Adverse Event|0|||
124973928|NCT00844597|449531702|FG002|Overall Study|Adverse Event|0|||
124973929|NCT00844597|449531703|FG003|Overall Study|Adverse Event|1|||
124973930|NCT00844597|449531704|FG004|Overall Study|Adverse Event|0|||
124973931|NCT00844597|449531705|FG005|Overall Study|Adverse Event|0|||
124973932|NCT04160988|449531706|FG000|Overall Study|poor image quality|28|||
124973933|NCT02670122|449531707|FG000|Overall Study|Lost to Follow-up|4|||
124973934|NCT02762903|449531709|FG000|Overall Study|Lost to Follow-up|0|||
124973935|NCT02762903|449531710|FG001|Overall Study|Lost to Follow-up|1|||
124973936|NCT00243074|449531711|FG000|Overall Study|Ineligible|6|||
124973937|NCT00243074|449531711|FG000|Overall Study|Adverse Event|6|||
124973938|NCT00243074|449531711|FG000|Overall Study|Withdrawal by Subject|2|||
124973939|NCT00243074|449531711|FG000|Overall Study|Lack of Efficacy|36|||
124973940|NCT00243074|449531711|FG000|Overall Study|Death|2|||
124973941|NCT00243074|449531711|FG000|Overall Study|not protocol specified|1|||
124973942|NCT00243074|449531711|FG000|Overall Study|Did not receive any treatment|1|||
124973943|NCT00664534|449531712|FG000|Overall Study|Adverse Event|2|||
124973944|NCT00664534|449531713|FG001|Overall Study|Adverse Event|3|||
124973945|NCT00664534|449531712|FG000|Overall Study|Lost to Follow-up|6|||
124973946|NCT00664534|449531713|FG001|Overall Study|Lost to Follow-up|10|||
124973947|NCT00664534|449531712|FG000|Overall Study|Protocol Violation|10|||
124973948|NCT00664534|449531713|FG001|Overall Study|Protocol Violation|8|||
124973949|NCT00664534|449531712|FG000|Overall Study|Withdrawal by Subject|7|||
124973950|NCT00664534|449531713|FG001|Overall Study|Withdrawal by Subject|6|||
124973951|NCT00664534|449531712|FG000|Overall Study|Physician Decision|8|||
124973952|NCT00664534|449531713|FG001|Overall Study|Physician Decision|0|||
124973953|NCT00664534|449531712|FG000|Overall Study|Sponsor decision|8|||
124973954|NCT00664534|449531713|FG001|Overall Study|Sponsor decision|6|||
124973955|NCT03041792|449531714|FG000|Overall Study|Adverse Event|4|||
124973956|NCT03041792|449531715|FG001|Overall Study|Adverse Event|0|||
124973957|NCT03041792|449531714|FG000|Overall Study|Death in the family|0|||
124973958|NCT03041792|449531715|FG001|Overall Study|Death in the family|2|||
124973959|NCT03041792|449531714|FG000|Overall Study|Randomized but not treated|0|||
124973960|NCT03041792|449531715|FG001|Overall Study|Randomized but not treated|1|||
124973961|NCT04978090|449531716|FG000|Overall Study|unable to adequately fit device|2|||
125134002|NCT00795821|450115509|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
125134003|NCT00795821|450115510|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
125134004|NCT00795821|450115509|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
125134005|NCT00795821|450115510|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
125134006|NCT00795821|450115509|FG000|Long-term Extension Phase|Physician Decision|1|||
125134007|NCT00795821|450115510|FG001|Long-term Extension Phase|Physician Decision|2|||
125134008|NCT00795821|450115509|FG000|Long-term Extension Phase|Protocol Violation|3|||
125134009|NCT00795821|450115510|FG001|Long-term Extension Phase|Protocol Violation|5|||
125134010|NCT00795821|450115509|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
125134011|NCT00795821|450115510|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
125134012|NCT00795821|450115509|FG000|Taper Phase|Adverse Event|2|||
125134013|NCT00795821|450115510|FG001|Taper Phase|Adverse Event|0|||
125134014|NCT00795821|450115509|FG000|Taper Phase|Lost to Follow-up|1|||
125134015|NCT00795821|450115510|FG001|Taper Phase|Lost to Follow-up|0|||
125134016|NCT00795821|450115509|FG000|Taper Phase|Physician Decision|2|||
125134017|NCT00795821|450115510|FG001|Taper Phase|Physician Decision|0|||
125134018|NCT00795821|450115509|FG000|Taper Phase|Withdrawal by Subject|4|||
125134019|NCT00795821|450115510|FG001|Taper Phase|Withdrawal by Subject|0|||
125134020|NCT02301975|450115519|FG000|Overall Study|Adverse Event|8|||
125134021|NCT02301975|450115520|FG001|Overall Study|Adverse Event|3|||
124973962|NCT03075527|449531719|FG000|Overall Study|Death|1|||
124973963|NCT03075527|449531719|FG000|Overall Study|Withdrawal by Subject|1|||
124973964|NCT03075527|449531719|FG000|Overall Study|Physician Decision|3|||
124973965|NCT03075527|449531719|FG000|Overall Study|Progression/Relapse|14|||
124973966|NCT06926673|449531720|FG000|Overall Study|Lost to Follow-up|0|||
124973967|NCT06926673|449531721|FG001|Overall Study|Lost to Follow-up|0|||
124973968|NCT06926673|449531722|FG002|Overall Study|Lost to Follow-up|0|||
124973969|NCT06926673|449531723|FG003|Overall Study|Lost to Follow-up|1|||
124973970|NCT06926673|449531724|FG004|Overall Study|Lost to Follow-up|0|||
124973971|NCT06926673|449531725|FG005|Overall Study|Lost to Follow-up|0|||
124973972|NCT06926673|449531726|FG006|Overall Study|Lost to Follow-up|0|||
124973973|NCT06926673|449531720|FG000|Overall Study|Physician Decision|0|||
124973974|NCT06926673|449531721|FG001|Overall Study|Physician Decision|0|||
124973975|NCT06926673|449531722|FG002|Overall Study|Physician Decision|0|||
124973976|NCT06926673|449531723|FG003|Overall Study|Physician Decision|0|||
124973977|NCT06926673|449531724|FG004|Overall Study|Physician Decision|0|||
124973978|NCT06926673|449531725|FG005|Overall Study|Physician Decision|0|||
124973979|NCT06926673|449531726|FG006|Overall Study|Physician Decision|1|||
124973980|NCT06926673|449531720|FG000|Overall Study|Withdrawal by Subject|0|||
124973981|NCT06926673|449531721|FG001|Overall Study|Withdrawal by Subject|3|||
124973982|NCT06926673|449531722|FG002|Overall Study|Withdrawal by Subject|2|||
124973983|NCT06926673|449531723|FG003|Overall Study|Withdrawal by Subject|1|||
124973984|NCT06926673|449531724|FG004|Overall Study|Withdrawal by Subject|0|||
124973985|NCT06926673|449531725|FG005|Overall Study|Withdrawal by Subject|2|||
124973986|NCT06926673|449531726|FG006|Overall Study|Withdrawal by Subject|0|||
124973987|NCT02358668|449534377|FG000|Overall Study|Adverse Event|2|||
124973988|NCT02358668|449534378|FG001|Overall Study|Adverse Event|0|||
124973989|NCT02358668|449534379|FG002|Overall Study|Adverse Event|0|||
124973990|NCT02358668|449534377|FG000|Overall Study|Withdrawal by Subject|0|||
124973991|NCT02358668|449534378|FG001|Overall Study|Withdrawal by Subject|1|||
124973992|NCT02358668|449534379|FG002|Overall Study|Withdrawal by Subject|0|||
124973993|NCT04057573|449534380|FG000|24-Week Double-Blind Period|Adverse Event|2|||
124973994|NCT04057573|449534381|FG001|24-Week Double-Blind Period|Adverse Event|0|||
124973995|NCT04057573|449534382|FG002|24-Week Double-Blind Period|Adverse Event|0|||
124973996|NCT04057573|449534383|FG003|24-Week Double-Blind Period|Adverse Event|0|||
124973997|NCT04057573|449534380|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
124973998|NCT04057573|449534381|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
124973999|NCT04057573|449534382|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
124974000|NCT04057573|449534383|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
124974001|NCT04057573|449534380|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
124974002|NCT04057573|449534381|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
124974003|NCT04057573|449534382|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
124974004|NCT04057573|449534383|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
124974005|NCT04057573|449534380|FG000|24-Week Double-Blind Period|Physician Decision|1|||
124974006|NCT04057573|449534381|FG001|24-Week Double-Blind Period|Physician Decision|0|||
124974007|NCT04057573|449534382|FG002|24-Week Double-Blind Period|Physician Decision|0|||
124974008|NCT04057573|449534383|FG003|24-Week Double-Blind Period|Physician Decision|0|||
124974009|NCT04057573|449534380|FG000|24-Week Double-Blind Period|Pregnancy|1|||
124974010|NCT04057573|449534381|FG001|24-Week Double-Blind Period|Pregnancy|0|||
125134022|NCT02301975|450115521|FG002|Overall Study|Adverse Event|2|||
125134023|NCT02301975|450115519|FG000|Overall Study|Lack of Efficacy|1|||
125134024|NCT02301975|450115520|FG001|Overall Study|Lack of Efficacy|1|||
125134025|NCT02301975|450115521|FG002|Overall Study|Lack of Efficacy|1|||
125134026|NCT02301975|450115519|FG000|Overall Study|Protocol Violation|3|||
125134027|NCT02301975|450115520|FG001|Overall Study|Protocol Violation|5|||
124974011|NCT04057573|449534382|FG002|24-Week Double-Blind Period|Pregnancy|0|||
125037941|NCT02371629|449757939|FG000|Overall Study|Noncompliance with study treatment|1|||
125037942|NCT02371629|449757940|FG001|Overall Study|Noncompliance with study treatment|0|||
125037943|NCT02371629|449757939|FG000|Overall Study|Lack of Efficacy|0|||
125037944|NCT02371629|449757940|FG001|Overall Study|Lack of Efficacy|2|||
125037945|NCT02371629|449757939|FG000|Overall Study|Protocol deviation|0|||
125037946|NCT02371629|449757940|FG001|Overall Study|Protocol deviation|1|||
125037947|NCT00805207|449757941|FG000|Overall Study|Protocol Violation|0|||
125037948|NCT00805207|449757942|FG001|Overall Study|Protocol Violation|0|||
125037949|NCT00805207|449757943|FG002|Overall Study|Protocol Violation|1|||
125037950|NCT00805207|449757944|FG003|Overall Study|Protocol Violation|0|||
125037951|NCT00805207|449757945|FG004|Overall Study|Protocol Violation|0|||
125037952|NCT00805207|449757946|FG005|Overall Study|Protocol Violation|0|||
125037953|NCT00805207|449757947|FG006|Overall Study|Protocol Violation|0|||
125037954|NCT00805207|449757948|FG007|Overall Study|Protocol Violation|0|||
125037955|NCT00805207|449757949|FG008|Overall Study|Protocol Violation|0|||
125037956|NCT00805207|449757941|FG000|Overall Study|Physician Decision|0|||
125037957|NCT00805207|449757942|FG001|Overall Study|Physician Decision|1|||
125037958|NCT00805207|449757943|FG002|Overall Study|Physician Decision|0|||
125037959|NCT00805207|449757944|FG003|Overall Study|Physician Decision|0|||
125037960|NCT00805207|449757945|FG004|Overall Study|Physician Decision|0|||
125037961|NCT00805207|449757946|FG005|Overall Study|Physician Decision|1|||
125037962|NCT00805207|449757947|FG006|Overall Study|Physician Decision|0|||
125037963|NCT00805207|449757948|FG007|Overall Study|Physician Decision|0|||
125037964|NCT00805207|449757949|FG008|Overall Study|Physician Decision|0|||
125037965|NCT00805207|449757941|FG000|Overall Study|Withdrawal by Subject|0|||
125037966|NCT00805207|449757942|FG001|Overall Study|Withdrawal by Subject|1|||
125037967|NCT00805207|449757943|FG002|Overall Study|Withdrawal by Subject|0|||
125037968|NCT00805207|449757944|FG003|Overall Study|Withdrawal by Subject|0|||
125037969|NCT00805207|449757945|FG004|Overall Study|Withdrawal by Subject|1|||
125037970|NCT00805207|449757946|FG005|Overall Study|Withdrawal by Subject|2|||
125037971|NCT00805207|449757947|FG006|Overall Study|Withdrawal by Subject|0|||
125037972|NCT00805207|449757948|FG007|Overall Study|Withdrawal by Subject|0|||
125037973|NCT00805207|449757949|FG008|Overall Study|Withdrawal by Subject|0|||
125037974|NCT02469246|449757950|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
125037975|NCT02469246|449757951|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
125037976|NCT02469246|449757950|FG000|Double-Blind Phase|Adverse Event|12|||
125037977|NCT02469246|449757951|FG001|Double-Blind Phase|Adverse Event|9|||
125037978|NCT02469246|449757950|FG000|Double-Blind Phase|Death|2|||
125037979|NCT02469246|449757951|FG001|Double-Blind Phase|Death|0|||
125037980|NCT02469246|449757950|FG000|Double-Blind Phase|Lack of Efficacy|2|||
125037981|NCT02469246|449757951|FG001|Double-Blind Phase|Lack of Efficacy|1|||
125037982|NCT02469246|449757950|FG000|Double-Blind Phase|Investigator's Discretion|8|||
125037983|NCT02469246|449757951|FG001|Double-Blind Phase|Investigator's Discretion|8|||
125037984|NCT02469246|449757950|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
125037985|NCT02469246|449757951|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
125037986|NCT02469246|449757950|FG000|Double-Blind Phase|Protocol Violation|1|||
125037987|NCT02469246|449757951|FG001|Double-Blind Phase|Protocol Violation|1|||
125037988|NCT02469246|449757950|FG000|Double-Blind Phase|Withdrew Consent|25|||
125037989|NCT02469246|449757951|FG001|Double-Blind Phase|Withdrew Consent|25|||
125037990|NCT02469246|449757950|FG000|Double-Blind Phase|Lost to Follow-up|9|||
125037991|NCT02469246|449757951|FG001|Double-Blind Phase|Lost to Follow-up|5|||
125037992|NCT05681715|449757955|FG000|Training Period (6-weeks)|Adverse Event|3|||
125037993|NCT05681715|449757956|FG001|Training Period (6-weeks)|Adverse Event|0|||
125037994|NCT05681715|449757957|FG002|Training Period (6-weeks)|Adverse Event|0|||
125037995|NCT05681715|449757955|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
125037996|NCT05681715|449757956|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
125037997|NCT05681715|449757957|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
125037998|NCT05681715|449757955|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
125037999|NCT05681715|449757956|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
125038000|NCT05681715|449757957|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
125038001|NCT05681715|449757955|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
125038002|NCT05681715|449757956|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
125038003|NCT05681715|449757957|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
125038004|NCT05681715|449757955|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
125038005|NCT05681715|449757956|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
125038006|NCT05681715|449757957|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
125038007|NCT05681715|449757955|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
125038008|NCT05681715|449757956|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
125038009|NCT05681715|449757957|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
125134028|NCT02301975|450115521|FG002|Overall Study|Protocol Violation|3|||
125134029|NCT02301975|450115519|FG000|Overall Study|Lost to Follow-up|0|||
125134030|NCT02301975|450115520|FG001|Overall Study|Lost to Follow-up|2|||
125038010|NCT05681715|449757955|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
125038011|NCT05681715|449757956|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
125038012|NCT05681715|449757957|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
125038013|NCT05681715|449757955|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
125038014|NCT05681715|449757956|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
125038015|NCT05681715|449757957|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
125038016|NCT05564052|449757958|FG000|Overall Study|Withdrawal by Subject|0|||
125038017|NCT05564052|449757959|FG001|Overall Study|Withdrawal by Subject|0|||
125038018|NCT05564052|449757960|FG002|Overall Study|Withdrawal by Subject|0|||
125038019|NCT05564052|449757961|FG003|Overall Study|Withdrawal by Subject|1|||
125038020|NCT05564052|449757958|FG000|Overall Study|Ongoing|8|||
125038021|NCT05564052|449757959|FG001|Overall Study|Ongoing|5|||
125038022|NCT05564052|449757960|FG002|Overall Study|Ongoing|4|||
125038023|NCT05564052|449757961|FG003|Overall Study|Ongoing|1|||
125038024|NCT04325503|449758001|FG000|Overall Study|Withdrawal by Subject|1|||
125134031|NCT02301975|450115521|FG002|Overall Study|Lost to Follow-up|2|||
125134032|NCT02301975|450115519|FG000|Overall Study|Physician Decision|4|||
125134033|NCT02301975|450115520|FG001|Overall Study|Physician Decision|2|||
125134034|NCT02301975|450115521|FG002|Overall Study|Physician Decision|3|||
125134035|NCT02301975|450115519|FG000|Overall Study|Withdrawal by Subject|15|||
125134036|NCT02301975|450115520|FG001|Overall Study|Withdrawal by Subject|12|||
125134037|NCT02301975|450115521|FG002|Overall Study|Withdrawal by Subject|11|||
125134038|NCT01440803|450115522|FG000|Overall Study|Met study stopping rule|2|||
125134039|NCT01440803|450115523|FG001|Overall Study|Met study stopping rule|1|||
125134040|NCT01440803|450115522|FG000|Overall Study|Lost to Follow-up|0|||
125134041|NCT01440803|450115523|FG001|Overall Study|Lost to Follow-up|2|||
125134042|NCT01440803|450115522|FG000|Overall Study|Withdrawal by Subject|0|||
125134043|NCT01440803|450115523|FG001|Overall Study|Withdrawal by Subject|1|||
125134044|NCT01609257|450115526|FG000|Overall Study|Lost to Follow-up|2|||
125134045|NCT01609257|450115527|FG001|Overall Study|Lost to Follow-up|1|||
125134046|NCT01609257|450115526|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
125134047|NCT01609257|450115527|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
125134048|NCT01609257|450115526|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
125134049|NCT01609257|450115527|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
125134050|NCT02125461|450115528|FG000|Overall Study|Withdrawal by Subject|30|||
125134051|NCT02125461|450115529|FG001|Overall Study|Withdrawal by Subject|16|||
125134052|NCT02125461|450115528|FG000|Overall Study|Lost to Follow-up|8|||
125134053|NCT02125461|450115529|FG001|Overall Study|Lost to Follow-up|3|||
125134054|NCT02125461|450115528|FG000|Overall Study|Death|260|||
125134055|NCT02125461|450115529|FG001|Overall Study|Death|149|||
125218490|NCT00436826|450427346|FG000|Double Blind Period (DBP)|Adverse Event|2|||
125218491|NCT00436826|450427347|FG001|Double Blind Period (DBP)|Adverse Event|0|||
124974012|NCT04057573|449534383|FG003|24-Week Double-Blind Period|Pregnancy|0|||
124974013|NCT04057573|449534380|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
124974014|NCT04057573|449534381|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
124974015|NCT04057573|449534382|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
124974016|NCT04057573|449534383|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
124974017|NCT04057573|449534380|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
124974018|NCT04057573|449534381|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
124974019|NCT04057573|449534382|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
124974020|NCT04057573|449534383|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
124974021|NCT04057573|449534380|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
124974022|NCT04057573|449534381|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
124974023|NCT04057573|449534382|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
124974024|NCT04057573|449534383|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
124974025|NCT04057573|449534380|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
124974026|NCT04057573|449534381|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
124974027|NCT04057573|449534382|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
124974028|NCT04057573|449534383|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
124974029|NCT04057573|449534380|FG000|24-Week Double-Blind Period|Not Treated|1|||
124974030|NCT04057573|449534381|FG001|24-Week Double-Blind Period|Not Treated|0|||
124974031|NCT04057573|449534382|FG002|24-Week Double-Blind Period|Not Treated|0|||
124974032|NCT04057573|449534383|FG003|24-Week Double-Blind Period|Not Treated|0|||
124974033|NCT04057573|449534380|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
125134056|NCT02125461|450115528|FG000|Overall Study|Missing Termination Reason|0|||
125134057|NCT02125461|450115529|FG001|Overall Study|Missing Termination Reason|1|||
125134058|NCT03049748|450115530|FG000|Overall Study|Lost to Follow-up|1|||
125134059|NCT03049748|450115531|FG001|Overall Study|Lost to Follow-up|0|||
125218492|NCT00436826|450427348|FG002|Double Blind Period (DBP)|Adverse Event|0|||
125218493|NCT00436826|450427349|FG003|Double Blind Period (DBP)|Adverse Event|0|||
125134060|NCT03049748|450115530|FG000|Overall Study|Death|3|||
125134061|NCT03049748|450115531|FG001|Overall Study|Death|0|||
125134062|NCT03049748|450115530|FG000|Overall Study|Withdrawal by Subject|0|||
125134063|NCT03049748|450115531|FG001|Overall Study|Withdrawal by Subject|3|||
125134064|NCT03049748|450115530|FG000|Overall Study|Protocol Violation|0|||
125134065|NCT03049748|450115531|FG001|Overall Study|Protocol Violation|2|||
125134066|NCT03049748|450115530|FG000|Overall Study|Moved out of state (relocation)|0|||
125134067|NCT03049748|450115531|FG001|Overall Study|Moved out of state (relocation)|1|||
125134068|NCT04994535|450115535|FG000|Overall Study|Lost to Follow-up|7|||
125134069|NCT04994535|450115536|FG001|Overall Study|Lost to Follow-up|7|||
125134070|NCT04994535|450115535|FG000|Overall Study|Withdrawal by Subject|10|||
124974034|NCT04057573|449534381|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
124974035|NCT04057573|449534382|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
124974036|NCT04057573|449534383|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
124974037|NCT04057573|449534380|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
124974038|NCT04057573|449534381|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
124974039|NCT04057573|449534382|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
124974040|NCT04057573|449534383|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
124974041|NCT04057573|449534380|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
124974042|NCT04057573|449534381|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
124974043|NCT04057573|449534382|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
124974044|NCT04057573|449534383|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
124974045|NCT04057573|449534380|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
124974046|NCT04057573|449534381|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
124974047|NCT04057573|449534382|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
124974048|NCT04057573|449534383|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
124974049|NCT04057573|449534380|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
124974050|NCT04057573|449534381|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
124974051|NCT04057573|449534382|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
124974052|NCT04057573|449534383|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
124974053|NCT01317875|449534386|FG000|Overall Study|Other|0|||
124974054|NCT01317875|449534387|FG001|Overall Study|Other|0|||
124974055|NCT01317875|449534388|FG002|Overall Study|Other|1|||
124974056|NCT01317875|449534389|FG003|Overall Study|Other|0|||
124974057|NCT01317875|449534390|FG004|Overall Study|Other|0|||
124974058|NCT01317875|449534391|FG005|Overall Study|Other|0|||
124974059|NCT01317875|449534392|FG006|Overall Study|Other|0|||
124974060|NCT01317875|449534393|FG007|Overall Study|Other|0|||
124974061|NCT01317875|449534394|FG008|Overall Study|Other|0|||
124974062|NCT01317875|449534395|FG009|Overall Study|Other|0|||
124974063|NCT01317875|449534386|FG000|Overall Study|Noncompliance with study drug|0|||
124974064|NCT01317875|449534387|FG001|Overall Study|Noncompliance with study drug|0|||
124974065|NCT01317875|449534388|FG002|Overall Study|Noncompliance with study drug|1|||
124974066|NCT01317875|449534389|FG003|Overall Study|Noncompliance with study drug|0|||
124974067|NCT01317875|449534390|FG004|Overall Study|Noncompliance with study drug|0|||
124974068|NCT01317875|449534391|FG005|Overall Study|Noncompliance with study drug|0|||
124974069|NCT01317875|449534392|FG006|Overall Study|Noncompliance with study drug|0|||
124974070|NCT01317875|449534393|FG007|Overall Study|Noncompliance with study drug|0|||
124974071|NCT01317875|449534394|FG008|Overall Study|Noncompliance with study drug|0|||
124974072|NCT01317875|449534395|FG009|Overall Study|Noncompliance with study drug|0|||
124974073|NCT01317875|449534386|FG000|Overall Study|Progressive Disease|1|||
124974074|NCT01317875|449534387|FG001|Overall Study|Progressive Disease|0|||
124974075|NCT01317875|449534388|FG002|Overall Study|Progressive Disease|2|||
124974076|NCT01317875|449534389|FG003|Overall Study|Progressive Disease|0|||
124974077|NCT01317875|449534390|FG004|Overall Study|Progressive Disease|1|||
124974078|NCT01317875|449534391|FG005|Overall Study|Progressive Disease|0|||
124974079|NCT01317875|449534392|FG006|Overall Study|Progressive Disease|0|||
124974080|NCT01317875|449534393|FG007|Overall Study|Progressive Disease|1|||
124974081|NCT01317875|449534394|FG008|Overall Study|Progressive Disease|0|||
124974082|NCT01317875|449534395|FG009|Overall Study|Progressive Disease|0|||
125134071|NCT04994535|450115536|FG001|Overall Study|Withdrawal by Subject|7|||
125134072|NCT04994535|450115535|FG000|Overall Study|Other|1|||
125134073|NCT04994535|450115536|FG001|Overall Study|Other|1|||
124974083|NCT01317875|449534386|FG000|Overall Study|Withdrawal by Subject|0|||
125134074|NCT01158118|450115537|FG000|Overall Study|Screen failure|1|||
125134075|NCT01158118|450115538|FG001|Overall Study|Screen failure|0|||
125134076|NCT01158118|450115537|FG000|Overall Study|Donor match was a screen failure|0|||
124974084|NCT01317875|449534387|FG001|Overall Study|Withdrawal by Subject|0|||
124974085|NCT01317875|449534388|FG002|Overall Study|Withdrawal by Subject|0|||
124974086|NCT01317875|449534389|FG003|Overall Study|Withdrawal by Subject|0|||
124974087|NCT01317875|449534390|FG004|Overall Study|Withdrawal by Subject|1|||
125134077|NCT01158118|450115538|FG001|Overall Study|Donor match was a screen failure|1|||
125134078|NCT01158118|450115537|FG000|Overall Study|Suffered stroke prior to transplant|0|||
125134079|NCT01158118|450115538|FG001|Overall Study|Suffered stroke prior to transplant|1|||
125134080|NCT01158118|450115537|FG000|Overall Study|Death|0|||
125134081|NCT01158118|450115538|FG001|Overall Study|Death|1|||
125134082|NCT00604162|450115539|FG000|Overall Study|Physician Decision|3|||
125134083|NCT00604162|450115539|FG000|Overall Study|Withdrawal by Subject|1|||
125134084|NCT01015287|450115542|FG000|Overall Study|Death|21|||
125134085|NCT01015287|450115543|FG001|Overall Study|Death|16|||
125134086|NCT01015287|450115542|FG000|Overall Study|Adverse Event|1|||
125134087|NCT01015287|450115543|FG001|Overall Study|Adverse Event|0|||
125134088|NCT01015287|450115542|FG000|Overall Study|Sponsor Decision|3|||
125134089|NCT01015287|450115543|FG001|Overall Study|Sponsor Decision|7|||
125134090|NCT01015287|450115542|FG000|Overall Study|Physician Decision|19|||
125134091|NCT01015287|450115543|FG001|Overall Study|Physician Decision|21|||
125134092|NCT01015287|450115542|FG000|Overall Study|Withdrawal by Subject|14|||
125134093|NCT01015287|450115543|FG001|Overall Study|Withdrawal by Subject|19|||
125134094|NCT01015287|450115542|FG000|Overall Study|Entry Criteria not Met|11|||
125134095|NCT01015287|450115543|FG001|Overall Study|Entry Criteria not Met|14|||
125134096|NCT01015287|450115542|FG000|Overall Study|Lost to Follow-up|2|||
125134097|NCT01015287|450115543|FG001|Overall Study|Lost to Follow-up|1|||
125134098|NCT01015287|450115542|FG000|Overall Study|Protocol Violation|1|||
125134099|NCT01015287|450115543|FG001|Overall Study|Protocol Violation|1|||
125134100|NCT00905840|450115544|FG000|Overall Study|Lost to Follow-up|11|||
125134101|NCT00905840|450115544|FG000|Overall Study|Death|3|||
125134102|NCT00905840|450115544|FG000|Overall Study|Withdrawal by Subject|1|||
125134103|NCT00905840|450115544|FG000|Overall Study|Adverse Event|1|||
125134104|NCT01370317|450115545|FG000|Overall Study|Participant withdrew consent|1|||
125134105|NCT01370317|450115546|FG001|Overall Study|Participant withdrew consent|0|||
125134106|NCT01370317|450115545|FG000|Overall Study|Protocol deviation|0|||
125134107|NCT01370317|450115546|FG001|Overall Study|Protocol deviation|1|||
125134108|NCT02105272|450115554|FG000|Overall Study|Adverse Event|1|||
125134109|NCT02105272|450115555|FG001|Overall Study|Adverse Event|2|||
125134110|NCT02105272|450115554|FG000|Overall Study|Physician Decision|0|||
125218494|NCT00436826|450427350|FG004|Double Blind Period (DBP)|Adverse Event|0|||
125218495|NCT00436826|450427351|FG005|Double Blind Period (DBP)|Adverse Event|0|||
125218496|NCT00436826|450427346|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
125218497|NCT00436826|450427347|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
124974088|NCT01317875|449534391|FG005|Overall Study|Withdrawal by Subject|0|||
124974089|NCT01317875|449534392|FG006|Overall Study|Withdrawal by Subject|0|||
124974090|NCT01317875|449534393|FG007|Overall Study|Withdrawal by Subject|3|||
124974091|NCT01317875|449534394|FG008|Overall Study|Withdrawal by Subject|0|||
124974092|NCT01317875|449534395|FG009|Overall Study|Withdrawal by Subject|0|||
124974093|NCT01317875|449534386|FG000|Overall Study|Physician Decision|0|||
124974094|NCT01317875|449534387|FG001|Overall Study|Physician Decision|1|||
124974095|NCT01317875|449534388|FG002|Overall Study|Physician Decision|1|||
124974096|NCT01317875|449534389|FG003|Overall Study|Physician Decision|0|||
124974097|NCT01317875|449534390|FG004|Overall Study|Physician Decision|2|||
124974098|NCT01317875|449534391|FG005|Overall Study|Physician Decision|0|||
124974099|NCT01317875|449534392|FG006|Overall Study|Physician Decision|0|||
124974100|NCT01317875|449534393|FG007|Overall Study|Physician Decision|2|||
124974101|NCT01317875|449534394|FG008|Overall Study|Physician Decision|0|||
124974102|NCT01317875|449534395|FG009|Overall Study|Physician Decision|0|||
124974103|NCT01317875|449534386|FG000|Overall Study|Death|0|||
125134111|NCT02105272|450115555|FG001|Overall Study|Physician Decision|1|||
125134112|NCT02105272|450115554|FG000|Overall Study|Protocol Violation|2|||
125134113|NCT02105272|450115555|FG001|Overall Study|Protocol Violation|0|||
125134114|NCT02105272|450115554|FG000|Overall Study|Withdrawal by Subject|2|||
125218498|NCT00436826|450427348|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
124974104|NCT01317875|449534387|FG001|Overall Study|Death|0|||
125134115|NCT02105272|450115555|FG001|Overall Study|Withdrawal by Subject|0|||
125134116|NCT03190915|450115557|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
125134117|NCT03190915|450115557|FG000|Overall Study|Progressive Disease|3|||
125134118|NCT02964039|450115558|FG000|Overall Study|Medical reason unrelated to study participation|1|||
125134119|NCT02964039|450115559|FG001|Overall Study|Medical reason unrelated to study participation|0|||
125134120|NCT02964039|450115560|FG002|Overall Study|Medical reason unrelated to study participation|3|||
125134121|NCT02964039|450115558|FG000|Overall Study|Research shutdown due to pandemic|2|||
125218499|NCT00436826|450427349|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
124974105|NCT01317875|449534388|FG002|Overall Study|Death|2|||
124974106|NCT01317875|449534389|FG003|Overall Study|Death|1|||
124974107|NCT01317875|449534390|FG004|Overall Study|Death|0|||
125134122|NCT02964039|450115559|FG001|Overall Study|Research shutdown due to pandemic|0|||
124974108|NCT01317875|449534391|FG005|Overall Study|Death|1|||
124974109|NCT01317875|449534392|FG006|Overall Study|Death|0|||
124974110|NCT01317875|449534393|FG007|Overall Study|Death|4|||
124974111|NCT01317875|449534394|FG008|Overall Study|Death|0|||
124974112|NCT01317875|449534395|FG009|Overall Study|Death|0|||
124974113|NCT01317875|449534386|FG000|Overall Study|Adverse Event|2|||
124974114|NCT01317875|449534387|FG001|Overall Study|Adverse Event|1|||
124974115|NCT01317875|449534388|FG002|Overall Study|Adverse Event|2|||
124974116|NCT01317875|449534389|FG003|Overall Study|Adverse Event|1|||
124974117|NCT01317875|449534390|FG004|Overall Study|Adverse Event|5|||
125038025|NCT04325503|449758001|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
125038026|NCT03832387|449758002|FG000|Overall Study|Protocol Violation|2|||
125038027|NCT03832387|449758003|FG001|Overall Study|Protocol Violation|6|||
125038028|NCT03832387|449758002|FG000|Overall Study|EXCLUSION CRITERIA|3|||
125038029|NCT03832387|449758003|FG001|Overall Study|EXCLUSION CRITERIA|1|||
125038030|NCT01856114|449758004|FG000|Overall Study|Withdrawal by Subject|1|||
125038031|NCT01856114|449758005|FG001|Overall Study|Withdrawal by Subject|0|||
125038032|NCT01856114|449758004|FG000|Overall Study|Adverse Event|1|||
125038033|NCT01856114|449758005|FG001|Overall Study|Adverse Event|0|||
125038034|NCT00144170|449758006|FG000|Overall Study|Adverse Event|84|||
125038035|NCT00144170|449758007|FG001|Overall Study|Adverse Event|41|||
125038036|NCT00144170|449758006|FG000|Overall Study|Protocol Violation|23|||
125038037|NCT00144170|449758007|FG001|Overall Study|Protocol Violation|16|||
125038038|NCT00144170|449758006|FG000|Overall Study|Lost to Follow-up|5|||
125038039|NCT00144170|449758007|FG001|Overall Study|Lost to Follow-up|10|||
125038040|NCT00144170|449758006|FG000|Overall Study|Withdrawal by Subject|29|||
125038041|NCT00144170|449758007|FG001|Overall Study|Withdrawal by Subject|13|||
125038042|NCT00144170|449758006|FG000|Overall Study|Other reason not defined above|211|||
125038043|NCT00144170|449758007|FG001|Overall Study|Other reason not defined above|316|||
125038044|NCT00981526|449758008|FG000|Overall Study|Withdrawal by Subject|0|||
125038045|NCT00981526|449758009|FG001|Overall Study|Withdrawal by Subject|2|||
125038046|NCT00981526|449758008|FG000|Overall Study|Physician Decision|4|||
125038047|NCT00981526|449758009|FG001|Overall Study|Physician Decision|4|||
125038048|NCT01564784|449758010|FG000|Overall Study|Other|1|||
125038049|NCT01564784|449758011|FG001|Overall Study|Other|0|||
125038050|NCT01564784|449758010|FG000|Overall Study|Subject refused further follow-up|1|||
125038051|NCT01564784|449758011|FG001|Overall Study|Subject refused further follow-up|6|||
125038052|NCT01564784|449758010|FG000|Overall Study|Lost to Follow-up|1|||
125038053|NCT01564784|449758011|FG001|Overall Study|Lost to Follow-up|1|||
125038054|NCT01564784|449758010|FG000|Overall Study|Death|131|||
125038055|NCT01564784|449758011|FG001|Overall Study|Death|126|||
125038056|NCT05202808|449758012|FG000|Overall Study|Lost to Follow-up|3|||
125038057|NCT05202808|449758013|FG001|Overall Study|Lost to Follow-up|1|||
125038058|NCT02495948|449758014|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
125038059|NCT02495948|449758015|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
125038060|NCT02495948|449758014|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
125038061|NCT02495948|449758015|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
125038062|NCT00741819|449758017|FG000|Overall Study|Adverse Event|3|||
125038063|NCT00741819|449758017|FG000|Overall Study|Withdrawal by Subject|3|||
125038064|NCT00741819|449758017|FG000|Overall Study|Death|1|||
125038065|NCT00741819|449758017|FG000|Overall Study|Disease progression|1|||
125038066|NCT00752986|449758018|FG000|Overall Study|Withdrawal by Subject|2|||
125038067|NCT00752986|449758019|FG001|Overall Study|Withdrawal by Subject|1|||
125038068|NCT00752986|449758020|FG002|Overall Study|Withdrawal by Subject|2|||
125038069|NCT00752986|449758018|FG000|Overall Study|Protocol Violation|3|||
125038070|NCT00752986|449758019|FG001|Overall Study|Protocol Violation|0|||
125038071|NCT00752986|449758020|FG002|Overall Study|Protocol Violation|0|||
125038072|NCT02970929|449758024|FG000|Overall Study|Adverse Event|18|||
125038073|NCT02970929|449758024|FG000|Overall Study|Lack of Efficacy|8|||
125038074|NCT02970929|449758024|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
124974118|NCT01317875|449534391|FG005|Overall Study|Adverse Event|1|||
125038075|NCT02970929|449758024|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
125038076|NCT02970929|449758024|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
125038077|NCT02970929|449758024|FG000|Overall Study|LOST TO FOLLOWUP|6|||
125038078|NCT02970929|449758024|FG000|Overall Study|MOVED OUT OF STATE|1|||
125038079|NCT02970929|449758024|FG000|Overall Study|Withdrawal by Subject|16|||
125038080|NCT02370121|449758029|FG000|Overall Study|Lost to Follow-up|1|||
125038081|NCT02370121|449758030|FG001|Overall Study|Lost to Follow-up|1|||
125038082|NCT00275561|449758036|FG000|Overall Study|Withdrawal by Subject|0|||
125038083|NCT00275561|449758037|FG001|Overall Study|Withdrawal by Subject|1|||
125038084|NCT00275561|449758036|FG000|Overall Study|Travel|1|||
125038085|NCT00275561|449758037|FG001|Overall Study|Travel|1|||
125038086|NCT00275561|449758036|FG000|Overall Study|Scheduling|1|||
124974119|NCT01317875|449534392|FG006|Overall Study|Adverse Event|2|||
124974120|NCT01317875|449534393|FG007|Overall Study|Adverse Event|5|||
125134123|NCT02964039|450115560|FG002|Overall Study|Research shutdown due to pandemic|1|||
125134124|NCT02964039|450115558|FG000|Overall Study|Withdrawal by Subject|0|||
125134125|NCT02964039|450115559|FG001|Overall Study|Withdrawal by Subject|1|||
125134126|NCT02964039|450115560|FG002|Overall Study|Withdrawal by Subject|0|||
125134127|NCT02964039|450115558|FG000|Overall Study|Lost to Follow-up|1|||
125134128|NCT02964039|450115559|FG001|Overall Study|Lost to Follow-up|0|||
125134129|NCT02964039|450115560|FG002|Overall Study|Lost to Follow-up|1|||
125134130|NCT01103713|450115561|FG000|Overall Study|Lost to Follow-up|2|||
125134131|NCT01103713|450115561|FG000|Overall Study|Withdrawal by Subject|8|||
125134132|NCT01103713|450115561|FG000|Overall Study|Study terminated by sponsor|2|||
125134133|NCT01103713|450115561|FG000|Overall Study|Other|1|||
125134134|NCT03084471|450115564|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
125134135|NCT03084471|450115564|FG000|Overall Study|Condition under investigation worsened|84|||
125134136|NCT03084471|450115564|FG000|Overall Study|Lack of therapeutic response|2|||
125134137|NCT03084471|450115564|FG000|Overall Study|Protocol Violation|1|||
125134138|NCT03084471|450115564|FG000|Overall Study|Adverse Event|73|||
125134139|NCT03084471|450115564|FG000|Overall Study|Withdrawal by Subject|12|||
125134140|NCT03084471|450115564|FG000|Overall Study|Disease relapse|181|||
125134141|NCT03084471|450115564|FG000|Overall Study|Subjective disease progression|359|||
125134142|NCT03084471|450115564|FG000|Overall Study|Other (as recorded)|33|||
125134143|NCT03084471|450115564|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
125134144|NCT00505622|450115567|FG000|Overall Study|Adverse Event|5|||
125134145|NCT00505622|450115568|FG001|Overall Study|Adverse Event|6|||
125134146|NCT00505622|450115569|FG002|Overall Study|Adverse Event|4|||
125134147|NCT00505622|450115567|FG000|Overall Study|Protocol Violation|1|||
125134148|NCT00505622|450115568|FG001|Overall Study|Protocol Violation|1|||
125134149|NCT00505622|450115569|FG002|Overall Study|Protocol Violation|0|||
125134150|NCT00505622|450115567|FG000|Overall Study|Withdrawal by Subject|0|||
125134151|NCT00505622|450115568|FG001|Overall Study|Withdrawal by Subject|3|||
125134152|NCT00505622|450115569|FG002|Overall Study|Withdrawal by Subject|2|||
125134153|NCT00505622|450115567|FG000|Overall Study|Study termination by sponsor|115|||
125134154|NCT00505622|450115568|FG001|Overall Study|Study termination by sponsor|98|||
124974121|NCT01317875|449534394|FG008|Overall Study|Adverse Event|0|||
124974122|NCT01317875|449534395|FG009|Overall Study|Adverse Event|0|||
124974123|NCT02271984|449534400|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
124974124|NCT02271984|449534401|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
124974125|NCT02271984|449534402|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
124974126|NCT02271984|449534403|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
124974127|NCT02271984|449534404|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
124974128|NCT02271984|449534405|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
124974129|NCT02271984|449534406|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
124974130|NCT02271984|449534407|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
124974131|NCT02271984|449534408|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
124974132|NCT02271984|449534409|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
124974133|NCT02271984|449534410|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
124974134|NCT02271984|449534411|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
124974135|NCT01020877|449534412|FG000|Second Intervention|Withdrawal by Subject|1|||
124974136|NCT01020877|449534413|FG001|Second Intervention|Withdrawal by Subject|0|||
124974137|NCT04307940|449534415|FG000|Overall Study|Adverse Event|1|||
124974138|NCT04307940|449534416|FG001|Overall Study|Adverse Event|0|||
125134155|NCT00505622|450115569|FG002|Overall Study|Study termination by sponsor|90|||
125134156|NCT01848938|450115576|FG000|Overall Study|Lost to Follow-up|1|||
125134157|NCT01848938|450115577|FG001|Overall Study|Lost to Follow-up|1|||
125134158|NCT01757392|450115578|FG000|Overall Study|Withdrawal by Subject|1|||
125134159|NCT01757392|450115578|FG000|Overall Study|Screen Fail|3|||
125134160|NCT00651820|450115587|FG000|Overall Study|Lost to Follow-up|2|||
125134161|NCT01878292|450115588|FG000|Randomized|Protocol Violation|1|||
125134162|NCT01878292|450115589|FG001|Randomized|Protocol Violation|0|||
125134163|NCT01878292|450115590|FG002|Randomized|Protocol Violation|0|||
125134164|NCT01878292|450115588|FG000|Randomized|Lost to Follow-up|1|||
125134165|NCT01878292|450115589|FG001|Randomized|Lost to Follow-up|0|||
125134166|NCT01878292|450115590|FG002|Randomized|Lost to Follow-up|0|||
125134167|NCT01878292|450115588|FG000|Randomized|Adverse Event|1|||
125134168|NCT01878292|450115589|FG001|Randomized|Adverse Event|0|||
124974139|NCT04307940|449534417|FG002|Overall Study|Adverse Event|0|||
124974140|NCT04307940|449534415|FG000|Overall Study|Withdrawal by Subject|2|||
124974141|NCT04307940|449534416|FG001|Overall Study|Withdrawal by Subject|3|||
124974142|NCT04307940|449534417|FG002|Overall Study|Withdrawal by Subject|1|||
125134169|NCT01878292|450115590|FG002|Randomized|Adverse Event|0|||
125134170|NCT01878292|450115588|FG000|Double-blind Treatment Period|Other Reasons|2|||
125134171|NCT01878292|450115589|FG001|Double-blind Treatment Period|Other Reasons|0|||
125134172|NCT01878292|450115590|FG002|Double-blind Treatment Period|Other Reasons|0|||
125134173|NCT01878292|450115588|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
125134174|NCT01878292|450115589|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
125134175|NCT01878292|450115590|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
125218500|NCT00436826|450427350|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
125218501|NCT00436826|450427351|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
125218502|NCT00436826|450427346|FG000|Double Blind Period (DBP)|Other|10|||
125218503|NCT00436826|450427347|FG001|Double Blind Period (DBP)|Other|11|||
125218504|NCT00436826|450427348|FG002|Double Blind Period (DBP)|Other|0|||
125218505|NCT00436826|450427349|FG003|Double Blind Period (DBP)|Other|0|||
125218506|NCT00436826|450427350|FG004|Double Blind Period (DBP)|Other|0|||
124974143|NCT04307940|449534415|FG000|Overall Study|Lost to Follow-up|2|||
124974144|NCT04307940|449534416|FG001|Overall Study|Lost to Follow-up|0|||
124974145|NCT04307940|449534417|FG002|Overall Study|Lost to Follow-up|1|||
124974146|NCT04624243|449534418|FG000|Overall Study|Death|0|||
124974147|NCT04624243|449534419|FG001|Overall Study|Death|1|||
124974148|NCT04624243|449534420|FG002|Overall Study|Death|0|||
124974149|NCT04624243|449534421|FG003|Overall Study|Death|0|||
124974150|NCT04624243|449534422|FG004|Overall Study|Death|0|||
124974151|NCT04624243|449534418|FG000|Overall Study|Lost to Follow-up|2|||
124974152|NCT04624243|449534419|FG001|Overall Study|Lost to Follow-up|3|||
125038087|NCT00275561|449758037|FG001|Overall Study|Scheduling|2|||
125038088|NCT00275561|449758036|FG000|Overall Study|Family Issues|0|||
125038089|NCT00275561|449758037|FG001|Overall Study|Family Issues|2|||
125038090|NCT01769105|449758038|FG000|First Intervention|Protocol Violation|2|||
125038091|NCT01769105|449758039|FG001|First Intervention|Protocol Violation|2|||
125038092|NCT01769105|449758038|FG000|Cross-over|Lost to Follow-up|5|||
125038093|NCT01769105|449758039|FG001|Cross-over|Lost to Follow-up|0|||
125038094|NCT04321343|449758044|FG000|Overall Study|Adverse Event|0|||
125038095|NCT04321343|449758045|FG001|Overall Study|Adverse Event|0|||
125038096|NCT04321343|449758046|FG002|Overall Study|Adverse Event|1|||
125038097|NCT04321343|449758047|FG003|Overall Study|Adverse Event|0|||
125038098|NCT04321343|449758044|FG000|Overall Study|Death|0|||
125038099|NCT04321343|449758045|FG001|Overall Study|Death|0|||
125038100|NCT04321343|449758046|FG002|Overall Study|Death|0|||
125038101|NCT04321343|449758047|FG003|Overall Study|Death|1|||
125038102|NCT04321343|449758044|FG000|Overall Study|Pregnancy|1|||
125038103|NCT04321343|449758045|FG001|Overall Study|Pregnancy|0|||
125038104|NCT04321343|449758046|FG002|Overall Study|Pregnancy|0|||
125038105|NCT04321343|449758047|FG003|Overall Study|Pregnancy|0|||
125038106|NCT04321343|449758044|FG000|Overall Study|Protocol Violation|1|||
125038107|NCT04321343|449758045|FG001|Overall Study|Protocol Violation|1|||
125038108|NCT04321343|449758046|FG002|Overall Study|Protocol Violation|1|||
125038109|NCT04321343|449758047|FG003|Overall Study|Protocol Violation|1|||
125038110|NCT04321343|449758044|FG000|Overall Study|Withdrawal by Subject|0|||
125038111|NCT04321343|449758045|FG001|Overall Study|Withdrawal by Subject|6|||
125038112|NCT04321343|449758046|FG002|Overall Study|Withdrawal by Subject|0|||
125038113|NCT04321343|449758047|FG003|Overall Study|Withdrawal by Subject|2|||
125038114|NCT04321343|449758044|FG000|Overall Study|Lost to Follow-up|2|||
125038115|NCT04321343|449758045|FG001|Overall Study|Lost to Follow-up|2|||
125038116|NCT04321343|449758046|FG002|Overall Study|Lost to Follow-up|1|||
125038117|NCT04321343|449758047|FG003|Overall Study|Lost to Follow-up|3|||
125038118|NCT04194944|449758048|FG000|Overall Study|Lost to Follow-up|3|||
125038119|NCT04194944|449758049|FG001|Overall Study|Lost to Follow-up|0|||
125038120|NCT04194944|449758048|FG000|Overall Study|Withdrawal by Subject|2|||
125038121|NCT04194944|449758049|FG001|Overall Study|Withdrawal by Subject|2|||
125038122|NCT04194944|449758048|FG000|Overall Study|On Treatment|93|||
125038123|NCT04194944|449758049|FG001|Overall Study|On Treatment|30|||
125038124|NCT04238819|449758050|FG000|Overall Study|Ongoing Treatment|0|||
125038125|NCT04238819|449758051|FG001|Overall Study|Ongoing Treatment|0|||
125038126|NCT04238819|449758052|FG002|Overall Study|Ongoing Treatment|0|||
125038127|NCT04238819|449758053|FG003|Overall Study|Ongoing Treatment|0|||
125038128|NCT04238819|449758054|FG004|Overall Study|Ongoing Treatment|1|||
125038129|NCT04238819|449758055|FG005|Overall Study|Ongoing Treatment|4|||
125038130|NCT04238819|449758056|FG006|Overall Study|Ongoing Treatment|0|||
125038131|NCT04238819|449758050|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
125038132|NCT04238819|449758051|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
125038133|NCT04238819|449758052|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
125038134|NCT04238819|449758053|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
125038135|NCT04238819|449758054|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
125038136|NCT04238819|449758055|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
125038137|NCT04238819|449758056|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
125218507|NCT00436826|450427351|FG005|Double Blind Period (DBP)|Other|0|||
125038138|NCT00045032|449758067|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
125038139|NCT00045032|449758068|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
125038140|NCT00045032|449758069|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
124974153|NCT04624243|449534420|FG002|Overall Study|Lost to Follow-up|7|||
125038141|NCT00045032|449758067|FG000|Overall Study|Death|22|||
125038142|NCT00045032|449758068|FG001|Overall Study|Death|24|||
125038143|NCT00045032|449758069|FG002|Overall Study|Death|17|||
125038144|NCT00045032|449758067|FG000|Overall Study|Insufficient Therapeutic Response|542|||
125038145|NCT00045032|449758068|FG001|Overall Study|Insufficient Therapeutic Response|437|||
125038146|NCT00045032|449758069|FG002|Overall Study|Insufficient Therapeutic Response|445|||
125038147|NCT00045032|449758067|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
125038148|NCT00045032|449758068|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
125038149|NCT00045032|449758069|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
125038150|NCT00045032|449758067|FG000|Overall Study|Other Protocol Violation|2|||
125038151|NCT00045032|449758068|FG001|Overall Study|Other Protocol Violation|0|||
125038152|NCT00045032|449758069|FG002|Overall Study|Other Protocol Violation|1|||
125038153|NCT00045032|449758067|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
125038154|NCT00045032|449758068|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
125038155|NCT00045032|449758069|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
125038156|NCT00045032|449758067|FG000|Overall Study|Failure to Return|57|||
125038157|NCT00045032|449758068|FG001|Overall Study|Failure to Return|62|||
125038158|NCT00045032|449758069|FG002|Overall Study|Failure to Return|61|||
125038159|NCT00045032|449758067|FG000|Overall Study|Other|93|||
125038160|NCT00045032|449758068|FG001|Overall Study|Other|84|||
125038161|NCT00045032|449758069|FG002|Overall Study|Other|105|||
125038162|NCT02581995|449758077|FG000|Overall Study|Unspecified other|3|||
125038163|NCT02581995|449758077|FG000|Overall Study|Adverse Event|6|||
125038164|NCT02581995|449758077|FG000|Overall Study|Lost to Follow-up|5|||
125038165|NCT02581995|449758077|FG000|Overall Study|Withdrawal by participant|12|||
125038166|NCT02581995|449758077|FG000|Overall Study|Physician Decision|1|||
125038167|NCT02581995|449758077|FG000|Overall Study|Death|4|||
125038168|NCT02031679|449759332|FG000|Overall Study|Protocol Violation|0|||
125038169|NCT02031679|449759333|FG001|Overall Study|Protocol Violation|1|||
125038170|NCT02031679|449759332|FG000|Overall Study|Lack of Efficacy|0|||
125038171|NCT02031679|449759333|FG001|Overall Study|Lack of Efficacy|1|||
125038172|NCT04030195|449759334|FG000|Overall Study|Withdrawal by Subject|2|||
125038173|NCT04030195|449759335|FG001|Overall Study|Withdrawal by Subject|0|||
125038174|NCT04030195|449759336|FG002|Overall Study|Withdrawal by Subject|0|||
125038175|NCT01024244|449759337|FG000|Overall Study|Adverse Event|1|||
125038176|NCT01024244|449759338|FG001|Overall Study|Adverse Event|2|||
125038177|NCT01024244|449759339|FG002|Overall Study|Adverse Event|0|||
125038178|NCT01024244|449759340|FG003|Overall Study|Adverse Event|1|||
125038179|NCT01024244|449759341|FG004|Overall Study|Adverse Event|2|||
125038180|NCT01024244|449759337|FG000|Overall Study|Entry Criteria Not Met|0|||
125038181|NCT01024244|449759338|FG001|Overall Study|Entry Criteria Not Met|1|||
125038182|NCT01024244|449759339|FG002|Overall Study|Entry Criteria Not Met|0|||
125038183|NCT01024244|449759340|FG003|Overall Study|Entry Criteria Not Met|0|||
125038184|NCT01024244|449759341|FG004|Overall Study|Entry Criteria Not Met|0|||
125038185|NCT01024244|449759337|FG000|Overall Study|Lack of Efficacy|1|||
125038186|NCT01024244|449759338|FG001|Overall Study|Lack of Efficacy|0|||
125038187|NCT01024244|449759339|FG002|Overall Study|Lack of Efficacy|0|||
125038188|NCT01024244|449759340|FG003|Overall Study|Lack of Efficacy|0|||
125038189|NCT01024244|449759341|FG004|Overall Study|Lack of Efficacy|0|||
125038190|NCT01024244|449759337|FG000|Overall Study|Protocol Violation|1|||
125038191|NCT01024244|449759338|FG001|Overall Study|Protocol Violation|0|||
125038192|NCT01024244|449759339|FG002|Overall Study|Protocol Violation|0|||
125038193|NCT01024244|449759340|FG003|Overall Study|Protocol Violation|0|||
125038194|NCT01024244|449759341|FG004|Overall Study|Protocol Violation|2|||
125038195|NCT01024244|449759337|FG000|Overall Study|Sponsor Decision|14|||
125038196|NCT01024244|449759338|FG001|Overall Study|Sponsor Decision|7|||
125038197|NCT01024244|449759339|FG002|Overall Study|Sponsor Decision|14|||
125038198|NCT01024244|449759340|FG003|Overall Study|Sponsor Decision|12|||
125038199|NCT01024244|449759341|FG004|Overall Study|Sponsor Decision|10|||
125038200|NCT01024244|449759337|FG000|Overall Study|Withdrawal by Subject|0|||
125038201|NCT01024244|449759338|FG001|Overall Study|Withdrawal by Subject|1|||
125038202|NCT01024244|449759339|FG002|Overall Study|Withdrawal by Subject|0|||
125038203|NCT01024244|449759340|FG003|Overall Study|Withdrawal by Subject|0|||
125038204|NCT01024244|449759341|FG004|Overall Study|Withdrawal by Subject|0|||
125038205|NCT02660580|449759347|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
125038206|NCT02660580|449759348|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
125038207|NCT02660580|449759349|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
125134176|NCT01878292|450115588|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
125134177|NCT01878292|450115589|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
125134178|NCT01878292|450115590|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
125038208|NCT02660580|449759350|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
125038209|NCT02660580|449759351|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
125038210|NCT02660580|449759347|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
125038211|NCT02660580|449759348|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
125038212|NCT02660580|449759349|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
125038213|NCT02660580|449759350|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
125038214|NCT02660580|449759351|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
125134179|NCT01878292|450115588|FG000|Double-blind Treatment Period|Protocol Violation|3|||
125134180|NCT01878292|450115589|FG001|Double-blind Treatment Period|Protocol Violation|4|||
125134181|NCT01878292|450115590|FG002|Double-blind Treatment Period|Protocol Violation|2|||
125134182|NCT01878292|450115588|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
125134183|NCT01878292|450115589|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
125134184|NCT01878292|450115590|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
125134185|NCT01878292|450115588|FG000|Double-blind Treatment Period|Adverse Event|4|||
125134186|NCT01878292|450115589|FG001|Double-blind Treatment Period|Adverse Event|9|||
125134187|NCT01878292|450115590|FG002|Double-blind Treatment Period|Adverse Event|8|||
125134188|NCT01878292|450115588|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
125134189|NCT01878292|450115589|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
125134190|NCT01878292|450115590|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
125134191|NCT01302548|450115591|FG000|Overall Study|Lost to Follow-up|2|||
125134192|NCT01302548|450115592|FG001|Overall Study|Lost to Follow-up|1|||
125134193|NCT00950989|450115593|FG000|Overall Study|Death|0|||
125134194|NCT00950989|450115594|FG001|Overall Study|Death|0|||
125134195|NCT00950989|450115595|FG002|Overall Study|Death|1|||
125134196|NCT00950989|450115596|FG003|Overall Study|Death|0|||
125134197|NCT00950989|450115593|FG000|Overall Study|Administrative Decision|0|||
125134198|NCT00950989|450115594|FG001|Overall Study|Administrative Decision|1|||
125134199|NCT00950989|450115595|FG002|Overall Study|Administrative Decision|0|||
125134200|NCT00950989|450115596|FG003|Overall Study|Administrative Decision|0|||
125134201|NCT00950989|450115593|FG000|Overall Study|Disease Progression|0|||
125134202|NCT00950989|450115594|FG001|Overall Study|Disease Progression|0|||
125134203|NCT00950989|450115595|FG002|Overall Study|Disease Progression|1|||
125134204|NCT00950989|450115596|FG003|Overall Study|Disease Progression|0|||
125134205|NCT00950989|450115593|FG000|Overall Study|Withdrawal by Subject|2|||
125134206|NCT00950989|450115594|FG001|Overall Study|Withdrawal by Subject|1|||
125134207|NCT00950989|450115595|FG002|Overall Study|Withdrawal by Subject|0|||
124974154|NCT04624243|449534421|FG003|Overall Study|Lost to Follow-up|1|||
124974155|NCT04624243|449534422|FG004|Overall Study|Lost to Follow-up|3|||
124974156|NCT04624243|449534418|FG000|Overall Study|Physician Decision|3|||
124974157|NCT04624243|449534419|FG001|Overall Study|Physician Decision|8|||
124974158|NCT04624243|449534420|FG002|Overall Study|Physician Decision|15|||
124974159|NCT04624243|449534421|FG003|Overall Study|Physician Decision|2|||
124974160|NCT04624243|449534422|FG004|Overall Study|Physician Decision|11|||
124974161|NCT04624243|449534418|FG000|Overall Study|Withdrawal by Subject|19|||
124974162|NCT04624243|449534419|FG001|Overall Study|Withdrawal by Subject|44|||
124974163|NCT04624243|449534420|FG002|Overall Study|Withdrawal by Subject|40|||
124974164|NCT04624243|449534421|FG003|Overall Study|Withdrawal by Subject|21|||
124974165|NCT04624243|449534422|FG004|Overall Study|Withdrawal by Subject|39|||
124974166|NCT04624243|449534418|FG000|Overall Study|Miscellaneous|3|||
124974167|NCT04624243|449534419|FG001|Overall Study|Miscellaneous|12|||
124974168|NCT04624243|449534420|FG002|Overall Study|Miscellaneous|9|||
124974169|NCT04624243|449534421|FG003|Overall Study|Miscellaneous|4|||
124974170|NCT04624243|449534422|FG004|Overall Study|Miscellaneous|6|||
124974171|NCT05543174|449534423|FG000|Overall Study|Ongoing|7|||
124974172|NCT00953771|449534424|FG000|Overall Study|Death|1|||
124974173|NCT00953771|449534425|FG001|Overall Study|Death|0|||
124974174|NCT04896008|449534426|FG000|Overall Study|Ongoing|70|||
124974175|NCT04896008|449534427|FG001|Overall Study|Ongoing|38|||
124974176|NCT04896008|449534426|FG000|Overall Study|Adverse Event|0|||
124974177|NCT04896008|449534427|FG001|Overall Study|Adverse Event|2|||
124974178|NCT04896008|449534426|FG000|Overall Study|Death|5|||
124974179|NCT04896008|449534427|FG001|Overall Study|Death|10|||
124974180|NCT04896008|449534426|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
124974181|NCT04896008|449534427|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
124974182|NCT04896008|449534426|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
124974183|NCT04896008|449534427|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
124974184|NCT04896008|449534426|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
124974185|NCT04896008|449534427|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
125218508|NCT00436826|450427346|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
124974186|NCT04896008|449534426|FG000|Overall Study|Withdrawal by Subject|1|||
125134208|NCT00950989|450115596|FG003|Overall Study|Withdrawal by Subject|0|||
125134209|NCT00950989|450115593|FG000|Overall Study|Adverse Event|2|||
125134210|NCT00950989|450115594|FG001|Overall Study|Adverse Event|1|||
124974187|NCT04896008|449534427|FG001|Overall Study|Withdrawal by Subject|4|||
124974188|NCT04896008|449534426|FG000|Overall Study|Investigator Decision|2|||
124974189|NCT04896008|449534427|FG001|Overall Study|Investigator Decision|0|||
124974190|NCT04896008|449534426|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
124974191|NCT04896008|449534427|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
124974192|NCT01270828|449534432|FG000|Pregabalin CR SB|Reason Unspecified|0|||
125134211|NCT00950989|450115595|FG002|Overall Study|Adverse Event|1|||
125134212|NCT00950989|450115596|FG003|Overall Study|Adverse Event|0|||
125134213|NCT00730691|450115599|FG000|Overall Study|Adverse Event|4|||
125134214|NCT00730691|450115600|FG001|Overall Study|Adverse Event|8|||
125134215|NCT00730691|450115601|FG002|Overall Study|Adverse Event|11|||
125134216|NCT00730691|450115602|FG003|Overall Study|Adverse Event|11|||
125134217|NCT00730691|450115603|FG004|Overall Study|Adverse Event|23|||
125134218|NCT00730691|450115599|FG000|Overall Study|Lack of Efficacy|4|||
125134219|NCT00730691|450115600|FG001|Overall Study|Lack of Efficacy|4|||
125134220|NCT00730691|450115601|FG002|Overall Study|Lack of Efficacy|2|||
125134221|NCT00730691|450115602|FG003|Overall Study|Lack of Efficacy|1|||
125134222|NCT00730691|450115603|FG004|Overall Study|Lack of Efficacy|1|||
125134223|NCT00730691|450115599|FG000|Overall Study|Non-compliance with Study Drug|6|||
125134224|NCT00730691|450115600|FG001|Overall Study|Non-compliance with Study Drug|1|||
125134225|NCT00730691|450115601|FG002|Overall Study|Non-compliance with Study Drug|6|||
125134226|NCT00730691|450115602|FG003|Overall Study|Non-compliance with Study Drug|3|||
125134227|NCT00730691|450115603|FG004|Overall Study|Non-compliance with Study Drug|3|||
125134228|NCT00730691|450115599|FG000|Overall Study|Protocol Deviations|3|||
125134229|NCT00730691|450115600|FG001|Overall Study|Protocol Deviations|5|||
125134230|NCT00730691|450115601|FG002|Overall Study|Protocol Deviations|3|||
125134231|NCT00730691|450115602|FG003|Overall Study|Protocol Deviations|7|||
125134232|NCT00730691|450115603|FG004|Overall Study|Protocol Deviations|5|||
125134233|NCT00730691|450115599|FG000|Overall Study|Withdrawal of Consent|7|||
125134234|NCT00730691|450115600|FG001|Overall Study|Withdrawal of Consent|9|||
125134235|NCT00730691|450115601|FG002|Overall Study|Withdrawal of Consent|3|||
125134236|NCT00730691|450115602|FG003|Overall Study|Withdrawal of Consent|6|||
125134237|NCT00730691|450115603|FG004|Overall Study|Withdrawal of Consent|3|||
125134238|NCT00730691|450115599|FG000|Overall Study|Lost to Follow-up|11|||
125134239|NCT00730691|450115600|FG001|Overall Study|Lost to Follow-up|8|||
124974193|NCT01270828|449534433|FG001|Pregabalin CR SB|Reason Unspecified|0|||
124974194|NCT01270828|449534434|FG002|Pregabalin CR SB|Reason Unspecified|8|||
124974195|NCT01270828|449534432|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
124974196|NCT01270828|449534433|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
124974197|NCT01270828|449534434|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
124974198|NCT01270828|449534432|FG000|Pregabalin CR SB|Related adverse event|0|||
124974199|NCT01270828|449534433|FG001|Pregabalin CR SB|Related adverse event|0|||
124974200|NCT01270828|449534434|FG002|Pregabalin CR SB|Related adverse event|46|||
124974201|NCT01270828|449534432|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
124974202|NCT01270828|449534433|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
124974203|NCT01270828|449534434|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
124974204|NCT01270828|449534432|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
124974205|NCT01270828|449534433|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
124974206|NCT01270828|449534434|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
124974207|NCT01270828|449534432|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
124974208|NCT01270828|449534433|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
124974209|NCT01270828|449534434|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
124974210|NCT01270828|449534432|FG000|Pregabalin CR SB|Unrelated AE|0|||
124974211|NCT01270828|449534433|FG001|Pregabalin CR SB|Unrelated AE|0|||
124974212|NCT01270828|449534434|FG002|Pregabalin CR SB|Unrelated AE|8|||
124974213|NCT01270828|449534432|FG000|Pregabalin CR SB|Protocol Violation|0|||
125134240|NCT00730691|450115601|FG002|Overall Study|Lost to Follow-up|13|||
125134241|NCT00730691|450115602|FG003|Overall Study|Lost to Follow-up|15|||
125134242|NCT00730691|450115603|FG004|Overall Study|Lost to Follow-up|13|||
125134243|NCT00730691|450115599|FG000|Overall Study|Other|1|||
125134244|NCT00730691|450115600|FG001|Overall Study|Other|1|||
125134245|NCT00730691|450115601|FG002|Overall Study|Other|1|||
125134246|NCT00730691|450115602|FG003|Overall Study|Other|2|||
125134247|NCT00730691|450115603|FG004|Overall Study|Other|2|||
125134248|NCT02178787|450115604|FG000|Overall Study|Lost to Follow-up|1|||
125134249|NCT02178787|450115605|FG001|Overall Study|Lost to Follow-up|0|||
125134250|NCT02178787|450115604|FG000|Overall Study|Withdrawal by Subject|0|||
124974214|NCT01270828|449534433|FG001|Pregabalin CR SB|Protocol Violation|0|||
125134251|NCT02178787|450115605|FG001|Overall Study|Withdrawal by Subject|2|||
125134252|NCT02178787|450115604|FG000|Overall Study|No TCD window|3|||
125134253|NCT02178787|450115605|FG001|Overall Study|No TCD window|7|||
125134254|NCT02178787|450115604|FG000|Overall Study|Physician Decision|1|||
125134255|NCT02178787|450115605|FG001|Overall Study|Physician Decision|0|||
125134256|NCT02554890|450115606|FG000|Double-blind|Adverse Event|45|||
125134257|NCT02554890|450115607|FG001|Double-blind|Adverse Event|51|||
125134258|NCT02554890|450115606|FG000|Double-blind|Death|6|||
125134259|NCT02554890|450115607|FG001|Double-blind|Death|4|||
125134260|NCT02554890|450115606|FG000|Double-blind|Protocol Violation|1|||
125134261|NCT02554890|450115607|FG001|Double-blind|Protocol Violation|1|||
125134262|NCT02554890|450115606|FG000|Double-blind|Physician Decision|4|||
125134263|NCT02554890|450115607|FG001|Double-blind|Physician Decision|3|||
125134264|NCT02554890|450115606|FG000|Double-blind|Subject/Guardian decision|21|||
125134265|NCT02554890|450115607|FG001|Double-blind|Subject/Guardian decision|16|||
125134266|NCT02554890|450115606|FG000|Double-blind|Lost to Follow-up|7|||
125134267|NCT02554890|450115607|FG001|Double-blind|Lost to Follow-up|5|||
125134268|NCT02554890|450115606|FG000|Double-blind|Technical problems|1|||
125134269|NCT02554890|450115607|FG001|Double-blind|Technical problems|0|||
125134270|NCT02554890|450115606|FG000|Double-blind|Withdrawal by Subject|5|||
125038215|NCT02660580|449759347|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
125038216|NCT02660580|449759348|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
125038217|NCT02660580|449759349|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
125038218|NCT02660580|449759350|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
125038219|NCT02660580|449759351|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
125038220|NCT02660580|449759347|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
125038221|NCT02660580|449759348|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
125038222|NCT02660580|449759349|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
125038223|NCT02660580|449759350|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
125038224|NCT02660580|449759351|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
125038225|NCT02660580|449759347|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
125038226|NCT02660580|449759348|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
125038227|NCT02660580|449759349|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
125038228|NCT02660580|449759350|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
125038229|NCT02660580|449759351|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
125038230|NCT02660580|449759347|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
125038231|NCT02660580|449759348|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
125038232|NCT02660580|449759349|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
125038233|NCT02660580|449759350|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
125038234|NCT02660580|449759351|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
125038235|NCT02660580|449759347|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
125038236|NCT02660580|449759348|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
125038237|NCT02660580|449759349|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
125038238|NCT02660580|449759350|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
125038239|NCT02660580|449759351|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
125038240|NCT02660580|449759347|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
125038241|NCT02660580|449759348|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
125038242|NCT02660580|449759349|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
125038243|NCT02660580|449759350|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
125038244|NCT02660580|449759351|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
125038245|NCT02660580|449759347|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
125038246|NCT02660580|449759348|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
125038247|NCT02660580|449759349|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
125134271|NCT02554890|450115607|FG001|Double-blind|Withdrawal by Subject|6|||
125134272|NCT02554890|450115606|FG000|Double-blind|Noncompliance with study treatment|6|||
125134273|NCT02554890|450115607|FG001|Double-blind|Noncompliance with study treatment|5|||
125134274|NCT02554890|450115606|FG000|Open-label|Adverse Event|0|||
125134275|NCT02554890|450115607|FG001|Open-label|Adverse Event|30|||
125038248|NCT02660580|449759350|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
125038249|NCT02660580|449759351|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
125038250|NCT02660580|449759347|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
125038251|NCT02660580|449759348|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
125038252|NCT02660580|449759349|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
125134276|NCT02554890|450115606|FG000|Open-label|Death|0|||
125134277|NCT02554890|450115607|FG001|Open-label|Death|1|||
125134278|NCT02554890|450115606|FG000|Open-label|Physician Decision|0|||
125134279|NCT02554890|450115607|FG001|Open-label|Physician Decision|1|||
125134280|NCT02554890|450115606|FG000|Open-label|Subject/Guardian decision|0|||
125134281|NCT02554890|450115607|FG001|Open-label|Subject/Guardian decision|11|||
125134282|NCT02554890|450115606|FG000|Open-label|Lost to Follow-up|0|||
125134283|NCT02554890|450115607|FG001|Open-label|Lost to Follow-up|7|||
125134284|NCT02554890|450115606|FG000|Open-label|Technical problems|0|||
125134285|NCT02554890|450115607|FG001|Open-label|Technical problems|1|||
124974215|NCT01270828|449534434|FG002|Pregabalin CR SB|Protocol Violation|8|||
124974216|NCT01270828|449534432|FG000|Double Blind Phase|Death|0|||
124974217|NCT01270828|449534433|FG001|Double Blind Phase|Death|1|||
124974218|NCT01270828|449534434|FG002|Double Blind Phase|Death|0|||
124974219|NCT01270828|449534432|FG000|Double Blind Phase|Protocol Violation|0|||
124974220|NCT01270828|449534433|FG001|Double Blind Phase|Protocol Violation|1|||
124974221|NCT01270828|449534434|FG002|Double Blind Phase|Protocol Violation|0|||
124974222|NCT01270828|449534432|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
124974223|NCT01270828|449534433|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
124974224|NCT01270828|449534434|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
124974225|NCT01270828|449534432|FG000|Double Blind Phase|Reason Unspecified|7|||
124974226|NCT01270828|449534433|FG001|Double Blind Phase|Reason Unspecified|4|||
124974227|NCT01270828|449534434|FG002|Double Blind Phase|Reason Unspecified|0|||
124974228|NCT01270828|449534432|FG000|Double Blind Phase|Withdrawal by Subject|6|||
124974229|NCT01270828|449534433|FG001|Double Blind Phase|Withdrawal by Subject|15|||
124974230|NCT01270828|449534434|FG002|Double Blind Phase|Withdrawal by Subject|0|||
124974231|NCT01270828|449534432|FG000|Double Blind Phase|Lost to Follow-up|1|||
124974232|NCT01270828|449534433|FG001|Double Blind Phase|Lost to Follow-up|2|||
124974233|NCT01270828|449534434|FG002|Double Blind Phase|Lost to Follow-up|0|||
124974234|NCT01270828|449534432|FG000|Double Blind Phase|Lack of Efficacy|2|||
124974235|NCT01270828|449534433|FG001|Double Blind Phase|Lack of Efficacy|11|||
124974236|NCT01270828|449534434|FG002|Double Blind Phase|Lack of Efficacy|0|||
124974237|NCT01270828|449534432|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
124974238|NCT01270828|449534433|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
124974239|NCT01270828|449534434|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
124974240|NCT01270828|449534432|FG000|Double Blind Phase|Adverse event related to study drug|5|||
124974241|NCT01270828|449534433|FG001|Double Blind Phase|Adverse event related to study drug|7|||
124974242|NCT01270828|449534434|FG002|Double Blind Phase|Adverse event related to study drug|0|||
124974243|NCT00709228|449534442|FG000|Overall Study|Not treated|14|||
124974244|NCT00709228|449534442|FG000|Overall Study|Eligibility criteria not met|281|||
124974245|NCT00709228|449534442|FG000|Overall Study|Adverse events|2|||
124974246|NCT00709228|449534442|FG000|Overall Study|Discontinued treatment|14|||
124974247|NCT00709228|449534442|FG000|Overall Study|Did not enter follow-up|4|||
124974248|NCT00709228|449534442|FG000|Overall Study|Discontinued follow-up|5|||
124974249|NCT00709228|449534442|FG000|Overall Study|Disease progression|1|||
124974250|NCT00709228|449534442|FG000|Overall Study|Lost to Follow-up|6|||
124974251|NCT00709228|449534442|FG000|Overall Study|Non-compliance|5|||
124974252|NCT02870972|449534445|FG000|Overall Study|Adverse Event|1|||
124974253|NCT02870972|449534446|FG001|Overall Study|Adverse Event|0|||
124974254|NCT02870972|449534447|FG002|Overall Study|Adverse Event|0|||
124974255|NCT02870972|449534448|FG003|Overall Study|Adverse Event|0|||
124974256|NCT02870972|449534449|FG004|Overall Study|Adverse Event|0|||
124974257|NCT04497389|449534450|FG000|Overall Study|Withdrawal by Subject|1|||
124974258|NCT04497389|449534451|FG001|Overall Study|Withdrawal by Subject|0|||
124974259|NCT02179177|449534452|FG000|Overall Study|Lost to Follow-up|1|||
124974260|NCT02179177|449534453|FG001|Overall Study|Lost to Follow-up|1|||
124974261|NCT02179177|449534452|FG000|Overall Study|Withdrawal by Subject|1|||
124974262|NCT02179177|449534453|FG001|Overall Study|Withdrawal by Subject|1|||
124974263|NCT03322540|449534454|FG000|Overall Study|Death|21|||
124974264|NCT03322540|449534455|FG001|Overall Study|Death|28|||
124974265|NCT03322540|449534454|FG000|Overall Study|Lost to Follow-up|0|||
124974266|NCT03322540|449534455|FG001|Overall Study|Lost to Follow-up|1|||
124974267|NCT03322540|449534454|FG000|Overall Study|Physician Decision|7|||
124974268|NCT03322540|449534455|FG001|Overall Study|Physician Decision|6|||
124974269|NCT03322540|449534454|FG000|Overall Study|Withdrawal by Subject|3|||
124974270|NCT03322540|449534455|FG001|Overall Study|Withdrawal by Subject|1|||
124974271|NCT03322540|449534454|FG000|Overall Study|Study terminated by sponsor|0|||
125218509|NCT00436826|450427347|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
124974272|NCT03322540|449534455|FG001|Overall Study|Study terminated by sponsor|1|||
124974273|NCT04052425|449534456|FG000|24-Week Double-blind Period|Adverse Event|0|||
124974274|NCT04052425|449534457|FG001|24-Week Double-blind Period|Adverse Event|1|||
124974275|NCT04052425|449534458|FG002|24-Week Double-blind Period|Adverse Event|0|||
124974276|NCT04052425|449534459|FG003|24-Week Double-blind Period|Adverse Event|0|||
124974277|NCT04052425|449534456|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
124974278|NCT04052425|449534457|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
124974279|NCT04052425|449534458|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
124974280|NCT04052425|449534459|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
124974281|NCT04052425|449534456|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
124974282|NCT04052425|449534457|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
124974283|NCT04052425|449534458|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
124974284|NCT04052425|449534459|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
124974285|NCT04052425|449534456|FG000|24-Week Double-blind Period|Physician Decision|1|||
124974286|NCT04052425|449534457|FG001|24-Week Double-blind Period|Physician Decision|0|||
124974287|NCT04052425|449534458|FG002|24-Week Double-blind Period|Physician Decision|0|||
124974288|NCT04052425|449534459|FG003|24-Week Double-blind Period|Physician Decision|0|||
124974289|NCT04052425|449534456|FG000|24-Week Double-blind Period|Protocol Violation|1|||
124974290|NCT04052425|449534457|FG001|24-Week Double-blind Period|Protocol Violation|0|||
124974291|NCT04052425|449534458|FG002|24-Week Double-blind Period|Protocol Violation|0|||
124974292|NCT04052425|449534459|FG003|24-Week Double-blind Period|Protocol Violation|0|||
124974293|NCT04052425|449534456|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
124974294|NCT04052425|449534457|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
124974295|NCT04052425|449534458|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
124974296|NCT04052425|449534459|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
124974297|NCT04052425|449534456|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
124974298|NCT04052425|449534457|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
124974299|NCT04052425|449534458|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
124974300|NCT04052425|449534459|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
124974301|NCT04052425|449534456|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
124974302|NCT04052425|449534457|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
124974303|NCT04052425|449534458|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
124974304|NCT04052425|449534459|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
124974305|NCT04052425|449534456|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
124974306|NCT04052425|449534457|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
124974307|NCT04052425|449534458|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
124974308|NCT04052425|449534459|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
124974309|NCT04052425|449534456|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
124974310|NCT04052425|449534457|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
124974311|NCT04052425|449534458|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
124974312|NCT04052425|449534459|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
124974313|NCT04052425|449534456|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
124974314|NCT04052425|449534457|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
124974315|NCT04052425|449534458|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
124974316|NCT04052425|449534459|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
124974317|NCT04052425|449534456|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
124974318|NCT04052425|449534457|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
124974319|NCT04052425|449534458|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
124974320|NCT04052425|449534459|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
124974321|NCT04052425|449534456|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
124974322|NCT04052425|449534457|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
124974323|NCT04052425|449534458|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
124974324|NCT04052425|449534459|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
124974325|NCT04052425|449534456|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
124974326|NCT04052425|449534457|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
124974327|NCT04052425|449534458|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
124974328|NCT04052425|449534459|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
124974329|NCT04334278|449534460|FG000|Overall Study|Lost to Follow-up|0|||
124974330|NCT04334278|449534461|FG001|Overall Study|Lost to Follow-up|3|||
124974331|NCT04334278|449534460|FG000|Overall Study|Withdrawal by Subject|4|||
124974332|NCT04334278|449534461|FG001|Overall Study|Withdrawal by Subject|2|||
124974333|NCT04829747|449534464|FG000|Overall Study|Protocol Violation|1|||
124974334|NCT03445533|449534467|FG000|Overall Study|Progressive Disease|48|||
124974335|NCT03445533|449534468|FG001|Overall Study|Progressive Disease|81|||
124974336|NCT03445533|449534467|FG000|Overall Study|Adverse Event|60|||
124974337|NCT03445533|449534468|FG001|Overall Study|Adverse Event|64|||
124974338|NCT03445533|449534467|FG000|Overall Study|Death|9|||
124974339|NCT03445533|449534468|FG001|Overall Study|Death|19|||
124974340|NCT03445533|449534467|FG000|Overall Study|Miscellaneous|0|||
124974341|NCT03445533|449534468|FG001|Overall Study|Miscellaneous|16|||
124974342|NCT03445533|449534467|FG000|Overall Study|Withdrawal by Subject|3|||
124974343|NCT03445533|449534468|FG001|Overall Study|Withdrawal by Subject|4|||
124974344|NCT03445533|449534467|FG000|Overall Study|Physician Decision|1|||
124974345|NCT03445533|449534468|FG001|Overall Study|Physician Decision|3|||
124974346|NCT03445533|449534467|FG000|Overall Study|Sponsor Decision|0|||
124974347|NCT03445533|449534468|FG001|Overall Study|Sponsor Decision|1|||
124974348|NCT03445533|449534467|FG000|Overall Study|Lost to Follow-up|0|||
124974349|NCT03445533|449534468|FG001|Overall Study|Lost to Follow-up|1|||
124974350|NCT03445533|449534467|FG000|Overall Study|Never Received any Study Treatment|7|||
124974351|NCT03445533|449534468|FG001|Overall Study|Never Received any Study Treatment|4|||
124974352|NCT02615509|449534469|FG000|Overall Study|Lost to Follow-up|134|||
125134286|NCT02554890|450115606|FG000|Open-label|Withdrawal by Subject|0|||
125134287|NCT02554890|450115607|FG001|Open-label|Withdrawal by Subject|1|||
125134288|NCT03043872|450115611|FG000|Overall Study|Withdrawal by Subject|6|||
125134289|NCT03043872|450115612|FG001|Overall Study|Withdrawal by Subject|6|||
125134290|NCT03043872|450115613|FG002|Overall Study|Withdrawal by Subject|15|||
125134291|NCT03043872|450115611|FG000|Overall Study|Lost to Follow-up|2|||
125134292|NCT03043872|450115612|FG001|Overall Study|Lost to Follow-up|1|||
125134293|NCT03043872|450115613|FG002|Overall Study|Lost to Follow-up|1|||
125134294|NCT03043872|450115611|FG000|Overall Study|Death|270|||
125134295|NCT03043872|450115612|FG001|Overall Study|Death|269|||
125134296|NCT03043872|450115613|FG002|Overall Study|Death|296|||
125134297|NCT03649477|450115614|FG000|Overall Study|Adverse Event|2|||
125134298|NCT03649477|450115615|FG001|Overall Study|Adverse Event|0|||
125134299|NCT03649477|450115616|FG002|Overall Study|Adverse Event|0|||
125134300|NCT02430480|450115617|FG000|Overall Study|Death|1|||
125134301|NCT02430480|450115617|FG000|Overall Study|Anesthesia concerns|1|||
125134302|NCT02430480|450115617|FG000|Overall Study|Progressed on treatment|1|||
125134303|NCT01154231|450115618|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
125134304|NCT01154231|450115618|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
125134305|NCT04852978|450115624|FG000|Overall Study|Physician Decision|0|||
125134306|NCT04852978|450115625|FG001|Overall Study|Physician Decision|1|||
125134307|NCT04852978|450115626|FG002|Overall Study|Physician Decision|0|||
125134308|NCT04852978|450115627|FG003|Overall Study|Physician Decision|0|||
125134309|NCT04852978|450115628|FG004|Overall Study|Physician Decision|0|||
125134310|NCT04852978|450115629|FG005|Overall Study|Physician Decision|0|||
125134311|NCT04852978|450115630|FG006|Overall Study|Physician Decision|0|||
125134312|NCT04852978|450115631|FG007|Overall Study|Physician Decision|2|||
125134313|NCT04852978|450115632|FG008|Overall Study|Physician Decision|0|||
125134314|NCT04852978|450115624|FG000|Overall Study|Sponsor request|0|||
125134315|NCT04852978|450115625|FG001|Overall Study|Sponsor request|0|||
125134316|NCT04852978|450115626|FG002|Overall Study|Sponsor request|1|||
125134317|NCT04852978|450115627|FG003|Overall Study|Sponsor request|0|||
125134318|NCT04852978|450115628|FG004|Overall Study|Sponsor request|0|||
125134319|NCT04852978|450115629|FG005|Overall Study|Sponsor request|0|||
125134320|NCT04852978|450115630|FG006|Overall Study|Sponsor request|0|||
124974353|NCT02615509|449534469|FG000|Overall Study|Death|4|||
124974354|NCT02615509|449534469|FG000|Overall Study|Withdrawal by Subject|8|||
124974355|NCT00945672|449534471|FG000|Overall Study|Withdrawal by Subject|0|||
124974356|NCT00945672|449534472|FG001|Overall Study|Withdrawal by Subject|0|||
124974357|NCT00945672|449534473|FG002|Overall Study|Withdrawal by Subject|0|||
124974358|NCT00945672|449534474|FG003|Overall Study|Withdrawal by Subject|1|||
124974359|NCT00968526|449534475|FG000|Overall Study|Adverse Event|2|||
124974360|NCT00968526|449534476|FG001|Overall Study|Adverse Event|0|||
124974361|NCT00968526|449534475|FG000|Overall Study|Migrated/moved from study area|1|||
124974362|NCT00968526|449534476|FG001|Overall Study|Migrated/moved from study area|0|||
124974363|NCT03926195|449534478|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
124974364|NCT03926195|449534479|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
124974365|NCT03926195|449534478|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
124974366|NCT03926195|449534479|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
124974367|NCT03926195|449534478|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
124974368|NCT03926195|449534479|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
124974369|NCT03926195|449534478|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
125038253|NCT02660580|449759350|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
125038254|NCT02660580|449759351|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
125038255|NCT02660580|449759347|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
125038256|NCT02660580|449759348|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
125038257|NCT02660580|449759349|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
125038258|NCT02660580|449759350|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
125038259|NCT02660580|449759351|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
125038260|NCT02660580|449759347|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
125038261|NCT02660580|449759348|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
125038262|NCT02660580|449759349|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
125038263|NCT02660580|449759350|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
125038264|NCT02660580|449759351|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
125038265|NCT02660580|449759347|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
125134321|NCT04852978|450115631|FG007|Overall Study|Sponsor request|0|||
125134322|NCT04852978|450115632|FG008|Overall Study|Sponsor request|0|||
125134323|NCT04852978|450115624|FG000|Overall Study|Death|0|||
125134324|NCT04852978|450115625|FG001|Overall Study|Death|0|||
125134325|NCT04852978|450115626|FG002|Overall Study|Death|0|||
125134326|NCT04852978|450115627|FG003|Overall Study|Death|0|||
125134327|NCT04852978|450115628|FG004|Overall Study|Death|0|||
125134328|NCT04852978|450115629|FG005|Overall Study|Death|0|||
125134329|NCT04852978|450115630|FG006|Overall Study|Death|1|||
125134330|NCT04852978|450115631|FG007|Overall Study|Death|0|||
125134331|NCT04852978|450115632|FG008|Overall Study|Death|0|||
125134332|NCT04852978|450115624|FG000|Overall Study|Lost to Follow-up|3|||
125134333|NCT04852978|450115625|FG001|Overall Study|Lost to Follow-up|2|||
125134334|NCT04852978|450115626|FG002|Overall Study|Lost to Follow-up|2|||
125134335|NCT04852978|450115627|FG003|Overall Study|Lost to Follow-up|0|||
125134336|NCT04852978|450115628|FG004|Overall Study|Lost to Follow-up|2|||
125134337|NCT04852978|450115629|FG005|Overall Study|Lost to Follow-up|4|||
125134338|NCT04852978|450115630|FG006|Overall Study|Lost to Follow-up|1|||
125134339|NCT04852978|450115631|FG007|Overall Study|Lost to Follow-up|2|||
125134340|NCT04852978|450115632|FG008|Overall Study|Lost to Follow-up|2|||
124974370|NCT03926195|449534479|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
124974371|NCT03926195|449534478|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
124974372|NCT03926195|449534479|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
124974373|NCT03926195|449534478|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
124974374|NCT03926195|449534479|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
124974375|NCT00447590|449534486|FG000|Overall Study|Withdrawal by Subject|26|||
124974376|NCT00447590|449534486|FG000|Overall Study|Lost to Follow-up|24|||
124974377|NCT00447590|449534486|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
124974378|NCT01689857|449534487|FG000|Overall Study|Lost to Follow-up|5|||
124974379|NCT01689857|449534488|FG001|Overall Study|Lost to Follow-up|2|||
124974380|NCT05105087|449534489|FG000|Overall Study|Withdrawal by Subject|2|||
124974381|NCT05105087|449534489|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
124974382|NCT01736540|449534490|FG000|Overall Study|Did not complete scan within 45 days|2|||
124974383|NCT01736540|449534490|FG000|Overall Study|Death|1|||
124974384|NCT01736540|449534490|FG000|Overall Study|Abnormal test procedure|1|||
124974385|NCT01736540|449534490|FG000|Overall Study|Withdrawal by Subject|5|||
124974386|NCT01736540|449534490|FG000|Overall Study|Protocol Violation|1|||
124974387|NCT01736540|449534490|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
124974388|NCT01736540|449534490|FG000|Overall Study|No show for MRI appointment|1|||
124974389|NCT01736540|449534490|FG000|Overall Study|Unable to make MRI appointment|3|||
124974390|NCT00479882|449534491|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
124974391|NCT00479882|449534492|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
124974392|NCT00479882|449534493|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
124974393|NCT00479882|449534494|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
124974394|NCT00479882|449534491|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
124974395|NCT00479882|449534492|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
124974396|NCT00479882|449534493|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
124974397|NCT00479882|449534494|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
124974398|NCT00479882|449534491|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
124974399|NCT00479882|449534492|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
124974400|NCT00479882|449534493|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
124974401|NCT00479882|449534494|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
124974402|NCT00479882|449534491|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
124974403|NCT00479882|449534492|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
124974404|NCT00479882|449534493|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
124974405|NCT00479882|449534494|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
124974406|NCT00479882|449534491|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
124974407|NCT00479882|449534492|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
124974408|NCT00479882|449534493|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
124974409|NCT00479882|449534494|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
124974410|NCT00479882|449534491|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
124974411|NCT00479882|449534492|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
124974412|NCT00479882|449534493|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
124974413|NCT00479882|449534494|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
124974414|NCT00479882|449534491|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
124974415|NCT00479882|449534492|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
124974416|NCT00479882|449534493|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
124974417|NCT00479882|449534494|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
124974418|NCT00479882|449534491|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
124974419|NCT00479882|449534492|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
124974420|NCT00479882|449534493|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
124974421|NCT00479882|449534494|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
124974422|NCT00479882|449534491|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
124974423|NCT00479882|449534492|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
125134341|NCT04852978|450115624|FG000|Overall Study|Withdrawal by Subject|4|||
125218510|NCT00436826|450427348|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
125134342|NCT04852978|450115625|FG001|Overall Study|Withdrawal by Subject|2|||
125134343|NCT04852978|450115626|FG002|Overall Study|Withdrawal by Subject|2|||
125134344|NCT04852978|450115627|FG003|Overall Study|Withdrawal by Subject|1|||
125134345|NCT04852978|450115628|FG004|Overall Study|Withdrawal by Subject|5|||
125134346|NCT04852978|450115629|FG005|Overall Study|Withdrawal by Subject|3|||
125134347|NCT04852978|450115630|FG006|Overall Study|Withdrawal by Subject|2|||
125134348|NCT04852978|450115631|FG007|Overall Study|Withdrawal by Subject|2|||
124974424|NCT00479882|449534493|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
124974425|NCT00479882|449534494|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
124974426|NCT00479882|449534491|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
124974427|NCT00479882|449534492|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
124974428|NCT00479882|449534493|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
124974429|NCT00479882|449534494|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
124974430|NCT00479882|449534491|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
124974431|NCT00479882|449534492|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
124974432|NCT00479882|449534493|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
124974433|NCT00479882|449534494|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
124974434|NCT00479882|449534491|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
124974435|NCT00479882|449534492|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
124974436|NCT00479882|449534493|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
124974437|NCT00479882|449534494|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
124974438|NCT00479882|449534491|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
124974439|NCT00479882|449534492|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
124974440|NCT00479882|449534493|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
124974441|NCT00479882|449534494|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
124974442|NCT00479882|449534491|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
124974443|NCT00479882|449534492|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
124974444|NCT00479882|449534493|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
124974445|NCT00479882|449534494|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
124974446|NCT03738475|449534495|FG000|Overall Study|Participant Non-Compliance|1|||
124974447|NCT03738475|449534496|FG001|Overall Study|Participant Non-Compliance|0|||
124974448|NCT02159040|449534499|FG000|Overall Study|Death|1|||
124974449|NCT02803593|449534502|FG000|Overall Study|Lost to Follow-up|17|||
124974450|NCT02803593|449534503|FG001|Overall Study|Lost to Follow-up|35|||
124974451|NCT03443414|449534506|FG000|Overall Study|Adverse Event|6|||
124974452|NCT03443414|449534507|FG001|Overall Study|Adverse Event|0|||
124974453|NCT03443414|449534508|FG002|Overall Study|Adverse Event|4|||
124974454|NCT03443414|449534509|FG003|Overall Study|Adverse Event|2|||
124974455|NCT03443414|449534510|FG004|Overall Study|Adverse Event|3|||
124974456|NCT03443414|449534506|FG000|Overall Study|Withdrawal by Subject|3|||
124974457|NCT03443414|449534507|FG001|Overall Study|Withdrawal by Subject|2|||
124974458|NCT03443414|449534508|FG002|Overall Study|Withdrawal by Subject|2|||
124974459|NCT03443414|449534509|FG003|Overall Study|Withdrawal by Subject|2|||
124974460|NCT03443414|449534510|FG004|Overall Study|Withdrawal by Subject|1|||
124974461|NCT03443414|449534506|FG000|Overall Study|Death|0|||
124974462|NCT03443414|449534507|FG001|Overall Study|Death|1|||
124974463|NCT03443414|449534508|FG002|Overall Study|Death|0|||
124974464|NCT03443414|449534509|FG003|Overall Study|Death|1|||
124974465|NCT03443414|449534510|FG004|Overall Study|Death|0|||
124974466|NCT03443414|449534506|FG000|Overall Study|Reason not specified|2|||
124974467|NCT03443414|449534507|FG001|Overall Study|Reason not specified|0|||
124974468|NCT03443414|449534508|FG002|Overall Study|Reason not specified|0|||
124974469|NCT03443414|449534509|FG003|Overall Study|Reason not specified|0|||
124974470|NCT03443414|449534510|FG004|Overall Study|Reason not specified|1|||
124974471|NCT00732992|449534511|FG000|Overall Study|Adverse Event|1|||
124974472|NCT00732992|449534512|FG001|Overall Study|Adverse Event|1|||
124974473|NCT00732992|449534511|FG000|Overall Study|Objective Progression or Relapse|3|||
124974474|NCT00732992|449534512|FG001|Overall Study|Objective Progression or Relapse|5|||
124974475|NCT00732992|449534511|FG000|Overall Study|Global Deterioration of Health Status|1|||
124974476|NCT00732992|449534512|FG001|Overall Study|Global Deterioration of Health Status|0|||
124974477|NCT00732992|449534511|FG000|Overall Study|Withdrawal by Subject|1|||
124974478|NCT00732992|449534512|FG001|Overall Study|Withdrawal by Subject|0|||
124974479|NCT03933462|449534515|FG000|Overall Study|Adverse Event|2|||
124974480|NCT03933462|449534516|FG001|Overall Study|Adverse Event|0|||
124974481|NCT00422734|449534522|FG000|Overall Study|Physician Decision|1|||
124974482|NCT00422734|449534523|FG001|Overall Study|Physician Decision|1|||
124974483|NCT00422734|449534522|FG000|Overall Study|Protocol Violation|1|||
124974484|NCT00422734|449534523|FG001|Overall Study|Protocol Violation|6|||
124974485|NCT00422734|449534522|FG000|Overall Study|Withdrawal by Subject|12|||
125038266|NCT02660580|449759348|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
125038267|NCT02660580|449759349|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
125038268|NCT02660580|449759350|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
125038269|NCT02660580|449759351|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
125038270|NCT00377962|449759352|FG000|Core Study: 0-12 Months|Adverse Event|18|||
125038271|NCT00377962|449759353|FG001|Core Study: 0-12 Months|Adverse Event|2|||
125038272|NCT00377962|449759352|FG000|Core Study: 0-12 Months|Death|3|||
125038273|NCT00377962|449759353|FG001|Core Study: 0-12 Months|Death|0|||
125038274|NCT00377962|449759352|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
125038275|NCT00377962|449759353|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
125038276|NCT00377962|449759352|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
125038277|NCT00377962|449759353|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
125038278|NCT00377962|449759352|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
125038279|NCT00377962|449759353|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
125038280|NCT00377962|449759352|FG000|Extension Study: 12-24 Months|Death|1|||
125038281|NCT00377962|449759353|FG001|Extension Study: 12-24 Months|Death|1|||
125038282|NCT00377962|449759352|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
125038283|NCT00377962|449759353|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
125038284|NCT00377962|449759352|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
125038285|NCT00377962|449759353|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
125038286|NCT00377962|449759352|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
125038287|NCT00377962|449759353|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
125038288|NCT05224258|449759356|FG000|Overall Study|Withdrawal by Subject|1|||
125038289|NCT05224258|449759357|FG001|Overall Study|Withdrawal by Subject|1|||
125038290|NCT05224258|449759356|FG000|Overall Study|Physician Decision|1|||
125038291|NCT05224258|449759357|FG001|Overall Study|Physician Decision|1|||
125038292|NCT05224258|449759356|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
125038293|NCT05224258|449759357|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125038294|NCT05224258|449759356|FG000|Overall Study|Study Product No Longer in Use|1|||
125038295|NCT05224258|449759357|FG001|Overall Study|Study Product No Longer in Use|0|||
125038296|NCT05224258|449759356|FG000|Overall Study|Adverse Event|0|||
125038297|NCT05224258|449759357|FG001|Overall Study|Adverse Event|1|||
125038298|NCT05224258|449759356|FG000|Overall Study|Protocol Deviation|0|||
125038299|NCT05224258|449759357|FG001|Overall Study|Protocol Deviation|1|||
125038300|NCT00486902|449759358|FG000|Overall Study|Withdrawal by Subject|1|||
125038301|NCT00486902|449759359|FG001|Overall Study|Withdrawal by Subject|2|||
125038302|NCT00486902|449759358|FG000|Overall Study|decision for postpartum tubal ligation|3|||
125038303|NCT00486902|449759359|FG001|Overall Study|decision for postpartum tubal ligation|1|||
125038304|NCT00486902|449759358|FG000|Overall Study|spinal anesthetic protocal violation|1|||
125038305|NCT00486902|449759359|FG001|Overall Study|spinal anesthetic protocal violation|1|||
125038306|NCT00486902|449759358|FG000|Overall Study|Did not meet inclusion criteria|1|||
125038307|NCT00486902|449759359|FG001|Overall Study|Did not meet inclusion criteria|0|||
125038308|NCT00486902|449759358|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
125038309|NCT00486902|449759359|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
125038310|NCT04645797|449759362|FG000|Overall Study|Disease Progression|3|||
125038311|NCT04645797|449759363|FG001|Overall Study|Disease Progression|3|||
125038312|NCT04645797|449759364|FG002|Overall Study|Disease Progression|1|||
125038313|NCT04645797|449759365|FG003|Overall Study|Disease Progression|0|||
125038314|NCT04645797|449759366|FG004|Overall Study|Disease Progression|0|||
125038315|NCT04645797|449759367|FG005|Overall Study|Disease Progression|0|||
125038316|NCT04645797|449759368|FG006|Overall Study|Disease Progression|0|||
125038317|NCT04645797|449759362|FG000|Overall Study|Death|3|||
125038318|NCT04645797|449759363|FG001|Overall Study|Death|1|||
125038319|NCT04645797|449759364|FG002|Overall Study|Death|0|||
125038320|NCT04645797|449759365|FG003|Overall Study|Death|0|||
125038321|NCT04645797|449759366|FG004|Overall Study|Death|0|||
125038322|NCT04645797|449759367|FG005|Overall Study|Death|0|||
125038323|NCT04645797|449759368|FG006|Overall Study|Death|0|||
125038324|NCT00733902|449759369|FG000|Overall Study|Death|0|||
125038325|NCT00733902|449759370|FG001|Overall Study|Death|0|||
125038326|NCT00733902|449759371|FG002|Overall Study|Death|0|||
125038327|NCT00733902|449759372|FG003|Overall Study|Death|1|||
125038328|NCT00733902|449759369|FG000|Overall Study|Adverse Event|3|||
125038329|NCT00733902|449759370|FG001|Overall Study|Adverse Event|4|||
125038330|NCT00733902|449759371|FG002|Overall Study|Adverse Event|7|||
125038331|NCT00733902|449759372|FG003|Overall Study|Adverse Event|11|||
125038332|NCT00733902|449759369|FG000|Overall Study|Lack of Efficacy|56|||
125038333|NCT00733902|449759370|FG001|Overall Study|Lack of Efficacy|21|||
125038334|NCT00733902|449759371|FG002|Overall Study|Lack of Efficacy|34|||
125038335|NCT00733902|449759372|FG003|Overall Study|Lack of Efficacy|23|||
125038336|NCT00733902|449759369|FG000|Overall Study|Protocol Violation|4|||
125038337|NCT00733902|449759370|FG001|Overall Study|Protocol Violation|6|||
125038338|NCT00733902|449759371|FG002|Overall Study|Protocol Violation|3|||
125038339|NCT00733902|449759372|FG003|Overall Study|Protocol Violation|3|||
125038340|NCT00733902|449759369|FG000|Overall Study|Withdrawal by Subject|10|||
125038341|NCT00733902|449759370|FG001|Overall Study|Withdrawal by Subject|5|||
124974486|NCT00422734|449534523|FG001|Overall Study|Withdrawal by Subject|8|||
124974487|NCT00422734|449534522|FG000|Overall Study|Adverse Event|0|||
124974488|NCT00422734|449534523|FG001|Overall Study|Adverse Event|3|||
124974489|NCT00422734|449534522|FG000|Overall Study|Partner Decision|0|||
124974490|NCT00422734|449534523|FG001|Overall Study|Partner Decision|3|||
124974491|NCT00368875|449534531|FG000|Overall Study|Adverse Event|0|||
124974492|NCT00368875|449534532|FG001|Overall Study|Adverse Event|12|||
124974493|NCT00368875|449534531|FG000|Overall Study|Progressive disease|3|||
124974494|NCT00368875|449534532|FG001|Overall Study|Progressive disease|27|||
124974495|NCT00368875|449534531|FG000|Overall Study|Withdrawal by Subject|2|||
124974496|NCT00368875|449534532|FG001|Overall Study|Withdrawal by Subject|6|||
124974497|NCT00368875|449534531|FG000|Overall Study|Other Reason|0|||
124974498|NCT00368875|449534532|FG001|Overall Study|Other Reason|2|||
124974499|NCT00368875|449534531|FG000|Overall Study|Alternative Therapy|1|||
124974500|NCT00368875|449534532|FG001|Overall Study|Alternative Therapy|1|||
124974501|NCT00996606|449534540|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
124974502|NCT00996606|449534540|FG000|Overall Study|Insufficient Therapeutic Response|2|||
124974503|NCT00996606|449534540|FG000|Overall Study|Protocol Violation|1|||
124974504|NCT00996606|449534540|FG000|Overall Study|Withdrawal by Subject|3|||
124974505|NCT00632502|449534543|FG000|Overall Study|Adverse Event|0|||
124974506|NCT00632502|449534544|FG001|Overall Study|Adverse Event|1|||
124974507|NCT00632502|449534543|FG000|Overall Study|Randomized not treated|3|||
124974508|NCT00632502|449534544|FG001|Overall Study|Randomized not treated|0|||
124974509|NCT00681668|449534547|FG000|Overall Study|Protocol Violation|1|||
124974510|NCT00681668|449534547|FG000|Overall Study|Withdrawal by Subject|1|||
124974511|NCT02209181|449534548|FG000|Overall Study|Adverse Event|1|||
124974512|NCT02209181|449534549|FG001|Overall Study|Adverse Event|0|||
124974513|NCT02209181|449534550|FG002|Overall Study|Adverse Event|1|||
124974514|NCT02209181|449534551|FG003|Overall Study|Adverse Event|0|||
124974515|NCT02209181|449534548|FG000|Overall Study|Withdrawal by Subject|0|||
124974516|NCT02209181|449534549|FG001|Overall Study|Withdrawal by Subject|1|||
124974517|NCT02209181|449534550|FG002|Overall Study|Withdrawal by Subject|0|||
124974518|NCT02209181|449534551|FG003|Overall Study|Withdrawal by Subject|0|||
124974519|NCT02548078|449534552|FG000|Overall Study|Serious adverse event/Adverse event|1|||
124974520|NCT02548078|449534553|FG001|Overall Study|Serious adverse event/Adverse event|0|||
124974521|NCT02548078|449534552|FG000|Overall Study|Moved from study area|3|||
124974522|NCT02548078|449534553|FG001|Overall Study|Moved from study area|3|||
124974523|NCT02548078|449534552|FG000|Overall Study|Lost to Follow-up|1|||
124974524|NCT02548078|449534553|FG001|Overall Study|Lost to Follow-up|3|||
124974525|NCT03128671|449534558|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
124974526|NCT03128671|449534559|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
124974527|NCT03128671|449534558|FG000|Allocation|Death|1|||
124974528|NCT03128671|449534559|FG001|Allocation|Death|0|||
124974529|NCT03128671|449534558|FG000|Allocation|Withdrawal by Subject|4|||
124974530|NCT03128671|449534559|FG001|Allocation|Withdrawal by Subject|0|||
124974531|NCT03128671|449534558|FG000|Intervention|Withdrawal by Subject|11|||
124974532|NCT03128671|449534559|FG001|Intervention|Withdrawal by Subject|10|||
124974533|NCT03128671|449534558|FG000|Intervention|Palliative/hospice care initiated|9|||
124974534|NCT03128671|449534559|FG001|Intervention|Palliative/hospice care initiated|10|||
124974535|NCT03128671|449534558|FG000|Intervention|Death|13|||
124974536|NCT03128671|449534559|FG001|Intervention|Death|11|||
124974537|NCT03128671|449534558|FG000|Intervention|Interrupted by hurricane|1|||
124974538|NCT03128671|449534559|FG001|Intervention|Interrupted by hurricane|0|||
124974539|NCT03128671|449534558|FG000|Intervention|Physician Decision|2|||
124974540|NCT03128671|449534559|FG001|Intervention|Physician Decision|3|||
124974541|NCT04641962|449534561|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
124974542|NCT04641962|449534562|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
124974543|NCT04641962|449534563|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
124974544|NCT04641962|449534564|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
124974545|NCT04641962|449534565|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
124974546|NCT04641962|449534561|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
124974547|NCT04641962|449534562|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
124974548|NCT04641962|449534563|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
124974549|NCT04641962|449534564|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
124974550|NCT04641962|449534565|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
124974551|NCT04641962|449534561|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
124974552|NCT04641962|449534562|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
124974553|NCT04641962|449534563|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
124974554|NCT04641962|449534564|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
124974555|NCT04641962|449534565|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
124974556|NCT04641962|449534561|FG000|DBT Period: Up to 52 Weeks|Death|1|||
124974557|NCT04641962|449534562|FG001|DBT Period: Up to 52 Weeks|Death|0|||
124974558|NCT04641962|449534563|FG002|DBT Period: Up to 52 Weeks|Death|0|||
124974559|NCT04641962|449534564|FG003|DBT Period: Up to 52 Weeks|Death|0|||
124974560|NCT04641962|449534565|FG004|DBT Period: Up to 52 Weeks|Death|0|||
125038342|NCT00733902|449759371|FG002|Overall Study|Withdrawal by Subject|4|||
125038343|NCT00733902|449759372|FG003|Overall Study|Withdrawal by Subject|16|||
125038344|NCT00733902|449759369|FG000|Overall Study|Entered extension study|89|||
125038345|NCT00733902|449759370|FG001|Overall Study|Entered extension study|124|||
125038346|NCT00733902|449759371|FG002|Overall Study|Entered extension study|111|||
125038347|NCT00733902|449759372|FG003|Overall Study|Entered extension study|109|||
125038348|NCT00733902|449759369|FG000|Overall Study|Randomized but not treated|2|||
125038349|NCT00733902|449759370|FG001|Overall Study|Randomized but not treated|2|||
125038350|NCT00733902|449759371|FG002|Overall Study|Randomized but not treated|2|||
125038351|NCT00733902|449759372|FG003|Overall Study|Randomized but not treated|1|||
125038352|NCT00049127|449759373|FG000|Overall Study|Withdrawal by Subject|0|||
125038353|NCT00049127|449759374|FG001|Overall Study|Withdrawal by Subject|0|||
125038354|NCT00049127|449759375|FG002|Overall Study|Withdrawal by Subject|1|||
125038355|NCT00049127|449759376|FG003|Overall Study|Withdrawal by Subject|0|||
125038356|NCT00049127|449759377|FG004|Overall Study|Withdrawal by Subject|0|||
125038357|NCT02599402|449759378|FG000|Overall Study|Disease progression|153|||
125038358|NCT02599402|449759378|FG000|Overall Study|Study drug toxicity|201|||
125038359|NCT02599402|449759378|FG000|Overall Study|Death|26|||
125038360|NCT02599402|449759378|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
125038361|NCT02599402|449759378|FG000|Overall Study|Participant request to discontinue study treatment|13|||
125038362|NCT02599402|449759378|FG000|Overall Study|Participant withdrew consent|5|||
125038363|NCT02599402|449759378|FG000|Overall Study|Lost to Follow-up|1|||
125038364|NCT02599402|449759378|FG000|Overall Study|Maximum Clinical Benefit|7|||
125038365|NCT02599402|449759378|FG000|Overall Study|Poor/non-compliance|1|||
125038366|NCT02599402|449759378|FG000|Overall Study|Pregnancy|1|||
125038367|NCT02599402|449759378|FG000|Overall Study|Participant no longer met study criteria|7|||
125038368|NCT02599402|449759378|FG000|Overall Study|Other Reasons|95|||
125038369|NCT00833092|449759379|FG000|Overall Study|Withdrawal by Subject|2|||
125038370|NCT00833092|449759380|FG001|Overall Study|Withdrawal by Subject|3|||
125038371|NCT00833092|449759379|FG000|Overall Study|Protocol Violation|2|||
125038372|NCT00833092|449759380|FG001|Overall Study|Protocol Violation|1|||
125038373|NCT00833092|449759379|FG000|Overall Study|Diarrhea|0|||
125038374|NCT00833092|449759380|FG001|Overall Study|Diarrhea|2|||
125038375|NCT00833092|449759379|FG000|Overall Study|constipation|0|||
125038376|NCT00833092|449759380|FG001|Overall Study|constipation|1|||
125038377|NCT00699192|449759381|FG000|Overall Study|Missing|1|||
125038378|NCT00699192|449759382|FG001|Overall Study|Missing|1|||
125038379|NCT00699192|449759383|FG002|Overall Study|Missing|1|||
125038380|NCT00699192|449759381|FG000|Overall Study|Adverse Event|9|||
125038381|NCT00699192|449759382|FG001|Overall Study|Adverse Event|4|||
125038382|NCT00699192|449759383|FG002|Overall Study|Adverse Event|3|||
125038383|NCT00699192|449759381|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125038384|NCT00699192|449759382|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125038385|NCT00699192|449759383|FG002|Overall Study|Abnormal test procedure result(s)|1|||
125038386|NCT00699192|449759381|FG000|Overall Study|Lack of Efficacy|0|||
125038387|NCT00699192|449759382|FG001|Overall Study|Lack of Efficacy|0|||
125038388|NCT00699192|449759383|FG002|Overall Study|Lack of Efficacy|1|||
125038389|NCT00699192|449759381|FG000|Overall Study|Withdrawal by Subject|3|||
125038390|NCT00699192|449759382|FG001|Overall Study|Withdrawal by Subject|2|||
125038391|NCT00699192|449759383|FG002|Overall Study|Withdrawal by Subject|4|||
125038392|NCT00699192|449759381|FG000|Overall Study|Administrative problems|1|||
125038393|NCT00699192|449759382|FG001|Overall Study|Administrative problems|3|||
125038394|NCT00699192|449759383|FG002|Overall Study|Administrative problems|1|||
125038395|NCT00699192|449759381|FG000|Overall Study|Protocol Violation|2|||
125038396|NCT00699192|449759382|FG001|Overall Study|Protocol Violation|2|||
125038397|NCT00699192|449759383|FG002|Overall Study|Protocol Violation|0|||
125038398|NCT01773473|449759384|FG000|Overall Study|Adverse Event|3|||
125038399|NCT01773473|449759385|FG001|Overall Study|Adverse Event|2|||
125038400|NCT01773473|449759384|FG000|Overall Study|Protocol Violation|0|||
125038401|NCT01773473|449759385|FG001|Overall Study|Protocol Violation|4|||
125134349|NCT04852978|450115632|FG008|Overall Study|Withdrawal by Subject|1|||
125134350|NCT00859430|450115633|FG000|First Intervention|Withdrawal by Subject|0|||
125134351|NCT00859430|450115634|FG001|First Intervention|Withdrawal by Subject|1|||
125134352|NCT00001703|450118134|FG000|Overall Study|progressed disease|2|||
125038402|NCT01773473|449759384|FG000|Overall Study|Physician Decision|3|||
125038403|NCT01773473|449759385|FG001|Overall Study|Physician Decision|5|||
125038404|NCT01773473|449759384|FG000|Overall Study|Sponsor Decision|2|||
125038405|NCT01773473|449759385|FG001|Overall Study|Sponsor Decision|0|||
125038406|NCT01773473|449759384|FG000|Overall Study|Lack of Efficacy|0|||
125038407|NCT01773473|449759385|FG001|Overall Study|Lack of Efficacy|1|||
125038408|NCT01773473|449759384|FG000|Overall Study|Non-Compliance with study drug|1|||
125038409|NCT01773473|449759385|FG001|Overall Study|Non-Compliance with study drug|4|||
125038410|NCT01773473|449759384|FG000|Overall Study|Withdrawal by Subject|5|||
125038411|NCT01773473|449759385|FG001|Overall Study|Withdrawal by Subject|3|||
125038412|NCT01773473|449759384|FG000|Overall Study|Lost to Follow-up|2|||
125038413|NCT01773473|449759385|FG001|Overall Study|Lost to Follow-up|0|||
125134353|NCT00001703|450118134|FG000|Overall Study|No evidence of disease|1|||
125134354|NCT00001703|450118134|FG000|Overall Study|recurrent disease|2|||
125038414|NCT04927312|449759388|FG000|Overall Study|Adverse Event|1|||
125038415|NCT04927312|449759388|FG000|Overall Study|Death|1|||
125038416|NCT04927312|449759388|FG000|Overall Study|Withdrawal by Subject|1|||
125038417|NCT04927312|449759388|FG000|Overall Study|Other|1|||
125038418|NCT04919564|449759391|FG000|Overall Study|Lost to Follow-up|1|||
125038419|NCT04919564|449759392|FG001|Overall Study|Lost to Follow-up|0|||
125038420|NCT04919564|449759391|FG000|Overall Study|Physician Decision|1|||
125134355|NCT03733730|450118137|FG000|Overall Study|Lost to Follow-up|1|||
125134356|NCT03733730|450118138|FG001|Overall Study|Lost to Follow-up|32|||
125038421|NCT04919564|449759392|FG001|Overall Study|Physician Decision|1|||
125038422|NCT01241786|449759393|FG000|Overall Study|Lack of Efficacy|5|||
125038423|NCT01122927|449759395|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
125038424|NCT01122927|449759396|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
125038425|NCT01122927|449759395|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
125038426|NCT01122927|449759396|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
125038427|NCT01122927|449759395|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
125038428|NCT01122927|449759396|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
125038429|NCT01122927|449759395|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
125038430|NCT01122927|449759396|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
125038431|NCT01122927|449759395|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
125038432|NCT01122927|449759396|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
125038433|NCT01122927|449759395|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
125038434|NCT01122927|449759396|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
125038435|NCT01122927|449759395|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
125038436|NCT01122927|449759396|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
125038437|NCT01122927|449759395|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
125038438|NCT01122927|449759396|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
125038439|NCT01122927|449759395|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
125038440|NCT01122927|449759396|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
125038441|NCT01122927|449759395|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
125038442|NCT01122927|449759396|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
125038443|NCT01122927|449759395|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
125038444|NCT01122927|449759396|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
125038445|NCT01122927|449759395|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
125038446|NCT01122927|449759396|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
125038447|NCT02286102|449759399|FG000|Overall Study|Screen Failure|1|||
125038448|NCT02286102|449759400|FG001|Overall Study|Screen Failure|1|||
125038449|NCT01440101|449759401|FG000|Overall Study|Adverse Event|2|||
125038450|NCT01440101|449759402|FG001|Overall Study|Adverse Event|0|||
125038451|NCT01440101|449759403|FG002|Overall Study|Adverse Event|0|||
125038452|NCT01440101|449759401|FG000|Overall Study|Withdrawal by Subject|0|||
125134357|NCT03733730|450118137|FG000|Overall Study|Other|1|||
125134358|NCT03733730|450118138|FG001|Overall Study|Other|0|||
125134359|NCT03733730|450118137|FG000|Overall Study|Adverse Event|0|||
124974561|NCT04641962|449534561|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
124974562|NCT04641962|449534562|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
124974563|NCT04641962|449534563|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
124974564|NCT04641962|449534564|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
124974565|NCT04641962|449534565|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
124974566|NCT04641962|449534561|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
124974567|NCT04641962|449534562|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
124974568|NCT04641962|449534563|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
124974569|NCT04641962|449534564|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
124974570|NCT04641962|449534565|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
124974571|NCT04641962|449534561|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
124974572|NCT04641962|449534562|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
124974573|NCT04641962|449534563|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
124974574|NCT04641962|449534564|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
125038453|NCT01440101|449759402|FG001|Overall Study|Withdrawal by Subject|3|||
125134360|NCT03733730|450118138|FG001|Overall Study|Adverse Event|4|||
125134361|NCT03733730|450118137|FG000|Overall Study|Death|0|||
125134362|NCT03733730|450118138|FG001|Overall Study|Death|5|||
124974575|NCT04641962|449534565|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
124974576|NCT00862836|449534567|FG000|Overall Study|Withdrawal by Subject|1|||
124974577|NCT04463680|449534568|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
124974578|NCT04463680|449534568|FG000|Overall Study|Not eligible due to implant duration of use|1|||
125038454|NCT01440101|449759403|FG002|Overall Study|Withdrawal by Subject|1|||
125038455|NCT01440101|449759401|FG000|Overall Study|Other|0|||
125038456|NCT01440101|449759402|FG001|Overall Study|Other|1|||
125038457|NCT01440101|449759403|FG002|Overall Study|Other|0|||
125038458|NCT00201851|449759404|FG000|Overall Study|Lost to Follow-up|2|||
125134363|NCT03733730|450118137|FG000|Overall Study|Withdrawal by Subject|0|||
124974579|NCT04463680|449534568|FG000|Overall Study|Withdrawal by Subject|3|||
124974580|NCT05239598|449534571|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
124974581|NCT05239598|449534572|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
124974582|NCT05239598|449534571|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
124974583|NCT05239598|449534572|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
124974584|NCT05823012|449534575|FG000|Titration Period|Adverse Event|1|||
124974585|NCT05823012|449534575|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
124974586|NCT05823012|449534575|FG000|Maintenance Period|Adverse Event|1|||
124974587|NCT05823012|449534575|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
124974588|NCT05823012|449534575|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
124974589|NCT01381575|449536426|FG000|Overall Study|Serious Adverse Event|1|||
124974590|NCT01381575|449536427|FG001|Overall Study|Serious Adverse Event|0|||
124974591|NCT01381575|449536428|FG002|Overall Study|Serious Adverse Event|0|||
124974592|NCT01381575|449536426|FG000|Overall Study|Non-Serious Adverse Event|0|||
124974593|NCT01381575|449536427|FG001|Overall Study|Non-Serious Adverse Event|0|||
124974594|NCT01381575|449536428|FG002|Overall Study|Non-Serious Adverse Event|1|||
124974595|NCT01381575|449536426|FG000|Overall Study|Protocol Violation|0|||
124974596|NCT01381575|449536427|FG001|Overall Study|Protocol Violation|1|||
124974597|NCT01381575|449536428|FG002|Overall Study|Protocol Violation|1|||
124974598|NCT01381575|449536426|FG000|Overall Study|Withdrawal by Subject|15|||
125134364|NCT03733730|450118138|FG001|Overall Study|Withdrawal by Subject|8|||
125134365|NCT01531894|450118139|FG000|Overall Study|Physician Decision|8|||
125134366|NCT01531894|450118139|FG000|Overall Study|Death|1|||
125218511|NCT00436826|450427349|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
125218512|NCT00436826|450427350|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
125218513|NCT00436826|450427351|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
125218514|NCT00436826|450427346|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
125218515|NCT00436826|450427347|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
124974599|NCT01381575|449536427|FG001|Overall Study|Withdrawal by Subject|9|||
124974600|NCT01381575|449536428|FG002|Overall Study|Withdrawal by Subject|7|||
124974601|NCT01381575|449536426|FG000|Overall Study|Migrated/moved from study area|2|||
124974602|NCT01381575|449536427|FG001|Overall Study|Migrated/moved from study area|12|||
124974603|NCT01381575|449536428|FG002|Overall Study|Migrated/moved from study area|2|||
124974604|NCT01381575|449536426|FG000|Overall Study|Lost to Follow-up|8|||
124974605|NCT01381575|449536427|FG001|Overall Study|Lost to Follow-up|17|||
124974606|NCT01381575|449536428|FG002|Overall Study|Lost to Follow-up|9|||
124974607|NCT01920477|449536429|FG000|Overall Study|Adverse Event|0|||
125134367|NCT06195579|450118140|FG000|Overall Study|Withdrawal by Subject|1|||
125134368|NCT02545283|450118141|FG000|Overall Study|Lost to Follow-up|2|||
125134369|NCT02545283|450118142|FG001|Overall Study|Lost to Follow-up|4|||
125134370|NCT02545283|450118141|FG000|Overall Study|Withdrawal by Subject|5|||
125134371|NCT02545283|450118142|FG001|Overall Study|Withdrawal by Subject|9|||
125218516|NCT00436826|450427348|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
125218517|NCT00436826|450427349|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
125218518|NCT00436826|450427350|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
125218519|NCT00436826|450427351|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
125218520|NCT00436826|450427346|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
125218521|NCT00436826|450427347|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
125218522|NCT00436826|450427348|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
125218523|NCT00436826|450427349|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
125134372|NCT02545283|450118141|FG000|Overall Study|Death|109|||
125218524|NCT00436826|450427350|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
125218525|NCT00436826|450427351|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
125218526|NCT00784719|450427352|FG000|Overall Study|Adverse Event|0|||
125218527|NCT00784719|450427353|FG001|Overall Study|Adverse Event|2|||
125218528|NCT00784719|450427354|FG002|Overall Study|Adverse Event|0|||
125218529|NCT00784719|450427355|FG003|Overall Study|Adverse Event|0|||
124974608|NCT01920477|449536430|FG001|Overall Study|Adverse Event|1|||
124974609|NCT01920477|449536429|FG000|Overall Study|Lack of Efficacy|1|||
124974610|NCT01920477|449536430|FG001|Overall Study|Lack of Efficacy|0|||
124974611|NCT01920477|449536429|FG000|Overall Study|Study closed/terminated|14|||
124974612|NCT01920477|449536430|FG001|Overall Study|Study closed/terminated|15|||
124974613|NCT01920477|449536429|FG000|Overall Study|Withdrawal by Subject|0|||
124974614|NCT01920477|449536430|FG001|Overall Study|Withdrawal by Subject|1|||
124974615|NCT01443403|449536431|FG000|Overall Study|Adverse Event|1|||
124974616|NCT01443403|449536432|FG001|Overall Study|Adverse Event|1|||
124974617|NCT01443403|449536433|FG002|Overall Study|Adverse Event|4|||
124974618|NCT01443403|449536434|FG003|Overall Study|Adverse Event|5|||
124974619|NCT01443403|449536431|FG000|Overall Study|Withdrawal by Subject|0|||
124974620|NCT01443403|449536432|FG001|Overall Study|Withdrawal by Subject|1|||
124974621|NCT01443403|449536433|FG002|Overall Study|Withdrawal by Subject|2|||
124974622|NCT01443403|449536434|FG003|Overall Study|Withdrawal by Subject|1|||
124974623|NCT01443403|449536431|FG000|Overall Study|Lost to Follow-up|0|||
124974624|NCT01443403|449536432|FG001|Overall Study|Lost to Follow-up|0|||
124974625|NCT01443403|449536433|FG002|Overall Study|Lost to Follow-up|0|||
124974626|NCT01443403|449536434|FG003|Overall Study|Lost to Follow-up|1|||
124974627|NCT01443403|449536431|FG000|Overall Study|Protocol Violation|2|||
124974628|NCT01443403|449536432|FG001|Overall Study|Protocol Violation|1|||
124974629|NCT01443403|449536433|FG002|Overall Study|Protocol Violation|1|||
125038459|NCT00201851|449759405|FG001|Overall Study|Lost to Follow-up|1|||
125038460|NCT00201851|449759406|FG002|Overall Study|Lost to Follow-up|0|||
125038461|NCT00201851|449759404|FG000|Overall Study|Ineligible post enrollment|6|||
125038462|NCT00201851|449759405|FG001|Overall Study|Ineligible post enrollment|1|||
125038463|NCT00201851|449759406|FG002|Overall Study|Ineligible post enrollment|1|||
125038464|NCT00636818|449759407|FG000|Overall Study|Adverse Event|1|||
125038465|NCT00636818|449759407|FG000|Overall Study|Lost to Follow-up|2|||
125038466|NCT00636818|449759407|FG000|Overall Study|Entry Criteria Exclusion|3|||
125038467|NCT00636818|449759407|FG000|Overall Study|Protocol Violation|1|||
125038468|NCT00636818|449759407|FG000|Overall Study|Withdrawal by Subject|4|||
125038469|NCT00074958|449759408|FG000|Overall Study|Adverse Event|1|||
125038470|NCT01658514|449759412|FG000|Overall Study|Protocol Violation|1|||
125038471|NCT01658514|449759413|FG001|Overall Study|Protocol Violation|0|||
125038472|NCT01658514|449759414|FG002|Overall Study|Protocol Violation|2|||
125038473|NCT01243268|449759415|FG000|Overall Study|Lost to Follow-up|4|||
125038474|NCT01243268|449759415|FG000|Overall Study|Protocol Violation|51|||
125038475|NCT01243268|449759415|FG000|Overall Study|Deviation with contract date|7|||
125038476|NCT01243268|449759415|FG000|Overall Study|Duplicate subject|2|||
125038477|NCT00957853|449759416|FG000|Overall Study|Withdrawal by Subject|1|||
125038478|NCT00957853|449759417|FG001|Overall Study|Withdrawal by Subject|0|||
125038479|NCT00957853|449759418|FG002|Overall Study|Withdrawal by Subject|0|||
125038480|NCT00702143|449759419|FG000|Overall Study|Lost to Follow-up|0|||
125038481|NCT00702143|449759420|FG001|Overall Study|Lost to Follow-up|0|||
125038482|NCT00702143|449759421|FG002|Overall Study|Lost to Follow-up|1|||
125038483|NCT00609622|449759424|FG000|Overall Study|Adverse Event|14|||
125038484|NCT00609622|449759425|FG001|Overall Study|Adverse Event|10|||
125038485|NCT00609622|449759424|FG000|Overall Study|Withdrawal by Subject|4|||
125038486|NCT00609622|449759425|FG001|Overall Study|Withdrawal by Subject|20|||
125038487|NCT00609622|449759424|FG000|Overall Study|Death|1|||
125038488|NCT00609622|449759425|FG001|Overall Study|Death|4|||
125038489|NCT00609622|449759424|FG000|Overall Study|Protocol Violation|1|||
125038490|NCT00609622|449759425|FG001|Overall Study|Protocol Violation|1|||
125038491|NCT00609622|449759424|FG000|Overall Study|Objective progression or relapse|47|||
125038492|NCT00609622|449759425|FG001|Overall Study|Objective progression or relapse|41|||
125038493|NCT00609622|449759424|FG000|Overall Study|Study terminated by sponsor|16|||
125038494|NCT00609622|449759425|FG001|Overall Study|Study terminated by sponsor|3|||
125218530|NCT00784719|450427356|FG004|Overall Study|Adverse Event|1|||
124974630|NCT01443403|449536434|FG003|Overall Study|Protocol Violation|1|||
124974631|NCT01443403|449536431|FG000|Overall Study|Use of Prohibited Treatment|2|||
125038495|NCT00609622|449759424|FG000|Overall Study|Other|7|||
125038496|NCT00609622|449759425|FG001|Overall Study|Other|14|||
125038497|NCT00609622|449759424|FG000|Overall Study|Global deterioration of health status|6|||
125038498|NCT00609622|449759425|FG001|Overall Study|Global deterioration of health status|2|||
125038499|NCT03972488|449759429|FG000|Overall Study|Progressive disease|42|||
125038500|NCT03972488|449759430|FG001|Overall Study|Progressive disease|44|||
125038501|NCT03972488|449759429|FG000|Overall Study|Physician Decision|13|||
125038502|NCT03972488|449759430|FG001|Overall Study|Physician Decision|7|||
125038503|NCT03972488|449759429|FG000|Overall Study|Adverse Event|8|||
125038504|NCT03972488|449759430|FG001|Overall Study|Adverse Event|1|||
125038505|NCT03972488|449759429|FG000|Overall Study|Death|4|||
125134373|NCT02545283|450118142|FG001|Overall Study|Death|211|||
124974632|NCT01443403|449536432|FG001|Overall Study|Use of Prohibited Treatment|3|||
124974633|NCT01443403|449536433|FG002|Overall Study|Use of Prohibited Treatment|0|||
124974634|NCT01443403|449536434|FG003|Overall Study|Use of Prohibited Treatment|0|||
124974635|NCT01443403|449536431|FG000|Overall Study|Other - Miscellaneous|1|||
124974636|NCT01443403|449536432|FG001|Overall Study|Other - Miscellaneous|0|||
124974637|NCT01443403|449536433|FG002|Overall Study|Other - Miscellaneous|0|||
124974638|NCT01443403|449536434|FG003|Overall Study|Other - Miscellaneous|1|||
124974639|NCT01681277|449536435|FG000|Overall Study|Adverse Event|1|||
124974640|NCT01681277|449536436|FG001|Overall Study|Adverse Event|0|||
124974641|NCT01681277|449536437|FG002|Overall Study|Adverse Event|0|||
124974642|NCT01681277|449536438|FG003|Overall Study|Adverse Event|0|||
124974643|NCT01681277|449536439|FG004|Overall Study|Adverse Event|0|||
124974644|NCT00474526|449536440|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
124974645|NCT00474526|449536441|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
124974646|NCT00474526|449536442|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
124974647|NCT00474526|449536443|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
124974648|NCT00474526|449536444|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
124974649|NCT00474526|449536445|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
124974650|NCT00474526|449536446|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
124974651|NCT00474526|449536447|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
124974652|NCT00474526|449536448|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
124974653|NCT00474526|449536449|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
124974654|NCT00474526|449536450|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
124974655|NCT00474526|449536451|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
124974656|NCT00474526|449536452|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
124974657|NCT00474526|449536453|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
124974658|NCT00474526|449536454|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
124974659|NCT00474526|449536455|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
124974660|NCT00474526|449536456|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
124974661|NCT00474526|449536440|FG000|Overall Study|Adverse Event|2|||
124974662|NCT00474526|449536441|FG001|Overall Study|Adverse Event|0|||
124974663|NCT00474526|449536442|FG002|Overall Study|Adverse Event|2|||
124974664|NCT00474526|449536443|FG003|Overall Study|Adverse Event|4|||
124974665|NCT00474526|449536444|FG004|Overall Study|Adverse Event|2|||
124974666|NCT00474526|449536445|FG005|Overall Study|Adverse Event|1|||
124974667|NCT00474526|449536446|FG006|Overall Study|Adverse Event|1|||
124974668|NCT00474526|449536447|FG007|Overall Study|Adverse Event|0|||
124974669|NCT00474526|449536448|FG008|Overall Study|Adverse Event|0|||
124974670|NCT00474526|449536449|FG009|Overall Study|Adverse Event|0|||
124974671|NCT00474526|449536450|FG010|Overall Study|Adverse Event|0|||
124974672|NCT00474526|449536451|FG011|Overall Study|Adverse Event|0|||
124974673|NCT00474526|449536452|FG012|Overall Study|Adverse Event|0|||
124974674|NCT00474526|449536453|FG013|Overall Study|Adverse Event|0|||
124974675|NCT00474526|449536454|FG014|Overall Study|Adverse Event|1|||
124974676|NCT00474526|449536455|FG015|Overall Study|Adverse Event|1|||
124974677|NCT00474526|449536456|FG016|Overall Study|Adverse Event|0|||
124974678|NCT00474526|449536440|FG000|Overall Study|Death|0|||
124974679|NCT00474526|449536441|FG001|Overall Study|Death|0|||
124974680|NCT00474526|449536442|FG002|Overall Study|Death|0|||
124974681|NCT00474526|449536443|FG003|Overall Study|Death|0|||
124974682|NCT00474526|449536444|FG004|Overall Study|Death|0|||
124974683|NCT00474526|449536445|FG005|Overall Study|Death|0|||
124974684|NCT00474526|449536446|FG006|Overall Study|Death|0|||
124974685|NCT00474526|449536447|FG007|Overall Study|Death|0|||
124974686|NCT00474526|449536448|FG008|Overall Study|Death|0|||
124974687|NCT00474526|449536449|FG009|Overall Study|Death|0|||
124974688|NCT00474526|449536450|FG010|Overall Study|Death|0|||
124974689|NCT00474526|449536451|FG011|Overall Study|Death|0|||
124974690|NCT00474526|449536452|FG012|Overall Study|Death|0|||
124974691|NCT00474526|449536453|FG013|Overall Study|Death|3|||
124974692|NCT00474526|449536454|FG014|Overall Study|Death|0|||
124974693|NCT00474526|449536455|FG015|Overall Study|Death|0|||
124974694|NCT00474526|449536456|FG016|Overall Study|Death|0|||
124974695|NCT00474526|449536440|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124974696|NCT00474526|449536441|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
124974697|NCT00474526|449536442|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124974698|NCT00474526|449536443|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
124974699|NCT00474526|449536444|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
124974700|NCT00474526|449536445|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124974701|NCT00474526|449536446|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124974702|NCT00474526|449536447|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124974703|NCT00474526|449536448|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124974704|NCT00474526|449536449|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124974705|NCT00474526|449536450|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
125038506|NCT03972488|449759430|FG001|Overall Study|Death|4|||
125038507|NCT03972488|449759429|FG000|Overall Study|Withdrawal by Subject|3|||
125038508|NCT03972488|449759430|FG001|Overall Study|Withdrawal by Subject|4|||
125038509|NCT03972488|449759429|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
125134374|NCT02545283|450118141|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
125134375|NCT02545283|450118142|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
125134376|NCT02545283|450118141|FG000|Overall Study|Study Terminated By Sponsor|33|||
125134377|NCT02545283|450118142|FG001|Overall Study|Study Terminated By Sponsor|71|||
125134378|NCT03635320|450118143|FG000|Overall Study|not implanted the device|1|||
125134379|NCT03635320|450118144|FG001|Overall Study|not implanted the device|2|||
125134380|NCT03635320|450118143|FG000|Overall Study|Withdrawal by Subject|11|||
125134381|NCT03635320|450118144|FG001|Overall Study|Withdrawal by Subject|6|||
125134382|NCT00835575|450118148|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
125134383|NCT00835575|450118149|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
125134384|NCT00443651|450118150|FG000|Overall Study|Death|1|||
125134385|NCT00443651|450118151|FG001|Overall Study|Death|5|||
125134386|NCT00443651|450118150|FG000|Overall Study|Adverse Event|5|||
125134387|NCT00443651|450118151|FG001|Overall Study|Adverse Event|6|||
125134388|NCT00443651|450118150|FG000|Overall Study|Lost to Follow-up|18|||
125134389|NCT00443651|450118151|FG001|Overall Study|Lost to Follow-up|12|||
125134390|NCT00443651|450118150|FG000|Overall Study|Patient's/Guardian's Decision|58|||
125134391|NCT00443651|450118151|FG001|Overall Study|Patient's/Guardian's Decision|30|||
125134392|NCT00443651|450118150|FG000|Overall Study|Physician Decision|13|||
125134393|NCT00443651|450118151|FG001|Overall Study|Physician Decision|4|||
125134394|NCT00443651|450118150|FG000|Overall Study|Pregnancy|0|||
125134395|NCT00443651|450118151|FG001|Overall Study|Pregnancy|1|||
125134396|NCT03606174|450118152|FG000|Overall Study|Death|37|||
125134397|NCT03606174|450118153|FG001|Overall Study|Death|15|||
125134398|NCT03606174|450118154|FG002|Overall Study|Death|15|||
125134399|NCT03606174|450118155|FG003|Overall Study|Death|7|||
125134400|NCT03606174|450118156|FG004|Overall Study|Death|35|||
125134401|NCT03606174|450118157|FG005|Overall Study|Death|12|||
125134402|NCT03606174|450118158|FG006|Overall Study|Death|35|||
125134403|NCT03606174|450118159|FG007|Overall Study|Death|8|||
125134404|NCT03606174|450118160|FG008|Overall Study|Death|5|||
125134405|NCT03606174|450118161|FG009|Overall Study|Death|3|||
125134406|NCT03606174|450118162|FG010|Overall Study|Death|0|||
125134407|NCT03606174|450118152|FG000|Overall Study|Lost to Follow-up|0|||
125218531|NCT00784719|450427357|FG005|Overall Study|Adverse Event|1|||
125218532|NCT00784719|450427358|FG006|Overall Study|Adverse Event|1|||
125218533|NCT00784719|450427352|FG000|Overall Study|Lost to Follow-up|0|||
125218534|NCT00784719|450427353|FG001|Overall Study|Lost to Follow-up|0|||
125218535|NCT00784719|450427354|FG002|Overall Study|Lost to Follow-up|0|||
125218536|NCT00784719|450427355|FG003|Overall Study|Lost to Follow-up|0|||
125218537|NCT00784719|450427356|FG004|Overall Study|Lost to Follow-up|1|||
125218538|NCT00784719|450427357|FG005|Overall Study|Lost to Follow-up|1|||
125218539|NCT00784719|450427358|FG006|Overall Study|Lost to Follow-up|0|||
125218540|NCT00784719|450427352|FG000|Overall Study|Other|2|||
124974706|NCT00474526|449536451|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124974707|NCT00474526|449536452|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124974708|NCT00474526|449536453|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
124974709|NCT00474526|449536454|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
124974710|NCT00474526|449536455|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124974711|NCT00474526|449536456|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124974712|NCT00474526|449536440|FG000|Overall Study|Lost to Follow-up|8|||
124974713|NCT00474526|449536441|FG001|Overall Study|Lost to Follow-up|6|||
124974714|NCT00474526|449536442|FG002|Overall Study|Lost to Follow-up|13|||
124974715|NCT00474526|449536443|FG003|Overall Study|Lost to Follow-up|29|||
124974716|NCT00474526|449536444|FG004|Overall Study|Lost to Follow-up|11|||
124974717|NCT00474526|449536445|FG005|Overall Study|Lost to Follow-up|5|||
124974718|NCT00474526|449536446|FG006|Overall Study|Lost to Follow-up|8|||
124974719|NCT00474526|449536447|FG007|Overall Study|Lost to Follow-up|1|||
124974720|NCT00474526|449536448|FG008|Overall Study|Lost to Follow-up|0|||
124974721|NCT00474526|449536449|FG009|Overall Study|Lost to Follow-up|6|||
124974722|NCT00474526|449536450|FG010|Overall Study|Lost to Follow-up|2|||
124974723|NCT00474526|449536451|FG011|Overall Study|Lost to Follow-up|4|||
125134408|NCT03606174|450118153|FG001|Overall Study|Lost to Follow-up|0|||
125134409|NCT03606174|450118154|FG002|Overall Study|Lost to Follow-up|0|||
125134410|NCT03606174|450118155|FG003|Overall Study|Lost to Follow-up|0|||
125134411|NCT03606174|450118156|FG004|Overall Study|Lost to Follow-up|1|||
125218541|NCT00784719|450427353|FG001|Overall Study|Other|1|||
125134412|NCT03606174|450118157|FG005|Overall Study|Lost to Follow-up|1|||
125134413|NCT03606174|450118158|FG006|Overall Study|Lost to Follow-up|0|||
125134414|NCT03606174|450118159|FG007|Overall Study|Lost to Follow-up|0|||
124974724|NCT00474526|449536452|FG012|Overall Study|Lost to Follow-up|6|||
124974725|NCT00474526|449536453|FG013|Overall Study|Lost to Follow-up|74|||
125218542|NCT00784719|450427354|FG002|Overall Study|Other|1|||
125218543|NCT00784719|450427355|FG003|Overall Study|Other|0|||
124974726|NCT00474526|449536454|FG014|Overall Study|Lost to Follow-up|29|||
124974727|NCT00474526|449536455|FG015|Overall Study|Lost to Follow-up|4|||
124974728|NCT00474526|449536456|FG016|Overall Study|Lost to Follow-up|5|||
124974729|NCT00474526|449536440|FG000|Overall Study|Protocol Violation|2|||
124974730|NCT00474526|449536441|FG001|Overall Study|Protocol Violation|6|||
124974731|NCT00474526|449536442|FG002|Overall Study|Protocol Violation|4|||
124974732|NCT00474526|449536443|FG003|Overall Study|Protocol Violation|12|||
124974733|NCT00474526|449536444|FG004|Overall Study|Protocol Violation|3|||
124974734|NCT00474526|449536445|FG005|Overall Study|Protocol Violation|1|||
124974735|NCT00474526|449536446|FG006|Overall Study|Protocol Violation|3|||
124974736|NCT00474526|449536447|FG007|Overall Study|Protocol Violation|0|||
124974737|NCT00474526|449536448|FG008|Overall Study|Protocol Violation|0|||
124974738|NCT00474526|449536449|FG009|Overall Study|Protocol Violation|4|||
124974739|NCT00474526|449536450|FG010|Overall Study|Protocol Violation|2|||
124974740|NCT00474526|449536451|FG011|Overall Study|Protocol Violation|2|||
124974741|NCT00474526|449536452|FG012|Overall Study|Protocol Violation|4|||
124974742|NCT00474526|449536453|FG013|Overall Study|Protocol Violation|19|||
124974743|NCT00474526|449536454|FG014|Overall Study|Protocol Violation|9|||
124974744|NCT00474526|449536455|FG015|Overall Study|Protocol Violation|6|||
124974745|NCT00474526|449536456|FG016|Overall Study|Protocol Violation|2|||
124974746|NCT00474526|449536440|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
124974747|NCT00474526|449536441|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
124974748|NCT00474526|449536442|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
124974749|NCT00474526|449536443|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
124974750|NCT00474526|449536444|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
124974751|NCT00474526|449536445|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
124974752|NCT00474526|449536446|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
124974753|NCT00474526|449536447|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
124974754|NCT00474526|449536448|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
124974755|NCT00474526|449536449|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
124974756|NCT00474526|449536450|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
124974757|NCT00474526|449536451|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
124974758|NCT00474526|449536452|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
124974759|NCT00474526|449536453|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
124974760|NCT00474526|449536454|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
124974761|NCT00474526|449536455|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
124974762|NCT00474526|449536456|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
124974763|NCT00474526|449536440|FG000|Overall Study|Withdrawal by Subject|9|||
125038510|NCT03972488|449759430|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
125038511|NCT03277196|449759431|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
125038512|NCT03277196|449759431|FG000|Overall Study|Lost to Follow-up|3|||
125038513|NCT03277196|449759431|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
125038514|NCT03277196|449759431|FG000|Overall Study|Other|2|||
125038515|NCT00684814|449760969|FG000|Washout Period of 7 Days|Adverse Event|1|||
125038516|NCT00684814|449760970|FG001|Washout Period of 7 Days|Adverse Event|2|||
125038517|NCT00684814|449760969|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
125038518|NCT00684814|449760970|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
125038519|NCT00684814|449760969|FG000|Second Intervention|Adverse Event|1|||
125038520|NCT00684814|449760970|FG001|Second Intervention|Adverse Event|0|||
125038521|NCT00503399|449760971|FG000|Overall Study|Death|2|||
125038522|NCT00503399|449760972|FG001|Overall Study|Death|1|||
125038523|NCT00503399|449760971|FG000|Overall Study|Protocol Violation|1|||
125038524|NCT00503399|449760972|FG001|Overall Study|Protocol Violation|0|||
125038525|NCT00503399|449760971|FG000|Overall Study|Withdrawal by Subject|4|||
125038526|NCT00503399|449760972|FG001|Overall Study|Withdrawal by Subject|2|||
125038527|NCT00503399|449760971|FG000|Overall Study|Adverse Event|0|||
125038528|NCT00503399|449760972|FG001|Overall Study|Adverse Event|3|||
125038529|NCT00503399|449760971|FG000|Overall Study|Lost to Follow-up|0|||
125038530|NCT00503399|449760972|FG001|Overall Study|Lost to Follow-up|2|||
125038531|NCT01676961|449760973|FG000|Overall Study|Death|3|||
125038532|NCT01676961|449760973|FG000|Overall Study|Lost to Follow-up|1|||
125038533|NCT01676961|449760973|FG000|Overall Study|Withdrawal by Subject|1|||
125038534|NCT00768560|449760974|FG000|Intervention Set 1|Adverse Event|0|||
125038535|NCT00768560|449760975|FG001|Intervention Set 1|Adverse Event|1|||
125134415|NCT03606174|450118160|FG008|Overall Study|Lost to Follow-up|0|||
124974764|NCT00474526|449536441|FG001|Overall Study|Withdrawal by Subject|24|||
124974765|NCT00474526|449536442|FG002|Overall Study|Withdrawal by Subject|21|||
124974766|NCT00474526|449536443|FG003|Overall Study|Withdrawal by Subject|52|||
124974767|NCT00474526|449536444|FG004|Overall Study|Withdrawal by Subject|38|||
124974768|NCT00474526|449536445|FG005|Overall Study|Withdrawal by Subject|6|||
125038536|NCT00768560|449760976|FG002|Intervention Set 1|Adverse Event|0|||
125038537|NCT00768560|449760977|FG003|Intervention Set 1|Adverse Event|0|||
125038538|NCT00768560|449760978|FG004|Intervention Set 1|Adverse Event|0|||
125038539|NCT00768560|449760979|FG005|Intervention Set 1|Adverse Event|0|||
125038540|NCT00117312|449760980|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
125038541|NCT00117312|449760981|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
125038542|NCT00117312|449760982|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
125038543|NCT00117312|449760983|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
125038544|NCT00117312|449760980|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
125038545|NCT00117312|449760981|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
125134416|NCT03606174|450118161|FG009|Overall Study|Lost to Follow-up|0|||
125134417|NCT03606174|450118162|FG010|Overall Study|Lost to Follow-up|0|||
125134418|NCT03606174|450118152|FG000|Overall Study|Withdrawal by Subject|6|||
125134419|NCT03606174|450118153|FG001|Overall Study|Withdrawal by Subject|0|||
125134420|NCT03606174|450118154|FG002|Overall Study|Withdrawal by Subject|0|||
125134421|NCT03606174|450118155|FG003|Overall Study|Withdrawal by Subject|1|||
125134422|NCT03606174|450118156|FG004|Overall Study|Withdrawal by Subject|2|||
125134423|NCT03606174|450118157|FG005|Overall Study|Withdrawal by Subject|1|||
125134424|NCT03606174|450118158|FG006|Overall Study|Withdrawal by Subject|4|||
125134425|NCT03606174|450118159|FG007|Overall Study|Withdrawal by Subject|0|||
125134426|NCT03606174|450118160|FG008|Overall Study|Withdrawal by Subject|0|||
125134427|NCT03606174|450118161|FG009|Overall Study|Withdrawal by Subject|0|||
125134428|NCT03606174|450118162|FG010|Overall Study|Withdrawal by Subject|1|||
125134429|NCT03606174|450118152|FG000|Overall Study|Study Terminated by Sponsor|5|||
125134430|NCT03606174|450118153|FG001|Overall Study|Study Terminated by Sponsor|7|||
125134431|NCT03606174|450118154|FG002|Overall Study|Study Terminated by Sponsor|3|||
125134432|NCT03606174|450118155|FG003|Overall Study|Study Terminated by Sponsor|0|||
125134433|NCT03606174|450118156|FG004|Overall Study|Study Terminated by Sponsor|11|||
125134434|NCT03606174|450118157|FG005|Overall Study|Study Terminated by Sponsor|6|||
125134435|NCT03606174|450118158|FG006|Overall Study|Study Terminated by Sponsor|12|||
125134436|NCT03606174|450118159|FG007|Overall Study|Study Terminated by Sponsor|1|||
125134437|NCT03606174|450118160|FG008|Overall Study|Study Terminated by Sponsor|3|||
125134438|NCT03606174|450118161|FG009|Overall Study|Study Terminated by Sponsor|1|||
125134439|NCT03606174|450118162|FG010|Overall Study|Study Terminated by Sponsor|2|||
125134440|NCT03606174|450118152|FG000|Overall Study|Miscellaneous|1|||
125134441|NCT03606174|450118153|FG001|Overall Study|Miscellaneous|1|||
125134442|NCT03606174|450118154|FG002|Overall Study|Miscellaneous|0|||
125134443|NCT03606174|450118155|FG003|Overall Study|Miscellaneous|1|||
125134444|NCT03606174|450118156|FG004|Overall Study|Miscellaneous|4|||
125134445|NCT03606174|450118157|FG005|Overall Study|Miscellaneous|7|||
125134446|NCT03606174|450118158|FG006|Overall Study|Miscellaneous|5|||
125134447|NCT03606174|450118159|FG007|Overall Study|Miscellaneous|0|||
125134448|NCT03606174|450118160|FG008|Overall Study|Miscellaneous|0|||
125134449|NCT03606174|450118161|FG009|Overall Study|Miscellaneous|0|||
125134450|NCT03606174|450118162|FG010|Overall Study|Miscellaneous|1|||
125218544|NCT00784719|450427356|FG004|Overall Study|Other|2|||
125038546|NCT00117312|449760982|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
125038547|NCT00117312|449760983|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
125038548|NCT00117312|449760980|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
125038549|NCT00117312|449760981|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
125038550|NCT00117312|449760982|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
125038551|NCT00117312|449760983|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
125038552|NCT00117312|449760980|FG000|Overall Study|Other|0|||
125038553|NCT00117312|449760981|FG001|Overall Study|Other|1|||
125038554|NCT00117312|449760982|FG002|Overall Study|Other|3|||
125038555|NCT00117312|449760983|FG003|Overall Study|Other|1|||
125038556|NCT00117312|449760980|FG000|Overall Study|Patient choice|0|||
125038557|NCT00117312|449760981|FG001|Overall Study|Patient choice|0|||
125038558|NCT00117312|449760982|FG002|Overall Study|Patient choice|2|||
125038559|NCT00117312|449760983|FG003|Overall Study|Patient choice|1|||
125038560|NCT00117312|449760980|FG000|Overall Study|Adverse Event|0|||
125038561|NCT00117312|449760981|FG001|Overall Study|Adverse Event|2|||
125038562|NCT00117312|449760982|FG002|Overall Study|Adverse Event|0|||
125038563|NCT00117312|449760983|FG003|Overall Study|Adverse Event|0|||
125038564|NCT00117312|449760980|FG000|Overall Study|Protocol Violation|0|||
125134451|NCT02241551|450118165|FG000|Overall Study|Adverse Event|1|||
125218545|NCT00784719|450427357|FG005|Overall Study|Other|1|||
125218546|NCT00784719|450427358|FG006|Overall Study|Other|3|||
125218547|NCT00784719|450427352|FG000|Overall Study|Withdrawal by Subject|1|||
125218548|NCT00784719|450427353|FG001|Overall Study|Withdrawal by Subject|0|||
125218549|NCT00784719|450427354|FG002|Overall Study|Withdrawal by Subject|0|||
125134452|NCT02241551|450118166|FG001|Overall Study|Adverse Event|0|||
125134453|NCT00469898|450118167|FG000|Overall Study|Adverse Event|7|||
125134454|NCT00469898|450118167|FG000|Overall Study|Withdrawal by Subject|4|||
125134455|NCT00469898|450118167|FG000|Overall Study|Death|4|||
125218550|NCT00784719|450427355|FG003|Overall Study|Withdrawal by Subject|0|||
125038565|NCT00117312|449760981|FG001|Overall Study|Protocol Violation|1|||
125038566|NCT00117312|449760982|FG002|Overall Study|Protocol Violation|3|||
125134456|NCT00469898|450118167|FG000|Overall Study|Disease progression|9|||
125038567|NCT00117312|449760983|FG003|Overall Study|Protocol Violation|0|||
125038568|NCT00117312|449760980|FG000|Overall Study|PSA decrease <=50%|0|||
125038569|NCT00117312|449760981|FG001|Overall Study|PSA decrease <=50%|2|||
125038570|NCT00117312|449760982|FG002|Overall Study|PSA decrease <=50%|2|||
125038571|NCT00117312|449760983|FG003|Overall Study|PSA decrease <=50%|4|||
125038572|NCT00117312|449760980|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
125038573|NCT00117312|449760981|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
125038574|NCT00117312|449760982|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
125038575|NCT00117312|449760983|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
125038576|NCT00117312|449760980|FG000|Overall Study|Hepatic abnormality|0|||
125038577|NCT00117312|449760981|FG001|Overall Study|Hepatic abnormality|1|||
125038578|NCT00117312|449760982|FG002|Overall Study|Hepatic abnormality|0|||
125038579|NCT00117312|449760983|FG003|Overall Study|Hepatic abnormality|1|||
125038580|NCT00117312|449760980|FG000|Overall Study|Withdrawal by Subject|0|||
125038581|NCT00117312|449760981|FG001|Overall Study|Withdrawal by Subject|2|||
125038582|NCT00117312|449760982|FG002|Overall Study|Withdrawal by Subject|0|||
125038583|NCT00117312|449760983|FG003|Overall Study|Withdrawal by Subject|0|||
125038584|NCT00195650|449760984|FG000|Overall Study|Adverse Event|194|||
125038585|NCT00195650|449760984|FG000|Overall Study|Lack of Efficacy|99|||
125038586|NCT00195650|449760984|FG000|Overall Study|Withdrawal by Subject|67|||
125038587|NCT00195650|449760984|FG000|Overall Study|Lost to Follow-up|44|||
125038588|NCT00195650|449760984|FG000|Overall Study|Death|23|||
125038589|NCT00195650|449760984|FG000|Overall Study|Protocol Violation|15|||
125038590|NCT00195650|449760984|FG000|Overall Study|Administrative reasons|83|||
125038591|NCT03375320|449760985|FG000|Overall Study|Adverse Event|34|||
125038592|NCT03375320|449760986|FG001|Overall Study|Adverse Event|9|||
125038593|NCT03375320|449760987|FG002|Overall Study|Adverse Event|10|||
125038594|NCT03375320|449760988|FG003|Overall Study|Adverse Event|0|||
125038595|NCT03375320|449760985|FG000|Overall Study|Death|6|||
125038596|NCT03375320|449760986|FG001|Overall Study|Death|3|||
125038597|NCT03375320|449760987|FG002|Overall Study|Death|0|||
125038598|NCT03375320|449760988|FG003|Overall Study|Death|0|||
125038599|NCT03375320|449760985|FG000|Overall Study|Withdrawal by Subject|7|||
125038600|NCT03375320|449760986|FG001|Overall Study|Withdrawal by Subject|4|||
125038601|NCT03375320|449760987|FG002|Overall Study|Withdrawal by Subject|5|||
125038602|NCT03375320|449760988|FG003|Overall Study|Withdrawal by Subject|4|||
125038603|NCT03375320|449760985|FG000|Overall Study|Progressive disease|55|||
125038604|NCT03375320|449760986|FG001|Overall Study|Progressive disease|41|||
125038605|NCT03375320|449760987|FG002|Overall Study|Progressive disease|29|||
125134457|NCT00469898|450118167|FG000|Overall Study|Decreased performance status|1|||
125134458|NCT01205035|450118168|FG000|Overall Study|Withdrawal by Subject|1|||
125134459|NCT01205035|450118169|FG001|Overall Study|Withdrawal by Subject|0|||
125134460|NCT01205035|450118168|FG000|Overall Study|Physician Decision|1|||
125134461|NCT01205035|450118169|FG001|Overall Study|Physician Decision|0|||
125134462|NCT01667679|450118171|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
125134463|NCT01667679|450118172|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
125134464|NCT01667679|450118171|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
125134465|NCT01667679|450118172|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
125134466|NCT01667679|450118171|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
125134467|NCT01667679|450118172|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
125134468|NCT01667679|450118171|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
125134469|NCT01667679|450118172|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
125134470|NCT01667679|450118171|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
125134471|NCT01667679|450118172|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
125134472|NCT01667679|450118171|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
125134473|NCT01667679|450118172|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
125134474|NCT01667679|450118171|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
125038606|NCT03375320|449760988|FG003|Overall Study|Progressive disease|24|||
125038607|NCT03375320|449760985|FG000|Overall Study|Alternative treatment|6|||
125038608|NCT03375320|449760986|FG001|Overall Study|Alternative treatment|1|||
125038609|NCT03375320|449760987|FG002|Overall Study|Alternative treatment|1|||
125038610|NCT03375320|449760988|FG003|Overall Study|Alternative treatment|0|||
125038611|NCT03375320|449760985|FG000|Overall Study|Other disease|1|||
125038612|NCT03375320|449760986|FG001|Overall Study|Other disease|1|||
125038613|NCT03375320|449760987|FG002|Overall Study|Other disease|3|||
125038614|NCT03375320|449760988|FG003|Overall Study|Other disease|0|||
125038615|NCT03375320|449760985|FG000|Overall Study|Withdrawal prior to initiation|2|||
125038616|NCT03375320|449760986|FG001|Overall Study|Withdrawal prior to initiation|2|||
125038617|NCT03375320|449760987|FG002|Overall Study|Withdrawal prior to initiation|1|||
125038618|NCT03375320|449760988|FG003|Overall Study|Withdrawal prior to initiation|0|||
125134475|NCT01667679|450118172|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
125134476|NCT01667679|450118171|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
125134477|NCT01667679|450118172|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
125134478|NCT01667679|450118171|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
125134479|NCT01667679|450118172|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
125134480|NCT01667679|450118171|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
125134481|NCT01667679|450118172|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
125134482|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
125134483|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
125134484|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
125134485|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
125134486|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
125218551|NCT00784719|450427356|FG004|Overall Study|Withdrawal by Subject|2|||
125218552|NCT00784719|450427357|FG005|Overall Study|Withdrawal by Subject|0|||
124974769|NCT00474526|449536446|FG006|Overall Study|Withdrawal by Subject|12|||
124974770|NCT00474526|449536447|FG007|Overall Study|Withdrawal by Subject|4|||
124974771|NCT00474526|449536448|FG008|Overall Study|Withdrawal by Subject|4|||
124974772|NCT00474526|449536449|FG009|Overall Study|Withdrawal by Subject|13|||
124974773|NCT00474526|449536450|FG010|Overall Study|Withdrawal by Subject|5|||
124974774|NCT00474526|449536451|FG011|Overall Study|Withdrawal by Subject|4|||
124974775|NCT00474526|449536452|FG012|Overall Study|Withdrawal by Subject|4|||
124974776|NCT00474526|449536453|FG013|Overall Study|Withdrawal by Subject|37|||
124974777|NCT00474526|449536454|FG014|Overall Study|Withdrawal by Subject|22|||
124974778|NCT00474526|449536455|FG015|Overall Study|Withdrawal by Subject|1|||
124974779|NCT00474526|449536456|FG016|Overall Study|Withdrawal by Subject|1|||
124974780|NCT01251770|449536460|FG000|Overall Study|Protocol Violation|13|||
124974781|NCT01251770|449536461|FG001|Overall Study|Protocol Violation|7|||
124974782|NCT02113124|449536462|FG000|Overall Study|Unable to retrieve blood sample|1|||
124974783|NCT02113124|449536463|FG001|Overall Study|Unable to retrieve blood sample|1|||
124974784|NCT02514239|449536464|FG000|Overall Study|Refused to continue trial medication|0|||
124974785|NCT02514239|449536465|FG001|Overall Study|Refused to continue trial medication|0|||
124974786|NCT02514239|449536466|FG002|Overall Study|Refused to continue trial medication|0|||
124974787|NCT02514239|449536467|FG003|Overall Study|Refused to continue trial medication|0|||
124974788|NCT02514239|449536468|FG004|Overall Study|Refused to continue trial medication|0|||
124974789|NCT02514239|449536469|FG005|Overall Study|Refused to continue trial medication|0|||
124974790|NCT02514239|449536470|FG006|Overall Study|Refused to continue trial medication|0|||
124974791|NCT02514239|449536471|FG007|Overall Study|Refused to continue trial medication|0|||
124974792|NCT02514239|449536472|FG008|Overall Study|Refused to continue trial medication|0|||
124974793|NCT02514239|449536473|FG009|Overall Study|Refused to continue trial medication|1|||
124974794|NCT02514239|449536464|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
124974795|NCT02514239|449536465|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
124974796|NCT02514239|449536466|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
124974797|NCT02514239|449536467|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
124974798|NCT02514239|449536468|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
124974799|NCT02514239|449536469|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
124974800|NCT02514239|449536470|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
124974801|NCT02514239|449536471|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
124974802|NCT02514239|449536472|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
124974803|NCT02514239|449536473|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
124974804|NCT02514239|449536464|FG000|Overall Study|Not treated|0|||
124974805|NCT02514239|449536465|FG001|Overall Study|Not treated|1|||
124974806|NCT02514239|449536466|FG002|Overall Study|Not treated|0|||
124974807|NCT02514239|449536467|FG003|Overall Study|Not treated|0|||
124974808|NCT02514239|449536468|FG004|Overall Study|Not treated|0|||
124974809|NCT02514239|449536469|FG005|Overall Study|Not treated|0|||
124974810|NCT02514239|449536470|FG006|Overall Study|Not treated|0|||
124974811|NCT02514239|449536471|FG007|Overall Study|Not treated|0|||
124974812|NCT02514239|449536472|FG008|Overall Study|Not treated|0|||
124974813|NCT02514239|449536473|FG009|Overall Study|Not treated|0|||
124974814|NCT02514239|449536464|FG000|Overall Study|Other Adverse Events|2|||
124974815|NCT02514239|449536465|FG001|Overall Study|Other Adverse Events|0|||
124974816|NCT02514239|449536466|FG002|Overall Study|Other Adverse Events|0|||
124974817|NCT02514239|449536467|FG003|Overall Study|Other Adverse Events|1|||
125134487|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
125134488|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
125218553|NCT00784719|450427358|FG006|Overall Study|Withdrawal by Subject|1|||
125218554|NCT03131687|450427362|FG000|Overall Study|Adverse Event|0|||
124974818|NCT02514239|449536468|FG004|Overall Study|Other Adverse Events|0|||
124974819|NCT02514239|449536469|FG005|Overall Study|Other Adverse Events|1|||
124974820|NCT02514239|449536470|FG006|Overall Study|Other Adverse Events|0|||
124974821|NCT02514239|449536471|FG007|Overall Study|Other Adverse Events|1|||
125218555|NCT03131687|450427363|FG001|Overall Study|Adverse Event|1|||
125218556|NCT03131687|450427364|FG002|Overall Study|Adverse Event|0|||
124974822|NCT02514239|449536472|FG008|Overall Study|Other Adverse Events|2|||
124974823|NCT02514239|449536473|FG009|Overall Study|Other Adverse Events|0|||
124974824|NCT02514239|449536464|FG000|Overall Study|Progressive disease|3|||
124974825|NCT02514239|449536465|FG001|Overall Study|Progressive disease|3|||
124974826|NCT02514239|449536466|FG002|Overall Study|Progressive disease|2|||
124974827|NCT02514239|449536467|FG003|Overall Study|Progressive disease|2|||
124974828|NCT02514239|449536468|FG004|Overall Study|Progressive disease|3|||
124974829|NCT02514239|449536469|FG005|Overall Study|Progressive disease|3|||
124974830|NCT02514239|449536470|FG006|Overall Study|Progressive disease|4|||
124974831|NCT02514239|449536471|FG007|Overall Study|Progressive disease|2|||
124974832|NCT02514239|449536472|FG008|Overall Study|Progressive disease|5|||
124974833|NCT02514239|449536473|FG009|Overall Study|Progressive disease|0|||
124974834|NCT03104075|449536474|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
124974835|NCT03104075|449536475|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
124974836|NCT04024462|449536476|FG000|Overall Study|Withdrawal by Subject|6|||
124974837|NCT04024462|449536477|FG001|Overall Study|Withdrawal by Subject|7|||
124974838|NCT04024462|449536476|FG000|Overall Study|Progressive Disease|0|||
124974839|NCT04024462|449536477|FG001|Overall Study|Progressive Disease|1|||
124974840|NCT04024462|449536476|FG000|Overall Study|Adverse Event|0|||
124974841|NCT04024462|449536477|FG001|Overall Study|Adverse Event|1|||
124974842|NCT04024462|449536476|FG000|Overall Study|Death|0|||
124974843|NCT04024462|449536477|FG001|Overall Study|Death|1|||
124974844|NCT04024462|449536476|FG000|Overall Study|Lost to Follow-up|1|||
124974845|NCT04024462|449536477|FG001|Overall Study|Lost to Follow-up|0|||
124974846|NCT04024462|449536476|FG000|Overall Study|Ongoing in the Study|94|||
124974847|NCT04024462|449536477|FG001|Overall Study|Ongoing in the Study|89|||
124974848|NCT00789360|449536480|FG000|Overall Study|Protocol Violation|3|||
124974849|NCT00789360|449536481|FG001|Overall Study|Protocol Violation|1|||
124974850|NCT04400487|449536482|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
124974851|NCT04400487|449536482|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
124974852|NCT04400487|449536482|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
124974853|NCT00022659|449536483|FG000|Overall Study|Ineligible: wrong primary|1|||
124974854|NCT00022659|449536483|FG000|Overall Study|Never treated|1|||
124974855|NCT03559062|449536484|FG000|Overall Study|Other|0|||
124974856|NCT03559062|449536485|FG001|Overall Study|Other|1|||
124974857|NCT03559062|449536486|FG002|Overall Study|Other|0|||
124974858|NCT00426127|449536487|FG000|Overall Study|Adverse Event|1|||
124974859|NCT00426127|449536487|FG000|Overall Study|Removed due to disease progression|1|||
124974860|NCT05048238|449536490|FG000|Overall Study|Withdrawal by Subject|1|||
124974861|NCT01730378|449536491|FG000|Overall Study|Lost to Follow-up|1|||
124974862|NCT01730378|449536492|FG001|Overall Study|Lost to Follow-up|0|||
124974863|NCT00955708|449536493|FG000|Overall Study|Death|269|||
124974864|NCT00955708|449536493|FG000|Overall Study|Lost to Follow-up|72|||
124974865|NCT00955708|449536493|FG000|Overall Study|Physician Decision|36|||
124974866|NCT00955708|449536493|FG000|Overall Study|Protocol Violation|134|||
124974867|NCT00955708|449536493|FG000|Overall Study|Registry Conclusion|186|||
124974868|NCT00955708|449536493|FG000|Overall Study|Product removed from service|94|||
124974869|NCT00955708|449536493|FG000|Overall Study|Patient Refused to participate further|116|||
124974870|NCT00955708|449536493|FG000|Overall Study|Closure of study location|60|||
124974871|NCT00955708|449536493|FG000|Overall Study|Patient changed care provider/moved|91|||
124974872|NCT01016262|449536494|FG000|Double-blind Phase|Adverse Event|0|||
124974873|NCT01016262|449536495|FG001|Double-blind Phase|Adverse Event|0|||
124974874|NCT01016262|449536496|FG002|Double-blind Phase|Adverse Event|1|||
125038619|NCT03375320|449760985|FG000|Overall Study|Physician Decision|1|||
124974875|NCT01016262|449536497|FG003|Double-blind Phase|Adverse Event|0|||
124974876|NCT01016262|449536498|FG004|Double-blind Phase|Adverse Event|0|||
124974877|NCT01016262|449536499|FG005|Double-blind Phase|Adverse Event|0|||
124974878|NCT01016262|449536494|FG000|Double-blind Phase|Lack of Efficacy|1|||
124974879|NCT01016262|449536495|FG001|Double-blind Phase|Lack of Efficacy|0|||
125038620|NCT03375320|449760986|FG001|Overall Study|Physician Decision|1|||
124974880|NCT01016262|449536496|FG002|Double-blind Phase|Lack of Efficacy|5|||
124974881|NCT01016262|449536497|FG003|Double-blind Phase|Lack of Efficacy|0|||
124974882|NCT01016262|449536498|FG004|Double-blind Phase|Lack of Efficacy|0|||
124974883|NCT01016262|449536499|FG005|Double-blind Phase|Lack of Efficacy|0|||
124974884|NCT01016262|449536494|FG000|Double-blind Phase|Disease Progression|0|||
124974885|NCT01016262|449536495|FG001|Double-blind Phase|Disease Progression|1|||
124974886|NCT01016262|449536496|FG002|Double-blind Phase|Disease Progression|2|||
124974887|NCT01016262|449536497|FG003|Double-blind Phase|Disease Progression|0|||
124974888|NCT01016262|449536498|FG004|Double-blind Phase|Disease Progression|0|||
124974889|NCT01016262|449536499|FG005|Double-blind Phase|Disease Progression|0|||
124974890|NCT01016262|449536494|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
124974891|NCT01016262|449536495|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
124974892|NCT01016262|449536496|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
124974893|NCT01016262|449536497|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
124974894|NCT01016262|449536498|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
124974895|NCT01016262|449536499|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
124974896|NCT01016262|449536494|FG000|Open-Label Phase|Adverse Event|0|||
124974897|NCT01016262|449536495|FG001|Open-Label Phase|Adverse Event|0|||
124974898|NCT01016262|449536496|FG002|Open-Label Phase|Adverse Event|0|||
124974899|NCT01016262|449536497|FG003|Open-Label Phase|Adverse Event|1|||
124974900|NCT01016262|449536498|FG004|Open-Label Phase|Adverse Event|0|||
124974901|NCT01016262|449536499|FG005|Open-Label Phase|Adverse Event|0|||
124974902|NCT01016262|449536494|FG000|Open-Label Phase|Lost to Follow-up|0|||
124974903|NCT01016262|449536495|FG001|Open-Label Phase|Lost to Follow-up|0|||
124974904|NCT01016262|449536496|FG002|Open-Label Phase|Lost to Follow-up|0|||
124974905|NCT01016262|449536497|FG003|Open-Label Phase|Lost to Follow-up|0|||
124974906|NCT01016262|449536498|FG004|Open-Label Phase|Lost to Follow-up|1|||
124974907|NCT01016262|449536499|FG005|Open-Label Phase|Lost to Follow-up|0|||
124974908|NCT01016262|449536494|FG000|Open-Label Phase|Lack of Efficacy|0|||
124974909|NCT01016262|449536495|FG001|Open-Label Phase|Lack of Efficacy|0|||
124974910|NCT01016262|449536496|FG002|Open-Label Phase|Lack of Efficacy|0|||
124974911|NCT01016262|449536497|FG003|Open-Label Phase|Lack of Efficacy|1|||
124974912|NCT01016262|449536498|FG004|Open-Label Phase|Lack of Efficacy|0|||
124974913|NCT01016262|449536499|FG005|Open-Label Phase|Lack of Efficacy|0|||
124974914|NCT01016262|449536494|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
124974915|NCT01016262|449536495|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
124974916|NCT01016262|449536496|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
124974917|NCT01016262|449536497|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
124974918|NCT01016262|449536498|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
124974919|NCT01016262|449536499|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
124974920|NCT00737477|449536500|FG000|Overall Study|Adverse Event|9|||
124974921|NCT00737477|449536500|FG000|Overall Study|Death|9|||
124974922|NCT00737477|449536500|FG000|Overall Study|Treatment Refusal|1|||
124974923|NCT00737477|449536500|FG000|Overall Study|Withdrawal by Subject|1|||
124974924|NCT00737477|449536500|FG000|Overall Study|Renal Transplantation|10|||
124974925|NCT00737477|449536500|FG000|Overall Study|Other|4|||
124974926|NCT01370655|449536501|FG000|Period 1|Adverse Event|2|||
124974927|NCT01370655|449536502|FG001|Period 1|Adverse Event|0|||
124974928|NCT01370655|449536503|FG002|Period 1|Adverse Event|0|||
124974929|NCT01370655|449536504|FG003|Period 1|Adverse Event|0|||
124974930|NCT01370655|449536505|FG004|Period 1|Adverse Event|0|||
124974931|NCT01370655|449536506|FG005|Period 1|Adverse Event|0|||
124974932|NCT01370655|449536507|FG006|Period 1|Adverse Event|1|||
124974933|NCT01370655|449536508|FG007|Period 1|Adverse Event|0|||
124974934|NCT01370655|449536509|FG008|Period 1|Adverse Event|0|||
124974935|NCT01370655|449536510|FG009|Period 1|Adverse Event|0|||
124974936|NCT01370655|449536511|FG010|Period 1|Adverse Event|0|||
124974937|NCT01370655|449536512|FG011|Period 1|Adverse Event|0|||
124974938|NCT01370655|449536501|FG000|Period 2|Adverse Event|0|||
124974939|NCT01370655|449536502|FG001|Period 2|Adverse Event|0|||
125038621|NCT03375320|449760987|FG002|Overall Study|Physician Decision|1|||
125038622|NCT03375320|449760988|FG003|Overall Study|Physician Decision|1|||
125038623|NCT03375320|449760985|FG000|Overall Study|Non-compliance|1|||
125038624|NCT03375320|449760986|FG001|Overall Study|Non-compliance|0|||
124974940|NCT01370655|449536503|FG002|Period 2|Adverse Event|1|||
124974941|NCT01370655|449536504|FG003|Period 2|Adverse Event|0|||
124974942|NCT01370655|449536505|FG004|Period 2|Adverse Event|1|||
124974943|NCT01370655|449536506|FG005|Period 2|Adverse Event|0|||
124974944|NCT01370655|449536507|FG006|Period 2|Adverse Event|0|||
124974945|NCT01370655|449536508|FG007|Period 2|Adverse Event|1|||
124974946|NCT01370655|449536509|FG008|Period 2|Adverse Event|0|||
124974947|NCT01370655|449536510|FG009|Period 2|Adverse Event|0|||
124974948|NCT01370655|449536511|FG010|Period 2|Adverse Event|0|||
124974949|NCT01370655|449536512|FG011|Period 2|Adverse Event|0|||
125038625|NCT03375320|449760987|FG002|Overall Study|Non-compliance|0|||
124974950|NCT01370655|449536501|FG000|Period 2|met protocol specified stopping criteria|0|||
124974951|NCT01370655|449536502|FG001|Period 2|met protocol specified stopping criteria|0|||
124974952|NCT01370655|449536503|FG002|Period 2|met protocol specified stopping criteria|1|||
125038626|NCT03375320|449760988|FG003|Overall Study|Non-compliance|0|||
125038627|NCT01128387|449760989|FG000|Overall Study|Physician Decision|0|||
125038628|NCT01128387|449760990|FG001|Overall Study|Physician Decision|1|||
125038629|NCT02635204|449760991|FG000|Overall Study|Adverse Event|1|||
125038630|NCT02635204|449760992|FG001|Overall Study|Adverse Event|0|||
125038631|NCT02635204|449760991|FG000|Overall Study|Lost to Follow-up|1|||
125038632|NCT02635204|449760992|FG001|Overall Study|Lost to Follow-up|1|||
125038633|NCT00858832|449760994|FG000|Overall Study|became ineligible: delivered vaginally|1|||
125038634|NCT00858832|449760995|FG001|Overall Study|became ineligible: delivered vaginally|0|||
125038635|NCT00858832|449760994|FG000|Overall Study|Adverse Event|0|||
125038636|NCT00858832|449760995|FG001|Overall Study|Adverse Event|1|||
125038637|NCT01535235|449760996|FG000|Overall Study|Adverse Event|1|||
125038638|NCT01535235|449760997|FG001|Overall Study|Adverse Event|0|||
125038639|NCT00389207|449760998|FG000|Overall Study|Adverse Event|26|||
125038640|NCT00389207|449760999|FG001|Overall Study|Adverse Event|32|||
125038641|NCT00389207|449761000|FG002|Overall Study|Adverse Event|10|||
125038642|NCT00389207|449760998|FG000|Overall Study|Protocol Violation|3|||
125038643|NCT00389207|449760999|FG001|Overall Study|Protocol Violation|1|||
125038644|NCT00389207|449761000|FG002|Overall Study|Protocol Violation|4|||
125038645|NCT00389207|449760998|FG000|Overall Study|Lost to Follow-up|12|||
125038646|NCT00389207|449760999|FG001|Overall Study|Lost to Follow-up|9|||
125038647|NCT00389207|449761000|FG002|Overall Study|Lost to Follow-up|7|||
125038648|NCT00389207|449760998|FG000|Overall Study|Withdrawal by Subject|5|||
125038649|NCT00389207|449760999|FG001|Overall Study|Withdrawal by Subject|7|||
125038650|NCT00389207|449761000|FG002|Overall Study|Withdrawal by Subject|11|||
125038651|NCT00389207|449760998|FG000|Overall Study|Other|17|||
125038652|NCT00389207|449760999|FG001|Overall Study|Other|23|||
125038653|NCT00389207|449761000|FG002|Overall Study|Other|9|||
125038654|NCT01794780|449761009|FG000|Overall Study|Adverse Event|0|||
125038655|NCT01794780|449761010|FG001|Overall Study|Adverse Event|1|||
125038656|NCT01794780|449761011|FG002|Overall Study|Adverse Event|2|||
125038657|NCT01794780|449761012|FG003|Overall Study|Adverse Event|0|||
125038658|NCT01794780|449761013|FG004|Overall Study|Adverse Event|0|||
125038659|NCT01794780|449761014|FG005|Overall Study|Adverse Event|0|||
125038660|NCT01794780|449761015|FG006|Overall Study|Adverse Event|0|||
125038661|NCT01794780|449761016|FG007|Overall Study|Adverse Event|0|||
125134489|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
125134490|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
125134491|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
125134492|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
125134493|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
125134494|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
125134495|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
125134496|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
125134497|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
125134498|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
125134499|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
125134500|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
125038662|NCT01794780|449761009|FG000|Overall Study|Death|0|||
125038663|NCT01794780|449761010|FG001|Overall Study|Death|2|||
125038664|NCT01794780|449761011|FG002|Overall Study|Death|14|||
125038665|NCT01794780|449761012|FG003|Overall Study|Death|1|||
125038666|NCT01794780|449761013|FG004|Overall Study|Death|0|||
125038667|NCT01794780|449761014|FG005|Overall Study|Death|9|||
125038668|NCT01794780|449761015|FG006|Overall Study|Death|4|||
125038669|NCT01794780|449761016|FG007|Overall Study|Death|0|||
125038670|NCT01794780|449761009|FG000|Overall Study|Lost to Follow-up|10|||
125038671|NCT01794780|449761010|FG001|Overall Study|Lost to Follow-up|64|||
125038672|NCT01794780|449761011|FG002|Overall Study|Lost to Follow-up|165|||
125038673|NCT01794780|449761012|FG003|Overall Study|Lost to Follow-up|53|||
125038674|NCT01794780|449761013|FG004|Overall Study|Lost to Follow-up|2|||
125038675|NCT01794780|449761014|FG005|Overall Study|Lost to Follow-up|99|||
125038676|NCT01794780|449761015|FG006|Overall Study|Lost to Follow-up|30|||
125038677|NCT01794780|449761016|FG007|Overall Study|Lost to Follow-up|5|||
125038678|NCT01794780|449761009|FG000|Overall Study|Withdrew informed consent|7|||
125038679|NCT01794780|449761010|FG001|Overall Study|Withdrew informed consent|17|||
125038680|NCT01794780|449761011|FG002|Overall Study|Withdrew informed consent|36|||
125038681|NCT01794780|449761012|FG003|Overall Study|Withdrew informed consent|9|||
125038682|NCT01794780|449761013|FG004|Overall Study|Withdrew informed consent|0|||
125218557|NCT03131687|450427365|FG003|Overall Study|Adverse Event|1|||
125038683|NCT01794780|449761014|FG005|Overall Study|Withdrew informed consent|48|||
125038684|NCT01794780|449761015|FG006|Overall Study|Withdrew informed consent|4|||
125038685|NCT01794780|449761016|FG007|Overall Study|Withdrew informed consent|3|||
125038686|NCT01794780|449761009|FG000|Overall Study|Other|0|||
125038687|NCT01794780|449761010|FG001|Overall Study|Other|12|||
125038688|NCT01794780|449761011|FG002|Overall Study|Other|25|||
124974953|NCT01370655|449536504|FG003|Period 2|met protocol specified stopping criteria|0|||
124974954|NCT01370655|449536505|FG004|Period 2|met protocol specified stopping criteria|0|||
124974955|NCT01370655|449536506|FG005|Period 2|met protocol specified stopping criteria|0|||
124974956|NCT01370655|449536507|FG006|Period 2|met protocol specified stopping criteria|1|||
124974957|NCT01370655|449536508|FG007|Period 2|met protocol specified stopping criteria|0|||
124974958|NCT01370655|449536509|FG008|Period 2|met protocol specified stopping criteria|1|||
124974959|NCT01370655|449536510|FG009|Period 2|met protocol specified stopping criteria|0|||
124974960|NCT01370655|449536511|FG010|Period 2|met protocol specified stopping criteria|1|||
124974961|NCT01370655|449536512|FG011|Period 2|met protocol specified stopping criteria|0|||
124974962|NCT01370655|449536501|FG000|Period 2|Withdrawal by Subject|0|||
124974963|NCT01370655|449536502|FG001|Period 2|Withdrawal by Subject|0|||
124974964|NCT01370655|449536503|FG002|Period 2|Withdrawal by Subject|0|||
124974965|NCT01370655|449536504|FG003|Period 2|Withdrawal by Subject|0|||
124974966|NCT01370655|449536505|FG004|Period 2|Withdrawal by Subject|0|||
124974967|NCT01370655|449536506|FG005|Period 2|Withdrawal by Subject|0|||
124974968|NCT01370655|449536507|FG006|Period 2|Withdrawal by Subject|0|||
124974969|NCT01370655|449536508|FG007|Period 2|Withdrawal by Subject|0|||
124974970|NCT01370655|449536509|FG008|Period 2|Withdrawal by Subject|1|||
124974971|NCT01370655|449536510|FG009|Period 2|Withdrawal by Subject|0|||
124974972|NCT01370655|449536511|FG010|Period 2|Withdrawal by Subject|0|||
124974973|NCT01370655|449536512|FG011|Period 2|Withdrawal by Subject|0|||
124974974|NCT00581477|449536513|FG000|Overall Study|Physician Decision|2|||
124974975|NCT02069366|449536514|FG000|Overall Study|Lost to Follow-up|0|||
124974976|NCT02069366|449536515|FG001|Overall Study|Lost to Follow-up|0|||
124974977|NCT02069366|449536516|FG002|Overall Study|Lost to Follow-up|1|||
124974978|NCT02069366|449536517|FG003|Overall Study|Lost to Follow-up|0|||
124974979|NCT02069366|449536518|FG004|Overall Study|Lost to Follow-up|0|||
124974980|NCT02069366|449536519|FG005|Overall Study|Lost to Follow-up|2|||
124974981|NCT02069366|449536514|FG000|Overall Study|Protocol Violation|0|||
124974982|NCT02069366|449536515|FG001|Overall Study|Protocol Violation|0|||
124974983|NCT02069366|449536516|FG002|Overall Study|Protocol Violation|1|||
124974984|NCT02069366|449536517|FG003|Overall Study|Protocol Violation|0|||
124974985|NCT02069366|449536518|FG004|Overall Study|Protocol Violation|0|||
124974986|NCT02069366|449536519|FG005|Overall Study|Protocol Violation|0|||
124974987|NCT02069366|449536514|FG000|Overall Study|Withdrawal by Subject|1|||
124974988|NCT02069366|449536515|FG001|Overall Study|Withdrawal by Subject|0|||
124974989|NCT02069366|449536516|FG002|Overall Study|Withdrawal by Subject|1|||
124974990|NCT02069366|449536517|FG003|Overall Study|Withdrawal by Subject|2|||
124974991|NCT02069366|449536518|FG004|Overall Study|Withdrawal by Subject|0|||
124974992|NCT02069366|449536519|FG005|Overall Study|Withdrawal by Subject|0|||
124974993|NCT02057575|449536521|FG000|Overall Study|Adverse Event|0|||
124974994|NCT02057575|449536522|FG001|Overall Study|Adverse Event|2|||
124974995|NCT02057575|449536523|FG002|Overall Study|Adverse Event|0|||
124974996|NCT02057575|449536524|FG003|Overall Study|Adverse Event|1|||
124974997|NCT02057575|449536521|FG000|Overall Study|Withdrawal by Subject|1|||
124974998|NCT02057575|449536522|FG001|Overall Study|Withdrawal by Subject|0|||
124974999|NCT02057575|449536523|FG002|Overall Study|Withdrawal by Subject|0|||
124975000|NCT02057575|449536524|FG003|Overall Study|Withdrawal by Subject|0|||
124975001|NCT02057575|449536521|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
125134501|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
125134502|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
125134503|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
125134504|NCT02159183|450118173|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
125134505|NCT02159183|450118174|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
125134506|NCT02159183|450118173|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
125134507|NCT02159183|450118174|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
125134508|NCT02159183|450118173|FG000|Analysis After the 36 Months Follow-up|Death|0|||
125134509|NCT02159183|450118174|FG001|Analysis After the 36 Months Follow-up|Death|1|||
125134510|NCT02159183|450118173|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
125134511|NCT02159183|450118174|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
124975002|NCT02057575|449536522|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
124975003|NCT02057575|449536523|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
124975004|NCT02057575|449536524|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
124975005|NCT02057575|449536521|FG000|Overall Study|Protocol Violation|0|||
124975006|NCT02057575|449536522|FG001|Overall Study|Protocol Violation|1|||
124975007|NCT02057575|449536523|FG002|Overall Study|Protocol Violation|0|||
124975008|NCT02057575|449536524|FG003|Overall Study|Protocol Violation|0|||
124975009|NCT00332462|449536525|FG000|Overall Study|Adverse Event|5|||
124975010|NCT00332462|449536525|FG000|Overall Study|Abnormal Lab Value|1|||
124975011|NCT00332462|449536525|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
124975012|NCT00332462|449536525|FG000|Overall Study|no longer requires study drug|1|||
124975013|NCT00332462|449536525|FG000|Overall Study|Death|3|||
124975014|NCT00332462|449536525|FG000|Overall Study|Graft Loss|2|||
124975015|NCT01643044|449536526|FG000|Overall Study|Lost to Follow-up|1|||
124975016|NCT01643044|449536527|FG001|Overall Study|Lost to Follow-up|1|||
124975017|NCT01643044|449536526|FG000|Overall Study|Miscarried baby|2|||
124975018|NCT01643044|449536527|FG001|Overall Study|Miscarried baby|2|||
124975019|NCT01643044|449536526|FG000|Overall Study|Delivered outside of hospital|1|||
124975020|NCT01643044|449536527|FG001|Overall Study|Delivered outside of hospital|2|||
124975021|NCT01735175|449536530|FG000|Overall Study|Withdrawal by Subject|9|||
124975022|NCT01735175|449536531|FG001|Overall Study|Withdrawal by Subject|2|||
124975023|NCT01735175|449536530|FG000|Overall Study|Lost to Follow-up|4|||
124975024|NCT01735175|449536531|FG001|Overall Study|Lost to Follow-up|2|||
124975025|NCT01735175|449536530|FG000|Overall Study|Death|3|||
124975026|NCT01735175|449536531|FG001|Overall Study|Death|2|||
124975027|NCT01735175|449536530|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
124975028|NCT01735175|449536531|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
124975029|NCT01853475|449536532|FG000|Overall Study|Withdrawal by Subject|0|||
124975030|NCT01853475|449536533|FG001|Overall Study|Withdrawal by Subject|1|||
124975031|NCT01853475|449536534|FG002|Overall Study|Withdrawal by Subject|0|||
124975032|NCT01023958|449536537|FG000|Overall Study|Progressive disease|48|||
124975033|NCT01023958|449536537|FG000|Overall Study|Other adverse event|1|||
124975034|NCT01023958|449536537|FG000|Overall Study|Refused to continue medication|1|||
124975035|NCT03080493|449536538|FG000|Overall Study|Did not provide NRS pain results|1|||
124975036|NCT03080493|449536539|FG001|Overall Study|Did not provide NRS pain results|0|||
124975037|NCT03080493|449536538|FG000|Overall Study|Adverse Event|0|||
124975038|NCT03080493|449536539|FG001|Overall Study|Adverse Event|1|||
124975039|NCT03080493|449536538|FG000|Overall Study|Randomization error (parity group)|0|||
124975040|NCT03080493|449536539|FG001|Overall Study|Randomization error (parity group)|1|||
124975041|NCT00755417|449536540|FG000|Overall Study|Adverse Event|28|||
124975042|NCT00755417|449536541|FG001|Overall Study|Adverse Event|20|||
124975043|NCT00755417|449536542|FG002|Overall Study|Adverse Event|7|||
124975044|NCT00755417|449536540|FG000|Overall Study|Lack of Efficacy|8|||
124975045|NCT00755417|449536541|FG001|Overall Study|Lack of Efficacy|4|||
124975046|NCT00755417|449536542|FG002|Overall Study|Lack of Efficacy|9|||
124975047|NCT00755417|449536540|FG000|Overall Study|Protocol Violation|2|||
124975048|NCT00755417|449536541|FG001|Overall Study|Protocol Violation|1|||
124975049|NCT00755417|449536542|FG002|Overall Study|Protocol Violation|1|||
124975050|NCT00755417|449536540|FG000|Overall Study|Lost to Follow-up|3|||
124975051|NCT00755417|449536541|FG001|Overall Study|Lost to Follow-up|0|||
124975052|NCT00755417|449536542|FG002|Overall Study|Lost to Follow-up|1|||
124975053|NCT00755417|449536540|FG000|Overall Study|Withdrawal by Subject|12|||
124975054|NCT00755417|449536541|FG001|Overall Study|Withdrawal by Subject|12|||
124975055|NCT00755417|449536542|FG002|Overall Study|Withdrawal by Subject|12|||
124975056|NCT00755417|449536540|FG000|Overall Study|Not specified or missing data|9|||
124975057|NCT00755417|449536541|FG001|Overall Study|Not specified or missing data|18|||
124975058|NCT00755417|449536542|FG002|Overall Study|Not specified or missing data|12|||
124975059|NCT02362503|449536543|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
124975060|NCT02362503|449536544|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
124975061|NCT02362503|449536545|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
124975062|NCT02362503|449536543|FG000|Double-blind Period-Up to 8 Days|Death|1|||
124975063|NCT02362503|449536544|FG001|Double-blind Period-Up to 8 Days|Death|0|||
124975064|NCT02362503|449536545|FG002|Double-blind Period-Up to 8 Days|Death|0|||
124975065|NCT02362503|449536543|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
124975066|NCT02362503|449536544|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
124975067|NCT02362503|449536545|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
124975068|NCT02362503|449536543|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
124975069|NCT02362503|449536544|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
124975070|NCT02362503|449536545|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
124975071|NCT02362503|449536543|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
124975072|NCT02362503|449536544|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
124975073|NCT02362503|449536545|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
124975074|NCT02362503|449536543|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
124975075|NCT02362503|449536544|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
124975076|NCT02362503|449536545|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
124975077|NCT02362503|449536543|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
124975078|NCT02362503|449536544|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
124975079|NCT02362503|449536545|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
124975080|NCT02362503|449536543|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
124975081|NCT02362503|449536544|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
124975082|NCT02362503|449536545|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
124975083|NCT02362503|449536543|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
124975084|NCT02362503|449536544|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
124975085|NCT02362503|449536545|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
124975086|NCT02362503|449536543|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
125038689|NCT01794780|449761012|FG003|Overall Study|Other|20|||
125134512|NCT02159183|450118173|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
125134513|NCT02159183|450118174|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
125134514|NCT01294917|450118178|FG000|Overall Study|Relocation|5|||
125134515|NCT01294917|450118178|FG000|Overall Study|Inconvenience|1|||
125134516|NCT02519348|450118179|FG000|Overall Study|Death|31|||
125134517|NCT02519348|450118180|FG001|Overall Study|Death|74|||
125134518|NCT02519348|450118181|FG002|Overall Study|Death|47|||
125134519|NCT02519348|450118182|FG003|Overall Study|Death|54|||
125134520|NCT02519348|450118183|FG004|Overall Study|Death|63|||
125134521|NCT02519348|450118184|FG005|Overall Study|Death|18|||
125134522|NCT02519348|450118185|FG006|Overall Study|Death|2|||
125134523|NCT02519348|450118186|FG007|Overall Study|Death|5|||
125134524|NCT02519348|450118187|FG008|Overall Study|Death|5|||
125134525|NCT02519348|450118179|FG000|Overall Study|Withdrawal by Subject|4|||
125134526|NCT02519348|450118180|FG001|Overall Study|Withdrawal by Subject|7|||
125134527|NCT02519348|450118181|FG002|Overall Study|Withdrawal by Subject|4|||
125218558|NCT03131687|450427366|FG004|Overall Study|Adverse Event|2|||
125218559|NCT03131687|450427367|FG005|Overall Study|Adverse Event|2|||
125218560|NCT03131687|450427362|FG000|Overall Study|Death|1|||
125218561|NCT03131687|450427363|FG001|Overall Study|Death|0|||
124975087|NCT02362503|449536544|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
124975088|NCT02362503|449536545|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
124975089|NCT02362503|449536543|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
124975090|NCT02362503|449536544|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
124975091|NCT02362503|449536545|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
124975092|NCT02362503|449536543|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
124975093|NCT02362503|449536544|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
124975094|NCT02362503|449536545|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
124975095|NCT02362503|449536543|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
124975096|NCT02362503|449536544|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
124975097|NCT02362503|449536545|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
124975098|NCT02362503|449536543|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
124975099|NCT02362503|449536544|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
124975100|NCT02362503|449536545|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
124975101|NCT05143138|449536546|FG000|Overall Study|Death|5|||
124975102|NCT05143138|449536547|FG001|Overall Study|Death|35|||
124975103|NCT05143138|449536548|FG002|Overall Study|Death|1|||
124975104|NCT05143138|449536546|FG000|Overall Study|Lost to Follow-up|2|||
124975105|NCT05143138|449536547|FG001|Overall Study|Lost to Follow-up|4|||
124975106|NCT05143138|449536548|FG002|Overall Study|Lost to Follow-up|0|||
124975107|NCT05143138|449536546|FG000|Overall Study|withdrawal|1|||
124975108|NCT05143138|449536547|FG001|Overall Study|withdrawal|1|||
124975109|NCT05143138|449536548|FG002|Overall Study|withdrawal|0|||
124975110|NCT03325777|449536551|FG000|Overall Study|Lost to Follow-up|9|||
124975111|NCT03325777|449536552|FG001|Overall Study|Lost to Follow-up|12|||
124975112|NCT01099917|449536555|FG000|Overall Study|Adverse Event|3|||
124975113|NCT01099917|449536555|FG000|Overall Study|Not Treated|24|||
124975114|NCT02990468|449536562|FG000|Phase 2: MTD|Change in treatment|0|||
124975115|NCT02990468|449536563|FG001|Phase 2: MTD|Change in treatment|0|||
124975116|NCT02990468|449536564|FG002|Phase 2: MTD|Change in treatment|1|||
124975117|NCT01485120|449536566|FG000|Overall Study|Withdrawal by Subject|2|||
124975118|NCT02567708|449536567|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
124975119|NCT02567708|449536568|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
124975120|NCT02567708|449536567|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
124975121|NCT02567708|449536568|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
124975122|NCT02567708|449536567|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
124975123|NCT02567708|449536568|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
124975124|NCT02567708|449536567|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
124975125|NCT02567708|449536568|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
124975126|NCT01154140|449536573|FG000|Overall Study|Death|71|||
124975127|NCT01154140|449536574|FG001|Overall Study|Death|81|||
124975128|NCT01154140|449536573|FG000|Overall Study|Lost to Follow-up|4|||
124975129|NCT01154140|449536574|FG001|Overall Study|Lost to Follow-up|5|||
124975130|NCT01154140|449536573|FG000|Overall Study|Withdrawal by Subject|12|||
124975131|NCT01154140|449536574|FG001|Overall Study|Withdrawal by Subject|13|||
124975132|NCT01154140|449536573|FG000|Overall Study|Other|3|||
124975133|NCT01154140|449536574|FG001|Overall Study|Other|1|||
124975134|NCT01154140|449536573|FG000|Overall Study|Randomized but not treated|1|||
124975135|NCT01154140|449536574|FG001|Overall Study|Randomized but not treated|2|||
124975136|NCT01818531|449536578|FG000|Overall Study|Withdrawn for case delay after block|1|||
124975137|NCT01818531|449536579|FG001|Overall Study|Withdrawn for case delay after block|0|||
125134528|NCT02519348|450118182|FG003|Overall Study|Withdrawal by Subject|3|||
125134529|NCT02519348|450118183|FG004|Overall Study|Withdrawal by Subject|3|||
124975138|NCT01818531|449536578|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
125218562|NCT03131687|450427364|FG002|Overall Study|Death|0|||
125134530|NCT02519348|450118184|FG005|Overall Study|Withdrawal by Subject|2|||
125134531|NCT02519348|450118185|FG006|Overall Study|Withdrawal by Subject|0|||
125134532|NCT02519348|450118186|FG007|Overall Study|Withdrawal by Subject|0|||
125134533|NCT02519348|450118187|FG008|Overall Study|Withdrawal by Subject|1|||
125134534|NCT02519348|450118179|FG000|Overall Study|Lost to Follow-up|0|||
125038690|NCT01794780|449761013|FG004|Overall Study|Other|1|||
125038691|NCT01794780|449761014|FG005|Overall Study|Other|24|||
125038692|NCT01794780|449761015|FG006|Overall Study|Other|4|||
125038693|NCT01794780|449761016|FG007|Overall Study|Other|1|||
125038694|NCT01985321|449761018|FG000|Overall Study|Protocol Violation|4|||
125038695|NCT01985321|449761019|FG001|Overall Study|Protocol Violation|3|||
125038696|NCT01985321|449761018|FG000|Overall Study|Withdrawal by Subject|1|||
125038697|NCT01985321|449761019|FG001|Overall Study|Withdrawal by Subject|0|||
125038698|NCT01985321|449761018|FG000|Overall Study|Lost to Follow-up|5|||
125038699|NCT01985321|449761019|FG001|Overall Study|Lost to Follow-up|2|||
125038700|NCT01985321|449761018|FG000|Overall Study|Subject treated wrong type of sore|1|||
125038701|NCT01985321|449761019|FG001|Overall Study|Subject treated wrong type of sore|0|||
125038702|NCT02690701|449761022|FG000|Treatment Period 1|Adverse Event|2|||
125038703|NCT02690701|449761023|FG001|Treatment Period 1|Adverse Event|2|||
125038704|NCT02690701|449761022|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125038705|NCT02690701|449761023|FG001|Treatment Period 1|Withdrawal by Subject|1|||
125038706|NCT02690701|449761022|FG000|Treatment Period 2|Adverse Event|2|||
125038707|NCT02690701|449761023|FG001|Treatment Period 2|Adverse Event|0|||
125038708|NCT02690701|449761022|FG000|Treatment Period 2|Lack of Efficacy|1|||
125038709|NCT02690701|449761023|FG001|Treatment Period 2|Lack of Efficacy|0|||
125038710|NCT02690701|449761022|FG000|Treatment Period 2|Lost to Follow-up|0|||
125038711|NCT02690701|449761023|FG001|Treatment Period 2|Lost to Follow-up|2|||
125038712|NCT02690701|449761022|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125038713|NCT02690701|449761023|FG001|Treatment Period 2|Withdrawal by Subject|2|||
125038714|NCT02690701|449761022|FG000|Treatment Period 2|Protocol Violation|0|||
125038715|NCT02690701|449761023|FG001|Treatment Period 2|Protocol Violation|1|||
125038716|NCT01442181|449761024|FG000|Overall Study|patient refused surgery|1|||
125038717|NCT01442181|449761025|FG001|Overall Study|patient refused surgery|0|||
125038718|NCT01442181|449761024|FG000|Overall Study|no insurance for surgery|1|||
125038719|NCT01442181|449761025|FG001|Overall Study|no insurance for surgery|0|||
125038720|NCT01442181|449761024|FG000|Overall Study|low ejection factor|0|||
125038721|NCT01442181|449761025|FG001|Overall Study|low ejection factor|1|||
125038722|NCT01442181|449761024|FG000|Overall Study|Lost to Follow-up|1|||
125038723|NCT01442181|449761025|FG001|Overall Study|Lost to Follow-up|1|||
125038724|NCT01442181|449761024|FG000|Overall Study|patient in an additional study|1|||
125038725|NCT01442181|449761025|FG001|Overall Study|patient in an additional study|0|||
125038726|NCT01442181|449761024|FG000|Overall Study|atrial fibrillation not noted|0|||
125038727|NCT01442181|449761025|FG001|Overall Study|atrial fibrillation not noted|1|||
125038728|NCT00749203|449761026|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
125038729|NCT00749203|449761027|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
125038730|NCT00749203|449761026|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
125038731|NCT00749203|449761027|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
125038732|NCT00749203|449761026|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
125038733|NCT00749203|449761027|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
125038734|NCT00749203|449761026|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
125038735|NCT00749203|449761027|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
125038736|NCT00749203|449761026|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
125038737|NCT00749203|449761027|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
125038738|NCT00749203|449761026|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
125038739|NCT00749203|449761027|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
125038740|NCT02853760|449761029|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
125134535|NCT02519348|450118180|FG001|Overall Study|Lost to Follow-up|0|||
125134536|NCT02519348|450118181|FG002|Overall Study|Lost to Follow-up|1|||
125134537|NCT02519348|450118182|FG003|Overall Study|Lost to Follow-up|0|||
125134538|NCT02519348|450118183|FG004|Overall Study|Lost to Follow-up|2|||
125134539|NCT02519348|450118184|FG005|Overall Study|Lost to Follow-up|1|||
125134540|NCT02519348|450118185|FG006|Overall Study|Lost to Follow-up|1|||
125134541|NCT02519348|450118186|FG007|Overall Study|Lost to Follow-up|0|||
125134542|NCT02519348|450118187|FG008|Overall Study|Lost to Follow-up|0|||
125038741|NCT02853760|449761030|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
125038742|NCT02853760|449761031|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
125038743|NCT02853760|449761032|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
125038744|NCT02853760|449761033|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
125038745|NCT02853760|449761034|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
125038746|NCT01642212|449761035|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
125038747|NCT01642212|449761036|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
125038748|NCT01642212|449761037|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
125134543|NCT02519348|450118179|FG000|Overall Study|Other|0|||
125134544|NCT02519348|450118180|FG001|Overall Study|Other|3|||
125134545|NCT02519348|450118181|FG002|Overall Study|Other|0|||
125134546|NCT02519348|450118182|FG003|Overall Study|Other|0|||
125134547|NCT02519348|450118183|FG004|Overall Study|Other|1|||
125134548|NCT02519348|450118184|FG005|Overall Study|Other|0|||
125134549|NCT02519348|450118185|FG006|Overall Study|Other|0|||
125134550|NCT02519348|450118186|FG007|Overall Study|Other|0|||
125134551|NCT02519348|450118187|FG008|Overall Study|Other|0|||
125134552|NCT02519348|450118179|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
125134553|NCT02519348|450118180|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
125134554|NCT02519348|450118181|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
125134555|NCT02519348|450118182|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
125134556|NCT02519348|450118183|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
125134557|NCT02519348|450118184|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
125134558|NCT02519348|450118185|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
125134559|NCT02519348|450118186|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
125134560|NCT02519348|450118187|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
125134561|NCT01444378|450118188|FG000|Overall Study|Lost to Follow-up|1|||
125134562|NCT01444378|450118188|FG000|Overall Study|Withdrawal by Subject|1|||
125134563|NCT01444378|450118188|FG000|Overall Study|Death|3|||
125134564|NCT01444378|450118188|FG000|Overall Study|Administrative Closure Of The Study|2|||
125134565|NCT01444378|450118188|FG000|Overall Study|Missed Visits|10|||
125134566|NCT02911792|450118189|FG000|Overall Study|Lost to Follow-up|3|||
125134567|NCT02911792|450118190|FG001|Overall Study|Lost to Follow-up|3|||
125134568|NCT02911792|450118191|FG002|Overall Study|Lost to Follow-up|3|||
125134569|NCT02911792|450118192|FG003|Overall Study|Lost to Follow-up|3|||
125134570|NCT01244620|450118195|FG000|Overall Study|Study terminated|4|||
125134571|NCT01244620|450118196|FG001|Overall Study|Study terminated|4|||
125134572|NCT01244620|450118197|FG002|Overall Study|Study terminated|4|||
125134573|NCT01244620|450118198|FG003|Overall Study|Study terminated|4|||
125134574|NCT02321098|450118200|FG000|12 Weeks Treament|Lost to Follow-up|1|||
125134575|NCT02321098|450118201|FG001|12 Weeks Treament|Lost to Follow-up|1|||
125134576|NCT02321098|450118202|FG002|12 Weeks Treament|Lost to Follow-up|0|||
125134577|NCT02321098|450118200|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
125134578|NCT02321098|450118201|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
125134579|NCT02321098|450118202|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
125134580|NCT02321098|450118200|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
125134581|NCT02321098|450118201|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
125134582|NCT02321098|450118202|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
125134583|NCT02321098|450118200|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
125134584|NCT02321098|450118201|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
125134585|NCT02321098|450118202|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
125134586|NCT01663233|450118203|FG000|Overall Study|Withdrawal by Subject|3|||
125134587|NCT01663233|450118204|FG001|Overall Study|Withdrawal by Subject|2|||
124975139|NCT01818531|449536579|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
124975140|NCT01818531|449536578|FG000|Overall Study|Withdrawn for failure to place block|0|||
124975141|NCT01818531|449536579|FG001|Overall Study|Withdrawn for failure to place block|1|||
124975142|NCT00477490|449536580|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
124975143|NCT00477490|449536581|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
124975144|NCT00477490|449536582|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
124975145|NCT00477490|449536583|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
124975146|NCT00477490|449536584|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
124975147|NCT00477490|449536585|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
124975148|NCT00477490|449536586|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
124975149|NCT00477490|449536587|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
124975150|NCT00477490|449536588|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
124975151|NCT00477490|449536580|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
124975152|NCT00477490|449536581|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
124975153|NCT00477490|449536582|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
124975154|NCT00477490|449536583|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
124975155|NCT00477490|449536584|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
124975156|NCT00477490|449536585|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
124975157|NCT00477490|449536586|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
124975158|NCT00477490|449536587|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
125134588|NCT01663233|450118203|FG000|Overall Study|Protocol Deviation|1|||
125134589|NCT01663233|450118204|FG001|Overall Study|Protocol Deviation|4|||
125134590|NCT01663233|450118203|FG000|Overall Study|Lost to Follow-up|0|||
125134591|NCT01663233|450118204|FG001|Overall Study|Lost to Follow-up|1|||
125134592|NCT05630885|450118207|FG000|Study Completion|Took prohibited medications|2|||
125134593|NCT05630885|450118208|FG001|Study Completion|Took prohibited medications|0|||
125218563|NCT03131687|450427365|FG003|Overall Study|Death|0|||
125038749|NCT01642212|449761038|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
125038750|NCT01642212|449761039|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
125038751|NCT01642212|449761035|FG000|Double-blind Treatment|Other|0|||
125038752|NCT01642212|449761036|FG001|Double-blind Treatment|Other|2|||
125038753|NCT01642212|449761037|FG002|Double-blind Treatment|Other|1|||
125038754|NCT01642212|449761038|FG003|Double-blind Treatment|Other|0|||
125038755|NCT01642212|449761039|FG004|Double-blind Treatment|Other|0|||
125038756|NCT01642212|449761035|FG000|Double-blind Treatment|Non-compliance|0|||
125038757|NCT01642212|449761036|FG001|Double-blind Treatment|Non-compliance|1|||
125038758|NCT01642212|449761037|FG002|Double-blind Treatment|Non-compliance|0|||
125038759|NCT01642212|449761038|FG003|Double-blind Treatment|Non-compliance|0|||
125038760|NCT01642212|449761039|FG004|Double-blind Treatment|Non-compliance|0|||
125038761|NCT01642212|449761035|FG000|Double-blind Treatment|Adverse Event|0|||
125038762|NCT01642212|449761036|FG001|Double-blind Treatment|Adverse Event|0|||
125038763|NCT01642212|449761037|FG002|Double-blind Treatment|Adverse Event|1|||
125038764|NCT01642212|449761038|FG003|Double-blind Treatment|Adverse Event|0|||
125038765|NCT01642212|449761039|FG004|Double-blind Treatment|Adverse Event|0|||
125038766|NCT01642212|449761035|FG000|Open-label Extension|Adverse Event|0|||
125038767|NCT01642212|449761036|FG001|Open-label Extension|Adverse Event|0|||
125038768|NCT01642212|449761037|FG002|Open-label Extension|Adverse Event|0|||
125038769|NCT01642212|449761038|FG003|Open-label Extension|Adverse Event|3|||
125038770|NCT01642212|449761039|FG004|Open-label Extension|Adverse Event|0|||
125038771|NCT01642212|449761035|FG000|Open-label Extension|Sponsor Decision|0|||
125038772|NCT01642212|449761036|FG001|Open-label Extension|Sponsor Decision|0|||
125038773|NCT01642212|449761037|FG002|Open-label Extension|Sponsor Decision|0|||
125038774|NCT01642212|449761038|FG003|Open-label Extension|Sponsor Decision|7|||
125038775|NCT01642212|449761039|FG004|Open-label Extension|Sponsor Decision|4|||
125038776|NCT01642212|449761035|FG000|Open-label Extension|Consent Withdrawn|0|||
125038777|NCT01642212|449761036|FG001|Open-label Extension|Consent Withdrawn|0|||
125038778|NCT01642212|449761037|FG002|Open-label Extension|Consent Withdrawn|0|||
125038779|NCT01642212|449761038|FG003|Open-label Extension|Consent Withdrawn|0|||
125038780|NCT01642212|449761039|FG004|Open-label Extension|Consent Withdrawn|2|||
125038781|NCT01642212|449761035|FG000|Open-label Extension|Lost to Follow-up|0|||
125038782|NCT01642212|449761036|FG001|Open-label Extension|Lost to Follow-up|0|||
125038783|NCT01642212|449761037|FG002|Open-label Extension|Lost to Follow-up|0|||
125038784|NCT01642212|449761038|FG003|Open-label Extension|Lost to Follow-up|0|||
125038785|NCT01642212|449761039|FG004|Open-label Extension|Lost to Follow-up|1|||
125038786|NCT01642212|449761035|FG000|Open-label Extension|Other|0|||
125038787|NCT01642212|449761036|FG001|Open-label Extension|Other|0|||
125038788|NCT01642212|449761037|FG002|Open-label Extension|Other|0|||
125038789|NCT01642212|449761038|FG003|Open-label Extension|Other|0|||
125038790|NCT01642212|449761039|FG004|Open-label Extension|Other|1|||
125038791|NCT00004980|449761040|FG000|Overall Study|Withdrawal by Subject|1|||
125038792|NCT00004980|449761041|FG001|Overall Study|Withdrawal by Subject|0|||
124975159|NCT00477490|449536588|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
124975160|NCT00477490|449536580|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
124975161|NCT00477490|449536581|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
124975162|NCT00477490|449536582|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
124975163|NCT00477490|449536583|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
124975164|NCT00477490|449536584|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
124975165|NCT00477490|449536585|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
124975166|NCT00477490|449536586|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
124975167|NCT00477490|449536587|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
124975168|NCT00477490|449536588|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
124975169|NCT00477490|449536580|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
124975170|NCT00477490|449536581|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
124975171|NCT00477490|449536582|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
124975172|NCT00477490|449536583|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
124975173|NCT00477490|449536584|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
124975174|NCT00477490|449536585|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
124975175|NCT00477490|449536586|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
124975176|NCT00477490|449536587|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
124975177|NCT00477490|449536588|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
124975178|NCT00477490|449536580|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
124975179|NCT00477490|449536581|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
124975180|NCT00477490|449536582|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
124975181|NCT00477490|449536583|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
124975182|NCT00477490|449536584|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
125038793|NCT00004980|449761040|FG000|Overall Study|memory difficulties|1|||
125038794|NCT00004980|449761041|FG001|Overall Study|memory difficulties|1|||
125038795|NCT00004980|449761040|FG000|Overall Study|Physician Decision|0|||
125038796|NCT00004980|449761041|FG001|Overall Study|Physician Decision|1|||
125038797|NCT01299025|449761042|FG000|Overall Study|Withdrawal by Subject|2|||
125038798|NCT01299025|449761043|FG001|Overall Study|Withdrawal by Subject|1|||
125038799|NCT01299025|449761042|FG000|Overall Study|Lost to Follow-up|1|||
125134594|NCT05630885|450118207|FG000|Study Completion|Non-compliance with study drug|1|||
125134595|NCT05630885|450118208|FG001|Study Completion|Non-compliance with study drug|0|||
125134596|NCT05630885|450118207|FG000|Study Completion|Adverse Event|1|||
125134597|NCT05630885|450118208|FG001|Study Completion|Adverse Event|0|||
125134598|NCT05630885|450118207|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
125134599|NCT05630885|450118208|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
125134600|NCT05630885|450118207|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
125134601|NCT05630885|450118208|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
125134602|NCT01370733|450118209|FG000|Overall Study|Withdrawal by Subject|8|||
125134603|NCT01370733|450118210|FG001|Overall Study|Withdrawal by Subject|8|||
125134604|NCT01370733|450118209|FG000|Overall Study|Lost to Follow-up|3|||
125134605|NCT01370733|450118210|FG001|Overall Study|Lost to Follow-up|0|||
125134606|NCT01370733|450118209|FG000|Overall Study|Adverse Event|2|||
125134607|NCT01370733|450118210|FG001|Overall Study|Adverse Event|4|||
125134608|NCT01370733|450118209|FG000|Overall Study|Lack of Efficacy|3|||
125134609|NCT01370733|450118210|FG001|Overall Study|Lack of Efficacy|5|||
125218564|NCT03131687|450427366|FG004|Overall Study|Death|0|||
124975183|NCT00477490|449536585|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
124975184|NCT00477490|449536586|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
124975185|NCT00477490|449536587|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
124975186|NCT00477490|449536588|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
124975187|NCT00477490|449536580|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
124975188|NCT00477490|449536581|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
124975189|NCT00477490|449536582|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
124975190|NCT00477490|449536583|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
124975191|NCT00477490|449536584|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
124975192|NCT00477490|449536585|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
124975193|NCT00477490|449536586|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
124975194|NCT00477490|449536587|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
124975195|NCT00477490|449536588|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
124975196|NCT00477490|449536580|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
124975197|NCT00477490|449536581|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
124975198|NCT00477490|449536582|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
124975199|NCT00477490|449536583|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
124975200|NCT00477490|449536584|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
124975201|NCT00477490|449536585|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
124975202|NCT00477490|449536586|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
124975203|NCT00477490|449536587|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
124975204|NCT00477490|449536588|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
124975205|NCT00477490|449536580|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
125038800|NCT01299025|449761043|FG001|Overall Study|Lost to Follow-up|0|||
125038801|NCT03577990|449761044|FG000|Overall Study|Lost to Follow-up|4|||
125038802|NCT03577990|449761045|FG001|Overall Study|Lost to Follow-up|6|||
125038803|NCT03577990|449761044|FG000|Overall Study|Withdrawal by Subject|4|||
125038804|NCT03577990|449761045|FG001|Overall Study|Withdrawal by Subject|7|||
125038805|NCT02793544|449761050|FG000|Overall Study|Death|10|||
125038806|NCT02793544|449761051|FG001|Overall Study|Death|8|||
125038807|NCT02793544|449761050|FG000|Overall Study|Lost to Follow-up|2|||
125038808|NCT02793544|449761051|FG001|Overall Study|Lost to Follow-up|0|||
125038809|NCT02793544|449761050|FG000|Overall Study|Withdrawal by Subject|1|||
125038810|NCT02793544|449761051|FG001|Overall Study|Withdrawal by Subject|0|||
125038811|NCT00100048|449761052|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
125038812|NCT00100048|449761053|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
125038813|NCT00100048|449761054|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
125038814|NCT00100048|449761055|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
125038815|NCT00100048|449761056|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
125038816|NCT00100048|449761057|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
125038817|NCT00100048|449761052|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
125038818|NCT00100048|449761053|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
125038819|NCT00100048|449761054|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
125038820|NCT00100048|449761055|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
125038821|NCT00100048|449761056|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
125038822|NCT00100048|449761057|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
125038823|NCT00100048|449761052|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
125038824|NCT00100048|449761053|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
125134610|NCT01370733|450118209|FG000|Overall Study|Physician Decision|0|||
125134611|NCT01370733|450118210|FG001|Overall Study|Physician Decision|2|||
125134612|NCT01370733|450118209|FG000|Overall Study|Protocol Violation|1|||
125134613|NCT01370733|450118210|FG001|Overall Study|Protocol Violation|3|||
125134614|NCT06539676|450118211|FG000|Overall Study|Early study termination|1|||
125218565|NCT03131687|450427367|FG005|Overall Study|Death|0|||
125134615|NCT06539676|450118212|FG001|Overall Study|Early study termination|0|||
125218566|NCT03131687|450427362|FG000|Overall Study|Withdrawal by Subject|3|||
124975206|NCT00477490|449536581|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
124975207|NCT00477490|449536582|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
124975208|NCT00477490|449536583|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
124975209|NCT00477490|449536584|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
124975210|NCT00477490|449536585|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
124975211|NCT00477490|449536586|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
124975212|NCT00477490|449536587|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
124975213|NCT00477490|449536588|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
124975214|NCT00477490|449536580|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
124975215|NCT00477490|449536581|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
125038825|NCT00100048|449761054|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
125038826|NCT00100048|449761055|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
124975216|NCT00477490|449536582|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
124975217|NCT00477490|449536583|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
124975218|NCT00477490|449536584|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
124975219|NCT00477490|449536585|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
124975220|NCT00477490|449536586|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
124975221|NCT00477490|449536587|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
124975222|NCT00477490|449536588|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
124975223|NCT00477490|449536580|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
124975224|NCT00477490|449536581|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
124975225|NCT00477490|449536582|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
124975226|NCT00477490|449536583|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
124975227|NCT00477490|449536584|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
124975228|NCT00477490|449536585|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
124975229|NCT00477490|449536586|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
124975230|NCT00477490|449536587|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
124975231|NCT00477490|449536588|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
124975232|NCT00477490|449536580|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
124975233|NCT00477490|449536581|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
124975234|NCT00477490|449536582|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
124975235|NCT00477490|449536583|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
124975236|NCT00477490|449536584|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
124975237|NCT00477490|449536585|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
124975238|NCT00477490|449536586|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
124975239|NCT00477490|449536587|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
124975240|NCT00477490|449536588|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
124975241|NCT00477490|449536580|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
124975242|NCT00477490|449536581|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
124975243|NCT00477490|449536582|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
124975244|NCT00477490|449536583|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
124975245|NCT00477490|449536584|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
124975246|NCT00477490|449536585|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
124975247|NCT00477490|449536586|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
124975248|NCT00477490|449536587|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
124975249|NCT00477490|449536588|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
124975250|NCT00477490|449536580|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
124975251|NCT00477490|449536581|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
124975252|NCT00477490|449536582|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
124975253|NCT00477490|449536583|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
124975254|NCT00477490|449536584|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
124975255|NCT00477490|449536585|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
124975256|NCT00477490|449536586|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
124975257|NCT00477490|449536587|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
124975258|NCT00477490|449536588|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
125038827|NCT00100048|449761056|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
125038828|NCT00100048|449761057|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
125038829|NCT00100048|449761052|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
125038830|NCT00100048|449761053|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
125038831|NCT00100048|449761054|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
125038832|NCT00100048|449761055|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
125038833|NCT00100048|449761056|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
125038834|NCT00100048|449761057|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
125038835|NCT00100048|449761052|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
125038836|NCT00100048|449761053|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
125038837|NCT00100048|449761054|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
125038838|NCT00100048|449761055|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
125038839|NCT00100048|449761056|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
125038840|NCT00100048|449761057|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
125038841|NCT00100048|449761052|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
125038842|NCT00100048|449761053|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
125038843|NCT00100048|449761054|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
125038844|NCT00100048|449761055|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
125038845|NCT00100048|449761056|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
125038846|NCT00100048|449761057|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
125038847|NCT00100048|449761052|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
125038848|NCT00100048|449761053|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
125038849|NCT00100048|449761054|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
125038850|NCT00100048|449761055|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
125038851|NCT00100048|449761056|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
125038852|NCT00100048|449761057|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
125038853|NCT00100048|449761052|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
125038854|NCT00100048|449761053|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
125038855|NCT00100048|449761054|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
125038856|NCT00100048|449761055|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
125038857|NCT00100048|449761056|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
125038858|NCT00100048|449761057|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
125038859|NCT01624142|449761058|FG000|Overall Study|Withdrawal by Subject|14|||
125038860|NCT01624142|449761059|FG001|Overall Study|Withdrawal by Subject|4|||
125038861|NCT01624142|449761058|FG000|Overall Study|Death|3|||
125038862|NCT01624142|449761059|FG001|Overall Study|Death|6|||
125038863|NCT01624142|449761058|FG000|Overall Study|Study Closure|12|||
125038864|NCT01624142|449761059|FG001|Overall Study|Study Closure|6|||
125038865|NCT01624142|449761058|FG000|Overall Study|Lost to Follow-up|2|||
125038866|NCT01624142|449761059|FG001|Overall Study|Lost to Follow-up|0|||
125038867|NCT01624142|449761058|FG000|Overall Study|Other|1|||
125038868|NCT01624142|449761059|FG001|Overall Study|Other|0|||
125038869|NCT01822561|449761060|FG000|Overall Study|Withdrawal by Subject|2|||
125038870|NCT04826900|449761061|FG000|Overall Study|Family factor|1|||
125038871|NCT04826900|449761062|FG001|Overall Study|Family factor|1|||
125038872|NCT02597062|449761063|FG000|Overall Study|Ineligible|1|||
125038873|NCT03372941|449761064|FG000|Overall Study|Lost to Follow-up|2|||
125038874|NCT03372941|449761065|FG001|Overall Study|Lost to Follow-up|4|||
125038875|NCT01126580|449761066|FG000|Overall Study|Adverse Event|14|||
125038876|NCT01126580|449761067|FG001|Overall Study|Adverse Event|8|||
125038877|NCT01126580|449761068|FG002|Overall Study|Adverse Event|12|||
125038878|NCT01126580|449761066|FG000|Overall Study|Withdrawal by Subject|11|||
125038879|NCT01126580|449761067|FG001|Overall Study|Withdrawal by Subject|19|||
125038880|NCT01126580|449761068|FG002|Overall Study|Withdrawal by Subject|14|||
125038881|NCT01126580|449761066|FG000|Overall Study|Sponsor Decision|5|||
125038882|NCT01126580|449761067|FG001|Overall Study|Sponsor Decision|4|||
125038883|NCT01126580|449761068|FG002|Overall Study|Sponsor Decision|7|||
125038884|NCT01126580|449761066|FG000|Overall Study|Physician Decision|1|||
125038885|NCT01126580|449761067|FG001|Overall Study|Physician Decision|1|||
125038886|NCT01126580|449761068|FG002|Overall Study|Physician Decision|2|||
125038887|NCT01126580|449761066|FG000|Overall Study|Entry Criteria Not Met|1|||
125038888|NCT01126580|449761067|FG001|Overall Study|Entry Criteria Not Met|1|||
125038889|NCT01126580|449761068|FG002|Overall Study|Entry Criteria Not Met|2|||
125038890|NCT01126580|449761066|FG000|Overall Study|Lack of Efficacy|2|||
125038891|NCT01126580|449761067|FG001|Overall Study|Lack of Efficacy|3|||
125038892|NCT01126580|449761068|FG002|Overall Study|Lack of Efficacy|4|||
125038893|NCT01126580|449761066|FG000|Overall Study|Protocol Violation|0|||
125038894|NCT01126580|449761067|FG001|Overall Study|Protocol Violation|1|||
125038895|NCT01126580|449761068|FG002|Overall Study|Protocol Violation|2|||
124975259|NCT00477490|449536580|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
124975260|NCT00477490|449536581|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
124975261|NCT00477490|449536582|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
124975262|NCT00477490|449536583|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
124975263|NCT00477490|449536584|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
124975264|NCT00477490|449536585|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
124975265|NCT00477490|449536586|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
124975266|NCT00477490|449536587|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
124975267|NCT00477490|449536588|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
124975268|NCT01646177|449536589|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
124975269|NCT01646177|449536590|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
124975270|NCT01646177|449536591|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
124975271|NCT01646177|449536592|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
124975272|NCT01646177|449536593|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
124975273|NCT01646177|449536594|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
124975274|NCT01646177|449536595|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
124975275|NCT01646177|449536596|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
124975276|NCT01646177|449536597|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
124975277|NCT01646177|449536598|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
124975278|NCT01646177|449536599|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
124975279|NCT01646177|449536600|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
124975280|NCT01646177|449536589|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
124975281|NCT01646177|449536590|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
124975282|NCT01646177|449536591|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
124975283|NCT01646177|449536592|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
124975284|NCT01646177|449536593|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
124975285|NCT01646177|449536594|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
124975286|NCT01646177|449536595|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
124975287|NCT01646177|449536596|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
124975288|NCT01646177|449536597|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
124975289|NCT01646177|449536598|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
124975290|NCT01646177|449536599|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
124975291|NCT01646177|449536600|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
124975292|NCT01646177|449536589|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
124975293|NCT01646177|449536590|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
124975294|NCT01646177|449536591|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
124975295|NCT01646177|449536592|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
124975296|NCT01646177|449536593|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
124975297|NCT01646177|449536594|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
124975298|NCT01646177|449536595|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
124975299|NCT01646177|449536596|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
124975300|NCT01646177|449536597|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
124975301|NCT01646177|449536598|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
124975302|NCT01646177|449536599|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
124975303|NCT01646177|449536600|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
124975304|NCT01646177|449536589|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
124975305|NCT01646177|449536590|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
124975306|NCT01646177|449536591|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
124975307|NCT01646177|449536592|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
124975308|NCT01646177|449536593|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
124975309|NCT01646177|449536594|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
124975310|NCT01646177|449536595|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
124975311|NCT01646177|449536596|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
124975312|NCT01646177|449536597|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
124975313|NCT01646177|449536598|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
124975314|NCT01646177|449536599|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
124975315|NCT01646177|449536600|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
124975316|NCT01646177|449536589|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
124975317|NCT01646177|449536590|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
125038896|NCT01126580|449761066|FG000|Overall Study|Lost to Follow-up|15|||
125038897|NCT01126580|449761067|FG001|Overall Study|Lost to Follow-up|13|||
125038898|NCT01126580|449761068|FG002|Overall Study|Lost to Follow-up|9|||
125038899|NCT01126580|449761066|FG000|Overall Study|Treatment Non-compliance|0|||
125038900|NCT01126580|449761067|FG001|Overall Study|Treatment Non-compliance|2|||
125038901|NCT01126580|449761068|FG002|Overall Study|Treatment Non-compliance|3|||
125038902|NCT00686543|449761069|FG000|Overall Study|Adverse Event|9|||
125038903|NCT00686543|449761070|FG001|Overall Study|Adverse Event|1|||
125038904|NCT00686543|449761071|FG002|Overall Study|Adverse Event|3|||
125038905|NCT00686543|449761072|FG003|Overall Study|Adverse Event|2|||
125038906|NCT00686543|449761069|FG000|Overall Study|Withdrawal by Subject|2|||
125038907|NCT00686543|449761070|FG001|Overall Study|Withdrawal by Subject|0|||
125038908|NCT00686543|449761071|FG002|Overall Study|Withdrawal by Subject|0|||
125038909|NCT00686543|449761072|FG003|Overall Study|Withdrawal by Subject|0|||
125038910|NCT00686543|449761069|FG000|Overall Study|Protocol Violation|3|||
125038911|NCT00686543|449761070|FG001|Overall Study|Protocol Violation|0|||
125038912|NCT00686543|449761071|FG002|Overall Study|Protocol Violation|2|||
125038913|NCT00686543|449761072|FG003|Overall Study|Protocol Violation|1|||
125038914|NCT01708057|449761075|FG000|Overall Study|Withdrawal due to study termination.|1|||
125038915|NCT01708057|449761076|FG001|Overall Study|Withdrawal due to study termination.|1|||
125038916|NCT01708057|449761077|FG002|Overall Study|Withdrawal due to study termination.|1|||
125038917|NCT00947349|449761080|FG000|Triple Treatment Combination Period|Adverse Event|0|||
125038918|NCT00947349|449761081|FG001|Triple Treatment Combination Period|Adverse Event|1|||
125038919|NCT00947349|449761082|FG002|Triple Treatment Combination Period|Adverse Event|0|||
125038920|NCT00947349|449761083|FG003|Triple Treatment Combination Period|Adverse Event|0|||
125038921|NCT00947349|449761080|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
125038922|NCT00947349|449761081|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
125038923|NCT00947349|449761082|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
125038924|NCT00947349|449761083|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
125038925|NCT00947349|449761080|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
125038926|NCT00947349|449761081|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
125134616|NCT06539676|450118213|FG002|Overall Study|Early study termination|6|||
125134617|NCT02645409|450118214|FG000|Overall Study|Withdrawal by Subject|3|||
125134618|NCT02645409|450118215|FG001|Overall Study|Withdrawal by Subject|0|||
125134619|NCT02645409|450118214|FG000|Overall Study|Physician Decision|1|||
125134620|NCT02645409|450118215|FG001|Overall Study|Physician Decision|0|||
125134621|NCT03419403|450118216|FG000|Overall Study|Withdrawal by Subject|5|||
125134622|NCT03419403|450118217|FG001|Overall Study|Withdrawal by Subject|2|||
125134623|NCT03419403|450118218|FG002|Overall Study|Withdrawal by Subject|5|||
125134624|NCT03419403|450118219|FG003|Overall Study|Withdrawal by Subject|1|||
125134625|NCT03419403|450118216|FG000|Overall Study|Progressive disease (per protocol)|0|||
125134626|NCT03419403|450118217|FG001|Overall Study|Progressive disease (per protocol)|2|||
125134627|NCT03419403|450118218|FG002|Overall Study|Progressive disease (per protocol)|2|||
125134628|NCT03419403|450118219|FG003|Overall Study|Progressive disease (per protocol)|0|||
125134629|NCT03419403|450118216|FG000|Overall Study|Other, not specified|6|||
125134630|NCT03419403|450118217|FG001|Overall Study|Other, not specified|4|||
125134631|NCT03419403|450118218|FG002|Overall Study|Other, not specified|5|||
125134632|NCT03419403|450118219|FG003|Overall Study|Other, not specified|1|||
125134633|NCT03419403|450118216|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
125218567|NCT03131687|450427363|FG001|Overall Study|Withdrawal by Subject|3|||
125218568|NCT03131687|450427364|FG002|Overall Study|Withdrawal by Subject|3|||
124975318|NCT01646177|449536591|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
125038927|NCT00947349|449761082|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
125038928|NCT00947349|449761083|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
125038929|NCT00947349|449761080|FG000|Overall Study Standard of Care|Other|0|||
125038930|NCT00947349|449761081|FG001|Overall Study Standard of Care|Other|0|||
124975319|NCT01646177|449536592|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
124975320|NCT01646177|449536593|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
124975321|NCT01646177|449536594|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
124975322|NCT01646177|449536595|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
124975323|NCT01646177|449536596|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
124975324|NCT01646177|449536597|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
124975325|NCT01646177|449536598|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
124975326|NCT01646177|449536599|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
125038931|NCT00947349|449761082|FG002|Overall Study Standard of Care|Other|0|||
125134634|NCT03419403|450118217|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
125134635|NCT03419403|450118218|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
125218569|NCT03131687|450427365|FG003|Overall Study|Withdrawal by Subject|1|||
125218570|NCT03131687|450427366|FG004|Overall Study|Withdrawal by Subject|2|||
125218571|NCT03131687|450427367|FG005|Overall Study|Withdrawal by Subject|1|||
124975327|NCT01646177|449536600|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
124975328|NCT01646177|449536589|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
125038932|NCT00947349|449761083|FG003|Overall Study Standard of Care|Other|1|||
125038933|NCT01697345|449761084|FG000|Overall Study|Withdrawal by Subject|1|||
125134636|NCT03419403|450118219|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
125218572|NCT03131687|450427362|FG000|Overall Study|Lost to Follow-up|1|||
125038934|NCT00538681|449761085|FG000|Overall Study|Progressive Disease|7|||
125038935|NCT00538681|449761086|FG001|Overall Study|Progressive Disease|0|||
125134637|NCT02089685|450118222|FG000|Overall Study|Adverse Event|1|||
125134638|NCT02089685|450118223|FG001|Overall Study|Adverse Event|0|||
125134639|NCT02089685|450118224|FG002|Overall Study|Adverse Event|0|||
125134640|NCT02089685|450118225|FG003|Overall Study|Adverse Event|0|||
125134641|NCT02089685|450118226|FG004|Overall Study|Adverse Event|1|||
125134642|NCT02089685|450118227|FG005|Overall Study|Adverse Event|0|||
125134643|NCT02089685|450118222|FG000|Overall Study|Clinical Progression|4|||
125134644|NCT02089685|450118223|FG001|Overall Study|Clinical Progression|0|||
125134645|NCT02089685|450118224|FG002|Overall Study|Clinical Progression|0|||
125134646|NCT02089685|450118225|FG003|Overall Study|Clinical Progression|5|||
125134647|NCT02089685|450118226|FG004|Overall Study|Clinical Progression|1|||
125134648|NCT02089685|450118227|FG005|Overall Study|Clinical Progression|2|||
125134649|NCT02089685|450118222|FG000|Overall Study|Excluded Medication|1|||
125134650|NCT02089685|450118223|FG001|Overall Study|Excluded Medication|0|||
125134651|NCT02089685|450118224|FG002|Overall Study|Excluded Medication|0|||
125134652|NCT02089685|450118225|FG003|Overall Study|Excluded Medication|11|||
125134653|NCT02089685|450118226|FG004|Overall Study|Excluded Medication|2|||
125134654|NCT02089685|450118227|FG005|Overall Study|Excluded Medication|1|||
125134655|NCT02089685|450118222|FG000|Overall Study|Progressive disease|13|||
125134656|NCT02089685|450118223|FG001|Overall Study|Progressive disease|10|||
125134657|NCT02089685|450118224|FG002|Overall Study|Progressive disease|3|||
125134658|NCT02089685|450118225|FG003|Overall Study|Progressive disease|51|||
125134659|NCT02089685|450118226|FG004|Overall Study|Progressive disease|17|||
125134660|NCT02089685|450118227|FG005|Overall Study|Progressive disease|12|||
125134661|NCT02089685|450118222|FG000|Overall Study|Follow up ended by sponsor|2|||
125134662|NCT02089685|450118223|FG001|Overall Study|Follow up ended by sponsor|2|||
125134663|NCT02089685|450118224|FG002|Overall Study|Follow up ended by sponsor|0|||
125134664|NCT02089685|450118225|FG003|Overall Study|Follow up ended by sponsor|70|||
125134665|NCT02089685|450118226|FG004|Overall Study|Follow up ended by sponsor|26|||
125134666|NCT02089685|450118227|FG005|Overall Study|Follow up ended by sponsor|26|||
125134667|NCT02089685|450118222|FG000|Overall Study|Withdrawal by Subject|0|||
125134668|NCT02089685|450118223|FG001|Overall Study|Withdrawal by Subject|2|||
125134669|NCT02089685|450118224|FG002|Overall Study|Withdrawal by Subject|0|||
125134670|NCT02089685|450118225|FG003|Overall Study|Withdrawal by Subject|8|||
125134671|NCT02089685|450118226|FG004|Overall Study|Withdrawal by Subject|1|||
124975329|NCT01646177|449536590|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
124975330|NCT01646177|449536591|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
124975331|NCT01646177|449536592|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
124975332|NCT01646177|449536593|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
124975333|NCT01646177|449536594|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
124975334|NCT01646177|449536595|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
124975335|NCT01646177|449536596|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
124975336|NCT01646177|449536597|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
124975337|NCT01646177|449536598|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
124975338|NCT01646177|449536599|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
124975339|NCT01646177|449536600|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
124975340|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
124975341|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
124975342|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
124975343|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
124975344|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
124975345|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
124975346|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
124975347|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
124975348|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
124975349|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
124975350|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
124975351|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
124975352|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
124975353|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
124975354|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
124975355|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
124975356|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
125134672|NCT02089685|450118227|FG005|Overall Study|Withdrawal by Subject|1|||
125134673|NCT02089685|450118222|FG000|Overall Study|Status not recorded|1|||
125134674|NCT02089685|450118223|FG001|Overall Study|Status not recorded|0|||
125134675|NCT02089685|450118224|FG002|Overall Study|Status not recorded|0|||
125134676|NCT02089685|450118225|FG003|Overall Study|Status not recorded|0|||
125134677|NCT02089685|450118226|FG004|Overall Study|Status not recorded|1|||
125134678|NCT02089685|450118227|FG005|Overall Study|Status not recorded|0|||
125134679|NCT02089685|450118222|FG000|Overall Study|Death|0|||
125134680|NCT02089685|450118223|FG001|Overall Study|Death|0|||
125134681|NCT02089685|450118224|FG002|Overall Study|Death|0|||
125134682|NCT02089685|450118225|FG003|Overall Study|Death|7|||
124975357|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
124975358|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
124975359|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
124975360|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
124975361|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
124975362|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
124975363|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
124975364|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
124975365|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
124975366|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
124975367|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
124975368|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
124975369|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
124975370|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
124975371|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
124975372|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
124975373|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
124975374|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
124975375|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
124975376|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
124975377|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
124975378|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
124975379|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
124975380|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
124975381|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
124975382|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
124975383|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
124975384|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
124975385|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
124975386|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
124975387|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
124975388|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
124975389|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
124975390|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
124975391|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
124975392|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
124975393|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
124975394|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
124975395|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
124975396|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
124975397|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
124975398|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
124975399|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
124975400|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
124975401|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
124975402|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
124975403|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
124975404|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
124975405|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
124975406|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
124975407|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
124975408|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
124975409|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
124975410|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
124975411|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
124975412|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
124975413|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
124975414|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
124975415|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
124975416|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
124975417|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
124975418|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
124975419|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
124975420|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
124975421|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
124975422|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
124975423|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
124975424|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
124975425|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
124975426|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
124975427|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
124975428|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
124975429|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
124975430|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
124975431|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
124975432|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
124975433|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
124975434|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
124975435|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
124975436|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
124975437|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
124975438|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
124975439|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
124975440|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
124975441|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
124975442|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
124975443|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
124975444|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
124975445|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
124975446|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
124975447|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
124975448|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
124975449|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
124975450|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
124975451|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
124975452|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
124975453|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
124975454|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
124975455|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
124975456|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
124975457|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
124975458|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
125134683|NCT02089685|450118226|FG004|Overall Study|Death|2|||
125134684|NCT02089685|450118227|FG005|Overall Study|Death|5|||
125134685|NCT02089685|450118222|FG000|Overall Study|Lost to Follow-up|0|||
125134686|NCT02089685|450118223|FG001|Overall Study|Lost to Follow-up|0|||
125134687|NCT02089685|450118224|FG002|Overall Study|Lost to Follow-up|0|||
125134688|NCT02089685|450118225|FG003|Overall Study|Lost to Follow-up|1|||
125134689|NCT02089685|450118226|FG004|Overall Study|Lost to Follow-up|0|||
125134690|NCT02089685|450118227|FG005|Overall Study|Lost to Follow-up|0|||
125134691|NCT02089685|450118222|FG000|Overall Study|Physician Decision|0|||
125134692|NCT02089685|450118223|FG001|Overall Study|Physician Decision|0|||
125134693|NCT02089685|450118224|FG002|Overall Study|Physician Decision|0|||
125134694|NCT02089685|450118225|FG003|Overall Study|Physician Decision|0|||
125134695|NCT02089685|450118226|FG004|Overall Study|Physician Decision|0|||
125134696|NCT02089685|450118227|FG005|Overall Study|Physician Decision|4|||
125134697|NCT02089685|450118222|FG000|Overall Study|Screen failure|1|||
125134698|NCT02089685|450118223|FG001|Overall Study|Screen failure|0|||
125134699|NCT02089685|450118224|FG002|Overall Study|Screen failure|0|||
125134700|NCT02089685|450118225|FG003|Overall Study|Screen failure|0|||
125134701|NCT02089685|450118226|FG004|Overall Study|Screen failure|0|||
125134702|NCT02089685|450118227|FG005|Overall Study|Screen failure|0|||
125134703|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Adverse Event|11|||
125134704|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Adverse Event|23|||
125134705|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Adverse Event|29|||
125134706|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Adverse Event|2|||
125134707|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Adverse Event|8|||
125134708|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
125134709|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
125134710|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
124975459|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
124975460|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
124975461|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
124975462|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
124975463|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
124975464|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
124975465|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
124975466|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
124975467|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
124975468|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
124975469|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
124975470|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
124975471|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
124975472|NCT01646177|449536589|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
124975473|NCT01646177|449536590|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
124975474|NCT01646177|449536591|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
124975475|NCT01646177|449536592|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
124975476|NCT01646177|449536593|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
124975477|NCT01646177|449536594|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
124975478|NCT01646177|449536595|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
124975479|NCT01646177|449536596|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
124975480|NCT01646177|449536597|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
124975481|NCT01646177|449536598|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
124975482|NCT01646177|449536599|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
124975483|NCT01646177|449536600|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
124975484|NCT01646177|449536589|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
124975485|NCT01646177|449536590|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
124975486|NCT01646177|449536591|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
124975487|NCT01646177|449536592|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
124975488|NCT01646177|449536593|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
124975489|NCT01646177|449536594|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
124975490|NCT01646177|449536595|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
124975491|NCT01646177|449536596|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
124975492|NCT01646177|449536597|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
124975493|NCT01646177|449536598|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
124975494|NCT01646177|449536599|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
124975495|NCT01646177|449536600|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
124975496|NCT01646177|449536589|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
124975497|NCT01646177|449536590|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
125038936|NCT00538681|449761087|FG002|Overall Study|Progressive Disease|1|||
125038937|NCT00538681|449761088|FG003|Overall Study|Progressive Disease|0|||
125038938|NCT00538681|449761085|FG000|Overall Study|Sponsor Decision|1|||
125038939|NCT00538681|449761086|FG001|Overall Study|Sponsor Decision|3|||
125038940|NCT00538681|449761087|FG002|Overall Study|Sponsor Decision|8|||
125038941|NCT00538681|449761088|FG003|Overall Study|Sponsor Decision|9|||
125038942|NCT00538681|449761085|FG000|Overall Study|Adverse Event|1|||
125038943|NCT00538681|449761086|FG001|Overall Study|Adverse Event|1|||
125038944|NCT00538681|449761087|FG002|Overall Study|Adverse Event|1|||
125038945|NCT00538681|449761088|FG003|Overall Study|Adverse Event|0|||
125038946|NCT00538681|449761085|FG000|Overall Study|Death|0|||
125038947|NCT00538681|449761086|FG001|Overall Study|Death|0|||
125038948|NCT00538681|449761087|FG002|Overall Study|Death|1|||
125038949|NCT00538681|449761088|FG003|Overall Study|Death|1|||
125038950|NCT00538681|449761085|FG000|Overall Study|Investigator Decision|0|||
125038951|NCT00538681|449761086|FG001|Overall Study|Investigator Decision|0|||
125038952|NCT00538681|449761087|FG002|Overall Study|Investigator Decision|0|||
125038953|NCT00538681|449761088|FG003|Overall Study|Investigator Decision|1|||
125038954|NCT05369806|449761089|FG000|Overall Study|Lost to Follow-up|1|||
125038955|NCT00140855|449761090|FG000|Overall Study|Progressive disease|2|||
125038956|NCT03929250|449761095|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
125038957|NCT03929250|449761096|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
125038958|NCT01097044|449761098|FG000|Overall Study|Withdrawal by Subject|4|||
125038959|NCT01097044|449761099|FG001|Overall Study|Withdrawal by Subject|4|||
125038960|NCT01097044|449761098|FG000|Overall Study|Lost to Follow-up|1|||
125038961|NCT01097044|449761099|FG001|Overall Study|Lost to Follow-up|0|||
125038962|NCT01097044|449761098|FG000|Overall Study|Withdrawal by Sponsor|0|||
125038963|NCT01097044|449761099|FG001|Overall Study|Withdrawal by Sponsor|1|||
125038964|NCT04865731|449761101|FG000|Overall Study|Physician Decision|2|||
125038965|NCT04865731|449761102|FG001|Overall Study|Physician Decision|1|||
125038966|NCT04865731|449761101|FG000|Overall Study|Adverse Event|1|||
125038967|NCT04865731|449761102|FG001|Overall Study|Adverse Event|0|||
125038968|NCT04865731|449761101|FG000|Overall Study|Withdrawal by Subject|0|||
125038969|NCT04865731|449761102|FG001|Overall Study|Withdrawal by Subject|1|||
125038970|NCT02770807|449761103|FG000|Overall Study|Adverse Event|3|||
125038971|NCT02770807|449761104|FG001|Overall Study|Adverse Event|3|||
125038972|NCT02770807|449761105|FG002|Overall Study|Adverse Event|1|||
125038973|NCT02770807|449761103|FG000|Overall Study|Withdrawal by Subject|7|||
125038974|NCT02770807|449761104|FG001|Overall Study|Withdrawal by Subject|3|||
125038975|NCT02770807|449761105|FG002|Overall Study|Withdrawal by Subject|4|||
125038976|NCT02770807|449761103|FG000|Overall Study|Other|0|||
125038977|NCT02770807|449761104|FG001|Overall Study|Other|1|||
125038978|NCT02770807|449761105|FG002|Overall Study|Other|0|||
125038979|NCT02770807|449761103|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
125038980|NCT02770807|449761104|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
125038981|NCT02770807|449761105|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
125038982|NCT02770807|449761103|FG000|Overall Study|Physician Decision|0|||
125038983|NCT02770807|449761104|FG001|Overall Study|Physician Decision|0|||
125038984|NCT02770807|449761105|FG002|Overall Study|Physician Decision|1|||
125038985|NCT02017444|449762621|FG000|Overall Study|Physician Decision|1|||
125038986|NCT02017444|449762622|FG001|Overall Study|Physician Decision|0|||
125038987|NCT02017444|449762621|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
125038988|NCT02017444|449762622|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
125038989|NCT03874234|449762623|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125038990|NCT03874234|449762624|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125038991|NCT03874234|449762625|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125038992|NCT03874234|449762626|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
125038993|NCT03874234|449762627|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125038994|NCT03874234|449762628|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125038995|NCT03874234|449762629|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125218573|NCT03131687|450427363|FG001|Overall Study|Lost to Follow-up|4|||
125038996|NCT03874234|449762630|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125038997|NCT03874234|449762631|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125038998|NCT03874234|449762632|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125038999|NCT03874234|449762633|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125039000|NCT03874234|449762634|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125039001|NCT03874234|449762635|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125039002|NCT03874234|449762623|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
125039003|NCT03874234|449762624|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125039004|NCT03874234|449762625|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125039005|NCT03874234|449762626|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125039006|NCT03874234|449762627|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125039007|NCT03874234|449762628|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125039008|NCT03874234|449762629|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125039009|NCT03874234|449762630|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125039010|NCT03874234|449762631|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125039011|NCT03874234|449762632|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125039012|NCT03874234|449762633|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125039013|NCT03874234|449762634|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125039014|NCT03874234|449762635|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125039015|NCT03874234|449762623|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125039016|NCT03874234|449762624|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125039017|NCT03874234|449762625|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125039018|NCT03874234|449762626|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
125039019|NCT03874234|449762627|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125039020|NCT03874234|449762628|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125039021|NCT03874234|449762629|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125039022|NCT03874234|449762630|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125039023|NCT03874234|449762631|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125039024|NCT03874234|449762632|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125039025|NCT03874234|449762633|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125039026|NCT03874234|449762634|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125039027|NCT03874234|449762635|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125039028|NCT03874234|449762623|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125039029|NCT03874234|449762624|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125218574|NCT03131687|450427364|FG002|Overall Study|Lost to Follow-up|0|||
125039030|NCT03874234|449762625|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125134711|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
125134712|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
125134713|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
124975498|NCT01646177|449536591|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
124975499|NCT01646177|449536592|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
124975500|NCT01646177|449536593|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
125039031|NCT03874234|449762626|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125039032|NCT03874234|449762627|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
125039033|NCT03874234|449762628|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125039034|NCT03874234|449762629|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125039035|NCT03874234|449762630|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125039036|NCT03874234|449762631|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125039037|NCT03874234|449762632|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125039038|NCT03874234|449762633|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125039039|NCT03874234|449762634|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125039040|NCT03874234|449762635|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125039041|NCT03874234|449762623|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125039042|NCT03874234|449762624|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125039043|NCT03874234|449762625|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125039044|NCT03874234|449762626|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
124975501|NCT01646177|449536594|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
124975502|NCT01646177|449536595|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
124975503|NCT01646177|449536596|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
124975504|NCT01646177|449536597|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
124975505|NCT01646177|449536598|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
124975506|NCT01646177|449536599|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
124975507|NCT01646177|449536600|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
124975508|NCT01646177|449536589|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
124975509|NCT01646177|449536590|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
124975510|NCT01646177|449536591|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
125039045|NCT03874234|449762627|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125039046|NCT03874234|449762628|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125039047|NCT03874234|449762629|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125039048|NCT03874234|449762630|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
125039049|NCT03874234|449762631|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125039050|NCT03874234|449762632|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125039051|NCT03874234|449762633|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125039052|NCT03874234|449762634|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125039053|NCT03874234|449762635|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125039054|NCT03874234|449762623|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125039055|NCT03874234|449762624|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125039056|NCT03874234|449762625|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125039057|NCT03874234|449762626|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125039058|NCT03874234|449762627|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
125039059|NCT03874234|449762628|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
125039060|NCT03874234|449762629|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125039061|NCT03874234|449762630|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125039062|NCT03874234|449762631|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125039063|NCT03874234|449762632|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125039064|NCT03874234|449762633|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125039065|NCT03874234|449762634|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125039066|NCT03874234|449762635|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125039067|NCT03874234|449762623|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125039068|NCT03874234|449762624|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125039069|NCT03874234|449762625|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125039070|NCT03874234|449762626|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125039071|NCT03874234|449762627|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125039072|NCT03874234|449762628|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125134714|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
125134715|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
124975511|NCT01646177|449536592|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
125134716|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
125134717|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
125134718|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
125134719|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
125134720|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
125134721|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
125134722|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
125134723|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
125134724|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
125134725|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
125134726|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
125134727|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
125134728|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
125134729|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
125134730|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
125134731|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
125134732|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
125134733|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
125134734|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
125134735|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
125134736|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
125134737|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
125134738|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Move|0|||
125134739|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Move|1|||
125134740|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Move|0|||
125134741|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Move|0|||
125134742|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Move|0|||
125134743|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
125134744|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
125134745|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
125134746|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
125134747|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
125134748|NCT00318461|450118230|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
125134749|NCT00318461|450118231|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
125134750|NCT00318461|450118232|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
125134751|NCT00318461|450118233|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
125134752|NCT00318461|450118234|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
125134753|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Work commitment|0|||
125134754|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Work commitment|0|||
125134755|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Work commitment|0|||
125134756|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Work commitment|0|||
125134757|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Work commitment|1|||
125218575|NCT03131687|450427365|FG003|Overall Study|Lost to Follow-up|1|||
125218576|NCT03131687|450427366|FG004|Overall Study|Lost to Follow-up|4|||
125039073|NCT03874234|449762629|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
125039074|NCT03874234|449762630|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125039075|NCT03874234|449762631|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125039076|NCT03874234|449762632|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125039077|NCT03874234|449762633|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125039078|NCT03874234|449762634|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125039079|NCT03874234|449762635|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125039080|NCT03874234|449762623|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125039081|NCT03874234|449762624|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125039082|NCT03874234|449762625|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125039083|NCT03874234|449762626|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125039084|NCT03874234|449762627|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
125039085|NCT03874234|449762628|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125039086|NCT03874234|449762629|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125039087|NCT03874234|449762630|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125039088|NCT03874234|449762631|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125039089|NCT03874234|449762632|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125039090|NCT03874234|449762633|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125039091|NCT03874234|449762634|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125039092|NCT03874234|449762635|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125039093|NCT02799381|449762638|FG000|Overall Study|Withdrew consent|3|||
125039094|NCT02799381|449762639|FG001|Overall Study|Withdrew consent|2|||
125039095|NCT02799381|449762638|FG000|Overall Study|Adverse Event|0|||
125039096|NCT02799381|449762639|FG001|Overall Study|Adverse Event|1|||
125134758|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Investigator decision|0|||
125134759|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Investigator decision|0|||
125134760|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Investigator decision|0|||
125039097|NCT02799381|449762638|FG000|Overall Study|Participant did not take any study drug|1|||
125039098|NCT02799381|449762639|FG001|Overall Study|Participant did not take any study drug|0|||
125039099|NCT00783289|449762640|FG000|Overall Study|Protocol Violation|0|||
125039100|NCT00783289|449762641|FG001|Overall Study|Protocol Violation|1|||
125039101|NCT00783289|449762642|FG002|Overall Study|Protocol Violation|0|||
125039102|NCT00783289|449762643|FG003|Overall Study|Protocol Violation|0|||
125039103|NCT03952130|449762644|FG000|Overall Study|Adverse Event|0|||
125039104|NCT03952130|449762645|FG001|Overall Study|Adverse Event|1|||
125039105|NCT03952130|449762644|FG000|Overall Study|Lost to Follow-up|1|||
125039106|NCT03952130|449762645|FG001|Overall Study|Lost to Follow-up|0|||
125039107|NCT03952130|449762644|FG000|Overall Study|Withdrawal by Subject|1|||
125039108|NCT03952130|449762645|FG001|Overall Study|Withdrawal by Subject|5|||
125039109|NCT00506389|449762646|FG000|In-treatment Period|Other|3|||
125039110|NCT00506389|449762647|FG001|In-treatment Period|Other|3|||
125039111|NCT00506389|449762648|FG002|In-treatment Period|Other|4|||
125039112|NCT00506389|449762646|FG000|In-treatment Period|Lost to Follow-up|0|||
125039113|NCT00506389|449762647|FG001|In-treatment Period|Lost to Follow-up|0|||
125039114|NCT00506389|449762648|FG002|In-treatment Period|Lost to Follow-up|1|||
125039115|NCT00506389|449762646|FG000|In-treatment Period|Lack of compliance|1|||
125039116|NCT00506389|449762647|FG001|In-treatment Period|Lack of compliance|0|||
125039117|NCT00506389|449762648|FG002|In-treatment Period|Lack of compliance|0|||
125039118|NCT00506389|449762646|FG000|In-treatment Period|Reasons not related to trial|4|||
125039119|NCT00506389|449762647|FG001|In-treatment Period|Reasons not related to trial|1|||
125039120|NCT00506389|449762648|FG002|In-treatment Period|Reasons not related to trial|0|||
125039121|NCT00506389|449762646|FG000|In-treatment Period|Withdrawal by Subject|3|||
125039122|NCT00506389|449762647|FG001|In-treatment Period|Withdrawal by Subject|3|||
125039123|NCT00506389|449762648|FG002|In-treatment Period|Withdrawal by Subject|4|||
125039124|NCT00506389|449762646|FG000|In-treatment Period|Lack of Efficacy|0|||
125039125|NCT00506389|449762647|FG001|In-treatment Period|Lack of Efficacy|2|||
125039126|NCT00506389|449762648|FG002|In-treatment Period|Lack of Efficacy|0|||
125039127|NCT00506389|449762646|FG000|In-treatment Period|Adverse Event|11|||
125039128|NCT00506389|449762647|FG001|In-treatment Period|Adverse Event|5|||
125039129|NCT00506389|449762648|FG002|In-treatment Period|Adverse Event|2|||
125039130|NCT00506389|449762646|FG000|In-treatment Period|Randomized but not treated|4|||
125039131|NCT00506389|449762647|FG001|In-treatment Period|Randomized but not treated|1|||
125039132|NCT00506389|449762648|FG002|In-treatment Period|Randomized but not treated|1|||
125039133|NCT01503021|449762657|FG000|Overall Study|Adverse Event|7|||
125039134|NCT01503021|449762658|FG001|Overall Study|Adverse Event|6|||
125039135|NCT01503021|449762657|FG000|Overall Study|Death|0|||
125039136|NCT01503021|449762658|FG001|Overall Study|Death|2|||
125039137|NCT01503021|449762657|FG000|Overall Study|Lost to Follow-up|2|||
125039138|NCT01503021|449762658|FG001|Overall Study|Lost to Follow-up|0|||
125039139|NCT01503021|449762657|FG000|Overall Study|Physician Decision|3|||
125039140|NCT01503021|449762658|FG001|Overall Study|Physician Decision|0|||
125039141|NCT01503021|449762657|FG000|Overall Study|Protocol Violation|1|||
125039142|NCT01503021|449762658|FG001|Overall Study|Protocol Violation|3|||
125039143|NCT01503021|449762657|FG000|Overall Study|Withdrawal by Subject|9|||
125039144|NCT01503021|449762658|FG001|Overall Study|Withdrawal by Subject|8|||
125039145|NCT01503021|449762657|FG000|Overall Study|Moved, received transplant, etc.|5|||
125039146|NCT01503021|449762658|FG001|Overall Study|Moved, received transplant, etc.|7|||
125039147|NCT00283387|449762666|FG000|First Intervention|Subject non-compliant|1|||
125039148|NCT00283387|449762667|FG001|First Intervention|Subject non-compliant|1|||
125039149|NCT00283387|449762666|FG000|First Intervention|Withdrawal by Subject|0|||
125039150|NCT00283387|449762667|FG001|First Intervention|Withdrawal by Subject|1|||
125039151|NCT01931865|449762668|FG000|Overall Study|Lost to Follow-up|2|||
125039152|NCT01931865|449762668|FG000|Overall Study|Withdrawal by Subject|2|||
125039153|NCT03584009|449762672|FG000|Overall Study|Death|25|||
125039154|NCT03584009|449762673|FG001|Overall Study|Death|18|||
125039155|NCT03584009|449762672|FG000|Overall Study|Lost to Follow-up|0|||
125039156|NCT03584009|449762673|FG001|Overall Study|Lost to Follow-up|1|||
125039157|NCT03584009|449762672|FG000|Overall Study|Physician Decision|1|||
125039158|NCT03584009|449762673|FG001|Overall Study|Physician Decision|1|||
125039159|NCT03584009|449762672|FG000|Overall Study|Study Terminated by Sponsor|22|||
125039160|NCT03584009|449762673|FG001|Overall Study|Study Terminated by Sponsor|30|||
125039161|NCT03584009|449762672|FG000|Overall Study|Withdrawal by Subject|3|||
125039162|NCT03584009|449762673|FG001|Overall Study|Withdrawal by Subject|2|||
125039163|NCT00446030|449762674|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
125039164|NCT00446030|449762675|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
125039165|NCT00446030|449762674|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
125039166|NCT00446030|449762675|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
125039167|NCT00446030|449762674|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
125039168|NCT00446030|449762675|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
125039169|NCT00446030|449762674|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
125134761|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Investigator decision|0|||
125134762|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Investigator decision|1|||
125134763|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Lack of time|1|||
125134764|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Lack of time|0|||
125134765|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Lack of time|0|||
125134766|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Lack of time|0|||
125134767|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Lack of time|0|||
125134768|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
125134769|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
125134770|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
125134771|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
125134772|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
125134773|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
125134774|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
125134775|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
125134776|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
125134777|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
125134778|NCT00318461|450118230|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
125134779|NCT00318461|450118231|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
125134780|NCT00318461|450118232|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
125039170|NCT00446030|449762675|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
125039171|NCT00446030|449762674|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
125039172|NCT00446030|449762675|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
125039173|NCT00446030|449762674|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
125039174|NCT00446030|449762675|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
125039175|NCT00446030|449762674|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
125039176|NCT00446030|449762675|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
125039177|NCT00446030|449762674|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
125039178|NCT00446030|449762675|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
125039179|NCT00446030|449762674|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
125039180|NCT00446030|449762675|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
125039181|NCT00446030|449762674|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
125039182|NCT00446030|449762675|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
125039183|NCT00446030|449762674|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
125039184|NCT00446030|449762675|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
125039185|NCT00446030|449762674|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
125039186|NCT00446030|449762675|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
125039187|NCT00446030|449762674|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
125039188|NCT00446030|449762675|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
125039189|NCT00446030|449762674|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
125039190|NCT00446030|449762675|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
125039191|NCT00446030|449762674|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
125039192|NCT00446030|449762675|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
125039193|NCT00446030|449762674|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
125039194|NCT00446030|449762675|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
125039195|NCT00446030|449762674|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
125039196|NCT00446030|449762675|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
125039197|NCT00446030|449762674|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
125039198|NCT00446030|449762675|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
125039199|NCT00446030|449762674|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
125039200|NCT00446030|449762675|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
125039201|NCT02886715|449762678|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125134781|NCT00318461|450118233|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
125134782|NCT00318461|450118234|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
125134783|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
125134784|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
125134785|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
125134786|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
125039202|NCT02886715|449762679|FG001|Overall Study|Non-Compliance With Study Drug|2|||
125039203|NCT02886715|449762680|FG002|Overall Study|Non-Compliance With Study Drug|0|||
125039204|NCT02886715|449762678|FG000|Overall Study|Adverse Event|4|||
125039205|NCT02886715|449762679|FG001|Overall Study|Adverse Event|2|||
125134787|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
125134788|NCT00318461|450118230|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
125134789|NCT00318461|450118231|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
125218577|NCT03131687|450427367|FG005|Overall Study|Lost to Follow-up|2|||
125039206|NCT02886715|449762680|FG002|Overall Study|Adverse Event|0|||
125039207|NCT02886715|449762678|FG000|Overall Study|Lack of Efficacy|0|||
125039208|NCT02886715|449762679|FG001|Overall Study|Lack of Efficacy|2|||
125039209|NCT02886715|449762680|FG002|Overall Study|Lack of Efficacy|1|||
125039210|NCT02886715|449762678|FG000|Overall Study|Lost to Follow-up|29|||
125039211|NCT02886715|449762679|FG001|Overall Study|Lost to Follow-up|26|||
125039212|NCT02886715|449762680|FG002|Overall Study|Lost to Follow-up|10|||
125039213|NCT02886715|449762678|FG000|Overall Study|Pregnancy|1|||
125039214|NCT02886715|449762679|FG001|Overall Study|Pregnancy|1|||
125039215|NCT02886715|449762680|FG002|Overall Study|Pregnancy|1|||
125039216|NCT02886715|449762678|FG000|Overall Study|Protocol Violation|3|||
125039217|NCT02886715|449762679|FG001|Overall Study|Protocol Violation|2|||
125039218|NCT02886715|449762680|FG002|Overall Study|Protocol Violation|1|||
125039219|NCT02886715|449762678|FG000|Overall Study|Withdrawal by Subject|20|||
125039220|NCT02886715|449762679|FG001|Overall Study|Withdrawal by Subject|18|||
125039221|NCT02886715|449762680|FG002|Overall Study|Withdrawal by Subject|5|||
125039222|NCT02886715|449762678|FG000|Overall Study|missing|7|||
125039223|NCT02886715|449762679|FG001|Overall Study|missing|2|||
125039224|NCT02886715|449762680|FG002|Overall Study|missing|2|||
125039225|NCT03812510|449762681|FG000|Overall Study|Lost to Follow-up|39|||
125039226|NCT03812510|449762681|FG000|Overall Study|Withdrawal by Subject|42|||
125039227|NCT03812510|449762681|FG000|Overall Study|Physician Decision|2|||
125039228|NCT03812510|449762681|FG000|Overall Study|Study Terminated by Sponsor|9|||
125039229|NCT03812510|449762681|FG000|Overall Study|Did Not Start Study Medication|55|||
125039230|NCT03812510|449762681|FG000|Overall Study|Adverse Event|5|||
125039231|NCT01120626|449762682|FG000|Overall Study|Withdrawal by Subject|1|||
125039232|NCT01120626|449762683|FG001|Overall Study|Withdrawal by Subject|0|||
125039233|NCT01073943|449762691|FG000|Overall Study|Withdrawal by Subject|8|||
125039234|NCT01073943|449762692|FG001|Overall Study|Withdrawal by Subject|2|||
125039235|NCT01073943|449762691|FG000|Overall Study|Protocol Violation|2|||
125039236|NCT01073943|449762692|FG001|Overall Study|Protocol Violation|1|||
125039237|NCT01073943|449762691|FG000|Overall Study|Adverse Event|1|||
125039238|NCT01073943|449762692|FG001|Overall Study|Adverse Event|1|||
125039239|NCT01073943|449762691|FG000|Overall Study|Lost to Follow-up|0|||
125039240|NCT01073943|449762692|FG001|Overall Study|Lost to Follow-up|2|||
125039241|NCT01073943|449762691|FG000|Overall Study|Power outage; colonoscopy not done|1|||
125039242|NCT01073943|449762692|FG001|Overall Study|Power outage; colonoscopy not done|0|||
125039243|NCT01073943|449762691|FG000|Overall Study|Subject forgot|0|||
125039244|NCT01073943|449762692|FG001|Overall Study|Subject forgot|1|||
125039245|NCT01073943|449762691|FG000|Overall Study|Unable to return for follow-up|0|||
125039246|NCT01073943|449762692|FG001|Overall Study|Unable to return for follow-up|1|||
125039247|NCT01073943|449762691|FG000|Overall Study|Could not tolerate prep|1|||
125039248|NCT01073943|449762692|FG001|Overall Study|Could not tolerate prep|0|||
125039249|NCT03527043|449762694|FG000|Overall Study|Withdrawal by Subject|1|||
125039250|NCT03527043|449762695|FG001|Overall Study|Withdrawal by Subject|0|||
125039251|NCT00927485|449762696|FG000|Overall Study|Adverse Event|4|||
125039252|NCT00927485|449762697|FG001|Overall Study|Adverse Event|2|||
125039253|NCT00927485|449762696|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
125039254|NCT00927485|449762697|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
125039255|NCT03830281|449762698|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
125039256|NCT03830281|449762699|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
125039257|NCT03830281|449762698|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
125039258|NCT03830281|449762699|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
125039259|NCT03830281|449762698|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
125039260|NCT03830281|449762699|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
125134790|NCT00318461|450118232|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
125134791|NCT00318461|450118233|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
125134792|NCT00318461|450118234|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
125039261|NCT03830281|449762698|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
125039262|NCT03830281|449762699|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
125039263|NCT03830281|449762698|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
125039264|NCT03830281|449762699|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
125039265|NCT03830281|449762698|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
125039266|NCT03830281|449762699|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
125039267|NCT03830281|449762698|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
125039268|NCT03830281|449762699|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
125039269|NCT03830281|449762698|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
125039270|NCT03830281|449762699|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
125039271|NCT03830281|449762698|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
125039272|NCT03830281|449762699|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
125039273|NCT03293680|449762700|FG000|Overall Study|Death|1|||
125039274|NCT03293680|449762700|FG000|Overall Study|Did not meet inclusion criteria|8|||
125039275|NCT02201940|449762701|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
125039276|NCT02201940|449762702|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
125039277|NCT02201940|449762701|FG000|Overall Study|Lack of Efficacy|2|||
125039278|NCT02201940|449762702|FG001|Overall Study|Lack of Efficacy|113|||
125039279|NCT02201940|449762701|FG000|Overall Study|Lost to Follow-up|5|||
125039280|NCT02201940|449762702|FG001|Overall Study|Lost to Follow-up|0|||
125039281|NCT02201940|449762701|FG000|Overall Study|Withdrew Consent|2|||
125039282|NCT02201940|449762702|FG001|Overall Study|Withdrew Consent|1|||
125039283|NCT02201940|449762701|FG000|Overall Study|Investigator's Discretion|1|||
125039284|NCT02201940|449762702|FG001|Overall Study|Investigator's Discretion|1|||
125039285|NCT02201940|449762701|FG000|Overall Study|Death|1|||
125039286|NCT02201940|449762702|FG001|Overall Study|Death|0|||
125039287|NCT02201940|449762701|FG000|Overall Study|Adverse Event|0|||
125039288|NCT02201940|449762702|FG001|Overall Study|Adverse Event|1|||
125039289|NCT03192904|449762703|FG000|Overall Study|Physician Decision|3|||
125039290|NCT03192904|449762704|FG001|Overall Study|Physician Decision|1|||
125039291|NCT03192904|449762703|FG000|Overall Study|Lost to Follow-up|0|||
125039292|NCT03192904|449762704|FG001|Overall Study|Lost to Follow-up|1|||
125039293|NCT01309737|449762705|FG000|Week 0 to 16|Death|1|||
125039294|NCT01309737|449762706|FG001|Week 0 to 16|Death|0|||
125039295|NCT01309737|449762707|FG002|Week 0 to 16|Death|1|||
125039296|NCT01309737|449762708|FG003|Week 0 to 16|Death|0|||
125039297|NCT01309737|449762709|FG004|Week 0 to 16|Death|0|||
125039298|NCT01309737|449762705|FG000|Week 0 to 16|Adverse Event|11|||
125039299|NCT01309737|449762706|FG001|Week 0 to 16|Adverse Event|10|||
125039300|NCT01309737|449762707|FG002|Week 0 to 16|Adverse Event|5|||
125039301|NCT01309737|449762708|FG003|Week 0 to 16|Adverse Event|0|||
125039302|NCT01309737|449762709|FG004|Week 0 to 16|Adverse Event|0|||
125039303|NCT01309737|449762705|FG000|Week 0 to 16|Lack of Efficacy|15|||
125039304|NCT01309737|449762706|FG001|Week 0 to 16|Lack of Efficacy|2|||
125039305|NCT01309737|449762707|FG002|Week 0 to 16|Lack of Efficacy|24|||
125039306|NCT01309737|449762708|FG003|Week 0 to 16|Lack of Efficacy|0|||
125039307|NCT01309737|449762709|FG004|Week 0 to 16|Lack of Efficacy|0|||
125039308|NCT01309737|449762705|FG000|Week 0 to 16|Lost to Follow-up|7|||
125039309|NCT01309737|449762706|FG001|Week 0 to 16|Lost to Follow-up|8|||
125039310|NCT01309737|449762707|FG002|Week 0 to 16|Lost to Follow-up|3|||
125039311|NCT01309737|449762708|FG003|Week 0 to 16|Lost to Follow-up|0|||
125039312|NCT01309737|449762709|FG004|Week 0 to 16|Lost to Follow-up|0|||
125039313|NCT01309737|449762705|FG000|Week 0 to 16|Withdrawal by Subject|7|||
125039314|NCT01309737|449762706|FG001|Week 0 to 16|Withdrawal by Subject|6|||
125039315|NCT01309737|449762707|FG002|Week 0 to 16|Withdrawal by Subject|7|||
125039316|NCT01309737|449762708|FG003|Week 0 to 16|Withdrawal by Subject|0|||
125039317|NCT01309737|449762709|FG004|Week 0 to 16|Withdrawal by Subject|0|||
125039318|NCT01309737|449762705|FG000|Week 0 to 16|Other|10|||
125039319|NCT01309737|449762706|FG001|Week 0 to 16|Other|14|||
125039320|NCT01309737|449762707|FG002|Week 0 to 16|Other|4|||
125039321|NCT01309737|449762708|FG003|Week 0 to 16|Other|0|||
125039322|NCT01309737|449762709|FG004|Week 0 to 16|Other|0|||
125039323|NCT01309737|449762705|FG000|Week 0 to 16|Randomized, but not treated|1|||
125039324|NCT01309737|449762706|FG001|Week 0 to 16|Randomized, but not treated|0|||
125039325|NCT01309737|449762707|FG002|Week 0 to 16|Randomized, but not treated|0|||
125039326|NCT01309737|449762708|FG003|Week 0 to 16|Randomized, but not treated|0|||
125039327|NCT01309737|449762709|FG004|Week 0 to 16|Randomized, but not treated|0|||
125039328|NCT01309737|449762705|FG000|Week 16 to 52|Death|0|||
125039329|NCT01309737|449762706|FG001|Week 16 to 52|Death|0|||
125039330|NCT01309737|449762707|FG002|Week 16 to 52|Death|0|||
125039331|NCT01309737|449762708|FG003|Week 16 to 52|Death|0|||
125039332|NCT01309737|449762709|FG004|Week 16 to 52|Death|1|||
125039333|NCT01309737|449762705|FG000|Week 16 to 52|Adverse Event|7|||
125039334|NCT01309737|449762706|FG001|Week 16 to 52|Adverse Event|7|||
125039335|NCT01309737|449762707|FG002|Week 16 to 52|Adverse Event|0|||
125039336|NCT01309737|449762708|FG003|Week 16 to 52|Adverse Event|6|||
125039337|NCT01309737|449762709|FG004|Week 16 to 52|Adverse Event|5|||
125039338|NCT01309737|449762705|FG000|Week 16 to 52|Lack of Efficacy|107|||
125039339|NCT01309737|449762706|FG001|Week 16 to 52|Lack of Efficacy|76|||
125039340|NCT01309737|449762707|FG002|Week 16 to 52|Lack of Efficacy|0|||
125039341|NCT01309737|449762708|FG003|Week 16 to 52|Lack of Efficacy|25|||
125039342|NCT01309737|449762709|FG004|Week 16 to 52|Lack of Efficacy|21|||
125039343|NCT01309737|449762705|FG000|Week 16 to 52|Lost to Follow-up|4|||
125039344|NCT01309737|449762706|FG001|Week 16 to 52|Lost to Follow-up|2|||
125039345|NCT01309737|449762707|FG002|Week 16 to 52|Lost to Follow-up|0|||
125039346|NCT01309737|449762708|FG003|Week 16 to 52|Lost to Follow-up|1|||
125039347|NCT01309737|449762709|FG004|Week 16 to 52|Lost to Follow-up|4|||
125039348|NCT01309737|449762705|FG000|Week 16 to 52|Withdrawal by Subject|5|||
125039349|NCT01309737|449762706|FG001|Week 16 to 52|Withdrawal by Subject|6|||
125039350|NCT01309737|449762707|FG002|Week 16 to 52|Withdrawal by Subject|0|||
125039351|NCT01309737|449762708|FG003|Week 16 to 52|Withdrawal by Subject|0|||
125039352|NCT01309737|449762709|FG004|Week 16 to 52|Withdrawal by Subject|2|||
125134793|NCT00318461|450118230|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
125134794|NCT00318461|450118231|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
125134795|NCT00318461|450118232|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
125134796|NCT00318461|450118233|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
125134797|NCT00318461|450118234|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
125134798|NCT00318461|450118230|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
125134799|NCT00318461|450118231|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
125134800|NCT00318461|450118232|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
125134801|NCT00318461|450118233|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
125039353|NCT01309737|449762705|FG000|Week 16 to 52|Other|10|||
125039354|NCT01309737|449762706|FG001|Week 16 to 52|Other|12|||
125134802|NCT00318461|450118234|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
125134803|NCT00318461|450118230|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
125134804|NCT00318461|450118231|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
125134805|NCT00318461|450118232|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
125134806|NCT00318461|450118233|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
125134807|NCT00318461|450118234|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
125134808|NCT00796653|450118238|FG000|Overall Study|Adverse Event|19|||
125134809|NCT00796653|450118239|FG001|Overall Study|Adverse Event|16|||
125134810|NCT00796653|450118240|FG002|Overall Study|Adverse Event|16|||
125134811|NCT00796653|450118241|FG003|Overall Study|Adverse Event|16|||
125134812|NCT00796653|450118238|FG000|Overall Study|Lost to Follow-up|2|||
125134813|NCT00796653|450118239|FG001|Overall Study|Lost to Follow-up|1|||
125134814|NCT00796653|450118240|FG002|Overall Study|Lost to Follow-up|2|||
125134815|NCT00796653|450118241|FG003|Overall Study|Lost to Follow-up|3|||
125134816|NCT00796653|450118238|FG000|Overall Study|Withdrawal by Subject|16|||
125134817|NCT00796653|450118239|FG001|Overall Study|Withdrawal by Subject|8|||
125134818|NCT00796653|450118240|FG002|Overall Study|Withdrawal by Subject|8|||
125134819|NCT00796653|450118241|FG003|Overall Study|Withdrawal by Subject|13|||
125134820|NCT00796653|450118238|FG000|Overall Study|Lack of Efficacy|8|||
125134821|NCT00796653|450118239|FG001|Overall Study|Lack of Efficacy|1|||
125134822|NCT00796653|450118240|FG002|Overall Study|Lack of Efficacy|3|||
125039355|NCT01309737|449762707|FG002|Week 16 to 52|Other|0|||
125039356|NCT01309737|449762708|FG003|Week 16 to 52|Other|2|||
125039357|NCT01309737|449762709|FG004|Week 16 to 52|Other|0|||
125039358|NCT00709202|449762711|FG000|Overall Study|Withdrawal by Subject|6|||
125039359|NCT00709202|449762712|FG001|Overall Study|Withdrawal by Subject|6|||
125039360|NCT03934684|449762719|FG000|Overall Study|Participants continuing in study|11|||
125039361|NCT03934684|449762720|FG001|Overall Study|Participants continuing in study|4|||
125039362|NCT03934684|449762719|FG000|Overall Study|Discontinuation of carfilzomib|20|||
125039363|NCT03934684|449762720|FG001|Overall Study|Discontinuation of carfilzomib|30|||
125039364|NCT03934684|449762719|FG000|Overall Study|Death|2|||
125039365|NCT03934684|449762720|FG001|Overall Study|Death|2|||
125039366|NCT03934684|449762719|FG000|Overall Study|Lost to Follow-up|2|||
125039367|NCT03934684|449762720|FG001|Overall Study|Lost to Follow-up|5|||
125039368|NCT03934684|449762719|FG000|Overall Study|Withdrawal by Subject|7|||
125039369|NCT03934684|449762720|FG001|Overall Study|Withdrawal by Subject|8|||
125134823|NCT00796653|450118241|FG003|Overall Study|Lack of Efficacy|2|||
125039370|NCT04996797|449762721|FG000|Overall Study|Adverse Event|0|||
125134824|NCT00796653|450118238|FG000|Overall Study|Non compliance with protocol|2|||
125039371|NCT04996797|449762722|FG001|Overall Study|Adverse Event|2|||
125134825|NCT00796653|450118239|FG001|Overall Study|Non compliance with protocol|2|||
125134826|NCT00796653|450118240|FG002|Overall Study|Non compliance with protocol|0|||
125134827|NCT00796653|450118241|FG003|Overall Study|Non compliance with protocol|2|||
125134828|NCT00796653|450118238|FG000|Overall Study|Other reason not described above|4|||
125134829|NCT00796653|450118239|FG001|Overall Study|Other reason not described above|9|||
125134830|NCT00796653|450118240|FG002|Overall Study|Other reason not described above|7|||
125134831|NCT00796653|450118241|FG003|Overall Study|Other reason not described above|4|||
125134832|NCT00207090|450118248|FG000|Overall Study|Study drug toxicity|3|||
125134833|NCT00207090|450118248|FG000|Overall Study|Chest wall mass larger|1|||
125134834|NCT00207090|450118248|FG000|Overall Study|Disease progression/relapse|2|||
125134835|NCT00207090|450118248|FG000|Overall Study|Physician Decision|1|||
125134836|NCT01911676|450118251|FG000|Period 1 of Study|Withdrawal by Subject|4|||
125134837|NCT01911676|450118252|FG001|Period 1 of Study|Withdrawal by Subject|2|||
125134838|NCT01911676|450118253|FG002|Period 1 of Study|Withdrawal by Subject|1|||
125039372|NCT04996797|449762723|FG002|Overall Study|Adverse Event|0|||
125039373|NCT04996797|449762724|FG003|Overall Study|Adverse Event|1|||
125039374|NCT04996797|449762721|FG000|Overall Study|Lack of Efficacy|0|||
125039375|NCT04996797|449762722|FG001|Overall Study|Lack of Efficacy|2|||
125039376|NCT04996797|449762723|FG002|Overall Study|Lack of Efficacy|0|||
124975512|NCT01646177|449536593|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
124975513|NCT01646177|449536594|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
124975514|NCT01646177|449536595|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
124975515|NCT01646177|449536596|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
124975516|NCT01646177|449536597|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
124975517|NCT01646177|449536598|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
124975518|NCT01646177|449536599|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
124975519|NCT01646177|449536600|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
124975520|NCT01646177|449536589|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
124975521|NCT01646177|449536590|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
124975522|NCT01646177|449536591|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
124975523|NCT01646177|449536592|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
124975524|NCT01646177|449536593|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
124975525|NCT01646177|449536594|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
124975526|NCT01646177|449536595|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
124975527|NCT01646177|449536596|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
124975528|NCT01646177|449536597|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
124975529|NCT01646177|449536598|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
124975530|NCT01646177|449536599|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
124975531|NCT01646177|449536600|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
124975532|NCT01646177|449536589|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
125039377|NCT04996797|449762724|FG003|Overall Study|Lack of Efficacy|0|||
125039378|NCT04996797|449762721|FG000|Overall Study|Prohibited Medication|0|||
125039379|NCT04996797|449762722|FG001|Overall Study|Prohibited Medication|1|||
125039380|NCT04996797|449762723|FG002|Overall Study|Prohibited Medication|0|||
125039381|NCT04996797|449762724|FG003|Overall Study|Prohibited Medication|0|||
125039382|NCT04996797|449762721|FG000|Overall Study|Ongoing|68|||
125039383|NCT04996797|449762722|FG001|Overall Study|Ongoing|60|||
125039384|NCT04996797|449762723|FG002|Overall Study|Ongoing|22|||
125039385|NCT04996797|449762724|FG003|Overall Study|Ongoing|20|||
125039386|NCT04996797|449762721|FG000|Overall Study|Withdrawal by Subject|0|||
125039387|NCT04996797|449762722|FG001|Overall Study|Withdrawal by Subject|2|||
125039388|NCT04996797|449762723|FG002|Overall Study|Withdrawal by Subject|0|||
125039389|NCT04996797|449762724|FG003|Overall Study|Withdrawal by Subject|0|||
125039390|NCT04091217|449762725|FG000|Overall Study|Lost to Follow-up|2|||
125039391|NCT05662332|449762726|FG000|Overall Study|Death|3|||
125039392|NCT05662332|449762727|FG001|Overall Study|Death|3|||
125039393|NCT05662332|449762726|FG000|Overall Study|Lost to Follow-up|3|||
125039394|NCT05662332|449762727|FG001|Overall Study|Lost to Follow-up|8|||
125039395|NCT05662332|449762726|FG000|Overall Study|Physician Decision|1|||
125039396|NCT05662332|449762727|FG001|Overall Study|Physician Decision|2|||
125039397|NCT05662332|449762726|FG000|Overall Study|Protocol Deviation|2|||
125039398|NCT05662332|449762727|FG001|Overall Study|Protocol Deviation|1|||
125039399|NCT05662332|449762726|FG000|Overall Study|Withdrawal by Subject|14|||
125039400|NCT05662332|449762727|FG001|Overall Study|Withdrawal by Subject|14|||
125039401|NCT05662332|449762726|FG000|Overall Study|Assigned Treatment by Mistake|5|||
125039402|NCT05662332|449762727|FG001|Overall Study|Assigned Treatment by Mistake|7|||
125039403|NCT05662332|449762726|FG000|Overall Study|Non-compliance with study drug|4|||
125039404|NCT05662332|449762727|FG001|Overall Study|Non-compliance with study drug|1|||
125039405|NCT05662332|449762726|FG000|Overall Study|Due to Bariatric surgery|1|||
125039406|NCT05662332|449762727|FG001|Overall Study|Due to Bariatric surgery|0|||
125039407|NCT05662332|449762726|FG000|Overall Study|Subject Moving out of State|0|||
125039408|NCT05662332|449762727|FG001|Overall Study|Subject Moving out of State|1|||
125039409|NCT05662332|449762726|FG000|Overall Study|Subject Missed the Schedule|1|||
125039410|NCT05662332|449762727|FG001|Overall Study|Subject Missed the Schedule|0|||
125039411|NCT05662332|449762726|FG000|Overall Study|The Patient Moved to Another City|1|||
125039412|NCT05662332|449762727|FG001|Overall Study|The Patient Moved to Another City|0|||
125039413|NCT05262764|449762732|FG000|Overall Study|Case report form not collected|9|||
125039414|NCT05262764|449762732|FG000|Overall Study|No patient visits after entry|23|||
125039415|NCT05262764|449762732|FG000|Overall Study|Registration rule not followed|2|||
125039416|NCT05262764|449762732|FG000|Overall Study|Patient of non-chronic heart failure|1|||
125039417|NCT01392183|449762733|FG000|First Drug Administration|Adverse Event|3|||
125039418|NCT01392183|449762734|FG001|First Drug Administration|Adverse Event|2|||
125039419|NCT01392183|449762733|FG000|First Drug Administration|Death|1|||
125039420|NCT01392183|449762734|FG001|First Drug Administration|Death|0|||
125039421|NCT01392183|449762733|FG000|First Drug Administration|Withdrawal by Subject|10|||
125039422|NCT01392183|449762734|FG001|First Drug Administration|Withdrawal by Subject|17|||
125039423|NCT03430310|449762735|FG000|Overall Study|Protocol Violation|2|||
125039424|NCT03430310|449762736|FG001|Overall Study|Protocol Violation|0|||
125039425|NCT03430310|449762735|FG000|Overall Study|Withdrawal by Subject|3|||
125039426|NCT03430310|449762736|FG001|Overall Study|Withdrawal by Subject|2|||
125039427|NCT03430310|449762735|FG000|Overall Study|COVID shutdown March 2020|0|||
125039428|NCT03430310|449762736|FG001|Overall Study|COVID shutdown March 2020|1|||
125039429|NCT03476239|449762738|FG000|Overall Study|Withdrawal by Subject|10|||
125039430|NCT03476239|449762738|FG000|Overall Study|Death|80|||
125039431|NCT03476239|449762738|FG000|Overall Study|Lost to Follow-up|8|||
125039432|NCT01446809|449762742|FG000|Overall Study|Adverse Event|0|||
125039433|NCT01446809|449762743|FG001|Overall Study|Adverse Event|0|||
125039434|NCT01446809|449762744|FG002|Overall Study|Adverse Event|1|||
125039435|NCT01446809|449762742|FG000|Overall Study|Failure to complete study procedures|0|||
125039436|NCT01446809|449762743|FG001|Overall Study|Failure to complete study procedures|0|||
125039437|NCT01446809|449762744|FG002|Overall Study|Failure to complete study procedures|1|||
125039438|NCT01331161|449762745|FG000|Overall Study|Physician Decision|1|||
125039439|NCT01331161|449762746|FG001|Overall Study|Physician Decision|0|||
125039440|NCT01331161|449762745|FG000|Overall Study|Lost to Follow-up|0|||
125039441|NCT01331161|449762746|FG001|Overall Study|Lost to Follow-up|1|||
125039442|NCT01331161|449762745|FG000|Overall Study|Pregnancy|0|||
125039443|NCT01331161|449762746|FG001|Overall Study|Pregnancy|1|||
125039444|NCT00785577|449762747|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
125039445|NCT00785577|449762748|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
125039446|NCT00785577|449762749|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
125039447|NCT00785577|449762750|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
125039448|NCT00785577|449762751|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
125039449|NCT00785577|449762747|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
125039450|NCT00785577|449762748|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
125039451|NCT00785577|449762749|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
125039452|NCT00785577|449762750|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
125039453|NCT00785577|449762751|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
125039454|NCT00785577|449762747|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
125039455|NCT00785577|449762748|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
125039456|NCT00785577|449762749|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
125039457|NCT00785577|449762750|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
125039458|NCT00785577|449762751|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
125039459|NCT00785577|449762747|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
125039460|NCT00785577|449762748|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
125039461|NCT00785577|449762749|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
125039462|NCT00785577|449762750|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
125039463|NCT00785577|449762751|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
125039464|NCT00785577|449762747|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
125039465|NCT00785577|449762748|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
125039466|NCT00785577|449762749|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
125039467|NCT00785577|449762750|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
125039468|NCT00785577|449762751|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
125039469|NCT00785577|449762747|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
125039470|NCT00785577|449762748|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
125039471|NCT00785577|449762749|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
125039472|NCT00785577|449762750|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
125039473|NCT00785577|449762751|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
125039474|NCT00785577|449762747|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
125039475|NCT00785577|449762748|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
125039476|NCT00785577|449762749|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
125039477|NCT00785577|449762750|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
125039478|NCT00785577|449762751|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
125039479|NCT00785577|449762747|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
125039480|NCT00785577|449762748|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
125039481|NCT00785577|449762749|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
125039482|NCT00785577|449762750|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
125039483|NCT00785577|449762751|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
125039484|NCT00785577|449762747|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
125039485|NCT00785577|449762748|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
125039486|NCT00785577|449762749|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
125039487|NCT00785577|449762750|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
125039488|NCT00785577|449762751|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
125039489|NCT00785577|449762747|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
125039490|NCT00785577|449762748|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
125039491|NCT00785577|449762749|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
125039492|NCT00785577|449762750|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
125039493|NCT00785577|449762751|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
125039494|NCT01682044|449762755|FG000|Overall Study|Death|1|||
125039495|NCT01682044|449762755|FG000|Overall Study|Progression|3|||
125039496|NCT01659151|449762756|FG000|Overall Study|Inadequate TIL growth|1|||
125039497|NCT01826214|449764250|FG000|Overall Study|Adverse Event|7|||
125039498|NCT01826214|449764251|FG001|Overall Study|Adverse Event|6|||
125039499|NCT01826214|449764250|FG000|Overall Study|Death|3|||
125039500|NCT01826214|449764251|FG001|Overall Study|Death|1|||
125039501|NCT01826214|449764250|FG000|Overall Study|Lost to Follow-up|1|||
125039502|NCT01826214|449764251|FG001|Overall Study|Lost to Follow-up|0|||
125039503|NCT01826214|449764250|FG000|Overall Study|Physician Decision|0|||
125039504|NCT01826214|449764251|FG001|Overall Study|Physician Decision|2|||
125039505|NCT01826214|449764250|FG000|Overall Study|Progressive disease|22|||
125039506|NCT01826214|449764251|FG001|Overall Study|Progressive disease|21|||
125039507|NCT01826214|449764250|FG000|Overall Study|Study terminated by Sponsor|0|||
125039508|NCT01826214|449764251|FG001|Overall Study|Study terminated by Sponsor|1|||
125039509|NCT01826214|449764250|FG000|Overall Study|Subject/guardian decision|2|||
125039510|NCT01826214|449764251|FG001|Overall Study|Subject/guardian decision|3|||
125039511|NCT01056107|449764268|FG000|Overall Study|Withdrawal by Subject|0|||
125039512|NCT01056107|449764269|FG001|Overall Study|Withdrawal by Subject|1|||
125039513|NCT01056107|449764270|FG002|Overall Study|Withdrawal by Subject|3|||
125039514|NCT01056107|449764271|FG003|Overall Study|Withdrawal by Subject|0|||
125039515|NCT01614457|449764272|FG000|Overall Study|Non-Compliance|1|||
125039516|NCT01614457|449764273|FG001|Overall Study|Non-Compliance|0|||
125039517|NCT01614457|449764272|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
125039518|NCT01614457|449764273|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
125039519|NCT00886821|449764274|FG000|Stage 2|Adverse Event|0|||
125039520|NCT00886821|449764275|FG001|Stage 2|Adverse Event|0|||
125039521|NCT00886821|449764276|FG002|Stage 2|Adverse Event|0|||
125039522|NCT00886821|449764277|FG003|Stage 2|Adverse Event|0|||
125039523|NCT00886821|449764278|FG004|Stage 2|Adverse Event|0|||
125039524|NCT00886821|449764279|FG005|Stage 2|Adverse Event|0|||
125039525|NCT00886821|449764280|FG006|Stage 2|Adverse Event|0|||
125039526|NCT00886821|449764281|FG007|Stage 2|Adverse Event|0|||
125039527|NCT00886821|449764282|FG008|Stage 2|Adverse Event|0|||
125039528|NCT00886821|449764283|FG009|Stage 2|Adverse Event|0|||
125039529|NCT00886821|449764284|FG010|Stage 2|Adverse Event|0|||
125039530|NCT00886821|449764285|FG011|Stage 2|Adverse Event|1|||
125039531|NCT00886821|449764286|FG012|Stage 2|Adverse Event|3|||
125039532|NCT00886821|449764287|FG013|Stage 2|Adverse Event|0|||
125039533|NCT00886821|449764274|FG000|Stage 2|Lost to Follow-up|0|||
125039534|NCT00886821|449764275|FG001|Stage 2|Lost to Follow-up|0|||
125039535|NCT00886821|449764276|FG002|Stage 2|Lost to Follow-up|0|||
125039536|NCT00886821|449764277|FG003|Stage 2|Lost to Follow-up|0|||
125039537|NCT00886821|449764278|FG004|Stage 2|Lost to Follow-up|0|||
125039538|NCT00886821|449764279|FG005|Stage 2|Lost to Follow-up|0|||
125039539|NCT00886821|449764280|FG006|Stage 2|Lost to Follow-up|0|||
125039540|NCT00886821|449764281|FG007|Stage 2|Lost to Follow-up|0|||
125039541|NCT00886821|449764282|FG008|Stage 2|Lost to Follow-up|0|||
125039542|NCT00886821|449764283|FG009|Stage 2|Lost to Follow-up|0|||
125039543|NCT00886821|449764284|FG010|Stage 2|Lost to Follow-up|0|||
125039544|NCT00886821|449764285|FG011|Stage 2|Lost to Follow-up|0|||
125039545|NCT00886821|449764286|FG012|Stage 2|Lost to Follow-up|2|||
125039546|NCT00886821|449764287|FG013|Stage 2|Lost to Follow-up|1|||
125039547|NCT00914628|449764288|FG000|Overall Study|Death|35|||
125039548|NCT00914628|449764289|FG001|Overall Study|Death|17|||
125134839|NCT01911676|450118254|FG003|Period 1 of Study|Withdrawal by Subject|2|||
125134840|NCT01911676|450118251|FG000|Period 1 of Study|Physician Decision|2|||
125134841|NCT01911676|450118252|FG001|Period 1 of Study|Physician Decision|0|||
125134842|NCT01911676|450118253|FG002|Period 1 of Study|Physician Decision|0|||
125134843|NCT01911676|450118254|FG003|Period 1 of Study|Physician Decision|1|||
125134844|NCT01911676|450118251|FG000|Period 2 of Study|Physician Decision|2|||
125039549|NCT00914628|449764288|FG000|Overall Study|Medical decision|4|||
125039550|NCT00914628|449764289|FG001|Overall Study|Medical decision|0|||
125134845|NCT01911676|450118252|FG001|Period 2 of Study|Physician Decision|0|||
125039551|NCT00914628|449764288|FG000|Overall Study|Protocol Violation|1|||
125039552|NCT00914628|449764289|FG001|Overall Study|Protocol Violation|0|||
125039553|NCT00914628|449764288|FG000|Overall Study|Lack of Efficacy|1|||
125039554|NCT00914628|449764289|FG001|Overall Study|Lack of Efficacy|0|||
125039555|NCT00914628|449764288|FG000|Overall Study|non-randomized|1|||
125134846|NCT01911676|450118253|FG002|Period 2 of Study|Physician Decision|0|||
125134847|NCT01911676|450118254|FG003|Period 2 of Study|Physician Decision|1|||
125039556|NCT00914628|449764289|FG001|Overall Study|non-randomized|0|||
125039557|NCT00914628|449764288|FG000|Overall Study|Relapse|1|||
125039558|NCT00914628|449764289|FG001|Overall Study|Relapse|2|||
125039559|NCT00914628|449764288|FG000|Overall Study|Study terminated by Sponsor|14|||
125039560|NCT00914628|449764289|FG001|Overall Study|Study terminated by Sponsor|8|||
125039561|NCT00914628|449764288|FG000|Overall Study|Patients who did not receive a single dose|7|||
125039562|NCT00914628|449764289|FG001|Overall Study|Patients who did not receive a single dose|1|||
125039563|NCT03404960|449764290|FG000|Overall Study|Adverse Event|0|||
125134848|NCT01911676|450118251|FG000|Period 2 of Study|Lost to Follow-up|0|||
125134849|NCT01911676|450118252|FG001|Period 2 of Study|Lost to Follow-up|0|||
125039564|NCT03404960|449764291|FG001|Overall Study|Adverse Event|2|||
125039565|NCT03404960|449764290|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
125039566|NCT03404960|449764291|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
125039567|NCT03404960|449764290|FG000|Overall Study|Bowel obstruction|0|||
125039568|NCT03404960|449764291|FG001|Overall Study|Bowel obstruction|1|||
125039569|NCT03404960|449764290|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
125039570|NCT03404960|449764291|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
125039571|NCT03311126|449764292|FG000|Induction|Death|1|||
125039572|NCT03311126|449764292|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
125039573|NCT00374556|449764293|FG000|Overall Study|Lost to Follow-up|1|||
125039574|NCT00374556|449764294|FG001|Overall Study|Lost to Follow-up|0|||
125039575|NCT00374556|449764293|FG000|Overall Study|Removed at baseline due to medical cond|0|||
125039576|NCT00374556|449764294|FG001|Overall Study|Removed at baseline due to medical cond|1|||
125039577|NCT00473694|449764295|FG000|Overall Study|Adverse Event|0|||
125039578|NCT00473694|449764296|FG001|Overall Study|Adverse Event|1|||
125039579|NCT00473694|449764297|FG002|Overall Study|Adverse Event|0|||
125039580|NCT00473694|449764298|FG003|Overall Study|Adverse Event|0|||
125039581|NCT00473694|449764295|FG000|Overall Study|Participants did not receive treatment|11|||
125039582|NCT00473694|449764296|FG001|Overall Study|Participants did not receive treatment|3|||
125039583|NCT00473694|449764297|FG002|Overall Study|Participants did not receive treatment|5|||
125039584|NCT00473694|449764298|FG003|Overall Study|Participants did not receive treatment|6|||
125039585|NCT00473694|449764295|FG000|Overall Study|Lost to Follow-up|0|||
125039586|NCT00473694|449764296|FG001|Overall Study|Lost to Follow-up|0|||
125039587|NCT00473694|449764297|FG002|Overall Study|Lost to Follow-up|0|||
125039588|NCT00473694|449764298|FG003|Overall Study|Lost to Follow-up|1|||
125039589|NCT00469079|449764308|FG000|Overall Study|Lack of Efficacy|3|||
125039590|NCT00469079|449764309|FG001|Overall Study|Lack of Efficacy|8|||
125039591|NCT00469079|449764310|FG002|Overall Study|Lack of Efficacy|5|||
125039592|NCT00469079|449764308|FG000|Overall Study|Adverse Event|1|||
125039593|NCT00469079|449764309|FG001|Overall Study|Adverse Event|3|||
125039594|NCT00469079|449764310|FG002|Overall Study|Adverse Event|2|||
125039595|NCT00469079|449764308|FG000|Overall Study|Lost to Follow-up|4|||
125039596|NCT00469079|449764309|FG001|Overall Study|Lost to Follow-up|8|||
125218578|NCT03131687|450427362|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
125218579|NCT03131687|450427363|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
125218580|NCT03131687|450427364|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
125218581|NCT03131687|450427365|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
125218582|NCT03131687|450427366|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
125218583|NCT03131687|450427367|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
125218584|NCT03131687|450427362|FG000|Overall Study|Principle Investigator Decision|0|||
125218585|NCT03131687|450427363|FG001|Overall Study|Principle Investigator Decision|1|||
125218586|NCT03131687|450427364|FG002|Overall Study|Principle Investigator Decision|0|||
125218587|NCT03131687|450427365|FG003|Overall Study|Principle Investigator Decision|0|||
125218588|NCT03131687|450427366|FG004|Overall Study|Principle Investigator Decision|0|||
125218589|NCT03131687|450427367|FG005|Overall Study|Principle Investigator Decision|0|||
125218590|NCT03131687|450427362|FG000|Overall Study|Inadvertent Enrollment|0|||
125218591|NCT03131687|450427363|FG001|Overall Study|Inadvertent Enrollment|0|||
125218592|NCT03131687|450427364|FG002|Overall Study|Inadvertent Enrollment|0|||
125218593|NCT03131687|450427365|FG003|Overall Study|Inadvertent Enrollment|1|||
125218594|NCT03131687|450427366|FG004|Overall Study|Inadvertent Enrollment|0|||
125218595|NCT03131687|450427367|FG005|Overall Study|Inadvertent Enrollment|0|||
125218596|NCT01904032|450427377|FG000|Overall Study|Adverse Event|3|||
125218597|NCT01904032|450427378|FG001|Overall Study|Adverse Event|1|||
125218598|NCT01904032|450427377|FG000|Overall Study|Lost to Follow-up|4|||
125218599|NCT01904032|450427378|FG001|Overall Study|Lost to Follow-up|2|||
125218600|NCT04074330|450427386|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
125218601|NCT04074330|450427387|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
125218602|NCT04074330|450427388|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
125218603|NCT04074330|450427389|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
125218604|NCT04074330|450427390|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
125039597|NCT00469079|449764310|FG002|Overall Study|Lost to Follow-up|10|||
125039598|NCT00469079|449764308|FG000|Overall Study|Withdrawal by Subject|1|||
125039599|NCT00469079|449764309|FG001|Overall Study|Withdrawal by Subject|2|||
125039600|NCT00469079|449764310|FG002|Overall Study|Withdrawal by Subject|2|||
125039601|NCT00469079|449764308|FG000|Overall Study|Ineligible|0|||
125218605|NCT04074330|450427391|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
125218606|NCT04074330|450427392|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
125218607|NCT04074330|450427393|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
125039602|NCT00469079|449764309|FG001|Overall Study|Ineligible|1|||
125039603|NCT00469079|449764310|FG002|Overall Study|Ineligible|0|||
125039604|NCT00942162|449764311|FG000|Overall Study|Death|45|||
125039605|NCT00942162|449764312|FG001|Overall Study|Death|35|||
125039606|NCT00942162|449764313|FG002|Overall Study|Death|0|||
125039607|NCT00942162|449764311|FG000|Overall Study|Withdrawal by Subject|7|||
125039608|NCT00942162|449764312|FG001|Overall Study|Withdrawal by Subject|2|||
125039609|NCT00942162|449764313|FG002|Overall Study|Withdrawal by Subject|0|||
125039610|NCT00942162|449764311|FG000|Overall Study|Lost to Follow-up|4|||
125039611|NCT00942162|449764312|FG001|Overall Study|Lost to Follow-up|0|||
125039612|NCT00942162|449764313|FG002|Overall Study|Lost to Follow-up|0|||
125039613|NCT00942162|449764311|FG000|Overall Study|Other|14|||
125039614|NCT00942162|449764312|FG001|Overall Study|Other|13|||
125039615|NCT00942162|449764313|FG002|Overall Study|Other|2|||
125039616|NCT01821963|449764323|FG000|Overall Study|Adverse Event|1|||
125039617|NCT03368859|449764324|FG000|Overall Study|Withdrew Consent|5|||
125039618|NCT03368859|449764325|FG001|Overall Study|Withdrew Consent|4|||
125039619|NCT03368859|449764324|FG000|Overall Study|Death|12|||
125039620|NCT03368859|449764325|FG001|Overall Study|Death|6|||
125039621|NCT03368859|449764324|FG000|Overall Study|Study terminated by Sponsor|18|||
125039622|NCT03368859|449764325|FG001|Overall Study|Study terminated by Sponsor|23|||
125039623|NCT03368859|449764324|FG000|Overall Study|Other|1|||
125039624|NCT03368859|449764325|FG001|Overall Study|Other|1|||
125039625|NCT02698410|449764326|FG000|Overall Study|Adverse Event|2|||
125039626|NCT02698410|449764326|FG000|Overall Study|Withdrawal by Subject|1|||
125039627|NCT02698410|449764326|FG000|Overall Study|Other|1|||
125039628|NCT01713348|449764327|FG000|Overall Study|Withdrawal by Subject|3|||
125039629|NCT01713348|449764328|FG001|Overall Study|Withdrawal by Subject|2|||
125039630|NCT01713348|449764329|FG002|Overall Study|Withdrawal by Subject|2|||
125039631|NCT01713348|449764330|FG003|Overall Study|Withdrawal by Subject|0|||
125039632|NCT01713348|449764327|FG000|Overall Study|Lost to Follow-up|1|||
125039633|NCT01713348|449764328|FG001|Overall Study|Lost to Follow-up|0|||
125039634|NCT01713348|449764329|FG002|Overall Study|Lost to Follow-up|0|||
125039635|NCT01713348|449764330|FG003|Overall Study|Lost to Follow-up|0|||
125039636|NCT01896232|449764331|FG000|Overall Study|Death|6|||
125039637|NCT01896232|449764332|FG001|Overall Study|Death|10|||
125039638|NCT01896232|449764331|FG000|Overall Study|Withdrawal by Subject|32|||
125039639|NCT01896232|449764332|FG001|Overall Study|Withdrawal by Subject|31|||
125039640|NCT01896232|449764331|FG000|Overall Study|Sponsor Decision|2|||
125039641|NCT01896232|449764332|FG001|Overall Study|Sponsor Decision|0|||
125039642|NCT01896232|449764331|FG000|Overall Study|Lost to Follow-up|9|||
125039643|NCT01896232|449764332|FG001|Overall Study|Lost to Follow-up|12|||
125039644|NCT00686205|449764341|FG000|Overall Study|Protocol Violation|127|||
125039645|NCT00686205|449764342|FG001|Overall Study|Protocol Violation|0|||
125039646|NCT00686205|449764341|FG000|Overall Study|Withdrawal by Subject|2|||
125039647|NCT00686205|449764342|FG001|Overall Study|Withdrawal by Subject|0|||
125039648|NCT00686205|449764341|FG000|Overall Study|Specimen handling procedure altered|5878|||
125039649|NCT00686205|449764342|FG001|Overall Study|Specimen handling procedure altered|0|||
125039650|NCT00686205|449764341|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
125039651|NCT00686205|449764342|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
125039652|NCT00265941|449764343|FG000|Overall Study|Protocol Violation|22|||
125134850|NCT01911676|450118253|FG002|Period 2 of Study|Lost to Follow-up|0|||
125134851|NCT01911676|450118254|FG003|Period 2 of Study|Lost to Follow-up|1|||
125134852|NCT00773253|450118255|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
125134853|NCT00773253|450118256|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
125134854|NCT01566721|450118257|FG000|Treatment Period|Withdrawal by Subject|35|||
125039653|NCT00265941|449764344|FG001|Overall Study|Protocol Violation|25|||
125134855|NCT01566721|450118258|FG001|Treatment Period|Withdrawal by Subject|9|||
125039654|NCT00265941|449764343|FG000|Overall Study|Lost to Follow-up|1|||
125039655|NCT00265941|449764344|FG001|Overall Study|Lost to Follow-up|1|||
125039656|NCT03816995|449764347|FG000|Overall Study|Withdrawal by Subject|3|||
125039657|NCT03816995|449764348|FG001|Overall Study|Withdrawal by Subject|1|||
125039658|NCT03816995|449764347|FG000|Overall Study|Cancelled Surgery|8|||
125039659|NCT03816995|449764348|FG001|Overall Study|Cancelled Surgery|12|||
125039660|NCT03816995|449764347|FG000|Overall Study|No wound protector used|11|||
125218608|NCT04074330|450427394|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
125218609|NCT04074330|450427395|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
125039661|NCT03816995|449764348|FG001|Overall Study|No wound protector used|17|||
125039662|NCT03816995|449764347|FG000|Overall Study|Protocol Violation|2|||
125039663|NCT03816995|449764348|FG001|Overall Study|Protocol Violation|3|||
125039664|NCT05882890|449764350|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
125039665|NCT00613314|449764353|FG000|Overall Study|Adverse Event|5|||
125039666|NCT00613314|449764353|FG000|Overall Study|Protocol Violation|14|||
125134856|NCT01566721|450118257|FG000|Treatment Period|Disease Progression/Recurrence|37|||
125218610|NCT04074330|450427386|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
125039667|NCT00613314|449764353|FG000|Overall Study|Lost to Follow-up|46|||
125039668|NCT00613314|449764353|FG000|Overall Study|Other reason not defined above|90|||
125039669|NCT00719810|449764354|FG000|Overall Study|Adverse Event|0|||
125039670|NCT00719810|449764355|FG001|Overall Study|Adverse Event|2|||
125039671|NCT00719810|449764356|FG002|Overall Study|Adverse Event|3|||
125039672|NCT00719810|449764354|FG000|Overall Study|Lost to Follow-up|2|||
125039673|NCT00719810|449764355|FG001|Overall Study|Lost to Follow-up|0|||
125039674|NCT00719810|449764356|FG002|Overall Study|Lost to Follow-up|3|||
125039675|NCT00719810|449764354|FG000|Overall Study|Physician Decision|0|||
125039676|NCT00719810|449764355|FG001|Overall Study|Physician Decision|1|||
125039677|NCT00719810|449764356|FG002|Overall Study|Physician Decision|0|||
125039678|NCT00719810|449764354|FG000|Overall Study|Withdrawal by Subject|1|||
125039679|NCT00719810|449764355|FG001|Overall Study|Withdrawal by Subject|1|||
125039680|NCT00719810|449764356|FG002|Overall Study|Withdrawal by Subject|2|||
125039681|NCT03090191|449764357|FG000|Overall Study|Adverse Event|90|||
125039682|NCT03090191|449764358|FG001|Overall Study|Adverse Event|72|||
125039683|NCT03090191|449764357|FG000|Overall Study|Death|365|||
125039684|NCT03090191|449764358|FG001|Overall Study|Death|358|||
125039685|NCT03090191|449764357|FG000|Overall Study|Lost to Follow-up|382|||
125039686|NCT03090191|449764358|FG001|Overall Study|Lost to Follow-up|394|||
125039687|NCT03090191|449764357|FG000|Overall Study|Physician Decision|77|||
125039688|NCT03090191|449764358|FG001|Overall Study|Physician Decision|66|||
125039689|NCT03090191|449764357|FG000|Overall Study|Protocol Violation|43|||
125039690|NCT03090191|449764358|FG001|Overall Study|Protocol Violation|52|||
125039691|NCT03090191|449764357|FG000|Overall Study|Withdrawal by Subject|2160|||
125039692|NCT03090191|449764358|FG001|Overall Study|Withdrawal by Subject|2133|||
125039693|NCT03090191|449764357|FG000|Overall Study|Site terminated|7|||
125039694|NCT03090191|449764358|FG001|Overall Study|Site terminated|8|||
125039695|NCT03090191|449764357|FG000|Overall Study|Other|66|||
125039696|NCT03090191|449764358|FG001|Overall Study|Other|60|||
125039697|NCT03090191|449764357|FG000|Overall Study|Withdrawn before any study vaccination|43|||
125039698|NCT03090191|449764358|FG001|Overall Study|Withdrawn before any study vaccination|52|||
125039699|NCT02432807|449764359|FG000|Overall Study|Adverse Event|0|||
125039700|NCT02432807|449764360|FG001|Overall Study|Adverse Event|2|||
125039701|NCT02432807|449764359|FG000|Overall Study|Lost to Follow-up|1|||
125039702|NCT02432807|449764360|FG001|Overall Study|Lost to Follow-up|0|||
125039703|NCT02432807|449764359|FG000|Overall Study|Withdrawal by Subject|1|||
125039704|NCT02432807|449764360|FG001|Overall Study|Withdrawal by Subject|1|||
125039705|NCT02432807|449764359|FG000|Overall Study|Other|1|||
125039706|NCT02432807|449764360|FG001|Overall Study|Other|1|||
125039707|NCT03976401|449764361|FG000|Overall Study|Adverse Event|2|||
125039708|NCT03976401|449764362|FG001|Overall Study|Adverse Event|0|||
125039709|NCT03976401|449764363|FG002|Overall Study|Adverse Event|4|||
125039710|NCT03976401|449764364|FG003|Overall Study|Adverse Event|1|||
125039711|NCT03976401|449764365|FG004|Overall Study|Adverse Event|1|||
125039712|NCT03976401|449764366|FG005|Overall Study|Adverse Event|0|||
125039713|NCT03976401|449764361|FG000|Overall Study|Withdrawal by Subject|0|||
125039714|NCT03976401|449764362|FG001|Overall Study|Withdrawal by Subject|1|||
125039715|NCT03976401|449764363|FG002|Overall Study|Withdrawal by Subject|0|||
125039716|NCT03976401|449764364|FG003|Overall Study|Withdrawal by Subject|0|||
125039717|NCT03976401|449764365|FG004|Overall Study|Withdrawal by Subject|0|||
125039718|NCT03976401|449764366|FG005|Overall Study|Withdrawal by Subject|1|||
125039719|NCT03976401|449764361|FG000|Overall Study|Physician Decision|0|||
125039720|NCT03976401|449764362|FG001|Overall Study|Physician Decision|0|||
125039721|NCT03976401|449764363|FG002|Overall Study|Physician Decision|1|||
125039722|NCT03976401|449764364|FG003|Overall Study|Physician Decision|0|||
125039723|NCT03976401|449764365|FG004|Overall Study|Physician Decision|0|||
125039724|NCT03976401|449764366|FG005|Overall Study|Physician Decision|0|||
125039725|NCT03976401|449764361|FG000|Overall Study|Lost to Follow-up|1|||
125039726|NCT03976401|449764362|FG001|Overall Study|Lost to Follow-up|2|||
125039727|NCT03976401|449764363|FG002|Overall Study|Lost to Follow-up|0|||
125039728|NCT03976401|449764364|FG003|Overall Study|Lost to Follow-up|0|||
125039729|NCT03976401|449764365|FG004|Overall Study|Lost to Follow-up|0|||
125134857|NCT01566721|450118258|FG001|Treatment Period|Disease Progression/Recurrence|13|||
125039730|NCT03976401|449764366|FG005|Overall Study|Lost to Follow-up|0|||
125039731|NCT03976401|449764361|FG000|Overall Study|Protocol Violation|0|||
125039732|NCT03976401|449764362|FG001|Overall Study|Protocol Violation|1|||
125039733|NCT03976401|449764363|FG002|Overall Study|Protocol Violation|0|||
125039734|NCT03976401|449764364|FG003|Overall Study|Protocol Violation|0|||
125039735|NCT03976401|449764365|FG004|Overall Study|Protocol Violation|0|||
125039736|NCT03976401|449764366|FG005|Overall Study|Protocol Violation|0|||
125039737|NCT03976401|449764361|FG000|Overall Study|Withdrew Consent|0|||
125039738|NCT03976401|449764362|FG001|Overall Study|Withdrew Consent|0|||
125039739|NCT03976401|449764363|FG002|Overall Study|Withdrew Consent|0|||
125039740|NCT03976401|449764364|FG003|Overall Study|Withdrew Consent|1|||
125039741|NCT03976401|449764365|FG004|Overall Study|Withdrew Consent|0|||
125039742|NCT03976401|449764366|FG005|Overall Study|Withdrew Consent|0|||
125039743|NCT01845025|449764367|FG000|Overall Study|Adverse Event|6|||
125039744|NCT01845025|449764368|FG001|Overall Study|Adverse Event|3|||
125134858|NCT01566721|450118257|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
125134859|NCT01566721|450118258|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
125134860|NCT01566721|450118257|FG000|Treatment Period|Other|13|||
125039745|NCT01845025|449764367|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
125039746|NCT01845025|449764368|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125039747|NCT01845025|449764367|FG000|Overall Study|Withdrawal by Subject|48|||
125039748|NCT01845025|449764368|FG001|Overall Study|Withdrawal by Subject|44|||
125039749|NCT01845025|449764367|FG000|Overall Study|Lost to Follow-up|13|||
125039750|NCT01845025|449764368|FG001|Overall Study|Lost to Follow-up|13|||
125039751|NCT01845025|449764367|FG000|Overall Study|Administrative problems|8|||
125039752|NCT01845025|449764368|FG001|Overall Study|Administrative problems|8|||
125039753|NCT01845025|449764367|FG000|Overall Study|Death|2|||
125039754|NCT01845025|449764368|FG001|Overall Study|Death|0|||
125039755|NCT01845025|449764367|FG000|Overall Study|Protocol deviation|3|||
125039756|NCT01845025|449764368|FG001|Overall Study|Protocol deviation|6|||
125039757|NCT01845025|449764367|FG000|Overall Study|Missing|1|||
125039758|NCT01845025|449764368|FG001|Overall Study|Missing|1|||
125039759|NCT01324830|449764370|FG000|Overall Study|Progressive Disease|3|||
125039760|NCT01324830|449764371|FG001|Overall Study|Progressive Disease|2|||
125039761|NCT01324830|449764372|FG002|Overall Study|Progressive Disease|3|||
125039762|NCT01324830|449764373|FG003|Overall Study|Progressive Disease|3|||
125039763|NCT01324830|449764374|FG004|Overall Study|Progressive Disease|6|||
125039764|NCT01324830|449764375|FG005|Overall Study|Progressive Disease|6|||
125039765|NCT01324830|449764376|FG006|Overall Study|Progressive Disease|3|||
125039766|NCT01324830|449764377|FG007|Overall Study|Progressive Disease|3|||
125039767|NCT01324830|449764378|FG008|Overall Study|Progressive Disease|3|||
125039768|NCT01324830|449764379|FG009|Overall Study|Progressive Disease|6|||
125039769|NCT01324830|449764380|FG010|Overall Study|Progressive Disease|2|||
125039770|NCT01324830|449764381|FG011|Overall Study|Progressive Disease|1|||
125039771|NCT01324830|449764382|FG012|Overall Study|Progressive Disease|1|||
125039772|NCT01324830|449764383|FG013|Overall Study|Progressive Disease|1|||
125039773|NCT01324830|449764384|FG014|Overall Study|Progressive Disease|1|||
125039774|NCT01324830|449764385|FG015|Overall Study|Progressive Disease|3|||
125039775|NCT01324830|449764386|FG016|Overall Study|Progressive Disease|2|||
125039776|NCT01324830|449764387|FG017|Overall Study|Progressive Disease|3|||
125039777|NCT01324830|449764388|FG018|Overall Study|Progressive Disease|4|||
125039778|NCT01324830|449764370|FG000|Overall Study|Dose limiting toxicity|0|||
125039779|NCT01324830|449764371|FG001|Overall Study|Dose limiting toxicity|0|||
125039780|NCT01324830|449764372|FG002|Overall Study|Dose limiting toxicity|0|||
125039781|NCT01324830|449764373|FG003|Overall Study|Dose limiting toxicity|0|||
125039782|NCT01324830|449764374|FG004|Overall Study|Dose limiting toxicity|1|||
125039783|NCT01324830|449764375|FG005|Overall Study|Dose limiting toxicity|0|||
125039784|NCT01324830|449764376|FG006|Overall Study|Dose limiting toxicity|0|||
125039785|NCT01324830|449764377|FG007|Overall Study|Dose limiting toxicity|0|||
125039786|NCT01324830|449764378|FG008|Overall Study|Dose limiting toxicity|0|||
125039787|NCT01324830|449764379|FG009|Overall Study|Dose limiting toxicity|0|||
125039788|NCT01324830|449764380|FG010|Overall Study|Dose limiting toxicity|0|||
125039789|NCT01324830|449764381|FG011|Overall Study|Dose limiting toxicity|0|||
125039790|NCT01324830|449764382|FG012|Overall Study|Dose limiting toxicity|0|||
125039791|NCT01324830|449764383|FG013|Overall Study|Dose limiting toxicity|0|||
125039792|NCT01324830|449764384|FG014|Overall Study|Dose limiting toxicity|0|||
125039793|NCT01324830|449764385|FG015|Overall Study|Dose limiting toxicity|0|||
125039794|NCT01324830|449764386|FG016|Overall Study|Dose limiting toxicity|1|||
125039795|NCT01324830|449764387|FG017|Overall Study|Dose limiting toxicity|1|||
125039796|NCT01324830|449764388|FG018|Overall Study|Dose limiting toxicity|1|||
125039797|NCT01324830|449764370|FG000|Overall Study|Reason not mentioned above|0|||
125039798|NCT01324830|449764371|FG001|Overall Study|Reason not mentioned above|0|||
125039799|NCT01324830|449764372|FG002|Overall Study|Reason not mentioned above|0|||
125039800|NCT01324830|449764373|FG003|Overall Study|Reason not mentioned above|0|||
125039801|NCT01324830|449764374|FG004|Overall Study|Reason not mentioned above|0|||
125039802|NCT01324830|449764375|FG005|Overall Study|Reason not mentioned above|0|||
125039803|NCT01324830|449764376|FG006|Overall Study|Reason not mentioned above|0|||
125039804|NCT01324830|449764377|FG007|Overall Study|Reason not mentioned above|0|||
125039805|NCT01324830|449764378|FG008|Overall Study|Reason not mentioned above|0|||
125039806|NCT01324830|449764379|FG009|Overall Study|Reason not mentioned above|0|||
125039807|NCT01324830|449764380|FG010|Overall Study|Reason not mentioned above|0|||
125039808|NCT01324830|449764381|FG011|Overall Study|Reason not mentioned above|0|||
125039809|NCT01324830|449764382|FG012|Overall Study|Reason not mentioned above|0|||
125039810|NCT01324830|449764383|FG013|Overall Study|Reason not mentioned above|0|||
125039811|NCT01324830|449764384|FG014|Overall Study|Reason not mentioned above|0|||
125039812|NCT01324830|449764385|FG015|Overall Study|Reason not mentioned above|0|||
125039813|NCT01324830|449764386|FG016|Overall Study|Reason not mentioned above|0|||
125039814|NCT01324830|449764387|FG017|Overall Study|Reason not mentioned above|1|||
125039815|NCT01324830|449764388|FG018|Overall Study|Reason not mentioned above|0|||
125039816|NCT01324830|449764370|FG000|Overall Study|Adverse Event, serious fatal|0|||
125039817|NCT01324830|449764371|FG001|Overall Study|Adverse Event, serious fatal|1|||
125039818|NCT01324830|449764372|FG002|Overall Study|Adverse Event, serious fatal|0|||
125039819|NCT01324830|449764373|FG003|Overall Study|Adverse Event, serious fatal|0|||
125039820|NCT01324830|449764374|FG004|Overall Study|Adverse Event, serious fatal|0|||
125039821|NCT01324830|449764375|FG005|Overall Study|Adverse Event, serious fatal|0|||
125039822|NCT01324830|449764376|FG006|Overall Study|Adverse Event, serious fatal|0|||
125039823|NCT01324830|449764377|FG007|Overall Study|Adverse Event, serious fatal|0|||
125039824|NCT01324830|449764378|FG008|Overall Study|Adverse Event, serious fatal|0|||
125039825|NCT01324830|449764379|FG009|Overall Study|Adverse Event, serious fatal|0|||
125039826|NCT01324830|449764380|FG010|Overall Study|Adverse Event, serious fatal|0|||
125039827|NCT01324830|449764381|FG011|Overall Study|Adverse Event, serious fatal|0|||
125039828|NCT01324830|449764382|FG012|Overall Study|Adverse Event, serious fatal|0|||
125039829|NCT01324830|449764383|FG013|Overall Study|Adverse Event, serious fatal|0|||
125039830|NCT01324830|449764384|FG014|Overall Study|Adverse Event, serious fatal|0|||
125039831|NCT01324830|449764385|FG015|Overall Study|Adverse Event, serious fatal|0|||
125039832|NCT01324830|449764386|FG016|Overall Study|Adverse Event, serious fatal|0|||
125039833|NCT01324830|449764387|FG017|Overall Study|Adverse Event, serious fatal|0|||
125039834|NCT01324830|449764388|FG018|Overall Study|Adverse Event, serious fatal|0|||
125039835|NCT01324830|449764370|FG000|Overall Study|Adverse Event, non-fatal|0|||
125039836|NCT01324830|449764371|FG001|Overall Study|Adverse Event, non-fatal|0|||
125039837|NCT01324830|449764372|FG002|Overall Study|Adverse Event, non-fatal|0|||
125039838|NCT01324830|449764373|FG003|Overall Study|Adverse Event, non-fatal|0|||
125039839|NCT01324830|449764374|FG004|Overall Study|Adverse Event, non-fatal|0|||
125039840|NCT01324830|449764375|FG005|Overall Study|Adverse Event, non-fatal|0|||
125039841|NCT01324830|449764376|FG006|Overall Study|Adverse Event, non-fatal|0|||
125039842|NCT01324830|449764377|FG007|Overall Study|Adverse Event, non-fatal|0|||
125039843|NCT01324830|449764378|FG008|Overall Study|Adverse Event, non-fatal|2|||
125039844|NCT01324830|449764379|FG009|Overall Study|Adverse Event, non-fatal|0|||
125039845|NCT01324830|449764380|FG010|Overall Study|Adverse Event, non-fatal|1|||
125039846|NCT01324830|449764381|FG011|Overall Study|Adverse Event, non-fatal|0|||
125039847|NCT01324830|449764382|FG012|Overall Study|Adverse Event, non-fatal|0|||
125039848|NCT01324830|449764383|FG013|Overall Study|Adverse Event, non-fatal|0|||
125039849|NCT01324830|449764384|FG014|Overall Study|Adverse Event, non-fatal|0|||
125039850|NCT01324830|449764385|FG015|Overall Study|Adverse Event, non-fatal|0|||
125039851|NCT01324830|449764386|FG016|Overall Study|Adverse Event, non-fatal|0|||
125039852|NCT01324830|449764387|FG017|Overall Study|Adverse Event, non-fatal|1|||
125039853|NCT01324830|449764388|FG018|Overall Study|Adverse Event, non-fatal|0|||
125039854|NCT01324830|449764370|FG000|Overall Study|Withdrawal by Subject|0|||
125039855|NCT01324830|449764371|FG001|Overall Study|Withdrawal by Subject|0|||
125039856|NCT01324830|449764372|FG002|Overall Study|Withdrawal by Subject|0|||
125039857|NCT01324830|449764373|FG003|Overall Study|Withdrawal by Subject|0|||
125039858|NCT01324830|449764374|FG004|Overall Study|Withdrawal by Subject|0|||
125039859|NCT01324830|449764375|FG005|Overall Study|Withdrawal by Subject|1|||
125039860|NCT01324830|449764376|FG006|Overall Study|Withdrawal by Subject|0|||
125039861|NCT01324830|449764377|FG007|Overall Study|Withdrawal by Subject|0|||
125039862|NCT01324830|449764378|FG008|Overall Study|Withdrawal by Subject|0|||
125039863|NCT01324830|449764379|FG009|Overall Study|Withdrawal by Subject|0|||
125039864|NCT01324830|449764380|FG010|Overall Study|Withdrawal by Subject|1|||
125039865|NCT01324830|449764381|FG011|Overall Study|Withdrawal by Subject|0|||
125039866|NCT01324830|449764382|FG012|Overall Study|Withdrawal by Subject|0|||
125039867|NCT01324830|449764383|FG013|Overall Study|Withdrawal by Subject|0|||
125039868|NCT01324830|449764384|FG014|Overall Study|Withdrawal by Subject|0|||
125039869|NCT01324830|449764385|FG015|Overall Study|Withdrawal by Subject|0|||
125039870|NCT01324830|449764386|FG016|Overall Study|Withdrawal by Subject|0|||
125039871|NCT01324830|449764387|FG017|Overall Study|Withdrawal by Subject|0|||
125039872|NCT01324830|449764388|FG018|Overall Study|Withdrawal by Subject|1|||
125039873|NCT00942409|449764389|FG000|Overall Study|Lack of Efficacy|1|||
125039874|NCT00942409|449764389|FG000|Overall Study|study drug unavailable|2|||
125039875|NCT00817414|449764392|FG000|Overall Study|Adverse Event|1|||
125039876|NCT00817414|449764393|FG001|Overall Study|Adverse Event|1|||
125039877|NCT00817414|449764394|FG002|Overall Study|Adverse Event|1|||
125039878|NCT00817414|449764395|FG003|Overall Study|Adverse Event|0|||
125039879|NCT00817414|449764396|FG004|Overall Study|Adverse Event|0|||
125039880|NCT00817414|449764392|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
125039881|NCT00817414|449764393|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
125039882|NCT00817414|449764394|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
125039883|NCT00817414|449764395|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
125039884|NCT00817414|449764396|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
125039885|NCT00817414|449764392|FG000|Overall Study|Withdrawal by Subject|1|||
125039886|NCT00817414|449764393|FG001|Overall Study|Withdrawal by Subject|1|||
125039887|NCT00817414|449764394|FG002|Overall Study|Withdrawal by Subject|0|||
125039888|NCT00817414|449764395|FG003|Overall Study|Withdrawal by Subject|0|||
125039889|NCT00817414|449764396|FG004|Overall Study|Withdrawal by Subject|0|||
125039890|NCT00817414|449764392|FG000|Overall Study|Lost to Follow-up|0|||
125039891|NCT00817414|449764393|FG001|Overall Study|Lost to Follow-up|0|||
125039892|NCT00817414|449764394|FG002|Overall Study|Lost to Follow-up|1|||
125039893|NCT00817414|449764395|FG003|Overall Study|Lost to Follow-up|1|||
125039894|NCT00817414|449764396|FG004|Overall Study|Lost to Follow-up|1|||
125039895|NCT00817414|449764392|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
125039896|NCT00817414|449764393|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
125039897|NCT00817414|449764394|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
125039898|NCT00817414|449764395|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
125039899|NCT00817414|449764396|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
125039900|NCT00817414|449764392|FG000|Overall Study|Protocol Violation|0|||
125039901|NCT00817414|449764393|FG001|Overall Study|Protocol Violation|0|||
125039902|NCT00817414|449764394|FG002|Overall Study|Protocol Violation|0|||
125039903|NCT00817414|449764395|FG003|Overall Study|Protocol Violation|0|||
125039904|NCT00817414|449764396|FG004|Overall Study|Protocol Violation|1|||
125039905|NCT02966314|449764397|FG000|Overall Study|Lost to Follow-up|1|||
125039906|NCT02966314|449764398|FG001|Overall Study|Lost to Follow-up|0|||
125039907|NCT00222105|449764399|FG000|Overall Study|Removed due to wrong diagnosis|1|||
125039908|NCT00222105|449764399|FG000|Overall Study|Withdrawal by Subject|1|||
125039909|NCT00222105|449764399|FG000|Overall Study|Adverse Event|8|||
125039910|NCT00222105|449764399|FG000|Overall Study|Treatment delays|2|||
125039911|NCT00222105|449764399|FG000|Overall Study|Death|2|||
125039912|NCT00824421|449764411|FG000|Overall Study|Adverse Event|6|||
125039913|NCT00824421|449764412|FG001|Overall Study|Adverse Event|6|||
125039914|NCT00824421|449764413|FG002|Overall Study|Adverse Event|6|||
125039915|NCT00824421|449764411|FG000|Overall Study|Death|0|||
125039916|NCT00824421|449764412|FG001|Overall Study|Death|1|||
125039917|NCT00824421|449764413|FG002|Overall Study|Death|0|||
125039918|NCT00824421|449764411|FG000|Overall Study|Lack of Efficacy|5|||
125039919|NCT00824421|449764412|FG001|Overall Study|Lack of Efficacy|7|||
125039920|NCT00824421|449764413|FG002|Overall Study|Lack of Efficacy|4|||
125039921|NCT00824421|449764411|FG000|Overall Study|Lost to Follow-up|2|||
125039922|NCT00824421|449764412|FG001|Overall Study|Lost to Follow-up|3|||
125039923|NCT00824421|449764413|FG002|Overall Study|Lost to Follow-up|0|||
125039924|NCT00824421|449764411|FG000|Overall Study|Pregnancy|1|||
125039925|NCT00824421|449764412|FG001|Overall Study|Pregnancy|0|||
125039926|NCT00824421|449764413|FG002|Overall Study|Pregnancy|1|||
125039927|NCT00824421|449764411|FG000|Overall Study|Withdrawal by Subject|2|||
125039928|NCT00824421|449764412|FG001|Overall Study|Withdrawal by Subject|3|||
125039929|NCT00824421|449764413|FG002|Overall Study|Withdrawal by Subject|3|||
125039930|NCT00824421|449764411|FG000|Overall Study|Randomized but not Treated|1|||
125039931|NCT00824421|449764412|FG001|Overall Study|Randomized but not Treated|1|||
125039932|NCT00824421|449764413|FG002|Overall Study|Randomized but not Treated|0|||
125039933|NCT00824421|449764411|FG000|Overall Study|Other|0|||
125039934|NCT00824421|449764412|FG001|Overall Study|Other|1|||
125039935|NCT00824421|449764413|FG002|Overall Study|Other|0|||
125039936|NCT02120417|449764415|FG000|Overall Study|Death|5|||
125039937|NCT02120417|449764416|FG001|Overall Study|Death|1|||
125039938|NCT02120417|449764415|FG000|Overall Study|Adverse Event|3|||
125039939|NCT02120417|449764416|FG001|Overall Study|Adverse Event|9|||
125039940|NCT02120417|449764415|FG000|Overall Study|Participant decision|4|||
125039941|NCT02120417|449764416|FG001|Overall Study|Participant decision|4|||
125039942|NCT02120417|449764415|FG000|Overall Study|Disease progression|41|||
125039943|NCT02120417|449764416|FG001|Overall Study|Disease progression|45|||
125039944|NCT02120417|449764415|FG000|Overall Study|Noncompliance with study treatment|0|||
125039945|NCT02120417|449764416|FG001|Overall Study|Noncompliance with study treatment|2|||
125039946|NCT02120417|449764415|FG000|Overall Study|Physician Decision|2|||
125039947|NCT02120417|449764416|FG001|Overall Study|Physician Decision|3|||
125039948|NCT02120417|449764415|FG000|Overall Study|Other unspecified|5|||
125039949|NCT02120417|449764416|FG001|Overall Study|Other unspecified|4|||
125039950|NCT02604264|449764417|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
125039951|NCT02604264|449764418|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
125039952|NCT00256295|449764421|FG000|Overall Study|Withdrawal by Subject|3|||
125039953|NCT00256295|449764421|FG000|Overall Study|Death|1|||
125039954|NCT01731002|449764431|FG000|Overall Study|Adverse Event|0|||
125039955|NCT01731002|449764432|FG001|Overall Study|Adverse Event|2|||
125039956|NCT01731002|449764433|FG002|Overall Study|Adverse Event|2|||
125039957|NCT01731002|449764431|FG000|Overall Study|Non-Compliant|0|||
125039958|NCT01731002|449764432|FG001|Overall Study|Non-Compliant|1|||
125039959|NCT01731002|449764433|FG002|Overall Study|Non-Compliant|0|||
125039960|NCT01731002|449764431|FG000|Overall Study|Lost to Follow-up|1|||
125039961|NCT01731002|449764432|FG001|Overall Study|Lost to Follow-up|0|||
125134861|NCT01566721|450118258|FG001|Treatment Period|Other|2|||
125134862|NCT01566721|450118257|FG000|Treatment Period|Lack of Compliance|5|||
125134863|NCT01566721|450118258|FG001|Treatment Period|Lack of Compliance|1|||
125134864|NCT01566721|450118257|FG000|Treatment Period|Adverse Event|100|||
125134865|NCT01566721|450118258|FG001|Treatment Period|Adverse Event|30|||
125134866|NCT01566721|450118257|FG000|Treatment Period|Pregnancy|1|||
125134867|NCT01566721|450118258|FG001|Treatment Period|Pregnancy|0|||
125134868|NCT01566721|450118257|FG000|Safety Follow-up|Physician Decision|6|||
125039962|NCT01731002|449764433|FG002|Overall Study|Lost to Follow-up|0|||
125039963|NCT01731002|449764431|FG000|Overall Study|Test Agent Discontinuation|0|||
125039964|NCT01731002|449764432|FG001|Overall Study|Test Agent Discontinuation|1|||
125039965|NCT01731002|449764433|FG002|Overall Study|Test Agent Discontinuation|0|||
125039966|NCT01731002|449764431|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
125039967|NCT01731002|449764432|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
125039968|NCT01731002|449764433|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
125039969|NCT01731002|449764431|FG000|Overall Study|Elevated IOP|1|||
125039970|NCT01731002|449764432|FG001|Overall Study|Elevated IOP|0|||
125039971|NCT01731002|449764433|FG002|Overall Study|Elevated IOP|0|||
125039972|NCT01731002|449764431|FG000|Overall Study|Inappropriate use of study medications|0|||
125039973|NCT01731002|449764432|FG001|Overall Study|Inappropriate use of study medications|0|||
125039974|NCT01731002|449764433|FG002|Overall Study|Inappropriate use of study medications|1|||
125039975|NCT00628355|449764436|FG000|Overall Study|Withdrawal by Subject|1|||
125039976|NCT00628355|449764437|FG001|Overall Study|Withdrawal by Subject|1|||
125039977|NCT03542682|449764438|FG000|Overall Study|COVID-19 Protocol|0|||
125039978|NCT03542682|449764439|FG001|Overall Study|COVID-19 Protocol|1|||
125039979|NCT00853632|449765607|FG000|Overall Study|Death|88|||
125039980|NCT00853632|449765607|FG000|Overall Study|Withdrawal by Subject|45|||
125039981|NCT00853632|449765607|FG000|Overall Study|Lost to Follow-up|30|||
125039982|NCT00853632|449765607|FG000|Overall Study|Reoperation/Explant|17|||
125039983|NCT00853632|449765607|FG000|Overall Study|Exit with other reason|22|||
125039984|NCT01672892|449765608|FG000|Overall Study|Protocol Violation|7|||
125039985|NCT01672892|449765609|FG001|Overall Study|Protocol Violation|3|||
125039986|NCT02559505|449765613|FG000|Overall Study|Lost to Follow-up|23|||
125039987|NCT02559505|449765614|FG001|Overall Study|Lost to Follow-up|20|||
125039988|NCT02559505|449765613|FG000|Overall Study|Withdrawal by Subject|4|||
125039989|NCT02559505|449765614|FG001|Overall Study|Withdrawal by Subject|2|||
125039990|NCT01584024|449765615|FG000|Overall Study|Lost to Follow-up|10|||
125039991|NCT01584024|449765615|FG000|Overall Study|Withdrawal by Subject|3|||
125039992|NCT01217606|449765616|FG000|Initial Treatment Phase|Other Reasons|0|||
125039993|NCT01217606|449765617|FG001|Initial Treatment Phase|Other Reasons|2|||
125039994|NCT01217606|449765616|FG000|Initial Treatment Phase|Protocol Violation|3|||
125134869|NCT01566721|450118258|FG001|Safety Follow-up|Physician Decision|4|||
125134870|NCT01566721|450118257|FG000|Safety Follow-up|Lost to Follow-up|101|||
125134871|NCT01566721|450118258|FG001|Safety Follow-up|Lost to Follow-up|48|||
125134872|NCT01566721|450118257|FG000|Safety Follow-up|Withdrawal by Subject|155|||
125134873|NCT01566721|450118258|FG001|Safety Follow-up|Withdrawal by Subject|49|||
125134874|NCT01566721|450118257|FG000|Safety Follow-up|Death|28|||
125134875|NCT01566721|450118258|FG001|Safety Follow-up|Death|4|||
125039995|NCT01217606|449765617|FG001|Initial Treatment Phase|Protocol Violation|2|||
125039996|NCT01217606|449765616|FG000|Initial Treatment Phase|Personal Reasons|0|||
125039997|NCT01217606|449765617|FG001|Initial Treatment Phase|Personal Reasons|2|||
125039998|NCT01217606|449765616|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
125039999|NCT01217606|449765617|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
125040000|NCT01217606|449765616|FG000|Initial Treatment Phase|Adverse Event|10|||
125040001|NCT01217606|449765617|FG001|Initial Treatment Phase|Adverse Event|6|||
125040002|NCT01217606|449765616|FG000|9-Month Masked Extension|Adverse Event|3|||
125040003|NCT01217606|449765617|FG001|9-Month Masked Extension|Adverse Event|6|||
125040004|NCT01217606|449765616|FG000|9-Month Masked Extension|Other Reasons|4|||
125134876|NCT01566721|450118257|FG000|Safety Follow-up|Non-compliance|7|||
125134877|NCT01566721|450118258|FG001|Safety Follow-up|Non-compliance|3|||
125134878|NCT01566721|450118257|FG000|Safety Follow-up|Protocol Violation|7|||
125218611|NCT04074330|450427387|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
125040005|NCT01217606|449765617|FG001|9-Month Masked Extension|Other Reasons|4|||
125040006|NCT01217606|449765616|FG000|9-Month Masked Extension|Personal Reasons|2|||
125040007|NCT01217606|449765617|FG001|9-Month Masked Extension|Personal Reasons|1|||
125040008|NCT01217606|449765616|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
125040009|NCT01217606|449765617|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
125040010|NCT01217606|449765616|FG000|9-Month Masked Extension|Pregnancy|1|||
125040011|NCT01217606|449765617|FG001|9-Month Masked Extension|Pregnancy|0|||
125040012|NCT01217606|449765616|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
125040013|NCT01217606|449765617|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
125040014|NCT00893789|449765627|FG000|Overall Study|Withdrawal by Subject|3|||
125134879|NCT01566721|450118258|FG001|Safety Follow-up|Protocol Violation|0|||
125134880|NCT01566721|450118257|FG000|Safety Follow-up|Site closure|2|||
125134881|NCT01566721|450118258|FG001|Safety Follow-up|Site closure|3|||
125134882|NCT01566721|450118257|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
125040015|NCT00893789|449765628|FG001|Overall Study|Withdrawal by Subject|1|||
125040016|NCT00893789|449765629|FG002|Overall Study|Withdrawal by Subject|3|||
125040017|NCT00893789|449765630|FG003|Overall Study|Withdrawal by Subject|1|||
125040018|NCT00893789|449765627|FG000|Overall Study|Noncompliance With Study Drug|1|||
125040019|NCT00893789|449765628|FG001|Overall Study|Noncompliance With Study Drug|0|||
125040020|NCT00893789|449765629|FG002|Overall Study|Noncompliance With Study Drug|1|||
125040021|NCT00893789|449765630|FG003|Overall Study|Noncompliance With Study Drug|2|||
125040022|NCT00893789|449765627|FG000|Overall Study|Noncompliance With Study Procedures|1|||
125040023|NCT00893789|449765628|FG001|Overall Study|Noncompliance With Study Procedures|0|||
125040024|NCT00893789|449765629|FG002|Overall Study|Noncompliance With Study Procedures|0|||
125040025|NCT00893789|449765630|FG003|Overall Study|Noncompliance With Study Procedures|0|||
125040026|NCT00893789|449765627|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
125040027|NCT00893789|449765628|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
125040028|NCT00893789|449765629|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
125040029|NCT00893789|449765630|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
125040030|NCT00893789|449765627|FG000|Overall Study|Adverse Event|0|||
125040031|NCT00893789|449765628|FG001|Overall Study|Adverse Event|2|||
125040032|NCT00893789|449765629|FG002|Overall Study|Adverse Event|1|||
125040033|NCT00893789|449765630|FG003|Overall Study|Adverse Event|5|||
125040034|NCT00893789|449765627|FG000|Overall Study|Protocol Violation|0|||
125040035|NCT00893789|449765628|FG001|Overall Study|Protocol Violation|1|||
125040036|NCT00893789|449765629|FG002|Overall Study|Protocol Violation|1|||
125040037|NCT00893789|449765630|FG003|Overall Study|Protocol Violation|4|||
125040038|NCT00893789|449765627|FG000|Overall Study|Lost to Follow-up|0|||
125040039|NCT00893789|449765628|FG001|Overall Study|Lost to Follow-up|0|||
125040040|NCT00893789|449765629|FG002|Overall Study|Lost to Follow-up|0|||
125040041|NCT00893789|449765630|FG003|Overall Study|Lost to Follow-up|1|||
125040042|NCT04723537|449765631|FG000|Overall Study|Withdrawal by Subject|3|||
125040043|NCT04723537|449765632|FG001|Overall Study|Withdrawal by Subject|0|||
125040044|NCT04723537|449765633|FG002|Overall Study|Withdrawal by Subject|0|||
125040045|NCT04723537|449765631|FG000|Overall Study|Physician Decision|0|||
125040046|NCT04723537|449765632|FG001|Overall Study|Physician Decision|0|||
125040047|NCT04723537|449765633|FG002|Overall Study|Physician Decision|1|||
125040048|NCT04723537|449765631|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
125040049|NCT04723537|449765632|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
125040050|NCT04723537|449765633|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
125040051|NCT05408858|449765634|FG000|Overall Study|no longer met eligibility criteria|1|||
125040052|NCT04419506|449765635|FG000|Overall Study|Adverse Event|0|||
125040053|NCT04419506|449765636|FG001|Overall Study|Adverse Event|10|||
125040054|NCT04419506|449765637|FG002|Overall Study|Adverse Event|0|||
125040055|NCT04419506|449765638|FG003|Overall Study|Adverse Event|3|||
125040056|NCT04419506|449765635|FG000|Overall Study|Withdrawal by Subject|0|||
125040057|NCT04419506|449765636|FG001|Overall Study|Withdrawal by Subject|0|||
125040058|NCT04419506|449765637|FG002|Overall Study|Withdrawal by Subject|0|||
125040059|NCT04419506|449765638|FG003|Overall Study|Withdrawal by Subject|1|||
125040060|NCT04419506|449765635|FG000|Overall Study|poor-compliance|0|||
125040061|NCT04419506|449765636|FG001|Overall Study|poor-compliance|0|||
125040062|NCT04419506|449765637|FG002|Overall Study|poor-compliance|0|||
125040063|NCT04419506|449765638|FG003|Overall Study|poor-compliance|1|||
125040064|NCT01973283|449765645|FG000|Overall Study|Lost to Follow-up|4|||
125040065|NCT00097539|449765648|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
125040066|NCT00097539|449765649|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
125040067|NCT00097539|449765650|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
125040068|NCT00097539|449765651|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
125040069|NCT00097539|449765652|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
125040070|NCT00097539|449765653|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
125040071|NCT00097539|449765654|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
125040072|NCT00097539|449765648|FG000|Overall Study|Withdrawal by Subject|925|||
125040073|NCT00097539|449765649|FG001|Overall Study|Withdrawal by Subject|323|||
125040074|NCT00097539|449765650|FG002|Overall Study|Withdrawal by Subject|346|||
125040075|NCT00097539|449765651|FG003|Overall Study|Withdrawal by Subject|217|||
125040076|NCT00097539|449765652|FG004|Overall Study|Withdrawal by Subject|68|||
125040077|NCT00097539|449765653|FG005|Overall Study|Withdrawal by Subject|229|||
125040078|NCT00097539|449765654|FG006|Overall Study|Withdrawal by Subject|3|||
125040079|NCT00097539|449765648|FG000|Overall Study|Participant Non-compliant|2140|||
125040080|NCT00097539|449765649|FG001|Overall Study|Participant Non-compliant|567|||
125040081|NCT00097539|449765650|FG002|Overall Study|Participant Non-compliant|1067|||
125040082|NCT00097539|449765651|FG003|Overall Study|Participant Non-compliant|353|||
125040083|NCT00097539|449765652|FG004|Overall Study|Participant Non-compliant|136|||
125040084|NCT00097539|449765653|FG005|Overall Study|Participant Non-compliant|543|||
125040085|NCT00097539|449765654|FG006|Overall Study|Participant Non-compliant|18|||
125040086|NCT00097539|449765648|FG000|Overall Study|Lack of Efficacy|249|||
125040087|NCT00097539|449765649|FG001|Overall Study|Lack of Efficacy|122|||
125040088|NCT00097539|449765650|FG002|Overall Study|Lack of Efficacy|202|||
125040089|NCT00097539|449765651|FG003|Overall Study|Lack of Efficacy|105|||
125040090|NCT00097539|449765652|FG004|Overall Study|Lack of Efficacy|45|||
125040091|NCT00097539|449765653|FG005|Overall Study|Lack of Efficacy|228|||
125040092|NCT00097539|449765654|FG006|Overall Study|Lack of Efficacy|5|||
125040093|NCT00097539|449765648|FG000|Overall Study|Adverse Event|78|||
125040094|NCT00097539|449765649|FG001|Overall Study|Adverse Event|133|||
125040095|NCT00097539|449765650|FG002|Overall Study|Adverse Event|37|||
125040096|NCT00097539|449765651|FG003|Overall Study|Adverse Event|27|||
125040097|NCT00097539|449765652|FG004|Overall Study|Adverse Event|30|||
125040098|NCT00097539|449765653|FG005|Overall Study|Adverse Event|59|||
125040099|NCT00097539|449765654|FG006|Overall Study|Adverse Event|1|||
125040100|NCT00097539|449765648|FG000|Overall Study|Death|2|||
125040101|NCT00097539|449765649|FG001|Overall Study|Death|7|||
125040102|NCT00097539|449765650|FG002|Overall Study|Death|0|||
125040103|NCT00097539|449765651|FG003|Overall Study|Death|0|||
125040104|NCT00097539|449765652|FG004|Overall Study|Death|1|||
125040105|NCT00097539|449765653|FG005|Overall Study|Death|3|||
125040106|NCT00097539|449765654|FG006|Overall Study|Death|0|||
125040107|NCT00097539|449765648|FG000|Overall Study|Reasons Other Than Above|3602|||
125040108|NCT00097539|449765649|FG001|Overall Study|Reasons Other Than Above|1382|||
125040109|NCT00097539|449765650|FG002|Overall Study|Reasons Other Than Above|1757|||
125040110|NCT00097539|449765651|FG003|Overall Study|Reasons Other Than Above|692|||
125040111|NCT00097539|449765652|FG004|Overall Study|Reasons Other Than Above|361|||
125040112|NCT00097539|449765653|FG005|Overall Study|Reasons Other Than Above|1244|||
125040113|NCT00097539|449765654|FG006|Overall Study|Reasons Other Than Above|34|||
125040114|NCT00097539|449765648|FG000|Overall Study|Reason not Specified|111|||
125040115|NCT00097539|449765649|FG001|Overall Study|Reason not Specified|49|||
125040116|NCT00097539|449765650|FG002|Overall Study|Reason not Specified|53|||
125040117|NCT00097539|449765651|FG003|Overall Study|Reason not Specified|21|||
125040118|NCT00097539|449765652|FG004|Overall Study|Reason not Specified|11|||
125134883|NCT01566721|450118258|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
125040119|NCT00097539|449765653|FG005|Overall Study|Reason not Specified|40|||
125040120|NCT00097539|449765654|FG006|Overall Study|Reason not Specified|2|||
125134884|NCT01566721|450118257|FG000|Safety Follow-up|Missing|7|||
125040121|NCT03941548|449765658|FG000|Overall Study|Adverse Event|0|||
125040122|NCT03941548|449765659|FG001|Overall Study|Adverse Event|1|||
125040123|NCT03941548|449765658|FG000|Overall Study|Lost to Follow-up|0|||
125040124|NCT03941548|449765659|FG001|Overall Study|Lost to Follow-up|1|||
125040125|NCT03941548|449765658|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
125040126|NCT03941548|449765659|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
125040127|NCT03717922|449765662|FG000|Overall Study|Lost to Follow-up|2|||
125040128|NCT03717922|449765663|FG001|Overall Study|Lost to Follow-up|2|||
125040129|NCT01242111|449765664|FG000|Overall Study|Adverse Event|1|||
125040130|NCT01242111|449765664|FG000|Overall Study|Withdrawal by Subject|1|||
125040131|NCT01242111|449765664|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
125134885|NCT01566721|450118258|FG001|Safety Follow-up|Missing|2|||
125040132|NCT01021007|449765667|FG000|Overall Study|Lost to Follow-up|1|||
125040133|NCT01021007|449765668|FG001|Overall Study|Lost to Follow-up|1|||
125040134|NCT01021007|449765667|FG000|Overall Study|Adverse Event|1|||
125040135|NCT01021007|449765668|FG001|Overall Study|Adverse Event|3|||
125040136|NCT02015819|449765669|FG000|Overall Study|Rickham catheter was misaligned|0|||
125040137|NCT02015819|449765670|FG001|Overall Study|Rickham catheter was misaligned|0|||
125040138|NCT02015819|449765671|FG002|Overall Study|Rickham catheter was misaligned|0|||
125040139|NCT02015819|449765672|FG003|Overall Study|Rickham catheter was misaligned|1|||
125040140|NCT02945657|449765673|FG000|Overall Study|Adverse Event|1|||
125040141|NCT02945657|449765673|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
125040142|NCT00087438|449765675|FG000|Overall Study|Ineligible / No protocol treatment|4|||
125040143|NCT00466505|449765676|FG000|Overall Study|disease progression|13|||
125040144|NCT00466505|449765676|FG000|Overall Study|Adverse Event|4|||
125040145|NCT00811252|449765677|FG000|Overall Study|Adverse Event|6|||
125040146|NCT00811252|449765678|FG001|Overall Study|Adverse Event|10|||
125040147|NCT00811252|449765679|FG002|Overall Study|Adverse Event|15|||
125040148|NCT00811252|449765677|FG000|Overall Study|Lack of Efficacy|7|||
125040149|NCT00811252|449765678|FG001|Overall Study|Lack of Efficacy|2|||
125040150|NCT00811252|449765679|FG002|Overall Study|Lack of Efficacy|0|||
125040151|NCT00811252|449765677|FG000|Overall Study|Protocol Violation|3|||
125040152|NCT00811252|449765678|FG001|Overall Study|Protocol Violation|3|||
125040153|NCT00811252|449765679|FG002|Overall Study|Protocol Violation|2|||
125040154|NCT00811252|449765677|FG000|Overall Study|Withdrawal of Consent|1|||
125040155|NCT00811252|449765678|FG001|Overall Study|Withdrawal of Consent|2|||
125040156|NCT00811252|449765679|FG002|Overall Study|Withdrawal of Consent|2|||
125040157|NCT00811252|449765677|FG000|Overall Study|Lost to Follow-up|0|||
125040158|NCT00811252|449765678|FG001|Overall Study|Lost to Follow-up|0|||
125040159|NCT00811252|449765679|FG002|Overall Study|Lost to Follow-up|2|||
125040160|NCT00811252|449765677|FG000|Overall Study|Administrative or Other Reasons|0|||
125040161|NCT00811252|449765678|FG001|Overall Study|Administrative or Other Reasons|3|||
125040162|NCT00811252|449765679|FG002|Overall Study|Administrative or Other Reasons|2|||
125040163|NCT01486264|449765680|FG000|Overall Study|Death|1|||
125040164|NCT01486264|449765681|FG001|Overall Study|Death|1|||
125040165|NCT01486264|449765680|FG000|Overall Study|Adverse Event|3|||
125040166|NCT01486264|449765681|FG001|Overall Study|Adverse Event|3|||
125134886|NCT01566721|450118257|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
125134887|NCT01566721|450118258|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
125134888|NCT01566721|450118257|FG000|Safety Follow-up|Sponsor decision|1|||
125134889|NCT01566721|450118258|FG001|Safety Follow-up|Sponsor decision|0|||
125134890|NCT01566721|450118257|FG000|Safety Follow-up|Adverse Event|8|||
125134891|NCT01566721|450118258|FG001|Safety Follow-up|Adverse Event|4|||
125134892|NCT02911701|450118263|FG000|Overall Study|Withdrawal by Subject|2|||
125134893|NCT02911701|450118264|FG001|Overall Study|Withdrawal by Subject|4|||
125134894|NCT02911701|450118263|FG000|Overall Study|Adverse Event|1|||
125040167|NCT01486264|449765680|FG000|Overall Study|Lack of Efficacy|6|||
125040168|NCT01486264|449765681|FG001|Overall Study|Lack of Efficacy|10|||
125040169|NCT01486264|449765680|FG000|Overall Study|Withdrawal by Subject|7|||
125040170|NCT01486264|449765681|FG001|Overall Study|Withdrawal by Subject|18|||
125040171|NCT01486264|449765680|FG000|Overall Study|Physician Decision|1|||
125040172|NCT01486264|449765681|FG001|Overall Study|Physician Decision|1|||
125040173|NCT01486264|449765680|FG000|Overall Study|Protocol Violation|3|||
125134895|NCT02911701|450118264|FG001|Overall Study|Adverse Event|0|||
125040174|NCT01486264|449765681|FG001|Overall Study|Protocol Violation|0|||
125040175|NCT01486264|449765680|FG000|Overall Study|Lost to Follow-up|3|||
125040176|NCT01486264|449765681|FG001|Overall Study|Lost to Follow-up|2|||
125040177|NCT01486264|449765680|FG000|Overall Study|Other|5|||
125040178|NCT01486264|449765681|FG001|Overall Study|Other|11|||
125040179|NCT01486264|449765680|FG000|Overall Study|Not treated|0|||
125040180|NCT01486264|449765681|FG001|Overall Study|Not treated|1|||
125040181|NCT00813748|449765682|FG000|Skin Test Substudy|Physician Decision|0|||
125040182|NCT00813748|449765683|FG001|Skin Test Substudy|Physician Decision|1|||
125040183|NCT00424398|449765690|FG000|Overall Study|Withdrawal by Subject|2|||
125040184|NCT00424398|449765691|FG001|Overall Study|Withdrawal by Subject|1|||
125040185|NCT00424398|449765692|FG002|Overall Study|Withdrawal by Subject|0|||
125040186|NCT00424398|449765690|FG000|Overall Study|Subject met exclusion criteria|1|||
125040187|NCT00424398|449765691|FG001|Overall Study|Subject met exclusion criteria|0|||
125040188|NCT00424398|449765692|FG002|Overall Study|Subject met exclusion criteria|0|||
125040189|NCT00855439|449765693|FG000|Overall Study|Withdrawal by Subject|2|||
125040190|NCT00855439|449765694|FG001|Overall Study|Withdrawal by Subject|0|||
125040191|NCT00855439|449765693|FG000|Overall Study|Pregnancy|1|||
125040192|NCT00855439|449765694|FG001|Overall Study|Pregnancy|0|||
125040193|NCT00613626|449765696|FG000|Overall Study|Ineligible|0|||
125040194|NCT00613626|449765697|FG001|Overall Study|Ineligible|1|||
125040195|NCT00613626|449765698|FG002|Overall Study|Ineligible|0|||
125040196|NCT03212261|449765699|FG000|Overall Study|Became ineligible d/t tech|2|||
125040197|NCT03212261|449765699|FG000|Overall Study|Tech Trouble- No first study visit|1|||
125040198|NCT03212261|449765699|FG000|Overall Study|Lost to Follow-up|7|||
125040199|NCT03212261|449765699|FG000|Overall Study|Family Emergency|1|||
125040200|NCT03212261|449765699|FG000|Overall Study|Too busy/ No time|5|||
125040201|NCT01076179|449765700|FG000|Overall Study|Withdrawal by Subject|1|||
125040202|NCT05480514|449765701|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
125040203|NCT05480514|449765702|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
125040204|NCT05480514|449765701|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
125040205|NCT05480514|449765702|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
125040206|NCT05480514|449765701|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
125040207|NCT05480514|449765702|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
125040208|NCT05480514|449765701|FG000|Period 1|Covid-19 Related|1|||
125040209|NCT05480514|449765702|FG001|Period 1|Covid-19 Related|0|||
125040210|NCT05480514|449765701|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
125040211|NCT05480514|449765702|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
125040212|NCT02299934|449765705|FG000|Overall Study|Termination of study|13|||
125040213|NCT00457639|449765706|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
125040214|NCT00457639|449765707|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
125040215|NCT00457639|449765706|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
125040216|NCT00457639|449765707|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
125040217|NCT00457639|449765706|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
125040218|NCT00457639|449765707|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
125040219|NCT04885257|449765708|FG000|Overall Study|Withdrawal by Subject|1|||
125040220|NCT04885257|449765709|FG001|Overall Study|Withdrawal by Subject|0|||
125040221|NCT02117687|449765710|FG000|Overall Study|Lost to Follow-up|0|||
125040222|NCT02117687|449765711|FG001|Overall Study|Lost to Follow-up|1|||
125040223|NCT02117687|449765710|FG000|Overall Study|Adverse Event|0|||
125040224|NCT02117687|449765711|FG001|Overall Study|Adverse Event|2|||
125040225|NCT02117687|449765710|FG000|Overall Study|Other Reasons|1|||
125040226|NCT02117687|449765711|FG001|Overall Study|Other Reasons|1|||
125040227|NCT02579603|449767288|FG000|Overall Study|Not treated|1|||
125040228|NCT02579603|449767289|FG001|Overall Study|Not treated|0|||
125040229|NCT02579603|449767288|FG000|Overall Study|Adverse Event|2|||
125040230|NCT02579603|449767289|FG001|Overall Study|Adverse Event|2|||
125040231|NCT02579603|449767288|FG000|Overall Study|Other than stated|1|||
125040232|NCT02579603|449767289|FG001|Overall Study|Other than stated|0|||
125040233|NCT01006356|449767290|FG000|Overall Study|Adverse Event|6|||
125040234|NCT01006356|449767290|FG000|Overall Study|Physician Decision|1|||
125040235|NCT01006356|449767290|FG000|Overall Study|Paticipants did not cooperate|6|||
125040236|NCT01006356|449767290|FG000|Overall Study|Withdrawal by Subject|1|||
125040237|NCT01006356|449767290|FG000|Overall Study|Choice by participants|2|||
125040238|NCT01006356|449767290|FG000|Overall Study|Protocol Violation|3|||
125040239|NCT01006356|449767290|FG000|Overall Study|Other|23|||
125040240|NCT02981472|449767293|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
125040241|NCT02981472|449767294|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
125040242|NCT02981472|449767293|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
125040243|NCT02981472|449767294|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125040244|NCT02981472|449767293|FG000|Treatment Period|Adverse Event|6|||
125040245|NCT02981472|449767294|FG001|Treatment Period|Adverse Event|1|||
125040246|NCT02981472|449767293|FG000|Treatment Period|Participant withdrew consent|1|||
125040247|NCT02981472|449767294|FG001|Treatment Period|Participant withdrew consent|0|||
125040248|NCT02981472|449767293|FG000|Treatment Period|Lost to Follow-up|0|||
125040249|NCT02981472|449767294|FG001|Treatment Period|Lost to Follow-up|1|||
125040250|NCT01756157|449767295|FG000|First Intervention Period|Withdrawal by Subject|1|||
125040251|NCT01756157|449767296|FG001|First Intervention Period|Withdrawal by Subject|0|||
125040252|NCT01756157|449767295|FG000|First Intervention Period|Lost to Follow-up|0|||
125040253|NCT01756157|449767296|FG001|First Intervention Period|Lost to Follow-up|2|||
125040254|NCT04430348|449767301|FG000|Overall Study|Death|3|||
125040255|NCT04430348|449767302|FG001|Overall Study|Death|2|||
125040256|NCT04430348|449767303|FG002|Overall Study|Death|2|||
125040257|NCT04430348|449767304|FG003|Overall Study|Death|2|||
125040258|NCT04430348|449767305|FG004|Overall Study|Death|2|||
125040259|NCT04430348|449767306|FG005|Overall Study|Death|3|||
125040260|NCT04430348|449767301|FG000|Overall Study|Lost to Follow-up|0|||
125040261|NCT04430348|449767302|FG001|Overall Study|Lost to Follow-up|0|||
125040262|NCT04430348|449767303|FG002|Overall Study|Lost to Follow-up|0|||
125040263|NCT04430348|449767304|FG003|Overall Study|Lost to Follow-up|1|||
125040264|NCT04430348|449767305|FG004|Overall Study|Lost to Follow-up|0|||
125040265|NCT04430348|449767306|FG005|Overall Study|Lost to Follow-up|0|||
125040266|NCT04430348|449767301|FG000|Overall Study|Adverse Event|0|||
125040267|NCT04430348|449767302|FG001|Overall Study|Adverse Event|0|||
125040268|NCT04430348|449767303|FG002|Overall Study|Adverse Event|0|||
125040269|NCT04430348|449767304|FG003|Overall Study|Adverse Event|0|||
125040270|NCT04430348|449767305|FG004|Overall Study|Adverse Event|0|||
125040271|NCT04430348|449767306|FG005|Overall Study|Adverse Event|1|||
125040272|NCT04430348|449767301|FG000|Overall Study|Withdrawal by Subject|0|||
125040273|NCT04430348|449767302|FG001|Overall Study|Withdrawal by Subject|1|||
125040274|NCT04430348|449767303|FG002|Overall Study|Withdrawal by Subject|0|||
125040275|NCT04430348|449767304|FG003|Overall Study|Withdrawal by Subject|0|||
125040276|NCT04430348|449767305|FG004|Overall Study|Withdrawal by Subject|0|||
125040277|NCT04430348|449767306|FG005|Overall Study|Withdrawal by Subject|1|||
125040278|NCT04430348|449767301|FG000|Overall Study|Study Terminated by Sponsor|0|||
125040279|NCT04430348|449767302|FG001|Overall Study|Study Terminated by Sponsor|0|||
125040280|NCT04430348|449767303|FG002|Overall Study|Study Terminated by Sponsor|2|||
125040281|NCT04430348|449767304|FG003|Overall Study|Study Terminated by Sponsor|0|||
125040282|NCT04430348|449767305|FG004|Overall Study|Study Terminated by Sponsor|1|||
125040283|NCT04430348|449767306|FG005|Overall Study|Study Terminated by Sponsor|1|||
125040284|NCT03715465|449767307|FG000|Overall Study|Withdrawal by Subject|1|||
125040285|NCT03715465|449767308|FG001|Overall Study|Withdrawal by Subject|2|||
125134896|NCT01237054|450118265|FG000|Overall Study|imaging 10C0096|1|||
125134897|NCT01983969|450118266|FG000|Overall Study|Disease Progression|0|||
125134898|NCT01983969|450118267|FG001|Overall Study|Disease Progression|1|||
125134899|NCT01983969|450118268|FG002|Overall Study|Disease Progression|0|||
125134900|NCT02619682|450118269|FG000|Overall Study|Withdrawal by Subject|3|||
125134901|NCT02619682|450118269|FG000|Overall Study|Lack of Efficacy|8|||
125134902|NCT02619682|450118269|FG000|Overall Study|new secondary cancer|1|||
125134903|NCT02619682|450118269|FG000|Overall Study|post surgery complications|2|||
125134904|NCT00268203|450118272|FG000|Overall Study|Lost to Follow-up|92|||
125134905|NCT00268203|450118272|FG000|Overall Study|Withdrawal by Subject|9|||
125134906|NCT00268203|450118272|FG000|Overall Study|Received Other NHL Therapy|7|||
125040286|NCT04331899|449767316|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
125134907|NCT00268203|450118272|FG000|Overall Study|Progressive Disease|359|||
125134908|NCT00268203|450118272|FG000|Overall Study|Death|84|||
125134909|NCT00268203|450118272|FG000|Overall Study|Reason Not Specified|34|||
125040287|NCT04331899|449767317|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
125134910|NCT00268203|450118272|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
125040288|NCT02424539|449767320|FG000|Overall Study|Adverse Event|0|||
125040289|NCT02424539|449767321|FG001|Overall Study|Adverse Event|0|||
125040290|NCT02424539|449767322|FG002|Overall Study|Adverse Event|1|||
125040291|NCT02424539|449767320|FG000|Overall Study|Physician Decision|0|||
125040292|NCT02424539|449767321|FG001|Overall Study|Physician Decision|0|||
125040293|NCT02424539|449767322|FG002|Overall Study|Physician Decision|1|||
125040294|NCT02424539|449767320|FG000|Overall Study|Withdrawal by Subject|3|||
125040295|NCT02424539|449767321|FG001|Overall Study|Withdrawal by Subject|1|||
125040296|NCT02424539|449767322|FG002|Overall Study|Withdrawal by Subject|0|||
125040297|NCT02424539|449767320|FG000|Overall Study|Other: Reached stopping criteria|11|||
125040298|NCT02424539|449767321|FG001|Overall Study|Other: Reached stopping criteria|7|||
125134911|NCT01841554|450118274|FG000|Overall Study|Death|7|||
125134912|NCT01841554|450118274|FG000|Overall Study|No Implantation|1|||
125134913|NCT01841554|450118274|FG000|Overall Study|Discontinued Follow Up|5|||
125134914|NCT01841554|450118274|FG000|Overall Study|Study exit due to secondary intervention|6|||
125134915|NCT03600376|450118278|FG000|Overall Study|Adverse Event|1|||
125134916|NCT03600376|450118279|FG001|Overall Study|Adverse Event|1|||
125040299|NCT02424539|449767322|FG002|Overall Study|Other: Reached stopping criteria|6|||
125040300|NCT01697215|449767332|FG000|Overall Study|Physician Decision|5|||
125040301|NCT01697215|449767332|FG000|Overall Study|Malfunction|9|||
125040302|NCT01697215|449767332|FG000|Overall Study|CXR not available|9|||
125040303|NCT01829048|449767333|FG000|Overall Study|Withdrawal by Subject|0|||
125040304|NCT01829048|449767334|FG001|Overall Study|Withdrawal by Subject|0|||
125040305|NCT01829048|449767335|FG002|Overall Study|Withdrawal by Subject|0|||
125040306|NCT01829048|449767336|FG003|Overall Study|Withdrawal by Subject|2|||
125040307|NCT01829048|449767337|FG004|Overall Study|Withdrawal by Subject|0|||
125040308|NCT00504257|449767338|FG000|Overall Study|Withdrawal by Subject|2|||
125040309|NCT00504257|449767338|FG000|Overall Study|ineligible histology|2|||
125040310|NCT02317510|449767342|FG000|Overall Study|Adverse Event|0|||
125040311|NCT02317510|449767343|FG001|Overall Study|Adverse Event|1|||
125040312|NCT00728416|449767352|FG000|Overall Study|Adverse Event|1|||
125040313|NCT00728416|449767353|FG001|Overall Study|Adverse Event|1|||
125040314|NCT00728416|449767352|FG000|Overall Study|Treatment Failure|0|||
125040315|NCT00728416|449767353|FG001|Overall Study|Treatment Failure|1|||
125040316|NCT00728416|449767352|FG000|Overall Study|Withdrawal by Subject|1|||
125040317|NCT00728416|449767353|FG001|Overall Study|Withdrawal by Subject|0|||
125040318|NCT01244737|449767361|FG000|Overall Study|Physician Decision|2|||
125040319|NCT01244737|449767362|FG001|Overall Study|Physician Decision|18|||
125040320|NCT01244737|449767363|FG002|Overall Study|Physician Decision|5|||
125040321|NCT01244737|449767361|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
125040322|NCT01244737|449767362|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
125040323|NCT01244737|449767363|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
125040324|NCT01244737|449767361|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
125040325|NCT01244737|449767362|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
125040326|NCT01244737|449767363|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
125040327|NCT01244737|449767361|FG000|Overall Study|MIB immunopathology results not available|3|||
125040328|NCT01244737|449767362|FG001|Overall Study|MIB immunopathology results not available|2|||
125040329|NCT01244737|449767363|FG002|Overall Study|MIB immunopathology results not available|0|||
125040330|NCT01244737|449767361|FG000|Overall Study|PET data failure|0|||
125134917|NCT03600376|450118278|FG000|Overall Study|Transferred to other facility|1|||
125134918|NCT03600376|450118279|FG001|Overall Study|Transferred to other facility|0|||
125134919|NCT03600376|450118278|FG000|Overall Study|Investigator Decision|0|||
125134920|NCT03600376|450118279|FG001|Overall Study|Investigator Decision|4|||
125134921|NCT03600376|450118278|FG000|Overall Study|Determined to be ineligible for study|0|||
125134922|NCT03600376|450118279|FG001|Overall Study|Determined to be ineligible for study|1|||
125134923|NCT03804983|450118280|FG000|Overall Study|Adverse Event|0|||
125040331|NCT01244737|449767362|FG001|Overall Study|PET data failure|1|||
125040332|NCT01244737|449767363|FG002|Overall Study|PET data failure|0|||
125040333|NCT01244737|449767361|FG000|Overall Study|Withdrawal by Subject|0|||
125040334|NCT01244737|449767362|FG001|Overall Study|Withdrawal by Subject|0|||
125040335|NCT01244737|449767363|FG002|Overall Study|Withdrawal by Subject|1|||
125040336|NCT00730236|449767367|FG000|Overall Study|Adverse Event|4|||
125040337|NCT00730236|449767367|FG000|Overall Study|Withdrawal by Subject|1|||
125040338|NCT00730236|449767367|FG000|Overall Study|Non-compliance|1|||
125040339|NCT01772134|449767372|FG000|Overall Study|Adverse Event|6|||
125040340|NCT01772134|449767373|FG001|Overall Study|Adverse Event|5|||
125040341|NCT01772134|449767374|FG002|Overall Study|Adverse Event|10|||
125040342|NCT01772134|449767372|FG000|Overall Study|Withdrew Consent|3|||
125040343|NCT01772134|449767373|FG001|Overall Study|Withdrew Consent|1|||
125040344|NCT01772134|449767374|FG002|Overall Study|Withdrew Consent|5|||
125040345|NCT01772134|449767372|FG000|Overall Study|Lost to Follow-up|2|||
125040346|NCT01772134|449767373|FG001|Overall Study|Lost to Follow-up|0|||
125040347|NCT01772134|449767374|FG002|Overall Study|Lost to Follow-up|0|||
125040348|NCT01772134|449767372|FG000|Overall Study|Protocol Deviation|4|||
125040349|NCT01772134|449767373|FG001|Overall Study|Protocol Deviation|3|||
125040350|NCT01772134|449767374|FG002|Overall Study|Protocol Deviation|3|||
125040351|NCT01772134|449767372|FG000|Overall Study|Lack of Efficacy|11|||
125040352|NCT01772134|449767373|FG001|Overall Study|Lack of Efficacy|5|||
125040353|NCT01772134|449767374|FG002|Overall Study|Lack of Efficacy|3|||
125040354|NCT01772134|449767372|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
125040355|NCT01772134|449767373|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
125040356|NCT01772134|449767374|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
125040357|NCT01772134|449767372|FG000|Overall Study|Randomized Study Medication Not Received|2|||
125040358|NCT01772134|449767373|FG001|Overall Study|Randomized Study Medication Not Received|0|||
125040359|NCT01772134|449767374|FG002|Overall Study|Randomized Study Medication Not Received|1|||
125040360|NCT00594399|449767379|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
125040361|NCT00594399|449767380|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
125040362|NCT00594399|449767381|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
125040363|NCT00594399|449767379|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
125040364|NCT00594399|449767380|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
125040365|NCT00594399|449767381|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
125040366|NCT00594399|449767379|FG000|Initial 3 Month Counseling|Personal issues|2|||
125040367|NCT00594399|449767380|FG001|Initial 3 Month Counseling|Personal issues|0|||
125040368|NCT00594399|449767381|FG002|Initial 3 Month Counseling|Personal issues|0|||
125040369|NCT00594399|449767379|FG000|Initial 3 Month Counseling|Too busy|7|||
125040370|NCT00594399|449767380|FG001|Initial 3 Month Counseling|Too busy|1|||
125040371|NCT00594399|449767381|FG002|Initial 3 Month Counseling|Too busy|0|||
125040372|NCT00594399|449767379|FG000|Initial 3 Month Counseling|Pain|2|||
125040373|NCT00594399|449767380|FG001|Initial 3 Month Counseling|Pain|0|||
125040374|NCT00594399|449767381|FG002|Initial 3 Month Counseling|Pain|0|||
125040375|NCT00594399|449767379|FG000|Initial 3 Month Counseling|Moved|1|||
125040376|NCT00594399|449767380|FG001|Initial 3 Month Counseling|Moved|0|||
125040377|NCT00594399|449767381|FG002|Initial 3 Month Counseling|Moved|0|||
125040378|NCT00594399|449767379|FG000|Initial 3 Month Counseling|Family illness|1|||
125040379|NCT00594399|449767380|FG001|Initial 3 Month Counseling|Family illness|0|||
125134924|NCT03804983|450118281|FG001|Overall Study|Adverse Event|1|||
125134925|NCT03804983|450118280|FG000|Overall Study|Family Obligation|1|||
125134926|NCT03804983|450118281|FG001|Overall Study|Family Obligation|0|||
125134927|NCT02152163|450118282|FG000|Overall Study|Physician Decision|12|||
125134928|NCT02152163|450118283|FG001|Overall Study|Physician Decision|13|||
125134929|NCT00796562|450118287|FG000|Overall Study|Death|49|||
125134930|NCT00424047|450118288|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
125134931|NCT00424047|450118289|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
125134932|NCT00424047|450118288|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
125134933|NCT00424047|450118289|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
125040380|NCT00594399|449767381|FG002|Initial 3 Month Counseling|Family illness|0|||
125040381|NCT00594399|449767379|FG000|Rerandomization Arm 1 Only|Death|2|||
125040382|NCT00594399|449767380|FG001|Rerandomization Arm 1 Only|Death|1|||
125040383|NCT00594399|449767381|FG002|Rerandomization Arm 1 Only|Death|0|||
125040384|NCT00594399|449767379|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
125040385|NCT00594399|449767380|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
125040386|NCT00594399|449767381|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
125040387|NCT03953118|449767382|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
125134934|NCT00424047|450118288|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
125218612|NCT04074330|450427388|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
125218613|NCT04074330|450427389|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
125218614|NCT04074330|450427390|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
125218615|NCT04074330|450427391|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
125134935|NCT00424047|450118289|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
125134936|NCT00424047|450118288|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
125134937|NCT00424047|450118289|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
125134938|NCT00424047|450118288|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
125134939|NCT00424047|450118289|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
125134940|NCT00424047|450118288|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
125134941|NCT00424047|450118289|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
125134942|NCT00424047|450118288|FG000|On Study at Time of Unblinding|Adverse Event|22|||
125134943|NCT00424047|450118289|FG001|On Study at Time of Unblinding|Adverse Event|12|||
125134944|NCT00424047|450118288|FG000|On Study at Time of Unblinding|Progression of disease|92|||
125134945|NCT00424047|450118289|FG001|On Study at Time of Unblinding|Progression of disease|128|||
125134946|NCT00424047|450118288|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
125134947|NCT00424047|450118289|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
125134948|NCT00424047|450118288|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
125134949|NCT00424047|450118289|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
125134950|NCT00424047|450118288|FG000|On Study at Time of Unblinding|Death|11|||
125134951|NCT00424047|450118289|FG001|On Study at Time of Unblinding|Death|11|||
125134952|NCT00424047|450118288|FG000|On Study at Time of Unblinding|Other|5|||
125134953|NCT00424047|450118289|FG001|On Study at Time of Unblinding|Other|4|||
125134954|NCT00424047|450118288|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
125134955|NCT00424047|450118289|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
125134956|NCT00424047|450118288|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
125134957|NCT00424047|450118289|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
125134958|NCT00424047|450118288|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
125134959|NCT00424047|450118289|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
125134960|NCT00424047|450118288|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
125134961|NCT00424047|450118289|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
125134962|NCT00424047|450118288|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
125134963|NCT00424047|450118289|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
125134964|NCT00312897|450118291|FG000|Overall Study|Adverse Event|1|||
125134965|NCT00312897|450118292|FG001|Overall Study|Adverse Event|0|||
125134966|NCT00312897|450118291|FG000|Overall Study|Lost to Follow-up|2|||
125134967|NCT00312897|450118292|FG001|Overall Study|Lost to Follow-up|0|||
125134968|NCT00312897|450118291|FG000|Overall Study|Physician Decision|1|||
125134969|NCT00312897|450118292|FG001|Overall Study|Physician Decision|0|||
125134970|NCT00312897|450118291|FG000|Overall Study|Withdrawal by Subject|1|||
125134971|NCT00312897|450118292|FG001|Overall Study|Withdrawal by Subject|3|||
125134972|NCT00312897|450118291|FG000|Overall Study|Pregnancy|1|||
125134973|NCT00312897|450118292|FG001|Overall Study|Pregnancy|0|||
125134974|NCT00312897|450118291|FG000|Overall Study|discontinued prior to getting treatment|0|||
125218616|NCT04074330|450427392|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
125040388|NCT03953118|449767383|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
125040389|NCT01023789|449767385|FG000|3 - Year Visit|Death|29|||
125040390|NCT01023789|449767385|FG000|3 - Year Visit|Withdrawal of consent|1|||
125040391|NCT01023789|449767385|FG000|3 - Year Visit|Lost to Follow-up|13|||
125040392|NCT02034123|449767387|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125040393|NCT02034123|449767388|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125040394|NCT02034123|449767389|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125040395|NCT02034123|449767390|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125040396|NCT02034123|449767391|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
125040397|NCT02034123|449767392|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125040398|NCT02034123|449767393|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125040399|NCT02034123|449767394|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
125040400|NCT02034123|449767395|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
125040401|NCT02034123|449767396|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125040402|NCT02034123|449767397|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125040403|NCT02034123|449767398|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125040404|NCT02034123|449767399|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125218617|NCT04074330|450427393|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
125218618|NCT04074330|450427394|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
125040405|NCT02034123|449767400|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125040406|NCT02034123|449767401|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125040407|NCT02034123|449767402|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125040408|NCT02034123|449767403|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125040409|NCT02034123|449767404|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125040410|NCT02034123|449767387|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125040411|NCT02034123|449767388|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125040412|NCT02034123|449767389|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125040413|NCT02034123|449767390|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
125040414|NCT02034123|449767391|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125040415|NCT02034123|449767392|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125040416|NCT02034123|449767393|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125040417|NCT02034123|449767394|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125040418|NCT02034123|449767395|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125040419|NCT02034123|449767396|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125040420|NCT02034123|449767397|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125040421|NCT02034123|449767398|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125040422|NCT02034123|449767399|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125040423|NCT02034123|449767400|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125040424|NCT02034123|449767401|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125040425|NCT02034123|449767402|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125040426|NCT02034123|449767403|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125040427|NCT02034123|449767404|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125040428|NCT02034123|449767387|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125040429|NCT02034123|449767388|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125040430|NCT02034123|449767389|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125040431|NCT02034123|449767390|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125040432|NCT02034123|449767391|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125040433|NCT02034123|449767392|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125040434|NCT02034123|449767393|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125134975|NCT00312897|450118292|FG001|Overall Study|discontinued prior to getting treatment|3|||
125134976|NCT04633564|450118293|FG000|Period 1|Adverse Event|28|||
125134977|NCT04633564|450118294|FG001|Period 1|Adverse Event|19|||
125134978|NCT04633564|450118293|FG000|Period 1|Death|8|||
125134979|NCT04633564|450118294|FG001|Period 1|Death|7|||
125134980|NCT04633564|450118293|FG000|Period 1|Lost to Follow-up|3|||
125134981|NCT04633564|450118294|FG001|Period 1|Lost to Follow-up|5|||
125134982|NCT04633564|450118293|FG000|Period 1|Physician Decision|4|||
125134983|NCT04633564|450118294|FG001|Period 1|Physician Decision|12|||
125134984|NCT04633564|450118293|FG000|Period 1|Protocol Violation|0|||
125134985|NCT04633564|450118294|FG001|Period 1|Protocol Violation|1|||
125134986|NCT04633564|450118293|FG000|Period 1|Withdrawal by Subject|10|||
125134987|NCT04633564|450118294|FG001|Period 1|Withdrawal by Subject|8|||
125134988|NCT04633564|450118293|FG000|Period 1|Progressive disease|47|||
125134989|NCT04633564|450118294|FG001|Period 1|Progressive disease|51|||
125134990|NCT04633564|450118293|FG000|Period 1|Terminated by Sponsor|8|||
125134991|NCT04633564|450118294|FG001|Period 1|Terminated by Sponsor|6|||
125134992|NCT04633564|450118293|FG000|Period 2|Adverse Event|3|||
125134993|NCT04633564|450118294|FG001|Period 2|Adverse Event|4|||
125134994|NCT04633564|450118293|FG000|Period 2|Death|0|||
125134995|NCT04633564|450118294|FG001|Period 2|Death|2|||
125134996|NCT04633564|450118293|FG000|Period 2|Lost to Follow-up|0|||
125134997|NCT04633564|450118294|FG001|Period 2|Lost to Follow-up|1|||
125134998|NCT04633564|450118293|FG000|Period 2|Physician Decision|2|||
125134999|NCT04633564|450118294|FG001|Period 2|Physician Decision|4|||
125135000|NCT04633564|450118293|FG000|Period 2|Withdrawal by Subject|5|||
125135001|NCT04633564|450118294|FG001|Period 2|Withdrawal by Subject|1|||
125135002|NCT04633564|450118293|FG000|Period 2|Progressive Disease|74|||
125135003|NCT04633564|450118294|FG001|Period 2|Progressive Disease|82|||
125135004|NCT04633564|450118293|FG000|Period 2|Terminated by Sponsor|9|||
125135005|NCT04633564|450118294|FG001|Period 2|Terminated by Sponsor|3|||
125135006|NCT01010503|450118295|FG000|Overall Study|Adverse Event|1|||
125135007|NCT01010503|450118295|FG000|Overall Study|Death|1|||
125135008|NCT01097577|450118296|FG000|Overall Study|Adverse Event|0|||
125135009|NCT01097577|450118297|FG001|Overall Study|Adverse Event|1|||
125135010|NCT04493684|450118300|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
125218619|NCT04074330|450427395|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
125135011|NCT04493684|450118301|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135012|NCT04493684|450118302|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
125135013|NCT04493684|450118303|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125040435|NCT02034123|449767394|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125040436|NCT02034123|449767395|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
125040437|NCT02034123|449767396|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125040438|NCT02034123|449767397|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125040439|NCT02034123|449767398|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125040440|NCT02034123|449767399|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125040441|NCT02034123|449767400|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125040442|NCT02034123|449767401|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125040443|NCT02034123|449767402|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125040444|NCT02034123|449767403|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125040445|NCT02034123|449767404|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125040446|NCT02034123|449767387|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125040447|NCT02034123|449767388|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125040448|NCT02034123|449767389|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125040449|NCT02034123|449767390|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
125040450|NCT02034123|449767391|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
125040451|NCT02034123|449767392|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125040452|NCT02034123|449767393|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125040453|NCT02034123|449767394|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125040454|NCT02034123|449767395|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125040455|NCT02034123|449767396|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125040456|NCT02034123|449767397|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125040457|NCT02034123|449767398|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125040458|NCT02034123|449767399|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125040459|NCT02034123|449767400|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125040460|NCT02034123|449767401|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125040461|NCT02034123|449767402|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125040462|NCT02034123|449767403|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125040463|NCT02034123|449767404|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125040464|NCT02698189|449767405|FG000|Overall Study|Physician Decision|3|||
125040465|NCT02698189|449767406|FG001|Overall Study|Physician Decision|0|||
125040466|NCT02698189|449767405|FG000|Overall Study|Progressive disease|0|||
125040467|NCT02698189|449767406|FG001|Overall Study|Progressive disease|5|||
125040468|NCT02698189|449767405|FG000|Overall Study|Study terminated by sponsor|0|||
125040469|NCT02698189|449767406|FG001|Overall Study|Study terminated by sponsor|1|||
125135014|NCT04493684|450118304|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135015|NCT04493684|450118305|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
125135016|NCT04493684|450118306|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135017|NCT04493684|450118307|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135018|NCT04493684|450118308|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135019|NCT04493684|450118309|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135020|NCT04493684|450118310|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135021|NCT04493684|450118311|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135022|NCT04493684|450118312|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135023|NCT04493684|450118313|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135024|NCT04493684|450118314|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135025|NCT04493684|450118315|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135026|NCT04493684|450118316|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135027|NCT04493684|450118300|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
125135028|NCT04493684|450118301|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135029|NCT04493684|450118302|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135030|NCT04493684|450118303|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135031|NCT04493684|450118304|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135032|NCT04493684|450118305|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135033|NCT04493684|450118306|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135034|NCT04493684|450118307|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135035|NCT04493684|450118308|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135036|NCT04493684|450118309|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135037|NCT04493684|450118310|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135038|NCT04493684|450118311|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135039|NCT04493684|450118312|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135040|NCT04493684|450118313|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125040470|NCT02240706|449767409|FG000|Overall Study|Lack of Efficacy|2|||
125040471|NCT02240706|449767410|FG001|Overall Study|Lack of Efficacy|2|||
125040472|NCT02240706|449767411|FG002|Overall Study|Lack of Efficacy|2|||
125040473|NCT02240706|449767412|FG003|Overall Study|Lack of Efficacy|2|||
125040474|NCT02240706|449767413|FG004|Overall Study|Lack of Efficacy|5|||
125040475|NCT02240706|449767414|FG005|Overall Study|Lack of Efficacy|0|||
125040476|NCT02240706|449767415|FG006|Overall Study|Lack of Efficacy|0|||
125040477|NCT02240706|449767409|FG000|Overall Study|Adverse Event|1|||
125040478|NCT02240706|449767410|FG001|Overall Study|Adverse Event|0|||
125040479|NCT02240706|449767411|FG002|Overall Study|Adverse Event|1|||
125040480|NCT02240706|449767412|FG003|Overall Study|Adverse Event|0|||
125040481|NCT02240706|449767413|FG004|Overall Study|Adverse Event|2|||
125040482|NCT02240706|449767414|FG005|Overall Study|Adverse Event|0|||
125040483|NCT02240706|449767415|FG006|Overall Study|Adverse Event|0|||
125040484|NCT02240706|449767409|FG000|Overall Study|Progressive disease|0|||
125040485|NCT02240706|449767410|FG001|Overall Study|Progressive disease|0|||
125040486|NCT02240706|449767411|FG002|Overall Study|Progressive disease|0|||
125040487|NCT02240706|449767412|FG003|Overall Study|Progressive disease|0|||
125040488|NCT02240706|449767413|FG004|Overall Study|Progressive disease|1|||
125040489|NCT02240706|449767414|FG005|Overall Study|Progressive disease|0|||
125040490|NCT02240706|449767415|FG006|Overall Study|Progressive disease|0|||
125040491|NCT02240706|449767409|FG000|Overall Study|Dose limiting toxicity|0|||
125040492|NCT02240706|449767410|FG001|Overall Study|Dose limiting toxicity|0|||
125040493|NCT02240706|449767411|FG002|Overall Study|Dose limiting toxicity|0|||
125040494|NCT02240706|449767412|FG003|Overall Study|Dose limiting toxicity|0|||
125040495|NCT02240706|449767413|FG004|Overall Study|Dose limiting toxicity|1|||
125040496|NCT02240706|449767414|FG005|Overall Study|Dose limiting toxicity|0|||
125040497|NCT02240706|449767415|FG006|Overall Study|Dose limiting toxicity|0|||
125040498|NCT02240706|449767409|FG000|Overall Study|Refused to continue taking medication|0|||
125040499|NCT02240706|449767410|FG001|Overall Study|Refused to continue taking medication|1|||
125040500|NCT02240706|449767411|FG002|Overall Study|Refused to continue taking medication|3|||
125040501|NCT02240706|449767412|FG003|Overall Study|Refused to continue taking medication|1|||
125040502|NCT02240706|449767413|FG004|Overall Study|Refused to continue taking medication|2|||
125040503|NCT02240706|449767414|FG005|Overall Study|Refused to continue taking medication|0|||
125040504|NCT02240706|449767415|FG006|Overall Study|Refused to continue taking medication|0|||
125040505|NCT02240706|449767409|FG000|Overall Study|Insurance billing concerns|0|||
125040506|NCT02240706|449767410|FG001|Overall Study|Insurance billing concerns|0|||
125040507|NCT02240706|449767411|FG002|Overall Study|Insurance billing concerns|0|||
125040508|NCT02240706|449767412|FG003|Overall Study|Insurance billing concerns|1|||
125040509|NCT02240706|449767413|FG004|Overall Study|Insurance billing concerns|0|||
125040510|NCT02240706|449767414|FG005|Overall Study|Insurance billing concerns|0|||
125040511|NCT02240706|449767415|FG006|Overall Study|Insurance billing concerns|0|||
125040512|NCT03301857|449767416|FG000|Overall Study|Death|0|||
125040513|NCT03301857|449767417|FG001|Overall Study|Death|2|||
125040514|NCT03301857|449767416|FG000|Overall Study|Lost to Follow-up|4|||
125040515|NCT03301857|449767417|FG001|Overall Study|Lost to Follow-up|2|||
125040516|NCT03301857|449767416|FG000|Overall Study|Decision by Sponsor|6|||
125040517|NCT03301857|449767417|FG001|Overall Study|Decision by Sponsor|0|||
125040518|NCT03301857|449767416|FG000|Overall Study|Withdrawal by Subject|12|||
125040519|NCT03301857|449767417|FG001|Overall Study|Withdrawal by Subject|4|||
125040520|NCT00816036|449767418|FG000|Overall Study|Death|47|||
125040521|NCT00816036|449767419|FG001|Overall Study|Death|28|||
125135041|NCT04493684|450118314|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135042|NCT04493684|450118315|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135043|NCT04493684|450118316|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135044|NCT04493684|450118300|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135045|NCT04493684|450118301|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135046|NCT04493684|450118302|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135047|NCT04493684|450118303|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125040522|NCT00816036|449767418|FG000|Overall Study|Lost to Follow-up|75|||
125135048|NCT04493684|450118304|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135049|NCT04493684|450118305|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135050|NCT04493684|450118306|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
125135051|NCT04493684|450118307|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135052|NCT04493684|450118308|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125040523|NCT00816036|449767419|FG001|Overall Study|Lost to Follow-up|57|||
125040524|NCT00816036|449767418|FG000|Overall Study|Withdrawal by Subject|54|||
125040525|NCT00816036|449767419|FG001|Overall Study|Withdrawal by Subject|23|||
125040526|NCT00986349|449767420|FG000|Overall Study|Unsuccessful implant procedure|3|||
125040527|NCT00986349|449767420|FG000|Overall Study|Adverse Event|2|||
125040528|NCT00986349|449767420|FG000|Overall Study|Physician Decision|1|||
125040529|NCT00986349|449767420|FG000|Overall Study|device migration|1|||
125040530|NCT02722044|449767421|FG000|Overall Study|Adverse Event|2|||
125040531|NCT02722044|449767421|FG000|Overall Study|Physician Decision|1|||
125040532|NCT02722044|449767421|FG000|Overall Study|Withdrawal by Subject|1|||
125040533|NCT02722044|449767421|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
125040534|NCT01901328|449767427|FG000|Overall Study|Lost to Follow-up|1|||
125040535|NCT01901328|449767428|FG001|Overall Study|Lost to Follow-up|0|||
125040536|NCT01901328|449767427|FG000|Overall Study|Physician Decision|0|||
125040537|NCT01901328|449767428|FG001|Overall Study|Physician Decision|1|||
125040538|NCT01901328|449767427|FG000|Overall Study|Protocol Violation|1|||
125040539|NCT01901328|449767428|FG001|Overall Study|Protocol Violation|1|||
125040540|NCT01901328|449767427|FG000|Overall Study|Study Terminated by Sponsor|19|||
125040541|NCT01901328|449767428|FG001|Overall Study|Study Terminated by Sponsor|16|||
125040542|NCT01901328|449767427|FG000|Overall Study|Withdrawal by Subject|1|||
125040543|NCT01901328|449767428|FG001|Overall Study|Withdrawal by Subject|2|||
125040544|NCT01901328|449767427|FG000|Overall Study|Lack of Efficacy|0|||
125040545|NCT01901328|449767428|FG001|Overall Study|Lack of Efficacy|1|||
125040546|NCT03232073|449767429|FG000|Overall Study|Death|1|||
125040547|NCT03232073|449767430|FG001|Overall Study|Death|0|||
125040548|NCT03232073|449767429|FG000|Overall Study|Adverse Event|7|||
125040549|NCT03232073|449767430|FG001|Overall Study|Adverse Event|12|||
125040550|NCT03232073|449767429|FG000|Overall Study|Lost to Follow-up|6|||
125040551|NCT03232073|449767430|FG001|Overall Study|Lost to Follow-up|6|||
125040552|NCT03232073|449767429|FG000|Overall Study|Lack of Efficacy|10|||
125040553|NCT03232073|449767430|FG001|Overall Study|Lack of Efficacy|8|||
125040554|NCT03232073|449767429|FG000|Overall Study|Physician Decision|9|||
125040555|NCT03232073|449767430|FG001|Overall Study|Physician Decision|2|||
125040556|NCT03232073|449767429|FG000|Overall Study|Withdrawal by Subject|54|||
125040557|NCT03232073|449767430|FG001|Overall Study|Withdrawal by Subject|39|||
125040558|NCT03528681|449769389|FG000|Open-Label Phase|Physician Decision|2|||
125040559|NCT03528681|449769390|FG001|Open-Label Phase|Physician Decision|0|||
125040560|NCT03528681|449769391|FG002|Open-Label Phase|Physician Decision|0|||
125040561|NCT03528681|449769392|FG003|Open-Label Phase|Physician Decision|0|||
125040562|NCT03528681|449769389|FG000|Open-Label Phase|Withdrawal by Subject|8|||
125040563|NCT03528681|449769390|FG001|Open-Label Phase|Withdrawal by Subject|0|||
125040564|NCT03528681|449769391|FG002|Open-Label Phase|Withdrawal by Subject|0|||
125040565|NCT03528681|449769392|FG003|Open-Label Phase|Withdrawal by Subject|0|||
125040566|NCT03528681|449769389|FG000|Open-Label Phase|(Not collected)|4|||
125040567|NCT03528681|449769390|FG001|Open-Label Phase|(Not collected)|0|||
125040568|NCT03528681|449769391|FG002|Open-Label Phase|(Not collected)|0|||
125040569|NCT03528681|449769392|FG003|Open-Label Phase|(Not collected)|0|||
125040570|NCT03528681|449769389|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
125040571|NCT03528681|449769390|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
125040572|NCT03528681|449769391|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
125040573|NCT03528681|449769392|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
125040574|NCT03528681|449769389|FG000|Randomized Treatment Phase|Physician Decision|0|||
125040575|NCT03528681|449769390|FG001|Randomized Treatment Phase|Physician Decision|5|||
125040576|NCT03528681|449769391|FG002|Randomized Treatment Phase|Physician Decision|1|||
125040577|NCT03528681|449769392|FG003|Randomized Treatment Phase|Physician Decision|2|||
125040578|NCT03528681|449769389|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
125040579|NCT03528681|449769390|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
125040580|NCT03528681|449769391|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
125040581|NCT03528681|449769392|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
125040582|NCT03528681|449769389|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
125040583|NCT03528681|449769390|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
125040584|NCT03528681|449769391|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
125040585|NCT03528681|449769392|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
125040586|NCT03528681|449769389|FG000|Randomized Treatment Phase|(Not collected)|0|||
125040587|NCT03528681|449769390|FG001|Randomized Treatment Phase|(Not collected)|4|||
125040588|NCT03528681|449769391|FG002|Randomized Treatment Phase|(Not collected)|6|||
125040589|NCT03528681|449769392|FG003|Randomized Treatment Phase|(Not collected)|5|||
125040590|NCT00955110|449769393|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
125040591|NCT00955110|449769393|FG000|Treatment Phase|Adverse Event|2|||
125040592|NCT00955110|449769393|FG000|Treatment Phase|Administrative reasons|2|||
125135053|NCT04493684|450118309|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135054|NCT04493684|450118310|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135055|NCT04493684|450118311|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125040593|NCT00955110|449769393|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
125040594|NCT00955110|449769393|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
125040595|NCT00621023|449769399|FG000|Overall Study|Death|5|||
125040596|NCT00621023|449769399|FG000|Overall Study|Follow up discontinued|1|||
125040597|NCT04893265|449769408|FG000|Overall Study|Withdrawal by Subject|2|||
125040598|NCT04893265|449769409|FG001|Overall Study|Withdrawal by Subject|5|||
125040599|NCT04893265|449769408|FG000|Overall Study|Lost to Follow-up|0|||
125040600|NCT04893265|449769409|FG001|Overall Study|Lost to Follow-up|4|||
125135056|NCT04493684|450118312|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125218620|NCT04074330|450427386|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
125218621|NCT04074330|450427387|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
125218622|NCT04074330|450427388|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
125218623|NCT04074330|450427389|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
125218624|NCT04074330|450427390|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
125218625|NCT04074330|450427391|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
125218626|NCT04074330|450427392|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
125218627|NCT04074330|450427393|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
125218628|NCT04074330|450427394|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
125218629|NCT04074330|450427395|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
125218630|NCT04074330|450427386|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
125218631|NCT04074330|450427387|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
125218632|NCT04074330|450427388|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
125218633|NCT04074330|450427389|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
125218634|NCT04074330|450427390|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
125218635|NCT04074330|450427391|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
125218636|NCT04074330|450427392|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
125218637|NCT04074330|450427393|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
125218638|NCT04074330|450427394|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
125218639|NCT04074330|450427395|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
125218640|NCT04074330|450427386|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
125218641|NCT04074330|450427387|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
125218642|NCT04074330|450427388|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
125218643|NCT04074330|450427389|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
125218644|NCT04074330|450427390|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
125218645|NCT04074330|450427391|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
125218646|NCT04074330|450427392|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
125218647|NCT04074330|450427393|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
125218648|NCT04074330|450427394|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
125218649|NCT04074330|450427395|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
125218650|NCT04074330|450427386|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
125218651|NCT04074330|450427387|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
125218652|NCT04074330|450427388|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
125218653|NCT04074330|450427389|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
125218654|NCT04074330|450427390|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
125218655|NCT04074330|450427391|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
125218656|NCT04074330|450427392|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
125218657|NCT04074330|450427393|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
125218658|NCT04074330|450427394|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
125218659|NCT04074330|450427395|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
125218660|NCT04074330|450427386|FG000|Dose Expansion (up to 42 Months)|Death|0|||
125218661|NCT04074330|450427387|FG001|Dose Expansion (up to 42 Months)|Death|0|||
125218662|NCT04074330|450427388|FG002|Dose Expansion (up to 42 Months)|Death|0|||
125218663|NCT04074330|450427389|FG003|Dose Expansion (up to 42 Months)|Death|0|||
125218664|NCT04074330|450427390|FG004|Dose Expansion (up to 42 Months)|Death|0|||
125218665|NCT04074330|450427391|FG005|Dose Expansion (up to 42 Months)|Death|0|||
125218666|NCT04074330|450427392|FG006|Dose Expansion (up to 42 Months)|Death|0|||
125218667|NCT04074330|450427393|FG007|Dose Expansion (up to 42 Months)|Death|0|||
125218668|NCT04074330|450427394|FG008|Dose Expansion (up to 42 Months)|Death|1|||
125218669|NCT04074330|450427395|FG009|Dose Expansion (up to 42 Months)|Death|0|||
125218670|NCT04074330|450427386|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
125218671|NCT04074330|450427387|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
125218672|NCT04074330|450427388|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
125218673|NCT04074330|450427389|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
125218674|NCT04074330|450427390|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
125218675|NCT04074330|450427391|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
125218676|NCT04074330|450427392|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
125218677|NCT04074330|450427393|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
125218678|NCT04074330|450427394|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
125218679|NCT04074330|450427395|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
125218680|NCT01903993|450427396|FG000|Overall Study|Death|118|||
125218681|NCT01903993|450427397|FG001|Overall Study|Death|121|||
125218682|NCT01903993|450427396|FG000|Overall Study|Withdrawal by Subject|15|||
125218683|NCT01903993|450427397|FG001|Overall Study|Withdrawal by Subject|4|||
124975533|NCT01646177|449536590|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
125040601|NCT00573131|449769410|FG000|Overall Study|Withdrawal by Subject|10|||
125040602|NCT00573131|449769411|FG001|Overall Study|Withdrawal by Subject|8|||
125040603|NCT02024464|449769413|FG000|Overall Study|Discontinued|5|||
125040604|NCT02024464|449769414|FG001|Overall Study|Discontinued|4|||
125040605|NCT02024464|449769413|FG000|Overall Study|Missed Visits|1|||
125040606|NCT02024464|449769414|FG001|Overall Study|Missed Visits|0|||
125040607|NCT02024464|449769413|FG000|Overall Study|Lost to Follow-up|4|||
125040608|NCT02024464|449769414|FG001|Overall Study|Lost to Follow-up|7|||
125040609|NCT02158533|449769418|FG000|Stage 1|Adverse Event|6|||
125040610|NCT02158533|449769419|FG001|Stage 1|Adverse Event|4|||
124975534|NCT01646177|449536591|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
124975535|NCT01646177|449536592|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
124975536|NCT01646177|449536593|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
124975537|NCT01646177|449536594|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
124975538|NCT01646177|449536595|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
124975539|NCT01646177|449536596|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
124975540|NCT01646177|449536597|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
124975541|NCT01646177|449536598|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
124975542|NCT01646177|449536599|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
124975543|NCT01646177|449536600|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
124975544|NCT01646177|449536589|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
124975545|NCT01646177|449536590|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
124975546|NCT01646177|449536591|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
124975547|NCT01646177|449536592|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
124975548|NCT01646177|449536593|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
124975549|NCT01646177|449536594|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
125040611|NCT02158533|449769420|FG002|Stage 1|Adverse Event|7|||
125040612|NCT02158533|449769421|FG003|Stage 1|Adverse Event|0|||
125040613|NCT02158533|449769422|FG004|Stage 1|Adverse Event|0|||
125040614|NCT02158533|449769423|FG005|Stage 1|Adverse Event|0|||
125040615|NCT02158533|449769418|FG000|Stage 1|Withdrawal by Subject|3|||
125040616|NCT02158533|449769419|FG001|Stage 1|Withdrawal by Subject|2|||
125040617|NCT02158533|449769420|FG002|Stage 1|Withdrawal by Subject|1|||
125040618|NCT02158533|449769421|FG003|Stage 1|Withdrawal by Subject|0|||
125040619|NCT02158533|449769422|FG004|Stage 1|Withdrawal by Subject|0|||
125040620|NCT02158533|449769423|FG005|Stage 1|Withdrawal by Subject|0|||
125040621|NCT02158533|449769418|FG000|Stage 1|Lack of Efficacy|1|||
125040622|NCT02158533|449769419|FG001|Stage 1|Lack of Efficacy|0|||
125040623|NCT02158533|449769420|FG002|Stage 1|Lack of Efficacy|0|||
125040624|NCT02158533|449769421|FG003|Stage 1|Lack of Efficacy|0|||
125040625|NCT02158533|449769422|FG004|Stage 1|Lack of Efficacy|0|||
125040626|NCT02158533|449769423|FG005|Stage 1|Lack of Efficacy|0|||
125040627|NCT02158533|449769418|FG000|Stage 1|Lost to Follow-up|3|||
125040628|NCT02158533|449769419|FG001|Stage 1|Lost to Follow-up|1|||
125040629|NCT02158533|449769420|FG002|Stage 1|Lost to Follow-up|0|||
125040630|NCT02158533|449769421|FG003|Stage 1|Lost to Follow-up|0|||
125040631|NCT02158533|449769422|FG004|Stage 1|Lost to Follow-up|0|||
125040632|NCT02158533|449769423|FG005|Stage 1|Lost to Follow-up|0|||
125040633|NCT02158533|449769418|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
125040634|NCT02158533|449769419|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
124975550|NCT01646177|449536595|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
124975551|NCT01646177|449536596|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
124975552|NCT01646177|449536597|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
124975553|NCT01646177|449536598|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
124975554|NCT01646177|449536599|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
125040635|NCT02158533|449769420|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
125040636|NCT02158533|449769421|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
125040637|NCT02158533|449769422|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
125040638|NCT02158533|449769423|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
125040639|NCT02158533|449769418|FG000|Stage 1|Non-compliance with study visits|1|||
125040640|NCT02158533|449769419|FG001|Stage 1|Non-compliance with study visits|0|||
125040641|NCT02158533|449769420|FG002|Stage 1|Non-compliance with study visits|0|||
125040642|NCT02158533|449769421|FG003|Stage 1|Non-compliance with study visits|0|||
125040643|NCT02158533|449769422|FG004|Stage 1|Non-compliance with study visits|0|||
125040644|NCT02158533|449769423|FG005|Stage 1|Non-compliance with study visits|0|||
125040645|NCT02158533|449769418|FG000|Stage 2|Adverse Event|0|||
125135057|NCT04493684|450118313|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135058|NCT04493684|450118314|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135059|NCT04493684|450118315|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135060|NCT04493684|450118316|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135061|NCT04493684|450118300|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
125135062|NCT04493684|450118301|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135063|NCT04493684|450118302|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135064|NCT04493684|450118303|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135065|NCT04493684|450118304|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135066|NCT04493684|450118305|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135067|NCT04493684|450118306|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135068|NCT04493684|450118307|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135069|NCT04493684|450118308|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135070|NCT04493684|450118309|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135071|NCT04493684|450118310|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135072|NCT04493684|450118311|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135073|NCT04493684|450118312|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135074|NCT04493684|450118313|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135075|NCT04493684|450118314|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135076|NCT04493684|450118315|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135077|NCT04493684|450118316|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135078|NCT04493684|450118300|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125040646|NCT02158533|449769419|FG001|Stage 2|Adverse Event|0|||
125040647|NCT02158533|449769420|FG002|Stage 2|Adverse Event|0|||
125040648|NCT02158533|449769421|FG003|Stage 2|Adverse Event|0|||
125040649|NCT02158533|449769422|FG004|Stage 2|Adverse Event|0|||
125040650|NCT02158533|449769423|FG005|Stage 2|Adverse Event|1|||
125040651|NCT02158533|449769418|FG000|Stage 2|Lack of Efficacy|0|||
125040652|NCT02158533|449769419|FG001|Stage 2|Lack of Efficacy|0|||
125040653|NCT02158533|449769420|FG002|Stage 2|Lack of Efficacy|0|||
125040654|NCT02158533|449769421|FG003|Stage 2|Lack of Efficacy|0|||
125040655|NCT02158533|449769422|FG004|Stage 2|Lack of Efficacy|1|||
125040656|NCT02158533|449769423|FG005|Stage 2|Lack of Efficacy|0|||
125040657|NCT02158533|449769418|FG000|Stage 2|Lost to Follow-up|0|||
125040658|NCT02158533|449769419|FG001|Stage 2|Lost to Follow-up|0|||
125040659|NCT02158533|449769420|FG002|Stage 2|Lost to Follow-up|0|||
125040660|NCT02158533|449769421|FG003|Stage 2|Lost to Follow-up|1|||
125040661|NCT02158533|449769422|FG004|Stage 2|Lost to Follow-up|1|||
125040662|NCT02158533|449769423|FG005|Stage 2|Lost to Follow-up|2|||
125040663|NCT02158533|449769418|FG000|Stage 2|Withdrawal by Subject|0|||
125040664|NCT02158533|449769419|FG001|Stage 2|Withdrawal by Subject|0|||
125040665|NCT02158533|449769420|FG002|Stage 2|Withdrawal by Subject|0|||
125040666|NCT02158533|449769421|FG003|Stage 2|Withdrawal by Subject|0|||
125040667|NCT02158533|449769422|FG004|Stage 2|Withdrawal by Subject|1|||
125040668|NCT02158533|449769423|FG005|Stage 2|Withdrawal by Subject|2|||
125040669|NCT02158533|449769418|FG000|Stage 2|Physician Decision|0|||
125040670|NCT02158533|449769419|FG001|Stage 2|Physician Decision|0|||
125040671|NCT02158533|449769420|FG002|Stage 2|Physician Decision|0|||
125135079|NCT04493684|450118301|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135080|NCT04493684|450118302|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135081|NCT04493684|450118303|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135082|NCT04493684|450118304|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125218684|NCT01903993|450427396|FG000|Overall Study|Lost to Follow-up|2|||
125218685|NCT01903993|450427397|FG001|Overall Study|Lost to Follow-up|3|||
125040672|NCT02158533|449769421|FG003|Stage 2|Physician Decision|0|||
125040673|NCT02158533|449769422|FG004|Stage 2|Physician Decision|1|||
125040674|NCT02158533|449769423|FG005|Stage 2|Physician Decision|0|||
125040675|NCT02158533|449769418|FG000|Stage 2|Pregnancy|0|||
125040676|NCT02158533|449769419|FG001|Stage 2|Pregnancy|0|||
125040677|NCT02158533|449769420|FG002|Stage 2|Pregnancy|0|||
125040678|NCT02158533|449769421|FG003|Stage 2|Pregnancy|1|||
125040679|NCT02158533|449769422|FG004|Stage 2|Pregnancy|0|||
125040680|NCT02158533|449769423|FG005|Stage 2|Pregnancy|0|||
125040681|NCT02158533|449769418|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
125040682|NCT02158533|449769419|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
125040683|NCT02158533|449769420|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
125040684|NCT02158533|449769421|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
125135083|NCT04493684|450118305|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
125135084|NCT04493684|450118306|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135085|NCT04493684|450118307|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135086|NCT04493684|450118308|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135087|NCT04493684|450118309|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135088|NCT04493684|450118310|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135089|NCT04493684|450118311|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135090|NCT04493684|450118312|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135091|NCT04493684|450118313|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135092|NCT04493684|450118314|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135093|NCT04493684|450118315|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135094|NCT04493684|450118316|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135095|NCT04493684|450118300|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135096|NCT04493684|450118301|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135097|NCT04493684|450118302|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135098|NCT04493684|450118303|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135099|NCT04493684|450118304|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135100|NCT04493684|450118305|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135101|NCT04493684|450118306|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135102|NCT04493684|450118307|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135103|NCT04493684|450118308|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135104|NCT04493684|450118309|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135105|NCT04493684|450118310|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135106|NCT04493684|450118311|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
125135107|NCT04493684|450118312|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125040685|NCT02158533|449769422|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
125040686|NCT02158533|449769423|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
125040687|NCT02158533|449769418|FG000|Stage 2|Non-adherence with study visits|0|||
125040688|NCT02158533|449769419|FG001|Stage 2|Non-adherence with study visits|0|||
125040689|NCT02158533|449769420|FG002|Stage 2|Non-adherence with study visits|0|||
125040690|NCT02158533|449769421|FG003|Stage 2|Non-adherence with study visits|0|||
125040691|NCT02158533|449769422|FG004|Stage 2|Non-adherence with study visits|0|||
125040692|NCT02158533|449769423|FG005|Stage 2|Non-adherence with study visits|1|||
125040693|NCT02037919|449769424|FG000|Overall Study|Lost to Follow-up|30|||
125040694|NCT02037919|449769425|FG001|Overall Study|Lost to Follow-up|45|||
125040695|NCT00756002|449769433|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
125040696|NCT00756002|449769434|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
125040697|NCT00756002|449769433|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
125040698|NCT00756002|449769434|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
125040699|NCT00756002|449769433|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
125040700|NCT00756002|449769434|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
125040701|NCT00756002|449769433|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
125040702|NCT00756002|449769434|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
125040703|NCT00756002|449769433|FG000|Double-Blind Treatment Period|Other|2|||
125040704|NCT00756002|449769434|FG001|Double-Blind Treatment Period|Other|2|||
125040705|NCT04899271|449769441|FG000|Overall Study|Lost to Follow-up|1|||
125040706|NCT04899271|449769442|FG001|Overall Study|Lost to Follow-up|0|||
125040707|NCT04899271|449769441|FG000|Overall Study|Subject request/consent withdrawal|2|||
125040708|NCT04899271|449769442|FG001|Overall Study|Subject request/consent withdrawal|0|||
125040709|NCT01929083|449769443|FG000|Intervention 1|Lost to Follow-up|2|||
125040710|NCT01929083|449769444|FG001|Intervention 1|Lost to Follow-up|0|||
125040711|NCT01929083|449769443|FG000|Intervention 1|Nonadherent to study medications|1|||
125040712|NCT01929083|449769444|FG001|Intervention 1|Nonadherent to study medications|0|||
125040713|NCT01929083|449769443|FG000|Intervention 2|Adverse Event|0|||
125040714|NCT01929083|449769444|FG001|Intervention 2|Adverse Event|1|||
125040715|NCT02586805|449769451|FG000|Overall Study|Withdrawal by Subject|3|||
125040716|NCT02586805|449769452|FG001|Overall Study|Withdrawal by Subject|1|||
125135108|NCT04493684|450118313|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135109|NCT04493684|450118314|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125040717|NCT02586805|449769453|FG002|Overall Study|Withdrawal by Subject|1|||
125040718|NCT02586805|449769454|FG003|Overall Study|Withdrawal by Subject|2|||
125040719|NCT02586805|449769451|FG000|Overall Study|Adverse Event|2|||
125040720|NCT02586805|449769452|FG001|Overall Study|Adverse Event|0|||
125040721|NCT02586805|449769453|FG002|Overall Study|Adverse Event|1|||
125040722|NCT02586805|449769454|FG003|Overall Study|Adverse Event|0|||
125040723|NCT02586805|449769451|FG000|Overall Study|Lost to Follow-up|0|||
125135110|NCT04493684|450118315|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135111|NCT04493684|450118316|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135112|NCT04493684|450118300|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135113|NCT04493684|450118301|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135114|NCT04493684|450118302|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125040724|NCT02586805|449769452|FG001|Overall Study|Lost to Follow-up|0|||
125040725|NCT02586805|449769453|FG002|Overall Study|Lost to Follow-up|1|||
125040726|NCT02586805|449769454|FG003|Overall Study|Lost to Follow-up|0|||
125040727|NCT02586805|449769451|FG000|Overall Study|Physician Decision|1|||
125040728|NCT02586805|449769452|FG001|Overall Study|Physician Decision|0|||
125040729|NCT02586805|449769453|FG002|Overall Study|Physician Decision|0|||
125040730|NCT02586805|449769454|FG003|Overall Study|Physician Decision|0|||
125040731|NCT02504541|449769455|FG000|Overall Study|Adverse Event|4|||
125040732|NCT02504541|449769455|FG000|Overall Study|Withdrawal by Subject|4|||
125040733|NCT02504541|449769455|FG000|Overall Study|Lost to Follow-up|1|||
125040734|NCT02504541|449769455|FG000|Overall Study|Met Stopping Criteria|1|||
125040735|NCT02504541|449769455|FG000|Overall Study|Protocol Violation|2|||
125040736|NCT02504541|449769455|FG000|Overall Study|Termination by Sponsor|1|||
125040737|NCT02504541|449769455|FG000|Overall Study|Other|2|||
125040738|NCT02504541|449769455|FG000|Overall Study|Multiple|5|||
125040739|NCT00500071|449769456|FG000|Screening and Washout Phase|Protocol Violation|1|||
125040740|NCT00500071|449769456|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
125040741|NCT00500071|449769456|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
125040742|NCT00500071|449769456|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
125040743|NCT00500071|449769456|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
125040744|NCT00500071|449769456|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
125040745|NCT00500071|449769456|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
125040746|NCT00472303|449769457|FG000|Titration Phase|Adverse Event|22|||
125040747|NCT00472303|449769458|FG001|Titration Phase|Adverse Event|12|||
125040748|NCT00472303|449769459|FG002|Titration Phase|Adverse Event|0|||
125040749|NCT00472303|449769457|FG000|Titration Phase|Death|4|||
125040750|NCT00472303|449769458|FG001|Titration Phase|Death|2|||
125040751|NCT00472303|449769459|FG002|Titration Phase|Death|0|||
125040752|NCT00472303|449769457|FG000|Titration Phase|Lack of Efficacy|10|||
125040753|NCT00472303|449769458|FG001|Titration Phase|Lack of Efficacy|0|||
125040754|NCT00472303|449769459|FG002|Titration Phase|Lack of Efficacy|0|||
125040755|NCT00472303|449769457|FG000|Titration Phase|Withdrawal by Subject|16|||
125040756|NCT00472303|449769458|FG001|Titration Phase|Withdrawal by Subject|13|||
125040757|NCT00472303|449769459|FG002|Titration Phase|Withdrawal by Subject|0|||
125040758|NCT00472303|449769457|FG000|Titration Phase|Trial Medication non-compliant|4|||
125040759|NCT00472303|449769458|FG001|Titration Phase|Trial Medication non-compliant|1|||
125040760|NCT00472303|449769459|FG002|Titration Phase|Trial Medication non-compliant|0|||
125040761|NCT00472303|449769457|FG000|Titration Phase|Other|3|||
125040762|NCT00472303|449769458|FG001|Titration Phase|Other|1|||
125040763|NCT00472303|449769459|FG002|Titration Phase|Other|0|||
125040764|NCT00472303|449769457|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
125040765|NCT00472303|449769458|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
125040766|NCT00472303|449769459|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
125040767|NCT00472303|449769457|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
125040768|NCT00472303|449769458|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
125040769|NCT00472303|449769459|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
125040770|NCT00472303|449769457|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
125040771|NCT00472303|449769458|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
125040772|NCT00472303|449769459|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
125040773|NCT00472303|449769457|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
125040774|NCT00472303|449769458|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
125040775|NCT00472303|449769459|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
125040776|NCT00472303|449769457|FG000|Discontinuations After Titration Phase|Other|5|||
125040777|NCT00472303|449769458|FG001|Discontinuations After Titration Phase|Other|0|||
125040778|NCT00472303|449769459|FG002|Discontinuations After Titration Phase|Other|0|||
125040779|NCT00472303|449769457|FG000|Maintenance Phase|Adverse Event|5|||
125040780|NCT00472303|449769458|FG001|Maintenance Phase|Adverse Event|6|||
125040781|NCT00472303|449769459|FG002|Maintenance Phase|Adverse Event|6|||
125040782|NCT00472303|449769457|FG000|Maintenance Phase|Death|3|||
125040783|NCT00472303|449769458|FG001|Maintenance Phase|Death|0|||
125040784|NCT00472303|449769459|FG002|Maintenance Phase|Death|2|||
125040785|NCT00472303|449769457|FG000|Maintenance Phase|Lack of Efficacy|2|||
125040786|NCT00472303|449769458|FG001|Maintenance Phase|Lack of Efficacy|2|||
125040787|NCT00472303|449769459|FG002|Maintenance Phase|Lack of Efficacy|4|||
125040788|NCT00472303|449769457|FG000|Maintenance Phase|Withdrawal by Subject|6|||
125040789|NCT00472303|449769458|FG001|Maintenance Phase|Withdrawal by Subject|7|||
125040790|NCT00472303|449769459|FG002|Maintenance Phase|Withdrawal by Subject|3|||
125040791|NCT00472303|449769457|FG000|Maintenance Phase|Trial medication non-compliant|0|||
125040792|NCT00472303|449769458|FG001|Maintenance Phase|Trial medication non-compliant|0|||
125040793|NCT00472303|449769459|FG002|Maintenance Phase|Trial medication non-compliant|1|||
125040794|NCT00472303|449769457|FG000|Maintenance Phase|Resolution of pain|0|||
125040795|NCT00472303|449769458|FG001|Maintenance Phase|Resolution of pain|0|||
125040796|NCT00472303|449769459|FG002|Maintenance Phase|Resolution of pain|1|||
125040797|NCT00472303|449769457|FG000|Maintenance Phase|Other|1|||
125040798|NCT00472303|449769458|FG001|Maintenance Phase|Other|1|||
125040799|NCT00472303|449769459|FG002|Maintenance Phase|Other|0|||
125040800|NCT03182738|449769460|FG000|Overall Study|Lost to Follow-up|9|||
125040801|NCT03182738|449769461|FG001|Overall Study|Lost to Follow-up|3|||
125040802|NCT03182738|449769460|FG000|Overall Study|Pregnancy|0|||
125040803|NCT03182738|449769461|FG001|Overall Study|Pregnancy|1|||
125040804|NCT03182738|449769460|FG000|Overall Study|Withdrawal by Subject|0|||
125040805|NCT03182738|449769461|FG001|Overall Study|Withdrawal by Subject|1|||
125040806|NCT01486238|449769467|FG000|Overall Study|Death|0|||
125040807|NCT01486238|449769468|FG001|Overall Study|Death|2|||
125040808|NCT01486238|449769467|FG000|Overall Study|Withdrawal by Subject|2|||
125040809|NCT01486238|449769468|FG001|Overall Study|Withdrawal by Subject|1|||
125040810|NCT01486238|449769467|FG000|Overall Study|Lost to Follow-up|0|||
125040811|NCT01486238|449769468|FG001|Overall Study|Lost to Follow-up|3|||
125040812|NCT00356915|449769470|FG000|Overall Study|Non compliance|1|||
125040813|NCT00356915|449769471|FG001|Overall Study|Non compliance|2|||
125040814|NCT00356915|449769472|FG002|Overall Study|Non compliance|1|||
125040815|NCT00356915|449769470|FG000|Overall Study|Protocol Violation|2|||
125040816|NCT00356915|449769471|FG001|Overall Study|Protocol Violation|3|||
125040817|NCT00356915|449769472|FG002|Overall Study|Protocol Violation|2|||
125135115|NCT04493684|450118303|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135116|NCT04493684|450118304|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135117|NCT04493684|450118305|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135118|NCT04493684|450118306|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135119|NCT04493684|450118307|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135120|NCT04493684|450118308|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125218686|NCT01903993|450427396|FG000|Overall Study|Study Terminated by Sponsor|8|||
125218687|NCT01903993|450427397|FG001|Overall Study|Study Terminated by Sponsor|14|||
125218688|NCT01903993|450427396|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
125218689|NCT01903993|450427397|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
125218690|NCT00184093|450427398|FG000|Overall Study|Adverse Event|3|||
125218691|NCT00184093|450427398|FG000|Overall Study|Lost to Follow-up|3|||
125218692|NCT00184093|450427398|FG000|Overall Study|Physician Decision|1|||
125218693|NCT00184093|450427398|FG000|Overall Study|Withdrawal by Subject|2|||
125218694|NCT00972283|450427402|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
125218695|NCT00972283|450427403|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
125218696|NCT00972283|450427402|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
125218697|NCT00972283|450427403|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
125218698|NCT00972283|450427402|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
125218699|NCT00972283|450427403|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
125218700|NCT00972283|450427402|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
125218701|NCT00972283|450427403|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
125218702|NCT00972283|450427402|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
125218703|NCT00972283|450427403|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
125218704|NCT00972283|450427402|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
125218705|NCT00972283|450427403|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
125218706|NCT00972283|450427402|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
125218707|NCT00972283|450427403|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
125040818|NCT00356915|449769470|FG000|Overall Study|Withdrawal by Subject|14|||
125040819|NCT00356915|449769471|FG001|Overall Study|Withdrawal by Subject|14|||
125135121|NCT04493684|450118309|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135122|NCT04493684|450118310|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135123|NCT04493684|450118311|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125218708|NCT00972283|450427402|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
125218709|NCT00972283|450427403|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
125040820|NCT00356915|449769472|FG002|Overall Study|Withdrawal by Subject|10|||
125040821|NCT00356915|449769470|FG000|Overall Study|Lack of Efficacy|0|||
125218710|NCT00972283|450427402|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
125040822|NCT00356915|449769471|FG001|Overall Study|Lack of Efficacy|0|||
125040823|NCT00356915|449769472|FG002|Overall Study|Lack of Efficacy|3|||
125040824|NCT00356915|449769470|FG000|Overall Study|Lost to Follow-up|27|||
125040825|NCT00356915|449769471|FG001|Overall Study|Lost to Follow-up|34|||
125040826|NCT00356915|449769472|FG002|Overall Study|Lost to Follow-up|14|||
125040827|NCT00356915|449769470|FG000|Overall Study|Administrative Decision|0|||
125040828|NCT00356915|449769471|FG001|Overall Study|Administrative Decision|0|||
125040829|NCT00356915|449769472|FG002|Overall Study|Administrative Decision|1|||
125040830|NCT00356915|449769470|FG000|Overall Study|Physician Decision|0|||
125135124|NCT04493684|450118312|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135125|NCT04493684|450118313|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135126|NCT04493684|450118314|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135127|NCT04493684|450118315|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
125135128|NCT04493684|450118316|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135129|NCT04493684|450118300|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135130|NCT04493684|450118301|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135131|NCT04493684|450118302|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135132|NCT04493684|450118303|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135133|NCT04493684|450118304|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135134|NCT04493684|450118305|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135135|NCT04493684|450118306|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135136|NCT04493684|450118307|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135137|NCT04493684|450118308|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135138|NCT04493684|450118309|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135139|NCT04493684|450118310|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125040831|NCT00356915|449769471|FG001|Overall Study|Physician Decision|2|||
125040832|NCT00356915|449769472|FG002|Overall Study|Physician Decision|0|||
125040833|NCT00356915|449769470|FG000|Overall Study|Adverse Event|21|||
125040834|NCT00356915|449769471|FG001|Overall Study|Adverse Event|31|||
125040835|NCT00356915|449769472|FG002|Overall Study|Adverse Event|8|||
125040836|NCT00356915|449769470|FG000|Overall Study|Miscellaneous reasons|11|||
125040837|NCT00356915|449769471|FG001|Overall Study|Miscellaneous reasons|8|||
125040838|NCT00356915|449769472|FG002|Overall Study|Miscellaneous reasons|3|||
125040839|NCT00509106|449769473|FG000|Overall Study|Adverse Event|3|||
125040840|NCT00509106|449769474|FG001|Overall Study|Adverse Event|2|||
125040841|NCT00509106|449769473|FG000|Overall Study|Noncompliance|0|||
125040842|NCT00509106|449769474|FG001|Overall Study|Noncompliance|1|||
125040843|NCT00509106|449769473|FG000|Overall Study|At the request of sponsor/investigator|1|||
125040844|NCT00509106|449769474|FG001|Overall Study|At the request of sponsor/investigator|2|||
125040845|NCT00509106|449769473|FG000|Overall Study|Withdrew consent|4|||
125040846|NCT00509106|449769474|FG001|Overall Study|Withdrew consent|8|||
125040847|NCT00509106|449769473|FG000|Overall Study|Lost to Follow-up|16|||
125040848|NCT00509106|449769474|FG001|Overall Study|Lost to Follow-up|10|||
125040849|NCT00509106|449769473|FG000|Overall Study|Other|1|||
125040850|NCT00509106|449769474|FG001|Overall Study|Other|0|||
125040851|NCT00509106|449769473|FG000|Overall Study|Death|6|||
125040852|NCT00509106|449769474|FG001|Overall Study|Death|6|||
125040853|NCT02318602|449769475|FG000|Overall Study|Adverse Event|0|||
125040854|NCT02318602|449769476|FG001|Overall Study|Adverse Event|1|||
125040855|NCT02318602|449769477|FG002|Overall Study|Adverse Event|1|||
125040856|NCT02318602|449769475|FG000|Overall Study|Withdrawal by Subject|0|||
125040857|NCT02318602|449769476|FG001|Overall Study|Withdrawal by Subject|3|||
125040858|NCT02318602|449769477|FG002|Overall Study|Withdrawal by Subject|0|||
125040859|NCT02318602|449769475|FG000|Overall Study|Death|1|||
125040860|NCT02318602|449769476|FG001|Overall Study|Death|0|||
125040861|NCT02318602|449769477|FG002|Overall Study|Death|0|||
125040862|NCT02318602|449769475|FG000|Overall Study|Guardian decision to withdraw|0|||
125040863|NCT02318602|449769476|FG001|Overall Study|Guardian decision to withdraw|0|||
125040864|NCT02318602|449769477|FG002|Overall Study|Guardian decision to withdraw|1|||
125040865|NCT00693706|449769478|FG000|Overall Study|Protocol Violation|0|||
125040866|NCT00693706|449769479|FG001|Overall Study|Protocol Violation|1|||
125040867|NCT00488631|449769480|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
125040868|NCT00488631|449769481|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
125040869|NCT00488631|449769482|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
125040870|NCT00488631|449769483|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
125040871|NCT00488631|449769484|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
125040872|NCT00488631|449769485|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
125040873|NCT00488631|449769486|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
125040874|NCT00488631|449769487|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
125040875|NCT00488631|449769488|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
125040876|NCT00488631|449769489|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
125040877|NCT00488631|449769480|FG000|Double Blind Period (Week 0-54)|Death|0|||
125135140|NCT04493684|450118311|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
124975555|NCT01646177|449536600|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
124975556|NCT01646177|449536589|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
124975557|NCT01646177|449536590|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
124975558|NCT01646177|449536591|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
124975559|NCT01646177|449536592|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
124975560|NCT01646177|449536593|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
124975561|NCT01646177|449536594|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
124975562|NCT01646177|449536595|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
124975563|NCT01646177|449536596|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
124975564|NCT01646177|449536597|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
124975565|NCT01646177|449536598|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
124975566|NCT01646177|449536599|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
124975567|NCT01646177|449536600|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
124975568|NCT01646177|449536589|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
124975569|NCT01646177|449536590|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
124975570|NCT01646177|449536591|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
124975571|NCT01646177|449536592|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
124975572|NCT01646177|449536593|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
124975573|NCT01646177|449536594|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
124975574|NCT01646177|449536595|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
124975575|NCT01646177|449536596|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
124975576|NCT01646177|449536597|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
124975577|NCT01646177|449536598|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
124975578|NCT01646177|449536599|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
124975579|NCT01646177|449536600|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
124975580|NCT01646177|449536589|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
124975581|NCT01646177|449536590|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
124975582|NCT01646177|449536591|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
124975583|NCT01646177|449536592|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
124975584|NCT01646177|449536593|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
124975585|NCT01646177|449536594|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
124975586|NCT01646177|449536595|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
124975587|NCT01646177|449536596|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
124975588|NCT01646177|449536597|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
124975589|NCT01646177|449536598|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
124975590|NCT01646177|449536599|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
124975591|NCT01646177|449536600|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
124975592|NCT01305239|449536604|FG000|Overall Study|Adverse Event|22|||
124975593|NCT01305239|449536604|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
124975594|NCT00402051|449536607|FG000|Overall Study|Progressive Disease|13|||
124975595|NCT00402051|449536608|FG001|Overall Study|Progressive Disease|20|||
124975596|NCT00402051|449536607|FG000|Overall Study|Adverse Event|11|||
124975597|NCT00402051|449536608|FG001|Overall Study|Adverse Event|4|||
124975598|NCT00402051|449536607|FG000|Overall Study|Physician Decision|7|||
124975599|NCT00402051|449536608|FG001|Overall Study|Physician Decision|3|||
124975600|NCT00402051|449536607|FG000|Overall Study|Withdrawal by Subject|3|||
124975601|NCT00402051|449536608|FG001|Overall Study|Withdrawal by Subject|3|||
125040878|NCT00488631|449769481|FG001|Double Blind Period (Week 0-54)|Death|0|||
125040879|NCT00488631|449769482|FG002|Double Blind Period (Week 0-54)|Death|0|||
125040880|NCT00488631|449769483|FG003|Double Blind Period (Week 0-54)|Death|0|||
125040881|NCT00488631|449769484|FG004|Double Blind Period (Week 0-54)|Death|0|||
125040882|NCT00488631|449769485|FG005|Double Blind Period (Week 0-54)|Death|1|||
125040883|NCT00488631|449769486|FG006|Double Blind Period (Week 0-54)|Death|0|||
125040884|NCT00488631|449769487|FG007|Double Blind Period (Week 0-54)|Death|0|||
125040885|NCT00488631|449769488|FG008|Double Blind Period (Week 0-54)|Death|0|||
125040886|NCT00488631|449769489|FG009|Double Blind Period (Week 0-54)|Death|0|||
125040887|NCT00488631|449769480|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
125040888|NCT00488631|449769481|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
125040889|NCT00488631|449769482|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
125040890|NCT00488631|449769483|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
125040891|NCT00488631|449769484|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
125040892|NCT00488631|449769485|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
125040893|NCT00488631|449769486|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
125040894|NCT00488631|449769487|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
125040895|NCT00488631|449769488|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
125040896|NCT00488631|449769489|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
125040897|NCT00488631|449769480|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
125040898|NCT00488631|449769481|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
125040899|NCT00488631|449769482|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
125040900|NCT00488631|449769483|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
125040901|NCT00488631|449769484|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
125040902|NCT00488631|449769485|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
125040903|NCT00488631|449769486|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
125040904|NCT00488631|449769487|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
125040905|NCT00488631|449769488|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
125040906|NCT00488631|449769489|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
125040907|NCT00488631|449769480|FG000|Double Blind Period (Week 0-54)|Other|6|||
125040908|NCT00488631|449769481|FG001|Double Blind Period (Week 0-54)|Other|12|||
125040909|NCT00488631|449769482|FG002|Double Blind Period (Week 0-54)|Other|10|||
125040910|NCT00488631|449769483|FG003|Double Blind Period (Week 0-54)|Other|11|||
125040911|NCT00488631|449769484|FG004|Double Blind Period (Week 0-54)|Other|14|||
125040912|NCT00488631|449769485|FG005|Double Blind Period (Week 0-54)|Other|34|||
125040913|NCT00488631|449769486|FG006|Double Blind Period (Week 0-54)|Other|0|||
125040914|NCT00488631|449769487|FG007|Double Blind Period (Week 0-54)|Other|0|||
125040915|NCT00488631|449769488|FG008|Double Blind Period (Week 0-54)|Other|0|||
125040916|NCT00488631|449769489|FG009|Double Blind Period (Week 0-54)|Other|0|||
125040917|NCT00488631|449769480|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
125040918|NCT00488631|449769481|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
125040919|NCT00488631|449769482|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
125040920|NCT00488631|449769483|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
125040921|NCT00488631|449769484|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
125135141|NCT04493684|450118312|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135142|NCT04493684|450118313|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135143|NCT04493684|450118314|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135144|NCT04493684|450118315|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
125135145|NCT04493684|450118316|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135146|NCT01963728|450118317|FG000|Overall Study|Study terminated early|0|||
125135147|NCT01963728|450118318|FG001|Overall Study|Study terminated early|1|||
125135148|NCT05152576|450118319|FG000|Overall Study|Lost to Follow-up|3|||
125135149|NCT05152576|450118320|FG001|Overall Study|Lost to Follow-up|0|||
125135150|NCT05152576|450118321|FG002|Overall Study|Lost to Follow-up|0|||
125040922|NCT00488631|449769485|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
125040923|NCT00488631|449769486|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
125135151|NCT05152576|450118322|FG003|Overall Study|Lost to Follow-up|1|||
125135152|NCT05152576|450118319|FG000|Overall Study|Withdrawal by Subject|0|||
125040924|NCT00488631|449769487|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
125040925|NCT00488631|449769488|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
125040926|NCT00488631|449769489|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
125040927|NCT00488631|449769480|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
125040928|NCT00488631|449769481|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
125040929|NCT00488631|449769482|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
125040930|NCT00488631|449769483|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
125040931|NCT00488631|449769484|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
125040932|NCT00488631|449769485|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
125040933|NCT00488631|449769486|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
125040934|NCT00488631|449769487|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
125040935|NCT00488631|449769488|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
125040936|NCT00488631|449769489|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
125040937|NCT00488631|449769480|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
125040938|NCT00488631|449769481|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
125040939|NCT00488631|449769482|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
125040940|NCT00488631|449769483|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
125040941|NCT00488631|449769484|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
125040942|NCT00488631|449769485|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
125040943|NCT00488631|449769486|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
125040944|NCT00488631|449769487|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
125040945|NCT00488631|449769488|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
125040946|NCT00488631|449769489|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
125040947|NCT00488631|449769480|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
125040948|NCT00488631|449769481|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
125040949|NCT00488631|449769482|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
125040950|NCT00488631|449769483|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
125040951|NCT00488631|449769484|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
125040952|NCT00488631|449769485|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
125040953|NCT00488631|449769486|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
125040954|NCT00488631|449769487|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
125040955|NCT00488631|449769488|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
125040956|NCT00488631|449769489|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
125040957|NCT00488631|449769480|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
125040958|NCT00488631|449769481|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
125040959|NCT00488631|449769482|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
125040960|NCT00488631|449769483|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
125040961|NCT00488631|449769484|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
125040962|NCT00488631|449769485|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
125040963|NCT00488631|449769486|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
125040964|NCT00488631|449769487|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
125040965|NCT00488631|449769488|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
125040966|NCT00488631|449769489|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
125040967|NCT01873950|449769490|FG000|Period 5|Withdrawal by Subject|0|||
125040968|NCT01873950|449769491|FG001|Period 5|Withdrawal by Subject|0|||
125040969|NCT01873950|449769492|FG002|Period 5|Withdrawal by Subject|0|||
125040970|NCT01873950|449769493|FG003|Period 5|Withdrawal by Subject|1|||
125040971|NCT01873950|449769494|FG004|Period 5|Withdrawal by Subject|0|||
125040972|NCT01193335|449769496|FG000|After Infant Series|Lost to Follow-up|1|||
125040973|NCT01193335|449769497|FG001|After Infant Series|Lost to Follow-up|2|||
125040974|NCT01193335|449769496|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
125040975|NCT01193335|449769497|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
125040976|NCT01193335|449769496|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
125040977|NCT01193335|449769497|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
125040978|NCT01193335|449769496|FG000|1-Year Follow-up|Lost to Follow-up|4|||
125040979|NCT01193335|449769497|FG001|1-Year Follow-up|Lost to Follow-up|0|||
125040980|NCT01193335|449769496|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
125040981|NCT01193335|449769497|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
125040982|NCT01193335|449769496|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
125040983|NCT01193335|449769497|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
124975602|NCT00402051|449536607|FG000|Overall Study|Death - Related to Study Drug|1|||
124975603|NCT00402051|449536608|FG001|Overall Study|Death - Related to Study Drug|2|||
124975604|NCT00402051|449536607|FG000|Overall Study|Death Due to Study Disease|2|||
124975605|NCT00402051|449536608|FG001|Overall Study|Death Due to Study Disease|1|||
124975606|NCT00402051|449536607|FG000|Overall Study|Death Due to Adverse Event|0|||
124975607|NCT00402051|449536608|FG001|Overall Study|Death Due to Adverse Event|2|||
124975608|NCT00402051|449536607|FG000|Overall Study|Lost to Follow-up|1|||
124975609|NCT00402051|449536608|FG001|Overall Study|Lost to Follow-up|0|||
124975610|NCT00570908|449536622|FG000|Overall Study|Adverse Event|5|||
124975611|NCT00570908|449536622|FG000|Overall Study|Withdrawal by Subject|2|||
124975612|NCT01213524|449536623|FG000|Baseline|Withdrawal by Subject|5|||
124975613|NCT01213524|449536623|FG000|Baseline|high breath alcohol levels|1|||
124975614|NCT01213524|449536623|FG000|Baseline|Physician Decision|1|||
124975615|NCT01213524|449536623|FG000|Session 2|Withdrawal by Subject|5|||
124975616|NCT01213524|449536623|FG000|Session 3|Withdrawal by Subject|4|||
124975617|NCT01213524|449536623|FG000|Session 4|Physician Decision|1|||
124975618|NCT01213524|449536623|FG000|Session 4|Withdrawal by Subject|2|||
124975619|NCT06152224|449536629|FG000|Overall Study|Withdrawal by Subject|1|||
124975620|NCT06152224|449536630|FG001|Overall Study|Withdrawal by Subject|0|||
124975621|NCT06152224|449536629|FG000|Overall Study|Lost to Follow-up|0|||
124975622|NCT06152224|449536630|FG001|Overall Study|Lost to Follow-up|1|||
124975623|NCT06152224|449536629|FG000|Overall Study|On Follow Up|18|||
124975624|NCT06152224|449536630|FG001|Overall Study|On Follow Up|18|||
124975625|NCT00281320|449536631|FG000|Overall Study|Adverse Event|12|||
124975626|NCT00281320|449536632|FG001|Overall Study|Adverse Event|9|||
124975627|NCT00281320|449536631|FG000|Overall Study|Lack of Efficacy|4|||
124975628|NCT00281320|449536632|FG001|Overall Study|Lack of Efficacy|3|||
124975629|NCT00281320|449536631|FG000|Overall Study|Withdrawal by Subject|5|||
124975630|NCT00281320|449536632|FG001|Overall Study|Withdrawal by Subject|6|||
124975631|NCT00281320|449536631|FG000|Overall Study|Lost to Follow-up|1|||
124975632|NCT00281320|449536632|FG001|Overall Study|Lost to Follow-up|2|||
124975633|NCT00281320|449536631|FG000|Overall Study|Other|3|||
124975634|NCT00281320|449536632|FG001|Overall Study|Other|1|||
124975635|NCT01447576|449536641|FG000|Overall Study|Lost to Follow-up|52|||
124975636|NCT01447576|449536641|FG000|Overall Study|Adverse Event|127|||
124975637|NCT01447576|449536641|FG000|Overall Study|Participant met withdrawal criteria|40|||
124975638|NCT01447576|449536641|FG000|Overall Study|Withdrawal by Subject|100|||
124975639|NCT01447576|449536641|FG000|Overall Study|Protocol deviation|83|||
124975640|NCT01447576|449536641|FG000|Overall Study|Lack of Efficacy|68|||
124975641|NCT01447576|449536641|FG000|Overall Study|Physician Decision|6|||
124975642|NCT00975676|449536642|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
124975643|NCT00975676|449536643|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
124975644|NCT02579772|449536644|FG000|Overall Study|Withdrawal by Subject|0|||
125040984|NCT01733329|449769498|FG000|Overall Study|Protocol Violation|1|||
125040985|NCT01733329|449769499|FG001|Overall Study|Protocol Violation|1|||
125040986|NCT01733329|449769498|FG000|Overall Study|Uterine artery injury|1|||
125040987|NCT01733329|449769499|FG001|Overall Study|Uterine artery injury|0|||
125040988|NCT02500550|449769505|FG000|Overall Study|Death|7|||
125040989|NCT04003610|449769511|FG000|Overall Study|Lost to Follow-up|0|||
125040990|NCT04003610|449769512|FG001|Overall Study|Lost to Follow-up|1|||
125040991|NCT04003610|449769513|FG002|Overall Study|Lost to Follow-up|0|||
125040992|NCT04003610|449769511|FG000|Overall Study|Death|0|||
125040993|NCT04003610|449769512|FG001|Overall Study|Death|0|||
125040994|NCT04003610|449769513|FG002|Overall Study|Death|3|||
125040995|NCT04003610|449769511|FG000|Overall Study|Study Terminated by Sponsor|0|||
125040996|NCT04003610|449769512|FG001|Overall Study|Study Terminated by Sponsor|0|||
125040997|NCT04003610|449769513|FG002|Overall Study|Study Terminated by Sponsor|3|||
125040998|NCT02502864|449769519|FG000|Overall Study|Withdrawal by Subject|1|||
125040999|NCT03772327|449769520|FG000|Overall Study|Lost to Follow-up|3|||
125041000|NCT03772327|449769521|FG001|Overall Study|Lost to Follow-up|4|||
125041001|NCT03772327|449769520|FG000|Overall Study|Withdrawal by Subject|2|||
125041002|NCT03772327|449769521|FG001|Overall Study|Withdrawal by Subject|3|||
125041003|NCT00246259|449769523|FG000|Overall Study|Other|3|||
125041004|NCT00246259|449769524|FG001|Overall Study|Other|3|||
125041005|NCT00246259|449769523|FG000|Overall Study|Not stable by Week 18|2|||
125041006|NCT00246259|449769524|FG001|Overall Study|Not stable by Week 18|1|||
125041007|NCT00246259|449769523|FG000|Overall Study|Participant non-compliant|4|||
125041008|NCT00246259|449769524|FG001|Overall Study|Participant non-compliant|9|||
125041009|NCT00246259|449769523|FG000|Overall Study|Lack of Efficacy|2|||
125041010|NCT00246259|449769524|FG001|Overall Study|Lack of Efficacy|2|||
125041011|NCT00246259|449769523|FG000|Overall Study|Investigator withdrew participant|2|||
125041012|NCT00246259|449769524|FG001|Overall Study|Investigator withdrew participant|0|||
125041013|NCT00246259|449769523|FG000|Overall Study|Adverse Event|5|||
125041014|NCT00246259|449769524|FG001|Overall Study|Adverse Event|0|||
125041015|NCT00246259|449769523|FG000|Overall Study|Lost to Follow-up|3|||
125041016|NCT00246259|449769524|FG001|Overall Study|Lost to Follow-up|4|||
125135153|NCT05152576|450118320|FG001|Overall Study|Withdrawal by Subject|1|||
125135154|NCT05152576|450118321|FG002|Overall Study|Withdrawal by Subject|0|||
125135155|NCT05152576|450118322|FG003|Overall Study|Withdrawal by Subject|1|||
125135156|NCT05152576|450118319|FG000|Overall Study|Other|2|||
125135157|NCT05152576|450118320|FG001|Overall Study|Other|0|||
125041017|NCT00246259|449769523|FG000|Overall Study|Withdrawal by Subject|5|||
125041018|NCT00246259|449769524|FG001|Overall Study|Withdrawal by Subject|1|||
125041019|NCT00246259|449769523|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
125041020|NCT00246259|449769524|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
125041021|NCT03133767|449769531|FG000|Overall Study|Lost to Follow-up|38|||
125041022|NCT03133767|449769532|FG001|Overall Study|Lost to Follow-up|24|||
125041023|NCT03133767|449769531|FG000|Overall Study|Protocol Violation|0|||
125041024|NCT03133767|449769532|FG001|Overall Study|Protocol Violation|1|||
125041025|NCT04233424|449769533|FG000|Overall Study|Death|15|||
125135158|NCT05152576|450118321|FG002|Overall Study|Other|0|||
125041026|NCT04233424|449769534|FG001|Overall Study|Death|16|||
125041027|NCT04233424|449769533|FG000|Overall Study|Withdrawal by Subject|2|||
125041028|NCT04233424|449769534|FG001|Overall Study|Withdrawal by Subject|8|||
125041029|NCT04233424|449769533|FG000|Overall Study|Physician Decision|1|||
125041030|NCT04233424|449769534|FG001|Overall Study|Physician Decision|3|||
125041031|NCT04233424|449769533|FG000|Overall Study|Protocol Violation|3|||
125041032|NCT04233424|449769534|FG001|Overall Study|Protocol Violation|1|||
125041033|NCT04233424|449769533|FG000|Overall Study|Lost to Follow-up|1|||
125041034|NCT04233424|449769534|FG001|Overall Study|Lost to Follow-up|3|||
125041035|NCT04233424|449769533|FG000|Overall Study|subject refuse to visit site|2|||
125041036|NCT04233424|449769534|FG001|Overall Study|subject refuse to visit site|0|||
125041037|NCT03517436|449769535|FG000|Overall Study|Death|3|||
125041038|NCT03517436|449769535|FG000|Overall Study|Withdrawal by Subject|4|||
125041039|NCT03517436|449769535|FG000|Overall Study|Did not receive study valve.|1|||
125041040|NCT05502289|449769542|FG000|Period 1|Out Of Window|1|||
125041041|NCT05502289|449769543|FG001|Period 1|Out Of Window|0|||
125041042|NCT02333227|449769549|FG000|Overall Study|Lost to Follow-up|137|||
125041043|NCT02333227|449769550|FG001|Overall Study|Lost to Follow-up|106|||
125041044|NCT02333227|449769549|FG000|Overall Study|Pregnancy Interrupted|42|||
125041045|NCT02333227|449769550|FG001|Overall Study|Pregnancy Interrupted|89|||
125041046|NCT02333227|449769549|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
125041047|NCT02333227|449769550|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
125041048|NCT01254344|449769551|FG000|Overall Study|Adverse Event|2|||
125041049|NCT01254344|449769552|FG001|Overall Study|Adverse Event|5|||
125041050|NCT01254344|449769551|FG000|Overall Study|Physician Decision|7|||
125041051|NCT01254344|449769552|FG001|Overall Study|Physician Decision|4|||
125041052|NCT01254344|449769551|FG000|Overall Study|Protocol Violation|1|||
125041053|NCT01254344|449769552|FG001|Overall Study|Protocol Violation|4|||
125041054|NCT01254344|449769551|FG000|Overall Study|Withdrawal by Subject|3|||
125041055|NCT01254344|449769552|FG001|Overall Study|Withdrawal by Subject|6|||
125041056|NCT03022461|449769555|FG000|Overall Study|Death|3|||
125041057|NCT01624194|449769556|FG000|Overall Study|Lost to Follow-up|1|||
125041058|NCT01624194|449769557|FG001|Overall Study|Lost to Follow-up|0|||
125041059|NCT01624194|449769556|FG000|Overall Study|Withdrawal by Subject|1|||
125041060|NCT01624194|449769557|FG001|Overall Study|Withdrawal by Subject|0|||
125041061|NCT00561353|449769558|FG000|Overall Study|Subject reached a virologic endpoint|2|||
125041062|NCT00561353|449769559|FG001|Overall Study|Subject reached a virologic endpoint|1|||
125041063|NCT00561353|449769560|FG002|Overall Study|Subject reached a virologic endpoint|1|||
125041064|NCT00561353|449769561|FG003|Overall Study|Subject reached a virologic endpoint|4|||
125041065|NCT00561353|449769562|FG004|Overall Study|Subject reached a virologic endpoint|1|||
125041066|NCT00561353|449769563|FG005|Overall Study|Subject reached a virologic endpoint|3|||
125041067|NCT00561353|449769564|FG006|Overall Study|Subject reached a virologic endpoint|4|||
125041068|NCT00561353|449769565|FG007|Overall Study|Subject reached a virologic endpoint|4|||
125041069|NCT00561353|449769566|FG008|Overall Study|Subject reached a virologic endpoint|5|||
125041070|NCT00561353|449769567|FG009|Overall Study|Subject reached a virologic endpoint|0|||
125041071|NCT00561353|449769558|FG000|Overall Study|Subject ineligible to continue the trial|0|||
125041072|NCT00561353|449769559|FG001|Overall Study|Subject ineligible to continue the trial|0|||
125041073|NCT00561353|449769560|FG002|Overall Study|Subject ineligible to continue the trial|0|||
125041074|NCT00561353|449769561|FG003|Overall Study|Subject ineligible to continue the trial|0|||
125041075|NCT00561353|449769562|FG004|Overall Study|Subject ineligible to continue the trial|0|||
125041076|NCT00561353|449769563|FG005|Overall Study|Subject ineligible to continue the trial|1|||
125041077|NCT00561353|449769564|FG006|Overall Study|Subject ineligible to continue the trial|1|||
125041078|NCT00561353|449769565|FG007|Overall Study|Subject ineligible to continue the trial|0|||
125041079|NCT00561353|449769566|FG008|Overall Study|Subject ineligible to continue the trial|2|||
125041080|NCT00561353|449769567|FG009|Overall Study|Subject ineligible to continue the trial|1|||
125041081|NCT00561353|449769558|FG000|Overall Study|Other|1|||
125041082|NCT00561353|449769559|FG001|Overall Study|Other|0|||
125041083|NCT00561353|449769560|FG002|Overall Study|Other|1|||
125041084|NCT00561353|449769561|FG003|Overall Study|Other|0|||
125041085|NCT00561353|449769562|FG004|Overall Study|Other|0|||
125041086|NCT00561353|449769563|FG005|Overall Study|Other|2|||
125041087|NCT00561353|449769564|FG006|Overall Study|Other|0|||
125041088|NCT00561353|449769565|FG007|Overall Study|Other|0|||
125041089|NCT00561353|449769566|FG008|Overall Study|Other|0|||
125041090|NCT00561353|449769567|FG009|Overall Study|Other|0|||
125041091|NCT00561353|449769558|FG000|Overall Study|Adverse Event|0|||
125041092|NCT00561353|449769559|FG001|Overall Study|Adverse Event|0|||
125041093|NCT00561353|449769560|FG002|Overall Study|Adverse Event|0|||
125041094|NCT00561353|449769561|FG003|Overall Study|Adverse Event|2|||
125041095|NCT00561353|449769562|FG004|Overall Study|Adverse Event|0|||
125041096|NCT00561353|449769563|FG005|Overall Study|Adverse Event|0|||
125135159|NCT05152576|450118322|FG003|Overall Study|Other|0|||
125135160|NCT04115293|450120062|FG000|Overall Study|Adverse Event|0|||
125135161|NCT04115293|450120063|FG001|Overall Study|Adverse Event|2|||
125135162|NCT04115293|450120062|FG000|Overall Study|Withdrawal by Subject|2|||
125218711|NCT00972283|450427403|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
125218712|NCT00972283|450427402|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
125218713|NCT00972283|450427403|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
125218714|NCT01868165|450427408|FG000|Overall Study|Withdrawal by Subject|36|||
125218715|NCT01868165|450427408|FG000|Overall Study|Physician Decision|2|||
125218716|NCT01868165|450427408|FG000|Overall Study|Lost to Follow-up|3|||
125218717|NCT01868165|450427408|FG000|Overall Study|Death|4|||
125218718|NCT02282163|450427411|FG000|Overall Study|Protocol Violation|1|||
125218719|NCT01603407|450427412|FG000|Overall Study|Adverse Event|1|||
125218720|NCT01603407|450427413|FG001|Overall Study|Adverse Event|1|||
125218721|NCT01603407|450427414|FG002|Overall Study|Adverse Event|1|||
125218722|NCT01603407|450427412|FG000|Overall Study|Protocol Violation|2|||
125218723|NCT01603407|450427413|FG001|Overall Study|Protocol Violation|2|||
125218724|NCT01603407|450427414|FG002|Overall Study|Protocol Violation|0|||
125218725|NCT01603407|450427412|FG000|Overall Study|Withdrawal by Subject|8|||
125218726|NCT01603407|450427413|FG001|Overall Study|Withdrawal by Subject|5|||
125218727|NCT01603407|450427414|FG002|Overall Study|Withdrawal by Subject|7|||
125218728|NCT01603407|450427412|FG000|Overall Study|Lost to Follow-up|0|||
125218729|NCT01603407|450427413|FG001|Overall Study|Lost to Follow-up|3|||
125218730|NCT01603407|450427414|FG002|Overall Study|Lost to Follow-up|2|||
125218731|NCT02500719|450427415|FG000|Overall Study|Lost to Follow-up|2|||
125218732|NCT02500719|450427416|FG001|Overall Study|Lost to Follow-up|3|||
125218733|NCT02500719|450427415|FG000|Overall Study|Trauma history|1|||
125218734|NCT02500719|450427416|FG001|Overall Study|Trauma history|0|||
125218735|NCT02500719|450427415|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
125218736|NCT02500719|450427416|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
125218737|NCT02500719|450427415|FG000|Overall Study|Did not meet criteria for PTSD|0|||
125218738|NCT02500719|450427416|FG001|Overall Study|Did not meet criteria for PTSD|1|||
125218739|NCT02500719|450427415|FG000|Overall Study|Claustrophobia|0|||
125218740|NCT02500719|450427416|FG001|Overall Study|Claustrophobia|1|||
125218741|NCT02500719|450427415|FG000|Overall Study|History of head trauma|0|||
125218742|NCT02500719|450427416|FG001|Overall Study|History of head trauma|1|||
125041097|NCT00561353|449769564|FG006|Overall Study|Adverse Event|1|||
125041098|NCT00561353|449769565|FG007|Overall Study|Adverse Event|0|||
125041099|NCT00561353|449769566|FG008|Overall Study|Adverse Event|0|||
125041100|NCT00561353|449769567|FG009|Overall Study|Adverse Event|1|||
125041101|NCT00561353|449769558|FG000|Overall Study|Lost to Follow-up|2|||
125041102|NCT00561353|449769559|FG001|Overall Study|Lost to Follow-up|0|||
125041103|NCT00561353|449769560|FG002|Overall Study|Lost to Follow-up|1|||
125041104|NCT00561353|449769561|FG003|Overall Study|Lost to Follow-up|0|||
125041105|NCT00561353|449769562|FG004|Overall Study|Lost to Follow-up|0|||
125041106|NCT00561353|449769563|FG005|Overall Study|Lost to Follow-up|0|||
125041107|NCT00561353|449769564|FG006|Overall Study|Lost to Follow-up|0|||
125041108|NCT00561353|449769565|FG007|Overall Study|Lost to Follow-up|0|||
125041109|NCT00561353|449769566|FG008|Overall Study|Lost to Follow-up|0|||
125041110|NCT00561353|449769567|FG009|Overall Study|Lost to Follow-up|0|||
125041111|NCT00561353|449769558|FG000|Overall Study|Withdrawal by Subject|0|||
125041112|NCT00561353|449769559|FG001|Overall Study|Withdrawal by Subject|2|||
125041113|NCT00561353|449769560|FG002|Overall Study|Withdrawal by Subject|0|||
125041114|NCT00561353|449769561|FG003|Overall Study|Withdrawal by Subject|0|||
125041115|NCT00561353|449769562|FG004|Overall Study|Withdrawal by Subject|0|||
125041116|NCT00561353|449769563|FG005|Overall Study|Withdrawal by Subject|0|||
125041117|NCT00561353|449769564|FG006|Overall Study|Withdrawal by Subject|0|||
125041118|NCT00561353|449769565|FG007|Overall Study|Withdrawal by Subject|0|||
125041119|NCT00561353|449769566|FG008|Overall Study|Withdrawal by Subject|0|||
125041120|NCT00561353|449769567|FG009|Overall Study|Withdrawal by Subject|0|||
125041121|NCT01084252|449771529|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125041122|NCT01084252|449771530|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125041123|NCT01084252|449771531|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125041124|NCT01084252|449771532|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125041125|NCT01084252|449771533|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125041126|NCT01084252|449771534|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125041127|NCT01084252|449771535|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125218743|NCT01990768|450427417|FG000|Intervention Started|Found to be ineligible|14|||
125218744|NCT01990768|450427418|FG001|Intervention Started|Found to be ineligible|13|||
125041128|NCT01084252|449771536|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125041129|NCT01084252|449771537|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125041130|NCT01084252|449771538|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125041131|NCT01084252|449771539|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125041132|NCT01084252|449771540|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125218745|NCT01990768|450427419|FG002|Intervention Started|Found to be ineligible|11|||
125218746|NCT01990768|450427417|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
125218747|NCT01990768|450427418|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
125218748|NCT01990768|450427419|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
125135163|NCT04115293|450120063|FG001|Overall Study|Withdrawal by Subject|1|||
125135164|NCT04115293|450120062|FG000|Overall Study|Physician Decision|1|||
125135165|NCT04115293|450120063|FG001|Overall Study|Physician Decision|0|||
125135166|NCT04115293|450120062|FG000|Overall Study|Death|1|||
125135167|NCT04115293|450120063|FG001|Overall Study|Death|1|||
125135168|NCT02057835|450120068|FG000|Overall Study|Withdrawal by Subject|0|||
125135169|NCT02057835|450120069|FG001|Overall Study|Withdrawal by Subject|2|||
125135170|NCT02057835|450120070|FG002|Overall Study|Withdrawal by Subject|0|||
125218749|NCT01990768|450427417|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
125218750|NCT01990768|450427418|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
125218751|NCT01990768|450427419|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
125218752|NCT01990768|450427417|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
125218753|NCT01990768|450427418|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
125218754|NCT01990768|450427419|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
125218755|NCT01990768|450427417|FG000|Intervention Started|Patient care priority|1|||
125218756|NCT01990768|450427418|FG001|Intervention Started|Patient care priority|2|||
125218757|NCT01990768|450427419|FG002|Intervention Started|Patient care priority|3|||
125218758|NCT01990768|450427417|FG000|Intervention Started|IV lost|2|||
125218759|NCT01990768|450427418|FG001|Intervention Started|IV lost|2|||
125218760|NCT01990768|450427419|FG002|Intervention Started|IV lost|2|||
125218761|NCT01990768|450427417|FG000|Intervention Started|Required CPR|1|||
125218762|NCT01990768|450427418|FG001|Intervention Started|Required CPR|1|||
125218763|NCT01990768|450427419|FG002|Intervention Started|Required CPR|0|||
125218764|NCT01990768|450427417|FG000|Intervention Started|Seizure or hx of seizure|0|||
125218765|NCT01990768|450427418|FG001|Intervention Started|Seizure or hx of seizure|0|||
124975645|NCT02579772|449536645|FG001|Overall Study|Withdrawal by Subject|1|||
124975646|NCT02579772|449536644|FG000|Overall Study|Usage of additional antioxidants|1|||
124975647|NCT02579772|449536645|FG001|Overall Study|Usage of additional antioxidants|0|||
124975648|NCT02579772|449536644|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
124975649|NCT02579772|449536645|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
124975650|NCT04991753|449538506|FG000|Overall Study|Withdrawal by Subject|0|||
124975651|NCT04991753|449538507|FG001|Overall Study|Withdrawal by Subject|1|||
124975652|NCT03299049|449538510|FG000|Overall Study|On-going|486|||
124975653|NCT03299049|449538511|FG001|Overall Study|On-going|481|||
124975654|NCT03299049|449538510|FG000|Overall Study|Withdrawal by Subject|6|||
124975655|NCT03299049|449538511|FG001|Overall Study|Withdrawal by Subject|21|||
124975656|NCT03299049|449538510|FG000|Overall Study|Physician Decision|5|||
124975657|NCT03299049|449538511|FG001|Overall Study|Physician Decision|1|||
124975658|NCT03299049|449538510|FG000|Overall Study|Lost to Follow-up|2|||
124975659|NCT03299049|449538511|FG001|Overall Study|Lost to Follow-up|0|||
124975660|NCT03299049|449538510|FG000|Overall Study|Pregnancy|1|||
124975661|NCT03299049|449538511|FG001|Overall Study|Pregnancy|3|||
124975662|NCT03299049|449538510|FG000|Overall Study|Protocol Violation|1|||
124975663|NCT03299049|449538511|FG001|Overall Study|Protocol Violation|1|||
124975664|NCT03299049|449538510|FG000|Overall Study|Lack of Efficacy|9|||
124975665|NCT03299049|449538511|FG001|Overall Study|Lack of Efficacy|3|||
124975666|NCT03299049|449538510|FG000|Overall Study|Adverse Event|12|||
124975667|NCT03299049|449538511|FG001|Overall Study|Adverse Event|13|||
124975668|NCT01901419|449538512|FG000|Overall Study|Protocol Violation|2|||
124975669|NCT01901419|449538513|FG001|Overall Study|Protocol Violation|6|||
124975670|NCT01901419|449538512|FG000|Overall Study|unavailable researchers|6|||
124975671|NCT01901419|449538513|FG001|Overall Study|unavailable researchers|3|||
124975672|NCT01667926|449538518|FG000|Overall Study|Withdrawal by Subject|1|||
125135171|NCT02057835|450120071|FG003|Overall Study|Withdrawal by Subject|0|||
125041133|NCT01084252|449771541|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
125041134|NCT01084252|449771542|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125041135|NCT04909463|449771543|FG000|Overall Study|Withdrawal by Subject|0|||
125041136|NCT04909463|449771544|FG001|Overall Study|Withdrawal by Subject|1|||
125041137|NCT04909463|449771545|FG002|Overall Study|Withdrawal by Subject|0|||
125041138|NCT04909463|449771546|FG003|Overall Study|Withdrawal by Subject|0|||
125041139|NCT04909463|449771543|FG000|Overall Study|Lost to Follow-up|2|||
125041140|NCT04909463|449771544|FG001|Overall Study|Lost to Follow-up|1|||
125041141|NCT04909463|449771545|FG002|Overall Study|Lost to Follow-up|1|||
125041142|NCT04909463|449771546|FG003|Overall Study|Lost to Follow-up|0|||
125041143|NCT03199911|449771551|FG000|Overall Study|Lost to Follow-up|5|||
125041144|NCT03199911|449771552|FG001|Overall Study|Lost to Follow-up|5|||
125041145|NCT03199911|449771551|FG000|Overall Study|Did not proceed with surgery|2|||
125041146|NCT03199911|449771552|FG001|Overall Study|Did not proceed with surgery|1|||
125041147|NCT00698516|449771553|FG000|Overall Study|Study Termination|2|||
125041148|NCT00698516|449771553|FG000|Overall Study|Withdrawal by Subject|3|||
125041149|NCT02586207|449771558|FG000|Overall Study|Physician Decision|1|||
125041150|NCT02586207|449771558|FG000|Overall Study|Withdrawal by Subject|1|||
125041151|NCT00345605|449771572|FG000|Arm 1|Adverse Event|0|||
125041152|NCT00345605|449771573|FG001|Arm 1|Adverse Event|1|||
125041153|NCT00345605|449771572|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
125041154|NCT00345605|449771573|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
125041155|NCT01335971|449771574|FG000|Overall Study|Withdrawal by Subject|1|||
125041156|NCT01335971|449771575|FG001|Overall Study|Withdrawal by Subject|0|||
125041157|NCT01335971|449771576|FG002|Overall Study|Withdrawal by Subject|0|||
125041158|NCT01335971|449771574|FG000|Overall Study|Did not complete bronchoscopy|1|||
125041159|NCT01335971|449771575|FG001|Overall Study|Did not complete bronchoscopy|1|||
125041160|NCT01335971|449771576|FG002|Overall Study|Did not complete bronchoscopy|1|||
125041161|NCT00384956|449771577|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
125041162|NCT00917384|449771578|FG000|Overall Study|Lost to Follow-up|4|||
125041163|NCT00917384|449771579|FG001|Overall Study|Lost to Follow-up|2|||
125041164|NCT00917384|449771578|FG000|Overall Study|Withdrawal by Subject|10|||
125041165|NCT00917384|449771579|FG001|Overall Study|Withdrawal by Subject|2|||
125041166|NCT00149214|449771580|FG000|Overall Study|Adverse Event|12|||
125041167|NCT00149214|449771581|FG001|Overall Study|Adverse Event|9|||
125041168|NCT00149214|449771580|FG000|Overall Study|Withdrawal by Subject|4|||
125041169|NCT00149214|449771581|FG001|Overall Study|Withdrawal by Subject|1|||
125041170|NCT00149214|449771580|FG000|Overall Study|Physician Decision|3|||
125041171|NCT00149214|449771581|FG001|Overall Study|Physician Decision|3|||
125041172|NCT00149214|449771580|FG000|Overall Study|Sponsor Decision|0|||
125041173|NCT00149214|449771581|FG001|Overall Study|Sponsor Decision|1|||
125041174|NCT00149214|449771580|FG000|Overall Study|Progressive Disease|7|||
125041175|NCT00149214|449771581|FG001|Overall Study|Progressive Disease|3|||
125041176|NCT01859403|449771586|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
125041177|NCT01859403|449771587|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
125041178|NCT01859403|449771586|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
125041179|NCT01859403|449771587|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
125041180|NCT01859403|449771586|FG000|Primary Endpoint Measure|Physician Decision|0|||
125041181|NCT01859403|449771587|FG001|Primary Endpoint Measure|Physician Decision|1|||
125041182|NCT01859403|449771586|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
125041183|NCT01859403|449771587|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
125041184|NCT00892437|449771595|FG000|Randomized Phase|Randomized but not treated|6|||
125041185|NCT00892437|449771596|FG001|Randomized Phase|Randomized but not treated|0|||
125041186|NCT00892437|449771595|FG000|Randomized Phase|Adverse Event|2|||
125041187|NCT00892437|449771596|FG001|Randomized Phase|Adverse Event|2|||
125041188|NCT00892437|449771595|FG000|Randomized Phase|Lost to Follow-up|1|||
125041189|NCT00892437|449771596|FG001|Randomized Phase|Lost to Follow-up|3|||
125041190|NCT00892437|449771595|FG000|Randomized Phase|Investigator's Discretion|1|||
125041191|NCT00892437|449771596|FG001|Randomized Phase|Investigator's Discretion|0|||
125041192|NCT00892437|449771595|FG000|Randomized Phase|Withdrew Consent|1|||
125041193|NCT00892437|449771596|FG001|Randomized Phase|Withdrew Consent|0|||
125041194|NCT00892437|449771595|FG000|Open-Label Extension Phase|Adverse Event|4|||
125041195|NCT00892437|449771596|FG001|Open-Label Extension Phase|Adverse Event|2|||
125041196|NCT00892437|449771595|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
125041197|NCT00892437|449771596|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
125041198|NCT00892437|449771595|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
125041199|NCT00892437|449771596|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
125041200|NCT00892437|449771595|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
125041201|NCT00892437|449771596|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
125041202|NCT00892437|449771595|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
125041203|NCT00892437|449771596|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
125041204|NCT02750410|449771598|FG000|Double-Blind Treatment Period|Adverse Event|2|||
125041205|NCT02750410|449771599|FG001|Double-Blind Treatment Period|Adverse Event|2|||
125041206|NCT02750410|449771598|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125135172|NCT02057835|450120072|FG004|Overall Study|Withdrawal by Subject|0|||
125135173|NCT02057835|450120073|FG005|Overall Study|Withdrawal by Subject|0|||
125135174|NCT02057835|450120074|FG006|Overall Study|Withdrawal by Subject|0|||
125135175|NCT02057835|450120075|FG007|Overall Study|Withdrawal by Subject|0|||
125135176|NCT02057835|450120076|FG008|Overall Study|Withdrawal by Subject|0|||
125135177|NCT02057835|450120077|FG009|Overall Study|Withdrawal by Subject|0|||
125135178|NCT00712959|450120081|FG000|Overall Study|Protocol Violation|3|||
125135179|NCT00712959|450120082|FG001|Overall Study|Protocol Violation|1|||
125135180|NCT00712959|450120081|FG000|Overall Study|Lost to Follow-up|13|||
125135181|NCT00712959|450120082|FG001|Overall Study|Lost to Follow-up|2|||
125135182|NCT00712959|450120081|FG000|Overall Study|Withdrawal by Subject|3|||
125135183|NCT00712959|450120082|FG001|Overall Study|Withdrawal by Subject|0|||
125135184|NCT01376037|450120092|FG000|Overall Study|Lost to Follow-up|0|||
125135185|NCT01376037|450120093|FG001|Overall Study|Lost to Follow-up|2|||
125135186|NCT02328040|450120094|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
125135187|NCT02328040|450120095|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
125135188|NCT04278560|450120100|FG000|Overall Study|Adverse Event|1|||
125135189|NCT04278560|450120101|FG001|Overall Study|Adverse Event|2|||
125135190|NCT04278560|450120100|FG000|Overall Study|Withdrawal by Subject|0|||
125135191|NCT04278560|450120101|FG001|Overall Study|Withdrawal by Subject|1|||
125135192|NCT02832063|450120102|FG000|Overall Study|Adverse Event|2|||
125041207|NCT02750410|449771599|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125041208|NCT02750410|449771598|FG000|Open-Label Extension Period|Adverse Event|5|||
125041209|NCT02750410|449771599|FG001|Open-Label Extension Period|Adverse Event|3|||
125041210|NCT02750410|449771598|FG000|Open-Label Extension Period|Protocol Violation|0|||
125041211|NCT02750410|449771599|FG001|Open-Label Extension Period|Protocol Violation|1|||
125041212|NCT02750410|449771598|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
125041213|NCT02750410|449771599|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
125041214|NCT01531725|449771603|FG000|Overall Study|Protocol Violation|5|||
125041215|NCT01238120|449771604|FG000|Overall Study|Withdrawal by Subject|4|||
125041216|NCT01238120|449771605|FG001|Overall Study|Withdrawal by Subject|1|||
125041217|NCT01238120|449771606|FG002|Overall Study|Withdrawal by Subject|2|||
125041218|NCT01238120|449771607|FG003|Overall Study|Withdrawal by Subject|5|||
125041219|NCT01238120|449771604|FG000|Overall Study|Lost to Follow-up|2|||
125041220|NCT01238120|449771605|FG001|Overall Study|Lost to Follow-up|0|||
125041221|NCT01238120|449771606|FG002|Overall Study|Lost to Follow-up|1|||
125041222|NCT01238120|449771607|FG003|Overall Study|Lost to Follow-up|1|||
125041223|NCT01238120|449771604|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
125041224|NCT01238120|449771605|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
125041225|NCT01238120|449771606|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
125041226|NCT01238120|449771607|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
125041227|NCT03596164|449771609|FG000|Overall Study|Adverse Event|0|||
125041228|NCT03596164|449771610|FG001|Overall Study|Adverse Event|1|||
125041229|NCT03596164|449771609|FG000|Overall Study|Death|1|||
125041230|NCT03596164|449771610|FG001|Overall Study|Death|0|||
125041231|NCT04112914|449771611|FG000|Overall Study|Lost to Follow-up|13|||
125041232|NCT04112914|449771612|FG001|Overall Study|Lost to Follow-up|9|||
125041233|NCT04112914|449771611|FG000|Overall Study|Withdrawal by Subject|1|||
125041234|NCT04112914|449771612|FG001|Overall Study|Withdrawal by Subject|0|||
125041235|NCT03427073|449771613|FG000|Overall Study|Disease Progression|1|||
125041236|NCT03427073|449771614|FG001|Overall Study|Disease Progression|1|||
125041237|NCT03427073|449771615|FG002|Overall Study|Disease Progression|1|||
125041238|NCT03427073|449771616|FG003|Overall Study|Disease Progression|3|||
125041239|NCT03427073|449771617|FG004|Overall Study|Disease Progression|3|||
125041240|NCT03427073|449771618|FG005|Overall Study|Disease Progression|4|||
125041241|NCT03427073|449771619|FG006|Overall Study|Disease Progression|2|||
125041242|NCT03427073|449771620|FG007|Overall Study|Disease Progression|3|||
125041243|NCT03427073|449771613|FG000|Overall Study|Physician Decision|0|||
125041244|NCT03427073|449771614|FG001|Overall Study|Physician Decision|0|||
125041245|NCT03427073|449771615|FG002|Overall Study|Physician Decision|0|||
125041246|NCT03427073|449771616|FG003|Overall Study|Physician Decision|0|||
125135193|NCT02832063|450120103|FG001|Overall Study|Adverse Event|1|||
125135194|NCT02832063|450120102|FG000|Overall Study|Physician Decision|5|||
125135195|NCT02832063|450120103|FG001|Overall Study|Physician Decision|7|||
125135196|NCT02832063|450120102|FG000|Overall Study|Lost to Follow-up|15|||
125135197|NCT02832063|450120103|FG001|Overall Study|Lost to Follow-up|8|||
125041247|NCT03427073|449771617|FG004|Overall Study|Physician Decision|0|||
125041248|NCT03427073|449771618|FG005|Overall Study|Physician Decision|0|||
125041249|NCT03427073|449771619|FG006|Overall Study|Physician Decision|1|||
125041250|NCT03427073|449771620|FG007|Overall Study|Physician Decision|1|||
125041251|NCT02835495|449771623|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
125041252|NCT02835495|449771624|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
125041253|NCT02835495|449771623|FG000|Overall Study|Declined in-person follow-up visit|4|||
125041254|NCT02835495|449771624|FG001|Overall Study|Declined in-person follow-up visit|2|||
125041255|NCT05421754|449771625|FG000|Overall Study|Technical issue with sensor|1|||
125041256|NCT02580058|449771629|FG000|Overall Study|Adverse Event|16|||
125135198|NCT02832063|450120102|FG000|Overall Study|Withdrawal by Subject|10|||
125041257|NCT02580058|449771630|FG001|Overall Study|Adverse Event|30|||
125041258|NCT02580058|449771631|FG002|Overall Study|Adverse Event|20|||
125041259|NCT02580058|449771629|FG000|Overall Study|Death|4|||
125041260|NCT02580058|449771630|FG001|Overall Study|Death|4|||
125041261|NCT02580058|449771631|FG002|Overall Study|Death|5|||
125041262|NCT02580058|449771629|FG000|Overall Study|Physician Decision|1|||
125041263|NCT02580058|449771630|FG001|Overall Study|Physician Decision|3|||
125041264|NCT02580058|449771631|FG002|Overall Study|Physician Decision|11|||
125041265|NCT02580058|449771629|FG000|Overall Study|Other|5|||
125041266|NCT02580058|449771630|FG001|Overall Study|Other|1|||
125041267|NCT02580058|449771631|FG002|Overall Study|Other|3|||
125041268|NCT02580058|449771629|FG000|Overall Study|Withdrawal by Subject|4|||
125041269|NCT02580058|449771630|FG001|Overall Study|Withdrawal by Subject|7|||
125041270|NCT02580058|449771631|FG002|Overall Study|Withdrawal by Subject|31|||
125041271|NCT02580058|449771629|FG000|Overall Study|Global Deterioration of Health Status|19|||
125041272|NCT02580058|449771630|FG001|Overall Study|Global Deterioration of Health Status|18|||
125041273|NCT02580058|449771631|FG002|Overall Study|Global Deterioration of Health Status|24|||
125041274|NCT02580058|449771629|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
125041275|NCT02580058|449771630|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
125041276|NCT02580058|449771631|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
125041277|NCT02580058|449771629|FG000|Overall Study|Progressive Disease|137|||
125041278|NCT02580058|449771630|FG001|Overall Study|Progressive Disease|125|||
125041279|NCT02580058|449771631|FG002|Overall Study|Progressive Disease|94|||
125041280|NCT02580058|449771629|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125041281|NCT02580058|449771630|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125041282|NCT02580058|449771631|FG002|Overall Study|Non-Compliance With Study Drug|0|||
125041283|NCT03486314|449771632|FG000|Part A|Adverse Event|1|||
125041284|NCT03486314|449771633|FG001|Part A|Adverse Event|0|||
125041285|NCT03486314|449771634|FG002|Part A|Adverse Event|0|||
125041286|NCT03486314|449771632|FG000|Part A|Symptomatic Deterioration|2|||
125041287|NCT03486314|449771633|FG001|Part A|Symptomatic Deterioration|0|||
125041288|NCT03486314|449771634|FG002|Part A|Symptomatic Deterioration|0|||
125041289|NCT00659438|449771635|FG000|Overall Study|Withdrawal by Subject|2|||
125041290|NCT00659438|449771636|FG001|Overall Study|Withdrawal by Subject|2|||
125041291|NCT00659438|449771635|FG000|Overall Study|Death|11|||
125041292|NCT00659438|449771636|FG001|Overall Study|Death|6|||
125041293|NCT00659438|449771635|FG000|Overall Study|Lost to Follow-up|1|||
125041294|NCT00659438|449771636|FG001|Overall Study|Lost to Follow-up|0|||
125041295|NCT02388776|449771637|FG000|Overall Study|Death|1|||
125041296|NCT02388776|449771637|FG000|Overall Study|Lost to Follow-up|1|||
125041297|NCT03826914|449771638|FG000|Overall Study|Withdrawal by Subject|1|||
125041298|NCT03826914|449771639|FG001|Overall Study|Withdrawal by Subject|1|||
125041299|NCT04334148|449771640|FG000|Overall Study|positive nasal swab at baseline|0|||
125041300|NCT04334148|449771641|FG001|Overall Study|positive nasal swab at baseline|1|||
125135199|NCT02832063|450120103|FG001|Overall Study|Withdrawal by Subject|21|||
125135200|NCT02832063|450120102|FG000|Overall Study|Other|2|||
125135201|NCT02832063|450120103|FG001|Overall Study|Other|1|||
125135202|NCT03086460|450120108|FG000|Study Participants|Lost to Follow-up|2|||
125135203|NCT03086460|450120108|FG000|Study Participants|Protocol Violation|1|||
125135204|NCT03086460|450120108|FG000|Study Participants|Withdrawal by Subject|6|||
125135205|NCT03086460|450120108|FG000|Treatment A|Lost to Follow-up|1|||
125135206|NCT03086460|450120108|FG000|Treatment A|Protocol Violation|1|||
125135207|NCT03086460|450120108|FG000|Treatment A|Withdrawal by Subject|2|||
125135208|NCT03086460|450120108|FG000|Treatment C|Withdrawal by Subject|2|||
125135209|NCT03086460|450120108|FG000|Treatment E|Lost to Follow-up|1|||
125135210|NCT03086460|450120108|FG000|Treatment E|Withdrawal by Subject|3|||
125135211|NCT03600805|450120109|FG000|Overall Study|Adverse Event|2|||
125135212|NCT03600805|450120110|FG001|Overall Study|Adverse Event|1|||
125135213|NCT03600805|450120111|FG002|Overall Study|Adverse Event|1|||
125135214|NCT03600805|450120112|FG003|Overall Study|Adverse Event|7|||
125135215|NCT03600805|450120109|FG000|Overall Study|Lack of Efficacy|2|||
125135216|NCT03600805|450120110|FG001|Overall Study|Lack of Efficacy|1|||
125135217|NCT03600805|450120111|FG002|Overall Study|Lack of Efficacy|0|||
125135218|NCT03600805|450120112|FG003|Overall Study|Lack of Efficacy|0|||
125135219|NCT03600805|450120109|FG000|Overall Study|Withdrawal by Subject|1|||
125135220|NCT03600805|450120110|FG001|Overall Study|Withdrawal by Subject|0|||
125135221|NCT03600805|450120111|FG002|Overall Study|Withdrawal by Subject|0|||
125041301|NCT00542828|449771642|FG000|Overall Study|Physician Decision|1|||
125135222|NCT03600805|450120112|FG003|Overall Study|Withdrawal by Subject|1|||
125041302|NCT00542828|449771642|FG000|Overall Study|Need for Prohibited Treatment|3|||
125041303|NCT00542828|449771642|FG000|Overall Study|Study Prematurely Discontinued|7|||
125041304|NCT00542828|449771642|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
125041305|NCT03228186|449771645|FG000|Overall Study|Patient never started treatment|1|||
125041306|NCT04246047|449771648|FG000|Overall Study|Death|50|||
125135223|NCT03600805|450120109|FG000|Overall Study|Other unspecified|14|||
125135224|NCT03600805|450120110|FG001|Overall Study|Other unspecified|6|||
125135225|NCT03600805|450120111|FG002|Overall Study|Other unspecified|7|||
125135226|NCT03600805|450120112|FG003|Overall Study|Other unspecified|11|||
125041307|NCT04246047|449771649|FG001|Overall Study|Death|77|||
125041308|NCT04246047|449771648|FG000|Overall Study|Lost to Follow-up|1|||
125041309|NCT04246047|449771649|FG001|Overall Study|Lost to Follow-up|3|||
125041310|NCT04246047|449771648|FG000|Overall Study|Physician Decision|4|||
125041311|NCT04246047|449771649|FG001|Overall Study|Physician Decision|10|||
125041312|NCT04246047|449771648|FG000|Overall Study|Withdrawal by Subject|19|||
125041313|NCT04246047|449771649|FG001|Overall Study|Withdrawal by Subject|26|||
125041314|NCT04246047|449771648|FG000|Overall Study|Ongoing|169|||
125041315|NCT04246047|449771649|FG001|Overall Study|Ongoing|135|||
125041316|NCT05139030|449771653|FG000|Overall Study|Withdrawal by Subject|1|||
125041317|NCT05139030|449771654|FG001|Overall Study|Withdrawal by Subject|3|||
125041318|NCT05139030|449771653|FG000|Overall Study|Adverse Event|0|||
125041319|NCT05139030|449771654|FG001|Overall Study|Adverse Event|1|||
125041320|NCT05139030|449771653|FG000|Overall Study|Failure to meet continuation criteria|0|||
125218766|NCT01990768|450427419|FG002|Intervention Started|Seizure or hx of seizure|2|||
125041321|NCT05139030|449771654|FG001|Overall Study|Failure to meet continuation criteria|1|||
125041322|NCT01982630|449771655|FG000|Overall Study|Adverse Event|2|||
125041323|NCT01982630|449771656|FG001|Overall Study|Adverse Event|0|||
125041324|NCT01982630|449771657|FG002|Overall Study|Adverse Event|1|||
125041325|NCT01982630|449771658|FG003|Overall Study|Adverse Event|0|||
125041326|NCT01982630|449771659|FG004|Overall Study|Adverse Event|1|||
125041327|NCT01982630|449771660|FG005|Overall Study|Adverse Event|2|||
125041328|NCT01982630|449771661|FG006|Overall Study|Adverse Event|1|||
125041329|NCT01982630|449771662|FG007|Overall Study|Adverse Event|0|||
125041330|NCT01982630|449771655|FG000|Overall Study|Physician Decision|1|||
125041331|NCT01982630|449771656|FG001|Overall Study|Physician Decision|0|||
125041332|NCT01982630|449771657|FG002|Overall Study|Physician Decision|2|||
125041333|NCT01982630|449771658|FG003|Overall Study|Physician Decision|1|||
125041334|NCT01982630|449771659|FG004|Overall Study|Physician Decision|2|||
125041335|NCT01982630|449771660|FG005|Overall Study|Physician Decision|0|||
125041336|NCT01982630|449771661|FG006|Overall Study|Physician Decision|0|||
125041337|NCT01982630|449771662|FG007|Overall Study|Physician Decision|0|||
125041338|NCT01982630|449771655|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
125041339|NCT01982630|449771656|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
125041340|NCT01982630|449771657|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
125041341|NCT01982630|449771658|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
125041342|NCT01982630|449771659|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
125041343|NCT01982630|449771660|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
125041344|NCT01982630|449771661|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
125041345|NCT01982630|449771662|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
125041346|NCT01982630|449771655|FG000|Overall Study|Withdrawal by Subject|0|||
125041347|NCT01982630|449771656|FG001|Overall Study|Withdrawal by Subject|0|||
125041348|NCT01982630|449771657|FG002|Overall Study|Withdrawal by Subject|0|||
125041349|NCT01982630|449771658|FG003|Overall Study|Withdrawal by Subject|0|||
125041350|NCT01982630|449771659|FG004|Overall Study|Withdrawal by Subject|0|||
125041351|NCT01982630|449771660|FG005|Overall Study|Withdrawal by Subject|1|||
125041352|NCT01982630|449771661|FG006|Overall Study|Withdrawal by Subject|0|||
125041353|NCT01982630|449771662|FG007|Overall Study|Withdrawal by Subject|0|||
125041354|NCT03459040|449771663|FG000|Overall Study|Death|8|||
125041355|NCT03459040|449771663|FG000|Overall Study|Withdrawal by Subject|1|||
125041356|NCT01273818|449771664|FG000|Overall Study|Physician Decision|13|||
125041357|NCT01273818|449771665|FG001|Overall Study|Physician Decision|2|||
125041358|NCT01273818|449771666|FG002|Overall Study|Physician Decision|9|||
125041359|NCT03815175|449771667|FG000|Overall Study|Subject Lost to Follow-up|6|||
125041360|NCT03815175|449771667|FG000|Overall Study|Subject Withdrew Consent|48|||
125041361|NCT03815175|449771667|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
125041362|NCT03815175|449771667|FG000|Overall Study|Death|86|||
125041363|NCT03815175|449771667|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
125041364|NCT03815175|449771667|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
125041365|NCT03815175|449771667|FG000|Overall Study|Other Status Change Reason|1|||
125041366|NCT03815175|449771667|FG000|Overall Study|Missed Visit|12|||
125041367|NCT00820040|449771668|FG000|Overall Study|Death|1|||
125041368|NCT00820040|449771668|FG000|Overall Study|Sponsor terminated study|1|||
125041369|NCT00820040|449771668|FG000|Overall Study|Screen failure|1|||
125041370|NCT02493751|449771669|FG000|Overall Study|Withdrawal by Subject|2|||
125041371|NCT02493751|449771670|FG001|Overall Study|Withdrawal by Subject|8|||
125041372|NCT02493751|449771669|FG000|Overall Study|Death|6|||
125041373|NCT02493751|449771670|FG001|Overall Study|Death|13|||
125041374|NCT02493751|449771669|FG000|Overall Study|Lost to Follow-up|2|||
125041375|NCT02493751|449771670|FG001|Overall Study|Lost to Follow-up|3|||
125041376|NCT02493751|449771669|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
125218767|NCT01990768|450427417|FG000|Intervention Started|Discovered to be pregnant|0|||
125041377|NCT02493751|449771670|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
125041378|NCT01824602|449771673|FG000|Overall Study|Withdrawal by Subject|0|||
125041379|NCT01824602|449771674|FG001|Overall Study|Withdrawal by Subject|0|||
125041380|NCT01824602|449771675|FG002|Overall Study|Withdrawal by Subject|1|||
125041381|NCT01824602|449771676|FG003|Overall Study|Withdrawal by Subject|2|||
125041382|NCT01824602|449771673|FG000|Overall Study|Patient non-compliance|0|||
125041383|NCT01824602|449771674|FG001|Overall Study|Patient non-compliance|0|||
125041384|NCT01824602|449771675|FG002|Overall Study|Patient non-compliance|1|||
125041385|NCT01824602|449771676|FG003|Overall Study|Patient non-compliance|0|||
125041386|NCT01824602|449771673|FG000|Overall Study|Adverse Event|1|||
125041387|NCT01824602|449771674|FG001|Overall Study|Adverse Event|0|||
125041388|NCT01824602|449771675|FG002|Overall Study|Adverse Event|2|||
125041389|NCT01824602|449771676|FG003|Overall Study|Adverse Event|2|||
125041390|NCT01824602|449771673|FG000|Overall Study|Treatment failure|0|||
125041391|NCT01824602|449771674|FG001|Overall Study|Treatment failure|0|||
125041392|NCT01824602|449771675|FG002|Overall Study|Treatment failure|0|||
125041393|NCT01824602|449771676|FG003|Overall Study|Treatment failure|1|||
125041394|NCT02485717|449771679|FG000|Overall Study|Lost to Follow-up|6|||
125041395|NCT02485717|449771680|FG001|Overall Study|Lost to Follow-up|0|||
125041396|NCT02485717|449771681|FG002|Overall Study|Lost to Follow-up|0|||
125041397|NCT02485717|449771679|FG000|Overall Study|Withdrawal by Subject|0|||
125041398|NCT02485717|449771680|FG001|Overall Study|Withdrawal by Subject|0|||
125041399|NCT02485717|449771681|FG002|Overall Study|Withdrawal by Subject|1|||
125041400|NCT02485717|449771679|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
125041401|NCT02485717|449771680|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
125041402|NCT02485717|449771681|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
125041403|NCT02485717|449771679|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
125041404|NCT02485717|449771680|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
125041405|NCT02485717|449771681|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
125041406|NCT03822468|449771684|FG000|Treatment Period|Progressive disease|98|||
125041407|NCT03822468|449771685|FG001|Treatment Period|Progressive disease|94|||
125041408|NCT03822468|449771684|FG000|Treatment Period|Adverse Event|21|||
125041409|NCT03822468|449771685|FG001|Treatment Period|Adverse Event|24|||
125041410|NCT03822468|449771684|FG000|Treatment Period|Withdrawal by Subject|9|||
125041411|NCT03822468|449771685|FG001|Treatment Period|Withdrawal by Subject|5|||
125041412|NCT03822468|449771684|FG000|Treatment Period|Physician Decision|9|||
125041413|NCT03822468|449771685|FG001|Treatment Period|Physician Decision|7|||
125041414|NCT03822468|449771684|FG000|Treatment Period|Protocol Violation|2|||
125041415|NCT03822468|449771685|FG001|Treatment Period|Protocol Violation|1|||
125041416|NCT03822468|449771684|FG000|Treatment Period|Death|2|||
125041417|NCT03822468|449771685|FG001|Treatment Period|Death|3|||
125041418|NCT03822468|449771684|FG000|Treatment Period|Lost to Follow-up|1|||
125041419|NCT03822468|449771685|FG001|Treatment Period|Lost to Follow-up|1|||
125041420|NCT03822468|449771684|FG000|Treatment Period|Sponsor decision|46|||
125041421|NCT03822468|449771685|FG001|Treatment Period|Sponsor decision|53|||
125041422|NCT03822468|449771684|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
125041423|NCT03822468|449771685|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
125041424|NCT03822468|449771684|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
125041425|NCT03822468|449771685|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
125041426|NCT03822468|449771684|FG000|Post-treatment Efficacy Follow-up|Death|1|||
125041427|NCT03822468|449771685|FG001|Post-treatment Efficacy Follow-up|Death|0|||
125041428|NCT03822468|449771684|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
125041429|NCT03822468|449771685|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
125041430|NCT03822468|449771684|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
125041431|NCT03822468|449771685|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
125041432|NCT03822468|449771684|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
125041433|NCT03822468|449771685|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
125041434|NCT03822468|449771684|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
125041435|NCT03822468|449771685|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
125041436|NCT05300087|449771686|FG000|Overall Study|Withdrawal by Subject|0|||
125041437|NCT05300087|449771687|FG001|Overall Study|Withdrawal by Subject|1|||
125041438|NCT03248128|449771688|FG000|Overall Study|Lost to Follow-up|1|||
125041439|NCT03248128|449771689|FG001|Overall Study|Lost to Follow-up|0|||
125041440|NCT03248128|449771688|FG000|Overall Study|Withdrawal by Subject|16|||
125041441|NCT03248128|449771689|FG001|Overall Study|Withdrawal by Subject|14|||
125041442|NCT03248128|449771688|FG000|Overall Study|Site Closed|4|||
125041443|NCT03248128|449771689|FG001|Overall Study|Site Closed|3|||
125041444|NCT03248128|449771688|FG000|Overall Study|Randomized, but did not receive treatment|1|||
125041445|NCT03248128|449771689|FG001|Overall Study|Randomized, but did not receive treatment|3|||
125041446|NCT01914679|449771690|FG000|Overall Study|Lack of Efficacy|1|||
125041447|NCT01914679|449771690|FG000|Overall Study|Sponsor terminated study|4|||
125041448|NCT00002850|449771692|FG000|Overall Study|Death|4|||
125041449|NCT00002850|449771693|FG001|Overall Study|Death|1|||
125041450|NCT00002850|449771694|FG002|Overall Study|Death|3|||
125041451|NCT00002850|449771692|FG000|Overall Study|Protocol Violation|1|||
125041452|NCT00002850|449771693|FG001|Overall Study|Protocol Violation|0|||
125041453|NCT00002850|449771694|FG002|Overall Study|Protocol Violation|1|||
125041454|NCT00002850|449771692|FG000|Overall Study|Withdrawal by Subject|0|||
125041455|NCT00002850|449771693|FG001|Overall Study|Withdrawal by Subject|1|||
125041456|NCT00002850|449771694|FG002|Overall Study|Withdrawal by Subject|0|||
125041457|NCT02452359|449771698|FG000|Overall Study|Adverse Event|1|||
125041458|NCT02452359|449771698|FG000|Overall Study|Lost to Follow-up|15|||
125041459|NCT02452359|449771698|FG000|Overall Study|Pregnancy|1|||
125041460|NCT02452359|449771698|FG000|Overall Study|Withdrawal by Subject|4|||
125041461|NCT05635838|449773148|FG000|16-Week DBVC Period|Adverse Event|2|||
125041462|NCT05635838|449773149|FG001|16-Week DBVC Period|Adverse Event|0|||
125041463|NCT05635838|449773150|FG002|16-Week DBVC Period|Adverse Event|0|||
125041464|NCT05635838|449773151|FG003|16-Week DBVC Period|Adverse Event|0|||
125041465|NCT05635838|449773148|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
125041466|NCT05635838|449773149|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
125041467|NCT05635838|449773150|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
125041468|NCT05635838|449773151|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
125041469|NCT05635838|449773148|FG000|16-Week DBVC Period|Physician Decision|0|||
125041470|NCT05635838|449773149|FG001|16-Week DBVC Period|Physician Decision|1|||
125041471|NCT05635838|449773150|FG002|16-Week DBVC Period|Physician Decision|0|||
125041472|NCT05635838|449773151|FG003|16-Week DBVC Period|Physician Decision|0|||
125041473|NCT05635838|449773148|FG000|16-Week DBVC Period|Protocol Violation|1|||
125041474|NCT05635838|449773149|FG001|16-Week DBVC Period|Protocol Violation|0|||
125041475|NCT05635838|449773150|FG002|16-Week DBVC Period|Protocol Violation|0|||
125041476|NCT05635838|449773151|FG003|16-Week DBVC Period|Protocol Violation|0|||
125041477|NCT05635838|449773148|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
125041478|NCT05635838|449773149|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
125041479|NCT05635838|449773150|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
125041480|NCT05635838|449773151|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
125041481|NCT05635838|449773148|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
125041482|NCT05635838|449773149|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
125041483|NCT05635838|449773150|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
125041484|NCT05635838|449773151|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
125041485|NCT05635838|449773148|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
125041486|NCT05635838|449773149|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
125041487|NCT05635838|449773150|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
125041488|NCT05635838|449773151|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
125041489|NCT05635838|449773148|FG000|16-Week OLE Period|Adverse Event|0|||
125041490|NCT05635838|449773149|FG001|16-Week OLE Period|Adverse Event|0|||
125041491|NCT05635838|449773150|FG002|16-Week OLE Period|Adverse Event|0|||
125041492|NCT05635838|449773151|FG003|16-Week OLE Period|Adverse Event|2|||
125041493|NCT05635838|449773148|FG000|16-Week OLE Period|Lost to Follow-up|0|||
125041494|NCT05635838|449773149|FG001|16-Week OLE Period|Lost to Follow-up|0|||
125041495|NCT05635838|449773150|FG002|16-Week OLE Period|Lost to Follow-up|1|||
125041496|NCT05635838|449773151|FG003|16-Week OLE Period|Lost to Follow-up|3|||
125041497|NCT05635838|449773148|FG000|16-Week OLE Period|Physician Decision|0|||
125041498|NCT05635838|449773149|FG001|16-Week OLE Period|Physician Decision|0|||
125041499|NCT05635838|449773150|FG002|16-Week OLE Period|Physician Decision|0|||
125041500|NCT05635838|449773151|FG003|16-Week OLE Period|Physician Decision|1|||
125041501|NCT05635838|449773148|FG000|16-Week OLE Period|Protocol Violation|0|||
125041502|NCT05635838|449773149|FG001|16-Week OLE Period|Protocol Violation|0|||
125041503|NCT05635838|449773150|FG002|16-Week OLE Period|Protocol Violation|1|||
125041504|NCT05635838|449773151|FG003|16-Week OLE Period|Protocol Violation|1|||
125041505|NCT05635838|449773148|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
125135227|NCT03415308|450120115|FG000|Overall Study|Lost to Follow-up|0|||
125135228|NCT03415308|450120116|FG001|Overall Study|Lost to Follow-up|0|||
125135229|NCT03415308|450120117|FG002|Overall Study|Lost to Follow-up|1|||
125135230|NCT03415308|450120115|FG000|Overall Study|Scheduling Conflicts|0|||
125135231|NCT03415308|450120116|FG001|Overall Study|Scheduling Conflicts|0|||
125135232|NCT03415308|450120117|FG002|Overall Study|Scheduling Conflicts|7|||
125135233|NCT01471353|450120119|FG000|Overall Study|remain on study|3|||
125041506|NCT05635838|449773149|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
125041507|NCT05635838|449773150|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
125041508|NCT05635838|449773151|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
125041509|NCT05635838|449773148|FG000|16-Week OLE Period|Pregnancy|0|||
125135234|NCT00836472|450120120|FG000|Washout|Adverse Event|1|||
125041510|NCT05635838|449773149|FG001|16-Week OLE Period|Pregnancy|0|||
125041511|NCT05635838|449773150|FG002|16-Week OLE Period|Pregnancy|1|||
125041512|NCT05635838|449773151|FG003|16-Week OLE Period|Pregnancy|0|||
125041513|NCT03518840|449773157|FG000|Overall Study|Lost to Follow-up|6|||
125041514|NCT00875420|449773159|FG000|Overall Study|Adverse Event|0|||
125041515|NCT00875420|449773160|FG001|Overall Study|Adverse Event|1|||
125135235|NCT00836472|450120121|FG001|Washout|Adverse Event|2|||
125135236|NCT00836472|450120120|FG000|Washout|Withdrawal by Subject|1|||
125218768|NCT01990768|450427418|FG001|Intervention Started|Discovered to be pregnant|1|||
125135237|NCT00836472|450120121|FG001|Washout|Withdrawal by Subject|1|||
125135238|NCT01695239|450120122|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
125041516|NCT00875420|449773161|FG002|Overall Study|Adverse Event|1|||
125041517|NCT00875420|449773162|FG003|Overall Study|Adverse Event|0|||
125041518|NCT00875420|449773163|FG004|Overall Study|Adverse Event|0|||
125041519|NCT00875420|449773159|FG000|Overall Study|Inability to complete study procedures|1|||
125041520|NCT00875420|449773160|FG001|Overall Study|Inability to complete study procedures|0|||
125041521|NCT00875420|449773161|FG002|Overall Study|Inability to complete study procedures|1|||
125041522|NCT00875420|449773162|FG003|Overall Study|Inability to complete study procedures|1|||
125041523|NCT00875420|449773163|FG004|Overall Study|Inability to complete study procedures|1|||
125041524|NCT00875420|449773159|FG000|Overall Study|Lost to Follow-up|1|||
125041525|NCT00875420|449773160|FG001|Overall Study|Lost to Follow-up|0|||
125041526|NCT00875420|449773161|FG002|Overall Study|Lost to Follow-up|0|||
125041527|NCT00875420|449773162|FG003|Overall Study|Lost to Follow-up|0|||
125041528|NCT00875420|449773163|FG004|Overall Study|Lost to Follow-up|0|||
125041529|NCT00875420|449773159|FG000|Overall Study|Personal reason|0|||
125041530|NCT00875420|449773160|FG001|Overall Study|Personal reason|0|||
125041531|NCT00875420|449773161|FG002|Overall Study|Personal reason|0|||
125041532|NCT00875420|449773162|FG003|Overall Study|Personal reason|0|||
125041533|NCT00875420|449773163|FG004|Overall Study|Personal reason|1|||
125041534|NCT00875420|449773159|FG000|Overall Study|Prohibited medication|0|||
125041535|NCT00875420|449773160|FG001|Overall Study|Prohibited medication|0|||
125041536|NCT00875420|449773161|FG002|Overall Study|Prohibited medication|0|||
125041537|NCT00875420|449773162|FG003|Overall Study|Prohibited medication|1|||
125041538|NCT00875420|449773163|FG004|Overall Study|Prohibited medication|0|||
125041539|NCT00875420|449773159|FG000|Overall Study|Sponsor decision|0|||
125041540|NCT00875420|449773160|FG001|Overall Study|Sponsor decision|1|||
125041541|NCT00875420|449773161|FG002|Overall Study|Sponsor decision|0|||
125041542|NCT00875420|449773162|FG003|Overall Study|Sponsor decision|0|||
125041543|NCT00875420|449773163|FG004|Overall Study|Sponsor decision|0|||
125041544|NCT00875420|449773159|FG000|Overall Study|Withdrawal by Subject|0|||
125041545|NCT00875420|449773160|FG001|Overall Study|Withdrawal by Subject|0|||
125041546|NCT00875420|449773161|FG002|Overall Study|Withdrawal by Subject|1|||
125041547|NCT00875420|449773162|FG003|Overall Study|Withdrawal by Subject|0|||
125041548|NCT00875420|449773163|FG004|Overall Study|Withdrawal by Subject|0|||
125041549|NCT00001259|449773164|FG000|Study 2|Adverse Event|0|||
125041550|NCT00001259|449773165|FG001|Study 2|Adverse Event|0|||
125041551|NCT00001259|449773166|FG002|Study 2|Adverse Event|0|||
125041552|NCT00001259|449773167|FG003|Study 2|Adverse Event|0|||
125041553|NCT00001259|449773168|FG004|Study 2|Adverse Event|2|||
125041554|NCT00001259|449773169|FG005|Study 2|Adverse Event|0|||
125041555|NCT00001259|449773170|FG006|Study 2|Adverse Event|0|||
125041556|NCT03716726|449773173|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
125041557|NCT03716726|449773174|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
125041558|NCT03716726|449773173|FG000|12 Months Followup|Lost to Follow-up|10|||
125041559|NCT03716726|449773174|FG001|12 Months Followup|Lost to Follow-up|17|||
125041560|NCT01416181|449773175|FG000|Part 1|Other|10|||
125041561|NCT01416181|449773176|FG001|Part 1|Other|24|||
125041562|NCT01416181|449773175|FG000|Part 1|Death|0|||
125041563|NCT01416181|449773176|FG001|Part 1|Death|1|||
125041564|NCT01416181|449773175|FG000|Part 1|Investigator Decision|7|||
125041565|NCT01416181|449773176|FG001|Part 1|Investigator Decision|6|||
125041566|NCT01416181|449773175|FG000|Part 1|Withdrawal by Subject|74|||
125041567|NCT01416181|449773176|FG001|Part 1|Withdrawal by Subject|48|||
125041568|NCT01416181|449773175|FG000|Part 1|Lack of Efficacy|16|||
125041569|NCT01416181|449773176|FG001|Part 1|Lack of Efficacy|8|||
125041570|NCT01416181|449773175|FG000|Part 1|Lost to Follow-up|1|||
125041571|NCT01416181|449773176|FG001|Part 1|Lost to Follow-up|1|||
125135239|NCT01695239|450120123|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
125041572|NCT01416181|449773175|FG000|Part 1|Adverse Event|15|||
125041573|NCT01416181|449773176|FG001|Part 1|Adverse Event|18|||
125041574|NCT01416181|449773175|FG000|Part 1|Ongoing in Follow-Up|14|||
125041575|NCT01416181|449773176|FG001|Part 1|Ongoing in Follow-Up|8|||
125041576|NCT01416181|449773175|FG000|Part 2|Adverse Event|11|||
125041577|NCT01416181|449773176|FG001|Part 2|Adverse Event|4|||
125135240|NCT01695239|450120124|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
125135241|NCT01695239|450120125|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
125041578|NCT01416181|449773175|FG000|Part 2|Other|234|||
125041579|NCT01416181|449773176|FG001|Part 2|Other|267|||
125041580|NCT01416181|449773175|FG000|Part 2|Investigator Decision|6|||
125041581|NCT01416181|449773176|FG001|Part 2|Investigator Decision|7|||
125041582|NCT01416181|449773175|FG000|Part 2|Withdrawal by Subject|14|||
125041583|NCT01416181|449773176|FG001|Part 2|Withdrawal by Subject|5|||
125041584|NCT01416181|449773175|FG000|Part 2|Lack of Efficacy|4|||
125041585|NCT01416181|449773176|FG001|Part 2|Lack of Efficacy|1|||
125041586|NCT01416181|449773175|FG000|Part 2|Lost to Follow-up|2|||
125041587|NCT01416181|449773176|FG001|Part 2|Lost to Follow-up|2|||
125041588|NCT01451515|449773181|FG000|Overall Study|Death|0|||
125041589|NCT01451515|449773182|FG001|Overall Study|Death|1|||
125041590|NCT01451515|449773183|FG002|Overall Study|Death|0|||
125041591|NCT01451515|449773181|FG000|Overall Study|Withdrawal by Subject|0|||
125041592|NCT01451515|449773182|FG001|Overall Study|Withdrawal by Subject|1|||
125041593|NCT01451515|449773183|FG002|Overall Study|Withdrawal by Subject|0|||
125041594|NCT01451515|449773181|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
125041595|NCT01451515|449773182|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
125041596|NCT01451515|449773183|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
125041597|NCT01451515|449773181|FG000|Overall Study|Relapse (except CNS)|1|||
125041598|NCT01451515|449773182|FG001|Overall Study|Relapse (except CNS)|1|||
125041599|NCT01451515|449773183|FG002|Overall Study|Relapse (except CNS)|0|||
125041600|NCT03126227|449773184|FG000|Overall Study|Adverse Event|43|||
125041601|NCT03126227|449773185|FG001|Overall Study|Adverse Event|4|||
125041602|NCT03126227|449773184|FG000|Overall Study|Death|0|||
125041603|NCT03126227|449773185|FG001|Overall Study|Death|1|||
125041604|NCT03126227|449773184|FG000|Overall Study|Lost to Follow-up|0|||
125041605|NCT03126227|449773185|FG001|Overall Study|Lost to Follow-up|1|||
125041606|NCT03126227|449773184|FG000|Overall Study|Physician Decision|2|||
125041607|NCT03126227|449773185|FG001|Overall Study|Physician Decision|0|||
125041608|NCT03126227|449773184|FG000|Overall Study|Protocol Violation|1|||
125041609|NCT03126227|449773185|FG001|Overall Study|Protocol Violation|0|||
125041610|NCT03126227|449773184|FG000|Overall Study|Withdrawal by Subject|19|||
125041611|NCT03126227|449773185|FG001|Overall Study|Withdrawal by Subject|3|||
125041612|NCT03126227|449773184|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
125041613|NCT03126227|449773185|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
125041614|NCT03126227|449773184|FG000|Overall Study|Lack of dosing compliance|2|||
125041615|NCT03126227|449773185|FG001|Overall Study|Lack of dosing compliance|0|||
125041616|NCT03126227|449773184|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
125041617|NCT03126227|449773185|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
125041618|NCT03126227|449773184|FG000|Overall Study|Scheduling conflict|1|||
125041619|NCT03126227|449773185|FG001|Overall Study|Scheduling conflict|0|||
125041620|NCT00900796|449773190|FG000|Phase 1|Lacked sufficient information|4|||
125041621|NCT00900796|449773190|FG000|Phase 1|Missing information at Week 16|7|||
125041622|NCT00900796|449773190|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
125041623|NCT00900796|449773190|FG000|Phase 2|Lost to Follow-up|5|||
125041624|NCT01121406|449773191|FG000|Overall Study|Progressive disease RECIST|44|||
125041625|NCT01121406|449773192|FG001|Overall Study|Progressive disease RECIST|28|||
125041626|NCT01121406|449773191|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
125041627|NCT01121406|449773192|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
125041628|NCT01121406|449773191|FG000|Overall Study|Other AE|3|||
125041629|NCT01121406|449773192|FG001|Overall Study|Other AE|10|||
125041630|NCT01121406|449773191|FG000|Overall Study|Non-compliant with protocol|0|||
125041631|NCT01121406|449773192|FG001|Overall Study|Non-compliant with protocol|2|||
125041632|NCT01121406|449773191|FG000|Overall Study|Lost to Follow-up|0|||
125041633|NCT01121406|449773192|FG001|Overall Study|Lost to Follow-up|1|||
125041634|NCT01121406|449773191|FG000|Overall Study|Refused continuation of study med.|1|||
125041635|NCT01121406|449773192|FG001|Overall Study|Refused continuation of study med.|2|||
125041636|NCT01121406|449773191|FG000|Overall Study|Reason other than specified above|2|||
125041637|NCT01121406|449773192|FG001|Overall Study|Reason other than specified above|6|||
125041638|NCT01121406|449773191|FG000|Overall Study|Not treated|1|||
125041639|NCT01121406|449773192|FG001|Overall Study|Not treated|0|||
125041640|NCT03185130|449773193|FG000|Overall Study|Withdrawal by Subject|0|||
125041641|NCT03185130|449773194|FG001|Overall Study|Withdrawal by Subject|2|||
125041642|NCT01925703|449773195|FG000|Overall Study|Physician Decision|1|||
125041643|NCT01925703|449773195|FG000|Overall Study|Lost to Follow-up|2|||
125041644|NCT01925703|449773195|FG000|Overall Study|Discharge prior to full iron repletion|1|||
125041645|NCT03215277|449773197|FG000|Overall Study|Adverse Event|2|||
125041646|NCT03215277|449773198|FG001|Overall Study|Adverse Event|3|||
125041647|NCT03215277|449773197|FG000|Overall Study|Death|1|||
125041648|NCT03215277|449773198|FG001|Overall Study|Death|0|||
125041649|NCT03215277|449773197|FG000|Overall Study|Lost to Follow-up|0|||
125041650|NCT03215277|449773198|FG001|Overall Study|Lost to Follow-up|1|||
125041651|NCT03215277|449773197|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
125041652|NCT03215277|449773198|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
125041653|NCT03794986|449773199|FG000|Overall Study|0 Sessions Attended|34|||
125041654|NCT03794986|449773200|FG001|Overall Study|0 Sessions Attended|37|||
125041655|NCT03794986|449773199|FG000|Overall Study|Withdrawal by Subject|4|||
125041656|NCT03794986|449773200|FG001|Overall Study|Withdrawal by Subject|6|||
125041657|NCT03794986|449773199|FG000|Overall Study|Protocol Violation|1|||
125041658|NCT03794986|449773200|FG001|Overall Study|Protocol Violation|0|||
125041659|NCT02498652|449773204|FG000|Overall Study|Protocol Violation|0|||
125041660|NCT02498652|449773205|FG001|Overall Study|Protocol Violation|1|||
125041661|NCT00465569|449773207|FG000|Overall Study|persistent eczema during dose escalation|1|||
125041662|NCT00465569|449773208|FG001|Overall Study|persistent eczema during dose escalation|0|||
125041663|NCT00922935|449773209|FG000|Overall Study|Protocol Violation|0|||
125041664|NCT00922935|449773210|FG001|Overall Study|Protocol Violation|3|||
125041665|NCT00922935|449773211|FG002|Overall Study|Protocol Violation|0|||
125041666|NCT00922935|449773209|FG000|Overall Study|Physician Decision|1|||
125041667|NCT00922935|449773210|FG001|Overall Study|Physician Decision|1|||
125041668|NCT00922935|449773211|FG002|Overall Study|Physician Decision|0|||
125041669|NCT00922935|449773209|FG000|Overall Study|Lost to Follow-up|0|||
125041670|NCT00922935|449773210|FG001|Overall Study|Lost to Follow-up|1|||
125041671|NCT00922935|449773211|FG002|Overall Study|Lost to Follow-up|0|||
125041672|NCT00849212|449773212|FG000|Overall Study|Lack of Efficacy|1|||
125041673|NCT00849212|449773212|FG000|Overall Study|Withdrawal by Subject|3|||
125041674|NCT00849212|449773212|FG000|Overall Study|Adverse Event|2|||
125041675|NCT00849212|449773212|FG000|Overall Study|Miscellaneous|1|||
125041676|NCT00095303|449773213|FG000|Main Study|Lost to Follow-up|91|||
125041677|NCT00095303|449773214|FG001|Main Study|Lost to Follow-up|87|||
125041678|NCT00095303|449773213|FG000|Follow Up Study|Lost to Follow-up|59|||
125041679|NCT00095303|449773214|FG001|Follow Up Study|Lost to Follow-up|58|||
125041680|NCT01499576|449773215|FG000|Overall Study|Physician Decision|12|||
125041681|NCT01499576|449773215|FG000|Overall Study|Withdrawal by Subject|9|||
125041682|NCT04283461|449773216|FG000|Overall Study|Enrolled in separate trial|0|||
125041683|NCT04283461|449773217|FG001|Overall Study|Enrolled in separate trial|0|||
125041684|NCT04283461|449773218|FG002|Overall Study|Enrolled in separate trial|8|||
125041685|NCT04283461|449773219|FG003|Overall Study|Enrolled in separate trial|13|||
125041686|NCT04283461|449773220|FG004|Overall Study|Enrolled in separate trial|12|||
125041687|NCT04283461|449773221|FG005|Overall Study|Enrolled in separate trial|0|||
125041688|NCT04283461|449773222|FG006|Overall Study|Enrolled in separate trial|0|||
125041689|NCT04283461|449773223|FG007|Overall Study|Enrolled in separate trial|8|||
125041690|NCT04283461|449773224|FG008|Overall Study|Enrolled in separate trial|0|||
125041691|NCT04283461|449773225|FG009|Overall Study|Enrolled in separate trial|0|||
125041692|NCT04283461|449773226|FG010|Overall Study|Enrolled in separate trial|0|||
125041693|NCT04283461|449773227|FG011|Overall Study|Enrolled in separate trial|7|||
125041694|NCT04283461|449773228|FG012|Overall Study|Enrolled in separate trial|0|||
125041695|NCT04375878|449773235|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
125041696|NCT04375878|449773236|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
125041697|NCT04375878|449773237|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
125041698|NCT04375878|449773238|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
125041699|NCT04375878|449773239|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
125041700|NCT04375878|449773240|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
125041701|NCT04375878|449773235|FG000|Crossover First and Second Interventions|Adverse Event|0|||
125041702|NCT04375878|449773236|FG001|Crossover First and Second Interventions|Adverse Event|0|||
125041703|NCT04375878|449773237|FG002|Crossover First and Second Interventions|Adverse Event|1|||
125041704|NCT04375878|449773238|FG003|Crossover First and Second Interventions|Adverse Event|0|||
125041705|NCT04375878|449773239|FG004|Crossover First and Second Interventions|Adverse Event|0|||
125041706|NCT04375878|449773240|FG005|Crossover First and Second Interventions|Adverse Event|0|||
125041707|NCT04375878|449773235|FG000|Extension Phase|Withdrawal by Subject|0|||
125041708|NCT04375878|449773236|FG001|Extension Phase|Withdrawal by Subject|0|||
125041709|NCT04375878|449773237|FG002|Extension Phase|Withdrawal by Subject|0|||
125041710|NCT04375878|449773238|FG003|Extension Phase|Withdrawal by Subject|0|||
125041711|NCT04375878|449773239|FG004|Extension Phase|Withdrawal by Subject|1|||
125041712|NCT04375878|449773240|FG005|Extension Phase|Withdrawal by Subject|0|||
125041713|NCT00195351|449773241|FG000|Overall Study|Lost to Follow-up|9|||
125041714|NCT00195351|449773242|FG001|Overall Study|Lost to Follow-up|9|||
125041715|NCT00195351|449773241|FG000|Overall Study|Withdrawal by Subject|6|||
125041716|NCT00195351|449773242|FG001|Overall Study|Withdrawal by Subject|3|||
125041717|NCT00195351|449773241|FG000|Overall Study|Protocol Deviation|3|||
125041718|NCT00195351|449773242|FG001|Overall Study|Protocol Deviation|2|||
125041719|NCT00195351|449773241|FG000|Overall Study|Death|3|||
125041720|NCT00195351|449773242|FG001|Overall Study|Death|1|||
125041721|NCT00195351|449773241|FG000|Overall Study|Lack of Efficacy|0|||
125041722|NCT00195351|449773242|FG001|Overall Study|Lack of Efficacy|1|||
125041723|NCT02111369|449773243|FG000|Overall Study|Lost to Follow-up|2|||
125041724|NCT02111369|449773243|FG000|Overall Study|Withdrawal by Subject|1|||
125041725|NCT01259466|449773244|FG000|Overall Study|Withdrawal by Subject|1|||
125041726|NCT01259466|449773245|FG001|Overall Study|Withdrawal by Subject|9|||
125041727|NCT00519623|449773248|FG000|Overall Study|Adverse Event|1|||
125041728|NCT02296840|449773250|FG000|Overall Study|Adverse Event|1|||
125041729|NCT02296840|449773251|FG001|Overall Study|Adverse Event|1|||
125041730|NCT02296840|449773250|FG000|Overall Study|Protocol Violation|2|||
125135242|NCT01695239|450120126|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
125041731|NCT02296840|449773251|FG001|Overall Study|Protocol Violation|1|||
125041732|NCT02296840|449773250|FG000|Overall Study|Lost to Follow-up|6|||
125041733|NCT02296840|449773251|FG001|Overall Study|Lost to Follow-up|17|||
125041734|NCT00104871|449773252|FG000|Overall Study|Not evaluable|1|||
125041735|NCT00761215|449773255|FG000|Overall Study|Randomized but didn't receive drug|1|||
125041736|NCT00761215|449773256|FG001|Overall Study|Randomized but didn't receive drug|1|||
125041737|NCT00761215|449773257|FG002|Overall Study|Randomized but didn't receive drug|2|||
125041738|NCT00761215|449773255|FG000|Overall Study|Lost to Follow-up|6|||
125041739|NCT00761215|449773256|FG001|Overall Study|Lost to Follow-up|3|||
125041740|NCT00761215|449773257|FG002|Overall Study|Lost to Follow-up|6|||
125041741|NCT00761215|449773255|FG000|Overall Study|Withdrawal by Subject|1|||
125041742|NCT00761215|449773256|FG001|Overall Study|Withdrawal by Subject|0|||
125041743|NCT00761215|449773257|FG002|Overall Study|Withdrawal by Subject|0|||
125041744|NCT00761215|449773255|FG000|Overall Study|Bacteremia|1|||
125041745|NCT00761215|449773256|FG001|Overall Study|Bacteremia|0|||
125041746|NCT00761215|449773257|FG002|Overall Study|Bacteremia|0|||
125041747|NCT05121103|449773258|FG000|Overall Study|Progressive disease|2|||
125041748|NCT05121103|449773259|FG001|Overall Study|Progressive disease|1|||
125041749|NCT05121103|449773260|FG002|Overall Study|Progressive disease|6|||
125041750|NCT05121103|449773258|FG000|Overall Study|Physician Decision|2|||
125041751|NCT05121103|449773259|FG001|Overall Study|Physician Decision|1|||
125041752|NCT05121103|449773260|FG002|Overall Study|Physician Decision|0|||
125041753|NCT05121103|449773258|FG000|Overall Study|Withdrawal by Subject|0|||
125041754|NCT05121103|449773259|FG001|Overall Study|Withdrawal by Subject|1|||
125041755|NCT05121103|449773260|FG002|Overall Study|Withdrawal by Subject|0|||
125041756|NCT03885284|449773261|FG000|Overall Study|Disease Progression|1|||
125041757|NCT03885284|449773262|FG001|Overall Study|Disease Progression|3|||
125041758|NCT03885284|449773261|FG000|Overall Study|Physician Decision|0|||
125041759|NCT03885284|449773262|FG001|Overall Study|Physician Decision|1|||
125041760|NCT01662999|449773270|FG000|Period 3|Withdrawal by Subject|0|||
125041761|NCT01662999|449773271|FG001|Period 3|Withdrawal by Subject|1|||
125041762|NCT01662999|449773272|FG002|Period 3|Withdrawal by Subject|0|||
125041763|NCT01662999|449773273|FG003|Period 3|Withdrawal by Subject|0|||
125041764|NCT01662999|449773274|FG004|Period 3|Withdrawal by Subject|0|||
125041765|NCT01662999|449773275|FG005|Period 3|Withdrawal by Subject|0|||
125041766|NCT02932267|449773281|FG000|Overall Study|Withdrawal by Subject|3|||
125041767|NCT02932267|449773281|FG000|Overall Study|Lost to Follow-up|4|||
125041768|NCT02932267|449773281|FG000|Overall Study|Pregnancy|1|||
125041769|NCT01687673|449773286|FG000|Overall Study|Physician Decision|1|||
125041770|NCT02234622|449773287|FG000|Overall Study|Withdrawal by Subject|16|||
125041771|NCT02234622|449773288|FG001|Overall Study|Withdrawal by Subject|22|||
125041772|NCT02234622|449773287|FG000|Overall Study|Lost to Follow-up|27|||
125041773|NCT02234622|449773288|FG001|Overall Study|Lost to Follow-up|14|||
125041774|NCT02453841|449773289|FG000|Overall Study|Protocol Violation|1|||
125041775|NCT02453841|449773289|FG000|Overall Study|Unable to obtain blood samples|2|||
125041776|NCT00618956|449773290|FG000|Overall Study|Adverse Event|10|||
125041777|NCT00618956|449773291|FG001|Overall Study|Adverse Event|34|||
125041778|NCT00618956|449773290|FG000|Overall Study|Lack of Efficacy|2|||
125041779|NCT00618956|449773291|FG001|Overall Study|Lack of Efficacy|1|||
125041780|NCT00618956|449773290|FG000|Overall Study|Withdrawal by Subject|5|||
125041781|NCT00618956|449773291|FG001|Overall Study|Withdrawal by Subject|7|||
125041782|NCT00618956|449773290|FG000|Overall Study|Lost to Follow-up|4|||
125041783|NCT00618956|449773291|FG001|Overall Study|Lost to Follow-up|5|||
125041784|NCT00618956|449773290|FG000|Overall Study|Protocol Violation|2|||
125041785|NCT00618956|449773291|FG001|Overall Study|Protocol Violation|2|||
125041786|NCT00618956|449773290|FG000|Overall Study|did not meet criteria, non-compliance|2|||
125041787|NCT00618956|449773291|FG001|Overall Study|did not meet criteria, non-compliance|1|||
125041788|NCT02006576|449773292|FG000|Overall Study|Withdrawal by Subject|4|||
125041789|NCT02006576|449773293|FG001|Overall Study|Withdrawal by Subject|6|||
125041790|NCT02006576|449773294|FG002|Overall Study|Withdrawal by Subject|2|||
125041791|NCT02006576|449773292|FG000|Overall Study|Death|0|||
125041792|NCT02006576|449773293|FG001|Overall Study|Death|0|||
125041793|NCT02006576|449773294|FG002|Overall Study|Death|1|||
125041794|NCT02006576|449773292|FG000|Overall Study|Lost to Follow-up|1|||
125041795|NCT02006576|449773293|FG001|Overall Study|Lost to Follow-up|0|||
125041796|NCT02006576|449773294|FG002|Overall Study|Lost to Follow-up|1|||
125135243|NCT01695239|450120127|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
125135244|NCT01695239|450120128|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
125135245|NCT01695239|450120129|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
125135246|NCT01695239|450120130|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
125041797|NCT02006576|449773292|FG000|Overall Study|Screen Failure, too sick, other|13|||
125041798|NCT02006576|449773293|FG001|Overall Study|Screen Failure, too sick, other|1|||
125041799|NCT02006576|449773294|FG002|Overall Study|Screen Failure, too sick, other|13|||
125041800|NCT04090164|449773297|FG000|Overall Study|incomplete data on file|245|||
125041801|NCT04090164|449773298|FG001|Overall Study|incomplete data on file|0|||
125041802|NCT01650805|449773299|FG000|Overall Study|Withdrawal by Subject|1|||
125041803|NCT01650805|449773300|FG001|Overall Study|Withdrawal by Subject|0|||
125041804|NCT01877655|449773303|FG000|Overall Study|Death|57|||
125041805|NCT01877655|449773304|FG001|Overall Study|Death|52|||
125041806|NCT01877655|449773303|FG000|Overall Study|Withdrawal by Subject|18|||
125041807|NCT01877655|449773304|FG001|Overall Study|Withdrawal by Subject|26|||
125041808|NCT01877655|449773303|FG000|Overall Study|Physician Decision|11|||
125041809|NCT01877655|449773304|FG001|Overall Study|Physician Decision|10|||
125041810|NCT01877655|449773303|FG000|Overall Study|Miscellaneous|4|||
125135247|NCT01695239|450120131|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
125041811|NCT01877655|449773304|FG001|Overall Study|Miscellaneous|4|||
125041812|NCT01877655|449773303|FG000|Overall Study|Randomized but Never Received Drug|8|||
125041813|NCT01877655|449773304|FG001|Overall Study|Randomized but Never Received Drug|5|||
125041814|NCT05847881|449773305|FG000|Overall Study|Principal Investigator Decision|8|||
125041815|NCT05847881|449773305|FG000|Overall Study|Withdrawal by Subject|2|||
125041816|NCT04513158|449773308|FG000|Overall Study|Screen Failure|1|||
125041817|NCT03439345|449774972|FG000|Overall Study|Lost to Follow-up|0|||
125041818|NCT03439345|449774973|FG001|Overall Study|Lost to Follow-up|1|||
125041819|NCT03439345|449774972|FG000|Overall Study|Consent withdrawn|0|||
125041820|NCT03439345|449774973|FG001|Overall Study|Consent withdrawn|1|||
125041821|NCT04493619|449774976|FG000|Overall Study|Death|4|||
125041822|NCT04493619|449774977|FG001|Overall Study|Death|3|||
125041823|NCT04493619|449774978|FG002|Overall Study|Death|3|||
125041824|NCT04493619|449774979|FG003|Overall Study|Death|4|||
125041825|NCT04493619|449774976|FG000|Overall Study|Study discontinued early|10|||
125041826|NCT04493619|449774977|FG001|Overall Study|Study discontinued early|0|||
125041827|NCT04493619|449774978|FG002|Overall Study|Study discontinued early|4|||
125041828|NCT04493619|449774979|FG003|Overall Study|Study discontinued early|8|||
125041829|NCT04493619|449774976|FG000|Overall Study|Lost to Follow-up|0|||
125041830|NCT04493619|449774977|FG001|Overall Study|Lost to Follow-up|0|||
125041831|NCT04493619|449774978|FG002|Overall Study|Lost to Follow-up|0|||
125041832|NCT04493619|449774979|FG003|Overall Study|Lost to Follow-up|1|||
125041833|NCT02128490|449774982|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
125041834|NCT02128490|449774983|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
125041835|NCT02128490|449774984|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
125041836|NCT02128490|449774985|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
125041837|NCT02128490|449774986|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
125041838|NCT02128490|449774982|FG000|Overall Study|Major Protocol Deviation|1|||
125041839|NCT02128490|449774983|FG001|Overall Study|Major Protocol Deviation|2|||
125041840|NCT02128490|449774984|FG002|Overall Study|Major Protocol Deviation|0|||
125041841|NCT02128490|449774985|FG003|Overall Study|Major Protocol Deviation|2|||
125041842|NCT02128490|449774986|FG004|Overall Study|Major Protocol Deviation|2|||
125041843|NCT02128490|449774982|FG000|Overall Study|Lost to Follow-up|0|||
125041844|NCT02128490|449774983|FG001|Overall Study|Lost to Follow-up|0|||
125041845|NCT02128490|449774984|FG002|Overall Study|Lost to Follow-up|1|||
125041846|NCT02128490|449774985|FG003|Overall Study|Lost to Follow-up|1|||
125041847|NCT02128490|449774986|FG004|Overall Study|Lost to Follow-up|1|||
125041848|NCT02128490|449774982|FG000|Overall Study|Voluntary Withdrawal|3|||
125041849|NCT02128490|449774983|FG001|Overall Study|Voluntary Withdrawal|3|||
125041850|NCT02128490|449774984|FG002|Overall Study|Voluntary Withdrawal|1|||
125041851|NCT02128490|449774985|FG003|Overall Study|Voluntary Withdrawal|1|||
125041852|NCT02128490|449774986|FG004|Overall Study|Voluntary Withdrawal|2|||
125041853|NCT02128490|449774982|FG000|Overall Study|Lack of Efficacy|0|||
125041854|NCT02128490|449774983|FG001|Overall Study|Lack of Efficacy|1|||
125041855|NCT02128490|449774984|FG002|Overall Study|Lack of Efficacy|0|||
125041856|NCT02128490|449774985|FG003|Overall Study|Lack of Efficacy|0|||
125041857|NCT02128490|449774986|FG004|Overall Study|Lack of Efficacy|0|||
125041858|NCT02128490|449774982|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
125041859|NCT02128490|449774983|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
125041860|NCT02128490|449774984|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
125041861|NCT02128490|449774985|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
125041862|NCT02128490|449774986|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
125041863|NCT02128490|449774982|FG000|Overall Study|Other Miscellaneous Reasons|0|||
125041864|NCT02128490|449774983|FG001|Overall Study|Other Miscellaneous Reasons|0|||
125041865|NCT02128490|449774984|FG002|Overall Study|Other Miscellaneous Reasons|2|||
125041866|NCT02128490|449774985|FG003|Overall Study|Other Miscellaneous Reasons|1|||
125041867|NCT02128490|449774986|FG004|Overall Study|Other Miscellaneous Reasons|1|||
125041868|NCT02243176|449774987|FG000|Overall Study|Other reason|1|||
125041869|NCT02243176|449774988|FG001|Overall Study|Other reason|2|||
125041870|NCT02243176|449774987|FG000|Overall Study|protocol specified withdrawal critera|1|||
125041871|NCT02243176|449774988|FG001|Overall Study|protocol specified withdrawal critera|3|||
125041872|NCT02243176|449774987|FG000|Overall Study|Protocol Violation|2|||
125041873|NCT02243176|449774988|FG001|Overall Study|Protocol Violation|1|||
125041874|NCT02243176|449774987|FG000|Overall Study|Withdrawal by Subject|8|||
125041875|NCT02243176|449774988|FG001|Overall Study|Withdrawal by Subject|7|||
125041876|NCT02243176|449774987|FG000|Overall Study|Adverse Event|2|||
125041877|NCT02243176|449774988|FG001|Overall Study|Adverse Event|2|||
125041878|NCT03705494|449774991|FG000|Overall Study|Lost to Follow-up|2|||
125041879|NCT03705494|449774992|FG001|Overall Study|Lost to Follow-up|1|||
125135248|NCT01695239|450120132|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
125041880|NCT03705494|449774991|FG000|Overall Study|Withdrawal by Subject|5|||
125041881|NCT03705494|449774992|FG001|Overall Study|Withdrawal by Subject|2|||
125041882|NCT03704051|449774993|FG000|Overall Study|Withdrawal by Subject|4|||
125041883|NCT03704051|449774994|FG001|Overall Study|Withdrawal by Subject|0|||
125041884|NCT02629393|449774995|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
125041885|NCT02629393|449774995|FG000|Overall Study|Physician Decision|1|||
125041886|NCT01981187|449774999|FG000|Overall Study|Participant/guardian decision|2|||
125041887|NCT01981187|449774999|FG000|Overall Study|Physician Decision|1|||
125041888|NCT01981187|449774999|FG000|Overall Study|Disease progression|2|||
125041889|NCT01981187|449774999|FG000|Overall Study|Adverse Event|7|||
125041890|NCT01943539|449775003|FG000|Overall Study|Non-compliance with at-home intervention|4|||
125041891|NCT01943539|449775004|FG001|Overall Study|Non-compliance with at-home intervention|0|||
125041892|NCT02413255|449775005|FG000|Overall Study|Voluntary Withdrawal|0|||
125041893|NCT02413255|449775006|FG001|Overall Study|Voluntary Withdrawal|0|||
125041894|NCT02413255|449775007|FG002|Overall Study|Voluntary Withdrawal|0|||
125041895|NCT02413255|449775008|FG003|Overall Study|Voluntary Withdrawal|0|||
125041896|NCT02413255|449775009|FG004|Overall Study|Voluntary Withdrawal|0|||
125041897|NCT02413255|449775010|FG005|Overall Study|Voluntary Withdrawal|0|||
125041898|NCT02413255|449775011|FG006|Overall Study|Voluntary Withdrawal|0|||
125041899|NCT02413255|449775012|FG007|Overall Study|Voluntary Withdrawal|0|||
125041900|NCT02413255|449775013|FG008|Overall Study|Voluntary Withdrawal|0|||
125041901|NCT02413255|449775014|FG009|Overall Study|Voluntary Withdrawal|0|||
125041902|NCT02413255|449775015|FG010|Overall Study|Voluntary Withdrawal|0|||
125041903|NCT02413255|449775016|FG011|Overall Study|Voluntary Withdrawal|0|||
125041904|NCT02413255|449775017|FG012|Overall Study|Voluntary Withdrawal|0|||
125041905|NCT02413255|449775018|FG013|Overall Study|Voluntary Withdrawal|0|||
125041906|NCT02413255|449775019|FG014|Overall Study|Voluntary Withdrawal|1|||
125041907|NCT02413255|449775020|FG015|Overall Study|Voluntary Withdrawal|0|||
125041908|NCT02413255|449775021|FG016|Overall Study|Voluntary Withdrawal|0|||
125041909|NCT02333331|449775022|FG000|Overall Study|Adverse Event|1|||
125041910|NCT02333331|449775023|FG001|Overall Study|Adverse Event|0|||
125041911|NCT02333331|449775024|FG002|Overall Study|Adverse Event|4|||
125041912|NCT02333331|449775025|FG003|Overall Study|Adverse Event|1|||
125041913|NCT02333331|449775022|FG000|Overall Study|Death|0|||
125041914|NCT02333331|449775023|FG001|Overall Study|Death|0|||
125041915|NCT02333331|449775024|FG002|Overall Study|Death|2|||
125041916|NCT02333331|449775025|FG003|Overall Study|Death|0|||
125041917|NCT02333331|449775022|FG000|Overall Study|Lost to Follow-up|0|||
125041918|NCT02333331|449775023|FG001|Overall Study|Lost to Follow-up|0|||
125041919|NCT02333331|449775024|FG002|Overall Study|Lost to Follow-up|1|||
125041920|NCT02333331|449775025|FG003|Overall Study|Lost to Follow-up|0|||
125041921|NCT02333331|449775022|FG000|Overall Study|Physician Decision|0|||
125041922|NCT02333331|449775023|FG001|Overall Study|Physician Decision|1|||
125041923|NCT02333331|449775024|FG002|Overall Study|Physician Decision|0|||
125041924|NCT02333331|449775025|FG003|Overall Study|Physician Decision|0|||
125041925|NCT02333331|449775022|FG000|Overall Study|Protocol Deviation|0|||
125041926|NCT02333331|449775023|FG001|Overall Study|Protocol Deviation|3|||
125041927|NCT02333331|449775024|FG002|Overall Study|Protocol Deviation|2|||
125041928|NCT02333331|449775025|FG003|Overall Study|Protocol Deviation|1|||
125041929|NCT02333331|449775022|FG000|Overall Study|Patient/Guardian Decision|1|||
125041930|NCT02333331|449775023|FG001|Overall Study|Patient/Guardian Decision|2|||
125041931|NCT02333331|449775024|FG002|Overall Study|Patient/Guardian Decision|9|||
125041932|NCT02333331|449775025|FG003|Overall Study|Patient/Guardian Decision|1|||
125041933|NCT05309668|449775026|FG000|Overall Study|Ongoing at data cut-off|14|||
125041934|NCT05309668|449775027|FG001|Overall Study|Ongoing at data cut-off|17|||
125041935|NCT05309668|449775028|FG002|Overall Study|Ongoing at data cut-off|4|||
125041936|NCT04329949|449775034|FG000|Overall Study|Death|36|||
125041937|NCT04329949|449775034|FG000|Overall Study|Withdrawal by Subject|4|||
125041938|NCT04329949|449775034|FG000|Overall Study|Termination of study by sponsor|3|||
125041939|NCT03180736|449775037|FG000|Overall Study|Adverse Event|3|||
125041940|NCT03180736|449775038|FG001|Overall Study|Adverse Event|4|||
125041941|NCT03180736|449775037|FG000|Overall Study|Death|10|||
125041942|NCT03180736|449775038|FG001|Overall Study|Death|7|||
125041943|NCT03180736|449775037|FG000|Overall Study|Withdrawal by Subject|5|||
125041944|NCT03180736|449775038|FG001|Overall Study|Withdrawal by Subject|12|||
125041945|NCT03180736|449775037|FG000|Overall Study|Lost to Follow-up|1|||
125041946|NCT03180736|449775038|FG001|Overall Study|Lost to Follow-up|0|||
125041947|NCT03180736|449775037|FG000|Overall Study|Lack of Efficacy|66|||
125041948|NCT03180736|449775038|FG001|Overall Study|Lack of Efficacy|87|||
125041949|NCT03180736|449775037|FG000|Overall Study|Physician Decision|4|||
125041950|NCT03180736|449775038|FG001|Overall Study|Physician Decision|7|||
125041951|NCT03180736|449775037|FG000|Overall Study|randomized but not treated|2|||
125041952|NCT03180736|449775038|FG001|Overall Study|randomized but not treated|3|||
125041953|NCT00174941|449775039|FG000|Overall Study|Adverse Event|1|||
125041954|NCT00174941|449775040|FG001|Overall Study|Adverse Event|10|||
125041955|NCT00174941|449775041|FG002|Overall Study|Adverse Event|2|||
125041956|NCT00174941|449775042|FG003|Overall Study|Adverse Event|13|||
125041957|NCT00174941|449775039|FG000|Overall Study|Protocol Violation|0|||
125041958|NCT00174941|449775040|FG001|Overall Study|Protocol Violation|1|||
125041959|NCT00174941|449775041|FG002|Overall Study|Protocol Violation|0|||
125041960|NCT00174941|449775042|FG003|Overall Study|Protocol Violation|1|||
125041961|NCT00174941|449775039|FG000|Overall Study|Lost to Follow-up|0|||
125041962|NCT00174941|449775040|FG001|Overall Study|Lost to Follow-up|3|||
125041963|NCT00174941|449775041|FG002|Overall Study|Lost to Follow-up|2|||
125041964|NCT00174941|449775042|FG003|Overall Study|Lost to Follow-up|5|||
125041965|NCT00174941|449775039|FG000|Overall Study|Personal Reason(s)|0|||
125135249|NCT01695239|450120133|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
125135250|NCT01695239|450120134|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
125135251|NCT01695239|450120135|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
125135252|NCT01695239|450120122|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
125041966|NCT00174941|449775040|FG001|Overall Study|Personal Reason(s)|14|||
125041967|NCT00174941|449775041|FG002|Overall Study|Personal Reason(s)|8|||
125041968|NCT00174941|449775042|FG003|Overall Study|Personal Reason(s)|22|||
125041969|NCT00174941|449775039|FG000|Overall Study|Gout Flare|0|||
125041970|NCT00174941|449775040|FG001|Overall Study|Gout Flare|4|||
125041971|NCT00174941|449775041|FG002|Overall Study|Gout Flare|4|||
125041972|NCT00174941|449775042|FG003|Overall Study|Gout Flare|8|||
125041973|NCT00174941|449775039|FG000|Overall Study|Reason Not Specified|1|||
125041974|NCT00174941|449775040|FG001|Overall Study|Reason Not Specified|6|||
125041975|NCT00174941|449775041|FG002|Overall Study|Reason Not Specified|2|||
125041976|NCT00174941|449775042|FG003|Overall Study|Reason Not Specified|9|||
125041977|NCT03230097|449775046|FG000|Overall Study|Adverse Event|2|||
125041978|NCT03230097|449775047|FG001|Overall Study|Adverse Event|1|||
125041979|NCT03230097|449775046|FG000|Overall Study|non-compliance|0|||
125041980|NCT03230097|449775047|FG001|Overall Study|non-compliance|1|||
125041981|NCT03230097|449775046|FG000|Overall Study|Lost to Follow-up|2|||
125041982|NCT03230097|449775047|FG001|Overall Study|Lost to Follow-up|4|||
125041983|NCT03230097|449775046|FG000|Overall Study|Withdrawal by Subject|7|||
125041984|NCT03230097|449775047|FG001|Overall Study|Withdrawal by Subject|3|||
125041985|NCT03230097|449775046|FG000|Overall Study|Trial termination|4|||
125041986|NCT03230097|449775047|FG001|Overall Study|Trial termination|5|||
125041987|NCT03230097|449775046|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
125041988|NCT03230097|449775047|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
125041989|NCT03230097|449775046|FG000|Overall Study|outcome event|0|||
125041990|NCT03230097|449775047|FG001|Overall Study|outcome event|1|||
125041991|NCT05370157|449775048|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
125041992|NCT05370157|449775049|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
125041993|NCT05370157|449775048|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
125041994|NCT05370157|449775049|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
125041995|NCT01364467|449775059|FG000|Overall Study|Lost to Follow-up|1|||
125041996|NCT01364467|449775060|FG001|Overall Study|Lost to Follow-up|2|||
125041997|NCT00587223|449775068|FG000|Overall Study|Adverse Event|1|||
125041998|NCT00883753|449775069|FG000|Overall Study|Adverse Event|37|||
125041999|NCT00883753|449775069|FG000|Overall Study|Death|2|||
125042000|NCT00883753|449775069|FG000|Overall Study|Insufficient therapeutic response|16|||
125042001|NCT00883753|449775069|FG000|Overall Study|Lost to Follow-up|4|||
125042002|NCT00883753|449775069|FG000|Overall Study|Violation of selection criteria at entry|7|||
125042003|NCT00883753|449775069|FG000|Overall Study|Protocol Violation|2|||
125042004|NCT00883753|449775069|FG000|Overall Study|Refused treatment|4|||
125042005|NCT00883753|449775069|FG000|Overall Study|Withdrew consent|10|||
125042006|NCT00883753|449775069|FG000|Overall Study|Investigator's decision|17|||
125042007|NCT00883753|449775069|FG000|Overall Study|Administrative/Other|8|||
125042008|NCT00971321|449775074|FG000|Up to Month 7|Withdrawal by Subject|1|||
125042009|NCT00971321|449775075|FG001|Up to Month 7|Withdrawal by Subject|0|||
125042010|NCT00971321|449775074|FG000|Up to Month 7|Migrated/moved from study area|3|||
125042011|NCT00971321|449775075|FG001|Up to Month 7|Migrated/moved from study area|2|||
125042012|NCT00971321|449775074|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
125042013|NCT00971321|449775075|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
125042014|NCT00971321|449775074|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
125042015|NCT00971321|449775075|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
125042016|NCT00971321|449775074|FG000|Up to Month 11-12|Lost to Follow-up|1|||
125042017|NCT00971321|449775075|FG001|Up to Month 11-12|Lost to Follow-up|0|||
125042018|NCT00667277|449775078|FG000|Overall Study|Withdrawal by Subject|2|||
125042019|NCT01476787|449775079|FG000|Treatment|Progression|64|||
125042020|NCT01476787|449775080|FG001|Treatment|Progression|71|||
125042021|NCT01476787|449775079|FG000|Treatment|Toxicity|44|||
125042022|NCT01476787|449775080|FG001|Treatment|Toxicity|16|||
125042023|NCT01476787|449775079|FG000|Treatment|Death|0|||
125042024|NCT01476787|449775080|FG001|Treatment|Death|1|||
125042025|NCT01476787|449775079|FG000|Treatment|Withdrawal by Subject|3|||
125135253|NCT01695239|450120123|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
125135254|NCT01695239|450120124|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
125042026|NCT01476787|449775080|FG001|Treatment|Withdrawal by Subject|14|||
125042027|NCT01476787|449775079|FG000|Treatment|Major protocol violation|1|||
125042028|NCT01476787|449775080|FG001|Treatment|Major protocol violation|6|||
125135255|NCT01695239|450120125|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
125135256|NCT01695239|450120126|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
125042029|NCT01476787|449775079|FG000|Treatment|Other reasons|10|||
125042030|NCT01476787|449775080|FG001|Treatment|Other reasons|22|||
125042031|NCT01476787|449775079|FG000|Treatment|Concurrent illness|12|||
125042032|NCT01476787|449775080|FG001|Treatment|Concurrent illness|9|||
125042033|NCT01476787|449775079|FG000|Treatment|Insufficient response|15|||
125135257|NCT01695239|450120127|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
125135258|NCT01695239|450120128|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
125135259|NCT01695239|450120129|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
125135260|NCT01695239|450120130|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
125135261|NCT01695239|450120131|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
125135262|NCT01695239|450120132|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
125135263|NCT01695239|450120133|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
125135264|NCT01695239|450120134|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
125135265|NCT01695239|450120135|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
125135266|NCT01695239|450120122|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
125135267|NCT01695239|450120123|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135268|NCT01695239|450120124|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
125135269|NCT01695239|450120125|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135270|NCT01695239|450120126|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135271|NCT01695239|450120127|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135272|NCT01695239|450120128|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135273|NCT01695239|450120129|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135274|NCT01695239|450120130|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135275|NCT01695239|450120131|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135276|NCT01695239|450120132|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135277|NCT01695239|450120133|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135278|NCT01695239|450120134|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135279|NCT01695239|450120135|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135280|NCT01695239|450120122|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
125135281|NCT01695239|450120123|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
125135282|NCT01695239|450120124|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
125135283|NCT01695239|450120125|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135284|NCT01695239|450120126|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135285|NCT01695239|450120127|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135286|NCT01695239|450120128|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135287|NCT01695239|450120129|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135288|NCT01695239|450120130|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135289|NCT01695239|450120131|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135290|NCT01695239|450120132|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135291|NCT01695239|450120133|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135292|NCT01695239|450120134|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135293|NCT01695239|450120135|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135294|NCT01695239|450120122|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
125135295|NCT01695239|450120123|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135296|NCT01695239|450120124|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
125042034|NCT01476787|449775080|FG001|Treatment|Insufficient response|3|||
125042035|NCT01476787|449775079|FG000|Treatment|Voluntary treatment discontinuation|8|||
125042036|NCT01476787|449775080|FG001|Treatment|Voluntary treatment discontinuation|4|||
125042037|NCT01591330|449775081|FG000|Period 1|Adverse Event|1|||
125042038|NCT01591330|449775082|FG001|Period 1|Adverse Event|0|||
125042039|NCT01591330|449775083|FG002|Period 1|Adverse Event|0|||
125042040|NCT01591330|449775084|FG003|Period 1|Adverse Event|0|||
125042041|NCT01591330|449775081|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
125042042|NCT01591330|449775082|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
125042043|NCT01591330|449775083|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
125042044|NCT01591330|449775084|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
125042045|NCT01591330|449775081|FG000|Period 2|Adverse Event|1|||
125042046|NCT01591330|449775082|FG001|Period 2|Adverse Event|0|||
125042047|NCT01591330|449775083|FG002|Period 2|Adverse Event|0|||
125042048|NCT01591330|449775084|FG003|Period 2|Adverse Event|0|||
125042049|NCT01450137|449775085|FG000|Up to Week 12|Adverse Event|2|||
125042050|NCT01450137|449775086|FG001|Up to Week 12|Adverse Event|1|||
125042051|NCT01450137|449775085|FG000|Up to Week 12|Withdrawal by Subject|0|||
125135297|NCT01695239|450120125|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135298|NCT01695239|450120126|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135299|NCT01695239|450120127|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135300|NCT01695239|450120128|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135301|NCT01695239|450120129|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135302|NCT01695239|450120130|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135303|NCT01695239|450120131|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125042052|NCT01450137|449775086|FG001|Up to Week 12|Withdrawal by Subject|2|||
125042053|NCT01450137|449775085|FG000|Week 12 to Study End|Death|0|||
125042054|NCT01450137|449775086|FG001|Week 12 to Study End|Death|1|||
125042055|NCT01450137|449775085|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
125042056|NCT01450137|449775086|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
125042057|NCT01926886|449775087|FG000|Overall Study|Administrative/other|1|||
125042058|NCT01926886|449775088|FG001|Overall Study|Administrative/other|0|||
125042059|NCT01926886|449775087|FG000|Overall Study|Adverse event/intercurrent illness|4|||
125042060|NCT01926886|449775088|FG001|Overall Study|Adverse event/intercurrent illness|0|||
125042061|NCT01926886|449775087|FG000|Overall Study|Disease progression/recurrence|4|||
125135304|NCT01695239|450120132|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135305|NCT01695239|450120133|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135306|NCT01695239|450120134|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135307|NCT01695239|450120135|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135308|NCT01695239|450120122|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
125135309|NCT01695239|450120123|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135310|NCT01695239|450120124|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
125135311|NCT01695239|450120125|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135312|NCT01695239|450120126|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135313|NCT01695239|450120127|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135314|NCT01695239|450120128|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135315|NCT01695239|450120129|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135316|NCT01695239|450120130|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135317|NCT01695239|450120131|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135318|NCT01695239|450120132|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135319|NCT01695239|450120133|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125042062|NCT01926886|449775088|FG001|Overall Study|Disease progression/recurrence|0|||
125042063|NCT01926886|449775087|FG000|Overall Study|Withdrawal by Subject|15|||
125042064|NCT01926886|449775088|FG001|Overall Study|Withdrawal by Subject|0|||
125042065|NCT01926886|449775087|FG000|Overall Study|Failure to return|3|||
125042066|NCT01926886|449775088|FG001|Overall Study|Failure to return|0|||
125042067|NCT01926886|449775087|FG000|Overall Study|Recurrence of disease|1|||
125042068|NCT01926886|449775088|FG001|Overall Study|Recurrence of disease|0|||
125042069|NCT01926886|449775087|FG000|Overall Study|Progression of disease|2|||
125042070|NCT01926886|449775088|FG001|Overall Study|Progression of disease|0|||
125042071|NCT01926886|449775087|FG000|Overall Study|Death|1|||
125042072|NCT01926886|449775088|FG001|Overall Study|Death|0|||
125042073|NCT01926886|449775087|FG000|Overall Study|Did not cooperate|1|||
125042074|NCT01926886|449775088|FG001|Overall Study|Did not cooperate|0|||
125042075|NCT01450540|449775089|FG000|Overall Study|Withdrawal by Subject|19|||
125042076|NCT01450540|449775090|FG001|Overall Study|Withdrawal by Subject|13|||
125042077|NCT01450540|449775089|FG000|Overall Study|protocol deviation|3|||
125042078|NCT01450540|449775090|FG001|Overall Study|protocol deviation|23|||
125042079|NCT03875235|449775102|FG000|Overall Study|Ongoing study treatment|63|||
125042080|NCT03875235|449775103|FG001|Overall Study|Ongoing study treatment|20|||
125042081|NCT03875235|449775102|FG000|Overall Study|Off treatment|77|||
125042082|NCT03875235|449775103|FG001|Overall Study|Off treatment|91|||
125042083|NCT03875235|449775102|FG000|Overall Study|Withdrawal by Subject|3|||
125042084|NCT03875235|449775103|FG001|Overall Study|Withdrawal by Subject|10|||
125042085|NCT03875235|449775102|FG000|Overall Study|Death|198|||
125042086|NCT03875235|449775103|FG001|Overall Study|Death|223|||
125042087|NCT03851510|449775106|FG000|Overall Study|Screen Fail|1|||
125042088|NCT03851510|449775106|FG000|Overall Study|Adverse Event|1|||
125042089|NCT03851510|449775106|FG000|Overall Study|Withdrawal by Subject|1|||
125042090|NCT01151137|449775107|FG000|Overall Study|Death|15|||
125042091|NCT01151137|449775108|FG001|Overall Study|Death|27|||
125042092|NCT01151137|449775107|FG000|Overall Study|Lost to Follow-up|1|||
125042093|NCT01151137|449775108|FG001|Overall Study|Lost to Follow-up|1|||
125042094|NCT03478683|449775109|FG000|Overall Study|Adverse Event|5|||
125042095|NCT03478683|449775110|FG001|Overall Study|Adverse Event|3|||
125042096|NCT03478683|449775109|FG000|Overall Study|Lost to Follow-up|0|||
125042097|NCT03478683|449775110|FG001|Overall Study|Lost to Follow-up|5|||
125042098|NCT03478683|449775109|FG000|Overall Study|Physician Decision|1|||
125042099|NCT03478683|449775110|FG001|Overall Study|Physician Decision|3|||
125042100|NCT03478683|449775109|FG000|Overall Study|Withdrawal by Subject|7|||
125042101|NCT03478683|449775110|FG001|Overall Study|Withdrawal by Subject|7|||
125135320|NCT01695239|450120134|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135321|NCT01695239|450120135|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135322|NCT01695239|450120122|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
125135323|NCT01695239|450120123|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125042102|NCT01887210|449775111|FG000|Overall Study|Withdrawal by Subject|1|||
125042103|NCT01887210|449775112|FG001|Overall Study|Withdrawal by Subject|3|||
125042104|NCT01887210|449775111|FG000|Overall Study|Lost to Follow-up|0|||
125042105|NCT01887210|449775112|FG001|Overall Study|Lost to Follow-up|1|||
125042106|NCT01287117|449775119|FG000|Overall Study|Adverse Event|2|||
125042107|NCT01287117|449775120|FG001|Overall Study|Adverse Event|1|||
125042108|NCT01287117|449775121|FG002|Overall Study|Adverse Event|1|||
125042109|NCT01287117|449775122|FG003|Overall Study|Adverse Event|1|||
125042110|NCT01287117|449775119|FG000|Overall Study|Lost to Follow-up|1|||
125042111|NCT01287117|449775120|FG001|Overall Study|Lost to Follow-up|1|||
125042112|NCT01287117|449775121|FG002|Overall Study|Lost to Follow-up|0|||
125042113|NCT01287117|449775122|FG003|Overall Study|Lost to Follow-up|0|||
125042114|NCT01287117|449775119|FG000|Overall Study|Physician Decision|0|||
125042115|NCT01287117|449775120|FG001|Overall Study|Physician Decision|1|||
125042116|NCT01287117|449775121|FG002|Overall Study|Physician Decision|1|||
125042117|NCT01287117|449775122|FG003|Overall Study|Physician Decision|1|||
125042118|NCT01287117|449775119|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
125042119|NCT01287117|449775120|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
125042120|NCT01287117|449775121|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
125042121|NCT01287117|449775122|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
125042122|NCT01287117|449775119|FG000|Overall Study|Disease Progression|10|||
125042123|NCT01287117|449775120|FG001|Overall Study|Disease Progression|5|||
125042124|NCT01287117|449775121|FG002|Overall Study|Disease Progression|6|||
125042125|NCT01287117|449775122|FG003|Overall Study|Disease Progression|5|||
125042126|NCT00630032|449775123|FG000|Overall Study|Death|55|||
125042127|NCT00630032|449775124|FG001|Overall Study|Death|49|||
125042128|NCT00630032|449775123|FG000|Overall Study|Withdrawal by Subject|3|||
125042129|NCT00630032|449775124|FG001|Overall Study|Withdrawal by Subject|2|||
125042130|NCT00630032|449775123|FG000|Overall Study|Lost to Follow-up|18|||
125042131|NCT00630032|449775124|FG001|Overall Study|Lost to Follow-up|31|||
125042132|NCT00630032|449775123|FG000|Overall Study|Protocol Violation|1|||
125042133|NCT00630032|449775124|FG001|Overall Study|Protocol Violation|0|||
125042134|NCT00630032|449775123|FG000|Overall Study|Patient has moved|1|||
125042135|NCT00630032|449775124|FG001|Overall Study|Patient has moved|1|||
125042136|NCT00630032|449775123|FG000|Overall Study|Disease progression|1|||
125042137|NCT00630032|449775124|FG001|Overall Study|Disease progression|1|||
125042138|NCT00630032|449775123|FG000|Overall Study|End of monitoring in US centers|11|||
125042139|NCT00630032|449775124|FG001|Overall Study|End of monitoring in US centers|11|||
125042140|NCT02332915|449775125|FG000|Overall Study|Moved out of region|3|||
125042141|NCT02332915|449775126|FG001|Overall Study|Moved out of region|0|||
125042142|NCT02332915|449775125|FG000|Overall Study|Unrelated illness|1|||
125042143|NCT02332915|449775126|FG001|Overall Study|Unrelated illness|1|||
125042144|NCT02332915|449775125|FG000|Overall Study|Travel distance prohibitive|0|||
125042145|NCT02332915|449775126|FG001|Overall Study|Travel distance prohibitive|1|||
125042146|NCT02332915|449775125|FG000|Overall Study|did not meet inclusion criteria|2|||
125042147|NCT02332915|449775126|FG001|Overall Study|did not meet inclusion criteria|4|||
125042148|NCT02342171|449777134|FG000|Overall Study|Death|4|||
125042149|NCT02342171|449777135|FG001|Overall Study|Death|87|||
125042150|NCT02342171|449777134|FG000|Overall Study|Received favipiravir|10|||
125042151|NCT02342171|449777135|FG001|Overall Study|Received favipiravir|0|||
125042152|NCT02342171|449777134|FG000|Overall Study|Missing cycle treshold value|1|||
125042153|NCT02342171|449777135|FG001|Overall Study|Missing cycle treshold value|0|||
125042154|NCT02342171|449777134|FG000|Overall Study|Unknown outcome|0|||
125042155|NCT02342171|449777135|FG001|Overall Study|Unknown outcome|1|||
125042156|NCT02342171|449777134|FG000|Overall Study|Missing age data|0|||
125042157|NCT02342171|449777135|FG001|Overall Study|Missing age data|1|||
125042158|NCT05165394|449777136|FG000|Overall Study|Withdrawal by Subject|5|||
125042159|NCT05165394|449777137|FG001|Overall Study|Withdrawal by Subject|1|||
125042160|NCT05165394|449777136|FG000|Overall Study|Lost to Follow-up|1|||
125042161|NCT05165394|449777137|FG001|Overall Study|Lost to Follow-up|2|||
125042162|NCT05165394|449777136|FG000|Overall Study|Other Than Specified|0|||
125042163|NCT05165394|449777137|FG001|Overall Study|Other Than Specified|1|||
125135324|NCT01695239|450120124|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135325|NCT01695239|450120125|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135326|NCT01695239|450120126|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135327|NCT01695239|450120127|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135328|NCT01695239|450120128|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135329|NCT01695239|450120129|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135330|NCT01695239|450120130|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135331|NCT01695239|450120131|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135332|NCT01695239|450120132|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135333|NCT01695239|450120133|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135334|NCT01695239|450120134|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135335|NCT01695239|450120135|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135336|NCT01695239|450120122|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125042164|NCT02517515|449777143|FG000|Overall Study|Adverse Event|0|||
125042165|NCT02517515|449777144|FG001|Overall Study|Adverse Event|1|||
125042166|NCT02517515|449777143|FG000|Overall Study|Withdrew Consent|0|||
125042167|NCT02517515|449777144|FG001|Overall Study|Withdrew Consent|1|||
125042168|NCT02517515|449777143|FG000|Overall Study|Lost to Follow-up|1|||
125042169|NCT02517515|449777144|FG001|Overall Study|Lost to Follow-up|0|||
125042170|NCT02517515|449777143|FG000|Overall Study|Other|1|||
125042171|NCT02517515|449777144|FG001|Overall Study|Other|0|||
125042172|NCT02786537|449777145|FG000|As Randomized|Adverse Event|0|||
125218769|NCT01990768|450427419|FG002|Intervention Started|Discovered to be pregnant|0|||
125218770|NCT01990768|450427417|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
125218771|NCT01990768|450427418|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
125042173|NCT02786537|449777146|FG001|As Randomized|Adverse Event|11|||
125042174|NCT02786537|449777147|FG002|As Randomized|Adverse Event|0|||
125042175|NCT02786537|449777148|FG003|As Randomized|Adverse Event|4|||
125042176|NCT02786537|449777149|FG004|As Randomized|Adverse Event|6|||
125042177|NCT02786537|449777150|FG005|As Randomized|Adverse Event|2|||
125042178|NCT02786537|449777145|FG000|As Randomized|Lack of Efficacy|0|||
125042179|NCT02786537|449777146|FG001|As Randomized|Lack of Efficacy|0|||
125042180|NCT02786537|449777147|FG002|As Randomized|Lack of Efficacy|0|||
125042181|NCT02786537|449777148|FG003|As Randomized|Lack of Efficacy|1|||
125042182|NCT02786537|449777149|FG004|As Randomized|Lack of Efficacy|0|||
125042183|NCT02786537|449777150|FG005|As Randomized|Lack of Efficacy|0|||
125042184|NCT02786537|449777145|FG000|As Randomized|Withdrawal by Subject|1|||
125042185|NCT02786537|449777146|FG001|As Randomized|Withdrawal by Subject|2|||
125042186|NCT02786537|449777147|FG002|As Randomized|Withdrawal by Subject|0|||
125042187|NCT02786537|449777148|FG003|As Randomized|Withdrawal by Subject|1|||
125042188|NCT02786537|449777149|FG004|As Randomized|Withdrawal by Subject|1|||
125042189|NCT02786537|449777150|FG005|As Randomized|Withdrawal by Subject|0|||
125042190|NCT02786537|449777145|FG000|As Randomized|Death|0|||
125042191|NCT02786537|449777146|FG001|As Randomized|Death|2|||
125042192|NCT02786537|449777147|FG002|As Randomized|Death|0|||
125042193|NCT02786537|449777148|FG003|As Randomized|Death|3|||
125042194|NCT02786537|449777149|FG004|As Randomized|Death|1|||
125042195|NCT02786537|449777150|FG005|As Randomized|Death|0|||
125042196|NCT02786537|449777145|FG000|As Randomized|Non-compliance with study drug|1|||
125042197|NCT02786537|449777146|FG001|As Randomized|Non-compliance with study drug|11|||
125042198|NCT02786537|449777147|FG002|As Randomized|Non-compliance with study drug|0|||
125042199|NCT02786537|449777148|FG003|As Randomized|Non-compliance with study drug|1|||
125042200|NCT02786537|449777149|FG004|As Randomized|Non-compliance with study drug|0|||
125042201|NCT02786537|449777150|FG005|As Randomized|Non-compliance with study drug|1|||
125042202|NCT02786537|449777145|FG000|As Randomized|Lost to treatment follow-up|4|||
125042203|NCT02786537|449777146|FG001|As Randomized|Lost to treatment follow-up|32|||
125042204|NCT02786537|449777147|FG002|As Randomized|Lost to treatment follow-up|0|||
125042205|NCT02786537|449777148|FG003|As Randomized|Lost to treatment follow-up|24|||
125042206|NCT02786537|449777149|FG004|As Randomized|Lost to treatment follow-up|4|||
125042207|NCT02786537|449777150|FG005|As Randomized|Lost to treatment follow-up|4|||
125042208|NCT02786537|449777145|FG000|As Randomized|Incarceration|0|||
125042209|NCT02786537|449777146|FG001|As Randomized|Incarceration|1|||
125042210|NCT02786537|449777147|FG002|As Randomized|Incarceration|0|||
125042211|NCT02786537|449777148|FG003|As Randomized|Incarceration|0|||
125042212|NCT02786537|449777149|FG004|As Randomized|Incarceration|0|||
125042213|NCT02786537|449777150|FG005|As Randomized|Incarceration|0|||
125042214|NCT02786537|449777145|FG000|As Randomized|Opiate Dependency Relapse|0|||
125042215|NCT02786537|449777146|FG001|As Randomized|Opiate Dependency Relapse|1|||
125042216|NCT02786537|449777147|FG002|As Randomized|Opiate Dependency Relapse|0|||
125042217|NCT02786537|449777148|FG003|As Randomized|Opiate Dependency Relapse|0|||
125042218|NCT02786537|449777149|FG004|As Randomized|Opiate Dependency Relapse|0|||
125042219|NCT02786537|449777150|FG005|As Randomized|Opiate Dependency Relapse|0|||
125042220|NCT02786537|449777145|FG000|As Randomized|HCV drugs stolen from pt|0|||
125042221|NCT02786537|449777146|FG001|As Randomized|HCV drugs stolen from pt|1|||
125042222|NCT02786537|449777147|FG002|As Randomized|HCV drugs stolen from pt|0|||
125042223|NCT02786537|449777148|FG003|As Randomized|HCV drugs stolen from pt|0|||
125042224|NCT02786537|449777149|FG004|As Randomized|HCV drugs stolen from pt|0|||
125042225|NCT02786537|449777150|FG005|As Randomized|HCV drugs stolen from pt|0|||
125042226|NCT02786537|449777145|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
125042227|NCT02786537|449777146|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
125042228|NCT02786537|449777147|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
125042229|NCT02786537|449777148|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
125042230|NCT02786537|449777149|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
125042231|NCT02786537|449777150|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
125042232|NCT02786537|449777145|FG000|As Randomized|Subject lost insurance|0|||
125042233|NCT02786537|449777146|FG001|As Randomized|Subject lost insurance|0|||
125042234|NCT02786537|449777147|FG002|As Randomized|Subject lost insurance|0|||
125042235|NCT02786537|449777148|FG003|As Randomized|Subject lost insurance|1|||
125042236|NCT02786537|449777149|FG004|As Randomized|Subject lost insurance|0|||
125042237|NCT02786537|449777150|FG005|As Randomized|Subject lost insurance|0|||
125042238|NCT02786537|449777145|FG000|As Treated|Adverse Event|0|||
125042239|NCT02786537|449777146|FG001|As Treated|Adverse Event|11|||
125042240|NCT02786537|449777147|FG002|As Treated|Adverse Event|0|||
125042241|NCT02786537|449777148|FG003|As Treated|Adverse Event|4|||
125042242|NCT02786537|449777149|FG004|As Treated|Adverse Event|6|||
125218772|NCT01990768|450427419|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
125042243|NCT02786537|449777150|FG005|As Treated|Adverse Event|2|||
125042244|NCT02786537|449777145|FG000|As Treated|Death|0|||
125042245|NCT02786537|449777146|FG001|As Treated|Death|2|||
125042246|NCT02786537|449777147|FG002|As Treated|Death|0|||
125042247|NCT02786537|449777148|FG003|As Treated|Death|3|||
125042248|NCT02786537|449777149|FG004|As Treated|Death|1|||
125042249|NCT02786537|449777150|FG005|As Treated|Death|0|||
125042250|NCT02786537|449777145|FG000|As Treated|Lack of Efficacy|0|||
125042251|NCT02786537|449777146|FG001|As Treated|Lack of Efficacy|0|||
125042252|NCT02786537|449777147|FG002|As Treated|Lack of Efficacy|0|||
125042253|NCT02786537|449777148|FG003|As Treated|Lack of Efficacy|1|||
125042254|NCT02786537|449777149|FG004|As Treated|Lack of Efficacy|0|||
125042255|NCT02786537|449777150|FG005|As Treated|Lack of Efficacy|0|||
125042256|NCT02786537|449777145|FG000|As Treated|Lost to Follow-up|4|||
125042257|NCT02786537|449777146|FG001|As Treated|Lost to Follow-up|32|||
125042258|NCT02786537|449777147|FG002|As Treated|Lost to Follow-up|0|||
125042259|NCT02786537|449777148|FG003|As Treated|Lost to Follow-up|25|||
125042260|NCT02786537|449777149|FG004|As Treated|Lost to Follow-up|4|||
125042261|NCT02786537|449777150|FG005|As Treated|Lost to Follow-up|4|||
125042262|NCT02786537|449777145|FG000|As Treated|Non-compliance with study drug|1|||
125042263|NCT02786537|449777146|FG001|As Treated|Non-compliance with study drug|11|||
125042264|NCT02786537|449777147|FG002|As Treated|Non-compliance with study drug|0|||
125042265|NCT02786537|449777148|FG003|As Treated|Non-compliance with study drug|1|||
125042266|NCT02786537|449777149|FG004|As Treated|Non-compliance with study drug|0|||
125042267|NCT02786537|449777150|FG005|As Treated|Non-compliance with study drug|1|||
125042268|NCT02786537|449777145|FG000|As Treated|Lost insurance|0|||
125042269|NCT02786537|449777146|FG001|As Treated|Lost insurance|0|||
125042270|NCT02786537|449777147|FG002|As Treated|Lost insurance|0|||
125042271|NCT02786537|449777148|FG003|As Treated|Lost insurance|1|||
125042272|NCT02786537|449777149|FG004|As Treated|Lost insurance|0|||
125042273|NCT02786537|449777150|FG005|As Treated|Lost insurance|0|||
125042274|NCT02786537|449777145|FG000|As Treated|Withdrawal by Subject|1|||
125042275|NCT02786537|449777146|FG001|As Treated|Withdrawal by Subject|2|||
125042276|NCT02786537|449777147|FG002|As Treated|Withdrawal by Subject|0|||
125042277|NCT02786537|449777148|FG003|As Treated|Withdrawal by Subject|0|||
125042278|NCT02786537|449777149|FG004|As Treated|Withdrawal by Subject|1|||
125042279|NCT02786537|449777150|FG005|As Treated|Withdrawal by Subject|0|||
125042280|NCT02786537|449777145|FG000|As Treated|Incarceration|0|||
125042281|NCT02786537|449777146|FG001|As Treated|Incarceration|1|||
125042282|NCT02786537|449777147|FG002|As Treated|Incarceration|0|||
125042283|NCT02786537|449777148|FG003|As Treated|Incarceration|0|||
125042284|NCT02786537|449777149|FG004|As Treated|Incarceration|0|||
125042285|NCT02786537|449777150|FG005|As Treated|Incarceration|0|||
125042286|NCT02786537|449777145|FG000|As Treated|Opiate dependency relapse|0|||
125042287|NCT02786537|449777146|FG001|As Treated|Opiate dependency relapse|1|||
125042288|NCT02786537|449777147|FG002|As Treated|Opiate dependency relapse|0|||
125042289|NCT02786537|449777148|FG003|As Treated|Opiate dependency relapse|0|||
125042290|NCT02786537|449777149|FG004|As Treated|Opiate dependency relapse|0|||
125042291|NCT02786537|449777150|FG005|As Treated|Opiate dependency relapse|0|||
125042292|NCT02786537|449777145|FG000|As Treated|Drugs stolen from patient|0|||
125042293|NCT02786537|449777146|FG001|As Treated|Drugs stolen from patient|1|||
125042294|NCT02786537|449777147|FG002|As Treated|Drugs stolen from patient|0|||
125042295|NCT02786537|449777148|FG003|As Treated|Drugs stolen from patient|0|||
125042296|NCT02786537|449777149|FG004|As Treated|Drugs stolen from patient|0|||
125042297|NCT02786537|449777150|FG005|As Treated|Drugs stolen from patient|0|||
125042298|NCT02786537|449777145|FG000|As Treated|Advised to stop tx after loss of meds|0|||
125042299|NCT02786537|449777146|FG001|As Treated|Advised to stop tx after loss of meds|1|||
125042300|NCT02786537|449777147|FG002|As Treated|Advised to stop tx after loss of meds|0|||
125042301|NCT02786537|449777148|FG003|As Treated|Advised to stop tx after loss of meds|0|||
125042302|NCT02786537|449777149|FG004|As Treated|Advised to stop tx after loss of meds|0|||
125042303|NCT02786537|449777150|FG005|As Treated|Advised to stop tx after loss of meds|0|||
125042304|NCT02638012|449777151|FG000|Overall Study|Lost to Follow-up|1|||
125042305|NCT00443560|449777152|FG000|Overall Study|No intrathecal dose|58|||
125042306|NCT00443560|449777153|FG001|Overall Study|No intrathecal dose|26|||
125042307|NCT00443560|449777152|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
125042308|NCT00443560|449777153|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
125042309|NCT01494038|449777154|FG000|Overall Study|Protocol Violation|1|||
125042310|NCT01494038|449777155|FG001|Overall Study|Protocol Violation|1|||
125042311|NCT01494038|449777154|FG000|Overall Study|Lost to Follow-up|18|||
125042312|NCT01494038|449777155|FG001|Overall Study|Lost to Follow-up|20|||
125042313|NCT01494038|449777154|FG000|Overall Study|Withdrawal by Subject|44|||
125042314|NCT01494038|449777155|FG001|Overall Study|Withdrawal by Subject|34|||
125042315|NCT01494038|449777154|FG000|Overall Study|Not able to get to clinic|21|||
125042316|NCT01494038|449777155|FG001|Overall Study|Not able to get to clinic|15|||
125042317|NCT01494038|449777154|FG000|Overall Study|Not willing to adhere to reqs|2|||
125042318|NCT01494038|449777155|FG001|Overall Study|Not willing to adhere to reqs|9|||
125042319|NCT01494038|449777154|FG000|Overall Study|Death|2|||
125042320|NCT01494038|449777155|FG001|Overall Study|Death|4|||
125042321|NCT05299892|449777156|FG000|Overall Study|Withdrawal by Subject|2|||
125042322|NCT01458340|449777157|FG000|Overall Study|Adverse Event|5|||
125042323|NCT01458340|449777158|FG001|Overall Study|Adverse Event|4|||
125042324|NCT01458340|449777159|FG002|Overall Study|Adverse Event|2|||
125042325|NCT01458340|449777157|FG000|Overall Study|Lost to Follow-up|3|||
125042326|NCT01458340|449777158|FG001|Overall Study|Lost to Follow-up|3|||
125042327|NCT01458340|449777159|FG002|Overall Study|Lost to Follow-up|10|||
125042328|NCT01458340|449777157|FG000|Overall Study|Miscellaneous|0|||
125042329|NCT01458340|449777158|FG001|Overall Study|Miscellaneous|1|||
125042330|NCT01458340|449777159|FG002|Overall Study|Miscellaneous|0|||
125042331|NCT01458340|449777157|FG000|Overall Study|Physician Decision|1|||
125042332|NCT01458340|449777158|FG001|Overall Study|Physician Decision|1|||
125042333|NCT01458340|449777159|FG002|Overall Study|Physician Decision|2|||
125042334|NCT01458340|449777157|FG000|Overall Study|Protocol Violation|6|||
125042335|NCT01458340|449777158|FG001|Overall Study|Protocol Violation|6|||
125042336|NCT01458340|449777159|FG002|Overall Study|Protocol Violation|5|||
125042337|NCT01458340|449777157|FG000|Overall Study|Withdrawal by Subject|12|||
125042338|NCT01458340|449777158|FG001|Overall Study|Withdrawal by Subject|6|||
125042339|NCT01458340|449777159|FG002|Overall Study|Withdrawal by Subject|4|||
125042340|NCT01126619|449777162|FG000|Overall Study|Not eligible for the study|2|||
125042341|NCT01126619|449777162|FG000|Overall Study|Investigator decision|4|||
125042342|NCT01126619|449777162|FG000|Overall Study|Serious adverse event|1|||
125042343|NCT01126619|449777162|FG000|Overall Study|Withdrawal by Subject|9|||
125042344|NCT01126619|449777162|FG000|Overall Study|Non-compliance|1|||
125042345|NCT03351244|449777163|FG000|Overall Study|Adverse Event|7|||
125042346|NCT03351244|449777164|FG001|Overall Study|Adverse Event|11|||
125042347|NCT03351244|449777165|FG002|Overall Study|Adverse Event|12|||
125042348|NCT03351244|449777163|FG000|Overall Study|Investigator's decision|0|||
125042349|NCT03351244|449777164|FG001|Overall Study|Investigator's decision|0|||
125042350|NCT03351244|449777165|FG002|Overall Study|Investigator's decision|2|||
125042351|NCT03351244|449777163|FG000|Overall Study|System error|0|||
125042352|NCT03351244|449777164|FG001|Overall Study|System error|0|||
125042353|NCT03351244|449777165|FG002|Overall Study|System error|2|||
125042354|NCT03351244|449777163|FG000|Overall Study|COVID-19 restrictions|3|||
125042355|NCT03351244|449777164|FG001|Overall Study|COVID-19 restrictions|0|||
125042356|NCT03351244|449777165|FG002|Overall Study|COVID-19 restrictions|1|||
125042357|NCT03351244|449777163|FG000|Overall Study|Non-compliance|2|||
125042358|NCT03351244|449777164|FG001|Overall Study|Non-compliance|5|||
125042359|NCT03351244|449777165|FG002|Overall Study|Non-compliance|0|||
125042360|NCT03351244|449777163|FG000|Overall Study|Withdrawal by Subject|11|||
125042361|NCT03351244|449777164|FG001|Overall Study|Withdrawal by Subject|16|||
125042362|NCT03351244|449777165|FG002|Overall Study|Withdrawal by Subject|13|||
125042363|NCT03351244|449777163|FG000|Overall Study|Lost to Follow-up|2|||
125042364|NCT03351244|449777164|FG001|Overall Study|Lost to Follow-up|6|||
125042365|NCT03351244|449777165|FG002|Overall Study|Lost to Follow-up|4|||
125042366|NCT03351244|449777163|FG000|Overall Study|Protocol Violation|2|||
125042367|NCT03351244|449777164|FG001|Overall Study|Protocol Violation|2|||
125042368|NCT03351244|449777165|FG002|Overall Study|Protocol Violation|0|||
125042369|NCT00091793|449777167|FG000|Overall Study|Adverse Event|1|||
125042370|NCT00091793|449777168|FG001|Overall Study|Adverse Event|2|||
125042371|NCT00091793|449777167|FG000|Overall Study|Withdrawal by Subject|10|||
125042372|NCT00091793|449777168|FG001|Overall Study|Withdrawal by Subject|15|||
125042373|NCT00091793|449777167|FG000|Overall Study|Ineligibility determined|2|||
125042374|NCT00091793|449777168|FG001|Overall Study|Ineligibility determined|0|||
125042375|NCT00091793|449777167|FG000|Overall Study|Lost to Follow-up|7|||
125042376|NCT00091793|449777168|FG001|Overall Study|Lost to Follow-up|5|||
125042377|NCT00091793|449777167|FG000|Overall Study|Noncompliance|2|||
125042378|NCT00091793|449777168|FG001|Overall Study|Noncompliance|0|||
125042379|NCT00091793|449777167|FG000|Overall Study|Other|2|||
125042380|NCT00091793|449777168|FG001|Overall Study|Other|0|||
125042381|NCT05309083|449777170|FG000|Overall Study|Withdrawal by Subject|2|||
125042382|NCT01165229|449777171|FG000|Overall Study|Serious Adverse Event|456|||
125042383|NCT01165229|449777172|FG001|Overall Study|Serious Adverse Event|487|||
125042384|NCT01165229|449777171|FG000|Overall Study|Non-Serious Adverse Event|47|||
125042385|NCT01165229|449777172|FG001|Overall Study|Non-Serious Adverse Event|15|||
125042386|NCT01165229|449777171|FG000|Overall Study|Protocol Violation|6|||
125042387|NCT01165229|449777172|FG001|Overall Study|Protocol Violation|8|||
125042388|NCT01165229|449777171|FG000|Overall Study|Withdrawal by Subject|387|||
125135337|NCT01695239|450120123|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135338|NCT01695239|450120124|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135339|NCT01695239|450120125|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125042389|NCT01165229|449777172|FG001|Overall Study|Withdrawal by Subject|396|||
125042390|NCT01165229|449777171|FG000|Overall Study|Migrated/moved from study area|51|||
125042391|NCT01165229|449777172|FG001|Overall Study|Migrated/moved from study area|46|||
125042392|NCT01165229|449777171|FG000|Overall Study|Lost to Follow-up|123|||
125042393|NCT01165229|449777172|FG001|Overall Study|Lost to Follow-up|133|||
125042394|NCT01165229|449777171|FG000|Overall Study|Suspected HZ Episode|2|||
125042395|NCT01165229|449777172|FG001|Overall Study|Suspected HZ Episode|2|||
125042396|NCT01165229|449777171|FG000|Overall Study|No reason from the subject|108|||
125042397|NCT01165229|449777172|FG001|Overall Study|No reason from the subject|102|||
125042398|NCT01165229|449777171|FG000|Overall Study|Unknown completion status|0|||
125135340|NCT01695239|450120126|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135341|NCT01695239|450120127|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135342|NCT01695239|450120128|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135343|NCT01695239|450120129|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
125135344|NCT01695239|450120130|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135345|NCT01695239|450120131|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135346|NCT01695239|450120132|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135347|NCT01695239|450120133|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135348|NCT01695239|450120134|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135349|NCT01695239|450120135|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135350|NCT01695239|450120122|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135351|NCT01695239|450120123|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135352|NCT01695239|450120124|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135353|NCT01695239|450120125|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135354|NCT01695239|450120126|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135355|NCT01695239|450120127|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135356|NCT01695239|450120128|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135357|NCT01695239|450120129|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
125135358|NCT01695239|450120130|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135359|NCT01695239|450120131|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135360|NCT01695239|450120132|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135361|NCT01695239|450120133|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135362|NCT01695239|450120134|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135363|NCT01695239|450120135|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135364|NCT01695239|450120122|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135365|NCT01695239|450120123|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135366|NCT01695239|450120124|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135367|NCT01695239|450120125|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135368|NCT01695239|450120126|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135369|NCT01695239|450120127|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135370|NCT01695239|450120128|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135371|NCT01695239|450120129|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
125135372|NCT01695239|450120130|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135373|NCT01695239|450120131|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135374|NCT01695239|450120132|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135375|NCT01695239|450120133|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135376|NCT01695239|450120134|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125218773|NCT01990768|450427417|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
125218774|NCT01990768|450427418|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
125042399|NCT01165229|449777172|FG001|Overall Study|Unknown completion status|1|||
125042400|NCT00881205|449777176|FG000|Overall Study|Adverse Event|8|||
125042401|NCT00881205|449777177|FG001|Overall Study|Adverse Event|3|||
125042402|NCT00881205|449777176|FG000|Overall Study|Withdrawal by Subject|1|||
125042403|NCT00881205|449777177|FG001|Overall Study|Withdrawal by Subject|2|||
125042404|NCT00881205|449777176|FG000|Overall Study|Lost to Follow-up|0|||
125042405|NCT00881205|449777177|FG001|Overall Study|Lost to Follow-up|1|||
125042406|NCT00881205|449777176|FG000|Overall Study|Administrative problems|1|||
125042407|NCT00881205|449777177|FG001|Overall Study|Administrative problems|1|||
125042408|NCT00881205|449777176|FG000|Overall Study|Condition no longer requires drug|1|||
125042409|NCT00881205|449777177|FG001|Overall Study|Condition no longer requires drug|0|||
125042410|NCT00550238|449777178|FG000|Overall Study|Adverse Event|88|||
125042411|NCT00550238|449777178|FG000|Overall Study|Death|34|||
125042412|NCT00550238|449777178|FG000|Overall Study|Disease progression|46|||
125042413|NCT00550238|449777178|FG000|Overall Study|Withdrawal by Subject|167|||
125042414|NCT00550238|449777178|FG000|Overall Study|Physician Decision|31|||
125042415|NCT00550238|449777178|FG000|Overall Study|Patient noncompliance|25|||
125042416|NCT00550238|449777178|FG000|Overall Study|Lost to Follow-up|13|||
125042417|NCT00550238|449777178|FG000|Overall Study|Sponsor decision|55|||
125042418|NCT00779038|449777179|FG000|Overall Study|Study Prematurely Terminated|13|||
125042419|NCT00537745|449777180|FG000|Overall Study|Did not meet eligibility criteria|2|||
125042420|NCT00537745|449777180|FG000|Overall Study|Withdrawal by Subject|2|||
125042421|NCT00537745|449777180|FG000|Overall Study|Subject unable to provide Interlock info|1|||
125042422|NCT04786210|449777181|FG000|Overall Study|Lost to Follow-up|2|||
125042423|NCT04786210|449777181|FG000|Overall Study|Withdrawal by Subject|4|||
125042424|NCT03700892|449777182|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
125042425|NCT03700892|449777183|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
125042426|NCT03700892|449777184|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
125042427|NCT01634243|449777185|FG000|Overall Study|Adverse Event|5|||
125218775|NCT01990768|450427419|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
125218776|NCT01990768|450427417|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
125218777|NCT01990768|450427418|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
125218778|NCT01990768|450427419|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
125218779|NCT01990768|450427417|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
125218780|NCT01990768|450427418|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
125218781|NCT01990768|450427419|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
125218782|NCT01990768|450427417|FG000|Prehospital Study Drug Infusion|Death|3|||
125218783|NCT01990768|450427418|FG001|Prehospital Study Drug Infusion|Death|1|||
125218784|NCT01990768|450427419|FG002|Prehospital Study Drug Infusion|Death|1|||
125218785|NCT01990768|450427417|FG000|Prehospital Study Drug Infusion|Discharged|2|||
125218786|NCT01990768|450427418|FG001|Prehospital Study Drug Infusion|Discharged|1|||
125218787|NCT01990768|450427419|FG002|Prehospital Study Drug Infusion|Discharged|0|||
125218788|NCT01990768|450427417|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
125218789|NCT01990768|450427418|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
125218790|NCT01990768|450427419|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
125218791|NCT01990768|450427417|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
125218792|NCT01990768|450427418|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
125218793|NCT01990768|450427419|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
125218794|NCT01990768|450427417|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
125218795|NCT01990768|450427418|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
125218796|NCT01990768|450427419|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
125218797|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
125218798|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
125218799|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
125218800|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
125218801|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
125218802|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
125218803|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
125218804|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
125218805|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
125218806|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
125218807|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
125218808|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
125218809|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
125218810|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
125218811|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
125218812|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
125218813|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
125218814|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
125218815|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
125218816|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
125218817|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
125218818|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
125218819|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
125218820|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
124975673|NCT01667926|449538519|FG001|Overall Study|Withdrawal by Subject|2|||
124975674|NCT01667926|449538520|FG002|Overall Study|Withdrawal by Subject|2|||
124975675|NCT01667926|449538518|FG000|Overall Study|Physician Decision|0|||
124975676|NCT01667926|449538519|FG001|Overall Study|Physician Decision|0|||
124975677|NCT01667926|449538520|FG002|Overall Study|Physician Decision|1|||
124975678|NCT01667926|449538518|FG000|Overall Study|Time committment|0|||
124975679|NCT01667926|449538519|FG001|Overall Study|Time committment|0|||
124975680|NCT01667926|449538520|FG002|Overall Study|Time committment|2|||
124975681|NCT01667926|449538518|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
124975682|NCT01667926|449538519|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
124975683|NCT01667926|449538520|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
124975684|NCT01667926|449538518|FG000|Overall Study|Lost to Follow-up|1|||
124975685|NCT01667926|449538519|FG001|Overall Study|Lost to Follow-up|2|||
124975686|NCT01667926|449538520|FG002|Overall Study|Lost to Follow-up|1|||
124975687|NCT01667926|449538518|FG000|Overall Study|Side effects|3|||
124975688|NCT01667926|449538519|FG001|Overall Study|Side effects|0|||
124975689|NCT01667926|449538520|FG002|Overall Study|Side effects|0|||
124975690|NCT01088984|449538525|FG000|Phase 1|Death|2|||
124975691|NCT01088984|449538526|FG001|Phase 1|Death|1|||
125042428|NCT01634243|449777186|FG001|Overall Study|Adverse Event|5|||
125042429|NCT01634243|449777185|FG000|Overall Study|Lack of Efficacy|1|||
125042430|NCT01634243|449777186|FG001|Overall Study|Lack of Efficacy|0|||
125042431|NCT00845429|449777189|FG000|Overall Study|Protocol Violation|5|||
125042432|NCT00845429|449777190|FG001|Overall Study|Protocol Violation|4|||
125042433|NCT00845429|449777191|FG002|Overall Study|Protocol Violation|7|||
125042434|NCT00845429|449777189|FG000|Overall Study|Lost to Follow-up|7|||
125042435|NCT00845429|449777190|FG001|Overall Study|Lost to Follow-up|9|||
125042436|NCT00845429|449777191|FG002|Overall Study|Lost to Follow-up|10|||
125042437|NCT00845429|449777189|FG000|Overall Study|Withdrawal by Subject|2|||
125042438|NCT00845429|449777190|FG001|Overall Study|Withdrawal by Subject|2|||
125042439|NCT00845429|449777191|FG002|Overall Study|Withdrawal by Subject|2|||
125042440|NCT00845429|449777189|FG000|Overall Study|Serious adverse event|0|||
125042441|NCT00845429|449777190|FG001|Overall Study|Serious adverse event|0|||
125042442|NCT00845429|449777191|FG002|Overall Study|Serious adverse event|1|||
125042443|NCT03240081|449777198|FG000|Overall Study|Withdrawal by Subject|0|||
125042444|NCT03240081|449777199|FG001|Overall Study|Withdrawal by Subject|2|||
125042445|NCT03240081|449777198|FG000|Overall Study|Lost to Follow-up|0|||
125042446|NCT03240081|449777199|FG001|Overall Study|Lost to Follow-up|1|||
125042447|NCT01480180|449777200|FG000|Main Phase|Withdrawal criteria|12|||
125042448|NCT01480180|449777201|FG001|Main Phase|Withdrawal criteria|1|||
125042449|NCT01480180|449777202|FG002|Main Phase|Withdrawal criteria|0|||
125042450|NCT01480180|449777203|FG003|Main Phase|Withdrawal criteria|0|||
125042451|NCT01480180|449777204|FG004|Main Phase|Withdrawal criteria|0|||
125042452|NCT01480180|449777205|FG005|Main Phase|Withdrawal criteria|0|||
125042453|NCT01480180|449777200|FG000|Main Phase|Lack of Efficacy|1|||
125042454|NCT01480180|449777201|FG001|Main Phase|Lack of Efficacy|0|||
125042455|NCT01480180|449777202|FG002|Main Phase|Lack of Efficacy|0|||
125042456|NCT01480180|449777203|FG003|Main Phase|Lack of Efficacy|0|||
125042457|NCT01480180|449777204|FG004|Main Phase|Lack of Efficacy|0|||
125042458|NCT01480180|449777205|FG005|Main Phase|Lack of Efficacy|0|||
125042459|NCT01480180|449777200|FG000|Main Phase|Non-compliance|3|||
125042460|NCT01480180|449777201|FG001|Main Phase|Non-compliance|0|||
125042461|NCT01480180|449777202|FG002|Main Phase|Non-compliance|0|||
125042462|NCT01480180|449777203|FG003|Main Phase|Non-compliance|0|||
125042463|NCT01480180|449777204|FG004|Main Phase|Non-compliance|0|||
125042464|NCT01480180|449777205|FG005|Main Phase|Non-compliance|0|||
125042465|NCT01480180|449777200|FG000|Main Phase|Unclassified|3|||
125042466|NCT01480180|449777201|FG001|Main Phase|Unclassified|0|||
125042467|NCT01480180|449777202|FG002|Main Phase|Unclassified|0|||
125042468|NCT01480180|449777203|FG003|Main Phase|Unclassified|0|||
125042469|NCT01480180|449777204|FG004|Main Phase|Unclassified|0|||
125042470|NCT01480180|449777205|FG005|Main Phase|Unclassified|0|||
125042471|NCT01480180|449777200|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
125042472|NCT01480180|449777201|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
125042473|NCT01480180|449777202|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
125042474|NCT01480180|449777203|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
125042475|NCT01480180|449777204|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
125042476|NCT01480180|449777205|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
125042477|NCT01480180|449777200|FG000|Extension Phase, Part 1|Unclassified|0|||
125042478|NCT01480180|449777201|FG001|Extension Phase, Part 1|Unclassified|0|||
125042479|NCT01480180|449777202|FG002|Extension Phase, Part 1|Unclassified|1|||
125042480|NCT01480180|449777203|FG003|Extension Phase, Part 1|Unclassified|0|||
125042481|NCT01480180|449777204|FG004|Extension Phase, Part 1|Unclassified|0|||
125042482|NCT01480180|449777205|FG005|Extension Phase, Part 1|Unclassified|0|||
125042483|NCT01480180|449777200|FG000|Extension Phase, Part 1|Adverse Event|0|||
125042484|NCT01480180|449777201|FG001|Extension Phase, Part 1|Adverse Event|0|||
125042485|NCT01480180|449777202|FG002|Extension Phase, Part 1|Adverse Event|4|||
125042486|NCT01480180|449777203|FG003|Extension Phase, Part 1|Adverse Event|1|||
125042487|NCT01480180|449777204|FG004|Extension Phase, Part 1|Adverse Event|0|||
125042488|NCT01480180|449777205|FG005|Extension Phase, Part 1|Adverse Event|0|||
125042489|NCT01480180|449777200|FG000|Extension Phase, Part 1|Change of treatment|0|||
125042490|NCT01480180|449777201|FG001|Extension Phase, Part 1|Change of treatment|0|||
125042491|NCT01480180|449777202|FG002|Extension Phase, Part 1|Change of treatment|0|||
125042492|NCT01480180|449777203|FG003|Extension Phase, Part 1|Change of treatment|9|||
125042493|NCT01480180|449777204|FG004|Extension Phase, Part 1|Change of treatment|0|||
125042494|NCT01480180|449777205|FG005|Extension Phase, Part 1|Change of treatment|0|||
125042495|NCT01480180|449777200|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
125042496|NCT01480180|449777201|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
125042497|NCT01480180|449777202|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
125042498|NCT01480180|449777203|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
125042499|NCT01480180|449777204|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
125042500|NCT01480180|449777205|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
125042501|NCT01480180|449777200|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
125042502|NCT01480180|449777201|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
125042503|NCT01480180|449777202|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
125042504|NCT01480180|449777203|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
125042505|NCT01480180|449777204|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
125042506|NCT01480180|449777205|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
125042507|NCT01480180|449777200|FG000|Extension Phase, Part 2|Unclassified|0|||
125042508|NCT01480180|449777201|FG001|Extension Phase, Part 2|Unclassified|0|||
125042509|NCT01480180|449777202|FG002|Extension Phase, Part 2|Unclassified|3|||
125042510|NCT01480180|449777203|FG003|Extension Phase, Part 2|Unclassified|1|||
125042511|NCT01480180|449777204|FG004|Extension Phase, Part 2|Unclassified|1|||
125042512|NCT01480180|449777205|FG005|Extension Phase, Part 2|Unclassified|0|||
125042513|NCT02436239|449777207|FG000|Open-Lable Treatment Period|Adverse Event|12|||
125042514|NCT02436239|449777208|FG001|Open-Lable Treatment Period|Adverse Event|3|||
125042515|NCT02436239|449777209|FG002|Open-Lable Treatment Period|Adverse Event|4|||
125042516|NCT02436239|449777210|FG003|Open-Lable Treatment Period|Adverse Event|2|||
125042517|NCT02436239|449777207|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
125042518|NCT02436239|449777208|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
125135377|NCT01695239|450120135|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135378|NCT01695239|450120122|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125135379|NCT01695239|450120123|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125135380|NCT01695239|450120124|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125135381|NCT01695239|450120125|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125135382|NCT01695239|450120126|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
124975692|NCT01088984|449538525|FG000|Phase 1|Disease Progression|2|||
124975693|NCT01088984|449538526|FG001|Phase 1|Disease Progression|4|||
124975694|NCT01088984|449538525|FG000|Phase 1|Other|1|||
124975695|NCT01088984|449538526|FG001|Phase 1|Other|1|||
124975696|NCT01088984|449538525|FG000|Phase 2|Death|0|||
124975697|NCT01088984|449538526|FG001|Phase 2|Death|5|||
124975698|NCT01088984|449538525|FG000|Phase 2|Withdrawal by Subject|0|||
124975699|NCT01088984|449538526|FG001|Phase 2|Withdrawal by Subject|1|||
124975700|NCT01088984|449538525|FG000|Phase 2|DIsease Progression|0|||
124975701|NCT01088984|449538526|FG001|Phase 2|DIsease Progression|25|||
124975702|NCT01088984|449538525|FG000|Phase 2|Other|0|||
124975703|NCT01088984|449538526|FG001|Phase 2|Other|1|||
124975704|NCT04707664|449538527|FG000|Overall Study|Adverse Event|2|||
124975705|NCT04707664|449538528|FG001|Overall Study|Adverse Event|0|||
124975706|NCT04707664|449538527|FG000|Overall Study|Death|1|||
124975707|NCT04707664|449538528|FG001|Overall Study|Death|2|||
124975708|NCT04707664|449538527|FG000|Overall Study|Withdrawal by Subject|13|||
124975709|NCT04707664|449538528|FG001|Overall Study|Withdrawal by Subject|21|||
124975710|NCT04707664|449538527|FG000|Overall Study|Lost to Follow-up|11|||
124975711|NCT04707664|449538528|FG001|Overall Study|Lost to Follow-up|13|||
124975712|NCT04707664|449538527|FG000|Overall Study|Not treated|2|||
124975713|NCT04707664|449538528|FG001|Overall Study|Not treated|0|||
124975714|NCT00699153|449538529|FG000|Overall Study|Lost to Follow-up|1|||
124975715|NCT00699153|449538530|FG001|Overall Study|Lost to Follow-up|0|||
124975716|NCT00699153|449538529|FG000|Overall Study|Adverse Event|0|||
124975717|NCT00699153|449538530|FG001|Overall Study|Adverse Event|2|||
124975718|NCT00699153|449538529|FG000|Overall Study|Protocol Violation|1|||
124975719|NCT00699153|449538530|FG001|Overall Study|Protocol Violation|0|||
124975720|NCT00699153|449538529|FG000|Overall Study|Travel Problem|1|||
124975721|NCT00699153|449538530|FG001|Overall Study|Travel Problem|0|||
124975722|NCT02412735|449538533|FG000|Overall Study|Adverse Event|0|||
124975723|NCT02412735|449538534|FG001|Overall Study|Adverse Event|1|||
124975724|NCT02412735|449538535|FG002|Overall Study|Adverse Event|2|||
124975725|NCT02412735|449538533|FG000|Overall Study|Withdrawal by Subject|23|||
124975726|NCT02412735|449538534|FG001|Overall Study|Withdrawal by Subject|27|||
124975727|NCT02412735|449538535|FG002|Overall Study|Withdrawal by Subject|22|||
124975728|NCT02412735|449538533|FG000|Overall Study|Investigator Decision|3|||
124975729|NCT02412735|449538534|FG001|Overall Study|Investigator Decision|3|||
124975730|NCT02412735|449538535|FG002|Overall Study|Investigator Decision|2|||
124975731|NCT02412735|449538533|FG000|Overall Study|Lost to Follow-up|17|||
124975732|NCT02412735|449538534|FG001|Overall Study|Lost to Follow-up|11|||
124975733|NCT02412735|449538535|FG002|Overall Study|Lost to Follow-up|18|||
124975734|NCT02412735|449538533|FG000|Overall Study|Reason not Specified|3|||
124975735|NCT02412735|449538534|FG001|Overall Study|Reason not Specified|2|||
124975736|NCT02412735|449538535|FG002|Overall Study|Reason not Specified|2|||
124975737|NCT02521363|449538536|FG000|Overall Study|Withdrawal by Subject|1|||
124975738|NCT02521363|449538537|FG001|Overall Study|Withdrawal by Subject|2|||
124975739|NCT03374488|449538538|FG000|Overall Study|Death|13|||
124975740|NCT03374488|449538539|FG001|Overall Study|Death|13|||
124975741|NCT03374488|449538538|FG000|Overall Study|Withdrawal by Subject|3|||
124975742|NCT03374488|449538539|FG001|Overall Study|Withdrawal by Subject|1|||
124975743|NCT03374488|449538538|FG000|Overall Study|Physician Decision|3|||
124975744|NCT03374488|449538539|FG001|Overall Study|Physician Decision|0|||
124975745|NCT01757197|449538540|FG000|Overall Study|Death|2|||
124975746|NCT01077128|449538543|FG000|Overall Study|Adverse Event|8|||
124975747|NCT01077128|449538543|FG000|Overall Study|Lack of Efficacy|1|||
124975748|NCT01077128|449538543|FG000|Overall Study|Disease exacerbation|1|||
124975749|NCT01077128|449538543|FG000|Overall Study|Adverse event and consent withdrawal|1|||
125042519|NCT02436239|449777209|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
125042520|NCT02436239|449777210|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
125042521|NCT02436239|449777207|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
125042522|NCT02436239|449777208|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
125042523|NCT02436239|449777209|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
125042524|NCT02436239|449777210|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
125042525|NCT02436239|449777207|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
125042526|NCT02436239|449777208|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
125042527|NCT02436239|449777209|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
125042528|NCT02436239|449777210|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
125042529|NCT02436239|449777207|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
125042530|NCT02436239|449777208|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
125042531|NCT02436239|449777209|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
125042532|NCT02436239|449777210|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
125042533|NCT02436239|449777207|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
125042534|NCT02436239|449777208|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
125042535|NCT02436239|449777209|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
125042536|NCT02436239|449777210|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
125042537|NCT02436239|449777207|FG000|Open-Lable Treatment Period|Other Reason|1|||
125042538|NCT02436239|449777208|FG001|Open-Lable Treatment Period|Other Reason|1|||
125042539|NCT02436239|449777209|FG002|Open-Lable Treatment Period|Other Reason|0|||
125042540|NCT02436239|449777210|FG003|Open-Lable Treatment Period|Other Reason|0|||
125042541|NCT02436239|449777207|FG000|Down-Taper Period|Withdrawal by Subject|4|||
125042542|NCT02436239|449777208|FG001|Down-Taper Period|Withdrawal by Subject|4|||
125042543|NCT02436239|449777209|FG002|Down-Taper Period|Withdrawal by Subject|1|||
125042544|NCT02436239|449777210|FG003|Down-Taper Period|Withdrawal by Subject|2|||
125042545|NCT00184054|449777211|FG000|Overall Study|Adverse Event|1|||
125042546|NCT04925570|449777212|FG000|Overall Study|Protocol Violation|24|||
125042547|NCT04925570|449777213|FG001|Overall Study|Protocol Violation|30|||
125042548|NCT04925570|449777212|FG000|Overall Study|Withdrawal by Subject|0|||
125042549|NCT04925570|449777213|FG001|Overall Study|Withdrawal by Subject|2|||
125042550|NCT00828451|449777214|FG000|Overall Study|Death|2|||
125042551|NCT00828451|449777214|FG000|Overall Study|Lack of intravenous line|7|||
125042552|NCT00828451|449777214|FG000|Overall Study|Withdrawal by Subject|1|||
125042553|NCT00828451|449777214|FG000|Overall Study|Deterioration in clinical status|1|||
125042554|NCT00814710|449777218|FG000|Overall Study|Adverse Event|1|||
125042555|NCT00814710|449777219|FG001|Overall Study|Adverse Event|0|||
125042556|NCT00814710|449777218|FG000|Overall Study|Lost to Follow-up|7|||
125042557|NCT00814710|449777219|FG001|Overall Study|Lost to Follow-up|3|||
125042558|NCT02609399|449777228|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
125042559|NCT02609399|449777229|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
125042560|NCT02609399|449777228|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
125042561|NCT02609399|449777229|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
125042562|NCT02609399|449777228|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
125042563|NCT02609399|449777229|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
125042564|NCT02426086|449777233|FG000|Overall Study|Death|33|||
125042565|NCT02426086|449777234|FG001|Overall Study|Death|36|||
125042566|NCT02426086|449777233|FG000|Overall Study|Lost to Follow-up|2|||
125042567|NCT02426086|449777234|FG001|Overall Study|Lost to Follow-up|0|||
125042568|NCT02426086|449777233|FG000|Overall Study|Study Terminated by Sponsor|5|||
125042569|NCT02426086|449777234|FG001|Overall Study|Study Terminated by Sponsor|14|||
125042570|NCT02426086|449777233|FG000|Overall Study|Withdrawal by Subject|8|||
125135383|NCT01695239|450120127|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125042571|NCT02426086|449777234|FG001|Overall Study|Withdrawal by Subject|9|||
125042572|NCT00524303|449777235|FG000|Overall Study|Lost to Follow-up|6|||
125042573|NCT00524303|449777236|FG001|Overall Study|Lost to Follow-up|0|||
125135384|NCT01695239|450120128|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125135385|NCT01695239|450120129|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125135386|NCT01695239|450120130|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
125042574|NCT00524303|449777237|FG002|Overall Study|Lost to Follow-up|3|||
125042575|NCT00524303|449777235|FG000|Overall Study|Protocol Violation|0|||
125042576|NCT00524303|449777236|FG001|Overall Study|Protocol Violation|1|||
125042577|NCT00524303|449777237|FG002|Overall Study|Protocol Violation|1|||
125042578|NCT00524303|449777235|FG000|Overall Study|Withdrawal by Subject|3|||
125042579|NCT00524303|449777236|FG001|Overall Study|Withdrawal by Subject|0|||
125042580|NCT00524303|449777237|FG002|Overall Study|Withdrawal by Subject|4|||
125042581|NCT00524303|449777235|FG000|Overall Study|Death|0|||
125042582|NCT00524303|449777236|FG001|Overall Study|Death|2|||
125042583|NCT00524303|449777237|FG002|Overall Study|Death|3|||
125042584|NCT00524303|449777235|FG000|Overall Study|Adverse Event|1|||
125042585|NCT00524303|449777236|FG001|Overall Study|Adverse Event|2|||
125042586|NCT00524303|449777237|FG002|Overall Study|Adverse Event|3|||
125042587|NCT00524303|449777235|FG000|Overall Study|Did not Complete Study Dosing|1|||
125135387|NCT01695239|450120131|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
125042588|NCT00524303|449777236|FG001|Overall Study|Did not Complete Study Dosing|0|||
125042589|NCT00524303|449777237|FG002|Overall Study|Did not Complete Study Dosing|0|||
125042590|NCT00524303|449777235|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
125042591|NCT00524303|449777236|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
125042592|NCT00524303|449777237|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
125042593|NCT00524303|449777235|FG000|Overall Study|Disease Progression|0|||
125042594|NCT00524303|449777236|FG001|Overall Study|Disease Progression|4|||
125042595|NCT00524303|449777237|FG002|Overall Study|Disease Progression|1|||
125042596|NCT00524303|449777235|FG000|Overall Study|Disease Recurrence|0|||
125042597|NCT00524303|449777236|FG001|Overall Study|Disease Recurrence|1|||
125042598|NCT00524303|449777237|FG002|Overall Study|Disease Recurrence|0|||
125042599|NCT00524303|449777235|FG000|Overall Study|Sponsor Request|0|||
125042600|NCT00524303|449777236|FG001|Overall Study|Sponsor Request|0|||
125042601|NCT00524303|449777237|FG002|Overall Study|Sponsor Request|1|||
125042602|NCT00524303|449777235|FG000|Overall Study|Physician Decision|0|||
125042603|NCT00524303|449777236|FG001|Overall Study|Physician Decision|0|||
125042604|NCT00524303|449777237|FG002|Overall Study|Physician Decision|1|||
125042605|NCT00524303|449777235|FG000|Overall Study|Completed 5 years|0|||
125042606|NCT00524303|449777236|FG001|Overall Study|Completed 5 years|0|||
125042607|NCT00524303|449777237|FG002|Overall Study|Completed 5 years|1|||
125042608|NCT00840463|449777241|FG000|Overall Study|Adverse Event|1|||
125042609|NCT00840463|449777242|FG001|Overall Study|Adverse Event|0|||
125042610|NCT02515669|449777246|FG000|228 Week Open-Label Phase|Other|0|||
125042611|NCT02515669|449777247|FG001|228 Week Open-Label Phase|Other|0|||
125135388|NCT01695239|450120132|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125135389|NCT01695239|450120133|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125135390|NCT01695239|450120134|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125135391|NCT01695239|450120135|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125135392|NCT01695239|450120122|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
125135393|NCT01695239|450120123|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
125042612|NCT02515669|449777248|FG002|228 Week Open-Label Phase|Other|1|||
125042613|NCT02515669|449777249|FG003|228 Week Open-Label Phase|Other|4|||
125042614|NCT02515669|449777246|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
125042615|NCT02515669|449777247|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
125042616|NCT02515669|449777248|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
125042617|NCT02515669|449777249|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
125042618|NCT02515669|449777246|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
125042619|NCT02515669|449777247|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
125042620|NCT02515669|449777248|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
125042621|NCT02515669|449777249|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
125042622|NCT02515669|449777246|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
125042623|NCT02515669|449777247|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
125042624|NCT02515669|449777248|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
125042625|NCT02515669|449777249|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
125042626|NCT02515669|449777246|FG000|228 Week Open-Label Phase|Missing|0|||
125042627|NCT02515669|449777247|FG001|228 Week Open-Label Phase|Missing|2|||
125042628|NCT02515669|449777248|FG002|228 Week Open-Label Phase|Missing|2|||
125042629|NCT02515669|449777249|FG003|228 Week Open-Label Phase|Missing|2|||
125042630|NCT01739595|449777250|FG000|Overall Study|Adverse Event|3|||
125042631|NCT01739595|449777251|FG001|Overall Study|Adverse Event|0|||
125042632|NCT01739595|449777252|FG002|Overall Study|Adverse Event|0|||
125042633|NCT01739595|449777250|FG000|Overall Study|Lost to Follow-up|2|||
125042634|NCT01739595|449777251|FG001|Overall Study|Lost to Follow-up|0|||
125042635|NCT01739595|449777252|FG002|Overall Study|Lost to Follow-up|0|||
125042636|NCT01739595|449777250|FG000|Overall Study|Withdrawal by Subject|2|||
125042637|NCT01739595|449777251|FG001|Overall Study|Withdrawal by Subject|1|||
125042638|NCT01739595|449777252|FG002|Overall Study|Withdrawal by Subject|2|||
125042639|NCT01739595|449777250|FG000|Overall Study|Eligibility issue|3|||
125042640|NCT01739595|449777251|FG001|Overall Study|Eligibility issue|0|||
125042641|NCT01739595|449777252|FG002|Overall Study|Eligibility issue|0|||
125042642|NCT01739595|449777250|FG000|Overall Study|Protocol Violation|1|||
125042643|NCT01739595|449777251|FG001|Overall Study|Protocol Violation|0|||
125042644|NCT01739595|449777252|FG002|Overall Study|Protocol Violation|0|||
125042645|NCT01739595|449777250|FG000|Overall Study|Lab assessment|1|||
125135394|NCT01695239|450120124|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
125135395|NCT01695239|450120125|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
125135396|NCT01695239|450120126|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
125135397|NCT01695239|450120127|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
125042646|NCT01739595|449777251|FG001|Overall Study|Lab assessment|0|||
125042647|NCT01739595|449777252|FG002|Overall Study|Lab assessment|0|||
125042648|NCT01739595|449777250|FG000|Overall Study|Drug discrepancy|1|||
125042649|NCT01739595|449777251|FG001|Overall Study|Drug discrepancy|0|||
125042650|NCT01739595|449777252|FG002|Overall Study|Drug discrepancy|0|||
125042651|NCT01676116|449777256|FG000|Overall Study|Withdrawal criteria|2|||
125042652|NCT01676116|449777257|FG001|Overall Study|Withdrawal criteria|14|||
125042653|NCT01676116|449777256|FG000|Overall Study|Adverse Event|1|||
125042654|NCT01676116|449777257|FG001|Overall Study|Adverse Event|2|||
125042655|NCT01676116|449777256|FG000|Overall Study|Unclassified|4|||
125042656|NCT01676116|449777257|FG001|Overall Study|Unclassified|10|||
125042657|NCT01676116|449777256|FG000|Overall Study|Protocol Violation|9|||
125042658|NCT01676116|449777257|FG001|Overall Study|Protocol Violation|3|||
125042659|NCT00778999|449777258|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
125042660|NCT00778999|449777259|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
125042661|NCT00778999|449777258|FG000|Overall Study|Did not receive recFSH|14|||
125042662|NCT00778999|449777259|FG001|Overall Study|Did not receive recFSH|20|||
125042663|NCT02032524|449777260|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
125042664|NCT02032524|449777261|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
125042665|NCT02032524|449777262|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
125042666|NCT02032524|449777263|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
125042667|NCT02032524|449777264|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
125042668|NCT02032524|449777265|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
125042669|NCT02032524|449777260|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
125042670|NCT02032524|449777261|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
125042671|NCT02032524|449777262|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
125042672|NCT02032524|449777263|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
125042673|NCT02032524|449777264|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
125042674|NCT02032524|449777265|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
125042675|NCT02032524|449777260|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
125042676|NCT02032524|449777261|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
125042677|NCT02032524|449777262|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
125042678|NCT02032524|449777263|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
125042679|NCT02032524|449777264|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
125042680|NCT02032524|449777265|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
125042681|NCT02032524|449777260|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
125042682|NCT02032524|449777261|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
125042683|NCT02032524|449777262|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
125042684|NCT02032524|449777263|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
125042685|NCT02032524|449777264|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
125042686|NCT02032524|449777265|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
125042687|NCT02032524|449777260|FG000|Period 2: LTS13769 Study|Other|0|||
125042688|NCT02032524|449777261|FG001|Period 2: LTS13769 Study|Other|0|||
125042689|NCT02032524|449777262|FG002|Period 2: LTS13769 Study|Other|0|||
125042690|NCT02032524|449777263|FG003|Period 2: LTS13769 Study|Other|0|||
125042691|NCT02032524|449777264|FG004|Period 2: LTS13769 Study|Other|0|||
125042692|NCT02032524|449777265|FG005|Period 2: LTS13769 Study|Other|1|||
125042693|NCT02975349|449777268|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125042694|NCT02975349|449777269|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125042695|NCT02975349|449777270|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125042696|NCT02975349|449777271|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
125042697|NCT02975349|449777272|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
125042698|NCT02975349|449777273|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125042699|NCT02975349|449777274|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125042700|NCT02975349|449777268|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
125042701|NCT02975349|449777269|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125042702|NCT02975349|449777270|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125042703|NCT02975349|449777271|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125042704|NCT02975349|449777272|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125042705|NCT02975349|449777273|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125042706|NCT02975349|449777274|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125042707|NCT02975349|449777268|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
125042708|NCT02975349|449777269|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
125042709|NCT02975349|449777270|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
125042710|NCT02975349|449777271|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
125042711|NCT02975349|449777272|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
125042712|NCT02975349|449777273|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
125042713|NCT02975349|449777274|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
125042714|NCT02975349|449777268|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
125042715|NCT02975349|449777269|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
125042716|NCT02975349|449777270|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
125042717|NCT02975349|449777271|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
125042718|NCT02975349|449777272|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
125042719|NCT02975349|449777273|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
125042720|NCT02975349|449777274|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
125042721|NCT02975349|449777268|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
125042722|NCT02975349|449777269|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
125042723|NCT02975349|449777270|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
125042724|NCT02975349|449777271|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
125042725|NCT02975349|449777272|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
125042726|NCT02975349|449777273|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
125042727|NCT02975349|449777274|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
125042728|NCT02975349|449777268|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
125042729|NCT02975349|449777269|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
125042730|NCT02975349|449777270|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
125042731|NCT02975349|449777271|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
125042732|NCT02975349|449777272|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
125042733|NCT02975349|449777273|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
125042734|NCT02975349|449777274|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
125042735|NCT02975349|449777268|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
125042736|NCT02975349|449777269|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
125042737|NCT02975349|449777270|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
125042738|NCT02975349|449777271|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
125042739|NCT02975349|449777272|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
125042740|NCT02975349|449777273|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
125042741|NCT02975349|449777274|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
125042742|NCT02975349|449777268|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
125042743|NCT02975349|449777269|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
125042744|NCT02975349|449777270|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
125042745|NCT02975349|449777271|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
125042746|NCT02975349|449777272|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
125042747|NCT02975349|449777273|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
125042748|NCT02975349|449777274|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
125042749|NCT02975349|449777268|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
125042750|NCT02975349|449777269|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
125042751|NCT02975349|449777270|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
125042752|NCT02975349|449777271|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
125042753|NCT02975349|449777272|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
125042754|NCT02975349|449777273|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
125042755|NCT02975349|449777274|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
125042756|NCT02975349|449777268|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
125042757|NCT02975349|449777269|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
125042758|NCT02975349|449777270|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
125042759|NCT02975349|449777271|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
125042760|NCT02975349|449777272|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
125042761|NCT02975349|449777273|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
125042762|NCT02975349|449777274|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
125042763|NCT02975349|449777268|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
125042764|NCT02975349|449777269|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
125042765|NCT02975349|449777270|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
125042766|NCT02975349|449777271|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
125042767|NCT02975349|449777272|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
125042768|NCT02975349|449777273|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
125042769|NCT02975349|449777274|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
125042770|NCT02975349|449777268|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
125042771|NCT02975349|449777269|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
125042772|NCT02975349|449777270|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
125042773|NCT02975349|449777271|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
125042774|NCT02975349|449777272|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
125042775|NCT02975349|449777273|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
125042776|NCT02975349|449777274|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
125042777|NCT02975349|449777268|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
125042778|NCT02975349|449777269|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
125042779|NCT02975349|449777270|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
125042780|NCT02975349|449777271|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
125042781|NCT02975349|449777272|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
125042782|NCT02975349|449777273|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
125042783|NCT02975349|449777274|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
125042784|NCT02975349|449777268|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
125042785|NCT02975349|449777269|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
125042786|NCT02975349|449777270|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
125042787|NCT02975349|449777271|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
125042788|NCT02975349|449777272|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
125042789|NCT02975349|449777273|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
125042790|NCT02975349|449777274|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
125042791|NCT02975349|449777268|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
125042792|NCT02975349|449777269|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
125042793|NCT02975349|449777270|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
125042794|NCT02975349|449777271|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
125042795|NCT02975349|449777272|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
125042796|NCT02975349|449777273|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
125042797|NCT02975349|449777274|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
125042798|NCT03497689|449777280|FG000|Overall Study|Adverse Event|2|||
125042799|NCT03497689|449777280|FG000|Overall Study|Death|1|||
125042800|NCT03497689|449777280|FG000|Overall Study|Physician Decision|1|||
125042801|NCT03497689|449777280|FG000|Overall Study|Withdrawal by Subject|1|||
125042802|NCT03497689|449777280|FG000|Overall Study|Protocol Violation|2|||
125042803|NCT03191786|449777281|FG000|Overall Study|Death|236|||
125042804|NCT03191786|449777282|FG001|Overall Study|Death|127|||
125042805|NCT03191786|449777281|FG000|Overall Study|Lost to Follow-up|9|||
125042806|NCT03191786|449777282|FG001|Overall Study|Lost to Follow-up|3|||
125042807|NCT03191786|449777281|FG000|Overall Study|Physician Decision|1|||
125042808|NCT03191786|449777282|FG001|Overall Study|Physician Decision|0|||
125042809|NCT03191786|449777281|FG000|Overall Study|Moved to Post Trial Access Program|30|||
125042810|NCT03191786|449777282|FG001|Overall Study|Moved to Post Trial Access Program|5|||
125042811|NCT03191786|449777281|FG000|Overall Study|Withdrawal by Subject|26|||
125042812|NCT03191786|449777282|FG001|Overall Study|Withdrawal by Subject|16|||
125042813|NCT02082184|449778986|FG000|Overall Study|Adverse Event|1|||
125042814|NCT02082184|449778987|FG001|Overall Study|Adverse Event|0|||
125042815|NCT02082184|449778986|FG000|Overall Study|Medical diagnosis|1|||
125042816|NCT02082184|449778987|FG001|Overall Study|Medical diagnosis|2|||
125042817|NCT02082184|449778986|FG000|Overall Study|Device associated symptoms|5|||
125042818|NCT02082184|449778987|FG001|Overall Study|Device associated symptoms|0|||
125042819|NCT02082184|449778986|FG000|Overall Study|Withdrawal by Subject|3|||
125042820|NCT02082184|449778987|FG001|Overall Study|Withdrawal by Subject|2|||
125042821|NCT02082184|449778986|FG000|Overall Study|Protocol Violation|0|||
125042822|NCT02082184|449778987|FG001|Overall Study|Protocol Violation|6|||
125042823|NCT02082184|449778986|FG000|Overall Study|Lost to Follow-up|0|||
125042824|NCT02082184|449778987|FG001|Overall Study|Lost to Follow-up|2|||
125042825|NCT02082184|449778986|FG000|Overall Study|Subject non-compliance|0|||
125042826|NCT02082184|449778987|FG001|Overall Study|Subject non-compliance|1|||
125042827|NCT01362322|449778994|FG000|Overall Study|Withdrawal by Subject|3|||
125042828|NCT01362322|449778995|FG001|Overall Study|Withdrawal by Subject|1|||
125042829|NCT01362322|449778994|FG000|Overall Study|Lost to Follow-up|2|||
125042830|NCT01362322|449778995|FG001|Overall Study|Lost to Follow-up|6|||
125042831|NCT01009463|449778996|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
125042832|NCT01009463|449778997|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
125042833|NCT01009463|449778998|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
125042834|NCT01009463|449778999|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
125042835|NCT01009463|449779000|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
125042836|NCT01009463|449778996|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
125042837|NCT01009463|449778997|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
125042838|NCT01009463|449778998|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
125042839|NCT01009463|449778999|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
125042840|NCT01009463|449779000|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
125042841|NCT01009463|449778996|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
125042842|NCT01009463|449778997|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
125042843|NCT01009463|449778998|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
125042844|NCT01009463|449778999|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
125042845|NCT01009463|449779000|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
125042846|NCT01009463|449778996|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
125042847|NCT01009463|449778997|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
125042848|NCT01009463|449778998|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
125135398|NCT01695239|450120128|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
125135399|NCT01695239|450120129|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
125042849|NCT01009463|449778999|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
125042850|NCT01009463|449779000|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
125042851|NCT01009463|449778996|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
125042852|NCT01009463|449778997|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
125042853|NCT01009463|449778998|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
125042854|NCT01009463|449778999|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
125042855|NCT01009463|449779000|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
125042856|NCT01009463|449778996|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
125042857|NCT01009463|449778997|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
125042858|NCT01009463|449778998|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
125042859|NCT01009463|449778999|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
125042860|NCT01009463|449779000|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
125042861|NCT01009463|449778996|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
125042862|NCT01009463|449778997|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
125042863|NCT01009463|449778998|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
125042864|NCT01009463|449778999|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
125042865|NCT01009463|449779000|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
125042866|NCT01009463|449778996|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
125042867|NCT01009463|449778997|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
125042868|NCT01009463|449778998|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
125042869|NCT01009463|449778999|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
125042870|NCT01009463|449779000|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
125042871|NCT01009463|449778996|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
125042872|NCT01009463|449778997|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
125042873|NCT01009463|449778998|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
125042874|NCT01009463|449778999|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
125042875|NCT01009463|449779000|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
125042876|NCT01009463|449778996|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
125042877|NCT01009463|449778997|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
125042878|NCT01009463|449778998|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
125042879|NCT01009463|449778999|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
125042880|NCT01009463|449779000|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
125042881|NCT01009463|449778996|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
125042882|NCT01009463|449778997|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
125042883|NCT01009463|449778998|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
125042884|NCT01009463|449778999|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
125042885|NCT01009463|449779000|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
125042886|NCT01009463|449778996|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125042887|NCT01009463|449778997|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
125042888|NCT01009463|449778998|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
125042889|NCT01009463|449778999|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
125042890|NCT01009463|449779000|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
125042891|NCT01009463|449778996|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
125042892|NCT01009463|449778997|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
125042893|NCT01009463|449778998|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
125042894|NCT01009463|449778999|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
125042895|NCT01009463|449779000|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
125042896|NCT00634543|449779003|FG000|Overall Study|Other|1|||
125042897|NCT00634543|449779004|FG001|Overall Study|Other|2|||
125042898|NCT00634543|449779003|FG000|Overall Study|Protocol Violation|3|||
125042899|NCT00634543|449779004|FG001|Overall Study|Protocol Violation|3|||
125042900|NCT00634543|449779003|FG000|Overall Study|Adverse Event|11|||
125042901|NCT00634543|449779004|FG001|Overall Study|Adverse Event|11|||
125042902|NCT00634543|449779003|FG000|Overall Study|Withdrawal by Subject|4|||
125042903|NCT00634543|449779004|FG001|Overall Study|Withdrawal by Subject|4|||
125042904|NCT00634543|449779003|FG000|Overall Study|Lost to Follow-up|0|||
125042905|NCT00634543|449779004|FG001|Overall Study|Lost to Follow-up|1|||
125042906|NCT02401256|449779006|FG000|Overall Study|Adverse Event|5|||
125042907|NCT02401256|449779006|FG000|Overall Study|Withdrawal by Subject|12|||
125042908|NCT00430781|449779008|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
125042909|NCT00430781|449779009|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
125042910|NCT00430781|449779010|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
125042911|NCT00430781|449779008|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
125042912|NCT00430781|449779009|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
125042913|NCT00430781|449779010|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
125042914|NCT00430781|449779008|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
125042915|NCT00430781|449779009|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
125042916|NCT00430781|449779010|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
125042917|NCT00430781|449779008|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
125042918|NCT00430781|449779009|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
125042919|NCT00430781|449779010|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
125135400|NCT01695239|450120130|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
125135401|NCT01695239|450120131|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
125135402|NCT01695239|450120132|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
125135403|NCT01695239|450120133|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
125135404|NCT01695239|450120134|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
125135405|NCT01695239|450120135|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
125135406|NCT01695239|450120122|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125042920|NCT00430781|449779008|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
125042921|NCT00430781|449779009|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
125042922|NCT00430781|449779010|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
125042923|NCT00430781|449779008|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
125042924|NCT00430781|449779009|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
125042925|NCT00430781|449779010|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
125042926|NCT00430781|449779008|FG000|Interim Analysis; 11 February 2008|Death|0|||
125042927|NCT00430781|449779009|FG001|Interim Analysis; 11 February 2008|Death|1|||
125042928|NCT00430781|449779010|FG002|Interim Analysis; 11 February 2008|Death|0|||
125042929|NCT00430781|449779008|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
125042930|NCT00430781|449779009|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
125042931|NCT00430781|449779010|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
125042932|NCT00430781|449779008|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
125042933|NCT00430781|449779009|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
125042934|NCT00430781|449779010|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
125042935|NCT00430781|449779008|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
125042936|NCT00430781|449779009|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
125042937|NCT00430781|449779010|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
125042938|NCT00430781|449779008|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
125042939|NCT00430781|449779009|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
125042940|NCT00430781|449779010|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
125042941|NCT00430781|449779008|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
125042942|NCT00430781|449779009|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
125042943|NCT00430781|449779010|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
125042944|NCT00430781|449779008|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
125042945|NCT00430781|449779009|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
125042946|NCT00430781|449779010|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
125042947|NCT00430781|449779008|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
125042948|NCT00430781|449779009|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
125042949|NCT00430781|449779010|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
125042950|NCT00430781|449779008|FG000|Final Analysis; 31 July 2008|Other|0|||
125042951|NCT00430781|449779009|FG001|Final Analysis; 31 July 2008|Other|1|||
125042952|NCT00430781|449779010|FG002|Final Analysis; 31 July 2008|Other|0|||
125042953|NCT00430781|449779008|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
125042954|NCT00430781|449779009|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
125042955|NCT00430781|449779010|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
125042956|NCT00430781|449779008|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
125042957|NCT00430781|449779009|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
125042958|NCT00430781|449779010|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
125042959|NCT00430781|449779008|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
125042960|NCT00430781|449779009|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
125042961|NCT00430781|449779010|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
125042962|NCT00430781|449779008|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
125042963|NCT00430781|449779009|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
125042964|NCT00430781|449779010|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
125042965|NCT00430781|449779008|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
125042966|NCT00430781|449779009|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
125042967|NCT00430781|449779010|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
125042968|NCT00430781|449779008|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
125042969|NCT00430781|449779009|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
125042970|NCT00430781|449779010|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
125042971|NCT00430781|449779008|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
125042972|NCT00430781|449779009|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
125042973|NCT00430781|449779010|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
125042974|NCT01389128|449779013|FG000|Overall Study|Fetal distress|1|||
125042975|NCT01389128|449779014|FG001|Overall Study|Fetal distress|0|||
125042976|NCT01389128|449779013|FG000|Overall Study|Cervix dilation stop|1|||
125042977|NCT01389128|449779014|FG001|Overall Study|Cervix dilation stop|2|||
125042978|NCT01389128|449779013|FG000|Overall Study|Rapid labor evolution|3|||
125042979|NCT01389128|449779014|FG001|Overall Study|Rapid labor evolution|2|||
125042980|NCT01389128|449779013|FG000|Overall Study|Intolerance to procedure|0|||
125042981|NCT01389128|449779014|FG001|Overall Study|Intolerance to procedure|2|||
125042982|NCT01059812|449779015|FG000|Overall Study|Adverse Event|9|||
125042983|NCT01059812|449779016|FG001|Overall Study|Adverse Event|5|||
125042984|NCT01059812|449779015|FG000|Overall Study|Lack of Efficacy|2|||
125042985|NCT01059812|449779016|FG001|Overall Study|Lack of Efficacy|2|||
125042986|NCT01059812|449779015|FG000|Overall Study|Protocol Violation|3|||
125042987|NCT01059812|449779016|FG001|Overall Study|Protocol Violation|1|||
125042988|NCT01059812|449779015|FG000|Overall Study|Withdrawal Criteria|9|||
125042989|NCT01059812|449779016|FG001|Overall Study|Withdrawal Criteria|4|||
125042990|NCT01059812|449779015|FG000|Overall Study|Unclassified|14|||
125042991|NCT01059812|449779016|FG001|Overall Study|Unclassified|4|||
125042992|NCT03056287|449779021|FG000|Overall Study|Withdrawal by Subject|0|||
125042993|NCT03056287|449779022|FG001|Overall Study|Withdrawal by Subject|1|||
125042994|NCT03056287|449779023|FG002|Overall Study|Withdrawal by Subject|0|||
125042995|NCT03056287|449779024|FG003|Overall Study|Withdrawal by Subject|0|||
125042996|NCT03056287|449779021|FG000|Overall Study|move out of area|0|||
125042997|NCT03056287|449779022|FG001|Overall Study|move out of area|0|||
125042998|NCT03056287|449779023|FG002|Overall Study|move out of area|1|||
125042999|NCT03056287|449779024|FG003|Overall Study|move out of area|1|||
125043000|NCT00947154|449779028|FG000|Overall Study|Lost to Follow-up|1|||
125043001|NCT01588197|449779031|FG000|Overall Study|Lack of Efficacy|0|||
125043002|NCT01588197|449779032|FG001|Overall Study|Lack of Efficacy|1|||
125043003|NCT01588197|449779031|FG000|Overall Study|No MRI|1|||
125043004|NCT01588197|449779032|FG001|Overall Study|No MRI|0|||
125043005|NCT01844076|449779035|FG000|Overall Study|Adverse Event|1|||
125043006|NCT01844076|449779036|FG001|Overall Study|Adverse Event|0|||
125043007|NCT01844076|449779037|FG002|Overall Study|Adverse Event|0|||
125043008|NCT01844076|449779038|FG003|Overall Study|Adverse Event|0|||
125043009|NCT01844076|449779035|FG000|Overall Study|Withdrawal by Subject|1|||
125043010|NCT01844076|449779036|FG001|Overall Study|Withdrawal by Subject|0|||
125043011|NCT01844076|449779037|FG002|Overall Study|Withdrawal by Subject|0|||
125043012|NCT01844076|449779038|FG003|Overall Study|Withdrawal by Subject|0|||
125043013|NCT02286960|449779048|FG000|Overall Study|Lost to Follow-up|3|||
125043014|NCT02286960|449779049|FG001|Overall Study|Lost to Follow-up|3|||
125135407|NCT01695239|450120123|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135408|NCT01695239|450120124|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135409|NCT01695239|450120125|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135410|NCT01695239|450120126|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135411|NCT01695239|450120127|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135412|NCT01695239|450120128|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135413|NCT01695239|450120129|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135414|NCT01695239|450120130|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
125135415|NCT01695239|450120131|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
125135416|NCT01695239|450120132|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135417|NCT01695239|450120133|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135418|NCT01695239|450120134|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135419|NCT01695239|450120135|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135420|NCT01695239|450120122|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
125135421|NCT01695239|450120123|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
125135422|NCT01695239|450120124|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
125135423|NCT01695239|450120125|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
125135424|NCT01695239|450120126|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
125135425|NCT01695239|450120127|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
125135426|NCT01695239|450120128|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
125135427|NCT01695239|450120129|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
125135428|NCT01695239|450120130|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
125135429|NCT01695239|450120131|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
125135430|NCT01695239|450120132|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
125135431|NCT01695239|450120133|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
125043015|NCT00440401|449779050|FG000|Overall Study|Adverse Event|2|||
125043016|NCT00440401|449779051|FG001|Overall Study|Adverse Event|1|||
125043017|NCT00440401|449779050|FG000|Overall Study|Other|2|||
125043018|NCT00440401|449779051|FG001|Overall Study|Other|5|||
125043019|NCT01937312|449779052|FG000|Overall Study|Adverse Event|10|||
125043020|NCT01937312|449779053|FG001|Overall Study|Adverse Event|1|||
125043021|NCT01937312|449779052|FG000|Overall Study|Lack of Efficacy|0|||
125043022|NCT01937312|449779053|FG001|Overall Study|Lack of Efficacy|1|||
125135432|NCT01695239|450120134|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
125218821|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
125218822|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
125218823|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
125218824|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
125218825|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
125218826|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
125218827|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
125218828|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
125218829|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
125218830|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
125218831|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
125218832|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
125043023|NCT01937312|449779052|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
125043024|NCT01937312|449779053|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
125218833|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
125218834|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
125218835|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
125218836|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
125218837|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
125218838|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
125218839|NCT01990768|450427417|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
125218840|NCT01990768|450427418|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
125218841|NCT01990768|450427419|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
125218842|NCT01990768|450427417|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
125218843|NCT01990768|450427418|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
125218844|NCT01990768|450427419|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
125218845|NCT01990768|450427417|FG000|6-Month Follow-up|No contact information|5|||
125218846|NCT01990768|450427418|FG001|6-Month Follow-up|No contact information|6|||
125218847|NCT01990768|450427419|FG002|6-Month Follow-up|No contact information|5|||
125218848|NCT01990768|450427417|FG000|6-Month Follow-up|Homeless|4|||
125218849|NCT01990768|450427418|FG001|6-Month Follow-up|Homeless|3|||
125218850|NCT01990768|450427419|FG002|6-Month Follow-up|Homeless|6|||
125043025|NCT00474253|449779054|FG000|Overall Study|Withdrew consent|2|||
125043026|NCT00474253|449779055|FG001|Overall Study|Withdrew consent|0|||
125043027|NCT00474253|449779054|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
125043028|NCT00474253|449779055|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
125043029|NCT00474253|449779054|FG000|Overall Study|Lost to Follow-up|1|||
125043030|NCT00474253|449779055|FG001|Overall Study|Lost to Follow-up|0|||
125043031|NCT00474253|449779054|FG000|Overall Study|Discharged prior to study completion|0|||
125043032|NCT00474253|449779055|FG001|Overall Study|Discharged prior to study completion|1|||
125218851|NCT01990768|450427417|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
125218852|NCT01990768|450427418|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
125218853|NCT01990768|450427419|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
125218854|NCT01990768|450427417|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
125218855|NCT01990768|450427418|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
125218856|NCT01990768|450427419|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
125218857|NCT01990768|450427417|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
125043033|NCT00593112|449779066|FG000|Overall Study|Scan Anxiety|3|||
125043034|NCT00593112|449779067|FG001|Overall Study|Scan Anxiety|0|||
125043035|NCT00593112|449779066|FG000|Overall Study|Abnormal Scan|1|||
125043036|NCT00593112|449779067|FG001|Overall Study|Abnormal Scan|0|||
125043037|NCT00593112|449779066|FG000|Overall Study|Unreadable Scan|1|||
125043038|NCT00593112|449779067|FG001|Overall Study|Unreadable Scan|0|||
125043039|NCT00593112|449779066|FG000|Overall Study|Withdrawal by Subject|5|||
125043040|NCT00593112|449779067|FG001|Overall Study|Withdrawal by Subject|0|||
125043041|NCT00482001|449779068|FG000|Overall Study|Protocol Violation|1|||
125043042|NCT00482001|449779069|FG001|Overall Study|Protocol Violation|1|||
125043043|NCT00258154|449779070|FG000|Overall Study|Adverse Event|1|||
125043044|NCT00258154|449779071|FG001|Overall Study|Adverse Event|0|||
125218858|NCT01990768|450427418|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
125218859|NCT01990768|450427419|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
125218860|NCT03538691|450427420|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
125043045|NCT00258154|449779070|FG000|Overall Study|Lost to Follow-up|0|||
125218861|NCT03538691|450427421|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
125218862|NCT03538691|450427422|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
125043046|NCT00258154|449779071|FG001|Overall Study|Lost to Follow-up|1|||
125043047|NCT00258154|449779070|FG000|Overall Study|Protocol Violation|2|||
125043048|NCT00258154|449779071|FG001|Overall Study|Protocol Violation|1|||
125043049|NCT00258154|449779070|FG000|Overall Study|Withdrawal by Subject|3|||
125043050|NCT00258154|449779071|FG001|Overall Study|Withdrawal by Subject|4|||
125043051|NCT00258154|449779070|FG000|Overall Study|Patient Moved|3|||
125043052|NCT00258154|449779071|FG001|Overall Study|Patient Moved|1|||
125043053|NCT00754390|449779076|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
125043054|NCT00754390|449779076|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
125043055|NCT00754390|449779076|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
125043056|NCT00754390|449779076|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
125043057|NCT00847613|449779077|FG000|Overall Study|Ongoing at cut-off date|250|||
125043058|NCT00847613|449779078|FG001|Overall Study|Ongoing at cut-off date|265|||
125043059|NCT00847613|449779079|FG002|Overall Study|Ongoing at cut-off date|64|||
125043060|NCT00847613|449779080|FG003|Overall Study|Ongoing at cut-off date|64|||
125043061|NCT00847613|449779077|FG000|Overall Study|Death|1|||
125043062|NCT00847613|449779078|FG001|Overall Study|Death|1|||
125043063|NCT00847613|449779079|FG002|Overall Study|Death|0|||
125043064|NCT00847613|449779080|FG003|Overall Study|Death|0|||
125043065|NCT00847613|449779077|FG000|Overall Study|Adverse Event|36|||
125043066|NCT00847613|449779078|FG001|Overall Study|Adverse Event|26|||
125043067|NCT00847613|449779079|FG002|Overall Study|Adverse Event|5|||
125043068|NCT00847613|449779080|FG003|Overall Study|Adverse Event|6|||
125043069|NCT00847613|449779077|FG000|Overall Study|Lack of Efficacy|7|||
125043070|NCT00847613|449779078|FG001|Overall Study|Lack of Efficacy|3|||
125043071|NCT00847613|449779079|FG002|Overall Study|Lack of Efficacy|3|||
125043072|NCT00847613|449779080|FG003|Overall Study|Lack of Efficacy|1|||
125043073|NCT00847613|449779077|FG000|Overall Study|Study terminated by Sponsor|1|||
125043074|NCT00847613|449779078|FG001|Overall Study|Study terminated by Sponsor|0|||
125043075|NCT00847613|449779079|FG002|Overall Study|Study terminated by Sponsor|2|||
125043076|NCT00847613|449779080|FG003|Overall Study|Study terminated by Sponsor|1|||
125043077|NCT00847613|449779077|FG000|Overall Study|Lost to Follow-up|5|||
125043078|NCT00847613|449779078|FG001|Overall Study|Lost to Follow-up|0|||
125043079|NCT00847613|449779079|FG002|Overall Study|Lost to Follow-up|0|||
125043080|NCT00847613|449779080|FG003|Overall Study|Lost to Follow-up|3|||
125043081|NCT00847613|449779077|FG000|Overall Study|Protocol Violation|6|||
125043082|NCT00847613|449779078|FG001|Overall Study|Protocol Violation|6|||
125043083|NCT00847613|449779079|FG002|Overall Study|Protocol Violation|3|||
125043084|NCT00847613|449779080|FG003|Overall Study|Protocol Violation|1|||
125043085|NCT00847613|449779077|FG000|Overall Study|Pregnancy|1|||
125043086|NCT00847613|449779078|FG001|Overall Study|Pregnancy|1|||
125043087|NCT00847613|449779079|FG002|Overall Study|Pregnancy|0|||
125043088|NCT00847613|449779080|FG003|Overall Study|Pregnancy|0|||
125043089|NCT00847613|449779077|FG000|Overall Study|Site closure|1|||
125043090|NCT00847613|449779078|FG001|Overall Study|Site closure|0|||
125043091|NCT00847613|449779079|FG002|Overall Study|Site closure|0|||
125043092|NCT00847613|449779080|FG003|Overall Study|Site closure|1|||
125043093|NCT00847613|449779077|FG000|Overall Study|Withdrawal by Subject|8|||
125043094|NCT00847613|449779078|FG001|Overall Study|Withdrawal by Subject|11|||
125135433|NCT01695239|450120135|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
125135434|NCT01695239|450120122|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135435|NCT01695239|450120123|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135436|NCT01695239|450120124|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135437|NCT01695239|450120125|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135438|NCT01695239|450120126|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135439|NCT01695239|450120127|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135440|NCT01695239|450120128|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135441|NCT01695239|450120129|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135442|NCT01695239|450120130|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
125135443|NCT01695239|450120131|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
125135444|NCT01695239|450120132|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135445|NCT01695239|450120133|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135446|NCT01695239|450120134|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135447|NCT01695239|450120135|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135448|NCT01695239|450120122|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125135449|NCT01695239|450120123|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125135450|NCT01695239|450120124|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125135451|NCT01695239|450120125|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125043095|NCT00847613|449779079|FG002|Overall Study|Withdrawal by Subject|2|||
125043096|NCT00847613|449779080|FG003|Overall Study|Withdrawal by Subject|2|||
125043097|NCT00847613|449779077|FG000|Overall Study|Participant moved|4|||
125043098|NCT00847613|449779078|FG001|Overall Study|Participant moved|1|||
125135452|NCT01695239|450120126|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125043099|NCT00847613|449779079|FG002|Overall Study|Participant moved|0|||
125043100|NCT00847613|449779080|FG003|Overall Study|Participant moved|0|||
125043101|NCT00847613|449779077|FG000|Overall Study|Sponsor request|0|||
125043102|NCT00847613|449779078|FG001|Overall Study|Sponsor request|1|||
125043103|NCT00847613|449779079|FG002|Overall Study|Sponsor request|0|||
125043104|NCT00847613|449779080|FG003|Overall Study|Sponsor request|0|||
125043105|NCT00847613|449779077|FG000|Overall Study|Randomized, but not treated|0|||
125043106|NCT00847613|449779078|FG001|Overall Study|Randomized, but not treated|3|||
125043107|NCT00847613|449779079|FG002|Overall Study|Randomized, but not treated|0|||
125043108|NCT00847613|449779080|FG003|Overall Study|Randomized, but not treated|0|||
125043109|NCT00847613|449779077|FG000|Overall Study|Other|1|||
125043110|NCT00847613|449779078|FG001|Overall Study|Other|1|||
125043111|NCT00847613|449779079|FG002|Overall Study|Other|2|||
125043112|NCT00847613|449779080|FG003|Overall Study|Other|0|||
125043113|NCT03633331|449779081|FG000|Overall Study|Withdrawal by Subject|1|||
125043114|NCT01009294|449779082|FG000|Overall Study|Study discontinued by Sponsor|6|||
125043115|NCT01856673|449779083|FG000|Overall Study|Withdrawal by Subject|44|||
125043116|NCT01856673|449779084|FG001|Overall Study|Withdrawal by Subject|50|||
125043117|NCT01856673|449779085|FG002|Overall Study|Withdrawal by Subject|33|||
125043118|NCT01856673|449779083|FG000|Overall Study|Lost to Follow-up|31|||
125043119|NCT01856673|449779084|FG001|Overall Study|Lost to Follow-up|34|||
125043120|NCT01856673|449779085|FG002|Overall Study|Lost to Follow-up|0|||
125043121|NCT01856673|449779083|FG000|Overall Study|Unknown reasons|9|||
125043122|NCT01856673|449779084|FG001|Overall Study|Unknown reasons|0|||
125043123|NCT01856673|449779085|FG002|Overall Study|Unknown reasons|0|||
125043124|NCT01856673|449779083|FG000|Overall Study|Psychologist decision|1|||
125043125|NCT01856673|449779084|FG001|Overall Study|Psychologist decision|0|||
125043126|NCT01856673|449779085|FG002|Overall Study|Psychologist decision|0|||
125043127|NCT01856673|449779083|FG000|Overall Study|Paperwork errors|8|||
125043128|NCT01856673|449779084|FG001|Overall Study|Paperwork errors|0|||
125043129|NCT01856673|449779085|FG002|Overall Study|Paperwork errors|0|||
125043130|NCT01856673|449779083|FG000|Overall Study|Death|1|||
125043131|NCT01856673|449779084|FG001|Overall Study|Death|1|||
125043132|NCT01856673|449779085|FG002|Overall Study|Death|0|||
125043133|NCT01856673|449779083|FG000|Overall Study|Protocol Violation|1|||
125043134|NCT01856673|449779084|FG001|Overall Study|Protocol Violation|0|||
125043135|NCT01856673|449779085|FG002|Overall Study|Protocol Violation|1|||
125043136|NCT04332419|449779086|FG000|Overall Study|Withdrawal by Subject|1|||
125043137|NCT00658333|449779087|FG000|Overall Study|Adverse Event|2|||
125043138|NCT00658333|449779088|FG001|Overall Study|Adverse Event|1|||
125043139|NCT00519532|449779093|FG000|Overall Study|Adverse Event|11|||
125043140|NCT00519532|449779093|FG000|Overall Study|Withdrawal by Subject|5|||
125043141|NCT00519532|449779093|FG000|Overall Study|Lost to Follow-up|2|||
125043142|NCT03138564|449779094|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
125043143|NCT03138564|449779095|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
125043144|NCT03138564|449779094|FG000|Overall Study|Lost to Follow-up|16|||
125043145|NCT03138564|449779095|FG001|Overall Study|Lost to Follow-up|2|||
125043146|NCT03138564|449779094|FG000|Overall Study|Withdrawal by Subject|48|||
125043147|NCT03138564|449779095|FG001|Overall Study|Withdrawal by Subject|4|||
125043148|NCT03138564|449779094|FG000|Overall Study|No longer met eligibility criteria|2|||
125043149|NCT03138564|449779095|FG001|Overall Study|No longer met eligibility criteria|0|||
125043150|NCT03138564|449779094|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
125043151|NCT03138564|449779095|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
125043152|NCT03138564|449779094|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
125043153|NCT03138564|449779095|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
125043154|NCT03138564|449779094|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
125043155|NCT03138564|449779095|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
125043156|NCT03138564|449779094|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
125043157|NCT03138564|449779095|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
125043158|NCT03443024|449779099|FG000|Overall Study|Adverse Event|2|||
125043159|NCT03443024|449779100|FG001|Overall Study|Adverse Event|4|||
125043160|NCT03443024|449779101|FG002|Overall Study|Adverse Event|3|||
125043161|NCT03443024|449779102|FG003|Overall Study|Adverse Event|1|||
125043162|NCT03443024|449779099|FG000|Overall Study|Lost to Follow-up|9|||
125043163|NCT03443024|449779100|FG001|Overall Study|Lost to Follow-up|9|||
125043164|NCT03443024|449779101|FG002|Overall Study|Lost to Follow-up|7|||
125043165|NCT03443024|449779102|FG003|Overall Study|Lost to Follow-up|5|||
125043166|NCT03443024|449779099|FG000|Overall Study|Withdrawal by Subject|8|||
125043167|NCT03443024|449779100|FG001|Overall Study|Withdrawal by Subject|15|||
125043168|NCT03443024|449779101|FG002|Overall Study|Withdrawal by Subject|9|||
125043169|NCT03443024|449779102|FG003|Overall Study|Withdrawal by Subject|23|||
125043170|NCT03443024|449779099|FG000|Overall Study|Physician Decision|1|||
125043171|NCT03443024|449779100|FG001|Overall Study|Physician Decision|2|||
125043172|NCT03443024|449779101|FG002|Overall Study|Physician Decision|0|||
125043173|NCT03443024|449779102|FG003|Overall Study|Physician Decision|1|||
125043174|NCT03443024|449779099|FG000|Overall Study|Sponsor Decision|1|||
125043175|NCT03443024|449779100|FG001|Overall Study|Sponsor Decision|1|||
125043176|NCT03443024|449779101|FG002|Overall Study|Sponsor Decision|0|||
125043177|NCT03443024|449779102|FG003|Overall Study|Sponsor Decision|0|||
125043178|NCT03443024|449779099|FG000|Overall Study|Protocol Deviation|0|||
125043179|NCT03443024|449779100|FG001|Overall Study|Protocol Deviation|0|||
125043180|NCT03443024|449779101|FG002|Overall Study|Protocol Deviation|0|||
125043181|NCT03443024|449779102|FG003|Overall Study|Protocol Deviation|2|||
125043182|NCT00624338|449779103|FG000|Overall Study|Adverse Event|14|||
125043183|NCT00624338|449779104|FG001|Overall Study|Adverse Event|14|||
125043184|NCT00624338|449779105|FG002|Overall Study|Adverse Event|18|||
125043185|NCT00624338|449779103|FG000|Overall Study|Lost to Follow-up|1|||
125043186|NCT00624338|449779104|FG001|Overall Study|Lost to Follow-up|0|||
125043187|NCT00624338|449779105|FG002|Overall Study|Lost to Follow-up|0|||
125043188|NCT00624338|449779103|FG000|Overall Study|Lack of Efficacy|11|||
125043189|NCT00624338|449779104|FG001|Overall Study|Lack of Efficacy|3|||
125043190|NCT00624338|449779105|FG002|Overall Study|Lack of Efficacy|14|||
125043191|NCT00624338|449779103|FG000|Overall Study|Protocol Violation|3|||
125043192|NCT00624338|449779104|FG001|Overall Study|Protocol Violation|3|||
125043193|NCT00624338|449779105|FG002|Overall Study|Protocol Violation|2|||
125043194|NCT00624338|449779103|FG000|Overall Study|Death|0|||
125043195|NCT00624338|449779104|FG001|Overall Study|Death|2|||
125043196|NCT00624338|449779105|FG002|Overall Study|Death|0|||
125043197|NCT00624338|449779103|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
125043198|NCT00624338|449779104|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
125043199|NCT00624338|449779105|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
125043200|NCT00624338|449779103|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
125043201|NCT00624338|449779104|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
125043202|NCT00624338|449779105|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
125043203|NCT00624338|449779103|FG000|Overall Study|Other|15|||
125043204|NCT00624338|449779104|FG001|Overall Study|Other|5|||
125043205|NCT00624338|449779105|FG002|Overall Study|Other|9|||
125043206|NCT00624338|449779103|FG000|Overall Study|Randomized but not treated|2|||
125043207|NCT00624338|449779104|FG001|Overall Study|Randomized but not treated|1|||
125043208|NCT00624338|449779105|FG002|Overall Study|Randomized but not treated|3|||
125043209|NCT01548638|449779106|FG000|Overall Study|Protocol Violation|3|||
125043210|NCT01548638|449779106|FG000|Overall Study|Withdrawal by Subject|1|||
125043211|NCT05593432|449779107|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
125043212|NCT05593432|449779108|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
125043213|NCT05593432|449779109|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
125043214|NCT05593432|449779110|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
125043215|NCT05593432|449779107|FG000|16-Week OLE Period|Lack of Efficacy|0|||
125043216|NCT05593432|449779108|FG001|16-Week OLE Period|Lack of Efficacy|0|||
125043217|NCT05593432|449779109|FG002|16-Week OLE Period|Lack of Efficacy|0|||
125043218|NCT05593432|449779110|FG003|16-Week OLE Period|Lack of Efficacy|1|||
125043219|NCT05593432|449779107|FG000|16-Week OLE Period|Lost to Follow-up|0|||
125043220|NCT05593432|449779108|FG001|16-Week OLE Period|Lost to Follow-up|0|||
125043221|NCT05593432|449779109|FG002|16-Week OLE Period|Lost to Follow-up|1|||
125043222|NCT05593432|449779110|FG003|16-Week OLE Period|Lost to Follow-up|2|||
125043223|NCT05593432|449779107|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
125043224|NCT05593432|449779108|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
125043225|NCT05593432|449779109|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
125043226|NCT05593432|449779110|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
125043227|NCT02986373|449779115|FG000|Overall Study|Adverse Event|4|||
125043228|NCT02986373|449779115|FG000|Overall Study|Lost to Follow-up|1|||
125043229|NCT02986373|449779115|FG000|Overall Study|Withdrawal by Subject|10|||
125043230|NCT02986373|449779115|FG000|Overall Study|Other|24|||
125043231|NCT04800315|449779116|FG000|Randomization|Did not receive study treatment|1|||
125043232|NCT04800315|449779117|FG001|Randomization|Did not receive study treatment|0|||
125043233|NCT04800315|449779118|FG002|Randomization|Did not receive study treatment|0|||
125043234|NCT04800315|449779119|FG003|Randomization|Did not receive study treatment|0|||
125043235|NCT04800315|449779116|FG000|Treatment Period|Adverse Event|4|||
125043236|NCT04800315|449779117|FG001|Treatment Period|Adverse Event|2|||
125043237|NCT04800315|449779118|FG002|Treatment Period|Adverse Event|1|||
125043238|NCT04800315|449779119|FG003|Treatment Period|Adverse Event|2|||
125043239|NCT04800315|449779116|FG000|Treatment Period|Lack of Efficacy|1|||
125043240|NCT04800315|449779117|FG001|Treatment Period|Lack of Efficacy|0|||
125043241|NCT04800315|449779118|FG002|Treatment Period|Lack of Efficacy|0|||
125043242|NCT04800315|449779119|FG003|Treatment Period|Lack of Efficacy|3|||
125043243|NCT04800315|449779116|FG000|Treatment Period|Lost to Follow-up|0|||
125043244|NCT04800315|449779117|FG001|Treatment Period|Lost to Follow-up|1|||
125043245|NCT04800315|449779118|FG002|Treatment Period|Lost to Follow-up|2|||
125043246|NCT04800315|449779119|FG003|Treatment Period|Lost to Follow-up|2|||
125043247|NCT04800315|449779116|FG000|Treatment Period|Withdrawal by participant|0|||
125043248|NCT04800315|449779117|FG001|Treatment Period|Withdrawal by participant|0|||
125043249|NCT04800315|449779118|FG002|Treatment Period|Withdrawal by participant|0|||
125043250|NCT04800315|449779119|FG003|Treatment Period|Withdrawal by participant|4|||
125043251|NCT04800315|449779116|FG000|Treatment Period|Other Reasons|0|||
125043252|NCT04800315|449779117|FG001|Treatment Period|Other Reasons|2|||
125043253|NCT04800315|449779118|FG002|Treatment Period|Other Reasons|0|||
125043254|NCT04800315|449779119|FG003|Treatment Period|Other Reasons|1|||
125043255|NCT00753922|449779120|FG000|Overall Study|Lost to Follow-up|155|||
125043256|NCT00753922|449779121|FG001|Overall Study|Lost to Follow-up|24|||
125043257|NCT00753922|449779122|FG002|Overall Study|Lost to Follow-up|28|||
125043258|NCT00753922|449779123|FG003|Overall Study|Lost to Follow-up|5|||
125043259|NCT00753922|449779120|FG000|Overall Study|Withdrawal by Subject|9|||
125043260|NCT00753922|449779121|FG001|Overall Study|Withdrawal by Subject|11|||
125043261|NCT00753922|449779122|FG002|Overall Study|Withdrawal by Subject|4|||
125043262|NCT00753922|449779123|FG003|Overall Study|Withdrawal by Subject|2|||
125043263|NCT00753922|449779120|FG000|Overall Study|Patient Non-compliance|55|||
125043264|NCT00753922|449779121|FG001|Overall Study|Patient Non-compliance|22|||
125043265|NCT00753922|449779122|FG002|Overall Study|Patient Non-compliance|14|||
125043266|NCT00753922|449779123|FG003|Overall Study|Patient Non-compliance|11|||
125043267|NCT00753922|449779120|FG000|Overall Study|Patients Not Completing Visit|11|||
125043268|NCT00753922|449779121|FG001|Overall Study|Patients Not Completing Visit|0|||
125043269|NCT00753922|449779122|FG002|Overall Study|Patients Not Completing Visit|1|||
125043270|NCT00753922|449779123|FG003|Overall Study|Patients Not Completing Visit|0|||
125043271|NCT00753922|449779120|FG000|Overall Study|Death|2|||
125135453|NCT01695239|450120127|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125135454|NCT01695239|450120128|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125135455|NCT01695239|450120129|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125135456|NCT01695239|450120130|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
125135457|NCT01695239|450120131|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
125135458|NCT01695239|450120132|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125135459|NCT01695239|450120133|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125135460|NCT01695239|450120134|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125135461|NCT01695239|450120135|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125135462|NCT01695239|450120122|FG000|Extension Long-Term Extension Periods|Death|0|||
125135463|NCT01695239|450120123|FG001|Extension Long-Term Extension Periods|Death|0|||
125135464|NCT01695239|450120124|FG002|Extension Long-Term Extension Periods|Death|0|||
125135465|NCT01695239|450120125|FG003|Extension Long-Term Extension Periods|Death|0|||
125135466|NCT01695239|450120126|FG004|Extension Long-Term Extension Periods|Death|0|||
125135467|NCT01695239|450120127|FG005|Extension Long-Term Extension Periods|Death|0|||
125043272|NCT00753922|449779121|FG001|Overall Study|Death|23|||
125043273|NCT00753922|449779122|FG002|Overall Study|Death|2|||
125043274|NCT00753922|449779123|FG003|Overall Study|Death|1|||
125043275|NCT00753922|449779120|FG000|Overall Study|Discontinuation Due to Explantation|14|||
125043276|NCT00753922|449779121|FG001|Overall Study|Discontinuation Due to Explantation|14|||
125043277|NCT00753922|449779122|FG002|Overall Study|Discontinuation Due to Explantation|14|||
125043278|NCT00753922|449779123|FG003|Overall Study|Discontinuation Due to Explantation|4|||
125043279|NCT03598777|449779124|FG000|Overall Study|Study Terminated by Sponsor|3|||
125043280|NCT03598777|449779125|FG001|Overall Study|Study Terminated by Sponsor|0|||
125135468|NCT01695239|450120128|FG006|Extension Long-Term Extension Periods|Death|0|||
125135469|NCT01695239|450120129|FG007|Extension Long-Term Extension Periods|Death|0|||
125135470|NCT01695239|450120130|FG008|Extension Long-Term Extension Periods|Death|1|||
125043281|NCT03598777|449779126|FG002|Overall Study|Study Terminated by Sponsor|0|||
125135471|NCT01695239|450120131|FG009|Extension Long-Term Extension Periods|Death|0|||
125043282|NCT03598777|449779127|FG003|Overall Study|Study Terminated by Sponsor|0|||
125043283|NCT03598777|449779128|FG004|Overall Study|Study Terminated by Sponsor|15|||
125043284|NCT03598777|449779124|FG000|Overall Study|Withdrawal by Subject|1|||
125043285|NCT03598777|449779125|FG001|Overall Study|Withdrawal by Subject|1|||
125043286|NCT03598777|449779126|FG002|Overall Study|Withdrawal by Subject|0|||
125043287|NCT03598777|449779127|FG003|Overall Study|Withdrawal by Subject|0|||
125043288|NCT03598777|449779128|FG004|Overall Study|Withdrawal by Subject|0|||
125043289|NCT03598777|449779124|FG000|Overall Study|Adverse Event|1|||
125043290|NCT03598777|449779125|FG001|Overall Study|Adverse Event|0|||
125043291|NCT03598777|449779126|FG002|Overall Study|Adverse Event|0|||
125043292|NCT03598777|449779127|FG003|Overall Study|Adverse Event|0|||
125043293|NCT03598777|449779128|FG004|Overall Study|Adverse Event|0|||
125043294|NCT03598777|449779124|FG000|Overall Study|Lost to Follow-up|1|||
125043295|NCT03598777|449779125|FG001|Overall Study|Lost to Follow-up|0|||
125043296|NCT03598777|449779126|FG002|Overall Study|Lost to Follow-up|0|||
125043297|NCT03598777|449779127|FG003|Overall Study|Lost to Follow-up|0|||
125043298|NCT03598777|449779128|FG004|Overall Study|Lost to Follow-up|0|||
125043299|NCT01919411|449779129|FG000|Overall Study|Lost to Follow-up|2|||
125043300|NCT01919411|449779130|FG001|Overall Study|Lost to Follow-up|4|||
125043301|NCT01919411|449779129|FG000|Overall Study|Physician Decision|1|||
125043302|NCT01919411|449779130|FG001|Overall Study|Physician Decision|0|||
125043303|NCT01919411|449779129|FG000|Overall Study|Protocol Violation|2|||
125043304|NCT01919411|449779130|FG001|Overall Study|Protocol Violation|1|||
125043305|NCT00072189|449779131|FG000|Overall Study|Withdrawal by Subject|1|||
125043306|NCT01933672|449779132|FG000|Metformin Run-in Period|Adverse Event|1|||
125043307|NCT01933672|449779133|FG001|Metformin Run-in Period|Adverse Event|0|||
125043308|NCT01933672|449779134|FG002|Metformin Run-in Period|Adverse Event|0|||
125043309|NCT01933672|449779135|FG003|Metformin Run-in Period|Adverse Event|0|||
125043310|NCT01933672|449779136|FG004|Metformin Run-in Period|Adverse Event|0|||
125043311|NCT01933672|449779137|FG005|Metformin Run-in Period|Adverse Event|0|||
125043312|NCT01933672|449779138|FG006|Metformin Run-in Period|Adverse Event|0|||
125043313|NCT01933672|449779132|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
125043314|NCT01933672|449779133|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
125043315|NCT01933672|449779134|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
125043316|NCT01933672|449779135|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
125043317|NCT01933672|449779136|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
125043318|NCT01933672|449779137|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
125043319|NCT01933672|449779138|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
125043320|NCT01933672|449779132|FG000|Metformin Run-in Period|Other|5|||
125043321|NCT01933672|449779133|FG001|Metformin Run-in Period|Other|0|||
125043322|NCT01933672|449779134|FG002|Metformin Run-in Period|Other|0|||
125043323|NCT01933672|449779135|FG003|Metformin Run-in Period|Other|0|||
125043324|NCT01933672|449779136|FG004|Metformin Run-in Period|Other|0|||
125043325|NCT01933672|449779137|FG005|Metformin Run-in Period|Other|0|||
125043326|NCT01933672|449779138|FG006|Metformin Run-in Period|Other|0|||
125043327|NCT01933672|449779132|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125043328|NCT01933672|449779133|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125043329|NCT01933672|449779134|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125043330|NCT01933672|449779135|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125043331|NCT01933672|449779136|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
125043332|NCT01933672|449779137|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125043333|NCT01933672|449779138|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125043334|NCT01933672|449779132|FG000|First Intervention Period (12-16 Days)|Other|0|||
125043335|NCT01933672|449779133|FG001|First Intervention Period (12-16 Days)|Other|0|||
125043336|NCT01933672|449779134|FG002|First Intervention Period (12-16 Days)|Other|1|||
125218863|NCT03538691|450427423|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
125218864|NCT03538691|450427420|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
125218865|NCT03538691|450427421|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
125218866|NCT03538691|450427422|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
125043337|NCT01933672|449779135|FG003|First Intervention Period (12-16 Days)|Other|0|||
125043338|NCT01933672|449779136|FG004|First Intervention Period (12-16 Days)|Other|0|||
125043339|NCT01933672|449779137|FG005|First Intervention Period (12-16 Days)|Other|1|||
125043340|NCT01933672|449779138|FG006|First Intervention Period (12-16 Days)|Other|0|||
125043341|NCT01933672|449779132|FG000|Second Intervention Period (12-16 Days)|Other|0|||
125043342|NCT01933672|449779133|FG001|Second Intervention Period (12-16 Days)|Other|1|||
125043343|NCT01933672|449779134|FG002|Second Intervention Period (12-16 Days)|Other|1|||
125043344|NCT01933672|449779135|FG003|Second Intervention Period (12-16 Days)|Other|0|||
125043345|NCT01933672|449779136|FG004|Second Intervention Period (12-16 Days)|Other|0|||
125043346|NCT01933672|449779137|FG005|Second Intervention Period (12-16 Days)|Other|0|||
125043347|NCT01933672|449779138|FG006|Second Intervention Period (12-16 Days)|Other|0|||
125043348|NCT01933672|449779132|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125043349|NCT01933672|449779133|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125043350|NCT01933672|449779134|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125043351|NCT01933672|449779135|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
125043352|NCT01933672|449779136|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125043353|NCT01933672|449779137|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125043354|NCT01933672|449779138|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125043355|NCT01933672|449779132|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
125043356|NCT01933672|449779133|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
125043357|NCT01933672|449779134|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
125043358|NCT01933672|449779135|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
125043359|NCT01933672|449779136|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
125043360|NCT01933672|449779137|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
125043361|NCT01933672|449779138|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
125043362|NCT04358458|449779139|FG000|Overall Study|Death|1|||
125043363|NCT04358458|449779140|FG001|Overall Study|Death|1|||
125043364|NCT04358458|449779141|FG002|Overall Study|Death|3|||
125043365|NCT04358458|449779142|FG003|Overall Study|Death|8|||
125043366|NCT04358458|449779143|FG004|Overall Study|Death|1|||
125043367|NCT04358458|449779144|FG005|Overall Study|Death|6|||
125043368|NCT04358458|449779145|FG006|Overall Study|Death|2|||
125043369|NCT04358458|449779146|FG007|Overall Study|Death|3|||
125043370|NCT04358458|449779139|FG000|Overall Study|Lost to Follow-up|0|||
125043371|NCT04358458|449779140|FG001|Overall Study|Lost to Follow-up|0|||
125043372|NCT04358458|449779141|FG002|Overall Study|Lost to Follow-up|0|||
125043373|NCT04358458|449779142|FG003|Overall Study|Lost to Follow-up|0|||
125043374|NCT04358458|449779143|FG004|Overall Study|Lost to Follow-up|0|||
125043375|NCT04358458|449779144|FG005|Overall Study|Lost to Follow-up|0|||
125043376|NCT04358458|449779145|FG006|Overall Study|Lost to Follow-up|0|||
125043377|NCT04358458|449779146|FG007|Overall Study|Lost to Follow-up|1|||
125043378|NCT04358458|449779139|FG000|Overall Study|Site is closing study participation|0|||
125043379|NCT04358458|449779140|FG001|Overall Study|Site is closing study participation|0|||
125043380|NCT04358458|449779141|FG002|Overall Study|Site is closing study participation|0|||
125043381|NCT04358458|449779142|FG003|Overall Study|Site is closing study participation|1|||
125043382|NCT04358458|449779143|FG004|Overall Study|Site is closing study participation|0|||
125043383|NCT04358458|449779144|FG005|Overall Study|Site is closing study participation|0|||
125043384|NCT04358458|449779145|FG006|Overall Study|Site is closing study participation|0|||
125043385|NCT04358458|449779146|FG007|Overall Study|Site is closing study participation|0|||
125043386|NCT04358458|449779139|FG000|Overall Study|Sponsor request|2|||
125043387|NCT04358458|449779140|FG001|Overall Study|Sponsor request|3|||
125043388|NCT04358458|449779141|FG002|Overall Study|Sponsor request|3|||
125043389|NCT04358458|449779142|FG003|Overall Study|Sponsor request|0|||
125043390|NCT04358458|449779143|FG004|Overall Study|Sponsor request|2|||
125043391|NCT04358458|449779144|FG005|Overall Study|Sponsor request|3|||
125043392|NCT04358458|449779145|FG006|Overall Study|Sponsor request|1|||
125043393|NCT04358458|449779146|FG007|Overall Study|Sponsor request|1|||
125043394|NCT04358458|449779139|FG000|Overall Study|Withdrawal by Subject|0|||
125043395|NCT04358458|449779140|FG001|Overall Study|Withdrawal by Subject|0|||
125043396|NCT04358458|449779141|FG002|Overall Study|Withdrawal by Subject|1|||
125043397|NCT04358458|449779142|FG003|Overall Study|Withdrawal by Subject|1|||
125043398|NCT04358458|449779143|FG004|Overall Study|Withdrawal by Subject|0|||
125043399|NCT04358458|449779144|FG005|Overall Study|Withdrawal by Subject|1|||
125043400|NCT04358458|449779145|FG006|Overall Study|Withdrawal by Subject|0|||
125043401|NCT04358458|449779146|FG007|Overall Study|Withdrawal by Subject|1|||
125043402|NCT02031146|449780504|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
125043403|NCT02031146|449780505|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
125043404|NCT02031146|449780506|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
125043405|NCT02031146|449780507|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
125043406|NCT02031146|449780508|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
125043407|NCT02031146|449780509|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
125043408|NCT02031146|449780510|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
125135472|NCT01695239|450120132|FG010|Extension Long-Term Extension Periods|Death|0|||
125135473|NCT01695239|450120133|FG011|Extension Long-Term Extension Periods|Death|0|||
125135474|NCT01695239|450120134|FG012|Extension Long-Term Extension Periods|Death|0|||
125135475|NCT01695239|450120135|FG013|Extension Long-Term Extension Periods|Death|0|||
125043409|NCT01266148|449780515|FG000|Overall Study|Adverse Event|2|||
125043410|NCT01266148|449780516|FG001|Overall Study|Adverse Event|0|||
125043411|NCT01266148|449780515|FG000|Overall Study|Ongoing rejection|1|||
125043412|NCT01266148|449780516|FG001|Overall Study|Ongoing rejection|0|||
125043413|NCT01266148|449780515|FG000|Overall Study|2 2R rejections|1|||
125043414|NCT01266148|449780516|FG001|Overall Study|2 2R rejections|0|||
125135476|NCT01695239|450120122|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125135477|NCT01695239|450120123|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125043415|NCT01266148|449780515|FG000|Overall Study|Death|2|||
125043416|NCT01266148|449780516|FG001|Overall Study|Death|3|||
125043417|NCT01266148|449780515|FG000|Overall Study|missing mGFR value + AE|1|||
125043418|NCT01266148|449780516|FG001|Overall Study|missing mGFR value + AE|0|||
125043419|NCT03937986|449780519|FG000|Overall Study|COVID-19 Pandemic|1|||
125043420|NCT01853228|449780522|FG000|Phase 1|Lack of Efficacy|8|||
125043421|NCT01853228|449780523|FG001|Phase 1|Lack of Efficacy|0|||
125043422|NCT01853228|449780522|FG000|Phase 1|Other|1|||
125043423|NCT01853228|449780523|FG001|Phase 1|Other|0|||
125043424|NCT01853228|449780522|FG000|Phase 2|Physician Decision|0|||
125043425|NCT01853228|449780523|FG001|Phase 2|Physician Decision|1|||
125043426|NCT01853228|449780522|FG000|Phase 2|Proceed To Transplant|0|||
125043427|NCT01853228|449780523|FG001|Phase 2|Proceed To Transplant|3|||
125043428|NCT01853228|449780522|FG000|Phase 2|Lack of Efficacy|0|||
125043429|NCT01853228|449780523|FG001|Phase 2|Lack of Efficacy|4|||
125043430|NCT03167619|449780526|FG000|Overall Study|Death|11|||
125043431|NCT03167619|449780527|FG001|Overall Study|Death|8|||
125043432|NCT03167619|449780526|FG000|Overall Study|Withdrawal by Subject|1|||
125043433|NCT03167619|449780527|FG001|Overall Study|Withdrawal by Subject|2|||
125043434|NCT03167619|449780526|FG000|Overall Study|Physician Decision|0|||
125043435|NCT03167619|449780527|FG001|Overall Study|Physician Decision|1|||
125043436|NCT01348919|449780529|FG000|Overall Study|Adverse Event|3|||
125043437|NCT01348919|449780530|FG001|Overall Study|Adverse Event|1|||
125043438|NCT01348919|449780531|FG002|Overall Study|Adverse Event|0|||
125043439|NCT01348919|449780529|FG000|Overall Study|Withdrawal by Subject|0|||
125043440|NCT01348919|449780530|FG001|Overall Study|Withdrawal by Subject|1|||
125043441|NCT01348919|449780531|FG002|Overall Study|Withdrawal by Subject|0|||
125043442|NCT01348919|449780529|FG000|Overall Study|Disease progression|0|||
125043443|NCT01348919|449780530|FG001|Overall Study|Disease progression|1|||
125043444|NCT01348919|449780531|FG002|Overall Study|Disease progression|1|||
125043445|NCT02114203|449780532|FG000|Overall Study|Adverse Event|0|||
125043446|NCT02114203|449780533|FG001|Overall Study|Adverse Event|1|||
125043447|NCT02114203|449780534|FG002|Overall Study|Adverse Event|0|||
125043448|NCT02114203|449780532|FG000|Overall Study|Withdrawal by Subject|0|||
125043449|NCT02114203|449780533|FG001|Overall Study|Withdrawal by Subject|1|||
125043450|NCT02114203|449780534|FG002|Overall Study|Withdrawal by Subject|0|||
125043451|NCT01518699|449780535|FG000|Period 2|Protocol Violation|1|||
125043452|NCT01518699|449780536|FG001|Period 2|Protocol Violation|1|||
125043453|NCT01518699|449780537|FG002|Period 2|Protocol Violation|0|||
125043454|NCT01518699|449780538|FG003|Period 2|Protocol Violation|0|||
125043455|NCT01518699|449780539|FG004|Period 2|Protocol Violation|0|||
125043456|NCT01518699|449780540|FG005|Period 2|Protocol Violation|0|||
125043457|NCT01518699|449780535|FG000|Period 2|Lost to Follow-up|0|||
125043458|NCT01518699|449780536|FG001|Period 2|Lost to Follow-up|1|||
125043459|NCT01518699|449780537|FG002|Period 2|Lost to Follow-up|0|||
125043460|NCT01518699|449780538|FG003|Period 2|Lost to Follow-up|0|||
125043461|NCT01518699|449780539|FG004|Period 2|Lost to Follow-up|0|||
125043462|NCT01518699|449780540|FG005|Period 2|Lost to Follow-up|0|||
125043463|NCT01518699|449780535|FG000|Period 2|Adverse Event|1|||
125043464|NCT01518699|449780536|FG001|Period 2|Adverse Event|0|||
125043465|NCT01518699|449780537|FG002|Period 2|Adverse Event|0|||
125043466|NCT01518699|449780538|FG003|Period 2|Adverse Event|0|||
125043467|NCT01518699|449780539|FG004|Period 2|Adverse Event|0|||
125043468|NCT01518699|449780540|FG005|Period 2|Adverse Event|0|||
125043469|NCT02839746|449780542|FG000|Overall Study|Not met selection criteria|12|||
125043470|NCT00744055|449780543|FG000|Overall Study|Withdrawal by Subject|6|||
125043471|NCT00744055|449780544|FG001|Overall Study|Withdrawal by Subject|9|||
125043472|NCT00744055|449780543|FG000|Overall Study|Lack of Efficacy|0|||
125043473|NCT00744055|449780544|FG001|Overall Study|Lack of Efficacy|1|||
125135478|NCT01695239|450120124|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125135479|NCT01695239|450120125|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125135480|NCT01695239|450120126|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125135481|NCT01695239|450120127|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125135482|NCT01695239|450120128|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125135483|NCT01695239|450120129|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125043474|NCT00744055|449780543|FG000|Overall Study|Physician Decision|0|||
125043475|NCT00744055|449780544|FG001|Overall Study|Physician Decision|2|||
125135484|NCT01695239|450120130|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125135485|NCT01695239|450120131|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125135486|NCT01695239|450120132|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125043476|NCT00744055|449780543|FG000|Overall Study|Protocol Violation|1|||
125043477|NCT00744055|449780544|FG001|Overall Study|Protocol Violation|1|||
125043478|NCT00744055|449780543|FG000|Overall Study|Lost to Follow-up|0|||
125043479|NCT00744055|449780544|FG001|Overall Study|Lost to Follow-up|1|||
125043480|NCT02767570|449780545|FG000|Overall Study|Lost to Follow-up|3|||
125043481|NCT02767570|449780546|FG001|Overall Study|Lost to Follow-up|0|||
125043482|NCT02767570|449780545|FG000|Overall Study|COVID shutdown|2|||
125043483|NCT02767570|449780546|FG001|Overall Study|COVID shutdown|5|||
125043484|NCT02767570|449780545|FG000|Overall Study|Increased pain|2|||
125043485|NCT02767570|449780546|FG001|Overall Study|Increased pain|0|||
125043486|NCT02767570|449780545|FG000|Overall Study|Withdrawal by Subject|1|||
125043487|NCT02767570|449780546|FG001|Overall Study|Withdrawal by Subject|3|||
125043488|NCT02767570|449780545|FG000|Overall Study|Unrelated medical issue|1|||
125043489|NCT02767570|449780546|FG001|Overall Study|Unrelated medical issue|1|||
125043490|NCT02767570|449780545|FG000|Overall Study|Received intra-articular injection|0|||
125043491|NCT02767570|449780546|FG001|Overall Study|Received intra-articular injection|1|||
125043492|NCT00151411|449780547|FG000|Overall Study|Lost to Follow-up|15|||
125043493|NCT00151411|449780548|FG001|Overall Study|Lost to Follow-up|19|||
125043494|NCT00151411|449780547|FG000|Overall Study|Withdrawal by Subject|12|||
125043495|NCT00151411|449780548|FG001|Overall Study|Withdrawal by Subject|20|||
125043496|NCT00151411|449780547|FG000|Overall Study|Adverse Event|6|||
125043497|NCT00151411|449780548|FG001|Overall Study|Adverse Event|0|||
125043498|NCT00151411|449780547|FG000|Overall Study|Pregnancy|0|||
125043499|NCT00151411|449780548|FG001|Overall Study|Pregnancy|4|||
125043500|NCT01712438|449780549|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
125043501|NCT01712438|449780549|FG000|Overall Study|Ongoing ITI treatment|6|||
125043502|NCT01712438|449780549|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
125043503|NCT01712438|449780549|FG000|Overall Study|Prematurely Discontinued|25|||
125043504|NCT01157169|449780552|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
125043505|NCT01157169|449780553|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
125043506|NCT01157169|449780552|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
125043507|NCT01157169|449780553|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
125043508|NCT01123889|449780554|FG000|Overall Study|Lost to Follow-up|3|||
125043509|NCT01123889|449780555|FG001|Overall Study|Lost to Follow-up|1|||
125043510|NCT03846947|449780560|FG000|Overall Study|technical issues with imaging sequence|2|||
125043511|NCT02413398|449780564|FG000|Overall Study|Lost to Follow-up|2|||
125043512|NCT02413398|449780565|FG001|Overall Study|Lost to Follow-up|4|||
125043513|NCT02413398|449780564|FG000|Overall Study|Withdrawal by Subject|1|||
125043514|NCT02413398|449780565|FG001|Overall Study|Withdrawal by Subject|1|||
125043515|NCT02413398|449780564|FG000|Overall Study|Other Eligibility criteria|1|||
125043516|NCT02413398|449780565|FG001|Overall Study|Other Eligibility criteria|2|||
125043517|NCT02874794|449780566|FG000|Overall Study|Physician Decision|3|||
125043518|NCT02874794|449780567|FG001|Overall Study|Physician Decision|2|||
125043519|NCT02874794|449780566|FG000|Overall Study|Withdrawal by Subject|2|||
125043520|NCT02874794|449780567|FG001|Overall Study|Withdrawal by Subject|8|||
125043521|NCT02874794|449780566|FG000|Overall Study|Death|2|||
125043522|NCT02874794|449780567|FG001|Overall Study|Death|1|||
125043523|NCT00537940|449780568|FG000|Overall Study|Adverse Event|20|||
125043524|NCT00537940|449780569|FG001|Overall Study|Adverse Event|19|||
125043525|NCT00537940|449780568|FG000|Overall Study|Lack of Efficacy|8|||
125043526|NCT00537940|449780569|FG001|Overall Study|Lack of Efficacy|16|||
125043527|NCT00537940|449780568|FG000|Overall Study|Lost to Follow-up|23|||
125043528|NCT00537940|449780569|FG001|Overall Study|Lost to Follow-up|29|||
125043529|NCT00537940|449780568|FG000|Overall Study|Withdrawal by Subject|113|||
125043530|NCT00537940|449780569|FG001|Overall Study|Withdrawal by Subject|95|||
125043531|NCT00537940|449780568|FG000|Overall Study|Protocol Violation|6|||
125043532|NCT00537940|449780569|FG001|Overall Study|Protocol Violation|4|||
125043533|NCT00537940|449780568|FG000|Overall Study|Pregnancy|1|||
125043534|NCT00537940|449780569|FG001|Overall Study|Pregnancy|1|||
125043535|NCT00537940|449780568|FG000|Overall Study|Study terminated by sponsor|2|||
125043536|NCT00537940|449780569|FG001|Overall Study|Study terminated by sponsor|3|||
125043537|NCT00537940|449780568|FG000|Overall Study|Other|10|||
125043538|NCT00537940|449780569|FG001|Overall Study|Other|12|||
125043539|NCT02465034|449780572|FG000|Overall Study|Withdrawal by Subject|1|||
125043540|NCT02465034|449780573|FG001|Overall Study|Withdrawal by Subject|1|||
125043541|NCT02465034|449780572|FG000|Overall Study|Screen fail|2|||
125043542|NCT02465034|449780573|FG001|Overall Study|Screen fail|0|||
125043543|NCT02465034|449780572|FG000|Overall Study|Could not be scheduled for study visit|0|||
125043544|NCT02465034|449780573|FG001|Overall Study|Could not be scheduled for study visit|5|||
125043545|NCT02397655|449780579|FG000|Overall Study|data not completed|1301|||
125043546|NCT01736683|449780580|FG000|Overall Study|Disease Relapse|0|||
125043547|NCT01736683|449780581|FG001|Overall Study|Disease Relapse|0|||
125043548|NCT01736683|449780582|FG002|Overall Study|Disease Relapse|2|||
125043549|NCT01736683|449780583|FG003|Overall Study|Disease Relapse|1|||
125043550|NCT01736683|449780584|FG004|Overall Study|Disease Relapse|0|||
125043551|NCT01736683|449780580|FG000|Overall Study|Adverse Event|0|||
125043552|NCT01736683|449780581|FG001|Overall Study|Adverse Event|2|||
125043553|NCT01736683|449780582|FG002|Overall Study|Adverse Event|2|||
125043554|NCT01736683|449780583|FG003|Overall Study|Adverse Event|3|||
125043555|NCT01736683|449780584|FG004|Overall Study|Adverse Event|2|||
125135487|NCT01695239|450120133|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
125135488|NCT01695239|450120134|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
125043556|NCT01736683|449780580|FG000|Overall Study|Withdrawal by Subject|0|||
125043557|NCT01736683|449780581|FG001|Overall Study|Withdrawal by Subject|0|||
125043558|NCT01736683|449780582|FG002|Overall Study|Withdrawal by Subject|3|||
125043559|NCT01736683|449780583|FG003|Overall Study|Withdrawal by Subject|1|||
125043560|NCT01736683|449780584|FG004|Overall Study|Withdrawal by Subject|1|||
125043561|NCT01736683|449780580|FG000|Overall Study|Lack of Therapeutic Effect|7|||
125043562|NCT01736683|449780581|FG001|Overall Study|Lack of Therapeutic Effect|4|||
125043563|NCT01736683|449780582|FG002|Overall Study|Lack of Therapeutic Effect|13|||
125043564|NCT01736683|449780583|FG003|Overall Study|Lack of Therapeutic Effect|20|||
125043565|NCT01736683|449780584|FG004|Overall Study|Lack of Therapeutic Effect|1|||
125043566|NCT01736683|449780580|FG000|Overall Study|Progressive Disease|0|||
125043567|NCT01736683|449780581|FG001|Overall Study|Progressive Disease|0|||
125043568|NCT01736683|449780582|FG002|Overall Study|Progressive Disease|0|||
125043569|NCT01736683|449780583|FG003|Overall Study|Progressive Disease|1|||
125043570|NCT01736683|449780584|FG004|Overall Study|Progressive Disease|0|||
125043571|NCT01736683|449780580|FG000|Overall Study|Other|0|||
125043572|NCT01736683|449780581|FG001|Overall Study|Other|0|||
125043573|NCT01736683|449780582|FG002|Overall Study|Other|1|||
125043574|NCT01736683|449780583|FG003|Overall Study|Other|9|||
125043575|NCT01736683|449780584|FG004|Overall Study|Other|1|||
125043576|NCT03334214|449780585|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
125043577|NCT03334214|449780586|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
125043578|NCT03334214|449780585|FG000|Overall Study|Withdrawal by Subject|0|||
125043579|NCT03334214|449780586|FG001|Overall Study|Withdrawal by Subject|1|||
125043580|NCT03334214|449780585|FG000|Overall Study|Other|1|||
125043581|NCT03334214|449780586|FG001|Overall Study|Other|0|||
125043582|NCT00995371|449780592|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
125043583|NCT00995371|449780593|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
125043584|NCT04725682|449780594|FG000|Overall Study|Withdrawal by Subject|7|||
125043585|NCT04725682|449780595|FG001|Overall Study|Withdrawal by Subject|5|||
125043586|NCT04725682|449780594|FG000|Overall Study|Failed to comply with the requirements|2|||
125043587|NCT04725682|449780595|FG001|Overall Study|Failed to comply with the requirements|1|||
125043588|NCT04725682|449780594|FG000|Overall Study|Adverse Event|1|||
125043589|NCT04725682|449780595|FG001|Overall Study|Adverse Event|1|||
125043590|NCT04725682|449780594|FG000|Overall Study|Death|0|||
125043591|NCT04725682|449780595|FG001|Overall Study|Death|1|||
125043592|NCT02190591|449780596|FG000|Overall Study|Withdrawal by Subject|1|||
125043593|NCT02190591|449780597|FG001|Overall Study|Withdrawal by Subject|8|||
125043594|NCT02190591|449780596|FG000|Overall Study|Protocol Violation|1|||
125043595|NCT02190591|449780597|FG001|Overall Study|Protocol Violation|0|||
125043596|NCT02190591|449780596|FG000|Overall Study|did not use peanut ball as instructed|0|||
125043597|NCT02190591|449780597|FG001|Overall Study|did not use peanut ball as instructed|2|||
125043598|NCT02190591|449780596|FG000|Overall Study|face presentation so she was ineligible|0|||
125043599|NCT02190591|449780597|FG001|Overall Study|face presentation so she was ineligible|1|||
125043600|NCT00857246|449780598|FG000|Induction Regimen|Adverse Event|1|||
125043601|NCT00857246|449780598|FG000|Induction Regimen|disease-related complications|1|||
125043602|NCT00857246|449780598|FG000|Induction Regimen|Withdrawal by Subject|1|||
125043603|NCT00857246|449780598|FG000|Surgery (Curative)|disease progression|6|||
125135489|NCT01695239|450120135|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
125135490|NCT01695239|450120122|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135491|NCT01695239|450120123|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135492|NCT01695239|450120124|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135493|NCT01695239|450120125|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135494|NCT01695239|450120126|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135495|NCT01695239|450120127|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135496|NCT01695239|450120128|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135497|NCT01695239|450120129|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135498|NCT01695239|450120130|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135499|NCT01695239|450120131|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135500|NCT01695239|450120132|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135501|NCT01695239|450120133|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135502|NCT01695239|450120134|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
125135503|NCT01695239|450120135|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
125135504|NCT01695239|450120122|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135505|NCT01695239|450120123|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135506|NCT01695239|450120124|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135507|NCT01695239|450120125|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135508|NCT01695239|450120126|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135509|NCT01695239|450120127|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135510|NCT01695239|450120128|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
125043604|NCT00857246|449780598|FG000|ChemoRT|Withdrawal by Subject|1|||
125043605|NCT00857246|449780598|FG000|ChemoRT|Adverse Event|2|||
125043606|NCT00144300|449780599|FG000|Overall Study|Adverse Event|18|||
125043607|NCT00144300|449780600|FG001|Overall Study|Adverse Event|16|||
125135511|NCT01695239|450120129|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
125043608|NCT00144300|449780599|FG000|Overall Study|Protocol Violation|1|||
125043609|NCT00144300|449780600|FG001|Overall Study|Protocol Violation|3|||
125043610|NCT00144300|449780599|FG000|Overall Study|Lost to Follow-up|3|||
125043611|NCT00144300|449780600|FG001|Overall Study|Lost to Follow-up|0|||
125043612|NCT00144300|449780599|FG000|Overall Study|Withdrawal by Subject|6|||
125043613|NCT00144300|449780600|FG001|Overall Study|Withdrawal by Subject|6|||
125043614|NCT00144300|449780599|FG000|Overall Study|Other reason (not specified)|1|||
125043615|NCT00144300|449780600|FG001|Overall Study|Other reason (not specified)|3|||
125043616|NCT01607892|449780602|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
125043617|NCT01607892|449780603|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
125043618|NCT01607892|449780604|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
125043619|NCT01607892|449780605|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
125043620|NCT01607892|449780606|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
125043621|NCT01607892|449780602|FG000|Overall Study|Death|4|||
125043622|NCT01607892|449780603|FG001|Overall Study|Death|2|||
125043623|NCT01607892|449780604|FG002|Overall Study|Death|8|||
125043624|NCT01607892|449780605|FG003|Overall Study|Death|10|||
125043625|NCT01607892|449780606|FG004|Overall Study|Death|3|||
125043626|NCT01607892|449780602|FG000|Overall Study|Investigator discretion|2|||
125043627|NCT01607892|449780603|FG001|Overall Study|Investigator discretion|4|||
125043628|NCT01607892|449780604|FG002|Overall Study|Investigator discretion|4|||
125043629|NCT01607892|449780605|FG003|Overall Study|Investigator discretion|8|||
125043630|NCT01607892|449780606|FG004|Overall Study|Investigator discretion|0|||
125043631|NCT01607892|449780602|FG000|Overall Study|Other treatments became available|1|||
125043632|NCT01607892|449780603|FG001|Overall Study|Other treatments became available|1|||
125043633|NCT01607892|449780604|FG002|Overall Study|Other treatments became available|0|||
125043634|NCT01607892|449780605|FG003|Overall Study|Other treatments became available|0|||
125043635|NCT01607892|449780606|FG004|Overall Study|Other treatments became available|2|||
125043636|NCT01607892|449780602|FG000|Overall Study|Intercurrent illness|1|||
125043637|NCT01607892|449780603|FG001|Overall Study|Intercurrent illness|0|||
125043638|NCT01607892|449780604|FG002|Overall Study|Intercurrent illness|0|||
125043639|NCT01607892|449780605|FG003|Overall Study|Intercurrent illness|3|||
125043640|NCT01607892|449780606|FG004|Overall Study|Intercurrent illness|0|||
125043641|NCT01607892|449780602|FG000|Overall Study|Non-Compliance with study procedures|0|||
125043642|NCT01607892|449780603|FG001|Overall Study|Non-Compliance with study procedures|0|||
125043643|NCT01607892|449780604|FG002|Overall Study|Non-Compliance with study procedures|1|||
125043644|NCT01607892|449780605|FG003|Overall Study|Non-Compliance with study procedures|0|||
125043645|NCT01607892|449780606|FG004|Overall Study|Non-Compliance with study procedures|0|||
125043646|NCT01607892|449780602|FG000|Overall Study|Consent withdrawn by participant|9|||
125043647|NCT01607892|449780603|FG001|Overall Study|Consent withdrawn by participant|4|||
125043648|NCT01607892|449780604|FG002|Overall Study|Consent withdrawn by participant|24|||
125043649|NCT01607892|449780605|FG003|Overall Study|Consent withdrawn by participant|14|||
125043650|NCT01607892|449780606|FG004|Overall Study|Consent withdrawn by participant|4|||
125043651|NCT01607892|449780602|FG000|Overall Study|Disease progression|38|||
125043652|NCT01607892|449780603|FG001|Overall Study|Disease progression|13|||
125043653|NCT01607892|449780604|FG002|Overall Study|Disease progression|37|||
125043654|NCT01607892|449780605|FG003|Overall Study|Disease progression|57|||
125043655|NCT01607892|449780606|FG004|Overall Study|Disease progression|9|||
125043656|NCT01607892|449780602|FG000|Overall Study|Incidence or severity of Adverse events|3|||
125043657|NCT01607892|449780603|FG001|Overall Study|Incidence or severity of Adverse events|3|||
125043658|NCT01607892|449780604|FG002|Overall Study|Incidence or severity of Adverse events|7|||
125043659|NCT01607892|449780605|FG003|Overall Study|Incidence or severity of Adverse events|2|||
125043660|NCT01607892|449780606|FG004|Overall Study|Incidence or severity of Adverse events|6|||
125043661|NCT03414359|449780610|FG000|Overall Study|Lack of Efficacy|1|||
125043662|NCT03414359|449780611|FG001|Overall Study|Lack of Efficacy|1|||
125043663|NCT03414359|449780610|FG000|Overall Study|Protocol Violation|0|||
125043664|NCT03414359|449780611|FG001|Overall Study|Protocol Violation|1|||
125043665|NCT02273973|449780612|FG000|Overall Study|Adverse Event|4|||
125043666|NCT02273973|449780613|FG001|Overall Study|Adverse Event|0|||
125043667|NCT02273973|449780612|FG000|Overall Study|Withdrawal by Subject|2|||
125043668|NCT02273973|449780613|FG001|Overall Study|Withdrawal by Subject|3|||
125043669|NCT02273973|449780612|FG000|Overall Study|Death|1|||
125043670|NCT02273973|449780613|FG001|Overall Study|Death|0|||
125043671|NCT02273973|449780612|FG000|Overall Study|Non-compliance|1|||
125043672|NCT02273973|449780613|FG001|Overall Study|Non-compliance|0|||
125043673|NCT02273973|449780612|FG000|Overall Study|Protocol Violation|1|||
125043674|NCT02273973|449780613|FG001|Overall Study|Protocol Violation|0|||
125043675|NCT02273973|449780612|FG000|Overall Study|Progression of disease|0|||
125043676|NCT02273973|449780613|FG001|Overall Study|Progression of disease|2|||
125043677|NCT02273973|449780612|FG000|Overall Study|Lost to Follow-up|0|||
125043678|NCT02273973|449780613|FG001|Overall Study|Lost to Follow-up|1|||
125043679|NCT02273973|449780612|FG000|Overall Study|Physician Decision|0|||
125043680|NCT02273973|449780613|FG001|Overall Study|Physician Decision|1|||
125043681|NCT02273973|449780612|FG000|Overall Study|Reason not specified|0|||
125043682|NCT02273973|449780613|FG001|Overall Study|Reason not specified|1|||
125043683|NCT02403206|449780615|FG000|Overall Study|Lost to Follow-up|4|||
125043684|NCT02403206|449780616|FG001|Overall Study|Lost to Follow-up|3|||
125043685|NCT02403206|449780615|FG000|Overall Study|Physician Decision|2|||
125043686|NCT02403206|449780616|FG001|Overall Study|Physician Decision|0|||
125043687|NCT02403206|449780615|FG000|Overall Study|Withdrawal by Subject|3|||
125043688|NCT02403206|449780616|FG001|Overall Study|Withdrawal by Subject|3|||
125043689|NCT02403206|449780615|FG000|Overall Study|Reason not given|2|||
125043690|NCT02403206|449780616|FG001|Overall Study|Reason not given|4|||
125043691|NCT03750838|449780617|FG000|Overall Study|Lost to Follow-up|10|||
125043692|NCT03750838|449780618|FG001|Overall Study|Lost to Follow-up|6|||
125043693|NCT01769404|449780623|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
125043694|NCT01769404|449780624|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
125043695|NCT01769404|449780623|FG000|Treatment Period 1|Withdrawal by Subject|3|||
125043696|NCT01769404|449780624|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125043697|NCT01769404|449780623|FG000|Treatment Period 1|Sponsor decision|1|||
125043698|NCT01769404|449780624|FG001|Treatment Period 1|Sponsor decision|0|||
125043699|NCT01769404|449780623|FG000|Treatment Period 2|Sponsor decision|7|||
125043700|NCT01769404|449780624|FG001|Treatment Period 2|Sponsor decision|0|||
125043701|NCT00538733|449780625|FG000|Overall Study|Adverse Event|8|||
125043702|NCT00538733|449780625|FG000|Overall Study|Death|1|||
125043703|NCT00538733|449780625|FG000|Overall Study|declined to participate|2|||
125043704|NCT00538733|449780625|FG000|Overall Study|still on therapy|1|||
125043705|NCT00095121|449780630|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
125043706|NCT00095121|449780631|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
125043707|NCT00095121|449780630|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
125043708|NCT00095121|449780631|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
125043709|NCT02209597|449780632|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
125043710|NCT02209597|449780632|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
125043711|NCT02209597|449780632|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
125135512|NCT01695239|450120130|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135513|NCT01695239|450120131|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135514|NCT01695239|450120132|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135515|NCT01695239|450120133|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135516|NCT01695239|450120134|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
125135517|NCT01695239|450120135|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135518|NCT01695239|450120122|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135519|NCT01695239|450120123|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135520|NCT01695239|450120124|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135521|NCT01695239|450120125|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135522|NCT01695239|450120126|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135523|NCT01695239|450120127|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135524|NCT01695239|450120128|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135525|NCT01695239|450120129|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135526|NCT01695239|450120130|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135527|NCT01695239|450120131|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135528|NCT01695239|450120132|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135529|NCT01695239|450120133|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135530|NCT01695239|450120134|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135531|NCT01695239|450120135|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
125135532|NCT03502811|450120137|FG000|Overall Study|Death|157|||
125135533|NCT03502811|450120137|FG000|Overall Study|Withdrawal by Subject|105|||
125135534|NCT03502811|450120137|FG000|Overall Study|Lost to Follow-up|26|||
125135535|NCT03502811|450120137|FG000|Overall Study|No Visits (Missed)|31|||
125135536|NCT01735994|450120138|FG000|Overall Study|Withdrawal by Subject|6|||
125135537|NCT01735994|450120139|FG001|Overall Study|Withdrawal by Subject|4|||
125135538|NCT01735994|450120138|FG000|Overall Study|Injury|2|||
125135539|NCT01735994|450120139|FG001|Overall Study|Injury|0|||
125135540|NCT01735994|450120138|FG000|Overall Study|Kicked off team|5|||
125135541|NCT01735994|450120139|FG001|Overall Study|Kicked off team|0|||
125135542|NCT01735994|450120138|FG000|Overall Study|Lost to Follow-up|50|||
125135543|NCT01735994|450120139|FG001|Overall Study|Lost to Follow-up|62|||
125135544|NCT05239195|450120140|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
125135545|NCT05239195|450120141|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
125135546|NCT03552484|450120144|FG000|Overall Study|Death|6|||
125218867|NCT03538691|450427423|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
125218868|NCT03538691|450427420|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
125043712|NCT02209597|449780632|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
125043713|NCT03567187|449780643|FG000|Overall Study|Lost to Follow-up|18|||
125043714|NCT00907738|449780646|FG000|Overall Study|Adverse Event|2|||
125043715|NCT00907738|449780647|FG001|Overall Study|Adverse Event|0|||
125043716|NCT00907738|449780648|FG002|Overall Study|Adverse Event|1|||
125043717|NCT00907738|449780649|FG003|Overall Study|Adverse Event|0|||
125043718|NCT00907738|449780650|FG004|Overall Study|Adverse Event|0|||
125043719|NCT00907738|449780646|FG000|Overall Study|not specified or withdrew consent|3|||
125043720|NCT00907738|449780647|FG001|Overall Study|not specified or withdrew consent|0|||
125043721|NCT00907738|449780648|FG002|Overall Study|not specified or withdrew consent|0|||
125043722|NCT00907738|449780649|FG003|Overall Study|not specified or withdrew consent|0|||
125043723|NCT00907738|449780650|FG004|Overall Study|not specified or withdrew consent|0|||
125043724|NCT00907738|449780646|FG000|Overall Study|Disease progression|8|||
125043725|NCT00907738|449780647|FG001|Overall Study|Disease progression|1|||
125043726|NCT00907738|449780648|FG002|Overall Study|Disease progression|6|||
125043727|NCT00907738|449780649|FG003|Overall Study|Disease progression|4|||
125043728|NCT00907738|449780650|FG004|Overall Study|Disease progression|2|||
125043729|NCT02032875|449780651|FG000|Treatment Period|Adverse Event|1|||
125043730|NCT02032875|449780652|FG001|Treatment Period|Adverse Event|0|||
125043731|NCT02032875|449780651|FG000|Treatment Period|Liver transplant, No extension needed|0|||
125043732|NCT02032875|449780652|FG001|Treatment Period|Liver transplant, No extension needed|1|||
125043733|NCT02032875|449780651|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
125043734|NCT02032875|449780652|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
125043735|NCT02032875|449780651|FG000|Follow-up Period|Death|0|||
125043736|NCT02032875|449780652|FG001|Follow-up Period|Death|1|||
125043737|NCT02032875|449780651|FG000|Follow-up Period|Virologic Relapse|3|||
125043738|NCT02032875|449780652|FG001|Follow-up Period|Virologic Relapse|10|||
125043739|NCT02089737|449782132|FG000|Overall Study|Survey form not completed|5|||
125043740|NCT02089737|449782132|FG000|Overall Study|Not treated|1|||
125043741|NCT04426630|449782133|FG000|Overall Study|Death|4|||
125043742|NCT04426630|449782133|FG000|Overall Study|Lost to Follow-up|2|||
125043743|NCT00849693|449782140|FG000|Acute Treatment Phase|Adverse Event|12|||
125043744|NCT00849693|449782141|FG001|Acute Treatment Phase|Adverse Event|7|||
125043745|NCT00849693|449782142|FG002|Acute Treatment Phase|Adverse Event|6|||
125043746|NCT00849693|449782143|FG003|Acute Treatment Phase|Adverse Event|4|||
125043747|NCT00849693|449782140|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
125043748|NCT00849693|449782141|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
125043749|NCT00849693|449782142|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
125043750|NCT00849693|449782143|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
125043751|NCT00849693|449782140|FG000|Acute Treatment Phase|Protocol Violation|1|||
125043752|NCT00849693|449782141|FG001|Acute Treatment Phase|Protocol Violation|5|||
125043753|NCT00849693|449782142|FG002|Acute Treatment Phase|Protocol Violation|2|||
125043754|NCT00849693|449782143|FG003|Acute Treatment Phase|Protocol Violation|6|||
125043755|NCT00849693|449782140|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
125043756|NCT00849693|449782141|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
125043757|NCT00849693|449782142|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
125043758|NCT00849693|449782143|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
125043759|NCT00849693|449782140|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
125043760|NCT00849693|449782141|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
125043761|NCT00849693|449782142|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
125043762|NCT00849693|449782143|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
125043763|NCT00849693|449782140|FG000|Acute Treatment Phase|Physician Decision|2|||
125043764|NCT00849693|449782141|FG001|Acute Treatment Phase|Physician Decision|1|||
125043765|NCT00849693|449782142|FG002|Acute Treatment Phase|Physician Decision|2|||
125043766|NCT00849693|449782143|FG003|Acute Treatment Phase|Physician Decision|1|||
125043767|NCT00849693|449782140|FG000|Acute Treatment Phase|Sponsor decision|0|||
125043768|NCT00849693|449782141|FG001|Acute Treatment Phase|Sponsor decision|0|||
125043769|NCT00849693|449782142|FG002|Acute Treatment Phase|Sponsor decision|1|||
125043770|NCT00849693|449782143|FG003|Acute Treatment Phase|Sponsor decision|0|||
125043771|NCT00849693|449782140|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
125043772|NCT00849693|449782141|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
125043773|NCT00849693|449782142|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
125043774|NCT00849693|449782143|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
125043775|NCT00849693|449782140|FG000|Extension Phase|Adverse Event|4|||
125043776|NCT00849693|449782141|FG001|Extension Phase|Adverse Event|6|||
125043777|NCT00849693|449782142|FG002|Extension Phase|Adverse Event|3|||
125043778|NCT00849693|449782143|FG003|Extension Phase|Adverse Event|7|||
125043779|NCT00849693|449782140|FG000|Extension Phase|Lost to Follow-up|7|||
125043780|NCT00849693|449782141|FG001|Extension Phase|Lost to Follow-up|5|||
125043781|NCT00849693|449782142|FG002|Extension Phase|Lost to Follow-up|6|||
125043782|NCT00849693|449782143|FG003|Extension Phase|Lost to Follow-up|6|||
125043783|NCT00849693|449782140|FG000|Extension Phase|Protocol Violation|0|||
125043784|NCT00849693|449782141|FG001|Extension Phase|Protocol Violation|3|||
125043785|NCT00849693|449782142|FG002|Extension Phase|Protocol Violation|2|||
125043786|NCT00849693|449782143|FG003|Extension Phase|Protocol Violation|3|||
125043787|NCT00849693|449782140|FG000|Extension Phase|Withdrawal by Subject|6|||
125043788|NCT00849693|449782141|FG001|Extension Phase|Withdrawal by Subject|9|||
125043789|NCT00849693|449782142|FG002|Extension Phase|Withdrawal by Subject|10|||
125043790|NCT00849693|449782143|FG003|Extension Phase|Withdrawal by Subject|15|||
125043791|NCT00849693|449782140|FG000|Extension Phase|Parent or caregiver decision|9|||
125043792|NCT00849693|449782141|FG001|Extension Phase|Parent or caregiver decision|4|||
125043793|NCT00849693|449782142|FG002|Extension Phase|Parent or caregiver decision|10|||
125043794|NCT00849693|449782143|FG003|Extension Phase|Parent or caregiver decision|5|||
125043795|NCT00849693|449782140|FG000|Extension Phase|Physician Decision|1|||
125043796|NCT00849693|449782141|FG001|Extension Phase|Physician Decision|1|||
125043797|NCT00849693|449782142|FG002|Extension Phase|Physician Decision|2|||
125043798|NCT00849693|449782143|FG003|Extension Phase|Physician Decision|0|||
125043799|NCT00849693|449782140|FG000|Extension Phase|Sponsor decision|1|||
125043800|NCT00849693|449782141|FG001|Extension Phase|Sponsor decision|0|||
125043801|NCT00849693|449782142|FG002|Extension Phase|Sponsor decision|0|||
125043802|NCT00849693|449782143|FG003|Extension Phase|Sponsor decision|1|||
125043803|NCT00849693|449782140|FG000|Extension Phase|Lack of Efficacy|2|||
125043804|NCT00849693|449782141|FG001|Extension Phase|Lack of Efficacy|2|||
125043805|NCT00849693|449782142|FG002|Extension Phase|Lack of Efficacy|2|||
125135547|NCT03552484|450120145|FG001|Overall Study|Death|4|||
125135548|NCT03552484|450120144|FG000|Overall Study|Lost to Follow-up|0|||
125135549|NCT03552484|450120145|FG001|Overall Study|Lost to Follow-up|16|||
125135550|NCT02663349|450120154|FG000|Overall Study|Withdrawal by Subject|6|||
125135551|NCT01204294|450120155|FG000|Overall Study|Adverse Event|2|||
125135552|NCT01204294|450120156|FG001|Overall Study|Adverse Event|6|||
125135553|NCT01204294|450120157|FG002|Overall Study|Adverse Event|0|||
125135554|NCT01204294|450120158|FG003|Overall Study|Adverse Event|7|||
125135555|NCT01204294|450120159|FG004|Overall Study|Adverse Event|1|||
125135556|NCT01204294|450120160|FG005|Overall Study|Adverse Event|4|||
125135557|NCT01204294|450120161|FG006|Overall Study|Adverse Event|0|||
125135558|NCT01204294|450120155|FG000|Overall Study|Protocol Violation|1|||
125135559|NCT01204294|450120156|FG001|Overall Study|Protocol Violation|0|||
125135560|NCT01204294|450120157|FG002|Overall Study|Protocol Violation|2|||
125135561|NCT01204294|450120158|FG003|Overall Study|Protocol Violation|1|||
125135562|NCT01204294|450120159|FG004|Overall Study|Protocol Violation|0|||
125135563|NCT01204294|450120160|FG005|Overall Study|Protocol Violation|0|||
125135564|NCT01204294|450120161|FG006|Overall Study|Protocol Violation|0|||
125135565|NCT01204294|450120155|FG000|Overall Study|Withdrawal by Subject|0|||
125135566|NCT01204294|450120156|FG001|Overall Study|Withdrawal by Subject|2|||
125135567|NCT01204294|450120157|FG002|Overall Study|Withdrawal by Subject|2|||
125135568|NCT01204294|450120158|FG003|Overall Study|Withdrawal by Subject|1|||
125135569|NCT01204294|450120159|FG004|Overall Study|Withdrawal by Subject|1|||
125135570|NCT01204294|450120160|FG005|Overall Study|Withdrawal by Subject|1|||
125135571|NCT01204294|450120161|FG006|Overall Study|Withdrawal by Subject|2|||
125135572|NCT01204294|450120155|FG000|Overall Study|Lack of Efficacy|0|||
125135573|NCT01204294|450120156|FG001|Overall Study|Lack of Efficacy|0|||
125135574|NCT01204294|450120157|FG002|Overall Study|Lack of Efficacy|0|||
125135575|NCT01204294|450120158|FG003|Overall Study|Lack of Efficacy|2|||
125135576|NCT01204294|450120159|FG004|Overall Study|Lack of Efficacy|0|||
125135577|NCT01204294|450120160|FG005|Overall Study|Lack of Efficacy|0|||
125135578|NCT01204294|450120161|FG006|Overall Study|Lack of Efficacy|0|||
125135579|NCT01204294|450120155|FG000|Overall Study|Other (house moving)|0|||
125135580|NCT01204294|450120156|FG001|Overall Study|Other (house moving)|0|||
125135581|NCT01204294|450120157|FG002|Overall Study|Other (house moving)|1|||
125135582|NCT01204294|450120158|FG003|Overall Study|Other (house moving)|0|||
125135583|NCT01204294|450120159|FG004|Overall Study|Other (house moving)|0|||
125135584|NCT01204294|450120160|FG005|Overall Study|Other (house moving)|0|||
125135585|NCT01204294|450120161|FG006|Overall Study|Other (house moving)|0|||
125135586|NCT03128723|450120164|FG000|Overall Study|Withdrawal by Subject|2|||
125135587|NCT00673660|450120165|FG000|Overall Study|Lost to Follow-up|107|||
125135588|NCT01383486|450120166|FG000|Overall Study|Lost to Follow-up|10|||
125135589|NCT01383486|450120166|FG000|Overall Study|Incomplete information for analysis|2|||
125135590|NCT01383486|450120166|FG000|Overall Study|Did not take any product|6|||
125135591|NCT01929863|450120176|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
125135592|NCT01929863|450120177|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
125135593|NCT01929863|450120176|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
125135594|NCT01929863|450120177|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
125135595|NCT01929863|450120176|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
125135596|NCT01929863|450120177|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
125135597|NCT00323882|450120178|FG000|Overall Study|Adverse Event|2|||
125135598|NCT00323882|450120179|FG001|Overall Study|Adverse Event|1|||
125135599|NCT00323882|450120180|FG002|Overall Study|Adverse Event|1|||
125135600|NCT00323882|450120181|FG003|Overall Study|Adverse Event|1|||
125135601|NCT00323882|450120182|FG004|Overall Study|Adverse Event|3|||
125135602|NCT00323882|450120178|FG000|Overall Study|Disease Progression|6|||
125135603|NCT00323882|450120179|FG001|Overall Study|Disease Progression|4|||
125043806|NCT00849693|449782143|FG003|Extension Phase|Lack of Efficacy|1|||
125043807|NCT01062399|449782144|FG000|Overall Study|Protocol Violation|0|||
125043808|NCT01062399|449782145|FG001|Overall Study|Protocol Violation|1|||
125043809|NCT01062399|449782146|FG002|Overall Study|Protocol Violation|0|||
125135604|NCT00323882|450120180|FG002|Overall Study|Disease Progression|10|||
125135605|NCT00323882|450120181|FG003|Overall Study|Disease Progression|5|||
125135606|NCT00323882|450120182|FG004|Overall Study|Disease Progression|22|||
125135607|NCT00323882|450120178|FG000|Overall Study|Death|0|||
125135608|NCT00323882|450120179|FG001|Overall Study|Death|1|||
125135609|NCT00323882|450120180|FG002|Overall Study|Death|1|||
125135610|NCT00323882|450120181|FG003|Overall Study|Death|0|||
125135611|NCT00323882|450120182|FG004|Overall Study|Death|5|||
125135612|NCT00323882|450120178|FG000|Overall Study|Lost to Follow-up|0|||
125135613|NCT00323882|450120179|FG001|Overall Study|Lost to Follow-up|0|||
125135614|NCT00323882|450120180|FG002|Overall Study|Lost to Follow-up|1|||
125135615|NCT00323882|450120181|FG003|Overall Study|Lost to Follow-up|0|||
125135616|NCT00323882|450120182|FG004|Overall Study|Lost to Follow-up|1|||
125135617|NCT00323882|450120178|FG000|Overall Study|Other|0|||
125135618|NCT00323882|450120179|FG001|Overall Study|Other|0|||
125135619|NCT00323882|450120180|FG002|Overall Study|Other|0|||
125135620|NCT00323882|450120181|FG003|Overall Study|Other|1|||
125043810|NCT01062399|449782147|FG003|Overall Study|Protocol Violation|6|||
125043811|NCT01062399|449782148|FG004|Overall Study|Protocol Violation|4|||
125043812|NCT01260181|449782156|FG000|Overall Study|Decision of Investigator|1|||
125043813|NCT00984659|449782159|FG000|2-week Run-in Period|Adverse Event|8|||
125043814|NCT00984659|449782160|FG001|2-week Run-in Period|Adverse Event|0|||
125043815|NCT00984659|449782161|FG002|2-week Run-in Period|Adverse Event|0|||
125043816|NCT00984659|449782162|FG003|2-week Run-in Period|Adverse Event|0|||
125043817|NCT00984659|449782159|FG000|2-week Run-in Period|Protocol Violation|5|||
125043818|NCT00984659|449782160|FG001|2-week Run-in Period|Protocol Violation|0|||
125043819|NCT00984659|449782161|FG002|2-week Run-in Period|Protocol Violation|0|||
125043820|NCT00984659|449782162|FG003|2-week Run-in Period|Protocol Violation|0|||
125043821|NCT00984659|449782159|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
125043822|NCT00984659|449782160|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
125043823|NCT00984659|449782161|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
125043824|NCT00984659|449782162|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
125043825|NCT00984659|449782159|FG000|2-week Run-in Period|Lost to Follow-up|3|||
125043826|NCT00984659|449782160|FG001|2-week Run-in Period|Lost to Follow-up|0|||
125043827|NCT00984659|449782161|FG002|2-week Run-in Period|Lost to Follow-up|0|||
125043828|NCT00984659|449782162|FG003|2-week Run-in Period|Lost to Follow-up|0|||
125043829|NCT00984659|449782159|FG000|2-week Run-in Period|Physician Decision|10|||
125043830|NCT00984659|449782160|FG001|2-week Run-in Period|Physician Decision|0|||
125043831|NCT00984659|449782161|FG002|2-week Run-in Period|Physician Decision|0|||
125043832|NCT00984659|449782162|FG003|2-week Run-in Period|Physician Decision|0|||
125043833|NCT00984659|449782159|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
125043834|NCT00984659|449782160|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
125043835|NCT00984659|449782161|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
125043836|NCT00984659|449782162|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
125043837|NCT00984659|449782159|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
125043838|NCT00984659|449782160|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
125043839|NCT00984659|449782161|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
125043840|NCT00984659|449782162|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
125043841|NCT00984659|449782159|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
125043842|NCT00984659|449782160|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
125043843|NCT00984659|449782161|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
125043844|NCT00984659|449782162|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
125043845|NCT00984659|449782159|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
125043846|NCT00984659|449782160|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
125043847|NCT00984659|449782161|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
125043848|NCT00984659|449782162|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
125043849|NCT00984659|449782159|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
125043850|NCT00984659|449782160|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
125043851|NCT00984659|449782161|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
125043852|NCT00984659|449782162|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
125043853|NCT00984659|449782159|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
125043854|NCT00984659|449782160|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
125043855|NCT00984659|449782161|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
125043856|NCT00984659|449782162|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
125043857|NCT00984659|449782159|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
125043858|NCT00984659|449782160|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
125043859|NCT00984659|449782161|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
125135621|NCT00323882|450120182|FG004|Overall Study|Other|1|||
125135622|NCT00830024|450120184|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
125135623|NCT00830024|450120185|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
125043860|NCT00984659|449782162|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
125043861|NCT00635102|449782165|FG000|Overall Study|Withdrawal by Subject|7|||
125043862|NCT00635102|449782166|FG001|Overall Study|Withdrawal by Subject|8|||
125043863|NCT01938625|449782167|FG000|Overall Study|Withdrawal by Subject|0|||
125135624|NCT01456221|450120186|FG000|Overall Study|Withdrawal by Subject|56|||
125135625|NCT01456221|450120187|FG001|Overall Study|Withdrawal by Subject|49|||
125135626|NCT01456221|450120186|FG000|Overall Study|Lost to Follow-up|1|||
125043864|NCT01938625|449782168|FG001|Overall Study|Withdrawal by Subject|1|||
125043865|NCT01938625|449782167|FG000|Overall Study|Adverse Event|0|||
125043866|NCT01938625|449782168|FG001|Overall Study|Adverse Event|1|||
125043867|NCT02088034|449782169|FG000|Overall Study|Lost to Follow-up|1|||
125043868|NCT02088034|449782170|FG001|Overall Study|Lost to Follow-up|1|||
125043869|NCT02088034|449782171|FG002|Overall Study|Lost to Follow-up|0|||
125043870|NCT02088034|449782169|FG000|Overall Study|Pregnancy|2|||
125043871|NCT02088034|449782170|FG001|Overall Study|Pregnancy|1|||
125043872|NCT02088034|449782171|FG002|Overall Study|Pregnancy|2|||
125043873|NCT00308620|449782172|FG000|Overall Study|Death|1|||
125043874|NCT00308620|449782173|FG001|Overall Study|Death|1|||
125043875|NCT00308620|449782174|FG002|Overall Study|Death|0|||
125043876|NCT00308620|449782172|FG000|Overall Study|Lost to Follow-up|0|||
125043877|NCT00308620|449782173|FG001|Overall Study|Lost to Follow-up|0|||
125043878|NCT00308620|449782174|FG002|Overall Study|Lost to Follow-up|1|||
125043879|NCT00546351|449782177|FG000|Overall Study|Adverse Event|76|||
125043880|NCT00546351|449782177|FG000|Overall Study|Lack of Efficacy|15|||
125043881|NCT00546351|449782177|FG000|Overall Study|Withdrawal by Subject|109|||
125043882|NCT00546351|449782177|FG000|Overall Study|Lost to Follow-up|9|||
125043883|NCT00546351|449782177|FG000|Overall Study|Protocol Deviation|1|||
125043884|NCT00546351|449782177|FG000|Overall Study|Unsatisfactory compliance|9|||
125043885|NCT00546351|449782177|FG000|Overall Study|Other reasons for premature termination|17|||
125043886|NCT02424149|449782178|FG000|Overall Study|surgery cancelled|2|||
125135627|NCT01456221|450120187|FG001|Overall Study|Lost to Follow-up|4|||
125135628|NCT01456221|450120186|FG000|Overall Study|Received medication|3|||
125043887|NCT02424149|449782179|FG001|Overall Study|surgery cancelled|0|||
125043888|NCT02424149|449782178|FG000|Overall Study|Withdrawal by Subject|0|||
125043889|NCT02424149|449782179|FG001|Overall Study|Withdrawal by Subject|1|||
125043890|NCT01025336|449782180|FG000|Overall Study|Protocol Violation|0|||
125043891|NCT01025336|449782181|FG001|Overall Study|Protocol Violation|0|||
125043892|NCT01025336|449782182|FG002|Overall Study|Protocol Violation|0|||
125043893|NCT01025336|449782183|FG003|Overall Study|Protocol Violation|2|||
125043894|NCT01025336|449782184|FG004|Overall Study|Protocol Violation|0|||
125043895|NCT00592683|449782187|FG000|Overall Study|Found ineligible|0|||
125043896|NCT00592683|449782188|FG001|Overall Study|Found ineligible|1|||
125043897|NCT00592683|449782187|FG000|Overall Study|Withdrawal by Subject|1|||
125043898|NCT00592683|449782188|FG001|Overall Study|Withdrawal by Subject|0|||
125043899|NCT00592683|449782187|FG000|Overall Study|Adverse Event|0|||
125043900|NCT00592683|449782188|FG001|Overall Study|Adverse Event|2|||
125043901|NCT00592683|449782187|FG000|Overall Study|Protocol Violation|1|||
125043902|NCT00592683|449782188|FG001|Overall Study|Protocol Violation|0|||
125043903|NCT00592683|449782187|FG000|Overall Study|Study drug expired|1|||
125135629|NCT01456221|450120187|FG001|Overall Study|Received medication|2|||
125135630|NCT01456221|450120186|FG000|Overall Study|Incomplete data|4|||
125135631|NCT01456221|450120187|FG001|Overall Study|Incomplete data|2|||
125135632|NCT00436163|450120188|FG000|Overall Study|Lost to Follow-up|2|||
125043904|NCT00592683|449782188|FG001|Overall Study|Study drug expired|0|||
125043905|NCT00592683|449782187|FG000|Overall Study|Other|1|||
125043906|NCT00592683|449782188|FG001|Overall Study|Other|0|||
125043907|NCT00592683|449782187|FG000|Overall Study|Lost to Follow-up|0|||
125043908|NCT00592683|449782188|FG001|Overall Study|Lost to Follow-up|1|||
125043909|NCT00545818|449782191|FG000|Overall Study|Protocol Violation|1|||
125043910|NCT00545818|449782192|FG001|Overall Study|Protocol Violation|0|||
125043911|NCT00545818|449782191|FG000|Overall Study|Adverse Event|1|||
125043912|NCT00545818|449782192|FG001|Overall Study|Adverse Event|1|||
125043913|NCT00545818|449782191|FG000|Overall Study|Lost to Follow-up|1|||
125043914|NCT00545818|449782192|FG001|Overall Study|Lost to Follow-up|6|||
125043915|NCT02723630|449782193|FG000|Intervention Period 1|Adverse Event|1|||
125043916|NCT02723630|449782194|FG001|Intervention Period 1|Adverse Event|0|||
125043917|NCT02723630|449782195|FG002|Intervention Period 1|Adverse Event|0|||
125043918|NCT02723630|449782196|FG003|Intervention Period 1|Adverse Event|0|||
125043919|NCT02723630|449782197|FG004|Intervention Period 1|Adverse Event|0|||
125043920|NCT02723630|449782198|FG005|Intervention Period 1|Adverse Event|0|||
125043921|NCT02723630|449782193|FG000|Intervention Period 3|consumption of restricted item|0|||
125043922|NCT02723630|449782194|FG001|Intervention Period 3|consumption of restricted item|1|||
125043923|NCT02723630|449782195|FG002|Intervention Period 3|consumption of restricted item|0|||
125043924|NCT02723630|449782196|FG003|Intervention Period 3|consumption of restricted item|0|||
125043925|NCT02723630|449782197|FG004|Intervention Period 3|consumption of restricted item|0|||
125043926|NCT02723630|449782198|FG005|Intervention Period 3|consumption of restricted item|0|||
125043927|NCT00479466|449782201|FG000|Overall Study|Adverse Event|5|||
125043928|NCT00479466|449782202|FG001|Overall Study|Adverse Event|1|||
125043929|NCT00479466|449782203|FG002|Overall Study|Adverse Event|0|||
125043930|NCT00479466|449782204|FG003|Overall Study|Adverse Event|1|||
125135633|NCT00436163|450120188|FG000|Overall Study|Adverse Event|1|||
125043931|NCT00479466|449782205|FG004|Overall Study|Adverse Event|2|||
125043932|NCT00479466|449782206|FG005|Overall Study|Adverse Event|0|||
125135634|NCT06647173|450120191|FG000|Overall Study|Lost to Follow-up|24|||
125043933|NCT00479466|449782201|FG000|Overall Study|Hyperglycemia|0|||
125043934|NCT00479466|449782202|FG001|Overall Study|Hyperglycemia|0|||
125043935|NCT00479466|449782203|FG002|Overall Study|Hyperglycemia|0|||
125043936|NCT00479466|449782204|FG003|Overall Study|Hyperglycemia|0|||
125043937|NCT00479466|449782205|FG004|Overall Study|Hyperglycemia|0|||
125043938|NCT00479466|449782206|FG005|Overall Study|Hyperglycemia|1|||
125043939|NCT00479466|449782201|FG000|Overall Study|Lack of Efficacy|2|||
125043940|NCT00479466|449782202|FG001|Overall Study|Lack of Efficacy|0|||
125043941|NCT00479466|449782203|FG002|Overall Study|Lack of Efficacy|1|||
125218869|NCT03538691|450427421|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
125043942|NCT00479466|449782204|FG003|Overall Study|Lack of Efficacy|0|||
125043943|NCT00479466|449782205|FG004|Overall Study|Lack of Efficacy|0|||
125043944|NCT00479466|449782206|FG005|Overall Study|Lack of Efficacy|0|||
125043945|NCT00479466|449782201|FG000|Overall Study|Lost to Follow-up|0|||
125043946|NCT00479466|449782202|FG001|Overall Study|Lost to Follow-up|1|||
125043947|NCT00479466|449782203|FG002|Overall Study|Lost to Follow-up|1|||
125043948|NCT00479466|449782204|FG003|Overall Study|Lost to Follow-up|0|||
125043949|NCT00479466|449782205|FG004|Overall Study|Lost to Follow-up|2|||
125043950|NCT00479466|449782206|FG005|Overall Study|Lost to Follow-up|2|||
125043951|NCT00479466|449782201|FG000|Overall Study|Physician Decision|2|||
125043952|NCT00479466|449782202|FG001|Overall Study|Physician Decision|1|||
125043953|NCT00479466|449782203|FG002|Overall Study|Physician Decision|1|||
125043954|NCT00479466|449782204|FG003|Overall Study|Physician Decision|0|||
125043955|NCT00479466|449782205|FG004|Overall Study|Physician Decision|0|||
125043956|NCT00479466|449782206|FG005|Overall Study|Physician Decision|0|||
125043957|NCT00479466|449782201|FG000|Overall Study|Pregnancy|0|||
125043958|NCT00479466|449782202|FG001|Overall Study|Pregnancy|0|||
125043959|NCT00479466|449782203|FG002|Overall Study|Pregnancy|0|||
125043960|NCT00479466|449782204|FG003|Overall Study|Pregnancy|0|||
125043961|NCT00479466|449782205|FG004|Overall Study|Pregnancy|1|||
125043962|NCT00479466|449782206|FG005|Overall Study|Pregnancy|0|||
125043963|NCT00479466|449782201|FG000|Overall Study|Protocol Violation|1|||
125043964|NCT00479466|449782202|FG001|Overall Study|Protocol Violation|0|||
125043965|NCT00479466|449782203|FG002|Overall Study|Protocol Violation|0|||
125043966|NCT00479466|449782204|FG003|Overall Study|Protocol Violation|0|||
125043967|NCT00479466|449782205|FG004|Overall Study|Protocol Violation|0|||
125043968|NCT00479466|449782206|FG005|Overall Study|Protocol Violation|0|||
125043969|NCT00479466|449782201|FG000|Overall Study|Withdrawal by Subject|3|||
125043970|NCT00479466|449782202|FG001|Overall Study|Withdrawal by Subject|5|||
125043971|NCT00479466|449782203|FG002|Overall Study|Withdrawal by Subject|0|||
125043972|NCT00479466|449782204|FG003|Overall Study|Withdrawal by Subject|2|||
125043973|NCT00479466|449782205|FG004|Overall Study|Withdrawal by Subject|3|||
125043974|NCT00479466|449782206|FG005|Overall Study|Withdrawal by Subject|1|||
125043975|NCT01325493|449782207|FG000|Overall Study|Protocol Violation|0|||
125043976|NCT01325493|449782208|FG001|Overall Study|Protocol Violation|1|||
125043977|NCT01325493|449782207|FG000|Overall Study|loss of neuromonitoring signals|0|||
125043978|NCT01325493|449782208|FG001|Overall Study|loss of neuromonitoring signals|2|||
125043979|NCT01325493|449782207|FG000|Overall Study|Allergy|1|||
125043980|NCT01325493|449782208|FG001|Overall Study|Allergy|0|||
125043981|NCT05372315|449782211|FG000|Overall Study|Withdrawal by Subject|1|||
125043982|NCT05372315|449782212|FG001|Overall Study|Withdrawal by Subject|0|||
125043983|NCT01184989|449782213|FG000|Overall Study|Adverse Event|11|||
125043984|NCT01184989|449782213|FG000|Overall Study|Withdrawal by Subject|1|||
125043985|NCT01570491|449782214|FG000|Overall Study|Lost to Follow-up|3|||
125043986|NCT01570491|449782215|FG001|Overall Study|Lost to Follow-up|1|||
125043987|NCT01570491|449782214|FG000|Overall Study|treatment: not given or discontinued|2|||
125043988|NCT01570491|449782215|FG001|Overall Study|treatment: not given or discontinued|0|||
125043989|NCT03047213|449782216|FG000|Overall Study|Withdrawal by Subject|2|||
125043990|NCT03047213|449782217|FG001|Overall Study|Withdrawal by Subject|0|||
125043991|NCT03047213|449782216|FG000|Overall Study|Adverse Event|2|||
125043992|NCT03047213|449782217|FG001|Overall Study|Adverse Event|0|||
125043993|NCT00650585|449782223|FG000|Overall Study|Lost to Follow-up|505|||
125043994|NCT00650585|449782224|FG001|Overall Study|Lost to Follow-up|482|||
125043995|NCT00650585|449782223|FG000|Overall Study|No parental consent|935|||
125043996|NCT00650585|449782224|FG001|Overall Study|No parental consent|866|||
125043997|NCT00650585|449782223|FG000|Overall Study|Excluded/ruled ineligible|357|||
125043998|NCT00650585|449782224|FG001|Overall Study|Excluded/ruled ineligible|129|||
125043999|NCT04407507|449782225|FG000|Overall Study|Withdrawal by Subject|0|||
125044000|NCT04407507|449782226|FG001|Overall Study|Withdrawal by Subject|1|||
125044001|NCT00923091|449782227|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
125044002|NCT00923091|449782228|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
125044003|NCT00923091|449782229|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
125044004|NCT00923091|449782230|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
125044005|NCT00923091|449782231|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
125044006|NCT00923091|449782232|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
125044007|NCT00923091|449782233|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
125044008|NCT00923091|449782234|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
125044009|NCT00923091|449782235|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
125044010|NCT00923091|449782236|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
125044011|NCT00923091|449782237|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
125044012|NCT00923091|449782238|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
125044013|NCT00923091|449782239|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
125044014|NCT00923091|449782227|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
125044015|NCT00923091|449782228|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
125044016|NCT00923091|449782229|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
125044017|NCT00923091|449782230|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
125044018|NCT00923091|449782231|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
125044019|NCT00923091|449782232|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
125044020|NCT00923091|449782233|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
125044021|NCT00923091|449782234|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
125044022|NCT00923091|449782235|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
125044023|NCT00923091|449782236|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
125044024|NCT00923091|449782237|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
125044025|NCT00923091|449782238|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
125044026|NCT00923091|449782239|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
125044027|NCT00923091|449782227|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
125044028|NCT00923091|449782228|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
125044029|NCT00923091|449782229|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
125044030|NCT00923091|449782230|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
125044031|NCT00923091|449782231|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
125044032|NCT00923091|449782232|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
125044033|NCT00923091|449782233|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
125044034|NCT00923091|449782234|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
125044035|NCT00923091|449782235|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
125044036|NCT00923091|449782236|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
125044037|NCT00923091|449782237|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
125044038|NCT00923091|449782238|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
125044039|NCT00923091|449782239|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
125044040|NCT00923091|449782227|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125044041|NCT00923091|449782228|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125044042|NCT00923091|449782229|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125044043|NCT00923091|449782230|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125044044|NCT00923091|449782231|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125044045|NCT00923091|449782232|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
125044046|NCT00923091|449782233|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125044047|NCT00923091|449782234|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125044048|NCT00923091|449782235|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125044049|NCT00923091|449782236|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125044050|NCT00923091|449782237|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125044051|NCT00923091|449782238|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125044052|NCT00923091|449782239|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125044053|NCT00923091|449782227|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
125044054|NCT00923091|449782228|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
125044055|NCT00923091|449782229|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
125044056|NCT00923091|449782230|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
125044057|NCT00923091|449782231|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
125044058|NCT00923091|449782232|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
125044059|NCT00923091|449782233|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
125044060|NCT00923091|449782234|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
125044061|NCT00923091|449782235|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
125044062|NCT00923091|449782236|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
125044063|NCT00923091|449782237|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
125044064|NCT00923091|449782238|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
125044065|NCT00923091|449782239|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
125044066|NCT00923091|449782227|FG000|Period III (Single-Blind)|Adverse Event|5|||
125044067|NCT00923091|449782228|FG001|Period III (Single-Blind)|Adverse Event|0|||
125044068|NCT00923091|449782229|FG002|Period III (Single-Blind)|Adverse Event|0|||
125044069|NCT00923091|449782230|FG003|Period III (Single-Blind)|Adverse Event|0|||
125044070|NCT00923091|449782231|FG004|Period III (Single-Blind)|Adverse Event|0|||
125044071|NCT00923091|449782232|FG005|Period III (Single-Blind)|Adverse Event|0|||
125044072|NCT00923091|449782233|FG006|Period III (Single-Blind)|Adverse Event|0|||
125044073|NCT00923091|449782234|FG007|Period III (Single-Blind)|Adverse Event|0|||
125044074|NCT00923091|449782235|FG008|Period III (Single-Blind)|Adverse Event|0|||
125044075|NCT00923091|449782236|FG009|Period III (Single-Blind)|Adverse Event|0|||
125044076|NCT00923091|449782237|FG010|Period III (Single-Blind)|Adverse Event|0|||
125044077|NCT00923091|449782238|FG011|Period III (Single-Blind)|Adverse Event|0|||
125044078|NCT00923091|449782239|FG012|Period III (Single-Blind)|Adverse Event|0|||
125044079|NCT00923091|449782227|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
125044080|NCT00923091|449782228|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
125044081|NCT00923091|449782229|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
125044082|NCT00923091|449782230|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
125044083|NCT00923091|449782231|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
125044084|NCT00923091|449782232|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
125044085|NCT00923091|449782233|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
125044086|NCT00923091|449782234|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
125044087|NCT00923091|449782235|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
125044088|NCT00923091|449782236|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
125044089|NCT00923091|449782237|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
125044090|NCT00923091|449782238|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
125044091|NCT00923091|449782239|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
125044092|NCT00923091|449782227|FG000|Period III (Single-Blind)|Protocol Violation|3|||
125044093|NCT00923091|449782228|FG001|Period III (Single-Blind)|Protocol Violation|0|||
125044094|NCT00923091|449782229|FG002|Period III (Single-Blind)|Protocol Violation|0|||
125044095|NCT00923091|449782230|FG003|Period III (Single-Blind)|Protocol Violation|0|||
125044096|NCT00923091|449782231|FG004|Period III (Single-Blind)|Protocol Violation|0|||
125044097|NCT00923091|449782232|FG005|Period III (Single-Blind)|Protocol Violation|0|||
125044098|NCT00923091|449782233|FG006|Period III (Single-Blind)|Protocol Violation|0|||
125044099|NCT00923091|449782234|FG007|Period III (Single-Blind)|Protocol Violation|0|||
125044100|NCT00923091|449782235|FG008|Period III (Single-Blind)|Protocol Violation|0|||
125044101|NCT00923091|449782236|FG009|Period III (Single-Blind)|Protocol Violation|0|||
125044102|NCT00923091|449782237|FG010|Period III (Single-Blind)|Protocol Violation|0|||
125044103|NCT00923091|449782238|FG011|Period III (Single-Blind)|Protocol Violation|0|||
125044104|NCT00923091|449782239|FG012|Period III (Single-Blind)|Protocol Violation|0|||
125044105|NCT00923091|449782227|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
125044106|NCT00923091|449782228|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
125044107|NCT00923091|449782229|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
125044108|NCT00923091|449782230|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
125044109|NCT00923091|449782231|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
125044110|NCT00923091|449782232|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
125044111|NCT00923091|449782233|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
125044112|NCT00923091|449782234|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
125044113|NCT00923091|449782235|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
125044114|NCT00923091|449782236|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
125044115|NCT00923091|449782237|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
125044116|NCT00923091|449782238|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
125044117|NCT00923091|449782239|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
125044118|NCT00923091|449782227|FG000|Period IV (Double-Blind)|Adverse Event|2|||
125044119|NCT00923091|449782228|FG001|Period IV (Double-Blind)|Adverse Event|0|||
125044120|NCT00923091|449782229|FG002|Period IV (Double-Blind)|Adverse Event|0|||
125044121|NCT00923091|449782230|FG003|Period IV (Double-Blind)|Adverse Event|0|||
125044122|NCT00923091|449782231|FG004|Period IV (Double-Blind)|Adverse Event|0|||
125044123|NCT00923091|449782232|FG005|Period IV (Double-Blind)|Adverse Event|0|||
125044124|NCT00923091|449782233|FG006|Period IV (Double-Blind)|Adverse Event|0|||
125044125|NCT00923091|449782234|FG007|Period IV (Double-Blind)|Adverse Event|0|||
125044126|NCT00923091|449782235|FG008|Period IV (Double-Blind)|Adverse Event|0|||
125218870|NCT03538691|450427422|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
125218871|NCT03538691|450427423|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
125218872|NCT03538691|450427420|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
125218873|NCT03538691|450427421|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
125218874|NCT03538691|450427422|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
125218875|NCT03538691|450427423|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
125218876|NCT03538691|450427420|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
125044127|NCT00923091|449782236|FG009|Period IV (Double-Blind)|Adverse Event|0|||
125044128|NCT00923091|449782237|FG010|Period IV (Double-Blind)|Adverse Event|0|||
125044129|NCT00923091|449782238|FG011|Period IV (Double-Blind)|Adverse Event|0|||
125044130|NCT00923091|449782239|FG012|Period IV (Double-Blind)|Adverse Event|0|||
125044131|NCT00923091|449782227|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125044132|NCT00923091|449782228|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
125044133|NCT00923091|449782229|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125044134|NCT00923091|449782230|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125044135|NCT00923091|449782231|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125044136|NCT00923091|449782232|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125044137|NCT00923091|449782233|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125044138|NCT00923091|449782234|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125044139|NCT00923091|449782235|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125044140|NCT00923091|449782236|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125044141|NCT00923091|449782237|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125044142|NCT00923091|449782238|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125044143|NCT00923091|449782239|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125218877|NCT03538691|450427421|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
125218878|NCT03538691|450427422|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
125218879|NCT03538691|450427423|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
125218880|NCT03538691|450427420|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
125218881|NCT03538691|450427421|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
125218882|NCT03538691|450427422|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
125218883|NCT03538691|450427423|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
125218884|NCT03538691|450427420|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
125218885|NCT03538691|450427421|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
125044144|NCT00923091|449782227|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
125044145|NCT00923091|449782228|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
125218886|NCT03538691|450427422|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
125218887|NCT03538691|450427423|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
125218888|NCT03538691|450427420|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
125044146|NCT00923091|449782229|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
125044147|NCT00923091|449782230|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
125044148|NCT00923091|449782231|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
125044149|NCT00923091|449782232|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
125044150|NCT00923091|449782233|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
125044151|NCT00923091|449782234|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
125044152|NCT00923091|449782235|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
125044153|NCT00923091|449782236|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
125044154|NCT00923091|449782237|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
125044155|NCT00923091|449782238|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
125044156|NCT00923091|449782239|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
125044157|NCT00923091|449782227|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
125044158|NCT00923091|449782228|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
125044159|NCT00923091|449782229|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
125044160|NCT00923091|449782230|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
125044161|NCT00923091|449782231|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
125044162|NCT00923091|449782232|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
125044163|NCT00923091|449782233|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
125044164|NCT00923091|449782234|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
125044165|NCT00923091|449782235|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
125044166|NCT00923091|449782236|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
125044167|NCT00923091|449782237|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
125044168|NCT00923091|449782238|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
125044169|NCT00923091|449782239|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
125044170|NCT00923091|449782227|FG000|Period V (Double -Blind)|Protocol Violation|0|||
125044171|NCT00923091|449782228|FG001|Period V (Double -Blind)|Protocol Violation|0|||
125044172|NCT00923091|449782229|FG002|Period V (Double -Blind)|Protocol Violation|0|||
125044173|NCT00923091|449782230|FG003|Period V (Double -Blind)|Protocol Violation|0|||
125044174|NCT00923091|449782231|FG004|Period V (Double -Blind)|Protocol Violation|0|||
125044175|NCT00923091|449782232|FG005|Period V (Double -Blind)|Protocol Violation|0|||
125044176|NCT00923091|449782233|FG006|Period V (Double -Blind)|Protocol Violation|0|||
125044177|NCT00923091|449782234|FG007|Period V (Double -Blind)|Protocol Violation|0|||
125044178|NCT00923091|449782235|FG008|Period V (Double -Blind)|Protocol Violation|0|||
125044179|NCT00923091|449782236|FG009|Period V (Double -Blind)|Protocol Violation|0|||
125044180|NCT00923091|449782237|FG010|Period V (Double -Blind)|Protocol Violation|0|||
125044181|NCT00923091|449782238|FG011|Period V (Double -Blind)|Protocol Violation|0|||
125044182|NCT00923091|449782239|FG012|Period V (Double -Blind)|Protocol Violation|1|||
125044183|NCT00923091|449782227|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
125044184|NCT00923091|449782228|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
125044185|NCT00923091|449782229|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
125044186|NCT00923091|449782230|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
125044187|NCT00923091|449782231|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
125044188|NCT00923091|449782232|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
125044189|NCT00923091|449782233|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
125044190|NCT00923091|449782234|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
125044191|NCT00923091|449782235|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
125044192|NCT00923091|449782236|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
125044193|NCT00923091|449782237|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
125044194|NCT00923091|449782238|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
125044195|NCT00923091|449782239|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
125044196|NCT00923091|449782227|FG000|Period VI (Open-Label)|Adverse Event|17|||
125044197|NCT00923091|449782228|FG001|Period VI (Open-Label)|Adverse Event|0|||
125044198|NCT00923091|449782229|FG002|Period VI (Open-Label)|Adverse Event|4|||
125044199|NCT00923091|449782230|FG003|Period VI (Open-Label)|Adverse Event|1|||
125044200|NCT00923091|449782231|FG004|Period VI (Open-Label)|Adverse Event|1|||
125044201|NCT00923091|449782232|FG005|Period VI (Open-Label)|Adverse Event|0|||
125044202|NCT00923091|449782233|FG006|Period VI (Open-Label)|Adverse Event|0|||
125044203|NCT00923091|449782234|FG007|Period VI (Open-Label)|Adverse Event|0|||
125044204|NCT00923091|449782235|FG008|Period VI (Open-Label)|Adverse Event|0|||
125044205|NCT00923091|449782236|FG009|Period VI (Open-Label)|Adverse Event|0|||
125044206|NCT00923091|449782237|FG010|Period VI (Open-Label)|Adverse Event|0|||
125044207|NCT00923091|449782238|FG011|Period VI (Open-Label)|Adverse Event|0|||
125044208|NCT00923091|449782239|FG012|Period VI (Open-Label)|Adverse Event|0|||
125044209|NCT00923091|449782227|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
125044210|NCT00923091|449782228|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
125044211|NCT00923091|449782229|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
125044212|NCT00923091|449782230|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
125044213|NCT00923091|449782231|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
125044214|NCT00923091|449782232|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
125044215|NCT00923091|449782233|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
125044216|NCT00923091|449782234|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
125044217|NCT00923091|449782235|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
125044218|NCT00923091|449782236|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
125044219|NCT00923091|449782237|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
125044220|NCT00923091|449782238|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
125044221|NCT00923091|449782239|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
125044222|NCT00923091|449782227|FG000|Period VI (Open-Label)|Protocol Violation|6|||
125044223|NCT00923091|449782228|FG001|Period VI (Open-Label)|Protocol Violation|1|||
125044224|NCT00923091|449782229|FG002|Period VI (Open-Label)|Protocol Violation|3|||
125044225|NCT00923091|449782230|FG003|Period VI (Open-Label)|Protocol Violation|1|||
125044226|NCT00923091|449782231|FG004|Period VI (Open-Label)|Protocol Violation|4|||
125044227|NCT00923091|449782232|FG005|Period VI (Open-Label)|Protocol Violation|0|||
125044228|NCT00923091|449782233|FG006|Period VI (Open-Label)|Protocol Violation|0|||
125044229|NCT00923091|449782234|FG007|Period VI (Open-Label)|Protocol Violation|0|||
125044230|NCT00923091|449782235|FG008|Period VI (Open-Label)|Protocol Violation|0|||
125044231|NCT00923091|449782236|FG009|Period VI (Open-Label)|Protocol Violation|0|||
125044232|NCT00923091|449782237|FG010|Period VI (Open-Label)|Protocol Violation|0|||
125044233|NCT00923091|449782238|FG011|Period VI (Open-Label)|Protocol Violation|0|||
125044234|NCT00923091|449782239|FG012|Period VI (Open-Label)|Protocol Violation|0|||
125044235|NCT00923091|449782227|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
125044236|NCT00923091|449782228|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
125044237|NCT00923091|449782229|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
125044238|NCT00923091|449782230|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
125044239|NCT00923091|449782231|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
125044240|NCT00923091|449782232|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
125044241|NCT00923091|449782233|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
125044242|NCT00923091|449782234|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
125044243|NCT00923091|449782235|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
125044244|NCT00923091|449782236|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
125044245|NCT00923091|449782237|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
125044246|NCT00923091|449782238|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
125044247|NCT00923091|449782239|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
125044248|NCT00923091|449782227|FG000|Period VI (Open-Label)|Other Reason|0|||
125044249|NCT00923091|449782228|FG001|Period VI (Open-Label)|Other Reason|0|||
125044250|NCT00923091|449782229|FG002|Period VI (Open-Label)|Other Reason|0|||
125044251|NCT00923091|449782230|FG003|Period VI (Open-Label)|Other Reason|1|||
125044252|NCT00923091|449782231|FG004|Period VI (Open-Label)|Other Reason|1|||
125044253|NCT00923091|449782232|FG005|Period VI (Open-Label)|Other Reason|0|||
125044254|NCT00923091|449782233|FG006|Period VI (Open-Label)|Other Reason|0|||
125044255|NCT00923091|449782234|FG007|Period VI (Open-Label)|Other Reason|0|||
125044256|NCT00923091|449782235|FG008|Period VI (Open-Label)|Other Reason|0|||
125044257|NCT00923091|449782236|FG009|Period VI (Open-Label)|Other Reason|0|||
125044258|NCT00923091|449782237|FG010|Period VI (Open-Label)|Other Reason|0|||
125044259|NCT00923091|449782238|FG011|Period VI (Open-Label)|Other Reason|0|||
125044260|NCT00923091|449782239|FG012|Period VI (Open-Label)|Other Reason|0|||
125044261|NCT00467649|449782240|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
125044262|NCT00467649|449782241|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
125044263|NCT00467649|449782242|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
125044264|NCT00467649|449782243|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
125044265|NCT00467649|449782244|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
125044266|NCT00467649|449782245|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
125044267|NCT00467649|449782240|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
125044268|NCT00467649|449782241|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
125044269|NCT00467649|449782242|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
125044270|NCT00467649|449782243|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
125044271|NCT00467649|449782244|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
125044272|NCT00467649|449782245|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
125044273|NCT00467649|449782240|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
125044274|NCT00467649|449782241|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
125044275|NCT00467649|449782242|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
125044276|NCT00467649|449782243|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
125044277|NCT00467649|449782244|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
125044278|NCT00467649|449782245|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
125044279|NCT00467649|449782240|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
125044280|NCT00467649|449782241|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
125044281|NCT00467649|449782242|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
125044282|NCT00467649|449782243|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
125044283|NCT00467649|449782244|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
125044284|NCT00467649|449782245|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
125044285|NCT00467649|449782240|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
125044286|NCT00467649|449782241|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
125044287|NCT00467649|449782242|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
125044288|NCT00467649|449782243|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
125135635|NCT02530905|450120192|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
125135636|NCT02530905|450120193|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
125135637|NCT02530905|450120194|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
125135638|NCT01473953|450120197|FG000|Overall Study|Other|1|||
125135639|NCT01473953|450120198|FG001|Overall Study|Other|0|||
125135640|NCT01473953|450120199|FG002|Overall Study|Other|0|||
125135641|NCT01473953|450120200|FG003|Overall Study|Other|0|||
125135642|NCT01473953|450120201|FG004|Overall Study|Other|0|||
125135643|NCT03100344|450120202|FG000|Overall Study|Adverse Event|0|||
125135644|NCT03100344|450120203|FG001|Overall Study|Adverse Event|3|||
125135645|NCT03100344|450120204|FG002|Overall Study|Adverse Event|2|||
125135646|NCT03100344|450120205|FG003|Overall Study|Adverse Event|3|||
125135647|NCT03100344|450120202|FG000|Overall Study|Lack of Efficacy|2|||
125135648|NCT03100344|450120203|FG001|Overall Study|Lack of Efficacy|0|||
125135649|NCT03100344|450120204|FG002|Overall Study|Lack of Efficacy|0|||
125135650|NCT03100344|450120205|FG003|Overall Study|Lack of Efficacy|0|||
125135651|NCT03100344|450120202|FG000|Overall Study|Protocol Violation|1|||
125135652|NCT03100344|450120203|FG001|Overall Study|Protocol Violation|0|||
125135653|NCT03100344|450120204|FG002|Overall Study|Protocol Violation|0|||
125135654|NCT03100344|450120205|FG003|Overall Study|Protocol Violation|0|||
125135655|NCT03100344|450120202|FG000|Overall Study|Withdrawal by Subject|10|||
125135656|NCT03100344|450120203|FG001|Overall Study|Withdrawal by Subject|7|||
125135657|NCT03100344|450120204|FG002|Overall Study|Withdrawal by Subject|4|||
125135658|NCT03100344|450120205|FG003|Overall Study|Withdrawal by Subject|8|||
125135659|NCT03100344|450120202|FG000|Overall Study|Lost to Follow-up|1|||
125135660|NCT03100344|450120203|FG001|Overall Study|Lost to Follow-up|1|||
125135661|NCT03100344|450120204|FG002|Overall Study|Lost to Follow-up|1|||
125135662|NCT03100344|450120205|FG003|Overall Study|Lost to Follow-up|1|||
125135663|NCT02358538|450120206|FG000|Through Week 26|Adverse Event|0|||
125135664|NCT02358538|450120207|FG001|Through Week 26|Adverse Event|1|||
125135665|NCT02358538|450120208|FG002|Through Week 26|Adverse Event|1|||
125135666|NCT02358538|450120209|FG003|Through Week 26|Adverse Event|2|||
125135667|NCT02358538|450120206|FG000|Through Week 26|Lack of Efficacy|1|||
125135668|NCT02358538|450120207|FG001|Through Week 26|Lack of Efficacy|1|||
125135669|NCT02358538|450120208|FG002|Through Week 26|Lack of Efficacy|3|||
125135670|NCT02358538|450120209|FG003|Through Week 26|Lack of Efficacy|3|||
125135671|NCT02358538|450120206|FG000|Through Week 26|Withdrawal by Subject|1|||
125135672|NCT02358538|450120207|FG001|Through Week 26|Withdrawal by Subject|0|||
125135673|NCT02358538|450120208|FG002|Through Week 26|Withdrawal by Subject|0|||
125135674|NCT02358538|450120209|FG003|Through Week 26|Withdrawal by Subject|0|||
125135675|NCT02358538|450120206|FG000|Through Week 26|Non-Compliance|0|||
125135676|NCT02358538|450120207|FG001|Through Week 26|Non-Compliance|0|||
125135677|NCT02358538|450120208|FG002|Through Week 26|Non-Compliance|1|||
125135678|NCT02358538|450120209|FG003|Through Week 26|Non-Compliance|0|||
125135679|NCT02358538|450120206|FG000|Through Week 26|Family did not see benefit from IP|1|||
125135680|NCT02358538|450120207|FG001|Through Week 26|Family did not see benefit from IP|0|||
125135681|NCT02358538|450120208|FG002|Through Week 26|Family did not see benefit from IP|0|||
125135682|NCT02358538|450120209|FG003|Through Week 26|Family did not see benefit from IP|0|||
125135683|NCT02358538|450120206|FG000|52 Week Extension Period|Lack of Efficacy|0|||
125135684|NCT02358538|450120207|FG001|52 Week Extension Period|Lack of Efficacy|0|||
125135685|NCT02358538|450120208|FG002|52 Week Extension Period|Lack of Efficacy|2|||
125135686|NCT02358538|450120209|FG003|52 Week Extension Period|Lack of Efficacy|4|||
125135687|NCT01494532|450120212|FG000|Overall Study|Adverse Event|4|||
125044289|NCT00467649|449782244|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
125044290|NCT00467649|449782245|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
125044291|NCT00467649|449782240|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
125044292|NCT00467649|449782241|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
125044293|NCT00467649|449782242|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
125044294|NCT00467649|449782243|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
125044295|NCT00467649|449782244|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
125044296|NCT00467649|449782245|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
125044297|NCT00467649|449782240|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
125044298|NCT00467649|449782241|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
125044299|NCT00467649|449782242|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
125044300|NCT00467649|449782243|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
125044301|NCT00467649|449782244|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
125044302|NCT00467649|449782245|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
125044303|NCT03233048|449782248|FG000|Overall Study|Withdrawal by Subject|1|||
125044304|NCT05897853|449782258|FG000|Overall Study|Lost to Follow-up|2|||
125044305|NCT05897853|449782259|FG001|Overall Study|Lost to Follow-up|0|||
125044306|NCT05897853|449782258|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
125044307|NCT05897853|449782259|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
125044308|NCT02782715|449782264|FG000|Overall Study|Withdrawal by Subject|1|||
125044309|NCT04458857|449782265|FG000|Overall Study|Adverse Event|0|||
125044310|NCT04458857|449782266|FG001|Overall Study|Adverse Event|1|||
125044311|NCT04458857|449782267|FG002|Overall Study|Adverse Event|0|||
125044312|NCT04458857|449782265|FG000|Overall Study|Withdrawal by Subject|2|||
125044313|NCT04458857|449782266|FG001|Overall Study|Withdrawal by Subject|0|||
125044314|NCT04458857|449782267|FG002|Overall Study|Withdrawal by Subject|0|||
125044315|NCT04458857|449782265|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125044316|NCT04458857|449782266|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125044317|NCT04458857|449782267|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125044318|NCT04458857|449782265|FG000|Overall Study|Non-compliance with study drug|0|||
125044319|NCT04458857|449782266|FG001|Overall Study|Non-compliance with study drug|1|||
125044320|NCT04458857|449782267|FG002|Overall Study|Non-compliance with study drug|0|||
125044321|NCT04458857|449782265|FG000|Overall Study|Lost to Follow-up|4|||
125044322|NCT04458857|449782266|FG001|Overall Study|Lost to Follow-up|1|||
125044323|NCT04458857|449782267|FG002|Overall Study|Lost to Follow-up|0|||
125044324|NCT03368404|449782270|FG000|Overall Study|Adverse Event|2|||
125044325|NCT03368404|449782271|FG001|Overall Study|Adverse Event|1|||
125044326|NCT03368404|449782270|FG000|Overall Study|Withdrawal by Subject|1|||
125044327|NCT03368404|449782271|FG001|Overall Study|Withdrawal by Subject|1|||
125044328|NCT02983292|449782272|FG000|Overall Study|Participant unwell & cannot travel|2|||
125044329|NCT02983292|449782272|FG000|Overall Study|Lost to Follow-up|3|||
125044330|NCT02983292|449782272|FG000|Overall Study|Participant withdrew consent|2|||
125044331|NCT02983292|449782272|FG000|Overall Study|Revision|7|||
125044332|NCT02983292|449782272|FG000|Overall Study|Death|1|||
125044333|NCT02983292|449782272|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
125044334|NCT02983292|449782272|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
125044335|NCT02983292|449782272|FG000|Overall Study|Participant relocation|1|||
125044336|NCT00964795|449782273|FG000|Overall Study|Withdrawal by Subject|79|||
125044337|NCT00964795|449782273|FG000|Overall Study|Adverse Event|12|||
125044338|NCT00964795|449782273|FG000|Overall Study|Death|14|||
125044339|NCT00964795|449782273|FG000|Overall Study|Lost to Follow-up|7|||
125044340|NCT00964795|449782273|FG000|Overall Study|Termination of Study by Sponsor|169|||
125044341|NCT00964795|449782273|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
125044342|NCT00964795|449782273|FG000|Overall Study|Other|23|||
125044343|NCT00586690|449782278|FG000|Overall Study|Death|2|||
125044344|NCT00586690|449782279|FG001|Overall Study|Death|0|||
125044345|NCT00586690|449782278|FG000|Overall Study|Disease Progression|10|||
125044346|NCT00586690|449782279|FG001|Overall Study|Disease Progression|0|||
125044347|NCT00586690|449782278|FG000|Overall Study|Adverse Event|1|||
125044348|NCT00586690|449782279|FG001|Overall Study|Adverse Event|0|||
125044349|NCT00586690|449782278|FG000|Overall Study|Lack of Efficacy|2|||
125044350|NCT00586690|449782279|FG001|Overall Study|Lack of Efficacy|0|||
125044351|NCT00586690|449782278|FG000|Overall Study|Lab can't accommodate|1|||
125135688|NCT01494532|450120213|FG001|Overall Study|Adverse Event|1|||
125135689|NCT01494532|450120214|FG002|Overall Study|Adverse Event|8|||
125135690|NCT01494532|450120215|FG003|Overall Study|Adverse Event|6|||
125044352|NCT00586690|449782279|FG001|Overall Study|Lab can't accommodate|0|||
125044353|NCT03022422|449782284|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
125135691|NCT01494532|450120216|FG004|Overall Study|Adverse Event|5|||
125044354|NCT03022422|449782285|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
125044355|NCT03022422|449782286|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
125044356|NCT03022422|449782287|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
125044357|NCT03022422|449782288|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
125044358|NCT03022422|449782289|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
125044359|NCT01282814|449782290|FG000|First Intervention|Emesis During Dosing Interval|0|||
125044360|NCT01282814|449782291|FG001|First Intervention|Emesis During Dosing Interval|3|||
125044361|NCT01282814|449782290|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
125044362|NCT01282814|449782291|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
125044363|NCT00957372|449782292|FG000|PART I|Lost to Follow-up|0|||
125044364|NCT00957372|449782293|FG001|PART I|Lost to Follow-up|0|||
125044365|NCT00957372|449782294|FG002|PART I|Lost to Follow-up|1|||
125044366|NCT00957372|449782295|FG003|PART I|Lost to Follow-up|0|||
125044367|NCT00957372|449782292|FG000|PART II|Withdrawal by Subject|0|||
125044368|NCT00957372|449782293|FG001|PART II|Withdrawal by Subject|0|||
125044369|NCT00957372|449782294|FG002|PART II|Withdrawal by Subject|0|||
125044370|NCT00957372|449782295|FG003|PART II|Withdrawal by Subject|8|||
125044371|NCT00957372|449782292|FG000|PART II|Physician Decision|0|||
125044372|NCT00957372|449782293|FG001|PART II|Physician Decision|0|||
125044373|NCT00957372|449782294|FG002|PART II|Physician Decision|0|||
125044374|NCT00957372|449782295|FG003|PART II|Physician Decision|1|||
125044375|NCT00957372|449782292|FG000|PART II|Pregnancy|0|||
125044376|NCT00957372|449782293|FG001|PART II|Pregnancy|0|||
125044377|NCT00957372|449782294|FG002|PART II|Pregnancy|0|||
125044378|NCT00957372|449782295|FG003|PART II|Pregnancy|1|||
125044379|NCT00957372|449782292|FG000|PART II|Not Know|0|||
125044380|NCT00957372|449782293|FG001|PART II|Not Know|0|||
125044381|NCT00957372|449782294|FG002|PART II|Not Know|0|||
125044382|NCT00957372|449782295|FG003|PART II|Not Know|20|||
125044383|NCT00957372|449782292|FG000|PART II|Adverse Event|0|||
125044384|NCT00957372|449782293|FG001|PART II|Adverse Event|0|||
125044385|NCT00957372|449782294|FG002|PART II|Adverse Event|0|||
125044386|NCT00957372|449782295|FG003|PART II|Adverse Event|10|||
125044387|NCT00957372|449782292|FG000|PART II|Patient non-compliance|0|||
125044388|NCT00957372|449782293|FG001|PART II|Patient non-compliance|0|||
125044389|NCT00957372|449782294|FG002|PART II|Patient non-compliance|0|||
125044390|NCT00957372|449782295|FG003|PART II|Patient non-compliance|4|||
125044391|NCT01524289|449782296|FG000|Overall Study|Lost to Follow-up|0|||
125044392|NCT01524289|449782297|FG001|Overall Study|Lost to Follow-up|1|||
125044393|NCT01524289|449782296|FG000|Overall Study|Physician Decision|1|||
125044394|NCT01524289|449782297|FG001|Overall Study|Physician Decision|0|||
125044395|NCT01524289|449782296|FG000|Overall Study|Protocol Violation|5|||
125044396|NCT01524289|449782297|FG001|Overall Study|Protocol Violation|1|||
125044397|NCT01524289|449782296|FG000|Overall Study|Withdrawal by Subject|11|||
125044398|NCT01524289|449782297|FG001|Overall Study|Withdrawal by Subject|7|||
125044399|NCT01524289|449782296|FG000|Overall Study|Adverse Event|12|||
125044400|NCT01524289|449782297|FG001|Overall Study|Adverse Event|5|||
125044401|NCT01524289|449782296|FG000|Overall Study|Did not take study medication|1|||
125044402|NCT01524289|449782297|FG001|Overall Study|Did not take study medication|0|||
125044403|NCT02104180|449782298|FG000|Overall Study|Protocol Violation|1|||
125044404|NCT02104180|449782299|FG001|Overall Study|Protocol Violation|0|||
125044405|NCT01089725|449782300|FG000|Overall Study|Adverse Event|1|||
125044406|NCT01089725|449782301|FG001|Overall Study|Adverse Event|1|||
125044407|NCT01089725|449782302|FG002|Overall Study|Adverse Event|0|||
125044408|NCT01089725|449782303|FG003|Overall Study|Adverse Event|0|||
125044409|NCT01089725|449782304|FG004|Overall Study|Adverse Event|2|||
125044410|NCT01089725|449782300|FG000|Overall Study|Lack of Efficacy|4|||
125044411|NCT01089725|449782301|FG001|Overall Study|Lack of Efficacy|3|||
125044412|NCT01089725|449782302|FG002|Overall Study|Lack of Efficacy|1|||
125044413|NCT01089725|449782303|FG003|Overall Study|Lack of Efficacy|0|||
125044414|NCT01089725|449782304|FG004|Overall Study|Lack of Efficacy|4|||
125044415|NCT01089725|449782300|FG000|Overall Study|Lost to Follow-up|2|||
125044416|NCT01089725|449782301|FG001|Overall Study|Lost to Follow-up|2|||
125044417|NCT01089725|449782302|FG002|Overall Study|Lost to Follow-up|0|||
125044418|NCT01089725|449782303|FG003|Overall Study|Lost to Follow-up|3|||
125044419|NCT01089725|449782304|FG004|Overall Study|Lost to Follow-up|0|||
125044420|NCT01089725|449782300|FG000|Overall Study|Protocol Violation|0|||
125044421|NCT01089725|449782301|FG001|Overall Study|Protocol Violation|0|||
125044422|NCT01089725|449782302|FG002|Overall Study|Protocol Violation|1|||
125218889|NCT03538691|450427421|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
125044423|NCT01089725|449782303|FG003|Overall Study|Protocol Violation|1|||
125044424|NCT01089725|449782304|FG004|Overall Study|Protocol Violation|0|||
125044425|NCT01089725|449782300|FG000|Overall Study|Withdrawal by Subject|5|||
125044426|NCT01089725|449782301|FG001|Overall Study|Withdrawal by Subject|5|||
125044427|NCT01089725|449782302|FG002|Overall Study|Withdrawal by Subject|4|||
125044428|NCT01089725|449782303|FG003|Overall Study|Withdrawal by Subject|5|||
125044429|NCT01089725|449782304|FG004|Overall Study|Withdrawal by Subject|4|||
125044430|NCT01089725|449782300|FG000|Overall Study|Study Terminated by Sponsor|51|||
125044431|NCT01089725|449782301|FG001|Overall Study|Study Terminated by Sponsor|56|||
125044432|NCT01089725|449782302|FG002|Overall Study|Study Terminated by Sponsor|53|||
125044433|NCT01089725|449782303|FG003|Overall Study|Study Terminated by Sponsor|68|||
125044434|NCT01089725|449782304|FG004|Overall Study|Study Terminated by Sponsor|68|||
125044435|NCT01089725|449782300|FG000|Overall Study|Randomized, but not treated|0|||
125044436|NCT01089725|449782301|FG001|Overall Study|Randomized, but not treated|1|||
125044437|NCT01089725|449782302|FG002|Overall Study|Randomized, but not treated|2|||
125044438|NCT01089725|449782303|FG003|Overall Study|Randomized, but not treated|1|||
125044439|NCT01089725|449782304|FG004|Overall Study|Randomized, but not treated|2|||
125044440|NCT01089725|449782300|FG000|Overall Study|Other|3|||
125044441|NCT01089725|449782301|FG001|Overall Study|Other|0|||
125044442|NCT01089725|449782302|FG002|Overall Study|Other|0|||
125044443|NCT01089725|449782303|FG003|Overall Study|Other|1|||
125044444|NCT01089725|449782304|FG004|Overall Study|Other|0|||
125044445|NCT02495077|449784095|FG000|Overall Study|Adverse Event|0|||
125044446|NCT02495077|449784096|FG001|Overall Study|Adverse Event|1|||
125044447|NCT02495077|449784097|FG002|Overall Study|Adverse Event|1|||
125044448|NCT02495077|449784098|FG003|Overall Study|Adverse Event|0|||
125044449|NCT02495077|449784095|FG000|Overall Study|Death|3|||
125044450|NCT02495077|449784096|FG001|Overall Study|Death|5|||
125044451|NCT02495077|449784097|FG002|Overall Study|Death|0|||
125044452|NCT02495077|449784098|FG003|Overall Study|Death|0|||
125044453|NCT02495077|449784095|FG000|Overall Study|Lost to Follow-up|6|||
125044454|NCT02495077|449784096|FG001|Overall Study|Lost to Follow-up|4|||
125044455|NCT02495077|449784097|FG002|Overall Study|Lost to Follow-up|0|||
125044456|NCT02495077|449784098|FG003|Overall Study|Lost to Follow-up|0|||
125044457|NCT02495077|449784095|FG000|Overall Study|Physician Decision|2|||
125044458|NCT02495077|449784096|FG001|Overall Study|Physician Decision|1|||
125044459|NCT02495077|449784097|FG002|Overall Study|Physician Decision|4|||
125044460|NCT02495077|449784098|FG003|Overall Study|Physician Decision|0|||
125044461|NCT02495077|449784095|FG000|Overall Study|Protocol Violation|0|||
125044462|NCT02495077|449784096|FG001|Overall Study|Protocol Violation|1|||
125044463|NCT02495077|449784097|FG002|Overall Study|Protocol Violation|0|||
125044464|NCT02495077|449784098|FG003|Overall Study|Protocol Violation|0|||
125044465|NCT02495077|449784095|FG000|Overall Study|Screen Failure|0|||
125044466|NCT02495077|449784096|FG001|Overall Study|Screen Failure|0|||
125044467|NCT02495077|449784097|FG002|Overall Study|Screen Failure|0|||
125044468|NCT02495077|449784098|FG003|Overall Study|Screen Failure|48|||
125044469|NCT02495077|449784095|FG000|Overall Study|Withdrawal by Subject|7|||
125044470|NCT02495077|449784096|FG001|Overall Study|Withdrawal by Subject|7|||
125044471|NCT02495077|449784097|FG002|Overall Study|Withdrawal by Subject|7|||
125044472|NCT02495077|449784098|FG003|Overall Study|Withdrawal by Subject|0|||
125044473|NCT02495077|449784095|FG000|Overall Study|Covid-19 research restrictions|1|||
125044474|NCT02495077|449784096|FG001|Overall Study|Covid-19 research restrictions|0|||
125044475|NCT02495077|449784097|FG002|Overall Study|Covid-19 research restrictions|0|||
125044476|NCT02495077|449784098|FG003|Overall Study|Covid-19 research restrictions|0|||
125044477|NCT02495077|449784095|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
125044478|NCT02495077|449784096|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
125044479|NCT02495077|449784097|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
125044480|NCT02495077|449784098|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
125044481|NCT02495077|449784095|FG000|Overall Study|Incarcerated|0|||
125044482|NCT02495077|449784096|FG001|Overall Study|Incarcerated|1|||
125044483|NCT02495077|449784097|FG002|Overall Study|Incarcerated|0|||
125044484|NCT02495077|449784098|FG003|Overall Study|Incarcerated|0|||
125044485|NCT02495077|449784095|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
125044486|NCT02495077|449784096|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
125044487|NCT02495077|449784097|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
125044488|NCT02495077|449784098|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
125044489|NCT02495077|449784095|FG000|Overall Study|Timing of transplant and randomization|0|||
125044490|NCT02495077|449784096|FG001|Overall Study|Timing of transplant and randomization|0|||
125044491|NCT02495077|449784097|FG002|Overall Study|Timing of transplant and randomization|5|||
125044492|NCT02495077|449784098|FG003|Overall Study|Timing of transplant and randomization|0|||
125044493|NCT02742649|449784105|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
125044494|NCT02742649|449784106|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
125044495|NCT02742649|449784107|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
125044496|NCT02742649|449784108|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
125044497|NCT02742649|449784109|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
125044498|NCT02742649|449784105|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125044499|NCT02742649|449784106|FG001|Double-Blind Treatment Period|Adverse Event|1|||
125044500|NCT02742649|449784107|FG002|Double-Blind Treatment Period|Adverse Event|0|||
125044501|NCT02742649|449784108|FG003|Double-Blind Treatment Period|Adverse Event|0|||
125044502|NCT02742649|449784109|FG004|Double-Blind Treatment Period|Adverse Event|0|||
125044503|NCT02742649|449784105|FG000|Open-Label Period|Lost to Follow-up|0|||
125044504|NCT02742649|449784106|FG001|Open-Label Period|Lost to Follow-up|0|||
125044505|NCT02742649|449784107|FG002|Open-Label Period|Lost to Follow-up|0|||
125044506|NCT02742649|449784108|FG003|Open-Label Period|Lost to Follow-up|0|||
125044507|NCT02742649|449784109|FG004|Open-Label Period|Lost to Follow-up|1|||
125044508|NCT01978912|449784118|FG000|Overall Study|Adverse Event|0|||
125044509|NCT01978912|449784119|FG001|Overall Study|Adverse Event|1|||
125044510|NCT01978912|449784120|FG002|Overall Study|Adverse Event|0|||
125044511|NCT01978912|449784121|FG003|Overall Study|Adverse Event|0|||
125044512|NCT01978912|449784118|FG000|Overall Study|Lost to Follow-up|1|||
125044513|NCT01978912|449784119|FG001|Overall Study|Lost to Follow-up|1|||
125044514|NCT01978912|449784120|FG002|Overall Study|Lost to Follow-up|0|||
125044515|NCT01978912|449784121|FG003|Overall Study|Lost to Follow-up|1|||
125044516|NCT01978912|449784118|FG000|Overall Study|Withdrawal by Subject|1|||
125044517|NCT01978912|449784119|FG001|Overall Study|Withdrawal by Subject|0|||
125044518|NCT01978912|449784120|FG002|Overall Study|Withdrawal by Subject|2|||
125044519|NCT01978912|449784121|FG003|Overall Study|Withdrawal by Subject|2|||
125044520|NCT01978912|449784118|FG000|Overall Study|Lumbar Surgery|1|||
125044521|NCT01978912|449784119|FG001|Overall Study|Lumbar Surgery|0|||
125044522|NCT01978912|449784120|FG002|Overall Study|Lumbar Surgery|1|||
125044523|NCT01978912|449784121|FG003|Overall Study|Lumbar Surgery|0|||
125044524|NCT01978912|449784118|FG000|Overall Study|Intradiscal Steroid Injection|0|||
125044525|NCT01978912|449784119|FG001|Overall Study|Intradiscal Steroid Injection|1|||
125044526|NCT01978912|449784120|FG002|Overall Study|Intradiscal Steroid Injection|0|||
125044527|NCT01978912|449784121|FG003|Overall Study|Intradiscal Steroid Injection|0|||
125044528|NCT04220866|449784122|FG000|Overall Study|Death|4|||
125044529|NCT04220866|449784123|FG001|Overall Study|Death|5|||
125044530|NCT04220866|449784122|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
125044531|NCT04220866|449784123|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
125044532|NCT04220866|449784122|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
125044533|NCT04220866|449784123|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
125044534|NCT04220866|449784122|FG000|Overall Study|Withdrawal by Subject|0|||
125044535|NCT04220866|449784123|FG001|Overall Study|Withdrawal by Subject|1|||
125044536|NCT02138110|449784124|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
125044537|NCT02138110|449784124|FG000|Overall Scaffold Implantation|Death|3|||
125044538|NCT01408537|449784128|FG000|Overall Study|Withdrawal by Subject|2|||
125044539|NCT01408537|449784128|FG000|Overall Study|Protocol Violation|3|||
125044540|NCT01408537|449784128|FG000|Overall Study|Lost to Follow-up|3|||
125044541|NCT03842709|449784133|FG000|Overall Study|Withdrawal by Subject|3|||
125044542|NCT03842709|449784134|FG001|Overall Study|Withdrawal by Subject|3|||
125044543|NCT03842709|449784133|FG000|Overall Study|Lost to Follow-up|1|||
125044544|NCT03842709|449784134|FG001|Overall Study|Lost to Follow-up|0|||
125044545|NCT00791128|449784135|FG000|Overall Study|Adverse Event|4|||
125044546|NCT00791128|449784135|FG000|Overall Study|Device migration|2|||
125044547|NCT00791128|449784135|FG000|Overall Study|non-compliance by subject|2|||
125044548|NCT00791128|449784135|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
125044549|NCT03952650|449784138|FG000|Overall Study|TRAVEL|0|||
125044550|NCT03952650|449784139|FG001|Overall Study|TRAVEL|4|||
125044551|NCT03952650|449784140|FG002|Overall Study|TRAVEL|0|||
125044552|NCT03952650|449784141|FG003|Overall Study|TRAVEL|4|||
125044553|NCT03952650|449784142|FG004|Overall Study|TRAVEL|0|||
125044554|NCT03952650|449784143|FG005|Overall Study|TRAVEL|3|||
125044555|NCT03952650|449784144|FG006|Overall Study|TRAVEL|2|||
125044556|NCT03952650|449784138|FG000|Overall Study|Withdrawal by Subject|0|||
125044557|NCT03952650|449784139|FG001|Overall Study|Withdrawal by Subject|2|||
125044558|NCT03952650|449784140|FG002|Overall Study|Withdrawal by Subject|0|||
125044559|NCT03952650|449784141|FG003|Overall Study|Withdrawal by Subject|3|||
125044560|NCT03952650|449784142|FG004|Overall Study|Withdrawal by Subject|0|||
125044561|NCT03952650|449784143|FG005|Overall Study|Withdrawal by Subject|1|||
125044562|NCT03952650|449784144|FG006|Overall Study|Withdrawal by Subject|1|||
125044563|NCT03952650|449784138|FG000|Overall Study|Lost to Follow-up|0|||
125044564|NCT03952650|449784139|FG001|Overall Study|Lost to Follow-up|1|||
125044565|NCT03952650|449784140|FG002|Overall Study|Lost to Follow-up|0|||
125044566|NCT03952650|449784141|FG003|Overall Study|Lost to Follow-up|0|||
125044567|NCT03952650|449784142|FG004|Overall Study|Lost to Follow-up|0|||
125044568|NCT03952650|449784143|FG005|Overall Study|Lost to Follow-up|1|||
125044569|NCT03952650|449784144|FG006|Overall Study|Lost to Follow-up|1|||
125044570|NCT03952650|449784138|FG000|Overall Study|Received wrong vaccine and travelled|0|||
125044571|NCT03952650|449784139|FG001|Overall Study|Received wrong vaccine and travelled|0|||
125044572|NCT03952650|449784140|FG002|Overall Study|Received wrong vaccine and travelled|0|||
125044573|NCT03952650|449784141|FG003|Overall Study|Received wrong vaccine and travelled|0|||
125044574|NCT03952650|449784142|FG004|Overall Study|Received wrong vaccine and travelled|0|||
125044575|NCT03952650|449784143|FG005|Overall Study|Received wrong vaccine and travelled|1|||
125044576|NCT03952650|449784144|FG006|Overall Study|Received wrong vaccine and travelled|0|||
125044577|NCT03952650|449784138|FG000|Overall Study|Unable to make study visit|0|||
125044578|NCT03952650|449784139|FG001|Overall Study|Unable to make study visit|0|||
125044579|NCT03952650|449784140|FG002|Overall Study|Unable to make study visit|0|||
125044580|NCT03952650|449784141|FG003|Overall Study|Unable to make study visit|0|||
125044581|NCT03952650|449784142|FG004|Overall Study|Unable to make study visit|0|||
125044582|NCT03952650|449784143|FG005|Overall Study|Unable to make study visit|1|||
125044583|NCT03952650|449784144|FG006|Overall Study|Unable to make study visit|0|||
125044584|NCT01357239|449784149|FG000|Stratum: All Patients|Adverse Event|0|||
125044585|NCT01357239|449784150|FG001|Stratum: All Patients|Adverse Event|0|||
125044586|NCT01357239|449784151|FG002|Stratum: All Patients|Adverse Event|1|||
125044587|NCT01357239|449784152|FG003|Stratum: All Patients|Adverse Event|1|||
125044588|NCT01357239|449784149|FG000|Stratum: All Patients|Subject withdrew consent|0|||
125044589|NCT01357239|449784150|FG001|Stratum: All Patients|Subject withdrew consent|0|||
125044590|NCT01357239|449784151|FG002|Stratum: All Patients|Subject withdrew consent|1|||
125044591|NCT01357239|449784152|FG003|Stratum: All Patients|Subject withdrew consent|1|||
125044592|NCT01357239|449784149|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
125044593|NCT01357239|449784150|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
125044594|NCT01357239|449784151|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
125044595|NCT01357239|449784152|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
125044596|NCT01357239|449784149|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
125044597|NCT01357239|449784150|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
125044598|NCT01357239|449784151|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
125044599|NCT01357239|449784152|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
125044600|NCT01357239|449784149|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
125044601|NCT01357239|449784150|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
125044602|NCT01357239|449784151|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
125044603|NCT01357239|449784152|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
125044604|NCT03133481|449784153|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
125044605|NCT03133481|449784154|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
125044606|NCT00637728|449784158|FG000|Double-blind Phase|Adverse Event|1|||
125044607|NCT00637728|449784159|FG001|Double-blind Phase|Adverse Event|0|||
125044608|NCT00637728|449784160|FG002|Double-blind Phase|Adverse Event|0|||
125044609|NCT00637728|449784158|FG000|Double-blind Phase|Non-compliance|2|||
125044610|NCT00637728|449784159|FG001|Double-blind Phase|Non-compliance|0|||
125044611|NCT00637728|449784160|FG002|Double-blind Phase|Non-compliance|0|||
125044612|NCT00637728|449784158|FG000|Double-blind Phase|Study Discontinued|1|||
125044613|NCT00637728|449784159|FG001|Double-blind Phase|Study Discontinued|1|||
125044614|NCT00637728|449784160|FG002|Double-blind Phase|Study Discontinued|0|||
125044615|NCT01050062|449784163|FG000|Overall Study|Adverse Event|75|||
125044616|NCT01050062|449784164|FG001|Overall Study|Adverse Event|22|||
125044617|NCT01050062|449784163|FG000|Overall Study|Lost to Follow-up|83|||
125044618|NCT01050062|449784164|FG001|Overall Study|Lost to Follow-up|35|||
125044619|NCT01050062|449784163|FG000|Overall Study|Lack of Efficacy|22|||
125044620|NCT01050062|449784164|FG001|Overall Study|Lack of Efficacy|35|||
125044621|NCT01050062|449784163|FG000|Overall Study|Physician Decision|74|||
125044622|NCT01050062|449784164|FG001|Overall Study|Physician Decision|9|||
125044623|NCT01050062|449784163|FG000|Overall Study|Others|17|||
125044624|NCT01050062|449784164|FG001|Overall Study|Others|11|||
125044625|NCT00670111|449784167|FG000|Enrollment to One Month|Testing Failure|0|||
125044626|NCT00670111|449784168|FG001|Enrollment to One Month|Testing Failure|0|||
125044627|NCT00670111|449784169|FG002|Enrollment to One Month|Testing Failure|13|||
125044628|NCT00670111|449784167|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
125044629|NCT00670111|449784168|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
125044630|NCT00670111|449784169|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
125044631|NCT00670111|449784167|FG000|Enrollment to One Month|Physician Decision|1|||
125044632|NCT00670111|449784168|FG001|Enrollment to One Month|Physician Decision|0|||
125044633|NCT00670111|449784169|FG002|Enrollment to One Month|Physician Decision|0|||
125044634|NCT03988751|449784170|FG000|Overall Study|Withdrawal by Subject|1|||
125044635|NCT03988751|449784171|FG001|Overall Study|Withdrawal by Subject|0|||
125044636|NCT03988751|449784170|FG000|Overall Study|Protocol Violation|0|||
125044637|NCT03988751|449784171|FG001|Overall Study|Protocol Violation|1|||
125044638|NCT00844883|449784172|FG000|Overall Study|Bridged to liver transplant|3|||
125044639|NCT00844883|449784172|FG000|Overall Study|Bridged to resection|1|||
125044640|NCT02623361|449784173|FG000|Overall Study|Protocol Violation|0|||
125044641|NCT02623361|449784174|FG001|Overall Study|Protocol Violation|1|||
125044642|NCT02623361|449784173|FG000|Overall Study|Withdrawal by Subject|0|||
125044643|NCT02623361|449784174|FG001|Overall Study|Withdrawal by Subject|1|||
125044644|NCT03894540|449784177|FG000|Overall Study|Adverse Event|0|||
125044645|NCT03894540|449784178|FG001|Overall Study|Adverse Event|0|||
125044646|NCT03894540|449784179|FG002|Overall Study|Adverse Event|0|||
125044647|NCT03894540|449784180|FG003|Overall Study|Adverse Event|0|||
125044648|NCT03894540|449784181|FG004|Overall Study|Adverse Event|1|||
125044649|NCT03894540|449784182|FG005|Overall Study|Adverse Event|0|||
125044650|NCT03894540|449784177|FG000|Overall Study|Withdrawal by Subject|0|||
125044651|NCT03894540|449784178|FG001|Overall Study|Withdrawal by Subject|0|||
125044652|NCT03894540|449784179|FG002|Overall Study|Withdrawal by Subject|0|||
125044653|NCT03894540|449784180|FG003|Overall Study|Withdrawal by Subject|0|||
125044654|NCT03894540|449784181|FG004|Overall Study|Withdrawal by Subject|1|||
125044655|NCT03894540|449784182|FG005|Overall Study|Withdrawal by Subject|0|||
125044656|NCT03894540|449784177|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
125044657|NCT03894540|449784178|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
125218890|NCT03538691|450427422|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
125218891|NCT03538691|450427423|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
125044658|NCT03894540|449784179|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
125044659|NCT03894540|449784180|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
125044660|NCT03894540|449784181|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
125044661|NCT03894540|449784182|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
125044662|NCT03894540|449784177|FG000|Overall Study|Progressive Disease Clinical|1|||
125218892|NCT03538691|450427420|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
125044663|NCT03894540|449784178|FG001|Overall Study|Progressive Disease Clinical|1|||
125044664|NCT03894540|449784179|FG002|Overall Study|Progressive Disease Clinical|0|||
125044665|NCT03894540|449784180|FG003|Overall Study|Progressive Disease Clinical|1|||
125044666|NCT03894540|449784181|FG004|Overall Study|Progressive Disease Clinical|5|||
125044667|NCT03894540|449784182|FG005|Overall Study|Progressive Disease Clinical|1|||
125044668|NCT03894540|449784177|FG000|Overall Study|Study termination by sponsor|0|||
125044669|NCT03894540|449784178|FG001|Overall Study|Study termination by sponsor|0|||
125044670|NCT03894540|449784179|FG002|Overall Study|Study termination by sponsor|0|||
125044671|NCT03894540|449784180|FG003|Overall Study|Study termination by sponsor|0|||
125044672|NCT03894540|449784181|FG004|Overall Study|Study termination by sponsor|2|||
125044673|NCT03894540|449784182|FG005|Overall Study|Study termination by sponsor|0|||
125044674|NCT03000452|449784185|FG000|Treatment Period|Death|1|||
125044675|NCT03000452|449784185|FG000|Treatment Period|Progressive Disease (PD)|14|||
125044676|NCT03000452|449784185|FG000|Treatment Period|Physician Decision|1|||
125044677|NCT03000452|449784185|FG000|Treatment Period|Miscellaneous|2|||
125044678|NCT03000452|449784185|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
125044679|NCT03000452|449784185|FG000|Follow-Up Period|Death|3|||
125044680|NCT03000452|449784185|FG000|Follow-Up Period|Withdrawal by Subject|3|||
125044681|NCT03043365|449784186|FG000|Weeks 0 to Week 8|Adverse Event|1|||
125044682|NCT03043365|449784187|FG001|Weeks 0 to Week 8|Adverse Event|3|||
125044683|NCT03043365|449784186|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
125044684|NCT03043365|449784187|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
125044685|NCT03043365|449784186|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
125044686|NCT03043365|449784187|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
125044687|NCT03455543|449784188|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
125044688|NCT03455543|449784189|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
125044689|NCT03455543|449784190|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
125044690|NCT03455543|449784188|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
125044691|NCT03455543|449784189|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
125044692|NCT03455543|449784190|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
125044693|NCT03455543|449784188|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
125044694|NCT03455543|449784189|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
125218893|NCT03538691|450427421|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
125218894|NCT03538691|450427422|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
125218895|NCT03538691|450427423|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
125218896|NCT03538691|450427420|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
125218897|NCT03538691|450427421|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
125218898|NCT03538691|450427422|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
125044695|NCT03455543|449784190|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
125044696|NCT03455543|449784188|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
125044697|NCT03455543|449784189|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
125044698|NCT03455543|449784190|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
125044699|NCT03455543|449784188|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
125044700|NCT03455543|449784189|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
125044701|NCT03455543|449784190|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
125044702|NCT03455543|449784188|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
125044703|NCT03455543|449784189|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
125044704|NCT03455543|449784190|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
125044705|NCT03455543|449784188|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
125044706|NCT03455543|449784189|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
125044707|NCT03455543|449784190|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
125044708|NCT03455543|449784188|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
125044709|NCT03455543|449784189|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
125044710|NCT03455543|449784190|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
125044711|NCT03455543|449784188|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
125044712|NCT03455543|449784189|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
125044713|NCT03455543|449784190|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
125044714|NCT02873221|449784191|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
125044715|NCT02873221|449784192|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
125044716|NCT02873221|449784193|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
125044717|NCT02873221|449784191|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
125044718|NCT02873221|449784192|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
125044719|NCT02873221|449784193|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
125044720|NCT02873221|449784191|FG000|Treatment Period|Protocol Violation|2|||
125044721|NCT02873221|449784192|FG001|Treatment Period|Protocol Violation|5|||
125044722|NCT02873221|449784193|FG002|Treatment Period|Protocol Violation|8|||
125044723|NCT02873221|449784191|FG000|Treatment Period|Pregnancy|4|||
125044724|NCT02873221|449784192|FG001|Treatment Period|Pregnancy|6|||
125044725|NCT02873221|449784193|FG002|Treatment Period|Pregnancy|3|||
125044726|NCT02873221|449784191|FG000|Treatment Period|Lack of Qualifying Event|0|||
125044727|NCT02873221|449784192|FG001|Treatment Period|Lack of Qualifying Event|3|||
125044728|NCT02873221|449784193|FG002|Treatment Period|Lack of Qualifying Event|1|||
125044729|NCT02873221|449784191|FG000|Treatment Period|Withdrawal of Consent|52|||
125044730|NCT02873221|449784192|FG001|Treatment Period|Withdrawal of Consent|51|||
125044731|NCT02873221|449784193|FG002|Treatment Period|Withdrawal of Consent|41|||
125044732|NCT02873221|449784191|FG000|Treatment Period|Lack of Efficacy|0|||
125044733|NCT02873221|449784192|FG001|Treatment Period|Lack of Efficacy|17|||
125044734|NCT02873221|449784193|FG002|Treatment Period|Lack of Efficacy|12|||
125044735|NCT02873221|449784191|FG000|Treatment Period|Adverse Event|4|||
125044736|NCT02873221|449784192|FG001|Treatment Period|Adverse Event|9|||
125044737|NCT02873221|449784193|FG002|Treatment Period|Adverse Event|11|||
125044738|NCT02873221|449784191|FG000|Treatment Period|Lost to Follow-up|26|||
125044739|NCT02873221|449784192|FG001|Treatment Period|Lost to Follow-up|30|||
125044740|NCT02873221|449784193|FG002|Treatment Period|Lost to Follow-up|26|||
125044741|NCT02873221|449784191|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
125044742|NCT02873221|449784192|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
125044743|NCT02873221|449784193|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
125044744|NCT02873221|449784191|FG000|Safety Follow-up Period|Protocol Violation|0|||
125044745|NCT02873221|449784192|FG001|Safety Follow-up Period|Protocol Violation|0|||
125044746|NCT02873221|449784193|FG002|Safety Follow-up Period|Protocol Violation|1|||
125044747|NCT02873221|449784191|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
125044748|NCT02873221|449784192|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
125044749|NCT02873221|449784193|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
125044750|NCT02873221|449784191|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
125044751|NCT02873221|449784192|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
125044752|NCT02873221|449784193|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
125044753|NCT01508676|449784194|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
125044754|NCT01508676|449784195|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
125044755|NCT01508676|449784194|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
125044756|NCT01508676|449784195|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
125044757|NCT01508676|449784194|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
125044758|NCT01508676|449784195|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
125044759|NCT01508676|449784194|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
125044760|NCT01508676|449784195|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
125044761|NCT01508676|449784194|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
125044762|NCT01508676|449784195|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
125044763|NCT02532543|449784196|FG000|Overall Study|Lost to Follow-up|0|||
125044764|NCT02532543|449784197|FG001|Overall Study|Lost to Follow-up|0|||
125044765|NCT02532543|449784198|FG002|Overall Study|Lost to Follow-up|1|||
125044766|NCT02532543|449784199|FG003|Overall Study|Lost to Follow-up|0|||
125044767|NCT02614794|449784202|FG000|Overall Study|Death|258|||
125044768|NCT02614794|449784203|FG001|Overall Study|Death|151|||
125044769|NCT02614794|449784202|FG000|Overall Study|Study closure by Sponsor|119|||
125044770|NCT02614794|449784203|FG001|Overall Study|Study closure by Sponsor|45|||
125044771|NCT02614794|449784202|FG000|Overall Study|Withdrawal by Subject|24|||
125044772|NCT02614794|449784203|FG001|Overall Study|Withdrawal by Subject|5|||
125135692|NCT01494532|450120217|FG005|Overall Study|Adverse Event|0|||
125044773|NCT02614794|449784202|FG000|Overall Study|Lost to Follow-up|7|||
125044774|NCT02614794|449784203|FG001|Overall Study|Lost to Follow-up|0|||
125135693|NCT01494532|450120212|FG000|Overall Study|Lack of Efficacy|0|||
125135694|NCT01494532|450120213|FG001|Overall Study|Lack of Efficacy|0|||
125044775|NCT02614794|449784202|FG000|Overall Study|Physician Decision|1|||
125044776|NCT02614794|449784203|FG001|Overall Study|Physician Decision|1|||
125044777|NCT02614794|449784202|FG000|Overall Study|Hospital closure|1|||
125044778|NCT02614794|449784203|FG001|Overall Study|Hospital closure|0|||
125044779|NCT02460822|449784213|FG000|Overall Study|Withdrawal by Subject|1|||
125044780|NCT01633060|449784214|FG000|Randomization Phase|Protocol deviation|1|||
125135695|NCT01494532|450120214|FG002|Overall Study|Lack of Efficacy|0|||
125044781|NCT01633060|449784215|FG001|Randomization Phase|Protocol deviation|2|||
125044782|NCT01633060|449784214|FG000|Randomization Phase|Technical problem|0|||
125044783|NCT01633060|449784215|FG001|Randomization Phase|Technical problem|1|||
125044784|NCT01633060|449784214|FG000|Treatment Phase|Adverse Event|24|||
125044785|NCT01633060|449784215|FG001|Treatment Phase|Adverse Event|3|||
125044786|NCT01633060|449784214|FG000|Treatment Phase|Lost to Follow-up|1|||
125044787|NCT01633060|449784215|FG001|Treatment Phase|Lost to Follow-up|0|||
125044788|NCT01633060|449784214|FG000|Treatment Phase|Physician Decision|16|||
125044789|NCT01633060|449784215|FG001|Treatment Phase|Physician Decision|7|||
125044790|NCT01633060|449784214|FG000|Treatment Phase|Progressive Disease|210|||
125044791|NCT01633060|449784215|FG001|Treatment Phase|Progressive Disease|120|||
125044792|NCT01633060|449784214|FG000|Treatment Phase|Protocol Deviation|1|||
125044793|NCT01633060|449784215|FG001|Treatment Phase|Protocol Deviation|0|||
125044794|NCT01633060|449784214|FG000|Treatment Phase|Study Terminated by sponsor|7|||
125044795|NCT01633060|449784215|FG001|Treatment Phase|Study Terminated by sponsor|3|||
125044796|NCT01633060|449784214|FG000|Treatment Phase|Subject/guardian decision|25|||
125044797|NCT01633060|449784215|FG001|Treatment Phase|Subject/guardian decision|4|||
125044798|NCT01633060|449784214|FG000|Treatment Phase|Death|4|||
125044799|NCT01633060|449784215|FG001|Treatment Phase|Death|3|||
125044800|NCT01633060|449784214|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
125044801|NCT01633060|449784215|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
125044802|NCT01633060|449784214|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
125044803|NCT01633060|449784215|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
125044804|NCT01633060|449784214|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
125044805|NCT01633060|449784215|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
125044806|NCT01633060|449784214|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
125044807|NCT01633060|449784215|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
125044808|NCT01633060|449784214|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
125044809|NCT01633060|449784215|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
125044810|NCT01633060|449784214|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
125044811|NCT01633060|449784215|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
125044812|NCT01396525|449784220|FG000|Overall Study|Withdrawal by Subject|8|||
125135696|NCT01494532|450120215|FG003|Overall Study|Lack of Efficacy|0|||
125135697|NCT01494532|450120216|FG004|Overall Study|Lack of Efficacy|2|||
125135698|NCT01494532|450120217|FG005|Overall Study|Lack of Efficacy|0|||
125135699|NCT01494532|450120212|FG000|Overall Study|Protocol deviation|2|||
125135700|NCT01494532|450120213|FG001|Overall Study|Protocol deviation|1|||
125135701|NCT01494532|450120214|FG002|Overall Study|Protocol deviation|3|||
125135702|NCT01494532|450120215|FG003|Overall Study|Protocol deviation|2|||
125135703|NCT01494532|450120216|FG004|Overall Study|Protocol deviation|3|||
125135704|NCT01494532|450120217|FG005|Overall Study|Protocol deviation|0|||
125135705|NCT01494532|450120212|FG000|Overall Study|Protocol-defined stopping criteria|0|||
125135706|NCT01494532|450120213|FG001|Overall Study|Protocol-defined stopping criteria|0|||
125135707|NCT01494532|450120214|FG002|Overall Study|Protocol-defined stopping criteria|1|||
125135708|NCT01494532|450120215|FG003|Overall Study|Protocol-defined stopping criteria|0|||
125135709|NCT01494532|450120216|FG004|Overall Study|Protocol-defined stopping criteria|0|||
125135710|NCT01494532|450120217|FG005|Overall Study|Protocol-defined stopping criteria|0|||
125135711|NCT01494532|450120212|FG000|Overall Study|Lost to Follow-up|1|||
125135712|NCT01494532|450120213|FG001|Overall Study|Lost to Follow-up|0|||
125135713|NCT01494532|450120214|FG002|Overall Study|Lost to Follow-up|0|||
125135714|NCT01494532|450120215|FG003|Overall Study|Lost to Follow-up|2|||
125135715|NCT01494532|450120216|FG004|Overall Study|Lost to Follow-up|0|||
125135716|NCT01494532|450120217|FG005|Overall Study|Lost to Follow-up|0|||
125135717|NCT01494532|450120212|FG000|Overall Study|Physician Decision|0|||
125135718|NCT01494532|450120213|FG001|Overall Study|Physician Decision|1|||
125135719|NCT01494532|450120214|FG002|Overall Study|Physician Decision|1|||
125135720|NCT01494532|450120215|FG003|Overall Study|Physician Decision|2|||
125135721|NCT01494532|450120216|FG004|Overall Study|Physician Decision|0|||
125135722|NCT01494532|450120217|FG005|Overall Study|Physician Decision|0|||
125135723|NCT01494532|450120212|FG000|Overall Study|Withdrawal by Subject|3|||
125135724|NCT01494532|450120213|FG001|Overall Study|Withdrawal by Subject|1|||
125044813|NCT01396525|449784220|FG000|Overall Study|Death|14|||
125135725|NCT01494532|450120214|FG002|Overall Study|Withdrawal by Subject|4|||
125135726|NCT01494532|450120215|FG003|Overall Study|Withdrawal by Subject|3|||
125135727|NCT01494532|450120216|FG004|Overall Study|Withdrawal by Subject|2|||
125135728|NCT01494532|450120217|FG005|Overall Study|Withdrawal by Subject|0|||
125135729|NCT00834717|450121669|FG000|First Intervention|Adverse Event|1|||
125044814|NCT01396525|449784220|FG000|Overall Study|Lost to Follow-up|4|||
125044815|NCT03114969|449784221|FG000|Overall Study|Lost to Follow-up|0|||
125044816|NCT03114969|449784222|FG001|Overall Study|Lost to Follow-up|0|||
125135730|NCT00834717|450121670|FG001|First Intervention|Adverse Event|0|||
125135731|NCT00834717|450121669|FG000|First Intervention|Withdrawal by Subject|0|||
125135732|NCT00834717|450121670|FG001|First Intervention|Withdrawal by Subject|1|||
125135733|NCT02222818|450121671|FG000|Period 1|Eligibility criteria not met|0|||
125135734|NCT02222818|450121672|FG001|Period 1|Eligibility criteria not met|3|||
125135735|NCT01660243|450121673|FG000|Overall Study|Adverse Event|1|||
125135736|NCT01660243|450121674|FG001|Overall Study|Adverse Event|0|||
125135737|NCT01660243|450121675|FG002|Overall Study|Adverse Event|1|||
125135738|NCT01660243|450121676|FG003|Overall Study|Adverse Event|0|||
125135739|NCT01660243|450121673|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
125135740|NCT01660243|450121674|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
125135741|NCT01660243|450121675|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
125135742|NCT01660243|450121676|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
125135743|NCT01660243|450121673|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
125135744|NCT01660243|450121674|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
125135745|NCT01660243|450121675|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
125135746|NCT01660243|450121676|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
125135747|NCT01660243|450121673|FG000|Overall Study|Randomization error|0|||
125135748|NCT01660243|450121674|FG001|Overall Study|Randomization error|0|||
125135749|NCT01660243|450121675|FG002|Overall Study|Randomization error|0|||
125135750|NCT01660243|450121676|FG003|Overall Study|Randomization error|1|||
125135751|NCT03025087|450121677|FG000|Overall Study|Physician Decision|3|||
125135752|NCT03025087|450121678|FG001|Overall Study|Physician Decision|3|||
125135753|NCT03025087|450121679|FG002|Overall Study|Physician Decision|0|||
125135754|NCT03025087|450121680|FG003|Overall Study|Physician Decision|0|||
125135755|NCT03025087|450121681|FG004|Overall Study|Physician Decision|0|||
125135756|NCT03025087|450121677|FG000|Overall Study|Withdrawal by Subject|1|||
125135757|NCT03025087|450121678|FG001|Overall Study|Withdrawal by Subject|1|||
125135758|NCT03025087|450121679|FG002|Overall Study|Withdrawal by Subject|0|||
125135759|NCT03025087|450121680|FG003|Overall Study|Withdrawal by Subject|0|||
125218899|NCT03538691|450427423|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
125218900|NCT03538691|450427420|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
125218901|NCT03538691|450427421|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
125218902|NCT03538691|450427422|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
125218903|NCT03538691|450427423|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
125218904|NCT03538691|450427420|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
125218905|NCT03538691|450427421|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
125044817|NCT03114969|449784223|FG002|Overall Study|Lost to Follow-up|3|||
125044818|NCT03114969|449784224|FG003|Overall Study|Lost to Follow-up|2|||
125044819|NCT03114969|449784225|FG004|Overall Study|Lost to Follow-up|0|||
125044820|NCT03114969|449784226|FG005|Overall Study|Lost to Follow-up|0|||
125044821|NCT03114969|449784227|FG006|Overall Study|Lost to Follow-up|0|||
125044822|NCT03114969|449784228|FG007|Overall Study|Lost to Follow-up|0|||
125044823|NCT03114969|449784229|FG008|Overall Study|Lost to Follow-up|0|||
125044824|NCT03114969|449784221|FG000|Overall Study|Adverse Event|0|||
125044825|NCT03114969|449784222|FG001|Overall Study|Adverse Event|0|||
125044826|NCT03114969|449784223|FG002|Overall Study|Adverse Event|1|||
125044827|NCT03114969|449784224|FG003|Overall Study|Adverse Event|0|||
125044828|NCT03114969|449784225|FG004|Overall Study|Adverse Event|0|||
125044829|NCT03114969|449784226|FG005|Overall Study|Adverse Event|1|||
125044830|NCT03114969|449784227|FG006|Overall Study|Adverse Event|1|||
125044831|NCT03114969|449784228|FG007|Overall Study|Adverse Event|0|||
125044832|NCT03114969|449784229|FG008|Overall Study|Adverse Event|2|||
125044833|NCT00949650|449784230|FG000|Overall Study|Progressive disease|188|||
125044834|NCT00949650|449784231|FG001|Overall Study|Progressive disease|19|||
125044835|NCT00949650|449784230|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
125044836|NCT00949650|449784231|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
125044837|NCT00949650|449784230|FG000|Overall Study|Other Adverse Event (AE)|28|||
125044838|NCT00949650|449784231|FG001|Overall Study|Other Adverse Event (AE)|17|||
125044839|NCT00949650|449784230|FG000|Overall Study|Protocol Violation|1|||
125044840|NCT00949650|449784231|FG001|Overall Study|Protocol Violation|4|||
125044841|NCT00949650|449784230|FG000|Overall Study|Refusal to continue medication|7|||
125044842|NCT00949650|449784231|FG001|Overall Study|Refusal to continue medication|11|||
125044843|NCT00949650|449784230|FG000|Overall Study|Not treated|1|||
125044844|NCT00949650|449784231|FG001|Overall Study|Not treated|4|||
125044845|NCT00949650|449784230|FG000|Overall Study|Other not specified above|5|||
125044846|NCT00949650|449784231|FG001|Overall Study|Other not specified above|0|||
125044847|NCT04601272|449784232|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
125044848|NCT04601272|449784233|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
125044849|NCT04601272|449784234|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
125044850|NCT00414440|449784235|FG000|Core Period|Withdrawal by Subject|70|||
125044851|NCT00414440|449784236|FG001|Core Period|Withdrawal by Subject|32|||
125044852|NCT00414440|449784235|FG000|Extension Period|Lost to Follow-up|44|||
125044853|NCT00414440|449784236|FG001|Extension Period|Lost to Follow-up|52|||
125044854|NCT00414440|449784235|FG000|Extension Period|Did not consent to continue follow up|61|||
125044855|NCT00414440|449784236|FG001|Extension Period|Did not consent to continue follow up|54|||
125044856|NCT00414440|449784235|FG000|Extension Period|Other|1|||
125044857|NCT00414440|449784236|FG001|Extension Period|Other|1|||
125044858|NCT00414440|449784235|FG000|Extension Period|Administrative|16|||
125044859|NCT00414440|449784236|FG001|Extension Period|Administrative|16|||
125044860|NCT00414440|449784235|FG000|Extension Period|Death|1|||
125044861|NCT00414440|449784236|FG001|Extension Period|Death|2|||
125044862|NCT00414440|449784235|FG000|Extension Period|Withdrawal by Subject|9|||
125044863|NCT00414440|449784236|FG001|Extension Period|Withdrawal by Subject|7|||
125044864|NCT00414440|449784235|FG000|Extension Period|Not included in follow up period|18|||
125044865|NCT00414440|449784236|FG001|Extension Period|Not included in follow up period|8|||
125044866|NCT02168946|449784237|FG000|Overall Study|Adverse Event|8|||
125044867|NCT02168946|449784238|FG001|Overall Study|Adverse Event|5|||
125044868|NCT02168946|449784237|FG000|Overall Study|Lost to Follow-up|3|||
125044869|NCT02168946|449784238|FG001|Overall Study|Lost to Follow-up|0|||
125044870|NCT02168946|449784237|FG000|Overall Study|Subject unable to come back for visits|1|||
125044871|NCT02168946|449784238|FG001|Overall Study|Subject unable to come back for visits|0|||
125044872|NCT04222725|449784242|FG000|Overall Study|Adverse Event|0|||
125044873|NCT04222725|449784243|FG001|Overall Study|Adverse Event|1|||
125044874|NCT04222725|449784244|FG002|Overall Study|Adverse Event|0|||
125044875|NCT04222725|449784245|FG003|Overall Study|Adverse Event|0|||
125044876|NCT01743027|449784250|FG000|Overall Study|Adverse Event|2|||
125044877|NCT01743027|449784251|FG001|Overall Study|Adverse Event|0|||
125044878|NCT01743027|449784252|FG002|Overall Study|Adverse Event|0|||
125044879|NCT01743027|449784253|FG003|Overall Study|Adverse Event|0|||
125044880|NCT01743027|449784250|FG000|Overall Study|Lost to Follow-up|0|||
125044881|NCT01743027|449784251|FG001|Overall Study|Lost to Follow-up|0|||
125044882|NCT01743027|449784252|FG002|Overall Study|Lost to Follow-up|2|||
125044883|NCT01743027|449784253|FG003|Overall Study|Lost to Follow-up|0|||
125044884|NCT01743027|449784250|FG000|Overall Study|Progressive Disease|1|||
125044885|NCT01743027|449784251|FG001|Overall Study|Progressive Disease|4|||
125135760|NCT03025087|450121681|FG004|Overall Study|Withdrawal by Subject|0|||
125135761|NCT03025087|450121677|FG000|Overall Study|Unable to complete MRI|2|||
125135762|NCT03025087|450121678|FG001|Overall Study|Unable to complete MRI|2|||
125135763|NCT03025087|450121679|FG002|Overall Study|Unable to complete MRI|0|||
125135764|NCT03025087|450121680|FG003|Overall Study|Unable to complete MRI|0|||
125135765|NCT03025087|450121681|FG004|Overall Study|Unable to complete MRI|0|||
125135766|NCT00508651|450121684|FG000|Overall Study|Lost to Follow-up|3|||
125135767|NCT00508651|450121685|FG001|Overall Study|Lost to Follow-up|1|||
125135768|NCT00508651|450121684|FG000|Overall Study|Withdrawal by Subject|1|||
125135769|NCT00508651|450121685|FG001|Overall Study|Withdrawal by Subject|1|||
125135770|NCT05710718|450121692|FG000|Overall Study|Withdrawal by Subject|5|||
125135771|NCT05710718|450121693|FG001|Overall Study|Withdrawal by Subject|1|||
125135772|NCT05710718|450121692|FG000|Overall Study|Lost to Follow-up|0|||
125135773|NCT05710718|450121693|FG001|Overall Study|Lost to Follow-up|1|||
125044886|NCT01743027|449784252|FG002|Overall Study|Progressive Disease|3|||
125044887|NCT01743027|449784253|FG003|Overall Study|Progressive Disease|0|||
125044888|NCT01743027|449784250|FG000|Overall Study|Protocol Violation|1|||
125044889|NCT01743027|449784251|FG001|Overall Study|Protocol Violation|1|||
125044890|NCT01743027|449784252|FG002|Overall Study|Protocol Violation|1|||
125044891|NCT01743027|449784253|FG003|Overall Study|Protocol Violation|0|||
125044892|NCT01743027|449784250|FG000|Overall Study|Withdrawal by Subject|1|||
125044893|NCT01743027|449784251|FG001|Overall Study|Withdrawal by Subject|0|||
125044894|NCT01743027|449784252|FG002|Overall Study|Withdrawal by Subject|3|||
125044895|NCT01743027|449784253|FG003|Overall Study|Withdrawal by Subject|1|||
125044896|NCT00069121|449784257|FG000|Overall Study|Death|286|||
125044897|NCT00069121|449784258|FG001|Overall Study|Death|242|||
125044898|NCT00069121|449784257|FG000|Overall Study|Withdrawal by Subject|18|||
125044899|NCT00069121|449784258|FG001|Overall Study|Withdrawal by Subject|20|||
125044900|NCT00069121|449784257|FG000|Overall Study|Lost to Follow-up|63|||
125044901|NCT00069121|449784258|FG001|Overall Study|Lost to Follow-up|63|||
125044902|NCT00231478|449784264|FG000|Overall Study|Protocol Violation|3|||
125044903|NCT00231478|449784265|FG001|Overall Study|Protocol Violation|2|||
125044904|NCT00231478|449784264|FG000|Overall Study|Refused Treatment|1|||
125044905|NCT00231478|449784265|FG001|Overall Study|Refused Treatment|1|||
125044906|NCT00231478|449784264|FG000|Overall Study|Withdrawal by Subject|1|||
125044907|NCT00231478|449784265|FG001|Overall Study|Withdrawal by Subject|0|||
125044908|NCT00231478|449784264|FG000|Overall Study|Adverse Event|0|||
125135774|NCT05710718|450121692|FG000|Overall Study|Death|0|||
125135775|NCT05710718|450121693|FG001|Overall Study|Death|1|||
125135776|NCT06381102|450121694|FG000|Washout 5 Days|Withdrawal by Subject|0|||
125135777|NCT06381102|450121695|FG001|Washout 5 Days|Withdrawal by Subject|2|||
125044909|NCT00231478|449784265|FG001|Overall Study|Adverse Event|1|||
125044910|NCT00231478|449784264|FG000|Overall Study|Administrative|3|||
125044911|NCT00231478|449784265|FG001|Overall Study|Administrative|2|||
125044912|NCT00393458|449784272|FG000|Overall Study|Adverse Event|35|||
125044913|NCT00393458|449784273|FG001|Overall Study|Adverse Event|24|||
125044914|NCT00393458|449784274|FG002|Overall Study|Adverse Event|40|||
125044915|NCT00393458|449784275|FG003|Overall Study|Adverse Event|35|||
125044916|NCT00393458|449784272|FG000|Overall Study|Subject withdrew consent|27|||
125044917|NCT00393458|449784273|FG001|Overall Study|Subject withdrew consent|40|||
125044918|NCT00393458|449784274|FG002|Overall Study|Subject withdrew consent|33|||
125044919|NCT00393458|449784275|FG003|Overall Study|Subject withdrew consent|50|||
125044920|NCT00393458|449784272|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
125044921|NCT00393458|449784273|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
125044922|NCT00393458|449784274|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
125044923|NCT00393458|449784275|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
125044924|NCT00393458|449784272|FG000|Overall Study|Protocol deviation|11|||
125044925|NCT00393458|449784273|FG001|Overall Study|Protocol deviation|11|||
125044926|NCT00393458|449784274|FG002|Overall Study|Protocol deviation|11|||
125044927|NCT00393458|449784275|FG003|Overall Study|Protocol deviation|10|||
125044928|NCT00393458|449784272|FG000|Overall Study|Administrative problems|7|||
125044929|NCT00393458|449784273|FG001|Overall Study|Administrative problems|8|||
125044930|NCT00393458|449784274|FG002|Overall Study|Administrative problems|5|||
125044931|NCT00393458|449784275|FG003|Overall Study|Administrative problems|2|||
125044932|NCT00393458|449784272|FG000|Overall Study|Lost to Follow-up|5|||
125044933|NCT00393458|449784273|FG001|Overall Study|Lost to Follow-up|6|||
125044934|NCT00393458|449784274|FG002|Overall Study|Lost to Follow-up|5|||
125044935|NCT00393458|449784275|FG003|Overall Study|Lost to Follow-up|3|||
125044936|NCT00393458|449784272|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125044937|NCT00393458|449784273|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125044938|NCT00393458|449784274|FG002|Overall Study|Abnormal laboratory value(s)|0|||
125044939|NCT00393458|449784275|FG003|Overall Study|Abnormal laboratory value(s)|0|||
125044940|NCT00393458|449784272|FG000|Overall Study|Death|1|||
125044941|NCT00393458|449784273|FG001|Overall Study|Death|1|||
125044942|NCT00393458|449784274|FG002|Overall Study|Death|5|||
125044943|NCT00393458|449784275|FG003|Overall Study|Death|5|||
125044944|NCT00393458|449784272|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125044945|NCT00393458|449784273|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125044946|NCT00393458|449784274|FG002|Overall Study|Abnormal test procedure result(s)|1|||
125044947|NCT00393458|449784275|FG003|Overall Study|Abnormal test procedure result(s)|2|||
125044948|NCT00393458|449784272|FG000|Overall Study|Subject no longer requires study drug|0|||
125044949|NCT00393458|449784273|FG001|Overall Study|Subject no longer requires study drug|1|||
125044950|NCT00393458|449784274|FG002|Overall Study|Subject no longer requires study drug|0|||
125044951|NCT00393458|449784275|FG003|Overall Study|Subject no longer requires study drug|0|||
125044952|NCT01444391|449784282|FG000|Overall Study|Death|1|||
125044953|NCT02704429|449784285|FG000|Part A: 24 Weeks|Adverse Event|3|||
125044954|NCT02704429|449784286|FG001|Part A: 24 Weeks|Adverse Event|0|||
125044955|NCT02704429|449784285|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
125044956|NCT02704429|449784286|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
125044957|NCT00104104|449784287|FG000|Overall Study|Adverse Event|8|||
125044958|NCT00104104|449784288|FG001|Overall Study|Adverse Event|8|||
125044959|NCT00104104|449784287|FG000|Overall Study|Abnormal laboratory value(s)|20|||
125044960|NCT00104104|449784288|FG001|Overall Study|Abnormal laboratory value(s)|14|||
125044961|NCT00104104|449784287|FG000|Overall Study|Lack of Efficacy|0|||
125044962|NCT00104104|449784288|FG001|Overall Study|Lack of Efficacy|3|||
125044963|NCT00104104|449784287|FG000|Overall Study|Condition no longer requires study drug|7|||
125044964|NCT00104104|449784288|FG001|Overall Study|Condition no longer requires study drug|4|||
125044965|NCT00104104|449784287|FG000|Overall Study|Protocol Violation|5|||
125044966|NCT00104104|449784288|FG001|Overall Study|Protocol Violation|2|||
125044967|NCT00104104|449784287|FG000|Overall Study|Withdrawal by Subject|11|||
125044968|NCT00104104|449784288|FG001|Overall Study|Withdrawal by Subject|15|||
125044969|NCT00104104|449784287|FG000|Overall Study|Lost to Follow-up|3|||
125044970|NCT00104104|449784288|FG001|Overall Study|Lost to Follow-up|7|||
125044971|NCT00104104|449784287|FG000|Overall Study|Administrative problems|12|||
125044972|NCT00104104|449784288|FG001|Overall Study|Administrative problems|13|||
125044973|NCT00104104|449784287|FG000|Overall Study|Death|9|||
125044974|NCT00104104|449784288|FG001|Overall Study|Death|6|||
125044975|NCT01821677|449784291|FG000|Overall Study|Adverse Event|4|||
125044976|NCT01821677|449784292|FG001|Overall Study|Adverse Event|6|||
125044977|NCT01821677|449784293|FG002|Overall Study|Adverse Event|5|||
125044978|NCT01821677|449784291|FG000|Overall Study|Physician Decision|1|||
125044979|NCT01821677|449784292|FG001|Overall Study|Physician Decision|4|||
125044980|NCT01821677|449784293|FG002|Overall Study|Physician Decision|1|||
125044981|NCT01821677|449784291|FG000|Overall Study|Non-compliance|0|||
125044982|NCT01821677|449784292|FG001|Overall Study|Non-compliance|1|||
125135778|NCT01319383|450121696|FG000|Overall Study|No ex vivo or in vivo response|4|||
125135779|NCT01319383|450121697|FG001|Overall Study|No ex vivo or in vivo response|0|||
125135780|NCT01319383|450121696|FG000|Overall Study|Physician Decision|3|||
125135781|NCT01319383|450121697|FG001|Overall Study|Physician Decision|0|||
125135782|NCT01319383|450121696|FG000|Overall Study|Lack of Efficacy|5|||
125135783|NCT01319383|450121697|FG001|Overall Study|Lack of Efficacy|9|||
125135784|NCT01319383|450121696|FG000|Overall Study|No in vivo response to interval doses|0|||
125135785|NCT01319383|450121697|FG001|Overall Study|No in vivo response to interval doses|1|||
125135786|NCT01987765|450121698|FG000|Overall Study|Protocol Violation|65|||
125135787|NCT01987765|450121698|FG000|Overall Study|Lost to Follow-up|37|||
125135788|NCT00772603|450121699|FG000|Overall Study|Withdrawal by Subject|11|||
125135789|NCT00772603|450121700|FG001|Overall Study|Withdrawal by Subject|10|||
125135790|NCT00772603|450121701|FG002|Overall Study|Withdrawal by Subject|6|||
125135791|NCT00772603|450121699|FG000|Overall Study|Adverse Event|37|||
125135792|NCT00772603|450121700|FG001|Overall Study|Adverse Event|18|||
125135793|NCT00772603|450121701|FG002|Overall Study|Adverse Event|10|||
125135794|NCT00772603|450121699|FG000|Overall Study|Subject Non-compliance|1|||
125135795|NCT00772603|450121700|FG001|Overall Study|Subject Non-compliance|6|||
125135796|NCT00772603|450121701|FG002|Overall Study|Subject Non-compliance|4|||
125135797|NCT00772603|450121699|FG000|Overall Study|Protocol Violation|0|||
125135798|NCT00772603|450121700|FG001|Overall Study|Protocol Violation|1|||
125135799|NCT00772603|450121701|FG002|Overall Study|Protocol Violation|1|||
125135800|NCT00772603|450121699|FG000|Overall Study|Lost to Follow-up|1|||
125135801|NCT00772603|450121700|FG001|Overall Study|Lost to Follow-up|5|||
125135802|NCT00772603|450121701|FG002|Overall Study|Lost to Follow-up|2|||
125135803|NCT00772603|450121699|FG000|Overall Study|Physician Decision|0|||
125135804|NCT00772603|450121700|FG001|Overall Study|Physician Decision|0|||
125135805|NCT00772603|450121701|FG002|Overall Study|Physician Decision|1|||
125135806|NCT00772603|450121699|FG000|Overall Study|Other|2|||
125135807|NCT00772603|450121700|FG001|Overall Study|Other|0|||
125135808|NCT00772603|450121701|FG002|Overall Study|Other|2|||
125135809|NCT01528696|450121712|FG000|Overall Study|See detailed description|18|||
125135810|NCT01528696|450121713|FG001|Overall Study|See detailed description|19|||
125135811|NCT01056484|450121714|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
125135812|NCT01056484|450121715|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
125135813|NCT01056484|450121714|FG000|Randomized Controlled Trial|Physician Decision|1|||
125135814|NCT01056484|450121715|FG001|Randomized Controlled Trial|Physician Decision|0|||
125135815|NCT01056484|450121714|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
125135816|NCT01056484|450121715|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
125135817|NCT00446966|450121718|FG000|Overall Study|Lost to Follow-up|10|||
125135818|NCT00446966|450121719|FG001|Overall Study|Lost to Follow-up|7|||
125135819|NCT01564394|450121722|FG000|Overall Study|Withdrawal by Subject|6|||
125135820|NCT01564394|450121723|FG001|Overall Study|Withdrawal by Subject|10|||
125135821|NCT00859521|450121724|FG000|Washout|Withdrawal by Subject|0|||
125135822|NCT00859521|450121725|FG001|Washout|Withdrawal by Subject|1|||
125135823|NCT02888756|450121726|FG000|Analytical Treatment Interruption|Physician Decision|10|||
125135824|NCT02888756|450121727|FG001|Analytical Treatment Interruption|Physician Decision|6|||
125135825|NCT02888756|450121728|FG002|Analytical Treatment Interruption|Physician Decision|5|||
125135826|NCT01547286|450121736|FG000|Overall Study|Did not meet all eligibility criteria|1|||
125135827|NCT01547286|450121736|FG000|Overall Study|Physician Decision|1|||
125135828|NCT00488774|450121739|FG000|Overall Study|Withdrawal of consent|2|||
125135829|NCT00488774|450121740|FG001|Overall Study|Withdrawal of consent|2|||
125135830|NCT00488774|450121741|FG002|Overall Study|Withdrawal of consent|2|||
125135831|NCT00488774|450121742|FG003|Overall Study|Withdrawal of consent|0|||
125135832|NCT00488774|450121739|FG000|Overall Study|Other|6|||
125135833|NCT00488774|450121740|FG001|Overall Study|Other|3|||
125135834|NCT00488774|450121741|FG002|Overall Study|Other|2|||
125135835|NCT00488774|450121742|FG003|Overall Study|Other|2|||
125135836|NCT00488774|450121739|FG000|Overall Study|Lost to Follow-up|0|||
125135837|NCT00488774|450121740|FG001|Overall Study|Lost to Follow-up|0|||
125135838|NCT00488774|450121741|FG002|Overall Study|Lost to Follow-up|1|||
125135839|NCT00488774|450121742|FG003|Overall Study|Lost to Follow-up|1|||
125135840|NCT02682238|450121743|FG000|Overall Study|Lost to Follow-up|0|||
125135841|NCT02682238|450121744|FG001|Overall Study|Lost to Follow-up|2|||
125135842|NCT02682238|450121743|FG000|Overall Study|Withdrawal by Subject|1|||
125135843|NCT02682238|450121744|FG001|Overall Study|Withdrawal by Subject|0|||
125135844|NCT02682238|450121743|FG000|Overall Study|Adverse Event|1|||
125135845|NCT02682238|450121744|FG001|Overall Study|Adverse Event|0|||
125135846|NCT02682238|450121743|FG000|Overall Study|Non-compliance with Study Drug|1|||
125135847|NCT02682238|450121744|FG001|Overall Study|Non-compliance with Study Drug|0|||
125135848|NCT02682238|450121743|FG000|Overall Study|Non-compliance with Protocol|0|||
125135849|NCT02682238|450121744|FG001|Overall Study|Non-compliance with Protocol|2|||
125135850|NCT00075478|450121745|FG000|Overall Study|not eligible|1|||
125135851|NCT00075478|450121746|FG001|Overall Study|not eligible|0|||
125135852|NCT00075478|450121745|FG000|Overall Study|Physician Decision|0|||
125044983|NCT01821677|449784293|FG002|Overall Study|Non-compliance|2|||
125044984|NCT01821677|449784291|FG000|Overall Study|Lost to Follow-up|2|||
125044985|NCT01821677|449784292|FG001|Overall Study|Lost to Follow-up|1|||
125044986|NCT01821677|449784293|FG002|Overall Study|Lost to Follow-up|3|||
125044987|NCT01821677|449784291|FG000|Overall Study|Protocol Violation|0|||
125044988|NCT01821677|449784292|FG001|Overall Study|Protocol Violation|0|||
125044989|NCT01821677|449784293|FG002|Overall Study|Protocol Violation|2|||
125044990|NCT01821677|449784291|FG000|Overall Study|Withdrawal by Subject|7|||
125044991|NCT01821677|449784292|FG001|Overall Study|Withdrawal by Subject|3|||
125044992|NCT01821677|449784293|FG002|Overall Study|Withdrawal by Subject|2|||
125044993|NCT01821677|449784291|FG000|Overall Study|Other|9|||
125044994|NCT01821677|449784292|FG001|Overall Study|Other|0|||
125044995|NCT01821677|449784293|FG002|Overall Study|Other|0|||
125044996|NCT01855789|449784294|FG000|1) Baseline up to Week 24|Adverse Event|37|||
125044997|NCT01855789|449784295|FG001|1) Baseline up to Week 24|Adverse Event|0|||
125044998|NCT01855789|449784296|FG002|1) Baseline up to Week 24|Adverse Event|0|||
125044999|NCT01855789|449784297|FG003|1) Baseline up to Week 24|Adverse Event|0|||
125045000|NCT01855789|449784294|FG000|1) Baseline up to Week 24|Death|2|||
125045001|NCT01855789|449784295|FG001|1) Baseline up to Week 24|Death|0|||
125045002|NCT01855789|449784296|FG002|1) Baseline up to Week 24|Death|0|||
125045003|NCT01855789|449784297|FG003|1) Baseline up to Week 24|Death|0|||
125045004|NCT01855789|449784294|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
125045005|NCT01855789|449784295|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
125045006|NCT01855789|449784296|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
125045007|NCT01855789|449784297|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
125045008|NCT01855789|449784294|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
125045009|NCT01855789|449784295|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
125045010|NCT01855789|449784296|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
125045011|NCT01855789|449784297|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
125045012|NCT01855789|449784294|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
125045013|NCT01855789|449784295|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
125045014|NCT01855789|449784296|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
125045015|NCT01855789|449784297|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
125045016|NCT01855789|449784294|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
125045017|NCT01855789|449784295|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
125045018|NCT01855789|449784296|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
125045019|NCT01855789|449784297|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
125045020|NCT01855789|449784294|FG000|1) Baseline up to Week 24|Physician Decision|4|||
125045021|NCT01855789|449784295|FG001|1) Baseline up to Week 24|Physician Decision|0|||
125045022|NCT01855789|449784296|FG002|1) Baseline up to Week 24|Physician Decision|0|||
125045023|NCT01855789|449784297|FG003|1) Baseline up to Week 24|Physician Decision|0|||
125045024|NCT01855789|449784294|FG000|1) Baseline up to Week 24|Pregnancy|1|||
125045025|NCT01855789|449784295|FG001|1) Baseline up to Week 24|Pregnancy|0|||
125045026|NCT01855789|449784296|FG002|1) Baseline up to Week 24|Pregnancy|0|||
125045027|NCT01855789|449784297|FG003|1) Baseline up to Week 24|Pregnancy|0|||
125045028|NCT01855789|449784294|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
125045029|NCT01855789|449784295|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
125045030|NCT01855789|449784296|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
125045031|NCT01855789|449784297|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
125045032|NCT01855789|449784294|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
125045033|NCT01855789|449784295|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
125045034|NCT01855789|449784296|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
125045035|NCT01855789|449784297|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
125045036|NCT01855789|449784294|FG000|1) Baseline up to Week 24|Other|4|||
125045037|NCT01855789|449784295|FG001|1) Baseline up to Week 24|Other|0|||
125045038|NCT01855789|449784296|FG002|1) Baseline up to Week 24|Other|0|||
125045039|NCT01855789|449784297|FG003|1) Baseline up to Week 24|Other|0|||
125045040|NCT01855789|449784294|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
125045041|NCT01855789|449784295|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
125045042|NCT01855789|449784296|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
125045043|NCT01855789|449784297|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
125045044|NCT01855789|449784294|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
125045045|NCT01855789|449784295|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
125045046|NCT01855789|449784296|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
125045047|NCT01855789|449784297|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
125045048|NCT01855789|449784294|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
125045049|NCT01855789|449784295|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
125045050|NCT01855789|449784296|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
125045051|NCT01855789|449784297|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
125218906|NCT03538691|450427422|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
125218907|NCT03538691|450427423|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
125218908|NCT03538691|450427420|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
125218909|NCT03538691|450427421|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
125218910|NCT03538691|450427422|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
125218911|NCT03538691|450427423|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
125218912|NCT03538691|450427420|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
125218913|NCT03538691|450427421|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
125218914|NCT03538691|450427422|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
125218915|NCT03538691|450427423|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
125218916|NCT03538691|450427420|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
125218917|NCT03538691|450427421|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
125218918|NCT03538691|450427422|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
125218919|NCT03538691|450427423|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
125218920|NCT03538691|450427420|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
125218921|NCT03538691|450427421|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
125218922|NCT03538691|450427422|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
125218923|NCT03538691|450427423|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
125218924|NCT03538691|450427420|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
125218925|NCT03538691|450427421|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
125218926|NCT03538691|450427422|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
125218927|NCT03538691|450427423|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
125218928|NCT03538691|450427420|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
125218929|NCT03538691|450427421|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
125218930|NCT03538691|450427422|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
125218931|NCT03538691|450427423|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
125218932|NCT03538691|450427420|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
125218933|NCT03538691|450427421|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
125045052|NCT01855789|449784294|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
125045053|NCT01855789|449784295|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
125045054|NCT01855789|449784296|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
125045055|NCT01855789|449784297|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
125045056|NCT01855789|449784294|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
125045057|NCT01855789|449784295|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
125045058|NCT01855789|449784296|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
125045059|NCT01855789|449784297|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
125045060|NCT01855789|449784294|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
125045061|NCT01855789|449784295|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
125045062|NCT01855789|449784296|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
125045063|NCT01855789|449784297|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
125045064|NCT01855789|449784294|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
125045065|NCT01855789|449784295|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
125045066|NCT01855789|449784296|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
125045067|NCT01855789|449784297|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
125045068|NCT01855789|449784294|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
125045069|NCT01855789|449784295|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
125045070|NCT01855789|449784296|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
125045071|NCT01855789|449784297|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
125045072|NCT01855789|449784294|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
125045073|NCT01855789|449784295|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
125045074|NCT01855789|449784296|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
125045075|NCT01855789|449784297|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
125045076|NCT01855789|449784294|FG000|2) Week 24 up to End of Study|Other|0|||
125045077|NCT01855789|449784295|FG001|2) Week 24 up to End of Study|Other|0|||
125045078|NCT01855789|449784296|FG002|2) Week 24 up to End of Study|Other|0|||
125045079|NCT01855789|449784297|FG003|2) Week 24 up to End of Study|Other|1|||
125218934|NCT03538691|450427422|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
125045080|NCT03067311|449784298|FG000|Overall Study|Lost to Follow-up|1|||
125218935|NCT03538691|450427423|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
125045081|NCT03067311|449784299|FG001|Overall Study|Lost to Follow-up|1|||
125045082|NCT03067311|449784298|FG000|Overall Study|Moved away|1|||
125045083|NCT03067311|449784299|FG001|Overall Study|Moved away|1|||
125045084|NCT01582282|449785780|FG000|Overall Study|Adverse Event|1|||
125045085|NCT01582282|449785781|FG001|Overall Study|Adverse Event|1|||
125045086|NCT01582282|449785782|FG002|Overall Study|Adverse Event|0|||
125045087|NCT01582282|449785780|FG000|Overall Study|Lost to Follow-up|1|||
125045088|NCT01582282|449785781|FG001|Overall Study|Lost to Follow-up|0|||
125045089|NCT01582282|449785782|FG002|Overall Study|Lost to Follow-up|0|||
125045090|NCT01582282|449785780|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
125045091|NCT01582282|449785781|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
125045092|NCT01582282|449785782|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
125045093|NCT01486316|449785783|FG000|Overall Study|Device explanted with/without re-implant|3|||
125045094|NCT01486316|449785784|FG001|Overall Study|Device explanted with/without re-implant|2|||
125045095|NCT01486316|449785785|FG002|Overall Study|Device explanted with/without re-implant|0|||
125045096|NCT01486316|449785786|FG003|Overall Study|Device explanted with/without re-implant|2|||
125045097|NCT01486316|449785783|FG000|Overall Study|Not meeting eligibility criteria|0|||
125045098|NCT01486316|449785784|FG001|Overall Study|Not meeting eligibility criteria|0|||
125045099|NCT01486316|449785785|FG002|Overall Study|Not meeting eligibility criteria|1|||
125045100|NCT01486316|449785786|FG003|Overall Study|Not meeting eligibility criteria|0|||
125045101|NCT01486316|449785783|FG000|Overall Study|Withdrawal by Subject|1|||
125045102|NCT01486316|449785784|FG001|Overall Study|Withdrawal by Subject|0|||
125045103|NCT01486316|449785785|FG002|Overall Study|Withdrawal by Subject|3|||
125045104|NCT01486316|449785786|FG003|Overall Study|Withdrawal by Subject|0|||
125045105|NCT01486316|449785783|FG000|Overall Study|Physician Decision|0|||
125045106|NCT01486316|449785784|FG001|Overall Study|Physician Decision|0|||
125045107|NCT01486316|449785785|FG002|Overall Study|Physician Decision|1|||
125045108|NCT01486316|449785786|FG003|Overall Study|Physician Decision|0|||
125045109|NCT01486316|449785783|FG000|Overall Study|Death|0|||
125045110|NCT01486316|449785784|FG001|Overall Study|Death|1|||
125045111|NCT01486316|449785785|FG002|Overall Study|Death|0|||
125045112|NCT01486316|449785786|FG003|Overall Study|Death|0|||
125045113|NCT03191396|449785794|FG000|Overall Study|Lost to Follow-up|0|||
125045114|NCT03191396|449785795|FG001|Overall Study|Lost to Follow-up|3|||
125045115|NCT03191396|449785794|FG000|Overall Study|Withdrawal by Subject|3|||
125045116|NCT03191396|449785795|FG001|Overall Study|Withdrawal by Subject|2|||
125045117|NCT03635190|449785797|FG000|Overall Study|Lost to Follow-up|4|||
125045118|NCT03635190|449785797|FG000|Overall Study|Death|3|||
125045119|NCT03635190|449785797|FG000|Overall Study|Withdrawal by Subject|1|||
125045120|NCT03635190|449785797|FG000|Overall Study|Patient moved and did not return for follow up|1|||
125045121|NCT03692910|449785800|FG000|Overall Study|Lost to Follow-up|4|||
125045122|NCT03692910|449785801|FG001|Overall Study|Lost to Follow-up|0|||
125045123|NCT03692910|449785802|FG002|Overall Study|Lost to Follow-up|0|||
125045124|NCT03692910|449785800|FG000|Overall Study|Withdrawal by Subject|2|||
125045125|NCT03692910|449785801|FG001|Overall Study|Withdrawal by Subject|0|||
125045126|NCT03692910|449785802|FG002|Overall Study|Withdrawal by Subject|0|||
125045127|NCT01981122|449785807|FG000|Overall Study|Withdrawal by Subject|0|||
125045128|NCT01981122|449785808|FG001|Overall Study|Withdrawal by Subject|2|||
125045129|NCT01981122|449785807|FG000|Overall Study|Protocol Violation|0|||
125045130|NCT01981122|449785808|FG001|Overall Study|Protocol Violation|1|||
125045131|NCT01981122|449785807|FG000|Overall Study|Lost to Follow-up|0|||
125045132|NCT01981122|449785808|FG001|Overall Study|Lost to Follow-up|1|||
125045133|NCT01981122|449785807|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
125045134|NCT01981122|449785808|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
125045135|NCT01981122|449785807|FG000|Overall Study|Death|14|||
125045136|NCT01981122|449785808|FG001|Overall Study|Death|15|||
125045137|NCT03060577|449785809|FG000|Overall Study|Withdrawal by Subject|25|||
125045138|NCT03060577|449785810|FG001|Overall Study|Withdrawal by Subject|5|||
125045139|NCT03060577|449785809|FG000|Overall Study|Physician Decision|4|||
125045140|NCT03060577|449785810|FG001|Overall Study|Physician Decision|3|||
125045141|NCT03060577|449785809|FG000|Overall Study|Lost to Follow-up|3|||
125045142|NCT03060577|449785810|FG001|Overall Study|Lost to Follow-up|0|||
125045143|NCT03060577|449785809|FG000|Overall Study|Death|7|||
125045144|NCT03060577|449785810|FG001|Overall Study|Death|1|||
125045145|NCT03060577|449785809|FG000|Overall Study|Adverse Event|9|||
125045146|NCT03060577|449785810|FG001|Overall Study|Adverse Event|1|||
125045147|NCT03060577|449785809|FG000|Overall Study|Inclusion/Exclusion|1|||
125045148|NCT03060577|449785810|FG001|Overall Study|Inclusion/Exclusion|0|||
125045149|NCT03060577|449785809|FG000|Overall Study|Other|8|||
125045150|NCT03060577|449785810|FG001|Overall Study|Other|2|||
125045151|NCT00092547|449785815|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
125045152|NCT00092547|449785816|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
125045153|NCT00092547|449785817|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
125135853|NCT00075478|450121746|FG001|Overall Study|Physician Decision|1|||
125045154|NCT00092547|449785815|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
125045155|NCT00092547|449785816|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
125045156|NCT00092547|449785817|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
125045157|NCT00092547|449785815|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
125045158|NCT00092547|449785816|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
125045159|NCT00092547|449785817|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
125045160|NCT00092547|449785815|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
125045161|NCT00092547|449785816|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
125045162|NCT00092547|449785817|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
125045163|NCT00092547|449785815|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
125045164|NCT00092547|449785816|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
125045165|NCT00092547|449785817|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
125045166|NCT00092547|449785815|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
125045167|NCT00092547|449785816|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
125045168|NCT00092547|449785817|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
125045169|NCT00092547|449785815|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
125045170|NCT00092547|449785816|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
125045171|NCT00092547|449785817|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
125045172|NCT00092547|449785815|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
125045173|NCT00092547|449785816|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
125045174|NCT00092547|449785817|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
125045175|NCT00092547|449785815|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
125045176|NCT00092547|449785816|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
125045177|NCT00092547|449785817|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
125045178|NCT00092547|449785815|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
125045179|NCT00092547|449785816|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
125045180|NCT00092547|449785817|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
125045181|NCT00092547|449785815|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
125045182|NCT00092547|449785816|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
125045183|NCT00092547|449785817|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
125045184|NCT00092547|449785815|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
125045185|NCT00092547|449785816|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
125045186|NCT00092547|449785817|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
125045187|NCT00092547|449785815|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
125045188|NCT00092547|449785816|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
125045189|NCT00092547|449785817|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
125045190|NCT00092547|449785815|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
125045191|NCT00092547|449785816|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
125045192|NCT00092547|449785817|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
125045193|NCT00092547|449785815|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
125045194|NCT00092547|449785816|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
125045195|NCT00092547|449785817|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
125045196|NCT00092547|449785815|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
125045197|NCT00092547|449785816|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
125045198|NCT00092547|449785817|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
125045199|NCT00092547|449785815|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
125045200|NCT00092547|449785816|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
125045201|NCT00092547|449785817|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
125045202|NCT00092547|449785815|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
125045203|NCT00092547|449785816|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
125045204|NCT00092547|449785817|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
125045205|NCT00092547|449785815|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
125045206|NCT00092547|449785816|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
125045207|NCT00092547|449785817|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
125045208|NCT00092547|449785815|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
125045209|NCT00092547|449785816|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
125045210|NCT00092547|449785817|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
125045211|NCT00092547|449785815|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
125045212|NCT00092547|449785816|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
125045213|NCT00092547|449785817|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
125045214|NCT04328623|449785818|FG000|Overall Study|Protocol Violation|0|||
125045215|NCT04328623|449785819|FG001|Overall Study|Protocol Violation|1|||
125045216|NCT01539837|449785820|FG000|Overall Study|reduce neutrophil level|0|||
125045217|NCT01539837|449785821|FG001|Overall Study|reduce neutrophil level|1|||
125045218|NCT01539837|449785822|FG002|Overall Study|reduce neutrophil level|1|||
125045219|NCT01539837|449785820|FG000|Overall Study|bad compliance|0|||
125045220|NCT01539837|449785821|FG001|Overall Study|bad compliance|0|||
125045221|NCT01539837|449785822|FG002|Overall Study|bad compliance|1|||
125045222|NCT02760602|449785823|FG000|Overall Study|Withdrawal by Subject|1|||
125045223|NCT02760602|449785824|FG001|Overall Study|Withdrawal by Subject|0|||
125045224|NCT02760602|449785823|FG000|Overall Study|Terminated by sponsor|12|||
125045225|NCT02760602|449785824|FG001|Overall Study|Terminated by sponsor|13|||
125045226|NCT02747043|449785829|FG000|Overall Study|Other|1|||
125045227|NCT02747043|449785830|FG001|Overall Study|Other|1|||
125045228|NCT02747043|449785829|FG000|Overall Study|Adverse Event|3|||
125045229|NCT02747043|449785830|FG001|Overall Study|Adverse Event|1|||
125045230|NCT02747043|449785829|FG000|Overall Study|Withdrawal by Subject|1|||
125045231|NCT02747043|449785830|FG001|Overall Study|Withdrawal by Subject|1|||
125045232|NCT02747043|449785829|FG000|Overall Study|Physician Decision|1|||
125045233|NCT02747043|449785830|FG001|Overall Study|Physician Decision|1|||
125045234|NCT02747043|449785829|FG000|Overall Study|Protocol Violation|0|||
125045235|NCT02747043|449785830|FG001|Overall Study|Protocol Violation|1|||
125045236|NCT02747043|449785829|FG000|Overall Study|Disease progression|4|||
125045237|NCT02747043|449785830|FG001|Overall Study|Disease progression|0|||
125045238|NCT02046564|449785831|FG000|Overall Study|Adverse Event|6|||
125045239|NCT02046564|449785832|FG001|Overall Study|Adverse Event|3|||
125045240|NCT02046564|449785831|FG000|Overall Study|Physician Decision|0|||
125045241|NCT02046564|449785832|FG001|Overall Study|Physician Decision|1|||
125045242|NCT02046564|449785831|FG000|Overall Study|Protocol Violation|3|||
125045243|NCT02046564|449785832|FG001|Overall Study|Protocol Violation|1|||
125045244|NCT02046564|449785831|FG000|Overall Study|Withdrawal by Subject|4|||
125045245|NCT02046564|449785832|FG001|Overall Study|Withdrawal by Subject|10|||
125045246|NCT02046564|449785831|FG000|Overall Study|Subject met withdrawal criteria|2|||
125045247|NCT02046564|449785832|FG001|Overall Study|Subject met withdrawal criteria|5|||
125045248|NCT01295905|449785835|FG000|Overall Study|Did not meet inclusion criteria|1|||
125045249|NCT01295905|449785836|FG001|Overall Study|Did not meet inclusion criteria|0|||
125045250|NCT01295905|449785835|FG000|Overall Study|Met exclusion criteria|1|||
125045251|NCT01295905|449785836|FG001|Overall Study|Met exclusion criteria|0|||
125045252|NCT03707977|449785839|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
125045253|NCT03707977|449785840|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
125045254|NCT03707977|449785841|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
125045255|NCT03707977|449785839|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
125045256|NCT03707977|449785840|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
125045257|NCT03707977|449785841|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
125045258|NCT02564120|449785842|FG000|Overall Study|Did not return release forms|160|||
125045259|NCT02564120|449785842|FG000|Overall Study|Death|58|||
125045260|NCT02564120|449785842|FG000|Overall Study|Withdrawal by Subject|204|||
125045261|NCT02564120|449785842|FG000|Overall Study|Other medical condition|24|||
125045262|NCT01629667|449785843|FG000|Overall Study|Lost to Follow-up|0|||
125045263|NCT01629667|449785844|FG001|Overall Study|Lost to Follow-up|1|||
125045264|NCT01629667|449785845|FG002|Overall Study|Lost to Follow-up|1|||
125045265|NCT01629667|449785843|FG000|Overall Study|Withdrawal by Subject|31|||
125045266|NCT01629667|449785844|FG001|Overall Study|Withdrawal by Subject|20|||
125045267|NCT01629667|449785845|FG002|Overall Study|Withdrawal by Subject|28|||
125045268|NCT01629667|449785843|FG000|Overall Study|Death|1|||
125045269|NCT01629667|449785844|FG001|Overall Study|Death|5|||
125045270|NCT01629667|449785845|FG002|Overall Study|Death|3|||
125045271|NCT01629667|449785843|FG000|Overall Study|Randomized, not treated|2|||
125045272|NCT01629667|449785844|FG001|Overall Study|Randomized, not treated|1|||
125045273|NCT01629667|449785845|FG002|Overall Study|Randomized, not treated|0|||
125045274|NCT01629667|449785843|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
125045275|NCT01629667|449785844|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
125045276|NCT01629667|449785845|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
125045277|NCT01629667|449785843|FG000|Overall Study|Requiring lung transplant|2|||
125045278|NCT01629667|449785844|FG001|Overall Study|Requiring lung transplant|1|||
125045279|NCT01629667|449785845|FG002|Overall Study|Requiring lung transplant|3|||
125045280|NCT01629667|449785843|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
125045281|NCT01629667|449785844|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
125045282|NCT01629667|449785845|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
125045283|NCT01629667|449785843|FG000|Overall Study|Started other medicine|1|||
125045284|NCT01629667|449785844|FG001|Overall Study|Started other medicine|0|||
125045285|NCT01629667|449785845|FG002|Overall Study|Started other medicine|1|||
125045286|NCT01629667|449785843|FG000|Overall Study|Site error in safety follow-up|0|||
125045287|NCT01629667|449785844|FG001|Overall Study|Site error in safety follow-up|0|||
125045288|NCT01629667|449785845|FG002|Overall Study|Site error in safety follow-up|1|||
125045289|NCT01629667|449785843|FG000|Overall Study|Enrolled in another clinical study|0|||
125135854|NCT02075463|450121748|FG000|Overall Study|Adverse Event|3|||
125045290|NCT01629667|449785844|FG001|Overall Study|Enrolled in another clinical study|1|||
125045291|NCT01629667|449785845|FG002|Overall Study|Enrolled in another clinical study|0|||
125045292|NCT01629667|449785843|FG000|Overall Study|Code break|1|||
125045293|NCT01629667|449785844|FG001|Overall Study|Code break|0|||
125045294|NCT01629667|449785845|FG002|Overall Study|Code break|0|||
125045295|NCT00609609|449785848|FG000|Overall Study|Withdrawal by Subject|2|||
125045296|NCT00609609|449785849|FG001|Overall Study|Withdrawal by Subject|0|||
125045297|NCT00609609|449785848|FG000|Overall Study|Progression|4|||
125045298|NCT00609609|449785849|FG001|Overall Study|Progression|2|||
125045299|NCT02441803|449785850|FG000|Overall Study|Physician Decision|0|||
125045300|NCT02441803|449785851|FG001|Overall Study|Physician Decision|2|||
125045301|NCT02441803|449785852|FG002|Overall Study|Physician Decision|2|||
125045302|NCT00537823|449785856|FG000|Overall Study|Adverse Event|2|||
125045303|NCT00537823|449785857|FG001|Overall Study|Adverse Event|0|||
125045304|NCT03065530|449785858|FG000|Overall Study|Lack of Efficacy|1|||
125045305|NCT03065530|449785859|FG001|Overall Study|Lack of Efficacy|1|||
125045306|NCT03065530|449785860|FG002|Overall Study|Lack of Efficacy|0|||
125045307|NCT03065530|449785861|FG003|Overall Study|Lack of Efficacy|1|||
125045308|NCT03065530|449785858|FG000|Overall Study|Protocol Violation|1|||
125045309|NCT03065530|449785859|FG001|Overall Study|Protocol Violation|0|||
125045310|NCT03065530|449785860|FG002|Overall Study|Protocol Violation|1|||
125045311|NCT03065530|449785861|FG003|Overall Study|Protocol Violation|1|||
125045312|NCT00852930|449785862|FG000|Overall Study|Withdrawal by Subject|1|||
125045313|NCT00852930|449785863|FG001|Overall Study|Withdrawal by Subject|1|||
125045314|NCT00852930|449785864|FG002|Overall Study|Withdrawal by Subject|1|||
125045315|NCT00852930|449785862|FG000|Overall Study|Physician Decision|0|||
125045316|NCT00852930|449785863|FG001|Overall Study|Physician Decision|0|||
125045317|NCT00852930|449785864|FG002|Overall Study|Physician Decision|1|||
125045318|NCT01512368|449785868|FG000|Overall Study|Protocol Violation|3|||
125045319|NCT02717546|449785873|FG000|Overall Study|Lost to Follow-up|12|||
125045320|NCT02498821|449785880|FG000|Overall Study|Screen failure|3|||
125045321|NCT02498821|449785881|FG001|Overall Study|Screen failure|5|||
125045322|NCT05258058|449785896|FG000|Overall Study|Withdrawal by Subject|2|||
125045323|NCT01333189|449785901|FG000|Overall Study|Time constraints|1|||
125045324|NCT01333189|449785902|FG001|Overall Study|Time constraints|0|||
125045325|NCT01333189|449785901|FG000|Overall Study|Adverse Event|1|||
125045326|NCT01333189|449785902|FG001|Overall Study|Adverse Event|0|||
125045327|NCT01333189|449785901|FG000|Overall Study|Transportation difficulties|0|||
125045328|NCT01333189|449785902|FG001|Overall Study|Transportation difficulties|1|||
125045329|NCT01333189|449785901|FG000|Overall Study|Moved from region|0|||
125045330|NCT01333189|449785902|FG001|Overall Study|Moved from region|1|||
125045331|NCT01787591|449785910|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
125045332|NCT01787591|449785911|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
125045333|NCT01787591|449785912|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
125045334|NCT01787591|449785913|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
125045335|NCT02725177|449785914|FG000|Overall Study|Physician Decision|4|||
125045336|NCT02725177|449785914|FG000|Overall Study|Adverse Event|1|||
125045337|NCT00793585|449785917|FG000|Overall Study|Adverse Event|1|||
125045338|NCT00793585|449785918|FG001|Overall Study|Adverse Event|1|||
125045339|NCT00793585|449785917|FG000|Overall Study|Protocol Violation|1|||
125045340|NCT00793585|449785918|FG001|Overall Study|Protocol Violation|2|||
125045341|NCT00377299|449785919|FG000|Overall Study|Lost to Follow-up|14|||
125045342|NCT00377299|449785920|FG001|Overall Study|Lost to Follow-up|19|||
125045343|NCT00377299|449785919|FG000|Overall Study|Adverse Event|0|||
125045344|NCT00377299|449785920|FG001|Overall Study|Adverse Event|1|||
125045345|NCT00377299|449785919|FG000|Overall Study|Withdrawal by Subject|5|||
125045346|NCT00377299|449785920|FG001|Overall Study|Withdrawal by Subject|4|||
125045347|NCT00035815|449785922|FG000|Overall Study|Withdrawal by Subject|17|||
125045348|NCT00035815|449785923|FG001|Overall Study|Withdrawal by Subject|11|||
125045349|NCT01894516|449787573|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
125045350|NCT01894516|449787574|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
125045351|NCT01894516|449787575|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
125045352|NCT01894516|449787576|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
125045353|NCT01894516|449787573|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
125045354|NCT01894516|449787574|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
125045355|NCT01894516|449787575|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
125045356|NCT01894516|449787576|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
125045357|NCT01894516|449787573|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
125045358|NCT01894516|449787574|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
125045359|NCT01894516|449787575|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
125045360|NCT01894516|449787576|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
125045361|NCT01894516|449787573|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
125045362|NCT01894516|449787574|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
125045363|NCT01894516|449787575|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
125045364|NCT01894516|449787576|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
125045365|NCT01894516|449787573|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
125045366|NCT01894516|449787574|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
125045367|NCT01894516|449787575|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
125045368|NCT01894516|449787576|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
125045369|NCT01894516|449787573|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
125045370|NCT01894516|449787574|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
125045371|NCT01894516|449787575|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
125045372|NCT01894516|449787576|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
125045373|NCT01894516|449787573|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
125045374|NCT01894516|449787574|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
125045375|NCT01894516|449787575|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
125045376|NCT01894516|449787576|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
125045377|NCT01894516|449787573|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
125045378|NCT01894516|449787574|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
125045379|NCT01894516|449787575|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
125045380|NCT01894516|449787576|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
125045381|NCT03270085|449787577|FG000|Overall Study|Withdrawal by Subject|1|||
125045382|NCT03270085|449787578|FG001|Overall Study|Withdrawal by Subject|0|||
125045383|NCT01300286|449787579|FG000|Overall Study|did not get dosed|1|||
125045384|NCT00417612|449787580|FG000|Overall Study|Errant diagnosis|0|||
125045385|NCT00417612|449787581|FG001|Overall Study|Errant diagnosis|1|||
125045386|NCT00417612|449787580|FG000|Overall Study|Adverse Event|2|||
125045387|NCT00417612|449787581|FG001|Overall Study|Adverse Event|0|||
125045388|NCT00417612|449787580|FG000|Overall Study|Protocol Violation|0|||
125045389|NCT00417612|449787581|FG001|Overall Study|Protocol Violation|2|||
125045390|NCT00417612|449787580|FG000|Overall Study|Lost to Follow-up|1|||
125045391|NCT00417612|449787581|FG001|Overall Study|Lost to Follow-up|0|||
125045392|NCT01330381|449787582|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
125045393|NCT01330381|449787583|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
125045394|NCT01330381|449787584|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
125045395|NCT01330381|449787582|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
125045396|NCT01330381|449787583|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
125045397|NCT01330381|449787584|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
125045398|NCT01330381|449787582|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
125045399|NCT01330381|449787583|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
125045400|NCT01330381|449787584|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
125045401|NCT01330381|449787582|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
125045402|NCT01330381|449787583|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
125045403|NCT01330381|449787584|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
125045404|NCT01330381|449787582|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
125045405|NCT01330381|449787583|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
125045406|NCT01330381|449787584|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
125045407|NCT01330381|449787582|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
125045408|NCT01330381|449787583|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
125045409|NCT01330381|449787584|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
125045410|NCT01330381|449787582|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
125045411|NCT01330381|449787583|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
125045412|NCT01330381|449787584|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
125045413|NCT01330381|449787582|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
125045414|NCT01330381|449787583|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
125045415|NCT01330381|449787584|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
125045416|NCT01330381|449787582|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
125045417|NCT01330381|449787583|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
125045418|NCT01330381|449787584|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
125045419|NCT01330381|449787582|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
125045420|NCT01330381|449787583|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
125045421|NCT01330381|449787584|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
125045422|NCT00663858|449787585|FG000|Overall Study|Adverse Event|9|||
125045423|NCT00663858|449787586|FG001|Overall Study|Adverse Event|1|||
125045424|NCT00663858|449787587|FG002|Overall Study|Adverse Event|6|||
125045425|NCT00663858|449787585|FG000|Overall Study|Lack of Efficacy|5|||
125045426|NCT00663858|449787586|FG001|Overall Study|Lack of Efficacy|1|||
125045427|NCT00663858|449787587|FG002|Overall Study|Lack of Efficacy|3|||
125045428|NCT00663858|449787585|FG000|Overall Study|Withdrawal by Subject|7|||
125045429|NCT00663858|449787586|FG001|Overall Study|Withdrawal by Subject|3|||
125045430|NCT00663858|449787587|FG002|Overall Study|Withdrawal by Subject|3|||
125045431|NCT00663858|449787585|FG000|Overall Study|Protocol Violation|5|||
125045432|NCT00663858|449787586|FG001|Overall Study|Protocol Violation|3|||
125135855|NCT02075463|450121748|FG000|Overall Study|Par. reached stopping criteria|4|||
125135856|NCT02075463|450121748|FG000|Overall Study|Withdrawal by Subject|1|||
125135857|NCT00245063|450121750|FG000|Overall Study|Adverse Event|6|||
125135858|NCT00245063|450121751|FG001|Overall Study|Adverse Event|5|||
125135859|NCT00245063|450121750|FG000|Overall Study|Death|1|||
125045433|NCT00663858|449787587|FG002|Overall Study|Protocol Violation|4|||
125045434|NCT00663858|449787585|FG000|Overall Study|Other|8|||
125045435|NCT00663858|449787586|FG001|Overall Study|Other|2|||
125045436|NCT00663858|449787587|FG002|Overall Study|Other|4|||
125045437|NCT03216265|449787588|FG000|Overall Study|Adverse Event|2|||
125045438|NCT03216265|449787589|FG001|Overall Study|Adverse Event|0|||
125045439|NCT03216265|449787590|FG002|Overall Study|Adverse Event|2|||
125045440|NCT03216265|449787588|FG000|Overall Study|Lost to Follow-up|0|||
125045441|NCT03216265|449787589|FG001|Overall Study|Lost to Follow-up|1|||
125045442|NCT03216265|449787590|FG002|Overall Study|Lost to Follow-up|0|||
125045443|NCT03216265|449787588|FG000|Overall Study|Withdrawal by Subject|0|||
125045444|NCT03216265|449787589|FG001|Overall Study|Withdrawal by Subject|0|||
125045445|NCT03216265|449787590|FG002|Overall Study|Withdrawal by Subject|1|||
125045446|NCT01277289|449787591|FG000|Overall Study|fragile vein|1|||
125045447|NCT01277289|449787592|FG001|Overall Study|fragile vein|0|||
125045448|NCT01277289|449787591|FG000|Overall Study|Physician Decision|1|||
125045449|NCT01277289|449787592|FG001|Overall Study|Physician Decision|0|||
125045450|NCT01277289|449787591|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
125045451|NCT01277289|449787592|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
125045452|NCT01277289|449787591|FG000|Overall Study|Protocol Violation|1|||
125045453|NCT01277289|449787592|FG001|Overall Study|Protocol Violation|1|||
125045454|NCT01277289|449787591|FG000|Overall Study|Adverse Event|2|||
125045455|NCT01277289|449787592|FG001|Overall Study|Adverse Event|1|||
125045456|NCT01277289|449787591|FG000|Overall Study|consent withdrawn|1|||
125045457|NCT01277289|449787592|FG001|Overall Study|consent withdrawn|1|||
125045458|NCT01277289|449787591|FG000|Overall Study|premature closure of the study|4|||
125045459|NCT01277289|449787592|FG001|Overall Study|premature closure of the study|2|||
125045460|NCT00224107|449787594|FG000|Overall Study|Adverse Event|20|||
125045461|NCT00224107|449787595|FG001|Overall Study|Adverse Event|6|||
125045462|NCT00224107|449787594|FG000|Overall Study|Protocol Violation|2|||
125045463|NCT00224107|449787595|FG001|Overall Study|Protocol Violation|3|||
125045464|NCT00224107|449787594|FG000|Overall Study|Withdrawal by Subject|1|||
125045465|NCT00224107|449787595|FG001|Overall Study|Withdrawal by Subject|4|||
125045466|NCT00224107|449787594|FG000|Overall Study|Lack of Efficacy|2|||
125045467|NCT00224107|449787595|FG001|Overall Study|Lack of Efficacy|0|||
125045468|NCT00224107|449787594|FG000|Overall Study|Lost to Follow-up|4|||
125045469|NCT00224107|449787595|FG001|Overall Study|Lost to Follow-up|0|||
125045470|NCT00224107|449787594|FG000|Overall Study|Physician Decision|1|||
125045471|NCT00224107|449787595|FG001|Overall Study|Physician Decision|0|||
125045472|NCT00224107|449787594|FG000|Overall Study|Other|1|||
125045473|NCT00224107|449787595|FG001|Overall Study|Other|1|||
125045474|NCT00685178|449787596|FG000|Overall Study|Adverse Event|1|||
125045475|NCT00685178|449787597|FG001|Overall Study|Adverse Event|5|||
125045476|NCT00685178|449787598|FG002|Overall Study|Adverse Event|2|||
125045477|NCT00685178|449787599|FG003|Overall Study|Adverse Event|4|||
125045478|NCT00685178|449787596|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
125045479|NCT00685178|449787597|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
125045480|NCT00685178|449787598|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
125045481|NCT00685178|449787599|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
125045482|NCT00685178|449787596|FG000|Overall Study|voluntary study discharge|4|||
125045483|NCT00685178|449787597|FG001|Overall Study|voluntary study discharge|5|||
125045484|NCT00685178|449787598|FG002|Overall Study|voluntary study discharge|1|||
125045485|NCT00685178|449787599|FG003|Overall Study|voluntary study discharge|1|||
125045486|NCT00685178|449787596|FG000|Overall Study|incarcerated|1|||
125045487|NCT00685178|449787597|FG001|Overall Study|incarcerated|3|||
125045488|NCT00685178|449787598|FG002|Overall Study|incarcerated|7|||
125135860|NCT00245063|450121751|FG001|Overall Study|Death|0|||
125135861|NCT05099380|450121753|FG000|Overall Study|Subject enrolled in error|1|||
125135862|NCT05099380|450121754|FG001|Overall Study|Subject enrolled in error|0|||
125045489|NCT00685178|449787599|FG003|Overall Study|incarcerated|0|||
125045490|NCT00685178|449787596|FG000|Overall Study|administrative (disciplinary) discharge|0|||
125045491|NCT00685178|449787597|FG001|Overall Study|administrative (disciplinary) discharge|1|||
125045492|NCT00685178|449787598|FG002|Overall Study|administrative (disciplinary) discharge|0|||
125045493|NCT00685178|449787599|FG003|Overall Study|administrative (disciplinary) discharge|2|||
125045494|NCT00685178|449787596|FG000|Overall Study|Pregnancy|0|||
125045495|NCT00685178|449787597|FG001|Overall Study|Pregnancy|0|||
125045496|NCT00685178|449787598|FG002|Overall Study|Pregnancy|0|||
125045497|NCT00685178|449787599|FG003|Overall Study|Pregnancy|1|||
125045498|NCT00077623|449787600|FG000|Overall Study|Adverse Event|1|||
125045499|NCT00077623|449787601|FG001|Overall Study|Adverse Event|0|||
125045500|NCT00077623|449787602|FG002|Overall Study|Adverse Event|1|||
125045501|NCT00077623|449787600|FG000|Overall Study|Withdrawal by Subject|2|||
125045502|NCT00077623|449787601|FG001|Overall Study|Withdrawal by Subject|10|||
125045503|NCT00077623|449787602|FG002|Overall Study|Withdrawal by Subject|1|||
125045504|NCT00077623|449787600|FG000|Overall Study|Other-Non safety reason|18|||
125045505|NCT00077623|449787601|FG001|Overall Study|Other-Non safety reason|15|||
125045506|NCT00077623|449787602|FG002|Overall Study|Other-Non safety reason|19|||
125045507|NCT00077623|449787600|FG000|Overall Study|Insufficient therapeutic response|2|||
125045508|NCT00077623|449787601|FG001|Overall Study|Insufficient therapeutic response|0|||
125045509|NCT00077623|449787602|FG002|Overall Study|Insufficient therapeutic response|0|||
125045510|NCT00077623|449787600|FG000|Overall Study|Death|12|||
125045511|NCT00077623|449787601|FG001|Overall Study|Death|18|||
125045512|NCT00077623|449787602|FG002|Overall Study|Death|11|||
125045513|NCT00077623|449787600|FG000|Overall Study|Failure to return|1|||
125045514|NCT00077623|449787601|FG001|Overall Study|Failure to return|0|||
125045515|NCT00077623|449787602|FG002|Overall Study|Failure to return|0|||
125045516|NCT00882713|449787605|FG000|Overall Study|Adverse Event|2|||
125045517|NCT00882713|449787605|FG000|Overall Study|Death|3|||
125045518|NCT00882713|449787605|FG000|Overall Study|Administrative reasons|4|||
125045519|NCT00882713|449787605|FG000|Overall Study|refused treatment/withdrew consent|4|||
125045520|NCT00882713|449787605|FG000|Overall Study|Blood transfusion|2|||
125045521|NCT00882713|449787605|FG000|Overall Study|Insufficient therapeutic response|3|||
125045522|NCT00882713|449787605|FG000|Overall Study|Failure to return|2|||
125045523|NCT00882713|449787605|FG000|Overall Study|Other - Reasons|2|||
125045524|NCT00401973|449787606|FG000|Overall Study|Adverse Event|2|||
125045525|NCT00401973|449787607|FG001|Overall Study|Adverse Event|8|||
125045526|NCT00401973|449787608|FG002|Overall Study|Adverse Event|4|||
125045527|NCT00401973|449787606|FG000|Overall Study|Clinical Relapse|0|||
125045528|NCT00401973|449787607|FG001|Overall Study|Clinical Relapse|1|||
125045529|NCT00401973|449787608|FG002|Overall Study|Clinical Relapse|1|||
125045530|NCT00401973|449787606|FG000|Overall Study|Lack of Efficacy|0|||
125045531|NCT00401973|449787607|FG001|Overall Study|Lack of Efficacy|0|||
125045532|NCT00401973|449787608|FG002|Overall Study|Lack of Efficacy|3|||
125045533|NCT00401973|449787606|FG000|Overall Study|Lost to Follow-up|2|||
125045534|NCT00401973|449787607|FG001|Overall Study|Lost to Follow-up|2|||
125045535|NCT00401973|449787608|FG002|Overall Study|Lost to Follow-up|2|||
125045536|NCT00401973|449787606|FG000|Overall Study|Physician Decision|2|||
125045537|NCT00401973|449787607|FG001|Overall Study|Physician Decision|0|||
125045538|NCT00401973|449787608|FG002|Overall Study|Physician Decision|1|||
125045539|NCT00401973|449787606|FG000|Overall Study|Protocol Violation|1|||
125045540|NCT00401973|449787607|FG001|Overall Study|Protocol Violation|2|||
125045541|NCT00401973|449787608|FG002|Overall Study|Protocol Violation|3|||
125045542|NCT00401973|449787606|FG000|Overall Study|Sponsor Decision|0|||
125045543|NCT00401973|449787607|FG001|Overall Study|Sponsor Decision|1|||
125045544|NCT00401973|449787608|FG002|Overall Study|Sponsor Decision|0|||
125045545|NCT00401973|449787606|FG000|Overall Study|Withdrawal by Subject|4|||
125045546|NCT00401973|449787607|FG001|Overall Study|Withdrawal by Subject|12|||
125045547|NCT00401973|449787608|FG002|Overall Study|Withdrawal by Subject|9|||
125045548|NCT05523362|449787609|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
125045549|NCT05523362|449787609|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
125045550|NCT05523362|449787609|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
125045551|NCT05523362|449787609|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
125045552|NCT03515538|449787610|FG000|Overall Study|Lack of Efficacy|2|||
125045553|NCT03515538|449787611|FG001|Overall Study|Lack of Efficacy|0|||
125045554|NCT03515538|449787612|FG002|Overall Study|Lack of Efficacy|2|||
125045555|NCT03515538|449787613|FG003|Overall Study|Lack of Efficacy|0|||
125045556|NCT03515538|449787610|FG000|Overall Study|Death|0|||
125045557|NCT03515538|449787611|FG001|Overall Study|Death|0|||
125045558|NCT03515538|449787612|FG002|Overall Study|Death|1|||
125045559|NCT03515538|449787613|FG003|Overall Study|Death|0|||
125045560|NCT03515538|449787610|FG000|Overall Study|Protocol Violation|0|||
125045561|NCT03515538|449787611|FG001|Overall Study|Protocol Violation|0|||
125045562|NCT03515538|449787612|FG002|Overall Study|Protocol Violation|0|||
125045563|NCT03515538|449787613|FG003|Overall Study|Protocol Violation|1|||
125045564|NCT03515538|449787610|FG000|Overall Study|Screen failure (baseline dropout)|0|||
125045565|NCT03515538|449787611|FG001|Overall Study|Screen failure (baseline dropout)|1|||
125045566|NCT03515538|449787612|FG002|Overall Study|Screen failure (baseline dropout)|0|||
125045567|NCT03515538|449787613|FG003|Overall Study|Screen failure (baseline dropout)|0|||
125045568|NCT03515538|449787610|FG000|Overall Study|Withdrawal by Subject|2|||
125045569|NCT03515538|449787611|FG001|Overall Study|Withdrawal by Subject|2|||
125045570|NCT03515538|449787612|FG002|Overall Study|Withdrawal by Subject|1|||
125045571|NCT03515538|449787613|FG003|Overall Study|Withdrawal by Subject|3|||
125045572|NCT03515538|449787610|FG000|Overall Study|Physician Decision|1|||
125045573|NCT03515538|449787611|FG001|Overall Study|Physician Decision|0|||
125045574|NCT03515538|449787612|FG002|Overall Study|Physician Decision|0|||
125045575|NCT03515538|449787613|FG003|Overall Study|Physician Decision|1|||
125045576|NCT04075604|449787614|FG000|Overall Study|Adverse Event|0|||
125045577|NCT04075604|449787615|FG001|Overall Study|Adverse Event|0|||
125045578|NCT04075604|449787616|FG002|Overall Study|Adverse Event|3|||
125045579|NCT04075604|449787614|FG000|Overall Study|Participant request to discontinue study treatment|0|||
125045580|NCT04075604|449787615|FG001|Overall Study|Participant request to discontinue study treatment|0|||
125045581|NCT04075604|449787616|FG002|Overall Study|Participant request to discontinue study treatment|1|||
125045582|NCT04075604|449787614|FG000|Overall Study|Participant withdrew consent|0|||
125045583|NCT04075604|449787615|FG001|Overall Study|Participant withdrew consent|0|||
125045584|NCT04075604|449787616|FG002|Overall Study|Participant withdrew consent|1|||
125045585|NCT04075604|449787614|FG000|Overall Study|Other reasons|1|||
125045586|NCT04075604|449787615|FG001|Overall Study|Other reasons|0|||
125045587|NCT04075604|449787616|FG002|Overall Study|Other reasons|0|||
125045588|NCT04075604|449787614|FG000|Overall Study|Disease progression|0|||
125045589|NCT04075604|449787615|FG001|Overall Study|Disease progression|1|||
125045590|NCT04075604|449787616|FG002|Overall Study|Disease progression|0|||
125045591|NCT04075604|449787614|FG000|Overall Study|Study drug toxicity|0|||
125045592|NCT04075604|449787615|FG001|Overall Study|Study drug toxicity|5|||
125045593|NCT04075604|449787616|FG002|Overall Study|Study drug toxicity|1|||
125045594|NCT01650779|449787623|FG000|Overall Study|Withdrawal by Subject|1|||
125045595|NCT03666143|449787624|FG000|Overall Study|Death|158|||
125045596|NCT03666143|449787624|FG000|Overall Study|Sponsor Decision|31|||
125045597|NCT03666143|449787624|FG000|Overall Study|Withdrawal by Subject|11|||
125045598|NCT03666143|449787624|FG000|Overall Study|Lost to Follow-up|5|||
125045599|NCT03666143|449787624|FG000|Overall Study|Physician Decision|1|||
125045600|NCT03666143|449787624|FG000|Overall Study|Rolled into extension study|9|||
125045601|NCT03666143|449787624|FG000|Overall Study|Progressive Disease|1|||
125045602|NCT00283712|449787627|FG000|Overall Study|Death|0|||
125045603|NCT00283712|449787628|FG001|Overall Study|Death|1|||
125045604|NCT04329923|449787633|FG000|Overall Study|Withdrawal by Subject|1|||
125045605|NCT04329923|449787634|FG001|Overall Study|Withdrawal by Subject|4|||
125045606|NCT04329923|449787635|FG002|Overall Study|Withdrawal by Subject|1|||
125045607|NCT04329923|449787636|FG003|Overall Study|Withdrawal by Subject|1|||
125045608|NCT04329923|449787637|FG004|Overall Study|Withdrawal by Subject|1|||
125045609|NCT04329923|449787638|FG005|Overall Study|Withdrawal by Subject|1|||
125045610|NCT04329923|449787633|FG000|Overall Study|early termination of study|0|||
125045611|NCT04329923|449787634|FG001|Overall Study|early termination of study|0|||
125045612|NCT04329923|449787635|FG002|Overall Study|early termination of study|0|||
125045613|NCT04329923|449787636|FG003|Overall Study|early termination of study|0|||
125045614|NCT04329923|449787637|FG004|Overall Study|early termination of study|1|||
125045615|NCT04329923|449787638|FG005|Overall Study|early termination of study|2|||
125045616|NCT04329923|449787633|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
125045617|NCT04329923|449787634|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
125045618|NCT04329923|449787635|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
125045619|NCT04329923|449787636|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
125045620|NCT04329923|449787637|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
125045621|NCT04329923|449787638|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
125045622|NCT01272180|449787639|FG000|Overall Study|Adverse Event|0|||
125045623|NCT01272180|449787640|FG001|Overall Study|Adverse Event|0|||
125045624|NCT01272180|449787641|FG002|Overall Study|Adverse Event|1|||
125045625|NCT01272180|449787642|FG003|Overall Study|Adverse Event|0|||
125045626|NCT01272180|449787639|FG000|Overall Study|Withdrawal by Subject|2|||
125045627|NCT01272180|449787640|FG001|Overall Study|Withdrawal by Subject|6|||
125045628|NCT01272180|449787641|FG002|Overall Study|Withdrawal by Subject|3|||
125045629|NCT01272180|449787642|FG003|Overall Study|Withdrawal by Subject|2|||
125045630|NCT01272180|449787639|FG000|Overall Study|Lost to Follow-up|15|||
125045631|NCT01272180|449787640|FG001|Overall Study|Lost to Follow-up|14|||
125045632|NCT01272180|449787641|FG002|Overall Study|Lost to Follow-up|8|||
125045633|NCT01272180|449787642|FG003|Overall Study|Lost to Follow-up|10|||
125045634|NCT01272180|449787639|FG000|Overall Study|Inappropriate enrollment|0|||
125045635|NCT01272180|449787640|FG001|Overall Study|Inappropriate enrollment|0|||
125045636|NCT01272180|449787641|FG002|Overall Study|Inappropriate enrollment|1|||
125045637|NCT01272180|449787642|FG003|Overall Study|Inappropriate enrollment|1|||
125045638|NCT01272180|449787639|FG000|Overall Study|Protocol Violation|0|||
125045639|NCT01272180|449787640|FG001|Overall Study|Protocol Violation|1|||
125045640|NCT01272180|449787641|FG002|Overall Study|Protocol Violation|0|||
125045641|NCT01272180|449787642|FG003|Overall Study|Protocol Violation|1|||
125045642|NCT01183858|449787643|FG000|Overall Study|Death not related to Progressive Disease|5|||
125045643|NCT01183858|449787644|FG001|Overall Study|Death not related to Progressive Disease|6|||
125045644|NCT01183858|449787643|FG000|Overall Study|Adverse Event|14|||
125045645|NCT01183858|449787644|FG001|Overall Study|Adverse Event|11|||
125045646|NCT01183858|449787643|FG000|Overall Study|Investigator's Decision|0|||
125045647|NCT01183858|449787644|FG001|Overall Study|Investigator's Decision|3|||
125045648|NCT01183858|449787643|FG000|Overall Study|Insufficient Therapeutic Response|2|||
125045649|NCT01183858|449787644|FG001|Overall Study|Insufficient Therapeutic Response|0|||
125045650|NCT01183858|449787643|FG000|Overall Study|Refused Treatment|1|||
125045651|NCT01183858|449787644|FG001|Overall Study|Refused Treatment|4|||
125045652|NCT01183858|449787643|FG000|Overall Study|Withdrew Consent|4|||
125045653|NCT01183858|449787644|FG001|Overall Study|Withdrew Consent|4|||
125045654|NCT01183858|449787643|FG000|Overall Study|Discontinued Smoking|3|||
125045655|NCT01183858|449787644|FG001|Overall Study|Discontinued Smoking|1|||
125045656|NCT01183858|449787643|FG000|Overall Study|Protocol Violation|1|||
125045657|NCT01183858|449787644|FG001|Overall Study|Protocol Violation|0|||
125045658|NCT01183858|449787643|FG000|Overall Study|Administrative/Other|6|||
125045659|NCT01183858|449787644|FG001|Overall Study|Administrative/Other|6|||
125045660|NCT01183858|449787643|FG000|Overall Study|Progressive Disease|112|||
125045661|NCT01183858|449787644|FG001|Overall Study|Progressive Disease|115|||
125045662|NCT01183858|449787643|FG000|Overall Study|Death related to Progressive Disease|4|||
125045663|NCT01183858|449787644|FG001|Overall Study|Death related to Progressive Disease|5|||
125045664|NCT01183858|449787643|FG000|Overall Study|Lost to Follow-up|1|||
125045665|NCT01183858|449787644|FG001|Overall Study|Lost to Follow-up|1|||
125045666|NCT00098345|449787645|FG000|Overall Study|Adverse Event|7|||
125045667|NCT00098345|449787645|FG000|Overall Study|Withdrawal by Subject|2|||
125045668|NCT00098345|449787645|FG000|Overall Study|progression|4|||
125045669|NCT00641147|449787652|FG000|Completed 4 Months.|Physician Decision|1|||
125045670|NCT00641147|449787653|FG001|Completed 4 Months.|Physician Decision|0|||
125045671|NCT00641147|449787652|FG000|Completed 4 Months.|Adverse Event|1|||
125045672|NCT00641147|449787653|FG001|Completed 4 Months.|Adverse Event|0|||
125045673|NCT00641147|449787652|FG000|Completed 8 Months.|Physician Decision|2|||
125045674|NCT00641147|449787653|FG001|Completed 8 Months.|Physician Decision|1|||
125045675|NCT00641147|449787652|FG000|Completed 8 Months.|non compliance|1|||
125045676|NCT00641147|449787653|FG001|Completed 8 Months.|non compliance|0|||
125045677|NCT00641147|449787652|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
125045678|NCT00641147|449787653|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
125045679|NCT00641147|449787652|FG000|Completed 12 Months.|Physician Decision|1|||
125045680|NCT00641147|449787653|FG001|Completed 12 Months.|Physician Decision|1|||
125045681|NCT00641147|449787652|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
125045682|NCT00641147|449787653|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
125045683|NCT00641147|449787652|FG000|Completed 16 Months.|Physician Decision|1|||
125045684|NCT00641147|449787653|FG001|Completed 16 Months.|Physician Decision|0|||
125045685|NCT00641147|449787652|FG000|Completed 16 Months.|Lost to Follow-up|1|||
125135863|NCT05099380|450121753|FG000|Overall Study|Study Procedure|1|||
125135864|NCT05099380|450121754|FG001|Overall Study|Study Procedure|0|||
125135865|NCT05099380|450121753|FG000|Overall Study|Protocol Violation|1|||
125135866|NCT05099380|450121754|FG001|Overall Study|Protocol Violation|0|||
125135867|NCT05099380|450121753|FG000|Overall Study|Adverse Event|1|||
125135868|NCT05099380|450121754|FG001|Overall Study|Adverse Event|1|||
125135869|NCT05099380|450121753|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
125135870|NCT05099380|450121754|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
125135871|NCT00392665|450121755|FG000|Overall Study|Death|16|||
125135872|NCT00392665|450121756|FG001|Overall Study|Death|14|||
125135873|NCT00392665|450121755|FG000|Overall Study|Lost to Follow-up|1|||
125135874|NCT00392665|450121756|FG001|Overall Study|Lost to Follow-up|1|||
125135875|NCT03276754|450121757|FG000|Overall Study|Withdrawal of informed consent|4|||
125135876|NCT03276754|450121757|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
125135877|NCT03276754|450121757|FG000|Overall Study|Lost to Follow-up|27|||
125135878|NCT03276754|450121757|FG000|Overall Study|No data reported at Month 24|31|||
125135879|NCT03276754|450121757|FG000|Overall Study|Death|39|||
125135880|NCT02294786|450121760|FG000|Overall Study|Withdrawal by Subject|0|||
125135881|NCT02294786|450121761|FG001|Overall Study|Withdrawal by Subject|1|||
125135882|NCT02294786|450121760|FG000|Overall Study|Physician Decision|6|||
125135883|NCT02294786|450121761|FG001|Overall Study|Physician Decision|7|||
125135884|NCT02294786|450121760|FG000|Overall Study|Lost to Follow-up|1|||
125135885|NCT02294786|450121761|FG001|Overall Study|Lost to Follow-up|2|||
125045686|NCT00641147|449787653|FG001|Completed 16 Months.|Lost to Follow-up|0|||
125045687|NCT01966731|449787654|FG000|Overall Study|Death|2|||
125045688|NCT01966731|449787654|FG000|Overall Study|Lost to Follow-up|1|||
125045689|NCT01966731|449787654|FG000|Overall Study|Physician Decision|2|||
125135886|NCT02294786|450121760|FG000|Overall Study|Protocol Violation|1|||
125135887|NCT02294786|450121761|FG001|Overall Study|Protocol Violation|0|||
125135888|NCT02294786|450121760|FG000|Overall Study|Adverse Event|1|||
125135889|NCT02294786|450121761|FG001|Overall Study|Adverse Event|1|||
125135890|NCT02294786|450121760|FG000|Overall Study|Death|2|||
125135891|NCT02294786|450121761|FG001|Overall Study|Death|3|||
125045690|NCT01966731|449787654|FG000|Overall Study|Follow up is not complete|600|||
125045691|NCT01966731|449787654|FG000|Overall Study|Screening Failure|29|||
125045692|NCT01966731|449787654|FG000|Overall Study|Found to be ineligible|1|||
125045693|NCT01380093|449787656|FG000|Naloxone Challenge Phase|Screen failures|21|||
125045694|NCT01380093|449787657|FG001|Naloxone Challenge Phase|Screen failures|0|||
125045695|NCT01380093|449787658|FG002|Naloxone Challenge Phase|Screen failures|0|||
125045696|NCT01380093|449787659|FG003|Naloxone Challenge Phase|Screen failures|0|||
125045697|NCT01380093|449787660|FG004|Naloxone Challenge Phase|Screen failures|0|||
125045698|NCT01380093|449787661|FG005|Naloxone Challenge Phase|Screen failures|0|||
125045699|NCT01380093|449787662|FG006|Naloxone Challenge Phase|Screen failures|0|||
125045700|NCT01380093|449787663|FG007|Naloxone Challenge Phase|Screen failures|0|||
125045701|NCT01380093|449787664|FG008|Naloxone Challenge Phase|Screen failures|0|||
125045702|NCT01380093|449787656|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
125045703|NCT01380093|449787657|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
125045704|NCT01380093|449787658|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
125045705|NCT01380093|449787659|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
125045706|NCT01380093|449787660|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
125045707|NCT01380093|449787661|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
125045708|NCT01380093|449787662|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
125045709|NCT01380093|449787663|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
125045710|NCT01380093|449787664|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
125045711|NCT01380093|449787656|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
125045712|NCT01380093|449787657|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
125045713|NCT01380093|449787658|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
125045714|NCT01380093|449787659|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
125045715|NCT01380093|449787660|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
125045716|NCT01380093|449787661|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
125045717|NCT01380093|449787662|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
125045718|NCT01380093|449787663|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
125045719|NCT01380093|449787664|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
125045720|NCT01380093|449787656|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
125045721|NCT01380093|449787657|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
125045722|NCT01380093|449787658|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
125045723|NCT01380093|449787659|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
125045724|NCT01380093|449787660|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
125045725|NCT01380093|449787661|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
125045726|NCT01380093|449787662|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
125045727|NCT01380093|449787663|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
125045728|NCT01380093|449787664|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
125045729|NCT01380093|449787656|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
125045730|NCT01380093|449787657|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
125045731|NCT01380093|449787658|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
125045732|NCT01380093|449787659|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
125045733|NCT01380093|449787660|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
125045734|NCT01380093|449787661|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
125045735|NCT01380093|449787662|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
125045736|NCT01380093|449787663|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
125045737|NCT01380093|449787664|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
125045738|NCT01380093|449787656|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
125045739|NCT01380093|449787657|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
125045740|NCT01380093|449787658|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
125045741|NCT01380093|449787659|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
125045742|NCT01380093|449787660|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
125045743|NCT01380093|449787661|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
125045744|NCT01380093|449787662|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
125045745|NCT01380093|449787663|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
125045746|NCT01380093|449787664|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
125045747|NCT01380093|449787656|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
125045748|NCT01380093|449787657|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
125045749|NCT01380093|449787658|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
125045750|NCT01380093|449787659|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
125045751|NCT01380093|449787660|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
125045752|NCT01380093|449787661|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
125045753|NCT01380093|449787662|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
125045754|NCT01380093|449787663|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
125045755|NCT01380093|449787664|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
125045756|NCT01380093|449787656|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
125045757|NCT01380093|449787657|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
125045758|NCT01380093|449787658|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
125045759|NCT01380093|449787659|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
125045760|NCT01380093|449787660|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
125045761|NCT01380093|449787661|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
125045762|NCT01380093|449787662|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
125045763|NCT01380093|449787663|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
125045764|NCT01380093|449787664|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
125045765|NCT01380093|449787656|FG000|Treatment Phase: Second Intervention|Other|0|||
125045766|NCT01380093|449787657|FG001|Treatment Phase: Second Intervention|Other|0|||
125045767|NCT01380093|449787658|FG002|Treatment Phase: Second Intervention|Other|0|||
125045768|NCT01380093|449787659|FG003|Treatment Phase: Second Intervention|Other|1|||
125045769|NCT01380093|449787660|FG004|Treatment Phase: Second Intervention|Other|0|||
125045770|NCT01380093|449787661|FG005|Treatment Phase: Second Intervention|Other|0|||
125045771|NCT01380093|449787662|FG006|Treatment Phase: Second Intervention|Other|0|||
125045772|NCT01380093|449787663|FG007|Treatment Phase: Second Intervention|Other|0|||
125045773|NCT01380093|449787664|FG008|Treatment Phase: Second Intervention|Other|0|||
125045774|NCT01380093|449787656|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
125045775|NCT01380093|449787657|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
125045776|NCT01380093|449787658|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
125045777|NCT01380093|449787659|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
125045778|NCT01380093|449787660|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
125045779|NCT01380093|449787661|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
125045780|NCT01380093|449787662|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
125045781|NCT01380093|449787663|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
125045782|NCT01380093|449787664|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
125045783|NCT01380093|449787656|FG000|Treatment Phase: Third Intervention|Other|0|||
125045784|NCT01380093|449787657|FG001|Treatment Phase: Third Intervention|Other|0|||
125045785|NCT01380093|449787658|FG002|Treatment Phase: Third Intervention|Other|0|||
125045786|NCT01380093|449787659|FG003|Treatment Phase: Third Intervention|Other|0|||
125045787|NCT01380093|449787660|FG004|Treatment Phase: Third Intervention|Other|0|||
125045788|NCT01380093|449787661|FG005|Treatment Phase: Third Intervention|Other|0|||
125045789|NCT01380093|449787662|FG006|Treatment Phase: Third Intervention|Other|0|||
125045790|NCT01380093|449787663|FG007|Treatment Phase: Third Intervention|Other|0|||
125045791|NCT01380093|449787664|FG008|Treatment Phase: Third Intervention|Other|1|||
125045792|NCT04734873|449787665|FG000|Overall Study|Lost to Follow-up|1|||
125045793|NCT04734873|449787666|FG001|Overall Study|Lost to Follow-up|3|||
125045794|NCT04734873|449787667|FG002|Overall Study|Lost to Follow-up|2|||
125045795|NCT04734873|449787665|FG000|Overall Study|Randomized but not dosed|1|||
125045796|NCT04734873|449787666|FG001|Overall Study|Randomized but not dosed|0|||
125045797|NCT04734873|449787667|FG002|Overall Study|Randomized but not dosed|1|||
125045798|NCT00328198|449787671|FG000|Treatment|Adverse Event|21|||
125045799|NCT00328198|449787671|FG000|Treatment|Death|1|||
125045800|NCT00328198|449787671|FG000|Treatment|Physician Decision|5|||
125045801|NCT00328198|449787671|FG000|Treatment|Withdrawal by Subject|5|||
125045802|NCT00328198|449787671|FG000|Treatment|Evidence of disease progression|2|||
125045803|NCT00328198|449787671|FG000|Treatment|Non-compliance|1|||
125045804|NCT00328198|449787671|FG000|Treatment|Confirmed complete response, MRD -|3|||
125045805|NCT00328198|449787671|FG000|Follow-up|Lost to Follow-up|4|||
125045806|NCT00328198|449787671|FG000|Follow-up|Death|31|||
125045807|NCT03396471|449787672|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
125045808|NCT03396471|449787672|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
125045809|NCT03396471|449787672|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
125045810|NCT03396471|449787672|FG000|Study Treatment - Up to 22 Months|Death|2|||
125045811|NCT03396471|449787672|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
125045812|NCT03396471|449787672|FG000|Follow up - Up to 2 Years|Death|9|||
125045813|NCT03396471|449787672|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
125045814|NCT03396471|449787672|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
125045815|NCT03396471|449787672|FG000|Follow up - Up to 2 Years|study terminated|1|||
125045816|NCT03396471|449787672|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
125135892|NCT01778010|450121762|FG000|Overall Study|Withdrawal by Subject|2|||
125135893|NCT01778010|450121762|FG000|Overall Study|abnormal ECG before meds|1|||
125135894|NCT01778010|450121762|FG000|Overall Study|Arrested|1|||
125135895|NCT01778010|450121762|FG000|Overall Study|rash while on placebo|1|||
125045817|NCT03396471|449787672|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
125045818|NCT00718861|449787673|FG000|Overall Study|Withdrawal by Subject|15|||
125045819|NCT00718861|449787674|FG001|Overall Study|Withdrawal by Subject|10|||
125045820|NCT00718861|449787673|FG000|Overall Study|Adverse Event|2|||
125045821|NCT00718861|449787674|FG001|Overall Study|Adverse Event|1|||
125045822|NCT00718861|449787673|FG000|Overall Study|Lost to Follow-up|2|||
125045823|NCT00718861|449787674|FG001|Overall Study|Lost to Follow-up|1|||
125045824|NCT00718861|449787673|FG000|Overall Study|Administrative Problems|1|||
125045825|NCT00718861|449787674|FG001|Overall Study|Administrative Problems|1|||
125045826|NCT00718861|449787673|FG000|Overall Study|Death|1|||
125045827|NCT00718861|449787674|FG001|Overall Study|Death|5|||
125045828|NCT03237845|449787675|FG000|Overall Study|Adverse Event|0|||
125045829|NCT03237845|449787676|FG001|Overall Study|Adverse Event|1|||
125045830|NCT03237845|449787675|FG000|Overall Study|Lost to Follow-up|13|||
125045831|NCT03237845|449787676|FG001|Overall Study|Lost to Follow-up|10|||
125045832|NCT03237845|449787675|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
125045833|NCT03237845|449787676|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
125045834|NCT03237845|449787675|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
125045835|NCT03237845|449787676|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
125045836|NCT03237845|449787675|FG000|Overall Study|Physician Decision|1|||
125045837|NCT03237845|449787676|FG001|Overall Study|Physician Decision|2|||
125045838|NCT03237845|449787675|FG000|Overall Study|Pregnancy|1|||
125045839|NCT03237845|449787676|FG001|Overall Study|Pregnancy|0|||
125045840|NCT03237845|449787675|FG000|Overall Study|Protocol Deviation|0|||
125045841|NCT03237845|449787676|FG001|Overall Study|Protocol Deviation|1|||
125045842|NCT03237845|449787675|FG000|Overall Study|Technical Problems|8|||
125045843|NCT03237845|449787676|FG001|Overall Study|Technical Problems|1|||
125045844|NCT03237845|449787675|FG000|Overall Study|Withdrawal by Subject|3|||
125045845|NCT03237845|449787676|FG001|Overall Study|Withdrawal by Subject|3|||
125045846|NCT03237845|449787675|FG000|Overall Study|Other Reasons|4|||
125045847|NCT03237845|449787676|FG001|Overall Study|Other Reasons|0|||
125045848|NCT03865407|449787680|FG000|Overall Study|Adverse Event|1|||
125045849|NCT03865407|449787681|FG001|Overall Study|Adverse Event|0|||
125045850|NCT03865407|449787680|FG000|Overall Study|Withdrawal by Subject|1|||
125045851|NCT03865407|449787681|FG001|Overall Study|Withdrawal by Subject|0|||
125045852|NCT03865407|449787680|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
125045853|NCT03865407|449787681|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
125045854|NCT02117050|449787682|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
125045855|NCT01645280|449787683|FG000|Overall Study|Death|0|||
125045856|NCT01645280|449787684|FG001|Overall Study|Death|1|||
125045857|NCT01645280|449787685|FG002|Overall Study|Death|0|||
125045858|NCT01645280|449787686|FG003|Overall Study|Death|0|||
125045859|NCT01645280|449787687|FG004|Overall Study|Death|0|||
125045860|NCT01645280|449787683|FG000|Overall Study|Withdrawal by Subject|4|||
125045861|NCT01645280|449787684|FG001|Overall Study|Withdrawal by Subject|0|||
125045862|NCT01645280|449787685|FG002|Overall Study|Withdrawal by Subject|2|||
125045863|NCT01645280|449787686|FG003|Overall Study|Withdrawal by Subject|4|||
125045864|NCT01645280|449787687|FG004|Overall Study|Withdrawal by Subject|5|||
125045865|NCT01645280|449787683|FG000|Overall Study|Lost to Follow-up|0|||
125045866|NCT01645280|449787684|FG001|Overall Study|Lost to Follow-up|0|||
125045867|NCT01645280|449787685|FG002|Overall Study|Lost to Follow-up|0|||
125045868|NCT01645280|449787686|FG003|Overall Study|Lost to Follow-up|2|||
125045869|NCT01645280|449787687|FG004|Overall Study|Lost to Follow-up|1|||
125045870|NCT01645280|449787683|FG000|Overall Study|Other|1|||
125045871|NCT01645280|449787684|FG001|Overall Study|Other|1|||
125045872|NCT01645280|449787685|FG002|Overall Study|Other|2|||
125045873|NCT01645280|449787686|FG003|Overall Study|Other|0|||
125045874|NCT01645280|449787687|FG004|Overall Study|Other|0|||
125045875|NCT01645280|449787683|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
125045876|NCT01645280|449787684|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
125135896|NCT00927069|450121764|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
125135897|NCT00927069|450121765|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
125135898|NCT00927069|450121766|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
125135899|NCT00927069|450121767|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
125135900|NCT00927069|450121764|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
125135901|NCT00927069|450121765|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
125135902|NCT00927069|450121766|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
125218936|NCT03538691|450427420|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
125045877|NCT01645280|449787685|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
125045878|NCT01645280|449787686|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
125045879|NCT01645280|449787687|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
125045880|NCT00234104|449787692|FG000|Overall Study|Adverse Event|4|||
125045881|NCT00234104|449787693|FG001|Overall Study|Adverse Event|0|||
125045882|NCT00234104|449787694|FG002|Overall Study|Adverse Event|3|||
125045883|NCT00234104|449787695|FG003|Overall Study|Adverse Event|5|||
125045884|NCT00234104|449787692|FG000|Overall Study|Protocol Violation|0|||
125045885|NCT00234104|449787693|FG001|Overall Study|Protocol Violation|0|||
125045886|NCT00234104|449787694|FG002|Overall Study|Protocol Violation|0|||
125045887|NCT00234104|449787695|FG003|Overall Study|Protocol Violation|1|||
125135903|NCT00927069|450121767|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
125135904|NCT00927069|450121764|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
125045888|NCT00234104|449787692|FG000|Overall Study|Physician Decision|0|||
125045889|NCT00234104|449787693|FG001|Overall Study|Physician Decision|1|||
125045890|NCT00234104|449787694|FG002|Overall Study|Physician Decision|2|||
125045891|NCT00234104|449787695|FG003|Overall Study|Physician Decision|2|||
125045892|NCT01716169|449787697|FG000|Overall Study|Adverse Event|1|||
125045893|NCT01716169|449787697|FG000|Overall Study|Lost to Follow-up|1|||
125045894|NCT01716169|449787697|FG000|Overall Study|Withdrawal by Subject|1|||
125045895|NCT01716169|449787697|FG000|Overall Study|inconsistent dressing application|1|||
125045896|NCT01088412|449787698|FG000|Overall Study|Adverse Event|38|||
125045897|NCT01088412|449787699|FG001|Overall Study|Adverse Event|0|||
125045898|NCT01088412|449787700|FG002|Overall Study|Adverse Event|0|||
125045899|NCT01088412|449787698|FG000|Overall Study|Death|42|||
125045900|NCT01088412|449787699|FG001|Overall Study|Death|6|||
125045901|NCT01088412|449787700|FG002|Overall Study|Death|0|||
125045902|NCT01088412|449787698|FG000|Overall Study|Other Reason per Case Report Form|2089|||
125045903|NCT01088412|449787699|FG001|Overall Study|Other Reason per Case Report Form|103|||
125045904|NCT01088412|449787700|FG002|Overall Study|Other Reason per Case Report Form|9|||
125045905|NCT01088412|449787698|FG000|Overall Study|Withdrawal by Subject|1761|||
125045906|NCT01088412|449787699|FG001|Overall Study|Withdrawal by Subject|25|||
125045907|NCT01088412|449787700|FG002|Overall Study|Withdrawal by Subject|1|||
125045908|NCT01088412|449787698|FG000|Overall Study|Received Another GH Product|79|||
125045909|NCT01088412|449787699|FG001|Overall Study|Received Another GH Product|0|||
125045910|NCT01088412|449787700|FG002|Overall Study|Received Another GH Product|0|||
125045911|NCT01088412|449787698|FG000|Overall Study|Participant Moved|601|||
125045912|NCT01088412|449787699|FG001|Overall Study|Participant Moved|21|||
125045913|NCT01088412|449787700|FG002|Overall Study|Participant Moved|2|||
125045914|NCT01088412|449787698|FG000|Overall Study|Physician Decision|1041|||
125045915|NCT01088412|449787699|FG001|Overall Study|Physician Decision|8|||
125045916|NCT01088412|449787700|FG002|Overall Study|Physician Decision|4|||
125045917|NCT01088412|449787698|FG000|Overall Study|Sponsor Decision|4467|||
125045918|NCT01088412|449787699|FG001|Overall Study|Sponsor Decision|79|||
125045919|NCT01088412|449787700|FG002|Overall Study|Sponsor Decision|23|||
125045920|NCT01088412|449787698|FG000|Overall Study|Third Party Required to Change Brand|487|||
125045921|NCT01088412|449787699|FG001|Overall Study|Third Party Required to Change Brand|0|||
125045922|NCT01088412|449787700|FG002|Overall Study|Third Party Required to Change Brand|0|||
125045923|NCT01088412|449787698|FG000|Overall Study|Lost to Follow-up|3052|||
125045924|NCT01088412|449787699|FG001|Overall Study|Lost to Follow-up|130|||
125045925|NCT01088412|449787700|FG002|Overall Study|Lost to Follow-up|11|||
125045926|NCT01088412|449787698|FG000|Overall Study|Study Summary Not Completed|4360|||
125045927|NCT01088412|449787699|FG001|Overall Study|Study Summary Not Completed|64|||
125045928|NCT01088412|449787700|FG002|Overall Study|Study Summary Not Completed|22|||
125045929|NCT02111811|449787701|FG000|Treatment Phase|Lost to Follow-up|22|||
125045930|NCT02111811|449787702|FG001|Treatment Phase|Lost to Follow-up|18|||
125045931|NCT02111811|449787701|FG000|Treatment Phase|Death|2|||
125045932|NCT02111811|449787702|FG001|Treatment Phase|Death|0|||
125045933|NCT02111811|449787701|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
125045934|NCT02111811|449787702|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
125045935|NCT02111811|449787701|FG000|Follow up Period (Aim 2)|Death|2|||
125045936|NCT02111811|449787702|FG001|Follow up Period (Aim 2)|Death|0|||
125045937|NCT01478347|449787707|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
125045938|NCT01478347|449787707|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
125045939|NCT01478347|449787707|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
125045940|NCT04579393|449787708|FG000|Overall Study|Withdrawal by Subject|2|||
125045941|NCT04579393|449787709|FG001|Overall Study|Withdrawal by Subject|2|||
125045942|NCT04579393|449787708|FG000|Overall Study|Death|1|||
125045943|NCT04579393|449787709|FG001|Overall Study|Death|3|||
125045944|NCT01326962|449787710|FG000|Overall Study|Adverse Event|1|||
125045945|NCT01326962|449787710|FG000|Overall Study|Withdrawal by Subject|1|||
125045946|NCT01326962|449787710|FG000|Overall Study|Lost to Follow-up|3|||
125135905|NCT00927069|450121765|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
125045947|NCT01326962|449787710|FG000|Overall Study|Other|2|||
125045948|NCT02369510|449787713|FG000|Overall Study|Spilled Medication|1|||
125045949|NCT02369510|449787714|FG001|Overall Study|Spilled Medication|2|||
125045950|NCT02369510|449787715|FG002|Overall Study|Spilled Medication|1|||
125045951|NCT02369510|449787713|FG000|Overall Study|Epidural Activation|1|||
125135906|NCT00927069|450121766|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
125135907|NCT00927069|450121767|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
125135908|NCT00927069|450121764|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
125045952|NCT02369510|449787714|FG001|Overall Study|Epidural Activation|1|||
125045953|NCT02369510|449787715|FG002|Overall Study|Epidural Activation|5|||
125045954|NCT01507246|449787717|FG000|Overall Study|Required different surgical procedures|2|||
125045955|NCT01507246|449787718|FG001|Overall Study|Required different surgical procedures|1|||
125045956|NCT02903511|449787722|FG000|Overall Study|Withdrawal by Subject|1|||
125135909|NCT00927069|450121765|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
125135910|NCT00927069|450121766|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
125045957|NCT02903511|449787723|FG001|Overall Study|Withdrawal by Subject|0|||
125045958|NCT02903511|449787722|FG000|Overall Study|Lost to Follow-up|3|||
125045959|NCT02903511|449787723|FG001|Overall Study|Lost to Follow-up|2|||
125045960|NCT00969618|449787724|FG000|Overall Study|Adverse Event|29|||
125045961|NCT00969618|449787724|FG000|Overall Study|Entry Criteria Not Met|3|||
125045962|NCT00969618|449787724|FG000|Overall Study|Lack of Efficacy|2|||
125045963|NCT00969618|449787724|FG000|Overall Study|Lost to Follow-up|7|||
125045964|NCT00969618|449787724|FG000|Overall Study|Physician Decision|1|||
125045965|NCT00969618|449787724|FG000|Overall Study|Protocol Violation|9|||
125045966|NCT00969618|449787724|FG000|Overall Study|Withdrawal by Subject|27|||
125045967|NCT05363293|449787727|FG000|Overall Study|Withdrawal by Subject|1|||
125045968|NCT05363293|449787728|FG001|Overall Study|Withdrawal by Subject|0|||
125045969|NCT05363293|449787729|FG002|Overall Study|Withdrawal by Subject|0|||
125045970|NCT05363293|449787730|FG003|Overall Study|Withdrawal by Subject|0|||
125045971|NCT05363293|449787731|FG004|Overall Study|Withdrawal by Subject|0|||
125045972|NCT05363293|449787732|FG005|Overall Study|Withdrawal by Subject|0|||
125045973|NCT05363293|449787733|FG006|Overall Study|Withdrawal by Subject|0|||
125045974|NCT05363293|449787734|FG007|Overall Study|Withdrawal by Subject|0|||
125045975|NCT05363293|449787735|FG008|Overall Study|Withdrawal by Subject|0|||
125045976|NCT05363293|449787736|FG009|Overall Study|Withdrawal by Subject|0|||
125045977|NCT01318902|449787737|FG000|Overall Study|Symptomatic Deterioration|0|||
125045978|NCT01318902|449787738|FG001|Overall Study|Symptomatic Deterioration|1|||
125045979|NCT01318902|449787739|FG002|Overall Study|Symptomatic Deterioration|1|||
125045980|NCT01318902|449787740|FG003|Overall Study|Symptomatic Deterioration|2|||
125045981|NCT01318902|449787737|FG000|Overall Study|Withdrawal by Patient|0|||
125045982|NCT01318902|449787738|FG001|Overall Study|Withdrawal by Patient|1|||
125045983|NCT01318902|449787739|FG002|Overall Study|Withdrawal by Patient|0|||
125045984|NCT01318902|449787740|FG003|Overall Study|Withdrawal by Patient|3|||
125045985|NCT01318902|449787737|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
125045986|NCT01318902|449787738|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
125045987|NCT01318902|449787739|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
125045988|NCT01318902|449787740|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
125045989|NCT01318902|449787737|FG000|Overall Study|Adverse Event|0|||
125045990|NCT01318902|449787738|FG001|Overall Study|Adverse Event|1|||
125045991|NCT01318902|449787739|FG002|Overall Study|Adverse Event|0|||
125045992|NCT01318902|449787740|FG003|Overall Study|Adverse Event|0|||
125045993|NCT01318902|449787737|FG000|Overall Study|Terminated by Sponsor|0|||
125045994|NCT01318902|449787738|FG001|Overall Study|Terminated by Sponsor|0|||
125045995|NCT01318902|449787739|FG002|Overall Study|Terminated by Sponsor|1|||
125045996|NCT01318902|449787740|FG003|Overall Study|Terminated by Sponsor|0|||
125045997|NCT05243550|449789396|FG000|Overall Study|Ongoing in the Study|171|||
125045998|NCT05243550|449789396|FG000|Overall Study|Withdrawal by Subject|10|||
125045999|NCT05243550|449789396|FG000|Overall Study|Lost to Follow-up|7|||
125046000|NCT05243550|449789396|FG000|Overall Study|Adverse Event|3|||
125046001|NCT05243550|449789396|FG000|Overall Study|Noncompliance|1|||
125046002|NCT05243550|449789396|FG000|Overall Study|Physician Decision|1|||
125046003|NCT05243550|449789396|FG000|Overall Study|Other Reason|4|||
125046004|NCT02452970|449789403|FG000|Overall Study|Adverse Event|1|||
125046005|NCT00128206|449789406|FG000|Overall Study|Lost to Follow-up|137|||
125046006|NCT00128206|449789407|FG001|Overall Study|Lost to Follow-up|118|||
125046007|NCT00128206|449789406|FG000|Overall Study|Adverse Event|0|||
125046008|NCT00128206|449789407|FG001|Overall Study|Adverse Event|2|||
125046009|NCT01936649|449789412|FG000|Overall Study|Withdrawal by Subject|4|||
125046010|NCT01936649|449789412|FG000|Overall Study|Physician Decision|2|||
125046011|NCT01936649|449789412|FG000|Overall Study|Protocol Violation|2|||
125046012|NCT01936649|449789412|FG000|Overall Study|Other than specified above|5|||
125046013|NCT04655586|449789415|FG000|Overall Study|Physician Decision|1|||
125046014|NCT04655586|449789416|FG001|Overall Study|Physician Decision|3|||
125046015|NCT04655586|449789417|FG002|Overall Study|Physician Decision|4|||
125046016|NCT04655586|449789415|FG000|Overall Study|Withdrawal by Subject|1|||
125046017|NCT04655586|449789416|FG001|Overall Study|Withdrawal by Subject|3|||
125046018|NCT04655586|449789417|FG002|Overall Study|Withdrawal by Subject|1|||
125046019|NCT00201201|449789420|FG000|Overall Study|Death|0|||
125046020|NCT00201201|449789421|FG001|Overall Study|Death|2|||
125046021|NCT00201201|449789420|FG000|Overall Study|Withdrawal by Subject|5|||
125046022|NCT00201201|449789421|FG001|Overall Study|Withdrawal by Subject|5|||
125218937|NCT03538691|450427421|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
125046023|NCT01342640|449789423|FG000|Overall Study|Adverse Event|3|||
125046024|NCT01342640|449789423|FG000|Overall Study|Protocol Violation|16|||
125046025|NCT01342640|449789423|FG000|Overall Study|Lost to Follow-up|21|||
125046026|NCT01342640|449789423|FG000|Overall Study|Other|1|||
125046027|NCT04101422|449789427|FG000|Overall Study|Ineligible|1|||
125046028|NCT04101422|449789428|FG001|Overall Study|Ineligible|0|||
125046029|NCT04101422|449789429|FG002|Overall Study|Ineligible|9|||
125046030|NCT04101422|449789430|FG003|Overall Study|Ineligible|0|||
125046031|NCT04101422|449789427|FG000|Overall Study|Withdrawal by Subject|0|||
125046032|NCT04101422|449789428|FG001|Overall Study|Withdrawal by Subject|0|||
125046033|NCT04101422|449789429|FG002|Overall Study|Withdrawal by Subject|1|||
125046034|NCT04101422|449789430|FG003|Overall Study|Withdrawal by Subject|0|||
125046035|NCT04101422|449789427|FG000|Overall Study|Not attending to the stimuli|0|||
125046036|NCT04101422|449789428|FG001|Overall Study|Not attending to the stimuli|0|||
125046037|NCT04101422|449789429|FG002|Overall Study|Not attending to the stimuli|4|||
125046038|NCT04101422|449789430|FG003|Overall Study|Not attending to the stimuli|0|||
125046039|NCT04101422|449789427|FG000|Overall Study|Did not download app|0|||
125046040|NCT04101422|449789428|FG001|Overall Study|Did not download app|0|||
125046041|NCT04101422|449789429|FG002|Overall Study|Did not download app|0|||
125046042|NCT04101422|449789430|FG003|Overall Study|Did not download app|17|||
125046043|NCT04101422|449789427|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
125046044|NCT04101422|449789428|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
125046045|NCT04101422|449789429|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
125046046|NCT04101422|449789430|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
125046047|NCT02640612|449789431|FG000|Overall Study|Adverse Event|6|||
125046048|NCT02640612|449789432|FG001|Overall Study|Adverse Event|7|||
125046049|NCT02640612|449789433|FG002|Overall Study|Adverse Event|2|||
125046050|NCT02640612|449789431|FG000|Overall Study|Death|1|||
125046051|NCT02640612|449789432|FG001|Overall Study|Death|0|||
125046052|NCT02640612|449789433|FG002|Overall Study|Death|0|||
125046053|NCT02640612|449789431|FG000|Overall Study|Withdrawal by Subject|10|||
125046054|NCT02640612|449789432|FG001|Overall Study|Withdrawal by Subject|3|||
125046055|NCT02640612|449789433|FG002|Overall Study|Withdrawal by Subject|3|||
125046056|NCT02640612|449789431|FG000|Overall Study|Lost to Follow-up|4|||
125046057|NCT02640612|449789432|FG001|Overall Study|Lost to Follow-up|1|||
125046058|NCT02640612|449789433|FG002|Overall Study|Lost to Follow-up|1|||
125046059|NCT02640612|449789431|FG000|Overall Study|Protocol Violation|0|||
125046060|NCT02640612|449789432|FG001|Overall Study|Protocol Violation|2|||
125046061|NCT02640612|449789433|FG002|Overall Study|Protocol Violation|0|||
125046062|NCT02640612|449789431|FG000|Overall Study|Lack of Efficacy|1|||
125046063|NCT02640612|449789432|FG001|Overall Study|Lack of Efficacy|1|||
125046064|NCT02640612|449789433|FG002|Overall Study|Lack of Efficacy|0|||
125046065|NCT03472534|449789434|FG000|Overall Study|Withdrawal by Subject|9|||
125046066|NCT03472534|449789434|FG000|Overall Study|Adverse Event|2|||
125046067|NCT00552305|449789435|FG000|Overall Study|Adverse Event|43|||
125046068|NCT00552305|449789435|FG000|Overall Study|Lack of Efficacy|120|||
125046069|NCT00552305|449789435|FG000|Overall Study|Lost to Follow-up|4|||
125046070|NCT00552305|449789435|FG000|Overall Study|Protocol Violation|3|||
125046071|NCT00552305|449789435|FG000|Overall Study|Withdrawal by Subject|44|||
125046072|NCT00552305|449789435|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
125046073|NCT00552305|449789435|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
125046074|NCT00552305|449789435|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
125046075|NCT00552305|449789435|FG000|Overall Study|Unsatisfactory compliance|11|||
125046076|NCT00552305|449789435|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
125046077|NCT00552305|449789435|FG000|Overall Study|AE/Other: prohibited drug required|1|||
125046078|NCT00552305|449789435|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
125046079|NCT00552305|449789435|FG000|Overall Study|Other: Site closed|4|||
125046080|NCT00552305|449789435|FG000|Overall Study|Other: Personal problems|1|||
125046081|NCT00552305|449789435|FG000|Overall Study|Other: Unable to attend visits|1|||
125046082|NCT00552305|449789435|FG000|Overall Study|Other: Subject underwent surgery|4|||
125046083|NCT00552305|449789435|FG000|Overall Study|Other: Subject became pregnant|1|||
125046084|NCT00552305|449789435|FG000|Overall Study|Other: Health problems, not drug related|1|||
125046085|NCT00552305|449789435|FG000|Overall Study|Other: Subject moved from area|2|||
125046086|NCT00552305|449789435|FG000|Overall Study|Other: Subject incarcerated|1|||
125046087|NCT00552305|449789435|FG000|Overall Study|Other: Subject went to rehab|1|||
125046088|NCT00546819|449789438|FG000|Overall Study|Adverse Event|2|||
125046089|NCT00546819|449789439|FG001|Overall Study|Adverse Event|3|||
125046090|NCT00546819|449789438|FG000|Overall Study|Lost to Follow-up|2|||
125046091|NCT00546819|449789439|FG001|Overall Study|Lost to Follow-up|1|||
125218938|NCT03538691|450427422|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
125046092|NCT00546819|449789438|FG000|Overall Study|Withdrawal by Subject|4|||
125046093|NCT00546819|449789439|FG001|Overall Study|Withdrawal by Subject|2|||
125046094|NCT02052960|449789441|FG000|Overall Study|Adverse Event|19|||
125046095|NCT02052960|449789442|FG001|Overall Study|Adverse Event|17|||
125046096|NCT02052960|449789441|FG000|Overall Study|Protocol Violation|4|||
125046097|NCT02052960|449789442|FG001|Overall Study|Protocol Violation|3|||
125046098|NCT02052960|449789441|FG000|Overall Study|Withdrawal by Subject|6|||
125046099|NCT02052960|449789442|FG001|Overall Study|Withdrawal by Subject|11|||
125046100|NCT02052960|449789441|FG000|Overall Study|Other|25|||
125046101|NCT02052960|449789442|FG001|Overall Study|Other|15|||
125046102|NCT03849560|449789443|FG000|Overall Study|Withdrawal by Subject|1|||
125046103|NCT03849560|449789444|FG001|Overall Study|Withdrawal by Subject|0|||
125046104|NCT03849560|449789445|FG002|Overall Study|Withdrawal by Subject|0|||
125046105|NCT04045613|449789446|FG000|Overall Study|Adverse Event|2|||
125046106|NCT04045613|449789447|FG001|Overall Study|Adverse Event|2|||
125046107|NCT04045613|449789448|FG002|Overall Study|Adverse Event|1|||
125046108|NCT04045613|449789449|FG003|Overall Study|Adverse Event|1|||
125046109|NCT04045613|449789450|FG004|Overall Study|Adverse Event|0|||
125046110|NCT04045613|449789451|FG005|Overall Study|Adverse Event|0|||
125046111|NCT04045613|449789452|FG006|Overall Study|Adverse Event|1|||
125046112|NCT04045613|449789446|FG000|Overall Study|Withdrawal by Subject|0|||
125046113|NCT04045613|449789447|FG001|Overall Study|Withdrawal by Subject|5|||
125046114|NCT04045613|449789448|FG002|Overall Study|Withdrawal by Subject|0|||
125046115|NCT04045613|449789449|FG003|Overall Study|Withdrawal by Subject|0|||
125046116|NCT04045613|449789450|FG004|Overall Study|Withdrawal by Subject|0|||
125046117|NCT04045613|449789451|FG005|Overall Study|Withdrawal by Subject|1|||
125046118|NCT04045613|449789452|FG006|Overall Study|Withdrawal by Subject|0|||
125046119|NCT04045613|449789446|FG000|Overall Study|Physician Decision|2|||
125046120|NCT04045613|449789447|FG001|Overall Study|Physician Decision|0|||
125046121|NCT04045613|449789448|FG002|Overall Study|Physician Decision|0|||
125046122|NCT04045613|449789449|FG003|Overall Study|Physician Decision|0|||
125046123|NCT04045613|449789450|FG004|Overall Study|Physician Decision|1|||
125046124|NCT04045613|449789451|FG005|Overall Study|Physician Decision|0|||
125046125|NCT04045613|449789452|FG006|Overall Study|Physician Decision|0|||
125046126|NCT04045613|449789446|FG000|Overall Study|Death|3|||
125046127|NCT04045613|449789447|FG001|Overall Study|Death|0|||
125046128|NCT04045613|449789448|FG002|Overall Study|Death|0|||
125046129|NCT04045613|449789449|FG003|Overall Study|Death|0|||
125046130|NCT04045613|449789450|FG004|Overall Study|Death|0|||
125046131|NCT04045613|449789451|FG005|Overall Study|Death|0|||
125046132|NCT04045613|449789452|FG006|Overall Study|Death|1|||
125046133|NCT04045613|449789446|FG000|Overall Study|Other reasons|0|||
125046134|NCT04045613|449789447|FG001|Overall Study|Other reasons|1|||
125046135|NCT04045613|449789448|FG002|Overall Study|Other reasons|0|||
125046136|NCT04045613|449789449|FG003|Overall Study|Other reasons|0|||
125046137|NCT04045613|449789450|FG004|Overall Study|Other reasons|0|||
125046138|NCT04045613|449789451|FG005|Overall Study|Other reasons|0|||
125046139|NCT04045613|449789452|FG006|Overall Study|Other reasons|1|||
125046140|NCT04045613|449789446|FG000|Overall Study|Progressive disease: Clinical progression|1|||
125046141|NCT04045613|449789447|FG001|Overall Study|Progressive disease: Clinical progression|0|||
125046142|NCT04045613|449789448|FG002|Overall Study|Progressive disease: Clinical progression|3|||
125046143|NCT04045613|449789449|FG003|Overall Study|Progressive disease: Clinical progression|1|||
125046144|NCT04045613|449789450|FG004|Overall Study|Progressive disease: Clinical progression|1|||
125046145|NCT04045613|449789451|FG005|Overall Study|Progressive disease: Clinical progression|3|||
125046146|NCT04045613|449789452|FG006|Overall Study|Progressive disease: Clinical progression|3|||
125046147|NCT04045613|449789446|FG000|Overall Study|Progressive disease: Radiological progression|24|||
125046148|NCT04045613|449789447|FG001|Overall Study|Progressive disease: Radiological progression|6|||
125046149|NCT04045613|449789448|FG002|Overall Study|Progressive disease: Radiological progression|8|||
125046150|NCT04045613|449789449|FG003|Overall Study|Progressive disease: Radiological progression|0|||
125046151|NCT04045613|449789450|FG004|Overall Study|Progressive disease: Radiological progression|6|||
125046152|NCT04045613|449789451|FG005|Overall Study|Progressive disease: Radiological progression|6|||
125046153|NCT04045613|449789452|FG006|Overall Study|Progressive disease: Radiological progression|11|||
125046154|NCT04983901|449789453|FG000|Overall Study|Death|1|||
125046155|NCT04983901|449789454|FG001|Overall Study|Death|4|||
125046156|NCT04983901|449789453|FG000|Overall Study|Lost to Follow-up|3|||
125046157|NCT04983901|449789454|FG001|Overall Study|Lost to Follow-up|0|||
125046158|NCT04983901|449789453|FG000|Overall Study|Protocol Violation|1|||
125046159|NCT04983901|449789454|FG001|Overall Study|Protocol Violation|0|||
125046160|NCT04983901|449789453|FG000|Overall Study|Withdrawal by Subject|1|||
125046161|NCT04983901|449789454|FG001|Overall Study|Withdrawal by Subject|2|||
125046162|NCT02859415|449789462|FG000|Overall Study|Physician Decision|1|||
125046163|NCT02859415|449789463|FG001|Overall Study|Physician Decision|0|||
125046164|NCT02859415|449789462|FG000|Overall Study|Off treatment due to cardiac event|0|||
125046165|NCT02859415|449789463|FG001|Overall Study|Off treatment due to cardiac event|1|||
125046166|NCT01174784|449789464|FG000|Overall Study|Screen fails|4|||
125046167|NCT01507545|449789469|FG000|Overall Study|Withdrawal by Subject|6|||
125046168|NCT01507545|449789470|FG001|Overall Study|Withdrawal by Subject|2|||
125046169|NCT01507545|449789469|FG000|Overall Study|Lost to Follow-up|1|||
125046170|NCT01507545|449789470|FG001|Overall Study|Lost to Follow-up|0|||
125046171|NCT01507545|449789469|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
125046172|NCT01507545|449789470|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
125046173|NCT01507545|449789469|FG000|Overall Study|Progressive disease|60|||
125046174|NCT01507545|449789470|FG001|Overall Study|Progressive disease|27|||
125046175|NCT01507545|449789469|FG000|Overall Study|Other|6|||
125135911|NCT00927069|450121767|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
125135912|NCT00927069|450121764|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
125135913|NCT00927069|450121765|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
125135914|NCT00927069|450121766|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
125046176|NCT01507545|449789470|FG001|Overall Study|Other|4|||
125135915|NCT00927069|450121767|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
125135916|NCT02558491|450121768|FG000|First Invention|Withdrawal by Subject|3|||
125135917|NCT02558491|450121769|FG001|First Invention|Withdrawal by Subject|1|||
125046177|NCT00450866|449789471|FG000|Overall Study|Adverse Event|0|||
125046178|NCT00450866|449789472|FG001|Overall Study|Adverse Event|1|||
125046179|NCT00450866|449789471|FG000|Overall Study|Withdrawal by Subject|5|||
125046180|NCT00450866|449789472|FG001|Overall Study|Withdrawal by Subject|2|||
125046181|NCT00450866|449789471|FG000|Overall Study|Death|1|||
125046182|NCT00450866|449789472|FG001|Overall Study|Death|0|||
125046183|NCT00450866|449789471|FG000|Overall Study|Physician Decision|1|||
125046184|NCT00450866|449789472|FG001|Overall Study|Physician Decision|0|||
125046185|NCT00553787|449789473|FG000|Overall Study|Adverse Event|34|||
125046186|NCT00553787|449789474|FG001|Overall Study|Adverse Event|21|||
125046187|NCT00553787|449789475|FG002|Overall Study|Adverse Event|67|||
125046188|NCT00553787|449789473|FG000|Overall Study|Lost to Follow-up|132|||
125046189|NCT00553787|449789474|FG001|Overall Study|Lost to Follow-up|44|||
125046190|NCT00553787|449789475|FG002|Overall Study|Lost to Follow-up|78|||
125046191|NCT00553787|449789473|FG000|Overall Study|Withdrawal by Subject|151|||
125046192|NCT00553787|449789474|FG001|Overall Study|Withdrawal by Subject|40|||
125046193|NCT00553787|449789475|FG002|Overall Study|Withdrawal by Subject|83|||
125046194|NCT00553787|449789473|FG000|Overall Study|Lack of Efficacy|31|||
125046195|NCT00553787|449789474|FG001|Overall Study|Lack of Efficacy|1|||
125046196|NCT00553787|449789475|FG002|Overall Study|Lack of Efficacy|3|||
125046197|NCT00553787|449789473|FG000|Overall Study|Pregnancy|0|||
125046198|NCT00553787|449789474|FG001|Overall Study|Pregnancy|1|||
125046199|NCT00553787|449789475|FG002|Overall Study|Pregnancy|2|||
125046200|NCT00553787|449789473|FG000|Overall Study|non compliance|4|||
125046201|NCT00553787|449789474|FG001|Overall Study|non compliance|0|||
125046202|NCT00553787|449789475|FG002|Overall Study|non compliance|11|||
125046203|NCT00553787|449789473|FG000|Overall Study|Requirement for restricted medication|8|||
125046204|NCT00553787|449789474|FG001|Overall Study|Requirement for restricted medication|7|||
125046205|NCT00553787|449789475|FG002|Overall Study|Requirement for restricted medication|5|||
125046206|NCT00553787|449789473|FG000|Overall Study|Other|18|||
125046207|NCT00553787|449789474|FG001|Overall Study|Other|10|||
125046208|NCT00553787|449789475|FG002|Overall Study|Other|13|||
125046209|NCT02285010|449789476|FG000|Overall Study|not abdominal hysterectomy|2|||
125046210|NCT02285010|449789477|FG001|Overall Study|not abdominal hysterectomy|0|||
125046211|NCT02285010|449789476|FG000|Overall Study|Not spinal anesthesia|3|||
125046212|NCT02285010|449789477|FG001|Overall Study|Not spinal anesthesia|1|||
125046213|NCT01426386|449789481|FG000|Overall Study|Adverse Event|0|||
125046214|NCT01426386|449789482|FG001|Overall Study|Adverse Event|1|||
125046215|NCT01426386|449789483|FG002|Overall Study|Adverse Event|0|||
125046216|NCT01426386|449789484|FG003|Overall Study|Adverse Event|0|||
125046217|NCT01426386|449789485|FG004|Overall Study|Adverse Event|0|||
125046218|NCT01426386|449789486|FG005|Overall Study|Adverse Event|0|||
125046219|NCT01426386|449789481|FG000|Overall Study|Did not attend scheduled visit|1|||
125046220|NCT01426386|449789482|FG001|Overall Study|Did not attend scheduled visit|4|||
125046221|NCT01426386|449789483|FG002|Overall Study|Did not attend scheduled visit|0|||
125046222|NCT01426386|449789484|FG003|Overall Study|Did not attend scheduled visit|0|||
125046223|NCT01426386|449789485|FG004|Overall Study|Did not attend scheduled visit|2|||
125046224|NCT01426386|449789486|FG005|Overall Study|Did not attend scheduled visit|1|||
125046225|NCT01426386|449789481|FG000|Overall Study|Poor response|2|||
125046226|NCT01426386|449789482|FG001|Overall Study|Poor response|1|||
125046227|NCT01426386|449789483|FG002|Overall Study|Poor response|2|||
125046228|NCT01426386|449789484|FG003|Overall Study|Poor response|0|||
125046229|NCT01426386|449789485|FG004|Overall Study|Poor response|1|||
125218939|NCT03538691|450427423|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
125046230|NCT01426386|449789486|FG005|Overall Study|Poor response|0|||
125046231|NCT01426386|449789481|FG000|Overall Study|Personal reasons|0|||
125046232|NCT01426386|449789482|FG001|Overall Study|Personal reasons|0|||
125046233|NCT01426386|449789483|FG002|Overall Study|Personal reasons|0|||
125046234|NCT01426386|449789484|FG003|Overall Study|Personal reasons|0|||
125046235|NCT01426386|449789485|FG004|Overall Study|Personal reasons|1|||
125046236|NCT01426386|449789486|FG005|Overall Study|Personal reasons|0|||
125046237|NCT00196937|449789487|FG000|Overall Study|Serious Adverse Event|1|||
125046238|NCT00196937|449789488|FG001|Overall Study|Serious Adverse Event|0|||
125046239|NCT00196937|449789489|FG002|Overall Study|Serious Adverse Event|0|||
125046240|NCT00196937|449789487|FG000|Overall Study|Non-serious adverse event|1|||
125046241|NCT00196937|449789488|FG001|Overall Study|Non-serious adverse event|1|||
125046242|NCT00196937|449789489|FG002|Overall Study|Non-serious adverse event|1|||
125046243|NCT00196937|449789487|FG000|Overall Study|Withdrawal by Subject|0|||
125046244|NCT00196937|449789488|FG001|Overall Study|Withdrawal by Subject|0|||
125046245|NCT00196937|449789489|FG002|Overall Study|Withdrawal by Subject|2|||
125046246|NCT00196937|449789487|FG000|Overall Study|Lost to Follow-up|4|||
125046247|NCT00196937|449789488|FG001|Overall Study|Lost to Follow-up|3|||
125046248|NCT00196937|449789489|FG002|Overall Study|Lost to Follow-up|3|||
125046249|NCT00196937|449789487|FG000|Overall Study|Other|3|||
125046250|NCT00196937|449789488|FG001|Overall Study|Other|1|||
125046251|NCT00196937|449789489|FG002|Overall Study|Other|1|||
125046252|NCT01096667|449789490|FG000|Overall Study|Lost to Follow-up|1|||
125046253|NCT01096667|449789491|FG001|Overall Study|Lost to Follow-up|1|||
125046254|NCT01096667|449789492|FG002|Overall Study|Lost to Follow-up|1|||
125046255|NCT01096667|449789493|FG003|Overall Study|Lost to Follow-up|0|||
125046256|NCT01096667|449789494|FG004|Overall Study|Lost to Follow-up|0|||
125046257|NCT01096667|449789490|FG000|Overall Study|Withdrawal by Subject|1|||
125046258|NCT01096667|449789491|FG001|Overall Study|Withdrawal by Subject|0|||
125046259|NCT01096667|449789492|FG002|Overall Study|Withdrawal by Subject|0|||
125046260|NCT01096667|449789493|FG003|Overall Study|Withdrawal by Subject|1|||
125046261|NCT01096667|449789494|FG004|Overall Study|Withdrawal by Subject|0|||
125046262|NCT01096667|449789490|FG000|Overall Study|Reason not available|0|||
125046263|NCT01096667|449789491|FG001|Overall Study|Reason not available|1|||
125046264|NCT01096667|449789492|FG002|Overall Study|Reason not available|1|||
125046265|NCT01096667|449789493|FG003|Overall Study|Reason not available|1|||
125046266|NCT01096667|449789494|FG004|Overall Study|Reason not available|0|||
125046267|NCT01096667|449789490|FG000|Overall Study|Protocol Violation|0|||
125046268|NCT01096667|449789491|FG001|Overall Study|Protocol Violation|0|||
125046269|NCT01096667|449789492|FG002|Overall Study|Protocol Violation|0|||
125046270|NCT01096667|449789493|FG003|Overall Study|Protocol Violation|1|||
125046271|NCT01096667|449789494|FG004|Overall Study|Protocol Violation|0|||
125046272|NCT01096667|449789490|FG000|Overall Study|Not treated|1|||
125046273|NCT01096667|449789491|FG001|Overall Study|Not treated|0|||
125046274|NCT01096667|449789492|FG002|Overall Study|Not treated|0|||
125046275|NCT01096667|449789493|FG003|Overall Study|Not treated|0|||
125046276|NCT01096667|449789494|FG004|Overall Study|Not treated|0|||
125046277|NCT01751646|449789498|FG000|Overall Study|Lost to Follow-up|5|||
125046278|NCT01751646|449789499|FG001|Overall Study|Lost to Follow-up|1|||
125046279|NCT01751646|449789498|FG000|Overall Study|Withdrawal by Subject|0|||
125046280|NCT01751646|449789499|FG001|Overall Study|Withdrawal by Subject|4|||
125046281|NCT01751646|449789498|FG000|Overall Study|Starting hormone therapy|1|||
125046282|NCT01751646|449789499|FG001|Overall Study|Starting hormone therapy|0|||
125046283|NCT01751646|449789498|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
125046284|NCT01751646|449789499|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
125046285|NCT01751646|449789498|FG000|Overall Study|Inadvertent enrollment|1|||
125046286|NCT01751646|449789499|FG001|Overall Study|Inadvertent enrollment|1|||
125046287|NCT01751646|449789498|FG000|Overall Study|Moved out of the area|1|||
125046288|NCT01751646|449789499|FG001|Overall Study|Moved out of the area|5|||
125046289|NCT01751646|449789498|FG000|Overall Study|Inability to attend required visits|0|||
125046290|NCT01751646|449789499|FG001|Overall Study|Inability to attend required visits|1|||
125046291|NCT01751646|449789498|FG000|Overall Study|Off study due to multiple obligations|0|||
125046292|NCT01751646|449789499|FG001|Overall Study|Off study due to multiple obligations|1|||
125046293|NCT01751646|449789498|FG000|Overall Study|Fails to comply with study requirements|0|||
125046294|NCT01751646|449789499|FG001|Overall Study|Fails to comply with study requirements|1|||
125046295|NCT01751646|449789498|FG000|Overall Study|Childcare issues|1|||
125046296|NCT01751646|449789499|FG001|Overall Study|Childcare issues|1|||
125046297|NCT02335450|449789500|FG000|Overall Study|Pregnancy|1|||
125046298|NCT02973815|449789501|FG000|Post Intervention|Death|1|||
125046299|NCT02973815|449789502|FG001|Post Intervention|Death|0|||
125046300|NCT02973815|449789501|FG000|Post Intervention|Lost to Follow-up|7|||
125046301|NCT02973815|449789502|FG001|Post Intervention|Lost to Follow-up|24|||
125046302|NCT02973815|449789501|FG000|Follow-up|Lost to Follow-up|2|||
125046303|NCT02973815|449789502|FG001|Follow-up|Lost to Follow-up|0|||
125046304|NCT02613572|449789503|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
125046305|NCT02613572|449789504|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
125046306|NCT02613572|449789505|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
125046307|NCT02613572|449789503|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
125046308|NCT02613572|449789504|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
125046309|NCT02613572|449789505|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
125046310|NCT00853905|449789510|FG000|Overall Study|Lost to Follow-up|1|||
125046311|NCT00853905|449789511|FG001|Overall Study|Lost to Follow-up|3|||
125046312|NCT00853905|449789510|FG000|Overall Study|Withdrawal by Subject|0|||
125046313|NCT00853905|449789511|FG001|Overall Study|Withdrawal by Subject|1|||
125046314|NCT00853905|449789510|FG000|Overall Study|never had surgery|1|||
125046315|NCT00853905|449789511|FG001|Overall Study|never had surgery|0|||
125046316|NCT04538950|449789512|FG000|Overall Study|Pulmonary Issues|2|||
125046317|NCT04538950|449789512|FG000|Overall Study|illness|2|||
125046318|NCT01004146|449789515|FG000|Overall Study|Withdrawal by Subject|4|||
125046319|NCT01004146|449789516|FG001|Overall Study|Withdrawal by Subject|5|||
125046320|NCT00465738|449789519|FG000|Overall Study|Lost to Follow-up|2|||
125046321|NCT00465738|449789520|FG001|Overall Study|Lost to Follow-up|0|||
125046322|NCT00465738|449789519|FG000|Overall Study|Adverse Event|0|||
125046323|NCT00465738|449789520|FG001|Overall Study|Adverse Event|1|||
125046324|NCT00465738|449789519|FG000|Overall Study|Withdrawal by Subject|2|||
125046325|NCT00465738|449789520|FG001|Overall Study|Withdrawal by Subject|0|||
125046326|NCT00465738|449789519|FG000|Overall Study|Other|2|||
125046327|NCT00465738|449789520|FG001|Overall Study|Other|5|||
125046328|NCT02489630|449789522|FG000|Overall Study|Oversedation|1|||
125046329|NCT02489630|449789523|FG001|Overall Study|Oversedation|1|||
125046330|NCT02489630|449789522|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
125046331|NCT02489630|449789523|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
125046332|NCT01056523|449789524|FG000|Overall Study|Death|1|||
125046333|NCT01056523|449789525|FG001|Overall Study|Death|0|||
125046334|NCT01056523|449789526|FG002|Overall Study|Death|2|||
125046335|NCT01056523|449789527|FG003|Overall Study|Death|3|||
125046336|NCT01056523|449789528|FG004|Overall Study|Death|0|||
125046337|NCT01056523|449789529|FG005|Overall Study|Death|0|||
125046338|NCT01056523|449789530|FG006|Overall Study|Death|1|||
125046339|NCT03429556|449789531|FG000|Overall Study|Lost to Follow-up|0|||
125046340|NCT03429556|449789532|FG001|Overall Study|Lost to Follow-up|1|||
125046341|NCT03429556|449789533|FG002|Overall Study|Lost to Follow-up|0|||
125046342|NCT03429556|449789534|FG003|Overall Study|Lost to Follow-up|0|||
125046343|NCT01863758|449789539|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
125046344|NCT01863758|449789539|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
125046345|NCT04952389|449789540|FG000|Overall Study|Withdrawal by Subject|8|||
125046346|NCT04952389|449789541|FG001|Overall Study|Withdrawal by Subject|4|||
125046347|NCT02050048|449789542|FG000|Overall Study|Lost to Follow-up|0|||
125046348|NCT02050048|449789543|FG001|Overall Study|Lost to Follow-up|1|||
125046349|NCT02050048|449789542|FG000|Overall Study|Death|1|||
125046350|NCT02050048|449789543|FG001|Overall Study|Death|0|||
125046351|NCT02050048|449789542|FG000|Overall Study|Ineligible after ERCP|4|||
125046352|NCT02050048|449789543|FG001|Overall Study|Ineligible after ERCP|1|||
125046353|NCT04285723|449789546|FG000|Overall Study|Subject decision|1|||
125046354|NCT04285723|449789547|FG001|Overall Study|Subject decision|2|||
125046355|NCT04285723|449789546|FG000|Overall Study|Physician Decision|1|||
125046356|NCT04285723|449789547|FG001|Overall Study|Physician Decision|0|||
125046357|NCT04285723|449789546|FG000|Overall Study|No efficiency|1|||
125046358|NCT04285723|449789547|FG001|Overall Study|No efficiency|0|||
125046359|NCT02699515|449791706|FG000|Overall Study|Death|3|||
125046360|NCT02699515|449791707|FG001|Overall Study|Death|3|||
125046361|NCT02699515|449791708|FG002|Overall Study|Death|3|||
125046362|NCT02699515|449791709|FG003|Overall Study|Death|23|||
125046363|NCT02699515|449791710|FG004|Overall Study|Death|22|||
125046364|NCT02699515|449791711|FG005|Overall Study|Death|23|||
125046365|NCT02699515|449791712|FG006|Overall Study|Death|3|||
125046366|NCT02699515|449791713|FG007|Overall Study|Death|5|||
125046367|NCT02699515|449791706|FG000|Overall Study|Withdrawal by Subject|0|||
125046368|NCT02699515|449791707|FG001|Overall Study|Withdrawal by Subject|0|||
125046369|NCT02699515|449791708|FG002|Overall Study|Withdrawal by Subject|3|||
125046370|NCT02699515|449791709|FG003|Overall Study|Withdrawal by Subject|1|||
125046371|NCT02699515|449791710|FG004|Overall Study|Withdrawal by Subject|5|||
125046372|NCT02699515|449791711|FG005|Overall Study|Withdrawal by Subject|3|||
125135918|NCT02558491|450121768|FG000|First Invention|Data collection issues|1|||
125135919|NCT02558491|450121769|FG001|First Invention|Data collection issues|0|||
125135920|NCT02558491|450121768|FG000|First Invention|Stopping criteria|0|||
125135921|NCT02558491|450121769|FG001|First Invention|Stopping criteria|1|||
125046373|NCT02699515|449791712|FG006|Overall Study|Withdrawal by Subject|0|||
125046374|NCT02699515|449791713|FG007|Overall Study|Withdrawal by Subject|1|||
125046375|NCT02699515|449791706|FG000|Overall Study|Other|1|||
125046376|NCT02699515|449791707|FG001|Overall Study|Other|0|||
125046377|NCT02699515|449791708|FG002|Overall Study|Other|1|||
125046378|NCT02699515|449791709|FG003|Overall Study|Other|6|||
125046379|NCT02699515|449791710|FG004|Overall Study|Other|4|||
125046380|NCT02699515|449791711|FG005|Overall Study|Other|3|||
125135922|NCT02558491|450121768|FG000|First Invention|Changed parameters during trial|1|||
125135923|NCT02558491|450121769|FG001|First Invention|Changed parameters during trial|0|||
125135924|NCT02558491|450121768|FG000|Second Intervention|Withdrawal by Subject|1|||
125046381|NCT02699515|449791712|FG006|Overall Study|Other|0|||
125046382|NCT02699515|449791713|FG007|Overall Study|Other|0|||
125046383|NCT00375934|449791716|FG000|Overall Study|Adverse Event|1|||
125046384|NCT00375934|449791717|FG001|Overall Study|Adverse Event|1|||
125046385|NCT00375934|449791716|FG000|Overall Study|Withdrawal by Subject|2|||
125046386|NCT00375934|449791717|FG001|Overall Study|Withdrawal by Subject|2|||
125046387|NCT00375934|449791716|FG000|Overall Study|Lack of Efficacy|0|||
125046388|NCT00375934|449791717|FG001|Overall Study|Lack of Efficacy|2|||
125046389|NCT00375934|449791716|FG000|Overall Study|Physician Decision|0|||
125046390|NCT00375934|449791717|FG001|Overall Study|Physician Decision|1|||
125046391|NCT00893113|449791718|FG000|Overall Study|Lost to Follow-up|4|||
125046392|NCT00893113|449791719|FG001|Overall Study|Lost to Follow-up|8|||
125046393|NCT00893113|449791718|FG000|Overall Study|Early Termination|1|||
125046394|NCT00893113|449791719|FG001|Overall Study|Early Termination|1|||
125046395|NCT00893113|449791718|FG000|Overall Study|Withdrew Consent|8|||
125046396|NCT00893113|449791719|FG001|Overall Study|Withdrew Consent|7|||
125046397|NCT02400346|449791726|FG000|Overall Study|Adverse Event|24|||
125046398|NCT02400346|449791726|FG000|Overall Study|Lack of Efficacy|9|||
125046399|NCT02400346|449791726|FG000|Overall Study|Non-compliance with IMP|1|||
125046400|NCT02400346|449791726|FG000|Overall Study|Withdrawal by Subject|7|||
125135925|NCT02558491|450121769|FG001|Second Intervention|Withdrawal by Subject|0|||
125046401|NCT02400346|449791726|FG000|Overall Study|Administrative or other reason(s)|2|||
125046402|NCT02400346|449791726|FG000|Overall Study|Lost to Follow-up|1|||
125046403|NCT01269125|449791727|FG000|Overall Study|Adverse Event|3|||
125046404|NCT01269125|449791728|FG001|Overall Study|Adverse Event|5|||
125046405|NCT01269125|449791729|FG002|Overall Study|Adverse Event|0|||
125046406|NCT01269125|449791727|FG000|Overall Study|Lost to Follow-up|4|||
125046407|NCT01269125|449791728|FG001|Overall Study|Lost to Follow-up|0|||
125046408|NCT01269125|449791729|FG002|Overall Study|Lost to Follow-up|0|||
125046409|NCT01283581|449791730|FG000|Overall Study|Lost to Follow-up|8|||
125046410|NCT01283581|449791731|FG001|Overall Study|Lost to Follow-up|6|||
125046411|NCT01283581|449791732|FG002|Overall Study|Lost to Follow-up|8|||
125046412|NCT01283581|449791730|FG000|Overall Study|Withdrawal by Subject|2|||
125046413|NCT01283581|449791731|FG001|Overall Study|Withdrawal by Subject|5|||
125046414|NCT01283581|449791732|FG002|Overall Study|Withdrawal by Subject|2|||
125046415|NCT01283581|449791730|FG000|Overall Study|Adverse Event|1|||
125046416|NCT01283581|449791731|FG001|Overall Study|Adverse Event|1|||
125046417|NCT01283581|449791732|FG002|Overall Study|Adverse Event|4|||
125046418|NCT01283581|449791730|FG000|Overall Study|Physician Decision|0|||
125046419|NCT01283581|449791731|FG001|Overall Study|Physician Decision|1|||
125046420|NCT01283581|449791732|FG002|Overall Study|Physician Decision|2|||
125046421|NCT01283581|449791730|FG000|Overall Study|Protocol Violation|0|||
125046422|NCT01283581|449791731|FG001|Overall Study|Protocol Violation|1|||
125046423|NCT01283581|449791732|FG002|Overall Study|Protocol Violation|2|||
125046424|NCT01283581|449791730|FG000|Overall Study|Noncompliance|1|||
125046425|NCT01283581|449791731|FG001|Overall Study|Noncompliance|0|||
125046426|NCT01283581|449791732|FG002|Overall Study|Noncompliance|0|||
125046427|NCT01283581|449791730|FG000|Overall Study|Investigator unblinded|0|||
125046428|NCT01283581|449791731|FG001|Overall Study|Investigator unblinded|0|||
125046429|NCT01283581|449791732|FG002|Overall Study|Investigator unblinded|1|||
125046430|NCT01283581|449791730|FG000|Overall Study|"Early termination"|0|||
125046431|NCT01283581|449791731|FG001|Overall Study|"Early termination"|0|||
125046432|NCT01283581|449791732|FG002|Overall Study|"Early termination"|1|||
125046433|NCT00486226|449791733|FG000|Overall Study|Death|3|||
125046434|NCT00486226|449791733|FG000|Overall Study|Adverse Event|1|||
125046435|NCT00486226|449791733|FG000|Overall Study|Withdrawal by Subject|1|||
125046436|NCT00486226|449791733|FG000|Overall Study|Lost to Follow-up|8|||
125046437|NCT01259492|449791734|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
125046438|NCT01259492|449791735|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
125046439|NCT01259492|449791736|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
125046440|NCT01259492|449791737|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
125046441|NCT01259492|449791734|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
125046442|NCT01259492|449791735|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
125046443|NCT01259492|449791736|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
125046444|NCT01259492|449791737|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
125046445|NCT01259492|449791734|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
125046446|NCT01259492|449791735|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
125046447|NCT01259492|449791736|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
125046448|NCT01259492|449791737|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
125046449|NCT01259492|449791734|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
125046450|NCT01259492|449791735|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
125046451|NCT01259492|449791736|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
125046452|NCT01259492|449791737|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
125046453|NCT01259492|449791734|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
125046454|NCT01259492|449791735|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
125046455|NCT01259492|449791736|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
125046456|NCT01259492|449791737|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
125046457|NCT01259492|449791734|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
125046458|NCT01259492|449791735|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
125046459|NCT01259492|449791736|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
125046460|NCT01259492|449791737|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
125046461|NCT01259492|449791734|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
125046462|NCT01259492|449791735|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
125046463|NCT01259492|449791736|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
125046464|NCT01259492|449791737|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
125046465|NCT01259492|449791734|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
125046466|NCT01259492|449791735|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
125046467|NCT01259492|449791736|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
125046468|NCT01259492|449791737|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
125046469|NCT01259492|449791734|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
125046470|NCT01259492|449791735|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
125046471|NCT01259492|449791736|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
125046472|NCT01259492|449791737|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
125046473|NCT01259492|449791734|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
125046474|NCT01259492|449791735|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
125046475|NCT01259492|449791736|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
125046476|NCT01259492|449791737|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
125046477|NCT01259492|449791734|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
125046478|NCT01259492|449791735|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
125046479|NCT01259492|449791736|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
125046480|NCT01259492|449791737|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
125046481|NCT01259492|449791734|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
125046482|NCT01259492|449791735|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
125046483|NCT01259492|449791736|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
125046484|NCT01259492|449791737|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
125046485|NCT01259492|449791734|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
125046486|NCT01259492|449791735|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
125046487|NCT01259492|449791736|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
125046488|NCT01259492|449791737|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
125046489|NCT01259492|449791734|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
125046490|NCT01259492|449791735|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
125046491|NCT01259492|449791736|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
125046492|NCT01259492|449791737|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
125046493|NCT01259492|449791734|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
125046494|NCT01259492|449791735|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
125046495|NCT01259492|449791736|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
125046496|NCT01259492|449791737|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
125046497|NCT01259492|449791734|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
125046498|NCT01259492|449791735|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
125046499|NCT01259492|449791736|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
125046500|NCT01259492|449791737|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
125046501|NCT01259492|449791734|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
125046502|NCT01259492|449791735|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
125046503|NCT01259492|449791736|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
125046504|NCT01259492|449791737|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
125046505|NCT01259492|449791734|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
125046506|NCT01259492|449791735|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
125046507|NCT01259492|449791736|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
125046508|NCT01259492|449791737|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
125046509|NCT01259492|449791734|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
125046510|NCT01259492|449791735|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
125046511|NCT01259492|449791736|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
125046512|NCT01259492|449791737|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
125046513|NCT01259492|449791734|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
125046514|NCT01259492|449791735|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
125046515|NCT01259492|449791736|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
125046516|NCT01259492|449791737|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
125046517|NCT01166659|449791746|FG000|Overall Study|Subject Decision|8|||
125046518|NCT01166659|449791746|FG000|Overall Study|Investigator Decision|2|||
125046519|NCT01166659|449791746|FG000|Overall Study|Death|1|||
125046520|NCT01166659|449791746|FG000|Overall Study|Lost to Follow-up|1|||
125046521|NCT01166659|449791746|FG000|Overall Study|Study Closed at Site|1|||
125046522|NCT01371838|449791765|FG000|Overall Study|Withdrawal by Subject|27|||
125046523|NCT01371838|449791766|FG001|Overall Study|Withdrawal by Subject|33|||
125046524|NCT01371838|449791765|FG000|Overall Study|Lost to Follow-up|10|||
125046525|NCT01371838|449791766|FG001|Overall Study|Lost to Follow-up|20|||
125046526|NCT01371838|449791765|FG000|Overall Study|Death|3|||
125046527|NCT01371838|449791766|FG001|Overall Study|Death|4|||
125046528|NCT01371838|449791765|FG000|Overall Study|Protocol Violation|3|||
125046529|NCT01371838|449791766|FG001|Overall Study|Protocol Violation|0|||
125046530|NCT01371838|449791765|FG000|Overall Study|Investigator Decision|3|||
125046531|NCT01371838|449791766|FG001|Overall Study|Investigator Decision|8|||
125046532|NCT01371838|449791765|FG000|Overall Study|Last follow-up visit not conducted|2|||
125046533|NCT01371838|449791766|FG001|Overall Study|Last follow-up visit not conducted|0|||
125046534|NCT01371838|449791765|FG000|Overall Study|Lack of therapeutic response|0|||
125046535|NCT01371838|449791766|FG001|Overall Study|Lack of therapeutic response|1|||
125046536|NCT01371838|449791765|FG000|Overall Study|Surgery|1|||
125046537|NCT01371838|449791766|FG001|Overall Study|Surgery|0|||
125046538|NCT01334125|449791767|FG000|Overall Study|Lost to Follow-up|3|||
125046539|NCT01334125|449791768|FG001|Overall Study|Lost to Follow-up|3|||
125046540|NCT00641043|449791775|FG000|Overall Study|Adverse Event|6|||
125046541|NCT00641043|449791776|FG001|Overall Study|Adverse Event|4|||
125046542|NCT00641043|449791775|FG000|Overall Study|Protocol Violation|2|||
125046543|NCT00641043|449791776|FG001|Overall Study|Protocol Violation|3|||
125046544|NCT00641043|449791775|FG000|Overall Study|Lost to Follow-up|3|||
125046545|NCT00641043|449791776|FG001|Overall Study|Lost to Follow-up|2|||
125046546|NCT00641043|449791775|FG000|Overall Study|Withdrawal by Subject|4|||
125046547|NCT00641043|449791776|FG001|Overall Study|Withdrawal by Subject|4|||
125046548|NCT00641043|449791775|FG000|Overall Study|Other incl. lack of efficacy|4|||
125046549|NCT00641043|449791776|FG001|Overall Study|Other incl. lack of efficacy|2|||
125046550|NCT02584634|449791777|FG000|Overall Study|Adverse Event|3|||
125046551|NCT02584634|449791778|FG001|Overall Study|Adverse Event|5|||
125046552|NCT02584634|449791777|FG000|Overall Study|Death|0|||
125046553|NCT02584634|449791778|FG001|Overall Study|Death|1|||
125046554|NCT02584634|449791777|FG000|Overall Study|Lost to Follow-up|0|||
125046555|NCT02584634|449791778|FG001|Overall Study|Lost to Follow-up|1|||
125046556|NCT02584634|449791777|FG000|Overall Study|Physician Decision|1|||
125046557|NCT02584634|449791778|FG001|Overall Study|Physician Decision|2|||
125046558|NCT02584634|449791777|FG000|Overall Study|Progressive disease|7|||
125046559|NCT02584634|449791778|FG001|Overall Study|Progressive disease|15|||
125046560|NCT02584634|449791777|FG000|Overall Study|Withdrawal by Subject|1|||
125046561|NCT02584634|449791778|FG001|Overall Study|Withdrawal by Subject|1|||
125046562|NCT02584634|449791777|FG000|Overall Study|Other|0|||
125046563|NCT02584634|449791778|FG001|Overall Study|Other|6|||
125046564|NCT04275310|449791779|FG000|Overall Study|Non-randomized due to running out of funding|4|||
125046565|NCT04275310|449791780|FG001|Overall Study|Non-randomized due to running out of funding|0|||
125046566|NCT03088605|449791781|FG000|Overall Study|Withdrawal by Subject|1|||
125046567|NCT03088605|449791782|FG001|Overall Study|Withdrawal by Subject|0|||
125046568|NCT02225223|449791783|FG000|Overall Study|Death|10|||
125046569|NCT02225223|449791784|FG001|Overall Study|Death|1|||
125046570|NCT02225223|449791783|FG000|Overall Study|Lost to Follow-up|5|||
125046571|NCT02225223|449791784|FG001|Overall Study|Lost to Follow-up|0|||
125046572|NCT02225223|449791783|FG000|Overall Study|Other|1|||
125046573|NCT02225223|449791784|FG001|Overall Study|Other|2|||
125046574|NCT02225223|449791783|FG000|Overall Study|Physician Decision|1|||
125046575|NCT02225223|449791784|FG001|Overall Study|Physician Decision|0|||
125046576|NCT02225223|449791783|FG000|Overall Study|Withdrawal by Subject|2|||
125046577|NCT02225223|449791784|FG001|Overall Study|Withdrawal by Subject|2|||
125046578|NCT00891657|449791794|FG000|Overall Study|Withdrawal by Subject|1|||
125046579|NCT00891657|449791795|FG001|Overall Study|Withdrawal by Subject|1|||
125046580|NCT02927171|449791798|FG000|Overall Study|Lost to Follow-up|0|||
125046581|NCT02927171|449791799|FG001|Overall Study|Lost to Follow-up|1|||
125046582|NCT04530825|449791800|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
125046583|NCT04530825|449791801|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
125046584|NCT04530825|449791802|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
125046585|NCT04530825|449791803|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
125046586|NCT04530825|449791800|FG000|Overall Study|Did not complete follow-up|3|||
125046587|NCT04530825|449791801|FG001|Overall Study|Did not complete follow-up|0|||
125046588|NCT04530825|449791802|FG002|Overall Study|Did not complete follow-up|0|||
125046589|NCT04530825|449791803|FG003|Overall Study|Did not complete follow-up|0|||
125046590|NCT01720667|449791805|FG000|Overall Study|Adverse Event|1|||
125046591|NCT01720667|449791806|FG001|Overall Study|Adverse Event|1|||
125046592|NCT01720667|449791805|FG000|Overall Study|Withdrawal by Subject|3|||
125046593|NCT01720667|449791806|FG001|Overall Study|Withdrawal by Subject|0|||
125046594|NCT01319929|449791807|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
125046595|NCT01319929|449791808|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
125046596|NCT01319929|449791807|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
125046597|NCT01319929|449791808|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
125046598|NCT01319929|449791807|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
125046599|NCT01319929|449791808|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
125046600|NCT01319929|449791807|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
125046601|NCT01319929|449791808|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
125046602|NCT01319929|449791807|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
125046603|NCT01319929|449791808|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
125046604|NCT01749735|449791810|FG000|Overall Study|Withdrawal by Subject|1|||
125046605|NCT01749735|449791811|FG001|Overall Study|Withdrawal by Subject|0|||
125046606|NCT01221233|449791812|FG000|Overall Study|Withdrawal by Subject|3|||
125046607|NCT01221233|449791813|FG001|Overall Study|Withdrawal by Subject|1|||
125046608|NCT00611455|449791818|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
125046609|NCT00611455|449791819|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
125046610|NCT00611455|449791820|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
125046611|NCT00611455|449791818|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
125046612|NCT00611455|449791819|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
125046613|NCT00611455|449791820|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
125046614|NCT00611455|449791818|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
125046615|NCT00611455|449791819|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
125046616|NCT00611455|449791820|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
125046617|NCT00611455|449791818|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
125046618|NCT00611455|449791819|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
125046619|NCT00611455|449791820|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125046620|NCT00611455|449791818|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
125046621|NCT00611455|449791819|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
125046622|NCT00611455|449791820|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
125046623|NCT00611455|449791818|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
125046624|NCT00611455|449791819|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
125046625|NCT00611455|449791820|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
125046626|NCT00611455|449791818|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
125046627|NCT00611455|449791819|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
125046628|NCT00611455|449791820|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
125046629|NCT00611455|449791818|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
125046630|NCT00611455|449791819|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
125046631|NCT00611455|449791820|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
125046632|NCT00611455|449791818|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
125046633|NCT00611455|449791819|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
125046634|NCT00611455|449791820|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
125046635|NCT00611455|449791818|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
125046636|NCT00611455|449791819|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
125046637|NCT00611455|449791820|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
125046638|NCT00611455|449791818|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
125046639|NCT00611455|449791819|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
125046640|NCT00611455|449791820|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
125046641|NCT00611455|449791818|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
125046642|NCT00611455|449791819|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
125046643|NCT00611455|449791820|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
125046644|NCT00611455|449791818|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
125046645|NCT00611455|449791819|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
125046646|NCT00611455|449791820|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
125046647|NCT00611455|449791818|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
125046648|NCT00611455|449791819|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
125046649|NCT00611455|449791820|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
125046650|NCT00611455|449791818|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
125046651|NCT00611455|449791819|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
125046652|NCT00611455|449791820|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
125046653|NCT00611455|449791818|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
125046654|NCT00611455|449791819|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
125046655|NCT00611455|449791820|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
125046656|NCT00611455|449791818|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
125046657|NCT00611455|449791819|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
125046658|NCT00611455|449791820|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
125135926|NCT02558491|450121768|FG000|Second Intervention|Stopping Criteria|1|||
125135927|NCT02558491|450121769|FG001|Second Intervention|Stopping Criteria|0|||
125135928|NCT00834431|450121770|FG000|First Intervention|Adverse Event|0|||
125046659|NCT00611455|449791818|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
125046660|NCT00611455|449791819|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
125135929|NCT00834431|450121771|FG001|First Intervention|Adverse Event|1|||
125135930|NCT00834431|450121770|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
125135931|NCT00834431|450121771|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
125135932|NCT00835263|450121774|FG000|Second Intervention|Adverse Event|1|||
125135933|NCT00835263|450121775|FG001|Second Intervention|Adverse Event|0|||
125135934|NCT03249454|450121776|FG000|Overall Study|Withdrawal by Subject|0|||
125135935|NCT03249454|450121777|FG001|Overall Study|Withdrawal by Subject|0|||
125135936|NCT03249454|450121778|FG002|Overall Study|Withdrawal by Subject|0|||
125135937|NCT03249454|450121779|FG003|Overall Study|Withdrawal by Subject|0|||
125135938|NCT03249454|450121780|FG004|Overall Study|Withdrawal by Subject|0|||
125135939|NCT03249454|450121781|FG005|Overall Study|Withdrawal by Subject|0|||
125135940|NCT03249454|450121782|FG006|Overall Study|Withdrawal by Subject|0|||
125135941|NCT03249454|450121783|FG007|Overall Study|Withdrawal by Subject|0|||
125135942|NCT03249454|450121784|FG008|Overall Study|Withdrawal by Subject|0|||
125135943|NCT03249454|450121785|FG009|Overall Study|Withdrawal by Subject|1|||
125135944|NCT03249454|450121786|FG010|Overall Study|Withdrawal by Subject|1|||
125135945|NCT01913405|450121787|FG000|Overall Study|Withdrawal by Subject|1|||
125135946|NCT01913405|450121787|FG000|Overall Study|Adverse Event|1|||
125135947|NCT01020474|450121790|FG000|Overall Study|Adverse Event|4|||
125135948|NCT01020474|450121791|FG001|Overall Study|Adverse Event|4|||
125135949|NCT01020474|450121790|FG000|Overall Study|Protocol Violation|0|||
125135950|NCT01020474|450121791|FG001|Overall Study|Protocol Violation|2|||
125135951|NCT01020474|450121790|FG000|Overall Study|Withdrawal by Subject|5|||
125135952|NCT01020474|450121791|FG001|Overall Study|Withdrawal by Subject|7|||
125135953|NCT01020474|450121790|FG000|Overall Study|Other Reasons|1|||
125135954|NCT01020474|450121791|FG001|Overall Study|Other Reasons|1|||
125135955|NCT01020474|450121790|FG000|Overall Study|Insufficient Clinical Response|0|||
125135956|NCT01020474|450121791|FG001|Overall Study|Insufficient Clinical Response|3|||
125135957|NCT03987191|450121792|FG000|Overall Study|COVID-19 related research disruption|0|||
125046661|NCT00611455|449791820|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
125046662|NCT00611455|449791818|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
125046663|NCT00611455|449791819|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
125046664|NCT00611455|449791820|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
125046665|NCT00611455|449791818|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
125046666|NCT00611455|449791819|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
125046667|NCT00611455|449791820|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
125046668|NCT00611455|449791818|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
125046669|NCT00611455|449791819|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
125046670|NCT00611455|449791820|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
125046671|NCT00858702|449791821|FG000|Overall Study|Lack of Efficacy|1|||
125046672|NCT00858702|449791822|FG001|Overall Study|Lack of Efficacy|0|||
125046673|NCT00858702|449791821|FG000|Overall Study|Protocol Violation|1|||
125046674|NCT00858702|449791822|FG001|Overall Study|Protocol Violation|1|||
125046675|NCT00858702|449791821|FG000|Overall Study|Other|2|||
125046676|NCT00858702|449791822|FG001|Overall Study|Other|1|||
125046677|NCT00858702|449791821|FG000|Overall Study|Withdrawal by Subject|1|||
125046678|NCT00858702|449791822|FG001|Overall Study|Withdrawal by Subject|0|||
125046679|NCT00491530|449791823|FG000|Overall Study|Adverse Event|6|||
125046680|NCT00491530|449791824|FG001|Overall Study|Adverse Event|1|||
125046681|NCT00491530|449791825|FG002|Overall Study|Adverse Event|2|||
125046682|NCT00491530|449791823|FG000|Overall Study|Withdrawal by Subject|3|||
125046683|NCT00491530|449791824|FG001|Overall Study|Withdrawal by Subject|0|||
125046684|NCT00491530|449791825|FG002|Overall Study|Withdrawal by Subject|0|||
125046685|NCT00491530|449791823|FG000|Overall Study|Lost to Follow-up|3|||
125046686|NCT00491530|449791824|FG001|Overall Study|Lost to Follow-up|2|||
125046687|NCT00491530|449791825|FG002|Overall Study|Lost to Follow-up|2|||
125046688|NCT00491530|449791823|FG000|Overall Study|Lack of Efficacy|0|||
125046689|NCT00491530|449791824|FG001|Overall Study|Lack of Efficacy|1|||
125046690|NCT00491530|449791825|FG002|Overall Study|Lack of Efficacy|0|||
125046691|NCT00491530|449791823|FG000|Overall Study|Investigator Discretion|0|||
125046692|NCT00491530|449791824|FG001|Overall Study|Investigator Discretion|1|||
125046693|NCT00491530|449791825|FG002|Overall Study|Investigator Discretion|0|||
125046694|NCT00491530|449791823|FG000|Overall Study|Patient Request|0|||
125046695|NCT00491530|449791824|FG001|Overall Study|Patient Request|1|||
125046696|NCT00491530|449791825|FG002|Overall Study|Patient Request|0|||
125046697|NCT00491530|449791823|FG000|Overall Study|Use of Prohibited Medication|0|||
125046698|NCT00491530|449791824|FG001|Overall Study|Use of Prohibited Medication|0|||
125135958|NCT03987191|450121793|FG001|Overall Study|COVID-19 related research disruption|2|||
125046699|NCT00491530|449791825|FG002|Overall Study|Use of Prohibited Medication|1|||
125046700|NCT03671369|449791828|FG000|Overall Study|Other|1|||
125046701|NCT03671369|449791828|FG000|Overall Study|Withdrawal by Subject|289|||
125046702|NCT03671369|449791828|FG000|Overall Study|Not willing to be vaccinated|1|||
125046703|NCT02732912|449791829|FG000|Overall Study|Discharged before night|2|||
125135959|NCT03261167|450121794|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
125135960|NCT03261167|450121795|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
124975750|NCT01077128|449538543|FG000|Overall Study|Adverse event and disease exacerbation|1|||
124975751|NCT01077128|449538543|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
124975752|NCT01077128|449538543|FG000|Overall Study|Other|54|||
124975753|NCT01706705|449538544|FG000|Overall Study|Death|1|||
124975754|NCT01706705|449538544|FG000|Overall Study|Lack of Efficacy|13|||
124975755|NCT01706705|449538544|FG000|Overall Study|Non-clinical|6|||
124975756|NCT04703192|449538545|FG000|Overall Study|Withdrawal by Subject|2|||
124975757|NCT04703192|449538546|FG001|Overall Study|Withdrawal by Subject|0|||
124975758|NCT04703192|449538545|FG000|Overall Study|Death|3|||
124975759|NCT04703192|449538546|FG001|Overall Study|Death|1|||
124975760|NCT04703192|449538545|FG000|Overall Study|Adverse Event|13|||
124975761|NCT04703192|449538546|FG001|Overall Study|Adverse Event|2|||
124975762|NCT04703192|449538545|FG000|Overall Study|Progressive or Relapsed Disease|46|||
124975763|NCT04703192|449538546|FG001|Overall Study|Progressive or Relapsed Disease|7|||
124975764|NCT04703192|449538545|FG000|Overall Study|Clinical Progression|19|||
124975765|NCT04703192|449538546|FG001|Overall Study|Clinical Progression|8|||
124975766|NCT04703192|449538545|FG000|Overall Study|Lost to Follow-up|1|||
124975767|NCT04703192|449538546|FG001|Overall Study|Lost to Follow-up|0|||
124975768|NCT04703192|449538545|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
124975769|NCT04703192|449538546|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
124975770|NCT04703192|449538545|FG000|Overall Study|Other|5|||
124975771|NCT04703192|449538546|FG001|Overall Study|Other|1|||
124975772|NCT02088957|449538547|FG000|Overall Study|Lack of Efficacy|1|||
124975773|NCT02088957|449538548|FG001|Overall Study|Lack of Efficacy|0|||
124975774|NCT01939353|449538549|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
124975775|NCT01939353|449538549|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
124975776|NCT01939353|449538549|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
124975777|NCT01939353|449538549|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
125046704|NCT02732912|449791830|FG001|Overall Study|Discharged before night|6|||
125046705|NCT02732912|449791829|FG000|Overall Study|Incomplete completion of questionnaire|2|||
125046706|NCT02732912|449791830|FG001|Overall Study|Incomplete completion of questionnaire|3|||
125046707|NCT02732912|449791829|FG000|Overall Study|No outcome; discharged or refused|6|||
125046708|NCT02732912|449791830|FG001|Overall Study|No outcome; discharged or refused|9|||
125046709|NCT04382651|449791831|FG000|Overall Study|Death|26|||
125046710|NCT04382651|449791832|FG001|Overall Study|Death|23|||
125046711|NCT04382651|449791831|FG000|Overall Study|Lost to Follow-up|3|||
125046712|NCT04382651|449791832|FG001|Overall Study|Lost to Follow-up|4|||
125046713|NCT04382651|449791831|FG000|Overall Study|Withdrawal by Subject|2|||
125046714|NCT04382651|449791832|FG001|Overall Study|Withdrawal by Subject|0|||
125046715|NCT04382651|449791831|FG000|Overall Study|Physician Decision|0|||
125046716|NCT04382651|449791832|FG001|Overall Study|Physician Decision|1|||
125046717|NCT01873742|449791833|FG000|Overall Study|Lost to Follow-up|68|||
125046718|NCT01873742|449791834|FG001|Overall Study|Lost to Follow-up|76|||
125046719|NCT00790296|449791836|FG000|Overall Study|Did not meet study eligibility criteria|1|||
125046720|NCT00790296|449791837|FG001|Overall Study|Did not meet study eligibility criteria|1|||
125046721|NCT00790296|449791836|FG000|Overall Study|Adverse Event|0|||
125046722|NCT00790296|449791837|FG001|Overall Study|Adverse Event|1|||
125046723|NCT01671488|449791838|FG000|Overall Study|Withdrawal by Subject|1|||
125046724|NCT02612077|449791839|FG000|Overall Study|Adverse Event|3|||
125046725|NCT02612077|449791839|FG000|Overall Study|Withdrawal by Subject|9|||
125046726|NCT02612077|449791839|FG000|Overall Study|Protocol Violation|28|||
125046727|NCT02612077|449791839|FG000|Overall Study|Lost to Follow-up|20|||
125046728|NCT02612077|449791839|FG000|Overall Study|Death|377|||
125046729|NCT02612077|449791839|FG000|Overall Study|Moved or Changed Medical Team|23|||
125046730|NCT02612077|449791839|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
125046731|NCT02612077|449791839|FG000|Overall Study|Disease Progression|3|||
125046732|NCT02612077|449791839|FG000|Overall Study|Unknown reason|2|||
125046733|NCT01022853|449791840|FG000|Overall Study|Progressive disease|2|||
125046734|NCT01022853|449791841|FG001|Overall Study|Progressive disease|3|||
125046735|NCT01022853|449791842|FG002|Overall Study|Progressive disease|11|||
125046736|NCT01022853|449791843|FG003|Overall Study|Progressive disease|7|||
125046737|NCT01022853|449791844|FG004|Overall Study|Progressive disease|1|||
125046738|NCT01022853|449791840|FG000|Overall Study|Dose-limiting toxicity|0|||
125046739|NCT01022853|449791841|FG001|Overall Study|Dose-limiting toxicity|0|||
125046740|NCT01022853|449791842|FG002|Overall Study|Dose-limiting toxicity|0|||
124975778|NCT01939353|449538549|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
124975779|NCT00874731|449538555|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
125046741|NCT01022853|449791843|FG003|Overall Study|Dose-limiting toxicity|0|||
124975780|NCT00874731|449538556|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
125046742|NCT01022853|449791844|FG004|Overall Study|Dose-limiting toxicity|1|||
125046743|NCT01022853|449791840|FG000|Overall Study|Withdrawal by Subject|0|||
125046744|NCT01022853|449791841|FG001|Overall Study|Withdrawal by Subject|1|||
125046745|NCT01022853|449791842|FG002|Overall Study|Withdrawal by Subject|1|||
125046746|NCT01022853|449791843|FG003|Overall Study|Withdrawal by Subject|1|||
125218940|NCT03538691|450427420|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
125218941|NCT03538691|450427421|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
125218942|NCT03538691|450427422|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
125218943|NCT03538691|450427423|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
125218944|NCT03538691|450427420|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
125046747|NCT01022853|449791844|FG004|Overall Study|Withdrawal by Subject|0|||
125046748|NCT01022853|449791840|FG000|Overall Study|Other not stated above|1|||
125046749|NCT01022853|449791841|FG001|Overall Study|Other not stated above|0|||
125046750|NCT01022853|449791842|FG002|Overall Study|Other not stated above|1|||
125046751|NCT01022853|449791843|FG003|Overall Study|Other not stated above|0|||
125046752|NCT01022853|449791844|FG004|Overall Study|Other not stated above|0|||
125046753|NCT01753518|449791845|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
125046754|NCT01753518|449791846|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
125046755|NCT01753518|449791845|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
125046756|NCT01753518|449791846|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
125046757|NCT01753518|449791845|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
125046758|NCT01753518|449791846|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
125046759|NCT01753518|449791845|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
125046760|NCT01753518|449791846|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
125046761|NCT01971476|449791847|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
125046762|NCT01971476|449791848|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
125046763|NCT01971476|449791849|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
125046764|NCT01971476|449791847|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
125046765|NCT01971476|449791848|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
125046766|NCT01971476|449791849|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
125046767|NCT01971476|449791847|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
125046768|NCT01971476|449791848|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
125046769|NCT01971476|449791849|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
125218945|NCT03538691|450427421|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
125218946|NCT03538691|450427422|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
124975781|NCT00874731|449538557|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
124975782|NCT00874731|449538555|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
124975783|NCT00874731|449538556|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
124975784|NCT00874731|449538557|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
124975785|NCT00874731|449538555|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
124975786|NCT00874731|449538556|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
124975787|NCT00874731|449538557|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
124975788|NCT01132820|449538564|FG000|Overall Study|Ineligible: wrong cell type|1|||
124975789|NCT01132820|449538564|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
124975790|NCT01132820|449538564|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
124975791|NCT01132820|449538564|FG000|Overall Study|Never treated|1|||
124975792|NCT01132820|449538564|FG000|Overall Study|Inadequate data|1|||
124975793|NCT00667394|449538568|FG000|Overall Study|Adverse Event|3|||
124975794|NCT00667394|449538569|FG001|Overall Study|Adverse Event|0|||
124975795|NCT00667394|449538568|FG000|Overall Study|Progressive disease|1|||
124975796|NCT00667394|449538569|FG001|Overall Study|Progressive disease|0|||
124975797|NCT05000216|449538570|FG000|Stage 1|Lost to Follow-up|0|||
124975798|NCT05000216|449538571|FG001|Stage 1|Lost to Follow-up|0|||
124975799|NCT05000216|449538572|FG002|Stage 1|Lost to Follow-up|0|||
125046770|NCT02075255|449791850|FG000|Overall Study|Study specific withdrawal criteria|0|||
125046771|NCT02075255|449791851|FG001|Overall Study|Study specific withdrawal criteria|1|||
125046772|NCT02075255|449791852|FG002|Overall Study|Study specific withdrawal criteria|1|||
125046773|NCT02075255|449791850|FG000|Overall Study|Withdrawal by Subject|4|||
125046774|NCT02075255|449791851|FG001|Overall Study|Withdrawal by Subject|1|||
125046775|NCT02075255|449791852|FG002|Overall Study|Withdrawal by Subject|0|||
125046776|NCT02075255|449791850|FG000|Overall Study|Lost to Follow-up|0|||
125046777|NCT02075255|449791851|FG001|Overall Study|Lost to Follow-up|0|||
125046778|NCT02075255|449791852|FG002|Overall Study|Lost to Follow-up|1|||
125046779|NCT02075255|449791850|FG000|Overall Study|Adverse Event|0|||
125046780|NCT02075255|449791851|FG001|Overall Study|Adverse Event|0|||
125046781|NCT02075255|449791852|FG002|Overall Study|Adverse Event|1|||
125046782|NCT02075255|449791850|FG000|Overall Study|Death|0|||
125046783|NCT02075255|449791851|FG001|Overall Study|Death|2|||
125046784|NCT02075255|449791852|FG002|Overall Study|Death|0|||
125046785|NCT03503773|449791853|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
125046786|NCT03503773|449791854|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
125046787|NCT03503773|449791853|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
125046788|NCT03503773|449791854|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
125046789|NCT03503773|449791853|FG000|Overall Study|Not completing the primary ABPM|3|||
125046790|NCT03503773|449791854|FG001|Overall Study|Not completing the primary ABPM|1|||
125046791|NCT03503773|449791853|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
125046792|NCT03503773|449791854|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
125046793|NCT02675517|449791857|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
125046794|NCT02675517|449791857|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
125046795|NCT00425438|449791858|FG000|Overall Study|Termination by Sponsor|25|||
125046796|NCT00425438|449791859|FG001|Overall Study|Termination by Sponsor|27|||
125046797|NCT02619253|449791860|FG000|Overall Study|Adverse Event|0|||
125046798|NCT02619253|449791861|FG001|Overall Study|Adverse Event|0|||
125046799|NCT02619253|449791862|FG002|Overall Study|Adverse Event|1|||
125046800|NCT02619253|449791863|FG003|Overall Study|Adverse Event|1|||
125046801|NCT02619253|449791864|FG004|Overall Study|Adverse Event|3|||
124975800|NCT05000216|449538573|FG003|Stage 1|Lost to Follow-up|0|||
124975801|NCT05000216|449538574|FG004|Stage 1|Lost to Follow-up|0|||
124975802|NCT05000216|449538575|FG005|Stage 1|Lost to Follow-up|0|||
124975803|NCT05000216|449538576|FG006|Stage 1|Lost to Follow-up|1|||
124975804|NCT05000216|449538577|FG007|Stage 1|Lost to Follow-up|1|||
124975805|NCT05000216|449538578|FG008|Stage 1|Lost to Follow-up|0|||
124975806|NCT05000216|449538579|FG009|Stage 1|Lost to Follow-up|2|||
124975807|NCT05000216|449538580|FG010|Stage 1|Lost to Follow-up|3|||
124975808|NCT05000216|449538581|FG011|Stage 1|Lost to Follow-up|0|||
124975809|NCT05000216|449538582|FG012|Stage 1|Lost to Follow-up|0|||
124975810|NCT05000216|449538583|FG013|Stage 1|Lost to Follow-up|0|||
124975811|NCT05000216|449538584|FG014|Stage 1|Lost to Follow-up|0|||
124975812|NCT05000216|449538585|FG015|Stage 1|Lost to Follow-up|0|||
124975813|NCT05000216|449538586|FG016|Stage 1|Lost to Follow-up|0|||
124975814|NCT05000216|449538587|FG017|Stage 1|Lost to Follow-up|0|||
124975815|NCT05000216|449538588|FG018|Stage 1|Lost to Follow-up|0|||
124975816|NCT05000216|449538589|FG019|Stage 1|Lost to Follow-up|0|||
124975817|NCT05000216|449538590|FG020|Stage 1|Lost to Follow-up|0|||
124975818|NCT05000216|449538591|FG021|Stage 1|Lost to Follow-up|0|||
124975819|NCT05000216|449538570|FG000|Stage 1|Physician Decision|0|||
124975820|NCT05000216|449538571|FG001|Stage 1|Physician Decision|0|||
124975821|NCT05000216|449538572|FG002|Stage 1|Physician Decision|0|||
125046802|NCT02619253|449791860|FG000|Overall Study|Alternative Therapy|0|||
125046803|NCT02619253|449791861|FG001|Overall Study|Alternative Therapy|0|||
125046804|NCT02619253|449791862|FG002|Overall Study|Alternative Therapy|1|||
125046805|NCT02619253|449791863|FG003|Overall Study|Alternative Therapy|0|||
125046806|NCT02619253|449791864|FG004|Overall Study|Alternative Therapy|0|||
125046807|NCT02619253|449791860|FG000|Overall Study|Death|0|||
125046808|NCT02619253|449791861|FG001|Overall Study|Death|0|||
125046809|NCT02619253|449791862|FG002|Overall Study|Death|0|||
125046810|NCT02619253|449791863|FG003|Overall Study|Death|1|||
124975822|NCT05000216|449538573|FG003|Stage 1|Physician Decision|0|||
124975823|NCT05000216|449538574|FG004|Stage 1|Physician Decision|0|||
124975824|NCT05000216|449538575|FG005|Stage 1|Physician Decision|0|||
124975825|NCT05000216|449538576|FG006|Stage 1|Physician Decision|0|||
124975826|NCT05000216|449538577|FG007|Stage 1|Physician Decision|1|||
124975827|NCT05000216|449538578|FG008|Stage 1|Physician Decision|1|||
124975828|NCT05000216|449538579|FG009|Stage 1|Physician Decision|0|||
124975829|NCT05000216|449538580|FG010|Stage 1|Physician Decision|0|||
124975830|NCT05000216|449538581|FG011|Stage 1|Physician Decision|0|||
124975831|NCT05000216|449538582|FG012|Stage 1|Physician Decision|0|||
124975832|NCT05000216|449538583|FG013|Stage 1|Physician Decision|0|||
124975833|NCT05000216|449538584|FG014|Stage 1|Physician Decision|0|||
124975834|NCT05000216|449538585|FG015|Stage 1|Physician Decision|0|||
124975835|NCT05000216|449538586|FG016|Stage 1|Physician Decision|0|||
124975836|NCT05000216|449538587|FG017|Stage 1|Physician Decision|0|||
124975837|NCT05000216|449538588|FG018|Stage 1|Physician Decision|0|||
124975838|NCT05000216|449538589|FG019|Stage 1|Physician Decision|0|||
124975839|NCT05000216|449538590|FG020|Stage 1|Physician Decision|0|||
124975840|NCT05000216|449538591|FG021|Stage 1|Physician Decision|0|||
124975841|NCT05000216|449538570|FG000|Stage 1|Withdrawal by Subject|0|||
124975842|NCT05000216|449538571|FG001|Stage 1|Withdrawal by Subject|1|||
124975843|NCT05000216|449538572|FG002|Stage 1|Withdrawal by Subject|0|||
124975844|NCT05000216|449538573|FG003|Stage 1|Withdrawal by Subject|0|||
124975845|NCT05000216|449538574|FG004|Stage 1|Withdrawal by Subject|0|||
124975846|NCT05000216|449538575|FG005|Stage 1|Withdrawal by Subject|0|||
124975847|NCT05000216|449538576|FG006|Stage 1|Withdrawal by Subject|0|||
124975848|NCT05000216|449538577|FG007|Stage 1|Withdrawal by Subject|0|||
124975849|NCT05000216|449538578|FG008|Stage 1|Withdrawal by Subject|0|||
124975850|NCT05000216|449538579|FG009|Stage 1|Withdrawal by Subject|3|||
124975851|NCT05000216|449538580|FG010|Stage 1|Withdrawal by Subject|10|||
124975852|NCT05000216|449538581|FG011|Stage 1|Withdrawal by Subject|0|||
124975853|NCT05000216|449538582|FG012|Stage 1|Withdrawal by Subject|0|||
124975854|NCT05000216|449538583|FG013|Stage 1|Withdrawal by Subject|0|||
124975855|NCT05000216|449538584|FG014|Stage 1|Withdrawal by Subject|0|||
124975856|NCT05000216|449538585|FG015|Stage 1|Withdrawal by Subject|0|||
124975857|NCT05000216|449538586|FG016|Stage 1|Withdrawal by Subject|0|||
124975858|NCT05000216|449538587|FG017|Stage 1|Withdrawal by Subject|0|||
124975859|NCT05000216|449538588|FG018|Stage 1|Withdrawal by Subject|0|||
124975860|NCT05000216|449538589|FG019|Stage 1|Withdrawal by Subject|0|||
124975861|NCT05000216|449538590|FG020|Stage 1|Withdrawal by Subject|0|||
124975862|NCT05000216|449538591|FG021|Stage 1|Withdrawal by Subject|0|||
124975863|NCT05000216|449538570|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
124975864|NCT05000216|449538571|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
124975865|NCT05000216|449538572|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
124975866|NCT05000216|449538573|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
124975867|NCT05000216|449538574|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
124975868|NCT05000216|449538575|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
124975869|NCT05000216|449538576|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
124975870|NCT05000216|449538577|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
124975871|NCT05000216|449538578|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
124975872|NCT05000216|449538579|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
124975873|NCT05000216|449538580|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
124975874|NCT05000216|449538581|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
124975875|NCT05000216|449538582|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
124975876|NCT05000216|449538583|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
124975877|NCT05000216|449538584|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
124975878|NCT05000216|449538585|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
124975879|NCT05000216|449538586|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
124975880|NCT05000216|449538587|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
124975881|NCT05000216|449538588|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
124975882|NCT05000216|449538589|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
124975883|NCT05000216|449538590|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
125046811|NCT02619253|449791864|FG004|Overall Study|Death|0|||
124975884|NCT05000216|449538591|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
124975885|NCT05000216|449538570|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975886|NCT05000216|449538571|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975887|NCT05000216|449538572|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975888|NCT05000216|449538573|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975889|NCT05000216|449538574|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975890|NCT05000216|449538575|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975891|NCT05000216|449538576|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975892|NCT05000216|449538577|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975893|NCT05000216|449538578|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
124975894|NCT05000216|449538579|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975895|NCT05000216|449538580|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975896|NCT05000216|449538581|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975897|NCT05000216|449538582|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975898|NCT05000216|449538583|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975899|NCT05000216|449538584|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975900|NCT05000216|449538585|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975901|NCT05000216|449538586|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975902|NCT05000216|449538587|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975903|NCT05000216|449538588|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975904|NCT05000216|449538589|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975905|NCT05000216|449538590|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975906|NCT05000216|449538591|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975907|NCT05000216|449538570|FG000|Stage 1|Other|0|||
124975908|NCT05000216|449538571|FG001|Stage 1|Other|0|||
124975909|NCT05000216|449538572|FG002|Stage 1|Other|0|||
124975910|NCT05000216|449538573|FG003|Stage 1|Other|0|||
124975911|NCT05000216|449538574|FG004|Stage 1|Other|1|||
124975912|NCT05000216|449538575|FG005|Stage 1|Other|0|||
124975913|NCT05000216|449538576|FG006|Stage 1|Other|0|||
124975914|NCT05000216|449538577|FG007|Stage 1|Other|2|||
124975915|NCT05000216|449538578|FG008|Stage 1|Other|0|||
124975916|NCT05000216|449538579|FG009|Stage 1|Other|0|||
124975917|NCT05000216|449538580|FG010|Stage 1|Other|1|||
124975918|NCT05000216|449538581|FG011|Stage 1|Other|1|||
124975919|NCT05000216|449538582|FG012|Stage 1|Other|0|||
124975920|NCT05000216|449538583|FG013|Stage 1|Other|0|||
124975921|NCT05000216|449538584|FG014|Stage 1|Other|0|||
124975922|NCT05000216|449538585|FG015|Stage 1|Other|0|||
124975923|NCT05000216|449538586|FG016|Stage 1|Other|0|||
124975924|NCT05000216|449538587|FG017|Stage 1|Other|0|||
124975925|NCT05000216|449538588|FG018|Stage 1|Other|0|||
124975926|NCT05000216|449538589|FG019|Stage 1|Other|0|||
124975927|NCT05000216|449538590|FG020|Stage 1|Other|0|||
124975928|NCT05000216|449538591|FG021|Stage 1|Other|0|||
124975929|NCT05000216|449538570|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
124975930|NCT05000216|449538571|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
124975931|NCT05000216|449538572|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
124975932|NCT05000216|449538573|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
124975933|NCT05000216|449538574|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
124975934|NCT05000216|449538575|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
124975935|NCT05000216|449538576|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
124975936|NCT05000216|449538577|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
124975937|NCT05000216|449538578|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
124975938|NCT05000216|449538579|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
124975939|NCT05000216|449538580|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
124975940|NCT05000216|449538581|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
124975941|NCT05000216|449538582|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
124975942|NCT05000216|449538583|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
124975943|NCT05000216|449538584|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
124975944|NCT05000216|449538585|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
124975945|NCT05000216|449538586|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
124975946|NCT05000216|449538587|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
124975947|NCT05000216|449538588|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
124975948|NCT05000216|449538589|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
124975949|NCT05000216|449538590|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
124975950|NCT05000216|449538591|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
124975951|NCT05000216|449538570|FG000|Stage 2|Lost to Follow-up|0|||
124975952|NCT05000216|449538571|FG001|Stage 2|Lost to Follow-up|0|||
124975953|NCT05000216|449538572|FG002|Stage 2|Lost to Follow-up|0|||
124975954|NCT05000216|449538573|FG003|Stage 2|Lost to Follow-up|0|||
124975955|NCT05000216|449538574|FG004|Stage 2|Lost to Follow-up|0|||
124975956|NCT05000216|449538575|FG005|Stage 2|Lost to Follow-up|0|||
124975957|NCT05000216|449538576|FG006|Stage 2|Lost to Follow-up|0|||
124975958|NCT05000216|449538577|FG007|Stage 2|Lost to Follow-up|0|||
124975959|NCT05000216|449538578|FG008|Stage 2|Lost to Follow-up|0|||
124975960|NCT05000216|449538579|FG009|Stage 2|Lost to Follow-up|0|||
124975961|NCT05000216|449538580|FG010|Stage 2|Lost to Follow-up|0|||
124975962|NCT05000216|449538581|FG011|Stage 2|Lost to Follow-up|0|||
124975963|NCT05000216|449538582|FG012|Stage 2|Lost to Follow-up|0|||
124975964|NCT05000216|449538583|FG013|Stage 2|Lost to Follow-up|0|||
124975965|NCT05000216|449538584|FG014|Stage 2|Lost to Follow-up|0|||
124975966|NCT05000216|449538585|FG015|Stage 2|Lost to Follow-up|0|||
124975967|NCT05000216|449538586|FG016|Stage 2|Lost to Follow-up|4|||
124975968|NCT05000216|449538587|FG017|Stage 2|Lost to Follow-up|0|||
124975969|NCT05000216|449538588|FG018|Stage 2|Lost to Follow-up|0|||
124975970|NCT05000216|449538589|FG019|Stage 2|Lost to Follow-up|0|||
124975971|NCT05000216|449538590|FG020|Stage 2|Lost to Follow-up|0|||
124975972|NCT05000216|449538591|FG021|Stage 2|Lost to Follow-up|0|||
124975973|NCT05000216|449538570|FG000|Stage 2|Physician Decision|0|||
124975974|NCT05000216|449538571|FG001|Stage 2|Physician Decision|0|||
124975975|NCT05000216|449538572|FG002|Stage 2|Physician Decision|0|||
124975976|NCT05000216|449538573|FG003|Stage 2|Physician Decision|0|||
124975977|NCT05000216|449538574|FG004|Stage 2|Physician Decision|0|||
124975978|NCT05000216|449538575|FG005|Stage 2|Physician Decision|0|||
124975979|NCT05000216|449538576|FG006|Stage 2|Physician Decision|0|||
124975980|NCT05000216|449538577|FG007|Stage 2|Physician Decision|0|||
124975981|NCT05000216|449538578|FG008|Stage 2|Physician Decision|0|||
124975982|NCT05000216|449538579|FG009|Stage 2|Physician Decision|0|||
124975983|NCT05000216|449538580|FG010|Stage 2|Physician Decision|0|||
124975984|NCT05000216|449538581|FG011|Stage 2|Physician Decision|0|||
124975985|NCT05000216|449538582|FG012|Stage 2|Physician Decision|1|||
124975986|NCT05000216|449538583|FG013|Stage 2|Physician Decision|0|||
124975987|NCT05000216|449538584|FG014|Stage 2|Physician Decision|0|||
124975988|NCT05000216|449538585|FG015|Stage 2|Physician Decision|0|||
124975989|NCT05000216|449538586|FG016|Stage 2|Physician Decision|0|||
124975990|NCT05000216|449538587|FG017|Stage 2|Physician Decision|0|||
124975991|NCT05000216|449538588|FG018|Stage 2|Physician Decision|0|||
124975992|NCT05000216|449538589|FG019|Stage 2|Physician Decision|0|||
124975993|NCT05000216|449538590|FG020|Stage 2|Physician Decision|0|||
124975994|NCT05000216|449538591|FG021|Stage 2|Physician Decision|0|||
124975995|NCT05000216|449538570|FG000|Stage 2|Withdrawal by Subject|0|||
124975996|NCT05000216|449538571|FG001|Stage 2|Withdrawal by Subject|0|||
124975997|NCT05000216|449538572|FG002|Stage 2|Withdrawal by Subject|0|||
124975998|NCT05000216|449538573|FG003|Stage 2|Withdrawal by Subject|0|||
124975999|NCT05000216|449538574|FG004|Stage 2|Withdrawal by Subject|0|||
124976000|NCT05000216|449538575|FG005|Stage 2|Withdrawal by Subject|0|||
124976001|NCT05000216|449538576|FG006|Stage 2|Withdrawal by Subject|0|||
124976002|NCT05000216|449538577|FG007|Stage 2|Withdrawal by Subject|0|||
124976003|NCT05000216|449538578|FG008|Stage 2|Withdrawal by Subject|0|||
124976004|NCT05000216|449538579|FG009|Stage 2|Withdrawal by Subject|0|||
124976005|NCT05000216|449538580|FG010|Stage 2|Withdrawal by Subject|0|||
124976006|NCT05000216|449538581|FG011|Stage 2|Withdrawal by Subject|0|||
124976007|NCT05000216|449538582|FG012|Stage 2|Withdrawal by Subject|0|||
124976008|NCT05000216|449538583|FG013|Stage 2|Withdrawal by Subject|0|||
124976009|NCT05000216|449538584|FG014|Stage 2|Withdrawal by Subject|2|||
124976010|NCT05000216|449538585|FG015|Stage 2|Withdrawal by Subject|0|||
124976011|NCT05000216|449538586|FG016|Stage 2|Withdrawal by Subject|9|||
124976012|NCT05000216|449538587|FG017|Stage 2|Withdrawal by Subject|0|||
124976013|NCT05000216|449538588|FG018|Stage 2|Withdrawal by Subject|0|||
124976014|NCT05000216|449538589|FG019|Stage 2|Withdrawal by Subject|0|||
124976015|NCT05000216|449538590|FG020|Stage 2|Withdrawal by Subject|0|||
124976016|NCT05000216|449538591|FG021|Stage 2|Withdrawal by Subject|0|||
124976017|NCT05000216|449538570|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
124976018|NCT05000216|449538571|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
124976019|NCT05000216|449538572|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
124976020|NCT05000216|449538573|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
124976021|NCT05000216|449538574|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
124976022|NCT05000216|449538575|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
124976023|NCT05000216|449538576|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
124976024|NCT05000216|449538577|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
124976025|NCT05000216|449538578|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
124976026|NCT05000216|449538579|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
124976027|NCT05000216|449538580|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
124976028|NCT05000216|449538581|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
124976029|NCT05000216|449538582|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
124976030|NCT05000216|449538583|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
124976031|NCT05000216|449538584|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
124976032|NCT05000216|449538585|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
124976033|NCT05000216|449538586|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
124976034|NCT05000216|449538587|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
124976035|NCT05000216|449538588|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
124976036|NCT05000216|449538589|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
124976037|NCT05000216|449538590|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
124976038|NCT05000216|449538591|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
124976039|NCT05000216|449538570|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976040|NCT05000216|449538571|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976041|NCT05000216|449538572|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976042|NCT05000216|449538573|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125046812|NCT02619253|449791860|FG000|Overall Study|Disease Progression|4|||
125046813|NCT02619253|449791861|FG001|Overall Study|Disease Progression|2|||
125046814|NCT02619253|449791862|FG002|Overall Study|Disease Progression|8|||
125046815|NCT02619253|449791863|FG003|Overall Study|Disease Progression|9|||
125046816|NCT02619253|449791864|FG004|Overall Study|Disease Progression|10|||
125046817|NCT02619253|449791860|FG000|Overall Study|Needed a disqualifying therapy|0|||
125046818|NCT02619253|449791861|FG001|Overall Study|Needed a disqualifying therapy|0|||
125046819|NCT02619253|449791862|FG002|Overall Study|Needed a disqualifying therapy|1|||
125046820|NCT02619253|449791863|FG003|Overall Study|Needed a disqualifying therapy|0|||
125046821|NCT02619253|449791864|FG004|Overall Study|Needed a disqualifying therapy|0|||
125046822|NCT02619253|449791860|FG000|Overall Study|Transferred to hospice|0|||
125046823|NCT02619253|449791861|FG001|Overall Study|Transferred to hospice|0|||
125046824|NCT02619253|449791862|FG002|Overall Study|Transferred to hospice|1|||
125046825|NCT02619253|449791863|FG003|Overall Study|Transferred to hospice|0|||
125046826|NCT02619253|449791864|FG004|Overall Study|Transferred to hospice|0|||
125046827|NCT02619253|449791860|FG000|Overall Study|Physician Decision|0|||
125046828|NCT02619253|449791861|FG001|Overall Study|Physician Decision|1|||
125046829|NCT02619253|449791862|FG002|Overall Study|Physician Decision|2|||
125046830|NCT02619253|449791863|FG003|Overall Study|Physician Decision|3|||
125046831|NCT02619253|449791864|FG004|Overall Study|Physician Decision|0|||
125046832|NCT02619253|449791860|FG000|Overall Study|Withdrawal by Subject|0|||
125046833|NCT02619253|449791861|FG001|Overall Study|Withdrawal by Subject|1|||
125046834|NCT02619253|449791862|FG002|Overall Study|Withdrawal by Subject|0|||
125046835|NCT02619253|449791863|FG003|Overall Study|Withdrawal by Subject|0|||
125046836|NCT02619253|449791864|FG004|Overall Study|Withdrawal by Subject|2|||
125046837|NCT01208181|449791868|FG000|Part 1|Withdrawal by Subject|11|||
125046838|NCT01208181|449791869|FG001|Part 1|Withdrawal by Subject|10|||
125046839|NCT01208181|449791870|FG002|Part 1|Withdrawal by Subject|0|||
125046840|NCT01208181|449791871|FG003|Part 1|Withdrawal by Subject|0|||
125046841|NCT01208181|449791872|FG004|Part 1|Withdrawal by Subject|0|||
125046842|NCT01208181|449791868|FG000|Part 1|Technical problem|5|||
125046843|NCT01208181|449791869|FG001|Part 1|Technical problem|0|||
125046844|NCT01208181|449791870|FG002|Part 1|Technical problem|0|||
125046845|NCT01208181|449791871|FG003|Part 1|Technical problem|0|||
125046846|NCT01208181|449791872|FG004|Part 1|Technical problem|0|||
125046847|NCT01208181|449791868|FG000|Part 1|Protocol Violation|10|||
125046848|NCT01208181|449791869|FG001|Part 1|Protocol Violation|5|||
125046849|NCT01208181|449791870|FG002|Part 1|Protocol Violation|0|||
125046850|NCT01208181|449791871|FG003|Part 1|Protocol Violation|0|||
125046851|NCT01208181|449791872|FG004|Part 1|Protocol Violation|0|||
125046852|NCT01208181|449791868|FG000|Part 1|Physician Decision|4|||
125046853|NCT01208181|449791869|FG001|Part 1|Physician Decision|0|||
125046854|NCT01208181|449791870|FG002|Part 1|Physician Decision|0|||
125046855|NCT01208181|449791871|FG003|Part 1|Physician Decision|0|||
125046856|NCT01208181|449791872|FG004|Part 1|Physician Decision|0|||
125046857|NCT01208181|449791868|FG000|Part 1|Non-compliance with study drug|1|||
125046858|NCT01208181|449791869|FG001|Part 1|Non-compliance with study drug|1|||
125046859|NCT01208181|449791870|FG002|Part 1|Non-compliance with study drug|0|||
125046860|NCT01208181|449791871|FG003|Part 1|Non-compliance with study drug|0|||
125046861|NCT01208181|449791872|FG004|Part 1|Non-compliance with study drug|0|||
125046862|NCT01208181|449791868|FG000|Part 1|Lost to Follow-up|5|||
125046863|NCT01208181|449791869|FG001|Part 1|Lost to Follow-up|3|||
125046864|NCT01208181|449791870|FG002|Part 1|Lost to Follow-up|0|||
125046865|NCT01208181|449791871|FG003|Part 1|Lost to Follow-up|0|||
125046866|NCT01208181|449791872|FG004|Part 1|Lost to Follow-up|1|||
125046867|NCT01208181|449791868|FG000|Part 1|Lack of Efficacy|37|||
125046868|NCT01208181|449791869|FG001|Part 1|Lack of Efficacy|12|||
125046869|NCT01208181|449791870|FG002|Part 1|Lack of Efficacy|0|||
125046870|NCT01208181|449791871|FG003|Part 1|Lack of Efficacy|0|||
125046871|NCT01208181|449791872|FG004|Part 1|Lack of Efficacy|17|||
125046872|NCT01208181|449791868|FG000|Part 1|Adverse Event|26|||
125046873|NCT01208181|449791869|FG001|Part 1|Adverse Event|24|||
125046874|NCT01208181|449791870|FG002|Part 1|Adverse Event|0|||
125046875|NCT01208181|449791871|FG003|Part 1|Adverse Event|0|||
125046876|NCT01208181|449791872|FG004|Part 1|Adverse Event|4|||
125046877|NCT01208181|449791868|FG000|Part 2|Adverse Event|0|||
125046878|NCT01208181|449791869|FG001|Part 2|Adverse Event|0|||
125046879|NCT01208181|449791870|FG002|Part 2|Adverse Event|6|||
125046880|NCT01208181|449791871|FG003|Part 2|Adverse Event|7|||
125046881|NCT01208181|449791872|FG004|Part 2|Adverse Event|0|||
125046882|NCT01208181|449791868|FG000|Part 2|Withdrawal by Subject|0|||
125046883|NCT01208181|449791869|FG001|Part 2|Withdrawal by Subject|0|||
125046884|NCT01208181|449791870|FG002|Part 2|Withdrawal by Subject|1|||
125046885|NCT01208181|449791871|FG003|Part 2|Withdrawal by Subject|1|||
125046886|NCT01208181|449791872|FG004|Part 2|Withdrawal by Subject|0|||
125046887|NCT01208181|449791868|FG000|Part 2|Protocol Violation|0|||
125046888|NCT01208181|449791869|FG001|Part 2|Protocol Violation|0|||
125046889|NCT01208181|449791870|FG002|Part 2|Protocol Violation|1|||
125046890|NCT01208181|449791871|FG003|Part 2|Protocol Violation|0|||
125046891|NCT01208181|449791872|FG004|Part 2|Protocol Violation|0|||
125046892|NCT01208181|449791868|FG000|Part 2|Physician Decision|0|||
125046893|NCT01208181|449791869|FG001|Part 2|Physician Decision|0|||
125046894|NCT01208181|449791870|FG002|Part 2|Physician Decision|1|||
125046895|NCT01208181|449791871|FG003|Part 2|Physician Decision|2|||
125046896|NCT01208181|449791872|FG004|Part 2|Physician Decision|0|||
125046897|NCT01208181|449791868|FG000|Part 2|Non-compliance with study drug|0|||
125046898|NCT01208181|449791869|FG001|Part 2|Non-compliance with study drug|0|||
125046899|NCT01208181|449791870|FG002|Part 2|Non-compliance with study drug|1|||
125046900|NCT01208181|449791871|FG003|Part 2|Non-compliance with study drug|1|||
125046901|NCT01208181|449791872|FG004|Part 2|Non-compliance with study drug|0|||
125046902|NCT01208181|449791868|FG000|Part 2|Lost to Follow-up|0|||
125046903|NCT01208181|449791869|FG001|Part 2|Lost to Follow-up|0|||
125046904|NCT01208181|449791870|FG002|Part 2|Lost to Follow-up|1|||
125046905|NCT01208181|449791871|FG003|Part 2|Lost to Follow-up|2|||
125046906|NCT01208181|449791872|FG004|Part 2|Lost to Follow-up|0|||
125046907|NCT01208181|449791868|FG000|Part 2|Lack of Efficacy|0|||
125046908|NCT01208181|449791869|FG001|Part 2|Lack of Efficacy|0|||
125046909|NCT01208181|449791870|FG002|Part 2|Lack of Efficacy|5|||
125046910|NCT01208181|449791871|FG003|Part 2|Lack of Efficacy|7|||
125046911|NCT01208181|449791872|FG004|Part 2|Lack of Efficacy|0|||
125046912|NCT01457339|449791877|FG000|Period 3 (100 mg)|Adverse Event|0|||
125046913|NCT01457339|449791878|FG001|Period 3 (100 mg)|Adverse Event|1|||
125046914|NCT01457339|449791877|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
125046915|NCT01457339|449791878|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
125046916|NCT01457339|449791877|FG000|Period 6 (250 mg)|Family Emergency|1|||
125046917|NCT01457339|449791878|FG001|Period 6 (250 mg)|Family Emergency|0|||
125046918|NCT01457339|449791877|FG000|Period 6 (250 mg)|Personal appointment|0|||
125046919|NCT01457339|449791878|FG001|Period 6 (250 mg)|Personal appointment|1|||
125046920|NCT03694522|449791880|FG000|Overall Study|Withdrawal by Subject|8|||
125046921|NCT03694522|449791881|FG001|Overall Study|Withdrawal by Subject|10|||
125046922|NCT03694522|449791880|FG000|Overall Study|Physician Decision|53|||
125046923|NCT03694522|449791881|FG001|Overall Study|Physician Decision|54|||
125046924|NCT03694522|449791880|FG000|Overall Study|Other|1|||
125046925|NCT03694522|449791881|FG001|Overall Study|Other|1|||
125046926|NCT03694522|449791880|FG000|Overall Study|Lost to Follow-up|0|||
125046927|NCT03694522|449791881|FG001|Overall Study|Lost to Follow-up|1|||
125046928|NCT01748760|449791882|FG000|Overall Study|Withdrawal by Subject|1|||
125046929|NCT01748760|449791883|FG001|Overall Study|Withdrawal by Subject|1|||
125046930|NCT01748760|449791882|FG000|Overall Study|Lost to Follow-up|5|||
125046931|NCT01748760|449791883|FG001|Overall Study|Lost to Follow-up|1|||
125046932|NCT01164501|449791884|FG000|Overall Study|Not treated|2|||
125046933|NCT01164501|449791885|FG001|Overall Study|Not treated|0|||
125046934|NCT01164501|449791886|FG002|Overall Study|Not treated|1|||
125046935|NCT01164501|449791884|FG000|Overall Study|Adverse Event|18|||
125046936|NCT01164501|449791885|FG001|Overall Study|Adverse Event|4|||
125046937|NCT01164501|449791886|FG002|Overall Study|Adverse Event|21|||
125046938|NCT01164501|449791884|FG000|Overall Study|Lack of Efficacy|0|||
125046939|NCT01164501|449791885|FG001|Overall Study|Lack of Efficacy|0|||
125046940|NCT01164501|449791886|FG002|Overall Study|Lack of Efficacy|1|||
125046941|NCT01164501|449791884|FG000|Overall Study|Non compliant with protocol|1|||
125046942|NCT01164501|449791885|FG001|Overall Study|Non compliant with protocol|1|||
125046943|NCT01164501|449791886|FG002|Overall Study|Non compliant with protocol|4|||
125046944|NCT01164501|449791884|FG000|Overall Study|Lost to Follow-up|3|||
125046945|NCT01164501|449791885|FG001|Overall Study|Lost to Follow-up|0|||
125046946|NCT01164501|449791886|FG002|Overall Study|Lost to Follow-up|3|||
125046947|NCT01164501|449791884|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
125046948|NCT01164501|449791885|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
125046949|NCT01164501|449791886|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
125046950|NCT01164501|449791884|FG000|Overall Study|Other reason not defined above|9|||
125046951|NCT01164501|449791885|FG001|Overall Study|Other reason not defined above|1|||
125046952|NCT01164501|449791886|FG002|Overall Study|Other reason not defined above|4|||
125046953|NCT02522377|449791887|FG000|Overall Study|Withdrawal by Subject|1|||
125046954|NCT02522377|449791888|FG001|Overall Study|Withdrawal by Subject|0|||
125046955|NCT02522377|449791887|FG000|Overall Study|Remission Achieved|3|||
125046956|NCT02522377|449791888|FG001|Overall Study|Remission Achieved|0|||
125046957|NCT00306891|449791889|FG000|Part A|Withdrawal by Subject|1|||
125046958|NCT00306891|449791890|FG001|Part A|Withdrawal by Subject|1|||
125046959|NCT00306891|449791891|FG002|Part A|Withdrawal by Subject|0|||
125046960|NCT00306891|449791892|FG003|Part A|Withdrawal by Subject|0|||
124976043|NCT05000216|449538574|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976044|NCT05000216|449538575|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976045|NCT05000216|449538576|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976046|NCT05000216|449538577|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976047|NCT05000216|449538578|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976048|NCT05000216|449538579|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976049|NCT05000216|449538580|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976050|NCT05000216|449538581|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976051|NCT05000216|449538582|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976052|NCT05000216|449538583|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976053|NCT05000216|449538584|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
124976054|NCT05000216|449538585|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125046961|NCT00306891|449791889|FG000|Part A|Condition under investigation worsened|2|||
125046962|NCT00306891|449791890|FG001|Part A|Condition under investigation worsened|2|||
125046963|NCT00306891|449791891|FG002|Part A|Condition under investigation worsened|0|||
125046964|NCT00306891|449791892|FG003|Part A|Condition under investigation worsened|0|||
125046965|NCT00306891|449791889|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
125046966|NCT00306891|449791890|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
125046967|NCT00306891|449791891|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
125046968|NCT00306891|449791892|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
125046969|NCT00306891|449791889|FG000|Part A|Partial bowel obstruction|1|||
125046970|NCT00306891|449791890|FG001|Part A|Partial bowel obstruction|0|||
124976055|NCT05000216|449538586|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
124976056|NCT05000216|449538587|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976057|NCT05000216|449538588|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125046971|NCT00306891|449791891|FG002|Part A|Partial bowel obstruction|0|||
125046972|NCT00306891|449791892|FG003|Part A|Partial bowel obstruction|0|||
125046973|NCT00306891|449791889|FG000|Part A|Reaccumul. of ascites following drainage|0|||
125046974|NCT00306891|449791890|FG001|Part A|Reaccumul. of ascites following drainage|1|||
125046975|NCT00306891|449791891|FG002|Part A|Reaccumul. of ascites following drainage|0|||
125046976|NCT00306891|449791892|FG003|Part A|Reaccumul. of ascites following drainage|0|||
125046977|NCT00306891|449791889|FG000|Part A|Suspicion of second malignancy|0|||
125046978|NCT00306891|449791890|FG001|Part A|Suspicion of second malignancy|1|||
125046979|NCT00306891|449791891|FG002|Part A|Suspicion of second malignancy|0|||
125046980|NCT00306891|449791892|FG003|Part A|Suspicion of second malignancy|0|||
125046981|NCT00306891|449791889|FG000|Part A|QTC interval outwith elig. criteria|1|||
125046982|NCT00306891|449791890|FG001|Part A|QTC interval outwith elig. criteria|0|||
125046983|NCT00306891|449791891|FG002|Part A|QTC interval outwith elig. criteria|0|||
125046984|NCT00306891|449791892|FG003|Part A|QTC interval outwith elig. criteria|0|||
125046985|NCT00306891|449791889|FG000|Part B|Death|0|||
125046986|NCT00306891|449791890|FG001|Part B|Death|0|||
125046987|NCT00306891|449791891|FG002|Part B|Death|1|||
125046988|NCT00306891|449791892|FG003|Part B|Death|2|||
125046989|NCT00306891|449791889|FG000|Part B|Adverse Event|0|||
125046990|NCT00306891|449791890|FG001|Part B|Adverse Event|0|||
125046991|NCT00306891|449791891|FG002|Part B|Adverse Event|5|||
125046992|NCT00306891|449791892|FG003|Part B|Adverse Event|5|||
125046993|NCT00306891|449791889|FG000|Part B|Withdrawal by Subject|0|||
125046994|NCT00306891|449791890|FG001|Part B|Withdrawal by Subject|0|||
125046995|NCT00306891|449791891|FG002|Part B|Withdrawal by Subject|3|||
125046996|NCT00306891|449791892|FG003|Part B|Withdrawal by Subject|1|||
125046997|NCT00306891|449791889|FG000|Part B|Condition under investigation worsened|0|||
125046998|NCT00306891|449791890|FG001|Part B|Condition under investigation worsened|0|||
125046999|NCT00306891|449791891|FG002|Part B|Condition under investigation worsened|2|||
125047000|NCT00306891|449791892|FG003|Part B|Condition under investigation worsened|8|||
125047001|NCT00306891|449791889|FG000|Part B|Development of study specific disc crit.|0|||
125047002|NCT00306891|449791890|FG001|Part B|Development of study specific disc crit.|0|||
125047003|NCT00306891|449791891|FG002|Part B|Development of study specific disc crit.|0|||
125047004|NCT00306891|449791892|FG003|Part B|Development of study specific disc crit.|1|||
125047005|NCT00673673|449791893|FG000|Overall Study|Progressive disease|27|||
125047006|NCT00673673|449791893|FG000|Overall Study|Adverse Event|4|||
125047007|NCT00673673|449791893|FG000|Overall Study|Withdrawal by Subject|3|||
125047008|NCT00673673|449791893|FG000|Overall Study|Investigators' discretion|2|||
125047009|NCT02263365|449791894|FG000|Overall Study|Physician Decision|22|||
125047010|NCT02263365|449791895|FG001|Overall Study|Physician Decision|18|||
125047011|NCT00945191|449791896|FG000|Overall Study|Did not achieve a complete response|18|||
125047012|NCT00945191|449791896|FG000|Overall Study|Participant relocated to another state|1|||
125047013|NCT00945191|449791896|FG000|Overall Study|Disease progression|3|||
125047014|NCT00945191|449791896|FG000|Overall Study|Serious adverse event or adverse event|1|||
125047015|NCT00945191|449791896|FG000|Overall Study|Investigator's discretion|1|||
125047016|NCT04542291|449791899|FG000|Overall Study|Adverse Event|1|||
125047017|NCT04542291|449791899|FG000|Overall Study|Physician Decision|2|||
125047018|NCT00970294|449791902|FG000|Overall Study|Physician Decision|4|||
125047019|NCT00970294|449791902|FG000|Overall Study|Withdrawal by Subject|1|||
125047020|NCT00847561|449791903|FG000|Overall Study|Withdrawal by Subject|4|||
125047021|NCT00847561|449791904|FG001|Overall Study|Withdrawal by Subject|3|||
125047022|NCT00847561|449791903|FG000|Overall Study|Unable to schedule|9|||
125047023|NCT00847561|449791904|FG001|Overall Study|Unable to schedule|1|||
125047024|NCT00408681|449791905|FG000|Overall Study|Lack of Efficacy|2|||
125047025|NCT00408681|449791905|FG000|Overall Study|Adverse Event|7|||
125047026|NCT00447421|449791906|FG000|Overall Study|Lack of Efficacy|1|||
125047027|NCT00447421|449791906|FG000|Overall Study|Adverse Event|3|||
125047028|NCT00447421|449791906|FG000|Overall Study|Sponsor Decision|2|||
125047029|NCT01707147|449791907|FG000|Overall Study|Administered Trajenta prior to contract|5|||
125047030|NCT01707147|449791907|FG000|Overall Study|Patients who have not taken Trajenta|1|||
125047031|NCT01707147|449791907|FG000|Overall Study|Follow-up failure|17|||
125047032|NCT01707147|449791907|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
125047033|NCT02792777|449791908|FG000|Overall Study|Withdrawal by Subject|2|||
125047034|NCT02792777|449791909|FG001|Overall Study|Withdrawal by Subject|0|||
125047035|NCT02792777|449791908|FG000|Overall Study|Recording malfunction|2|||
125047036|NCT02792777|449791909|FG001|Overall Study|Recording malfunction|0|||
125047037|NCT02792777|449791908|FG000|Overall Study|Later determined to be ineligible|2|||
125047038|NCT02792777|449791909|FG001|Overall Study|Later determined to be ineligible|0|||
125047039|NCT02792777|449791908|FG000|Overall Study|Participant interviewed twice|1|||
125047040|NCT02792777|449791909|FG001|Overall Study|Participant interviewed twice|0|||
125047041|NCT01040832|449793171|FG000|Overall Study|Adverse Event|4|||
125047042|NCT01040832|449793172|FG001|Overall Study|Adverse Event|5|||
125047043|NCT01040832|449793171|FG000|Overall Study|Death|4|||
125047044|NCT01040832|449793172|FG001|Overall Study|Death|6|||
125047045|NCT01040832|449793171|FG000|Overall Study|Withdrawal by Subject|2|||
125047046|NCT01040832|449793172|FG001|Overall Study|Withdrawal by Subject|3|||
125047047|NCT01040832|449793171|FG000|Overall Study|Progressive disease|32|||
125047048|NCT01040832|449793172|FG001|Overall Study|Progressive disease|17|||
125047049|NCT01040832|449793171|FG000|Overall Study|Symptomatic deterioration|2|||
125047050|NCT01040832|449793172|FG001|Overall Study|Symptomatic deterioration|5|||
125047051|NCT01040832|449793171|FG000|Overall Study|Other|2|||
125047052|NCT01040832|449793172|FG001|Overall Study|Other|1|||
125047053|NCT01058369|449793178|FG000|Overall Study|Adverse Event|1|||
124976058|NCT05000216|449538589|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976059|NCT05000216|449538590|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976060|NCT05000216|449538591|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976061|NCT05000216|449538570|FG000|Stage 2|Other reason|0|||
124976062|NCT05000216|449538571|FG001|Stage 2|Other reason|0|||
124976063|NCT05000216|449538572|FG002|Stage 2|Other reason|0|||
124976064|NCT05000216|449538573|FG003|Stage 2|Other reason|0|||
124976065|NCT05000216|449538574|FG004|Stage 2|Other reason|0|||
124976066|NCT05000216|449538575|FG005|Stage 2|Other reason|0|||
124976067|NCT05000216|449538576|FG006|Stage 2|Other reason|0|||
124976068|NCT05000216|449538577|FG007|Stage 2|Other reason|0|||
124976069|NCT05000216|449538578|FG008|Stage 2|Other reason|0|||
124976070|NCT05000216|449538579|FG009|Stage 2|Other reason|0|||
124976071|NCT05000216|449538580|FG010|Stage 2|Other reason|0|||
124976072|NCT05000216|449538581|FG011|Stage 2|Other reason|0|||
124976073|NCT05000216|449538582|FG012|Stage 2|Other reason|0|||
124976074|NCT05000216|449538583|FG013|Stage 2|Other reason|0|||
124976075|NCT05000216|449538584|FG014|Stage 2|Other reason|0|||
124976076|NCT05000216|449538585|FG015|Stage 2|Other reason|0|||
124976077|NCT05000216|449538586|FG016|Stage 2|Other reason|1|||
124976078|NCT05000216|449538587|FG017|Stage 2|Other reason|0|||
124976079|NCT05000216|449538588|FG018|Stage 2|Other reason|0|||
124976080|NCT05000216|449538589|FG019|Stage 2|Other reason|0|||
124976081|NCT05000216|449538590|FG020|Stage 2|Other reason|0|||
124976082|NCT05000216|449538591|FG021|Stage 2|Other reason|0|||
124976083|NCT05000216|449538570|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
124976084|NCT05000216|449538571|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
125218947|NCT03538691|450427423|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
125218948|NCT03538691|450427420|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
125218949|NCT03538691|450427421|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
125218950|NCT03538691|450427422|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
125218951|NCT03538691|450427423|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
125218952|NCT03538691|450427420|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
125218953|NCT03538691|450427421|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
125218954|NCT03538691|450427422|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
124976085|NCT05000216|449538572|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
124976086|NCT05000216|449538573|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
124976087|NCT05000216|449538574|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
124976088|NCT05000216|449538575|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
125047054|NCT01058369|449793178|FG000|Overall Study|Early termination study|1|||
125047055|NCT02940886|449793179|FG000|Overall Study|Adverse Event|7|||
125047056|NCT02940886|449793180|FG001|Overall Study|Adverse Event|3|||
125047057|NCT02940886|449793179|FG000|Overall Study|Protocol Violation|0|||
125047058|NCT02940886|449793180|FG001|Overall Study|Protocol Violation|2|||
125047059|NCT02940886|449793179|FG000|Overall Study|Withdrawal by Subject|28|||
125047060|NCT02940886|449793180|FG001|Overall Study|Withdrawal by Subject|20|||
125047061|NCT02940886|449793179|FG000|Overall Study|Death|1|||
125047062|NCT02940886|449793180|FG001|Overall Study|Death|0|||
125047063|NCT02940886|449793179|FG000|Overall Study|Lack of Efficacy|1|||
125047064|NCT02940886|449793180|FG001|Overall Study|Lack of Efficacy|0|||
125047065|NCT02940886|449793179|FG000|Overall Study|Lost to Follow-up|49|||
125047066|NCT02940886|449793180|FG001|Overall Study|Lost to Follow-up|21|||
125047067|NCT02940886|449793179|FG000|Overall Study|Physician Decision|9|||
125047068|NCT02940886|449793180|FG001|Overall Study|Physician Decision|4|||
125047069|NCT02940886|449793179|FG000|Overall Study|Sponsor decision|0|||
125047070|NCT02940886|449793180|FG001|Overall Study|Sponsor decision|1|||
125047071|NCT02940886|449793179|FG000|Overall Study|No treatment|7|||
125047072|NCT02940886|449793180|FG001|Overall Study|No treatment|2|||
125047073|NCT02940886|449793179|FG000|Overall Study|Enrolment error|0|||
125047074|NCT02940886|449793180|FG001|Overall Study|Enrolment error|1|||
125047075|NCT01306058|449793182|FG000|Overall Study|Death|1|||
125047076|NCT01306058|449793182|FG000|Overall Study|Enrolled but did not get treatment|1|||
125047077|NCT01666444|449793183|FG000|Overall Study|Did not initiate treatment|2|||
125047078|NCT01666444|449793184|FG001|Overall Study|Did not initiate treatment|1|||
125047079|NCT00592358|449793187|FG000|Overall Study|Withdrawal by Subject|2|||
125047080|NCT00592358|449793187|FG000|Overall Study|Adverse Event|1|||
124976089|NCT05000216|449538576|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
124976090|NCT05000216|449538577|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
124976091|NCT05000216|449538578|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
124976092|NCT05000216|449538579|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
124976093|NCT05000216|449538580|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
124976094|NCT05000216|449538581|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
124976095|NCT05000216|449538582|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
124976096|NCT05000216|449538583|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
125047081|NCT00592358|449793187|FG000|Overall Study|Lack of Efficacy|2|||
125047082|NCT00592358|449793187|FG000|Overall Study|Inability to swallow pills|1|||
125047083|NCT00084682|449793188|FG000|Overall Study|Withdrawal by Subject|1|||
125047084|NCT03238248|449793196|FG000|Overall Study|Death|5|||
124976097|NCT05000216|449538584|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
124976098|NCT05000216|449538585|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
124976099|NCT05000216|449538586|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
124976100|NCT05000216|449538587|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
124976101|NCT05000216|449538588|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
124976102|NCT05000216|449538589|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
124976103|NCT05000216|449538590|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
125047085|NCT03238248|449793196|FG000|Overall Study|Withdrawal by Subject|7|||
125047086|NCT03238248|449793196|FG000|Overall Study|Participant proceeding to transplant|10|||
125047087|NCT03238248|449793196|FG000|Overall Study|Lack of Efficacy|4|||
125047088|NCT03238248|449793196|FG000|Overall Study|Physician Decision|3|||
125047089|NCT03238248|449793196|FG000|Overall Study|Transitioning to another study|1|||
125047090|NCT03238248|449793196|FG000|Overall Study|No longer benefiting|1|||
125047091|NCT03238248|449793196|FG000|Overall Study|Other complicating disease|1|||
125047092|NCT03238248|449793196|FG000|Overall Study|Adverse Event|5|||
125047093|NCT03238248|449793196|FG000|Overall Study|Disease progression|26|||
125047094|NCT03238248|449793196|FG000|Overall Study|N/A participant is still on treatment|1|||
125047095|NCT03238248|449793196|FG000|Overall Study|Decline in condition|1|||
125047096|NCT03238248|449793196|FG000|Overall Study|Alternative therapy|2|||
125047097|NCT01013883|449793197|FG000|Overall Study|Lost to Follow-up|2|||
125047098|NCT01013883|449793198|FG001|Overall Study|Lost to Follow-up|2|||
125047099|NCT02241512|449793199|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
125047100|NCT02241512|449793200|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
125047101|NCT00474630|449793201|FG000|Overall Study|Adverse Event|98|||
125047102|NCT00474630|449793202|FG001|Overall Study|Adverse Event|26|||
125047103|NCT00474630|449793201|FG000|Overall Study|Lost to Follow-up|22|||
125047104|NCT00474630|449793202|FG001|Overall Study|Lost to Follow-up|15|||
125047105|NCT00474630|449793201|FG000|Overall Study|Withdrawal by Subject|21|||
125047106|NCT00474630|449793202|FG001|Overall Study|Withdrawal by Subject|15|||
125047107|NCT00474630|449793201|FG000|Overall Study|Protocol Violation|3|||
125047108|NCT00474630|449793202|FG001|Overall Study|Protocol Violation|4|||
125047109|NCT00474630|449793201|FG000|Overall Study|Lack of Efficacy|5|||
125047110|NCT00474630|449793202|FG001|Overall Study|Lack of Efficacy|6|||
125047111|NCT00474630|449793201|FG000|Overall Study|Drug noncompliance, other|11|||
125047112|NCT00474630|449793202|FG001|Overall Study|Drug noncompliance, other|4|||
125047113|NCT00958568|449793204|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
125047114|NCT00958568|449793205|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
125047115|NCT00958568|449793206|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
125047116|NCT00958568|449793207|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
125047117|NCT00958568|449793204|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
125047118|NCT00958568|449793205|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
125047119|NCT00958568|449793206|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
125047120|NCT00958568|449793207|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
125047121|NCT00958568|449793204|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
125047122|NCT00958568|449793205|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
125047123|NCT00958568|449793206|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
125047124|NCT00958568|449793207|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
125047125|NCT00958568|449793204|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
125047126|NCT00958568|449793205|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
125047127|NCT00958568|449793206|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
125047128|NCT00958568|449793207|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
125047129|NCT00958568|449793204|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
125047130|NCT00958568|449793205|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
125047131|NCT00958568|449793206|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
125047132|NCT00958568|449793207|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
125047133|NCT00958568|449793204|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
125047134|NCT00958568|449793205|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
125047135|NCT00958568|449793206|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
125047136|NCT00958568|449793207|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
125047137|NCT00958568|449793204|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
125047138|NCT00958568|449793205|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
125047139|NCT00958568|449793206|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
125047140|NCT00958568|449793207|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
125047141|NCT00958568|449793204|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
125047142|NCT00958568|449793205|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
125047143|NCT00958568|449793206|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
125047144|NCT00958568|449793207|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
125047145|NCT00958568|449793204|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
125047146|NCT00958568|449793205|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
124976104|NCT05000216|449538591|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
125047147|NCT00958568|449793206|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
124976105|NCT05000216|449538570|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976106|NCT05000216|449538571|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976107|NCT05000216|449538572|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976108|NCT05000216|449538573|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976109|NCT05000216|449538574|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976110|NCT05000216|449538575|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976111|NCT05000216|449538576|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976112|NCT05000216|449538577|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976113|NCT05000216|449538578|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976114|NCT05000216|449538579|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976115|NCT05000216|449538580|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976116|NCT05000216|449538581|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976117|NCT05000216|449538582|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976118|NCT05000216|449538583|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976119|NCT05000216|449538584|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976120|NCT05000216|449538585|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
124976121|NCT05000216|449538586|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976122|NCT05000216|449538587|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976123|NCT05000216|449538588|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976124|NCT05000216|449538589|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976125|NCT05000216|449538590|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976126|NCT05000216|449538591|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976127|NCT05000216|449538570|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976128|NCT05000216|449538571|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976129|NCT05000216|449538572|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976130|NCT05000216|449538573|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976131|NCT05000216|449538574|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976132|NCT05000216|449538575|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976133|NCT05000216|449538576|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976134|NCT05000216|449538577|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976135|NCT05000216|449538578|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976136|NCT05000216|449538579|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976137|NCT05000216|449538580|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976138|NCT05000216|449538581|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976139|NCT05000216|449538582|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976140|NCT05000216|449538583|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
124976141|NCT05000216|449538584|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976142|NCT05000216|449538585|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
124976143|NCT05000216|449538586|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976144|NCT05000216|449538587|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976145|NCT05000216|449538588|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
124976146|NCT05000216|449538589|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976147|NCT05000216|449538590|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976148|NCT05000216|449538591|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976149|NCT02195479|449538596|FG000|Overall Study|Lost to Follow-up|18|||
124976150|NCT02195479|449538597|FG001|Overall Study|Lost to Follow-up|15|||
124976151|NCT02195479|449538596|FG000|Overall Study|Death|217|||
124976152|NCT02195479|449538597|FG001|Overall Study|Death|171|||
124976153|NCT02195479|449538596|FG000|Overall Study|Physician Decision|1|||
124976154|NCT02195479|449538597|FG001|Overall Study|Physician Decision|0|||
124976155|NCT02195479|449538596|FG000|Overall Study|Withdrawal by Subject|30|||
124976156|NCT02195479|449538597|FG001|Overall Study|Withdrawal by Subject|30|||
124976157|NCT02195479|449538596|FG000|Overall Study|Other|3|||
124976158|NCT02195479|449538597|FG001|Overall Study|Other|4|||
124976159|NCT02195479|449538596|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
124976160|NCT02195479|449538597|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
124976161|NCT03004404|449538600|FG000|Period 2|Adverse Event|0|||
124976162|NCT03004404|449538601|FG001|Period 2|Adverse Event|0|||
124976163|NCT03004404|449538602|FG002|Period 2|Adverse Event|0|||
124976164|NCT03004404|449538603|FG003|Period 2|Adverse Event|0|||
124976165|NCT03004404|449538604|FG004|Period 2|Adverse Event|0|||
124976166|NCT03004404|449538605|FG005|Period 2|Adverse Event|0|||
125135961|NCT03261167|450121794|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
125135962|NCT03261167|450121795|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
125135963|NCT03261167|450121794|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
125135964|NCT03261167|450121795|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
125135965|NCT03261167|450121794|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
125047148|NCT00958568|449793207|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
125047149|NCT00958568|449793204|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
125047150|NCT00958568|449793205|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
125047151|NCT00958568|449793206|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
125047152|NCT00958568|449793207|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
125047153|NCT00958568|449793204|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
125047154|NCT00958568|449793205|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
125047155|NCT00958568|449793206|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
125047156|NCT00958568|449793207|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
125047157|NCT00958568|449793204|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
125047158|NCT00958568|449793205|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
125047159|NCT00958568|449793206|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
125047160|NCT00958568|449793207|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
125047161|NCT00958568|449793204|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
125047162|NCT00958568|449793205|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
125047163|NCT00958568|449793206|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
125047164|NCT00958568|449793207|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
125047165|NCT00958568|449793204|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
125047166|NCT00958568|449793205|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
125047167|NCT00958568|449793206|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
125047168|NCT00958568|449793207|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
125047169|NCT00958568|449793204|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
125047170|NCT00958568|449793205|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
125047171|NCT00958568|449793206|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
125047172|NCT00958568|449793207|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
125047173|NCT00958568|449793204|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
125047174|NCT00958568|449793205|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
125047175|NCT00958568|449793206|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
125047176|NCT00958568|449793207|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
125047177|NCT00958568|449793204|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
125047178|NCT00958568|449793205|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
125047179|NCT00958568|449793206|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
125047180|NCT00958568|449793207|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
125047181|NCT00958568|449793204|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
125047182|NCT00958568|449793205|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
125047183|NCT00958568|449793206|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
125047184|NCT00958568|449793207|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
125047185|NCT00958568|449793204|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
125047186|NCT00958568|449793205|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
125047187|NCT00958568|449793206|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
125047188|NCT00958568|449793207|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
125047189|NCT00958568|449793204|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
125047190|NCT00958568|449793205|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
125047191|NCT00958568|449793206|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
125047192|NCT00958568|449793207|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
125047193|NCT00958568|449793204|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
125047194|NCT00958568|449793205|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
125047195|NCT00958568|449793206|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
125047196|NCT00958568|449793207|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
124976167|NCT03004404|449538606|FG006|Period 2|Adverse Event|0|||
124976168|NCT03004404|449538607|FG007|Period 2|Adverse Event|0|||
124976169|NCT03004404|449538608|FG008|Period 2|Adverse Event|1|||
124976170|NCT03004404|449538609|FG009|Period 2|Adverse Event|0|||
124976171|NCT03004404|449538610|FG010|Period 2|Adverse Event|0|||
124976172|NCT03004404|449538611|FG011|Period 2|Adverse Event|0|||
124976173|NCT03004404|449538612|FG012|Period 2|Adverse Event|0|||
124976174|NCT03004404|449538613|FG013|Period 2|Adverse Event|0|||
124976175|NCT03004404|449538614|FG014|Period 2|Adverse Event|0|||
124976176|NCT03004404|449538615|FG015|Period 2|Adverse Event|1|||
124976177|NCT02522728|449538619|FG000|Overall Study|Withdrawal by Subject|6|||
124976178|NCT02522728|449538620|FG001|Overall Study|Withdrawal by Subject|6|||
124976179|NCT02522728|449538619|FG000|Overall Study|Death|4|||
124976180|NCT02522728|449538620|FG001|Overall Study|Death|3|||
124976181|NCT02522728|449538619|FG000|Overall Study|Adverse Event|2|||
124976182|NCT02522728|449538620|FG001|Overall Study|Adverse Event|1|||
124976183|NCT02522728|449538619|FG000|Overall Study|Did not receive randomized study device|0|||
124976184|NCT02522728|449538620|FG001|Overall Study|Did not receive randomized study device|1|||
124976185|NCT01266161|449538622|FG000|Overall Study|Ineligible|1|||
124976186|NCT01266161|449538623|FG001|Overall Study|Ineligible|0|||
124976187|NCT01266161|449538622|FG000|Overall Study|Lack of Efficacy|0|||
124976188|NCT01266161|449538623|FG001|Overall Study|Lack of Efficacy|1|||
124976189|NCT01266161|449538622|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
124976190|NCT01266161|449538623|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
124976191|NCT01436305|449538624|FG000|Overall Study|Death|1|||
124976192|NCT01436305|449538625|FG001|Overall Study|Death|0|||
124976193|NCT01436305|449538626|FG002|Overall Study|Death|0|||
124976194|NCT01436305|449538624|FG000|Overall Study|Lost to Follow-up|0|||
124976195|NCT01436305|449538625|FG001|Overall Study|Lost to Follow-up|1|||
124976196|NCT01436305|449538626|FG002|Overall Study|Lost to Follow-up|0|||
124976197|NCT01436305|449538624|FG000|Overall Study|Withdrawal by Subject|1|||
124976198|NCT01436305|449538625|FG001|Overall Study|Withdrawal by Subject|3|||
124976199|NCT01436305|449538626|FG002|Overall Study|Withdrawal by Subject|0|||
124976200|NCT05071053|449538629|FG000|Overall Study|Progressive disease|30|||
124976201|NCT05071053|449538629|FG000|Overall Study|Adverse Event|5|||
124976202|NCT01081886|449538630|FG000|Overall Study|Study termination|11|||
124976203|NCT01081886|449538631|FG001|Overall Study|Study termination|13|||
124976204|NCT04148651|449538632|FG000|Overall Study|Lost to Follow-up|2|||
124976205|NCT01602510|449538633|FG000|Open Label Phase|Adverse Event|46|||
124976206|NCT01602510|449538634|FG001|Open Label Phase|Adverse Event|0|||
124976207|NCT01602510|449538635|FG002|Open Label Phase|Adverse Event|0|||
124976208|NCT01602510|449538633|FG000|Open Label Phase|Lack of Efficacy|22|||
124976209|NCT01602510|449538634|FG001|Open Label Phase|Lack of Efficacy|0|||
124976210|NCT01602510|449538635|FG002|Open Label Phase|Lack of Efficacy|0|||
124976211|NCT01602510|449538633|FG000|Open Label Phase|Protocol Violation|15|||
124976212|NCT01602510|449538634|FG001|Open Label Phase|Protocol Violation|0|||
124976213|NCT01602510|449538635|FG002|Open Label Phase|Protocol Violation|0|||
124976214|NCT01602510|449538633|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
124976215|NCT01602510|449538634|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
125047197|NCT00958568|449793204|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
125047198|NCT00958568|449793205|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
125047199|NCT00958568|449793206|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
125047200|NCT00958568|449793207|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
125047201|NCT00958568|449793204|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
125047202|NCT00958568|449793205|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
125047203|NCT00958568|449793206|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
125047204|NCT00958568|449793207|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
125047205|NCT00958568|449793204|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
125047206|NCT00958568|449793205|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
125047207|NCT00958568|449793206|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
125047208|NCT00958568|449793207|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
125047209|NCT00958568|449793204|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
125047210|NCT00958568|449793205|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
125047211|NCT00958568|449793206|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
125047212|NCT00958568|449793207|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
125047213|NCT00958568|449793204|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
125047214|NCT00958568|449793205|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
125047215|NCT00958568|449793206|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
125047216|NCT00958568|449793207|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
125047217|NCT00958568|449793204|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
125047218|NCT00958568|449793205|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
125047219|NCT00958568|449793206|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
125047220|NCT00958568|449793207|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
125047221|NCT00958568|449793204|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
125047222|NCT00958568|449793205|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
125047223|NCT00958568|449793206|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
125135966|NCT03261167|450121795|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
125135967|NCT03261167|450121794|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
124976216|NCT01602510|449538635|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
124976217|NCT01602510|449538633|FG000|Open Label Phase|Lost to Follow-up|22|||
124976218|NCT01602510|449538634|FG001|Open Label Phase|Lost to Follow-up|0|||
124976219|NCT01602510|449538635|FG002|Open Label Phase|Lost to Follow-up|0|||
124976220|NCT01602510|449538633|FG000|Open Label Phase|Physician Decision|19|||
124976221|NCT01602510|449538634|FG001|Open Label Phase|Physician Decision|0|||
124976222|NCT01602510|449538635|FG002|Open Label Phase|Physician Decision|0|||
124976223|NCT01602510|449538633|FG000|Open Label Phase|Withdrawal by Subject|57|||
124976224|NCT01602510|449538634|FG001|Open Label Phase|Withdrawal by Subject|0|||
124976225|NCT01602510|449538635|FG002|Open Label Phase|Withdrawal by Subject|0|||
124976226|NCT01602510|449538633|FG000|Randomized Phase|Adverse Event|0|||
124976227|NCT01602510|449538634|FG001|Randomized Phase|Adverse Event|2|||
125047224|NCT00958568|449793207|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
125047225|NCT00958568|449793204|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
125047226|NCT00958568|449793205|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
125047227|NCT00958568|449793206|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
125047228|NCT00958568|449793207|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
125047229|NCT03268746|449793218|FG000|Overall Study|Withdrawal by Subject|1|||
125047230|NCT00850499|449793221|FG000|Overall Study|Adverse Event|3|||
125047231|NCT00850499|449793222|FG001|Overall Study|Adverse Event|1|||
125047232|NCT00850499|449793221|FG000|Overall Study|Lack of Efficacy|0|||
125047233|NCT00850499|449793222|FG001|Overall Study|Lack of Efficacy|1|||
125047234|NCT00909090|449793228|FG000|Overall Study|Lost to Follow-up|17|||
125047235|NCT00909090|449793229|FG001|Overall Study|Lost to Follow-up|17|||
125047236|NCT02345434|449793231|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
125047237|NCT02345434|449793232|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
125047238|NCT01214434|449793239|FG000|Overall Study|Withdrawal by Subject|1|||
125047239|NCT01214434|449793240|FG001|Overall Study|Withdrawal by Subject|0|||
125047240|NCT01214434|449793239|FG000|Overall Study|Lost to Follow-up|2|||
125047241|NCT01214434|449793240|FG001|Overall Study|Lost to Follow-up|2|||
125047242|NCT01214434|449793239|FG000|Overall Study|Site error|1|||
125047243|NCT01214434|449793240|FG001|Overall Study|Site error|0|||
125047244|NCT03792750|449793242|FG000|Overall Study|Death|3|||
125047245|NCT00138151|449793243|FG000|Overall Study|Withdrawal by Subject|3|||
125047246|NCT00138151|449793243|FG000|Overall Study|Physician Decision|1|||
125047247|NCT02902809|449793247|FG000|Overall Study|Discontinuation of asthma program|28|||
125047248|NCT00532259|449793248|FG000|Overall Study|Withdrawal by Subject|2|||
125047249|NCT00532259|449793248|FG000|Overall Study|Adverse Event|1|||
125047250|NCT00532259|449793248|FG000|Overall Study|Death|1|||
125047251|NCT00532259|449793248|FG000|Overall Study|Lack of Efficacy|21|||
125047252|NCT00532259|449793248|FG000|Overall Study|Lost to Follow-up|3|||
125047253|NCT00532259|449793248|FG000|Overall Study|Physician Decision|3|||
125047254|NCT00532259|449793248|FG000|Overall Study|Protocol Violation|1|||
125047255|NCT00793104|449793249|FG000|Overall Study|Lost to Follow-up|1|||
125047256|NCT03494725|449793250|FG000|Overall Study|Withdrawal by Subject|0|||
125047257|NCT03494725|449793251|FG001|Overall Study|Withdrawal by Subject|2|||
125047258|NCT03494725|449793250|FG000|Overall Study|Antibiotic use|1|||
125047259|NCT03494725|449793251|FG001|Overall Study|Antibiotic use|0|||
125047260|NCT04983940|449793252|FG000|Overall Study|Lost to Follow-up|14|||
125047261|NCT04983940|449793252|FG000|Overall Study|Lack of Efficacy|2|||
125047262|NCT00514449|449793253|FG000|Overall Study|Withdrawal by Subject|1|||
125047263|NCT00514449|449793254|FG001|Overall Study|Withdrawal by Subject|2|||
125047264|NCT00514449|449793253|FG000|Overall Study|Protocol Violation|1|||
125047265|NCT00514449|449793254|FG001|Overall Study|Protocol Violation|2|||
125047266|NCT00514449|449793253|FG000|Overall Study|Lost to Follow-up|1|||
125047267|NCT00514449|449793254|FG001|Overall Study|Lost to Follow-up|0|||
125047268|NCT00301067|449793255|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
125047269|NCT00301067|449793256|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
125047270|NCT00301067|449793257|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
125047271|NCT00301067|449793258|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
125047272|NCT00301067|449793255|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
125047273|NCT00301067|449793256|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
125047274|NCT00301067|449793257|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
125047275|NCT00301067|449793258|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
125047276|NCT00301067|449793255|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
125047277|NCT00301067|449793256|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
125047278|NCT00301067|449793257|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
125047279|NCT00301067|449793258|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
125047280|NCT00301067|449793255|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
125047281|NCT00301067|449793256|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
125047282|NCT00301067|449793257|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
125047283|NCT00301067|449793258|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
125047284|NCT00301067|449793255|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
125047285|NCT00301067|449793256|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
125047286|NCT00301067|449793257|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
125047287|NCT00301067|449793258|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
125047288|NCT00301067|449793255|FG000|Follow up Until Death|Alive at last data cut point|1|||
125047289|NCT00301067|449793256|FG001|Follow up Until Death|Alive at last data cut point|0|||
124976228|NCT01602510|449538635|FG002|Randomized Phase|Adverse Event|6|||
125047290|NCT00301067|449793257|FG002|Follow up Until Death|Alive at last data cut point|0|||
125047291|NCT00301067|449793258|FG003|Follow up Until Death|Alive at last data cut point|1|||
125047292|NCT00149825|449793259|FG000|Overall Study|Intolerance to medication side effects|1|||
125047293|NCT00149825|449793260|FG001|Overall Study|Intolerance to medication side effects|2|||
125047294|NCT00149825|449793259|FG000|Overall Study|Time commitments|2|||
125047295|NCT00149825|449793260|FG001|Overall Study|Time commitments|1|||
125047296|NCT00149825|449793259|FG000|Overall Study|Not liking insomnia therapy|1|||
125047297|NCT00149825|449793260|FG001|Overall Study|Not liking insomnia therapy|0|||
125047298|NCT00149825|449793259|FG000|Overall Study|Other|1|||
125047299|NCT00149825|449793260|FG001|Overall Study|Other|0|||
125047300|NCT01359982|449793261|FG000|Overall Study|Adverse Event|2|||
125047301|NCT01359982|449793262|FG001|Overall Study|Adverse Event|0|||
125047302|NCT01359982|449793263|FG002|Overall Study|Adverse Event|0|||
125047303|NCT01359982|449793264|FG003|Overall Study|Adverse Event|1|||
124976229|NCT01602510|449538633|FG000|Randomized Phase|Lack of Efficacy|0|||
124976230|NCT01602510|449538634|FG001|Randomized Phase|Lack of Efficacy|4|||
124976231|NCT01602510|449538635|FG002|Randomized Phase|Lack of Efficacy|4|||
124976232|NCT01602510|449538633|FG000|Randomized Phase|Protocol Violation|0|||
124976233|NCT01602510|449538634|FG001|Randomized Phase|Protocol Violation|3|||
124976234|NCT01602510|449538635|FG002|Randomized Phase|Protocol Violation|3|||
124976235|NCT01602510|449538633|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
124976236|NCT01602510|449538634|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
124976237|NCT01602510|449538635|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
124976238|NCT01602510|449538633|FG000|Randomized Phase|Lost to Follow-up|0|||
124976239|NCT01602510|449538634|FG001|Randomized Phase|Lost to Follow-up|1|||
124976240|NCT01602510|449538635|FG002|Randomized Phase|Lost to Follow-up|3|||
124976241|NCT01602510|449538633|FG000|Randomized Phase|Physician Decision|0|||
124976242|NCT01602510|449538634|FG001|Randomized Phase|Physician Decision|0|||
124976243|NCT01602510|449538635|FG002|Randomized Phase|Physician Decision|2|||
124976244|NCT01602510|449538633|FG000|Randomized Phase|Withdrawal by Subject|0|||
124976245|NCT01602510|449538634|FG001|Randomized Phase|Withdrawal by Subject|6|||
124976246|NCT01602510|449538635|FG002|Randomized Phase|Withdrawal by Subject|7|||
124976247|NCT05262751|449538636|FG000|Washout Period 2|Adverse Event|1|||
124976248|NCT05262751|449538637|FG001|Washout Period 2|Adverse Event|0|||
124976249|NCT05262751|449538638|FG002|Washout Period 2|Adverse Event|0|||
124976250|NCT05262751|449538639|FG003|Washout Period 2|Adverse Event|0|||
124976251|NCT05262751|449538640|FG004|Washout Period 2|Adverse Event|0|||
124976252|NCT05262751|449538641|FG005|Washout Period 2|Adverse Event|0|||
124976253|NCT05262751|449538636|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
124976254|NCT05262751|449538637|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
124976255|NCT05262751|449538638|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
124976256|NCT05262751|449538639|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
124976257|NCT05262751|449538640|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
124976258|NCT05262751|449538641|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
124976259|NCT03519204|449538642|FG000|Overall Study|Lost to Follow-up|3|||
124976260|NCT03519204|449538643|FG001|Overall Study|Lost to Follow-up|8|||
124976261|NCT03519204|449538642|FG000|Overall Study|Withdrawal by Subject|9|||
124976262|NCT03519204|449538643|FG001|Overall Study|Withdrawal by Subject|7|||
124976263|NCT03519204|449538642|FG000|Overall Study|Other Miscellaneous Reasons|1|||
124976264|NCT03519204|449538643|FG001|Overall Study|Other Miscellaneous Reasons|0|||
124976265|NCT01572740|449538645|FG000|Overall Study|Adverse Event|1|||
124976266|NCT01572740|449538646|FG001|Overall Study|Adverse Event|1|||
124976267|NCT01572740|449538645|FG000|Overall Study|Withdrawal by Subject|1|||
124976268|NCT01572740|449538646|FG001|Overall Study|Withdrawal by Subject|1|||
124976269|NCT01572740|449538645|FG000|Overall Study|unclassified|4|||
124976270|NCT01572740|449538646|FG001|Overall Study|unclassified|3|||
124976271|NCT01289210|449538647|FG000|Overall Study|Adverse Event|1|||
124976272|NCT01110408|449538650|FG000|Overall Study|Protocol Violation|1|||
124976273|NCT01110408|449538651|FG001|Overall Study|Protocol Violation|0|||
124976274|NCT02269423|449538652|FG000|Overall Study|Discontinued due to change in residence|0|||
124976275|NCT02269423|449538653|FG001|Overall Study|Discontinued due to change in residence|1|||
124976276|NCT02269423|449538654|FG002|Overall Study|Discontinued due to change in residence|0|||
124976277|NCT02269423|449538655|FG003|Overall Study|Discontinued due to change in residence|1|||
124976278|NCT00839956|449538656|FG000|Overall Study|Adverse Event|2|||
124976279|NCT00839956|449538656|FG000|Overall Study|Lack of Efficacy|6|||
125218955|NCT03538691|450427423|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
125218956|NCT03538691|450427420|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
124976280|NCT00839956|449538656|FG000|Overall Study|Physician Decision|1|||
125047304|NCT01359982|449793265|FG004|Overall Study|Adverse Event|0|||
124976281|NCT00839956|449538656|FG000|Overall Study|Withdrawal by Subject|3|||
125047305|NCT01359982|449793266|FG005|Overall Study|Adverse Event|0|||
125047306|NCT01359982|449793261|FG000|Overall Study|Death|1|||
125047307|NCT01359982|449793262|FG001|Overall Study|Death|0|||
124976282|NCT01509547|449538657|FG000|Overall Study|Lost to Follow-up|24|||
125218957|NCT03538691|450427421|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
125218958|NCT03538691|450427422|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
125218959|NCT03538691|450427423|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
125218960|NCT03538691|450427420|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
125218961|NCT03538691|450427421|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
125218962|NCT03538691|450427422|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
125218963|NCT03538691|450427423|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
125218964|NCT03538691|450427420|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
125218965|NCT03538691|450427421|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
125218966|NCT03538691|450427422|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
125218967|NCT03538691|450427423|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
125218968|NCT03538691|450427420|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
125218969|NCT03538691|450427421|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
125218970|NCT03538691|450427422|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
125218971|NCT03538691|450427423|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
125218972|NCT06597084|450427424|FG000|Overall Study|Withdrawal by Subject|4|||
125218973|NCT06597084|450427425|FG001|Overall Study|Withdrawal by Subject|9|||
125218974|NCT06597084|450427424|FG000|Overall Study|Consent was not given by the patient until V2|0|||
125218975|NCT06597084|450427425|FG001|Overall Study|Consent was not given by the patient until V2|3|||
125218976|NCT06597084|450427424|FG000|Overall Study|Physician Decision|1|||
125218977|NCT06597084|450427425|FG001|Overall Study|Physician Decision|0|||
125218978|NCT06597084|450427424|FG000|Overall Study|Adverse Event|3|||
125218979|NCT06597084|450427425|FG001|Overall Study|Adverse Event|2|||
125218980|NCT06597084|450427424|FG000|Overall Study|Death|4|||
125218981|NCT06597084|450427425|FG001|Overall Study|Death|0|||
125218982|NCT06597084|450427424|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
125218983|NCT06597084|450427425|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
125218984|NCT06597084|450427424|FG000|Overall Study|Lost to Follow-up|4|||
125218985|NCT06597084|450427425|FG001|Overall Study|Lost to Follow-up|2|||
125218986|NCT06597084|450427424|FG000|Overall Study|Other. Not specified|1|||
125218987|NCT06597084|450427425|FG001|Overall Study|Other. Not specified|0|||
125218988|NCT01588405|450427426|FG000|Overall Study|Adverse Event|1|||
125218989|NCT01588405|450427426|FG000|Overall Study|Clinical Worsening|1|||
125218990|NCT02029274|450427432|FG000|Overall Study|Adverse Event|1|||
125218991|NCT02029274|450427433|FG001|Overall Study|Adverse Event|0|||
125218992|NCT02029274|450427434|FG002|Overall Study|Adverse Event|2|||
125218993|NCT02029274|450427435|FG003|Overall Study|Adverse Event|2|||
125218994|NCT01243177|450427438|FG000|Overall Study|Lack of Efficacy|47|||
125218995|NCT01243177|450427439|FG001|Overall Study|Lack of Efficacy|31|||
125218996|NCT01243177|450427438|FG000|Overall Study|Protocol Violation|11|||
125218997|NCT01243177|450427439|FG001|Overall Study|Protocol Violation|10|||
125218998|NCT01243177|450427438|FG000|Overall Study|Lost to Follow-up|15|||
125218999|NCT01243177|450427439|FG001|Overall Study|Lost to Follow-up|18|||
125219000|NCT01243177|450427438|FG000|Overall Study|Withdrawal by Subject|46|||
125219001|NCT01243177|450427439|FG001|Overall Study|Withdrawal by Subject|38|||
125219002|NCT01243177|450427438|FG000|Overall Study|AE, serious fatal|0|||
125219003|NCT01243177|450427439|FG001|Overall Study|AE, serious fatal|1|||
125219004|NCT01243177|450427438|FG000|Overall Study|SAE, non-fatal|7|||
125219005|NCT01243177|450427439|FG001|Overall Study|SAE, non-fatal|9|||
125219006|NCT01243177|450427438|FG000|Overall Study|AE, non-serious non-fatal|40|||
125219007|NCT01243177|450427439|FG001|Overall Study|AE, non-serious non-fatal|58|||
125219008|NCT01243177|450427438|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
125219009|NCT01243177|450427439|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
125219010|NCT01243177|450427438|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
125219011|NCT01243177|450427439|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
125219012|NCT01243177|450427438|FG000|Overall Study|Other Reason|11|||
125047308|NCT01359982|449793263|FG002|Overall Study|Death|0|||
125047309|NCT01359982|449793264|FG003|Overall Study|Death|0|||
125047310|NCT01359982|449793265|FG004|Overall Study|Death|0|||
125047311|NCT01359982|449793266|FG005|Overall Study|Death|0|||
125047312|NCT00942708|449793267|FG000|Overall Study|Withdrawal by Subject|1|||
125219013|NCT01243177|450427439|FG001|Overall Study|Other Reason|12|||
125219014|NCT05251233|450429253|FG000|Overall Study|Disease progression - did not start treatment|0|||
125219015|NCT05251233|450429254|FG001|Overall Study|Disease progression - did not start treatment|0|||
125219016|NCT05251233|450429255|FG002|Overall Study|Disease progression - did not start treatment|5|||
125047313|NCT02760407|449793268|FG000|Overall Study|Death|2|||
125219017|NCT05251233|450429253|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
125219018|NCT05251233|450429254|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
125219019|NCT05251233|450429255|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
125219020|NCT05251233|450429253|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
125219021|NCT05251233|450429254|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
125219022|NCT05251233|450429255|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
125219023|NCT05251233|450429253|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
125219024|NCT05251233|450429254|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
125219025|NCT05251233|450429255|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
125219026|NCT05251233|450429253|FG000|Overall Study|Death - did not start treatment|3|||
125219027|NCT05251233|450429254|FG001|Overall Study|Death - did not start treatment|0|||
125219028|NCT05251233|450429255|FG002|Overall Study|Death - did not start treatment|0|||
125219029|NCT05251233|450429253|FG000|Overall Study|Withdrawal by Subject|2|||
125219030|NCT05251233|450429254|FG001|Overall Study|Withdrawal by Subject|2|||
125219031|NCT05251233|450429255|FG002|Overall Study|Withdrawal by Subject|0|||
125219032|NCT05251233|450429253|FG000|Overall Study|Other complicating disease|2|||
125219033|NCT05251233|450429254|FG001|Overall Study|Other complicating disease|1|||
125219034|NCT05251233|450429255|FG002|Overall Study|Other complicating disease|0|||
125219035|NCT05251233|450429253|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
125219036|NCT05251233|450429254|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
125219037|NCT05251233|450429255|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
125219038|NCT05251233|450429253|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
125219039|NCT05251233|450429254|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
125219040|NCT05251233|450429255|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
125219041|NCT01919164|450429266|FG000|Overall Study|Adverse Event|6|||
125219042|NCT01919164|450429267|FG001|Overall Study|Adverse Event|4|||
125219043|NCT01919164|450429268|FG002|Overall Study|Adverse Event|9|||
125219044|NCT01919164|450429269|FG003|Overall Study|Adverse Event|3|||
125219045|NCT01919164|450429270|FG004|Overall Study|Adverse Event|2|||
125219046|NCT01919164|450429266|FG000|Overall Study|Lost to Follow-up|2|||
125219047|NCT01919164|450429267|FG001|Overall Study|Lost to Follow-up|2|||
125219048|NCT01919164|450429268|FG002|Overall Study|Lost to Follow-up|2|||
125219049|NCT01919164|450429269|FG003|Overall Study|Lost to Follow-up|0|||
125219050|NCT01919164|450429270|FG004|Overall Study|Lost to Follow-up|4|||
125219051|NCT01919164|450429266|FG000|Overall Study|Death|1|||
125219052|NCT01919164|450429267|FG001|Overall Study|Death|0|||
125219053|NCT01919164|450429268|FG002|Overall Study|Death|0|||
125219054|NCT01919164|450429269|FG003|Overall Study|Death|0|||
125219055|NCT01919164|450429270|FG004|Overall Study|Death|0|||
125219056|NCT01919164|450429266|FG000|Overall Study|Protocol Violation|6|||
125219057|NCT01919164|450429267|FG001|Overall Study|Protocol Violation|0|||
125219058|NCT01919164|450429268|FG002|Overall Study|Protocol Violation|3|||
125219059|NCT01919164|450429269|FG003|Overall Study|Protocol Violation|2|||
125219060|NCT01919164|450429270|FG004|Overall Study|Protocol Violation|2|||
125219061|NCT01919164|450429266|FG000|Overall Study|Disease progression|2|||
125219062|NCT01919164|450429267|FG001|Overall Study|Disease progression|2|||
125219063|NCT01919164|450429268|FG002|Overall Study|Disease progression|1|||
125219064|NCT01919164|450429269|FG003|Overall Study|Disease progression|2|||
125219065|NCT01919164|450429270|FG004|Overall Study|Disease progression|1|||
125219066|NCT01919164|450429266|FG000|Overall Study|Withdrew consent|13|||
125219067|NCT01919164|450429267|FG001|Overall Study|Withdrew consent|13|||
125219068|NCT01919164|450429268|FG002|Overall Study|Withdrew consent|14|||
125219069|NCT01919164|450429269|FG003|Overall Study|Withdrew consent|14|||
125219070|NCT01919164|450429270|FG004|Overall Study|Withdrew consent|9|||
125219071|NCT01919164|450429266|FG000|Overall Study|Other Un-specified|13|||
125219072|NCT01919164|450429267|FG001|Overall Study|Other Un-specified|9|||
125219073|NCT01919164|450429268|FG002|Overall Study|Other Un-specified|8|||
125219074|NCT01919164|450429269|FG003|Overall Study|Other Un-specified|7|||
125219075|NCT01919164|450429270|FG004|Overall Study|Other Un-specified|15|||
125219076|NCT00667992|450429273|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
125219077|NCT00667992|450429274|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
125047314|NCT02760407|449793269|FG001|Overall Study|Death|3|||
125047315|NCT02760407|449793270|FG002|Overall Study|Death|1|||
125047316|NCT02760407|449793271|FG003|Overall Study|Death|1|||
125047317|NCT02760407|449793268|FG000|Overall Study|Lost to Follow-up|1|||
125219078|NCT00667992|450429273|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
125219079|NCT00667992|450429274|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
125219080|NCT00667992|450429273|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
125219081|NCT00667992|450429274|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
125219082|NCT00667992|450429273|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
125219083|NCT00667992|450429274|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
125219084|NCT00667992|450429273|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
125219085|NCT00667992|450429274|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
125219086|NCT00667992|450429273|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
125219087|NCT00667992|450429274|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
125219088|NCT00667992|450429273|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
125219089|NCT00667992|450429274|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
125219090|NCT00667992|450429273|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
125219091|NCT00667992|450429274|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
125219092|NCT00667992|450429273|FG000|Wash-out|Not within one doubling dilution|4|||
125219093|NCT00667992|450429274|FG001|Wash-out|Not within one doubling dilution|3|||
125219094|NCT00667992|450429273|FG000|Wash-out|Failure to wash-out|2|||
125219095|NCT00667992|450429274|FG001|Wash-out|Failure to wash-out|2|||
125219096|NCT00667992|450429273|FG000|Wash-out|Withdrawal by Subject|1|||
125219097|NCT00667992|450429274|FG001|Wash-out|Withdrawal by Subject|0|||
125219098|NCT00667992|450429273|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
125219099|NCT00667992|450429274|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
125219100|NCT00667992|450429273|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
125219101|NCT00667992|450429274|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
125219102|NCT02748057|450429278|FG000|Overall Study|Adverse Event|1|||
125219103|NCT02748057|450429279|FG001|Overall Study|Adverse Event|0|||
125219104|NCT02748057|450429278|FG000|Overall Study|Physician Decision|0|||
125219105|NCT02748057|450429279|FG001|Overall Study|Physician Decision|1|||
125219106|NCT02748057|450429278|FG000|Overall Study|Protocol Violation|2|||
125219107|NCT02748057|450429279|FG001|Overall Study|Protocol Violation|1|||
125219108|NCT02748057|450429278|FG000|Overall Study|Participant Moved|1|||
125219109|NCT02748057|450429279|FG001|Overall Study|Participant Moved|0|||
125219110|NCT02748057|450429278|FG000|Overall Study|Withdrawal by Subject|1|||
125219111|NCT02748057|450429279|FG001|Overall Study|Withdrawal by Subject|0|||
125219112|NCT00524771|450429290|FG000|Overall Study|Protocol Violation|220|||
125219113|NCT00524771|450429291|FG001|Overall Study|Protocol Violation|585|||
125219114|NCT01266824|450429294|FG000|Overall Study|Study terminated prior to completion|2|||
125219115|NCT01266824|450429295|FG001|Overall Study|Study terminated prior to completion|3|||
125219116|NCT02982863|450429296|FG000|Overall Study|Not eligible patients|809|||
125219117|NCT02982863|450429297|FG001|Overall Study|Not eligible patients|4261|||
125219118|NCT02982863|450429298|FG002|Overall Study|Not eligible patients|1852|||
125219119|NCT02982863|450429299|FG003|Overall Study|Not eligible patients|1400|||
125219120|NCT02982863|450429300|FG004|Overall Study|Not eligible patients|492|||
125219121|NCT00807612|450429302|FG000|Overall Study|Death|8|||
125219122|NCT00807612|450429302|FG000|Overall Study|Study early termination|5|||
125219123|NCT00807612|450429302|FG000|Overall Study|Withdrawal by Subject|1|||
125219124|NCT01300247|450429303|FG000|Overall Study|Death|1|||
125219125|NCT01300247|450429304|FG001|Overall Study|Death|1|||
125219126|NCT01300247|450429303|FG000|Overall Study|Lost to Follow-up|2|||
125219127|NCT01300247|450429304|FG001|Overall Study|Lost to Follow-up|0|||
125047318|NCT02760407|449793269|FG001|Overall Study|Lost to Follow-up|7|||
125047319|NCT02760407|449793270|FG002|Overall Study|Lost to Follow-up|4|||
125047320|NCT02760407|449793271|FG003|Overall Study|Lost to Follow-up|6|||
125047321|NCT02760407|449793268|FG000|Overall Study|Withdrawal by Subject|25|||
125047322|NCT02760407|449793269|FG001|Overall Study|Withdrawal by Subject|31|||
125047323|NCT02760407|449793270|FG002|Overall Study|Withdrawal by Subject|37|||
125047324|NCT02760407|449793271|FG003|Overall Study|Withdrawal by Subject|25|||
125047325|NCT02760407|449793268|FG000|Overall Study|Violation of Eligibility criteria|0|||
125047326|NCT02760407|449793269|FG001|Overall Study|Violation of Eligibility criteria|0|||
125047327|NCT02760407|449793270|FG002|Overall Study|Violation of Eligibility criteria|1|||
125047328|NCT02760407|449793271|FG003|Overall Study|Violation of Eligibility criteria|1|||
125047329|NCT02760407|449793268|FG000|Overall Study|Personal reasons|0|||
125047330|NCT02760407|449793269|FG001|Overall Study|Personal reasons|0|||
125047331|NCT02760407|449793270|FG002|Overall Study|Personal reasons|0|||
125047332|NCT02760407|449793271|FG003|Overall Study|Personal reasons|1|||
125047333|NCT02760407|449793268|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
125047334|NCT02760407|449793269|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
125047335|NCT02760407|449793270|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
125219128|NCT01300247|450429303|FG000|Overall Study|Withdrawal by Subject|1|||
125047336|NCT02760407|449793271|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
125047337|NCT02760407|449793268|FG000|Overall Study|Use of prohibited Medication|0|||
125047338|NCT02760407|449793269|FG001|Overall Study|Use of prohibited Medication|0|||
125047339|NCT02760407|449793270|FG002|Overall Study|Use of prohibited Medication|1|||
125047340|NCT02760407|449793271|FG003|Overall Study|Use of prohibited Medication|0|||
125047341|NCT02760407|449793268|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
125047342|NCT02760407|449793269|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
125047343|NCT02760407|449793270|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
125047344|NCT02760407|449793271|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
125047345|NCT02760407|449793268|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
125047346|NCT02760407|449793269|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
125047347|NCT02760407|449793270|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
125047348|NCT02760407|449793271|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
125047349|NCT02760407|449793268|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
125047350|NCT02760407|449793269|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
125047351|NCT02760407|449793270|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
125047352|NCT02760407|449793271|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
125047353|NCT02760407|449793268|FG000|Overall Study|Inadequately Enrolled|0|||
125047354|NCT02760407|449793269|FG001|Overall Study|Inadequately Enrolled|0|||
125047355|NCT02760407|449793270|FG002|Overall Study|Inadequately Enrolled|0|||
125047356|NCT02760407|449793271|FG003|Overall Study|Inadequately Enrolled|1|||
125047357|NCT02760407|449793268|FG000|Overall Study|Withdrawal By PI's Decision|0|||
125047358|NCT02760407|449793269|FG001|Overall Study|Withdrawal By PI's Decision|1|||
125047359|NCT02760407|449793270|FG002|Overall Study|Withdrawal By PI's Decision|0|||
125047360|NCT02760407|449793271|FG003|Overall Study|Withdrawal By PI's Decision|0|||
125047361|NCT02760407|449793268|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
125047362|NCT02760407|449793269|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
125047363|NCT02760407|449793270|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
124976283|NCT01509547|449538658|FG001|Overall Study|Lost to Follow-up|14|||
124976284|NCT01509547|449538657|FG000|Overall Study|Withdrawal by Subject|11|||
124976285|NCT01509547|449538658|FG001|Overall Study|Withdrawal by Subject|24|||
124976286|NCT01509547|449538657|FG000|Overall Study|Physician Decision|0|||
124976287|NCT01509547|449538658|FG001|Overall Study|Physician Decision|1|||
124976288|NCT00277095|449538659|FG000|Overall Study|Death|2|||
124976289|NCT00277095|449538659|FG000|Overall Study|Explanted|7|||
124976290|NCT00277095|449538659|FG000|Overall Study|Lost to Follow-up|2|||
124976291|NCT00277095|449538659|FG000|Overall Study|Missed Follow-up|9|||
124976292|NCT00277095|449538659|FG000|Overall Study|Physician Decision|1|||
124976293|NCT04147195|449538660|FG000|Overall Study|Adverse Event|0|||
124976294|NCT04147195|449538661|FG001|Overall Study|Adverse Event|3|||
124976295|NCT04147195|449538660|FG000|Overall Study|Study Terminated by Sponsor|4|||
124976296|NCT04147195|449538661|FG001|Overall Study|Study Terminated by Sponsor|2|||
124976297|NCT04147195|449538660|FG000|Overall Study|Withdrawal by Subject|0|||
124976298|NCT04147195|449538661|FG001|Overall Study|Withdrawal by Subject|1|||
124976299|NCT01006980|449539893|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
124976300|NCT01006980|449539894|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
124976301|NCT01006980|449539893|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
124976302|NCT01006980|449539894|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
124976303|NCT01006980|449539893|FG000|Vemurafenib and Dacarbazine|Death|13|||
124976304|NCT01006980|449539894|FG001|Vemurafenib and Dacarbazine|Death|12|||
124976305|NCT01006980|449539893|FG000|Vemurafenib and Dacarbazine|Progression|257|||
124976306|NCT01006980|449539894|FG001|Vemurafenib and Dacarbazine|Progression|218|||
124976307|NCT01006980|449539893|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
124976308|NCT01006980|449539894|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
124976309|NCT01006980|449539893|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
124976310|NCT01006980|449539894|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
124976311|NCT01006980|449539893|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
124976312|NCT01006980|449539894|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
124976313|NCT01006980|449539893|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
124976314|NCT01006980|449539894|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
124976315|NCT01006980|449539893|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
124976316|NCT01006980|449539894|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
125135968|NCT03261167|450121795|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
124976317|NCT01006980|449539893|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
124976318|NCT01006980|449539894|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
124976319|NCT01006980|449539893|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
125047364|NCT02760407|449793271|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
125047365|NCT02760407|449793268|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
125047366|NCT02760407|449793269|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
125047367|NCT02760407|449793270|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
125047368|NCT02760407|449793271|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
125047369|NCT02760407|449793268|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
125047370|NCT02760407|449793269|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
125047371|NCT02760407|449793270|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
125047372|NCT02760407|449793271|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
125047373|NCT02760407|449793268|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
125047374|NCT02760407|449793269|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
125047375|NCT02760407|449793270|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
125047376|NCT02760407|449793271|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
125047377|NCT02760407|449793268|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
125047378|NCT02760407|449793269|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
125219129|NCT01300247|450429304|FG001|Overall Study|Withdrawal by Subject|0|||
125219130|NCT01300247|450429303|FG000|Overall Study|Non-Compliance|0|||
125219131|NCT01300247|450429304|FG001|Overall Study|Non-Compliance|1|||
125219132|NCT04819438|450429305|FG000|Overall Study|Withdrawal by Subject|1|||
124976320|NCT01006980|449539894|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
124976321|NCT01006980|449539893|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
124976322|NCT01006980|449539894|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
125219133|NCT04819438|450429306|FG001|Overall Study|Withdrawal by Subject|0|||
125219134|NCT04819438|450429305|FG000|Overall Study|Adverse Event|0|||
125219135|NCT04819438|450429306|FG001|Overall Study|Adverse Event|1|||
125219136|NCT04819438|450429305|FG000|Overall Study|Protocol Violation|0|||
124976323|NCT01006980|449539893|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
124976324|NCT01006980|449539894|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
124976325|NCT02706405|449539899|FG000|Overall Study|Death|3|||
124976326|NCT02706405|449539900|FG001|Overall Study|Death|2|||
124976327|NCT02706405|449539901|FG002|Overall Study|Death|0|||
124976328|NCT02706405|449539902|FG003|Overall Study|Death|1|||
124976329|NCT02706405|449539903|FG004|Overall Study|Death|0|||
124976330|NCT02706405|449539904|FG005|Overall Study|Death|0|||
124976331|NCT02706405|449539905|FG006|Overall Study|Death|3|||
124976332|NCT02706405|449539906|FG007|Overall Study|Death|4|||
124976333|NCT02706405|449539899|FG000|Overall Study|Disease progression|0|||
124976334|NCT02706405|449539900|FG001|Overall Study|Disease progression|0|||
124976335|NCT02706405|449539901|FG002|Overall Study|Disease progression|0|||
124976336|NCT02706405|449539902|FG003|Overall Study|Disease progression|0|||
124976337|NCT02706405|449539903|FG004|Overall Study|Disease progression|0|||
124976338|NCT02706405|449539904|FG005|Overall Study|Disease progression|0|||
124976339|NCT02706405|449539905|FG006|Overall Study|Disease progression|0|||
124976340|NCT02706405|449539906|FG007|Overall Study|Disease progression|1|||
124976341|NCT02706405|449539899|FG000|Overall Study|Pt moved to new therapy|0|||
124976342|NCT02706405|449539900|FG001|Overall Study|Pt moved to new therapy|0|||
124976343|NCT02706405|449539901|FG002|Overall Study|Pt moved to new therapy|0|||
124976344|NCT02706405|449539902|FG003|Overall Study|Pt moved to new therapy|0|||
124976345|NCT02706405|449539903|FG004|Overall Study|Pt moved to new therapy|0|||
124976346|NCT02706405|449539904|FG005|Overall Study|Pt moved to new therapy|1|||
124976347|NCT02706405|449539905|FG006|Overall Study|Pt moved to new therapy|0|||
124976348|NCT02706405|449539906|FG007|Overall Study|Pt moved to new therapy|1|||
124976349|NCT02706405|449539899|FG000|Overall Study|Physician Decision|1|||
124976350|NCT02706405|449539900|FG001|Overall Study|Physician Decision|0|||
124976351|NCT02706405|449539901|FG002|Overall Study|Physician Decision|0|||
124976352|NCT02706405|449539902|FG003|Overall Study|Physician Decision|0|||
124976353|NCT02706405|449539903|FG004|Overall Study|Physician Decision|0|||
124976354|NCT02706405|449539904|FG005|Overall Study|Physician Decision|0|||
124976355|NCT02706405|449539905|FG006|Overall Study|Physician Decision|0|||
124976356|NCT02706405|449539906|FG007|Overall Study|Physician Decision|0|||
124976357|NCT01228318|449539907|FG000|Overall Study|Clinic no show to receive intervention|1|||
124976358|NCT01228318|449539908|FG001|Overall Study|Clinic no show to receive intervention|0|||
124976359|NCT01228318|449539907|FG000|Overall Study|Unable to contact|2|||
124976360|NCT01228318|449539908|FG001|Overall Study|Unable to contact|5|||
124976361|NCT01228318|449539907|FG000|Overall Study|Moved|0|||
124976362|NCT01228318|449539908|FG001|Overall Study|Moved|2|||
124976363|NCT01228318|449539907|FG000|Overall Study|Incarcerated|1|||
124976364|NCT01228318|449539908|FG001|Overall Study|Incarcerated|0|||
125219137|NCT04819438|450429306|FG001|Overall Study|Protocol Violation|1|||
125219138|NCT03465709|450429308|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
125219139|NCT03465709|450429308|FG000|Overall Study|Withdrawal by Subject|3|||
125219140|NCT05359952|450429309|FG000|Overall Study|Lost to Follow-up|1|||
125219141|NCT05359952|450429310|FG001|Overall Study|Lost to Follow-up|0|||
125219142|NCT02258659|450429311|FG000|Overall Study|Withdrawal by Subject|1|||
125219143|NCT04892446|450429312|FG000|Overall Study|Death|4|||
125219144|NCT04892446|450429313|FG001|Overall Study|Death|4|||
125219145|NCT04892446|450429314|FG002|Overall Study|Death|0|||
125219146|NCT04892446|450429312|FG000|Overall Study|Withdrew consent|3|||
125219147|NCT04892446|450429313|FG001|Overall Study|Withdrew consent|0|||
125219148|NCT04892446|450429314|FG002|Overall Study|Withdrew consent|1|||
125219149|NCT04892446|450429312|FG000|Overall Study|Investigator's discretion|1|||
125219150|NCT04892446|450429313|FG001|Overall Study|Investigator's discretion|1|||
125219151|NCT04892446|450429314|FG002|Overall Study|Investigator's discretion|0|||
125219152|NCT04892446|450429312|FG000|Overall Study|Study terminated by sponsor|0|||
125219153|NCT04892446|450429313|FG001|Overall Study|Study terminated by sponsor|0|||
125219154|NCT04892446|450429314|FG002|Overall Study|Study terminated by sponsor|2|||
125219155|NCT00272844|450429315|FG000|Overall Study|Withdrawal by Subject|5|||
125219156|NCT03060291|450429316|FG000|3-month Follow-up|Declined to respond|8|||
125219157|NCT03060291|450429317|FG001|3-month Follow-up|Declined to respond|10|||
125219158|NCT03060291|450429318|FG002|3-month Follow-up|Declined to respond|2|||
125219159|NCT03060291|450429316|FG000|6-month Follow-up|Declined to respond|7|||
125219160|NCT03060291|450429317|FG001|6-month Follow-up|Declined to respond|13|||
125219161|NCT03060291|450429318|FG002|6-month Follow-up|Declined to respond|4|||
125219162|NCT03060291|450429316|FG000|12-month Follow-up|Declined to respond|7|||
125219163|NCT03060291|450429317|FG001|12-month Follow-up|Declined to respond|16|||
125219164|NCT03060291|450429318|FG002|12-month Follow-up|Declined to respond|6|||
125219165|NCT01556932|450429322|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
125219166|NCT01556932|450429323|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
125047379|NCT02760407|449793270|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
125047380|NCT02760407|449793271|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
125219167|NCT01882803|450429324|FG000|Overall Study|Disease Progression|1|||
125219168|NCT01882803|450429324|FG000|Overall Study|Withdrawal by Subject|9|||
125219169|NCT01882803|450429324|FG000|Overall Study|Death|68|||
125219170|NCT01882803|450429324|FG000|Overall Study|Physician Decision|3|||
125219171|NCT01882803|450429324|FG000|Overall Study|Lost to Follow-up|3|||
125219172|NCT01882803|450429324|FG000|Overall Study|Follow-up Completed|39|||
125219173|NCT01882803|450429324|FG000|Overall Study|Study Terminated by the Sponsor|6|||
125219174|NCT01563913|450429325|FG000|Overall Study|Physician Decision|1|||
125219175|NCT01563913|450429326|FG001|Overall Study|Physician Decision|0|||
125047381|NCT02760407|449793268|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
125047382|NCT02760407|449793269|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
125047383|NCT02760407|449793270|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
125047384|NCT02760407|449793271|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
125047385|NCT02760407|449793268|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
125047386|NCT02760407|449793269|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
125047387|NCT02760407|449793270|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
125047388|NCT02760407|449793271|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
125047389|NCT02760407|449793268|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
125047390|NCT02760407|449793269|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
125047391|NCT02760407|449793270|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
125047392|NCT02760407|449793271|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
125047393|NCT02760407|449793268|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
125047394|NCT02760407|449793269|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
125047395|NCT02760407|449793270|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
125047396|NCT02760407|449793271|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
125047397|NCT01645930|449793272|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
125219176|NCT01563913|450429325|FG000|Overall Study|Spouse Passed Away|1|||
125219177|NCT01563913|450429326|FG001|Overall Study|Spouse Passed Away|0|||
125219178|NCT00705341|450429327|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
125219179|NCT00705341|450429328|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
125219180|NCT00705341|450429329|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
125219181|NCT00705341|450429330|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
125047398|NCT01645930|449793272|FG000|Overall Study|Progressive Disease|12|||
125047399|NCT01645930|449793272|FG000|Overall Study|Adverse Event|4|||
125047400|NCT01645930|449793272|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
125047401|NCT01645930|449793272|FG000|Overall Study|Withdrawal by Participant|2|||
125047402|NCT01645930|449793272|FG000|Overall Study|Reason not Defined|1|||
125047403|NCT03245814|449793273|FG000|Overall Study|Lost to Follow-up|5|||
125047404|NCT03245814|449793274|FG001|Overall Study|Lost to Follow-up|8|||
125047405|NCT03245814|449793273|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
125047406|NCT03245814|449793274|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
125047407|NCT01158950|449793275|FG000|1st Intervention (1 Day)|Physician Decision|1|||
125047408|NCT01158950|449793276|FG001|1st Intervention (1 Day)|Physician Decision|2|||
125047409|NCT00206518|449793277|FG000|Overall Study|Lack of Efficacy|6|||
125047410|NCT00206518|449793278|FG001|Overall Study|Lack of Efficacy|4|||
125047411|NCT00206518|449793277|FG000|Overall Study|Adverse Event|2|||
125047412|NCT00206518|449793278|FG001|Overall Study|Adverse Event|1|||
125047413|NCT00206518|449793277|FG000|Overall Study|Physician Decision|1|||
125047414|NCT00206518|449793278|FG001|Overall Study|Physician Decision|0|||
125047415|NCT00206518|449793277|FG000|Overall Study|Protocol Violation|1|||
125047416|NCT00206518|449793278|FG001|Overall Study|Protocol Violation|1|||
125047417|NCT02053246|449793289|FG000|Overall Study|Withdrawal by Subject|3|||
125047418|NCT02053246|449793289|FG000|Overall Study|Physician Decision|1|||
125047419|NCT02795156|449793290|FG000|Overall Study|Progressive Disease|22|||
125047420|NCT02795156|449793291|FG001|Overall Study|Progressive Disease|7|||
125047421|NCT02795156|449793292|FG002|Overall Study|Progressive Disease|34|||
125047422|NCT02795156|449793293|FG003|Overall Study|Progressive Disease|7|||
125047423|NCT02795156|449793290|FG000|Overall Study|Adverse Event|13|||
125047424|NCT02795156|449793291|FG001|Overall Study|Adverse Event|2|||
125047425|NCT02795156|449793292|FG002|Overall Study|Adverse Event|3|||
125047426|NCT02795156|449793293|FG003|Overall Study|Adverse Event|2|||
125047427|NCT02795156|449793290|FG000|Overall Study|Death|1|||
125047428|NCT02795156|449793291|FG001|Overall Study|Death|1|||
125047429|NCT02795156|449793292|FG002|Overall Study|Death|1|||
125047430|NCT02795156|449793293|FG003|Overall Study|Death|0|||
125047431|NCT02795156|449793290|FG000|Overall Study|Physician Decision|1|||
125047432|NCT02795156|449793291|FG001|Overall Study|Physician Decision|0|||
125047433|NCT02795156|449793292|FG002|Overall Study|Physician Decision|1|||
125047434|NCT02795156|449793293|FG003|Overall Study|Physician Decision|0|||
125047435|NCT02795156|449793290|FG000|Overall Study|Withdrawal by Subject|2|||
125047436|NCT02795156|449793291|FG001|Overall Study|Withdrawal by Subject|0|||
125047437|NCT02795156|449793292|FG002|Overall Study|Withdrawal by Subject|3|||
125047438|NCT02795156|449793293|FG003|Overall Study|Withdrawal by Subject|0|||
125047439|NCT02707757|449793294|FG000|Overall Study|Protocol Violation|3|||
125047440|NCT02707757|449793295|FG001|Overall Study|Protocol Violation|2|||
125047441|NCT02707757|449793294|FG000|Overall Study|Withdrawal by Subject|2|||
125047442|NCT02707757|449793295|FG001|Overall Study|Withdrawal by Subject|0|||
125047443|NCT02707757|449793294|FG000|Overall Study|Death|0|||
125047444|NCT02707757|449793295|FG001|Overall Study|Death|1|||
125047445|NCT02707757|449793294|FG000|Overall Study|Adverse Event|6|||
125047446|NCT02707757|449793295|FG001|Overall Study|Adverse Event|4|||
125047447|NCT02707757|449793294|FG000|Overall Study|Renal transplant/elective operation|1|||
125047448|NCT02707757|449793295|FG001|Overall Study|Renal transplant/elective operation|5|||
125047449|NCT00638846|449793299|FG000|Overall Study|Adverse Event|0|||
125047450|NCT00638846|449793300|FG001|Overall Study|Adverse Event|1|||
125047451|NCT00638846|449793299|FG000|Overall Study|Lost to Follow-up|3|||
125047452|NCT00638846|449793300|FG001|Overall Study|Lost to Follow-up|2|||
125047453|NCT00638846|449793299|FG000|Overall Study|lens issue|1|||
125047454|NCT00638846|449793300|FG001|Overall Study|lens issue|3|||
125047455|NCT01171521|449793301|FG000|Overall Study|Lost to Follow-up|5|||
125047456|NCT01171521|449793301|FG000|Overall Study|screen failure|1|||
125047457|NCT01589094|449793302|FG000|Overall Study|Did not receive treatment|2|||
125047458|NCT03575468|449793303|FG000|Overall Study|Withdrawal by Subject|3|||
125047459|NCT03575468|449793304|FG001|Overall Study|Withdrawal by Subject|0|||
125047460|NCT03575468|449793303|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
125047461|NCT03575468|449793304|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
125047462|NCT03575468|449793303|FG000|Overall Study|Lost to Follow-up|13|||
125047463|NCT03575468|449793304|FG001|Overall Study|Lost to Follow-up|17|||
125047464|NCT03123939|449793305|FG000|Overall Study|Lack of Efficacy|6|||
125047465|NCT03123939|449793305|FG000|Overall Study|Death|5|||
125047466|NCT03123939|449793305|FG000|Overall Study|Physician Decision|2|||
125047467|NCT03123939|449793305|FG000|Overall Study|Subject/guardian decision|2|||
125047468|NCT03123939|449793305|FG000|Overall Study|Lost to Follow-up|1|||
125047469|NCT03123939|449793305|FG000|Overall Study|New therapy for study indication|1|||
125219182|NCT00705341|450429327|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
125219183|NCT00705341|450429328|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
125047470|NCT03123939|449793305|FG000|Overall Study|Protocol deviation|1|||
125047471|NCT03123939|449793305|FG000|Overall Study|Progressive disease|18|||
125047472|NCT03123939|449793305|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
125047473|NCT03123939|449793305|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
125047474|NCT02112448|449793306|FG000|Overall Study|lab values precluding use of ketorolac|2|||
125047475|NCT02112448|449793307|FG001|Overall Study|lab values precluding use of ketorolac|2|||
125047476|NCT02112448|449793306|FG000|Overall Study|Protocol Violation|1|||
125219184|NCT00705341|450429329|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
125219185|NCT00705341|450429330|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
125219186|NCT00791700|450429331|FG000|Overall Study|Insufficient clinical response|1|||
125219187|NCT00791700|450429332|FG001|Overall Study|Insufficient clinical response|4|||
125219188|NCT00791700|450429333|FG002|Overall Study|Insufficient clinical response|1|||
125047477|NCT02112448|449793307|FG001|Overall Study|Protocol Violation|2|||
125047478|NCT02112448|449793306|FG000|Overall Study|Physician Decision|4|||
125047479|NCT02112448|449793307|FG001|Overall Study|Physician Decision|6|||
125047480|NCT02112448|449793306|FG000|Overall Study|required heparin so could not use ketoro|1|||
125047481|NCT02112448|449793307|FG001|Overall Study|required heparin so could not use ketoro|0|||
125047482|NCT05270694|449794525|FG000|Overall Study|Death|1|||
125047483|NCT05270694|449794525|FG000|Overall Study|Medical issues impacted ability to participate|2|||
125047484|NCT05270694|449794525|FG000|Overall Study|Lost to Follow-up|3|||
125047485|NCT05270694|449794525|FG000|Overall Study|Withdrawal by Subject|3|||
125047486|NCT01991977|449794528|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
125047487|NCT01991977|449794528|FG000|Overall Study|Withdrew after start of treatment|5|||
125047488|NCT02531035|449794535|FG000|Overall Study|Death|0|||
125047489|NCT02531035|449794536|FG001|Overall Study|Death|1|||
125047490|NCT02531035|449794535|FG000|Overall Study|Protocol Violation|1|||
125047491|NCT02531035|449794536|FG001|Overall Study|Protocol Violation|1|||
125047492|NCT02531035|449794535|FG000|Overall Study|Noncompliance with study drug|8|||
125047493|NCT02531035|449794536|FG001|Overall Study|Noncompliance with study drug|3|||
125047494|NCT02531035|449794535|FG000|Overall Study|Physician Decision|1|||
125047495|NCT02531035|449794536|FG001|Overall Study|Physician Decision|0|||
125047496|NCT02531035|449794535|FG000|Overall Study|Adverse Event|16|||
125047497|NCT02531035|449794536|FG001|Overall Study|Adverse Event|45|||
125047498|NCT02531035|449794535|FG000|Overall Study|Other|3|||
125047499|NCT02531035|449794536|FG001|Overall Study|Other|2|||
125047500|NCT02531035|449794535|FG000|Overall Study|Withdrawal by Subject|42|||
125047501|NCT02531035|449794536|FG001|Overall Study|Withdrawal by Subject|32|||
125047502|NCT02531035|449794535|FG000|Overall Study|Lost to Follow-up|8|||
125047503|NCT02531035|449794536|FG001|Overall Study|Lost to Follow-up|10|||
125047504|NCT02531035|449794535|FG000|Overall Study|Randomized, not treated|2|||
125047505|NCT02531035|449794536|FG001|Overall Study|Randomized, not treated|1|||
125047506|NCT03032068|449794546|FG000|Overall Study|Adverse Event|1|||
125047507|NCT01597622|449794547|FG000|Overall Study|Adverse Event|7|||
125047508|NCT01597622|449794547|FG000|Overall Study|Lack of Efficacy|3|||
125047509|NCT01597622|449794547|FG000|Overall Study|Protocol Violation|1|||
125047510|NCT01597622|449794547|FG000|Overall Study|Lost to Follow-up|1|||
125047511|NCT01597622|449794547|FG000|Overall Study|Investigator Discretion|5|||
124976365|NCT01182441|449539913|FG000|Overall Study|Patient Still in Follow-up|152|||
124976366|NCT01182441|449539914|FG001|Overall Study|Patient Still in Follow-up|72|||
124976367|NCT01182441|449539913|FG000|Overall Study|Death|37|||
124976368|NCT01182441|449539914|FG001|Overall Study|Death|25|||
124976369|NCT01182441|449539913|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
124976370|NCT01182441|449539914|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
124976371|NCT01182441|449539913|FG000|Overall Study|Lost to Follow-up|5|||
124976372|NCT01182441|449539914|FG001|Overall Study|Lost to Follow-up|8|||
124976373|NCT01182441|449539913|FG000|Overall Study|Withdrawal by Subject|6|||
124976374|NCT01182441|449539914|FG001|Overall Study|Withdrawal by Subject|13|||
124976375|NCT01182441|449539913|FG000|Overall Study|Implant Not Attempted|4|||
124976376|NCT01182441|449539914|FG001|Overall Study|Implant Not Attempted|0|||
124976377|NCT01182441|449539913|FG000|Overall Study|Adverse Event|2|||
125047512|NCT01597622|449794547|FG000|Overall Study|Withdrawal by Subject|20|||
124976378|NCT01182441|449539914|FG001|Overall Study|Adverse Event|0|||
124976379|NCT01182441|449539913|FG000|Overall Study|Physician Decision|1|||
125047513|NCT01597622|449794547|FG000|Overall Study|Death|1|||
125047514|NCT03567291|449794552|FG000|Period I|Adverse Event|14|||
124976380|NCT01182441|449539914|FG001|Overall Study|Physician Decision|1|||
124976381|NCT02124811|449539915|FG000|Overall Study|Early termination|2|||
124976382|NCT02124811|449539916|FG001|Overall Study|Early termination|2|||
124976383|NCT02124811|449539915|FG000|Overall Study|Withdrawal by Subject|1|||
125047515|NCT03567291|449794553|FG001|Period I|Adverse Event|0|||
125047516|NCT03567291|449794554|FG002|Period I|Adverse Event|0|||
125047517|NCT03567291|449794555|FG003|Period I|Adverse Event|0|||
125047518|NCT03567291|449794552|FG000|Period I|Protocol Violation|1|||
124976384|NCT02124811|449539916|FG001|Overall Study|Withdrawal by Subject|0|||
124976385|NCT04043143|449539917|FG000|Overall Study|Lost to Follow-up|5|||
124976386|NCT04043143|449539918|FG001|Overall Study|Lost to Follow-up|5|||
124976387|NCT04043143|449539917|FG000|Overall Study|screen failure|1|||
124976388|NCT04043143|449539918|FG001|Overall Study|screen failure|0|||
124976389|NCT03480932|449539919|FG000|Overall Study|Death|1|||
124976390|NCT03480932|449539920|FG001|Overall Study|Death|1|||
124976391|NCT03480932|449539921|FG002|Overall Study|Death|0|||
124976392|NCT03480932|449539919|FG000|Overall Study|Lost to Follow-up|0|||
125219189|NCT00791700|450429334|FG003|Overall Study|Insufficient clinical response|8|||
125219190|NCT00791700|450429331|FG000|Overall Study|No longer willing to participate|1|||
125219191|NCT00791700|450429332|FG001|Overall Study|No longer willing to participate|1|||
125219192|NCT00791700|450429333|FG002|Overall Study|No longer willing to participate|0|||
125219193|NCT00791700|450429334|FG003|Overall Study|No longer willing to participate|8|||
125219194|NCT00791700|450429331|FG000|Overall Study|Non-compliance with study treatment|0|||
125219195|NCT00791700|450429332|FG001|Overall Study|Non-compliance with study treatment|2|||
125219196|NCT00791700|450429333|FG002|Overall Study|Non-compliance with study treatment|0|||
125219197|NCT00791700|450429334|FG003|Overall Study|Non-compliance with study treatment|4|||
125219198|NCT00791700|450429331|FG000|Overall Study|Withdrawn due to pregnancy|0|||
125219199|NCT00791700|450429332|FG001|Overall Study|Withdrawn due to pregnancy|0|||
125219200|NCT00791700|450429333|FG002|Overall Study|Withdrawn due to pregnancy|0|||
125219201|NCT00791700|450429334|FG003|Overall Study|Withdrawn due to pregnancy|1|||
125219202|NCT00791700|450429331|FG000|Overall Study|Other|0|||
125219203|NCT00791700|450429332|FG001|Overall Study|Other|1|||
125047519|NCT03567291|449794553|FG001|Period I|Protocol Violation|0|||
125047520|NCT03567291|449794554|FG002|Period I|Protocol Violation|0|||
125047521|NCT03567291|449794555|FG003|Period I|Protocol Violation|0|||
125047522|NCT03567291|449794552|FG000|Period I|Withdrawal by Subject|23|||
125047523|NCT03567291|449794553|FG001|Period I|Withdrawal by Subject|0|||
125047524|NCT03567291|449794554|FG002|Period I|Withdrawal by Subject|0|||
125047525|NCT03567291|449794555|FG003|Period I|Withdrawal by Subject|0|||
125047526|NCT03567291|449794552|FG000|Period I|Lost to Follow-up|2|||
125047527|NCT03567291|449794553|FG001|Period I|Lost to Follow-up|0|||
125047528|NCT03567291|449794554|FG002|Period I|Lost to Follow-up|0|||
125047529|NCT03567291|449794555|FG003|Period I|Lost to Follow-up|0|||
125047530|NCT03567291|449794552|FG000|Period I|Terminated by sponsor|44|||
125047531|NCT03567291|449794553|FG001|Period I|Terminated by sponsor|0|||
125047532|NCT03567291|449794554|FG002|Period I|Terminated by sponsor|0|||
125047533|NCT03567291|449794555|FG003|Period I|Terminated by sponsor|0|||
125047534|NCT03567291|449794552|FG000|Period I|Missing or unknown|7|||
125047535|NCT03567291|449794553|FG001|Period I|Missing or unknown|0|||
125047536|NCT03567291|449794554|FG002|Period I|Missing or unknown|0|||
125047537|NCT03567291|449794555|FG003|Period I|Missing or unknown|0|||
125047538|NCT03567291|449794552|FG000|Period II|Adverse Event|0|||
125047539|NCT03567291|449794553|FG001|Period II|Adverse Event|1|||
125047540|NCT03567291|449794554|FG002|Period II|Adverse Event|0|||
125047541|NCT03567291|449794555|FG003|Period II|Adverse Event|0|||
125047542|NCT03567291|449794552|FG000|Period II|Missing or unknown|0|||
125047543|NCT03567291|449794553|FG001|Period II|Missing or unknown|2|||
125047544|NCT03567291|449794554|FG002|Period II|Missing or unknown|1|||
125047545|NCT03567291|449794555|FG003|Period II|Missing or unknown|0|||
125047546|NCT03567291|449794552|FG000|Period III|Adverse Event|0|||
125047547|NCT03567291|449794553|FG001|Period III|Adverse Event|0|||
125219204|NCT00791700|450429333|FG002|Overall Study|Other|0|||
125047548|NCT03567291|449794554|FG002|Period III|Adverse Event|0|||
125047549|NCT03567291|449794555|FG003|Period III|Adverse Event|4|||
125047550|NCT03567291|449794552|FG000|Period III|Withdrawal by Subject|0|||
125047551|NCT03567291|449794553|FG001|Period III|Withdrawal by Subject|0|||
125047552|NCT03567291|449794554|FG002|Period III|Withdrawal by Subject|0|||
125047553|NCT03567291|449794555|FG003|Period III|Withdrawal by Subject|4|||
125047554|NCT03567291|449794552|FG000|Period III|Lost to Follow-up|0|||
125047555|NCT03567291|449794553|FG001|Period III|Lost to Follow-up|0|||
124976393|NCT03480932|449539920|FG001|Overall Study|Lost to Follow-up|2|||
125047556|NCT03567291|449794554|FG002|Period III|Lost to Follow-up|0|||
125047557|NCT03567291|449794555|FG003|Period III|Lost to Follow-up|1|||
124976394|NCT03480932|449539921|FG002|Overall Study|Lost to Follow-up|3|||
124976395|NCT03480932|449539919|FG000|Overall Study|Incarcerated|2|||
124976396|NCT03480932|449539920|FG001|Overall Study|Incarcerated|2|||
125219205|NCT00791700|450429334|FG003|Overall Study|Other|1|||
125219206|NCT00791700|450429331|FG000|Overall Study|Death|0|||
125047558|NCT03567291|449794552|FG000|Period III|Terminated by sponsor|0|||
125047559|NCT03567291|449794553|FG001|Period III|Terminated by sponsor|0|||
125047560|NCT03567291|449794554|FG002|Period III|Terminated by sponsor|0|||
125047561|NCT03567291|449794555|FG003|Period III|Terminated by sponsor|68|||
124976397|NCT03480932|449539921|FG002|Overall Study|Incarcerated|2|||
125047562|NCT03567291|449794552|FG000|Period III|Missing or unknown|0|||
125047563|NCT03567291|449794553|FG001|Period III|Missing or unknown|0|||
124976398|NCT02138786|449539924|FG000|Overall Study|Adverse Event|0|||
124976399|NCT02138786|449539925|FG001|Overall Study|Adverse Event|2|||
124976400|NCT02138786|449539926|FG002|Overall Study|Adverse Event|1|||
124976401|NCT02138786|449539924|FG000|Overall Study|Death|1|||
124976402|NCT02138786|449539925|FG001|Overall Study|Death|7|||
124976403|NCT02138786|449539926|FG002|Overall Study|Death|2|||
124976404|NCT02138786|449539924|FG000|Overall Study|Disease Progression|1|||
124976405|NCT02138786|449539925|FG001|Overall Study|Disease Progression|1|||
124976406|NCT02138786|449539926|FG002|Overall Study|Disease Progression|3|||
124976407|NCT02138786|449539924|FG000|Overall Study|Withdrawal by Subject|1|||
124976408|NCT02138786|449539925|FG001|Overall Study|Withdrawal by Subject|2|||
124976409|NCT02138786|449539926|FG002|Overall Study|Withdrawal by Subject|0|||
124976410|NCT02138786|449539924|FG000|Overall Study|Patient's Wish|0|||
124976411|NCT02138786|449539925|FG001|Overall Study|Patient's Wish|2|||
124976412|NCT02138786|449539926|FG002|Overall Study|Patient's Wish|0|||
124976413|NCT02138786|449539924|FG000|Overall Study|Sponsor Terminated Study|0|||
124976414|NCT02138786|449539925|FG001|Overall Study|Sponsor Terminated Study|1|||
124976415|NCT02138786|449539926|FG002|Overall Study|Sponsor Terminated Study|1|||
124976416|NCT02138786|449539924|FG000|Overall Study|Non-Compliance|0|||
124976417|NCT02138786|449539925|FG001|Overall Study|Non-Compliance|0|||
124976418|NCT02138786|449539926|FG002|Overall Study|Non-Compliance|1|||
124976419|NCT01923662|449539927|FG000|Overall Study|Withdrawal by Subject|1|||
124976420|NCT00659880|449539928|FG000|Overall Study|Lost to Follow-up|5|||
124976421|NCT00669877|449539935|FG000|Overall Study|Disease Progression/Death|4|||
124976422|NCT01465763|449539936|FG000|Overall Study|Withdrawal by Subject|4|||
124976423|NCT01465763|449539937|FG001|Overall Study|Withdrawal by Subject|0|||
124976424|NCT01465763|449539938|FG002|Overall Study|Withdrawal by Subject|1|||
124976425|NCT01465763|449539936|FG000|Overall Study|Insufficient Clinical Response|11|||
124976426|NCT01465763|449539937|FG001|Overall Study|Insufficient Clinical Response|0|||
124976427|NCT01465763|449539938|FG002|Overall Study|Insufficient Clinical Response|1|||
124976428|NCT01465763|449539936|FG000|Overall Study|Adverse Event|9|||
124976429|NCT01465763|449539937|FG001|Overall Study|Adverse Event|0|||
124976430|NCT01465763|449539938|FG002|Overall Study|Adverse Event|1|||
124976431|NCT01465763|449539936|FG000|Overall Study|Other|2|||
124976432|NCT01465763|449539937|FG001|Overall Study|Other|0|||
124976433|NCT01465763|449539938|FG002|Overall Study|Other|0|||
124976434|NCT01465763|449539936|FG000|Overall Study|Protocol Violation|4|||
124976435|NCT01465763|449539937|FG001|Overall Study|Protocol Violation|1|||
124976436|NCT01465763|449539938|FG002|Overall Study|Protocol Violation|1|||
124976437|NCT01465763|449539936|FG000|Overall Study|Death|1|||
124976438|NCT01465763|449539937|FG001|Overall Study|Death|0|||
124976439|NCT01465763|449539938|FG002|Overall Study|Death|0|||
124976440|NCT02920970|449539939|FG000|First Intervention|Protocol Violation|0|||
124976441|NCT02920970|449539940|FG001|First Intervention|Protocol Violation|1|||
124976442|NCT02920970|449539939|FG000|First Intervention|Adverse Event|0|||
124976443|NCT02920970|449539940|FG001|First Intervention|Adverse Event|1|||
124976444|NCT02920970|449539939|FG000|Second Intervention|Poor Lens Fit|1|||
124976445|NCT02920970|449539940|FG001|Second Intervention|Poor Lens Fit|0|||
124976446|NCT01711853|449539942|FG000|Overall Study|Not treated|3|||
124976447|NCT02992691|449539947|FG000|Overall Study|Adverse Event|2|||
124976448|NCT02992691|449539947|FG000|Overall Study|Withdrawal by Subject|1|||
124976449|NCT01427725|449539948|FG000|Overall Study|Lost to Follow-up|17|||
124976450|NCT01427725|449539948|FG000|Overall Study|Protocol Violation|1|||
124976451|NCT01427725|449539948|FG000|Overall Study|Drug not administered|1|||
124976452|NCT01427725|449539948|FG000|Overall Study|Failure to visit|7|||
124976453|NCT01427725|449539948|FG000|Overall Study|Adverse Event|46|||
124976454|NCT01427725|449539948|FG000|Overall Study|Failure to visit after administration|40|||
124976455|NCT01427725|449539948|FG000|Overall Study|Patient's rejection|27|||
124976456|NCT01427725|449539948|FG000|Overall Study|Transfer to a different hospital|17|||
124976457|NCT01427725|449539948|FG000|Overall Study|Lack of Efficacy|8|||
124976458|NCT01427725|449539948|FG000|Overall Study|Death|7|||
124976459|NCT01427725|449539948|FG000|Overall Study|Symptom improvement|6|||
124976460|NCT01427725|449539948|FG000|Overall Study|AE and Patient's rejection|5|||
124976461|NCT01427725|449539948|FG000|Overall Study|Physician Decision|5|||
124976462|NCT01427725|449539948|FG000|Overall Study|Exacerbation of underlying disease|5|||
124976463|NCT01427725|449539948|FG000|Overall Study|Oral feeding difficulty|5|||
124976464|NCT01427725|449539948|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
124976465|NCT01427725|449539948|FG000|Overall Study|Forgetting prescription|1|||
124976466|NCT01427725|449539948|FG000|Overall Study|Other|2|||
124976467|NCT04276051|449539950|FG000|Overall Study|Lost to Follow-up|0|||
124976468|NCT04276051|449539951|FG001|Overall Study|Lost to Follow-up|1|||
124976469|NCT04276051|449539950|FG000|Overall Study|Physician Decision|0|||
124976470|NCT04276051|449539951|FG001|Overall Study|Physician Decision|1|||
124976471|NCT04276051|449539950|FG000|Overall Study|Withdrawal by Subject|1|||
125047564|NCT03567291|449794554|FG002|Period III|Missing or unknown|0|||
125047565|NCT03567291|449794555|FG003|Period III|Missing or unknown|8|||
125047566|NCT01103349|449794556|FG000|Overall Study|Adverse Event|8|||
125047567|NCT01103349|449794557|FG001|Overall Study|Adverse Event|5|||
125047568|NCT01103349|449794558|FG002|Overall Study|Adverse Event|3|||
125047569|NCT01103349|449794556|FG000|Overall Study|Consent withdrawn|1|||
125047570|NCT01103349|449794557|FG001|Overall Study|Consent withdrawn|0|||
125047571|NCT01103349|449794558|FG002|Overall Study|Consent withdrawn|0|||
125047572|NCT01103349|449794556|FG000|Overall Study|Incorrectly included in the trial|1|||
125047573|NCT01103349|449794557|FG001|Overall Study|Incorrectly included in the trial|0|||
125047574|NCT01103349|449794558|FG002|Overall Study|Incorrectly included in the trial|0|||
125047575|NCT01103349|449794556|FG000|Overall Study|Withdrawal by Subject|1|||
125047576|NCT01103349|449794557|FG001|Overall Study|Withdrawal by Subject|1|||
125047577|NCT01103349|449794558|FG002|Overall Study|Withdrawal by Subject|0|||
125047578|NCT01103349|449794556|FG000|Overall Study|did not want to take trial medication|0|||
125047579|NCT01103349|449794557|FG001|Overall Study|did not want to take trial medication|1|||
125047580|NCT01103349|449794558|FG002|Overall Study|did not want to take trial medication|0|||
125047581|NCT01103349|449794556|FG000|Overall Study|forgot to take medication|0|||
125047582|NCT01103349|449794557|FG001|Overall Study|forgot to take medication|0|||
125047583|NCT01103349|449794558|FG002|Overall Study|forgot to take medication|1|||
125047584|NCT00090285|449794559|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
125047585|NCT00090285|449794560|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
125047586|NCT00090285|449794561|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
125047587|NCT00090285|449794562|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
125047588|NCT00090285|449794563|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
125047589|NCT00090285|449794564|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
125047590|NCT00090285|449794559|FG000|Base Study Vaccination Period|Adverse Event|2|||
125047591|NCT00090285|449794560|FG001|Base Study Vaccination Period|Adverse Event|4|||
125047592|NCT00090285|449794561|FG002|Base Study Vaccination Period|Adverse Event|0|||
125047593|NCT00090285|449794562|FG003|Base Study Vaccination Period|Adverse Event|0|||
125047594|NCT00090285|449794563|FG004|Base Study Vaccination Period|Adverse Event|0|||
125047595|NCT00090285|449794564|FG005|Base Study Vaccination Period|Adverse Event|0|||
125047596|NCT00090285|449794559|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
125047597|NCT00090285|449794560|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
125047598|NCT00090285|449794561|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
125047599|NCT00090285|449794562|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
125047600|NCT00090285|449794563|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
125047601|NCT00090285|449794564|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
125047602|NCT00090285|449794559|FG000|Base Study Vaccination Period|Protocol Violation|2|||
125047603|NCT00090285|449794560|FG001|Base Study Vaccination Period|Protocol Violation|3|||
125047604|NCT00090285|449794561|FG002|Base Study Vaccination Period|Protocol Violation|0|||
125047605|NCT00090285|449794562|FG003|Base Study Vaccination Period|Protocol Violation|0|||
125047606|NCT00090285|449794563|FG004|Base Study Vaccination Period|Protocol Violation|0|||
125047607|NCT00090285|449794564|FG005|Base Study Vaccination Period|Protocol Violation|0|||
125047608|NCT00090285|449794559|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
125047609|NCT00090285|449794560|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
125047610|NCT00090285|449794561|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
125047611|NCT00090285|449794562|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
125047612|NCT00090285|449794563|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
125047613|NCT00090285|449794564|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
125047614|NCT00090285|449794559|FG000|Base Study Vaccination Period|Uncooperative|2|||
125047615|NCT00090285|449794560|FG001|Base Study Vaccination Period|Uncooperative|2|||
125047616|NCT00090285|449794561|FG002|Base Study Vaccination Period|Uncooperative|0|||
125047617|NCT00090285|449794562|FG003|Base Study Vaccination Period|Uncooperative|0|||
124976472|NCT04276051|449539951|FG001|Overall Study|Withdrawal by Subject|1|||
124976473|NCT00392925|449539952|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
124976474|NCT00392925|449539953|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
124976475|NCT00392925|449539954|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
124976476|NCT00392925|449539955|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
124976477|NCT00392925|449539952|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
124976478|NCT00392925|449539953|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
124976479|NCT00392925|449539954|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
124976480|NCT00392925|449539955|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
124976481|NCT00392925|449539952|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
124976482|NCT00392925|449539953|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
124976483|NCT00392925|449539954|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
124976484|NCT00392925|449539955|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
124976485|NCT00392925|449539952|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
124976486|NCT00392925|449539953|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
125047618|NCT00090285|449794563|FG004|Base Study Vaccination Period|Uncooperative|0|||
125047619|NCT00090285|449794564|FG005|Base Study Vaccination Period|Uncooperative|0|||
125047620|NCT00090285|449794559|FG000|Base Study Vaccination Period|Moved|20|||
125047621|NCT00090285|449794560|FG001|Base Study Vaccination Period|Moved|21|||
125047622|NCT00090285|449794561|FG002|Base Study Vaccination Period|Moved|0|||
125047623|NCT00090285|449794562|FG003|Base Study Vaccination Period|Moved|0|||
125047624|NCT00090285|449794563|FG004|Base Study Vaccination Period|Moved|0|||
125047625|NCT00090285|449794564|FG005|Base Study Vaccination Period|Moved|0|||
124976487|NCT00392925|449539954|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
124976488|NCT00392925|449539955|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
124976489|NCT00392925|449539952|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
124976490|NCT00392925|449539953|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
124976491|NCT00392925|449539954|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
124976492|NCT00392925|449539955|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
124976493|NCT00392925|449539952|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
124976494|NCT00392925|449539953|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
124976495|NCT00392925|449539954|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
124976496|NCT00392925|449539955|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
124976497|NCT00392925|449539952|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
124976498|NCT00392925|449539953|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
124976499|NCT00392925|449539954|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
124976500|NCT00392925|449539955|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
124976501|NCT00392925|449539952|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
124976502|NCT00392925|449539953|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
124976503|NCT00392925|449539954|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
124976504|NCT00392925|449539955|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
124976505|NCT00392925|449539952|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
124976506|NCT00392925|449539953|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
124976507|NCT00392925|449539954|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
124976508|NCT00392925|449539955|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
124976509|NCT01281839|449539957|FG000|Overall Study|Lost to Follow-up|6|||
124976510|NCT01281839|449539958|FG001|Overall Study|Lost to Follow-up|3|||
124976511|NCT01281839|449539957|FG000|Overall Study|Withdrawal by Subject|4|||
124976512|NCT01281839|449539958|FG001|Overall Study|Withdrawal by Subject|10|||
124976513|NCT01281839|449539957|FG000|Overall Study|Reason not specified|0|||
124976514|NCT01281839|449539958|FG001|Overall Study|Reason not specified|1|||
124976515|NCT01277887|449539959|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
124976516|NCT01277887|449539960|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
124976517|NCT01277887|449539959|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
124976518|NCT01277887|449539960|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
124976519|NCT01277887|449539959|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
124976520|NCT01277887|449539960|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
124976521|NCT00415051|449539961|FG000|Overall Study|Protocol Violation|1|||
124976522|NCT00780559|449539962|FG000|Overall Study|Lost to Follow-up|2|||
124976523|NCT00780559|449539963|FG001|Overall Study|Lost to Follow-up|7|||
124976524|NCT00780559|449539962|FG000|Overall Study|Death|1|||
124976525|NCT00780559|449539963|FG001|Overall Study|Death|0|||
124976526|NCT04462289|449539966|FG000|Overall Study|Lost to Follow-up|4|||
124976527|NCT04462289|449539967|FG001|Overall Study|Lost to Follow-up|5|||
124976528|NCT04462289|449539966|FG000|Overall Study|Death|0|||
124976529|NCT04462289|449539967|FG001|Overall Study|Death|3|||
124976530|NCT04462289|449539966|FG000|Overall Study|Withdrawal by Subject|1|||
124976531|NCT04462289|449539967|FG001|Overall Study|Withdrawal by Subject|3|||
125219207|NCT00791700|450429332|FG001|Overall Study|Death|0|||
125219208|NCT00791700|450429333|FG002|Overall Study|Death|0|||
124976532|NCT01518153|449539968|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
124976533|NCT01518153|449539969|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
124976534|NCT01518153|449539970|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
125047626|NCT00090285|449794559|FG000|Base Study Vaccination Period|Site Terminated|1|||
125219209|NCT00791700|450429334|FG003|Overall Study|Death|1|||
125219210|NCT00791700|450429331|FG000|Overall Study|Lost to Follow-up|4|||
125047627|NCT00090285|449794560|FG001|Base Study Vaccination Period|Site Terminated|0|||
125047628|NCT00090285|449794561|FG002|Base Study Vaccination Period|Site Terminated|0|||
125047629|NCT00090285|449794562|FG003|Base Study Vaccination Period|Site Terminated|0|||
125047630|NCT00090285|449794563|FG004|Base Study Vaccination Period|Site Terminated|0|||
125047631|NCT00090285|449794564|FG005|Base Study Vaccination Period|Site Terminated|0|||
125047632|NCT00090285|449794559|FG000|Base Study Vaccination Period|Other|2|||
125047633|NCT00090285|449794560|FG001|Base Study Vaccination Period|Other|2|||
125047634|NCT00090285|449794561|FG002|Base Study Vaccination Period|Other|0|||
125047635|NCT00090285|449794562|FG003|Base Study Vaccination Period|Other|0|||
125047636|NCT00090285|449794563|FG004|Base Study Vaccination Period|Other|0|||
125047637|NCT00090285|449794564|FG005|Base Study Vaccination Period|Other|0|||
125047638|NCT00090285|449794559|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
125047639|NCT00090285|449794560|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
125047640|NCT00090285|449794561|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
125047641|NCT00090285|449794562|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
125047642|NCT00090285|449794563|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
125047643|NCT00090285|449794564|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
125047644|NCT00090285|449794559|FG000|Base Study Vaccination Period|HIV positive|1|||
125047645|NCT00090285|449794560|FG001|Base Study Vaccination Period|HIV positive|1|||
125047646|NCT00090285|449794561|FG002|Base Study Vaccination Period|HIV positive|0|||
125047647|NCT00090285|449794562|FG003|Base Study Vaccination Period|HIV positive|0|||
125047648|NCT00090285|449794563|FG004|Base Study Vaccination Period|HIV positive|0|||
125047649|NCT00090285|449794564|FG005|Base Study Vaccination Period|HIV positive|0|||
125047650|NCT00090285|449794559|FG000|Base Study Follow-up Period|Adverse Event|3|||
125047651|NCT00090285|449794560|FG001|Base Study Follow-up Period|Adverse Event|10|||
125047652|NCT00090285|449794561|FG002|Base Study Follow-up Period|Adverse Event|0|||
125047653|NCT00090285|449794562|FG003|Base Study Follow-up Period|Adverse Event|0|||
125047654|NCT00090285|449794563|FG004|Base Study Follow-up Period|Adverse Event|0|||
125047655|NCT00090285|449794564|FG005|Base Study Follow-up Period|Adverse Event|0|||
125047656|NCT00090285|449794559|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
125047657|NCT00090285|449794560|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
125047658|NCT00090285|449794561|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
125047659|NCT00090285|449794562|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
125047660|NCT00090285|449794563|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
125047661|NCT00090285|449794564|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
125047662|NCT00090285|449794559|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
125047663|NCT00090285|449794560|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
125047664|NCT00090285|449794561|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
125047665|NCT00090285|449794562|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
125047666|NCT00090285|449794563|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
125047667|NCT00090285|449794564|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
125047668|NCT00090285|449794559|FG000|Base Study Follow-up Period|Moved|41|||
125047669|NCT00090285|449794560|FG001|Base Study Follow-up Period|Moved|36|||
125047670|NCT00090285|449794561|FG002|Base Study Follow-up Period|Moved|0|||
125047671|NCT00090285|449794562|FG003|Base Study Follow-up Period|Moved|0|||
125047672|NCT00090285|449794563|FG004|Base Study Follow-up Period|Moved|0|||
125047673|NCT00090285|449794564|FG005|Base Study Follow-up Period|Moved|0|||
125047674|NCT00090285|449794559|FG000|Base Study Follow-up Period|Other|2|||
125047675|NCT00090285|449794560|FG001|Base Study Follow-up Period|Other|0|||
125047676|NCT00090285|449794561|FG002|Base Study Follow-up Period|Other|0|||
125047677|NCT00090285|449794562|FG003|Base Study Follow-up Period|Other|0|||
125047678|NCT00090285|449794563|FG004|Base Study Follow-up Period|Other|0|||
125047679|NCT00090285|449794564|FG005|Base Study Follow-up Period|Other|0|||
125047680|NCT00090285|449794559|FG000|Base Study Follow-up Period|Protocol Violation|1|||
125047681|NCT00090285|449794560|FG001|Base Study Follow-up Period|Protocol Violation|0|||
125047682|NCT00090285|449794561|FG002|Base Study Follow-up Period|Protocol Violation|0|||
125047683|NCT00090285|449794562|FG003|Base Study Follow-up Period|Protocol Violation|0|||
125047684|NCT00090285|449794563|FG004|Base Study Follow-up Period|Protocol Violation|0|||
125135969|NCT03199963|450121798|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
125135970|NCT03199963|450121799|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
125135971|NCT03199963|450121798|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
125135972|NCT03199963|450121799|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
125135973|NCT03199963|450121798|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
125135974|NCT03199963|450121799|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
125135975|NCT03199963|450121798|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
125047685|NCT00090285|449794564|FG005|Base Study Follow-up Period|Protocol Violation|0|||
125047686|NCT00090285|449794559|FG000|Base Study Follow-up Period|Uncooperative|3|||
125047687|NCT00090285|449794560|FG001|Base Study Follow-up Period|Uncooperative|4|||
125047688|NCT00090285|449794561|FG002|Base Study Follow-up Period|Uncooperative|0|||
125047689|NCT00090285|449794562|FG003|Base Study Follow-up Period|Uncooperative|0|||
125047690|NCT00090285|449794563|FG004|Base Study Follow-up Period|Uncooperative|0|||
125047691|NCT00090285|449794564|FG005|Base Study Follow-up Period|Uncooperative|0|||
125047692|NCT00090285|449794559|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
125047693|NCT00090285|449794560|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
125047694|NCT00090285|449794561|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
125047695|NCT00090285|449794562|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
124976535|NCT01518153|449539968|FG000|Stem Cell Transplant|Death|2|||
124976536|NCT01518153|449539969|FG001|Stem Cell Transplant|Death|0|||
124976537|NCT01518153|449539970|FG002|Stem Cell Transplant|Death|0|||
124976538|NCT01518153|449539968|FG000|Stem Cell Transplant|Secondary graft failure|1|||
124976539|NCT01518153|449539969|FG001|Stem Cell Transplant|Secondary graft failure|0|||
124976540|NCT01518153|449539970|FG002|Stem Cell Transplant|Secondary graft failure|0|||
124976541|NCT01518153|449539968|FG000|Stem Cell Transplant|Adverse Event|1|||
124976542|NCT01518153|449539969|FG001|Stem Cell Transplant|Adverse Event|0|||
124976543|NCT01518153|449539970|FG002|Stem Cell Transplant|Adverse Event|0|||
124976544|NCT01518153|449539968|FG000|Donor Lymphocyte Infusion|Death|0|||
124976545|NCT01518153|449539969|FG001|Donor Lymphocyte Infusion|Death|2|||
124976546|NCT01518153|449539970|FG002|Donor Lymphocyte Infusion|Death|1|||
124976547|NCT00856245|449539971|FG000|Overall Study|Was not transplanted|5|||
124976548|NCT02514551|449539975|FG000|Overall Study|Lost to Follow-up|0|||
124976549|NCT02514551|449539976|FG001|Overall Study|Lost to Follow-up|1|||
124976550|NCT02514551|449539975|FG000|Overall Study|Participant Never Treated|0|||
124976551|NCT02514551|449539976|FG001|Overall Study|Participant Never Treated|2|||
124976552|NCT02998476|449539999|FG000|Overall Study|Lost to Follow-up|1|||
124976553|NCT02998476|449540000|FG001|Overall Study|Lost to Follow-up|0|||
124976554|NCT02998476|449539999|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
124976555|NCT02998476|449540000|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
124976556|NCT02998476|449539999|FG000|Overall Study|Withdrawal by Subject|1|||
124976557|NCT02998476|449540000|FG001|Overall Study|Withdrawal by Subject|2|||
124976558|NCT02998476|449539999|FG000|Overall Study|Death|45|||
124976559|NCT02998476|449540000|FG001|Overall Study|Death|2|||
124976560|NCT02998476|449539999|FG000|Overall Study|Other|6|||
124976561|NCT02998476|449540000|FG001|Overall Study|Other|1|||
124976562|NCT03832595|449540001|FG000|Overall Study|Death|142|||
124976563|NCT03832595|449540002|FG001|Overall Study|Death|130|||
125047696|NCT00090285|449794563|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
125047697|NCT00090285|449794564|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
125047698|NCT00090285|449794559|FG000|Extension 1|Adverse Event|0|||
125047699|NCT00090285|449794560|FG001|Extension 1|Adverse Event|0|||
125047700|NCT00090285|449794561|FG002|Extension 1|Adverse Event|2|||
125047701|NCT00090285|449794562|FG003|Extension 1|Adverse Event|0|||
125047702|NCT00090285|449794563|FG004|Extension 1|Adverse Event|0|||
125047703|NCT00090285|449794564|FG005|Extension 1|Adverse Event|0|||
125047704|NCT00090285|449794559|FG000|Extension 1|Lost to Follow-up|0|||
125047705|NCT00090285|449794560|FG001|Extension 1|Lost to Follow-up|0|||
125047706|NCT00090285|449794561|FG002|Extension 1|Lost to Follow-up|35|||
125047707|NCT00090285|449794562|FG003|Extension 1|Lost to Follow-up|0|||
125047708|NCT00090285|449794563|FG004|Extension 1|Lost to Follow-up|0|||
125047709|NCT00090285|449794564|FG005|Extension 1|Lost to Follow-up|0|||
125047710|NCT00090285|449794559|FG000|Extension 1|Withdrawal by Subject|0|||
125047711|NCT00090285|449794560|FG001|Extension 1|Withdrawal by Subject|0|||
125047712|NCT00090285|449794561|FG002|Extension 1|Withdrawal by Subject|13|||
125047713|NCT00090285|449794562|FG003|Extension 1|Withdrawal by Subject|1|||
125047714|NCT00090285|449794563|FG004|Extension 1|Withdrawal by Subject|0|||
125047715|NCT00090285|449794564|FG005|Extension 1|Withdrawal by Subject|0|||
125047716|NCT00090285|449794559|FG000|Extension 1|Other|0|||
125047717|NCT00090285|449794560|FG001|Extension 1|Other|0|||
125047718|NCT00090285|449794561|FG002|Extension 1|Other|4|||
125047719|NCT00090285|449794562|FG003|Extension 1|Other|0|||
125047720|NCT00090285|449794563|FG004|Extension 1|Other|0|||
125047721|NCT00090285|449794564|FG005|Extension 1|Other|0|||
125047722|NCT00090285|449794559|FG000|Extension 1|Moved|0|||
125047723|NCT00090285|449794560|FG001|Extension 1|Moved|0|||
125047724|NCT00090285|449794561|FG002|Extension 1|Moved|3|||
125047725|NCT00090285|449794562|FG003|Extension 1|Moved|0|||
125047726|NCT00090285|449794563|FG004|Extension 1|Moved|0|||
125047727|NCT00090285|449794564|FG005|Extension 1|Moved|0|||
125047728|NCT00090285|449794559|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
125219211|NCT00791700|450429332|FG001|Overall Study|Lost to Follow-up|3|||
125219212|NCT00791700|450429333|FG002|Overall Study|Lost to Follow-up|4|||
125219213|NCT00791700|450429334|FG003|Overall Study|Lost to Follow-up|6|||
125219214|NCT00791700|450429331|FG000|Overall Study|Adverse Event|0|||
125047729|NCT00090285|449794560|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
125047730|NCT00090285|449794561|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
125047731|NCT00090285|449794562|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
125047732|NCT00090285|449794563|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
125047733|NCT00090285|449794564|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
125047734|NCT00090285|449794559|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
125047735|NCT00090285|449794560|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
125047736|NCT00090285|449794561|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
125047737|NCT00090285|449794562|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
125047738|NCT00090285|449794563|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
125047739|NCT00090285|449794564|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
125047740|NCT00090285|449794559|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
125047741|NCT00090285|449794560|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
125047742|NCT00090285|449794561|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
125047743|NCT00090285|449794562|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
125047744|NCT00090285|449794563|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
125047745|NCT00090285|449794564|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
125047746|NCT00090285|449794559|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
125047747|NCT00090285|449794560|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
125047748|NCT00090285|449794561|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
125047749|NCT00090285|449794562|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
125047750|NCT00090285|449794563|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
125047751|NCT00090285|449794564|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
125047752|NCT04498910|449794565|FG000|Overall Study|Lost to Follow-up|0|||
125047753|NCT04498910|449794566|FG001|Overall Study|Lost to Follow-up|1|||
125047754|NCT04498910|449794565|FG000|Overall Study|Withdrawal by Subject|2|||
125047755|NCT04498910|449794566|FG001|Overall Study|Withdrawal by Subject|1|||
125047756|NCT04498910|449794565|FG000|Overall Study|Adverse Event|1|||
125047757|NCT04498910|449794566|FG001|Overall Study|Adverse Event|0|||
125047758|NCT01849848|449794567|FG000|Overall Study|Physician Decision|1|||
125047759|NCT01849848|449794567|FG000|Overall Study|Progression of the primary disease|3|||
125047760|NCT01070303|449794568|FG000|Overall Study|Adverse Event|39|||
125047761|NCT01070303|449794568|FG000|Overall Study|Withdrawal by Subject|20|||
125047762|NCT01070303|449794568|FG000|Overall Study|Lost to Follow-up|9|||
125047763|NCT01070303|449794568|FG000|Overall Study|Protocol Violation|0|||
125047764|NCT01070303|449794568|FG000|Overall Study|Lack of Efficacy|2|||
125047765|NCT01070303|449794568|FG000|Overall Study|Administrative Reason|1|||
125047766|NCT01070303|449794568|FG000|Overall Study|Other|18|||
125047767|NCT02926573|449794570|FG000|Overall Study|Nausea|1|||
125047768|NCT02926573|449794571|FG001|Overall Study|Nausea|0|||
125047769|NCT02926573|449794570|FG000|Overall Study|Remain intubated|2|||
125047770|NCT02926573|449794571|FG001|Overall Study|Remain intubated|2|||
125047771|NCT02926573|449794570|FG000|Overall Study|Change in surgery plan|3|||
125047772|NCT02926573|449794571|FG001|Overall Study|Change in surgery plan|1|||
125047773|NCT02926573|449794570|FG000|Overall Study|Change to outpatient status|5|||
125047774|NCT02926573|449794571|FG001|Overall Study|Change to outpatient status|1|||
125047775|NCT02926573|449794570|FG000|Overall Study|Withdrawal by Subject|0|||
125047776|NCT02926573|449794571|FG001|Overall Study|Withdrawal by Subject|2|||
125047777|NCT02926573|449794570|FG000|Overall Study|Return to operating room|0|||
125047778|NCT02926573|449794571|FG001|Overall Study|Return to operating room|2|||
125047779|NCT02926573|449794570|FG000|Overall Study|Delirium|0|||
125047780|NCT02926573|449794571|FG001|Overall Study|Delirium|1|||
125047781|NCT00510692|449794581|FG000|Overall Study|Adverse Event|1|||
125047782|NCT00510692|449794582|FG001|Overall Study|Adverse Event|3|||
125047783|NCT00510692|449794581|FG000|Overall Study|Withdrawal by Subject|1|||
125047784|NCT00510692|449794582|FG001|Overall Study|Withdrawal by Subject|0|||
125047785|NCT01001494|449794591|FG000|Overall Study|Adverse Event|8|||
125047786|NCT01001494|449794592|FG001|Overall Study|Adverse Event|4|||
125047787|NCT01001494|449794593|FG002|Overall Study|Adverse Event|6|||
125047788|NCT01001494|449794591|FG000|Overall Study|Protocol Violation|0|||
125047789|NCT01001494|449794592|FG001|Overall Study|Protocol Violation|1|||
125047790|NCT01001494|449794593|FG002|Overall Study|Protocol Violation|1|||
125047791|NCT01001494|449794591|FG000|Overall Study|Lost to Follow-up|2|||
125047792|NCT01001494|449794592|FG001|Overall Study|Lost to Follow-up|0|||
125047793|NCT01001494|449794593|FG002|Overall Study|Lost to Follow-up|1|||
125219215|NCT00791700|450429332|FG001|Overall Study|Adverse Event|0|||
125047794|NCT01001494|449794591|FG000|Overall Study|Withdrawal by Subject|9|||
125047795|NCT01001494|449794592|FG001|Overall Study|Withdrawal by Subject|7|||
125047796|NCT01001494|449794593|FG002|Overall Study|Withdrawal by Subject|17|||
125047797|NCT01001494|449794591|FG000|Overall Study|COPD exacerbation|3|||
125047798|NCT01001494|449794592|FG001|Overall Study|COPD exacerbation|4|||
125047799|NCT01001494|449794593|FG002|Overall Study|COPD exacerbation|5|||
125047800|NCT01001494|449794591|FG000|Overall Study|Lack of Efficacy|2|||
125047801|NCT01001494|449794592|FG001|Overall Study|Lack of Efficacy|0|||
125047802|NCT01001494|449794593|FG002|Overall Study|Lack of Efficacy|8|||
125047803|NCT01001494|449794591|FG000|Overall Study|Other|0|||
125047804|NCT01001494|449794592|FG001|Overall Study|Other|1|||
125047805|NCT01001494|449794593|FG002|Overall Study|Other|3|||
125047806|NCT02519231|449794597|FG000|Overall Study|Lost to Follow-up|2|||
125047807|NCT02519231|449794598|FG001|Overall Study|Lost to Follow-up|5|||
125047808|NCT02519231|449794597|FG000|Overall Study|Withdrawal by Subject|0|||
125047809|NCT02519231|449794598|FG001|Overall Study|Withdrawal by Subject|1|||
125047810|NCT02124798|449794600|FG000|Overall Study|Adverse Event|3|||
125047811|NCT02124798|449794600|FG000|Overall Study|Lost to Follow-up|1|||
125047812|NCT01797432|449794603|FG000|Overall Study|Lost to Follow-up|1|||
125047813|NCT01797432|449794603|FG000|Overall Study|Adverse Event|1|||
125047814|NCT01797432|449794603|FG000|Overall Study|Withdrawal by Subject|1|||
125047815|NCT01797432|449794603|FG000|Overall Study|lived too far from study site|1|||
125047816|NCT00815308|449794604|FG000|Overall Study|Adverse Event|4|||
125047817|NCT00815308|449794604|FG000|Overall Study|Withdrawal by Subject|0|||
125047818|NCT00815308|449794604|FG000|Overall Study|Protocol Violation|6|||
125047819|NCT02746679|449794611|FG000|Overall Study|Lost to Follow-up|4|||
125047820|NCT02746679|449794612|FG001|Overall Study|Lost to Follow-up|6|||
125047821|NCT00542815|449794618|FG000|Overall Study|Adverse Event|19|||
125047822|NCT00542815|449794619|FG001|Overall Study|Adverse Event|6|||
125047823|NCT00542815|449794620|FG002|Overall Study|Adverse Event|9|||
125047824|NCT00542815|449794618|FG000|Overall Study|Death|10|||
125047825|NCT00542815|449794619|FG001|Overall Study|Death|7|||
125047826|NCT00542815|449794620|FG002|Overall Study|Death|3|||
125047827|NCT00542815|449794618|FG000|Overall Study|Lack of Efficacy|9|||
125047828|NCT00542815|449794619|FG001|Overall Study|Lack of Efficacy|2|||
125047829|NCT00542815|449794620|FG002|Overall Study|Lack of Efficacy|0|||
125047830|NCT00542815|449794618|FG000|Overall Study|Physician Decision|2|||
125047831|NCT00542815|449794619|FG001|Overall Study|Physician Decision|1|||
125047832|NCT00542815|449794620|FG002|Overall Study|Physician Decision|0|||
125047833|NCT00542815|449794618|FG000|Overall Study|Protocol Violation|1|||
125047834|NCT00542815|449794619|FG001|Overall Study|Protocol Violation|1|||
125047835|NCT00542815|449794620|FG002|Overall Study|Protocol Violation|2|||
125047836|NCT00542815|449794618|FG000|Overall Study|Withdrawal by Subject|41|||
125047837|NCT00542815|449794619|FG001|Overall Study|Withdrawal by Subject|5|||
125047838|NCT00542815|449794620|FG002|Overall Study|Withdrawal by Subject|8|||
125047839|NCT00542815|449794618|FG000|Overall Study|Other reasons|24|||
125047840|NCT00542815|449794619|FG001|Overall Study|Other reasons|10|||
125047841|NCT00542815|449794620|FG002|Overall Study|Other reasons|10|||
125047842|NCT00734929|449794621|FG000|Overall Study|Lost to Follow-up|1|||
125047843|NCT00734929|449794622|FG001|Overall Study|Lost to Follow-up|2|||
125047844|NCT00734929|449794621|FG000|Overall Study|No intervention/ screen fail|5|||
125047845|NCT00734929|449794622|FG001|Overall Study|No intervention/ screen fail|3|||
125047846|NCT02955186|449794623|FG000|Overall Study|Withdrawal by Subject|6|||
125047847|NCT02955186|449794624|FG001|Overall Study|Withdrawal by Subject|2|||
125047848|NCT02955186|449794623|FG000|Overall Study|Protocol Violation|1|||
125047849|NCT02955186|449794624|FG001|Overall Study|Protocol Violation|0|||
125047850|NCT02961764|449794625|FG000|Overall Study|Protocol Violation|0|||
125047851|NCT02961764|449794626|FG001|Overall Study|Protocol Violation|1|||
125047852|NCT02961764|449794625|FG000|Overall Study|Death|2|||
125047853|NCT02961764|449794626|FG001|Overall Study|Death|0|||
125047854|NCT02961764|449794625|FG000|Overall Study|Lost to Follow-up|35|||
125047855|NCT02961764|449794626|FG001|Overall Study|Lost to Follow-up|24|||
125047856|NCT02961764|449794625|FG000|Overall Study|Withdrawal by Subject|2|||
125047857|NCT02961764|449794626|FG001|Overall Study|Withdrawal by Subject|0|||
125047858|NCT01422304|449794627|FG000|Overall Study|Adverse Event|0|||
125047859|NCT01422304|449794628|FG001|Overall Study|Adverse Event|1|||
125047860|NCT01422304|449794627|FG000|Overall Study|Lost to Follow-up|14|||
125047861|NCT01422304|449794628|FG001|Overall Study|Lost to Follow-up|20|||
125047862|NCT01422304|449794627|FG000|Overall Study|Never Entered Follow-up|2|||
125047863|NCT01422304|449794628|FG001|Overall Study|Never Entered Follow-up|1|||
125047864|NCT01422304|449794627|FG000|Overall Study|Protocol Violation|1|||
125047865|NCT01422304|449794628|FG001|Overall Study|Protocol Violation|0|||
125047866|NCT01422304|449794627|FG000|Overall Study|Withdrawal by Subject|4|||
125047867|NCT01422304|449794628|FG001|Overall Study|Withdrawal by Subject|2|||
125047868|NCT01422304|449794627|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
125047869|NCT01422304|449794628|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
125047870|NCT01422304|449794627|FG000|Overall Study|Not Treated|3|||
125047871|NCT01422304|449794628|FG001|Overall Study|Not Treated|11|||
125047872|NCT03321929|449794629|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
125047873|NCT00866294|449794630|FG000|Overall Study|Adverse Event|12|||
125047874|NCT00866294|449794631|FG001|Overall Study|Adverse Event|13|||
125047875|NCT00866294|449794632|FG002|Overall Study|Adverse Event|9|||
125047876|NCT00866294|449794630|FG000|Overall Study|Lack of Efficacy|7|||
125047877|NCT00866294|449794631|FG001|Overall Study|Lack of Efficacy|1|||
125047878|NCT00866294|449794632|FG002|Overall Study|Lack of Efficacy|0|||
125219216|NCT00791700|450429333|FG002|Overall Study|Adverse Event|1|||
125219217|NCT00791700|450429334|FG003|Overall Study|Adverse Event|1|||
125219218|NCT01720524|450429341|FG000|Part A|Insufficient Clinical Response|2|||
125219219|NCT01720524|450429342|FG001|Part A|Insufficient Clinical Response|4|||
125219220|NCT01720524|450429341|FG000|Part A|Adverse Event|2|||
125219221|NCT01720524|450429342|FG001|Part A|Adverse Event|2|||
125219222|NCT01720524|450429341|FG000|Part A|Death|2|||
125219223|NCT01720524|450429342|FG001|Part A|Death|1|||
125219224|NCT01720524|450429341|FG000|Part A|Lost to Follow-up|0|||
125219225|NCT01720524|450429342|FG001|Part A|Lost to Follow-up|1|||
125219226|NCT01720524|450429341|FG000|Part A|Missed 28 day follow-up visit|1|||
125219227|NCT01720524|450429342|FG001|Part A|Missed 28 day follow-up visit|1|||
125219228|NCT01720524|450429341|FG000|Part A|Withdrawal by Subject|0|||
125219229|NCT01720524|450429342|FG001|Part A|Withdrawal by Subject|1|||
125219230|NCT01720524|450429341|FG000|Part A|Other|0|||
125219231|NCT01720524|450429342|FG001|Part A|Other|1|||
125219232|NCT01720524|450429341|FG000|Part A|Lost to Follow-up|0|||
125219233|NCT01720524|450429342|FG001|Part A|Lost to Follow-up|1|||
125219234|NCT01720524|450429341|FG000|Part B|No longer willing to participate in study|1|||
125047879|NCT00866294|449794630|FG000|Overall Study|Protocol Violation|2|||
125047880|NCT00866294|449794631|FG001|Overall Study|Protocol Violation|0|||
125047881|NCT00866294|449794632|FG002|Overall Study|Protocol Violation|0|||
125047882|NCT00866294|449794630|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
125047883|NCT00866294|449794631|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
125047884|NCT00866294|449794632|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
125047885|NCT00866294|449794630|FG000|Overall Study|Lost to Follow-up|1|||
125047886|NCT00866294|449794631|FG001|Overall Study|Lost to Follow-up|3|||
125047887|NCT00866294|449794632|FG002|Overall Study|Lost to Follow-up|0|||
125047888|NCT00866294|449794630|FG000|Overall Study|Physician Decision|6|||
125047889|NCT00866294|449794631|FG001|Overall Study|Physician Decision|2|||
125047890|NCT00866294|449794632|FG002|Overall Study|Physician Decision|1|||
125047891|NCT04799782|449794633|FG000|Washout|Physician Decision|2|||
125047892|NCT04799782|449794634|FG001|Washout|Physician Decision|0|||
125047893|NCT04799782|449794633|FG000|Washout|Withdrawal by Subject|0|||
125219235|NCT01720524|450429342|FG001|Part B|No longer willing to participate in study|4|||
125219236|NCT01720524|450429341|FG000|Part B|Other|2|||
125047894|NCT04799782|449794634|FG001|Washout|Withdrawal by Subject|2|||
125047895|NCT04799782|449794633|FG000|Washout|Lost to Follow-up|0|||
125047896|NCT04799782|449794634|FG001|Washout|Lost to Follow-up|1|||
125047897|NCT02606877|449794635|FG000|Overall Study|Adverse Event|3|||
125047898|NCT02606877|449794636|FG001|Overall Study|Adverse Event|0|||
125047899|NCT02606877|449794635|FG000|Overall Study|Non-compliance with protocol|0|||
125047900|NCT02606877|449794636|FG001|Overall Study|Non-compliance with protocol|1|||
125047901|NCT02606877|449794635|FG000|Overall Study|Other than listed above|1|||
125047902|NCT02606877|449794636|FG001|Overall Study|Other than listed above|0|||
125047903|NCT00515463|449794648|FG000|Overall Study|Physician Decision|4|||
125047904|NCT00515463|449794649|FG001|Overall Study|Physician Decision|2|||
125047905|NCT00515463|449794648|FG000|Overall Study|Adverse Event|1|||
125047906|NCT00515463|449794649|FG001|Overall Study|Adverse Event|2|||
125047907|NCT00515463|449794648|FG000|Overall Study|Withdrawal by Subject|3|||
125047908|NCT00515463|449794649|FG001|Overall Study|Withdrawal by Subject|4|||
125047909|NCT00515463|449794648|FG000|Overall Study|Lost to Follow-up|6|||
125047910|NCT00515463|449794649|FG001|Overall Study|Lost to Follow-up|5|||
125047911|NCT00515463|449794648|FG000|Overall Study|Other|0|||
125047912|NCT00515463|449794649|FG001|Overall Study|Other|1|||
125047913|NCT01558089|449794652|FG000|Overall Study|Adverse Event|1|||
125047914|NCT01558089|449794652|FG000|Overall Study|Lack of Efficacy|1|||
125047915|NCT01558089|449794652|FG000|Overall Study|Lost to Follow-up|5|||
125047916|NCT01558089|449794652|FG000|Overall Study|Withdrawal by Subject|6|||
125047917|NCT01903434|449794653|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
125047918|NCT01903434|449794654|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
125047919|NCT01903434|449794653|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
125047920|NCT01903434|449794654|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
125047921|NCT02190435|449794657|FG000|Overall Study|First 12 patients were lead-ins|12|||
125047922|NCT02190435|449794658|FG001|Overall Study|First 12 patients were lead-ins|0|||
125047923|NCT02190435|449794657|FG000|Overall Study|3 consented screen fails|3|||
125219237|NCT01720524|450429342|FG001|Part B|Other|0|||
125047924|NCT02190435|449794658|FG001|Overall Study|3 consented screen fails|0|||
125047925|NCT01781026|449794659|FG000|Overall Study|Lack of Efficacy|2|||
125047926|NCT02269319|449794660|FG000|Overall Study|Lost to Follow-up|4|||
125219238|NCT01720524|450429341|FG000|Part B|Lost to Follow-up|2|||
125219239|NCT01720524|450429342|FG001|Part B|Lost to Follow-up|3|||
125219240|NCT01720524|450429341|FG000|Part B|Death|0|||
125219241|NCT01720524|450429342|FG001|Part B|Death|2|||
125219242|NCT00996034|450429343|FG000|Overall Study|Lost to Follow-up|2|||
125219243|NCT00996034|450429343|FG000|Overall Study|withdrawn by PI|1|||
125219244|NCT00158262|450429347|FG000|Overall Study|Lost to Follow-up|1|||
125047927|NCT02269319|449794661|FG001|Overall Study|Lost to Follow-up|3|||
125219245|NCT00158262|450429348|FG001|Overall Study|Lost to Follow-up|1|||
125219246|NCT00527826|450429349|FG000|Overall Study|Adverse Event|10|||
125047928|NCT02269319|449794660|FG000|Overall Study|Adverse Event|0|||
125047929|NCT02269319|449794661|FG001|Overall Study|Adverse Event|1|||
125047930|NCT02269319|449794660|FG000|Overall Study|Instructions not followed|1|||
125047931|NCT02269319|449794661|FG001|Overall Study|Instructions not followed|0|||
125047932|NCT01118143|449794664|FG000|Overall Study|Withdrawal by Subject|2|||
125047933|NCT01118143|449794665|FG001|Overall Study|Withdrawal by Subject|5|||
125047934|NCT01937130|449796071|FG000|Overall Study|Withdrawal by Subject|0|||
125047935|NCT01937130|449796072|FG001|Overall Study|Withdrawal by Subject|0|||
125047936|NCT01937130|449796073|FG002|Overall Study|Withdrawal by Subject|0|||
125047937|NCT01937130|449796074|FG003|Overall Study|Withdrawal by Subject|1|||
125047938|NCT01937130|449796071|FG000|Overall Study|Adverse Event|0|||
125047939|NCT01937130|449796072|FG001|Overall Study|Adverse Event|1|||
125047940|NCT01937130|449796073|FG002|Overall Study|Adverse Event|0|||
125047941|NCT01937130|449796074|FG003|Overall Study|Adverse Event|1|||
125047942|NCT01937130|449796071|FG000|Overall Study|Death|1|||
125047943|NCT01937130|449796072|FG001|Overall Study|Death|1|||
125047944|NCT01937130|449796073|FG002|Overall Study|Death|1|||
125047945|NCT01937130|449796074|FG003|Overall Study|Death|0|||
125047946|NCT01937130|449796071|FG000|Overall Study|Lost to Follow-up|2|||
125047947|NCT01937130|449796072|FG001|Overall Study|Lost to Follow-up|0|||
125047948|NCT01937130|449796073|FG002|Overall Study|Lost to Follow-up|2|||
125047949|NCT01937130|449796074|FG003|Overall Study|Lost to Follow-up|0|||
125047950|NCT01937130|449796071|FG000|Overall Study|Physician Decision|0|||
125047951|NCT01937130|449796072|FG001|Overall Study|Physician Decision|1|||
125047952|NCT01937130|449796073|FG002|Overall Study|Physician Decision|0|||
125047953|NCT01937130|449796074|FG003|Overall Study|Physician Decision|0|||
125047954|NCT01937130|449796071|FG000|Overall Study|Patients unable to swallow|0|||
125047955|NCT01937130|449796072|FG001|Overall Study|Patients unable to swallow|1|||
125047956|NCT01937130|449796073|FG002|Overall Study|Patients unable to swallow|0|||
125047957|NCT01937130|449796074|FG003|Overall Study|Patients unable to swallow|0|||
125047958|NCT01937130|449796071|FG000|Overall Study|Patient lost to FU due to death|2|||
125047959|NCT01937130|449796072|FG001|Overall Study|Patient lost to FU due to death|0|||
125047960|NCT01937130|449796073|FG002|Overall Study|Patient lost to FU due to death|0|||
125047961|NCT01937130|449796074|FG003|Overall Study|Patient lost to FU due to death|0|||
125047962|NCT04168645|449796079|FG000|Overall Study|Lost to Follow-up|23|||
125047963|NCT04168645|449796080|FG001|Overall Study|Lost to Follow-up|28|||
125047964|NCT04168645|449796081|FG002|Overall Study|Lost to Follow-up|15|||
125047965|NCT04168645|449796082|FG003|Overall Study|Lost to Follow-up|12|||
125047966|NCT04168645|449796079|FG000|Overall Study|Death|1|||
125047967|NCT04168645|449796080|FG001|Overall Study|Death|1|||
125047968|NCT04168645|449796081|FG002|Overall Study|Death|0|||
125047969|NCT04168645|449796082|FG003|Overall Study|Death|0|||
125047970|NCT04168645|449796079|FG000|Overall Study|Withdrawal by Subject|5|||
125047971|NCT04168645|449796080|FG001|Overall Study|Withdrawal by Subject|2|||
125047972|NCT04168645|449796081|FG002|Overall Study|Withdrawal by Subject|2|||
125047973|NCT04168645|449796082|FG003|Overall Study|Withdrawal by Subject|2|||
125047974|NCT04168645|449796079|FG000|Overall Study|Administrative Withdrawal|3|||
125047975|NCT04168645|449796080|FG001|Overall Study|Administrative Withdrawal|1|||
125047976|NCT04168645|449796081|FG002|Overall Study|Administrative Withdrawal|1|||
125047977|NCT04168645|449796082|FG003|Overall Study|Administrative Withdrawal|3|||
125047978|NCT03825042|449796083|FG000|Overall Study|Adverse Event|1|||
125047979|NCT03825042|449796084|FG001|Overall Study|Adverse Event|0|||
125047980|NCT03825042|449796083|FG000|Overall Study|Withdrawal by Subject|1|||
125047981|NCT03825042|449796084|FG001|Overall Study|Withdrawal by Subject|0|||
125047982|NCT01988012|449796091|FG000|Overall Study|Adverse Event|5|||
125047983|NCT01988012|449796091|FG000|Overall Study|Insufficient Therapeutic Response|3|||
125047984|NCT01988012|449796091|FG000|Overall Study|Patient Withdrawal of Consent|4|||
125047985|NCT01988012|449796091|FG000|Overall Study|Lost to Follow-up|1|||
125047986|NCT01988012|449796091|FG000|Overall Study|Physician Decision|1|||
125047987|NCT01988012|449796091|FG000|Overall Study|Protocol Violation|1|||
125047988|NCT00089843|449796092|FG000|Overall Study|Withdrawal by Subject|1|||
125047989|NCT00089843|449796093|FG001|Overall Study|Withdrawal by Subject|4|||
125047990|NCT00089843|449796094|FG002|Overall Study|Withdrawal by Subject|5|||
125047991|NCT00089843|449796095|FG003|Overall Study|Withdrawal by Subject|6|||
125047992|NCT00089843|449796092|FG000|Overall Study|Physician Decision|1|||
125047993|NCT00089843|449796093|FG001|Overall Study|Physician Decision|0|||
125047994|NCT00089843|449796094|FG002|Overall Study|Physician Decision|0|||
125047995|NCT00089843|449796095|FG003|Overall Study|Physician Decision|1|||
125047996|NCT03042611|449796096|FG000|Core Phase|Withdrawal by Subject|13|||
125047997|NCT03042611|449796097|FG001|Core Phase|Withdrawal by Subject|4|||
125047998|NCT03042611|449796098|FG002|Core Phase|Withdrawal by Subject|0|||
125047999|NCT03042611|449796099|FG003|Core Phase|Withdrawal by Subject|0|||
125048000|NCT03042611|449796096|FG000|Core Phase|Death|232|||
125048001|NCT03042611|449796097|FG001|Core Phase|Death|110|||
125048002|NCT03042611|449796098|FG002|Core Phase|Death|0|||
125048003|NCT03042611|449796099|FG003|Core Phase|Death|0|||
125048004|NCT03042611|449796096|FG000|Core Phase|Lost to Follow-up|4|||
125048005|NCT03042611|449796097|FG001|Core Phase|Lost to Follow-up|7|||
125048006|NCT03042611|449796098|FG002|Core Phase|Lost to Follow-up|0|||
125219247|NCT00527826|450429350|FG001|Overall Study|Adverse Event|10|||
125219248|NCT00527826|450429349|FG000|Overall Study|Lost to Follow-up|3|||
125219249|NCT00527826|450429350|FG001|Overall Study|Lost to Follow-up|2|||
125219250|NCT00527826|450429349|FG000|Overall Study|Withdrawal by Subject|5|||
125219251|NCT00527826|450429350|FG001|Overall Study|Withdrawal by Subject|8|||
125219252|NCT00527826|450429349|FG000|Overall Study|Inclusion Criteria Not Met|3|||
125219253|NCT00527826|450429350|FG001|Overall Study|Inclusion Criteria Not Met|3|||
125219254|NCT00527826|450429349|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
125219255|NCT00527826|450429350|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
125219256|NCT00527826|450429349|FG000|Overall Study|Additional Intake of Viani forte|0|||
125219257|NCT00527826|450429350|FG001|Overall Study|Additional Intake of Viani forte|1|||
125219258|NCT00527826|450429349|FG000|Overall Study|Participant moved away|0|||
125219259|NCT00527826|450429350|FG001|Overall Study|Participant moved away|1|||
125219260|NCT02105285|450429353|FG000|Overall Study|Adverse Event|1|||
125219261|NCT02105285|450429354|FG001|Overall Study|Adverse Event|1|||
125219262|NCT02105285|450429355|FG002|Overall Study|Adverse Event|0|||
125219263|NCT02105285|450429353|FG000|Overall Study|Protocol Violation|0|||
125219264|NCT02105285|450429354|FG001|Overall Study|Protocol Violation|1|||
125219265|NCT02105285|450429355|FG002|Overall Study|Protocol Violation|0|||
125219266|NCT02105285|450429353|FG000|Overall Study|Withdrawal by Subject|1|||
125219267|NCT02105285|450429354|FG001|Overall Study|Withdrawal by Subject|0|||
125219268|NCT02105285|450429355|FG002|Overall Study|Withdrawal by Subject|0|||
125219269|NCT01421641|450429356|FG000|Overall Study|Protocol Violation|2|||
125219270|NCT01421641|450429357|FG001|Overall Study|Protocol Violation|2|||
125219271|NCT02585713|450429362|FG000|Overall Study|Withdrew prior to treatment|2|||
125219272|NCT02585713|450429363|FG001|Overall Study|Withdrew prior to treatment|7|||
125219273|NCT02585713|450429362|FG000|Overall Study|Other|3|||
125219274|NCT02585713|450429363|FG001|Overall Study|Other|1|||
125219275|NCT03173456|450429366|FG000|Baseline|Medication dispensing system malfunction'|0|||
125219276|NCT03173456|450429367|FG001|Baseline|Medication dispensing system malfunction'|1|||
125219277|NCT03173456|450429368|FG002|Baseline|Medication dispensing system malfunction'|0|||
125219278|NCT03173456|450429369|FG003|Baseline|Medication dispensing system malfunction'|0|||
125219279|NCT03173456|450429370|FG004|Baseline|Medication dispensing system malfunction'|2|||
125219280|NCT03173456|450429366|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
125219281|NCT03173456|450429367|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
125219282|NCT03173456|450429368|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
125219283|NCT03173456|450429369|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
125219284|NCT03173456|450429370|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
125219285|NCT01733121|450429371|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
125219286|NCT01733121|450429372|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
125219287|NCT01733121|450429371|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
125219288|NCT01733121|450429372|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
125219289|NCT01733121|450429371|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
125219290|NCT01733121|450429372|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
125219291|NCT01733121|450429371|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
125219292|NCT01733121|450429372|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
125219293|NCT03061188|450429381|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
125219294|NCT03061188|450429382|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
125219295|NCT03061188|450429383|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
125219296|NCT03061188|450429384|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
125219297|NCT03061188|450429381|FG000|On Follow-up for 3 Years|Death|0|||
125219298|NCT03061188|450429382|FG001|On Follow-up for 3 Years|Death|3|||
125219299|NCT03061188|450429383|FG002|On Follow-up for 3 Years|Death|5|||
125219300|NCT03061188|450429384|FG003|On Follow-up for 3 Years|Death|4|||
125048007|NCT03042611|449796099|FG003|Core Phase|Lost to Follow-up|0|||
125048008|NCT03042611|449796096|FG000|Core Phase|Physician Decision|7|||
125048009|NCT03042611|449796097|FG001|Core Phase|Physician Decision|2|||
125048010|NCT03042611|449796098|FG002|Core Phase|Physician Decision|0|||
125048011|NCT03042611|449796099|FG003|Core Phase|Physician Decision|0|||
125048012|NCT03042611|449796096|FG000|Core Phase|Study Closed|0|||
125219301|NCT03061188|450429381|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
125219302|NCT03061188|450429382|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
125219303|NCT03061188|450429383|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
125219304|NCT03061188|450429384|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
125219305|NCT04501952|450429385|FG000|Overall Study|Adverse Event|0|||
125219306|NCT04501952|450429386|FG001|Overall Study|Adverse Event|3|||
125048013|NCT03042611|449796097|FG001|Core Phase|Study Closed|1|||
125048014|NCT03042611|449796098|FG002|Core Phase|Study Closed|0|||
125048015|NCT03042611|449796099|FG003|Core Phase|Study Closed|0|||
125048016|NCT03042611|449796096|FG000|Extension Phase|Death|0|||
125048017|NCT03042611|449796097|FG001|Extension Phase|Death|0|||
125048018|NCT03042611|449796098|FG002|Extension Phase|Death|34|||
125048019|NCT03042611|449796099|FG003|Extension Phase|Death|16|||
125048020|NCT03042611|449796096|FG000|Extension Phase|Lost to Follow-up|0|||
125048021|NCT03042611|449796097|FG001|Extension Phase|Lost to Follow-up|0|||
125048022|NCT03042611|449796098|FG002|Extension Phase|Lost to Follow-up|1|||
125048023|NCT03042611|449796099|FG003|Extension Phase|Lost to Follow-up|1|||
125048024|NCT03042611|449796096|FG000|Extension Phase|Study Closed|0|||
125048025|NCT03042611|449796097|FG001|Extension Phase|Study Closed|0|||
125048026|NCT03042611|449796098|FG002|Extension Phase|Study Closed|17|||
125048027|NCT03042611|449796099|FG003|Extension Phase|Study Closed|11|||
125048028|NCT00907478|449796104|FG000|Overall Study|Ineligibility determined|0|||
125048029|NCT00907478|449796105|FG001|Overall Study|Ineligibility determined|0|||
125048030|NCT00907478|449796106|FG002|Overall Study|Ineligibility determined|1|||
125048031|NCT00907478|449796104|FG000|Overall Study|Noncompliance|0|||
125048032|NCT00907478|449796105|FG001|Overall Study|Noncompliance|0|||
125048033|NCT00907478|449796106|FG002|Overall Study|Noncompliance|1|||
125048034|NCT00907478|449796104|FG000|Overall Study|Adverse Event|3|||
125048035|NCT00907478|449796105|FG001|Overall Study|Adverse Event|1|||
125048036|NCT00907478|449796106|FG002|Overall Study|Adverse Event|2|||
125048037|NCT00907478|449796104|FG000|Overall Study|Withdrawal by Subject|8|||
125048038|NCT00907478|449796105|FG001|Overall Study|Withdrawal by Subject|9|||
125048039|NCT00907478|449796106|FG002|Overall Study|Withdrawal by Subject|6|||
125048040|NCT00907478|449796104|FG000|Overall Study|Requirement for alternative therapy|1|||
125048041|NCT00907478|449796105|FG001|Overall Study|Requirement for alternative therapy|2|||
125048042|NCT00907478|449796106|FG002|Overall Study|Requirement for alternative therapy|3|||
125048043|NCT00907478|449796104|FG000|Overall Study|Physician Decision|2|||
125048044|NCT00907478|449796105|FG001|Overall Study|Physician Decision|0|||
125048045|NCT00907478|449796106|FG002|Overall Study|Physician Decision|3|||
125048046|NCT00907478|449796104|FG000|Overall Study|Death|4|||
125048047|NCT00907478|449796105|FG001|Overall Study|Death|2|||
125048048|NCT00907478|449796106|FG002|Overall Study|Death|1|||
125048049|NCT00907478|449796104|FG000|Overall Study|Protocol-specified criteria|5|||
125048050|NCT00907478|449796105|FG001|Overall Study|Protocol-specified criteria|2|||
125048051|NCT00907478|449796106|FG002|Overall Study|Protocol-specified criteria|3|||
125048052|NCT00907478|449796104|FG000|Overall Study|Pregnancy|0|||
125048053|NCT00907478|449796105|FG001|Overall Study|Pregnancy|1|||
125048054|NCT00907478|449796106|FG002|Overall Study|Pregnancy|1|||
125048055|NCT00907478|449796104|FG000|Overall Study|Lost to Follow-up|1|||
125048056|NCT00907478|449796105|FG001|Overall Study|Lost to Follow-up|0|||
125048057|NCT00907478|449796106|FG002|Overall Study|Lost to Follow-up|0|||
125048058|NCT00907478|449796104|FG000|Overall Study|Other|3|||
125048059|NCT00907478|449796105|FG001|Overall Study|Other|0|||
125048060|NCT00907478|449796106|FG002|Overall Study|Other|1|||
125048061|NCT02639182|449796107|FG000|Overall Study|Disease Progression|50|||
125048062|NCT02639182|449796108|FG001|Overall Study|Disease Progression|49|||
125048063|NCT02639182|449796107|FG000|Overall Study|Adverse Event|7|||
125048064|NCT02639182|449796108|FG001|Overall Study|Adverse Event|5|||
125048065|NCT02639182|449796107|FG000|Overall Study|Physician Decision|3|||
125048066|NCT02639182|449796108|FG001|Overall Study|Physician Decision|3|||
125048067|NCT02639182|449796107|FG000|Overall Study|Withdrew Consent|5|||
125048068|NCT02639182|449796108|FG001|Overall Study|Withdrew Consent|4|||
125048069|NCT02639182|449796107|FG000|Overall Study|Lost to Follow-up|0|||
125048070|NCT02639182|449796108|FG001|Overall Study|Lost to Follow-up|1|||
125048071|NCT02639182|449796107|FG000|Overall Study|Study Closure|1|||
125048072|NCT02639182|449796108|FG001|Overall Study|Study Closure|2|||
125048073|NCT02639182|449796107|FG000|Overall Study|Sponsor Ended Study|0|||
125048074|NCT02639182|449796108|FG001|Overall Study|Sponsor Ended Study|1|||
125048075|NCT02639182|449796107|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
125219307|NCT04501952|450429385|FG000|Overall Study|Investigator's Discretion|0|||
125048076|NCT02639182|449796108|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
125048077|NCT03069690|449796111|FG000|Pregnancy Intervention|Pregnancy loss|9|||
125048078|NCT03069690|449796112|FG001|Pregnancy Intervention|Pregnancy loss|4|||
125048079|NCT03069690|449796113|FG002|Pregnancy Intervention|Pregnancy loss|0|||
125048080|NCT03069690|449796114|FG003|Pregnancy Intervention|Pregnancy loss|0|||
125048081|NCT03069690|449796115|FG004|Pregnancy Intervention|Pregnancy loss|0|||
125048082|NCT03069690|449796116|FG005|Pregnancy Intervention|Pregnancy loss|0|||
125048083|NCT03069690|449796111|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
125219308|NCT04501952|450429386|FG001|Overall Study|Investigator's Discretion|1|||
125048084|NCT03069690|449796112|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
125048085|NCT03069690|449796113|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
125048086|NCT03069690|449796114|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
125048087|NCT03069690|449796115|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
125048088|NCT03069690|449796116|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
125048089|NCT03069690|449796111|FG000|Postpartum Intervention|Lost to Follow-up|0|||
125048090|NCT03069690|449796112|FG001|Postpartum Intervention|Lost to Follow-up|0|||
125219309|NCT04501952|450429385|FG000|Overall Study|Protocol Violation|1|||
125048091|NCT03069690|449796113|FG002|Postpartum Intervention|Lost to Follow-up|5|||
125048092|NCT03069690|449796114|FG003|Postpartum Intervention|Lost to Follow-up|5|||
125048093|NCT03069690|449796115|FG004|Postpartum Intervention|Lost to Follow-up|2|||
125048094|NCT03069690|449796116|FG005|Postpartum Intervention|Lost to Follow-up|4|||
125048095|NCT01372878|449796117|FG000|Overall Study|Withdrawal by Subject|63|||
125048096|NCT01372878|449796117|FG000|Overall Study|Protocol Violation|17|||
125048097|NCT01372878|449796117|FG000|Overall Study|incomplete study procedure|104|||
125048098|NCT02240628|449796118|FG000|Overall Study|Physician Decision|6|||
125048099|NCT02240628|449796119|FG001|Overall Study|Physician Decision|5|||
125048100|NCT02385123|449796120|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
125048101|NCT01302769|449796133|FG000|Overall Study|Lost to Follow-up|1|||
125048102|NCT01302769|449796134|FG001|Overall Study|Lost to Follow-up|1|||
125048103|NCT01845077|449796135|FG000|Washout Period|Lost to Follow-up|0|||
125048104|NCT01845077|449796136|FG001|Washout Period|Lost to Follow-up|1|||
125048105|NCT01845077|449796137|FG002|Washout Period|Lost to Follow-up|0|||
125048106|NCT01845077|449796138|FG003|Washout Period|Lost to Follow-up|1|||
125048107|NCT01845077|449796139|FG004|Washout Period|Lost to Follow-up|0|||
125048108|NCT01845077|449796140|FG005|Washout Period|Lost to Follow-up|1|||
125048109|NCT01845077|449796135|FG000|Washout Period|Adverse Event|1|||
125048110|NCT01845077|449796136|FG001|Washout Period|Adverse Event|0|||
125048111|NCT01845077|449796137|FG002|Washout Period|Adverse Event|0|||
125048112|NCT01845077|449796138|FG003|Washout Period|Adverse Event|0|||
125048113|NCT01845077|449796139|FG004|Washout Period|Adverse Event|0|||
125048114|NCT01845077|449796140|FG005|Washout Period|Adverse Event|0|||
125048115|NCT01845077|449796135|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
125048116|NCT01845077|449796136|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
125048117|NCT01845077|449796137|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
125048118|NCT01845077|449796138|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
125048119|NCT01845077|449796139|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
125048120|NCT01845077|449796140|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
125048121|NCT01845077|449796135|FG000|Washout Period|Protocol Violation|0|||
125048122|NCT01845077|449796136|FG001|Washout Period|Protocol Violation|0|||
125048123|NCT01845077|449796137|FG002|Washout Period|Protocol Violation|0|||
125048124|NCT01845077|449796138|FG003|Washout Period|Protocol Violation|1|||
125048125|NCT01845077|449796139|FG004|Washout Period|Protocol Violation|1|||
125048126|NCT01845077|449796140|FG005|Washout Period|Protocol Violation|0|||
125048127|NCT00394914|449796141|FG000|Treatment Period|Adverse Event|0|||
125048128|NCT00394914|449796142|FG001|Treatment Period|Adverse Event|3|||
125048129|NCT00394914|449796143|FG002|Treatment Period|Adverse Event|1|||
125048130|NCT00394914|449796141|FG000|Treatment Period|Lost to Follow-up|0|||
125048131|NCT00394914|449796142|FG001|Treatment Period|Lost to Follow-up|1|||
125048132|NCT00394914|449796143|FG002|Treatment Period|Lost to Follow-up|0|||
125048133|NCT00394914|449796141|FG000|Treatment Period|Withdrawal by Subject|0|||
125048134|NCT00394914|449796142|FG001|Treatment Period|Withdrawal by Subject|2|||
125048135|NCT00394914|449796143|FG002|Treatment Period|Withdrawal by Subject|2|||
125048136|NCT00394914|449796141|FG000|Treatment Period|Noncompliance with protocol|0|||
125048137|NCT00394914|449796142|FG001|Treatment Period|Noncompliance with protocol|3|||
125048138|NCT00394914|449796143|FG002|Treatment Period|Noncompliance with protocol|2|||
125048139|NCT00394914|449796141|FG000|Treatment Period|Did not meet protocol eligibility|0|||
125048140|NCT00394914|449796142|FG001|Treatment Period|Did not meet protocol eligibility|1|||
125048141|NCT00394914|449796143|FG002|Treatment Period|Did not meet protocol eligibility|1|||
125048142|NCT00312377|449796148|FG000|Overall Study|Death|403|||
125048143|NCT00312377|449796149|FG001|Overall Study|Death|418|||
125048144|NCT00312377|449796148|FG000|Overall Study|Withdrawal by Subject|23|||
125048145|NCT00312377|449796149|FG001|Overall Study|Withdrawal by Subject|30|||
125048146|NCT00312377|449796148|FG000|Overall Study|Lost to Follow-up|9|||
125048147|NCT00312377|449796149|FG001|Overall Study|Lost to Follow-up|12|||
125048148|NCT00312377|449796148|FG000|Overall Study|Non-compliance|0|||
125048149|NCT00312377|449796149|FG001|Overall Study|Non-compliance|2|||
125048150|NCT00312377|449796148|FG000|Overall Study|Randomised but never received treatment|6|||
125048151|NCT00312377|449796149|FG001|Overall Study|Randomised but never received treatment|6|||
125048152|NCT00312377|449796148|FG000|Overall Study|Discontinue treatment survival follow up|202|||
125048153|NCT00312377|449796149|FG001|Overall Study|Discontinue treatment survival follow up|200|||
125048154|NCT00312377|449796148|FG000|Overall Study|Site ended participation in study|1|||
125048155|NCT00312377|449796149|FG001|Overall Study|Site ended participation in study|0|||
125048156|NCT00872898|449796150|FG000|Part Two - Double Blind|Adverse Event|4|||
125048157|NCT00872898|449796151|FG001|Part Two - Double Blind|Adverse Event|3|||
125048158|NCT00872898|449796150|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
125048159|NCT00872898|449796151|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
125048160|NCT00872898|449796150|FG000|Part Two - Double Blind|Protocol Violation|1|||
125048161|NCT00872898|449796151|FG001|Part Two - Double Blind|Protocol Violation|0|||
125048162|NCT00872898|449796150|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
125048163|NCT00872898|449796151|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
125048164|NCT00872898|449796150|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
125048165|NCT00872898|449796151|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
125048166|NCT00872898|449796150|FG000|Part Two - Double Blind|Other reasons|2|||
125048167|NCT00872898|449796151|FG001|Part Two - Double Blind|Other reasons|0|||
125048168|NCT02179398|449796157|FG000|Overall Study|Lack of obligatory data|3|||
125048169|NCT02179398|449796158|FG001|Overall Study|Lack of obligatory data|3|||
125048170|NCT02179398|449796157|FG000|Overall Study|Lost to Follow-up|0|||
125048171|NCT02179398|449796158|FG001|Overall Study|Lost to Follow-up|1|||
125048172|NCT01137435|449796159|FG000|Overall Study|Lost to Follow-up|24|||
125048173|NCT01137435|449796159|FG000|Overall Study|Off label usage|4|||
125048174|NCT00487279|449796164|FG000|Overall Study|Death|1|||
125048175|NCT00487279|449796165|FG001|Overall Study|Death|0|||
125048176|NCT00487279|449796164|FG000|Overall Study|Withdrawal by Subject|0|||
125048177|NCT00487279|449796165|FG001|Overall Study|Withdrawal by Subject|2|||
125048178|NCT00501852|449796166|FG000|Overall Study|Adverse Event|3|||
125048179|NCT00501852|449796166|FG000|Overall Study|Withdrawal by Subject|2|||
125048180|NCT01416610|449796167|FG000|Overall Study|Adverse Event|4|||
125048181|NCT01416610|449796167|FG000|Overall Study|Adverse Event -Patient decision|3|||
125048182|NCT01416610|449796167|FG000|Overall Study|Lack of Efficacy|4|||
125048183|NCT01416610|449796167|FG000|Overall Study|No reason given|5|||
125048184|NCT01416610|449796167|FG000|Overall Study|Withdrawal by Subject|13|||
125048185|NCT01416610|449796167|FG000|Overall Study|Lost to Follow-up|7|||
125048186|NCT01416610|449796167|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
125048187|NCT01927562|449796169|FG000|Overall Study|Lost to Follow-up|30|||
125048188|NCT01927562|449796169|FG000|Overall Study|Withdrawal by Subject|3|||
125048189|NCT01927562|449796169|FG000|Overall Study|Physician Decision|5|||
125048190|NCT00642616|449796170|FG000|Overall Study|Adverse Event|2|||
125048191|NCT00642616|449796171|FG001|Overall Study|Adverse Event|0|||
125048192|NCT00642616|449796172|FG002|Overall Study|Adverse Event|1|||
125048193|NCT00642616|449796173|FG003|Overall Study|Adverse Event|0|||
125048194|NCT00642616|449796170|FG000|Overall Study|Study Terminated by Sponsor|7|||
125048195|NCT00642616|449796171|FG001|Overall Study|Study Terminated by Sponsor|6|||
125048196|NCT00642616|449796172|FG002|Overall Study|Study Terminated by Sponsor|4|||
125048197|NCT00642616|449796173|FG003|Overall Study|Study Terminated by Sponsor|5|||
125048198|NCT00642616|449796170|FG000|Overall Study|Withdrawal by Subject|0|||
125048199|NCT00642616|449796171|FG001|Overall Study|Withdrawal by Subject|1|||
125048200|NCT00642616|449796172|FG002|Overall Study|Withdrawal by Subject|1|||
125048201|NCT00642616|449796173|FG003|Overall Study|Withdrawal by Subject|1|||
125048202|NCT00642616|449796170|FG000|Overall Study|Protocol Violation|0|||
125048203|NCT00642616|449796171|FG001|Overall Study|Protocol Violation|0|||
125048204|NCT00642616|449796172|FG002|Overall Study|Protocol Violation|2|||
125048205|NCT00642616|449796173|FG003|Overall Study|Protocol Violation|0|||
125048206|NCT00642616|449796170|FG000|Overall Study|Physician Decision|0|||
125048207|NCT00642616|449796171|FG001|Overall Study|Physician Decision|0|||
125048208|NCT00642616|449796172|FG002|Overall Study|Physician Decision|1|||
125048209|NCT00642616|449796173|FG003|Overall Study|Physician Decision|1|||
125048210|NCT00399802|449796174|FG000|Overall Study|Adverse Event|0|||
125048211|NCT00399802|449796175|FG001|Overall Study|Adverse Event|2|||
125048212|NCT00399802|449796174|FG000|Overall Study|Participant discontinued by mistake|0|||
125048213|NCT00399802|449796175|FG001|Overall Study|Participant discontinued by mistake|1|||
125048214|NCT00492921|449796176|FG000|Overall Study|Death|1|||
125048215|NCT00492921|449796177|FG001|Overall Study|Death|0|||
125048216|NCT00492921|449796178|FG002|Overall Study|Death|1|||
125048217|NCT00652093|449796179|FG000|Overall Study|Withdrawal by Subject|0|||
125048218|NCT00652093|449796180|FG001|Overall Study|Withdrawal by Subject|0|||
125048219|NCT00652093|449796181|FG002|Overall Study|Withdrawal by Subject|1|||
125048220|NCT00652093|449796182|FG003|Overall Study|Withdrawal by Subject|0|||
125048221|NCT00652093|449796183|FG004|Overall Study|Withdrawal by Subject|1|||
125048222|NCT00652093|449796184|FG005|Overall Study|Withdrawal by Subject|0|||
125048223|NCT00652093|449796179|FG000|Overall Study|Physician Decision|0|||
125048224|NCT00652093|449796180|FG001|Overall Study|Physician Decision|0|||
125048225|NCT00652093|449796181|FG002|Overall Study|Physician Decision|0|||
125048226|NCT00652093|449796182|FG003|Overall Study|Physician Decision|0|||
125048227|NCT00652093|449796183|FG004|Overall Study|Physician Decision|1|||
125048228|NCT00652093|449796184|FG005|Overall Study|Physician Decision|0|||
125048229|NCT03176966|449796188|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
125048230|NCT03176966|449796189|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
125048231|NCT03176966|449796188|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
125048232|NCT03176966|449796189|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
125048233|NCT03176966|449796188|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
125048234|NCT03176966|449796189|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
125048235|NCT03176966|449796188|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
125048236|NCT03176966|449796189|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
125048237|NCT03176966|449796188|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
125048238|NCT03176966|449796189|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
125048239|NCT03176966|449796188|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
125048240|NCT03176966|449796189|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
125048241|NCT03176966|449796188|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
125048242|NCT03176966|449796189|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
125048243|NCT01520922|449796190|FG000|Treatment Phase|Physician Decision|2|||
125048244|NCT01520922|449796191|FG001|Treatment Phase|Physician Decision|1|||
125048245|NCT01520922|449796190|FG000|Treatment Phase|Progression|0|||
125048246|NCT01520922|449796191|FG001|Treatment Phase|Progression|2|||
125048247|NCT01520922|449796190|FG000|Treatment Phase|Adverse Event|3|||
125048248|NCT01520922|449796191|FG001|Treatment Phase|Adverse Event|5|||
125048249|NCT01520922|449796190|FG000|Follow up|Lost to Follow-up|0|||
125048250|NCT01520922|449796191|FG001|Follow up|Lost to Follow-up|1|||
125048251|NCT01520922|449796190|FG000|Survival Follow-up|Withdrawal by Subject|1|||
125048252|NCT01520922|449796191|FG001|Survival Follow-up|Withdrawal by Subject|0|||
125048253|NCT01696877|449796194|FG000|Overall Study|Adverse Event|0|||
125048254|NCT01696877|449796195|FG001|Overall Study|Adverse Event|1|||
125048255|NCT01618656|449796196|FG000|Overall Study|Withdrawal by Subject|7|||
125048256|NCT01618656|449796197|FG001|Overall Study|Withdrawal by Subject|3|||
125048257|NCT01618656|449796196|FG000|Overall Study|Physician Decision|1|||
125048258|NCT01618656|449796197|FG001|Overall Study|Physician Decision|1|||
125048259|NCT04770155|449796200|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
125048260|NCT04770155|449796201|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
125048261|NCT04770155|449796202|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
125048262|NCT04770155|449796203|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
125048263|NCT04770155|449796204|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
125048264|NCT04770155|449796205|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
125048265|NCT04770155|449796206|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
125048266|NCT04770155|449796207|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
125048267|NCT00469014|449796210|FG000|Initial Phase Randomization|Disease Progression|0|||
125048268|NCT00469014|449796211|FG001|Initial Phase Randomization|Disease Progression|1|||
125048269|NCT00469014|449796212|FG002|Initial Phase Randomization|Disease Progression|1|||
125048270|NCT00469014|449796213|FG003|Initial Phase Randomization|Disease Progression|0|||
125048271|NCT00469014|449796210|FG000|Initial Phase Randomization|No Response|1|||
125048272|NCT00469014|449796211|FG001|Initial Phase Randomization|No Response|0|||
125048273|NCT00469014|449796212|FG002|Initial Phase Randomization|No Response|0|||
125048274|NCT00469014|449796213|FG003|Initial Phase Randomization|No Response|1|||
125048275|NCT00469014|449796210|FG000|Adaptive Randomization|Not Evaluable|1|||
125048276|NCT00469014|449796211|FG001|Adaptive Randomization|Not Evaluable|0|||
125048277|NCT00469014|449796212|FG002|Adaptive Randomization|Not Evaluable|0|||
125048278|NCT00469014|449796213|FG003|Adaptive Randomization|Not Evaluable|1|||
125048279|NCT00469014|449796210|FG000|Adaptive Randomization|No Response|0|||
125048280|NCT00469014|449796211|FG001|Adaptive Randomization|No Response|1|||
125048281|NCT00469014|449796212|FG002|Adaptive Randomization|No Response|0|||
125048282|NCT00469014|449796213|FG003|Adaptive Randomization|No Response|0|||
125048283|NCT00469014|449796210|FG000|Adaptive Randomization|Death|0|||
125048284|NCT00469014|449796211|FG001|Adaptive Randomization|Death|0|||
125048285|NCT00469014|449796212|FG002|Adaptive Randomization|Death|1|||
125048286|NCT00469014|449796213|FG003|Adaptive Randomization|Death|0|||
125048287|NCT01632878|449796214|FG000|Screening|Physician Decision|268|||
125048288|NCT01632878|449796214|FG000|Treatment|Lost to Follow-up|41|||
125048289|NCT01632878|449796214|FG000|Treatment|Withdrawal by Subject|36|||
125048290|NCT01632878|449796214|FG000|Treatment|Physician Decision|34|||
125048291|NCT01632878|449796214|FG000|Treatment|missing information|4|||
125048292|NCT01632878|449796214|FG000|Treatment|no information on study completion|43|||
125048293|NCT00336492|449796227|FG000|Overall Study|Adverse Event|4|||
125048294|NCT00336492|449796228|FG001|Overall Study|Adverse Event|3|||
125048295|NCT00336492|449796229|FG002|Overall Study|Adverse Event|6|||
125048296|NCT00336492|449796227|FG000|Overall Study|Lack of Efficacy|6|||
125048297|NCT00336492|449796228|FG001|Overall Study|Lack of Efficacy|1|||
125048298|NCT00336492|449796229|FG002|Overall Study|Lack of Efficacy|4|||
125048299|NCT00336492|449796227|FG000|Overall Study|Other|5|||
125048300|NCT00336492|449796228|FG001|Overall Study|Other|0|||
125048301|NCT00336492|449796229|FG002|Overall Study|Other|1|||
125048302|NCT00227877|449796230|FG000|Pre-visit Assessment|Technical difficulties|7|||
125048303|NCT00227877|449796231|FG001|Pre-visit Assessment|Technical difficulties|3|||
125048304|NCT00227877|449796232|FG002|Pre-visit Assessment|Technical difficulties|0|||
125048305|NCT00227877|449796233|FG003|Pre-visit Assessment|Technical difficulties|0|||
125048306|NCT00227877|449796230|FG000|Post-visit Checklist|Lost to Follow-up|24|||
125048307|NCT00227877|449796231|FG001|Post-visit Checklist|Lost to Follow-up|13|||
125048308|NCT00227877|449796232|FG002|Post-visit Checklist|Lost to Follow-up|1|||
125048309|NCT00227877|449796233|FG003|Post-visit Checklist|Lost to Follow-up|0|||
125048310|NCT00227877|449796230|FG000|3-months Follow-up|Completed late|135|||
125048311|NCT00227877|449796231|FG001|3-months Follow-up|Completed late|128|||
125048312|NCT00227877|449796232|FG002|3-months Follow-up|Completed late|34|||
125048313|NCT00227877|449796233|FG003|3-months Follow-up|Completed late|8|||
125048314|NCT00227877|449796230|FG000|3-months Follow-up|Lost to Follow-up|178|||
125048315|NCT00227877|449796231|FG001|3-months Follow-up|Lost to Follow-up|139|||
125048316|NCT00227877|449796232|FG002|3-months Follow-up|Lost to Follow-up|18|||
125048317|NCT00227877|449796233|FG003|3-months Follow-up|Lost to Follow-up|13|||
125048318|NCT00227877|449796230|FG000|12-months Follow-up|Completed late|78|||
125048319|NCT00227877|449796231|FG001|12-months Follow-up|Completed late|74|||
125048320|NCT00227877|449796232|FG002|12-months Follow-up|Completed late|1|||
125048321|NCT00227877|449796233|FG003|12-months Follow-up|Completed late|0|||
125048322|NCT00227877|449796230|FG000|12-months Follow-up|Lost to Follow-up|232|||
125048323|NCT00227877|449796231|FG001|12-months Follow-up|Lost to Follow-up|189|||
125048324|NCT00227877|449796232|FG002|12-months Follow-up|Lost to Follow-up|30|||
125048325|NCT00227877|449796233|FG003|12-months Follow-up|Lost to Follow-up|26|||
125048326|NCT05094154|449797963|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
125048327|NCT05094154|449797964|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
125048328|NCT05094154|449797963|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
125048329|NCT05094154|449797964|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
125048330|NCT01543490|449797967|FG000|Overall Study|Adverse Event|4|||
125048331|NCT01543490|449797968|FG001|Overall Study|Adverse Event|0|||
125048332|NCT01543490|449797967|FG000|Overall Study|Physician Decision|1|||
125048333|NCT01543490|449797968|FG001|Overall Study|Physician Decision|0|||
125048334|NCT01543490|449797967|FG000|Overall Study|Lack of Efficacy|3|||
125048335|NCT01543490|449797968|FG001|Overall Study|Lack of Efficacy|3|||
125048336|NCT01543490|449797967|FG000|Overall Study|Lost to Follow-up|5|||
125048337|NCT01543490|449797968|FG001|Overall Study|Lost to Follow-up|0|||
125048338|NCT01543490|449797967|FG000|Overall Study|Withdrawal by Subject|2|||
125048339|NCT01543490|449797968|FG001|Overall Study|Withdrawal by Subject|0|||
125048340|NCT01543490|449797967|FG000|Overall Study|Other-Various Administrative Reasons|1|||
125048341|NCT01543490|449797968|FG001|Overall Study|Other-Various Administrative Reasons|2|||
125048342|NCT03918642|449797969|FG000|Overall Study|Lost to Follow-up|12|||
125048343|NCT03918642|449797970|FG001|Overall Study|Lost to Follow-up|10|||
125048344|NCT02601001|449797971|FG000|Dosing Period 2|Adverse Event|0|||
125048345|NCT02601001|449797972|FG001|Dosing Period 2|Adverse Event|0|||
125048346|NCT02601001|449797973|FG002|Dosing Period 2|Adverse Event|0|||
125048347|NCT02601001|449797974|FG003|Dosing Period 2|Adverse Event|0|||
125048348|NCT02601001|449797975|FG004|Dosing Period 2|Adverse Event|0|||
125048349|NCT02601001|449797976|FG005|Dosing Period 2|Adverse Event|0|||
125048350|NCT02601001|449797977|FG006|Dosing Period 2|Adverse Event|1|||
125048351|NCT02115815|449797978|FG000|Overall Study|Withdrawal by Subject|2|||
125048352|NCT02115815|449797979|FG001|Overall Study|Withdrawal by Subject|0|||
125048353|NCT02115815|449797980|FG002|Overall Study|Withdrawal by Subject|0|||
125048354|NCT02115815|449797981|FG003|Overall Study|Withdrawal by Subject|0|||
125048355|NCT02115815|449797982|FG004|Overall Study|Withdrawal by Subject|0|||
125048356|NCT02115815|449797983|FG005|Overall Study|Withdrawal by Subject|0|||
125048357|NCT02115815|449797984|FG006|Overall Study|Withdrawal by Subject|0|||
125048358|NCT02115815|449797978|FG000|Overall Study|Not enough drug to dose participant|0|||
125048359|NCT02115815|449797979|FG001|Overall Study|Not enough drug to dose participant|0|||
125048360|NCT02115815|449797980|FG002|Overall Study|Not enough drug to dose participant|0|||
125048361|NCT02115815|449797981|FG003|Overall Study|Not enough drug to dose participant|0|||
125048362|NCT02115815|449797982|FG004|Overall Study|Not enough drug to dose participant|0|||
125048363|NCT02115815|449797983|FG005|Overall Study|Not enough drug to dose participant|1|||
125048364|NCT02115815|449797984|FG006|Overall Study|Not enough drug to dose participant|0|||
125048365|NCT02115815|449797978|FG000|Overall Study|Missed appointment, randomized in error|0|||
125048366|NCT02115815|449797979|FG001|Overall Study|Missed appointment, randomized in error|0|||
125048367|NCT02115815|449797980|FG002|Overall Study|Missed appointment, randomized in error|0|||
125048368|NCT02115815|449797981|FG003|Overall Study|Missed appointment, randomized in error|0|||
125048369|NCT02115815|449797982|FG004|Overall Study|Missed appointment, randomized in error|0|||
125048370|NCT02115815|449797983|FG005|Overall Study|Missed appointment, randomized in error|1|||
125048371|NCT02115815|449797984|FG006|Overall Study|Missed appointment, randomized in error|0|||
125048372|NCT01228071|449797985|FG000|Overall Study|Protocol Violation|1|||
125048373|NCT01228071|449797985|FG000|Overall Study|Withdrawal by Subject|1|||
125048374|NCT03314519|449797986|FG000|Overall Study|Protocol Violation|3|||
125048375|NCT03314519|449797987|FG001|Overall Study|Protocol Violation|2|||
125048376|NCT04003155|449797988|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
125048377|NCT04003155|449797989|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
125048378|NCT04003155|449797990|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
125048379|NCT04003155|449797991|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
125048380|NCT04003155|449797992|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
125048381|NCT04003155|449797988|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
125048382|NCT04003155|449797989|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
125048383|NCT04003155|449797990|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
125048384|NCT04003155|449797991|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
125048385|NCT04003155|449797992|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
125048386|NCT04003155|449797988|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
125048387|NCT04003155|449797989|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
125048388|NCT04003155|449797990|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
125048389|NCT04003155|449797991|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
125048390|NCT04003155|449797992|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
125048391|NCT04003155|449797988|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
125048392|NCT04003155|449797989|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
125048393|NCT04003155|449797990|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
125048394|NCT04003155|449797991|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
125048395|NCT04003155|449797992|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
125048396|NCT04003155|449797988|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
125048397|NCT04003155|449797989|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
125048398|NCT04003155|449797990|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
125048399|NCT04003155|449797991|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
125048400|NCT04003155|449797992|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
125048401|NCT04003155|449797988|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
125048402|NCT04003155|449797989|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
125048403|NCT04003155|449797990|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
125048404|NCT04003155|449797991|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
125048405|NCT04003155|449797992|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
125048406|NCT04003155|449797988|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
125048407|NCT04003155|449797989|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
125048408|NCT04003155|449797990|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
125048409|NCT04003155|449797991|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
125048410|NCT04003155|449797992|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
125048411|NCT04003155|449797988|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
125048412|NCT04003155|449797989|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
125048413|NCT04003155|449797990|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
125048414|NCT04003155|449797991|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
125048415|NCT04003155|449797992|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
125048416|NCT04003155|449797988|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
125048417|NCT04003155|449797989|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
125048418|NCT04003155|449797990|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
125048419|NCT04003155|449797991|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
125048420|NCT04003155|449797992|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
125048421|NCT01912872|449797993|FG000|Overall Study|Lost to Follow-up|2|||
125048422|NCT01912872|449797994|FG001|Overall Study|Lost to Follow-up|3|||
125048423|NCT01912872|449797995|FG002|Overall Study|Lost to Follow-up|5|||
125048424|NCT01912872|449797996|FG003|Overall Study|Lost to Follow-up|5|||
125048425|NCT01912872|449797993|FG000|Overall Study|Other unspecified|3|||
125048426|NCT01912872|449797994|FG001|Overall Study|Other unspecified|1|||
125048427|NCT01912872|449797995|FG002|Overall Study|Other unspecified|3|||
125048428|NCT01912872|449797996|FG003|Overall Study|Other unspecified|0|||
125048429|NCT01912872|449797993|FG000|Overall Study|Informed consent withdrawn|0|||
125048430|NCT01912872|449797994|FG001|Overall Study|Informed consent withdrawn|0|||
125048431|NCT01912872|449797995|FG002|Overall Study|Informed consent withdrawn|1|||
125048432|NCT01912872|449797996|FG003|Overall Study|Informed consent withdrawn|1|||
125048433|NCT01912872|449797993|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
125048434|NCT01912872|449797994|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
125048435|NCT01912872|449797995|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
125048436|NCT01912872|449797996|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
125048437|NCT01912872|449797993|FG000|Overall Study|Protocol Violation|0|||
125048438|NCT01912872|449797994|FG001|Overall Study|Protocol Violation|0|||
125048439|NCT01912872|449797995|FG002|Overall Study|Protocol Violation|1|||
125048440|NCT01912872|449797996|FG003|Overall Study|Protocol Violation|0|||
125048441|NCT01912872|449797993|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125048442|NCT01912872|449797994|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125048443|NCT01912872|449797995|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
125048444|NCT01912872|449797996|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
125048445|NCT01912872|449797993|FG000|Overall Study|Withdrawal of study medication|0|||
125048446|NCT01912872|449797994|FG001|Overall Study|Withdrawal of study medication|0|||
125048447|NCT01912872|449797995|FG002|Overall Study|Withdrawal of study medication|0|||
125048448|NCT01912872|449797996|FG003|Overall Study|Withdrawal of study medication|2|||
125048449|NCT01912872|449797993|FG000|Overall Study|Missing|0|||
125048450|NCT01912872|449797994|FG001|Overall Study|Missing|0|||
125048451|NCT01912872|449797995|FG002|Overall Study|Missing|0|||
125048452|NCT01912872|449797996|FG003|Overall Study|Missing|1|||
125048453|NCT01713036|449797997|FG000|Overall Study|Death|1|||
125048454|NCT02778867|449797998|FG000|Phase 1|Withdrawal by Subject|2|||
125048455|NCT02778867|449797999|FG001|Phase 1|Withdrawal by Subject|3|||
125048456|NCT02778867|449798000|FG002|Phase 1|Withdrawal by Subject|0|||
125048457|NCT02778867|449798001|FG003|Phase 1|Withdrawal by Subject|0|||
125048458|NCT02778867|449797998|FG000|Phase 2|Withdrawal by Subject|0|||
125048459|NCT02778867|449797999|FG001|Phase 2|Withdrawal by Subject|0|||
125048460|NCT02778867|449798000|FG002|Phase 2|Withdrawal by Subject|1|||
125048461|NCT02778867|449798001|FG003|Phase 2|Withdrawal by Subject|0|||
125048462|NCT02778867|449797998|FG000|Phase 2|Physician Decision|0|||
125048463|NCT02778867|449797999|FG001|Phase 2|Physician Decision|0|||
125048464|NCT02778867|449798000|FG002|Phase 2|Physician Decision|0|||
125048465|NCT02778867|449798001|FG003|Phase 2|Physician Decision|1|||
125048466|NCT02778867|449797998|FG000|Phase 2|Adverse Event|0|||
125048467|NCT02778867|449797999|FG001|Phase 2|Adverse Event|0|||
125048468|NCT02778867|449798000|FG002|Phase 2|Adverse Event|0|||
125048469|NCT02778867|449798001|FG003|Phase 2|Adverse Event|1|||
125048470|NCT03504774|449798002|FG000|Overall Study|Adverse Event|2|||
125048471|NCT03504774|449798003|FG001|Overall Study|Adverse Event|0|||
125048472|NCT03504774|449798002|FG000|Overall Study|Lost to Follow-up|0|||
125048473|NCT03504774|449798003|FG001|Overall Study|Lost to Follow-up|1|||
125048474|NCT03504774|449798002|FG000|Overall Study|Protocol Violation|11|||
125048475|NCT03504774|449798003|FG001|Overall Study|Protocol Violation|3|||
125048476|NCT03504774|449798002|FG000|Overall Study|failed wk 52 DBPCFC|1|||
125048477|NCT03504774|449798003|FG001|Overall Study|failed wk 52 DBPCFC|0|||
125048478|NCT00915005|449798009|FG000|Overall Study|Withdrawal by Subject|4|||
125048479|NCT00915005|449798010|FG001|Overall Study|Withdrawal by Subject|4|||
125048480|NCT00915005|449798009|FG000|Overall Study|Patient preferred protons therapy|6|||
125048481|NCT00915005|449798010|FG001|Overall Study|Patient preferred protons therapy|0|||
125048482|NCT00915005|449798009|FG000|Overall Study|Insurance denial|3|||
125048483|NCT00915005|449798010|FG001|Overall Study|Insurance denial|15|||
125048484|NCT00305006|449798015|FG000|Overall Study|Withdrawal by Subject|1|||
125048485|NCT00305006|449798016|FG001|Overall Study|Withdrawal by Subject|0|||
125048486|NCT00305006|449798015|FG000|Overall Study|Failure to complete pretest|0|||
125048487|NCT00305006|449798016|FG001|Overall Study|Failure to complete pretest|1|||
125048488|NCT00631488|449798017|FG000|Overall Study|Adverse Event|1|||
125048489|NCT00631488|449798018|FG001|Overall Study|Adverse Event|0|||
125048490|NCT00631488|449798019|FG002|Overall Study|Adverse Event|0|||
125048491|NCT00631488|449798017|FG000|Overall Study|Lost to Follow-up|2|||
125048492|NCT00631488|449798018|FG001|Overall Study|Lost to Follow-up|2|||
125048493|NCT00631488|449798019|FG002|Overall Study|Lost to Follow-up|0|||
125048494|NCT00631488|449798017|FG000|Overall Study|Physician Decision|1|||
125048495|NCT00631488|449798018|FG001|Overall Study|Physician Decision|0|||
125048496|NCT00631488|449798019|FG002|Overall Study|Physician Decision|1|||
125048497|NCT00631488|449798017|FG000|Overall Study|Protocol Violation|0|||
125048498|NCT00631488|449798018|FG001|Overall Study|Protocol Violation|0|||
125048499|NCT00631488|449798019|FG002|Overall Study|Protocol Violation|1|||
125048500|NCT03648476|449798020|FG000|Overall Study|Withdrawal by Subject|2|||
125048501|NCT03648476|449798021|FG001|Overall Study|Withdrawal by Subject|1|||
125048502|NCT02546856|449798024|FG000|4 Months Evaluation|Death|2|||
125048503|NCT02546856|449798025|FG001|4 Months Evaluation|Death|3|||
125048504|NCT02546856|449798024|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
125048505|NCT02546856|449798025|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
125048506|NCT02546856|449798024|FG000|4 Months Evaluation|Lost to Follow-up|3|||
125048507|NCT02546856|449798025|FG001|4 Months Evaluation|Lost to Follow-up|3|||
125048508|NCT02546856|449798024|FG000|4 Months Evaluation|Physician Decision|3|||
125048509|NCT02546856|449798025|FG001|4 Months Evaluation|Physician Decision|0|||
125048510|NCT02546856|449798024|FG000|4 Months Evaluation|Working or living abroad|5|||
125048511|NCT02546856|449798025|FG001|4 Months Evaluation|Working or living abroad|1|||
125048512|NCT02546856|449798024|FG000|4 Months Evaluation|reasons not due to titration|4|||
125048513|NCT02546856|449798025|FG001|4 Months Evaluation|reasons not due to titration|1|||
125048514|NCT02546856|449798024|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
125048515|NCT02546856|449798025|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
125048516|NCT02546856|449798024|FG000|6 Months Evaluation|Death|1|||
125048517|NCT02546856|449798025|FG001|6 Months Evaluation|Death|1|||
125048518|NCT02546856|449798024|FG000|6 Months Evaluation|Lost to Follow-up|1|||
125048519|NCT02546856|449798025|FG001|6 Months Evaluation|Lost to Follow-up|1|||
125048520|NCT02546856|449798024|FG000|6 Months Evaluation|Working or living abroad|6|||
125048521|NCT02546856|449798025|FG001|6 Months Evaluation|Working or living abroad|4|||
125048522|NCT02546856|449798024|FG000|6 Months Evaluation|reasons not due to titration|0|||
125048523|NCT02546856|449798025|FG001|6 Months Evaluation|reasons not due to titration|1|||
125048524|NCT01097616|449798026|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
125048525|NCT01097616|449798027|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
125048526|NCT01097616|449798028|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
125048527|NCT01097616|449798029|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
125048528|NCT01097616|449798030|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
125048529|NCT01097616|449798031|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
125048530|NCT01097616|449798032|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
125048531|NCT01097616|449798033|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
125048532|NCT01097616|449798026|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
125048533|NCT01097616|449798027|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
125048534|NCT01097616|449798028|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
125048535|NCT01097616|449798029|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
125048536|NCT01097616|449798030|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
125048537|NCT01097616|449798031|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
125048538|NCT01097616|449798032|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
125048539|NCT01097616|449798033|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
125219310|NCT04501952|450429386|FG001|Overall Study|Protocol Violation|1|||
125219311|NCT04501952|450429385|FG000|Overall Study|Withdrew Consent|5|||
125219312|NCT04501952|450429386|FG001|Overall Study|Withdrew Consent|4|||
125219313|NCT04501952|450429385|FG000|Overall Study|Lost to Follow-up|7|||
125219314|NCT04501952|450429386|FG001|Overall Study|Lost to Follow-up|2|||
125219315|NCT04501952|450429385|FG000|Overall Study|Randomized and Never Treated|13|||
125219316|NCT04501952|450429386|FG001|Overall Study|Randomized and Never Treated|9|||
125219317|NCT02080364|450429388|FG000|Baseline Period|Protocol Violation|2|||
125219318|NCT02080364|450429389|FG001|Baseline Period|Protocol Violation|1|||
125048540|NCT01097616|449798026|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
125048541|NCT01097616|449798027|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
125048542|NCT01097616|449798028|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
125048543|NCT01097616|449798029|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
125048544|NCT01097616|449798030|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
125048545|NCT01097616|449798031|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
125219319|NCT02080364|450429390|FG002|Baseline Period|Protocol Violation|0|||
125219320|NCT02080364|450429391|FG003|Baseline Period|Protocol Violation|0|||
125219321|NCT02080364|450429388|FG000|Baseline Period|Other|0|||
125219322|NCT02080364|450429389|FG001|Baseline Period|Other|1|||
125219323|NCT02080364|450429390|FG002|Baseline Period|Other|1|||
125219324|NCT02080364|450429391|FG003|Baseline Period|Other|0|||
125219325|NCT02080364|450429388|FG000|Treatment Period|Adverse Event|10|||
125219326|NCT02080364|450429389|FG001|Treatment Period|Adverse Event|15|||
125219327|NCT02080364|450429390|FG002|Treatment Period|Adverse Event|11|||
125048546|NCT01097616|449798032|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
125048547|NCT01097616|449798033|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
125048548|NCT01097616|449798026|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
125048549|NCT01097616|449798027|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
125048550|NCT01097616|449798028|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125048551|NCT01097616|449798029|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125048552|NCT01097616|449798030|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125048553|NCT01097616|449798031|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125048554|NCT01097616|449798032|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125048555|NCT01097616|449798033|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125048556|NCT01097616|449798026|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
125048557|NCT01097616|449798027|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
125048558|NCT01097616|449798028|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
125048559|NCT01097616|449798029|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
125048560|NCT01097616|449798030|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
125048561|NCT01097616|449798031|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
125048562|NCT01097616|449798032|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
125048563|NCT01097616|449798033|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
125048564|NCT01097616|449798026|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
125048565|NCT01097616|449798027|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
125048566|NCT01097616|449798028|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
125048567|NCT01097616|449798029|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
125048568|NCT01097616|449798030|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
125048569|NCT01097616|449798031|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
125048570|NCT01097616|449798032|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
125048571|NCT01097616|449798033|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
125048572|NCT01097616|449798026|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
125048573|NCT01097616|449798027|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
125048574|NCT01097616|449798028|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125048575|NCT01097616|449798029|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125048576|NCT01097616|449798030|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125048577|NCT01097616|449798031|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125048578|NCT01097616|449798032|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125048579|NCT01097616|449798033|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125048580|NCT01097616|449798026|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125048581|NCT01097616|449798027|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125048582|NCT01097616|449798028|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
125048583|NCT01097616|449798029|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125048584|NCT01097616|449798030|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125048585|NCT01097616|449798031|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125048586|NCT01097616|449798032|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125048587|NCT01097616|449798033|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125219328|NCT02080364|450429391|FG003|Treatment Period|Adverse Event|14|||
125048588|NCT01097616|449798026|FG000|Optional DB EXT Phase|Adverse Event|0|||
125219329|NCT02080364|450429388|FG000|Treatment Period|Lost to Follow-up|2|||
125219330|NCT02080364|450429389|FG001|Treatment Period|Lost to Follow-up|3|||
125048589|NCT01097616|449798027|FG001|Optional DB EXT Phase|Adverse Event|7|||
125048590|NCT01097616|449798028|FG002|Optional DB EXT Phase|Adverse Event|2|||
125048591|NCT01097616|449798029|FG003|Optional DB EXT Phase|Adverse Event|0|||
125048592|NCT01097616|449798030|FG004|Optional DB EXT Phase|Adverse Event|0|||
125048593|NCT01097616|449798031|FG005|Optional DB EXT Phase|Adverse Event|0|||
125048594|NCT01097616|449798032|FG006|Optional DB EXT Phase|Adverse Event|0|||
125048595|NCT01097616|449798033|FG007|Optional DB EXT Phase|Adverse Event|0|||
125048596|NCT01097616|449798026|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
125048597|NCT01097616|449798027|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
125048598|NCT01097616|449798028|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
125048599|NCT01097616|449798029|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
125048600|NCT01097616|449798030|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
125048601|NCT01097616|449798031|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
125048602|NCT01097616|449798032|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
125048603|NCT01097616|449798033|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
125048604|NCT01097616|449798026|FG000|Optional DB EXT Phase|Protocol Violation|0|||
125048605|NCT01097616|449798027|FG001|Optional DB EXT Phase|Protocol Violation|2|||
125048606|NCT01097616|449798028|FG002|Optional DB EXT Phase|Protocol Violation|3|||
125048607|NCT01097616|449798029|FG003|Optional DB EXT Phase|Protocol Violation|0|||
125048608|NCT01097616|449798030|FG004|Optional DB EXT Phase|Protocol Violation|0|||
125048609|NCT01097616|449798031|FG005|Optional DB EXT Phase|Protocol Violation|0|||
125048610|NCT01097616|449798032|FG006|Optional DB EXT Phase|Protocol Violation|0|||
125048611|NCT01097616|449798033|FG007|Optional DB EXT Phase|Protocol Violation|0|||
125048612|NCT01097616|449798026|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
125048613|NCT01097616|449798027|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
125048614|NCT01097616|449798028|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
125048615|NCT01097616|449798029|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
125048616|NCT01097616|449798030|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
125048617|NCT01097616|449798031|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
125048618|NCT01097616|449798032|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
125048619|NCT01097616|449798033|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
125048620|NCT01097616|449798026|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
125048621|NCT01097616|449798027|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
125048622|NCT01097616|449798028|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
125048623|NCT01097616|449798029|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
125048624|NCT01097616|449798030|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
125048625|NCT01097616|449798031|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
125048626|NCT01097616|449798032|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
125048627|NCT01097616|449798033|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
125048628|NCT01097616|449798026|FG000|Optional DB EXT Phase|Physician Decision|1|||
125048629|NCT01097616|449798027|FG001|Optional DB EXT Phase|Physician Decision|0|||
125048630|NCT01097616|449798028|FG002|Optional DB EXT Phase|Physician Decision|0|||
125048631|NCT01097616|449798029|FG003|Optional DB EXT Phase|Physician Decision|0|||
125048632|NCT01097616|449798030|FG004|Optional DB EXT Phase|Physician Decision|0|||
125048633|NCT01097616|449798031|FG005|Optional DB EXT Phase|Physician Decision|0|||
125048634|NCT01097616|449798032|FG006|Optional DB EXT Phase|Physician Decision|0|||
125048635|NCT01097616|449798033|FG007|Optional DB EXT Phase|Physician Decision|0|||
125048636|NCT01097616|449798026|FG000|DB RO Phase|Adverse Event|0|||
125048637|NCT01097616|449798027|FG001|DB RO Phase|Adverse Event|0|||
125048638|NCT01097616|449798028|FG002|DB RO Phase|Adverse Event|0|||
125048639|NCT01097616|449798029|FG003|DB RO Phase|Adverse Event|0|||
125048640|NCT01097616|449798030|FG004|DB RO Phase|Adverse Event|0|||
125048641|NCT01097616|449798031|FG005|DB RO Phase|Adverse Event|0|||
125048642|NCT01097616|449798032|FG006|DB RO Phase|Adverse Event|1|||
125048643|NCT01097616|449798033|FG007|DB RO Phase|Adverse Event|0|||
125048644|NCT01097616|449798026|FG000|DB RO Phase|Withdrawal by Subject|0|||
125048645|NCT01097616|449798027|FG001|DB RO Phase|Withdrawal by Subject|0|||
125048646|NCT01097616|449798028|FG002|DB RO Phase|Withdrawal by Subject|0|||
125048647|NCT01097616|449798029|FG003|DB RO Phase|Withdrawal by Subject|0|||
125048648|NCT01097616|449798030|FG004|DB RO Phase|Withdrawal by Subject|0|||
125048649|NCT01097616|449798031|FG005|DB RO Phase|Withdrawal by Subject|1|||
125048650|NCT01097616|449798032|FG006|DB RO Phase|Withdrawal by Subject|0|||
125048651|NCT01097616|449798033|FG007|DB RO Phase|Withdrawal by Subject|0|||
125048652|NCT01097616|449798026|FG000|DB RO Phase|Lost to Follow-up|0|||
125048653|NCT01097616|449798027|FG001|DB RO Phase|Lost to Follow-up|0|||
125048654|NCT01097616|449798028|FG002|DB RO Phase|Lost to Follow-up|0|||
125048655|NCT01097616|449798029|FG003|DB RO Phase|Lost to Follow-up|1|||
125048656|NCT01097616|449798030|FG004|DB RO Phase|Lost to Follow-up|1|||
125048657|NCT01097616|449798031|FG005|DB RO Phase|Lost to Follow-up|0|||
125048658|NCT01097616|449798032|FG006|DB RO Phase|Lost to Follow-up|0|||
125048659|NCT01097616|449798033|FG007|DB RO Phase|Lost to Follow-up|1|||
125048660|NCT01097616|449798026|FG000|DB RO Phase|Not Treated in RO|0|||
125048661|NCT01097616|449798027|FG001|DB RO Phase|Not Treated in RO|0|||
125048662|NCT01097616|449798028|FG002|DB RO Phase|Not Treated in RO|0|||
125048663|NCT01097616|449798029|FG003|DB RO Phase|Not Treated in RO|0|||
125048664|NCT01097616|449798030|FG004|DB RO Phase|Not Treated in RO|0|||
125048665|NCT01097616|449798031|FG005|DB RO Phase|Not Treated in RO|1|||
125048666|NCT01097616|449798032|FG006|DB RO Phase|Not Treated in RO|0|||
125048667|NCT01097616|449798033|FG007|DB RO Phase|Not Treated in RO|0|||
125048668|NCT01703819|449798040|FG000|Overall Study|Adverse Event|0|||
125048669|NCT01703819|449798041|FG001|Overall Study|Adverse Event|1|||
125048670|NCT01703819|449798040|FG000|Overall Study|Withdrawal by Subject|0|||
125048671|NCT01703819|449798041|FG001|Overall Study|Withdrawal by Subject|1|||
125048672|NCT00859898|449798042|FG000|Overall Study|Lack of Efficacy|0|||
125048673|NCT00859898|449798043|FG001|Overall Study|Lack of Efficacy|1|||
125048674|NCT00859898|449798044|FG002|Overall Study|Lack of Efficacy|1|||
125048675|NCT00859898|449798042|FG000|Overall Study|Adverse Event|4|||
125048676|NCT00859898|449798043|FG001|Overall Study|Adverse Event|9|||
125048677|NCT00859898|449798044|FG002|Overall Study|Adverse Event|8|||
125048678|NCT00859898|449798042|FG000|Overall Study|Withdrawal by Subject|11|||
125048679|NCT00859898|449798043|FG001|Overall Study|Withdrawal by Subject|8|||
125048680|NCT00859898|449798044|FG002|Overall Study|Withdrawal by Subject|11|||
125048681|NCT00859898|449798042|FG000|Overall Study|Death|0|||
125048682|NCT00859898|449798043|FG001|Overall Study|Death|0|||
125048683|NCT00859898|449798044|FG002|Overall Study|Death|1|||
125048684|NCT00859898|449798042|FG000|Overall Study|Lost to Follow-up|10|||
125048685|NCT00859898|449798043|FG001|Overall Study|Lost to Follow-up|11|||
125048686|NCT00859898|449798044|FG002|Overall Study|Lost to Follow-up|5|||
125048687|NCT00859898|449798042|FG000|Overall Study|poor/non-compliance|2|||
125048688|NCT00859898|449798043|FG001|Overall Study|poor/non-compliance|0|||
125048689|NCT00859898|449798044|FG002|Overall Study|poor/non-compliance|0|||
125048690|NCT00859898|449798042|FG000|Overall Study|No longer meets criteria|0|||
125048691|NCT00859898|449798043|FG001|Overall Study|No longer meets criteria|1|||
125048692|NCT00859898|449798044|FG002|Overall Study|No longer meets criteria|0|||
125048693|NCT00859898|449798042|FG000|Overall Study|non-specified|1|||
125048694|NCT00859898|449798043|FG001|Overall Study|non-specified|1|||
125048695|NCT00859898|449798044|FG002|Overall Study|non-specified|1|||
125048696|NCT02145156|449798045|FG000|Overall Study|No match to vaccination records|60|||
125048697|NCT02145156|449798046|FG001|Overall Study|No match to vaccination records|52|||
125048698|NCT02145156|449798047|FG002|Overall Study|No match to vaccination records|41|||
125048699|NCT01302041|449798048|FG000|Overall Study|Death|5|||
125048700|NCT01302041|449798048|FG000|Overall Study|Withdrawal by Subject|4|||
125048701|NCT01302041|449798048|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
125048702|NCT01302041|449798048|FG000|Overall Study|Other-Miscellaneous Reason|2|||
125048703|NCT04504032|449798051|FG000|Overall Study|Adverse Event|1|||
125048704|NCT04504032|449798052|FG001|Overall Study|Adverse Event|2|||
125048705|NCT04504032|449798051|FG000|Overall Study|Lost to Follow-up|6|||
125048706|NCT04504032|449798052|FG001|Overall Study|Lost to Follow-up|9|||
125048707|NCT04504032|449798051|FG000|Overall Study|Protocol Violation|2|||
125048708|NCT04504032|449798052|FG001|Overall Study|Protocol Violation|0|||
125048709|NCT04504032|449798051|FG000|Overall Study|Study terminated by sponsor|1|||
125048710|NCT04504032|449798052|FG001|Overall Study|Study terminated by sponsor|2|||
125048711|NCT04504032|449798051|FG000|Overall Study|Withdrawal by Subject|9|||
125048712|NCT04504032|449798052|FG001|Overall Study|Withdrawal by Subject|11|||
125048713|NCT04504032|449798051|FG000|Overall Study|Disease progression prior to dosing|15|||
125048714|NCT04504032|449798052|FG001|Overall Study|Disease progression prior to dosing|3|||
125048715|NCT04504032|449798051|FG000|Overall Study|Drug supply issues|1|||
125048716|NCT04504032|449798052|FG001|Overall Study|Drug supply issues|1|||
125048717|NCT04504032|449798051|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
125048718|NCT04504032|449798052|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
125048719|NCT00771030|449798053|FG000|Overall Study|Adverse Event|0|||
125048720|NCT00771030|449798054|FG001|Overall Study|Adverse Event|1|||
125048721|NCT00771030|449798055|FG002|Overall Study|Adverse Event|0|||
125048722|NCT00771030|449798056|FG003|Overall Study|Adverse Event|0|||
125048723|NCT00771030|449798057|FG004|Overall Study|Adverse Event|0|||
125048724|NCT00771030|449798058|FG005|Overall Study|Adverse Event|0|||
125048725|NCT00771030|449798059|FG006|Overall Study|Adverse Event|0|||
125048726|NCT01839188|449798060|FG000|Overall Study|Withdrawal by Subject|1|||
125048727|NCT02416908|449798061|FG000|Dose Escalation Phase|Adverse Event|0|||
125048728|NCT02416908|449798062|FG001|Dose Escalation Phase|Adverse Event|0|||
125048729|NCT02416908|449798063|FG002|Dose Escalation Phase|Adverse Event|3|||
125048730|NCT02416908|449798064|FG003|Dose Escalation Phase|Adverse Event|0|||
125048731|NCT02416908|449798061|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
125048732|NCT02416908|449798062|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
125048733|NCT02416908|449798063|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
125048734|NCT02416908|449798064|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
125048735|NCT01797783|449798065|FG000|Overall Study|Adverse Event|1|||
125048736|NCT01797783|449798066|FG001|Overall Study|Adverse Event|1|||
125048737|NCT01797783|449798065|FG000|Overall Study|Withdrawal by Subject|1|||
125048738|NCT01797783|449798066|FG001|Overall Study|Withdrawal by Subject|0|||
125048739|NCT00940342|449798067|FG000|Overall Study|Adverse Event|0|||
125048740|NCT00940342|449798068|FG001|Overall Study|Adverse Event|2|||
125048741|NCT00940342|449798069|FG002|Overall Study|Adverse Event|1|||
125048742|NCT05232097|449798070|FG000|Overall Study|Physician Decision|1|||
125048743|NCT01327339|449798071|FG000|Overall Study|Protocol Violation|8|||
125048744|NCT00700752|449798076|FG000|First Intervention|Withdrawal by Subject|0|||
125048745|NCT00700752|449798077|FG001|First Intervention|Withdrawal by Subject|2|||
125048746|NCT03662334|449798078|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
125048747|NCT03662334|449798079|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
125048748|NCT01097330|449798082|FG000|Overall Study|Study terminated early|7|||
125048749|NCT01097330|449798083|FG001|Overall Study|Study terminated early|5|||
125048750|NCT00864227|449798090|FG000|Overall Study|Withdrawal by Subject|1|||
125048751|NCT00864227|449798090|FG000|Overall Study|Disease Relapse/Progression|3|||
125048752|NCT03461289|449798093|FG000|Overall Study|Death|1|||
125048753|NCT00081289|449798094|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
125048754|NCT00081289|449798095|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
125048755|NCT00081289|449798094|FG000|Overall Study|Ineligible / no protocol treatment|3|||
125048756|NCT00081289|449798095|FG001|Overall Study|Ineligible / no protocol treatment|4|||
125048757|NCT00916721|449798096|FG000|Overall Study|Lost to Follow-up|0|||
125048758|NCT00916721|449798097|FG001|Overall Study|Lost to Follow-up|1|||
125048759|NCT00916721|449798096|FG000|Overall Study|Adverse Event|6|||
125048760|NCT00916721|449798097|FG001|Overall Study|Adverse Event|3|||
125048761|NCT00916721|449798096|FG000|Overall Study|Withdrawal by Subject|2|||
125048762|NCT00916721|449798097|FG001|Overall Study|Withdrawal by Subject|2|||
125048763|NCT00916721|449798096|FG000|Overall Study|Protocol Violation|2|||
125048764|NCT00916721|449798097|FG001|Overall Study|Protocol Violation|4|||
125048765|NCT01469052|449798102|FG000|Overall Study|Adverse Event|2|||
125048766|NCT01469052|449798103|FG001|Overall Study|Adverse Event|3|||
125048767|NCT01469052|449798104|FG002|Overall Study|Adverse Event|0|||
125048768|NCT01469052|449798105|FG003|Overall Study|Adverse Event|2|||
125048769|NCT01469052|449798106|FG004|Overall Study|Adverse Event|0|||
125048770|NCT01469052|449798107|FG005|Overall Study|Adverse Event|1|||
125048771|NCT01469052|449798102|FG000|Overall Study|Progressive disease|3|||
125048772|NCT01469052|449798103|FG001|Overall Study|Progressive disease|0|||
125048773|NCT01469052|449798104|FG002|Overall Study|Progressive disease|5|||
125048774|NCT01469052|449798105|FG003|Overall Study|Progressive disease|3|||
125048775|NCT01469052|449798106|FG004|Overall Study|Progressive disease|7|||
125048776|NCT01469052|449798107|FG005|Overall Study|Progressive disease|2|||
125048777|NCT01469052|449798102|FG000|Overall Study|Lack of Efficacy|0|||
125048778|NCT01469052|449798103|FG001|Overall Study|Lack of Efficacy|0|||
125048779|NCT01469052|449798104|FG002|Overall Study|Lack of Efficacy|0|||
125048780|NCT01469052|449798105|FG003|Overall Study|Lack of Efficacy|0|||
125048781|NCT01469052|449798106|FG004|Overall Study|Lack of Efficacy|0|||
125048782|NCT01469052|449798107|FG005|Overall Study|Lack of Efficacy|2|||
125048783|NCT01469052|449798102|FG000|Overall Study|Moved to rollover protocol|1|||
125048784|NCT01469052|449798103|FG001|Overall Study|Moved to rollover protocol|0|||
125048785|NCT01469052|449798104|FG002|Overall Study|Moved to rollover protocol|1|||
125048786|NCT01469052|449798105|FG003|Overall Study|Moved to rollover protocol|0|||
125048787|NCT01469052|449798106|FG004|Overall Study|Moved to rollover protocol|0|||
125048788|NCT01469052|449798107|FG005|Overall Study|Moved to rollover protocol|1|||
125048789|NCT01469052|449798102|FG000|Overall Study|Other|0|||
125048790|NCT01469052|449798103|FG001|Overall Study|Other|1|||
125048791|NCT01469052|449798104|FG002|Overall Study|Other|0|||
125048792|NCT01469052|449798105|FG003|Overall Study|Other|0|||
125048793|NCT01469052|449798106|FG004|Overall Study|Other|1|||
125219331|NCT02080364|450429390|FG002|Treatment Period|Lost to Follow-up|5|||
125048794|NCT01469052|449798107|FG005|Overall Study|Other|0|||
125048795|NCT02749370|449798111|FG000|Overall Study|Withdrawal by Subject|11|||
125048796|NCT02749370|449798111|FG000|Overall Study|Lost to Follow-up|3|||
125048797|NCT01519427|449798115|FG000|Overall Study|disease progression|2|||
125048798|NCT03894904|449798116|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
125048799|NCT03894904|449798117|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
125219332|NCT02080364|450429391|FG003|Treatment Period|Lost to Follow-up|0|||
125048800|NCT03894904|449798116|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
125048801|NCT03894904|449798117|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
125048802|NCT03242759|449798118|FG000|Overall Study|Adverse Event|5|||
125048803|NCT03242759|449798119|FG001|Overall Study|Adverse Event|1|||
125048804|NCT03242759|449798118|FG000|Overall Study|Withdrawal by Subject|4|||
125048805|NCT03242759|449798119|FG001|Overall Study|Withdrawal by Subject|3|||
125048806|NCT03242759|449798118|FG000|Overall Study|Lost to Follow-up|3|||
125048807|NCT03242759|449798119|FG001|Overall Study|Lost to Follow-up|1|||
125048808|NCT03242759|449798118|FG000|Overall Study|Administrative problems|1|||
125048809|NCT03242759|449798119|FG001|Overall Study|Administrative problems|1|||
125048810|NCT03242759|449798118|FG000|Overall Study|Death|22|||
125048811|NCT03242759|449798119|FG001|Overall Study|Death|0|||
125048812|NCT03242759|449798118|FG000|Overall Study|Change visit schedule|0|||
125048813|NCT03242759|449798119|FG001|Overall Study|Change visit schedule|1|||
125048814|NCT04430582|449798123|FG000|Overall Study|Found to meet exclusionary criteria|1|||
125048815|NCT04430582|449798124|FG001|Overall Study|Found to meet exclusionary criteria|0|||
125048816|NCT04430582|449798123|FG000|Overall Study|Withdrawal by Subject|0|||
125048817|NCT04430582|449798124|FG001|Overall Study|Withdrawal by Subject|1|||
125048818|NCT02522481|449798125|FG000|Overall Study|discontinued|1|||
125048819|NCT02522481|449798125|FG000|Overall Study|Not dosed|2|||
125048820|NCT00404768|449798128|FG000|Part A and B|Withdrawn due to labor progression|1|||
125048821|NCT00404768|449798129|FG001|Part A and B|Withdrawn due to labor progression|0|||
125048822|NCT00404768|449798130|FG002|Part A and B|Withdrawn due to labor progression|0|||
125048823|NCT00404768|449798131|FG003|Part A and B|Withdrawn due to labor progression|0|||
125048824|NCT00404768|449798128|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
125048825|NCT00404768|449798129|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
125048826|NCT00404768|449798130|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
125048827|NCT00404768|449798131|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
125048828|NCT00404768|449798128|FG000|Part C|Adverse Event|0|||
125048829|NCT00404768|449798129|FG001|Part C|Adverse Event|0|||
125048830|NCT00404768|449798130|FG002|Part C|Adverse Event|0|||
125048831|NCT00404768|449798131|FG003|Part C|Adverse Event|3|||
125048832|NCT00404768|449798128|FG000|Part C|Lost to Follow-up|0|||
125048833|NCT00404768|449798129|FG001|Part C|Lost to Follow-up|0|||
125048834|NCT00404768|449798130|FG002|Part C|Lost to Follow-up|3|||
125048835|NCT00404768|449798131|FG003|Part C|Lost to Follow-up|1|||
125048836|NCT00404768|449798128|FG000|Part C|Withdrawal by Subject|0|||
125048837|NCT00404768|449798129|FG001|Part C|Withdrawal by Subject|0|||
125048838|NCT00404768|449798130|FG002|Part C|Withdrawal by Subject|2|||
125048839|NCT00404768|449798131|FG003|Part C|Withdrawal by Subject|1|||
125048840|NCT00404768|449798128|FG000|Part C|Early withdrawal from study medication|0|||
125048841|NCT00404768|449798129|FG001|Part C|Early withdrawal from study medication|0|||
125048842|NCT00404768|449798130|FG002|Part C|Early withdrawal from study medication|1|||
125048843|NCT00404768|449798131|FG003|Part C|Early withdrawal from study medication|0|||
125048844|NCT00404768|449798128|FG000|Part C|Participant did not respond to therapy|0|||
125048845|NCT00404768|449798129|FG001|Part C|Participant did not respond to therapy|0|||
125048846|NCT00404768|449798130|FG002|Part C|Participant did not respond to therapy|1|||
125048847|NCT00404768|449798131|FG003|Part C|Participant did not respond to therapy|1|||
125048848|NCT00404768|449798128|FG000|Part C|Physician withdrew the study medication|0|||
125048849|NCT00404768|449798129|FG001|Part C|Physician withdrew the study medication|0|||
125048850|NCT00404768|449798130|FG002|Part C|Physician withdrew the study medication|1|||
125048851|NCT00404768|449798131|FG003|Part C|Physician withdrew the study medication|0|||
125048852|NCT00404768|449798128|FG000|Part C|Participant delivered baby|0|||
125048853|NCT00404768|449798129|FG001|Part C|Participant delivered baby|0|||
125048854|NCT00404768|449798130|FG002|Part C|Participant delivered baby|0|||
125048855|NCT00404768|449798131|FG003|Part C|Participant delivered baby|1|||
125048856|NCT00404768|449798128|FG000|Part C|Unsatisfactory uterine response to IP|0|||
125048857|NCT00404768|449798129|FG001|Part C|Unsatisfactory uterine response to IP|0|||
125048858|NCT00404768|449798130|FG002|Part C|Unsatisfactory uterine response to IP|0|||
125048859|NCT00404768|449798131|FG003|Part C|Unsatisfactory uterine response to IP|1|||
125048860|NCT00404768|449798128|FG000|Part C|Active labor|0|||
125048861|NCT00404768|449798129|FG001|Part C|Active labor|0|||
125048862|NCT00404768|449798130|FG002|Part C|Active labor|0|||
125048863|NCT00404768|449798131|FG003|Part C|Active labor|1|||
125048864|NCT00404768|449798128|FG000|Part C|Lack of Efficacy|0|||
125048865|NCT00404768|449798129|FG001|Part C|Lack of Efficacy|0|||
125048866|NCT00404768|449798130|FG002|Part C|Lack of Efficacy|0|||
125048867|NCT00404768|449798131|FG003|Part C|Lack of Efficacy|2|||
125048868|NCT00404768|449798128|FG000|Part C|Treatment failure|0|||
125048869|NCT00404768|449798129|FG001|Part C|Treatment failure|0|||
125048870|NCT00404768|449798130|FG002|Part C|Treatment failure|0|||
125048871|NCT00404768|449798131|FG003|Part C|Treatment failure|1|||
125048872|NCT00404768|449798128|FG000|Part C|Investigator discretion|0|||
125048873|NCT00404768|449798129|FG001|Part C|Investigator discretion|0|||
125048874|NCT00404768|449798130|FG002|Part C|Investigator discretion|0|||
125048875|NCT00404768|449798131|FG003|Part C|Investigator discretion|1|||
125048876|NCT00404768|449798128|FG000|Part C|Researcher suspended study medication|0|||
125048877|NCT00404768|449798129|FG001|Part C|Researcher suspended study medication|0|||
125048878|NCT00404768|449798130|FG002|Part C|Researcher suspended study medication|0|||
125048879|NCT00404768|449798131|FG003|Part C|Researcher suspended study medication|1|||
125048880|NCT04773041|449798132|FG000|Overall Study|Unable to data match|1|||
125219333|NCT02080364|450429388|FG000|Treatment Period|Protocol Violation|5|||
125219334|NCT02080364|450429389|FG001|Treatment Period|Protocol Violation|3|||
125219335|NCT02080364|450429390|FG002|Treatment Period|Protocol Violation|5|||
125219336|NCT02080364|450429391|FG003|Treatment Period|Protocol Violation|1|||
125219337|NCT02080364|450429388|FG000|Treatment Period|Withdrawal by Subject|16|||
125219338|NCT02080364|450429389|FG001|Treatment Period|Withdrawal by Subject|16|||
125219339|NCT02080364|450429390|FG002|Treatment Period|Withdrawal by Subject|15|||
125219340|NCT02080364|450429391|FG003|Treatment Period|Withdrawal by Subject|10|||
125219341|NCT02080364|450429388|FG000|Treatment Period|Study Terminated by Sponsor|0|||
125219342|NCT02080364|450429389|FG001|Treatment Period|Study Terminated by Sponsor|0|||
125219343|NCT02080364|450429390|FG002|Treatment Period|Study Terminated by Sponsor|180|||
125219344|NCT02080364|450429391|FG003|Treatment Period|Study Terminated by Sponsor|183|||
125219345|NCT02080364|450429388|FG000|Treatment Period|Other|14|||
125219346|NCT02080364|450429389|FG001|Treatment Period|Other|12|||
125219347|NCT02080364|450429390|FG002|Treatment Period|Other|21|||
125219348|NCT02080364|450429391|FG003|Treatment Period|Other|16|||
125219349|NCT02609984|450429395|FG000|Overall Study|Death|29|||
125219350|NCT02609984|450429396|FG001|Overall Study|Death|26|||
125219351|NCT02609984|450429395|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
125219352|NCT02609984|450429396|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
125219353|NCT02609984|450429395|FG000|Overall Study|Lost to Follow-up|1|||
125219354|NCT02609984|450429396|FG001|Overall Study|Lost to Follow-up|2|||
125219355|NCT02609984|450429395|FG000|Overall Study|Withdrawal by Subject|0|||
125048881|NCT04773041|449798133|FG001|Overall Study|Unable to data match|0|||
125048882|NCT04773041|449798134|FG002|Overall Study|Unable to data match|0|||
125048883|NCT02100657|449799333|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
125048884|NCT02100657|449799334|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
125219356|NCT02609984|450429396|FG001|Overall Study|Withdrawal by Subject|1|||
125219357|NCT02609984|450429395|FG000|Overall Study|Disease Progression|2|||
125219358|NCT02609984|450429396|FG001|Overall Study|Disease Progression|0|||
125048885|NCT02100657|449799335|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
125048886|NCT02100657|449799333|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
125048887|NCT02100657|449799334|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
125048888|NCT02100657|449799335|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
125048889|NCT02100657|449799333|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
125048890|NCT02100657|449799334|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
125048891|NCT02100657|449799335|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
125048892|NCT02100657|449799333|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
125048893|NCT02100657|449799334|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
125048894|NCT02100657|449799335|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
125048895|NCT02100657|449799333|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
125048896|NCT02100657|449799334|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
125048897|NCT02100657|449799335|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
125048898|NCT02100657|449799333|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
125048899|NCT02100657|449799334|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
125048900|NCT02100657|449799335|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
125048901|NCT02100657|449799333|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
125048902|NCT02100657|449799334|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
125048903|NCT02100657|449799335|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
125048904|NCT02100657|449799333|FG000|Cohort 3: Dose Level 3|Death|0|||
125048905|NCT02100657|449799334|FG001|Cohort 3: Dose Level 3|Death|0|||
125048906|NCT02100657|449799335|FG002|Cohort 3: Dose Level 3|Death|1|||
125048907|NCT02100657|449799333|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
125048908|NCT02100657|449799334|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
125048909|NCT02100657|449799335|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
125048910|NCT02100657|449799333|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
125048911|NCT02100657|449799334|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
125048912|NCT02100657|449799335|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
125048913|NCT02100657|449799333|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
125048914|NCT02100657|449799334|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
125048915|NCT02100657|449799335|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
125048916|NCT02100657|449799333|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
125048917|NCT02100657|449799334|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
125219359|NCT02504320|450429397|FG000|Treatment Period 1|Positive Drug Screen|0|||
125219360|NCT02504320|450429398|FG001|Treatment Period 1|Positive Drug Screen|0|||
125219361|NCT02504320|450429399|FG002|Treatment Period 1|Positive Drug Screen|1|||
125048918|NCT02100657|449799335|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
125048919|NCT02100657|449799333|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
125048920|NCT02100657|449799334|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
125219362|NCT02504320|450429400|FG003|Treatment Period 1|Positive Drug Screen|0|||
125219363|NCT02504320|450429397|FG000|Treatment Period 2|Positive Drug Screen|0|||
125219364|NCT02504320|450429398|FG001|Treatment Period 2|Positive Drug Screen|1|||
125219365|NCT02504320|450429399|FG002|Treatment Period 2|Positive Drug Screen|0|||
125219366|NCT02504320|450429400|FG003|Treatment Period 2|Positive Drug Screen|0|||
125219367|NCT02504320|450429397|FG000|Treatment Period 3|Positive Drug Screen|0|||
125219368|NCT02504320|450429398|FG001|Treatment Period 3|Positive Drug Screen|0|||
125219369|NCT02504320|450429399|FG002|Treatment Period 3|Positive Drug Screen|0|||
125219370|NCT02504320|450429400|FG003|Treatment Period 3|Positive Drug Screen|1|||
125219371|NCT02504320|450429397|FG000|Treatment Period 3|Adverse Event|0|||
125219372|NCT02504320|450429398|FG001|Treatment Period 3|Adverse Event|0|||
125219373|NCT02504320|450429399|FG002|Treatment Period 3|Adverse Event|1|||
125219374|NCT02504320|450429400|FG003|Treatment Period 3|Adverse Event|0|||
125219375|NCT01210222|450429401|FG000|Overall Study|Ineligible|2|||
125219376|NCT01210222|450429401|FG000|Overall Study|Never treated|1|||
125219377|NCT04978337|450429404|FG000|Overall Study|Withdrawal by Subject|0|||
125219378|NCT04978337|450429405|FG001|Overall Study|Withdrawal by Subject|1|||
125219379|NCT02497404|450429406|FG000|Overall Study|Adverse Event|1|||
125219380|NCT01408901|450429409|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
125219381|NCT01408901|450429410|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
125219382|NCT01408901|450429411|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
125219383|NCT01408901|450429412|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
125219384|NCT01408901|450429409|FG000|6-Week Follow-Up|Death|1|||
125219385|NCT01408901|450429410|FG001|6-Week Follow-Up|Death|0|||
125219386|NCT01408901|450429411|FG002|6-Week Follow-Up|Death|0|||
125219387|NCT01408901|450429412|FG003|6-Week Follow-Up|Death|0|||
125219388|NCT01408901|450429409|FG000|6-Week Follow-Up|Cancelled visit|0|||
125219389|NCT01408901|450429410|FG001|6-Week Follow-Up|Cancelled visit|1|||
125219390|NCT01408901|450429411|FG002|6-Week Follow-Up|Cancelled visit|0|||
125219391|NCT01408901|450429412|FG003|6-Week Follow-Up|Cancelled visit|2|||
125219392|NCT01408901|450429409|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
125219393|NCT01408901|450429410|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
125219394|NCT01408901|450429411|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
125219395|NCT01408901|450429412|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
125219396|NCT01408901|450429409|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
125219397|NCT01408901|450429410|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
125219398|NCT01408901|450429411|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
125219399|NCT01408901|450429412|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
125219400|NCT01408901|450429409|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
125219401|NCT01408901|450429410|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
125219402|NCT01408901|450429411|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
125219403|NCT01408901|450429412|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
125219404|NCT01408901|450429409|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
125219405|NCT01408901|450429410|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
125219406|NCT01408901|450429411|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
125219407|NCT01408901|450429412|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
125219408|NCT01408901|450429409|FG000|26-Week Follow-Up|Death|0|||
125219409|NCT01408901|450429410|FG001|26-Week Follow-Up|Death|1|||
125219410|NCT01408901|450429411|FG002|26-Week Follow-Up|Death|0|||
125219411|NCT01408901|450429412|FG003|26-Week Follow-Up|Death|0|||
125219412|NCT01436227|450429416|FG000|Overall Study|Adverse Event|7|||
125219413|NCT01436227|450429416|FG000|Overall Study|Death|1|||
125219414|NCT01436227|450429416|FG000|Overall Study|Lack of Efficacy|1|||
125219415|NCT01436227|450429416|FG000|Overall Study|Lost to Follow-up|3|||
125219416|NCT01436227|450429416|FG000|Overall Study|Physician Decision|1|||
125219417|NCT01436227|450429416|FG000|Overall Study|Withdrawal by Subject|7|||
125219418|NCT01436227|450429416|FG000|Overall Study|Disease progression, relapse|6|||
125219419|NCT05464420|450429421|FG000|Overall Study|Death|0|||
125219420|NCT05464420|450429422|FG001|Overall Study|Death|0|||
125219421|NCT05464420|450429423|FG002|Overall Study|Death|0|||
125219422|NCT05464420|450429424|FG003|Overall Study|Death|1|||
125219423|NCT05464420|450429421|FG000|Overall Study|Lost to Follow-up|16|||
125219424|NCT05464420|450429422|FG001|Overall Study|Lost to Follow-up|11|||
125219425|NCT05464420|450429423|FG002|Overall Study|Lost to Follow-up|11|||
125219426|NCT05464420|450429424|FG003|Overall Study|Lost to Follow-up|11|||
125219427|NCT05464420|450429421|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
125219428|NCT05464420|450429422|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
125219429|NCT05464420|450429423|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
125219430|NCT05464420|450429424|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
125219431|NCT05464420|450429421|FG000|Overall Study|Withdrawal by Subject|4|||
125219432|NCT05464420|450429422|FG001|Overall Study|Withdrawal by Subject|8|||
125219433|NCT05464420|450429423|FG002|Overall Study|Withdrawal by Subject|3|||
125219434|NCT05464420|450429424|FG003|Overall Study|Withdrawal by Subject|1|||
125048921|NCT02100657|449799335|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
125219435|NCT05464420|450429421|FG000|Overall Study|Protocol Violation|0|||
125219436|NCT05464420|450429422|FG001|Overall Study|Protocol Violation|0|||
125219437|NCT05464420|450429423|FG002|Overall Study|Protocol Violation|1|||
125219438|NCT05464420|450429424|FG003|Overall Study|Protocol Violation|1|||
125048922|NCT01240811|449799336|FG000|Overall Study|Physician Decision|0|||
125048923|NCT01240811|449799337|FG001|Overall Study|Physician Decision|1|||
125048924|NCT01240811|449799338|FG002|Overall Study|Physician Decision|0|||
125048925|NCT01240811|449799336|FG000|Overall Study|Withdrawal by Subject|0|||
125048926|NCT01240811|449799337|FG001|Overall Study|Withdrawal by Subject|0|||
125048927|NCT01240811|449799338|FG002|Overall Study|Withdrawal by Subject|1|||
125048928|NCT03132805|449799341|FG000|Overall Study|Lost to Follow-up|142|||
125048929|NCT03132805|449799342|FG001|Overall Study|Lost to Follow-up|141|||
125048930|NCT03132805|449799343|FG002|Overall Study|Lost to Follow-up|113|||
125048931|NCT00710034|449799344|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
125048932|NCT00710034|449799345|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
125048933|NCT00710034|449799344|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
125048934|NCT00710034|449799345|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
125048935|NCT00710034|449799344|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
125048936|NCT00710034|449799345|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
125048937|NCT00710034|449799344|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
125048938|NCT00710034|449799345|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
125048939|NCT00710034|449799344|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
125048940|NCT00710034|449799345|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
125048941|NCT00710034|449799344|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
125048942|NCT00710034|449799345|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
125048943|NCT00710034|449799344|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
125048944|NCT00710034|449799345|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
125048945|NCT00710034|449799344|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
125048946|NCT00710034|449799345|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
125048947|NCT00710034|449799344|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
125048948|NCT00710034|449799345|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
125048949|NCT00710034|449799344|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
125048950|NCT00710034|449799345|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
125048951|NCT00710034|449799344|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
125048952|NCT00710034|449799345|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
125048953|NCT00500149|449799346|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
125048954|NCT00500149|449799347|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
125048955|NCT00500149|449799346|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
125048956|NCT00500149|449799347|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
125048957|NCT00500149|449799346|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
125048958|NCT00500149|449799347|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
125048959|NCT00500149|449799346|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
125048960|NCT00500149|449799347|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
125048961|NCT00500149|449799346|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
125048962|NCT00500149|449799347|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
125048963|NCT00500149|449799346|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
125048964|NCT00500149|449799347|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
125048965|NCT00500149|449799346|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
125048966|NCT00500149|449799347|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
125048967|NCT01158534|449799348|FG000|Overall Study|Withdrawal by Subject|1|||
125048968|NCT01158534|449799348|FG000|Overall Study|Death|1|||
125048969|NCT01158534|449799348|FG000|Overall Study|Other|1|||
125048970|NCT00521339|449799349|FG000|Treatment Phase|Adverse Event|2|||
125048971|NCT00521339|449799350|FG001|Treatment Phase|Adverse Event|0|||
125048972|NCT00521339|449799351|FG002|Treatment Phase|Adverse Event|0|||
125048973|NCT00521339|449799349|FG000|Treatment Phase|Intolerability to study drug|2|||
125048974|NCT00521339|449799350|FG001|Treatment Phase|Intolerability to study drug|0|||
125048975|NCT00521339|449799351|FG002|Treatment Phase|Intolerability to study drug|0|||
125048976|NCT00521339|449799349|FG000|Treatment Phase|Lack of Efficacy|3|||
125048977|NCT00521339|449799350|FG001|Treatment Phase|Lack of Efficacy|0|||
125048978|NCT00521339|449799351|FG002|Treatment Phase|Lack of Efficacy|0|||
125048979|NCT00521339|449799349|FG000|Treatment Phase|Withdrawal by Subject|3|||
125048980|NCT00521339|449799350|FG001|Treatment Phase|Withdrawal by Subject|0|||
125048981|NCT00521339|449799351|FG002|Treatment Phase|Withdrawal by Subject|0|||
125048982|NCT00521339|449799349|FG000|Treatment Phase|Lost to Follow-up|1|||
125048983|NCT00521339|449799350|FG001|Treatment Phase|Lost to Follow-up|0|||
125048984|NCT00521339|449799351|FG002|Treatment Phase|Lost to Follow-up|0|||
125048985|NCT00521339|449799349|FG000|Treatment Phase|Protocol Violation|1|||
125048986|NCT00521339|449799350|FG001|Treatment Phase|Protocol Violation|0|||
125048987|NCT00521339|449799351|FG002|Treatment Phase|Protocol Violation|0|||
125048988|NCT00521339|449799349|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
125048989|NCT00521339|449799350|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
125048990|NCT00521339|449799351|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
125048991|NCT00521339|449799349|FG000|Treatment Extension Phase|Death|0|||
125048992|NCT00521339|449799350|FG001|Treatment Extension Phase|Death|0|||
125048993|NCT00521339|449799351|FG002|Treatment Extension Phase|Death|1|||
125048994|NCT03123354|449799352|FG000|Overall Study|Physician Decision|6|||
125048995|NCT00950690|449799353|FG000|Overall Study|Death|4|||
125048996|NCT00950690|449799353|FG000|Overall Study|Adverse Event|15|||
125048997|NCT00950690|449799353|FG000|Overall Study|Lack of Efficacy|22|||
125048998|NCT00950690|449799353|FG000|Overall Study|Lost to Follow-up|40|||
125048999|NCT00950690|449799353|FG000|Overall Study|Other|163|||
125049000|NCT01996319|449799357|FG000|Overall Study|Protocol Violation|1|||
125049001|NCT01996319|449799358|FG001|Overall Study|Protocol Violation|0|||
125049002|NCT01996319|449799357|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
125049003|NCT01996319|449799358|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
125049004|NCT01996319|449799357|FG000|Overall Study|Adverse Event|2|||
125049005|NCT01996319|449799358|FG001|Overall Study|Adverse Event|2|||
125049006|NCT00130208|449799361|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
125049007|NCT00130208|449799362|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
125049008|NCT00130208|449799361|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
125049009|NCT00130208|449799362|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
125049010|NCT00130208|449799361|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
125049011|NCT00130208|449799362|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
125049012|NCT00130208|449799361|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
125049013|NCT00130208|449799362|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
125049014|NCT00130208|449799361|FG000|Maintenance Period (26 Weeks)|Other|1|||
125049015|NCT00130208|449799362|FG001|Maintenance Period (26 Weeks)|Other|1|||
125049016|NCT00130208|449799361|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
125049017|NCT00130208|449799362|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
125049018|NCT00130208|449799361|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
125049019|NCT00130208|449799362|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
125049020|NCT00130208|449799361|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
125049021|NCT00130208|449799362|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
125049022|NCT00130208|449799361|FG000|Washout Period (8 Weeks)|Other|1|||
125049023|NCT00130208|449799362|FG001|Washout Period (8 Weeks)|Other|1|||
125049024|NCT00589472|449799364|FG000|Overall Study|Adverse Event|1|||
125049025|NCT00553059|449799365|FG000|Overall Study|Deemed ineligible|1|||
125049026|NCT00553059|449799366|FG001|Overall Study|Deemed ineligible|1|||
125049027|NCT00553059|449799365|FG000|Overall Study|Drug supply not available|0|||
125049028|NCT00553059|449799366|FG001|Overall Study|Drug supply not available|1|||
125049029|NCT00117338|449799367|FG000|Overall Study|Adverse Event|0|||
125049030|NCT00117338|449799368|FG001|Overall Study|Adverse Event|1|||
125049031|NCT00117338|449799367|FG000|Overall Study|Protocol Violation|3|||
125049032|NCT00117338|449799368|FG001|Overall Study|Protocol Violation|2|||
125049033|NCT00117338|449799367|FG000|Overall Study|Withdrawal by Subject|1|||
125049034|NCT00117338|449799368|FG001|Overall Study|Withdrawal by Subject|0|||
125049035|NCT00117338|449799367|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
125049036|NCT00117338|449799368|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
125049037|NCT00117338|449799367|FG000|Overall Study|Lack of Efficacy|0|||
125049038|NCT00117338|449799368|FG001|Overall Study|Lack of Efficacy|1|||
125049039|NCT02805907|449799369|FG000|Overall Study|Lost to Follow-up|3|||
125049040|NCT02805907|449799370|FG001|Overall Study|Lost to Follow-up|3|||
125049041|NCT01264965|449799371|FG000|Overall Study|Withdrawal by Subject|10|||
125049042|NCT02202031|449799372|FG000|Overall Study|Lost to Follow-up|1|||
125049043|NCT02202031|449799373|FG001|Overall Study|Lost to Follow-up|0|||
125049044|NCT02202031|449799372|FG000|Overall Study|Too Busy|1|||
125049045|NCT02202031|449799373|FG001|Overall Study|Too Busy|3|||
125049046|NCT02202031|449799372|FG000|Overall Study|Illness/Medical Reason|0|||
125049047|NCT02202031|449799373|FG001|Overall Study|Illness/Medical Reason|2|||
125049048|NCT02202031|449799372|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
125049049|NCT02202031|449799373|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
125049050|NCT00871858|449799376|FG000|Overall Study|Protocol Violation|3|||
125049051|NCT00871858|449799377|FG001|Overall Study|Protocol Violation|4|||
125049052|NCT00871858|449799376|FG000|Overall Study|Adverse Event|1|||
125049053|NCT00871858|449799377|FG001|Overall Study|Adverse Event|1|||
125049054|NCT00871858|449799376|FG000|Overall Study|Withdrawal by Subject|1|||
125049055|NCT00871858|449799377|FG001|Overall Study|Withdrawal by Subject|1|||
125049056|NCT00871858|449799376|FG000|Overall Study|Lost to Follow-up|0|||
125049057|NCT00871858|449799377|FG001|Overall Study|Lost to Follow-up|1|||
125049058|NCT02853331|449799388|FG000|Overall Study|Death|59|||
125049059|NCT02853331|449799389|FG001|Overall Study|Death|95|||
125049060|NCT02853331|449799388|FG000|Overall Study|Withdrawal by Subject|5|||
125049061|NCT02853331|449799389|FG001|Overall Study|Withdrawal by Subject|9|||
125049062|NCT02853331|449799388|FG000|Overall Study|Ongoing in study|368|||
125049063|NCT02853331|449799389|FG001|Overall Study|Ongoing in study|325|||
125049064|NCT00844428|449799394|FG000|Screening Period|Screen Failure|3|||
125049065|NCT00844428|449799394|FG000|Extension Treatment Period|Death|1|||
125049066|NCT00844428|449799394|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
125049067|NCT03290300|449799395|FG000|Overall Study|Lost to Follow-up|3|||
125049068|NCT01276847|449799397|FG000|Overall Study|Withdrawal by Subject|1|||
125049069|NCT01276847|449799398|FG001|Overall Study|Withdrawal by Subject|0|||
125049070|NCT01276847|449799399|FG002|Overall Study|Withdrawal by Subject|0|||
125049071|NCT01899144|449799402|FG000|Treatment Period 2|Other|1|||
125049072|NCT01899144|449799402|FG000|Treatment Period 3|Other|2|||
125049073|NCT01899144|449799402|FG000|Treatment Period 5|Other|1|||
125049074|NCT00751881|449799405|FG000|Core Treatment Period|Not treated|1|||
125049075|NCT00751881|449799406|FG001|Core Treatment Period|Not treated|1|||
125049076|NCT00751881|449799407|FG002|Core Treatment Period|Not treated|2|||
125219439|NCT05464420|450429421|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
125219440|NCT05464420|450429422|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
125219441|NCT05464420|450429423|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
125219442|NCT05464420|450429424|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
125219443|NCT01383018|450429425|FG000|Overall Study|Adverse Event|14|||
125219444|NCT01383018|450429425|FG000|Overall Study|Death|10|||
125219445|NCT01383018|450429425|FG000|Overall Study|Lost to Follow-up|5|||
125219446|NCT01383018|450429425|FG000|Overall Study|Physician Decision|5|||
125219447|NCT01383018|450429425|FG000|Overall Study|Withdrawal by Subject|9|||
125219448|NCT01383018|450429425|FG000|Overall Study|Subject not implanted|76|||
125219449|NCT01383018|450429425|FG000|Overall Study|Missed Visit|247|||
125049077|NCT00751881|449799405|FG000|Core Treatment Period|Adverse Event|26|||
125049078|NCT00751881|449799406|FG001|Core Treatment Period|Adverse Event|54|||
125049079|NCT00751881|449799407|FG002|Core Treatment Period|Adverse Event|58|||
125049080|NCT00751881|449799405|FG000|Core Treatment Period|Lack of Efficacy|37|||
125049081|NCT00751881|449799406|FG001|Core Treatment Period|Lack of Efficacy|30|||
125049082|NCT00751881|449799407|FG002|Core Treatment Period|Lack of Efficacy|20|||
125049083|NCT00751881|449799405|FG000|Core Treatment Period|Poor compliance to protocol|15|||
125049084|NCT00751881|449799406|FG001|Core Treatment Period|Poor compliance to protocol|3|||
125049085|NCT00751881|449799407|FG002|Core Treatment Period|Poor compliance to protocol|4|||
125049086|NCT00751881|449799405|FG000|Core Treatment Period|Lost to Follow-up|6|||
125049087|NCT00751881|449799406|FG001|Core Treatment Period|Lost to Follow-up|4|||
125049088|NCT00751881|449799407|FG002|Core Treatment Period|Lost to Follow-up|3|||
125049089|NCT00751881|449799405|FG000|Core Treatment Period|Other: protocol deviation|3|||
125049090|NCT00751881|449799406|FG001|Core Treatment Period|Other: protocol deviation|3|||
125049091|NCT00751881|449799407|FG002|Core Treatment Period|Other: protocol deviation|7|||
125049092|NCT00751881|449799405|FG000|Core Treatment Period|Other: wish to parent|5|||
125219450|NCT01383018|450429425|FG000|Overall Study|Site closed early-not compliance related|7|||
125219451|NCT01383018|450429425|FG000|Overall Study|Patient moved away from site|1|||
125219452|NCT01383018|450429425|FG000|Overall Study|Subject Incarcerated|1|||
125219453|NCT03414229|450429428|FG000|Overall Study|Adverse Event|1|||
125219454|NCT03414229|450429429|FG001|Overall Study|Adverse Event|0|||
125219455|NCT03414229|450429430|FG002|Overall Study|Adverse Event|2|||
125219456|NCT03414229|450429431|FG003|Overall Study|Adverse Event|1|||
125219457|NCT03414229|450429428|FG000|Overall Study|Lack of Efficacy|7|||
125219458|NCT03414229|450429429|FG001|Overall Study|Lack of Efficacy|4|||
125049093|NCT00751881|449799406|FG001|Core Treatment Period|Other: wish to parent|7|||
125049094|NCT00751881|449799407|FG002|Core Treatment Period|Other: wish to parent|4|||
125049095|NCT00751881|449799405|FG000|Core Treatment Period|Other: personal/family constraints|6|||
125049096|NCT00751881|449799406|FG001|Core Treatment Period|Other: personal/family constraints|7|||
125049097|NCT00751881|449799407|FG002|Core Treatment Period|Other: personal/family constraints|10|||
125049098|NCT00751881|449799405|FG000|Core Treatment Period|Other: MS treatment change|6|||
125049099|NCT00751881|449799406|FG001|Core Treatment Period|Other: MS treatment change|4|||
125049100|NCT00751881|449799407|FG002|Core Treatment Period|Other: MS treatment change|4|||
125049101|NCT00751881|449799405|FG000|Core Treatment Period|Other: tolerability complaints|2|||
125049102|NCT00751881|449799406|FG001|Core Treatment Period|Other: tolerability complaints|0|||
125049103|NCT00751881|449799407|FG002|Core Treatment Period|Other: tolerability complaints|0|||
125049104|NCT00751881|449799405|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
125049105|NCT00751881|449799406|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
125049106|NCT00751881|449799407|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
125049107|NCT00751881|449799405|FG000|Extension Study Period|Adverse Event|18|||
125219459|NCT03414229|450429430|FG002|Overall Study|Lack of Efficacy|1|||
125219460|NCT03414229|450429431|FG003|Overall Study|Lack of Efficacy|9|||
125219461|NCT03414229|450429428|FG000|Overall Study|Change in therapy|1|||
125219462|NCT03414229|450429429|FG001|Overall Study|Change in therapy|0|||
125219463|NCT03414229|450429430|FG002|Overall Study|Change in therapy|0|||
125049108|NCT00751881|449799406|FG001|Extension Study Period|Adverse Event|20|||
125049109|NCT00751881|449799407|FG002|Extension Study Period|Adverse Event|21|||
125049110|NCT00751881|449799405|FG000|Extension Study Period|Lack of Efficacy|14|||
125049111|NCT00751881|449799406|FG001|Extension Study Period|Lack of Efficacy|10|||
125049112|NCT00751881|449799407|FG002|Extension Study Period|Lack of Efficacy|20|||
125049113|NCT00751881|449799405|FG000|Extension Study Period|Lost to Follow-up|4|||
125049114|NCT00751881|449799406|FG001|Extension Study Period|Lost to Follow-up|9|||
125049115|NCT00751881|449799407|FG002|Extension Study Period|Lost to Follow-up|6|||
125049116|NCT00751881|449799405|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
125049117|NCT00751881|449799406|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
125049118|NCT00751881|449799407|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
125049119|NCT00751881|449799405|FG000|Extension Study Period|Other than specified above|26|||
125049120|NCT00751881|449799406|FG001|Extension Study Period|Other than specified above|30|||
125049121|NCT00751881|449799407|FG002|Extension Study Period|Other than specified above|18|||
125049122|NCT02119104|449799408|FG000|Overall Study|Protocol Violation|16|||
125049123|NCT00530712|449799411|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
125049124|NCT00530712|449799411|FG000|30 Day Follow-up Visit|Missed Visit|5|||
125049125|NCT00530712|449799411|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
125049126|NCT00530712|449799411|FG000|6 Month Follow-up Visit|Missed Visit|3|||
125049127|NCT00530712|449799411|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
125049128|NCT00530712|449799411|FG000|6 Month Follow-up Visit|Death|2|||
125049129|NCT00530712|449799411|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
125049130|NCT00530712|449799411|FG000|12 Month Follow-up Visit|Missed Visit|3|||
125049131|NCT00530712|449799411|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
125049132|NCT00530712|449799411|FG000|12 Month Follow-up Visit|Death|9|||
125049133|NCT00651118|449799419|FG000|Overall Study|Adverse Event|4|||
125049134|NCT00651118|449799420|FG001|Overall Study|Adverse Event|0|||
125049135|NCT00651118|449799421|FG002|Overall Study|Adverse Event|1|||
125049136|NCT00651118|449799422|FG003|Overall Study|Adverse Event|1|||
125049137|NCT00651118|449799419|FG000|Overall Study|Protocol Violation|2|||
125219464|NCT03414229|450429431|FG003|Overall Study|Change in therapy|0|||
125219465|NCT03414229|450429428|FG000|Overall Study|Pregnancy|0|||
125049138|NCT00651118|449799420|FG001|Overall Study|Protocol Violation|2|||
125049139|NCT00651118|449799421|FG002|Overall Study|Protocol Violation|6|||
125049140|NCT00651118|449799422|FG003|Overall Study|Protocol Violation|2|||
125049141|NCT00651118|449799419|FG000|Overall Study|Lost to Follow-up|2|||
125049142|NCT00651118|449799420|FG001|Overall Study|Lost to Follow-up|0|||
125049143|NCT00651118|449799421|FG002|Overall Study|Lost to Follow-up|1|||
125049144|NCT00651118|449799422|FG003|Overall Study|Lost to Follow-up|2|||
125049145|NCT00651118|449799419|FG000|Overall Study|administrative|1|||
125049146|NCT00651118|449799420|FG001|Overall Study|administrative|4|||
125049147|NCT00651118|449799421|FG002|Overall Study|administrative|2|||
125049148|NCT00651118|449799422|FG003|Overall Study|administrative|1|||
125049149|NCT00651118|449799419|FG000|Overall Study|Withdrawal by Subject|0|||
125049150|NCT00651118|449799420|FG001|Overall Study|Withdrawal by Subject|1|||
125049151|NCT00651118|449799421|FG002|Overall Study|Withdrawal by Subject|1|||
125049152|NCT00651118|449799422|FG003|Overall Study|Withdrawal by Subject|1|||
125049153|NCT03117049|449799423|FG000|Overall Study|Continued the follow-up period|109|||
125049154|NCT03117049|449799424|FG001|Overall Study|Continued the follow-up period|129|||
125049155|NCT03117049|449799423|FG000|Overall Study|Died|82|||
125049156|NCT03117049|449799424|FG001|Overall Study|Died|93|||
125049157|NCT03117049|449799423|FG000|Overall Study|Consent withdrawal|7|||
125049158|NCT03117049|449799424|FG001|Overall Study|Consent withdrawal|6|||
125049159|NCT03117049|449799423|FG000|Overall Study|Missing contact|3|||
125049160|NCT03117049|449799424|FG001|Overall Study|Missing contact|3|||
125049161|NCT00839098|449799425|FG000|Overall Study|Withdrawal by Subject|2|||
125049162|NCT00839098|449799426|FG001|Overall Study|Withdrawal by Subject|1|||
125049163|NCT00839098|449799427|FG002|Overall Study|Withdrawal by Subject|7|||
125049164|NCT00365976|449799430|FG000|Overall Study|Withdrawal by Subject|1|||
125219466|NCT03414229|450429429|FG001|Overall Study|Pregnancy|0|||
125219467|NCT03414229|450429430|FG002|Overall Study|Pregnancy|1|||
125219468|NCT03414229|450429431|FG003|Overall Study|Pregnancy|0|||
125219469|NCT03414229|450429428|FG000|Overall Study|Withdrawal by Subject|0|||
125219470|NCT03414229|450429429|FG001|Overall Study|Withdrawal by Subject|1|||
125219471|NCT03414229|450429430|FG002|Overall Study|Withdrawal by Subject|1|||
125219472|NCT03414229|450429431|FG003|Overall Study|Withdrawal by Subject|0|||
125219473|NCT04533438|450429435|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
125219474|NCT04533438|450429436|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
125219475|NCT05279131|450429437|FG000|Overall Study|Lost to Follow-up|1|||
125219476|NCT05279131|450429437|FG000|Overall Study|Death|1|||
125219477|NCT05279131|450429437|FG000|Overall Study|Physician Decision|1|||
125219478|NCT01066871|450429450|FG000|Overall Study|Lost to Follow-up|0|||
125219479|NCT01066871|450429451|FG001|Overall Study|Lost to Follow-up|2|||
125219480|NCT01066871|450429452|FG002|Overall Study|Lost to Follow-up|2|||
125219481|NCT01066871|450429453|FG003|Overall Study|Lost to Follow-up|0|||
125219482|NCT01066871|450429450|FG000|Overall Study|Protocol Violation|1|||
125219483|NCT01066871|450429451|FG001|Overall Study|Protocol Violation|0|||
125219484|NCT01066871|450429452|FG002|Overall Study|Protocol Violation|3|||
125219485|NCT01066871|450429453|FG003|Overall Study|Protocol Violation|2|||
125219486|NCT01066871|450429450|FG000|Overall Study|Lack of Efficacy|0|||
125219487|NCT01066871|450429451|FG001|Overall Study|Lack of Efficacy|0|||
125219488|NCT01066871|450429452|FG002|Overall Study|Lack of Efficacy|0|||
125219489|NCT01066871|450429453|FG003|Overall Study|Lack of Efficacy|1|||
125049165|NCT00365976|449799431|FG001|Overall Study|Withdrawal by Subject|5|||
125049166|NCT02260193|449799432|FG000|Overall Study|Lack of Efficacy|0|||
125049167|NCT02260193|449799433|FG001|Overall Study|Lack of Efficacy|1|||
125049168|NCT02260193|449799434|FG002|Overall Study|Lack of Efficacy|6|||
125049169|NCT02260193|449799432|FG000|Overall Study|Adverse Event|3|||
125049170|NCT02260193|449799433|FG001|Overall Study|Adverse Event|4|||
125049171|NCT02260193|449799434|FG002|Overall Study|Adverse Event|1|||
125049172|NCT02260193|449799432|FG000|Overall Study|Protocol Violation|0|||
125049173|NCT02260193|449799433|FG001|Overall Study|Protocol Violation|4|||
125049174|NCT02260193|449799434|FG002|Overall Study|Protocol Violation|0|||
125049175|NCT02260193|449799432|FG000|Overall Study|Withdrawal by Subject|3|||
125049176|NCT02260193|449799433|FG001|Overall Study|Withdrawal by Subject|0|||
125049177|NCT02260193|449799434|FG002|Overall Study|Withdrawal by Subject|2|||
125049178|NCT02260193|449799432|FG000|Overall Study|Kidney Transplantation|0|||
125049179|NCT02260193|449799433|FG001|Overall Study|Kidney Transplantation|0|||
125049180|NCT02260193|449799434|FG002|Overall Study|Kidney Transplantation|1|||
125049181|NCT00633139|449799441|FG000|Overall Study|Non compliance|0|||
125049182|NCT00633139|449799442|FG001|Overall Study|Non compliance|0|||
125049183|NCT00633139|449799443|FG002|Overall Study|Non compliance|1|||
125049184|NCT00633139|449799441|FG000|Overall Study|Withdrawal by Subject|0|||
125049185|NCT00633139|449799442|FG001|Overall Study|Withdrawal by Subject|1|||
125219490|NCT01066871|450429450|FG000|Overall Study|Withdrawal by Subject|3|||
125219491|NCT01066871|450429451|FG001|Overall Study|Withdrawal by Subject|1|||
125219492|NCT01066871|450429452|FG002|Overall Study|Withdrawal by Subject|0|||
125219493|NCT01066871|450429453|FG003|Overall Study|Withdrawal by Subject|0|||
125219494|NCT01066871|450429450|FG000|Overall Study|Other|0|||
125219495|NCT01066871|450429451|FG001|Overall Study|Other|2|||
125219496|NCT01066871|450429452|FG002|Overall Study|Other|1|||
125219497|NCT01066871|450429453|FG003|Overall Study|Other|2|||
125219498|NCT04162795|450429454|FG000|Overall Study|Other|16|||
125219499|NCT04162795|450429454|FG000|Overall Study|Screen failures|10|||
125219500|NCT04530838|450431124|FG000|Overall Study|Other|2|||
125219501|NCT04530838|450431125|FG001|Overall Study|Other|1|||
125219502|NCT04530838|450431126|FG002|Overall Study|Other|0|||
125219503|NCT04530838|450431124|FG000|Overall Study|Physician Decision|0|||
125049186|NCT00633139|449799443|FG002|Overall Study|Withdrawal by Subject|0|||
125049187|NCT01522651|449799446|FG000|Overall Study|Adverse Event|3|||
125049188|NCT01522651|449799447|FG001|Overall Study|Adverse Event|4|||
125049189|NCT01522651|449799448|FG002|Overall Study|Adverse Event|4|||
125219504|NCT04530838|450431125|FG001|Overall Study|Physician Decision|0|||
125219505|NCT04530838|450431126|FG002|Overall Study|Physician Decision|1|||
125219506|NCT04530838|450431124|FG000|Overall Study|Death|0|||
125219507|NCT04530838|450431125|FG001|Overall Study|Death|0|||
125219508|NCT04530838|450431126|FG002|Overall Study|Death|1|||
125219509|NCT04530838|450431124|FG000|Overall Study|Adverse Event|0|||
125219510|NCT04530838|450431125|FG001|Overall Study|Adverse Event|1|||
125219511|NCT04530838|450431126|FG002|Overall Study|Adverse Event|0|||
125219512|NCT04530838|450431124|FG000|Overall Study|No longer meets eligibility criteria|1|||
125219513|NCT04530838|450431125|FG001|Overall Study|No longer meets eligibility criteria|0|||
125219514|NCT04530838|450431126|FG002|Overall Study|No longer meets eligibility criteria|2|||
125219515|NCT04530838|450431124|FG000|Overall Study|Withdrawal by parent/guardian|5|||
125219516|NCT04530838|450431125|FG001|Overall Study|Withdrawal by parent/guardian|2|||
125219517|NCT04530838|450431126|FG002|Overall Study|Withdrawal by parent/guardian|2|||
125219518|NCT00803712|450431127|FG000|Overall Study|Noncompliance|3|||
125219519|NCT00803712|450431128|FG001|Overall Study|Noncompliance|0|||
125219520|NCT00803712|450431127|FG000|Overall Study|Adverse Event|5|||
125219521|NCT00803712|450431128|FG001|Overall Study|Adverse Event|0|||
125219522|NCT00803712|450431127|FG000|Overall Study|Death|8|||
125219523|NCT00803712|450431128|FG001|Overall Study|Death|7|||
125219524|NCT00803712|450431127|FG000|Overall Study|Lost to Follow-up|3|||
125219525|NCT00803712|450431128|FG001|Overall Study|Lost to Follow-up|1|||
125219526|NCT00803712|450431127|FG000|Overall Study|Withdrawal by Subject|2|||
125219527|NCT00803712|450431128|FG001|Overall Study|Withdrawal by Subject|4|||
125219528|NCT00803712|450431127|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
125219529|NCT00803712|450431128|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
125219530|NCT00803712|450431127|FG000|Overall Study|Protocol criteria (other)|0|||
125219531|NCT00803712|450431128|FG001|Overall Study|Protocol criteria (other)|2|||
125219532|NCT00803712|450431127|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
125219533|NCT00803712|450431128|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
125219534|NCT00803712|450431127|FG000|Overall Study|Administrative decision|2|||
125219535|NCT00803712|450431128|FG001|Overall Study|Administrative decision|3|||
125219536|NCT00803712|450431127|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
125219537|NCT00803712|450431128|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
125219538|NCT00669318|450431140|FG000|Overall Study|Withdrawal by Subject|2|||
125219539|NCT01073163|450431141|FG000|Overall Study|Adverse Event|1|||
125219540|NCT01073163|450431141|FG000|Overall Study|Disease Progression|1|||
125219541|NCT01073163|450431141|FG000|Overall Study|Early termination|1|||
125219542|NCT03272347|450431142|FG000|Overall Study|Death|0|||
125219543|NCT03272347|450431143|FG001|Overall Study|Death|0|||
125219544|NCT03272347|450431144|FG002|Overall Study|Death|0|||
125219545|NCT03272347|450431145|FG003|Overall Study|Death|1|||
125219546|NCT03272347|450431142|FG000|Overall Study|Lost to Follow-up|1|||
125219547|NCT03272347|450431143|FG001|Overall Study|Lost to Follow-up|3|||
125219548|NCT03272347|450431144|FG002|Overall Study|Lost to Follow-up|5|||
125219549|NCT03272347|450431145|FG003|Overall Study|Lost to Follow-up|1|||
125219550|NCT03272347|450431142|FG000|Overall Study|Physician Decision|4|||
125219551|NCT03272347|450431143|FG001|Overall Study|Physician Decision|2|||
125219552|NCT03272347|450431144|FG002|Overall Study|Physician Decision|5|||
125219553|NCT03272347|450431145|FG003|Overall Study|Physician Decision|4|||
125219554|NCT03272347|450431142|FG000|Overall Study|Screen Failure|1|||
125219555|NCT03272347|450431143|FG001|Overall Study|Screen Failure|0|||
125219556|NCT03272347|450431144|FG002|Overall Study|Screen Failure|0|||
125219557|NCT03272347|450431145|FG003|Overall Study|Screen Failure|0|||
125219558|NCT03272347|450431142|FG000|Overall Study|Withdrawal by Subject|5|||
125219559|NCT03272347|450431143|FG001|Overall Study|Withdrawal by Subject|1|||
125219560|NCT03272347|450431144|FG002|Overall Study|Withdrawal by Subject|2|||
125219561|NCT03272347|450431145|FG003|Overall Study|Withdrawal by Subject|1|||
125219562|NCT01677182|450431150|FG000|Overall Study|Adverse Event|2|||
125219563|NCT01677182|450431151|FG001|Overall Study|Adverse Event|1|||
125219564|NCT01677182|450431152|FG002|Overall Study|Adverse Event|8|||
125219565|NCT01677182|450431150|FG000|Overall Study|Protocol Violation|5|||
125219566|NCT01677182|450431151|FG001|Overall Study|Protocol Violation|1|||
125219567|NCT01677182|450431152|FG002|Overall Study|Protocol Violation|4|||
125219568|NCT01677182|450431150|FG000|Overall Study|Lost to Follow-up|4|||
125219569|NCT01677182|450431151|FG001|Overall Study|Lost to Follow-up|0|||
125219570|NCT01677182|450431152|FG002|Overall Study|Lost to Follow-up|3|||
125219571|NCT01677182|450431150|FG000|Overall Study|Withdrawal by Subject|7|||
125219572|NCT01677182|450431151|FG001|Overall Study|Withdrawal by Subject|12|||
125219573|NCT01677182|450431152|FG002|Overall Study|Withdrawal by Subject|10|||
125219574|NCT01677182|450431150|FG000|Overall Study|Study termination|12|||
125219575|NCT01677182|450431151|FG001|Overall Study|Study termination|9|||
125219576|NCT01677182|450431152|FG002|Overall Study|Study termination|11|||
125219577|NCT01677182|450431150|FG000|Overall Study|Lack of Efficacy|3|||
125219578|NCT01677182|450431151|FG001|Overall Study|Lack of Efficacy|0|||
125219579|NCT01677182|450431152|FG002|Overall Study|Lack of Efficacy|1|||
125219580|NCT01677182|450431150|FG000|Overall Study|Other reasons|1|||
125219581|NCT01677182|450431151|FG001|Overall Study|Other reasons|5|||
125219582|NCT01677182|450431152|FG002|Overall Study|Other reasons|2|||
125219583|NCT00762762|450431155|FG000|Overall Study|Did not return for appointments|6|||
125219584|NCT00762762|450431156|FG001|Overall Study|Did not return for appointments|8|||
125219585|NCT02489448|450431157|FG000|Overall Study|Death|3|||
125219586|NCT02489448|450431157|FG000|Overall Study|Withdrawal by Subject|2|||
125219587|NCT00391872|450431158|FG000|Overall Study|Protocol Violation|7|||
125219588|NCT00391872|450431159|FG001|Overall Study|Protocol Violation|2|||
125219589|NCT00391872|450431158|FG000|Overall Study|Withdrawal by Subject|296|||
125219590|NCT00391872|450431159|FG001|Overall Study|Withdrawal by Subject|249|||
125049190|NCT01522651|449799449|FG003|Overall Study|Adverse Event|5|||
125049191|NCT01522651|449799450|FG004|Overall Study|Adverse Event|4|||
125049192|NCT01522651|449799446|FG000|Overall Study|Cardioversion|1|||
125049193|NCT01522651|449799447|FG001|Overall Study|Cardioversion|0|||
125049194|NCT01522651|449799448|FG002|Overall Study|Cardioversion|0|||
125049195|NCT01522651|449799449|FG003|Overall Study|Cardioversion|0|||
125049196|NCT01522651|449799450|FG004|Overall Study|Cardioversion|0|||
125049197|NCT01522651|449799446|FG000|Overall Study|Device Malfunction|0|||
125049198|NCT01522651|449799447|FG001|Overall Study|Device Malfunction|1|||
125049199|NCT01522651|449799448|FG002|Overall Study|Device Malfunction|0|||
125049200|NCT01522651|449799449|FG003|Overall Study|Device Malfunction|0|||
125049201|NCT01522651|449799450|FG004|Overall Study|Device Malfunction|0|||
125049202|NCT01522651|449799446|FG000|Overall Study|Investigator's Discretion|0|||
125049203|NCT01522651|449799447|FG001|Overall Study|Investigator's Discretion|1|||
125049204|NCT01522651|449799448|FG002|Overall Study|Investigator's Discretion|0|||
125049205|NCT01522651|449799449|FG003|Overall Study|Investigator's Discretion|0|||
125049206|NCT01522651|449799450|FG004|Overall Study|Investigator's Discretion|0|||
125049207|NCT01522651|449799446|FG000|Overall Study|Protocol Violation|3|||
125049208|NCT01522651|449799447|FG001|Overall Study|Protocol Violation|0|||
125049209|NCT01522651|449799448|FG002|Overall Study|Protocol Violation|0|||
125049210|NCT01522651|449799449|FG003|Overall Study|Protocol Violation|0|||
125049211|NCT01522651|449799450|FG004|Overall Study|Protocol Violation|0|||
125049212|NCT01522651|449799446|FG000|Overall Study|Reason Not Specified|0|||
125049213|NCT01522651|449799447|FG001|Overall Study|Reason Not Specified|0|||
125049214|NCT01522651|449799448|FG002|Overall Study|Reason Not Specified|0|||
125049215|NCT01522651|449799449|FG003|Overall Study|Reason Not Specified|1|||
125049216|NCT01522651|449799450|FG004|Overall Study|Reason Not Specified|0|||
125049217|NCT01522651|449799446|FG000|Overall Study|Participant Non-Compliance|1|||
125049218|NCT01522651|449799447|FG001|Overall Study|Participant Non-Compliance|0|||
125049219|NCT01522651|449799448|FG002|Overall Study|Participant Non-Compliance|0|||
125049220|NCT01522651|449799449|FG003|Overall Study|Participant Non-Compliance|0|||
125049221|NCT01522651|449799450|FG004|Overall Study|Participant Non-Compliance|0|||
125049222|NCT01522651|449799446|FG000|Overall Study|Withdrew Consent|1|||
125049223|NCT01522651|449799447|FG001|Overall Study|Withdrew Consent|1|||
125049224|NCT01522651|449799448|FG002|Overall Study|Withdrew Consent|0|||
125049225|NCT01522651|449799449|FG003|Overall Study|Withdrew Consent|1|||
125049226|NCT01522651|449799450|FG004|Overall Study|Withdrew Consent|1|||
125049227|NCT01522651|449799446|FG000|Overall Study|Randomized but Never Treated|0|||
125049228|NCT01522651|449799447|FG001|Overall Study|Randomized but Never Treated|1|||
125049229|NCT01522651|449799448|FG002|Overall Study|Randomized but Never Treated|0|||
125049230|NCT01522651|449799449|FG003|Overall Study|Randomized but Never Treated|1|||
125049231|NCT01522651|449799450|FG004|Overall Study|Randomized but Never Treated|1|||
125049232|NCT02658656|449799451|FG000|Screening|Failed eligibility criteria|0|||
125049233|NCT02658656|449799452|FG001|Screening|Failed eligibility criteria|0|||
125049234|NCT02658656|449799453|FG002|Screening|Failed eligibility criteria|263|||
125049235|NCT02658656|449799451|FG000|Randomization|Withdrawal by Subject|8|||
125049236|NCT02658656|449799452|FG001|Randomization|Withdrawal by Subject|7|||
125049237|NCT02658656|449799453|FG002|Randomization|Withdrawal by Subject|0|||
125049238|NCT02658656|449799451|FG000|Randomization|Lost to Follow-up|1|||
125049239|NCT02658656|449799452|FG001|Randomization|Lost to Follow-up|3|||
125049240|NCT02658656|449799453|FG002|Randomization|Lost to Follow-up|0|||
125049241|NCT02658656|449799451|FG000|Randomization|Adverse Event|4|||
125049242|NCT02658656|449799452|FG001|Randomization|Adverse Event|0|||
125049243|NCT02658656|449799453|FG002|Randomization|Adverse Event|0|||
125049244|NCT02658656|449799451|FG000|Randomization|Administrative Termination|3|||
125049245|NCT02658656|449799452|FG001|Randomization|Administrative Termination|1|||
125049246|NCT02658656|449799453|FG002|Randomization|Administrative Termination|0|||
125049247|NCT02658656|449799451|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
125049248|NCT02658656|449799452|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
125049249|NCT02658656|449799453|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
125049250|NCT02658656|449799451|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
125049251|NCT02658656|449799452|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
125049252|NCT02658656|449799453|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
125049253|NCT02658656|449799451|FG000|Randomization|Not eligible for Randomization|1|||
125049254|NCT02658656|449799452|FG001|Randomization|Not eligible for Randomization|0|||
125049255|NCT02658656|449799453|FG002|Randomization|Not eligible for Randomization|0|||
125049256|NCT02658656|449799451|FG000|Randomization|Protocol Violation|1|||
125049257|NCT02658656|449799452|FG001|Randomization|Protocol Violation|0|||
125049258|NCT02658656|449799453|FG002|Randomization|Protocol Violation|0|||
125049259|NCT01850563|449800897|FG000|Overall Study|Not eligible|3|||
125049260|NCT01850563|449800898|FG001|Overall Study|Not eligible|0|||
125049261|NCT04359823|449800899|FG000|Overall Study|Lost to Follow-up|0|||
125049262|NCT04359823|449800900|FG001|Overall Study|Lost to Follow-up|1|||
125049263|NCT04359823|449800899|FG000|Overall Study|Withdrawal by Subject|0|||
125049264|NCT04359823|449800900|FG001|Overall Study|Withdrawal by Subject|1|||
125049265|NCT02322892|449800904|FG000|Overall Study|Surgery cancelled|1|||
125049266|NCT02322892|449800905|FG001|Overall Study|Surgery cancelled|2|||
125049267|NCT02322892|449800904|FG000|Overall Study|Met exclusion criteria|0|||
125049268|NCT02322892|449800905|FG001|Overall Study|Met exclusion criteria|1|||
125049269|NCT02322892|449800904|FG000|Overall Study|Protocol Violation|1|||
125049270|NCT02322892|449800905|FG001|Overall Study|Protocol Violation|0|||
125049271|NCT02125331|449800908|FG000|Overall Study|Protocol Violation|1|||
125049272|NCT02125331|449800909|FG001|Overall Study|Protocol Violation|0|||
125049273|NCT02125331|449800908|FG000|Overall Study|technical problem|2|||
125049274|NCT02125331|449800909|FG001|Overall Study|technical problem|0|||
125049275|NCT02125331|449800908|FG000|Overall Study|screen failure|2|||
125049276|NCT02125331|449800909|FG001|Overall Study|screen failure|0|||
125049277|NCT04230486|449800918|FG000|Overall Study|Screen Failure|1|||
125049278|NCT03215264|449800919|FG000|Dose Level 2|Adverse Event|0|||
125049279|NCT03215264|449800920|FG001|Dose Level 2|Adverse Event|1|||
125049280|NCT03215264|449800921|FG002|Dose Level 2|Adverse Event|0|||
125049281|NCT03215264|449800919|FG000|Dose Level 3|Withdrawal by Subject|0|||
125049282|NCT03215264|449800920|FG001|Dose Level 3|Withdrawal by Subject|0|||
125049283|NCT03215264|449800921|FG002|Dose Level 3|Withdrawal by Subject|1|||
125049284|NCT02234583|449800924|FG000|Overall Study|Adverse Event|172|||
125049285|NCT02234583|449800925|FG001|Overall Study|Adverse Event|156|||
125049286|NCT02234583|449800924|FG000|Overall Study|Withdrawal by Subject|109|||
125049287|NCT02234583|449800925|FG001|Overall Study|Withdrawal by Subject|157|||
125049288|NCT02234583|449800924|FG000|Overall Study|Lost to Follow-up|0|||
125049289|NCT02234583|449800925|FG001|Overall Study|Lost to Follow-up|1|||
125219591|NCT00391872|450431158|FG000|Overall Study|Reason unknown|2|||
125219592|NCT00391872|450431159|FG001|Overall Study|Reason unknown|4|||
125219593|NCT00391872|450431158|FG000|Overall Study|Lost to Follow-up|2|||
125219594|NCT00391872|450431159|FG001|Overall Study|Lost to Follow-up|0|||
125219595|NCT00215644|450431163|FG000|Overall Study|Disease Progression|28|||
125219596|NCT00215644|450431164|FG001|Overall Study|Disease Progression|10|||
125219597|NCT00215644|450431163|FG000|Overall Study|Adverse Event|2|||
125219598|NCT00215644|450431164|FG001|Overall Study|Adverse Event|9|||
125219599|NCT00215644|450431163|FG000|Overall Study|Death|1|||
125049290|NCT02234583|449800924|FG000|Overall Study|Lack of Efficacy|58|||
125049291|NCT02234583|449800925|FG001|Overall Study|Lack of Efficacy|103|||
125049292|NCT02234583|449800924|FG000|Overall Study|Protocol Violation|35|||
125049293|NCT02234583|449800925|FG001|Overall Study|Protocol Violation|42|||
125049294|NCT02234583|449800924|FG000|Overall Study|Other|39|||
125049295|NCT02234583|449800925|FG001|Overall Study|Other|97|||
125049296|NCT01740440|449800926|FG000|Overall Study|Lost to Follow-up|3|||
125049297|NCT00532883|449800927|FG000|Overall Study|Adverse Event|1|||
125049298|NCT00532883|449800928|FG001|Overall Study|Adverse Event|0|||
125049299|NCT00532883|449800929|FG002|Overall Study|Adverse Event|0|||
125049300|NCT00532883|449800930|FG003|Overall Study|Adverse Event|1|||
125049301|NCT00532883|449800927|FG000|Overall Study|Lost to Follow-up|1|||
125049302|NCT00532883|449800928|FG001|Overall Study|Lost to Follow-up|1|||
125049303|NCT00532883|449800929|FG002|Overall Study|Lost to Follow-up|1|||
125049304|NCT00532883|449800930|FG003|Overall Study|Lost to Follow-up|0|||
125049305|NCT00532883|449800927|FG000|Overall Study|Withdrawal by Subject|0|||
125049306|NCT00532883|449800928|FG001|Overall Study|Withdrawal by Subject|1|||
125049307|NCT00532883|449800929|FG002|Overall Study|Withdrawal by Subject|1|||
125049308|NCT00532883|449800930|FG003|Overall Study|Withdrawal by Subject|0|||
125049309|NCT00532883|449800927|FG000|Overall Study|Subject was Nonadherent|0|||
125049310|NCT00532883|449800928|FG001|Overall Study|Subject was Nonadherent|1|||
125049311|NCT00532883|449800929|FG002|Overall Study|Subject was Nonadherent|1|||
125219600|NCT00215644|450431164|FG001|Overall Study|Death|2|||
125219601|NCT00215644|450431163|FG000|Overall Study|Withdrawal by Subject|1|||
125219602|NCT00215644|450431164|FG001|Overall Study|Withdrawal by Subject|0|||
125049312|NCT00532883|449800930|FG003|Overall Study|Subject was Nonadherent|0|||
125049313|NCT00532883|449800927|FG000|Overall Study|Early Study Termination|4|||
125049314|NCT00532883|449800928|FG001|Overall Study|Early Study Termination|4|||
125049315|NCT00532883|449800929|FG002|Overall Study|Early Study Termination|1|||
125049316|NCT00532883|449800930|FG003|Overall Study|Early Study Termination|4|||
125049317|NCT01172288|449800933|FG000|Overall Study|Adverse Event|1|||
125049318|NCT01172288|449800934|FG001|Overall Study|Adverse Event|0|||
125219603|NCT00215644|450431163|FG000|Overall Study|Other|3|||
125049319|NCT01172288|449800933|FG000|Overall Study|Protocol Violation|0|||
125049320|NCT01172288|449800934|FG001|Overall Study|Protocol Violation|1|||
125049321|NCT01188798|449800939|FG000|Overall Study|Death|0|||
125049322|NCT01188798|449800940|FG001|Overall Study|Death|1|||
125049323|NCT01188798|449800939|FG000|Overall Study|Required additional transplant|1|||
125049324|NCT01188798|449800940|FG001|Overall Study|Required additional transplant|1|||
125219604|NCT00215644|450431164|FG001|Overall Study|Other|15|||
125219605|NCT00215644|450431163|FG000|Overall Study|Randomized but Not Treated|1|||
125049325|NCT01188798|449800939|FG000|Overall Study|Protocol closure|1|||
125049326|NCT01188798|449800940|FG001|Overall Study|Protocol closure|1|||
125049327|NCT00611130|449800941|FG000|Overall Study|Lost to Follow-up|25|||
125049328|NCT00611130|449800942|FG001|Overall Study|Lost to Follow-up|29|||
125049329|NCT00611130|449800941|FG000|Overall Study|Protocol noncompliance|7|||
125049330|NCT00611130|449800942|FG001|Overall Study|Protocol noncompliance|6|||
125049331|NCT00611130|449800941|FG000|Overall Study|Withdrawal by Subject|6|||
125049332|NCT00611130|449800942|FG001|Overall Study|Withdrawal by Subject|5|||
125049333|NCT00611130|449800941|FG000|Overall Study|Other|5|||
125049334|NCT00611130|449800942|FG001|Overall Study|Other|4|||
125049335|NCT00611130|449800941|FG000|Overall Study|Incarceration|3|||
125049336|NCT00611130|449800942|FG001|Overall Study|Incarceration|2|||
125049337|NCT00611130|449800941|FG000|Overall Study|Administrative|1|||
125049338|NCT00611130|449800942|FG001|Overall Study|Administrative|1|||
125049339|NCT00611130|449800941|FG000|Overall Study|Adverse Event|1|||
125049340|NCT00611130|449800942|FG001|Overall Study|Adverse Event|0|||
125049341|NCT00611130|449800941|FG000|Overall Study|Death|1|||
125049342|NCT00611130|449800942|FG001|Overall Study|Death|0|||
125049343|NCT02795767|449800943|FG000|Overall Study|Received Commercial Emicizumab|1|||
125049344|NCT02795767|449800944|FG001|Overall Study|Received Commercial Emicizumab|0|||
125049345|NCT02795767|449800945|FG002|Overall Study|Received Commercial Emicizumab|0|||
125049346|NCT03078608|449800955|FG000|Overall Study|Death|1|||
125049347|NCT03078608|449800956|FG001|Overall Study|Death|2|||
125049348|NCT03078608|449800957|FG002|Overall Study|Death|0|||
125049349|NCT03078608|449800958|FG003|Overall Study|Death|0|||
125049350|NCT03078608|449800955|FG000|Overall Study|Withdrawal by Subject|8|||
125049351|NCT03078608|449800956|FG001|Overall Study|Withdrawal by Subject|1|||
125049352|NCT03078608|449800957|FG002|Overall Study|Withdrawal by Subject|0|||
125049353|NCT03078608|449800958|FG003|Overall Study|Withdrawal by Subject|0|||
125049354|NCT03078608|449800955|FG000|Overall Study|Lost to Follow-up|5|||
125049355|NCT03078608|449800956|FG001|Overall Study|Lost to Follow-up|8|||
125049356|NCT03078608|449800957|FG002|Overall Study|Lost to Follow-up|4|||
125049357|NCT03078608|449800958|FG003|Overall Study|Lost to Follow-up|1|||
125049358|NCT00723840|449800959|FG000|Overall Study|Lost to Follow-up|2|||
125049359|NCT00723840|449800959|FG000|Overall Study|Failure to return|18|||
125049360|NCT00723840|449800959|FG000|Overall Study|Withdrawal by Subject|55|||
125049361|NCT00723840|449800959|FG000|Overall Study|Serious Adverse Events|3|||
125049362|NCT00723840|449800959|FG000|Overall Study|Other Medical Event|2|||
125049363|NCT00723840|449800959|FG000|Overall Study|Unspecified reason|2|||
125049364|NCT04156646|449800960|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
125049365|NCT04156646|449800961|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
125049366|NCT00751101|449800962|FG000|Overall Study|Withdrawal by Subject|1|||
125049367|NCT00751101|449800963|FG001|Overall Study|Withdrawal by Subject|0|||
125049368|NCT00751101|449800962|FG000|Overall Study|No HFS / Never Started Patch/|0|||
125049369|NCT00751101|449800963|FG001|Overall Study|No HFS / Never Started Patch/|4|||
125049370|NCT00751101|449800962|FG000|Overall Study|Never began capecitabine|1|||
125049371|NCT00751101|449800963|FG001|Overall Study|Never began capecitabine|0|||
125049372|NCT00751101|449800962|FG000|Overall Study|Physician Decision|0|||
125049373|NCT00751101|449800963|FG001|Overall Study|Physician Decision|1|||
125049374|NCT00784784|449800964|FG000|Overall Study|Withdrawal by Subject|2|||
125049375|NCT00784784|449800965|FG001|Overall Study|Withdrawal by Subject|2|||
125049376|NCT01905397|449800968|FG000|Overall Study|Death|0|||
125049377|NCT01905397|449800969|FG001|Overall Study|Death|1|||
125049378|NCT01905397|449800968|FG000|Overall Study|Withdrawal by Subject|2|||
125049379|NCT01905397|449800969|FG001|Overall Study|Withdrawal by Subject|0|||
125049380|NCT01905397|449800968|FG000|Overall Study|Surgery canceled/aborted|9|||
125049381|NCT01905397|449800969|FG001|Overall Study|Surgery canceled/aborted|5|||
125049382|NCT01905397|449800968|FG000|Overall Study|Incision < 7 cm|2|||
125049383|NCT01905397|449800969|FG001|Overall Study|Incision < 7 cm|0|||
125049384|NCT01905397|449800968|FG000|Overall Study|Wrong treatment|1|||
125049385|NCT01905397|449800969|FG001|Overall Study|Wrong treatment|1|||
125049386|NCT01905397|449800968|FG000|Overall Study|Device not applied|3|||
125049387|NCT01905397|449800969|FG001|Overall Study|Device not applied|0|||
125049388|NCT01905397|449800968|FG000|Overall Study|Dressing not applied in operating room|1|||
125049389|NCT01905397|449800969|FG001|Overall Study|Dressing not applied in operating room|0|||
125049390|NCT01905397|449800968|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
125049391|NCT01905397|449800969|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
125049392|NCT00863928|449800972|FG000|Overall Study|Protocol Violation|26|||
125049393|NCT00863928|449800973|FG001|Overall Study|Protocol Violation|0|||
125049394|NCT00863928|449800972|FG000|Overall Study|Withdrawal by Subject|3|||
125049395|NCT00863928|449800973|FG001|Overall Study|Withdrawal by Subject|0|||
125049396|NCT00863928|449800972|FG000|Overall Study|surgery cancellation|4|||
125049397|NCT00863928|449800973|FG001|Overall Study|surgery cancellation|0|||
125049398|NCT00863928|449800972|FG000|Overall Study|medication allergy|3|||
125049399|NCT00863928|449800973|FG001|Overall Study|medication allergy|0|||
125049400|NCT00772967|449800974|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
125049401|NCT00772967|449800975|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
125049402|NCT00772967|449800976|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
125049403|NCT00772967|449800977|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
125049404|NCT00772967|449800978|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
125049405|NCT00772967|449800979|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
125049406|NCT00772967|449800974|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
125049407|NCT00772967|449800975|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
125049408|NCT00772967|449800976|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
125049409|NCT00772967|449800977|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
125049410|NCT00772967|449800978|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
125049411|NCT00772967|449800979|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
125049412|NCT00772967|449800974|FG000|Crossover Treatment 3|Adverse Event|0|||
125049413|NCT00772967|449800975|FG001|Crossover Treatment 3|Adverse Event|0|||
125049414|NCT00772967|449800976|FG002|Crossover Treatment 3|Adverse Event|0|||
125049415|NCT00772967|449800977|FG003|Crossover Treatment 3|Adverse Event|0|||
125049416|NCT00772967|449800978|FG004|Crossover Treatment 3|Adverse Event|1|||
125049417|NCT00772967|449800979|FG005|Crossover Treatment 3|Adverse Event|0|||
125049418|NCT04172831|449800981|FG000|Overall Study|Adverse Event|21|||
125049419|NCT04172831|449800982|FG001|Overall Study|Adverse Event|9|||
125049420|NCT04172831|449800981|FG000|Overall Study|Lack of Efficacy|2|||
125049421|NCT04172831|449800982|FG001|Overall Study|Lack of Efficacy|8|||
125049422|NCT04172831|449800981|FG000|Overall Study|Physician Decision|0|||
125049423|NCT04172831|449800982|FG001|Overall Study|Physician Decision|1|||
125049424|NCT04172831|449800981|FG000|Overall Study|Withdrawal by Subject|12|||
125049425|NCT04172831|449800982|FG001|Overall Study|Withdrawal by Subject|11|||
125049426|NCT04172831|449800981|FG000|Overall Study|Lost to Follow-up|4|||
125049427|NCT04172831|449800982|FG001|Overall Study|Lost to Follow-up|9|||
125049428|NCT04172831|449800981|FG000|Overall Study|COVID-19 related crisis|3|||
125049429|NCT04172831|449800982|FG001|Overall Study|COVID-19 related crisis|3|||
125049430|NCT04172831|449800981|FG000|Overall Study|Subject non-compliance|1|||
125049431|NCT04172831|449800982|FG001|Overall Study|Subject non-compliance|1|||
125049432|NCT04172831|449800981|FG000|Overall Study|Family emergency|1|||
125049433|NCT04172831|449800982|FG001|Overall Study|Family emergency|0|||
125049434|NCT01041573|449800983|FG000|Overall Study|Withdrawal by Subject|2|||
125049435|NCT01041573|449800984|FG001|Overall Study|Withdrawal by Subject|5|||
125049436|NCT01041573|449800985|FG002|Overall Study|Withdrawal by Subject|2|||
125049437|NCT01041573|449800986|FG003|Overall Study|Withdrawal by Subject|0|||
125049438|NCT01041573|449800983|FG000|Overall Study|Death|1|||
125049439|NCT01041573|449800984|FG001|Overall Study|Death|0|||
125049440|NCT01041573|449800985|FG002|Overall Study|Death|0|||
125049441|NCT01041573|449800986|FG003|Overall Study|Death|0|||
125049442|NCT01041573|449800983|FG000|Overall Study|Lost to Follow-up|0|||
125049443|NCT01041573|449800984|FG001|Overall Study|Lost to Follow-up|1|||
125049444|NCT01041573|449800985|FG002|Overall Study|Lost to Follow-up|2|||
125049445|NCT01041573|449800986|FG003|Overall Study|Lost to Follow-up|1|||
125049446|NCT01041573|449800983|FG000|Overall Study|Adverse Event|0|||
125049447|NCT01041573|449800984|FG001|Overall Study|Adverse Event|2|||
125049448|NCT01041573|449800985|FG002|Overall Study|Adverse Event|0|||
125049449|NCT01041573|449800986|FG003|Overall Study|Adverse Event|0|||
125049450|NCT01041573|449800983|FG000|Overall Study|relocation|1|||
125049451|NCT01041573|449800984|FG001|Overall Study|relocation|4|||
125049452|NCT01041573|449800985|FG002|Overall Study|relocation|3|||
125049453|NCT01041573|449800986|FG003|Overall Study|relocation|1|||
125049454|NCT01041573|449800983|FG000|Overall Study|further blood extraction|0|||
125049455|NCT01041573|449800984|FG001|Overall Study|further blood extraction|1|||
125049456|NCT01041573|449800985|FG002|Overall Study|further blood extraction|0|||
125049457|NCT01041573|449800986|FG003|Overall Study|further blood extraction|0|||
125049458|NCT01041573|449800983|FG000|Overall Study|positive to anti-HCV|1|||
125049459|NCT01041573|449800984|FG001|Overall Study|positive to anti-HCV|0|||
125049460|NCT01041573|449800985|FG002|Overall Study|positive to anti-HCV|0|||
125049461|NCT01041573|449800986|FG003|Overall Study|positive to anti-HCV|0|||
125049462|NCT01052012|449800987|FG000|Overall Study|Not treated|2|||
125049463|NCT01052012|449800988|FG001|Overall Study|Not treated|5|||
125049464|NCT01052012|449800989|FG002|Overall Study|Not treated|0|||
125049465|NCT01052012|449800990|FG003|Overall Study|Not treated|0|||
125049466|NCT01052012|449800991|FG004|Overall Study|Not treated|11|||
125049467|NCT01052012|449800992|FG005|Overall Study|Not treated|8|||
125049468|NCT01052012|449800987|FG000|Overall Study|Adverse Event|1|||
125049469|NCT01052012|449800988|FG001|Overall Study|Adverse Event|0|||
125049470|NCT01052012|449800989|FG002|Overall Study|Adverse Event|0|||
125049471|NCT01052012|449800990|FG003|Overall Study|Adverse Event|1|||
125049472|NCT01052012|449800991|FG004|Overall Study|Adverse Event|0|||
125049473|NCT01052012|449800992|FG005|Overall Study|Adverse Event|0|||
125049474|NCT01052012|449800987|FG000|Overall Study|Lost to Follow-up|0|||
125049475|NCT01052012|449800988|FG001|Overall Study|Lost to Follow-up|0|||
125049476|NCT01052012|449800989|FG002|Overall Study|Lost to Follow-up|0|||
125049477|NCT01052012|449800990|FG003|Overall Study|Lost to Follow-up|0|||
125049478|NCT01052012|449800991|FG004|Overall Study|Lost to Follow-up|1|||
125049479|NCT01052012|449800992|FG005|Overall Study|Lost to Follow-up|0|||
125049480|NCT01052012|449800987|FG000|Overall Study|Withdrawal by Subject|1|||
125049481|NCT01052012|449800988|FG001|Overall Study|Withdrawal by Subject|1|||
125049482|NCT01052012|449800989|FG002|Overall Study|Withdrawal by Subject|0|||
125049483|NCT01052012|449800990|FG003|Overall Study|Withdrawal by Subject|0|||
125049484|NCT01052012|449800991|FG004|Overall Study|Withdrawal by Subject|3|||
125049485|NCT01052012|449800992|FG005|Overall Study|Withdrawal by Subject|1|||
125049486|NCT01052012|449800987|FG000|Overall Study|Physician Decision|0|||
125049487|NCT01052012|449800988|FG001|Overall Study|Physician Decision|0|||
125049488|NCT01052012|449800989|FG002|Overall Study|Physician Decision|0|||
125049489|NCT01052012|449800990|FG003|Overall Study|Physician Decision|0|||
125049490|NCT01052012|449800991|FG004|Overall Study|Physician Decision|0|||
125049491|NCT01052012|449800992|FG005|Overall Study|Physician Decision|1|||
125049492|NCT01052012|449800987|FG000|Overall Study|Other|0|||
125049493|NCT01052012|449800988|FG001|Overall Study|Other|0|||
125049494|NCT01052012|449800989|FG002|Overall Study|Other|0|||
125049495|NCT01052012|449800990|FG003|Overall Study|Other|0|||
125049496|NCT01052012|449800991|FG004|Overall Study|Other|1|||
125049497|NCT01052012|449800992|FG005|Overall Study|Other|0|||
125049498|NCT01765764|449801002|FG000|Treatment Period|Adverse Event|1|||
125049499|NCT01765764|449801003|FG001|Treatment Period|Adverse Event|2|||
125049500|NCT01765764|449801004|FG002|Treatment Period|Adverse Event|1|||
125049501|NCT01765764|449801002|FG000|Treatment Period|Lost to Follow-up|0|||
125049502|NCT01765764|449801003|FG001|Treatment Period|Lost to Follow-up|3|||
125049503|NCT01765764|449801004|FG002|Treatment Period|Lost to Follow-up|2|||
125049504|NCT01765764|449801002|FG000|Treatment Period|Personal Reasons|1|||
125049505|NCT01765764|449801003|FG001|Treatment Period|Personal Reasons|2|||
125049506|NCT01765764|449801004|FG002|Treatment Period|Personal Reasons|1|||
125049507|NCT01765764|449801002|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
125049508|NCT01765764|449801003|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
125049509|NCT01765764|449801004|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
125049510|NCT01597193|449801006|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
125049511|NCT01597193|449801007|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
125049512|NCT01597193|449801008|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
125049513|NCT01597193|449801009|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
125049514|NCT01597193|449801010|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
125049515|NCT01597193|449801011|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
125049516|NCT01597193|449801012|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
125049517|NCT01597193|449801006|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
125049518|NCT01597193|449801007|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
125049519|NCT01597193|449801008|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
125049520|NCT01597193|449801009|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
125049521|NCT01597193|449801010|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
125049522|NCT01597193|449801011|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
125049523|NCT01597193|449801012|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
125049524|NCT01597193|449801006|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
125049525|NCT01597193|449801007|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
125049526|NCT01597193|449801008|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
125049527|NCT01597193|449801009|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
125049528|NCT01597193|449801010|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
125049529|NCT01597193|449801011|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
125049530|NCT01597193|449801012|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
125049531|NCT01597193|449801006|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
125049532|NCT01597193|449801007|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
125049533|NCT01597193|449801008|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
125049534|NCT01597193|449801009|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
125049535|NCT01597193|449801010|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
125049536|NCT01597193|449801011|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
125049537|NCT01597193|449801012|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
125049538|NCT01597193|449801006|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
125049539|NCT01597193|449801007|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
125049540|NCT01597193|449801008|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
125049541|NCT01597193|449801009|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
125049542|NCT01597193|449801010|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
125049543|NCT01597193|449801011|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
125049544|NCT01597193|449801012|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
125049545|NCT02508701|449801013|FG000|Overall Study|Lost to Follow-up|9|||
125049546|NCT02508701|449801014|FG001|Overall Study|Lost to Follow-up|5|||
125049547|NCT02508701|449801015|FG002|Overall Study|Lost to Follow-up|5|||
125049548|NCT02508701|449801016|FG003|Overall Study|Lost to Follow-up|3|||
125049549|NCT03184701|449801017|FG000|Overall Study|Death|3|||
125049550|NCT03184701|449801017|FG000|Overall Study|Physician Decision|3|||
125049551|NCT03184701|449801017|FG000|Overall Study|Withdrawal by Subject|6|||
125049552|NCT03184701|449801017|FG000|Overall Study|Lost to Follow-up|5|||
125049553|NCT00935220|449801028|FG000|Overall Study|Adverse Event|1|||
125049554|NCT00935220|449801028|FG000|Overall Study|Other reason (not specified)|1|||
125049555|NCT01000064|449801029|FG000|Overall Study|Withdrawal by Subject|1|||
125049556|NCT01000064|449801030|FG001|Overall Study|Withdrawal by Subject|1|||
125049557|NCT01518192|449801031|FG000|Overall Study|Lost to Follow-up|29|||
125049558|NCT01518192|449801032|FG001|Overall Study|Lost to Follow-up|26|||
125049559|NCT01518192|449801033|FG002|Overall Study|Lost to Follow-up|35|||
125049560|NCT00798967|449801034|FG000|Overall Study|Adverse Event|2|||
125049561|NCT00798967|449801035|FG001|Overall Study|Adverse Event|3|||
125049562|NCT00798967|449801034|FG000|Overall Study|Withdrawal by Subject|0|||
125049563|NCT00798967|449801035|FG001|Overall Study|Withdrawal by Subject|1|||
125049564|NCT00798967|449801034|FG000|Overall Study|Physician Decision|1|||
125049565|NCT00798967|449801035|FG001|Overall Study|Physician Decision|0|||
125049566|NCT00798967|449801034|FG000|Overall Study|Randomized in error by site|1|||
125049567|NCT00798967|449801035|FG001|Overall Study|Randomized in error by site|0|||
125049568|NCT01415440|449801036|FG000|Overall Study|Lost to Follow-up|0|||
125049569|NCT01415440|449801037|FG001|Overall Study|Lost to Follow-up|1|||
125049570|NCT01415440|449801038|FG002|Overall Study|Lost to Follow-up|2|||
125049571|NCT01415440|449801036|FG000|Overall Study|Physician Decision|3|||
125049572|NCT01415440|449801037|FG001|Overall Study|Physician Decision|0|||
125049573|NCT01415440|449801038|FG002|Overall Study|Physician Decision|0|||
125049574|NCT01415440|449801036|FG000|Overall Study|Withdrawal by Subject|1|||
125049575|NCT01415440|449801037|FG001|Overall Study|Withdrawal by Subject|0|||
125049576|NCT01415440|449801038|FG002|Overall Study|Withdrawal by Subject|0|||
125049577|NCT03090737|449801039|FG000|Overall Study|Other reasons|1|||
125049578|NCT03090737|449801039|FG000|Overall Study|Completed treatment as per protocol|17|||
125049579|NCT03090737|449801039|FG000|Overall Study|Maximum clinical benefit|2|||
125049580|NCT03090737|449801039|FG000|Overall Study|Adverse event unrelated to study drug|7|||
125049581|NCT03090737|449801039|FG000|Overall Study|Study drug toxicity|4|||
125049582|NCT03090737|449801039|FG000|Overall Study|Disease progression|98|||
125049583|NCT03141307|449801040|FG000|In-Hospital|Withdrawal by Subject|0|||
125049584|NCT03141307|449801041|FG001|In-Hospital|Withdrawal by Subject|2|||
125049585|NCT03141307|449801040|FG000|In-Hospital|Protocol Violation|4|||
125049586|NCT03141307|449801041|FG001|In-Hospital|Protocol Violation|0|||
125049587|NCT03141307|449801040|FG000|Follow-Up|Lost to Follow-up|97|||
125049588|NCT03141307|449801041|FG001|Follow-Up|Lost to Follow-up|54|||
125049589|NCT02160977|449801042|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
125049590|NCT02160977|449801043|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
125049591|NCT02160977|449801042|FG000|Three Months After Surgery|Lost to Follow-up|0|||
125049592|NCT02160977|449801043|FG001|Three Months After Surgery|Lost to Follow-up|2|||
125049593|NCT02160977|449801042|FG000|Six Months After Surgery|Lost to Follow-up|2|||
125049594|NCT02160977|449801043|FG001|Six Months After Surgery|Lost to Follow-up|1|||
125049595|NCT00408421|449802784|FG000|Treatment Initial Randomization|Adverse Event|5|||
125049596|NCT00408421|449802785|FG001|Treatment Initial Randomization|Adverse Event|9|||
125049597|NCT00408421|449802786|FG002|Treatment Initial Randomization|Adverse Event|0|||
125049598|NCT00408421|449802784|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
125049599|NCT00408421|449802785|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
125049600|NCT00408421|449802786|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
125049601|NCT00408421|449802784|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
125049602|NCT00408421|449802785|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
125049603|NCT00408421|449802786|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
125049604|NCT00408421|449802784|FG000|Treatment Initial Randomization|Physician Decision|1|||
125049605|NCT00408421|449802785|FG001|Treatment Initial Randomization|Physician Decision|0|||
125049606|NCT00408421|449802786|FG002|Treatment Initial Randomization|Physician Decision|0|||
125049607|NCT00408421|449802784|FG000|Treatment Initial Randomization|Protocol Violation|0|||
125049608|NCT00408421|449802785|FG001|Treatment Initial Randomization|Protocol Violation|1|||
125049609|NCT00408421|449802786|FG002|Treatment Initial Randomization|Protocol Violation|0|||
125049610|NCT00408421|449802784|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
125049611|NCT00408421|449802785|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
125219606|NCT00215644|450431164|FG001|Overall Study|Randomized but Not Treated|0|||
125049612|NCT00408421|449802786|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
125049613|NCT00408421|449802784|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
125049614|NCT00408421|449802785|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
125049615|NCT00408421|449802786|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
125049616|NCT00408421|449802784|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
125049617|NCT00408421|449802785|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
125049618|NCT00408421|449802786|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
125049619|NCT00408421|449802784|FG000|Treatment Re-Randomization|Adverse Event|2|||
125049620|NCT00408421|449802785|FG001|Treatment Re-Randomization|Adverse Event|2|||
125049621|NCT00408421|449802786|FG002|Treatment Re-Randomization|Adverse Event|4|||
125049622|NCT00408421|449802784|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
125049623|NCT00408421|449802785|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
125049624|NCT00408421|449802786|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
125049625|NCT00408421|449802784|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
125049626|NCT00408421|449802785|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
125049627|NCT00408421|449802786|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
125049628|NCT00408421|449802784|FG000|Treatment Re-Randomization|Physician Decision|1|||
125049629|NCT00408421|449802785|FG001|Treatment Re-Randomization|Physician Decision|3|||
125049630|NCT00408421|449802786|FG002|Treatment Re-Randomization|Physician Decision|0|||
125049631|NCT00408421|449802784|FG000|Treatment Re-Randomization|Protocol Violation|1|||
125049632|NCT00408421|449802785|FG001|Treatment Re-Randomization|Protocol Violation|1|||
125049633|NCT00408421|449802786|FG002|Treatment Re-Randomization|Protocol Violation|0|||
125049634|NCT00408421|449802784|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
125049635|NCT00408421|449802785|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
125049636|NCT00408421|449802786|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
125049637|NCT01790438|449802791|FG000|Overall Study|Adverse Event|3|||
125049638|NCT01790438|449802792|FG001|Overall Study|Adverse Event|2|||
125049639|NCT01790438|449802791|FG000|Overall Study|Death|4|||
125049640|NCT01790438|449802792|FG001|Overall Study|Death|0|||
125049641|NCT01790438|449802791|FG000|Overall Study|Lost to Follow-up|5|||
125049642|NCT01790438|449802792|FG001|Overall Study|Lost to Follow-up|2|||
125049643|NCT01790438|449802791|FG000|Overall Study|Withdrawal by Subject|13|||
125049644|NCT01790438|449802792|FG001|Overall Study|Withdrawal by Subject|2|||
125049645|NCT01790438|449802791|FG000|Overall Study|Physician Decision|3|||
125049646|NCT01790438|449802792|FG001|Overall Study|Physician Decision|1|||
125049647|NCT01790438|449802791|FG000|Overall Study|Sponsor Decision|0|||
125049648|NCT01790438|449802792|FG001|Overall Study|Sponsor Decision|3|||
125049649|NCT01790438|449802791|FG000|Overall Study|Protocol Required Discontinuation|7|||
125049650|NCT01790438|449802792|FG001|Overall Study|Protocol Required Discontinuation|1|||
125049651|NCT01614769|449802798|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
125049652|NCT01614769|449802799|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
125049653|NCT01614769|449802800|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
125049654|NCT01614769|449802801|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
125049655|NCT01614769|449802802|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
125049656|NCT01614769|449802803|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
125049657|NCT01614769|449802798|FG000|Period 1|Protocol Violation|0|||
125049658|NCT01614769|449802799|FG001|Period 1|Protocol Violation|0|||
125049659|NCT01614769|449802800|FG002|Period 1|Protocol Violation|0|||
125049660|NCT01614769|449802801|FG003|Period 1|Protocol Violation|1|||
125049661|NCT01614769|449802802|FG004|Period 1|Protocol Violation|0|||
125049662|NCT01614769|449802803|FG005|Period 1|Protocol Violation|0|||
125049663|NCT01614769|449802798|FG000|Period 1|Withdrawal by Subject|1|||
125049664|NCT01614769|449802799|FG001|Period 1|Withdrawal by Subject|0|||
125049665|NCT01614769|449802800|FG002|Period 1|Withdrawal by Subject|0|||
125049666|NCT01614769|449802801|FG003|Period 1|Withdrawal by Subject|0|||
125049667|NCT01614769|449802802|FG004|Period 1|Withdrawal by Subject|0|||
125049668|NCT01614769|449802803|FG005|Period 1|Withdrawal by Subject|0|||
125049669|NCT01614769|449802798|FG000|Period 3|Withdrawal by Subject|0|||
125049670|NCT01614769|449802799|FG001|Period 3|Withdrawal by Subject|0|||
125049671|NCT01614769|449802800|FG002|Period 3|Withdrawal by Subject|1|||
125049672|NCT01614769|449802801|FG003|Period 3|Withdrawal by Subject|0|||
125049673|NCT01614769|449802802|FG004|Period 3|Withdrawal by Subject|0|||
125049674|NCT01614769|449802803|FG005|Period 3|Withdrawal by Subject|0|||
125049675|NCT04760314|449802806|FG000|Induction Period|Withdrawal by Subject|0|||
125049676|NCT04760314|449802807|FG001|Induction Period|Withdrawal by Subject|1|||
125049677|NCT04760314|449802808|FG002|Induction Period|Withdrawal by Subject|1|||
125049678|NCT04760314|449802809|FG003|Induction Period|Withdrawal by Subject|0|||
125049679|NCT04760314|449802810|FG004|Induction Period|Withdrawal by Subject|0|||
125049680|NCT04760314|449802811|FG005|Induction Period|Withdrawal by Subject|0|||
125049681|NCT04760314|449802812|FG006|Induction Period|Withdrawal by Subject|0|||
125049682|NCT04760314|449802813|FG007|Induction Period|Withdrawal by Subject|0|||
125049683|NCT04760314|449802814|FG008|Induction Period|Withdrawal by Subject|0|||
125049684|NCT04760314|449802815|FG009|Induction Period|Withdrawal by Subject|0|||
125049685|NCT04760314|449802816|FG010|Induction Period|Withdrawal by Subject|0|||
125049686|NCT04760314|449802806|FG000|Induction Period|Adverse Event|0|||
125049687|NCT04760314|449802807|FG001|Induction Period|Adverse Event|0|||
125049688|NCT04760314|449802808|FG002|Induction Period|Adverse Event|2|||
125049689|NCT04760314|449802809|FG003|Induction Period|Adverse Event|0|||
125049690|NCT04760314|449802810|FG004|Induction Period|Adverse Event|0|||
125049691|NCT04760314|449802811|FG005|Induction Period|Adverse Event|0|||
125049692|NCT04760314|449802812|FG006|Induction Period|Adverse Event|0|||
125049693|NCT04760314|449802813|FG007|Induction Period|Adverse Event|0|||
125049694|NCT04760314|449802814|FG008|Induction Period|Adverse Event|0|||
125049695|NCT04760314|449802815|FG009|Induction Period|Adverse Event|0|||
125049696|NCT04760314|449802816|FG010|Induction Period|Adverse Event|0|||
125049697|NCT04760314|449802806|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
125049698|NCT04760314|449802807|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
125049699|NCT04760314|449802808|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
125049700|NCT04760314|449802809|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
125049701|NCT04760314|449802810|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
125049702|NCT04760314|449802811|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
125049703|NCT04760314|449802812|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
125049704|NCT04760314|449802813|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
125049705|NCT04760314|449802814|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
125049706|NCT04760314|449802815|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
125049707|NCT04760314|449802816|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
125049708|NCT04760314|449802806|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
125049709|NCT04760314|449802807|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
125049710|NCT04760314|449802808|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
125049711|NCT04760314|449802809|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
125049712|NCT04760314|449802810|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
125049713|NCT04760314|449802811|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
125049714|NCT04760314|449802812|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
125049715|NCT04760314|449802813|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
125049716|NCT04760314|449802814|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
125049717|NCT04760314|449802815|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
125049718|NCT04760314|449802816|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
125049719|NCT04760314|449802806|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
125049720|NCT04760314|449802807|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
125049721|NCT04760314|449802808|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
125049722|NCT04760314|449802809|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
125049723|NCT04760314|449802810|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
125049724|NCT04760314|449802811|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
125049725|NCT04760314|449802812|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
125049726|NCT04760314|449802813|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
125049727|NCT04760314|449802814|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
125049728|NCT04760314|449802815|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
125049729|NCT04760314|449802816|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
125049730|NCT04760314|449802806|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
125049731|NCT04760314|449802807|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
125049732|NCT04760314|449802808|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
125049733|NCT04760314|449802809|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
125049734|NCT04760314|449802810|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
125049735|NCT04760314|449802811|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
125049736|NCT04760314|449802812|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
125049737|NCT04760314|449802813|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
125049738|NCT04760314|449802814|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
125049739|NCT04760314|449802815|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
125049740|NCT04760314|449802816|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
125049741|NCT04760314|449802806|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125049742|NCT04760314|449802807|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125049743|NCT04760314|449802808|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125049744|NCT04760314|449802809|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125049745|NCT04760314|449802810|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125049746|NCT04760314|449802811|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125049747|NCT04760314|449802812|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125049748|NCT04760314|449802813|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
125049749|NCT04760314|449802814|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125049750|NCT04760314|449802815|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
125049751|NCT04760314|449802816|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
125049752|NCT04760314|449802806|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125049753|NCT04760314|449802807|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125049754|NCT04760314|449802808|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125049755|NCT04760314|449802809|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125049756|NCT04760314|449802810|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125049757|NCT04760314|449802811|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125049758|NCT04760314|449802812|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125049759|NCT04760314|449802813|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
125049760|NCT04760314|449802814|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
125049761|NCT04760314|449802815|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
125049762|NCT04760314|449802816|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125049763|NCT04760314|449802806|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125049764|NCT04760314|449802807|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125049765|NCT04760314|449802808|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125049766|NCT04760314|449802809|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125049767|NCT04760314|449802810|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125049768|NCT04760314|449802811|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125049769|NCT04760314|449802812|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125049770|NCT04760314|449802813|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
125049771|NCT04760314|449802814|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125049772|NCT04760314|449802815|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125049773|NCT04760314|449802816|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125049774|NCT04760314|449802806|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
125049775|NCT04760314|449802807|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
125049776|NCT04760314|449802808|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
125049777|NCT04760314|449802809|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
125049778|NCT04760314|449802810|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
125049779|NCT04760314|449802811|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
125049780|NCT04760314|449802812|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
125049781|NCT04760314|449802813|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
125049782|NCT04760314|449802814|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
125049783|NCT04760314|449802815|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
125049784|NCT04760314|449802816|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
125049785|NCT00960440|449802818|FG000|Overall Study|Death|0|||
125049786|NCT00960440|449802819|FG001|Overall Study|Death|0|||
125049787|NCT00960440|449802820|FG002|Overall Study|Death|0|||
125049788|NCT00960440|449802821|FG003|Overall Study|Death|1|||
125049789|NCT00960440|449802818|FG000|Overall Study|Adverse Event|12|||
125049790|NCT00960440|449802819|FG001|Overall Study|Adverse Event|12|||
125049791|NCT00960440|449802820|FG002|Overall Study|Adverse Event|4|||
125049792|NCT00960440|449802821|FG003|Overall Study|Adverse Event|4|||
125049793|NCT00960440|449802818|FG000|Overall Study|Lack of Efficacy|2|||
125049794|NCT00960440|449802819|FG001|Overall Study|Lack of Efficacy|5|||
125049795|NCT00960440|449802820|FG002|Overall Study|Lack of Efficacy|3|||
125049796|NCT00960440|449802821|FG003|Overall Study|Lack of Efficacy|8|||
125049797|NCT00960440|449802818|FG000|Overall Study|Protocol Violation|2|||
125049798|NCT00960440|449802819|FG001|Overall Study|Protocol Violation|8|||
125049799|NCT00960440|449802820|FG002|Overall Study|Protocol Violation|3|||
125049800|NCT00960440|449802821|FG003|Overall Study|Protocol Violation|4|||
125049801|NCT00960440|449802818|FG000|Overall Study|Withdrawal by Subject|9|||
125049802|NCT00960440|449802819|FG001|Overall Study|Withdrawal by Subject|5|||
125049803|NCT00960440|449802820|FG002|Overall Study|Withdrawal by Subject|2|||
125049804|NCT00960440|449802821|FG003|Overall Study|Withdrawal by Subject|1|||
125049805|NCT00960440|449802818|FG000|Overall Study|Other|1|||
125049806|NCT00960440|449802819|FG001|Overall Study|Other|1|||
125049807|NCT00960440|449802820|FG002|Overall Study|Other|1|||
125049808|NCT00960440|449802821|FG003|Overall Study|Other|0|||
125049809|NCT02421120|449802822|FG000|Overall Study|Adverse Event|1|||
125049810|NCT02207530|449802823|FG000|Overall Study|Worsening condition under investigation|78|||
125049811|NCT02207530|449802823|FG000|Overall Study|Patient decision to stop study treatment|5|||
125049812|NCT02207530|449802823|FG000|Overall Study|Adverse Event|8|||
125049813|NCT02345161|449802824|FG000|Overall Study|Withdrawal by Subject|25|||
125049814|NCT02345161|449802825|FG001|Overall Study|Withdrawal by Subject|33|||
125049815|NCT02345161|449802824|FG000|Overall Study|Adverse Event|16|||
125049816|NCT02345161|449802825|FG001|Overall Study|Adverse Event|19|||
125049817|NCT02345161|449802824|FG000|Overall Study|Physician Decision|4|||
125049818|NCT02345161|449802825|FG001|Overall Study|Physician Decision|4|||
125049819|NCT02345161|449802824|FG000|Overall Study|Lost to Follow-up|0|||
125049820|NCT02345161|449802825|FG001|Overall Study|Lost to Follow-up|1|||
125049825|NCT03554005|449802834|FG000|Overall Study|Not in participant's best interest|0|||
125219607|NCT02861664|450431165|FG000|Overall Study|Withdrawal of Consent|0|||
125219608|NCT02861664|450431166|FG001|Overall Study|Withdrawal of Consent|1|||
125049826|NCT03554005|449802835|FG001|Overall Study|Not in participant's best interest|0|||
125049827|NCT03554005|449802836|FG002|Overall Study|Not in participant's best interest|0|||
125049828|NCT03554005|449802837|FG003|Overall Study|Not in participant's best interest|0|||
125049829|NCT03554005|449802838|FG004|Overall Study|Not in participant's best interest|0|||
125049830|NCT03554005|449802839|FG005|Overall Study|Not in participant's best interest|1|||
125049831|NCT03554005|449802834|FG000|Overall Study|Disease Progression|1|||
125049832|NCT03554005|449802835|FG001|Overall Study|Disease Progression|1|||
125049833|NCT03554005|449802836|FG002|Overall Study|Disease Progression|1|||
125049834|NCT03554005|449802837|FG003|Overall Study|Disease Progression|1|||
125049835|NCT03554005|449802838|FG004|Overall Study|Disease Progression|5|||
125049836|NCT03554005|449802839|FG005|Overall Study|Disease Progression|6|||
125049837|NCT03554005|449802834|FG000|Overall Study|Adverse Event|0|||
125049838|NCT03554005|449802835|FG001|Overall Study|Adverse Event|0|||
125049839|NCT03554005|449802836|FG002|Overall Study|Adverse Event|0|||
125049840|NCT03554005|449802837|FG003|Overall Study|Adverse Event|0|||
125049841|NCT03554005|449802838|FG004|Overall Study|Adverse Event|0|||
125049842|NCT03554005|449802839|FG005|Overall Study|Adverse Event|3|||
125049843|NCT03554005|449802834|FG000|Overall Study|Physician Decision|0|||
125049844|NCT03554005|449802835|FG001|Overall Study|Physician Decision|0|||
125049845|NCT03554005|449802836|FG002|Overall Study|Physician Decision|0|||
125049846|NCT03554005|449802837|FG003|Overall Study|Physician Decision|0|||
125049847|NCT03554005|449802838|FG004|Overall Study|Physician Decision|1|||
125049848|NCT03554005|449802839|FG005|Overall Study|Physician Decision|0|||
125049849|NCT03554005|449802834|FG000|Overall Study|Other|0|||
125049850|NCT03554005|449802835|FG001|Overall Study|Other|0|||
125049851|NCT03554005|449802836|FG002|Overall Study|Other|0|||
125049852|NCT03554005|449802837|FG003|Overall Study|Other|0|||
125049853|NCT03554005|449802838|FG004|Overall Study|Other|0|||
125049854|NCT03554005|449802839|FG005|Overall Study|Other|1|||
125049855|NCT02855411|449802843|FG000|Overall Study|Study terminated by sponsor|21|||
125049856|NCT02855411|449802843|FG000|Overall Study|Does not meet entrance criteria|14|||
125049857|NCT02606045|449802844|FG000|Overall Study|Study closed before treament could begin|1|||
125049858|NCT02606045|449802845|FG001|Overall Study|Study closed before treament could begin|2|||
125049859|NCT00907881|449802846|FG000|Overall Study|Lost to Follow-up|59|||
125049860|NCT00907881|449802846|FG000|Overall Study|Noncompliance|5|||
125049861|NCT00907881|449802846|FG000|Overall Study|Withdrawal by Subject|5|||
125049862|NCT00907881|449802846|FG000|Overall Study|Protocol Violation|1|||
125049863|NCT00907881|449802846|FG000|Overall Study|Missing discontinuation information|15|||
125049864|NCT01671085|449802847|FG000|Overall Study|Withdrawal by Subject|1|||
125049865|NCT01671085|449802848|FG001|Overall Study|Withdrawal by Subject|0|||
125049866|NCT00637273|449802849|FG000|Overall Study|Adverse Event|11|||
125049867|NCT00637273|449802850|FG001|Overall Study|Adverse Event|5|||
125049868|NCT00637273|449802851|FG002|Overall Study|Adverse Event|7|||
125049869|NCT00637273|449802849|FG000|Overall Study|Lost to Follow-up|8|||
125049870|NCT00637273|449802850|FG001|Overall Study|Lost to Follow-up|9|||
125049871|NCT00637273|449802851|FG002|Overall Study|Lost to Follow-up|13|||
125049872|NCT00637273|449802849|FG000|Overall Study|Protocol Violation|2|||
125049873|NCT00637273|449802850|FG001|Overall Study|Protocol Violation|4|||
125049874|NCT00637273|449802851|FG002|Overall Study|Protocol Violation|1|||
125049875|NCT00637273|449802849|FG000|Overall Study|Withdrawal of Consent|18|||
125049876|NCT00637273|449802850|FG001|Overall Study|Withdrawal of Consent|6|||
125049877|NCT00637273|449802851|FG002|Overall Study|Withdrawal of Consent|18|||
125049878|NCT00637273|449802849|FG000|Overall Study|Investigator Decision|1|||
125049879|NCT00637273|449802850|FG001|Overall Study|Investigator Decision|3|||
125049880|NCT00637273|449802851|FG002|Overall Study|Investigator Decision|1|||
125049881|NCT00637273|449802849|FG000|Overall Study|Administrative|2|||
125049882|NCT00637273|449802850|FG001|Overall Study|Administrative|0|||
125049883|NCT00637273|449802851|FG002|Overall Study|Administrative|0|||
125049884|NCT00637273|449802849|FG000|Overall Study|Loss of Glucose Control|1|||
125049885|NCT00637273|449802850|FG001|Overall Study|Loss of Glucose Control|1|||
125049886|NCT00637273|449802851|FG002|Overall Study|Loss of Glucose Control|1|||
125049887|NCT00986258|449802852|FG000|Observation Period|Not eligible to be dosed|11|||
125049888|NCT00986258|449802852|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
125049889|NCT00986258|449802852|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
125049890|NCT00986258|449802852|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
125049891|NCT00986258|449802852|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
125219609|NCT01239394|450431167|FG000|Overall Study|Adverse Event|1|||
125219610|NCT00905632|450431169|FG000|Overall Study|Adverse Event|0|||
125049892|NCT00986258|449802852|FG000|Titration and Optimal Dose Period|Other|1|||
125049893|NCT00986258|449802852|FG000|Maintenance Period|Adverse Event|5|||
125049894|NCT00986258|449802852|FG000|Maintenance Period|Lack of Efficacy|2|||
125049895|NCT00986258|449802852|FG000|Maintenance Period|Withdrawal by Subject|2|||
125049896|NCT02616029|449802854|FG000|Overall Study|Adverse Event|1|||
125049897|NCT02616029|449802855|FG001|Overall Study|Adverse Event|0|||
125049898|NCT02616029|449802854|FG000|Overall Study|Death|0|||
125049899|NCT02616029|449802855|FG001|Overall Study|Death|1|||
125049900|NCT02616029|449802854|FG000|Overall Study|Protocol Violation|1|||
125049901|NCT02616029|449802855|FG001|Overall Study|Protocol Violation|0|||
125049902|NCT02616029|449802854|FG000|Overall Study|Withdrew Consent|1|||
125049903|NCT02616029|449802855|FG001|Overall Study|Withdrew Consent|0|||
125049904|NCT02616029|449802854|FG000|Overall Study|Enrolled and Never Treated|1|||
125049905|NCT02616029|449802855|FG001|Overall Study|Enrolled and Never Treated|1|||
125049906|NCT01505491|449802856|FG000|Overall Study|Other reason not listed|1|||
125049907|NCT01505491|449802857|FG001|Overall Study|Other reason not listed|0|||
125049908|NCT01505491|449802858|FG002|Overall Study|Other reason not listed|0|||
125049909|NCT01505491|449802856|FG000|Overall Study|Withdrawal by Subject|1|||
125049910|NCT01505491|449802857|FG001|Overall Study|Withdrawal by Subject|1|||
125049911|NCT01505491|449802858|FG002|Overall Study|Withdrawal by Subject|4|||
125049912|NCT01505491|449802856|FG000|Overall Study|Lost to Follow-up|0|||
125049913|NCT01505491|449802857|FG001|Overall Study|Lost to Follow-up|0|||
125049914|NCT01505491|449802858|FG002|Overall Study|Lost to Follow-up|1|||
125049915|NCT01063751|449802867|FG000|Overall Study|Censored from analyses|42|||
125049916|NCT01063751|449802867|FG000|Overall Study|Withdrawal by Subject|34|||
125049917|NCT01063751|449802867|FG000|Overall Study|Lost to Follow-up|30|||
125049918|NCT01063751|449802867|FG000|Overall Study|Death|13|||
125049919|NCT01063751|449802867|FG000|Overall Study|Sponsored Terminated Study|60|||
125049920|NCT01063751|449802867|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
125049921|NCT01063751|449802867|FG000|Overall Study|Investigator site closed|10|||
125049922|NCT01063751|449802867|FG000|Overall Study|Revision|6|||
125049923|NCT01063751|449802867|FG000|Overall Study|Physician Decision|4|||
125049924|NCT03408873|449802873|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
125049925|NCT03408873|449802873|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
125049926|NCT03408873|449802873|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
125049927|NCT03408873|449802873|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
125049928|NCT03408873|449802873|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
125049929|NCT03408873|449802873|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
125049930|NCT01312428|449802877|FG000|Overall Study|Study Termination|3|||
125049931|NCT01312428|449802878|FG001|Overall Study|Study Termination|4|||
125049932|NCT03799718|449802879|FG000|Overall Study|Adverse Event|2|||
125049933|NCT02214186|449802881|FG000|Overall Study|Lost to Follow-up|1|||
125049934|NCT02214186|449802882|FG001|Overall Study|Lost to Follow-up|1|||
125049935|NCT02214186|449802881|FG000|Overall Study|Protocol Violation|1|||
125049936|NCT02214186|449802882|FG001|Overall Study|Protocol Violation|1|||
125049937|NCT01651052|449802883|FG000|Overall Study|Death|21|||
125049938|NCT01651052|449802883|FG000|Overall Study|Explant|1|||
125049939|NCT01651052|449802883|FG000|Overall Study|Withdrawal by Subject|1|||
125049940|NCT01651052|449802883|FG000|Overall Study|Lost to Follow-up|3|||
125049941|NCT03964415|449802888|FG000|Overall Study|Sponsor's decision|1563|||
125049942|NCT03964415|449802889|FG001|Overall Study|Sponsor's decision|1528|||
125049943|NCT03964415|449802888|FG000|Overall Study|Lost to Follow-up|139|||
125049944|NCT03964415|449802889|FG001|Overall Study|Lost to Follow-up|146|||
125049945|NCT03964415|449802888|FG000|Overall Study|Withdrawal by Subject|68|||
125049946|NCT03964415|449802889|FG001|Overall Study|Withdrawal by Subject|72|||
125049947|NCT03964415|449802888|FG000|Overall Study|Physician Decision|34|||
125049948|NCT03964415|449802889|FG001|Overall Study|Physician Decision|48|||
125049949|NCT03964415|449802888|FG000|Overall Study|Adverse Event|3|||
125049950|NCT03964415|449802889|FG001|Overall Study|Adverse Event|0|||
125049951|NCT03964415|449802888|FG000|Overall Study|Death|4|||
125049952|NCT03964415|449802889|FG001|Overall Study|Death|6|||
125049953|NCT03964415|449802888|FG000|Overall Study|Protocol Violation|1|||
125049954|NCT03964415|449802889|FG001|Overall Study|Protocol Violation|4|||
125049955|NCT03964415|449802888|FG000|Overall Study|Other|35|||
125049956|NCT03964415|449802889|FG001|Overall Study|Other|38|||
125049957|NCT03964415|449802888|FG000|Overall Study|Randomized but not treated|6|||
125049958|NCT03964415|449802889|FG001|Overall Study|Randomized but not treated|7|||
125049959|NCT01734993|449802890|FG000|Overall Study|Adverse Event|1|||
125049960|NCT01734993|449802890|FG000|Overall Study|Lack of Efficacy|1|||
125049961|NCT01024465|449802891|FG000|Overall Study|Adverse Event|2|||
125049962|NCT01024465|449802891|FG000|Overall Study|Physician Decision|1|||
125049963|NCT02062151|449802894|FG000|Overall Study|screen failure|1|||
125049964|NCT02086565|449802895|FG000|Overall Study|Lost to Follow-up|9|||
125049965|NCT02086565|449802896|FG001|Overall Study|Lost to Follow-up|7|||
125049966|NCT02086565|449802895|FG000|Overall Study|Withdrawal by Subject|2|||
125049967|NCT02086565|449802896|FG001|Overall Study|Withdrawal by Subject|1|||
125049968|NCT02086565|449802895|FG000|Overall Study|Death|3|||
125049969|NCT02086565|449802896|FG001|Overall Study|Death|2|||
125049970|NCT02086565|449802895|FG000|Overall Study|withdrawn by research team|2|||
125049971|NCT02086565|449802896|FG001|Overall Study|withdrawn by research team|2|||
125049972|NCT02116972|449802897|FG000|Overall Study|Adverse Event|4|||
125049973|NCT02116972|449802898|FG001|Overall Study|Adverse Event|4|||
125049974|NCT02116972|449802899|FG002|Overall Study|Adverse Event|1|||
125049975|NCT02116972|449802897|FG000|Overall Study|Withdrawal by Subject|1|||
125049976|NCT02116972|449802898|FG001|Overall Study|Withdrawal by Subject|1|||
125049977|NCT02116972|449802899|FG002|Overall Study|Withdrawal by Subject|5|||
125049978|NCT02116972|449802897|FG000|Overall Study|Protocol Violation|1|||
125049979|NCT02116972|449802898|FG001|Overall Study|Protocol Violation|0|||
125049980|NCT02116972|449802899|FG002|Overall Study|Protocol Violation|1|||
125049981|NCT02116972|449802897|FG000|Overall Study|Lost to Follow-up|4|||
125049982|NCT02116972|449802898|FG001|Overall Study|Lost to Follow-up|3|||
125049983|NCT02116972|449802899|FG002|Overall Study|Lost to Follow-up|1|||
125049984|NCT02116972|449802897|FG000|Overall Study|Lack of Efficacy|6|||
125049985|NCT02116972|449802898|FG001|Overall Study|Lack of Efficacy|6|||
125049986|NCT02116972|449802899|FG002|Overall Study|Lack of Efficacy|5|||
125049987|NCT02116972|449802897|FG000|Overall Study|scheduling conflicts and relocation|3|||
125049988|NCT02116972|449802898|FG001|Overall Study|scheduling conflicts and relocation|3|||
125049989|NCT02116972|449802899|FG002|Overall Study|scheduling conflicts and relocation|6|||
125049990|NCT00789477|449802902|FG000|Overall Study|Withdrawal by Subject|2|||
125219611|NCT00905632|450431170|FG001|Overall Study|Adverse Event|0|||
125219612|NCT00905632|450431171|FG002|Overall Study|Adverse Event|0|||
125219613|NCT00905632|450431172|FG003|Overall Study|Adverse Event|0|||
125219614|NCT00905632|450431173|FG004|Overall Study|Adverse Event|0|||
125049991|NCT00789477|449802903|FG001|Overall Study|Withdrawal by Subject|1|||
125049992|NCT00789477|449802904|FG002|Overall Study|Withdrawal by Subject|3|||
125049993|NCT00789477|449802905|FG003|Overall Study|Withdrawal by Subject|2|||
125049994|NCT00789477|449802906|FG004|Overall Study|Withdrawal by Subject|3|||
125049995|NCT00789477|449802902|FG000|Overall Study|Protocol Violation|1|||
125049996|NCT00789477|449802903|FG001|Overall Study|Protocol Violation|0|||
125049997|NCT00789477|449802904|FG002|Overall Study|Protocol Violation|0|||
125049998|NCT00789477|449802905|FG003|Overall Study|Protocol Violation|1|||
125049999|NCT00789477|449802906|FG004|Overall Study|Protocol Violation|0|||
125050000|NCT00789477|449802902|FG000|Overall Study|Adverse Event|3|||
125050001|NCT00789477|449802903|FG001|Overall Study|Adverse Event|3|||
125050002|NCT00789477|449802904|FG002|Overall Study|Adverse Event|1|||
125050003|NCT00789477|449802905|FG003|Overall Study|Adverse Event|0|||
125050004|NCT00789477|449802906|FG004|Overall Study|Adverse Event|0|||
125050005|NCT00789477|449802902|FG000|Overall Study|Death|1|||
125050006|NCT00789477|449802903|FG001|Overall Study|Death|1|||
125050007|NCT00789477|449802904|FG002|Overall Study|Death|2|||
125050008|NCT00789477|449802905|FG003|Overall Study|Death|2|||
125050009|NCT00789477|449802906|FG004|Overall Study|Death|0|||
125050010|NCT00789477|449802902|FG000|Overall Study|Lost to Follow-up|0|||
125050011|NCT00789477|449802903|FG001|Overall Study|Lost to Follow-up|1|||
125050012|NCT00789477|449802904|FG002|Overall Study|Lost to Follow-up|4|||
125050013|NCT00789477|449802905|FG003|Overall Study|Lost to Follow-up|2|||
125050014|NCT00789477|449802906|FG004|Overall Study|Lost to Follow-up|4|||
125219615|NCT00905632|450431174|FG005|Overall Study|Adverse Event|1|||
125050015|NCT00789477|449802902|FG000|Overall Study|Lack of Efficacy|2|||
125050016|NCT00789477|449802903|FG001|Overall Study|Lack of Efficacy|0|||
125050017|NCT00789477|449802904|FG002|Overall Study|Lack of Efficacy|0|||
125050018|NCT00789477|449802905|FG003|Overall Study|Lack of Efficacy|0|||
125050019|NCT00789477|449802906|FG004|Overall Study|Lack of Efficacy|0|||
125050020|NCT00789477|449802902|FG000|Overall Study|Other|2|||
125050021|NCT00789477|449802903|FG001|Overall Study|Other|0|||
125050022|NCT00789477|449802904|FG002|Overall Study|Other|1|||
125050023|NCT00789477|449802905|FG003|Overall Study|Other|3|||
125050024|NCT00789477|449802906|FG004|Overall Study|Other|0|||
125050025|NCT02092389|449802908|FG000|Overall Study|Adverse Event|1|||
125050026|NCT02092389|449802908|FG000|Overall Study|Other|5|||
125050027|NCT01242020|449802909|FG000|Overall Study|Withdrawal by Subject|2|||
125050028|NCT01242020|449802910|FG001|Overall Study|Withdrawal by Subject|0|||
125050029|NCT01242020|449802909|FG000|Overall Study|Failed screening|1|||
125050030|NCT01242020|449802910|FG001|Overall Study|Failed screening|0|||
125050031|NCT01161524|449802911|FG000|Core Study (23 Weeks)|Adverse Event|3|||
125050032|NCT01161524|449802912|FG001|Core Study (23 Weeks)|Adverse Event|0|||
125050033|NCT01161524|449802913|FG002|Core Study (23 Weeks)|Adverse Event|0|||
125050034|NCT01161524|449802911|FG000|Core Study (23 Weeks)|Other|1|||
125050035|NCT01161524|449802912|FG001|Core Study (23 Weeks)|Other|0|||
125050036|NCT01161524|449802913|FG002|Core Study (23 Weeks)|Other|0|||
125050037|NCT01161524|449802911|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
125050038|NCT01161524|449802912|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
125050039|NCT01161524|449802913|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
125050040|NCT01161524|449802911|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
125050041|NCT01161524|449802912|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
125050042|NCT01161524|449802913|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
125050043|NCT01161524|449802911|FG000|Core Study (23 Weeks)|Subject Choice|3|||
125050044|NCT01161524|449802912|FG001|Core Study (23 Weeks)|Subject Choice|2|||
125050045|NCT01161524|449802913|FG002|Core Study (23 Weeks)|Subject Choice|0|||
125050046|NCT01161524|449802911|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
125050047|NCT01161524|449802912|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
125050048|NCT01161524|449802913|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
125050049|NCT01161524|449802911|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
125050050|NCT01161524|449802912|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
125050051|NCT01161524|449802913|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
125050052|NCT01161524|449802911|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
125050053|NCT01161524|449802912|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
125050054|NCT01161524|449802913|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
125050055|NCT01161524|449802911|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
125050056|NCT01161524|449802912|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
125050057|NCT01161524|449802913|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
125050058|NCT01161524|449802911|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
125050059|NCT01161524|449802912|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
125050060|NCT01161524|449802913|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
125050061|NCT00564629|449802920|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
125050062|NCT00564629|449802921|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
125050063|NCT03634072|449802922|FG000|Overall Study|Early termination of overall study|1|||
125050064|NCT03634072|449802923|FG001|Overall Study|Early termination of overall study|0|||
125050065|NCT01952015|449802926|FG000|Induction|Protocol Violation|1|||
125050066|NCT01952015|449802926|FG000|Maintenance|Adverse Event|2|||
125050067|NCT01952015|449802926|FG000|Treatment Period 3|Physician Decision|9|||
125050068|NCT02239094|449802927|FG000|Overall Study|Withdrawal by Subject|1|||
125050069|NCT02239094|449802927|FG000|Overall Study|Remitted before started|1|||
125050070|NCT00592501|449802928|FG000|Overall Study|Withdrawal by Subject|1|||
125050071|NCT00592501|449802928|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
125050072|NCT03880227|449802932|FG000|First Visit|Withdrawal by Subject|1|||
125050073|NCT03880227|449802933|FG001|First Visit|Withdrawal by Subject|0|||
125050074|NCT03880227|449802934|FG002|First Visit|Withdrawal by Subject|0|||
125050075|NCT03880227|449802935|FG003|First Visit|Withdrawal by Subject|0|||
125050076|NCT03880227|449802932|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
125050077|NCT03880227|449802933|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
125050078|NCT03880227|449802934|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
125050079|NCT03880227|449802935|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
125050080|NCT03880227|449802932|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
125050081|NCT03880227|449802933|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
125050082|NCT03880227|449802934|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
125050083|NCT03880227|449802935|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
125050084|NCT03880227|449802932|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
125219616|NCT00905632|450431175|FG006|Overall Study|Adverse Event|4|||
125050085|NCT03880227|449802933|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
125050086|NCT03880227|449802934|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
125050087|NCT03880227|449802935|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
125050088|NCT02399475|449802938|FG000|Overall Study|Physician Decision|1|||
125050089|NCT02399475|449802939|FG001|Overall Study|Physician Decision|0|||
125050090|NCT01963117|449802940|FG000|Overall Study|Death|1|||
125050091|NCT01605396|449802941|FG000|Overall Study|Adverse Event|5|||
125050092|NCT01605396|449802942|FG001|Overall Study|Adverse Event|3|||
125050093|NCT01605396|449802941|FG000|Overall Study|Lost to Follow-up|1|||
125050094|NCT01605396|449802942|FG001|Overall Study|Lost to Follow-up|0|||
125050095|NCT01605396|449802941|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125050096|NCT01605396|449802942|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125050097|NCT01605396|449802941|FG000|Overall Study|Physician Decision|2|||
125050098|NCT01605396|449802942|FG001|Overall Study|Physician Decision|2|||
125219617|NCT02781818|450431179|FG000|Overall Study|Lost to Follow-up|4|||
125219618|NCT02781818|450431180|FG001|Overall Study|Lost to Follow-up|2|||
125219619|NCT02781818|450431181|FG002|Overall Study|Lost to Follow-up|1|||
125219620|NCT01223404|450431182|FG000|First Intervention (1 Day)|Adverse Event|0|||
125219621|NCT01223404|450431183|FG001|First Intervention (1 Day)|Adverse Event|0|||
125219622|NCT01223404|450431184|FG002|First Intervention (1 Day)|Adverse Event|0|||
125219623|NCT01223404|450431185|FG003|First Intervention (1 Day)|Adverse Event|1|||
125219624|NCT01223404|450431186|FG004|First Intervention (1 Day)|Adverse Event|0|||
125219625|NCT01223404|450431187|FG005|First Intervention (1 Day)|Adverse Event|0|||
125219626|NCT01223404|450431182|FG000|Second Intervention (1 Day)|Adverse Event|1|||
125219627|NCT01223404|450431183|FG001|Second Intervention (1 Day)|Adverse Event|0|||
125219628|NCT01223404|450431184|FG002|Second Intervention (1 Day)|Adverse Event|0|||
125219629|NCT01223404|450431185|FG003|Second Intervention (1 Day)|Adverse Event|0|||
125219630|NCT01223404|450431186|FG004|Second Intervention (1 Day)|Adverse Event|0|||
125219631|NCT01223404|450431187|FG005|Second Intervention (1 Day)|Adverse Event|0|||
125219632|NCT01223404|450431182|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
125219633|NCT01223404|450431183|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
125219634|NCT01223404|450431184|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
125219635|NCT01223404|450431185|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
125219636|NCT01223404|450431186|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
125219637|NCT01223404|450431187|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
125219638|NCT02492165|450431188|FG000|Overall Study|Withdrawal by Subject|0|||
125219639|NCT02492165|450431189|FG001|Overall Study|Withdrawal by Subject|1|||
125219640|NCT02492165|450431190|FG002|Overall Study|Withdrawal by Subject|0|||
125219641|NCT02492165|450431191|FG003|Overall Study|Withdrawal by Subject|0|||
125050099|NCT01605396|449802941|FG000|Overall Study|Progressive Disease|23|||
125050100|NCT01605396|449802942|FG001|Overall Study|Progressive Disease|27|||
125050101|NCT01605396|449802941|FG000|Overall Study|Withdrawal by Subject|4|||
125050102|NCT01605396|449802942|FG001|Overall Study|Withdrawal by Subject|2|||
125050103|NCT01605396|449802941|FG000|Overall Study|Transfer Off Study|4|||
125050104|NCT01605396|449802942|FG001|Overall Study|Transfer Off Study|5|||
125050105|NCT02795988|449804632|FG000|Phase 1b|Withdrawal by Subject|0|||
125050106|NCT02795988|449804633|FG001|Phase 1b|Withdrawal by Subject|1|||
125050107|NCT02795988|449804634|FG002|Phase 1b|Withdrawal by Subject|0|||
125050108|NCT02795988|449804635|FG003|Phase 1b|Withdrawal by Subject|0|||
125050109|NCT02795988|449804636|FG004|Phase 1b|Withdrawal by Subject|0|||
125050110|NCT02795988|449804637|FG005|Phase 1b|Withdrawal by Subject|0|||
125050111|NCT02795988|449804638|FG006|Phase 1b|Withdrawal by Subject|0|||
125050112|NCT02795988|449804632|FG000|Phase 1b|Death|1|||
125050113|NCT02795988|449804633|FG001|Phase 1b|Death|2|||
125050114|NCT02795988|449804634|FG002|Phase 1b|Death|1|||
125050115|NCT02795988|449804635|FG003|Phase 1b|Death|0|||
125050116|NCT02795988|449804636|FG004|Phase 1b|Death|0|||
125050117|NCT02795988|449804637|FG005|Phase 1b|Death|0|||
125050118|NCT02795988|449804638|FG006|Phase 1b|Death|0|||
125050119|NCT02795988|449804632|FG000|Phase 1b|Physician Decision|0|||
125050120|NCT02795988|449804633|FG001|Phase 1b|Physician Decision|0|||
125050121|NCT02795988|449804634|FG002|Phase 1b|Physician Decision|1|||
125050122|NCT02795988|449804635|FG003|Phase 1b|Physician Decision|0|||
125219642|NCT00707057|450431192|FG000|Overall Study|Withdrawal by Subject|8|||
125219643|NCT00707057|450431193|FG001|Overall Study|Withdrawal by Subject|3|||
125219644|NCT00707057|450431192|FG000|Overall Study|Dosed incorrectly|0|||
125050123|NCT02795988|449804636|FG004|Phase 1b|Physician Decision|0|||
125050124|NCT02795988|449804637|FG005|Phase 1b|Physician Decision|0|||
125219645|NCT00707057|450431193|FG001|Overall Study|Dosed incorrectly|1|||
125219646|NCT02915159|450431199|FG000|Overall Study|Participant no longer meets criteria|2|||
125219647|NCT02915159|450431200|FG001|Overall Study|Participant no longer meets criteria|0|||
125050125|NCT02795988|449804638|FG006|Phase 1b|Physician Decision|0|||
125050126|NCT02795988|449804632|FG000|Phase 1b|Progressive Disease|2|||
125050127|NCT02795988|449804633|FG001|Phase 1b|Progressive Disease|2|||
125219648|NCT02915159|450431199|FG000|Overall Study|poor/non-compliance|1|||
125050128|NCT02795988|449804634|FG002|Phase 1b|Progressive Disease|0|||
125050129|NCT02795988|449804635|FG003|Phase 1b|Progressive Disease|0|||
125050130|NCT02795988|449804636|FG004|Phase 1b|Progressive Disease|0|||
125050131|NCT02795988|449804637|FG005|Phase 1b|Progressive Disease|0|||
125050132|NCT02795988|449804638|FG006|Phase 1b|Progressive Disease|0|||
125050133|NCT02795988|449804632|FG000|Phase 2|Withdrawal by Subject|0|||
125050134|NCT02795988|449804633|FG001|Phase 2|Withdrawal by Subject|0|||
125050135|NCT02795988|449804634|FG002|Phase 2|Withdrawal by Subject|0|||
125050136|NCT02795988|449804635|FG003|Phase 2|Withdrawal by Subject|1|||
125050137|NCT02795988|449804636|FG004|Phase 2|Withdrawal by Subject|0|||
125050138|NCT02795988|449804637|FG005|Phase 2|Withdrawal by Subject|0|||
125050139|NCT02795988|449804638|FG006|Phase 2|Withdrawal by Subject|0|||
125050140|NCT02795988|449804632|FG000|Phase 2|Death|0|||
125050141|NCT02795988|449804633|FG001|Phase 2|Death|0|||
125050142|NCT02795988|449804634|FG002|Phase 2|Death|0|||
125050143|NCT02795988|449804635|FG003|Phase 2|Death|17|||
125050144|NCT02795988|449804636|FG004|Phase 2|Death|17|||
125050145|NCT02795988|449804637|FG005|Phase 2|Death|0|||
125050146|NCT02795988|449804638|FG006|Phase 2|Death|0|||
125050147|NCT02795988|449804632|FG000|Phase 2|Other|0|||
125050148|NCT02795988|449804633|FG001|Phase 2|Other|0|||
125050149|NCT02795988|449804634|FG002|Phase 2|Other|0|||
125050150|NCT02795988|449804635|FG003|Phase 2|Other|1|||
125050151|NCT02795988|449804636|FG004|Phase 2|Other|0|||
125050152|NCT02795988|449804637|FG005|Phase 2|Other|0|||
125050153|NCT02795988|449804638|FG006|Phase 2|Other|0|||
125050154|NCT02795988|449804632|FG000|Phase 2 Extension|Death|0|||
125050155|NCT02795988|449804633|FG001|Phase 2 Extension|Death|0|||
125050156|NCT02795988|449804634|FG002|Phase 2 Extension|Death|0|||
125050157|NCT02795988|449804635|FG003|Phase 2 Extension|Death|0|||
125050158|NCT02795988|449804636|FG004|Phase 2 Extension|Death|0|||
125050159|NCT02795988|449804637|FG005|Phase 2 Extension|Death|5|||
125050160|NCT02795988|449804638|FG006|Phase 2 Extension|Death|6|||
125050161|NCT02795988|449804632|FG000|Phase 2 Extension|Other reasons|0|||
125050162|NCT02795988|449804633|FG001|Phase 2 Extension|Other reasons|0|||
125050163|NCT02795988|449804634|FG002|Phase 2 Extension|Other reasons|0|||
125050164|NCT02795988|449804635|FG003|Phase 2 Extension|Other reasons|0|||
125050165|NCT02795988|449804636|FG004|Phase 2 Extension|Other reasons|0|||
125050166|NCT02795988|449804637|FG005|Phase 2 Extension|Other reasons|2|||
125050167|NCT02795988|449804638|FG006|Phase 2 Extension|Other reasons|1|||
125050168|NCT02341014|449804639|FG000|Overall Study|Adverse Event|0|||
125050169|NCT02341014|449804640|FG001|Overall Study|Adverse Event|1|||
125050170|NCT02341014|449804641|FG002|Overall Study|Adverse Event|0|||
125050171|NCT02341014|449804642|FG003|Overall Study|Adverse Event|0|||
125050172|NCT02341014|449804643|FG004|Overall Study|Adverse Event|2|||
125050173|NCT00390780|449804644|FG000|Overall Study|Not completed|10|||
125050174|NCT00390780|449804645|FG001|Overall Study|Not completed|4|||
125050175|NCT00390780|449804644|FG000|Overall Study|Protocol Violation|6|||
125050176|NCT00390780|449804645|FG001|Overall Study|Protocol Violation|4|||
125050177|NCT00390780|449804644|FG000|Overall Study|Lost to Follow-up|3|||
125050178|NCT00390780|449804645|FG001|Overall Study|Lost to Follow-up|6|||
125050179|NCT00390780|449804644|FG000|Overall Study|Adverse Event|2|||
125050180|NCT00390780|449804645|FG001|Overall Study|Adverse Event|3|||
125050181|NCT00390780|449804644|FG000|Overall Study|Death|1|||
125050182|NCT00390780|449804645|FG001|Overall Study|Death|3|||
125050183|NCT00390780|449804644|FG000|Overall Study|Withdrawal by Subject|1|||
125050184|NCT00390780|449804645|FG001|Overall Study|Withdrawal by Subject|2|||
125050185|NCT00390780|449804644|FG000|Overall Study|Inclusion criteria not satisfied|0|||
125050186|NCT00390780|449804645|FG001|Overall Study|Inclusion criteria not satisfied|2|||
125050187|NCT00390780|449804644|FG000|Overall Study|Lost to follow up and other reasons|0|||
125050188|NCT00390780|449804645|FG001|Overall Study|Lost to follow up and other reasons|1|||
125050189|NCT00390780|449804644|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
125050190|NCT00390780|449804645|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
125050191|NCT00390780|449804644|FG000|Overall Study|SAE, death|0|||
125050192|NCT00390780|449804645|FG001|Overall Study|SAE, death|1|||
125050193|NCT01585961|449804646|FG000|Overall Study|Death|6|||
125050194|NCT01585961|449804646|FG000|Overall Study|Physician Decision|1|||
125050195|NCT01585961|449804646|FG000|Overall Study|Decision to use non-study catheter|1|||
125050196|NCT01585961|449804646|FG000|Overall Study|Withdrawal by Subject|1|||
125050197|NCT01585961|449804646|FG000|Overall Study|Lost to Follow-up|23|||
125050198|NCT01585961|449804646|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
125050199|NCT01258348|449804647|FG000|Overall Study|Adverse Event|1|||
125050200|NCT01258348|449804648|FG001|Overall Study|Adverse Event|1|||
125050201|NCT01258348|449804649|FG002|Overall Study|Adverse Event|3|||
125050202|NCT01258348|449804650|FG003|Overall Study|Adverse Event|2|||
125050203|NCT01258348|449804651|FG004|Overall Study|Adverse Event|4|||
125050204|NCT01258348|449804647|FG000|Overall Study|Progressive Disease|0|||
125050205|NCT01258348|449804648|FG001|Overall Study|Progressive Disease|3|||
125050206|NCT01258348|449804649|FG002|Overall Study|Progressive Disease|0|||
125050207|NCT01258348|449804650|FG003|Overall Study|Progressive Disease|2|||
125050208|NCT01258348|449804651|FG004|Overall Study|Progressive Disease|2|||
125050209|NCT01258348|449804647|FG000|Overall Study|Physician Decision|0|||
125050210|NCT01258348|449804648|FG001|Overall Study|Physician Decision|0|||
125050211|NCT01258348|449804649|FG002|Overall Study|Physician Decision|0|||
125050212|NCT01258348|449804650|FG003|Overall Study|Physician Decision|2|||
125050213|NCT01258348|449804651|FG004|Overall Study|Physician Decision|0|||
125050214|NCT01258348|449804647|FG000|Overall Study|Withdrawal by Subject|0|||
125050215|NCT01258348|449804648|FG001|Overall Study|Withdrawal by Subject|1|||
125050216|NCT01258348|449804649|FG002|Overall Study|Withdrawal by Subject|0|||
125050217|NCT01258348|449804650|FG003|Overall Study|Withdrawal by Subject|0|||
125050218|NCT01258348|449804651|FG004|Overall Study|Withdrawal by Subject|0|||
125050219|NCT00109733|449804652|FG000|Overall Study|Protocol Violation|0|||
125050220|NCT00109733|449804653|FG001|Overall Study|Protocol Violation|1|||
125050221|NCT00109733|449804652|FG000|Overall Study|Stopped taking study drug|1|||
125050222|NCT00109733|449804653|FG001|Overall Study|Stopped taking study drug|1|||
125050223|NCT00109733|449804652|FG000|Overall Study|Non-compliant|0|||
125050224|NCT00109733|449804653|FG001|Overall Study|Non-compliant|1|||
125050225|NCT00109733|449804652|FG000|Overall Study|Could not commit time for study|1|||
125050226|NCT00109733|449804653|FG001|Overall Study|Could not commit time for study|1|||
125050227|NCT02433288|449804660|FG000|Overall Study|Severe non-compliance to protocol|13|||
125050228|NCT02433288|449804661|FG001|Overall Study|Severe non-compliance to protocol|7|||
125050229|NCT02433288|449804660|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
125050230|NCT02433288|449804661|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
125050231|NCT02433288|449804660|FG000|Overall Study|Withdrawal by Subject|101|||
125050232|NCT02433288|449804661|FG001|Overall Study|Withdrawal by Subject|99|||
125050233|NCT02433288|449804660|FG000|Overall Study|Lost to Follow-up|2|||
125050234|NCT02433288|449804661|FG001|Overall Study|Lost to Follow-up|14|||
125050235|NCT02433288|449804660|FG000|Overall Study|Death|0|||
125050236|NCT02433288|449804661|FG001|Overall Study|Death|3|||
125050237|NCT00367640|449804662|FG000|Overall Study|Adverse Event|3|||
125050238|NCT00367640|449804663|FG001|Overall Study|Adverse Event|6|||
125050239|NCT00367640|449804664|FG002|Overall Study|Adverse Event|8|||
125050240|NCT00367640|449804665|FG003|Overall Study|Adverse Event|0|||
125050241|NCT00367640|449804662|FG000|Overall Study|Withdrawal by Subject|8|||
125050242|NCT00367640|449804663|FG001|Overall Study|Withdrawal by Subject|11|||
125050243|NCT00367640|449804664|FG002|Overall Study|Withdrawal by Subject|8|||
125050244|NCT00367640|449804665|FG003|Overall Study|Withdrawal by Subject|6|||
125050245|NCT00367640|449804662|FG000|Overall Study|Any other reason not above-mentioned|7|||
125050246|NCT00367640|449804663|FG001|Overall Study|Any other reason not above-mentioned|5|||
125050247|NCT00367640|449804664|FG002|Overall Study|Any other reason not above-mentioned|3|||
125050248|NCT00367640|449804665|FG003|Overall Study|Any other reason not above-mentioned|4|||
125050249|NCT00406315|449804667|FG000|Overall Study|Death|1|||
125050250|NCT00406315|449804667|FG000|Overall Study|Adverse Event|39|||
125050251|NCT00406315|449804667|FG000|Overall Study|Laboratory Abnormality|4|||
125050252|NCT00406315|449804667|FG000|Overall Study|Lack of Efficacy|13|||
125050253|NCT00406315|449804667|FG000|Overall Study|Other|33|||
125050254|NCT00406315|449804667|FG000|Overall Study|Lost to Follow-up|21|||
125050255|NCT00406315|449804667|FG000|Overall Study|Withdrawal by Subject|30|||
125050256|NCT02142894|449804671|FG000|Overall Study|Protocol Violation|8|||
125050257|NCT01455428|449804678|FG000|Overall Study|Protocol Violation|2|||
125050258|NCT01455428|449804679|FG001|Overall Study|Protocol Violation|1|||
125050259|NCT01455428|449804678|FG000|Overall Study|Adverse Event|6|||
125050260|NCT01455428|449804679|FG001|Overall Study|Adverse Event|2|||
125050261|NCT01455428|449804678|FG000|Overall Study|Lost to Follow-up|1|||
125050262|NCT01455428|449804679|FG001|Overall Study|Lost to Follow-up|1|||
125050263|NCT01455428|449804678|FG000|Overall Study|Withdrawal by Subject|2|||
125050264|NCT01455428|449804679|FG001|Overall Study|Withdrawal by Subject|5|||
125050265|NCT01455428|449804678|FG000|Overall Study|Did not meet entrance criteria|0|||
125050266|NCT01455428|449804679|FG001|Overall Study|Did not meet entrance criteria|2|||
125050267|NCT01455428|449804678|FG000|Overall Study|Insufficient clinical response|0|||
125050268|NCT01455428|449804679|FG001|Overall Study|Insufficient clinical response|2|||
125050269|NCT01455428|449804678|FG000|Overall Study|Did not receive treatment|1|||
125050270|NCT01455428|449804679|FG001|Overall Study|Did not receive treatment|1|||
125050271|NCT01455428|449804678|FG000|Overall Study|Other|2|||
125050272|NCT01455428|449804679|FG001|Overall Study|Other|4|||
125050273|NCT03303339|449804680|FG000|Overall Study|Death|2|||
125050274|NCT03303339|449804681|FG001|Overall Study|Death|2|||
125050275|NCT03303339|449804682|FG002|Overall Study|Death|2|||
125050276|NCT03303339|449804683|FG003|Overall Study|Death|1|||
125050277|NCT03303339|449804684|FG004|Overall Study|Death|4|||
125050278|NCT03303339|449804685|FG005|Overall Study|Death|2|||
125050279|NCT03303339|449804686|FG006|Overall Study|Death|2|||
125050280|NCT03303339|449804687|FG007|Overall Study|Death|2|||
125050281|NCT03303339|449804688|FG008|Overall Study|Death|3|||
125050282|NCT03303339|449804689|FG009|Overall Study|Death|3|||
125050283|NCT03303339|449804690|FG010|Overall Study|Death|4|||
125050284|NCT03303339|449804691|FG011|Overall Study|Death|24|||
125050285|NCT03303339|449804680|FG000|Overall Study|Study Terminated by Sponsor|0|||
125050286|NCT03303339|449804681|FG001|Overall Study|Study Terminated by Sponsor|0|||
125050287|NCT03303339|449804682|FG002|Overall Study|Study Terminated by Sponsor|0|||
125050288|NCT03303339|449804683|FG003|Overall Study|Study Terminated by Sponsor|0|||
125050289|NCT03303339|449804684|FG004|Overall Study|Study Terminated by Sponsor|0|||
125050290|NCT03303339|449804685|FG005|Overall Study|Study Terminated by Sponsor|0|||
125050291|NCT03303339|449804686|FG006|Overall Study|Study Terminated by Sponsor|0|||
125050292|NCT03303339|449804687|FG007|Overall Study|Study Terminated by Sponsor|0|||
125050293|NCT03303339|449804688|FG008|Overall Study|Study Terminated by Sponsor|1|||
125050294|NCT03303339|449804689|FG009|Overall Study|Study Terminated by Sponsor|0|||
125050295|NCT03303339|449804690|FG010|Overall Study|Study Terminated by Sponsor|1|||
125050296|NCT03303339|449804691|FG011|Overall Study|Study Terminated by Sponsor|1|||
125050297|NCT03303339|449804680|FG000|Overall Study|Withdrawal by Subject|1|||
125050298|NCT03303339|449804681|FG001|Overall Study|Withdrawal by Subject|0|||
125050299|NCT03303339|449804682|FG002|Overall Study|Withdrawal by Subject|0|||
125050300|NCT03303339|449804683|FG003|Overall Study|Withdrawal by Subject|0|||
125050301|NCT03303339|449804684|FG004|Overall Study|Withdrawal by Subject|0|||
125050302|NCT03303339|449804685|FG005|Overall Study|Withdrawal by Subject|1|||
125050303|NCT03303339|449804686|FG006|Overall Study|Withdrawal by Subject|1|||
125050304|NCT03303339|449804687|FG007|Overall Study|Withdrawal by Subject|0|||
125050305|NCT03303339|449804688|FG008|Overall Study|Withdrawal by Subject|0|||
125050306|NCT03303339|449804689|FG009|Overall Study|Withdrawal by Subject|0|||
125050307|NCT03303339|449804690|FG010|Overall Study|Withdrawal by Subject|0|||
125050308|NCT03303339|449804691|FG011|Overall Study|Withdrawal by Subject|2|||
125050309|NCT03303339|449804680|FG000|Overall Study|Physician Decision|0|||
125050310|NCT03303339|449804681|FG001|Overall Study|Physician Decision|0|||
125050311|NCT03303339|449804682|FG002|Overall Study|Physician Decision|0|||
125050312|NCT03303339|449804683|FG003|Overall Study|Physician Decision|0|||
125050313|NCT03303339|449804684|FG004|Overall Study|Physician Decision|1|||
125050314|NCT03303339|449804685|FG005|Overall Study|Physician Decision|0|||
125050315|NCT03303339|449804686|FG006|Overall Study|Physician Decision|0|||
125050316|NCT03303339|449804687|FG007|Overall Study|Physician Decision|0|||
125050317|NCT03303339|449804688|FG008|Overall Study|Physician Decision|0|||
125050318|NCT03303339|449804689|FG009|Overall Study|Physician Decision|0|||
125050319|NCT03303339|449804690|FG010|Overall Study|Physician Decision|0|||
125050320|NCT03303339|449804691|FG011|Overall Study|Physician Decision|0|||
125050321|NCT03303339|449804680|FG000|Overall Study|Safety/Non-compliance|0|||
125050322|NCT03303339|449804681|FG001|Overall Study|Safety/Non-compliance|0|||
125050323|NCT03303339|449804682|FG002|Overall Study|Safety/Non-compliance|0|||
125050324|NCT03303339|449804683|FG003|Overall Study|Safety/Non-compliance|0|||
125050325|NCT03303339|449804684|FG004|Overall Study|Safety/Non-compliance|0|||
125050326|NCT03303339|449804685|FG005|Overall Study|Safety/Non-compliance|0|||
125050327|NCT03303339|449804686|FG006|Overall Study|Safety/Non-compliance|0|||
125050328|NCT03303339|449804687|FG007|Overall Study|Safety/Non-compliance|0|||
125050329|NCT03303339|449804688|FG008|Overall Study|Safety/Non-compliance|0|||
125050330|NCT03303339|449804689|FG009|Overall Study|Safety/Non-compliance|0|||
125050331|NCT03303339|449804690|FG010|Overall Study|Safety/Non-compliance|0|||
125050332|NCT03303339|449804691|FG011|Overall Study|Safety/Non-compliance|1|||
125050333|NCT00257192|449804694|FG000|Overall Study|Adverse Event|21|||
125050334|NCT00257192|449804695|FG001|Overall Study|Adverse Event|10|||
125050335|NCT00257192|449804694|FG000|Overall Study|Laboratory abnormality|1|||
125050336|NCT00257192|449804695|FG001|Overall Study|Laboratory abnormality|1|||
125050337|NCT00257192|449804694|FG000|Overall Study|Lost to Follow-up|3|||
125050338|NCT00257192|449804695|FG001|Overall Study|Lost to Follow-up|3|||
125050339|NCT00257192|449804694|FG000|Overall Study|Insufficient clinical response|18|||
125050340|NCT00257192|449804695|FG001|Overall Study|Insufficient clinical response|18|||
125050341|NCT00257192|449804694|FG000|Overall Study|Withdrawal by Subject|14|||
125050342|NCT00257192|449804695|FG001|Overall Study|Withdrawal by Subject|2|||
125050343|NCT00257192|449804694|FG000|Overall Study|Randomized but not treated|0|||
125050344|NCT00257192|449804695|FG001|Overall Study|Randomized but not treated|1|||
125050345|NCT00257192|449804694|FG000|Overall Study|Study terminated by sponsor|1|||
125050346|NCT00257192|449804695|FG001|Overall Study|Study terminated by sponsor|0|||
125050347|NCT00257192|449804694|FG000|Overall Study|Miscellaneous|0|||
125050348|NCT00257192|449804695|FG001|Overall Study|Miscellaneous|4|||
125050349|NCT00570739|449804696|FG000|Overall Study|Adverse Event|8|||
125050350|NCT00570739|449804697|FG001|Overall Study|Adverse Event|6|||
125050351|NCT00570739|449804698|FG002|Overall Study|Adverse Event|2|||
125050352|NCT00570739|449804699|FG003|Overall Study|Adverse Event|2|||
125050353|NCT00570739|449804696|FG000|Overall Study|Lost to Follow-up|4|||
125050354|NCT00570739|449804697|FG001|Overall Study|Lost to Follow-up|5|||
125050355|NCT00570739|449804698|FG002|Overall Study|Lost to Follow-up|4|||
125050356|NCT00570739|449804699|FG003|Overall Study|Lost to Follow-up|1|||
125050357|NCT00570739|449804696|FG000|Overall Study|Physician Decision|1|||
125050358|NCT00570739|449804697|FG001|Overall Study|Physician Decision|1|||
125050359|NCT00570739|449804698|FG002|Overall Study|Physician Decision|0|||
125050360|NCT00570739|449804699|FG003|Overall Study|Physician Decision|0|||
125050361|NCT00570739|449804696|FG000|Overall Study|Withdrawal by Subject|7|||
125050362|NCT00570739|449804697|FG001|Overall Study|Withdrawal by Subject|7|||
125050363|NCT00570739|449804698|FG002|Overall Study|Withdrawal by Subject|3|||
125050364|NCT00570739|449804699|FG003|Overall Study|Withdrawal by Subject|5|||
125050365|NCT00570739|449804696|FG000|Overall Study|Required restricted medication|0|||
125050366|NCT00570739|449804697|FG001|Overall Study|Required restricted medication|0|||
125050367|NCT00570739|449804698|FG002|Overall Study|Required restricted medication|1|||
125050368|NCT00570739|449804699|FG003|Overall Study|Required restricted medication|0|||
125050369|NCT00570739|449804696|FG000|Overall Study|Met discontinuation criteria|1|||
125050370|NCT00570739|449804697|FG001|Overall Study|Met discontinuation criteria|0|||
125050371|NCT00570739|449804698|FG002|Overall Study|Met discontinuation criteria|1|||
125050372|NCT00570739|449804699|FG003|Overall Study|Met discontinuation criteria|1|||
125050373|NCT00570739|449804696|FG000|Overall Study|Other|0|||
125050374|NCT00570739|449804697|FG001|Overall Study|Other|2|||
125050375|NCT00570739|449804698|FG002|Overall Study|Other|5|||
125050376|NCT00570739|449804699|FG003|Overall Study|Other|3|||
125050377|NCT01400971|449804703|FG000|Overall Study|Death|82|||
125050378|NCT01400971|449804703|FG000|Overall Study|Lost to Follow-up|196|||
125050379|NCT01400971|449804703|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
125050380|NCT01400971|449804703|FG000|Overall Study|Physician Decision|57|||
125050381|NCT01400971|449804703|FG000|Overall Study|Withdrawal by Subject|158|||
125050382|NCT01400971|449804703|FG000|Overall Study|Other|422|||
125050383|NCT01921270|449804707|FG000|Overall Study|Withdrawal by Subject|1|||
125050384|NCT00455858|449804708|FG000|Overall Study|Lost to Follow-up|2|||
125050385|NCT00455858|449804708|FG000|Overall Study|Protocol Violation|1|||
125050386|NCT00455858|449804708|FG000|Overall Study|Lack of Efficacy|1|||
125050387|NCT00455858|449804708|FG000|Overall Study|Well controlled FPG without insulin|1|||
125050388|NCT00455858|449804708|FG000|Overall Study|Withdrawal|1|||
125050389|NCT02375698|449804709|FG000|Overall Study|Withdrawal by Subject|0|||
125050390|NCT02375698|449804710|FG001|Overall Study|Withdrawal by Subject|2|||
125050391|NCT02375698|449804709|FG000|Overall Study|Physician Decision|2|||
125050392|NCT02375698|449804710|FG001|Overall Study|Physician Decision|0|||
125050393|NCT01595646|449804713|FG000|Overall Study|Withdrawal by Subject|1|||
125050394|NCT01595646|449804714|FG001|Overall Study|Withdrawal by Subject|0|||
125050395|NCT01595646|449804715|FG002|Overall Study|Withdrawal by Subject|0|||
125050396|NCT00231062|449804719|FG000|Overall Study|Physician Decision|6|||
125050397|NCT00803244|449804720|FG000|Overall Study|Adverse Event|1|||
125050398|NCT00803244|449804721|FG001|Overall Study|Adverse Event|2|||
125050399|NCT00803244|449804720|FG000|Overall Study|Withdrawal by Subject|2|||
125050400|NCT00803244|449804721|FG001|Overall Study|Withdrawal by Subject|3|||
125050401|NCT00803244|449804720|FG000|Overall Study|Any other reason not above-mentioned|4|||
125050402|NCT00803244|449804721|FG001|Overall Study|Any other reason not above-mentioned|10|||
125050403|NCT00616239|449804722|FG000|Overall Study|Withdrawal by Subject|2|||
125050404|NCT02873715|449804723|FG000|Overall Study|Lost to Follow-up|84|||
125050405|NCT02873715|449804724|FG001|Overall Study|Lost to Follow-up|94|||
125050406|NCT02873715|449804723|FG000|Overall Study|Withdrawal by Subject|7|||
125050407|NCT02873715|449804724|FG001|Overall Study|Withdrawal by Subject|26|||
125050408|NCT02021812|449804725|FG000|Overall Study|Death|8|||
125050409|NCT02021812|449804725|FG000|Overall Study|Withdrawal by Subject|3|||
125050410|NCT02021812|449804725|FG000|Overall Study|Lost to Follow-up|2|||
125050411|NCT02021812|449804725|FG000|Overall Study|Refuse to return, COVD 19|2|||
125050412|NCT03241173|449804726|FG000|Overall Study|Death|3|||
125050413|NCT03241173|449804727|FG001|Overall Study|Death|2|||
125050414|NCT03241173|449804728|FG002|Overall Study|Death|4|||
125050415|NCT03241173|449804729|FG003|Overall Study|Death|4|||
125050416|NCT03241173|449804730|FG004|Overall Study|Death|2|||
125050417|NCT03241173|449804731|FG005|Overall Study|Death|2|||
125050418|NCT03241173|449804732|FG006|Overall Study|Death|3|||
125050419|NCT03241173|449804733|FG007|Overall Study|Death|1|||
125050420|NCT03241173|449804734|FG008|Overall Study|Death|0|||
125050421|NCT03241173|449804735|FG009|Overall Study|Death|5|||
125050422|NCT03241173|449804736|FG010|Overall Study|Death|4|||
125050423|NCT03241173|449804737|FG011|Overall Study|Death|3|||
125050424|NCT03241173|449804738|FG012|Overall Study|Death|0|||
125050425|NCT03241173|449804739|FG013|Overall Study|Death|0|||
125050426|NCT03241173|449804740|FG014|Overall Study|Death|0|||
125050427|NCT03241173|449804726|FG000|Overall Study|Withdrawal by Subject|0|||
125050428|NCT03241173|449804727|FG001|Overall Study|Withdrawal by Subject|0|||
125050429|NCT03241173|449804728|FG002|Overall Study|Withdrawal by Subject|1|||
125050430|NCT03241173|449804729|FG003|Overall Study|Withdrawal by Subject|0|||
125050431|NCT03241173|449804730|FG004|Overall Study|Withdrawal by Subject|0|||
125050432|NCT03241173|449804731|FG005|Overall Study|Withdrawal by Subject|1|||
125050433|NCT03241173|449804732|FG006|Overall Study|Withdrawal by Subject|0|||
125050434|NCT03241173|449804733|FG007|Overall Study|Withdrawal by Subject|0|||
125050435|NCT03241173|449804734|FG008|Overall Study|Withdrawal by Subject|0|||
125050436|NCT03241173|449804735|FG009|Overall Study|Withdrawal by Subject|0|||
125050437|NCT03241173|449804736|FG010|Overall Study|Withdrawal by Subject|0|||
125050438|NCT03241173|449804737|FG011|Overall Study|Withdrawal by Subject|0|||
125050439|NCT03241173|449804738|FG012|Overall Study|Withdrawal by Subject|0|||
125050440|NCT03241173|449804739|FG013|Overall Study|Withdrawal by Subject|0|||
125050441|NCT03241173|449804740|FG014|Overall Study|Withdrawal by Subject|0|||
125050442|NCT03241173|449804726|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
125050443|NCT03241173|449804727|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
125050444|NCT03241173|449804728|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
125050445|NCT03241173|449804729|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
125050446|NCT03241173|449804730|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
125050447|NCT03241173|449804731|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
125050448|NCT03241173|449804732|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
125050449|NCT03241173|449804733|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
125050450|NCT03241173|449804734|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
125050451|NCT03241173|449804735|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
125050452|NCT03241173|449804736|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
125050453|NCT03241173|449804737|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
125050454|NCT03241173|449804738|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
125050455|NCT03241173|449804739|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
125219649|NCT02915159|450431200|FG001|Overall Study|poor/non-compliance|0|||
125050456|NCT03241173|449804740|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
125050457|NCT03241173|449804726|FG000|Overall Study|Lost to Follow-up|0|||
125050458|NCT03241173|449804727|FG001|Overall Study|Lost to Follow-up|0|||
125050459|NCT03241173|449804728|FG002|Overall Study|Lost to Follow-up|0|||
125050460|NCT03241173|449804729|FG003|Overall Study|Lost to Follow-up|0|||
125050461|NCT03241173|449804730|FG004|Overall Study|Lost to Follow-up|1|||
125050462|NCT03241173|449804731|FG005|Overall Study|Lost to Follow-up|0|||
125050463|NCT03241173|449804732|FG006|Overall Study|Lost to Follow-up|0|||
125050464|NCT03241173|449804733|FG007|Overall Study|Lost to Follow-up|0|||
125050465|NCT03241173|449804734|FG008|Overall Study|Lost to Follow-up|0|||
125050466|NCT03241173|449804735|FG009|Overall Study|Lost to Follow-up|1|||
125050467|NCT03241173|449804736|FG010|Overall Study|Lost to Follow-up|0|||
125050468|NCT03241173|449804737|FG011|Overall Study|Lost to Follow-up|0|||
125050469|NCT03241173|449804738|FG012|Overall Study|Lost to Follow-up|0|||
125050470|NCT03241173|449804739|FG013|Overall Study|Lost to Follow-up|0|||
125050471|NCT03241173|449804740|FG014|Overall Study|Lost to Follow-up|0|||
125050472|NCT02698423|449804741|FG000|Overall Study|Lost to Follow-up|19|||
125050473|NCT02698423|449804742|FG001|Overall Study|Lost to Follow-up|24|||
125050474|NCT01651260|449804744|FG000|Overall Study|unable to apply product|3|||
125050475|NCT01259297|449804748|FG000|Double Blind Randomized Period|Death|1|||
125050476|NCT01259297|449804749|FG001|Double Blind Randomized Period|Death|1|||
125050477|NCT01259297|449804750|FG002|Double Blind Randomized Period|Death|1|||
125050478|NCT01259297|449804751|FG003|Double Blind Randomized Period|Death|2|||
125050479|NCT01259297|449804752|FG004|Double Blind Randomized Period|Death|1|||
125050480|NCT01259297|449804753|FG005|Double Blind Randomized Period|Death|5|||
125050481|NCT01259297|449804754|FG006|Double Blind Randomized Period|Death|2|||
125050482|NCT01259297|449804755|FG007|Double Blind Randomized Period|Death|1|||
125050483|NCT01259297|449804748|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
125050484|NCT01259297|449804749|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
125050485|NCT01259297|449804750|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
125050486|NCT01259297|449804751|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
125050487|NCT01259297|449804752|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
125050488|NCT01259297|449804753|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
125050489|NCT01259297|449804754|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
125050490|NCT01259297|449804755|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
125050491|NCT01259297|449804748|FG000|Double Blind Randomized Period|Other reasons|0|||
125050492|NCT01259297|449804749|FG001|Double Blind Randomized Period|Other reasons|1|||
125050493|NCT01259297|449804750|FG002|Double Blind Randomized Period|Other reasons|0|||
125050494|NCT01259297|449804751|FG003|Double Blind Randomized Period|Other reasons|0|||
125050495|NCT01259297|449804752|FG004|Double Blind Randomized Period|Other reasons|1|||
125050496|NCT01259297|449804753|FG005|Double Blind Randomized Period|Other reasons|2|||
125050497|NCT01259297|449804754|FG006|Double Blind Randomized Period|Other reasons|3|||
125050498|NCT01259297|449804755|FG007|Double Blind Randomized Period|Other reasons|1|||
125050499|NCT00053846|449804758|FG000|Overall Study|Changed mind|8|||
125050500|NCT00053846|449804759|FG001|Overall Study|Changed mind|13|||
125050501|NCT00053846|449804758|FG000|Overall Study|Became too ill|8|||
125050502|NCT00053846|449804759|FG001|Overall Study|Became too ill|7|||
125050503|NCT00053846|449804758|FG000|Overall Study|Expired|5|||
125050504|NCT00053846|449804759|FG001|Overall Study|Expired|0|||
125050505|NCT00053846|449804758|FG000|Overall Study|Became ineligible|3|||
125050506|NCT00053846|449804759|FG001|Overall Study|Became ineligible|1|||
125050507|NCT00053846|449804758|FG000|Overall Study|Did not return data|1|||
125050508|NCT00053846|449804759|FG001|Overall Study|Did not return data|2|||
125050509|NCT00053846|449804758|FG000|Overall Study|Quit due to side effects|1|||
125050510|NCT00053846|449804759|FG001|Overall Study|Quit due to side effects|3|||
125050511|NCT00053846|449804758|FG000|Overall Study|Pills too large|0|||
125050512|NCT00053846|449804759|FG001|Overall Study|Pills too large|1|||
125050513|NCT00064662|449804760|FG000|Overall Study|Death|1|||
125050514|NCT00064662|449804761|FG001|Overall Study|Death|1|||
125050515|NCT00064662|449804760|FG000|Overall Study|Lost to Follow-up|57|||
125050516|NCT00064662|449804761|FG001|Overall Study|Lost to Follow-up|44|||
125050517|NCT00064662|449804760|FG000|Overall Study|Withdrawal by Subject|14|||
125050518|NCT00064662|449804761|FG001|Overall Study|Withdrawal by Subject|14|||
125050519|NCT00064662|449804760|FG000|Overall Study|Administratively withdrawn|2|||
125050520|NCT00064662|449804761|FG001|Overall Study|Administratively withdrawn|2|||
125050521|NCT01345786|449804771|FG000|Overall Study|Adverse Event|0|||
125050522|NCT01345786|449804772|FG001|Overall Study|Adverse Event|1|||
125050523|NCT01345786|449804773|FG002|Overall Study|Adverse Event|3|||
125050524|NCT01345786|449804774|FG003|Overall Study|Adverse Event|1|||
125050525|NCT01345786|449804771|FG000|Overall Study|Subject withdrew consent|2|||
125050526|NCT01345786|449804772|FG001|Overall Study|Subject withdrew consent|2|||
125050527|NCT01345786|449804773|FG002|Overall Study|Subject withdrew consent|1|||
125050528|NCT01345786|449804774|FG003|Overall Study|Subject withdrew consent|0|||
125050529|NCT01345786|449804771|FG000|Overall Study|Noncompliance with protocol|1|||
125050530|NCT01345786|449804772|FG001|Overall Study|Noncompliance with protocol|0|||
125050531|NCT01345786|449804773|FG002|Overall Study|Noncompliance with protocol|1|||
125050532|NCT01345786|449804774|FG003|Overall Study|Noncompliance with protocol|0|||
125050533|NCT01345786|449804771|FG000|Overall Study|Administrative|3|||
125050534|NCT01345786|449804772|FG001|Overall Study|Administrative|5|||
125050535|NCT01345786|449804773|FG002|Overall Study|Administrative|0|||
125050536|NCT01345786|449804774|FG003|Overall Study|Administrative|0|||
125050537|NCT01345786|449804771|FG000|Overall Study|Lost to Follow-up|0|||
125050538|NCT01345786|449804772|FG001|Overall Study|Lost to Follow-up|0|||
125050539|NCT01345786|449804773|FG002|Overall Study|Lost to Follow-up|0|||
125050540|NCT01345786|449804774|FG003|Overall Study|Lost to Follow-up|2|||
125050541|NCT01929044|449804775|FG000|Overall Study|Adverse Event|1|||
125050542|NCT01929044|449804776|FG001|Overall Study|Adverse Event|0|||
125050543|NCT01929044|449804775|FG000|Overall Study|Protocol Violation|9|||
125050544|NCT01929044|449804776|FG001|Overall Study|Protocol Violation|14|||
125050545|NCT01929044|449804775|FG000|Overall Study|Not Treated|1|||
125050546|NCT01929044|449804776|FG001|Overall Study|Not Treated|3|||
125050547|NCT02807454|449804779|FG000|Overall Study|Adverse Event|1|||
125050548|NCT02807454|449804780|FG001|Overall Study|Adverse Event|0|||
125050549|NCT02807454|449804779|FG000|Overall Study|Withdrawal by Subject|0|||
125050550|NCT02807454|449804780|FG001|Overall Study|Withdrawal by Subject|1|||
125050551|NCT02807454|449804779|FG000|Overall Study|Progressive Disease|30|||
125050552|NCT02807454|449804780|FG001|Overall Study|Progressive Disease|3|||
125050553|NCT02807454|449804779|FG000|Overall Study|Other Reasons|1|||
125050554|NCT02807454|449804780|FG001|Overall Study|Other Reasons|1|||
125050555|NCT01165203|449804781|FG000|Active Phase|Serious Adverse Event|1|||
125050556|NCT01165203|449804782|FG001|Active Phase|Serious Adverse Event|0|||
125050557|NCT01165203|449804781|FG000|Active Phase|Withdrawal by Subject|2|||
125050558|NCT01165203|449804782|FG001|Active Phase|Withdrawal by Subject|1|||
125050559|NCT01165203|449804781|FG000|Active Phase|Migrated/moved from study area|0|||
125050560|NCT01165203|449804782|FG001|Active Phase|Migrated/moved from study area|1|||
125050561|NCT01165203|449804781|FG000|Active Phase|Lost to Follow-up|2|||
125050562|NCT01165203|449804782|FG001|Active Phase|Lost to Follow-up|0|||
125050563|NCT01165203|449804781|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
125050564|NCT01165203|449804782|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
125050565|NCT01165203|449804781|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
125050566|NCT01165203|449804782|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
125050567|NCT01165203|449804781|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
125050568|NCT01165203|449804782|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
125050569|NCT01165203|449804781|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
125050570|NCT01165203|449804782|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
125050571|NCT01165203|449804781|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
125050572|NCT01165203|449804782|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
125050573|NCT01070784|449804783|FG000|Overall Study|Withdrawal by Subject|6|||
125050574|NCT01070784|449804784|FG001|Overall Study|Withdrawal by Subject|9|||
125050575|NCT01070784|449804783|FG000|Overall Study|Adverse Event|14|||
125050576|NCT01070784|449804784|FG001|Overall Study|Adverse Event|9|||
125050577|NCT02582749|449804785|FG000|Overall Study|Study terminated by funder|5|||
125050578|NCT02582749|449804786|FG001|Overall Study|Study terminated by funder|10|||
125050579|NCT02582749|449804785|FG000|Overall Study|Withdrawal by Subject|0|||
125050580|NCT02582749|449804786|FG001|Overall Study|Withdrawal by Subject|1|||
125050581|NCT02815397|449804787|FG000|Overall Study|Physician Decision|2|||
125050582|NCT02518620|449804788|FG000|Overall Study|Adverse Event|23|||
125050583|NCT02518620|449804789|FG001|Overall Study|Adverse Event|11|||
125050584|NCT02518620|449804788|FG000|Overall Study|Lack of Efficacy|2|||
125050585|NCT02518620|449804789|FG001|Overall Study|Lack of Efficacy|0|||
125050586|NCT02518620|449804788|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125050587|NCT02518620|449804789|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125050588|NCT02518620|449804788|FG000|Overall Study|Physician Decision|1|||
125050589|NCT02518620|449804789|FG001|Overall Study|Physician Decision|1|||
125050590|NCT02518620|449804788|FG000|Overall Study|Sponsor's Decision|0|||
125050591|NCT02518620|449804789|FG001|Overall Study|Sponsor's Decision|3|||
125050592|NCT02518620|449804788|FG000|Overall Study|Lost to Follow-up|1|||
125050593|NCT02518620|449804789|FG001|Overall Study|Lost to Follow-up|1|||
125050594|NCT02518620|449804788|FG000|Overall Study|Withdrawal by Subject|17|||
125050595|NCT02518620|449804789|FG001|Overall Study|Withdrawal by Subject|9|||
125050596|NCT02518620|449804788|FG000|Overall Study|Death|1|||
125050597|NCT02518620|449804789|FG001|Overall Study|Death|0|||
125050598|NCT02518620|449804788|FG000|Overall Study|Pregnancy Wish|3|||
125050599|NCT02518620|449804789|FG001|Overall Study|Pregnancy Wish|0|||
125050600|NCT02518620|449804788|FG000|Overall Study|Pregnancy|1|||
125050601|NCT02518620|449804789|FG001|Overall Study|Pregnancy|0|||
125050602|NCT02518620|449804788|FG000|Overall Study|Relocation|2|||
125050603|NCT02518620|449804789|FG001|Overall Study|Relocation|1|||
125050604|NCT00085540|449804790|FG000|Overall Study|Withdrawal by Subject|0|||
125050605|NCT00085540|449804791|FG001|Overall Study|Withdrawal by Subject|1|||
125050606|NCT00085540|449804790|FG000|Overall Study|Protocol Violation|0|||
125050607|NCT00085540|449804791|FG001|Overall Study|Protocol Violation|1|||
125050608|NCT01663740|449804794|FG000|Overall Study|Lost to Follow-up|1|||
125050609|NCT01663740|449804795|FG001|Overall Study|Lost to Follow-up|4|||
125050610|NCT01663740|449804794|FG000|Overall Study|Other|9|||
125050611|NCT01663740|449804795|FG001|Overall Study|Other|2|||
125050612|NCT01663740|449804794|FG000|Overall Study|Inclusion/Exclusion not met|1|||
125050613|NCT01663740|449804795|FG001|Overall Study|Inclusion/Exclusion not met|0|||
125050614|NCT01663740|449804794|FG000|Overall Study|Death|0|||
125050615|NCT01663740|449804795|FG001|Overall Study|Death|1|||
125050616|NCT01663740|449804794|FG000|Overall Study|Withdrawal by Subject|2|||
125050617|NCT01663740|449804795|FG001|Overall Study|Withdrawal by Subject|1|||
125050618|NCT01663740|449804794|FG000|Overall Study|No end of study status|3|||
125050619|NCT01663740|449804795|FG001|Overall Study|No end of study status|0|||
125050620|NCT03607682|449804796|FG000|Overall Study|Withdrawal by Subject|1|||
125050621|NCT03607682|449804796|FG000|Overall Study|Disease progression|1|||
125050622|NCT01770353|449804797|FG000|Overall Study|Progressive disease|2|||
125050623|NCT01770353|449804798|FG001|Overall Study|Progressive disease|1|||
125050624|NCT01770353|449804797|FG000|Overall Study|Adverse Event|0|||
125050625|NCT01770353|449804798|FG001|Overall Study|Adverse Event|1|||
125050626|NCT01770353|449804797|FG000|Overall Study|Protocol Violation|1|||
125050627|NCT01770353|449804798|FG001|Overall Study|Protocol Violation|0|||
125050628|NCT01770353|449804797|FG000|Overall Study|Physician Decision|0|||
125050629|NCT01770353|449804798|FG001|Overall Study|Physician Decision|3|||
125050630|NCT01770353|449804797|FG000|Overall Study|Clinical deterioration|3|||
125050631|NCT01770353|449804798|FG001|Overall Study|Clinical deterioration|6|||
125050632|NCT01770353|449804797|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
125050633|NCT01770353|449804798|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
125050634|NCT00376688|449804799|FG000|Overall Study|Adverse Event|3|||
125050635|NCT00376688|449804799|FG000|Overall Study|Death|1|||
125050636|NCT02574312|449804800|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
125050637|NCT02574312|449804801|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
125050638|NCT04267562|449806482|FG000|Assessed for Eligibility|Screen Failure|64|||
125050639|NCT04267562|449806482|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
125050640|NCT04267562|449806482|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
125050641|NCT04267562|449806482|FG000|Assessed for Eligibility|Site closure|6|||
125050642|NCT04267562|449806482|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
125050643|NCT04267562|449806482|FG000|Assessed for Eligibility|Physician Decision|1|||
125050644|NCT04267562|449806482|FG000|Month 24|Elective hysterectomy|1|||
125050645|NCT04267562|449806482|FG000|Month 24|Lost to Follow-up|1|||
125050646|NCT04267562|449806482|FG000|Month 36|Elective hysterectomy|2|||
125050647|NCT04267562|449806482|FG000|Month 36|Lost to Follow-up|3|||
125050648|NCT03009539|449806483|FG000|Overall Study|Lost to Follow-up|132|||
125050649|NCT03009539|449806484|FG001|Overall Study|Lost to Follow-up|113|||
125050650|NCT03009539|449806485|FG002|Overall Study|Lost to Follow-up|132|||
125050651|NCT03009539|449806486|FG003|Overall Study|Lost to Follow-up|113|||
125050652|NCT03151148|449806487|FG000|Overall Study|Lost to Follow-up|1|||
125050653|NCT03151148|449806488|FG001|Overall Study|Lost to Follow-up|0|||
125050654|NCT03151148|449806487|FG000|Overall Study|Withdrawal by Subject|1|||
125050655|NCT03151148|449806488|FG001|Overall Study|Withdrawal by Subject|0|||
125050656|NCT00494871|449806489|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
125050657|NCT00494871|449806490|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
125050658|NCT00494871|449806489|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
125050659|NCT00494871|449806490|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
125050660|NCT00494871|449806489|FG000|Double-blind (DB) Treatment Period|Death|8|||
125050661|NCT00494871|449806490|FG001|Double-blind (DB) Treatment Period|Death|3|||
125050662|NCT00494871|449806489|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
125050663|NCT00494871|449806490|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
125050664|NCT00494871|449806489|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
125050665|NCT00494871|449806490|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
125050666|NCT00494871|449806489|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
125050667|NCT00494871|449806490|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
125050668|NCT00494871|449806489|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
125050669|NCT00494871|449806490|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
125050670|NCT00494871|449806489|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
125050671|NCT00494871|449806490|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
125050672|NCT00494871|449806489|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
125050673|NCT00494871|449806490|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
125050674|NCT00494871|449806489|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
125050675|NCT00494871|449806490|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
125050676|NCT00494871|449806489|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
125050677|NCT00494871|449806490|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
125050678|NCT00494871|449806489|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
125050679|NCT00494871|449806490|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
125050680|NCT00494871|449806489|FG000|Follow-up (FU) Period|Adverse Event|1|||
125050681|NCT00494871|449806490|FG001|Follow-up (FU) Period|Adverse Event|1|||
125050682|NCT00494871|449806489|FG000|Follow-up (FU) Period|Death|13|||
125050683|NCT00494871|449806490|FG001|Follow-up (FU) Period|Death|12|||
125050684|NCT00494871|449806489|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
125050685|NCT00494871|449806490|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
125050686|NCT00494871|449806489|FG000|Follow-up (FU) Period|Physician Decision|0|||
125050687|NCT00494871|449806490|FG001|Follow-up (FU) Period|Physician Decision|1|||
125050688|NCT00494871|449806489|FG000|Follow-up (FU) Period|Protocol Violation|1|||
125050689|NCT00494871|449806490|FG001|Follow-up (FU) Period|Protocol Violation|0|||
125050690|NCT00494871|449806489|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
125050691|NCT00494871|449806490|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
125050692|NCT00494871|449806489|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
125050693|NCT00494871|449806490|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
125050694|NCT04543955|449806491|FG000|Overall Study|Company cancelled study|1|||
125050695|NCT04543955|449806492|FG001|Overall Study|Company cancelled study|0|||
125050696|NCT02433210|449806496|FG000|Overall Study|Physician Decision|1|||
125050697|NCT02433210|449806497|FG001|Overall Study|Physician Decision|0|||
125050698|NCT02433210|449806498|FG002|Overall Study|Physician Decision|0|||
125050699|NCT02090114|449806499|FG000|Overall Study|Withdrawal by Subject|3|||
125050700|NCT02090114|449806500|FG001|Overall Study|Withdrawal by Subject|6|||
125050701|NCT02090114|449806501|FG002|Overall Study|Withdrawal by Subject|2|||
125050702|NCT02090114|449806502|FG003|Overall Study|Withdrawal by Subject|1|||
125050703|NCT02090114|449806499|FG000|Overall Study|Physician Decision|5|||
125050704|NCT02090114|449806500|FG001|Overall Study|Physician Decision|0|||
125050705|NCT02090114|449806501|FG002|Overall Study|Physician Decision|1|||
125050706|NCT02090114|449806502|FG003|Overall Study|Physician Decision|1|||
125050707|NCT02090114|449806499|FG000|Overall Study|Adverse Event|1|||
125050708|NCT02090114|449806500|FG001|Overall Study|Adverse Event|2|||
125050709|NCT02090114|449806501|FG002|Overall Study|Adverse Event|2|||
125050710|NCT02090114|449806502|FG003|Overall Study|Adverse Event|0|||
125050711|NCT02090114|449806499|FG000|Overall Study|Progressive Disease|20|||
125050712|NCT02090114|449806500|FG001|Overall Study|Progressive Disease|21|||
125050713|NCT02090114|449806501|FG002|Overall Study|Progressive Disease|23|||
125050714|NCT02090114|449806502|FG003|Overall Study|Progressive Disease|6|||
125050715|NCT02090114|449806499|FG000|Overall Study|Death|1|||
125050716|NCT02090114|449806500|FG001|Overall Study|Death|0|||
125050717|NCT02090114|449806501|FG002|Overall Study|Death|1|||
125050718|NCT02090114|449806502|FG003|Overall Study|Death|0|||
125050719|NCT01989546|449806507|FG000|Overall Study|Clinical Progression|1|||
125050720|NCT01989546|449806507|FG000|Overall Study|Disease progression on study|8|||
125050721|NCT01958671|449806508|FG000|Overall Study|Adverse Event|1|||
125050722|NCT01958671|449806509|FG001|Overall Study|Adverse Event|1|||
125050723|NCT01958671|449806510|FG002|Overall Study|Adverse Event|5|||
125050724|NCT01958671|449806508|FG000|Overall Study|Death|1|||
125050725|NCT01958671|449806509|FG001|Overall Study|Death|0|||
125050726|NCT01958671|449806510|FG002|Overall Study|Death|0|||
125050727|NCT01958671|449806508|FG000|Overall Study|Excluded medication|0|||
125050728|NCT01958671|449806509|FG001|Overall Study|Excluded medication|0|||
125050729|NCT01958671|449806510|FG002|Overall Study|Excluded medication|1|||
125050730|NCT01958671|449806508|FG000|Overall Study|Hyperglycemia|0|||
125050731|NCT01958671|449806509|FG001|Overall Study|Hyperglycemia|0|||
125050732|NCT01958671|449806510|FG002|Overall Study|Hyperglycemia|2|||
125050733|NCT01958671|449806508|FG000|Overall Study|Lost to Follow-up|7|||
125050734|NCT01958671|449806509|FG001|Overall Study|Lost to Follow-up|11|||
125050735|NCT01958671|449806510|FG002|Overall Study|Lost to Follow-up|7|||
125050736|NCT01958671|449806508|FG000|Overall Study|Non-compliance with study drug|1|||
125050737|NCT01958671|449806509|FG001|Overall Study|Non-compliance with study drug|1|||
125050738|NCT01958671|449806510|FG002|Overall Study|Non-compliance with study drug|1|||
125050739|NCT01958671|449806508|FG000|Overall Study|Pregnancy|0|||
125050740|NCT01958671|449806509|FG001|Overall Study|Pregnancy|0|||
125050741|NCT01958671|449806510|FG002|Overall Study|Pregnancy|1|||
125050742|NCT01958671|449806508|FG000|Overall Study|Protocol Violation|0|||
125050743|NCT01958671|449806509|FG001|Overall Study|Protocol Violation|1|||
125050744|NCT01958671|449806510|FG002|Overall Study|Protocol Violation|0|||
125050745|NCT01958671|449806508|FG000|Overall Study|Study site terminated by sponsor|1|||
125050746|NCT01958671|449806509|FG001|Overall Study|Study site terminated by sponsor|0|||
125050747|NCT01958671|449806510|FG002|Overall Study|Study site terminated by sponsor|1|||
125050748|NCT01958671|449806508|FG000|Overall Study|Participant moved|0|||
125050749|NCT01958671|449806509|FG001|Overall Study|Participant moved|0|||
125050750|NCT01958671|449806510|FG002|Overall Study|Participant moved|1|||
125050751|NCT01958671|449806508|FG000|Overall Study|Withdrawal by Subject|8|||
125050752|NCT01958671|449806509|FG001|Overall Study|Withdrawal by Subject|10|||
125050753|NCT01958671|449806510|FG002|Overall Study|Withdrawal by Subject|13|||
125050754|NCT01993329|449806511|FG000|Period 2|Adverse Event|0|||
125050755|NCT01993329|449806512|FG001|Period 2|Adverse Event|0|||
125050756|NCT01993329|449806513|FG002|Period 2|Adverse Event|0|||
125050757|NCT01993329|449806514|FG003|Period 2|Adverse Event|0|||
125050758|NCT01993329|449806515|FG004|Period 2|Adverse Event|0|||
125050759|NCT01993329|449806516|FG005|Period 2|Adverse Event|1|||
125050760|NCT01993329|449806511|FG000|Wash-out|Personal reasons|0|||
125050761|NCT01993329|449806512|FG001|Wash-out|Personal reasons|1|||
125050762|NCT01993329|449806513|FG002|Wash-out|Personal reasons|0|||
125050763|NCT01993329|449806514|FG003|Wash-out|Personal reasons|0|||
125050764|NCT01993329|449806515|FG004|Wash-out|Personal reasons|0|||
125050765|NCT01993329|449806516|FG005|Wash-out|Personal reasons|0|||
125050766|NCT02948777|449806517|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
125050767|NCT02311478|449806518|FG000|Overall Study|Withdrawal by Subject|1|||
125050768|NCT02311478|449806518|FG000|Overall Study|Lost to Follow-up|5|||
125050769|NCT02311478|449806518|FG000|Overall Study|Failed IUD Insertion|1|||
125050770|NCT03242928|449806519|FG000|Overall Study|Adverse Event|2|||
125050771|NCT03242928|449806520|FG001|Overall Study|Adverse Event|1|||
125050772|NCT03242928|449806519|FG000|Overall Study|Lost to Follow-up|2|||
125050773|NCT03242928|449806520|FG001|Overall Study|Lost to Follow-up|0|||
125050774|NCT03242928|449806519|FG000|Overall Study|Physician Decision|0|||
125050775|NCT03242928|449806520|FG001|Overall Study|Physician Decision|1|||
125050776|NCT03242928|449806519|FG000|Overall Study|Withdrawal by Subject|5|||
125050777|NCT03242928|449806520|FG001|Overall Study|Withdrawal by Subject|3|||
125050778|NCT02834403|449806521|FG000|Overall Study|Physician Decision|2|||
125050779|NCT02834403|449806522|FG001|Overall Study|Physician Decision|1|||
125050780|NCT02834403|449806523|FG002|Overall Study|Physician Decision|2|||
125050781|NCT02834403|449806524|FG003|Overall Study|Physician Decision|1|||
125050782|NCT02834403|449806525|FG004|Overall Study|Physician Decision|1|||
125050783|NCT02834403|449806526|FG005|Overall Study|Physician Decision|2|||
125050784|NCT02834403|449806527|FG006|Overall Study|Physician Decision|12|||
125050785|NCT02834403|449806521|FG000|Overall Study|Adverse Event|0|||
125050786|NCT02834403|449806522|FG001|Overall Study|Adverse Event|0|||
125050787|NCT02834403|449806523|FG002|Overall Study|Adverse Event|0|||
125050788|NCT02834403|449806524|FG003|Overall Study|Adverse Event|0|||
125050789|NCT02834403|449806525|FG004|Overall Study|Adverse Event|1|||
125050790|NCT02834403|449806526|FG005|Overall Study|Adverse Event|1|||
125050791|NCT02834403|449806527|FG006|Overall Study|Adverse Event|3|||
125050792|NCT02834403|449806521|FG000|Overall Study|Withdrawal by Subject|0|||
125050793|NCT02834403|449806522|FG001|Overall Study|Withdrawal by Subject|1|||
125050794|NCT02834403|449806523|FG002|Overall Study|Withdrawal by Subject|0|||
125050795|NCT02834403|449806524|FG003|Overall Study|Withdrawal by Subject|0|||
125050796|NCT02834403|449806525|FG004|Overall Study|Withdrawal by Subject|1|||
125050797|NCT02834403|449806526|FG005|Overall Study|Withdrawal by Subject|0|||
125050798|NCT02834403|449806527|FG006|Overall Study|Withdrawal by Subject|0|||
125050799|NCT02834403|449806521|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
125050800|NCT02834403|449806522|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
125050801|NCT02834403|449806523|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
125050802|NCT02834403|449806524|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
125050803|NCT02834403|449806525|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
125050804|NCT02834403|449806526|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
125050805|NCT02834403|449806527|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
125050806|NCT00273858|449806537|FG000|Overall Study|Not completed 24 month observation time|334|||
125050807|NCT00273858|449806537|FG000|Overall Study|Lost to Follow-up|101|||
125050808|NCT00273858|449806537|FG000|Overall Study|Withdrawal by Subject|21|||
125050809|NCT00273858|449806537|FG000|Overall Study|Adverse Event|81|||
125050810|NCT02232516|449806538|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
125050811|NCT02232516|449806538|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
125050812|NCT02232516|449806538|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
125050813|NCT02232516|449806538|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
125050814|NCT02232516|449806538|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
125050815|NCT02232516|449806538|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
125050816|NCT02232516|449806538|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
125050817|NCT02232516|449806538|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
125050818|NCT02232516|449806538|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
125050819|NCT02232516|449806538|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
125050820|NCT02232516|449806538|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
125050821|NCT02232516|449806538|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
125050822|NCT02232516|449806538|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
125050823|NCT02232516|449806538|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
125050824|NCT02232516|449806538|FG000|Survival Follow-up|Death|15|||
125050825|NCT02232516|449806538|FG000|Survival Follow-up|Withdrawal by Subject|3|||
125050826|NCT02232516|449806538|FG000|Survival Follow-up|Lost to Follow-up|1|||
125050827|NCT02232516|449806538|FG000|Survival Follow-up|Still in follow-up|5|||
125050828|NCT01070550|449806539|FG000|Overall Study|Adverse Event|43|||
125219650|NCT02915159|450431199|FG000|Overall Study|Participant withdrew consent|5|||
125219651|NCT02915159|450431200|FG001|Overall Study|Participant withdrew consent|1|||
125219652|NCT02915159|450431199|FG000|Overall Study|Request to discontinue treatment|1|||
125219653|NCT02915159|450431200|FG001|Overall Study|Request to discontinue treatment|2|||
125219654|NCT02915159|450431199|FG000|Overall Study|Adverse Event|2|||
125219655|NCT02915159|450431200|FG001|Overall Study|Adverse Event|2|||
125219656|NCT02915159|450431199|FG000|Overall Study|Lack of Efficacy|0|||
125219657|NCT02915159|450431200|FG001|Overall Study|Lack of Efficacy|3|||
125219658|NCT02821416|450431203|FG000|Overall Study|Adverse Event|0|||
125219659|NCT02821416|450431204|FG001|Overall Study|Adverse Event|1|||
125219660|NCT02821416|450431203|FG000|Overall Study|Withdrawal by Subject|2|||
125219661|NCT02821416|450431204|FG001|Overall Study|Withdrawal by Subject|0|||
125219662|NCT02821416|450431203|FG000|Overall Study|Lost to Follow-up|1|||
125219663|NCT02821416|450431204|FG001|Overall Study|Lost to Follow-up|0|||
125219664|NCT01001520|450431211|FG000|Medication Period 1|Withdrawal by Subject|2|||
125219665|NCT01001520|450431212|FG001|Medication Period 1|Withdrawal by Subject|2|||
125219666|NCT01001520|450431211|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
125219667|NCT01001520|450431212|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
125219668|NCT01001520|450431211|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
125219669|NCT01001520|450431212|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
125219670|NCT01001520|450431211|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
125219671|NCT01001520|450431212|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
125219672|NCT01001520|450431211|FG000|Washout Period|Withdrawal by Subject|2|||
125219673|NCT01001520|450431212|FG001|Washout Period|Withdrawal by Subject|1|||
125219674|NCT01001520|450431211|FG000|Medication Period 2|Withdrawal by Subject|0|||
125219675|NCT01001520|450431212|FG001|Medication Period 2|Withdrawal by Subject|3|||
125219676|NCT00878800|450431223|FG000|Overall Study|Adverse Event|0|||
125219677|NCT00878800|450431224|FG001|Overall Study|Adverse Event|0|||
125219678|NCT00878800|450431225|FG002|Overall Study|Adverse Event|2|||
125219679|NCT00878800|450431226|FG003|Overall Study|Adverse Event|0|||
125219680|NCT00878800|450431227|FG004|Overall Study|Adverse Event|1|||
125219681|NCT00878800|450431223|FG000|Overall Study|Progressive disease|1|||
125219682|NCT00878800|450431224|FG001|Overall Study|Progressive disease|5|||
125219683|NCT00878800|450431225|FG002|Overall Study|Progressive disease|6|||
125219684|NCT00878800|450431226|FG003|Overall Study|Progressive disease|5|||
125219685|NCT00878800|450431227|FG004|Overall Study|Progressive disease|13|||
125219686|NCT00878800|450431223|FG000|Overall Study|Withdrew consent|1|||
125219687|NCT00878800|450431224|FG001|Overall Study|Withdrew consent|1|||
125219688|NCT00878800|450431225|FG002|Overall Study|Withdrew consent|0|||
125219689|NCT00878800|450431226|FG003|Overall Study|Withdrew consent|1|||
125219690|NCT00878800|450431227|FG004|Overall Study|Withdrew consent|1|||
125219691|NCT00878800|450431223|FG000|Overall Study|Death|0|||
125219692|NCT00878800|450431224|FG001|Overall Study|Death|0|||
125050829|NCT01070550|449806540|FG001|Overall Study|Adverse Event|1|||
125050830|NCT01070550|449806541|FG002|Overall Study|Adverse Event|3|||
125050831|NCT01070550|449806542|FG003|Overall Study|Adverse Event|0|||
125050832|NCT01070550|449806543|FG004|Overall Study|Adverse Event|0|||
125050833|NCT01070550|449806544|FG005|Overall Study|Adverse Event|0|||
125050834|NCT01070550|449806539|FG000|Overall Study|Death|20|||
125050835|NCT01070550|449806540|FG001|Overall Study|Death|4|||
125050836|NCT01070550|449806541|FG002|Overall Study|Death|3|||
125050837|NCT01070550|449806542|FG003|Overall Study|Death|0|||
125050838|NCT01070550|449806543|FG004|Overall Study|Death|0|||
125050839|NCT01070550|449806544|FG005|Overall Study|Death|0|||
125050840|NCT01070550|449806539|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
125219693|NCT00878800|450431225|FG002|Overall Study|Death|1|||
125219694|NCT00878800|450431226|FG003|Overall Study|Death|0|||
125219695|NCT00878800|450431227|FG004|Overall Study|Death|0|||
125219696|NCT00878800|450431223|FG000|Overall Study|Other|1|||
125219697|NCT00878800|450431224|FG001|Overall Study|Other|1|||
125219698|NCT00878800|450431225|FG002|Overall Study|Other|0|||
125219699|NCT00878800|450431226|FG003|Overall Study|Other|0|||
125219700|NCT00878800|450431227|FG004|Overall Study|Other|1|||
125219701|NCT00613821|450431228|FG000|Overall Study|Withdrawal by Subject|1|||
125219702|NCT00613821|450431229|FG001|Overall Study|Withdrawal by Subject|0|||
125219703|NCT00613821|450431228|FG000|Overall Study|Physician Decision|1|||
125219704|NCT00613821|450431229|FG001|Overall Study|Physician Decision|1|||
125219705|NCT02302846|450431231|FG000|Overall Study|Withdrawal by Subject|1|||
125219706|NCT00715299|450431232|FG000|Overall Study|Withdrawal by Subject|1|||
125050841|NCT01070550|449806540|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
125219707|NCT00715299|450431232|FG000|Overall Study|Adverse Event|3|||
125050842|NCT01070550|449806541|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
125050843|NCT01070550|449806542|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
125050844|NCT01070550|449806543|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
125050845|NCT01070550|449806544|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
125050846|NCT01070550|449806539|FG000|Overall Study|Early termination|3|||
125050847|NCT01070550|449806540|FG001|Overall Study|Early termination|0|||
125050848|NCT01070550|449806541|FG002|Overall Study|Early termination|0|||
125050849|NCT01070550|449806542|FG003|Overall Study|Early termination|0|||
125050850|NCT01070550|449806543|FG004|Overall Study|Early termination|0|||
125050851|NCT01070550|449806544|FG005|Overall Study|Early termination|0|||
125050852|NCT01070550|449806539|FG000|Overall Study|Failed to return|450|||
125050853|NCT01070550|449806540|FG001|Overall Study|Failed to return|33|||
125050854|NCT01070550|449806541|FG002|Overall Study|Failed to return|144|||
125050855|NCT01070550|449806542|FG003|Overall Study|Failed to return|40|||
125050856|NCT01070550|449806543|FG004|Overall Study|Failed to return|1|||
125050857|NCT01070550|449806544|FG005|Overall Study|Failed to return|2|||
125050858|NCT01070550|449806539|FG000|Overall Study|Incomplete treatment|2|||
125050859|NCT01070550|449806540|FG001|Overall Study|Incomplete treatment|0|||
125050860|NCT01070550|449806541|FG002|Overall Study|Incomplete treatment|0|||
125050861|NCT01070550|449806542|FG003|Overall Study|Incomplete treatment|0|||
125050862|NCT01070550|449806543|FG004|Overall Study|Incomplete treatment|0|||
125050863|NCT01070550|449806544|FG005|Overall Study|Incomplete treatment|0|||
125050864|NCT01070550|449806539|FG000|Overall Study|Lab test not done|22|||
125050865|NCT01070550|449806540|FG001|Overall Study|Lab test not done|3|||
125050866|NCT01070550|449806541|FG002|Overall Study|Lab test not done|4|||
125050867|NCT01070550|449806542|FG003|Overall Study|Lab test not done|1|||
125050868|NCT01070550|449806543|FG004|Overall Study|Lab test not done|0|||
125050869|NCT01070550|449806544|FG005|Overall Study|Lab test not done|1|||
125050870|NCT01070550|449806539|FG000|Overall Study|Lack of Efficacy|65|||
125050871|NCT01070550|449806540|FG001|Overall Study|Lack of Efficacy|1|||
125050872|NCT01070550|449806541|FG002|Overall Study|Lack of Efficacy|5|||
125050873|NCT01070550|449806542|FG003|Overall Study|Lack of Efficacy|5|||
125050874|NCT01070550|449806543|FG004|Overall Study|Lack of Efficacy|0|||
125050875|NCT01070550|449806544|FG005|Overall Study|Lack of Efficacy|1|||
125050876|NCT01070550|449806539|FG000|Overall Study|Miscellaneous|12|||
125050877|NCT01070550|449806540|FG001|Overall Study|Miscellaneous|2|||
125050878|NCT01070550|449806541|FG002|Overall Study|Miscellaneous|3|||
125050879|NCT01070550|449806542|FG003|Overall Study|Miscellaneous|1|||
125050880|NCT01070550|449806543|FG004|Overall Study|Miscellaneous|0|||
125050881|NCT01070550|449806544|FG005|Overall Study|Miscellaneous|0|||
125050882|NCT01070550|449806539|FG000|Overall Study|New treatment started|3|||
125050883|NCT01070550|449806540|FG001|Overall Study|New treatment started|1|||
125050884|NCT01070550|449806541|FG002|Overall Study|New treatment started|0|||
125050885|NCT01070550|449806542|FG003|Overall Study|New treatment started|2|||
125050886|NCT01070550|449806543|FG004|Overall Study|New treatment started|0|||
125050887|NCT01070550|449806544|FG005|Overall Study|New treatment started|0|||
125050888|NCT01070550|449806539|FG000|Overall Study|Non-responders|493|||
125050889|NCT01070550|449806540|FG001|Overall Study|Non-responders|4|||
125050890|NCT01070550|449806541|FG002|Overall Study|Non-responders|21|||
125050891|NCT01070550|449806542|FG003|Overall Study|Non-responders|20|||
125050892|NCT01070550|449806543|FG004|Overall Study|Non-responders|0|||
125050893|NCT01070550|449806544|FG005|Overall Study|Non-responders|2|||
125050894|NCT01070550|449806539|FG000|Overall Study|Not categorized|33|||
125050895|NCT01070550|449806540|FG001|Overall Study|Not categorized|2|||
125050896|NCT01070550|449806541|FG002|Overall Study|Not categorized|6|||
125050897|NCT01070550|449806542|FG003|Overall Study|Not categorized|1|||
125050898|NCT01070550|449806543|FG004|Overall Study|Not categorized|0|||
125050899|NCT01070550|449806544|FG005|Overall Study|Not categorized|1|||
125050900|NCT01070550|449806539|FG000|Overall Study|Protocol Violation|15|||
125050901|NCT01070550|449806540|FG001|Overall Study|Protocol Violation|1|||
125050902|NCT01070550|449806541|FG002|Overall Study|Protocol Violation|1|||
125050903|NCT01070550|449806542|FG003|Overall Study|Protocol Violation|1|||
125050904|NCT01070550|449806543|FG004|Overall Study|Protocol Violation|0|||
125050905|NCT01070550|449806544|FG005|Overall Study|Protocol Violation|0|||
125050906|NCT01070550|449806539|FG000|Overall Study|Relapse|44|||
125050907|NCT01070550|449806540|FG001|Overall Study|Relapse|5|||
125050908|NCT01070550|449806541|FG002|Overall Study|Relapse|14|||
125050909|NCT01070550|449806542|FG003|Overall Study|Relapse|4|||
125050910|NCT01070550|449806543|FG004|Overall Study|Relapse|0|||
125050911|NCT01070550|449806544|FG005|Overall Study|Relapse|0|||
125050912|NCT01070550|449806539|FG000|Overall Study|Result not available|3|||
125050913|NCT01070550|449806540|FG001|Overall Study|Result not available|1|||
125050914|NCT01070550|449806541|FG002|Overall Study|Result not available|3|||
125050915|NCT01070550|449806542|FG003|Overall Study|Result not available|0|||
125050916|NCT01070550|449806543|FG004|Overall Study|Result not available|0|||
125050917|NCT01070550|449806544|FG005|Overall Study|Result not available|0|||
125050918|NCT01070550|449806539|FG000|Overall Study|Screen failure|1|||
125050919|NCT01070550|449806540|FG001|Overall Study|Screen failure|0|||
125050920|NCT01070550|449806541|FG002|Overall Study|Screen failure|0|||
125050921|NCT01070550|449806542|FG003|Overall Study|Screen failure|0|||
125050922|NCT01070550|449806543|FG004|Overall Study|Screen failure|0|||
125050923|NCT01070550|449806544|FG005|Overall Study|Screen failure|0|||
125050924|NCT01070550|449806539|FG000|Overall Study|Sponsor decision|1|||
125050925|NCT01070550|449806540|FG001|Overall Study|Sponsor decision|0|||
125050926|NCT01070550|449806541|FG002|Overall Study|Sponsor decision|0|||
125050927|NCT01070550|449806542|FG003|Overall Study|Sponsor decision|0|||
125050928|NCT01070550|449806543|FG004|Overall Study|Sponsor decision|0|||
125219708|NCT00715299|450431232|FG000|Overall Study|failed the pre-screen exercise test|2|||
125219709|NCT00411450|450431233|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
125219710|NCT00872521|450431234|FG000|Completed PAD Induction|Patient choice|0|||
125219711|NCT00872521|450431235|FG001|Completed PAD Induction|Patient choice|1|||
125219712|NCT00872521|450431236|FG002|Completed PAD Induction|Patient choice|0|||
125219713|NCT00872521|450431234|FG000|Completed PAD Induction|Disease progression|0|||
125219714|NCT00872521|450431235|FG001|Completed PAD Induction|Disease progression|2|||
125050929|NCT01070550|449806544|FG005|Overall Study|Sponsor decision|0|||
125050930|NCT01070550|449806539|FG000|Overall Study|Treatment duration shortened|1|||
125050931|NCT01070550|449806540|FG001|Overall Study|Treatment duration shortened|0|||
125050932|NCT01070550|449806541|FG002|Overall Study|Treatment duration shortened|0|||
125050933|NCT01070550|449806542|FG003|Overall Study|Treatment duration shortened|0|||
125050934|NCT01070550|449806543|FG004|Overall Study|Treatment duration shortened|0|||
125050935|NCT01070550|449806544|FG005|Overall Study|Treatment duration shortened|0|||
125050936|NCT01070550|449806539|FG000|Overall Study|Treatment interrupted|7|||
125050937|NCT01070550|449806540|FG001|Overall Study|Treatment interrupted|0|||
125050938|NCT01070550|449806541|FG002|Overall Study|Treatment interrupted|1|||
125050939|NCT01070550|449806542|FG003|Overall Study|Treatment interrupted|1|||
125219715|NCT00872521|450431236|FG002|Completed PAD Induction|Disease progression|0|||
125219716|NCT00872521|450431234|FG000|Completed PAD Induction|Adverse Event|4|||
125050940|NCT01070550|449806543|FG004|Overall Study|Treatment interrupted|0|||
125050941|NCT01070550|449806544|FG005|Overall Study|Treatment interrupted|0|||
125219717|NCT00872521|450431235|FG001|Completed PAD Induction|Adverse Event|0|||
125219718|NCT00872521|450431236|FG002|Completed PAD Induction|Adverse Event|0|||
125219719|NCT00872521|450431234|FG000|Completed PAD Induction|Death|1|||
125219720|NCT00872521|450431235|FG001|Completed PAD Induction|Death|1|||
125219721|NCT00872521|450431236|FG002|Completed PAD Induction|Death|0|||
125219722|NCT00872521|450431234|FG000|Primary Endpoint Analysis|Other|1|||
125219723|NCT00872521|450431235|FG001|Primary Endpoint Analysis|Other|2|||
125219724|NCT00872521|450431236|FG002|Primary Endpoint Analysis|Other|0|||
125219725|NCT00872521|450431234|FG000|Primary Endpoint Analysis|Patient choice|0|||
125219726|NCT00872521|450431235|FG001|Primary Endpoint Analysis|Patient choice|1|||
125219727|NCT00872521|450431236|FG002|Primary Endpoint Analysis|Patient choice|0|||
125219728|NCT00872521|450431234|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
125219729|NCT00872521|450431235|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
125219730|NCT00872521|450431236|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
125219731|NCT00872521|450431234|FG000|Primary Endpoint Analysis|Patient response missing|0|||
125219732|NCT00872521|450431235|FG001|Primary Endpoint Analysis|Patient response missing|0|||
125219733|NCT00872521|450431236|FG002|Primary Endpoint Analysis|Patient response missing|1|||
125219734|NCT00872521|450431234|FG000|Completed 3-month Follow up|Other|0|||
125219735|NCT00872521|450431235|FG001|Completed 3-month Follow up|Other|2|||
125219736|NCT00872521|450431236|FG002|Completed 3-month Follow up|Other|0|||
125219737|NCT00872521|450431234|FG000|Completed 3-month Follow up|Physician Decision|0|||
125219738|NCT00872521|450431235|FG001|Completed 3-month Follow up|Physician Decision|1|||
125219739|NCT00872521|450431236|FG002|Completed 3-month Follow up|Physician Decision|0|||
125219740|NCT00872521|450431234|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
125219741|NCT00872521|450431235|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
125219742|NCT00872521|450431236|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
125219743|NCT00614874|450431237|FG000|Overall Study|Protocol Violation|1|||
125050942|NCT01070550|449806539|FG000|Overall Study|Treatment not started|14|||
125219744|NCT00614874|450431237|FG000|Overall Study|Withdrawal by Subject|1|||
125050943|NCT01070550|449806540|FG001|Overall Study|Treatment not started|2|||
125050944|NCT01070550|449806541|FG002|Overall Study|Treatment not started|4|||
125050945|NCT01070550|449806542|FG003|Overall Study|Treatment not started|0|||
125050946|NCT01070550|449806543|FG004|Overall Study|Treatment not started|0|||
125050947|NCT01070550|449806544|FG005|Overall Study|Treatment not started|0|||
125050948|NCT01070550|449806539|FG000|Overall Study|Treatment restarted|0|||
125219745|NCT01468454|450431238|FG000|Overall Study|Did not have surgery after PET|9|||
125219746|NCT02620787|450431239|FG000|Overall Study|Adverse Event|1|||
125219747|NCT02620787|450431240|FG001|Overall Study|Adverse Event|0|||
125219748|NCT02620787|450431239|FG000|Overall Study|Eligibility Criteria Not Met|1|||
125050949|NCT01070550|449806540|FG001|Overall Study|Treatment restarted|1|||
125050950|NCT01070550|449806541|FG002|Overall Study|Treatment restarted|0|||
125050951|NCT01070550|449806542|FG003|Overall Study|Treatment restarted|0|||
125050952|NCT01070550|449806543|FG004|Overall Study|Treatment restarted|0|||
125050953|NCT01070550|449806544|FG005|Overall Study|Treatment restarted|0|||
125050954|NCT01070550|449806539|FG000|Overall Study|Treatment stopped|3|||
125050955|NCT01070550|449806540|FG001|Overall Study|Treatment stopped|0|||
125050956|NCT01070550|449806541|FG002|Overall Study|Treatment stopped|0|||
125050957|NCT01070550|449806542|FG003|Overall Study|Treatment stopped|0|||
125050958|NCT01070550|449806543|FG004|Overall Study|Treatment stopped|0|||
125050959|NCT01070550|449806544|FG005|Overall Study|Treatment stopped|0|||
125050960|NCT01070550|449806539|FG000|Overall Study|Treatment unavailable|1|||
125050961|NCT01070550|449806540|FG001|Overall Study|Treatment unavailable|0|||
125050962|NCT01070550|449806541|FG002|Overall Study|Treatment unavailable|0|||
125050963|NCT01070550|449806542|FG003|Overall Study|Treatment unavailable|0|||
125050964|NCT01070550|449806543|FG004|Overall Study|Treatment unavailable|0|||
125050965|NCT01070550|449806544|FG005|Overall Study|Treatment unavailable|0|||
125050966|NCT01070550|449806539|FG000|Overall Study|Treatment was stopped early|7|||
125050967|NCT01070550|449806540|FG001|Overall Study|Treatment was stopped early|0|||
125050968|NCT01070550|449806541|FG002|Overall Study|Treatment was stopped early|0|||
125050969|NCT01070550|449806542|FG003|Overall Study|Treatment was stopped early|0|||
125050970|NCT01070550|449806543|FG004|Overall Study|Treatment was stopped early|0|||
125050971|NCT01070550|449806544|FG005|Overall Study|Treatment was stopped early|0|||
125050972|NCT01070550|449806539|FG000|Overall Study|Other|5|||
125050973|NCT01070550|449806540|FG001|Overall Study|Other|0|||
125050974|NCT01070550|449806541|FG002|Overall Study|Other|0|||
125050975|NCT01070550|449806542|FG003|Overall Study|Other|1|||
125050976|NCT01070550|449806543|FG004|Overall Study|Other|0|||
125050977|NCT01070550|449806544|FG005|Overall Study|Other|0|||
125050978|NCT01070550|449806539|FG000|Overall Study|Withdrawal by Subject|35|||
125050979|NCT01070550|449806540|FG001|Overall Study|Withdrawal by Subject|0|||
125050980|NCT01070550|449806541|FG002|Overall Study|Withdrawal by Subject|3|||
125050981|NCT01070550|449806542|FG003|Overall Study|Withdrawal by Subject|0|||
125050982|NCT01070550|449806543|FG004|Overall Study|Withdrawal by Subject|0|||
125050983|NCT01070550|449806544|FG005|Overall Study|Withdrawal by Subject|0|||
125050984|NCT04964063|449806545|FG000|Overall Study|Adverse Event|4|||
125050985|NCT04964063|449806545|FG000|Overall Study|Lost to Follow-up|47|||
125050986|NCT04964063|449806545|FG000|Overall Study|Withdrawal by Subject|5|||
125050987|NCT04964063|449806545|FG000|Overall Study|Baseline Tasks Expired|41|||
125050988|NCT04964063|449806545|FG000|Overall Study|Participant withdrawn in error|1|||
125050989|NCT03350750|449806546|FG000|Overall Study|Death|1|||
125050990|NCT03350750|449806547|FG001|Overall Study|Death|1|||
125050991|NCT01849250|449806548|FG000|Overall Study|Withdrawal by Subject|1|||
125050992|NCT01849250|449806549|FG001|Overall Study|Withdrawal by Subject|0|||
125050993|NCT01849250|449806548|FG000|Overall Study|Not Evaluable|5|||
125050994|NCT01849250|449806549|FG001|Overall Study|Not Evaluable|3|||
125050995|NCT01849250|449806548|FG000|Overall Study|Screen Failure|1|||
125050996|NCT01849250|449806549|FG001|Overall Study|Screen Failure|0|||
125050997|NCT01525849|449806553|FG000|Overall Study|Lost to Follow-up|3|||
125050998|NCT01525849|449806554|FG001|Overall Study|Lost to Follow-up|2|||
125050999|NCT01525849|449806553|FG000|Overall Study|Withdrawal by Subject|1|||
125051000|NCT01525849|449806554|FG001|Overall Study|Withdrawal by Subject|9|||
125051001|NCT01525849|449806553|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
125051002|NCT01525849|449806554|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
125051003|NCT01525849|449806553|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
125051004|NCT01525849|449806554|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
125051005|NCT00339183|449806555|FG000|Overall Study|Adverse Event|5|||
125051006|NCT00339183|449806556|FG001|Overall Study|Adverse Event|3|||
125051007|NCT00339183|449806555|FG000|Overall Study|Withdrawal by Subject|16|||
125051008|NCT00339183|449806556|FG001|Overall Study|Withdrawal by Subject|19|||
125051009|NCT00339183|449806555|FG000|Overall Study|Physician Decision|2|||
125051010|NCT00339183|449806556|FG001|Overall Study|Physician Decision|4|||
125051011|NCT00339183|449806555|FG000|Overall Study|Lost to Follow-up|17|||
125051012|NCT00339183|449806556|FG001|Overall Study|Lost to Follow-up|17|||
125051013|NCT00339183|449806555|FG000|Overall Study|Protocol-specified criteria|12|||
125051014|NCT00339183|449806556|FG001|Overall Study|Protocol-specified criteria|8|||
125051015|NCT00339183|449806555|FG000|Overall Study|Missing reason|3|||
125051016|NCT00339183|449806556|FG001|Overall Study|Missing reason|1|||
125051017|NCT00339183|449806555|FG000|Overall Study|Other|46|||
125051018|NCT00339183|449806556|FG001|Overall Study|Other|40|||
125051019|NCT00339183|449806555|FG000|Overall Study|Ongoing|20|||
125051020|NCT00339183|449806556|FG001|Overall Study|Ongoing|13|||
125051021|NCT00793819|449806557|FG000|Overall Study|Adverse Event|8|||
125051022|NCT00793819|449806558|FG001|Overall Study|Adverse Event|4|||
125051023|NCT00793819|449806557|FG000|Overall Study|Lack of Efficacy|1|||
125051024|NCT00793819|449806558|FG001|Overall Study|Lack of Efficacy|1|||
125051025|NCT00793819|449806557|FG000|Overall Study|Withdrawal by Subject|4|||
125051026|NCT00793819|449806558|FG001|Overall Study|Withdrawal by Subject|3|||
125051027|NCT00793819|449806557|FG000|Overall Study|Lost to Follow-up|1|||
125051028|NCT00793819|449806558|FG001|Overall Study|Lost to Follow-up|1|||
125219749|NCT02620787|450431240|FG001|Overall Study|Eligibility Criteria Not Met|0|||
125219750|NCT01502033|450431242|FG000|Overall Study|1 participant had scalp discomfort|1|||
125219751|NCT01502033|450431242|FG000|Overall Study|1 participant had worsening depression|1|||
125219752|NCT01502033|450431242|FG000|Overall Study|1 participant went back to school|1|||
125219753|NCT01808261|450431243|FG000|Overall Study|Physician Decision|0|||
125219754|NCT01808261|450431244|FG001|Overall Study|Physician Decision|2|||
125219755|NCT01808261|450431243|FG000|Overall Study|Study Closed/Terminated|25|||
125219756|NCT01808261|450431244|FG001|Overall Study|Study Closed/Terminated|23|||
125219757|NCT01808261|450431243|FG000|Overall Study|Adverse event, non-fatal|2|||
125219758|NCT01808261|450431244|FG001|Overall Study|Adverse event, non-fatal|0|||
125219759|NCT01808261|450431243|FG000|Overall Study|Consent withdrawn by subject|6|||
125219760|NCT01808261|450431244|FG001|Overall Study|Consent withdrawn by subject|7|||
125219761|NCT01808261|450431243|FG000|Overall Study|Lost to Follow-up|3|||
125219762|NCT01808261|450431244|FG001|Overall Study|Lost to Follow-up|1|||
125219763|NCT00941304|450431245|FG000|Overall Study|Lost to Follow-up|1|||
125219764|NCT00941304|450431246|FG001|Overall Study|Lost to Follow-up|0|||
125219765|NCT00941304|450431247|FG002|Overall Study|Lost to Follow-up|0|||
125219766|NCT00941304|450431248|FG003|Overall Study|Lost to Follow-up|0|||
125219767|NCT00941304|450431249|FG004|Overall Study|Lost to Follow-up|0|||
125219768|NCT03293394|450431250|FG000|Follow-up (6 Months)|Adverse Event|4|||
125219769|NCT03293394|450431251|FG001|Follow-up (6 Months)|Adverse Event|2|||
125219770|NCT04004260|450431253|FG000|Overall Study|Withdrawal by Subject|7|||
125219771|NCT04004260|450431254|FG001|Overall Study|Withdrawal by Subject|3|||
125219772|NCT04004260|450431253|FG000|Overall Study|Lost to Follow-up|22|||
125219773|NCT04004260|450431254|FG001|Overall Study|Lost to Follow-up|12|||
125219774|NCT04004260|450431253|FG000|Overall Study|Did not engage in intervention|13|||
125219775|NCT04004260|450431254|FG001|Overall Study|Did not engage in intervention|17|||
125219776|NCT01765569|450431255|FG000|Period B|Withdrawal by Subject|1|||
125219777|NCT01765569|450431255|FG000|Period C|Death|1|||
125219778|NCT05568797|450431259|FG000|Overall Study|Adverse Event|0|||
125219779|NCT05568797|450431260|FG001|Overall Study|Adverse Event|8|||
125219780|NCT05568797|450431259|FG000|Overall Study|Lost to Follow-up|2|||
125219781|NCT05568797|450431260|FG001|Overall Study|Lost to Follow-up|3|||
125219782|NCT05568797|450431259|FG000|Overall Study|Withdrawal by Subject|1|||
125219783|NCT05568797|450431260|FG001|Overall Study|Withdrawal by Subject|10|||
125051029|NCT00446446|449806559|FG000|Overall Study|Death|10|||
125051030|NCT00446446|449806559|FG000|Overall Study|Withdrawal by Subject|6|||
125051031|NCT00446446|449806559|FG000|Overall Study|Other|4|||
125051032|NCT00446446|449806559|FG000|Overall Study|Disease Progession|2|||
125051033|NCT00446446|449806559|FG000|Overall Study|Adverse Event|1|||
125051034|NCT00446446|449806559|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
125051035|NCT01757704|449806565|FG000|Overall Study|Protocol Violation|1|||
125051036|NCT01757704|449806566|FG001|Overall Study|Protocol Violation|3|||
125051037|NCT02691247|449806567|FG000|Overall Study|Withdrawal by Subject|1|||
125051038|NCT02691247|449806568|FG001|Overall Study|Withdrawal by Subject|2|||
125051039|NCT02691247|449806569|FG002|Overall Study|Withdrawal by Subject|2|||
125051040|NCT02691247|449806567|FG000|Overall Study|Lost to Follow-up|2|||
125051041|NCT02691247|449806568|FG001|Overall Study|Lost to Follow-up|0|||
125051042|NCT02691247|449806569|FG002|Overall Study|Lost to Follow-up|1|||
125051043|NCT01844700|449806570|FG000|Overall Study|Lack of Efficacy|1|||
125051044|NCT01844700|449806571|FG001|Overall Study|Lack of Efficacy|0|||
125051045|NCT01844700|449806570|FG000|Overall Study|refused medication switch|1|||
125051046|NCT01844700|449806571|FG001|Overall Study|refused medication switch|0|||
125051047|NCT01844700|449806570|FG000|Overall Study|Withdrawal by Subject|1|||
125051048|NCT01844700|449806571|FG001|Overall Study|Withdrawal by Subject|0|||
125051049|NCT01844700|449806570|FG000|Overall Study|stopped taking meds|0|||
125219784|NCT05568797|450431259|FG000|Overall Study|Other|2|||
125219785|NCT05568797|450431260|FG001|Overall Study|Other|2|||
125219786|NCT02401035|450431262|FG000|Overall Study|Withdrawal by Subject|1|||
125219787|NCT02401035|450431263|FG001|Overall Study|Withdrawal by Subject|0|||
125219788|NCT00869128|450431264|FG000|Overall Study|lack of Compliance|6|||
125219789|NCT00869128|450431265|FG001|Overall Study|lack of Compliance|6|||
125219790|NCT02998996|450431271|FG000|Overall Study|Lost to Follow-up|0|||
125219791|NCT02998996|450431272|FG001|Overall Study|Lost to Follow-up|0|||
125219792|NCT02998996|450431273|FG002|Overall Study|Lost to Follow-up|1|||
125051050|NCT01844700|449806571|FG001|Overall Study|stopped taking meds|1|||
125051051|NCT02680847|449806572|FG000|Overall Study|Other|2|||
125051052|NCT02680847|449806573|FG001|Overall Study|Other|0|||
125051053|NCT02680847|449806574|FG002|Overall Study|Other|0|||
125051054|NCT02680847|449806572|FG000|Overall Study|No longer met eligibility criteria|2|||
125051055|NCT02680847|449806573|FG001|Overall Study|No longer met eligibility criteria|2|||
125051056|NCT02680847|449806574|FG002|Overall Study|No longer met eligibility criteria|0|||
125051057|NCT02680847|449806572|FG000|Overall Study|Unwilling to participate in study|1|||
125051058|NCT02680847|449806573|FG001|Overall Study|Unwilling to participate in study|1|||
125051059|NCT02680847|449806574|FG002|Overall Study|Unwilling to participate in study|0|||
125051060|NCT02680847|449806572|FG000|Overall Study|Lack of Efficacy|0|||
125051061|NCT02680847|449806573|FG001|Overall Study|Lack of Efficacy|0|||
125051062|NCT02680847|449806574|FG002|Overall Study|Lack of Efficacy|2|||
125051063|NCT02680847|449806572|FG000|Overall Study|Adverse Event|0|||
125051064|NCT02680847|449806573|FG001|Overall Study|Adverse Event|0|||
125051065|NCT02680847|449806574|FG002|Overall Study|Adverse Event|1|||
125051066|NCT02144220|449806575|FG000|Overall Study|technology incompatibility|9|||
125051067|NCT02144220|449806575|FG000|Overall Study|Lack of Efficacy|4|||
125051068|NCT02144220|449806575|FG000|Overall Study|Physician Decision|3|||
125051069|NCT02144220|449806575|FG000|Overall Study|Withdrawal by Subject|2|||
125051070|NCT02144220|449806575|FG000|Overall Study|Protocol Violation|1|||
125051071|NCT03648996|449806576|FG000|Overall Study|Withdrawal by Subject|0|||
125051072|NCT03648996|449806577|FG001|Overall Study|Withdrawal by Subject|2|||
125051073|NCT03648996|449806578|FG002|Overall Study|Withdrawal by Subject|2|||
125051074|NCT03648996|449806576|FG000|Overall Study|Physician Decision|2|||
125051075|NCT03648996|449806577|FG001|Overall Study|Physician Decision|0|||
125051076|NCT03648996|449806578|FG002|Overall Study|Physician Decision|0|||
125051077|NCT00590681|449806579|FG000|Overall Study|Withdrawal by Subject|7|||
125051078|NCT00590681|449806579|FG000|Overall Study|Adverse Event|8|||
125051079|NCT00590681|449806579|FG000|Overall Study|Death|3|||
125051080|NCT00590681|449806579|FG000|Overall Study|Lost to Follow-up|1|||
125051081|NCT00590681|449806579|FG000|Overall Study|disease progression|1|||
125051082|NCT00504166|449806580|FG000|Overall Study|Adverse Event|1|||
125051083|NCT00504166|449806581|FG001|Overall Study|Adverse Event|4|||
125051084|NCT00504166|449806580|FG000|Overall Study|Withdrawal by Subject|3|||
125051085|NCT00504166|449806581|FG001|Overall Study|Withdrawal by Subject|6|||
125051086|NCT00504166|449806580|FG000|Overall Study|Physician Decision|1|||
125051087|NCT00504166|449806581|FG001|Overall Study|Physician Decision|1|||
125051088|NCT00504166|449806580|FG000|Overall Study|Lost to Follow-up|1|||
125051089|NCT00504166|449806581|FG001|Overall Study|Lost to Follow-up|3|||
125051090|NCT02229864|449806582|FG000|Overall Study|Death|2|||
125051091|NCT02229864|449806582|FG000|Overall Study|Lost to Follow-up|1|||
125051092|NCT02650284|449806583|FG000|Overall Study|Lost to Follow-up|3|||
125051093|NCT02650284|449806584|FG001|Overall Study|Lost to Follow-up|3|||
125051094|NCT02650284|449806583|FG000|Overall Study|Consent incorrectly taken|0|||
125051095|NCT02650284|449806584|FG001|Overall Study|Consent incorrectly taken|1|||
125051096|NCT01780389|449806590|FG000|Overall Study|Adverse Event|1|||
125051097|NCT02566525|449806595|FG000|Overall Study|Protocol Violation|3|||
125051098|NCT02566525|449806596|FG001|Overall Study|Protocol Violation|5|||
125051099|NCT00337467|449806597|FG000|Overall Study|Adverse Event|3|||
125051100|NCT00337467|449806597|FG000|Overall Study|Subject Withdrew Consent|2|||
125051101|NCT00337467|449806597|FG000|Overall Study|Pregnancy|1|||
125051102|NCT00337467|449806597|FG000|Overall Study|Lost to Follow-up|2|||
125051103|NCT00337467|449806597|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
125051104|NCT02488759|449806598|FG000|Overall Study|Disease progression|73|||
125051105|NCT02488759|449806599|FG001|Overall Study|Disease progression|111|||
125051106|NCT02488759|449806600|FG002|Overall Study|Disease progression|62|||
125051107|NCT02488759|449806601|FG003|Overall Study|Disease progression|7|||
125051108|NCT02488759|449806602|FG004|Overall Study|Disease progression|4|||
125051109|NCT02488759|449806603|FG005|Overall Study|Disease progression|2|||
125051110|NCT02488759|449806598|FG000|Overall Study|Study drug toxicity|11|||
125051111|NCT02488759|449806599|FG001|Overall Study|Study drug toxicity|33|||
125051112|NCT02488759|449806600|FG002|Overall Study|Study drug toxicity|31|||
125051113|NCT02488759|449806601|FG003|Overall Study|Study drug toxicity|0|||
125051114|NCT02488759|449806602|FG004|Overall Study|Study drug toxicity|0|||
125051115|NCT02488759|449806603|FG005|Overall Study|Study drug toxicity|2|||
125051116|NCT02488759|449806598|FG000|Overall Study|Adverse event unrelated to study drug|9|||
125051117|NCT02488759|449806599|FG001|Overall Study|Adverse event unrelated to study drug|11|||
125051118|NCT02488759|449806600|FG002|Overall Study|Adverse event unrelated to study drug|7|||
125051119|NCT02488759|449806601|FG003|Overall Study|Adverse event unrelated to study drug|0|||
125051120|NCT02488759|449806602|FG004|Overall Study|Adverse event unrelated to study drug|1|||
125051121|NCT02488759|449806603|FG005|Overall Study|Adverse event unrelated to study drug|0|||
125051122|NCT02488759|449806598|FG000|Overall Study|Participant request to discontinue study treatment|6|||
125051123|NCT02488759|449806599|FG001|Overall Study|Participant request to discontinue study treatment|8|||
125051124|NCT02488759|449806600|FG002|Overall Study|Participant request to discontinue study treatment|4|||
125051125|NCT02488759|449806601|FG003|Overall Study|Participant request to discontinue study treatment|0|||
125051126|NCT02488759|449806602|FG004|Overall Study|Participant request to discontinue study treatment|0|||
125051127|NCT02488759|449806603|FG005|Overall Study|Participant request to discontinue study treatment|0|||
125051128|NCT02488759|449806598|FG000|Overall Study|Withdrawal by Subject|4|||
125051129|NCT02488759|449806599|FG001|Overall Study|Withdrawal by Subject|0|||
125051130|NCT02488759|449806600|FG002|Overall Study|Withdrawal by Subject|3|||
125051131|NCT02488759|449806601|FG003|Overall Study|Withdrawal by Subject|0|||
125051132|NCT02488759|449806602|FG004|Overall Study|Withdrawal by Subject|0|||
125051133|NCT02488759|449806603|FG005|Overall Study|Withdrawal by Subject|2|||
125051134|NCT02488759|449806598|FG000|Overall Study|Lost to Follow-up|0|||
125051135|NCT02488759|449806599|FG001|Overall Study|Lost to Follow-up|0|||
125051136|NCT02488759|449806600|FG002|Overall Study|Lost to Follow-up|2|||
125051137|NCT02488759|449806601|FG003|Overall Study|Lost to Follow-up|0|||
125051138|NCT02488759|449806602|FG004|Overall Study|Lost to Follow-up|0|||
125051139|NCT02488759|449806603|FG005|Overall Study|Lost to Follow-up|0|||
125051140|NCT02488759|449806598|FG000|Overall Study|Maximum clinical benefit|3|||
125051141|NCT02488759|449806599|FG001|Overall Study|Maximum clinical benefit|0|||
125051142|NCT02488759|449806600|FG002|Overall Study|Maximum clinical benefit|1|||
125051143|NCT02488759|449806601|FG003|Overall Study|Maximum clinical benefit|0|||
125051144|NCT02488759|449806602|FG004|Overall Study|Maximum clinical benefit|0|||
125051145|NCT02488759|449806603|FG005|Overall Study|Maximum clinical benefit|0|||
125051146|NCT02488759|449806598|FG000|Overall Study|Other reasons|7|||
125051147|NCT02488759|449806599|FG001|Overall Study|Other reasons|32|||
125051148|NCT02488759|449806600|FG002|Overall Study|Other reasons|23|||
125051149|NCT02488759|449806601|FG003|Overall Study|Other reasons|1|||
125051150|NCT02488759|449806602|FG004|Overall Study|Other reasons|1|||
125051151|NCT02488759|449806603|FG005|Overall Study|Other reasons|1|||
125051152|NCT04083222|449806604|FG000|Overall Study|Voluntary Withdrawal|0|||
125051153|NCT04083222|449806605|FG001|Overall Study|Voluntary Withdrawal|1|||
125051154|NCT04083222|449806604|FG000|Overall Study|Reason not Specified|0|||
125051155|NCT04083222|449806605|FG001|Overall Study|Reason not Specified|1|||
125051156|NCT03103750|449806606|FG000|Overall Study|Adverse Event|1|||
125051157|NCT03103750|449806607|FG001|Overall Study|Adverse Event|0|||
125051158|NCT03103750|449806606|FG000|Overall Study|Lost to Follow-up|1|||
125051159|NCT03103750|449806607|FG001|Overall Study|Lost to Follow-up|0|||
125051160|NCT03103750|449806606|FG000|Overall Study|PET Equipment Related|2|||
125051161|NCT03103750|449806607|FG001|Overall Study|PET Equipment Related|2|||
125051162|NCT02429427|449806615|FG000|Overall Study|Adverse Event|220|||
125051163|NCT02429427|449806616|FG001|Overall Study|Adverse Event|92|||
125051164|NCT02429427|449806615|FG000|Overall Study|Protocol Violation|10|||
125051165|NCT02429427|449806616|FG001|Overall Study|Protocol Violation|6|||
125051166|NCT02429427|449806615|FG000|Overall Study|Lost to Follow-up|15|||
125051167|NCT02429427|449806616|FG001|Overall Study|Lost to Follow-up|6|||
125051168|NCT02429427|449806615|FG000|Overall Study|Withdrawal by Subject|64|||
125051169|NCT02429427|449806616|FG001|Overall Study|Withdrawal by Subject|34|||
125051170|NCT02429427|449806615|FG000|Overall Study|Other|62|||
125051171|NCT02429427|449806616|FG001|Overall Study|Other|41|||
125051172|NCT02078713|449808831|FG000|Overall Study|Lost to Follow-up|49|||
125051173|NCT02078713|449808832|FG001|Overall Study|Lost to Follow-up|55|||
125051174|NCT02078713|449808833|FG002|Overall Study|Lost to Follow-up|0|||
125051175|NCT02078713|449808834|FG003|Overall Study|Lost to Follow-up|0|||
125051176|NCT02078713|449808831|FG000|Overall Study|Pregnant at baseline|3|||
125051177|NCT02078713|449808832|FG001|Overall Study|Pregnant at baseline|5|||
125051178|NCT02078713|449808833|FG002|Overall Study|Pregnant at baseline|0|||
125051179|NCT02078713|449808834|FG003|Overall Study|Pregnant at baseline|0|||
125051180|NCT02078713|449808831|FG000|Overall Study|Enrolled twice|0|||
125051181|NCT02078713|449808832|FG001|Overall Study|Enrolled twice|1|||
125051182|NCT02078713|449808833|FG002|Overall Study|Enrolled twice|0|||
125051183|NCT02078713|449808834|FG003|Overall Study|Enrolled twice|0|||
125051184|NCT00696657|449808839|FG000|Overall Study|Protocol Violation|0|||
125051185|NCT00696657|449808840|FG001|Overall Study|Protocol Violation|0|||
125051186|NCT00696657|449808841|FG002|Overall Study|Protocol Violation|0|||
125051187|NCT00696657|449808842|FG003|Overall Study|Protocol Violation|0|||
125051188|NCT00696657|449808843|FG004|Overall Study|Protocol Violation|0|||
125051189|NCT00696657|449808844|FG005|Overall Study|Protocol Violation|1|||
125051190|NCT00696657|449808845|FG006|Overall Study|Protocol Violation|0|||
125051191|NCT00696657|449808846|FG007|Overall Study|Protocol Violation|0|||
125051192|NCT00696657|449808847|FG008|Overall Study|Protocol Violation|1|||
125051193|NCT00696657|449808839|FG000|Overall Study|Lack of Efficacy|0|||
125051194|NCT00696657|449808840|FG001|Overall Study|Lack of Efficacy|1|||
125051195|NCT00696657|449808841|FG002|Overall Study|Lack of Efficacy|0|||
125051196|NCT00696657|449808842|FG003|Overall Study|Lack of Efficacy|0|||
125051197|NCT00696657|449808843|FG004|Overall Study|Lack of Efficacy|0|||
125051198|NCT00696657|449808844|FG005|Overall Study|Lack of Efficacy|0|||
125051199|NCT00696657|449808845|FG006|Overall Study|Lack of Efficacy|0|||
125051200|NCT00696657|449808846|FG007|Overall Study|Lack of Efficacy|0|||
125051201|NCT00696657|449808847|FG008|Overall Study|Lack of Efficacy|0|||
125051202|NCT00696657|449808839|FG000|Overall Study|Withdrawal criteria|1|||
125051203|NCT00696657|449808840|FG001|Overall Study|Withdrawal criteria|3|||
125051204|NCT00696657|449808841|FG002|Overall Study|Withdrawal criteria|2|||
125219793|NCT02998996|450431274|FG003|Overall Study|Lost to Follow-up|0|||
125219794|NCT02998996|450431275|FG004|Overall Study|Lost to Follow-up|0|||
125219795|NCT02998996|450431276|FG005|Overall Study|Lost to Follow-up|0|||
125219796|NCT02998996|450431271|FG000|Overall Study|Pregnancy|0|||
125219797|NCT02998996|450431272|FG001|Overall Study|Pregnancy|1|||
125219798|NCT02998996|450431273|FG002|Overall Study|Pregnancy|0|||
125219799|NCT02998996|450431274|FG003|Overall Study|Pregnancy|0|||
125219800|NCT02998996|450431275|FG004|Overall Study|Pregnancy|0|||
125219801|NCT02998996|450431276|FG005|Overall Study|Pregnancy|0|||
125219802|NCT02998996|450431271|FG000|Overall Study|Family reasons|0|||
125219803|NCT02998996|450431272|FG001|Overall Study|Family reasons|0|||
125219804|NCT02998996|450431273|FG002|Overall Study|Family reasons|0|||
125219805|NCT02998996|450431274|FG003|Overall Study|Family reasons|0|||
125219806|NCT02998996|450431275|FG004|Overall Study|Family reasons|1|||
125219807|NCT02998996|450431276|FG005|Overall Study|Family reasons|0|||
125219808|NCT01118663|450431278|FG000|Overall Study|Adverse Event|2|||
125051205|NCT00696657|449808842|FG003|Overall Study|Withdrawal criteria|2|||
125051206|NCT00696657|449808843|FG004|Overall Study|Withdrawal criteria|0|||
125051207|NCT00696657|449808844|FG005|Overall Study|Withdrawal criteria|0|||
125051208|NCT00696657|449808845|FG006|Overall Study|Withdrawal criteria|1|||
125051209|NCT00696657|449808846|FG007|Overall Study|Withdrawal criteria|1|||
125051210|NCT00696657|449808847|FG008|Overall Study|Withdrawal criteria|2|||
125051211|NCT00696657|449808839|FG000|Overall Study|Unclassified|0|||
125051212|NCT00696657|449808840|FG001|Overall Study|Unclassified|1|||
125051213|NCT00696657|449808841|FG002|Overall Study|Unclassified|3|||
125051214|NCT00696657|449808842|FG003|Overall Study|Unclassified|2|||
125051215|NCT00696657|449808843|FG004|Overall Study|Unclassified|4|||
125051216|NCT00696657|449808844|FG005|Overall Study|Unclassified|2|||
125051217|NCT00696657|449808845|FG006|Overall Study|Unclassified|0|||
125051218|NCT00696657|449808846|FG007|Overall Study|Unclassified|0|||
125051219|NCT00696657|449808847|FG008|Overall Study|Unclassified|1|||
125051220|NCT00696657|449808839|FG000|Overall Study|Adverse Event|0|||
125051221|NCT00696657|449808840|FG001|Overall Study|Adverse Event|0|||
125051222|NCT00696657|449808841|FG002|Overall Study|Adverse Event|3|||
125051223|NCT00696657|449808842|FG003|Overall Study|Adverse Event|7|||
125051224|NCT00696657|449808843|FG004|Overall Study|Adverse Event|6|||
125051225|NCT00696657|449808844|FG005|Overall Study|Adverse Event|9|||
125051226|NCT00696657|449808845|FG006|Overall Study|Adverse Event|14|||
125051227|NCT00696657|449808846|FG007|Overall Study|Adverse Event|2|||
125051228|NCT00696657|449808847|FG008|Overall Study|Adverse Event|5|||
125051229|NCT00059215|449808851|FG000|Overall Study|Adverse Event|5|||
125051230|NCT00059215|449808852|FG001|Overall Study|Adverse Event|5|||
125051231|NCT00059215|449808853|FG002|Overall Study|Adverse Event|9|||
125051232|NCT00059215|449808854|FG003|Overall Study|Adverse Event|9|||
125051233|NCT00059215|449808851|FG000|Overall Study|Death|0|||
125051234|NCT00059215|449808852|FG001|Overall Study|Death|0|||
125051235|NCT00059215|449808853|FG002|Overall Study|Death|3|||
125051236|NCT00059215|449808854|FG003|Overall Study|Death|0|||
125051237|NCT00059215|449808851|FG000|Overall Study|Lost to Follow-up|1|||
125051238|NCT00059215|449808852|FG001|Overall Study|Lost to Follow-up|2|||
125051239|NCT00059215|449808853|FG002|Overall Study|Lost to Follow-up|0|||
125051240|NCT00059215|449808854|FG003|Overall Study|Lost to Follow-up|0|||
125051241|NCT00059215|449808851|FG000|Overall Study|Withdrawal by Subject|4|||
125051242|NCT00059215|449808852|FG001|Overall Study|Withdrawal by Subject|4|||
125051243|NCT00059215|449808853|FG002|Overall Study|Withdrawal by Subject|1|||
125051244|NCT00059215|449808854|FG003|Overall Study|Withdrawal by Subject|3|||
125219809|NCT01118663|450431279|FG001|Overall Study|Adverse Event|1|||
125219810|NCT01118663|450431278|FG000|Overall Study|Withdrawal by Subject|0|||
125219811|NCT01118663|450431279|FG001|Overall Study|Withdrawal by Subject|1|||
125051245|NCT00059215|449808851|FG000|Overall Study|Protocol Violation|1|||
125051246|NCT00059215|449808852|FG001|Overall Study|Protocol Violation|0|||
125051247|NCT00059215|449808853|FG002|Overall Study|Protocol Violation|1|||
125051248|NCT00059215|449808854|FG003|Overall Study|Protocol Violation|0|||
125051249|NCT00059215|449808851|FG000|Overall Study|Protocol entry criteria not met|1|||
125051250|NCT00059215|449808852|FG001|Overall Study|Protocol entry criteria not met|1|||
125051251|NCT00059215|449808853|FG002|Overall Study|Protocol entry criteria not met|0|||
125051252|NCT00059215|449808854|FG003|Overall Study|Protocol entry criteria not met|2|||
125051253|NCT00059215|449808851|FG000|Overall Study|Physician Decision|1|||
125051254|NCT00059215|449808852|FG001|Overall Study|Physician Decision|2|||
125051255|NCT00059215|449808853|FG002|Overall Study|Physician Decision|1|||
125051256|NCT00059215|449808854|FG003|Overall Study|Physician Decision|1|||
125051257|NCT04439838|449808855|FG000|Overall Study|Withdrawal by Subject|0|||
125219812|NCT03046953|450431280|FG000|Overall Study|Relapse/progressive disease|21|||
125219813|NCT03046953|450431280|FG000|Overall Study|Death|2|||
125219814|NCT03046953|450431280|FG000|Overall Study|Withdrawal by Subject|3|||
125219815|NCT04039204|450431281|FG000|Overall Study|Withdrawal by Subject|0|||
125051258|NCT04439838|449808856|FG001|Overall Study|Withdrawal by Subject|0|||
125051259|NCT04439838|449808857|FG002|Overall Study|Withdrawal by Subject|0|||
125051260|NCT04439838|449808858|FG003|Overall Study|Withdrawal by Subject|0|||
125051261|NCT04439838|449808859|FG004|Overall Study|Withdrawal by Subject|0|||
125051262|NCT04439838|449808860|FG005|Overall Study|Withdrawal by Subject|0|||
125051263|NCT04439838|449808861|FG006|Overall Study|Withdrawal by Subject|0|||
125051264|NCT04439838|449808862|FG007|Overall Study|Withdrawal by Subject|0|||
125051265|NCT04439838|449808863|FG008|Overall Study|Withdrawal by Subject|1|||
125051266|NCT04494633|449808866|FG000|Overall Study|Lost to Follow-up|5|||
125051267|NCT04494633|449808867|FG001|Overall Study|Lost to Follow-up|3|||
125051268|NCT04494633|449808866|FG000|Overall Study|Protocol Violation|1|||
125051269|NCT04494633|449808867|FG001|Overall Study|Protocol Violation|1|||
125051270|NCT00414310|449808868|FG000|Overall Study|Not treated|1|||
125051271|NCT00414310|449808869|FG001|Overall Study|Not treated|0|||
125051272|NCT01254604|449808870|FG000|Overall Study|Lost to Follow-up|1|||
125051273|NCT01254604|449808871|FG001|Overall Study|Lost to Follow-up|1|||
125051274|NCT01254604|449808870|FG000|Overall Study|Protocol Violation|2|||
125051275|NCT01254604|449808871|FG001|Overall Study|Protocol Violation|2|||
125051276|NCT01254604|449808870|FG000|Overall Study|Withdrawal by Subject|2|||
125051277|NCT01254604|449808871|FG001|Overall Study|Withdrawal by Subject|4|||
125051278|NCT01254604|449808870|FG000|Overall Study|Adverse Event|3|||
125051279|NCT01254604|449808871|FG001|Overall Study|Adverse Event|2|||
125219816|NCT04039204|450431282|FG001|Overall Study|Withdrawal by Subject|2|||
125219817|NCT01189461|450431283|FG000|Overall Study|Lack of Efficacy|13|||
125051280|NCT03074162|449808872|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
125051281|NCT03074162|449808873|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
125051282|NCT03074162|449808874|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
125051283|NCT03074162|449808875|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
125051284|NCT03074162|449808876|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
125051285|NCT03074162|449808877|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
125051286|NCT03074162|449808872|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
125051287|NCT03074162|449808873|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
125051288|NCT03074162|449808874|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
125051289|NCT03074162|449808875|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
125051290|NCT03074162|449808876|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
125051291|NCT03074162|449808877|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
125051292|NCT03074162|449808872|FG000|Period 3|Withdrawal by Subject|1|||
125051293|NCT03074162|449808873|FG001|Period 3|Withdrawal by Subject|0|||
125051294|NCT03074162|449808874|FG002|Period 3|Withdrawal by Subject|0|||
125051295|NCT03074162|449808875|FG003|Period 3|Withdrawal by Subject|0|||
125051296|NCT03074162|449808876|FG004|Period 3|Withdrawal by Subject|1|||
125051297|NCT03074162|449808877|FG005|Period 3|Withdrawal by Subject|0|||
125051298|NCT03041116|449808878|FG000|Double-blind|Death|0|||
125051299|NCT03041116|449808879|FG001|Double-blind|Death|2|||
125051300|NCT03041116|449808878|FG000|Double-blind|Withdrawal by Subject|0|||
125051301|NCT03041116|449808879|FG001|Double-blind|Withdrawal by Subject|4|||
125051302|NCT03041116|449808878|FG000|Open-label|Death|1|||
125051303|NCT03041116|449808879|FG001|Open-label|Death|0|||
125051304|NCT03041116|449808878|FG000|Open-label|Termination of the study by Sponsor|39|||
125051305|NCT03041116|449808879|FG001|Open-label|Termination of the study by Sponsor|37|||
125051306|NCT03041116|449808878|FG000|Open-label|Withdrawal by Subject|1|||
125051307|NCT03041116|449808879|FG001|Open-label|Withdrawal by Subject|0|||
125051308|NCT03097328|449808880|FG000|Overall Study|Still on Therapy|2|||
125051309|NCT03097328|449808880|FG000|Overall Study|Progressive Disease|29|||
125051310|NCT03097328|449808880|FG000|Overall Study|Adverse Event|4|||
125051311|NCT03097328|449808880|FG000|Overall Study|Withdrawal by Subject|1|||
125051312|NCT03097328|449808880|FG000|Overall Study|Physician Decision|1|||
125051313|NCT03097328|449808880|FG000|Overall Study|Patient Decision|1|||
125051314|NCT03097328|449808880|FG000|Overall Study|Ineligible for Study Drug|1|||
125051315|NCT02436577|449808881|FG000|Overall Study|Protocol Deviation|0|||
125051316|NCT02436577|449808882|FG001|Overall Study|Protocol Deviation|1|||
125051317|NCT02436577|449808883|FG002|Overall Study|Protocol Deviation|0|||
125051318|NCT02436577|449808884|FG003|Overall Study|Protocol Deviation|0|||
125051319|NCT02436577|449808885|FG004|Overall Study|Protocol Deviation|0|||
125051320|NCT02436577|449808886|FG005|Overall Study|Protocol Deviation|0|||
125051321|NCT01675011|449808890|FG000|Overall Study|Trial terminated by Sponsor|3|||
125051322|NCT01675011|449808891|FG001|Overall Study|Trial terminated by Sponsor|1|||
125051323|NCT00931892|449808895|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
125051324|NCT00931892|449808896|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
125051325|NCT01876732|449808897|FG000|Overall Study|MMA was not over 800mg/dL|75|||
125051326|NCT02531373|449808900|FG000|Overall Study|Lack of Efficacy|0|||
125051327|NCT02531373|449808901|FG001|Overall Study|Lack of Efficacy|0|||
125051328|NCT02531373|449808902|FG002|Overall Study|Lack of Efficacy|0|||
125051329|NCT02531373|449808903|FG003|Overall Study|Lack of Efficacy|0|||
125051330|NCT02531373|449808904|FG004|Overall Study|Lack of Efficacy|3|||
125051331|NCT02531373|449808905|FG005|Overall Study|Lack of Efficacy|2|||
125051332|NCT02531373|449808906|FG006|Overall Study|Lack of Efficacy|4|||
125051333|NCT02531373|449808907|FG007|Overall Study|Lack of Efficacy|8|||
125051334|NCT02531373|449808908|FG008|Overall Study|Lack of Efficacy|5|||
125051335|NCT02531373|449808900|FG000|Overall Study|Lost to Follow-up|0|||
125051336|NCT02531373|449808901|FG001|Overall Study|Lost to Follow-up|0|||
125051337|NCT02531373|449808902|FG002|Overall Study|Lost to Follow-up|0|||
125051338|NCT02531373|449808903|FG003|Overall Study|Lost to Follow-up|0|||
125051339|NCT02531373|449808904|FG004|Overall Study|Lost to Follow-up|0|||
125051340|NCT02531373|449808905|FG005|Overall Study|Lost to Follow-up|2|||
125051341|NCT02531373|449808906|FG006|Overall Study|Lost to Follow-up|2|||
125051342|NCT02531373|449808907|FG007|Overall Study|Lost to Follow-up|0|||
125051343|NCT02531373|449808908|FG008|Overall Study|Lost to Follow-up|0|||
125051344|NCT02531373|449808900|FG000|Overall Study|Physician Decision|0|||
125051345|NCT02531373|449808901|FG001|Overall Study|Physician Decision|0|||
125051346|NCT02531373|449808902|FG002|Overall Study|Physician Decision|0|||
125051347|NCT02531373|449808903|FG003|Overall Study|Physician Decision|0|||
125051348|NCT02531373|449808904|FG004|Overall Study|Physician Decision|2|||
125051349|NCT02531373|449808905|FG005|Overall Study|Physician Decision|1|||
125051350|NCT02531373|449808906|FG006|Overall Study|Physician Decision|0|||
125051351|NCT02531373|449808907|FG007|Overall Study|Physician Decision|0|||
125051352|NCT02531373|449808908|FG008|Overall Study|Physician Decision|0|||
125051353|NCT02531373|449808900|FG000|Overall Study|Protocol Violation|0|||
125051354|NCT02531373|449808901|FG001|Overall Study|Protocol Violation|0|||
125051355|NCT02531373|449808902|FG002|Overall Study|Protocol Violation|0|||
125051356|NCT02531373|449808903|FG003|Overall Study|Protocol Violation|0|||
125051357|NCT02531373|449808904|FG004|Overall Study|Protocol Violation|0|||
125051358|NCT02531373|449808905|FG005|Overall Study|Protocol Violation|1|||
125051359|NCT02531373|449808906|FG006|Overall Study|Protocol Violation|1|||
125051360|NCT02531373|449808907|FG007|Overall Study|Protocol Violation|0|||
125051361|NCT02531373|449808908|FG008|Overall Study|Protocol Violation|1|||
125051362|NCT02531373|449808900|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125051363|NCT02531373|449808901|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125051364|NCT02531373|449808902|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
125051365|NCT02531373|449808903|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
125051366|NCT02531373|449808904|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
125051367|NCT02531373|449808905|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
125051368|NCT02531373|449808906|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
125051369|NCT02531373|449808907|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
125051370|NCT02531373|449808908|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
125051371|NCT02531373|449808900|FG000|Overall Study|Withdrawal by Subject|0|||
125051372|NCT02531373|449808901|FG001|Overall Study|Withdrawal by Subject|0|||
125051373|NCT02531373|449808902|FG002|Overall Study|Withdrawal by Subject|0|||
125051374|NCT02531373|449808903|FG003|Overall Study|Withdrawal by Subject|0|||
125051375|NCT02531373|449808904|FG004|Overall Study|Withdrawal by Subject|3|||
125051376|NCT02531373|449808905|FG005|Overall Study|Withdrawal by Subject|0|||
125051377|NCT02531373|449808906|FG006|Overall Study|Withdrawal by Subject|0|||
125051378|NCT02531373|449808907|FG007|Overall Study|Withdrawal by Subject|0|||
125051379|NCT02531373|449808908|FG008|Overall Study|Withdrawal by Subject|0|||
125051380|NCT00536731|449808909|FG000|Overall Study|Adverse Event|3|||
125051381|NCT00536731|449808910|FG001|Overall Study|Adverse Event|2|||
125051382|NCT00536731|449808911|FG002|Overall Study|Adverse Event|3|||
125051383|NCT00536731|449808909|FG000|Overall Study|Withdrawal by Subject|0|||
125051384|NCT00536731|449808910|FG001|Overall Study|Withdrawal by Subject|2|||
125051385|NCT00536731|449808911|FG002|Overall Study|Withdrawal by Subject|0|||
125051386|NCT00536731|449808909|FG000|Overall Study|Intake of prohibited conc. medication|0|||
125051387|NCT00536731|449808910|FG001|Overall Study|Intake of prohibited conc. medication|0|||
125051388|NCT00536731|449808911|FG002|Overall Study|Intake of prohibited conc. medication|1|||
125051389|NCT00536731|449808909|FG000|Overall Study|Safety reasons|0|||
125051390|NCT00536731|449808910|FG001|Overall Study|Safety reasons|0|||
125051391|NCT00536731|449808911|FG002|Overall Study|Safety reasons|1|||
125051392|NCT00536731|449808909|FG000|Overall Study|Other|1|||
125051393|NCT00536731|449808910|FG001|Overall Study|Other|1|||
125051394|NCT00536731|449808911|FG002|Overall Study|Other|0|||
125051395|NCT01675531|449808912|FG000|Overall Study|Adverse Event|9|||
125051396|NCT01675531|449808912|FG000|Overall Study|Withdrawal by Subject|7|||
125051397|NCT01675531|449808912|FG000|Overall Study|Lack of Efficacy|1|||
125051398|NCT01675531|449808912|FG000|Overall Study|Protocol Violation|8|||
125051399|NCT00623467|449808913|FG000|Overall Study|Lost to Follow-up|1|||
125051400|NCT00623467|449808913|FG000|Overall Study|Protocol Violation|4|||
125051401|NCT00623467|449808913|FG000|Overall Study|Withdrawal by Subject|2|||
125051402|NCT04705597|449808918|FG000|Overall Study|Death|16|||
125051403|NCT04705597|449808919|FG001|Overall Study|Death|9|||
125051404|NCT04705597|449808918|FG000|Overall Study|Lost to Follow-up|1|||
125051405|NCT04705597|449808919|FG001|Overall Study|Lost to Follow-up|0|||
125051406|NCT04705597|449808918|FG000|Overall Study|Withdrawal by Subject|1|||
125051407|NCT04705597|449808919|FG001|Overall Study|Withdrawal by Subject|2|||
125051408|NCT06094296|449808922|FG000|Overall Study|Progressive Disease|1|||
125051409|NCT06094296|449808923|FG001|Overall Study|Progressive Disease|0|||
125051410|NCT06094296|449808924|FG002|Overall Study|Progressive Disease|0|||
125051411|NCT06094296|449808925|FG003|Overall Study|Progressive Disease|0|||
125051412|NCT03332667|449808926|FG000|Overall Study|Adverse Event|0|||
125051413|NCT03332667|449808927|FG001|Overall Study|Adverse Event|0|||
125051414|NCT03332667|449808928|FG002|Overall Study|Adverse Event|2|||
125051415|NCT03332667|449808929|FG003|Overall Study|Adverse Event|1|||
125051416|NCT03332667|449808926|FG000|Overall Study|Withdrawal by Subject|2|||
125051417|NCT03332667|449808927|FG001|Overall Study|Withdrawal by Subject|1|||
125051418|NCT03332667|449808928|FG002|Overall Study|Withdrawal by Subject|5|||
125051419|NCT03332667|449808929|FG003|Overall Study|Withdrawal by Subject|1|||
125051420|NCT03332667|449808926|FG000|Overall Study|Disease Progression or Relapse|2|||
125051421|NCT03332667|449808927|FG001|Overall Study|Disease Progression or Relapse|1|||
125051422|NCT03332667|449808928|FG002|Overall Study|Disease Progression or Relapse|3|||
125051423|NCT03332667|449808929|FG003|Overall Study|Disease Progression or Relapse|0|||
125051424|NCT03332667|449808926|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
125051425|NCT03332667|449808927|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
125051426|NCT03332667|449808928|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
125051427|NCT03332667|449808929|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
125051428|NCT03332667|449808926|FG000|Overall Study|No Treatment Received|0|||
125051429|NCT03332667|449808927|FG001|Overall Study|No Treatment Received|0|||
125051430|NCT03332667|449808928|FG002|Overall Study|No Treatment Received|1|||
125051431|NCT03332667|449808929|FG003|Overall Study|No Treatment Received|0|||
125051432|NCT01035606|449808930|FG000|Overall Study|change in health, job demands,family|3|||
125051433|NCT01035606|449808931|FG001|Overall Study|change in health, job demands,family|3|||
125051434|NCT01035606|449808932|FG002|Overall Study|change in health, job demands,family|4|||
125051435|NCT01809262|449808933|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
125051436|NCT01809262|449808934|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
125051437|NCT01809262|449808935|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
125051438|NCT01809262|449808936|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
125051439|NCT01809262|449808937|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
125051440|NCT01809262|449808938|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
125051441|NCT01809262|449808939|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
125051442|NCT01809262|449808940|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
125051443|NCT01809262|449808941|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
125051444|NCT01809262|449808942|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
125051445|NCT01809262|449808933|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
125051446|NCT01809262|449808934|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
125051447|NCT01809262|449808935|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
125051448|NCT01809262|449808936|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
125051449|NCT01809262|449808937|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
125051450|NCT01809262|449808938|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
125051451|NCT01809262|449808939|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
125051452|NCT01809262|449808940|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
125051453|NCT01809262|449808941|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
125051454|NCT01809262|449808942|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
125051455|NCT02064439|449808944|FG000|Overall Study|Adverse Event|51|||
125051456|NCT02064439|449808945|FG001|Overall Study|Adverse Event|47|||
125051457|NCT02064439|449808946|FG002|Overall Study|Adverse Event|46|||
125051458|NCT02064439|449808944|FG000|Overall Study|Death|0|||
125051459|NCT02064439|449808945|FG001|Overall Study|Death|2|||
125051460|NCT02064439|449808946|FG002|Overall Study|Death|3|||
125051461|NCT02064439|449808944|FG000|Overall Study|Withdrawal by Subject|29|||
125051462|NCT02064439|449808945|FG001|Overall Study|Withdrawal by Subject|18|||
125051463|NCT02064439|449808946|FG002|Overall Study|Withdrawal by Subject|26|||
125051464|NCT02064439|449808944|FG000|Overall Study|Protocol Violation|3|||
125051465|NCT02064439|449808945|FG001|Overall Study|Protocol Violation|5|||
125051466|NCT02064439|449808946|FG002|Overall Study|Protocol Violation|3|||
125051467|NCT02064439|449808944|FG000|Overall Study|Lost to Follow-up|1|||
125051468|NCT02064439|449808945|FG001|Overall Study|Lost to Follow-up|3|||
125051469|NCT02064439|449808946|FG002|Overall Study|Lost to Follow-up|4|||
125051470|NCT02064439|449808944|FG000|Overall Study|Non-compliance with study medication|21|||
125051471|NCT02064439|449808945|FG001|Overall Study|Non-compliance with study medication|19|||
125051472|NCT02064439|449808946|FG002|Overall Study|Non-compliance with study medication|23|||
125051473|NCT02064439|449808944|FG000|Overall Study|Physician Decision|0|||
125051474|NCT02064439|449808945|FG001|Overall Study|Physician Decision|1|||
125051475|NCT02064439|449808946|FG002|Overall Study|Physician Decision|1|||
125051476|NCT02064439|449808944|FG000|Overall Study|Logistical difficulties|6|||
125051477|NCT02064439|449808945|FG001|Overall Study|Logistical difficulties|5|||
125051478|NCT02064439|449808946|FG002|Overall Study|Logistical difficulties|2|||
125051479|NCT02064439|449808944|FG000|Overall Study|Efficacy outcome reached|18|||
125051480|NCT02064439|449808945|FG001|Overall Study|Efficacy outcome reached|16|||
125051481|NCT02064439|449808946|FG002|Overall Study|Efficacy outcome reached|57|||
125051482|NCT02064439|449808944|FG000|Overall Study|Safety outcome reached|12|||
125051483|NCT02064439|449808945|FG001|Overall Study|Safety outcome reached|20|||
125051484|NCT02064439|449808946|FG002|Overall Study|Safety outcome reached|10|||
125051485|NCT02064439|449808944|FG000|Overall Study|Other|2|||
125051486|NCT02064439|449808945|FG001|Overall Study|Other|2|||
125051487|NCT02064439|449808946|FG002|Overall Study|Other|7|||
125051488|NCT01120093|449808951|FG000|Treatment Period 1|Adverse Event|0|||
125051489|NCT01120093|449808952|FG001|Treatment Period 1|Adverse Event|0|||
125051490|NCT01120093|449808953|FG002|Treatment Period 1|Adverse Event|1|||
125051491|NCT01120093|449808954|FG003|Treatment Period 1|Adverse Event|0|||
125051492|NCT01120093|449808955|FG004|Treatment Period 1|Adverse Event|1|||
125051493|NCT01120093|449808951|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125051494|NCT01120093|449808952|FG001|Treatment Period 1|Withdrawal by Subject|1|||
125051495|NCT01120093|449808953|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125051496|NCT01120093|449808954|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125051497|NCT01120093|449808955|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125051498|NCT01120093|449808951|FG000|Treatment Period 2|Adverse Event|0|||
125051499|NCT01120093|449808952|FG001|Treatment Period 2|Adverse Event|0|||
125051500|NCT01120093|449808953|FG002|Treatment Period 2|Adverse Event|0|||
125051501|NCT01120093|449808954|FG003|Treatment Period 2|Adverse Event|1|||
125051502|NCT01120093|449808955|FG004|Treatment Period 2|Adverse Event|0|||
125051503|NCT01120093|449808951|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125051504|NCT01120093|449808952|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125051505|NCT01120093|449808953|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125051506|NCT01120093|449808954|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125051507|NCT01120093|449808955|FG004|Treatment Period 2|Withdrawal by Subject|1|||
125051508|NCT01120093|449808951|FG000|Treatment Period 3|Lack of Efficacy|0|||
125051509|NCT01120093|449808952|FG001|Treatment Period 3|Lack of Efficacy|0|||
125051510|NCT01120093|449808953|FG002|Treatment Period 3|Lack of Efficacy|0|||
125051511|NCT01120093|449808954|FG003|Treatment Period 3|Lack of Efficacy|1|||
125051512|NCT01120093|449808955|FG004|Treatment Period 3|Lack of Efficacy|0|||
125051513|NCT01120093|449808951|FG000|Treatment Period 3|Adverse Event|0|||
125051514|NCT01120093|449808952|FG001|Treatment Period 3|Adverse Event|0|||
125051515|NCT01120093|449808953|FG002|Treatment Period 3|Adverse Event|0|||
125051516|NCT01120093|449808954|FG003|Treatment Period 3|Adverse Event|0|||
125051517|NCT01120093|449808955|FG004|Treatment Period 3|Adverse Event|1|||
125051518|NCT01120093|449808951|FG000|Treatment Period 3|Withdrawal by Subject|0|||
125051519|NCT01120093|449808952|FG001|Treatment Period 3|Withdrawal by Subject|0|||
125051520|NCT01120093|449808953|FG002|Treatment Period 3|Withdrawal by Subject|1|||
125051521|NCT01120093|449808954|FG003|Treatment Period 3|Withdrawal by Subject|0|||
125051522|NCT01120093|449808955|FG004|Treatment Period 3|Withdrawal by Subject|0|||
125051523|NCT01120093|449808951|FG000|Treatment Period 4|Adverse Event|1|||
125051524|NCT01120093|449808952|FG001|Treatment Period 4|Adverse Event|0|||
125051525|NCT01120093|449808953|FG002|Treatment Period 4|Adverse Event|0|||
125051526|NCT01120093|449808954|FG003|Treatment Period 4|Adverse Event|0|||
125051527|NCT01120093|449808955|FG004|Treatment Period 4|Adverse Event|0|||
125051528|NCT01120093|449808951|FG000|Treatment Period 5|Adverse Event|0|||
125051529|NCT01120093|449808952|FG001|Treatment Period 5|Adverse Event|1|||
125051530|NCT01120093|449808953|FG002|Treatment Period 5|Adverse Event|0|||
125051531|NCT01120093|449808954|FG003|Treatment Period 5|Adverse Event|1|||
125051532|NCT01120093|449808955|FG004|Treatment Period 5|Adverse Event|0|||
125051533|NCT02389816|449808960|FG000|Overall Study|Randomized but Not Treated|1|||
125051534|NCT02389816|449808961|FG001|Overall Study|Randomized but Not Treated|0|||
125051535|NCT02389816|449808962|FG002|Overall Study|Randomized but Not Treated|0|||
125051536|NCT02389816|449808960|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
125051537|NCT02389816|449808961|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
125051538|NCT02389816|449808962|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
125051539|NCT02389816|449808960|FG000|Overall Study|Major Protocol Deviation|1|||
125051540|NCT02389816|449808961|FG001|Overall Study|Major Protocol Deviation|0|||
125051541|NCT02389816|449808962|FG002|Overall Study|Major Protocol Deviation|0|||
125051542|NCT02389816|449808960|FG000|Overall Study|Lost to Follow-up|1|||
125051543|NCT02389816|449808961|FG001|Overall Study|Lost to Follow-up|0|||
125051544|NCT02389816|449808962|FG002|Overall Study|Lost to Follow-up|0|||
125051545|NCT02389816|449808960|FG000|Overall Study|Withdrawal of Consent|6|||
125051546|NCT02389816|449808961|FG001|Overall Study|Withdrawal of Consent|4|||
125051547|NCT02389816|449808962|FG002|Overall Study|Withdrawal of Consent|4|||
125051548|NCT02389816|449808960|FG000|Overall Study|Lack of Efficacy|1|||
125051549|NCT02389816|449808961|FG001|Overall Study|Lack of Efficacy|0|||
125051550|NCT02389816|449808962|FG002|Overall Study|Lack of Efficacy|0|||
125051551|NCT02389816|449808960|FG000|Overall Study|Non Compliance with Study Drug|1|||
125051552|NCT02389816|449808961|FG001|Overall Study|Non Compliance with Study Drug|1|||
125051553|NCT02389816|449808962|FG002|Overall Study|Non Compliance with Study Drug|1|||
125051554|NCT02389816|449808960|FG000|Overall Study|Reason not Specified|0|||
125051555|NCT02389816|449808961|FG001|Overall Study|Reason not Specified|2|||
125051556|NCT02389816|449808962|FG002|Overall Study|Reason not Specified|0|||
125051557|NCT02417233|449808963|FG000|Overall Study|Death|4|||
125051558|NCT02417233|449808964|FG001|Overall Study|Death|10|||
125051559|NCT02417233|449808965|FG002|Overall Study|Death|14|||
125051560|NCT02417233|449808963|FG000|Overall Study|Lost to Follow-up|27|||
125051561|NCT02417233|449808964|FG001|Overall Study|Lost to Follow-up|39|||
125051562|NCT02417233|449808965|FG002|Overall Study|Lost to Follow-up|34|||
125051563|NCT02417233|449808963|FG000|Overall Study|Protocol Violation|2|||
125051564|NCT02417233|449808964|FG001|Overall Study|Protocol Violation|0|||
125051565|NCT02417233|449808965|FG002|Overall Study|Protocol Violation|2|||
125051566|NCT02417233|449808963|FG000|Overall Study|Withdrawal by Subject|2|||
125051567|NCT02417233|449808964|FG001|Overall Study|Withdrawal by Subject|1|||
125051568|NCT02417233|449808965|FG002|Overall Study|Withdrawal by Subject|8|||
125051569|NCT02417233|449808963|FG000|Overall Study|Relocation out of study area|1|||
125051570|NCT02417233|449808964|FG001|Overall Study|Relocation out of study area|0|||
125051571|NCT02417233|449808965|FG002|Overall Study|Relocation out of study area|1|||
125051572|NCT02417233|449808963|FG000|Overall Study|Mentally unstable|0|||
125051573|NCT02417233|449808964|FG001|Overall Study|Mentally unstable|1|||
125051574|NCT02417233|449808965|FG002|Overall Study|Mentally unstable|0|||
125051575|NCT03649321|449808966|FG000|Overall Study|Withdrawal by Subject|1|||
125051576|NCT03649321|449808967|FG001|Overall Study|Withdrawal by Subject|0|||
125051577|NCT03649321|449808966|FG000|Overall Study|Death|1|||
125051578|NCT03649321|449808967|FG001|Overall Study|Death|0|||
125051579|NCT01702363|449808968|FG000|Overall Study|Adverse Event|14|||
125051580|NCT01702363|449808968|FG000|Overall Study|Lack of Efficacy|4|||
125051581|NCT01702363|449808968|FG000|Overall Study|Withdrawal by Subject|2|||
125051582|NCT01293032|449808969|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
125051583|NCT01293032|449808970|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
125051584|NCT01293032|449808971|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
125051585|NCT01293032|449808972|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
125051586|NCT01293032|449808969|FG000|Treatment|Adverse Event|0|||
125051587|NCT01293032|449808970|FG001|Treatment|Adverse Event|0|||
125051588|NCT01293032|449808971|FG002|Treatment|Adverse Event|1|||
125051589|NCT01293032|449808972|FG003|Treatment|Adverse Event|1|||
125051590|NCT01293032|449808969|FG000|Treatment|Withdrawal by Subject|2|||
125051591|NCT01293032|449808970|FG001|Treatment|Withdrawal by Subject|4|||
125051592|NCT01293032|449808971|FG002|Treatment|Withdrawal by Subject|0|||
125051593|NCT01293032|449808972|FG003|Treatment|Withdrawal by Subject|0|||
125051594|NCT01293032|449808969|FG000|Treatment|Disease Progression, relapse|0|||
125051595|NCT01293032|449808970|FG001|Treatment|Disease Progression, relapse|1|||
125051596|NCT01293032|449808971|FG002|Treatment|Disease Progression, relapse|0|||
125051597|NCT01293032|449808972|FG003|Treatment|Disease Progression, relapse|0|||
125051598|NCT02184143|449808979|FG000|Overall Study|Withdrawal by Subject|4|||
125051599|NCT02184143|449808980|FG001|Overall Study|Withdrawal by Subject|4|||
125051600|NCT02184143|449808979|FG000|Overall Study|Lost to Follow-up|5|||
125051601|NCT02184143|449808980|FG001|Overall Study|Lost to Follow-up|3|||
125051602|NCT02184143|449808979|FG000|Overall Study|Death|1|||
125051603|NCT02184143|449808980|FG001|Overall Study|Death|0|||
125051604|NCT00321984|449808981|FG000|Overall Study|Adverse Event|9|||
125051605|NCT00321984|449808982|FG001|Overall Study|Adverse Event|6|||
125051606|NCT00321984|449808983|FG002|Overall Study|Adverse Event|8|||
125051607|NCT00321984|449808981|FG000|Overall Study|Protocol Violation|0|||
125051608|NCT00321984|449808982|FG001|Overall Study|Protocol Violation|1|||
125051609|NCT00321984|449808983|FG002|Overall Study|Protocol Violation|1|||
125051610|NCT00321984|449808981|FG000|Overall Study|Lost to Follow-up|2|||
125051611|NCT00321984|449808982|FG001|Overall Study|Lost to Follow-up|4|||
125051612|NCT00321984|449808983|FG002|Overall Study|Lost to Follow-up|2|||
125051613|NCT00321984|449808981|FG000|Overall Study|Withdrawal by Subject|8|||
125051614|NCT00321984|449808982|FG001|Overall Study|Withdrawal by Subject|6|||
125051615|NCT00321984|449808983|FG002|Overall Study|Withdrawal by Subject|5|||
125051616|NCT00321984|449808981|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
125051617|NCT00321984|449808982|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
125051618|NCT00321984|449808983|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
125051619|NCT00321984|449808981|FG000|Overall Study|Lack of Efficacy|3|||
125051620|NCT00321984|449808982|FG001|Overall Study|Lack of Efficacy|1|||
125051621|NCT00321984|449808983|FG002|Overall Study|Lack of Efficacy|3|||
125051622|NCT00321984|449808981|FG000|Overall Study|Noncompliant|0|||
125051623|NCT00321984|449808982|FG001|Overall Study|Noncompliant|0|||
125051624|NCT00321984|449808983|FG002|Overall Study|Noncompliant|2|||
125051625|NCT00321984|449808981|FG000|Overall Study|Pregnancy|0|||
125051626|NCT00321984|449808982|FG001|Overall Study|Pregnancy|1|||
125051627|NCT00321984|449808983|FG002|Overall Study|Pregnancy|0|||
125051628|NCT00321984|449808981|FG000|Overall Study|Per Subject Request|1|||
125051629|NCT00321984|449808982|FG001|Overall Study|Per Subject Request|0|||
125051630|NCT00321984|449808983|FG002|Overall Study|Per Subject Request|0|||
125051631|NCT00321984|449808981|FG000|Overall Study|Per Investigator Request|1|||
125051632|NCT00321984|449808982|FG001|Overall Study|Per Investigator Request|0|||
125051633|NCT00321984|449808983|FG002|Overall Study|Per Investigator Request|0|||
125051634|NCT00321984|449808981|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
125051635|NCT00321984|449808982|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
125051636|NCT00321984|449808983|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
125219818|NCT01189461|450431283|FG000|Overall Study|Lost to Follow-up|1|||
125051637|NCT02985450|449808990|FG000|Overall Study|Lost to Follow-up|7|||
125051638|NCT00431847|449808993|FG000|Overall Study|completion of less than two study visits|6|||
125051639|NCT00431847|449808994|FG001|Overall Study|completion of less than two study visits|3|||
125051640|NCT00431847|449808995|FG002|Overall Study|completion of less than two study visits|4|||
125051641|NCT00431847|449808996|FG003|Overall Study|completion of less than two study visits|14|||
125051642|NCT00431847|449808997|FG004|Overall Study|completion of less than two study visits|0|||
125051643|NCT00431847|449808993|FG000|Overall Study|Protocol Violation|0|||
125051644|NCT00431847|449808994|FG001|Overall Study|Protocol Violation|0|||
125051645|NCT00431847|449808995|FG002|Overall Study|Protocol Violation|0|||
125051646|NCT00431847|449808996|FG003|Overall Study|Protocol Violation|0|||
125051647|NCT00431847|449808997|FG004|Overall Study|Protocol Violation|1|||
125051648|NCT01469013|449808998|FG000|Part A (Treatment Period)|Adverse Event|1|||
125051649|NCT01469013|449808999|FG001|Part A (Treatment Period)|Adverse Event|0|||
125051650|NCT01469013|449809000|FG002|Part A (Treatment Period)|Adverse Event|0|||
125051651|NCT01469013|449809001|FG003|Part A (Treatment Period)|Adverse Event|0|||
125051652|NCT01469013|449809002|FG004|Part A (Treatment Period)|Adverse Event|1|||
125051653|NCT01469013|449809003|FG005|Part A (Treatment Period)|Adverse Event|0|||
125051654|NCT01469013|449809004|FG006|Part A (Treatment Period)|Adverse Event|0|||
125051655|NCT01469013|449809005|FG007|Part A (Treatment Period)|Adverse Event|0|||
125051656|NCT01469013|449809006|FG008|Part A (Treatment Period)|Adverse Event|0|||
125051657|NCT01469013|449809007|FG009|Part A (Treatment Period)|Adverse Event|0|||
125051658|NCT01469013|449809008|FG010|Part A (Treatment Period)|Adverse Event|0|||
125051659|NCT01469013|449809009|FG011|Part A (Treatment Period)|Adverse Event|0|||
125051660|NCT01469013|449809010|FG012|Part A (Treatment Period)|Adverse Event|0|||
125051661|NCT01469013|449808998|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
125051662|NCT01469013|449808999|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
125051663|NCT01469013|449809000|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
125051664|NCT01469013|449809001|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
125051665|NCT01469013|449809002|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
125051666|NCT01469013|449809003|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
125051667|NCT01469013|449809004|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
125051668|NCT01469013|449809005|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
125051669|NCT01469013|449809006|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
125051670|NCT01469013|449809007|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
125051671|NCT01469013|449809008|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
125051672|NCT01469013|449809009|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
125051673|NCT01469013|449809010|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
125051674|NCT01469013|449808998|FG000|Part B (Extension Period)|Adverse Event|0|||
125051675|NCT01469013|449808999|FG001|Part B (Extension Period)|Adverse Event|0|||
125051676|NCT01469013|449809000|FG002|Part B (Extension Period)|Adverse Event|0|||
125051677|NCT01469013|449809001|FG003|Part B (Extension Period)|Adverse Event|0|||
125051678|NCT01469013|449809002|FG004|Part B (Extension Period)|Adverse Event|0|||
125051679|NCT01469013|449809003|FG005|Part B (Extension Period)|Adverse Event|2|||
125051680|NCT01469013|449809004|FG006|Part B (Extension Period)|Adverse Event|5|||
125051681|NCT01469013|449809005|FG007|Part B (Extension Period)|Adverse Event|5|||
125051682|NCT01469013|449809006|FG008|Part B (Extension Period)|Adverse Event|3|||
125051683|NCT01469013|449809007|FG009|Part B (Extension Period)|Adverse Event|3|||
125051684|NCT01469013|449809008|FG010|Part B (Extension Period)|Adverse Event|1|||
125051685|NCT01469013|449809009|FG011|Part B (Extension Period)|Adverse Event|6|||
125051686|NCT01469013|449809010|FG012|Part B (Extension Period)|Adverse Event|3|||
125051687|NCT01469013|449808998|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
125051688|NCT01469013|449808999|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
125219819|NCT01189461|450431283|FG000|Overall Study|Withdrawal by Subject|6|||
125219820|NCT01189461|450431283|FG000|Overall Study|Protocol Violation|1|||
125051689|NCT01469013|449809000|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
125051690|NCT01469013|449809001|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
125051691|NCT01469013|449809002|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
125219821|NCT01189461|450431283|FG000|Overall Study|Adverse Event|2|||
125219822|NCT01189461|450431283|FG000|Overall Study|Did not meet entrance criteria|3|||
125219823|NCT01189461|450431283|FG000|Overall Study|Other|8|||
125219824|NCT02716584|450431284|FG000|Overall Study|Lost to Follow-up|8|||
125219825|NCT02716584|450431285|FG001|Overall Study|Lost to Follow-up|5|||
125219826|NCT05259163|450432637|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
125219827|NCT05259163|450432638|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
125219828|NCT01381926|450432640|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
125219829|NCT01381926|450432641|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
125219830|NCT01381926|450432640|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
125219831|NCT01381926|450432641|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
125219832|NCT02100839|450432645|FG000|Multiple Ascending Dose|Adverse Event|2|||
125051692|NCT01469013|449809003|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
125051693|NCT01469013|449809004|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
125051694|NCT01469013|449809005|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
125051695|NCT01469013|449809006|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
125051696|NCT01469013|449809007|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
125051697|NCT01469013|449809008|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
125051698|NCT01469013|449809009|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
125051699|NCT01469013|449809010|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
125219833|NCT02100839|450432646|FG001|Multiple Ascending Dose|Adverse Event|0|||
125219834|NCT02100839|450432645|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
125051700|NCT00002663|449809011|FG000|Overall Study|Death|4|||
125051701|NCT00002663|449809012|FG001|Overall Study|Death|1|||
125051702|NCT00002663|449809013|FG002|Overall Study|Death|1|||
125219835|NCT02100839|450432646|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
125219836|NCT00703677|450432648|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
125219837|NCT00940888|450432649|FG000|Overall Study|Unsuccessful Implant|4|||
125219838|NCT00940888|450432649|FG000|Overall Study|Death|461|||
125219839|NCT00940888|450432649|FG000|Overall Study|Withdrawn - Non-Death|364|||
125219840|NCT00940888|450432649|FG000|Overall Study|Lost to Follow-up|6|||
125219841|NCT04441788|450432650|FG000|Overall Study|Voluntary Withdrawl|0|||
125219842|NCT04441788|450432651|FG001|Overall Study|Voluntary Withdrawl|1|||
125219843|NCT04441788|450432652|FG002|Overall Study|Voluntary Withdrawl|0|||
125219844|NCT04441788|450432650|FG000|Overall Study|Ineligibility|1|||
125219845|NCT04441788|450432651|FG001|Overall Study|Ineligibility|0|||
125219846|NCT04441788|450432652|FG002|Overall Study|Ineligibility|0|||
125219847|NCT04441788|450432650|FG000|Overall Study|Adverse Event|0|||
125219848|NCT04441788|450432651|FG001|Overall Study|Adverse Event|0|||
125219849|NCT04441788|450432652|FG002|Overall Study|Adverse Event|4|||
125219850|NCT04441788|450432650|FG000|Overall Study|Study Terminated by Sponsor|16|||
125219851|NCT04441788|450432651|FG001|Overall Study|Study Terminated by Sponsor|16|||
125219852|NCT04441788|450432652|FG002|Overall Study|Study Terminated by Sponsor|12|||
125219853|NCT03859648|450432657|FG000|Overall Study|Lost to Follow-up|1|||
125219854|NCT03859648|450432657|FG000|Overall Study|Adverse Event|1|||
125219855|NCT01971567|450432661|FG000|Overall Study|Withdrawal by Subject|3|||
125219856|NCT01971567|450432662|FG001|Overall Study|Withdrawal by Subject|2|||
125219857|NCT01971567|450432661|FG000|Overall Study|Lost to Follow-up|1|||
125219858|NCT01971567|450432662|FG001|Overall Study|Lost to Follow-up|0|||
125219859|NCT01409915|450432663|FG000|Overall Study|Adverse Event|0|||
125219860|NCT01409915|450432664|FG001|Overall Study|Adverse Event|2|||
125219861|NCT01409915|450432663|FG000|Overall Study|Withdrawal by Subject|0|||
125219862|NCT01409915|450432664|FG001|Overall Study|Withdrawal by Subject|1|||
125219863|NCT01409915|450432663|FG000|Overall Study|Protocol Violation|1|||
125219864|NCT01409915|450432664|FG001|Overall Study|Protocol Violation|0|||
125219865|NCT04826484|450432665|FG000|Overall Study|Lost to Follow-up|2|||
125219866|NCT04826484|450432666|FG001|Overall Study|Lost to Follow-up|0|||
125219867|NCT02250300|450432668|FG000|Expansion Phase|Death|6|||
125219868|NCT02250300|450432669|FG001|Expansion Phase|Death|7|||
125219869|NCT02250300|450432670|FG002|Expansion Phase|Death|0|||
125219870|NCT02250300|450432671|FG003|Expansion Phase|Death|0|||
125219871|NCT00758498|450432675|FG000|Overall Study|Adverse Event|2|||
125051703|NCT00002663|449809014|FG003|Overall Study|Death|0|||
125051704|NCT00002663|449809015|FG004|Overall Study|Death|0|||
125051705|NCT00002663|449809016|FG005|Overall Study|Death|13|||
125051706|NCT00002663|449809017|FG006|Overall Study|Death|0|||
125051707|NCT00002663|449809018|FG007|Overall Study|Death|1|||
125051708|NCT00002663|449809019|FG008|Overall Study|Death|1|||
125051709|NCT00002663|449809020|FG009|Overall Study|Death|1|||
125051710|NCT00002663|449809011|FG000|Overall Study|Lost to Follow-up|3|||
125051711|NCT00002663|449809012|FG001|Overall Study|Lost to Follow-up|0|||
125051712|NCT00002663|449809013|FG002|Overall Study|Lost to Follow-up|0|||
125051713|NCT00002663|449809014|FG003|Overall Study|Lost to Follow-up|1|||
125219872|NCT00758498|450432676|FG001|Overall Study|Adverse Event|2|||
125219873|NCT00758498|450432677|FG002|Overall Study|Adverse Event|3|||
125219874|NCT00758498|450432675|FG000|Overall Study|Subject legally detained out of state|1|||
125219875|NCT00758498|450432676|FG001|Overall Study|Subject legally detained out of state|0|||
125219876|NCT00758498|450432677|FG002|Overall Study|Subject legally detained out of state|0|||
125051714|NCT00002663|449809015|FG004|Overall Study|Lost to Follow-up|0|||
125051715|NCT00002663|449809016|FG005|Overall Study|Lost to Follow-up|1|||
125051716|NCT00002663|449809017|FG006|Overall Study|Lost to Follow-up|0|||
125219877|NCT00758498|450432675|FG000|Overall Study|Withdrawal by Subject|0|||
125219878|NCT00758498|450432676|FG001|Overall Study|Withdrawal by Subject|0|||
125219879|NCT00758498|450432677|FG002|Overall Study|Withdrawal by Subject|1|||
125219880|NCT00758498|450432675|FG000|Overall Study|Noncompliance to study procedures|0|||
125219881|NCT00758498|450432676|FG001|Overall Study|Noncompliance to study procedures|0|||
125051717|NCT00002663|449809018|FG007|Overall Study|Lost to Follow-up|0|||
125051718|NCT00002663|449809019|FG008|Overall Study|Lost to Follow-up|0|||
125051719|NCT00002663|449809020|FG009|Overall Study|Lost to Follow-up|0|||
125051720|NCT00002663|449809011|FG000|Overall Study|Other|0|||
125051721|NCT00002663|449809012|FG001|Overall Study|Other|1|||
125051722|NCT00002663|449809013|FG002|Overall Study|Other|0|||
125051723|NCT00002663|449809014|FG003|Overall Study|Other|0|||
125051724|NCT00002663|449809015|FG004|Overall Study|Other|0|||
125051725|NCT00002663|449809016|FG005|Overall Study|Other|1|||
125051726|NCT00002663|449809017|FG006|Overall Study|Other|1|||
125051727|NCT00002663|449809018|FG007|Overall Study|Other|0|||
125051728|NCT00002663|449809019|FG008|Overall Study|Other|0|||
125051729|NCT00002663|449809020|FG009|Overall Study|Other|0|||
125051730|NCT00002663|449809011|FG000|Overall Study|Physician Decision|0|||
125051731|NCT00002663|449809012|FG001|Overall Study|Physician Decision|0|||
125051732|NCT00002663|449809013|FG002|Overall Study|Physician Decision|0|||
125051733|NCT00002663|449809014|FG003|Overall Study|Physician Decision|0|||
125051734|NCT00002663|449809015|FG004|Overall Study|Physician Decision|1|||
125051735|NCT00002663|449809016|FG005|Overall Study|Physician Decision|0|||
125051736|NCT00002663|449809017|FG006|Overall Study|Physician Decision|0|||
125051737|NCT00002663|449809018|FG007|Overall Study|Physician Decision|0|||
125051738|NCT00002663|449809019|FG008|Overall Study|Physician Decision|1|||
125051739|NCT00002663|449809020|FG009|Overall Study|Physician Decision|1|||
125051740|NCT00002663|449809011|FG000|Overall Study|Adverse Event|0|||
125051741|NCT00002663|449809012|FG001|Overall Study|Adverse Event|0|||
125051742|NCT00002663|449809013|FG002|Overall Study|Adverse Event|0|||
125051743|NCT00002663|449809014|FG003|Overall Study|Adverse Event|1|||
125051744|NCT00002663|449809015|FG004|Overall Study|Adverse Event|0|||
125051745|NCT00002663|449809016|FG005|Overall Study|Adverse Event|0|||
125051746|NCT00002663|449809017|FG006|Overall Study|Adverse Event|0|||
125051747|NCT00002663|449809018|FG007|Overall Study|Adverse Event|1|||
125051748|NCT00002663|449809019|FG008|Overall Study|Adverse Event|0|||
125051749|NCT00002663|449809020|FG009|Overall Study|Adverse Event|0|||
125051750|NCT01603641|449809024|FG000|Overall Study|Did not Receive Treatment|3|||
125051751|NCT01603641|449809024|FG000|Overall Study|Adverse Event|1|||
125051752|NCT01603641|449809024|FG000|Overall Study|Lack of Efficacy|1|||
125051753|NCT01603641|449809024|FG000|Overall Study|Lost to Follow-up|6|||
125051754|NCT01603641|449809024|FG000|Overall Study|Personal Reasons|18|||
125051755|NCT01603641|449809024|FG000|Overall Study|Other Miscellaneous Reasons|6|||
125051756|NCT03161678|449809025|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
125051757|NCT03161678|449809026|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
125051758|NCT03161678|449809027|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
125051759|NCT03161678|449809028|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
125051760|NCT03161678|449809029|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
125051761|NCT03161678|449809030|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
125051762|NCT03161678|449809025|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
125051763|NCT03161678|449809026|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
125051764|NCT03161678|449809027|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
125051765|NCT03161678|449809028|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
125051766|NCT03161678|449809029|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
125051767|NCT03161678|449809030|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
125051768|NCT03161678|449809025|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
125051769|NCT03161678|449809026|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
125051770|NCT03161678|449809027|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
125051771|NCT03161678|449809028|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
125051772|NCT03161678|449809029|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
125051773|NCT03161678|449809030|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
125051774|NCT03161678|449809025|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
125051775|NCT03161678|449809026|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
125051776|NCT03161678|449809027|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
125051777|NCT03161678|449809028|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
125051778|NCT03161678|449809029|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
125051779|NCT03161678|449809030|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
125051780|NCT00739297|449809031|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
125051781|NCT00739297|449809032|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
125051782|NCT00739297|449809033|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
125051783|NCT00739297|449809034|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
125051784|NCT00739297|449809035|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
125051785|NCT00739297|449809036|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
125051786|NCT00739297|449809037|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
125051787|NCT00739297|449809031|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
125219882|NCT00758498|450432677|FG002|Overall Study|Noncompliance to study procedures|1|||
125219883|NCT01516736|450432678|FG000|Overall Study|Withdrawal by Subject|10|||
125219884|NCT01516736|450432679|FG001|Overall Study|Withdrawal by Subject|4|||
125219885|NCT01516736|450432678|FG000|Overall Study|Adverse Event|4|||
125219886|NCT01516736|450432679|FG001|Overall Study|Adverse Event|5|||
125219887|NCT01516736|450432678|FG000|Overall Study|Death|3|||
125219888|NCT01516736|450432679|FG001|Overall Study|Death|1|||
125219889|NCT01516736|450432678|FG000|Overall Study|Physician Decision|2|||
125051788|NCT00739297|449809032|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
125051789|NCT00739297|449809033|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
125051790|NCT00739297|449809034|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
125051791|NCT00739297|449809035|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
125051792|NCT00739297|449809036|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
125051793|NCT00739297|449809037|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
125051794|NCT02749721|449809043|FG000|Screening|Withdrawal by Subject|1|||
125051795|NCT02749721|449809043|FG000|Screening|Lost to Follow-up|2|||
125051796|NCT02749721|449809043|FG000|Screening|Protocol Violation|3|||
125051797|NCT02749721|449809043|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
125051798|NCT02749721|449809043|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
125051799|NCT02137772|449809044|FG000|Overall Study|Adverse Event|6|||
125051800|NCT02137772|449809045|FG001|Overall Study|Adverse Event|3|||
125051801|NCT02137772|449809044|FG000|Overall Study|Death|71|||
125051802|NCT02137772|449809045|FG001|Overall Study|Death|44|||
125051803|NCT02137772|449809044|FG000|Overall Study|Lost to Follow-up|8|||
125051804|NCT02137772|449809045|FG001|Overall Study|Lost to Follow-up|4|||
125051805|NCT02137772|449809044|FG000|Overall Study|Physician Decision|15|||
125051806|NCT02137772|449809045|FG001|Overall Study|Physician Decision|5|||
125051807|NCT02137772|449809044|FG000|Overall Study|Withdrawal by Subject|28|||
125051808|NCT02137772|449809045|FG001|Overall Study|Withdrawal by Subject|17|||
125051809|NCT02137772|449809044|FG000|Overall Study|Non-compliance with study drug|1|||
125051810|NCT02137772|449809045|FG001|Overall Study|Non-compliance with study drug|0|||
125051811|NCT02137772|449809044|FG000|Overall Study|Not treated|3|||
125051812|NCT02137772|449809045|FG001|Overall Study|Not treated|2|||
125051813|NCT00443430|449809047|FG000|Overall Study|Lack of Efficacy|3|||
125051814|NCT00443430|449809048|FG001|Overall Study|Lack of Efficacy|3|||
125051815|NCT00443430|449809047|FG000|Overall Study|Adverse Event|1|||
125051816|NCT00443430|449809048|FG001|Overall Study|Adverse Event|1|||
125051817|NCT00933335|449809052|FG000|Overall Study|Lost to Follow-up|1|||
125051818|NCT00933335|449809053|FG001|Overall Study|Lost to Follow-up|3|||
125051819|NCT00933335|449809052|FG000|Overall Study|Withdrawal by Subject|0|||
125219890|NCT01516736|450432679|FG001|Overall Study|Physician Decision|1|||
125219891|NCT01516736|450432678|FG000|Overall Study|Lack of Efficacy|1|||
125219892|NCT01516736|450432679|FG001|Overall Study|Lack of Efficacy|0|||
125051820|NCT00933335|449809053|FG001|Overall Study|Withdrawal by Subject|1|||
125051821|NCT00933335|449809052|FG000|Overall Study|Progressive Disease|0|||
125051822|NCT00933335|449809053|FG001|Overall Study|Progressive Disease|11|||
125051823|NCT00933335|449809052|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
125051824|NCT00933335|449809053|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
125051825|NCT00933335|449809052|FG000|Overall Study|Co-morbid Illness|1|||
125051826|NCT00933335|449809053|FG001|Overall Study|Co-morbid Illness|0|||
125051827|NCT02084134|449809058|FG000|Overall Study|Protocol Violation|4|||
125051828|NCT02084134|449809059|FG001|Overall Study|Protocol Violation|2|||
125051829|NCT02084134|449809058|FG000|Overall Study|Death|0|||
125051830|NCT02084134|449809059|FG001|Overall Study|Death|1|||
125051831|NCT01095250|449809065|FG000|Overall Study|administrative reasons|8|||
125051832|NCT01095250|449809066|FG001|Overall Study|administrative reasons|10|||
125051833|NCT01095250|449809067|FG002|Overall Study|administrative reasons|7|||
125051834|NCT01095250|449809068|FG003|Overall Study|administrative reasons|5|||
125051835|NCT01095250|449809065|FG000|Overall Study|Withdrawal by Subject|0|||
125051836|NCT01095250|449809066|FG001|Overall Study|Withdrawal by Subject|0|||
125051837|NCT01095250|449809067|FG002|Overall Study|Withdrawal by Subject|1|||
125051838|NCT01095250|449809068|FG003|Overall Study|Withdrawal by Subject|0|||
125051839|NCT01323673|449809069|FG000|Overall Study|Adverse Event|0|||
125051840|NCT01323673|449809070|FG001|Overall Study|Adverse Event|1|||
125051841|NCT01323673|449809069|FG000|Overall Study|Lost to Follow-up|0|||
125051842|NCT01323673|449809070|FG001|Overall Study|Lost to Follow-up|1|||
125051843|NCT01323673|449809069|FG000|Overall Study|Protocol Violation|1|||
125051844|NCT01323673|449809070|FG001|Overall Study|Protocol Violation|0|||
125051845|NCT01323673|449809069|FG000|Overall Study|Withdrawal by Subject|2|||
125051846|NCT01323673|449809070|FG001|Overall Study|Withdrawal by Subject|3|||
125051847|NCT04598165|449809072|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
125051848|NCT04598165|449809073|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
125219893|NCT01516736|450432678|FG000|Overall Study|Protocol Violation|0|||
125219894|NCT01516736|450432679|FG001|Overall Study|Protocol Violation|1|||
125219895|NCT01516736|450432678|FG000|Overall Study|Other (not specified)|0|||
125219896|NCT01516736|450432679|FG001|Overall Study|Other (not specified)|1|||
125051849|NCT04598165|449809072|FG000|Completed 6-week Follow-up|Death|2|||
125051850|NCT04598165|449809073|FG001|Completed 6-week Follow-up|Death|1|||
125051851|NCT04598165|449809072|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
125051852|NCT04598165|449809073|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
125051853|NCT04598165|449809072|FG000|Completed 6-week Follow-up|Ineligible|4|||
125051854|NCT04598165|449809073|FG001|Completed 6-week Follow-up|Ineligible|3|||
125051855|NCT04598165|449809072|FG000|Completed 6-week Follow-up|Partner refusal|0|||
125051856|NCT04598165|449809073|FG001|Completed 6-week Follow-up|Partner refusal|1|||
125051857|NCT04598165|449809072|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
125051858|NCT04598165|449809073|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
125051859|NCT00426751|449809074|FG000|Overall Study|Adverse Event|8|||
125051860|NCT00426751|449809075|FG001|Overall Study|Adverse Event|1|||
125051861|NCT00426751|449809074|FG000|Overall Study|Lost to Follow-up|7|||
125051862|NCT00426751|449809075|FG001|Overall Study|Lost to Follow-up|6|||
125051863|NCT00426751|449809074|FG000|Overall Study|Consent Withdrawn|0|||
125051864|NCT00426751|449809075|FG001|Overall Study|Consent Withdrawn|1|||
125051865|NCT00426751|449809074|FG000|Overall Study|Other Reasons|7|||
125051866|NCT00426751|449809075|FG001|Overall Study|Other Reasons|12|||
125051867|NCT02504892|449809077|FG000|Overall Study|Adverse event-pneumonitis|2|||
125051868|NCT04229446|449809078|FG000|Overall Study|Death|12|||
125051869|NCT04229446|449809079|FG001|Overall Study|Death|10|||
125051870|NCT04229446|449809078|FG000|Overall Study|Lost to Follow-up|5|||
125051871|NCT04229446|449809079|FG001|Overall Study|Lost to Follow-up|8|||
125051872|NCT00747617|449810382|FG000|Overall Study|Lost to Follow-up|3|||
125051873|NCT00747617|449810383|FG001|Overall Study|Lost to Follow-up|1|||
125051874|NCT02279524|449810384|FG000|Overall Study|Withdrawal by Subject|3|||
125051875|NCT02279524|449810385|FG001|Overall Study|Withdrawal by Subject|6|||
125051876|NCT02279524|449810386|FG002|Overall Study|Withdrawal by Subject|3|||
125051877|NCT02279524|449810384|FG000|Overall Study|Adverse Event|4|||
125051878|NCT02279524|449810385|FG001|Overall Study|Adverse Event|3|||
125051879|NCT02279524|449810386|FG002|Overall Study|Adverse Event|2|||
125051880|NCT02279524|449810384|FG000|Overall Study|Lost to Follow-up|1|||
125051881|NCT02279524|449810385|FG001|Overall Study|Lost to Follow-up|1|||
125051882|NCT02279524|449810386|FG002|Overall Study|Lost to Follow-up|0|||
125051883|NCT02279524|449810384|FG000|Overall Study|Disallowed medication|1|||
125051884|NCT02279524|449810385|FG001|Overall Study|Disallowed medication|1|||
125051885|NCT02279524|449810386|FG002|Overall Study|Disallowed medication|2|||
125051886|NCT02279524|449810384|FG000|Overall Study|Bariatric surgery|1|||
125051887|NCT02279524|449810385|FG001|Overall Study|Bariatric surgery|0|||
125051888|NCT02279524|449810386|FG002|Overall Study|Bariatric surgery|0|||
125051889|NCT01746732|449810387|FG000|Lead-In Period|Withdrawal by Subject|1|||
125051890|NCT01746732|449810388|FG001|Lead-In Period|Withdrawal by Subject|0|||
125051891|NCT01746732|449810389|FG002|Lead-In Period|Withdrawal by Subject|0|||
125051892|NCT01746732|449810387|FG000|Period 1|Physician Decision|0|||
125051893|NCT01746732|449810388|FG001|Period 1|Physician Decision|1|||
125051894|NCT01746732|449810389|FG002|Period 1|Physician Decision|0|||
125051895|NCT01746732|449810387|FG000|Period 2|Withdrawal by Subject|0|||
125051896|NCT01746732|449810388|FG001|Period 2|Withdrawal by Subject|0|||
125051897|NCT01746732|449810389|FG002|Period 2|Withdrawal by Subject|2|||
125051898|NCT01746732|449810387|FG000|Period 2|Adverse Event|0|||
125051899|NCT01746732|449810388|FG001|Period 2|Adverse Event|0|||
125051900|NCT01746732|449810389|FG002|Period 2|Adverse Event|1|||
125051901|NCT01746732|449810387|FG000|Period 2|Lost to Follow-up|0|||
125051902|NCT01746732|449810388|FG001|Period 2|Lost to Follow-up|0|||
125051903|NCT01746732|449810389|FG002|Period 2|Lost to Follow-up|1|||
125051904|NCT03509207|449810390|FG000|Overall Study|Death|2|||
125051905|NCT02817555|449810391|FG000|Overall Study|Death|1|||
125051906|NCT02817555|449810392|FG001|Overall Study|Death|3|||
125051907|NCT02817555|449810391|FG000|Overall Study|moved away|1|||
125051908|NCT02817555|449810392|FG001|Overall Study|moved away|0|||
125051909|NCT02817555|449810391|FG000|Overall Study|transplant|1|||
125051910|NCT02817555|449810392|FG001|Overall Study|transplant|1|||
125051911|NCT02817555|449810391|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
125051912|NCT02817555|449810392|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
125051913|NCT00137436|449810393|FG000|Overall Study|Adverse Event|13|||
125051914|NCT00137436|449810393|FG000|Overall Study|Death|2|||
125051915|NCT00137436|449810393|FG000|Overall Study|Lack of Efficacy|17|||
125051916|NCT00137436|449810393|FG000|Overall Study|Withdrawal by Subject|6|||
125051917|NCT00137436|449810393|FG000|Overall Study|Other|5|||
125051918|NCT00165646|449810394|FG000|Overall Study|Adverse Event|1|||
125051919|NCT00165646|449810395|FG001|Overall Study|Adverse Event|1|||
125051920|NCT00165646|449810396|FG002|Overall Study|Adverse Event|1|||
125051921|NCT00165646|449810394|FG000|Overall Study|Lack of Efficacy|1|||
125051922|NCT00165646|449810395|FG001|Overall Study|Lack of Efficacy|2|||
125051923|NCT00165646|449810396|FG002|Overall Study|Lack of Efficacy|0|||
125051924|NCT00165646|449810394|FG000|Overall Study|Withdrawal by Subject|0|||
125051925|NCT00165646|449810395|FG001|Overall Study|Withdrawal by Subject|2|||
125051926|NCT00165646|449810396|FG002|Overall Study|Withdrawal by Subject|1|||
125051927|NCT00165646|449810394|FG000|Overall Study|Physician Decision|2|||
125051928|NCT00165646|449810395|FG001|Overall Study|Physician Decision|0|||
125051929|NCT00165646|449810396|FG002|Overall Study|Physician Decision|2|||
125051930|NCT00165646|449810394|FG000|Overall Study|Protocol Violation|1|||
125051931|NCT00165646|449810395|FG001|Overall Study|Protocol Violation|0|||
125051932|NCT00165646|449810396|FG002|Overall Study|Protocol Violation|0|||
125051933|NCT00912015|449810400|FG000|Overall Study|Lack of Efficacy|1|||
125051934|NCT00912015|449810401|FG001|Overall Study|Lack of Efficacy|0|||
125051935|NCT00912015|449810402|FG002|Overall Study|Lack of Efficacy|0|||
125051936|NCT00912015|449810403|FG003|Overall Study|Lack of Efficacy|0|||
125051937|NCT00912015|449810400|FG000|Overall Study|Withdrawal by Subject|8|||
125051938|NCT00912015|449810401|FG001|Overall Study|Withdrawal by Subject|8|||
125051939|NCT00912015|449810402|FG002|Overall Study|Withdrawal by Subject|3|||
125051940|NCT00912015|449810403|FG003|Overall Study|Withdrawal by Subject|0|||
125051941|NCT00912015|449810400|FG000|Overall Study|Protocol Violation|1|||
125051942|NCT00912015|449810401|FG001|Overall Study|Protocol Violation|0|||
125051943|NCT00912015|449810402|FG002|Overall Study|Protocol Violation|0|||
125051944|NCT00912015|449810403|FG003|Overall Study|Protocol Violation|1|||
125051945|NCT00912015|449810400|FG000|Overall Study|Adverse Event|6|||
125051946|NCT00912015|449810401|FG001|Overall Study|Adverse Event|0|||
125051947|NCT00912015|449810402|FG002|Overall Study|Adverse Event|0|||
125051948|NCT00912015|449810403|FG003|Overall Study|Adverse Event|1|||
125051949|NCT01356602|449810404|FG000|Overall Study|Protocol Deviation|0|||
125051950|NCT01356602|449810405|FG001|Overall Study|Protocol Deviation|1|||
125051951|NCT01356602|449810406|FG002|Overall Study|Protocol Deviation|1|||
125051952|NCT01356602|449810404|FG000|Overall Study|Administrative Problems|1|||
125051953|NCT01356602|449810405|FG001|Overall Study|Administrative Problems|4|||
125051954|NCT01356602|449810406|FG002|Overall Study|Administrative Problems|5|||
125051955|NCT01356602|449810404|FG000|Overall Study|Lost to Follow-up|4|||
125051956|NCT01356602|449810405|FG001|Overall Study|Lost to Follow-up|5|||
125051957|NCT01356602|449810406|FG002|Overall Study|Lost to Follow-up|6|||
125051958|NCT01356602|449810404|FG000|Overall Study|Withdrawal by Subject|4|||
125051959|NCT01356602|449810405|FG001|Overall Study|Withdrawal by Subject|3|||
125051960|NCT01356602|449810406|FG002|Overall Study|Withdrawal by Subject|7|||
125051961|NCT01356602|449810404|FG000|Overall Study|Lack of Efficacy|0|||
125051962|NCT01356602|449810405|FG001|Overall Study|Lack of Efficacy|1|||
125051963|NCT01356602|449810406|FG002|Overall Study|Lack of Efficacy|4|||
125051964|NCT01356602|449810404|FG000|Overall Study|Adverse Event|0|||
125051965|NCT01356602|449810405|FG001|Overall Study|Adverse Event|1|||
125051966|NCT01356602|449810406|FG002|Overall Study|Adverse Event|1|||
125051967|NCT01115569|449810407|FG000|Conversion/Titration Phase|Adverse Event|59|||
125051968|NCT01115569|449810408|FG001|Conversion/Titration Phase|Adverse Event|0|||
125051969|NCT01115569|449810407|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
125051970|NCT01115569|449810408|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
125051971|NCT01115569|449810407|FG000|Conversion/Titration Phase|Physician Decision|5|||
125051972|NCT01115569|449810408|FG001|Conversion/Titration Phase|Physician Decision|0|||
125051973|NCT01115569|449810407|FG000|Conversion/Titration Phase|Protocol Violation|68|||
125051974|NCT01115569|449810408|FG001|Conversion/Titration Phase|Protocol Violation|0|||
125051975|NCT01115569|449810407|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
125051976|NCT01115569|449810408|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
125051977|NCT01115569|449810407|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
125051978|NCT01115569|449810408|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
125051979|NCT01115569|449810407|FG000|Maintenance Phase|Adverse Event|0|||
125051980|NCT01115569|449810408|FG001|Maintenance Phase|Adverse Event|43|||
125051981|NCT01115569|449810407|FG000|Maintenance Phase|Lost to Follow-up|0|||
125051982|NCT01115569|449810408|FG001|Maintenance Phase|Lost to Follow-up|8|||
125051983|NCT01115569|449810407|FG000|Maintenance Phase|Physician Decision|0|||
125051984|NCT01115569|449810408|FG001|Maintenance Phase|Physician Decision|3|||
125051985|NCT01115569|449810407|FG000|Maintenance Phase|Protocol Violation|0|||
125051986|NCT01115569|449810408|FG001|Maintenance Phase|Protocol Violation|9|||
125051987|NCT01115569|449810407|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125051988|NCT01115569|449810408|FG001|Maintenance Phase|Withdrawal by Subject|27|||
125051989|NCT01115569|449810407|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
125051990|NCT01115569|449810408|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
125051991|NCT01115569|449810407|FG000|Maintenance Phase|Administrative|0|||
125051992|NCT01115569|449810408|FG001|Maintenance Phase|Administrative|1|||
125051993|NCT01931462|449810409|FG000|Overall Study|Withdrawal by Subject|1|||
125051994|NCT02819310|449810410|FG000|Overall Study|Withdrawal by Subject|37|||
125051995|NCT02819310|449810410|FG000|Overall Study|Lost to Follow-up|16|||
125051996|NCT02819310|449810410|FG000|Overall Study|Adverse Event|13|||
125051997|NCT02819310|449810410|FG000|Overall Study|Lack of Efficacy|5|||
125051998|NCT02819310|449810410|FG000|Overall Study|Physician Decision|8|||
125051999|NCT02819310|449810410|FG000|Overall Study|Protocol Violation|30|||
125052000|NCT05070429|449810416|FG000|Overall Study|Death|0|||
125052001|NCT05070429|449810417|FG001|Overall Study|Death|4|||
125052002|NCT05070429|449810416|FG000|Overall Study|Withdrawal by Subject|2|||
125052003|NCT05070429|449810417|FG001|Overall Study|Withdrawal by Subject|1|||
125052004|NCT05070429|449810416|FG000|Overall Study|Other|15|||
125052005|NCT05070429|449810417|FG001|Overall Study|Other|5|||
125052006|NCT00943319|449810418|FG000|Overall Study|Death|1|||
125052007|NCT02043301|449810419|FG000|Overall Study|Discontinued|0|||
125052008|NCT02043301|449810420|FG001|Overall Study|Discontinued|1|||
125052009|NCT02043301|449810421|FG002|Overall Study|Discontinued|0|||
125052010|NCT02653976|449810422|FG000|Overall Study|Withdrawal by Subject|5|||
125052011|NCT02653976|449810422|FG000|Overall Study|Death|4|||
125052012|NCT02023164|449810423|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
125052013|NCT02023164|449810424|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
125052014|NCT00883558|449810425|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
125052015|NCT00883558|449810426|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
125052016|NCT00883558|449810427|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
125052017|NCT00883558|449810425|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
125052018|NCT00883558|449810426|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
125052019|NCT00883558|449810427|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
125052020|NCT00883558|449810425|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
125052021|NCT00883558|449810426|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
125052022|NCT00883558|449810427|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
125052023|NCT00883558|449810425|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
125052024|NCT00883558|449810426|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
125052025|NCT00883558|449810427|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
125052026|NCT00883558|449810425|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
125052027|NCT00883558|449810426|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
125052028|NCT00883558|449810427|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
125052029|NCT03703375|449810428|FG000|Randomization Period|Withdrawal by Subject|0|||
125052030|NCT03703375|449810429|FG001|Randomization Period|Withdrawal by Subject|0|||
125052031|NCT03703375|449810430|FG002|Randomization Period|Withdrawal by Subject|0|||
125052032|NCT03703375|449810431|FG003|Randomization Period|Withdrawal by Subject|1|||
125052033|NCT03703375|449810428|FG000|Randomization Period|Completed safety run-in treatment|7|||
125052034|NCT03703375|449810429|FG001|Randomization Period|Completed safety run-in treatment|0|||
125052035|NCT03703375|449810430|FG002|Randomization Period|Completed safety run-in treatment|0|||
125052036|NCT03703375|449810431|FG003|Randomization Period|Completed safety run-in treatment|0|||
125052037|NCT03703375|449810428|FG000|Treatment Period|Other Reasons|0|||
125052038|NCT03703375|449810429|FG001|Treatment Period|Other Reasons|1|||
125052039|NCT03703375|449810430|FG002|Treatment Period|Other Reasons|0|||
125052040|NCT03703375|449810431|FG003|Treatment Period|Other Reasons|3|||
125052041|NCT03703375|449810428|FG000|Treatment Period|Consent Withdrawal|0|||
125052042|NCT03703375|449810429|FG001|Treatment Period|Consent Withdrawal|0|||
125052043|NCT03703375|449810430|FG002|Treatment Period|Consent Withdrawal|0|||
125052044|NCT03703375|449810431|FG003|Treatment Period|Consent Withdrawal|1|||
125052045|NCT03703375|449810428|FG000|Treatment Period|Death|1|||
125052046|NCT03703375|449810429|FG001|Treatment Period|Death|0|||
125052047|NCT03703375|449810430|FG002|Treatment Period|Death|1|||
125052048|NCT03703375|449810431|FG003|Treatment Period|Death|2|||
125052049|NCT03703375|449810428|FG000|Treatment Period|Toxicity of Study Treatment|2|||
125052050|NCT03703375|449810429|FG001|Treatment Period|Toxicity of Study Treatment|0|||
125052051|NCT03703375|449810430|FG002|Treatment Period|Toxicity of Study Treatment|4|||
125052052|NCT03703375|449810431|FG003|Treatment Period|Toxicity of Study Treatment|1|||
125052053|NCT03703375|449810428|FG000|Treatment Period|Progression|32|||
125052054|NCT03703375|449810429|FG001|Treatment Period|Progression|1|||
125052055|NCT03703375|449810430|FG002|Treatment Period|Progression|7|||
125052056|NCT03703375|449810431|FG003|Treatment Period|Progression|11|||
125052057|NCT03703375|449810428|FG000|Treatment Period|Completed treatment|7|||
125052058|NCT03703375|449810429|FG001|Treatment Period|Completed treatment|2|||
125052059|NCT03703375|449810430|FG002|Treatment Period|Completed treatment|0|||
125052060|NCT03703375|449810431|FG003|Treatment Period|Completed treatment|0|||
125052061|NCT01781429|449810433|FG000|Overall Study|Death|0|||
125052062|NCT01781429|449810434|FG001|Overall Study|Death|0|||
125052063|NCT01781429|449810435|FG002|Overall Study|Death|0|||
125052064|NCT01781429|449810436|FG003|Overall Study|Death|0|||
125052065|NCT01781429|449810437|FG004|Overall Study|Death|0|||
125052066|NCT01781429|449810438|FG005|Overall Study|Death|0|||
125052067|NCT01781429|449810439|FG006|Overall Study|Death|0|||
125052068|NCT01781429|449810440|FG007|Overall Study|Death|0|||
125052069|NCT01781429|449810441|FG008|Overall Study|Death|0|||
125052070|NCT01781429|449810442|FG009|Overall Study|Death|1|||
125052071|NCT01781429|449810443|FG010|Overall Study|Death|0|||
125052072|NCT01781429|449810444|FG011|Overall Study|Death|0|||
125052073|NCT01781429|449810445|FG012|Overall Study|Death|1|||
125052074|NCT01781429|449810446|FG013|Overall Study|Death|0|||
125052075|NCT01781429|449810447|FG014|Overall Study|Death|1|||
125052076|NCT01781429|449810448|FG015|Overall Study|Death|0|||
125052077|NCT01781429|449810433|FG000|Overall Study|Withdrawal by Subject|0|||
125052078|NCT01781429|449810434|FG001|Overall Study|Withdrawal by Subject|0|||
125052079|NCT01781429|449810435|FG002|Overall Study|Withdrawal by Subject|0|||
125052080|NCT01781429|449810436|FG003|Overall Study|Withdrawal by Subject|0|||
125052081|NCT01781429|449810437|FG004|Overall Study|Withdrawal by Subject|0|||
125052082|NCT01781429|449810438|FG005|Overall Study|Withdrawal by Subject|0|||
125052083|NCT01781429|449810439|FG006|Overall Study|Withdrawal by Subject|0|||
125052084|NCT01781429|449810440|FG007|Overall Study|Withdrawal by Subject|0|||
125052085|NCT01781429|449810441|FG008|Overall Study|Withdrawal by Subject|1|||
125052086|NCT01781429|449810442|FG009|Overall Study|Withdrawal by Subject|3|||
125052087|NCT01781429|449810443|FG010|Overall Study|Withdrawal by Subject|1|||
125052088|NCT01781429|449810444|FG011|Overall Study|Withdrawal by Subject|1|||
125052089|NCT01781429|449810445|FG012|Overall Study|Withdrawal by Subject|5|||
125052090|NCT01781429|449810446|FG013|Overall Study|Withdrawal by Subject|2|||
125052091|NCT01781429|449810447|FG014|Overall Study|Withdrawal by Subject|3|||
125052092|NCT01781429|449810448|FG015|Overall Study|Withdrawal by Subject|0|||
125052093|NCT01781429|449810433|FG000|Overall Study|Disease Progression|1|||
125052094|NCT01781429|449810434|FG001|Overall Study|Disease Progression|0|||
125052095|NCT01781429|449810435|FG002|Overall Study|Disease Progression|1|||
125052096|NCT01781429|449810436|FG003|Overall Study|Disease Progression|1|||
125052097|NCT01781429|449810437|FG004|Overall Study|Disease Progression|1|||
125052098|NCT01781429|449810438|FG005|Overall Study|Disease Progression|4|||
125052099|NCT01781429|449810439|FG006|Overall Study|Disease Progression|7|||
125052100|NCT01781429|449810440|FG007|Overall Study|Disease Progression|4|||
125052101|NCT01781429|449810441|FG008|Overall Study|Disease Progression|6|||
125052102|NCT01781429|449810442|FG009|Overall Study|Disease Progression|15|||
125052103|NCT01781429|449810443|FG010|Overall Study|Disease Progression|15|||
125052104|NCT01781429|449810444|FG011|Overall Study|Disease Progression|15|||
125052105|NCT01781429|449810445|FG012|Overall Study|Disease Progression|15|||
125052106|NCT01781429|449810446|FG013|Overall Study|Disease Progression|4|||
125052107|NCT01781429|449810447|FG014|Overall Study|Disease Progression|11|||
125052108|NCT01781429|449810448|FG015|Overall Study|Disease Progression|0|||
125052109|NCT01781429|449810433|FG000|Overall Study|Unacceptable Toxicity|0|||
125052110|NCT01781429|449810434|FG001|Overall Study|Unacceptable Toxicity|0|||
125052111|NCT01781429|449810435|FG002|Overall Study|Unacceptable Toxicity|0|||
125052112|NCT01781429|449810436|FG003|Overall Study|Unacceptable Toxicity|0|||
125052113|NCT01781429|449810437|FG004|Overall Study|Unacceptable Toxicity|0|||
125052114|NCT01781429|449810438|FG005|Overall Study|Unacceptable Toxicity|0|||
125052115|NCT01781429|449810439|FG006|Overall Study|Unacceptable Toxicity|0|||
125052116|NCT01781429|449810440|FG007|Overall Study|Unacceptable Toxicity|0|||
125052117|NCT01781429|449810441|FG008|Overall Study|Unacceptable Toxicity|0|||
125052118|NCT01781429|449810442|FG009|Overall Study|Unacceptable Toxicity|0|||
125052119|NCT01781429|449810443|FG010|Overall Study|Unacceptable Toxicity|0|||
125052120|NCT01781429|449810444|FG011|Overall Study|Unacceptable Toxicity|2|||
125052121|NCT01781429|449810445|FG012|Overall Study|Unacceptable Toxicity|0|||
125052122|NCT01781429|449810446|FG013|Overall Study|Unacceptable Toxicity|0|||
125052123|NCT01781429|449810447|FG014|Overall Study|Unacceptable Toxicity|0|||
125052124|NCT01781429|449810448|FG015|Overall Study|Unacceptable Toxicity|0|||
125052125|NCT01781429|449810433|FG000|Overall Study|Patient Condition Changed|0|||
125052126|NCT01781429|449810434|FG001|Overall Study|Patient Condition Changed|0|||
125052127|NCT01781429|449810435|FG002|Overall Study|Patient Condition Changed|0|||
125052128|NCT01781429|449810436|FG003|Overall Study|Patient Condition Changed|0|||
125052129|NCT01781429|449810437|FG004|Overall Study|Patient Condition Changed|0|||
125052130|NCT01781429|449810438|FG005|Overall Study|Patient Condition Changed|0|||
125052131|NCT01781429|449810439|FG006|Overall Study|Patient Condition Changed|0|||
125052132|NCT01781429|449810440|FG007|Overall Study|Patient Condition Changed|0|||
125052133|NCT01781429|449810441|FG008|Overall Study|Patient Condition Changed|0|||
125052134|NCT01781429|449810442|FG009|Overall Study|Patient Condition Changed|4|||
125052135|NCT01781429|449810443|FG010|Overall Study|Patient Condition Changed|0|||
125052136|NCT01781429|449810444|FG011|Overall Study|Patient Condition Changed|1|||
125052137|NCT01781429|449810445|FG012|Overall Study|Patient Condition Changed|0|||
125052138|NCT01781429|449810446|FG013|Overall Study|Patient Condition Changed|1|||
125052139|NCT01781429|449810447|FG014|Overall Study|Patient Condition Changed|0|||
125052140|NCT01781429|449810448|FG015|Overall Study|Patient Condition Changed|0|||
125052141|NCT01781429|449810433|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
125052142|NCT01781429|449810434|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
125052143|NCT01781429|449810435|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
125052144|NCT01781429|449810436|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
125052145|NCT01781429|449810437|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
125052146|NCT01781429|449810438|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
125052147|NCT01781429|449810439|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
125052148|NCT01781429|449810440|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
125052149|NCT01781429|449810441|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
125052150|NCT01781429|449810442|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
125052151|NCT01781429|449810443|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
125052152|NCT01781429|449810444|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
125052153|NCT01781429|449810445|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
125052154|NCT01781429|449810446|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
125052155|NCT01781429|449810447|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
125052156|NCT01781429|449810448|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
125052157|NCT01781429|449810433|FG000|Overall Study|Enrolled, but not treated|0|||
125052158|NCT01781429|449810434|FG001|Overall Study|Enrolled, but not treated|0|||
125052159|NCT01781429|449810435|FG002|Overall Study|Enrolled, but not treated|0|||
125052160|NCT01781429|449810436|FG003|Overall Study|Enrolled, but not treated|0|||
125052161|NCT01781429|449810437|FG004|Overall Study|Enrolled, but not treated|0|||
125052162|NCT01781429|449810438|FG005|Overall Study|Enrolled, but not treated|0|||
125052163|NCT01781429|449810439|FG006|Overall Study|Enrolled, but not treated|0|||
125052164|NCT01781429|449810440|FG007|Overall Study|Enrolled, but not treated|0|||
125052165|NCT01781429|449810441|FG008|Overall Study|Enrolled, but not treated|0|||
125052166|NCT01781429|449810442|FG009|Overall Study|Enrolled, but not treated|0|||
125052167|NCT01781429|449810443|FG010|Overall Study|Enrolled, but not treated|1|||
125052168|NCT01781429|449810444|FG011|Overall Study|Enrolled, but not treated|0|||
125052169|NCT01781429|449810445|FG012|Overall Study|Enrolled, but not treated|0|||
125052170|NCT01781429|449810446|FG013|Overall Study|Enrolled, but not treated|0|||
125052171|NCT01781429|449810447|FG014|Overall Study|Enrolled, but not treated|0|||
125052172|NCT01781429|449810448|FG015|Overall Study|Enrolled, but not treated|0|||
125052173|NCT02678741|449810449|FG000|Overall Study|Death|4|||
125052174|NCT02678741|449810449|FG000|Overall Study|Withdrawal by Subject|1|||
125052175|NCT02678741|449810449|FG000|Overall Study|ineligible|3|||
125052176|NCT02678741|449810449|FG000|Overall Study|Not RECIST Measurable|2|||
125052177|NCT02678741|449810449|FG000|Overall Study|Lack of Efficacy|10|||
125052178|NCT00903032|449810450|FG000|Overall Study|Withdrawal by Subject|5|||
125052179|NCT00903032|449810451|FG001|Overall Study|Withdrawal by Subject|3|||
125052180|NCT00903032|449810450|FG000|Overall Study|Lost to Follow-up|2|||
125219897|NCT03365934|450432685|FG000|Overall Study|Adverse Event|1|||
125052181|NCT00903032|449810451|FG001|Overall Study|Lost to Follow-up|2|||
125052182|NCT01703286|449810464|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
125052183|NCT01703286|449810465|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
125052184|NCT01703286|449810466|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
125052185|NCT01703286|449810467|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
125052186|NCT01703286|449810468|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
125052187|NCT01703286|449810469|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
125052188|NCT01703286|449810464|FG000|Period 2 Including Washout|Adverse Event|0|||
125052189|NCT01703286|449810465|FG001|Period 2 Including Washout|Adverse Event|0|||
125052190|NCT01703286|449810466|FG002|Period 2 Including Washout|Adverse Event|0|||
125052191|NCT01703286|449810467|FG003|Period 2 Including Washout|Adverse Event|1|||
125052192|NCT01703286|449810468|FG004|Period 2 Including Washout|Adverse Event|0|||
125052193|NCT01703286|449810469|FG005|Period 2 Including Washout|Adverse Event|0|||
125052194|NCT01984346|449810470|FG000|Overall Study|Physician Decision|4|||
125052195|NCT01984346|449810471|FG001|Overall Study|Physician Decision|2|||
125052196|NCT01984346|449810470|FG000|Overall Study|Withdrawal by Subject|2|||
125052197|NCT01984346|449810471|FG001|Overall Study|Withdrawal by Subject|2|||
125052198|NCT01984346|449810470|FG000|Overall Study|Enrollment Closed|8|||
125052199|NCT01984346|449810471|FG001|Overall Study|Enrollment Closed|1|||
125052200|NCT01984346|449810470|FG000|Overall Study|Insurance Coverage|1|||
125052201|NCT01984346|449810471|FG001|Overall Study|Insurance Coverage|0|||
125052202|NCT01984346|449810470|FG000|Overall Study|Intra-operative Exclusion|2|||
125052203|NCT01984346|449810471|FG001|Overall Study|Intra-operative Exclusion|0|||
125052204|NCT05058664|449810474|FG000|Overall Study|No follow-up data provided|4|||
125052205|NCT05058664|449810475|FG001|Overall Study|No follow-up data provided|0|||
125052206|NCT05058664|449810476|FG002|Overall Study|No follow-up data provided|2|||
125219898|NCT03365934|450432685|FG000|Overall Study|Withdrawal by Subject|1|||
125219899|NCT01307891|450432687|FG000|Overall Study|Progressive Disease|3|||
125219900|NCT01307891|450432688|FG001|Overall Study|Progressive Disease|1|||
125219901|NCT02937740|450432689|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
125219902|NCT02937740|450432690|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
125219903|NCT02937740|450432689|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
125219904|NCT02937740|450432690|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
125219905|NCT02937740|450432689|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
125219906|NCT02937740|450432690|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
125219907|NCT02937740|450432689|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
125219908|NCT02937740|450432690|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
125219909|NCT02937740|450432689|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
125219910|NCT02937740|450432690|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
125219911|NCT02937740|450432689|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
125219912|NCT02937740|450432690|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
125219913|NCT04194489|450432691|FG000|Overall Study|Withdrawal by Subject|5|||
125219914|NCT04194489|450432691|FG000|Overall Study|Lost to Follow-up|48|||
125219915|NCT00305227|450432699|FG000|Overall Study|Lost to Follow-up|7|||
125219916|NCT00305227|450432700|FG001|Overall Study|Lost to Follow-up|6|||
125219917|NCT04085601|450432701|FG000|Overall Study|Lost to Follow-up|1|||
125219918|NCT04085601|450432702|FG001|Overall Study|Lost to Follow-up|0|||
125219919|NCT04085601|450432701|FG000|Overall Study|Death|1|||
125219920|NCT04085601|450432702|FG001|Overall Study|Death|1|||
125219921|NCT03492437|450432703|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125219922|NCT03492437|450432704|FG001|Treatment Period 2|Withdrawal by Subject|1|||
125219923|NCT04534517|450432706|FG000|Overall Study|Adverse Event|1|||
125052207|NCT05058664|449810474|FG000|Overall Study|Withdrawal by Subject|0|||
125052208|NCT05058664|449810475|FG001|Overall Study|Withdrawal by Subject|0|||
125052209|NCT05058664|449810476|FG002|Overall Study|Withdrawal by Subject|1|||
125052210|NCT00972244|449810477|FG000|Overall Study|Incorrect Enrolment|1|||
125052211|NCT00972244|449810478|FG001|Overall Study|Incorrect Enrolment|0|||
125052212|NCT00972244|449810479|FG002|Overall Study|Incorrect Enrolment|0|||
125052213|NCT00972244|449810480|FG003|Overall Study|Incorrect Enrolment|0|||
125052214|NCT00972244|449810481|FG004|Overall Study|Incorrect Enrolment|0|||
125052215|NCT00972244|449810477|FG000|Overall Study|Adverse Event|0|||
125052216|NCT00972244|449810478|FG001|Overall Study|Adverse Event|1|||
125052217|NCT00972244|449810479|FG002|Overall Study|Adverse Event|1|||
125052218|NCT00972244|449810480|FG003|Overall Study|Adverse Event|0|||
125052219|NCT00972244|449810481|FG004|Overall Study|Adverse Event|0|||
125052220|NCT00972244|449810477|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
125219924|NCT04534517|450432706|FG000|Overall Study|Withdrawal by Subject|1|||
125219925|NCT04534517|450432706|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
125219926|NCT04534517|450432706|FG000|Overall Study|COVID-19 Related|1|||
125219927|NCT03872843|450432707|FG000|Overall Study|Lost to Follow-up|5|||
125219928|NCT03872843|450432708|FG001|Overall Study|Lost to Follow-up|7|||
125219929|NCT00823264|450432709|FG000|Overall Study|Protocol Violation|2|||
125052221|NCT00972244|449810478|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
125052222|NCT00972244|449810479|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
125052223|NCT00972244|449810480|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
125052224|NCT00972244|449810481|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
125052225|NCT00972244|449810477|FG000|Overall Study|Withdrawal by Subject|1|||
125052226|NCT00972244|449810478|FG001|Overall Study|Withdrawal by Subject|2|||
125052227|NCT00972244|449810479|FG002|Overall Study|Withdrawal by Subject|1|||
125052228|NCT00972244|449810480|FG003|Overall Study|Withdrawal by Subject|0|||
125052229|NCT00972244|449810481|FG004|Overall Study|Withdrawal by Subject|1|||
125052230|NCT00972244|449810477|FG000|Overall Study|Safety|0|||
125052231|NCT00972244|449810478|FG001|Overall Study|Safety|0|||
125052232|NCT00972244|449810479|FG002|Overall Study|Safety|0|||
125052233|NCT00972244|449810480|FG003|Overall Study|Safety|0|||
125052234|NCT00972244|449810481|FG004|Overall Study|Safety|1|||
125052235|NCT00972244|449810477|FG000|Overall Study|Death|1|||
125052236|NCT00972244|449810478|FG001|Overall Study|Death|0|||
125052237|NCT00972244|449810479|FG002|Overall Study|Death|0|||
125052238|NCT00972244|449810480|FG003|Overall Study|Death|0|||
125052239|NCT00972244|449810481|FG004|Overall Study|Death|0|||
125052240|NCT00972244|449810477|FG000|Overall Study|Various|0|||
125052241|NCT00972244|449810478|FG001|Overall Study|Various|0|||
125052242|NCT00972244|449810479|FG002|Overall Study|Various|0|||
125052243|NCT00972244|449810480|FG003|Overall Study|Various|0|||
125052244|NCT00972244|449810481|FG004|Overall Study|Various|2|||
125052245|NCT01597557|449810482|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
125052246|NCT01597557|449810483|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
125052247|NCT02561000|449810486|FG000|Overall Study|Withdrawal by Subject|2|||
125052248|NCT02561000|449810487|FG001|Overall Study|Withdrawal by Subject|3|||
125052249|NCT02561000|449810488|FG002|Overall Study|Withdrawal by Subject|0|||
125052250|NCT02561000|449810486|FG000|Overall Study|Adverse Event|0|||
125052251|NCT02561000|449810487|FG001|Overall Study|Adverse Event|1|||
125052252|NCT02561000|449810488|FG002|Overall Study|Adverse Event|0|||
125052253|NCT01234402|449810489|FG000|Overall Study|Lost to Follow-up|0|||
125052254|NCT01234402|449810490|FG001|Overall Study|Lost to Follow-up|1|||
125052255|NCT01234402|449810491|FG002|Overall Study|Lost to Follow-up|3|||
125052256|NCT01234402|449810489|FG000|Overall Study|Withdrawal by Subject|1|||
125052257|NCT01234402|449810490|FG001|Overall Study|Withdrawal by Subject|3|||
125052258|NCT01234402|449810491|FG002|Overall Study|Withdrawal by Subject|4|||
125052259|NCT01234402|449810489|FG000|Overall Study|Never treated: Death|0|||
125052260|NCT01234402|449810490|FG001|Overall Study|Never treated: Death|0|||
125052261|NCT01234402|449810491|FG002|Overall Study|Never treated: Death|1|||
125052262|NCT01234402|449810489|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
125052263|NCT01234402|449810490|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
125052264|NCT01234402|449810491|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
125052265|NCT01234402|449810489|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
125052266|NCT01234402|449810490|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
125052267|NCT01234402|449810491|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
125052268|NCT01594476|449810493|FG000|Overall Study|Protocol Violation|1|||
125052269|NCT01594476|449810494|FG001|Overall Study|Protocol Violation|3|||
125052270|NCT01106534|449810495|FG000|Overall Study|Withdrawal by Subject|18|||
125052271|NCT01106534|449810495|FG000|Overall Study|Lost to Follow-up|2|||
125052272|NCT01106534|449810495|FG000|Overall Study|Death|16|||
125052273|NCT01106534|449810495|FG000|Overall Study|Physician Decision|1|||
125052274|NCT02275026|449810496|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
125052275|NCT02275026|449810496|FG000|Overall Study|Withdrawal by Subject|4|||
125052276|NCT02275026|449810496|FG000|Overall Study|Ineligible due to medical history|13|||
125052277|NCT02275026|449810496|FG000|Overall Study|MRI malfunction precluded testing|1|||
125052278|NCT02275026|449810496|FG000|Overall Study|Ineligible after MRI findings|1|||
125052279|NCT02275026|449810496|FG000|Overall Study|Lost to Follow-up|2|||
125052280|NCT02275026|449810496|FG000|Overall Study|Scanner failure|1|||
125052281|NCT05468086|449810497|FG000|Overall Study|Withdrawal by Subject|3|||
125052282|NCT05468086|449810497|FG000|Overall Study|Subject was found ineligible after consent|1|||
125052283|NCT00374907|449810498|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
125052284|NCT00374907|449810499|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
125052285|NCT00374907|449810498|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
125052286|NCT00374907|449810499|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
125052287|NCT00374907|449810498|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
125052288|NCT00374907|449810499|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
125052289|NCT00374907|449810498|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
125052290|NCT00374907|449810499|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
125052291|NCT00374907|449810498|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
125052292|NCT00374907|449810499|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
125052293|NCT01108809|449810500|FG000|Overall Study|Adverse Event|3|||
125052294|NCT01108809|449810500|FG000|Overall Study|Lost to Follow-up|1|||
125052295|NCT00783705|449810502|FG000|Overall Study|Adverse Event|2|||
125052296|NCT00783705|449810503|FG001|Overall Study|Adverse Event|0|||
125052297|NCT00783705|449810502|FG000|Overall Study|Withdrawal by Subject|3|||
125052298|NCT00783705|449810503|FG001|Overall Study|Withdrawal by Subject|2|||
125052299|NCT00783705|449810502|FG000|Overall Study|Lost to Follow-up|1|||
125052300|NCT00783705|449810503|FG001|Overall Study|Lost to Follow-up|3|||
125052301|NCT02379923|449810504|FG000|Overall Study|Death|5|||
125052302|NCT01200511|449810510|FG000|Overall Study|Lost to Follow-up|3|||
125052303|NCT01200511|449810510|FG000|Overall Study|Withdrawal by Subject|1|||
125052304|NCT01200511|449810510|FG000|Overall Study|Adverse Event|1|||
125052305|NCT00576693|449810513|FG000|Overall Study|Lost to Follow-up|7|||
125052306|NCT00576693|449810514|FG001|Overall Study|Lost to Follow-up|11|||
125052307|NCT00576693|449810513|FG000|Overall Study|Withdrawal by Subject|3|||
125052308|NCT00576693|449810514|FG001|Overall Study|Withdrawal by Subject|13|||
125052309|NCT00804193|449810515|FG000|Overall Study|Lack of baseline fungus|32|||
125052310|NCT00804193|449810516|FG001|Overall Study|Lack of baseline fungus|31|||
125052311|NCT00804193|449810517|FG002|Overall Study|Lack of baseline fungus|19|||
125052312|NCT00804193|449810515|FG000|Overall Study|Adverse Event|0|||
125052313|NCT00804193|449810516|FG001|Overall Study|Adverse Event|0|||
125052314|NCT00804193|449810517|FG002|Overall Study|Adverse Event|2|||
125052315|NCT00804193|449810515|FG000|Overall Study|Lack of Efficacy|1|||
125052316|NCT00804193|449810516|FG001|Overall Study|Lack of Efficacy|1|||
125052317|NCT00804193|449810517|FG002|Overall Study|Lack of Efficacy|3|||
125052318|NCT00804193|449810515|FG000|Overall Study|Protocol Violation|0|||
125052319|NCT00804193|449810516|FG001|Overall Study|Protocol Violation|8|||
125052320|NCT00804193|449810517|FG002|Overall Study|Protocol Violation|2|||
125052321|NCT00804193|449810515|FG000|Overall Study|Lost to Follow-up|3|||
125052322|NCT00804193|449810516|FG001|Overall Study|Lost to Follow-up|3|||
125052323|NCT00804193|449810517|FG002|Overall Study|Lost to Follow-up|4|||
125052324|NCT00804193|449810515|FG000|Overall Study|Withdrawal by Subject|3|||
125052325|NCT00804193|449810516|FG001|Overall Study|Withdrawal by Subject|1|||
125052326|NCT00804193|449810517|FG002|Overall Study|Withdrawal by Subject|2|||
125052327|NCT01617434|449810518|FG000|Overall Study|Adverse Event|12|||
125052328|NCT01617434|449810519|FG001|Overall Study|Adverse Event|3|||
125219930|NCT00823264|450432710|FG001|Overall Study|Protocol Violation|0|||
125219931|NCT05133323|450432711|FG000|Overall Study|Lack of Efficacy|0|||
125219932|NCT05133323|450432712|FG001|Overall Study|Lack of Efficacy|0|||
125052329|NCT01617434|449810518|FG000|Overall Study|Protocol Violation|8|||
125052330|NCT01617434|449810519|FG001|Overall Study|Protocol Violation|7|||
125052331|NCT01617434|449810518|FG000|Overall Study|Withdrawal Criteria|12|||
125052332|NCT01617434|449810519|FG001|Overall Study|Withdrawal Criteria|37|||
125052333|NCT01617434|449810518|FG000|Overall Study|Unclassified|3|||
125052334|NCT01617434|449810519|FG001|Overall Study|Unclassified|4|||
125052335|NCT01987986|449810520|FG000|Overall Study|Lost to Follow-up|1|||
125052336|NCT01987986|449810521|FG001|Overall Study|Lost to Follow-up|0|||
125052337|NCT01987986|449810522|FG002|Overall Study|Lost to Follow-up|0|||
125052338|NCT01987986|449810523|FG003|Overall Study|Lost to Follow-up|0|||
125052339|NCT01987986|449810520|FG000|Overall Study|Adverse Event|1|||
125052340|NCT01987986|449810521|FG001|Overall Study|Adverse Event|0|||
125052341|NCT01987986|449810522|FG002|Overall Study|Adverse Event|2|||
125052342|NCT01987986|449810523|FG003|Overall Study|Adverse Event|0|||
125052343|NCT00705224|449810524|FG000|Overall Study|Adverse Event|1|||
125219933|NCT05133323|450432713|FG002|Overall Study|Lack of Efficacy|1|||
125052344|NCT00705224|449810524|FG000|Overall Study|Lack of Efficacy|2|||
125052345|NCT00705224|449810524|FG000|Overall Study|Withdrawal by Subject|3|||
125052346|NCT00705224|449810524|FG000|Overall Study|Lost to Follow-up|5|||
125052347|NCT03283163|449810525|FG000|Overall Study|Lost to Follow-up|1|||
125219934|NCT05133323|450432711|FG000|Overall Study|Withdrawal by Subject|2|||
125052348|NCT03283163|449810525|FG000|Overall Study|other life commitments|6|||
125052349|NCT03283163|449810525|FG000|Overall Study|COVID-19 institution wide halting|1|||
125052350|NCT03283163|449810525|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
125052351|NCT03283163|449810525|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
125052352|NCT04238663|449810526|FG000|Overall Study|Lost to Follow-up|0|||
125052353|NCT04238663|449810527|FG001|Overall Study|Lost to Follow-up|1|||
125052354|NCT04238663|449810528|FG002|Overall Study|Lost to Follow-up|0|||
125052355|NCT03596177|449810529|FG000|Single Blind Period|Withdrawal by Subject|1|||
125052356|NCT03596177|449810530|FG001|Single Blind Period|Withdrawal by Subject|1|||
125052357|NCT03596177|449810529|FG000|Single Blind Period|Other|1|||
125052358|NCT03596177|449810530|FG001|Single Blind Period|Other|0|||
125052359|NCT03596177|449810529|FG000|Double Blind Period|Withdrawal by Subject|0|||
125052360|NCT03596177|449810530|FG001|Double Blind Period|Withdrawal by Subject|1|||
125052361|NCT03596177|449810529|FG000|Double Blind Period|Other|0|||
125052362|NCT03596177|449810530|FG001|Double Blind Period|Other|4|||
125052363|NCT03596177|449810529|FG000|Double Blind Period|Death during safety follow-up|0|||
125052364|NCT03596177|449810530|FG001|Double Blind Period|Death during safety follow-up|1|||
125052365|NCT00968253|449810532|FG000|Overall Study|Death|0|||
125052366|NCT00968253|449810533|FG001|Overall Study|Death|0|||
125052367|NCT00968253|449810534|FG002|Overall Study|Death|2|||
125052368|NCT00968253|449810532|FG000|Overall Study|Withdrawal by Subject|0|||
125052369|NCT00968253|449810533|FG001|Overall Study|Withdrawal by Subject|0|||
125052370|NCT00968253|449810534|FG002|Overall Study|Withdrawal by Subject|1|||
125052371|NCT00968253|449810532|FG000|Overall Study|Disease Progression|0|||
125052372|NCT00968253|449810533|FG001|Overall Study|Disease Progression|3|||
125052373|NCT00968253|449810534|FG002|Overall Study|Disease Progression|3|||
125052374|NCT00968253|449810532|FG000|Overall Study|Adverse Event|0|||
125052375|NCT00968253|449810533|FG001|Overall Study|Adverse Event|0|||
125052376|NCT00968253|449810534|FG002|Overall Study|Adverse Event|1|||
125052377|NCT01432262|449811983|FG000|Overall Study|Withdrawal by Subject|2|||
125052378|NCT01432262|449811984|FG001|Overall Study|Withdrawal by Subject|1|||
125052379|NCT04657016|449811985|FG000|Overall Study|Adverse Event|2|||
125052380|NCT04657016|449811986|FG001|Overall Study|Adverse Event|4|||
125052381|NCT04657016|449811985|FG000|Overall Study|Death|1|||
125052382|NCT04657016|449811986|FG001|Overall Study|Death|1|||
125052383|NCT04657016|449811985|FG000|Overall Study|Lost to Follow-up|24|||
125052384|NCT04657016|449811986|FG001|Overall Study|Lost to Follow-up|12|||
125052385|NCT04657016|449811985|FG000|Overall Study|Physician Decision|1|||
125052386|NCT04657016|449811986|FG001|Overall Study|Physician Decision|2|||
125052387|NCT04657016|449811985|FG000|Overall Study|Pregnancy|2|||
125052388|NCT04657016|449811986|FG001|Overall Study|Pregnancy|2|||
125052389|NCT04657016|449811985|FG000|Overall Study|Protocol Deviation|1|||
125052390|NCT04657016|449811986|FG001|Overall Study|Protocol Deviation|0|||
125052391|NCT04657016|449811985|FG000|Overall Study|Withdrawal by Subject|28|||
125052392|NCT04657016|449811986|FG001|Overall Study|Withdrawal by Subject|14|||
125052393|NCT04657016|449811985|FG000|Overall Study|Other - as reported by the investigator|6|||
125052394|NCT04657016|449811986|FG001|Overall Study|Other - as reported by the investigator|0|||
125052395|NCT01755195|449811987|FG000|Overall Study|Participant noncompliance|2|||
125052396|NCT01755195|449811987|FG000|Overall Study|Switched to alternative treatment|4|||
125052397|NCT01755195|449811987|FG000|Overall Study|Withdrawal by Subject|1|||
125052398|NCT01755195|449811987|FG000|Overall Study|Participant refused to start treatment|1|||
125052399|NCT01755195|449811987|FG000|Overall Study|Participant has been consented for another trial|1|||
125052400|NCT01755195|449811987|FG000|Overall Study|Refused further treatment|3|||
125052401|NCT01755195|449811987|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
125052416|NCT01605071|449811990|FG000|Overall Study|Withdrawal by Subject|3|||
125052417|NCT01605071|449811991|FG001|Overall Study|Withdrawal by Subject|2|||
125052418|NCT00392171|449811992|FG000|Overall Study|Did not meet inclusion criteria|4|||
125052419|NCT00392171|449811992|FG000|Overall Study|Disease progression|101|||
125052420|NCT03470922|449811994|FG000|Overall Study|Death|107|||
125052421|NCT03470922|449811995|FG001|Overall Study|Death|118|||
125052422|NCT03470922|449811994|FG000|Overall Study|Lost to Follow-up|5|||
125052423|NCT03470922|449811995|FG001|Overall Study|Lost to Follow-up|5|||
125052424|NCT03470922|449811994|FG000|Overall Study|Participant Withdrew Consent|4|||
125052425|NCT03470922|449811995|FG001|Overall Study|Participant Withdrew Consent|9|||
125052426|NCT03470922|449811994|FG000|Overall Study|Other reasons|1|||
125052427|NCT03470922|449811995|FG001|Overall Study|Other reasons|0|||
125052428|NCT03470922|449811994|FG000|Overall Study|Not reported|1|||
125052429|NCT03470922|449811995|FG001|Overall Study|Not reported|0|||
125052430|NCT02340819|449811996|FG000|Overall Study|Adverse Event|1|||
125052431|NCT02340819|449811996|FG000|Overall Study|Withdrawal by Subject|2|||
125052432|NCT02340819|449811996|FG000|Overall Study|Discontinued with other reason|1|||
125052433|NCT02361762|449811997|FG000|Overall Study|Withdrawal by Subject|0|||
125052434|NCT02361762|449811998|FG001|Overall Study|Withdrawal by Subject|1|||
125052435|NCT02361762|449811997|FG000|Overall Study|Lost to Follow-up|0|||
125052436|NCT02361762|449811998|FG001|Overall Study|Lost to Follow-up|1|||
125052437|NCT00028002|449811999|FG000|Overall Study|Withdrawal by Subject|3|||
125052438|NCT00028002|449811999|FG000|Overall Study|Ineligible|8|||
125052439|NCT01793051|449812000|FG000|Overall Study|Withdrawal by Subject|6|||
125052440|NCT01793051|449812001|FG001|Overall Study|Withdrawal by Subject|4|||
125052441|NCT01793051|449812000|FG000|Overall Study|Adverse Event|0|||
125052442|NCT01793051|449812001|FG001|Overall Study|Adverse Event|2|||
125219935|NCT05133323|450432712|FG001|Overall Study|Withdrawal by Subject|1|||
125219936|NCT05133323|450432713|FG002|Overall Study|Withdrawal by Subject|0|||
125219937|NCT00113295|450432714|FG000|Overall Study|Adverse Event|4|||
125219938|NCT00113295|450432715|FG001|Overall Study|Adverse Event|1|||
125219939|NCT00113295|450432714|FG000|Overall Study|Unrelated Medical Illness|1|||
125219940|NCT00113295|450432715|FG001|Overall Study|Unrelated Medical Illness|0|||
125219941|NCT01714544|450432716|FG000|Overall Study|Lost to Follow-up|1|||
125219942|NCT01714544|450432716|FG000|Overall Study|Physician Decision|1|||
125219943|NCT01714544|450432716|FG000|Overall Study|Withdrawal by Subject|1|||
125219944|NCT00577772|450432725|FG000|Overall Study|Lost to Follow-up|0|||
125219945|NCT00577772|450432726|FG001|Overall Study|Lost to Follow-up|1|||
125219946|NCT00572455|450432727|FG000|Stage I (14 Days)|Adverse Event|0|||
125219947|NCT00572455|450432728|FG001|Stage I (14 Days)|Adverse Event|0|||
125219948|NCT00572455|450432729|FG002|Stage I (14 Days)|Adverse Event|0|||
125219949|NCT00572455|450432730|FG003|Stage I (14 Days)|Adverse Event|0|||
125219950|NCT00572455|450432731|FG004|Stage I (14 Days)|Adverse Event|0|||
125219951|NCT00572455|450432732|FG005|Stage I (14 Days)|Adverse Event|3|||
125219952|NCT00572455|450432733|FG006|Stage I (14 Days)|Adverse Event|0|||
125219953|NCT00572455|450432734|FG007|Stage I (14 Days)|Adverse Event|0|||
125219954|NCT00572455|450432735|FG008|Stage I (14 Days)|Adverse Event|0|||
125219955|NCT00572455|450432736|FG009|Stage I (14 Days)|Adverse Event|0|||
125219956|NCT00572455|450432737|FG010|Stage I (14 Days)|Adverse Event|0|||
125219957|NCT00572455|450432738|FG011|Stage I (14 Days)|Adverse Event|0|||
125219958|NCT00572455|450432739|FG012|Stage I (14 Days)|Adverse Event|0|||
125219959|NCT00572455|450432740|FG013|Stage I (14 Days)|Adverse Event|0|||
125219960|NCT00572455|450432727|FG000|Stage I (14 Days)|Other|0|||
125219961|NCT00572455|450432728|FG001|Stage I (14 Days)|Other|0|||
125219962|NCT00572455|450432729|FG002|Stage I (14 Days)|Other|0|||
125219963|NCT00572455|450432730|FG003|Stage I (14 Days)|Other|0|||
125219964|NCT00572455|450432731|FG004|Stage I (14 Days)|Other|1|||
125219965|NCT00572455|450432732|FG005|Stage I (14 Days)|Other|0|||
125219966|NCT00572455|450432733|FG006|Stage I (14 Days)|Other|0|||
125219967|NCT00572455|450432734|FG007|Stage I (14 Days)|Other|0|||
125219968|NCT00572455|450432735|FG008|Stage I (14 Days)|Other|0|||
125052443|NCT01793051|449812000|FG000|Overall Study|Too ill to continue|1|||
125052444|NCT01793051|449812001|FG001|Overall Study|Too ill to continue|0|||
125052445|NCT01793051|449812000|FG000|Overall Study|Switched chemo|1|||
125052446|NCT01793051|449812001|FG001|Overall Study|Switched chemo|1|||
125052447|NCT01793051|449812000|FG000|Overall Study|Lack of compliance|1|||
125052448|NCT01793051|449812001|FG001|Overall Study|Lack of compliance|0|||
125052449|NCT01793051|449812000|FG000|Overall Study|Requested to be removed from the study|1|||
125052450|NCT01793051|449812001|FG001|Overall Study|Requested to be removed from the study|1|||
125052451|NCT04907539|449812002|FG000|Overall Study|Consent withdrawn|1|||
125052452|NCT04907539|449812003|FG001|Overall Study|Consent withdrawn|0|||
125052453|NCT04907539|449812002|FG000|Overall Study|Death|14|||
125052454|NCT04907539|449812003|FG001|Overall Study|Death|3|||
125052455|NCT01881620|449812004|FG000|Overall Study|Protocol Violation|4|||
125219969|NCT00572455|450432736|FG009|Stage I (14 Days)|Other|0|||
125219970|NCT00572455|450432737|FG010|Stage I (14 Days)|Other|0|||
125219971|NCT00572455|450432738|FG011|Stage I (14 Days)|Other|0|||
125219972|NCT00572455|450432739|FG012|Stage I (14 Days)|Other|0|||
125219973|NCT00572455|450432740|FG013|Stage I (14 Days)|Other|0|||
125219974|NCT00572455|450432727|FG000|Stage II (28 Days)|Adverse Event|0|||
125052456|NCT04467164|449812008|FG000|Washout (1 Week)|Lost to Follow-up|2|||
125052457|NCT04467164|449812009|FG001|Washout (1 Week)|Lost to Follow-up|0|||
125052458|NCT01701583|449812012|FG000|Overall Study|Withdrawal by Subject|2|||
125052459|NCT01701583|449812013|FG001|Overall Study|Withdrawal by Subject|0|||
125219975|NCT00572455|450432728|FG001|Stage II (28 Days)|Adverse Event|0|||
125219976|NCT00572455|450432729|FG002|Stage II (28 Days)|Adverse Event|0|||
125219977|NCT00572455|450432730|FG003|Stage II (28 Days)|Adverse Event|0|||
125219978|NCT00572455|450432731|FG004|Stage II (28 Days)|Adverse Event|0|||
125219979|NCT00572455|450432732|FG005|Stage II (28 Days)|Adverse Event|0|||
125219980|NCT00572455|450432733|FG006|Stage II (28 Days)|Adverse Event|0|||
125052460|NCT01441440|449812014|FG000|Overall Study|Death|1|||
125052461|NCT01441440|449812015|FG001|Overall Study|Death|0|||
125052462|NCT01441440|449812016|FG002|Overall Study|Death|1|||
125052463|NCT01441440|449812014|FG000|Overall Study|Adverse Event|2|||
125052464|NCT01441440|449812015|FG001|Overall Study|Adverse Event|9|||
125052465|NCT01441440|449812016|FG002|Overall Study|Adverse Event|9|||
125052466|NCT01441440|449812014|FG000|Overall Study|Lost to Follow-up|0|||
125052467|NCT01441440|449812015|FG001|Overall Study|Lost to Follow-up|2|||
125052468|NCT01441440|449812016|FG002|Overall Study|Lost to Follow-up|1|||
125052469|NCT01441440|449812014|FG000|Overall Study|Withdrawal by Subject|11|||
125052470|NCT01441440|449812015|FG001|Overall Study|Withdrawal by Subject|9|||
125052471|NCT01441440|449812016|FG002|Overall Study|Withdrawal by Subject|9|||
125052472|NCT01441440|449812014|FG000|Overall Study|Pregnancy|1|||
125052473|NCT01441440|449812015|FG001|Overall Study|Pregnancy|0|||
125052474|NCT01441440|449812016|FG002|Overall Study|Pregnancy|0|||
125052475|NCT01441440|449812014|FG000|Overall Study|Lack of Efficacy|1|||
125052476|NCT01441440|449812015|FG001|Overall Study|Lack of Efficacy|0|||
125052477|NCT01441440|449812016|FG002|Overall Study|Lack of Efficacy|1|||
125052478|NCT01441440|449812014|FG000|Overall Study|Moving|0|||
125052479|NCT01441440|449812015|FG001|Overall Study|Moving|1|||
125052480|NCT01441440|449812016|FG002|Overall Study|Moving|1|||
125052481|NCT01441440|449812014|FG000|Overall Study|Work-related matter|0|||
125052482|NCT01441440|449812015|FG001|Overall Study|Work-related matter|1|||
125052483|NCT01441440|449812016|FG002|Overall Study|Work-related matter|0|||
125052484|NCT01441440|449812014|FG000|Overall Study|Difficllty in keeping the schedule|1|||
125052485|NCT01441440|449812015|FG001|Overall Study|Difficllty in keeping the schedule|1|||
125052486|NCT01441440|449812016|FG002|Overall Study|Difficllty in keeping the schedule|0|||
125052487|NCT02750813|449812022|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
125052488|NCT02750813|449812023|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
125052489|NCT02750813|449812022|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
125052490|NCT02750813|449812023|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
125052491|NCT03276936|449812024|FG000|Overall Study|Adverse Event|4|||
125052492|NCT03276936|449812025|FG001|Overall Study|Adverse Event|2|||
125052493|NCT03276936|449812024|FG000|Overall Study|Lost to Follow-up|16|||
125052494|NCT03276936|449812025|FG001|Overall Study|Lost to Follow-up|13|||
125052495|NCT03276936|449812024|FG000|Overall Study|Withdrawal by Subject|30|||
125052496|NCT03276936|449812025|FG001|Overall Study|Withdrawal by Subject|20|||
125052497|NCT03276936|449812024|FG000|Overall Study|Not mentioned|6|||
125052498|NCT03276936|449812025|FG001|Overall Study|Not mentioned|3|||
125052499|NCT01798134|449812026|FG000|Overall Study|Lost to Follow-up|1|||
125052500|NCT01798134|449812026|FG000|Overall Study|Withdrawal by Subject|3|||
125052501|NCT01798134|449812026|FG000|Overall Study|Death|2|||
125052502|NCT01798134|449812026|FG000|Overall Study|Adverse Event|3|||
125052503|NCT01798134|449812026|FG000|Overall Study|Physician Decision|3|||
125052504|NCT01798134|449812026|FG000|Overall Study|Liver transplant/surgery|4|||
125052505|NCT00625365|449812027|FG000|Overall Study|Withdrawal by Subject|1|||
125052506|NCT00625365|449812027|FG000|Overall Study|No IV access|5|||
125052507|NCT00625365|449812027|FG000|Overall Study|VSD|1|||
125052508|NCT02245568|449812028|FG000|Overall Study|Study terminated by Sponsor|346|||
125052509|NCT02245568|449812028|FG000|Overall Study|Adverse Event|144|||
125052510|NCT02245568|449812028|FG000|Overall Study|Lack of Efficacy|98|||
125052511|NCT02245568|449812028|FG000|Overall Study|Withdrawal by Caregiver|85|||
125052512|NCT02245568|449812028|FG000|Overall Study|Withdrawal by Subject|77|||
125052513|NCT02245568|449812028|FG000|Overall Study|Withdrawal by Legal Representative|31|||
125052514|NCT02245568|449812028|FG000|Overall Study|Missing (Site closure)|16|||
125052515|NCT02245568|449812028|FG000|Overall Study|Physician Decision|14|||
125052516|NCT02245568|449812028|FG000|Overall Study|Non-compliance with study drug|11|||
125052517|NCT02245568|449812028|FG000|Overall Study|Death|9|||
125052518|NCT02245568|449812028|FG000|Overall Study|Blue staining|6|||
125052519|NCT02245568|449812028|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
125052520|NCT02245568|449812028|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
125052521|NCT02245568|449812028|FG000|Overall Study|Lost to Follow-up|5|||
125052522|NCT00366548|449812029|FG000|Infant Series|Adverse Event|1|||
125052523|NCT00366548|449812030|FG001|Infant Series|Adverse Event|3|||
125052524|NCT00366548|449812029|FG000|Infant Series|Protocol Violation|0|||
125052525|NCT00366548|449812030|FG001|Infant Series|Protocol Violation|1|||
125052526|NCT00366548|449812029|FG000|Infant Series|Withdrawal by Subject|3|||
125052527|NCT00366548|449812030|FG001|Infant Series|Withdrawal by Subject|1|||
125052528|NCT00366548|449812029|FG000|After Infant Series|Withdrawal by Subject|3|||
125052529|NCT00366548|449812030|FG001|After Infant Series|Withdrawal by Subject|1|||
125052530|NCT00366548|449812029|FG000|After Infant Series|Adverse Event|2|||
125052531|NCT00366548|449812030|FG001|After Infant Series|Adverse Event|0|||
125052532|NCT00366548|449812029|FG000|After Infant Series|Lost to Follow-up|1|||
125052533|NCT00366548|449812030|FG001|After Infant Series|Lost to Follow-up|0|||
125052534|NCT01252134|449812031|FG000|Period 1, 8 Hours|Personal Reasons|0|||
125052535|NCT01252134|449812032|FG001|Period 1, 8 Hours|Personal Reasons|1|||
125052536|NCT01252134|449812033|FG002|Period 1, 8 Hours|Personal Reasons|1|||
125052537|NCT01252134|449812034|FG003|Period 1, 8 Hours|Personal Reasons|0|||
125052538|NCT01252134|449812035|FG004|Period 1, 8 Hours|Personal Reasons|0|||
125052539|NCT01252134|449812036|FG005|Period 1, 8 Hours|Personal Reasons|0|||
125052540|NCT03650452|449812038|FG000|Overall Study|Physician Decision|1|||
125052541|NCT03650452|449812039|FG001|Overall Study|Physician Decision|0|||
125052542|NCT03650452|449812038|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
125052543|NCT03650452|449812039|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
125052544|NCT03650452|449812038|FG000|Overall Study|Adverse Event|3|||
125052545|NCT03650452|449812039|FG001|Overall Study|Adverse Event|4|||
125052546|NCT03650452|449812038|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
125052547|NCT03650452|449812039|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
125052548|NCT02273050|449812040|FG000|Overall Study|Adverse Event|4|||
125052549|NCT02273050|449812041|FG001|Overall Study|Adverse Event|3|||
125052550|NCT02273050|449812042|FG002|Overall Study|Adverse Event|3|||
125052551|NCT02273050|449812040|FG000|Overall Study|Death|0|||
125052552|NCT02273050|449812041|FG001|Overall Study|Death|0|||
125052553|NCT02273050|449812042|FG002|Overall Study|Death|1|||
125052554|NCT02273050|449812040|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
125052555|NCT02273050|449812041|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
125052556|NCT02273050|449812042|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
125052557|NCT02273050|449812040|FG000|Overall Study|Lack of Efficacy|0|||
125052558|NCT02273050|449812041|FG001|Overall Study|Lack of Efficacy|1|||
125052559|NCT02273050|449812042|FG002|Overall Study|Lack of Efficacy|1|||
125052560|NCT02273050|449812040|FG000|Overall Study|Withdrawal by Subject|17|||
125052561|NCT02273050|449812041|FG001|Overall Study|Withdrawal by Subject|14|||
125052562|NCT02273050|449812042|FG002|Overall Study|Withdrawal by Subject|16|||
125052563|NCT02273050|449812040|FG000|Overall Study|Lost to Follow-up|0|||
125052564|NCT02273050|449812041|FG001|Overall Study|Lost to Follow-up|2|||
125052565|NCT02273050|449812042|FG002|Overall Study|Lost to Follow-up|3|||
125052566|NCT02273050|449812040|FG000|Overall Study|Protocol Violation|3|||
125052567|NCT02273050|449812041|FG001|Overall Study|Protocol Violation|1|||
125052568|NCT02273050|449812042|FG002|Overall Study|Protocol Violation|4|||
125052569|NCT02297438|449812043|FG000|Overall Study|Death|79|||
125052570|NCT02297438|449812044|FG001|Overall Study|Death|86|||
125052571|NCT02297438|449812043|FG000|Overall Study|Lost to Follow-up|9|||
125052572|NCT02297438|449812044|FG001|Overall Study|Lost to Follow-up|7|||
125052573|NCT02297438|449812043|FG000|Overall Study|Withdrawal by Subject|7|||
125052574|NCT02297438|449812044|FG001|Overall Study|Withdrawal by Subject|0|||
125052575|NCT02297438|449812043|FG000|Overall Study|Other|9|||
125052576|NCT02297438|449812044|FG001|Overall Study|Other|5|||
125052577|NCT02297438|449812043|FG000|Overall Study|Ongoing|65|||
125052578|NCT02297438|449812044|FG001|Overall Study|Ongoing|73|||
125052579|NCT02042404|449812045|FG000|Overall Study|Death|1|||
125052580|NCT02042404|449812046|FG001|Overall Study|Death|0|||
125052581|NCT02042404|449812045|FG000|Overall Study|Unrelated Adverse Event|3|||
125052582|NCT02042404|449812046|FG001|Overall Study|Unrelated Adverse Event|0|||
125052583|NCT02042404|449812045|FG000|Overall Study|Inability to meet time requirements|1|||
125052584|NCT02042404|449812046|FG001|Overall Study|Inability to meet time requirements|0|||
125052585|NCT03952468|449812048|FG000|Overall Study|Death|0|||
125052586|NCT03952468|449812049|FG001|Overall Study|Death|1|||
125052587|NCT03952468|449812048|FG000|Overall Study|Adverse Event|0|||
125052588|NCT03952468|449812049|FG001|Overall Study|Adverse Event|1|||
125052589|NCT03952468|449812048|FG000|Overall Study|Physician Decision|1|||
125052590|NCT03952468|449812049|FG001|Overall Study|Physician Decision|0|||
125052591|NCT03952468|449812048|FG000|Overall Study|Lost to Follow-up|3|||
125052592|NCT03952468|449812049|FG001|Overall Study|Lost to Follow-up|4|||
125052593|NCT03952468|449812048|FG000|Overall Study|Withdrawal by Subject|2|||
125052594|NCT03952468|449812049|FG001|Overall Study|Withdrawal by Subject|1|||
125052595|NCT05761444|449812050|FG000|Overall Study|Protocol Violation|2|||
125052596|NCT05761444|449812051|FG001|Overall Study|Protocol Violation|1|||
125052597|NCT05761444|449812050|FG000|Overall Study|Adverse Event|2|||
125052598|NCT05761444|449812051|FG001|Overall Study|Adverse Event|2|||
125052599|NCT05761444|449812050|FG000|Overall Study|Withdrawal by Subject|3|||
125052600|NCT05761444|449812051|FG001|Overall Study|Withdrawal by Subject|2|||
125052601|NCT05761444|449812050|FG000|Overall Study|Other|1|||
125052602|NCT05761444|449812051|FG001|Overall Study|Other|0|||
125052603|NCT04716933|449812052|FG000|Overall Study|Sponsor Decision|36|||
125052604|NCT04716933|449812053|FG001|Overall Study|Sponsor Decision|33|||
125052605|NCT04716933|449812052|FG000|Overall Study|Death|65|||
125052606|NCT04716933|449812053|FG001|Overall Study|Death|67|||
125052607|NCT01005719|449812056|FG000|Period 1|Adverse Event|0|||
125052608|NCT01005719|449812057|FG001|Period 1|Adverse Event|0|||
125052609|NCT01005719|449812058|FG002|Period 1|Adverse Event|0|||
125052610|NCT01005719|449812059|FG003|Period 1|Adverse Event|1|||
125052611|NCT01005719|449812060|FG004|Period 1|Adverse Event|0|||
125052612|NCT01005719|449812061|FG005|Period 1|Adverse Event|0|||
125052613|NCT01005719|449812056|FG000|Period 1|Delay in completing study procedures|0|||
125052614|NCT01005719|449812057|FG001|Period 1|Delay in completing study procedures|0|||
125052615|NCT01005719|449812058|FG002|Period 1|Delay in completing study procedures|0|||
125052616|NCT01005719|449812059|FG003|Period 1|Delay in completing study procedures|0|||
125219981|NCT00572455|450432734|FG007|Stage II (28 Days)|Adverse Event|0|||
125052617|NCT01005719|449812060|FG004|Period 1|Delay in completing study procedures|0|||
125052618|NCT01005719|449812061|FG005|Period 1|Delay in completing study procedures|1|||
125052619|NCT01005719|449812056|FG000|Period 2|Adverse Event|0|||
125052620|NCT01005719|449812057|FG001|Period 2|Adverse Event|0|||
125052621|NCT01005719|449812058|FG002|Period 2|Adverse Event|0|||
125052622|NCT01005719|449812059|FG003|Period 2|Adverse Event|0|||
125052623|NCT01005719|449812060|FG004|Period 2|Adverse Event|1|||
125052624|NCT01005719|449812061|FG005|Period 2|Adverse Event|1|||
125052625|NCT04430738|449812062|FG000|Phase 1: Dose Escalation|Death|1|||
125052626|NCT04430738|449812063|FG001|Phase 1: Dose Escalation|Death|4|||
125052627|NCT04430738|449812064|FG002|Phase 1: Dose Escalation|Death|4|||
125052628|NCT04430738|449812065|FG003|Phase 1: Dose Escalation|Death|1|||
125052629|NCT04430738|449812066|FG004|Phase 1: Dose Escalation|Death|6|||
125052630|NCT04430738|449812067|FG005|Phase 1: Dose Escalation|Death|0|||
125052631|NCT04430738|449812062|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
125052632|NCT04430738|449812063|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
125052633|NCT04430738|449812064|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
125052634|NCT04430738|449812065|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
125052635|NCT04430738|449812066|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
125052636|NCT04430738|449812067|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
125052637|NCT04430738|449812062|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
125052638|NCT04430738|449812063|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
125052639|NCT04430738|449812064|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
125052640|NCT04430738|449812065|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
125052641|NCT04430738|449812066|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
125052642|NCT04430738|449812067|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
125052643|NCT04430738|449812062|FG000|Phase 1: Dose Escalation|Other|1|||
125052644|NCT04430738|449812063|FG001|Phase 1: Dose Escalation|Other|0|||
125052645|NCT04430738|449812064|FG002|Phase 1: Dose Escalation|Other|0|||
125052646|NCT04430738|449812065|FG003|Phase 1: Dose Escalation|Other|0|||
125052647|NCT04430738|449812066|FG004|Phase 1: Dose Escalation|Other|0|||
125052648|NCT04430738|449812067|FG005|Phase 1: Dose Escalation|Other|0|||
125052649|NCT04430738|449812062|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
125052650|NCT04430738|449812063|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
125052651|NCT04430738|449812064|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
125052652|NCT04430738|449812065|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
125052653|NCT04430738|449812066|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
125052654|NCT04430738|449812067|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
125052655|NCT04430738|449812062|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
125052656|NCT04430738|449812063|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
125052657|NCT04430738|449812064|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
125052658|NCT04430738|449812065|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
125052659|NCT04430738|449812066|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
125052660|NCT04430738|449812067|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
125052661|NCT05187013|449812068|FG000|Overall Study|Withdrawal by Subject|1|||
125052662|NCT05187013|449812069|FG001|Overall Study|Withdrawal by Subject|1|||
125052663|NCT05187013|449812070|FG002|Overall Study|Withdrawal by Subject|0|||
125052664|NCT05187013|449812068|FG000|Overall Study|Death|0|||
125052665|NCT05187013|449812069|FG001|Overall Study|Death|1|||
125052666|NCT05187013|449812070|FG002|Overall Study|Death|0|||
125052667|NCT05187013|449812068|FG000|Overall Study|Lost to Follow-up|20|||
125052668|NCT05187013|449812069|FG001|Overall Study|Lost to Follow-up|17|||
125219982|NCT00572455|450432735|FG008|Stage II (28 Days)|Adverse Event|1|||
125219983|NCT00572455|450432736|FG009|Stage II (28 Days)|Adverse Event|3|||
125219984|NCT00572455|450432737|FG010|Stage II (28 Days)|Adverse Event|3|||
125219985|NCT00572455|450432738|FG011|Stage II (28 Days)|Adverse Event|4|||
125219986|NCT00572455|450432739|FG012|Stage II (28 Days)|Adverse Event|5|||
125219987|NCT00572455|450432740|FG013|Stage II (28 Days)|Adverse Event|1|||
125219988|NCT00572455|450432727|FG000|Stage II (28 Days)|Death|0|||
125219989|NCT00572455|450432728|FG001|Stage II (28 Days)|Death|0|||
125219990|NCT00572455|450432729|FG002|Stage II (28 Days)|Death|0|||
125219991|NCT00572455|450432730|FG003|Stage II (28 Days)|Death|0|||
125052669|NCT05187013|449812070|FG002|Overall Study|Lost to Follow-up|0|||
125052670|NCT05187013|449812068|FG000|Overall Study|Ongoing Participants|3|||
125052671|NCT05187013|449812069|FG001|Overall Study|Ongoing Participants|5|||
125219992|NCT00572455|450432731|FG004|Stage II (28 Days)|Death|0|||
125219993|NCT00572455|450432732|FG005|Stage II (28 Days)|Death|0|||
125219994|NCT00572455|450432733|FG006|Stage II (28 Days)|Death|0|||
125219995|NCT00572455|450432734|FG007|Stage II (28 Days)|Death|0|||
125219996|NCT00572455|450432735|FG008|Stage II (28 Days)|Death|1|||
125219997|NCT00572455|450432736|FG009|Stage II (28 Days)|Death|0|||
125219998|NCT00572455|450432737|FG010|Stage II (28 Days)|Death|0|||
125052672|NCT05187013|449812070|FG002|Overall Study|Ongoing Participants|0|||
125052673|NCT04488822|449812071|FG000|Overall Study|Adverse Event|8|||
125052674|NCT04488822|449812071|FG000|Overall Study|Withdrawal by Subject|1|||
125219999|NCT00572455|450432738|FG011|Stage II (28 Days)|Death|0|||
125220000|NCT00572455|450432739|FG012|Stage II (28 Days)|Death|0|||
125052675|NCT03838367|449812072|FG000|Overall Study|Early termination of study|3|||
125220001|NCT00572455|450432740|FG013|Stage II (28 Days)|Death|0|||
125052676|NCT03838367|449812073|FG001|Overall Study|Early termination of study|4|||
125052677|NCT03838367|449812074|FG002|Overall Study|Early termination of study|3|||
125052678|NCT03838367|449812075|FG003|Overall Study|Early termination of study|0|||
125052679|NCT03406104|449812076|FG000|Overall Study|Lost to Follow-up|2|||
125220002|NCT00572455|450432727|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
125220003|NCT00572455|450432728|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
125220004|NCT00572455|450432729|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
125220005|NCT00572455|450432730|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
125052680|NCT03406104|449812076|FG000|Overall Study|Withdrawal by Subject|2|||
125052681|NCT03406104|449812076|FG000|Overall Study|due to Covid patient did not want to travel|1|||
125052682|NCT03406104|449812076|FG000|Overall Study|Death|2|||
125052683|NCT02499146|449812090|FG000|Overall Study|Lost to Follow-up|1|||
125052684|NCT02499146|449812090|FG000|Overall Study|Withdrawal by Subject|1|||
125052685|NCT02499146|449812090|FG000|Overall Study|Other|2|||
125052686|NCT02499146|449812090|FG000|Overall Study|Ongoing at date of cut-off|9|||
125052687|NCT02499146|449812090|FG000|Overall Study|Began other treatment/therapy|13|||
125052688|NCT01879618|449812091|FG000|Overall Study|Does not meet entrance criteria|1|||
125052689|NCT01879618|449812091|FG000|Overall Study|Withdrawal by Subject|1|||
125052690|NCT01879618|449812091|FG000|Overall Study|Surgery;changed schedule; not available|8|||
125052691|NCT01879618|449812091|FG000|Overall Study|Protocol Violation|6|||
125052692|NCT01879618|449812091|FG000|Overall Study|Adverse Event|5|||
125052693|NCT02890329|449812092|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
125052694|NCT02890329|449812093|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
125052695|NCT02890329|449812094|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
125052696|NCT02890329|449812095|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
125052697|NCT02890329|449812096|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
125052698|NCT02890329|449812097|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
125052699|NCT02890329|449812092|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
125052700|NCT02890329|449812093|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
125052701|NCT02890329|449812094|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
125052702|NCT02890329|449812095|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
125052703|NCT02890329|449812096|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
125052704|NCT02890329|449812097|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
125052705|NCT02890329|449812092|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
125052706|NCT02890329|449812093|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
125052707|NCT02890329|449812094|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
125052708|NCT02890329|449812095|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
125052709|NCT02890329|449812096|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
125052710|NCT02890329|449812097|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
125052711|NCT02890329|449812092|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
125052712|NCT02890329|449812093|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
125052713|NCT02890329|449812094|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
125052714|NCT02890329|449812095|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
125052715|NCT02890329|449812096|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
125052716|NCT02890329|449812097|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
125052717|NCT00001262|449812100|FG000|Overall Study|Death|10|||
125052718|NCT00001262|449812101|FG001|Overall Study|Death|11|||
125052719|NCT00001262|449812102|FG002|Overall Study|Death|0|||
125052720|NCT00001262|449812100|FG000|Overall Study|Withdrawal by Subject|0|||
125052721|NCT00001262|449812101|FG001|Overall Study|Withdrawal by Subject|3|||
125052722|NCT00001262|449812102|FG002|Overall Study|Withdrawal by Subject|0|||
125052723|NCT00878072|449812103|FG000|Overall Study|Withdrew consent|2|||
125052724|NCT01954121|449812104|FG000|Overall Study|Lack of Efficacy|94|||
125052725|NCT01954121|449812105|FG001|Overall Study|Lack of Efficacy|41|||
125052726|NCT01954121|449812104|FG000|Overall Study|Protocol Violation|0|||
125052727|NCT01954121|449812105|FG001|Overall Study|Protocol Violation|2|||
125052728|NCT01954121|449812104|FG000|Overall Study|Lost to Follow-up|5|||
125052729|NCT01954121|449812105|FG001|Overall Study|Lost to Follow-up|6|||
125052730|NCT01954121|449812104|FG000|Overall Study|Withdrawal by Subject|18|||
125052731|NCT01954121|449812105|FG001|Overall Study|Withdrawal by Subject|12|||
125052732|NCT01954121|449812104|FG000|Overall Study|Pregnancy|1|||
125052733|NCT01954121|449812105|FG001|Overall Study|Pregnancy|1|||
125052734|NCT01954121|449812104|FG000|Overall Study|AE, serious fatal|1|||
125052735|NCT01954121|449812105|FG001|Overall Study|AE, serious fatal|0|||
125052736|NCT01954121|449812104|FG000|Overall Study|AE, non-serious non-fatal|5|||
125052737|NCT01954121|449812105|FG001|Overall Study|AE, non-serious non-fatal|22|||
125052738|NCT01954121|449812104|FG000|Overall Study|SAE, non-fatal|1|||
125052739|NCT01954121|449812105|FG001|Overall Study|SAE, non-fatal|4|||
125052740|NCT01954121|449812104|FG000|Overall Study|Non-compliant with study procedures|1|||
125052741|NCT01954121|449812105|FG001|Overall Study|Non-compliant with study procedures|0|||
125052742|NCT01954121|449812104|FG000|Overall Study|Non-compliant patient|1|||
125052743|NCT01954121|449812105|FG001|Overall Study|Non-compliant patient|1|||
125052744|NCT01954121|449812104|FG000|Overall Study|Subject did not follow instructions|0|||
125052745|NCT01954121|449812105|FG001|Overall Study|Subject did not follow instructions|2|||
125052746|NCT03844633|449812106|FG000|1 Week FU|Lost to Follow-up|0|||
125052747|NCT03844633|449812107|FG001|1 Week FU|Lost to Follow-up|1|||
125052748|NCT03844633|449812108|FG002|1 Week FU|Lost to Follow-up|4|||
125052749|NCT03844633|449812106|FG000|12-month Follow-up|Lost to Follow-up|7|||
125052750|NCT03844633|449812107|FG001|12-month Follow-up|Lost to Follow-up|5|||
125052751|NCT03844633|449812108|FG002|12-month Follow-up|Lost to Follow-up|8|||
125052752|NCT02588248|449812109|FG000|Overall Study|Physician Decision|4|||
125052753|NCT02588248|449812110|FG001|Overall Study|Physician Decision|3|||
125052754|NCT01413178|449812111|FG000|Overall Study|Toxicity|1|||
125052755|NCT01413178|449812112|FG001|Overall Study|Toxicity|0|||
125052756|NCT01413178|449812111|FG000|Overall Study|Ineligible|0|||
125052757|NCT01413178|449812112|FG001|Overall Study|Ineligible|2|||
125052758|NCT00237796|449812113|FG000|Overall Study|Baseline and one other ILSS required|10|||
125052759|NCT00237796|449812114|FG001|Overall Study|Baseline and one other ILSS required|5|||
125052760|NCT03860844|449812115|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
125052761|NCT03860844|449812116|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
125052762|NCT03860844|449812117|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
125052763|NCT03860844|449812115|FG000|Overall Study|Progressive disease|5|||
125052764|NCT03860844|449812116|FG001|Overall Study|Progressive disease|3|||
125052765|NCT03860844|449812117|FG002|Overall Study|Progressive disease|4|||
125052766|NCT03860844|449812115|FG000|Overall Study|Other, Not related to COVID-19|0|||
125052767|NCT03860844|449812116|FG001|Overall Study|Other, Not related to COVID-19|1|||
125052768|NCT03860844|449812117|FG002|Overall Study|Other, Not related to COVID-19|0|||
125052769|NCT01678807|449812118|FG000|Overall Study|Adverse Event|4|||
125052770|NCT01678807|449812119|FG001|Overall Study|Adverse Event|4|||
125052771|NCT01678807|449812120|FG002|Overall Study|Adverse Event|0|||
125052772|NCT01678807|449812118|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
125052773|NCT01678807|449812119|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
125052774|NCT01678807|449812120|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
125052775|NCT00370149|449812121|FG000|Overall Study|Physician Decision|16|||
125052776|NCT00370149|449812122|FG001|Overall Study|Physician Decision|16|||
125052777|NCT00370149|449812121|FG000|Overall Study|Protocol Violation|1|||
125052778|NCT00370149|449812122|FG001|Overall Study|Protocol Violation|0|||
125052779|NCT00370149|449812121|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
125220006|NCT00572455|450432731|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
125220007|NCT00572455|450432732|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
125052780|NCT00370149|449812122|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
125052781|NCT00370149|449812121|FG000|Overall Study|Pre-existing infection|0|||
125052782|NCT00370149|449812122|FG001|Overall Study|Pre-existing infection|1|||
125052783|NCT00370149|449812121|FG000|Overall Study|Antibiotic coated dressing placed|0|||
125052784|NCT00370149|449812122|FG001|Overall Study|Antibiotic coated dressing placed|1|||
125052785|NCT04400318|449813182|FG000|Overall Study|Adverse Event|1|||
125052786|NCT04400318|449813183|FG001|Overall Study|Adverse Event|0|||
125052787|NCT04400318|449813182|FG000|Overall Study|Withdrawal by Subject|1|||
125052788|NCT04400318|449813183|FG001|Overall Study|Withdrawal by Subject|1|||
125052789|NCT04400318|449813182|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
125052790|NCT04400318|449813183|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
125052791|NCT01096446|449813184|FG000|Overall Study|Death|1|||
125052792|NCT01096446|449813185|FG001|Overall Study|Death|0|||
125052793|NCT01096446|449813184|FG000|Overall Study|Protocol Violation|2|||
125052794|NCT01096446|449813185|FG001|Overall Study|Protocol Violation|0|||
125052795|NCT01043185|449813186|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
125052796|NCT01043185|449813187|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
125052797|NCT01043185|449813188|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
125052798|NCT01043185|449813189|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
125052799|NCT01043185|449813190|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
125052800|NCT01043185|449813191|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
125052801|NCT01043185|449813192|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
125052802|NCT01043185|449813193|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
125052803|NCT01043185|449813194|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
125052804|NCT01043185|449813195|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
125052805|NCT01104558|449813196|FG000|Overall Study|Protocol Violation|6|||
125052806|NCT01104558|449813196|FG000|Overall Study|Missing of primary efficacy assessment|10|||
125052807|NCT01104558|449813196|FG000|Overall Study|Missing of genetic analysis results|1|||
125052808|NCT03395197|449813199|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
125052809|NCT03395197|449813200|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
125052810|NCT03395197|449813201|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
125052811|NCT03395197|449813202|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
125052812|NCT03395197|449813203|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
125052813|NCT03395197|449813204|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
125052814|NCT03395197|449813199|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
125052815|NCT03395197|449813200|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
125052816|NCT03395197|449813201|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
125052817|NCT03395197|449813202|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
125052818|NCT03395197|449813203|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
125052819|NCT03395197|449813204|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
125052820|NCT03395197|449813199|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
125052821|NCT03395197|449813200|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
125052822|NCT03395197|449813201|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
125052823|NCT03395197|449813202|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
125052824|NCT03395197|449813203|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
125052825|NCT03395197|449813204|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
125052826|NCT03395197|449813199|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
125052827|NCT03395197|449813200|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
125052828|NCT03395197|449813201|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
125052829|NCT03395197|449813202|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
125220008|NCT00572455|450432733|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
125220009|NCT00572455|450432734|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
125220010|NCT00572455|450432735|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
125220011|NCT00572455|450432736|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
125220012|NCT00572455|450432737|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
125220013|NCT00572455|450432738|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
125220014|NCT00572455|450432739|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
125220015|NCT00572455|450432740|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
125220016|NCT00572455|450432727|FG000|Stage II (28 Days)|Other|0|||
125220017|NCT00572455|450432728|FG001|Stage II (28 Days)|Other|0|||
125220018|NCT00572455|450432729|FG002|Stage II (28 Days)|Other|0|||
125220019|NCT00572455|450432730|FG003|Stage II (28 Days)|Other|0|||
125220020|NCT00572455|450432731|FG004|Stage II (28 Days)|Other|0|||
125220021|NCT00572455|450432732|FG005|Stage II (28 Days)|Other|0|||
125220022|NCT00572455|450432733|FG006|Stage II (28 Days)|Other|0|||
125220023|NCT00572455|450432734|FG007|Stage II (28 Days)|Other|0|||
125220024|NCT00572455|450432735|FG008|Stage II (28 Days)|Other|1|||
125220025|NCT00572455|450432736|FG009|Stage II (28 Days)|Other|0|||
125220026|NCT00572455|450432737|FG010|Stage II (28 Days)|Other|0|||
125220027|NCT00572455|450432738|FG011|Stage II (28 Days)|Other|0|||
125220028|NCT00572455|450432739|FG012|Stage II (28 Days)|Other|0|||
125220029|NCT00572455|450432740|FG013|Stage II (28 Days)|Other|0|||
125220030|NCT00572455|450432727|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
125220031|NCT00572455|450432728|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
125220032|NCT00572455|450432729|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
125220033|NCT00572455|450432730|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
125220034|NCT00572455|450432731|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
125220035|NCT00572455|450432732|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
125220036|NCT00572455|450432733|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
125220037|NCT00572455|450432734|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
125220038|NCT00572455|450432735|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
125220039|NCT00572455|450432736|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
125220040|NCT00572455|450432737|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
125220041|NCT00572455|450432738|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
125220042|NCT00572455|450432739|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
125220043|NCT00572455|450432740|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
125220044|NCT02824224|450432741|FG000|Overall Study|Discontinued, IUS expulsion|0|||
125220045|NCT02824224|450432742|FG001|Overall Study|Discontinued, IUS expulsion|1|||
125220046|NCT02824224|450432741|FG000|Overall Study|Did not show up for allocation visit|2|||
125220047|NCT02824224|450432742|FG001|Overall Study|Did not show up for allocation visit|0|||
125220048|NCT04152083|450432747|FG000|Overall Study|Lost to Follow-up|2|||
125220049|NCT04152083|450432748|FG001|Overall Study|Lost to Follow-up|1|||
125220050|NCT04152083|450432747|FG000|Overall Study|Adverse Event|1|||
125220051|NCT04152083|450432748|FG001|Overall Study|Adverse Event|0|||
125220052|NCT04152083|450432747|FG000|Overall Study|Randomized but not treated|3|||
125220053|NCT04152083|450432748|FG001|Overall Study|Randomized but not treated|2|||
125220054|NCT00856999|450432749|FG000|Overall Study|Withdrawal by Subject|5|||
125220055|NCT02465437|450432754|FG000|Overall Study|Physician Decision|0|||
125220056|NCT02465437|450432755|FG001|Overall Study|Physician Decision|0|||
125220057|NCT02465437|450432756|FG002|Overall Study|Physician Decision|1|||
125220058|NCT02465437|450432757|FG003|Overall Study|Physician Decision|0|||
125220059|NCT02465437|450432754|FG000|Overall Study|Withdrawal by Subject|1|||
125220060|NCT02465437|450432755|FG001|Overall Study|Withdrawal by Subject|0|||
125220061|NCT02465437|450432756|FG002|Overall Study|Withdrawal by Subject|0|||
125220062|NCT02465437|450432757|FG003|Overall Study|Withdrawal by Subject|1|||
125220063|NCT02465437|450432754|FG000|Overall Study|Adverse Event|0|||
125220064|NCT02465437|450432755|FG001|Overall Study|Adverse Event|1|||
125220065|NCT02465437|450432756|FG002|Overall Study|Adverse Event|0|||
125052830|NCT03395197|449813203|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
125052831|NCT03395197|449813204|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
125052832|NCT03395197|449813199|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
125052833|NCT03395197|449813200|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
125052834|NCT03395197|449813201|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
125052835|NCT03395197|449813202|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
125052836|NCT03395197|449813203|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
125052837|NCT03395197|449813204|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
125052838|NCT03395197|449813199|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
125052839|NCT03395197|449813200|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
125052840|NCT03395197|449813201|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
125052841|NCT03395197|449813202|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
125052842|NCT03395197|449813203|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
125052843|NCT03395197|449813204|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
125052844|NCT03395197|449813199|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
125052845|NCT03395197|449813200|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
125052846|NCT03395197|449813201|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
125052847|NCT03395197|449813202|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
125052848|NCT03395197|449813203|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
125052849|NCT03395197|449813204|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
125052850|NCT03395197|449813199|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
125052851|NCT03395197|449813200|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
125052852|NCT03395197|449813201|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
125052853|NCT03395197|449813202|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
125052854|NCT03395197|449813203|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
125052855|NCT03395197|449813204|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
125052856|NCT03395197|449813199|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
125052857|NCT03395197|449813200|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
125052858|NCT03395197|449813201|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
125052859|NCT03395197|449813202|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
125052860|NCT03395197|449813203|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
125052861|NCT03395197|449813204|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
125052862|NCT03395197|449813199|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
125052863|NCT03395197|449813200|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
125052864|NCT03395197|449813201|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
125052865|NCT03395197|449813202|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
125052866|NCT03395197|449813203|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
125052867|NCT03395197|449813204|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
125052868|NCT03395197|449813199|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
125052869|NCT03395197|449813200|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
125052870|NCT03395197|449813201|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
125052871|NCT03395197|449813202|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
125052872|NCT03395197|449813203|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
125052873|NCT03395197|449813204|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
125052874|NCT03395197|449813199|FG000|Analysis for DDR-Deficient Participants|Death|0|||
125052875|NCT03395197|449813200|FG001|Analysis for DDR-Deficient Participants|Death|0|||
125052876|NCT03395197|449813201|FG002|Analysis for DDR-Deficient Participants|Death|0|||
125052877|NCT03395197|449813202|FG003|Analysis for DDR-Deficient Participants|Death|0|||
125052878|NCT03395197|449813203|FG004|Analysis for DDR-Deficient Participants|Death|1|||
125052879|NCT03395197|449813204|FG005|Analysis for DDR-Deficient Participants|Death|4|||
125052880|NCT03395197|449813199|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
125052881|NCT03395197|449813200|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
125052882|NCT03395197|449813201|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
125052883|NCT03395197|449813202|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
125052884|NCT03395197|449813203|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
125052885|NCT03395197|449813204|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
125052886|NCT03395197|449813199|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
125052887|NCT03395197|449813200|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
125052888|NCT03395197|449813201|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
125052889|NCT03395197|449813202|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
125052890|NCT03395197|449813203|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
125052891|NCT03395197|449813204|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
125220066|NCT02465437|450432757|FG003|Overall Study|Adverse Event|0|||
125220067|NCT00003483|450432758|FG000|Overall Study|Not evaluable|1|||
125220068|NCT00656175|450432759|FG000|Overall Study|Adverse Event|1|||
125220069|NCT00656175|450432760|FG001|Overall Study|Adverse Event|0|||
125220070|NCT00656175|450432759|FG000|Overall Study|Transportation issues|0|||
125220071|NCT00656175|450432760|FG001|Overall Study|Transportation issues|1|||
125220072|NCT02149264|450432763|FG000|Overall Study|Withdrawal by Subject|9|||
125220073|NCT02149264|450432763|FG000|Overall Study|Adverse Event|7|||
125220074|NCT02149264|450432763|FG000|Overall Study|Physician Decision|3|||
125220075|NCT02149264|450432763|FG000|Overall Study|Protocol Violation|1|||
125220076|NCT03472521|450432764|FG000|Overall Study|Lost to Follow-up|3|||
125220077|NCT03472521|450432765|FG001|Overall Study|Lost to Follow-up|2|||
125220078|NCT03472521|450432764|FG000|Overall Study|Discontinued intervention|3|||
125220079|NCT03472521|450432765|FG001|Overall Study|Discontinued intervention|1|||
125220080|NCT02308228|450432773|FG000|Overall Study|Adverse Event|3|||
125220081|NCT02308228|450432774|FG001|Overall Study|Adverse Event|4|||
125220082|NCT02308228|450432773|FG000|Overall Study|Withdrawal by Subject|5|||
125220083|NCT02308228|450432774|FG001|Overall Study|Withdrawal by Subject|3|||
125220084|NCT03999749|450432775|FG000|Overall Study|Toxicity|16|||
125220085|NCT03999749|450432775|FG000|Overall Study|Withdrawal by Subject|3|||
125220086|NCT03999749|450432775|FG000|Overall Study|Disease progression|26|||
125220087|NCT03999749|450432775|FG000|Overall Study|Physician Decision|4|||
125220088|NCT03999749|450432775|FG000|Overall Study|Death|5|||
125220089|NCT03999749|450432775|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
125220090|NCT00103285|450434391|FG000|Induction|Adverse Event|14|||
125220091|NCT00103285|450434392|FG001|Induction|Adverse Event|0|||
125220092|NCT00103285|450434393|FG002|Induction|Adverse Event|0|||
125220093|NCT00103285|450434394|FG003|Induction|Adverse Event|0|||
125220094|NCT00103285|450434395|FG004|Induction|Adverse Event|0|||
125220095|NCT00103285|450434396|FG005|Induction|Adverse Event|0|||
125220096|NCT00103285|450434397|FG006|Induction|Adverse Event|0|||
125220097|NCT00103285|450434398|FG007|Induction|Adverse Event|0|||
125220098|NCT00103285|450434391|FG000|Induction|Death|24|||
125220099|NCT00103285|450434392|FG001|Induction|Death|0|||
125220100|NCT00103285|450434393|FG002|Induction|Death|0|||
125220101|NCT00103285|450434394|FG003|Induction|Death|0|||
125220102|NCT00103285|450434395|FG004|Induction|Death|0|||
125220103|NCT00103285|450434396|FG005|Induction|Death|0|||
125135976|NCT03199963|450121799|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
125135977|NCT03199963|450121798|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
125135978|NCT03199963|450121799|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
125135979|NCT03199963|450121798|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
125135980|NCT03199963|450121799|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
125135981|NCT00466167|450121800|FG000|Overall Study|Adverse Event|8|||
125135982|NCT00466167|450121801|FG001|Overall Study|Adverse Event|8|||
125135983|NCT00466167|450121802|FG002|Overall Study|Adverse Event|7|||
125135984|NCT00466167|450121800|FG000|Overall Study|Lack of Efficacy|2|||
125135985|NCT00466167|450121801|FG001|Overall Study|Lack of Efficacy|0|||
125135986|NCT00466167|450121802|FG002|Overall Study|Lack of Efficacy|3|||
125135987|NCT00466167|450121800|FG000|Overall Study|Protocol Violation|1|||
125135988|NCT00466167|450121801|FG001|Overall Study|Protocol Violation|1|||
125135989|NCT00466167|450121802|FG002|Overall Study|Protocol Violation|2|||
125135990|NCT00466167|450121800|FG000|Overall Study|Lost to Follow-up|3|||
125135991|NCT00466167|450121801|FG001|Overall Study|Lost to Follow-up|2|||
125135992|NCT00466167|450121802|FG002|Overall Study|Lost to Follow-up|2|||
125135993|NCT00466167|450121800|FG000|Overall Study|Withdrawal by Subject|4|||
125135994|NCT00466167|450121801|FG001|Overall Study|Withdrawal by Subject|1|||
125135995|NCT00466167|450121802|FG002|Overall Study|Withdrawal by Subject|6|||
125135996|NCT00466167|450121800|FG000|Overall Study|patient did not meet inclusion criteria|1|||
125220104|NCT00103285|450434397|FG006|Induction|Death|0|||
125220105|NCT00103285|450434398|FG007|Induction|Death|0|||
125220106|NCT00103285|450434391|FG000|Induction|Physician Decision|103|||
125220107|NCT00103285|450434392|FG001|Induction|Physician Decision|0|||
125135997|NCT00466167|450121801|FG001|Overall Study|patient did not meet inclusion criteria|0|||
125135998|NCT00466167|450121802|FG002|Overall Study|patient did not meet inclusion criteria|1|||
125220108|NCT00103285|450434393|FG002|Induction|Physician Decision|0|||
125220109|NCT00103285|450434394|FG003|Induction|Physician Decision|0|||
125220110|NCT00103285|450434395|FG004|Induction|Physician Decision|0|||
125220111|NCT00103285|450434396|FG005|Induction|Physician Decision|0|||
125135999|NCT00466167|450121800|FG000|Overall Study|Not treated|1|||
125136000|NCT00466167|450121801|FG001|Overall Study|Not treated|0|||
125220112|NCT00103285|450434397|FG006|Induction|Physician Decision|0|||
125220113|NCT00103285|450434398|FG007|Induction|Physician Decision|0|||
125220114|NCT00103285|450434391|FG000|Induction|Withdrawal by Subject|1|||
125220115|NCT00103285|450434392|FG001|Induction|Withdrawal by Subject|0|||
125220116|NCT00103285|450434393|FG002|Induction|Withdrawal by Subject|0|||
125220117|NCT00103285|450434394|FG003|Induction|Withdrawal by Subject|0|||
125220118|NCT00103285|450434395|FG004|Induction|Withdrawal by Subject|0|||
125052892|NCT03395197|449813199|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
125052893|NCT03395197|449813200|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
125052894|NCT03395197|449813201|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
125052895|NCT03395197|449813202|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
125052896|NCT03395197|449813203|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
125052897|NCT03395197|449813204|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
125052898|NCT03395197|449813199|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
125052899|NCT03395197|449813200|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
125052900|NCT03395197|449813201|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
125052901|NCT03395197|449813202|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
125052902|NCT03395197|449813203|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
125052903|NCT03395197|449813204|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
125052904|NCT03395197|449813199|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
125052905|NCT03395197|449813200|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
125052906|NCT03395197|449813201|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
125052907|NCT03395197|449813202|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
125052908|NCT03395197|449813203|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
125052909|NCT03395197|449813204|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
125052910|NCT03395197|449813199|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
125052911|NCT03395197|449813200|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
125052912|NCT03395197|449813201|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
125052913|NCT03395197|449813202|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
125052914|NCT03395197|449813203|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
125052915|NCT03395197|449813204|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
125052916|NCT03395197|449813199|FG000|Analysis for DDR-Deficient Participants|Other|0|||
125052917|NCT03395197|449813200|FG001|Analysis for DDR-Deficient Participants|Other|0|||
125052918|NCT03395197|449813201|FG002|Analysis for DDR-Deficient Participants|Other|0|||
125052919|NCT03395197|449813202|FG003|Analysis for DDR-Deficient Participants|Other|0|||
125052920|NCT03395197|449813203|FG004|Analysis for DDR-Deficient Participants|Other|3|||
125052921|NCT03395197|449813204|FG005|Analysis for DDR-Deficient Participants|Other|3|||
125052922|NCT03395197|449813199|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
125052923|NCT03395197|449813200|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
125052924|NCT03395197|449813201|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
125052925|NCT03395197|449813202|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
125052926|NCT03395197|449813203|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
125052927|NCT03395197|449813204|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
125052928|NCT05137041|449813205|FG000|Overall Study|Lost to Follow-up|1|||
125052929|NCT05137041|449813206|FG001|Overall Study|Lost to Follow-up|1|||
125052930|NCT05137041|449813205|FG000|Overall Study|Withdrawal by Subject|0|||
125052931|NCT05137041|449813206|FG001|Overall Study|Withdrawal by Subject|2|||
125052932|NCT05137041|449813205|FG000|Overall Study|Reason not Specified|0|||
125052933|NCT05137041|449813206|FG001|Overall Study|Reason not Specified|1|||
125052934|NCT01808118|449813212|FG000|Period 1|Adverse Event|15|||
125052935|NCT01808118|449813213|FG001|Period 1|Adverse Event|0|||
125052936|NCT01808118|449813214|FG002|Period 1|Adverse Event|0|||
125052937|NCT01808118|449813212|FG000|Period 1|Withdrew consent|24|||
125052938|NCT01808118|449813213|FG001|Period 1|Withdrew consent|0|||
125052939|NCT01808118|449813214|FG002|Period 1|Withdrew consent|0|||
125052940|NCT01808118|449813212|FG000|Period 1|Lost to Follow-up|9|||
125052941|NCT01808118|449813213|FG001|Period 1|Lost to Follow-up|0|||
125052942|NCT01808118|449813214|FG002|Period 1|Lost to Follow-up|0|||
125052943|NCT01808118|449813212|FG000|Period 1|Did not meet criteria for remission|303|||
125052944|NCT01808118|449813213|FG001|Period 1|Did not meet criteria for remission|0|||
125136001|NCT00466167|450121802|FG002|Overall Study|Not treated|0|||
125136002|NCT03366792|450121809|FG000|Overall Study|Withdrawal by Subject|7|||
125136003|NCT03366792|450121809|FG000|Overall Study|Lost to Follow-up|2|||
125136004|NCT03366792|450121809|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
125136005|NCT03366792|450121809|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
125052945|NCT01808118|449813214|FG002|Period 1|Did not meet criteria for remission|0|||
125052946|NCT01808118|449813212|FG000|Period 1|Enrolled in error|7|||
125052947|NCT01808118|449813213|FG001|Period 1|Enrolled in error|0|||
125052948|NCT01808118|449813214|FG002|Period 1|Enrolled in error|0|||
125052949|NCT01808118|449813212|FG000|Period 1|Did not meet inclusion criteria|3|||
125052950|NCT01808118|449813213|FG001|Period 1|Did not meet inclusion criteria|0|||
125136006|NCT02450539|450121810|FG000|Overall Study|Withdrawal by Subject|12|||
125052951|NCT01808118|449813214|FG002|Period 1|Did not meet inclusion criteria|0|||
125052952|NCT01808118|449813212|FG000|Period 1|Non-conformance with inclusion criteria|3|||
125052953|NCT01808118|449813213|FG001|Period 1|Non-conformance with inclusion criteria|0|||
125136007|NCT02450539|450121811|FG001|Overall Study|Withdrawal by Subject|6|||
125052954|NCT01808118|449813214|FG002|Period 1|Non-conformance with inclusion criteria|0|||
125052955|NCT01808118|449813212|FG000|Period 1|Investigator decision: site closure|2|||
125052956|NCT01808118|449813213|FG001|Period 1|Investigator decision: site closure|0|||
125052957|NCT01808118|449813214|FG002|Period 1|Investigator decision: site closure|0|||
125052958|NCT01808118|449813212|FG000|Period 1|Non-compliance per sponsor|1|||
125052959|NCT01808118|449813213|FG001|Period 1|Non-compliance per sponsor|0|||
125052960|NCT01808118|449813214|FG002|Period 1|Non-compliance per sponsor|0|||
125052961|NCT01808118|449813212|FG000|Period 1|Lack of Efficacy|1|||
125052962|NCT01808118|449813213|FG001|Period 1|Lack of Efficacy|0|||
125052963|NCT01808118|449813214|FG002|Period 1|Lack of Efficacy|0|||
125052964|NCT01808118|449813212|FG000|Period 2|Adverse Event|0|||
125052965|NCT01808118|449813213|FG001|Period 2|Adverse Event|4|||
125052966|NCT01808118|449813214|FG002|Period 2|Adverse Event|0|||
125052967|NCT01808118|449813212|FG000|Period 2|Withdrew consent|0|||
125052968|NCT01808118|449813213|FG001|Period 2|Withdrew consent|7|||
125052969|NCT01808118|449813214|FG002|Period 2|Withdrew consent|6|||
125052970|NCT01808118|449813212|FG000|Period 2|Lost to Follow-up|0|||
125052971|NCT01808118|449813213|FG001|Period 2|Lost to Follow-up|0|||
125052972|NCT01808118|449813214|FG002|Period 2|Lost to Follow-up|2|||
125052973|NCT01808118|449813212|FG000|Period 2|Investigator no longer conducting trials|0|||
125052974|NCT01808118|449813213|FG001|Period 2|Investigator no longer conducting trials|1|||
125052975|NCT01808118|449813214|FG002|Period 2|Investigator no longer conducting trials|0|||
125136008|NCT02450539|450121810|FG000|Overall Study|Lost to Follow-up|4|||
125136009|NCT02450539|450121811|FG001|Overall Study|Lost to Follow-up|1|||
125052976|NCT01808118|449813212|FG000|Period 2|Switched to other therapy|0|||
125136010|NCT00402103|450121814|FG000|Overall Study|Adverse Event|60|||
125136011|NCT00402103|450121815|FG001|Overall Study|Adverse Event|7|||
125136012|NCT00402103|450121814|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125136013|NCT00402103|450121815|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125136014|NCT00402103|450121814|FG000|Overall Study|Condition no longer requires study drug|2|||
125136015|NCT00402103|450121815|FG001|Overall Study|Condition no longer requires study drug|0|||
125136016|NCT00402103|450121814|FG000|Overall Study|Protocol Deviation|8|||
125136017|NCT00402103|450121815|FG001|Overall Study|Protocol Deviation|0|||
125136018|NCT00402103|450121814|FG000|Overall Study|Patient withdrew consent|12|||
125136019|NCT00402103|450121815|FG001|Overall Study|Patient withdrew consent|1|||
125136020|NCT00402103|450121814|FG000|Overall Study|Lost to Follow-up|6|||
125136021|NCT00402103|450121815|FG001|Overall Study|Lost to Follow-up|3|||
125136022|NCT00402103|450121814|FG000|Overall Study|Administrative problems|2|||
125136023|NCT00402103|450121815|FG001|Overall Study|Administrative problems|0|||
125136024|NCT04078022|450121816|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
125220119|NCT00103285|450434396|FG005|Induction|Withdrawal by Subject|0|||
125220120|NCT00103285|450434397|FG006|Induction|Withdrawal by Subject|0|||
125220121|NCT00103285|450434398|FG007|Induction|Withdrawal by Subject|0|||
125052977|NCT01808118|449813213|FG001|Period 2|Switched to other therapy|1|||
125052978|NCT01808118|449813214|FG002|Period 2|Switched to other therapy|0|||
125052979|NCT00615290|449813215|FG000|Overall Study|Adverse Event|2|||
125220122|NCT00103285|450434391|FG000|Induction|Ineligible|43|||
125052980|NCT00615290|449813215|FG000|Overall Study|Lost to Follow-up|3|||
125052981|NCT00615290|449813215|FG000|Overall Study|Withdrawal by Subject|1|||
125052982|NCT00615290|449813215|FG000|Overall Study|Other|2|||
125052983|NCT02044159|449813216|FG000|Overall Study|Consent declined (deferred consent)|2|||
125052984|NCT02044159|449813217|FG001|Overall Study|Consent declined (deferred consent)|4|||
125052985|NCT02044159|449813216|FG000|Overall Study|No longer eligible, drug not given|1|||
125052986|NCT02044159|449813217|FG001|Overall Study|No longer eligible, drug not given|0|||
125052987|NCT02044159|449813216|FG000|Overall Study|Nurse declined to give study drug|1|||
125052988|NCT02044159|449813217|FG001|Overall Study|Nurse declined to give study drug|0|||
125136025|NCT04078022|450121817|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
125136026|NCT01895335|450121822|FG000|Overall Study|Adverse Event|106|||
125136027|NCT01895335|450121822|FG000|Overall Study|Lack of Efficacy|53|||
125136028|NCT01895335|450121822|FG000|Overall Study|Poor Compliance to Protocol|11|||
125136029|NCT01895335|450121822|FG000|Overall Study|Included But Not treated|1|||
125136030|NCT01895335|450121822|FG000|Overall Study|Other than Specified Above|44|||
125136031|NCT00418938|450121823|FG000|Overall Study|Reimbursement|1|||
125136032|NCT00418938|450121824|FG001|Overall Study|Reimbursement|0|||
125136033|NCT00418938|450121823|FG000|Overall Study|Administrative decision|3|||
125136034|NCT00418938|450121824|FG001|Overall Study|Administrative decision|3|||
125136035|NCT00418938|450121823|FG000|Overall Study|Withdrawal by Subject|16|||
125136036|NCT00418938|450121824|FG001|Overall Study|Withdrawal by Subject|15|||
125136037|NCT00418938|450121823|FG000|Overall Study|Lost to Follow-up|1|||
125136038|NCT00418938|450121824|FG001|Overall Study|Lost to Follow-up|3|||
125136039|NCT00418938|450121823|FG000|Overall Study|Adverse Event|1|||
125136040|NCT00418938|450121824|FG001|Overall Study|Adverse Event|1|||
125136041|NCT00418938|450121823|FG000|Overall Study|On-going|1|||
125136042|NCT00418938|450121824|FG001|Overall Study|On-going|1|||
125136043|NCT00418938|450121823|FG000|Overall Study|Ineligibility Determined|1|||
125052989|NCT01795898|449813218|FG000|Overall Study|Adverse Event|27|||
125136044|NCT00418938|450121824|FG001|Overall Study|Ineligibility Determined|0|||
125136045|NCT00463684|450121825|FG000|Overall Study|Withdrawal by Subject|1|||
125136046|NCT00463684|450121825|FG000|Overall Study|Lost to Follow-up|3|||
125052990|NCT01795898|449813218|FG000|Overall Study|Lost to Follow-up|20|||
125052991|NCT01795898|449813218|FG000|Overall Study|Withdrawal of consent|6|||
125052992|NCT01795898|449813218|FG000|Overall Study|Diagnosed with metastasis|1|||
125052993|NCT01795898|449813218|FG000|Overall Study|No pain|1|||
125052994|NCT01795898|449813218|FG000|Overall Study|Death|1|||
125052995|NCT01795898|449813218|FG000|Overall Study|Withdrew consent & had adverse events|3|||
125052996|NCT01795898|449813218|FG000|Overall Study|Physician Decision|1|||
125052997|NCT00972478|449813234|FG000|Overall Study|Adverse Event|3|||
125052998|NCT00972478|449813235|FG001|Overall Study|Adverse Event|16|||
125052999|NCT00972478|449813234|FG000|Overall Study|Withdrawal by Subject|1|||
125053000|NCT00972478|449813235|FG001|Overall Study|Withdrawal by Subject|8|||
125053001|NCT00972478|449813234|FG000|Overall Study|Progression/Relapse|0|||
125053002|NCT00972478|449813235|FG001|Overall Study|Progression/Relapse|2|||
125053003|NCT00972478|449813234|FG000|Overall Study|Death|0|||
125053004|NCT00972478|449813235|FG001|Overall Study|Death|2|||
125053005|NCT00972478|449813234|FG000|Overall Study|Not protocol specified|1|||
125053006|NCT00972478|449813235|FG001|Overall Study|Not protocol specified|1|||
125053007|NCT00972478|449813234|FG000|Overall Study|Ineligible|1|||
125053008|NCT00972478|449813235|FG001|Overall Study|Ineligible|7|||
125053009|NCT00972478|449813234|FG000|Overall Study|Not start protocol treatment|1|||
125053010|NCT00972478|449813235|FG001|Overall Study|Not start protocol treatment|2|||
125053011|NCT01522976|449813236|FG000|Overall Study|Ineligible|4|||
125053012|NCT01522976|449813237|FG001|Overall Study|Ineligible|0|||
125053013|NCT01522976|449813238|FG002|Overall Study|Ineligible|1|||
125053014|NCT01522976|449813236|FG000|Overall Study|Death|7|||
125053015|NCT01522976|449813237|FG001|Overall Study|Death|6|||
125053016|NCT01522976|449813238|FG002|Overall Study|Death|2|||
125053017|NCT01522976|449813236|FG000|Overall Study|Still on treatment|9|||
125053018|NCT01522976|449813237|FG001|Overall Study|Still on treatment|9|||
125053019|NCT01522976|449813238|FG002|Overall Study|Still on treatment|6|||
125053020|NCT01522976|449813236|FG000|Overall Study|Disease progression|28|||
125053021|NCT01522976|449813237|FG001|Overall Study|Disease progression|30|||
125053022|NCT01522976|449813238|FG002|Overall Study|Disease progression|25|||
125053023|NCT01522976|449813236|FG000|Overall Study|Adverse Event|17|||
125053024|NCT01522976|449813237|FG001|Overall Study|Adverse Event|7|||
125053025|NCT01522976|449813238|FG002|Overall Study|Adverse Event|18|||
125053026|NCT01522976|449813236|FG000|Overall Study|Refusal unrelated to adverse event|10|||
125053027|NCT01522976|449813237|FG001|Overall Study|Refusal unrelated to adverse event|13|||
125053028|NCT01522976|449813238|FG002|Overall Study|Refusal unrelated to adverse event|14|||
125053029|NCT01522976|449813236|FG000|Overall Study|Not protocol specified|22|||
125053030|NCT01522976|449813237|FG001|Overall Study|Not protocol specified|27|||
125053031|NCT01522976|449813238|FG002|Overall Study|Not protocol specified|27|||
125053032|NCT04075266|449813241|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
125053033|NCT04075266|449813242|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
125053034|NCT04075266|449813241|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
125053035|NCT04075266|449813242|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
125220123|NCT00103285|450434392|FG001|Induction|Ineligible|0|||
125220124|NCT00103285|450434393|FG002|Induction|Ineligible|0|||
125220125|NCT00103285|450434394|FG003|Induction|Ineligible|0|||
125220126|NCT00103285|450434395|FG004|Induction|Ineligible|0|||
125220127|NCT00103285|450434396|FG005|Induction|Ineligible|0|||
125220128|NCT00103285|450434397|FG006|Induction|Ineligible|0|||
125220129|NCT00103285|450434398|FG007|Induction|Ineligible|0|||
125220130|NCT00103285|450434391|FG000|Induction|Refusal|906|||
125220131|NCT00103285|450434392|FG001|Induction|Refusal|0|||
125220132|NCT00103285|450434393|FG002|Induction|Refusal|0|||
125220133|NCT00103285|450434394|FG003|Induction|Refusal|0|||
125220134|NCT00103285|450434395|FG004|Induction|Refusal|0|||
125220135|NCT00103285|450434396|FG005|Induction|Refusal|0|||
125220136|NCT00103285|450434397|FG006|Induction|Refusal|0|||
125220137|NCT00103285|450434398|FG007|Induction|Refusal|0|||
125220138|NCT00103285|450434391|FG000|Induction|Other|258|||
125220139|NCT00103285|450434392|FG001|Induction|Other|0|||
125220140|NCT00103285|450434393|FG002|Induction|Other|0|||
125220141|NCT00103285|450434394|FG003|Induction|Other|0|||
125220142|NCT00103285|450434395|FG004|Induction|Other|0|||
125220143|NCT00103285|450434396|FG005|Induction|Other|0|||
125220144|NCT00103285|450434397|FG006|Induction|Other|0|||
125220145|NCT00103285|450434398|FG007|Induction|Other|0|||
125220146|NCT00103285|450434391|FG000|Response Assignment|Adverse Event|0|||
125220147|NCT00103285|450434392|FG001|Response Assignment|Adverse Event|8|||
125220148|NCT00103285|450434393|FG002|Response Assignment|Adverse Event|3|||
125220149|NCT00103285|450434394|FG003|Response Assignment|Adverse Event|2|||
125220150|NCT00103285|450434395|FG004|Response Assignment|Adverse Event|3|||
125220151|NCT00103285|450434396|FG005|Response Assignment|Adverse Event|1|||
125220152|NCT00103285|450434397|FG006|Response Assignment|Adverse Event|1|||
125220153|NCT00103285|450434398|FG007|Response Assignment|Adverse Event|2|||
125220154|NCT00103285|450434391|FG000|Response Assignment|Death|0|||
125220155|NCT00103285|450434392|FG001|Response Assignment|Death|5|||
125220156|NCT00103285|450434393|FG002|Response Assignment|Death|2|||
125220157|NCT00103285|450434394|FG003|Response Assignment|Death|2|||
125136047|NCT00115063|450121826|FG000|Overall Study|Lost to Follow-up|98|||
125136048|NCT00115063|450121827|FG001|Overall Study|Lost to Follow-up|104|||
125136049|NCT00115063|450121826|FG000|Overall Study|Death|1|||
125136050|NCT00115063|450121827|FG001|Overall Study|Death|0|||
125136051|NCT00191815|450121828|FG000|Overall Study|Adverse Event|2|||
125136052|NCT00191815|450121828|FG000|Overall Study|Disease progression or relapse|24|||
125136053|NCT00191815|450121828|FG000|Overall Study|Death|2|||
125136054|NCT00191815|450121828|FG000|Overall Study|Protocol Violation|3|||
125136055|NCT00191815|450121828|FG000|Overall Study|Physician Decision|2|||
125136056|NCT00191815|450121828|FG000|Overall Study|Withdrawal by Subject|7|||
125053036|NCT05132569|449813243|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
125053037|NCT05132569|449813244|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
125053038|NCT05132569|449813243|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
125136057|NCT01075282|450121829|FG000|Overall Study|Withdrawal by Subject|11|||
125136058|NCT01075282|450121830|FG001|Overall Study|Withdrawal by Subject|7|||
125136059|NCT01075282|450121831|FG002|Overall Study|Withdrawal by Subject|11|||
125136060|NCT01075282|450121829|FG000|Overall Study|Adverse Event|9|||
125136061|NCT01075282|450121830|FG001|Overall Study|Adverse Event|8|||
125136062|NCT01075282|450121831|FG002|Overall Study|Adverse Event|5|||
125136063|NCT01075282|450121829|FG000|Overall Study|Entry Criteria Not Met|3|||
125136064|NCT01075282|450121830|FG001|Overall Study|Entry Criteria Not Met|2|||
125136065|NCT01075282|450121831|FG002|Overall Study|Entry Criteria Not Met|0|||
125136066|NCT01075282|450121829|FG000|Overall Study|Lost to Follow-up|3|||
125136067|NCT01075282|450121830|FG001|Overall Study|Lost to Follow-up|3|||
125136068|NCT01075282|450121831|FG002|Overall Study|Lost to Follow-up|3|||
125136069|NCT01075282|450121829|FG000|Overall Study|Physician Decision|3|||
125136070|NCT01075282|450121830|FG001|Overall Study|Physician Decision|3|||
125136071|NCT01075282|450121831|FG002|Overall Study|Physician Decision|3|||
125136072|NCT01075282|450121829|FG000|Overall Study|Lack of Efficacy|1|||
125136073|NCT01075282|450121830|FG001|Overall Study|Lack of Efficacy|1|||
125136074|NCT01075282|450121831|FG002|Overall Study|Lack of Efficacy|0|||
125220158|NCT00103285|450434395|FG004|Response Assignment|Death|3|||
125053039|NCT05132569|449813244|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
125053040|NCT05132569|449813243|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
125053041|NCT05132569|449813244|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
125053042|NCT04102098|449813245|FG000|Main Study Period|Ongoing in study|302|||
125053043|NCT04102098|449813246|FG001|Main Study Period|Ongoing in study|291|||
125136075|NCT01075282|450121829|FG000|Overall Study|Treatment Non-compliance|1|||
125136076|NCT01075282|450121830|FG001|Overall Study|Treatment Non-compliance|2|||
125136077|NCT01075282|450121831|FG002|Overall Study|Treatment Non-compliance|2|||
125136078|NCT01075282|450121829|FG000|Overall Study|Protocol Violation|0|||
125136079|NCT01075282|450121830|FG001|Overall Study|Protocol Violation|2|||
125136080|NCT01075282|450121831|FG002|Overall Study|Protocol Violation|1|||
125136081|NCT01075282|450121829|FG000|Overall Study|Death|0|||
125136082|NCT01075282|450121830|FG001|Overall Study|Death|1|||
125136083|NCT01075282|450121831|FG002|Overall Study|Death|2|||
125220159|NCT00103285|450434396|FG005|Response Assignment|Death|1|||
125053044|NCT04102098|449813245|FG000|Main Study Period|Death|20|||
125053045|NCT04102098|449813246|FG001|Main Study Period|Death|27|||
125053046|NCT04102098|449813245|FG000|Main Study Period|Lost to Follow-up|1|||
125053047|NCT04102098|449813246|FG001|Main Study Period|Lost to Follow-up|1|||
125136084|NCT01794845|450121832|FG000|Overall Study|Withdrawal by Subject|1|||
125136085|NCT02139826|450121833|FG000|Overall Study|Adverse Event|1|||
125136086|NCT00429416|450121834|FG000|Overall Study|Death|1|||
125136087|NCT06999265|450121835|FG000|Overall Study|Lost to Follow-up|1|||
125136088|NCT06999265|450121836|FG001|Overall Study|Lost to Follow-up|1|||
125136089|NCT02316548|450122827|FG000|Overall Study|Protocol Violation|0|||
125136090|NCT02316548|450122828|FG001|Overall Study|Protocol Violation|1|||
125136091|NCT02571907|450122829|FG000|Overall Study|Death|4|||
125136092|NCT02571907|450122829|FG000|Overall Study|Lost to Follow-up|3|||
125053048|NCT04102098|449813245|FG000|Main Study Period|Physician Decision|0|||
125053049|NCT04102098|449813246|FG001|Main Study Period|Physician Decision|1|||
125053050|NCT04102098|449813245|FG000|Main Study Period|Withdrawal by Subject|11|||
125053051|NCT04102098|449813246|FG001|Main Study Period|Withdrawal by Subject|14|||
125053052|NCT04102098|449813245|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
125053053|NCT04102098|449813246|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
125053054|NCT04102098|449813245|FG000|Crossover: AS Who Crossed Over|Death|11|||
125053055|NCT04102098|449813246|FG001|Crossover: AS Who Crossed Over|Death|0|||
125053056|NCT04102098|449813245|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
125053057|NCT04102098|449813246|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
125053058|NCT04742907|449813247|FG000|Overall Study|Adverse Event|1|||
125053059|NCT04742907|449813248|FG001|Overall Study|Adverse Event|0|||
125053060|NCT04742907|449813249|FG002|Overall Study|Adverse Event|1|||
125053061|NCT04742907|449813247|FG000|Overall Study|Lost to Follow-up|3|||
125053062|NCT04742907|449813248|FG001|Overall Study|Lost to Follow-up|3|||
125053063|NCT04742907|449813249|FG002|Overall Study|Lost to Follow-up|2|||
125053064|NCT04742907|449813247|FG000|Overall Study|Physician Decision|0|||
125053065|NCT04742907|449813248|FG001|Overall Study|Physician Decision|1|||
125053066|NCT04742907|449813249|FG002|Overall Study|Physician Decision|0|||
125053067|NCT04742907|449813247|FG000|Overall Study|Protocol Violation|1|||
125136093|NCT02571907|450122829|FG000|Overall Study|Withdrawal by Subject|3|||
125136094|NCT02286739|450122835|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
125220160|NCT00103285|450434397|FG006|Response Assignment|Death|0|||
125220161|NCT00103285|450434398|FG007|Response Assignment|Death|8|||
125220162|NCT00103285|450434391|FG000|Response Assignment|Lost to Follow-up|0|||
125220163|NCT00103285|450434392|FG001|Response Assignment|Lost to Follow-up|9|||
125220164|NCT00103285|450434393|FG002|Response Assignment|Lost to Follow-up|5|||
125220165|NCT00103285|450434394|FG003|Response Assignment|Lost to Follow-up|5|||
125220166|NCT00103285|450434395|FG004|Response Assignment|Lost to Follow-up|1|||
125220167|NCT00103285|450434396|FG005|Response Assignment|Lost to Follow-up|2|||
125220168|NCT00103285|450434397|FG006|Response Assignment|Lost to Follow-up|2|||
125220169|NCT00103285|450434398|FG007|Response Assignment|Lost to Follow-up|5|||
125220170|NCT00103285|450434391|FG000|Response Assignment|Physician Decision|0|||
125220171|NCT00103285|450434392|FG001|Response Assignment|Physician Decision|13|||
125220172|NCT00103285|450434393|FG002|Response Assignment|Physician Decision|14|||
125220173|NCT00103285|450434394|FG003|Response Assignment|Physician Decision|9|||
125220174|NCT00103285|450434395|FG004|Response Assignment|Physician Decision|13|||
125220175|NCT00103285|450434396|FG005|Response Assignment|Physician Decision|7|||
125220176|NCT00103285|450434397|FG006|Response Assignment|Physician Decision|4|||
125053068|NCT04742907|449813248|FG001|Overall Study|Protocol Violation|1|||
125053069|NCT04742907|449813249|FG002|Overall Study|Protocol Violation|1|||
125053070|NCT04742907|449813247|FG000|Overall Study|Withdrawal by Subject|5|||
125053071|NCT04742907|449813248|FG001|Overall Study|Withdrawal by Subject|6|||
125053072|NCT04742907|449813249|FG002|Overall Study|Withdrawal by Subject|4|||
125053073|NCT04742907|449813247|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
125053074|NCT04742907|449813248|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
125053075|NCT04742907|449813249|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
125053076|NCT04742907|449813247|FG000|Overall Study|Did Not Receive the Study Drug|2|||
125053077|NCT04742907|449813248|FG001|Overall Study|Did Not Receive the Study Drug|4|||
125053078|NCT04742907|449813249|FG002|Overall Study|Did Not Receive the Study Drug|4|||
125053079|NCT02280291|449813250|FG000|Overall Study|Lost to Follow-up|2|||
125053080|NCT02280291|449813251|FG001|Overall Study|Lost to Follow-up|1|||
125053081|NCT02280291|449813252|FG002|Overall Study|Lost to Follow-up|3|||
125053082|NCT02280291|449813253|FG003|Overall Study|Lost to Follow-up|8|||
125053083|NCT02280291|449813250|FG000|Overall Study|Protocol Violation|1|||
125053084|NCT02280291|449813251|FG001|Overall Study|Protocol Violation|0|||
125053085|NCT02280291|449813252|FG002|Overall Study|Protocol Violation|0|||
125053086|NCT02280291|449813253|FG003|Overall Study|Protocol Violation|0|||
125053087|NCT02280291|449813250|FG000|Overall Study|Other|1|||
125053088|NCT02280291|449813251|FG001|Overall Study|Other|1|||
125053089|NCT02280291|449813252|FG002|Overall Study|Other|0|||
125053090|NCT02280291|449813253|FG003|Overall Study|Other|0|||
125053091|NCT03508622|449813254|FG000|Overall Study|Protocol Violation|1|||
125053092|NCT03508622|449813255|FG001|Overall Study|Protocol Violation|0|||
125053093|NCT03508622|449813254|FG000|Overall Study|Withdrawal by Subject|1|||
125053094|NCT03508622|449813255|FG001|Overall Study|Withdrawal by Subject|0|||
125053095|NCT03508622|449813254|FG000|Overall Study|Lost to Follow-up|16|||
125053096|NCT03508622|449813255|FG001|Overall Study|Lost to Follow-up|0|||
125053097|NCT03508622|449813254|FG000|Overall Study|Incomplete data|0|||
125053098|NCT03508622|449813255|FG001|Overall Study|Incomplete data|24|||
125053099|NCT00210158|449813257|FG000|Overall Study|Protocol Violation|0|||
125053100|NCT00210158|449813258|FG001|Overall Study|Protocol Violation|2|||
125053101|NCT03196505|449813260|FG000|Overall Study|Physician Decision|26|||
125053102|NCT03196505|449813261|FG001|Overall Study|Physician Decision|26|||
125053103|NCT05590793|449813263|FG000|Overall Study|Withdrawal by Subject|6|||
125053104|NCT05590793|449813263|FG000|Overall Study|Physician Decision|1|||
125053105|NCT03015610|449813268|FG000|Overall Study|Lost to Follow-up|1|||
125220177|NCT00103285|450434398|FG007|Response Assignment|Physician Decision|35|||
125220178|NCT00103285|450434391|FG000|Response Assignment|Protocol Violation|0|||
125220179|NCT00103285|450434392|FG001|Response Assignment|Protocol Violation|2|||
125220180|NCT00103285|450434393|FG002|Response Assignment|Protocol Violation|0|||
125220181|NCT00103285|450434394|FG003|Response Assignment|Protocol Violation|0|||
125220182|NCT00103285|450434395|FG004|Response Assignment|Protocol Violation|0|||
125220183|NCT00103285|450434396|FG005|Response Assignment|Protocol Violation|0|||
125220184|NCT00103285|450434397|FG006|Response Assignment|Protocol Violation|0|||
125053106|NCT03015610|449813269|FG001|Overall Study|Lost to Follow-up|5|||
125053107|NCT05692154|449813271|FG000|Overall Study|Adverse Event|0|||
125053108|NCT05692154|449813272|FG001|Overall Study|Adverse Event|1|||
125053109|NCT00938327|449813278|FG000|Overall Study|Adverse Event|2|||
125053110|NCT00938327|449813278|FG000|Overall Study|Protocol Violation|1|||
125220185|NCT00103285|450434398|FG007|Response Assignment|Protocol Violation|0|||
125220186|NCT00103285|450434391|FG000|Response Assignment|Withdrawal by Subject|0|||
125053111|NCT00938327|449813278|FG000|Overall Study|Withdrawal by Subject|4|||
125053112|NCT00938327|449813278|FG000|Overall Study|Lost to Follow-up|37|||
125053113|NCT00938327|449813278|FG000|Overall Study|2nd dose received outside of the study|7|||
125053114|NCT00938327|449813278|FG000|Overall Study|Vaccine not received as out of stock|9|||
125053115|NCT01379534|449813279|FG000|Treatment Phase|Withdrawal by Subject|2|||
125053116|NCT01379534|449813280|FG001|Treatment Phase|Withdrawal by Subject|2|||
125053117|NCT01379534|449813279|FG000|Treatment Phase|Progressive disease|13|||
125136095|NCT02286739|450122836|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
125136096|NCT02286739|450122835|FG000|Overall Study|No Verasense type documented|0|||
125136097|NCT02286739|450122836|FG001|Overall Study|No Verasense type documented|23|||
125136098|NCT02286739|450122835|FG000|Overall Study|Adverse Event|1|||
125136099|NCT02286739|450122836|FG001|Overall Study|Adverse Event|2|||
125136100|NCT02286739|450122835|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
125136101|NCT02286739|450122836|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
125136102|NCT02566850|450122837|FG000|Overall Study|Protocol Violation|1|||
125136103|NCT03447353|450122841|FG000|Overall Study|Failure at Screening Visit|2|||
125136104|NCT03447353|450122841|FG000|Overall Study|Lost to Follow-up|4|||
125136105|NCT03447353|450122841|FG000|Overall Study|Scheduling Conflicts|3|||
125136106|NCT03447353|450122841|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
125220187|NCT00103285|450434392|FG001|Response Assignment|Withdrawal by Subject|4|||
125220188|NCT00103285|450434393|FG002|Response Assignment|Withdrawal by Subject|1|||
125220189|NCT00103285|450434394|FG003|Response Assignment|Withdrawal by Subject|1|||
125136107|NCT02642653|450122846|FG000|Overall Study|Adverse Event|2|||
125136108|NCT02642653|450122847|FG001|Overall Study|Adverse Event|0|||
125053118|NCT01379534|449813280|FG001|Treatment Phase|Progressive disease|22|||
125053119|NCT01379534|449813279|FG000|Treatment Phase|Adverse Event|7|||
125053120|NCT01379534|449813280|FG001|Treatment Phase|Adverse Event|7|||
125053121|NCT01379534|449813279|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
125053122|NCT01379534|449813280|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
125053123|NCT01379534|449813279|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
125053124|NCT01379534|449813280|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
125053125|NCT01379534|449813279|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
125053126|NCT01379534|449813280|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
125053127|NCT01379534|449813279|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
125053128|NCT01379534|449813280|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
125220190|NCT00103285|450434395|FG004|Response Assignment|Withdrawal by Subject|2|||
125053129|NCT02552355|449813281|FG000|Overall Study|Adverse Event|0|||
125053130|NCT02552355|449813282|FG001|Overall Study|Adverse Event|2|||
125053131|NCT02552355|449813283|FG002|Overall Study|Adverse Event|2|||
125053132|NCT02552355|449813284|FG003|Overall Study|Adverse Event|0|||
125053133|NCT02552355|449813281|FG000|Overall Study|Withdrawal by Subject|0|||
125053134|NCT02552355|449813282|FG001|Overall Study|Withdrawal by Subject|0|||
125053135|NCT02552355|449813283|FG002|Overall Study|Withdrawal by Subject|0|||
125053136|NCT02552355|449813284|FG003|Overall Study|Withdrawal by Subject|1|||
125053137|NCT01519245|449813285|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
125053138|NCT01519245|449813286|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
125053139|NCT04072146|449813289|FG000|Overall Study|Adverse Event|0|||
125053140|NCT04072146|449813290|FG001|Overall Study|Adverse Event|1|||
125053141|NCT01193348|449813294|FG000|Screening Period|Screen Failure|5|||
125053142|NCT01193348|449813294|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
125053143|NCT01193348|449813294|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
125053144|NCT01193348|449813294|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
125053145|NCT01193348|449813294|FG000|Extension Treatment Period|Physician Decision|1|||
125136109|NCT00830258|450122848|FG000|First Intervention|Adverse Event|1|||
125136110|NCT00830258|450122849|FG001|First Intervention|Adverse Event|0|||
125136111|NCT00830258|450122848|FG000|Washout: 7 Days|Protocol Violation|1|||
125053146|NCT01193348|449813294|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
125053147|NCT04070378|449813295|FG000|Overall Study|Withdrawal by Subject|2|||
125136112|NCT00830258|450122849|FG001|Washout: 7 Days|Protocol Violation|0|||
125136113|NCT02267187|450122853|FG000|Overall Study|Physician Decision|2|||
125136114|NCT02267187|450122853|FG000|Overall Study|Screen fail|3|||
125136115|NCT00682461|450122854|FG000|Overall Study|Adverse Event|5|||
125136116|NCT00682461|450122855|FG001|Overall Study|Adverse Event|7|||
125136117|NCT00682461|450122854|FG000|Overall Study|Lost to Follow-up|8|||
125136118|NCT00682461|450122855|FG001|Overall Study|Lost to Follow-up|5|||
125136119|NCT00682461|450122854|FG000|Overall Study|Withdrawal by Subject|12|||
125136120|NCT00682461|450122855|FG001|Overall Study|Withdrawal by Subject|19|||
125136121|NCT04035187|450122858|FG000|Overall Study|Withdrawal by Subject|2|||
125136122|NCT04035187|450122859|FG001|Overall Study|Withdrawal by Subject|1|||
125136123|NCT04035187|450122860|FG002|Overall Study|Withdrawal by Subject|0|||
125136124|NCT04035187|450122861|FG003|Overall Study|Withdrawal by Subject|0|||
125220191|NCT00103285|450434396|FG005|Response Assignment|Withdrawal by Subject|2|||
125053148|NCT04070378|449813295|FG000|Overall Study|Screen Failure|6|||
125053149|NCT04070378|449813295|FG000|Overall Study|Physician Decision|1|||
125053150|NCT04070378|449813295|FG000|Overall Study|Adverse Event|1|||
125053151|NCT03259334|449813296|FG000|Overall Study|Adverse Event|3|||
125053152|NCT03259334|449813297|FG001|Overall Study|Adverse Event|8|||
125053153|NCT03259334|449813298|FG002|Overall Study|Adverse Event|5|||
125053154|NCT03259334|449813296|FG000|Overall Study|Withdrawal by Subject|4|||
125053155|NCT03259334|449813297|FG001|Overall Study|Withdrawal by Subject|2|||
125053156|NCT03259334|449813298|FG002|Overall Study|Withdrawal by Subject|4|||
125053157|NCT03259334|449813296|FG000|Overall Study|Physician Decision|1|||
125053158|NCT03259334|449813297|FG001|Overall Study|Physician Decision|0|||
125053159|NCT03259334|449813298|FG002|Overall Study|Physician Decision|0|||
125053160|NCT03259334|449813296|FG000|Overall Study|Lost to Follow-up|0|||
125053161|NCT03259334|449813297|FG001|Overall Study|Lost to Follow-up|2|||
125053162|NCT03259334|449813298|FG002|Overall Study|Lost to Follow-up|1|||
125053163|NCT03259334|449813296|FG000|Overall Study|Protocol Deviation|0|||
125053164|NCT03259334|449813297|FG001|Overall Study|Protocol Deviation|3|||
125053165|NCT03259334|449813298|FG002|Overall Study|Protocol Deviation|2|||
125053166|NCT03259334|449813296|FG000|Overall Study|Lack of Efficacy|2|||
125053167|NCT03259334|449813297|FG001|Overall Study|Lack of Efficacy|0|||
125053168|NCT03259334|449813298|FG002|Overall Study|Lack of Efficacy|1|||
125053169|NCT03259334|449813296|FG000|Overall Study|Randomized but never treated|0|||
125053170|NCT03259334|449813297|FG001|Overall Study|Randomized but never treated|2|||
125053171|NCT03259334|449813298|FG002|Overall Study|Randomized but never treated|0|||
125053172|NCT03141086|449813299|FG000|Overall Study|Study Terminated By Sponsor|1|||
125053173|NCT03141086|449813300|FG001|Overall Study|Study Terminated By Sponsor|1|||
125053174|NCT03141086|449813299|FG000|Overall Study|Withdrawal by Subject|0|||
125053175|NCT03141086|449813300|FG001|Overall Study|Withdrawal by Subject|1|||
125053176|NCT03141086|449813299|FG000|Overall Study|Protocol Violation|0|||
125053177|NCT03141086|449813300|FG001|Overall Study|Protocol Violation|1|||
125053178|NCT03141086|449813299|FG000|Overall Study|Adverse Event|0|||
125053179|NCT03141086|449813300|FG001|Overall Study|Adverse Event|2|||
125053180|NCT00719732|449813301|FG000|Overall Study|Lost to Follow-up|20|||
125053181|NCT00719732|449813301|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
125053182|NCT00719732|449813301|FG000|Overall Study|Illness not associated with device|1|||
125053183|NCT04491877|449814794|FG000|Overall Study|Protocol Deviation|1|||
125053184|NCT04491877|449814795|FG001|Overall Study|Protocol Deviation|0|||
125053185|NCT04491877|449814796|FG002|Overall Study|Protocol Deviation|2|||
125053186|NCT04491877|449814797|FG003|Overall Study|Protocol Deviation|0|||
125053187|NCT04491877|449814798|FG004|Overall Study|Protocol Deviation|0|||
125053188|NCT04491877|449814799|FG005|Overall Study|Protocol Deviation|0|||
125053189|NCT04491877|449814800|FG006|Overall Study|Protocol Deviation|1|||
125053190|NCT04491877|449814801|FG007|Overall Study|Protocol Deviation|1|||
125053191|NCT04491877|449814802|FG008|Overall Study|Protocol Deviation|0|||
125053192|NCT04491877|449814794|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125053193|NCT04491877|449814795|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125053194|NCT04491877|449814796|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
125053195|NCT04491877|449814797|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
125053196|NCT04491877|449814798|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
125053197|NCT04491877|449814799|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
125053198|NCT04491877|449814800|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
125053199|NCT04491877|449814801|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
125053200|NCT04491877|449814802|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
125053201|NCT04491877|449814794|FG000|Overall Study|Lost to Follow-up|0|||
125053202|NCT04491877|449814795|FG001|Overall Study|Lost to Follow-up|2|||
125053203|NCT04491877|449814796|FG002|Overall Study|Lost to Follow-up|0|||
125053204|NCT04491877|449814797|FG003|Overall Study|Lost to Follow-up|0|||
125053205|NCT04491877|449814798|FG004|Overall Study|Lost to Follow-up|0|||
125053206|NCT04491877|449814799|FG005|Overall Study|Lost to Follow-up|0|||
125053207|NCT04491877|449814800|FG006|Overall Study|Lost to Follow-up|2|||
125053208|NCT04491877|449814801|FG007|Overall Study|Lost to Follow-up|1|||
125053209|NCT04491877|449814802|FG008|Overall Study|Lost to Follow-up|1|||
125053210|NCT05306873|449814803|FG000|Stage 2|Study stopped|1|||
125053211|NCT05306873|449814804|FG001|Stage 2|Study stopped|1|||
125053212|NCT05306873|449814805|FG002|Stage 2|Study stopped|0|||
125053213|NCT05306873|449814806|FG003|Stage 2|Study stopped|0|||
125053214|NCT05306873|449814803|FG000|Stage 2|Stage 2 Treatment Failure|2|||
125053215|NCT05306873|449814804|FG001|Stage 2|Stage 2 Treatment Failure|3|||
125053216|NCT05306873|449814805|FG002|Stage 2|Stage 2 Treatment Failure|0|||
125053217|NCT05306873|449814806|FG003|Stage 2|Stage 2 Treatment Failure|0|||
125053218|NCT05306873|449814803|FG000|Stage 2|Logistical issues due to participant moving|1|||
125053219|NCT05306873|449814804|FG001|Stage 2|Logistical issues due to participant moving|0|||
125053220|NCT05306873|449814805|FG002|Stage 2|Logistical issues due to participant moving|0|||
125053221|NCT05306873|449814806|FG003|Stage 2|Logistical issues due to participant moving|0|||
125053222|NCT05306873|449814803|FG000|Stage 3|Stage 3 Treatment Failure|0|||
125053223|NCT05306873|449814804|FG001|Stage 3|Stage 3 Treatment Failure|0|||
125053224|NCT05306873|449814805|FG002|Stage 3|Stage 3 Treatment Failure|0|||
125053225|NCT05306873|449814806|FG003|Stage 3|Stage 3 Treatment Failure|1|||
125053226|NCT05306873|449814803|FG000|Stage 3|Study Stopped|0|||
125053227|NCT05306873|449814804|FG001|Stage 3|Study Stopped|0|||
125053228|NCT05306873|449814805|FG002|Stage 3|Study Stopped|1|||
125053229|NCT05306873|449814806|FG003|Stage 3|Study Stopped|0|||
125053230|NCT01286272|449814807|FG000|Overall Study|Ineligible after beginning treatment|1|||
125053231|NCT01286272|449814808|FG001|Overall Study|Ineligible after beginning treatment|3|||
125053232|NCT03625986|449814817|FG000|Randomization Period|Lost to Follow-up|7|||
125053233|NCT03625986|449814818|FG001|Randomization Period|Lost to Follow-up|12|||
125053234|NCT03625986|449814817|FG000|Randomization Period|Withdrawal by Subject|10|||
125053235|NCT03625986|449814818|FG001|Randomization Period|Withdrawal by Subject|6|||
125053236|NCT04920084|449814820|FG000|Overall Study|Adverse Event|1|||
125053237|NCT04920084|449814820|FG000|Overall Study|Lost to Follow-up|2|||
125053238|NCT04920084|449814820|FG000|Overall Study|Withdrawal by Subject|2|||
125053239|NCT00620321|449814821|FG000|Overall Study|Adverse Event|1|||
125053240|NCT00620321|449814822|FG001|Overall Study|Adverse Event|1|||
125053241|NCT00620321|449814821|FG000|Overall Study|Death|1|||
125053242|NCT00620321|449814822|FG001|Overall Study|Death|1|||
125053243|NCT00620321|449814821|FG000|Overall Study|Physician Decision|0|||
125053244|NCT00620321|449814822|FG001|Overall Study|Physician Decision|7|||
125053245|NCT00620321|449814821|FG000|Overall Study|Progressive Disease|5|||
125053246|NCT00620321|449814822|FG001|Overall Study|Progressive Disease|5|||
125053247|NCT00620321|449814821|FG000|Overall Study|Sponsor Decision|0|||
125136125|NCT04035187|450122858|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
125136126|NCT04035187|450122859|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
125136127|NCT04035187|450122860|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
125136128|NCT04035187|450122861|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
125136129|NCT01116739|450122868|FG000|Overall Study|Child had 2 years of HS|110|||
125136130|NCT01116739|450122869|FG001|Overall Study|Child had 2 years of HS|128|||
125136131|NCT01116739|450122868|FG000|Overall Study|Withdrawal by Subject|6|||
125136132|NCT01116739|450122869|FG001|Overall Study|Withdrawal by Subject|0|||
125053248|NCT00620321|449814822|FG001|Overall Study|Sponsor Decision|1|||
125053249|NCT00620321|449814821|FG000|Overall Study|Withdrawal by Subject|1|||
125053250|NCT00620321|449814822|FG001|Overall Study|Withdrawal by Subject|1|||
125053251|NCT04191967|449814823|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
125053252|NCT04191967|449814823|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
125053253|NCT01431144|449814824|FG000|Overall Study|Implant mobility and removal|2|||
125053254|NCT01431144|449814825|FG001|Overall Study|Implant mobility and removal|0|||
125053255|NCT02410902|449814834|FG000|Overall Study|Adverse Event|2|||
125053256|NCT02410902|449814835|FG001|Overall Study|Adverse Event|3|||
125053257|NCT02410902|449814834|FG000|Overall Study|Lost to Follow-up|4|||
125053258|NCT02410902|449814835|FG001|Overall Study|Lost to Follow-up|1|||
125053259|NCT02410902|449814834|FG000|Overall Study|Protocol Violation|1|||
125053260|NCT02410902|449814835|FG001|Overall Study|Protocol Violation|4|||
125053261|NCT02410902|449814834|FG000|Overall Study|Withdrawal by Subject|6|||
125053262|NCT02410902|449814835|FG001|Overall Study|Withdrawal by Subject|8|||
125053263|NCT02410902|449814834|FG000|Overall Study|Non-Compliance|8|||
125053264|NCT02410902|449814835|FG001|Overall Study|Non-Compliance|2|||
125053265|NCT00953043|449814836|FG000|Overall Study|Withdrawal by Subject|4|||
125053266|NCT00953043|449814837|FG001|Overall Study|Withdrawal by Subject|0|||
125053267|NCT00953043|449814836|FG000|Overall Study|Physician Decision|0|||
125053268|NCT00953043|449814837|FG001|Overall Study|Physician Decision|2|||
125053269|NCT00701727|449814839|FG000|First Treatment Period|Adverse Event|0|||
125053270|NCT00701727|449814840|FG001|First Treatment Period|Adverse Event|0|||
125053271|NCT00701727|449814839|FG000|First Treatment Period|Withdrawal by Subject|1|||
125053272|NCT00701727|449814840|FG001|First Treatment Period|Withdrawal by Subject|0|||
125053273|NCT00701727|449814839|FG000|First Treatment Period|sponsor decision|0|||
125053274|NCT00701727|449814840|FG001|First Treatment Period|sponsor decision|1|||
125053275|NCT00701727|449814839|FG000|First Treatment Period|Lost to Follow-up|0|||
125053276|NCT00701727|449814840|FG001|First Treatment Period|Lost to Follow-up|1|||
125053277|NCT00701727|449814839|FG000|Second Treatment Period|Withdrawal by Subject|2|||
125053278|NCT00701727|449814840|FG001|Second Treatment Period|Withdrawal by Subject|0|||
125053279|NCT05113953|449814843|FG000|Overall Study|Adverse Event|5|||
125053280|NCT05113953|449814844|FG001|Overall Study|Adverse Event|0|||
125053281|NCT05113953|449814845|FG002|Overall Study|Adverse Event|3|||
125053282|NCT05113953|449814843|FG000|Overall Study|Lost to Follow-up|3|||
125053283|NCT05113953|449814844|FG001|Overall Study|Lost to Follow-up|4|||
125053284|NCT05113953|449814845|FG002|Overall Study|Lost to Follow-up|2|||
125053285|NCT05113953|449814843|FG000|Overall Study|Non-compliance with Study Drug|1|||
125053286|NCT05113953|449814844|FG001|Overall Study|Non-compliance with Study Drug|0|||
125053287|NCT05113953|449814845|FG002|Overall Study|Non-compliance with Study Drug|0|||
125053288|NCT05113953|449814843|FG000|Overall Study|Withdrawal by Subject|2|||
125053289|NCT05113953|449814844|FG001|Overall Study|Withdrawal by Subject|6|||
125053290|NCT05113953|449814845|FG002|Overall Study|Withdrawal by Subject|4|||
125053291|NCT05113953|449814843|FG000|Overall Study|Reason not Specified|2|||
125053292|NCT05113953|449814844|FG001|Overall Study|Reason not Specified|0|||
125053293|NCT05113953|449814845|FG002|Overall Study|Reason not Specified|0|||
125053294|NCT00523341|449814846|FG000|Overall Study|Withdrawal by Subject|399|||
125053295|NCT00523341|449814847|FG001|Overall Study|Withdrawal by Subject|427|||
125053296|NCT00523341|449814846|FG000|Overall Study|Other|181|||
125053297|NCT00523341|449814847|FG001|Overall Study|Other|198|||
125136133|NCT01116739|450122868|FG000|Overall Study|child too young|2|||
125136134|NCT01116739|450122869|FG001|Overall Study|child too young|6|||
125136135|NCT01116739|450122868|FG000|Overall Study|child not enrolled in head start|10|||
125136136|NCT01116739|450122869|FG001|Overall Study|child not enrolled in head start|2|||
125053298|NCT00523341|449814846|FG000|Overall Study|Adverse Event|122|||
125053299|NCT00523341|449814847|FG001|Overall Study|Adverse Event|155|||
125053300|NCT00523341|449814846|FG000|Overall Study|Death|101|||
125053301|NCT00523341|449814847|FG001|Overall Study|Death|110|||
125053302|NCT00523341|449814846|FG000|Overall Study|Lost to Follow-up|73|||
125053303|NCT00523341|449814847|FG001|Overall Study|Lost to Follow-up|61|||
125053304|NCT00523341|449814846|FG000|Overall Study|Non-compliance|20|||
125053305|NCT00523341|449814847|FG001|Overall Study|Non-compliance|13|||
125053306|NCT00523341|449814846|FG000|Overall Study|Physician Decision|14|||
125136137|NCT01116739|450122868|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
125136138|NCT01116739|450122869|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
125136139|NCT02255149|450122870|FG000|Overall Study|Lost to Follow-up|2|||
125136140|NCT02255149|450122870|FG000|Overall Study|Withdrawal by Subject|1|||
125136141|NCT02255149|450122870|FG000|Overall Study|Withdrawal by PI|1|||
125136142|NCT02255149|450122870|FG000|Overall Study|Implant Failure|1|||
125053307|NCT00523341|449814847|FG001|Overall Study|Physician Decision|13|||
125053308|NCT00523341|449814846|FG000|Overall Study|Requirement for Alternative Therapy|4|||
125136143|NCT03121586|450122873|FG000|Overall Study|Study terminated by sponsor|0|||
125053309|NCT00523341|449814847|FG001|Overall Study|Requirement for Alternative Therapy|14|||
125053310|NCT00523341|449814846|FG000|Overall Study|Protocol Deviation|6|||
125053311|NCT00523341|449814847|FG001|Overall Study|Protocol Deviation|5|||
125053312|NCT00523341|449814846|FG000|Overall Study|Ineligibility Determined|3|||
125053313|NCT00523341|449814847|FG001|Overall Study|Ineligibility Determined|4|||
125053314|NCT00523341|449814846|FG000|Overall Study|Disease Progression|1|||
125053315|NCT00523341|449814847|FG001|Overall Study|Disease Progression|0|||
125053316|NCT02626819|449814848|FG000|Overall Study|Lost to Follow-up|3|||
125053317|NCT02626819|449814849|FG001|Overall Study|Lost to Follow-up|2|||
125053318|NCT02626819|449814848|FG000|Overall Study|Withdrawal by Subject|1|||
125053319|NCT02626819|449814849|FG001|Overall Study|Withdrawal by Subject|0|||
125053320|NCT02626819|449814848|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
125053321|NCT02626819|449814849|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
125053322|NCT00502307|449814852|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
125053323|NCT00502307|449814853|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
125053324|NCT00502307|449814854|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
125053325|NCT00502307|449814852|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
125053326|NCT00502307|449814853|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
125053327|NCT00502307|449814854|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
125053328|NCT00502307|449814852|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
125053329|NCT00502307|449814853|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
125053330|NCT00502307|449814854|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
125053331|NCT00502307|449814852|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
125053332|NCT00502307|449814853|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
125053333|NCT00502307|449814854|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
125053334|NCT00502307|449814852|FG000|Maintenance Period|Progressive disease|80|||
125053335|NCT00502307|449814853|FG001|Maintenance Period|Progressive disease|0|||
125053336|NCT00502307|449814854|FG002|Maintenance Period|Progressive disease|0|||
125053337|NCT00502307|449814852|FG000|Maintenance Period|Discontinued due to other reasons|68|||
125053338|NCT00502307|449814853|FG001|Maintenance Period|Discontinued due to other reasons|0|||
125053339|NCT00502307|449814854|FG002|Maintenance Period|Discontinued due to other reasons|0|||
125053340|NCT00051558|449814855|FG000|Overall Study|Adverse Event|30|||
125053341|NCT00051558|449814856|FG001|Overall Study|Adverse Event|18|||
125053342|NCT00051558|449814855|FG000|Overall Study|Withdrawal by Subject|29|||
125053343|NCT00051558|449814856|FG001|Overall Study|Withdrawal by Subject|42|||
125053344|NCT00051558|449814855|FG000|Overall Study|Death|9|||
125053345|NCT00051558|449814856|FG001|Overall Study|Death|15|||
125053346|NCT00051558|449814855|FG000|Overall Study|Lost to Follow-up|4|||
125053347|NCT00051558|449814856|FG001|Overall Study|Lost to Follow-up|13|||
125053348|NCT00051558|449814855|FG000|Overall Study|Protocol Violation|3|||
125053349|NCT00051558|449814856|FG001|Overall Study|Protocol Violation|4|||
125053350|NCT00051558|449814855|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
125053351|NCT00051558|449814856|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
125053352|NCT00051558|449814855|FG000|Overall Study|Sponsor Decision|6|||
125053353|NCT00051558|449814856|FG001|Overall Study|Sponsor Decision|1|||
125053354|NCT00051558|449814855|FG000|Overall Study|Other|2|||
125053355|NCT00051558|449814856|FG001|Overall Study|Other|1|||
125053356|NCT00051558|449814855|FG000|Overall Study|Significant Lab Value|2|||
125053357|NCT00051558|449814856|FG001|Overall Study|Significant Lab Value|0|||
125053358|NCT00051558|449814855|FG000|Overall Study|Physician Decision|5|||
125053359|NCT00051558|449814856|FG001|Overall Study|Physician Decision|0|||
125053360|NCT02849990|449814864|FG000|Overall Study|Adverse Event|1|||
125053361|NCT02849990|449814864|FG000|Overall Study|Withdrawal by Subject|1|||
125053362|NCT01051986|449814865|FG000|Overall Study|Death|1|||
125053363|NCT01051986|449814866|FG001|Overall Study|Death|0|||
125053364|NCT01051986|449814865|FG000|Overall Study|Withdrawal by Subject|2|||
125053365|NCT01051986|449814866|FG001|Overall Study|Withdrawal by Subject|1|||
125053366|NCT01051986|449814865|FG000|Overall Study|Protocol Violation|2|||
125053367|NCT01051986|449814866|FG001|Overall Study|Protocol Violation|3|||
125053368|NCT01725152|449814868|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
125053369|NCT01725152|449814869|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
125053370|NCT01725152|449814868|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
125053371|NCT01725152|449814869|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
125053372|NCT01725152|449814868|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
125053373|NCT01725152|449814869|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
125053374|NCT01725152|449814868|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
125053375|NCT01725152|449814869|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
125053376|NCT01111539|449814871|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
125053377|NCT01111539|449814872|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
125053378|NCT01111539|449814873|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
125053379|NCT01111539|449814874|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
125053380|NCT01111539|449814875|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
125053381|NCT01111539|449814871|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
125136144|NCT03121586|450122874|FG001|Overall Study|Study terminated by sponsor|0|||
125136145|NCT03121586|450122875|FG002|Overall Study|Study terminated by sponsor|99|||
125136146|NCT03121586|450122873|FG000|Overall Study|Withdrawal by Subject|37|||
125053382|NCT01111539|449814872|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
125053383|NCT01111539|449814873|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
125053384|NCT01111539|449814874|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
125053385|NCT01111539|449814875|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
125053386|NCT01111539|449814871|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
125053387|NCT01111539|449814872|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
125053388|NCT01111539|449814873|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
125053389|NCT01111539|449814874|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
125053390|NCT01111539|449814875|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
125053391|NCT01111539|449814871|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
125053392|NCT01111539|449814872|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
125053393|NCT01111539|449814873|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
125053394|NCT01111539|449814874|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
125053395|NCT01111539|449814875|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
125053396|NCT01111539|449814871|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
125053397|NCT01111539|449814872|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
125053398|NCT01111539|449814873|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
125053399|NCT01111539|449814874|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
125053400|NCT01111539|449814875|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
125053401|NCT01111539|449814871|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
125053402|NCT01111539|449814872|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
125053403|NCT01111539|449814873|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
125053404|NCT01111539|449814874|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
125053405|NCT01111539|449814875|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
125053406|NCT01111539|449814871|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
125053407|NCT01111539|449814872|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
125053408|NCT01111539|449814873|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
125053409|NCT01111539|449814874|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
125053410|NCT01111539|449814875|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
125053411|NCT01111539|449814871|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
125053412|NCT01111539|449814872|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
125053413|NCT01111539|449814873|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
125053414|NCT01111539|449814874|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
125053415|NCT01111539|449814875|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
125053416|NCT01111539|449814871|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125136147|NCT03121586|450122874|FG001|Overall Study|Withdrawal by Subject|14|||
125136148|NCT03121586|450122875|FG002|Overall Study|Withdrawal by Subject|9|||
125136149|NCT03121586|450122873|FG000|Overall Study|Not further specified|6|||
125136150|NCT03121586|450122874|FG001|Overall Study|Not further specified|11|||
125136151|NCT03121586|450122875|FG002|Overall Study|Not further specified|10|||
125136152|NCT03121586|450122873|FG000|Overall Study|Adverse Event|16|||
125136153|NCT03121586|450122874|FG001|Overall Study|Adverse Event|5|||
125136154|NCT03121586|450122875|FG002|Overall Study|Adverse Event|6|||
125136155|NCT03121586|450122873|FG000|Overall Study|Protocol Violation|0|||
125136156|NCT03121586|450122874|FG001|Overall Study|Protocol Violation|5|||
125136157|NCT03121586|450122875|FG002|Overall Study|Protocol Violation|0|||
125220192|NCT00103285|450434397|FG006|Response Assignment|Withdrawal by Subject|0|||
125220193|NCT00103285|450434398|FG007|Response Assignment|Withdrawal by Subject|2|||
125053417|NCT01111539|449814872|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125053418|NCT01111539|449814873|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
125053419|NCT01111539|449814874|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125053420|NCT01111539|449814875|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
125053421|NCT01111539|449814871|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
125053422|NCT01111539|449814872|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
125053423|NCT01111539|449814873|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
125053424|NCT01111539|449814874|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
125053425|NCT01111539|449814875|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
125053426|NCT01111539|449814871|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
125053427|NCT01111539|449814872|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
125136158|NCT03121586|450122873|FG000|Overall Study|Lack of Efficacy|3|||
125136159|NCT03121586|450122874|FG001|Overall Study|Lack of Efficacy|3|||
125220194|NCT00103285|450434391|FG000|Response Assignment|Ineligible|0|||
125053428|NCT01111539|449814873|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
125053429|NCT01111539|449814874|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
125053430|NCT01111539|449814875|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
125053431|NCT01111539|449814871|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
125053432|NCT01111539|449814872|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
125053433|NCT01111539|449814873|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
125053434|NCT01111539|449814874|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
125053435|NCT01111539|449814875|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
125053436|NCT01111539|449814871|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
125053437|NCT01111539|449814872|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
125053438|NCT01111539|449814873|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
125053439|NCT01111539|449814874|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
125053440|NCT01111539|449814875|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
125053441|NCT01111539|449814871|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
125053442|NCT01111539|449814872|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
125053443|NCT01111539|449814873|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
125053444|NCT01111539|449814874|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
125053445|NCT01111539|449814875|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
125136160|NCT03121586|450122875|FG002|Overall Study|Lack of Efficacy|1|||
125136161|NCT03121586|450122873|FG000|Overall Study|Physician Decision|2|||
125136162|NCT03121586|450122874|FG001|Overall Study|Physician Decision|2|||
125136163|NCT03121586|450122875|FG002|Overall Study|Physician Decision|0|||
125220195|NCT00103285|450434392|FG001|Response Assignment|Ineligible|8|||
125220196|NCT00103285|450434393|FG002|Response Assignment|Ineligible|6|||
125220197|NCT00103285|450434394|FG003|Response Assignment|Ineligible|2|||
125220198|NCT00103285|450434395|FG004|Response Assignment|Ineligible|0|||
125053446|NCT03628417|449814876|FG000|Overall Study|Death|1|||
125053447|NCT03628417|449814877|FG001|Overall Study|Death|1|||
125053448|NCT03539458|449814878|FG000|Overall Study|Death|1|||
125053449|NCT00372190|449814879|FG000|Overall Study|Lost to Follow-up|3|||
125053450|NCT00372190|449814880|FG001|Overall Study|Lost to Follow-up|1|||
125053451|NCT00718419|449814881|FG000|Overall Study|Adverse Event|2|||
125053452|NCT00718419|449814882|FG001|Overall Study|Adverse Event|1|||
125053453|NCT00718419|449814881|FG000|Overall Study|Physician Decision|1|||
125053454|NCT00718419|449814882|FG001|Overall Study|Physician Decision|6|||
125053455|NCT00718419|449814881|FG000|Overall Study|Sponsor decision|0|||
125053456|NCT00718419|449814882|FG001|Overall Study|Sponsor decision|1|||
125053457|NCT00718419|449814881|FG000|Overall Study|Withdrawal by Subject|0|||
125136164|NCT03121586|450122873|FG000|Overall Study|Noncompliance with study drug|5|||
125053458|NCT00718419|449814882|FG001|Overall Study|Withdrawal by Subject|5|||
125053459|NCT00718419|449814881|FG000|Overall Study|Progressive Disease|7|||
125136165|NCT03121586|450122874|FG001|Overall Study|Noncompliance with study drug|3|||
125053460|NCT00718419|449814882|FG001|Overall Study|Progressive Disease|25|||
125053461|NCT00718419|449814881|FG000|Overall Study|Death Due to Progressive Disease|2|||
125053462|NCT00718419|449814882|FG001|Overall Study|Death Due to Progressive Disease|0|||
125136166|NCT03121586|450122875|FG002|Overall Study|Noncompliance with study drug|5|||
125136167|NCT03121586|450122873|FG000|Overall Study|Lost to Follow-up|4|||
125136168|NCT03121586|450122874|FG001|Overall Study|Lost to Follow-up|2|||
125136169|NCT03121586|450122875|FG002|Overall Study|Lost to Follow-up|0|||
125136170|NCT03121586|450122873|FG000|Overall Study|Death|2|||
125136171|NCT03121586|450122874|FG001|Overall Study|Death|0|||
125136172|NCT03121586|450122875|FG002|Overall Study|Death|0|||
125136173|NCT04590027|450122876|FG000|Overall Study|Lost to Follow-up|17|||
125136174|NCT04590027|450122877|FG001|Overall Study|Lost to Follow-up|14|||
125136175|NCT04590027|450122876|FG000|Overall Study|Protocol Violation|0|||
125136176|NCT04590027|450122877|FG001|Overall Study|Protocol Violation|3|||
125053463|NCT00718419|449814881|FG000|Overall Study|Death Due to Study Drug Related|0|||
125053464|NCT00718419|449814882|FG001|Overall Study|Death Due to Study Drug Related|1|||
125053465|NCT00718419|449814881|FG000|Overall Study|Death Due to Adverse Events|1|||
125053466|NCT00718419|449814882|FG001|Overall Study|Death Due to Adverse Events|0|||
125053467|NCT00726323|449814885|FG000|Overall Study|Withdrawal by Subject|3|||
125053468|NCT00726323|449814886|FG001|Overall Study|Withdrawal by Subject|1|||
125053469|NCT00726323|449814885|FG000|Overall Study|Physician Decision|1|||
125053470|NCT00726323|449814886|FG001|Overall Study|Physician Decision|0|||
125053471|NCT00726323|449814885|FG000|Overall Study|Progressive disease|23|||
125053472|NCT00726323|449814886|FG001|Overall Study|Progressive disease|16|||
125053473|NCT00726323|449814885|FG000|Overall Study|Clinical progression|0|||
125053474|NCT00726323|449814886|FG001|Overall Study|Clinical progression|3|||
125053475|NCT00726323|449814885|FG000|Overall Study|Adverse Event|9|||
125053476|NCT00726323|449814886|FG001|Overall Study|Adverse Event|9|||
125053477|NCT00726323|449814885|FG000|Overall Study|Death|1|||
125053478|NCT00726323|449814886|FG001|Overall Study|Death|0|||
125053479|NCT00726323|449814885|FG000|Overall Study|Participant wished to discontinue|0|||
125053480|NCT00726323|449814886|FG001|Overall Study|Participant wished to discontinue|1|||
125053481|NCT00726323|449814885|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
125136177|NCT02909907|450122878|FG000|Overall Study|Withdrawal by Subject|0|||
125053482|NCT00726323|449814886|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
125053483|NCT03521154|449814896|FG000|Overall Study|Ongoing study at data cut-off|111|||
125053484|NCT03521154|449814897|FG001|Overall Study|Ongoing study at data cut-off|52|||
125053485|NCT00365716|449814900|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
125136178|NCT02909907|450122879|FG001|Overall Study|Withdrawal by Subject|1|||
125136179|NCT01839279|450122881|FG000|Overall Study|Adverse Event|4|||
125136180|NCT01839279|450122882|FG001|Overall Study|Adverse Event|1|||
125136181|NCT01839279|450122883|FG002|Overall Study|Adverse Event|1|||
125136182|NCT01839279|450122881|FG000|Overall Study|Withdrawal by Subject|4|||
125136183|NCT01839279|450122882|FG001|Overall Study|Withdrawal by Subject|1|||
125136184|NCT01839279|450122883|FG002|Overall Study|Withdrawal by Subject|1|||
125136185|NCT01839279|450122881|FG000|Overall Study|Classified as 'Other'|5|||
125053486|NCT00365716|449814901|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
125053487|NCT00365716|449814902|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
125053488|NCT00365716|449814903|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
125053489|NCT00365716|449814904|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
125053490|NCT00365716|449814905|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
125053491|NCT00365716|449814906|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
125053492|NCT00365716|449814900|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
125053493|NCT00365716|449814901|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
125053494|NCT00365716|449814902|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
125053495|NCT00365716|449814903|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
125053496|NCT00365716|449814904|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
125053497|NCT00365716|449814905|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
125053498|NCT00365716|449814906|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
125053499|NCT00365716|449814900|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
125053500|NCT00365716|449814901|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
125053501|NCT00365716|449814902|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
125053502|NCT00365716|449814903|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
125053503|NCT00365716|449814904|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
125053504|NCT00365716|449814905|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
125053505|NCT00365716|449814906|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
125053506|NCT00365716|449814900|FG000|Base Study (Day 1 to Month 7)|Other|0|||
125053507|NCT00365716|449814901|FG001|Base Study (Day 1 to Month 7)|Other|1|||
125053508|NCT00365716|449814902|FG002|Base Study (Day 1 to Month 7)|Other|0|||
125053509|NCT00365716|449814903|FG003|Base Study (Day 1 to Month 7)|Other|0|||
125053510|NCT00365716|449814904|FG004|Base Study (Day 1 to Month 7)|Other|0|||
125053511|NCT00365716|449814905|FG005|Base Study (Day 1 to Month 7)|Other|0|||
125053512|NCT00365716|449814906|FG006|Base Study (Day 1 to Month 7)|Other|0|||
125053513|NCT00365716|449814900|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
125053514|NCT00365716|449814901|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
125053515|NCT00365716|449814902|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
125053516|NCT00365716|449814903|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
125053517|NCT00365716|449814904|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
125053518|NCT00365716|449814905|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
125053519|NCT00365716|449814906|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
125053520|NCT00365716|449814900|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
125053521|NCT00365716|449814901|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
125053522|NCT00365716|449814902|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
125053523|NCT00365716|449814903|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
125053524|NCT00365716|449814904|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
125053525|NCT00365716|449814905|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
125053526|NCT00365716|449814906|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
125053527|NCT00365716|449814900|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
125053528|NCT00365716|449814901|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
125053529|NCT00365716|449814902|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
125136186|NCT01839279|450122882|FG001|Overall Study|Classified as 'Other'|0|||
125053530|NCT00365716|449814903|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
125053531|NCT00365716|449814904|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
125053532|NCT00365716|449814905|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
125053533|NCT00365716|449814906|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
125053534|NCT00365716|449814900|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
125053535|NCT00365716|449814901|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
125053536|NCT00365716|449814902|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
125053537|NCT00365716|449814903|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
125053538|NCT00365716|449814904|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
125053539|NCT00365716|449814905|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
125053540|NCT00365716|449814906|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
125053541|NCT00365716|449814900|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
125053542|NCT00365716|449814901|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
125053543|NCT00365716|449814902|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
125053544|NCT00365716|449814903|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
125053545|NCT00365716|449814904|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
125053546|NCT00365716|449814905|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
125053547|NCT00365716|449814906|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
125053548|NCT00365716|449814900|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
125053549|NCT00365716|449814901|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
125053550|NCT00365716|449814902|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
125053551|NCT00365716|449814903|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
125053552|NCT00365716|449814904|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
125053553|NCT00365716|449814905|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
125053554|NCT00365716|449814906|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
125053555|NCT00365716|449814900|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
125053556|NCT00365716|449814901|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
125053557|NCT00365716|449814902|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
125053558|NCT00365716|449814903|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
125053559|NCT00365716|449814904|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
125053560|NCT00365716|449814905|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
125136187|NCT01839279|450122883|FG002|Overall Study|Classified as 'Other'|0|||
125136188|NCT03437265|450122884|FG000|Overall Study|Protocol Violation|6|||
125136189|NCT00316277|450122885|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
125136190|NCT00316277|450122886|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
125136191|NCT00316277|450122885|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
125136192|NCT00316277|450122886|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
125136193|NCT00316277|450122885|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
125136194|NCT00316277|450122886|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
125136195|NCT00316277|450122885|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
125136196|NCT00316277|450122886|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
125136197|NCT00316277|450122885|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
125220199|NCT00103285|450434396|FG005|Response Assignment|Ineligible|3|||
125220200|NCT00103285|450434397|FG006|Response Assignment|Ineligible|1|||
125220201|NCT00103285|450434398|FG007|Response Assignment|Ineligible|5|||
125220202|NCT00103285|450434391|FG000|Response Assignment|Refusal|0|||
125220203|NCT00103285|450434392|FG001|Response Assignment|Refusal|53|||
125053561|NCT00365716|449814906|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
125053562|NCT00365716|449814900|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
125053563|NCT00365716|449814901|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
125053564|NCT00365716|449814902|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
125053565|NCT00365716|449814903|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
125053566|NCT00365716|449814904|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
125053567|NCT00365716|449814905|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
125053568|NCT00365716|449814906|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
125053569|NCT00365716|449814900|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
125053570|NCT00365716|449814901|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
125053571|NCT00365716|449814902|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
125053572|NCT00365716|449814903|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
125053573|NCT00365716|449814904|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
125053574|NCT00365716|449814905|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
125053575|NCT00365716|449814906|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
125053576|NCT00365716|449814900|FG000|Extension 1|Lost to Follow-up|0|||
125053577|NCT00365716|449814901|FG001|Extension 1|Lost to Follow-up|0|||
125053578|NCT00365716|449814902|FG002|Extension 1|Lost to Follow-up|0|||
125053579|NCT00365716|449814903|FG003|Extension 1|Lost to Follow-up|0|||
125053580|NCT00365716|449814904|FG004|Extension 1|Lost to Follow-up|0|||
125053581|NCT00365716|449814905|FG005|Extension 1|Lost to Follow-up|1|||
125053582|NCT00365716|449814906|FG006|Extension 1|Lost to Follow-up|0|||
125053583|NCT00365716|449814900|FG000|Extension 1|Other|0|||
125053584|NCT00365716|449814901|FG001|Extension 1|Other|0|||
125053585|NCT00365716|449814902|FG002|Extension 1|Other|0|||
125053586|NCT00365716|449814903|FG003|Extension 1|Other|0|||
125053587|NCT00365716|449814904|FG004|Extension 1|Other|0|||
125053588|NCT00365716|449814905|FG005|Extension 1|Other|9|||
125053589|NCT00365716|449814906|FG006|Extension 1|Other|0|||
125053590|NCT00365716|449814900|FG000|Extension 1|Moved|0|||
125053591|NCT00365716|449814901|FG001|Extension 1|Moved|0|||
125053592|NCT00365716|449814902|FG002|Extension 1|Moved|0|||
125053593|NCT00365716|449814903|FG003|Extension 1|Moved|0|||
125053594|NCT00365716|449814904|FG004|Extension 1|Moved|0|||
125053595|NCT00365716|449814905|FG005|Extension 1|Moved|4|||
125053596|NCT00365716|449814906|FG006|Extension 1|Moved|0|||
125053597|NCT00365716|449814900|FG000|Extension 1|Withdrawal by Subject|0|||
125053598|NCT00365716|449814901|FG001|Extension 1|Withdrawal by Subject|0|||
125053599|NCT00365716|449814902|FG002|Extension 1|Withdrawal by Subject|0|||
125053600|NCT00365716|449814903|FG003|Extension 1|Withdrawal by Subject|0|||
125053601|NCT00365716|449814904|FG004|Extension 1|Withdrawal by Subject|0|||
125053602|NCT00365716|449814905|FG005|Extension 1|Withdrawal by Subject|3|||
125053603|NCT00365716|449814906|FG006|Extension 1|Withdrawal by Subject|0|||
125053604|NCT00365716|449814900|FG000|Extension 1|Pregnancy|0|||
125053605|NCT00365716|449814901|FG001|Extension 1|Pregnancy|0|||
125053606|NCT00365716|449814902|FG002|Extension 1|Pregnancy|0|||
125053607|NCT00365716|449814903|FG003|Extension 1|Pregnancy|0|||
125053608|NCT00365716|449814904|FG004|Extension 1|Pregnancy|0|||
125053609|NCT00365716|449814905|FG005|Extension 1|Pregnancy|4|||
125053610|NCT00365716|449814906|FG006|Extension 1|Pregnancy|0|||
125053611|NCT00365716|449814900|FG000|Extension 1|Protocol Violation|0|||
125053612|NCT00365716|449814901|FG001|Extension 1|Protocol Violation|0|||
125053613|NCT00365716|449814902|FG002|Extension 1|Protocol Violation|0|||
125053614|NCT00365716|449814903|FG003|Extension 1|Protocol Violation|0|||
125053615|NCT00365716|449814904|FG004|Extension 1|Protocol Violation|0|||
125053616|NCT00365716|449814905|FG005|Extension 1|Protocol Violation|1|||
125053617|NCT00365716|449814906|FG006|Extension 1|Protocol Violation|0|||
125053618|NCT00365716|449814900|FG000|Extension 2|Lost to Follow-up|0|||
125053619|NCT00365716|449814901|FG001|Extension 2|Lost to Follow-up|0|||
125053620|NCT00365716|449814902|FG002|Extension 2|Lost to Follow-up|0|||
125053621|NCT00365716|449814903|FG003|Extension 2|Lost to Follow-up|0|||
125053622|NCT00365716|449814904|FG004|Extension 2|Lost to Follow-up|0|||
125053623|NCT00365716|449814905|FG005|Extension 2|Lost to Follow-up|0|||
125053624|NCT00365716|449814906|FG006|Extension 2|Lost to Follow-up|2|||
125220204|NCT00103285|450434393|FG002|Response Assignment|Refusal|5|||
125220205|NCT00103285|450434394|FG003|Response Assignment|Refusal|3|||
125220206|NCT00103285|450434395|FG004|Response Assignment|Refusal|25|||
125053625|NCT00365716|449814900|FG000|Extension 2|Other|0|||
125053626|NCT00365716|449814901|FG001|Extension 2|Other|0|||
125053627|NCT00365716|449814902|FG002|Extension 2|Other|0|||
125053628|NCT00365716|449814903|FG003|Extension 2|Other|0|||
125053629|NCT00365716|449814904|FG004|Extension 2|Other|0|||
125053630|NCT00365716|449814905|FG005|Extension 2|Other|0|||
125053631|NCT00365716|449814906|FG006|Extension 2|Other|3|||
125053632|NCT00365716|449814900|FG000|Extension 2|Withdrawal by Subject|0|||
125053633|NCT00365716|449814901|FG001|Extension 2|Withdrawal by Subject|0|||
125053634|NCT00365716|449814902|FG002|Extension 2|Withdrawal by Subject|0|||
125053635|NCT00365716|449814903|FG003|Extension 2|Withdrawal by Subject|0|||
125053636|NCT00365716|449814904|FG004|Extension 2|Withdrawal by Subject|0|||
125053637|NCT00365716|449814905|FG005|Extension 2|Withdrawal by Subject|0|||
125053638|NCT00365716|449814906|FG006|Extension 2|Withdrawal by Subject|5|||
125053639|NCT06150573|449814907|FG000|Overall Study|Did not meet study criteria|1|||
125053640|NCT06150573|449814908|FG001|Overall Study|Did not meet study criteria|0|||
125053641|NCT06150573|449814907|FG000|Overall Study|Adverse Event|1|||
125053642|NCT06150573|449814908|FG001|Overall Study|Adverse Event|0|||
125053643|NCT06150573|449814907|FG000|Overall Study|Lost to Follow-up|0|||
125053644|NCT06150573|449814908|FG001|Overall Study|Lost to Follow-up|1|||
125053645|NCT06150573|449814907|FG000|Overall Study|Protocol Violation|0|||
125053646|NCT06150573|449814908|FG001|Overall Study|Protocol Violation|1|||
125053647|NCT06150573|449814907|FG000|Overall Study|Withdrawal by Subject|2|||
125053648|NCT06150573|449814908|FG001|Overall Study|Withdrawal by Subject|0|||
125053649|NCT00069095|449814909|FG000|Primary Treatment Phase|Ongoing|0|||
125053650|NCT00069095|449814910|FG001|Primary Treatment Phase|Ongoing|0|||
125053651|NCT00069095|449814911|FG002|Primary Treatment Phase|Ongoing|5|||
125053652|NCT00069095|449814912|FG003|Primary Treatment Phase|Ongoing|7|||
125053653|NCT00069095|449814913|FG004|Primary Treatment Phase|Ongoing|7|||
125053654|NCT00069095|449814914|FG005|Primary Treatment Phase|Ongoing|4|||
125053655|NCT00069095|449814909|FG000|Primary Treatment Phase|Admin/Other|29|||
125053656|NCT00069095|449814910|FG001|Primary Treatment Phase|Admin/Other|38|||
125053657|NCT00069095|449814911|FG002|Primary Treatment Phase|Admin/Other|31|||
125053658|NCT00069095|449814912|FG003|Primary Treatment Phase|Admin/Other|45|||
125053659|NCT00069095|449814913|FG004|Primary Treatment Phase|Admin/Other|48|||
125053660|NCT00069095|449814914|FG005|Primary Treatment Phase|Admin/Other|42|||
125053661|NCT00069095|449814909|FG000|Primary Treatment Phase|Adverse Event|99|||
125053662|NCT00069095|449814910|FG001|Primary Treatment Phase|Adverse Event|92|||
125053663|NCT00069095|449814911|FG002|Primary Treatment Phase|Adverse Event|71|||
125053664|NCT00069095|449814912|FG003|Primary Treatment Phase|Adverse Event|72|||
125053665|NCT00069095|449814913|FG004|Primary Treatment Phase|Adverse Event|109|||
125053666|NCT00069095|449814914|FG005|Primary Treatment Phase|Adverse Event|101|||
125053667|NCT00069095|449814909|FG000|Primary Treatment Phase|Death|14|||
125053668|NCT00069095|449814910|FG001|Primary Treatment Phase|Death|8|||
125053669|NCT00069095|449814911|FG002|Primary Treatment Phase|Death|2|||
125053670|NCT00069095|449814912|FG003|Primary Treatment Phase|Death|5|||
125053671|NCT00069095|449814913|FG004|Primary Treatment Phase|Death|8|||
125053672|NCT00069095|449814914|FG005|Primary Treatment Phase|Death|8|||
125053673|NCT00069095|449814909|FG000|Primary Treatment Phase|Failure to return|5|||
125053674|NCT00069095|449814910|FG001|Primary Treatment Phase|Failure to return|5|||
125220207|NCT00103285|450434396|FG005|Response Assignment|Refusal|15|||
125220208|NCT00103285|450434397|FG006|Response Assignment|Refusal|30|||
125220209|NCT00103285|450434398|FG007|Response Assignment|Refusal|10|||
125220210|NCT00103285|450434391|FG000|Response Assignment|Other|0|||
125220211|NCT00103285|450434392|FG001|Response Assignment|Other|30|||
125220212|NCT00103285|450434393|FG002|Response Assignment|Other|48|||
125220213|NCT00103285|450434394|FG003|Response Assignment|Other|38|||
125220214|NCT00103285|450434395|FG004|Response Assignment|Other|37|||
125220215|NCT00103285|450434396|FG005|Response Assignment|Other|17|||
125220216|NCT00103285|450434397|FG006|Response Assignment|Other|11|||
125220217|NCT00103285|450434398|FG007|Response Assignment|Other|53|||
125220218|NCT02624947|450434401|FG000|Maternal Participants|Adverse Event|5|||
125220219|NCT02624947|450434402|FG001|Maternal Participants|Adverse Event|0|||
125220220|NCT02624947|450434401|FG000|Maternal Participants|Investigator Decision|5|||
125220221|NCT02624947|450434402|FG001|Maternal Participants|Investigator Decision|3|||
125220222|NCT02624947|450434401|FG000|Maternal Participants|Lost to Follow-up|54|||
125220223|NCT02624947|450434402|FG001|Maternal Participants|Lost to Follow-up|24|||
125220224|NCT02624947|450434401|FG000|Maternal Participants|Non Compliance|8|||
125220225|NCT02624947|450434402|FG001|Maternal Participants|Non Compliance|5|||
125220226|NCT02624947|450434401|FG000|Maternal Participants|Sponsor Request|1|||
125220227|NCT02624947|450434402|FG001|Maternal Participants|Sponsor Request|1|||
125220228|NCT02624947|450434401|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
125220229|NCT02624947|450434402|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
125220230|NCT02624947|450434401|FG000|Maternal Participants|Miscellaneous|23|||
125220231|NCT02624947|450434402|FG001|Maternal Participants|Miscellaneous|15|||
125220232|NCT02624947|450434401|FG000|Infant Participants|Adverse Event|18|||
125220233|NCT02624947|450434402|FG001|Infant Participants|Adverse Event|11|||
125220234|NCT02624947|450434401|FG000|Infant Participants|Investigator Decision|5|||
125220235|NCT02624947|450434402|FG001|Infant Participants|Investigator Decision|4|||
125220236|NCT02624947|450434401|FG000|Infant Participants|Lost to Follow-up|93|||
125220237|NCT02624947|450434402|FG001|Infant Participants|Lost to Follow-up|58|||
125220238|NCT02624947|450434401|FG000|Infant Participants|Non Compliance|17|||
125220239|NCT02624947|450434402|FG001|Infant Participants|Non Compliance|7|||
125220240|NCT02624947|450434401|FG000|Infant Participants|Sponsor Request|0|||
125220241|NCT02624947|450434402|FG001|Infant Participants|Sponsor Request|1|||
125220242|NCT02624947|450434401|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
125220243|NCT02624947|450434402|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
125220244|NCT02624947|450434401|FG000|Infant Participants|Miscellaneous|50|||
125220245|NCT02624947|450434402|FG001|Infant Participants|Miscellaneous|26|||
125220246|NCT03569098|450434408|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
125220247|NCT03569098|450434409|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
125220248|NCT03569098|450434410|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
125220249|NCT03569098|450434408|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
125220250|NCT03569098|450434409|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
125220251|NCT03569098|450434410|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
125220252|NCT03569098|450434408|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
125220253|NCT03569098|450434409|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
125220254|NCT03569098|450434410|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
125220255|NCT03569098|450434408|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
125220256|NCT03569098|450434409|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
125220257|NCT03569098|450434410|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
125220258|NCT03569098|450434408|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
125220259|NCT03569098|450434409|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
125220260|NCT03569098|450434410|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
125220261|NCT03569098|450434408|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
125220262|NCT03569098|450434409|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
125220263|NCT03569098|450434410|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
125220264|NCT03569098|450434408|FG000|Double-Blind Treatment Cycle 1|Other|1|||
125220265|NCT03569098|450434409|FG001|Double-Blind Treatment Cycle 1|Other|0|||
125220266|NCT03569098|450434410|FG002|Double-Blind Treatment Cycle 1|Other|1|||
125220267|NCT03569098|450434408|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
125220268|NCT03569098|450434409|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
125220269|NCT03569098|450434410|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
125220270|NCT03569098|450434408|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
125220271|NCT03569098|450434409|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
125220272|NCT03569098|450434410|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
125053675|NCT00069095|449814911|FG002|Primary Treatment Phase|Failure to return|0|||
125053676|NCT00069095|449814912|FG003|Primary Treatment Phase|Failure to return|0|||
125053677|NCT00069095|449814913|FG004|Primary Treatment Phase|Failure to return|0|||
125053678|NCT00069095|449814914|FG005|Primary Treatment Phase|Failure to return|2|||
125220273|NCT03569098|450434408|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
125220274|NCT03569098|450434409|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
125136198|NCT00316277|450122886|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
125136199|NCT01572662|450122897|FG000|Overall Study|Withdrawal by Subject|1|||
125053679|NCT00069095|449814909|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
125053680|NCT00069095|449814910|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
125053681|NCT00069095|449814911|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
125136200|NCT01572662|450122898|FG001|Overall Study|Withdrawal by Subject|0|||
125136201|NCT01572662|450122897|FG000|Overall Study|Physician Decision|0|||
125136202|NCT01572662|450122898|FG001|Overall Study|Physician Decision|1|||
125136203|NCT03364192|450122899|FG000|Overall Study|Ineligible|10|||
125136204|NCT03364192|450122899|FG000|Overall Study|Withdrawal by Subject|5|||
125136205|NCT03364192|450122899|FG000|Overall Study|Lost to Follow-up|1|||
125136206|NCT00918645|450122900|FG000|Overall Study|Withdrawal by Subject|1|||
125136207|NCT03446768|450122901|FG000|Overall Study|Withdrawal by Subject|0|||
125136208|NCT03446768|450122902|FG001|Overall Study|Withdrawal by Subject|1|||
125136209|NCT05133180|450122903|FG000|Overall Study|Withdrawal of consent|1|||
125136210|NCT05133180|450122904|FG001|Overall Study|Withdrawal of consent|1|||
125136211|NCT05133180|450122903|FG000|Overall Study|Lost to Follow-up|1|||
125136212|NCT05133180|450122904|FG001|Overall Study|Lost to Follow-up|1|||
125136213|NCT05133180|450122903|FG000|Overall Study|Documented disease progression|0|||
125136214|NCT05133180|450122904|FG001|Overall Study|Documented disease progression|1|||
125136215|NCT00107991|450122905|FG000|Eligibility Assessment|Disease not severe enough|7|||
125136216|NCT00107991|450122905|FG000|Eligibility Assessment|Unwilling to participate|7|||
125136217|NCT00107991|450122905|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
125136218|NCT00107991|450122905|FG000|Eligibility Assessment|Abnormal labs|2|||
125136219|NCT00107991|450122905|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
125136220|NCT00107991|450122905|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
125136221|NCT00107991|450122905|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
125136222|NCT00107991|450122905|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
125136223|NCT00107991|450122905|FG000|12 Week Treatment Period|Adverse Event|1|||
125136224|NCT00107991|450122905|FG000|12 Week Treatment Period|Protocol Violation|1|||
125136225|NCT00107991|450122905|FG000|12 Week Treatment Period|Incarcerated|1|||
125053682|NCT00069095|449814912|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
125053683|NCT00069095|449814913|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
125053684|NCT00069095|449814914|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
125053685|NCT00069095|449814909|FG000|Primary Treatment Phase|Refused treatment|15|||
125053686|NCT00069095|449814910|FG001|Primary Treatment Phase|Refused treatment|26|||
125053687|NCT00069095|449814911|FG002|Primary Treatment Phase|Refused treatment|17|||
125053688|NCT00069095|449814912|FG003|Primary Treatment Phase|Refused treatment|31|||
125053689|NCT00069095|449814913|FG004|Primary Treatment Phase|Refused treatment|24|||
125053690|NCT00069095|449814914|FG005|Primary Treatment Phase|Refused treatment|27|||
125053691|NCT00069095|449814909|FG000|Primary Treatment Phase|Withdrew|2|||
125053692|NCT00069095|449814910|FG001|Primary Treatment Phase|Withdrew|3|||
125053693|NCT00069095|449814911|FG002|Primary Treatment Phase|Withdrew|8|||
125053694|NCT00069095|449814912|FG003|Primary Treatment Phase|Withdrew|2|||
125053695|NCT00069095|449814913|FG004|Primary Treatment Phase|Withdrew|4|||
125053696|NCT00069095|449814914|FG005|Primary Treatment Phase|Withdrew|9|||
125053697|NCT00069095|449814909|FG000|Primary Treatment Phase|Other Violation|0|||
125053698|NCT00069095|449814910|FG001|Primary Treatment Phase|Other Violation|1|||
125053699|NCT00069095|449814911|FG002|Primary Treatment Phase|Other Violation|1|||
125053700|NCT00069095|449814912|FG003|Primary Treatment Phase|Other Violation|1|||
125053701|NCT00069095|449814913|FG004|Primary Treatment Phase|Other Violation|0|||
125053702|NCT00069095|449814914|FG005|Primary Treatment Phase|Other Violation|1|||
125053703|NCT00069095|449814909|FG000|Primary Treatment Phase|Violation criteria|0|||
125053704|NCT00069095|449814910|FG001|Primary Treatment Phase|Violation criteria|2|||
125053705|NCT00069095|449814911|FG002|Primary Treatment Phase|Violation criteria|4|||
125053706|NCT00069095|449814912|FG003|Primary Treatment Phase|Violation criteria|3|||
125053707|NCT00069095|449814913|FG004|Primary Treatment Phase|Violation criteria|1|||
125136226|NCT00107991|450122905|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
125136227|NCT01535222|450122906|FG000|Overall Study|Inclusion/exclusion|0|||
125136228|NCT01535222|450122907|FG001|Overall Study|Inclusion/exclusion|0|||
125053708|NCT00069095|449814914|FG005|Primary Treatment Phase|Violation criteria|5|||
125053709|NCT00069095|449814909|FG000|Post-study Treatment Phase|Missing reason|1|||
125053710|NCT00069095|449814910|FG001|Post-study Treatment Phase|Missing reason|3|||
125136229|NCT01535222|450122908|FG002|Overall Study|Inclusion/exclusion|1|||
125053711|NCT00069095|449814911|FG002|Post-study Treatment Phase|Missing reason|12|||
125053712|NCT00069095|449814912|FG003|Post-study Treatment Phase|Missing reason|8|||
125053713|NCT00069095|449814913|FG004|Post-study Treatment Phase|Missing reason|18|||
125053714|NCT00069095|449814914|FG005|Post-study Treatment Phase|Missing reason|17|||
125053715|NCT00069095|449814909|FG000|Post-study Treatment Phase|Adverse Event|2|||
125053716|NCT00069095|449814910|FG001|Post-study Treatment Phase|Adverse Event|3|||
125053717|NCT00069095|449814911|FG002|Post-study Treatment Phase|Adverse Event|1|||
125053718|NCT00069095|449814912|FG003|Post-study Treatment Phase|Adverse Event|0|||
125053719|NCT00069095|449814913|FG004|Post-study Treatment Phase|Adverse Event|5|||
125053720|NCT00069095|449814914|FG005|Post-study Treatment Phase|Adverse Event|1|||
125053721|NCT00069095|449814909|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
125053722|NCT00069095|449814910|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
125053723|NCT00069095|449814911|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
125053724|NCT00069095|449814912|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
125136230|NCT01535222|450122909|FG003|Overall Study|Inclusion/exclusion|0|||
125136231|NCT01535222|450122910|FG004|Overall Study|Inclusion/exclusion|0|||
125136232|NCT01535222|450122911|FG005|Overall Study|Inclusion/exclusion|0|||
125136233|NCT00935012|450122912|FG000|Overall Study|Death|19|||
125136234|NCT00935012|450122912|FG000|Overall Study|Withdrawal by Subject|3|||
125136235|NCT00935012|450122912|FG000|Overall Study|Other|5|||
125136236|NCT00935012|450122912|FG000|Overall Study|Adverse Event|2|||
125136237|NCT01442155|450122913|FG000|Overall Study|Complete remission|35|||
125136238|NCT01442155|450122913|FG000|Overall Study|Recurrence|26|||
125136239|NCT01442155|450122913|FG000|Overall Study|Adverse Event|2|||
125053725|NCT00069095|449814913|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
125053726|NCT00069095|449814914|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
125053727|NCT00069095|449814909|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
125053728|NCT00069095|449814910|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
125053729|NCT00069095|449814911|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
125053730|NCT00069095|449814912|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
125053731|NCT00069095|449814913|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
125053732|NCT00069095|449814914|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
125053733|NCT00069095|449814909|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
125053734|NCT00069095|449814910|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
125053735|NCT00069095|449814911|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
125053736|NCT00069095|449814912|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
125053737|NCT00069095|449814913|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
125053738|NCT00069095|449814914|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
125053739|NCT00069095|449814909|FG000|Post-study Treatment Phase|Participant had complete response|1|||
125053740|NCT00069095|449814910|FG001|Post-study Treatment Phase|Participant had complete response|1|||
125053741|NCT00069095|449814911|FG002|Post-study Treatment Phase|Participant had complete response|0|||
125053742|NCT00069095|449814912|FG003|Post-study Treatment Phase|Participant had complete response|0|||
125053743|NCT00069095|449814913|FG004|Post-study Treatment Phase|Participant had complete response|0|||
125053744|NCT00069095|449814914|FG005|Post-study Treatment Phase|Participant had complete response|0|||
125053745|NCT00069095|449814909|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
125053746|NCT00069095|449814910|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
125053747|NCT00069095|449814911|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
125053748|NCT00069095|449814912|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
125053749|NCT00069095|449814913|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
125053750|NCT00069095|449814914|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
125053751|NCT00069095|449814909|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
125053752|NCT00069095|449814910|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
125053753|NCT00069095|449814911|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
125053754|NCT00069095|449814912|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
125053755|NCT00069095|449814913|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
125053756|NCT00069095|449814914|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
125053757|NCT00069095|449814909|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
125053758|NCT00069095|449814910|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
125053759|NCT00069095|449814911|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
125053760|NCT00069095|449814912|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
125053761|NCT00069095|449814913|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
125053762|NCT00069095|449814914|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
125053763|NCT00069095|449814909|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
125136240|NCT01442155|450122913|FG000|Overall Study|Lost to Follow-up|2|||
125136241|NCT03669861|450122914|FG000|Overall Study|Disease Flare|5|||
125136242|NCT03669861|450122914|FG000|Overall Study|Lack of Efficacy|2|||
125136243|NCT00705666|450122916|FG000|Overall Study|No post-treatment questionnaire|279|||
125136244|NCT00705666|450122916|FG000|Overall Study|Withdrawal by Subject|21|||
125053764|NCT00069095|449814910|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
125053765|NCT00069095|449814911|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
125053766|NCT00069095|449814912|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
125053767|NCT00069095|449814913|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
125053768|NCT00069095|449814914|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
125053769|NCT00069095|449814909|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
125053770|NCT00069095|449814910|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
125053771|NCT00069095|449814911|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
125053772|NCT00069095|449814912|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
125053773|NCT00069095|449814913|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
125053774|NCT00069095|449814914|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
125053775|NCT00069095|449814909|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
125053776|NCT00069095|449814910|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
125053777|NCT00069095|449814911|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
125053778|NCT00069095|449814912|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
125053779|NCT00069095|449814913|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
125053780|NCT00069095|449814914|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
125053781|NCT00069095|449814909|FG000|Post-study Treatment Phase|Surgery|0|||
125053782|NCT00069095|449814910|FG001|Post-study Treatment Phase|Surgery|0|||
125053783|NCT00069095|449814911|FG002|Post-study Treatment Phase|Surgery|0|||
125053784|NCT00069095|449814912|FG003|Post-study Treatment Phase|Surgery|1|||
125053785|NCT00069095|449814913|FG004|Post-study Treatment Phase|Surgery|1|||
125053786|NCT00069095|449814914|FG005|Post-study Treatment Phase|Surgery|0|||
125053787|NCT00069095|449814909|FG000|Post-study Treatment Phase|Death|0|||
125053788|NCT00069095|449814910|FG001|Post-study Treatment Phase|Death|0|||
125053789|NCT00069095|449814911|FG002|Post-study Treatment Phase|Death|0|||
125053790|NCT00069095|449814912|FG003|Post-study Treatment Phase|Death|0|||
125053791|NCT00069095|449814913|FG004|Post-study Treatment Phase|Death|1|||
125053792|NCT00069095|449814914|FG005|Post-study Treatment Phase|Death|0|||
125053793|NCT00069095|449814909|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
125053794|NCT00069095|449814910|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
125053795|NCT00069095|449814911|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
125053796|NCT00069095|449814912|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
125053797|NCT00069095|449814913|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
125053798|NCT00069095|449814914|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
125053799|NCT00069095|449814909|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
125053800|NCT00069095|449814910|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
125053801|NCT00069095|449814911|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
125053802|NCT00069095|449814912|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
125053803|NCT00069095|449814913|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
125053804|NCT00069095|449814914|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
125053805|NCT00069095|449814909|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
125053806|NCT00069095|449814910|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
125053807|NCT00069095|449814911|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
125053808|NCT00069095|449814912|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
125053809|NCT00069095|449814913|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
125053810|NCT00069095|449814914|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
125053811|NCT00069095|449814909|FG000|Post-study Treatment Phase|Investigator decision|0|||
125053812|NCT00069095|449814910|FG001|Post-study Treatment Phase|Investigator decision|0|||
125053813|NCT00069095|449814911|FG002|Post-study Treatment Phase|Investigator decision|0|||
125053814|NCT00069095|449814912|FG003|Post-study Treatment Phase|Investigator decision|0|||
125053815|NCT00069095|449814913|FG004|Post-study Treatment Phase|Investigator decision|0|||
125053816|NCT00069095|449814914|FG005|Post-study Treatment Phase|Investigator decision|1|||
125053817|NCT00069095|449814909|FG000|Follow-up Phase|Death|174|||
125053818|NCT00069095|449814910|FG001|Follow-up Phase|Death|206|||
125053819|NCT00069095|449814911|FG002|Follow-up Phase|Death|120|||
125053820|NCT00069095|449814912|FG003|Follow-up Phase|Death|112|||
125053821|NCT00069095|449814913|FG004|Follow-up Phase|Death|92|||
125053822|NCT00069095|449814914|FG005|Follow-up Phase|Death|101|||
125053823|NCT05114590|449814920|FG000|Overall Study|Adverse Event|1|||
125053824|NCT05114590|449814920|FG000|Overall Study|Investigator decision|1|||
125053825|NCT05114590|449814920|FG000|Overall Study|Lost to Follow-up|5|||
125053826|NCT05114590|449814920|FG000|Overall Study|Withdrawal by Subject|5|||
125053827|NCT05114590|449814920|FG000|Overall Study|Other|2|||
125053828|NCT00358917|449814923|FG000|Overall Study|Adverse Event|14|||
125053829|NCT00358917|449814924|FG001|Overall Study|Adverse Event|21|||
125053830|NCT00358917|449814923|FG000|Overall Study|Withdrawal by Subject|5|||
125053831|NCT00358917|449814924|FG001|Overall Study|Withdrawal by Subject|7|||
125053832|NCT00358917|449814923|FG000|Overall Study|Lost to Follow-up|20|||
125053833|NCT00358917|449814924|FG001|Overall Study|Lost to Follow-up|17|||
125053834|NCT00358917|449814923|FG000|Overall Study|Noncompliance|12|||
125053835|NCT00358917|449814924|FG001|Overall Study|Noncompliance|11|||
125053836|NCT00358917|449814923|FG000|Overall Study|Death|2|||
125053837|NCT00358917|449814924|FG001|Overall Study|Death|3|||
125053838|NCT00358917|449814923|FG000|Overall Study|Virologic failure|11|||
125053839|NCT00358917|449814924|FG001|Overall Study|Virologic failure|8|||
125053840|NCT00358917|449814923|FG000|Overall Study|Unable to Continue Participation|2|||
125053841|NCT00358917|449814924|FG001|Overall Study|Unable to Continue Participation|2|||
125053842|NCT05372575|449814928|FG000|Overall Study|Protocol Violation|7|||
125053843|NCT05372575|449814929|FG001|Overall Study|Protocol Violation|16|||
125053844|NCT01544595|449814930|FG000|Status at Week 68|Adverse Event|3|||
125053845|NCT01544595|449814931|FG001|Status at Week 68|Adverse Event|2|||
125053846|NCT01544595|449814932|FG002|Status at Week 68|Adverse Event|1|||
125053847|NCT01544595|449814933|FG003|Status at Week 68|Adverse Event|0|||
125053848|NCT01544595|449814934|FG004|Status at Week 68|Adverse Event|0|||
125053849|NCT01544595|449814935|FG005|Status at Week 68|Adverse Event|0|||
125053850|NCT01544595|449814930|FG000|Status at Week 68|Lack of Efficacy|1|||
125053851|NCT01544595|449814931|FG001|Status at Week 68|Lack of Efficacy|0|||
125053852|NCT01544595|449814932|FG002|Status at Week 68|Lack of Efficacy|0|||
125053853|NCT01544595|449814933|FG003|Status at Week 68|Lack of Efficacy|0|||
125053854|NCT01544595|449814934|FG004|Status at Week 68|Lack of Efficacy|0|||
125053855|NCT01544595|449814935|FG005|Status at Week 68|Lack of Efficacy|0|||
125053856|NCT01544595|449814930|FG000|Status at Week 68|Lost to Follow-up|1|||
125053857|NCT01544595|449814931|FG001|Status at Week 68|Lost to Follow-up|1|||
125053858|NCT01544595|449814932|FG002|Status at Week 68|Lost to Follow-up|0|||
125053859|NCT01544595|449814933|FG003|Status at Week 68|Lost to Follow-up|0|||
125053860|NCT01544595|449814934|FG004|Status at Week 68|Lost to Follow-up|0|||
125053861|NCT01544595|449814935|FG005|Status at Week 68|Lost to Follow-up|0|||
125053862|NCT01544595|449814930|FG000|Status at Week 68|Non-compliance with study treatment|1|||
125053863|NCT01544595|449814931|FG001|Status at Week 68|Non-compliance with study treatment|0|||
125053864|NCT01544595|449814932|FG002|Status at Week 68|Non-compliance with study treatment|0|||
125053865|NCT01544595|449814933|FG003|Status at Week 68|Non-compliance with study treatment|1|||
125053866|NCT01544595|449814934|FG004|Status at Week 68|Non-compliance with study treatment|0|||
125053867|NCT01544595|449814935|FG005|Status at Week 68|Non-compliance with study treatment|0|||
125053868|NCT01544595|449814930|FG000|Status at Week 68|Protocol Violation|2|||
125053869|NCT01544595|449814931|FG001|Status at Week 68|Protocol Violation|0|||
125053870|NCT01544595|449814932|FG002|Status at Week 68|Protocol Violation|1|||
125053871|NCT01544595|449814933|FG003|Status at Week 68|Protocol Violation|1|||
125053872|NCT01544595|449814934|FG004|Status at Week 68|Protocol Violation|0|||
125053873|NCT01544595|449814935|FG005|Status at Week 68|Protocol Violation|0|||
125053874|NCT01544595|449814930|FG000|Status at Week 68|Technical problems|1|||
125053875|NCT01544595|449814931|FG001|Status at Week 68|Technical problems|0|||
125053876|NCT01544595|449814932|FG002|Status at Week 68|Technical problems|0|||
125053877|NCT01544595|449814933|FG003|Status at Week 68|Technical problems|1|||
125053878|NCT01544595|449814934|FG004|Status at Week 68|Technical problems|0|||
125053879|NCT01544595|449814935|FG005|Status at Week 68|Technical problems|0|||
125053880|NCT01544595|449814930|FG000|Status at Week 68|Withdrawal by Subject|0|||
125053881|NCT01544595|449814931|FG001|Status at Week 68|Withdrawal by Subject|1|||
125053882|NCT01544595|449814932|FG002|Status at Week 68|Withdrawal by Subject|1|||
125053883|NCT01544595|449814933|FG003|Status at Week 68|Withdrawal by Subject|2|||
125053884|NCT01544595|449814934|FG004|Status at Week 68|Withdrawal by Subject|0|||
125053885|NCT01544595|449814935|FG005|Status at Week 68|Withdrawal by Subject|0|||
125136245|NCT00705666|450122916|FG000|Overall Study|Physician Decision|7|||
125136246|NCT00705666|450122916|FG000|Overall Study|Lost to Follow-up|5|||
125136247|NCT00705666|450122916|FG000|Overall Study|Death|1|||
125053886|NCT01544595|449814930|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
125053887|NCT01544595|449814931|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
125053888|NCT01544595|449814932|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
125136248|NCT00705666|450122916|FG000|Overall Study|Adverse Event|4|||
125136249|NCT00705666|450122916|FG000|Overall Study|Other|12|||
125136250|NCT00705666|450122916|FG000|Overall Study|Other|2|||
125053889|NCT01544595|449814933|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
125053890|NCT01544595|449814934|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
125053891|NCT01544595|449814935|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
125053892|NCT01544595|449814930|FG000|Status at Week 156|Withdrawal by Subject|9|||
125053893|NCT01544595|449814931|FG001|Status at Week 156|Withdrawal by Subject|10|||
125053894|NCT01544595|449814932|FG002|Status at Week 156|Withdrawal by Subject|4|||
125053895|NCT01544595|449814933|FG003|Status at Week 156|Withdrawal by Subject|9|||
125136251|NCT00705666|450122916|FG000|Overall Study|Lack of data|3|||
125053896|NCT01544595|449814934|FG004|Status at Week 156|Withdrawal by Subject|20|||
125053897|NCT01544595|449814935|FG005|Status at Week 156|Withdrawal by Subject|6|||
125053898|NCT01544595|449814930|FG000|Status at Week 156|Adverse Event|9|||
125053899|NCT01544595|449814931|FG001|Status at Week 156|Adverse Event|11|||
125053900|NCT01544595|449814932|FG002|Status at Week 156|Adverse Event|1|||
125053901|NCT01544595|449814933|FG003|Status at Week 156|Adverse Event|3|||
125053902|NCT01544595|449814934|FG004|Status at Week 156|Adverse Event|4|||
125053903|NCT01544595|449814935|FG005|Status at Week 156|Adverse Event|2|||
125053904|NCT01544595|449814930|FG000|Status at Week 156|Lost to Follow-up|4|||
125053905|NCT01544595|449814931|FG001|Status at Week 156|Lost to Follow-up|4|||
125053906|NCT01544595|449814932|FG002|Status at Week 156|Lost to Follow-up|0|||
125053907|NCT01544595|449814933|FG003|Status at Week 156|Lost to Follow-up|1|||
125053908|NCT01544595|449814934|FG004|Status at Week 156|Lost to Follow-up|4|||
125053909|NCT01544595|449814935|FG005|Status at Week 156|Lost to Follow-up|1|||
125053910|NCT01544595|449814930|FG000|Status at Week 156|Non-compliance with study treatement|0|||
125053911|NCT01544595|449814931|FG001|Status at Week 156|Non-compliance with study treatement|1|||
125053912|NCT01544595|449814932|FG002|Status at Week 156|Non-compliance with study treatement|0|||
125053913|NCT01544595|449814933|FG003|Status at Week 156|Non-compliance with study treatement|1|||
125053914|NCT01544595|449814934|FG004|Status at Week 156|Non-compliance with study treatement|0|||
125053915|NCT01544595|449814935|FG005|Status at Week 156|Non-compliance with study treatement|1|||
125053916|NCT01544595|449814930|FG000|Status at Week 156|Physician Decision|0|||
125053917|NCT01544595|449814931|FG001|Status at Week 156|Physician Decision|3|||
125053918|NCT01544595|449814932|FG002|Status at Week 156|Physician Decision|1|||
125053919|NCT01544595|449814933|FG003|Status at Week 156|Physician Decision|0|||
125053920|NCT01544595|449814934|FG004|Status at Week 156|Physician Decision|0|||
125053921|NCT01544595|449814935|FG005|Status at Week 156|Physician Decision|0|||
125053922|NCT01544595|449814930|FG000|Status at Week 156|Pregnancy|2|||
125053923|NCT01544595|449814931|FG001|Status at Week 156|Pregnancy|3|||
125053924|NCT01544595|449814932|FG002|Status at Week 156|Pregnancy|0|||
125053925|NCT01544595|449814933|FG003|Status at Week 156|Pregnancy|0|||
125053926|NCT01544595|449814934|FG004|Status at Week 156|Pregnancy|0|||
125053927|NCT01544595|449814935|FG005|Status at Week 156|Pregnancy|0|||
125053928|NCT01544595|449814930|FG000|Status at Week 156|Protocol Violation|3|||
125053929|NCT01544595|449814931|FG001|Status at Week 156|Protocol Violation|1|||
125053930|NCT01544595|449814932|FG002|Status at Week 156|Protocol Violation|2|||
125053931|NCT01544595|449814933|FG003|Status at Week 156|Protocol Violation|2|||
125053932|NCT01544595|449814934|FG004|Status at Week 156|Protocol Violation|0|||
125053933|NCT01544595|449814935|FG005|Status at Week 156|Protocol Violation|0|||
125053934|NCT01544595|449814930|FG000|Status at Week 156|Technical problems|3|||
125053935|NCT01544595|449814931|FG001|Status at Week 156|Technical problems|1|||
125053936|NCT01544595|449814932|FG002|Status at Week 156|Technical problems|0|||
125053937|NCT01544595|449814933|FG003|Status at Week 156|Technical problems|1|||
125136252|NCT00705666|450122916|FG000|Overall Study|Untreated|5|||
125136253|NCT01590563|450122926|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
125136254|NCT03256695|450122927|FG000|Overall Study|Adverse Event|8|||
125136255|NCT03256695|450122927|FG000|Overall Study|Death|2|||
125136256|NCT03256695|450122927|FG000|Overall Study|Withdrawal by Subject|14|||
125136257|NCT03256695|450122927|FG000|Overall Study|Non-compliance with study drug|1|||
125136258|NCT03256695|450122927|FG000|Overall Study|Lost to Follow-up|3|||
125136259|NCT03256695|450122927|FG000|Overall Study|Lack of Efficacy|3|||
125136260|NCT03256695|450122927|FG000|Overall Study|Protocol Violation|5|||
125136261|NCT03256695|450122927|FG000|Overall Study|Other than specified|3|||
125136262|NCT01604941|450122928|FG000|Overall Study|Adverse Event|1|||
125136263|NCT01604941|450122929|FG001|Overall Study|Adverse Event|2|||
125136264|NCT01604941|450122930|FG002|Overall Study|Adverse Event|0|||
125136265|NCT01604941|450122931|FG003|Overall Study|Adverse Event|0|||
125136266|NCT01604941|450122932|FG004|Overall Study|Adverse Event|1|||
125136267|NCT01604941|450122933|FG005|Overall Study|Adverse Event|5|||
125136268|NCT01604941|450122928|FG000|Overall Study|Non-compliance|1|||
125136269|NCT01604941|450122929|FG001|Overall Study|Non-compliance|0|||
125136270|NCT01604941|450122930|FG002|Overall Study|Non-compliance|0|||
125136271|NCT01604941|450122931|FG003|Overall Study|Non-compliance|0|||
125136272|NCT01604941|450122932|FG004|Overall Study|Non-compliance|0|||
125220275|NCT03569098|450434410|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
125220276|NCT03569098|450434408|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
125220277|NCT03569098|450434409|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
125053938|NCT01544595|449814934|FG004|Status at Week 156|Technical problems|0|||
125053939|NCT01544595|449814935|FG005|Status at Week 156|Technical problems|0|||
125053940|NCT01544595|449814930|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
125136273|NCT01604941|450122933|FG005|Overall Study|Non-compliance|0|||
125136274|NCT01604941|450122928|FG000|Overall Study|Participant Decision|0|||
125136275|NCT01604941|450122929|FG001|Overall Study|Participant Decision|0|||
125136276|NCT01604941|450122930|FG002|Overall Study|Participant Decision|0|||
125136277|NCT01604941|450122931|FG003|Overall Study|Participant Decision|0|||
125136278|NCT01604941|450122932|FG004|Overall Study|Participant Decision|0|||
125053941|NCT01544595|449814931|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
125053942|NCT01544595|449814932|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
125053943|NCT01544595|449814933|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
125053944|NCT01544595|449814934|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
125053945|NCT01544595|449814935|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
125053946|NCT01544595|449814930|FG000|Status at Week 156|Lack of Efficacy|1|||
125053947|NCT01544595|449814931|FG001|Status at Week 156|Lack of Efficacy|0|||
125053948|NCT01544595|449814932|FG002|Status at Week 156|Lack of Efficacy|1|||
125053949|NCT01544595|449814933|FG003|Status at Week 156|Lack of Efficacy|4|||
125053950|NCT01544595|449814934|FG004|Status at Week 156|Lack of Efficacy|10|||
125136279|NCT01604941|450122933|FG005|Overall Study|Participant Decision|2|||
125136280|NCT01604941|450122928|FG000|Overall Study|Early Study Termination|9|||
125136281|NCT01604941|450122929|FG001|Overall Study|Early Study Termination|2|||
125136282|NCT01604941|450122930|FG002|Overall Study|Early Study Termination|3|||
125053951|NCT01544595|449814935|FG005|Status at Week 156|Lack of Efficacy|5|||
125053952|NCT00601523|449814937|FG000|Overall Study|Adverse Event|42|||
125053953|NCT00601523|449814938|FG001|Overall Study|Adverse Event|14|||
125053954|NCT00601523|449814937|FG000|Overall Study|Lack of Efficacy|3|||
125053955|NCT00601523|449814938|FG001|Overall Study|Lack of Efficacy|0|||
125053956|NCT00601523|449814937|FG000|Overall Study|Protocol Violation|5|||
125053957|NCT00601523|449814938|FG001|Overall Study|Protocol Violation|1|||
125053958|NCT00601523|449814937|FG000|Overall Study|Lost to Follow-up|0|||
125053959|NCT00601523|449814938|FG001|Overall Study|Lost to Follow-up|1|||
125053960|NCT00601523|449814937|FG000|Overall Study|Withdrawal by Subject|18|||
125053961|NCT00601523|449814938|FG001|Overall Study|Withdrawal by Subject|9|||
125053962|NCT00601523|449814937|FG000|Overall Study|Other|9|||
125053963|NCT00601523|449814938|FG001|Overall Study|Other|1|||
125053964|NCT03643432|449814939|FG000|Overall Study|Lost to Follow-up|1|||
125053965|NCT03643432|449814940|FG001|Overall Study|Lost to Follow-up|0|||
125053966|NCT01064648|449814947|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
125053967|NCT01064648|449814948|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
125053968|NCT01064648|449814949|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
125053969|NCT01064648|449814950|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
125053970|NCT01064648|449814947|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
125053971|NCT01064648|449814948|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
125053972|NCT01064648|449814949|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
125053973|NCT01064648|449814950|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
125053974|NCT01064648|449814947|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
125053975|NCT01064648|449814948|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
125053976|NCT01064648|449814949|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
125053977|NCT01064648|449814950|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
125053978|NCT01064648|449814947|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
125136283|NCT01604941|450122931|FG003|Overall Study|Early Study Termination|3|||
125136284|NCT01604941|450122932|FG004|Overall Study|Early Study Termination|0|||
125136285|NCT01604941|450122933|FG005|Overall Study|Early Study Termination|0|||
125136286|NCT03930732|450122934|FG000|Overall Study|Adverse Event|9|||
125136287|NCT03930732|450122935|FG001|Overall Study|Adverse Event|7|||
125136288|NCT03930732|450122934|FG000|Overall Study|Poor compliance to protocol|0|||
125136289|NCT03930732|450122935|FG001|Overall Study|Poor compliance to protocol|1|||
125136290|NCT03930732|450122934|FG000|Overall Study|Withdrawal by Subject|23|||
125136291|NCT03930732|450122935|FG001|Overall Study|Withdrawal by Subject|11|||
125136292|NCT03930732|450122934|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
125136293|NCT03930732|450122935|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
125136294|NCT03930732|450122934|FG000|Overall Study|Other reason not related to COVID-19|5|||
125136295|NCT03930732|450122935|FG001|Overall Study|Other reason not related to COVID-19|8|||
125136296|NCT03406156|450122936|FG000|Overall Study|Death|9|||
125136297|NCT03406156|450122937|FG001|Overall Study|Death|3|||
125136298|NCT03406156|450122936|FG000|Overall Study|Withdrawal by Subject|1|||
125136299|NCT03406156|450122937|FG001|Overall Study|Withdrawal by Subject|2|||
125220278|NCT03569098|450434410|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
125220279|NCT03569098|450434408|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
125220280|NCT03569098|450434409|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
125053979|NCT01064648|449814948|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
125053980|NCT01064648|449814949|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
125053981|NCT01064648|449814950|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
125053982|NCT01064648|449814947|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
125053983|NCT01064648|449814948|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
125053984|NCT01064648|449814949|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
125053985|NCT01064648|449814950|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
125136300|NCT03406156|450122936|FG000|Overall Study|COVID-19 infection|1|||
125136301|NCT03406156|450122937|FG001|Overall Study|COVID-19 infection|0|||
125136302|NCT03406156|450122936|FG000|Overall Study|Non-compliance with study procedures|1|||
125136303|NCT03406156|450122937|FG001|Overall Study|Non-compliance with study procedures|1|||
125136304|NCT03406156|450122936|FG000|Overall Study|Lost to Follow-up|0|||
125136305|NCT03406156|450122937|FG001|Overall Study|Lost to Follow-up|2|||
125136306|NCT03406156|450122936|FG000|Overall Study|Other, not specified|72|||
125136307|NCT03406156|450122937|FG001|Overall Study|Other, not specified|28|||
125136308|NCT02699463|450122940|FG000|Overall Study|Lost to Follow-up|11|||
125136309|NCT02699463|450122941|FG001|Overall Study|Lost to Follow-up|8|||
125136310|NCT02699463|450122940|FG000|Overall Study|Withdrawal by Subject|4|||
125136311|NCT02699463|450122941|FG001|Overall Study|Withdrawal by Subject|1|||
125136312|NCT00585286|450122944|FG000|Overall Study|Lost to Follow-up|1|||
125136313|NCT01316055|450122951|FG000|Overall Study|Lost to Follow-up|1|||
125136314|NCT01316055|450122952|FG001|Overall Study|Lost to Follow-up|0|||
125136315|NCT01316055|450122953|FG002|Overall Study|Lost to Follow-up|0|||
125136316|NCT00003470|450122954|FG000|Overall Study|Not evaluable|6|||
125136317|NCT01825798|450122955|FG000|Overall Study|Adverse Event|1|||
125136318|NCT01825798|450122956|FG001|Overall Study|Adverse Event|5|||
125136319|NCT01825798|450122955|FG000|Overall Study|Lost to Follow-up|1|||
125136320|NCT01825798|450122956|FG001|Overall Study|Lost to Follow-up|0|||
125136321|NCT03500094|450122961|FG000|Overall Study|Withdrawal by Subject|1|||
125136322|NCT03500094|450122961|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
125136323|NCT03500094|450122961|FG000|Overall Study|Lost to Follow-up|1|||
125136324|NCT01030133|450122962|FG000|Overall Study|failed to experience pain at level 7/10|2|||
125136325|NCT01030133|450122963|FG001|Overall Study|failed to experience pain at level 7/10|2|||
125136326|NCT04025229|450124332|FG000|Overall Study|Adverse Event|1|||
125136327|NCT04025229|450124333|FG001|Overall Study|Adverse Event|0|||
125136328|NCT04025229|450124332|FG000|Overall Study|Withdrawal by Subject|0|||
125136329|NCT04025229|450124333|FG001|Overall Study|Withdrawal by Subject|2|||
125136330|NCT04025229|450124332|FG000|Overall Study|Death|0|||
125136331|NCT04025229|450124333|FG001|Overall Study|Death|1|||
125136332|NCT04025229|450124332|FG000|Overall Study|Physician Decision|0|||
125136333|NCT04025229|450124333|FG001|Overall Study|Physician Decision|1|||
125136334|NCT01958294|450124336|FG000|Overall Study|Clinical Circumstances|2|||
125136335|NCT05511935|450124337|FG000|Overall Study|Lost to Follow-up|9|||
125136336|NCT05511935|450124338|FG001|Overall Study|Lost to Follow-up|27|||
125136337|NCT05090839|450124339|FG000|Overall Study|Lost to Follow-up|2|||
125136338|NCT05090839|450124340|FG001|Overall Study|Lost to Follow-up|3|||
125136339|NCT05090839|450124341|FG002|Overall Study|Lost to Follow-up|1|||
125136340|NCT05090839|450124342|FG003|Overall Study|Lost to Follow-up|1|||
125136341|NCT03913377|450124343|FG000|Period 1|Test Article no longer available|0|||
125053986|NCT01064648|449814947|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
125053987|NCT01064648|449814948|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
125053988|NCT01064648|449814949|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
125053989|NCT01064648|449814950|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
125053990|NCT01064648|449814947|FG000|Phase II|Adverse Event|0|||
125053991|NCT01064648|449814948|FG001|Phase II|Adverse Event|0|||
125053992|NCT01064648|449814949|FG002|Phase II|Adverse Event|15|||
125053993|NCT01064648|449814950|FG003|Phase II|Adverse Event|8|||
125053994|NCT01064648|449814947|FG000|Phase II|Death|0|||
125053995|NCT01064648|449814948|FG001|Phase II|Death|0|||
125053996|NCT01064648|449814949|FG002|Phase II|Death|4|||
125053997|NCT01064648|449814950|FG003|Phase II|Death|5|||
125053998|NCT01064648|449814947|FG000|Phase II|Withdrawal by Subject|0|||
125053999|NCT01064648|449814948|FG001|Phase II|Withdrawal by Subject|0|||
125054000|NCT01064648|449814949|FG002|Phase II|Withdrawal by Subject|2|||
125054001|NCT01064648|449814950|FG003|Phase II|Withdrawal by Subject|5|||
125054002|NCT01064648|449814947|FG000|Phase II|Progression|0|||
125054003|NCT01064648|449814948|FG001|Phase II|Progression|0|||
125054004|NCT01064648|449814949|FG002|Phase II|Progression|21|||
125054005|NCT01064648|449814950|FG003|Phase II|Progression|27|||
125054006|NCT01064648|449814947|FG000|Phase II|Non-protocol specified|0|||
125054007|NCT01064648|449814948|FG001|Phase II|Non-protocol specified|0|||
125054008|NCT01064648|449814949|FG002|Phase II|Non-protocol specified|5|||
125054009|NCT01064648|449814950|FG003|Phase II|Non-protocol specified|3|||
125054010|NCT01064648|449814947|FG000|Phase II|Under Review|0|||
125054011|NCT01064648|449814948|FG001|Phase II|Under Review|0|||
125054012|NCT01064648|449814949|FG002|Phase II|Under Review|2|||
125054013|NCT01064648|449814950|FG003|Phase II|Under Review|0|||
125054014|NCT00977574|449814951|FG000|Overall Study|Never Treated|4|||
125054015|NCT00977574|449814952|FG001|Overall Study|Never Treated|2|||
125054016|NCT00977574|449814953|FG002|Overall Study|Never Treated|4|||
125054017|NCT04038255|449816628|FG000|Overall Study|Lost to Follow-up|0|||
125054018|NCT04038255|449816629|FG001|Overall Study|Lost to Follow-up|9|||
125054019|NCT04038255|449816630|FG002|Overall Study|Lost to Follow-up|5|||
125054020|NCT04038255|449816628|FG000|Overall Study|Withdrawal by Subject|0|||
125054021|NCT04038255|449816629|FG001|Overall Study|Withdrawal by Subject|0|||
125054022|NCT04038255|449816630|FG002|Overall Study|Withdrawal by Subject|1|||
125054023|NCT05183867|449816633|FG000|Overall Study|Withdrawal by Subject|3|||
125054024|NCT05183867|449816634|FG001|Overall Study|Withdrawal by Subject|2|||
125054025|NCT05183867|449816635|FG002|Overall Study|Withdrawal by Subject|0|||
125054026|NCT00074412|449816641|FG000|Overall Study|Death|30|||
125054027|NCT00074412|449816642|FG001|Overall Study|Death|26|||
125054028|NCT00074412|449816641|FG000|Overall Study|Lost to Follow-up|52|||
125054029|NCT00074412|449816642|FG001|Overall Study|Lost to Follow-up|58|||
125054030|NCT00418834|449816647|FG000|Overall Study|Adverse Event|16|||
125054031|NCT00418834|449816648|FG001|Overall Study|Adverse Event|9|||
125054032|NCT00418834|449816647|FG000|Overall Study|Lost to Follow-up|0|||
125054033|NCT00418834|449816648|FG001|Overall Study|Lost to Follow-up|1|||
125054034|NCT00418834|449816647|FG000|Overall Study|Protocol Violation|4|||
125054035|NCT00418834|449816648|FG001|Overall Study|Protocol Violation|3|||
125054036|NCT00418834|449816647|FG000|Overall Study|Withdrawal by Subject|3|||
125054037|NCT00418834|449816648|FG001|Overall Study|Withdrawal by Subject|7|||
125054038|NCT01953328|449816649|FG000|Overall Study|Withdrawal by Subject|0|||
125054039|NCT01953328|449816650|FG001|Overall Study|Withdrawal by Subject|0|||
125054040|NCT01953328|449816651|FG002|Overall Study|Withdrawal by Subject|0|||
125054041|NCT01953328|449816652|FG003|Overall Study|Withdrawal by Subject|0|||
125136342|NCT03913377|450124344|FG001|Period 1|Test Article no longer available|1|||
125136343|NCT03913377|450124345|FG002|Period 1|Test Article no longer available|0|||
125136344|NCT03913377|450124343|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
125136345|NCT03913377|450124344|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
125136346|NCT03913377|450124345|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
125136347|NCT03499353|450124346|FG000|Treatment|Adverse Event|3|||
125136348|NCT03499353|450124346|FG000|Treatment|Progressive Disease|10|||
125054042|NCT01953328|449816653|FG004|Overall Study|Withdrawal by Subject|1|||
125054043|NCT01953328|449816654|FG005|Overall Study|Withdrawal by Subject|0|||
125136349|NCT03499353|450124346|FG000|Treatment|Other|1|||
125136350|NCT03499353|450124346|FG000|Treatment|Withdrawal by Subject|2|||
125136351|NCT03499353|450124346|FG000|Long-Term Follow-up|Death|2|||
125054044|NCT01953328|449816655|FG006|Overall Study|Withdrawal by Subject|0|||
125054045|NCT01953328|449816656|FG007|Overall Study|Withdrawal by Subject|0|||
125054046|NCT01953328|449816649|FG000|Overall Study|Lost to Follow-up|0|||
125054047|NCT01953328|449816650|FG001|Overall Study|Lost to Follow-up|0|||
125054048|NCT01953328|449816651|FG002|Overall Study|Lost to Follow-up|0|||
125054049|NCT01953328|449816652|FG003|Overall Study|Lost to Follow-up|0|||
125054050|NCT01953328|449816653|FG004|Overall Study|Lost to Follow-up|1|||
125054051|NCT01953328|449816654|FG005|Overall Study|Lost to Follow-up|0|||
125054052|NCT01953328|449816655|FG006|Overall Study|Lost to Follow-up|0|||
125054053|NCT01953328|449816656|FG007|Overall Study|Lost to Follow-up|0|||
125054054|NCT02364947|449816661|FG000|Overall Study|Withdrawal by Subject|10|||
125136352|NCT03499353|450124346|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
125054055|NCT02364947|449816662|FG001|Overall Study|Withdrawal by Subject|8|||
125054056|NCT02364947|449816663|FG002|Overall Study|Withdrawal by Subject|9|||
125054057|NCT02364947|449816661|FG000|Overall Study|Adverse Event|45|||
125054058|NCT02364947|449816662|FG001|Overall Study|Adverse Event|33|||
125054059|NCT02364947|449816663|FG002|Overall Study|Adverse Event|11|||
125054060|NCT02364947|449816661|FG000|Overall Study|Protocol Violation|1|||
125054061|NCT02364947|449816662|FG001|Overall Study|Protocol Violation|1|||
125054062|NCT02364947|449816663|FG002|Overall Study|Protocol Violation|1|||
125054063|NCT02364947|449816661|FG000|Overall Study|Physician Decision|3|||
125054064|NCT02364947|449816662|FG001|Overall Study|Physician Decision|2|||
125054065|NCT02364947|449816663|FG002|Overall Study|Physician Decision|5|||
125054066|NCT02364947|449816661|FG000|Overall Study|Death|0|||
125054067|NCT02364947|449816662|FG001|Overall Study|Death|1|||
125054068|NCT02364947|449816663|FG002|Overall Study|Death|0|||
125054069|NCT05525975|449816664|FG000|Overall Study|Surgery cancellation|4|||
125054070|NCT05525975|449816665|FG001|Overall Study|Surgery cancellation|5|||
125054071|NCT05525975|449816664|FG000|Overall Study|didn't fill prescription|1|||
125054072|NCT05525975|449816665|FG001|Overall Study|didn't fill prescription|0|||
125054073|NCT05525975|449816664|FG000|Overall Study|Withdrawal by Subject|0|||
125054074|NCT05525975|449816665|FG001|Overall Study|Withdrawal by Subject|3|||
125054075|NCT04009096|449816666|FG000|Overall Study|Withdrawal by Subject|0|||
125054076|NCT04009096|449816667|FG001|Overall Study|Withdrawal by Subject|7|||
125054077|NCT04009096|449816668|FG002|Overall Study|Withdrawal by Subject|0|||
125054078|NCT04009096|449816666|FG000|Overall Study|Physician Decision|0|||
125054079|NCT04009096|449816667|FG001|Overall Study|Physician Decision|1|||
125054080|NCT04009096|449816668|FG002|Overall Study|Physician Decision|0|||
125054081|NCT05151471|449816669|FG000|Overall Study|Adverse Event|21|||
125054082|NCT05151471|449816670|FG001|Overall Study|Adverse Event|16|||
125054083|NCT05151471|449816669|FG000|Overall Study|Death|1|||
125054084|NCT05151471|449816670|FG001|Overall Study|Death|0|||
125054085|NCT05151471|449816669|FG000|Overall Study|Lost to Follow-up|0|||
125054086|NCT05151471|449816670|FG001|Overall Study|Lost to Follow-up|1|||
125054087|NCT05151471|449816669|FG000|Overall Study|Withdrawal by Subject|7|||
125054088|NCT05151471|449816670|FG001|Overall Study|Withdrawal by Subject|9|||
125054089|NCT05151471|449816669|FG000|Overall Study|Study terminated by sponsor|49|||
125054090|NCT05151471|449816670|FG001|Overall Study|Study terminated by sponsor|47|||
125054091|NCT05151471|449816669|FG000|Overall Study|Other|2|||
125054092|NCT05151471|449816670|FG001|Overall Study|Other|1|||
125054093|NCT01028651|449816674|FG000|Overall Study|Death|2|||
125054094|NCT01028651|449816674|FG000|Overall Study|Adverse Event|1|||
125054095|NCT01554956|449816675|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
125054096|NCT01554956|449816676|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
125054097|NCT01554956|449816677|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
125054098|NCT01554956|449816675|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
125054099|NCT01554956|449816676|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
125054100|NCT01554956|449816677|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
125054101|NCT01554956|449816675|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
125136353|NCT03499353|450124346|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
125136354|NCT01117623|450124347|FG000|Overall Study|Adverse Event|0|||
125136355|NCT01117623|450124348|FG001|Overall Study|Adverse Event|2|||
125136356|NCT01117623|450124349|FG002|Overall Study|Adverse Event|4|||
125136357|NCT01117623|450124350|FG003|Overall Study|Adverse Event|0|||
125136358|NCT01117623|450124351|FG004|Overall Study|Adverse Event|2|||
125136359|NCT01117623|450124352|FG005|Overall Study|Adverse Event|0|||
125136360|NCT01117623|450124353|FG006|Overall Study|Adverse Event|0|||
125136361|NCT01117623|450124354|FG007|Overall Study|Adverse Event|2|||
125136362|NCT01117623|450124347|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
125054102|NCT01554956|449816676|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
125054103|NCT01554956|449816677|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
125054104|NCT00913978|449816678|FG000|Overall Study|Surgeon choice|1|||
125054105|NCT00913978|449816679|FG001|Overall Study|Surgeon choice|3|||
125054106|NCT01327651|449816680|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
125054107|NCT01327651|449816681|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
125054108|NCT01327651|449816682|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
125054109|NCT01327651|449816683|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
125054110|NCT01327651|449816684|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
125136363|NCT01117623|450124348|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
125136364|NCT01117623|450124349|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
125054111|NCT01327651|449816685|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
125054112|NCT01327651|449816686|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
125054113|NCT01327651|449816687|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
125054114|NCT01327651|449816688|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
125054115|NCT01327651|449816680|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
125054116|NCT01327651|449816681|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
125054117|NCT01327651|449816682|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
125054118|NCT01327651|449816683|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
125054119|NCT01327651|449816684|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
125054120|NCT01327651|449816685|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
125054121|NCT01327651|449816686|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
125054122|NCT01327651|449816687|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
125054123|NCT01327651|449816688|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
125054124|NCT01327651|449816680|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
125054125|NCT01327651|449816681|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
125054126|NCT01327651|449816682|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
125054127|NCT01327651|449816683|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
125054128|NCT01327651|449816684|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
125054129|NCT01327651|449816685|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
125054130|NCT01327651|449816686|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
125054131|NCT01327651|449816687|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
125054132|NCT01327651|449816688|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
125054133|NCT01327651|449816680|FG000|Post Study Follow-up|Lost to Follow-up|0|||
125054134|NCT01327651|449816681|FG001|Post Study Follow-up|Lost to Follow-up|1|||
125054135|NCT01327651|449816682|FG002|Post Study Follow-up|Lost to Follow-up|1|||
125054136|NCT01327651|449816683|FG003|Post Study Follow-up|Lost to Follow-up|0|||
125054137|NCT01327651|449816684|FG004|Post Study Follow-up|Lost to Follow-up|0|||
125054138|NCT01327651|449816685|FG005|Post Study Follow-up|Lost to Follow-up|0|||
125054139|NCT01327651|449816686|FG006|Post Study Follow-up|Lost to Follow-up|4|||
125054140|NCT01327651|449816687|FG007|Post Study Follow-up|Lost to Follow-up|1|||
125054141|NCT01327651|449816688|FG008|Post Study Follow-up|Lost to Follow-up|2|||
125054142|NCT03249792|449816693|FG000|Arms 1, 2, and 4|Death|1|||
125054143|NCT03249792|449816694|FG001|Arms 1, 2, and 4|Death|1|||
125054144|NCT03249792|449816695|FG002|Arms 1, 2, and 4|Death|0|||
125054145|NCT03249792|449816696|FG003|Arms 1, 2, and 4|Death|2|||
125054146|NCT03249792|449816697|FG004|Arms 1, 2, and 4|Death|3|||
125054147|NCT03249792|449816698|FG005|Arms 1, 2, and 4|Death|2|||
125054148|NCT03249792|449816699|FG006|Arms 1, 2, and 4|Death|2|||
125054149|NCT03249792|449816700|FG007|Arms 1, 2, and 4|Death|4|||
125054150|NCT03249792|449816701|FG008|Arms 1, 2, and 4|Death|2|||
125054151|NCT03249792|449816702|FG009|Arms 1, 2, and 4|Death|1|||
125054152|NCT03249792|449816703|FG010|Arms 1, 2, and 4|Death|7|||
125054153|NCT03249792|449816704|FG011|Arms 1, 2, and 4|Death|7|||
125054154|NCT03249792|449816705|FG012|Arms 1, 2, and 4|Death|12|||
125054155|NCT03249792|449816706|FG013|Arms 1, 2, and 4|Death|7|||
125054156|NCT03249792|449816707|FG014|Arms 1, 2, and 4|Death|0|||
125054157|NCT03249792|449816708|FG015|Arms 1, 2, and 4|Death|4|||
125054158|NCT03249792|449816709|FG016|Arms 1, 2, and 4|Death|4|||
125054159|NCT03249792|449816710|FG017|Arms 1, 2, and 4|Death|12|||
125054160|NCT03249792|449816711|FG018|Arms 1, 2, and 4|Death|6|||
125054161|NCT03249792|449816712|FG019|Arms 1, 2, and 4|Death|4|||
125054162|NCT03249792|449816713|FG020|Arms 1, 2, and 4|Death|2|||
125054163|NCT03249792|449816714|FG021|Arms 1, 2, and 4|Death|3|||
125054164|NCT03249792|449816715|FG022|Arms 1, 2, and 4|Death|1|||
125054165|NCT03249792|449816716|FG023|Arms 1, 2, and 4|Death|1|||
125054166|NCT03249792|449816717|FG024|Arms 1, 2, and 4|Death|4|||
125054167|NCT03249792|449816718|FG025|Arms 1, 2, and 4|Death|0|||
125054168|NCT03249792|449816719|FG026|Arms 1, 2, and 4|Death|0|||
125054169|NCT03249792|449816720|FG027|Arms 1, 2, and 4|Death|0|||
125054170|NCT03249792|449816721|FG028|Arms 1, 2, and 4|Death|0|||
125054171|NCT03249792|449816722|FG029|Arms 1, 2, and 4|Death|0|||
125054172|NCT03249792|449816723|FG030|Arms 1, 2, and 4|Death|0|||
125054173|NCT03249792|449816724|FG031|Arms 1, 2, and 4|Death|0|||
125054174|NCT03249792|449816725|FG032|Arms 1, 2, and 4|Death|0|||
125054175|NCT03249792|449816693|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125054176|NCT03249792|449816694|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125054177|NCT03249792|449816695|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
125054178|NCT03249792|449816696|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125054179|NCT03249792|449816697|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125054180|NCT03249792|449816698|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
125054181|NCT03249792|449816699|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
125054182|NCT03249792|449816700|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125054183|NCT03249792|449816701|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
125054184|NCT03249792|449816702|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
125054185|NCT03249792|449816703|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
125054186|NCT03249792|449816704|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
125054187|NCT03249792|449816705|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
125054188|NCT03249792|449816706|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
125054189|NCT03249792|449816707|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125054190|NCT03249792|449816708|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125136365|NCT01117623|450124350|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
125136366|NCT01117623|450124351|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
125136367|NCT01117623|450124352|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
125054191|NCT03249792|449816709|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
125054192|NCT03249792|449816710|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125054193|NCT03249792|449816711|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
125054194|NCT03249792|449816712|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125054195|NCT03249792|449816713|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125054196|NCT03249792|449816714|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125054197|NCT03249792|449816715|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
125054198|NCT03249792|449816716|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
125054199|NCT03249792|449816717|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125054200|NCT03249792|449816718|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125054201|NCT03249792|449816719|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125054202|NCT03249792|449816720|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125054203|NCT03249792|449816721|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125054204|NCT03249792|449816722|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125054205|NCT03249792|449816723|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125054206|NCT03249792|449816724|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125054207|NCT03249792|449816725|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125054208|NCT03249792|449816693|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
125054209|NCT03249792|449816694|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
125054210|NCT03249792|449816695|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
125054211|NCT03249792|449816696|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
125054212|NCT03249792|449816697|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
125054213|NCT03249792|449816698|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
125054214|NCT03249792|449816699|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
125054215|NCT03249792|449816700|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
125054216|NCT03249792|449816701|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
125054217|NCT03249792|449816702|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
125054218|NCT03249792|449816703|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
125054219|NCT03249792|449816704|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
125054220|NCT03249792|449816705|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
125054221|NCT03249792|449816706|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
125054222|NCT03249792|449816707|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
125054223|NCT03249792|449816708|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
125054224|NCT03249792|449816709|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
125054225|NCT03249792|449816710|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
125054226|NCT03249792|449816711|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
125054227|NCT03249792|449816712|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
125054228|NCT03249792|449816713|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
125054229|NCT03249792|449816714|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
125054230|NCT03249792|449816715|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
125054231|NCT03249792|449816716|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
125054232|NCT03249792|449816717|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
125054233|NCT03249792|449816718|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
125054234|NCT03249792|449816719|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
125054235|NCT03249792|449816720|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
125054236|NCT03249792|449816721|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
125054237|NCT03249792|449816722|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
125054238|NCT03249792|449816723|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
125054239|NCT03249792|449816724|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
125054240|NCT03249792|449816725|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
125054241|NCT03249792|449816693|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054242|NCT03249792|449816694|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054243|NCT03249792|449816695|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054244|NCT03249792|449816696|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054245|NCT03249792|449816697|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054246|NCT03249792|449816698|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054247|NCT03249792|449816699|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054248|NCT03249792|449816700|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054249|NCT03249792|449816701|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
125054250|NCT03249792|449816702|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054251|NCT03249792|449816703|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054252|NCT03249792|449816704|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054253|NCT03249792|449816705|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054254|NCT03249792|449816706|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054255|NCT03249792|449816707|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054256|NCT03249792|449816708|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054257|NCT03249792|449816709|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
125054258|NCT03249792|449816710|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
125054259|NCT03249792|449816711|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054260|NCT03249792|449816712|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
125054261|NCT03249792|449816713|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054262|NCT03249792|449816714|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054263|NCT03249792|449816715|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054264|NCT03249792|449816716|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054265|NCT03249792|449816717|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054266|NCT03249792|449816718|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054267|NCT03249792|449816719|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054268|NCT03249792|449816720|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054269|NCT03249792|449816721|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054270|NCT03249792|449816722|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054271|NCT03249792|449816723|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054272|NCT03249792|449816724|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054273|NCT03249792|449816725|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
125054274|NCT03249792|449816693|FG000|Switch Over Period|Withdrawal by Subject|0|||
125054275|NCT03249792|449816694|FG001|Switch Over Period|Withdrawal by Subject|0|||
125054276|NCT03249792|449816695|FG002|Switch Over Period|Withdrawal by Subject|0|||
125054277|NCT03249792|449816696|FG003|Switch Over Period|Withdrawal by Subject|0|||
125136368|NCT01117623|450124353|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
125136369|NCT01117623|450124354|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
125136370|NCT01117623|450124347|FG000|Overall Study|Withdrawal by Subject|0|||
125136371|NCT01117623|450124348|FG001|Overall Study|Withdrawal by Subject|0|||
125136372|NCT01117623|450124349|FG002|Overall Study|Withdrawal by Subject|2|||
125136373|NCT01117623|450124350|FG003|Overall Study|Withdrawal by Subject|0|||
125136374|NCT01117623|450124351|FG004|Overall Study|Withdrawal by Subject|0|||
125136375|NCT01117623|450124352|FG005|Overall Study|Withdrawal by Subject|1|||
125136376|NCT01117623|450124353|FG006|Overall Study|Withdrawal by Subject|1|||
125136377|NCT01117623|450124354|FG007|Overall Study|Withdrawal by Subject|1|||
125136378|NCT01117623|450124347|FG000|Overall Study|Non-compliance with study medication|0|||
125136379|NCT01117623|450124348|FG001|Overall Study|Non-compliance with study medication|0|||
125136380|NCT01117623|450124349|FG002|Overall Study|Non-compliance with study medication|0|||
125136381|NCT01117623|450124350|FG003|Overall Study|Non-compliance with study medication|0|||
125136382|NCT01117623|450124351|FG004|Overall Study|Non-compliance with study medication|0|||
125136383|NCT01117623|450124352|FG005|Overall Study|Non-compliance with study medication|0|||
125136384|NCT01117623|450124353|FG006|Overall Study|Non-compliance with study medication|0|||
125136385|NCT01117623|450124354|FG007|Overall Study|Non-compliance with study medication|1|||
125136386|NCT01117623|450124347|FG000|Overall Study|Invest. text: completed all planned txs|0|||
125136387|NCT01117623|450124348|FG001|Overall Study|Invest. text: completed all planned txs|0|||
125136388|NCT01117623|450124349|FG002|Overall Study|Invest. text: completed all planned txs|0|||
125136389|NCT01117623|450124350|FG003|Overall Study|Invest. text: completed all planned txs|0|||
125136390|NCT01117623|450124351|FG004|Overall Study|Invest. text: completed all planned txs|0|||
125136391|NCT01117623|450124352|FG005|Overall Study|Invest. text: completed all planned txs|1|||
125054278|NCT03249792|449816697|FG004|Switch Over Period|Withdrawal by Subject|0|||
125054279|NCT03249792|449816698|FG005|Switch Over Period|Withdrawal by Subject|0|||
125136392|NCT01117623|450124353|FG006|Overall Study|Invest. text: completed all planned txs|0|||
125136393|NCT01117623|450124354|FG007|Overall Study|Invest. text: completed all planned txs|0|||
125136394|NCT00736190|450124359|FG000|Overall Study|Pregnancy|1|||
125054280|NCT03249792|449816699|FG006|Switch Over Period|Withdrawal by Subject|0|||
125054281|NCT03249792|449816700|FG007|Switch Over Period|Withdrawal by Subject|0|||
125054282|NCT03249792|449816701|FG008|Switch Over Period|Withdrawal by Subject|0|||
125054283|NCT03249792|449816702|FG009|Switch Over Period|Withdrawal by Subject|0|||
125054284|NCT03249792|449816703|FG010|Switch Over Period|Withdrawal by Subject|0|||
125054285|NCT03249792|449816704|FG011|Switch Over Period|Withdrawal by Subject|0|||
125054286|NCT03249792|449816705|FG012|Switch Over Period|Withdrawal by Subject|0|||
125054287|NCT03249792|449816706|FG013|Switch Over Period|Withdrawal by Subject|0|||
125054288|NCT03249792|449816707|FG014|Switch Over Period|Withdrawal by Subject|0|||
125054289|NCT03249792|449816708|FG015|Switch Over Period|Withdrawal by Subject|0|||
125054290|NCT03249792|449816709|FG016|Switch Over Period|Withdrawal by Subject|0|||
125054291|NCT03249792|449816710|FG017|Switch Over Period|Withdrawal by Subject|0|||
125054292|NCT03249792|449816711|FG018|Switch Over Period|Withdrawal by Subject|0|||
125054293|NCT03249792|449816712|FG019|Switch Over Period|Withdrawal by Subject|0|||
125054294|NCT03249792|449816713|FG020|Switch Over Period|Withdrawal by Subject|0|||
125054295|NCT03249792|449816714|FG021|Switch Over Period|Withdrawal by Subject|0|||
125054296|NCT03249792|449816715|FG022|Switch Over Period|Withdrawal by Subject|0|||
125054297|NCT03249792|449816716|FG023|Switch Over Period|Withdrawal by Subject|0|||
125054298|NCT03249792|449816717|FG024|Switch Over Period|Withdrawal by Subject|0|||
125054299|NCT03249792|449816718|FG025|Switch Over Period|Withdrawal by Subject|0|||
125054300|NCT03249792|449816719|FG026|Switch Over Period|Withdrawal by Subject|0|||
125054301|NCT03249792|449816720|FG027|Switch Over Period|Withdrawal by Subject|0|||
125054302|NCT03249792|449816721|FG028|Switch Over Period|Withdrawal by Subject|0|||
125054303|NCT03249792|449816722|FG029|Switch Over Period|Withdrawal by Subject|0|||
125054304|NCT03249792|449816723|FG030|Switch Over Period|Withdrawal by Subject|0|||
125054305|NCT03249792|449816724|FG031|Switch Over Period|Withdrawal by Subject|1|||
125054306|NCT03249792|449816725|FG032|Switch Over Period|Withdrawal by Subject|0|||
125054307|NCT03249792|449816693|FG000|Switch Over Period|Progressive Disease|0|||
125054308|NCT03249792|449816694|FG001|Switch Over Period|Progressive Disease|0|||
125054309|NCT03249792|449816695|FG002|Switch Over Period|Progressive Disease|0|||
125054310|NCT03249792|449816696|FG003|Switch Over Period|Progressive Disease|0|||
125054311|NCT03249792|449816697|FG004|Switch Over Period|Progressive Disease|0|||
125054312|NCT03249792|449816698|FG005|Switch Over Period|Progressive Disease|0|||
125054313|NCT03249792|449816699|FG006|Switch Over Period|Progressive Disease|0|||
125054314|NCT03249792|449816700|FG007|Switch Over Period|Progressive Disease|0|||
125054315|NCT03249792|449816701|FG008|Switch Over Period|Progressive Disease|0|||
125054316|NCT03249792|449816702|FG009|Switch Over Period|Progressive Disease|0|||
125054317|NCT03249792|449816703|FG010|Switch Over Period|Progressive Disease|0|||
125054318|NCT03249792|449816704|FG011|Switch Over Period|Progressive Disease|0|||
125054319|NCT03249792|449816705|FG012|Switch Over Period|Progressive Disease|0|||
125054320|NCT03249792|449816706|FG013|Switch Over Period|Progressive Disease|0|||
125054321|NCT03249792|449816707|FG014|Switch Over Period|Progressive Disease|0|||
125054322|NCT03249792|449816708|FG015|Switch Over Period|Progressive Disease|0|||
125054323|NCT03249792|449816709|FG016|Switch Over Period|Progressive Disease|0|||
125054324|NCT03249792|449816710|FG017|Switch Over Period|Progressive Disease|0|||
125054325|NCT03249792|449816711|FG018|Switch Over Period|Progressive Disease|0|||
125054326|NCT03249792|449816712|FG019|Switch Over Period|Progressive Disease|0|||
125054327|NCT03249792|449816713|FG020|Switch Over Period|Progressive Disease|0|||
125054328|NCT03249792|449816714|FG021|Switch Over Period|Progressive Disease|0|||
125054329|NCT03249792|449816715|FG022|Switch Over Period|Progressive Disease|0|||
125054330|NCT03249792|449816716|FG023|Switch Over Period|Progressive Disease|0|||
125054331|NCT03249792|449816717|FG024|Switch Over Period|Progressive Disease|0|||
125054332|NCT03249792|449816718|FG025|Switch Over Period|Progressive Disease|0|||
125054333|NCT03249792|449816719|FG026|Switch Over Period|Progressive Disease|1|||
125054334|NCT03249792|449816720|FG027|Switch Over Period|Progressive Disease|0|||
125054335|NCT03249792|449816721|FG028|Switch Over Period|Progressive Disease|1|||
125054336|NCT03249792|449816722|FG029|Switch Over Period|Progressive Disease|2|||
125054337|NCT03249792|449816723|FG030|Switch Over Period|Progressive Disease|1|||
125054338|NCT03249792|449816724|FG031|Switch Over Period|Progressive Disease|0|||
125054339|NCT03249792|449816725|FG032|Switch Over Period|Progressive Disease|1|||
125054340|NCT03249792|449816693|FG000|Switch Over Period|Adverse Event|0|||
125054341|NCT03249792|449816694|FG001|Switch Over Period|Adverse Event|0|||
125054342|NCT03249792|449816695|FG002|Switch Over Period|Adverse Event|0|||
125054343|NCT03249792|449816696|FG003|Switch Over Period|Adverse Event|0|||
125054344|NCT03249792|449816697|FG004|Switch Over Period|Adverse Event|0|||
125054345|NCT03249792|449816698|FG005|Switch Over Period|Adverse Event|0|||
125054346|NCT03249792|449816699|FG006|Switch Over Period|Adverse Event|0|||
125054347|NCT03249792|449816700|FG007|Switch Over Period|Adverse Event|0|||
125054348|NCT03249792|449816701|FG008|Switch Over Period|Adverse Event|0|||
125054349|NCT03249792|449816702|FG009|Switch Over Period|Adverse Event|0|||
125054350|NCT03249792|449816703|FG010|Switch Over Period|Adverse Event|0|||
125054351|NCT03249792|449816704|FG011|Switch Over Period|Adverse Event|0|||
125054352|NCT03249792|449816705|FG012|Switch Over Period|Adverse Event|0|||
125054353|NCT03249792|449816706|FG013|Switch Over Period|Adverse Event|0|||
125054354|NCT03249792|449816707|FG014|Switch Over Period|Adverse Event|0|||
125054355|NCT03249792|449816708|FG015|Switch Over Period|Adverse Event|0|||
125054356|NCT03249792|449816709|FG016|Switch Over Period|Adverse Event|0|||
125054357|NCT03249792|449816710|FG017|Switch Over Period|Adverse Event|0|||
125054358|NCT03249792|449816711|FG018|Switch Over Period|Adverse Event|0|||
125054359|NCT03249792|449816712|FG019|Switch Over Period|Adverse Event|0|||
125054360|NCT03249792|449816713|FG020|Switch Over Period|Adverse Event|0|||
125054361|NCT03249792|449816714|FG021|Switch Over Period|Adverse Event|0|||
125054362|NCT03249792|449816715|FG022|Switch Over Period|Adverse Event|0|||
125054363|NCT03249792|449816716|FG023|Switch Over Period|Adverse Event|0|||
125054364|NCT03249792|449816717|FG024|Switch Over Period|Adverse Event|0|||
125054365|NCT03249792|449816718|FG025|Switch Over Period|Adverse Event|1|||
125054366|NCT03249792|449816719|FG026|Switch Over Period|Adverse Event|0|||
125054367|NCT03249792|449816720|FG027|Switch Over Period|Adverse Event|1|||
125054368|NCT03249792|449816721|FG028|Switch Over Period|Adverse Event|0|||
125054369|NCT03249792|449816722|FG029|Switch Over Period|Adverse Event|0|||
125054370|NCT03249792|449816723|FG030|Switch Over Period|Adverse Event|0|||
125054371|NCT03249792|449816724|FG031|Switch Over Period|Adverse Event|0|||
125054372|NCT03249792|449816725|FG032|Switch Over Period|Adverse Event|0|||
125054373|NCT02284906|449816726|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
125054374|NCT02284906|449816727|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
125054375|NCT02284906|449816728|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
125054376|NCT02284906|449816726|FG000|Overall Study|Major Protocol Deviation|0|||
125054377|NCT02284906|449816727|FG001|Overall Study|Major Protocol Deviation|1|||
125054378|NCT02284906|449816728|FG002|Overall Study|Major Protocol Deviation|0|||
125054379|NCT02284906|449816726|FG000|Overall Study|Voluntary Withdrawal|2|||
125054380|NCT02284906|449816727|FG001|Overall Study|Voluntary Withdrawal|4|||
125054381|NCT02284906|449816728|FG002|Overall Study|Voluntary Withdrawal|5|||
125054382|NCT02284906|449816726|FG000|Overall Study|Study Termination|0|||
125054383|NCT02284906|449816727|FG001|Overall Study|Study Termination|11|||
125054384|NCT02284906|449816728|FG002|Overall Study|Study Termination|14|||
125054385|NCT02284906|449816726|FG000|Overall Study|Reason not Specified|1|||
125054386|NCT02284906|449816727|FG001|Overall Study|Reason not Specified|1|||
125054387|NCT02284906|449816728|FG002|Overall Study|Reason not Specified|0|||
125054388|NCT00069576|449816730|FG000|Original Trial|Lost to Follow-up|25|||
125054389|NCT00069576|449816731|FG001|Original Trial|Lost to Follow-up|33|||
125054390|NCT00069576|449816730|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
125054391|NCT00069576|449816731|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
125054392|NCT04060667|449816732|FG000|Overall Study|Lost to Follow-up|75|||
125054393|NCT04060667|449816733|FG001|Overall Study|Lost to Follow-up|10|||
125054394|NCT00525148|449816735|FG000|Overall Study|Other Adverse Event|3|||
125054395|NCT00525148|449816736|FG001|Overall Study|Other Adverse Event|5|||
125054396|NCT00525148|449816737|FG002|Overall Study|Other Adverse Event|1|||
125054397|NCT00525148|449816738|FG003|Overall Study|Other Adverse Event|8|||
125054398|NCT00525148|449816735|FG000|Overall Study|Progressive disease|18|||
125054399|NCT00525148|449816736|FG001|Overall Study|Progressive disease|30|||
125054400|NCT00525148|449816737|FG002|Overall Study|Progressive disease|6|||
125054401|NCT00525148|449816738|FG003|Overall Study|Progressive disease|49|||
125054402|NCT00525148|449816735|FG000|Overall Study|Refused continuation of study medication|0|||
125054403|NCT00525148|449816736|FG001|Overall Study|Refused continuation of study medication|2|||
125054404|NCT00525148|449816737|FG002|Overall Study|Refused continuation of study medication|0|||
125054405|NCT00525148|449816738|FG003|Overall Study|Refused continuation of study medication|1|||
125054406|NCT00525148|449816735|FG000|Overall Study|Other than stated|2|||
125054407|NCT00525148|449816736|FG001|Overall Study|Other than stated|1|||
125054408|NCT00525148|449816737|FG002|Overall Study|Other than stated|0|||
125054409|NCT00525148|449816738|FG003|Overall Study|Other than stated|3|||
125054410|NCT05100199|449816740|FG000|Overall Study|Lost to Follow-up|5|||
125054411|NCT05100199|449816741|FG001|Overall Study|Lost to Follow-up|8|||
125054412|NCT05100199|449816742|FG002|Overall Study|Lost to Follow-up|3|||
125054413|NCT05100199|449816743|FG003|Overall Study|Lost to Follow-up|6|||
125054414|NCT05100199|449816740|FG000|Overall Study|Withdrawal by Subject|3|||
125054415|NCT05100199|449816741|FG001|Overall Study|Withdrawal by Subject|3|||
125054416|NCT05100199|449816742|FG002|Overall Study|Withdrawal by Subject|9|||
125054417|NCT05100199|449816743|FG003|Overall Study|Withdrawal by Subject|7|||
125054418|NCT05100199|449816740|FG000|Overall Study|Other|0|||
125054419|NCT05100199|449816741|FG001|Overall Study|Other|0|||
125054420|NCT05100199|449816742|FG002|Overall Study|Other|1|||
125054421|NCT05100199|449816743|FG003|Overall Study|Other|1|||
125054422|NCT00830037|449816744|FG000|Overall Study|Withdrawal by Subject|2|||
125054423|NCT00830037|449816745|FG001|Overall Study|Withdrawal by Subject|3|||
125054424|NCT00830037|449816744|FG000|Overall Study|Lost to Follow-up|1|||
125054425|NCT00830037|449816745|FG001|Overall Study|Lost to Follow-up|2|||
125054426|NCT00830037|449816744|FG000|Overall Study|Active when terminated by DSMB|15|||
125054427|NCT00830037|449816745|FG001|Overall Study|Active when terminated by DSMB|14|||
125054428|NCT00752609|449816746|FG000|Overall Study|Adverse Event|2|||
125054429|NCT00752609|449816747|FG001|Overall Study|Adverse Event|2|||
125054430|NCT00752609|449816746|FG000|Overall Study|Withdrawal by Subject|3|||
125054431|NCT00752609|449816747|FG001|Overall Study|Withdrawal by Subject|0|||
125054432|NCT00752609|449816746|FG000|Overall Study|Physician Decision|1|||
125054433|NCT00752609|449816747|FG001|Overall Study|Physician Decision|0|||
125054434|NCT00752609|449816746|FG000|Overall Study|Death|1|||
125054435|NCT00752609|449816747|FG001|Overall Study|Death|0|||
125054436|NCT00752609|449816746|FG000|Overall Study|Met exclusion criteria|1|||
125054437|NCT00752609|449816747|FG001|Overall Study|Met exclusion criteria|0|||
125054438|NCT00752609|449816746|FG000|Overall Study|Received Aranesp in error|1|||
125054439|NCT00752609|449816747|FG001|Overall Study|Received Aranesp in error|0|||
125054440|NCT01096550|449816755|FG000|Overall Study|discontinued site|10|||
125054441|NCT01096550|449816756|FG001|Overall Study|discontinued site|11|||
125054442|NCT01096550|449816755|FG000|Overall Study|non-regular treatment track at clinic|1|||
125054443|NCT01096550|449816756|FG001|Overall Study|non-regular treatment track at clinic|1|||
125054444|NCT01096550|449816755|FG000|Overall Study|clinic readmission|1|||
125054445|NCT01096550|449816756|FG001|Overall Study|clinic readmission|1|||
125054446|NCT01096550|449816755|FG000|Overall Study|Withdrawal by Subject|0|||
125054447|NCT01096550|449816756|FG001|Overall Study|Withdrawal by Subject|1|||
125054448|NCT01096550|449816755|FG000|Overall Study|non-African American participant|13|||
125054449|NCT01096550|449816756|FG001|Overall Study|non-African American participant|6|||
125054450|NCT01096550|449816755|FG000|Overall Study|Lost to Follow-up|12|||
125054451|NCT01096550|449816756|FG001|Overall Study|Lost to Follow-up|9|||
125054452|NCT03288779|449816765|FG000|Overall Study|Withdrawal by Subject|3|||
125054453|NCT02928406|449816770|FG000|Overall Study|Death|780|||
125054454|NCT02928406|449816770|FG000|Overall Study|Progressive disease|3|||
125054455|NCT02928406|449816770|FG000|Overall Study|Lost to Follow-up|49|||
125054456|NCT02928406|449816770|FG000|Overall Study|Non-compliance|2|||
125054457|NCT02928406|449816770|FG000|Overall Study|Withdrawal by Subject|40|||
125054458|NCT02928406|449816770|FG000|Overall Study|Study terminated by sponsor|57|||
125054459|NCT02928406|449816770|FG000|Overall Study|Physician Decision|1|||
125054460|NCT02928406|449816770|FG000|Overall Study|Various reasons|72|||
125054461|NCT02149836|449816771|FG000|Overall Study|Withdrawal by Subject|1|||
125054462|NCT05281523|449816776|FG000|Overall Study|Adverse Event|1|||
125054463|NCT05281523|449816777|FG001|Overall Study|Adverse Event|1|||
125054464|NCT05281523|449816776|FG000|Overall Study|Physician Decision|1|||
125054465|NCT05281523|449816777|FG001|Overall Study|Physician Decision|1|||
125054466|NCT05281523|449816776|FG000|Overall Study|Withdrawal by Subject|5|||
125054467|NCT05281523|449816777|FG001|Overall Study|Withdrawal by Subject|15|||
125054468|NCT05281523|449816776|FG000|Overall Study|GCP violations|3|||
125054469|NCT05281523|449816777|FG001|Overall Study|GCP violations|4|||
125054470|NCT05513391|449816778|FG000|Overall Study|Adverse Event|1|||
125054471|NCT05513391|449816779|FG001|Overall Study|Adverse Event|0|||
125054472|NCT05513391|449816778|FG000|Overall Study|Protocol Deviation|0|||
125054473|NCT05513391|449816779|FG001|Overall Study|Protocol Deviation|1|||
125054474|NCT05513391|449816778|FG000|Overall Study|Withdrawal by Subject|3|||
125054475|NCT05513391|449816779|FG001|Overall Study|Withdrawal by Subject|1|||
125054476|NCT05513391|449816778|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
125054477|NCT05513391|449816779|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
125136395|NCT00736190|450124359|FG000|Overall Study|Withdrawal by Subject|1|||
125136396|NCT00736190|450124359|FG000|Overall Study|Adverse Event|1|||
125136397|NCT01896934|450124361|FG000|Overall Study|Adverse Event|1|||
125136398|NCT01896934|450124361|FG000|Overall Study|Withdrawal by Subject|1|||
125136399|NCT00933686|450124362|FG000|Overall Study|Protocol Violation|0|||
125136400|NCT00933686|450124363|FG001|Overall Study|Protocol Violation|1|||
125136401|NCT00933686|450124362|FG000|Overall Study|Lost to Follow-up|2|||
125136402|NCT00933686|450124363|FG001|Overall Study|Lost to Follow-up|2|||
125136403|NCT00933686|450124362|FG000|Overall Study|Withdrawal by Subject|6|||
125136404|NCT00933686|450124363|FG001|Overall Study|Withdrawal by Subject|5|||
125136405|NCT00933686|450124362|FG000|Overall Study|Adverse Event|1|||
125136406|NCT00933686|450124363|FG001|Overall Study|Adverse Event|1|||
125136407|NCT00933686|450124362|FG000|Overall Study|Physician Decision|1|||
125136408|NCT00933686|450124363|FG001|Overall Study|Physician Decision|0|||
125136409|NCT00933686|450124362|FG000|Overall Study|Failure to show up at endpoint visits|0|||
125136410|NCT00933686|450124363|FG001|Overall Study|Failure to show up at endpoint visits|2|||
125054478|NCT05513391|449816778|FG000|Overall Study|Lost to Follow-up|0|||
125054479|NCT05513391|449816779|FG001|Overall Study|Lost to Follow-up|2|||
125054480|NCT05128162|449816780|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
125054481|NCT05128162|449816780|FG000|Overall Study|Physician Decision|1|||
125054482|NCT05513053|449816781|FG000|Overall Study|Lost to Follow-up|9|||
125054483|NCT05513053|449816782|FG001|Overall Study|Lost to Follow-up|11|||
125136411|NCT00840216|450124367|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
125220281|NCT03569098|450434410|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
125054484|NCT05513053|449816781|FG000|Overall Study|Withdrawal by parent/guardian|2|||
125054485|NCT05513053|449816782|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125054486|NCT05513053|449816781|FG000|Overall Study|Withdrawal by Subject|2|||
125136412|NCT00840216|450124368|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
125220282|NCT03569098|450434408|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
125054487|NCT05513053|449816782|FG001|Overall Study|Withdrawal by Subject|9|||
125054488|NCT05513053|449816781|FG000|Overall Study|Protocol Violation|6|||
125054489|NCT05513053|449816782|FG001|Overall Study|Protocol Violation|3|||
125054490|NCT05513053|449816781|FG000|Overall Study|Adverse Event|0|||
125054491|NCT05513053|449816782|FG001|Overall Study|Adverse Event|2|||
125054492|NCT01520324|449818956|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
125054493|NCT00423085|449818958|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
125054494|NCT00423085|449818959|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
125054495|NCT00423085|449818960|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
125054496|NCT00423085|449818961|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
125054497|NCT00423085|449818958|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
125054498|NCT00423085|449818959|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
125054499|NCT00423085|449818960|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
125054500|NCT00423085|449818961|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
125054501|NCT00423085|449818958|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
125054502|NCT00423085|449818959|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
125054503|NCT00423085|449818960|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
125054504|NCT00423085|449818961|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
125054505|NCT00423085|449818958|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
125054506|NCT00423085|449818959|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
125054507|NCT00423085|449818960|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
125054508|NCT00423085|449818961|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
125054509|NCT00423085|449818958|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
125054510|NCT00423085|449818959|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
125054511|NCT00423085|449818960|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
125054512|NCT00423085|449818961|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
125054513|NCT00423085|449818958|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
125054514|NCT00423085|449818959|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
125054515|NCT00423085|449818960|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
125054516|NCT00423085|449818961|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
125054517|NCT00423085|449818958|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
125054518|NCT00423085|449818959|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
125054519|NCT00423085|449818960|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
125054520|NCT00423085|449818961|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
125054521|NCT00423085|449818958|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
125054522|NCT00423085|449818959|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
125054523|NCT00423085|449818960|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
125054524|NCT00423085|449818961|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
125054525|NCT00423085|449818958|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
125054526|NCT00423085|449818959|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
125054527|NCT00423085|449818960|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
125054528|NCT00423085|449818961|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
125054529|NCT00423085|449818958|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
125054530|NCT00423085|449818959|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
125054531|NCT00423085|449818960|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
125054532|NCT00423085|449818961|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
125054533|NCT00423085|449818958|FG000|52-Week Open-Label Extension Phase|Death|0|||
125054534|NCT00423085|449818959|FG001|52-Week Open-Label Extension Phase|Death|0|||
125054535|NCT00423085|449818960|FG002|52-Week Open-Label Extension Phase|Death|0|||
125054536|NCT00423085|449818961|FG003|52-Week Open-Label Extension Phase|Death|2|||
125054537|NCT02163993|449818962|FG000|Treatment Period|Adverse Event|0|||
125054538|NCT02163993|449818963|FG001|Treatment Period|Adverse Event|1|||
125054539|NCT02163993|449818964|FG002|Treatment Period|Adverse Event|0|||
125054540|NCT02163993|449818965|FG003|Treatment Period|Adverse Event|0|||
125054541|NCT02163993|449818966|FG004|Treatment Period|Adverse Event|1|||
125054542|NCT02163993|449818962|FG000|Treatment Period|Lost to Follow-up|2|||
125054543|NCT02163993|449818963|FG001|Treatment Period|Lost to Follow-up|3|||
125054544|NCT02163993|449818964|FG002|Treatment Period|Lost to Follow-up|1|||
125054545|NCT02163993|449818965|FG003|Treatment Period|Lost to Follow-up|3|||
125054546|NCT02163993|449818966|FG004|Treatment Period|Lost to Follow-up|1|||
125054547|NCT02163993|449818962|FG000|Treatment Period|Physician Decision|1|||
125054548|NCT02163993|449818963|FG001|Treatment Period|Physician Decision|0|||
125054549|NCT02163993|449818964|FG002|Treatment Period|Physician Decision|0|||
125136413|NCT05041361|450124369|FG000|Overall Study|Lost to Follow-up|1|||
125136414|NCT05041361|450124370|FG001|Overall Study|Lost to Follow-up|3|||
125136415|NCT01642277|450124371|FG000|Overall Study|Adverse Event|10|||
125136416|NCT01642277|450124372|FG001|Overall Study|Adverse Event|0|||
125136417|NCT01642277|450124371|FG000|Overall Study|Physician Decision|2|||
125136418|NCT01642277|450124372|FG001|Overall Study|Physician Decision|0|||
125136419|NCT01642277|450124371|FG000|Overall Study|Protocol Violation|1|||
125136420|NCT01642277|450124372|FG001|Overall Study|Protocol Violation|0|||
125136421|NCT01642277|450124371|FG000|Overall Study|Withdrawal by Subject|11|||
125136422|NCT01642277|450124372|FG001|Overall Study|Withdrawal by Subject|0|||
125136423|NCT03605342|450124375|FG000|Overall Study|Withdrawal by Subject|9|||
125136424|NCT03605342|450124376|FG001|Overall Study|Withdrawal by Subject|7|||
125136425|NCT03605342|450124375|FG000|Overall Study|Lost to Follow-up|1|||
125136426|NCT03605342|450124376|FG001|Overall Study|Lost to Follow-up|1|||
125136427|NCT00848536|450124377|FG000|Overall Study|Adverse Event|2|||
125136428|NCT00848536|450124378|FG001|Overall Study|Adverse Event|2|||
125136429|NCT00848536|450124377|FG000|Overall Study|Withdrawal by Subject|0|||
125136430|NCT00848536|450124378|FG001|Overall Study|Withdrawal by Subject|1|||
125136431|NCT00848536|450124377|FG000|Overall Study|Protocol Violation|0|||
125136432|NCT00848536|450124378|FG001|Overall Study|Protocol Violation|1|||
125136433|NCT00848536|450124377|FG000|Overall Study|Noncompliance|1|||
125136434|NCT00848536|450124378|FG001|Overall Study|Noncompliance|0|||
125136435|NCT00848536|450124377|FG000|Overall Study|Inadequate Control of IOP|1|||
125136436|NCT00848536|450124378|FG001|Overall Study|Inadequate Control of IOP|1|||
125136437|NCT00848536|450124377|FG000|Overall Study|Patient Moved|0|||
125136438|NCT00848536|450124378|FG001|Overall Study|Patient Moved|2|||
125136439|NCT00796328|450124379|FG000|Overall Study|experienced hypotension requiring tx|6|||
125136440|NCT00506831|450124387|FG000|Overall Study|Death|1|||
125054550|NCT02163993|449818965|FG003|Treatment Period|Physician Decision|0|||
125054551|NCT02163993|449818966|FG004|Treatment Period|Physician Decision|0|||
125054552|NCT02163993|449818962|FG000|Treatment Period|Protocol Violation|2|||
125054553|NCT02163993|449818963|FG001|Treatment Period|Protocol Violation|1|||
125054554|NCT02163993|449818964|FG002|Treatment Period|Protocol Violation|0|||
125054555|NCT02163993|449818965|FG003|Treatment Period|Protocol Violation|1|||
125054556|NCT02163993|449818966|FG004|Treatment Period|Protocol Violation|2|||
125054557|NCT02163993|449818962|FG000|Treatment Period|Withdrawal by Subject|6|||
125054558|NCT02163993|449818963|FG001|Treatment Period|Withdrawal by Subject|4|||
125054559|NCT02163993|449818964|FG002|Treatment Period|Withdrawal by Subject|1|||
125054560|NCT02163993|449818965|FG003|Treatment Period|Withdrawal by Subject|4|||
125054561|NCT02163993|449818966|FG004|Treatment Period|Withdrawal by Subject|1|||
125054562|NCT02163993|449818962|FG000|Treatment Period|Not treated|1|||
125054563|NCT02163993|449818963|FG001|Treatment Period|Not treated|0|||
125054564|NCT02163993|449818964|FG002|Treatment Period|Not treated|0|||
125054565|NCT02163993|449818965|FG003|Treatment Period|Not treated|1|||
125054566|NCT02163993|449818966|FG004|Treatment Period|Not treated|2|||
125054567|NCT02163993|449818962|FG000|Post-treatment Period|Adverse Event|0|||
125054568|NCT02163993|449818963|FG001|Post-treatment Period|Adverse Event|0|||
125054569|NCT02163993|449818964|FG002|Post-treatment Period|Adverse Event|1|||
125054570|NCT02163993|449818965|FG003|Post-treatment Period|Adverse Event|0|||
125054571|NCT02163993|449818966|FG004|Post-treatment Period|Adverse Event|0|||
125054572|NCT02163993|449818962|FG000|Post-treatment Period|Lost to Follow-up|2|||
125054573|NCT02163993|449818963|FG001|Post-treatment Period|Lost to Follow-up|2|||
125054574|NCT02163993|449818964|FG002|Post-treatment Period|Lost to Follow-up|3|||
125054575|NCT02163993|449818965|FG003|Post-treatment Period|Lost to Follow-up|1|||
125054576|NCT02163993|449818966|FG004|Post-treatment Period|Lost to Follow-up|0|||
125054577|NCT02163993|449818962|FG000|Post-treatment Period|Protocol Violation|0|||
125054578|NCT02163993|449818963|FG001|Post-treatment Period|Protocol Violation|0|||
125054579|NCT02163993|449818964|FG002|Post-treatment Period|Protocol Violation|0|||
125054580|NCT02163993|449818965|FG003|Post-treatment Period|Protocol Violation|0|||
125054581|NCT02163993|449818966|FG004|Post-treatment Period|Protocol Violation|1|||
125054582|NCT02163993|449818962|FG000|Post-treatment Period|Withdrawal by Subject|2|||
125054583|NCT02163993|449818963|FG001|Post-treatment Period|Withdrawal by Subject|4|||
125054584|NCT02163993|449818964|FG002|Post-treatment Period|Withdrawal by Subject|0|||
125136441|NCT00506831|450124387|FG000|Overall Study|Withdrawal by Subject|1|||
125136442|NCT02488239|450124388|FG000|Overall Study|Death|3|||
125136443|NCT02488239|450124388|FG000|Overall Study|Withdrawal by Subject|3|||
125136444|NCT02488239|450124388|FG000|Overall Study|Physician Decision|2|||
125136445|NCT02488239|450124388|FG000|Overall Study|Consent ineligible|1|||
125136446|NCT02488239|450124388|FG000|Overall Study|Did not undergo implant procedure|1|||
125136447|NCT05479058|450124391|FG000|Overall Study|Withdrawal by Subject|1|||
125054585|NCT02163993|449818965|FG003|Post-treatment Period|Withdrawal by Subject|1|||
125136448|NCT05479058|450124392|FG001|Overall Study|Withdrawal by Subject|1|||
125136449|NCT05479058|450124391|FG000|Overall Study|Study terminated by sponsor|10|||
125054586|NCT02163993|449818966|FG004|Post-treatment Period|Withdrawal by Subject|2|||
125054587|NCT00853489|449818967|FG000|Overall Study|Lost to Follow-up|5|||
125054588|NCT00853489|449818968|FG001|Overall Study|Lost to Follow-up|2|||
125054589|NCT00441441|449818973|FG000|Overall Study|Adverse Event|2|||
125054590|NCT00441441|449818974|FG001|Overall Study|Adverse Event|1|||
125054591|NCT00441441|449818973|FG000|Overall Study|Protocol Violation|4|||
125054592|NCT00441441|449818974|FG001|Overall Study|Protocol Violation|6|||
125054593|NCT00441441|449818973|FG000|Overall Study|Exacerbation of asthma|1|||
125054594|NCT00441441|449818974|FG001|Overall Study|Exacerbation of asthma|2|||
125054595|NCT00441441|449818973|FG000|Overall Study|Withdrawal by Subject|1|||
125054596|NCT00441441|449818974|FG001|Overall Study|Withdrawal by Subject|2|||
125054597|NCT00441441|449818973|FG000|Overall Study|Other|3|||
125054598|NCT00441441|449818974|FG001|Overall Study|Other|3|||
125054599|NCT00262080|449818975|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
125054600|NCT00262080|449818976|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
125054601|NCT00262080|449818977|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
125054602|NCT00262080|449818975|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
125054603|NCT00262080|449818976|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
125054604|NCT00262080|449818977|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
125054605|NCT00262080|449818975|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
125054606|NCT00262080|449818976|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
125054607|NCT00262080|449818977|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
125054608|NCT00262080|449818975|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
125054609|NCT00262080|449818976|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
125054610|NCT00262080|449818977|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
125054611|NCT00262080|449818975|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
125054612|NCT00262080|449818976|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
125054613|NCT00262080|449818977|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
125054614|NCT00262080|449818975|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
125054615|NCT00262080|449818976|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
125054616|NCT00262080|449818977|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
125054617|NCT02273752|449818978|FG000|Overall Study|Trial was terminated early|2|||
125054618|NCT02808312|449818979|FG000|Overall Study|Enrolled but Never Treated|0|||
125054619|NCT02808312|449818980|FG001|Overall Study|Enrolled but Never Treated|0|||
125054620|NCT02808312|449818981|FG002|Overall Study|Enrolled but Never Treated|1|||
125054621|NCT02808312|449818982|FG003|Overall Study|Enrolled but Never Treated|0|||
125054622|NCT02808312|449818983|FG004|Overall Study|Enrolled but Never Treated|0|||
125054623|NCT03100942|449818987|FG000|Randomized Treatment Period|Withdrew Consent|4|||
125054624|NCT03100942|449818988|FG001|Randomized Treatment Period|Withdrew Consent|5|||
125054625|NCT03100942|449818989|FG002|Randomized Treatment Period|Withdrew Consent|3|||
125054626|NCT03100942|449818990|FG003|Randomized Treatment Period|Withdrew Consent|3|||
125054627|NCT03100942|449818991|FG004|Randomized Treatment Period|Withdrew Consent|0|||
125054628|NCT03100942|449818992|FG005|Randomized Treatment Period|Withdrew Consent|0|||
125054629|NCT03100942|449818993|FG006|Randomized Treatment Period|Withdrew Consent|0|||
125054630|NCT03100942|449818987|FG000|Randomized Treatment Period|Adverse Event|5|||
125054631|NCT03100942|449818988|FG001|Randomized Treatment Period|Adverse Event|2|||
125054632|NCT03100942|449818989|FG002|Randomized Treatment Period|Adverse Event|1|||
125054633|NCT03100942|449818990|FG003|Randomized Treatment Period|Adverse Event|0|||
125054634|NCT03100942|449818991|FG004|Randomized Treatment Period|Adverse Event|0|||
125054635|NCT03100942|449818992|FG005|Randomized Treatment Period|Adverse Event|0|||
125054636|NCT03100942|449818993|FG006|Randomized Treatment Period|Adverse Event|0|||
125054637|NCT03100942|449818987|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
125054638|NCT03100942|449818988|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
125054639|NCT03100942|449818989|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
125054640|NCT03100942|449818990|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
125054641|NCT03100942|449818991|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
125054642|NCT03100942|449818992|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
125054643|NCT03100942|449818993|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
125054644|NCT03100942|449818987|FG000|Randomized Treatment Period|Protocol Violation|0|||
125054645|NCT03100942|449818988|FG001|Randomized Treatment Period|Protocol Violation|1|||
125054646|NCT03100942|449818989|FG002|Randomized Treatment Period|Protocol Violation|1|||
125054647|NCT03100942|449818990|FG003|Randomized Treatment Period|Protocol Violation|1|||
125054648|NCT03100942|449818991|FG004|Randomized Treatment Period|Protocol Violation|0|||
125054649|NCT03100942|449818992|FG005|Randomized Treatment Period|Protocol Violation|0|||
125054650|NCT03100942|449818993|FG006|Randomized Treatment Period|Protocol Violation|0|||
125054651|NCT03100942|449818987|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
125054652|NCT03100942|449818988|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
125136450|NCT05479058|450124392|FG001|Overall Study|Study terminated by sponsor|10|||
125054653|NCT03100942|449818989|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
125054654|NCT03100942|449818990|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
125136451|NCT00263588|450124397|FG000|Overall Study|Death|54|||
125136452|NCT00263588|450124398|FG001|Overall Study|Death|90|||
125054655|NCT03100942|449818991|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
125054656|NCT03100942|449818992|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
125054657|NCT03100942|449818993|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
125054658|NCT03100942|449818987|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
125054659|NCT03100942|449818988|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
125054660|NCT03100942|449818989|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
125054661|NCT03100942|449818990|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
125054662|NCT03100942|449818991|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
125054663|NCT03100942|449818992|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
125054664|NCT03100942|449818993|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
125054665|NCT03100942|449818987|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
125054666|NCT03100942|449818988|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
125054667|NCT03100942|449818989|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
125054668|NCT03100942|449818990|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
125054669|NCT03100942|449818991|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
125054670|NCT03100942|449818992|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
125054671|NCT03100942|449818993|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
125054672|NCT04263142|449818994|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
125054673|NCT04263142|449818995|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
125054674|NCT04263142|449818996|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
125054675|NCT04263142|449818997|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
125054676|NCT04263142|449818998|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
125054677|NCT04263142|449818994|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
125054678|NCT04263142|449818995|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
125054679|NCT04263142|449818996|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
125054680|NCT04263142|449818997|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
125054681|NCT04263142|449818998|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
125054682|NCT01623531|449818999|FG000|Overall Study|Death|1|||
125054683|NCT01623531|449819000|FG001|Overall Study|Death|0|||
125054684|NCT01623531|449818999|FG000|Overall Study|Protocol Violation|2|||
125054685|NCT01623531|449819000|FG001|Overall Study|Protocol Violation|1|||
125054686|NCT01623531|449818999|FG000|Overall Study|Missing data at primary outcome time poi|1|||
125054687|NCT01623531|449819000|FG001|Overall Study|Missing data at primary outcome time poi|1|||
125054688|NCT01429792|449819001|FG000|Overall Study|Other Reasons|67|||
125054689|NCT01429792|449819001|FG000|Overall Study|Unknown Disposition|94|||
125054690|NCT01429792|449819001|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
125054691|NCT01429792|449819001|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
125054692|NCT01429792|449819001|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
125054693|NCT01429792|449819001|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
125054694|NCT01429792|449819001|FG000|Overall Study|Withdrawal by Subject|70|||
125054695|NCT01429792|449819001|FG000|Overall Study|Lost to Follow-up|88|||
125054696|NCT04184622|449819003|FG000|Primary Treatment Period|Adverse Event|6|||
125054697|NCT04184622|449819004|FG001|Primary Treatment Period|Adverse Event|4|||
125054698|NCT04184622|449819005|FG002|Primary Treatment Period|Adverse Event|8|||
125054699|NCT04184622|449819006|FG003|Primary Treatment Period|Adverse Event|6|||
125054700|NCT04184622|449819003|FG000|Primary Treatment Period|Death|4|||
125054701|NCT04184622|449819004|FG001|Primary Treatment Period|Death|4|||
125054702|NCT04184622|449819005|FG002|Primary Treatment Period|Death|2|||
125054703|NCT04184622|449819006|FG003|Primary Treatment Period|Death|1|||
125054704|NCT04184622|449819003|FG000|Primary Treatment Period|Lost to Follow-up|41|||
125054705|NCT04184622|449819004|FG001|Primary Treatment Period|Lost to Follow-up|17|||
125054706|NCT04184622|449819005|FG002|Primary Treatment Period|Lost to Follow-up|15|||
125054707|NCT04184622|449819006|FG003|Primary Treatment Period|Lost to Follow-up|13|||
125054708|NCT04184622|449819003|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
125054709|NCT04184622|449819004|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
125054710|NCT04184622|449819005|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
125054711|NCT04184622|449819006|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
125054712|NCT04184622|449819003|FG000|Primary Treatment Period|Physician Decision|0|||
125054713|NCT04184622|449819004|FG001|Primary Treatment Period|Physician Decision|0|||
125136453|NCT00263588|450124397|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
125136454|NCT00263588|450124398|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
125136455|NCT00263588|450124397|FG000|Overall Study|Lost to Follow-up|7|||
125054714|NCT04184622|449819005|FG002|Primary Treatment Period|Physician Decision|3|||
125054715|NCT04184622|449819006|FG003|Primary Treatment Period|Physician Decision|1|||
125054716|NCT04184622|449819003|FG000|Primary Treatment Period|Pregnancy|4|||
125054717|NCT04184622|449819004|FG001|Primary Treatment Period|Pregnancy|3|||
125054718|NCT04184622|449819005|FG002|Primary Treatment Period|Pregnancy|4|||
125054719|NCT04184622|449819006|FG003|Primary Treatment Period|Pregnancy|1|||
125054720|NCT04184622|449819003|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
125054721|NCT04184622|449819004|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
125054722|NCT04184622|449819005|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
125054723|NCT04184622|449819006|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
125054724|NCT04184622|449819003|FG000|Additional Treatment Period|Adverse Event|1|||
125054725|NCT04184622|449819004|FG001|Additional Treatment Period|Adverse Event|2|||
125054726|NCT04184622|449819005|FG002|Additional Treatment Period|Adverse Event|1|||
125054727|NCT04184622|449819006|FG003|Additional Treatment Period|Adverse Event|0|||
125054728|NCT04184622|449819003|FG000|Additional Treatment Period|Death|0|||
125054729|NCT04184622|449819004|FG001|Additional Treatment Period|Death|0|||
125054730|NCT04184622|449819005|FG002|Additional Treatment Period|Death|1|||
125054731|NCT04184622|449819006|FG003|Additional Treatment Period|Death|1|||
125054732|NCT04184622|449819003|FG000|Additional Treatment Period|Lost to Follow-up|6|||
125054733|NCT04184622|449819004|FG001|Additional Treatment Period|Lost to Follow-up|4|||
125054734|NCT04184622|449819005|FG002|Additional Treatment Period|Lost to Follow-up|8|||
125054735|NCT04184622|449819006|FG003|Additional Treatment Period|Lost to Follow-up|6|||
125054736|NCT04184622|449819003|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
125054737|NCT04184622|449819004|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
125054738|NCT04184622|449819005|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
125054739|NCT04184622|449819006|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
125054740|NCT04184622|449819003|FG000|Additional Treatment Period|Physician Decision|0|||
125054741|NCT04184622|449819004|FG001|Additional Treatment Period|Physician Decision|0|||
125054742|NCT04184622|449819005|FG002|Additional Treatment Period|Physician Decision|1|||
125054743|NCT04184622|449819006|FG003|Additional Treatment Period|Physician Decision|0|||
125054744|NCT04184622|449819003|FG000|Additional Treatment Period|Pregnancy|0|||
125054745|NCT04184622|449819004|FG001|Additional Treatment Period|Pregnancy|0|||
125054746|NCT04184622|449819005|FG002|Additional Treatment Period|Pregnancy|0|||
125054747|NCT04184622|449819006|FG003|Additional Treatment Period|Pregnancy|1|||
125054748|NCT04184622|449819003|FG000|Additional Treatment Period|Protocol deviation|0|||
125054749|NCT04184622|449819004|FG001|Additional Treatment Period|Protocol deviation|0|||
125054750|NCT04184622|449819005|FG002|Additional Treatment Period|Protocol deviation|1|||
125054751|NCT04184622|449819006|FG003|Additional Treatment Period|Protocol deviation|0|||
125054752|NCT04184622|449819003|FG000|Additional Treatment Period|Site closed|1|||
125054753|NCT04184622|449819004|FG001|Additional Treatment Period|Site closed|0|||
125054754|NCT04184622|449819005|FG002|Additional Treatment Period|Site closed|1|||
125054755|NCT04184622|449819006|FG003|Additional Treatment Period|Site closed|0|||
125054756|NCT04184622|449819003|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
125054757|NCT04184622|449819004|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
125054758|NCT04184622|449819005|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
125054759|NCT04184622|449819006|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
125054760|NCT04184622|449819003|FG000|Safety Follow-up Period|Adverse Event|6|||
125054761|NCT04184622|449819004|FG001|Safety Follow-up Period|Adverse Event|8|||
125054762|NCT04184622|449819005|FG002|Safety Follow-up Period|Adverse Event|9|||
125054763|NCT04184622|449819006|FG003|Safety Follow-up Period|Adverse Event|16|||
125054764|NCT04184622|449819003|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
125054765|NCT04184622|449819004|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
125054766|NCT04184622|449819005|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
125054767|NCT04184622|449819006|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
125054768|NCT04184622|449819003|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
125054769|NCT04184622|449819004|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
125054770|NCT04184622|449819005|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
125054771|NCT04184622|449819006|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
125054772|NCT04184622|449819003|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
125054773|NCT04184622|449819004|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
125054774|NCT04184622|449819005|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
125054775|NCT04184622|449819006|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
125054776|NCT04184622|449819003|FG000|Safety Follow-up Period|Physician Decision|1|||
125136456|NCT00263588|450124398|FG001|Overall Study|Lost to Follow-up|10|||
125136457|NCT00263588|450124397|FG000|Overall Study|Withdrawal by Subject|3|||
125136458|NCT00263588|450124398|FG001|Overall Study|Withdrawal by Subject|4|||
125054777|NCT04184622|449819004|FG001|Safety Follow-up Period|Physician Decision|0|||
125054778|NCT04184622|449819005|FG002|Safety Follow-up Period|Physician Decision|0|||
125054779|NCT04184622|449819006|FG003|Safety Follow-up Period|Physician Decision|1|||
125054780|NCT04184622|449819003|FG000|Safety Follow-up Period|Pregnancy|1|||
125054781|NCT04184622|449819004|FG001|Safety Follow-up Period|Pregnancy|3|||
125054782|NCT04184622|449819005|FG002|Safety Follow-up Period|Pregnancy|0|||
125054783|NCT04184622|449819006|FG003|Safety Follow-up Period|Pregnancy|6|||
125054784|NCT04184622|449819003|FG000|Safety Follow-up Period|Protocol deviation|1|||
125054785|NCT04184622|449819004|FG001|Safety Follow-up Period|Protocol deviation|0|||
125054786|NCT04184622|449819005|FG002|Safety Follow-up Period|Protocol deviation|0|||
125054787|NCT04184622|449819006|FG003|Safety Follow-up Period|Protocol deviation|0|||
125054788|NCT04184622|449819003|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
125054789|NCT04184622|449819004|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
125054790|NCT04184622|449819005|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
125054791|NCT04184622|449819006|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
125054792|NCT00769704|449819008|FG000|Overall Study|Lost to Follow-up|3|||
125054793|NCT00769704|449819009|FG001|Overall Study|Lost to Follow-up|2|||
125054794|NCT00769704|449819008|FG000|Overall Study|Death|95|||
125054795|NCT00769704|449819009|FG001|Overall Study|Death|190|||
125054796|NCT00769704|449819008|FG000|Overall Study|Withdrawal by Subject|12|||
125054797|NCT00769704|449819009|FG001|Overall Study|Withdrawal by Subject|5|||
125054798|NCT00769704|449819008|FG000|Overall Study|Other|1|||
125054799|NCT00769704|449819009|FG001|Overall Study|Other|2|||
125054800|NCT03010423|449819010|FG000|Overall Study|Study termination|8|||
125054801|NCT01617681|449819013|FG000|Period 1 Double Blind|Adverse Event|2|||
125054802|NCT01617681|449819014|FG001|Period 1 Double Blind|Adverse Event|0|||
125054803|NCT01617681|449819015|FG002|Period 1 Double Blind|Adverse Event|0|||
125054804|NCT01617681|449819016|FG003|Period 1 Double Blind|Adverse Event|2|||
125054805|NCT01617681|449819017|FG004|Period 1 Double Blind|Adverse Event|0|||
125054806|NCT01617681|449819013|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
125054807|NCT01617681|449819014|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
125054808|NCT01617681|449819015|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
125054809|NCT01617681|449819016|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
125054810|NCT01617681|449819017|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
125054811|NCT01617681|449819013|FG000|Period 2 Open Label|Adverse Event|0|||
125054812|NCT01617681|449819014|FG001|Period 2 Open Label|Adverse Event|0|||
125054813|NCT01617681|449819015|FG002|Period 2 Open Label|Adverse Event|0|||
125054814|NCT01617681|449819016|FG003|Period 2 Open Label|Adverse Event|0|||
125054815|NCT01617681|449819017|FG004|Period 2 Open Label|Adverse Event|3|||
125054816|NCT01617681|449819013|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
125054817|NCT01617681|449819014|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
125054818|NCT01617681|449819015|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
125054819|NCT01617681|449819016|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
125054820|NCT01617681|449819017|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
125054821|NCT01856595|449819024|FG000|Overall Study|Withdrawal by Subject|0|||
125054822|NCT01856595|449819025|FG001|Overall Study|Withdrawal by Subject|1|||
125054823|NCT01856595|449819026|FG002|Overall Study|Withdrawal by Subject|0|||
125054824|NCT01856595|449819027|FG003|Overall Study|Withdrawal by Subject|0|||
125054825|NCT01856595|449819028|FG004|Overall Study|Withdrawal by Subject|0|||
125054826|NCT01856595|449819029|FG005|Overall Study|Withdrawal by Subject|0|||
125054827|NCT01856595|449819030|FG006|Overall Study|Withdrawal by Subject|1|||
125054828|NCT01856595|449819031|FG007|Overall Study|Withdrawal by Subject|0|||
125054829|NCT01856595|449819032|FG008|Overall Study|Withdrawal by Subject|0|||
125054830|NCT04426825|449819033|FG000|Overall Study|Death|17|||
125054831|NCT04426825|449819033|FG000|Overall Study|Lost to Follow-up|1|||
125054832|NCT04426825|449819033|FG000|Overall Study|Study terminated by sponsor|5|||
125054833|NCT04346628|449819034|FG000|Overall Study|Lost to Follow-up|4|||
125054834|NCT04346628|449819035|FG001|Overall Study|Lost to Follow-up|4|||
125054835|NCT04346628|449819034|FG000|Overall Study|Withdrew (had personal reasons)|2|||
125054836|NCT04346628|449819035|FG001|Overall Study|Withdrew (had personal reasons)|5|||
125054837|NCT04346628|449819034|FG000|Overall Study|Withdrew (medication intolerant)|0|||
125054838|NCT04346628|449819035|FG001|Overall Study|Withdrew (medication intolerant)|3|||
125054839|NCT04346628|449819034|FG000|Overall Study|Withdrew (declined intervention)|0|||
125054840|NCT04346628|449819035|FG001|Overall Study|Withdrew (declined intervention)|1|||
125054841|NCT01763905|449819036|FG000|Overall Study|Withdrawal by Subject|1|||
125054842|NCT01763905|449819037|FG001|Overall Study|Withdrawal by Subject|1|||
125054843|NCT01763905|449819038|FG002|Overall Study|Withdrawal by Subject|0|||
125054844|NCT01763905|449819039|FG003|Overall Study|Withdrawal by Subject|1|||
125054845|NCT01763905|449819036|FG000|Overall Study|Decision by sponsor|5|||
125054846|NCT01763905|449819037|FG001|Overall Study|Decision by sponsor|0|||
125054847|NCT01763905|449819038|FG002|Overall Study|Decision by sponsor|8|||
125054848|NCT01763905|449819039|FG003|Overall Study|Decision by sponsor|0|||
125054849|NCT01763905|449819036|FG000|Overall Study|Lost to Follow-up|0|||
125054850|NCT01763905|449819037|FG001|Overall Study|Lost to Follow-up|0|||
125054851|NCT01763905|449819038|FG002|Overall Study|Lost to Follow-up|1|||
125054852|NCT01763905|449819039|FG003|Overall Study|Lost to Follow-up|0|||
125054853|NCT00411788|449819040|FG000|Overall Study|Protocol Violation|1|||
125054854|NCT00411788|449819040|FG000|Overall Study|Adverse Event|1|||
125054855|NCT01428063|449819042|FG000|Overall Study|Lack of Efficacy|8|||
125054856|NCT01428063|449819043|FG001|Overall Study|Lack of Efficacy|4|||
125054857|NCT01428063|449819044|FG002|Overall Study|Lack of Efficacy|1|||
125054858|NCT01428063|449819042|FG000|Overall Study|Adverse Event|2|||
125054859|NCT01428063|449819043|FG001|Overall Study|Adverse Event|3|||
125054860|NCT01428063|449819044|FG002|Overall Study|Adverse Event|0|||
125054861|NCT01428063|449819042|FG000|Overall Study|Lost to Follow-up|0|||
125054862|NCT01428063|449819043|FG001|Overall Study|Lost to Follow-up|2|||
125054863|NCT01428063|449819044|FG002|Overall Study|Lost to Follow-up|0|||
125054864|NCT01428063|449819042|FG000|Overall Study|No longer meets study criteria|0|||
125054865|NCT01428063|449819043|FG001|Overall Study|No longer meets study criteria|1|||
125054866|NCT01428063|449819044|FG002|Overall Study|No longer meets study criteria|0|||
125054867|NCT00578864|449819045|FG000|Overall Study|Death|1|||
125054868|NCT00578864|449819046|FG001|Overall Study|Death|0|||
125054869|NCT01087528|449819047|FG000|Overall Study|Withdrawal by Subject|1|||
125054870|NCT01087528|449819047|FG000|Overall Study|Incomplete CE procedure|6|||
125054871|NCT02702193|449819052|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
125054872|NCT02702193|449819053|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
125054873|NCT02702193|449819052|FG000|4 Month Follow up|Withdrawal by Subject|1|||
125054874|NCT02702193|449819053|FG001|4 Month Follow up|Withdrawal by Subject|0|||
125054875|NCT02702193|449819052|FG000|4 Month Follow up|Lost to Follow-up|17|||
125054876|NCT02702193|449819053|FG001|4 Month Follow up|Lost to Follow-up|18|||
125054877|NCT02702193|449819052|FG000|8 Month Follow up|Withdrawal by Subject|1|||
125054878|NCT02702193|449819053|FG001|8 Month Follow up|Withdrawal by Subject|0|||
125054879|NCT02702193|449819052|FG000|8 Month Follow up|Lost to Follow-up|14|||
125054880|NCT02702193|449819053|FG001|8 Month Follow up|Lost to Follow-up|18|||
125054881|NCT02702193|449819052|FG000|12 Month Follow up|Withdrawal by Subject|1|||
125054882|NCT02702193|449819053|FG001|12 Month Follow up|Withdrawal by Subject|0|||
125054883|NCT02702193|449819052|FG000|12 Month Follow up|Lost to Follow-up|16|||
125054884|NCT02702193|449819053|FG001|12 Month Follow up|Lost to Follow-up|18|||
125054885|NCT01201798|449819056|FG000|Overall Study|Adverse Event|2|||
125054886|NCT01201798|449819057|FG001|Overall Study|Adverse Event|0|||
125054887|NCT01201798|449819056|FG000|Overall Study|Lost to Follow-up|3|||
125054888|NCT01201798|449819057|FG001|Overall Study|Lost to Follow-up|5|||
125054889|NCT01201798|449819056|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
125054890|NCT01201798|449819057|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
125054891|NCT01201798|449819056|FG000|Overall Study|Noncompliance|1|||
125054892|NCT01201798|449819057|FG001|Overall Study|Noncompliance|0|||
125054893|NCT01201798|449819056|FG000|Overall Study|Protocol Violation|1|||
125054894|NCT01201798|449819057|FG001|Overall Study|Protocol Violation|1|||
125054895|NCT01201798|449819056|FG000|Overall Study|Treatment Failure|1|||
125054896|NCT01201798|449819057|FG001|Overall Study|Treatment Failure|8|||
125054897|NCT03609359|449819058|FG000|Overall Study|Progression of primary disease (PD)|25|||
125054898|NCT03609359|449819058|FG000|Overall Study|Patient's refusal|1|||
125054899|NCT03609359|449819058|FG000|Overall Study|Physician Decision|1|||
125054900|NCT03609359|449819058|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
125054901|NCT01035255|449819059|FG000|Overall Study|Death|724|||
125054902|NCT01035255|449819060|FG001|Overall Study|Death|844|||
125054903|NCT01035255|449819059|FG000|Overall Study|Lost to Follow-up|2|||
125054904|NCT01035255|449819060|FG001|Overall Study|Lost to Follow-up|5|||
125054905|NCT01035255|449819059|FG000|Overall Study|patient's request|15|||
125054906|NCT01035255|449819060|FG001|Overall Study|patient's request|13|||
125054907|NCT03007953|449819061|FG000|Overall Study|Withdrawal by Subject|5|||
125054908|NCT03007953|449819062|FG001|Overall Study|Withdrawal by Subject|2|||
125054909|NCT03007953|449819061|FG000|Overall Study|Death|5|||
125054910|NCT03007953|449819062|FG001|Overall Study|Death|7|||
125054911|NCT03007953|449819061|FG000|Overall Study|Lost to Follow-up|3|||
125054912|NCT03007953|449819062|FG001|Overall Study|Lost to Follow-up|2|||
125054913|NCT03007953|449819061|FG000|Overall Study|Enrolled in Hospice|3|||
125054914|NCT03007953|449819062|FG001|Overall Study|Enrolled in Hospice|2|||
125054915|NCT02203838|449819063|FG000|Overall Study|Lack of Efficacy|7|||
125054916|NCT02203838|449819064|FG001|Overall Study|Lack of Efficacy|0|||
125054917|NCT02203838|449819065|FG002|Overall Study|Lack of Efficacy|1|||
125054918|NCT02203838|449819066|FG003|Overall Study|Lack of Efficacy|1|||
125054919|NCT02203838|449819063|FG000|Overall Study|Adverse Event|46|||
125054920|NCT02203838|449819064|FG001|Overall Study|Adverse Event|6|||
125054921|NCT02203838|449819065|FG002|Overall Study|Adverse Event|3|||
125054922|NCT02203838|449819066|FG003|Overall Study|Adverse Event|2|||
125054923|NCT02203838|449819063|FG000|Overall Study|Lost to Follow-up|39|||
125054924|NCT02203838|449819064|FG001|Overall Study|Lost to Follow-up|3|||
125054925|NCT02203838|449819065|FG002|Overall Study|Lost to Follow-up|2|||
125054926|NCT02203838|449819066|FG003|Overall Study|Lost to Follow-up|1|||
125054927|NCT02203838|449819063|FG000|Overall Study|Protocol Violation|7|||
125054928|NCT02203838|449819064|FG001|Overall Study|Protocol Violation|3|||
125054929|NCT02203838|449819065|FG002|Overall Study|Protocol Violation|0|||
125054930|NCT02203838|449819066|FG003|Overall Study|Protocol Violation|0|||
125054931|NCT02203838|449819063|FG000|Overall Study|Withdrawal by Subject|83|||
125054932|NCT02203838|449819064|FG001|Overall Study|Withdrawal by Subject|10|||
125054933|NCT02203838|449819065|FG002|Overall Study|Withdrawal by Subject|8|||
125054934|NCT02203838|449819066|FG003|Overall Study|Withdrawal by Subject|11|||
125220283|NCT03569098|450434409|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
125220284|NCT03569098|450434410|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
125220285|NCT01697800|450434411|FG000|Overall Study|Death|0|||
125220286|NCT01697800|450434412|FG001|Overall Study|Death|1|||
125220287|NCT00954122|450434413|FG000|Overall Study|Withdrawal by Subject|5|||
125220288|NCT00954122|450434413|FG000|Overall Study|Adverse Event|1|||
125220289|NCT00954122|450434413|FG000|Overall Study|Safety Reason|1|||
125220290|NCT00522548|450434417|FG000|Overall Study|Adverse Event|2|||
125220291|NCT00522548|450434418|FG001|Overall Study|Adverse Event|2|||
125220292|NCT00522548|450434417|FG000|Overall Study|Withdrawal by Subject|0|||
125220293|NCT00522548|450434418|FG001|Overall Study|Withdrawal by Subject|2|||
125220294|NCT02121795|450434419|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
125220295|NCT02121795|450434420|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
125220296|NCT02121795|450434419|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
125220297|NCT02121795|450434420|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
125220298|NCT02121795|450434419|FG000|Double-Blind Phase|Lost to Follow-up|7|||
125220299|NCT02121795|450434420|FG001|Double-Blind Phase|Lost to Follow-up|4|||
125220300|NCT02121795|450434419|FG000|Double-Blind Phase|Physician Decision|2|||
125220301|NCT02121795|450434420|FG001|Double-Blind Phase|Physician Decision|5|||
125220302|NCT02121795|450434419|FG000|Double-Blind Phase|Adverse Event|5|||
125220303|NCT02121795|450434420|FG001|Double-Blind Phase|Adverse Event|0|||
125220304|NCT02121795|450434419|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
125220305|NCT02121795|450434420|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
125220306|NCT02121795|450434419|FG000|Double-Blind Phase|Protocol Violation|0|||
125220307|NCT02121795|450434420|FG001|Double-Blind Phase|Protocol Violation|3|||
125220308|NCT02121795|450434419|FG000|Double-Blind Phase|Death|1|||
125220309|NCT02121795|450434420|FG001|Double-Blind Phase|Death|1|||
125220310|NCT02121795|450434419|FG000|Open-Label Phase|Physician Decision|8|||
125054935|NCT02203838|449819063|FG000|Overall Study|Physician Decision|27|||
125054936|NCT02203838|449819064|FG001|Overall Study|Physician Decision|0|||
125054937|NCT02203838|449819065|FG002|Overall Study|Physician Decision|2|||
125054938|NCT02203838|449819066|FG003|Overall Study|Physician Decision|3|||
125054939|NCT02203838|449819063|FG000|Overall Study|Other|1|||
125054940|NCT02203838|449819064|FG001|Overall Study|Other|0|||
125054941|NCT02203838|449819065|FG002|Overall Study|Other|0|||
125054942|NCT02203838|449819066|FG003|Overall Study|Other|0|||
125054943|NCT03196297|449819067|FG000|Main Period|Withdrawal by Subject|4|||
125054944|NCT03196297|449819067|FG000|Extension Period|Withdrawal by Subject|1|||
125054945|NCT03196297|449819067|FG000|Extension Period|Lack of Efficacy|2|||
125054946|NCT00829166|449819068|FG000|Overall Study|Death|305|||
125054947|NCT00829166|449819069|FG001|Overall Study|Death|333|||
125054948|NCT00829166|449819068|FG000|Overall Study|Lost to Follow-up|5|||
125054949|NCT00829166|449819069|FG001|Overall Study|Lost to Follow-up|4|||
125054950|NCT00829166|449819068|FG000|Overall Study|Physician's Decision|4|||
125054951|NCT00829166|449819069|FG001|Overall Study|Physician's Decision|3|||
125054952|NCT00829166|449819068|FG000|Overall Study|Subject's Decision|41|||
125054953|NCT00829166|449819069|FG001|Overall Study|Subject's Decision|55|||
125054954|NCT00829166|449819068|FG000|Overall Study|Sponsor's Decision|137|||
125054955|NCT00829166|449819069|FG001|Overall Study|Sponsor's Decision|98|||
125054956|NCT00829166|449819068|FG000|Overall Study|Reason Not Specified|3|||
125054957|NCT00829166|449819069|FG001|Overall Study|Reason Not Specified|3|||
125054958|NCT04590937|449819070|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
125054959|NCT01635933|449819071|FG000|Overall Study|Adverse Event|1|||
125054960|NCT01635933|449819072|FG001|Overall Study|Adverse Event|0|||
125054961|NCT01635933|449819071|FG000|Overall Study|Lost to Follow-up|0|||
125054962|NCT01635933|449819072|FG001|Overall Study|Lost to Follow-up|5|||
125054963|NCT01635933|449819071|FG000|Overall Study|Subject decision|1|||
125054964|NCT01635933|449819072|FG001|Overall Study|Subject decision|1|||
125054965|NCT01635933|449819071|FG000|Overall Study|Noncompliance|0|||
125054966|NCT01635933|449819072|FG001|Overall Study|Noncompliance|1|||
125054967|NCT01635933|449819071|FG000|Overall Study|No longer had transportation|0|||
125220311|NCT02121795|450434420|FG001|Open-Label Phase|Physician Decision|8|||
125220312|NCT02121795|450434419|FG000|Open-Label Phase|Withdrawal by Subject|3|||
125054968|NCT01635933|449819072|FG001|Overall Study|No longer had transportation|1|||
125054969|NCT02026271|449819079|FG000|Overall Study|Adverse Event|2|||
125054970|NCT02026271|449819080|FG001|Overall Study|Adverse Event|3|||
125220313|NCT02121795|450434420|FG001|Open-Label Phase|Withdrawal by Subject|2|||
125220314|NCT02121795|450434419|FG000|Open-Label Phase|Lost to Follow-up|1|||
125220315|NCT02121795|450434420|FG001|Open-Label Phase|Lost to Follow-up|0|||
125054971|NCT02026271|449819081|FG002|Overall Study|Adverse Event|2|||
125054972|NCT02026271|449819082|FG003|Overall Study|Adverse Event|3|||
125054973|NCT02026271|449819083|FG004|Overall Study|Adverse Event|0|||
125054974|NCT02026271|449819079|FG000|Overall Study|Withdrawal by Subject|0|||
125054975|NCT02026271|449819080|FG001|Overall Study|Withdrawal by Subject|0|||
125136459|NCT00263588|450124397|FG000|Overall Study|Protocol Violation|0|||
125136460|NCT00263588|450124398|FG001|Overall Study|Protocol Violation|1|||
125136461|NCT00263588|450124397|FG000|Overall Study|Investigator decision|7|||
125136462|NCT00263588|450124398|FG001|Overall Study|Investigator decision|15|||
125136463|NCT00263588|450124397|FG000|Overall Study|Sponsor terminated study|0|||
125136464|NCT00263588|450124398|FG001|Overall Study|Sponsor terminated study|1|||
125136465|NCT00918684|450124399|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
125136466|NCT00918684|450124399|FG000|Treatment Phase|Lack of Efficacy|6|||
125136467|NCT00918684|450124399|FG000|Treatment Phase|Lost to Follow-up|2|||
125136468|NCT00918684|450124399|FG000|Treatment Phase|Physician Decision|8|||
125136469|NCT00918684|450124399|FG000|Treatment Phase|Protocol Violation|1|||
125136470|NCT00918684|450124399|FG000|Treatment Phase|Withdrawal by Subject|8|||
125136471|NCT00909038|450124400|FG000|Overall Study|Protocol Violation|187|||
125054976|NCT02026271|449819081|FG002|Overall Study|Withdrawal by Subject|0|||
125054977|NCT02026271|449819082|FG003|Overall Study|Withdrawal by Subject|0|||
125054978|NCT02026271|449819083|FG004|Overall Study|Withdrawal by Subject|1|||
125054979|NCT04333433|449819084|FG000|Overall Study|Withdrawal by Subject|6|||
125054980|NCT04333433|449819085|FG001|Overall Study|Withdrawal by Subject|3|||
125054981|NCT04333433|449819084|FG000|Overall Study|Death|3|||
125054982|NCT04333433|449819085|FG001|Overall Study|Death|0|||
125054983|NCT04333433|449819084|FG000|Overall Study|Lost to Follow-up|6|||
125054984|NCT04333433|449819085|FG001|Overall Study|Lost to Follow-up|1|||
125054985|NCT04333433|449819084|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
125054986|NCT04333433|449819085|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
125054987|NCT00320385|449819086|FG000|Overall Study|Lost to Follow-up|7|||
125054988|NCT00320385|449819087|FG001|Overall Study|Lost to Follow-up|10|||
125054989|NCT00320385|449819086|FG000|Overall Study|Withdrawal by Subject|6|||
125054990|NCT00320385|449819087|FG001|Overall Study|Withdrawal by Subject|7|||
125054991|NCT00320385|449819086|FG000|Overall Study|Sponsor Terminated Study|2|||
125054992|NCT00320385|449819087|FG001|Overall Study|Sponsor Terminated Study|1|||
125054993|NCT00320385|449819086|FG000|Overall Study|Investigator Decision|0|||
125054994|NCT00320385|449819087|FG001|Overall Study|Investigator Decision|1|||
125054995|NCT00320385|449819086|FG000|Overall Study|Death|1|||
125054996|NCT00320385|449819087|FG001|Overall Study|Death|2|||
125054997|NCT00320385|449819086|FG000|Overall Study|Serious Adverse Event|1|||
125054998|NCT00320385|449819087|FG001|Overall Study|Serious Adverse Event|0|||
125054999|NCT00320385|449819086|FG000|Overall Study|Withdrew Consent|1|||
125055000|NCT00320385|449819087|FG001|Overall Study|Withdrew Consent|0|||
125055001|NCT00320385|449819086|FG000|Overall Study|Adverse Event|0|||
125055002|NCT00320385|449819087|FG001|Overall Study|Adverse Event|1|||
125055003|NCT04743635|449819088|FG000|Overall Study|Lost to Follow-up|2|||
125055004|NCT04743635|449819089|FG001|Overall Study|Lost to Follow-up|0|||
125055005|NCT03382899|449819095|FG000|Overall Study|Ineligibility Determined|0|||
125055006|NCT03382899|449819096|FG001|Overall Study|Ineligibility Determined|1|||
125055007|NCT03382899|449819095|FG000|Overall Study|Lost to Follow-up|0|||
125055008|NCT03382899|449819096|FG001|Overall Study|Lost to Follow-up|1|||
125055009|NCT03382899|449819095|FG000|Overall Study|Sponsor's decision|31|||
125055010|NCT03382899|449819096|FG001|Overall Study|Sponsor's decision|28|||
125055011|NCT03382899|449819095|FG000|Overall Study|Withdrawal by Subject|0|||
125055012|NCT03382899|449819096|FG001|Overall Study|Withdrawal by Subject|5|||
125055013|NCT01355068|449819097|FG000|First Intervention Period|Adverse Event|0|||
125055014|NCT01355068|449819098|FG001|First Intervention Period|Adverse Event|1|||
125055015|NCT01355068|449819097|FG000|First Intervention Period|Withdrawal by Subject|0|||
125136472|NCT00909038|450124400|FG000|Overall Study|Non-evaluable Subjects|230|||
125136473|NCT00484679|450124401|FG000|Overall Study|Withdrawal by Subject|3|||
125136474|NCT00835692|450124402|FG000|First Intervention|Withdrawal by Subject|1|||
125136475|NCT00835692|450124403|FG001|First Intervention|Withdrawal by Subject|0|||
125136476|NCT04345653|450124406|FG000|Overall Study|Withdrawal by Subject|2|||
125136477|NCT03808376|450124407|FG000|Overall Study|Withdrawal by Subject|10|||
125055016|NCT01355068|449819098|FG001|First Intervention Period|Withdrawal by Subject|1|||
125055017|NCT00524745|449819099|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
125055018|NCT00524745|449819100|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
125055019|NCT00524745|449819101|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
125055020|NCT00524745|449819102|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
125055021|NCT00872170|449819103|FG000|Overall Study|Adverse Event|1|||
125055022|NCT00872170|449819104|FG001|Overall Study|Adverse Event|0|||
125055023|NCT00540449|449819105|FG000|Overall Study|Adverse Event|12|||
125055024|NCT00540449|449819106|FG001|Overall Study|Adverse Event|32|||
125055025|NCT00540449|449819105|FG000|Overall Study|Sponsor's Decision|1|||
125136478|NCT03644550|450124408|FG000|Overall Study|Withdrawal by Subject|3|||
125136479|NCT03644550|450124408|FG000|Overall Study|Progressive disease|15|||
125136480|NCT00700739|450124409|FG000|Overall Study|Lost to Follow-up|4|||
125136481|NCT00700739|450124410|FG001|Overall Study|Lost to Follow-up|4|||
125055026|NCT00540449|449819106|FG001|Overall Study|Sponsor's Decision|1|||
125055027|NCT00540449|449819105|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
125136482|NCT03488108|450124419|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
125055028|NCT00540449|449819106|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
125055029|NCT00540449|449819105|FG000|Overall Study|Lost to Follow-up|19|||
125055030|NCT00540449|449819106|FG001|Overall Study|Lost to Follow-up|17|||
125055031|NCT00540449|449819105|FG000|Overall Study|Subject Non-Compliant|7|||
125055032|NCT00540449|449819106|FG001|Overall Study|Subject Non-Compliant|5|||
125055033|NCT00540449|449819105|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
125055034|NCT00540449|449819106|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
125055035|NCT00540449|449819105|FG000|Overall Study|Withdrawal by Subject|10|||
125055036|NCT00540449|449819106|FG001|Overall Study|Withdrawal by Subject|10|||
125055037|NCT00540449|449819105|FG000|Overall Study|Other|1|||
125055038|NCT00540449|449819106|FG001|Overall Study|Other|4|||
125055039|NCT01721408|449819107|FG000|Overall Study|Adverse Event|6|||
125055040|NCT01721408|449819108|FG001|Overall Study|Adverse Event|1|||
125055041|NCT01721408|449819107|FG000|Overall Study|Death|1|||
125055042|NCT01721408|449819108|FG001|Overall Study|Death|0|||
125055043|NCT01721408|449819107|FG000|Overall Study|Insufficient clinical response|15|||
125055044|NCT01721408|449819108|FG001|Overall Study|Insufficient clinical response|6|||
125055045|NCT01721408|449819107|FG000|Overall Study|No longer willing to participate study|9|||
125055046|NCT01721408|449819108|FG001|Overall Study|No longer willing to participate study|10|||
125055047|NCT01721408|449819107|FG000|Overall Study|Protocol Violation|0|||
125055048|NCT01721408|449819108|FG001|Overall Study|Protocol Violation|2|||
125055049|NCT01721408|449819107|FG000|Overall Study|Other|3|||
125055050|NCT01721408|449819108|FG001|Overall Study|Other|3|||
125055051|NCT01721408|449819107|FG000|Overall Study|Lost to Follow-up|1|||
125055052|NCT01721408|449819108|FG001|Overall Study|Lost to Follow-up|2|||
125055053|NCT01721408|449819107|FG000|Overall Study|Does not meet entrance criteria|1|||
125055054|NCT01721408|449819108|FG001|Overall Study|Does not meet entrance criteria|0|||
125055055|NCT02426658|449819109|FG000|Overall Study|Withdrawal by Subject|1|||
125055056|NCT02426658|449819109|FG000|Overall Study|Patient expired before treatment|2|||
125055057|NCT00524316|449819110|FG000|Overall Study|Withdrawal by Subject|2|||
125055058|NCT00524316|449819110|FG000|Overall Study|Adverse Event|7|||
125055059|NCT00524316|449819110|FG000|Overall Study|Disease Progression|7|||
125055060|NCT01402284|449819111|FG000|Overall Study|Withdrawal consent|2|||
125055061|NCT01402284|449819111|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
125055062|NCT01402284|449819111|FG000|Overall Study|Physician Decision|1|||
125136483|NCT03488108|450124420|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
125136484|NCT03488108|450124419|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
125136485|NCT03488108|450124420|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
125136486|NCT01297504|450124424|FG000|Overall Study|Invalid Consent|1|||
125136487|NCT01297504|450124424|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
125136488|NCT01297504|450124424|FG000|Overall Study|No Study Visits|4|||
125136489|NCT01297504|450124424|FG000|Overall Study|Death|3|||
125136490|NCT01297504|450124424|FG000|Overall Study|Lost to Follow-up|43|||
125136491|NCT01297504|450124424|FG000|Overall Study|Withdrawal by Subject|9|||
125136492|NCT01297504|450124424|FG000|Overall Study|Site Closure|3|||
125136493|NCT01297504|450124424|FG000|Overall Study|Protocol Violation|3|||
125136494|NCT03602339|450124425|FG000|Overall Study|Withdrawal by Subject|9|||
125136495|NCT03602339|450124425|FG000|Overall Study|Physician Decision|2|||
125136496|NCT03602339|450124425|FG000|Overall Study|Other reason|4|||
125136497|NCT01348789|450124426|FG000|Overall Study|Protocol Violation|2|||
125136498|NCT01348789|450124426|FG000|Overall Study|Withdrawal by Subject|2|||
125136499|NCT03503318|450124429|FG000|Overall Study|Death|1|||
125136500|NCT03503318|450124430|FG001|Overall Study|Death|0|||
125136501|NCT03503318|450124431|FG002|Overall Study|Death|4|||
125136502|NCT03503318|450124429|FG000|Overall Study|Adverse Event|3|||
125136503|NCT03503318|450124430|FG001|Overall Study|Adverse Event|4|||
125136504|NCT03503318|450124431|FG002|Overall Study|Adverse Event|2|||
125136505|NCT03503318|450124429|FG000|Overall Study|Withdrawal by Subject|12|||
125136506|NCT03503318|450124430|FG001|Overall Study|Withdrawal by Subject|17|||
125136507|NCT03503318|450124431|FG002|Overall Study|Withdrawal by Subject|16|||
125136508|NCT03503318|450124429|FG000|Overall Study|Protocol Violation|5|||
125136509|NCT03503318|450124430|FG001|Overall Study|Protocol Violation|0|||
125136510|NCT03503318|450124431|FG002|Overall Study|Protocol Violation|3|||
125136511|NCT03503318|450124429|FG000|Overall Study|Lost to Follow-up|17|||
125136512|NCT03503318|450124430|FG001|Overall Study|Lost to Follow-up|15|||
125136513|NCT03503318|450124431|FG002|Overall Study|Lost to Follow-up|12|||
125136514|NCT03503318|450124429|FG000|Overall Study|Other than specified|1|||
125136515|NCT03503318|450124430|FG001|Overall Study|Other than specified|3|||
125136516|NCT03503318|450124431|FG002|Overall Study|Other than specified|3|||
125055063|NCT01402284|449819111|FG000|Overall Study|Disease progression on study|10|||
125055064|NCT01199263|449819112|FG000|Overall Study|Ineligible|0|||
125055065|NCT01199263|449819113|FG001|Overall Study|Ineligible|2|||
125136517|NCT00834873|450124438|FG000|First Intervention|Adverse Event|0|||
125055066|NCT01199263|449819112|FG000|Overall Study|Never Treated|6|||
125055067|NCT01199263|449819113|FG001|Overall Study|Never Treated|0|||
125055068|NCT04937816|449819114|FG000|Overall Study|Study drug stopped, reason missing|5|||
125055069|NCT04937816|449819115|FG001|Overall Study|Study drug stopped, reason missing|3|||
125055070|NCT04937816|449819116|FG002|Overall Study|Study drug stopped, reason missing|4|||
125055071|NCT04937816|449819117|FG003|Overall Study|Study drug stopped, reason missing|6|||
125055072|NCT04937816|449819118|FG004|Overall Study|Study drug stopped, reason missing|1|||
125055073|NCT04937816|449819119|FG005|Overall Study|Study drug stopped, reason missing|0|||
125055074|NCT04937816|449819120|FG006|Overall Study|Study drug stopped, reason missing|0|||
125055075|NCT04937816|449819114|FG000|Overall Study|Other than stated below|173|||
125055076|NCT04937816|449819115|FG001|Overall Study|Other than stated below|143|||
125055077|NCT04937816|449819116|FG002|Overall Study|Other than stated below|125|||
125055078|NCT04937816|449819117|FG003|Overall Study|Other than stated below|44|||
125055079|NCT04937816|449819118|FG004|Overall Study|Other than stated below|45|||
125055080|NCT04937816|449819119|FG005|Overall Study|Other than stated below|28|||
125055081|NCT04937816|449819120|FG006|Overall Study|Other than stated below|31|||
125055082|NCT04937816|449819114|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
125055083|NCT04937816|449819115|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
125136518|NCT00834873|450124439|FG001|First Intervention|Adverse Event|1|||
125136519|NCT04827394|450124441|FG000|Overall Study|Physician Decision|0|||
125136520|NCT04827394|450124442|FG001|Overall Study|Physician Decision|2|||
125136521|NCT04594252|450124443|FG000|Overall Study|Adverse Event|0|||
125136522|NCT04594252|450124444|FG001|Overall Study|Adverse Event|2|||
125136523|NCT00477594|450124449|FG000|Year 1 and Year 2|Adverse Event|4|||
125136524|NCT00477594|450124450|FG001|Year 1 and Year 2|Adverse Event|2|||
125136525|NCT00477594|450124449|FG000|Year 1 and Year 2|Physician Decision|2|||
125136526|NCT00477594|450124450|FG001|Year 1 and Year 2|Physician Decision|1|||
125136527|NCT00477594|450124449|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
125136528|NCT00477594|450124450|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
125136529|NCT00477594|450124449|FG000|Year 1 and Year 2|Other|1|||
125136530|NCT00477594|450124450|FG001|Year 1 and Year 2|Other|0|||
125136531|NCT00477594|450124449|FG000|Year 3|Adverse Event|1|||
125136532|NCT00477594|450124450|FG001|Year 3|Adverse Event|0|||
125136533|NCT00477594|450124449|FG000|Year 3|Withdrawal by Subject|1|||
125136534|NCT00477594|450124450|FG001|Year 3|Withdrawal by Subject|0|||
125136535|NCT00477594|450124449|FG000|Follow-up Period|Withdrawal by Subject|2|||
125136536|NCT00477594|450124450|FG001|Follow-up Period|Withdrawal by Subject|1|||
125136537|NCT00477594|450124449|FG000|Follow-up Period|Other|1|||
125136538|NCT00477594|450124450|FG001|Follow-up Period|Other|0|||
125136539|NCT03114891|450124451|FG000|First Treatment Round|Lost to Follow-up|0|||
125136540|NCT03114891|450124452|FG001|First Treatment Round|Lost to Follow-up|1|||
125136541|NCT03114891|450124453|FG002|First Treatment Round|Lost to Follow-up|1|||
125136542|NCT03114891|450124454|FG003|First Treatment Round|Lost to Follow-up|0|||
125136543|NCT03114891|450124451|FG000|First Treatment Round|Withdrawal by Subject|0|||
125136544|NCT03114891|450124452|FG001|First Treatment Round|Withdrawal by Subject|2|||
125136545|NCT03114891|450124453|FG002|First Treatment Round|Withdrawal by Subject|0|||
125136546|NCT03114891|450124454|FG003|First Treatment Round|Withdrawal by Subject|1|||
125136547|NCT03114891|450124451|FG000|3 Week Break|Lost to Follow-up|1|||
125136548|NCT03114891|450124452|FG001|3 Week Break|Lost to Follow-up|0|||
125136549|NCT03114891|450124453|FG002|3 Week Break|Lost to Follow-up|0|||
125136550|NCT03114891|450124454|FG003|3 Week Break|Lost to Follow-up|1|||
125136551|NCT03114891|450124451|FG000|3 Week Break|Withdrawal by Subject|0|||
125136552|NCT03114891|450124452|FG001|3 Week Break|Withdrawal by Subject|1|||
125136553|NCT03114891|450124453|FG002|3 Week Break|Withdrawal by Subject|0|||
125136554|NCT03114891|450124454|FG003|3 Week Break|Withdrawal by Subject|0|||
125136555|NCT03114891|450124451|FG000|Second Treatment Round|Lost to Follow-up|1|||
125136556|NCT03114891|450124452|FG001|Second Treatment Round|Lost to Follow-up|0|||
125055084|NCT04937816|449819116|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
125136557|NCT03114891|450124453|FG002|Second Treatment Round|Lost to Follow-up|0|||
125136558|NCT03114891|450124454|FG003|Second Treatment Round|Lost to Follow-up|0|||
125136559|NCT03114891|450124451|FG000|Second Treatment Round|Physician Decision|1|||
125136560|NCT03114891|450124452|FG001|Second Treatment Round|Physician Decision|0|||
125136561|NCT03114891|450124453|FG002|Second Treatment Round|Physician Decision|0|||
125136562|NCT03114891|450124454|FG003|Second Treatment Round|Physician Decision|0|||
125136563|NCT02068794|450126297|FG000|Overall Study|Withdrawal by Subject|0|||
125055085|NCT04937816|449819117|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
125055086|NCT04937816|449819118|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
125136564|NCT02068794|450126298|FG001|Overall Study|Withdrawal by Subject|1|||
125136565|NCT02068794|450126299|FG002|Overall Study|Withdrawal by Subject|2|||
125136566|NCT02068794|450126297|FG000|Overall Study|Early Progression|1|||
125136567|NCT02068794|450126298|FG001|Overall Study|Early Progression|0|||
125136568|NCT02068794|450126299|FG002|Overall Study|Early Progression|1|||
125136569|NCT02068794|450126297|FG000|Overall Study|Ineligible|0|||
125136570|NCT02068794|450126298|FG001|Overall Study|Ineligible|0|||
125055087|NCT04937816|449819119|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
125055088|NCT04937816|449819120|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
125055089|NCT04937816|449819114|FG000|Overall Study|Lost to Follow-up|15|||
125055090|NCT04937816|449819115|FG001|Overall Study|Lost to Follow-up|9|||
125055091|NCT04937816|449819116|FG002|Overall Study|Lost to Follow-up|6|||
125055092|NCT04937816|449819117|FG003|Overall Study|Lost to Follow-up|6|||
125055093|NCT04937816|449819118|FG004|Overall Study|Lost to Follow-up|16|||
125055094|NCT04937816|449819119|FG005|Overall Study|Lost to Follow-up|11|||
125055095|NCT04937816|449819120|FG006|Overall Study|Lost to Follow-up|17|||
125055096|NCT04937816|449819114|FG000|Overall Study|Protocol Violation|15|||
125055097|NCT04937816|449819115|FG001|Overall Study|Protocol Violation|15|||
125055098|NCT04937816|449819116|FG002|Overall Study|Protocol Violation|12|||
125055099|NCT04937816|449819117|FG003|Overall Study|Protocol Violation|30|||
125055100|NCT04937816|449819118|FG004|Overall Study|Protocol Violation|24|||
125055101|NCT04937816|449819119|FG005|Overall Study|Protocol Violation|5|||
125055102|NCT04937816|449819120|FG006|Overall Study|Protocol Violation|5|||
125055103|NCT04937816|449819114|FG000|Overall Study|Adverse Event|303|||
125055104|NCT04937816|449819115|FG001|Overall Study|Adverse Event|267|||
125055105|NCT04937816|449819116|FG002|Overall Study|Adverse Event|273|||
125055106|NCT04937816|449819117|FG003|Overall Study|Adverse Event|553|||
125055107|NCT04937816|449819118|FG004|Overall Study|Adverse Event|575|||
125055108|NCT04937816|449819119|FG005|Overall Study|Adverse Event|343|||
125055109|NCT04937816|449819120|FG006|Overall Study|Adverse Event|337|||
125055110|NCT04937816|449819114|FG000|Overall Study|Not treated|4|||
125055111|NCT04937816|449819115|FG001|Overall Study|Not treated|2|||
125055112|NCT04937816|449819116|FG002|Overall Study|Not treated|2|||
125055113|NCT04937816|449819117|FG003|Overall Study|Not treated|2|||
125055114|NCT04937816|449819118|FG004|Overall Study|Not treated|1|||
125055115|NCT04937816|449819119|FG005|Overall Study|Not treated|4|||
125055116|NCT04937816|449819120|FG006|Overall Study|Not treated|0|||
125055117|NCT00436215|449819121|FG000|Overall Study|Refused further treatment|3|||
125055118|NCT00436215|449819121|FG000|Overall Study|Small bowel obstruction|1|||
125055119|NCT00309777|449819122|FG000|Overall Study|Adverse Event|13|||
125055120|NCT00309777|449819123|FG001|Overall Study|Adverse Event|2|||
125055121|NCT00309777|449819124|FG002|Overall Study|Adverse Event|8|||
125055122|NCT00309777|449819125|FG003|Overall Study|Adverse Event|1|||
125055123|NCT00309777|449819122|FG000|Overall Study|Protocol Violation|4|||
125055124|NCT00309777|449819123|FG001|Overall Study|Protocol Violation|1|||
125055125|NCT00309777|449819124|FG002|Overall Study|Protocol Violation|3|||
125055126|NCT00309777|449819125|FG003|Overall Study|Protocol Violation|1|||
125055127|NCT00309777|449819122|FG000|Overall Study|Withdrawal by Subject|6|||
125055128|NCT00309777|449819123|FG001|Overall Study|Withdrawal by Subject|5|||
125055129|NCT00309777|449819124|FG002|Overall Study|Withdrawal by Subject|7|||
125055130|NCT00309777|449819125|FG003|Overall Study|Withdrawal by Subject|2|||
125055131|NCT00309777|449819122|FG000|Overall Study|Lost to Follow-up|0|||
125055132|NCT00309777|449819123|FG001|Overall Study|Lost to Follow-up|0|||
125055133|NCT00309777|449819124|FG002|Overall Study|Lost to Follow-up|1|||
125055134|NCT00309777|449819125|FG003|Overall Study|Lost to Follow-up|0|||
125136571|NCT02068794|450126299|FG002|Overall Study|Ineligible|1|||
125136572|NCT02635750|450126300|FG000|Part 1, Period 2|Adverse Event|1|||
125136573|NCT02635750|450126301|FG001|Part 1, Period 2|Adverse Event|0|||
125136574|NCT02635750|450126302|FG002|Part 1, Period 2|Adverse Event|0|||
125136575|NCT02875392|450126304|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
125136576|NCT02875392|450126305|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
125136577|NCT03599193|450126306|FG000|Overall Study|Adverse Event|0|||
125136578|NCT03599193|450126307|FG001|Overall Study|Adverse Event|2|||
125136579|NCT03599193|450126306|FG000|Overall Study|Withdrawal by Subject|1|||
125136580|NCT03599193|450126307|FG001|Overall Study|Withdrawal by Subject|0|||
125136581|NCT03599193|450126306|FG000|Overall Study|Protocol Violation|1|||
125055135|NCT00309777|449819122|FG000|Overall Study|Death|0|||
125055136|NCT00309777|449819123|FG001|Overall Study|Death|1|||
125055137|NCT00309777|449819124|FG002|Overall Study|Death|0|||
125055138|NCT00309777|449819125|FG003|Overall Study|Death|0|||
125055139|NCT00492856|449820653|FG000|Induction|Adverse Event|2|||
125055140|NCT00492856|449820654|FG001|Induction|Adverse Event|0|||
125055141|NCT00492856|449820655|FG002|Induction|Adverse Event|0|||
125136582|NCT03599193|450126307|FG001|Overall Study|Protocol Violation|0|||
125055142|NCT00492856|449820656|FG003|Induction|Adverse Event|0|||
125055143|NCT00492856|449820653|FG000|Induction|Withdrawal by Subject|1|||
125055144|NCT00492856|449820654|FG001|Induction|Withdrawal by Subject|0|||
125055145|NCT00492856|449820655|FG002|Induction|Withdrawal by Subject|0|||
125055146|NCT00492856|449820656|FG003|Induction|Withdrawal by Subject|0|||
125055147|NCT00492856|449820653|FG000|Induction|Death|3|||
125055148|NCT00492856|449820654|FG001|Induction|Death|0|||
125055149|NCT00492856|449820655|FG002|Induction|Death|0|||
125055150|NCT00492856|449820656|FG003|Induction|Death|0|||
125055151|NCT00492856|449820653|FG000|Consolidation|Adverse Event|6|||
125055152|NCT00492856|449820654|FG001|Consolidation|Adverse Event|0|||
125055153|NCT00492856|449820655|FG002|Consolidation|Adverse Event|0|||
125055154|NCT00492856|449820656|FG003|Consolidation|Adverse Event|0|||
125055155|NCT00492856|449820653|FG000|Consolidation|Not protocol specified|2|||
125055156|NCT00492856|449820654|FG001|Consolidation|Not protocol specified|0|||
125055157|NCT00492856|449820655|FG002|Consolidation|Not protocol specified|0|||
125055158|NCT00492856|449820656|FG003|Consolidation|Not protocol specified|0|||
125055159|NCT00492856|449820653|FG000|Consolidation|Lost to Follow-up|1|||
125055160|NCT00492856|449820654|FG001|Consolidation|Lost to Follow-up|0|||
125055161|NCT00492856|449820655|FG002|Consolidation|Lost to Follow-up|0|||
125055162|NCT00492856|449820656|FG003|Consolidation|Lost to Follow-up|0|||
125055163|NCT00492856|449820653|FG000|Post-consolidation|Adverse Event|0|||
125055164|NCT00492856|449820654|FG001|Post-consolidation|Adverse Event|4|||
125055165|NCT00492856|449820655|FG002|Post-consolidation|Adverse Event|0|||
125055166|NCT00492856|449820656|FG003|Post-consolidation|Adverse Event|1|||
125055167|NCT00492856|449820653|FG000|Post-consolidation|Withdrawal by Subject|0|||
125055168|NCT00492856|449820654|FG001|Post-consolidation|Withdrawal by Subject|4|||
125055169|NCT00492856|449820655|FG002|Post-consolidation|Withdrawal by Subject|0|||
125055170|NCT00492856|449820656|FG003|Post-consolidation|Withdrawal by Subject|0|||
125055171|NCT00492856|449820653|FG000|Post-consolidation|Death|0|||
125055172|NCT00492856|449820654|FG001|Post-consolidation|Death|1|||
125055173|NCT00492856|449820655|FG002|Post-consolidation|Death|0|||
125055174|NCT00492856|449820656|FG003|Post-consolidation|Death|0|||
125055175|NCT00492856|449820653|FG000|Post-consolidation|Not protocol specified|0|||
125055176|NCT00492856|449820654|FG001|Post-consolidation|Not protocol specified|1|||
125055177|NCT00492856|449820655|FG002|Post-consolidation|Not protocol specified|0|||
125055178|NCT00492856|449820656|FG003|Post-consolidation|Not protocol specified|0|||
125055179|NCT00492856|449820653|FG000|Post-consolidation|Lost to Follow-up|0|||
125055180|NCT00492856|449820654|FG001|Post-consolidation|Lost to Follow-up|2|||
125055181|NCT00492856|449820655|FG002|Post-consolidation|Lost to Follow-up|0|||
125055182|NCT00492856|449820656|FG003|Post-consolidation|Lost to Follow-up|0|||
125055183|NCT00492856|449820653|FG000|Post-consolidation|Observation Arm|0|||
125055184|NCT00492856|449820654|FG001|Post-consolidation|Observation Arm|0|||
125055185|NCT00492856|449820655|FG002|Post-consolidation|Observation Arm|27|||
125055186|NCT00492856|449820656|FG003|Post-consolidation|Observation Arm|0|||
125055187|NCT03488472|449820657|FG000|Overall Study|disease progression additional mets|1|||
125055188|NCT01998581|449820658|FG000|Overall Study|Refused repeat treatment|20|||
125055189|NCT01998581|449820659|FG001|Overall Study|Refused repeat treatment|4|||
125055190|NCT01998581|449820658|FG000|Overall Study|Protocol Violation|1|||
125055191|NCT01998581|449820659|FG001|Overall Study|Protocol Violation|0|||
125055192|NCT01998581|449820658|FG000|Overall Study|Withdrawal by Subject|8|||
125055193|NCT01998581|449820659|FG001|Overall Study|Withdrawal by Subject|1|||
125055194|NCT01998581|449820658|FG000|Overall Study|Lost to Follow-up|12|||
125055195|NCT01998581|449820659|FG001|Overall Study|Lost to Follow-up|4|||
125055196|NCT01998581|449820658|FG000|Overall Study|Adverse Event|1|||
125055197|NCT01998581|449820659|FG001|Overall Study|Adverse Event|1|||
125055198|NCT01998581|449820658|FG000|Overall Study|Other reasons|3|||
125055199|NCT01998581|449820659|FG001|Overall Study|Other reasons|2|||
125055200|NCT01998581|449820658|FG000|Overall Study|Randomized but withdrew before treatment|1|||
125055201|NCT01998581|449820659|FG001|Overall Study|Randomized but withdrew before treatment|0|||
125055202|NCT01251276|449820660|FG000|Overall Study|Protocol Violation|1|||
125055203|NCT01251276|449820661|FG001|Overall Study|Protocol Violation|0|||
125055204|NCT01251276|449820660|FG000|Overall Study|Lost to Follow-up|0|||
125055205|NCT01251276|449820661|FG001|Overall Study|Lost to Follow-up|1|||
125055206|NCT01345123|449820662|FG000|Overall Study|participants no longer with health plan|79|||
125055207|NCT01345123|449820663|FG001|Overall Study|participants no longer with health plan|85|||
125055208|NCT01345123|449820664|FG002|Overall Study|participants no longer with health plan|88|||
125055209|NCT03165721|449820671|FG000|Overall Study|Refused further treatment|3|||
125055210|NCT03165721|449820672|FG001|Overall Study|Refused further treatment|0|||
125055211|NCT03165721|449820673|FG002|Overall Study|Refused further treatment|0|||
125055212|NCT03165721|449820671|FG000|Overall Study|Physician Decision|1|||
125055213|NCT03165721|449820672|FG001|Overall Study|Physician Decision|0|||
125055214|NCT03165721|449820673|FG002|Overall Study|Physician Decision|0|||
125055215|NCT01863849|449820675|FG000|Overall Study|Lost to Follow-up|1|||
125055216|NCT01863849|449820676|FG001|Overall Study|Lost to Follow-up|0|||
125055217|NCT01457118|449820677|FG000|Overall Study|Adverse Event|1|||
125055218|NCT01457118|449820678|FG001|Overall Study|Adverse Event|0|||
125055219|NCT01457118|449820679|FG002|Overall Study|Adverse Event|0|||
125055220|NCT01457118|449820680|FG003|Overall Study|Adverse Event|1|||
125055221|NCT01457118|449820677|FG000|Overall Study|Clinical Progression|0|||
125055222|NCT01457118|449820678|FG001|Overall Study|Clinical Progression|1|||
125055223|NCT01457118|449820679|FG002|Overall Study|Clinical Progression|0|||
125055224|NCT01457118|449820680|FG003|Overall Study|Clinical Progression|1|||
125055225|NCT01457118|449820677|FG000|Overall Study|Physician Decision|2|||
125055226|NCT01457118|449820678|FG001|Overall Study|Physician Decision|0|||
125055227|NCT01457118|449820679|FG002|Overall Study|Physician Decision|0|||
125055228|NCT01457118|449820680|FG003|Overall Study|Physician Decision|0|||
125055229|NCT01457118|449820677|FG000|Overall Study|Progressive Disease by RECIST|12|||
125055230|NCT01457118|449820678|FG001|Overall Study|Progressive Disease by RECIST|3|||
125055231|NCT01457118|449820679|FG002|Overall Study|Progressive Disease by RECIST|1|||
125055232|NCT01457118|449820680|FG003|Overall Study|Progressive Disease by RECIST|0|||
125055233|NCT01457118|449820677|FG000|Overall Study|Withdrawal by Subject|5|||
125055234|NCT01457118|449820678|FG001|Overall Study|Withdrawal by Subject|0|||
125055235|NCT01457118|449820679|FG002|Overall Study|Withdrawal by Subject|0|||
125055236|NCT01457118|449820680|FG003|Overall Study|Withdrawal by Subject|0|||
125055237|NCT03456713|449820682|FG000|Overall Study|Lost to Follow-up|1|||
125055238|NCT03456713|449820683|FG001|Overall Study|Lost to Follow-up|0|||
125055239|NCT03456713|449820684|FG002|Overall Study|Lost to Follow-up|0|||
125055240|NCT03456713|449820685|FG003|Overall Study|Lost to Follow-up|0|||
125055241|NCT01263691|449820687|FG000|Overall Study|Lost to Follow-up|1|||
125055242|NCT01263691|449820688|FG001|Overall Study|Lost to Follow-up|0|||
125055243|NCT01263691|449820689|FG002|Overall Study|Lost to Follow-up|1|||
125055244|NCT01263691|449820690|FG003|Overall Study|Lost to Follow-up|1|||
125055245|NCT01263691|449820691|FG004|Overall Study|Lost to Follow-up|0|||
125055246|NCT01263691|449820692|FG005|Overall Study|Lost to Follow-up|0|||
125055247|NCT01263691|449820687|FG000|Overall Study|Withdrawal by Subject|1|||
125055248|NCT01263691|449820688|FG001|Overall Study|Withdrawal by Subject|0|||
125055249|NCT01263691|449820689|FG002|Overall Study|Withdrawal by Subject|0|||
125055250|NCT01263691|449820690|FG003|Overall Study|Withdrawal by Subject|0|||
125055251|NCT01263691|449820691|FG004|Overall Study|Withdrawal by Subject|0|||
125055252|NCT01263691|449820692|FG005|Overall Study|Withdrawal by Subject|0|||
125055253|NCT01263691|449820687|FG000|Overall Study|Adverse Event|1|||
125055254|NCT01263691|449820688|FG001|Overall Study|Adverse Event|0|||
125055255|NCT01263691|449820689|FG002|Overall Study|Adverse Event|0|||
125055256|NCT01263691|449820690|FG003|Overall Study|Adverse Event|0|||
125055257|NCT01263691|449820691|FG004|Overall Study|Adverse Event|0|||
125055258|NCT01263691|449820692|FG005|Overall Study|Adverse Event|0|||
125055259|NCT01202227|449820695|FG000|Overall Study|Adverse Event|16|||
125136583|NCT03599193|450126306|FG000|Overall Study|Lost to Follow-up|0|||
125136584|NCT03599193|450126307|FG001|Overall Study|Lost to Follow-up|1|||
125136585|NCT00835705|450126308|FG000|First Intervention|Difficulty with vein|1|||
125136586|NCT00835705|450126309|FG001|First Intervention|Difficulty with vein|0|||
125136587|NCT00835705|450126308|FG000|Second Intervention|Difficulty with vein|1|||
125136588|NCT00835705|450126309|FG001|Second Intervention|Difficulty with vein|0|||
125136589|NCT01592240|450126310|FG000|Overall Study|Adverse Event|1|||
125136590|NCT01592240|450126311|FG001|Overall Study|Adverse Event|0|||
125136591|NCT01592240|450126312|FG002|Overall Study|Adverse Event|0|||
125136592|NCT01592240|450126313|FG003|Overall Study|Adverse Event|1|||
125136593|NCT01592240|450126314|FG004|Overall Study|Adverse Event|1|||
125136594|NCT01592240|450126315|FG005|Overall Study|Adverse Event|0|||
125136595|NCT01592240|450126316|FG006|Overall Study|Adverse Event|0|||
125136596|NCT01592240|450126310|FG000|Overall Study|Death|0|||
125136597|NCT01592240|450126311|FG001|Overall Study|Death|1|||
125136598|NCT01592240|450126312|FG002|Overall Study|Death|0|||
125136599|NCT01592240|450126313|FG003|Overall Study|Death|0|||
125136600|NCT01592240|450126314|FG004|Overall Study|Death|0|||
125136601|NCT01592240|450126315|FG005|Overall Study|Death|0|||
125136602|NCT01592240|450126316|FG006|Overall Study|Death|0|||
125136603|NCT01592240|450126310|FG000|Overall Study|Lost to Follow-up|1|||
125136604|NCT01592240|450126311|FG001|Overall Study|Lost to Follow-up|3|||
125220316|NCT00994110|450434421|FG000|Overall Study|Withdrawal by Subject|9|||
125220317|NCT00994110|450434422|FG001|Overall Study|Withdrawal by Subject|9|||
125220318|NCT00994110|450434421|FG000|Overall Study|Not Treated|4|||
125220319|NCT00994110|450434422|FG001|Overall Study|Not Treated|8|||
125220320|NCT00994110|450434421|FG000|Overall Study|Adverse Event|1|||
125220321|NCT00994110|450434422|FG001|Overall Study|Adverse Event|0|||
125220322|NCT00994110|450434421|FG000|Overall Study|Patient not resected|41|||
125220323|NCT00994110|450434422|FG001|Overall Study|Patient not resected|52|||
125220324|NCT00994110|450434421|FG000|Overall Study|Pt not eligible|10|||
125055260|NCT01202227|449820695|FG000|Overall Study|Withdrawal by Subject|2|||
125055261|NCT01202227|449820695|FG000|Overall Study|Lack of Efficacy|1|||
125055262|NCT04402008|449820698|FG000|Overall Study|Adverse Event|0|||
125055263|NCT04402008|449820699|FG001|Overall Study|Adverse Event|0|||
125055264|NCT04402008|449820700|FG002|Overall Study|Adverse Event|0|||
125055265|NCT04402008|449820701|FG003|Overall Study|Adverse Event|1|||
125055266|NCT04402008|449820702|FG004|Overall Study|Adverse Event|0|||
125055267|NCT04402008|449820703|FG005|Overall Study|Adverse Event|0|||
125136605|NCT01592240|450126312|FG002|Overall Study|Lost to Follow-up|1|||
125136606|NCT01592240|450126313|FG003|Overall Study|Lost to Follow-up|0|||
125136607|NCT01592240|450126314|FG004|Overall Study|Lost to Follow-up|3|||
125136608|NCT01592240|450126315|FG005|Overall Study|Lost to Follow-up|2|||
125220325|NCT00994110|450434422|FG001|Overall Study|Pt not eligible|5|||
125055268|NCT04402008|449820704|FG006|Overall Study|Adverse Event|0|||
125055269|NCT04402008|449820698|FG000|Overall Study|Disease Progression|3|||
125136609|NCT01592240|450126316|FG006|Overall Study|Lost to Follow-up|0|||
125055270|NCT04402008|449820699|FG001|Overall Study|Disease Progression|2|||
125055271|NCT04402008|449820700|FG002|Overall Study|Disease Progression|3|||
125055272|NCT04402008|449820701|FG003|Overall Study|Disease Progression|3|||
125055273|NCT04402008|449820702|FG004|Overall Study|Disease Progression|4|||
125055274|NCT04402008|449820703|FG005|Overall Study|Disease Progression|3|||
125055275|NCT04402008|449820704|FG006|Overall Study|Disease Progression|10|||
125055276|NCT04402008|449820698|FG000|Overall Study|Withdrawal by Subject|0|||
125055277|NCT04402008|449820699|FG001|Overall Study|Withdrawal by Subject|1|||
125055278|NCT04402008|449820700|FG002|Overall Study|Withdrawal by Subject|0|||
125055279|NCT04402008|449820701|FG003|Overall Study|Withdrawal by Subject|0|||
125055280|NCT04402008|449820702|FG004|Overall Study|Withdrawal by Subject|1|||
125055281|NCT04402008|449820703|FG005|Overall Study|Withdrawal by Subject|0|||
125055282|NCT04402008|449820704|FG006|Overall Study|Withdrawal by Subject|0|||
125055283|NCT04402008|449820698|FG000|Overall Study|Sponsor Decision|0|||
125055284|NCT04402008|449820699|FG001|Overall Study|Sponsor Decision|0|||
125055285|NCT04402008|449820700|FG002|Overall Study|Sponsor Decision|0|||
125055286|NCT04402008|449820701|FG003|Overall Study|Sponsor Decision|0|||
125055287|NCT04402008|449820702|FG004|Overall Study|Sponsor Decision|0|||
125055288|NCT04402008|449820703|FG005|Overall Study|Sponsor Decision|0|||
125055289|NCT04402008|449820704|FG006|Overall Study|Sponsor Decision|3|||
125055290|NCT04402008|449820698|FG000|Overall Study|Death|0|||
125055291|NCT04402008|449820699|FG001|Overall Study|Death|0|||
125055292|NCT04402008|449820700|FG002|Overall Study|Death|0|||
125055293|NCT04402008|449820701|FG003|Overall Study|Death|0|||
125055294|NCT04402008|449820702|FG004|Overall Study|Death|1|||
125055295|NCT04402008|449820703|FG005|Overall Study|Death|0|||
125055296|NCT04402008|449820704|FG006|Overall Study|Death|2|||
125055297|NCT04402008|449820698|FG000|Overall Study|Other|0|||
125055298|NCT04402008|449820699|FG001|Overall Study|Other|0|||
125055299|NCT04402008|449820700|FG002|Overall Study|Other|0|||
125055300|NCT04402008|449820701|FG003|Overall Study|Other|0|||
125055301|NCT04402008|449820702|FG004|Overall Study|Other|0|||
125055302|NCT04402008|449820703|FG005|Overall Study|Other|0|||
125055303|NCT04402008|449820704|FG006|Overall Study|Other|5|||
125055304|NCT01533935|449820705|FG000|Overall Study|Adverse Event|5|||
125136610|NCT01592240|450126310|FG000|Overall Study|Protocol Violation|0|||
125136611|NCT01592240|450126311|FG001|Overall Study|Protocol Violation|0|||
125136612|NCT01592240|450126312|FG002|Overall Study|Protocol Violation|0|||
125136613|NCT01592240|450126313|FG003|Overall Study|Protocol Violation|0|||
125136614|NCT01592240|450126314|FG004|Overall Study|Protocol Violation|0|||
125136615|NCT01592240|450126315|FG005|Overall Study|Protocol Violation|1|||
125136616|NCT01592240|450126316|FG006|Overall Study|Protocol Violation|0|||
125136617|NCT01592240|450126310|FG000|Overall Study|Withdrawal by Subject|0|||
125136618|NCT01592240|450126311|FG001|Overall Study|Withdrawal by Subject|4|||
125136619|NCT01592240|450126312|FG002|Overall Study|Withdrawal by Subject|4|||
125136620|NCT01592240|450126313|FG003|Overall Study|Withdrawal by Subject|1|||
125136621|NCT01592240|450126314|FG004|Overall Study|Withdrawal by Subject|3|||
125136622|NCT01592240|450126315|FG005|Overall Study|Withdrawal by Subject|0|||
125136623|NCT01592240|450126316|FG006|Overall Study|Withdrawal by Subject|2|||
125136624|NCT01592240|450126310|FG000|Overall Study|Other|0|||
125136625|NCT01592240|450126311|FG001|Overall Study|Other|3|||
125136626|NCT01592240|450126312|FG002|Overall Study|Other|1|||
125136627|NCT01592240|450126313|FG003|Overall Study|Other|1|||
125136628|NCT01592240|450126314|FG004|Overall Study|Other|0|||
125136629|NCT01592240|450126315|FG005|Overall Study|Other|0|||
125136630|NCT01592240|450126316|FG006|Overall Study|Other|1|||
125136631|NCT01592240|450126310|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
125136632|NCT01592240|450126311|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
125136633|NCT01592240|450126312|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
125136634|NCT01592240|450126313|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
125136635|NCT01592240|450126314|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
125136636|NCT01592240|450126315|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
125136637|NCT01592240|450126316|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
125136638|NCT03246503|450126320|FG000|Overall Study|Lost to Follow-up|23|||
125136639|NCT03246503|450126320|FG000|Overall Study|Withdrawal by Subject|20|||
125136640|NCT03246503|450126320|FG000|Overall Study|Physician Decision|5|||
125136641|NCT03246503|450126320|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
125136642|NCT02751424|450126321|FG000|Part 2|Adverse Event|0|||
125136643|NCT02751424|450126322|FG001|Part 2|Adverse Event|0|||
125055305|NCT01533935|449820706|FG001|Overall Study|Adverse Event|7|||
125055306|NCT01533935|449820707|FG002|Overall Study|Adverse Event|1|||
125055307|NCT01533935|449820708|FG003|Overall Study|Adverse Event|5|||
125055308|NCT01533935|449820709|FG004|Overall Study|Adverse Event|3|||
125055309|NCT01533935|449820705|FG000|Overall Study|Protocol Violation|0|||
125136644|NCT02751424|450126323|FG002|Part 2|Adverse Event|0|||
125136645|NCT02751424|450126324|FG003|Part 2|Adverse Event|0|||
125055310|NCT01533935|449820706|FG001|Overall Study|Protocol Violation|2|||
125055311|NCT01533935|449820707|FG002|Overall Study|Protocol Violation|0|||
125055312|NCT01533935|449820708|FG003|Overall Study|Protocol Violation|0|||
125055313|NCT01533935|449820709|FG004|Overall Study|Protocol Violation|0|||
125055314|NCT01533935|449820705|FG000|Overall Study|Lost to Follow-up|0|||
125055315|NCT01533935|449820706|FG001|Overall Study|Lost to Follow-up|0|||
125055316|NCT01533935|449820707|FG002|Overall Study|Lost to Follow-up|1|||
125055317|NCT01533935|449820708|FG003|Overall Study|Lost to Follow-up|0|||
125055318|NCT01533935|449820709|FG004|Overall Study|Lost to Follow-up|0|||
125055319|NCT01533935|449820705|FG000|Overall Study|Withdrawal by Subject|0|||
125055320|NCT01533935|449820706|FG001|Overall Study|Withdrawal by Subject|4|||
125055321|NCT01533935|449820707|FG002|Overall Study|Withdrawal by Subject|5|||
125055322|NCT01533935|449820708|FG003|Overall Study|Withdrawal by Subject|2|||
125055323|NCT01533935|449820709|FG004|Overall Study|Withdrawal by Subject|4|||
125055324|NCT01533935|449820705|FG000|Overall Study|Other reason not defined above|1|||
125055325|NCT01533935|449820706|FG001|Overall Study|Other reason not defined above|0|||
125055326|NCT01533935|449820707|FG002|Overall Study|Other reason not defined above|1|||
125055327|NCT01533935|449820708|FG003|Overall Study|Other reason not defined above|0|||
125055328|NCT01533935|449820709|FG004|Overall Study|Other reason not defined above|1|||
125055329|NCT03430245|449820710|FG000|Overall Study|Withdrawal by Subject|6|||
125055330|NCT03430245|449820710|FG000|Overall Study|Lost to Follow-up|1|||
125055331|NCT00316303|449820711|FG000|Overall Study|Lost to Follow-up|11|||
125055332|NCT00316303|449820712|FG001|Overall Study|Lost to Follow-up|16|||
125055333|NCT00850759|449820713|FG000|Overall Study|Lost to Follow-up|7|||
125055334|NCT00850759|449820714|FG001|Overall Study|Lost to Follow-up|5|||
125055335|NCT00850759|449820715|FG002|Overall Study|Lost to Follow-up|5|||
125055336|NCT00850759|449820716|FG003|Overall Study|Lost to Follow-up|3|||
125055337|NCT00532948|449820717|FG000|Overall Study|Protocol Violation|1|||
125055338|NCT00532948|449820718|FG001|Overall Study|Protocol Violation|0|||
125055339|NCT00532948|449820719|FG002|Overall Study|Protocol Violation|0|||
125055340|NCT00532948|449820717|FG000|Overall Study|Death|3|||
125055341|NCT00532948|449820718|FG001|Overall Study|Death|3|||
125055342|NCT00532948|449820719|FG002|Overall Study|Death|4|||
125055343|NCT00532948|449820717|FG000|Overall Study|Violation of selection criteria at entry|0|||
125055344|NCT00532948|449820718|FG001|Overall Study|Violation of selection criteria at entry|1|||
125055345|NCT00532948|449820719|FG002|Overall Study|Violation of selection criteria at entry|0|||
125055346|NCT00532948|449820717|FG000|Overall Study|Failure to return|0|||
125055347|NCT00532948|449820718|FG001|Overall Study|Failure to return|1|||
125055348|NCT00532948|449820719|FG002|Overall Study|Failure to return|0|||
125055349|NCT01753076|449820720|FG000|Overall Study|Adverse Event|17|||
125055350|NCT01753076|449820721|FG001|Overall Study|Adverse Event|18|||
125055351|NCT01753076|449820720|FG000|Overall Study|Lack of Efficacy|3|||
125055352|NCT01753076|449820721|FG001|Overall Study|Lack of Efficacy|1|||
125055353|NCT01753076|449820720|FG000|Overall Study|Lost to Follow-up|2|||
125136646|NCT02751424|450126325|FG004|Part 2|Adverse Event|0|||
125136647|NCT02751424|450126326|FG005|Part 2|Adverse Event|0|||
125136648|NCT02751424|450126327|FG006|Part 2|Adverse Event|0|||
125136649|NCT02751424|450126328|FG007|Part 2|Adverse Event|5|||
125136650|NCT02751424|450126329|FG008|Part 2|Adverse Event|0|||
125136651|NCT03206749|450126330|FG000|Overall Study|Withdrawal of consent|5|||
125136652|NCT03206749|450126331|FG001|Overall Study|Withdrawal of consent|3|||
125136653|NCT03206749|450126332|FG002|Overall Study|Withdrawal of consent|6|||
125136654|NCT03206749|450126330|FG000|Overall Study|Lost to Follow-up|0|||
125136655|NCT03206749|450126331|FG001|Overall Study|Lost to Follow-up|0|||
125136656|NCT03206749|450126332|FG002|Overall Study|Lost to Follow-up|1|||
125136657|NCT00716625|450126333|FG000|Overall Study|Safety was not Assessable|1|||
125136658|NCT01492439|450126334|FG000|Overall Study|Withdrew from RTE|4|||
125136659|NCT01492439|450126335|FG001|Overall Study|Withdrew from RTE|9|||
125136660|NCT05523895|450126336|FG000|Overall Study|Adverse Event|2|||
125136661|NCT05523895|450126337|FG001|Overall Study|Adverse Event|1|||
125136662|NCT05523895|450126338|FG002|Overall Study|Adverse Event|1|||
125136663|NCT05523895|450126336|FG000|Overall Study|Lost to Follow-up|0|||
125136664|NCT05523895|450126337|FG001|Overall Study|Lost to Follow-up|1|||
125136665|NCT05523895|450126338|FG002|Overall Study|Lost to Follow-up|2|||
125136666|NCT05523895|450126336|FG000|Overall Study|Noncompliance with study drug|1|||
125136667|NCT05523895|450126337|FG001|Overall Study|Noncompliance with study drug|1|||
125136668|NCT05523895|450126338|FG002|Overall Study|Noncompliance with study drug|1|||
125136669|NCT05523895|450126336|FG000|Overall Study|Protocol Violation|0|||
125136670|NCT05523895|450126337|FG001|Overall Study|Protocol Violation|2|||
125055354|NCT01753076|449820721|FG001|Overall Study|Lost to Follow-up|1|||
125055355|NCT01753076|449820720|FG000|Overall Study|Physician Decision|4|||
125055356|NCT01753076|449820721|FG001|Overall Study|Physician Decision|2|||
125136671|NCT05523895|450126338|FG002|Overall Study|Protocol Violation|0|||
125136672|NCT05523895|450126336|FG000|Overall Study|Withdrawal by Subject|1|||
125055357|NCT01753076|449820720|FG000|Overall Study|Withdrawal by Subject|14|||
125136673|NCT05523895|450126337|FG001|Overall Study|Withdrawal by Subject|3|||
125136674|NCT05523895|450126338|FG002|Overall Study|Withdrawal by Subject|1|||
125055358|NCT01753076|449820721|FG001|Overall Study|Withdrawal by Subject|24|||
125136675|NCT05523895|450126336|FG000|Overall Study|Not further specified|0|||
125055359|NCT01753076|449820720|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
125055360|NCT01753076|449820721|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
125055361|NCT02575079|449820722|FG000|Overall Study|Death|3|||
125055362|NCT02575079|449820723|FG001|Overall Study|Death|0|||
125055363|NCT02575079|449820722|FG000|Overall Study|Withdrawal by Subject|3|||
125055364|NCT02575079|449820723|FG001|Overall Study|Withdrawal by Subject|0|||
125055365|NCT02918266|449820724|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
125055366|NCT02918266|449820725|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
125055367|NCT02918266|449820726|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
125055368|NCT02918266|449820727|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
125055369|NCT02918266|449820728|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
125055370|NCT02918266|449820729|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
125055371|NCT02918266|449820730|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
125055372|NCT02918266|449820731|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
125055373|NCT02918266|449820732|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
125055374|NCT02918266|449820733|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
125055375|NCT02918266|449820734|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
125055376|NCT01259856|449820741|FG000|Overall Study|Adverse Event|12|||
125055377|NCT01259856|449820742|FG001|Overall Study|Adverse Event|9|||
125055378|NCT01259856|449820741|FG000|Overall Study|Death|0|||
125055379|NCT01259856|449820742|FG001|Overall Study|Death|1|||
125055380|NCT01259856|449820741|FG000|Overall Study|Lack of Efficacy|3|||
125055381|NCT01259856|449820742|FG001|Overall Study|Lack of Efficacy|1|||
125055382|NCT01259856|449820741|FG000|Overall Study|Lost to Follow-up|1|||
125055383|NCT01259856|449820742|FG001|Overall Study|Lost to Follow-up|1|||
125055384|NCT01259856|449820741|FG000|Overall Study|Physician Decision|2|||
125055385|NCT01259856|449820742|FG001|Overall Study|Physician Decision|1|||
125055386|NCT01259856|449820741|FG000|Overall Study|Withdrawal by Subject|9|||
125055387|NCT01259856|449820742|FG001|Overall Study|Withdrawal by Subject|10|||
125055388|NCT01259856|449820741|FG000|Overall Study|Treatment never started|0|||
125055389|NCT01259856|449820742|FG001|Overall Study|Treatment never started|6|||
125055390|NCT01259856|449820741|FG000|Overall Study|Study closure by sponsor|40|||
125055391|NCT01259856|449820742|FG001|Overall Study|Study closure by sponsor|41|||
125055392|NCT01259856|449820741|FG000|Overall Study|Patient developed other disease|0|||
125055393|NCT01259856|449820742|FG001|Overall Study|Patient developed other disease|1|||
125055394|NCT01259856|449820741|FG000|Overall Study|Transfer to another study|0|||
125055395|NCT01259856|449820742|FG001|Overall Study|Transfer to another study|1|||
125055396|NCT01259856|449820741|FG000|Overall Study|Unknown/missing|2|||
125055397|NCT01259856|449820742|FG001|Overall Study|Unknown/missing|2|||
125055398|NCT00788775|449820743|FG000|Overall Study|Progressive Disease|8|||
125055399|NCT00788775|449820744|FG001|Overall Study|Progressive Disease|6|||
125055400|NCT00788775|449820743|FG000|Overall Study|Withdrawal by Subject|0|||
125055401|NCT00788775|449820744|FG001|Overall Study|Withdrawal by Subject|2|||
125055402|NCT00788775|449820743|FG000|Overall Study|Patient Non-Compliance|1|||
125055403|NCT00788775|449820744|FG001|Overall Study|Patient Non-Compliance|0|||
125055404|NCT00788775|449820743|FG000|Overall Study|Patient's measurable disease resected.|1|||
125055405|NCT00788775|449820744|FG001|Overall Study|Patient's measurable disease resected.|0|||
125055406|NCT01864018|449820752|FG000|Overall Study|Ineligible|3|||
125055407|NCT01864018|449820753|FG001|Overall Study|Ineligible|1|||
125055408|NCT00114972|449820754|FG000|Overall Study|Withdrawal by Subject|40|||
125055409|NCT00114972|449820755|FG001|Overall Study|Withdrawal by Subject|7|||
125055410|NCT00114972|449820754|FG000|Overall Study|Lost to Follow-up|8|||
125055411|NCT00114972|449820755|FG001|Overall Study|Lost to Follow-up|5|||
125055412|NCT01425190|449820757|FG000|Overall Study|Full dose not consumed.|1|||
125055413|NCT01425190|449820758|FG001|Overall Study|Full dose not consumed.|0|||
125055414|NCT01425190|449820759|FG002|Overall Study|Full dose not consumed.|0|||
125055415|NCT01912729|449820760|FG000|Overall Study|Withdrawal by Subject|0|||
125055416|NCT01912729|449820761|FG001|Overall Study|Withdrawal by Subject|1|||
125055417|NCT01952834|449820764|FG000|Overall Study|Adverse Event|1|||
125055418|NCT04285346|449820765|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
125055419|NCT04285346|449820766|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
125055420|NCT04285346|449820765|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
125055421|NCT04285346|449820766|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125055422|NCT04285346|449820765|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
125055423|NCT04285346|449820766|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
125055424|NCT00610935|449820769|FG000|Overall Study|Lost to Follow-up|0|||
125055425|NCT00610935|449820770|FG001|Overall Study|Lost to Follow-up|1|||
125055426|NCT00610935|449820769|FG000|Overall Study|Withdrawal by Subject|0|||
125055427|NCT00610935|449820770|FG001|Overall Study|Withdrawal by Subject|2|||
125055428|NCT00610935|449820769|FG000|Overall Study|Sponsor Discontinuation|1|||
125055429|NCT00610935|449820770|FG001|Overall Study|Sponsor Discontinuation|0|||
125055430|NCT00740779|449820771|FG000|Overall Study|Adverse Event|4|||
125055431|NCT00740779|449820772|FG001|Overall Study|Adverse Event|6|||
125055432|NCT00740779|449820773|FG002|Overall Study|Adverse Event|3|||
125055433|NCT00740779|449820771|FG000|Overall Study|Protocol Violation|1|||
125055434|NCT00740779|449820772|FG001|Overall Study|Protocol Violation|1|||
125055435|NCT00740779|449820773|FG002|Overall Study|Protocol Violation|1|||
125055436|NCT00740779|449820771|FG000|Overall Study|Lack of Efficacy|0|||
125055437|NCT00740779|449820772|FG001|Overall Study|Lack of Efficacy|0|||
125055438|NCT00740779|449820773|FG002|Overall Study|Lack of Efficacy|2|||
125055439|NCT00740779|449820771|FG000|Overall Study|Withdrawal by Subject|2|||
125055440|NCT00740779|449820772|FG001|Overall Study|Withdrawal by Subject|4|||
125055441|NCT00740779|449820773|FG002|Overall Study|Withdrawal by Subject|2|||
125055442|NCT00740779|449820771|FG000|Overall Study|Lost to Follow-up|2|||
125055443|NCT00740779|449820772|FG001|Overall Study|Lost to Follow-up|3|||
125055444|NCT00740779|449820773|FG002|Overall Study|Lost to Follow-up|5|||
125055445|NCT00850460|449820774|FG000|Overall Study|Lost to Follow-up|4|||
125055446|NCT00850460|449820775|FG001|Overall Study|Lost to Follow-up|4|||
125055447|NCT02399813|449820778|FG000|Overall Study|Progressive Disease-Radiographic|2|||
125055448|NCT02399813|449820778|FG000|Overall Study|Death|20|||
125055449|NCT02399813|449820778|FG000|Overall Study|Withdrawal by Subject|3|||
125055450|NCT02399813|449820778|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
125055451|NCT02399813|449820778|FG000|Overall Study|Lost to Follow-up|2|||
125055452|NCT02399813|449820778|FG000|Overall Study|Other than specified|5|||
125055453|NCT00988559|449820779|FG000|Overall Study|Withdrawal by Subject|1|||
125055454|NCT00988559|449820780|FG001|Overall Study|Withdrawal by Subject|1|||
125055455|NCT00988559|449820781|FG002|Overall Study|Withdrawal by Subject|0|||
125055456|NCT00988559|449820782|FG003|Overall Study|Withdrawal by Subject|1|||
125055457|NCT00988559|449820779|FG000|Overall Study|Pregnancy|0|||
125055458|NCT00988559|449820780|FG001|Overall Study|Pregnancy|1|||
125055459|NCT00988559|449820781|FG002|Overall Study|Pregnancy|1|||
125055460|NCT00988559|449820782|FG003|Overall Study|Pregnancy|0|||
125055461|NCT00988559|449820779|FG000|Overall Study|Lost to Follow-up|0|||
125055462|NCT00988559|449820780|FG001|Overall Study|Lost to Follow-up|0|||
125055463|NCT00988559|449820781|FG002|Overall Study|Lost to Follow-up|1|||
125055464|NCT00988559|449820782|FG003|Overall Study|Lost to Follow-up|0|||
125055465|NCT02224846|449820783|FG000|Period 1 (Month 3)|Adverse Event|2|||
125055466|NCT02224846|449820784|FG001|Period 1 (Month 3)|Adverse Event|1|||
125055467|NCT02224846|449820783|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
125055468|NCT02224846|449820784|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
125055469|NCT02224846|449820783|FG000|Period 1 (Month 3)|Protocol Violation|4|||
125055470|NCT02224846|449820784|FG001|Period 1 (Month 3)|Protocol Violation|8|||
125055471|NCT02224846|449820783|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
125055472|NCT02224846|449820784|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
125055473|NCT02224846|449820783|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
125055474|NCT02224846|449820784|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
125055475|NCT02224846|449820783|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
125055476|NCT02224846|449820784|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
125055477|NCT02224846|449820783|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
125055478|NCT02224846|449820784|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
125055479|NCT02224846|449820783|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
125055480|NCT02224846|449820784|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
125055481|NCT02224846|449820783|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
125055482|NCT02224846|449820784|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
125055483|NCT02224846|449820783|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
125055484|NCT02224846|449820784|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
125055485|NCT02224846|449820783|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
125055486|NCT02224846|449820784|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
125055487|NCT02224846|449820783|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
125055488|NCT02224846|449820784|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
125055489|NCT02224846|449820783|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
125055490|NCT02224846|449820784|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
125055491|NCT02224846|449820783|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
125055492|NCT02224846|449820784|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
125055493|NCT02224846|449820783|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
125055494|NCT02224846|449820784|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
125055495|NCT02224846|449820783|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
125055496|NCT02224846|449820784|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
125055497|NCT02224846|449820783|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
125055498|NCT02224846|449820784|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
125055499|NCT02538666|449820787|FG000|Pre-Treatment|Disease progression|1|||
125055500|NCT02538666|449820788|FG001|Pre-Treatment|Disease progression|0|||
125055501|NCT02538666|449820789|FG002|Pre-Treatment|Disease progression|0|||
125055502|NCT02538666|449820787|FG000|Pre-Treatment|no longer meets study criteria|1|||
125055503|NCT02538666|449820788|FG001|Pre-Treatment|no longer meets study criteria|0|||
125055504|NCT02538666|449820789|FG002|Pre-Treatment|no longer meets study criteria|0|||
125055505|NCT02538666|449820787|FG000|Pre-Treatment|Withdrew Consent|0|||
125055506|NCT02538666|449820788|FG001|Pre-Treatment|Withdrew Consent|1|||
125055507|NCT02538666|449820789|FG002|Pre-Treatment|Withdrew Consent|1|||
125055508|NCT02538666|449820787|FG000|Treatment|Disease progression|270|||
125055509|NCT02538666|449820788|FG001|Treatment|Disease progression|227|||
125055510|NCT02538666|449820789|FG002|Treatment|Disease progression|165|||
125055511|NCT02538666|449820787|FG000|Treatment|Study drug toxicity|1|||
125055512|NCT02538666|449820788|FG001|Treatment|Study drug toxicity|29|||
125055513|NCT02538666|449820789|FG002|Treatment|Study drug toxicity|92|||
125055514|NCT02538666|449820787|FG000|Treatment|Death|0|||
125055515|NCT02538666|449820788|FG001|Treatment|Death|2|||
125055516|NCT02538666|449820789|FG002|Treatment|Death|3|||
125055517|NCT02538666|449820787|FG000|Treatment|Adverse event unrelated to study drug|8|||
125055518|NCT02538666|449820788|FG001|Treatment|Adverse event unrelated to study drug|10|||
125055519|NCT02538666|449820789|FG002|Treatment|Adverse event unrelated to study drug|15|||
125055520|NCT02538666|449820787|FG000|Treatment|Participant request to discontinue study treatment|3|||
125055521|NCT02538666|449820788|FG001|Treatment|Participant request to discontinue study treatment|6|||
125055522|NCT02538666|449820789|FG002|Treatment|Participant request to discontinue study treatment|11|||
125055523|NCT02538666|449820787|FG000|Treatment|Participant withdrew consent|2|||
125055524|NCT02538666|449820788|FG001|Treatment|Participant withdrew consent|5|||
125055525|NCT02538666|449820789|FG002|Treatment|Participant withdrew consent|3|||
125055526|NCT02538666|449820787|FG000|Treatment|Lost to Follow-up|0|||
125055527|NCT02538666|449820788|FG001|Treatment|Lost to Follow-up|1|||
125055528|NCT02538666|449820789|FG002|Treatment|Lost to Follow-up|1|||
125055529|NCT02538666|449820787|FG000|Treatment|Maximum clinical benefit|4|||
125055530|NCT02538666|449820788|FG001|Treatment|Maximum clinical benefit|3|||
125055531|NCT02538666|449820789|FG002|Treatment|Maximum clinical benefit|4|||
125055532|NCT02538666|449820787|FG000|Treatment|Poor/non-compliance|0|||
125055533|NCT02538666|449820788|FG001|Treatment|Poor/non-compliance|1|||
125055534|NCT02538666|449820789|FG002|Treatment|Poor/non-compliance|0|||
125055535|NCT02538666|449820787|FG000|Treatment|Participant no longer meets study criteria|0|||
125055536|NCT02538666|449820788|FG001|Treatment|Participant no longer meets study criteria|2|||
125055537|NCT02538666|449820789|FG002|Treatment|Participant no longer meets study criteria|0|||
125055538|NCT02538666|449820787|FG000|Treatment|Administrative reason by sponsor|0|||
125055539|NCT02538666|449820788|FG001|Treatment|Administrative reason by sponsor|0|||
125055540|NCT02538666|449820789|FG002|Treatment|Administrative reason by sponsor|1|||
125055541|NCT02538666|449820787|FG000|Treatment|Other reasons|8|||
125055542|NCT02538666|449820788|FG001|Treatment|Other reasons|15|||
125055543|NCT02538666|449820789|FG002|Treatment|Other reasons|5|||
125055544|NCT02538666|449820787|FG000|Treatment|Not reported|2|||
125055545|NCT02538666|449820788|FG001|Treatment|Not reported|2|||
125136676|NCT05523895|450126337|FG001|Overall Study|Not further specified|3|||
125136677|NCT05523895|450126338|FG002|Overall Study|Not further specified|1|||
125136678|NCT03674892|450126339|FG000|Overall Study|Lack of Efficacy|5|||
125055546|NCT02538666|449820789|FG002|Treatment|Not reported|2|||
125055547|NCT03510663|449820792|FG000|Overall Study|Withdrawal by Subject|0|||
125055548|NCT03510663|449820793|FG001|Overall Study|Withdrawal by Subject|1|||
125055549|NCT03510663|449820794|FG002|Overall Study|Withdrawal by Subject|0|||
125055550|NCT03510663|449820795|FG003|Overall Study|Withdrawal by Subject|0|||
125055551|NCT03510663|449820796|FG004|Overall Study|Withdrawal by Subject|0|||
125055552|NCT03510663|449820797|FG005|Overall Study|Withdrawal by Subject|0|||
125055553|NCT03510663|449820798|FG006|Overall Study|Withdrawal by Subject|0|||
125055554|NCT03510663|449820799|FG007|Overall Study|Withdrawal by Subject|0|||
125055555|NCT01921257|449820803|FG000|Overall Study|Adverse Event|1|||
125055556|NCT01921257|449820803|FG000|Overall Study|Protocol Violation|1|||
125055557|NCT01921257|449820803|FG000|Overall Study|Withdrawal by Subject|1|||
125055558|NCT00777491|449820804|FG000|Overall Study|Protocol Violation|0|||
125055559|NCT00777491|449820805|FG001|Overall Study|Protocol Violation|2|||
125055560|NCT00777491|449820804|FG000|Overall Study|Did not receive any protocol treatment|2|||
125055561|NCT00777491|449820805|FG001|Overall Study|Did not receive any protocol treatment|0|||
125055562|NCT03987620|449820806|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
125055563|NCT03987620|449820807|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
125055564|NCT03987620|449820806|FG000|Overall Study|Adverse Event|3|||
125055565|NCT03987620|449820807|FG001|Overall Study|Adverse Event|0|||
125055566|NCT03987620|449820806|FG000|Overall Study|Lost to Follow-up|1|||
125055567|NCT03987620|449820807|FG001|Overall Study|Lost to Follow-up|2|||
125055568|NCT03987620|449820806|FG000|Overall Study|Physician Decision|0|||
125055569|NCT03987620|449820807|FG001|Overall Study|Physician Decision|1|||
125055570|NCT03987620|449820806|FG000|Overall Study|Pregnancy|1|||
125055571|NCT03987620|449820807|FG001|Overall Study|Pregnancy|0|||
125055572|NCT03987620|449820806|FG000|Overall Study|Withdrawal by Subject|7|||
125055573|NCT03987620|449820807|FG001|Overall Study|Withdrawal by Subject|1|||
125055574|NCT03987620|449820806|FG000|Overall Study|Other|2|||
125055575|NCT03987620|449820807|FG001|Overall Study|Other|5|||
125055576|NCT01745393|449820809|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
125055577|NCT01745393|449820810|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
125055578|NCT01745393|449820809|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
125055579|NCT01745393|449820810|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
125055580|NCT01745393|449820809|FG000|12-month Follow-up|Lost to Follow-up|6|||
125055581|NCT01745393|449820810|FG001|12-month Follow-up|Lost to Follow-up|5|||
125055582|NCT00471445|449820811|FG000|Overall Study|Withdrawal by Subject|1|||
125055583|NCT00471445|449820812|FG001|Overall Study|Withdrawal by Subject|1|||
125055584|NCT00471445|449820811|FG000|Overall Study|Ineligible|1|||
125055585|NCT00471445|449820812|FG001|Overall Study|Ineligible|0|||
125055586|NCT00471445|449820811|FG000|Overall Study|Protocol Violation|0|||
125055587|NCT00471445|449820812|FG001|Overall Study|Protocol Violation|1|||
125055588|NCT03591146|449820815|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
125055589|NCT03591146|449820816|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
125055590|NCT03591146|449820817|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
125055591|NCT03591146|449820818|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
125055592|NCT03591146|449820819|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
125055593|NCT03591146|449820815|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
125055594|NCT03591146|449820816|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
125055595|NCT03591146|449820817|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
125055596|NCT03591146|449820818|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
125055597|NCT03591146|449820819|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
125055598|NCT03591146|449820815|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
125055599|NCT03591146|449820816|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
125055600|NCT03591146|449820817|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
125055601|NCT03591146|449820818|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
125055602|NCT03591146|449820819|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
125055603|NCT03591146|449820815|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
125055604|NCT03591146|449820816|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
125136679|NCT03674892|450126339|FG000|Overall Study|Lost to Follow-up|3|||
125136680|NCT03674892|450126339|FG000|Overall Study|Migraine|2|||
125136681|NCT03674892|450126339|FG000|Overall Study|Excessive Tearing|1|||
125136682|NCT03674892|450126339|FG000|Overall Study|Increased Eye Pain|1|||
125136683|NCT03674892|450126339|FG000|Overall Study|Increased Facial Pain|1|||
125136684|NCT03674892|450126339|FG000|Overall Study|Sinus Irritation|1|||
125136685|NCT03674892|450126339|FG000|Overall Study|Sinus Infection|1|||
125136686|NCT00824291|450126340|FG000|Overall Study|Adverse Event|15|||
125136687|NCT00824291|450126341|FG001|Overall Study|Adverse Event|6|||
125136688|NCT00824291|450126340|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
125136689|NCT00824291|450126341|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
125055605|NCT03591146|449820817|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
125055606|NCT03591146|449820818|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
125055607|NCT03591146|449820819|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
125055608|NCT04737031|449820820|FG000|Overall Study|Patients who did not have a treatment visit|0|||
125055609|NCT04737031|449820821|FG001|Overall Study|Patients who did not have a treatment visit|31|||
125055610|NCT04737031|449820822|FG002|Overall Study|Patients who did not have a treatment visit|93|||
125055611|NCT04737031|449820823|FG003|Overall Study|Patients who did not have a treatment visit|227|||
125136690|NCT00824291|450126340|FG000|Overall Study|Lost to Follow-up|11|||
125136691|NCT00824291|450126341|FG001|Overall Study|Lost to Follow-up|9|||
125136692|NCT00824291|450126340|FG000|Overall Study|Non-compliance|1|||
125136693|NCT00824291|450126341|FG001|Overall Study|Non-compliance|1|||
125055612|NCT01468909|449820824|FG000|Overall Study|Never Treated|2|||
125055613|NCT01468909|449820825|FG001|Overall Study|Never Treated|2|||
125055614|NCT01204658|449820829|FG000|Primary Phase|Adverse Event|0|||
125055615|NCT01204658|449820830|FG001|Primary Phase|Adverse Event|0|||
125055616|NCT01204658|449820831|FG002|Primary Phase|Adverse Event|1|||
125055617|NCT01204658|449820832|FG003|Primary Phase|Adverse Event|0|||
125055618|NCT00905021|449820833|FG000|Overall Study|Adverse Event|2|||
125055619|NCT01511419|449820834|FG000|Dose 2|Physician Decision|1|||
125055620|NCT01511419|449820835|FG001|Dose 2|Physician Decision|0|||
125055621|NCT00786838|449820836|FG000|Overall Study|Physician Decision|4|||
125055622|NCT00786838|449820836|FG000|Overall Study|Death|4|||
125055623|NCT00786838|449820836|FG000|Overall Study|Adverse Event|6|||
125055624|NCT00786838|449820836|FG000|Overall Study|Progressive disease|31|||
125055625|NCT00786838|449820836|FG000|Overall Study|Withdrawal by Subject|4|||
125055626|NCT04594239|449820837|FG000|Overall Study|Withdrawal by Subject|3|||
125055627|NCT04594239|449820838|FG001|Overall Study|Withdrawal by Subject|4|||
125055628|NCT04594239|449820839|FG002|Overall Study|Withdrawal by Subject|2|||
125055629|NCT04594239|449820840|FG003|Overall Study|Withdrawal by Subject|4|||
125055630|NCT04594239|449820837|FG000|Overall Study|Lost to Follow-up|8|||
125055631|NCT04594239|449820838|FG001|Overall Study|Lost to Follow-up|5|||
125055632|NCT04594239|449820839|FG002|Overall Study|Lost to Follow-up|4|||
125055633|NCT04594239|449820840|FG003|Overall Study|Lost to Follow-up|6|||
125055634|NCT04594239|449820837|FG000|Overall Study|Subject relocated|0|||
125055635|NCT04594239|449820838|FG001|Overall Study|Subject relocated|0|||
125055636|NCT04594239|449820839|FG002|Overall Study|Subject relocated|0|||
125055637|NCT04594239|449820840|FG003|Overall Study|Subject relocated|1|||
125055638|NCT03484923|449822202|FG000|Overall Study|Adverse Event|3|||
125055639|NCT03484923|449822203|FG001|Overall Study|Adverse Event|3|||
125055640|NCT03484923|449822204|FG002|Overall Study|Adverse Event|5|||
125055641|NCT03484923|449822205|FG003|Overall Study|Adverse Event|11|||
125055642|NCT03484923|449822206|FG004|Overall Study|Adverse Event|1|||
125055643|NCT03484923|449822202|FG000|Overall Study|Death|2|||
125055644|NCT03484923|449822203|FG001|Overall Study|Death|2|||
125055645|NCT03484923|449822204|FG002|Overall Study|Death|3|||
125055646|NCT03484923|449822205|FG003|Overall Study|Death|0|||
125055647|NCT03484923|449822206|FG004|Overall Study|Death|1|||
125055648|NCT03484923|449822202|FG000|Overall Study|Physician Decision|6|||
125055649|NCT03484923|449822203|FG001|Overall Study|Physician Decision|7|||
125055650|NCT03484923|449822204|FG002|Overall Study|Physician Decision|6|||
125055651|NCT03484923|449822205|FG003|Overall Study|Physician Decision|3|||
125055652|NCT03484923|449822206|FG004|Overall Study|Physician Decision|2|||
125055653|NCT03484923|449822202|FG000|Overall Study|Progressive disease|33|||
125055654|NCT03484923|449822203|FG001|Overall Study|Progressive disease|28|||
125055655|NCT03484923|449822204|FG002|Overall Study|Progressive disease|26|||
125055656|NCT03484923|449822205|FG003|Overall Study|Progressive disease|30|||
125055657|NCT03484923|449822206|FG004|Overall Study|Progressive disease|16|||
125055658|NCT03484923|449822202|FG000|Overall Study|Subject Decision|1|||
125055659|NCT03484923|449822203|FG001|Overall Study|Subject Decision|3|||
125055660|NCT03484923|449822204|FG002|Overall Study|Subject Decision|3|||
125055661|NCT03484923|449822205|FG003|Overall Study|Subject Decision|0|||
125055662|NCT03484923|449822206|FG004|Overall Study|Subject Decision|1|||
125055663|NCT00630812|449822212|FG000|Randomisation to First Dose|Adverse Event|1|||
125055664|NCT00630812|449822213|FG001|Randomisation to First Dose|Adverse Event|1|||
125055665|NCT00630812|449822212|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
125055666|NCT00630812|449822213|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
125055667|NCT00630812|449822212|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
125055668|NCT00630812|449822213|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
125055669|NCT00630812|449822212|FG000|Randomisation to First Dose|Protocol Violation|4|||
125055670|NCT00630812|449822213|FG001|Randomisation to First Dose|Protocol Violation|1|||
125055671|NCT00630812|449822212|FG000|Double Blind Treatment Period|Adverse Event|13|||
125055672|NCT00630812|449822213|FG001|Double Blind Treatment Period|Adverse Event|5|||
125055673|NCT00630812|449822212|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
125055674|NCT00630812|449822213|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
125055675|NCT00630812|449822212|FG000|Double Blind Treatment Period|Physician Decision|2|||
125055676|NCT00630812|449822213|FG001|Double Blind Treatment Period|Physician Decision|1|||
125055677|NCT00630812|449822212|FG000|Double Blind Treatment Period|Protocol Violation|1|||
125055678|NCT00630812|449822213|FG001|Double Blind Treatment Period|Protocol Violation|0|||
125055679|NCT00630812|449822212|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
125055680|NCT00630812|449822213|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
125055681|NCT00630812|449822212|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
125055682|NCT00630812|449822213|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
125055683|NCT00630812|449822212|FG000|Double Blind Treatment Period|Non-compliance|0|||
125055684|NCT00630812|449822213|FG001|Double Blind Treatment Period|Non-compliance|1|||
125136694|NCT00824291|450126340|FG000|Overall Study|Protocol Violation|4|||
125055685|NCT01728584|449822214|FG000|Overall Study|Adverse Event|1|||
125055686|NCT01728584|449822215|FG001|Overall Study|Adverse Event|0|||
125055687|NCT01728584|449822216|FG002|Overall Study|Adverse Event|0|||
125055688|NCT01728584|449822217|FG003|Overall Study|Adverse Event|0|||
125055689|NCT01728584|449822214|FG000|Overall Study|Physician Decision|4|||
125055690|NCT01728584|449822215|FG001|Overall Study|Physician Decision|0|||
125055691|NCT01728584|449822216|FG002|Overall Study|Physician Decision|1|||
125055692|NCT01728584|449822217|FG003|Overall Study|Physician Decision|0|||
125055693|NCT01728584|449822214|FG000|Overall Study|Withdrawal by Subject|1|||
125055694|NCT01728584|449822215|FG001|Overall Study|Withdrawal by Subject|0|||
125055695|NCT01728584|449822216|FG002|Overall Study|Withdrawal by Subject|0|||
125055696|NCT01728584|449822217|FG003|Overall Study|Withdrawal by Subject|0|||
125055697|NCT01728584|449822214|FG000|Overall Study|Screen failure|1|||
125055698|NCT01728584|449822215|FG001|Overall Study|Screen failure|0|||
125055699|NCT01728584|449822216|FG002|Overall Study|Screen failure|0|||
125055700|NCT01728584|449822217|FG003|Overall Study|Screen failure|0|||
125055701|NCT01728584|449822214|FG000|Overall Study|Other reason (not specified)|1|||
125055702|NCT01728584|449822215|FG001|Overall Study|Other reason (not specified)|0|||
125055703|NCT01728584|449822216|FG002|Overall Study|Other reason (not specified)|0|||
125055704|NCT01728584|449822217|FG003|Overall Study|Other reason (not specified)|1|||
125055705|NCT05628181|449822218|FG000|Overall Study|Death|2|||
125055706|NCT05628181|449822219|FG001|Overall Study|Death|4|||
125055707|NCT05628181|449822220|FG002|Overall Study|Death|0|||
125055708|NCT03656926|449822230|FG000|Overall Study|Adverse Event|5|||
125055709|NCT03656926|449822231|FG001|Overall Study|Adverse Event|4|||
125055710|NCT03656926|449822230|FG000|Overall Study|Withdrawal by Subject|7|||
125055711|NCT03656926|449822231|FG001|Overall Study|Withdrawal by Subject|2|||
125055712|NCT03656926|449822230|FG000|Overall Study|Screen fail after randomization|1|||
125055713|NCT03656926|449822231|FG001|Overall Study|Screen fail after randomization|0|||
125055714|NCT03656926|449822230|FG000|Overall Study|PI decision due to patient condition|1|||
125055715|NCT03656926|449822231|FG001|Overall Study|PI decision due to patient condition|0|||
125055716|NCT03656926|449822230|FG000|Overall Study|Patient unresponsiveness|1|||
125055717|NCT03656926|449822231|FG001|Overall Study|Patient unresponsiveness|0|||
125055718|NCT05610176|449822232|FG000|Overall Study|Death|6|||
125055719|NCT00471536|449822233|FG000|Overall Study|Withdrawal by Subject|1|||
125055720|NCT01253044|449822237|FG000|Overall Study|Lost to Follow-up|38|||
125055721|NCT01253044|449822238|FG001|Overall Study|Lost to Follow-up|29|||
125055722|NCT03116399|449822239|FG000|Overall Study|Death|8|||
125055723|NCT03116399|449822240|FG001|Overall Study|Death|3|||
125055724|NCT03116399|449822239|FG000|Overall Study|Lost to Follow-up|7|||
125055725|NCT03116399|449822240|FG001|Overall Study|Lost to Follow-up|11|||
125055726|NCT03116399|449822239|FG000|Overall Study|Investigator Decision|1|||
125055727|NCT03116399|449822240|FG001|Overall Study|Investigator Decision|1|||
125055728|NCT03116399|449822239|FG000|Overall Study|Withdrawal by Subject|24|||
125055729|NCT03116399|449822240|FG001|Overall Study|Withdrawal by Subject|9|||
125055730|NCT00905307|449822241|FG000|Overall Study|Switched to Open Label Rescue|7|||
125055731|NCT00905307|449822242|FG001|Overall Study|Switched to Open Label Rescue|17|||
125055732|NCT00905307|449822243|FG002|Overall Study|Switched to Open Label Rescue|11|||
125055733|NCT00905307|449822244|FG003|Overall Study|Switched to Open Label Rescue|11|||
125055734|NCT00905307|449822245|FG004|Overall Study|Switched to Open Label Rescue|4|||
125055735|NCT00905307|449822246|FG005|Overall Study|Switched to Open Label Rescue|15|||
125055736|NCT00905307|449822241|FG000|Overall Study|Lost to Follow-up|0|||
125055737|NCT00905307|449822242|FG001|Overall Study|Lost to Follow-up|0|||
125055738|NCT00905307|449822243|FG002|Overall Study|Lost to Follow-up|0|||
125055739|NCT00905307|449822244|FG003|Overall Study|Lost to Follow-up|0|||
125055740|NCT00905307|449822245|FG004|Overall Study|Lost to Follow-up|1|||
125055741|NCT00905307|449822246|FG005|Overall Study|Lost to Follow-up|1|||
125055742|NCT00905307|449822241|FG000|Overall Study|Adverse Event|3|||
125055743|NCT00905307|449822242|FG001|Overall Study|Adverse Event|4|||
125055744|NCT00905307|449822243|FG002|Overall Study|Adverse Event|5|||
125055745|NCT00905307|449822244|FG003|Overall Study|Adverse Event|11|||
125055746|NCT00905307|449822245|FG004|Overall Study|Adverse Event|3|||
125055747|NCT00905307|449822246|FG005|Overall Study|Adverse Event|5|||
125055748|NCT00905307|449822241|FG000|Overall Study|Withdrawal by Subject|5|||
125055749|NCT00905307|449822242|FG001|Overall Study|Withdrawal by Subject|13|||
125055750|NCT00905307|449822243|FG002|Overall Study|Withdrawal by Subject|15|||
125055751|NCT00905307|449822244|FG003|Overall Study|Withdrawal by Subject|11|||
125055752|NCT00905307|449822245|FG004|Overall Study|Withdrawal by Subject|4|||
125055753|NCT00905307|449822246|FG005|Overall Study|Withdrawal by Subject|13|||
125055754|NCT00905307|449822241|FG000|Overall Study|Protocol Violation|1|||
125055755|NCT00905307|449822242|FG001|Overall Study|Protocol Violation|0|||
125055756|NCT00905307|449822243|FG002|Overall Study|Protocol Violation|1|||
125055757|NCT00905307|449822244|FG003|Overall Study|Protocol Violation|0|||
125055758|NCT00905307|449822245|FG004|Overall Study|Protocol Violation|0|||
125055759|NCT00905307|449822246|FG005|Overall Study|Protocol Violation|0|||
125055760|NCT00905307|449822241|FG000|Overall Study|Lack of Efficacy|6|||
125055761|NCT00905307|449822242|FG001|Overall Study|Lack of Efficacy|3|||
125055762|NCT00905307|449822243|FG002|Overall Study|Lack of Efficacy|5|||
125055763|NCT00905307|449822244|FG003|Overall Study|Lack of Efficacy|4|||
125055764|NCT00905307|449822245|FG004|Overall Study|Lack of Efficacy|4|||
125055765|NCT00905307|449822246|FG005|Overall Study|Lack of Efficacy|8|||
125055766|NCT03280550|449822249|FG000|Overall Study|Withdrawal by Subject|2|||
125055767|NCT03280550|449822250|FG001|Overall Study|Withdrawal by Subject|2|||
125055768|NCT03280550|449822249|FG000|Overall Study|Physician Decision|0|||
125055769|NCT03280550|449822250|FG001|Overall Study|Physician Decision|1|||
125055770|NCT03345836|449822251|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
125055771|NCT03345836|449822252|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
125055772|NCT03345836|449822253|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
125055773|NCT03345836|449822254|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
125055774|NCT03345836|449822255|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
125055775|NCT03345836|449822256|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
125055776|NCT03345836|449822251|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
125055777|NCT03345836|449822252|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
125055778|NCT03345836|449822253|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
125055779|NCT03345836|449822254|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
125055780|NCT03345836|449822255|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
125055781|NCT03345836|449822256|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
125055782|NCT03345836|449822251|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
125055783|NCT03345836|449822252|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
125055784|NCT03345836|449822253|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
125055785|NCT03345836|449822254|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
125055786|NCT03345836|449822255|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
125055787|NCT03345836|449822256|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
125055788|NCT03345836|449822251|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
125055789|NCT03345836|449822252|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
125055790|NCT03345836|449822253|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
125055791|NCT03345836|449822254|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
125055792|NCT03345836|449822255|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
125055793|NCT03345836|449822256|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
125055794|NCT03345836|449822251|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
125055795|NCT03345836|449822252|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
125055796|NCT03345836|449822253|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
125055797|NCT03345836|449822254|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
125055798|NCT03345836|449822255|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
125055799|NCT03345836|449822256|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
125055800|NCT03345836|449822251|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
125055801|NCT03345836|449822252|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
125055802|NCT03345836|449822253|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
125055803|NCT03345836|449822254|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
125055804|NCT03345836|449822255|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
125055805|NCT03345836|449822256|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
125055806|NCT03345836|449822251|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
125055807|NCT03345836|449822252|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
125055808|NCT03345836|449822253|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
125055809|NCT03345836|449822254|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
125055810|NCT03345836|449822255|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
125055811|NCT03345836|449822256|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
125055812|NCT03345836|449822251|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
125055813|NCT03345836|449822252|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
125055814|NCT03345836|449822253|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
125055815|NCT03345836|449822254|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
125055816|NCT03345836|449822255|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
125055817|NCT03345836|449822256|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
125055818|NCT03345836|449822251|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
125055819|NCT03345836|449822252|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
125136695|NCT00824291|450126341|FG001|Overall Study|Protocol Violation|1|||
125136696|NCT00824291|450126340|FG000|Overall Study|Withdrawal by Subject|14|||
125136697|NCT00824291|450126341|FG001|Overall Study|Withdrawal by Subject|8|||
125136698|NCT00824291|450126340|FG000|Overall Study|Lack of Efficacy|7|||
125136699|NCT00824291|450126341|FG001|Overall Study|Lack of Efficacy|8|||
125055820|NCT03345836|449822253|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
125055821|NCT03345836|449822254|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
125055822|NCT03345836|449822255|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
125055823|NCT03345836|449822256|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
125055824|NCT03345836|449822251|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
125055825|NCT03345836|449822252|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
125055826|NCT03345836|449822253|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
125055827|NCT03345836|449822254|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
125055828|NCT03345836|449822255|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
125055829|NCT03345836|449822256|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
125055830|NCT03345836|449822251|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
125055831|NCT03345836|449822252|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
125055832|NCT03345836|449822253|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
125055833|NCT03345836|449822254|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
125055834|NCT03345836|449822255|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
125055835|NCT03345836|449822256|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
125055836|NCT01555463|449822257|FG000|Treatment|Adverse Event|6|||
125055837|NCT01555463|449822258|FG001|Treatment|Adverse Event|12|||
125055838|NCT01555463|449822257|FG000|Treatment|Withdrawal by Subject|24|||
125055839|NCT01555463|449822258|FG001|Treatment|Withdrawal by Subject|36|||
125055840|NCT01555463|449822257|FG000|Treatment|Lost to Follow-up|28|||
125055841|NCT01555463|449822258|FG001|Treatment|Lost to Follow-up|23|||
125055842|NCT01555463|449822257|FG000|Treatment|Protocol Violation|4|||
125055843|NCT01555463|449822258|FG001|Treatment|Protocol Violation|5|||
125055844|NCT01555463|449822257|FG000|Treatment|Other reason|2|||
125055845|NCT01555463|449822258|FG001|Treatment|Other reason|3|||
125055846|NCT01555463|449822257|FG000|Follow up|Adverse Event|2|||
125055847|NCT01555463|449822258|FG001|Follow up|Adverse Event|5|||
125055848|NCT01555463|449822257|FG000|Follow up|Death|0|||
125055849|NCT01555463|449822258|FG001|Follow up|Death|1|||
125055850|NCT01555463|449822257|FG000|Follow up|Withdrawal by Subject|22|||
125055851|NCT01555463|449822258|FG001|Follow up|Withdrawal by Subject|22|||
125055852|NCT01555463|449822257|FG000|Follow up|Lost to Follow-up|9|||
125055853|NCT01555463|449822258|FG001|Follow up|Lost to Follow-up|10|||
125055854|NCT01555463|449822257|FG000|Follow up|Protocol Violation|2|||
125055855|NCT01555463|449822258|FG001|Follow up|Protocol Violation|4|||
125055856|NCT01555463|449822257|FG000|Follow up|Other reason|3|||
125055857|NCT01555463|449822258|FG001|Follow up|Other reason|3|||
125055858|NCT04370028|449822260|FG000|Overall Study|Withdrawal by Subject|695|||
125055859|NCT04370028|449822260|FG000|Overall Study|Protocol Violation|9|||
125055860|NCT04370028|449822260|FG000|Overall Study|Adverse Event|3|||
125055861|NCT02213198|449822263|FG000|Baseline|No show for intake|7|||
125055862|NCT02213198|449822264|FG001|Baseline|No show for intake|9|||
125055863|NCT02213198|449822263|FG000|Baseline|Withdrawal by Subject|34|||
125055864|NCT02213198|449822264|FG001|Baseline|Withdrawal by Subject|11|||
125055865|NCT02213198|449822263|FG000|Baseline|transferred out of clinic|7|||
125055866|NCT02213198|449822264|FG001|Baseline|transferred out of clinic|9|||
125055867|NCT02213198|449822263|FG000|Baseline|Lost to Follow-up|40|||
125055868|NCT02213198|449822264|FG001|Baseline|Lost to Follow-up|21|||
125055869|NCT02213198|449822263|FG000|Baseline|incarcerated,violent|0|||
125055870|NCT02213198|449822264|FG001|Baseline|incarcerated,violent|1|||
125055871|NCT02213198|449822263|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
125055872|NCT02213198|449822264|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
125055873|NCT02213198|449822263|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
125055874|NCT02213198|449822264|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
125055875|NCT02213198|449822263|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
125055876|NCT02213198|449822264|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
125055877|NCT02213198|449822263|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
125055878|NCT02213198|449822264|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
125055879|NCT02213198|449822263|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
125055880|NCT02213198|449822264|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
125055881|NCT02213198|449822263|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
125055882|NCT02213198|449822264|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
125055883|NCT05091060|449822265|FG000|Overall Study|Lost to Follow-up|1|||
125055884|NCT01798706|449822266|FG000|Overall Study|Adverse Event|15|||
125055885|NCT01798706|449822267|FG001|Overall Study|Adverse Event|10|||
125055886|NCT01798706|449822266|FG000|Overall Study|Lack of Efficacy|0|||
125055887|NCT01798706|449822267|FG001|Overall Study|Lack of Efficacy|2|||
125055888|NCT01798706|449822266|FG000|Overall Study|Poor compliance to protocol|1|||
125055889|NCT01798706|449822267|FG001|Overall Study|Poor compliance to protocol|0|||
125055890|NCT01798706|449822266|FG000|Overall Study|Other than specified above|5|||
125055891|NCT01798706|449822267|FG001|Overall Study|Other than specified above|9|||
125055892|NCT00496873|449822268|FG000|Overall Study|Ineligible|2|||
125055893|NCT00496873|449822268|FG000|Overall Study|Death|2|||
125055894|NCT00496873|449822268|FG000|Overall Study|Withdrawal by Subject|3|||
125055895|NCT05896761|449822271|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
125055896|NCT05896761|449822272|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
125055897|NCT05896761|449822271|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
125055898|NCT05896761|449822272|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
125055899|NCT03552549|449822274|FG000|Overall Study|Disease progression|25|||
125055900|NCT03552549|449822275|FG001|Overall Study|Disease progression|17|||
125055901|NCT03552549|449822274|FG000|Overall Study|Adverse event in first 12 months|12|||
125055902|NCT03552549|449822275|FG001|Overall Study|Adverse event in first 12 months|8|||
125055903|NCT03552549|449822274|FG000|Overall Study|Withdrawal by Subject|7|||
125055904|NCT03552549|449822275|FG001|Overall Study|Withdrawal by Subject|7|||
125055905|NCT03552549|449822274|FG000|Overall Study|Unknown (no reason provided)|4|||
125055906|NCT03552549|449822275|FG001|Overall Study|Unknown (no reason provided)|2|||
125055907|NCT03552549|449822274|FG000|Overall Study|Not in participant's best interest|2|||
125055908|NCT03552549|449822275|FG001|Overall Study|Not in participant's best interest|1|||
125055909|NCT03552549|449822274|FG000|Overall Study|Did not complete study treatment|2|||
125055910|NCT03552549|449822275|FG001|Overall Study|Did not complete study treatment|3|||
125055911|NCT03552549|449822274|FG000|Overall Study|Did not meet eligibility criteria|1|||
125055912|NCT03552549|449822275|FG001|Overall Study|Did not meet eligibility criteria|0|||
125055913|NCT03552549|449822274|FG000|Overall Study|Administrative|0|||
125055914|NCT03552549|449822275|FG001|Overall Study|Administrative|14|||
125055915|NCT02739594|449822281|FG000|Overall Study|Undesired Event|3|||
125055916|NCT02739594|449822282|FG001|Overall Study|Undesired Event|4|||
125055917|NCT02739594|449822281|FG000|Overall Study|Violation of Eligibility Criteria|1|||
125055918|NCT02739594|449822282|FG001|Overall Study|Violation of Eligibility Criteria|2|||
125055919|NCT02739594|449822281|FG000|Overall Study|Protocol Violation|5|||
125055920|NCT02739594|449822282|FG001|Overall Study|Protocol Violation|6|||
125055921|NCT02739594|449822281|FG000|Overall Study|Death|4|||
125055922|NCT02739594|449822282|FG001|Overall Study|Death|2|||
125055923|NCT02739594|449822281|FG000|Overall Study|Renal Insufficiency|4|||
125055924|NCT02739594|449822282|FG001|Overall Study|Renal Insufficiency|6|||
125055925|NCT02739594|449822281|FG000|Overall Study|Administrative Reasons|1|||
125055926|NCT02739594|449822282|FG001|Overall Study|Administrative Reasons|3|||
125055927|NCT02739594|449822281|FG000|Overall Study|Withdrawal by Subject|1|||
125055928|NCT02739594|449822282|FG001|Overall Study|Withdrawal by Subject|1|||
125055929|NCT02739594|449822281|FG000|Overall Study|Lost to Follow-up|0|||
125136700|NCT00824291|450126340|FG000|Overall Study|Participant on prohibited medication|1|||
125136701|NCT00824291|450126341|FG001|Overall Study|Participant on prohibited medication|0|||
125136702|NCT00395694|450126345|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
125055930|NCT02739594|449822282|FG001|Overall Study|Lost to Follow-up|1|||
125055931|NCT02739594|449822281|FG000|Overall Study|Elevated Serum Creatinine|0|||
125055932|NCT02739594|449822282|FG001|Overall Study|Elevated Serum Creatinine|1|||
125055933|NCT02739594|449822281|FG000|Overall Study|Other|6|||
125055934|NCT02739594|449822282|FG001|Overall Study|Other|2|||
125055935|NCT01465178|449822283|FG000|Overall Study|Withdrawal by Subject|1|||
125055936|NCT01465178|449822284|FG001|Overall Study|Withdrawal by Subject|0|||
125055937|NCT00527111|449822287|FG000|Overall Study|Adverse Event|14|||
125055938|NCT00527111|449822288|FG001|Overall Study|Adverse Event|13|||
125055939|NCT00527111|449822287|FG000|Overall Study|Death|0|||
125055940|NCT00527111|449822288|FG001|Overall Study|Death|1|||
125055941|NCT00527111|449822287|FG000|Overall Study|Investigator Request|2|||
125055942|NCT00527111|449822288|FG001|Overall Study|Investigator Request|1|||
125055943|NCT00527111|449822287|FG000|Overall Study|Patient Request|2|||
125055944|NCT00527111|449822288|FG001|Overall Study|Patient Request|5|||
125055945|NCT00527111|449822287|FG000|Overall Study|Other|2|||
125055946|NCT00527111|449822288|FG001|Overall Study|Other|2|||
125055947|NCT03827473|449822291|FG000|Overall Study|Withdrawal by Subject|1|||
125055948|NCT03827473|449822292|FG001|Overall Study|Withdrawal by Subject|0|||
125055949|NCT00875017|449822293|FG000|First Intervention|Withdrawal by Subject|1|||
125055950|NCT00875017|449822294|FG001|First Intervention|Withdrawal by Subject|0|||
125055951|NCT00875017|449822295|FG002|First Intervention|Withdrawal by Subject|1|||
125055952|NCT00875017|449822296|FG003|First Intervention|Withdrawal by Subject|0|||
125055953|NCT00875017|449822297|FG004|First Intervention|Withdrawal by Subject|0|||
125055954|NCT00875017|449822298|FG005|First Intervention|Withdrawal by Subject|0|||
125055955|NCT00875017|449822293|FG000|First Intervention|Adverse Event|0|||
125136703|NCT00395694|450126346|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
125055956|NCT00875017|449822294|FG001|First Intervention|Adverse Event|0|||
125055957|NCT00875017|449822295|FG002|First Intervention|Adverse Event|0|||
125055958|NCT00875017|449822296|FG003|First Intervention|Adverse Event|1|||
125055959|NCT00875017|449822297|FG004|First Intervention|Adverse Event|0|||
125055960|NCT00875017|449822298|FG005|First Intervention|Adverse Event|0|||
125055961|NCT00875017|449822293|FG000|First Intervention|Problems collecting rectal effluent|1|||
125055962|NCT00875017|449822294|FG001|First Intervention|Problems collecting rectal effluent|0|||
125055963|NCT00875017|449822295|FG002|First Intervention|Problems collecting rectal effluent|0|||
125055964|NCT00875017|449822296|FG003|First Intervention|Problems collecting rectal effluent|0|||
125055965|NCT00875017|449822297|FG004|First Intervention|Problems collecting rectal effluent|0|||
125055966|NCT00875017|449822298|FG005|First Intervention|Problems collecting rectal effluent|0|||
125055967|NCT00875017|449822293|FG000|First Intervention|Intolerance to nasogastric tube|0|||
125055968|NCT00875017|449822294|FG001|First Intervention|Intolerance to nasogastric tube|0|||
125055969|NCT00875017|449822295|FG002|First Intervention|Intolerance to nasogastric tube|0|||
125055970|NCT00875017|449822296|FG003|First Intervention|Intolerance to nasogastric tube|0|||
125055971|NCT00875017|449822297|FG004|First Intervention|Intolerance to nasogastric tube|1|||
125055972|NCT00875017|449822298|FG005|First Intervention|Intolerance to nasogastric tube|0|||
125055973|NCT00875017|449822293|FG000|Washout|Problem collecting rectal effluent|0|||
125055974|NCT00875017|449822294|FG001|Washout|Problem collecting rectal effluent|0|||
125055975|NCT00875017|449822295|FG002|Washout|Problem collecting rectal effluent|1|||
125055976|NCT00875017|449822296|FG003|Washout|Problem collecting rectal effluent|0|||
125055977|NCT00875017|449822297|FG004|Washout|Problem collecting rectal effluent|0|||
125055978|NCT00875017|449822298|FG005|Washout|Problem collecting rectal effluent|0|||
125055979|NCT00875017|449822293|FG000|Second Intervention|Adverse Event|0|||
125055980|NCT00875017|449822294|FG001|Second Intervention|Adverse Event|0|||
125055981|NCT00875017|449822295|FG002|Second Intervention|Adverse Event|0|||
125055982|NCT00875017|449822296|FG003|Second Intervention|Adverse Event|1|||
125055983|NCT00875017|449822297|FG004|Second Intervention|Adverse Event|0|||
125055984|NCT00875017|449822298|FG005|Second Intervention|Adverse Event|0|||
125055985|NCT00875017|449822293|FG000|Washout|Problems collecting rectal effluent|0|||
125055986|NCT00875017|449822294|FG001|Washout|Problems collecting rectal effluent|1|||
125136704|NCT00395694|450126345|FG000|Continuation Phase|Adverse Event|1|||
125136705|NCT00395694|450126346|FG001|Continuation Phase|Adverse Event|0|||
125136706|NCT00395694|450126345|FG000|Continuation Phase|Lack of Efficacy|12|||
125136707|NCT00395694|450126346|FG001|Continuation Phase|Lack of Efficacy|11|||
125136708|NCT00395694|450126345|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
125136709|NCT00395694|450126346|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
125136710|NCT00395694|450126345|FG000|Continuation Phase|Poor Compliance|1|||
125136711|NCT00395694|450126346|FG001|Continuation Phase|Poor Compliance|0|||
125136712|NCT00395694|450126345|FG000|Continuation Phase|Withdrawal by Subject|0|||
125055987|NCT00875017|449822295|FG002|Washout|Problems collecting rectal effluent|0|||
125055988|NCT00875017|449822296|FG003|Washout|Problems collecting rectal effluent|0|||
125055989|NCT00875017|449822297|FG004|Washout|Problems collecting rectal effluent|0|||
125055990|NCT00875017|449822298|FG005|Washout|Problems collecting rectal effluent|0|||
125055991|NCT00875017|449822293|FG000|Third Intervention|Adverse Event|0|||
125055992|NCT00875017|449822294|FG001|Third Intervention|Adverse Event|1|||
125055993|NCT00875017|449822295|FG002|Third Intervention|Adverse Event|1|||
125055994|NCT00875017|449822296|FG003|Third Intervention|Adverse Event|0|||
125055995|NCT00875017|449822297|FG004|Third Intervention|Adverse Event|0|||
125055996|NCT00875017|449822298|FG005|Third Intervention|Adverse Event|0|||
125055997|NCT00875017|449822293|FG000|Washout|Withdrawal by Subject|0|||
125055998|NCT00875017|449822294|FG001|Washout|Withdrawal by Subject|0|||
125055999|NCT00875017|449822295|FG002|Washout|Withdrawal by Subject|0|||
125056000|NCT00875017|449822296|FG003|Washout|Withdrawal by Subject|0|||
125056001|NCT00875017|449822297|FG004|Washout|Withdrawal by Subject|1|||
125056002|NCT00875017|449822298|FG005|Washout|Withdrawal by Subject|0|||
125056003|NCT00875017|449822293|FG000|Fourth Intervention|Inability to comply with fasting|0|||
125056004|NCT00875017|449822294|FG001|Fourth Intervention|Inability to comply with fasting|0|||
125056005|NCT00875017|449822295|FG002|Fourth Intervention|Inability to comply with fasting|0|||
125056006|NCT00875017|449822296|FG003|Fourth Intervention|Inability to comply with fasting|0|||
125056007|NCT00875017|449822297|FG004|Fourth Intervention|Inability to comply with fasting|0|||
125056008|NCT00875017|449822298|FG005|Fourth Intervention|Inability to comply with fasting|1|||
125056009|NCT02689219|449822299|FG000|Overall Study|Death|1|||
125056010|NCT02689219|449822300|FG001|Overall Study|Death|1|||
125056011|NCT02689219|449822299|FG000|Overall Study|Disease Progression|10|||
125056012|NCT02689219|449822300|FG001|Overall Study|Disease Progression|6|||
125056013|NCT01477892|449822301|FG000|Overall Study|Withdrawal by Subject|0|||
125056014|NCT01477892|449822302|FG001|Overall Study|Withdrawal by Subject|2|||
125056015|NCT05515601|449822308|FG000|Overall Study|Withdrawal by Subject|1|||
125056016|NCT05515601|449822309|FG001|Overall Study|Withdrawal by Subject|3|||
125056017|NCT05515601|449822310|FG002|Overall Study|Withdrawal by Subject|2|||
125056018|NCT05515601|449822311|FG003|Overall Study|Withdrawal by Subject|1|||
125056019|NCT05515601|449822312|FG004|Overall Study|Withdrawal by Subject|1|||
125136713|NCT00395694|450126346|FG001|Continuation Phase|Withdrawal by Subject|2|||
125136714|NCT01648582|450126347|FG000|Overall Study|Adverse Event|6|||
125056020|NCT05515601|449822313|FG005|Overall Study|Withdrawal by Subject|1|||
125056021|NCT05515601|449822308|FG000|Overall Study|Lost to Follow-up|0|||
125056022|NCT05515601|449822309|FG001|Overall Study|Lost to Follow-up|0|||
125056023|NCT05515601|449822310|FG002|Overall Study|Lost to Follow-up|0|||
125056024|NCT05515601|449822311|FG003|Overall Study|Lost to Follow-up|0|||
125056025|NCT05515601|449822312|FG004|Overall Study|Lost to Follow-up|1|||
125056026|NCT05515601|449822313|FG005|Overall Study|Lost to Follow-up|0|||
125056027|NCT00364845|449822314|FG000|Overall Study|Adverse Event|1|||
125056028|NCT00364845|449822315|FG001|Overall Study|Adverse Event|0|||
125056029|NCT00364845|449822314|FG000|Overall Study|Withdrawal by Subject|2|||
125056030|NCT00364845|449822315|FG001|Overall Study|Withdrawal by Subject|1|||
125056031|NCT00364845|449822314|FG000|Overall Study|Physician Decision|8|||
125056032|NCT00364845|449822315|FG001|Overall Study|Physician Decision|8|||
125056033|NCT00364845|449822314|FG000|Overall Study|Lost to Follow-up|0|||
125056034|NCT00364845|449822315|FG001|Overall Study|Lost to Follow-up|1|||
125056035|NCT00364845|449822314|FG000|Overall Study|Death|0|||
125056036|NCT00364845|449822315|FG001|Overall Study|Death|1|||
125056037|NCT01187901|449822316|FG000|Overall Study|Protocol Violation|1|||
125056038|NCT01187901|449822317|FG001|Overall Study|Protocol Violation|0|||
125056039|NCT01187901|449822316|FG000|Overall Study|Lost to Follow-up|1|||
125056040|NCT01187901|449822317|FG001|Overall Study|Lost to Follow-up|2|||
125056041|NCT01187901|449822316|FG000|Overall Study|Unrelated Health Reasons|1|||
125056042|NCT01187901|449822317|FG001|Overall Study|Unrelated Health Reasons|2|||
125056043|NCT01187901|449822316|FG000|Overall Study|Suspected Allergic Reaction|1|||
125056044|NCT01187901|449822317|FG001|Overall Study|Suspected Allergic Reaction|1|||
125056045|NCT01187901|449822316|FG000|Overall Study|Adverse Event|3|||
125056046|NCT01187901|449822317|FG001|Overall Study|Adverse Event|0|||
125056047|NCT01187901|449822316|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
125056048|NCT01187901|449822317|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
125056049|NCT01187901|449822316|FG000|Overall Study|Pregnancy|0|||
125056050|NCT01187901|449822317|FG001|Overall Study|Pregnancy|2|||
125056051|NCT04160468|449822318|FG000|Overall Study|Lost to Follow-up|19|||
125056052|NCT04160468|449822319|FG001|Overall Study|Lost to Follow-up|4|||
125056053|NCT04160468|449822318|FG000|Overall Study|Randomized but not dosed|6|||
125056054|NCT04160468|449822319|FG001|Overall Study|Randomized but not dosed|0|||
125056055|NCT04160468|449822318|FG000|Overall Study|Withdrawal by Subject|4|||
125056056|NCT04160468|449822319|FG001|Overall Study|Withdrawal by Subject|1|||
125056057|NCT04160468|449822318|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
125056058|NCT04160468|449822319|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
125056059|NCT04160468|449822318|FG000|Overall Study|Participant incarcerated|1|||
125056060|NCT04160468|449822319|FG001|Overall Study|Participant incarcerated|0|||
125056061|NCT01912768|449822320|FG000|Overall Study|Adverse Event|2|||
125056062|NCT01912768|449822321|FG001|Overall Study|Adverse Event|0|||
125056063|NCT01912768|449822320|FG000|Overall Study|Lost to Follow-up|2|||
125056064|NCT01912768|449822321|FG001|Overall Study|Lost to Follow-up|1|||
125056065|NCT01912768|449822320|FG000|Overall Study|Withdrawal by Subject|5|||
125056066|NCT01912768|449822321|FG001|Overall Study|Withdrawal by Subject|3|||
125056067|NCT01912768|449822320|FG000|Overall Study|Randomized in error|1|||
125136715|NCT01648582|450126348|FG001|Overall Study|Adverse Event|11|||
125136716|NCT01648582|450126349|FG002|Overall Study|Adverse Event|2|||
125056068|NCT01912768|449822321|FG001|Overall Study|Randomized in error|0|||
125056069|NCT00540436|449822324|FG000|First 12-Week Treatment Period|Adverse Event|1|||
125056070|NCT00540436|449822324|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
125056071|NCT00540436|449822324|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
125056072|NCT00540436|449822324|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
125056073|NCT03255291|449822325|FG000|Overall Study|Determined to be ineligible|10|||
125056074|NCT03255291|449822326|FG001|Overall Study|Determined to be ineligible|12|||
125056075|NCT03255291|449822327|FG002|Overall Study|Determined to be ineligible|6|||
125056076|NCT03255291|449822328|FG003|Overall Study|Determined to be ineligible|6|||
125056077|NCT03255291|449822329|FG004|Overall Study|Determined to be ineligible|5|||
125136717|NCT01648582|450126347|FG000|Overall Study|Lost to Follow-up|9|||
125136718|NCT01648582|450126348|FG001|Overall Study|Lost to Follow-up|6|||
125220326|NCT00666211|450434423|FG000|Overall Study|Withdrawal by Subject|10|||
125220327|NCT00666211|450434424|FG001|Overall Study|Withdrawal by Subject|13|||
125220328|NCT00666211|450434423|FG000|Overall Study|went off medication, no more pain|1|||
125220329|NCT00666211|450434424|FG001|Overall Study|went off medication, no more pain|0|||
125220330|NCT00666211|450434423|FG000|Overall Study|patient non-compliant|6|||
125220331|NCT00666211|450434424|FG001|Overall Study|patient non-compliant|6|||
125220332|NCT00666211|450434423|FG000|Overall Study|disease progression|1|||
125220333|NCT00666211|450434424|FG001|Overall Study|disease progression|8|||
125220334|NCT00666211|450434423|FG000|Overall Study|Lost to Follow-up|2|||
125220335|NCT00666211|450434424|FG001|Overall Study|Lost to Follow-up|0|||
125220336|NCT00666211|450434423|FG000|Overall Study|toxicity|0|||
125220337|NCT00666211|450434424|FG001|Overall Study|toxicity|2|||
125220338|NCT00666211|450434423|FG000|Overall Study|hospital admission|0|||
125220339|NCT00666211|450434424|FG001|Overall Study|hospital admission|5|||
125220340|NCT00666211|450434423|FG000|Overall Study|Death|0|||
125220341|NCT00666211|450434424|FG001|Overall Study|Death|2|||
125220342|NCT00666211|450434423|FG000|Overall Study|off tx for other complicating disease|0|||
125220343|NCT00666211|450434424|FG001|Overall Study|off tx for other complicating disease|1|||
125220344|NCT00666211|450434423|FG000|Overall Study|Physician Decision|0|||
125220345|NCT00666211|450434424|FG001|Overall Study|Physician Decision|1|||
125220346|NCT02683239|450434425|FG000|Overall Study|Protocol Violation|35|||
125220347|NCT02683239|450434426|FG001|Overall Study|Protocol Violation|23|||
125220348|NCT02683239|450434427|FG002|Overall Study|Protocol Violation|26|||
125220349|NCT02683239|450434428|FG003|Overall Study|Protocol Violation|4|||
125056078|NCT03255291|449822330|FG005|Overall Study|Determined to be ineligible|10|||
125056079|NCT03255291|449822325|FG000|Overall Study|Baseline data collection issues|3|||
125056080|NCT03255291|449822326|FG001|Overall Study|Baseline data collection issues|0|||
125056081|NCT03255291|449822327|FG002|Overall Study|Baseline data collection issues|0|||
125056082|NCT03255291|449822328|FG003|Overall Study|Baseline data collection issues|0|||
125056083|NCT03255291|449822329|FG004|Overall Study|Baseline data collection issues|2|||
125056084|NCT03255291|449822330|FG005|Overall Study|Baseline data collection issues|0|||
125056085|NCT01067508|449822338|FG000|Overall Study|Physician Decision|0|||
125056086|NCT01067508|449822339|FG001|Overall Study|Physician Decision|1|||
125056087|NCT01067508|449822338|FG000|Overall Study|Withdrawal by Subject|0|||
125056088|NCT01067508|449822339|FG001|Overall Study|Withdrawal by Subject|1|||
125056089|NCT00444626|449822340|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
125056090|NCT00444626|449822340|FG000|Initial Treatment Period|Adverse Event|1|||
125056091|NCT00444626|449822340|FG000|Initial Treatment Period|Lost to Follow-up|9|||
125056092|NCT00091390|449822343|FG000|Overall Study|Protocol Violation|1|||
125220350|NCT02683239|450434429|FG004|Overall Study|Protocol Violation|35|||
125220351|NCT02683239|450434430|FG005|Overall Study|Protocol Violation|4|||
125220352|NCT02683239|450434431|FG006|Overall Study|Protocol Violation|5|||
125220353|NCT02683239|450434425|FG000|Overall Study|Adverse Event|64|||
125220354|NCT02683239|450434426|FG001|Overall Study|Adverse Event|39|||
125220355|NCT02683239|450434427|FG002|Overall Study|Adverse Event|42|||
125220356|NCT02683239|450434428|FG003|Overall Study|Adverse Event|16|||
125220357|NCT02683239|450434429|FG004|Overall Study|Adverse Event|189|||
125220358|NCT02683239|450434430|FG005|Overall Study|Adverse Event|9|||
125220359|NCT02683239|450434431|FG006|Overall Study|Adverse Event|9|||
125220360|NCT02683239|450434425|FG000|Overall Study|Physician Decision|38|||
125220361|NCT02683239|450434426|FG001|Overall Study|Physician Decision|19|||
125220362|NCT02683239|450434427|FG002|Overall Study|Physician Decision|14|||
125220363|NCT02683239|450434428|FG003|Overall Study|Physician Decision|73|||
125220364|NCT02683239|450434429|FG004|Overall Study|Physician Decision|143|||
125056093|NCT00091390|449822343|FG000|Overall Study|No protocol treatment|3|||
125056094|NCT03229759|449822344|FG000|Overall Study|Screen Failure|30|||
125056095|NCT00833248|449823801|FG000|Overall Study|Adverse Event|3|||
125056096|NCT00833248|449823802|FG001|Overall Study|Adverse Event|0|||
125056097|NCT00833248|449823801|FG000|Overall Study|Protocol Violation|1|||
125056098|NCT00833248|449823802|FG001|Overall Study|Protocol Violation|2|||
125056099|NCT00833248|449823801|FG000|Overall Study|Withdrawal by Subject|0|||
125056100|NCT00833248|449823802|FG001|Overall Study|Withdrawal by Subject|1|||
125056101|NCT03580382|449823805|FG000|Overall Study|Early Termination of Study|0|||
125056102|NCT03580382|449823806|FG001|Overall Study|Early Termination of Study|3|||
125056103|NCT05619172|449823812|FG000|Safety Cohort 1|Death|7|||
125056104|NCT05619172|449823813|FG001|Safety Cohort 1|Death|0|||
125056105|NCT05619172|449823812|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
125056106|NCT05619172|449823813|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
125056107|NCT05619172|449823812|FG000|Safety Cohort 2|Death|0|||
125056108|NCT05619172|449823813|FG001|Safety Cohort 2|Death|1|||
125056109|NCT05619172|449823812|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
125056110|NCT05619172|449823813|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
125056111|NCT00520676|449823817|FG000|Overall Study|Death|84|||
125056112|NCT00520676|449823818|FG001|Overall Study|Death|81|||
125056113|NCT00520676|449823817|FG000|Overall Study|Lost to Follow-up|6|||
125056114|NCT00520676|449823818|FG001|Overall Study|Lost to Follow-up|10|||
125056115|NCT00520676|449823817|FG000|Overall Study|Physician Decision|4|||
125056116|NCT00520676|449823818|FG001|Overall Study|Physician Decision|1|||
125056117|NCT00520676|449823817|FG000|Overall Study|Withdrawal by Subject|7|||
125056118|NCT00520676|449823818|FG001|Overall Study|Withdrawal by Subject|11|||
125056119|NCT02179515|449823819|FG000|Overall Study|switched to alternative treatment|0|||
125056120|NCT02179515|449823820|FG001|Overall Study|switched to alternative treatment|1|||
125056121|NCT02179515|449823821|FG002|Overall Study|switched to alternative treatment|1|||
125056122|NCT02179515|449823819|FG000|Overall Study|Death|0|||
125056123|NCT02179515|449823820|FG001|Overall Study|Death|1|||
125136719|NCT01648582|450126349|FG002|Overall Study|Lost to Follow-up|8|||
125136720|NCT01648582|450126347|FG000|Overall Study|Protocol Violation|1|||
125136721|NCT01648582|450126348|FG001|Overall Study|Protocol Violation|2|||
125136722|NCT01648582|450126349|FG002|Overall Study|Protocol Violation|1|||
125136723|NCT01648582|450126347|FG000|Overall Study|Withdrawal by Subject|15|||
125136724|NCT01648582|450126348|FG001|Overall Study|Withdrawal by Subject|17|||
125136725|NCT01648582|450126349|FG002|Overall Study|Withdrawal by Subject|17|||
125136726|NCT01648582|450126347|FG000|Overall Study|Physician Decision|0|||
125136727|NCT01648582|450126348|FG001|Overall Study|Physician Decision|1|||
125136728|NCT01648582|450126349|FG002|Overall Study|Physician Decision|3|||
125136729|NCT01648582|450126347|FG000|Overall Study|Death|1|||
125136730|NCT01648582|450126348|FG001|Overall Study|Death|0|||
125136731|NCT01648582|450126349|FG002|Overall Study|Death|0|||
125136732|NCT01648582|450126347|FG000|Overall Study|Sponsor Decision|0|||
125136733|NCT01648582|450126348|FG001|Overall Study|Sponsor Decision|1|||
125136734|NCT01648582|450126349|FG002|Overall Study|Sponsor Decision|1|||
125136735|NCT02699866|450126350|FG000|Overall Study|Withdrawal by Subject|3|||
125136736|NCT02699866|450126350|FG000|Overall Study|Physician Decision|2|||
125136737|NCT02699866|450126350|FG000|Overall Study|Adverse Event|3|||
125136738|NCT01959672|450126351|FG000|Overall Study|Death|1|||
125136739|NCT01058668|450126352|FG000|Double-blind Treatment Phase|Adverse Event|8|||
125136740|NCT01058668|450126353|FG001|Double-blind Treatment Phase|Adverse Event|15|||
125136741|NCT01058668|450126354|FG002|Double-blind Treatment Phase|Adverse Event|25|||
125136742|NCT01058668|450126352|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
125136743|NCT01058668|450126353|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
125136744|NCT01058668|450126354|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
125136745|NCT01058668|450126352|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
125136746|NCT01058668|450126353|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
125136747|NCT01058668|450126354|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
125220365|NCT02683239|450434430|FG005|Overall Study|Physician Decision|14|||
125220366|NCT02683239|450434431|FG006|Overall Study|Physician Decision|15|||
125220367|NCT02683239|450434425|FG000|Overall Study|Withdrawal by Subject|187|||
125220368|NCT02683239|450434426|FG001|Overall Study|Withdrawal by Subject|99|||
125056124|NCT02179515|449823821|FG002|Overall Study|Death|1|||
125056125|NCT02179515|449823819|FG000|Overall Study|refused further treatment|0|||
125056126|NCT02179515|449823820|FG001|Overall Study|refused further treatment|3|||
125056127|NCT02179515|449823821|FG002|Overall Study|refused further treatment|4|||
125136748|NCT01058668|450126352|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
125136749|NCT01058668|450126353|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
125136750|NCT01058668|450126354|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
125136751|NCT01058668|450126352|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
125220369|NCT02683239|450434427|FG002|Overall Study|Withdrawal by Subject|91|||
125220370|NCT02683239|450434428|FG003|Overall Study|Withdrawal by Subject|18|||
125220371|NCT02683239|450434429|FG004|Overall Study|Withdrawal by Subject|248|||
125220372|NCT02683239|450434430|FG005|Overall Study|Withdrawal by Subject|22|||
125220373|NCT02683239|450434431|FG006|Overall Study|Withdrawal by Subject|28|||
125220374|NCT02683239|450434425|FG000|Overall Study|Lost to Follow-up|77|||
125220375|NCT02683239|450434426|FG001|Overall Study|Lost to Follow-up|24|||
125220376|NCT02683239|450434427|FG002|Overall Study|Lost to Follow-up|25|||
125220377|NCT02683239|450434428|FG003|Overall Study|Lost to Follow-up|7|||
125220378|NCT02683239|450434429|FG004|Overall Study|Lost to Follow-up|88|||
125220379|NCT02683239|450434430|FG005|Overall Study|Lost to Follow-up|8|||
125220380|NCT02683239|450434431|FG006|Overall Study|Lost to Follow-up|11|||
125220381|NCT02683239|450434425|FG000|Overall Study|Death|9|||
125220382|NCT02683239|450434426|FG001|Overall Study|Death|5|||
125056128|NCT02179515|449823819|FG000|Overall Study|Disease progression on study|2|||
125056129|NCT02179515|449823820|FG001|Overall Study|Disease progression on study|11|||
125056130|NCT02179515|449823821|FG002|Overall Study|Disease progression on study|8|||
125056131|NCT03439748|449823822|FG000|Overall Study|Withdrawal by Subject|11|||
125136752|NCT01058668|450126353|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
125136753|NCT01058668|450126354|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
125136754|NCT01058668|450126352|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
125136755|NCT01058668|450126353|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
125136756|NCT01058668|450126354|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
125220383|NCT02683239|450434427|FG002|Overall Study|Death|8|||
125220384|NCT02683239|450434428|FG003|Overall Study|Death|0|||
125220385|NCT02683239|450434429|FG004|Overall Study|Death|12|||
125220386|NCT02683239|450434430|FG005|Overall Study|Death|1|||
125220387|NCT02683239|450434431|FG006|Overall Study|Death|0|||
125056132|NCT03439748|449823823|FG001|Overall Study|Withdrawal by Subject|17|||
125056133|NCT05131451|449823824|FG000|Overall Study|Protocol Violation|1|||
125056134|NCT05131451|449823825|FG001|Overall Study|Protocol Violation|0|||
125056135|NCT00782418|449823826|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
125056136|NCT00782418|449823827|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
125056137|NCT00782418|449823828|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
125056138|NCT00782418|449823829|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
125056139|NCT00782418|449823830|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
125056140|NCT00782418|449823831|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
125056141|NCT00782418|449823832|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
125056142|NCT00782418|449823826|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
125056143|NCT00782418|449823827|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
125056144|NCT00782418|449823828|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
125056145|NCT00782418|449823829|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
125056146|NCT00782418|449823830|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
125056147|NCT00782418|449823831|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
125056148|NCT00782418|449823832|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
125056149|NCT01718509|449823833|FG000|Overall Study|Lost to Follow-up|18|||
125056150|NCT01718509|449823834|FG001|Overall Study|Lost to Follow-up|15|||
125056151|NCT01718509|449823833|FG000|Overall Study|Withdrawal by Subject|7|||
125056152|NCT01718509|449823834|FG001|Overall Study|Withdrawal by Subject|13|||
125056153|NCT01718509|449823833|FG000|Overall Study|Adverse Event|5|||
125056154|NCT01718509|449823834|FG001|Overall Study|Adverse Event|7|||
125056155|NCT01718509|449823833|FG000|Overall Study|Other|13|||
125056156|NCT01718509|449823834|FG001|Overall Study|Other|11|||
125056157|NCT01718509|449823833|FG000|Overall Study|Protocol Violation|4|||
125056158|NCT01718509|449823834|FG001|Overall Study|Protocol Violation|2|||
125056159|NCT01718509|449823833|FG000|Overall Study|Lack of Efficacy|1|||
125056160|NCT01718509|449823834|FG001|Overall Study|Lack of Efficacy|0|||
125056161|NCT00643487|449823840|FG000|Overall Study|Technical difficulty|3|||
125056162|NCT00879814|449823842|FG000|Overall Study|Adverse Event|0|||
125056163|NCT00879814|449823843|FG001|Overall Study|Adverse Event|1|||
125056164|NCT00879814|449823844|FG002|Overall Study|Adverse Event|0|||
125056165|NCT00879814|449823845|FG003|Overall Study|Adverse Event|0|||
125056166|NCT00879814|449823842|FG000|Overall Study|Lost to Follow-up|1|||
125056167|NCT00879814|449823843|FG001|Overall Study|Lost to Follow-up|0|||
125056168|NCT00879814|449823844|FG002|Overall Study|Lost to Follow-up|0|||
125056169|NCT00879814|449823845|FG003|Overall Study|Lost to Follow-up|2|||
125056170|NCT00879814|449823842|FG000|Overall Study|Participant Failed to Return|0|||
125056171|NCT00879814|449823843|FG001|Overall Study|Participant Failed to Return|0|||
125056172|NCT00879814|449823844|FG002|Overall Study|Participant Failed to Return|0|||
125056173|NCT00879814|449823845|FG003|Overall Study|Participant Failed to Return|1|||
125056174|NCT00879814|449823842|FG000|Overall Study|Withdrawal by Subject|3|||
125056175|NCT00879814|449823843|FG001|Overall Study|Withdrawal by Subject|1|||
125056176|NCT00879814|449823844|FG002|Overall Study|Withdrawal by Subject|1|||
125056177|NCT00879814|449823845|FG003|Overall Study|Withdrawal by Subject|2|||
125056178|NCT00879814|449823842|FG000|Overall Study|Physician Decision|0|||
125056179|NCT00879814|449823843|FG001|Overall Study|Physician Decision|0|||
125056180|NCT00879814|449823844|FG002|Overall Study|Physician Decision|1|||
125056181|NCT00879814|449823845|FG003|Overall Study|Physician Decision|0|||
125056182|NCT00879814|449823842|FG000|Overall Study|Other|0|||
125056183|NCT00879814|449823843|FG001|Overall Study|Other|0|||
125056184|NCT00879814|449823844|FG002|Overall Study|Other|1|||
125056185|NCT00879814|449823845|FG003|Overall Study|Other|0|||
125056186|NCT00390416|449823856|FG000|Overall Study|Withdrawal by Subject|1|||
125056187|NCT00390416|449823856|FG000|Overall Study|Not treated|3|||
125056188|NCT01219959|449823857|FG000|Overall Study|Adverse Event|6|||
125056189|NCT01219959|449823858|FG001|Overall Study|Adverse Event|14|||
125056190|NCT01219959|449823857|FG000|Overall Study|Physician Decision|0|||
125056191|NCT01219959|449823858|FG001|Overall Study|Physician Decision|4|||
125056192|NCT01219959|449823857|FG000|Overall Study|Withdrawal by Subject|0|||
125056193|NCT01219959|449823858|FG001|Overall Study|Withdrawal by Subject|2|||
125056194|NCT01219959|449823857|FG000|Overall Study|Renal Transplantation|0|||
125056195|NCT01219959|449823858|FG001|Overall Study|Renal Transplantation|3|||
125056196|NCT01219959|449823857|FG000|Overall Study|Other|1|||
125056197|NCT01219959|449823858|FG001|Overall Study|Other|0|||
125056198|NCT02935634|449823859|FG000|Randomization|Participant withdrew consent|0|||
125056199|NCT02935634|449823860|FG001|Randomization|Participant withdrew consent|1|||
125056200|NCT02935634|449823861|FG002|Randomization|Participant withdrew consent|0|||
125056201|NCT02935634|449823862|FG003|Randomization|Participant withdrew consent|0|||
125056202|NCT02935634|449823863|FG004|Randomization|Participant withdrew consent|0|||
125056203|NCT02935634|449823864|FG005|Randomization|Participant withdrew consent|0|||
125056204|NCT02935634|449823859|FG000|Randomization|Death|2|||
125056205|NCT02935634|449823860|FG001|Randomization|Death|1|||
125056206|NCT02935634|449823861|FG002|Randomization|Death|1|||
125056207|NCT02935634|449823862|FG003|Randomization|Death|0|||
125056208|NCT02935634|449823863|FG004|Randomization|Death|0|||
125056209|NCT02935634|449823864|FG005|Randomization|Death|0|||
125056210|NCT02935634|449823859|FG000|Randomization|Other reasons|0|||
125056211|NCT02935634|449823860|FG001|Randomization|Other reasons|2|||
125056212|NCT02935634|449823861|FG002|Randomization|Other reasons|2|||
125056213|NCT02935634|449823862|FG003|Randomization|Other reasons|0|||
125056214|NCT02935634|449823863|FG004|Randomization|Other reasons|0|||
125056215|NCT02935634|449823864|FG005|Randomization|Other reasons|0|||
125056216|NCT02935634|449823859|FG000|Treatment: Track 1|Disease progression|15|||
125056217|NCT02935634|449823860|FG001|Treatment: Track 1|Disease progression|17|||
125056218|NCT02935634|449823861|FG002|Treatment: Track 1|Disease progression|28|||
125056219|NCT02935634|449823862|FG003|Treatment: Track 1|Disease progression|4|||
125056220|NCT02935634|449823863|FG004|Treatment: Track 1|Disease progression|6|||
125056221|NCT02935634|449823864|FG005|Treatment: Track 1|Disease progression|2|||
125056222|NCT02935634|449823859|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
125056223|NCT02935634|449823860|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
125056224|NCT02935634|449823861|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
125056225|NCT02935634|449823862|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
125056226|NCT02935634|449823863|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
125136757|NCT02842853|450126363|FG000|Overall Study|Non-compliance with the protocol|3|||
125136758|NCT02842853|450126364|FG001|Overall Study|Non-compliance with the protocol|7|||
125136759|NCT02842853|450126365|FG002|Overall Study|Non-compliance with the protocol|2|||
125136760|NCT02842853|450126366|FG003|Overall Study|Non-compliance with the protocol|5|||
125136761|NCT02842853|450126363|FG000|Overall Study|Subject met exclusion criteria|0|||
125136762|NCT02842853|450126364|FG001|Overall Study|Subject met exclusion criteria|1|||
125136763|NCT02842853|450126365|FG002|Overall Study|Subject met exclusion criteria|0|||
125136764|NCT02842853|450126366|FG003|Overall Study|Subject met exclusion criteria|0|||
125056227|NCT02935634|449823864|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
125056228|NCT02935634|449823859|FG000|Treatment: Track 1|Lost to Follow-up|1|||
125056229|NCT02935634|449823860|FG001|Treatment: Track 1|Lost to Follow-up|0|||
125056230|NCT02935634|449823861|FG002|Treatment: Track 1|Lost to Follow-up|0|||
125056231|NCT02935634|449823862|FG003|Treatment: Track 1|Lost to Follow-up|0|||
125056232|NCT02935634|449823863|FG004|Treatment: Track 1|Lost to Follow-up|0|||
125056233|NCT02935634|449823864|FG005|Treatment: Track 1|Lost to Follow-up|0|||
125220388|NCT02683239|450434425|FG000|Overall Study|Lack of Efficacy|50|||
125220389|NCT02683239|450434426|FG001|Overall Study|Lack of Efficacy|23|||
125220390|NCT02683239|450434427|FG002|Overall Study|Lack of Efficacy|12|||
125220391|NCT02683239|450434428|FG003|Overall Study|Lack of Efficacy|2|||
125220392|NCT02683239|450434429|FG004|Overall Study|Lack of Efficacy|29|||
125220393|NCT02683239|450434430|FG005|Overall Study|Lack of Efficacy|2|||
125220394|NCT02683239|450434431|FG006|Overall Study|Lack of Efficacy|3|||
125056234|NCT02935634|449823859|FG000|Treatment: Track 1|Study drug toxicity|2|||
125220395|NCT02683239|450434425|FG000|Overall Study|Missing data|0|||
125220396|NCT02683239|450434426|FG001|Overall Study|Missing data|1|||
125220397|NCT02683239|450434427|FG002|Overall Study|Missing data|1|||
125220398|NCT02683239|450434428|FG003|Overall Study|Missing data|0|||
125220399|NCT02683239|450434429|FG004|Overall Study|Missing data|1|||
125056235|NCT02935634|449823860|FG001|Treatment: Track 1|Study drug toxicity|1|||
125056236|NCT02935634|449823861|FG002|Treatment: Track 1|Study drug toxicity|3|||
125056237|NCT02935634|449823862|FG003|Treatment: Track 1|Study drug toxicity|0|||
125056238|NCT02935634|449823863|FG004|Treatment: Track 1|Study drug toxicity|0|||
125056239|NCT02935634|449823864|FG005|Treatment: Track 1|Study drug toxicity|1|||
125056240|NCT02935634|449823859|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
125056241|NCT02935634|449823860|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
125056242|NCT02935634|449823861|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
125056243|NCT02935634|449823862|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
125056244|NCT02935634|449823863|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
125056245|NCT02935634|449823864|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
125056246|NCT02935634|449823859|FG000|Treatment: Track 1|Participant withdrew consent|2|||
125056247|NCT02935634|449823860|FG001|Treatment: Track 1|Participant withdrew consent|0|||
125056248|NCT02935634|449823861|FG002|Treatment: Track 1|Participant withdrew consent|1|||
125056249|NCT02935634|449823862|FG003|Treatment: Track 1|Participant withdrew consent|0|||
125220400|NCT02683239|450434430|FG005|Overall Study|Missing data|0|||
125220401|NCT02683239|450434431|FG006|Overall Study|Missing data|0|||
125220402|NCT02609386|450434434|FG000|Overall Study|Withdrawal by Subject|6|||
125220403|NCT02609386|450434435|FG001|Overall Study|Withdrawal by Subject|1|||
125220404|NCT02609386|450434434|FG000|Overall Study|Lost to Follow-up|3|||
125220405|NCT02609386|450434435|FG001|Overall Study|Lost to Follow-up|5|||
125220406|NCT02609386|450434434|FG000|Overall Study|Death|19|||
125220407|NCT02609386|450434435|FG001|Overall Study|Death|9|||
125220408|NCT02609386|450434434|FG000|Overall Study|Physician Decision|0|||
125220409|NCT02609386|450434435|FG001|Overall Study|Physician Decision|2|||
125220410|NCT04131712|450434436|FG000|Overall Study|COVID related|0|||
125220411|NCT04131712|450434437|FG001|Overall Study|COVID related|0|||
125220412|NCT04131712|450434438|FG002|Overall Study|COVID related|2|||
125220413|NCT04131712|450434439|FG003|Overall Study|COVID related|0|||
125220414|NCT04131712|450434436|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
125220415|NCT04131712|450434437|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
125220416|NCT04131712|450434438|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
125220417|NCT04131712|450434439|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
125220418|NCT00873730|450434440|FG000|Overall Study|Protocol Deviation|5|||
125220419|NCT00873730|450434441|FG001|Overall Study|Protocol Deviation|2|||
125220420|NCT00873730|450434440|FG000|Overall Study|Adverse Event|0|||
125056250|NCT02935634|449823863|FG004|Treatment: Track 1|Participant withdrew consent|1|||
125056251|NCT02935634|449823864|FG005|Treatment: Track 1|Participant withdrew consent|0|||
125056252|NCT02935634|449823859|FG000|Treatment: Track 1|Other reasons|0|||
125056253|NCT02935634|449823860|FG001|Treatment: Track 1|Other reasons|0|||
125056254|NCT02935634|449823861|FG002|Treatment: Track 1|Other reasons|2|||
125056255|NCT02935634|449823862|FG003|Treatment: Track 1|Other reasons|0|||
125056256|NCT02935634|449823863|FG004|Treatment: Track 1|Other reasons|0|||
125056257|NCT02935634|449823864|FG005|Treatment: Track 1|Other reasons|0|||
125056258|NCT02935634|449823859|FG000|Treatment: Track 2|Disease progression|13|||
125056259|NCT02935634|449823860|FG001|Treatment: Track 2|Disease progression|26|||
125056260|NCT02935634|449823861|FG002|Treatment: Track 2|Disease progression|20|||
125056261|NCT02935634|449823862|FG003|Treatment: Track 2|Disease progression|5|||
125056262|NCT02935634|449823863|FG004|Treatment: Track 2|Disease progression|1|||
125056263|NCT02935634|449823864|FG005|Treatment: Track 2|Disease progression|4|||
125056264|NCT02935634|449823859|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
125220421|NCT00873730|450434441|FG001|Overall Study|Adverse Event|2|||
125220422|NCT00873730|450434440|FG000|Overall Study|Withdrawal by Subject|0|||
125220423|NCT00873730|450434441|FG001|Overall Study|Withdrawal by Subject|1|||
125056265|NCT02935634|449823860|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
125056266|NCT02935634|449823861|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
125056267|NCT02935634|449823862|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
125220424|NCT00873730|450434440|FG000|Overall Study|Sponsor decision|1|||
125220425|NCT00873730|450434441|FG001|Overall Study|Sponsor decision|0|||
125056268|NCT02935634|449823863|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
125056269|NCT02935634|449823864|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
125056270|NCT02935634|449823859|FG000|Treatment: Track 2|Study drug toxicity|7|||
125056271|NCT02935634|449823860|FG001|Treatment: Track 2|Study drug toxicity|3|||
125056272|NCT02935634|449823861|FG002|Treatment: Track 2|Study drug toxicity|0|||
125056273|NCT02935634|449823862|FG003|Treatment: Track 2|Study drug toxicity|0|||
125056274|NCT02935634|449823863|FG004|Treatment: Track 2|Study drug toxicity|0|||
125056275|NCT02935634|449823864|FG005|Treatment: Track 2|Study drug toxicity|0|||
125056276|NCT02935634|449823859|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
125056277|NCT02935634|449823860|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
125056278|NCT02935634|449823861|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
125056279|NCT02935634|449823862|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
125056280|NCT02935634|449823863|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
125056281|NCT02935634|449823864|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
125056282|NCT02935634|449823859|FG000|Treatment: Track 2|Participant withdrew consent|0|||
125056283|NCT02935634|449823860|FG001|Treatment: Track 2|Participant withdrew consent|1|||
125056284|NCT02935634|449823861|FG002|Treatment: Track 2|Participant withdrew consent|1|||
125056285|NCT02935634|449823862|FG003|Treatment: Track 2|Participant withdrew consent|0|||
125056286|NCT02935634|449823863|FG004|Treatment: Track 2|Participant withdrew consent|1|||
125056287|NCT02935634|449823864|FG005|Treatment: Track 2|Participant withdrew consent|0|||
125056288|NCT05906732|449823865|FG000|Overall Study|Withdrawal by Subject|1|||
125056289|NCT05906732|449823866|FG001|Overall Study|Withdrawal by Subject|0|||
125056290|NCT05906732|449823867|FG002|Overall Study|Withdrawal by Subject|0|||
125056291|NCT05906732|449823868|FG003|Overall Study|Withdrawal by Subject|0|||
125056292|NCT05906732|449823865|FG000|Overall Study|Physician Decision|2|||
125056293|NCT05906732|449823866|FG001|Overall Study|Physician Decision|4|||
125056294|NCT05906732|449823867|FG002|Overall Study|Physician Decision|0|||
125056295|NCT05906732|449823868|FG003|Overall Study|Physician Decision|0|||
125056296|NCT00506077|449823869|FG000|Treatment Period 1|Adverse Event|2|||
125056297|NCT00506077|449823870|FG001|Treatment Period 1|Adverse Event|1|||
125056298|NCT00506077|449823869|FG000|Treatment Period 1|Lost to Follow-up|0|||
125056299|NCT00506077|449823870|FG001|Treatment Period 1|Lost to Follow-up|2|||
125056300|NCT00506077|449823869|FG000|Treatment Period 1|Withdrawal by Subject|2|||
125056301|NCT00506077|449823870|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125056302|NCT00506077|449823869|FG000|Treatment Period 2|Adverse Event|0|||
125056303|NCT00506077|449823870|FG001|Treatment Period 2|Adverse Event|1|||
125056304|NCT00506077|449823869|FG000|Treatment Period 2|Withdrawal by Subject|1|||
125056305|NCT00506077|449823870|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125056306|NCT01727713|449823874|FG000|Overall Study|Lost to Follow-up|5|||
125056307|NCT01727713|449823874|FG000|Overall Study|Adverse Event|10|||
125056308|NCT01727713|449823874|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
125056309|NCT01727713|449823874|FG000|Overall Study|Withdrawal by Subject|13|||
125056310|NCT01727713|449823874|FG000|Overall Study|Protocol Deviation|2|||
125056311|NCT02651194|449823875|FG000|Overall Study|Lost to Follow-up|3|||
125056312|NCT02651194|449823875|FG000|Overall Study|Other|2|||
125056313|NCT03885726|449823878|FG000|Overall Study|Staffing issues/lost interest|1|||
125056314|NCT03885726|449823878|FG000|Overall Study|Early discharge from hospital|3|||
125056315|NCT01217190|449823879|FG000|Second Dosing|Withdrawal by Subject|0|||
125056316|NCT01217190|449823880|FG001|Second Dosing|Withdrawal by Subject|2|||
125056317|NCT02868216|449823881|FG000|Overall Study|Death|0|||
125056318|NCT02868216|449823882|FG001|Overall Study|Death|1|||
125056319|NCT02868216|449823881|FG000|Overall Study|coronary artery bypass|1|||
125056320|NCT02868216|449823882|FG001|Overall Study|coronary artery bypass|0|||
125056321|NCT02868216|449823881|FG000|Overall Study|Withdrawal by Subject|7|||
125056322|NCT02868216|449823882|FG001|Overall Study|Withdrawal by Subject|5|||
125136765|NCT02842853|450126363|FG000|Overall Study|Withdrawal by Subject|11|||
125136766|NCT02842853|450126364|FG001|Overall Study|Withdrawal by Subject|13|||
125136767|NCT02842853|450126365|FG002|Overall Study|Withdrawal by Subject|9|||
125136768|NCT02842853|450126366|FG003|Overall Study|Withdrawal by Subject|8|||
125056323|NCT02496585|449823883|FG000|Overall Study|Death|3|||
125056324|NCT02496585|449823884|FG001|Overall Study|Death|0|||
125056325|NCT02496585|449823883|FG000|Overall Study|Lost to Follow-up|2|||
125056326|NCT02496585|449823884|FG001|Overall Study|Lost to Follow-up|0|||
125056327|NCT02496585|449823883|FG000|Overall Study|Withdrawal by Subject|1|||
125056328|NCT02496585|449823884|FG001|Overall Study|Withdrawal by Subject|2|||
125056329|NCT02496585|449823883|FG000|Overall Study|Progression of Malignancy|4|||
125136769|NCT02842853|450126363|FG000|Overall Study|Lost to Follow-up|9|||
125136770|NCT02842853|450126364|FG001|Overall Study|Lost to Follow-up|13|||
125056330|NCT02496585|449823884|FG001|Overall Study|Progression of Malignancy|1|||
125136771|NCT02842853|450126365|FG002|Overall Study|Lost to Follow-up|10|||
125056331|NCT01401010|449823888|FG000|Overall Study|Could not interpret assay results|1|||
125056332|NCT01401010|449823889|FG001|Overall Study|Could not interpret assay results|0|||
125136772|NCT02842853|450126366|FG003|Overall Study|Lost to Follow-up|11|||
125136773|NCT04089553|450126367|FG000|Overall Study|Death|1|||
125056333|NCT01975272|449823892|FG000|Overall Study|Excluded after protocol amendment|1|||
125136774|NCT04089553|450126368|FG001|Overall Study|Death|1|||
125136775|NCT04089553|450126367|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
125136776|NCT04089553|450126368|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
125136777|NCT04089553|450126367|FG000|Overall Study|Withdrawal by Subject|3|||
125136778|NCT04089553|450126368|FG001|Overall Study|Withdrawal by Subject|3|||
125136779|NCT04089553|450126367|FG000|Overall Study|Physician Decision|1|||
125136780|NCT04089553|450126368|FG001|Overall Study|Physician Decision|0|||
125136781|NCT04089553|450126367|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
125136782|NCT04089553|450126368|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
125136783|NCT04089553|450126367|FG000|Overall Study|Other|1|||
125136784|NCT04089553|450126368|FG001|Overall Study|Other|0|||
125136785|NCT04089553|450126367|FG000|Overall Study|Adverse Event|1|||
125136786|NCT04089553|450126368|FG001|Overall Study|Adverse Event|1|||
125136787|NCT01403194|450126369|FG000|Overall Study|Screen Failure|2|||
125136788|NCT01403194|450126369|FG000|Overall Study|Lost to Follow-up|8|||
125136789|NCT01808651|450126379|FG000|Study Period 1|Lost to Follow-up|1|||
125136790|NCT01808651|450126380|FG001|Study Period 1|Lost to Follow-up|3|||
125136791|NCT01808651|450126381|FG002|Study Period 1|Lost to Follow-up|0|||
125136792|NCT01808651|450126379|FG000|Study Period 1|Protocol Violation|1|||
125136793|NCT01808651|450126380|FG001|Study Period 1|Protocol Violation|0|||
125136794|NCT01808651|450126381|FG002|Study Period 1|Protocol Violation|1|||
125136795|NCT01808651|450126379|FG000|Study Period 1|Physician Decision|3|||
125136796|NCT01808651|450126380|FG001|Study Period 1|Physician Decision|2|||
125136797|NCT01808651|450126381|FG002|Study Period 1|Physician Decision|0|||
125136798|NCT01808651|450126379|FG000|Study Period 1|Lack of Efficacy|2|||
125136799|NCT01808651|450126380|FG001|Study Period 1|Lack of Efficacy|1|||
125136800|NCT01808651|450126381|FG002|Study Period 1|Lack of Efficacy|0|||
125136801|NCT01808651|450126379|FG000|Study Period 1|Adverse Event|10|||
125136802|NCT01808651|450126380|FG001|Study Period 1|Adverse Event|4|||
125136803|NCT01808651|450126381|FG002|Study Period 1|Adverse Event|1|||
125136804|NCT01808651|450126379|FG000|Study Period 1|Participant Decision|9|||
125136805|NCT01808651|450126380|FG001|Study Period 1|Participant Decision|7|||
125136806|NCT01808651|450126381|FG002|Study Period 1|Participant Decision|3|||
125136807|NCT00608322|450126384|FG000|Overall Study|Death|2|||
125136808|NCT00608322|450126385|FG001|Overall Study|Death|1|||
125136809|NCT00834444|450126386|FG000|First Intervention|Adverse Event|1|||
125136810|NCT00834444|450126387|FG001|First Intervention|Adverse Event|0|||
125136811|NCT00834444|450126386|FG000|First Intervention|Intolerance to Venopuncture|0|||
125136812|NCT00834444|450126387|FG001|First Intervention|Intolerance to Venopuncture|1|||
125136813|NCT00834444|450126386|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
125136814|NCT00834444|450126387|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
125136815|NCT00834444|450126386|FG000|Second Intervention|Adverse Event|1|||
125136816|NCT00834444|450126387|FG001|Second Intervention|Adverse Event|0|||
125136817|NCT03325881|450126390|FG000|Overall Study|Protocol Violation|0|||
125136818|NCT03325881|450126391|FG001|Overall Study|Protocol Violation|1|||
125136819|NCT03325881|450126390|FG000|Overall Study|Withdrawal by Subject|0|||
125136820|NCT03325881|450126391|FG001|Overall Study|Withdrawal by Subject|2|||
125136821|NCT03325881|450126390|FG000|Overall Study|Lack of Efficacy|2|||
125136822|NCT03325881|450126391|FG001|Overall Study|Lack of Efficacy|0|||
125136823|NCT03325881|450126390|FG000|Overall Study|Not treated|1|||
125136824|NCT03325881|450126391|FG001|Overall Study|Not treated|0|||
125136825|NCT00829712|450126396|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
125136826|NCT00829712|450126397|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
125136827|NCT00606281|450126398|FG000|Overall Study|Adverse Event|11|||
125136828|NCT00606281|450126399|FG001|Overall Study|Adverse Event|12|||
125136829|NCT00606281|450126398|FG000|Overall Study|Death|1|||
125136830|NCT00606281|450126399|FG001|Overall Study|Death|0|||
125136831|NCT00606281|450126398|FG000|Overall Study|Lack of Efficacy|28|||
125136832|NCT00606281|450126399|FG001|Overall Study|Lack of Efficacy|35|||
125136833|NCT00606281|450126398|FG000|Overall Study|Physician Decision|0|||
125136834|NCT00606281|450126399|FG001|Overall Study|Physician Decision|1|||
125136835|NCT00606281|450126398|FG000|Overall Study|Protocol Violation|3|||
125220426|NCT02299388|450434444|FG000|Overall Study|Withdrawal by Subject|0|||
125220427|NCT02299388|450434445|FG001|Overall Study|Withdrawal by Subject|1|||
125220428|NCT00103662|450434446|FG000|Overall Study|Entered Rescue Procedure|0|||
125136836|NCT00606281|450126399|FG001|Overall Study|Protocol Violation|3|||
125136837|NCT00606281|450126398|FG000|Overall Study|Withdrawal by Subject|11|||
125136838|NCT00606281|450126399|FG001|Overall Study|Withdrawal by Subject|13|||
125136839|NCT00606281|450126398|FG000|Overall Study|Progression to depressive phase|1|||
125136840|NCT00606281|450126399|FG001|Overall Study|Progression to depressive phase|1|||
125136841|NCT00606281|450126398|FG000|Overall Study|Change of residence or other commitments|1|||
125136842|NCT00606281|450126399|FG001|Overall Study|Change of residence or other commitments|1|||
125136843|NCT02294981|450126400|FG000|Overall Study|Lost to Follow-up|1|||
125220429|NCT00103662|450434447|FG001|Overall Study|Entered Rescue Procedure|7|||
125220430|NCT00103662|450434446|FG000|Overall Study|Death|7|||
125136844|NCT02213263|450126404|FG000|Overall Study|Insufficient clinical response|4|||
125136845|NCT02213263|450126405|FG001|Overall Study|Insufficient clinical response|3|||
125136846|NCT02213263|450126404|FG000|Overall Study|Lost to Follow-up|0|||
125056334|NCT01975272|449823893|FG001|Overall Study|Excluded after protocol amendment|1|||
125056335|NCT01975272|449823894|FG002|Overall Study|Excluded after protocol amendment|2|||
125056336|NCT00515008|449823897|FG000|Overall Study|Lost to Follow-up|1|||
125056337|NCT00515008|449823898|FG001|Overall Study|Lost to Follow-up|0|||
125056338|NCT00515008|449823897|FG000|Overall Study|Declined|0|||
125056339|NCT00515008|449823898|FG001|Overall Study|Declined|3|||
125056340|NCT00515008|449823897|FG000|Overall Study|Left the Boston Area|1|||
125056341|NCT00515008|449823898|FG001|Overall Study|Left the Boston Area|1|||
125056342|NCT00515008|449823897|FG000|Overall Study|Scheduling conflict|1|||
125056343|NCT00515008|449823898|FG001|Overall Study|Scheduling conflict|0|||
125056344|NCT01915849|449823901|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
125056345|NCT01915849|449823902|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
125056346|NCT01915849|449823903|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
125056347|NCT01915849|449823904|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
125056348|NCT01915849|449823901|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
125056349|NCT01915849|449823902|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
125056350|NCT01915849|449823903|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
125056351|NCT01915849|449823904|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
125056352|NCT02775864|449823905|FG000|Overall Study|Data ended end of 2010|1764|||
125056353|NCT02775864|449823906|FG001|Overall Study|Data ended end of 2010|2880|||
125056354|NCT02775864|449823907|FG002|Overall Study|Data ended end of 2010|1140|||
125056355|NCT02775864|449823908|FG003|Overall Study|Data ended end of 2010|1194|||
125056356|NCT02775864|449823905|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
125056357|NCT02775864|449823906|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
125056358|NCT02775864|449823907|FG002|Overall Study|Medicaid eligibility discontinued|720|||
125056359|NCT02775864|449823908|FG003|Overall Study|Medicaid eligibility discontinued|890|||
125056360|NCT03238235|449823909|FG000|Overall Study|Adverse Event|2|||
125056361|NCT03238235|449823910|FG001|Overall Study|Adverse Event|0|||
125056362|NCT03238235|449823909|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
125056363|NCT03238235|449823910|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
125056364|NCT02028338|449823912|FG000|Overall Study|Withdrawal by Subject|3|||
125056365|NCT02028338|449823913|FG001|Overall Study|Withdrawal by Subject|1|||
125056366|NCT02028338|449823912|FG000|Overall Study|Unable to contact participant|1|||
125056367|NCT02028338|449823913|FG001|Overall Study|Unable to contact participant|0|||
125056368|NCT02761993|449823918|FG000|Overall Study|Adverse Event|0|||
125056369|NCT02761993|449823919|FG001|Overall Study|Adverse Event|2|||
125056370|NCT02761993|449823920|FG002|Overall Study|Adverse Event|0|||
125056371|NCT02761993|449823918|FG000|Overall Study|Lost to Follow-up|1|||
125056372|NCT02761993|449823919|FG001|Overall Study|Lost to Follow-up|3|||
125056373|NCT02761993|449823920|FG002|Overall Study|Lost to Follow-up|2|||
125056374|NCT02761993|449823918|FG000|Overall Study|Withdrawal by Subject|1|||
125056375|NCT02761993|449823919|FG001|Overall Study|Withdrawal by Subject|1|||
125056376|NCT02761993|449823920|FG002|Overall Study|Withdrawal by Subject|2|||
125056377|NCT01842620|449823921|FG000|Period 1|Withdrawal by Subject|1|||
125056378|NCT01842620|449823922|FG001|Period 1|Withdrawal by Subject|0|||
125056379|NCT03342469|449823929|FG000|Overall Study|Withdrawal by Subject|0|||
125056380|NCT03342469|449823930|FG001|Overall Study|Withdrawal by Subject|1|||
125056381|NCT03342469|449823931|FG002|Overall Study|Withdrawal by Subject|0|||
125056382|NCT03342469|449823932|FG003|Overall Study|Withdrawal by Subject|0|||
125056383|NCT03050359|449825480|FG000|Overall Study|Randomized But Not Treated|2|||
125056384|NCT03050359|449825481|FG001|Overall Study|Randomized But Not Treated|0|||
125056385|NCT03050359|449825480|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
125056386|NCT03050359|449825481|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
125056387|NCT03050359|449825480|FG000|Overall Study|Significant Protocol Deviation|2|||
125056388|NCT03050359|449825481|FG001|Overall Study|Significant Protocol Deviation|3|||
125056389|NCT03050359|449825480|FG000|Overall Study|Lost to Follow-up|2|||
125056390|NCT03050359|449825481|FG001|Overall Study|Lost to Follow-up|1|||
125056391|NCT03050359|449825480|FG000|Overall Study|Voluntary Withdrawal|4|||
125056392|NCT03050359|449825481|FG001|Overall Study|Voluntary Withdrawal|6|||
125056393|NCT03050359|449825480|FG000|Overall Study|Pregnancy|1|||
125056394|NCT03050359|449825481|FG001|Overall Study|Pregnancy|0|||
125056395|NCT03050359|449825480|FG000|Overall Study|Reason Not Specified|1|||
125056396|NCT03050359|449825481|FG001|Overall Study|Reason Not Specified|0|||
125056397|NCT02614287|449825484|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
125056398|NCT02614287|449825485|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
125056399|NCT02614287|449825484|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
125056400|NCT02614287|449825485|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
125056401|NCT02614287|449825484|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
125056402|NCT02614287|449825485|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
125056403|NCT02614287|449825484|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
125056404|NCT02614287|449825485|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
125056405|NCT02614287|449825484|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
125056406|NCT02614287|449825485|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
125056407|NCT02614287|449825484|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
125056408|NCT02614287|449825485|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
125056409|NCT02614287|449825484|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
125056410|NCT02614287|449825485|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
125056411|NCT02614287|449825484|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
125056412|NCT02614287|449825485|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
125136847|NCT02213263|450126405|FG001|Overall Study|Lost to Follow-up|1|||
125056413|NCT02006667|449825491|FG000|Overall Study|Adverse Event|3|||
125056414|NCT02006667|449825491|FG000|Overall Study|Death|2|||
125056415|NCT02006667|449825491|FG000|Overall Study|Withdrawal by Subject|1|||
125056416|NCT02939937|449825492|FG000|Overall Study|Adverse Event|5|||
125056417|NCT02939937|449825493|FG001|Overall Study|Adverse Event|0|||
125056418|NCT02939937|449825492|FG000|Overall Study|Lost to Follow-up|1|||
125056419|NCT02939937|449825493|FG001|Overall Study|Lost to Follow-up|3|||
125056420|NCT04281030|449825498|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
125056421|NCT04281030|449825499|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
125056422|NCT04281030|449825498|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
125056423|NCT04281030|449825499|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
125056424|NCT01361009|449825500|FG000|Overall Study|Protocol Violation|116|||
125136848|NCT02213263|450126404|FG000|Overall Study|No longer willing to participate|3|||
125136849|NCT02213263|450126405|FG001|Overall Study|No longer willing to participate|4|||
125136850|NCT02213263|450126404|FG000|Overall Study|Progressive disease|20|||
125136851|NCT02213263|450126405|FG001|Overall Study|Progressive disease|14|||
125136852|NCT02213263|450126404|FG000|Overall Study|Protocol Violation|0|||
125136853|NCT02213263|450126405|FG001|Overall Study|Protocol Violation|1|||
125136854|NCT02213263|450126404|FG000|Overall Study|Adverse Event|1|||
125136855|NCT02213263|450126405|FG001|Overall Study|Adverse Event|3|||
125136856|NCT05752721|450126406|FG000|Overall Study|Lost to Follow-up|22|||
125136857|NCT05752721|450126407|FG001|Overall Study|Lost to Follow-up|20|||
125136858|NCT05752721|450126406|FG000|Overall Study|Withdrawal by Subject|15|||
125136859|NCT05752721|450126407|FG001|Overall Study|Withdrawal by Subject|12|||
125136860|NCT01188681|450126408|FG000|Overall Study|bladder cancer|0|||
125136861|NCT01188681|450126409|FG001|Overall Study|bladder cancer|0|||
125136862|NCT01188681|450126410|FG002|Overall Study|bladder cancer|1|||
125136863|NCT01188681|450126411|FG003|Overall Study|bladder cancer|0|||
125136864|NCT01188681|450126408|FG000|Overall Study|Withdrawal by Subject|0|||
125136865|NCT01188681|450126409|FG001|Overall Study|Withdrawal by Subject|0|||
125136866|NCT01188681|450126410|FG002|Overall Study|Withdrawal by Subject|0|||
125136867|NCT01188681|450126411|FG003|Overall Study|Withdrawal by Subject|1|||
125136868|NCT02280863|450126412|FG000|Integrated Platform|Met stopping criteria|0|||
125136869|NCT02280863|450126413|FG001|Integrated Platform|Met stopping criteria|1|||
125136870|NCT03236311|450126414|FG000|Overall Study|Study terminated by sponsor|0|||
125136871|NCT03236311|450126415|FG001|Overall Study|Study terminated by sponsor|2|||
125136872|NCT03236311|450126414|FG000|Overall Study|Adverse Event|0|||
125136873|NCT03236311|450126415|FG001|Overall Study|Adverse Event|1|||
125136874|NCT00909753|450126416|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
125136875|NCT00909753|450126417|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
125136876|NCT00909753|450126416|FG000|Period: Second Intervention|Protocol Violation|1|||
125136877|NCT00909753|450126417|FG001|Period: Second Intervention|Protocol Violation|0|||
125136878|NCT02336074|450126420|FG000|Overall Study|Adverse Event|0|||
125136879|NCT02336074|450126421|FG001|Overall Study|Adverse Event|2|||
125136880|NCT02679729|450126422|FG000|Overall Study|Lost to Follow-up|0|||
125136881|NCT02679729|450126423|FG001|Overall Study|Lost to Follow-up|1|||
125136882|NCT02679729|450126424|FG002|Overall Study|Lost to Follow-up|0|||
125136883|NCT02679729|450126425|FG003|Overall Study|Lost to Follow-up|0|||
125136884|NCT02679729|450126426|FG004|Overall Study|Lost to Follow-up|1|||
125136885|NCT02679729|450126427|FG005|Overall Study|Lost to Follow-up|0|||
125136886|NCT02679729|450126428|FG006|Overall Study|Lost to Follow-up|0|||
125136887|NCT02679729|450126429|FG007|Overall Study|Lost to Follow-up|0|||
125136888|NCT02679729|450126430|FG008|Overall Study|Lost to Follow-up|0|||
125136889|NCT02679729|450126422|FG000|Overall Study|Participant decision|0|||
125136890|NCT02679729|450126423|FG001|Overall Study|Participant decision|1|||
125136891|NCT02679729|450126424|FG002|Overall Study|Participant decision|0|||
125136892|NCT02679729|450126425|FG003|Overall Study|Participant decision|0|||
125136893|NCT02679729|450126426|FG004|Overall Study|Participant decision|0|||
125136894|NCT02679729|450126427|FG005|Overall Study|Participant decision|0|||
125136895|NCT02679729|450126428|FG006|Overall Study|Participant decision|1|||
125136896|NCT02679729|450126429|FG007|Overall Study|Participant decision|0|||
125136897|NCT02679729|450126430|FG008|Overall Study|Participant decision|0|||
125136898|NCT00906399|450126432|FG000|Year 1|Randomized But Not Treated|0|||
125136899|NCT00906399|450126433|FG001|Year 1|Randomized But Not Treated|1|||
125136900|NCT00906399|450126434|FG002|Year 1|Randomized But Not Treated|3|||
125136901|NCT00906399|450126435|FG003|Year 1|Randomized But Not Treated|0|||
125136902|NCT00906399|450126436|FG004|Year 1|Randomized But Not Treated|0|||
125136903|NCT00906399|450126437|FG005|Year 1|Randomized But Not Treated|0|||
125136904|NCT00906399|450126438|FG006|Year 1|Randomized But Not Treated|0|||
125136905|NCT00906399|450126432|FG000|Year 1|Adverse Event|4|||
125136906|NCT00906399|450126433|FG001|Year 1|Adverse Event|22|||
125136907|NCT00906399|450126434|FG002|Year 1|Adverse Event|24|||
125136908|NCT00906399|450126435|FG003|Year 1|Adverse Event|0|||
125136909|NCT00906399|450126436|FG004|Year 1|Adverse Event|0|||
125136910|NCT00906399|450126437|FG005|Year 1|Adverse Event|0|||
125136911|NCT00906399|450126438|FG006|Year 1|Adverse Event|0|||
125136912|NCT00906399|450126432|FG000|Year 1|Lost to Follow-up|4|||
125136913|NCT00906399|450126433|FG001|Year 1|Lost to Follow-up|4|||
125136914|NCT00906399|450126434|FG002|Year 1|Lost to Follow-up|2|||
125136915|NCT00906399|450126435|FG003|Year 1|Lost to Follow-up|0|||
125136916|NCT00906399|450126436|FG004|Year 1|Lost to Follow-up|0|||
125136917|NCT00906399|450126437|FG005|Year 1|Lost to Follow-up|0|||
125136918|NCT00906399|450126438|FG006|Year 1|Lost to Follow-up|0|||
125136919|NCT00906399|450126432|FG000|Year 1|Withdrawal by Subject|30|||
125136920|NCT00906399|450126433|FG001|Year 1|Withdrawal by Subject|32|||
125136921|NCT00906399|450126434|FG002|Year 1|Withdrawal by Subject|36|||
125136922|NCT00906399|450126435|FG003|Year 1|Withdrawal by Subject|0|||
125136923|NCT00906399|450126436|FG004|Year 1|Withdrawal by Subject|0|||
125136924|NCT00906399|450126437|FG005|Year 1|Withdrawal by Subject|0|||
125136925|NCT00906399|450126438|FG006|Year 1|Withdrawal by Subject|0|||
125136926|NCT00906399|450126432|FG000|Year 1|Physician Decision|0|||
125136927|NCT00906399|450126433|FG001|Year 1|Physician Decision|1|||
125136928|NCT00906399|450126434|FG002|Year 1|Physician Decision|3|||
125136929|NCT00906399|450126435|FG003|Year 1|Physician Decision|0|||
125136930|NCT00906399|450126436|FG004|Year 1|Physician Decision|0|||
125136931|NCT00906399|450126437|FG005|Year 1|Physician Decision|0|||
125136932|NCT00906399|450126438|FG006|Year 1|Physician Decision|0|||
125136933|NCT00906399|450126432|FG000|Year 1|Death|2|||
125136934|NCT00906399|450126433|FG001|Year 1|Death|1|||
125136935|NCT00906399|450126434|FG002|Year 1|Death|1|||
125136936|NCT00906399|450126435|FG003|Year 1|Death|0|||
125136937|NCT00906399|450126436|FG004|Year 1|Death|0|||
125136938|NCT00906399|450126437|FG005|Year 1|Death|0|||
125136939|NCT00906399|450126438|FG006|Year 1|Death|0|||
125136940|NCT00906399|450126432|FG000|Year 1|Other|4|||
125136941|NCT00906399|450126433|FG001|Year 1|Other|2|||
125136942|NCT00906399|450126434|FG002|Year 1|Other|7|||
125136943|NCT00906399|450126435|FG003|Year 1|Other|0|||
125056425|NCT01826422|449825501|FG000|Overall Study|Withdrawal by Subject|1|||
125056426|NCT01826422|449825502|FG001|Overall Study|Withdrawal by Subject|3|||
125056427|NCT00450372|449825503|FG000|Overall Study|Physician Decision|1|||
125056428|NCT00115349|449825506|FG000|Overall Study|Study closed due to low enrollment.|11|||
125056429|NCT00115349|449825507|FG001|Overall Study|Study closed due to low enrollment.|9|||
125056430|NCT02116660|449825508|FG000|Overall Study|Deteriorating renal function|0|||
125056431|NCT02116660|449825509|FG001|Overall Study|Deteriorating renal function|1|||
125056432|NCT02116660|449825508|FG000|Overall Study|Adverse Event|1|||
125056433|NCT02116660|449825509|FG001|Overall Study|Adverse Event|1|||
125056434|NCT02116660|449825508|FG000|Overall Study|Withdrawal by Subject|0|||
125056435|NCT02116660|449825509|FG001|Overall Study|Withdrawal by Subject|2|||
125056436|NCT02116660|449825508|FG000|Overall Study|Organization reason|1|||
125056437|NCT02116660|449825509|FG001|Overall Study|Organization reason|0|||
125056438|NCT02750800|449825510|FG000|Overall Study|Adverse Event|18|||
125056439|NCT02750800|449825510|FG000|Overall Study|Lost to Follow-up|12|||
125056440|NCT02750800|449825510|FG000|Overall Study|Investigator decision|53|||
125056441|NCT02750800|449825510|FG000|Overall Study|Patient request|12|||
125056442|NCT02750800|449825510|FG000|Overall Study|Other, not specified|3|||
125056443|NCT03298412|449825511|FG000|Run-in Period|Other, Not Specified|1|||
125056444|NCT03298412|449825511|FG000|Run-in Period|Disease Progression|1|||
125056445|NCT03298412|449825511|FG000|Run-in Period|Ineligibility Determined|1|||
125056446|NCT03298412|449825511|FG000|Run-in Period|Decision by Sponsor|6|||
125056447|NCT05631548|449825512|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
125056448|NCT05631548|449825513|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
125056449|NCT00995345|449825518|FG000|Overall Study|Withdrawal by Subject|4|||
125056450|NCT00995345|449825519|FG001|Overall Study|Withdrawal by Subject|2|||
125056451|NCT00995345|449825520|FG002|Overall Study|Withdrawal by Subject|1|||
125056452|NCT00995345|449825521|FG003|Overall Study|Withdrawal by Subject|3|||
125056453|NCT00995345|449825522|FG004|Overall Study|Withdrawal by Subject|1|||
125056454|NCT00995345|449825518|FG000|Overall Study|Adverse Event|3|||
125056455|NCT00995345|449825519|FG001|Overall Study|Adverse Event|1|||
125056456|NCT00995345|449825520|FG002|Overall Study|Adverse Event|2|||
125056457|NCT00995345|449825521|FG003|Overall Study|Adverse Event|0|||
125056458|NCT00995345|449825522|FG004|Overall Study|Adverse Event|1|||
125056459|NCT00995345|449825518|FG000|Overall Study|Lost to Follow-up|2|||
125136944|NCT00906399|450126436|FG004|Year 1|Other|0|||
125136945|NCT00906399|450126437|FG005|Year 1|Other|0|||
125136946|NCT00906399|450126438|FG006|Year 1|Other|0|||
125136947|NCT00906399|450126432|FG000|Year 2|Adverse Event|0|||
125136948|NCT00906399|450126433|FG001|Year 2|Adverse Event|0|||
125136949|NCT00906399|450126434|FG002|Year 2|Adverse Event|0|||
125056460|NCT00995345|449825519|FG001|Overall Study|Lost to Follow-up|2|||
125056461|NCT00995345|449825520|FG002|Overall Study|Lost to Follow-up|2|||
125056462|NCT00995345|449825521|FG003|Overall Study|Lost to Follow-up|1|||
125056463|NCT00995345|449825522|FG004|Overall Study|Lost to Follow-up|0|||
125056464|NCT00995345|449825518|FG000|Overall Study|all other reasons combined|2|||
125056465|NCT00995345|449825519|FG001|Overall Study|all other reasons combined|2|||
125056466|NCT00995345|449825520|FG002|Overall Study|all other reasons combined|2|||
125056467|NCT00995345|449825521|FG003|Overall Study|all other reasons combined|1|||
125056468|NCT00995345|449825522|FG004|Overall Study|all other reasons combined|3|||
125056469|NCT01860534|449825527|FG000|ROP #1|Needed treatment for ROP|0|||
125056470|NCT01860534|449825528|FG001|ROP #1|Needed treatment for ROP|1|||
125056471|NCT01860534|449825527|FG000|ROP #2|discharged prior to ROP #2|1|||
125056472|NCT01860534|449825528|FG001|ROP #2|discharged prior to ROP #2|0|||
125056473|NCT04891770|449825531|FG000|Overall Study|Withdrew consent|1|||
125056474|NCT04891770|449825532|FG001|Overall Study|Withdrew consent|3|||
125056475|NCT04891770|449825533|FG002|Overall Study|Withdrew consent|0|||
125056476|NCT04891770|449825531|FG000|Overall Study|Enrolled but never treated|0|||
125056477|NCT04891770|449825532|FG001|Overall Study|Enrolled but never treated|0|||
125056478|NCT04891770|449825533|FG002|Overall Study|Enrolled but never treated|1|||
125056479|NCT04891770|449825531|FG000|Overall Study|Investigator's discretion|0|||
125056480|NCT04891770|449825532|FG001|Overall Study|Investigator's discretion|1|||
125056481|NCT04891770|449825533|FG002|Overall Study|Investigator's discretion|0|||
125056482|NCT00195260|449825538|FG000|Part 1: Dose Escalation|Adverse Event|0|||
125056483|NCT00195260|449825539|FG001|Part 1: Dose Escalation|Adverse Event|1|||
125056484|NCT00195260|449825540|FG002|Part 1: Dose Escalation|Adverse Event|0|||
125056485|NCT00195260|449825541|FG003|Part 1: Dose Escalation|Adverse Event|1|||
125056486|NCT00195260|449825542|FG004|Part 1: Dose Escalation|Adverse Event|1|||
125056487|NCT00195260|449825543|FG005|Part 1: Dose Escalation|Adverse Event|0|||
125056488|NCT00195260|449825544|FG006|Part 1: Dose Escalation|Adverse Event|3|||
125056489|NCT00195260|449825545|FG007|Part 1: Dose Escalation|Adverse Event|0|||
125056490|NCT00195260|449825546|FG008|Part 1: Dose Escalation|Adverse Event|0|||
125056491|NCT00195260|449825547|FG009|Part 1: Dose Escalation|Adverse Event|0|||
125056492|NCT00195260|449825548|FG010|Part 1: Dose Escalation|Adverse Event|0|||
125056493|NCT00195260|449825538|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125056494|NCT00195260|449825539|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125056495|NCT00195260|449825540|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125056496|NCT00195260|449825541|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125056497|NCT00195260|449825542|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
125056498|NCT00195260|449825543|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125056499|NCT00195260|449825544|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125056500|NCT00195260|449825545|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
125056501|NCT00195260|449825546|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125056502|NCT00195260|449825547|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125056503|NCT00195260|449825548|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125056504|NCT00195260|449825538|FG000|Part 1: Dose Escalation|Death|0|||
125056505|NCT00195260|449825539|FG001|Part 1: Dose Escalation|Death|0|||
125056506|NCT00195260|449825540|FG002|Part 1: Dose Escalation|Death|0|||
125056507|NCT00195260|449825541|FG003|Part 1: Dose Escalation|Death|0|||
125056508|NCT00195260|449825542|FG004|Part 1: Dose Escalation|Death|0|||
125056509|NCT00195260|449825543|FG005|Part 1: Dose Escalation|Death|0|||
125056510|NCT00195260|449825544|FG006|Part 1: Dose Escalation|Death|0|||
125056511|NCT00195260|449825545|FG007|Part 1: Dose Escalation|Death|1|||
125056512|NCT00195260|449825546|FG008|Part 1: Dose Escalation|Death|0|||
125056513|NCT00195260|449825547|FG009|Part 1: Dose Escalation|Death|0|||
125056514|NCT00195260|449825548|FG010|Part 1: Dose Escalation|Death|0|||
125056515|NCT00195260|449825538|FG000|Part 1: Dose Escalation|Disease Progression|3|||
125056516|NCT00195260|449825539|FG001|Part 1: Dose Escalation|Disease Progression|2|||
125056517|NCT00195260|449825540|FG002|Part 1: Dose Escalation|Disease Progression|5|||
125056518|NCT00195260|449825541|FG003|Part 1: Dose Escalation|Disease Progression|6|||
125056519|NCT00195260|449825542|FG004|Part 1: Dose Escalation|Disease Progression|4|||
125056520|NCT00195260|449825543|FG005|Part 1: Dose Escalation|Disease Progression|6|||
125056521|NCT00195260|449825544|FG006|Part 1: Dose Escalation|Disease Progression|7|||
125056522|NCT00195260|449825545|FG007|Part 1: Dose Escalation|Disease Progression|4|||
125056523|NCT00195260|449825546|FG008|Part 1: Dose Escalation|Disease Progression|0|||
125056524|NCT00195260|449825547|FG009|Part 1: Dose Escalation|Disease Progression|0|||
125056525|NCT00195260|449825548|FG010|Part 1: Dose Escalation|Disease Progression|0|||
125056526|NCT00195260|449825538|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
125056527|NCT00195260|449825539|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
125056528|NCT00195260|449825540|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
125056529|NCT00195260|449825541|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
125056530|NCT00195260|449825542|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
125056531|NCT00195260|449825543|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
125056532|NCT00195260|449825544|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
125136950|NCT00906399|450126435|FG003|Year 2|Adverse Event|9|||
125136951|NCT00906399|450126436|FG004|Year 2|Adverse Event|8|||
125136952|NCT00906399|450126437|FG005|Year 2|Adverse Event|11|||
125136953|NCT00906399|450126438|FG006|Year 2|Adverse Event|6|||
125136954|NCT00906399|450126432|FG000|Year 2|Lost to Follow-up|0|||
125136955|NCT00906399|450126433|FG001|Year 2|Lost to Follow-up|0|||
125136956|NCT00906399|450126434|FG002|Year 2|Lost to Follow-up|0|||
125136957|NCT00906399|450126435|FG003|Year 2|Lost to Follow-up|1|||
125136958|NCT00906399|450126436|FG004|Year 2|Lost to Follow-up|4|||
125136959|NCT00906399|450126437|FG005|Year 2|Lost to Follow-up|2|||
125136960|NCT00906399|450126438|FG006|Year 2|Lost to Follow-up|4|||
125136961|NCT00906399|450126432|FG000|Year 2|Withdrawal by Subject|0|||
125136962|NCT00906399|450126433|FG001|Year 2|Withdrawal by Subject|0|||
125220431|NCT00103662|450434447|FG001|Overall Study|Death|7|||
125220432|NCT00103662|450434446|FG000|Overall Study|Elective Withdrawal|5|||
125220433|NCT00103662|450434447|FG001|Overall Study|Elective Withdrawal|5|||
125220434|NCT00103662|450434446|FG000|Overall Study|Lost to Follow-up|0|||
125220435|NCT00103662|450434447|FG001|Overall Study|Lost to Follow-up|1|||
125220436|NCT00103662|450434446|FG000|Overall Study|Other|6|||
125220437|NCT00103662|450434447|FG001|Overall Study|Other|9|||
125220438|NCT00103662|450434446|FG000|Overall Study|Failed mobilization|0|||
125220439|NCT00103662|450434447|FG001|Overall Study|Failed mobilization|4|||
125220440|NCT00103662|450434446|FG000|Overall Study|Intercurrent illness|1|||
125056533|NCT00195260|449825545|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
125056534|NCT00195260|449825546|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
125056535|NCT00195260|449825547|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
125056536|NCT00195260|449825548|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
125056537|NCT00195260|449825538|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
125056538|NCT00195260|449825539|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
125056539|NCT00195260|449825540|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
125056540|NCT00195260|449825541|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
125056541|NCT00195260|449825542|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
125220441|NCT00103662|450434447|FG001|Overall Study|Intercurrent illness|0|||
125220442|NCT03334188|450434451|FG000|Overall Study|Withdrawal by Subject|0|||
125220443|NCT03334188|450434452|FG001|Overall Study|Withdrawal by Subject|1|||
125220444|NCT03334188|450434451|FG000|Overall Study|Death|1|||
125220445|NCT03334188|450434452|FG001|Overall Study|Death|0|||
125220446|NCT03334188|450434451|FG000|Overall Study|Never had qualifying clinic visit|7|||
125220447|NCT03334188|450434452|FG001|Overall Study|Never had qualifying clinic visit|7|||
125220448|NCT03373760|450434453|FG000|Overall Study|Adverse Event|8|||
125220449|NCT03373760|450434453|FG000|Overall Study|Disease Progression|46|||
125220450|NCT03373760|450434453|FG000|Overall Study|Death|4|||
125220451|NCT01093586|450434456|FG000|Overall Study|Failed to engraft|3|||
125220452|NCT00105989|450434457|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
125220453|NCT00105989|450434458|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
125220454|NCT00105989|450434457|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
125220455|NCT00105989|450434458|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
125220456|NCT00105989|450434457|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
125220457|NCT00105989|450434458|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
125056542|NCT00195260|449825543|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
125056543|NCT00195260|449825544|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
125056544|NCT00195260|449825545|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
125136963|NCT00906399|450126434|FG002|Year 2|Withdrawal by Subject|0|||
125136964|NCT00906399|450126435|FG003|Year 2|Withdrawal by Subject|17|||
125136965|NCT00906399|450126436|FG004|Year 2|Withdrawal by Subject|18|||
125220458|NCT00105989|450434457|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
125220459|NCT00105989|450434458|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
125136966|NCT00906399|450126437|FG005|Year 2|Withdrawal by Subject|27|||
125220460|NCT00105989|450434457|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
125220461|NCT00105989|450434458|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
125056545|NCT00195260|449825546|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
125136967|NCT00906399|450126438|FG006|Year 2|Withdrawal by Subject|13|||
125136968|NCT00906399|450126432|FG000|Year 2|Physician Decision|0|||
125136969|NCT00906399|450126433|FG001|Year 2|Physician Decision|0|||
125136970|NCT00906399|450126434|FG002|Year 2|Physician Decision|0|||
125136971|NCT00906399|450126435|FG003|Year 2|Physician Decision|0|||
125136972|NCT00906399|450126436|FG004|Year 2|Physician Decision|2|||
125220462|NCT00105989|450434457|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
125056546|NCT00195260|449825547|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
125056547|NCT00195260|449825548|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
125056548|NCT00195260|449825538|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
125056549|NCT00195260|449825539|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
125056550|NCT00195260|449825540|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
125056551|NCT00195260|449825541|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
125056552|NCT00195260|449825542|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
125056553|NCT00195260|449825543|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
125056554|NCT00195260|449825544|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
125056555|NCT00195260|449825545|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
125056556|NCT00195260|449825546|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
125056557|NCT00195260|449825547|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
125056558|NCT00195260|449825548|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
125056559|NCT00195260|449825538|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
125056560|NCT00195260|449825539|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
125056561|NCT00195260|449825540|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
125056562|NCT00195260|449825541|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
125056563|NCT00195260|449825542|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
125056564|NCT00195260|449825543|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
125056565|NCT00195260|449825544|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
125056566|NCT00195260|449825545|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
125056567|NCT00195260|449825546|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
125056568|NCT00195260|449825547|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
125056569|NCT00195260|449825548|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
125056570|NCT00195260|449825538|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
125056571|NCT00195260|449825539|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
125056572|NCT00195260|449825540|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
125056573|NCT00195260|449825541|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
125056574|NCT00195260|449825542|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
125056575|NCT00195260|449825543|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
125056576|NCT00195260|449825544|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
125056577|NCT00195260|449825545|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
125056578|NCT00195260|449825546|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
125056579|NCT00195260|449825547|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
125056580|NCT00195260|449825548|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
125056581|NCT04360187|449825555|FG000|Double-Blind Treatment|Adverse Event|9|||
125056582|NCT04360187|449825556|FG001|Double-Blind Treatment|Adverse Event|11|||
125056583|NCT04360187|449825555|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
125056584|NCT04360187|449825556|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
125056585|NCT04360187|449825555|FG000|Double-Blind Treatment|Physician Decision|1|||
125056586|NCT04360187|449825556|FG001|Double-Blind Treatment|Physician Decision|0|||
125056587|NCT04360187|449825555|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
125056588|NCT04360187|449825556|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
125056589|NCT04360187|449825555|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
125056590|NCT04360187|449825556|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
125056591|NCT04360187|449825555|FG000|Follow-Up|Lost to Follow-up|1|||
125056592|NCT04360187|449825556|FG001|Follow-Up|Lost to Follow-up|0|||
125056593|NCT00222729|449825560|FG000|Overall Study|Adverse Event|3|||
125056594|NCT01318083|449825561|FG000|Overall Study|Adverse Event|4|||
125056595|NCT01318083|449825562|FG001|Overall Study|Adverse Event|1|||
125056596|NCT01318083|449825563|FG002|Overall Study|Adverse Event|2|||
125056597|NCT01318083|449825561|FG000|Overall Study|Withdrawal by Subject|1|||
125056598|NCT01318083|449825562|FG001|Overall Study|Withdrawal by Subject|0|||
125056599|NCT01318083|449825563|FG002|Overall Study|Withdrawal by Subject|2|||
125056600|NCT01318083|449825561|FG000|Overall Study|Lack of Efficacy|0|||
125056601|NCT01318083|449825562|FG001|Overall Study|Lack of Efficacy|0|||
125056602|NCT01318083|449825563|FG002|Overall Study|Lack of Efficacy|1|||
125056603|NCT01318083|449825561|FG000|Overall Study|Treatment Complications|1|||
125056604|NCT01318083|449825562|FG001|Overall Study|Treatment Complications|0|||
125056605|NCT01318083|449825563|FG002|Overall Study|Treatment Complications|0|||
125056606|NCT01318083|449825561|FG000|Overall Study|Lack of Study Medication Compliance|0|||
125056607|NCT01318083|449825562|FG001|Overall Study|Lack of Study Medication Compliance|1|||
125056608|NCT01318083|449825563|FG002|Overall Study|Lack of Study Medication Compliance|0|||
125056609|NCT00256867|449825564|FG000|Overall Study|Adverse Event|0|||
125220463|NCT00105989|450434458|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
125220464|NCT00105989|450434457|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
125056610|NCT00256867|449825565|FG001|Overall Study|Adverse Event|1|||
125136973|NCT00906399|450126437|FG005|Year 2|Physician Decision|6|||
125136974|NCT00906399|450126438|FG006|Year 2|Physician Decision|3|||
125136975|NCT00906399|450126432|FG000|Year 2|Death|0|||
125136976|NCT00906399|450126433|FG001|Year 2|Death|0|||
125136977|NCT00906399|450126434|FG002|Year 2|Death|0|||
125136978|NCT00906399|450126435|FG003|Year 2|Death|1|||
125136979|NCT00906399|450126436|FG004|Year 2|Death|0|||
125136980|NCT00906399|450126437|FG005|Year 2|Death|0|||
125136981|NCT00906399|450126438|FG006|Year 2|Death|3|||
125136982|NCT00906399|450126432|FG000|Year 2|Other|0|||
125136983|NCT00906399|450126433|FG001|Year 2|Other|0|||
125136984|NCT00906399|450126434|FG002|Year 2|Other|0|||
125136985|NCT00906399|450126435|FG003|Year 2|Other|2|||
125136986|NCT00906399|450126436|FG004|Year 2|Other|3|||
125136987|NCT00906399|450126437|FG005|Year 2|Other|1|||
125136988|NCT00906399|450126438|FG006|Year 2|Other|0|||
125220465|NCT00105989|450434458|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
125056611|NCT00256867|449825566|FG002|Overall Study|Adverse Event|1|||
125056612|NCT00256867|449825567|FG003|Overall Study|Adverse Event|1|||
125056613|NCT00256867|449825568|FG004|Overall Study|Adverse Event|2|||
125056614|NCT00256867|449825569|FG005|Overall Study|Adverse Event|2|||
125056615|NCT00256867|449825570|FG006|Overall Study|Adverse Event|1|||
125056616|NCT00256867|449825571|FG007|Overall Study|Adverse Event|4|||
125056617|NCT00256867|449825564|FG000|Overall Study|Lost to Follow-up|2|||
125056618|NCT00256867|449825565|FG001|Overall Study|Lost to Follow-up|2|||
125056619|NCT00256867|449825566|FG002|Overall Study|Lost to Follow-up|2|||
125056620|NCT00256867|449825567|FG003|Overall Study|Lost to Follow-up|3|||
125056621|NCT00256867|449825568|FG004|Overall Study|Lost to Follow-up|2|||
125056622|NCT00256867|449825569|FG005|Overall Study|Lost to Follow-up|0|||
125056623|NCT00256867|449825570|FG006|Overall Study|Lost to Follow-up|1|||
125056624|NCT00256867|449825571|FG007|Overall Study|Lost to Follow-up|2|||
125056625|NCT00256867|449825564|FG000|Overall Study|Protocol Violation|0|||
125056626|NCT00256867|449825565|FG001|Overall Study|Protocol Violation|0|||
125056627|NCT00256867|449825566|FG002|Overall Study|Protocol Violation|0|||
125056628|NCT00256867|449825567|FG003|Overall Study|Protocol Violation|1|||
125056629|NCT00256867|449825568|FG004|Overall Study|Protocol Violation|0|||
125056630|NCT00256867|449825569|FG005|Overall Study|Protocol Violation|1|||
125056631|NCT00256867|449825570|FG006|Overall Study|Protocol Violation|0|||
125056632|NCT00256867|449825571|FG007|Overall Study|Protocol Violation|1|||
125056633|NCT00256867|449825564|FG000|Overall Study|Withdrawal by Subject|0|||
125056634|NCT00256867|449825565|FG001|Overall Study|Withdrawal by Subject|0|||
125056635|NCT00256867|449825566|FG002|Overall Study|Withdrawal by Subject|1|||
125056636|NCT00256867|449825567|FG003|Overall Study|Withdrawal by Subject|1|||
125056637|NCT00256867|449825568|FG004|Overall Study|Withdrawal by Subject|2|||
125056638|NCT00256867|449825569|FG005|Overall Study|Withdrawal by Subject|2|||
125056639|NCT00256867|449825570|FG006|Overall Study|Withdrawal by Subject|3|||
125056640|NCT00256867|449825571|FG007|Overall Study|Withdrawal by Subject|2|||
125136989|NCT00574847|450126444|FG000|Overall Study|Adverse Event|2|||
125220466|NCT00105989|450434457|FG000|Acute - Open Label: Week 0-10|Death|1|||
125220467|NCT00105989|450434458|FG001|Acute - Open Label: Week 0-10|Death|0|||
125220468|NCT00105989|450434457|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
125220469|NCT00105989|450434458|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
125220470|NCT00105989|450434457|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
125220471|NCT00105989|450434458|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
125220472|NCT00105989|450434457|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
125220473|NCT00105989|450434458|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
125220474|NCT00105989|450434457|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
125220475|NCT00105989|450434458|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
125056641|NCT00256867|449825564|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
125056642|NCT00256867|449825565|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
125056643|NCT00256867|449825566|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
125056644|NCT00256867|449825567|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
125056645|NCT00256867|449825568|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
125056646|NCT00256867|449825569|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
125056647|NCT00256867|449825570|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
125136990|NCT00574847|450126445|FG001|Overall Study|Adverse Event|0|||
125056648|NCT00256867|449825571|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
125056649|NCT00256867|449825564|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
125056650|NCT00256867|449825565|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
125056651|NCT00256867|449825566|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
125056652|NCT00256867|449825567|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
125136991|NCT00574847|450126444|FG000|Overall Study|Death|1|||
125136992|NCT00574847|450126445|FG001|Overall Study|Death|0|||
125136993|NCT00574847|450126444|FG000|Overall Study|Withdrawal by Subject|2|||
125136994|NCT00574847|450126445|FG001|Overall Study|Withdrawal by Subject|2|||
125136995|NCT00574847|450126444|FG000|Overall Study|Physician Decision|1|||
125136996|NCT00574847|450126445|FG001|Overall Study|Physician Decision|0|||
125136997|NCT00574847|450126444|FG000|Overall Study|Did not receive medication (declined)|2|||
125220476|NCT00105989|450434457|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
125220477|NCT00105989|450434458|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
125220478|NCT00105989|450434457|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
125220479|NCT00105989|450434458|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
125220480|NCT00105989|450434457|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
125220481|NCT00105989|450434458|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
125220482|NCT00105989|450434457|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
125220483|NCT00105989|450434458|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
125220484|NCT00105989|450434457|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
125220485|NCT00105989|450434458|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
125220486|NCT00105989|450434457|FG000|Continuation - Open Label:Week 10-34|Death|0|||
125220487|NCT00105989|450434458|FG001|Continuation - Open Label:Week 10-34|Death|0|||
125220488|NCT00105989|450434457|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
125220489|NCT00105989|450434458|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
125220490|NCT00105989|450434457|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
125220491|NCT00105989|450434458|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
125220492|NCT00105989|450434457|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
125220493|NCT00105989|450434458|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
125220494|NCT00105989|450434457|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
125220495|NCT00105989|450434458|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
125220496|NCT00105989|450434457|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
125220497|NCT00105989|450434458|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
125220498|NCT00105989|450434457|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
125220499|NCT00105989|450434458|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
125220500|NCT00105989|450434457|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
125220501|NCT00105989|450434458|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
125220502|NCT00105989|450434457|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
125220503|NCT00105989|450434458|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
125220504|NCT00105989|450434457|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
125220505|NCT00105989|450434458|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
125220506|NCT00105989|450434457|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
125220507|NCT00105989|450434458|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
125220508|NCT00105989|450434457|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
125220509|NCT00105989|450434458|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
125220510|NCT00105989|450434457|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
125220511|NCT00105989|450434458|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
125220512|NCT03442088|450434459|FG000|Overall Study|Adverse Event|1|||
125220513|NCT03442088|450434459|FG000|Overall Study|Lack of Efficacy|2|||
125220514|NCT03442088|450434459|FG000|Overall Study|Lost to Follow-up|2|||
125220515|NCT00357877|450434460|FG000|Overall Study|Death|2|||
125220516|NCT00357877|450434461|FG001|Overall Study|Death|1|||
125220517|NCT00357877|450434460|FG000|Overall Study|Lost to Follow-up|20|||
125220518|NCT00357877|450434461|FG001|Overall Study|Lost to Follow-up|23|||
125220519|NCT00357877|450434460|FG000|Overall Study|Withdrawal by Subject|3|||
125220520|NCT00357877|450434461|FG001|Overall Study|Withdrawal by Subject|3|||
125220521|NCT00357877|450434460|FG000|Overall Study|Administrative withdrawal|1|||
125220522|NCT00357877|450434461|FG001|Overall Study|Administrative withdrawal|1|||
125220523|NCT00357877|450434460|FG000|Overall Study|Other|0|||
125220524|NCT00357877|450434461|FG001|Overall Study|Other|2|||
125220525|NCT04668209|450434462|FG000|Overall Study|Withdrawal by Subject|2|||
125220526|NCT04668209|450434463|FG001|Overall Study|Withdrawal by Subject|2|||
125220527|NCT04668209|450434462|FG000|Overall Study|Lost to Follow-up|3|||
125220528|NCT04668209|450434463|FG001|Overall Study|Lost to Follow-up|4|||
125220529|NCT04668209|450434462|FG000|Overall Study|Subject Expired|2|||
125220530|NCT04668209|450434463|FG001|Overall Study|Subject Expired|0|||
125220531|NCT04668209|450434462|FG000|Overall Study|Withdrawn from study|0|||
125220532|NCT04668209|450434463|FG001|Overall Study|Withdrawn from study|1|||
125220533|NCT04668209|450434462|FG000|Overall Study|Adverse Event|0|||
125220534|NCT04668209|450434463|FG001|Overall Study|Adverse Event|1|||
125220535|NCT01869777|450434470|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
125220536|NCT00613366|450434473|FG000|Overall Study|Withdrawal by Subject|3|||
125220537|NCT00613366|450434474|FG001|Overall Study|Withdrawal by Subject|2|||
125220538|NCT00766597|450434475|FG000|Overall Study|Unexpected closure of study|4|||
125220539|NCT00766597|450434475|FG000|Overall Study|Without CCR5-tropic virus|5|||
125220540|NCT01135524|450434479|FG000|Overall Study|Withdrawal by Subject|14|||
125136998|NCT00574847|450126445|FG001|Overall Study|Did not receive medication (declined)|5|||
125136999|NCT02055547|450126447|FG000|Overall Study|Protocol Violation|0|||
125137000|NCT02055547|450126448|FG001|Overall Study|Protocol Violation|0|||
125137001|NCT02055547|450126449|FG002|Overall Study|Protocol Violation|1|||
125137002|NCT02055547|450126450|FG003|Overall Study|Protocol Violation|0|||
125137003|NCT02055547|450126451|FG004|Overall Study|Protocol Violation|0|||
125137004|NCT02055547|450126452|FG005|Overall Study|Protocol Violation|0|||
125137005|NCT02055547|450126453|FG006|Overall Study|Protocol Violation|1|||
125056653|NCT00256867|449825568|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
125056654|NCT00256867|449825569|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
125056655|NCT00256867|449825570|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
125056656|NCT00256867|449825571|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
125056657|NCT00256867|449825564|FG000|Overall Study|Investigator's Decision|0|||
125056658|NCT00256867|449825565|FG001|Overall Study|Investigator's Decision|0|||
125056659|NCT00256867|449825566|FG002|Overall Study|Investigator's Decision|0|||
125056660|NCT00256867|449825567|FG003|Overall Study|Investigator's Decision|0|||
125056661|NCT00256867|449825568|FG004|Overall Study|Investigator's Decision|1|||
125056662|NCT00256867|449825569|FG005|Overall Study|Investigator's Decision|0|||
125056663|NCT00256867|449825570|FG006|Overall Study|Investigator's Decision|0|||
125056664|NCT00256867|449825571|FG007|Overall Study|Investigator's Decision|0|||
125056665|NCT00256867|449825564|FG000|Overall Study|Non-compliance with study medication|0|||
125056666|NCT00256867|449825565|FG001|Overall Study|Non-compliance with study medication|0|||
125056667|NCT00256867|449825566|FG002|Overall Study|Non-compliance with study medication|0|||
125056668|NCT00256867|449825567|FG003|Overall Study|Non-compliance with study medication|0|||
125056669|NCT00256867|449825568|FG004|Overall Study|Non-compliance with study medication|0|||
125056670|NCT00256867|449825569|FG005|Overall Study|Non-compliance with study medication|0|||
125056671|NCT00256867|449825570|FG006|Overall Study|Non-compliance with study medication|0|||
125056672|NCT00256867|449825571|FG007|Overall Study|Non-compliance with study medication|1|||
125056673|NCT00256867|449825564|FG000|Overall Study|Participant travelled Overseas|0|||
125056674|NCT00256867|449825565|FG001|Overall Study|Participant travelled Overseas|1|||
125056675|NCT00256867|449825566|FG002|Overall Study|Participant travelled Overseas|0|||
125056676|NCT00256867|449825567|FG003|Overall Study|Participant travelled Overseas|0|||
125056677|NCT00256867|449825568|FG004|Overall Study|Participant travelled Overseas|0|||
125056678|NCT00256867|449825569|FG005|Overall Study|Participant travelled Overseas|0|||
125056679|NCT00256867|449825570|FG006|Overall Study|Participant travelled Overseas|0|||
125056680|NCT00256867|449825571|FG007|Overall Study|Participant travelled Overseas|0|||
125056681|NCT00256867|449825564|FG000|Overall Study|Participant out of assessment window|0|||
125056682|NCT00256867|449825565|FG001|Overall Study|Participant out of assessment window|0|||
125056683|NCT00256867|449825566|FG002|Overall Study|Participant out of assessment window|1|||
125056684|NCT00256867|449825567|FG003|Overall Study|Participant out of assessment window|0|||
125056685|NCT00256867|449825568|FG004|Overall Study|Participant out of assessment window|0|||
125056686|NCT00256867|449825569|FG005|Overall Study|Participant out of assessment window|0|||
125056687|NCT00256867|449825570|FG006|Overall Study|Participant out of assessment window|0|||
125056688|NCT00256867|449825571|FG007|Overall Study|Participant out of assessment window|0|||
125056689|NCT00256867|449825564|FG000|Overall Study|Withdrawal by participant|0|||
125056690|NCT00256867|449825565|FG001|Overall Study|Withdrawal by participant|0|||
125056691|NCT00256867|449825566|FG002|Overall Study|Withdrawal by participant|0|||
125056692|NCT00256867|449825567|FG003|Overall Study|Withdrawal by participant|0|||
125056693|NCT00256867|449825568|FG004|Overall Study|Withdrawal by participant|0|||
125056694|NCT00256867|449825569|FG005|Overall Study|Withdrawal by participant|1|||
125056695|NCT00256867|449825570|FG006|Overall Study|Withdrawal by participant|0|||
125137006|NCT02055547|450126454|FG007|Overall Study|Protocol Violation|0|||
125137007|NCT02055547|450126455|FG008|Overall Study|Protocol Violation|0|||
125056696|NCT00256867|449825571|FG007|Overall Study|Withdrawal by participant|0|||
125056697|NCT02993224|449825572|FG000|Core Phase - Period 1|Adverse Event|4|||
125056698|NCT02993224|449825572|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
125056699|NCT02993224|449825572|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
125056700|NCT02993224|449825572|FG000|Core Phase- Period 2|Adverse Event|1|||
125056701|NCT02993224|449825572|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
125056702|NCT02993224|449825572|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
125137008|NCT02055547|450126456|FG009|Overall Study|Protocol Violation|0|||
125137009|NCT02055547|450126457|FG010|Overall Study|Protocol Violation|0|||
125137010|NCT02055547|450126458|FG011|Overall Study|Protocol Violation|0|||
125137011|NCT02055547|450126459|FG012|Overall Study|Protocol Violation|0|||
125056703|NCT02993224|449825572|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
125056704|NCT02993224|449825572|FG000|Extension Phase|Adverse Event|3|||
125056705|NCT02993224|449825572|FG000|Extension Phase|Withdrawal by Subject|3|||
125056706|NCT02993224|449825572|FG000|Extension Phase|Lost to Follow-up|2|||
125056707|NCT02993224|449825572|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
125056708|NCT01930799|449825574|FG000|Overall Study|Withdrawal by Subject|3|||
125056709|NCT01930799|449825574|FG000|Overall Study|Lost to Follow-up|5|||
125056710|NCT00952289|449825578|FG000|All Participants|Death|9|||
125056711|NCT00952289|449825579|FG001|All Participants|Death|9|||
125056712|NCT00952289|449825578|FG000|All Participants|Adverse Event|8|||
125056713|NCT00952289|449825579|FG001|All Participants|Adverse Event|8|||
125056714|NCT00952289|449825578|FG000|All Participants|Disease progression|3|||
125056715|NCT00952289|449825579|FG001|All Participants|Disease progression|12|||
125056716|NCT00952289|449825578|FG000|All Participants|Withdrawal by Subject|1|||
125056717|NCT00952289|449825579|FG001|All Participants|Withdrawal by Subject|10|||
125056718|NCT00952289|449825578|FG000|All Participants|Data lost during site relocation|0|||
125056719|NCT00952289|449825579|FG001|All Participants|Data lost during site relocation|1|||
125056720|NCT00952289|449825578|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
125056721|NCT00952289|449825579|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
125056722|NCT00952289|449825578|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
125056723|NCT00952289|449825579|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
125056724|NCT00952289|449825578|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
125056725|NCT00952289|449825579|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
125056726|NCT00952289|449825578|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
125056727|NCT00952289|449825579|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
125056728|NCT00952289|449825578|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
125056729|NCT00952289|449825579|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
125056730|NCT03136185|449825587|FG000|Overall Study|Adverse Event|0|||
125056731|NCT03136185|449825588|FG001|Overall Study|Adverse Event|1|||
125056732|NCT03136185|449825589|FG002|Overall Study|Adverse Event|3|||
125056733|NCT03136185|449825590|FG003|Overall Study|Adverse Event|1|||
125056734|NCT03136185|449825591|FG004|Overall Study|Adverse Event|2|||
125056735|NCT03136185|449825592|FG005|Overall Study|Adverse Event|2|||
125056736|NCT03136185|449825593|FG006|Overall Study|Adverse Event|5|||
125056737|NCT03136185|449825594|FG007|Overall Study|Adverse Event|1|||
125056738|NCT03136185|449825595|FG008|Overall Study|Adverse Event|1|||
125056739|NCT03136185|449825587|FG000|Overall Study|Death|0|||
125056740|NCT03136185|449825588|FG001|Overall Study|Death|0|||
125056741|NCT03136185|449825589|FG002|Overall Study|Death|0|||
125056742|NCT03136185|449825590|FG003|Overall Study|Death|1|||
125056743|NCT03136185|449825591|FG004|Overall Study|Death|1|||
125056744|NCT03136185|449825592|FG005|Overall Study|Death|0|||
125056745|NCT03136185|449825593|FG006|Overall Study|Death|1|||
125056746|NCT03136185|449825594|FG007|Overall Study|Death|0|||
125056747|NCT03136185|449825595|FG008|Overall Study|Death|0|||
125056748|NCT03136185|449825587|FG000|Overall Study|Physician Decision|3|||
125056749|NCT03136185|449825588|FG001|Overall Study|Physician Decision|1|||
125056750|NCT03136185|449825589|FG002|Overall Study|Physician Decision|1|||
125056751|NCT03136185|449825590|FG003|Overall Study|Physician Decision|2|||
125056752|NCT03136185|449825591|FG004|Overall Study|Physician Decision|1|||
125056753|NCT03136185|449825592|FG005|Overall Study|Physician Decision|2|||
125056754|NCT03136185|449825593|FG006|Overall Study|Physician Decision|1|||
125056755|NCT03136185|449825594|FG007|Overall Study|Physician Decision|0|||
125056756|NCT03136185|449825595|FG008|Overall Study|Physician Decision|1|||
125056757|NCT03136185|449825587|FG000|Overall Study|Protocol Defined Disease Progression|0|||
125056758|NCT03136185|449825588|FG001|Overall Study|Protocol Defined Disease Progression|0|||
125056759|NCT03136185|449825589|FG002|Overall Study|Protocol Defined Disease Progression|1|||
125056760|NCT03136185|449825590|FG003|Overall Study|Protocol Defined Disease Progression|0|||
125056761|NCT03136185|449825591|FG004|Overall Study|Protocol Defined Disease Progression|0|||
125056762|NCT03136185|449825592|FG005|Overall Study|Protocol Defined Disease Progression|1|||
125056763|NCT03136185|449825593|FG006|Overall Study|Protocol Defined Disease Progression|0|||
125056764|NCT03136185|449825594|FG007|Overall Study|Protocol Defined Disease Progression|1|||
125056765|NCT03136185|449825595|FG008|Overall Study|Protocol Defined Disease Progression|1|||
125056766|NCT03136185|449825587|FG000|Overall Study|Withdrawal by Subject|1|||
125056767|NCT03136185|449825588|FG001|Overall Study|Withdrawal by Subject|0|||
125056768|NCT03136185|449825589|FG002|Overall Study|Withdrawal by Subject|1|||
125056769|NCT03136185|449825590|FG003|Overall Study|Withdrawal by Subject|1|||
125056770|NCT03136185|449825591|FG004|Overall Study|Withdrawal by Subject|1|||
125056771|NCT03136185|449825592|FG005|Overall Study|Withdrawal by Subject|1|||
125056772|NCT03136185|449825593|FG006|Overall Study|Withdrawal by Subject|2|||
125056773|NCT03136185|449825594|FG007|Overall Study|Withdrawal by Subject|3|||
125056774|NCT03136185|449825595|FG008|Overall Study|Withdrawal by Subject|3|||
125056775|NCT03136185|449825587|FG000|Overall Study|Not Reported|4|||
125056776|NCT03136185|449825588|FG001|Overall Study|Not Reported|1|||
125220541|NCT01135524|450434479|FG000|Overall Study|Adverse Event|20|||
125220542|NCT01135524|450434479|FG000|Overall Study|Lost to Follow-up|3|||
125220543|NCT01135524|450434479|FG000|Overall Study|Administrative|151|||
125220544|NCT01135524|450434479|FG000|Overall Study|Lack of Efficacy|8|||
125220545|NCT03318003|450434480|FG000|Overall Study|Withdrawal by Subject|1|||
125220546|NCT03318003|450434481|FG001|Overall Study|Withdrawal by Subject|1|||
125220547|NCT03318003|450434480|FG000|Overall Study|fetal loss|0|||
125220548|NCT03318003|450434481|FG001|Overall Study|fetal loss|1|||
125220549|NCT02907463|450434483|FG000|Overall Study|Lost to Follow-up|17|||
125056777|NCT03136185|449825589|FG002|Overall Study|Not Reported|0|||
125056778|NCT03136185|449825590|FG003|Overall Study|Not Reported|1|||
125056779|NCT03136185|449825591|FG004|Overall Study|Not Reported|0|||
125056780|NCT03136185|449825592|FG005|Overall Study|Not Reported|2|||
125056781|NCT03136185|449825593|FG006|Overall Study|Not Reported|1|||
125056782|NCT03136185|449825594|FG007|Overall Study|Not Reported|1|||
125056783|NCT03136185|449825595|FG008|Overall Study|Not Reported|0|||
125056784|NCT00488033|449825599|FG000|Overall Study|Withdrawal by Subject|1|||
125056785|NCT00488033|449825600|FG001|Overall Study|Withdrawal by Subject|0|||
125056786|NCT04715230|449825603|FG000|Overall Study|Withdrawal by Subject|1|||
125056787|NCT04715230|449825604|FG001|Overall Study|Withdrawal by Subject|0|||
125056788|NCT04715230|449825605|FG002|Overall Study|Withdrawal by Subject|0|||
125056789|NCT04715230|449825603|FG000|Overall Study|Lost to Follow-up|0|||
125056790|NCT04715230|449825604|FG001|Overall Study|Lost to Follow-up|5|||
125056791|NCT04715230|449825605|FG002|Overall Study|Lost to Follow-up|1|||
125056792|NCT03453151|449825606|FG000|Overall Study|Withdrawal by Subject|1|||
125056793|NCT03453151|449825606|FG000|Overall Study|Physician Decision|3|||
125056794|NCT02065622|449825610|FG000|Induction Study|Adverse Event|13|||
125056795|NCT02065622|449825611|FG001|Induction Study|Adverse Event|19|||
125056796|NCT02065622|449825612|FG002|Induction Study|Adverse Event|0|||
125056797|NCT02065622|449825613|FG003|Induction Study|Adverse Event|0|||
125056798|NCT02065622|449825614|FG004|Induction Study|Adverse Event|0|||
125056799|NCT02065622|449825610|FG000|Induction Study|Withdrawal by Subject|3|||
125056800|NCT02065622|449825611|FG001|Induction Study|Withdrawal by Subject|5|||
125056801|NCT02065622|449825612|FG002|Induction Study|Withdrawal by Subject|0|||
125056802|NCT02065622|449825613|FG003|Induction Study|Withdrawal by Subject|0|||
125056803|NCT02065622|449825614|FG004|Induction Study|Withdrawal by Subject|0|||
125056804|NCT02065622|449825610|FG000|Induction Study|Lost to Follow-up|1|||
125056805|NCT02065622|449825611|FG001|Induction Study|Lost to Follow-up|0|||
125056806|NCT02065622|449825612|FG002|Induction Study|Lost to Follow-up|0|||
125056807|NCT02065622|449825613|FG003|Induction Study|Lost to Follow-up|0|||
125056808|NCT02065622|449825614|FG004|Induction Study|Lost to Follow-up|0|||
125056809|NCT02065622|449825610|FG000|Induction Study|Lack of Efficacy|22|||
125056810|NCT02065622|449825611|FG001|Induction Study|Lack of Efficacy|27|||
125056811|NCT02065622|449825612|FG002|Induction Study|Lack of Efficacy|0|||
125056812|NCT02065622|449825613|FG003|Induction Study|Lack of Efficacy|0|||
125056813|NCT02065622|449825614|FG004|Induction Study|Lack of Efficacy|0|||
125056814|NCT02065622|449825610|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
125056815|NCT02065622|449825611|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
125056816|NCT02065622|449825612|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
125056817|NCT02065622|449825613|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
125056818|NCT02065622|449825614|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
125056819|NCT02065622|449825610|FG000|Induction Study|Subject Noncompliance|1|||
125056820|NCT02065622|449825611|FG001|Induction Study|Subject Noncompliance|1|||
125056821|NCT02065622|449825612|FG002|Induction Study|Subject Noncompliance|0|||
125056822|NCT02065622|449825613|FG003|Induction Study|Subject Noncompliance|0|||
125056823|NCT02065622|449825614|FG004|Induction Study|Subject Noncompliance|0|||
125056824|NCT02065622|449825610|FG000|Induction Study|Other, Not Specified|3|||
125220550|NCT02907463|450434483|FG000|Overall Study|Death|10|||
125220551|NCT02907463|450434483|FG000|Overall Study|Withdrawal by Subject|4|||
125220552|NCT02907463|450434483|FG000|Overall Study|MIS Approach was not used|2|||
125220553|NCT02907463|450434483|FG000|Overall Study|Not Implanted with Study Device|2|||
125220554|NCT02907463|450434483|FG000|Overall Study|Device Explanted|1|||
125056825|NCT02065622|449825611|FG001|Induction Study|Other, Not Specified|2|||
125056826|NCT02065622|449825612|FG002|Induction Study|Other, Not Specified|0|||
125056827|NCT02065622|449825613|FG003|Induction Study|Other, Not Specified|0|||
125220555|NCT02907463|450434483|FG000|Overall Study|Missing Exit Form|1|||
125220556|NCT01716663|450434484|FG000|Overall Study|Withdrawn prior to procedure|4|||
125220557|NCT01716663|450434484|FG000|Overall Study|Treated with non-study catheter|2|||
125220558|NCT00511810|450434491|FG000|Overall Study|Lost to Follow-up|1|||
125220559|NCT00511810|450434492|FG001|Overall Study|Lost to Follow-up|2|||
125220560|NCT00511810|450434491|FG000|Overall Study|Lack of Efficacy|0|||
125220561|NCT00511810|450434492|FG001|Overall Study|Lack of Efficacy|2|||
125056828|NCT02065622|449825614|FG004|Induction Study|Other, Not Specified|0|||
125056829|NCT02065622|449825610|FG000|Maintenance Study|Adverse Event|0|||
125056830|NCT02065622|449825611|FG001|Maintenance Study|Adverse Event|0|||
125056831|NCT02065622|449825612|FG002|Maintenance Study|Adverse Event|25|||
125056832|NCT02065622|449825613|FG003|Maintenance Study|Adverse Event|22|||
125056833|NCT02065622|449825614|FG004|Maintenance Study|Adverse Event|11|||
125056834|NCT02065622|449825610|FG000|Maintenance Study|Withdrawal by Subject|0|||
125056835|NCT02065622|449825611|FG001|Maintenance Study|Withdrawal by Subject|0|||
125056836|NCT02065622|449825612|FG002|Maintenance Study|Withdrawal by Subject|11|||
125056837|NCT02065622|449825613|FG003|Maintenance Study|Withdrawal by Subject|5|||
125056838|NCT02065622|449825614|FG004|Maintenance Study|Withdrawal by Subject|7|||
125056839|NCT02065622|449825610|FG000|Maintenance Study|Lost to Follow-up|0|||
125056840|NCT02065622|449825611|FG001|Maintenance Study|Lost to Follow-up|0|||
125056841|NCT02065622|449825612|FG002|Maintenance Study|Lost to Follow-up|4|||
125056842|NCT02065622|449825613|FG003|Maintenance Study|Lost to Follow-up|1|||
125056843|NCT02065622|449825614|FG004|Maintenance Study|Lost to Follow-up|1|||
125056844|NCT02065622|449825610|FG000|Maintenance Study|Lack of Efficacy|0|||
125056845|NCT02065622|449825611|FG001|Maintenance Study|Lack of Efficacy|0|||
125056846|NCT02065622|449825612|FG002|Maintenance Study|Lack of Efficacy|70|||
125056847|NCT02065622|449825613|FG003|Maintenance Study|Lack of Efficacy|55|||
125056848|NCT02065622|449825614|FG004|Maintenance Study|Lack of Efficacy|19|||
125056849|NCT02065622|449825610|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
125056850|NCT02065622|449825611|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
125056851|NCT02065622|449825612|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
125056852|NCT02065622|449825613|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
125056853|NCT02065622|449825614|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
125056854|NCT02065622|449825610|FG000|Maintenance Study|Subject Non-Compliance|0|||
125056855|NCT02065622|449825611|FG001|Maintenance Study|Subject Non-Compliance|0|||
125056856|NCT02065622|449825612|FG002|Maintenance Study|Subject Non-Compliance|1|||
125056857|NCT02065622|449825613|FG003|Maintenance Study|Subject Non-Compliance|3|||
125056858|NCT02065622|449825614|FG004|Maintenance Study|Subject Non-Compliance|2|||
125056859|NCT02065622|449825610|FG000|Maintenance Study|Other, Not Specified|0|||
125056860|NCT02065622|449825611|FG001|Maintenance Study|Other, Not Specified|0|||
125056861|NCT02065622|449825612|FG002|Maintenance Study|Other, Not Specified|6|||
125056862|NCT02065622|449825613|FG003|Maintenance Study|Other, Not Specified|14|||
125056863|NCT02065622|449825614|FG004|Maintenance Study|Other, Not Specified|2|||
125056864|NCT02065622|449825610|FG000|Maintenance Study|Unknown Reason|0|||
125056865|NCT02065622|449825611|FG001|Maintenance Study|Unknown Reason|0|||
125056866|NCT02065622|449825612|FG002|Maintenance Study|Unknown Reason|0|||
125056867|NCT02065622|449825613|FG003|Maintenance Study|Unknown Reason|1|||
125056868|NCT02065622|449825614|FG004|Maintenance Study|Unknown Reason|0|||
125056869|NCT02349789|449826850|FG000|Overall Study|Withdrawal by Subject|2|||
125056870|NCT00683475|449826853|FG000|Overall Study|Withdrawal by Subject|1|||
125056871|NCT00683475|449826854|FG001|Overall Study|Withdrawal by Subject|0|||
125056872|NCT00683475|449826853|FG000|Overall Study|Never Treated: Adverse Event|2|||
125056873|NCT00683475|449826854|FG001|Overall Study|Never Treated: Adverse Event|3|||
125056874|NCT00683475|449826853|FG000|Overall Study|Never Treated: Progressive Disease|1|||
125056875|NCT00683475|449826854|FG001|Overall Study|Never Treated: Progressive Disease|0|||
125056876|NCT02922634|449826855|FG000|Overall Study|Withdrawal by Subject|5|||
125056877|NCT02922634|449826855|FG000|Overall Study|Did not have their surgery|5|||
125056878|NCT02723604|449826856|FG000|Overall Study|ineligible|1|||
125056879|NCT02723604|449826856|FG000|Overall Study|never received treatment|1|||
125056880|NCT00352755|449826859|FG000|Overall Study|Physician Decision|1|||
125056881|NCT00352755|449826859|FG000|Overall Study|Adverse Event|1|||
125056882|NCT01694420|449826861|FG000|Overall Study|Lost to Follow-up|3|||
125056883|NCT03987919|449826862|FG000|Overall Study|Adverse Event|1|||
125056884|NCT03987919|449826863|FG001|Overall Study|Adverse Event|4|||
125056885|NCT03987919|449826864|FG002|Overall Study|Adverse Event|1|||
125056886|NCT03987919|449826865|FG003|Overall Study|Adverse Event|3|||
125056887|NCT03987919|449826862|FG000|Overall Study|Death|4|||
125056888|NCT03987919|449826863|FG001|Overall Study|Death|4|||
125056889|NCT03987919|449826864|FG002|Overall Study|Death|4|||
125056890|NCT03987919|449826865|FG003|Overall Study|Death|1|||
125056891|NCT03987919|449826862|FG000|Overall Study|Lost to Follow-up|5|||
125056892|NCT03987919|449826863|FG001|Overall Study|Lost to Follow-up|6|||
125056893|NCT03987919|449826864|FG002|Overall Study|Lost to Follow-up|8|||
125056894|NCT03987919|449826865|FG003|Overall Study|Lost to Follow-up|12|||
125220562|NCT00511810|450434491|FG000|Overall Study|Refused second scn|0|||
125056895|NCT03987919|449826862|FG000|Overall Study|Physician Decision|0|||
125220563|NCT00511810|450434492|FG001|Overall Study|Refused second scn|1|||
125056896|NCT03987919|449826863|FG001|Overall Study|Physician Decision|2|||
125056897|NCT03987919|449826864|FG002|Overall Study|Physician Decision|0|||
125056898|NCT03987919|449826865|FG003|Overall Study|Physician Decision|4|||
125056899|NCT03987919|449826862|FG000|Overall Study|Pregnancy|1|||
125056900|NCT03987919|449826863|FG001|Overall Study|Pregnancy|0|||
125056901|NCT03987919|449826864|FG002|Overall Study|Pregnancy|1|||
125056902|NCT03987919|449826865|FG003|Overall Study|Pregnancy|1|||
125056903|NCT03987919|449826862|FG000|Overall Study|Protocol Violation|0|||
125056904|NCT03987919|449826863|FG001|Overall Study|Protocol Violation|1|||
125056905|NCT03987919|449826864|FG002|Overall Study|Protocol Violation|0|||
125056906|NCT03987919|449826865|FG003|Overall Study|Protocol Violation|0|||
125056907|NCT03987919|449826862|FG000|Overall Study|Site terminated by Sponsor|0|||
125056908|NCT03987919|449826863|FG001|Overall Study|Site terminated by Sponsor|0|||
125056909|NCT03987919|449826864|FG002|Overall Study|Site terminated by Sponsor|0|||
125056910|NCT03987919|449826865|FG003|Overall Study|Site terminated by Sponsor|1|||
125056911|NCT03987919|449826862|FG000|Overall Study|Withdrawal by Subject|7|||
125056912|NCT03987919|449826863|FG001|Overall Study|Withdrawal by Subject|7|||
125056913|NCT03987919|449826864|FG002|Overall Study|Withdrawal by Subject|8|||
125056914|NCT03987919|449826865|FG003|Overall Study|Withdrawal by Subject|4|||
125056915|NCT03987919|449826862|FG000|Overall Study|Other - as reported by the investigator|1|||
125056916|NCT03987919|449826863|FG001|Overall Study|Other - as reported by the investigator|3|||
125056917|NCT03987919|449826864|FG002|Overall Study|Other - as reported by the investigator|2|||
125056918|NCT03987919|449826865|FG003|Overall Study|Other - as reported by the investigator|0|||
125056919|NCT01194804|449826866|FG000|Overall Study|Withdrawal by Subject|1|||
125056920|NCT03621943|449826867|FG000|First Randomized Intervention|Lost to Follow-up|51|||
125056921|NCT03621943|449826868|FG001|First Randomized Intervention|Lost to Follow-up|54|||
125056922|NCT03621943|449826867|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
125056923|NCT03621943|449826868|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
125056924|NCT03621943|449826867|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
125056925|NCT03621943|449826868|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
125056926|NCT03621943|449826867|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
125056927|NCT03621943|449826868|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
125056928|NCT00948818|449826869|FG000|Overall Study|Adverse Event|10|||
125056929|NCT00948818|449826870|FG001|Overall Study|Adverse Event|32|||
125056930|NCT00948818|449826869|FG000|Overall Study|Protocol Violation|9|||
125056931|NCT00948818|449826870|FG001|Overall Study|Protocol Violation|10|||
125056932|NCT00948818|449826869|FG000|Overall Study|Withdrawal by Subject|25|||
125056933|NCT00948818|449826870|FG001|Overall Study|Withdrawal by Subject|25|||
125056934|NCT00948818|449826869|FG000|Overall Study|Lost to Follow-up|10|||
125056935|NCT00948818|449826870|FG001|Overall Study|Lost to Follow-up|17|||
125056936|NCT00948818|449826869|FG000|Overall Study|Lack of Efficacy|4|||
125056937|NCT00948818|449826870|FG001|Overall Study|Lack of Efficacy|5|||
125056938|NCT00948818|449826869|FG000|Overall Study|Other Reason|4|||
125056939|NCT00948818|449826870|FG001|Overall Study|Other Reason|5|||
125056940|NCT02324842|449826875|FG000|Overall Study|Lost to Follow-up|1|||
125056941|NCT02324842|449826876|FG001|Overall Study|Lost to Follow-up|1|||
125056942|NCT02324842|449826877|FG002|Overall Study|Lost to Follow-up|2|||
125056943|NCT05122650|449826878|FG000|Overall Study|Adverse Event|4|||
125056944|NCT05122650|449826879|FG001|Overall Study|Adverse Event|16|||
125056945|NCT05122650|449826880|FG002|Overall Study|Adverse Event|11|||
125056946|NCT05122650|449826881|FG003|Overall Study|Adverse Event|12|||
125056947|NCT05122650|449826878|FG000|Overall Study|Lack of Efficacy|0|||
125137012|NCT02055547|450126460|FG013|Overall Study|Protocol Violation|0|||
125056948|NCT05122650|449826879|FG001|Overall Study|Lack of Efficacy|1|||
125137013|NCT02055547|450126461|FG014|Overall Study|Protocol Violation|0|||
125137014|NCT02055547|450126462|FG015|Overall Study|Protocol Violation|0|||
125137015|NCT02055547|450126463|FG016|Overall Study|Protocol Violation|0|||
125137016|NCT02055547|450126464|FG017|Overall Study|Protocol Violation|0|||
125137017|NCT02055547|450126465|FG018|Overall Study|Protocol Violation|0|||
125137018|NCT02055547|450126447|FG000|Overall Study|Physician Decision|0|||
125137019|NCT02055547|450126448|FG001|Overall Study|Physician Decision|1|||
125137020|NCT02055547|450126449|FG002|Overall Study|Physician Decision|1|||
125137021|NCT02055547|450126450|FG003|Overall Study|Physician Decision|0|||
125137022|NCT02055547|450126451|FG004|Overall Study|Physician Decision|1|||
125137023|NCT02055547|450126452|FG005|Overall Study|Physician Decision|0|||
125137024|NCT02055547|450126453|FG006|Overall Study|Physician Decision|0|||
125137025|NCT02055547|450126454|FG007|Overall Study|Physician Decision|0|||
125137026|NCT02055547|450126455|FG008|Overall Study|Physician Decision|0|||
125137027|NCT02055547|450126456|FG009|Overall Study|Physician Decision|1|||
125137028|NCT02055547|450126457|FG010|Overall Study|Physician Decision|1|||
125137029|NCT02055547|450126458|FG011|Overall Study|Physician Decision|0|||
125137030|NCT02055547|450126459|FG012|Overall Study|Physician Decision|0|||
125137031|NCT02055547|450126460|FG013|Overall Study|Physician Decision|0|||
125137032|NCT02055547|450126461|FG014|Overall Study|Physician Decision|0|||
125137033|NCT02055547|450126462|FG015|Overall Study|Physician Decision|0|||
125137034|NCT02055547|450126463|FG016|Overall Study|Physician Decision|0|||
125137035|NCT02055547|450126464|FG017|Overall Study|Physician Decision|0|||
125137036|NCT02055547|450126465|FG018|Overall Study|Physician Decision|0|||
125137037|NCT02055547|450126447|FG000|Overall Study|Adverse Event|0|||
125137038|NCT02055547|450126448|FG001|Overall Study|Adverse Event|0|||
125137039|NCT02055547|450126449|FG002|Overall Study|Adverse Event|0|||
125137040|NCT02055547|450126450|FG003|Overall Study|Adverse Event|0|||
125137041|NCT02055547|450126451|FG004|Overall Study|Adverse Event|0|||
125137042|NCT02055547|450126452|FG005|Overall Study|Adverse Event|0|||
125137043|NCT02055547|450126453|FG006|Overall Study|Adverse Event|1|||
125137044|NCT02055547|450126454|FG007|Overall Study|Adverse Event|0|||
125137045|NCT02055547|450126455|FG008|Overall Study|Adverse Event|1|||
125137046|NCT02055547|450126456|FG009|Overall Study|Adverse Event|0|||
125137047|NCT02055547|450126457|FG010|Overall Study|Adverse Event|0|||
125137048|NCT02055547|450126458|FG011|Overall Study|Adverse Event|0|||
125137049|NCT02055547|450126459|FG012|Overall Study|Adverse Event|0|||
125137050|NCT02055547|450126460|FG013|Overall Study|Adverse Event|0|||
125137051|NCT02055547|450126461|FG014|Overall Study|Adverse Event|0|||
125137052|NCT02055547|450126462|FG015|Overall Study|Adverse Event|0|||
125137053|NCT02055547|450126463|FG016|Overall Study|Adverse Event|0|||
125137054|NCT02055547|450126464|FG017|Overall Study|Adverse Event|0|||
125137055|NCT02055547|450126465|FG018|Overall Study|Adverse Event|0|||
125137056|NCT02055547|450126447|FG000|Overall Study|Withdrawal by Subject|0|||
125137057|NCT02055547|450126448|FG001|Overall Study|Withdrawal by Subject|0|||
125137058|NCT02055547|450126449|FG002|Overall Study|Withdrawal by Subject|0|||
125137059|NCT02055547|450126450|FG003|Overall Study|Withdrawal by Subject|0|||
125137060|NCT02055547|450126451|FG004|Overall Study|Withdrawal by Subject|0|||
125137061|NCT02055547|450126452|FG005|Overall Study|Withdrawal by Subject|1|||
125137062|NCT02055547|450126453|FG006|Overall Study|Withdrawal by Subject|0|||
125137063|NCT02055547|450126454|FG007|Overall Study|Withdrawal by Subject|0|||
125137064|NCT02055547|450126455|FG008|Overall Study|Withdrawal by Subject|1|||
125137065|NCT02055547|450126456|FG009|Overall Study|Withdrawal by Subject|0|||
125137066|NCT02055547|450126457|FG010|Overall Study|Withdrawal by Subject|0|||
125137067|NCT02055547|450126458|FG011|Overall Study|Withdrawal by Subject|0|||
125137068|NCT02055547|450126459|FG012|Overall Study|Withdrawal by Subject|0|||
125137069|NCT02055547|450126460|FG013|Overall Study|Withdrawal by Subject|1|||
125137070|NCT02055547|450126461|FG014|Overall Study|Withdrawal by Subject|0|||
125137071|NCT02055547|450126462|FG015|Overall Study|Withdrawal by Subject|1|||
125137072|NCT02055547|450126463|FG016|Overall Study|Withdrawal by Subject|0|||
125137073|NCT02055547|450126464|FG017|Overall Study|Withdrawal by Subject|0|||
125137074|NCT02055547|450126465|FG018|Overall Study|Withdrawal by Subject|0|||
125137075|NCT02055547|450126447|FG000|Overall Study|Lost to Follow-up|0|||
125137076|NCT02055547|450126448|FG001|Overall Study|Lost to Follow-up|0|||
125137077|NCT02055547|450126449|FG002|Overall Study|Lost to Follow-up|1|||
125137078|NCT02055547|450126450|FG003|Overall Study|Lost to Follow-up|0|||
125137079|NCT02055547|450126451|FG004|Overall Study|Lost to Follow-up|0|||
125137080|NCT02055547|450126452|FG005|Overall Study|Lost to Follow-up|0|||
125137081|NCT02055547|450126453|FG006|Overall Study|Lost to Follow-up|0|||
125137082|NCT02055547|450126454|FG007|Overall Study|Lost to Follow-up|0|||
125137083|NCT02055547|450126455|FG008|Overall Study|Lost to Follow-up|0|||
125137084|NCT02055547|450126456|FG009|Overall Study|Lost to Follow-up|0|||
125137085|NCT02055547|450126457|FG010|Overall Study|Lost to Follow-up|0|||
125137086|NCT02055547|450126458|FG011|Overall Study|Lost to Follow-up|0|||
125137087|NCT02055547|450126459|FG012|Overall Study|Lost to Follow-up|0|||
125220564|NCT02427841|450434493|FG000|Overall Study|Lack of Efficacy|5|||
125220565|NCT02427841|450434493|FG000|Overall Study|Physician Decision|2|||
125220566|NCT02427841|450434493|FG000|Overall Study|Withdrawal by Subject|1|||
125220567|NCT02896569|450434494|FG000|Overall Study|Lost to Follow-up|2|||
125220568|NCT02896569|450434495|FG001|Overall Study|Lost to Follow-up|1|||
125220569|NCT02896569|450434494|FG000|Overall Study|Physician Decision|1|||
125220570|NCT02896569|450434495|FG001|Overall Study|Physician Decision|3|||
125220571|NCT02896569|450434494|FG000|Overall Study|Adverse Event|0|||
125220572|NCT02896569|450434495|FG001|Overall Study|Adverse Event|1|||
125220573|NCT02896569|450434494|FG000|Overall Study|Withdrawal by Subject|1|||
125220574|NCT02896569|450434495|FG001|Overall Study|Withdrawal by Subject|0|||
125220575|NCT03478371|450434496|FG000|Overall Study|non-compliance|1|||
125220576|NCT03478371|450434496|FG000|Overall Study|Lost to Follow-up|4|||
125220577|NCT00618826|450434501|FG000|Overall Study|Adverse Event|1|||
125220578|NCT01509664|450434502|FG000|Overall Study|Lost to Follow-up|15|||
125220579|NCT01509664|450434503|FG001|Overall Study|Lost to Follow-up|21|||
125220580|NCT00905424|450434508|FG000|Overall Study|Lost to Follow-up|3|||
125056949|NCT05122650|449826880|FG002|Overall Study|Lack of Efficacy|1|||
125056950|NCT05122650|449826881|FG003|Overall Study|Lack of Efficacy|2|||
125056951|NCT05122650|449826878|FG000|Overall Study|Lost to Follow-up|1|||
125056952|NCT05122650|449826879|FG001|Overall Study|Lost to Follow-up|1|||
125056953|NCT05122650|449826880|FG002|Overall Study|Lost to Follow-up|3|||
125056954|NCT05122650|449826881|FG003|Overall Study|Lost to Follow-up|0|||
125056955|NCT05122650|449826878|FG000|Overall Study|Non-compliance with study intervention|0|||
125056956|NCT05122650|449826879|FG001|Overall Study|Non-compliance with study intervention|0|||
125056957|NCT05122650|449826880|FG002|Overall Study|Non-compliance with study intervention|0|||
125056958|NCT05122650|449826881|FG003|Overall Study|Non-compliance with study intervention|2|||
125056959|NCT05122650|449826878|FG000|Overall Study|Protocol Violation|0|||
125056960|NCT05122650|449826879|FG001|Overall Study|Protocol Violation|1|||
125056961|NCT05122650|449826880|FG002|Overall Study|Protocol Violation|0|||
125056962|NCT05122650|449826881|FG003|Overall Study|Protocol Violation|1|||
125056963|NCT05122650|449826878|FG000|Overall Study|Randomized by mistake|0|||
125056964|NCT05122650|449826879|FG001|Overall Study|Randomized by mistake|0|||
125056965|NCT05122650|449826880|FG002|Overall Study|Randomized by mistake|3|||
125056966|NCT05122650|449826881|FG003|Overall Study|Randomized by mistake|2|||
125056967|NCT05122650|449826878|FG000|Overall Study|Sponsor request|0|||
125056968|NCT05122650|449826879|FG001|Overall Study|Sponsor request|1|||
125056969|NCT05122650|449826880|FG002|Overall Study|Sponsor request|1|||
125056970|NCT05122650|449826881|FG003|Overall Study|Sponsor request|2|||
125056971|NCT05122650|449826878|FG000|Overall Study|Withdrawal by Subject|3|||
125056972|NCT05122650|449826879|FG001|Overall Study|Withdrawal by Subject|7|||
125056973|NCT05122650|449826880|FG002|Overall Study|Withdrawal by Subject|4|||
125056974|NCT05122650|449826881|FG003|Overall Study|Withdrawal by Subject|8|||
125056975|NCT05122650|449826878|FG000|Overall Study|Other|5|||
125220581|NCT00905424|450434509|FG001|Overall Study|Lost to Follow-up|3|||
125220582|NCT00905424|450434508|FG000|Overall Study|Withdrawal by Subject|1|||
125220583|NCT00905424|450434509|FG001|Overall Study|Withdrawal by Subject|2|||
125220584|NCT00905424|450434508|FG000|Overall Study|Adverse Event|4|||
125220585|NCT00905424|450434509|FG001|Overall Study|Adverse Event|2|||
125220586|NCT00905424|450434508|FG000|Overall Study|Non-compliance with study medication|2|||
125220587|NCT00905424|450434509|FG001|Overall Study|Non-compliance with study medication|0|||
125220588|NCT00905424|450434508|FG000|Overall Study|Sponsor decision|1|||
125220589|NCT00905424|450434509|FG001|Overall Study|Sponsor decision|0|||
125220590|NCT00905424|450434508|FG000|Overall Study|Positive urine drug screen|0|||
125220591|NCT00905424|450434509|FG001|Overall Study|Positive urine drug screen|1|||
125220592|NCT00905424|450434508|FG000|Overall Study|Non-adherence to visit schedule|0|||
125220593|NCT00905424|450434509|FG001|Overall Study|Non-adherence to visit schedule|1|||
125220594|NCT00426764|450434510|FG000|Overall Study|Protocol Violation|1|||
125220595|NCT00426764|450434510|FG000|Overall Study|Withdrawal by Subject|4|||
125220596|NCT00426764|450434510|FG000|Overall Study|Physician Decision|6|||
125220597|NCT00426764|450434510|FG000|Overall Study|Compassionate Use|1|||
125220598|NCT00426764|450434510|FG000|Overall Study|Progressive Disease|83|||
125220599|NCT00426764|450434510|FG000|Overall Study|Adverse Event|24|||
125220600|NCT00426764|450434510|FG000|Overall Study|Other|1|||
125220601|NCT00426764|450434510|FG000|Overall Study|Death|1|||
125220602|NCT00426764|450434510|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
125220603|NCT05225389|450434511|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
125220604|NCT03804268|450434512|FG000|Overall Study|Adverse Event|2|||
125220605|NCT03804268|450434513|FG001|Overall Study|Adverse Event|2|||
125220606|NCT03804268|450434512|FG000|Overall Study|Withdrawal by Subject|2|||
125220607|NCT03804268|450434513|FG001|Overall Study|Withdrawal by Subject|0|||
125220608|NCT03804268|450434512|FG000|Overall Study|Lost to Follow-up|1|||
125220609|NCT03804268|450434513|FG001|Overall Study|Lost to Follow-up|0|||
125220610|NCT03804268|450434512|FG000|Overall Study|Physician Decision|2|||
125220611|NCT03804268|450434513|FG001|Overall Study|Physician Decision|0|||
125220612|NCT01737879|450434514|FG000|Overall Study|Death|1|||
125220613|NCT01737879|450434514|FG000|Overall Study|Sponsor decision|40|||
125220614|NCT01843803|450434517|FG000|Overall Study|not a Veteran, did not see provider|1|||
125220615|NCT01843803|450434518|FG001|Overall Study|not a Veteran, did not see provider|3|||
125220616|NCT03311841|450434519|FG000|14-day Wash-out|Adverse Event|0|||
125220617|NCT03311841|450434520|FG001|14-day Wash-out|Adverse Event|1|||
125220618|NCT03311841|450434521|FG002|14-day Wash-out|Adverse Event|0|||
125220619|NCT03311841|450434522|FG003|14-day Wash-out|Adverse Event|0|||
125220620|NCT03311841|450434523|FG004|14-day Wash-out|Adverse Event|0|||
125220621|NCT03311841|450434519|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
125220622|NCT03311841|450434520|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
125220623|NCT03311841|450434521|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
125220624|NCT03311841|450434522|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
125220625|NCT03311841|450434523|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
125220626|NCT03360019|450434524|FG000|Overall Study|Withdrawal by Subject|2|||
125220627|NCT03360019|450434525|FG001|Overall Study|Withdrawal by Subject|0|||
125220628|NCT03360019|450434526|FG002|Overall Study|Withdrawal by Subject|0|||
125220629|NCT03360019|450434524|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
125056976|NCT05122650|449826879|FG001|Overall Study|Other|0|||
125056977|NCT05122650|449826880|FG002|Overall Study|Other|0|||
125056978|NCT05122650|449826881|FG003|Overall Study|Other|0|||
125056979|NCT02371759|449826888|FG000|Overall Study|Protocol Violation|3|||
125056980|NCT02371759|449826889|FG001|Overall Study|Protocol Violation|1|||
125056981|NCT02371759|449826890|FG002|Overall Study|Protocol Violation|1|||
125056982|NCT02371759|449826891|FG003|Overall Study|Protocol Violation|0|||
125056983|NCT02371759|449826892|FG004|Overall Study|Protocol Violation|3|||
125056984|NCT02371759|449826893|FG005|Overall Study|Protocol Violation|1|||
125056985|NCT02371759|449826894|FG006|Overall Study|Protocol Violation|0|||
125056986|NCT02371759|449826895|FG007|Overall Study|Protocol Violation|3|||
125056987|NCT02371759|449826888|FG000|Overall Study|Withdrawal by Subject|0|||
125056988|NCT02371759|449826889|FG001|Overall Study|Withdrawal by Subject|0|||
125056989|NCT02371759|449826890|FG002|Overall Study|Withdrawal by Subject|0|||
125056990|NCT02371759|449826891|FG003|Overall Study|Withdrawal by Subject|0|||
125056991|NCT02371759|449826892|FG004|Overall Study|Withdrawal by Subject|0|||
125056992|NCT02371759|449826893|FG005|Overall Study|Withdrawal by Subject|0|||
125220630|NCT03360019|450434525|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
125220631|NCT03360019|450434526|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
125220632|NCT01462110|450434527|FG000|Overall Study|Adverse Event|1|||
125220633|NCT01462110|450434528|FG001|Overall Study|Adverse Event|0|||
125220634|NCT00964028|450434529|FG000|Overall Study|Withdrawal by Subject|0|||
125220635|NCT00964028|450434530|FG001|Overall Study|Withdrawal by Subject|1|||
125056993|NCT02371759|449826894|FG006|Overall Study|Withdrawal by Subject|0|||
125220636|NCT02385110|450434531|FG000|Overall Study|Early Death|1|||
125220637|NCT02385110|450434532|FG001|Overall Study|Early Death|0|||
125056994|NCT02371759|449826895|FG007|Overall Study|Withdrawal by Subject|1|||
125056995|NCT01689207|449826896|FG000|Overall Study|Adverse Event|0|||
125056996|NCT01689207|449826897|FG001|Overall Study|Adverse Event|1|||
125056997|NCT01689207|449826898|FG002|Overall Study|Adverse Event|0|||
125056998|NCT01689207|449826899|FG003|Overall Study|Adverse Event|0|||
125056999|NCT01689207|449826900|FG004|Overall Study|Adverse Event|2|||
125057000|NCT01689207|449826901|FG005|Overall Study|Adverse Event|1|||
125057001|NCT01689207|449826902|FG006|Overall Study|Adverse Event|0|||
125057002|NCT01689207|449826903|FG007|Overall Study|Adverse Event|0|||
125057003|NCT01689207|449826904|FG008|Overall Study|Adverse Event|1|||
125057004|NCT01689207|449826905|FG009|Overall Study|Adverse Event|0|||
125057005|NCT01689207|449826906|FG010|Overall Study|Adverse Event|0|||
125057006|NCT01515306|449826910|FG000|Overall Study|Adverse Event|3|||
125057007|NCT01515306|449826911|FG001|Overall Study|Adverse Event|2|||
125057008|NCT01515306|449826910|FG000|Overall Study|Progressive Disease|19|||
125057009|NCT01515306|449826911|FG001|Overall Study|Progressive Disease|9|||
125057010|NCT01515306|449826910|FG000|Overall Study|Withdrawal by Subject|1|||
125057011|NCT01515306|449826911|FG001|Overall Study|Withdrawal by Subject|2|||
125057012|NCT01515306|449826910|FG000|Overall Study|Physician Decision|1|||
125057013|NCT01515306|449826911|FG001|Overall Study|Physician Decision|1|||
125057014|NCT00634244|449826915|FG000|Overall Study|Never started treatment|0|||
125057015|NCT00634244|449826916|FG001|Overall Study|Never started treatment|1|||
125057016|NCT00634244|449826917|FG002|Overall Study|Never started treatment|0|||
125057017|NCT00634244|449826915|FG000|Overall Study|Death|1|||
125057018|NCT00634244|449826916|FG001|Overall Study|Death|6|||
125057019|NCT00634244|449826917|FG002|Overall Study|Death|0|||
125057020|NCT00634244|449826915|FG000|Overall Study|Adverse Event|0|||
125057021|NCT00634244|449826916|FG001|Overall Study|Adverse Event|2|||
125057022|NCT00634244|449826917|FG002|Overall Study|Adverse Event|0|||
125057023|NCT00634244|449826915|FG000|Overall Study|Withdrawal by Subject|0|||
125057024|NCT00634244|449826916|FG001|Overall Study|Withdrawal by Subject|1|||
125057025|NCT00634244|449826917|FG002|Overall Study|Withdrawal by Subject|0|||
125137088|NCT02055547|450126460|FG013|Overall Study|Lost to Follow-up|0|||
125137089|NCT02055547|450126461|FG014|Overall Study|Lost to Follow-up|0|||
125137090|NCT02055547|450126462|FG015|Overall Study|Lost to Follow-up|0|||
125137091|NCT02055547|450126463|FG016|Overall Study|Lost to Follow-up|0|||
125137092|NCT02055547|450126464|FG017|Overall Study|Lost to Follow-up|0|||
125137093|NCT02055547|450126465|FG018|Overall Study|Lost to Follow-up|0|||
125137094|NCT01279486|450126466|FG000|Overall Study|Lost to Follow-up|1|||
125137095|NCT03067987|450126467|FG000|Overall Study|Lost to Follow-up|7|||
125137096|NCT03067987|450126468|FG001|Overall Study|Lost to Follow-up|10|||
125137097|NCT03067987|450126467|FG000|Overall Study|Protocol Violation|1|||
125137098|NCT03067987|450126468|FG001|Overall Study|Protocol Violation|2|||
125137099|NCT03067987|450126467|FG000|Overall Study|Withdrawal by Subject|2|||
125137100|NCT03067987|450126468|FG001|Overall Study|Withdrawal by Subject|1|||
125137101|NCT00829764|450126471|FG000|First Intervention|Adverse Event|1|||
125137102|NCT00829764|450126472|FG001|First Intervention|Adverse Event|0|||
125137103|NCT00829764|450126471|FG000|First Intervention|Withdrawal by Subject|1|||
125137104|NCT00829764|450126472|FG001|First Intervention|Withdrawal by Subject|1|||
125137105|NCT01750294|450128840|FG000|Overall Study|Withdrawal by Subject|1|||
125137106|NCT01750294|450128840|FG000|Overall Study|Safety Endpoint|1|||
125137107|NCT00665925|450128841|FG000|Overall Study|Lack of Efficacy|10|||
125137108|NCT00665925|450128842|FG001|Overall Study|Lack of Efficacy|8|||
125137109|NCT00665925|450128843|FG002|Overall Study|Lack of Efficacy|9|||
125137110|NCT00665925|450128844|FG003|Overall Study|Lack of Efficacy|8|||
125137111|NCT00665925|450128841|FG000|Overall Study|Lost to Follow-up|1|||
125137112|NCT00665925|450128842|FG001|Overall Study|Lost to Follow-up|2|||
125137113|NCT00665925|450128843|FG002|Overall Study|Lost to Follow-up|2|||
125057026|NCT00634244|449826915|FG000|Overall Study|Physician Decision|0|||
125057027|NCT00634244|449826916|FG001|Overall Study|Physician Decision|1|||
125057028|NCT00634244|449826917|FG002|Overall Study|Physician Decision|0|||
125137114|NCT00665925|450128844|FG003|Overall Study|Lost to Follow-up|2|||
125137115|NCT00665925|450128841|FG000|Overall Study|Withdrawal by Subject|2|||
125137116|NCT00665925|450128842|FG001|Overall Study|Withdrawal by Subject|2|||
125137117|NCT00665925|450128843|FG002|Overall Study|Withdrawal by Subject|3|||
125057029|NCT00634244|449826915|FG000|Overall Study|Disease progression/relapse|0|||
125057030|NCT00634244|449826916|FG001|Overall Study|Disease progression/relapse|1|||
125057031|NCT00634244|449826917|FG002|Overall Study|Disease progression/relapse|0|||
125137118|NCT00665925|450128844|FG003|Overall Study|Withdrawal by Subject|2|||
125057032|NCT00634244|449826915|FG000|Overall Study|Other complicating disease|0|||
125057033|NCT00634244|449826916|FG001|Overall Study|Other complicating disease|1|||
125057034|NCT00634244|449826917|FG002|Overall Study|Other complicating disease|0|||
125057035|NCT02427477|449826919|FG000|Period 1|Adverse Event|1|||
125057036|NCT02427477|449826920|FG001|Period 1|Adverse Event|0|||
125057037|NCT04369430|449826921|FG000|Overall Study|Adverse Event|2|||
125057038|NCT04369430|449826922|FG001|Overall Study|Adverse Event|3|||
125057039|NCT04369430|449826921|FG000|Overall Study|Death|1|||
125057040|NCT04369430|449826922|FG001|Overall Study|Death|0|||
125057041|NCT04369430|449826921|FG000|Overall Study|Withdrawal by Subject|4|||
125057042|NCT04369430|449826922|FG001|Overall Study|Withdrawal by Subject|3|||
125057043|NCT04369430|449826921|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
125057044|NCT04369430|449826922|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
125057045|NCT04369430|449826921|FG000|Overall Study|Lost to Follow-up|0|||
125057046|NCT04369430|449826922|FG001|Overall Study|Lost to Follow-up|1|||
125057047|NCT02635737|449826929|FG000|Overall Study|Protocol Violation|1|||
125057048|NCT00937768|449826930|FG000|Overall Study|Refused Further Treatment|3|||
125057049|NCT00937768|449826931|FG001|Overall Study|Refused Further Treatment|2|||
125057050|NCT00937768|449826930|FG000|Overall Study|Disease Progression|1|||
125057051|NCT00937768|449826931|FG001|Overall Study|Disease Progression|1|||
125057052|NCT00937768|449826930|FG000|Overall Study|Alternate Treatment|0|||
125057053|NCT00937768|449826931|FG001|Overall Study|Alternate Treatment|1|||
125057054|NCT00937768|449826930|FG000|Overall Study|No Further Funding|4|||
125057055|NCT00937768|449826931|FG001|Overall Study|No Further Funding|4|||
125057056|NCT01687413|449826932|FG000|Overall Study|Withdrawal by Subject|0|||
125057057|NCT01687413|449826933|FG001|Overall Study|Withdrawal by Subject|2|||
125057058|NCT01687413|449826932|FG000|Overall Study|Not eligible|0|||
125057059|NCT01687413|449826933|FG001|Overall Study|Not eligible|2|||
125057060|NCT01687413|449826932|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
125057061|NCT01687413|449826933|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
125057062|NCT01767194|449826934|FG000|Overall Study|Adverse Event|1|||
125057063|NCT01767194|449826935|FG001|Overall Study|Adverse Event|1|||
125057064|NCT01767194|449826934|FG000|Overall Study|Death|0|||
125057065|NCT01767194|449826935|FG001|Overall Study|Death|1|||
125057066|NCT01767194|449826934|FG000|Overall Study|Lack of Efficacy|12|||
125057067|NCT01767194|449826935|FG001|Overall Study|Lack of Efficacy|11|||
125057068|NCT01767194|449826934|FG000|Overall Study|Physician Decision|2|||
125057069|NCT01767194|449826935|FG001|Overall Study|Physician Decision|23|||
125057070|NCT01767194|449826934|FG000|Overall Study|Withdrawal by Subject|0|||
125057071|NCT01767194|449826935|FG001|Overall Study|Withdrawal by Subject|1|||
125057072|NCT01767194|449826934|FG000|Overall Study|Ineligible|1|||
125057073|NCT01767194|449826935|FG001|Overall Study|Ineligible|1|||
125057074|NCT01767194|449826934|FG000|Overall Study|Refusal by patient/parent|2|||
125057075|NCT01767194|449826935|FG001|Overall Study|Refusal by patient/parent|4|||
125057076|NCT01767194|449826934|FG000|Overall Study|Criteria not met on time for next cycle|0|||
125057077|NCT01767194|449826935|FG001|Overall Study|Criteria not met on time for next cycle|1|||
125057078|NCT04973228|449826936|FG000|Overall Study|Adverse Event|2|||
125057079|NCT04973228|449826937|FG001|Overall Study|Adverse Event|3|||
125057080|NCT04973228|449826936|FG000|Overall Study|Lack of Efficacy|1|||
125057081|NCT04973228|449826937|FG001|Overall Study|Lack of Efficacy|3|||
125057082|NCT04973228|449826936|FG000|Overall Study|Lost to Follow-up|12|||
125137119|NCT00665925|450128841|FG000|Overall Study|Physician Decision|0|||
125137120|NCT00665925|450128842|FG001|Overall Study|Physician Decision|0|||
125137121|NCT00665925|450128843|FG002|Overall Study|Physician Decision|1|||
125137122|NCT00665925|450128844|FG003|Overall Study|Physician Decision|2|||
125137123|NCT00665925|450128841|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
125137124|NCT00665925|450128842|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
125137125|NCT00665925|450128843|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
125137126|NCT00665925|450128844|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
125137127|NCT00665925|450128841|FG000|Overall Study|Adverse Event|1|||
125137128|NCT00665925|450128842|FG001|Overall Study|Adverse Event|5|||
125137129|NCT00665925|450128843|FG002|Overall Study|Adverse Event|10|||
125137130|NCT00665925|450128844|FG003|Overall Study|Adverse Event|5|||
125137131|NCT00665925|450128841|FG000|Overall Study|Enrolled by mistake|0|||
125057083|NCT04973228|449826937|FG001|Overall Study|Lost to Follow-up|4|||
125057084|NCT04973228|449826936|FG000|Overall Study|Withdrawal by Subject|11|||
125057085|NCT04973228|449826937|FG001|Overall Study|Withdrawal by Subject|4|||
125057086|NCT04973228|449826936|FG000|Overall Study|Did not tolerate application|1|||
125057087|NCT04973228|449826937|FG001|Overall Study|Did not tolerate application|0|||
125137132|NCT00665925|450128842|FG001|Overall Study|Enrolled by mistake|0|||
125220638|NCT00534638|450434534|FG000|Overall Study|Withdrawal by Subject|3|||
125057088|NCT04973228|449826936|FG000|Overall Study|Wanted to early terminate and use own product|0|||
125057089|NCT04973228|449826937|FG001|Overall Study|Wanted to early terminate and use own product|1|||
125057090|NCT04973228|449826936|FG000|Overall Study|Missed visits due to new work schedule|1|||
125137133|NCT00665925|450128843|FG002|Overall Study|Enrolled by mistake|0|||
125220639|NCT00534638|450434535|FG001|Overall Study|Withdrawal by Subject|4|||
125220640|NCT00534638|450434534|FG000|Overall Study|Migrated/moved from study area|13|||
125220641|NCT00534638|450434535|FG001|Overall Study|Migrated/moved from study area|11|||
125220642|NCT00534638|450434534|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
125220643|NCT00534638|450434535|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
125220644|NCT00534638|450434534|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
125220645|NCT00534638|450434535|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
125220646|NCT00534638|450434534|FG000|Overall Study|Other|1685|||
125057091|NCT04973228|449826937|FG001|Overall Study|Missed visits due to new work schedule|0|||
125057092|NCT02678780|449826943|FG000|Overall Study|Adverse Event|11|||
125057093|NCT02678780|449826944|FG001|Overall Study|Adverse Event|14|||
125057094|NCT02678780|449826943|FG000|Overall Study|Withdrawal by Subject|2|||
125057095|NCT02678780|449826944|FG001|Overall Study|Withdrawal by Subject|1|||
125057096|NCT02678780|449826943|FG000|Overall Study|Sponsor discontinuation|7|||
125057097|NCT02678780|449826944|FG001|Overall Study|Sponsor discontinuation|4|||
125057098|NCT02678780|449826943|FG000|Overall Study|Death|1|||
125057099|NCT02678780|449826944|FG001|Overall Study|Death|1|||
125057100|NCT02678780|449826943|FG000|Overall Study|Other|6|||
125057101|NCT02678780|449826944|FG001|Overall Study|Other|8|||
125057102|NCT01454401|449826959|FG000|Overall Study|Death|1|||
125057103|NCT01454401|449826959|FG000|Overall Study|hospitalised|1|||
125057104|NCT01454401|449826959|FG000|Overall Study|osteomyelitis|2|||
125057105|NCT01454401|449826959|FG000|Overall Study|non-adherence|1|||
125057106|NCT00488618|449826965|FG000|Overall Study|Adverse Event|13|||
125057107|NCT00488618|449826966|FG001|Overall Study|Adverse Event|17|||
125057108|NCT00488618|449826965|FG000|Overall Study|Insufficient Therapeutic Response|18|||
125057109|NCT00488618|449826966|FG001|Overall Study|Insufficient Therapeutic Response|11|||
125057110|NCT00488618|449826965|FG000|Overall Study|Protocol Violation|0|||
125057111|NCT00488618|449826966|FG001|Overall Study|Protocol Violation|2|||
125057112|NCT00488618|449826965|FG000|Overall Study|Withdrawal of Consent|15|||
125057113|NCT00488618|449826966|FG001|Overall Study|Withdrawal of Consent|13|||
125057114|NCT00488618|449826965|FG000|Overall Study|Lost to Follow-up|1|||
125057115|NCT00488618|449826966|FG001|Overall Study|Lost to Follow-up|0|||
125057116|NCT00992446|449826967|FG000|Overall Study|Disease Progression|1|||
125057117|NCT00992446|449826967|FG000|Overall Study|Withdrawal by Subject|2|||
125057118|NCT00992446|449826967|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
125057119|NCT03675737|449826970|FG000|Overall Study|Death|593|||
125057120|NCT03675737|449826971|FG001|Overall Study|Death|660|||
125057121|NCT03675737|449826970|FG000|Overall Study|Lost to Follow-up|1|||
125057122|NCT03675737|449826971|FG001|Overall Study|Lost to Follow-up|5|||
125057123|NCT03675737|449826970|FG000|Overall Study|Physician Decision|1|||
125057124|NCT03675737|449826971|FG001|Overall Study|Physician Decision|0|||
125057125|NCT03675737|449826970|FG000|Overall Study|Withdrawal by Subject|14|||
125057126|NCT03675737|449826971|FG001|Overall Study|Withdrawal by Subject|12|||
125057127|NCT03675737|449826970|FG000|Overall Study|Ongoing in Study|181|||
125057128|NCT03675737|449826971|FG001|Overall Study|Ongoing in Study|112|||
125057129|NCT02294318|449828615|FG000|Overall Study|Worsening of drinking|3|||
125057130|NCT02294318|449828616|FG001|Overall Study|Worsening of drinking|0|||
125057131|NCT02294318|449828615|FG000|Overall Study|Not exposed to intervention|0|||
125057132|NCT02294318|449828616|FG001|Overall Study|Not exposed to intervention|2|||
125057133|NCT03725202|449828618|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
125057134|NCT03725202|449828619|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
125057135|NCT03725202|449828620|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
125057136|NCT03725202|449828621|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
125057137|NCT03725202|449828622|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
125057138|NCT03725202|449828623|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
125057139|NCT03725202|449828624|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
125057140|NCT03725202|449828625|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
125057141|NCT03725202|449828618|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
125057142|NCT03725202|449828619|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
125057143|NCT03725202|449828620|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
125057144|NCT03725202|449828621|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
125057145|NCT03725202|449828622|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
125057146|NCT03725202|449828623|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
125057147|NCT03725202|449828624|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
125057148|NCT03725202|449828625|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
125057149|NCT03725202|449828618|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
125057150|NCT03725202|449828619|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
125057151|NCT03725202|449828620|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
125057152|NCT03725202|449828621|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
125057153|NCT03725202|449828622|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
125057154|NCT03725202|449828623|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
125057155|NCT03725202|449828624|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
125057156|NCT03725202|449828625|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
125057157|NCT03725202|449828618|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
125057158|NCT03725202|449828619|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
125057159|NCT03725202|449828620|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
125057160|NCT03725202|449828621|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
125057161|NCT03725202|449828622|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
125057162|NCT03725202|449828623|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
125057163|NCT03725202|449828624|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
125057164|NCT03725202|449828625|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
125057165|NCT03725202|449828618|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
125137134|NCT00665925|450128844|FG003|Overall Study|Enrolled by mistake|1|||
125057166|NCT03725202|449828619|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
125057167|NCT03725202|449828620|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
125057168|NCT03725202|449828621|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
125057169|NCT03725202|449828622|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
125057170|NCT03725202|449828623|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
125057171|NCT03725202|449828624|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
125057172|NCT03725202|449828625|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
125057173|NCT03725202|449828618|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
125057174|NCT03725202|449828619|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
125057175|NCT03725202|449828620|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
125057176|NCT03725202|449828621|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
125057177|NCT03725202|449828622|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
125057178|NCT03725202|449828623|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
125057179|NCT03725202|449828624|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
125057180|NCT03725202|449828625|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
125057181|NCT03725202|449828618|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
125057182|NCT03725202|449828619|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
125137135|NCT00665925|450128841|FG000|Overall Study|Due to exclusion criteria|1|||
125137136|NCT00665925|450128842|FG001|Overall Study|Due to exclusion criteria|0|||
125137137|NCT00665925|450128843|FG002|Overall Study|Due to exclusion criteria|0|||
125137138|NCT00665925|450128844|FG003|Overall Study|Due to exclusion criteria|0|||
125137139|NCT00334815|450128845|FG000|Overall Study|Adverse Event|3|||
125137140|NCT00334815|450128846|FG001|Overall Study|Adverse Event|2|||
125137141|NCT00334815|450128845|FG000|Overall Study|Death|0|||
125137142|NCT00334815|450128846|FG001|Overall Study|Death|2|||
125137143|NCT00334815|450128845|FG000|Overall Study|Progression|1|||
125137144|NCT00334815|450128846|FG001|Overall Study|Progression|0|||
125137145|NCT00334815|450128845|FG000|Overall Study|ineligible|1|||
125220647|NCT00534638|450434535|FG001|Overall Study|Other|902|||
125220648|NCT00452439|450436156|FG000|Overall Study|Lost to Follow-up|1|||
125137146|NCT00334815|450128846|FG001|Overall Study|ineligible|1|||
125137147|NCT00334815|450128845|FG000|Overall Study|patient refused treatment|0|||
125220649|NCT00452439|450436157|FG001|Overall Study|Lost to Follow-up|1|||
125220650|NCT00452439|450436156|FG000|Overall Study|Refused Treatment|4|||
125220651|NCT00452439|450436157|FG001|Overall Study|Refused Treatment|3|||
125220652|NCT00452439|450436156|FG000|Overall Study|Death|3|||
125220653|NCT00452439|450436157|FG001|Overall Study|Death|1|||
125220654|NCT00452439|450436156|FG000|Overall Study|Bone Marrow Transplant|0|||
125220655|NCT00452439|450436157|FG001|Overall Study|Bone Marrow Transplant|1|||
125220656|NCT00452439|450436156|FG000|Overall Study|Too Ill to Continue|0|||
125220657|NCT00452439|450436157|FG001|Overall Study|Too Ill to Continue|1|||
125220658|NCT00452439|450436156|FG000|Overall Study|Failed to achieve complete response|2|||
125220659|NCT00452439|450436157|FG001|Overall Study|Failed to achieve complete response|0|||
125220660|NCT00452439|450436156|FG000|Overall Study|Relapse|3|||
125220661|NCT00452439|450436157|FG001|Overall Study|Relapse|0|||
125220662|NCT00452439|450436156|FG000|Overall Study|Fracture|1|||
125220663|NCT00452439|450436157|FG001|Overall Study|Fracture|0|||
125220664|NCT04147247|450436164|FG000|Overall Study|Progressive disease|3|||
125220665|NCT04147247|450436165|FG001|Overall Study|Progressive disease|3|||
125220666|NCT04147247|450436166|FG002|Overall Study|Progressive disease|4|||
125220667|NCT04147247|450436167|FG003|Overall Study|Progressive disease|4|||
125220668|NCT04147247|450436168|FG004|Overall Study|Progressive disease|3|||
125057183|NCT03725202|449828620|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
125057184|NCT03725202|449828621|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
125057185|NCT03725202|449828622|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
125057186|NCT03725202|449828623|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
125057187|NCT03725202|449828624|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
125057188|NCT03725202|449828625|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
125057189|NCT03725202|449828618|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
125057190|NCT03725202|449828619|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
125057191|NCT03725202|449828620|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
125057192|NCT03725202|449828621|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
125057193|NCT03725202|449828622|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
125057194|NCT03725202|449828623|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
125057195|NCT03725202|449828624|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
125057196|NCT03725202|449828625|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
125057197|NCT03725202|449828618|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
125057198|NCT03725202|449828619|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
125057199|NCT03725202|449828620|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
125057200|NCT03725202|449828621|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
125057201|NCT03725202|449828622|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
125057202|NCT03725202|449828623|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
125057203|NCT03725202|449828624|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
125057204|NCT03725202|449828625|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
125057205|NCT03725202|449828618|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
125057206|NCT03725202|449828619|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
125220669|NCT04147247|450436164|FG000|Overall Study|Physician Decision|0|||
125220670|NCT04147247|450436165|FG001|Overall Study|Physician Decision|1|||
125220671|NCT04147247|450436166|FG002|Overall Study|Physician Decision|0|||
125220672|NCT04147247|450436167|FG003|Overall Study|Physician Decision|0|||
125220673|NCT04147247|450436168|FG004|Overall Study|Physician Decision|0|||
125220674|NCT04147247|450436164|FG000|Overall Study|Clinical Disease Progression|0|||
125057207|NCT03725202|449828620|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
125057208|NCT03725202|449828621|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
125057209|NCT03725202|449828622|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
125057210|NCT03725202|449828623|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
125057211|NCT03725202|449828624|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
125057212|NCT03725202|449828625|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
125057213|NCT03725202|449828618|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
125057214|NCT03725202|449828619|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
125057215|NCT03725202|449828620|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
125057216|NCT03725202|449828621|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
125057217|NCT03725202|449828622|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
125057218|NCT03725202|449828623|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
125137148|NCT00334815|450128846|FG001|Overall Study|patient refused treatment|1|||
125137149|NCT00334815|450128845|FG000|Overall Study|Physician Decision|2|||
125137150|NCT00334815|450128846|FG001|Overall Study|Physician Decision|4|||
125137151|NCT02197416|450128847|FG000|Overall Study|Other reasons|0|||
125137152|NCT02197416|450128848|FG001|Overall Study|Other reasons|2|||
125137153|NCT02197416|450128849|FG002|Overall Study|Other reasons|5|||
125137154|NCT02197416|450128847|FG000|Overall Study|Withdrawal by Subject|0|||
125137155|NCT02197416|450128848|FG001|Overall Study|Withdrawal by Subject|2|||
125137156|NCT02197416|450128849|FG002|Overall Study|Withdrawal by Subject|1|||
125137157|NCT02197416|450128847|FG000|Overall Study|Protocol Violation|1|||
125137158|NCT02197416|450128848|FG001|Overall Study|Protocol Violation|0|||
125137159|NCT02197416|450128849|FG002|Overall Study|Protocol Violation|1|||
125137160|NCT02197416|450128847|FG000|Overall Study|Adverse Event|0|||
125137161|NCT02197416|450128848|FG001|Overall Study|Adverse Event|0|||
125137162|NCT02197416|450128849|FG002|Overall Study|Adverse Event|1|||
125137163|NCT02451696|450128850|FG000|Overall Study|Surgery postponed|1|||
125137164|NCT02451696|450128851|FG001|Overall Study|Surgery postponed|0|||
125137165|NCT05014828|450128853|FG000|Overall Study|Study Completed by Sponsor|16|||
125137166|NCT05014828|450128854|FG001|Overall Study|Study Completed by Sponsor|16|||
125137167|NCT05014828|450128855|FG002|Overall Study|Study Completed by Sponsor|3|||
125137168|NCT05014828|450128856|FG003|Overall Study|Study Completed by Sponsor|3|||
125137169|NCT05014828|450128853|FG000|Overall Study|Death|11|||
125137170|NCT05014828|450128854|FG001|Overall Study|Death|6|||
125137171|NCT05014828|450128855|FG002|Overall Study|Death|0|||
125137172|NCT05014828|450128856|FG003|Overall Study|Death|0|||
125137173|NCT05014828|450128853|FG000|Overall Study|Lost to Follow-up|0|||
125137174|NCT05014828|450128854|FG001|Overall Study|Lost to Follow-up|0|||
125137175|NCT05014828|450128855|FG002|Overall Study|Lost to Follow-up|2|||
125137176|NCT05014828|450128856|FG003|Overall Study|Lost to Follow-up|0|||
125137177|NCT05014828|450128853|FG000|Overall Study|Miscellaneous.|0|||
125137178|NCT05014828|450128854|FG001|Overall Study|Miscellaneous.|1|||
125137179|NCT05014828|450128855|FG002|Overall Study|Miscellaneous.|0|||
125137180|NCT05014828|450128856|FG003|Overall Study|Miscellaneous.|0|||
125137181|NCT02392195|450128859|FG000|Overall Study|Lost to Follow-up|4|||
125137182|NCT02392195|450128859|FG000|Overall Study|Withdrawal by Subject|4|||
125057219|NCT03725202|449828624|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
125057220|NCT03725202|449828625|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
125057221|NCT03725202|449828618|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
125057222|NCT03725202|449828619|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
125057223|NCT03725202|449828620|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
125057224|NCT03725202|449828621|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
125137183|NCT00545792|450128862|FG000|Overall Study|Withdrawal by Subject|1|||
125137184|NCT03679598|450128864|FG000|Overall Study|Adverse Event|2|||
125137185|NCT03679598|450128865|FG001|Overall Study|Adverse Event|0|||
125137186|NCT03779334|450128868|FG000|Overall Study|Withdrawal by Subject|3|||
125057225|NCT03725202|449828622|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
125057226|NCT03725202|449828623|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
125137187|NCT03779334|450128869|FG001|Overall Study|Withdrawal by Subject|0|||
125137188|NCT03779334|450128870|FG002|Overall Study|Withdrawal by Subject|0|||
125137189|NCT03779334|450128868|FG000|Overall Study|Ongoing in Study|5|||
125137190|NCT03779334|450128869|FG001|Overall Study|Ongoing in Study|13|||
125057227|NCT03725202|449828624|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
125057228|NCT03725202|449828625|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
125057229|NCT01328249|449828628|FG000|Overall Study|Adverse Event|3|||
125057230|NCT01328249|449828629|FG001|Overall Study|Adverse Event|0|||
125137191|NCT03779334|450128870|FG002|Overall Study|Ongoing in Study|5|||
125137192|NCT01175135|450128871|FG000|Overall Study|Adverse Event|2|||
125137193|NCT01175135|450128872|FG001|Overall Study|Adverse Event|5|||
125137194|NCT01175135|450128873|FG002|Overall Study|Adverse Event|3|||
125137195|NCT01175135|450128874|FG003|Overall Study|Adverse Event|4|||
125137196|NCT01175135|450128871|FG000|Overall Study|Death|1|||
125137197|NCT01175135|450128872|FG001|Overall Study|Death|0|||
125137198|NCT01175135|450128873|FG002|Overall Study|Death|0|||
125137199|NCT01175135|450128874|FG003|Overall Study|Death|0|||
125137200|NCT01175135|450128871|FG000|Overall Study|Lack of Efficacy|4|||
125137201|NCT01175135|450128872|FG001|Overall Study|Lack of Efficacy|5|||
125137202|NCT01175135|450128873|FG002|Overall Study|Lack of Efficacy|0|||
125137203|NCT01175135|450128874|FG003|Overall Study|Lack of Efficacy|5|||
125137204|NCT01175135|450128871|FG000|Overall Study|Lost to Follow-up|1|||
125137205|NCT01175135|450128872|FG001|Overall Study|Lost to Follow-up|2|||
125137206|NCT01175135|450128873|FG002|Overall Study|Lost to Follow-up|0|||
125137207|NCT01175135|450128874|FG003|Overall Study|Lost to Follow-up|0|||
125137208|NCT01175135|450128871|FG000|Overall Study|Protocol Violation|1|||
125137209|NCT01175135|450128872|FG001|Overall Study|Protocol Violation|1|||
125137210|NCT01175135|450128873|FG002|Overall Study|Protocol Violation|0|||
125137211|NCT01175135|450128874|FG003|Overall Study|Protocol Violation|0|||
125137212|NCT01175135|450128871|FG000|Overall Study|Withdrawal by Subject|4|||
125137213|NCT01175135|450128872|FG001|Overall Study|Withdrawal by Subject|8|||
125137214|NCT01175135|450128873|FG002|Overall Study|Withdrawal by Subject|5|||
125137215|NCT01175135|450128874|FG003|Overall Study|Withdrawal by Subject|5|||
125137216|NCT01175135|450128871|FG000|Overall Study|Other|3|||
125137217|NCT01175135|450128872|FG001|Overall Study|Other|1|||
125137218|NCT01175135|450128873|FG002|Overall Study|Other|3|||
125137219|NCT01175135|450128874|FG003|Overall Study|Other|0|||
125137220|NCT01175135|450128871|FG000|Overall Study|Randomized But Not Treated|0|||
125137221|NCT01175135|450128872|FG001|Overall Study|Randomized But Not Treated|0|||
125137222|NCT01175135|450128873|FG002|Overall Study|Randomized But Not Treated|1|||
125137223|NCT01175135|450128874|FG003|Overall Study|Randomized But Not Treated|0|||
125137224|NCT04692155|450128878|FG000|Overall Study|Death|1|||
125137225|NCT03957551|450128879|FG000|Overall Study|Adverse Event|2|||
125137226|NCT03957551|450128880|FG001|Overall Study|Adverse Event|2|||
125137227|NCT03957551|450128881|FG002|Overall Study|Adverse Event|6|||
125137228|NCT03957551|450128879|FG000|Overall Study|Physician Decision|1|||
125057231|NCT01328249|449828628|FG000|Overall Study|Disease progression|1|||
125057232|NCT01328249|449828629|FG001|Overall Study|Disease progression|0|||
125057233|NCT01328249|449828628|FG000|Overall Study|Withdrawal by Subject|1|||
125057234|NCT01328249|449828629|FG001|Overall Study|Withdrawal by Subject|1|||
125057235|NCT01328249|449828628|FG000|Overall Study|Moved before end of treatment visit|1|||
125057236|NCT01328249|449828629|FG001|Overall Study|Moved before end of treatment visit|0|||
125057237|NCT01328249|449828628|FG000|Overall Study|Subject choice|1|||
125057238|NCT01328249|449828629|FG001|Overall Study|Subject choice|1|||
125057239|NCT01328249|449828628|FG000|Overall Study|Protocol Violation|0|||
125057240|NCT01328249|449828629|FG001|Overall Study|Protocol Violation|1|||
125057241|NCT01215734|449828630|FG000|Overall Study|Death|0|||
125057242|NCT01215734|449828631|FG001|Overall Study|Death|1|||
125137229|NCT03957551|450128880|FG001|Overall Study|Physician Decision|0|||
125137230|NCT03957551|450128881|FG002|Overall Study|Physician Decision|2|||
125137231|NCT03957551|450128879|FG000|Overall Study|Withdrawal by Subject|1|||
125137232|NCT03957551|450128880|FG001|Overall Study|Withdrawal by Subject|0|||
125137233|NCT03957551|450128881|FG002|Overall Study|Withdrawal by Subject|2|||
125220675|NCT04147247|450436165|FG001|Overall Study|Clinical Disease Progression|0|||
125057243|NCT00748553|449828632|FG000|Overall Study|Adverse Event|0|||
125057244|NCT00748553|449828633|FG001|Overall Study|Adverse Event|1|||
125057245|NCT00748553|449828632|FG000|Overall Study|disease progression|2|||
125057246|NCT00748553|449828633|FG001|Overall Study|disease progression|0|||
125137234|NCT03957551|450128879|FG000|Overall Study|Disease progression|1|||
125220676|NCT04147247|450436166|FG002|Overall Study|Clinical Disease Progression|0|||
125057247|NCT00748553|449828632|FG000|Overall Study|noncompliance|1|||
125057248|NCT00748553|449828633|FG001|Overall Study|noncompliance|0|||
125137235|NCT03957551|450128880|FG001|Overall Study|Disease progression|0|||
125137236|NCT03957551|450128881|FG002|Overall Study|Disease progression|8|||
125137237|NCT03676634|450128884|FG000|Overall Study|Red blood cell loss|1|||
125220677|NCT04147247|450436167|FG003|Overall Study|Clinical Disease Progression|0|||
125137238|NCT03676634|450128884|FG000|Overall Study|Out-of-limit pulse|2|||
125057249|NCT00315705|449828634|FG000|Phase 1|Refused further treatment|1|||
125057250|NCT00315705|449828634|FG000|Phase 1|Failure to achieve response|8|||
125057251|NCT00315705|449828634|FG000|Phase 1|Disease relapse|4|||
125057252|NCT00315705|449828634|FG000|Phase 1|Scheduled for transplant|9|||
125057253|NCT00315705|449828634|FG000|Phase 1|Death|3|||
125057254|NCT00315705|449828634|FG000|Phase 2|Physician Decision|4|||
125057255|NCT00315705|449828634|FG000|Phase 2|Adverse Event|1|||
125057256|NCT00315705|449828634|FG000|Phase 2|Failure to achieve response|3|||
125057257|NCT00315705|449828634|FG000|Phase 2|Disease relapse|1|||
125057258|NCT00315705|449828634|FG000|Phase 2|Scheduled for transplant|8|||
125057259|NCT00315705|449828634|FG000|Phase 2|Other|1|||
125057260|NCT00315705|449828634|FG000|Phase 2|Death|7|||
125057261|NCT01716533|449828636|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
125057262|NCT01716533|449828637|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
125057263|NCT01716533|449828638|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
125057264|NCT01716533|449828639|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
125057265|NCT01716533|449828636|FG000|Overall Study|Withdrawal by Subject|0|||
125057266|NCT01716533|449828637|FG001|Overall Study|Withdrawal by Subject|0|||
125137239|NCT00540423|450128890|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125137240|NCT00540423|450128891|FG001|Double-Blind Treatment Period|Adverse Event|1|||
125057267|NCT01716533|449828638|FG002|Overall Study|Withdrawal by Subject|0|||
125057268|NCT01716533|449828639|FG003|Overall Study|Withdrawal by Subject|5|||
125137241|NCT00540423|450128892|FG002|Double-Blind Treatment Period|Adverse Event|0|||
125057269|NCT01716533|449828636|FG000|Overall Study|Death|0|||
125057270|NCT01716533|449828637|FG001|Overall Study|Death|0|||
125057271|NCT01716533|449828638|FG002|Overall Study|Death|0|||
125057272|NCT01716533|449828639|FG003|Overall Study|Death|2|||
125057273|NCT01716533|449828636|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
125057274|NCT01716533|449828637|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
125057275|NCT01716533|449828638|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
125057276|NCT01716533|449828639|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
125057277|NCT02330549|449828640|FG000|Overall Study|Adverse Event|1|||
125057278|NCT02330549|449828641|FG001|Overall Study|Adverse Event|0|||
125057279|NCT02330549|449828640|FG000|Overall Study|Subject withdrew consent|2|||
125057280|NCT02330549|449828641|FG001|Overall Study|Subject withdrew consent|1|||
125057281|NCT02330549|449828640|FG000|Overall Study|Failure to meet randomization criteria|1|||
125057282|NCT02330549|449828641|FG001|Overall Study|Failure to meet randomization criteria|0|||
125057283|NCT00745368|449828647|FG000|Overall Study|Unable to provide sample|3|||
125057284|NCT00495495|449828648|FG000|Overall Study|Protocol Violation|99|||
125057285|NCT03331666|449828652|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
125057286|NCT03331666|449828653|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
125057287|NCT02326467|449828654|FG000|Overall Study|Withdrawal by Subject|1|||
125057288|NCT00434512|449828655|FG000|Overall Study|Migrated/moved from study area|0|||
125057289|NCT00434512|449828656|FG001|Overall Study|Migrated/moved from study area|0|||
125057290|NCT00434512|449828657|FG002|Overall Study|Migrated/moved from study area|0|||
125057291|NCT00434512|449828658|FG003|Overall Study|Migrated/moved from study area|1|||
125057292|NCT00434512|449828659|FG004|Overall Study|Migrated/moved from study area|1|||
125057293|NCT00434512|449828660|FG005|Overall Study|Migrated/moved from study area|1|||
125057294|NCT00434512|449828655|FG000|Overall Study|Other|0|||
125057295|NCT00434512|449828656|FG001|Overall Study|Other|1|||
125057296|NCT00434512|449828657|FG002|Overall Study|Other|0|||
125057297|NCT00434512|449828658|FG003|Overall Study|Other|0|||
125057298|NCT00434512|449828659|FG004|Overall Study|Other|0|||
125057299|NCT00434512|449828660|FG005|Overall Study|Other|0|||
125057300|NCT01575197|449828663|FG000|Overall Study|Migration out of study area|1|||
125057301|NCT01575197|449828664|FG001|Overall Study|Migration out of study area|5|||
125057302|NCT01575197|449828665|FG002|Overall Study|Migration out of study area|4|||
125057303|NCT01575197|449828663|FG000|Overall Study|SAE|0|||
125057304|NCT01575197|449828664|FG001|Overall Study|SAE|1|||
125057305|NCT01575197|449828665|FG002|Overall Study|SAE|0|||
125057306|NCT01575197|449828663|FG000|Overall Study|Lost to Follow-up|0|||
125057307|NCT01575197|449828664|FG001|Overall Study|Lost to Follow-up|1|||
125057308|NCT01575197|449828665|FG002|Overall Study|Lost to Follow-up|0|||
125137242|NCT00540423|450128890|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
125137243|NCT00540423|450128891|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
125137244|NCT00540423|450128892|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
125137245|NCT03131895|450128893|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
125057309|NCT01575197|449828663|FG000|Overall Study|Withdrawal by Subject|0|||
125057310|NCT01575197|449828664|FG001|Overall Study|Withdrawal by Subject|1|||
125057311|NCT01575197|449828665|FG002|Overall Study|Withdrawal by Subject|1|||
125057312|NCT01575197|449828663|FG000|Overall Study|Protocol Violation|2|||
125057313|NCT01575197|449828664|FG001|Overall Study|Protocol Violation|1|||
125057314|NCT01575197|449828665|FG002|Overall Study|Protocol Violation|1|||
125057315|NCT03137121|449828668|FG000|Overall Study|Withdrawal by Subject|0|||
125057316|NCT03137121|449828669|FG001|Overall Study|Withdrawal by Subject|1|||
125137246|NCT03131895|450128894|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
125057317|NCT00111475|449828673|FG000|Overall Study|Lost to Follow-up|0|||
125137247|NCT03131895|450128895|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
125137248|NCT03131895|450128896|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
125137249|NCT03131895|450128893|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
125137250|NCT03131895|450128894|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
125137251|NCT03131895|450128895|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
125137252|NCT03131895|450128896|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
125137253|NCT03131895|450128893|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
125137254|NCT03131895|450128894|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
125137255|NCT03131895|450128895|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
125137256|NCT03131895|450128896|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
125137257|NCT03131895|450128893|FG000|Washout Period (at Least 5 Days)|Other|0|||
125137258|NCT03131895|450128894|FG001|Washout Period (at Least 5 Days)|Other|0|||
125137259|NCT03131895|450128895|FG002|Washout Period (at Least 5 Days)|Other|2|||
125137260|NCT03131895|450128896|FG003|Washout Period (at Least 5 Days)|Other|0|||
125137261|NCT03131895|450128893|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
125137262|NCT03131895|450128894|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
125137263|NCT03131895|450128895|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
125137264|NCT03131895|450128896|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
125137265|NCT03131895|450128893|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
125137266|NCT03131895|450128894|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
125137267|NCT03131895|450128895|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
125137268|NCT03131895|450128896|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
125137269|NCT00216736|450128905|FG000|Overall Study|Lost to Follow-up|1|||
125137270|NCT00216736|450128906|FG001|Overall Study|Lost to Follow-up|1|||
125137271|NCT00418145|450128907|FG000|Overall Study|study terminated|6|||
125137272|NCT03214588|450128908|FG000|Overall Study|Adverse Event|1|||
125137273|NCT03214588|450128909|FG001|Overall Study|Adverse Event|0|||
125137274|NCT03214588|450128910|FG002|Overall Study|Adverse Event|2|||
125137275|NCT03214588|450128908|FG000|Overall Study|Reason Not Specified|0|||
125137276|NCT03214588|450128909|FG001|Overall Study|Reason Not Specified|1|||
125137277|NCT03214588|450128910|FG002|Overall Study|Reason Not Specified|0|||
125137278|NCT03480763|450128915|FG000|Overall Study|Withdrawal by Subject|18|||
125137279|NCT03480763|450128916|FG001|Overall Study|Withdrawal by Subject|10|||
125137280|NCT03480763|450128915|FG000|Overall Study|Lost to Follow-up|4|||
125057318|NCT00111475|449828674|FG001|Overall Study|Lost to Follow-up|0|||
125057319|NCT00111475|449828675|FG002|Overall Study|Lost to Follow-up|0|||
125057320|NCT00111475|449828676|FG003|Overall Study|Lost to Follow-up|0|||
125057321|NCT00111475|449828677|FG004|Overall Study|Lost to Follow-up|0|||
125057322|NCT00111475|449828678|FG005|Overall Study|Lost to Follow-up|1|||
125057323|NCT00111475|449828679|FG006|Overall Study|Lost to Follow-up|0|||
125057324|NCT00111475|449828680|FG007|Overall Study|Lost to Follow-up|0|||
125057325|NCT00111475|449828681|FG008|Overall Study|Lost to Follow-up|0|||
125057326|NCT00111475|449828682|FG009|Overall Study|Lost to Follow-up|0|||
125057327|NCT03303092|449828683|FG000|Overall Study|Adverse Event|1|||
125057328|NCT03303092|449828684|FG001|Overall Study|Adverse Event|0|||
125057329|NCT03303092|449828685|FG002|Overall Study|Adverse Event|1|||
125137281|NCT03480763|450128916|FG001|Overall Study|Lost to Follow-up|7|||
125137282|NCT03480763|450128915|FG000|Overall Study|non-study pneumococcal vaccine|1|||
125137283|NCT03480763|450128916|FG001|Overall Study|non-study pneumococcal vaccine|0|||
125057330|NCT03303092|449828683|FG000|Overall Study|Protocol Violation|1|||
125137284|NCT03480763|450128915|FG000|Overall Study|oncological treatment|0|||
125057331|NCT03303092|449828684|FG001|Overall Study|Protocol Violation|5|||
125137285|NCT03480763|450128916|FG001|Overall Study|oncological treatment|2|||
125137286|NCT03480763|450128915|FG000|Overall Study|pain with vaccination|1|||
125137287|NCT03480763|450128916|FG001|Overall Study|pain with vaccination|0|||
125137288|NCT03629054|450128920|FG000|Period 2 (4 Days)|Not treated|0|||
125137289|NCT03629054|450128921|FG001|Period 2 (4 Days)|Not treated|1|||
125137290|NCT00205777|450128922|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
125137291|NCT00205777|450128923|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
125137292|NCT00205777|450128924|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
125137293|NCT00205777|450128925|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
125137294|NCT00205777|450128926|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
125137295|NCT00205777|450128927|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
125137296|NCT00205777|450128922|FG000|Core Study (Up to 3 Years)|Death|9|||
125220678|NCT04147247|450436168|FG004|Overall Study|Clinical Disease Progression|1|||
125137297|NCT00205777|450128923|FG001|Core Study (Up to 3 Years)|Death|7|||
125137298|NCT00205777|450128924|FG002|Core Study (Up to 3 Years)|Death|14|||
125137299|NCT00205777|450128925|FG003|Core Study (Up to 3 Years)|Death|7|||
125137300|NCT00205777|450128926|FG004|Core Study (Up to 3 Years)|Death|0|||
125137301|NCT00205777|450128927|FG005|Core Study (Up to 3 Years)|Death|0|||
125137302|NCT00205777|450128922|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
125137303|NCT00205777|450128923|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
125137304|NCT00205777|450128924|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
125137305|NCT00205777|450128925|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
125137306|NCT00205777|450128926|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
125137307|NCT00205777|450128927|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
125137308|NCT00205777|450128922|FG000|Core Study (Up to 3 Years)|Other Event|49|||
125137309|NCT00205777|450128923|FG001|Core Study (Up to 3 Years)|Other Event|52|||
125137310|NCT00205777|450128924|FG002|Core Study (Up to 3 Years)|Other Event|41|||
125137311|NCT00205777|450128925|FG003|Core Study (Up to 3 Years)|Other Event|58|||
125137312|NCT00205777|450128926|FG004|Core Study (Up to 3 Years)|Other Event|0|||
125137313|NCT00205777|450128927|FG005|Core Study (Up to 3 Years)|Other Event|0|||
125137314|NCT00205777|450128922|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
125137315|NCT00205777|450128923|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
125137316|NCT00205777|450128924|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
125137317|NCT00205777|450128925|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
125137318|NCT00205777|450128926|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
125137319|NCT00205777|450128927|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
125137320|NCT00205777|450128922|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
125137321|NCT00205777|450128923|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
125137322|NCT00205777|450128924|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
125137323|NCT00205777|450128925|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
125137324|NCT00205777|450128926|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
125137325|NCT00205777|450128927|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
125137326|NCT00205777|450128922|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
125137327|NCT00205777|450128923|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
125137328|NCT00205777|450128924|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
125137329|NCT00205777|450128925|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
125137330|NCT00205777|450128926|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
125137331|NCT00205777|450128927|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
125137332|NCT00205777|450128922|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
125137333|NCT00205777|450128923|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
125137334|NCT00205777|450128924|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
125137335|NCT00205777|450128925|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
125137336|NCT00205777|450128926|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
125137337|NCT00205777|450128927|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
125137338|NCT00205777|450128922|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
125137339|NCT00205777|450128923|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
125137340|NCT00205777|450128924|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
125137341|NCT00205777|450128925|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
125137342|NCT00205777|450128926|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
125137343|NCT00205777|450128927|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
125137344|NCT00205777|450128922|FG000|Completed Core Study, Entered SE I|Other Event|52|||
125137345|NCT00205777|450128923|FG001|Completed Core Study, Entered SE I|Other Event|46|||
125137346|NCT00205777|450128924|FG002|Completed Core Study, Entered SE I|Other Event|47|||
125137347|NCT00205777|450128925|FG003|Completed Core Study, Entered SE I|Other Event|50|||
125137348|NCT00205777|450128926|FG004|Completed Core Study, Entered SE I|Other Event|0|||
125137349|NCT00205777|450128927|FG005|Completed Core Study, Entered SE I|Other Event|0|||
125220679|NCT04147247|450436164|FG000|Overall Study|Adverse Event|0|||
125137350|NCT00205777|450128922|FG000|Study Extension I|Adverse Event|57|||
125137351|NCT00205777|450128923|FG001|Study Extension I|Adverse Event|0|||
125137352|NCT00205777|450128924|FG002|Study Extension I|Adverse Event|0|||
125137353|NCT00205777|450128925|FG003|Study Extension I|Adverse Event|61|||
125137354|NCT00205777|450128926|FG004|Study Extension I|Adverse Event|58|||
125220680|NCT04147247|450436165|FG001|Overall Study|Adverse Event|0|||
125220681|NCT04147247|450436166|FG002|Overall Study|Adverse Event|1|||
125220682|NCT04147247|450436167|FG003|Overall Study|Adverse Event|0|||
125220683|NCT04147247|450436168|FG004|Overall Study|Adverse Event|1|||
125220684|NCT00130689|450436169|FG000|Overall Study|Progressive Disease|29|||
125220685|NCT00130689|450436169|FG000|Overall Study|Death|1|||
125220686|NCT00130689|450436169|FG000|Overall Study|Clinical Deterioration|4|||
125220687|NCT00130689|450436169|FG000|Overall Study|Withdrawal by Subject|3|||
125220688|NCT00130689|450436169|FG000|Overall Study|Ineligible|6|||
125220689|NCT00943397|450436170|FG000|Overall Study|Adverse Event|0|||
125220690|NCT00943397|450436171|FG001|Overall Study|Adverse Event|6|||
125057332|NCT03303092|449828685|FG002|Overall Study|Protocol Violation|1|||
125057333|NCT03303092|449828683|FG000|Overall Study|Withdrawal by Subject|1|||
125057334|NCT03303092|449828684|FG001|Overall Study|Withdrawal by Subject|1|||
125057335|NCT03303092|449828685|FG002|Overall Study|Withdrawal by Subject|3|||
125057336|NCT01026389|449828688|FG000|Overall Study|Withdrawal by Subject|1|||
125057337|NCT01026389|449828689|FG001|Overall Study|Withdrawal by Subject|3|||
125057338|NCT01026389|449828688|FG000|Overall Study|change of treatment, patient moved|4|||
125057339|NCT01026389|449828689|FG001|Overall Study|change of treatment, patient moved|2|||
125057340|NCT00836277|449828690|FG000|Overall Study|Not evaluable for response|6|||
125057341|NCT01995136|449828691|FG000|Overall Study|Change in residence|1|||
125057342|NCT04410198|449828692|FG000|Overall Study|Death|10|||
125057343|NCT04410198|449828692|FG000|Overall Study|Withdrawal by Subject|7|||
125057344|NCT04410198|449828692|FG000|Overall Study|Transferred/Relocation|4|||
125057345|NCT04410198|449828692|FG000|Overall Study|Kidney Transplant|9|||
125057346|NCT04410198|449828692|FG000|Overall Study|Adverse Event|4|||
125057347|NCT04410198|449828692|FG000|Overall Study|Physician Decision|2|||
125057348|NCT04410198|449828692|FG000|Overall Study|Other than specified|1|||
125057349|NCT01830543|449828698|FG000|Overall Study|Subject Decision|19|||
125057350|NCT01830543|449828699|FG001|Overall Study|Subject Decision|21|||
125057351|NCT01830543|449828700|FG002|Overall Study|Subject Decision|57|||
125057352|NCT01830543|449828698|FG000|Overall Study|Adverse Event|91|||
125057353|NCT01830543|449828699|FG001|Overall Study|Adverse Event|77|||
125057354|NCT01830543|449828700|FG002|Overall Study|Adverse Event|76|||
125057355|NCT01830543|449828698|FG000|Overall Study|Death|20|||
125057356|NCT01830543|449828699|FG001|Overall Study|Death|22|||
125057357|NCT01830543|449828700|FG002|Overall Study|Death|22|||
125137355|NCT00205777|450128927|FG005|Study Extension I|Adverse Event|0|||
125137356|NCT00205777|450128922|FG000|Study Extension I|Death|5|||
125137357|NCT00205777|450128923|FG001|Study Extension I|Death|0|||
125137358|NCT00205777|450128924|FG002|Study Extension I|Death|0|||
125137359|NCT00205777|450128925|FG003|Study Extension I|Death|1|||
125137360|NCT00205777|450128926|FG004|Study Extension I|Death|2|||
125137361|NCT00205777|450128927|FG005|Study Extension I|Death|0|||
125137362|NCT00205777|450128922|FG000|Study Extension I|Withdrawal by Subject|99|||
125137363|NCT00205777|450128923|FG001|Study Extension I|Withdrawal by Subject|0|||
125137364|NCT00205777|450128924|FG002|Study Extension I|Withdrawal by Subject|0|||
125137365|NCT00205777|450128925|FG003|Study Extension I|Withdrawal by Subject|106|||
125137366|NCT00205777|450128926|FG004|Study Extension I|Withdrawal by Subject|89|||
125137367|NCT00205777|450128927|FG005|Study Extension I|Withdrawal by Subject|0|||
125137368|NCT00205777|450128922|FG000|Study Extension I|Protocol Violation|4|||
125137369|NCT00205777|450128923|FG001|Study Extension I|Protocol Violation|0|||
125137370|NCT00205777|450128924|FG002|Study Extension I|Protocol Violation|0|||
125137371|NCT00205777|450128925|FG003|Study Extension I|Protocol Violation|8|||
125137372|NCT00205777|450128926|FG004|Study Extension I|Protocol Violation|8|||
125137373|NCT00205777|450128927|FG005|Study Extension I|Protocol Violation|0|||
125137374|NCT00205777|450128922|FG000|Study Extension I|Lack of Efficacy|0|||
125137375|NCT00205777|450128923|FG001|Study Extension I|Lack of Efficacy|0|||
125137376|NCT00205777|450128924|FG002|Study Extension I|Lack of Efficacy|0|||
125137377|NCT00205777|450128925|FG003|Study Extension I|Lack of Efficacy|1|||
125137378|NCT00205777|450128926|FG004|Study Extension I|Lack of Efficacy|2|||
125137379|NCT00205777|450128927|FG005|Study Extension I|Lack of Efficacy|0|||
125137380|NCT00205777|450128922|FG000|Study Extension I|Failed to return|15|||
125137381|NCT00205777|450128923|FG001|Study Extension I|Failed to return|0|||
125137382|NCT00205777|450128924|FG002|Study Extension I|Failed to return|0|||
125220691|NCT00943397|450436170|FG000|Overall Study|Lost to Follow-up|0|||
125057358|NCT01830543|449828698|FG000|Overall Study|Protocol Violation|3|||
125057359|NCT01830543|449828699|FG001|Overall Study|Protocol Violation|7|||
125057360|NCT01830543|449828700|FG002|Overall Study|Protocol Violation|7|||
125057361|NCT01830543|449828698|FG000|Overall Study|Physician Decision|11|||
125057362|NCT01830543|449828699|FG001|Overall Study|Physician Decision|5|||
125220692|NCT00943397|450436171|FG001|Overall Study|Lost to Follow-up|4|||
125057363|NCT01830543|449828700|FG002|Overall Study|Physician Decision|12|||
125057364|NCT01830543|449828698|FG000|Overall Study|Withdrawal by consent|3|||
125057365|NCT01830543|449828699|FG001|Overall Study|Withdrawal by consent|3|||
125137383|NCT00205777|450128925|FG003|Study Extension I|Failed to return|17|||
125137384|NCT00205777|450128926|FG004|Study Extension I|Failed to return|13|||
125220693|NCT00943397|450436170|FG000|Overall Study|Protocol Violation|2|||
125057366|NCT01830543|449828700|FG002|Overall Study|Withdrawal by consent|3|||
125057367|NCT01830543|449828698|FG000|Overall Study|Other|12|||
125057368|NCT01830543|449828699|FG001|Overall Study|Other|17|||
125057369|NCT01830543|449828700|FG002|Overall Study|Other|37|||
125057370|NCT00568958|449828705|FG000|Allocation|Withdrawal by Subject|7|||
125057371|NCT00568958|449828706|FG001|Allocation|Withdrawal by Subject|3|||
125057372|NCT00568958|449828705|FG000|Allocation|Physician Decision|2|||
125057373|NCT00568958|449828706|FG001|Allocation|Physician Decision|0|||
125057374|NCT00568958|449828705|FG000|Follow-Up|Withdrawal by Subject|6|||
125057375|NCT00568958|449828706|FG001|Follow-Up|Withdrawal by Subject|6|||
125057376|NCT00568958|449828705|FG000|Follow-Up|Physician Decision|1|||
125057377|NCT00568958|449828706|FG001|Follow-Up|Physician Decision|1|||
125057378|NCT00568958|449828705|FG000|Follow-Up|Family Emergency|1|||
125057379|NCT00568958|449828706|FG001|Follow-Up|Family Emergency|0|||
125057380|NCT00568958|449828705|FG000|Follow-Up|Adverse Event|1|||
125057381|NCT00568958|449828706|FG001|Follow-Up|Adverse Event|0|||
125057382|NCT01354353|449828708|FG000|Overall Study|Adverse Event|1|||
125057383|NCT01354353|449828709|FG001|Overall Study|Adverse Event|0|||
125057384|NCT01354353|449828710|FG002|Overall Study|Adverse Event|0|||
125057385|NCT01354353|449828711|FG003|Overall Study|Adverse Event|4|||
125057386|NCT01354353|449828712|FG004|Overall Study|Adverse Event|0|||
125057387|NCT01354353|449828713|FG005|Overall Study|Adverse Event|5|||
125057388|NCT01354353|449828708|FG000|Overall Study|Entry Criteria Not Met|0|||
125057389|NCT01354353|449828709|FG001|Overall Study|Entry Criteria Not Met|0|||
125057390|NCT01354353|449828710|FG002|Overall Study|Entry Criteria Not Met|0|||
125057391|NCT01354353|449828711|FG003|Overall Study|Entry Criteria Not Met|1|||
125057392|NCT01354353|449828712|FG004|Overall Study|Entry Criteria Not Met|1|||
125057393|NCT01354353|449828713|FG005|Overall Study|Entry Criteria Not Met|0|||
125057394|NCT01354353|449828708|FG000|Overall Study|Physician Decision|0|||
125057395|NCT01354353|449828709|FG001|Overall Study|Physician Decision|1|||
125057396|NCT01354353|449828710|FG002|Overall Study|Physician Decision|1|||
125057397|NCT01354353|449828711|FG003|Overall Study|Physician Decision|0|||
125057398|NCT01354353|449828712|FG004|Overall Study|Physician Decision|0|||
125057399|NCT01354353|449828713|FG005|Overall Study|Physician Decision|0|||
125057400|NCT01354353|449828708|FG000|Overall Study|Withdrawal by Subject|2|||
125057401|NCT01354353|449828709|FG001|Overall Study|Withdrawal by Subject|0|||
125057402|NCT01354353|449828710|FG002|Overall Study|Withdrawal by Subject|1|||
125057403|NCT01354353|449828711|FG003|Overall Study|Withdrawal by Subject|0|||
125057404|NCT01354353|449828712|FG004|Overall Study|Withdrawal by Subject|0|||
125057405|NCT01354353|449828713|FG005|Overall Study|Withdrawal by Subject|1|||
125057406|NCT03583372|449828714|FG000|Overall Study|Withdrawal by Subject|6|||
125057407|NCT03583372|449828715|FG001|Overall Study|Withdrawal by Subject|11|||
125057408|NCT03583372|449828716|FG002|Overall Study|Withdrawal by Subject|7|||
125057409|NCT03583372|449828717|FG003|Overall Study|Withdrawal by Subject|8|||
125057410|NCT03583372|449828714|FG000|Overall Study|Lost to Follow-up|4|||
125057411|NCT03583372|449828715|FG001|Overall Study|Lost to Follow-up|6|||
125057412|NCT03583372|449828716|FG002|Overall Study|Lost to Follow-up|3|||
125057413|NCT03583372|449828717|FG003|Overall Study|Lost to Follow-up|2|||
125057414|NCT03583372|449828714|FG000|Overall Study|Adverse Event|1|||
125137385|NCT00205777|450128927|FG005|Study Extension I|Failed to return|0|||
125137386|NCT00205777|450128922|FG000|Study Extension I|Other Event|34|||
125137387|NCT00205777|450128923|FG001|Study Extension I|Other Event|0|||
125137388|NCT00205777|450128924|FG002|Study Extension I|Other Event|0|||
125137389|NCT00205777|450128925|FG003|Study Extension I|Other Event|34|||
125137390|NCT00205777|450128926|FG004|Study Extension I|Other Event|29|||
125137391|NCT00205777|450128927|FG005|Study Extension I|Other Event|0|||
125137392|NCT00205777|450128922|FG000|Study Extension I|Withdrawn as per protocol|0|||
125137393|NCT00205777|450128923|FG001|Study Extension I|Withdrawn as per protocol|0|||
125137394|NCT00205777|450128924|FG002|Study Extension I|Withdrawn as per protocol|1070|||
125137395|NCT00205777|450128925|FG003|Study Extension I|Withdrawn as per protocol|0|||
125137396|NCT00205777|450128926|FG004|Study Extension I|Withdrawn as per protocol|0|||
125137397|NCT00205777|450128927|FG005|Study Extension I|Withdrawn as per protocol|0|||
125137398|NCT00205777|450128922|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
125137399|NCT00205777|450128923|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
125137400|NCT00205777|450128924|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
125057415|NCT03583372|449828715|FG001|Overall Study|Adverse Event|3|||
125057416|NCT03583372|449828716|FG002|Overall Study|Adverse Event|4|||
125057417|NCT03583372|449828717|FG003|Overall Study|Adverse Event|4|||
125057418|NCT03583372|449828714|FG000|Overall Study|Physician Decision|0|||
125057419|NCT03583372|449828715|FG001|Overall Study|Physician Decision|1|||
125057420|NCT03583372|449828716|FG002|Overall Study|Physician Decision|1|||
125057421|NCT03583372|449828717|FG003|Overall Study|Physician Decision|1|||
125137401|NCT00205777|450128925|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
125137402|NCT00205777|450128926|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
125220694|NCT00943397|450436171|FG001|Overall Study|Protocol Violation|5|||
125057422|NCT03583372|449828714|FG000|Overall Study|Lack of Efficacy|0|||
125057423|NCT03583372|449828715|FG001|Overall Study|Lack of Efficacy|1|||
125057424|NCT03583372|449828716|FG002|Overall Study|Lack of Efficacy|0|||
125057425|NCT03583372|449828717|FG003|Overall Study|Lack of Efficacy|1|||
125057426|NCT03583372|449828714|FG000|Overall Study|Death|1|||
125057427|NCT03583372|449828715|FG001|Overall Study|Death|0|||
125057428|NCT03583372|449828716|FG002|Overall Study|Death|0|||
125057429|NCT03583372|449828717|FG003|Overall Study|Death|0|||
125057430|NCT03583372|449828714|FG000|Overall Study|Protocol Violation|0|||
125057431|NCT03583372|449828715|FG001|Overall Study|Protocol Violation|1|||
125057432|NCT03583372|449828716|FG002|Overall Study|Protocol Violation|0|||
125057433|NCT03583372|449828717|FG003|Overall Study|Protocol Violation|0|||
125057434|NCT03583372|449828714|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
125057435|NCT03583372|449828715|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
125057436|NCT03583372|449828716|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
125057437|NCT03583372|449828717|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
125057438|NCT03583372|449828714|FG000|Overall Study|Did Not Receive Study Drug|0|||
125057439|NCT03583372|449828715|FG001|Overall Study|Did Not Receive Study Drug|1|||
125057440|NCT03583372|449828716|FG002|Overall Study|Did Not Receive Study Drug|0|||
125057441|NCT03583372|449828717|FG003|Overall Study|Did Not Receive Study Drug|0|||
125137403|NCT00205777|450128927|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
125137404|NCT00205777|450128922|FG000|Study Extension II|Adverse Event|0|||
125137405|NCT00205777|450128923|FG001|Study Extension II|Adverse Event|0|||
125137406|NCT00205777|450128924|FG002|Study Extension II|Adverse Event|0|||
125137407|NCT00205777|450128925|FG003|Study Extension II|Adverse Event|14|||
125137408|NCT00205777|450128926|FG004|Study Extension II|Adverse Event|0|||
125137409|NCT00205777|450128927|FG005|Study Extension II|Adverse Event|30|||
125137410|NCT00205777|450128922|FG000|Study Extension II|Death|0|||
125137411|NCT00205777|450128923|FG001|Study Extension II|Death|0|||
125057442|NCT03583372|449828714|FG000|Overall Study|Captured as Other in the Database|1|||
125057443|NCT03583372|449828715|FG001|Overall Study|Captured as Other in the Database|2|||
125057444|NCT03583372|449828716|FG002|Overall Study|Captured as Other in the Database|4|||
125057445|NCT03583372|449828717|FG003|Overall Study|Captured as Other in the Database|1|||
125057446|NCT03446651|449828725|FG000|Overall Study|Lost to Follow-up|4|||
125057447|NCT03446651|449828726|FG001|Overall Study|Lost to Follow-up|0|||
125057448|NCT03446651|449828725|FG000|Overall Study|Open Label Participants|5|||
125057449|NCT03446651|449828726|FG001|Overall Study|Open Label Participants|0|||
125057450|NCT02420223|449828727|FG000|Overall Study|Adverse Event|1|||
125057451|NCT02420223|449828728|FG001|Overall Study|Adverse Event|0|||
125057452|NCT02420223|449828727|FG000|Overall Study|Physician Decision|0|||
125057453|NCT02420223|449828728|FG001|Overall Study|Physician Decision|2|||
125057454|NCT05142332|449828731|FG000|Overall Study|Withdrawal by Subject|0|||
125137412|NCT00205777|450128924|FG002|Study Extension II|Death|0|||
125137413|NCT00205777|450128925|FG003|Study Extension II|Death|2|||
125137414|NCT00205777|450128926|FG004|Study Extension II|Death|0|||
125137415|NCT00205777|450128927|FG005|Study Extension II|Death|5|||
125137416|NCT00205777|450128922|FG000|Study Extension II|Withdrawal by Subject|0|||
125137417|NCT00205777|450128923|FG001|Study Extension II|Withdrawal by Subject|0|||
125137418|NCT00205777|450128924|FG002|Study Extension II|Withdrawal by Subject|0|||
125137419|NCT00205777|450128925|FG003|Study Extension II|Withdrawal by Subject|35|||
125137420|NCT00205777|450128926|FG004|Study Extension II|Withdrawal by Subject|0|||
125137421|NCT00205777|450128927|FG005|Study Extension II|Withdrawal by Subject|59|||
125137422|NCT00205777|450128922|FG000|Study Extension II|Protocol Violation|0|||
125137423|NCT00205777|450128923|FG001|Study Extension II|Protocol Violation|0|||
125137424|NCT00205777|450128924|FG002|Study Extension II|Protocol Violation|0|||
125137425|NCT00205777|450128925|FG003|Study Extension II|Protocol Violation|1|||
125137426|NCT00205777|450128926|FG004|Study Extension II|Protocol Violation|0|||
125137427|NCT00205777|450128927|FG005|Study Extension II|Protocol Violation|10|||
125137428|NCT00205777|450128922|FG000|Study Extension II|Lack of Efficacy|0|||
125137429|NCT00205777|450128923|FG001|Study Extension II|Lack of Efficacy|0|||
125137430|NCT00205777|450128924|FG002|Study Extension II|Lack of Efficacy|0|||
125137431|NCT00205777|450128925|FG003|Study Extension II|Lack of Efficacy|0|||
125137432|NCT00205777|450128926|FG004|Study Extension II|Lack of Efficacy|0|||
125137433|NCT00205777|450128927|FG005|Study Extension II|Lack of Efficacy|1|||
125137434|NCT00205777|450128922|FG000|Study Extension II|Failed to return|0|||
125137435|NCT00205777|450128923|FG001|Study Extension II|Failed to return|0|||
125137436|NCT00205777|450128924|FG002|Study Extension II|Failed to return|0|||
125137437|NCT00205777|450128925|FG003|Study Extension II|Failed to return|14|||
125137438|NCT00205777|450128926|FG004|Study Extension II|Failed to return|0|||
125137439|NCT00205777|450128927|FG005|Study Extension II|Failed to return|26|||
125137440|NCT00205777|450128922|FG000|Study Extension II|Other Event|0|||
125137441|NCT00205777|450128923|FG001|Study Extension II|Other Event|0|||
125137442|NCT00205777|450128924|FG002|Study Extension II|Other Event|0|||
125137443|NCT00205777|450128925|FG003|Study Extension II|Other Event|12|||
125137444|NCT00205777|450128926|FG004|Study Extension II|Other Event|0|||
125137445|NCT00205777|450128927|FG005|Study Extension II|Other Event|20|||
125137446|NCT00205777|450128922|FG000|Study Extension II|Enrolled but not treated|0|||
125137447|NCT00205777|450128923|FG001|Study Extension II|Enrolled but not treated|0|||
125137448|NCT00205777|450128924|FG002|Study Extension II|Enrolled but not treated|0|||
125137449|NCT00205777|450128925|FG003|Study Extension II|Enrolled but not treated|71|||
125137450|NCT00205777|450128926|FG004|Study Extension II|Enrolled but not treated|0|||
125137451|NCT00205777|450128927|FG005|Study Extension II|Enrolled but not treated|131|||
125137452|NCT00367133|450128930|FG000|2 Years|Death|20|||
125137453|NCT00367133|450128931|FG001|2 Years|Death|12|||
125137454|NCT00367133|450128932|FG002|2 Years|Death|12|||
125137455|NCT00367133|450128930|FG000|2 Years|Dropped|34|||
125220695|NCT00943397|450436170|FG000|Overall Study|Withdrawal by Subject|1|||
125057455|NCT05142332|449828732|FG001|Overall Study|Withdrawal by Subject|1|||
125057456|NCT05142332|449828733|FG002|Overall Study|Withdrawal by Subject|2|||
125057457|NCT05142332|449828734|FG003|Overall Study|Withdrawal by Subject|0|||
125057458|NCT05142332|449828735|FG004|Overall Study|Withdrawal by Subject|0|||
125137456|NCT00367133|450128931|FG001|2 Years|Dropped|19|||
125137457|NCT00367133|450128932|FG002|2 Years|Dropped|33|||
125137458|NCT00367133|450128930|FG000|2 Years|Missed visit|4|||
125137459|NCT00367133|450128931|FG001|2 Years|Missed visit|5|||
125137460|NCT00367133|450128932|FG002|2 Years|Missed visit|4|||
125137461|NCT01252953|450128934|FG000|Overall Study|Withdrawal by Subject|16|||
125137462|NCT01252953|450128935|FG001|Overall Study|Withdrawal by Subject|17|||
125137463|NCT01252953|450128934|FG000|Overall Study|Lost to Follow-up|22|||
125137464|NCT01252953|450128935|FG001|Overall Study|Lost to Follow-up|21|||
125137465|NCT00858780|450128945|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
125057459|NCT05142332|449828736|FG005|Overall Study|Withdrawal by Subject|2|||
125057460|NCT05142332|449828737|FG006|Overall Study|Withdrawal by Subject|6|||
125057461|NCT05142332|449828731|FG000|Overall Study|Left ED|3|||
125057462|NCT05142332|449828732|FG001|Overall Study|Left ED|0|||
125057463|NCT05142332|449828733|FG002|Overall Study|Left ED|4|||
125057464|NCT05142332|449828734|FG003|Overall Study|Left ED|6|||
125057465|NCT05142332|449828735|FG004|Overall Study|Left ED|1|||
125057466|NCT05142332|449828736|FG005|Overall Study|Left ED|2|||
125057467|NCT05142332|449828737|FG006|Overall Study|Left ED|6|||
125057468|NCT05142332|449828731|FG000|Overall Study|Physician Decision|0|||
125057469|NCT05142332|449828732|FG001|Overall Study|Physician Decision|0|||
125057470|NCT05142332|449828733|FG002|Overall Study|Physician Decision|2|||
125057471|NCT05142332|449828734|FG003|Overall Study|Physician Decision|1|||
125057472|NCT05142332|449828735|FG004|Overall Study|Physician Decision|0|||
125057473|NCT05142332|449828736|FG005|Overall Study|Physician Decision|0|||
125057474|NCT05142332|449828737|FG006|Overall Study|Physician Decision|3|||
125057475|NCT05142332|449828731|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
125057476|NCT05142332|449828732|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
125057477|NCT05142332|449828733|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
125057478|NCT05142332|449828734|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
125057479|NCT05142332|449828735|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
125057480|NCT05142332|449828736|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
125057481|NCT05142332|449828737|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
125057482|NCT01894477|449828742|FG000|Overall Study|Protocol Violation|0|||
125057483|NCT01894477|449828743|FG001|Overall Study|Protocol Violation|1|||
125220696|NCT00943397|450436171|FG001|Overall Study|Withdrawal by Subject|1|||
125220697|NCT00943397|450436170|FG000|Overall Study|Site terminated and other|12|||
125220698|NCT00943397|450436171|FG001|Overall Study|Site terminated and other|56|||
125220699|NCT04878055|450436172|FG000|Overall Study|Patient transferred in another department|0|||
125220700|NCT04878055|450436173|FG001|Overall Study|Patient transferred in another department|2|||
125220701|NCT04878055|450436172|FG000|Overall Study|Physician Decision|1|||
125220702|NCT04878055|450436173|FG001|Overall Study|Physician Decision|1|||
125220703|NCT04878055|450436172|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
125220704|NCT04878055|450436173|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
125220705|NCT04878055|450436172|FG000|Overall Study|Adverse Event|12|||
125220706|NCT04878055|450436173|FG001|Overall Study|Adverse Event|7|||
125057484|NCT01894477|449828742|FG000|Overall Study|protocol changed due SC changed to cord|0|||
125057485|NCT01894477|449828743|FG001|Overall Study|protocol changed due SC changed to cord|1|||
125137466|NCT00858780|450128946|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
125057486|NCT02052778|449828744|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
125057487|NCT02052778|449828745|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
125057488|NCT02052778|449828746|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
125057489|NCT02052778|449828747|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
125057490|NCT02052778|449828748|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
125057491|NCT02052778|449828749|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
125057492|NCT02052778|449828750|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
125057493|NCT02052778|449828751|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
125057494|NCT02052778|449828752|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
125057495|NCT02052778|449828753|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
125057496|NCT02052778|449828754|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
125057497|NCT02052778|449828755|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
125057498|NCT02052778|449828756|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
125057499|NCT02052778|449828757|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
125057500|NCT02052778|449828758|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
125057501|NCT02052778|449828759|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
125057502|NCT02052778|449828760|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
125057503|NCT02052778|449828761|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
125057504|NCT02052778|449828762|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
125057505|NCT02052778|449828763|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
125057506|NCT02052778|449828764|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
125057507|NCT02052778|449828765|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
125057508|NCT02052778|449828766|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
125057509|NCT02052778|449828744|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
125057510|NCT02052778|449828745|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
125057511|NCT02052778|449828746|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
125057512|NCT02052778|449828747|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
125057513|NCT02052778|449828748|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
125057514|NCT02052778|449828749|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
125057515|NCT02052778|449828750|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
125057516|NCT02052778|449828751|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
125057517|NCT02052778|449828752|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
125057518|NCT02052778|449828753|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125057519|NCT02052778|449828754|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125057520|NCT02052778|449828755|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
125057521|NCT02052778|449828756|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
125057522|NCT02052778|449828757|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
125057523|NCT02052778|449828758|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125057524|NCT02052778|449828759|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125057525|NCT02052778|449828760|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125057526|NCT02052778|449828761|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125057527|NCT02052778|449828762|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125057528|NCT02052778|449828763|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125057529|NCT02052778|449828764|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125057530|NCT02052778|449828765|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125137467|NCT00858780|450128947|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
125137468|NCT00858780|450128948|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
125137469|NCT00858780|450128949|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
125137470|NCT00858780|450128945|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
125137471|NCT00858780|450128946|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
125137472|NCT00858780|450128947|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
125137473|NCT00858780|450128948|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
125137474|NCT00858780|450128949|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
125137475|NCT00858780|450128945|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
125137476|NCT00858780|450128946|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
125137477|NCT00858780|450128947|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
125057531|NCT02052778|449828766|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125057532|NCT02052778|449828744|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057533|NCT02052778|449828745|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057534|NCT02052778|449828746|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057535|NCT02052778|449828747|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057536|NCT02052778|449828748|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057537|NCT02052778|449828749|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057538|NCT02052778|449828750|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057539|NCT02052778|449828751|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057540|NCT02052778|449828752|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057541|NCT02052778|449828753|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057542|NCT02052778|449828754|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057543|NCT02052778|449828755|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057544|NCT02052778|449828756|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057545|NCT02052778|449828757|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
125057546|NCT02052778|449828758|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057547|NCT02052778|449828759|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057548|NCT02052778|449828760|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057549|NCT02052778|449828761|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057550|NCT02052778|449828762|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057551|NCT02052778|449828763|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057552|NCT02052778|449828764|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057553|NCT02052778|449828765|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057554|NCT02052778|449828766|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125057555|NCT02052778|449828744|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
125057556|NCT02052778|449828745|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
125057557|NCT02052778|449828746|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
125057558|NCT02052778|449828747|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
125057559|NCT02052778|449828748|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
125057560|NCT02052778|449828749|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
125057561|NCT02052778|449828750|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
125057562|NCT02052778|449828751|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
125057563|NCT02052778|449828752|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
125057564|NCT02052778|449828753|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
125057565|NCT02052778|449828754|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
125057566|NCT02052778|449828755|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
125057567|NCT02052778|449828756|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
125057568|NCT02052778|449828757|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
125057569|NCT02052778|449828758|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
125057570|NCT02052778|449828759|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
125057571|NCT02052778|449828760|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
125057572|NCT02052778|449828761|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
125057573|NCT02052778|449828762|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
125057574|NCT02052778|449828763|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
125057575|NCT02052778|449828764|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
125057576|NCT02052778|449828765|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
125057577|NCT02052778|449828766|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
125057578|NCT02052778|449828744|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125057579|NCT02052778|449828745|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125057580|NCT02052778|449828746|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125057581|NCT02052778|449828747|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125057582|NCT02052778|449828748|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125057583|NCT02052778|449828749|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125057584|NCT02052778|449828750|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125057585|NCT02052778|449828751|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125057586|NCT02052778|449828752|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
125057587|NCT02052778|449828753|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125057588|NCT02052778|449828754|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125057589|NCT02052778|449828755|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125057590|NCT02052778|449828756|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125057591|NCT02052778|449828757|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
125057592|NCT02052778|449828758|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125057593|NCT02052778|449828759|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125057594|NCT02052778|449828760|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125057595|NCT02052778|449828761|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125057596|NCT02052778|449828762|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125057597|NCT02052778|449828763|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125057598|NCT02052778|449828764|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125057599|NCT02052778|449828765|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125057600|NCT02052778|449828766|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125057601|NCT02052778|449828744|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125057602|NCT02052778|449828745|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125057603|NCT02052778|449828746|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125057604|NCT02052778|449828747|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125057605|NCT02052778|449828748|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125057606|NCT02052778|449828749|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
125057607|NCT02052778|449828750|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125057608|NCT02052778|449828751|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125057609|NCT02052778|449828752|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125057610|NCT02052778|449828753|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125057611|NCT02052778|449828754|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125057612|NCT02052778|449828755|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125057613|NCT02052778|449828756|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
125057614|NCT02052778|449828757|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125057615|NCT02052778|449828758|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125057616|NCT02052778|449828759|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125057617|NCT02052778|449828760|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125057618|NCT02052778|449828761|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125057619|NCT02052778|449828762|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125057620|NCT02052778|449828763|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125057621|NCT02052778|449828764|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125057622|NCT02052778|449828765|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125057623|NCT02052778|449828766|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125057624|NCT02052778|449828744|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125057625|NCT02052778|449828745|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125057626|NCT02052778|449828746|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125057627|NCT02052778|449828747|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125057628|NCT02052778|449828748|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125137478|NCT00858780|450128948|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
125137479|NCT00858780|450128949|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
125137480|NCT00858780|450128945|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
125137481|NCT00858780|450128946|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
125137482|NCT00858780|450128947|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
125137483|NCT00858780|450128948|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
125137484|NCT00858780|450128949|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
125137485|NCT00858780|450128945|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
125137486|NCT00858780|450128946|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
125137487|NCT00858780|450128947|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
125137488|NCT00858780|450128948|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
125137489|NCT00858780|450128949|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
125057629|NCT02052778|449828749|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125057630|NCT02052778|449828750|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125057631|NCT02052778|449828751|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125057632|NCT02052778|449828752|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125057633|NCT02052778|449828753|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125220707|NCT04878055|450436172|FG000|Overall Study|Other|5|||
125220708|NCT04878055|450436173|FG001|Overall Study|Other|0|||
125220709|NCT04878055|450436172|FG000|Overall Study|Withdrawal by Subject|7|||
125220710|NCT04878055|450436173|FG001|Overall Study|Withdrawal by Subject|3|||
125220711|NCT04878055|450436172|FG000|Overall Study|Lost to Follow-up|10|||
125220712|NCT04878055|450436173|FG001|Overall Study|Lost to Follow-up|1|||
125220713|NCT01968811|450436174|FG000|Overall Study|Protocol Violation|4|||
125220714|NCT01968811|450436174|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
125220715|NCT01254656|450436175|FG000|Overall Study|Discontinued due to termination of study|40|||
125220716|NCT01254656|450436176|FG001|Overall Study|Discontinued due to termination of study|39|||
125220717|NCT01254656|450436177|FG002|Overall Study|Discontinued due to termination of study|13|||
125220718|NCT01254656|450436175|FG000|Overall Study|Lack of Efficacy|3|||
125220719|NCT01254656|450436176|FG001|Overall Study|Lack of Efficacy|0|||
125220720|NCT01254656|450436177|FG002|Overall Study|Lack of Efficacy|0|||
125220721|NCT01254656|450436175|FG000|Overall Study|Lost to Follow-up|1|||
125220722|NCT01254656|450436176|FG001|Overall Study|Lost to Follow-up|0|||
125220723|NCT01254656|450436177|FG002|Overall Study|Lost to Follow-up|2|||
125220724|NCT01254656|450436175|FG000|Overall Study|Withdrawal by Subject|2|||
125220725|NCT01254656|450436176|FG001|Overall Study|Withdrawal by Subject|2|||
125220726|NCT01254656|450436177|FG002|Overall Study|Withdrawal by Subject|1|||
125220727|NCT01254656|450436175|FG000|Overall Study|Pregnancy|0|||
125220728|NCT01254656|450436176|FG001|Overall Study|Pregnancy|0|||
125220729|NCT01254656|450436177|FG002|Overall Study|Pregnancy|2|||
125220730|NCT01254656|450436175|FG000|Overall Study|Adverse Event|1|||
125220731|NCT01254656|450436176|FG001|Overall Study|Adverse Event|1|||
125220732|NCT01254656|450436177|FG002|Overall Study|Adverse Event|0|||
125220733|NCT01254656|450436175|FG000|Overall Study|Death|0|||
125220734|NCT01254656|450436176|FG001|Overall Study|Death|1|||
125220735|NCT01254656|450436177|FG002|Overall Study|Death|0|||
125220736|NCT02532374|450436185|FG000|Overall Study|Withdrawal by Subject|1|||
125220737|NCT02532374|450436185|FG000|Overall Study|Physician Decision|1|||
125220738|NCT02254772|450436186|FG000|Overall Study|Ineligible|1|||
125220739|NCT02254772|450436186|FG000|Overall Study|Withdrawal by Subject|1|||
125220740|NCT05225558|450436187|FG000|Overall Study|Withdrawal by Subject|4|||
125220741|NCT05225558|450436188|FG001|Overall Study|Withdrawal by Subject|3|||
125220742|NCT05225558|450436187|FG000|Overall Study|Adverse Event|1|||
125220743|NCT05225558|450436188|FG001|Overall Study|Adverse Event|0|||
125220744|NCT05225558|450436187|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
125220745|NCT05225558|450436188|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
125220746|NCT05225558|450436187|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
125220747|NCT05225558|450436188|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
125220748|NCT03904420|450436189|FG000|Overall Study|Study terminated|2|||
125220749|NCT03904420|450436190|FG001|Overall Study|Study terminated|2|||
125220750|NCT03006562|450436191|FG000|Overall Study|Lost to Follow-up|0|||
125220751|NCT03006562|450436192|FG001|Overall Study|Lost to Follow-up|1|||
125220752|NCT00447772|450436193|FG000|Overall Study|Lack of Efficacy|3|||
125220753|NCT00447772|450436193|FG000|Overall Study|Insufficient compliance|6|||
125220754|NCT00447772|450436193|FG000|Overall Study|Discontinuation of drug therapy|1|||
125220755|NCT00447772|450436193|FG000|Overall Study|Lost to Follow-up|9|||
125220756|NCT00447772|450436193|FG000|Overall Study|Withdrawal by Subject|1|||
125220757|NCT00447772|450436193|FG000|Overall Study|Unable to attend all study visits|2|||
125220758|NCT00447772|450436193|FG000|Overall Study|Adverse Event|1|||
125220759|NCT00447772|450436193|FG000|Overall Study|Patient relocated|1|||
125220760|NCT00447772|450436193|FG000|Overall Study|Incomplete documentation at visit 1|1|||
125220761|NCT00447772|450436193|FG000|Overall Study|Chemotherapy for lung cancer|1|||
125220762|NCT00447772|450436193|FG000|Overall Study|Premature re-injection required|1|||
125220763|NCT00716456|450436194|FG000|Overall Study|Adverse Event|0|||
125220764|NCT00716456|450436195|FG001|Overall Study|Adverse Event|2|||
125220765|NCT00716456|450436196|FG002|Overall Study|Adverse Event|0|||
125220766|NCT00875563|450436198|FG000|Overall Study|Death|4|||
125220767|NCT00875563|450436198|FG000|Overall Study|Withdrawal by Subject|7|||
125220768|NCT00875563|450436198|FG000|Overall Study|No long-term (3-5 year) consent|6|||
125220769|NCT00875563|450436198|FG000|Overall Study|Still be eligible for follow-up|7|||
125220770|NCT05417412|450436199|FG000|Overall Study|Lost to Follow-up|2|||
125220771|NCT01841970|450436202|FG000|Overall Study|Withdrawal by Subject|1|||
125220772|NCT01841970|450436202|FG000|Overall Study|Physician Decision|2|||
125220773|NCT01841970|450436202|FG000|Overall Study|Lost to Follow-up|8|||
125220774|NCT02592447|450436203|FG000|Overall Study|Lost to Follow-up|1|||
125220775|NCT02592447|450436204|FG001|Overall Study|Lost to Follow-up|0|||
125220776|NCT02592447|450436203|FG000|Overall Study|Ineligible after randomization|1|||
125220777|NCT02592447|450436204|FG001|Overall Study|Ineligible after randomization|0|||
125220778|NCT02592447|450436203|FG000|Overall Study|Withdrawal by Subject|0|||
125220779|NCT02592447|450436204|FG001|Overall Study|Withdrawal by Subject|1|||
125137490|NCT00858780|450128945|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
125137491|NCT00858780|450128946|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
125137492|NCT00858780|450128947|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
125137493|NCT00858780|450128948|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
125137494|NCT00858780|450128949|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
125137495|NCT00863330|450128950|FG000|Overall Study|study terminated early due to administra|6|||
125137496|NCT02615249|450128951|FG000|Overall Study|Withdrawal by Subject|1|||
125137497|NCT05098743|450128952|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
125137498|NCT05098743|450128953|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
125137499|NCT05098743|450128952|FG000|Overall Study|Lost to Follow-up|1|||
125137500|NCT05098743|450128953|FG001|Overall Study|Lost to Follow-up|2|||
125137501|NCT00842309|450128963|FG000|Overall Study|Withdrawal by Subject|3|||
125137502|NCT00842309|450128964|FG001|Overall Study|Withdrawal by Subject|1|||
125137503|NCT02911025|450128965|FG000|Overall Study|Lost to Follow-up|3|||
125137504|NCT03218787|450128966|FG000|Overall Study|Lost to Follow-up|12|||
125137505|NCT03218787|450128966|FG000|Overall Study|Withdrawal by Subject|72|||
125137506|NCT03218787|450128966|FG000|Overall Study|Physician Decision|11|||
125137507|NCT03218787|450128966|FG000|Overall Study|Death|111|||
125137508|NCT03719040|450128967|FG000|Overall Study|Withdrawal by Subject|177|||
125137509|NCT03719040|450128967|FG000|Overall Study|Lost to Follow-up|26|||
125137510|NCT02264977|450128968|FG000|Overall Study|Death|3|||
125137511|NCT02264977|450128968|FG000|Overall Study|Physician Decision|1|||
125137512|NCT02264977|450128968|FG000|Overall Study|Refuse to return|1|||
125137513|NCT00227370|450128970|FG000|Overall Study|Withdrawal by Subject|1|||
125137514|NCT00227370|450128971|FG001|Overall Study|Withdrawal by Subject|2|||
125137515|NCT00227370|450128970|FG000|Overall Study|Death|3|||
125137516|NCT00227370|450128971|FG001|Overall Study|Death|4|||
125137517|NCT00227370|450128970|FG000|Overall Study|Adverse Event|6|||
125137518|NCT00227370|450128971|FG001|Overall Study|Adverse Event|11|||
125137519|NCT00227370|450128970|FG000|Overall Study|Physician Decision|9|||
125137520|NCT00227370|450128971|FG001|Overall Study|Physician Decision|6|||
125137521|NCT00227370|450128970|FG000|Overall Study|Other reasons|2|||
125137522|NCT00227370|450128971|FG001|Overall Study|Other reasons|1|||
125137523|NCT02923349|450128972|FG000|Overall Study|Other|1|||
125137524|NCT02923349|450128973|FG001|Overall Study|Other|2|||
125137525|NCT02923349|450128974|FG002|Overall Study|Other|4|||
125137526|NCT02923349|450128975|FG003|Overall Study|Other|1|||
125137527|NCT02923349|450128976|FG004|Overall Study|Other|3|||
125137528|NCT02923349|450128977|FG005|Overall Study|Other|0|||
125137529|NCT02923349|450128978|FG006|Overall Study|Other|1|||
125137530|NCT02923349|450128972|FG000|Overall Study|Withdrawal by Subject|2|||
125137531|NCT02923349|450128973|FG001|Overall Study|Withdrawal by Subject|2|||
125137532|NCT02923349|450128974|FG002|Overall Study|Withdrawal by Subject|8|||
125137533|NCT02923349|450128975|FG003|Overall Study|Withdrawal by Subject|10|||
125137534|NCT02923349|450128976|FG004|Overall Study|Withdrawal by Subject|12|||
125137535|NCT02923349|450128977|FG005|Overall Study|Withdrawal by Subject|3|||
125137536|NCT02923349|450128978|FG006|Overall Study|Withdrawal by Subject|0|||
125137537|NCT02923349|450128972|FG000|Overall Study|Physician Decision|0|||
125137538|NCT02923349|450128973|FG001|Overall Study|Physician Decision|0|||
125137539|NCT02923349|450128974|FG002|Overall Study|Physician Decision|0|||
125137540|NCT02923349|450128975|FG003|Overall Study|Physician Decision|1|||
125137541|NCT02923349|450128976|FG004|Overall Study|Physician Decision|1|||
125137542|NCT02923349|450128977|FG005|Overall Study|Physician Decision|0|||
125137543|NCT02923349|450128978|FG006|Overall Study|Physician Decision|2|||
125137544|NCT02923349|450128972|FG000|Overall Study|Lost to Follow-up|0|||
125057634|NCT02052778|449828754|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125057635|NCT02052778|449828755|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125057636|NCT02052778|449828756|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125057637|NCT02052778|449828757|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125057638|NCT02052778|449828758|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
125057639|NCT02052778|449828759|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
125057640|NCT02052778|449828760|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
125057641|NCT02052778|449828761|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
125137545|NCT02923349|450128973|FG001|Overall Study|Lost to Follow-up|0|||
125137546|NCT02923349|450128974|FG002|Overall Study|Lost to Follow-up|3|||
125137547|NCT02923349|450128975|FG003|Overall Study|Lost to Follow-up|0|||
125137548|NCT02923349|450128976|FG004|Overall Study|Lost to Follow-up|1|||
125137549|NCT02923349|450128977|FG005|Overall Study|Lost to Follow-up|1|||
125057642|NCT02052778|449828762|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
125057643|NCT02052778|449828763|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
125057644|NCT02052778|449828764|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
125057645|NCT02052778|449828765|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
125057646|NCT02052778|449828766|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125057647|NCT02052778|449828744|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125057648|NCT02052778|449828745|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125057649|NCT02052778|449828746|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125057650|NCT02052778|449828747|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125057651|NCT02052778|449828748|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125057652|NCT02052778|449828749|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125057653|NCT02052778|449828750|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125057654|NCT02052778|449828751|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125057655|NCT02052778|449828752|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125057656|NCT02052778|449828753|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125057657|NCT02052778|449828754|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125057658|NCT02052778|449828755|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125057659|NCT02052778|449828756|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125220780|NCT02849743|450436206|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
125220781|NCT02849743|450436207|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
125220782|NCT02849743|450436206|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
125220783|NCT02849743|450436207|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
125220784|NCT01048541|450436210|FG000|Overall Study|Withdrawal by Subject|1|||
125220785|NCT01048541|450436211|FG001|Overall Study|Withdrawal by Subject|0|||
125220786|NCT00627497|450436212|FG000|Overall Study|Lost to Follow-up|1|||
125220787|NCT00627497|450436213|FG001|Overall Study|Lost to Follow-up|1|||
125220788|NCT00627497|450436214|FG002|Overall Study|Lost to Follow-up|0|||
125057660|NCT02052778|449828757|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125057661|NCT02052778|449828758|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
125057662|NCT02052778|449828759|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
125057663|NCT02052778|449828760|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125057664|NCT02052778|449828761|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
125057665|NCT02052778|449828762|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
125057666|NCT02052778|449828763|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
125057667|NCT02052778|449828764|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
125057668|NCT02052778|449828765|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
125057669|NCT02052778|449828766|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125057670|NCT02052778|449828744|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125057671|NCT02052778|449828745|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125057672|NCT02052778|449828746|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125057673|NCT02052778|449828747|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125057674|NCT02052778|449828748|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125057675|NCT02052778|449828749|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125057676|NCT02052778|449828750|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125057677|NCT02052778|449828751|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125057678|NCT02052778|449828752|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125057679|NCT02052778|449828753|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125057680|NCT02052778|449828754|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125057681|NCT02052778|449828755|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125057682|NCT02052778|449828756|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125057683|NCT02052778|449828757|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125057684|NCT02052778|449828758|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
125057685|NCT02052778|449828759|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
125057686|NCT02052778|449828760|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
125057687|NCT02052778|449828761|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125057688|NCT02052778|449828762|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
125057689|NCT02052778|449828763|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
125057690|NCT02052778|449828764|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125057691|NCT02052778|449828765|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125057692|NCT02052778|449828766|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125137550|NCT02923349|450128978|FG006|Overall Study|Lost to Follow-up|0|||
125137551|NCT02923349|450128972|FG000|Overall Study|Death|1|||
125137552|NCT02923349|450128973|FG001|Overall Study|Death|0|||
125137553|NCT02923349|450128974|FG002|Overall Study|Death|2|||
125137554|NCT02923349|450128975|FG003|Overall Study|Death|4|||
125137555|NCT02923349|450128976|FG004|Overall Study|Death|2|||
125137556|NCT02923349|450128977|FG005|Overall Study|Death|3|||
125137557|NCT02923349|450128978|FG006|Overall Study|Death|0|||
125137558|NCT04063878|450128981|FG000|Overall Study|Withdrawal by Subject|2|||
125137559|NCT04063878|450128981|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
125137560|NCT02751827|450128982|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
125137561|NCT02751827|450128983|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
125057693|NCT02052778|449828744|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125057694|NCT02052778|449828745|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125057695|NCT02052778|449828746|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125057696|NCT02052778|449828747|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125057697|NCT02052778|449828748|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125057698|NCT02052778|449828749|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125057699|NCT02052778|449828750|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125057700|NCT02052778|449828751|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125057701|NCT02052778|449828752|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125057702|NCT02052778|449828753|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125057703|NCT02052778|449828754|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125057704|NCT02052778|449828755|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125057705|NCT02052778|449828756|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125057706|NCT02052778|449828757|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125057707|NCT02052778|449828758|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
125057708|NCT02052778|449828759|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
125057709|NCT02052778|449828760|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125057710|NCT02052778|449828761|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125057711|NCT02052778|449828762|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125057712|NCT02052778|449828763|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125057713|NCT02052778|449828764|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125057714|NCT02052778|449828765|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125057715|NCT02052778|449828766|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125057716|NCT02052778|449828744|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125057717|NCT02052778|449828745|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125057718|NCT02052778|449828746|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125057719|NCT02052778|449828747|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125057720|NCT02052778|449828748|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125057721|NCT02052778|449828749|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125057722|NCT02052778|449828750|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125057723|NCT02052778|449828751|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125057724|NCT02052778|449828752|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125057725|NCT02052778|449828753|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125057726|NCT02052778|449828754|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125057727|NCT02052778|449828755|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125057728|NCT02052778|449828756|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125057729|NCT02052778|449828757|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125057730|NCT02052778|449828758|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
125057731|NCT02052778|449828759|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
125057732|NCT02052778|449828760|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125057733|NCT02052778|449828761|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125057734|NCT02052778|449828762|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125057735|NCT02052778|449828763|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
125057736|NCT02052778|449828764|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125057737|NCT02052778|449828765|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125057738|NCT02052778|449828766|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125057739|NCT02052778|449828744|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
125057740|NCT02052778|449828745|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
125057741|NCT02052778|449828746|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
125057742|NCT02052778|449828747|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
125057743|NCT02052778|449828748|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
125057744|NCT02052778|449828749|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
125057745|NCT02052778|449828750|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
125057746|NCT02052778|449828751|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
125057747|NCT02052778|449828752|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
125057748|NCT02052778|449828753|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
125057749|NCT02052778|449828754|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
125057750|NCT02052778|449828755|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
125057751|NCT02052778|449828756|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
125057752|NCT02052778|449828757|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
125057753|NCT02052778|449828758|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
125057754|NCT02052778|449828759|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
125057755|NCT02052778|449828760|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
125137562|NCT02751827|450128984|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
125137563|NCT01248728|450128985|FG000|Overall Study|Adverse Event|1|||
125137564|NCT01248728|450128986|FG001|Overall Study|Adverse Event|1|||
125137565|NCT01248728|450128985|FG000|Overall Study|Withdrawal by Subject|2|||
125137566|NCT01248728|450128986|FG001|Overall Study|Withdrawal by Subject|1|||
125137567|NCT01248728|450128985|FG000|Overall Study|Lack of Efficacy|1|||
125057756|NCT02052778|449828761|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
125057757|NCT02052778|449828762|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
125057758|NCT02052778|449828763|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
125137568|NCT01248728|450128986|FG001|Overall Study|Lack of Efficacy|0|||
125137569|NCT00147498|450128987|FG000|Overall Study|Adverse Event|1|||
125137570|NCT00147498|450128988|FG001|Overall Study|Adverse Event|6|||
125137571|NCT00147498|450128989|FG002|Overall Study|Adverse Event|7|||
125137572|NCT00147498|450128990|FG003|Overall Study|Adverse Event|3|||
125137573|NCT00147498|450128987|FG000|Overall Study|Lack of Efficacy|1|||
125137574|NCT00147498|450128988|FG001|Overall Study|Lack of Efficacy|1|||
125137575|NCT00147498|450128989|FG002|Overall Study|Lack of Efficacy|1|||
125137576|NCT00147498|450128990|FG003|Overall Study|Lack of Efficacy|8|||
125137577|NCT00147498|450128987|FG000|Overall Study|Laboratory abnormality|0|||
125137578|NCT00147498|450128988|FG001|Overall Study|Laboratory abnormality|0|||
125137579|NCT00147498|450128989|FG002|Overall Study|Laboratory abnormality|2|||
125137580|NCT00147498|450128990|FG003|Overall Study|Laboratory abnormality|0|||
125137581|NCT00147498|450128987|FG000|Overall Study|Participant defaulted|0|||
125137582|NCT00147498|450128988|FG001|Overall Study|Participant defaulted|1|||
125137583|NCT00147498|450128989|FG002|Overall Study|Participant defaulted|4|||
125137584|NCT00147498|450128990|FG003|Overall Study|Participant defaulted|3|||
125137585|NCT00147498|450128987|FG000|Overall Study|Other|1|||
125137586|NCT00147498|450128988|FG001|Overall Study|Other|1|||
125137587|NCT00147498|450128989|FG002|Overall Study|Other|3|||
125137588|NCT00147498|450128990|FG003|Overall Study|Other|3|||
125137589|NCT01838681|450128991|FG000|Period A|Adverse Event|39|||
125137590|NCT01838681|450128992|FG001|Period A|Adverse Event|0|||
125137591|NCT01838681|450128993|FG002|Period A|Adverse Event|0|||
125137592|NCT01838681|450128994|FG003|Period A|Adverse Event|0|||
125137593|NCT01838681|450128991|FG000|Period A|Lack of Efficacy|21|||
125137594|NCT01838681|450128992|FG001|Period A|Lack of Efficacy|0|||
125137595|NCT01838681|450128993|FG002|Period A|Lack of Efficacy|0|||
125137596|NCT01838681|450128994|FG003|Period A|Lack of Efficacy|0|||
125137597|NCT01838681|450128991|FG000|Period A|Early response|148|||
125137598|NCT01838681|450128992|FG001|Period A|Early response|0|||
125137599|NCT01838681|450128993|FG002|Period A|Early response|0|||
125137600|NCT01838681|450128994|FG003|Period A|Early response|0|||
125137601|NCT01838681|450128991|FG000|Period A|Withdrawal by Subject|70|||
125137602|NCT01838681|450128992|FG001|Period A|Withdrawal by Subject|0|||
125137603|NCT01838681|450128993|FG002|Period A|Withdrawal by Subject|0|||
125137604|NCT01838681|450128994|FG003|Period A|Withdrawal by Subject|0|||
125137605|NCT01838681|450128991|FG000|Period A|Protocol Violation|16|||
125137606|NCT01838681|450128992|FG001|Period A|Protocol Violation|0|||
125137607|NCT01838681|450128993|FG002|Period A|Protocol Violation|0|||
125137608|NCT01838681|450128994|FG003|Period A|Protocol Violation|0|||
125137609|NCT01838681|450128991|FG000|Period A|Non-compliance with IMP|6|||
125137610|NCT01838681|450128992|FG001|Period A|Non-compliance with IMP|0|||
125137611|NCT01838681|450128993|FG002|Period A|Non-compliance with IMP|0|||
125137612|NCT01838681|450128994|FG003|Period A|Non-compliance with IMP|0|||
125137613|NCT01838681|450128991|FG000|Period A|Lost to Follow-up|4|||
125137614|NCT01838681|450128992|FG001|Period A|Lost to Follow-up|0|||
125137615|NCT01838681|450128993|FG002|Period A|Lost to Follow-up|0|||
125137616|NCT01838681|450128994|FG003|Period A|Lost to Follow-up|0|||
125137617|NCT01838681|450128991|FG000|Period A|Withdrawal before treatment|4|||
125137618|NCT01838681|450128992|FG001|Period A|Withdrawal before treatment|0|||
125137619|NCT01838681|450128993|FG002|Period A|Withdrawal before treatment|0|||
125137620|NCT01838681|450128994|FG003|Period A|Withdrawal before treatment|0|||
125137621|NCT01838681|450128991|FG000|Period A|Administrative or other reasons|17|||
125137622|NCT01838681|450128992|FG001|Period A|Administrative or other reasons|0|||
125137623|NCT01838681|450128993|FG002|Period A|Administrative or other reasons|0|||
125137624|NCT01838681|450128994|FG003|Period A|Administrative or other reasons|0|||
125137625|NCT01838681|450128991|FG000|Period B/A+|Adverse Event|0|||
125137626|NCT01838681|450128992|FG001|Period B/A+|Adverse Event|13|||
125137627|NCT01838681|450128993|FG002|Period B/A+|Adverse Event|27|||
125137628|NCT01838681|450128994|FG003|Period B/A+|Adverse Event|16|||
125137629|NCT01838681|450128991|FG000|Period B/A+|Lack of Efficacy|0|||
125137630|NCT01838681|450128992|FG001|Period B/A+|Lack of Efficacy|9|||
125137631|NCT01838681|450128993|FG002|Period B/A+|Lack of Efficacy|11|||
125137632|NCT01838681|450128994|FG003|Period B/A+|Lack of Efficacy|6|||
125137633|NCT01838681|450128991|FG000|Period B/A+|Withdrawal by Subject|0|||
125137634|NCT01838681|450128992|FG001|Period B/A+|Withdrawal by Subject|28|||
125137635|NCT01838681|450128993|FG002|Period B/A+|Withdrawal by Subject|35|||
125137636|NCT01838681|450128994|FG003|Period B/A+|Withdrawal by Subject|47|||
125137637|NCT01838681|450128991|FG000|Period B/A+|Protocol Violation|0|||
125137638|NCT01838681|450128992|FG001|Period B/A+|Protocol Violation|1|||
125137639|NCT01838681|450128993|FG002|Period B/A+|Protocol Violation|4|||
125137640|NCT01838681|450128994|FG003|Period B/A+|Protocol Violation|6|||
125137641|NCT01838681|450128991|FG000|Period B/A+|Non-compliance with IMP|0|||
125137642|NCT01838681|450128992|FG001|Period B/A+|Non-compliance with IMP|2|||
125137643|NCT01838681|450128993|FG002|Period B/A+|Non-compliance with IMP|3|||
125137644|NCT01838681|450128994|FG003|Period B/A+|Non-compliance with IMP|3|||
125137645|NCT01838681|450128991|FG000|Period B/A+|Lost to Follow-up|0|||
125137646|NCT01838681|450128992|FG001|Period B/A+|Lost to Follow-up|2|||
125137647|NCT01838681|450128993|FG002|Period B/A+|Lost to Follow-up|5|||
125137648|NCT01838681|450128994|FG003|Period B/A+|Lost to Follow-up|11|||
125220789|NCT00627497|450436215|FG003|Overall Study|Lost to Follow-up|0|||
125057759|NCT02052778|449828764|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
125057760|NCT02052778|449828765|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
125057761|NCT02052778|449828766|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
125057762|NCT02052778|449828744|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125057763|NCT02052778|449828745|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125057764|NCT02052778|449828746|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125057765|NCT02052778|449828747|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125057766|NCT02052778|449828748|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125057767|NCT02052778|449828749|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125057768|NCT02052778|449828750|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125057769|NCT02052778|449828751|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125057770|NCT02052778|449828752|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125057771|NCT02052778|449828753|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125057772|NCT02052778|449828754|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125057773|NCT02052778|449828755|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125057774|NCT02052778|449828756|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125137649|NCT01838681|450128991|FG000|Period B/A+|Withdrawal before treatment|0|||
125137650|NCT01838681|450128992|FG001|Period B/A+|Withdrawal before treatment|1|||
125137651|NCT01838681|450128993|FG002|Period B/A+|Withdrawal before treatment|0|||
125137652|NCT01838681|450128994|FG003|Period B/A+|Withdrawal before treatment|0|||
125137653|NCT01838681|450128991|FG000|Period B/A+|Administrative or other reasons|0|||
125137654|NCT01838681|450128992|FG001|Period B/A+|Administrative or other reasons|6|||
125137655|NCT01838681|450128993|FG002|Period B/A+|Administrative or other reasons|10|||
125137656|NCT01838681|450128994|FG003|Period B/A+|Administrative or other reasons|28|||
125137657|NCT01229150|450128997|FG000|Overall Study|Toxicity|2|||
125137658|NCT01229150|450128998|FG001|Overall Study|Toxicity|2|||
125137659|NCT01229150|450128999|FG002|Overall Study|Toxicity|0|||
125137660|NCT01229150|450129000|FG003|Overall Study|Toxicity|0|||
125137661|NCT02011945|450129001|FG000|Overall Study|Participant requested to Discontinue|0|||
125137662|NCT02011945|450129002|FG001|Overall Study|Participant requested to Discontinue|1|||
125137663|NCT02011945|450129003|FG002|Overall Study|Participant requested to Discontinue|1|||
125137664|NCT02011945|450129001|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
125137665|NCT02011945|450129002|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
125137666|NCT02011945|450129003|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
125137667|NCT02011945|450129001|FG000|Overall Study|Study Drug Toxicity|0|||
125137668|NCT02011945|450129002|FG001|Overall Study|Study Drug Toxicity|0|||
125137669|NCT02011945|450129003|FG002|Overall Study|Study Drug Toxicity|1|||
125137670|NCT02011945|450129001|FG000|Overall Study|Treatment Failure|0|||
125137671|NCT02011945|450129002|FG001|Overall Study|Treatment Failure|7|||
125137672|NCT02011945|450129003|FG002|Overall Study|Treatment Failure|6|||
125137673|NCT02011945|450129001|FG000|Overall Study|No Longer Meets Study Criteria|1|||
125137674|NCT02011945|450129002|FG001|Overall Study|No Longer Meets Study Criteria|0|||
125137675|NCT02011945|450129003|FG002|Overall Study|No Longer Meets Study Criteria|0|||
125137676|NCT02011945|450129001|FG000|Overall Study|Proceeded to stem cell transplant|0|||
125137677|NCT02011945|450129002|FG001|Overall Study|Proceeded to stem cell transplant|0|||
125137678|NCT02011945|450129003|FG002|Overall Study|Proceeded to stem cell transplant|1|||
125137679|NCT02011945|450129001|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
125137680|NCT02011945|450129002|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
125137681|NCT02011945|450129003|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
125137682|NCT03531827|450129004|FG000|Overall Study|Adverse Event|2|||
125137683|NCT03531827|450129005|FG001|Overall Study|Adverse Event|0|||
125137684|NCT03531827|450129004|FG000|Overall Study|Progressive disease|1|||
125137685|NCT03531827|450129005|FG001|Overall Study|Progressive disease|0|||
125137686|NCT00849797|450129006|FG000|First Intervention|bad veins|1|||
125137687|NCT00849797|450129007|FG001|First Intervention|bad veins|0|||
125137688|NCT00849797|450129006|FG000|First Intervention|Adverse Event|0|||
125137689|NCT00849797|450129007|FG001|First Intervention|Adverse Event|1|||
125137690|NCT00849797|450129006|FG000|Washout: One Week|Withdrawal by Subject|0|||
125137691|NCT00849797|450129007|FG001|Washout: One Week|Withdrawal by Subject|2|||
125137692|NCT00679081|450129008|FG000|Overall Study|Lost to Follow-up|1|||
125137693|NCT04198363|450129010|FG000|Overall Study|Adverse Event|1|||
125137694|NCT04198363|450129011|FG001|Overall Study|Adverse Event|1|||
125137695|NCT04198363|450129010|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
125137696|NCT04198363|450129011|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
125137697|NCT04198363|450129010|FG000|Overall Study|Reason not Specified|1|||
125137698|NCT04198363|450129011|FG001|Overall Study|Reason not Specified|0|||
125137699|NCT01404988|450129015|FG000|Overall Study|Death|2|||
125137700|NCT01404988|450129016|FG001|Overall Study|Death|0|||
125137701|NCT01404988|450129017|FG002|Overall Study|Death|2|||
125137702|NCT01404988|450129015|FG000|Overall Study|Adverse Event|1|||
125137703|NCT01404988|450129016|FG001|Overall Study|Adverse Event|0|||
125137704|NCT01404988|450129017|FG002|Overall Study|Adverse Event|0|||
125137705|NCT01404988|450129015|FG000|Overall Study|Withdrawal by Subject|2|||
125137706|NCT01404988|450129016|FG001|Overall Study|Withdrawal by Subject|2|||
125137707|NCT01404988|450129017|FG002|Overall Study|Withdrawal by Subject|0|||
125137708|NCT01404988|450129015|FG000|Overall Study|Lost to Follow-up|1|||
125137709|NCT01404988|450129016|FG001|Overall Study|Lost to Follow-up|2|||
125137710|NCT01404988|450129017|FG002|Overall Study|Lost to Follow-up|1|||
125137711|NCT02588339|450129018|FG000|Overall Study|Withdrawal by Subject|1|||
125137712|NCT02588339|450129018|FG000|Overall Study|GVHD Progression prior to treatment|2|||
125137713|NCT03578809|450131053|FG000|Overall Study|Death|0|||
125137714|NCT03578809|450131054|FG001|Overall Study|Death|2|||
125137715|NCT03578809|450131055|FG002|Overall Study|Death|0|||
125137716|NCT03578809|450131056|FG003|Overall Study|Death|1|||
125137717|NCT03578809|450131053|FG000|Overall Study|Lost to Follow-up|0|||
125137718|NCT03578809|450131054|FG001|Overall Study|Lost to Follow-up|1|||
125137719|NCT03578809|450131055|FG002|Overall Study|Lost to Follow-up|0|||
125137720|NCT03578809|450131056|FG003|Overall Study|Lost to Follow-up|0|||
125137721|NCT03578809|450131053|FG000|Overall Study|Withdrawal by Subject|3|||
125137722|NCT03578809|450131054|FG001|Overall Study|Withdrawal by Subject|5|||
125137723|NCT03578809|450131055|FG002|Overall Study|Withdrawal by Subject|2|||
125137724|NCT03578809|450131056|FG003|Overall Study|Withdrawal by Subject|0|||
125137725|NCT03578809|450131053|FG000|Overall Study|Other|3|||
125137726|NCT03578809|450131054|FG001|Overall Study|Other|6|||
125137727|NCT03578809|450131055|FG002|Overall Study|Other|2|||
125137728|NCT03578809|450131056|FG003|Overall Study|Other|8|||
125137729|NCT02997176|450131059|FG000|Overall Study|Adverse Event|0|||
125137730|NCT02997176|450131060|FG001|Overall Study|Adverse Event|0|||
125137731|NCT02997176|450131061|FG002|Overall Study|Adverse Event|0|||
125137732|NCT02997176|450131062|FG003|Overall Study|Adverse Event|8|||
125137733|NCT02997176|450131059|FG000|Overall Study|Progressive Disease|1|||
125137734|NCT02997176|450131060|FG001|Overall Study|Progressive Disease|0|||
125137735|NCT02997176|450131061|FG002|Overall Study|Progressive Disease|1|||
125137736|NCT02997176|450131062|FG003|Overall Study|Progressive Disease|1|||
125137737|NCT02997176|450131059|FG000|Overall Study|Death|0|||
125137738|NCT02997176|450131060|FG001|Overall Study|Death|0|||
125137739|NCT02997176|450131061|FG002|Overall Study|Death|1|||
125137740|NCT02997176|450131062|FG003|Overall Study|Death|1|||
125137741|NCT02997176|450131059|FG000|Overall Study|Withdrawal by Subject|0|||
125137742|NCT02997176|450131060|FG001|Overall Study|Withdrawal by Subject|2|||
125137743|NCT02997176|450131061|FG002|Overall Study|Withdrawal by Subject|0|||
125137744|NCT02997176|450131062|FG003|Overall Study|Withdrawal by Subject|1|||
125137745|NCT01624233|450131065|FG000|Period 2 - Induction|Adverse Event|1|||
125137746|NCT01624233|450131065|FG000|Period 3 - Maintenance|Adverse Event|2|||
125137747|NCT01624233|450131065|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
125137748|NCT01624233|450131065|FG000|Period 3 - Maintenance|Physician Decision|2|||
125137749|NCT01624233|450131065|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
125137750|NCT01624233|450131065|FG000|Period 4 - Drug Free Period|Relapsed|61|||
125220790|NCT00922116|450436216|FG000|Overall Study|Adverse Event|4|||
125220791|NCT00922116|450436216|FG000|Overall Study|Death|1|||
125220792|NCT00922116|450436216|FG000|Overall Study|Lost to Follow-up|1|||
125220793|NCT00922116|450436216|FG000|Overall Study|Withdrawal by Subject|4|||
125057775|NCT02052778|449828757|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125057776|NCT02052778|449828758|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
125057777|NCT02052778|449828759|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
125057778|NCT02052778|449828760|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
125057779|NCT02052778|449828761|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125057780|NCT02052778|449828762|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
125057781|NCT02052778|449828763|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125057782|NCT02052778|449828764|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125057783|NCT02052778|449828765|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125057784|NCT02052778|449828766|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125057785|NCT02052778|449828744|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057786|NCT02052778|449828745|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057787|NCT02052778|449828746|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057788|NCT02052778|449828747|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057789|NCT02052778|449828748|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057790|NCT02052778|449828749|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057791|NCT02052778|449828750|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057792|NCT02052778|449828751|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057793|NCT02052778|449828752|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057794|NCT02052778|449828753|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057795|NCT02052778|449828754|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057796|NCT02052778|449828755|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057797|NCT02052778|449828756|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057798|NCT02052778|449828757|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057799|NCT02052778|449828758|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057800|NCT02052778|449828759|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057801|NCT02052778|449828760|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057802|NCT02052778|449828761|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057803|NCT02052778|449828762|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057804|NCT02052778|449828763|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057805|NCT02052778|449828764|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057806|NCT02052778|449828765|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125057807|NCT02052778|449828766|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
125057808|NCT02052778|449828744|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125057809|NCT02052778|449828745|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125057810|NCT02052778|449828746|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125057811|NCT02052778|449828747|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125057812|NCT02052778|449828748|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125057813|NCT02052778|449828749|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125057814|NCT02052778|449828750|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125057815|NCT02052778|449828751|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125057816|NCT02052778|449828752|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125057817|NCT02052778|449828753|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125057818|NCT02052778|449828754|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125057819|NCT02052778|449828755|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125057820|NCT02052778|449828756|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125057821|NCT02052778|449828757|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125220794|NCT00922116|450436216|FG000|Overall Study|Other|5|||
125220795|NCT04607135|450436217|FG000|Overall Study|Physician Decision|1|||
125220796|NCT04607135|450436217|FG000|Overall Study|Withdrawal by Subject|1|||
125220797|NCT04607135|450436217|FG000|Overall Study|Equipment not working|3|||
125220798|NCT00807885|450436218|FG000|Overall Study|Lost to Follow-up|0|||
125220799|NCT00807885|450436219|FG001|Overall Study|Lost to Follow-up|0|||
125220800|NCT00807885|450436220|FG002|Overall Study|Lost to Follow-up|0|||
125220801|NCT00807885|450436221|FG003|Overall Study|Lost to Follow-up|0|||
125220802|NCT00807885|450436222|FG004|Overall Study|Lost to Follow-up|0|||
125220803|NCT00807885|450436223|FG005|Overall Study|Lost to Follow-up|1|||
125057822|NCT02052778|449828758|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125057823|NCT02052778|449828759|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125057824|NCT02052778|449828760|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125057825|NCT02052778|449828761|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125057826|NCT02052778|449828762|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125057827|NCT02052778|449828763|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125057828|NCT02052778|449828764|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125057829|NCT02052778|449828765|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125057830|NCT02052778|449828766|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
125057831|NCT02052778|449828744|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125057832|NCT02052778|449828745|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125057833|NCT02052778|449828746|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125057834|NCT02052778|449828747|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125057835|NCT02052778|449828748|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125137751|NCT01624233|450131065|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
125137752|NCT01624233|450131065|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
125220804|NCT00807885|450436224|FG006|Overall Study|Lost to Follow-up|0|||
125220805|NCT00807885|450436225|FG007|Overall Study|Lost to Follow-up|0|||
125220806|NCT00807885|450436226|FG008|Overall Study|Lost to Follow-up|0|||
125220807|NCT02364388|450436227|FG000|Overall Study|Protocol Violation|1|||
125220808|NCT02364388|450436227|FG000|Overall Study|Technical Failure|3|||
125220809|NCT02364388|450436227|FG000|Overall Study|No OA/US data|2|||
125220810|NCT02364388|450436227|FG000|Overall Study|No Biopsy|2|||
125220811|NCT00327717|450436228|FG000|Overall Study|Adverse Event|6|||
125220812|NCT00327717|450436229|FG001|Overall Study|Adverse Event|6|||
125220813|NCT00327717|450436228|FG000|Overall Study|Lack of Efficacy|0|||
125220814|NCT00327717|450436229|FG001|Overall Study|Lack of Efficacy|1|||
125220815|NCT00327717|450436228|FG000|Overall Study|Withdrawal by Subject|3|||
125137753|NCT01624233|450131065|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
125137754|NCT01624233|450131065|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
125137755|NCT01624233|450131065|FG000|Period 6: Follow-up|Adverse Event|3|||
125137756|NCT01624233|450131065|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
125137757|NCT01624233|450131065|FG000|Period 6: Follow-up|Physician Decision|1|||
125137758|NCT01624233|450131065|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
125137759|NCT00373256|450131066|FG000|Overall Study|Adverse Event (AE)|1|||
125137760|NCT00373256|450131067|FG001|Overall Study|Adverse Event (AE)|5|||
125137761|NCT00373256|450131066|FG000|Overall Study|Lost to Follow-up|2|||
125137762|NCT00373256|450131067|FG001|Overall Study|Lost to Follow-up|1|||
125137763|NCT00373256|450131066|FG000|Overall Study|Death|9|||
125137764|NCT00373256|450131067|FG001|Overall Study|Death|8|||
125137765|NCT00373256|450131066|FG000|Overall Study|Objective Progression or Relapse|111|||
125137766|NCT00373256|450131067|FG001|Overall Study|Objective Progression or Relapse|104|||
125137767|NCT00373256|450131066|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
125137768|NCT00373256|450131067|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
125137769|NCT00373256|450131066|FG000|Overall Study|Other|73|||
125137770|NCT00373256|450131067|FG001|Overall Study|Other|107|||
125137771|NCT00373256|450131066|FG000|Overall Study|Protocol Violation|0|||
125137772|NCT00373256|450131067|FG001|Overall Study|Protocol Violation|2|||
125137773|NCT00373256|450131066|FG000|Overall Study|Study Terminated by Sponsor|41|||
125137774|NCT00373256|450131067|FG001|Overall Study|Study Terminated by Sponsor|13|||
125137775|NCT04372238|450131068|FG000|Overall Study|Duplicate|3|||
125137776|NCT04372238|450131069|FG001|Overall Study|Duplicate|3|||
125137777|NCT04372238|450131068|FG000|Overall Study|Did not consent for data linkage|6|||
125137778|NCT04372238|450131069|FG001|Overall Study|Did not consent for data linkage|10|||
125220816|NCT00327717|450436229|FG001|Overall Study|Withdrawal by Subject|7|||
125220817|NCT05285787|450436230|FG000|Overall Study|Withdrawal by Subject|1|||
125137779|NCT04241458|450131070|FG000|Overall Study|Withdrawal by Subject|0|||
125137780|NCT04241458|450131071|FG001|Overall Study|Withdrawal by Subject|0|||
125137781|NCT04241458|450131072|FG002|Overall Study|Withdrawal by Subject|0|||
125137782|NCT04241458|450131073|FG003|Overall Study|Withdrawal by Subject|0|||
125137783|NCT04241458|450131074|FG004|Overall Study|Withdrawal by Subject|1|||
125137784|NCT06144424|450131075|FG000|Overall Study|Withdrawal by Subject|2|||
125220818|NCT02360280|450436234|FG000|Overall Study|Withdrawal by Subject|2|||
125220819|NCT02360280|450436235|FG001|Overall Study|Withdrawal by Subject|0|||
125220820|NCT02360280|450436234|FG000|Overall Study|Adverse Event|0|||
125220821|NCT02360280|450436235|FG001|Overall Study|Adverse Event|1|||
125220822|NCT02360280|450436234|FG000|Overall Study|Lost to Follow-up|1|||
125220823|NCT02360280|450436235|FG001|Overall Study|Lost to Follow-up|0|||
125057836|NCT02052778|449828749|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125057837|NCT02052778|449828750|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125057838|NCT02052778|449828751|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125057839|NCT02052778|449828752|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125057840|NCT02052778|449828753|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125057841|NCT02052778|449828754|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125057842|NCT02052778|449828755|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125057843|NCT02052778|449828756|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125057844|NCT02052778|449828757|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125057845|NCT02052778|449828758|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125057846|NCT02052778|449828759|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125057847|NCT02052778|449828760|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125057848|NCT02052778|449828761|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125057849|NCT02052778|449828762|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125057850|NCT02052778|449828763|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125057851|NCT02052778|449828764|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125057852|NCT02052778|449828765|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125057853|NCT02052778|449828766|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
125057854|NCT02052778|449828744|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125057855|NCT02052778|449828745|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125057856|NCT02052778|449828746|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125057857|NCT02052778|449828747|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125057858|NCT02052778|449828748|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125057859|NCT02052778|449828749|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125057860|NCT02052778|449828750|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125057861|NCT02052778|449828751|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125057862|NCT02052778|449828752|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125057863|NCT02052778|449828753|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125057864|NCT02052778|449828754|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125057865|NCT02052778|449828755|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125220824|NCT02472886|450436236|FG000|Overall Study|Lack of Efficacy|0|||
125220825|NCT02472886|450436237|FG001|Overall Study|Lack of Efficacy|2|||
125137785|NCT06144424|450131076|FG001|Overall Study|Withdrawal by Subject|0|||
125137786|NCT06144424|450131075|FG000|Overall Study|Incarceration|1|||
125137787|NCT06144424|450131076|FG001|Overall Study|Incarceration|0|||
125137788|NCT02752074|450131088|FG000|Overall Study|Lost to Follow-up|1|||
125137789|NCT02752074|450131089|FG001|Overall Study|Lost to Follow-up|4|||
125137790|NCT02752074|450131088|FG000|Overall Study|Death|146|||
125137791|NCT02752074|450131089|FG001|Overall Study|Death|129|||
125137792|NCT02752074|450131088|FG000|Overall Study|Withdrawal by Subject|9|||
125137793|NCT02752074|450131089|FG001|Overall Study|Withdrawal by Subject|10|||
125137794|NCT01701063|450131092|FG000|Overall Study|Lost to Follow-up|0|||
125137795|NCT01701063|450131093|FG001|Overall Study|Lost to Follow-up|1|||
125137796|NCT01701063|450131094|FG002|Overall Study|Lost to Follow-up|0|||
125137797|NCT01701063|450131092|FG000|Overall Study|Withdrawal by Subject|0|||
125137798|NCT01701063|450131093|FG001|Overall Study|Withdrawal by Subject|0|||
125137799|NCT01701063|450131094|FG002|Overall Study|Withdrawal by Subject|1|||
125137800|NCT01701063|450131092|FG000|Overall Study|Other|0|||
125137801|NCT01701063|450131093|FG001|Overall Study|Other|0|||
125137802|NCT01701063|450131094|FG002|Overall Study|Other|1|||
125137803|NCT02554877|450131095|FG000|Overall Study|Adverse Event|2|||
125137804|NCT02554877|450131096|FG001|Overall Study|Adverse Event|0|||
125137805|NCT02554877|450131097|FG002|Overall Study|Adverse Event|0|||
125137806|NCT02554877|450131098|FG003|Overall Study|Adverse Event|1|||
125137807|NCT02554877|450131095|FG000|Overall Study|Lost to Follow-up|1|||
125137808|NCT02554877|450131096|FG001|Overall Study|Lost to Follow-up|1|||
125137809|NCT02554877|450131097|FG002|Overall Study|Lost to Follow-up|1|||
125137810|NCT02554877|450131098|FG003|Overall Study|Lost to Follow-up|2|||
125137811|NCT02554877|450131095|FG000|Overall Study|Did not meet entrance criteria|0|||
125137812|NCT02554877|450131096|FG001|Overall Study|Did not meet entrance criteria|0|||
125137813|NCT02554877|450131097|FG002|Overall Study|Did not meet entrance criteria|1|||
125137814|NCT02554877|450131098|FG003|Overall Study|Did not meet entrance criteria|0|||
125137815|NCT02554877|450131095|FG000|Overall Study|No longer met eligibility criteria|1|||
125137816|NCT02554877|450131096|FG001|Overall Study|No longer met eligibility criteria|0|||
125137817|NCT02554877|450131097|FG002|Overall Study|No longer met eligibility criteria|1|||
125137818|NCT02554877|450131098|FG003|Overall Study|No longer met eligibility criteria|1|||
125137819|NCT02554877|450131095|FG000|Overall Study|Protocol Violation|3|||
125137820|NCT02554877|450131096|FG001|Overall Study|Protocol Violation|1|||
125137821|NCT02554877|450131097|FG002|Overall Study|Protocol Violation|1|||
125137822|NCT02554877|450131098|FG003|Overall Study|Protocol Violation|0|||
125137823|NCT02554877|450131095|FG000|Overall Study|Other|1|||
125137824|NCT02554877|450131096|FG001|Overall Study|Other|3|||
125137825|NCT02554877|450131097|FG002|Overall Study|Other|0|||
125137826|NCT02554877|450131098|FG003|Overall Study|Other|3|||
125137827|NCT02554877|450131095|FG000|Overall Study|Insufficient clinical response|4|||
125137828|NCT02554877|450131096|FG001|Overall Study|Insufficient clinical response|0|||
125137829|NCT02554877|450131097|FG002|Overall Study|Insufficient clinical response|0|||
125137830|NCT02554877|450131098|FG003|Overall Study|Insufficient clinical response|0|||
125137831|NCT02554877|450131095|FG000|Overall Study|No longer willing to participate|0|||
125137832|NCT02554877|450131096|FG001|Overall Study|No longer willing to participate|2|||
125137833|NCT02554877|450131097|FG002|Overall Study|No longer willing to participate|2|||
125137834|NCT02554877|450131098|FG003|Overall Study|No longer willing to participate|0|||
125137835|NCT04474405|450131099|FG000|Overall Study|Withdrawal by Subject|0|||
125137836|NCT04474405|450131100|FG001|Overall Study|Withdrawal by Subject|0|||
125137837|NCT04474405|450131101|FG002|Overall Study|Withdrawal by Subject|1|||
125137838|NCT04474405|450131102|FG003|Overall Study|Withdrawal by Subject|0|||
125137839|NCT04474405|450131103|FG004|Overall Study|Withdrawal by Subject|1|||
125137840|NCT04474405|450131104|FG005|Overall Study|Withdrawal by Subject|0|||
125137841|NCT04474405|450131099|FG000|Overall Study|Other|0|||
125137842|NCT04474405|450131100|FG001|Overall Study|Other|0|||
125137843|NCT04474405|450131101|FG002|Overall Study|Other|0|||
125137844|NCT04474405|450131102|FG003|Overall Study|Other|0|||
125137845|NCT04474405|450131103|FG004|Overall Study|Other|3|||
125137846|NCT04474405|450131104|FG005|Overall Study|Other|0|||
125137847|NCT00274651|450131105|FG000|Overall Study|Adverse Event|6|||
125137848|NCT00274651|450131106|FG001|Overall Study|Adverse Event|3|||
125137849|NCT00274651|450131105|FG000|Overall Study|Lack of Efficacy|13|||
125137850|NCT00274651|450131106|FG001|Overall Study|Lack of Efficacy|6|||
125137851|NCT00274651|450131105|FG000|Overall Study|Death|1|||
125137852|NCT00274651|450131106|FG001|Overall Study|Death|3|||
125137853|NCT00274651|450131105|FG000|Overall Study|Withdrawal by Subject|0|||
125137854|NCT00274651|450131106|FG001|Overall Study|Withdrawal by Subject|1|||
125137855|NCT00274651|450131105|FG000|Overall Study|Physician Decision|8|||
125137856|NCT00274651|450131106|FG001|Overall Study|Physician Decision|7|||
125137857|NCT04547192|450131107|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
125137858|NCT04547192|450131108|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
125137859|NCT04547192|450131109|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
125137860|NCT04547192|450131110|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
125137861|NCT04547192|450131107|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
125137862|NCT04547192|450131108|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
125057866|NCT02052778|449828756|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125057867|NCT02052778|449828757|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125057868|NCT02052778|449828758|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125057869|NCT02052778|449828759|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125057870|NCT02052778|449828760|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125057871|NCT02052778|449828761|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125057872|NCT02052778|449828762|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125057873|NCT02052778|449828763|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125057874|NCT02052778|449828764|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125057875|NCT02052778|449828765|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125057876|NCT02052778|449828766|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
125057877|NCT02052778|449828744|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125057878|NCT02052778|449828745|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125057879|NCT02052778|449828746|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125057880|NCT02052778|449828747|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125137863|NCT04547192|450131109|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
125137864|NCT04547192|450131110|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
125137865|NCT04547192|450131107|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
125137866|NCT04547192|450131108|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
125137867|NCT04547192|450131109|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
125137868|NCT04547192|450131110|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
125137869|NCT04547192|450131107|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
125137870|NCT04547192|450131108|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
125137871|NCT04547192|450131109|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
125137872|NCT04547192|450131110|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
125137873|NCT04547192|450131107|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
125137874|NCT04547192|450131108|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
125137875|NCT04547192|450131109|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
125137876|NCT04547192|450131110|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
125137877|NCT04723693|450131111|FG000|Overall Study|Withdrawal by Subject|2|||
125137878|NCT01410227|450131114|FG000|Overall Study|Adverse Event|1|||
125137879|NCT01410227|450131115|FG001|Overall Study|Adverse Event|0|||
125137880|NCT01410227|450131116|FG002|Overall Study|Adverse Event|0|||
125137881|NCT01410227|450131117|FG003|Overall Study|Adverse Event|0|||
125137882|NCT01410227|450131114|FG000|Overall Study|Withdrawal by Subject|3|||
125137883|NCT01410227|450131115|FG001|Overall Study|Withdrawal by Subject|0|||
125137884|NCT01410227|450131116|FG002|Overall Study|Withdrawal by Subject|1|||
125137885|NCT01410227|450131117|FG003|Overall Study|Withdrawal by Subject|0|||
125137886|NCT01410227|450131114|FG000|Overall Study|Pregnancy|0|||
125137887|NCT01410227|450131115|FG001|Overall Study|Pregnancy|0|||
125137888|NCT01410227|450131116|FG002|Overall Study|Pregnancy|0|||
125137889|NCT01410227|450131117|FG003|Overall Study|Pregnancy|1|||
125137890|NCT01410227|450131114|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
125137891|NCT01410227|450131115|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
125137892|NCT01410227|450131116|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
125137893|NCT01410227|450131117|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
125137894|NCT03497130|450131118|FG000|Overall Study|Lost to Follow-up|1|||
125137895|NCT03497130|450131119|FG001|Overall Study|Lost to Follow-up|1|||
125137896|NCT04002648|450131120|FG000|Overall Study|Lost to Follow-up|2|||
125137897|NCT04002648|450131121|FG001|Overall Study|Lost to Follow-up|0|||
125137898|NCT01484912|450131122|FG000|Overall Study|Withdrawal by Subject|1|||
125137899|NCT01484912|450131123|FG001|Overall Study|Withdrawal by Subject|0|||
125137900|NCT01484912|450131122|FG000|Overall Study|Physician Decision|0|||
125137901|NCT01484912|450131123|FG001|Overall Study|Physician Decision|1|||
125137902|NCT02622386|450131124|FG000|First Assignment|Withdrawal by Subject|3|||
125137903|NCT02622386|450131125|FG001|First Assignment|Withdrawal by Subject|2|||
125137904|NCT02622386|450131124|FG000|Washout|Withdrawal by Subject|4|||
125137905|NCT02622386|450131125|FG001|Washout|Withdrawal by Subject|4|||
125137906|NCT02622386|450131124|FG000|Second Assignment|Withdrawal by Subject|0|||
125137907|NCT02622386|450131125|FG001|Second Assignment|Withdrawal by Subject|2|||
125057881|NCT02052778|449828748|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125057882|NCT02052778|449828749|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125057883|NCT02052778|449828750|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125057884|NCT02052778|449828751|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125057885|NCT02052778|449828752|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125057886|NCT02052778|449828753|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125057887|NCT02052778|449828754|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125057888|NCT02052778|449828755|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125057889|NCT02052778|449828756|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125057890|NCT02052778|449828757|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125057891|NCT02052778|449828758|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125057892|NCT02052778|449828759|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125057893|NCT02052778|449828760|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125057894|NCT02052778|449828761|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125057895|NCT02052778|449828762|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125137908|NCT02890992|450131126|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
125137909|NCT02890992|450131127|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
125137910|NCT02890992|450131128|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
125137911|NCT02890992|450131129|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
125137912|NCT02890992|450131130|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
125137913|NCT02890992|450131131|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
125137914|NCT02890992|450131132|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
125137915|NCT02890992|450131133|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
125137916|NCT02890992|450131126|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
125220826|NCT02472886|450436238|FG002|Overall Study|Lack of Efficacy|1|||
125220827|NCT00320788|450436239|FG000|Overall Study|Adverse Event|0|||
125220828|NCT00320788|450436240|FG001|Overall Study|Adverse Event|0|||
125057896|NCT02052778|449828763|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125057897|NCT02052778|449828764|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125057898|NCT02052778|449828765|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125057899|NCT02052778|449828766|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
125057900|NCT02052778|449828744|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
125057901|NCT02052778|449828745|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
125057902|NCT02052778|449828746|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
125057903|NCT02052778|449828747|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
125057904|NCT02052778|449828748|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
125057905|NCT02052778|449828749|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
125057906|NCT02052778|449828750|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
125057907|NCT02052778|449828751|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
125057908|NCT02052778|449828752|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
125057909|NCT02052778|449828753|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
125057910|NCT02052778|449828754|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
125057911|NCT02052778|449828755|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
125057912|NCT02052778|449828756|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
125057913|NCT02052778|449828757|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
125057914|NCT02052778|449828758|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
125057915|NCT02052778|449828759|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
125057916|NCT02052778|449828760|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
125057917|NCT02052778|449828761|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
125057918|NCT02052778|449828762|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
125057919|NCT02052778|449828763|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
125057920|NCT02052778|449828764|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
125057921|NCT02052778|449828765|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
125057922|NCT02052778|449828766|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
125057923|NCT02052778|449828744|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057924|NCT02052778|449828745|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057925|NCT02052778|449828746|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057926|NCT02052778|449828747|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057927|NCT02052778|449828748|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057928|NCT02052778|449828749|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057929|NCT02052778|449828750|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057930|NCT02052778|449828751|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057931|NCT02052778|449828752|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057932|NCT02052778|449828753|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057933|NCT02052778|449828754|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057934|NCT02052778|449828755|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057935|NCT02052778|449828756|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057936|NCT02052778|449828757|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057937|NCT02052778|449828758|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057938|NCT02052778|449828759|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057939|NCT02052778|449828760|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057940|NCT02052778|449828761|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057941|NCT02052778|449828762|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057942|NCT02052778|449828763|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057943|NCT02052778|449828764|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057944|NCT02052778|449828765|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
125057945|NCT02052778|449828766|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
125057946|NCT01409031|449828767|FG000|Overall Study|transferred to other hosp|1|||
125057947|NCT01409031|449828768|FG001|Overall Study|transferred to other hosp|0|||
125057948|NCT04171037|449828770|FG000|Overall Study|Lost to Follow-up|1|||
125057949|NCT04171037|449828771|FG001|Overall Study|Lost to Follow-up|0|||
125057950|NCT04171037|449828770|FG000|Overall Study|Physician Decision|3|||
125057951|NCT04171037|449828771|FG001|Overall Study|Physician Decision|3|||
125057952|NCT00748540|449828772|FG000|Overall Study|Physician Decision|1|||
125057953|NCT01814800|449828773|FG000|Overall Study|Adverse Event|2|||
125057954|NCT01814800|449828773|FG000|Overall Study|Pregnancy|1|||
125057955|NCT01814800|449828773|FG000|Overall Study|Sponsor decision|1|||
125057956|NCT01814800|449828773|FG000|Overall Study|Subject relocation|1|||
125057957|NCT00243230|449828776|FG000|Double-Blind Period|Adverse Event|0|||
125057958|NCT00243230|449828777|FG001|Double-Blind Period|Adverse Event|2|||
125057959|NCT00243230|449828778|FG002|Double-Blind Period|Adverse Event|2|||
125057960|NCT00243230|449828779|FG003|Double-Blind Period|Adverse Event|0|||
125220829|NCT00320788|450436241|FG002|Overall Study|Adverse Event|0|||
125057961|NCT00243230|449828776|FG000|Double-Blind Period|Withdrawal by Subject|1|||
125057962|NCT00243230|449828777|FG001|Double-Blind Period|Withdrawal by Subject|0|||
125057963|NCT00243230|449828778|FG002|Double-Blind Period|Withdrawal by Subject|0|||
125057964|NCT00243230|449828779|FG003|Double-Blind Period|Withdrawal by Subject|0|||
125220830|NCT00320788|450436242|FG003|Overall Study|Adverse Event|1|||
125220831|NCT00320788|450436243|FG004|Overall Study|Adverse Event|0|||
125220832|NCT00320788|450436239|FG000|Overall Study|Death|0|||
125220833|NCT00320788|450436240|FG001|Overall Study|Death|0|||
125220834|NCT00320788|450436241|FG002|Overall Study|Death|1|||
125220835|NCT00320788|450436242|FG003|Overall Study|Death|0|||
125220836|NCT00320788|450436243|FG004|Overall Study|Death|1|||
125220837|NCT00320788|450436239|FG000|Overall Study|Lost to Follow-up|0|||
125220838|NCT00320788|450436240|FG001|Overall Study|Lost to Follow-up|2|||
125220839|NCT00320788|450436241|FG002|Overall Study|Lost to Follow-up|1|||
125220840|NCT00320788|450436242|FG003|Overall Study|Lost to Follow-up|0|||
125220841|NCT00320788|450436243|FG004|Overall Study|Lost to Follow-up|0|||
125057965|NCT00243230|449828776|FG000|Double-Blind Period|Protocol Violation|0|||
125057966|NCT00243230|449828777|FG001|Double-Blind Period|Protocol Violation|0|||
125057967|NCT00243230|449828778|FG002|Double-Blind Period|Protocol Violation|1|||
125057968|NCT00243230|449828779|FG003|Double-Blind Period|Protocol Violation|0|||
125057969|NCT00243230|449828776|FG000|Double-Blind Period|Randomized but Not Treated|0|||
125057970|NCT00243230|449828777|FG001|Double-Blind Period|Randomized but Not Treated|0|||
125057971|NCT00243230|449828778|FG002|Double-Blind Period|Randomized but Not Treated|2|||
125057972|NCT00243230|449828779|FG003|Double-Blind Period|Randomized but Not Treated|0|||
125057973|NCT00243230|449828776|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
125057974|NCT00243230|449828777|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
125057975|NCT00243230|449828778|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
125057976|NCT00243230|449828779|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
125057977|NCT00243230|449828776|FG000|Open Label Period|Adverse Event|0|||
125057978|NCT00243230|449828777|FG001|Open Label Period|Adverse Event|0|||
125057979|NCT00243230|449828778|FG002|Open Label Period|Adverse Event|0|||
125057980|NCT00243230|449828779|FG003|Open Label Period|Adverse Event|2|||
125057981|NCT00243230|449828776|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
125057982|NCT00243230|449828777|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
125057983|NCT00243230|449828778|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
125057984|NCT00243230|449828779|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
125057985|NCT00243230|449828776|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
125057986|NCT00243230|449828777|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
125057987|NCT00243230|449828778|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
125057988|NCT00243230|449828779|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
125057989|NCT00243230|449828776|FG000|Open Label Period|Lost to Follow-up|0|||
125057990|NCT00243230|449828777|FG001|Open Label Period|Lost to Follow-up|0|||
125057991|NCT00243230|449828778|FG002|Open Label Period|Lost to Follow-up|0|||
125057992|NCT00243230|449828779|FG003|Open Label Period|Lost to Follow-up|2|||
125057993|NCT00243230|449828776|FG000|Open Label Period|Withdrawal by Subject|0|||
125057994|NCT00243230|449828777|FG001|Open Label Period|Withdrawal by Subject|0|||
125057995|NCT00243230|449828778|FG002|Open Label Period|Withdrawal by Subject|0|||
125057996|NCT00243230|449828779|FG003|Open Label Period|Withdrawal by Subject|2|||
125057997|NCT00243230|449828776|FG000|Open Label Period|Protocol Violation|0|||
125057998|NCT00243230|449828777|FG001|Open Label Period|Protocol Violation|0|||
125057999|NCT00243230|449828778|FG002|Open Label Period|Protocol Violation|0|||
125058000|NCT00243230|449828779|FG003|Open Label Period|Protocol Violation|2|||
125058001|NCT00243230|449828776|FG000|Open Label Period|Administrative Reason|0|||
125058002|NCT00243230|449828777|FG001|Open Label Period|Administrative Reason|0|||
125058003|NCT00243230|449828778|FG002|Open Label Period|Administrative Reason|0|||
125058004|NCT00243230|449828779|FG003|Open Label Period|Administrative Reason|63|||
125058005|NCT05118386|449828780|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
125058006|NCT05118386|449828781|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
125058007|NCT05118386|449828782|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
125220842|NCT00320788|450436239|FG000|Overall Study|Decision by the Sponsor|1|||
125220843|NCT00320788|450436240|FG001|Overall Study|Decision by the Sponsor|1|||
125220844|NCT00320788|450436241|FG002|Overall Study|Decision by the Sponsor|0|||
125058008|NCT05118386|449828783|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
125058009|NCT05118386|449828784|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
125058010|NCT05118386|449828785|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
125058011|NCT05118386|449828780|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
125058012|NCT05118386|449828781|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
125058013|NCT05118386|449828782|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
125058014|NCT05118386|449828783|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
125058015|NCT05118386|449828784|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
125058016|NCT05118386|449828785|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
125058017|NCT01423617|449828786|FG000|Overall Study|Lost to Follow-up|0|||
125058018|NCT01423617|449828787|FG001|Overall Study|Lost to Follow-up|1|||
125058019|NCT00303108|449828790|FG000|Overall Study|Adverse Event|5|||
125058020|NCT00303108|449828791|FG001|Overall Study|Adverse Event|6|||
125058021|NCT00303108|449828792|FG002|Overall Study|Adverse Event|7|||
125058022|NCT00303108|449828790|FG000|Overall Study|Patient Request|4|||
125058023|NCT00303108|449828791|FG001|Overall Study|Patient Request|2|||
125058024|NCT00303108|449828792|FG002|Overall Study|Patient Request|8|||
125058025|NCT00303108|449828790|FG000|Overall Study|Failed Entry|1|||
125058026|NCT00303108|449828791|FG001|Overall Study|Failed Entry|0|||
125058027|NCT00303108|449828792|FG002|Overall Study|Failed Entry|1|||
125058028|NCT00303108|449828790|FG000|Overall Study|ineligible|2|||
125058029|NCT00303108|449828791|FG001|Overall Study|ineligible|1|||
125058030|NCT00303108|449828792|FG002|Overall Study|ineligible|0|||
125058031|NCT03201198|449828793|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
125058032|NCT03201198|449828794|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
125058033|NCT03201198|449828793|FG000|Overall Study|Withdrawal by Subject|2|||
125058034|NCT03201198|449828794|FG001|Overall Study|Withdrawal by Subject|3|||
125058035|NCT03855137|449828795|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
125058036|NCT03855137|449828796|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
125058037|NCT03855137|449828797|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
125058038|NCT03855137|449828795|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
125058039|NCT03855137|449828796|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
125058040|NCT03855137|449828797|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
125058041|NCT03855137|449828795|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
125058042|NCT03855137|449828796|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
125058043|NCT03855137|449828797|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
125058044|NCT03855137|449828795|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
125058045|NCT03855137|449828796|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
125058046|NCT03855137|449828797|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
125058047|NCT03855137|449828795|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
125058048|NCT03855137|449828796|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
125058049|NCT03855137|449828797|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
125058050|NCT03855137|449828795|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
125058051|NCT03855137|449828796|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
125058052|NCT03855137|449828797|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
125058053|NCT03855137|449828795|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
125058054|NCT03855137|449828796|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
125058055|NCT03855137|449828797|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
125058056|NCT03855137|449828795|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
125058057|NCT03855137|449828796|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
125058058|NCT03855137|449828797|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
125058059|NCT03855137|449828795|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
125058060|NCT03855137|449828796|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
125058061|NCT03855137|449828797|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
125058062|NCT03855137|449828795|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
125058063|NCT03855137|449828796|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
125058064|NCT03855137|449828797|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
125058065|NCT02435277|449828803|FG000|Overall Study|Adverse Event|1|||
125058066|NCT02435277|449828804|FG001|Overall Study|Adverse Event|1|||
125058067|NCT02435277|449828805|FG002|Overall Study|Adverse Event|0|||
125058068|NCT02435277|449828806|FG003|Overall Study|Adverse Event|0|||
125058069|NCT02435277|449828803|FG000|Overall Study|Withdrawal by Subject|1|||
125058070|NCT02435277|449828804|FG001|Overall Study|Withdrawal by Subject|0|||
125058071|NCT02435277|449828805|FG002|Overall Study|Withdrawal by Subject|0|||
125058072|NCT02435277|449828806|FG003|Overall Study|Withdrawal by Subject|0|||
125220845|NCT00320788|450436242|FG003|Overall Study|Decision by the Sponsor|0|||
125220846|NCT00320788|450436243|FG004|Overall Study|Decision by the Sponsor|1|||
125220847|NCT00320788|450436239|FG000|Overall Study|Other|1|||
125220848|NCT00320788|450436240|FG001|Overall Study|Other|2|||
125220849|NCT00320788|450436241|FG002|Overall Study|Other|1|||
125220850|NCT00320788|450436242|FG003|Overall Study|Other|1|||
125220851|NCT00320788|450436243|FG004|Overall Study|Other|1|||
125220852|NCT00320788|450436239|FG000|Overall Study|Physician Decision|1|||
125220853|NCT00320788|450436240|FG001|Overall Study|Physician Decision|1|||
125220854|NCT00320788|450436241|FG002|Overall Study|Physician Decision|0|||
125220855|NCT00320788|450436242|FG003|Overall Study|Physician Decision|0|||
125220856|NCT00320788|450436243|FG004|Overall Study|Physician Decision|0|||
125058073|NCT00008138|449828807|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
125058074|NCT00008138|449828807|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
125058075|NCT00008138|449828807|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
125058076|NCT00008138|449828807|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
125058077|NCT00008138|449828807|FG000|Interval Debulking|Withdrawal by Subject|2|||
125220857|NCT00320788|450436239|FG000|Overall Study|Protocol Violation|0|||
125220858|NCT00320788|450436240|FG001|Overall Study|Protocol Violation|0|||
125220859|NCT00320788|450436241|FG002|Overall Study|Protocol Violation|0|||
125220860|NCT00320788|450436242|FG003|Overall Study|Protocol Violation|0|||
125220861|NCT00320788|450436243|FG004|Overall Study|Protocol Violation|1|||
125137917|NCT02890992|450131127|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
125137918|NCT02890992|450131128|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
125137919|NCT02890992|450131129|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
125137920|NCT02890992|450131130|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
125137921|NCT02890992|450131131|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
125137922|NCT02890992|450131132|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
125137923|NCT02890992|450131133|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
125137924|NCT02890992|450131126|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
125137925|NCT02890992|450131127|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
125137926|NCT02890992|450131128|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
125137927|NCT02890992|450131129|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
125137928|NCT02890992|450131130|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
125137929|NCT02890992|450131131|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
125137930|NCT02890992|450131132|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
125137931|NCT02890992|450131133|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
125137932|NCT03158727|450131134|FG000|Overall Study|Withdrawal by Subject|2|||
125137933|NCT03158727|450131135|FG001|Overall Study|Withdrawal by Subject|6|||
125137934|NCT03158727|450131134|FG000|Overall Study|Death|11|||
125137935|NCT03158727|450131135|FG001|Overall Study|Death|12|||
125137936|NCT03158727|450131134|FG000|Overall Study|Lost to Follow-up|1|||
125137937|NCT03158727|450131135|FG001|Overall Study|Lost to Follow-up|0|||
125137938|NCT03158727|450131134|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
125137939|NCT03158727|450131135|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
125137940|NCT03158727|450131134|FG000|Overall Study|Visit 11 not done by mistake|0|||
125137941|NCT03158727|450131135|FG001|Overall Study|Visit 11 not done by mistake|1|||
125137942|NCT03158727|450131134|FG000|Overall Study|Enrolled, not treated|1|||
125220862|NCT00320788|450436239|FG000|Overall Study|Withdrawal by Subject|3|||
125137943|NCT03158727|450131135|FG001|Overall Study|Enrolled, not treated|0|||
125137944|NCT00669162|450131136|FG000|Overall Study|Withdrawal by Subject|1|||
125137945|NCT00807495|450131139|FG000|Overall Study|Adverse Event|6|||
125137946|NCT00807495|450131140|FG001|Overall Study|Adverse Event|3|||
125137947|NCT00807495|450131141|FG002|Overall Study|Adverse Event|1|||
125137948|NCT00807495|450131142|FG003|Overall Study|Adverse Event|1|||
125137949|NCT00807495|450131143|FG004|Overall Study|Adverse Event|2|||
125137950|NCT00807495|450131139|FG000|Overall Study|Withdrawal by Patient|2|||
125137951|NCT00807495|450131140|FG001|Overall Study|Withdrawal by Patient|0|||
125137952|NCT00807495|450131141|FG002|Overall Study|Withdrawal by Patient|1|||
125137953|NCT00807495|450131142|FG003|Overall Study|Withdrawal by Patient|0|||
125137954|NCT00807495|450131143|FG004|Overall Study|Withdrawal by Patient|0|||
125137955|NCT00807495|450131139|FG000|Overall Study|Reason Not Specified|0|||
125137956|NCT00807495|450131140|FG001|Overall Study|Reason Not Specified|3|||
125137957|NCT00807495|450131141|FG002|Overall Study|Reason Not Specified|2|||
125137958|NCT00807495|450131142|FG003|Overall Study|Reason Not Specified|0|||
125137959|NCT00807495|450131143|FG004|Overall Study|Reason Not Specified|3|||
125137960|NCT02412852|450131145|FG000|Overall Study|Withdrawal by Subject|0|||
125137961|NCT02412852|450131146|FG001|Overall Study|Withdrawal by Subject|1|||
125137962|NCT02412852|450131147|FG002|Overall Study|Withdrawal by Subject|0|||
125137963|NCT02412852|450131148|FG003|Overall Study|Withdrawal by Subject|0|||
125137964|NCT02412852|450131145|FG000|Overall Study|Physician Decision|0|||
125137965|NCT02412852|450131146|FG001|Overall Study|Physician Decision|0|||
125137966|NCT02412852|450131147|FG002|Overall Study|Physician Decision|0|||
125137967|NCT02412852|450131148|FG003|Overall Study|Physician Decision|1|||
125137968|NCT00841542|450131149|FG000|Period 1|Adverse Event|1|||
125137969|NCT00841542|450131150|FG001|Period 1|Adverse Event|0|||
125137970|NCT00924638|450131156|FG000|Overall Study|Death|3|||
125137971|NCT00924638|450131157|FG001|Overall Study|Death|2|||
125137972|NCT00924638|450131156|FG000|Overall Study|Lost to Follow-up|1|||
125137973|NCT00924638|450131157|FG001|Overall Study|Lost to Follow-up|1|||
125137974|NCT00924638|450131156|FG000|Overall Study|Withdrawal by Subject|5|||
125137975|NCT00924638|450131157|FG001|Overall Study|Withdrawal by Subject|7|||
125137976|NCT00924638|450131156|FG000|Overall Study|Physician Decision|3|||
125137977|NCT00924638|450131157|FG001|Overall Study|Physician Decision|3|||
125137978|NCT04411680|450131161|FG000|Treatment Period|Adverse Event|3|||
125137979|NCT04411680|450131162|FG001|Treatment Period|Adverse Event|0|||
125137980|NCT04411680|450131161|FG000|Treatment Period|Discharged from hospital|18|||
125137981|NCT04411680|450131162|FG001|Treatment Period|Discharged from hospital|7|||
125137982|NCT04411680|450131161|FG000|Treatment Period|Missed 1 or more doses|8|||
125137983|NCT04411680|450131162|FG001|Treatment Period|Missed 1 or more doses|0|||
125137984|NCT04411680|450131161|FG000|Treatment Period|Transferred to another hospital|0|||
125137985|NCT04411680|450131162|FG001|Treatment Period|Transferred to another hospital|1|||
125137986|NCT04411680|450131161|FG000|Follow up Period|Withdrawal by Subject|2|||
125137987|NCT04411680|450131162|FG001|Follow up Period|Withdrawal by Subject|0|||
125137988|NCT04411680|450131161|FG000|Follow up Period|Lost to Follow-up|5|||
125137989|NCT04411680|450131162|FG001|Follow up Period|Lost to Follow-up|6|||
125137990|NCT04411680|450131161|FG000|Follow up Period|Death|11|||
125220863|NCT00320788|450436240|FG001|Overall Study|Withdrawal by Subject|0|||
125220864|NCT00320788|450436241|FG002|Overall Study|Withdrawal by Subject|0|||
125058078|NCT00008138|449828807|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
125058079|NCT00008138|449828807|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
125058080|NCT00008138|449828807|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
125058081|NCT00755846|449830282|FG000|Overall Study|Adverse Event|0|||
125058082|NCT00755846|449830283|FG001|Overall Study|Adverse Event|0|||
125058083|NCT00755846|449830284|FG002|Overall Study|Adverse Event|0|||
125058084|NCT00755846|449830285|FG003|Overall Study|Adverse Event|1|||
125058085|NCT00755846|449830286|FG004|Overall Study|Adverse Event|3|||
125058086|NCT00755846|449830287|FG005|Overall Study|Adverse Event|2|||
125058087|NCT00755846|449830282|FG000|Overall Study|Protocol Violation|1|||
125058088|NCT00755846|449830283|FG001|Overall Study|Protocol Violation|1|||
125058089|NCT00755846|449830284|FG002|Overall Study|Protocol Violation|1|||
125058090|NCT00755846|449830285|FG003|Overall Study|Protocol Violation|1|||
125058091|NCT00755846|449830286|FG004|Overall Study|Protocol Violation|1|||
125058092|NCT00755846|449830287|FG005|Overall Study|Protocol Violation|1|||
125058093|NCT00755846|449830282|FG000|Overall Study|Lost to Follow-up|0|||
125058094|NCT00755846|449830283|FG001|Overall Study|Lost to Follow-up|2|||
125058095|NCT00755846|449830284|FG002|Overall Study|Lost to Follow-up|1|||
125058096|NCT00755846|449830285|FG003|Overall Study|Lost to Follow-up|0|||
125058097|NCT00755846|449830286|FG004|Overall Study|Lost to Follow-up|4|||
125058098|NCT00755846|449830287|FG005|Overall Study|Lost to Follow-up|2|||
125058099|NCT00755846|449830282|FG000|Overall Study|Withdrawal by Subject|2|||
125220865|NCT00320788|450436242|FG003|Overall Study|Withdrawal by Subject|3|||
125220866|NCT00320788|450436243|FG004|Overall Study|Withdrawal by Subject|1|||
125058100|NCT00755846|449830283|FG001|Overall Study|Withdrawal by Subject|3|||
125058101|NCT00755846|449830284|FG002|Overall Study|Withdrawal by Subject|5|||
125058102|NCT00755846|449830285|FG003|Overall Study|Withdrawal by Subject|2|||
125058103|NCT00755846|449830286|FG004|Overall Study|Withdrawal by Subject|0|||
125058104|NCT00755846|449830287|FG005|Overall Study|Withdrawal by Subject|1|||
125058105|NCT00755846|449830282|FG000|Overall Study|Hyperglycemic Rescue|21|||
125058106|NCT00755846|449830283|FG001|Overall Study|Hyperglycemic Rescue|7|||
125058107|NCT00755846|449830284|FG002|Overall Study|Hyperglycemic Rescue|5|||
125058108|NCT00755846|449830285|FG003|Overall Study|Hyperglycemic Rescue|8|||
125137991|NCT04411680|450131162|FG001|Follow up Period|Death|8|||
125137992|NCT00748566|450131163|FG000|Overall Study|Adverse Event|49|||
125137993|NCT00748566|450131163|FG000|Overall Study|Death|1|||
125137994|NCT00748566|450131163|FG000|Overall Study|Lack of Efficacy|12|||
125137995|NCT00748566|450131163|FG000|Overall Study|Lost to Follow-up|1|||
125137996|NCT00748566|450131163|FG000|Overall Study|Protocol Violation|13|||
125137997|NCT00748566|450131163|FG000|Overall Study|Withdrawal by Subject|22|||
125137998|NCT00748566|450131163|FG000|Overall Study|Study terminated by sponsor|5|||
125137999|NCT00748566|450131163|FG000|Overall Study|Other|9|||
125138000|NCT00624286|450131164|FG000|Overall Study|Protocol Deviation|7|||
125138001|NCT00624286|450131165|FG001|Overall Study|Protocol Deviation|9|||
125138002|NCT00624286|450131164|FG000|Overall Study|Adverse Event|6|||
125138003|NCT00624286|450131165|FG001|Overall Study|Adverse Event|3|||
125138004|NCT00624286|450131164|FG000|Overall Study|Withdrawal by Subject|5|||
125220867|NCT00627926|450436244|FG000|Overall Study|Adverse Event|26|||
125058109|NCT00755846|449830286|FG004|Overall Study|Hyperglycemic Rescue|8|||
125058110|NCT00755846|449830287|FG005|Overall Study|Hyperglycemic Rescue|7|||
125058111|NCT00755846|449830282|FG000|Overall Study|Physician Decision|1|||
125058112|NCT00755846|449830283|FG001|Overall Study|Physician Decision|3|||
125058113|NCT00755846|449830284|FG002|Overall Study|Physician Decision|0|||
125058114|NCT00755846|449830285|FG003|Overall Study|Physician Decision|1|||
125058115|NCT00755846|449830286|FG004|Overall Study|Physician Decision|0|||
125058116|NCT00755846|449830287|FG005|Overall Study|Physician Decision|1|||
125058117|NCT00755846|449830282|FG000|Overall Study|Administrative Error|0|||
125058118|NCT00755846|449830283|FG001|Overall Study|Administrative Error|1|||
125058119|NCT00755846|449830284|FG002|Overall Study|Administrative Error|0|||
125138005|NCT00624286|450131165|FG001|Overall Study|Withdrawal by Subject|4|||
125138006|NCT00624286|450131164|FG000|Overall Study|Lost to Follow-up|3|||
125138007|NCT00624286|450131165|FG001|Overall Study|Lost to Follow-up|2|||
125138008|NCT00624286|450131164|FG000|Overall Study|Administrative problems|3|||
125138009|NCT00624286|450131165|FG001|Overall Study|Administrative problems|0|||
125138010|NCT00624286|450131164|FG000|Overall Study|Lack of Efficacy|1|||
125058120|NCT00755846|449830285|FG003|Overall Study|Administrative Error|0|||
125058121|NCT00755846|449830286|FG004|Overall Study|Administrative Error|0|||
125058122|NCT00755846|449830287|FG005|Overall Study|Administrative Error|0|||
125058123|NCT00755846|449830282|FG000|Overall Study|Participant Non-compliance|0|||
125058124|NCT00755846|449830283|FG001|Overall Study|Participant Non-compliance|0|||
125058125|NCT00755846|449830284|FG002|Overall Study|Participant Non-compliance|0|||
125058126|NCT00755846|449830285|FG003|Overall Study|Participant Non-compliance|0|||
125058127|NCT00755846|449830286|FG004|Overall Study|Participant Non-compliance|1|||
125058128|NCT00755846|449830287|FG005|Overall Study|Participant Non-compliance|0|||
125058129|NCT00786032|449830288|FG000|Overall Study|Death|4|||
125058130|NCT00786032|449830288|FG000|Overall Study|Withdrawal by Subject|14|||
125058131|NCT00786032|449830288|FG000|Overall Study|Did not complete in the timeframe|6|||
125058132|NCT00311181|449830289|FG000|Overall Study|Final DFTs were not obtained|96|||
125058133|NCT02669862|449830290|FG000|Overall Study|Lost to Follow-up|0|||
125058134|NCT02669862|449830291|FG001|Overall Study|Lost to Follow-up|2|||
125058135|NCT02669862|449830292|FG002|Overall Study|Lost to Follow-up|1|||
125058136|NCT02669862|449830290|FG000|Overall Study|Withdrawal by Subject|2|||
125058137|NCT02669862|449830291|FG001|Overall Study|Withdrawal by Subject|2|||
125058138|NCT02669862|449830292|FG002|Overall Study|Withdrawal by Subject|3|||
125058139|NCT02669862|449830290|FG000|Overall Study|moved|0|||
125058140|NCT02669862|449830291|FG001|Overall Study|moved|1|||
125058141|NCT02669862|449830292|FG002|Overall Study|moved|0|||
125058142|NCT02669862|449830290|FG000|Overall Study|Protocol Violation|0|||
125058143|NCT02669862|449830291|FG001|Overall Study|Protocol Violation|0|||
125058144|NCT02669862|449830292|FG002|Overall Study|Protocol Violation|1|||
125058145|NCT02429258|449830293|FG000|Overall Study|Withdrawal by Subject|2|||
125058146|NCT02429258|449830294|FG001|Overall Study|Withdrawal by Subject|0|||
125058147|NCT02429258|449830293|FG000|Overall Study|Protocol Violation|0|||
125058148|NCT02429258|449830294|FG001|Overall Study|Protocol Violation|1|||
125058149|NCT02397694|449830295|FG000|Double-Blinded Phase|Adverse Event|1|||
125058150|NCT02397694|449830296|FG001|Double-Blinded Phase|Adverse Event|0|||
125058151|NCT02397694|449830295|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
125058152|NCT02397694|449830296|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
125058153|NCT02397694|449830295|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
125058154|NCT02397694|449830296|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
125058155|NCT02397694|449830295|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
125058156|NCT02397694|449830296|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
125058157|NCT02397694|449830295|FG000|Open Label Extension Phase|Protocol Violation|1|||
125058158|NCT02397694|449830296|FG001|Open Label Extension Phase|Protocol Violation|0|||
125058159|NCT02397694|449830295|FG000|Open Label Extension Phase|Withdrew Consent|3|||
125058160|NCT02397694|449830296|FG001|Open Label Extension Phase|Withdrew Consent|1|||
125058161|NCT02397694|449830295|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
125058162|NCT02397694|449830296|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
125058163|NCT02616185|449830298|FG000|Overall Study|Death|0|||
125058164|NCT02616185|449830299|FG001|Overall Study|Death|0|||
125058165|NCT02616185|449830300|FG002|Overall Study|Death|0|||
125058166|NCT02616185|449830301|FG003|Overall Study|Death|1|||
125058167|NCT02616185|449830302|FG004|Overall Study|Death|2|||
125058168|NCT02616185|449830303|FG005|Overall Study|Death|0|||
125058169|NCT02616185|449830304|FG006|Overall Study|Death|0|||
125058170|NCT02616185|449830305|FG007|Overall Study|Death|2|||
125058171|NCT02616185|449830306|FG008|Overall Study|Death|1|||
125220868|NCT00627926|450436245|FG001|Overall Study|Adverse Event|37|||
125220869|NCT00627926|450436246|FG002|Overall Study|Adverse Event|36|||
125220870|NCT00627926|450436244|FG000|Overall Study|Death|1|||
125220871|NCT00627926|450436245|FG001|Overall Study|Death|0|||
125220872|NCT00627926|450436246|FG002|Overall Study|Death|0|||
125220873|NCT00627926|450436244|FG000|Overall Study|Lost to Follow-up|4|||
125220874|NCT00627926|450436245|FG001|Overall Study|Lost to Follow-up|3|||
125220875|NCT00627926|450436246|FG002|Overall Study|Lost to Follow-up|4|||
125220876|NCT00627926|450436244|FG000|Overall Study|Withdrawal by Subject|2|||
125220877|NCT00627926|450436245|FG001|Overall Study|Withdrawal by Subject|1|||
125220878|NCT00627926|450436246|FG002|Overall Study|Withdrawal by Subject|0|||
125220879|NCT00627926|450436244|FG000|Overall Study|Lack of Efficacy|118|||
125220880|NCT00627926|450436245|FG001|Overall Study|Lack of Efficacy|40|||
125220881|NCT00627926|450436246|FG002|Overall Study|Lack of Efficacy|38|||
125220882|NCT00627926|450436244|FG000|Overall Study|Noncompliance/unspecified|8|||
125220883|NCT00627926|450436245|FG001|Overall Study|Noncompliance/unspecified|23|||
125220884|NCT00627926|450436246|FG002|Overall Study|Noncompliance/unspecified|17|||
125220885|NCT05216835|450436249|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
125220886|NCT05216835|450436250|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
125220887|NCT05216835|450436251|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
125220888|NCT05216835|450436252|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
125058172|NCT02616185|449830298|FG000|Overall Study|Study terminated by sponsor|0|||
125058173|NCT02616185|449830299|FG001|Overall Study|Study terminated by sponsor|0|||
125058174|NCT02616185|449830300|FG002|Overall Study|Study terminated by sponsor|1|||
125058175|NCT02616185|449830301|FG003|Overall Study|Study terminated by sponsor|0|||
125058176|NCT02616185|449830302|FG004|Overall Study|Study terminated by sponsor|0|||
125058177|NCT02616185|449830303|FG005|Overall Study|Study terminated by sponsor|0|||
125058178|NCT02616185|449830304|FG006|Overall Study|Study terminated by sponsor|5|||
125058179|NCT02616185|449830305|FG007|Overall Study|Study terminated by sponsor|2|||
125058180|NCT02616185|449830306|FG008|Overall Study|Study terminated by sponsor|0|||
125058181|NCT02616185|449830298|FG000|Overall Study|Participant refused further follow-up|1|||
125058182|NCT02616185|449830299|FG001|Overall Study|Participant refused further follow-up|1|||
125058183|NCT02616185|449830300|FG002|Overall Study|Participant refused further follow-up|2|||
125058184|NCT02616185|449830301|FG003|Overall Study|Participant refused further follow-up|3|||
125058185|NCT02616185|449830302|FG004|Overall Study|Participant refused further follow-up|4|||
125058186|NCT02616185|449830303|FG005|Overall Study|Participant refused further follow-up|0|||
125058187|NCT02616185|449830304|FG006|Overall Study|Participant refused further follow-up|3|||
125058188|NCT02616185|449830305|FG007|Overall Study|Participant refused further follow-up|4|||
125058189|NCT02616185|449830306|FG008|Overall Study|Participant refused further follow-up|3|||
125058190|NCT02616185|449830298|FG000|Overall Study|Not reported|0|||
125058191|NCT02616185|449830299|FG001|Overall Study|Not reported|0|||
125058192|NCT02616185|449830300|FG002|Overall Study|Not reported|0|||
125058193|NCT02616185|449830301|FG003|Overall Study|Not reported|1|||
125058194|NCT02616185|449830302|FG004|Overall Study|Not reported|3|||
125058195|NCT02616185|449830303|FG005|Overall Study|Not reported|1|||
125220889|NCT05216835|450436253|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
124819522|NCT00543140|448965739|FG000|Overall Study|Conversion to different procedure|1|||
125058196|NCT02616185|449830304|FG006|Overall Study|Not reported|0|||
125058197|NCT02616185|449830305|FG007|Overall Study|Not reported|5|||
125058198|NCT02616185|449830306|FG008|Overall Study|Not reported|2|||
125058199|NCT01346371|449830307|FG000|Overall Study|Lost to Follow-up|2|||
125220890|NCT05216835|450436254|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
125058200|NCT01346371|449830308|FG001|Overall Study|Lost to Follow-up|0|||
125220891|NCT05216835|450436255|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
125058201|NCT01640925|449830320|FG000|Overall Study|Withdrawal by Subject|1|||
125058202|NCT01640925|449830321|FG001|Overall Study|Withdrawal by Subject|0|||
125058203|NCT01640925|449830320|FG000|Overall Study|Previously enrolled in this trial|13|||
125058204|NCT01640925|449830321|FG001|Overall Study|Previously enrolled in this trial|11|||
125058205|NCT01592409|449830338|FG000|Overall Study|Withdrawal by Subject|0|||
125058206|NCT01592409|449830339|FG001|Overall Study|Withdrawal by Subject|1|||
125058207|NCT02345252|449830349|FG000|Double-Blind Phase|Adverse Event|2|||
125058208|NCT02345252|449830350|FG001|Double-Blind Phase|Adverse Event|3|||
125058209|NCT02345252|449830349|FG000|Double-Blind Phase|Death|1|||
125058210|NCT02345252|449830350|FG001|Double-Blind Phase|Death|2|||
125058211|NCT02345252|449830349|FG000|Double-Blind Phase|Lack of Efficacy|1|||
125058212|NCT02345252|449830350|FG001|Double-Blind Phase|Lack of Efficacy|0|||
125058213|NCT02345252|449830349|FG000|Double-Blind Phase|Investigator's Discretion|4|||
125058214|NCT02345252|449830350|FG001|Double-Blind Phase|Investigator's Discretion|6|||
125058215|NCT02345252|449830349|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
125058216|NCT02345252|449830350|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
125058217|NCT02345252|449830349|FG000|Double-Blind Phase|Protocol Violation|2|||
125058218|NCT02345252|449830350|FG001|Double-Blind Phase|Protocol Violation|1|||
125058219|NCT02345252|449830349|FG000|Double-Blind Phase|Withdrew Consent|21|||
125058220|NCT02345252|449830350|FG001|Double-Blind Phase|Withdrew Consent|23|||
125058221|NCT02345252|449830349|FG000|Double-Blind Phase|Lost to Follow-up|8|||
125058222|NCT02345252|449830350|FG001|Double-Blind Phase|Lost to Follow-up|10|||
125058223|NCT02345252|449830349|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
125058224|NCT02345252|449830350|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
125058225|NCT01094730|449830351|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
125058226|NCT01094730|449830352|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
125058227|NCT01094730|449830351|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
125058228|NCT01094730|449830352|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
125058229|NCT01094730|449830351|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
125058230|NCT01094730|449830352|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
125058231|NCT01094730|449830351|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
125058232|NCT01094730|449830352|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
125058233|NCT01094730|449830351|FG000|Period 2 (14 Days)|Protocol Violation|2|||
125058234|NCT01094730|449830352|FG001|Period 2 (14 Days)|Protocol Violation|0|||
125058235|NCT01094730|449830351|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
125058236|NCT01094730|449830352|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
125058237|NCT01094730|449830351|FG000|Period 2 (14 Days)|Adverse Event|0|||
125058238|NCT01094730|449830352|FG001|Period 2 (14 Days)|Adverse Event|1|||
125058239|NCT01094730|449830351|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
125058240|NCT01094730|449830352|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
125058241|NCT00779324|449830353|FG000|Overall Study|Lost to Follow-up|2|||
125058242|NCT00779324|449830354|FG001|Overall Study|Lost to Follow-up|1|||
125058243|NCT00779324|449830353|FG000|Overall Study|Withdrawal by Subject|4|||
125058244|NCT00779324|449830354|FG001|Overall Study|Withdrawal by Subject|2|||
125058245|NCT00779324|449830353|FG000|Overall Study|Missed visit|1|||
125058246|NCT00779324|449830354|FG001|Overall Study|Missed visit|1|||
125058247|NCT00617409|449830355|FG000|Overall Study|Withdrawal by Subject|4|||
125058248|NCT00617409|449830356|FG001|Overall Study|Withdrawal by Subject|1|||
125058249|NCT00617409|449830357|FG002|Overall Study|Withdrawal by Subject|2|||
125058250|NCT00617409|449830355|FG000|Overall Study|Adverse Event|0|||
125058251|NCT00617409|449830356|FG001|Overall Study|Adverse Event|2|||
125058252|NCT00617409|449830357|FG002|Overall Study|Adverse Event|3|||
125058253|NCT00617409|449830355|FG000|Overall Study|Disease Progression|8|||
125058254|NCT00617409|449830356|FG001|Overall Study|Disease Progression|8|||
125058255|NCT00617409|449830357|FG002|Overall Study|Disease Progression|18|||
125058256|NCT00617409|449830355|FG000|Overall Study|Death|3|||
124819523|NCT03902574|448965742|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
125058257|NCT00617409|449830356|FG001|Overall Study|Death|5|||
125058258|NCT00617409|449830357|FG002|Overall Study|Death|4|||
125058259|NCT00617409|449830355|FG000|Overall Study|Alternative Therapy|1|||
125058260|NCT00617409|449830356|FG001|Overall Study|Alternative Therapy|2|||
125058261|NCT00617409|449830357|FG002|Overall Study|Alternative Therapy|0|||
125058262|NCT00987623|449830362|FG000|Overall Study|Lost to Follow-up|2|||
125058263|NCT00987623|449830363|FG001|Overall Study|Lost to Follow-up|1|||
125058264|NCT00987623|449830362|FG000|Overall Study|Time/job conflict|2|||
125058265|NCT00987623|449830363|FG001|Overall Study|Time/job conflict|0|||
125058266|NCT00987623|449830362|FG000|Overall Study|Discomfort|1|||
125058267|NCT00987623|449830363|FG001|Overall Study|Discomfort|0|||
125058268|NCT00987623|449830362|FG000|Overall Study|Biomicroscopy|0|||
125058269|NCT00987623|449830363|FG001|Overall Study|Biomicroscopy|1|||
125058270|NCT00987623|449830362|FG000|Overall Study|Influenza|0|||
125058271|NCT00987623|449830363|FG001|Overall Study|Influenza|1|||
125058272|NCT01496430|449830365|FG000|Overall Study|Adverse Event|0|||
125058273|NCT01496430|449830366|FG001|Overall Study|Adverse Event|0|||
125058274|NCT01496430|449830367|FG002|Overall Study|Adverse Event|1|||
125058275|NCT01496430|449830365|FG000|Overall Study|Major Protocol Deviation|0|||
125058276|NCT01496430|449830366|FG001|Overall Study|Major Protocol Deviation|0|||
125058277|NCT01496430|449830367|FG002|Overall Study|Major Protocol Deviation|1|||
125058278|NCT01496430|449830365|FG000|Overall Study|Lost to Follow-up|2|||
125058279|NCT01496430|449830366|FG001|Overall Study|Lost to Follow-up|3|||
125058280|NCT01496430|449830367|FG002|Overall Study|Lost to Follow-up|1|||
125058281|NCT01496430|449830365|FG000|Overall Study|Voluntary Withdrawal|2|||
125058282|NCT01496430|449830366|FG001|Overall Study|Voluntary Withdrawal|1|||
125138011|NCT00624286|450131165|FG001|Overall Study|Lack of Efficacy|6|||
125138012|NCT00624286|450131164|FG000|Overall Study|Not stated|0|||
125138013|NCT00624286|450131165|FG001|Overall Study|Not stated|1|||
125138014|NCT00624286|450131164|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125138015|NCT00624286|450131165|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125058283|NCT01496430|449830367|FG002|Overall Study|Voluntary Withdrawal|6|||
125058284|NCT01496430|449830365|FG000|Overall Study|Principal Investigator Discretion|0|||
125058285|NCT01496430|449830366|FG001|Overall Study|Principal Investigator Discretion|1|||
125058286|NCT01496430|449830367|FG002|Overall Study|Principal Investigator Discretion|1|||
125058287|NCT01496430|449830365|FG000|Overall Study|Other|2|||
125058288|NCT01496430|449830366|FG001|Overall Study|Other|0|||
125058289|NCT01496430|449830367|FG002|Overall Study|Other|0|||
125058290|NCT01100307|449830368|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
125058291|NCT01100307|449830369|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
125058292|NCT01100307|449830368|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
125058293|NCT01100307|449830369|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
125138016|NCT00624286|450131164|FG000|Overall Study|Death|0|||
125058294|NCT01100307|449830368|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
125058295|NCT01100307|449830369|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
125058296|NCT01100307|449830368|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
125058297|NCT01100307|449830369|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
125058298|NCT01100307|449830368|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
125058299|NCT01100307|449830369|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
125058300|NCT01100307|449830368|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
125058301|NCT01100307|449830369|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
125058302|NCT02509598|449830370|FG000|Overall Study|Withdrawal by Subject|1|||
125058303|NCT02196038|449830371|FG000|Overall Study|Death|16|||
125058304|NCT02196038|449830372|FG001|Overall Study|Death|21|||
125058305|NCT02196038|449830371|FG000|Overall Study|Withdrawal by Subject|0|||
125058306|NCT02196038|449830372|FG001|Overall Study|Withdrawal by Subject|1|||
125058307|NCT02196038|449830371|FG000|Overall Study|Lost to Follow-up|1|||
125058308|NCT02196038|449830372|FG001|Overall Study|Lost to Follow-up|0|||
125058309|NCT04056455|449830373|FG000|Overall Study|Adverse Event|1|||
125058310|NCT04056455|449830374|FG001|Overall Study|Adverse Event|0|||
125058311|NCT03135028|449830381|FG000|Overall Study|Death|6|||
125058312|NCT03135028|449830381|FG000|Overall Study|Study Terminated by Sponsor|2|||
125058313|NCT03135028|449830381|FG000|Overall Study|Withdrew Consent|1|||
125058314|NCT02065869|449830383|FG000|Overall Study|Death|7|||
125058315|NCT02065869|449830383|FG000|Overall Study|Disease relapse|16|||
125058316|NCT02065869|449830383|FG000|Overall Study|Lost to Follow-up|4|||
125058317|NCT02065869|449830383|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
125058318|NCT02065869|449830383|FG000|Overall Study|Withdrawal by Subject|1|||
125058319|NCT04436822|449830384|FG000|Overall Study|Physician Decision|2|||
125058320|NCT04436822|449830385|FG001|Overall Study|Physician Decision|0|||
125058321|NCT04436822|449830384|FG000|Overall Study|Sponsor request|1|||
125058322|NCT04436822|449830385|FG001|Overall Study|Sponsor request|0|||
125058323|NCT04436822|449830384|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125058324|NCT04436822|449830385|FG001|Overall Study|Withdrawal by parent/guardian|3|||
125058325|NCT04436822|449830384|FG000|Overall Study|Unsuccessful procedure|0|||
125058326|NCT04436822|449830385|FG001|Overall Study|Unsuccessful procedure|1|||
125058327|NCT04436822|449830384|FG000|Overall Study|Withdrawal due to Covid-19|8|||
125058328|NCT04436822|449830385|FG001|Overall Study|Withdrawal due to Covid-19|1|||
125058329|NCT04436822|449830384|FG000|Overall Study|Withdrawal by Subject|1|||
125058330|NCT04436822|449830385|FG001|Overall Study|Withdrawal by Subject|0|||
125058331|NCT04436822|449830384|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
125058332|NCT04436822|449830385|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
125058333|NCT03375112|449830386|FG000|Overall Study|Withdrawal by Subject|3|||
125058334|NCT03375112|449830387|FG001|Overall Study|Withdrawal by Subject|0|||
125058335|NCT00369668|449830388|FG000|Overall Study|Lack of Efficacy|4|||
125058336|NCT00369668|449830389|FG001|Overall Study|Lack of Efficacy|5|||
125058337|NCT00369668|449830390|FG002|Overall Study|Lack of Efficacy|7|||
125058338|NCT00894413|449830393|FG000|Overall Study|Physician Decision|0|||
125058339|NCT00894413|449830394|FG001|Overall Study|Physician Decision|2|||
125058340|NCT00894413|449830393|FG000|Overall Study|Adverse Event|0|||
125058341|NCT00894413|449830394|FG001|Overall Study|Adverse Event|2|||
125058342|NCT00894413|449830393|FG000|Overall Study|Withdrawal by Subject|0|||
125058343|NCT00894413|449830394|FG001|Overall Study|Withdrawal by Subject|4|||
125058344|NCT03352414|449830402|FG000|Overall Study|Ineligible by operative criteria|12|||
125058345|NCT03352414|449830403|FG001|Overall Study|Ineligible by operative criteria|10|||
125058346|NCT03213626|449830404|FG000|Overall Study|Adverse Event|1|||
125058347|NCT03213626|449830404|FG000|Overall Study|Progressive Disease|6|||
125058348|NCT00142519|449830405|FG000|Overall Study|Not Treated|7|||
125058349|NCT00142519|449830406|FG001|Overall Study|Not Treated|9|||
125058350|NCT00142519|449830405|FG000|Overall Study|Protocol Violation|1|||
125058351|NCT00142519|449830406|FG001|Overall Study|Protocol Violation|0|||
125058352|NCT00142519|449830405|FG000|Overall Study|Withdrawal by Subject|10|||
125058353|NCT00142519|449830406|FG001|Overall Study|Withdrawal by Subject|7|||
125058354|NCT01079962|449830419|FG000|Overall Study|Adverse Event|2|||
125058355|NCT01079962|449830420|FG001|Overall Study|Adverse Event|2|||
125058356|NCT01079962|449830419|FG000|Overall Study|Withdrawal by Subject|5|||
125058357|NCT01079962|449830420|FG001|Overall Study|Withdrawal by Subject|7|||
125058358|NCT01079962|449830419|FG000|Overall Study|Protocol Violation|2|||
125058359|NCT01079962|449830420|FG001|Overall Study|Protocol Violation|2|||
125058360|NCT01079962|449830419|FG000|Overall Study|No blood pressure (BP) control|3|||
125058361|NCT01079962|449830420|FG001|Overall Study|No blood pressure (BP) control|0|||
125058362|NCT01079962|449830419|FG000|Overall Study|Inclusion/exclusion criteria|1|||
125058363|NCT01079962|449830420|FG001|Overall Study|Inclusion/exclusion criteria|3|||
125058364|NCT01079962|449830419|FG000|Overall Study|Participant not returning for next visit|1|||
125058365|NCT01079962|449830420|FG001|Overall Study|Participant not returning for next visit|0|||
125058366|NCT01079962|449830419|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
125058367|NCT01079962|449830420|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
125058368|NCT01331239|449830421|FG000|Part II: Core Study|Adverse Event|0|||
125058369|NCT01331239|449830422|FG001|Part II: Core Study|Adverse Event|3|||
125058370|NCT01331239|449830423|FG002|Part II: Core Study|Adverse Event|0|||
125058371|NCT01331239|449830421|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
125058372|NCT01331239|449830422|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
125058373|NCT01331239|449830423|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
125058374|NCT01331239|449830421|FG000|Part II: Core Study|Withdrawal by Subject|0|||
125058375|NCT01331239|449830422|FG001|Part II: Core Study|Withdrawal by Subject|2|||
125058376|NCT01331239|449830423|FG002|Part II: Core Study|Withdrawal by Subject|0|||
125058377|NCT01331239|449830421|FG000|Part II: Core Study|Administrative problems|0|||
125058378|NCT01331239|449830422|FG001|Part II: Core Study|Administrative problems|1|||
125058379|NCT01331239|449830423|FG002|Part II: Core Study|Administrative problems|0|||
125058380|NCT00946530|449830426|FG000|Overall Study|Withdrawal by Subject|0|||
125058381|NCT00946530|449830427|FG001|Overall Study|Withdrawal by Subject|3|||
125058382|NCT00946530|449830428|FG002|Overall Study|Withdrawal by Subject|0|||
125058383|NCT00946530|449830429|FG003|Overall Study|Withdrawal by Subject|3|||
125058384|NCT00946530|449830426|FG000|Overall Study|Physician Decision|1|||
125058385|NCT00946530|449830427|FG001|Overall Study|Physician Decision|1|||
125058386|NCT00946530|449830428|FG002|Overall Study|Physician Decision|1|||
125058387|NCT00946530|449830429|FG003|Overall Study|Physician Decision|1|||
125058388|NCT01008995|449830430|FG000|Controlled Period|Adverse Event|1|||
125058389|NCT01008995|449830431|FG001|Controlled Period|Adverse Event|2|||
125058390|NCT01008995|449830432|FG002|Controlled Period|Adverse Event|0|||
125058391|NCT01008995|449830433|FG003|Controlled Period|Adverse Event|0|||
125058392|NCT01008995|449830430|FG000|Controlled Period|Other|2|||
125058393|NCT01008995|449830431|FG001|Controlled Period|Other|1|||
125058394|NCT01008995|449830432|FG002|Controlled Period|Other|0|||
125058395|NCT01008995|449830433|FG003|Controlled Period|Other|0|||
125058396|NCT01008995|449830430|FG000|After Controlled Period|Adverse Event|0|||
125058397|NCT01008995|449830431|FG001|After Controlled Period|Adverse Event|0|||
125058398|NCT01008995|449830432|FG002|After Controlled Period|Adverse Event|1|||
125058399|NCT01008995|449830433|FG003|After Controlled Period|Adverse Event|1|||
125058400|NCT01008995|449830430|FG000|After Controlled Period|Other|0|||
125058401|NCT01008995|449830431|FG001|After Controlled Period|Other|0|||
125058402|NCT01008995|449830432|FG002|After Controlled Period|Other|1|||
125058403|NCT01008995|449830433|FG003|After Controlled Period|Other|0|||
125058404|NCT00406640|449830434|FG000|Acute Phase|Adverse Event|18|||
125058405|NCT00406640|449830435|FG001|Acute Phase|Adverse Event|13|||
125058406|NCT00406640|449830434|FG000|Acute Phase|Failed to Return|5|||
125058407|NCT00406640|449830435|FG001|Acute Phase|Failed to Return|1|||
125058408|NCT00406640|449830434|FG000|Acute Phase|Physician Decision|0|||
125138017|NCT00624286|450131165|FG001|Overall Study|Death|1|||
125138018|NCT00841659|450131166|FG000|Washout: 2 Weeks|Protocol Violation|1|||
125138019|NCT00841659|450131167|FG001|Washout: 2 Weeks|Protocol Violation|0|||
125138020|NCT00073307|450131169|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
125138021|NCT00073307|450131170|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
125138022|NCT00073307|450131171|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
125138023|NCT00073307|450131169|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
125138024|NCT00073307|450131170|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
125138025|NCT00073307|450131171|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
125138026|NCT00073307|450131169|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
125138027|NCT00073307|450131170|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
125058409|NCT00406640|449830435|FG001|Acute Phase|Physician Decision|1|||
125058410|NCT00406640|449830434|FG000|Acute Phase|Lost to Follow-up|7|||
125058411|NCT00406640|449830435|FG001|Acute Phase|Lost to Follow-up|4|||
125058412|NCT00406640|449830434|FG000|Acute Phase|Protocol deviation|4|||
125058413|NCT00406640|449830435|FG001|Acute Phase|Protocol deviation|10|||
125058414|NCT00406640|449830434|FG000|Acute Phase|Protocol Violation|3|||
125058415|NCT00406640|449830435|FG001|Acute Phase|Protocol Violation|2|||
125058416|NCT00406640|449830434|FG000|Acute Phase|Withdrawal by Subject|11|||
125058417|NCT00406640|449830435|FG001|Acute Phase|Withdrawal by Subject|9|||
125058418|NCT00406640|449830434|FG000|Acute Phase|Lack of Efficacy|3|||
125058419|NCT00406640|449830435|FG001|Acute Phase|Lack of Efficacy|3|||
125058420|NCT00406640|449830434|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
125058421|NCT00406640|449830435|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
125058422|NCT00406640|449830434|FG000|DB Continuation Phase for Responders|Death|1|||
125058423|NCT00406640|449830435|FG001|DB Continuation Phase for Responders|Death|0|||
125058424|NCT00406640|449830434|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
125058425|NCT00406640|449830435|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
125058426|NCT00406640|449830434|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
125058427|NCT00406640|449830435|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
125058428|NCT00406640|449830434|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
125058429|NCT00406640|449830435|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
125058430|NCT00406640|449830434|FG000|DB Continuation Phase for Responders|non-compliance|7|||
125058431|NCT00406640|449830435|FG001|DB Continuation Phase for Responders|non-compliance|5|||
125058432|NCT00406640|449830434|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
125058433|NCT00406640|449830435|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
125058434|NCT00406640|449830434|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
125058435|NCT00406640|449830435|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
125058436|NCT00406640|449830434|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
125058437|NCT00406640|449830435|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
125058438|NCT00406640|449830434|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
125058439|NCT00406640|449830435|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
125058440|NCT00406640|449830434|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
125058441|NCT00406640|449830435|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
125058442|NCT00406640|449830434|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
125058443|NCT00406640|449830435|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
125058444|NCT00406640|449830434|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
125058445|NCT00406640|449830435|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
125058446|NCT00406640|449830434|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
125058447|NCT00406640|449830435|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
125058448|NCT00406640|449830434|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
125058449|NCT00406640|449830435|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
125058450|NCT00406640|449830434|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
125058451|NCT00406640|449830435|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
125058452|NCT01303380|449831821|FG000|Overall Study|Lack of compliance to study procedures|1|||
125058453|NCT01670656|449831822|FG000|Overall Study|Non-compliance with study drug|0|||
125058454|NCT01670656|449831823|FG001|Overall Study|Non-compliance with study drug|0|||
125058455|NCT01670656|449831824|FG002|Overall Study|Non-compliance with study drug|3|||
125058456|NCT01670656|449831825|FG003|Overall Study|Non-compliance with study drug|0|||
125058457|NCT01670656|449831826|FG004|Overall Study|Non-compliance with study drug|1|||
125058458|NCT01670656|449831822|FG000|Overall Study|Pregnancy|0|||
125058459|NCT01670656|449831823|FG001|Overall Study|Pregnancy|0|||
125058460|NCT01670656|449831824|FG002|Overall Study|Pregnancy|0|||
125058461|NCT01670656|449831825|FG003|Overall Study|Pregnancy|0|||
125058462|NCT01670656|449831826|FG004|Overall Study|Pregnancy|1|||
125058463|NCT01670656|449831822|FG000|Overall Study|Withdrawal by Subject|1|||
125058464|NCT01670656|449831823|FG001|Overall Study|Withdrawal by Subject|1|||
125058465|NCT01670656|449831824|FG002|Overall Study|Withdrawal by Subject|0|||
125058466|NCT01670656|449831825|FG003|Overall Study|Withdrawal by Subject|0|||
125058467|NCT01670656|449831826|FG004|Overall Study|Withdrawal by Subject|0|||
125058468|NCT01670656|449831822|FG000|Overall Study|Non-compliance with protocol|0|||
125058469|NCT01670656|449831823|FG001|Overall Study|Non-compliance with protocol|3|||
125058470|NCT01670656|449831824|FG002|Overall Study|Non-compliance with protocol|1|||
125058471|NCT01670656|449831825|FG003|Overall Study|Non-compliance with protocol|1|||
125058472|NCT01670656|449831826|FG004|Overall Study|Non-compliance with protocol|2|||
125058473|NCT01670656|449831822|FG000|Overall Study|Adverse Event|2|||
125058474|NCT01670656|449831823|FG001|Overall Study|Adverse Event|2|||
125058475|NCT01670656|449831824|FG002|Overall Study|Adverse Event|2|||
125058476|NCT01670656|449831825|FG003|Overall Study|Adverse Event|3|||
125058477|NCT01670656|449831826|FG004|Overall Study|Adverse Event|3|||
125058478|NCT01670656|449831822|FG000|Overall Study|Subject withdrew consent|0|||
125058479|NCT01670656|449831823|FG001|Overall Study|Subject withdrew consent|1|||
125058480|NCT01670656|449831824|FG002|Overall Study|Subject withdrew consent|2|||
125058481|NCT01670656|449831825|FG003|Overall Study|Subject withdrew consent|1|||
125058482|NCT01670656|449831826|FG004|Overall Study|Subject withdrew consent|1|||
125058483|NCT01670656|449831822|FG000|Overall Study|Lost to Follow-up|0|||
125058484|NCT01670656|449831823|FG001|Overall Study|Lost to Follow-up|0|||
125058485|NCT01670656|449831824|FG002|Overall Study|Lost to Follow-up|0|||
125058486|NCT01670656|449831825|FG003|Overall Study|Lost to Follow-up|0|||
125058487|NCT01670656|449831826|FG004|Overall Study|Lost to Follow-up|3|||
125058488|NCT01670656|449831822|FG000|Overall Study|Subject moved|0|||
125058489|NCT01670656|449831823|FG001|Overall Study|Subject moved|0|||
125058490|NCT01670656|449831824|FG002|Overall Study|Subject moved|0|||
125058491|NCT01670656|449831825|FG003|Overall Study|Subject moved|1|||
125058492|NCT01670656|449831826|FG004|Overall Study|Subject moved|0|||
125058493|NCT00789958|449831827|FG000|Overall Study|Adverse Event|3|||
125058494|NCT00789958|449831827|FG000|Overall Study|Withdrawal by Subject|4|||
125058495|NCT00789958|449831827|FG000|Overall Study|Progression|3|||
125058496|NCT00789958|449831827|FG000|Overall Study|not protocol specified|1|||
125058497|NCT00789958|449831827|FG000|Overall Study|Not eligible/not analyzable|26|||
125058498|NCT01000727|449831829|FG000|Overall Study|Lost to Follow-up|41|||
125058499|NCT01000727|449831830|FG001|Overall Study|Lost to Follow-up|43|||
125058500|NCT01000727|449831829|FG000|Overall Study|Withdrawal by Subject|111|||
125058501|NCT01000727|449831830|FG001|Overall Study|Withdrawal by Subject|109|||
125058502|NCT01000727|449831829|FG000|Overall Study|Study closed/terminated|23|||
125058503|NCT01000727|449831830|FG001|Overall Study|Study closed/terminated|24|||
125058504|NCT03544268|449831831|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
125058505|NCT03544268|449831832|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
125058506|NCT00377611|449831833|FG000|Overall Study|Adverse Event|2|||
125058507|NCT00377611|449831834|FG001|Overall Study|Adverse Event|9|||
125058508|NCT00377611|449831833|FG000|Overall Study|Protocol Violation|2|||
125058509|NCT00377611|449831834|FG001|Overall Study|Protocol Violation|0|||
125058510|NCT00377611|449831833|FG000|Overall Study|Withdrawal by Subject|0|||
125058511|NCT00377611|449831834|FG001|Overall Study|Withdrawal by Subject|5|||
125058512|NCT00377611|449831833|FG000|Overall Study|Lost to Follow-up|18|||
125058513|NCT00377611|449831834|FG001|Overall Study|Lost to Follow-up|16|||
125058514|NCT00377611|449831833|FG000|Overall Study|Other|0|||
125058515|NCT00377611|449831834|FG001|Overall Study|Other|3|||
125058516|NCT04831515|449831835|FG000|First Intervention|Adverse Event|0|||
125058517|NCT04831515|449831836|FG001|First Intervention|Adverse Event|1|||
125058518|NCT01030458|449831848|FG000|Overall Study|Lost to Follow-up|9|||
125058519|NCT01030458|449831849|FG001|Overall Study|Lost to Follow-up|10|||
125058520|NCT01030458|449831848|FG000|Overall Study|Withdrawal by Subject|2|||
125058521|NCT01030458|449831849|FG001|Overall Study|Withdrawal by Subject|3|||
125058522|NCT01030458|449831848|FG000|Overall Study|Logistical reasons|9|||
125058523|NCT01030458|449831849|FG001|Overall Study|Logistical reasons|5|||
125058524|NCT01030458|449831848|FG000|Overall Study|Moved or changed job|6|||
125058525|NCT01030458|449831849|FG001|Overall Study|Moved or changed job|13|||
125138028|NCT00073307|450131171|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
125138029|NCT00073307|450131169|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
125138030|NCT00073307|450131170|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
125138031|NCT00073307|450131171|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
125138032|NCT00073307|450131169|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
125138033|NCT00073307|450131170|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
125138034|NCT00073307|450131171|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
125058526|NCT01030458|449831848|FG000|Overall Study|Side effect of medication|1|||
125058527|NCT01030458|449831849|FG001|Overall Study|Side effect of medication|1|||
125058528|NCT01332019|449831850|FG000|Overall Study|Was Not Dosed|1|||
125058529|NCT01332019|449831851|FG001|Overall Study|Was Not Dosed|0|||
125058530|NCT01332019|449831850|FG000|Overall Study|Other|16|||
125058531|NCT01332019|449831851|FG001|Overall Study|Other|18|||
125058532|NCT01332019|449831850|FG000|Overall Study|Death|2|||
125058533|NCT01332019|449831851|FG001|Overall Study|Death|1|||
125058534|NCT01332019|449831850|FG000|Overall Study|Physician Decision|4|||
125058535|NCT01332019|449831851|FG001|Overall Study|Physician Decision|3|||
125058536|NCT01332019|449831850|FG000|Overall Study|Withdrawal by Subject|73|||
125058537|NCT01332019|449831851|FG001|Overall Study|Withdrawal by Subject|71|||
125058538|NCT01332019|449831850|FG000|Overall Study|Lost to Follow-up|4|||
125058539|NCT01332019|449831851|FG001|Overall Study|Lost to Follow-up|7|||
125058540|NCT01332019|449831850|FG000|Overall Study|Adverse Event|13|||
125058541|NCT01332019|449831851|FG001|Overall Study|Adverse Event|22|||
125058542|NCT00871377|449831854|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
125058543|NCT00871377|449831855|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
125058544|NCT00871377|449831856|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
125058545|NCT00871377|449831857|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
125058546|NCT00871377|449831858|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
125058547|NCT00871377|449831859|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
125058548|NCT00871377|449831854|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
125058549|NCT00871377|449831855|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
125058550|NCT00871377|449831856|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
125058551|NCT00871377|449831857|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
125058552|NCT00871377|449831858|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
125058553|NCT00871377|449831859|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
125058554|NCT00871377|449831854|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
125058555|NCT00871377|449831855|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
125058556|NCT00871377|449831856|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
125058557|NCT00871377|449831857|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
125058558|NCT00871377|449831858|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
125058559|NCT00871377|449831859|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
125058560|NCT00871377|449831854|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
125058561|NCT00871377|449831855|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
125058562|NCT00871377|449831856|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
125058563|NCT00871377|449831857|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
125058564|NCT00871377|449831858|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
125058565|NCT00871377|449831859|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
125058566|NCT00871377|449831854|FG000|Third Intervention (10 Weeks)|Death|0|||
125058567|NCT00871377|449831855|FG001|Third Intervention (10 Weeks)|Death|0|||
125058568|NCT00871377|449831856|FG002|Third Intervention (10 Weeks)|Death|0|||
125058569|NCT00871377|449831857|FG003|Third Intervention (10 Weeks)|Death|1|||
125058570|NCT00871377|449831858|FG004|Third Intervention (10 Weeks)|Death|0|||
125058571|NCT00871377|449831859|FG005|Third Intervention (10 Weeks)|Death|0|||
125058572|NCT01395368|449831861|FG000|Overall Study|Physician Decision|14|||
125058573|NCT01395368|449831861|FG000|Overall Study|Withdrawal by Subject|2|||
125058574|NCT00288860|449831864|FG000|Overall Study|Did not complete intake|4|||
125058575|NCT00288860|449831865|FG001|Overall Study|Did not complete intake|8|||
125058576|NCT00288860|449831864|FG000|Overall Study|Death|4|||
125058577|NCT00288860|449831865|FG001|Overall Study|Death|3|||
125058578|NCT00288860|449831864|FG000|Overall Study|Withdrawal by Subject|20|||
125058579|NCT00288860|449831865|FG001|Overall Study|Withdrawal by Subject|15|||
125058580|NCT00288860|449831864|FG000|Overall Study|Lost to Follow-up|74|||
125058581|NCT00288860|449831865|FG001|Overall Study|Lost to Follow-up|71|||
125058582|NCT03072719|449831870|FG000|Overall Study|Adverse Event|1|||
125058583|NCT03072719|449831871|FG001|Overall Study|Adverse Event|1|||
125058584|NCT00882999|449831873|FG000|Overall Study|Adverse Event|0|||
125058585|NCT00882999|449831874|FG001|Overall Study|Adverse Event|0|||
125058586|NCT00882999|449831875|FG002|Overall Study|Adverse Event|0|||
125138035|NCT00073307|450131169|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
125138036|NCT00073307|450131170|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
125058587|NCT00882999|449831876|FG003|Overall Study|Adverse Event|0|||
125058588|NCT00882999|449831877|FG004|Overall Study|Adverse Event|1|||
125058589|NCT00882999|449831878|FG005|Overall Study|Adverse Event|0|||
125058590|NCT00882999|449831879|FG006|Overall Study|Adverse Event|0|||
125058591|NCT00882999|449831873|FG000|Overall Study|Death|0|||
125058592|NCT00882999|449831874|FG001|Overall Study|Death|1|||
125058593|NCT00882999|449831875|FG002|Overall Study|Death|0|||
125058594|NCT00882999|449831876|FG003|Overall Study|Death|0|||
125058595|NCT00882999|449831877|FG004|Overall Study|Death|0|||
125058596|NCT00882999|449831878|FG005|Overall Study|Death|0|||
125058597|NCT00882999|449831879|FG006|Overall Study|Death|0|||
125058598|NCT00882999|449831873|FG000|Overall Study|Withdrawal by Subject|7|||
125138037|NCT00073307|450131171|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
125138038|NCT00073307|450131169|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
125138039|NCT00073307|450131170|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
125138040|NCT00073307|450131171|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
125138041|NCT00073307|450131169|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
125138042|NCT00073307|450131170|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
125138043|NCT00073307|450131171|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
125138044|NCT00073307|450131169|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
125138045|NCT00073307|450131170|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
125138046|NCT00073307|450131171|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
125138047|NCT00073307|450131169|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
125138048|NCT00073307|450131170|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
125138049|NCT00073307|450131171|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
125138050|NCT00073307|450131169|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
125138051|NCT00073307|450131170|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
125138052|NCT00073307|450131171|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
125138053|NCT00073307|450131169|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
125138054|NCT00073307|450131170|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
125138055|NCT00073307|450131171|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
125138056|NCT00073307|450131169|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
125138057|NCT00073307|450131170|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
125138058|NCT00073307|450131171|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
125138059|NCT00073307|450131169|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
125138060|NCT00073307|450131170|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
125138061|NCT00073307|450131171|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
125138062|NCT00073307|450131169|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
125138063|NCT00073307|450131170|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
125138064|NCT00073307|450131171|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
125138065|NCT00073307|450131169|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
125138066|NCT00073307|450131170|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
125138067|NCT00073307|450131171|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
125138068|NCT00073307|450131169|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
125138069|NCT00073307|450131170|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
125138070|NCT00073307|450131171|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
125138071|NCT00073307|450131169|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
125138072|NCT00073307|450131170|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
125138073|NCT00073307|450131171|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
125138074|NCT00073307|450131169|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
125138075|NCT00073307|450131170|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
125138076|NCT00073307|450131171|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
125138077|NCT01438060|450131172|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
125138078|NCT01438060|450131173|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
125138079|NCT01438060|450131172|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
125138080|NCT01438060|450131173|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
125138081|NCT01438060|450131172|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
125138082|NCT01438060|450131173|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
125138083|NCT01438060|450131172|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
125138084|NCT01438060|450131173|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
125138085|NCT01438060|450131172|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
125138086|NCT01438060|450131173|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
125138087|NCT01438060|450131172|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
125138088|NCT01438060|450131173|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
125138089|NCT01438060|450131172|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
125058599|NCT00882999|449831874|FG001|Overall Study|Withdrawal by Subject|6|||
125058600|NCT00882999|449831875|FG002|Overall Study|Withdrawal by Subject|3|||
125058601|NCT00882999|449831876|FG003|Overall Study|Withdrawal by Subject|3|||
125138090|NCT01438060|450131173|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
125138091|NCT01438060|450131172|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
125138092|NCT01438060|450131173|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
125138093|NCT01438060|450131172|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
125138094|NCT01438060|450131173|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
125138095|NCT01438060|450131172|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
125138096|NCT01438060|450131173|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
125138097|NCT01438060|450131172|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
125138098|NCT01438060|450131173|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
125138099|NCT01438060|450131172|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
125138100|NCT01438060|450131173|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
125138101|NCT01438060|450131172|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
125138102|NCT01438060|450131173|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
125220892|NCT05216835|450436256|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
125220893|NCT05216835|450436249|FG000|Overall Study|Death|0|||
125220894|NCT05216835|450436250|FG001|Overall Study|Death|0|||
125220895|NCT05216835|450436251|FG002|Overall Study|Death|0|||
125220896|NCT05216835|450436252|FG003|Overall Study|Death|1|||
125220897|NCT05216835|450436253|FG004|Overall Study|Death|1|||
125220898|NCT05216835|450436254|FG005|Overall Study|Death|1|||
125220899|NCT05216835|450436255|FG006|Overall Study|Death|1|||
125220900|NCT05216835|450436256|FG007|Overall Study|Death|1|||
125220901|NCT05216835|450436249|FG000|Overall Study|Physician Decision|0|||
125220902|NCT05216835|450436250|FG001|Overall Study|Physician Decision|0|||
125220903|NCT05216835|450436251|FG002|Overall Study|Physician Decision|0|||
125220904|NCT05216835|450436252|FG003|Overall Study|Physician Decision|0|||
125220905|NCT05216835|450436253|FG004|Overall Study|Physician Decision|0|||
125220906|NCT05216835|450436254|FG005|Overall Study|Physician Decision|1|||
125220907|NCT05216835|450436255|FG006|Overall Study|Physician Decision|1|||
125220908|NCT05216835|450436256|FG007|Overall Study|Physician Decision|0|||
125220909|NCT05216835|450436249|FG000|Overall Study|Study terminated by Sponsor|0|||
125220910|NCT05216835|450436250|FG001|Overall Study|Study terminated by Sponsor|0|||
125220911|NCT05216835|450436251|FG002|Overall Study|Study terminated by Sponsor|0|||
125220912|NCT05216835|450436252|FG003|Overall Study|Study terminated by Sponsor|0|||
125220913|NCT05216835|450436253|FG004|Overall Study|Study terminated by Sponsor|0|||
125220914|NCT05216835|450436254|FG005|Overall Study|Study terminated by Sponsor|0|||
125220915|NCT05216835|450436255|FG006|Overall Study|Study terminated by Sponsor|0|||
125220916|NCT05216835|450436256|FG007|Overall Study|Study terminated by Sponsor|1|||
125220917|NCT05216835|450436249|FG000|Overall Study|Withdrawal by Subject|1|||
125220918|NCT05216835|450436250|FG001|Overall Study|Withdrawal by Subject|0|||
125220919|NCT05216835|450436251|FG002|Overall Study|Withdrawal by Subject|1|||
125220920|NCT05216835|450436252|FG003|Overall Study|Withdrawal by Subject|0|||
125220921|NCT05216835|450436253|FG004|Overall Study|Withdrawal by Subject|1|||
125220922|NCT05216835|450436254|FG005|Overall Study|Withdrawal by Subject|0|||
125220923|NCT05216835|450436255|FG006|Overall Study|Withdrawal by Subject|0|||
125220924|NCT05216835|450436256|FG007|Overall Study|Withdrawal by Subject|1|||
125220925|NCT05216835|450436249|FG000|Overall Study|Other|0|||
125220926|NCT05216835|450436250|FG001|Overall Study|Other|1|||
125220927|NCT05216835|450436251|FG002|Overall Study|Other|0|||
125220928|NCT05216835|450436252|FG003|Overall Study|Other|0|||
125220929|NCT05216835|450436253|FG004|Overall Study|Other|0|||
125220930|NCT05216835|450436254|FG005|Overall Study|Other|0|||
125220931|NCT05216835|450436255|FG006|Overall Study|Other|0|||
125220932|NCT05216835|450436256|FG007|Overall Study|Other|0|||
125058602|NCT00882999|449831877|FG004|Overall Study|Withdrawal by Subject|6|||
125058603|NCT00882999|449831878|FG005|Overall Study|Withdrawal by Subject|5|||
125058604|NCT00882999|449831879|FG006|Overall Study|Withdrawal by Subject|5|||
125058605|NCT00882999|449831873|FG000|Overall Study|Lost to Follow-up|0|||
125058606|NCT00882999|449831874|FG001|Overall Study|Lost to Follow-up|1|||
125058607|NCT00882999|449831875|FG002|Overall Study|Lost to Follow-up|1|||
125058608|NCT00882999|449831876|FG003|Overall Study|Lost to Follow-up|2|||
125138103|NCT01438060|450131172|FG000|On Study Beyond Week 140|Adverse Event|0|||
125138104|NCT01438060|450131173|FG001|On Study Beyond Week 140|Adverse Event|2|||
125220933|NCT02797678|450436278|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
125058609|NCT00882999|449831877|FG004|Overall Study|Lost to Follow-up|1|||
125058610|NCT00882999|449831878|FG005|Overall Study|Lost to Follow-up|1|||
125058611|NCT00882999|449831879|FG006|Overall Study|Lost to Follow-up|2|||
125058612|NCT00882999|449831873|FG000|Overall Study|Physician Decision|1|||
125058613|NCT00882999|449831874|FG001|Overall Study|Physician Decision|0|||
125058614|NCT00882999|449831875|FG002|Overall Study|Physician Decision|0|||
125058615|NCT00882999|449831876|FG003|Overall Study|Physician Decision|0|||
125058616|NCT00882999|449831877|FG004|Overall Study|Physician Decision|0|||
125058617|NCT00882999|449831878|FG005|Overall Study|Physician Decision|1|||
125058618|NCT00882999|449831879|FG006|Overall Study|Physician Decision|1|||
125058619|NCT01104584|449831880|FG000|Overall Study|Study drug never administered|21|||
125058620|NCT01104584|449831880|FG000|Overall Study|Study prematurely discontinued|2|||
125058621|NCT04017442|449831881|FG000|Overall Study|Withdrawal by Subject|0|||
125058622|NCT04017442|449831882|FG001|Overall Study|Withdrawal by Subject|3|||
125058623|NCT04017442|449831881|FG000|Overall Study|Lost to Follow-up|21|||
125058624|NCT04017442|449831882|FG001|Overall Study|Lost to Follow-up|19|||
125058625|NCT02586233|449831885|FG000|Overall Study|Randomized but did not receive treatment|0|||
125058626|NCT02586233|449831886|FG001|Overall Study|Randomized but did not receive treatment|1|||
125058627|NCT02586233|449831887|FG002|Overall Study|Randomized but did not receive treatment|0|||
125058628|NCT02586233|449831888|FG003|Overall Study|Randomized but did not receive treatment|0|||
125058629|NCT02586233|449831889|FG004|Overall Study|Randomized but did not receive treatment|0|||
125058630|NCT02586233|449831890|FG005|Overall Study|Randomized but did not receive treatment|2|||
125058631|NCT02586233|449831891|FG006|Overall Study|Randomized but did not receive treatment|2|||
125058632|NCT02586233|449831885|FG000|Overall Study|Death|0|||
125058633|NCT02586233|449831886|FG001|Overall Study|Death|1|||
125058634|NCT02586233|449831887|FG002|Overall Study|Death|0|||
125058635|NCT02586233|449831888|FG003|Overall Study|Death|0|||
125058636|NCT02586233|449831889|FG004|Overall Study|Death|2|||
125058637|NCT02586233|449831890|FG005|Overall Study|Death|0|||
125058638|NCT02586233|449831891|FG006|Overall Study|Death|0|||
125058639|NCT01757405|449831892|FG000|Overall Study|Lost to Follow-up|1|||
125058640|NCT01757405|449831893|FG001|Overall Study|Lost to Follow-up|1|||
125058641|NCT01757405|449831892|FG000|Overall Study|Withdrawal by Subject|0|||
125058642|NCT01757405|449831893|FG001|Overall Study|Withdrawal by Subject|1|||
125058643|NCT00082758|449831894|FG000|Overall Study|Adverse Event|0|||
125058644|NCT00082758|449831895|FG001|Overall Study|Adverse Event|2|||
125058645|NCT00082758|449831896|FG002|Overall Study|Adverse Event|0|||
125058646|NCT00082758|449831894|FG000|Overall Study|Lack of Efficacy|12|||
125058647|NCT00082758|449831895|FG001|Overall Study|Lack of Efficacy|13|||
125058648|NCT00082758|449831896|FG002|Overall Study|Lack of Efficacy|0|||
125058649|NCT00082758|449831894|FG000|Overall Study|Physician Decision|0|||
125058650|NCT00082758|449831895|FG001|Overall Study|Physician Decision|1|||
125058651|NCT00082758|449831896|FG002|Overall Study|Physician Decision|0|||
125058652|NCT00082758|449831894|FG000|Overall Study|Withdrawal by Subject|3|||
125058653|NCT00082758|449831895|FG001|Overall Study|Withdrawal by Subject|0|||
125058654|NCT00082758|449831896|FG002|Overall Study|Withdrawal by Subject|0|||
125058655|NCT00082758|449831894|FG000|Overall Study|Protocol Violation|0|||
125058656|NCT00082758|449831895|FG001|Overall Study|Protocol Violation|1|||
125058657|NCT00082758|449831896|FG002|Overall Study|Protocol Violation|0|||
125058658|NCT00238303|449831897|FG000|Overall Study|Withdrawal by Subject|11|||
125058659|NCT00238303|449831898|FG001|Overall Study|Withdrawal by Subject|1|||
125058660|NCT00238303|449831899|FG002|Overall Study|Withdrawal by Subject|2|||
125058661|NCT00238303|449831897|FG000|Overall Study|Death|1|||
125058662|NCT00238303|449831898|FG001|Overall Study|Death|0|||
125058663|NCT00238303|449831899|FG002|Overall Study|Death|1|||
125058664|NCT00238303|449831897|FG000|Overall Study|Other Medical Problems|2|||
125058665|NCT00238303|449831898|FG001|Overall Study|Other Medical Problems|0|||
125058666|NCT00238303|449831899|FG002|Overall Study|Other Medical Problems|2|||
125058667|NCT00238303|449831897|FG000|Overall Study|Poor tolerance of study treatment|1|||
125058668|NCT00238303|449831898|FG001|Overall Study|Poor tolerance of study treatment|0|||
125058669|NCT00238303|449831899|FG002|Overall Study|Poor tolerance of study treatment|1|||
125058670|NCT00238303|449831897|FG000|Overall Study|Adverse Event|0|||
125058671|NCT00238303|449831898|FG001|Overall Study|Adverse Event|1|||
125058672|NCT00238303|449831899|FG002|Overall Study|Adverse Event|3|||
125058673|NCT02561299|449831903|FG000|Overall Study|Death|2|||
125058674|NCT02561299|449831904|FG001|Overall Study|Death|4|||
125058675|NCT02561299|449831903|FG000|Overall Study|Lost to Follow-up|1|||
125058676|NCT02561299|449831904|FG001|Overall Study|Lost to Follow-up|0|||
125058677|NCT02561299|449831903|FG000|Overall Study|Withdrawal by Subject|2|||
125058678|NCT02561299|449831904|FG001|Overall Study|Withdrawal by Subject|2|||
125058679|NCT01358877|449831905|FG000|Overall Study|Death|80|||
125058680|NCT01358877|449831906|FG001|Overall Study|Death|89|||
125058681|NCT01358877|449831905|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
125058682|NCT01358877|449831906|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
125058683|NCT01358877|449831905|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
125058684|NCT01358877|449831906|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
125058685|NCT01358877|449831905|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
125058686|NCT01358877|449831906|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
125058687|NCT01358877|449831905|FG000|Overall Study|Other|142|||
125058688|NCT01358877|449831906|FG001|Overall Study|Other|129|||
125058689|NCT01911845|449831911|FG000|Overall Study|Adverse Event|2|||
125058690|NCT01911845|449831911|FG000|Overall Study|Lost to Follow-up|1|||
125058691|NCT01911845|449831911|FG000|Overall Study|Other (not specified)|3|||
125058692|NCT01994226|449831912|FG000|Overall Study|Protocol Violation|13|||
125058693|NCT01994226|449831913|FG001|Overall Study|Protocol Violation|10|||
125058694|NCT01994226|449831912|FG000|Overall Study|Early Cessation of treatment|6|||
125058695|NCT01994226|449831913|FG001|Overall Study|Early Cessation of treatment|11|||
125058696|NCT00501046|449831918|FG000|Overall Study|Adverse Event|21|||
125058697|NCT00501046|449831919|FG001|Overall Study|Adverse Event|25|||
125058698|NCT00501046|449831918|FG000|Overall Study|Death|23|||
125058699|NCT00501046|449831919|FG001|Overall Study|Death|30|||
125058700|NCT00501046|449831918|FG000|Overall Study|Lost to Follow-up|14|||
125138105|NCT01438060|450131172|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
125058701|NCT00501046|449831919|FG001|Overall Study|Lost to Follow-up|13|||
125138106|NCT01438060|450131173|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
125138107|NCT01438060|450131172|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
125058702|NCT00501046|449831918|FG000|Overall Study|Physician Decision|7|||
125058703|NCT00501046|449831919|FG001|Overall Study|Physician Decision|2|||
125058704|NCT00501046|449831918|FG000|Overall Study|Pregnancy|0|||
125058705|NCT00501046|449831919|FG001|Overall Study|Pregnancy|3|||
125058706|NCT00501046|449831918|FG000|Overall Study|Protocol Violation|2|||
125058707|NCT00501046|449831919|FG001|Overall Study|Protocol Violation|1|||
125058708|NCT00501046|449831918|FG000|Overall Study|Withdrawal by Subject|84|||
125058709|NCT00501046|449831919|FG001|Overall Study|Withdrawal by Subject|83|||
125058710|NCT00501046|449831918|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
125058711|NCT00501046|449831919|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
125058712|NCT00436566|449831920|FG000|Overall Study|Withdrawal by Subject|2|||
125058713|NCT00436566|449831920|FG000|Overall Study|Protocol Violation|1|||
125058714|NCT01980706|449831921|FG000|Overall Study|Withdrawal by Subject|9|||
125058715|NCT01980706|449831922|FG001|Overall Study|Withdrawal by Subject|6|||
125058716|NCT01980706|449831923|FG002|Overall Study|Withdrawal by Subject|2|||
125058717|NCT01980706|449831921|FG000|Overall Study|Adverse Event|1|||
125058718|NCT01980706|449831922|FG001|Overall Study|Adverse Event|2|||
125058719|NCT01980706|449831923|FG002|Overall Study|Adverse Event|5|||
125058720|NCT01980706|449831921|FG000|Overall Study|Lost to Follow-up|3|||
125058721|NCT01980706|449831922|FG001|Overall Study|Lost to Follow-up|4|||
125058722|NCT01980706|449831923|FG002|Overall Study|Lost to Follow-up|3|||
125138108|NCT01438060|450131173|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
125058723|NCT01980706|449831921|FG000|Overall Study|miscellaneous|4|||
125058724|NCT01980706|449831922|FG001|Overall Study|miscellaneous|5|||
125058725|NCT01980706|449831923|FG002|Overall Study|miscellaneous|3|||
125058726|NCT01934894|449831928|FG000|Overall Study|Adverse Event|1|||
125058727|NCT01934894|449831929|FG001|Overall Study|Adverse Event|2|||
125058728|NCT01934894|449831928|FG000|Overall Study|Death|2|||
125138109|NCT01438060|450131172|FG000|On Study Beyond Week 140|Death|0|||
125138110|NCT01438060|450131173|FG001|On Study Beyond Week 140|Death|1|||
125058729|NCT01934894|449831929|FG001|Overall Study|Death|0|||
125058730|NCT01934894|449831928|FG000|Overall Study|Withdrawal by Subject|0|||
125058731|NCT01934894|449831929|FG001|Overall Study|Withdrawal by Subject|1|||
125058732|NCT01934894|449831928|FG000|Overall Study|Progressive Disease|3|||
125058733|NCT01934894|449831929|FG001|Overall Study|Progressive Disease|2|||
125058734|NCT01842308|449831930|FG000|Overall Study|Withdrawal by Subject|0|||
125058735|NCT01842308|449831931|FG001|Overall Study|Withdrawal by Subject|0|||
125058736|NCT01842308|449831932|FG002|Overall Study|Withdrawal by Subject|0|||
125058737|NCT01842308|449831933|FG003|Overall Study|Withdrawal by Subject|0|||
125058738|NCT01842308|449831934|FG004|Overall Study|Withdrawal by Subject|1|||
125058739|NCT01106625|449831937|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
125058740|NCT01106625|449831938|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
125058741|NCT01106625|449831939|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
125058742|NCT01106625|449831937|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
125058743|NCT01106625|449831938|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
125058744|NCT01106625|449831939|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
125058745|NCT01106625|449831937|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
125058746|NCT01106625|449831938|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
125058747|NCT01106625|449831939|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
125058748|NCT01106625|449831937|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
125058749|NCT01106625|449831938|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
125058750|NCT01106625|449831939|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
125058751|NCT01106625|449831937|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
125058752|NCT01106625|449831938|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
125058753|NCT01106625|449831939|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
125058754|NCT01106625|449831937|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
125058755|NCT01106625|449831938|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
125058756|NCT01106625|449831939|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
125058757|NCT01106625|449831937|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
125058758|NCT01106625|449831938|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
125058759|NCT01106625|449831939|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
125058760|NCT01106625|449831937|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
125058761|NCT01106625|449831938|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
125058762|NCT01106625|449831939|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
125058763|NCT01106625|449831937|FG000|Core Period: Baseline to Week 26|Other|8|||
125058764|NCT01106625|449831938|FG001|Core Period: Baseline to Week 26|Other|7|||
125058765|NCT01106625|449831939|FG002|Core Period: Baseline to Week 26|Other|4|||
125058766|NCT01106625|449831937|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
125058767|NCT01106625|449831938|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
125058768|NCT01106625|449831939|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
125058769|NCT01106625|449831937|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
125058770|NCT01106625|449831938|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
125058771|NCT01106625|449831939|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
125058772|NCT01106625|449831937|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
125058773|NCT01106625|449831938|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
125058774|NCT01106625|449831939|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
125058775|NCT01106625|449831937|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
125058776|NCT01106625|449831938|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
125058777|NCT01106625|449831939|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
125058778|NCT01106625|449831937|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
125058779|NCT01106625|449831938|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
125058780|NCT01106625|449831939|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
125058781|NCT01106625|449831937|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
125058782|NCT01106625|449831938|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
125058783|NCT01106625|449831939|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
125058784|NCT01106625|449831937|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
125138111|NCT01438060|450131172|FG000|On Study Beyond Week 140|Other Reason|0|||
125138112|NCT01438060|450131173|FG001|On Study Beyond Week 140|Other Reason|3|||
125058785|NCT01106625|449831938|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
125058786|NCT01106625|449831939|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
125058787|NCT01106625|449831937|FG000|Extension Period: Week 26 to Week 52|Other|5|||
125138113|NCT04404725|450131174|FG000|First Intervention|Withdrawal by Subject|0|||
125058788|NCT01106625|449831938|FG001|Extension Period: Week 26 to Week 52|Other|5|||
125058789|NCT01106625|449831939|FG002|Extension Period: Week 26 to Week 52|Other|4|||
125058790|NCT01088438|449831948|FG000|Overall Study|Withdrawal by Subject|11|||
125058791|NCT01088438|449831949|FG001|Overall Study|Withdrawal by Subject|6|||
125058792|NCT01088438|449831948|FG000|Overall Study|Lost to Follow-up|18|||
125058793|NCT01088438|449831949|FG001|Overall Study|Lost to Follow-up|30|||
125058794|NCT00511342|449831950|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
125058795|NCT00511342|449831951|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
125058796|NCT00511342|449831950|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
125058797|NCT00511342|449831951|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
125058798|NCT00511342|449831950|FG000|Overall Study|Pregnancy|0|||
125058799|NCT00511342|449831951|FG001|Overall Study|Pregnancy|1|||
125058800|NCT00511342|449831950|FG000|Overall Study|Pregnancy wish|0|||
125058801|NCT00511342|449831951|FG001|Overall Study|Pregnancy wish|1|||
125058802|NCT00511342|449831950|FG000|Overall Study|Lost to Follow-up|1|||
125058803|NCT00511342|449831951|FG001|Overall Study|Lost to Follow-up|5|||
125058804|NCT00511342|449831950|FG000|Overall Study|Other Reason|2|||
125058805|NCT00511342|449831951|FG001|Overall Study|Other Reason|2|||
125058806|NCT00997321|449831952|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
125058807|NCT00997321|449831953|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
125058808|NCT01153763|449831962|FG000|Overall Study|Study Closed|16|||
125058809|NCT01153763|449831962|FG000|Overall Study|Lost to Follow-up|1|||
125058810|NCT01153763|449831962|FG000|Overall Study|Physician Decision|2|||
125058811|NCT01153763|449831962|FG000|Overall Study|Withdrawal by Subject|2|||
125058812|NCT02402218|449831963|FG000|Overall Study|Did not pickup study medication|12|||
125058813|NCT02402218|449831964|FG001|Overall Study|Did not pickup study medication|9|||
125058814|NCT02402218|449831965|FG002|Overall Study|Did not pickup study medication|13|||
125058815|NCT02402218|449831963|FG000|Overall Study|Lack of Efficacy|0|||
125058816|NCT02402218|449831964|FG001|Overall Study|Lack of Efficacy|1|||
125058817|NCT02402218|449831965|FG002|Overall Study|Lack of Efficacy|1|||
125058818|NCT02402218|449831963|FG000|Overall Study|Death|1|||
125058819|NCT02402218|449831964|FG001|Overall Study|Death|0|||
125058820|NCT02402218|449831965|FG002|Overall Study|Death|0|||
125058821|NCT02402218|449831963|FG000|Overall Study|Reinfection|0|||
125058822|NCT02402218|449831964|FG001|Overall Study|Reinfection|0|||
125058823|NCT02402218|449831965|FG002|Overall Study|Reinfection|1|||
125058824|NCT02402218|449831963|FG000|Overall Study|Adverse Event|0|||
125058825|NCT02402218|449831964|FG001|Overall Study|Adverse Event|2|||
125058826|NCT02402218|449831965|FG002|Overall Study|Adverse Event|1|||
125058827|NCT02402218|449831963|FG000|Overall Study|Withdrawal by Subject|1|||
125058828|NCT02402218|449831964|FG001|Overall Study|Withdrawal by Subject|1|||
125058829|NCT02402218|449831965|FG002|Overall Study|Withdrawal by Subject|1|||
125058830|NCT02457182|449834139|FG000|Overall Study|Lost to Follow-up|1|||
125058831|NCT02457182|449834140|FG001|Overall Study|Lost to Follow-up|0|||
125058832|NCT00789191|449834145|FG000|Overall Study|Adverse Event|2|||
125058833|NCT00789191|449834146|FG001|Overall Study|Adverse Event|4|||
125058834|NCT00789191|449834145|FG000|Overall Study|Lack of Efficacy|0|||
125058835|NCT00789191|449834146|FG001|Overall Study|Lack of Efficacy|5|||
125058836|NCT00789191|449834145|FG000|Overall Study|Protocol Violation|5|||
125058837|NCT00789191|449834146|FG001|Overall Study|Protocol Violation|3|||
125058838|NCT00789191|449834145|FG000|Overall Study|Withdrawal Criteria|2|||
125058839|NCT00789191|449834146|FG001|Overall Study|Withdrawal Criteria|4|||
125058840|NCT00789191|449834145|FG000|Overall Study|Unclassified|5|||
125058841|NCT00789191|449834146|FG001|Overall Study|Unclassified|3|||
125058842|NCT01009983|449834147|FG000|Overall Study|necessary scans not completed|1|||
125058843|NCT03497429|449834148|FG000|Overall Study|Progressive disease|3|||
125058844|NCT03497429|449834149|FG001|Overall Study|Progressive disease|4|||
125058845|NCT03497429|449834148|FG000|Overall Study|Adverse Event|0|||
125058846|NCT03497429|449834149|FG001|Overall Study|Adverse Event|2|||
125058847|NCT00506948|449834150|FG000|Overall Study|Death|4|||
125058848|NCT00506948|449834150|FG000|Overall Study|Adverse Event|5|||
125058849|NCT00506948|449834150|FG000|Overall Study|Physician Decision|1|||
125058850|NCT00762372|449834152|FG000|Overall Study|Adverse Event|1|||
125058851|NCT00762372|449834153|FG001|Overall Study|Adverse Event|0|||
125220934|NCT02797678|450436279|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
125220935|NCT02797678|450436280|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
125058852|NCT00762372|449834154|FG002|Overall Study|Adverse Event|0|||
125058853|NCT03364335|449834155|FG000|Overall Study|Adverse Event|3|||
125058854|NCT03364335|449834156|FG001|Overall Study|Adverse Event|4|||
125058855|NCT03364335|449834157|FG002|Overall Study|Adverse Event|1|||
125058856|NCT03364335|449834158|FG003|Overall Study|Adverse Event|2|||
125058857|NCT03364335|449834159|FG004|Overall Study|Adverse Event|0|||
125058858|NCT03364335|449834155|FG000|Overall Study|Lost to Follow-up|7|||
125058859|NCT03364335|449834156|FG001|Overall Study|Lost to Follow-up|7|||
125058860|NCT03364335|449834157|FG002|Overall Study|Lost to Follow-up|10|||
125058861|NCT03364335|449834158|FG003|Overall Study|Lost to Follow-up|11|||
125058862|NCT03364335|449834159|FG004|Overall Study|Lost to Follow-up|11|||
125058863|NCT02670915|449834160|FG000|Overall Study|Withdrawal by Subject|0|||
125058864|NCT02670915|449834161|FG001|Overall Study|Withdrawal by Subject|1|||
125058865|NCT02670915|449834162|FG002|Overall Study|Withdrawal by Subject|4|||
125058866|NCT02670915|449834160|FG000|Overall Study|Withdrawal by parent/guardian|4|||
125058867|NCT02670915|449834161|FG001|Overall Study|Withdrawal by parent/guardian|4|||
125058868|NCT02670915|449834162|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125058869|NCT02670915|449834160|FG000|Overall Study|Unclassified|0|||
125058870|NCT02670915|449834161|FG001|Overall Study|Unclassified|3|||
125058871|NCT02670915|449834162|FG002|Overall Study|Unclassified|0|||
125058872|NCT00818207|449834163|FG000|Overall Study|Adverse Event|6|||
125058873|NCT00818207|449834164|FG001|Overall Study|Adverse Event|0|||
125058874|NCT00818207|449834163|FG000|Overall Study|Lost to Follow-up|160|||
125058875|NCT00818207|449834164|FG001|Overall Study|Lost to Follow-up|146|||
125058876|NCT00818207|449834163|FG000|Overall Study|Multiple reasons|11|||
125058877|NCT00818207|449834164|FG001|Overall Study|Multiple reasons|12|||
125058878|NCT00818207|449834163|FG000|Overall Study|Withdrawal by Subject|42|||
125058879|NCT00818207|449834164|FG001|Overall Study|Withdrawal by Subject|104|||
125058880|NCT00818207|449834163|FG000|Overall Study|Death|3|||
125058881|NCT00818207|449834164|FG001|Overall Study|Death|5|||
125058882|NCT02494778|449834165|FG000|Overall Study|Death|3|||
125058883|NCT02494778|449834165|FG000|Overall Study|Other|173|||
125058884|NCT02494778|449834165|FG000|Overall Study|Lack of Efficacy|4|||
125058885|NCT02494778|449834165|FG000|Overall Study|Adverse Event|18|||
125058886|NCT02494778|449834165|FG000|Overall Study|Withdrawal by Subject|20|||
125058887|NCT02494778|449834165|FG000|Overall Study|Lost to Follow-up|2|||
125058888|NCT02494778|449834165|FG000|Overall Study|Noncompliant with study drug admin.|1|||
125058889|NCT02174861|449834166|FG000|Overall Study|Decision by sponsor|8|||
125058890|NCT02174861|449834166|FG000|Overall Study|Withdrawal by Subject|124|||
125058891|NCT02174861|449834166|FG000|Overall Study|Lost to Follow-up|26|||
125058892|NCT03196193|449834180|FG000|Overall Study|Adverse Event|1|||
125058893|NCT03196193|449834181|FG001|Overall Study|Adverse Event|0|||
125058894|NCT03196193|449834180|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
125058895|NCT03196193|449834181|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
125058896|NCT02709083|449834182|FG000|Overall Study|Original PI left institution|7|||
125058897|NCT01697267|449834183|FG000|Overall Study|Death|3|||
125058898|NCT01697267|449834184|FG001|Overall Study|Death|1|||
125058899|NCT01697267|449834183|FG000|Overall Study|Withdrawal by Subject|5|||
125058900|NCT01697267|449834184|FG001|Overall Study|Withdrawal by Subject|5|||
125058901|NCT01697267|449834183|FG000|Overall Study|Adverse Event|2|||
125058902|NCT01697267|449834184|FG001|Overall Study|Adverse Event|1|||
125058903|NCT01697267|449834183|FG000|Overall Study|Lost to Follow-up|2|||
125058904|NCT01697267|449834184|FG001|Overall Study|Lost to Follow-up|4|||
125058905|NCT01697267|449834183|FG000|Overall Study|Physician Decision|2|||
125058906|NCT01697267|449834184|FG001|Overall Study|Physician Decision|4|||
125058907|NCT00333619|449834185|FG000|Overall Study|Death|12|||
125058908|NCT00333619|449834186|FG001|Overall Study|Death|6|||
125058909|NCT00333619|449834185|FG000|Overall Study|Withdrawal by Subject|6|||
125058910|NCT00333619|449834186|FG001|Overall Study|Withdrawal by Subject|1|||
125058911|NCT00333619|449834185|FG000|Overall Study|Lost to Follow-up|3|||
125058912|NCT00333619|449834186|FG001|Overall Study|Lost to Follow-up|3|||
125058913|NCT02681055|449834189|FG000|Weeks 5-12|Adverse Event|1|||
125058914|NCT02695524|449834190|FG000|Overall Study|Lost to Follow-up|3|||
125058915|NCT02695524|449834191|FG001|Overall Study|Lost to Follow-up|2|||
125058916|NCT02695524|449834190|FG000|Overall Study|Death|0|||
125058917|NCT02695524|449834191|FG001|Overall Study|Death|1|||
125058918|NCT00831441|449834192|FG000|Randomized|Death|82|||
125058919|NCT00831441|449834193|FG001|Randomized|Death|81|||
125058920|NCT00831441|449834192|FG000|Randomized|Adverse Event|248|||
125058921|NCT00831441|449834193|FG001|Randomized|Adverse Event|321|||
125058922|NCT00831441|449834192|FG000|Randomized|Emergency procedure|2|||
125058923|NCT00831441|449834193|FG001|Randomized|Emergency procedure|2|||
125058924|NCT00831441|449834192|FG000|Randomized|Elective procedure|26|||
125058925|NCT00831441|449834193|FG001|Randomized|Elective procedure|25|||
125058926|NCT00831441|449834192|FG000|Randomized|Physician Decision|26|||
125058927|NCT00831441|449834193|FG001|Randomized|Physician Decision|35|||
125058928|NCT00831441|449834192|FG000|Randomized|No longer met criteria|13|||
125058929|NCT00831441|449834193|FG001|Randomized|No longer met criteria|19|||
125058930|NCT00831441|449834192|FG000|Randomized|Withdrawal by Subject|178|||
125058931|NCT00831441|449834193|FG001|Randomized|Withdrawal by Subject|212|||
125058932|NCT00831441|449834192|FG000|Randomized|Lost to Follow-up|26|||
125058933|NCT00831441|449834193|FG001|Randomized|Lost to Follow-up|35|||
125058934|NCT00831441|449834192|FG000|Randomized|Administrative reason by sponsor|2780|||
125058935|NCT00831441|449834193|FG001|Randomized|Administrative reason by sponsor|2671|||
125058936|NCT00831441|449834192|FG000|Randomized|poor/non-compliance|30|||
125058937|NCT00831441|449834193|FG001|Randomized|poor/non-compliance|38|||
125058938|NCT00831441|449834192|FG000|Randomized|non-specified|276|||
125058939|NCT00831441|449834193|FG001|Randomized|non-specified|266|||
125058940|NCT00831441|449834192|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
125058941|NCT00831441|449834193|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
125058942|NCT00831441|449834192|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
125058943|NCT00831441|449834193|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
125058944|NCT00831441|449834192|FG000|Follow Up (30 Days)|Death|63|||
125058945|NCT00831441|449834193|FG001|Follow Up (30 Days)|Death|86|||
125058946|NCT00831441|449834192|FG000|Follow Up (30 Days)|non-specified|16|||
125058947|NCT00831441|449834193|FG001|Follow Up (30 Days)|non-specified|26|||
125058948|NCT00831441|449834192|FG000|Follow Up (30 Days)|missing end of study status|0|||
125058949|NCT00831441|449834193|FG001|Follow Up (30 Days)|missing end of study status|1|||
125058950|NCT00111917|449834194|FG000|Overall Study|Withdrawal by Subject|1|||
125058951|NCT00111917|449834195|FG001|Overall Study|Withdrawal by Subject|1|||
125058952|NCT02338492|449834202|FG000|Overall Study|Death|32|||
125058953|NCT02338492|449834202|FG000|Overall Study|Adverse Event|3|||
125058954|NCT02338492|449834202|FG000|Overall Study|Lost to Follow-up|4|||
125058955|NCT02338492|449834202|FG000|Overall Study|Reason not captured above|6|||
125058956|NCT00229203|449834203|FG000|Overall Study|Progressive disease|18|||
125058957|NCT00229203|449834204|FG001|Overall Study|Progressive disease|9|||
125058958|NCT00229203|449834203|FG000|Overall Study|Toxicity|6|||
125058959|NCT00229203|449834204|FG001|Overall Study|Toxicity|1|||
125058960|NCT00229203|449834203|FG000|Overall Study|Death|4|||
125058961|NCT00229203|449834204|FG001|Overall Study|Death|2|||
125058962|NCT00229203|449834203|FG000|Overall Study|Other|3|||
125058963|NCT00229203|449834204|FG001|Overall Study|Other|3|||
125058964|NCT00229203|449834203|FG000|Overall Study|Withdrawal by Subject|1|||
125058965|NCT00229203|449834204|FG001|Overall Study|Withdrawal by Subject|4|||
125058966|NCT04507867|449834207|FG000|Overall Study|Death|7|||
125058967|NCT04507867|449834208|FG001|Overall Study|Death|1|||
125058968|NCT04096326|449834209|FG000|Overall Study|Withdrawal by Subject|0|||
125058969|NCT04096326|449834210|FG001|Overall Study|Withdrawal by Subject|0|||
125058970|NCT04096326|449834211|FG002|Overall Study|Withdrawal by Subject|0|||
125058971|NCT04096326|449834212|FG003|Overall Study|Withdrawal by Subject|0|||
125058972|NCT04096326|449834213|FG004|Overall Study|Withdrawal by Subject|0|||
125058973|NCT04096326|449834214|FG005|Overall Study|Withdrawal by Subject|0|||
125058974|NCT04096326|449834215|FG006|Overall Study|Withdrawal by Subject|1|||
125058975|NCT04096326|449834216|FG007|Overall Study|Withdrawal by Subject|0|||
125058976|NCT04096326|449834217|FG008|Overall Study|Withdrawal by Subject|0|||
125058977|NCT04096326|449834218|FG009|Overall Study|Withdrawal by Subject|0|||
125058978|NCT04096326|449834209|FG000|Overall Study|Lost to Follow-up|0|||
125058979|NCT04096326|449834210|FG001|Overall Study|Lost to Follow-up|1|||
125058980|NCT04096326|449834211|FG002|Overall Study|Lost to Follow-up|0|||
125058981|NCT04096326|449834212|FG003|Overall Study|Lost to Follow-up|0|||
125058982|NCT04096326|449834213|FG004|Overall Study|Lost to Follow-up|0|||
125058983|NCT04096326|449834214|FG005|Overall Study|Lost to Follow-up|0|||
125058984|NCT04096326|449834215|FG006|Overall Study|Lost to Follow-up|0|||
125058985|NCT04096326|449834216|FG007|Overall Study|Lost to Follow-up|0|||
125058986|NCT04096326|449834217|FG008|Overall Study|Lost to Follow-up|0|||
125058987|NCT04096326|449834218|FG009|Overall Study|Lost to Follow-up|0|||
125058988|NCT04096326|449834209|FG000|Overall Study|COVID-19-related reasons|0|||
125058989|NCT04096326|449834210|FG001|Overall Study|COVID-19-related reasons|0|||
125058990|NCT04096326|449834211|FG002|Overall Study|COVID-19-related reasons|0|||
125058991|NCT04096326|449834212|FG003|Overall Study|COVID-19-related reasons|0|||
125058992|NCT04096326|449834213|FG004|Overall Study|COVID-19-related reasons|1|||
125058993|NCT04096326|449834214|FG005|Overall Study|COVID-19-related reasons|5|||
125058994|NCT04096326|449834215|FG006|Overall Study|COVID-19-related reasons|0|||
125058995|NCT04096326|449834216|FG007|Overall Study|COVID-19-related reasons|0|||
125058996|NCT04096326|449834217|FG008|Overall Study|COVID-19-related reasons|0|||
125058997|NCT04096326|449834218|FG009|Overall Study|COVID-19-related reasons|0|||
125058998|NCT02512068|449834229|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
125058999|NCT02512068|449834230|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
125059000|NCT02512068|449834229|FG000|Overall Study|Major Protocol Deviation|1|||
125059001|NCT02512068|449834230|FG001|Overall Study|Major Protocol Deviation|0|||
125059002|NCT02512068|449834229|FG000|Overall Study|Voluntary Withdrawal|0|||
125059003|NCT02512068|449834230|FG001|Overall Study|Voluntary Withdrawal|1|||
125059004|NCT02512068|449834229|FG000|Overall Study|Lack of Efficacy|0|||
125059005|NCT02512068|449834230|FG001|Overall Study|Lack of Efficacy|1|||
125059006|NCT02512068|449834229|FG000|Overall Study|Reason Not Specified|3|||
125059007|NCT02512068|449834230|FG001|Overall Study|Reason Not Specified|5|||
125059008|NCT03521687|449834233|FG000|Overall Study|Adverse Event|4|||
125059009|NCT03521687|449834233|FG000|Overall Study|Physician Decision|1|||
125059010|NCT01151579|449834239|FG000|Overall Study|Physician Decision|3|||
125059011|NCT01151579|449834240|FG001|Overall Study|Physician Decision|1|||
125059012|NCT01151579|449834239|FG000|Overall Study|Withdrawal by Subject|3|||
125059013|NCT01151579|449834240|FG001|Overall Study|Withdrawal by Subject|2|||
125059014|NCT01151579|449834239|FG000|Overall Study|Not meet inclusion criteria|6|||
125059015|NCT01151579|449834240|FG001|Overall Study|Not meet inclusion criteria|4|||
125059016|NCT01276457|449834241|FG000|Core Study|Adverse Event|6|||
125059017|NCT01276457|449834242|FG001|Core Study|Adverse Event|3|||
125059018|NCT01276457|449834241|FG000|Core Study|Lost to Follow-up|1|||
125059019|NCT01276457|449834242|FG001|Core Study|Lost to Follow-up|2|||
125059020|NCT01276457|449834241|FG000|Core Study|Administrative problems|1|||
125059021|NCT01276457|449834242|FG001|Core Study|Administrative problems|1|||
125059022|NCT01276457|449834241|FG000|Core Study|Death|2|||
125059023|NCT01276457|449834242|FG001|Core Study|Death|2|||
125059024|NCT01276457|449834241|FG000|Core Study|Lack of Efficacy|3|||
125059025|NCT01276457|449834242|FG001|Core Study|Lack of Efficacy|12|||
125059026|NCT01276457|449834241|FG000|Extension Study|Lost to Follow-up|3|||
125059027|NCT01276457|449834242|FG001|Extension Study|Lost to Follow-up|0|||
125059028|NCT01276457|449834241|FG000|Extension Study|Death|0|||
125059029|NCT01276457|449834242|FG001|Extension Study|Death|1|||
125059030|NCT01276457|449834241|FG000|Extension Study|Lack of Efficacy|3|||
125059031|NCT01276457|449834242|FG001|Extension Study|Lack of Efficacy|1|||
125059032|NCT01098461|449834247|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
125059033|NCT01098461|449834248|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
125059034|NCT01098461|449834249|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
125059035|NCT01098461|449834250|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
125059036|NCT01098461|449834247|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
125059037|NCT01098461|449834248|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
125059038|NCT01098461|449834249|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
125059039|NCT01098461|449834250|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
125059040|NCT01098461|449834247|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
125059041|NCT01098461|449834248|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
125059042|NCT01098461|449834249|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
125059043|NCT01098461|449834250|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
125059044|NCT01098461|449834247|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
125059045|NCT01098461|449834248|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
125059046|NCT01098461|449834249|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
125059047|NCT01098461|449834250|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
125059048|NCT01098461|449834247|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
125059049|NCT01098461|449834248|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
125059050|NCT01098461|449834249|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
125059051|NCT01098461|449834250|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
125059052|NCT01098461|449834247|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
125059053|NCT01098461|449834248|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
125059054|NCT01098461|449834249|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
125059055|NCT01098461|449834250|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
125059056|NCT01098461|449834247|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
125059057|NCT01098461|449834248|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
125059058|NCT01098461|449834249|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
125059059|NCT01098461|449834250|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
125059060|NCT01474746|449834251|FG000|Overall Study|Lost to Follow-up|1|||
125059061|NCT01474746|449834252|FG001|Overall Study|Lost to Follow-up|1|||
125059062|NCT01474746|449834251|FG000|Overall Study|Withdrawal by Subject|2|||
125059063|NCT01474746|449834252|FG001|Overall Study|Withdrawal by Subject|1|||
125059064|NCT01766336|449834254|FG000|Overall Study|Adverse Event|11|||
125059065|NCT01766336|449834255|FG001|Overall Study|Adverse Event|8|||
125059066|NCT01766336|449834254|FG000|Overall Study|Death|4|||
125138114|NCT04404725|450131175|FG001|First Intervention|Withdrawal by Subject|2|||
125138115|NCT04404725|450131174|FG000|Second Intervention|Adverse Event|1|||
125138116|NCT04404725|450131175|FG001|Second Intervention|Adverse Event|1|||
125059067|NCT01766336|449834255|FG001|Overall Study|Death|3|||
125059068|NCT01766336|449834254|FG000|Overall Study|Lost to Follow-up|1|||
125059069|NCT01766336|449834255|FG001|Overall Study|Lost to Follow-up|3|||
125059070|NCT01766336|449834254|FG000|Overall Study|Physician Decision|4|||
125059071|NCT01766336|449834255|FG001|Overall Study|Physician Decision|2|||
125059072|NCT01766336|449834254|FG000|Overall Study|Protocol Violation|0|||
125138117|NCT04404725|450131174|FG000|Second Intervention|Withdrawal by Subject|0|||
125059073|NCT01766336|449834255|FG001|Overall Study|Protocol Violation|1|||
125059074|NCT01766336|449834254|FG000|Overall Study|Sponsor Decision|52|||
125059075|NCT01766336|449834255|FG001|Overall Study|Sponsor Decision|43|||
125059076|NCT01766336|449834254|FG000|Overall Study|Withdrawal by Subject|18|||
125059077|NCT01766336|449834255|FG001|Overall Study|Withdrawal by Subject|15|||
125059078|NCT02605447|449834256|FG000|Overall Study|Death|66|||
125138118|NCT04404725|450131175|FG001|Second Intervention|Withdrawal by Subject|1|||
125138119|NCT01190865|450131191|FG000|Overall Study|Withdrawal by Subject|1|||
125138120|NCT01190865|450131191|FG000|Overall Study|Non-compliance|2|||
125138121|NCT02436200|450131193|FG000|Overall Study|Significant outlier|1|||
125138122|NCT00957021|450131194|FG000|Overall Study|Death|5|||
125138123|NCT00957021|450131194|FG000|Overall Study|Lost to Follow-up|8|||
125138124|NCT00957021|450131194|FG000|Overall Study|Withdrawal by Subject|34|||
125138125|NCT00957021|450131194|FG000|Overall Study|No 2 yr ROM data|35|||
125138126|NCT00957021|450131194|FG000|Overall Study|Revised study component by 2 yr visit|8|||
125138127|NCT00957021|450131194|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
125138128|NCT00957021|450131194|FG000|Overall Study|Surgery Cancelled|9|||
125138129|NCT00957021|450131194|FG000|Overall Study|Termination due to language issue|2|||
125138130|NCT01483820|450131198|FG000|Overall Study|Lack of Efficacy|6|||
125138131|NCT01483820|450131198|FG000|Overall Study|Adverse Event|1|||
125138132|NCT01483820|450131198|FG000|Overall Study|Death|1|||
125220936|NCT02797678|450436281|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
125220937|NCT02797678|450436278|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
125220938|NCT02797678|450436279|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
125059079|NCT02605447|449834256|FG000|Overall Study|Physician Decision|1|||
125059080|NCT02605447|449834256|FG000|Overall Study|Lost to Follow-up|24|||
125059081|NCT02605447|449834256|FG000|Overall Study|Withdrawal by Subject|10|||
125059082|NCT02605447|449834256|FG000|Overall Study|Not disclosed|1|||
125059083|NCT04544709|449834260|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
125059084|NCT03628508|449834261|FG000|Overall Study|Lost to Follow-up|1|||
125059085|NCT02045212|449834262|FG000|Overall Study|Adverse Event|0|||
125059086|NCT02045212|449834263|FG001|Overall Study|Adverse Event|1|||
125059087|NCT02045212|449834262|FG000|Overall Study|Withdrawal by Subject|1|||
125059088|NCT02045212|449834263|FG001|Overall Study|Withdrawal by Subject|0|||
125059089|NCT02045212|449834262|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
125059090|NCT02045212|449834263|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
125059091|NCT03807739|449834267|FG000|Overall Study|Adverse Event|1|||
125059092|NCT03807739|449834268|FG001|Overall Study|Adverse Event|0|||
125059093|NCT03807739|449834269|FG002|Overall Study|Adverse Event|0|||
125059094|NCT03807739|449834270|FG003|Overall Study|Adverse Event|0|||
125059095|NCT03807739|449834267|FG000|Overall Study|Withdrawal by Subject|1|||
125059096|NCT03807739|449834268|FG001|Overall Study|Withdrawal by Subject|0|||
125059097|NCT03807739|449834269|FG002|Overall Study|Withdrawal by Subject|0|||
125059098|NCT03807739|449834270|FG003|Overall Study|Withdrawal by Subject|0|||
125059099|NCT03126539|449834275|FG000|Overall Study|Lost to Follow-up|1|||
125059100|NCT03126539|449834276|FG001|Overall Study|Lost to Follow-up|1|||
125059101|NCT03126539|449834277|FG002|Overall Study|Lost to Follow-up|1|||
125059102|NCT03126539|449834278|FG003|Overall Study|Lost to Follow-up|0|||
125059103|NCT03126539|449834279|FG004|Overall Study|Lost to Follow-up|0|||
125059104|NCT02632110|449834280|FG000|Overall Study|Withdrawal by Subject|1|||
125059105|NCT02632110|449834281|FG001|Overall Study|Withdrawal by Subject|1|||
125059106|NCT02632110|449834282|FG002|Overall Study|Withdrawal by Subject|0|||
125059107|NCT02632110|449834283|FG003|Overall Study|Withdrawal by Subject|0|||
125059108|NCT02632110|449834284|FG004|Overall Study|Withdrawal by Subject|1|||
125059109|NCT02632110|449834285|FG005|Overall Study|Withdrawal by Subject|1|||
125059110|NCT02632110|449834286|FG006|Overall Study|Withdrawal by Subject|3|||
125059111|NCT02632110|449834287|FG007|Overall Study|Withdrawal by Subject|3|||
125059112|NCT02632110|449834288|FG008|Overall Study|Withdrawal by Subject|1|||
125059113|NCT02632110|449834289|FG009|Overall Study|Withdrawal by Subject|1|||
125059114|NCT00516269|449834292|FG000|Overall Study|Adverse Event|2|||
125059115|NCT00516269|449834293|FG001|Overall Study|Adverse Event|1|||
125059116|NCT00516269|449834292|FG000|Overall Study|Lost to Follow-up|0|||
125059117|NCT00516269|449834293|FG001|Overall Study|Lost to Follow-up|1|||
125059118|NCT00516269|449834292|FG000|Overall Study|Protocol Violation|0|||
125059119|NCT00516269|449834293|FG001|Overall Study|Protocol Violation|1|||
125059120|NCT01005732|449834294|FG000|Overall Study|Lost to Follow-up|10|||
125059121|NCT01005732|449834294|FG000|Overall Study|Death|1|||
125059122|NCT02596711|449834295|FG000|Overall Study|Lost to Follow-up|1|||
125059123|NCT02596711|449834296|FG001|Overall Study|Lost to Follow-up|2|||
125059124|NCT02596711|449834297|FG002|Overall Study|Lost to Follow-up|3|||
125138133|NCT00867360|450131199|FG000|Overall Study|Withdrawal by Subject|1|||
125138134|NCT00867360|450131200|FG001|Overall Study|Withdrawal by Subject|0|||
125138135|NCT00867360|450131199|FG000|Overall Study|Physician Decision|0|||
125138136|NCT00867360|450131200|FG001|Overall Study|Physician Decision|1|||
125138137|NCT00112437|450131204|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
125138138|NCT00112437|450131205|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
125138139|NCT00112437|450131206|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
125138140|NCT00112437|450131207|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
125059125|NCT01552928|449834298|FG000|Period 3|Adverse Event|0|||
125059126|NCT01552928|449834299|FG001|Period 3|Adverse Event|0|||
125059127|NCT01552928|449834300|FG002|Period 3|Adverse Event|1|||
125059128|NCT01552928|449834301|FG003|Period 3|Adverse Event|0|||
125138141|NCT00112437|450131208|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
125059129|NCT04570657|449834303|FG000|Overall Study|Adverse Event|0|||
125059130|NCT04570657|449834304|FG001|Overall Study|Adverse Event|0|||
125138142|NCT00112437|450131209|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
125059131|NCT04570657|449834305|FG002|Overall Study|Adverse Event|1|||
125059132|NCT04570657|449834303|FG000|Overall Study|Lost to Follow-up|0|||
125059133|NCT04570657|449834304|FG001|Overall Study|Lost to Follow-up|0|||
125059134|NCT04570657|449834305|FG002|Overall Study|Lost to Follow-up|1|||
125059135|NCT04570657|449834303|FG000|Overall Study|Physician Decision|0|||
125059136|NCT04570657|449834304|FG001|Overall Study|Physician Decision|1|||
125059137|NCT04570657|449834305|FG002|Overall Study|Physician Decision|0|||
125059138|NCT04570657|449834303|FG000|Overall Study|Withdrawal by Subject|1|||
125059139|NCT04570657|449834304|FG001|Overall Study|Withdrawal by Subject|2|||
125059140|NCT04570657|449834305|FG002|Overall Study|Withdrawal by Subject|2|||
125059141|NCT01072539|449834306|FG000|Overall Study|Treated prior to the Site Initiation|1|||
125059142|NCT01072539|449834306|FG000|Overall Study|Protocol Violation|2|||
125059143|NCT00115804|449834309|FG000|Overall Study|Adverse Event|2|||
125059144|NCT01752842|449834310|FG000|Overall Study|Adverse Event|3|||
125059145|NCT01752842|449834311|FG001|Overall Study|Adverse Event|0|||
125059146|NCT01752842|449834310|FG000|Overall Study|Withdrawal by Subject|0|||
125059147|NCT01752842|449834311|FG001|Overall Study|Withdrawal by Subject|2|||
125059148|NCT01683071|449834312|FG000|Part 1|Lack of Efficacy|1|||
125059149|NCT01683071|449834313|FG001|Part 1|Lack of Efficacy|0|||
125059150|NCT01683071|449834314|FG002|Part 1|Lack of Efficacy|0|||
125059151|NCT01683071|449834315|FG003|Part 1|Lack of Efficacy|3|||
125059152|NCT01683071|449834316|FG004|Part 1|Lack of Efficacy|0|||
125059153|NCT01683071|449834317|FG005|Part 1|Lack of Efficacy|0|||
125059154|NCT01683071|449834312|FG000|Part 1|Withdrawal by Subject|1|||
125059155|NCT01683071|449834313|FG001|Part 1|Withdrawal by Subject|2|||
125059156|NCT01683071|449834314|FG002|Part 1|Withdrawal by Subject|2|||
125059157|NCT01683071|449834315|FG003|Part 1|Withdrawal by Subject|1|||
125059158|NCT01683071|449834316|FG004|Part 1|Withdrawal by Subject|0|||
125059159|NCT01683071|449834317|FG005|Part 1|Withdrawal by Subject|0|||
125059160|NCT01683071|449834312|FG000|Part 1|Surgery Cancelled|1|||
125059161|NCT01683071|449834313|FG001|Part 1|Surgery Cancelled|0|||
125059162|NCT01683071|449834314|FG002|Part 1|Surgery Cancelled|0|||
125059163|NCT01683071|449834315|FG003|Part 1|Surgery Cancelled|0|||
125059164|NCT01683071|449834316|FG004|Part 1|Surgery Cancelled|0|||
125138143|NCT00112437|450131210|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138144|NCT00112437|450131211|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138145|NCT00112437|450131212|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138146|NCT00112437|450131213|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138147|NCT00112437|450131214|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138148|NCT00112437|450131215|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138149|NCT00112437|450131216|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138150|NCT00112437|450131217|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138151|NCT00112437|450131218|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138152|NCT00112437|450131219|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138153|NCT00112437|450131220|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138154|NCT00112437|450131221|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138155|NCT00112437|450131222|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138156|NCT00112437|450131223|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138157|NCT00112437|450131224|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138158|NCT00112437|450131225|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138159|NCT00112437|450131226|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138160|NCT00112437|450131227|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138161|NCT00112437|450131228|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138162|NCT00112437|450131229|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138163|NCT00112437|450131204|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138164|NCT00112437|450131205|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
125138165|NCT00112437|450131206|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138166|NCT00112437|450131207|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138167|NCT00112437|450131208|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138168|NCT00112437|450131209|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125059165|NCT01683071|449834317|FG005|Part 1|Surgery Cancelled|0|||
125059166|NCT01683071|449834312|FG000|Part 1|Did not receive study drug|1|||
125059167|NCT01683071|449834313|FG001|Part 1|Did not receive study drug|0|||
125059168|NCT01683071|449834314|FG002|Part 1|Did not receive study drug|0|||
125059169|NCT01683071|449834315|FG003|Part 1|Did not receive study drug|1|||
125059170|NCT01683071|449834316|FG004|Part 1|Did not receive study drug|0|||
125138169|NCT00112437|450131210|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125059171|NCT01683071|449834317|FG005|Part 1|Did not receive study drug|0|||
125059172|NCT01683071|449834312|FG000|Part 1|Early termination; met exclusion criteria|0|||
125059173|NCT01683071|449834313|FG001|Part 1|Early termination; met exclusion criteria|2|||
125059174|NCT01683071|449834314|FG002|Part 1|Early termination; met exclusion criteria|1|||
125138170|NCT00112437|450131211|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138171|NCT00112437|450131212|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138172|NCT00112437|450131213|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138173|NCT00112437|450131214|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138174|NCT00112437|450131215|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138175|NCT00112437|450131216|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138176|NCT00112437|450131217|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138177|NCT00112437|450131218|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138178|NCT00112437|450131219|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138179|NCT00112437|450131220|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138180|NCT00112437|450131221|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138181|NCT00112437|450131222|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138182|NCT00112437|450131223|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138183|NCT00112437|450131224|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138184|NCT00112437|450131225|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138185|NCT00112437|450131226|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138186|NCT00112437|450131227|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138187|NCT00112437|450131228|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138188|NCT00112437|450131229|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138189|NCT00112437|450131204|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138190|NCT00112437|450131205|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
125138191|NCT00112437|450131206|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138192|NCT00112437|450131207|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138193|NCT00112437|450131208|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138194|NCT00112437|450131209|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138195|NCT00112437|450131210|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138196|NCT00112437|450131211|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138197|NCT00112437|450131212|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138198|NCT00112437|450131213|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138199|NCT00112437|450131214|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138200|NCT00112437|450131215|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138201|NCT00112437|450131216|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138202|NCT00112437|450131217|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138203|NCT00112437|450131218|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138204|NCT00112437|450131219|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138205|NCT00112437|450131220|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138206|NCT00112437|450131221|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138207|NCT00112437|450131222|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138208|NCT00112437|450131223|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138209|NCT00112437|450131224|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138210|NCT00112437|450131225|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138211|NCT00112437|450131226|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138212|NCT00112437|450131227|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138213|NCT00112437|450131228|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138214|NCT00112437|450131229|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138215|NCT00112437|450131204|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
125138216|NCT00112437|450131205|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138217|NCT00112437|450131206|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
125138218|NCT00112437|450131207|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
125138219|NCT00112437|450131208|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
125138220|NCT00112437|450131209|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138221|NCT00112437|450131210|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138222|NCT00112437|450131211|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138223|NCT00112437|450131212|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138224|NCT00112437|450131213|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138225|NCT00112437|450131214|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138226|NCT00112437|450131215|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138227|NCT00112437|450131216|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138228|NCT00112437|450131217|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138229|NCT00112437|450131218|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138230|NCT00112437|450131219|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138231|NCT00112437|450131220|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138232|NCT00112437|450131221|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138233|NCT00112437|450131222|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138234|NCT00112437|450131223|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138235|NCT00112437|450131224|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138236|NCT00112437|450131225|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138237|NCT00112437|450131226|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138238|NCT00112437|450131227|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125059175|NCT01683071|449834315|FG003|Part 1|Early termination; met exclusion criteria|0|||
125059176|NCT01683071|449834316|FG004|Part 1|Early termination; met exclusion criteria|0|||
125059177|NCT01683071|449834317|FG005|Part 1|Early termination; met exclusion criteria|0|||
125059178|NCT01683071|449834312|FG000|Part 2|Lack of Efficacy|0|||
125059179|NCT01683071|449834313|FG001|Part 2|Lack of Efficacy|0|||
125059180|NCT01683071|449834314|FG002|Part 2|Lack of Efficacy|0|||
125059181|NCT01683071|449834315|FG003|Part 2|Lack of Efficacy|0|||
125059182|NCT01683071|449834316|FG004|Part 2|Lack of Efficacy|3|||
125059183|NCT01683071|449834317|FG005|Part 2|Lack of Efficacy|4|||
125059184|NCT01683071|449834312|FG000|Part 2|Lost to Follow-up|0|||
125059185|NCT01683071|449834313|FG001|Part 2|Lost to Follow-up|0|||
125059186|NCT01683071|449834314|FG002|Part 2|Lost to Follow-up|0|||
125059187|NCT01683071|449834315|FG003|Part 2|Lost to Follow-up|0|||
125059188|NCT01683071|449834316|FG004|Part 2|Lost to Follow-up|2|||
125059189|NCT01683071|449834317|FG005|Part 2|Lost to Follow-up|0|||
125059190|NCT01683071|449834312|FG000|Part 2|Withdrawal by Subject|0|||
125220939|NCT02797678|450436280|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
125220940|NCT02797678|450436281|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
125220941|NCT02797678|450436278|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
125220942|NCT02797678|450436279|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
125059191|NCT01683071|449834313|FG001|Part 2|Withdrawal by Subject|0|||
125059192|NCT01683071|449834314|FG002|Part 2|Withdrawal by Subject|0|||
125059193|NCT01683071|449834315|FG003|Part 2|Withdrawal by Subject|0|||
125059194|NCT01683071|449834316|FG004|Part 2|Withdrawal by Subject|3|||
125220943|NCT02797678|450436280|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
125220944|NCT02797678|450436281|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
125220945|NCT00753675|450436285|FG000|Overall Study|other reason|11|||
125220946|NCT00753675|450436286|FG001|Overall Study|other reason|12|||
125220947|NCT00753675|450436287|FG002|Overall Study|other reason|13|||
125220948|NCT00753675|450436285|FG000|Overall Study|Death|1|||
125220949|NCT00753675|450436286|FG001|Overall Study|Death|2|||
125220950|NCT00753675|450436287|FG002|Overall Study|Death|4|||
125220951|NCT00753675|450436285|FG000|Overall Study|Adverse Event|11|||
125220952|NCT00753675|450436286|FG001|Overall Study|Adverse Event|9|||
125220953|NCT00753675|450436287|FG002|Overall Study|Adverse Event|4|||
125220954|NCT00753675|450436285|FG000|Overall Study|Objective progression of disease|35|||
125220955|NCT00753675|450436286|FG001|Overall Study|Objective progression of disease|35|||
125059195|NCT01683071|449834317|FG005|Part 2|Withdrawal by Subject|3|||
125059196|NCT01683071|449834312|FG000|Part 2|Surgery cancelled|0|||
125059197|NCT01683071|449834313|FG001|Part 2|Surgery cancelled|0|||
125059198|NCT01683071|449834314|FG002|Part 2|Surgery cancelled|0|||
125059199|NCT01683071|449834315|FG003|Part 2|Surgery cancelled|0|||
125059200|NCT01683071|449834316|FG004|Part 2|Surgery cancelled|4|||
125059201|NCT01683071|449834317|FG005|Part 2|Surgery cancelled|2|||
125059202|NCT01683071|449834312|FG000|Part 2|Did not receive study drug|0|||
125059203|NCT01683071|449834313|FG001|Part 2|Did not receive study drug|0|||
125059204|NCT01683071|449834314|FG002|Part 2|Did not receive study drug|0|||
125059205|NCT01683071|449834315|FG003|Part 2|Did not receive study drug|0|||
125059206|NCT01683071|449834316|FG004|Part 2|Did not receive study drug|2|||
125059207|NCT01683071|449834317|FG005|Part 2|Did not receive study drug|1|||
125059208|NCT01683071|449834312|FG000|Part 2|Met exclusion criterion|0|||
125059209|NCT01683071|449834313|FG001|Part 2|Met exclusion criterion|0|||
125059210|NCT01683071|449834314|FG002|Part 2|Met exclusion criterion|0|||
125059211|NCT01683071|449834315|FG003|Part 2|Met exclusion criterion|0|||
125059212|NCT01683071|449834316|FG004|Part 2|Met exclusion criterion|1|||
125059213|NCT01683071|449834317|FG005|Part 2|Met exclusion criterion|1|||
125059214|NCT01683071|449834312|FG000|Part 2|Protocol deviation|0|||
125059215|NCT01683071|449834313|FG001|Part 2|Protocol deviation|0|||
125059216|NCT01683071|449834314|FG002|Part 2|Protocol deviation|0|||
125059217|NCT01683071|449834315|FG003|Part 2|Protocol deviation|0|||
125059218|NCT01683071|449834316|FG004|Part 2|Protocol deviation|1|||
125059219|NCT01683071|449834317|FG005|Part 2|Protocol deviation|2|||
125220956|NCT00753675|450436287|FG002|Overall Study|Objective progression of disease|35|||
125220957|NCT00753675|450436285|FG000|Overall Study|Withdrawal by Subject|0|||
125220958|NCT00753675|450436286|FG001|Overall Study|Withdrawal by Subject|1|||
125220959|NCT00753675|450436287|FG002|Overall Study|Withdrawal by Subject|0|||
125220960|NCT00753675|450436285|FG000|Overall Study|Lost to Follow-up|1|||
125220961|NCT00753675|450436286|FG001|Overall Study|Lost to Follow-up|0|||
125220962|NCT00753675|450436287|FG002|Overall Study|Lost to Follow-up|0|||
125220963|NCT02686164|450436291|FG000|Overall Study|Adverse Event|1|||
125220964|NCT02686164|450436291|FG000|Overall Study|Withdrawal of consent|1|||
125220965|NCT02686164|450436291|FG000|Overall Study|Clinical progression|1|||
125220966|NCT03283930|450436292|FG000|Overall Study|Scheduling conflict|8|||
125220967|NCT03283930|450436293|FG001|Overall Study|Scheduling conflict|10|||
125220968|NCT03283930|450436292|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
125220969|NCT03283930|450436293|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
125220970|NCT03283930|450436292|FG000|Overall Study|Technical software issue|2|||
125220971|NCT03283930|450436293|FG001|Overall Study|Technical software issue|2|||
125220972|NCT00805129|450436296|FG000|Overall Study|Not treated|1|||
125220973|NCT02499120|450436299|FG000|Overall Study|Death|52|||
125220974|NCT02499120|450436300|FG001|Overall Study|Death|43|||
125220975|NCT02499120|450436299|FG000|Overall Study|Lost to Follow-up|1|||
125220976|NCT02499120|450436300|FG001|Overall Study|Lost to Follow-up|2|||
125220977|NCT02499120|450436299|FG000|Overall Study|Participant refused further follow-up|1|||
125220978|NCT02499120|450436300|FG001|Overall Study|Participant refused further follow-up|0|||
125220979|NCT02499120|450436299|FG000|Overall Study|Withdrawal by Subject|2|||
125220980|NCT02499120|450436300|FG001|Overall Study|Withdrawal by Subject|5|||
125220981|NCT02499120|450436299|FG000|Overall Study|Other|9|||
125220982|NCT02499120|450436300|FG001|Overall Study|Other|10|||
125220983|NCT02106351|450436314|FG000|Treatment Cycle 1|Adverse Event|2|||
125220984|NCT02106351|450436315|FG001|Treatment Cycle 1|Adverse Event|0|||
125220985|NCT02106351|450436316|FG002|Treatment Cycle 1|Adverse Event|0|||
125138239|NCT00112437|450131228|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138240|NCT00112437|450131229|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138241|NCT00112437|450131204|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
125138242|NCT00112437|450131205|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
125138243|NCT00112437|450131206|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
125138244|NCT00112437|450131207|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
125138245|NCT00112437|450131208|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
125138246|NCT00112437|450131209|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138247|NCT00112437|450131210|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138248|NCT00112437|450131211|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138249|NCT00112437|450131212|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138250|NCT00112437|450131213|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138251|NCT00112437|450131214|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138252|NCT00112437|450131215|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138253|NCT00112437|450131216|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138254|NCT00112437|450131217|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138255|NCT00112437|450131218|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138256|NCT00112437|450131219|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138257|NCT00112437|450131220|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138258|NCT00112437|450131221|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125220986|NCT02106351|450436314|FG000|Treatment Cycle 1|Consent withdrawn|1|||
125220987|NCT02106351|450436315|FG001|Treatment Cycle 1|Consent withdrawn|0|||
125220988|NCT02106351|450436316|FG002|Treatment Cycle 1|Consent withdrawn|2|||
125220989|NCT02106351|450436314|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
125220990|NCT02106351|450436315|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
125220991|NCT02106351|450436316|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
125220992|NCT02106351|450436314|FG000|Treatment Cycle 1|Other|0|||
125220993|NCT02106351|450436315|FG001|Treatment Cycle 1|Other|3|||
125220994|NCT02106351|450436316|FG002|Treatment Cycle 1|Other|1|||
125220995|NCT02106351|450436314|FG000|Treatment Cycle 1|Randomised but not treated|1|||
125220996|NCT02106351|450436315|FG001|Treatment Cycle 1|Randomised but not treated|0|||
125220997|NCT02106351|450436316|FG002|Treatment Cycle 1|Randomised but not treated|1|||
125220998|NCT02106351|450436314|FG000|Treatment Cycle 2|Adverse Event|0|||
125220999|NCT02106351|450436315|FG001|Treatment Cycle 2|Adverse Event|2|||
125221000|NCT02106351|450436316|FG002|Treatment Cycle 2|Adverse Event|0|||
125221001|NCT02106351|450436314|FG000|Treatment Cycle 2|Consent withdrawn|0|||
125221002|NCT02106351|450436315|FG001|Treatment Cycle 2|Consent withdrawn|1|||
125221003|NCT02106351|450436316|FG002|Treatment Cycle 2|Consent withdrawn|1|||
125221004|NCT02106351|450436314|FG000|Treatment Cycle 2|Other|0|||
125221005|NCT02106351|450436315|FG001|Treatment Cycle 2|Other|2|||
125221006|NCT02106351|450436316|FG002|Treatment Cycle 2|Other|2|||
125221007|NCT02106351|450436314|FG000|Treatment Cycle 3|Adverse Event|0|||
125221008|NCT02106351|450436315|FG001|Treatment Cycle 3|Adverse Event|1|||
125221009|NCT02106351|450436316|FG002|Treatment Cycle 3|Adverse Event|0|||
125221010|NCT02106351|450436314|FG000|Treatment Cycle 3|Consent withdrawn|0|||
125221011|NCT02106351|450436315|FG001|Treatment Cycle 3|Consent withdrawn|0|||
125221012|NCT02106351|450436316|FG002|Treatment Cycle 3|Consent withdrawn|2|||
125059220|NCT01683071|449834312|FG000|Part 2|Withdrawal by investigator decision|0|||
125059221|NCT01683071|449834313|FG001|Part 2|Withdrawal by investigator decision|0|||
125059222|NCT01683071|449834314|FG002|Part 2|Withdrawal by investigator decision|0|||
125059223|NCT01683071|449834315|FG003|Part 2|Withdrawal by investigator decision|0|||
125059224|NCT01683071|449834316|FG004|Part 2|Withdrawal by investigator decision|1|||
125059225|NCT01683071|449834317|FG005|Part 2|Withdrawal by investigator decision|2|||
125059226|NCT02020031|449836177|FG000|Overall Study|Physician Decision|1|||
125059227|NCT02020031|449836178|FG001|Overall Study|Physician Decision|1|||
125059228|NCT02625324|449836185|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
125059229|NCT02625324|449836185|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
125059230|NCT02625324|449836185|FG000|6-Month Follow-up Subject Accountability|Death|5|||
125059231|NCT02625324|449836185|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
125059232|NCT02625324|449836185|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
125059233|NCT02625324|449836185|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
125059234|NCT02625324|449836185|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
125059235|NCT02625324|449836185|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
125059236|NCT02625324|449836185|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
125059237|NCT02625324|449836185|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
125059238|NCT02625324|449836185|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
125059239|NCT02625324|449836185|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
125059240|NCT02625324|449836185|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
125059241|NCT02625324|449836185|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
125059242|NCT02625324|449836185|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
125059243|NCT02625324|449836185|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
125059244|NCT02625324|449836185|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
125059245|NCT01116687|449836186|FG000|Overall Study|Withdrawal by Subject|4|||
125059246|NCT00424528|449836187|FG000|Overall Study|Adverse Event|2|||
125059247|NCT00424528|449836188|FG001|Overall Study|Adverse Event|1|||
125059248|NCT00424528|449836189|FG002|Overall Study|Adverse Event|2|||
125059249|NCT00424528|449836187|FG000|Overall Study|Protocol Violation|1|||
125059250|NCT00424528|449836188|FG001|Overall Study|Protocol Violation|1|||
125059251|NCT00424528|449836189|FG002|Overall Study|Protocol Violation|0|||
125059252|NCT00424528|449836187|FG000|Overall Study|Lost to Follow-up|0|||
125059253|NCT00424528|449836188|FG001|Overall Study|Lost to Follow-up|1|||
125059254|NCT00424528|449836189|FG002|Overall Study|Lost to Follow-up|0|||
125059255|NCT00424528|449836187|FG000|Overall Study|noncompliance with study requirements|2|||
125059256|NCT00424528|449836188|FG001|Overall Study|noncompliance with study requirements|1|||
125059257|NCT00424528|449836189|FG002|Overall Study|noncompliance with study requirements|2|||
125059258|NCT02395653|449836190|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
125059259|NCT02395653|449836190|FG000|Overall Study|Consent Withdrawn at Screening|1|||
125059260|NCT02395653|449836190|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
125059261|NCT02395653|449836190|FG000|Overall Study|Investigator Decision at Screening|1|||
125059262|NCT02395653|449836190|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
125059263|NCT02395653|449836190|FG000|Overall Study|Withdrawal by Subject|1|||
125059264|NCT02395653|449836190|FG000|Overall Study|Lost to Follow-up|1|||
125059265|NCT00967226|449836194|FG000|Overall Study|Adverse Event|0|||
125059266|NCT00967226|449836195|FG001|Overall Study|Adverse Event|5|||
125059267|NCT00967226|449836194|FG000|Overall Study|Protocol Violation|2|||
125059268|NCT00967226|449836195|FG001|Overall Study|Protocol Violation|0|||
125059269|NCT00967226|449836194|FG000|Overall Study|Physician Decision|0|||
125059270|NCT00967226|449836195|FG001|Overall Study|Physician Decision|1|||
125059271|NCT00605722|449836196|FG000|Overall Study|Adverse Event|6|||
125059272|NCT00605722|449836196|FG000|Overall Study|Insufficient therapeutic response|44|||
125059273|NCT00605722|449836196|FG000|Overall Study|Failure to return|1|||
125059274|NCT02702518|449836199|FG000|Overall Study|Lost to Follow-up|3|||
125059275|NCT02702518|449836200|FG001|Overall Study|Lost to Follow-up|4|||
125059276|NCT00165841|449836203|FG000|Overall Study|Adverse Event|2|||
125059277|NCT00165841|449836204|FG001|Overall Study|Adverse Event|3|||
125059278|NCT00165841|449836203|FG000|Overall Study|Lack of Efficacy|6|||
125059279|NCT00165841|449836204|FG001|Overall Study|Lack of Efficacy|33|||
125059280|NCT00165841|449836203|FG000|Overall Study|Lost to Follow-up|4|||
125059281|NCT00165841|449836204|FG001|Overall Study|Lost to Follow-up|4|||
125059282|NCT00165841|449836203|FG000|Overall Study|Withdrawal by Subject|7|||
125059283|NCT00165841|449836204|FG001|Overall Study|Withdrawal by Subject|8|||
125059284|NCT00165841|449836203|FG000|Overall Study|Physician Decision|1|||
125059285|NCT00165841|449836204|FG001|Overall Study|Physician Decision|0|||
125059286|NCT00165841|449836203|FG000|Overall Study|Protocol Violation|6|||
125059287|NCT00165841|449836204|FG001|Overall Study|Protocol Violation|8|||
125059288|NCT00165841|449836203|FG000|Overall Study|Other|3|||
125059289|NCT00165841|449836204|FG001|Overall Study|Other|5|||
125059290|NCT00165841|449836203|FG000|Overall Study|Medication Noncompliance|1|||
125059291|NCT00165841|449836204|FG001|Overall Study|Medication Noncompliance|1|||
125059292|NCT00487084|449836205|FG000|Overall Study|Did not receive intervention|4|||
125059293|NCT00487084|449836206|FG001|Overall Study|Did not receive intervention|3|||
125059294|NCT00487084|449836207|FG002|Overall Study|Did not receive intervention|5|||
125059295|NCT00254293|449836208|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
125059296|NCT00254293|449836209|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
125059297|NCT00254293|449836210|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
125059298|NCT00254293|449836211|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
125059299|NCT00254293|449836212|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
125059300|NCT00254293|449836213|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
125059301|NCT00254293|449836214|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
125059302|NCT00254293|449836208|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
125059303|NCT00254293|449836209|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
125059304|NCT00254293|449836210|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
125059305|NCT00254293|449836211|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
125059306|NCT00254293|449836212|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
125059307|NCT00254293|449836213|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
125138259|NCT00112437|450131222|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138260|NCT00112437|450131223|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138261|NCT00112437|450131224|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138262|NCT00112437|450131225|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138263|NCT00112437|450131226|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138264|NCT00112437|450131227|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138265|NCT00112437|450131228|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138266|NCT00112437|450131229|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138267|NCT00112437|450131204|FG000|Year 1 (12-Month Base Study)|moved|0|||
125138268|NCT00112437|450131205|FG001|Year 1 (12-Month Base Study)|moved|1|||
125138269|NCT00112437|450131206|FG002|Year 1 (12-Month Base Study)|moved|1|||
125138270|NCT00112437|450131207|FG003|Year 1 (12-Month Base Study)|moved|0|||
125138271|NCT00112437|450131208|FG004|Year 1 (12-Month Base Study)|moved|0|||
125138272|NCT00112437|450131209|FG005|Year 1 (12-Month Base Study)|moved|0|||
125138273|NCT00112437|450131210|FG006|Year 1 (12-Month Base Study)|moved|0|||
125138274|NCT00112437|450131211|FG007|Year 1 (12-Month Base Study)|moved|0|||
125138275|NCT00112437|450131212|FG008|Year 1 (12-Month Base Study)|moved|0|||
125138276|NCT00112437|450131213|FG009|Year 1 (12-Month Base Study)|moved|0|||
125138277|NCT00112437|450131214|FG010|Year 1 (12-Month Base Study)|moved|0|||
125138278|NCT00112437|450131215|FG011|Year 1 (12-Month Base Study)|moved|0|||
125138279|NCT00112437|450131216|FG012|Year 1 (12-Month Base Study)|moved|0|||
125138280|NCT00112437|450131217|FG013|Year 1 (12-Month Base Study)|moved|0|||
125138281|NCT00112437|450131218|FG014|Year 1 (12-Month Base Study)|moved|0|||
125138282|NCT00112437|450131219|FG015|Year 1 (12-Month Base Study)|moved|0|||
125138283|NCT00112437|450131220|FG016|Year 1 (12-Month Base Study)|moved|0|||
125138284|NCT00112437|450131221|FG017|Year 1 (12-Month Base Study)|moved|0|||
125138285|NCT00112437|450131222|FG018|Year 1 (12-Month Base Study)|moved|0|||
125138286|NCT00112437|450131223|FG019|Year 1 (12-Month Base Study)|moved|0|||
125138287|NCT00112437|450131224|FG020|Year 1 (12-Month Base Study)|moved|0|||
125138288|NCT00112437|450131225|FG021|Year 1 (12-Month Base Study)|moved|0|||
125138289|NCT00112437|450131226|FG022|Year 1 (12-Month Base Study)|moved|0|||
125138290|NCT00112437|450131227|FG023|Year 1 (12-Month Base Study)|moved|0|||
125138291|NCT00112437|450131228|FG024|Year 1 (12-Month Base Study)|moved|0|||
125138292|NCT00112437|450131229|FG025|Year 1 (12-Month Base Study)|moved|0|||
125138293|NCT00112437|450131204|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138294|NCT00112437|450131205|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138295|NCT00112437|450131206|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138296|NCT00112437|450131207|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
125138297|NCT00112437|450131208|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125221013|NCT02106351|450436314|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
125221014|NCT02106351|450436315|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
125059308|NCT00254293|449836214|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
125059309|NCT00254293|449836208|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
125059310|NCT00254293|449836209|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
125059311|NCT00254293|449836210|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
125059312|NCT00254293|449836211|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
125059313|NCT00254293|449836212|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
125059314|NCT00254293|449836213|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
125059315|NCT00254293|449836214|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
125059316|NCT00254293|449836208|FG000|LTE Open Label Variable SC Dosing|Death|0|||
125059317|NCT00254293|449836209|FG001|LTE Open Label Variable SC Dosing|Death|0|||
125059318|NCT00254293|449836210|FG002|LTE Open Label Variable SC Dosing|Death|1|||
125059319|NCT00254293|449836211|FG003|LTE Open Label Variable SC Dosing|Death|0|||
125059320|NCT00254293|449836212|FG004|LTE Open Label Variable SC Dosing|Death|0|||
125059321|NCT00254293|449836213|FG005|LTE Open Label Variable SC Dosing|Death|0|||
125059322|NCT00254293|449836214|FG006|LTE Open Label Variable SC Dosing|Death|0|||
125059323|NCT00254293|449836208|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
125138298|NCT00112437|450131209|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138299|NCT00112437|450131210|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138300|NCT00112437|450131211|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138301|NCT00112437|450131212|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138302|NCT00112437|450131213|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138303|NCT00112437|450131214|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138304|NCT00112437|450131215|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138305|NCT00112437|450131216|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138306|NCT00112437|450131217|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138307|NCT00112437|450131218|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138308|NCT00112437|450131219|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138309|NCT00112437|450131220|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138310|NCT00112437|450131221|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138311|NCT00112437|450131222|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138312|NCT00112437|450131223|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138313|NCT00112437|450131224|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138314|NCT00112437|450131225|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138315|NCT00112437|450131226|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138316|NCT00112437|450131227|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138317|NCT00112437|450131228|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138318|NCT00112437|450131229|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138319|NCT00112437|450131204|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138320|NCT00112437|450131205|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138321|NCT00112437|450131206|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138322|NCT00112437|450131207|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138323|NCT00112437|450131208|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
125138324|NCT00112437|450131209|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138325|NCT00112437|450131210|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138326|NCT00112437|450131211|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138327|NCT00112437|450131212|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138328|NCT00112437|450131213|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138329|NCT00112437|450131214|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138330|NCT00112437|450131215|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138331|NCT00112437|450131216|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138332|NCT00112437|450131217|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138333|NCT00112437|450131218|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138334|NCT00112437|450131219|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138335|NCT00112437|450131220|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138336|NCT00112437|450131221|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138337|NCT00112437|450131222|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138338|NCT00112437|450131223|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138339|NCT00112437|450131224|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125059324|NCT00254293|449836209|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
125059325|NCT00254293|449836210|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
125059326|NCT00254293|449836211|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
125059327|NCT00254293|449836212|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
125138340|NCT00112437|450131225|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138341|NCT00112437|450131226|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138342|NCT00112437|450131227|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138343|NCT00112437|450131228|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138344|NCT00112437|450131229|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138345|NCT00112437|450131204|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
125138346|NCT00112437|450131205|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
125138347|NCT00112437|450131206|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
125138348|NCT00112437|450131207|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
125138349|NCT00112437|450131208|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
125138350|NCT00112437|450131209|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
125138351|NCT00112437|450131210|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
125138352|NCT00112437|450131211|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
125138353|NCT00112437|450131212|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
125138354|NCT00112437|450131213|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
125138355|NCT00112437|450131214|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
125138356|NCT00112437|450131215|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
125138357|NCT00112437|450131216|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
125138358|NCT00112437|450131217|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
125138359|NCT00112437|450131218|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
125138360|NCT00112437|450131219|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
125138361|NCT00112437|450131220|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
125138362|NCT00112437|450131221|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
125138363|NCT00112437|450131222|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
125138364|NCT00112437|450131223|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
125138365|NCT00112437|450131224|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
125138366|NCT00112437|450131225|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
125138367|NCT00112437|450131226|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
125138368|NCT00112437|450131227|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
125138369|NCT00112437|450131228|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
125138370|NCT00112437|450131229|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
125138371|NCT00112437|450131204|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138372|NCT00112437|450131205|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138373|NCT00112437|450131206|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138374|NCT00112437|450131207|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138375|NCT00112437|450131208|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138376|NCT00112437|450131209|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
125138377|NCT00112437|450131210|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
125138378|NCT00112437|450131211|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138379|NCT00112437|450131212|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138380|NCT00112437|450131213|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
125138381|NCT00112437|450131214|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138382|NCT00112437|450131215|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138383|NCT00112437|450131216|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138384|NCT00112437|450131217|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138385|NCT00112437|450131218|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138386|NCT00112437|450131219|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138387|NCT00112437|450131220|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138388|NCT00112437|450131221|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138389|NCT00112437|450131222|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138390|NCT00112437|450131223|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138391|NCT00112437|450131224|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138392|NCT00112437|450131225|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138393|NCT00112437|450131226|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138394|NCT00112437|450131227|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138395|NCT00112437|450131228|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125221015|NCT02106351|450436316|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
125221016|NCT02106351|450436314|FG000|Treatment Cycle 3|Other|0|||
125221017|NCT02106351|450436315|FG001|Treatment Cycle 3|Other|2|||
125221018|NCT02106351|450436316|FG002|Treatment Cycle 3|Other|3|||
125221019|NCT02106351|450436314|FG000|Treatment Cycle 4|Consent withdrawn|0|||
125221020|NCT02106351|450436315|FG001|Treatment Cycle 4|Consent withdrawn|0|||
125221021|NCT02106351|450436316|FG002|Treatment Cycle 4|Consent withdrawn|2|||
125221022|NCT02106351|450436314|FG000|Treatment Cycle 4|Other|0|||
125221023|NCT02106351|450436315|FG001|Treatment Cycle 4|Other|1|||
125221024|NCT02106351|450436316|FG002|Treatment Cycle 4|Other|0|||
125221025|NCT01931397|450436317|FG000|Overall Study|Physician Decision|2|||
125221026|NCT01931397|450436317|FG000|Overall Study|Withdrawal by Subject|8|||
125221027|NCT01931397|450436317|FG000|Overall Study|moved out of state|1|||
125221028|NCT00520039|450436318|FG000|Overall Study|Exclusion criteria met at first visit|7|||
125221029|NCT00520039|450436319|FG001|Overall Study|Exclusion criteria met at first visit|5|||
125221030|NCT05176717|450436321|FG000|Overall Study|Sponsor Decision|1|||
125221031|NCT05176717|450436322|FG001|Overall Study|Sponsor Decision|2|||
125221032|NCT05176717|450436323|FG002|Overall Study|Sponsor Decision|2|||
125221033|NCT03284853|450436324|FG000|Overall Study|Adverse Event|40|||
125221034|NCT03284853|450436325|FG001|Overall Study|Adverse Event|4|||
125221035|NCT03284853|450436324|FG000|Overall Study|Withdrawal by Subject|5|||
125221036|NCT03284853|450436325|FG001|Overall Study|Withdrawal by Subject|1|||
125221037|NCT03284853|450436324|FG000|Overall Study|Lost to Follow-up|1|||
125221038|NCT03284853|450436325|FG001|Overall Study|Lost to Follow-up|0|||
125221039|NCT03284853|450436324|FG000|Overall Study|Lack of Efficacy|1|||
125221040|NCT03284853|450436325|FG001|Overall Study|Lack of Efficacy|0|||
125221041|NCT03284853|450436324|FG000|Overall Study|Disallowed Concurrent Medication|1|||
125221042|NCT03284853|450436325|FG001|Overall Study|Disallowed Concurrent Medication|1|||
125221043|NCT03284853|450436324|FG000|Overall Study|Protocol Violation|3|||
125221044|NCT03284853|450436325|FG001|Overall Study|Protocol Violation|3|||
125221045|NCT03284853|450436324|FG000|Overall Study|Death|0|||
125221046|NCT03284853|450436325|FG001|Overall Study|Death|1|||
125221047|NCT03284853|450436324|FG000|Overall Study|Other - Reason not reported in CSR|4|||
125221048|NCT03284853|450436325|FG001|Overall Study|Other - Reason not reported in CSR|3|||
125221049|NCT00765817|450436327|FG000|Overall Study|Adverse Event|13|||
125221050|NCT00765817|450436328|FG001|Overall Study|Adverse Event|1|||
125221051|NCT00765817|450436327|FG000|Overall Study|Death|0|||
125221052|NCT00765817|450436328|FG001|Overall Study|Death|1|||
125221053|NCT00765817|450436327|FG000|Overall Study|Entry criteria not met|2|||
125221054|NCT00765817|450436328|FG001|Overall Study|Entry criteria not met|2|||
125221055|NCT00765817|450436327|FG000|Overall Study|Loss of glucose control|0|||
125221056|NCT00765817|450436328|FG001|Overall Study|Loss of glucose control|2|||
125221057|NCT00765817|450436327|FG000|Overall Study|Lost to Follow-up|1|||
125221058|NCT00765817|450436328|FG001|Overall Study|Lost to Follow-up|3|||
125221059|NCT00765817|450436327|FG000|Overall Study|Physician Decision|2|||
125221060|NCT00765817|450436328|FG001|Overall Study|Physician Decision|1|||
125221061|NCT00765817|450436327|FG000|Overall Study|Protocol Violation|1|||
125221062|NCT00765817|450436328|FG001|Overall Study|Protocol Violation|1|||
125221063|NCT00765817|450436327|FG000|Overall Study|Subject decision|7|||
125221064|NCT00765817|450436328|FG001|Overall Study|Subject decision|11|||
125221065|NCT00255164|450436331|FG000|Overall Study|Adverse Event|10|||
125221066|NCT00255164|450436332|FG001|Overall Study|Adverse Event|6|||
125221067|NCT00255164|450436333|FG002|Overall Study|Adverse Event|9|||
125221068|NCT00255164|450436331|FG000|Overall Study|Lost to Follow-up|4|||
125221069|NCT00255164|450436332|FG001|Overall Study|Lost to Follow-up|3|||
125221070|NCT00255164|450436333|FG002|Overall Study|Lost to Follow-up|4|||
125221071|NCT00255164|450436331|FG000|Overall Study|Withdrawal by Subject|18|||
125221072|NCT00255164|450436332|FG001|Overall Study|Withdrawal by Subject|17|||
125221073|NCT00255164|450436333|FG002|Overall Study|Withdrawal by Subject|8|||
125221074|NCT00255164|450436331|FG000|Overall Study|Noncompliance|0|||
125221075|NCT00255164|450436332|FG001|Overall Study|Noncompliance|1|||
125221076|NCT00255164|450436333|FG002|Overall Study|Noncompliance|2|||
125221077|NCT00255164|450436331|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
125221078|NCT00255164|450436332|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
125221079|NCT00255164|450436333|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
125221080|NCT00255164|450436331|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
125221081|NCT00255164|450436332|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
125221082|NCT00255164|450436333|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
125221083|NCT00255164|450436331|FG000|Overall Study|Possible Barrett's Esophagus|1|||
125221084|NCT00255164|450436332|FG001|Overall Study|Possible Barrett's Esophagus|3|||
125221085|NCT00255164|450436333|FG002|Overall Study|Possible Barrett's Esophagus|8|||
125221086|NCT00255164|450436331|FG000|Overall Study|Esophageal Stricture|0|||
125221087|NCT00255164|450436332|FG001|Overall Study|Esophageal Stricture|0|||
125221088|NCT00255164|450436333|FG002|Overall Study|Esophageal Stricture|1|||
125221089|NCT00255164|450436331|FG000|Overall Study|Therapeutic Failure|11|||
125221090|NCT00255164|450436332|FG001|Overall Study|Therapeutic Failure|2|||
125221091|NCT00255164|450436333|FG002|Overall Study|Therapeutic Failure|3|||
125221092|NCT05219968|450436334|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
125221093|NCT05219968|450436335|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
125221094|NCT05219968|450436336|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
125221095|NCT05219968|450436337|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
125221096|NCT05219968|450436338|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
125221097|NCT05219968|450436334|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
125221098|NCT05219968|450436335|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
125221099|NCT05219968|450436336|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
125221100|NCT05219968|450436337|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
125221101|NCT05219968|450436338|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
125221102|NCT05219968|450436334|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
125221103|NCT05219968|450436335|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
125221104|NCT05219968|450436336|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
125221105|NCT05219968|450436337|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
125221106|NCT05219968|450436338|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
125221107|NCT05219968|450436334|FG000|Week 24 Treatment Period|Adverse Event|3|||
125221108|NCT05219968|450436335|FG001|Week 24 Treatment Period|Adverse Event|0|||
125221109|NCT05219968|450436336|FG002|Week 24 Treatment Period|Adverse Event|0|||
125221110|NCT05219968|450436337|FG003|Week 24 Treatment Period|Adverse Event|0|||
125221111|NCT05219968|450436338|FG004|Week 24 Treatment Period|Adverse Event|0|||
125221112|NCT05219968|450436334|FG000|Week 24 Treatment Period|Physician Decision|0|||
125221113|NCT05219968|450436335|FG001|Week 24 Treatment Period|Physician Decision|1|||
125221114|NCT05219968|450436336|FG002|Week 24 Treatment Period|Physician Decision|0|||
125221115|NCT05219968|450436337|FG003|Week 24 Treatment Period|Physician Decision|0|||
125221116|NCT05219968|450436338|FG004|Week 24 Treatment Period|Physician Decision|0|||
125221117|NCT05219968|450436334|FG000|Week 24 Treatment Period|Other, not specified|3|||
125221118|NCT05219968|450436335|FG001|Week 24 Treatment Period|Other, not specified|0|||
125221119|NCT05219968|450436336|FG002|Week 24 Treatment Period|Other, not specified|0|||
125221120|NCT05219968|450436337|FG003|Week 24 Treatment Period|Other, not specified|0|||
125221121|NCT05219968|450436338|FG004|Week 24 Treatment Period|Other, not specified|0|||
125221122|NCT05219968|450436334|FG000|Safety Extension Period|Treatment administration failure|0|||
125221123|NCT05219968|450436335|FG001|Safety Extension Period|Treatment administration failure|0|||
125221124|NCT05219968|450436336|FG002|Safety Extension Period|Treatment administration failure|0|||
125221125|NCT05219968|450436337|FG003|Safety Extension Period|Treatment administration failure|1|||
125221126|NCT05219968|450436338|FG004|Safety Extension Period|Treatment administration failure|4|||
125221127|NCT05219968|450436334|FG000|Safety Extension Period|Bilateral dislodgement|0|||
125221128|NCT05219968|450436335|FG001|Safety Extension Period|Bilateral dislodgement|0|||
125221129|NCT05219968|450436336|FG002|Safety Extension Period|Bilateral dislodgement|4|||
125221130|NCT05219968|450436337|FG003|Safety Extension Period|Bilateral dislodgement|0|||
125221131|NCT05219968|450436338|FG004|Safety Extension Period|Bilateral dislodgement|1|||
125221132|NCT05219968|450436334|FG000|Safety Extension Period|Withdrawal by Subject|0|||
125221133|NCT05219968|450436335|FG001|Safety Extension Period|Withdrawal by Subject|0|||
125221134|NCT05219968|450436336|FG002|Safety Extension Period|Withdrawal by Subject|2|||
125221135|NCT05219968|450436337|FG003|Safety Extension Period|Withdrawal by Subject|0|||
125221136|NCT05219968|450436338|FG004|Safety Extension Period|Withdrawal by Subject|4|||
125221137|NCT05219968|450436334|FG000|Safety Extension Period|Adverse Event|0|||
125221138|NCT05219968|450436335|FG001|Safety Extension Period|Adverse Event|0|||
125221139|NCT05219968|450436336|FG002|Safety Extension Period|Adverse Event|2|||
125221140|NCT05219968|450436337|FG003|Safety Extension Period|Adverse Event|1|||
125221141|NCT05219968|450436338|FG004|Safety Extension Period|Adverse Event|1|||
125221142|NCT05219968|450436334|FG000|Safety Extension Period|Lost to Follow-up|0|||
125221143|NCT05219968|450436335|FG001|Safety Extension Period|Lost to Follow-up|0|||
125221144|NCT05219968|450436336|FG002|Safety Extension Period|Lost to Follow-up|0|||
125221145|NCT05219968|450436337|FG003|Safety Extension Period|Lost to Follow-up|1|||
125221146|NCT05219968|450436338|FG004|Safety Extension Period|Lost to Follow-up|0|||
125221147|NCT04587336|450436339|FG000|Overall Study|Lost to Follow-up|1|||
125221148|NCT04587336|450436340|FG001|Overall Study|Lost to Follow-up|0|||
125221149|NCT03512353|450438264|FG000|Overall Study|Sponsor Decision|3|||
125221150|NCT03512353|450438264|FG000|Overall Study|Death|1|||
125221151|NCT01845597|450438265|FG000|Overall Study|Death|8|||
125221152|NCT01845597|450438265|FG000|Overall Study|Lost to Follow-up|22|||
125221153|NCT02581488|450438268|FG000|Overall Study|Adverse Event|6|||
125221154|NCT02581488|450438269|FG001|Overall Study|Adverse Event|7|||
125221155|NCT02581488|450438268|FG000|Overall Study|Lost to Follow-up|1|||
125221156|NCT02581488|450438269|FG001|Overall Study|Lost to Follow-up|0|||
125221157|NCT02581488|450438268|FG000|Overall Study|Withdrawal by Subject|1|||
125221158|NCT02581488|450438269|FG001|Overall Study|Withdrawal by Subject|0|||
125221159|NCT02581488|450438268|FG000|Overall Study|Non-Compliance|1|||
125221160|NCT02581488|450438269|FG001|Overall Study|Non-Compliance|0|||
125221161|NCT02581488|450438268|FG000|Overall Study|Protocol Violation|0|||
125221162|NCT02581488|450438269|FG001|Overall Study|Protocol Violation|4|||
125138396|NCT00112437|450131229|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138397|NCT00112437|450131204|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138398|NCT00112437|450131205|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138399|NCT00112437|450131206|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138400|NCT00112437|450131207|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138401|NCT00112437|450131208|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138402|NCT00112437|450131209|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138403|NCT00112437|450131210|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138404|NCT00112437|450131211|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138405|NCT00112437|450131212|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
125138406|NCT00112437|450131213|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138407|NCT00112437|450131214|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138408|NCT00112437|450131215|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138409|NCT00112437|450131216|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138410|NCT00112437|450131217|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138411|NCT00112437|450131218|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138412|NCT00112437|450131219|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138413|NCT00112437|450131220|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138414|NCT00112437|450131221|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138415|NCT00112437|450131222|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138416|NCT00112437|450131223|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138417|NCT00112437|450131224|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138418|NCT00112437|450131225|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138419|NCT00112437|450131226|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138420|NCT00112437|450131227|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138421|NCT00112437|450131228|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138422|NCT00112437|450131229|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138423|NCT00112437|450131204|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138424|NCT00112437|450131205|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138425|NCT00112437|450131206|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138426|NCT00112437|450131207|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138427|NCT00112437|450131208|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138428|NCT00112437|450131209|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138429|NCT00112437|450131210|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138430|NCT00112437|450131211|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138431|NCT00112437|450131212|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
125138432|NCT00112437|450131213|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138433|NCT00112437|450131214|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138434|NCT00112437|450131215|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138435|NCT00112437|450131216|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138436|NCT00112437|450131217|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138437|NCT00112437|450131218|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138438|NCT00112437|450131219|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138439|NCT00112437|450131220|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138440|NCT00112437|450131221|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138441|NCT00112437|450131222|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138442|NCT00112437|450131223|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138443|NCT00112437|450131224|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138444|NCT00112437|450131225|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138445|NCT00112437|450131226|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138446|NCT00112437|450131227|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138447|NCT00112437|450131228|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138448|NCT00112437|450131229|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138449|NCT00112437|450131204|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138450|NCT00112437|450131205|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138451|NCT00112437|450131206|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138452|NCT00112437|450131207|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138453|NCT00112437|450131208|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125221163|NCT01877668|450438270|FG000|Overall Study|Death|0|||
125221164|NCT01877668|450438271|FG001|Overall Study|Death|0|||
125138454|NCT00112437|450131209|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
125138455|NCT00112437|450131210|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
125138456|NCT00112437|450131211|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
125221165|NCT01877668|450438272|FG002|Overall Study|Death|0|||
125221166|NCT01877668|450438273|FG003|Overall Study|Death|1|||
125221167|NCT01877668|450438274|FG004|Overall Study|Death|0|||
125221168|NCT01877668|450438270|FG000|Overall Study|No longer met study criteria|1|||
125221169|NCT01877668|450438271|FG001|Overall Study|No longer met study criteria|0|||
125221170|NCT01877668|450438272|FG002|Overall Study|No longer met study criteria|1|||
125221171|NCT01877668|450438273|FG003|Overall Study|No longer met study criteria|0|||
125221172|NCT01877668|450438274|FG004|Overall Study|No longer met study criteria|0|||
125221173|NCT01877668|450438270|FG000|Overall Study|Insufficient clinical response|0|||
125221174|NCT01877668|450438271|FG001|Overall Study|Insufficient clinical response|1|||
125221175|NCT01877668|450438272|FG002|Overall Study|Insufficient clinical response|2|||
125221176|NCT01877668|450438273|FG003|Overall Study|Insufficient clinical response|2|||
125221177|NCT01877668|450438274|FG004|Overall Study|Insufficient clinical response|0|||
125221178|NCT01877668|450438270|FG000|Overall Study|Lost to Follow-up|0|||
125221179|NCT01877668|450438271|FG001|Overall Study|Lost to Follow-up|2|||
125221180|NCT01877668|450438272|FG002|Overall Study|Lost to Follow-up|1|||
125221181|NCT01877668|450438273|FG003|Overall Study|Lost to Follow-up|0|||
125221182|NCT01877668|450438274|FG004|Overall Study|Lost to Follow-up|0|||
125221183|NCT01877668|450438270|FG000|Overall Study|Withdrawal by Subject|2|||
125221184|NCT01877668|450438271|FG001|Overall Study|Withdrawal by Subject|0|||
125221185|NCT01877668|450438272|FG002|Overall Study|Withdrawal by Subject|3|||
125221186|NCT01877668|450438273|FG003|Overall Study|Withdrawal by Subject|2|||
125059328|NCT00254293|449836213|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
125059329|NCT00254293|449836214|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
125059330|NCT00254293|449836208|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
125059331|NCT00254293|449836209|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
125059332|NCT00254293|449836210|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
125221187|NCT01877668|450438274|FG004|Overall Study|Withdrawal by Subject|2|||
125221188|NCT01877668|450438270|FG000|Overall Study|Other|1|||
125221189|NCT01877668|450438271|FG001|Overall Study|Other|1|||
125221190|NCT01877668|450438272|FG002|Overall Study|Other|1|||
125221191|NCT01877668|450438273|FG003|Overall Study|Other|1|||
125221192|NCT01877668|450438274|FG004|Overall Study|Other|3|||
125221193|NCT01877668|450438270|FG000|Overall Study|Protocol Violation|1|||
125221194|NCT01877668|450438271|FG001|Overall Study|Protocol Violation|1|||
125221195|NCT01877668|450438272|FG002|Overall Study|Protocol Violation|0|||
125221196|NCT01877668|450438273|FG003|Overall Study|Protocol Violation|0|||
125221197|NCT01877668|450438274|FG004|Overall Study|Protocol Violation|3|||
125221198|NCT01877668|450438270|FG000|Overall Study|Adverse event related to study drug|2|||
125221199|NCT01877668|450438271|FG001|Overall Study|Adverse event related to study drug|2|||
125221200|NCT01877668|450438272|FG002|Overall Study|Adverse event related to study drug|2|||
125221201|NCT01877668|450438273|FG003|Overall Study|Adverse event related to study drug|2|||
125221202|NCT01877668|450438274|FG004|Overall Study|Adverse event related to study drug|1|||
125221203|NCT01877668|450438270|FG000|Overall Study|Adverse event unrelated to study drug|4|||
125221204|NCT01877668|450438271|FG001|Overall Study|Adverse event unrelated to study drug|1|||
125221205|NCT01877668|450438272|FG002|Overall Study|Adverse event unrelated to study drug|2|||
125221206|NCT01877668|450438273|FG003|Overall Study|Adverse event unrelated to study drug|0|||
125221207|NCT01877668|450438274|FG004|Overall Study|Adverse event unrelated to study drug|1|||
125221208|NCT01302418|450438275|FG000|Overall Study|Protocol Violation|9|||
125221209|NCT01302418|450438275|FG000|Overall Study|Non-evaluable|9|||
125221210|NCT00377637|450438277|FG000|Induction Phase|Adverse Event|12|||
125221211|NCT00377637|450438278|FG001|Induction Phase|Adverse Event|21|||
125221212|NCT00377637|450438279|FG002|Induction Phase|Adverse Event|0|||
125221213|NCT00377637|450438280|FG003|Induction Phase|Adverse Event|0|||
125221214|NCT00377637|450438277|FG000|Induction Phase|Deterioration/serum creatinine|2|||
125221215|NCT00377637|450438278|FG001|Induction Phase|Deterioration/serum creatinine|0|||
125221216|NCT00377637|450438279|FG002|Induction Phase|Deterioration/serum creatinine|0|||
125221217|NCT00377637|450438280|FG003|Induction Phase|Deterioration/serum creatinine|0|||
125221218|NCT00377637|450438277|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
125221219|NCT00377637|450438278|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
125221220|NCT00377637|450438279|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
125221221|NCT00377637|450438280|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
125221222|NCT00377637|450438277|FG000|Induction Phase|Lost to Follow-up|2|||
125221223|NCT00377637|450438278|FG001|Induction Phase|Lost to Follow-up|1|||
125221224|NCT00377637|450438279|FG002|Induction Phase|Lost to Follow-up|0|||
125221225|NCT00377637|450438280|FG003|Induction Phase|Lost to Follow-up|0|||
125221226|NCT00377637|450438277|FG000|Induction Phase|Death|1|||
125221227|NCT00377637|450438278|FG001|Induction Phase|Death|3|||
125221228|NCT00377637|450438279|FG002|Induction Phase|Death|0|||
125221229|NCT00377637|450438280|FG003|Induction Phase|Death|0|||
125221230|NCT00377637|450438277|FG000|Induction Phase|Withdrawal by Subject|5|||
125221231|NCT00377637|450438278|FG001|Induction Phase|Withdrawal by Subject|6|||
125221232|NCT00377637|450438279|FG002|Induction Phase|Withdrawal by Subject|0|||
125221233|NCT00377637|450438280|FG003|Induction Phase|Withdrawal by Subject|0|||
125221234|NCT00377637|450438277|FG000|Induction Phase|Physician Decision|3|||
125221235|NCT00377637|450438278|FG001|Induction Phase|Physician Decision|1|||
125221236|NCT00377637|450438279|FG002|Induction Phase|Physician Decision|0|||
125059333|NCT00254293|449836211|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
125059334|NCT00254293|449836212|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
125059335|NCT00254293|449836213|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
125059336|NCT00254293|449836214|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
125059337|NCT00254293|449836208|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
125059338|NCT00254293|449836209|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
125059339|NCT00254293|449836210|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
125138457|NCT00112437|450131212|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
125138458|NCT00112437|450131213|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
125138459|NCT00112437|450131214|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138460|NCT00112437|450131215|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138461|NCT00112437|450131216|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138462|NCT00112437|450131217|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138463|NCT00112437|450131218|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138464|NCT00112437|450131219|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138465|NCT00112437|450131220|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138466|NCT00112437|450131221|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138467|NCT00112437|450131222|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138468|NCT00112437|450131223|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138469|NCT00112437|450131224|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138470|NCT00112437|450131225|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138471|NCT00112437|450131226|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138472|NCT00112437|450131227|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138473|NCT00112437|450131228|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138474|NCT00112437|450131229|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138475|NCT00112437|450131204|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138476|NCT00112437|450131205|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138477|NCT00112437|450131206|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138478|NCT00112437|450131207|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138479|NCT00112437|450131208|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138480|NCT00112437|450131209|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138481|NCT00112437|450131210|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138482|NCT00112437|450131211|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138483|NCT00112437|450131212|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138484|NCT00112437|450131213|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
125138485|NCT00112437|450131214|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138486|NCT00112437|450131215|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138487|NCT00112437|450131216|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138488|NCT00112437|450131217|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138489|NCT00112437|450131218|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138490|NCT00112437|450131219|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138491|NCT00112437|450131220|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138492|NCT00112437|450131221|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138493|NCT00112437|450131222|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138494|NCT00112437|450131223|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138495|NCT00112437|450131224|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138496|NCT00112437|450131225|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138497|NCT00112437|450131226|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138498|NCT00112437|450131227|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138499|NCT00112437|450131228|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138500|NCT00112437|450131229|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138501|NCT00112437|450131204|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138502|NCT00112437|450131205|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138503|NCT00112437|450131206|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138504|NCT00112437|450131207|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138505|NCT00112437|450131208|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138506|NCT00112437|450131209|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138507|NCT00112437|450131210|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138508|NCT00112437|450131211|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138509|NCT00112437|450131212|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138510|NCT00112437|450131213|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
125138511|NCT00112437|450131214|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138512|NCT00112437|450131215|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138513|NCT00112437|450131216|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138514|NCT00112437|450131217|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138515|NCT00112437|450131218|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138516|NCT00112437|450131219|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138517|NCT00112437|450131220|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138518|NCT00112437|450131221|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138519|NCT00112437|450131222|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138520|NCT00112437|450131223|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138521|NCT00112437|450131224|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138522|NCT00112437|450131225|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138523|NCT00112437|450131226|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138524|NCT00112437|450131227|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138525|NCT00112437|450131228|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138526|NCT00112437|450131229|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138527|NCT00112437|450131204|FG000|Year 2 (12-Month Extension)|Moved|0|||
125138528|NCT00112437|450131205|FG001|Year 2 (12-Month Extension)|Moved|0|||
125138529|NCT00112437|450131206|FG002|Year 2 (12-Month Extension)|Moved|0|||
125138530|NCT00112437|450131207|FG003|Year 2 (12-Month Extension)|Moved|0|||
125138531|NCT00112437|450131208|FG004|Year 2 (12-Month Extension)|Moved|0|||
125138532|NCT00112437|450131209|FG005|Year 2 (12-Month Extension)|Moved|0|||
125138533|NCT00112437|450131210|FG006|Year 2 (12-Month Extension)|Moved|0|||
125138534|NCT00112437|450131211|FG007|Year 2 (12-Month Extension)|Moved|0|||
125138535|NCT00112437|450131212|FG008|Year 2 (12-Month Extension)|Moved|0|||
125138536|NCT00112437|450131213|FG009|Year 2 (12-Month Extension)|Moved|1|||
125138537|NCT00112437|450131214|FG010|Year 2 (12-Month Extension)|Moved|0|||
125138538|NCT00112437|450131215|FG011|Year 2 (12-Month Extension)|Moved|0|||
125138539|NCT00112437|450131216|FG012|Year 2 (12-Month Extension)|Moved|0|||
125138540|NCT00112437|450131217|FG013|Year 2 (12-Month Extension)|Moved|0|||
125138541|NCT00112437|450131218|FG014|Year 2 (12-Month Extension)|Moved|0|||
125138542|NCT00112437|450131219|FG015|Year 2 (12-Month Extension)|Moved|0|||
125138543|NCT00112437|450131220|FG016|Year 2 (12-Month Extension)|Moved|0|||
125138544|NCT00112437|450131221|FG017|Year 2 (12-Month Extension)|Moved|0|||
125138545|NCT00112437|450131222|FG018|Year 2 (12-Month Extension)|Moved|0|||
125138546|NCT00112437|450131223|FG019|Year 2 (12-Month Extension)|Moved|0|||
125138547|NCT00112437|450131224|FG020|Year 2 (12-Month Extension)|Moved|0|||
125138548|NCT00112437|450131225|FG021|Year 2 (12-Month Extension)|Moved|0|||
125138549|NCT00112437|450131226|FG022|Year 2 (12-Month Extension)|Moved|0|||
125138550|NCT00112437|450131227|FG023|Year 2 (12-Month Extension)|Moved|0|||
125138551|NCT00112437|450131228|FG024|Year 2 (12-Month Extension)|Moved|0|||
125138552|NCT00112437|450131229|FG025|Year 2 (12-Month Extension)|Moved|0|||
125138553|NCT00112437|450131204|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
125138554|NCT00112437|450131205|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
125138555|NCT00112437|450131206|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
125138556|NCT00112437|450131207|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
125138557|NCT00112437|450131208|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
125138558|NCT00112437|450131209|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
125138559|NCT00112437|450131210|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
125138560|NCT00112437|450131211|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
125138561|NCT00112437|450131212|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
125138562|NCT00112437|450131213|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
125138563|NCT00112437|450131214|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
125138564|NCT00112437|450131215|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
125138565|NCT00112437|450131216|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
125138566|NCT00112437|450131217|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
125138567|NCT00112437|450131218|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
125138568|NCT00112437|450131219|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
125138569|NCT00112437|450131220|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
125138570|NCT00112437|450131221|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
125138571|NCT00112437|450131222|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
125138572|NCT00112437|450131223|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
125138573|NCT00112437|450131224|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
125138574|NCT00112437|450131225|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
125138575|NCT00112437|450131226|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
125138576|NCT00112437|450131227|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
125138577|NCT00112437|450131228|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
125138578|NCT00112437|450131229|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
125138579|NCT00112437|450131204|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138580|NCT00112437|450131205|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138581|NCT00112437|450131206|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138582|NCT00112437|450131207|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138583|NCT00112437|450131208|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138584|NCT00112437|450131209|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138585|NCT00112437|450131210|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138586|NCT00112437|450131211|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138587|NCT00112437|450131212|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138588|NCT00112437|450131213|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138589|NCT00112437|450131214|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138590|NCT00112437|450131215|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
125138591|NCT00112437|450131216|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138592|NCT00112437|450131217|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
125138593|NCT00112437|450131218|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138594|NCT00112437|450131219|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
125138595|NCT00112437|450131220|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125221237|NCT00377637|450438280|FG003|Induction Phase|Physician Decision|0|||
125221238|NCT00377637|450438277|FG000|Induction Phase|Sponsor decision|1|||
125221239|NCT00377637|450438278|FG001|Induction Phase|Sponsor decision|2|||
125221240|NCT00377637|450438279|FG002|Induction Phase|Sponsor decision|0|||
125221241|NCT00377637|450438280|FG003|Induction Phase|Sponsor decision|0|||
125221242|NCT00377637|450438277|FG000|Induction Phase|Non-Compliance|1|||
125221243|NCT00377637|450438278|FG001|Induction Phase|Non-Compliance|0|||
125221244|NCT00377637|450438279|FG002|Induction Phase|Non-Compliance|0|||
125221245|NCT00377637|450438280|FG003|Induction Phase|Non-Compliance|0|||
125221246|NCT00377637|450438277|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
125221247|NCT00377637|450438278|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
125221248|NCT00377637|450438279|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
125221249|NCT00377637|450438280|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
125221250|NCT00377637|450438277|FG000|Maintenance Phase|Adverse Event|0|||
125221251|NCT00377637|450438278|FG001|Maintenance Phase|Adverse Event|0|||
125221252|NCT00377637|450438279|FG002|Maintenance Phase|Adverse Event|29|||
125221253|NCT00377637|450438280|FG003|Maintenance Phase|Adverse Event|43|||
125221254|NCT00377637|450438277|FG000|Maintenance Phase|Physician Decision|0|||
125221255|NCT00377637|450438278|FG001|Maintenance Phase|Physician Decision|0|||
125221256|NCT00377637|450438279|FG002|Maintenance Phase|Physician Decision|5|||
125221257|NCT00377637|450438280|FG003|Maintenance Phase|Physician Decision|4|||
125221258|NCT00377637|450438277|FG000|Maintenance Phase|Lost to Follow-up|0|||
125221259|NCT00377637|450438278|FG001|Maintenance Phase|Lost to Follow-up|0|||
125221260|NCT00377637|450438279|FG002|Maintenance Phase|Lost to Follow-up|3|||
125221261|NCT00377637|450438280|FG003|Maintenance Phase|Lost to Follow-up|1|||
125221262|NCT00377637|450438277|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125221263|NCT00377637|450438278|FG001|Maintenance Phase|Withdrawal by Subject|0|||
125221264|NCT00377637|450438279|FG002|Maintenance Phase|Withdrawal by Subject|3|||
125221265|NCT00377637|450438280|FG003|Maintenance Phase|Withdrawal by Subject|3|||
125221266|NCT00377637|450438277|FG000|Maintenance Phase|Sponsor decision|0|||
125221267|NCT00377637|450438278|FG001|Maintenance Phase|Sponsor decision|0|||
125221268|NCT00377637|450438279|FG002|Maintenance Phase|Sponsor decision|2|||
125221269|NCT00377637|450438280|FG003|Maintenance Phase|Sponsor decision|3|||
125221270|NCT00377637|450438277|FG000|Maintenance Phase|Non-compliance|0|||
125221271|NCT00377637|450438278|FG001|Maintenance Phase|Non-compliance|0|||
125221272|NCT00377637|450438279|FG002|Maintenance Phase|Non-compliance|1|||
125221273|NCT00377637|450438280|FG003|Maintenance Phase|Non-compliance|1|||
125221274|NCT00377637|450438277|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
125221275|NCT00377637|450438278|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
125221276|NCT00377637|450438279|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
125221277|NCT00377637|450438280|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
125221278|NCT00377637|450438277|FG000|Maintenance Phase|Death|0|||
125221279|NCT00377637|450438278|FG001|Maintenance Phase|Death|0|||
125221280|NCT00377637|450438279|FG002|Maintenance Phase|Death|0|||
125221281|NCT00377637|450438280|FG003|Maintenance Phase|Death|1|||
125221282|NCT01111565|450438282|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
125221283|NCT01111565|450438283|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
125221284|NCT01111565|450438284|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
125221285|NCT01111565|450438285|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
125221286|NCT01111565|450438286|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
125221287|NCT01111565|450438282|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
125221288|NCT01111565|450438283|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
125221289|NCT01111565|450438284|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
125221290|NCT01111565|450438285|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
125221291|NCT01111565|450438286|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
125221292|NCT01111565|450438282|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
125221293|NCT01111565|450438283|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
125221294|NCT01111565|450438284|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
125221295|NCT01111565|450438285|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
125221296|NCT01111565|450438286|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
125221297|NCT01111565|450438282|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
125221298|NCT01111565|450438283|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
125221299|NCT01111565|450438284|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
125221300|NCT01111565|450438285|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
125221301|NCT01111565|450438286|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
125221302|NCT01111565|450438282|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
125221303|NCT01111565|450438283|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
125221304|NCT01111565|450438284|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
125221305|NCT01111565|450438285|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
125221306|NCT01111565|450438286|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
125221307|NCT01111565|450438282|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
125221308|NCT01111565|450438283|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
125221309|NCT01111565|450438284|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
125221310|NCT01111565|450438285|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
125221311|NCT01111565|450438286|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
125221312|NCT01111565|450438282|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
125221313|NCT01111565|450438283|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
125221314|NCT01111565|450438284|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
125221315|NCT01111565|450438285|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
125221316|NCT01111565|450438286|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
125221317|NCT01111565|450438282|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
125221318|NCT01111565|450438283|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
125221319|NCT01111565|450438284|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
125221320|NCT01111565|450438285|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
125221321|NCT01111565|450438286|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
125221322|NCT01111565|450438282|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125221323|NCT01111565|450438283|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125221324|NCT01111565|450438284|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
125059340|NCT00254293|449836211|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
125059341|NCT00254293|449836212|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
125059342|NCT00254293|449836213|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
125059343|NCT00254293|449836214|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
125059344|NCT00254293|449836208|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
125059345|NCT00254293|449836209|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
125059346|NCT00254293|449836210|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
125059347|NCT00254293|449836211|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
125059348|NCT00254293|449836212|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
125059349|NCT00254293|449836213|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
125059350|NCT00254293|449836214|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
125059351|NCT00254293|449836208|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
125059352|NCT00254293|449836209|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
125059353|NCT00254293|449836210|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
125059354|NCT00254293|449836211|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
125059355|NCT00254293|449836212|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
125221325|NCT01111565|450438285|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125221326|NCT01111565|450438286|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125221327|NCT01111565|450438282|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
125221328|NCT01111565|450438283|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
125221329|NCT01111565|450438284|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
125221330|NCT01111565|450438285|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
125221331|NCT01111565|450438286|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
125221332|NCT01111565|450438282|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
125221333|NCT01111565|450438283|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
125221334|NCT01111565|450438284|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
125221335|NCT01111565|450438285|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
125221336|NCT01111565|450438286|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
125221337|NCT01111565|450438282|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
125221338|NCT01111565|450438283|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
125221339|NCT01111565|450438284|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
125221340|NCT01111565|450438285|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
125221341|NCT01111565|450438286|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
125221342|NCT00368108|450438287|FG000|Overall Study|Adverse Event|38|||
125221343|NCT00368108|450438288|FG001|Overall Study|Adverse Event|26|||
125221344|NCT00368108|450438289|FG002|Overall Study|Adverse Event|44|||
125221345|NCT00368108|450438287|FG000|Overall Study|Abnormal Laboratory Value|0|||
125221346|NCT00368108|450438288|FG001|Overall Study|Abnormal Laboratory Value|0|||
125221347|NCT00368108|450438289|FG002|Overall Study|Abnormal Laboratory Value|3|||
125221348|NCT00368108|450438287|FG000|Overall Study|Protocol Violation|5|||
125221349|NCT00368108|450438288|FG001|Overall Study|Protocol Violation|9|||
125221350|NCT00368108|450438289|FG002|Overall Study|Protocol Violation|9|||
125221351|NCT00368108|450438287|FG000|Overall Study|Withdrawal by Subject|9|||
125221352|NCT00368108|450438288|FG001|Overall Study|Withdrawal by Subject|3|||
125221353|NCT00368108|450438289|FG002|Overall Study|Withdrawal by Subject|5|||
125221354|NCT00368108|450438287|FG000|Overall Study|Lack of Efficacy|7|||
125221355|NCT00368108|450438288|FG001|Overall Study|Lack of Efficacy|8|||
125221356|NCT00368108|450438289|FG002|Overall Study|Lack of Efficacy|5|||
125221357|NCT00368108|450438287|FG000|Overall Study|Physician Decision|2|||
125221358|NCT00368108|450438288|FG001|Overall Study|Physician Decision|0|||
125221359|NCT00368108|450438289|FG002|Overall Study|Physician Decision|1|||
125221360|NCT00368108|450438287|FG000|Overall Study|Other|3|||
125138596|NCT00112437|450131221|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125221361|NCT00368108|450438288|FG001|Overall Study|Other|7|||
125138597|NCT00112437|450131222|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
125138598|NCT00112437|450131223|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138599|NCT00112437|450131224|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125221362|NCT00368108|450438289|FG002|Overall Study|Other|1|||
125221363|NCT01089127|450438312|FG000|Overall Study|Adverse Event|5|||
125221364|NCT01089127|450438313|FG001|Overall Study|Adverse Event|1|||
125221365|NCT01089127|450438314|FG002|Overall Study|Adverse Event|1|||
125221366|NCT01089127|450438315|FG003|Overall Study|Adverse Event|0|||
125221367|NCT01089127|450438316|FG004|Overall Study|Adverse Event|0|||
125221368|NCT01089127|450438317|FG005|Overall Study|Adverse Event|1|||
125221369|NCT01089127|450438312|FG000|Overall Study|Subject withdrew consent|0|||
125221370|NCT01089127|450438313|FG001|Overall Study|Subject withdrew consent|1|||
125221371|NCT01089127|450438314|FG002|Overall Study|Subject withdrew consent|1|||
125221372|NCT01089127|450438315|FG003|Overall Study|Subject withdrew consent|1|||
125221373|NCT01089127|450438316|FG004|Overall Study|Subject withdrew consent|0|||
125221374|NCT01089127|450438317|FG005|Overall Study|Subject withdrew consent|2|||
125221375|NCT01089127|450438312|FG000|Overall Study|Abnormal test procedure result(s)|2|||
125221376|NCT01089127|450438313|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125221377|NCT01089127|450438314|FG002|Overall Study|Abnormal test procedure result(s)|0|||
125221378|NCT01089127|450438315|FG003|Overall Study|Abnormal test procedure result(s)|0|||
125221379|NCT01089127|450438316|FG004|Overall Study|Abnormal test procedure result(s)|0|||
125221380|NCT01089127|450438317|FG005|Overall Study|Abnormal test procedure result(s)|0|||
125221381|NCT01089127|450438312|FG000|Overall Study|Lost to Follow-up|1|||
125221382|NCT01089127|450438313|FG001|Overall Study|Lost to Follow-up|1|||
125221383|NCT01089127|450438314|FG002|Overall Study|Lost to Follow-up|0|||
125221384|NCT01089127|450438315|FG003|Overall Study|Lost to Follow-up|0|||
125221385|NCT01089127|450438316|FG004|Overall Study|Lost to Follow-up|1|||
125221386|NCT01089127|450438317|FG005|Overall Study|Lost to Follow-up|0|||
125059356|NCT00254293|449836213|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
125059357|NCT00254293|449836214|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
125059358|NCT00254293|449836208|FG000|LTE Open Label Variable SC Dosing|Other|0|||
125059359|NCT00254293|449836209|FG001|LTE Open Label Variable SC Dosing|Other|0|||
125059360|NCT00254293|449836210|FG002|LTE Open Label Variable SC Dosing|Other|2|||
125059361|NCT00254293|449836211|FG003|LTE Open Label Variable SC Dosing|Other|0|||
125059362|NCT00254293|449836212|FG004|LTE Open Label Variable SC Dosing|Other|0|||
125059363|NCT00254293|449836213|FG005|LTE Open Label Variable SC Dosing|Other|0|||
125059364|NCT00254293|449836214|FG006|LTE Open Label Variable SC Dosing|Other|0|||
125059365|NCT00254293|449836208|FG000|LTE Open Label Fixed Dosing|Death|0|||
125059366|NCT00254293|449836209|FG001|LTE Open Label Fixed Dosing|Death|0|||
125059367|NCT00254293|449836210|FG002|LTE Open Label Fixed Dosing|Death|0|||
125059368|NCT00254293|449836211|FG003|LTE Open Label Fixed Dosing|Death|0|||
125059369|NCT00254293|449836212|FG004|LTE Open Label Fixed Dosing|Death|0|||
125059370|NCT00254293|449836213|FG005|LTE Open Label Fixed Dosing|Death|0|||
125059371|NCT00254293|449836214|FG006|LTE Open Label Fixed Dosing|Death|3|||
125059372|NCT00254293|449836208|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
125059373|NCT00254293|449836209|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
125059374|NCT00254293|449836210|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
125059375|NCT00254293|449836211|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
125059376|NCT00254293|449836212|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
125138600|NCT00112437|450131225|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138601|NCT00112437|450131226|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138602|NCT00112437|450131227|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138603|NCT00112437|450131228|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138604|NCT00112437|450131229|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138605|NCT00112437|450131204|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138606|NCT00112437|450131205|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138607|NCT00112437|450131206|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138608|NCT00112437|450131207|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138609|NCT00112437|450131208|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138610|NCT00112437|450131209|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125059377|NCT00254293|449836213|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
125059378|NCT00254293|449836214|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
125221387|NCT01089127|450438312|FG000|Overall Study|Protocol deviation|0|||
125059379|NCT00254293|449836208|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
125221388|NCT01089127|450438313|FG001|Overall Study|Protocol deviation|1|||
125221389|NCT01089127|450438314|FG002|Overall Study|Protocol deviation|0|||
125221390|NCT01089127|450438315|FG003|Overall Study|Protocol deviation|0|||
125221391|NCT01089127|450438316|FG004|Overall Study|Protocol deviation|1|||
125221392|NCT01089127|450438317|FG005|Overall Study|Protocol deviation|0|||
125221393|NCT03200548|450438318|FG000|Overall Study|Withdrawal by Subject|5|||
125221394|NCT03200548|450438319|FG001|Overall Study|Withdrawal by Subject|11|||
125059380|NCT00254293|449836209|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
125059381|NCT00254293|449836210|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
125221395|NCT03200548|450438320|FG002|Overall Study|Withdrawal by Subject|7|||
125221396|NCT03200548|450438321|FG003|Overall Study|Withdrawal by Subject|6|||
125221397|NCT03257436|450438324|FG000|Overall Study|Withdrawal by Subject|76|||
125059382|NCT00254293|449836211|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
125059383|NCT00254293|449836212|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
125059384|NCT00254293|449836213|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
125059385|NCT00254293|449836214|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
125059386|NCT00254293|449836208|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
125221398|NCT03257436|450438324|FG000|Overall Study|Death|19|||
125221399|NCT03874013|450438333|FG000|Overall Study|Adverse Event|0|||
125221400|NCT03874013|450438334|FG001|Overall Study|Adverse Event|1|||
125221401|NCT06060496|450438337|FG000|Overall Study|Withdrawal by Subject|2|||
125221402|NCT06060496|450438337|FG000|Overall Study|Lost to Follow-up|2|||
125221403|NCT03990051|450438338|FG000|Masked Period|Lost to Follow-up|1|||
125221404|NCT03990051|450438339|FG001|Masked Period|Lost to Follow-up|0|||
125221405|NCT03990051|450438338|FG000|Long Term Period|Death|1|||
125221406|NCT03990051|450438339|FG001|Long Term Period|Death|1|||
125221407|NCT03990051|450438338|FG000|Long Term Period|Lost to Follow-up|7|||
125221408|NCT03990051|450438339|FG001|Long Term Period|Lost to Follow-up|2|||
125221409|NCT01411852|450438340|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
125221410|NCT01411852|450438341|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
125221411|NCT01411852|450438340|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
125221412|NCT01411852|450438341|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
125221413|NCT01411852|450438340|FG000|Prehospital Intervention Phase|Found to be under age|0|||
125221414|NCT01411852|450438341|FG001|Prehospital Intervention Phase|Found to be under age|1|||
125221415|NCT01411852|450438340|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
125221416|NCT01411852|450438341|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
125221417|NCT01411852|450438340|FG000|Hospital Intervention Phase|Severe head injury|5|||
125221418|NCT01411852|450438341|FG001|Hospital Intervention Phase|Severe head injury|4|||
125221419|NCT01411852|450438340|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
125221420|NCT01411852|450438341|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
125221421|NCT01411852|450438340|FG000|Hospital Intervention Phase|Miscommunication error|1|||
125221422|NCT01411852|450438341|FG001|Hospital Intervention Phase|Miscommunication error|2|||
125221423|NCT01411852|450438340|FG000|Hospital Intervention Phase|CPR administered|3|||
125221424|NCT01411852|450438341|FG001|Hospital Intervention Phase|CPR administered|1|||
125221425|NCT01411852|450438340|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
125221426|NCT01411852|450438341|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
125221427|NCT01411852|450438340|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
125221428|NCT01411852|450438341|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
125221429|NCT01411852|450438340|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
125221430|NCT01411852|450438341|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
125221431|NCT01411852|450438340|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
125221432|NCT01411852|450438341|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
125221433|NCT01411852|450438340|FG000|Hospital Intervention Phase|Other ineligible|2|||
125221434|NCT01411852|450438341|FG001|Hospital Intervention Phase|Other ineligible|2|||
125221435|NCT01411852|450438340|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
125221436|NCT01411852|450438341|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
125221437|NCT01411852|450438340|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
125221438|NCT01411852|450438341|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
125221439|NCT01411852|450438340|FG000|Hospital Intervention Phase|Vascular access failed|1|||
125221440|NCT01411852|450438341|FG001|Hospital Intervention Phase|Vascular access failed|0|||
125221441|NCT03126786|450438346|FG000|Overall Study|Adverse Event|3|||
125221442|NCT03126786|450438347|FG001|Overall Study|Adverse Event|0|||
125221443|NCT03126786|450438346|FG000|Overall Study|Lost to Follow-up|0|||
125221444|NCT03126786|450438347|FG001|Overall Study|Lost to Follow-up|1|||
125221445|NCT03126786|450438346|FG000|Overall Study|Withdrawal by Subject|3|||
125221446|NCT03126786|450438347|FG001|Overall Study|Withdrawal by Subject|1|||
125221447|NCT00991289|450438348|FG000|Overall Study|Adverse Event|1|||
125221448|NCT00991289|450438348|FG000|Overall Study|Physician Decision|2|||
125221449|NCT00991289|450438348|FG000|Overall Study|Withdrawal by Subject|3|||
125221450|NCT00991289|450438348|FG000|Overall Study|Lost to Follow-up|4|||
125221451|NCT00991289|450438348|FG000|Overall Study|Protocol Violation|2|||
125221452|NCT00379899|450438349|FG000|Overall Study|Adverse Event|7|||
125221453|NCT00379899|450438350|FG001|Overall Study|Adverse Event|3|||
125221454|NCT00379899|450438349|FG000|Overall Study|Death|10|||
125221455|NCT00379899|450438350|FG001|Overall Study|Death|10|||
125221456|NCT00379899|450438349|FG000|Overall Study|Lost to Follow-up|2|||
125221457|NCT00379899|450438350|FG001|Overall Study|Lost to Follow-up|4|||
125221458|NCT00379899|450438349|FG000|Overall Study|Physician Decision|3|||
125221459|NCT00379899|450438350|FG001|Overall Study|Physician Decision|4|||
125059387|NCT00254293|449836209|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
125059388|NCT00254293|449836210|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
125059389|NCT00254293|449836211|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
125059390|NCT00254293|449836212|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
125221460|NCT00379899|450438349|FG000|Overall Study|Withdrawal by Subject|5|||
125221461|NCT00379899|450438350|FG001|Overall Study|Withdrawal by Subject|5|||
125059391|NCT00254293|449836213|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
125059392|NCT00254293|449836214|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
125059393|NCT00254293|449836208|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
125059394|NCT00254293|449836209|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
125059395|NCT00254293|449836210|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
125059396|NCT00254293|449836211|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
125059397|NCT00254293|449836212|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
125059398|NCT00254293|449836213|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
125059399|NCT00254293|449836214|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
125059400|NCT00254293|449836208|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
125059401|NCT00254293|449836209|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
125059402|NCT00254293|449836210|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
125059403|NCT00254293|449836211|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
125059404|NCT00254293|449836212|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
125059405|NCT00254293|449836213|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
125221462|NCT00379899|450438349|FG000|Overall Study|Ineligibility determined|0|||
125221463|NCT00379899|450438350|FG001|Overall Study|Ineligibility determined|1|||
125221464|NCT00379899|450438349|FG000|Overall Study|Noncompliance|1|||
125221465|NCT00379899|450438350|FG001|Overall Study|Noncompliance|1|||
125221466|NCT00379899|450438349|FG000|Overall Study|Parathyroidectomy|0|||
125059406|NCT00254293|449836214|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
125059407|NCT00254293|449836208|FG000|LTE Open Label Fixed Dosing|Other|0|||
125059408|NCT00254293|449836209|FG001|LTE Open Label Fixed Dosing|Other|0|||
125059409|NCT00254293|449836210|FG002|LTE Open Label Fixed Dosing|Other|0|||
125059410|NCT00254293|449836211|FG003|LTE Open Label Fixed Dosing|Other|0|||
125059411|NCT00254293|449836212|FG004|LTE Open Label Fixed Dosing|Other|0|||
125059412|NCT00254293|449836213|FG005|LTE Open Label Fixed Dosing|Other|0|||
125059413|NCT00254293|449836214|FG006|LTE Open Label Fixed Dosing|Other|1|||
125059414|NCT04031404|449836216|FG000|Baseline|Lost to Follow-up|0|||
125059415|NCT04031404|449836217|FG001|Baseline|Lost to Follow-up|1|||
125059416|NCT04031404|449836216|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
125059417|NCT04031404|449836217|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
125059418|NCT04031404|449836216|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
125059419|NCT04031404|449836217|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
125059420|NCT04031404|449836216|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
125059421|NCT04031404|449836217|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
125059422|NCT04031404|449836216|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
125059423|NCT04031404|449836217|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
125059424|NCT01626352|449836218|FG000|Overall Study|Disease Progression|3|||
125059425|NCT01626352|449836218|FG000|Overall Study|Intercurrent Illness|2|||
125059426|NCT01626352|449836218|FG000|Overall Study|Death|2|||
125059427|NCT01626352|449836218|FG000|Overall Study|Withdrawal by Subject|1|||
125059428|NCT01626352|449836218|FG000|Overall Study|Non-Compliance|1|||
125059429|NCT01626352|449836218|FG000|Overall Study|Never Treated|1|||
125059430|NCT02796391|449836219|FG000|Overall Study|Lost to Follow-up|2|||
125059431|NCT02796391|449836220|FG001|Overall Study|Lost to Follow-up|2|||
125059432|NCT02796391|449836221|FG002|Overall Study|Lost to Follow-up|13|||
125059433|NCT02796391|449836222|FG003|Overall Study|Lost to Follow-up|8|||
125059434|NCT02796391|449836223|FG004|Overall Study|Lost to Follow-up|14|||
125059435|NCT02796391|449836224|FG005|Overall Study|Lost to Follow-up|13|||
125059436|NCT02796391|449836219|FG000|Overall Study|COVID|0|||
125059437|NCT02796391|449836220|FG001|Overall Study|COVID|0|||
125059438|NCT02796391|449836221|FG002|Overall Study|COVID|5|||
125059439|NCT02796391|449836222|FG003|Overall Study|COVID|5|||
125059440|NCT02796391|449836223|FG004|Overall Study|COVID|2|||
125059441|NCT02796391|449836224|FG005|Overall Study|COVID|4|||
125059442|NCT02796391|449836219|FG000|Overall Study|Participant did not like study cigarettes|0|||
125059443|NCT02796391|449836220|FG001|Overall Study|Participant did not like study cigarettes|0|||
125059444|NCT02796391|449836221|FG002|Overall Study|Participant did not like study cigarettes|3|||
125059445|NCT02796391|449836222|FG003|Overall Study|Participant did not like study cigarettes|0|||
125059446|NCT02796391|449836223|FG004|Overall Study|Participant did not like study cigarettes|0|||
125059447|NCT02796391|449836224|FG005|Overall Study|Participant did not like study cigarettes|0|||
125059448|NCT02796391|449836219|FG000|Overall Study|Withdrawal by Subject|1|||
125059449|NCT02796391|449836220|FG001|Overall Study|Withdrawal by Subject|1|||
125059450|NCT02796391|449836221|FG002|Overall Study|Withdrawal by Subject|4|||
125059451|NCT02796391|449836222|FG003|Overall Study|Withdrawal by Subject|3|||
125059452|NCT02796391|449836223|FG004|Overall Study|Withdrawal by Subject|4|||
125059453|NCT02796391|449836224|FG005|Overall Study|Withdrawal by Subject|3|||
125059454|NCT02796391|449836219|FG000|Overall Study|Adverse Event|0|||
125059455|NCT02796391|449836220|FG001|Overall Study|Adverse Event|0|||
125059456|NCT02796391|449836221|FG002|Overall Study|Adverse Event|0|||
125059457|NCT02796391|449836222|FG003|Overall Study|Adverse Event|1|||
125059458|NCT02796391|449836223|FG004|Overall Study|Adverse Event|0|||
125059459|NCT02796391|449836224|FG005|Overall Study|Adverse Event|0|||
125059460|NCT02796391|449836219|FG000|Overall Study|Protocol Violation|0|||
125059461|NCT02796391|449836220|FG001|Overall Study|Protocol Violation|0|||
125059462|NCT02796391|449836221|FG002|Overall Study|Protocol Violation|0|||
125059463|NCT02796391|449836222|FG003|Overall Study|Protocol Violation|1|||
125059464|NCT02796391|449836223|FG004|Overall Study|Protocol Violation|0|||
125059465|NCT02796391|449836224|FG005|Overall Study|Protocol Violation|0|||
125059466|NCT05674344|449836225|FG000|Overall Study|Screen Fail|21|||
125059467|NCT05674344|449836225|FG000|Overall Study|Incomplete study procedures|3|||
125059468|NCT00798655|449836226|FG000|Overall Study|Did not receive at least one dose of pan|2|||
125059469|NCT00960934|449836227|FG000|Overall Study|Adverse Event|2|||
125059470|NCT00960934|449836228|FG001|Overall Study|Adverse Event|3|||
125059471|NCT00960934|449836229|FG002|Overall Study|Adverse Event|3|||
125059472|NCT00960934|449836230|FG003|Overall Study|Adverse Event|2|||
125059473|NCT00960934|449836231|FG004|Overall Study|Adverse Event|4|||
125059474|NCT00960934|449836232|FG005|Overall Study|Adverse Event|3|||
125059475|NCT00960934|449836227|FG000|Overall Study|Lack of Efficacy|1|||
125059476|NCT00960934|449836228|FG001|Overall Study|Lack of Efficacy|0|||
125059477|NCT00960934|449836229|FG002|Overall Study|Lack of Efficacy|0|||
125059478|NCT00960934|449836230|FG003|Overall Study|Lack of Efficacy|0|||
125059479|NCT00960934|449836231|FG004|Overall Study|Lack of Efficacy|0|||
125059480|NCT00960934|449836232|FG005|Overall Study|Lack of Efficacy|0|||
125059481|NCT00960934|449836227|FG000|Overall Study|Lost to Follow-up|0|||
125059482|NCT00960934|449836228|FG001|Overall Study|Lost to Follow-up|1|||
125059483|NCT00960934|449836229|FG002|Overall Study|Lost to Follow-up|0|||
125138611|NCT00112437|450131210|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138612|NCT00112437|450131211|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138613|NCT00112437|450131212|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138614|NCT00112437|450131213|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138615|NCT00112437|450131214|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138616|NCT00112437|450131215|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138617|NCT00112437|450131216|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138618|NCT00112437|450131217|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138619|NCT00112437|450131218|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138620|NCT00112437|450131219|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
125138621|NCT00112437|450131220|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138622|NCT00112437|450131221|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138623|NCT00112437|450131222|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138624|NCT00112437|450131223|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138625|NCT00112437|450131224|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138626|NCT00112437|450131225|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138627|NCT00112437|450131226|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138628|NCT00112437|450131227|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138629|NCT00112437|450131228|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125059484|NCT00960934|449836230|FG003|Overall Study|Lost to Follow-up|0|||
125059485|NCT00960934|449836231|FG004|Overall Study|Lost to Follow-up|0|||
125059486|NCT00960934|449836232|FG005|Overall Study|Lost to Follow-up|0|||
125059487|NCT00960934|449836227|FG000|Overall Study|Other|2|||
125059488|NCT00960934|449836228|FG001|Overall Study|Other|1|||
125059489|NCT00960934|449836229|FG002|Overall Study|Other|5|||
125059490|NCT00960934|449836230|FG003|Overall Study|Other|4|||
125059491|NCT00960934|449836231|FG004|Overall Study|Other|2|||
125059492|NCT00960934|449836232|FG005|Overall Study|Other|2|||
125059493|NCT00960934|449836227|FG000|Overall Study|Physician Decision|0|||
125059494|NCT00960934|449836228|FG001|Overall Study|Physician Decision|1|||
125059495|NCT00960934|449836229|FG002|Overall Study|Physician Decision|0|||
125138630|NCT00112437|450131229|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125059496|NCT00960934|449836230|FG003|Overall Study|Physician Decision|0|||
125138631|NCT00112437|450131204|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138632|NCT00112437|450131205|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138633|NCT00112437|450131206|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
125059497|NCT00960934|449836231|FG004|Overall Study|Physician Decision|0|||
125221467|NCT00379899|450438350|FG001|Overall Study|Parathyroidectomy|2|||
125221468|NCT00379899|450438349|FG000|Overall Study|Renal transplantation|5|||
125221469|NCT00379899|450438350|FG001|Overall Study|Renal transplantation|4|||
125221470|NCT00379899|450438349|FG000|Overall Study|Coronary artery bypass graft|1|||
125221471|NCT00379899|450438350|FG001|Overall Study|Coronary artery bypass graft|1|||
125221472|NCT00379899|450438349|FG000|Overall Study|Other protocol-specified criteria|3|||
125221473|NCT00379899|450438350|FG001|Overall Study|Other protocol-specified criteria|4|||
125221474|NCT00379899|450438349|FG000|Overall Study|Other|3|||
125221475|NCT00379899|450438350|FG001|Overall Study|Other|1|||
125221476|NCT02716779|450438353|FG000|Monotherapy|Adverse Event|0|||
125221477|NCT02716779|450438354|FG001|Monotherapy|Adverse Event|1|||
125221478|NCT02716779|450438355|FG002|Monotherapy|Adverse Event|1|||
125221479|NCT02716779|450438353|FG000|Combination Therapy|Adverse Event|0|||
125221480|NCT02716779|450438354|FG001|Combination Therapy|Adverse Event|2|||
125221481|NCT02716779|450438355|FG002|Combination Therapy|Adverse Event|1|||
125221482|NCT01051817|450438363|FG000|Overall Study|Adverse Event|0|||
125221483|NCT01051817|450438364|FG001|Overall Study|Adverse Event|2|||
125221484|NCT01051817|450438363|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
125221485|NCT01051817|450438364|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
125221486|NCT01051817|450438363|FG000|Overall Study|Withdrawal by Subject|3|||
125221487|NCT01051817|450438364|FG001|Overall Study|Withdrawal by Subject|5|||
125221488|NCT01051817|450438363|FG000|Overall Study|Protocol Violation|0|||
125221489|NCT01051817|450438364|FG001|Overall Study|Protocol Violation|1|||
125221490|NCT01026948|450438365|FG000|Overall Study|Physician Decision|8|||
125221491|NCT00672633|450438367|FG000|Overall Study|Withdrawal by Subject|0|||
125221492|NCT00672633|450438368|FG001|Overall Study|Withdrawal by Subject|1|||
125221493|NCT02824627|450438369|FG000|Overall Study|Adverse Event|1|||
125221494|NCT02824627|450438370|FG001|Overall Study|Adverse Event|2|||
125221495|NCT02824627|450438369|FG000|Overall Study|Lost to Follow-up|2|||
125221496|NCT02824627|450438370|FG001|Overall Study|Lost to Follow-up|1|||
125221497|NCT00571662|450438380|FG000|Overall Study|Withdrawal by Subject|2|||
125221498|NCT00571662|450438380|FG000|Overall Study|psychiatric instability|1|||
125221499|NCT00571662|450438380|FG000|Overall Study|Adverse Event|5|||
125221500|NCT01839916|450438381|FG000|Overall Study|Death|9|||
125221501|NCT01839916|450438381|FG000|Overall Study|Physician Decision|17|||
125221502|NCT01839916|450438381|FG000|Overall Study|Relapse|12|||
125221503|NCT01839916|450438381|FG000|Overall Study|GVHD|2|||
125221504|NCT01839916|450438381|FG000|Overall Study|Graft Failure|1|||
125221505|NCT04235504|450438384|FG000|Study Phase|Withdrawal by Subject|5|||
125221506|NCT04235504|450438385|FG001|Study Phase|Withdrawal by Subject|2|||
125221507|NCT04235504|450438386|FG002|Study Phase|Withdrawal by Subject|0|||
125221508|NCT04235504|450438387|FG003|Study Phase|Withdrawal by Subject|0|||
125221509|NCT04235504|450438384|FG000|Continuation Phase|Withdrawal by Subject|0|||
125221510|NCT04235504|450438385|FG001|Continuation Phase|Withdrawal by Subject|4|||
125221511|NCT04235504|450438386|FG002|Continuation Phase|Withdrawal by Subject|0|||
125221512|NCT04235504|450438387|FG003|Continuation Phase|Withdrawal by Subject|0|||
125221513|NCT04235504|450438384|FG000|Continuation Phase|Adverse Event|0|||
125221514|NCT04235504|450438385|FG001|Continuation Phase|Adverse Event|1|||
125221515|NCT04235504|450438386|FG002|Continuation Phase|Adverse Event|0|||
125221516|NCT04235504|450438387|FG003|Continuation Phase|Adverse Event|0|||
125221517|NCT04235504|450438384|FG000|Continuation Phase|Physician Decision|1|||
125221518|NCT04235504|450438385|FG001|Continuation Phase|Physician Decision|2|||
125221519|NCT04235504|450438386|FG002|Continuation Phase|Physician Decision|1|||
125221520|NCT04235504|450438387|FG003|Continuation Phase|Physician Decision|0|||
125221521|NCT00181883|450438388|FG000|Overall Study|Lack of Efficacy|2|||
125221522|NCT00181883|450438388|FG000|Overall Study|Treatment Limiting AEs|3|||
125221523|NCT00181883|450438388|FG000|Overall Study|Withdrawal by Subject|4|||
125221524|NCT00181883|450438388|FG000|Overall Study|Lost to Follow-up|1|||
125221525|NCT00101868|450438389|FG000|Overall Study|Death|10|||
125221526|NCT00101868|450438390|FG001|Overall Study|Death|10|||
125221527|NCT00101868|450438389|FG000|Overall Study|Withdrawal by Subject|8|||
125221528|NCT00101868|450438390|FG001|Overall Study|Withdrawal by Subject|9|||
125221529|NCT00101868|450438389|FG000|Overall Study|Protocol Violation|3|||
125221530|NCT00101868|450438390|FG001|Overall Study|Protocol Violation|0|||
125221531|NCT00101868|450438389|FG000|Overall Study|Lost to Follow-up|8|||
125221532|NCT00101868|450438390|FG001|Overall Study|Lost to Follow-up|13|||
125221533|NCT00069823|450438391|FG000|Overall Study|Did not have follow-up diary cards|6|||
125221534|NCT00069823|450438392|FG001|Overall Study|Did not have follow-up diary cards|3|||
125221535|NCT02329327|450438395|FG000|Overall Study|Death|78|||
125221536|NCT02329327|450438396|FG001|Overall Study|Death|0|||
125221537|NCT02329327|450438395|FG000|Overall Study|Withdrawal by Subject|3|||
125221538|NCT02329327|450438396|FG001|Overall Study|Withdrawal by Subject|0|||
125221539|NCT02329327|450438395|FG000|Overall Study|Lost to Follow-up|4|||
125221540|NCT02329327|450438396|FG001|Overall Study|Lost to Follow-up|0|||
125221541|NCT03560869|450438397|FG000|Overall Study|Withdrawal by Subject|3|||
125221542|NCT03560869|450438398|FG001|Overall Study|Withdrawal by Subject|4|||
125221543|NCT03560869|450438397|FG000|Overall Study|Screening failure|4|||
125221544|NCT03560869|450438398|FG001|Overall Study|Screening failure|4|||
125221545|NCT03560869|450438397|FG000|Overall Study|Withdrawal by PI|0|||
125221546|NCT03560869|450438398|FG001|Overall Study|Withdrawal by PI|1|||
125221547|NCT01801111|450438399|FG000|Overall Study|Adverse Event|12|||
125221548|NCT01801111|450438399|FG000|Overall Study|Death|8|||
125221549|NCT01801111|450438399|FG000|Overall Study|Physician Decision|5|||
125221550|NCT01801111|450438399|FG000|Overall Study|Other|1|||
125221551|NCT01801111|450438399|FG000|Overall Study|Withdrawal by Subject|4|||
125221552|NCT01801111|450438399|FG000|Overall Study|Study Terminated by Sponsor|27|||
125221553|NCT01801111|450438399|FG000|Overall Study|Progressive Disease|81|||
125221554|NCT01210482|450438400|FG000|Overall Study|Protocol Violation|1|||
125221555|NCT01210482|450438400|FG000|Overall Study|Case Report Forms were not collected|18|||
125221556|NCT01210482|450438400|FG000|Overall Study|Duplicated|2|||
125221557|NCT01210482|450438400|FG000|Overall Study|No Drug Administration|28|||
125221558|NCT01223937|450438401|FG000|Overall Study|Withdrawal by Subject|3|||
125221559|NCT01223937|450438402|FG001|Overall Study|Withdrawal by Subject|2|||
125221560|NCT01223937|450438401|FG000|Overall Study|Lost to Follow-up|1|||
125221561|NCT01223937|450438402|FG001|Overall Study|Lost to Follow-up|4|||
125221562|NCT01223937|450438401|FG000|Overall Study|Adverse Event|1|||
125221563|NCT01223937|450438402|FG001|Overall Study|Adverse Event|4|||
125221564|NCT01223937|450438401|FG000|Overall Study|Protocol Violation|8|||
125221565|NCT01223937|450438402|FG001|Overall Study|Protocol Violation|7|||
125221566|NCT01223937|450438401|FG000|Overall Study|Other|4|||
125221567|NCT01223937|450438402|FG001|Overall Study|Other|1|||
125221568|NCT02058589|450438403|FG000|Overall Study|Serious Adverse Event|1|||
125221569|NCT02058589|450438404|FG001|Overall Study|Serious Adverse Event|1|||
125221570|NCT02058589|450438403|FG000|Overall Study|Non-Serious Adverse Event|1|||
125221571|NCT02058589|450438404|FG001|Overall Study|Non-Serious Adverse Event|0|||
125221572|NCT02058589|450438403|FG000|Overall Study|Withdrawal by Subject|0|||
125059498|NCT00960934|449836232|FG005|Overall Study|Physician Decision|0|||
125221573|NCT02058589|450438404|FG001|Overall Study|Withdrawal by Subject|1|||
125221574|NCT02532283|450438406|FG000|Overall Study|Adverse Event|0|||
125221575|NCT02532283|450438407|FG001|Overall Study|Adverse Event|1|||
125221576|NCT02532283|450438406|FG000|Overall Study|Death|1|||
125221577|NCT02532283|450438407|FG001|Overall Study|Death|0|||
125221578|NCT02532283|450438406|FG000|Overall Study|Lost to Follow-up|0|||
125221579|NCT02532283|450438407|FG001|Overall Study|Lost to Follow-up|1|||
125221580|NCT02532283|450438406|FG000|Overall Study|Withdrawal by Subject|8|||
125221581|NCT02532283|450438407|FG001|Overall Study|Withdrawal by Subject|3|||
125221582|NCT02143024|450438408|FG000|Overall Study|Lost to Follow-up|1|||
125221583|NCT02143024|450438409|FG001|Overall Study|Lost to Follow-up|1|||
125221584|NCT02143024|450438408|FG000|Overall Study|Withdrawal by Subject|1|||
125059499|NCT00960934|449836227|FG000|Overall Study|Progressive Disease|1|||
125059500|NCT00960934|449836228|FG001|Overall Study|Progressive Disease|1|||
125059501|NCT00960934|449836229|FG002|Overall Study|Progressive Disease|0|||
125059502|NCT00960934|449836230|FG003|Overall Study|Progressive Disease|0|||
125059503|NCT00960934|449836231|FG004|Overall Study|Progressive Disease|1|||
125059504|NCT00960934|449836232|FG005|Overall Study|Progressive Disease|1|||
125059505|NCT00960934|449836227|FG000|Overall Study|Protocol Violation|3|||
125059506|NCT00960934|449836228|FG001|Overall Study|Protocol Violation|4|||
125059507|NCT00960934|449836229|FG002|Overall Study|Protocol Violation|0|||
125059508|NCT00960934|449836230|FG003|Overall Study|Protocol Violation|3|||
125059509|NCT00960934|449836231|FG004|Overall Study|Protocol Violation|3|||
125059510|NCT00960934|449836232|FG005|Overall Study|Protocol Violation|2|||
125059511|NCT00960934|449836227|FG000|Overall Study|Withdrawal by Subject|5|||
125059512|NCT00960934|449836228|FG001|Overall Study|Withdrawal by Subject|6|||
125059513|NCT00960934|449836229|FG002|Overall Study|Withdrawal by Subject|4|||
125221585|NCT02143024|450438409|FG001|Overall Study|Withdrawal by Subject|0|||
125059514|NCT00960934|449836230|FG003|Overall Study|Withdrawal by Subject|5|||
125059515|NCT00960934|449836231|FG004|Overall Study|Withdrawal by Subject|5|||
125059516|NCT00960934|449836232|FG005|Overall Study|Withdrawal by Subject|7|||
125221586|NCT01945944|450438410|FG000|Overall Study|Adverse Event|0|||
125221587|NCT01945944|450438411|FG001|Overall Study|Adverse Event|2|||
125221588|NCT01945944|450438410|FG000|Overall Study|Physician Decision|1|||
125221589|NCT01945944|450438411|FG001|Overall Study|Physician Decision|0|||
125221590|NCT01945944|450438410|FG000|Overall Study|Withdrawal by Subject|0|||
125221591|NCT01945944|450438411|FG001|Overall Study|Withdrawal by Subject|1|||
125221592|NCT00490971|450438416|FG000|Acute/Continuation|Adverse Event|62|||
125221593|NCT00490971|450438417|FG001|Acute/Continuation|Adverse Event|13|||
125221594|NCT00490971|450438418|FG002|Acute/Continuation|Adverse Event|0|||
125221595|NCT00490971|450438419|FG003|Acute/Continuation|Adverse Event|0|||
125221596|NCT00490971|450438420|FG004|Acute/Continuation|Adverse Event|0|||
125221597|NCT00490971|450438416|FG000|Acute/Continuation|Death|2|||
125221598|NCT00490971|450438417|FG001|Acute/Continuation|Death|0|||
125221599|NCT00490971|450438418|FG002|Acute/Continuation|Death|0|||
125221600|NCT00490971|450438419|FG003|Acute/Continuation|Death|0|||
125221601|NCT00490971|450438420|FG004|Acute/Continuation|Death|0|||
125221602|NCT00490971|450438416|FG000|Acute/Continuation|Lack of Efficacy|106|||
125221603|NCT00490971|450438417|FG001|Acute/Continuation|Lack of Efficacy|12|||
125221604|NCT00490971|450438418|FG002|Acute/Continuation|Lack of Efficacy|0|||
125221605|NCT00490971|450438419|FG003|Acute/Continuation|Lack of Efficacy|0|||
125221606|NCT00490971|450438420|FG004|Acute/Continuation|Lack of Efficacy|0|||
125221607|NCT00490971|450438416|FG000|Acute/Continuation|Lost to Follow-up|23|||
125221608|NCT00490971|450438417|FG001|Acute/Continuation|Lost to Follow-up|7|||
125221609|NCT00490971|450438418|FG002|Acute/Continuation|Lost to Follow-up|0|||
125221610|NCT00490971|450438419|FG003|Acute/Continuation|Lost to Follow-up|0|||
125221611|NCT00490971|450438420|FG004|Acute/Continuation|Lost to Follow-up|0|||
125221612|NCT00490971|450438416|FG000|Acute/Continuation|Protocol Violation|10|||
125221613|NCT00490971|450438417|FG001|Acute/Continuation|Protocol Violation|2|||
125221614|NCT00490971|450438418|FG002|Acute/Continuation|Protocol Violation|0|||
125059517|NCT00960934|449836227|FG000|Overall Study|Study Terminated by Sponsor|50|||
125059518|NCT00960934|449836228|FG001|Overall Study|Study Terminated by Sponsor|46|||
125059519|NCT00960934|449836229|FG002|Overall Study|Study Terminated by Sponsor|52|||
125059520|NCT00960934|449836230|FG003|Overall Study|Study Terminated by Sponsor|50|||
125059521|NCT00960934|449836231|FG004|Overall Study|Study Terminated by Sponsor|49|||
125059522|NCT00960934|449836232|FG005|Overall Study|Study Terminated by Sponsor|49|||
125059523|NCT02156492|449836233|FG000|Period 1|No Reason Given|0|||
125059524|NCT02156492|449836234|FG001|Period 1|No Reason Given|1|||
125059525|NCT02156492|449836235|FG002|Period 1|No Reason Given|0|||
125059526|NCT02156492|449836233|FG000|Period 3|Adverse Event|0|||
125059527|NCT02156492|449836234|FG001|Period 3|Adverse Event|1|||
125059528|NCT02156492|449836235|FG002|Period 3|Adverse Event|0|||
125059529|NCT05254613|449836236|FG000|Overall Study|Lost to Follow-up|0|||
125059530|NCT05254613|449836237|FG001|Overall Study|Lost to Follow-up|0|||
125059531|NCT05254613|449836238|FG002|Overall Study|Lost to Follow-up|1|||
125059532|NCT02387372|449836239|FG000|Overall Study|Not Treated|1|||
125059533|NCT02387372|449836240|FG001|Overall Study|Not Treated|0|||
125059534|NCT00848549|449836242|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
125059535|NCT00848549|449836243|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
125059536|NCT00848549|449836242|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
125059537|NCT00848549|449836243|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
125059538|NCT00848549|449836242|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
125059539|NCT00848549|449836243|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
125059540|NCT00848549|449836242|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
125059541|NCT00848549|449836243|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
125059542|NCT00848549|449836242|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
125059543|NCT00848549|449836243|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
125059544|NCT00848549|449836242|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
125059545|NCT00848549|449836243|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
125059546|NCT00848549|449836242|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
125059547|NCT00848549|449836243|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
125059548|NCT00848549|449836242|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
125059549|NCT00848549|449836243|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
125059550|NCT00848549|449836242|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
125059551|NCT00848549|449836243|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
125059552|NCT00848549|449836242|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
125059553|NCT00848549|449836243|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
125059554|NCT00848549|449836242|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
125059555|NCT00848549|449836243|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
125059556|NCT00848549|449836242|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
125059557|NCT00848549|449836243|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
125059558|NCT00848549|449836242|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
125059559|NCT00848549|449836243|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
125221615|NCT00490971|450438419|FG003|Acute/Continuation|Protocol Violation|0|||
125221616|NCT00490971|450438420|FG004|Acute/Continuation|Protocol Violation|0|||
125221617|NCT00490971|450438416|FG000|Acute/Continuation|Withdrawal by Subject|92|||
125221618|NCT00490971|450438417|FG001|Acute/Continuation|Withdrawal by Subject|24|||
125221619|NCT00490971|450438418|FG002|Acute/Continuation|Withdrawal by Subject|0|||
125221620|NCT00490971|450438419|FG003|Acute/Continuation|Withdrawal by Subject|0|||
125221621|NCT00490971|450438420|FG004|Acute/Continuation|Withdrawal by Subject|0|||
125221622|NCT00490971|450438416|FG000|Acute/Continuation|Other|11|||
125221623|NCT00490971|450438417|FG001|Acute/Continuation|Other|4|||
125221624|NCT00490971|450438418|FG002|Acute/Continuation|Other|0|||
125221625|NCT00490971|450438419|FG003|Acute/Continuation|Other|0|||
125221626|NCT00490971|450438420|FG004|Acute/Continuation|Other|0|||
125221627|NCT00490971|450438416|FG000|Maintenance|Adverse Event|0|||
125221628|NCT00490971|450438417|FG001|Maintenance|Adverse Event|0|||
125221629|NCT00490971|450438418|FG002|Maintenance|Adverse Event|4|||
125221630|NCT00490971|450438419|FG003|Maintenance|Adverse Event|5|||
125059560|NCT00848549|449836242|FG000|E2090-E044-314 (Extension Study)|Other|5|||
125059561|NCT00848549|449836243|FG001|E2090-E044-314 (Extension Study)|Other|6|||
125059562|NCT01248130|449836246|FG000|Overall Study|Protocol Violation|1|||
125059563|NCT01248130|449836247|FG001|Overall Study|Protocol Violation|0|||
125059564|NCT01248130|449836246|FG000|Overall Study|Ineligible|1|||
125059565|NCT01248130|449836247|FG001|Overall Study|Ineligible|0|||
125059566|NCT02106455|449836252|FG000|Overall Study|Case Report Form Uncollected|6|||
125059567|NCT02106455|449836252|FG000|Overall Study|Protocol Deviation|2|||
125059568|NCT03607838|449836256|FG000|Overall Study|Lack of Efficacy|14|||
125059569|NCT03607838|449836257|FG001|Overall Study|Lack of Efficacy|20|||
125059570|NCT03607838|449836256|FG000|Overall Study|Withdrawal by Subject|13|||
125059571|NCT03607838|449836257|FG001|Overall Study|Withdrawal by Subject|8|||
125059572|NCT03607838|449836256|FG000|Overall Study|Lost to Follow-up|6|||
125059573|NCT03607838|449836257|FG001|Overall Study|Lost to Follow-up|11|||
125059574|NCT03607838|449836256|FG000|Overall Study|Adverse Event|2|||
125059575|NCT03607838|449836257|FG001|Overall Study|Adverse Event|2|||
125059576|NCT03607838|449836256|FG000|Overall Study|Physician Decision|2|||
125059577|NCT03607838|449836257|FG001|Overall Study|Physician Decision|0|||
125059578|NCT03607838|449836256|FG000|Overall Study|Failure to meet randomization criteria|1|||
125059579|NCT03607838|449836257|FG001|Overall Study|Failure to meet randomization criteria|2|||
125059580|NCT03607838|449836256|FG000|Overall Study|Pregnancy|1|||
125059581|NCT03607838|449836257|FG001|Overall Study|Pregnancy|0|||
125059582|NCT03607838|449836256|FG000|Overall Study|Protocol Violation|1|||
125059583|NCT03607838|449836257|FG001|Overall Study|Protocol Violation|0|||
125059584|NCT03607838|449836256|FG000|Overall Study|Due to work|1|||
125059585|NCT03607838|449836257|FG001|Overall Study|Due to work|0|||
125059586|NCT03607838|449836256|FG000|Overall Study|Litigation|0|||
125059587|NCT03607838|449836257|FG001|Overall Study|Litigation|1|||
125059588|NCT03607838|449836256|FG000|Overall Study|Temperature excursion for study drug|0|||
125059589|NCT03607838|449836257|FG001|Overall Study|Temperature excursion for study drug|1|||
125059590|NCT03607838|449836256|FG000|Overall Study|Change of mind|0|||
125059591|NCT03607838|449836257|FG001|Overall Study|Change of mind|1|||
125059592|NCT01576016|449836258|FG000|Lead Safety|Death|132|||
125059593|NCT01576016|449836259|FG001|Lead Safety|Death|0|||
125059594|NCT01576016|449836258|FG000|Lead Safety|Withdrawal by Subject|81|||
125059595|NCT01576016|449836259|FG001|Lead Safety|Withdrawal by Subject|0|||
125059596|NCT01576016|449836258|FG000|Lead Safety|System Explanted without Replacement|24|||
125059597|NCT01576016|449836259|FG001|Lead Safety|System Explanted without Replacement|0|||
125059598|NCT01576016|449836258|FG000|Lead Safety|Physician Decision|14|||
125059599|NCT01576016|449836259|FG001|Lead Safety|Physician Decision|0|||
125059600|NCT01576016|449836258|FG000|Lead Safety|Lost to Follow-up|13|||
125059601|NCT01576016|449836259|FG001|Lead Safety|Lost to Follow-up|0|||
125059602|NCT01576016|449836258|FG000|Lead Safety|Unsuccessful implant|2|||
125059603|NCT01576016|449836259|FG001|Lead Safety|Unsuccessful implant|0|||
125059604|NCT01576016|449836258|FG000|Lead Safety|Sponsor request|1|||
125059605|NCT01576016|449836259|FG001|Lead Safety|Sponsor request|0|||
125221631|NCT00490971|450438420|FG004|Maintenance|Adverse Event|7|||
125221632|NCT00490971|450438416|FG000|Maintenance|Death|0|||
125221633|NCT00490971|450438417|FG001|Maintenance|Death|0|||
125221634|NCT00490971|450438418|FG002|Maintenance|Death|0|||
125221635|NCT00490971|450438419|FG003|Maintenance|Death|2|||
125221636|NCT00490971|450438420|FG004|Maintenance|Death|0|||
125059606|NCT01576016|449836258|FG000|Lead Safety|Device replaced with CRT-D|1|||
125059607|NCT01576016|449836259|FG001|Lead Safety|Device replaced with CRT-D|0|||
125059608|NCT01576016|449836258|FG000|Lead Safety|Patient on Palliative Care|1|||
125059609|NCT01576016|449836259|FG001|Lead Safety|Patient on Palliative Care|0|||
125059610|NCT01576016|449836258|FG000|Lead Safety|Patient noncompliance|1|||
125059611|NCT01576016|449836259|FG001|Lead Safety|Patient noncompliance|0|||
125059612|NCT01576016|449836258|FG000|Lead Safety|Too far from study site|1|||
125059613|NCT01576016|449836259|FG001|Lead Safety|Too far from study site|0|||
125059614|NCT01576016|449836258|FG000|Lead Safety|System deactivated|1|||
125059615|NCT01576016|449836259|FG001|Lead Safety|System deactivated|0|||
125059616|NCT01576016|449836258|FG000|Lead Safety|Patient no longer followed by study PI|1|||
125059617|NCT01576016|449836259|FG001|Lead Safety|Patient no longer followed by study PI|0|||
125059618|NCT01576016|449836258|FG000|MRI Safety|Withdrawal by Subject|0|||
125059619|NCT01576016|449836259|FG001|MRI Safety|Withdrawal by Subject|10|||
125059620|NCT01576016|449836258|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
125059621|NCT01576016|449836259|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
125059622|NCT01576016|449836258|FG000|MRI Safety|Has not yet completed MRI scan|0|||
125059623|NCT01576016|449836259|FG001|MRI Safety|Has not yet completed MRI scan|56|||
125059624|NCT01576016|449836258|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
125059625|NCT01576016|449836259|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
125059626|NCT02488551|449836262|FG000|Overall Study|Lost to Follow-up|4|||
125059627|NCT02488551|449836263|FG001|Overall Study|Lost to Follow-up|7|||
125059628|NCT02488551|449836264|FG002|Overall Study|Lost to Follow-up|0|||
125059629|NCT02488551|449836265|FG003|Overall Study|Lost to Follow-up|0|||
125059630|NCT02488551|449836262|FG000|Overall Study|Military Deployment|1|||
125059631|NCT02488551|449836263|FG001|Overall Study|Military Deployment|1|||
125059632|NCT02488551|449836264|FG002|Overall Study|Military Deployment|0|||
125059633|NCT02488551|449836265|FG003|Overall Study|Military Deployment|0|||
125059634|NCT01163253|449836268|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
125059635|NCT01163253|449836269|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
125059636|NCT01163253|449836268|FG000|Overall Study|Study Terminated by Sponsor|978|||
125059637|NCT01163253|449836269|FG001|Overall Study|Study Terminated by Sponsor|349|||
125059638|NCT01163253|449836268|FG000|Overall Study|Protocol Violation|43|||
125059639|NCT01163253|449836269|FG001|Overall Study|Protocol Violation|12|||
125059640|NCT01163253|449836268|FG000|Overall Study|Withdrawal by Subject|199|||
125059641|NCT01163253|449836269|FG001|Overall Study|Withdrawal by Subject|50|||
125138634|NCT00112437|450131207|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
125059642|NCT01163253|449836268|FG000|Overall Study|Medication Error|1|||
125221637|NCT00490971|450438416|FG000|Maintenance|Lost to Follow-up|0|||
125221638|NCT00490971|450438417|FG001|Maintenance|Lost to Follow-up|0|||
125221639|NCT00490971|450438418|FG002|Maintenance|Lost to Follow-up|5|||
125221640|NCT00490971|450438419|FG003|Maintenance|Lost to Follow-up|8|||
125221641|NCT00490971|450438420|FG004|Maintenance|Lost to Follow-up|10|||
125221642|NCT00490971|450438416|FG000|Maintenance|Pregnancy|0|||
125221643|NCT00490971|450438417|FG001|Maintenance|Pregnancy|0|||
125221644|NCT00490971|450438418|FG002|Maintenance|Pregnancy|1|||
125221645|NCT00490971|450438419|FG003|Maintenance|Pregnancy|0|||
125221646|NCT00490971|450438420|FG004|Maintenance|Pregnancy|0|||
125221647|NCT00490971|450438416|FG000|Maintenance|Protocol Violation|0|||
125221648|NCT00490971|450438417|FG001|Maintenance|Protocol Violation|0|||
125221649|NCT00490971|450438418|FG002|Maintenance|Protocol Violation|4|||
125221650|NCT00490971|450438419|FG003|Maintenance|Protocol Violation|1|||
125059643|NCT01163253|449836269|FG001|Overall Study|Medication Error|0|||
125059644|NCT01163253|449836268|FG000|Overall Study|Lost to Follow-up|125|||
125059645|NCT01163253|449836269|FG001|Overall Study|Lost to Follow-up|23|||
125059646|NCT01163253|449836268|FG000|Overall Study|Insufficient Clinical Response|423|||
125059647|NCT01163253|449836269|FG001|Overall Study|Insufficient Clinical Response|29|||
125059648|NCT01163253|449836268|FG000|Overall Study|Adverse Event|300|||
125059649|NCT01163253|449836269|FG001|Overall Study|Adverse Event|78|||
125059650|NCT01163253|449836268|FG000|Overall Study|Death|17|||
125059651|NCT01163253|449836269|FG001|Overall Study|Death|5|||
125059652|NCT01163253|449836268|FG000|Overall Study|Ongoing|13|||
125059653|NCT01163253|449836269|FG001|Overall Study|Ongoing|4|||
125059654|NCT01163253|449836268|FG000|Overall Study|Other Unspecified|170|||
125059655|NCT01163253|449836269|FG001|Overall Study|Other Unspecified|34|||
125059656|NCT01188564|449836270|FG000|Double-blind Phase|randomized not treated|1|||
125059657|NCT01188564|449836271|FG001|Double-blind Phase|randomized not treated|0|||
125059658|NCT02492997|449836272|FG000|Overall Study|Withdrawal by Subject|1|||
125059659|NCT02492997|449836273|FG001|Overall Study|Withdrawal by Subject|0|||
125059660|NCT02492997|449836272|FG000|Overall Study|Gained Weight|1|||
125059661|NCT02492997|449836273|FG001|Overall Study|Gained Weight|0|||
125059662|NCT02492997|449836272|FG000|Overall Study|Lost to Follow-up|0|||
125059663|NCT02492997|449836273|FG001|Overall Study|Lost to Follow-up|1|||
125059664|NCT00579501|449836274|FG000|Overall Study|Death|1|||
125059665|NCT00579501|449836274|FG000|Overall Study|End of neoadjuvant therapy|25|||
125059666|NCT00579501|449836274|FG000|Overall Study|toxicity|1|||
125059667|NCT00579501|449836274|FG000|Overall Study|Secondary lesion|1|||
125059668|NCT00579501|449836274|FG000|Overall Study|Radiation therapy before surgery|1|||
125059669|NCT03025217|449836275|FG000|Overall Study|Pregnancy|1|||
125059670|NCT03025217|449836275|FG000|Overall Study|Lost to Follow-up|1|||
125059671|NCT03025217|449836275|FG000|Overall Study|Not eligible, poor English|2|||
125059672|NCT04069156|449836276|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
125059673|NCT04069156|449836277|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
125059674|NCT04069156|449836276|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
125059675|NCT04069156|449836277|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
125059676|NCT04069156|449836276|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
125059677|NCT04069156|449836277|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
125059678|NCT04069156|449836276|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
125059679|NCT04069156|449836277|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
125059680|NCT02208024|449836278|FG000|Overall Study|Withdrawal by Subject|1|||
125059681|NCT02207556|449836279|FG000|Overall Study|Physician Decision|1|||
125059682|NCT02207556|449836280|FG001|Overall Study|Physician Decision|0|||
125059683|NCT02207556|449836279|FG000|Overall Study|Withdrawal by Subject|1|||
125059684|NCT02207556|449836280|FG001|Overall Study|Withdrawal by Subject|0|||
125059685|NCT02207556|449836279|FG000|Overall Study|Death|0|||
125059686|NCT02207556|449836280|FG001|Overall Study|Death|5|||
125059687|NCT03558555|449836281|FG000|Overall Study|Lost to Follow-up|2|||
125059688|NCT03558555|449836282|FG001|Overall Study|Lost to Follow-up|1|||
125221651|NCT00490971|450438420|FG004|Maintenance|Protocol Violation|1|||
125059689|NCT01958125|449836283|FG000|Overall Study|Missing diary data|2|||
125059690|NCT01958125|449836284|FG001|Overall Study|Missing diary data|6|||
125059691|NCT01958125|449836283|FG000|Overall Study|No headache attacks|0|||
125059692|NCT01958125|449836284|FG001|Overall Study|No headache attacks|2|||
125059693|NCT00194025|449836285|FG000|Overall Study|Adverse Event|1|||
125059694|NCT00194025|449836285|FG000|Overall Study|non-adherence with study medication|4|||
125059695|NCT04804033|449836287|FG000|Period 1: DBT Phase|Adverse Event|1|||
125059696|NCT04804033|449836288|FG001|Period 1: DBT Phase|Adverse Event|5|||
125059697|NCT04804033|449836289|FG002|Period 1: DBT Phase|Adverse Event|3|||
125059698|NCT04804033|449836290|FG003|Period 1: DBT Phase|Adverse Event|4|||
125059699|NCT04804033|449836287|FG000|Period 1: DBT Phase|Death|1|||
125059700|NCT04804033|449836288|FG001|Period 1: DBT Phase|Death|0|||
125059701|NCT04804033|449836289|FG002|Period 1: DBT Phase|Death|0|||
125221652|NCT00490971|450438416|FG000|Maintenance|Withdrawal by Subject|0|||
125221653|NCT00490971|450438417|FG001|Maintenance|Withdrawal by Subject|0|||
125221654|NCT00490971|450438418|FG002|Maintenance|Withdrawal by Subject|26|||
125138635|NCT00112437|450131208|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138636|NCT00112437|450131209|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138637|NCT00112437|450131210|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138638|NCT00112437|450131211|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138639|NCT00112437|450131212|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138640|NCT00112437|450131213|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138641|NCT00112437|450131214|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138642|NCT00112437|450131215|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138643|NCT00112437|450131216|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138644|NCT00112437|450131217|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138645|NCT00112437|450131218|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138646|NCT00112437|450131219|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
125138647|NCT00112437|450131220|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138648|NCT00112437|450131221|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138649|NCT00112437|450131222|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138650|NCT00112437|450131223|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138651|NCT00112437|450131224|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138652|NCT00112437|450131225|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138653|NCT00112437|450131226|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138654|NCT00112437|450131227|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138655|NCT00112437|450131228|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138656|NCT00112437|450131229|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138657|NCT00112437|450131204|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138658|NCT00112437|450131205|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138659|NCT00112437|450131206|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138660|NCT00112437|450131207|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138661|NCT00112437|450131208|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138662|NCT00112437|450131209|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138663|NCT00112437|450131210|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138664|NCT00112437|450131211|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138665|NCT00112437|450131212|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138666|NCT00112437|450131213|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138667|NCT00112437|450131214|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138668|NCT00112437|450131215|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
125138669|NCT00112437|450131216|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138670|NCT00112437|450131217|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138671|NCT00112437|450131218|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
125138672|NCT00112437|450131219|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138673|NCT00112437|450131220|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138674|NCT00112437|450131221|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138675|NCT00112437|450131222|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138676|NCT00112437|450131223|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138677|NCT00112437|450131224|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138678|NCT00112437|450131225|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138679|NCT00112437|450131226|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138680|NCT00112437|450131227|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138681|NCT00112437|450131228|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138682|NCT00112437|450131229|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138683|NCT00112437|450131204|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138684|NCT00112437|450131205|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138685|NCT00112437|450131206|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138686|NCT00112437|450131207|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138687|NCT00112437|450131208|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138688|NCT00112437|450131209|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138689|NCT00112437|450131210|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138690|NCT00112437|450131211|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138691|NCT00112437|450131212|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138692|NCT00112437|450131213|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138693|NCT00112437|450131214|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
125221655|NCT00490971|450438419|FG003|Maintenance|Withdrawal by Subject|28|||
125221656|NCT00490971|450438420|FG004|Maintenance|Withdrawal by Subject|18|||
125138694|NCT00112437|450131215|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
125138695|NCT00112437|450131216|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138696|NCT00112437|450131217|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138697|NCT00112437|450131218|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138698|NCT00112437|450131219|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138699|NCT00112437|450131220|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125221657|NCT00490971|450438416|FG000|Maintenance|Other|0|||
125138700|NCT00112437|450131221|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138701|NCT00112437|450131222|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138702|NCT00112437|450131223|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138703|NCT00112437|450131224|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138704|NCT00112437|450131225|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138705|NCT00112437|450131226|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138706|NCT00112437|450131227|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138707|NCT00112437|450131228|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138708|NCT00112437|450131229|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138709|NCT00112437|450131204|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138710|NCT00112437|450131205|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138711|NCT00112437|450131206|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138712|NCT00112437|450131207|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138713|NCT00112437|450131208|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138714|NCT00112437|450131209|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138715|NCT00112437|450131210|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138716|NCT00112437|450131211|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138717|NCT00112437|450131212|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138718|NCT00112437|450131213|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138719|NCT00112437|450131214|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138720|NCT00112437|450131215|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138721|NCT00112437|450131216|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138722|NCT00112437|450131217|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138723|NCT00112437|450131218|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138724|NCT00112437|450131219|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138725|NCT00112437|450131220|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138726|NCT00112437|450131221|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138727|NCT00112437|450131222|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138728|NCT00112437|450131223|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138729|NCT00112437|450131224|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
125138730|NCT00112437|450131225|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
125138731|NCT00112437|450131226|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138732|NCT00112437|450131227|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138733|NCT00112437|450131228|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138734|NCT00112437|450131229|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138735|NCT00112437|450131204|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138736|NCT00112437|450131205|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138737|NCT00112437|450131206|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138738|NCT00112437|450131207|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138739|NCT00112437|450131208|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138740|NCT00112437|450131209|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138741|NCT00112437|450131210|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138742|NCT00112437|450131211|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138743|NCT00112437|450131212|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138744|NCT00112437|450131213|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138745|NCT00112437|450131214|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138746|NCT00112437|450131215|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138747|NCT00112437|450131216|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138748|NCT00112437|450131217|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138749|NCT00112437|450131218|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138750|NCT00112437|450131219|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138751|NCT00112437|450131220|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138752|NCT00112437|450131221|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138753|NCT00112437|450131222|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138754|NCT00112437|450131223|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138755|NCT00112437|450131224|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
125138756|NCT00112437|450131225|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138757|NCT00112437|450131226|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138758|NCT00112437|450131227|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138759|NCT00112437|450131228|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138760|NCT00112437|450131229|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138761|NCT00112437|450131204|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125221658|NCT00490971|450438417|FG001|Maintenance|Other|0|||
125221659|NCT00490971|450438418|FG002|Maintenance|Other|11|||
125221660|NCT00490971|450438419|FG003|Maintenance|Other|9|||
125221661|NCT00490971|450438420|FG004|Maintenance|Other|3|||
125221662|NCT04376515|450438423|FG000|Overall Study|Found to have been vaccinated before study start|6|||
125221663|NCT04376515|450438424|FG001|Overall Study|Found to have been vaccinated before study start|6|||
125221664|NCT01683604|450438425|FG000|Overall Study|Adverse Event|2|||
125221665|NCT01683604|450438425|FG000|Overall Study|Lack of Efficacy|1|||
125221666|NCT01683604|450438425|FG000|Overall Study|Other|2|||
125221667|NCT03430856|450438429|FG000|Overall Study|Adverse Event|0|||
125221668|NCT03430856|450438430|FG001|Overall Study|Adverse Event|1|||
125221669|NCT03430856|450438431|FG002|Overall Study|Adverse Event|0|||
125221670|NCT03430856|450438429|FG000|Overall Study|Rescue criteria|1|||
125221671|NCT03430856|450438430|FG001|Overall Study|Rescue criteria|1|||
125221672|NCT03430856|450438431|FG002|Overall Study|Rescue criteria|0|||
125221673|NCT03430856|450438429|FG000|Overall Study|Voluntary withdrawal of consent|1|||
125221674|NCT03430856|450438430|FG001|Overall Study|Voluntary withdrawal of consent|1|||
125221675|NCT03430856|450438431|FG002|Overall Study|Voluntary withdrawal of consent|1|||
125221676|NCT01949142|450438432|FG000|Overall Study|Withdrawal of consent|1|||
125221677|NCT01949142|450438433|FG001|Overall Study|Withdrawal of consent|0|||
125059702|NCT04804033|449836290|FG003|Period 1: DBT Phase|Death|0|||
125059703|NCT04804033|449836287|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
125059704|NCT04804033|449836288|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
125059705|NCT04804033|449836289|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
125059706|NCT04804033|449836290|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
125059707|NCT04804033|449836287|FG000|Period 1: DBT Phase|Non-compliance|1|||
125059708|NCT04804033|449836288|FG001|Period 1: DBT Phase|Non-compliance|0|||
125059709|NCT04804033|449836289|FG002|Period 1: DBT Phase|Non-compliance|1|||
125059710|NCT04804033|449836290|FG003|Period 1: DBT Phase|Non-compliance|2|||
125059711|NCT04804033|449836287|FG000|Period 1: DBT Phase|Other|0|||
125059712|NCT04804033|449836288|FG001|Period 1: DBT Phase|Other|1|||
125059713|NCT04804033|449836289|FG002|Period 1: DBT Phase|Other|0|||
125059714|NCT04804033|449836290|FG003|Period 1: DBT Phase|Other|0|||
125059715|NCT04804033|449836287|FG000|Period 1: DBT Phase|Pregnancy|2|||
125059716|NCT04804033|449836288|FG001|Period 1: DBT Phase|Pregnancy|0|||
125059717|NCT04804033|449836289|FG002|Period 1: DBT Phase|Pregnancy|0|||
125059718|NCT04804033|449836290|FG003|Period 1: DBT Phase|Pregnancy|0|||
125059719|NCT04804033|449836287|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
125059720|NCT04804033|449836288|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
125059721|NCT04804033|449836289|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
125059722|NCT04804033|449836290|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
125059723|NCT04804033|449836287|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
125059724|NCT04804033|449836288|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
125059725|NCT04804033|449836289|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
125059726|NCT04804033|449836290|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
125059727|NCT04804033|449836287|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
125059728|NCT04804033|449836288|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
125059729|NCT04804033|449836289|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
125059730|NCT04804033|449836290|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
125059731|NCT04804033|449836287|FG000|Period 2: OLE Phase|Adverse Event|3|||
125059732|NCT04804033|449836288|FG001|Period 2: OLE Phase|Adverse Event|4|||
125059733|NCT04804033|449836289|FG002|Period 2: OLE Phase|Adverse Event|2|||
125059734|NCT04804033|449836290|FG003|Period 2: OLE Phase|Adverse Event|0|||
125059735|NCT04804033|449836287|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
125059736|NCT04804033|449836288|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
125059737|NCT04804033|449836289|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
125059738|NCT04804033|449836290|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
125059739|NCT04804033|449836287|FG000|Period 2: OLE Phase|Non-compliance|2|||
125059740|NCT04804033|449836288|FG001|Period 2: OLE Phase|Non-compliance|2|||
125059741|NCT04804033|449836289|FG002|Period 2: OLE Phase|Non-compliance|0|||
125059742|NCT04804033|449836290|FG003|Period 2: OLE Phase|Non-compliance|1|||
125059743|NCT04804033|449836287|FG000|Period 2: OLE Phase|Other|0|||
125221678|NCT01949142|450438432|FG000|Overall Study|Lost to Follow-up|1|||
125221679|NCT01949142|450438433|FG001|Overall Study|Lost to Follow-up|1|||
125221680|NCT01949142|450438432|FG000|Overall Study|Parent changed their mind|1|||
125221681|NCT01949142|450438433|FG001|Overall Study|Parent changed their mind|0|||
125221682|NCT00565604|450438439|FG000|Overall Study|Failure to treat|2|||
125221683|NCT00565604|450438439|FG000|Overall Study|Lost to Follow-up|2|||
125059744|NCT04804033|449836288|FG001|Period 2: OLE Phase|Other|2|||
125059745|NCT04804033|449836289|FG002|Period 2: OLE Phase|Other|0|||
125059746|NCT04804033|449836290|FG003|Period 2: OLE Phase|Other|0|||
125059747|NCT04804033|449836287|FG000|Period 2: OLE Phase|Physician Decision|1|||
125059748|NCT04804033|449836288|FG001|Period 2: OLE Phase|Physician Decision|1|||
125059749|NCT04804033|449836289|FG002|Period 2: OLE Phase|Physician Decision|0|||
125059750|NCT04804033|449836290|FG003|Period 2: OLE Phase|Physician Decision|0|||
125059751|NCT04804033|449836287|FG000|Period 2: OLE Phase|Pregnancy|0|||
125059752|NCT04804033|449836288|FG001|Period 2: OLE Phase|Pregnancy|0|||
125059753|NCT04804033|449836289|FG002|Period 2: OLE Phase|Pregnancy|2|||
125138762|NCT00112437|450131205|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138763|NCT00112437|450131206|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138764|NCT00112437|450131207|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138765|NCT00112437|450131208|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138766|NCT00112437|450131209|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138767|NCT00112437|450131210|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125059754|NCT04804033|449836290|FG003|Period 2: OLE Phase|Pregnancy|0|||
125138768|NCT00112437|450131211|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138769|NCT00112437|450131212|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138770|NCT00112437|450131213|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138771|NCT00112437|450131214|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138772|NCT00112437|450131215|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138773|NCT00112437|450131216|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138774|NCT00112437|450131217|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138775|NCT00112437|450131218|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138776|NCT00112437|450131219|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138777|NCT00112437|450131220|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138778|NCT00112437|450131221|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138779|NCT00112437|450131222|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138780|NCT00112437|450131223|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138781|NCT00112437|450131224|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138782|NCT00112437|450131225|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
125138783|NCT00112437|450131226|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138784|NCT00112437|450131227|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138785|NCT00112437|450131228|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138786|NCT00112437|450131229|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138787|NCT00112437|450131204|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138788|NCT00112437|450131205|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138789|NCT00112437|450131206|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138790|NCT00112437|450131207|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138791|NCT00112437|450131208|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
125221684|NCT01395810|450438440|FG000|Overall Study|Adverse Event|0|||
125221685|NCT01395810|450438441|FG001|Overall Study|Adverse Event|1|||
125059755|NCT04804033|449836287|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
125059756|NCT04804033|449836288|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
125059757|NCT04804033|449836289|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
125059758|NCT04804033|449836290|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
125059759|NCT04804033|449836287|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
125059760|NCT04804033|449836288|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
125059761|NCT04804033|449836289|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
125059762|NCT04804033|449836290|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
125059763|NCT04804033|449836287|FG000|Period 2: OLE Phase|Not reported|0|||
125059764|NCT04804033|449836288|FG001|Period 2: OLE Phase|Not reported|2|||
125059765|NCT04804033|449836289|FG002|Period 2: OLE Phase|Not reported|0|||
125059766|NCT04804033|449836290|FG003|Period 2: OLE Phase|Not reported|0|||
125138792|NCT00112437|450131209|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138793|NCT00112437|450131210|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138794|NCT00112437|450131211|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138795|NCT00112437|450131212|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138796|NCT00112437|450131213|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138797|NCT00112437|450131214|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
125059767|NCT04804033|449836287|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
125221686|NCT01395810|450438442|FG002|Overall Study|Adverse Event|0|||
125221687|NCT01395810|450438443|FG003|Overall Study|Adverse Event|0|||
125221688|NCT01395810|450438440|FG000|Overall Study|Lack of Efficacy|0|||
125221689|NCT01395810|450438441|FG001|Overall Study|Lack of Efficacy|1|||
125221690|NCT01395810|450438442|FG002|Overall Study|Lack of Efficacy|0|||
125221691|NCT01395810|450438443|FG003|Overall Study|Lack of Efficacy|0|||
125221692|NCT01395810|450438440|FG000|Overall Study|Withdrawal criteria|0|||
125221693|NCT01395810|450438441|FG001|Overall Study|Withdrawal criteria|2|||
125221694|NCT01395810|450438442|FG002|Overall Study|Withdrawal criteria|0|||
125221695|NCT01395810|450438443|FG003|Overall Study|Withdrawal criteria|0|||
125221696|NCT01395810|450438440|FG000|Overall Study|Unclassified|2|||
125221697|NCT01395810|450438441|FG001|Overall Study|Unclassified|0|||
125221698|NCT01395810|450438442|FG002|Overall Study|Unclassified|0|||
125221699|NCT01395810|450438443|FG003|Overall Study|Unclassified|0|||
125221700|NCT04265261|450438448|FG000|Overall Study|Adverse Event|2|||
125221701|NCT04265261|450438449|FG001|Overall Study|Adverse Event|0|||
125221702|NCT04265261|450438450|FG002|Overall Study|Adverse Event|0|||
125221703|NCT04265261|450438448|FG000|Overall Study|Death|1|||
125221704|NCT04265261|450438449|FG001|Overall Study|Death|0|||
125221705|NCT04265261|450438450|FG002|Overall Study|Death|0|||
125221706|NCT04265261|450438448|FG000|Overall Study|Lost to Follow-up|4|||
125221707|NCT04265261|450438449|FG001|Overall Study|Lost to Follow-up|1|||
125221708|NCT04265261|450438450|FG002|Overall Study|Lost to Follow-up|3|||
125221709|NCT04265261|450438448|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125221710|NCT04265261|450438449|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125221711|NCT04265261|450438450|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125221712|NCT04265261|450438448|FG000|Overall Study|Physician Decision|0|||
125221713|NCT04265261|450438449|FG001|Overall Study|Physician Decision|0|||
125059768|NCT04804033|449836288|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
125059769|NCT04804033|449836289|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
125059770|NCT04804033|449836290|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
125059771|NCT04804033|449836287|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
125059772|NCT04804033|449836288|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
125059773|NCT04804033|449836289|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
125059774|NCT04804033|449836290|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
125059775|NCT04804033|449836287|FG000|Period 3: Follow-up Phase|Other|0|||
125059776|NCT04804033|449836288|FG001|Period 3: Follow-up Phase|Other|1|||
125059777|NCT04804033|449836289|FG002|Period 3: Follow-up Phase|Other|2|||
125059778|NCT04804033|449836290|FG003|Period 3: Follow-up Phase|Other|1|||
125059779|NCT04804033|449836287|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
125059780|NCT04804033|449836288|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
125059781|NCT04804033|449836289|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
125059782|NCT04804033|449836290|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
125059783|NCT04804033|449836287|FG000|Period 3: Follow-up Phase|Not reported|18|||
125059784|NCT04804033|449836288|FG001|Period 3: Follow-up Phase|Not reported|15|||
125059785|NCT04804033|449836289|FG002|Period 3: Follow-up Phase|Not reported|1|||
125059786|NCT04804033|449836290|FG003|Period 3: Follow-up Phase|Not reported|4|||
125059787|NCT02130427|449836291|FG000|Overall Study|Imaging results not interpretable|30|||
125059788|NCT00543569|449836296|FG000|Overall Study|Death|2|||
125221714|NCT04265261|450438450|FG002|Overall Study|Physician Decision|1|||
125221715|NCT04265261|450438448|FG000|Overall Study|Protocol Deviation|0|||
125221716|NCT04265261|450438449|FG001|Overall Study|Protocol Deviation|2|||
125221717|NCT04265261|450438450|FG002|Overall Study|Protocol Deviation|0|||
125221718|NCT04265261|450438448|FG000|Overall Study|Withdrawal by Subject|2|||
125221719|NCT04265261|450438449|FG001|Overall Study|Withdrawal by Subject|1|||
125059789|NCT00543569|449836297|FG001|Overall Study|Death|2|||
125059790|NCT00543569|449836298|FG002|Overall Study|Death|3|||
125059791|NCT00543569|449836299|FG003|Overall Study|Death|1|||
125059792|NCT00543569|449836296|FG000|Overall Study|Lost to Follow-up|0|||
125059793|NCT00543569|449836297|FG001|Overall Study|Lost to Follow-up|0|||
125059794|NCT00543569|449836298|FG002|Overall Study|Lost to Follow-up|1|||
125059795|NCT00543569|449836299|FG003|Overall Study|Lost to Follow-up|1|||
125059796|NCT00543569|449836296|FG000|Overall Study|Miscellaneous Reasons|7|||
125059797|NCT00543569|449836297|FG001|Overall Study|Miscellaneous Reasons|3|||
125059798|NCT00543569|449836298|FG002|Overall Study|Miscellaneous Reasons|11|||
125059799|NCT00543569|449836299|FG003|Overall Study|Miscellaneous Reasons|4|||
125138798|NCT00112437|450131215|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138799|NCT00112437|450131216|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138800|NCT00112437|450131217|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138801|NCT00112437|450131218|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138802|NCT00112437|450131219|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138803|NCT00112437|450131220|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138804|NCT00112437|450131221|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138805|NCT00112437|450131222|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138806|NCT00112437|450131223|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138807|NCT00112437|450131224|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138808|NCT00112437|450131225|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
125138809|NCT00112437|450131226|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138810|NCT00112437|450131227|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138811|NCT00112437|450131228|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138812|NCT00112437|450131229|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138813|NCT00112437|450131204|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138814|NCT00112437|450131205|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138815|NCT00112437|450131206|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138816|NCT00112437|450131207|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138817|NCT00112437|450131208|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138818|NCT00112437|450131209|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138819|NCT00112437|450131210|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138820|NCT00112437|450131211|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138821|NCT00112437|450131212|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138822|NCT00112437|450131213|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138823|NCT00112437|450131214|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138824|NCT00112437|450131215|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138825|NCT00112437|450131216|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138826|NCT00112437|450131217|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138827|NCT00112437|450131218|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138828|NCT00112437|450131219|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138829|NCT00112437|450131220|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138830|NCT00112437|450131221|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138831|NCT00112437|450131222|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138832|NCT00112437|450131223|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138833|NCT00112437|450131224|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
125138834|NCT00112437|450131225|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
125138835|NCT00112437|450131226|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138836|NCT00112437|450131227|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138837|NCT00112437|450131228|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138838|NCT00112437|450131229|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138839|NCT00112437|450131204|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138840|NCT00112437|450131205|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138841|NCT00112437|450131206|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138842|NCT00112437|450131207|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138843|NCT00112437|450131208|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138844|NCT00112437|450131209|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138845|NCT00112437|450131210|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138846|NCT00112437|450131211|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138847|NCT00112437|450131212|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138848|NCT00112437|450131213|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138849|NCT00112437|450131214|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138850|NCT00112437|450131215|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138851|NCT00112437|450131216|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138852|NCT00112437|450131217|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138853|NCT00112437|450131218|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138854|NCT00112437|450131219|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125059800|NCT00543569|449836296|FG000|Overall Study|Randomized but never received study drug|3|||
125138855|NCT00112437|450131220|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138856|NCT00112437|450131221|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138857|NCT00112437|450131222|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138858|NCT00112437|450131223|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138859|NCT00112437|450131224|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125059801|NCT00543569|449836297|FG001|Overall Study|Randomized but never received study drug|3|||
125059802|NCT00543569|449836298|FG002|Overall Study|Randomized but never received study drug|5|||
125138860|NCT00112437|450131225|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138861|NCT00112437|450131226|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
125138862|NCT00112437|450131227|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
125138863|NCT00112437|450131228|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138864|NCT00112437|450131229|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
125138865|NCT00112437|450131204|FG000|Years 6-10 (60-Month Extension)|Death|0|||
125221720|NCT04265261|450438450|FG002|Overall Study|Withdrawal by Subject|4|||
125221721|NCT00493012|450440332|FG000|Overall Study|Lost to Follow-up|18|||
125059803|NCT00543569|449836299|FG003|Overall Study|Randomized but never received study drug|3|||
125059804|NCT00781599|449836304|FG000|Overall Study|Lost to Follow-up|7|||
125059805|NCT00781599|449836305|FG001|Overall Study|Lost to Follow-up|4|||
125059806|NCT00089479|449836311|FG000|Overall Study|Death|108|||
125059807|NCT00089479|449836312|FG001|Overall Study|Death|75|||
125059808|NCT00089479|449836311|FG000|Overall Study|Withdrawal by Subject|86|||
125059809|NCT00089479|449836312|FG001|Overall Study|Withdrawal by Subject|107|||
125059810|NCT00089479|449836311|FG000|Overall Study|Lost to Follow-up|137|||
125059811|NCT00089479|449836312|FG001|Overall Study|Lost to Follow-up|107|||
125059812|NCT01124448|449836315|FG000|Overall Study|Lost to Follow-up|0|||
125059813|NCT01124448|449836316|FG001|Overall Study|Lost to Follow-up|3|||
125059814|NCT01124448|449836315|FG000|Overall Study|Protocol Violation|2|||
125059815|NCT01124448|449836316|FG001|Overall Study|Protocol Violation|0|||
125059816|NCT03198754|449836317|FG000|Overall Study|Withdrawal by Subject|5|||
125059817|NCT03198754|449836318|FG001|Overall Study|Withdrawal by Subject|4|||
125059818|NCT03198754|449836317|FG000|Overall Study|Lost to Follow-up|4|||
125059819|NCT03198754|449836318|FG001|Overall Study|Lost to Follow-up|3|||
125059820|NCT03198754|449836317|FG000|Overall Study|Ineligible|2|||
125059821|NCT03198754|449836318|FG001|Overall Study|Ineligible|1|||
125059822|NCT01968187|449836324|FG000|Overall Study|Adverse Event|0|||
125059823|NCT01968187|449836325|FG001|Overall Study|Adverse Event|1|||
125059824|NCT01968187|449836324|FG000|Overall Study|Randomized but not treated|1|||
125059825|NCT01968187|449836325|FG001|Overall Study|Randomized but not treated|0|||
125059826|NCT04095286|449836326|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
125059827|NCT04095286|449836327|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
125059828|NCT04095286|449836328|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
125059829|NCT04095286|449836329|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
125059830|NCT04095286|449836330|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
125059831|NCT04095286|449836331|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
125059832|NCT04095286|449836326|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
125059833|NCT04095286|449836327|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
125059834|NCT04095286|449836328|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
125059835|NCT04095286|449836329|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
125059836|NCT04095286|449836330|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
125059837|NCT04095286|449836331|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
125059838|NCT04095286|449836326|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
125059839|NCT04095286|449836327|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
125059840|NCT04095286|449836328|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
125059841|NCT04095286|449836329|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
125059842|NCT04095286|449836330|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
125059843|NCT04095286|449836331|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
125059844|NCT04095286|449836326|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
125059845|NCT04095286|449836327|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
125059846|NCT04095286|449836328|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
125059847|NCT04095286|449836329|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
125059848|NCT04095286|449836330|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
125138866|NCT00112437|450131205|FG001|Years 6-10 (60-Month Extension)|Death|0|||
125138867|NCT00112437|450131206|FG002|Years 6-10 (60-Month Extension)|Death|0|||
125221722|NCT00493012|450440333|FG001|Overall Study|Lost to Follow-up|17|||
125059849|NCT04095286|449836331|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
125059850|NCT04095286|449836326|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
125138868|NCT00112437|450131207|FG003|Years 6-10 (60-Month Extension)|Death|0|||
125138869|NCT00112437|450131208|FG004|Years 6-10 (60-Month Extension)|Death|0|||
125221723|NCT03234036|450440337|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
125059851|NCT04095286|449836327|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
125059852|NCT04095286|449836328|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
125059853|NCT04095286|449836329|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
125059854|NCT04095286|449836330|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
125059855|NCT04095286|449836331|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
125059856|NCT04092816|449838419|FG000|Overall Study|Lost to Follow-up|1|||
125059857|NCT04092816|449838420|FG001|Overall Study|Lost to Follow-up|2|||
125059858|NCT02690207|449838430|FG000|Overall Study|Lost to Follow-up|48|||
125059859|NCT02690207|449838430|FG000|Overall Study|Withdrawal by Subject|46|||
125059860|NCT02690207|449838430|FG000|Overall Study|Protocol Violation|2|||
125059861|NCT02690207|449838430|FG000|Overall Study|Serious adverse event|110|||
125059862|NCT02690207|449838430|FG000|Overall Study|Non-serious Adverse Event|18|||
125059863|NCT02690207|449838430|FG000|Overall Study|Migrated/moved from study area|5|||
125059864|NCT02690207|449838430|FG000|Overall Study|Suspected HZ Episode|1|||
125059865|NCT02690207|449838430|FG000|Overall Study|Other reasons for withdrawal|23|||
125059866|NCT04348656|449838433|FG000|Overall Study|Withdrawal by Subject|2|||
125059867|NCT04348656|449838434|FG001|Overall Study|Withdrawal by Subject|0|||
125059868|NCT04348656|449838433|FG000|Overall Study|Lost to Follow-up|11|||
125059869|NCT04348656|449838434|FG001|Overall Study|Lost to Follow-up|6|||
125059870|NCT00937560|449838441|FG000|Initial Treatment|Death|6|||
125059871|NCT00937560|449838441|FG000|Initial Treatment|Withdraw consent|3|||
125059872|NCT00937560|449838441|FG000|Initial Treatment|Adverse Event|1|||
125059873|NCT00937560|449838441|FG000|Initial Treatment|Lost to Follow-up|1|||
125059874|NCT00937560|449838441|FG000|Initial Treatment|No end of study page|10|||
125059875|NCT00937560|449838441|FG000|Maintenance Treatment|Death|12|||
125059876|NCT00937560|449838441|FG000|Maintenance Treatment|Withdraw consent|5|||
125059877|NCT00937560|449838441|FG000|Maintenance Treatment|According to protocol|1|||
125059878|NCT03364608|449838444|FG000|Overall Study|Withdrawal by Subject|4|||
125059879|NCT03364608|449838444|FG000|Overall Study|Protocol Violation|2|||
125059880|NCT03364608|449838444|FG000|Overall Study|Lost to Follow-up|2|||
125059881|NCT02546674|449838451|FG000|Overall Study|Adverse Event|19|||
125059882|NCT02546674|449838451|FG000|Overall Study|Death|1|||
125059883|NCT02546674|449838451|FG000|Overall Study|Lost to Follow-up|1|||
125059884|NCT02546674|449838451|FG000|Overall Study|Physician Decision|13|||
125059885|NCT02546674|449838451|FG000|Overall Study|Pregnancy|1|||
125059886|NCT02546674|449838451|FG000|Overall Study|Progressive Disease|2|||
125059887|NCT02546674|449838451|FG000|Overall Study|Protocol Deviation|2|||
125059888|NCT02546674|449838451|FG000|Overall Study|Subject/Guardian Decision|6|||
125059889|NCT02546674|449838451|FG000|Overall Study|Withdrawal of Informed Consent|3|||
125059890|NCT03888391|449838458|FG000|Overall Study|Lost to Follow-up|15|||
125059891|NCT00423735|449838460|FG000|Overall Study|Ineligible / No protocol treatment|8|||
125059892|NCT00423735|449838461|FG001|Overall Study|Ineligible / No protocol treatment|6|||
125059893|NCT00423735|449838462|FG002|Overall Study|Ineligible / No protocol treatment|0|||
125059894|NCT01954251|449838466|FG000|Overall Study|Adverse Event|5|||
125059895|NCT01954251|449838467|FG001|Overall Study|Adverse Event|7|||
125059896|NCT01954251|449838466|FG000|Overall Study|Lost to Follow-up|6|||
125059897|NCT01954251|449838467|FG001|Overall Study|Lost to Follow-up|6|||
125059898|NCT01954251|449838466|FG000|Overall Study|Withdrawal by Subject|2|||
125059899|NCT01954251|449838467|FG001|Overall Study|Withdrawal by Subject|6|||
125059900|NCT02864940|449838468|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
125059901|NCT02864940|449838469|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
125059902|NCT02175771|449838472|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
125059903|NCT02175771|449838473|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125059904|NCT02175771|449838474|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125059905|NCT02175771|449838475|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125059906|NCT02175771|449838476|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125059907|NCT02175771|449838477|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125059908|NCT02175771|449838478|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125059909|NCT02175771|449838479|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125059910|NCT02175771|449838480|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125059911|NCT02175771|449838472|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
125221724|NCT03234036|450440338|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
125221725|NCT03234036|450440339|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
125221726|NCT03234036|450440340|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
125221727|NCT04547140|450440343|FG000|Overall Study|Adverse Event|0|||
125221728|NCT04547140|450440344|FG001|Overall Study|Adverse Event|1|||
125221729|NCT04547140|450440343|FG000|Overall Study|Withdrawal by Subject|0|||
125221730|NCT04547140|450440344|FG001|Overall Study|Withdrawal by Subject|1|||
125221731|NCT04547140|450440343|FG000|Overall Study|Lost to Follow-up|3|||
125221732|NCT04547140|450440344|FG001|Overall Study|Lost to Follow-up|1|||
125221733|NCT04547140|450440343|FG000|Overall Study|Death|2|||
125221734|NCT04547140|450440344|FG001|Overall Study|Death|1|||
125221735|NCT04547140|450440343|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
125221736|NCT04547140|450440344|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
125221737|NCT04547140|450440343|FG000|Overall Study|Pregnancy|1|||
125221738|NCT04547140|450440344|FG001|Overall Study|Pregnancy|0|||
125221739|NCT04547140|450440343|FG000|Overall Study|Reason Not Specified|4|||
125221740|NCT04547140|450440344|FG001|Overall Study|Reason Not Specified|1|||
125221741|NCT04613739|450440345|FG000|Overall Study|Lost to Follow-up|6|||
125221742|NCT04613739|450440346|FG001|Overall Study|Lost to Follow-up|9|||
125221743|NCT04613739|450440345|FG000|Overall Study|potentially duplicative/fraudulent|1|||
125221744|NCT04613739|450440346|FG001|Overall Study|potentially duplicative/fraudulent|3|||
125221745|NCT00003537|450440347|FG000|Overall Study|Not evalauable|1|||
125059912|NCT02175771|449838473|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125059913|NCT02175771|449838474|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125059914|NCT02175771|449838475|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125059915|NCT02175771|449838476|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125059916|NCT02175771|449838477|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125059917|NCT02175771|449838478|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125059918|NCT02175771|449838479|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125059919|NCT02175771|449838480|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125059920|NCT02175771|449838472|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
125059921|NCT02175771|449838473|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125059922|NCT02175771|449838474|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125059923|NCT02175771|449838475|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125059924|NCT02175771|449838476|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125059925|NCT02175771|449838477|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125059926|NCT02175771|449838478|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125059927|NCT02175771|449838479|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125059928|NCT02175771|449838480|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125059929|NCT02175771|449838472|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
125059930|NCT02175771|449838473|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
125059931|NCT02175771|449838474|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
125059932|NCT02175771|449838475|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
125059933|NCT02175771|449838476|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
125059934|NCT02175771|449838477|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
125059935|NCT02175771|449838478|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
125059936|NCT02175771|449838479|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
125059937|NCT02175771|449838480|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
125059938|NCT02175771|449838472|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
125059939|NCT02175771|449838473|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125059940|NCT02175771|449838474|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125059941|NCT02175771|449838475|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125059942|NCT02175771|449838476|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125059943|NCT02175771|449838477|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125059944|NCT02175771|449838478|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125059945|NCT02175771|449838479|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125059946|NCT02175771|449838480|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125059947|NCT02175771|449838472|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
125059948|NCT02175771|449838473|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125059949|NCT02175771|449838474|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125059950|NCT02175771|449838475|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125059951|NCT02175771|449838476|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125059952|NCT02175771|449838477|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125059953|NCT02175771|449838478|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125059954|NCT02175771|449838479|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125059955|NCT02175771|449838480|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125221746|NCT00735943|450440354|FG000|Overall Study|Lost to Follow-up|1|||
125221747|NCT00735943|450440354|FG000|Overall Study|Adverse Event|1|||
125221748|NCT01719380|450440359|FG000|Overall Study|Adverse Event|0|||
125221749|NCT01719380|450440360|FG001|Overall Study|Adverse Event|0|||
125221750|NCT01719380|450440361|FG002|Overall Study|Adverse Event|1|||
125221751|NCT01719380|450440362|FG003|Overall Study|Adverse Event|2|||
125221752|NCT01719380|450440363|FG004|Overall Study|Adverse Event|0|||
125221753|NCT01719380|450440364|FG005|Overall Study|Adverse Event|1|||
125221754|NCT01719380|450440365|FG006|Overall Study|Adverse Event|0|||
125221755|NCT01719380|450440366|FG007|Overall Study|Adverse Event|1|||
125221756|NCT01719380|450440367|FG008|Overall Study|Adverse Event|4|||
125221757|NCT01719380|450440368|FG009|Overall Study|Adverse Event|3|||
125221758|NCT01719380|450440359|FG000|Overall Study|Death|0|||
125221759|NCT01719380|450440360|FG001|Overall Study|Death|1|||
125221760|NCT01719380|450440361|FG002|Overall Study|Death|0|||
125221761|NCT01719380|450440362|FG003|Overall Study|Death|0|||
125221762|NCT01719380|450440363|FG004|Overall Study|Death|0|||
125221763|NCT01719380|450440364|FG005|Overall Study|Death|0|||
125221764|NCT01719380|450440365|FG006|Overall Study|Death|0|||
125221765|NCT01719380|450440366|FG007|Overall Study|Death|0|||
125221766|NCT01719380|450440367|FG008|Overall Study|Death|3|||
125221767|NCT01719380|450440368|FG009|Overall Study|Death|3|||
125221768|NCT01719380|450440359|FG000|Overall Study|Participant/Guardian Decision|0|||
125221769|NCT01719380|450440360|FG001|Overall Study|Participant/Guardian Decision|0|||
125221770|NCT01719380|450440361|FG002|Overall Study|Participant/Guardian Decision|1|||
125221771|NCT01719380|450440362|FG003|Overall Study|Participant/Guardian Decision|0|||
125221772|NCT01719380|450440363|FG004|Overall Study|Participant/Guardian Decision|0|||
125221773|NCT01719380|450440364|FG005|Overall Study|Participant/Guardian Decision|0|||
125221774|NCT01719380|450440365|FG006|Overall Study|Participant/Guardian Decision|0|||
125221775|NCT01719380|450440366|FG007|Overall Study|Participant/Guardian Decision|0|||
125221776|NCT01719380|450440367|FG008|Overall Study|Participant/Guardian Decision|2|||
125221777|NCT01719380|450440368|FG009|Overall Study|Participant/Guardian Decision|2|||
125221778|NCT01719380|450440359|FG000|Overall Study|Physician Decision|0|||
125221779|NCT01719380|450440360|FG001|Overall Study|Physician Decision|0|||
125221780|NCT01719380|450440361|FG002|Overall Study|Physician Decision|2|||
125221781|NCT01719380|450440362|FG003|Overall Study|Physician Decision|0|||
125221782|NCT01719380|450440363|FG004|Overall Study|Physician Decision|0|||
125221783|NCT01719380|450440364|FG005|Overall Study|Physician Decision|0|||
125221784|NCT01719380|450440365|FG006|Overall Study|Physician Decision|0|||
125221785|NCT01719380|450440366|FG007|Overall Study|Physician Decision|0|||
125221786|NCT01719380|450440367|FG008|Overall Study|Physician Decision|1|||
125221787|NCT01719380|450440368|FG009|Overall Study|Physician Decision|1|||
125221788|NCT01719380|450440359|FG000|Overall Study|Lack of Efficacy|2|||
125221789|NCT01719380|450440360|FG001|Overall Study|Lack of Efficacy|6|||
125221790|NCT01719380|450440361|FG002|Overall Study|Lack of Efficacy|5|||
125221791|NCT01719380|450440362|FG003|Overall Study|Lack of Efficacy|6|||
125221792|NCT01719380|450440363|FG004|Overall Study|Lack of Efficacy|3|||
125221793|NCT01719380|450440364|FG005|Overall Study|Lack of Efficacy|7|||
125221794|NCT01719380|450440365|FG006|Overall Study|Lack of Efficacy|10|||
125221795|NCT01719380|450440366|FG007|Overall Study|Lack of Efficacy|6|||
125221796|NCT01719380|450440367|FG008|Overall Study|Lack of Efficacy|39|||
125221797|NCT01719380|450440368|FG009|Overall Study|Lack of Efficacy|42|||
125221798|NCT01719380|450440359|FG000|Overall Study|Progressive Disease|0|||
125221799|NCT01719380|450440360|FG001|Overall Study|Progressive Disease|0|||
125221800|NCT01719380|450440361|FG002|Overall Study|Progressive Disease|0|||
125221801|NCT01719380|450440362|FG003|Overall Study|Progressive Disease|0|||
125221802|NCT01719380|450440363|FG004|Overall Study|Progressive Disease|0|||
125221803|NCT01719380|450440364|FG005|Overall Study|Progressive Disease|0|||
125221804|NCT01719380|450440365|FG006|Overall Study|Progressive Disease|0|||
125221805|NCT01719380|450440366|FG007|Overall Study|Progressive Disease|0|||
125221806|NCT01719380|450440367|FG008|Overall Study|Progressive Disease|1|||
125221807|NCT01719380|450440368|FG009|Overall Study|Progressive Disease|0|||
125221808|NCT01064414|450440369|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
125221809|NCT01064414|450440370|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
125221810|NCT01064414|450440371|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
125221811|NCT01064414|450440369|FG000|Core Period: Baseline to Week 26|Death|0|||
125221812|NCT01064414|450440370|FG001|Core Period: Baseline to Week 26|Death|1|||
125059956|NCT02175771|449838472|FG000|Run-In Period (Pre-assignment)|Other|8|||
125059957|NCT02175771|449838473|FG001|Run-In Period (Pre-assignment)|Other|0|||
125059958|NCT02175771|449838474|FG002|Run-In Period (Pre-assignment)|Other|0|||
125059959|NCT02175771|449838475|FG003|Run-In Period (Pre-assignment)|Other|0|||
125059960|NCT02175771|449838476|FG004|Run-In Period (Pre-assignment)|Other|0|||
125221813|NCT01064414|450440371|FG002|Core Period: Baseline to Week 26|Death|0|||
125221814|NCT01064414|450440369|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
125221815|NCT01064414|450440370|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
125221816|NCT01064414|450440371|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
125221817|NCT01064414|450440369|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
125221818|NCT01064414|450440370|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
125221819|NCT01064414|450440371|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
125221820|NCT01064414|450440369|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
125221821|NCT01064414|450440370|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
125221822|NCT01064414|450440371|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
125221823|NCT01064414|450440369|FG000|Core Period: Baseline to Week 26|Other|4|||
125221824|NCT01064414|450440370|FG001|Core Period: Baseline to Week 26|Other|7|||
125221825|NCT01064414|450440371|FG002|Core Period: Baseline to Week 26|Other|2|||
125221826|NCT01064414|450440369|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
125221827|NCT01064414|450440370|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
125221828|NCT01064414|450440371|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
125221829|NCT01064414|450440369|FG000|Extension Period: Week 26 to Week 52|Death|0|||
125221830|NCT01064414|450440370|FG001|Extension Period: Week 26 to Week 52|Death|1|||
125221831|NCT01064414|450440371|FG002|Extension Period: Week 26 to Week 52|Death|0|||
125221832|NCT01064414|450440369|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
125221833|NCT01064414|450440370|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
125221834|NCT01064414|450440371|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
125221835|NCT01064414|450440369|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
125221836|NCT01064414|450440370|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
125221837|NCT01064414|450440371|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
125221838|NCT01064414|450440369|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
125221839|NCT01064414|450440370|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
125221840|NCT01064414|450440371|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
125221841|NCT01064414|450440369|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
125221842|NCT01064414|450440370|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
125221843|NCT01064414|450440371|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
125221844|NCT01064414|450440369|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
125221845|NCT01064414|450440370|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
125221846|NCT01064414|450440371|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
125221847|NCT01064414|450440369|FG000|Extension Period: Week 26 to Week 52|Other|5|||
125221848|NCT01064414|450440370|FG001|Extension Period: Week 26 to Week 52|Other|2|||
125221849|NCT01064414|450440371|FG002|Extension Period: Week 26 to Week 52|Other|1|||
125221850|NCT00249873|450440372|FG000|Overall Study|Not treated|7|||
125221851|NCT00249873|450440373|FG001|Overall Study|Not treated|8|||
125221852|NCT00249873|450440372|FG000|Overall Study|Significant thrombocytopenia|9|||
125221853|NCT00249873|450440373|FG001|Overall Study|Significant thrombocytopenia|8|||
125221854|NCT00249873|450440372|FG000|Overall Study|Severe allergic reaction|8|||
125221855|NCT00249873|450440373|FG001|Overall Study|Severe allergic reaction|1|||
125221856|NCT00249873|450440372|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
125221857|NCT00249873|450440373|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
125221858|NCT00249873|450440372|FG000|Overall Study|Other Serious Adverse Event|86|||
125221859|NCT00249873|450440373|FG001|Overall Study|Other Serious Adverse Event|97|||
125221860|NCT00249873|450440372|FG000|Overall Study|Qualifying condition not present|20|||
125221861|NCT00249873|450440373|FG001|Overall Study|Qualifying condition not present|23|||
125221862|NCT00249873|450440372|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
125221863|NCT00249873|450440373|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
125221864|NCT00249873|450440372|FG000|Overall Study|Withdrawal by Subject|504|||
125221865|NCT00249873|450440373|FG001|Overall Study|Withdrawal by Subject|466|||
125221866|NCT00249873|450440372|FG000|Overall Study|Lost to Follow-up|4|||
125221867|NCT00249873|450440373|FG001|Overall Study|Lost to Follow-up|7|||
125221868|NCT00249873|450440372|FG000|Overall Study|Minor bleeding|99|||
125221869|NCT00249873|450440373|FG001|Overall Study|Minor bleeding|37|||
125221870|NCT00249873|450440372|FG000|Overall Study|Non-compliance|41|||
125221871|NCT00249873|450440373|FG001|Overall Study|Non-compliance|46|||
125221872|NCT00249873|450440372|FG000|Overall Study|Other non serious Adverse Event|112|||
125221873|NCT00249873|450440373|FG001|Overall Study|Other non serious Adverse Event|108|||
125221874|NCT00249873|450440372|FG000|Overall Study|Other contraindicated medication|1|||
125221875|NCT00249873|450440373|FG001|Overall Study|Other contraindicated medication|0|||
125221876|NCT00249873|450440372|FG000|Overall Study|Patient not wish to continue after May08|3|||
125221877|NCT00249873|450440373|FG001|Overall Study|Patient not wish to continue after May08|4|||
125221878|NCT00249873|450440372|FG000|Overall Study|Physician withdrew consent|59|||
125221879|NCT00249873|450440373|FG001|Overall Study|Physician withdrew consent|60|||
125221880|NCT00249873|450440372|FG000|Overall Study|Open label clopidogrel required|31|||
125221881|NCT00249873|450440373|FG001|Overall Study|Open label clopidogrel required|42|||
125221882|NCT00249873|450440372|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
125221883|NCT00249873|450440373|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
125221884|NCT00249873|450440372|FG000|Overall Study|Oral anticoagulant required|159|||
125221885|NCT00249873|450440373|FG001|Overall Study|Oral anticoagulant required|157|||
125221886|NCT00249873|450440372|FG000|Overall Study|Study drug intolerance|5|||
125221887|NCT00249873|450440373|FG001|Overall Study|Study drug intolerance|0|||
125221888|NCT00249873|450440372|FG000|Overall Study|Surgery/ procedure|9|||
125221889|NCT00249873|450440373|FG001|Overall Study|Surgery/ procedure|9|||
125059961|NCT02175771|449838477|FG005|Run-In Period (Pre-assignment)|Other|0|||
125059962|NCT02175771|449838478|FG006|Run-In Period (Pre-assignment)|Other|0|||
125059963|NCT02175771|449838479|FG007|Run-In Period (Pre-assignment)|Other|0|||
125059964|NCT02175771|449838480|FG008|Run-In Period (Pre-assignment)|Other|0|||
125059965|NCT02175771|449838472|FG000|Treatment Period|Adverse Event|0|||
125059966|NCT02175771|449838473|FG001|Treatment Period|Adverse Event|2|||
125059967|NCT02175771|449838474|FG002|Treatment Period|Adverse Event|1|||
125059968|NCT02175771|449838475|FG003|Treatment Period|Adverse Event|1|||
125059969|NCT02175771|449838476|FG004|Treatment Period|Adverse Event|1|||
125059970|NCT02175771|449838477|FG005|Treatment Period|Adverse Event|3|||
125059971|NCT02175771|449838478|FG006|Treatment Period|Adverse Event|2|||
125059972|NCT02175771|449838479|FG007|Treatment Period|Adverse Event|0|||
125059973|NCT02175771|449838480|FG008|Treatment Period|Adverse Event|1|||
125059974|NCT02175771|449838472|FG000|Treatment Period|Withdrawal by Subject|0|||
125059975|NCT02175771|449838473|FG001|Treatment Period|Withdrawal by Subject|9|||
125059976|NCT02175771|449838474|FG002|Treatment Period|Withdrawal by Subject|3|||
125059977|NCT02175771|449838475|FG003|Treatment Period|Withdrawal by Subject|6|||
125059978|NCT02175771|449838476|FG004|Treatment Period|Withdrawal by Subject|2|||
125059979|NCT02175771|449838477|FG005|Treatment Period|Withdrawal by Subject|4|||
125059980|NCT02175771|449838478|FG006|Treatment Period|Withdrawal by Subject|2|||
125059981|NCT02175771|449838479|FG007|Treatment Period|Withdrawal by Subject|9|||
125059982|NCT02175771|449838480|FG008|Treatment Period|Withdrawal by Subject|2|||
125059983|NCT02175771|449838472|FG000|Treatment Period|Noncompliance|0|||
125059984|NCT02175771|449838473|FG001|Treatment Period|Noncompliance|1|||
125059985|NCT02175771|449838474|FG002|Treatment Period|Noncompliance|2|||
125059986|NCT02175771|449838475|FG003|Treatment Period|Noncompliance|0|||
125059987|NCT02175771|449838476|FG004|Treatment Period|Noncompliance|0|||
125059988|NCT02175771|449838477|FG005|Treatment Period|Noncompliance|0|||
125059989|NCT02175771|449838478|FG006|Treatment Period|Noncompliance|0|||
125059990|NCT02175771|449838479|FG007|Treatment Period|Noncompliance|0|||
125138870|NCT00112437|450131209|FG005|Years 6-10 (60-Month Extension)|Death|0|||
125138871|NCT00112437|450131210|FG006|Years 6-10 (60-Month Extension)|Death|0|||
125138872|NCT00112437|450131211|FG007|Years 6-10 (60-Month Extension)|Death|0|||
125138873|NCT00112437|450131212|FG008|Years 6-10 (60-Month Extension)|Death|0|||
125138874|NCT00112437|450131213|FG009|Years 6-10 (60-Month Extension)|Death|0|||
125138875|NCT00112437|450131214|FG010|Years 6-10 (60-Month Extension)|Death|0|||
125138876|NCT00112437|450131215|FG011|Years 6-10 (60-Month Extension)|Death|0|||
125059991|NCT02175771|449838480|FG008|Treatment Period|Noncompliance|1|||
125059992|NCT02175771|449838472|FG000|Treatment Period|Protocol Violation|0|||
125059993|NCT02175771|449838473|FG001|Treatment Period|Protocol Violation|0|||
125059994|NCT02175771|449838474|FG002|Treatment Period|Protocol Violation|0|||
125138877|NCT00112437|450131216|FG012|Years 6-10 (60-Month Extension)|Death|0|||
125138878|NCT00112437|450131217|FG013|Years 6-10 (60-Month Extension)|Death|0|||
125138879|NCT00112437|450131218|FG014|Years 6-10 (60-Month Extension)|Death|0|||
125059995|NCT02175771|449838475|FG003|Treatment Period|Protocol Violation|0|||
125221890|NCT00249873|450440372|FG000|Overall Study|Event related to cardiac condition|12|||
125221891|NCT00249873|450440373|FG001|Overall Study|Event related to cardiac condition|21|||
125221892|NCT00249873|450440372|FG000|Overall Study|Thromboembolic/outcome event|82|||
125221893|NCT00249873|450440373|FG001|Overall Study|Thromboembolic/outcome event|122|||
125221894|NCT03286218|450440374|FG000|Qualification Phase Period 1|Adverse Event|1|||
125221895|NCT03286218|450440375|FG001|Qualification Phase Period 1|Adverse Event|0|||
125221896|NCT03286218|450440376|FG002|Qualification Phase Period 1|Adverse Event|0|||
125221897|NCT03286218|450440377|FG003|Qualification Phase Period 1|Adverse Event|0|||
125221898|NCT03286218|450440378|FG004|Qualification Phase Period 1|Adverse Event|0|||
125221899|NCT03286218|450440379|FG005|Qualification Phase Period 1|Adverse Event|0|||
125221900|NCT03286218|450440380|FG006|Qualification Phase Period 1|Adverse Event|0|||
125221901|NCT03286218|450440381|FG007|Qualification Phase Period 1|Adverse Event|0|||
125221902|NCT03286218|450440382|FG008|Qualification Phase Period 1|Adverse Event|0|||
125221903|NCT03286218|450440383|FG009|Qualification Phase Period 1|Adverse Event|0|||
125221904|NCT03286218|450440384|FG010|Qualification Phase Period 1|Adverse Event|0|||
125221905|NCT03286218|450440385|FG011|Qualification Phase Period 1|Adverse Event|0|||
125221906|NCT03286218|450440374|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221907|NCT03286218|450440375|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
125221908|NCT03286218|450440376|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221909|NCT03286218|450440377|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221910|NCT03286218|450440378|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221911|NCT03286218|450440379|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221912|NCT03286218|450440380|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221913|NCT03286218|450440381|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221914|NCT03286218|450440382|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221915|NCT03286218|450440383|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221916|NCT03286218|450440384|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221917|NCT03286218|450440385|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221918|NCT03286218|450440374|FG000|Qualification Phase Period 2|Adverse Event|0|||
125221919|NCT03286218|450440375|FG001|Qualification Phase Period 2|Adverse Event|1|||
125221920|NCT03286218|450440376|FG002|Qualification Phase Period 2|Adverse Event|0|||
125221921|NCT03286218|450440377|FG003|Qualification Phase Period 2|Adverse Event|0|||
125221922|NCT03286218|450440378|FG004|Qualification Phase Period 2|Adverse Event|0|||
125221923|NCT03286218|450440379|FG005|Qualification Phase Period 2|Adverse Event|0|||
125221924|NCT03286218|450440380|FG006|Qualification Phase Period 2|Adverse Event|0|||
125221925|NCT03286218|450440381|FG007|Qualification Phase Period 2|Adverse Event|0|||
125221926|NCT03286218|450440382|FG008|Qualification Phase Period 2|Adverse Event|0|||
125221927|NCT03286218|450440383|FG009|Qualification Phase Period 2|Adverse Event|0|||
125221928|NCT03286218|450440384|FG010|Qualification Phase Period 2|Adverse Event|0|||
125221929|NCT03286218|450440385|FG011|Qualification Phase Period 2|Adverse Event|0|||
125221930|NCT03286218|450440374|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
125221931|NCT03286218|450440375|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
125221932|NCT03286218|450440376|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
125221933|NCT03286218|450440377|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
125221934|NCT03286218|450440378|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
125221935|NCT03286218|450440379|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
125221936|NCT03286218|450440380|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
125221937|NCT03286218|450440381|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
125221938|NCT03286218|450440382|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
125221939|NCT03286218|450440383|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
125221940|NCT03286218|450440384|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
125221941|NCT03286218|450440385|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
125221942|NCT03286218|450440374|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
125221943|NCT03286218|450440375|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
125221944|NCT03286218|450440376|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
125221945|NCT03286218|450440377|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
125221946|NCT03286218|450440378|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
125221947|NCT03286218|450440379|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
125221948|NCT03286218|450440380|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
125221949|NCT03286218|450440381|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
125221950|NCT03286218|450440382|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
125221951|NCT03286218|450440383|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
125221952|NCT03286218|450440384|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
125221953|NCT03286218|450440385|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
125221954|NCT03286218|450440374|FG000|Qualification Phase Period 2|Protocol Violation|2|||
125221955|NCT03286218|450440375|FG001|Qualification Phase Period 2|Protocol Violation|0|||
125221956|NCT03286218|450440376|FG002|Qualification Phase Period 2|Protocol Violation|0|||
125221957|NCT03286218|450440377|FG003|Qualification Phase Period 2|Protocol Violation|0|||
125221958|NCT03286218|450440378|FG004|Qualification Phase Period 2|Protocol Violation|0|||
125221959|NCT03286218|450440379|FG005|Qualification Phase Period 2|Protocol Violation|0|||
125221960|NCT03286218|450440380|FG006|Qualification Phase Period 2|Protocol Violation|0|||
125221961|NCT03286218|450440381|FG007|Qualification Phase Period 2|Protocol Violation|0|||
125221962|NCT03286218|450440382|FG008|Qualification Phase Period 2|Protocol Violation|0|||
125221963|NCT03286218|450440383|FG009|Qualification Phase Period 2|Protocol Violation|0|||
125221964|NCT03286218|450440384|FG010|Qualification Phase Period 2|Protocol Violation|0|||
125221965|NCT03286218|450440385|FG011|Qualification Phase Period 2|Protocol Violation|0|||
125221966|NCT03286218|450440374|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
125221967|NCT03286218|450440375|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
125221968|NCT03286218|450440376|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
125221969|NCT03286218|450440377|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
125221970|NCT03286218|450440378|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
125221971|NCT03286218|450440379|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
125221972|NCT03286218|450440380|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
125221973|NCT03286218|450440381|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
125221974|NCT03286218|450440382|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
125221975|NCT03286218|450440383|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
125221976|NCT03286218|450440384|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
125221977|NCT03286218|450440385|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
125221978|NCT03286218|450440374|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
125221979|NCT03286218|450440375|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
125221980|NCT03286218|450440376|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
125221981|NCT03286218|450440377|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
125221982|NCT03286218|450440378|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
125221983|NCT03286218|450440379|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
125221984|NCT03286218|450440380|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
125221985|NCT03286218|450440381|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
125221986|NCT03286218|450440382|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
125221987|NCT03286218|450440383|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
125221988|NCT03286218|450440384|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
125221989|NCT03286218|450440385|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
125221990|NCT03286218|450440374|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
125221991|NCT03286218|450440375|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
125221992|NCT03286218|450440376|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
125221993|NCT03286218|450440377|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
125221994|NCT03286218|450440378|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
125221995|NCT03286218|450440379|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
125221996|NCT03286218|450440380|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
125221997|NCT03286218|450440381|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
125221998|NCT03286218|450440382|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
125221999|NCT03286218|450440383|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
125222000|NCT03286218|450440384|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
125222001|NCT03286218|450440385|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
125222002|NCT01348139|450440386|FG000|Period 1|Adverse Event|1|||
125222003|NCT01348139|450440387|FG001|Period 1|Adverse Event|0|||
125222004|NCT01348139|450440388|FG002|Period 1|Adverse Event|0|||
125222005|NCT01348139|450440389|FG003|Period 1|Adverse Event|0|||
125222006|NCT01348139|450440390|FG004|Period 1|Adverse Event|0|||
125222007|NCT01348139|450440391|FG005|Period 1|Adverse Event|0|||
125222008|NCT02762084|450440394|FG000|Overall Study|Withdrawal by Subject|1|||
125222009|NCT02762084|450440395|FG001|Overall Study|Withdrawal by Subject|0|||
125222010|NCT02762084|450440396|FG002|Overall Study|Withdrawal by Subject|0|||
125222011|NCT02762084|450440394|FG000|Overall Study|Adverse Event|0|||
125222012|NCT02762084|450440395|FG001|Overall Study|Adverse Event|0|||
125222013|NCT02762084|450440396|FG002|Overall Study|Adverse Event|1|||
125222014|NCT01001910|450440399|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
125222015|NCT01619852|450440404|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
125222016|NCT01619852|450440405|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
125222017|NCT01619852|450440404|FG000|3 Month Follow up|Lost to Follow-up|31|||
125222018|NCT01619852|450440405|FG001|3 Month Follow up|Lost to Follow-up|34|||
125222019|NCT00970489|450440408|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
125222020|NCT00970489|450440409|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
125222021|NCT02168491|450440410|FG000|Overall Study|Withdrawal by Subject|1|||
125222022|NCT01096160|450440411|FG000|Overall Study|Adverse Event|0|||
125222023|NCT01096160|450440412|FG001|Overall Study|Adverse Event|0|||
125222024|NCT01096160|450440413|FG002|Overall Study|Adverse Event|1|||
125222025|NCT01096160|450440414|FG003|Overall Study|Adverse Event|0|||
125222026|NCT01096160|450440415|FG004|Overall Study|Adverse Event|0|||
125222027|NCT01096160|450440416|FG005|Overall Study|Adverse Event|0|||
125222028|NCT01096160|450440417|FG006|Overall Study|Adverse Event|0|||
125059996|NCT02175771|449838476|FG004|Treatment Period|Protocol Violation|0|||
125059997|NCT02175771|449838477|FG005|Treatment Period|Protocol Violation|0|||
125222029|NCT01096160|450440418|FG007|Overall Study|Adverse Event|0|||
125222030|NCT01096160|450440419|FG008|Overall Study|Adverse Event|0|||
125222031|NCT01096160|450440420|FG009|Overall Study|Adverse Event|1|||
125222032|NCT01096160|450440411|FG000|Overall Study|Met stopping criteria per protocol|0|||
125222033|NCT01096160|450440412|FG001|Overall Study|Met stopping criteria per protocol|0|||
125222034|NCT01096160|450440413|FG002|Overall Study|Met stopping criteria per protocol|0|||
125222035|NCT01096160|450440414|FG003|Overall Study|Met stopping criteria per protocol|0|||
125222036|NCT01096160|450440415|FG004|Overall Study|Met stopping criteria per protocol|1|||
125222037|NCT01096160|450440416|FG005|Overall Study|Met stopping criteria per protocol|0|||
125222038|NCT01096160|450440417|FG006|Overall Study|Met stopping criteria per protocol|2|||
125222039|NCT01096160|450440418|FG007|Overall Study|Met stopping criteria per protocol|0|||
125222040|NCT01096160|450440419|FG008|Overall Study|Met stopping criteria per protocol|2|||
125222041|NCT01096160|450440420|FG009|Overall Study|Met stopping criteria per protocol|0|||
125222042|NCT01610037|450440421|FG000|All Patients|Adverse Event|27|||
125222043|NCT01610037|450440422|FG001|All Patients|Adverse Event|22|||
125222044|NCT01610037|450440423|FG002|All Patients|Adverse Event|26|||
125222045|NCT01610037|450440421|FG000|All Patients|Withdrawal by Subject|12|||
125222046|NCT01610037|450440422|FG001|All Patients|Withdrawal by Subject|10|||
125222047|NCT01610037|450440423|FG002|All Patients|Withdrawal by Subject|20|||
125222048|NCT01610037|450440421|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
125222049|NCT01610037|450440422|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
125222050|NCT01610037|450440423|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
125222051|NCT01610037|450440421|FG000|All Patients|Death|4|||
125222052|NCT01610037|450440422|FG001|All Patients|Death|2|||
125222053|NCT01610037|450440423|FG002|All Patients|Death|1|||
125222054|NCT01610037|450440421|FG000|All Patients|Protocol deviation|4|||
125222055|NCT01610037|450440422|FG001|All Patients|Protocol deviation|3|||
125222056|NCT01610037|450440423|FG002|All Patients|Protocol deviation|3|||
125222057|NCT01610037|450440421|FG000|All Patients|Abnormal laboratory value|1|||
125222058|NCT01610037|450440422|FG001|All Patients|Abnormal laboratory value|1|||
125222059|NCT01610037|450440423|FG002|All Patients|Abnormal laboratory value|0|||
125222060|NCT01610037|450440421|FG000|All Patients|Administrative problems|1|||
125222061|NCT01610037|450440422|FG001|All Patients|Administrative problems|4|||
125222062|NCT01610037|450440423|FG002|All Patients|Administrative problems|4|||
125222063|NCT01610037|450440421|FG000|All Patients|Lost to Follow-up|1|||
125222064|NCT01610037|450440422|FG001|All Patients|Lost to Follow-up|0|||
125222065|NCT01610037|450440423|FG002|All Patients|Lost to Follow-up|0|||
125222066|NCT01610037|450440421|FG000|All Patients|Abnormal test procedure result(s)|0|||
125222067|NCT01610037|450440422|FG001|All Patients|Abnormal test procedure result(s)|1|||
125222068|NCT01610037|450440423|FG002|All Patients|Abnormal test procedure result(s)|3|||
125222069|NCT01610037|450440421|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
125222070|NCT01610037|450440422|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
125222071|NCT01610037|450440423|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
125222072|NCT01610037|450440421|FG000|Treatment and Follow up Period|Death|10|||
125222073|NCT01610037|450440422|FG001|Treatment and Follow up Period|Death|5|||
125222074|NCT01610037|450440423|FG002|Treatment and Follow up Period|Death|4|||
125222075|NCT01610037|450440421|FG000|Treatment and Follow up Period|Administrative problems|1|||
125222076|NCT01610037|450440422|FG001|Treatment and Follow up Period|Administrative problems|3|||
125222077|NCT01610037|450440423|FG002|Treatment and Follow up Period|Administrative problems|2|||
125222078|NCT01610037|450440421|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
125222079|NCT01610037|450440422|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
125222080|NCT01610037|450440423|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
125222081|NCT00705757|450440424|FG000|Overall Study|Lack of Efficacy|5|||
125222082|NCT00705757|450440425|FG001|Overall Study|Lack of Efficacy|1|||
125222083|NCT00705757|450440426|FG002|Overall Study|Lack of Efficacy|3|||
125222084|NCT00705757|450440424|FG000|Overall Study|Lost to Follow-up|7|||
125222085|NCT00705757|450440425|FG001|Overall Study|Lost to Follow-up|6|||
125222086|NCT00705757|450440426|FG002|Overall Study|Lost to Follow-up|6|||
125222087|NCT00705757|450440424|FG000|Overall Study|Withdrawal by Subject|1|||
125222088|NCT00705757|450440425|FG001|Overall Study|Withdrawal by Subject|1|||
125222089|NCT00705757|450440426|FG002|Overall Study|Withdrawal by Subject|2|||
125222090|NCT03193047|450440427|FG000|Overall Study|Physician Decision|1|||
125222091|NCT03193047|450440428|FG001|Overall Study|Physician Decision|0|||
125059998|NCT02175771|449838478|FG006|Treatment Period|Protocol Violation|0|||
125059999|NCT02175771|449838479|FG007|Treatment Period|Protocol Violation|1|||
125222092|NCT03193047|450440427|FG000|Overall Study|Participant Left State|1|||
125222093|NCT03193047|450440428|FG001|Overall Study|Participant Left State|0|||
125222094|NCT03743025|450440429|FG000|Overall Study|Surgery was cancelled|2|||
125060000|NCT02175771|449838480|FG008|Treatment Period|Protocol Violation|0|||
125222095|NCT03743025|450440430|FG001|Overall Study|Surgery was cancelled|1|||
125222096|NCT02420119|450440431|FG000|Overall Study|insufficient laboratory data|5|||
125222097|NCT00149396|450440432|FG000|Overall Study|Death|15|||
125222098|NCT00149396|450440432|FG000|Overall Study|Withdrawal by Subject|1|||
125060001|NCT02175771|449838472|FG000|Treatment Period|Disease progression|0|||
125060002|NCT02175771|449838473|FG001|Treatment Period|Disease progression|0|||
125060003|NCT02175771|449838474|FG002|Treatment Period|Disease progression|0|||
125060004|NCT02175771|449838475|FG003|Treatment Period|Disease progression|0|||
125060005|NCT02175771|449838476|FG004|Treatment Period|Disease progression|0|||
125060006|NCT02175771|449838477|FG005|Treatment Period|Disease progression|0|||
125060007|NCT02175771|449838478|FG006|Treatment Period|Disease progression|0|||
125060008|NCT02175771|449838479|FG007|Treatment Period|Disease progression|2|||
125060009|NCT02175771|449838480|FG008|Treatment Period|Disease progression|0|||
125060010|NCT02175771|449838472|FG000|Treatment Period|Lost to Follow-up|0|||
125222099|NCT00149396|450440432|FG000|Overall Study|Subject noncompliance|2|||
125222100|NCT00149396|450440432|FG000|Overall Study|other treatment|5|||
125222101|NCT00186485|450440435|FG000|Overall Study|Lost to Follow-up|3|||
125222102|NCT00227539|450440438|FG000|Overall Study|Protocol Violation|1|||
125222103|NCT01922258|450440439|FG000|Overall Study|Lost to Follow-up|1|||
125222104|NCT01922258|450440440|FG001|Overall Study|Lost to Follow-up|1|||
125222105|NCT01922258|450440439|FG000|Overall Study|Adverse Event|9|||
125222106|NCT01922258|450440440|FG001|Overall Study|Adverse Event|2|||
125222107|NCT01922258|450440439|FG000|Overall Study|Met Withdrawal Criteria|0|||
125222108|NCT01922258|450440440|FG001|Overall Study|Met Withdrawal Criteria|4|||
125222109|NCT01922258|450440439|FG000|Overall Study|Withdrawn by the Investigator|1|||
125222110|NCT01922258|450440440|FG001|Overall Study|Withdrawn by the Investigator|4|||
125222111|NCT01922258|450440439|FG000|Overall Study|Withdrawal by participant|5|||
125222112|NCT01922258|450440440|FG001|Overall Study|Withdrawal by participant|5|||
125222113|NCT00673257|450440441|FG000|Overall Study|Withdrawal by Subject|4|||
125222114|NCT00673257|450440441|FG000|Overall Study|Unable to obtain specimen|1|||
125222115|NCT04552132|450440442|FG000|Overall Study|Lost to Follow-up|4|||
125222116|NCT04552132|450440443|FG001|Overall Study|Lost to Follow-up|3|||
125222117|NCT04552132|450440442|FG000|Overall Study|Protocol Violation|1|||
125222118|NCT04552132|450440443|FG001|Overall Study|Protocol Violation|0|||
125222119|NCT02256839|450440444|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
125222120|NCT02256839|450440445|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
125222121|NCT01951417|450440460|FG000|Overall Study|Withdrawal by Subject|1|||
125222122|NCT01951417|450440460|FG000|Overall Study|Protocol Violation|2|||
125222123|NCT01951417|450440460|FG000|Overall Study|Lost to Follow-up|6|||
125222124|NCT01705977|450440467|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
125222125|NCT01705977|450440468|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
125222126|NCT01705977|450440467|FG000|Treatment Period (Year 1)|Adverse Event|57|||
125060011|NCT02175771|449838473|FG001|Treatment Period|Lost to Follow-up|3|||
125222127|NCT01705977|450440468|FG001|Treatment Period (Year 1)|Adverse Event|49|||
125222128|NCT01705977|450440467|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
125060012|NCT02175771|449838474|FG002|Treatment Period|Lost to Follow-up|1|||
125060013|NCT02175771|449838475|FG003|Treatment Period|Lost to Follow-up|3|||
125060014|NCT02175771|449838476|FG004|Treatment Period|Lost to Follow-up|1|||
125060015|NCT02175771|449838477|FG005|Treatment Period|Lost to Follow-up|2|||
125060016|NCT02175771|449838478|FG006|Treatment Period|Lost to Follow-up|1|||
125060017|NCT02175771|449838479|FG007|Treatment Period|Lost to Follow-up|2|||
125060018|NCT02175771|449838480|FG008|Treatment Period|Lost to Follow-up|2|||
125060019|NCT02175771|449838472|FG000|Treatment Period|Lack of Efficacy|0|||
125060020|NCT02175771|449838473|FG001|Treatment Period|Lack of Efficacy|0|||
125060021|NCT02175771|449838474|FG002|Treatment Period|Lack of Efficacy|0|||
125060022|NCT02175771|449838475|FG003|Treatment Period|Lack of Efficacy|0|||
125060023|NCT02175771|449838476|FG004|Treatment Period|Lack of Efficacy|0|||
125060024|NCT02175771|449838477|FG005|Treatment Period|Lack of Efficacy|1|||
125060025|NCT02175771|449838478|FG006|Treatment Period|Lack of Efficacy|0|||
125060026|NCT02175771|449838479|FG007|Treatment Period|Lack of Efficacy|1|||
125060027|NCT02175771|449838480|FG008|Treatment Period|Lack of Efficacy|0|||
125060028|NCT02175771|449838472|FG000|Treatment Period|Other|0|||
125060029|NCT02175771|449838473|FG001|Treatment Period|Other|1|||
125222129|NCT01705977|450440468|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
125060030|NCT02175771|449838474|FG002|Treatment Period|Other|0|||
125060031|NCT02175771|449838475|FG003|Treatment Period|Other|3|||
125060032|NCT02175771|449838476|FG004|Treatment Period|Other|1|||
125060033|NCT02175771|449838477|FG005|Treatment Period|Other|0|||
125060034|NCT02175771|449838478|FG006|Treatment Period|Other|0|||
125060035|NCT02175771|449838479|FG007|Treatment Period|Other|2|||
125060036|NCT02175771|449838480|FG008|Treatment Period|Other|0|||
125060037|NCT03364673|449838483|FG000|Overall Study|Withdrawal by Subject|2|||
125222130|NCT01705977|450440467|FG000|Treatment Period (Year 1)|Site closure|3|||
125222131|NCT01705977|450440468|FG001|Treatment Period (Year 1)|Site closure|2|||
125222132|NCT01705977|450440467|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
125060038|NCT03364673|449838483|FG000|Overall Study|Injury unrelated to study|3|||
125060039|NCT02232087|449838484|FG000|Overall Study|Withdrawal by Subject|2|||
125060040|NCT02232087|449838485|FG001|Overall Study|Withdrawal by Subject|0|||
125060041|NCT02232087|449838486|FG002|Overall Study|Withdrawal by Subject|0|||
125060042|NCT02232087|449838487|FG003|Overall Study|Withdrawal by Subject|0|||
125060043|NCT02232087|449838488|FG004|Overall Study|Withdrawal by Subject|0|||
125138880|NCT00112437|450131219|FG015|Years 6-10 (60-Month Extension)|Death|0|||
125138881|NCT00112437|450131220|FG016|Years 6-10 (60-Month Extension)|Death|0|||
125138882|NCT00112437|450131221|FG017|Years 6-10 (60-Month Extension)|Death|0|||
125138883|NCT00112437|450131222|FG018|Years 6-10 (60-Month Extension)|Death|0|||
125138884|NCT00112437|450131223|FG019|Years 6-10 (60-Month Extension)|Death|0|||
125138885|NCT00112437|450131224|FG020|Years 6-10 (60-Month Extension)|Death|0|||
125138886|NCT00112437|450131225|FG021|Years 6-10 (60-Month Extension)|Death|0|||
125138887|NCT00112437|450131226|FG022|Years 6-10 (60-Month Extension)|Death|0|||
125138888|NCT00112437|450131227|FG023|Years 6-10 (60-Month Extension)|Death|2|||
125138889|NCT00112437|450131228|FG024|Years 6-10 (60-Month Extension)|Death|0|||
125138890|NCT00112437|450131229|FG025|Years 6-10 (60-Month Extension)|Death|0|||
125138891|NCT00112437|450131204|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138892|NCT00112437|450131205|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125060044|NCT02232087|449838489|FG005|Overall Study|Withdrawal by Subject|1|||
125060045|NCT02232087|449838484|FG000|Overall Study|poor inhalation technique|0|||
125060046|NCT02232087|449838485|FG001|Overall Study|poor inhalation technique|1|||
125060047|NCT02232087|449838486|FG002|Overall Study|poor inhalation technique|0|||
125060048|NCT02232087|449838487|FG003|Overall Study|poor inhalation technique|0|||
125060049|NCT02232087|449838488|FG004|Overall Study|poor inhalation technique|0|||
125060050|NCT02232087|449838489|FG005|Overall Study|poor inhalation technique|2|||
125060051|NCT02232087|449838484|FG000|Overall Study|protocol stop criteria|0|||
125060052|NCT02232087|449838485|FG001|Overall Study|protocol stop criteria|1|||
125060053|NCT02232087|449838486|FG002|Overall Study|protocol stop criteria|0|||
125060054|NCT02232087|449838487|FG003|Overall Study|protocol stop criteria|1|||
125060055|NCT02232087|449838488|FG004|Overall Study|protocol stop criteria|0|||
125060056|NCT02232087|449838489|FG005|Overall Study|protocol stop criteria|0|||
125060057|NCT02232087|449838484|FG000|Overall Study|Adverse Event|0|||
125060058|NCT02232087|449838485|FG001|Overall Study|Adverse Event|0|||
125060059|NCT02232087|449838486|FG002|Overall Study|Adverse Event|0|||
125060060|NCT02232087|449838487|FG003|Overall Study|Adverse Event|0|||
125060061|NCT02232087|449838488|FG004|Overall Study|Adverse Event|1|||
125060062|NCT02232087|449838489|FG005|Overall Study|Adverse Event|0|||
125060063|NCT02504268|449838491|FG000|Overall Study|Adverse Event|18|||
125060064|NCT02504268|449838492|FG001|Overall Study|Adverse Event|8|||
125060065|NCT02504268|449838493|FG002|Overall Study|Adverse Event|14|||
125060066|NCT02504268|449838494|FG003|Overall Study|Adverse Event|0|||
125060067|NCT02504268|449838495|FG004|Overall Study|Adverse Event|0|||
125138893|NCT00112437|450131206|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138894|NCT00112437|450131207|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138895|NCT00112437|450131208|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138896|NCT00112437|450131209|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138897|NCT00112437|450131210|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138898|NCT00112437|450131211|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138899|NCT00112437|450131212|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138900|NCT00112437|450131213|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138901|NCT00112437|450131214|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138902|NCT00112437|450131215|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138903|NCT00112437|450131216|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138904|NCT00112437|450131217|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138905|NCT00112437|450131218|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138906|NCT00112437|450131219|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138907|NCT00112437|450131220|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138908|NCT00112437|450131221|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138909|NCT00112437|450131222|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138910|NCT00112437|450131223|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138911|NCT00112437|450131224|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138912|NCT00112437|450131225|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138913|NCT00112437|450131226|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138914|NCT00112437|450131227|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138915|NCT00112437|450131228|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138916|NCT00112437|450131229|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
125138917|NCT00112437|450131204|FG000|Years 6-10 (60-Month Extension)|Other|0|||
125138918|NCT00112437|450131205|FG001|Years 6-10 (60-Month Extension)|Other|0|||
125138919|NCT00112437|450131206|FG002|Years 6-10 (60-Month Extension)|Other|0|||
125138920|NCT00112437|450131207|FG003|Years 6-10 (60-Month Extension)|Other|0|||
125138921|NCT00112437|450131208|FG004|Years 6-10 (60-Month Extension)|Other|0|||
125138922|NCT00112437|450131209|FG005|Years 6-10 (60-Month Extension)|Other|0|||
125138923|NCT00112437|450131210|FG006|Years 6-10 (60-Month Extension)|Other|0|||
125138924|NCT00112437|450131211|FG007|Years 6-10 (60-Month Extension)|Other|0|||
125138925|NCT00112437|450131212|FG008|Years 6-10 (60-Month Extension)|Other|0|||
125138926|NCT00112437|450131213|FG009|Years 6-10 (60-Month Extension)|Other|0|||
125138927|NCT00112437|450131214|FG010|Years 6-10 (60-Month Extension)|Other|0|||
125138928|NCT00112437|450131215|FG011|Years 6-10 (60-Month Extension)|Other|0|||
125138929|NCT00112437|450131216|FG012|Years 6-10 (60-Month Extension)|Other|0|||
125138930|NCT00112437|450131217|FG013|Years 6-10 (60-Month Extension)|Other|0|||
125138931|NCT00112437|450131218|FG014|Years 6-10 (60-Month Extension)|Other|0|||
125138932|NCT00112437|450131219|FG015|Years 6-10 (60-Month Extension)|Other|0|||
125138933|NCT00112437|450131220|FG016|Years 6-10 (60-Month Extension)|Other|0|||
125138934|NCT00112437|450131221|FG017|Years 6-10 (60-Month Extension)|Other|0|||
125138935|NCT00112437|450131222|FG018|Years 6-10 (60-Month Extension)|Other|0|||
125138936|NCT00112437|450131223|FG019|Years 6-10 (60-Month Extension)|Other|0|||
125138937|NCT00112437|450131224|FG020|Years 6-10 (60-Month Extension)|Other|0|||
125222133|NCT01705977|450440468|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
125222134|NCT01705977|450440467|FG000|Treatment Period (Year 1)|Physician Decision|48|||
125222135|NCT01705977|450440468|FG001|Treatment Period (Year 1)|Physician Decision|38|||
125222136|NCT01705977|450440467|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
125222137|NCT01705977|450440468|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
125222138|NCT01705977|450440467|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
125222139|NCT01705977|450440468|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
125222140|NCT01705977|450440467|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
125222141|NCT01705977|450440468|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
125222142|NCT01705977|450440467|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
125222143|NCT01705977|450440468|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
125222144|NCT01705977|450440467|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
125222145|NCT01705977|450440468|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
125222146|NCT01705977|450440467|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
125222147|NCT01705977|450440468|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
125222148|NCT00096538|450440470|FG000|Overall Study|Withdrawal by Subject|1|||
125222149|NCT01938846|450440471|FG000|Overall Study|Progressive disease|26|||
125222150|NCT01938846|450440472|FG001|Overall Study|Progressive disease|18|||
125222151|NCT01938846|450440473|FG002|Overall Study|Progressive disease|16|||
125222152|NCT01938846|450440471|FG000|Overall Study|Adverse Event|8|||
125222153|NCT01938846|450440472|FG001|Overall Study|Adverse Event|4|||
125222154|NCT01938846|450440473|FG002|Overall Study|Adverse Event|3|||
125222155|NCT01938846|450440471|FG000|Overall Study|Withdrawal by Subject|2|||
125222156|NCT01938846|450440472|FG001|Overall Study|Withdrawal by Subject|2|||
125222157|NCT01938846|450440473|FG002|Overall Study|Withdrawal by Subject|1|||
125222158|NCT01938846|450440471|FG000|Overall Study|Other than listed|5|||
125222159|NCT01938846|450440472|FG001|Overall Study|Other than listed|1|||
125222160|NCT01938846|450440473|FG002|Overall Study|Other than listed|4|||
125222161|NCT02324361|450440474|FG000|Overall Study|Lost to Follow-up|5|||
125222162|NCT02324361|450440475|FG001|Overall Study|Lost to Follow-up|2|||
125222163|NCT00808067|450440478|FG000|Overall Study|Major/minor bleed|30|||
125222164|NCT00808067|450440479|FG001|Overall Study|Major/minor bleed|44|||
125222165|NCT00808067|450440478|FG000|Overall Study|Outcome event - other|33|||
125222166|NCT00808067|450440479|FG001|Overall Study|Outcome event - other|25|||
125222167|NCT00808067|450440478|FG000|Overall Study|Adverse Event|111|||
125222168|NCT00808067|450440479|FG001|Overall Study|Adverse Event|121|||
125222169|NCT00808067|450440478|FG000|Overall Study|Hospitalization (not including surgery)|18|||
125222170|NCT00808067|450440479|FG001|Overall Study|Hospitalization (not including surgery)|17|||
125222171|NCT00808067|450440478|FG000|Overall Study|Hospitalization due to surgery|37|||
125222172|NCT00808067|450440479|FG001|Overall Study|Hospitalization due to surgery|40|||
125222173|NCT00808067|450440478|FG000|Overall Study|Reduced creatinine clearance|53|||
125222174|NCT00808067|450440479|FG001|Overall Study|Reduced creatinine clearance|55|||
125222175|NCT00808067|450440478|FG000|Overall Study|Elevated LFT results|7|||
125222176|NCT00808067|450440479|FG001|Overall Study|Elevated LFT results|3|||
125222177|NCT00808067|450440478|FG000|Overall Study|Patient refused to take study medication|65|||
125222178|NCT00808067|450440479|FG001|Overall Study|Patient refused to take study medication|76|||
125222179|NCT00808067|450440478|FG000|Overall Study|Missing|1|||
125222180|NCT00808067|450440479|FG001|Overall Study|Missing|0|||
125222181|NCT00808067|450440478|FG000|Overall Study|Death|1|||
125222182|NCT00808067|450440479|FG001|Overall Study|Death|1|||
125222183|NCT00808067|450440478|FG000|Overall Study|Procedure|6|||
125222184|NCT00808067|450440479|FG001|Overall Study|Procedure|7|||
125222185|NCT00808067|450440478|FG000|Overall Study|Withdrawal by Subject|21|||
125222186|NCT00808067|450440479|FG001|Overall Study|Withdrawal by Subject|25|||
125222187|NCT00808067|450440478|FG000|Overall Study|Site closed|4|||
125138938|NCT00112437|450131225|FG021|Years 6-10 (60-Month Extension)|Other|0|||
125138939|NCT00112437|450131226|FG022|Years 6-10 (60-Month Extension)|Other|0|||
125222188|NCT00808067|450440479|FG001|Overall Study|Site closed|3|||
125222189|NCT00808067|450440478|FG000|Overall Study|Physician Decision|47|||
125222190|NCT00808067|450440479|FG001|Overall Study|Physician Decision|38|||
125222191|NCT00808067|450440478|FG000|Overall Study|Protocol Violation|3|||
125138940|NCT00112437|450131227|FG023|Years 6-10 (60-Month Extension)|Other|0|||
125222192|NCT00808067|450440479|FG001|Overall Study|Protocol Violation|11|||
125222193|NCT00808067|450440478|FG000|Overall Study|Patient elected|7|||
125222194|NCT00808067|450440479|FG001|Overall Study|Patient elected|9|||
125222195|NCT00808067|450440478|FG000|Overall Study|Site closed for cause|19|||
125138941|NCT00112437|450131228|FG024|Years 6-10 (60-Month Extension)|Other|1|||
125138942|NCT00112437|450131229|FG025|Years 6-10 (60-Month Extension)|Other|0|||
125060068|NCT02504268|449838496|FG005|Overall Study|Adverse Event|0|||
125060069|NCT02504268|449838497|FG006|Overall Study|Adverse Event|0|||
125060070|NCT02504268|449838498|FG007|Overall Study|Adverse Event|0|||
125060071|NCT02504268|449838499|FG008|Overall Study|Adverse Event|0|||
125222196|NCT00808067|450440479|FG001|Overall Study|Site closed for cause|19|||
125222197|NCT00808067|450440478|FG000|Overall Study|Other reason not defined above|5|||
125222198|NCT00808067|450440479|FG001|Overall Study|Other reason not defined above|5|||
125222199|NCT00808067|450440478|FG000|Overall Study|Excluded from analysis|13|||
125060072|NCT02504268|449838491|FG000|Overall Study|Withdrawal of Consent|11|||
125060073|NCT02504268|449838492|FG001|Overall Study|Withdrawal of Consent|10|||
125060074|NCT02504268|449838493|FG002|Overall Study|Withdrawal of Consent|3|||
125060075|NCT02504268|449838494|FG003|Overall Study|Withdrawal of Consent|0|||
125060076|NCT02504268|449838495|FG004|Overall Study|Withdrawal of Consent|0|||
125060077|NCT02504268|449838496|FG005|Overall Study|Withdrawal of Consent|0|||
125060078|NCT02504268|449838497|FG006|Overall Study|Withdrawal of Consent|0|||
125060079|NCT02504268|449838498|FG007|Overall Study|Withdrawal of Consent|0|||
125060080|NCT02504268|449838499|FG008|Overall Study|Withdrawal of Consent|0|||
125060081|NCT02504268|449838491|FG000|Overall Study|Pregnancy|2|||
125060082|NCT02504268|449838492|FG001|Overall Study|Pregnancy|0|||
125060083|NCT02504268|449838493|FG002|Overall Study|Pregnancy|0|||
125060084|NCT02504268|449838494|FG003|Overall Study|Pregnancy|0|||
125060085|NCT02504268|449838495|FG004|Overall Study|Pregnancy|0|||
125060086|NCT02504268|449838496|FG005|Overall Study|Pregnancy|0|||
125060087|NCT02504268|449838497|FG006|Overall Study|Pregnancy|0|||
125060088|NCT02504268|449838498|FG007|Overall Study|Pregnancy|0|||
125060089|NCT02504268|449838499|FG008|Overall Study|Pregnancy|0|||
125060090|NCT02504268|449838491|FG000|Overall Study|Lost to Follow-up|3|||
125060091|NCT02504268|449838492|FG001|Overall Study|Lost to Follow-up|6|||
125060092|NCT02504268|449838493|FG002|Overall Study|Lost to Follow-up|4|||
125060093|NCT02504268|449838494|FG003|Overall Study|Lost to Follow-up|0|||
125060094|NCT02504268|449838495|FG004|Overall Study|Lost to Follow-up|0|||
125060095|NCT02504268|449838496|FG005|Overall Study|Lost to Follow-up|0|||
125060096|NCT02504268|449838497|FG006|Overall Study|Lost to Follow-up|0|||
125060097|NCT02504268|449838498|FG007|Overall Study|Lost to Follow-up|0|||
125060098|NCT02504268|449838499|FG008|Overall Study|Lost to Follow-up|0|||
125060099|NCT02504268|449838491|FG000|Overall Study|Death|1|||
125060100|NCT02504268|449838492|FG001|Overall Study|Death|1|||
125060101|NCT02504268|449838493|FG002|Overall Study|Death|0|||
125060102|NCT02504268|449838494|FG003|Overall Study|Death|0|||
125060103|NCT02504268|449838495|FG004|Overall Study|Death|0|||
125060104|NCT02504268|449838496|FG005|Overall Study|Death|0|||
125060105|NCT02504268|449838497|FG006|Overall Study|Death|0|||
125060106|NCT02504268|449838498|FG007|Overall Study|Death|0|||
125060107|NCT02504268|449838499|FG008|Overall Study|Death|0|||
125060108|NCT02504268|449838491|FG000|Overall Study|Subject Request to Discontinue|11|||
125060109|NCT02504268|449838492|FG001|Overall Study|Subject Request to Discontinue|3|||
125060110|NCT02504268|449838493|FG002|Overall Study|Subject Request to Discontinue|6|||
125060111|NCT02504268|449838494|FG003|Overall Study|Subject Request to Discontinue|0|||
125060112|NCT02504268|449838495|FG004|Overall Study|Subject Request to Discontinue|0|||
125060113|NCT02504268|449838496|FG005|Overall Study|Subject Request to Discontinue|0|||
125060114|NCT02504268|449838497|FG006|Overall Study|Subject Request to Discontinue|0|||
125060115|NCT02504268|449838498|FG007|Overall Study|Subject Request to Discontinue|0|||
125060116|NCT02504268|449838499|FG008|Overall Study|Subject Request to Discontinue|0|||
125060117|NCT02504268|449838491|FG000|Overall Study|No Longer Meets Study Criteria|2|||
125138943|NCT00112437|450131204|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138944|NCT00112437|450131205|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138945|NCT00112437|450131206|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138946|NCT00112437|450131207|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125060118|NCT02504268|449838492|FG001|Overall Study|No Longer Meets Study Criteria|3|||
125060119|NCT02504268|449838493|FG002|Overall Study|No Longer Meets Study Criteria|0|||
125060120|NCT02504268|449838494|FG003|Overall Study|No Longer Meets Study Criteria|0|||
125060121|NCT02504268|449838495|FG004|Overall Study|No Longer Meets Study Criteria|0|||
125060122|NCT02504268|449838496|FG005|Overall Study|No Longer Meets Study Criteria|0|||
125138947|NCT00112437|450131208|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138948|NCT00112437|450131209|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125060123|NCT02504268|449838497|FG006|Overall Study|No Longer Meets Study Criteria|0|||
125060124|NCT02504268|449838498|FG007|Overall Study|No Longer Meets Study Criteria|0|||
125060125|NCT02504268|449838499|FG008|Overall Study|No Longer Meets Study Criteria|0|||
125060126|NCT02504268|449838491|FG000|Overall Study|Lack of Efficacy|11|||
125060127|NCT02504268|449838492|FG001|Overall Study|Lack of Efficacy|35|||
125222200|NCT00808067|450440479|FG001|Overall Study|Excluded from analysis|19|||
125222201|NCT05027815|450440488|FG000|Overall Study|Death|2|||
125222202|NCT05027815|450440489|FG001|Overall Study|Death|1|||
125222203|NCT03677869|450440490|FG000|Overall Study|Withdrawal by Subject|1|||
125222204|NCT03877224|450440491|FG000|Overall Study|Death|3|||
125222205|NCT03877224|450440492|FG001|Overall Study|Death|2|||
125222206|NCT03877224|450440491|FG000|Overall Study|Withdrawal by Subject|1|||
125222207|NCT03877224|450440492|FG001|Overall Study|Withdrawal by Subject|6|||
125222208|NCT03877224|450440491|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
125222209|NCT03877224|450440492|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
125222210|NCT00447902|450440493|FG000|Overall Study|Adverse Event|0|||
125222211|NCT00447902|450440494|FG001|Overall Study|Adverse Event|3|||
125222212|NCT00447902|450440493|FG000|Overall Study|Protocol Violation|1|||
125222213|NCT00447902|450440494|FG001|Overall Study|Protocol Violation|0|||
125222214|NCT00447902|450440493|FG000|Overall Study|Withdrawal by Subject|0|||
125222215|NCT00447902|450440494|FG001|Overall Study|Withdrawal by Subject|1|||
125222216|NCT00447902|450440493|FG000|Overall Study|included patients who discontinued|1|||
125222217|NCT00447902|450440494|FG001|Overall Study|included patients who discontinued|1|||
125222218|NCT00447902|450440493|FG000|Overall Study|Lack of Efficacy|2|||
125222219|NCT00447902|450440494|FG001|Overall Study|Lack of Efficacy|1|||
125222220|NCT04754542|450440495|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
125222221|NCT04754542|450440496|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
125222222|NCT04771013|450442667|FG000|Overall Study|Withdrawal by Subject|2|||
125222223|NCT04771013|450442668|FG001|Overall Study|Withdrawal by Subject|0|||
125222224|NCT04771013|450442667|FG000|Overall Study|Death|0|||
125222225|NCT04771013|450442668|FG001|Overall Study|Death|5|||
125222226|NCT04771013|450442667|FG000|Overall Study|Referred to another hospital before day 20|0|||
125222227|NCT04771013|450442668|FG001|Overall Study|Referred to another hospital before day 20|1|||
125222228|NCT01519817|450442670|FG000|Overall Study|Withdrawal by Subject|1|||
125222229|NCT01519817|450442671|FG001|Overall Study|Withdrawal by Subject|0|||
125222230|NCT01519817|450442672|FG002|Overall Study|Withdrawal by Subject|0|||
125222231|NCT01519817|450442673|FG003|Overall Study|Withdrawal by Subject|0|||
125222232|NCT01519817|450442670|FG000|Overall Study|Off study due to infection|0|||
125222233|NCT01519817|450442671|FG001|Overall Study|Off study due to infection|0|||
125222234|NCT01519817|450442672|FG002|Overall Study|Off study due to infection|0|||
125222235|NCT01519817|450442673|FG003|Overall Study|Off study due to infection|1|||
125222236|NCT02999789|450442676|FG000|Overall Study|Withdrawal by Subject|0|||
125222237|NCT02999789|450442677|FG001|Overall Study|Withdrawal by Subject|1|||
125222238|NCT02999789|450442676|FG000|Overall Study|Became ineligible|1|||
125222239|NCT02999789|450442677|FG001|Overall Study|Became ineligible|2|||
125222240|NCT00737100|450442686|FG000|Overall Study|Adverse Event|6|||
125222241|NCT00737100|450442687|FG001|Overall Study|Adverse Event|5|||
125222242|NCT00737100|450442688|FG002|Overall Study|Adverse Event|3|||
125222243|NCT00737100|450442686|FG000|Overall Study|Lost to Follow-up|0|||
125222244|NCT00737100|450442687|FG001|Overall Study|Lost to Follow-up|1|||
125222245|NCT00737100|450442688|FG002|Overall Study|Lost to Follow-up|0|||
125222246|NCT00737100|450442686|FG000|Overall Study|Withdrawal by Subject|0|||
125222247|NCT00737100|450442687|FG001|Overall Study|Withdrawal by Subject|0|||
125222248|NCT00737100|450442688|FG002|Overall Study|Withdrawal by Subject|3|||
125222249|NCT00737100|450442686|FG000|Overall Study|Reason discontinued not explained above|1|||
125222250|NCT00737100|450442687|FG001|Overall Study|Reason discontinued not explained above|1|||
125222251|NCT00737100|450442688|FG002|Overall Study|Reason discontinued not explained above|1|||
125222252|NCT01447407|450442689|FG000|Overall Study|Withdrawal by Subject|2|||
125222253|NCT01447407|450442690|FG001|Overall Study|Withdrawal by Subject|0|||
125060128|NCT02504268|449838493|FG002|Overall Study|Lack of Efficacy|9|||
125222254|NCT01447407|450442691|FG002|Overall Study|Withdrawal by Subject|0|||
125222255|NCT01447407|450442692|FG003|Overall Study|Withdrawal by Subject|1|||
125222256|NCT01447407|450442689|FG000|Overall Study|Physician Decision|0|||
125222257|NCT01447407|450442690|FG001|Overall Study|Physician Decision|0|||
125222258|NCT01447407|450442691|FG002|Overall Study|Physician Decision|1|||
125222259|NCT01447407|450442692|FG003|Overall Study|Physician Decision|1|||
125222260|NCT01265394|450442693|FG000|Overall Study|Subjects withdrawn|37|||
125222261|NCT03131167|450442694|FG000|Overall Study|Other (Unspecified)|0|||
125222262|NCT03131167|450442695|FG001|Overall Study|Other (Unspecified)|0|||
125222263|NCT03131167|450442696|FG002|Overall Study|Other (Unspecified)|0|||
125222264|NCT03131167|450442697|FG003|Overall Study|Other (Unspecified)|0|||
125222265|NCT03131167|450442698|FG004|Overall Study|Other (Unspecified)|0|||
125222266|NCT03131167|450442699|FG005|Overall Study|Other (Unspecified)|1|||
125222267|NCT03131167|450442700|FG006|Overall Study|Other (Unspecified)|0|||
125222268|NCT03131167|450442701|FG007|Overall Study|Other (Unspecified)|0|||
125060129|NCT02504268|449838494|FG003|Overall Study|Lack of Efficacy|0|||
125060130|NCT02504268|449838495|FG004|Overall Study|Lack of Efficacy|0|||
125222269|NCT03131167|450442702|FG008|Overall Study|Other (Unspecified)|0|||
125222270|NCT03131167|450442703|FG009|Overall Study|Other (Unspecified)|0|||
125222271|NCT03131167|450442704|FG010|Overall Study|Other (Unspecified)|0|||
125222272|NCT03131167|450442705|FG011|Overall Study|Other (Unspecified)|0|||
125222273|NCT03131167|450442706|FG012|Overall Study|Other (Unspecified)|0|||
125222274|NCT00643201|450442707|FG000|Randomized, Completed 6 Months of Study|Death|20|||
125222275|NCT00643201|450442708|FG001|Randomized, Completed 6 Months of Study|Death|26|||
125222276|NCT00643201|450442707|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
125222277|NCT00643201|450442708|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
125222278|NCT00643201|450442707|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
125222279|NCT00643201|450442708|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
125222280|NCT00643201|450442707|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
125222281|NCT00643201|450442708|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
125222282|NCT00643201|450442707|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
125222283|NCT00643201|450442708|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
125222284|NCT00643201|450442707|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
125222285|NCT00643201|450442708|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
125222286|NCT00643201|450442707|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
125222287|NCT00643201|450442708|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
125222288|NCT00643201|450442707|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
125222289|NCT00643201|450442708|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
125222290|NCT00643201|450442707|FG000|Randomized, Completed 6 Months of Study|Other|107|||
125222291|NCT00643201|450442708|FG001|Randomized, Completed 6 Months of Study|Other|107|||
125222292|NCT00643201|450442707|FG000|Completed Study Follow Up|Death|28|||
125222293|NCT00643201|450442708|FG001|Completed Study Follow Up|Death|34|||
125222294|NCT00643201|450442707|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
125222295|NCT00643201|450442708|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
125222296|NCT00643201|450442707|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
125222297|NCT00643201|450442708|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
125222298|NCT00643201|450442707|FG000|Completed Study Follow Up|non-specified|1|||
125222299|NCT00643201|450442708|FG001|Completed Study Follow Up|non-specified|0|||
125222300|NCT00165503|450442709|FG000|Overall Study|Death|1|||
125222301|NCT00165503|450442709|FG000|Overall Study|Lost to Follow-up|12|||
125222302|NCT00165503|450442709|FG000|Overall Study|Unresectable|3|||
125222303|NCT02346708|450442710|FG000|Overall Study|Adverse Event|2|||
125222304|NCT02346708|450442711|FG001|Overall Study|Adverse Event|0|||
125222305|NCT02346708|450442710|FG000|Overall Study|Protocol Violation|0|||
125222306|NCT02346708|450442711|FG001|Overall Study|Protocol Violation|1|||
125222307|NCT02976519|450442712|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
125222308|NCT02976519|450442713|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
125222309|NCT02976519|450442714|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
125222310|NCT02976519|450442715|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
125222311|NCT02976519|450442716|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
125222312|NCT02976519|450442717|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
125222313|NCT02976519|450442718|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
125222314|NCT02976519|450442712|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
125222315|NCT02976519|450442713|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
125222316|NCT02976519|450442714|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
125222317|NCT02976519|450442715|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
125222318|NCT02976519|450442716|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
125222319|NCT02976519|450442717|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
125060131|NCT02504268|449838496|FG005|Overall Study|Lack of Efficacy|0|||
125060132|NCT02504268|449838497|FG006|Overall Study|Lack of Efficacy|0|||
125222320|NCT02976519|450442718|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
125222321|NCT02976519|450442712|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
125222322|NCT02976519|450442713|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
125222323|NCT02976519|450442714|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
125222324|NCT02976519|450442715|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
125222325|NCT02976519|450442716|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
125060133|NCT02504268|449838498|FG007|Overall Study|Lack of Efficacy|0|||
125060134|NCT02504268|449838499|FG008|Overall Study|Lack of Efficacy|0|||
125060135|NCT02504268|449838491|FG000|Overall Study|Poor/Non-Compliance|3|||
125060136|NCT02504268|449838492|FG001|Overall Study|Poor/Non-Compliance|2|||
125060137|NCT02504268|449838493|FG002|Overall Study|Poor/Non-Compliance|3|||
125060138|NCT02504268|449838494|FG003|Overall Study|Poor/Non-Compliance|0|||
125060139|NCT02504268|449838495|FG004|Overall Study|Poor/Non-Compliance|0|||
125060140|NCT02504268|449838496|FG005|Overall Study|Poor/Non-Compliance|0|||
125060141|NCT02504268|449838497|FG006|Overall Study|Poor/Non-Compliance|0|||
125060142|NCT02504268|449838498|FG007|Overall Study|Poor/Non-Compliance|0|||
125060143|NCT02504268|449838499|FG008|Overall Study|Poor/Non-Compliance|0|||
125060144|NCT02504268|449838491|FG000|Overall Study|Not Disclosed|1|||
125060145|NCT02504268|449838492|FG001|Overall Study|Not Disclosed|0|||
125060146|NCT02504268|449838493|FG002|Overall Study|Not Disclosed|2|||
125138949|NCT00112437|450131210|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138950|NCT00112437|450131211|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138951|NCT00112437|450131212|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138952|NCT00112437|450131213|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138953|NCT00112437|450131214|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138954|NCT00112437|450131215|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138955|NCT00112437|450131216|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138956|NCT00112437|450131217|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138957|NCT00112437|450131218|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138958|NCT00112437|450131219|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138959|NCT00112437|450131220|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138960|NCT00112437|450131221|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138961|NCT00112437|450131222|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138962|NCT00112437|450131223|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138963|NCT00112437|450131224|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138964|NCT00112437|450131225|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138965|NCT00112437|450131226|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138966|NCT00112437|450131227|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
125138967|NCT00112437|450131228|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138968|NCT00112437|450131229|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138969|NCT00112437|450131204|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138970|NCT00112437|450131205|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138971|NCT00112437|450131206|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138972|NCT00112437|450131207|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138973|NCT00112437|450131208|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138974|NCT00112437|450131209|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138975|NCT00112437|450131210|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138976|NCT00112437|450131211|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138977|NCT00112437|450131212|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138978|NCT00112437|450131213|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138979|NCT00112437|450131214|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138980|NCT00112437|450131215|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138981|NCT00112437|450131216|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138982|NCT00112437|450131217|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138983|NCT00112437|450131218|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138984|NCT00112437|450131219|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138985|NCT00112437|450131220|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138986|NCT00112437|450131221|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138987|NCT00112437|450131222|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138988|NCT00112437|450131223|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138989|NCT00112437|450131224|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138990|NCT00112437|450131225|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138991|NCT00112437|450131226|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
125138992|NCT00112437|450131227|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
125222326|NCT02976519|450442717|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
125222327|NCT02976519|450442718|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
125222328|NCT02976519|450442712|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
125222329|NCT02976519|450442713|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
125222330|NCT02976519|450442714|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
125222331|NCT02976519|450442715|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
125222332|NCT02976519|450442716|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
125222333|NCT02976519|450442717|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
125222334|NCT02976519|450442718|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
125222335|NCT02976519|450442712|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
125222336|NCT02976519|450442713|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
125222337|NCT02976519|450442714|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
125222338|NCT02976519|450442715|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
125222339|NCT02976519|450442716|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
125138993|NCT00112437|450131228|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138994|NCT00112437|450131229|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
125138995|NCT01960296|450131230|FG000|Overall Study|Postponed surgery|1|||
125222340|NCT02976519|450442717|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
125138996|NCT01960296|450131231|FG001|Overall Study|Postponed surgery|0|||
125138997|NCT01960296|450131230|FG000|Overall Study|Received different procedure|1|||
125060147|NCT02504268|449838494|FG003|Overall Study|Not Disclosed|0|||
125060148|NCT02504268|449838495|FG004|Overall Study|Not Disclosed|0|||
125060149|NCT02504268|449838496|FG005|Overall Study|Not Disclosed|0|||
125060150|NCT02504268|449838497|FG006|Overall Study|Not Disclosed|0|||
125060151|NCT02504268|449838498|FG007|Overall Study|Not Disclosed|0|||
125060152|NCT02504268|449838499|FG008|Overall Study|Not Disclosed|0|||
125060153|NCT00209170|449838502|FG000|Overall Study|Adverse Event|0|||
125060154|NCT00209170|449838503|FG001|Overall Study|Adverse Event|1|||
125060155|NCT00209170|449838502|FG000|Overall Study|Withdrawal by Subject|2|||
125060156|NCT00209170|449838503|FG001|Overall Study|Withdrawal by Subject|1|||
125060157|NCT00209170|449838502|FG000|Overall Study|Lack of Efficacy|0|||
125060158|NCT00209170|449838503|FG001|Overall Study|Lack of Efficacy|1|||
125060159|NCT02108600|449838504|FG000|Overall Study|Withdrawal by Subject|2|||
125060160|NCT02108600|449838505|FG001|Overall Study|Withdrawal by Subject|0|||
125060161|NCT02108600|449838504|FG000|Overall Study|Lost to Follow-up|1|||
125060162|NCT02108600|449838505|FG001|Overall Study|Lost to Follow-up|1|||
125060163|NCT03150095|449838506|FG000|Overall Study|Death|0|||
125060164|NCT03150095|449838507|FG001|Overall Study|Death|1|||
125060165|NCT03150095|449838506|FG000|Overall Study|Lost to Follow-up|1|||
125060166|NCT03150095|449838507|FG001|Overall Study|Lost to Follow-up|1|||
125060167|NCT03150095|449838506|FG000|Overall Study|Withdrawal by Subject|4|||
125060168|NCT03150095|449838507|FG001|Overall Study|Withdrawal by Subject|0|||
125060169|NCT03150095|449838506|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
125138998|NCT01960296|450131231|FG001|Overall Study|Received different procedure|3|||
125060170|NCT03150095|449838507|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
125060171|NCT04032171|449838508|FG000|Overall Study|Study Termination|1|||
125138999|NCT02003391|450131232|FG000|Overall Study|Withdrawal by Subject|2|||
125139000|NCT02003391|450131233|FG001|Overall Study|Withdrawal by Subject|1|||
125060172|NCT04032171|449838509|FG001|Overall Study|Study Termination|0|||
125060173|NCT02124707|449838510|FG000|Overall Study|Adverse Event|5|||
125222341|NCT02976519|450442718|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
125222342|NCT01781962|450442721|FG000|Overall Study|Other Miscellaneous Reasons|5|||
125222343|NCT00928434|450442722|FG000|Overall Study|Adverse Event|14|||
125222344|NCT00928434|450442723|FG001|Overall Study|Adverse Event|5|||
125222345|NCT00928434|450442724|FG002|Overall Study|Adverse Event|18|||
125222346|NCT00928434|450442722|FG000|Overall Study|Protocol Violation|5|||
125222347|NCT00928434|450442723|FG001|Overall Study|Protocol Violation|0|||
125222348|NCT00928434|450442724|FG002|Overall Study|Protocol Violation|8|||
125222349|NCT00928434|450442722|FG000|Overall Study|Physician Decision|2|||
125222350|NCT00928434|450442723|FG001|Overall Study|Physician Decision|0|||
125222351|NCT00928434|450442724|FG002|Overall Study|Physician Decision|3|||
125222352|NCT00928434|450442722|FG000|Overall Study|Lost to Follow-up|1|||
125222353|NCT00928434|450442723|FG001|Overall Study|Lost to Follow-up|0|||
125222354|NCT00928434|450442724|FG002|Overall Study|Lost to Follow-up|3|||
125222355|NCT00928434|450442722|FG000|Overall Study|Withdrawal by Subject|5|||
125222356|NCT00928434|450442723|FG001|Overall Study|Withdrawal by Subject|3|||
125222357|NCT00928434|450442724|FG002|Overall Study|Withdrawal by Subject|2|||
125222358|NCT00928434|450442722|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
125222359|NCT00928434|450442723|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
125060174|NCT02124707|449838510|FG000|Overall Study|Physician Decision|1|||
125060175|NCT02124707|449838510|FG000|Overall Study|Death|1|||
125060176|NCT00668200|449838517|FG000|Overall Study|Withdrawal by Subject|2|||
125060177|NCT00668200|449838517|FG000|Overall Study|Lost to Follow-up|1|||
125060178|NCT02108951|449838521|FG000|Overall Study|Lost to Follow-up|1|||
125060179|NCT02108951|449838521|FG000|Overall Study|Patient's/guardian's decision|1|||
125060180|NCT02108951|449838521|FG000|Overall Study|Study Terminated by Sponsor|14|||
125060181|NCT00718666|449838522|FG000|Booster Phase Year 5|No active participation request|0|||
125060182|NCT00718666|449838523|FG001|Booster Phase Year 5|No active participation request|0|||
125060183|NCT00718666|449838524|FG002|Booster Phase Year 5|No active participation request|1|||
125060184|NCT00718666|449838522|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
125060185|NCT00718666|449838523|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
125060186|NCT00718666|449838524|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
125060187|NCT00718666|449838522|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
125060188|NCT00718666|449838523|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
125060189|NCT00718666|449838524|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
125060190|NCT00718666|449838522|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
125060191|NCT00718666|449838523|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
125060192|NCT00718666|449838524|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
125060193|NCT00421343|449838527|FG000|Overall Study|Death|1|||
125060194|NCT00421343|449838527|FG000|Overall Study|Withdrawal by Subject|2|||
125060195|NCT00421343|449838527|FG000|Overall Study|Lost to Follow-up|3|||
125060196|NCT03471767|449838533|FG000|Overall Study|Withdrawal by Subject|3|||
125060197|NCT03471767|449838534|FG001|Overall Study|Withdrawal by Subject|1|||
125060198|NCT03471767|449838533|FG000|Overall Study|Adverse Event|1|||
125060199|NCT03471767|449838534|FG001|Overall Study|Adverse Event|0|||
125060200|NCT03471767|449838533|FG000|Overall Study|Lost to Follow-up|1|||
125060201|NCT03471767|449838534|FG001|Overall Study|Lost to Follow-up|0|||
125060202|NCT03471767|449838533|FG000|Overall Study|PI Withdrawal|1|||
125060203|NCT03471767|449838534|FG001|Overall Study|PI Withdrawal|3|||
125060204|NCT00678587|449838535|FG000|Overall Study|Adverse Event|3|||
125060205|NCT00678587|449838536|FG001|Overall Study|Adverse Event|3|||
125060206|NCT00678587|449838535|FG000|Overall Study|Lack of Efficacy|1|||
125060207|NCT00678587|449838536|FG001|Overall Study|Lack of Efficacy|0|||
125060208|NCT00678587|449838535|FG000|Overall Study|Protocol Violation|2|||
125060209|NCT00678587|449838536|FG001|Overall Study|Protocol Violation|1|||
125060210|NCT00678587|449838535|FG000|Overall Study|Study Closed/Terminated|1|||
125060211|NCT00678587|449838536|FG001|Overall Study|Study Closed/Terminated|0|||
125060212|NCT00678587|449838535|FG000|Overall Study|Lost to Follow-up|3|||
125060213|NCT00678587|449838536|FG001|Overall Study|Lost to Follow-up|5|||
125060214|NCT00678587|449838535|FG000|Overall Study|Investigator Discretion|2|||
125060215|NCT00678587|449838536|FG001|Overall Study|Investigator Discretion|6|||
125222360|NCT00928434|450442724|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
125060216|NCT00678587|449838535|FG000|Overall Study|Withdrew Consent|8|||
125060217|NCT00678587|449838536|FG001|Overall Study|Withdrew Consent|3|||
125060218|NCT03806179|449838537|FG000|Overall Study|Progressive disease|0|||
125060219|NCT03806179|449838538|FG001|Overall Study|Progressive disease|2|||
125060220|NCT01952730|449838541|FG000|Overall Study|FDA shut down core lab used by study|1|||
125060221|NCT01357915|449838546|FG000|Overall Study|Lost to Follow-up|3|||
125060222|NCT01357915|449838547|FG001|Overall Study|Lost to Follow-up|0|||
125060223|NCT00305253|449838548|FG000|Overall Study|Withdrawal by Subject|0|||
125060224|NCT00305253|449838549|FG001|Overall Study|Withdrawal by Subject|1|||
125060225|NCT01479374|449838552|FG000|Overall Study|Adverse Event|2|||
125060226|NCT01479374|449838553|FG001|Overall Study|Adverse Event|1|||
125060227|NCT01479374|449838554|FG002|Overall Study|Adverse Event|0|||
125222361|NCT00928434|450442722|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
125222362|NCT00928434|450442723|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
125060228|NCT01479374|449838552|FG000|Overall Study|Lost to Follow-up|1|||
125060229|NCT01479374|449838553|FG001|Overall Study|Lost to Follow-up|2|||
125060230|NCT01479374|449838554|FG002|Overall Study|Lost to Follow-up|0|||
125060231|NCT01479374|449838552|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
125060232|NCT01479374|449838553|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
125060233|NCT01479374|449838554|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
125060234|NCT01479374|449838552|FG000|Overall Study|Other|0|||
125060235|NCT01479374|449838553|FG001|Overall Study|Other|4|||
125060236|NCT01479374|449838554|FG002|Overall Study|Other|5|||
125060237|NCT01606761|449838555|FG000|Prior to Week 24|Lost to Follow-up|0|||
125060238|NCT01606761|449838556|FG001|Prior to Week 24|Lost to Follow-up|3|||
125060239|NCT01606761|449838557|FG002|Prior to Week 24|Lost to Follow-up|2|||
125060240|NCT01606761|449838558|FG003|Prior to Week 24|Lost to Follow-up|0|||
125060241|NCT01606761|449838559|FG004|Prior to Week 24|Lost to Follow-up|0|||
125060242|NCT01606761|449838555|FG000|Prior to Week 24|Withdrawal by Subject|12|||
125060243|NCT01606761|449838556|FG001|Prior to Week 24|Withdrawal by Subject|10|||
125060244|NCT01606761|449838557|FG002|Prior to Week 24|Withdrawal by Subject|9|||
125060245|NCT01606761|449838558|FG003|Prior to Week 24|Withdrawal by Subject|0|||
125060246|NCT01606761|449838559|FG004|Prior to Week 24|Withdrawal by Subject|0|||
125060247|NCT01606761|449838555|FG000|Prior to Week 24|Adverse Event|11|||
125060248|NCT01606761|449838556|FG001|Prior to Week 24|Adverse Event|18|||
125060249|NCT01606761|449838557|FG002|Prior to Week 24|Adverse Event|22|||
125060250|NCT01606761|449838558|FG003|Prior to Week 24|Adverse Event|0|||
125060251|NCT01606761|449838559|FG004|Prior to Week 24|Adverse Event|0|||
125060252|NCT01606761|449838555|FG000|Prior to Week 24|Lack of Efficacy|15|||
125060253|NCT01606761|449838556|FG001|Prior to Week 24|Lack of Efficacy|14|||
125060254|NCT01606761|449838557|FG002|Prior to Week 24|Lack of Efficacy|8|||
125060255|NCT01606761|449838558|FG003|Prior to Week 24|Lack of Efficacy|0|||
125060256|NCT01606761|449838559|FG004|Prior to Week 24|Lack of Efficacy|0|||
125060257|NCT01606761|449838555|FG000|Prior to Week 24|Physician Decision|0|||
125060258|NCT01606761|449838556|FG001|Prior to Week 24|Physician Decision|3|||
125060259|NCT01606761|449838557|FG002|Prior to Week 24|Physician Decision|1|||
125060260|NCT01606761|449838558|FG003|Prior to Week 24|Physician Decision|0|||
125060261|NCT01606761|449838559|FG004|Prior to Week 24|Physician Decision|0|||
125060262|NCT01606761|449838555|FG000|Prior to Week 24|Other|4|||
125139001|NCT02003391|450131232|FG000|Overall Study|Protocol Violation|0|||
125139002|NCT02003391|450131233|FG001|Overall Study|Protocol Violation|1|||
125139003|NCT02003391|450131232|FG000|Overall Study|Adverse Event|1|||
125139004|NCT02003391|450131233|FG001|Overall Study|Adverse Event|0|||
125139005|NCT02272803|450131234|FG000|Overall Study|Disease progression|16|||
125139006|NCT02272803|450131235|FG001|Overall Study|Disease progression|8|||
125139007|NCT02272803|450131234|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
125139008|NCT02272803|450131235|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
125139009|NCT02272803|450131234|FG000|Overall Study|Study drug toxicity|4|||
125139010|NCT02272803|450131235|FG001|Overall Study|Study drug toxicity|9|||
125139011|NCT02272803|450131234|FG000|Overall Study|Participant request to discontinue study treatment|3|||
125139012|NCT02272803|450131235|FG001|Overall Study|Participant request to discontinue study treatment|7|||
125139013|NCT02272803|450131234|FG000|Overall Study|Maximum clinical benefit|4|||
125139014|NCT02272803|450131235|FG001|Overall Study|Maximum clinical benefit|2|||
125139015|NCT02272803|450131234|FG000|Overall Study|Poor/non-compliance|2|||
125139016|NCT02272803|450131235|FG001|Overall Study|Poor/non-compliance|2|||
125139017|NCT02272803|450131234|FG000|Overall Study|Withdrawal by Subject|2|||
125139018|NCT02272803|450131235|FG001|Overall Study|Withdrawal by Subject|1|||
125139019|NCT02272803|450131234|FG000|Overall Study|Death|0|||
125139020|NCT02272803|450131235|FG001|Overall Study|Death|1|||
125139021|NCT02272803|450131234|FG000|Overall Study|Other reasons|1|||
125139022|NCT02272803|450131235|FG001|Overall Study|Other reasons|3|||
125139023|NCT02272803|450131234|FG000|Overall Study|Administrative reason by sponsor|5|||
125139024|NCT02272803|450131235|FG001|Overall Study|Administrative reason by sponsor|4|||
125139025|NCT03573544|450131236|FG000|Overall Study|Adverse Event|0|||
125139026|NCT03573544|450131237|FG001|Overall Study|Adverse Event|0|||
125139027|NCT03573544|450131238|FG002|Overall Study|Adverse Event|0|||
125139028|NCT03573544|450131239|FG003|Overall Study|Adverse Event|3|||
125139029|NCT03573544|450131240|FG004|Overall Study|Adverse Event|1|||
125139030|NCT03573544|450131241|FG005|Overall Study|Adverse Event|0|||
125139031|NCT03573544|450131242|FG006|Overall Study|Adverse Event|2|||
125139032|NCT03573544|450131243|FG007|Overall Study|Adverse Event|0|||
125139033|NCT03573544|450131236|FG000|Overall Study|Physician Decision|0|||
125139034|NCT03573544|450131237|FG001|Overall Study|Physician Decision|0|||
125060263|NCT01606761|449838556|FG001|Prior to Week 24|Other|7|||
125060264|NCT01606761|449838557|FG002|Prior to Week 24|Other|5|||
125060265|NCT01606761|449838558|FG003|Prior to Week 24|Other|0|||
125060266|NCT01606761|449838559|FG004|Prior to Week 24|Other|0|||
125060267|NCT01606761|449838555|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
125139035|NCT03573544|450131238|FG002|Overall Study|Physician Decision|0|||
125139036|NCT03573544|450131239|FG003|Overall Study|Physician Decision|0|||
125139037|NCT03573544|450131240|FG004|Overall Study|Physician Decision|0|||
125139038|NCT03573544|450131241|FG005|Overall Study|Physician Decision|0|||
125139039|NCT03573544|450131242|FG006|Overall Study|Physician Decision|1|||
125139040|NCT03573544|450131243|FG007|Overall Study|Physician Decision|0|||
125060268|NCT01606761|449838556|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
125060269|NCT01606761|449838557|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
125060270|NCT01606761|449838558|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
125060271|NCT01606761|449838559|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
125060272|NCT01606761|449838555|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
125060273|NCT01606761|449838556|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
125139041|NCT03573544|450131236|FG000|Overall Study|Withdrawal by Subject|2|||
125139042|NCT03573544|450131237|FG001|Overall Study|Withdrawal by Subject|0|||
125139043|NCT03573544|450131238|FG002|Overall Study|Withdrawal by Subject|0|||
125139044|NCT03573544|450131239|FG003|Overall Study|Withdrawal by Subject|1|||
125139045|NCT03573544|450131240|FG004|Overall Study|Withdrawal by Subject|1|||
125060274|NCT01606761|449838557|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
125060275|NCT01606761|449838558|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
125060276|NCT01606761|449838559|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
125060277|NCT01606761|449838555|FG000|Week 24 to Week 52|Adverse Event|0|||
125060278|NCT01606761|449838556|FG001|Week 24 to Week 52|Adverse Event|11|||
125060279|NCT01606761|449838557|FG002|Week 24 to Week 52|Adverse Event|14|||
125060280|NCT01606761|449838558|FG003|Week 24 to Week 52|Adverse Event|3|||
125060281|NCT01606761|449838559|FG004|Week 24 to Week 52|Adverse Event|15|||
125060282|NCT01606761|449838555|FG000|Week 24 to Week 52|Death|0|||
125060283|NCT01606761|449838556|FG001|Week 24 to Week 52|Death|0|||
125060284|NCT01606761|449838557|FG002|Week 24 to Week 52|Death|2|||
125060285|NCT01606761|449838558|FG003|Week 24 to Week 52|Death|1|||
125060286|NCT01606761|449838559|FG004|Week 24 to Week 52|Death|0|||
125060287|NCT01606761|449838555|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
125060288|NCT01606761|449838556|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
125060289|NCT01606761|449838557|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
125060290|NCT01606761|449838558|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
125060291|NCT01606761|449838559|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
125060292|NCT01606761|449838555|FG000|Week 24 to Week 52|Physician Decision|0|||
125060293|NCT01606761|449838556|FG001|Week 24 to Week 52|Physician Decision|1|||
125060294|NCT01606761|449838557|FG002|Week 24 to Week 52|Physician Decision|1|||
125060295|NCT01606761|449838558|FG003|Week 24 to Week 52|Physician Decision|0|||
125060296|NCT01606761|449838559|FG004|Week 24 to Week 52|Physician Decision|0|||
125060297|NCT01606761|449838555|FG000|Week 24 to Week 52|Other|0|||
125060298|NCT01606761|449838556|FG001|Week 24 to Week 52|Other|1|||
125060299|NCT01606761|449838557|FG002|Week 24 to Week 52|Other|5|||
125060300|NCT01606761|449838558|FG003|Week 24 to Week 52|Other|2|||
125060301|NCT01606761|449838559|FG004|Week 24 to Week 52|Other|2|||
125060302|NCT01606761|449838555|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
125060303|NCT01606761|449838556|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
125060304|NCT01606761|449838557|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
125060305|NCT01606761|449838558|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
125060306|NCT01606761|449838559|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
125060307|NCT01606761|449838555|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
125060308|NCT01606761|449838556|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
125060309|NCT01606761|449838557|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
125060310|NCT01606761|449838558|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
125060311|NCT01606761|449838559|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
125060312|NCT01606761|449838555|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
125060313|NCT01606761|449838556|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
125060314|NCT01606761|449838557|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
125060315|NCT01606761|449838558|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
125060316|NCT01606761|449838559|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
125060317|NCT01606761|449838555|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
125060318|NCT01606761|449838556|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
125060319|NCT01606761|449838557|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
125060320|NCT01606761|449838558|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
125060321|NCT01606761|449838559|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
125060322|NCT05086289|449838560|FG000|Overall Study|Adverse Event|4|||
125060323|NCT05086289|449838561|FG001|Overall Study|Adverse Event|2|||
125060324|NCT05086289|449838560|FG000|Overall Study|Lost to Follow-up|2|||
125060325|NCT05086289|449838561|FG001|Overall Study|Lost to Follow-up|0|||
125060326|NCT05086289|449838560|FG000|Overall Study|Non-compliance with study drug|2|||
125060327|NCT05086289|449838561|FG001|Overall Study|Non-compliance with study drug|1|||
125060328|NCT05086289|449838560|FG000|Overall Study|Physician Decision|2|||
125060329|NCT05086289|449838561|FG001|Overall Study|Physician Decision|0|||
125060330|NCT05086289|449838560|FG000|Overall Study|Withdrawal by Subject|5|||
125060331|NCT05086289|449838561|FG001|Overall Study|Withdrawal by Subject|2|||
125060332|NCT02237157|449838562|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
125139046|NCT03573544|450131241|FG005|Overall Study|Withdrawal by Subject|1|||
125139047|NCT03573544|450131242|FG006|Overall Study|Withdrawal by Subject|0|||
125139048|NCT03573544|450131243|FG007|Overall Study|Withdrawal by Subject|1|||
125060333|NCT02237157|449838563|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
125060334|NCT02237157|449838564|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
125060335|NCT02237157|449838565|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
125060336|NCT02237157|449838562|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
125060337|NCT02237157|449838563|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
125060338|NCT02237157|449838564|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
125060339|NCT02237157|449838565|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
125060340|NCT01996748|449838567|FG000|Overall Study|Personal reason|1|||
125060341|NCT01996748|449838568|FG001|Overall Study|Personal reason|0|||
125060342|NCT01996748|449838567|FG000|Overall Study|Physician Decision|2|||
125139049|NCT03573544|450131236|FG000|Overall Study|Disease progression|3|||
125139050|NCT03573544|450131237|FG001|Overall Study|Disease progression|3|||
125060343|NCT01996748|449838568|FG001|Overall Study|Physician Decision|0|||
125060344|NCT01996748|449838567|FG000|Overall Study|Adverse Event|1|||
125060345|NCT01996748|449838568|FG001|Overall Study|Adverse Event|4|||
125060346|NCT01996748|449838567|FG000|Overall Study|Withdrawal by Subject|0|||
125060347|NCT01996748|449838568|FG001|Overall Study|Withdrawal by Subject|1|||
125060348|NCT01996748|449838567|FG000|Overall Study|Lost to Follow-up|4|||
125060349|NCT01996748|449838568|FG001|Overall Study|Lost to Follow-up|1|||
125060350|NCT03599141|449838575|FG000|Overall Study|Lost to Follow-up|3|||
125060351|NCT03599141|449838576|FG001|Overall Study|Lost to Follow-up|1|||
125060352|NCT00807846|449838577|FG000|Overall Study|Adverse Event|5|||
125060353|NCT00807846|449838578|FG001|Overall Study|Adverse Event|0|||
125060354|NCT00807846|449838577|FG000|Overall Study|Lack of Efficacy|2|||
125060355|NCT00807846|449838578|FG001|Overall Study|Lack of Efficacy|0|||
125060356|NCT00807846|449838577|FG000|Overall Study|Protocol Violation|2|||
125060357|NCT00807846|449838578|FG001|Overall Study|Protocol Violation|1|||
125060358|NCT00807846|449838577|FG000|Overall Study|Withdrawal by Subject|2|||
125060359|NCT00807846|449838578|FG001|Overall Study|Withdrawal by Subject|1|||
125060360|NCT00807846|449838577|FG000|Overall Study|Other|1|||
125060361|NCT00807846|449838578|FG001|Overall Study|Other|2|||
125060362|NCT01081873|449838579|FG000|Overall Study|Death|86|||
125060363|NCT01081873|449838579|FG000|Overall Study|Withdrawal by Subject|10|||
125060364|NCT01081873|449838579|FG000|Overall Study|Lost to Follow-up|142|||
125060365|NCT01081873|449838579|FG000|Overall Study|Progression of prostate cancer|13|||
125060366|NCT01081873|449838579|FG000|Overall Study|Other|47|||
125060367|NCT03011840|449838580|FG000|Overall Study|Not received PIL in post PIL phase|0|||
125060368|NCT03011840|449838581|FG001|Overall Study|Not received PIL in post PIL phase|21|||
125060369|NCT01165021|449838583|FG000|Overall Study|Death|1|||
125060370|NCT02491073|449838584|FG000|Overall Study|screen failure|1|||
125060371|NCT02491073|449838585|FG001|Overall Study|screen failure|0|||
125060372|NCT01419665|449838586|FG000|Combination Treatment|Adverse Event|7|||
125060373|NCT01419665|449838587|FG001|Combination Treatment|Adverse Event|10|||
125060374|NCT01419665|449838586|FG000|Combination Treatment|Physician Decision|5|||
125060375|NCT01419665|449838587|FG001|Combination Treatment|Physician Decision|8|||
125060376|NCT01419665|449838586|FG000|Combination Treatment|Protocol Violation|6|||
125060377|NCT01419665|449838587|FG001|Combination Treatment|Protocol Violation|2|||
125060378|NCT01419665|449838586|FG000|Combination Treatment|disease progression|10|||
125060379|NCT01419665|449838587|FG001|Combination Treatment|disease progression|9|||
125060380|NCT01419665|449838586|FG000|Combination Treatment|Death|5|||
125060381|NCT01419665|449838587|FG001|Combination Treatment|Death|7|||
125060382|NCT01419665|449838586|FG000|Combination Treatment|administrative problems|0|||
125060383|NCT01419665|449838587|FG001|Combination Treatment|administrative problems|1|||
125060384|NCT01419665|449838586|FG000|Combination Treatment|Withdrawal by Subject|5|||
125060385|NCT01419665|449838587|FG001|Combination Treatment|Withdrawal by Subject|4|||
125060386|NCT01419665|449838586|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
125060387|NCT01419665|449838587|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
125060388|NCT01419665|449838586|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
125060389|NCT01419665|449838587|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
125060390|NCT01419665|449838586|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
125060391|NCT01419665|449838587|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
125060392|NCT01419665|449838586|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
125060393|NCT01419665|449838587|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
125060394|NCT01419665|449838586|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
125060395|NCT01419665|449838587|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
125060396|NCT01419665|449838586|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
125060397|NCT01419665|449838587|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
125060398|NCT01419665|449838586|FG000|Maintenance Treatment and/or Follow up|Death|1|||
125060399|NCT01419665|449838587|FG001|Maintenance Treatment and/or Follow up|Death|2|||
125060400|NCT01419665|449838586|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
125060401|NCT01419665|449838587|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
125060402|NCT01419665|449838586|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
125060403|NCT01419665|449838587|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
125060404|NCT01419665|449838586|FG000|Open Label Phase|Death|1|||
125060405|NCT01419665|449838587|FG001|Open Label Phase|Death|0|||
125060406|NCT01419665|449838586|FG000|Open Label Phase|disease progression|0|||
125060407|NCT01419665|449838587|FG001|Open Label Phase|disease progression|1|||
125060408|NCT03738566|449838588|FG000|Initial Study Phase|Withdrawal by Subject|1|||
125060409|NCT03738566|449838589|FG001|Initial Study Phase|Withdrawal by Subject|1|||
125060410|NCT03738566|449838590|FG002|Initial Study Phase|Withdrawal by Subject|2|||
125060411|NCT03738566|449838591|FG003|Initial Study Phase|Withdrawal by Subject|0|||
125060412|NCT03738566|449838588|FG000|Initial Study Phase|Death|0|||
125060413|NCT03738566|449838589|FG001|Initial Study Phase|Death|1|||
125060414|NCT03738566|449838590|FG002|Initial Study Phase|Death|0|||
125060415|NCT03738566|449838591|FG003|Initial Study Phase|Death|0|||
125060416|NCT03738566|449838588|FG000|Initial Study Phase|Treatment failure|5|||
125060417|NCT03738566|449838589|FG001|Initial Study Phase|Treatment failure|0|||
125060418|NCT03738566|449838590|FG002|Initial Study Phase|Treatment failure|0|||
125060419|NCT03738566|449838591|FG003|Initial Study Phase|Treatment failure|0|||
125060420|NCT03738566|449838588|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
125060421|NCT03738566|449838589|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
125060422|NCT03738566|449838590|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
125060423|NCT03738566|449838591|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
125060424|NCT01655823|449838592|FG000|Overall Study|Lost to Follow-up|0|||
125060425|NCT01655823|449838593|FG001|Overall Study|Lost to Follow-up|1|||
125060426|NCT01655823|449838594|FG002|Overall Study|Lost to Follow-up|0|||
125060427|NCT01655823|449838595|FG003|Overall Study|Lost to Follow-up|0|||
125060428|NCT01655823|449838596|FG004|Overall Study|Lost to Follow-up|1|||
125060429|NCT01655823|449838592|FG000|Overall Study|Withdrawal by Subject|0|||
125060430|NCT01655823|449838593|FG001|Overall Study|Withdrawal by Subject|1|||
125060431|NCT01655823|449838594|FG002|Overall Study|Withdrawal by Subject|0|||
125060432|NCT01655823|449838595|FG003|Overall Study|Withdrawal by Subject|1|||
125060433|NCT01655823|449838596|FG004|Overall Study|Withdrawal by Subject|0|||
125060434|NCT04799405|449838599|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
125060435|NCT02998554|449838602|FG000|Overall Study|Adverse Event|8|||
125060436|NCT02998554|449838603|FG001|Overall Study|Adverse Event|3|||
125060437|NCT02998554|449838602|FG000|Overall Study|Protocol deviation|1|||
125060438|NCT02998554|449838603|FG001|Overall Study|Protocol deviation|0|||
125060439|NCT02998554|449838602|FG000|Overall Study|Withdrawal by Subject|2|||
125060440|NCT02998554|449838603|FG001|Overall Study|Withdrawal by Subject|6|||
125060441|NCT02998554|449838602|FG000|Overall Study|Lost to Follow-up|0|||
125060442|NCT02998554|449838603|FG001|Overall Study|Lost to Follow-up|1|||
125060443|NCT02998554|449838602|FG000|Overall Study|Lack of Efficacy|0|||
125060444|NCT02998554|449838603|FG001|Overall Study|Lack of Efficacy|1|||
125060445|NCT02953782|449838606|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
125060446|NCT02953782|449838607|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
125060447|NCT02953782|449838608|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
125060448|NCT02953782|449838609|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
125060449|NCT02953782|449838610|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
125060450|NCT02953782|449838611|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
125060451|NCT02953782|449838612|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
125060452|NCT02953782|449838613|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
125060453|NCT02953782|449838606|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
125060454|NCT02953782|449838607|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
125060455|NCT02953782|449838608|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
125060456|NCT02953782|449838609|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
125060457|NCT02953782|449838610|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
125060458|NCT02953782|449838611|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
125060459|NCT02953782|449838612|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
125060460|NCT02953782|449838613|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
125060461|NCT02953782|449838606|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
125060462|NCT02953782|449838607|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
125060463|NCT02953782|449838608|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
125060464|NCT02953782|449838609|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
125060465|NCT02953782|449838610|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
125060466|NCT02953782|449838611|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
125060467|NCT02953782|449838612|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
125060468|NCT02953782|449838613|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
125060469|NCT02953782|449838606|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
125060470|NCT02953782|449838607|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
125060471|NCT02953782|449838608|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
125060472|NCT02953782|449838609|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
125060473|NCT02953782|449838610|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
125060474|NCT02953782|449838611|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
125060475|NCT02953782|449838612|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
125060476|NCT02953782|449838613|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
125060477|NCT02953782|449838606|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
125060478|NCT02953782|449838607|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
125060479|NCT02953782|449838608|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
125060480|NCT02953782|449838609|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
125060481|NCT02953782|449838610|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
125060482|NCT02953782|449838611|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
125060483|NCT02953782|449838612|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
125060484|NCT02953782|449838613|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
125139051|NCT03573544|450131238|FG002|Overall Study|Disease progression|6|||
125139052|NCT03573544|450131239|FG003|Overall Study|Disease progression|4|||
125139053|NCT03573544|450131240|FG004|Overall Study|Disease progression|5|||
125139054|NCT03573544|450131241|FG005|Overall Study|Disease progression|7|||
125139055|NCT03573544|450131242|FG006|Overall Study|Disease progression|6|||
125139056|NCT03573544|450131243|FG007|Overall Study|Disease progression|7|||
125139057|NCT03846193|450131244|FG000|Overall Study|Physician Decision|0|||
125139058|NCT03846193|450131245|FG001|Overall Study|Physician Decision|0|||
125139059|NCT03846193|450131246|FG002|Overall Study|Physician Decision|1|||
125139060|NCT03846193|450131247|FG003|Overall Study|Physician Decision|0|||
125139061|NCT03846193|450131248|FG004|Overall Study|Physician Decision|0|||
125222363|NCT00928434|450442724|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
125060485|NCT02953782|449838606|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
125060486|NCT02953782|449838607|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
125060487|NCT02953782|449838608|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
125060488|NCT02953782|449838609|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
125060489|NCT02953782|449838610|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
125060490|NCT02953782|449838611|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
125060491|NCT02953782|449838612|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
125060492|NCT02953782|449838613|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
125060493|NCT02953782|449838606|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
125060494|NCT02953782|449838607|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
125060495|NCT02953782|449838608|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
125060496|NCT02953782|449838609|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
125060497|NCT02953782|449838610|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
125060498|NCT02953782|449838611|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
125060499|NCT02953782|449838612|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
125060500|NCT02953782|449838613|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
125060501|NCT02953782|449838606|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
125060502|NCT02953782|449838607|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
125060503|NCT02953782|449838608|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
125060504|NCT02953782|449838609|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
125060505|NCT02953782|449838610|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
125060506|NCT02953782|449838611|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
125060507|NCT02953782|449838612|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
125060508|NCT02953782|449838613|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
125060509|NCT02357849|449838614|FG000|Overall Study|Withdrawal by Subject|2|||
125060510|NCT02357849|449838615|FG001|Overall Study|Withdrawal by Subject|3|||
125060511|NCT01536119|449838616|FG000|Overall Study|Lost to Follow-up|17|||
125060512|NCT01536119|449838617|FG001|Overall Study|Lost to Follow-up|14|||
125060513|NCT00430521|449838626|FG000|Overall Study|Adverse Event|0|||
125060514|NCT00430521|449838627|FG001|Overall Study|Adverse Event|0|||
125060515|NCT00430521|449838628|FG002|Overall Study|Adverse Event|0|||
125060516|NCT00430521|449838629|FG003|Overall Study|Adverse Event|0|||
125060517|NCT00430521|449838630|FG004|Overall Study|Adverse Event|0|||
125060518|NCT00430521|449838631|FG005|Overall Study|Adverse Event|2|||
125139062|NCT03846193|450131244|FG000|Overall Study|Lost to Follow-up|0|||
125139063|NCT03846193|450131245|FG001|Overall Study|Lost to Follow-up|0|||
125139064|NCT03846193|450131246|FG002|Overall Study|Lost to Follow-up|0|||
125139065|NCT03846193|450131247|FG003|Overall Study|Lost to Follow-up|0|||
125139066|NCT03846193|450131248|FG004|Overall Study|Lost to Follow-up|1|||
125060519|NCT00430521|449838632|FG006|Overall Study|Adverse Event|1|||
125060520|NCT00430521|449838633|FG007|Overall Study|Adverse Event|0|||
125060521|NCT00430521|449838626|FG000|Overall Study|Lost to Follow-up|7|||
125060522|NCT00430521|449838627|FG001|Overall Study|Lost to Follow-up|8|||
125060523|NCT00430521|449838628|FG002|Overall Study|Lost to Follow-up|3|||
125060524|NCT00430521|449838629|FG003|Overall Study|Lost to Follow-up|5|||
125060525|NCT00430521|449838630|FG004|Overall Study|Lost to Follow-up|5|||
125060526|NCT00430521|449838631|FG005|Overall Study|Lost to Follow-up|2|||
125060527|NCT00430521|449838632|FG006|Overall Study|Lost to Follow-up|8|||
125060528|NCT00430521|449838633|FG007|Overall Study|Lost to Follow-up|10|||
125060529|NCT00430521|449838626|FG000|Overall Study|Pregnancy|0|||
125060530|NCT00430521|449838627|FG001|Overall Study|Pregnancy|0|||
125060531|NCT00430521|449838628|FG002|Overall Study|Pregnancy|0|||
125060532|NCT00430521|449838629|FG003|Overall Study|Pregnancy|0|||
125060533|NCT00430521|449838630|FG004|Overall Study|Pregnancy|0|||
125060534|NCT00430521|449838631|FG005|Overall Study|Pregnancy|0|||
125060535|NCT00430521|449838632|FG006|Overall Study|Pregnancy|1|||
125060536|NCT00430521|449838633|FG007|Overall Study|Pregnancy|0|||
125060537|NCT00430521|449838626|FG000|Overall Study|Vaccine Expired|0|||
125060538|NCT00430521|449838627|FG001|Overall Study|Vaccine Expired|0|||
125060539|NCT00430521|449838628|FG002|Overall Study|Vaccine Expired|0|||
125060540|NCT00430521|449838629|FG003|Overall Study|Vaccine Expired|0|||
125060541|NCT00430521|449838630|FG004|Overall Study|Vaccine Expired|0|||
125060542|NCT00430521|449838631|FG005|Overall Study|Vaccine Expired|1|||
125060543|NCT00430521|449838632|FG006|Overall Study|Vaccine Expired|0|||
125060544|NCT00430521|449838633|FG007|Overall Study|Vaccine Expired|0|||
125060545|NCT00430521|449838626|FG000|Overall Study|Protocol Violation|1|||
125060546|NCT00430521|449838627|FG001|Overall Study|Protocol Violation|0|||
125060547|NCT00430521|449838628|FG002|Overall Study|Protocol Violation|0|||
125060548|NCT00430521|449838629|FG003|Overall Study|Protocol Violation|0|||
125060549|NCT00430521|449838630|FG004|Overall Study|Protocol Violation|0|||
125060550|NCT00430521|449838631|FG005|Overall Study|Protocol Violation|0|||
125060551|NCT00430521|449838632|FG006|Overall Study|Protocol Violation|0|||
125060552|NCT00430521|449838633|FG007|Overall Study|Protocol Violation|0|||
125060553|NCT00430521|449838626|FG000|Overall Study|Withdrawal by Subject|3|||
125060554|NCT00430521|449838627|FG001|Overall Study|Withdrawal by Subject|1|||
125060555|NCT00430521|449838628|FG002|Overall Study|Withdrawal by Subject|0|||
125139067|NCT03846193|450131244|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
125139068|NCT03846193|450131245|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
125139069|NCT03846193|450131246|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
125139070|NCT03846193|450131247|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
125139071|NCT03846193|450131248|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
125139072|NCT00902538|450131250|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
125139073|NCT00902538|450131251|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
125139074|NCT00902538|450131252|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
125139075|NCT00902538|450131253|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
125139076|NCT00902538|450131254|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
125139077|NCT00902538|450131255|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
125139078|NCT00902538|450131250|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
125139079|NCT00902538|450131251|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
125139080|NCT00902538|450131252|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
125060556|NCT00430521|449838629|FG003|Overall Study|Withdrawal by Subject|3|||
125060557|NCT00430521|449838630|FG004|Overall Study|Withdrawal by Subject|0|||
125060558|NCT00430521|449838631|FG005|Overall Study|Withdrawal by Subject|0|||
125060559|NCT00430521|449838632|FG006|Overall Study|Withdrawal by Subject|0|||
125060560|NCT00430521|449838633|FG007|Overall Study|Withdrawal by Subject|2|||
125060561|NCT05108805|449838634|FG000|Overall Study|T-cell expansion was not successful.|5|||
125222364|NCT00928434|450442722|FG000|Overall Study|Other (not meeting above criteria)|5|||
125139081|NCT00902538|450131253|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
125139082|NCT00902538|450131254|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
125222365|NCT00928434|450442723|FG001|Overall Study|Other (not meeting above criteria)|1|||
125139083|NCT00902538|450131255|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
125139084|NCT00902538|450131250|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
125139085|NCT00902538|450131251|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
125222366|NCT00928434|450442724|FG002|Overall Study|Other (not meeting above criteria)|2|||
125139086|NCT00902538|450131252|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
125139087|NCT00902538|450131253|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
125060562|NCT00343291|449840656|FG000|Overall Study|Adverse Event|13|||
125060563|NCT00343291|449840657|FG001|Overall Study|Adverse Event|13|||
125060564|NCT00343291|449840656|FG000|Overall Study|Death|3|||
125060565|NCT00343291|449840657|FG001|Overall Study|Death|2|||
125060566|NCT00343291|449840656|FG000|Overall Study|Progressive disease|33|||
125060567|NCT00343291|449840657|FG001|Overall Study|Progressive disease|34|||
125060568|NCT00343291|449840656|FG000|Overall Study|Withdrawal by Subject|0|||
125060569|NCT00343291|449840657|FG001|Overall Study|Withdrawal by Subject|2|||
125060570|NCT00343291|449840656|FG000|Overall Study|Other|8|||
125060571|NCT00343291|449840657|FG001|Overall Study|Other|5|||
125060572|NCT00839423|449840662|FG000|Overall Study|Adverse Event|4|||
125060573|NCT00839423|449840663|FG001|Overall Study|Adverse Event|3|||
125060574|NCT00839423|449840664|FG002|Overall Study|Adverse Event|7|||
125060575|NCT00839423|449840665|FG003|Overall Study|Adverse Event|16|||
125060576|NCT00839423|449840662|FG000|Overall Study|Lack of Efficacy|6|||
125060577|NCT00839423|449840663|FG001|Overall Study|Lack of Efficacy|6|||
125060578|NCT00839423|449840664|FG002|Overall Study|Lack of Efficacy|3|||
125060579|NCT00839423|449840665|FG003|Overall Study|Lack of Efficacy|2|||
125060580|NCT00839423|449840662|FG000|Overall Study|Non-compliance|0|||
125060581|NCT00839423|449840663|FG001|Overall Study|Non-compliance|0|||
125060582|NCT00839423|449840664|FG002|Overall Study|Non-compliance|0|||
125060583|NCT00839423|449840665|FG003|Overall Study|Non-compliance|1|||
125060584|NCT00839423|449840662|FG000|Overall Study|Protocol Violation|0|||
125060585|NCT00839423|449840663|FG001|Overall Study|Protocol Violation|1|||
125060586|NCT00839423|449840664|FG002|Overall Study|Protocol Violation|2|||
125060587|NCT00839423|449840665|FG003|Overall Study|Protocol Violation|0|||
125060588|NCT00839423|449840662|FG000|Overall Study|Withdrawal of consent|4|||
125060589|NCT00839423|449840663|FG001|Overall Study|Withdrawal of consent|0|||
125060590|NCT00839423|449840664|FG002|Overall Study|Withdrawal of consent|4|||
125060591|NCT00839423|449840665|FG003|Overall Study|Withdrawal of consent|1|||
125060592|NCT00839423|449840662|FG000|Overall Study|Lost to Follow-up|1|||
125060593|NCT00839423|449840663|FG001|Overall Study|Lost to Follow-up|0|||
125060594|NCT00839423|449840664|FG002|Overall Study|Lost to Follow-up|1|||
125060595|NCT00839423|449840665|FG003|Overall Study|Lost to Follow-up|0|||
125060596|NCT00839423|449840662|FG000|Overall Study|Administrative or other reasons|3|||
125060597|NCT00839423|449840663|FG001|Overall Study|Administrative or other reasons|0|||
125060598|NCT00839423|449840664|FG002|Overall Study|Administrative or other reasons|1|||
125060599|NCT00839423|449840665|FG003|Overall Study|Administrative or other reasons|0|||
125060600|NCT01071096|449840666|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
125060601|NCT01071096|449840667|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
125060602|NCT00756886|449840671|FG000|Overall Study|Lost to Follow-up|1|||
125060603|NCT00756886|449840672|FG001|Overall Study|Lost to Follow-up|0|||
125060604|NCT00756886|449840671|FG000|Overall Study|Adverse Event|0|||
125060605|NCT00756886|449840672|FG001|Overall Study|Adverse Event|3|||
125060606|NCT00756886|449840671|FG000|Overall Study|Lack of Efficacy|1|||
125060607|NCT00756886|449840672|FG001|Overall Study|Lack of Efficacy|0|||
125060608|NCT00756886|449840671|FG000|Overall Study|Ineligible|9|||
125060609|NCT00756886|449840672|FG001|Overall Study|Ineligible|4|||
125060610|NCT03421964|449840678|FG000|Overall Study|Lost to Follow-up|11|||
125060611|NCT03421964|449840679|FG001|Overall Study|Lost to Follow-up|21|||
125060612|NCT03421964|449840678|FG000|Overall Study|Withdrawal by Subject|9|||
125060613|NCT03421964|449840679|FG001|Overall Study|Withdrawal by Subject|3|||
125060614|NCT03421964|449840678|FG000|Overall Study|Incarcerated|1|||
125060615|NCT03421964|449840679|FG001|Overall Study|Incarcerated|0|||
125060616|NCT03421964|449840678|FG000|Overall Study|Inpt Treatment Facility|1|||
125060617|NCT03421964|449840679|FG001|Overall Study|Inpt Treatment Facility|1|||
125060618|NCT03421964|449840678|FG000|Overall Study|Virtual Platform Issues|1|||
125060619|NCT03421964|449840679|FG001|Overall Study|Virtual Platform Issues|1|||
125060620|NCT02411201|449840680|FG000|Overall Study|Adverse Event|2|||
125060621|NCT02411201|449840680|FG000|Overall Study|Withdrawal by Subject|2|||
125060622|NCT02411201|449840680|FG000|Overall Study|Age group completed|2|||
125060623|NCT01260467|449840681|FG000|Overall Study|Withdrawal by Subject|2|||
125060624|NCT01774344|449840682|FG000|Overall Study|Withdrawal by Subject|3|||
125060625|NCT01774344|449840683|FG001|Overall Study|Withdrawal by Subject|10|||
125060626|NCT01774344|449840682|FG000|Overall Study|Protocol Violation|0|||
125222367|NCT01278342|450442727|FG000|Overall Study|Physician Decision|0|||
125222368|NCT01278342|450442728|FG001|Overall Study|Physician Decision|1|||
125060627|NCT01774344|449840683|FG001|Overall Study|Protocol Violation|1|||
125060628|NCT01774344|449840682|FG000|Overall Study|Lost to Follow-up|4|||
125060629|NCT01774344|449840683|FG001|Overall Study|Lost to Follow-up|10|||
125060630|NCT01774344|449840682|FG000|Overall Study|End of survival follow-up not available|2|||
125060631|NCT01774344|449840683|FG001|Overall Study|End of survival follow-up not available|2|||
125060632|NCT01774344|449840682|FG000|Overall Study|Data collection finished|4|||
125060633|NCT01774344|449840683|FG001|Overall Study|Data collection finished|14|||
125060634|NCT01774344|449840682|FG000|Overall Study|Other|0|||
125060635|NCT01774344|449840683|FG001|Overall Study|Other|1|||
125060636|NCT01774344|449840682|FG000|Overall Study|Did not enter Survival Follow up|49|||
125060637|NCT01774344|449840683|FG001|Overall Study|Did not enter Survival Follow up|83|||
125060638|NCT01397552|449840684|FG000|Overall Study|Adverse Event|1|||
125060639|NCT01397552|449840685|FG001|Overall Study|Adverse Event|0|||
125060640|NCT01397552|449840684|FG000|Overall Study|Withdrawal by Subject|2|||
125060641|NCT01397552|449840685|FG001|Overall Study|Withdrawal by Subject|1|||
125060642|NCT00992784|449840691|FG000|Overall Study|Adverse Event|2|||
125060643|NCT00992784|449840692|FG001|Overall Study|Adverse Event|1|||
125060644|NCT00992784|449840693|FG002|Overall Study|Adverse Event|0|||
125060645|NCT00992784|449840691|FG000|Overall Study|Withdrawal by Subject|1|||
125060646|NCT00992784|449840692|FG001|Overall Study|Withdrawal by Subject|1|||
125060647|NCT00992784|449840693|FG002|Overall Study|Withdrawal by Subject|1|||
125060648|NCT01363713|449840694|FG000|Overall Study|Adverse Event|1|||
125060649|NCT01363713|449840694|FG000|Overall Study|Protocol Violation|3|||
125060650|NCT01363713|449840694|FG000|Overall Study|Withdrawal by Subject|2|||
125060651|NCT01658579|449840695|FG000|Treatment Period A|Other|0|||
125060652|NCT01658579|449840696|FG001|Treatment Period A|Other|0|||
125060653|NCT01658579|449840697|FG002|Treatment Period A|Other|1|||
125060654|NCT01658579|449840698|FG003|Treatment Period A|Other|1|||
125060655|NCT01658579|449840695|FG000|Treatment Period A|Adverse Event|1|||
125060656|NCT01658579|449840696|FG001|Treatment Period A|Adverse Event|0|||
125222369|NCT01278342|450442729|FG002|Overall Study|Physician Decision|0|||
125222370|NCT01278342|450442727|FG000|Overall Study|Lost to Follow-up|1|||
125222371|NCT01278342|450442728|FG001|Overall Study|Lost to Follow-up|0|||
125222372|NCT01278342|450442729|FG002|Overall Study|Lost to Follow-up|0|||
125222373|NCT01278342|450442727|FG000|Overall Study|Administrative problems|2|||
125222374|NCT01278342|450442728|FG001|Overall Study|Administrative problems|0|||
125222375|NCT01278342|450442729|FG002|Overall Study|Administrative problems|0|||
125222376|NCT01278342|450442727|FG000|Overall Study|Other|1|||
125222377|NCT01278342|450442728|FG001|Overall Study|Other|0|||
125222378|NCT01278342|450442729|FG002|Overall Study|Other|0|||
125222379|NCT00313846|450442735|FG000|Overall Study|Withdrawal by Subject|2|||
125222380|NCT00313846|450442736|FG001|Overall Study|Withdrawal by Subject|0|||
125222381|NCT00313846|450442735|FG000|Overall Study|Adverse Event|1|||
125222382|NCT00313846|450442736|FG001|Overall Study|Adverse Event|8|||
125222383|NCT00313846|450442735|FG000|Overall Study|Administrative|2|||
125222384|NCT00313846|450442736|FG001|Overall Study|Administrative|3|||
125222385|NCT01462630|450442738|FG000|Overall Study|Did not initiate therapy|3|||
125222386|NCT01462630|450442738|FG000|Overall Study|Death|1|||
125222387|NCT01462630|450442738|FG000|Overall Study|Protocol Violation|2|||
125060657|NCT01658579|449840697|FG002|Treatment Period A|Adverse Event|0|||
125060658|NCT01658579|449840698|FG003|Treatment Period A|Adverse Event|0|||
125060659|NCT01658579|449840695|FG000|Treatment Period B|Other|0|||
125060660|NCT01658579|449840696|FG001|Treatment Period B|Other|0|||
125222388|NCT01462630|450442738|FG000|Overall Study|Adverse Event|1|||
125060661|NCT01658579|449840697|FG002|Treatment Period B|Other|0|||
125060662|NCT01658579|449840698|FG003|Treatment Period B|Other|1|||
125060663|NCT00608530|449840701|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
125060664|NCT00608530|449840702|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
125060665|NCT00608530|449840703|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
125060666|NCT00608530|449840704|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
125060667|NCT00608530|449840701|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
125060668|NCT00608530|449840702|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
125060669|NCT00608530|449840703|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
125060670|NCT00608530|449840704|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
125060671|NCT00608530|449840701|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
125060672|NCT00608530|449840702|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
125060673|NCT00608530|449840703|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
125060674|NCT00608530|449840704|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
125060675|NCT00608530|449840701|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
125060676|NCT00608530|449840702|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
125060677|NCT00608530|449840703|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
125060678|NCT00608530|449840704|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
125060679|NCT00608530|449840701|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
125060680|NCT00608530|449840702|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
125060681|NCT00608530|449840703|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
125060682|NCT00608530|449840704|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
125060683|NCT00608530|449840701|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
125060684|NCT00608530|449840702|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
125060685|NCT00608530|449840703|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
125060686|NCT00608530|449840704|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
125060687|NCT01514188|449840705|FG000|Overall Study|Adverse Event|3|||
125060688|NCT01514188|449840706|FG001|Overall Study|Adverse Event|5|||
125060689|NCT01514188|449840705|FG000|Overall Study|Withdrawal by Subject|2|||
125060690|NCT01514188|449840706|FG001|Overall Study|Withdrawal by Subject|4|||
125060691|NCT01514188|449840705|FG000|Overall Study|Protocol Violation|2|||
125060692|NCT01514188|449840706|FG001|Overall Study|Protocol Violation|4|||
125060693|NCT01514188|449840705|FG000|Overall Study|Physician Decision|0|||
125060694|NCT01514188|449840706|FG001|Overall Study|Physician Decision|2|||
125060695|NCT01514188|449840705|FG000|Overall Study|Disease Progression|13|||
125060696|NCT01514188|449840706|FG001|Overall Study|Disease Progression|14|||
125060697|NCT01514188|449840705|FG000|Overall Study|Death|1|||
125060698|NCT01514188|449840706|FG001|Overall Study|Death|3|||
125060699|NCT01514188|449840705|FG000|Overall Study|Other|2|||
125060700|NCT01514188|449840706|FG001|Overall Study|Other|1|||
125060701|NCT01019486|449840707|FG000|Overall Study|Withdrawal by Subject|1|||
125060702|NCT01019486|449840708|FG001|Overall Study|Withdrawal by Subject|1|||
125060703|NCT01019486|449840709|FG002|Overall Study|Withdrawal by Subject|1|||
125060704|NCT02932332|449840714|FG000|Overall Study|Withdrawal by Subject|1|||
125060705|NCT02932332|449840715|FG001|Overall Study|Withdrawal by Subject|1|||
125060706|NCT02932332|449840716|FG002|Overall Study|Withdrawal by Subject|0|||
125060707|NCT02932332|449840717|FG003|Overall Study|Withdrawal by Subject|1|||
125060708|NCT02932332|449840714|FG000|Overall Study|Chest pain|0|||
125060709|NCT02932332|449840715|FG001|Overall Study|Chest pain|0|||
125060710|NCT02932332|449840716|FG002|Overall Study|Chest pain|0|||
125060711|NCT02932332|449840717|FG003|Overall Study|Chest pain|1|||
125060712|NCT02932332|449840714|FG000|Overall Study|Not Dyspneic cough|1|||
125060713|NCT02932332|449840715|FG001|Overall Study|Not Dyspneic cough|2|||
125060714|NCT02932332|449840716|FG002|Overall Study|Not Dyspneic cough|1|||
125060715|NCT02932332|449840717|FG003|Overall Study|Not Dyspneic cough|0|||
125060716|NCT05373706|449840719|FG000|Overall Study|Lost to Follow-up|2|||
125060717|NCT05373706|449840720|FG001|Overall Study|Lost to Follow-up|2|||
125060718|NCT02841787|449840721|FG000|Overall Study|Lost to Follow-up|1|||
125060719|NCT02841787|449840722|FG001|Overall Study|Lost to Follow-up|0|||
125060720|NCT02841787|449840723|FG002|Overall Study|Lost to Follow-up|0|||
125060721|NCT02841787|449840721|FG000|Overall Study|Symptoms dropped below threshold|1|||
125060722|NCT02841787|449840722|FG001|Overall Study|Symptoms dropped below threshold|0|||
125060723|NCT02841787|449840723|FG002|Overall Study|Symptoms dropped below threshold|0|||
125060724|NCT02841787|449840721|FG000|Overall Study|Withdrawal by Subject|1|||
125060725|NCT02841787|449840722|FG001|Overall Study|Withdrawal by Subject|4|||
125060726|NCT02841787|449840723|FG002|Overall Study|Withdrawal by Subject|0|||
125060727|NCT03029650|449840727|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
125060728|NCT03029650|449840728|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
125060729|NCT03029650|449840727|FG000|Washout (1 Week)|Physician Decision|0|||
125060730|NCT03029650|449840728|FG001|Washout (1 Week)|Physician Decision|1|||
125060731|NCT01875367|449840730|FG000|Overall Study|Not complete at least 2 questionaries|4|||
125060732|NCT01875367|449840731|FG001|Overall Study|Not complete at least 2 questionaries|2|||
125222389|NCT01765296|450442739|FG000|Overall Study|Protocol Violation|0|||
125222390|NCT01765296|450442740|FG001|Overall Study|Protocol Violation|5|||
125060733|NCT01875367|449840730|FG000|Overall Study|Not receive study treatment|1|||
125060734|NCT01875367|449840731|FG001|Overall Study|Not receive study treatment|0|||
125060735|NCT04533815|449840742|FG000|Overall Study|Adverse Event|2|||
125060736|NCT04533815|449840742|FG000|Overall Study|Site withdrew|5|||
125060737|NCT02951988|449840743|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
125060738|NCT02951988|449840744|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
125060739|NCT02951988|449840745|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
125060740|NCT02951988|449840746|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
125060741|NCT02951988|449840743|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
125060742|NCT02951988|449840744|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
125060743|NCT02951988|449840745|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
125060744|NCT02951988|449840746|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
125060745|NCT02951988|449840743|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
125060746|NCT02951988|449840744|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
125060747|NCT02951988|449840745|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
125060748|NCT02951988|449840746|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
125060749|NCT02951988|449840743|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
125060750|NCT02951988|449840744|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
125060751|NCT02951988|449840745|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
125060752|NCT02951988|449840746|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
125060753|NCT02951988|449840743|FG000|Open-Label Treatment Period|Protocol Violation|22|||
125060754|NCT02951988|449840744|FG001|Open-Label Treatment Period|Protocol Violation|0|||
125060755|NCT02951988|449840745|FG002|Open-Label Treatment Period|Protocol Violation|0|||
125060756|NCT02951988|449840746|FG003|Open-Label Treatment Period|Protocol Violation|0|||
125060757|NCT02951988|449840743|FG000|Open-Label Treatment Period|Pregnancy|2|||
125060758|NCT02951988|449840744|FG001|Open-Label Treatment Period|Pregnancy|0|||
125060759|NCT02951988|449840745|FG002|Open-Label Treatment Period|Pregnancy|0|||
125060760|NCT02951988|449840746|FG003|Open-Label Treatment Period|Pregnancy|0|||
125060761|NCT02951988|449840743|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
125060762|NCT02951988|449840744|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
125060763|NCT02951988|449840745|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
125060764|NCT02951988|449840746|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
125060765|NCT02951988|449840743|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
125060766|NCT02951988|449840744|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
125060767|NCT02951988|449840745|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
125060768|NCT02951988|449840746|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
125060769|NCT02951988|449840743|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
125060770|NCT02951988|449840744|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
125060771|NCT02951988|449840745|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
125060772|NCT02951988|449840746|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
125060773|NCT02951988|449840743|FG000|Open-Label Treatment Period|Adverse Event|45|||
125060774|NCT02951988|449840744|FG001|Open-Label Treatment Period|Adverse Event|0|||
125060775|NCT02951988|449840745|FG002|Open-Label Treatment Period|Adverse Event|0|||
125060776|NCT02951988|449840746|FG003|Open-Label Treatment Period|Adverse Event|0|||
125060777|NCT02951988|449840743|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
125060778|NCT02951988|449840744|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
125060779|NCT02951988|449840745|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
125060780|NCT02951988|449840746|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
125060781|NCT02951988|449840743|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
125060782|NCT02951988|449840744|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
125060783|NCT02951988|449840745|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
125060784|NCT02951988|449840746|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
125060785|NCT02951988|449840743|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
125060786|NCT02951988|449840744|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
125060787|NCT02951988|449840745|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
125060788|NCT02951988|449840746|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
125060789|NCT02951988|449840743|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
125060790|NCT02951988|449840744|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
125060791|NCT02951988|449840745|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
125060792|NCT02951988|449840746|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
125060793|NCT02951988|449840743|FG000|Double-Blind Treatment Period|Pregnancy|0|||
125060794|NCT02951988|449840744|FG001|Double-Blind Treatment Period|Pregnancy|1|||
125060795|NCT02951988|449840745|FG002|Double-Blind Treatment Period|Pregnancy|1|||
125060796|NCT02951988|449840746|FG003|Double-Blind Treatment Period|Pregnancy|0|||
125060797|NCT02951988|449840743|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
125060798|NCT02951988|449840744|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
125060799|NCT02951988|449840745|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
125060800|NCT02951988|449840746|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
125060801|NCT02951988|449840743|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125060802|NCT02951988|449840744|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
125060803|NCT02951988|449840745|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
125060804|NCT02951988|449840746|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
125060805|NCT02951988|449840743|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125060806|NCT02951988|449840744|FG001|Double-Blind Treatment Period|Adverse Event|8|||
125060807|NCT02951988|449840745|FG002|Double-Blind Treatment Period|Adverse Event|3|||
125060808|NCT02951988|449840746|FG003|Double-Blind Treatment Period|Adverse Event|6|||
125060809|NCT02951988|449840743|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
125060810|NCT02951988|449840744|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
125060811|NCT02951988|449840745|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
125060812|NCT02951988|449840746|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
125060813|NCT05836818|449840747|FG000|Overall Study|Physician Decision|1|||
125060814|NCT05836818|449840748|FG001|Overall Study|Physician Decision|1|||
125060815|NCT05836818|449840749|FG002|Overall Study|Physician Decision|0|||
125060816|NCT05836818|449840747|FG000|Overall Study|Withdrawal by Subject|0|||
125060817|NCT05836818|449840748|FG001|Overall Study|Withdrawal by Subject|0|||
125060818|NCT05836818|449840749|FG002|Overall Study|Withdrawal by Subject|1|||
125060819|NCT05836818|449840747|FG000|Overall Study|Later found to be previously vaccinated|0|||
125060820|NCT05836818|449840748|FG001|Overall Study|Later found to be previously vaccinated|1|||
125060821|NCT05836818|449840749|FG002|Overall Study|Later found to be previously vaccinated|3|||
125060822|NCT05836818|449840747|FG000|Overall Study|Pregnancy|0|||
125060823|NCT05836818|449840748|FG001|Overall Study|Pregnancy|1|||
125060824|NCT05836818|449840749|FG002|Overall Study|Pregnancy|0|||
125060825|NCT05836818|449840747|FG000|Overall Study|Allergic to vaccines|0|||
125060826|NCT05836818|449840748|FG001|Overall Study|Allergic to vaccines|1|||
125060827|NCT05836818|449840749|FG002|Overall Study|Allergic to vaccines|0|||
125060828|NCT03977727|449840750|FG000|Second Treatment|Lost to Follow-up|0|||
125060829|NCT03977727|449840751|FG001|Second Treatment|Lost to Follow-up|3|||
125060830|NCT00603980|449840757|FG000|Study Qualification|Protocol Violation|3|||
125060831|NCT00603980|449840757|FG000|Study Qualification|Inconsistent data reporting|13|||
125060832|NCT00603980|449840757|FG000|Main Study|14th subject completed trial|1|||
125060833|NCT02683525|449840758|FG000|Overall Study|Lost to Follow-up|1|||
125060834|NCT02683525|449840758|FG000|Overall Study|Physician Decision|1|||
125060835|NCT02683525|449840758|FG000|Overall Study|Disease Progression|6|||
125060836|NCT01627067|449840759|FG000|Overall Study|Screen Failure|1|||
125060837|NCT00926796|449840767|FG000|Overall Study|Did not receive randomized treatment|4|||
125060838|NCT00926796|449840768|FG001|Overall Study|Did not receive randomized treatment|7|||
125060839|NCT00926796|449840767|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
125060840|NCT00926796|449840768|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
125060841|NCT00926796|449840767|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
125060842|NCT00926796|449840768|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
125060843|NCT00926796|449840767|FG000|Overall Study|Adverse Event|7|||
125060844|NCT00926796|449840768|FG001|Overall Study|Adverse Event|14|||
125060845|NCT00926796|449840767|FG000|Overall Study|Lost to Follow-up|22|||
125060846|NCT00926796|449840768|FG001|Overall Study|Lost to Follow-up|13|||
125060847|NCT00926796|449840767|FG000|Overall Study|Protocol Violation|15|||
125060848|NCT00926796|449840768|FG001|Overall Study|Protocol Violation|11|||
125060849|NCT00926796|449840767|FG000|Overall Study|Withdrawal by Subject|1|||
125060850|NCT00926796|449840768|FG001|Overall Study|Withdrawal by Subject|0|||
125060851|NCT01341652|449840772|FG000|Overall Study|Incorrect Random Assignment|0|||
125060852|NCT01341652|449840773|FG001|Overall Study|Incorrect Random Assignment|1|||
125060853|NCT01341652|449840772|FG000|Overall Study|ineligible; presence metastatic disease|0|||
125060854|NCT01341652|449840773|FG001|Overall Study|ineligible; presence metastatic disease|1|||
125060855|NCT00632463|449840775|FG000|Overall Study|Adverse Event|0|||
125139088|NCT00902538|450131254|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
125139089|NCT00902538|450131255|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
125139090|NCT00902538|450131250|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
125139091|NCT00902538|450131251|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
125139092|NCT00902538|450131252|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
125139093|NCT00902538|450131253|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
125139094|NCT00902538|450131254|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
125222391|NCT01765296|450442741|FG002|Overall Study|Protocol Violation|4|||
125222392|NCT01765296|450442739|FG000|Overall Study|Withdrawal by Subject|4|||
125222393|NCT01765296|450442740|FG001|Overall Study|Withdrawal by Subject|2|||
125060856|NCT00632463|449840776|FG001|Overall Study|Adverse Event|1|||
125060857|NCT00632463|449840777|FG002|Overall Study|Adverse Event|0|||
125060858|NCT00586924|449840778|FG000|Overall Study|Adverse event/serious adverse event|0|||
125060859|NCT00586924|449840779|FG001|Overall Study|Adverse event/serious adverse event|0|||
125060860|NCT00586924|449840780|FG002|Overall Study|Adverse event/serious adverse event|0|||
125060861|NCT00586924|449840781|FG003|Overall Study|Adverse event/serious adverse event|1|||
125139095|NCT00902538|450131255|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
125222394|NCT01765296|450442741|FG002|Overall Study|Withdrawal by Subject|2|||
125060862|NCT00586924|449840782|FG004|Overall Study|Adverse event/serious adverse event|0|||
125060863|NCT00586924|449840783|FG005|Overall Study|Adverse event/serious adverse event|2|||
125060864|NCT00586924|449840778|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
125060865|NCT00586924|449840779|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
125060866|NCT00586924|449840780|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
125060867|NCT00586924|449840781|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
125060868|NCT00586924|449840782|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
125060869|NCT00586924|449840783|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
125060870|NCT00586924|449840778|FG000|Overall Study|Disease progression|0|||
125060871|NCT00586924|449840779|FG001|Overall Study|Disease progression|0|||
125060872|NCT00586924|449840780|FG002|Overall Study|Disease progression|0|||
125060873|NCT00586924|449840781|FG003|Overall Study|Disease progression|1|||
125060874|NCT00586924|449840782|FG004|Overall Study|Disease progression|1|||
125060875|NCT00586924|449840783|FG005|Overall Study|Disease progression|0|||
125060876|NCT00586924|449840778|FG000|Overall Study|Development of neutralizing antibodies|2|||
125060877|NCT00586924|449840779|FG001|Overall Study|Development of neutralizing antibodies|2|||
125060878|NCT00586924|449840780|FG002|Overall Study|Development of neutralizing antibodies|2|||
125060879|NCT00586924|449840781|FG003|Overall Study|Development of neutralizing antibodies|0|||
125060880|NCT00586924|449840782|FG004|Overall Study|Development of neutralizing antibodies|0|||
125060881|NCT00586924|449840783|FG005|Overall Study|Development of neutralizing antibodies|22|||
125060882|NCT00586924|449840778|FG000|Overall Study|Complete response|0|||
125060883|NCT00586924|449840779|FG001|Overall Study|Complete response|1|||
125060884|NCT00586924|449840780|FG002|Overall Study|Complete response|0|||
125060885|NCT00586924|449840781|FG003|Overall Study|Complete response|0|||
125060886|NCT00586924|449840782|FG004|Overall Study|Complete response|2|||
125060887|NCT00586924|449840783|FG005|Overall Study|Complete response|2|||
125060888|NCT00586924|449840778|FG000|Overall Study|Other|1|||
125060889|NCT00586924|449840779|FG001|Overall Study|Other|0|||
125060890|NCT00586924|449840780|FG002|Overall Study|Other|1|||
125060891|NCT00586924|449840781|FG003|Overall Study|Other|1|||
125060892|NCT00586924|449840782|FG004|Overall Study|Other|1|||
125060893|NCT00586924|449840783|FG005|Overall Study|Other|6|||
125060894|NCT04146467|449840788|FG000|Overall Study|Adverse Event|0|||
125060895|NCT04146467|449840789|FG001|Overall Study|Adverse Event|1|||
125060896|NCT04146467|449840788|FG000|Overall Study|Lost to Follow-up|0|||
125060897|NCT04146467|449840789|FG001|Overall Study|Lost to Follow-up|2|||
125060898|NCT00621855|449840792|FG000|Overall Study|Adverse Event|32|||
125060899|NCT00621855|449840793|FG001|Overall Study|Adverse Event|31|||
125060900|NCT00621855|449840794|FG002|Overall Study|Adverse Event|48|||
125060901|NCT00621855|449840795|FG003|Overall Study|Adverse Event|34|||
125060902|NCT00621855|449840796|FG004|Overall Study|Adverse Event|31|||
125060903|NCT00621855|449840792|FG000|Overall Study|Lost to Follow-up|0|||
125060904|NCT00621855|449840793|FG001|Overall Study|Lost to Follow-up|1|||
125060905|NCT00621855|449840794|FG002|Overall Study|Lost to Follow-up|3|||
125060906|NCT00621855|449840795|FG003|Overall Study|Lost to Follow-up|4|||
125060907|NCT00621855|449840796|FG004|Overall Study|Lost to Follow-up|1|||
125060908|NCT00621855|449840792|FG000|Overall Study|Protocol Violation|16|||
125060909|NCT00621855|449840793|FG001|Overall Study|Protocol Violation|8|||
125060910|NCT00621855|449840794|FG002|Overall Study|Protocol Violation|6|||
125060911|NCT00621855|449840795|FG003|Overall Study|Protocol Violation|7|||
125060912|NCT00621855|449840796|FG004|Overall Study|Protocol Violation|8|||
125060913|NCT00621855|449840792|FG000|Overall Study|Withdrawal by Subject|16|||
125060914|NCT00621855|449840793|FG001|Overall Study|Withdrawal by Subject|11|||
125060915|NCT00621855|449840794|FG002|Overall Study|Withdrawal by Subject|13|||
125060916|NCT00621855|449840795|FG003|Overall Study|Withdrawal by Subject|13|||
125060917|NCT00621855|449840796|FG004|Overall Study|Withdrawal by Subject|9|||
125060918|NCT00621855|449840792|FG000|Overall Study|Other|9|||
125139096|NCT00902538|450131250|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
125139097|NCT00902538|450131251|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
125139098|NCT00902538|450131252|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
125139099|NCT00902538|450131253|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
125139100|NCT00902538|450131254|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
125222395|NCT01765296|450442739|FG000|Overall Study|Adverse Event|1|||
125060919|NCT00621855|449840793|FG001|Overall Study|Other|7|||
125060920|NCT00621855|449840794|FG002|Overall Study|Other|6|||
125060921|NCT00621855|449840795|FG003|Overall Study|Other|5|||
125060922|NCT00621855|449840796|FG004|Overall Study|Other|4|||
125060923|NCT00621855|449840792|FG000|Overall Study|Patients did not receive study drug|3|||
125060924|NCT00621855|449840793|FG001|Overall Study|Patients did not receive study drug|3|||
125060925|NCT00621855|449840794|FG002|Overall Study|Patients did not receive study drug|5|||
125060926|NCT00621855|449840795|FG003|Overall Study|Patients did not receive study drug|4|||
125060927|NCT00621855|449840796|FG004|Overall Study|Patients did not receive study drug|2|||
125060928|NCT03731364|449840797|FG000|Overall Study|Adverse Event|0|||
125060929|NCT03731364|449840798|FG001|Overall Study|Adverse Event|0|||
125060930|NCT03731364|449840799|FG002|Overall Study|Adverse Event|1|||
125139101|NCT00902538|450131255|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
125060931|NCT03731364|449840800|FG003|Overall Study|Adverse Event|2|||
125060932|NCT03731364|449840801|FG004|Overall Study|Adverse Event|1|||
125060933|NCT01934192|449840802|FG000|Overall Study|Protocol Violation|0|||
125060934|NCT01934192|449840803|FG001|Overall Study|Protocol Violation|0|||
125060935|NCT01934192|449840804|FG002|Overall Study|Protocol Violation|0|||
125222396|NCT01765296|450442740|FG001|Overall Study|Adverse Event|13|||
125060936|NCT01934192|449840805|FG003|Overall Study|Protocol Violation|1|||
125060937|NCT01934192|449840802|FG000|Overall Study|Other: reached stopping criteria|6|||
125060938|NCT01934192|449840803|FG001|Overall Study|Other: reached stopping criteria|5|||
125060939|NCT01934192|449840804|FG002|Overall Study|Other: reached stopping criteria|1|||
125060940|NCT01934192|449840805|FG003|Overall Study|Other: reached stopping criteria|0|||
125060941|NCT01934192|449840802|FG000|Overall Study|Physician Decision|3|||
125060942|NCT01934192|449840803|FG001|Overall Study|Physician Decision|2|||
125060943|NCT01934192|449840804|FG002|Overall Study|Physician Decision|0|||
125060944|NCT01934192|449840805|FG003|Overall Study|Physician Decision|0|||
125060945|NCT01189435|449840806|FG000|Overall Study|Withdrawal by Subject|1|||
125060946|NCT01189435|449840806|FG000|Overall Study|Physician Decision|1|||
125060947|NCT03095521|449840807|FG000|Overall Study|Withdrawal by Subject|0|||
125060948|NCT03095521|449840808|FG001|Overall Study|Withdrawal by Subject|1|||
125060949|NCT03095521|449840807|FG000|Overall Study|Lost to Follow-up|0|||
125060950|NCT03095521|449840808|FG001|Overall Study|Lost to Follow-up|1|||
125060951|NCT03259490|449840809|FG000|Period 1|Withdrawal by Subject|0|||
125060952|NCT03259490|449840810|FG001|Period 1|Withdrawal by Subject|1|||
125060953|NCT03259490|449840809|FG000|Period 2|Protocol Violation|1|||
125060954|NCT03259490|449840810|FG001|Period 2|Protocol Violation|0|||
125060955|NCT01963208|449840811|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
125060956|NCT01963208|449840812|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
125060957|NCT01963208|449840813|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
125060958|NCT01963208|449840814|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
125060959|NCT01963208|449840815|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
125060960|NCT01963208|449840816|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
125060961|NCT01963208|449840811|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
125060962|NCT01963208|449840812|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
125060963|NCT01963208|449840813|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
125060964|NCT01963208|449840814|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
125060965|NCT01963208|449840815|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
125139102|NCT00902538|450131250|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
125139103|NCT00902538|450131251|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
125139104|NCT00902538|450131252|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
125139105|NCT00902538|450131253|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
125139106|NCT00902538|450131254|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
125139107|NCT00902538|450131255|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
125139108|NCT00902538|450131250|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
125139109|NCT00902538|450131251|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
125139110|NCT00902538|450131252|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
125139111|NCT00902538|450131253|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
125139112|NCT00902538|450131254|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
125139113|NCT00902538|450131255|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
125139114|NCT00902538|450131250|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
125139115|NCT00902538|450131251|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
125139116|NCT00902538|450131252|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
125139117|NCT00902538|450131253|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
125139118|NCT00902538|450131254|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
125139119|NCT00902538|450131255|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
125139120|NCT00902538|450131250|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
125139121|NCT00902538|450131251|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
125139122|NCT00902538|450131252|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
125139123|NCT00902538|450131253|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
125222397|NCT01765296|450442741|FG002|Overall Study|Adverse Event|5|||
125222398|NCT01765296|450442739|FG000|Overall Study|Lack of Efficacy|0|||
125222399|NCT01765296|450442740|FG001|Overall Study|Lack of Efficacy|0|||
125222400|NCT01765296|450442741|FG002|Overall Study|Lack of Efficacy|2|||
125222401|NCT03933449|450442742|FG000|Overall Study|Adverse Event|6|||
125222402|NCT03933449|450442743|FG001|Overall Study|Adverse Event|4|||
125222403|NCT03933449|450442742|FG000|Overall Study|Death|55|||
125222404|NCT03933449|450442743|FG001|Overall Study|Death|57|||
125222405|NCT03933449|450442742|FG000|Overall Study|Sponsor Decision|1|||
125222406|NCT03933449|450442743|FG001|Overall Study|Sponsor Decision|0|||
125222407|NCT02659943|450442744|FG000|Overall Study|Switched to alternative treatment|1|||
125060966|NCT01963208|449840816|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
125060967|NCT01963208|449840811|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
125139124|NCT00902538|450131254|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
125139125|NCT00902538|450131255|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
125139126|NCT00902538|450131250|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
125139127|NCT00902538|450131251|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
125139128|NCT00902538|450131252|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
125139129|NCT00902538|450131253|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
125139130|NCT00902538|450131254|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
125139131|NCT00902538|450131255|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
125139132|NCT00902538|450131250|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
125139133|NCT00902538|450131251|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
125139134|NCT00902538|450131252|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
125139135|NCT00902538|450131253|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
125139136|NCT00902538|450131254|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
125139137|NCT00902538|450131255|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
125139138|NCT00902538|450131250|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
125139139|NCT00902538|450131251|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
125139140|NCT00902538|450131252|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
125139141|NCT00902538|450131253|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
125139142|NCT00902538|450131254|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
125139143|NCT00902538|450131255|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
125139144|NCT00902538|450131250|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
125139145|NCT00902538|450131251|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
125139146|NCT00902538|450131252|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
125139147|NCT00902538|450131253|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
125139148|NCT00902538|450131254|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
125139149|NCT00902538|450131255|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
125139150|NCT00902538|450131250|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
125139151|NCT00902538|450131251|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
125139152|NCT00902538|450131252|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
125139153|NCT00902538|450131253|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
125139154|NCT00902538|450131254|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
125139155|NCT00902538|450131255|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
125139156|NCT00902538|450131250|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
125139157|NCT00902538|450131251|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
125139158|NCT00902538|450131252|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
125139159|NCT00902538|450131253|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
125139160|NCT00902538|450131254|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
125139161|NCT00902538|450131255|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
125139162|NCT00902538|450131250|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
125139163|NCT00902538|450131251|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
125139164|NCT00902538|450131252|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
125139165|NCT00902538|450131253|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
125139166|NCT00902538|450131254|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
125139167|NCT00902538|450131255|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
125139168|NCT00902538|450131250|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
125139169|NCT00902538|450131251|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
125139170|NCT00902538|450131252|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
125139171|NCT00902538|450131253|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
125139172|NCT00902538|450131254|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
125139173|NCT00902538|450131255|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
125139174|NCT00725322|450131256|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
125139175|NCT00725322|450131257|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
125139176|NCT00725322|450131256|FG000|Washout (28 Days)|Protocol Violation|0|||
125139177|NCT00725322|450131257|FG001|Washout (28 Days)|Protocol Violation|1|||
125139178|NCT00660660|450132791|FG000|Overall Study|Adverse Event|1|||
125139179|NCT00660660|450132792|FG001|Overall Study|Adverse Event|0|||
125139180|NCT00660660|450132791|FG000|Overall Study|Lost to Follow-up|0|||
125139181|NCT00660660|450132792|FG001|Overall Study|Lost to Follow-up|6|||
125139182|NCT00660660|450132791|FG000|Overall Study|Lack of Efficacy|0|||
125139183|NCT00660660|450132792|FG001|Overall Study|Lack of Efficacy|2|||
125139184|NCT00660660|450132791|FG000|Overall Study|Withdrawal by Subject|3|||
125222408|NCT02659943|450442745|FG001|Overall Study|Switched to alternative treatment|1|||
125139185|NCT00660660|450132792|FG001|Overall Study|Withdrawal by Subject|0|||
125139186|NCT00660660|450132791|FG000|Overall Study|Incorrect enrollment and other|0|||
125139187|NCT00660660|450132792|FG001|Overall Study|Incorrect enrollment and other|1|||
125139188|NCT00660660|450132791|FG000|Overall Study|New medication after randomization|1|||
125139189|NCT00660660|450132792|FG001|Overall Study|New medication after randomization|0|||
125139190|NCT00081653|450132802|FG000|Overall Study|Adverse Event|23|||
125139191|NCT00081653|450132803|FG001|Overall Study|Adverse Event|17|||
125139192|NCT00081653|450132802|FG000|Overall Study|Lost to Follow-up|2|||
125139193|NCT00081653|450132803|FG001|Overall Study|Lost to Follow-up|4|||
125139194|NCT00081653|450132802|FG000|Overall Study|Refused Treatment|18|||
125139195|NCT00081653|450132803|FG001|Overall Study|Refused Treatment|14|||
125139196|NCT00081653|450132802|FG000|Overall Study|Low bone mineral density|1|||
125139197|NCT00081653|450132803|FG001|Overall Study|Low bone mineral density|0|||
125139198|NCT00081653|450132802|FG000|Overall Study|Bone loss|2|||
125139199|NCT00081653|450132803|FG001|Overall Study|Bone loss|0|||
125139200|NCT00081653|450132802|FG000|Overall Study|Participant leaving country|1|||
125139201|NCT00081653|450132803|FG001|Overall Study|Participant leaving country|0|||
125060968|NCT01963208|449840812|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
125060969|NCT01963208|449840813|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
125060970|NCT01963208|449840814|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
125060971|NCT01963208|449840815|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
125060972|NCT01963208|449840816|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
125060973|NCT01963208|449840811|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
125060974|NCT01963208|449840812|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
125060975|NCT01963208|449840813|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
125060976|NCT01963208|449840814|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
125060977|NCT01963208|449840815|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
125060978|NCT01963208|449840816|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
125060979|NCT01963208|449840811|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
125060980|NCT01963208|449840812|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
125060981|NCT01963208|449840813|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
125060982|NCT01963208|449840814|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
125060983|NCT01963208|449840815|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
125060984|NCT01963208|449840816|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
125060985|NCT01963208|449840811|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
125060986|NCT01963208|449840812|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
125060987|NCT01963208|449840813|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
125060988|NCT01963208|449840814|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
125060989|NCT01963208|449840815|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
125060990|NCT01963208|449840816|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
125060991|NCT01963208|449840811|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
125060992|NCT01963208|449840812|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
125060993|NCT01963208|449840813|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
125060994|NCT01963208|449840814|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
125060995|NCT01963208|449840815|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
125060996|NCT01963208|449840816|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
125060997|NCT01963208|449840811|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
125060998|NCT01963208|449840812|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
125060999|NCT01963208|449840813|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
125061000|NCT01963208|449840814|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
125061001|NCT01963208|449840815|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
125061002|NCT01963208|449840816|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
125061003|NCT01963208|449840811|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
125061004|NCT01963208|449840812|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
125061005|NCT01963208|449840813|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
125061006|NCT01963208|449840814|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
125061007|NCT01963208|449840815|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
125061008|NCT01963208|449840816|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
125061009|NCT01963208|449840811|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
125061010|NCT01963208|449840812|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
125061011|NCT01963208|449840813|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
125061012|NCT01963208|449840814|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
125061013|NCT01963208|449840815|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
125061014|NCT01963208|449840816|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
125061015|NCT01963208|449840811|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
125139202|NCT00081653|450132802|FG000|Overall Study|Loss of bone mass|0|||
125139203|NCT00081653|450132803|FG001|Overall Study|Loss of bone mass|2|||
125139204|NCT02694536|450132811|FG000|Overall Study|Progressive Disease|40|||
125139205|NCT02694536|450132811|FG000|Overall Study|Lost to Follow-up|1|||
125139206|NCT02694536|450132811|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
125139207|NCT02694536|450132811|FG000|Overall Study|Withdrawal by Subject|8|||
125139208|NCT02694536|450132811|FG000|Overall Study|Death|8|||
125139209|NCT02694536|450132811|FG000|Overall Study|Other|22|||
125061016|NCT01963208|449840812|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
125139210|NCT00385736|450132812|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
125139211|NCT00385736|450132813|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
125139212|NCT00385736|450132814|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
125061017|NCT01963208|449840813|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
125061018|NCT01963208|449840814|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
125061019|NCT01963208|449840815|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
125061020|NCT01963208|449840816|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
125061021|NCT01963208|449840811|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
125061022|NCT01963208|449840812|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
125061023|NCT01963208|449840813|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
125061024|NCT01963208|449840814|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
125061025|NCT01963208|449840815|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
125061026|NCT01963208|449840816|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
125061027|NCT01963208|449840811|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
125061028|NCT01963208|449840812|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
125061029|NCT01963208|449840813|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
125061030|NCT01963208|449840814|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
125061031|NCT01963208|449840815|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
125061032|NCT01963208|449840816|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
125061033|NCT01963208|449840811|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
125061034|NCT01963208|449840812|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
125061035|NCT01963208|449840813|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
125061036|NCT01963208|449840814|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
125061037|NCT01963208|449840815|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
125061038|NCT01963208|449840816|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
125061039|NCT00448916|449840817|FG000|Overall Study|Adverse Event|2|||
125061040|NCT00448916|449840818|FG001|Overall Study|Adverse Event|2|||
125061041|NCT00448916|449840819|FG002|Overall Study|Adverse Event|3|||
125061042|NCT00448916|449840820|FG003|Overall Study|Adverse Event|2|||
125061043|NCT00448916|449840817|FG000|Overall Study|Lack of Efficacy|1|||
125061044|NCT00448916|449840818|FG001|Overall Study|Lack of Efficacy|0|||
125061045|NCT00448916|449840819|FG002|Overall Study|Lack of Efficacy|2|||
125061046|NCT00448916|449840820|FG003|Overall Study|Lack of Efficacy|1|||
125061047|NCT00448916|449840817|FG000|Overall Study|Withdrawal by Subject|3|||
125061048|NCT00448916|449840818|FG001|Overall Study|Withdrawal by Subject|3|||
125061049|NCT00448916|449840819|FG002|Overall Study|Withdrawal by Subject|1|||
125061050|NCT00448916|449840820|FG003|Overall Study|Withdrawal by Subject|1|||
125061051|NCT00448916|449840817|FG000|Overall Study|Other|1|||
125061052|NCT00448916|449840818|FG001|Overall Study|Other|0|||
125061053|NCT00448916|449840819|FG002|Overall Study|Other|0|||
125061054|NCT00448916|449840820|FG003|Overall Study|Other|0|||
125061055|NCT00448916|449840817|FG000|Overall Study|Lost to Follow-up|0|||
125061056|NCT00448916|449840818|FG001|Overall Study|Lost to Follow-up|1|||
125061057|NCT00448916|449840819|FG002|Overall Study|Lost to Follow-up|0|||
125061058|NCT00448916|449840820|FG003|Overall Study|Lost to Follow-up|1|||
125061059|NCT00448916|449840817|FG000|Overall Study|Protocol Violation|0|||
125061060|NCT00448916|449840818|FG001|Overall Study|Protocol Violation|0|||
125061061|NCT00448916|449840819|FG002|Overall Study|Protocol Violation|0|||
125061062|NCT00448916|449840820|FG003|Overall Study|Protocol Violation|1|||
125061063|NCT03521193|449840821|FG000|Overall Study|Withdrawal by Subject|8|||
125061064|NCT03521193|449840822|FG001|Overall Study|Withdrawal by Subject|0|||
125061065|NCT03521193|449840821|FG000|Overall Study|non compliant to ASA treatment|8|||
125061066|NCT03521193|449840822|FG001|Overall Study|non compliant to ASA treatment|0|||
125061067|NCT01810042|449840823|FG000|Overall Study|Lost to Follow-up|10|||
125061068|NCT03707158|449840824|FG000|Midtreatment|Lost to Follow-up|16|||
125061069|NCT03707158|449840825|FG001|Midtreatment|Lost to Follow-up|7|||
125061070|NCT03707158|449840824|FG000|Midtreatment|Withdrawal by Subject|28|||
125061071|NCT03707158|449840825|FG001|Midtreatment|Withdrawal by Subject|19|||
125061072|NCT03707158|449840824|FG000|Posttreatment|Lost to Follow-up|0|||
125061073|NCT03707158|449840825|FG001|Posttreatment|Lost to Follow-up|5|||
125061074|NCT03707158|449840824|FG000|Follow-up|Lost to Follow-up|19|||
125061075|NCT03707158|449840825|FG001|Follow-up|Lost to Follow-up|18|||
125061076|NCT03707158|449840824|FG000|Follow-up|Withdrawal by Subject|13|||
125061077|NCT03707158|449840825|FG001|Follow-up|Withdrawal by Subject|6|||
125061078|NCT02773238|449840826|FG000|Overall Study|Lack of Efficacy|4|||
125061079|NCT03260205|449840827|FG000|Overall Study|Adverse Event|2|||
125061080|NCT03260205|449840828|FG001|Overall Study|Adverse Event|0|||
125061081|NCT03260205|449840829|FG002|Overall Study|Adverse Event|2|||
125061082|NCT03260205|449840830|FG003|Overall Study|Adverse Event|2|||
125061083|NCT03260205|449840831|FG004|Overall Study|Adverse Event|4|||
125061084|NCT03260205|449840827|FG000|Overall Study|Lost to Follow-up|2|||
125061085|NCT03260205|449840828|FG001|Overall Study|Lost to Follow-up|2|||
125061086|NCT03260205|449840829|FG002|Overall Study|Lost to Follow-up|1|||
125061087|NCT03260205|449840830|FG003|Overall Study|Lost to Follow-up|1|||
125061088|NCT03260205|449840831|FG004|Overall Study|Lost to Follow-up|5|||
125061089|NCT03260205|449840827|FG000|Overall Study|Protocol Violation|0|||
125061090|NCT03260205|449840828|FG001|Overall Study|Protocol Violation|0|||
125061091|NCT03260205|449840829|FG002|Overall Study|Protocol Violation|2|||
125061092|NCT03260205|449840830|FG003|Overall Study|Protocol Violation|0|||
125061093|NCT03260205|449840831|FG004|Overall Study|Protocol Violation|1|||
125061094|NCT03260205|449840827|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
125061095|NCT03260205|449840828|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
125061096|NCT03260205|449840829|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
125061097|NCT03260205|449840830|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
125061098|NCT03260205|449840831|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
125061099|NCT03260205|449840827|FG000|Overall Study|Other: Unspecified|0|||
125061100|NCT03260205|449840828|FG001|Overall Study|Other: Unspecified|0|||
125061101|NCT03260205|449840829|FG002|Overall Study|Other: Unspecified|3|||
125061102|NCT03260205|449840830|FG003|Overall Study|Other: Unspecified|1|||
125061103|NCT03260205|449840831|FG004|Overall Study|Other: Unspecified|1|||
125061104|NCT03260205|449840827|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
125061105|NCT03260205|449840828|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
125061106|NCT03260205|449840829|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
125061107|NCT03260205|449840830|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
125061108|NCT03260205|449840831|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
125061109|NCT05301322|449840832|FG000|Overall Study|Adverse Event|7|||
125061110|NCT05301322|449840833|FG001|Overall Study|Adverse Event|3|||
125061111|NCT05301322|449840832|FG000|Overall Study|Death|0|||
125061112|NCT05301322|449840833|FG001|Overall Study|Death|1|||
125061113|NCT05301322|449840832|FG000|Overall Study|Lost to Follow-up|2|||
125061114|NCT05301322|449840833|FG001|Overall Study|Lost to Follow-up|1|||
125061115|NCT05301322|449840832|FG000|Overall Study|Protocol Violation|3|||
125061116|NCT05301322|449840833|FG001|Overall Study|Protocol Violation|1|||
125061117|NCT05301322|449840832|FG000|Overall Study|Withdrawal by Subject|3|||
125061118|NCT05301322|449840833|FG001|Overall Study|Withdrawal by Subject|0|||
125061119|NCT05301322|449840832|FG000|Overall Study|Other|4|||
125061120|NCT05301322|449840833|FG001|Overall Study|Other|0|||
125061121|NCT01877382|449840834|FG000|Dose Escalation|Progressive disease|2|||
125061122|NCT01877382|449840835|FG001|Dose Escalation|Progressive disease|0|||
125061123|NCT01877382|449840836|FG002|Dose Escalation|Progressive disease|1|||
125061124|NCT01877382|449840837|FG003|Dose Escalation|Progressive disease|6|||
125061125|NCT01877382|449840838|FG004|Dose Escalation|Progressive disease|1|||
125061126|NCT01877382|449840839|FG005|Dose Escalation|Progressive disease|0|||
125061127|NCT01877382|449840840|FG006|Dose Escalation|Progressive disease|3|||
125061128|NCT01877382|449840841|FG007|Dose Escalation|Progressive disease|10|||
125061129|NCT01877382|449840842|FG008|Dose Escalation|Progressive disease|4|||
125139213|NCT00385736|450132812|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
125139214|NCT00385736|450132813|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
125139215|NCT00385736|450132814|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
125139216|NCT00385736|450132812|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
125139217|NCT00385736|450132813|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
125139218|NCT00385736|450132814|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
125139219|NCT00385736|450132812|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
125139220|NCT00385736|450132813|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
125139221|NCT00385736|450132814|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
125139222|NCT00385736|450132812|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
125139223|NCT00385736|450132813|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
125139224|NCT00385736|450132814|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
125139225|NCT00385736|450132812|FG000|Efficacy Analysis Set - Induction|Other|0|||
125139226|NCT00385736|450132813|FG001|Efficacy Analysis Set - Induction|Other|0|||
125139227|NCT00385736|450132814|FG002|Efficacy Analysis Set - Induction|Other|1|||
125139228|NCT00385736|450132812|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
125139229|NCT00385736|450132813|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
125139230|NCT00385736|450132814|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
125139231|NCT00385736|450132812|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
125139232|NCT00385736|450132813|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
125139233|NCT00385736|450132814|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
125139234|NCT00385736|450132812|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
125139235|NCT00385736|450132813|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
125139236|NCT00385736|450132814|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
125139237|NCT00385736|450132812|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
125139238|NCT00385736|450132813|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
125139239|NCT00385736|450132814|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
125139240|NCT00385736|450132812|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
125139241|NCT00385736|450132813|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
125139242|NCT00385736|450132814|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
125139243|NCT00385736|450132812|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
125222409|NCT02659943|450442746|FG002|Overall Study|Switched to alternative treatment|0|||
125139244|NCT00385736|450132813|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
125222410|NCT02659943|450442747|FG003|Overall Study|Switched to alternative treatment|2|||
125061130|NCT01877382|449840843|FG009|Dose Escalation|Progressive disease|2|||
125061131|NCT01877382|449840844|FG010|Dose Escalation|Progressive disease|3|||
125061132|NCT01877382|449840845|FG011|Dose Escalation|Progressive disease|3|||
125061133|NCT01877382|449840846|FG012|Dose Escalation|Progressive disease|13|||
125061134|NCT01877382|449840847|FG013|Dose Escalation|Progressive disease|1|||
125061135|NCT01877382|449840848|FG014|Dose Escalation|Progressive disease|0|||
125061136|NCT01877382|449840834|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
125061137|NCT01877382|449840835|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061138|NCT01877382|449840836|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061139|NCT01877382|449840837|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
125061140|NCT01877382|449840838|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061141|NCT01877382|449840839|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061142|NCT01877382|449840840|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
125061143|NCT01877382|449840841|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061144|NCT01877382|449840842|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061145|NCT01877382|449840843|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061146|NCT01877382|449840844|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061147|NCT01877382|449840845|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061148|NCT01877382|449840846|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061149|NCT01877382|449840847|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061150|NCT01877382|449840848|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061151|NCT01877382|449840834|FG000|Dose Escalation|Clinical progression|0|||
125061152|NCT01877382|449840835|FG001|Dose Escalation|Clinical progression|1|||
125061153|NCT01877382|449840836|FG002|Dose Escalation|Clinical progression|0|||
125061154|NCT01877382|449840837|FG003|Dose Escalation|Clinical progression|2|||
125061155|NCT01877382|449840838|FG004|Dose Escalation|Clinical progression|0|||
125061156|NCT01877382|449840839|FG005|Dose Escalation|Clinical progression|0|||
125061157|NCT01877382|449840840|FG006|Dose Escalation|Clinical progression|1|||
125061158|NCT01877382|449840841|FG007|Dose Escalation|Clinical progression|0|||
125061159|NCT01877382|449840842|FG008|Dose Escalation|Clinical progression|0|||
125061160|NCT01877382|449840843|FG009|Dose Escalation|Clinical progression|1|||
125061161|NCT01877382|449840844|FG010|Dose Escalation|Clinical progression|0|||
125061162|NCT01877382|449840845|FG011|Dose Escalation|Clinical progression|0|||
125061163|NCT01877382|449840846|FG012|Dose Escalation|Clinical progression|2|||
125061164|NCT01877382|449840847|FG013|Dose Escalation|Clinical progression|1|||
125061165|NCT01877382|449840848|FG014|Dose Escalation|Clinical progression|0|||
125061166|NCT01877382|449840834|FG000|Dose Escalation|Adverse Event|0|||
125061167|NCT01877382|449840835|FG001|Dose Escalation|Adverse Event|0|||
125061168|NCT01877382|449840836|FG002|Dose Escalation|Adverse Event|0|||
125061169|NCT01877382|449840837|FG003|Dose Escalation|Adverse Event|4|||
125061170|NCT01877382|449840838|FG004|Dose Escalation|Adverse Event|1|||
125061171|NCT01877382|449840839|FG005|Dose Escalation|Adverse Event|2|||
125061172|NCT01877382|449840840|FG006|Dose Escalation|Adverse Event|1|||
125061173|NCT01877382|449840841|FG007|Dose Escalation|Adverse Event|2|||
125061174|NCT01877382|449840842|FG008|Dose Escalation|Adverse Event|0|||
125061175|NCT01877382|449840843|FG009|Dose Escalation|Adverse Event|0|||
125061176|NCT01877382|449840844|FG010|Dose Escalation|Adverse Event|0|||
125061177|NCT01877382|449840845|FG011|Dose Escalation|Adverse Event|0|||
125061178|NCT01877382|449840846|FG012|Dose Escalation|Adverse Event|1|||
125061179|NCT01877382|449840847|FG013|Dose Escalation|Adverse Event|0|||
125061180|NCT01877382|449840848|FG014|Dose Escalation|Adverse Event|0|||
125061181|NCT01877382|449840834|FG000|Dose Escalation|Withdrawal by Subject|0|||
125061182|NCT01877382|449840835|FG001|Dose Escalation|Withdrawal by Subject|0|||
125061183|NCT01877382|449840836|FG002|Dose Escalation|Withdrawal by Subject|0|||
125061184|NCT01877382|449840837|FG003|Dose Escalation|Withdrawal by Subject|0|||
125061185|NCT01877382|449840838|FG004|Dose Escalation|Withdrawal by Subject|0|||
125061186|NCT01877382|449840839|FG005|Dose Escalation|Withdrawal by Subject|3|||
125061187|NCT01877382|449840840|FG006|Dose Escalation|Withdrawal by Subject|2|||
125061188|NCT01877382|449840841|FG007|Dose Escalation|Withdrawal by Subject|1|||
125061189|NCT01877382|449840842|FG008|Dose Escalation|Withdrawal by Subject|1|||
125061190|NCT01877382|449840843|FG009|Dose Escalation|Withdrawal by Subject|0|||
125061191|NCT01877382|449840844|FG010|Dose Escalation|Withdrawal by Subject|0|||
125061192|NCT01877382|449840845|FG011|Dose Escalation|Withdrawal by Subject|0|||
125061193|NCT01877382|449840846|FG012|Dose Escalation|Withdrawal by Subject|0|||
125061194|NCT01877382|449840847|FG013|Dose Escalation|Withdrawal by Subject|0|||
125139245|NCT00385736|450132814|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
125139246|NCT00385736|450132812|FG000|Safety Analysis Set|Adverse Event|23|||
125061195|NCT01877382|449840848|FG014|Dose Escalation|Withdrawal by Subject|0|||
125061196|NCT01877382|449840834|FG000|Dose Escalation|Protocol Violation|0|||
125061197|NCT01877382|449840835|FG001|Dose Escalation|Protocol Violation|0|||
125061198|NCT01877382|449840836|FG002|Dose Escalation|Protocol Violation|0|||
125061199|NCT01877382|449840837|FG003|Dose Escalation|Protocol Violation|0|||
125061200|NCT01877382|449840838|FG004|Dose Escalation|Protocol Violation|0|||
125061201|NCT01877382|449840839|FG005|Dose Escalation|Protocol Violation|0|||
125061202|NCT01877382|449840840|FG006|Dose Escalation|Protocol Violation|1|||
125061203|NCT01877382|449840841|FG007|Dose Escalation|Protocol Violation|0|||
125061204|NCT01877382|449840842|FG008|Dose Escalation|Protocol Violation|0|||
125061205|NCT01877382|449840843|FG009|Dose Escalation|Protocol Violation|0|||
125061206|NCT01877382|449840844|FG010|Dose Escalation|Protocol Violation|0|||
125061207|NCT01877382|449840845|FG011|Dose Escalation|Protocol Violation|0|||
125061208|NCT01877382|449840846|FG012|Dose Escalation|Protocol Violation|0|||
125061209|NCT01877382|449840847|FG013|Dose Escalation|Protocol Violation|0|||
125061210|NCT01877382|449840848|FG014|Dose Escalation|Protocol Violation|0|||
125061211|NCT01877382|449840834|FG000|Dose Escalation|Study terminated by sponsor|0|||
125061212|NCT01877382|449840835|FG001|Dose Escalation|Study terminated by sponsor|0|||
125061213|NCT01877382|449840836|FG002|Dose Escalation|Study terminated by sponsor|0|||
125061214|NCT01877382|449840837|FG003|Dose Escalation|Study terminated by sponsor|0|||
125061215|NCT01877382|449840838|FG004|Dose Escalation|Study terminated by sponsor|0|||
125061216|NCT01877382|449840839|FG005|Dose Escalation|Study terminated by sponsor|0|||
125061217|NCT01877382|449840840|FG006|Dose Escalation|Study terminated by sponsor|0|||
125061218|NCT01877382|449840841|FG007|Dose Escalation|Study terminated by sponsor|1|||
125061219|NCT01877382|449840842|FG008|Dose Escalation|Study terminated by sponsor|1|||
125061220|NCT01877382|449840843|FG009|Dose Escalation|Study terminated by sponsor|0|||
125061221|NCT01877382|449840844|FG010|Dose Escalation|Study terminated by sponsor|0|||
125061222|NCT01877382|449840845|FG011|Dose Escalation|Study terminated by sponsor|0|||
125061223|NCT01877382|449840846|FG012|Dose Escalation|Study terminated by sponsor|3|||
125061224|NCT01877382|449840847|FG013|Dose Escalation|Study terminated by sponsor|0|||
125061225|NCT01877382|449840848|FG014|Dose Escalation|Study terminated by sponsor|0|||
125061226|NCT01877382|449840834|FG000|Dose Escalation|Death|0|||
125061227|NCT01877382|449840835|FG001|Dose Escalation|Death|0|||
125061228|NCT01877382|449840836|FG002|Dose Escalation|Death|0|||
125061229|NCT01877382|449840837|FG003|Dose Escalation|Death|0|||
125061230|NCT01877382|449840838|FG004|Dose Escalation|Death|0|||
125061231|NCT01877382|449840839|FG005|Dose Escalation|Death|0|||
125061232|NCT01877382|449840840|FG006|Dose Escalation|Death|0|||
125061233|NCT01877382|449840841|FG007|Dose Escalation|Death|1|||
125061234|NCT01877382|449840842|FG008|Dose Escalation|Death|0|||
125061235|NCT01877382|449840843|FG009|Dose Escalation|Death|0|||
125061236|NCT01877382|449840844|FG010|Dose Escalation|Death|0|||
125061237|NCT01877382|449840845|FG011|Dose Escalation|Death|0|||
125061238|NCT01877382|449840846|FG012|Dose Escalation|Death|1|||
125061239|NCT01877382|449840847|FG013|Dose Escalation|Death|1|||
125061240|NCT01877382|449840848|FG014|Dose Escalation|Death|0|||
125061241|NCT01877382|449840834|FG000|Dose Expansion|Progressive disease|0|||
125061242|NCT01877382|449840835|FG001|Dose Expansion|Progressive disease|0|||
125061243|NCT01877382|449840836|FG002|Dose Expansion|Progressive disease|0|||
125061244|NCT01877382|449840837|FG003|Dose Expansion|Progressive disease|0|||
125061245|NCT01877382|449840838|FG004|Dose Expansion|Progressive disease|0|||
125061246|NCT01877382|449840839|FG005|Dose Expansion|Progressive disease|0|||
125061247|NCT01877382|449840840|FG006|Dose Expansion|Progressive disease|0|||
125061248|NCT01877382|449840841|FG007|Dose Expansion|Progressive disease|0|||
125061249|NCT01877382|449840842|FG008|Dose Expansion|Progressive disease|0|||
125139247|NCT00385736|450132813|FG001|Safety Analysis Set|Adverse Event|15|||
125139248|NCT00385736|450132814|FG002|Safety Analysis Set|Adverse Event|23|||
125139249|NCT00385736|450132812|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
125139250|NCT00385736|450132813|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
125139251|NCT00385736|450132814|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
125139252|NCT00385736|450132812|FG000|Safety Analysis Set|Lost to Follow-up|0|||
125139253|NCT00385736|450132813|FG001|Safety Analysis Set|Lost to Follow-up|2|||
125139254|NCT00385736|450132814|FG002|Safety Analysis Set|Lost to Follow-up|2|||
125139255|NCT00385736|450132812|FG000|Safety Analysis Set|Lack of Efficacy|38|||
125139256|NCT00385736|450132813|FG001|Safety Analysis Set|Lack of Efficacy|16|||
125139257|NCT00385736|450132814|FG002|Safety Analysis Set|Lack of Efficacy|31|||
125139258|NCT00385736|450132812|FG000|Safety Analysis Set|Protocol Violation|2|||
125139259|NCT00385736|450132813|FG001|Safety Analysis Set|Protocol Violation|1|||
125139260|NCT00385736|450132814|FG002|Safety Analysis Set|Protocol Violation|6|||
125139261|NCT00385736|450132812|FG000|Safety Analysis Set|Other|1|||
125139262|NCT00385736|450132813|FG001|Safety Analysis Set|Other|4|||
125139263|NCT00385736|450132814|FG002|Safety Analysis Set|Other|4|||
125139264|NCT02727192|450132822|FG000|Overall Study|Lost to Follow-up|1|||
125139265|NCT02727192|450132823|FG001|Overall Study|Lost to Follow-up|0|||
125139266|NCT02727192|450132824|FG002|Overall Study|Lost to Follow-up|0|||
125139267|NCT00928057|450132825|FG000|Overall Study|Adverse Event|1|||
125139268|NCT00928057|450132826|FG001|Overall Study|Adverse Event|2|||
125139269|NCT00928057|450132825|FG000|Overall Study|Withdrawal by Subject|1|||
125139270|NCT00928057|450132826|FG001|Overall Study|Withdrawal by Subject|0|||
125139271|NCT00928057|450132825|FG000|Overall Study|Lost to Follow-up|0|||
125139272|NCT00928057|450132826|FG001|Overall Study|Lost to Follow-up|1|||
125061250|NCT01877382|449840843|FG009|Dose Expansion|Progressive disease|0|||
125139273|NCT00928057|450132825|FG000|Overall Study|Protocol Violation|0|||
125139274|NCT00928057|450132826|FG001|Overall Study|Protocol Violation|1|||
125139275|NCT05497557|450132829|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
125139276|NCT05497557|450132830|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
125139277|NCT05497557|450132831|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
125139278|NCT01380782|450132836|FG000|Overall Study|Adverse Event|0|||
125139279|NCT01380782|450132837|FG001|Overall Study|Adverse Event|1|||
125139280|NCT01380782|450132838|FG002|Overall Study|Adverse Event|0|||
125139281|NCT01380782|450132839|FG003|Overall Study|Adverse Event|0|||
125139282|NCT01380782|450132836|FG000|Overall Study|Death|1|||
125139283|NCT01380782|450132837|FG001|Overall Study|Death|0|||
125139284|NCT01380782|450132838|FG002|Overall Study|Death|0|||
125139285|NCT01380782|450132839|FG003|Overall Study|Death|0|||
125139286|NCT01380782|450132836|FG000|Overall Study|Lack of Efficacy|10|||
125139287|NCT01380782|450132837|FG001|Overall Study|Lack of Efficacy|9|||
125139288|NCT01380782|450132838|FG002|Overall Study|Lack of Efficacy|10|||
125139289|NCT01380782|450132839|FG003|Overall Study|Lack of Efficacy|3|||
125139290|NCT01380782|450132836|FG000|Overall Study|Physician Decision|1|||
125139291|NCT01380782|450132837|FG001|Overall Study|Physician Decision|0|||
125139292|NCT01380782|450132838|FG002|Overall Study|Physician Decision|0|||
125139293|NCT01380782|450132839|FG003|Overall Study|Physician Decision|0|||
125139294|NCT01380782|450132836|FG000|Overall Study|Withdrawal by Subject|0|||
125139295|NCT01380782|450132837|FG001|Overall Study|Withdrawal by Subject|0|||
125139296|NCT01380782|450132838|FG002|Overall Study|Withdrawal by Subject|1|||
125139297|NCT01380782|450132839|FG003|Overall Study|Withdrawal by Subject|1|||
125139298|NCT05387408|450132840|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
125139299|NCT03428750|450132841|FG000|Overall Study|Withdrawal by Subject|11|||
125139300|NCT03428750|450132842|FG001|Overall Study|Withdrawal by Subject|10|||
125139301|NCT03428750|450132841|FG000|Overall Study|Lost to Follow-up|3|||
125139302|NCT03428750|450132842|FG001|Overall Study|Lost to Follow-up|9|||
125139303|NCT03428750|450132841|FG000|Overall Study|Adverse Event|9|||
125139304|NCT03428750|450132842|FG001|Overall Study|Adverse Event|1|||
125139305|NCT03428750|450132841|FG000|Overall Study|Protocol Violation|1|||
125139306|NCT03428750|450132842|FG001|Overall Study|Protocol Violation|0|||
125139307|NCT03428750|450132841|FG000|Overall Study|Administrative|0|||
125061251|NCT01877382|449840844|FG010|Dose Expansion|Progressive disease|0|||
125061252|NCT01877382|449840845|FG011|Dose Expansion|Progressive disease|0|||
125061253|NCT01877382|449840846|FG012|Dose Expansion|Progressive disease|0|||
125061254|NCT01877382|449840847|FG013|Dose Expansion|Progressive disease|0|||
125061255|NCT01877382|449840848|FG014|Dose Expansion|Progressive disease|11|||
125061256|NCT01877382|449840834|FG000|Dose Expansion|Clinical progression|0|||
125061257|NCT01877382|449840835|FG001|Dose Expansion|Clinical progression|0|||
125061258|NCT01877382|449840836|FG002|Dose Expansion|Clinical progression|0|||
125061259|NCT01877382|449840837|FG003|Dose Expansion|Clinical progression|0|||
125061260|NCT01877382|449840838|FG004|Dose Expansion|Clinical progression|0|||
125061261|NCT01877382|449840839|FG005|Dose Expansion|Clinical progression|0|||
125061262|NCT01877382|449840840|FG006|Dose Expansion|Clinical progression|0|||
125061263|NCT01877382|449840841|FG007|Dose Expansion|Clinical progression|0|||
125061264|NCT01877382|449840842|FG008|Dose Expansion|Clinical progression|0|||
125061265|NCT01877382|449840843|FG009|Dose Expansion|Clinical progression|0|||
125061266|NCT01877382|449840844|FG010|Dose Expansion|Clinical progression|0|||
125061267|NCT01877382|449840845|FG011|Dose Expansion|Clinical progression|0|||
125061268|NCT01877382|449840846|FG012|Dose Expansion|Clinical progression|0|||
125061269|NCT01877382|449840847|FG013|Dose Expansion|Clinical progression|0|||
125061270|NCT01877382|449840848|FG014|Dose Expansion|Clinical progression|6|||
125061271|NCT01877382|449840834|FG000|Dose Expansion|Adverse Event|0|||
125061272|NCT01877382|449840835|FG001|Dose Expansion|Adverse Event|0|||
125139308|NCT03428750|450132842|FG001|Overall Study|Administrative|1|||
125139309|NCT01919112|450132843|FG000|Secondary Analysis-day 30|Death|1|||
125139310|NCT01919112|450132844|FG001|Secondary Analysis-day 30|Death|1|||
125139311|NCT01919112|450132845|FG002|Secondary Analysis-day 30|Death|1|||
125139312|NCT01919112|450132843|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
125139313|NCT01919112|450132844|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
125139314|NCT01919112|450132845|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
125139315|NCT00635648|450132846|FG000|Overall Study|Adverse Event|12|||
125061273|NCT01877382|449840836|FG002|Dose Expansion|Adverse Event|0|||
125061274|NCT01877382|449840837|FG003|Dose Expansion|Adverse Event|0|||
125139316|NCT00635648|450132846|FG000|Overall Study|Withdrawal by Subject|9|||
125139317|NCT00635648|450132846|FG000|Overall Study|Physician Decision|4|||
125139318|NCT00635648|450132846|FG000|Overall Study|Rapid progression of baseline disease|4|||
125139319|NCT00635648|450132846|FG000|Overall Study|Use of other antifungal agent needed|1|||
125061275|NCT01877382|449840838|FG004|Dose Expansion|Adverse Event|0|||
125139320|NCT00635648|450132846|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
125139321|NCT00635648|450132846|FG000|Overall Study|Noncompliance with protocol|1|||
125139322|NCT00635648|450132846|FG000|Overall Study|Other reason|2|||
125139323|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
125061276|NCT01877382|449840839|FG005|Dose Expansion|Adverse Event|0|||
125061277|NCT01877382|449840840|FG006|Dose Expansion|Adverse Event|0|||
125061278|NCT01877382|449840841|FG007|Dose Expansion|Adverse Event|0|||
125061279|NCT01877382|449840842|FG008|Dose Expansion|Adverse Event|0|||
125061280|NCT01877382|449840843|FG009|Dose Expansion|Adverse Event|0|||
125061281|NCT01877382|449840844|FG010|Dose Expansion|Adverse Event|0|||
125061282|NCT01877382|449840845|FG011|Dose Expansion|Adverse Event|0|||
125061283|NCT01877382|449840846|FG012|Dose Expansion|Adverse Event|0|||
125061284|NCT01877382|449840847|FG013|Dose Expansion|Adverse Event|0|||
125061285|NCT01877382|449840848|FG014|Dose Expansion|Adverse Event|1|||
125061286|NCT01877382|449840834|FG000|Dose Expansion|Death|0|||
125061287|NCT01877382|449840835|FG001|Dose Expansion|Death|0|||
125061288|NCT01877382|449840836|FG002|Dose Expansion|Death|0|||
125061289|NCT01877382|449840837|FG003|Dose Expansion|Death|0|||
125061290|NCT01877382|449840838|FG004|Dose Expansion|Death|0|||
125061291|NCT01877382|449840839|FG005|Dose Expansion|Death|0|||
125061292|NCT01877382|449840840|FG006|Dose Expansion|Death|0|||
125061293|NCT01877382|449840841|FG007|Dose Expansion|Death|0|||
125061294|NCT01877382|449840842|FG008|Dose Expansion|Death|0|||
125061295|NCT01877382|449840843|FG009|Dose Expansion|Death|0|||
125061296|NCT01877382|449840844|FG010|Dose Expansion|Death|0|||
125061297|NCT01877382|449840845|FG011|Dose Expansion|Death|0|||
125061298|NCT01877382|449840846|FG012|Dose Expansion|Death|0|||
125061299|NCT01877382|449840847|FG013|Dose Expansion|Death|0|||
125061300|NCT01877382|449840848|FG014|Dose Expansion|Death|1|||
125061301|NCT01877382|449840834|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061302|NCT01877382|449840835|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061303|NCT01877382|449840836|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061304|NCT01877382|449840837|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061305|NCT01877382|449840838|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061306|NCT01877382|449840839|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061307|NCT01877382|449840840|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061308|NCT01877382|449840841|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061309|NCT01877382|449840842|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061310|NCT01877382|449840843|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061311|NCT01877382|449840844|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061312|NCT01877382|449840845|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061313|NCT01877382|449840846|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061314|NCT01877382|449840847|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125061315|NCT01877382|449840848|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
125061316|NCT03829332|449840849|FG000|Overall Study|Death|225|||
125061317|NCT03829332|449840850|FG001|Overall Study|Death|230|||
125061318|NCT03829332|449840849|FG000|Overall Study|Lost to Follow-up|1|||
125061319|NCT03829332|449840850|FG001|Overall Study|Lost to Follow-up|3|||
125061320|NCT03829332|449840849|FG000|Overall Study|Physician Decision|1|||
125061321|NCT03829332|449840850|FG001|Overall Study|Physician Decision|0|||
125061322|NCT03829332|449840849|FG000|Overall Study|Sponsor Decision|71|||
125061323|NCT03829332|449840850|FG001|Overall Study|Sponsor Decision|72|||
125061324|NCT03829332|449840849|FG000|Overall Study|Withdrawal by Subject|11|||
125061325|NCT03829332|449840850|FG001|Overall Study|Withdrawal by Subject|9|||
125061326|NCT04752189|449840851|FG000|Overall Study|Withdrawal by Subject|0|||
125061327|NCT04752189|449840852|FG001|Overall Study|Withdrawal by Subject|150|||
125061328|NCT04752189|449840851|FG000|Overall Study|Lost to Follow-up|261|||
125061329|NCT04752189|449840852|FG001|Overall Study|Lost to Follow-up|126|||
125061330|NCT03422133|449840853|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
125061331|NCT03422133|449840854|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
125061332|NCT02198651|449843038|FG000|Lead-in Period|Withdrew consent|13|||
125061333|NCT02198651|449843039|FG001|Lead-in Period|Withdrew consent|0|||
125061334|NCT02198651|449843040|FG002|Lead-in Period|Withdrew consent|0|||
125061335|NCT02198651|449843041|FG003|Lead-in Period|Withdrew consent|0|||
125061336|NCT02198651|449843042|FG004|Lead-in Period|Withdrew consent|0|||
125061337|NCT02198651|449843038|FG000|Lead-in Period|Adverse Event|2|||
125061338|NCT02198651|449843039|FG001|Lead-in Period|Adverse Event|0|||
125061339|NCT02198651|449843040|FG002|Lead-in Period|Adverse Event|0|||
125061340|NCT02198651|449843041|FG003|Lead-in Period|Adverse Event|0|||
125061341|NCT02198651|449843042|FG004|Lead-in Period|Adverse Event|0|||
125061342|NCT02198651|449843038|FG000|Lead-in Period|Other, not specified|22|||
125061343|NCT02198651|449843039|FG001|Lead-in Period|Other, not specified|0|||
125061344|NCT02198651|449843040|FG002|Lead-in Period|Other, not specified|0|||
125061345|NCT02198651|449843041|FG003|Lead-in Period|Other, not specified|0|||
125061346|NCT02198651|449843042|FG004|Lead-in Period|Other, not specified|0|||
125061347|NCT02198651|449843038|FG000|Double-blind Period|Withdrew consent|0|||
125061348|NCT02198651|449843039|FG001|Double-blind Period|Withdrew consent|4|||
125061349|NCT02198651|449843040|FG002|Double-blind Period|Withdrew consent|0|||
125061350|NCT02198651|449843041|FG003|Double-blind Period|Withdrew consent|0|||
125061351|NCT02198651|449843042|FG004|Double-blind Period|Withdrew consent|0|||
125061352|NCT02198651|449843038|FG000|Double-blind Period|Adverse Event|0|||
125061353|NCT02198651|449843039|FG001|Double-blind Period|Adverse Event|1|||
125061354|NCT02198651|449843040|FG002|Double-blind Period|Adverse Event|0|||
125061355|NCT02198651|449843041|FG003|Double-blind Period|Adverse Event|0|||
125061356|NCT02198651|449843042|FG004|Double-blind Period|Adverse Event|0|||
125061357|NCT02198651|449843038|FG000|Double-blind Period|Other, not specified|0|||
125061358|NCT02198651|449843039|FG001|Double-blind Period|Other, not specified|4|||
125061359|NCT02198651|449843040|FG002|Double-blind Period|Other, not specified|1|||
125061360|NCT02198651|449843041|FG003|Double-blind Period|Other, not specified|0|||
125061361|NCT02198651|449843042|FG004|Double-blind Period|Other, not specified|0|||
125061362|NCT02198651|449843038|FG000|Open-label Rescue Period|Withdrew consent|0|||
125061363|NCT02198651|449843039|FG001|Open-label Rescue Period|Withdrew consent|0|||
125061364|NCT02198651|449843040|FG002|Open-label Rescue Period|Withdrew consent|0|||
125061365|NCT02198651|449843041|FG003|Open-label Rescue Period|Withdrew consent|2|||
125061366|NCT02198651|449843042|FG004|Open-label Rescue Period|Withdrew consent|0|||
125061367|NCT02198651|449843038|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
125061368|NCT02198651|449843039|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
125061369|NCT02198651|449843040|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
125061370|NCT02198651|449843041|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
125061371|NCT02198651|449843042|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
125061372|NCT02115113|449843043|FG000|Participants in Run-in Period|Death|0|||
125061373|NCT02115113|449843044|FG001|Participants in Run-in Period|Death|0|||
125061374|NCT02115113|449843045|FG002|Participants in Run-in Period|Death|1|||
125061375|NCT02115113|449843043|FG000|Participants in Run-in Period|Administrative problems|0|||
125061376|NCT02115113|449843044|FG001|Participants in Run-in Period|Administrative problems|0|||
125061377|NCT02115113|449843045|FG002|Participants in Run-in Period|Administrative problems|1|||
125061378|NCT02115113|449843043|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
125061379|NCT02115113|449843044|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
125061380|NCT02115113|449843045|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
125061381|NCT02115113|449843043|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
125061382|NCT02115113|449843044|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
125061383|NCT02115113|449843045|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
125061384|NCT02115113|449843043|FG000|Participants Randomized|Lost to Follow-up|1|||
125061385|NCT02115113|449843044|FG001|Participants Randomized|Lost to Follow-up|0|||
125061386|NCT02115113|449843045|FG002|Participants Randomized|Lost to Follow-up|0|||
125061387|NCT02115113|449843043|FG000|Participants Randomized|Death|1|||
125061388|NCT02115113|449843044|FG001|Participants Randomized|Death|0|||
125061389|NCT02115113|449843045|FG002|Participants Randomized|Death|0|||
125061390|NCT02622724|449843046|FG000|Overall Study|Death|51|||
125061391|NCT02622724|449843047|FG001|Overall Study|Death|53|||
125061392|NCT02622724|449843046|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
125061393|NCT02622724|449843047|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
125061394|NCT02622724|449843046|FG000|Overall Study|Early termination of study|38|||
125061395|NCT02622724|449843047|FG001|Overall Study|Early termination of study|43|||
125061396|NCT00296725|449843048|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
125061397|NCT00296725|449843048|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
125061398|NCT00296725|449843048|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
125222411|NCT02659943|450442748|FG004|Overall Study|Switched to alternative treatment|1|||
125061399|NCT00356863|449843049|FG000|Overall Study|Death|16|||
125061400|NCT00356863|449843050|FG001|Overall Study|Death|32|||
125061401|NCT00356863|449843049|FG000|Overall Study|Lost to Follow-up|76|||
125061402|NCT00356863|449843050|FG001|Overall Study|Lost to Follow-up|43|||
125061403|NCT03712345|449843053|FG000|Overall Study|Failure to meet randomization criteria|0|||
125061404|NCT03712345|449843054|FG001|Overall Study|Failure to meet randomization criteria|0|||
125222412|NCT02659943|450442749|FG005|Overall Study|Switched to alternative treatment|0|||
125061405|NCT03712345|449843055|FG002|Overall Study|Failure to meet randomization criteria|1|||
125061406|NCT00485589|449843059|FG000|Overall Study|Death|2|||
125061407|NCT00485589|449843060|FG001|Overall Study|Death|2|||
125061408|NCT00485589|449843061|FG002|Overall Study|Death|0|||
125061409|NCT00485589|449843059|FG000|Overall Study|Failure to return|6|||
125061410|NCT00485589|449843060|FG001|Overall Study|Failure to return|5|||
125061411|NCT00485589|449843061|FG002|Overall Study|Failure to return|1|||
125061412|NCT00485589|449843059|FG000|Overall Study|Protocol Violation|1|||
125061413|NCT00485589|449843060|FG001|Overall Study|Protocol Violation|0|||
125061414|NCT00485589|449843061|FG002|Overall Study|Protocol Violation|0|||
125061415|NCT00485589|449843059|FG000|Overall Study|Violation of selection criteria at entry|0|||
125061416|NCT00485589|449843060|FG001|Overall Study|Violation of selection criteria at entry|3|||
125061417|NCT00485589|449843061|FG002|Overall Study|Violation of selection criteria at entry|1|||
125061418|NCT00485589|449843059|FG000|Overall Study|Administrative/Other|1|||
125061419|NCT00485589|449843060|FG001|Overall Study|Administrative/Other|2|||
125061420|NCT00485589|449843061|FG002|Overall Study|Administrative/Other|1|||
125061421|NCT00485589|449843059|FG000|Overall Study|Insufficient therapeutic response|10|||
125061422|NCT00485589|449843060|FG001|Overall Study|Insufficient therapeutic response|3|||
125061423|NCT00485589|449843061|FG002|Overall Study|Insufficient therapeutic response|1|||
125061424|NCT00485589|449843059|FG000|Overall Study|Refused treatment/did not cooperate|1|||
125061425|NCT00485589|449843060|FG001|Overall Study|Refused treatment/did not cooperate|0|||
125061426|NCT00485589|449843061|FG002|Overall Study|Refused treatment/did not cooperate|2|||
125061427|NCT00485589|449843059|FG000|Overall Study|Withdrawal by Subject|3|||
125061428|NCT00485589|449843060|FG001|Overall Study|Withdrawal by Subject|2|||
125061429|NCT00485589|449843061|FG002|Overall Study|Withdrawal by Subject|2|||
125061430|NCT00485589|449843059|FG000|Overall Study|Adverse Event|3|||
125061431|NCT00485589|449843060|FG001|Overall Study|Adverse Event|3|||
125061432|NCT00485589|449843061|FG002|Overall Study|Adverse Event|10|||
125061433|NCT02585999|449843062|FG000|Overall Study|Lost to Follow-up|1|||
125061434|NCT02585999|449843062|FG000|Overall Study|Protocol Violation|1|||
125061435|NCT01369849|449843063|FG000|Overall Study|Ineligible prior to treatment|0|||
125061436|NCT01369849|449843064|FG001|Overall Study|Ineligible prior to treatment|0|||
125061437|NCT01369849|449843065|FG002|Overall Study|Ineligible prior to treatment|1|||
125061438|NCT01369849|449843063|FG000|Overall Study|Ineligible after receiving treatment|0|||
125061439|NCT01369849|449843064|FG001|Overall Study|Ineligible after receiving treatment|1|||
125061440|NCT01369849|449843065|FG002|Overall Study|Ineligible after receiving treatment|0|||
125061441|NCT02924688|449843066|FG000|Overall Study|Adverse Event|9|||
125061442|NCT02924688|449843067|FG001|Overall Study|Adverse Event|3|||
125061443|NCT02924688|449843068|FG002|Overall Study|Adverse Event|2|||
125061444|NCT02924688|449843069|FG003|Overall Study|Adverse Event|2|||
125061445|NCT02924688|449843070|FG004|Overall Study|Adverse Event|3|||
125061446|NCT02924688|449843071|FG005|Overall Study|Adverse Event|2|||
125061447|NCT02924688|449843066|FG000|Overall Study|Lack of Efficacy|2|||
125061448|NCT02924688|449843067|FG001|Overall Study|Lack of Efficacy|3|||
125061449|NCT02924688|449843068|FG002|Overall Study|Lack of Efficacy|4|||
125061450|NCT02924688|449843069|FG003|Overall Study|Lack of Efficacy|2|||
125061451|NCT02924688|449843070|FG004|Overall Study|Lack of Efficacy|1|||
125061452|NCT02924688|449843071|FG005|Overall Study|Lack of Efficacy|1|||
125061453|NCT02924688|449843066|FG000|Overall Study|Protocol Violation|3|||
125061454|NCT02924688|449843067|FG001|Overall Study|Protocol Violation|7|||
125061455|NCT02924688|449843068|FG002|Overall Study|Protocol Violation|5|||
125061456|NCT02924688|449843069|FG003|Overall Study|Protocol Violation|6|||
125061457|NCT02924688|449843070|FG004|Overall Study|Protocol Violation|2|||
125061458|NCT02924688|449843071|FG005|Overall Study|Protocol Violation|2|||
125061459|NCT02924688|449843066|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
125061460|NCT02924688|449843067|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
125061461|NCT02924688|449843068|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
125061462|NCT02924688|449843069|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
125061463|NCT02924688|449843070|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
125061464|NCT02924688|449843071|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
125061465|NCT02924688|449843066|FG000|Overall Study|Lost to Follow-up|2|||
125061466|NCT02924688|449843067|FG001|Overall Study|Lost to Follow-up|4|||
125061467|NCT02924688|449843068|FG002|Overall Study|Lost to Follow-up|2|||
125061468|NCT02924688|449843069|FG003|Overall Study|Lost to Follow-up|4|||
125061469|NCT02924688|449843070|FG004|Overall Study|Lost to Follow-up|2|||
125061470|NCT02924688|449843071|FG005|Overall Study|Lost to Follow-up|4|||
125061471|NCT02924688|449843066|FG000|Overall Study|Physician Decision|2|||
125061472|NCT02924688|449843067|FG001|Overall Study|Physician Decision|1|||
125061473|NCT02924688|449843068|FG002|Overall Study|Physician Decision|0|||
125061474|NCT02924688|449843069|FG003|Overall Study|Physician Decision|1|||
125061475|NCT02924688|449843070|FG004|Overall Study|Physician Decision|1|||
125061476|NCT02924688|449843071|FG005|Overall Study|Physician Decision|1|||
125061477|NCT02924688|449843066|FG000|Overall Study|Withdrawal by Subject|14|||
125061478|NCT02924688|449843067|FG001|Overall Study|Withdrawal by Subject|13|||
125061479|NCT02924688|449843068|FG002|Overall Study|Withdrawal by Subject|9|||
125061480|NCT02924688|449843069|FG003|Overall Study|Withdrawal by Subject|12|||
125061481|NCT02924688|449843070|FG004|Overall Study|Withdrawal by Subject|13|||
125061482|NCT02924688|449843071|FG005|Overall Study|Withdrawal by Subject|14|||
125061483|NCT00174785|449843072|FG000|Overall Study|Adverse Event|293|||
125061484|NCT00174785|449843073|FG001|Overall Study|Adverse Event|191|||
125061485|NCT00174785|449843072|FG000|Overall Study|Protocol Violation|14|||
125061486|NCT00174785|449843073|FG001|Overall Study|Protocol Violation|14|||
125061487|NCT00174785|449843072|FG000|Overall Study|Withdrawal by Subject|173|||
125061488|NCT00174785|449843073|FG001|Overall Study|Withdrawal by Subject|175|||
125061489|NCT00174785|449843072|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
125061490|NCT00174785|449843073|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
125061491|NCT00174785|449843072|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
125061492|NCT00174785|449843073|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
125061493|NCT00174785|449843072|FG000|Overall Study|Other prohibited medication|5|||
125061494|NCT00174785|449843073|FG001|Overall Study|Other prohibited medication|3|||
125061495|NCT00174785|449843072|FG000|Overall Study|Family request|6|||
125061496|NCT00174785|449843073|FG001|Overall Study|Family request|8|||
125061497|NCT00174785|449843072|FG000|Overall Study|Not pre-specified/Not coded|56|||
125061498|NCT00174785|449843073|FG001|Overall Study|Not pre-specified/Not coded|70|||
125061499|NCT00120289|449843075|FG000|Overall Study|Death|96|||
125061500|NCT00120289|449843076|FG001|Overall Study|Death|82|||
125061501|NCT00120289|449843075|FG000|Overall Study|Lost to Follow-up|11|||
125061502|NCT00120289|449843076|FG001|Overall Study|Lost to Follow-up|14|||
125061503|NCT00120289|449843075|FG000|Overall Study|Withdrawal by Subject|14|||
125061504|NCT00120289|449843076|FG001|Overall Study|Withdrawal by Subject|13|||
125061505|NCT01754922|449843077|FG000|Overall Study|Adverse Event|0|||
125061506|NCT01754922|449843078|FG001|Overall Study|Adverse Event|1|||
125061507|NCT01944969|449843080|FG000|Overall Study|Adverse Event|1|||
125061508|NCT01944969|449843080|FG000|Overall Study|Lack of Efficacy|1|||
125061509|NCT01944969|449843080|FG000|Overall Study|Non-compliance with IMP|1|||
125061510|NCT01944969|449843080|FG000|Overall Study|Administrative or other reasons|23|||
125061511|NCT00310388|449843081|FG000|Primary Reporting Phase|Adverse Event|101|||
125061512|NCT00310388|449843082|FG001|Primary Reporting Phase|Adverse Event|0|||
125061513|NCT00310388|449843081|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
125061514|NCT00310388|449843082|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
125061515|NCT00310388|449843081|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
125061516|NCT00310388|449843082|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
125061517|NCT00310388|449843081|FG000|Primary Reporting Phase|Protocol Violation|10|||
125061518|NCT00310388|449843082|FG001|Primary Reporting Phase|Protocol Violation|0|||
125061519|NCT00310388|449843081|FG000|Primary Reporting Phase|Pregnancy|3|||
125061520|NCT00310388|449843082|FG001|Primary Reporting Phase|Pregnancy|0|||
125061521|NCT00310388|449843081|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
125061522|NCT00310388|449843082|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
125061523|NCT00310388|449843081|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
125061524|NCT00310388|449843082|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
125061525|NCT00310388|449843081|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
125061526|NCT00310388|449843082|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
125061527|NCT00310388|449843081|FG000|Primary Reporting Phase|Physician Decision|2|||
125061528|NCT00310388|449843082|FG001|Primary Reporting Phase|Physician Decision|0|||
125061529|NCT00310388|449843081|FG000|Primary Reporting Phase|Request of the sponsor|19|||
125061530|NCT00310388|449843082|FG001|Primary Reporting Phase|Request of the sponsor|0|||
125061531|NCT00310388|449843081|FG000|Primary Reporting Phase|Failed to return|8|||
125061532|NCT00310388|449843082|FG001|Primary Reporting Phase|Failed to return|0|||
125061533|NCT00310388|449843081|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
125061534|NCT00310388|449843082|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
125061535|NCT00310388|449843081|FG000|Primary Reporting Phase|Participant request|2|||
125061536|NCT00310388|449843082|FG001|Primary Reporting Phase|Participant request|0|||
125061537|NCT00310388|449843081|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
125061538|NCT00310388|449843082|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
125061539|NCT00310388|449843081|FG000|Primary Reporting Phase|Discontinuation of study|1|||
125061540|NCT00310388|449843082|FG001|Primary Reporting Phase|Discontinuation of study|0|||
125061541|NCT00310388|449843081|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
125061542|NCT00310388|449843082|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
125061543|NCT00310388|449843081|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
125061544|NCT00310388|449843082|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
125139324|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
125061545|NCT00310388|449843081|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
125061546|NCT00310388|449843082|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
125061547|NCT00310388|449843081|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
125061548|NCT00310388|449843082|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
125061549|NCT00310388|449843081|FG000|Primary Reporting Phase|Participant passed away|1|||
125061550|NCT00310388|449843082|FG001|Primary Reporting Phase|Participant passed away|0|||
125061551|NCT00310388|449843081|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
125061552|NCT00310388|449843082|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
125061553|NCT00310388|449843081|FG000|Primary Reporting Phase|Missing|1|||
125061554|NCT00310388|449843082|FG001|Primary Reporting Phase|Missing|0|||
125061555|NCT00310388|449843081|FG000|Primary Reporting Phase|Other|1|||
125061556|NCT00310388|449843082|FG001|Primary Reporting Phase|Other|0|||
125061557|NCT00310388|449843081|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
125061558|NCT00310388|449843082|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
125061559|NCT00310388|449843081|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
125061560|NCT00310388|449843082|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
125061561|NCT00310388|449843081|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
125061562|NCT00310388|449843082|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
125061563|NCT00310388|449843081|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
125061564|NCT00310388|449843082|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
125061565|NCT00848250|449843084|FG000|Overall Study|surgery was completed without cardiopulm|0|||
125061566|NCT00848250|449843085|FG001|Overall Study|surgery was completed without cardiopulm|1|||
125061567|NCT02938585|449843086|FG000|Overall Study|Withdrawal by parent or guardian|0|||
125061568|NCT02938585|449843087|FG001|Overall Study|Withdrawal by parent or guardian|1|||
125061569|NCT02938585|449843088|FG002|Overall Study|Withdrawal by parent or guardian|0|||
125061570|NCT02938585|449843089|FG003|Overall Study|Withdrawal by parent or guardian|0|||
125061571|NCT02938585|449843086|FG000|Overall Study|Withdrawal by Subject|0|||
125061572|NCT02938585|449843087|FG001|Overall Study|Withdrawal by Subject|0|||
125061573|NCT02938585|449843088|FG002|Overall Study|Withdrawal by Subject|0|||
125061574|NCT02938585|449843089|FG003|Overall Study|Withdrawal by Subject|5|||
125061575|NCT03457103|449843093|FG000|Overall Study|illness/hospitalization|4|||
125061576|NCT03457103|449843094|FG001|Overall Study|illness/hospitalization|2|||
125061577|NCT03457103|449843093|FG000|Overall Study|Lost to Follow-up|2|||
125061578|NCT03457103|449843094|FG001|Overall Study|Lost to Follow-up|1|||
125061579|NCT03457103|449843093|FG000|Overall Study|Withdrawal by Subject|1|||
125061580|NCT03457103|449843094|FG001|Overall Study|Withdrawal by Subject|2|||
125061581|NCT03457103|449843093|FG000|Overall Study|financial/ insurance issues|1|||
125061582|NCT03457103|449843094|FG001|Overall Study|financial/ insurance issues|1|||
125061583|NCT00213980|449843095|FG000|Overall Study|Withdrawal by Subject|3|||
125061584|NCT00213980|449843096|FG001|Overall Study|Withdrawal by Subject|1|||
125061585|NCT00213980|449843095|FG000|Overall Study|Adverse Event|1|||
125061586|NCT00213980|449843096|FG001|Overall Study|Adverse Event|1|||
125061587|NCT00213980|449843095|FG000|Overall Study|Disease progression|0|||
125061588|NCT00213980|449843096|FG001|Overall Study|Disease progression|2|||
125061589|NCT00213980|449843095|FG000|Overall Study|Developed ovarian cancer|1|||
125061590|NCT00213980|449843096|FG001|Overall Study|Developed ovarian cancer|0|||
125061591|NCT00213980|449843095|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
125061592|NCT00213980|449843096|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
125061593|NCT00798694|449843097|FG000|Overall Study|Lost to Follow-up|1|||
125061594|NCT00798694|449843098|FG001|Overall Study|Lost to Follow-up|1|||
125139325|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
125139326|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
125061595|NCT00798694|449843097|FG000|Overall Study|Physician Decision|1|||
125061596|NCT00798694|449843098|FG001|Overall Study|Physician Decision|0|||
125061597|NCT01089582|449843112|FG000|Overall Study|Death|2|||
125061598|NCT01089582|449843112|FG000|Overall Study|Adverse Event|15|||
125061599|NCT01089582|449843112|FG000|Overall Study|Lost to Follow-up|8|||
125061600|NCT01089582|449843112|FG000|Overall Study|Other|4|||
125139327|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
125139328|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
125139329|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
125061601|NCT01089582|449843112|FG000|Overall Study|Withdrawal by Subject|1|||
125061602|NCT00862849|449843113|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
125061603|NCT00862849|449843114|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
125061604|NCT00862849|449843115|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
125061605|NCT00862849|449843116|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
125061606|NCT00862849|449843117|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
125061607|NCT00862849|449843118|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
125061608|NCT00862849|449843113|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
125061609|NCT00862849|449843114|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
125061610|NCT00862849|449843115|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
125061611|NCT00862849|449843116|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
125061612|NCT00862849|449843117|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
125061613|NCT00862849|449843118|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
125061614|NCT03943953|449843121|FG000|Trial of ITG 1|Lost to Follow-up|19|||
125061615|NCT03943953|449843122|FG001|Trial of ITG 1|Lost to Follow-up|1|||
125061616|NCT03943953|449843121|FG000|Trial of ITG 2|Lost to Follow-up|8|||
125061617|NCT03943953|449843122|FG001|Trial of ITG 2|Lost to Follow-up|0|||
125061618|NCT03943953|449843121|FG000|Trial of ITG 3|Lost to Follow-up|2|||
125061619|NCT03943953|449843122|FG001|Trial of ITG 3|Lost to Follow-up|0|||
125061620|NCT03943953|449843121|FG000|Trial of ITG 4|Lost to Follow-up|2|||
125061621|NCT03943953|449843122|FG001|Trial of ITG 4|Lost to Follow-up|0|||
125061622|NCT00289185|449843127|FG000|Overall Study|Withdrawal by Subject|4|||
125061623|NCT00289185|449843128|FG001|Overall Study|Withdrawal by Subject|8|||
125061624|NCT00289185|449843127|FG000|Overall Study|Lost to Follow-up|23|||
125061625|NCT00289185|449843128|FG001|Overall Study|Lost to Follow-up|17|||
125061626|NCT00289185|449843127|FG000|Overall Study|Death|1|||
125061627|NCT00289185|449843128|FG001|Overall Study|Death|1|||
125061628|NCT01199055|449843129|FG000|Overall Study|Death|0|||
125061629|NCT01199055|449843130|FG001|Overall Study|Death|1|||
125061630|NCT01199055|449843131|FG002|Overall Study|Death|0|||
125061631|NCT01199055|449843129|FG000|Overall Study|Physician Decision|0|||
125061632|NCT01199055|449843130|FG001|Overall Study|Physician Decision|1|||
125061633|NCT01199055|449843131|FG002|Overall Study|Physician Decision|1|||
125061634|NCT01199055|449843129|FG000|Overall Study|Progressive disease|2|||
125061635|NCT01199055|449843130|FG001|Overall Study|Progressive disease|1|||
125061636|NCT01199055|449843131|FG002|Overall Study|Progressive disease|2|||
125061637|NCT01199055|449843129|FG000|Overall Study|Withdrawal by Subject|0|||
125061638|NCT01199055|449843130|FG001|Overall Study|Withdrawal by Subject|0|||
125061639|NCT01199055|449843131|FG002|Overall Study|Withdrawal by Subject|1|||
125061640|NCT02432040|449843132|FG000|Overall Study|Lack of Efficacy|3|||
125061641|NCT02432040|449843133|FG001|Overall Study|Lack of Efficacy|0|||
125061642|NCT02432040|449843132|FG000|Overall Study|Lost to Follow-up|4|||
125061643|NCT02432040|449843133|FG001|Overall Study|Lost to Follow-up|5|||
125061644|NCT02432040|449843132|FG000|Overall Study|Physician Decision|1|||
125061645|NCT02432040|449843133|FG001|Overall Study|Physician Decision|1|||
125061646|NCT03633227|449843134|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
125061647|NCT03633227|449843135|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
125061648|NCT03633227|449843134|FG000|Double Blind (DB), up to Week 48|Death|2|||
125061649|NCT03633227|449843135|FG001|Double Blind (DB), up to Week 48|Death|1|||
125061650|NCT03633227|449843134|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
125061651|NCT03633227|449843135|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
125061652|NCT03633227|449843134|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
125061653|NCT03633227|449843135|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
125061654|NCT03633227|449843134|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
125061655|NCT03633227|449843135|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
125061656|NCT03633227|449843134|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
125061657|NCT03633227|449843135|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
125061658|NCT03633227|449843134|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
125061659|NCT03633227|449843135|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
125061660|NCT03633227|449843134|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
125061661|NCT03633227|449843135|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
125061662|NCT03633227|449843134|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
125139330|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
125139331|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
125139332|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
125139333|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
125139334|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
125139335|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
125139336|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
125061663|NCT03633227|449843135|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
125061664|NCT03633227|449843134|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
125061665|NCT03633227|449843135|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
125061666|NCT03633227|449843134|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
125061667|NCT03633227|449843135|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
125061668|NCT03633227|449843134|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
125061669|NCT03633227|449843135|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
125061670|NCT01069523|449843136|FG000|Overall Study|Withdrawal by Subject|4|||
125061671|NCT01069523|449843137|FG001|Overall Study|Withdrawal by Subject|7|||
125061672|NCT04167306|449843145|FG000|Overall Study|Lost to Follow-up|2|||
125061673|NCT04167306|449843146|FG001|Overall Study|Lost to Follow-up|2|||
125061674|NCT04167306|449843147|FG002|Overall Study|Lost to Follow-up|5|||
125061675|NCT04167306|449843148|FG003|Overall Study|Lost to Follow-up|5|||
125061676|NCT04167306|449843145|FG000|Overall Study|Adverse Event|13|||
125061677|NCT04167306|449843146|FG001|Overall Study|Adverse Event|14|||
125061678|NCT04167306|449843147|FG002|Overall Study|Adverse Event|5|||
125061679|NCT04167306|449843148|FG003|Overall Study|Adverse Event|4|||
125061680|NCT04167306|449843145|FG000|Overall Study|Withdrawal by Subject|4|||
125061681|NCT04167306|449843146|FG001|Overall Study|Withdrawal by Subject|6|||
125061682|NCT04167306|449843147|FG002|Overall Study|Withdrawal by Subject|8|||
125061683|NCT04167306|449843148|FG003|Overall Study|Withdrawal by Subject|3|||
125061684|NCT04167306|449843145|FG000|Overall Study|covid|1|||
125061685|NCT04167306|449843146|FG001|Overall Study|covid|1|||
125061686|NCT04167306|449843147|FG002|Overall Study|covid|2|||
125061687|NCT04167306|449843148|FG003|Overall Study|covid|1|||
125061688|NCT04167306|449843145|FG000|Overall Study|concomitant medication|0|||
125061689|NCT04167306|449843146|FG001|Overall Study|concomitant medication|0|||
125061690|NCT04167306|449843147|FG002|Overall Study|concomitant medication|0|||
125061691|NCT04167306|449843148|FG003|Overall Study|concomitant medication|1|||
125061692|NCT04167306|449843145|FG000|Overall Study|Alcohol treatment|0|||
125061693|NCT04167306|449843146|FG001|Overall Study|Alcohol treatment|4|||
125061694|NCT04167306|449843147|FG002|Overall Study|Alcohol treatment|3|||
125061695|NCT04167306|449843148|FG003|Overall Study|Alcohol treatment|2|||
125061696|NCT04167306|449843145|FG000|Overall Study|non-compliance|0|||
125061697|NCT04167306|449843146|FG001|Overall Study|non-compliance|0|||
125061698|NCT04167306|449843147|FG002|Overall Study|non-compliance|1|||
125061699|NCT04167306|449843148|FG003|Overall Study|non-compliance|0|||
125061700|NCT04167306|449843145|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
125061701|NCT04167306|449843146|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
125061702|NCT04167306|449843147|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
125061703|NCT04167306|449843148|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
125061704|NCT01737840|449843149|FG000|Overall Study|Diagnosed with an other pathology|2|||
125061705|NCT01737840|449843150|FG001|Overall Study|Diagnosed with an other pathology|2|||
125061706|NCT03105700|449843153|FG000|Overall Study|screen fail|3|||
125061707|NCT03105700|449843153|FG000|Overall Study|Lost to Follow-up|4|||
125061708|NCT00403559|449843156|FG000|Overall Study|Adverse Event|0|||
125061709|NCT00403559|449843157|FG001|Overall Study|Adverse Event|1|||
125061710|NCT00403559|449843156|FG000|Overall Study|Lost to Follow-up|3|||
125061711|NCT00403559|449843157|FG001|Overall Study|Lost to Follow-up|3|||
125061712|NCT00403559|449843156|FG000|Overall Study|Withdrawal by Subject|1|||
125061713|NCT00403559|449843157|FG001|Overall Study|Withdrawal by Subject|0|||
125061714|NCT01253421|449843158|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
125061715|NCT01253421|449843159|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
125061716|NCT01253421|449843160|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
125061717|NCT01253421|449843161|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
125061718|NCT01253421|449843162|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
125061719|NCT01253421|449843158|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
125061720|NCT01253421|449843159|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
125061721|NCT01253421|449843160|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
125061722|NCT01253421|449843161|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
125061723|NCT01253421|449843162|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
125061724|NCT01253421|449843158|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
125061725|NCT01253421|449843159|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
125061726|NCT01253421|449843160|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
125061727|NCT01253421|449843161|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
125061728|NCT01253421|449843162|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
125061729|NCT01253421|449843158|FG000|Assessment and Scheduling|Physician Decision|1|||
125061730|NCT01253421|449843159|FG001|Assessment and Scheduling|Physician Decision|0|||
125139337|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
125139338|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
125139339|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
125061731|NCT01253421|449843160|FG002|Assessment and Scheduling|Physician Decision|0|||
125061732|NCT01253421|449843161|FG003|Assessment and Scheduling|Physician Decision|0|||
125061733|NCT01253421|449843162|FG004|Assessment and Scheduling|Physician Decision|0|||
125139340|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
125139341|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
125061734|NCT01253421|449843158|FG000|Drug+Scanning Visit|Physician Decision|0|||
125061735|NCT01253421|449843159|FG001|Drug+Scanning Visit|Physician Decision|0|||
125061736|NCT01253421|449843160|FG002|Drug+Scanning Visit|Physician Decision|0|||
125061737|NCT01253421|449843161|FG003|Drug+Scanning Visit|Physician Decision|0|||
125061738|NCT01253421|449843162|FG004|Drug+Scanning Visit|Physician Decision|1|||
125061739|NCT00121992|449843163|FG000|Overall Study|Treatment not received|2|||
125061740|NCT00121992|449843164|FG001|Overall Study|Treatment not received|11|||
125061741|NCT04387136|449843165|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
125061742|NCT04387136|449843166|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
125061743|NCT01029886|449843171|FG000|Overall Study|Adverse Event|12|||
125061744|NCT01029886|449843172|FG001|Overall Study|Adverse Event|25|||
125061745|NCT01029886|449843171|FG000|Overall Study|Lost to Follow-up|1|||
125061746|NCT01029886|449843172|FG001|Overall Study|Lost to Follow-up|0|||
125061747|NCT01029886|449843171|FG000|Overall Study|Physician Decision|2|||
125061748|NCT01029886|449843172|FG001|Overall Study|Physician Decision|6|||
125061749|NCT01029886|449843171|FG000|Overall Study|Protocol Violation|17|||
125061750|NCT01029886|449843172|FG001|Overall Study|Protocol Violation|5|||
125061751|NCT01029886|449843171|FG000|Overall Study|Withdrawal by Subject|8|||
125061752|NCT01029886|449843172|FG001|Overall Study|Withdrawal by Subject|18|||
125061753|NCT01029886|449843171|FG000|Overall Study|Entry Criteria Not Met|13|||
125061754|NCT01029886|449843172|FG001|Overall Study|Entry Criteria Not Met|5|||
125061755|NCT01029886|449843171|FG000|Overall Study|Sponsor Decision|1|||
125061756|NCT01029886|449843172|FG001|Overall Study|Sponsor Decision|0|||
125061757|NCT01029886|449843171|FG000|Overall Study|Loss Glucose Control|7|||
125061758|NCT01029886|449843172|FG001|Overall Study|Loss Glucose Control|1|||
125061759|NCT01553916|449843173|FG000|Overall Study|Withdrawal by Subject|2|||
125061760|NCT01553916|449843173|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
125061761|NCT03089216|449843174|FG000|Overall Study|Adverse Event|0|||
125061762|NCT03089216|449843175|FG001|Overall Study|Adverse Event|0|||
125061763|NCT03089216|449843176|FG002|Overall Study|Adverse Event|0|||
125061764|NCT03089216|449843177|FG003|Overall Study|Adverse Event|1|||
125061765|NCT01968954|449843181|FG000|Overall Study|Adverse Event|6|||
125061766|NCT01968954|449843182|FG001|Overall Study|Adverse Event|3|||
125061767|NCT01968954|449843181|FG000|Overall Study|Death|1|||
125061768|NCT01968954|449843182|FG001|Overall Study|Death|2|||
125061769|NCT01968954|449843181|FG000|Overall Study|Lost to Follow-up|6|||
125061770|NCT01968954|449843182|FG001|Overall Study|Lost to Follow-up|4|||
125061771|NCT01968954|449843181|FG000|Overall Study|Withdrawal by Subject|20|||
125061772|NCT01968954|449843182|FG001|Overall Study|Withdrawal by Subject|23|||
125061773|NCT01968954|449843181|FG000|Overall Study|Other|7|||
125061774|NCT01968954|449843182|FG001|Overall Study|Other|8|||
125061775|NCT01968954|449843181|FG000|Overall Study|Protocol Violation|0|||
125061776|NCT01968954|449843182|FG001|Overall Study|Protocol Violation|1|||
125061777|NCT01968954|449843181|FG000|Overall Study|Did not met inclusion criteria|0|||
125061778|NCT01968954|449843182|FG001|Overall Study|Did not met inclusion criteria|2|||
125061779|NCT00434122|449843183|FG000|Overall Study|Non-compliance with protocol|0|||
125061780|NCT00434122|449843184|FG001|Overall Study|Non-compliance with protocol|1|||
125061781|NCT00434122|449843183|FG000|Overall Study|loss of subject contact|1|||
125061782|NCT00434122|449843184|FG001|Overall Study|loss of subject contact|1|||
125061783|NCT00434122|449843183|FG000|Overall Study|Personal reasons|1|||
125061784|NCT00434122|449843184|FG001|Overall Study|Personal reasons|1|||
125061785|NCT00434122|449843183|FG000|Overall Study|Large follicle size|2|||
125061786|NCT00434122|449843184|FG001|Overall Study|Large follicle size|2|||
125061787|NCT00434122|449843183|FG000|Overall Study|Low follicular response.|1|||
125061788|NCT00434122|449843184|FG001|Overall Study|Low follicular response.|2|||
125139342|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
125139343|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
125139344|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
125061789|NCT00434122|449843183|FG000|Overall Study|Travelling of subject.|1|||
125061790|NCT00434122|449843184|FG001|Overall Study|Travelling of subject.|0|||
125139345|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
125061791|NCT04191577|449843185|FG000|Overall Study|Withdrawal by Subject|2|||
125061792|NCT04191577|449843186|FG001|Overall Study|Withdrawal by Subject|2|||
125061793|NCT04191577|449843187|FG002|Overall Study|Withdrawal by Subject|1|||
125061794|NCT04191577|449843185|FG000|Overall Study|Physician Decision|1|||
125061795|NCT04191577|449843186|FG001|Overall Study|Physician Decision|1|||
125061796|NCT04191577|449843187|FG002|Overall Study|Physician Decision|0|||
125061797|NCT04191577|449843185|FG000|Overall Study|Adverse Event|0|||
125061798|NCT04191577|449843186|FG001|Overall Study|Adverse Event|0|||
125061799|NCT04191577|449843187|FG002|Overall Study|Adverse Event|1|||
125061800|NCT04191577|449843185|FG000|Overall Study|Death|0|||
125061801|NCT04191577|449843186|FG001|Overall Study|Death|0|||
125061802|NCT04191577|449843187|FG002|Overall Study|Death|1|||
125061803|NCT03655717|449843188|FG000|Overall Study|Withdrawal by Subject|4|||
125061804|NCT03655717|449843189|FG001|Overall Study|Withdrawal by Subject|8|||
125061805|NCT03655717|449843190|FG002|Overall Study|Withdrawal by Subject|1|||
125061806|NCT03655717|449843191|FG003|Overall Study|Withdrawal by Subject|0|||
125061807|NCT03655717|449843192|FG004|Overall Study|Withdrawal by Subject|0|||
125061808|NCT03655717|449843193|FG005|Overall Study|Withdrawal by Subject|1|||
125061809|NCT03655717|449843194|FG006|Overall Study|Withdrawal by Subject|3|||
125061810|NCT03655717|449843195|FG007|Overall Study|Withdrawal by Subject|1|||
125061811|NCT03655717|449843196|FG008|Overall Study|Withdrawal by Subject|2|||
125061812|NCT03655717|449843197|FG009|Overall Study|Withdrawal by Subject|0|||
125061813|NCT03655717|449843198|FG010|Overall Study|Withdrawal by Subject|0|||
125061814|NCT03655717|449843199|FG011|Overall Study|Withdrawal by Subject|1|||
125061815|NCT03655717|449843200|FG012|Overall Study|Withdrawal by Subject|0|||
125061816|NCT03655717|449843201|FG013|Overall Study|Withdrawal by Subject|3|||
125061817|NCT03655717|449843202|FG014|Overall Study|Withdrawal by Subject|0|||
125061818|NCT03655717|449843203|FG015|Overall Study|Withdrawal by Subject|1|||
125061819|NCT03655717|449843204|FG016|Overall Study|Withdrawal by Subject|0|||
125061820|NCT03655717|449843205|FG017|Overall Study|Withdrawal by Subject|0|||
125061821|NCT03655717|449843206|FG018|Overall Study|Withdrawal by Subject|1|||
125061822|NCT03655717|449843207|FG019|Overall Study|Withdrawal by Subject|0|||
125061823|NCT03655717|449843208|FG020|Overall Study|Withdrawal by Subject|0|||
125061824|NCT03655717|449843209|FG021|Overall Study|Withdrawal by Subject|1|||
125061825|NCT03655717|449843210|FG022|Overall Study|Withdrawal by Subject|2|||
125061826|NCT03655717|449843211|FG023|Overall Study|Withdrawal by Subject|1|||
125061827|NCT03655717|449843212|FG024|Overall Study|Withdrawal by Subject|1|||
125061828|NCT03655717|449843213|FG025|Overall Study|Withdrawal by Subject|0|||
125061829|NCT03655717|449843188|FG000|Overall Study|Physician Decision|3|||
125061830|NCT03655717|449843189|FG001|Overall Study|Physician Decision|3|||
125061831|NCT03655717|449843190|FG002|Overall Study|Physician Decision|0|||
125061832|NCT03655717|449843191|FG003|Overall Study|Physician Decision|0|||
125061833|NCT03655717|449843192|FG004|Overall Study|Physician Decision|0|||
125061834|NCT03655717|449843193|FG005|Overall Study|Physician Decision|0|||
125061835|NCT03655717|449843194|FG006|Overall Study|Physician Decision|0|||
125061836|NCT03655717|449843195|FG007|Overall Study|Physician Decision|0|||
125061837|NCT03655717|449843196|FG008|Overall Study|Physician Decision|0|||
125061838|NCT03655717|449843197|FG009|Overall Study|Physician Decision|1|||
125061839|NCT03655717|449843198|FG010|Overall Study|Physician Decision|0|||
125061840|NCT03655717|449843199|FG011|Overall Study|Physician Decision|0|||
125061841|NCT03655717|449843200|FG012|Overall Study|Physician Decision|0|||
125061842|NCT03655717|449843201|FG013|Overall Study|Physician Decision|0|||
125061843|NCT03655717|449843202|FG014|Overall Study|Physician Decision|0|||
125061844|NCT03655717|449843203|FG015|Overall Study|Physician Decision|0|||
125061845|NCT03655717|449843204|FG016|Overall Study|Physician Decision|0|||
125061846|NCT03655717|449843205|FG017|Overall Study|Physician Decision|0|||
125061847|NCT03655717|449843206|FG018|Overall Study|Physician Decision|0|||
125061848|NCT03655717|449843207|FG019|Overall Study|Physician Decision|1|||
125061849|NCT03655717|449843208|FG020|Overall Study|Physician Decision|0|||
125061850|NCT03655717|449843209|FG021|Overall Study|Physician Decision|0|||
125061851|NCT03655717|449843210|FG022|Overall Study|Physician Decision|0|||
125061852|NCT03655717|449843211|FG023|Overall Study|Physician Decision|1|||
125061853|NCT03655717|449843212|FG024|Overall Study|Physician Decision|0|||
125061854|NCT03655717|449843213|FG025|Overall Study|Physician Decision|0|||
125061855|NCT03655717|449843188|FG000|Overall Study|Lost to Follow-up|3|||
125061856|NCT03655717|449843189|FG001|Overall Study|Lost to Follow-up|1|||
125061857|NCT03655717|449843190|FG002|Overall Study|Lost to Follow-up|0|||
125061858|NCT03655717|449843191|FG003|Overall Study|Lost to Follow-up|1|||
125061859|NCT03655717|449843192|FG004|Overall Study|Lost to Follow-up|0|||
125061860|NCT03655717|449843193|FG005|Overall Study|Lost to Follow-up|1|||
125061861|NCT03655717|449843194|FG006|Overall Study|Lost to Follow-up|0|||
125061862|NCT03655717|449843195|FG007|Overall Study|Lost to Follow-up|0|||
125061863|NCT03655717|449843196|FG008|Overall Study|Lost to Follow-up|0|||
125061864|NCT03655717|449843197|FG009|Overall Study|Lost to Follow-up|0|||
125061865|NCT03655717|449843198|FG010|Overall Study|Lost to Follow-up|0|||
125061866|NCT03655717|449843199|FG011|Overall Study|Lost to Follow-up|1|||
125061867|NCT03655717|449843200|FG012|Overall Study|Lost to Follow-up|0|||
125061868|NCT03655717|449843201|FG013|Overall Study|Lost to Follow-up|0|||
125222413|NCT02659943|450442750|FG006|Overall Study|Switched to alternative treatment|1|||
125061869|NCT03655717|449843202|FG014|Overall Study|Lost to Follow-up|0|||
125061870|NCT03655717|449843203|FG015|Overall Study|Lost to Follow-up|0|||
125061871|NCT03655717|449843204|FG016|Overall Study|Lost to Follow-up|0|||
125061872|NCT03655717|449843205|FG017|Overall Study|Lost to Follow-up|0|||
125061873|NCT03655717|449843206|FG018|Overall Study|Lost to Follow-up|0|||
125061874|NCT03655717|449843207|FG019|Overall Study|Lost to Follow-up|0|||
125061875|NCT03655717|449843208|FG020|Overall Study|Lost to Follow-up|0|||
125061876|NCT03655717|449843209|FG021|Overall Study|Lost to Follow-up|0|||
125061877|NCT03655717|449843210|FG022|Overall Study|Lost to Follow-up|0|||
125061878|NCT03655717|449843211|FG023|Overall Study|Lost to Follow-up|0|||
125061879|NCT03655717|449843212|FG024|Overall Study|Lost to Follow-up|0|||
125061880|NCT03655717|449843213|FG025|Overall Study|Lost to Follow-up|0|||
125061881|NCT01185249|449843214|FG000|Overall Study|Patients discharged or change in status|42|||
125061882|NCT01208038|449843217|FG000|Overall Study|Withdrawal by Subject|1|||
125061883|NCT03003403|449843227|FG000|Overall Study|Ineligible|8|||
125061884|NCT03003403|449843228|FG001|Overall Study|Ineligible|7|||
125061885|NCT03003403|449843227|FG000|Overall Study|Withdrawal by Subject|3|||
125061886|NCT03003403|449843228|FG001|Overall Study|Withdrawal by Subject|1|||
125061887|NCT04124692|449845024|FG000|Overall Study|Medical reason|0|||
125061888|NCT04124692|449845025|FG001|Overall Study|Medical reason|1|||
125061889|NCT04124692|449845024|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
125061890|NCT04124692|449845025|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
125061891|NCT04124692|449845024|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
125061892|NCT04124692|449845025|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
125061893|NCT04124692|449845024|FG000|Overall Study|Lost to Follow-up|2|||
125061894|NCT04124692|449845025|FG001|Overall Study|Lost to Follow-up|4|||
125061895|NCT04124692|449845024|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
125061896|NCT04124692|449845025|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
125061897|NCT02370498|449845026|FG000|Overall Study|Adverse Event|10|||
125061898|NCT02370498|449845027|FG001|Overall Study|Adverse Event|8|||
125061899|NCT02370498|449845026|FG000|Overall Study|Death|263|||
125061900|NCT02370498|449845027|FG001|Overall Study|Death|265|||
125061901|NCT02370498|449845026|FG000|Overall Study|Protocol Violation|1|||
125061902|NCT02370498|449845027|FG001|Overall Study|Protocol Violation|2|||
125061903|NCT02370498|449845026|FG000|Overall Study|Withdrawal by Subject|7|||
125061904|NCT02370498|449845027|FG001|Overall Study|Withdrawal by Subject|12|||
125061905|NCT02370498|449845026|FG000|Overall Study|Sponsor's decision|15|||
125061906|NCT02370498|449845027|FG001|Overall Study|Sponsor's decision|9|||
125061907|NCT01453998|449845038|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
125061908|NCT01453998|449845039|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
125061909|NCT01453998|449845040|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
125061910|NCT01486784|449845041|FG000|Overall Study|Withdrawal by Subject|0|||
125061911|NCT01486784|449845042|FG001|Overall Study|Withdrawal by Subject|0|||
125061912|NCT01486784|449845043|FG002|Overall Study|Withdrawal by Subject|1|||
125061913|NCT01486784|449845044|FG003|Overall Study|Withdrawal by Subject|0|||
125061914|NCT01486784|449845045|FG004|Overall Study|Withdrawal by Subject|1|||
125061915|NCT01486784|449845046|FG005|Overall Study|Withdrawal by Subject|2|||
125061916|NCT01486784|449845041|FG000|Overall Study|Subject did not meet entry criteria|0|||
125061917|NCT01486784|449845042|FG001|Overall Study|Subject did not meet entry criteria|0|||
125061918|NCT01486784|449845043|FG002|Overall Study|Subject did not meet entry criteria|0|||
125061919|NCT01486784|449845044|FG003|Overall Study|Subject did not meet entry criteria|0|||
125061920|NCT01486784|449845045|FG004|Overall Study|Subject did not meet entry criteria|1|||
125061921|NCT01486784|449845046|FG005|Overall Study|Subject did not meet entry criteria|0|||
125061922|NCT01486784|449845041|FG000|Overall Study|Death|0|||
125061923|NCT01486784|449845042|FG001|Overall Study|Death|0|||
125061924|NCT01486784|449845043|FG002|Overall Study|Death|0|||
125061925|NCT01486784|449845044|FG003|Overall Study|Death|0|||
125061926|NCT01486784|449845045|FG004|Overall Study|Death|0|||
125061927|NCT01486784|449845046|FG005|Overall Study|Death|1|||
125061928|NCT03491553|449845047|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
125061929|NCT03491553|449845048|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
125061930|NCT03491553|449845049|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
125061931|NCT03491553|449845050|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
125061932|NCT03491553|449845051|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
125061933|NCT03491553|449845052|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
125061934|NCT03491553|449845047|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
125061935|NCT03491553|449845048|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
125061936|NCT03491553|449845049|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
125061937|NCT03491553|449845050|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
125061938|NCT03491553|449845051|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
125061939|NCT03491553|449845052|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
125061940|NCT00973921|449845055|FG000|Overall Study|IVUS results were not available|9|||
125061941|NCT00488592|449845056|FG000|Overall Study|Withdrawal by Subject|1|||
125061942|NCT00488592|449845056|FG000|Overall Study|Disease progression|1|||
125061943|NCT00488592|449845056|FG000|Overall Study|Enrolled but not treated|1|||
125061944|NCT01096849|449845061|FG000|Overall Study|Consent Withdrawn|1|||
125061945|NCT01096849|449845062|FG001|Overall Study|Consent Withdrawn|4|||
125061946|NCT01096849|449845063|FG002|Overall Study|Consent Withdrawn|2|||
125061947|NCT01096849|449845061|FG000|Overall Study|Lack of Efficacy|0|||
125061948|NCT01096849|449845062|FG001|Overall Study|Lack of Efficacy|2|||
125061949|NCT01096849|449845063|FG002|Overall Study|Lack of Efficacy|0|||
125061950|NCT01096849|449845061|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
125061951|NCT01096849|449845062|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
125061952|NCT01096849|449845063|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
125061953|NCT01096849|449845061|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
125061954|NCT01096849|449845062|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
125061955|NCT01096849|449845063|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
125061956|NCT01096849|449845061|FG000|Overall Study|Administrative Reasons|0|||
125061957|NCT01096849|449845062|FG001|Overall Study|Administrative Reasons|1|||
125061958|NCT01096849|449845063|FG002|Overall Study|Administrative Reasons|2|||
125061959|NCT01096849|449845061|FG000|Overall Study|Lost to Follow-up|1|||
125061960|NCT01096849|449845062|FG001|Overall Study|Lost to Follow-up|3|||
125061961|NCT01096849|449845063|FG002|Overall Study|Lost to Follow-up|1|||
125061962|NCT00242580|449845065|FG000|Overall Study|Adverse Event|3|||
125061963|NCT00242580|449845066|FG001|Overall Study|Adverse Event|0|||
125061964|NCT00242580|449845067|FG002|Overall Study|Adverse Event|2|||
125061965|NCT00242580|449845065|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
125061966|NCT00242580|449845066|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
125061967|NCT00242580|449845067|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
125061968|NCT00242580|449845065|FG000|Overall Study|Protocol Violation|0|||
125061969|NCT00242580|449845066|FG001|Overall Study|Protocol Violation|0|||
125061970|NCT00242580|449845067|FG002|Overall Study|Protocol Violation|1|||
125061971|NCT00242580|449845065|FG000|Overall Study|Subject withdrew consent|2|||
125061972|NCT00242580|449845066|FG001|Overall Study|Subject withdrew consent|2|||
125061973|NCT00242580|449845067|FG002|Overall Study|Subject withdrew consent|5|||
125061974|NCT00242580|449845065|FG000|Overall Study|Lost to Follow-up|0|||
125061975|NCT00242580|449845066|FG001|Overall Study|Lost to Follow-up|3|||
125061976|NCT00242580|449845067|FG002|Overall Study|Lost to Follow-up|0|||
125061977|NCT00242580|449845065|FG000|Overall Study|Death|1|||
125061978|NCT00242580|449845066|FG001|Overall Study|Death|2|||
125061979|NCT00242580|449845067|FG002|Overall Study|Death|1|||
125061980|NCT01232894|449845068|FG000|Overall Study|Lost to Follow-up|0|||
125061981|NCT01232894|449845069|FG001|Overall Study|Lost to Follow-up|1|||
125061982|NCT01232894|449845068|FG000|Overall Study|Death|1|||
125061983|NCT01232894|449845069|FG001|Overall Study|Death|0|||
125061984|NCT01232894|449845068|FG000|Overall Study|Protocol Violation|1|||
125061985|NCT01232894|449845069|FG001|Overall Study|Protocol Violation|1|||
125061986|NCT01232894|449845068|FG000|Overall Study|Withdrawal by Subject|8|||
125061987|NCT01232894|449845069|FG001|Overall Study|Withdrawal by Subject|5|||
125061988|NCT01232894|449845068|FG000|Overall Study|Physician Decision|2|||
125061989|NCT01232894|449845069|FG001|Overall Study|Physician Decision|1|||
125061990|NCT03970395|449845070|FG000|Overall Study|Withdrawal by Subject|3|||
125061991|NCT03970395|449845071|FG001|Overall Study|Withdrawal by Subject|4|||
125061992|NCT03970395|449845070|FG000|Overall Study|Lost to Follow-up|4|||
125061993|NCT03970395|449845071|FG001|Overall Study|Lost to Follow-up|8|||
125061994|NCT00125190|449845072|FG000|Overall Study|Subject/Parent Decision|7|||
125061995|NCT00125190|449845072|FG000|Overall Study|Non-compliance|2|||
125061996|NCT00125190|449845072|FG000|Overall Study|Adverse Event|1|||
125061997|NCT00125190|449845072|FG000|Overall Study|Other|1|||
125061998|NCT00125190|449845072|FG000|Overall Study|Lost to Follow-up|4|||
125061999|NCT00929734|449845074|FG000|Overall Study|Lost to Follow-up|2|||
125062000|NCT00929734|449845075|FG001|Overall Study|Lost to Follow-up|1|||
125062001|NCT00929734|449845074|FG000|Overall Study|Withdrawal by Subject|0|||
125062002|NCT00929734|449845075|FG001|Overall Study|Withdrawal by Subject|2|||
125062003|NCT00980980|449845076|FG000|Overall Study|Withdrawal by Hospital|0|||
125062004|NCT00980980|449845077|FG001|Overall Study|Withdrawal by Hospital|1|||
125062005|NCT00980980|449845078|FG002|Overall Study|Withdrawal by Hospital|0|||
125062006|NCT00414960|449845080|FG000|Overall Study|Adverse Event|4|||
125062007|NCT00414960|449845081|FG001|Overall Study|Adverse Event|0|||
125062008|NCT00414960|449845080|FG000|Overall Study|Withdrawal by Subject|3|||
125062009|NCT00414960|449845081|FG001|Overall Study|Withdrawal by Subject|0|||
125062010|NCT00414960|449845080|FG000|Overall Study|Physician Decision|0|||
125062011|NCT00414960|449845081|FG001|Overall Study|Physician Decision|1|||
125062012|NCT01449682|449845082|FG000|Overall Study|Death|0|||
125062013|NCT01449682|449845083|FG001|Overall Study|Death|1|||
125062014|NCT01449682|449845082|FG000|Overall Study|Adverse Event|1|||
125062015|NCT01449682|449845083|FG001|Overall Study|Adverse Event|0|||
125062016|NCT04863014|449845084|FG000|Overall Study|Lost to Follow-up|3|||
125062017|NCT04863014|449845085|FG001|Overall Study|Lost to Follow-up|2|||
125062018|NCT04863014|449845084|FG000|Overall Study|Subject Decision|0|||
125062019|NCT04863014|449845085|FG001|Overall Study|Subject Decision|4|||
125062020|NCT04633473|449845089|FG000|Overall Study|Withdrawal by Subject|6|||
125062021|NCT00264849|449845091|FG000|Overall Study|Adverse Event|7|||
125062022|NCT00264849|449845092|FG001|Overall Study|Adverse Event|2|||
125062023|NCT00264849|449845091|FG000|Overall Study|Withdrawal by Subject|7|||
125062024|NCT00264849|449845092|FG001|Overall Study|Withdrawal by Subject|11|||
125062025|NCT00264849|449845091|FG000|Overall Study|Protocol Violation|5|||
125062026|NCT00264849|449845092|FG001|Overall Study|Protocol Violation|3|||
125062027|NCT00264849|449845091|FG000|Overall Study|Lack of Efficacy|1|||
125062028|NCT00264849|449845092|FG001|Overall Study|Lack of Efficacy|6|||
125062029|NCT00264849|449845091|FG000|Overall Study|Lost to Follow-up|0|||
125062030|NCT00264849|449845092|FG001|Overall Study|Lost to Follow-up|2|||
125062031|NCT00264849|449845091|FG000|Overall Study|Death|0|||
125062032|NCT00264849|449845092|FG001|Overall Study|Death|1|||
125062033|NCT00264849|449845091|FG000|Overall Study|Administrative Problems|2|||
125062034|NCT00264849|449845092|FG001|Overall Study|Administrative Problems|0|||
125062035|NCT01982773|449845093|FG000|Overall Study|Withdrawal by Subject|1|||
125062036|NCT01982773|449845094|FG001|Overall Study|Withdrawal by Subject|3|||
125062037|NCT01982773|449845093|FG000|Overall Study|Lost to Follow-up|7|||
125062038|NCT01982773|449845094|FG001|Overall Study|Lost to Follow-up|1|||
125062039|NCT03294681|449845095|FG000|Overall Study|Withdrawal by Subject|1|||
125062040|NCT00417976|449845100|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
125062041|NCT00417976|449845100|FG000|Overall Study|Treatment -related toxicity|2|||
125062042|NCT04348591|449845101|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
125062043|NCT04348591|449845102|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
125062044|NCT04348591|449845101|FG000|Imaging Session (120 Min)|Physician Decision|0|||
125062045|NCT04348591|449845102|FG001|Imaging Session (120 Min)|Physician Decision|1|||
125062046|NCT04348591|449845101|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
125062047|NCT04348591|449845102|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
125062048|NCT01778127|449845103|FG000|Overall Study|Lost to Follow-up|5|||
125062049|NCT01778127|449845104|FG001|Overall Study|Lost to Follow-up|1|||
125062050|NCT01778127|449845105|FG002|Overall Study|Lost to Follow-up|2|||
125062051|NCT01778127|449845103|FG000|Overall Study|Withdrawal by Subject|3|||
125062052|NCT01778127|449845104|FG001|Overall Study|Withdrawal by Subject|1|||
125062053|NCT01778127|449845105|FG002|Overall Study|Withdrawal by Subject|4|||
125062054|NCT01348425|449845106|FG000|Overall Study|Imaging was not taken.|1|||
125062055|NCT01348425|449845107|FG001|Overall Study|Imaging was not taken.|1|||
125062056|NCT02104804|449845108|FG000|Overall Study|Did not take study medication|0|||
125062057|NCT02104804|449845109|FG001|Overall Study|Did not take study medication|1|||
125062058|NCT02104804|449845108|FG000|Overall Study|Study specific discontinuation criteria|6|||
125062059|NCT02104804|449845109|FG001|Overall Study|Study specific discontinuation criteria|1|||
125062060|NCT02104804|449845108|FG000|Overall Study|Other listed|2|||
125062061|NCT02104804|449845109|FG001|Overall Study|Other listed|1|||
125062062|NCT02104804|449845108|FG000|Overall Study|Protocol Violation|0|||
125062063|NCT02104804|449845109|FG001|Overall Study|Protocol Violation|1|||
125062064|NCT02104804|449845108|FG000|Overall Study|Adverse Event|4|||
125062065|NCT02104804|449845109|FG001|Overall Study|Adverse Event|3|||
125062066|NCT02104804|449845108|FG000|Overall Study|Withdrawal by Subject|4|||
125062067|NCT02104804|449845109|FG001|Overall Study|Withdrawal by Subject|12|||
125062068|NCT03722784|449845112|FG000|Overall Study|Withdrawal by Subject|1|||
125062069|NCT03722784|449845113|FG001|Overall Study|Withdrawal by Subject|0|||
125062070|NCT03722784|449845112|FG000|Overall Study|Physician Decision|1|||
125062071|NCT03722784|449845113|FG001|Overall Study|Physician Decision|1|||
125062072|NCT03722784|449845112|FG000|Overall Study|Protocol Violation|0|||
125062073|NCT03722784|449845113|FG001|Overall Study|Protocol Violation|1|||
125062074|NCT05319080|449845117|FG000|Overall Study|Withdrawal by Subject|2|||
125062075|NCT05319080|449845117|FG000|Overall Study|Physician Decision|4|||
125062076|NCT00751114|449845118|FG000|Overall Study|Adverse Event|2|||
125062077|NCT00751114|449845119|FG001|Overall Study|Adverse Event|4|||
125062078|NCT00751114|449845118|FG000|Overall Study|Protocol Violation|8|||
125062079|NCT00751114|449845119|FG001|Overall Study|Protocol Violation|9|||
125062080|NCT00751114|449845118|FG000|Overall Study|Withdrawal by Subject|9|||
125062081|NCT00751114|449845119|FG001|Overall Study|Withdrawal by Subject|4|||
125062082|NCT00751114|449845118|FG000|Overall Study|Lost to Follow-up|4|||
125062083|NCT00751114|449845119|FG001|Overall Study|Lost to Follow-up|7|||
125062084|NCT00751114|449845118|FG000|Overall Study|Lack of Efficacy|0|||
125062085|NCT00751114|449845119|FG001|Overall Study|Lack of Efficacy|7|||
125062086|NCT00751114|449845118|FG000|Overall Study|Not Treated|13|||
125062087|NCT00751114|449845119|FG001|Overall Study|Not Treated|1|||
125062088|NCT00751114|449845118|FG000|Overall Study|Out of country for 2 months|1|||
125062089|NCT00751114|449845119|FG001|Overall Study|Out of country for 2 months|0|||
125062090|NCT00751114|449845118|FG000|Overall Study|Move to another city|1|||
125062091|NCT00751114|449845119|FG001|Overall Study|Move to another city|0|||
125062092|NCT02648724|449845122|FG000|Overall Study|Withdrawal by Subject|0|||
125062093|NCT02648724|449845123|FG001|Overall Study|Withdrawal by Subject|1|||
125062094|NCT02648724|449845124|FG002|Overall Study|Withdrawal by Subject|1|||
125062095|NCT02648724|449845125|FG003|Overall Study|Withdrawal by Subject|0|||
125062096|NCT02648724|449845126|FG004|Overall Study|Withdrawal by Subject|1|||
125062097|NCT02648724|449845127|FG005|Overall Study|Withdrawal by Subject|0|||
125062098|NCT02648724|449845128|FG006|Overall Study|Withdrawal by Subject|0|||
125062099|NCT02648724|449845122|FG000|Overall Study|Progressive disease|2|||
125062100|NCT02648724|449845123|FG001|Overall Study|Progressive disease|2|||
125062101|NCT02648724|449845124|FG002|Overall Study|Progressive disease|2|||
125062102|NCT02648724|449845125|FG003|Overall Study|Progressive disease|3|||
125062103|NCT02648724|449845126|FG004|Overall Study|Progressive disease|22|||
125062104|NCT02648724|449845127|FG005|Overall Study|Progressive disease|7|||
125062105|NCT02648724|449845128|FG006|Overall Study|Progressive disease|8|||
125062106|NCT02648724|449845122|FG000|Overall Study|Other reason (unknown)|1|||
125062107|NCT02648724|449845123|FG001|Overall Study|Other reason (unknown)|0|||
125139346|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
125062108|NCT02648724|449845124|FG002|Overall Study|Other reason (unknown)|0|||
125062109|NCT02648724|449845125|FG003|Overall Study|Other reason (unknown)|0|||
125062110|NCT02648724|449845126|FG004|Overall Study|Other reason (unknown)|0|||
125062111|NCT02648724|449845127|FG005|Overall Study|Other reason (unknown)|0|||
125062112|NCT02648724|449845128|FG006|Overall Study|Other reason (unknown)|0|||
125062113|NCT02648724|449845122|FG000|Overall Study|Protocol Violation|0|||
125062114|NCT02648724|449845123|FG001|Overall Study|Protocol Violation|0|||
125062115|NCT02648724|449845124|FG002|Overall Study|Protocol Violation|0|||
125062116|NCT02648724|449845125|FG003|Overall Study|Protocol Violation|0|||
125062117|NCT02648724|449845126|FG004|Overall Study|Protocol Violation|1|||
125062118|NCT02648724|449845127|FG005|Overall Study|Protocol Violation|0|||
125062119|NCT02648724|449845128|FG006|Overall Study|Protocol Violation|0|||
125062120|NCT02648724|449845122|FG000|Overall Study|Death|0|||
125062121|NCT02648724|449845123|FG001|Overall Study|Death|0|||
125062122|NCT02648724|449845124|FG002|Overall Study|Death|0|||
125062123|NCT02648724|449845125|FG003|Overall Study|Death|0|||
125062124|NCT02648724|449845126|FG004|Overall Study|Death|0|||
125062125|NCT02648724|449845127|FG005|Overall Study|Death|0|||
125062126|NCT02648724|449845128|FG006|Overall Study|Death|3|||
125062127|NCT02648724|449845122|FG000|Overall Study|Physician Decision|0|||
125062128|NCT02648724|449845123|FG001|Overall Study|Physician Decision|0|||
125062129|NCT02648724|449845124|FG002|Overall Study|Physician Decision|0|||
125062130|NCT02648724|449845125|FG003|Overall Study|Physician Decision|0|||
125062131|NCT02648724|449845126|FG004|Overall Study|Physician Decision|1|||
125062132|NCT02648724|449845127|FG005|Overall Study|Physician Decision|0|||
125139347|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
125139348|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
125139349|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
125139350|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
125139351|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
125139352|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
125139353|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
125139354|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
125139355|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
125139356|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
125139357|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
125062133|NCT02648724|449845128|FG006|Overall Study|Physician Decision|1|||
125062134|NCT02648724|449845122|FG000|Overall Study|Transferred to named patient program|0|||
125062135|NCT02648724|449845123|FG001|Overall Study|Transferred to named patient program|0|||
125062136|NCT02648724|449845124|FG002|Overall Study|Transferred to named patient program|0|||
125062137|NCT02648724|449845125|FG003|Overall Study|Transferred to named patient program|0|||
125062138|NCT02648724|449845126|FG004|Overall Study|Transferred to named patient program|0|||
125062139|NCT02648724|449845127|FG005|Overall Study|Transferred to named patient program|1|||
125062140|NCT02648724|449845128|FG006|Overall Study|Transferred to named patient program|0|||
125062141|NCT03076190|449845129|FG000|Overall Study|Lost to Follow-up|9|||
125062142|NCT03076190|449845130|FG001|Overall Study|Lost to Follow-up|34|||
125062143|NCT03076190|449845129|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
125062144|NCT03076190|449845130|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
125062145|NCT00406783|449845131|FG000|Overall Study|Adverse Event|4|||
125062146|NCT00406783|449845132|FG001|Overall Study|Adverse Event|4|||
125062147|NCT00406783|449845131|FG000|Overall Study|Treatment Failure|2|||
125062148|NCT00406783|449845132|FG001|Overall Study|Treatment Failure|3|||
125062149|NCT00406783|449845131|FG000|Overall Study|Lost to Follow-up|3|||
125062150|NCT00406783|449845132|FG001|Overall Study|Lost to Follow-up|0|||
125062151|NCT00406783|449845131|FG000|Overall Study|Withdrawal by Subject|1|||
125062152|NCT00406783|449845132|FG001|Overall Study|Withdrawal by Subject|4|||
125062153|NCT00406783|449845131|FG000|Overall Study|Protocol Violation|4|||
125139358|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
125062154|NCT00406783|449845132|FG001|Overall Study|Protocol Violation|4|||
125062155|NCT00064350|449845133|FG000|Induction Treatment|Disease Progression|5|||
125062156|NCT00064350|449845134|FG001|Induction Treatment|Disease Progression|1|||
125062157|NCT00064350|449845135|FG002|Induction Treatment|Disease Progression|110|||
125062158|NCT00064350|449845133|FG000|Induction Treatment|Adverse Event|0|||
125062159|NCT00064350|449845134|FG001|Induction Treatment|Adverse Event|2|||
125062160|NCT00064350|449845135|FG002|Induction Treatment|Adverse Event|49|||
125062161|NCT00064350|449845133|FG000|Induction Treatment|Death|0|||
125062162|NCT00064350|449845134|FG001|Induction Treatment|Death|0|||
125062163|NCT00064350|449845135|FG002|Induction Treatment|Death|9|||
125062164|NCT00064350|449845133|FG000|Induction Treatment|Withdrawal by Subject|0|||
125062165|NCT00064350|449845134|FG001|Induction Treatment|Withdrawal by Subject|0|||
125062166|NCT00064350|449845135|FG002|Induction Treatment|Withdrawal by Subject|21|||
125062167|NCT00064350|449845133|FG000|Induction Treatment|Ineligible or never started treatment|3|||
125062168|NCT00064350|449845134|FG001|Induction Treatment|Ineligible or never started treatment|6|||
125062169|NCT00064350|449845135|FG002|Induction Treatment|Ineligible or never started treatment|34|||
125062170|NCT00064350|449845133|FG000|Induction Treatment|Other|0|||
125062171|NCT00064350|449845134|FG001|Induction Treatment|Other|0|||
125062172|NCT00064350|449845135|FG002|Induction Treatment|Other|13|||
125062173|NCT00064350|449845133|FG000|Randomization|Adverse Event|8|||
125062174|NCT00064350|449845134|FG001|Randomization|Adverse Event|3|||
125062175|NCT00064350|449845135|FG002|Randomization|Adverse Event|0|||
125062176|NCT00064350|449845133|FG000|Randomization|Death|3|||
125062177|NCT00064350|449845134|FG001|Randomization|Death|0|||
125062178|NCT00064350|449845135|FG002|Randomization|Death|0|||
125062179|NCT00064350|449845133|FG000|Randomization|Withdrawal by Subject|1|||
125062180|NCT00064350|449845134|FG001|Randomization|Withdrawal by Subject|0|||
125062181|NCT00064350|449845135|FG002|Randomization|Withdrawal by Subject|0|||
125062182|NCT00064350|449845133|FG000|Randomization|Ineligible or never started treatment|9|||
125062183|NCT00064350|449845134|FG001|Randomization|Ineligible or never started treatment|15|||
125062184|NCT00064350|449845135|FG002|Randomization|Ineligible or never started treatment|0|||
125062185|NCT00064350|449845133|FG000|Randomization|Other|5|||
125062186|NCT00064350|449845134|FG001|Randomization|Other|0|||
125062187|NCT00064350|449845135|FG002|Randomization|Other|0|||
125062188|NCT00064350|449845133|FG000|Cross-Over|Adverse Event|0|||
125062189|NCT00064350|449845134|FG001|Cross-Over|Adverse Event|1|||
125062190|NCT00064350|449845135|FG002|Cross-Over|Adverse Event|0|||
125062191|NCT00064350|449845133|FG000|Cross-Over|Death|1|||
125062192|NCT00064350|449845134|FG001|Cross-Over|Death|3|||
125062193|NCT00064350|449845135|FG002|Cross-Over|Death|0|||
125062194|NCT00064350|449845133|FG000|Cross-Over|Withdrawal by Subject|2|||
125062195|NCT00064350|449845134|FG001|Cross-Over|Withdrawal by Subject|2|||
125062196|NCT00064350|449845135|FG002|Cross-Over|Withdrawal by Subject|0|||
125062197|NCT00064350|449845133|FG000|Cross-Over|Ineligible or never started treatment|3|||
125062198|NCT00064350|449845134|FG001|Cross-Over|Ineligible or never started treatment|6|||
125062199|NCT00064350|449845135|FG002|Cross-Over|Ineligible or never started treatment|0|||
125062200|NCT00064350|449845133|FG000|Cross-Over|Other|0|||
125062201|NCT00064350|449845134|FG001|Cross-Over|Other|2|||
125062202|NCT00064350|449845135|FG002|Cross-Over|Other|0|||
125062203|NCT00012012|449845136|FG000|Overall Study|Protocol Violation|1|||
125062204|NCT00012012|449845137|FG001|Overall Study|Protocol Violation|1|||
125062205|NCT00012012|449845136|FG000|Overall Study|Withdrawal by Subject|0|||
125062206|NCT00012012|449845137|FG001|Overall Study|Withdrawal by Subject|2|||
125062207|NCT02034474|449845138|FG000|Overall Study|Adverse Event|3|||
125062208|NCT02034474|449845139|FG001|Overall Study|Adverse Event|2|||
125062209|NCT02034474|449845138|FG000|Overall Study|Withdrawal by Subject|1|||
125062210|NCT02034474|449845139|FG001|Overall Study|Withdrawal by Subject|2|||
125062211|NCT01391819|449845140|FG000|Overall Study|Withdrawal by Subject|56|||
125062212|NCT01391819|449845140|FG000|Overall Study|Migrated/moved from study area|82|||
125139359|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
125139360|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
125139361|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
125139362|NCT04194801|450132847|FG000|Part Ib/II End of Study|Death|2|||
125139363|NCT04194801|450132848|FG001|Part Ib/II End of Study|Death|3|||
125062213|NCT01391819|449845140|FG000|Overall Study|Lost to Follow-up|252|||
125139364|NCT04194801|450132849|FG002|Part Ib/II End of Study|Death|3|||
125139365|NCT04194801|450132847|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
125139366|NCT04194801|450132848|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
125139367|NCT04194801|450132849|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
125139368|NCT04194801|450132847|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
125139369|NCT04194801|450132848|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
125062214|NCT01391819|449845140|FG000|Overall Study|Death|3|||
125062215|NCT01391819|449845140|FG000|Overall Study|Other|9|||
125062216|NCT00808249|449845143|FG000|Overall Study|Adverse Event|4|||
125062217|NCT00808249|449845144|FG001|Overall Study|Adverse Event|7|||
125062218|NCT00808249|449845145|FG002|Overall Study|Adverse Event|10|||
125062219|NCT00808249|449845146|FG003|Overall Study|Adverse Event|6|||
125062220|NCT00808249|449845143|FG000|Overall Study|Lost to Follow-up|2|||
125062221|NCT00808249|449845144|FG001|Overall Study|Lost to Follow-up|3|||
125062222|NCT00808249|449845145|FG002|Overall Study|Lost to Follow-up|3|||
125062223|NCT00808249|449845146|FG003|Overall Study|Lost to Follow-up|5|||
125062224|NCT00808249|449845143|FG000|Overall Study|Withdrawal by Subject|4|||
125062225|NCT00808249|449845144|FG001|Overall Study|Withdrawal by Subject|0|||
125062226|NCT00808249|449845145|FG002|Overall Study|Withdrawal by Subject|2|||
125062227|NCT00808249|449845146|FG003|Overall Study|Withdrawal by Subject|4|||
125139370|NCT04194801|450132849|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
125139371|NCT04194801|450132847|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
125062228|NCT00808249|449845143|FG000|Overall Study|Protocol Violation|3|||
125062229|NCT00808249|449845144|FG001|Overall Study|Protocol Violation|3|||
125062230|NCT00808249|449845145|FG002|Overall Study|Protocol Violation|3|||
125062231|NCT00808249|449845146|FG003|Overall Study|Protocol Violation|0|||
125062232|NCT00808249|449845143|FG000|Overall Study|Lack of Efficacy|1|||
125062233|NCT00808249|449845144|FG001|Overall Study|Lack of Efficacy|1|||
125062234|NCT00808249|449845145|FG002|Overall Study|Lack of Efficacy|0|||
125062235|NCT00808249|449845146|FG003|Overall Study|Lack of Efficacy|0|||
125062236|NCT00808249|449845143|FG000|Overall Study|study specific discontinuation criteria|1|||
125062237|NCT00808249|449845144|FG001|Overall Study|study specific discontinuation criteria|0|||
125062238|NCT00808249|449845145|FG002|Overall Study|study specific discontinuation criteria|1|||
125062239|NCT00808249|449845146|FG003|Overall Study|study specific discontinuation criteria|0|||
125062240|NCT00808249|449845143|FG000|Overall Study|All other reasons|2|||
125062241|NCT00808249|449845144|FG001|Overall Study|All other reasons|1|||
125062242|NCT00808249|449845145|FG002|Overall Study|All other reasons|3|||
125062243|NCT00808249|449845146|FG003|Overall Study|All other reasons|1|||
125062244|NCT00479557|449845147|FG000|Overall Study|Death|0|||
125062245|NCT00479557|449845148|FG001|Overall Study|Death|0|||
125062246|NCT00479557|449845149|FG002|Overall Study|Death|0|||
125062247|NCT00479557|449845150|FG003|Overall Study|Death|0|||
125062248|NCT00479557|449845151|FG004|Overall Study|Death|0|||
125062249|NCT00479557|449845152|FG005|Overall Study|Death|1|||
125062250|NCT00479557|449845153|FG006|Overall Study|Death|0|||
125062251|NCT00479557|449845147|FG000|Overall Study|Lack of Efficacy|1|||
125062252|NCT00479557|449845148|FG001|Overall Study|Lack of Efficacy|0|||
125062253|NCT00479557|449845149|FG002|Overall Study|Lack of Efficacy|0|||
125062254|NCT00479557|449845150|FG003|Overall Study|Lack of Efficacy|0|||
125062255|NCT00479557|449845151|FG004|Overall Study|Lack of Efficacy|0|||
125062256|NCT00479557|449845152|FG005|Overall Study|Lack of Efficacy|0|||
125062257|NCT00479557|449845153|FG006|Overall Study|Lack of Efficacy|0|||
125062258|NCT00479557|449845147|FG000|Overall Study|Lost to Follow-up|0|||
125062259|NCT00479557|449845148|FG001|Overall Study|Lost to Follow-up|2|||
125062260|NCT00479557|449845149|FG002|Overall Study|Lost to Follow-up|0|||
125062261|NCT00479557|449845150|FG003|Overall Study|Lost to Follow-up|2|||
125062262|NCT00479557|449845151|FG004|Overall Study|Lost to Follow-up|0|||
125062263|NCT00479557|449845152|FG005|Overall Study|Lost to Follow-up|0|||
125062264|NCT00479557|449845153|FG006|Overall Study|Lost to Follow-up|0|||
125062265|NCT00479557|449845147|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
125062266|NCT00479557|449845148|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
125062267|NCT00479557|449845149|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
125062268|NCT00479557|449845150|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
125062269|NCT00479557|449845151|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
125062270|NCT00479557|449845152|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
125062271|NCT00479557|449845153|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
125062272|NCT00479557|449845147|FG000|Overall Study|AE not related to Study Drug|1|||
125062273|NCT00479557|449845148|FG001|Overall Study|AE not related to Study Drug|3|||
125062274|NCT00479557|449845149|FG002|Overall Study|AE not related to Study Drug|0|||
125062275|NCT00479557|449845150|FG003|Overall Study|AE not related to Study Drug|0|||
125062276|NCT00479557|449845151|FG004|Overall Study|AE not related to Study Drug|2|||
125062277|NCT00479557|449845152|FG005|Overall Study|AE not related to Study Drug|2|||
125062278|NCT00479557|449845153|FG006|Overall Study|AE not related to Study Drug|1|||
125062279|NCT00479557|449845147|FG000|Overall Study|Caregiver Request|2|||
125062280|NCT00479557|449845148|FG001|Overall Study|Caregiver Request|2|||
125062281|NCT00479557|449845149|FG002|Overall Study|Caregiver Request|2|||
125062282|NCT00479557|449845150|FG003|Overall Study|Caregiver Request|0|||
125062283|NCT00479557|449845151|FG004|Overall Study|Caregiver Request|1|||
125062284|NCT00479557|449845152|FG005|Overall Study|Caregiver Request|2|||
125062285|NCT00479557|449845153|FG006|Overall Study|Caregiver Request|0|||
125062286|NCT00479557|449845147|FG000|Overall Study|Investigator Request|0|||
125062287|NCT00479557|449845148|FG001|Overall Study|Investigator Request|0|||
125062288|NCT00479557|449845149|FG002|Overall Study|Investigator Request|1|||
125062289|NCT00479557|449845150|FG003|Overall Study|Investigator Request|0|||
125062290|NCT00479557|449845151|FG004|Overall Study|Investigator Request|0|||
125062291|NCT00479557|449845152|FG005|Overall Study|Investigator Request|0|||
125062292|NCT00479557|449845153|FG006|Overall Study|Investigator Request|0|||
125062293|NCT00479557|449845147|FG000|Overall Study|Subject Request|3|||
125062294|NCT00479557|449845148|FG001|Overall Study|Subject Request|0|||
125062295|NCT00479557|449845149|FG002|Overall Study|Subject Request|1|||
125062296|NCT00479557|449845150|FG003|Overall Study|Subject Request|1|||
125062297|NCT00479557|449845151|FG004|Overall Study|Subject Request|1|||
125062298|NCT00479557|449845152|FG005|Overall Study|Subject Request|4|||
125062299|NCT00479557|449845153|FG006|Overall Study|Subject Request|1|||
125062300|NCT00479557|449845147|FG000|Overall Study|Other|2|||
125062301|NCT00479557|449845148|FG001|Overall Study|Other|3|||
125062302|NCT00479557|449845149|FG002|Overall Study|Other|1|||
125062303|NCT00479557|449845150|FG003|Overall Study|Other|0|||
125062304|NCT00479557|449845151|FG004|Overall Study|Other|0|||
125062305|NCT00479557|449845152|FG005|Overall Study|Other|3|||
125062306|NCT00479557|449845153|FG006|Overall Study|Other|0|||
125062307|NCT02509494|449845156|FG000|Overall Study|Lost to Follow-up|8|||
125062308|NCT02509494|449845157|FG001|Overall Study|Lost to Follow-up|47|||
125062309|NCT02509494|449845158|FG002|Overall Study|Lost to Follow-up|19|||
125062310|NCT02509494|449845159|FG003|Overall Study|Lost to Follow-up|6|||
125062311|NCT02509494|449845160|FG004|Overall Study|Lost to Follow-up|3|||
125062312|NCT02509494|449845161|FG005|Overall Study|Lost to Follow-up|3|||
125062313|NCT02509494|449845162|FG006|Overall Study|Lost to Follow-up|1|||
125062314|NCT02509494|449845163|FG007|Overall Study|Lost to Follow-up|3|||
125062315|NCT02509494|449845164|FG008|Overall Study|Lost to Follow-up|1|||
125062316|NCT02509494|449845156|FG000|Overall Study|Physician Decision|2|||
125139372|NCT04194801|450132848|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
125139373|NCT04194801|450132849|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
125139374|NCT04194801|450132847|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
125139375|NCT04194801|450132848|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
125139376|NCT04194801|450132849|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
125139377|NCT00294047|450132850|FG000|Month 48|Adverse Event|28|||
125139378|NCT00294047|450132851|FG001|Month 48|Adverse Event|13|||
125139379|NCT00294047|450132850|FG000|Month 48|Protocol Violation|4|||
125139380|NCT00294047|450132851|FG001|Month 48|Protocol Violation|4|||
125139381|NCT00294047|450132850|FG000|Month 48|Withdrawal by Subject|111|||
125062317|NCT02509494|449845157|FG001|Overall Study|Physician Decision|1|||
125062318|NCT02509494|449845158|FG002|Overall Study|Physician Decision|0|||
125062319|NCT02509494|449845159|FG003|Overall Study|Physician Decision|0|||
125062320|NCT02509494|449845160|FG004|Overall Study|Physician Decision|0|||
125062321|NCT02509494|449845161|FG005|Overall Study|Physician Decision|0|||
125062322|NCT02509494|449845162|FG006|Overall Study|Physician Decision|0|||
125062323|NCT02509494|449845163|FG007|Overall Study|Physician Decision|0|||
125062324|NCT02509494|449845164|FG008|Overall Study|Physician Decision|0|||
125062325|NCT02509494|449845156|FG000|Overall Study|Withdrawal by Subject|4|||
125062326|NCT02509494|449845157|FG001|Overall Study|Withdrawal by Subject|17|||
125062327|NCT02509494|449845158|FG002|Overall Study|Withdrawal by Subject|7|||
125062328|NCT02509494|449845159|FG003|Overall Study|Withdrawal by Subject|5|||
125062329|NCT02509494|449845160|FG004|Overall Study|Withdrawal by Subject|0|||
125062330|NCT02509494|449845161|FG005|Overall Study|Withdrawal by Subject|6|||
125062331|NCT02509494|449845162|FG006|Overall Study|Withdrawal by Subject|1|||
125062332|NCT02509494|449845163|FG007|Overall Study|Withdrawal by Subject|2|||
125062333|NCT02509494|449845164|FG008|Overall Study|Withdrawal by Subject|1|||
125062334|NCT02509494|449845156|FG000|Overall Study|Death|0|||
125062335|NCT02509494|449845157|FG001|Overall Study|Death|1|||
125062336|NCT02509494|449845158|FG002|Overall Study|Death|0|||
125062337|NCT02509494|449845159|FG003|Overall Study|Death|0|||
125062338|NCT02509494|449845160|FG004|Overall Study|Death|1|||
125062339|NCT02509494|449845161|FG005|Overall Study|Death|0|||
125062340|NCT02509494|449845162|FG006|Overall Study|Death|0|||
125062341|NCT02509494|449845163|FG007|Overall Study|Death|1|||
125062342|NCT02509494|449845164|FG008|Overall Study|Death|0|||
125062343|NCT02509494|449845156|FG000|Overall Study|Other|0|||
125062344|NCT02509494|449845157|FG001|Overall Study|Other|4|||
125062345|NCT02509494|449845158|FG002|Overall Study|Other|5|||
125062346|NCT02509494|449845159|FG003|Overall Study|Other|0|||
125062347|NCT02509494|449845160|FG004|Overall Study|Other|0|||
125062348|NCT02509494|449845161|FG005|Overall Study|Other|0|||
125062349|NCT02509494|449845162|FG006|Overall Study|Other|0|||
125062350|NCT02509494|449845163|FG007|Overall Study|Other|0|||
125062351|NCT02509494|449845164|FG008|Overall Study|Other|0|||
125062352|NCT02509494|449845156|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125062353|NCT02509494|449845157|FG001|Overall Study|Non-Compliance With Study Drug|11|||
125062354|NCT02509494|449845158|FG002|Overall Study|Non-Compliance With Study Drug|7|||
125062355|NCT02509494|449845159|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125062356|NCT02509494|449845160|FG004|Overall Study|Non-Compliance With Study Drug|1|||
125062357|NCT02509494|449845161|FG005|Overall Study|Non-Compliance With Study Drug|2|||
125139382|NCT00294047|450132851|FG001|Month 48|Withdrawal by Subject|115|||
125139383|NCT00294047|450132850|FG000|Month 48|Lost to Follow-up|272|||
125139384|NCT00294047|450132851|FG001|Month 48|Lost to Follow-up|287|||
125139385|NCT00294047|450132850|FG000|Month 48|Other|10|||
125139386|NCT00294047|450132851|FG001|Month 48|Other|14|||
125222414|NCT02659943|450442744|FG000|Overall Study|Disease progression on study|0|||
125062358|NCT02509494|449845162|FG006|Overall Study|Non-Compliance With Study Drug|1|||
125139387|NCT00294047|450132850|FG000|Month 84|Adverse Event|4|||
125139388|NCT00294047|450132851|FG001|Month 84|Adverse Event|2|||
125062359|NCT02509494|449845163|FG007|Overall Study|Non-Compliance With Study Drug|1|||
125062360|NCT02509494|449845164|FG008|Overall Study|Non-Compliance With Study Drug|0|||
125062361|NCT02871401|449846629|FG000|Overall Study|Adverse Event|1|||
125062362|NCT02871401|449846630|FG001|Overall Study|Adverse Event|0|||
125062363|NCT01120379|449846631|FG000|One Year Timepoint|Withdrawal by Subject|41|||
125062364|NCT01120379|449846631|FG000|One Year Timepoint|Lost to Follow-up|115|||
125062365|NCT01120379|449846631|FG000|One Year Timepoint|Death|108|||
125062366|NCT01120379|449846631|FG000|One Year Timepoint|Physician Decision|9|||
125062367|NCT01120379|449846631|FG000|One Year Timepoint|Any other reason for early termination|5|||
125062368|NCT01120379|449846631|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
125062369|NCT01120379|449846631|FG000|Two Year Timepoint|Lost to Follow-up|87|||
125062370|NCT01120379|449846631|FG000|Two Year Timepoint|Death|123|||
125062371|NCT01120379|449846631|FG000|Two Year Timepoint|Physician Decision|12|||
125062372|NCT01120379|449846631|FG000|Two Year Timepoint|Any other reason for early termination|4|||
125062373|NCT01120379|449846631|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
125062374|NCT01120379|449846631|FG000|Three Year Timepoint|Lost to Follow-up|43|||
125062375|NCT01120379|449846631|FG000|Three Year Timepoint|Death|120|||
125062376|NCT01120379|449846631|FG000|Three Year Timepoint|Physician Decision|9|||
125062377|NCT01120379|449846631|FG000|Three Year Timepoint|Any other reason for early termination|17|||
125062378|NCT01120379|449846631|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
125062379|NCT01120379|449846631|FG000|Four Year Timepoint|Lost to Follow-up|10|||
125062380|NCT01120379|449846631|FG000|Four Year Timepoint|Death|131|||
125062381|NCT01120379|449846631|FG000|Four Year Timepoint|Physician Decision|5|||
125062382|NCT01120379|449846631|FG000|Four Year Timepoint|Any other reason for early termination|217|||
125062383|NCT03162055|449846632|FG000|Overall Study|Adverse Event|6|||
125062384|NCT03162055|449846633|FG001|Overall Study|Adverse Event|5|||
125062385|NCT03162055|449846632|FG000|Overall Study|Death|3|||
125062386|NCT03162055|449846633|FG001|Overall Study|Death|3|||
125062387|NCT03162055|449846632|FG000|Overall Study|Lost to Follow-up|0|||
125062388|NCT03162055|449846633|FG001|Overall Study|Lost to Follow-up|1|||
125062389|NCT03162055|449846632|FG000|Overall Study|Study-specific withdrawal criteria|22|||
125062390|NCT03162055|449846633|FG001|Overall Study|Study-specific withdrawal criteria|14|||
125062391|NCT03162055|449846632|FG000|Overall Study|Withdrawal by Subject|17|||
125062392|NCT03162055|449846633|FG001|Overall Study|Withdrawal by Subject|2|||
125062393|NCT03162055|449846632|FG000|Overall Study|Did not receive treatment|2|||
125062394|NCT03162055|449846633|FG001|Overall Study|Did not receive treatment|0|||
125062395|NCT03162055|449846632|FG000|Overall Study|Incorrect randomization|4|||
125062396|NCT03162055|449846633|FG001|Overall Study|Incorrect randomization|3|||
125062397|NCT03162055|449846632|FG000|Overall Study|Other|8|||
125062398|NCT03162055|449846633|FG001|Overall Study|Other|15|||
125062399|NCT01617655|449846634|FG000|Overall Study|Adverse Event|2|||
125062400|NCT01617655|449846635|FG001|Overall Study|Adverse Event|3|||
125062401|NCT01617655|449846634|FG000|Overall Study|Poor compliance to protocol|1|||
125062402|NCT01617655|449846635|FG001|Overall Study|Poor compliance to protocol|4|||
125062403|NCT01617655|449846634|FG000|Overall Study|Participants moved|0|||
125062404|NCT01617655|449846635|FG001|Overall Study|Participants moved|4|||
125062405|NCT01617655|449846634|FG000|Overall Study|Consent withdrawn by participant|1|||
125062406|NCT01617655|449846635|FG001|Overall Study|Consent withdrawn by participant|1|||
125062407|NCT01617655|449846634|FG000|Overall Study|Last visit outside protocol visit window|1|||
125062408|NCT01617655|449846635|FG001|Overall Study|Last visit outside protocol visit window|10|||
125062409|NCT01617655|449846634|FG000|Overall Study|Site closure|3|||
125062410|NCT01617655|449846635|FG001|Overall Study|Site closure|5|||
125062411|NCT01617655|449846634|FG000|Overall Study|Other than specified above|1|||
125062412|NCT01617655|449846635|FG001|Overall Study|Other than specified above|2|||
125062413|NCT02394808|449846644|FG000|Period 1|Unsatisfactory lens fitting|0|||
125062414|NCT02394808|449846645|FG001|Period 1|Unsatisfactory lens fitting|1|||
125062415|NCT02394808|449846644|FG000|Period 2|Lost to Follow-up|1|||
125062416|NCT02394808|449846645|FG001|Period 2|Lost to Follow-up|0|||
125062417|NCT04724733|449846646|FG000|Overall Study|Lost to Follow-up|1|||
125062418|NCT04724733|449846647|FG001|Overall Study|Lost to Follow-up|1|||
125062419|NCT04724733|449846648|FG002|Overall Study|Lost to Follow-up|1|||
125062420|NCT03341923|449846649|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
125062421|NCT03341923|449846650|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
125062422|NCT01742078|449846651|FG000|Overall Study|Withdrawal by Subject|0|||
125062423|NCT01742078|449846652|FG001|Overall Study|Withdrawal by Subject|0|||
125062424|NCT01742078|449846653|FG002|Overall Study|Withdrawal by Subject|0|||
125062425|NCT01742078|449846654|FG003|Overall Study|Withdrawal by Subject|1|||
125062426|NCT01742078|449846655|FG004|Overall Study|Withdrawal by Subject|0|||
125062427|NCT01742078|449846656|FG005|Overall Study|Withdrawal by Subject|0|||
125062428|NCT01742078|449846657|FG006|Overall Study|Withdrawal by Subject|0|||
125062429|NCT01742078|449846658|FG007|Overall Study|Withdrawal by Subject|0|||
125062430|NCT01742078|449846659|FG008|Overall Study|Withdrawal by Subject|0|||
125062431|NCT04580394|449846660|FG000|First Intervention|Incorrectly Randomized|1|||
125062432|NCT04580394|449846660|FG000|First Intervention|Physician Decision|1|||
125062433|NCT04580394|449846660|FG000|First Intervention|Lost to Follow-up|1|||
125062434|NCT04580394|449846660|FG000|Washout (One Week)|Withdrawal by Subject|1|||
125062435|NCT04580394|449846660|FG000|Washout (One Week)|Adverse Event|1|||
125062436|NCT04580394|449846660|FG000|Washout (One Week)|Withdrawal by Subject|2|||
125062437|NCT04580394|449846660|FG000|Third Intervention|Adverse Event|1|||
125062438|NCT04580394|449846660|FG000|Third Intervention|Withdrawal by Subject|1|||
125062439|NCT04580394|449846660|FG000|Washout (One Week)|Withdrawal by Subject|2|||
125062440|NCT00642746|449846661|FG000|Overall Study|Patient unevaluable|1|||
125062441|NCT00642746|449846662|FG001|Overall Study|Patient unevaluable|0|||
125062442|NCT03337152|449846665|FG000|Overall Study|Physician Decision|1|||
125062443|NCT03337152|449846666|FG001|Overall Study|Physician Decision|0|||
125062444|NCT03337152|449846665|FG000|Overall Study|Lost to Follow-up|1|||
125062445|NCT03337152|449846666|FG001|Overall Study|Lost to Follow-up|3|||
125062446|NCT03337152|449846665|FG000|Overall Study|Adverse Event|3|||
125062447|NCT03337152|449846666|FG001|Overall Study|Adverse Event|1|||
125062448|NCT03337152|449846665|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
125062449|NCT03337152|449846666|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
125062450|NCT02662985|449846667|FG000|Treatment Period 1|Adverse Event|0|||
125062451|NCT02662985|449846668|FG001|Treatment Period 1|Adverse Event|2|||
125062452|NCT02662985|449846667|FG000|Treatment Period 1|Protocol Violation|0|||
125062453|NCT02662985|449846668|FG001|Treatment Period 1|Protocol Violation|1|||
125062454|NCT02662985|449846667|FG000|Treatment Period 1|Physician Decision|1|||
125062455|NCT02662985|449846668|FG001|Treatment Period 1|Physician Decision|0|||
125062456|NCT02662985|449846667|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125062457|NCT02662985|449846668|FG001|Treatment Period 1|Withdrawal by Subject|1|||
125062458|NCT02662985|449846667|FG000|Treatment Period 2|Lack of Efficacy|0|||
125062459|NCT02662985|449846668|FG001|Treatment Period 2|Lack of Efficacy|1|||
125062460|NCT02662985|449846667|FG000|Treatment Period 2|Lost to Follow-up|1|||
125062461|NCT02662985|449846668|FG001|Treatment Period 2|Lost to Follow-up|0|||
125062462|NCT02662985|449846667|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
125062463|NCT02662985|449846668|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
125062464|NCT02662985|449846667|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
125062465|NCT02662985|449846668|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
125062466|NCT02662985|449846667|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
125062467|NCT02662985|449846668|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
125062468|NCT02662985|449846667|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
125062469|NCT02662985|449846668|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
125062470|NCT02662985|449846667|FG000|Treatment Period 3 (Extension Period)|Death|0|||
125062471|NCT02662985|449846668|FG001|Treatment Period 3 (Extension Period)|Death|1|||
125062472|NCT02493426|449846669|FG000|Overall Study|Withdrawal by Subject|0|||
125062473|NCT02493426|449846670|FG001|Overall Study|Withdrawal by Subject|1|||
125062474|NCT01025817|449846673|FG000|Completed Study Medication|Adverse Event|66|||
125062475|NCT01025817|449846674|FG001|Completed Study Medication|Adverse Event|39|||
125062476|NCT01025817|449846673|FG000|Completed Study Medication|Protocol Deviation|9|||
125062477|NCT01025817|449846674|FG001|Completed Study Medication|Protocol Deviation|8|||
125062478|NCT01025817|449846673|FG000|Completed Study Medication|Withdrawal by Subject|8|||
125062479|NCT01025817|449846674|FG001|Completed Study Medication|Withdrawal by Subject|9|||
125062480|NCT01025817|449846673|FG000|Completed Study Medication|Administrative problems|7|||
125062481|NCT01025817|449846674|FG001|Completed Study Medication|Administrative problems|5|||
125062482|NCT01025817|449846673|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
125062483|NCT01025817|449846674|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
125062484|NCT01025817|449846673|FG000|Completed Study Medication|Abnormal test procedure|4|||
125062485|NCT01025817|449846674|FG001|Completed Study Medication|Abnormal test procedure|0|||
125062486|NCT01025817|449846673|FG000|Completed Study Medication|Graft loss|2|||
125062487|NCT01025817|449846674|FG001|Completed Study Medication|Graft loss|5|||
125062488|NCT01025817|449846673|FG000|Completed Study Medication|Death|2|||
125062489|NCT01025817|449846674|FG001|Completed Study Medication|Death|2|||
125062490|NCT01025817|449846673|FG000|Completed Study Medication|Abnormal lab values|0|||
125062491|NCT01025817|449846674|FG001|Completed Study Medication|Abnormal lab values|2|||
125062492|NCT01025817|449846673|FG000|Completed Study Medication|Subject no longer required study drug|0|||
125062493|NCT01025817|449846674|FG001|Completed Study Medication|Subject no longer required study drug|1|||
125062494|NCT01025817|449846673|FG000|Completed Study Medication|Lost to Follow-up|0|||
125062495|NCT01025817|449846674|FG001|Completed Study Medication|Lost to Follow-up|1|||
125139389|NCT00294047|450132850|FG000|Month 84|Protocol Violation|1|||
125139390|NCT00294047|450132851|FG001|Month 84|Protocol Violation|1|||
125062496|NCT01025817|449846673|FG000|Completed Study|Withdrawal by Subject|8|||
125062497|NCT01025817|449846674|FG001|Completed Study|Withdrawal by Subject|16|||
125062498|NCT01025817|449846673|FG000|Completed Study|Death|6|||
125062499|NCT01025817|449846674|FG001|Completed Study|Death|5|||
125062500|NCT01025817|449846673|FG000|Completed Study|Missing|2|||
125139391|NCT00294047|450132850|FG000|Month 84|Withdrawal by Subject|33|||
125062501|NCT01025817|449846674|FG001|Completed Study|Missing|0|||
125062502|NCT01025817|449846673|FG000|Completed Study|Lost to Follow-up|0|||
125062503|NCT01025817|449846674|FG001|Completed Study|Lost to Follow-up|1|||
125062504|NCT01599754|449846676|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
125062505|NCT01599754|449846677|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
125062506|NCT01599754|449846676|FG000|Overall Study|Participant noncompliance|4|||
125062507|NCT01599754|449846677|FG001|Overall Study|Participant noncompliance|4|||
125062508|NCT01599754|449846676|FG000|Overall Study|Lost to Follow-up|13|||
125062509|NCT01599754|449846677|FG001|Overall Study|Lost to Follow-up|6|||
125062510|NCT01599754|449846676|FG000|Overall Study|Death|31|||
125062511|NCT01599754|449846677|FG001|Overall Study|Death|33|||
125062512|NCT01599754|449846676|FG000|Overall Study|Adverse Event|3|||
125062513|NCT01599754|449846677|FG001|Overall Study|Adverse Event|2|||
125062514|NCT01599754|449846676|FG000|Overall Study|Investigator decision|1|||
125062515|NCT01599754|449846677|FG001|Overall Study|Investigator decision|3|||
125062516|NCT01599754|449846676|FG000|Overall Study|Withdrawal by Subject|24|||
125062517|NCT01599754|449846677|FG001|Overall Study|Withdrawal by Subject|25|||
125062518|NCT01599754|449846676|FG000|Overall Study|Study terminated by sponsor|282|||
125062519|NCT01599754|449846677|FG001|Overall Study|Study terminated by sponsor|285|||
125062520|NCT02618928|449846678|FG000|Overall Study|Failure to Return|28|||
125062521|NCT02618928|449846678|FG000|Overall Study|Insufficient Virological Response|1|||
125062522|NCT02618928|449846678|FG000|Overall Study|Withdrawal by Subject|2|||
125062523|NCT02618928|449846678|FG000|Overall Study|Death|3|||
125062524|NCT02618928|449846678|FG000|Overall Study|Other|11|||
125062525|NCT02618928|449846678|FG000|Overall Study|Missing|6|||
125062526|NCT02618928|449846678|FG000|Overall Study|Treatment Never Started|7|||
125062527|NCT03670641|449846679|FG000|Overall Study|Lost to Follow-up|3|||
125062528|NCT00118482|449846680|FG000|Overall Study|Lost to Follow-up|7|||
125062529|NCT00118482|449846681|FG001|Overall Study|Lost to Follow-up|7|||
125062530|NCT00118482|449846680|FG000|Overall Study|Withdrawal by Subject|23|||
125062531|NCT00118482|449846681|FG001|Overall Study|Withdrawal by Subject|22|||
125062532|NCT02128763|449846682|FG000|Overall Study|Death|1|||
125062533|NCT02128763|449846683|FG001|Overall Study|Death|0|||
125062534|NCT02128763|449846682|FG000|Overall Study|Lost to Follow-up|19|||
125062535|NCT02128763|449846683|FG001|Overall Study|Lost to Follow-up|16|||
125062536|NCT03666858|449846684|FG000|Cohort 1|Adverse Event|1|||
125062537|NCT03666858|449846685|FG001|Cohort 1|Adverse Event|0|||
125062538|NCT03666858|449846684|FG000|Cohort 2|Adverse Event|0|||
125062539|NCT03666858|449846685|FG001|Cohort 2|Adverse Event|1|||
125062540|NCT02921919|449846686|FG000|Overall Study|Other|5|||
125062541|NCT02921919|449846687|FG001|Overall Study|Other|6|||
125062542|NCT02921919|449846686|FG000|Overall Study|Lost to Follow-up|0|||
125062543|NCT02921919|449846687|FG001|Overall Study|Lost to Follow-up|1|||
125062544|NCT02921919|449846686|FG000|Overall Study|Withdrawal by Subject|5|||
125062545|NCT02921919|449846687|FG001|Overall Study|Withdrawal by Subject|1|||
125062546|NCT02921919|449846686|FG000|Overall Study|Disease Progression|47|||
125062547|NCT02921919|449846687|FG001|Overall Study|Disease Progression|38|||
125062548|NCT02921919|449846686|FG000|Overall Study|Physician Decision|3|||
125062549|NCT02921919|449846687|FG001|Overall Study|Physician Decision|2|||
125062550|NCT02921919|449846686|FG000|Overall Study|Adverse Event|6|||
125062551|NCT02921919|449846687|FG001|Overall Study|Adverse Event|4|||
125062552|NCT00547378|449846688|FG000|Randomized Cohort|Withdrawal by Subject|7|||
125062553|NCT00547378|449846689|FG001|Randomized Cohort|Withdrawal by Subject|5|||
125062554|NCT00547378|449846690|FG002|Randomized Cohort|Withdrawal by Subject|0|||
125062555|NCT00547378|449846688|FG000|Randomized Cohort|Death|0|||
125062556|NCT00547378|449846689|FG001|Randomized Cohort|Death|1|||
125062557|NCT00547378|449846690|FG002|Randomized Cohort|Death|0|||
125062558|NCT00547378|449846688|FG000|Randomized Cohort|Lost to Follow-up|1|||
125139392|NCT00294047|450132851|FG001|Month 84|Withdrawal by Subject|31|||
125139393|NCT00294047|450132850|FG000|Month 84|Lost to Follow-up|187|||
125139394|NCT00294047|450132851|FG001|Month 84|Lost to Follow-up|190|||
125139395|NCT00294047|450132850|FG000|Month 84|Absent Cervix|2|||
125139396|NCT00294047|450132851|FG001|Month 84|Absent Cervix|0|||
125139397|NCT00294047|450132850|FG000|Month 84|Work related reasons|4|||
125139398|NCT00294047|450132851|FG001|Month 84|Work related reasons|2|||
125139399|NCT00294047|450132850|FG000|Month 84|Center closed, subject did not transfer|1|||
125139400|NCT00294047|450132851|FG001|Month 84|Center closed, subject did not transfer|0|||
125062559|NCT00547378|449846689|FG001|Randomized Cohort|Lost to Follow-up|0|||
125062560|NCT00547378|449846690|FG002|Randomized Cohort|Lost to Follow-up|0|||
125062561|NCT00547378|449846688|FG000|Randomized Cohort|Adverse Event|1|||
125062562|NCT00547378|449846689|FG001|Randomized Cohort|Adverse Event|0|||
125062563|NCT00547378|449846690|FG002|Randomized Cohort|Adverse Event|0|||
125062564|NCT00547378|449846688|FG000|Randomized Cohort|Other reasons|2|||
125062565|NCT00547378|449846689|FG001|Randomized Cohort|Other reasons|0|||
125062566|NCT00547378|449846690|FG002|Randomized Cohort|Other reasons|0|||
125062567|NCT00547378|449846688|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
125062568|NCT00547378|449846689|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
125062569|NCT00547378|449846690|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
125062570|NCT00547378|449846688|FG000|All Implanted Cohort|Adverse Event|4|||
125062571|NCT00547378|449846689|FG001|All Implanted Cohort|Adverse Event|10|||
125062572|NCT00547378|449846690|FG002|All Implanted Cohort|Adverse Event|17|||
125062573|NCT00547378|449846688|FG000|All Implanted Cohort|Lost to Follow-up|0|||
125062574|NCT00547378|449846689|FG001|All Implanted Cohort|Lost to Follow-up|1|||
125062575|NCT00547378|449846690|FG002|All Implanted Cohort|Lost to Follow-up|14|||
125062576|NCT00547378|449846688|FG000|All Implanted Cohort|Death|3|||
125062577|NCT00547378|449846689|FG001|All Implanted Cohort|Death|1|||
125062578|NCT00547378|449846690|FG002|All Implanted Cohort|Death|4|||
125062579|NCT00547378|449846688|FG000|All Implanted Cohort|Physician Decision|0|||
125062580|NCT00547378|449846689|FG001|All Implanted Cohort|Physician Decision|2|||
125062581|NCT00547378|449846690|FG002|All Implanted Cohort|Physician Decision|6|||
125062582|NCT00547378|449846688|FG000|All Implanted Cohort|Site closure|2|||
125062583|NCT00547378|449846689|FG001|All Implanted Cohort|Site closure|0|||
125062584|NCT00547378|449846690|FG002|All Implanted Cohort|Site closure|1|||
125062585|NCT00547378|449846688|FG000|All Implanted Cohort|Other reasons|1|||
125062586|NCT00547378|449846689|FG001|All Implanted Cohort|Other reasons|0|||
125062587|NCT00547378|449846690|FG002|All Implanted Cohort|Other reasons|1|||
125062588|NCT04105244|449846691|FG000|Overall Study|Withdrawal by Subject|10|||
125062589|NCT04105244|449846692|FG001|Overall Study|Withdrawal by Subject|12|||
125062590|NCT04105244|449846691|FG000|Overall Study|Lost to Follow-up|20|||
125062591|NCT04105244|449846692|FG001|Overall Study|Lost to Follow-up|15|||
125062592|NCT04105244|449846691|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
125062593|NCT04105244|449846692|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
125062594|NCT04105244|449846691|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
125062595|NCT04105244|449846692|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
125062596|NCT02112994|449846693|FG000|Overall Study|Progressive Disease|0|||
125062597|NCT02112994|449846694|FG001|Overall Study|Progressive Disease|0|||
125062598|NCT02112994|449846695|FG002|Overall Study|Progressive Disease|1|||
125062599|NCT02112994|449846693|FG000|Overall Study|Pregnancy|0|||
125062600|NCT02112994|449846694|FG001|Overall Study|Pregnancy|1|||
125062601|NCT02112994|449846695|FG002|Overall Study|Pregnancy|1|||
125062602|NCT02112994|449846693|FG000|Overall Study|Liver Transplant|0|||
125062603|NCT02112994|449846694|FG001|Overall Study|Liver Transplant|1|||
125062604|NCT02112994|449846695|FG002|Overall Study|Liver Transplant|0|||
125062605|NCT02112994|449846693|FG000|Overall Study|Withdrawal by Subject|0|||
125062606|NCT02112994|449846694|FG001|Overall Study|Withdrawal by Subject|0|||
125062607|NCT02112994|449846695|FG002|Overall Study|Withdrawal by Subject|1|||
125062608|NCT02768194|449846697|FG000|Period 1|Adverse Event|0|||
125062609|NCT02768194|449846698|FG001|Period 1|Adverse Event|0|||
125062610|NCT02768194|449846699|FG002|Period 1|Adverse Event|0|||
125062611|NCT02768194|449846700|FG003|Period 1|Adverse Event|1|||
125062612|NCT02768194|449846701|FG004|Period 1|Adverse Event|0|||
125062613|NCT02768194|449846702|FG005|Period 1|Adverse Event|0|||
125062614|NCT02768194|449846697|FG000|Period 2|Other (Reason not specified)|1|||
125062615|NCT02768194|449846698|FG001|Period 2|Other (Reason not specified)|0|||
125062616|NCT02768194|449846699|FG002|Period 2|Other (Reason not specified)|0|||
125062617|NCT02768194|449846700|FG003|Period 2|Other (Reason not specified)|0|||
125062618|NCT02768194|449846701|FG004|Period 2|Other (Reason not specified)|0|||
125062619|NCT02768194|449846702|FG005|Period 2|Other (Reason not specified)|0|||
125062620|NCT02768194|449846697|FG000|Period 3|Other (Reason not specified)|0|||
125139401|NCT00294047|450132850|FG000|Month 84|Family problems|2|||
125139402|NCT00294047|450132851|FG001|Month 84|Family problems|2|||
125139403|NCT00294047|450132850|FG000|Month 84|Lack of time|3|||
125139404|NCT00294047|450132851|FG001|Month 84|Lack of time|1|||
125062621|NCT02768194|449846698|FG001|Period 3|Other (Reason not specified)|1|||
125062622|NCT02768194|449846699|FG002|Period 3|Other (Reason not specified)|0|||
125062623|NCT02768194|449846700|FG003|Period 3|Other (Reason not specified)|0|||
125062624|NCT02768194|449846701|FG004|Period 3|Other (Reason not specified)|0|||
125062625|NCT02768194|449846702|FG005|Period 3|Other (Reason not specified)|0|||
125139405|NCT00294047|450132850|FG000|Month 84|Personal reason|2|||
125062626|NCT00975195|449846703|FG000|Overall Study|Adverse Event|108|||
125062627|NCT00975195|449846704|FG001|Overall Study|Adverse Event|101|||
125062628|NCT00975195|449846703|FG000|Overall Study|Lack of Efficacy|6|||
125062629|NCT00975195|449846704|FG001|Overall Study|Lack of Efficacy|6|||
125139406|NCT00294047|450132851|FG001|Month 84|Personal reason|4|||
125062630|NCT00975195|449846703|FG000|Overall Study|Protocol Violation|27|||
125062631|NCT00975195|449846704|FG001|Overall Study|Protocol Violation|23|||
125062632|NCT00975195|449846703|FG000|Overall Study|Lost to Follow-up|9|||
125062633|NCT00975195|449846704|FG001|Overall Study|Lost to Follow-up|7|||
125062634|NCT00975195|449846703|FG000|Overall Study|Withdrawal by Subject|48|||
125062635|NCT00975195|449846704|FG001|Overall Study|Withdrawal by Subject|61|||
125062636|NCT00975195|449846703|FG000|Overall Study|Other reason not defined above|29|||
125062637|NCT00975195|449846704|FG001|Overall Study|Other reason not defined above|33|||
125062638|NCT00975195|449846703|FG000|Overall Study|Not treated|1|||
125062639|NCT00975195|449846704|FG001|Overall Study|Not treated|2|||
125062640|NCT01608724|449846705|FG000|Overall Study|Withdrawal by Subject|131|||
125062641|NCT01608724|449846705|FG000|Overall Study|Lost to Follow-up|41|||
125062642|NCT01608724|449846705|FG000|Overall Study|Study-specific discontinuation criteria|32|||
125062643|NCT01608724|449846705|FG000|Overall Study|Adverse Event|29|||
125222415|NCT02659943|450442745|FG001|Overall Study|Disease progression on study|1|||
125062644|NCT01608724|449846705|FG000|Overall Study|Protocol Violation|6|||
125062645|NCT01608724|449846705|FG000|Overall Study|bood sugar too high, etc.|3|||
125062646|NCT01608724|449846705|FG000|Overall Study|Safety reasons|1|||
125062647|NCT00363246|449846710|FG000|Overall Study|Death|40|||
125062648|NCT00363246|449846710|FG000|Overall Study|Withdrawal by Subject|19|||
125062649|NCT00363246|449846710|FG000|Overall Study|Lost to Follow-up|14|||
125062650|NCT00363246|449846710|FG000|Overall Study|Bad health|6|||
125062651|NCT00363246|449846710|FG000|Overall Study|Stopped using wheelchair|11|||
125062652|NCT00363246|449846710|FG000|Overall Study|Subject expressed security concerns|2|||
125062653|NCT00363246|449846710|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
125062654|NCT00099359|449846711|FG000|Overall Study|Death|11|||
125062655|NCT00099359|449846712|FG001|Overall Study|Death|15|||
125062656|NCT00099359|449846713|FG002|Overall Study|Death|17|||
125062657|NCT00099359|449846711|FG000|Overall Study|Withdrawal by Subject|19|||
125062658|NCT00099359|449846712|FG001|Overall Study|Withdrawal by Subject|19|||
125062659|NCT00099359|449846713|FG002|Overall Study|Withdrawal by Subject|23|||
125062660|NCT00099359|449846711|FG000|Overall Study|Lost to Follow-up|15|||
125062661|NCT00099359|449846712|FG001|Overall Study|Lost to Follow-up|24|||
125062662|NCT00099359|449846713|FG002|Overall Study|Lost to Follow-up|24|||
125062663|NCT00099359|449846711|FG000|Overall Study|moved out of area|9|||
125062664|NCT00099359|449846712|FG001|Overall Study|moved out of area|7|||
125062665|NCT00099359|449846713|FG002|Overall Study|moved out of area|4|||
125062666|NCT01822691|449846714|FG000|Overall Study|Withdrawal by Subject|2|||
125062667|NCT02756650|449846715|FG000|Overall Study|Physician Decision|1|||
125062668|NCT02756650|449846715|FG000|Overall Study|Adverse Event|1|||
125062669|NCT02720016|449846722|FG000|Overall Study|Separation of couple|6|||
125062670|NCT02720016|449846723|FG001|Overall Study|Separation of couple|8|||
125062671|NCT02720016|449846724|FG002|Overall Study|Separation of couple|2|||
125062672|NCT02720016|449846722|FG000|Overall Study|Withdrawal by Subject|6|||
125062673|NCT02720016|449846723|FG001|Overall Study|Withdrawal by Subject|6|||
125062674|NCT02720016|449846724|FG002|Overall Study|Withdrawal by Subject|4|||
125062675|NCT02720016|449846722|FG000|Overall Study|Scheduling issues|2|||
125062676|NCT02720016|449846723|FG001|Overall Study|Scheduling issues|4|||
125062677|NCT02720016|449846724|FG002|Overall Study|Scheduling issues|7|||
125062678|NCT02720016|449846722|FG000|Overall Study|Childcare|2|||
125062679|NCT02720016|449846723|FG001|Overall Study|Childcare|0|||
125062680|NCT02720016|449846724|FG002|Overall Study|Childcare|2|||
125062681|NCT02720016|449846722|FG000|Overall Study|Withdrawal by PI|2|||
125062682|NCT02720016|449846723|FG001|Overall Study|Withdrawal by PI|2|||
125062683|NCT02720016|449846724|FG002|Overall Study|Withdrawal by PI|0|||
125062684|NCT02720016|449846722|FG000|Overall Study|Moved away|2|||
125062685|NCT02720016|449846723|FG001|Overall Study|Moved away|0|||
125062686|NCT02720016|449846724|FG002|Overall Study|Moved away|0|||
125062687|NCT02720016|449846722|FG000|Overall Study|Not Primary Health Concern|0|||
125062688|NCT02720016|449846723|FG001|Overall Study|Not Primary Health Concern|0|||
125062689|NCT02720016|449846724|FG002|Overall Study|Not Primary Health Concern|2|||
125062690|NCT02720016|449846722|FG000|Overall Study|Transportation issues|0|||
125062691|NCT02720016|449846723|FG001|Overall Study|Transportation issues|0|||
125062692|NCT02720016|449846724|FG002|Overall Study|Transportation issues|1|||
125062693|NCT02720016|449846722|FG000|Overall Study|Other|0|||
125062694|NCT02720016|449846723|FG001|Overall Study|Other|0|||
125062695|NCT02720016|449846724|FG002|Overall Study|Other|2|||
125062696|NCT04501679|449846727|FG000|Overall Study|Pregnancy|0|||
125062697|NCT04501679|449846728|FG001|Overall Study|Pregnancy|1|||
125062698|NCT04501679|449846727|FG000|Overall Study|Adverse Event|4|||
125062699|NCT04501679|449846728|FG001|Overall Study|Adverse Event|2|||
125062700|NCT04501679|449846727|FG000|Overall Study|Withdrawal by Subject|2|||
125062701|NCT04501679|449846728|FG001|Overall Study|Withdrawal by Subject|0|||
125062702|NCT04501679|449846727|FG000|Overall Study|Physician Decision|1|||
125062703|NCT04501679|449846728|FG001|Overall Study|Physician Decision|0|||
125062704|NCT04501679|449846727|FG000|Overall Study|Lost to Follow-up|2|||
125062705|NCT04501679|449846728|FG001|Overall Study|Lost to Follow-up|0|||
125062706|NCT00910429|449846731|FG000|Overall Study|Death|18|||
125062707|NCT00910429|449846732|FG001|Overall Study|Death|12|||
125062708|NCT00910429|449846731|FG000|Overall Study|Withdrawal by Subject|3|||
125062709|NCT00910429|449846732|FG001|Overall Study|Withdrawal by Subject|2|||
125062710|NCT00910429|449846731|FG000|Overall Study|Protocol Violation|1|||
125062711|NCT00910429|449846732|FG001|Overall Study|Protocol Violation|0|||
125062712|NCT00910429|449846731|FG000|Overall Study|Lost to Follow-up|2|||
125062713|NCT00910429|449846732|FG001|Overall Study|Lost to Follow-up|1|||
125062714|NCT00910429|449846731|FG000|Overall Study|Adverse Event|10|||
125062715|NCT00910429|449846732|FG001|Overall Study|Adverse Event|5|||
125062716|NCT00910429|449846731|FG000|Overall Study|Drug non-compliance|1|||
125062717|NCT00910429|449846732|FG001|Overall Study|Drug non-compliance|0|||
125062718|NCT00910429|449846731|FG000|Overall Study|Lack of Efficacy|4|||
125062719|NCT00910429|449846732|FG001|Overall Study|Lack of Efficacy|1|||
125062720|NCT02358369|449846736|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
125062721|NCT02358369|449846737|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
125062722|NCT02358369|449846738|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
125062723|NCT02358369|449846739|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
125062724|NCT02358369|449846740|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
125062725|NCT02358369|449846736|FG000|Treatment Period A/B|Adverse Event|0|||
125062726|NCT02358369|449846737|FG001|Treatment Period A/B|Adverse Event|0|||
125062727|NCT02358369|449846738|FG002|Treatment Period A/B|Adverse Event|1|||
125062728|NCT02358369|449846739|FG003|Treatment Period A/B|Adverse Event|2|||
125062729|NCT02358369|449846740|FG004|Treatment Period A/B|Adverse Event|0|||
125062730|NCT02358369|449846736|FG000|Treatment Period A/B|Death|0|||
125062731|NCT02358369|449846737|FG001|Treatment Period A/B|Death|0|||
125062732|NCT02358369|449846738|FG002|Treatment Period A/B|Death|1|||
125062733|NCT02358369|449846739|FG003|Treatment Period A/B|Death|0|||
125062734|NCT02358369|449846740|FG004|Treatment Period A/B|Death|0|||
125062735|NCT02358369|449846736|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
125062736|NCT02358369|449846737|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
125062737|NCT02358369|449846738|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
125062738|NCT02358369|449846739|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
125062739|NCT02358369|449846740|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
125062740|NCT02358369|449846736|FG000|Treatment Period C|Adverse Event|0|||
125062741|NCT02358369|449846737|FG001|Treatment Period C|Adverse Event|0|||
125062742|NCT02358369|449846738|FG002|Treatment Period C|Adverse Event|0|||
125062743|NCT02358369|449846739|FG003|Treatment Period C|Adverse Event|0|||
125062744|NCT02358369|449846740|FG004|Treatment Period C|Adverse Event|7|||
125062745|NCT04465396|449846741|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
125062746|NCT04465396|449846742|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
125062747|NCT04465396|449846743|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
125062748|NCT04465396|449846744|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
125062749|NCT02365584|449846752|FG000|Overall Study|Adverse Event|2|||
125062750|NCT02365584|449846753|FG001|Overall Study|Adverse Event|2|||
125062751|NCT02365584|449846752|FG000|Overall Study|Withdrawal by Subject|1|||
125062752|NCT02365584|449846753|FG001|Overall Study|Withdrawal by Subject|0|||
125062753|NCT02365584|449846752|FG000|Overall Study|Disease Progression|9|||
125062754|NCT02365584|449846753|FG001|Overall Study|Disease Progression|12|||
125062755|NCT00349752|449846754|FG000|Overall Study|Adverse Event|8|||
125062756|NCT00349752|449846755|FG001|Overall Study|Adverse Event|12|||
125062757|NCT00349752|449846754|FG000|Overall Study|Lack of Efficacy|37|||
125062758|NCT00349752|449846755|FG001|Overall Study|Lack of Efficacy|42|||
125062759|NCT00349752|449846754|FG000|Overall Study|Lost to Follow-up|4|||
125062760|NCT00349752|449846755|FG001|Overall Study|Lost to Follow-up|2|||
125062761|NCT00349752|449846754|FG000|Overall Study|Personal reasons|6|||
125062762|NCT00349752|449846755|FG001|Overall Study|Personal reasons|5|||
125062763|NCT00349752|449846754|FG000|Overall Study|Other: Required exclusionary medication|0|||
125062764|NCT00349752|449846755|FG001|Overall Study|Other: Required exclusionary medication|1|||
125062765|NCT00349752|449846754|FG000|Overall Study|Other: Non compliance|0|||
125062766|NCT00349752|449846755|FG001|Overall Study|Other: Non compliance|1|||
125062767|NCT00349752|449846754|FG000|Overall Study|Other: Patient stopped steroids|0|||
125062768|NCT00349752|449846755|FG001|Overall Study|Other: Patient stopped steroids|1|||
125062769|NCT00349752|449846754|FG000|Overall Study|Other: Patient's steroid use|1|||
125062770|NCT00349752|449846755|FG001|Overall Study|Other: Patient's steroid use|0|||
125062771|NCT00349752|449846754|FG000|Overall Study|Other: Ineligible|1|||
125062772|NCT00349752|449846755|FG001|Overall Study|Other: Ineligible|0|||
125062773|NCT00349752|449846754|FG000|Overall Study|Other: Inadvertently unblinded|1|||
125062774|NCT00349752|449846755|FG001|Overall Study|Other: Inadvertently unblinded|0|||
125062775|NCT00349752|449846754|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
125062776|NCT00349752|449846755|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
125062777|NCT01973452|449846760|FG000|Overall Study|Lack of Efficacy|0|||
125062778|NCT01973452|449846761|FG001|Overall Study|Lack of Efficacy|1|||
125062779|NCT01973452|449846760|FG000|Overall Study|Lost to Follow-up|1|||
125062780|NCT01973452|449846761|FG001|Overall Study|Lost to Follow-up|0|||
125062781|NCT01973452|449846760|FG000|Overall Study|Withdrawal by Subject|10|||
125062782|NCT01973452|449846761|FG001|Overall Study|Withdrawal by Subject|9|||
125062783|NCT01973452|449846760|FG000|Overall Study|Ineligible|1|||
125062784|NCT01973452|449846761|FG001|Overall Study|Ineligible|1|||
125062785|NCT01973452|449846760|FG000|Overall Study|Surgery canceled by participant|5|||
125062786|NCT01973452|449846761|FG001|Overall Study|Surgery canceled by participant|3|||
125062787|NCT05294211|449846763|FG000|Overall Study|Withdrawal by Subject|3|||
125062788|NCT05294211|449846763|FG000|Overall Study|Physician Decision|2|||
125062789|NCT05294211|449846763|FG000|Overall Study|Progressed to active labor|1|||
125062790|NCT05294211|449846763|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
125062791|NCT05294211|449846763|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
125062792|NCT00838916|449846764|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
125062793|NCT00838916|449846765|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
125062794|NCT00838916|449846764|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
125062795|NCT00838916|449846765|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
125062796|NCT00838916|449846764|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
125062797|NCT00838916|449846765|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
125062798|NCT00838916|449846764|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
125062799|NCT00838916|449846765|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
125062800|NCT00838916|449846764|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
125062801|NCT00838916|449846765|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
125062802|NCT00838916|449846764|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
125062803|NCT00838916|449846765|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
125062804|NCT00838916|449846764|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
125062805|NCT00838916|449846765|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
125062806|NCT00838916|449846764|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
125062807|NCT00838916|449846765|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
125062808|NCT00838916|449846764|FG000|Treatment Period (156 Weeks)|Missing|3|||
125062809|NCT00838916|449846765|FG001|Treatment Period (156 Weeks)|Missing|1|||
125062810|NCT00838916|449846764|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
125062811|NCT00838916|449846765|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
125062812|NCT00838916|449846764|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
125062813|NCT00838916|449846765|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
125139407|NCT00294047|450132850|FG000|Month 84|Subject does not want male physician|1|||
125139408|NCT00294047|450132851|FG001|Month 84|Subject does not want male physician|0|||
125139409|NCT00294047|450132850|FG000|Month 84|Transport reimbursement delayed|0|||
125139410|NCT00294047|450132851|FG001|Month 84|Transport reimbursement delayed|1|||
125139411|NCT00294047|450132850|FG000|Month 84|Unable to reach study site|1|||
125139412|NCT00294047|450132851|FG001|Month 84|Unable to reach study site|0|||
125139413|NCT00294047|450132850|FG000|Month 84|Under investigation locally|1|||
125139414|NCT00294047|450132851|FG001|Month 84|Under investigation locally|0|||
125139415|NCT00294047|450132850|FG000|Month 84|Visit missed|0|||
125222416|NCT02659943|450442746|FG002|Overall Study|Disease progression on study|1|||
125222417|NCT02659943|450442747|FG003|Overall Study|Disease progression on study|1|||
125222418|NCT02659943|450442748|FG004|Overall Study|Disease progression on study|1|||
125222419|NCT02659943|450442749|FG005|Overall Study|Disease progression on study|4|||
125222420|NCT02659943|450442750|FG006|Overall Study|Disease progression on study|0|||
125222421|NCT02659943|450442744|FG000|Overall Study|Patient's condition per principal investigator|0|||
125222422|NCT02659943|450442745|FG001|Overall Study|Patient's condition per principal investigator|0|||
125222423|NCT02659943|450442746|FG002|Overall Study|Patient's condition per principal investigator|0|||
125222424|NCT02659943|450442747|FG003|Overall Study|Patient's condition per principal investigator|0|||
125222425|NCT02659943|450442748|FG004|Overall Study|Patient's condition per principal investigator|0|||
125222426|NCT02659943|450442749|FG005|Overall Study|Patient's condition per principal investigator|1|||
125222427|NCT02659943|450442750|FG006|Overall Study|Patient's condition per principal investigator|0|||
125062814|NCT00838916|449846764|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
125222428|NCT02659943|450442744|FG000|Overall Study|Ineligible|0|||
125222429|NCT02659943|450442745|FG001|Overall Study|Ineligible|0|||
125222430|NCT02659943|450442746|FG002|Overall Study|Ineligible|0|||
125222431|NCT02659943|450442747|FG003|Overall Study|Ineligible|0|||
125222432|NCT02659943|450442748|FG004|Overall Study|Ineligible|0|||
125222433|NCT02659943|450442749|FG005|Overall Study|Ineligible|0|||
125222434|NCT02659943|450442750|FG006|Overall Study|Ineligible|1|||
125222435|NCT02659943|450442744|FG000|Overall Study|No longer meets eligibility|0|||
125222436|NCT02659943|450442745|FG001|Overall Study|No longer meets eligibility|0|||
125222437|NCT02659943|450442746|FG002|Overall Study|No longer meets eligibility|0|||
125222438|NCT02659943|450442747|FG003|Overall Study|No longer meets eligibility|0|||
125222439|NCT02659943|450442748|FG004|Overall Study|No longer meets eligibility|0|||
125222440|NCT02659943|450442749|FG005|Overall Study|No longer meets eligibility|0|||
125222441|NCT02659943|450442750|FG006|Overall Study|No longer meets eligibility|1|||
125222442|NCT02659943|450442744|FG000|Overall Study|No treatment, per protocol|0|||
125222443|NCT02659943|450442745|FG001|Overall Study|No treatment, per protocol|0|||
125222444|NCT02659943|450442746|FG002|Overall Study|No treatment, per protocol|0|||
125222445|NCT02659943|450442747|FG003|Overall Study|No treatment, per protocol|0|||
125062815|NCT00838916|449846765|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
125062816|NCT00838916|449846764|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
125062817|NCT00838916|449846765|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
125062818|NCT00838916|449846764|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
125062819|NCT00838916|449846765|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
125062820|NCT00838916|449846764|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
125062821|NCT00838916|449846765|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
125062822|NCT00838916|449846764|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
125062823|NCT00838916|449846765|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
125062824|NCT00838916|449846764|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
125062825|NCT00838916|449846765|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
125062826|NCT00838916|449846764|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
125062827|NCT00838916|449846765|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
125062828|NCT00838916|449846764|FG000|Follow-up Period (8 Weeks)|Missing|3|||
125062829|NCT00838916|449846765|FG001|Follow-up Period (8 Weeks)|Missing|0|||
125062830|NCT01842607|449846767|FG000|Overall Study|Adverse Event|11|||
125222446|NCT02659943|450442748|FG004|Overall Study|No treatment, per protocol|0|||
125062831|NCT01842607|449846767|FG000|Overall Study|Lack of Efficacy|19|||
125062832|NCT01842607|449846767|FG000|Overall Study|Protocol Violation|8|||
125139416|NCT00294047|450132851|FG001|Month 84|Visit missed|1|||
125222447|NCT02659943|450442749|FG005|Overall Study|No treatment, per protocol|0|||
125222448|NCT02659943|450442750|FG006|Overall Study|No treatment, per protocol|3|||
125062833|NCT01842607|449846767|FG000|Overall Study|Protocol defined stopping criteria|2|||
125062834|NCT01842607|449846767|FG000|Overall Study|Lost to Follow-up|3|||
125062835|NCT01842607|449846767|FG000|Overall Study|Physician Decision|9|||
125062836|NCT01842607|449846767|FG000|Overall Study|Withdrawal by Subject|14|||
125062837|NCT00675103|449846768|FG000|Overall Study|Lack of Efficacy|2|||
125062838|NCT00675103|449846768|FG000|Overall Study|Adverse Event|1|||
125062839|NCT03600714|449846769|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
125062840|NCT02164513|449846772|FG000|Overall Study|Adverse Event|162|||
125062841|NCT02164513|449846773|FG001|Overall Study|Adverse Event|180|||
125062842|NCT02164513|449846774|FG002|Overall Study|Adverse Event|111|||
125062843|NCT02164513|449846772|FG000|Overall Study|Other: Study Closed or terminated|5|||
125062844|NCT02164513|449846773|FG001|Overall Study|Other: Study Closed or terminated|2|||
125062845|NCT02164513|449846774|FG002|Overall Study|Other: Study Closed or terminated|4|||
125062846|NCT02164513|449846772|FG000|Overall Study|Lost to Follow-up|30|||
125062847|NCT02164513|449846773|FG001|Overall Study|Lost to Follow-up|36|||
125062848|NCT02164513|449846774|FG002|Overall Study|Lost to Follow-up|22|||
125062849|NCT02164513|449846772|FG000|Overall Study|Physician Decision|47|||
125062850|NCT02164513|449846773|FG001|Overall Study|Physician Decision|57|||
125062851|NCT02164513|449846774|FG002|Overall Study|Physician Decision|28|||
125062852|NCT02164513|449846772|FG000|Overall Study|Withdrawal by Subject|192|||
125062853|NCT02164513|449846773|FG001|Overall Study|Withdrawal by Subject|261|||
125062854|NCT02164513|449846774|FG002|Overall Study|Withdrawal by Subject|130|||
125062855|NCT02164513|449846772|FG000|Overall Study|Other: Reason not provided by site|1|||
125062856|NCT02164513|449846773|FG001|Overall Study|Other: Reason not provided by site|0|||
125062857|NCT02164513|449846774|FG002|Overall Study|Other: Reason not provided by site|0|||
125062858|NCT03073213|449848507|FG000|Multiple Dose Period|Protocol Violation|0|||
125062859|NCT03073213|449848508|FG001|Multiple Dose Period|Protocol Violation|0|||
125062860|NCT03073213|449848509|FG002|Multiple Dose Period|Protocol Violation|1|||
125062861|NCT00280150|449848513|FG000|Overall Study|Adverse Event|0|||
125062862|NCT00280150|449848514|FG001|Overall Study|Adverse Event|1|||
125062863|NCT00280150|449848515|FG002|Overall Study|Adverse Event|2|||
125062864|NCT00280150|449848516|FG003|Overall Study|Adverse Event|3|||
125062865|NCT00280150|449848513|FG000|Overall Study|Lack of Efficacy|0|||
125062866|NCT00280150|449848514|FG001|Overall Study|Lack of Efficacy|0|||
125062867|NCT00280150|449848515|FG002|Overall Study|Lack of Efficacy|0|||
125062868|NCT00280150|449848516|FG003|Overall Study|Lack of Efficacy|3|||
125062869|NCT00280150|449848513|FG000|Overall Study|Physician Decision|0|||
125062870|NCT00280150|449848514|FG001|Overall Study|Physician Decision|0|||
125062871|NCT00280150|449848515|FG002|Overall Study|Physician Decision|0|||
125062872|NCT00280150|449848516|FG003|Overall Study|Physician Decision|1|||
125062873|NCT00280150|449848513|FG000|Overall Study|Protocol Violation|0|||
125062874|NCT00280150|449848514|FG001|Overall Study|Protocol Violation|0|||
125062875|NCT00280150|449848515|FG002|Overall Study|Protocol Violation|0|||
125062876|NCT00280150|449848516|FG003|Overall Study|Protocol Violation|1|||
125062877|NCT00280150|449848513|FG000|Overall Study|Withdrawal by Subject|0|||
125062878|NCT00280150|449848514|FG001|Overall Study|Withdrawal by Subject|0|||
125062879|NCT00280150|449848515|FG002|Overall Study|Withdrawal by Subject|0|||
125062880|NCT00280150|449848516|FG003|Overall Study|Withdrawal by Subject|1|||
125062881|NCT00280150|449848513|FG000|Overall Study|Did not get consolidation therapy|3|||
125062882|NCT00280150|449848514|FG001|Overall Study|Did not get consolidation therapy|0|||
125062883|NCT00280150|449848515|FG002|Overall Study|Did not get consolidation therapy|3|||
125062884|NCT00280150|449848516|FG003|Overall Study|Did not get consolidation therapy|0|||
125062885|NCT00280150|449848513|FG000|Overall Study|Declining Performance Status|0|||
125062886|NCT00280150|449848514|FG001|Overall Study|Declining Performance Status|0|||
125062887|NCT00280150|449848515|FG002|Overall Study|Declining Performance Status|0|||
125062888|NCT00280150|449848516|FG003|Overall Study|Declining Performance Status|1|||
125062889|NCT02586077|449848524|FG000|Overall Study|Withdrawal by Subject|1|||
125062890|NCT02586077|449848524|FG000|Overall Study|Physician Decision|4|||
125062891|NCT02586077|449848524|FG000|Overall Study|Lost to Follow-up|3|||
125062892|NCT01993615|449848528|FG000|Overall Study|Death|1|||
125062893|NCT01993615|449848529|FG001|Overall Study|Death|0|||
125062894|NCT01175213|449848532|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
125062895|NCT01175213|449848533|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
125062896|NCT01175213|449848532|FG000|IGSC, 10%/rHuPH20|Death|1|||
125062897|NCT01175213|449848533|FG001|IGSC, 10%/rHuPH20|Death|0|||
125062898|NCT01175213|449848532|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
125062899|NCT01175213|449848533|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
125062900|NCT01175213|449848532|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
125062901|NCT01175213|449848533|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
125062902|NCT01175213|449848532|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
125062903|NCT01175213|449848533|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
125062904|NCT01175213|449848532|FG000|Safety Follow-up|Adverse Event|1|||
125062905|NCT01175213|449848533|FG001|Safety Follow-up|Adverse Event|0|||
125062906|NCT01245764|449848538|FG000|Study Phase A|Other|3|||
125062907|NCT01245764|449848539|FG001|Study Phase A|Other|2|||
125062908|NCT01245764|449848540|FG002|Study Phase A|Other|3|||
125062909|NCT01245764|449848541|FG003|Study Phase A|Other|1|||
125062910|NCT01245764|449848538|FG000|Study Phase A|Protocol Violation|6|||
125062911|NCT01245764|449848539|FG001|Study Phase A|Protocol Violation|3|||
125062912|NCT01245764|449848540|FG002|Study Phase A|Protocol Violation|2|||
125062913|NCT01245764|449848541|FG003|Study Phase A|Protocol Violation|2|||
125062914|NCT01245764|449848538|FG000|Study Phase A|Lost to Follow-up|0|||
125062915|NCT01245764|449848539|FG001|Study Phase A|Lost to Follow-up|0|||
125062916|NCT01245764|449848540|FG002|Study Phase A|Lost to Follow-up|5|||
125062917|NCT01245764|449848541|FG003|Study Phase A|Lost to Follow-up|0|||
125062918|NCT00003476|449848542|FG000|Overall Study|Not evaluable|1|||
125062919|NCT00781963|449848547|FG000|Overall Study|Death|3|||
125062920|NCT00781963|449848548|FG001|Overall Study|Death|0|||
125062921|NCT00781963|449848547|FG000|Overall Study|Lost to Follow-up|2|||
125062922|NCT00781963|449848548|FG001|Overall Study|Lost to Follow-up|1|||
125062923|NCT00781963|449848547|FG000|Overall Study|Withdrawal by Subject|3|||
125062924|NCT00781963|449848548|FG001|Overall Study|Withdrawal by Subject|1|||
125062925|NCT00781963|449848547|FG000|Overall Study|Refused follow-up|9|||
125062926|NCT00781963|449848548|FG001|Overall Study|Refused follow-up|0|||
125062927|NCT03057951|449848552|FG000|Overall Study|Adverse Event|553|||
125062928|NCT03057951|449848553|FG001|Overall Study|Adverse Event|575|||
125062929|NCT03057951|449848552|FG000|Overall Study|Protocol Violation|30|||
125062930|NCT03057951|449848553|FG001|Overall Study|Protocol Violation|24|||
125062931|NCT03057951|449848552|FG000|Overall Study|Lost to Follow-up|6|||
125062932|NCT03057951|449848553|FG001|Overall Study|Lost to Follow-up|16|||
125139417|NCT00294047|450132850|FG000|Month 84|No consent for Month 84 Follow-up|731|||
125139418|NCT00294047|450132851|FG001|Month 84|No consent for Month 84 Follow-up|754|||
125139419|NCT02157974|450132852|FG000|Overall Study|Withdrawal by Subject|0|||
125139420|NCT02157974|450132853|FG001|Overall Study|Withdrawal by Subject|1|||
125139421|NCT02157974|450132854|FG002|Overall Study|Withdrawal by Subject|0|||
125139422|NCT02157974|450132855|FG003|Overall Study|Withdrawal by Subject|0|||
125139423|NCT02157974|450132856|FG004|Overall Study|Withdrawal by Subject|0|||
125139424|NCT02157974|450132852|FG000|Overall Study|Screen Failure|0|||
125139425|NCT02157974|450132853|FG001|Overall Study|Screen Failure|1|||
125139426|NCT02157974|450132854|FG002|Overall Study|Screen Failure|0|||
125139427|NCT02157974|450132855|FG003|Overall Study|Screen Failure|0|||
125139428|NCT02157974|450132856|FG004|Overall Study|Screen Failure|0|||
125139429|NCT02157974|450132852|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
125139430|NCT02157974|450132853|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
125139431|NCT02157974|450132854|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
125139432|NCT02157974|450132855|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
125139433|NCT02157974|450132856|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
125139434|NCT00985439|450132859|FG000|Overall Study|Adverse Event|0|||
125139435|NCT00985439|450132860|FG001|Overall Study|Adverse Event|0|||
125139436|NCT00985439|450132861|FG002|Overall Study|Adverse Event|1|||
125139437|NCT00985439|450132862|FG003|Overall Study|Adverse Event|0|||
125139438|NCT01174186|450132863|FG000|Overall Study|Lost to Follow-up|0|||
125139439|NCT01174186|450132864|FG001|Overall Study|Lost to Follow-up|1|||
125139440|NCT01174186|450132863|FG000|Overall Study|Withdrawal by Subject|0|||
125139441|NCT01174186|450132864|FG001|Overall Study|Withdrawal by Subject|2|||
125139442|NCT05274763|450132865|FG000|Overall Study|Lost to Follow-up|1|||
125139443|NCT01051349|450132867|FG000|Overall Study|Adverse Event|88|||
125139444|NCT01051349|450132867|FG000|Overall Study|Consent Withdrawn|54|||
125139445|NCT01051349|450132867|FG000|Overall Study|Investigator Decision|6|||
125139446|NCT01051349|450132867|FG000|Overall Study|Lost to Follow-up|6|||
125139447|NCT01051349|450132867|FG000|Overall Study|Subject non-compliance|7|||
125139448|NCT01051349|450132867|FG000|Overall Study|Reason not Specified|12|||
125139449|NCT01647828|450132868|FG000|Overall Study|Death|3|||
125139450|NCT01647828|450132869|FG001|Overall Study|Death|4|||
125139451|NCT01647828|450132870|FG002|Overall Study|Death|4|||
125062933|NCT03057951|449848552|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
125139452|NCT01647828|450132871|FG003|Overall Study|Death|5|||
125062934|NCT03057951|449848553|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
125139453|NCT01647828|450132872|FG004|Overall Study|Death|6|||
125139454|NCT01647828|450132873|FG005|Overall Study|Death|3|||
125139455|NCT01647828|450132874|FG006|Overall Study|Death|10|||
125139456|NCT01647828|450132875|FG007|Overall Study|Death|60|||
125062935|NCT03057951|449848552|FG000|Overall Study|Study drug stopped, reason missing|6|||
125062936|NCT03057951|449848553|FG001|Overall Study|Study drug stopped, reason missing|1|||
125062937|NCT03057951|449848552|FG000|Overall Study|Medical advice|6|||
125062938|NCT03057951|449848553|FG001|Overall Study|Medical advice|2|||
125062939|NCT03057951|449848552|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
125062940|NCT03057951|449848553|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
125062941|NCT03057951|449848552|FG000|Overall Study|Investigator decision|2|||
125062942|NCT03057951|449848553|FG001|Overall Study|Investigator decision|0|||
125062943|NCT03057951|449848552|FG000|Overall Study|Patient decision|5|||
125062944|NCT03057951|449848553|FG001|Overall Study|Patient decision|2|||
125062945|NCT03057951|449848552|FG000|Overall Study|Not attending study visits|3|||
125062946|NCT03057951|449848553|FG001|Overall Study|Not attending study visits|0|||
125062947|NCT03057951|449848552|FG000|Overall Study|Patient moved away|3|||
125062948|NCT03057951|449848553|FG001|Overall Study|Patient moved away|4|||
125062949|NCT03057951|449848552|FG000|Overall Study|Other reason than stated above|23|||
125062950|NCT03057951|449848553|FG001|Overall Study|Other reason than stated above|29|||
125062951|NCT03057951|449848552|FG000|Overall Study|Not treated|2|||
125062952|NCT03057951|449848553|FG001|Overall Study|Not treated|1|||
125062953|NCT02064205|449848554|FG000|Overall Study|Withdrawal by Subject|1|||
125062954|NCT00696436|449848555|FG000|Overall Study|Adverse Event|7|||
125062955|NCT00696436|449848556|FG001|Overall Study|Adverse Event|9|||
125062956|NCT00696436|449848557|FG002|Overall Study|Adverse Event|8|||
125062957|NCT00696436|449848558|FG003|Overall Study|Adverse Event|6|||
125062958|NCT00696436|449848559|FG004|Overall Study|Adverse Event|4|||
125062959|NCT00696436|449848555|FG000|Overall Study|Protocol Violation|3|||
125062960|NCT00696436|449848556|FG001|Overall Study|Protocol Violation|2|||
125062961|NCT00696436|449848557|FG002|Overall Study|Protocol Violation|2|||
125062962|NCT00696436|449848558|FG003|Overall Study|Protocol Violation|0|||
125062963|NCT00696436|449848559|FG004|Overall Study|Protocol Violation|1|||
125062964|NCT00696436|449848555|FG000|Overall Study|Lost to Follow-up|1|||
125062965|NCT00696436|449848556|FG001|Overall Study|Lost to Follow-up|6|||
125062966|NCT00696436|449848557|FG002|Overall Study|Lost to Follow-up|2|||
125062967|NCT00696436|449848558|FG003|Overall Study|Lost to Follow-up|4|||
125062968|NCT00696436|449848559|FG004|Overall Study|Lost to Follow-up|3|||
125062969|NCT00696436|449848555|FG000|Overall Study|Withdrawal by Subject|4|||
125062970|NCT00696436|449848556|FG001|Overall Study|Withdrawal by Subject|11|||
125062971|NCT00696436|449848557|FG002|Overall Study|Withdrawal by Subject|5|||
125062972|NCT00696436|449848558|FG003|Overall Study|Withdrawal by Subject|7|||
125062973|NCT00696436|449848559|FG004|Overall Study|Withdrawal by Subject|1|||
125062974|NCT00696436|449848555|FG000|Overall Study|Lack of Efficacy|3|||
125062975|NCT00696436|449848556|FG001|Overall Study|Lack of Efficacy|1|||
125062976|NCT00696436|449848557|FG002|Overall Study|Lack of Efficacy|5|||
125062977|NCT00696436|449848558|FG003|Overall Study|Lack of Efficacy|2|||
125062978|NCT00696436|449848559|FG004|Overall Study|Lack of Efficacy|4|||
125062979|NCT00696436|449848555|FG000|Overall Study|Participant Unavailability|2|||
125062980|NCT00696436|449848556|FG001|Overall Study|Participant Unavailability|0|||
125062981|NCT00696436|449848557|FG002|Overall Study|Participant Unavailability|2|||
125062982|NCT00696436|449848558|FG003|Overall Study|Participant Unavailability|1|||
125062983|NCT00696436|449848559|FG004|Overall Study|Participant Unavailability|0|||
125062984|NCT00696436|449848555|FG000|Overall Study|Administrative Error|2|||
125062985|NCT00696436|449848556|FG001|Overall Study|Administrative Error|0|||
125062986|NCT00696436|449848557|FG002|Overall Study|Administrative Error|2|||
125062987|NCT00696436|449848558|FG003|Overall Study|Administrative Error|0|||
125062988|NCT00696436|449848559|FG004|Overall Study|Administrative Error|0|||
125062989|NCT00696436|449848555|FG000|Overall Study|Participant Non-compliance|0|||
125062990|NCT00696436|449848556|FG001|Overall Study|Participant Non-compliance|0|||
125062991|NCT00696436|449848557|FG002|Overall Study|Participant Non-compliance|1|||
125062992|NCT00696436|449848558|FG003|Overall Study|Participant Non-compliance|2|||
125062993|NCT00696436|449848559|FG004|Overall Study|Participant Non-compliance|0|||
125062994|NCT00696436|449848555|FG000|Overall Study|Administrative Decision|1|||
125062995|NCT00696436|449848556|FG001|Overall Study|Administrative Decision|0|||
125062996|NCT00696436|449848557|FG002|Overall Study|Administrative Decision|0|||
125062997|NCT00696436|449848558|FG003|Overall Study|Administrative Decision|0|||
125062998|NCT00696436|449848559|FG004|Overall Study|Administrative Decision|0|||
125062999|NCT00696436|449848555|FG000|Overall Study|Missing|0|||
125063000|NCT00696436|449848556|FG001|Overall Study|Missing|1|||
125063001|NCT00696436|449848557|FG002|Overall Study|Missing|1|||
125063002|NCT00696436|449848558|FG003|Overall Study|Missing|0|||
125063003|NCT00696436|449848559|FG004|Overall Study|Missing|0|||
125063004|NCT02282982|449848560|FG000|Overall Study|Lost to Follow-up|15|||
125063005|NCT02282982|449848560|FG000|Overall Study|Withdrew consent|2|||
125063006|NCT02282982|449848560|FG000|Overall Study|Death|4|||
125063007|NCT02282982|449848560|FG000|Overall Study|Lack of product|156|||
125063008|NCT02282982|449848560|FG000|Overall Study|Palivizumab is ended|11|||
125063009|NCT02282982|449848560|FG000|Overall Study|Other, not specified|18|||
125063010|NCT02062463|449848561|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
125063011|NCT02062463|449848562|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
125063012|NCT02062463|449848563|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
125063013|NCT02062463|449848564|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
125063014|NCT02062463|449848561|FG000|Stage 2|Adverse Event|0|||
125063015|NCT02062463|449848562|FG001|Stage 2|Adverse Event|0|||
125063016|NCT02062463|449848563|FG002|Stage 2|Adverse Event|12|||
125063017|NCT02062463|449848564|FG003|Stage 2|Adverse Event|20|||
125063018|NCT02062463|449848561|FG000|Stage 2|Lack of Efficacy|0|||
125063019|NCT02062463|449848562|FG001|Stage 2|Lack of Efficacy|0|||
125063020|NCT02062463|449848563|FG002|Stage 2|Lack of Efficacy|3|||
125063021|NCT02062463|449848564|FG003|Stage 2|Lack of Efficacy|4|||
125063022|NCT02062463|449848561|FG000|Stage 2|Lost to Follow-up|0|||
125063023|NCT02062463|449848562|FG001|Stage 2|Lost to Follow-up|0|||
125063024|NCT02062463|449848563|FG002|Stage 2|Lost to Follow-up|20|||
125063025|NCT02062463|449848564|FG003|Stage 2|Lost to Follow-up|20|||
125063026|NCT02062463|449848561|FG000|Stage 2|Non-Compliance|0|||
125063027|NCT02062463|449848562|FG001|Stage 2|Non-Compliance|0|||
125063028|NCT02062463|449848563|FG002|Stage 2|Non-Compliance|0|||
125063029|NCT02062463|449848564|FG003|Stage 2|Non-Compliance|1|||
125063030|NCT02062463|449848561|FG000|Stage 2|Other than specified|0|||
125063031|NCT02062463|449848562|FG001|Stage 2|Other than specified|0|||
125063032|NCT02062463|449848563|FG002|Stage 2|Other than specified|3|||
125063033|NCT02062463|449848564|FG003|Stage 2|Other than specified|1|||
125063034|NCT02062463|449848561|FG000|Stage 2|Withdrawal by Subject|0|||
125063035|NCT02062463|449848562|FG001|Stage 2|Withdrawal by Subject|0|||
125063036|NCT02062463|449848563|FG002|Stage 2|Withdrawal by Subject|15|||
125063037|NCT02062463|449848564|FG003|Stage 2|Withdrawal by Subject|10|||
125063038|NCT00363051|449848571|FG000|Overall Study|Adminstrative problems|1|||
125063039|NCT00363051|449848572|FG001|Overall Study|Adminstrative problems|1|||
125063040|NCT00363051|449848571|FG000|Overall Study|Adverse Event|21|||
125063041|NCT00363051|449848572|FG001|Overall Study|Adverse Event|12|||
125063042|NCT00363051|449848571|FG000|Overall Study|New Cancer Therapy|2|||
125063043|NCT00363051|449848572|FG001|Overall Study|New Cancer Therapy|1|||
125063044|NCT00363051|449848571|FG000|Overall Study|Withdrawal by Subject|11|||
125063045|NCT00363051|449848572|FG001|Overall Study|Withdrawal by Subject|3|||
125063046|NCT00363051|449848571|FG000|Overall Study|Lost to Follow-up|0|||
125063047|NCT00363051|449848572|FG001|Overall Study|Lost to Follow-up|1|||
125063048|NCT00363051|449848571|FG000|Overall Study|Protocol Violation|0|||
125063049|NCT00363051|449848572|FG001|Overall Study|Protocol Violation|2|||
125063050|NCT00363051|449848571|FG000|Overall Study|Death|3|||
125063051|NCT00363051|449848572|FG001|Overall Study|Death|2|||
125063052|NCT00205699|449848575|FG000|Overall Study|Lost to Follow-up|1|||
125063053|NCT00205699|449848576|FG001|Overall Study|Lost to Follow-up|3|||
125063054|NCT00205699|449848577|FG002|Overall Study|Lost to Follow-up|5|||
125063055|NCT00205699|449848575|FG000|Overall Study|Adverse Event|1|||
125063056|NCT00205699|449848576|FG001|Overall Study|Adverse Event|0|||
125063057|NCT00205699|449848577|FG002|Overall Study|Adverse Event|0|||
125063058|NCT00205699|449848575|FG000|Overall Study|Withdrawal by Subject|1|||
125063059|NCT00205699|449848576|FG001|Overall Study|Withdrawal by Subject|2|||
125063060|NCT00205699|449848577|FG002|Overall Study|Withdrawal by Subject|1|||
125063061|NCT00205699|449848575|FG000|Overall Study|Lack of Efficacy|0|||
125063062|NCT00205699|449848576|FG001|Overall Study|Lack of Efficacy|1|||
125063063|NCT00205699|449848577|FG002|Overall Study|Lack of Efficacy|0|||
125063064|NCT03225716|449848582|FG000|Overall Study|Withdrawal by Subject|2|||
125063065|NCT03225716|449848583|FG001|Overall Study|Withdrawal by Subject|2|||
125063066|NCT03225716|449848584|FG002|Overall Study|Withdrawal by Subject|0|||
125063067|NCT03225716|449848582|FG000|Overall Study|Lack of Efficacy|1|||
125063068|NCT03225716|449848583|FG001|Overall Study|Lack of Efficacy|0|||
125063069|NCT03225716|449848584|FG002|Overall Study|Lack of Efficacy|0|||
125063070|NCT03225716|449848582|FG000|Overall Study|Adverse Event|2|||
125063071|NCT03225716|449848583|FG001|Overall Study|Adverse Event|0|||
125063072|NCT03225716|449848584|FG002|Overall Study|Adverse Event|1|||
125063073|NCT03225716|449848582|FG000|Overall Study|Study early termination by Sponsor|0|||
125063074|NCT03225716|449848583|FG001|Overall Study|Study early termination by Sponsor|0|||
125063075|NCT03225716|449848584|FG002|Overall Study|Study early termination by Sponsor|2|||
125063076|NCT01114373|449848585|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
125063077|NCT01114373|449848586|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
125063078|NCT01114373|449848585|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
125063079|NCT01114373|449848586|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
125063080|NCT01114373|449848585|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
125063081|NCT01114373|449848586|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
125063082|NCT01114373|449848585|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
125063083|NCT01114373|449848586|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
125063084|NCT01653158|449848590|FG000|Overall Study|Death|0|||
125063085|NCT01653158|449848591|FG001|Overall Study|Death|0|||
125063086|NCT01653158|449848592|FG002|Overall Study|Death|0|||
125063087|NCT01653158|449848593|FG003|Overall Study|Death|1|||
125063088|NCT01653158|449848594|FG004|Overall Study|Death|0|||
125063089|NCT01653158|449848595|FG005|Overall Study|Death|0|||
125063090|NCT01653158|449848596|FG006|Overall Study|Death|0|||
125063091|NCT01653158|449848597|FG007|Overall Study|Death|2|||
125063092|NCT01653158|449848590|FG000|Overall Study|Adverse Event|0|||
125063093|NCT01653158|449848591|FG001|Overall Study|Adverse Event|0|||
125063094|NCT01653158|449848592|FG002|Overall Study|Adverse Event|0|||
125063095|NCT01653158|449848593|FG003|Overall Study|Adverse Event|1|||
125063096|NCT01653158|449848594|FG004|Overall Study|Adverse Event|0|||
125063097|NCT01653158|449848595|FG005|Overall Study|Adverse Event|0|||
125063098|NCT01653158|449848596|FG006|Overall Study|Adverse Event|0|||
125063099|NCT01653158|449848597|FG007|Overall Study|Adverse Event|3|||
125063100|NCT01653158|449848590|FG000|Overall Study|Other|0|||
125063101|NCT01653158|449848591|FG001|Overall Study|Other|0|||
125063102|NCT01653158|449848592|FG002|Overall Study|Other|0|||
125063103|NCT01653158|449848593|FG003|Overall Study|Other|0|||
125063104|NCT01653158|449848594|FG004|Overall Study|Other|0|||
125063105|NCT01653158|449848595|FG005|Overall Study|Other|0|||
125063106|NCT01653158|449848596|FG006|Overall Study|Other|0|||
125063107|NCT01653158|449848597|FG007|Overall Study|Other|1|||
125063108|NCT01653158|449848590|FG000|Overall Study|Progressive disease|0|||
125063109|NCT01653158|449848591|FG001|Overall Study|Progressive disease|0|||
125063110|NCT01653158|449848592|FG002|Overall Study|Progressive disease|0|||
125063111|NCT01653158|449848593|FG003|Overall Study|Progressive disease|0|||
125063112|NCT01653158|449848594|FG004|Overall Study|Progressive disease|1|||
125063113|NCT01653158|449848595|FG005|Overall Study|Progressive disease|1|||
125063114|NCT01653158|449848596|FG006|Overall Study|Progressive disease|2|||
125063115|NCT01653158|449848597|FG007|Overall Study|Progressive disease|9|||
125063116|NCT01653158|449848590|FG000|Overall Study|Withdrawal by Subject|1|||
125063117|NCT01653158|449848591|FG001|Overall Study|Withdrawal by Subject|0|||
125063118|NCT01653158|449848592|FG002|Overall Study|Withdrawal by Subject|0|||
125063119|NCT01653158|449848593|FG003|Overall Study|Withdrawal by Subject|0|||
125063120|NCT01653158|449848594|FG004|Overall Study|Withdrawal by Subject|0|||
125063121|NCT01653158|449848595|FG005|Overall Study|Withdrawal by Subject|0|||
125063122|NCT01653158|449848596|FG006|Overall Study|Withdrawal by Subject|0|||
125063123|NCT01653158|449848597|FG007|Overall Study|Withdrawal by Subject|0|||
125063124|NCT03444870|449848602|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
125063125|NCT03444870|449848603|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
125063126|NCT03444870|449848604|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
125063127|NCT03444870|449848605|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
125063128|NCT03444870|449848606|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
125063129|NCT03444870|449848607|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
125063130|NCT03444870|449848602|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
125063131|NCT03444870|449848603|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
125063132|NCT03444870|449848604|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
125063133|NCT03444870|449848605|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
125063134|NCT03444870|449848606|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
125063135|NCT03444870|449848607|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
125063136|NCT03444870|449848602|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
125063137|NCT03444870|449848603|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
125063138|NCT03444870|449848604|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
125063139|NCT03444870|449848605|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
125063140|NCT03444870|449848606|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
125063141|NCT03444870|449848607|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
125063142|NCT03444870|449848602|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
125063143|NCT03444870|449848603|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
125063144|NCT03444870|449848604|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
125063145|NCT03444870|449848605|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
125063146|NCT03444870|449848606|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
125063147|NCT03444870|449848607|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
125063148|NCT03444870|449848602|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
125063149|NCT03444870|449848603|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
125063150|NCT03444870|449848604|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
125063151|NCT03444870|449848605|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
125063152|NCT03444870|449848606|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
125063153|NCT03444870|449848607|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
125063154|NCT03444870|449848602|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
125063155|NCT03444870|449848603|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
125063156|NCT03444870|449848604|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
125063157|NCT03444870|449848605|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
125063158|NCT03444870|449848606|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
125063159|NCT03444870|449848607|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
125063160|NCT03444870|449848602|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
125063161|NCT03444870|449848603|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
125063162|NCT03444870|449848604|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
125063163|NCT03444870|449848605|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
125063164|NCT03444870|449848606|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
125063165|NCT03444870|449848607|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
125063166|NCT03444870|449848602|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
125063167|NCT03444870|449848603|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
125063168|NCT03444870|449848604|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
125063169|NCT03444870|449848605|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
125063170|NCT03444870|449848606|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
125063171|NCT03444870|449848607|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
125063172|NCT03444870|449848602|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
125063173|NCT03444870|449848603|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
125063174|NCT03444870|449848604|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
125063175|NCT03444870|449848605|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
125063176|NCT03444870|449848606|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
125063177|NCT03444870|449848607|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
125063178|NCT03444870|449848602|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
125063179|NCT03444870|449848603|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
125063180|NCT03444870|449848604|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
125063181|NCT03444870|449848605|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
125063182|NCT03444870|449848606|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
125063183|NCT03444870|449848607|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
125063184|NCT03444870|449848602|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
125063185|NCT03444870|449848603|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
125063186|NCT03444870|449848604|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
125063187|NCT03444870|449848605|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
125063188|NCT03444870|449848606|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
125063189|NCT03444870|449848607|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
125063190|NCT03444870|449848602|FG000|Open-Label Extension (OLE) Period|Death|0|||
125063191|NCT03444870|449848603|FG001|Open-Label Extension (OLE) Period|Death|0|||
125063192|NCT03444870|449848604|FG002|Open-Label Extension (OLE) Period|Death|0|||
125063193|NCT03444870|449848605|FG003|Open-Label Extension (OLE) Period|Death|0|||
125063194|NCT03444870|449848606|FG004|Open-Label Extension (OLE) Period|Death|1|||
125063195|NCT03444870|449848607|FG005|Open-Label Extension (OLE) Period|Death|0|||
125063196|NCT01170702|449848610|FG000|Overall Study|Exclusion criteria met after consent|1|||
125063197|NCT01170702|449848611|FG001|Overall Study|Exclusion criteria met after consent|2|||
125063198|NCT01170702|449848612|FG002|Overall Study|Exclusion criteria met after consent|0|||
125063199|NCT01170702|449848613|FG003|Overall Study|Exclusion criteria met after consent|2|||
125063200|NCT01677507|449848614|FG000|Initial Assignment|Adverse Event|0|||
125063201|NCT01677507|449848615|FG001|Initial Assignment|Adverse Event|1|||
125063202|NCT01677507|449848614|FG000|Initial Assignment|Protocol Violation|0|||
125063203|NCT01677507|449848615|FG001|Initial Assignment|Protocol Violation|1|||
125063204|NCT01677507|449848614|FG000|Second Assigment|Withdrawal by Subject|2|||
125063205|NCT01677507|449848615|FG001|Second Assigment|Withdrawal by Subject|2|||
125063206|NCT01677507|449848614|FG000|Second Assigment|Adverse Event|1|||
125063207|NCT01677507|449848615|FG001|Second Assigment|Adverse Event|3|||
125063208|NCT00571688|449848616|FG000|Overall Study|Lost to Follow-up|3|||
125063209|NCT00571688|449848617|FG001|Overall Study|Lost to Follow-up|6|||
125063210|NCT00571688|449848616|FG000|Overall Study|subject did not tolerate Consta|1|||
125063211|NCT00571688|449848617|FG001|Overall Study|subject did not tolerate Consta|0|||
125063212|NCT00571688|449848616|FG000|Overall Study|subject moved out of the area|1|||
125063213|NCT00571688|449848617|FG001|Overall Study|subject moved out of the area|0|||
125063214|NCT00190983|449848618|FG000|Overall Study|Inevaluable (never treated)|2|||
125063215|NCT02287402|449848619|FG000|Treatment Period|Adverse Event|17|||
125063216|NCT02287402|449848619|FG000|Treatment Period|Voluntary Withdrawal|10|||
125063217|NCT02287402|449848619|FG000|Follow-up|Lost to Follow-up|1|||
125063218|NCT02287402|449848619|FG000|Follow-up|Voluntary Withdrawal|2|||
125063219|NCT01844830|449848620|FG000|Overall Study|Withdrawal by Subject|1|||
125222449|NCT01576575|450442751|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
125063220|NCT01844830|449848621|FG001|Overall Study|Withdrawal by Subject|0|||
125063221|NCT04247815|449848622|FG000|Overall Study|Adverse Event|1|||
125063222|NCT04247815|449848623|FG001|Overall Study|Adverse Event|0|||
125063223|NCT04247815|449848622|FG000|Overall Study|Withdrawal by Subject|1|||
125063224|NCT04247815|449848623|FG001|Overall Study|Withdrawal by Subject|0|||
125063225|NCT04247815|449848622|FG000|Overall Study|Protocol Violation|0|||
125063226|NCT04247815|449848623|FG001|Overall Study|Protocol Violation|1|||
125063227|NCT00502320|449848625|FG000|Overall Study|Lost to Follow-up|1|||
125063228|NCT00502320|449848626|FG001|Overall Study|Lost to Follow-up|1|||
125063229|NCT00502320|449848625|FG000|Overall Study|Withdrew Consent|1|||
125063230|NCT00502320|449848626|FG001|Overall Study|Withdrew Consent|0|||
125063231|NCT00502320|449848625|FG000|Overall Study|No longer met criteria|1|||
125063232|NCT00502320|449848626|FG001|Overall Study|No longer met criteria|0|||
125063233|NCT00502320|449848625|FG000|Overall Study|Screen Failure|0|||
125063234|NCT00502320|449848626|FG001|Overall Study|Screen Failure|1|||
125063235|NCT00502320|449848625|FG000|Overall Study|Adverse Event|3|||
125063236|NCT00502320|449848626|FG001|Overall Study|Adverse Event|5|||
125063237|NCT00084929|449848628|FG000|Overall Study|ineligible - medical contraindication|1|||
125063238|NCT00084929|449848628|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
125063239|NCT00084929|449848628|FG000|Overall Study|Ineligible - Medical history|6|||
125063240|NCT00084929|449848628|FG000|Overall Study|Withdrawal by Subject|10|||
125063241|NCT00084929|449848628|FG000|Overall Study|Missing/incomplete CTC exam|9|||
125063242|NCT00084929|449848628|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
125063243|NCT00077610|449848630|FG000|Overall Study|Adverse Event|9|||
125063244|NCT00077610|449848631|FG001|Overall Study|Adverse Event|7|||
125063245|NCT00077610|449848632|FG002|Overall Study|Adverse Event|1|||
125063246|NCT00077610|449848630|FG000|Overall Study|Lost to Follow-up|0|||
125063247|NCT00077610|449848631|FG001|Overall Study|Lost to Follow-up|1|||
125063248|NCT00077610|449848632|FG002|Overall Study|Lost to Follow-up|2|||
125063249|NCT00077610|449848630|FG000|Overall Study|Withdrawal by Subject|4|||
125063250|NCT00077610|449848631|FG001|Overall Study|Withdrawal by Subject|10|||
125063251|NCT00077610|449848632|FG002|Overall Study|Withdrawal by Subject|6|||
125063252|NCT00077610|449848630|FG000|Overall Study|Death|17|||
125063253|NCT00077610|449848631|FG001|Overall Study|Death|13|||
125063254|NCT00077610|449848632|FG002|Overall Study|Death|13|||
125063255|NCT00077610|449848630|FG000|Overall Study|Renal transplant|12|||
125063256|NCT00077610|449848631|FG001|Overall Study|Renal transplant|15|||
125063257|NCT00077610|449848632|FG002|Overall Study|Renal transplant|11|||
125063258|NCT00077610|449848630|FG000|Overall Study|Withdrew from dialysis care|5|||
125063259|NCT00077610|449848631|FG001|Overall Study|Withdrew from dialysis care|0|||
125063260|NCT00077610|449848632|FG002|Overall Study|Withdrew from dialysis care|3|||
125063261|NCT00077610|449848630|FG000|Overall Study|Insufficient Therapeutic Response|1|||
125063262|NCT00077610|449848631|FG001|Overall Study|Insufficient Therapeutic Response|0|||
125063263|NCT00077610|449848632|FG002|Overall Study|Insufficient Therapeutic Response|0|||
125063264|NCT00077610|449848630|FG000|Overall Study|Multiple blood transfusions|0|||
125063265|NCT00077610|449848631|FG001|Overall Study|Multiple blood transfusions|0|||
125063266|NCT00077610|449848632|FG002|Overall Study|Multiple blood transfusions|1|||
125063267|NCT00077610|449848630|FG000|Overall Study|Principal Investigator's decision|1|||
125063268|NCT00077610|449848631|FG001|Overall Study|Principal Investigator's decision|0|||
125063269|NCT00077610|449848632|FG002|Overall Study|Principal Investigator's decision|1|||
125063270|NCT00077610|449848630|FG000|Overall Study|Worsening of health condition|1|||
125139457|NCT01647828|450132876|FG008|Overall Study|Death|71|||
125139458|NCT01647828|450132868|FG000|Overall Study|Withdrawal by Subject|2|||
125139459|NCT01647828|450132869|FG001|Overall Study|Withdrawal by Subject|0|||
125139460|NCT01647828|450132870|FG002|Overall Study|Withdrawal by Subject|0|||
125139461|NCT01647828|450132871|FG003|Overall Study|Withdrawal by Subject|1|||
125063271|NCT00077610|449848631|FG001|Overall Study|Worsening of health condition|1|||
125139462|NCT01647828|450132872|FG004|Overall Study|Withdrawal by Subject|0|||
125139463|NCT01647828|450132873|FG005|Overall Study|Withdrawal by Subject|0|||
125139464|NCT01647828|450132874|FG006|Overall Study|Withdrawal by Subject|1|||
125063272|NCT00077610|449848632|FG002|Overall Study|Worsening of health condition|0|||
125063273|NCT00077610|449848630|FG000|Overall Study|Given Epogen in hospital|1|||
125063274|NCT00077610|449848631|FG001|Overall Study|Given Epogen in hospital|0|||
125063275|NCT00077610|449848632|FG002|Overall Study|Given Epogen in hospital|0|||
125063276|NCT00077610|449848630|FG000|Overall Study|Transferred to other unit|0|||
125063277|NCT00077610|449848631|FG001|Overall Study|Transferred to other unit|0|||
125063278|NCT00077610|449848632|FG002|Overall Study|Transferred to other unit|1|||
125063279|NCT00077610|449848630|FG000|Overall Study|Transferred to nursing home|0|||
125063280|NCT00077610|449848631|FG001|Overall Study|Transferred to nursing home|0|||
125063281|NCT00077610|449848632|FG002|Overall Study|Transferred to nursing home|1|||
125063282|NCT00077610|449848630|FG000|Overall Study|Transfer to satellite unit|1|||
125063283|NCT00077610|449848631|FG001|Overall Study|Transfer to satellite unit|0|||
125139465|NCT01647828|450132875|FG007|Overall Study|Withdrawal by Subject|0|||
125139466|NCT01647828|450132876|FG008|Overall Study|Withdrawal by Subject|2|||
125139467|NCT01647828|450132868|FG000|Overall Study|Study terminated by Sponsor|0|||
125139468|NCT01647828|450132869|FG001|Overall Study|Study terminated by Sponsor|0|||
125063284|NCT00077610|449848632|FG002|Overall Study|Transfer to satellite unit|0|||
125063285|NCT00077610|449848630|FG000|Overall Study|Transfer to other center for surgery|1|||
125063286|NCT00077610|449848631|FG001|Overall Study|Transfer to other center for surgery|0|||
125063287|NCT00077610|449848632|FG002|Overall Study|Transfer to other center for surgery|0|||
125063288|NCT00077610|449848630|FG000|Overall Study|Change in dialysis modality|1|||
125063289|NCT00077610|449848631|FG001|Overall Study|Change in dialysis modality|0|||
125063290|NCT00077610|449848632|FG002|Overall Study|Change in dialysis modality|0|||
125063291|NCT00077610|449848630|FG000|Overall Study|Relocation|0|||
125063292|NCT00077610|449848631|FG001|Overall Study|Relocation|8|||
125063293|NCT00077610|449848632|FG002|Overall Study|Relocation|5|||
125063294|NCT00077610|449848630|FG000|Overall Study|Financial issues|0|||
125063295|NCT00077610|449848631|FG001|Overall Study|Financial issues|1|||
125063296|NCT00077610|449848632|FG002|Overall Study|Financial issues|0|||
125063297|NCT00077610|449848630|FG000|Overall Study|Sponsors decision to withdraw|0|||
125063298|NCT00077610|449848631|FG001|Overall Study|Sponsors decision to withdraw|0|||
125063299|NCT00077610|449848632|FG002|Overall Study|Sponsors decision to withdraw|1|||
125063300|NCT03442829|449848641|FG000|Overall Study|Scheduling clash|3|||
125063301|NCT03442829|449848642|FG001|Overall Study|Scheduling clash|1|||
125063302|NCT03442829|449848641|FG000|Overall Study|Illness unrelated to study|1|||
125063303|NCT03442829|449848642|FG001|Overall Study|Illness unrelated to study|1|||
125063304|NCT01029002|449848643|FG000|Overall Study|Lost to Follow-up|2|||
125063305|NCT01029002|449848644|FG001|Overall Study|Lost to Follow-up|4|||
125063306|NCT00702052|449848645|FG000|Overall Study|Adverse Event|23|||
125063307|NCT00702052|449848645|FG000|Overall Study|Disease Progression|30|||
125063308|NCT00702052|449848645|FG000|Overall Study|Withdrawal by Subject|5|||
125063309|NCT01577160|449848646|FG000|Overall Study|Adverse Event|9|||
125063310|NCT01577160|449848646|FG000|Overall Study|Lack of Efficacy|15|||
125063311|NCT01577160|449848646|FG000|Overall Study|Lost to Follow-up|40|||
125063312|NCT01577160|449848646|FG000|Overall Study|Withdrawal by Subject|18|||
125063313|NCT01577160|449848646|FG000|Overall Study|Subject Uncooperative|7|||
125063314|NCT01577160|449848646|FG000|Overall Study|Other|9|||
125063315|NCT01551758|449848647|FG000|Overall Study|Adverse Event|29|||
125063316|NCT01551758|449848648|FG001|Overall Study|Adverse Event|43|||
125063317|NCT01551758|449848647|FG000|Overall Study|Lack of Efficacy|0|||
125063318|NCT01551758|449848648|FG001|Overall Study|Lack of Efficacy|1|||
125063319|NCT01551758|449848647|FG000|Overall Study|Protocol Violation|5|||
125063320|NCT01551758|449848648|FG001|Overall Study|Protocol Violation|6|||
125063321|NCT01551758|449848647|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
125063322|NCT01551758|449848648|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
125063323|NCT01551758|449848647|FG000|Overall Study|Lost to Follow-up|29|||
125063324|NCT01551758|449848648|FG001|Overall Study|Lost to Follow-up|25|||
125063325|NCT01551758|449848647|FG000|Overall Study|Physician Decision|9|||
125063326|NCT01551758|449848648|FG001|Overall Study|Physician Decision|3|||
125063327|NCT01551758|449848647|FG000|Overall Study|Withdrawal by Subject|14|||
125063328|NCT01551758|449848648|FG001|Overall Study|Withdrawal by Subject|17|||
125063329|NCT00101192|449848649|FG000|Overall Study|Ineligible|6|||
125063330|NCT00101192|449848649|FG000|Overall Study|Inevaluable|1|||
125063331|NCT03282357|449848656|FG000|Overall Study|Lost to Follow-up|3|||
125063332|NCT03282357|449848656|FG000|Overall Study|Withdrawal by Subject|4|||
125063333|NCT03282357|449848656|FG000|Overall Study|Adverse Event|1|||
125063334|NCT03282357|449848656|FG000|Overall Study|Other|9|||
125063335|NCT01586156|449848657|FG000|Overall Study|Pregnancy|0|||
125063336|NCT01586156|449848658|FG001|Overall Study|Pregnancy|1|||
125063337|NCT01586156|449848659|FG002|Overall Study|Pregnancy|0|||
125063338|NCT02121756|449848662|FG000|Overall Study|Adverse Event|3|||
125063339|NCT02121756|449848663|FG001|Overall Study|Adverse Event|0|||
125063340|NCT02121756|449848662|FG000|Overall Study|Protocol Violation|1|||
125063341|NCT02121756|449848663|FG001|Overall Study|Protocol Violation|1|||
125063342|NCT02121756|449848662|FG000|Overall Study|Physician Decision|2|||
125063343|NCT02121756|449848663|FG001|Overall Study|Physician Decision|1|||
125063344|NCT00632541|449848664|FG000|Overall Study|Adverse Event|7|||
125063345|NCT01179347|449850755|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
125063346|NCT01179347|449850756|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
125063347|NCT01179347|449850755|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
125063348|NCT01179347|449850756|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
125063349|NCT01179347|449850755|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
125063350|NCT01179347|449850756|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
125063351|NCT01179347|449850755|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
125063352|NCT01179347|449850756|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
125063353|NCT01179347|449850755|FG000|Double-blind Period (12 Weeks)|Other|2|||
125063354|NCT01179347|449850756|FG001|Double-blind Period (12 Weeks)|Other|4|||
125063355|NCT01179347|449850755|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
125063356|NCT01179347|449850756|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
125063357|NCT01179347|449850755|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
125063358|NCT01179347|449850756|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
125063359|NCT01179347|449850755|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
125063360|NCT01179347|449850756|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
125063361|NCT01179347|449850755|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
125063362|NCT01179347|449850756|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
125063363|NCT01179347|449850755|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
125063364|NCT01179347|449850756|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
125063365|NCT01179347|449850755|FG000|Open-label Period (12 Weeks)|Other|7|||
125063366|NCT01179347|449850756|FG001|Open-label Period (12 Weeks)|Other|4|||
125063367|NCT00369967|449850758|FG000|Overall Study|Lost to Follow-up|23|||
125063368|NCT00369967|449850759|FG001|Overall Study|Lost to Follow-up|12|||
125063369|NCT01677624|449850760|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
125063370|NCT01830816|449850766|FG000|Overall Study|Progressive Disease|12|||
125063371|NCT01830816|449850767|FG001|Overall Study|Progressive Disease|7|||
125063372|NCT01830816|449850768|FG002|Overall Study|Progressive Disease|7|||
125063373|NCT01830816|449850766|FG000|Overall Study|Adverse Event|3|||
125063374|NCT01830816|449850767|FG001|Overall Study|Adverse Event|4|||
125063375|NCT01830816|449850768|FG002|Overall Study|Adverse Event|0|||
125063376|NCT01830816|449850766|FG000|Overall Study|Study Terminated by Sponsor|1|||
125063377|NCT01830816|449850767|FG001|Overall Study|Study Terminated by Sponsor|1|||
125063378|NCT01830816|449850768|FG002|Overall Study|Study Terminated by Sponsor|0|||
125063379|NCT01830816|449850766|FG000|Overall Study|Withdrawal by Subject|1|||
125063380|NCT01830816|449850767|FG001|Overall Study|Withdrawal by Subject|1|||
125063381|NCT01830816|449850768|FG002|Overall Study|Withdrawal by Subject|0|||
125063382|NCT01830816|449850766|FG000|Overall Study|Lost to Follow-up|0|||
125063383|NCT01830816|449850767|FG001|Overall Study|Lost to Follow-up|1|||
125063384|NCT01830816|449850768|FG002|Overall Study|Lost to Follow-up|0|||
125063385|NCT01830816|449850766|FG000|Overall Study|Symptomatic Deterioration|1|||
125063386|NCT01830816|449850767|FG001|Overall Study|Symptomatic Deterioration|0|||
125063387|NCT01830816|449850768|FG002|Overall Study|Symptomatic Deterioration|0|||
125063388|NCT01830816|449850766|FG000|Overall Study|Reason not Specified|2|||
125063389|NCT01830816|449850767|FG001|Overall Study|Reason not Specified|0|||
125063390|NCT01830816|449850768|FG002|Overall Study|Reason not Specified|0|||
125063391|NCT00830115|449850769|FG000|Overall Study|Adverse Event|2|||
125063392|NCT00830115|449850769|FG000|Overall Study|Improvement/recovery|1|||
125063393|NCT01207388|449850772|FG000|Overall Study|Death|67|||
125063394|NCT01207388|449850772|FG000|Overall Study|Withdrawal by Subject|1|||
125063395|NCT01885078|449850773|FG000|Treatment Period|Adverse Event|52|||
125063396|NCT01885078|449850774|FG001|Treatment Period|Adverse Event|136|||
125063397|NCT01885078|449850775|FG002|Treatment Period|Adverse Event|30|||
125063398|NCT01885078|449850776|FG003|Treatment Period|Adverse Event|73|||
125063399|NCT01885078|449850777|FG004|Treatment Period|Adverse Event|17|||
125063400|NCT01885078|449850778|FG005|Treatment Period|Adverse Event|72|||
125063401|NCT01885078|449850779|FG006|Treatment Period|Adverse Event|24|||
125063402|NCT01885078|449850780|FG007|Treatment Period|Adverse Event|5|||
125063403|NCT01885078|449850781|FG008|Treatment Period|Adverse Event|0|||
125063404|NCT01885078|449850782|FG009|Treatment Period|Adverse Event|0|||
125063405|NCT01885078|449850773|FG000|Treatment Period|Death|13|||
125063406|NCT01885078|449850774|FG001|Treatment Period|Death|33|||
125063407|NCT01885078|449850775|FG002|Treatment Period|Death|5|||
125063408|NCT01885078|449850776|FG003|Treatment Period|Death|9|||
125063409|NCT01885078|449850777|FG004|Treatment Period|Death|2|||
125063410|NCT01885078|449850778|FG005|Treatment Period|Death|10|||
125063411|NCT01885078|449850779|FG006|Treatment Period|Death|3|||
125063412|NCT01885078|449850780|FG007|Treatment Period|Death|2|||
125063413|NCT01885078|449850781|FG008|Treatment Period|Death|0|||
125063414|NCT01885078|449850782|FG009|Treatment Period|Death|0|||
125063415|NCT01885078|449850773|FG000|Treatment Period|Lack of Efficacy|12|||
125063416|NCT01885078|449850774|FG001|Treatment Period|Lack of Efficacy|33|||
125063417|NCT01885078|449850775|FG002|Treatment Period|Lack of Efficacy|10|||
125063418|NCT01885078|449850776|FG003|Treatment Period|Lack of Efficacy|23|||
125063419|NCT01885078|449850777|FG004|Treatment Period|Lack of Efficacy|24|||
125063420|NCT01885078|449850778|FG005|Treatment Period|Lack of Efficacy|58|||
125063421|NCT01885078|449850779|FG006|Treatment Period|Lack of Efficacy|9|||
125063422|NCT01885078|449850780|FG007|Treatment Period|Lack of Efficacy|5|||
125063423|NCT01885078|449850781|FG008|Treatment Period|Lack of Efficacy|0|||
125063424|NCT01885078|449850782|FG009|Treatment Period|Lack of Efficacy|0|||
125063425|NCT01885078|449850773|FG000|Treatment Period|Lost to Follow-up|16|||
125063426|NCT01885078|449850774|FG001|Treatment Period|Lost to Follow-up|19|||
125063427|NCT01885078|449850775|FG002|Treatment Period|Lost to Follow-up|7|||
125063428|NCT01885078|449850776|FG003|Treatment Period|Lost to Follow-up|9|||
125063429|NCT01885078|449850777|FG004|Treatment Period|Lost to Follow-up|2|||
125063430|NCT01885078|449850778|FG005|Treatment Period|Lost to Follow-up|8|||
125063431|NCT01885078|449850779|FG006|Treatment Period|Lost to Follow-up|2|||
125063432|NCT01885078|449850780|FG007|Treatment Period|Lost to Follow-up|0|||
125063433|NCT01885078|449850781|FG008|Treatment Period|Lost to Follow-up|0|||
125063434|NCT01885078|449850782|FG009|Treatment Period|Lost to Follow-up|0|||
125063435|NCT01885078|449850773|FG000|Treatment Period|Physician Decision|19|||
125063436|NCT01885078|449850774|FG001|Treatment Period|Physician Decision|21|||
125063437|NCT01885078|449850775|FG002|Treatment Period|Physician Decision|5|||
125139469|NCT01647828|450132870|FG002|Overall Study|Study terminated by Sponsor|0|||
125139470|NCT01647828|450132871|FG003|Overall Study|Study terminated by Sponsor|0|||
125139471|NCT01647828|450132872|FG004|Overall Study|Study terminated by Sponsor|0|||
125139472|NCT01647828|450132873|FG005|Overall Study|Study terminated by Sponsor|0|||
125063438|NCT01885078|449850776|FG003|Treatment Period|Physician Decision|12|||
125063439|NCT01885078|449850777|FG004|Treatment Period|Physician Decision|9|||
125063440|NCT01885078|449850778|FG005|Treatment Period|Physician Decision|24|||
125063441|NCT01885078|449850779|FG006|Treatment Period|Physician Decision|4|||
125063442|NCT01885078|449850780|FG007|Treatment Period|Physician Decision|3|||
125063443|NCT01885078|449850781|FG008|Treatment Period|Physician Decision|0|||
125063444|NCT01885078|449850782|FG009|Treatment Period|Physician Decision|0|||
125063445|NCT01885078|449850773|FG000|Treatment Period|Protocol Violation|3|||
125063446|NCT01885078|449850774|FG001|Treatment Period|Protocol Violation|5|||
125063447|NCT01885078|449850775|FG002|Treatment Period|Protocol Violation|0|||
125063448|NCT01885078|449850776|FG003|Treatment Period|Protocol Violation|3|||
125063449|NCT01885078|449850777|FG004|Treatment Period|Protocol Violation|1|||
125063450|NCT01885078|449850778|FG005|Treatment Period|Protocol Violation|6|||
125063451|NCT01885078|449850779|FG006|Treatment Period|Protocol Violation|0|||
125063452|NCT01885078|449850780|FG007|Treatment Period|Protocol Violation|0|||
125063453|NCT01885078|449850781|FG008|Treatment Period|Protocol Violation|0|||
125063454|NCT01885078|449850782|FG009|Treatment Period|Protocol Violation|0|||
125063455|NCT01885078|449850773|FG000|Treatment Period|Sponsor Decision|245|||
125063456|NCT01885078|449850774|FG001|Treatment Period|Sponsor Decision|648|||
125063457|NCT01885078|449850775|FG002|Treatment Period|Sponsor Decision|49|||
125063458|NCT01885078|449850776|FG003|Treatment Period|Sponsor Decision|90|||
125063459|NCT01885078|449850777|FG004|Treatment Period|Sponsor Decision|20|||
125063460|NCT01885078|449850778|FG005|Treatment Period|Sponsor Decision|38|||
125063461|NCT01885078|449850779|FG006|Treatment Period|Sponsor Decision|162|||
125063462|NCT01885078|449850780|FG007|Treatment Period|Sponsor Decision|3|||
125063463|NCT01885078|449850781|FG008|Treatment Period|Sponsor Decision|0|||
125063464|NCT01885078|449850782|FG009|Treatment Period|Sponsor Decision|0|||
125063465|NCT01885078|449850773|FG000|Treatment Period|Withdrawal by Subject|72|||
125063466|NCT01885078|449850774|FG001|Treatment Period|Withdrawal by Subject|132|||
125063467|NCT01885078|449850775|FG002|Treatment Period|Withdrawal by Subject|25|||
125063468|NCT01885078|449850776|FG003|Treatment Period|Withdrawal by Subject|63|||
125063469|NCT01885078|449850777|FG004|Treatment Period|Withdrawal by Subject|15|||
125063470|NCT01885078|449850778|FG005|Treatment Period|Withdrawal by Subject|34|||
125063471|NCT01885078|449850779|FG006|Treatment Period|Withdrawal by Subject|17|||
125063472|NCT01885078|449850780|FG007|Treatment Period|Withdrawal by Subject|10|||
125063473|NCT01885078|449850781|FG008|Treatment Period|Withdrawal by Subject|0|||
125063474|NCT01885078|449850782|FG009|Treatment Period|Withdrawal by Subject|0|||
125063475|NCT01885078|449850773|FG000|Treatment Period|Other|0|||
125063476|NCT01885078|449850774|FG001|Treatment Period|Other|0|||
125063477|NCT01885078|449850775|FG002|Treatment Period|Other|0|||
125063478|NCT01885078|449850776|FG003|Treatment Period|Other|1|||
125063479|NCT01885078|449850777|FG004|Treatment Period|Other|0|||
125063480|NCT01885078|449850778|FG005|Treatment Period|Other|0|||
125063481|NCT01885078|449850779|FG006|Treatment Period|Other|0|||
125063482|NCT01885078|449850780|FG007|Treatment Period|Other|0|||
125139473|NCT01647828|450132874|FG006|Overall Study|Study terminated by Sponsor|1|||
125139474|NCT01647828|450132875|FG007|Overall Study|Study terminated by Sponsor|26|||
125063483|NCT01885078|449850781|FG008|Treatment Period|Other|0|||
125063484|NCT01885078|449850782|FG009|Treatment Period|Other|0|||
125063485|NCT01885078|449850773|FG000|Step-down Period|Sponsor Decision|0|||
125063486|NCT01885078|449850774|FG001|Step-down Period|Sponsor Decision|0|||
125063487|NCT01885078|449850775|FG002|Step-down Period|Sponsor Decision|0|||
125063488|NCT01885078|449850776|FG003|Step-down Period|Sponsor Decision|0|||
125063489|NCT01885078|449850777|FG004|Step-down Period|Sponsor Decision|0|||
125063490|NCT01885078|449850778|FG005|Step-down Period|Sponsor Decision|0|||
125139475|NCT01647828|450132876|FG008|Overall Study|Study terminated by Sponsor|16|||
125139476|NCT01647828|450132868|FG000|Overall Study|Lost to Follow-up|0|||
125063491|NCT01885078|449850779|FG006|Step-down Period|Sponsor Decision|0|||
125063492|NCT01885078|449850780|FG007|Step-down Period|Sponsor Decision|0|||
125063493|NCT01885078|449850781|FG008|Step-down Period|Sponsor Decision|1|||
125063494|NCT01885078|449850782|FG009|Step-down Period|Sponsor Decision|1|||
125063495|NCT01885078|449850773|FG000|Step-down Period|Adverse Event|0|||
125063496|NCT01885078|449850774|FG001|Step-down Period|Adverse Event|0|||
125063497|NCT01885078|449850775|FG002|Step-down Period|Adverse Event|0|||
125063498|NCT01885078|449850776|FG003|Step-down Period|Adverse Event|0|||
125063499|NCT01885078|449850777|FG004|Step-down Period|Adverse Event|0|||
125063500|NCT01885078|449850778|FG005|Step-down Period|Adverse Event|0|||
125063501|NCT01885078|449850779|FG006|Step-down Period|Adverse Event|0|||
125063502|NCT01885078|449850780|FG007|Step-down Period|Adverse Event|0|||
125063503|NCT01885078|449850781|FG008|Step-down Period|Adverse Event|29|||
125063504|NCT01885078|449850782|FG009|Step-down Period|Adverse Event|38|||
125063505|NCT01885078|449850773|FG000|Step-down Period|Withdrawal by Subject|0|||
125139477|NCT01647828|450132869|FG001|Overall Study|Lost to Follow-up|0|||
125063506|NCT01885078|449850774|FG001|Step-down Period|Withdrawal by Subject|0|||
125063507|NCT01885078|449850775|FG002|Step-down Period|Withdrawal by Subject|0|||
125063508|NCT01885078|449850776|FG003|Step-down Period|Withdrawal by Subject|0|||
125063509|NCT01885078|449850777|FG004|Step-down Period|Withdrawal by Subject|0|||
125063510|NCT01885078|449850778|FG005|Step-down Period|Withdrawal by Subject|0|||
125063511|NCT01885078|449850779|FG006|Step-down Period|Withdrawal by Subject|0|||
125063512|NCT01885078|449850780|FG007|Step-down Period|Withdrawal by Subject|0|||
125063513|NCT01885078|449850781|FG008|Step-down Period|Withdrawal by Subject|25|||
125063514|NCT01885078|449850782|FG009|Step-down Period|Withdrawal by Subject|15|||
125063515|NCT01885078|449850773|FG000|Step-down Period|Physician Decision|0|||
125063516|NCT01885078|449850774|FG001|Step-down Period|Physician Decision|0|||
125063517|NCT01885078|449850775|FG002|Step-down Period|Physician Decision|0|||
125063518|NCT01885078|449850776|FG003|Step-down Period|Physician Decision|0|||
125063519|NCT01885078|449850777|FG004|Step-down Period|Physician Decision|0|||
125063520|NCT01885078|449850778|FG005|Step-down Period|Physician Decision|0|||
125063521|NCT01885078|449850779|FG006|Step-down Period|Physician Decision|0|||
125063522|NCT01885078|449850780|FG007|Step-down Period|Physician Decision|0|||
125063523|NCT01885078|449850781|FG008|Step-down Period|Physician Decision|7|||
125063524|NCT01885078|449850782|FG009|Step-down Period|Physician Decision|2|||
125063525|NCT01885078|449850773|FG000|Step-down Period|Death|0|||
125063526|NCT01885078|449850774|FG001|Step-down Period|Death|0|||
125063527|NCT01885078|449850775|FG002|Step-down Period|Death|0|||
125063528|NCT01885078|449850776|FG003|Step-down Period|Death|0|||
125063529|NCT01885078|449850777|FG004|Step-down Period|Death|0|||
125063530|NCT01885078|449850778|FG005|Step-down Period|Death|0|||
125063531|NCT01885078|449850779|FG006|Step-down Period|Death|0|||
125063532|NCT01885078|449850780|FG007|Step-down Period|Death|0|||
125063533|NCT01885078|449850781|FG008|Step-down Period|Death|4|||
125063534|NCT01885078|449850782|FG009|Step-down Period|Death|3|||
125063535|NCT01885078|449850773|FG000|Step-down Period|Lost to Follow-up|0|||
125063536|NCT01885078|449850774|FG001|Step-down Period|Lost to Follow-up|0|||
125063537|NCT01885078|449850775|FG002|Step-down Period|Lost to Follow-up|0|||
125063538|NCT01885078|449850776|FG003|Step-down Period|Lost to Follow-up|0|||
125063539|NCT01885078|449850777|FG004|Step-down Period|Lost to Follow-up|0|||
125063540|NCT01885078|449850778|FG005|Step-down Period|Lost to Follow-up|0|||
125063541|NCT01885078|449850779|FG006|Step-down Period|Lost to Follow-up|0|||
125063542|NCT01885078|449850780|FG007|Step-down Period|Lost to Follow-up|0|||
125063543|NCT01885078|449850781|FG008|Step-down Period|Lost to Follow-up|1|||
125063544|NCT01885078|449850782|FG009|Step-down Period|Lost to Follow-up|1|||
125063545|NCT01885078|449850773|FG000|Step-down Period|Lack of Efficacy|0|||
125063546|NCT01885078|449850774|FG001|Step-down Period|Lack of Efficacy|0|||
125063547|NCT01885078|449850775|FG002|Step-down Period|Lack of Efficacy|0|||
125063548|NCT01885078|449850776|FG003|Step-down Period|Lack of Efficacy|0|||
125063549|NCT01885078|449850777|FG004|Step-down Period|Lack of Efficacy|0|||
125063550|NCT01885078|449850778|FG005|Step-down Period|Lack of Efficacy|0|||
125063551|NCT01885078|449850779|FG006|Step-down Period|Lack of Efficacy|0|||
125063552|NCT01885078|449850780|FG007|Step-down Period|Lack of Efficacy|0|||
125063553|NCT01885078|449850781|FG008|Step-down Period|Lack of Efficacy|1|||
125063554|NCT01885078|449850782|FG009|Step-down Period|Lack of Efficacy|0|||
125063555|NCT01885078|449850773|FG000|Step-down Period|Protocol Violation|0|||
125063556|NCT01885078|449850774|FG001|Step-down Period|Protocol Violation|0|||
125063557|NCT01885078|449850775|FG002|Step-down Period|Protocol Violation|0|||
125063558|NCT01885078|449850776|FG003|Step-down Period|Protocol Violation|0|||
125063559|NCT01885078|449850777|FG004|Step-down Period|Protocol Violation|0|||
125063560|NCT01885078|449850778|FG005|Step-down Period|Protocol Violation|0|||
125063561|NCT01885078|449850779|FG006|Step-down Period|Protocol Violation|0|||
125063562|NCT01885078|449850780|FG007|Step-down Period|Protocol Violation|0|||
125063563|NCT01885078|449850781|FG008|Step-down Period|Protocol Violation|1|||
125063564|NCT01885078|449850782|FG009|Step-down Period|Protocol Violation|1|||
125063565|NCT01895452|449850788|FG000|Overall Study|Adverse Event|1|||
125063566|NCT01895452|449850789|FG001|Overall Study|Adverse Event|4|||
125063567|NCT01895452|449850788|FG000|Overall Study|Lost to Follow-up|1|||
125063568|NCT01895452|449850789|FG001|Overall Study|Lost to Follow-up|5|||
125063569|NCT01895452|449850788|FG000|Overall Study|Pregnancy|0|||
125063570|NCT01895452|449850789|FG001|Overall Study|Pregnancy|1|||
125063571|NCT01895452|449850788|FG000|Overall Study|Withdrawal by Subject|2|||
125063572|NCT01895452|449850789|FG001|Overall Study|Withdrawal by Subject|14|||
125063573|NCT01895452|449850788|FG000|Overall Study|Underlying disease|0|||
125063574|NCT01895452|449850789|FG001|Overall Study|Underlying disease|3|||
125063575|NCT01895452|449850788|FG000|Overall Study|Noncompliance with study drug|0|||
125063576|NCT01895452|449850789|FG001|Overall Study|Noncompliance with study drug|1|||
125063577|NCT01204697|449850791|FG000|Overall Study|Death|26|||
125063578|NCT01204697|449850792|FG001|Overall Study|Death|27|||
125063579|NCT01204697|449850791|FG000|Overall Study|Lost to Follow-up|3|||
125063580|NCT01204697|449850792|FG001|Overall Study|Lost to Follow-up|4|||
125063581|NCT01204697|449850791|FG000|Overall Study|Withdrawal by Subject|2|||
125063582|NCT01204697|449850792|FG001|Overall Study|Withdrawal by Subject|4|||
125063583|NCT01204697|449850791|FG000|Overall Study|Randomized, but not treated|0|||
125063584|NCT01204697|449850792|FG001|Overall Study|Randomized, but not treated|1|||
125063585|NCT01205451|449850793|FG000|Overall Study|Lost to Follow-up|1|||
125063586|NCT01205451|449850794|FG001|Overall Study|Lost to Follow-up|1|||
125063587|NCT01205451|449850793|FG000|Overall Study|Withdrawal by Subject|5|||
125063588|NCT01205451|449850794|FG001|Overall Study|Withdrawal by Subject|9|||
125063589|NCT01194869|449850795|FG000|Overall Study|Disease Progression|2|||
125063590|NCT01194869|449850795|FG000|Overall Study|Toxicity|2|||
125063591|NCT04321252|449850798|FG000|Overall Study|Withdrawal by Subject|0|||
125063592|NCT04321252|449850799|FG001|Overall Study|Withdrawal by Subject|0|||
125063593|NCT04321252|449850800|FG002|Overall Study|Withdrawal by Subject|0|||
125063594|NCT04321252|449850801|FG003|Overall Study|Withdrawal by Subject|0|||
125063595|NCT04321252|449850802|FG004|Overall Study|Withdrawal by Subject|0|||
125063596|NCT04321252|449850803|FG005|Overall Study|Withdrawal by Subject|1|||
125063597|NCT04321252|449850804|FG006|Overall Study|Withdrawal by Subject|0|||
125063598|NCT04321252|449850805|FG007|Overall Study|Withdrawal by Subject|0|||
125063599|NCT04321252|449850806|FG008|Overall Study|Withdrawal by Subject|0|||
125063600|NCT03004469|449850807|FG000|Overall Study|Adverse Event|6|||
125063601|NCT03004469|449850808|FG001|Overall Study|Adverse Event|4|||
125063602|NCT03004469|449850809|FG002|Overall Study|Adverse Event|6|||
125063603|NCT03004469|449850807|FG000|Overall Study|Lack of Efficacy|1|||
125063604|NCT03004469|449850808|FG001|Overall Study|Lack of Efficacy|0|||
125063605|NCT03004469|449850809|FG002|Overall Study|Lack of Efficacy|1|||
125063606|NCT03004469|449850807|FG000|Overall Study|Lost to Follow-up|23|||
125063607|NCT03004469|449850808|FG001|Overall Study|Lost to Follow-up|14|||
125063608|NCT03004469|449850809|FG002|Overall Study|Lost to Follow-up|6|||
125063609|NCT03004469|449850807|FG000|Overall Study|Non-Compliance with Study Drug|2|||
125063610|NCT03004469|449850808|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125063611|NCT03004469|449850809|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125063612|NCT03004469|449850807|FG000|Overall Study|Protocol Violation|0|||
125063613|NCT03004469|449850808|FG001|Overall Study|Protocol Violation|0|||
125063614|NCT03004469|449850809|FG002|Overall Study|Protocol Violation|1|||
125063615|NCT03004469|449850807|FG000|Overall Study|Withdrawal by Subject|29|||
125063616|NCT03004469|449850808|FG001|Overall Study|Withdrawal by Subject|27|||
125063617|NCT03004469|449850809|FG002|Overall Study|Withdrawal by Subject|10|||
125063618|NCT03004469|449850807|FG000|Overall Study|Other unspecified reason|0|||
125063619|NCT03004469|449850808|FG001|Overall Study|Other unspecified reason|4|||
125063620|NCT03004469|449850809|FG002|Overall Study|Other unspecified reason|1|||
125063621|NCT00259740|449850810|FG000|Overall Study|Physician Decision|1|||
125063622|NCT00259740|449850811|FG001|Overall Study|Physician Decision|1|||
125063623|NCT00259740|449850810|FG000|Overall Study|Adverse Event|0|||
125063624|NCT00259740|449850811|FG001|Overall Study|Adverse Event|2|||
125063625|NCT00259740|449850810|FG000|Overall Study|Withdrawal by Subject|2|||
125063626|NCT00259740|449850811|FG001|Overall Study|Withdrawal by Subject|6|||
125063627|NCT00259740|449850810|FG000|Overall Study|Death|1|||
125063628|NCT00259740|449850811|FG001|Overall Study|Death|1|||
125063629|NCT00259740|449850810|FG000|Overall Study|Disease progression|19|||
125063630|NCT00259740|449850811|FG001|Overall Study|Disease progression|36|||
125139478|NCT01647828|450132870|FG002|Overall Study|Lost to Follow-up|0|||
125139479|NCT01647828|450132871|FG003|Overall Study|Lost to Follow-up|0|||
125063631|NCT00259740|449850810|FG000|Overall Study|Ongoing|17|||
125063632|NCT00259740|449850811|FG001|Overall Study|Ongoing|3|||
125063633|NCT00259740|449850810|FG000|Overall Study|Other|3|||
125063634|NCT00259740|449850811|FG001|Overall Study|Other|0|||
125063635|NCT00259740|449850810|FG000|Overall Study|Requirement for alternative therapy|0|||
125063636|NCT00259740|449850811|FG001|Overall Study|Requirement for alternative therapy|4|||
125063637|NCT03654755|449850815|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
125063638|NCT03654755|449850816|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
125063639|NCT03654755|449850817|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
125139480|NCT01647828|450132872|FG004|Overall Study|Lost to Follow-up|0|||
125139481|NCT01647828|450132873|FG005|Overall Study|Lost to Follow-up|0|||
125139482|NCT01647828|450132874|FG006|Overall Study|Lost to Follow-up|0|||
125139483|NCT01647828|450132875|FG007|Overall Study|Lost to Follow-up|2|||
125063640|NCT03654755|449850815|FG000|Overall Study|Withdrawal by Subject|2|||
125063641|NCT03654755|449850816|FG001|Overall Study|Withdrawal by Subject|4|||
125063642|NCT03654755|449850817|FG002|Overall Study|Withdrawal by Subject|8|||
125063643|NCT03654755|449850815|FG000|Overall Study|Lost to Follow-up|1|||
125063644|NCT03654755|449850816|FG001|Overall Study|Lost to Follow-up|3|||
125063645|NCT03654755|449850817|FG002|Overall Study|Lost to Follow-up|7|||
125063646|NCT03654755|449850815|FG000|Overall Study|Physician Decision|0|||
125063647|NCT03654755|449850816|FG001|Overall Study|Physician Decision|1|||
125063648|NCT03654755|449850817|FG002|Overall Study|Physician Decision|0|||
125063649|NCT03654755|449850815|FG000|Overall Study|Adverse Event|0|||
125063650|NCT03654755|449850816|FG001|Overall Study|Adverse Event|0|||
125063651|NCT03654755|449850817|FG002|Overall Study|Adverse Event|4|||
125063652|NCT03654755|449850815|FG000|Overall Study|Lack of Efficacy|0|||
125063653|NCT03654755|449850816|FG001|Overall Study|Lack of Efficacy|0|||
125139484|NCT01647828|450132876|FG008|Overall Study|Lost to Follow-up|0|||
125063654|NCT03654755|449850817|FG002|Overall Study|Lack of Efficacy|1|||
125063655|NCT03495453|449850818|FG000|Overall Study|Withdrawal by Subject|0|||
125063656|NCT03495453|449850819|FG001|Overall Study|Withdrawal by Subject|1|||
125063657|NCT01360762|449850826|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
125063658|NCT01360762|449850826|FG000|Main Study Period (12-month Treatment)|Death|5|||
125063659|NCT01360762|449850826|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
125063660|NCT01360762|449850826|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
125063661|NCT01360762|449850826|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
125063662|NCT01360762|449850826|FG000|Whole Study Period|Lost to Follow-up|10|||
125063663|NCT01360762|449850826|FG000|Whole Study Period|Death|7|||
125063664|NCT01360762|449850826|FG000|Whole Study Period|Patient relapsed|18|||
125063665|NCT01360762|449850826|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
125063666|NCT04511819|449850827|FG000|Overall Study|Non-compliance with study drug|5|||
125063667|NCT04511819|449850828|FG001|Overall Study|Non-compliance with study drug|1|||
125063668|NCT04511819|449850827|FG000|Overall Study|Withdrawal by Subject|0|||
125063669|NCT04511819|449850828|FG001|Overall Study|Withdrawal by Subject|3|||
125063670|NCT04511819|449850827|FG000|Overall Study|Adverse Event|0|||
125063671|NCT04511819|449850828|FG001|Overall Study|Adverse Event|1|||
125063672|NCT04511819|449850827|FG000|Overall Study|Protocol deviation|1|||
125063673|NCT04511819|449850828|FG001|Overall Study|Protocol deviation|0|||
125063674|NCT03247413|449850831|FG000|Overall Study|Lost to Follow-up|28|||
125063675|NCT00844649|449850832|FG000|Overall Study|Progressive Disease|196|||
125063676|NCT00844649|449850833|FG001|Overall Study|Progressive Disease|245|||
125063677|NCT00844649|449850832|FG000|Overall Study|Adverse Event|128|||
125063678|NCT00844649|449850833|FG001|Overall Study|Adverse Event|73|||
125063679|NCT00844649|449850832|FG000|Overall Study|Physician Decision|25|||
125063680|NCT00844649|449850833|FG001|Overall Study|Physician Decision|18|||
125063681|NCT00844649|449850832|FG000|Overall Study|Protocol Violation|10|||
125063682|NCT00844649|449850833|FG001|Overall Study|Protocol Violation|6|||
125063683|NCT00844649|449850832|FG000|Overall Study|Withdrawal by Subject|28|||
125063684|NCT00844649|449850833|FG001|Overall Study|Withdrawal by Subject|39|||
125063685|NCT00844649|449850832|FG000|Overall Study|Other|7|||
125063686|NCT00844649|449850833|FG001|Overall Study|Other|10|||
125063687|NCT00844649|449850832|FG000|Overall Study|Withdrew prior to starting treatment|11|||
125063688|NCT00844649|449850833|FG001|Overall Study|Withdrew prior to starting treatment|27|||
125063689|NCT00424294|449850834|FG000|Overall Study|Adverse Event|4|||
125063690|NCT00424294|449850835|FG001|Overall Study|Adverse Event|10|||
125063691|NCT00424294|449850834|FG000|Overall Study|Lack of Efficacy|2|||
125063692|NCT00424294|449850835|FG001|Overall Study|Lack of Efficacy|1|||
125063693|NCT00424294|449850834|FG000|Overall Study|Withdrawal by Subject|1|||
125063694|NCT00424294|449850835|FG001|Overall Study|Withdrawal by Subject|2|||
125063695|NCT00424294|449850834|FG000|Overall Study|Other|0|||
125063696|NCT00424294|449850835|FG001|Overall Study|Other|2|||
125063697|NCT00424294|449850834|FG000|Overall Study|Randomized but not Treated|1|||
125063698|NCT00424294|449850835|FG001|Overall Study|Randomized but not Treated|0|||
125063699|NCT04397718|449850836|FG000|Overall Study|Death|7|||
125063700|NCT04397718|449850837|FG001|Overall Study|Death|11|||
125063701|NCT04397718|449850836|FG000|Overall Study|Lost to Follow-up|0|||
125063702|NCT04397718|449850837|FG001|Overall Study|Lost to Follow-up|4|||
125063703|NCT01797965|449850838|FG000|Overall Study|Adverse Event|104|||
125063704|NCT01797965|449850839|FG001|Overall Study|Adverse Event|129|||
125063705|NCT01797965|449850840|FG002|Overall Study|Adverse Event|4|||
125063706|NCT01797965|449850841|FG003|Overall Study|Adverse Event|21|||
125063707|NCT01797965|449850838|FG000|Overall Study|Lost to Follow-up|9|||
125139485|NCT01906372|450132877|FG000|Overall Study|Withdrawal by Subject|2|||
125139486|NCT00847535|450132881|FG000|Overall Study|Withdrawal by Subject|2|||
125139487|NCT00847535|450132882|FG001|Overall Study|Withdrawal by Subject|1|||
125139488|NCT00847535|450132883|FG002|Overall Study|Withdrawal by Subject|1|||
125139489|NCT00847535|450132881|FG000|Overall Study|Lost to Follow-up|0|||
125139490|NCT00847535|450132882|FG001|Overall Study|Lost to Follow-up|1|||
125139491|NCT00847535|450132883|FG002|Overall Study|Lost to Follow-up|0|||
125063708|NCT01797965|449850839|FG001|Overall Study|Lost to Follow-up|8|||
125139492|NCT05604014|450132884|FG000|Overall Study|Lost to Follow-up|13|||
125139493|NCT02054715|450132896|FG000|Baseline/Follow-up 1|Refused|1|||
125063709|NCT01797965|449850840|FG002|Overall Study|Lost to Follow-up|1|||
125063710|NCT01797965|449850841|FG003|Overall Study|Lost to Follow-up|2|||
125063711|NCT01797965|449850838|FG000|Overall Study|Consent withdrawn|130|||
125063712|NCT01797965|449850839|FG001|Overall Study|Consent withdrawn|117|||
125063713|NCT01797965|449850840|FG002|Overall Study|Consent withdrawn|3|||
125139494|NCT02054715|450132897|FG001|Baseline/Follow-up 1|Refused|3|||
125063714|NCT01797965|449850841|FG003|Overall Study|Consent withdrawn|35|||
125063715|NCT01797965|449850838|FG000|Overall Study|Investigator decision|21|||
125063716|NCT01797965|449850839|FG001|Overall Study|Investigator decision|15|||
125139495|NCT02054715|450132896|FG000|Baseline/Follow-up 1|Medical|0|||
125063717|NCT01797965|449850840|FG002|Overall Study|Investigator decision|0|||
125063718|NCT01797965|449850841|FG003|Overall Study|Investigator decision|0|||
125063719|NCT01797965|449850838|FG000|Overall Study|Death|2|||
125063720|NCT01797965|449850839|FG001|Overall Study|Death|4|||
125063721|NCT01797965|449850840|FG002|Overall Study|Death|0|||
125063722|NCT01797965|449850841|FG003|Overall Study|Death|0|||
125063723|NCT01797965|449850838|FG000|Overall Study|Disease progression, defined by protocol|3|||
125063724|NCT01797965|449850839|FG001|Overall Study|Disease progression, defined by protocol|1|||
125063725|NCT01797965|449850840|FG002|Overall Study|Disease progression, defined by protocol|0|||
125063726|NCT01797965|449850841|FG003|Overall Study|Disease progression, defined by protocol|0|||
125063727|NCT01797965|449850838|FG000|Overall Study|Reason Not Specified|280|||
125063728|NCT01797965|449850839|FG001|Overall Study|Reason Not Specified|295|||
125063729|NCT01797965|449850840|FG002|Overall Study|Reason Not Specified|0|||
125063730|NCT01797965|449850841|FG003|Overall Study|Reason Not Specified|15|||
125063731|NCT00976950|449850842|FG000|Overall Study|Adverse Event|3|||
125063732|NCT00976950|449850842|FG000|Overall Study|Events with no relationship to Aptivus|3|||
125063733|NCT00304915|449850843|FG000|Overall Study|Lost to Follow-up|11|||
125063734|NCT00304915|449850844|FG001|Overall Study|Lost to Follow-up|11|||
125063735|NCT00304915|449850843|FG000|Overall Study|Death|4|||
125063736|NCT00304915|449850844|FG001|Overall Study|Death|5|||
125063737|NCT00304915|449850843|FG000|Overall Study|Withdrawal by Subject|3|||
125063738|NCT00304915|449850844|FG001|Overall Study|Withdrawal by Subject|0|||
125063739|NCT01021852|449850847|FG000|Treatment Period 1|Adverse Event|3|||
125063740|NCT01021852|449850848|FG001|Treatment Period 1|Adverse Event|1|||
125063741|NCT01021852|449850849|FG002|Treatment Period 1|Adverse Event|1|||
125063742|NCT01021852|449850850|FG003|Treatment Period 1|Adverse Event|0|||
125063743|NCT01021852|449850851|FG004|Treatment Period 1|Adverse Event|2|||
125063744|NCT01021852|449850852|FG005|Treatment Period 1|Adverse Event|2|||
125063745|NCT01021852|449850853|FG006|Treatment Period 1|Adverse Event|0|||
125063746|NCT01021852|449850854|FG007|Treatment Period 1|Adverse Event|0|||
125063747|NCT01021852|449850847|FG000|Treatment Period 1|Pregnancy|0|||
125063748|NCT01021852|449850848|FG001|Treatment Period 1|Pregnancy|0|||
125063749|NCT01021852|449850849|FG002|Treatment Period 1|Pregnancy|1|||
125063750|NCT01021852|449850850|FG003|Treatment Period 1|Pregnancy|0|||
125063751|NCT01021852|449850851|FG004|Treatment Period 1|Pregnancy|0|||
125063752|NCT01021852|449850852|FG005|Treatment Period 1|Pregnancy|0|||
125063753|NCT01021852|449850853|FG006|Treatment Period 1|Pregnancy|0|||
125063754|NCT01021852|449850854|FG007|Treatment Period 1|Pregnancy|0|||
125063755|NCT01021852|449850847|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125063756|NCT01021852|449850848|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125063757|NCT01021852|449850849|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125063758|NCT01021852|449850850|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125063759|NCT01021852|449850851|FG004|Treatment Period 1|Withdrawal by Subject|1|||
125063760|NCT01021852|449850852|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125063761|NCT01021852|449850853|FG006|Treatment Period 1|Withdrawal by Subject|0|||
125063762|NCT01021852|449850854|FG007|Treatment Period 1|Withdrawal by Subject|1|||
125063763|NCT01021852|449850847|FG000|Treatment Period 1|Not Treated|0|||
125063764|NCT01021852|449850848|FG001|Treatment Period 1|Not Treated|0|||
125063765|NCT01021852|449850849|FG002|Treatment Period 1|Not Treated|0|||
125063766|NCT01021852|449850850|FG003|Treatment Period 1|Not Treated|2|||
125063767|NCT01021852|449850851|FG004|Treatment Period 1|Not Treated|0|||
125063768|NCT01021852|449850852|FG005|Treatment Period 1|Not Treated|0|||
125063769|NCT01021852|449850853|FG006|Treatment Period 1|Not Treated|0|||
125063770|NCT01021852|449850854|FG007|Treatment Period 1|Not Treated|0|||
125063771|NCT01021852|449850847|FG000|Washout Period-Placebo|Adverse Event|0|||
125063772|NCT01021852|449850848|FG001|Washout Period-Placebo|Adverse Event|0|||
125063773|NCT01021852|449850849|FG002|Washout Period-Placebo|Adverse Event|0|||
125063774|NCT01021852|449850850|FG003|Washout Period-Placebo|Adverse Event|1|||
125063775|NCT01021852|449850851|FG004|Washout Period-Placebo|Adverse Event|0|||
125063776|NCT01021852|449850852|FG005|Washout Period-Placebo|Adverse Event|1|||
125063777|NCT01021852|449850853|FG006|Washout Period-Placebo|Adverse Event|0|||
125063778|NCT01021852|449850854|FG007|Washout Period-Placebo|Adverse Event|0|||
125139496|NCT02054715|450132897|FG001|Baseline/Follow-up 1|Medical|1|||
125063779|NCT01021852|449850847|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
125063780|NCT01021852|449850848|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
125063781|NCT01021852|449850849|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
125063782|NCT01021852|449850850|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
125063783|NCT01021852|449850851|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
125063784|NCT01021852|449850852|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
125063785|NCT01021852|449850853|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
125063786|NCT01021852|449850854|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
125063787|NCT01021852|449850847|FG000|Washout Period-Placebo|Protocol Violation|0|||
125063788|NCT01021852|449850848|FG001|Washout Period-Placebo|Protocol Violation|0|||
125139497|NCT02054715|450132896|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
125222450|NCT01576575|450442751|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
125063789|NCT01021852|449850849|FG002|Washout Period-Placebo|Protocol Violation|0|||
125063790|NCT01021852|449850850|FG003|Washout Period-Placebo|Protocol Violation|0|||
125063791|NCT01021852|449850851|FG004|Washout Period-Placebo|Protocol Violation|0|||
125063792|NCT01021852|449850852|FG005|Washout Period-Placebo|Protocol Violation|0|||
125063793|NCT01021852|449850853|FG006|Washout Period-Placebo|Protocol Violation|1|||
125063794|NCT01021852|449850854|FG007|Washout Period-Placebo|Protocol Violation|0|||
125063795|NCT01021852|449850847|FG000|Washout Period-No Drug|Adverse Event|1|||
125063796|NCT01021852|449850848|FG001|Washout Period-No Drug|Adverse Event|0|||
125063797|NCT01021852|449850849|FG002|Washout Period-No Drug|Adverse Event|0|||
125063798|NCT01021852|449850850|FG003|Washout Period-No Drug|Adverse Event|0|||
125063799|NCT01021852|449850851|FG004|Washout Period-No Drug|Adverse Event|0|||
125063800|NCT01021852|449850852|FG005|Washout Period-No Drug|Adverse Event|1|||
125063801|NCT01021852|449850853|FG006|Washout Period-No Drug|Adverse Event|0|||
125063802|NCT01021852|449850854|FG007|Washout Period-No Drug|Adverse Event|0|||
125063803|NCT01021852|449850847|FG000|Treatment Period 2|Adverse Event|0|||
125063804|NCT01021852|449850848|FG001|Treatment Period 2|Adverse Event|1|||
125063805|NCT01021852|449850849|FG002|Treatment Period 2|Adverse Event|0|||
125063806|NCT01021852|449850850|FG003|Treatment Period 2|Adverse Event|0|||
125063807|NCT01021852|449850851|FG004|Treatment Period 2|Adverse Event|1|||
125063808|NCT01021852|449850852|FG005|Treatment Period 2|Adverse Event|0|||
125063809|NCT01021852|449850853|FG006|Treatment Period 2|Adverse Event|1|||
125063810|NCT01021852|449850854|FG007|Treatment Period 2|Adverse Event|0|||
125063811|NCT01021852|449850847|FG000|Treatment Period 2|Lack of Efficacy|0|||
125063812|NCT01021852|449850848|FG001|Treatment Period 2|Lack of Efficacy|0|||
125063813|NCT01021852|449850849|FG002|Treatment Period 2|Lack of Efficacy|0|||
125063814|NCT01021852|449850850|FG003|Treatment Period 2|Lack of Efficacy|0|||
125063815|NCT01021852|449850851|FG004|Treatment Period 2|Lack of Efficacy|0|||
125063816|NCT01021852|449850852|FG005|Treatment Period 2|Lack of Efficacy|1|||
125063817|NCT01021852|449850853|FG006|Treatment Period 2|Lack of Efficacy|0|||
125063818|NCT01021852|449850854|FG007|Treatment Period 2|Lack of Efficacy|0|||
125063819|NCT01021852|449850847|FG000|Treatment Period 2|Physician Decision|0|||
125063820|NCT01021852|449850848|FG001|Treatment Period 2|Physician Decision|0|||
125063821|NCT01021852|449850849|FG002|Treatment Period 2|Physician Decision|1|||
125063822|NCT01021852|449850850|FG003|Treatment Period 2|Physician Decision|0|||
125063823|NCT01021852|449850851|FG004|Treatment Period 2|Physician Decision|0|||
125063824|NCT01021852|449850852|FG005|Treatment Period 2|Physician Decision|0|||
125063825|NCT01021852|449850853|FG006|Treatment Period 2|Physician Decision|0|||
125063826|NCT01021852|449850854|FG007|Treatment Period 2|Physician Decision|0|||
125063827|NCT01021852|449850847|FG000|Treatment Period 2|Protocol Violation|0|||
125063828|NCT01021852|449850848|FG001|Treatment Period 2|Protocol Violation|0|||
125063829|NCT01021852|449850849|FG002|Treatment Period 2|Protocol Violation|0|||
125063830|NCT01021852|449850850|FG003|Treatment Period 2|Protocol Violation|0|||
125063831|NCT01021852|449850851|FG004|Treatment Period 2|Protocol Violation|1|||
125063832|NCT01021852|449850852|FG005|Treatment Period 2|Protocol Violation|0|||
125063833|NCT01021852|449850853|FG006|Treatment Period 2|Protocol Violation|1|||
125063834|NCT01021852|449850854|FG007|Treatment Period 2|Protocol Violation|0|||
125063835|NCT01021852|449850847|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125063836|NCT01021852|449850848|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125063837|NCT01021852|449850849|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125063838|NCT01021852|449850850|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125063839|NCT01021852|449850851|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125063840|NCT01021852|449850852|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125063841|NCT01021852|449850853|FG006|Treatment Period 2|Withdrawal by Subject|1|||
125063842|NCT01021852|449850854|FG007|Treatment Period 2|Withdrawal by Subject|2|||
125063843|NCT00712322|449850855|FG000|Overall Study|Protocol deviation|0|||
125063844|NCT00712322|449850856|FG001|Overall Study|Protocol deviation|1|||
125063845|NCT00712322|449850857|FG002|Overall Study|Protocol deviation|0|||
125063846|NCT02802878|449850862|FG000|Overall Study|Withdrawal by Subject|3|||
125063847|NCT02802878|449850863|FG001|Overall Study|Withdrawal by Subject|3|||
125063848|NCT02802878|449850862|FG000|Overall Study|Protocol Violation|1|||
125063849|NCT02802878|449850863|FG001|Overall Study|Protocol Violation|0|||
125063850|NCT00536978|449850864|FG000|Overall Study|Not eligible for Adback Infusion|22|||
125063851|NCT00916370|449850867|FG000|Overall Study|Death|3|||
125063852|NCT00916370|449850868|FG001|Overall Study|Death|1|||
125063853|NCT00916370|449850867|FG000|Overall Study|Withdrawal by Subject|2|||
125063854|NCT00916370|449850868|FG001|Overall Study|Withdrawal by Subject|0|||
125063855|NCT00916370|449850867|FG000|Overall Study|Physician Decision|0|||
125063856|NCT00916370|449850868|FG001|Overall Study|Physician Decision|1|||
125063857|NCT03550131|449850869|FG000|Overall Study|Lost to Follow-up|16|||
125063858|NCT03550131|449850870|FG001|Overall Study|Lost to Follow-up|24|||
125063859|NCT03550131|449850869|FG000|Overall Study|Withdrawal by Subject|36|||
125063860|NCT03550131|449850870|FG001|Overall Study|Withdrawal by Subject|28|||
125063861|NCT03550131|449850869|FG000|Overall Study|Illness of dyad member|10|||
125063862|NCT03550131|449850870|FG001|Overall Study|Illness of dyad member|2|||
125063863|NCT03550131|449850869|FG000|Overall Study|Death of person with dementia|4|||
125063864|NCT03550131|449850870|FG001|Overall Study|Death of person with dementia|8|||
125063865|NCT01318512|449850871|FG000|Maintenance Period (6 Months)|Death|2|||
125063866|NCT01318512|449850871|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
125063867|NCT00717366|449850872|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
125063868|NCT00717366|449850873|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
125063869|NCT00717366|449850872|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
125063870|NCT00717366|449850873|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
125063871|NCT00717366|449850872|FG000|Core Study Period (20 Weeks)|Death|0|||
125063872|NCT00717366|449850873|FG001|Core Study Period (20 Weeks)|Death|1|||
125063873|NCT00717366|449850872|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
125063874|NCT00717366|449850873|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
125063875|NCT00717366|449850872|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
125063876|NCT00717366|449850873|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
125063877|NCT00717366|449850872|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
125063878|NCT00717366|449850873|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
125063879|NCT00717366|449850872|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
125063880|NCT00717366|449850873|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
125063881|NCT01317615|449850876|FG000|Overall Study|Disease progression|25|||
125063882|NCT01317615|449850876|FG000|Overall Study|New cancer therapy|5|||
125063883|NCT01317615|449850876|FG000|Overall Study|Death|6|||
125063884|NCT01317615|449850876|FG000|Overall Study|Withdrawal by Subject|5|||
125063885|NCT01317615|449850876|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125063886|NCT01317615|449850876|FG000|Overall Study|Adverse Event|7|||
125063887|NCT00255086|449850877|FG000|Overall Study|Adverse Event|1|||
125063888|NCT00255086|449850878|FG001|Overall Study|Adverse Event|1|||
125063889|NCT00255086|449850877|FG000|Overall Study|Protocol Violation|1|||
125063890|NCT00255086|449850878|FG001|Overall Study|Protocol Violation|1|||
125222451|NCT01576575|450442751|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
125063891|NCT00438399|449850881|FG000|Overall Study|Lost to Follow-up|2|||
125063892|NCT00438399|449850882|FG001|Overall Study|Lost to Follow-up|2|||
125063893|NCT00438399|449850883|FG002|Overall Study|Lost to Follow-up|1|||
125063894|NCT00438399|449850884|FG003|Overall Study|Lost to Follow-up|1|||
125063895|NCT00438399|449850885|FG004|Overall Study|Lost to Follow-up|1|||
125063896|NCT00438399|449850886|FG005|Overall Study|Lost to Follow-up|1|||
125063897|NCT00438399|449850881|FG000|Overall Study|Adverse Event|0|||
125063898|NCT00438399|449850882|FG001|Overall Study|Adverse Event|0|||
125063899|NCT00438399|449850883|FG002|Overall Study|Adverse Event|1|||
125063900|NCT00438399|449850884|FG003|Overall Study|Adverse Event|1|||
125063901|NCT00438399|449850885|FG004|Overall Study|Adverse Event|0|||
125063902|NCT00438399|449850886|FG005|Overall Study|Adverse Event|1|||
125063903|NCT00438399|449850881|FG000|Overall Study|Withdrawal by Subject|5|||
125063904|NCT00438399|449850882|FG001|Overall Study|Withdrawal by Subject|6|||
125063905|NCT00438399|449850883|FG002|Overall Study|Withdrawal by Subject|3|||
125063906|NCT00438399|449850884|FG003|Overall Study|Withdrawal by Subject|2|||
125063907|NCT00438399|449850885|FG004|Overall Study|Withdrawal by Subject|2|||
125063908|NCT00438399|449850886|FG005|Overall Study|Withdrawal by Subject|2|||
125063909|NCT00438399|449850881|FG000|Overall Study|Protocol Violation|0|||
125063910|NCT00438399|449850882|FG001|Overall Study|Protocol Violation|0|||
125063911|NCT00438399|449850883|FG002|Overall Study|Protocol Violation|1|||
125063912|NCT00438399|449850884|FG003|Overall Study|Protocol Violation|0|||
125063913|NCT00438399|449850885|FG004|Overall Study|Protocol Violation|0|||
125063914|NCT00438399|449850886|FG005|Overall Study|Protocol Violation|1|||
125063915|NCT00438399|449850881|FG000|Overall Study|Subje stopped study|0|||
125063916|NCT00438399|449850882|FG001|Overall Study|Subje stopped study|0|||
125063917|NCT00438399|449850883|FG002|Overall Study|Subje stopped study|1|||
125063918|NCT00438399|449850884|FG003|Overall Study|Subje stopped study|0|||
125063919|NCT00438399|449850885|FG004|Overall Study|Subje stopped study|0|||
125063920|NCT00438399|449850886|FG005|Overall Study|Subje stopped study|0|||
125063921|NCT00438399|449850881|FG000|Overall Study|Pregnancy|0|||
125063922|NCT00438399|449850882|FG001|Overall Study|Pregnancy|0|||
125063923|NCT00438399|449850883|FG002|Overall Study|Pregnancy|0|||
125063924|NCT00438399|449850884|FG003|Overall Study|Pregnancy|0|||
125063925|NCT00438399|449850885|FG004|Overall Study|Pregnancy|0|||
125063926|NCT00438399|449850886|FG005|Overall Study|Pregnancy|1|||
125063927|NCT00438399|449850881|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
125063928|NCT00438399|449850882|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
125063929|NCT00438399|449850883|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
125063930|NCT00438399|449850884|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
125063931|NCT00438399|449850885|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
125063932|NCT00438399|449850886|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
125063933|NCT03334396|449850889|FG000|Overall Study|Adverse Event|1|||
125063934|NCT03334396|449850890|FG001|Overall Study|Adverse Event|0|||
125063935|NCT03334396|449850891|FG002|Overall Study|Adverse Event|1|||
125063936|NCT03334396|449850892|FG003|Overall Study|Adverse Event|0|||
125063937|NCT03334396|449850893|FG004|Overall Study|Adverse Event|0|||
125063938|NCT03334396|449850894|FG005|Overall Study|Adverse Event|0|||
125063939|NCT03334396|449850895|FG006|Overall Study|Adverse Event|0|||
125063940|NCT03334396|449850896|FG007|Overall Study|Adverse Event|0|||
125063941|NCT03334396|449850889|FG000|Overall Study|Lack of Efficacy|10|||
125063942|NCT03334396|449850890|FG001|Overall Study|Lack of Efficacy|4|||
125063943|NCT03334396|449850891|FG002|Overall Study|Lack of Efficacy|1|||
125063944|NCT03334396|449850892|FG003|Overall Study|Lack of Efficacy|3|||
125063945|NCT03334396|449850893|FG004|Overall Study|Lack of Efficacy|1|||
125063946|NCT03334396|449850894|FG005|Overall Study|Lack of Efficacy|0|||
125063947|NCT03334396|449850895|FG006|Overall Study|Lack of Efficacy|0|||
125063948|NCT03334396|449850896|FG007|Overall Study|Lack of Efficacy|1|||
125063949|NCT03334396|449850889|FG000|Overall Study|Lost to Follow-up|0|||
125063950|NCT03334396|449850890|FG001|Overall Study|Lost to Follow-up|0|||
125063951|NCT03334396|449850891|FG002|Overall Study|Lost to Follow-up|1|||
125063952|NCT03334396|449850892|FG003|Overall Study|Lost to Follow-up|0|||
125063953|NCT03334396|449850893|FG004|Overall Study|Lost to Follow-up|0|||
125063954|NCT03334396|449850894|FG005|Overall Study|Lost to Follow-up|0|||
125063955|NCT03334396|449850895|FG006|Overall Study|Lost to Follow-up|1|||
125063956|NCT03334396|449850896|FG007|Overall Study|Lost to Follow-up|0|||
125063957|NCT03334396|449850889|FG000|Overall Study|Physician Decision|1|||
125063958|NCT03334396|449850890|FG001|Overall Study|Physician Decision|0|||
125063959|NCT03334396|449850891|FG002|Overall Study|Physician Decision|0|||
125063960|NCT03334396|449850892|FG003|Overall Study|Physician Decision|0|||
125063961|NCT03334396|449850893|FG004|Overall Study|Physician Decision|0|||
125063962|NCT03334396|449850894|FG005|Overall Study|Physician Decision|0|||
125063963|NCT03334396|449850895|FG006|Overall Study|Physician Decision|0|||
125063964|NCT03334396|449850896|FG007|Overall Study|Physician Decision|0|||
125063965|NCT03334396|449850889|FG000|Overall Study|Withdrawal by Subject|10|||
125063966|NCT03334396|449850890|FG001|Overall Study|Withdrawal by Subject|5|||
125063967|NCT03334396|449850891|FG002|Overall Study|Withdrawal by Subject|7|||
125063968|NCT03334396|449850892|FG003|Overall Study|Withdrawal by Subject|2|||
125063969|NCT03334396|449850893|FG004|Overall Study|Withdrawal by Subject|2|||
125063970|NCT03334396|449850894|FG005|Overall Study|Withdrawal by Subject|1|||
125063971|NCT03334396|449850895|FG006|Overall Study|Withdrawal by Subject|2|||
125063972|NCT03334396|449850896|FG007|Overall Study|Withdrawal by Subject|0|||
125063973|NCT03334396|449850889|FG000|Overall Study|Pregnancy|0|||
125063974|NCT03334396|449850890|FG001|Overall Study|Pregnancy|1|||
125063975|NCT03334396|449850891|FG002|Overall Study|Pregnancy|0|||
125063976|NCT03334396|449850892|FG003|Overall Study|Pregnancy|0|||
125063977|NCT03334396|449850893|FG004|Overall Study|Pregnancy|0|||
125063978|NCT03334396|449850894|FG005|Overall Study|Pregnancy|0|||
125063979|NCT03334396|449850895|FG006|Overall Study|Pregnancy|0|||
125063980|NCT03334396|449850896|FG007|Overall Study|Pregnancy|0|||
125063981|NCT03334396|449850889|FG000|Overall Study|Ineligible|0|||
125063982|NCT03334396|449850890|FG001|Overall Study|Ineligible|1|||
125063983|NCT03334396|449850891|FG002|Overall Study|Ineligible|0|||
125063984|NCT03334396|449850892|FG003|Overall Study|Ineligible|0|||
125063985|NCT03334396|449850893|FG004|Overall Study|Ineligible|0|||
125063986|NCT03334396|449850894|FG005|Overall Study|Ineligible|0|||
125063987|NCT03334396|449850895|FG006|Overall Study|Ineligible|0|||
125063988|NCT03334396|449850896|FG007|Overall Study|Ineligible|0|||
125063989|NCT03334396|449850889|FG000|Overall Study|Started New Job|1|||
125063990|NCT03334396|449850890|FG001|Overall Study|Started New Job|0|||
125063991|NCT03334396|449850891|FG002|Overall Study|Started New Job|0|||
125063992|NCT03334396|449850892|FG003|Overall Study|Started New Job|0|||
125063993|NCT03334396|449850893|FG004|Overall Study|Started New Job|0|||
125063994|NCT03334396|449850894|FG005|Overall Study|Started New Job|0|||
125063995|NCT03334396|449850895|FG006|Overall Study|Started New Job|0|||
125063996|NCT03334396|449850896|FG007|Overall Study|Started New Job|0|||
125063997|NCT03629041|449850899|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
125063998|NCT03629041|449850900|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
125063999|NCT03629041|449850901|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
125064000|NCT03629041|449850902|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
125064001|NCT00592553|449850906|FG000|Overall Study|Protocol Noncompliance|1|||
125064002|NCT00592553|449850907|FG001|Overall Study|Protocol Noncompliance|0|||
125064003|NCT00592553|449850908|FG002|Overall Study|Protocol Noncompliance|0|||
125064004|NCT02379390|449850909|FG000|Overall Study|Adverse Event|1|||
125064005|NCT02379390|449850910|FG001|Overall Study|Adverse Event|1|||
125064006|NCT02379390|449850909|FG000|Overall Study|Investigator's decision|1|||
125064007|NCT02379390|449850910|FG001|Overall Study|Investigator's decision|0|||
125064008|NCT02379390|449850909|FG000|Overall Study|Study Termination|0|||
125064009|NCT02379390|449850910|FG001|Overall Study|Study Termination|1|||
125064010|NCT01255306|449852361|FG000|Overall Study|Physician Decision|1|||
125064011|NCT01255306|449852362|FG001|Overall Study|Physician Decision|1|||
125064012|NCT01283997|449852363|FG000|Overall Study|Physician Decision|8|||
125064013|NCT01283997|449852364|FG001|Overall Study|Physician Decision|10|||
125064014|NCT01283997|449852363|FG000|Overall Study|Withdrawal by Subject|3|||
125064015|NCT01283997|449852364|FG001|Overall Study|Withdrawal by Subject|2|||
125064016|NCT01283997|449852363|FG000|Overall Study|Physically unable to continue|0|||
125064017|NCT01283997|449852364|FG001|Overall Study|Physically unable to continue|1|||
125064018|NCT01283997|449852363|FG000|Overall Study|Progressive disease|1|||
125064019|NCT01283997|449852364|FG001|Overall Study|Progressive disease|0|||
125064020|NCT01283997|449852363|FG000|Overall Study|Other|4|||
125064021|NCT01283997|449852364|FG001|Overall Study|Other|4|||
125064022|NCT02017899|449852365|FG000|Overall Study|Withdrawal by Subject|0|||
125064023|NCT02017899|449852366|FG001|Overall Study|Withdrawal by Subject|0|||
125064024|NCT02017899|449852367|FG002|Overall Study|Withdrawal by Subject|0|||
125064025|NCT02017899|449852368|FG003|Overall Study|Withdrawal by Subject|1|||
125064026|NCT02017899|449852369|FG004|Overall Study|Withdrawal by Subject|1|||
125064027|NCT02017899|449852370|FG005|Overall Study|Withdrawal by Subject|0|||
125064028|NCT01747811|449852374|FG000|Overall Study|Lack of Efficacy|2|||
125064029|NCT01747811|449852375|FG001|Overall Study|Lack of Efficacy|4|||
125064030|NCT01337167|449852376|FG000|Infant Series|Adverse Event|1|||
125064031|NCT01337167|449852377|FG001|Infant Series|Adverse Event|1|||
125064032|NCT01337167|449852376|FG000|Infant Series|Death|1|||
125064033|NCT01337167|449852377|FG001|Infant Series|Death|1|||
125064034|NCT01337167|449852376|FG000|Infant Series|Lost to Follow-up|13|||
125064035|NCT01337167|449852377|FG001|Infant Series|Lost to Follow-up|7|||
125064036|NCT01337167|449852376|FG000|Infant Series|Non-compliance with study drug|2|||
125064037|NCT01337167|449852377|FG001|Infant Series|Non-compliance with study drug|1|||
125064038|NCT01337167|449852376|FG000|Infant Series|Physician Decision|3|||
125064039|NCT01337167|449852377|FG001|Infant Series|Physician Decision|1|||
125064040|NCT01337167|449852376|FG000|Infant Series|Protocol Violation|22|||
125064041|NCT01337167|449852377|FG001|Infant Series|Protocol Violation|9|||
125064042|NCT01337167|449852376|FG000|Infant Series|Withdrawal by Subject|15|||
125064043|NCT01337167|449852377|FG001|Infant Series|Withdrawal by Subject|4|||
125064044|NCT01337167|449852376|FG000|Infant Series|Randomized but not vaccinated|5|||
125064045|NCT01337167|449852377|FG001|Infant Series|Randomized but not vaccinated|3|||
125064046|NCT01337167|449852376|FG000|Interim Period|Lost to Follow-up|51|||
125064047|NCT01337167|449852377|FG001|Interim Period|Lost to Follow-up|23|||
125064048|NCT01337167|449852376|FG000|Interim Period|Non-compliance with study drug|1|||
125064049|NCT01337167|449852377|FG001|Interim Period|Non-compliance with study drug|0|||
125064050|NCT01337167|449852376|FG000|Interim Period|Physician Decision|6|||
125064051|NCT01337167|449852377|FG001|Interim Period|Physician Decision|3|||
125064052|NCT01337167|449852376|FG000|Interim Period|Protocol Violation|5|||
125064053|NCT01337167|449852377|FG001|Interim Period|Protocol Violation|3|||
125064054|NCT01337167|449852376|FG000|Interim Period|Withdrawal by Subject|18|||
125064055|NCT01337167|449852377|FG001|Interim Period|Withdrawal by Subject|10|||
125064056|NCT01337167|449852376|FG000|Interim Period|Other protocol criterion not met|0|||
125064057|NCT01337167|449852377|FG001|Interim Period|Other protocol criterion not met|1|||
125064058|NCT01337167|449852376|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
125064059|NCT01337167|449852377|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
125064060|NCT01337167|449852376|FG000|Toddler Vaccinations|Protocol Violation|0|||
125064061|NCT01337167|449852377|FG001|Toddler Vaccinations|Protocol Violation|1|||
125064062|NCT01337167|449852376|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
125064063|NCT01337167|449852377|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
125064064|NCT03833817|449852378|FG000|Overall Study|Withdrawal by Subject|3|||
125064065|NCT03833817|449852379|FG001|Overall Study|Withdrawal by Subject|3|||
125064066|NCT03833817|449852378|FG000|Overall Study|Lost to Follow-up|3|||
125064067|NCT03833817|449852379|FG001|Overall Study|Lost to Follow-up|3|||
125064068|NCT00884221|449852382|FG000|Overall Study|Withdrawal by Subject|0|||
125064069|NCT00884221|449852383|FG001|Overall Study|Withdrawal by Subject|3|||
125064070|NCT00884221|449852382|FG000|Overall Study|Adverse Event|6|||
125064071|NCT00884221|449852383|FG001|Overall Study|Adverse Event|3|||
125064072|NCT00884221|449852382|FG000|Overall Study|Protocol Violation|16|||
125064073|NCT00884221|449852383|FG001|Overall Study|Protocol Violation|13|||
125064074|NCT00884221|449852382|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
125064075|NCT00884221|449852383|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
125064076|NCT03363919|449852386|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
125064077|NCT03363919|449852387|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
125064078|NCT03363919|449852386|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
125064079|NCT03363919|449852387|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
125064080|NCT01646398|449852388|FG000|Overall Study|Withdrawal by Subject|1|||
125064081|NCT01646398|449852389|FG001|Overall Study|Withdrawal by Subject|0|||
125064082|NCT00255034|449852390|FG000|Overall Study|Withdrawal by Subject|15|||
125064083|NCT00255034|449852391|FG001|Overall Study|Withdrawal by Subject|38|||
125064084|NCT00574119|449852392|FG000|Overall Study|Adverse Event|1|||
125064085|NCT00574119|449852392|FG000|Overall Study|Protocol Violation|1|||
125064086|NCT00574119|449852392|FG000|Overall Study|Withdrawal by Subject|1|||
125064087|NCT00574119|449852392|FG000|Overall Study|Physician Decision|1|||
125064088|NCT03434418|449852393|FG000|Overall Study|Disease Progression|11|||
125064089|NCT03434418|449852393|FG000|Overall Study|Adverse Event|2|||
125064090|NCT03434418|449852393|FG000|Overall Study|Physician Decision|1|||
125064091|NCT03434418|449852393|FG000|Overall Study|Decline in Performance Status (PS)|1|||
125064092|NCT01956240|449852394|FG000|Overall Study|Lost to Follow-up|6|||
125064093|NCT01956240|449852395|FG001|Overall Study|Lost to Follow-up|20|||
125064094|NCT01956240|449852394|FG000|Overall Study|Adverse Event|17|||
125064095|NCT01956240|449852395|FG001|Overall Study|Adverse Event|4|||
125064096|NCT00600028|449852398|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
125064097|NCT00600028|449852399|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
125064098|NCT00600028|449852398|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
125064099|NCT00600028|449852399|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
125064100|NCT00600028|449852398|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
125064101|NCT00600028|449852399|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
125064102|NCT03172481|449852400|FG000|Double-blind|Withdrawal by Subject|1|||
125064103|NCT03172481|449852401|FG001|Double-blind|Withdrawal by Subject|0|||
125064104|NCT01957709|449852402|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
125064105|NCT01610076|449852412|FG000|Overall Study|Technical issue with video|0|||
125064106|NCT01610076|449852413|FG001|Overall Study|Technical issue with video|1|||
125064107|NCT01610076|449852412|FG000|Overall Study|Lost to Follow-up|3|||
125064108|NCT01610076|449852413|FG001|Overall Study|Lost to Follow-up|4|||
125139498|NCT02054715|450132897|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
125139499|NCT02054715|450132896|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
125139500|NCT02054715|450132897|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
125139501|NCT02054715|450132896|FG000|Baseline/Follow-up 1|No Reason|0|||
125139502|NCT02054715|450132897|FG001|Baseline/Follow-up 1|No Reason|1|||
125139503|NCT02054715|450132896|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
125139504|NCT02054715|450132897|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
125139505|NCT02054715|450132896|FG000|Baseline/Follow-up 1|Ineligible|3|||
125139506|NCT02054715|450132897|FG001|Baseline/Follow-up 1|Ineligible|0|||
125139507|NCT02054715|450132896|FG000|Baseline/Follow-up 1|Hospitalization|1|||
125139508|NCT02054715|450132897|FG001|Baseline/Follow-up 1|Hospitalization|0|||
125139509|NCT02054715|450132896|FG000|Baseline/Follow-up 1|Changed Mind|1|||
125139510|NCT02054715|450132897|FG001|Baseline/Follow-up 1|Changed Mind|0|||
125139511|NCT02054715|450132896|FG000|Follow-up 2|Lost to Followup|3|||
125139512|NCT02054715|450132897|FG001|Follow-up 2|Lost to Followup|1|||
125139513|NCT02054715|450132896|FG000|Follow-up 2|Refused|3|||
125139514|NCT02054715|450132897|FG001|Follow-up 2|Refused|2|||
125139515|NCT02054715|450132896|FG000|Follow-up 2|Followup Not Completed|3|||
125064109|NCT01107405|449852414|FG000|Overall Study|Adverse Event|1|||
125064110|NCT01107405|449852415|FG001|Overall Study|Adverse Event|1|||
125064111|NCT01107405|449852416|FG002|Overall Study|Adverse Event|0|||
125139516|NCT02054715|450132897|FG001|Follow-up 2|Followup Not Completed|4|||
125064112|NCT01107405|449852417|FG003|Overall Study|Adverse Event|0|||
125064113|NCT01107405|449852418|FG004|Overall Study|Adverse Event|2|||
125064114|NCT01107405|449852414|FG000|Overall Study|Withdrawal by Subject|1|||
125064115|NCT01107405|449852415|FG001|Overall Study|Withdrawal by Subject|0|||
125064116|NCT01107405|449852416|FG002|Overall Study|Withdrawal by Subject|1|||
125064117|NCT01107405|449852417|FG003|Overall Study|Withdrawal by Subject|2|||
125064118|NCT01107405|449852418|FG004|Overall Study|Withdrawal by Subject|1|||
125064119|NCT01107405|449852414|FG000|Overall Study|Protocol Violation|0|||
125064120|NCT01107405|449852415|FG001|Overall Study|Protocol Violation|0|||
125064121|NCT01107405|449852416|FG002|Overall Study|Protocol Violation|1|||
125064122|NCT01107405|449852417|FG003|Overall Study|Protocol Violation|1|||
125064123|NCT01107405|449852418|FG004|Overall Study|Protocol Violation|0|||
125064124|NCT00098020|449852424|FG000|Overall Study|Adverse Event|2|||
125064125|NCT00098020|449852424|FG000|Overall Study|Lost to Follow-up|1|||
125139517|NCT02054715|450132896|FG000|Follow-up 2|Ineligible|4|||
125139518|NCT02054715|450132897|FG001|Follow-up 2|Ineligible|5|||
125139519|NCT02054715|450132896|FG000|Follow-up 2|Death|3|||
125139520|NCT02054715|450132897|FG001|Follow-up 2|Death|3|||
125222452|NCT01723072|450442752|FG000|Overall Study|Withdrawal by Subject|7|||
125222453|NCT01723072|450442753|FG001|Overall Study|Withdrawal by Subject|13|||
125222454|NCT01723072|450442752|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
125222455|NCT01723072|450442753|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
125222456|NCT01723072|450442752|FG000|Overall Study|Other|4|||
125222457|NCT01723072|450442753|FG001|Overall Study|Other|3|||
125222458|NCT03428100|450442754|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
125222459|NCT03428100|450442755|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222460|NCT03428100|450442756|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
125222461|NCT03428100|450442757|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
125222462|NCT03428100|450442758|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222463|NCT03428100|450442759|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222464|NCT03428100|450442760|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222465|NCT03428100|450442761|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222466|NCT03428100|450442762|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222467|NCT03428100|450442763|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222468|NCT03428100|450442764|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222469|NCT03428100|450442765|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222470|NCT03428100|450442766|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222471|NCT03428100|450442767|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222472|NCT03428100|450442768|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222473|NCT03428100|450442769|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222474|NCT03428100|450442770|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222475|NCT03428100|450442771|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222476|NCT03428100|450442772|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222477|NCT03428100|450442754|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
125222478|NCT03428100|450442755|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
125222479|NCT03428100|450442756|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
125222480|NCT03428100|450442757|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
125222481|NCT03428100|450442758|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222482|NCT03428100|450442759|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222483|NCT03428100|450442760|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222484|NCT03428100|450442761|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222485|NCT03428100|450442762|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222486|NCT03428100|450442763|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222487|NCT03428100|450442764|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222488|NCT03428100|450442765|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222489|NCT03428100|450442766|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125139521|NCT02054715|450132896|FG000|Follow-up 2|Hospitalization|0|||
125139522|NCT02054715|450132897|FG001|Follow-up 2|Hospitalization|2|||
125139523|NCT02054715|450132896|FG000|Follow-up 2|Changed MD/Facility|0|||
125139524|NCT02054715|450132897|FG001|Follow-up 2|Changed MD/Facility|1|||
125139525|NCT02054715|450132896|FG000|Follow-up 2|Changed Mind|0|||
125139526|NCT02054715|450132897|FG001|Follow-up 2|Changed Mind|1|||
125139527|NCT02054715|450132896|FG000|Follow-up 2|No Reason|2|||
125222490|NCT03428100|450442767|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222491|NCT03428100|450442768|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125064126|NCT00098020|449852424|FG000|Overall Study|elevated liver enzymes|1|||
125139528|NCT02054715|450132897|FG001|Follow-up 2|No Reason|0|||
125139529|NCT02054715|450132896|FG000|Follow-up 2|Treatment Change or Delay|1|||
125139530|NCT02054715|450132897|FG001|Follow-up 2|Treatment Change or Delay|0|||
125139531|NCT01442376|450132899|FG000|Overall Study|Adverse Event|0|||
125064127|NCT00098020|449852424|FG000|Overall Study|Low urine PCR|1|||
125064128|NCT00098020|449852424|FG000|Overall Study|Low epidermal growth factor receptor|1|||
125064129|NCT01840228|449852428|FG000|Overall Study|Lost to Follow-up|1|||
125064130|NCT01840228|449852429|FG001|Overall Study|Lost to Follow-up|1|||
125064131|NCT01879319|449852432|FG000|Overall Study|Withdrawal by Subject|1|||
125064132|NCT01879319|449852433|FG001|Overall Study|Withdrawal by Subject|0|||
125064133|NCT01879319|449852432|FG000|Overall Study|Lost to Follow-up|1|||
125064134|NCT01879319|449852433|FG001|Overall Study|Lost to Follow-up|5|||
125064135|NCT02670330|449852436|FG000|Overall Study|Protocol Deviation|1|||
125064136|NCT02670330|449852437|FG001|Overall Study|Protocol Deviation|0|||
125064137|NCT02670330|449852436|FG000|Overall Study|Study Terminated By Sponsor|36|||
125064138|NCT02670330|449852437|FG001|Overall Study|Study Terminated By Sponsor|43|||
125064139|NCT02670330|449852436|FG000|Overall Study|Adverse Event|1|||
125064140|NCT02670330|449852437|FG001|Overall Study|Adverse Event|3|||
125064141|NCT02670330|449852436|FG000|Overall Study|Withdrawal by Subject|34|||
125064142|NCT02670330|449852437|FG001|Overall Study|Withdrawal by Subject|29|||
125064143|NCT02670330|449852436|FG000|Overall Study|Lost to Follow-up|3|||
125064144|NCT02670330|449852437|FG001|Overall Study|Lost to Follow-up|2|||
125064145|NCT04404010|449852440|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
125064146|NCT04404010|449852441|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
125064147|NCT02120157|449852442|FG000|Overall Study|Death|8|||
125064148|NCT00441103|449852446|FG000|Overall Study|Adverse Event|2|||
125064149|NCT00441103|449852447|FG001|Overall Study|Adverse Event|1|||
125064150|NCT00441103|449852446|FG000|Overall Study|Death|1|||
125064151|NCT00441103|449852447|FG001|Overall Study|Death|0|||
125064152|NCT00441103|449852446|FG000|Overall Study|Disease Progression|2|||
125064153|NCT00441103|449852447|FG001|Overall Study|Disease Progression|0|||
125064154|NCT00441103|449852446|FG000|Overall Study|Lost to Follow-up|1|||
125064155|NCT00441103|449852447|FG001|Overall Study|Lost to Follow-up|0|||
125064156|NCT00441103|449852446|FG000|Overall Study|Protocol Violation|1|||
125064157|NCT00441103|449852447|FG001|Overall Study|Protocol Violation|0|||
125064158|NCT00441103|449852446|FG000|Overall Study|Participant unable to use Rebiject II|1|||
125064159|NCT00441103|449852447|FG001|Overall Study|Participant unable to use Rebiject II|0|||
125064160|NCT00441103|449852446|FG000|Overall Study|Participant refused MRI|1|||
125064161|NCT00441103|449852447|FG001|Overall Study|Participant refused MRI|0|||
125064162|NCT00441103|449852446|FG000|Overall Study|Inclusion criteria absent|1|||
125064163|NCT00441103|449852447|FG001|Overall Study|Inclusion criteria absent|0|||
125064164|NCT00441103|449852446|FG000|Overall Study|Non-compliant|0|||
125139532|NCT01442376|450132900|FG001|Overall Study|Adverse Event|3|||
125139533|NCT01442376|450132901|FG002|Overall Study|Adverse Event|2|||
125139534|NCT01442376|450132899|FG000|Overall Study|Death|0|||
125139535|NCT01442376|450132900|FG001|Overall Study|Death|1|||
125139536|NCT01442376|450132901|FG002|Overall Study|Death|1|||
125139537|NCT01442376|450132899|FG000|Overall Study|Withdrawal of consent|0|||
125139538|NCT01442376|450132900|FG001|Overall Study|Withdrawal of consent|0|||
125139539|NCT01442376|450132901|FG002|Overall Study|Withdrawal of consent|1|||
125139540|NCT01442376|450132899|FG000|Overall Study|Patients not treated|2|||
125139541|NCT01442376|450132900|FG001|Overall Study|Patients not treated|3|||
125139542|NCT01442376|450132901|FG002|Overall Study|Patients not treated|1|||
125139543|NCT01442376|450132899|FG000|Overall Study|Not eligible for subsequent cycles|1|||
125139544|NCT01442376|450132900|FG001|Overall Study|Not eligible for subsequent cycles|2|||
125139545|NCT01442376|450132901|FG002|Overall Study|Not eligible for subsequent cycles|0|||
125139546|NCT01964950|450132902|FG000|Overall Study|Protocol Violation|25|||
125139547|NCT03499873|450132903|FG000|Overall Study|Withdrawal by Subject|4|||
125139548|NCT03499873|450132904|FG001|Overall Study|Withdrawal by Subject|6|||
125139549|NCT03499873|450132905|FG002|Overall Study|Withdrawal by Subject|1|||
125139550|NCT03499873|450132903|FG000|Overall Study|Subjects condition worsened|0|||
125064165|NCT00441103|449852447|FG001|Overall Study|Non-compliant|1|||
125139551|NCT03499873|450132904|FG001|Overall Study|Subjects condition worsened|3|||
125139552|NCT03499873|450132905|FG002|Overall Study|Subjects condition worsened|11|||
125064166|NCT00441103|449852446|FG000|Overall Study|Participant decided to withdraw|1|||
125064167|NCT00441103|449852447|FG001|Overall Study|Participant decided to withdraw|0|||
125064168|NCT00441103|449852446|FG000|Overall Study|Participant's reason|0|||
125064169|NCT00441103|449852447|FG001|Overall Study|Participant's reason|1|||
125064170|NCT00441103|449852446|FG000|Overall Study|Participant decided to stop|0|||
125064171|NCT00441103|449852447|FG001|Overall Study|Participant decided to stop|1|||
125064172|NCT00239837|449852450|FG000|Overall Study|Lost to Follow-up|3|||
125064173|NCT00239837|449852451|FG001|Overall Study|Lost to Follow-up|7|||
125064174|NCT01153893|449852452|FG000|Overall Study|Adverse Event|1|||
125064175|NCT01153893|449852453|FG001|Overall Study|Adverse Event|0|||
125064176|NCT01838590|449852454|FG000|Overall Study|Lack of Efficacy|12|||
125064177|NCT01838590|449852455|FG001|Overall Study|Lack of Efficacy|4|||
125064178|NCT01838590|449852454|FG000|Overall Study|Lost to Follow-up|0|||
125064179|NCT01838590|449852455|FG001|Overall Study|Lost to Follow-up|1|||
125064180|NCT01354431|449852456|FG000|Pre-Treatment Period|Not reported|1|||
125064181|NCT01354431|449852457|FG001|Pre-Treatment Period|Not reported|0|||
125064182|NCT01354431|449852458|FG002|Pre-Treatment Period|Not reported|0|||
125064183|NCT01354431|449852456|FG000|Treatment Period|Disease Progression|50|||
125064184|NCT01354431|449852457|FG001|Treatment Period|Disease Progression|40|||
125064185|NCT01354431|449852458|FG002|Treatment Period|Disease Progression|44|||
125064186|NCT01354431|449852456|FG000|Treatment Period|Study Drug Toxicity|5|||
125064187|NCT01354431|449852457|FG001|Treatment Period|Study Drug Toxicity|8|||
125064188|NCT01354431|449852458|FG002|Treatment Period|Study Drug Toxicity|4|||
125064189|NCT01354431|449852456|FG000|Treatment Period|Death|0|||
125064190|NCT01354431|449852457|FG001|Treatment Period|Death|1|||
125064191|NCT01354431|449852458|FG002|Treatment Period|Death|0|||
125064192|NCT01354431|449852456|FG000|Treatment Period|AE unrelated to study drug|1|||
125064193|NCT01354431|449852457|FG001|Treatment Period|AE unrelated to study drug|2|||
125064194|NCT01354431|449852458|FG002|Treatment Period|AE unrelated to study drug|5|||
125064195|NCT01354431|449852456|FG000|Treatment Period|Participant request to discontinue|2|||
125064196|NCT01354431|449852457|FG001|Treatment Period|Participant request to discontinue|2|||
125064197|NCT01354431|449852458|FG002|Treatment Period|Participant request to discontinue|1|||
125064198|NCT01354431|449852456|FG000|Treatment Period|Participant withdrew consent|0|||
125064199|NCT01354431|449852457|FG001|Treatment Period|Participant withdrew consent|1|||
125064200|NCT01354431|449852458|FG002|Treatment Period|Participant withdrew consent|0|||
125064201|NCT01354431|449852456|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
125064202|NCT01354431|449852457|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
125064203|NCT01354431|449852458|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
125064204|NCT01364233|449852465|FG000|Overall Study|Lost to Follow-up|1|||
125064205|NCT00878215|449852466|FG000|Overall Study|Determined to be ineligible|0|||
125064206|NCT00878215|449852467|FG001|Overall Study|Determined to be ineligible|10|||
125064207|NCT00878215|449852468|FG002|Overall Study|Determined to be ineligible|0|||
125064208|NCT00878215|449852469|FG003|Overall Study|Determined to be ineligible|0|||
125064209|NCT00302718|449852471|FG000|Overall Study|Participant left the hospital|1|||
125064210|NCT00302718|449852472|FG001|Overall Study|Participant left the hospital|0|||
125064211|NCT00302718|449852473|FG002|Overall Study|Participant left the hospital|0|||
125064212|NCT00302718|449852474|FG003|Overall Study|Participant left the hospital|1|||
125064213|NCT00302718|449852471|FG000|Overall Study|Withdrawal by Subject|0|||
125064214|NCT00302718|449852472|FG001|Overall Study|Withdrawal by Subject|1|||
125064215|NCT00302718|449852473|FG002|Overall Study|Withdrawal by Subject|0|||
125064216|NCT00302718|449852474|FG003|Overall Study|Withdrawal by Subject|0|||
125064217|NCT00302718|449852471|FG000|Overall Study|Participant left primary care setting|0|||
125064218|NCT00302718|449852472|FG001|Overall Study|Participant left primary care setting|0|||
125064219|NCT00302718|449852473|FG002|Overall Study|Participant left primary care setting|2|||
125064220|NCT00302718|449852474|FG003|Overall Study|Participant left primary care setting|1|||
125064221|NCT00819585|449852475|FG000|Core Study|Adverse Event|2|||
125064222|NCT00819585|449852476|FG001|Core Study|Adverse Event|1|||
125139553|NCT03499873|450132903|FG000|Overall Study|Adverse Event|8|||
125139554|NCT03499873|450132904|FG001|Overall Study|Adverse Event|3|||
125139555|NCT03499873|450132905|FG002|Overall Study|Adverse Event|6|||
125139556|NCT03499873|450132903|FG000|Overall Study|Physician Decision|1|||
125139557|NCT03499873|450132904|FG001|Overall Study|Physician Decision|0|||
125139558|NCT03499873|450132905|FG002|Overall Study|Physician Decision|0|||
125139559|NCT03499873|450132903|FG000|Overall Study|Administrative reasons|0|||
125139560|NCT03499873|450132904|FG001|Overall Study|Administrative reasons|1|||
125139561|NCT03499873|450132905|FG002|Overall Study|Administrative reasons|0|||
125139562|NCT03499873|450132903|FG000|Overall Study|Concomitant therapy|5|||
125139563|NCT03499873|450132904|FG001|Overall Study|Concomitant therapy|4|||
125064223|NCT00819585|449852477|FG002|Core Study|Adverse Event|1|||
125064224|NCT00819585|449852478|FG003|Core Study|Adverse Event|4|||
125064225|NCT00819585|449852479|FG004|Core Study|Adverse Event|1|||
125064226|NCT00819585|449852480|FG005|Core Study|Adverse Event|0|||
125139564|NCT03499873|450132905|FG002|Overall Study|Concomitant therapy|7|||
125064227|NCT00819585|449852481|FG006|Core Study|Adverse Event|2|||
125064228|NCT00819585|449852482|FG007|Core Study|Adverse Event|0|||
125064229|NCT00819585|449852483|FG008|Core Study|Adverse Event|0|||
125064230|NCT00819585|449852484|FG009|Core Study|Adverse Event|0|||
125064231|NCT00819585|449852485|FG010|Core Study|Adverse Event|0|||
125064232|NCT00819585|449852475|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
125064233|NCT00819585|449852476|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
125064234|NCT00819585|449852477|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
125064235|NCT00819585|449852478|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
125064236|NCT00819585|449852479|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
125064237|NCT00819585|449852480|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
125064238|NCT00819585|449852481|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
125064239|NCT00819585|449852482|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
125064240|NCT00819585|449852483|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
125064241|NCT00819585|449852484|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
125064242|NCT00819585|449852485|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
125139565|NCT03499873|450132903|FG000|Overall Study|Miscellaneous|1|||
125139566|NCT03499873|450132904|FG001|Overall Study|Miscellaneous|2|||
125139567|NCT03499873|450132905|FG002|Overall Study|Miscellaneous|2|||
125139568|NCT03499873|450132903|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
125064243|NCT00819585|449852475|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
125064244|NCT00819585|449852476|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
125139569|NCT03499873|450132904|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
125139570|NCT03499873|450132905|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
125139571|NCT01075516|450132906|FG000|Overall Study|Death|5|||
125139572|NCT01075516|450132907|FG001|Overall Study|Death|9|||
125139573|NCT01075516|450132906|FG000|Overall Study|Lost to Follow-up|10|||
125139574|NCT01075516|450132907|FG001|Overall Study|Lost to Follow-up|2|||
125139575|NCT01075516|450132906|FG000|Overall Study|Withdrawal by Subject|3|||
125139576|NCT01075516|450132907|FG001|Overall Study|Withdrawal by Subject|5|||
125139577|NCT02252016|450132908|FG000|Overall Study|Lost to Follow-up|2|||
125139578|NCT02252016|450132909|FG001|Overall Study|Lost to Follow-up|1|||
125139579|NCT02252016|450132908|FG000|Overall Study|Physician Decision|1|||
125139580|NCT02252016|450132909|FG001|Overall Study|Physician Decision|0|||
125139581|NCT02252016|450132908|FG000|Overall Study|Withdrawal by Subject|0|||
125139582|NCT02252016|450132909|FG001|Overall Study|Withdrawal by Subject|2|||
125139583|NCT04631562|450132912|FG000|Overall Study|Withdrawal by Subject|0|||
125139584|NCT04631562|450132913|FG001|Overall Study|Withdrawal by Subject|0|||
125139585|NCT04631562|450132914|FG002|Overall Study|Withdrawal by Subject|0|||
125139586|NCT04631562|450132915|FG003|Overall Study|Withdrawal by Subject|0|||
125139587|NCT04631562|450132916|FG004|Overall Study|Withdrawal by Subject|0|||
125139588|NCT04631562|450132917|FG005|Overall Study|Withdrawal by Subject|0|||
125064245|NCT00819585|449852477|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
125064246|NCT00819585|449852478|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
125064247|NCT00819585|449852479|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
125139589|NCT04631562|450132918|FG006|Overall Study|Withdrawal by Subject|0|||
125139590|NCT04631562|450132919|FG007|Overall Study|Withdrawal by Subject|1|||
125064248|NCT00819585|449852480|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
125064249|NCT00819585|449852481|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
125139591|NCT04631562|450132920|FG008|Overall Study|Withdrawal by Subject|0|||
125139592|NCT04631562|450132912|FG000|Overall Study|Other|0|||
125139593|NCT04631562|450132913|FG001|Overall Study|Other|0|||
125064250|NCT00819585|449852482|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
125064251|NCT00819585|449852483|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
125064252|NCT00819585|449852484|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
125064253|NCT00819585|449852485|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
125064254|NCT00819585|449852475|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
125064255|NCT00819585|449852476|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
125064256|NCT00819585|449852477|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
125064257|NCT00819585|449852478|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
125064258|NCT00819585|449852479|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
125064259|NCT00819585|449852480|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
125064260|NCT00819585|449852481|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
125064261|NCT00819585|449852482|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
125064262|NCT00819585|449852483|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
125064263|NCT00819585|449852484|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
125064264|NCT00819585|449852485|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
125064265|NCT00819585|449852475|FG000|Core Study|Subject Withdrew Consent|0|||
125064266|NCT00819585|449852476|FG001|Core Study|Subject Withdrew Consent|3|||
125064267|NCT00819585|449852477|FG002|Core Study|Subject Withdrew Consent|2|||
125064268|NCT00819585|449852478|FG003|Core Study|Subject Withdrew Consent|1|||
125064269|NCT00819585|449852479|FG004|Core Study|Subject Withdrew Consent|0|||
125064270|NCT00819585|449852480|FG005|Core Study|Subject Withdrew Consent|0|||
125064271|NCT00819585|449852481|FG006|Core Study|Subject Withdrew Consent|3|||
125064272|NCT00819585|449852482|FG007|Core Study|Subject Withdrew Consent|0|||
125064273|NCT00819585|449852483|FG008|Core Study|Subject Withdrew Consent|0|||
125064274|NCT00819585|449852484|FG009|Core Study|Subject Withdrew Consent|0|||
125064275|NCT00819585|449852485|FG010|Core Study|Subject Withdrew Consent|0|||
125064276|NCT00819585|449852475|FG000|Core Study|Lost to Follow-up|2|||
125064277|NCT00819585|449852476|FG001|Core Study|Lost to Follow-up|1|||
125064278|NCT00819585|449852477|FG002|Core Study|Lost to Follow-up|2|||
125064279|NCT00819585|449852478|FG003|Core Study|Lost to Follow-up|0|||
125064280|NCT00819585|449852479|FG004|Core Study|Lost to Follow-up|1|||
125064281|NCT00819585|449852480|FG005|Core Study|Lost to Follow-up|1|||
125064282|NCT00819585|449852481|FG006|Core Study|Lost to Follow-up|1|||
125064283|NCT00819585|449852482|FG007|Core Study|Lost to Follow-up|0|||
125064284|NCT00819585|449852483|FG008|Core Study|Lost to Follow-up|0|||
125064285|NCT00819585|449852484|FG009|Core Study|Lost to Follow-up|0|||
125064286|NCT00819585|449852485|FG010|Core Study|Lost to Follow-up|0|||
125064287|NCT00819585|449852475|FG000|Core Study|Administrative Problems|0|||
125064288|NCT00819585|449852476|FG001|Core Study|Administrative Problems|0|||
125064289|NCT00819585|449852477|FG002|Core Study|Administrative Problems|0|||
125064290|NCT00819585|449852478|FG003|Core Study|Administrative Problems|0|||
125064291|NCT00819585|449852479|FG004|Core Study|Administrative Problems|0|||
125064292|NCT00819585|449852480|FG005|Core Study|Administrative Problems|0|||
125064293|NCT00819585|449852481|FG006|Core Study|Administrative Problems|2|||
125064294|NCT00819585|449852482|FG007|Core Study|Administrative Problems|0|||
125064295|NCT00819585|449852483|FG008|Core Study|Administrative Problems|0|||
125064296|NCT00819585|449852484|FG009|Core Study|Administrative Problems|0|||
125064297|NCT00819585|449852485|FG010|Core Study|Administrative Problems|0|||
125064298|NCT00819585|449852475|FG000|Core Study|Death|0|||
125064299|NCT00819585|449852476|FG001|Core Study|Death|0|||
125064300|NCT00819585|449852477|FG002|Core Study|Death|0|||
125064301|NCT00819585|449852478|FG003|Core Study|Death|0|||
125064302|NCT00819585|449852479|FG004|Core Study|Death|0|||
125064303|NCT00819585|449852480|FG005|Core Study|Death|0|||
125064304|NCT00819585|449852481|FG006|Core Study|Death|1|||
125064305|NCT00819585|449852482|FG007|Core Study|Death|0|||
125064306|NCT00819585|449852483|FG008|Core Study|Death|0|||
125064307|NCT00819585|449852484|FG009|Core Study|Death|0|||
125064308|NCT00819585|449852485|FG010|Core Study|Death|0|||
125064309|NCT00819585|449852475|FG000|Core Study|Protocol Violation|0|||
125064310|NCT00819585|449852476|FG001|Core Study|Protocol Violation|0|||
125064311|NCT00819585|449852477|FG002|Core Study|Protocol Violation|1|||
125064312|NCT00819585|449852478|FG003|Core Study|Protocol Violation|0|||
125064313|NCT00819585|449852479|FG004|Core Study|Protocol Violation|0|||
125064314|NCT00819585|449852480|FG005|Core Study|Protocol Violation|1|||
125064315|NCT00819585|449852481|FG006|Core Study|Protocol Violation|3|||
125064316|NCT00819585|449852482|FG007|Core Study|Protocol Violation|0|||
125064317|NCT00819585|449852483|FG008|Core Study|Protocol Violation|0|||
125064318|NCT00819585|449852484|FG009|Core Study|Protocol Violation|0|||
125064319|NCT00819585|449852485|FG010|Core Study|Protocol Violation|0|||
125064320|NCT00819585|449852475|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
125064321|NCT00819585|449852476|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
125139594|NCT04631562|450132914|FG002|Overall Study|Other|0|||
125139595|NCT04631562|450132915|FG003|Overall Study|Other|0|||
125064322|NCT00819585|449852477|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
125064323|NCT00819585|449852478|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
125064324|NCT00819585|449852479|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
125064325|NCT00819585|449852480|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
125064326|NCT00819585|449852481|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
125139596|NCT04631562|450132916|FG004|Overall Study|Other|0|||
125064327|NCT00819585|449852482|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
125064328|NCT00819585|449852483|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
125064329|NCT00819585|449852484|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
125064330|NCT00819585|449852485|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
125064331|NCT00819585|449852475|FG000|Extension Study|Subject Withdrew Consent|0|||
125064332|NCT00819585|449852476|FG001|Extension Study|Subject Withdrew Consent|0|||
125064333|NCT00819585|449852477|FG002|Extension Study|Subject Withdrew Consent|0|||
125064334|NCT00819585|449852478|FG003|Extension Study|Subject Withdrew Consent|0|||
125064335|NCT00819585|449852479|FG004|Extension Study|Subject Withdrew Consent|0|||
125064336|NCT00819585|449852480|FG005|Extension Study|Subject Withdrew Consent|0|||
125064337|NCT00819585|449852481|FG006|Extension Study|Subject Withdrew Consent|0|||
125064338|NCT00819585|449852482|FG007|Extension Study|Subject Withdrew Consent|0|||
125064339|NCT00819585|449852483|FG008|Extension Study|Subject Withdrew Consent|3|||
125064340|NCT00819585|449852484|FG009|Extension Study|Subject Withdrew Consent|0|||
125064341|NCT00819585|449852485|FG010|Extension Study|Subject Withdrew Consent|1|||
125064342|NCT00819585|449852475|FG000|Extension Study|Lost to Follow-up|0|||
125064343|NCT00819585|449852476|FG001|Extension Study|Lost to Follow-up|0|||
125064344|NCT00819585|449852477|FG002|Extension Study|Lost to Follow-up|0|||
125064345|NCT00819585|449852478|FG003|Extension Study|Lost to Follow-up|0|||
125064346|NCT00819585|449852479|FG004|Extension Study|Lost to Follow-up|0|||
125064347|NCT00819585|449852480|FG005|Extension Study|Lost to Follow-up|0|||
125064348|NCT00819585|449852481|FG006|Extension Study|Lost to Follow-up|0|||
125064349|NCT00819585|449852482|FG007|Extension Study|Lost to Follow-up|0|||
125064350|NCT00819585|449852483|FG008|Extension Study|Lost to Follow-up|2|||
125064351|NCT00819585|449852484|FG009|Extension Study|Lost to Follow-up|1|||
125064352|NCT00819585|449852485|FG010|Extension Study|Lost to Follow-up|1|||
125064353|NCT00819585|449852475|FG000|Extension Study|Death|0|||
125064354|NCT00819585|449852476|FG001|Extension Study|Death|0|||
125064355|NCT00819585|449852477|FG002|Extension Study|Death|0|||
125064356|NCT00819585|449852478|FG003|Extension Study|Death|0|||
125064357|NCT00819585|449852479|FG004|Extension Study|Death|0|||
125064358|NCT00819585|449852480|FG005|Extension Study|Death|0|||
125064359|NCT00819585|449852481|FG006|Extension Study|Death|0|||
125064360|NCT00819585|449852482|FG007|Extension Study|Death|0|||
125064361|NCT00819585|449852483|FG008|Extension Study|Death|2|||
125064362|NCT00819585|449852484|FG009|Extension Study|Death|0|||
125064363|NCT00819585|449852485|FG010|Extension Study|Death|0|||
125064364|NCT00738374|449852486|FG000|Induction Treatment Phase|Adverse Event|14|||
125064365|NCT00738374|449852487|FG001|Induction Treatment Phase|Adverse Event|0|||
125064366|NCT00738374|449852488|FG002|Induction Treatment Phase|Adverse Event|0|||
125064367|NCT00738374|449852489|FG003|Induction Treatment Phase|Adverse Event|0|||
125064368|NCT00738374|449852486|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
125064369|NCT00738374|449852487|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
125064370|NCT00738374|449852488|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
125064371|NCT00738374|449852489|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
125064372|NCT00738374|449852486|FG000|Induction Treatment Phase|Physician Decision|2|||
125139597|NCT04631562|450132917|FG005|Overall Study|Other|0|||
125139598|NCT04631562|450132918|FG006|Overall Study|Other|0|||
125139599|NCT04631562|450132919|FG007|Overall Study|Other|0|||
125139600|NCT04631562|450132920|FG008|Overall Study|Other|1|||
125139601|NCT04631562|450132912|FG000|Overall Study|Lost to Follow-up|0|||
125139602|NCT04631562|450132913|FG001|Overall Study|Lost to Follow-up|0|||
125139603|NCT04631562|450132914|FG002|Overall Study|Lost to Follow-up|0|||
125139604|NCT04631562|450132915|FG003|Overall Study|Lost to Follow-up|1|||
125139605|NCT04631562|450132916|FG004|Overall Study|Lost to Follow-up|0|||
125139606|NCT04631562|450132917|FG005|Overall Study|Lost to Follow-up|0|||
125139607|NCT04631562|450132918|FG006|Overall Study|Lost to Follow-up|0|||
125139608|NCT04631562|450132919|FG007|Overall Study|Lost to Follow-up|0|||
125139609|NCT04631562|450132920|FG008|Overall Study|Lost to Follow-up|0|||
125139610|NCT04631562|450132912|FG000|Overall Study|Adverse Event|0|||
125064373|NCT00738374|449852487|FG001|Induction Treatment Phase|Physician Decision|0|||
125064374|NCT00738374|449852488|FG002|Induction Treatment Phase|Physician Decision|0|||
125064375|NCT00738374|449852489|FG003|Induction Treatment Phase|Physician Decision|0|||
125064376|NCT00738374|449852486|FG000|Induction Treatment Phase|Protocol Violation|2|||
125064377|NCT00738374|449852487|FG001|Induction Treatment Phase|Protocol Violation|0|||
125064378|NCT00738374|449852488|FG002|Induction Treatment Phase|Protocol Violation|0|||
125064379|NCT00738374|449852489|FG003|Induction Treatment Phase|Protocol Violation|0|||
125064380|NCT00738374|449852486|FG000|Induction Treatment Phase|Non-compliance|1|||
125139611|NCT04631562|450132913|FG001|Overall Study|Adverse Event|0|||
125222492|NCT03428100|450442769|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125064381|NCT00738374|449852487|FG001|Induction Treatment Phase|Non-compliance|0|||
125064382|NCT00738374|449852488|FG002|Induction Treatment Phase|Non-compliance|0|||
125064383|NCT00738374|449852489|FG003|Induction Treatment Phase|Non-compliance|0|||
125139612|NCT04631562|450132914|FG002|Overall Study|Adverse Event|0|||
125139613|NCT04631562|450132915|FG003|Overall Study|Adverse Event|0|||
125222493|NCT03428100|450442770|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125139614|NCT04631562|450132916|FG004|Overall Study|Adverse Event|0|||
125064384|NCT00738374|449852486|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
125064385|NCT00738374|449852487|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
125064386|NCT00738374|449852488|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
125064387|NCT00738374|449852489|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
125064388|NCT00738374|449852486|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
125064389|NCT00738374|449852487|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
125064390|NCT00738374|449852488|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
125064391|NCT00738374|449852489|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
125064392|NCT00738374|449852486|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
125064393|NCT00738374|449852487|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
125064394|NCT00738374|449852488|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
125064395|NCT00738374|449852489|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
125064396|NCT00738374|449852486|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
125064397|NCT00738374|449852487|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
125064398|NCT00738374|449852488|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
125064399|NCT00738374|449852489|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
125064400|NCT00738374|449852486|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
125064401|NCT00738374|449852487|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
125064402|NCT00738374|449852488|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
125064403|NCT00738374|449852489|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
125064404|NCT00738374|449852486|FG000|Maintenance Treatment/Observation Phase|Other|0|||
125064405|NCT00738374|449852487|FG001|Maintenance Treatment/Observation Phase|Other|1|||
125064406|NCT00738374|449852488|FG002|Maintenance Treatment/Observation Phase|Other|0|||
125064407|NCT00738374|449852489|FG003|Maintenance Treatment/Observation Phase|Other|0|||
125064408|NCT01969799|449852490|FG000|Overall Study|Adverse Event|0|||
125064409|NCT01969799|449852491|FG001|Overall Study|Adverse Event|1|||
125139615|NCT04631562|450132917|FG005|Overall Study|Adverse Event|0|||
125139616|NCT04631562|450132918|FG006|Overall Study|Adverse Event|1|||
125139617|NCT04631562|450132919|FG007|Overall Study|Adverse Event|0|||
125064410|NCT01969799|449852490|FG000|Overall Study|Death|16|||
125064411|NCT01969799|449852491|FG001|Overall Study|Death|11|||
125064412|NCT01969799|449852490|FG000|Overall Study|Lost to Follow-up|0|||
125064413|NCT01969799|449852491|FG001|Overall Study|Lost to Follow-up|2|||
125064414|NCT01969799|449852490|FG000|Overall Study|Physician Decision|1|||
125064415|NCT01969799|449852491|FG001|Overall Study|Physician Decision|0|||
125064416|NCT02927873|449852492|FG000|Overall Study|Lost to Follow-up|0|||
125064417|NCT02927873|449852493|FG001|Overall Study|Lost to Follow-up|1|||
125064418|NCT02927873|449852494|FG002|Overall Study|Lost to Follow-up|0|||
125064419|NCT02927873|449852495|FG003|Overall Study|Lost to Follow-up|0|||
125064420|NCT02927873|449852496|FG004|Overall Study|Lost to Follow-up|0|||
125064421|NCT02927873|449852497|FG005|Overall Study|Lost to Follow-up|0|||
125064422|NCT02927873|449852492|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
125064423|NCT02927873|449852493|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
125064424|NCT02927873|449852494|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
125064425|NCT02927873|449852495|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
125064426|NCT02927873|449852496|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
125064427|NCT02927873|449852497|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
125064428|NCT02927873|449852492|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125064429|NCT02927873|449852493|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125064430|NCT02927873|449852494|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125064431|NCT02927873|449852495|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125064432|NCT02927873|449852496|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125064433|NCT02927873|449852497|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125064434|NCT02927873|449852492|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
125064435|NCT02927873|449852493|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
125064436|NCT02927873|449852494|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
125064437|NCT02927873|449852495|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
125064438|NCT02927873|449852496|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
125064439|NCT02927873|449852497|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
125064440|NCT02927873|449852492|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
125139618|NCT04631562|450132920|FG008|Overall Study|Adverse Event|0|||
125139619|NCT02471807|450132926|FG000|Overall Study|Death|14|||
125139620|NCT02471807|450132926|FG000|Overall Study|Withdrawal by Subject|2|||
125139621|NCT02471807|450132926|FG000|Overall Study|Explant|5|||
125139622|NCT02471807|450132926|FG000|Overall Study|Lost to Follow-up|1|||
125139623|NCT02227238|450132938|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
125139624|NCT02227238|450132939|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
125222494|NCT03428100|450442771|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222495|NCT03428100|450442772|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222496|NCT03428100|450442754|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222497|NCT03428100|450442755|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
125222498|NCT03428100|450442756|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
125222499|NCT03428100|450442757|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222500|NCT03428100|450442758|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222501|NCT03428100|450442759|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222502|NCT03428100|450442760|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125064441|NCT02927873|449852493|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
125064442|NCT02927873|449852494|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
125064443|NCT02927873|449852495|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
125064444|NCT02927873|449852496|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
125064445|NCT02927873|449852497|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
125064446|NCT02927873|449852492|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
125064447|NCT02927873|449852493|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
125064448|NCT02927873|449852494|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
125064449|NCT02927873|449852495|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
125064450|NCT02927873|449852496|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
125064451|NCT02927873|449852497|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
125064452|NCT01927419|449852504|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
125064453|NCT01927419|449852505|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
125064454|NCT01927419|449852504|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
125064455|NCT01927419|449852505|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
125064456|NCT01927419|449852504|FG000|Treatment Period|Disease progression|17|||
125064457|NCT01927419|449852505|FG001|Treatment Period|Disease progression|20|||
125064458|NCT01927419|449852504|FG000|Treatment Period|Study drug toxicity|48|||
125064459|NCT01927419|449852505|FG001|Treatment Period|Study drug toxicity|10|||
125064460|NCT01927419|449852504|FG000|Treatment Period|Death|0|||
125064461|NCT01927419|449852505|FG001|Treatment Period|Death|1|||
125064462|NCT01927419|449852504|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
125064463|NCT01927419|449852505|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
125064464|NCT01927419|449852504|FG000|Treatment Period|Participant request to discontinue|12|||
125064465|NCT01927419|449852505|FG001|Treatment Period|Participant request to discontinue|4|||
125064466|NCT01927419|449852504|FG000|Treatment Period|Withdrawal by Subject|1|||
125064467|NCT01927419|449852505|FG001|Treatment Period|Withdrawal by Subject|1|||
125064468|NCT01927419|449852504|FG000|Treatment Period|Maximum Clinical Benefit|6|||
125064469|NCT01927419|449852505|FG001|Treatment Period|Maximum Clinical Benefit|2|||
125064470|NCT01927419|449852504|FG000|Treatment Period|Other reasons|3|||
125064471|NCT01927419|449852505|FG001|Treatment Period|Other reasons|4|||
125064472|NCT01927419|449852504|FG000|Treatment Period|Not Reported|1|||
125064473|NCT01927419|449852505|FG001|Treatment Period|Not Reported|1|||
125064474|NCT00393913|449852506|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
125064475|NCT00393913|449852506|FG000|Initial Assessment|Withdrawal by Subject|16|||
125064476|NCT00393913|449852506|FG000|CPAP|Withdrawal by Subject|3|||
125064477|NCT00393913|449852506|FG000|CPAP|Physician Decision|1|||
125064478|NCT00393913|449852506|FG000|CPAP|TEchnical problem with CPAP|3|||
125064479|NCT03488251|449852507|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
125064480|NCT03488251|449852508|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
125064481|NCT03488251|449852509|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
125064482|NCT03488251|449852510|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
125064483|NCT03488251|449852507|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
125064484|NCT03488251|449852508|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
125139625|NCT02227238|450132940|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
125139626|NCT02227238|450132938|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
125139627|NCT02227238|450132939|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
125139628|NCT02227238|450132940|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
125139629|NCT02227238|450132938|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
125139630|NCT02227238|450132939|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
125139631|NCT02227238|450132940|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
125139632|NCT02227238|450132938|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
125139633|NCT02227238|450132939|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
125139634|NCT02227238|450132940|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
125139635|NCT02227238|450132938|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
125139636|NCT02227238|450132939|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
125139637|NCT02227238|450132940|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
125064485|NCT03488251|449852509|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
125064486|NCT03488251|449852510|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
125064487|NCT03488251|449852507|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
125064488|NCT03488251|449852508|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
125064489|NCT03488251|449852509|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
125064490|NCT03488251|449852510|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
125064491|NCT03488251|449852507|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
125064492|NCT03488251|449852508|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
125064493|NCT03488251|449852509|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
125064494|NCT03488251|449852510|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
125064495|NCT03488251|449852507|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
125064496|NCT03488251|449852508|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
125064497|NCT03488251|449852509|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
125064498|NCT03488251|449852510|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
125064499|NCT01244191|449852513|FG000|Overall Study|Progressive disease|295|||
125064500|NCT01244191|449852514|FG001|Overall Study|Progressive disease|350|||
125064501|NCT01244191|449852513|FG000|Overall Study|Clinical disease progression|54|||
125064502|NCT01244191|449852514|FG001|Overall Study|Clinical disease progression|36|||
125064503|NCT01244191|449852513|FG000|Overall Study|Adverse Event|65|||
125064504|NCT01244191|449852514|FG001|Overall Study|Adverse Event|48|||
125064505|NCT01244191|449852513|FG000|Overall Study|Death|22|||
125064506|NCT01244191|449852514|FG001|Overall Study|Death|29|||
125064507|NCT01244191|449852513|FG000|Overall Study|Lost to Follow-up|0|||
125064508|NCT01244191|449852514|FG001|Overall Study|Lost to Follow-up|2|||
125064509|NCT01244191|449852513|FG000|Overall Study|Protocol Violation|1|||
125064510|NCT01244191|449852514|FG001|Overall Study|Protocol Violation|2|||
125064511|NCT01244191|449852513|FG000|Overall Study|Withdrawal by Subject|31|||
125064512|NCT01244191|449852514|FG001|Overall Study|Withdrawal by Subject|23|||
125064513|NCT01244191|449852513|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
125064514|NCT01244191|449852514|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
125064515|NCT01511107|449852521|FG000|Overall Study|Ineligible|3|||
125064516|NCT01511107|449852522|FG001|Overall Study|Ineligible|2|||
125064517|NCT01511107|449852521|FG000|Overall Study|Lost to Follow-up|10|||
125064518|NCT01511107|449852522|FG001|Overall Study|Lost to Follow-up|19|||
125064519|NCT01511107|449852521|FG000|Overall Study|Withdrawal by Subject|9|||
125064520|NCT01511107|449852522|FG001|Overall Study|Withdrawal by Subject|20|||
125064521|NCT01146951|449854253|FG000|Overall Study|Adverse Event|4|||
125064522|NCT01146951|449854254|FG001|Overall Study|Adverse Event|1|||
125064523|NCT00804843|449854258|FG000|Overall Study|Protocol Violation|1|||
125064524|NCT00804843|449854259|FG001|Overall Study|Protocol Violation|0|||
125064525|NCT00804843|449854258|FG000|Overall Study|Adverse Event|8|||
125064526|NCT00804843|449854259|FG001|Overall Study|Adverse Event|5|||
125064527|NCT00804843|449854258|FG000|Overall Study|Withdrawal by Subject|1|||
125064528|NCT00804843|449854259|FG001|Overall Study|Withdrawal by Subject|2|||
125064529|NCT02126670|449854268|FG000|Overall Study|Withdrawal by Subject|1|||
125064530|NCT02126670|449854269|FG001|Overall Study|Withdrawal by Subject|0|||
125064531|NCT02126670|449854270|FG002|Overall Study|Withdrawal by Subject|0|||
125064532|NCT02126670|449854271|FG003|Overall Study|Withdrawal by Subject|1|||
125064533|NCT01975246|449854272|FG000|Overall Study|Adverse Event|2|||
125064534|NCT01975246|449854273|FG001|Overall Study|Adverse Event|1|||
125064535|NCT01975246|449854272|FG000|Overall Study|Lack of Efficacy|1|||
125064536|NCT01975246|449854273|FG001|Overall Study|Lack of Efficacy|0|||
125064537|NCT01975246|449854272|FG000|Overall Study|Protocol Violation|1|||
125064538|NCT01975246|449854273|FG001|Overall Study|Protocol Violation|0|||
125064539|NCT01975246|449854272|FG000|Overall Study|Other than stated|0|||
125064540|NCT01975246|449854273|FG001|Overall Study|Other than stated|1|||
125064541|NCT01263093|449854274|FG000|Washout|Physician Decision|1|||
125064542|NCT01263093|449854275|FG001|Washout|Physician Decision|0|||
125064543|NCT01263093|449854274|FG000|Period 2|Adverse Event|1|||
125064544|NCT01263093|449854275|FG001|Period 2|Adverse Event|0|||
125064545|NCT00424346|449854276|FG000|Core Study|Adverse Event|5|||
125064546|NCT00424346|449854277|FG001|Core Study|Adverse Event|3|||
125064547|NCT00424346|449854278|FG002|Core Study|Adverse Event|1|||
125064548|NCT00424346|449854279|FG003|Core Study|Adverse Event|1|||
125064549|NCT00424346|449854276|FG000|Core Study|Abnormal Laboratory Values|0|||
125064550|NCT00424346|449854277|FG001|Core Study|Abnormal Laboratory Values|1|||
125064551|NCT00424346|449854278|FG002|Core Study|Abnormal Laboratory Values|0|||
125064552|NCT00424346|449854279|FG003|Core Study|Abnormal Laboratory Values|0|||
125064553|NCT00424346|449854276|FG000|Core Study|Lack of Efficacy|1|||
125064554|NCT00424346|449854277|FG001|Core Study|Lack of Efficacy|3|||
125064555|NCT00424346|449854278|FG002|Core Study|Lack of Efficacy|0|||
125064556|NCT00424346|449854279|FG003|Core Study|Lack of Efficacy|4|||
125064557|NCT00424346|449854276|FG000|Core Study|Withdrawal by Subject|1|||
125064558|NCT00424346|449854277|FG001|Core Study|Withdrawal by Subject|0|||
125064559|NCT00424346|449854278|FG002|Core Study|Withdrawal by Subject|0|||
125064560|NCT00424346|449854279|FG003|Core Study|Withdrawal by Subject|2|||
125064561|NCT00424346|449854276|FG000|Core Study|Lost to Follow-up|1|||
125064562|NCT00424346|449854277|FG001|Core Study|Lost to Follow-up|1|||
125064563|NCT00424346|449854278|FG002|Core Study|Lost to Follow-up|0|||
125064564|NCT00424346|449854279|FG003|Core Study|Lost to Follow-up|0|||
125064565|NCT00424346|449854276|FG000|Core Study|Administrative Problems|1|||
125064566|NCT00424346|449854277|FG001|Core Study|Administrative Problems|0|||
125064567|NCT00424346|449854278|FG002|Core Study|Administrative Problems|1|||
125064568|NCT00424346|449854279|FG003|Core Study|Administrative Problems|0|||
125064569|NCT00424346|449854276|FG000|Core Study|Protocol Violation|0|||
125064570|NCT00424346|449854277|FG001|Core Study|Protocol Violation|0|||
125064571|NCT00424346|449854278|FG002|Core Study|Protocol Violation|2|||
125064572|NCT00424346|449854279|FG003|Core Study|Protocol Violation|0|||
125064573|NCT00424346|449854276|FG000|Extension Phase|Adverse Event|0|||
125064574|NCT00424346|449854277|FG001|Extension Phase|Adverse Event|9|||
125064575|NCT00424346|449854278|FG002|Extension Phase|Adverse Event|5|||
125064576|NCT00424346|449854279|FG003|Extension Phase|Adverse Event|4|||
125064577|NCT00424346|449854276|FG000|Extension Phase|Lack of Efficacy|0|||
125064578|NCT00424346|449854277|FG001|Extension Phase|Lack of Efficacy|16|||
125064579|NCT00424346|449854278|FG002|Extension Phase|Lack of Efficacy|14|||
125064580|NCT00424346|449854279|FG003|Extension Phase|Lack of Efficacy|11|||
125064581|NCT00424346|449854276|FG000|Extension Phase|Withdrawal by Subject|0|||
125064582|NCT00424346|449854277|FG001|Extension Phase|Withdrawal by Subject|5|||
125064583|NCT00424346|449854278|FG002|Extension Phase|Withdrawal by Subject|3|||
125064584|NCT00424346|449854279|FG003|Extension Phase|Withdrawal by Subject|4|||
125064585|NCT00424346|449854276|FG000|Extension Phase|Lost to Follow-up|0|||
125064586|NCT00424346|449854277|FG001|Extension Phase|Lost to Follow-up|2|||
125064587|NCT00424346|449854278|FG002|Extension Phase|Lost to Follow-up|0|||
125064588|NCT00424346|449854279|FG003|Extension Phase|Lost to Follow-up|0|||
125064589|NCT00424346|449854276|FG000|Extension Phase|Administrative Problems|0|||
125064590|NCT00424346|449854277|FG001|Extension Phase|Administrative Problems|69|||
125064591|NCT00424346|449854278|FG002|Extension Phase|Administrative Problems|32|||
125064592|NCT00424346|449854279|FG003|Extension Phase|Administrative Problems|35|||
125064593|NCT00424346|449854276|FG000|Extension Phase|Death|0|||
125064594|NCT00424346|449854277|FG001|Extension Phase|Death|0|||
125064595|NCT00424346|449854278|FG002|Extension Phase|Death|0|||
125064596|NCT00424346|449854279|FG003|Extension Phase|Death|1|||
125064597|NCT00424346|449854276|FG000|Extension Phase|Protocol Violation|0|||
125064598|NCT00424346|449854277|FG001|Extension Phase|Protocol Violation|1|||
125064599|NCT00424346|449854278|FG002|Extension Phase|Protocol Violation|1|||
125064600|NCT00424346|449854279|FG003|Extension Phase|Protocol Violation|0|||
125064601|NCT01827319|449854280|FG000|Overall Study|Lost to Follow-up|3|||
125064602|NCT00571519|449854281|FG000|Overall Study|Subject withdrew consent|0|||
125064603|NCT00571519|449854282|FG001|Overall Study|Subject withdrew consent|1|||
125064604|NCT00571519|449854283|FG002|Overall Study|Subject withdrew consent|0|||
125064605|NCT00571519|449854284|FG003|Overall Study|Subject withdrew consent|2|||
125064606|NCT00571519|449854285|FG004|Overall Study|Subject withdrew consent|1|||
125064607|NCT00571519|449854286|FG005|Overall Study|Subject withdrew consent|1|||
125064608|NCT00571519|449854287|FG006|Overall Study|Subject withdrew consent|2|||
125064609|NCT00571519|449854281|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
125064610|NCT00571519|449854282|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
125064611|NCT00571519|449854283|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
125064612|NCT00571519|449854284|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
125064613|NCT00571519|449854285|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
125064614|NCT00571519|449854286|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
125064615|NCT00571519|449854287|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
125064616|NCT00571519|449854281|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
125064617|NCT00571519|449854282|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
125064618|NCT00571519|449854283|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
125064619|NCT00571519|449854284|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
125064620|NCT00571519|449854285|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
125064621|NCT00571519|449854286|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
125064622|NCT00571519|449854287|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
125064623|NCT00571519|449854281|FG000|Overall Study|Termination of study by Sponsor|2|||
125064624|NCT00571519|449854282|FG001|Overall Study|Termination of study by Sponsor|7|||
125064625|NCT00571519|449854283|FG002|Overall Study|Termination of study by Sponsor|10|||
125064626|NCT00571519|449854284|FG003|Overall Study|Termination of study by Sponsor|24|||
125064627|NCT00571519|449854285|FG004|Overall Study|Termination of study by Sponsor|8|||
125064628|NCT00571519|449854286|FG005|Overall Study|Termination of study by Sponsor|9|||
125064629|NCT00571519|449854287|FG006|Overall Study|Termination of study by Sponsor|22|||
125064630|NCT00571519|449854281|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
125064631|NCT00571519|449854282|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
125064632|NCT00571519|449854283|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
125064633|NCT00571519|449854284|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
125064634|NCT00571519|449854285|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
125064635|NCT00571519|449854286|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
125064636|NCT00571519|449854287|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
125064637|NCT00562640|449854289|FG000|Overall Study|Death|0|||
125064638|NCT00562640|449854290|FG001|Overall Study|Death|1|||
125064639|NCT00562640|449854291|FG002|Overall Study|Death|1|||
125064640|NCT00562640|449854292|FG003|Overall Study|Death|0|||
125064641|NCT05263921|449854293|FG000|Overall Study|Other: family emergency.|0|||
125064642|NCT05263921|449854294|FG001|Overall Study|Other: family emergency.|0|||
125064643|NCT05263921|449854295|FG002|Overall Study|Other: family emergency.|1|||
125064644|NCT05263921|449854296|FG003|Overall Study|Other: family emergency.|0|||
125064645|NCT02499575|449854297|FG000|Overall Study|Protocol Violation|0|||
125064646|NCT02499575|449854298|FG001|Overall Study|Protocol Violation|1|||
125064647|NCT02658968|449854299|FG000|Received Rituximab|Adverse Event|0|||
125064648|NCT02658968|449854300|FG001|Received Rituximab|Adverse Event|0|||
125064649|NCT02658968|449854301|FG002|Received Rituximab|Adverse Event|0|||
125064650|NCT02658968|449854302|FG003|Received Rituximab|Adverse Event|0|||
125064651|NCT02658968|449854303|FG004|Received Rituximab|Adverse Event|1|||
125064652|NCT02658968|449854299|FG000|Received Rituximab|Progressive disease|0|||
125064653|NCT02658968|449854300|FG001|Received Rituximab|Progressive disease|0|||
125064654|NCT02658968|449854301|FG002|Received Rituximab|Progressive disease|0|||
125064655|NCT02658968|449854302|FG003|Received Rituximab|Progressive disease|0|||
125064656|NCT02658968|449854303|FG004|Received Rituximab|Progressive disease|1|||
125064657|NCT02658968|449854299|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
125064658|NCT02658968|449854300|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
125064659|NCT02658968|449854301|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
125064660|NCT02658968|449854302|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
125064661|NCT02658968|449854303|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
125064662|NCT02658968|449854299|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
125064663|NCT02658968|449854300|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
125064664|NCT02658968|449854301|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
125064665|NCT02658968|449854302|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
125064666|NCT02658968|449854303|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
125064667|NCT02658968|449854299|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
125064668|NCT02658968|449854300|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
125064669|NCT02658968|449854301|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
125064670|NCT02658968|449854302|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
125064671|NCT02658968|449854303|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
125064672|NCT02658968|449854299|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
125064673|NCT02658968|449854300|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
125064674|NCT02658968|449854301|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
125064675|NCT02658968|449854302|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
125064676|NCT02658968|449854303|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
125064677|NCT02658968|449854299|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
125064678|NCT02658968|449854300|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
125064679|NCT02658968|449854301|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
125064680|NCT02658968|449854302|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
125064681|NCT02658968|449854303|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
125064682|NCT02667457|449854315|FG000|Overall Study|Withdrawal by Subject|1|||
125064683|NCT02667457|449854316|FG001|Overall Study|Withdrawal by Subject|0|||
125064684|NCT02667457|449854315|FG000|Overall Study|Other Reason|0|||
125064685|NCT02667457|449854316|FG001|Overall Study|Other Reason|2|||
125064686|NCT02475850|449854317|FG000|Overall Study|Death|155|||
125064687|NCT02475850|449854318|FG001|Overall Study|Death|141|||
125064688|NCT02475850|449854317|FG000|Overall Study|Lost to Follow-up|217|||
125064689|NCT02475850|449854318|FG001|Overall Study|Lost to Follow-up|188|||
125064690|NCT02475850|449854317|FG000|Overall Study|Withdrawal by Subject|221|||
125064691|NCT02475850|449854318|FG001|Overall Study|Withdrawal by Subject|155|||
125064692|NCT00603733|449854324|FG000|Active Phase ITT|Adverse Event|8|||
125064693|NCT00603733|449854325|FG001|Active Phase ITT|Adverse Event|7|||
125064694|NCT00603733|449854324|FG000|Active Phase ITT|Withdrawal by Subject|0|||
125064695|NCT00603733|449854325|FG001|Active Phase ITT|Withdrawal by Subject|3|||
125064696|NCT00603733|449854324|FG000|Active Phase ITT|Lost to Follow-up|0|||
125064697|NCT00603733|449854325|FG001|Active Phase ITT|Lost to Follow-up|1|||
125064698|NCT00603733|449854324|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
125064699|NCT00603733|449854325|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
125064700|NCT00603733|449854324|FG000|Active Phase ITT|Lack of Efficacy|1|||
125064701|NCT00603733|449854325|FG001|Active Phase ITT|Lack of Efficacy|2|||
125064702|NCT00603733|449854324|FG000|Active Phase ITT|Subject moved, site closed|1|||
125064703|NCT00603733|449854325|FG001|Active Phase ITT|Subject moved, site closed|1|||
125064704|NCT00603733|449854324|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
125064705|NCT00603733|449854325|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
125064706|NCT00603733|449854324|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
125064707|NCT00603733|449854325|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
125064708|NCT00603733|449854324|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
125064709|NCT00603733|449854325|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
125064710|NCT00603733|449854324|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
125064711|NCT00603733|449854325|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
125064712|NCT00603733|449854324|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
125064713|NCT00603733|449854325|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
125064714|NCT00603733|449854324|FG000|Maintenance Phase ITT|Adverse Event|3|||
125064715|NCT00603733|449854325|FG001|Maintenance Phase ITT|Adverse Event|6|||
125064716|NCT00603733|449854324|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
125064717|NCT00603733|449854325|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
125064718|NCT00603733|449854324|FG000|Maintenance Phase ITT|Protocol Violation|1|||
125064719|NCT00603733|449854325|FG001|Maintenance Phase ITT|Protocol Violation|1|||
125064720|NCT00603733|449854324|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
125064721|NCT00603733|449854325|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
125064722|NCT00603733|449854324|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
125064723|NCT00603733|449854325|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
125064724|NCT00603733|449854324|FG000|Maintenance Phase ITT|Physician Decision|0|||
125064725|NCT00603733|449854325|FG001|Maintenance Phase ITT|Physician Decision|1|||
125064726|NCT00603733|449854324|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
125064727|NCT00603733|449854325|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
125064728|NCT02700919|449854326|FG000|Overall Study|Physician Decision|1|||
125064729|NCT02700919|449854327|FG001|Overall Study|Physician Decision|0|||
125064730|NCT02700919|449854328|FG002|Overall Study|Physician Decision|0|||
125064731|NCT02700919|449854326|FG000|Overall Study|Protocol Violation|1|||
125064732|NCT02700919|449854327|FG001|Overall Study|Protocol Violation|0|||
125064733|NCT02700919|449854328|FG002|Overall Study|Protocol Violation|0|||
125064734|NCT02700919|449854326|FG000|Overall Study|Adverse Event|1|||
125064735|NCT02700919|449854327|FG001|Overall Study|Adverse Event|3|||
125064736|NCT02700919|449854328|FG002|Overall Study|Adverse Event|1|||
125064737|NCT02700919|449854326|FG000|Overall Study|Withdrawal by Subject|5|||
125064738|NCT02700919|449854327|FG001|Overall Study|Withdrawal by Subject|8|||
125064739|NCT02700919|449854328|FG002|Overall Study|Withdrawal by Subject|2|||
125064740|NCT02700919|449854326|FG000|Overall Study|Lost to Follow-up|2|||
125064741|NCT02700919|449854327|FG001|Overall Study|Lost to Follow-up|0|||
125064742|NCT02700919|449854328|FG002|Overall Study|Lost to Follow-up|0|||
125064743|NCT02700919|449854326|FG000|Overall Study|Other|2|||
125139638|NCT02227238|450132938|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
125064744|NCT02700919|449854327|FG001|Overall Study|Other|1|||
125064745|NCT02700919|449854328|FG002|Overall Study|Other|1|||
125064746|NCT00912340|449854335|FG000|Overall Study|Adverse Event|2|||
125064747|NCT00912340|449854336|FG001|Overall Study|Adverse Event|4|||
125064748|NCT00912340|449854337|FG002|Overall Study|Adverse Event|0|||
125064749|NCT00912340|449854335|FG000|Overall Study|Protocol revised to remove arm|0|||
125064750|NCT00912340|449854336|FG001|Overall Study|Protocol revised to remove arm|0|||
125064751|NCT00912340|449854337|FG002|Overall Study|Protocol revised to remove arm|4|||
125064752|NCT01517412|449854338|FG000|Overall Study|Adverse Event|10|||
125139639|NCT02227238|450132939|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
125139640|NCT02227238|450132940|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
125139641|NCT02227238|450132938|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
125139642|NCT02227238|450132939|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
125139643|NCT02227238|450132940|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
125139644|NCT02227238|450132938|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
125139645|NCT02227238|450132939|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
125139646|NCT02227238|450132940|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
125139647|NCT02227238|450132938|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
125139648|NCT02227238|450132939|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
125139649|NCT02227238|450132940|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
125139650|NCT02227238|450132938|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
125139651|NCT02227238|450132939|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
125139652|NCT02227238|450132940|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
125139653|NCT02227238|450132938|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
125139654|NCT02227238|450132939|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
125139655|NCT02227238|450132940|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
125139656|NCT02227238|450132938|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
125139657|NCT02227238|450132939|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
125139658|NCT02227238|450132940|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
125139659|NCT02227238|450132938|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
125139660|NCT02227238|450132939|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
125139661|NCT02227238|450132940|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
125139662|NCT02227238|450132938|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
125139663|NCT02227238|450132939|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
125139664|NCT02227238|450132940|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
125139665|NCT04025021|450132941|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
125139666|NCT04025021|450132942|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
125139667|NCT03966911|450132943|FG000|Overall Study|Adverse Event|1|||
125064753|NCT01517412|449854339|FG001|Overall Study|Adverse Event|11|||
125064754|NCT01517412|449854338|FG000|Overall Study|Lack of Efficacy|10|||
125222503|NCT03428100|450442761|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222504|NCT03428100|450442762|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222505|NCT03428100|450442763|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125064755|NCT01517412|449854339|FG001|Overall Study|Lack of Efficacy|5|||
125064756|NCT01517412|449854338|FG000|Overall Study|Poor compliance to protocol|8|||
125064757|NCT01517412|449854339|FG001|Overall Study|Poor compliance to protocol|3|||
125064758|NCT01517412|449854338|FG000|Overall Study|Other than specified above|8|||
125064759|NCT01517412|449854339|FG001|Overall Study|Other than specified above|5|||
125064760|NCT01149343|449854345|FG000|Overall Study|Withdrawal by Subject|1|||
125064761|NCT01149343|449854346|FG001|Overall Study|Withdrawal by Subject|1|||
125064762|NCT01149343|449854347|FG002|Overall Study|Withdrawal by Subject|1|||
125064763|NCT01149343|449854348|FG003|Overall Study|Withdrawal by Subject|5|||
125064764|NCT01149343|449854345|FG000|Overall Study|Death|10|||
125064765|NCT01149343|449854346|FG001|Overall Study|Death|13|||
125064766|NCT01149343|449854347|FG002|Overall Study|Death|18|||
125064767|NCT01149343|449854348|FG003|Overall Study|Death|18|||
125064768|NCT01149343|449854345|FG000|Overall Study|Lost to Follow-up|1|||
125064769|NCT01149343|449854346|FG001|Overall Study|Lost to Follow-up|0|||
125064770|NCT01149343|449854347|FG002|Overall Study|Lost to Follow-up|0|||
125064771|NCT01149343|449854348|FG003|Overall Study|Lost to Follow-up|1|||
125064772|NCT01149343|449854345|FG000|Overall Study|Other|8|||
125064773|NCT01149343|449854346|FG001|Overall Study|Other|10|||
125064774|NCT01149343|449854347|FG002|Overall Study|Other|2|||
125064775|NCT01149343|449854348|FG003|Overall Study|Other|14|||
125064776|NCT01149343|449854345|FG000|Overall Study|Sponsor study termination|0|||
125064777|NCT01149343|449854346|FG001|Overall Study|Sponsor study termination|0|||
125064778|NCT01149343|449854347|FG002|Overall Study|Sponsor study termination|0|||
125064779|NCT01149343|449854348|FG003|Overall Study|Sponsor study termination|2|||
125139668|NCT03966911|450132944|FG001|Overall Study|Adverse Event|1|||
125139669|NCT03966911|450132943|FG000|Overall Study|Withdrawal by Subject|8|||
125139670|NCT03966911|450132944|FG001|Overall Study|Withdrawal by Subject|2|||
125139671|NCT03966911|450132943|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
125139672|NCT03966911|450132944|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
125139673|NCT01986647|450132945|FG000|Overall Study|Lost to Follow-up|4|||
125139674|NCT01986647|450132946|FG001|Overall Study|Lost to Follow-up|1|||
125064780|NCT01149343|449854345|FG000|Overall Study|Recurrence / Progressive disease|0|||
125064781|NCT01149343|449854346|FG001|Overall Study|Recurrence / Progressive disease|0|||
125064782|NCT01149343|449854347|FG002|Overall Study|Recurrence / Progressive disease|1|||
125064783|NCT01149343|449854348|FG003|Overall Study|Recurrence / Progressive disease|0|||
125064784|NCT01061736|449854349|FG000|Overall Study|Dose regimen not selected|0|||
125064785|NCT01061736|449854350|FG001|Overall Study|Dose regimen not selected|0|||
125064786|NCT01061736|449854351|FG002|Overall Study|Dose regimen not selected|0|||
125064787|NCT01061736|449854352|FG003|Overall Study|Dose regimen not selected|0|||
125064788|NCT01061736|449854353|FG004|Overall Study|Dose regimen not selected|0|||
125064789|NCT01061736|449854354|FG005|Overall Study|Dose regimen not selected|0|||
125064790|NCT01061736|449854355|FG006|Overall Study|Dose regimen not selected|79|||
125064791|NCT01061736|449854356|FG007|Overall Study|Dose regimen not selected|0|||
125064792|NCT01061736|449854357|FG008|Overall Study|Dose regimen not selected|0|||
125064793|NCT01061736|449854358|FG009|Overall Study|Dose regimen not selected|0|||
125064794|NCT01061736|449854349|FG000|Overall Study|Adverse Event|13|||
125064795|NCT01061736|449854350|FG001|Overall Study|Adverse Event|1|||
125064796|NCT01061736|449854351|FG002|Overall Study|Adverse Event|3|||
125064797|NCT01061736|449854352|FG003|Overall Study|Adverse Event|2|||
125064798|NCT01061736|449854353|FG004|Overall Study|Adverse Event|4|||
125064799|NCT01061736|449854354|FG005|Overall Study|Adverse Event|1|||
125064800|NCT01061736|449854355|FG006|Overall Study|Adverse Event|4|||
125064801|NCT01061736|449854356|FG007|Overall Study|Adverse Event|63|||
125064802|NCT01061736|449854357|FG008|Overall Study|Adverse Event|67|||
125064803|NCT01061736|449854358|FG009|Overall Study|Adverse Event|34|||
125064804|NCT01061736|449854349|FG000|Overall Study|Lack of Efficacy|0|||
125064805|NCT01061736|449854350|FG001|Overall Study|Lack of Efficacy|2|||
125064806|NCT01061736|449854351|FG002|Overall Study|Lack of Efficacy|1|||
125064807|NCT01061736|449854352|FG003|Overall Study|Lack of Efficacy|1|||
125064808|NCT01061736|449854353|FG004|Overall Study|Lack of Efficacy|1|||
125139675|NCT01986647|450132947|FG002|Overall Study|Lost to Follow-up|4|||
125139676|NCT01986647|450132948|FG003|Overall Study|Lost to Follow-up|4|||
125139677|NCT01986647|450132945|FG000|Overall Study|Withdrawal by Subject|1|||
125139678|NCT01986647|450132946|FG001|Overall Study|Withdrawal by Subject|3|||
125139679|NCT01986647|450132947|FG002|Overall Study|Withdrawal by Subject|2|||
125139680|NCT01986647|450132948|FG003|Overall Study|Withdrawal by Subject|3|||
125139681|NCT01986647|450132945|FG000|Overall Study|Health|5|||
125139682|NCT01986647|450132946|FG001|Overall Study|Health|3|||
125139683|NCT01986647|450132947|FG002|Overall Study|Health|6|||
125139684|NCT01986647|450132948|FG003|Overall Study|Health|4|||
125139685|NCT00868998|450132949|FG000|Overall Study|Screen Failure|1|||
125139686|NCT00868998|450132949|FG000|Overall Study|Withdrawal by Subject|1|||
125139687|NCT00868998|450132949|FG000|Overall Study|Progression of disease|2|||
125139688|NCT00868998|450132949|FG000|Overall Study|Death|1|||
125139689|NCT03498560|450132953|FG000|Overall Study|Found Ineligible|2|||
125139690|NCT03498560|450132953|FG000|Overall Study|Withdrawal by Subject|14|||
125139691|NCT03498560|450132953|FG000|Overall Study|Lost to Follow-up|4|||
125139692|NCT03498560|450132953|FG000|Overall Study|Death|1|||
125139693|NCT01004510|450132958|FG000|Overall Study|Adverse Event|1|||
125139694|NCT00474188|450132961|FG000|Overall Study|Withdrawal by Subject|1|||
125139695|NCT00474188|450132961|FG000|Overall Study|Study discontinued by sponsor|5|||
125139696|NCT03541252|450132962|FG000|Overall Study|Withdrawal by Subject|1|||
125139697|NCT01952691|450134257|FG000|Overall Study|Lost to Follow-up|2|||
125139698|NCT00199901|450134258|FG000|Overall Study|Protocol Violation|2|||
125139699|NCT00199901|450134259|FG001|Overall Study|Protocol Violation|0|||
125139700|NCT00199901|450134258|FG000|Overall Study|Withdrawal by Subject|1|||
125139701|NCT00199901|450134259|FG001|Overall Study|Withdrawal by Subject|0|||
125139702|NCT00199901|450134258|FG000|Overall Study|Progressive Disease|24|||
125139703|NCT00199901|450134259|FG001|Overall Study|Progressive Disease|24|||
125139704|NCT05776901|450134262|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
125139705|NCT02302716|450134265|FG000|Overall Study|Adverse Event|1|||
125139706|NCT02302716|450134266|FG001|Overall Study|Adverse Event|1|||
125139707|NCT02302716|450134265|FG000|Overall Study|Death|0|||
125139708|NCT02302716|450134266|FG001|Overall Study|Death|1|||
125139709|NCT02302716|450134265|FG000|Overall Study|Lack of Efficacy|0|||
125139710|NCT02302716|450134266|FG001|Overall Study|Lack of Efficacy|1|||
125139711|NCT02302716|450134265|FG000|Overall Study|Lost to Follow-up|2|||
125139712|NCT02302716|450134266|FG001|Overall Study|Lost to Follow-up|4|||
125139713|NCT02302716|450134265|FG000|Overall Study|Physician Decision|3|||
125139714|NCT02302716|450134266|FG001|Overall Study|Physician Decision|4|||
125139715|NCT02302716|450134265|FG000|Overall Study|Withdrawal by Subject|13|||
125139716|NCT02302716|450134266|FG001|Overall Study|Withdrawal by Subject|7|||
125064809|NCT01061736|449854354|FG005|Overall Study|Lack of Efficacy|2|||
125064810|NCT01061736|449854355|FG006|Overall Study|Lack of Efficacy|1|||
125064811|NCT01061736|449854356|FG007|Overall Study|Lack of Efficacy|9|||
125064812|NCT01061736|449854357|FG008|Overall Study|Lack of Efficacy|9|||
125139717|NCT02302716|450134265|FG000|Overall Study|Protocol Violation|0|||
125139718|NCT02302716|450134266|FG001|Overall Study|Protocol Violation|1|||
125139719|NCT04523480|450134268|FG000|Overall Study|Lost to Follow-up|30|||
125139720|NCT04523480|450134269|FG001|Overall Study|Lost to Follow-up|35|||
125139721|NCT04523480|450134270|FG002|Overall Study|Lost to Follow-up|0|||
125139722|NCT01911429|450134273|FG000|Overall Study|Adverse Event|5|||
125139723|NCT01911429|450134274|FG001|Overall Study|Adverse Event|3|||
125139724|NCT01911429|450134275|FG002|Overall Study|Adverse Event|9|||
125064813|NCT01061736|449854358|FG009|Overall Study|Lack of Efficacy|10|||
125064814|NCT01061736|449854349|FG000|Overall Study|Poor compliance to protocol|0|||
125064815|NCT01061736|449854350|FG001|Overall Study|Poor compliance to protocol|0|||
125064816|NCT01061736|449854351|FG002|Overall Study|Poor compliance to protocol|0|||
125064817|NCT01061736|449854352|FG003|Overall Study|Poor compliance to protocol|0|||
125064818|NCT01061736|449854353|FG004|Overall Study|Poor compliance to protocol|0|||
125064819|NCT01061736|449854354|FG005|Overall Study|Poor compliance to protocol|0|||
125064820|NCT01061736|449854355|FG006|Overall Study|Poor compliance to protocol|0|||
125064821|NCT01061736|449854356|FG007|Overall Study|Poor compliance to protocol|2|||
125064822|NCT01061736|449854357|FG008|Overall Study|Poor compliance to protocol|5|||
125064823|NCT01061736|449854358|FG009|Overall Study|Poor compliance to protocol|9|||
125064824|NCT01061736|449854349|FG000|Overall Study|Not treated|0|||
125064825|NCT01061736|449854350|FG001|Overall Study|Not treated|0|||
125064826|NCT01061736|449854351|FG002|Overall Study|Not treated|0|||
125064827|NCT01061736|449854352|FG003|Overall Study|Not treated|0|||
125064828|NCT01061736|449854353|FG004|Overall Study|Not treated|1|||
125064829|NCT01061736|449854354|FG005|Overall Study|Not treated|0|||
125064830|NCT01061736|449854355|FG006|Overall Study|Not treated|0|||
125064831|NCT01061736|449854356|FG007|Overall Study|Not treated|2|||
125064832|NCT01061736|449854357|FG008|Overall Study|Not treated|1|||
125064833|NCT01061736|449854358|FG009|Overall Study|Not treated|0|||
125064834|NCT01061736|449854349|FG000|Overall Study|Other than specified above|0|||
125064835|NCT01061736|449854350|FG001|Overall Study|Other than specified above|1|||
125064836|NCT01061736|449854351|FG002|Overall Study|Other than specified above|2|||
125064837|NCT01061736|449854352|FG003|Overall Study|Other than specified above|0|||
125064838|NCT01061736|449854353|FG004|Overall Study|Other than specified above|1|||
125064839|NCT01061736|449854354|FG005|Overall Study|Other than specified above|0|||
125064840|NCT01061736|449854355|FG006|Overall Study|Other than specified above|0|||
125064841|NCT01061736|449854356|FG007|Overall Study|Other than specified above|18|||
125064842|NCT01061736|449854357|FG008|Overall Study|Other than specified above|15|||
125064843|NCT01061736|449854358|FG009|Overall Study|Other than specified above|21|||
125064844|NCT01093755|449854359|FG000|Overall Study|Withdrawal by Subject|3|||
125064845|NCT01093755|449854360|FG001|Overall Study|Withdrawal by Subject|4|||
125064846|NCT03115112|449854361|FG000|Overall Study|Adverse Event|5|||
125064847|NCT03115112|449854362|FG001|Overall Study|Adverse Event|1|||
125139725|NCT01911429|450134273|FG000|Overall Study|Lack of Efficacy|1|||
125139726|NCT01911429|450134274|FG001|Overall Study|Lack of Efficacy|2|||
125139727|NCT01911429|450134275|FG002|Overall Study|Lack of Efficacy|4|||
125139728|NCT01911429|450134273|FG000|Overall Study|Lost to Follow-up|0|||
125139729|NCT01911429|450134274|FG001|Overall Study|Lost to Follow-up|0|||
125139730|NCT01911429|450134275|FG002|Overall Study|Lost to Follow-up|1|||
125139731|NCT01911429|450134273|FG000|Overall Study|Protocol Violation|0|||
125139732|NCT01911429|450134274|FG001|Overall Study|Protocol Violation|0|||
125139733|NCT01911429|450134275|FG002|Overall Study|Protocol Violation|1|||
125139734|NCT01911429|450134273|FG000|Overall Study|Withdrawal by Subject|5|||
125139735|NCT01911429|450134274|FG001|Overall Study|Withdrawal by Subject|5|||
125139736|NCT01911429|450134275|FG002|Overall Study|Withdrawal by Subject|4|||
125139737|NCT01911429|450134273|FG000|Overall Study|Accidental randomization|0|||
125139738|NCT01911429|450134274|FG001|Overall Study|Accidental randomization|0|||
125139739|NCT01911429|450134275|FG002|Overall Study|Accidental randomization|1|||
125139740|NCT01911429|450134273|FG000|Overall Study|subject left study|1|||
125139741|NCT01911429|450134274|FG001|Overall Study|subject left study|0|||
125139742|NCT01911429|450134275|FG002|Overall Study|subject left study|0|||
125139743|NCT01557751|450134276|FG000|Overall Study|Physician Decision|3|||
125139744|NCT02043132|450134277|FG000|Overall Study|Lost to Follow-up|1|||
125139745|NCT02043132|450134278|FG001|Overall Study|Lost to Follow-up|1|||
125064848|NCT03115112|449854361|FG000|Overall Study|Withdrawal by Subject|4|||
125064849|NCT03115112|449854362|FG001|Overall Study|Withdrawal by Subject|2|||
125139746|NCT02043132|450134277|FG000|Overall Study|screen failures|4|||
125139747|NCT02043132|450134278|FG001|Overall Study|screen failures|8|||
125139748|NCT01923740|450134279|FG000|Overall Study|Lost to Follow-up|4|||
125222506|NCT03428100|450442764|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222507|NCT03428100|450442765|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125064850|NCT03115112|449854361|FG000|Overall Study|Lost to Follow-up|0|||
125064851|NCT03115112|449854362|FG001|Overall Study|Lost to Follow-up|1|||
125139749|NCT01923740|450134280|FG001|Overall Study|Lost to Follow-up|9|||
125139750|NCT01923740|450134279|FG000|Overall Study|Withdrawal by Subject|2|||
125139751|NCT01923740|450134280|FG001|Overall Study|Withdrawal by Subject|0|||
125064852|NCT03115112|449854361|FG000|Overall Study|Death|1|||
125064853|NCT03115112|449854362|FG001|Overall Study|Death|0|||
125064854|NCT03115112|449854361|FG000|Overall Study|Pregnancy|1|||
125064855|NCT03115112|449854362|FG001|Overall Study|Pregnancy|0|||
125139752|NCT00472212|450134282|FG000|Overall Study|Lost to Follow-up|6|||
125139753|NCT00472212|450134283|FG001|Overall Study|Lost to Follow-up|4|||
125064856|NCT03115112|449854361|FG000|Overall Study|Site closure|1|||
125139754|NCT02462837|450134284|FG000|Overall Study|pt developed hives|1|||
125139755|NCT02462837|450134285|FG001|Overall Study|pt developed hives|0|||
125064857|NCT03115112|449854362|FG001|Overall Study|Site closure|1|||
125064858|NCT04019795|449854363|FG000|Overall Study|Withdrawal by Subject|1|||
125064859|NCT04019795|449854364|FG001|Overall Study|Withdrawal by Subject|2|||
125064860|NCT04019795|449854365|FG002|Overall Study|Withdrawal by Subject|2|||
125064861|NCT04019795|449854366|FG003|Overall Study|Withdrawal by Subject|1|||
125064862|NCT04019795|449854363|FG000|Overall Study|Lost to Follow-up|0|||
125064863|NCT04019795|449854364|FG001|Overall Study|Lost to Follow-up|1|||
125064864|NCT04019795|449854365|FG002|Overall Study|Lost to Follow-up|1|||
125064865|NCT04019795|449854366|FG003|Overall Study|Lost to Follow-up|2|||
125064866|NCT04019795|449854363|FG000|Overall Study|Treatment non-compliance|3|||
125064867|NCT04019795|449854364|FG001|Overall Study|Treatment non-compliance|1|||
125064868|NCT04019795|449854365|FG002|Overall Study|Treatment non-compliance|2|||
125064869|NCT04019795|449854366|FG003|Overall Study|Treatment non-compliance|0|||
125064870|NCT04019795|449854363|FG000|Overall Study|Physician Decision|0|||
125064871|NCT04019795|449854364|FG001|Overall Study|Physician Decision|0|||
125064872|NCT04019795|449854365|FG002|Overall Study|Physician Decision|1|||
125064873|NCT04019795|449854366|FG003|Overall Study|Physician Decision|0|||
125064874|NCT04019795|449854363|FG000|Overall Study|Adverse Event|1|||
125064875|NCT04019795|449854364|FG001|Overall Study|Adverse Event|0|||
125064876|NCT04019795|449854365|FG002|Overall Study|Adverse Event|0|||
125064877|NCT04019795|449854366|FG003|Overall Study|Adverse Event|0|||
125064878|NCT02168803|449854367|FG000|Overall Study|Lost to Follow-up|1|||
125064879|NCT02168803|449854368|FG001|Overall Study|Lost to Follow-up|0|||
125064880|NCT02168803|449854369|FG002|Overall Study|Lost to Follow-up|1|||
125064881|NCT02168803|449854367|FG000|Overall Study|Withdrawal by Subject|1|||
125064882|NCT02168803|449854368|FG001|Overall Study|Withdrawal by Subject|1|||
125064883|NCT02168803|449854369|FG002|Overall Study|Withdrawal by Subject|2|||
125064884|NCT02168803|449854367|FG000|Overall Study|Physician Decision|0|||
125064885|NCT02168803|449854368|FG001|Overall Study|Physician Decision|1|||
125064886|NCT02168803|449854369|FG002|Overall Study|Physician Decision|0|||
125064887|NCT02168803|449854367|FG000|Overall Study|Adverse Event|0|||
125064888|NCT02168803|449854368|FG001|Overall Study|Adverse Event|1|||
125064889|NCT02168803|449854369|FG002|Overall Study|Adverse Event|1|||
125064890|NCT02168803|449854367|FG000|Overall Study|Death|0|||
125064891|NCT02168803|449854368|FG001|Overall Study|Death|0|||
125064892|NCT02168803|449854369|FG002|Overall Study|Death|1|||
125064893|NCT02168803|449854367|FG000|Overall Study|Sponsor Decision|0|||
125064894|NCT02168803|449854368|FG001|Overall Study|Sponsor Decision|0|||
125064895|NCT02168803|449854369|FG002|Overall Study|Sponsor Decision|1|||
125064896|NCT00980343|449854370|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
125064897|NCT00980343|449854371|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
125064898|NCT02310906|449854376|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
125064899|NCT02310906|449854377|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
125064900|NCT02310906|449854378|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
125064901|NCT02310906|449854379|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
125064902|NCT02310906|449854376|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
125064903|NCT02310906|449854377|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
125064904|NCT02310906|449854378|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
125064905|NCT02310906|449854379|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
125064906|NCT02310906|449854376|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
125064907|NCT02310906|449854377|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
125064908|NCT02310906|449854378|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
125064909|NCT02310906|449854379|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
125064910|NCT02310906|449854376|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
125064911|NCT02310906|449854377|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
125064912|NCT02310906|449854378|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
125064913|NCT02310906|449854379|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
125064914|NCT03084718|449854387|FG000|Overall Study|Withdrawal by Subject|4|||
125064915|NCT03084718|449854388|FG001|Overall Study|Withdrawal by Subject|3|||
125064916|NCT03084718|449854389|FG002|Overall Study|Withdrawal by Subject|4|||
125064917|NCT03084718|449854390|FG003|Overall Study|Withdrawal by Subject|0|||
125064918|NCT03084718|449854391|FG004|Overall Study|Withdrawal by Subject|0|||
125064919|NCT03084718|449854387|FG000|Overall Study|Physician Decision|1|||
125064920|NCT03084718|449854388|FG001|Overall Study|Physician Decision|0|||
125064921|NCT03084718|449854389|FG002|Overall Study|Physician Decision|0|||
125064922|NCT03084718|449854390|FG003|Overall Study|Physician Decision|0|||
125064923|NCT03084718|449854391|FG004|Overall Study|Physician Decision|0|||
125064924|NCT03084718|449854387|FG000|Overall Study|Adverse Event|3|||
125064925|NCT03084718|449854388|FG001|Overall Study|Adverse Event|5|||
125064926|NCT03084718|449854389|FG002|Overall Study|Adverse Event|5|||
125139756|NCT02462837|450134284|FG000|Overall Study|Withdrawal by Subject|1|||
125064927|NCT03084718|449854390|FG003|Overall Study|Adverse Event|8|||
125064928|NCT03084718|449854391|FG004|Overall Study|Adverse Event|2|||
125064929|NCT03084718|449854387|FG000|Overall Study|Lack of Efficacy|2|||
125064930|NCT03084718|449854388|FG001|Overall Study|Lack of Efficacy|0|||
125064931|NCT03084718|449854389|FG002|Overall Study|Lack of Efficacy|1|||
125064932|NCT03084718|449854390|FG003|Overall Study|Lack of Efficacy|4|||
125064933|NCT03084718|449854391|FG004|Overall Study|Lack of Efficacy|0|||
125064934|NCT03084718|449854387|FG000|Overall Study|Lost to Follow-up|0|||
125064935|NCT03084718|449854388|FG001|Overall Study|Lost to Follow-up|1|||
125064936|NCT03084718|449854389|FG002|Overall Study|Lost to Follow-up|0|||
125064937|NCT03084718|449854390|FG003|Overall Study|Lost to Follow-up|0|||
125064938|NCT03084718|449854391|FG004|Overall Study|Lost to Follow-up|2|||
125064939|NCT03084718|449854387|FG000|Overall Study|Protocol Violation|0|||
125064940|NCT03084718|449854388|FG001|Overall Study|Protocol Violation|0|||
125064941|NCT03084718|449854389|FG002|Overall Study|Protocol Violation|1|||
125064942|NCT03084718|449854390|FG003|Overall Study|Protocol Violation|0|||
125064943|NCT03084718|449854391|FG004|Overall Study|Protocol Violation|0|||
125064944|NCT03084718|449854387|FG000|Overall Study|Death|0|||
125064945|NCT03084718|449854388|FG001|Overall Study|Death|1|||
125064946|NCT03084718|449854389|FG002|Overall Study|Death|0|||
125064947|NCT03084718|449854390|FG003|Overall Study|Death|0|||
125064948|NCT03084718|449854391|FG004|Overall Study|Death|0|||
125064949|NCT03084718|449854387|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
125064950|NCT03084718|449854388|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
125064951|NCT03084718|449854389|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
125064952|NCT03084718|449854390|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
125064953|NCT03084718|449854391|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
125064954|NCT02767856|449854392|FG000|Overall Study|Lost to Follow-up|9|||
125064955|NCT02767856|449854393|FG001|Overall Study|Lost to Follow-up|1|||
125064956|NCT02767856|449854392|FG000|Overall Study|Withdrawal by Subject|2|||
125064957|NCT02767856|449854393|FG001|Overall Study|Withdrawal by Subject|1|||
125064958|NCT00091026|449854394|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
125064959|NCT00091026|449854395|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
125064960|NCT00091026|449854394|FG000|Overall Study|Patient withdrew and never received trea|0|||
125064961|NCT00091026|449854395|FG001|Overall Study|Patient withdrew and never received trea|2|||
125064962|NCT00091026|449854394|FG000|Overall Study|Unknown-never received treatment|0|||
125064963|NCT00091026|449854395|FG001|Overall Study|Unknown-never received treatment|1|||
125064964|NCT00843843|449854396|FG000|Overall Study|Physician Decision|1|||
125064965|NCT00843843|449854397|FG001|Overall Study|Physician Decision|1|||
125064966|NCT00843843|449854396|FG000|Overall Study|Protocol Violation|1|||
125064967|NCT00843843|449854397|FG001|Overall Study|Protocol Violation|1|||
125064968|NCT00589979|449854398|FG000|Run-In Period|Adverse Event|5|||
125064969|NCT00589979|449854399|FG001|Run-In Period|Adverse Event|0|||
125064970|NCT00589979|449854400|FG002|Run-In Period|Adverse Event|0|||
125064971|NCT00589979|449854398|FG000|Run-In Period|Protocol Violation|3|||
125064972|NCT00589979|449854399|FG001|Run-In Period|Protocol Violation|0|||
125064973|NCT00589979|449854400|FG002|Run-In Period|Protocol Violation|0|||
125064974|NCT00589979|449854398|FG000|Run-In Period|Did not qualify for randomization|54|||
125064975|NCT00589979|449854399|FG001|Run-In Period|Did not qualify for randomization|0|||
125064976|NCT00589979|449854400|FG002|Run-In Period|Did not qualify for randomization|0|||
125064977|NCT00589979|449854398|FG000|Run-In Period|Withdrawal by Subject|10|||
125064978|NCT00589979|449854399|FG001|Run-In Period|Withdrawal by Subject|0|||
125064979|NCT00589979|449854400|FG002|Run-In Period|Withdrawal by Subject|0|||
125064980|NCT00589979|449854398|FG000|Run-In Period|Informed Consent Withdrawn|4|||
125064981|NCT00589979|449854399|FG001|Run-In Period|Informed Consent Withdrawn|0|||
125064982|NCT00589979|449854400|FG002|Run-In Period|Informed Consent Withdrawn|0|||
125064983|NCT00589979|449854398|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
125064984|NCT00589979|449854399|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
125064985|NCT00589979|449854400|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
125064986|NCT00589979|449854398|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
125064987|NCT00589979|449854399|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
125064988|NCT00589979|449854400|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
125064989|NCT00589979|449854398|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
125064990|NCT00589979|449854399|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
125064991|NCT00589979|449854400|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
125064992|NCT00589979|449854398|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
125064993|NCT00589979|449854399|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
125064994|NCT00589979|449854400|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
125064995|NCT00589979|449854398|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
125064996|NCT00589979|449854399|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
125064997|NCT00589979|449854400|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
125064998|NCT00589979|449854398|FG000|Double-Blind Treatment Period 2|Other|0|||
125064999|NCT00589979|449854399|FG001|Double-Blind Treatment Period 2|Other|0|||
125065000|NCT00589979|449854400|FG002|Double-Blind Treatment Period 2|Other|1|||
125065001|NCT00589979|449854398|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
125065002|NCT00589979|449854399|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
125065003|NCT00589979|449854400|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
125065004|NCT00589979|449854398|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
125065005|NCT00589979|449854399|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
125065006|NCT00589979|449854400|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
125065007|NCT01397448|449854401|FG000|Overall Study|Adverse Event|4|||
125065008|NCT01397448|449854402|FG001|Overall Study|Adverse Event|4|||
125065009|NCT01397448|449854403|FG002|Overall Study|Adverse Event|6|||
125065010|NCT01397448|449854401|FG000|Overall Study|Withdrawal by Subject|4|||
125065011|NCT01397448|449854402|FG001|Overall Study|Withdrawal by Subject|4|||
125065012|NCT01397448|449854403|FG002|Overall Study|Withdrawal by Subject|3|||
125065013|NCT01397448|449854401|FG000|Overall Study|Lack of Efficacy|2|||
125065014|NCT01397448|449854402|FG001|Overall Study|Lack of Efficacy|0|||
125065015|NCT01397448|449854403|FG002|Overall Study|Lack of Efficacy|5|||
125065016|NCT01397448|449854401|FG000|Overall Study|Other|8|||
125065017|NCT01397448|449854402|FG001|Overall Study|Other|7|||
125065018|NCT01397448|449854403|FG002|Overall Study|Other|4|||
125065019|NCT02159469|449854408|FG000|Overall Study|Missing Completion status|1|||
125065020|NCT02159469|449854408|FG000|Overall Study|Adverse Event|5|||
125065021|NCT02159469|449854408|FG000|Overall Study|Non-compliance|2|||
125065022|NCT02159469|449854408|FG000|Overall Study|Withdrawal by Subject|9|||
125065023|NCT02159469|449854408|FG000|Overall Study|Lost to Follow-up|1|||
125065024|NCT02159469|449854408|FG000|Overall Study|Sponsor's request|2|||
125065025|NCT02159469|449854408|FG000|Overall Study|Met Stopping Criteria|3|||
125065026|NCT02159469|449854408|FG000|Overall Study|Other|1|||
125065027|NCT02159469|449854408|FG000|Overall Study|Multiple|29|||
125065028|NCT02475395|449854409|FG000|Overall Study|Protocol Violation|30|||
125065029|NCT02475395|449854410|FG001|Overall Study|Protocol Violation|3|||
125065030|NCT00995670|449854411|FG000|Overall Study|Failed arterial cannulation|1|||
125065031|NCT00995670|449854412|FG001|Overall Study|Failed arterial cannulation|0|||
125065032|NCT00995670|449854413|FG002|Overall Study|Failed arterial cannulation|3|||
125065033|NCT00383721|449854414|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
125065034|NCT00383721|449854415|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
125065035|NCT00383721|449854416|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
125065036|NCT00383721|449854417|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
125065037|NCT00383721|449854418|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
125065038|NCT00383721|449854414|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
125065039|NCT00383721|449854415|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
125065040|NCT00383721|449854416|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
125065041|NCT00383721|449854417|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
125065042|NCT00383721|449854418|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
125065043|NCT00383721|449854414|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
125065044|NCT00383721|449854415|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
125065045|NCT00383721|449854416|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
125065046|NCT00383721|449854417|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
125065047|NCT00383721|449854418|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
125065048|NCT00383721|449854414|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
125065049|NCT00383721|449854415|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
125065050|NCT00383721|449854416|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
125065051|NCT00383721|449854417|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
125065052|NCT00383721|449854418|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
125065053|NCT00383721|449854414|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
125065054|NCT00383721|449854415|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
125065055|NCT00383721|449854416|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
125065056|NCT00383721|449854417|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
125065057|NCT00383721|449854418|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
125065058|NCT00383721|449854414|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
125065059|NCT00383721|449854415|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
125065060|NCT00383721|449854416|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
125065061|NCT00383721|449854417|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
125065062|NCT00383721|449854418|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
125065063|NCT00383721|449854414|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
125065064|NCT00383721|449854415|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
125065065|NCT00383721|449854416|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
125065066|NCT00383721|449854417|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
125065067|NCT00383721|449854418|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
125065068|NCT00383721|449854414|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
125065069|NCT00383721|449854415|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
125065070|NCT00383721|449854416|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
125065071|NCT00383721|449854417|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
125065072|NCT00383721|449854418|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
125065073|NCT00383721|449854414|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
125065074|NCT00383721|449854415|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
125065075|NCT00383721|449854416|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
125065076|NCT00383721|449854417|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
125065077|NCT00383721|449854418|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
125065078|NCT00383721|449854414|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
125065079|NCT00383721|449854415|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
125065080|NCT00383721|449854416|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
125065081|NCT00383721|449854417|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
125065082|NCT00383721|449854418|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
125065083|NCT00383721|449854414|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
125065084|NCT00383721|449854415|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
125065085|NCT00383721|449854416|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
125065086|NCT00383721|449854417|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
125065087|NCT00383721|449854418|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
125065088|NCT00383721|449854414|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
125065089|NCT00383721|449854415|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
125065090|NCT00383721|449854416|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
125065091|NCT00383721|449854417|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
125065092|NCT00383721|449854418|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
125065093|NCT00383721|449854414|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
125065094|NCT00383721|449854415|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
125065095|NCT00383721|449854416|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
125065096|NCT00383721|449854417|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
125065097|NCT00383721|449854418|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
125065098|NCT00383721|449854414|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
125065099|NCT00383721|449854415|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
125065100|NCT00383721|449854416|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
125065101|NCT00383721|449854417|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
125065102|NCT00383721|449854418|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
125065103|NCT00383721|449854414|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
125065104|NCT00383721|449854415|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
125065105|NCT00383721|449854416|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
125065106|NCT00383721|449854417|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
125065107|NCT00383721|449854418|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
125065108|NCT00383721|449854414|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
125065109|NCT00383721|449854415|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
125065110|NCT00383721|449854416|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
125065111|NCT00383721|449854417|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
125065112|NCT00383721|449854418|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
125065113|NCT00383721|449854414|FG000|26-Week Treatment Safety Extension|Administrative|1|||
125065114|NCT00383721|449854415|FG001|26-Week Treatment Safety Extension|Administrative|2|||
125065115|NCT00383721|449854416|FG002|26-Week Treatment Safety Extension|Administrative|3|||
125065116|NCT00383721|449854417|FG003|26-Week Treatment Safety Extension|Administrative|1|||
125065117|NCT00383721|449854418|FG004|26-Week Treatment Safety Extension|Administrative|0|||
125065118|NCT03784027|449854421|FG000|Period 1|Withdrawal by Subject|0|||
125065119|NCT03784027|449854422|FG001|Period 1|Withdrawal by Subject|1|||
125065120|NCT03297216|449856973|FG000|Overall Study|Death|0|||
125065121|NCT03297216|449856974|FG001|Overall Study|Death|1|||
125065122|NCT03297216|449856973|FG000|Overall Study|Miscarriage|0|||
125065123|NCT03297216|449856974|FG001|Overall Study|Miscarriage|2|||
125065124|NCT03297216|449856973|FG000|Overall Study|Lost to Follow-up|3|||
125065125|NCT03297216|449856974|FG001|Overall Study|Lost to Follow-up|2|||
125065126|NCT01253187|449856981|FG000|Period 2|Withdrawal by Subject|0|||
125065127|NCT01253187|449856982|FG001|Period 2|Withdrawal by Subject|0|||
125065128|NCT01253187|449856983|FG002|Period 2|Withdrawal by Subject|0|||
125065129|NCT01253187|449856984|FG003|Period 2|Withdrawal by Subject|0|||
125065130|NCT01253187|449856985|FG004|Period 2|Withdrawal by Subject|1|||
125065131|NCT01253187|449856986|FG005|Period 2|Withdrawal by Subject|0|||
125065132|NCT01253187|449856981|FG000|Period 3|Pregnancy|1|||
125065133|NCT01253187|449856982|FG001|Period 3|Pregnancy|0|||
125065134|NCT01253187|449856983|FG002|Period 3|Pregnancy|0|||
125065135|NCT01253187|449856984|FG003|Period 3|Pregnancy|0|||
125065136|NCT01253187|449856985|FG004|Period 3|Pregnancy|0|||
125065137|NCT01253187|449856986|FG005|Period 3|Pregnancy|0|||
125065138|NCT01253187|449856981|FG000|Period 3|difficulty with blood sampling|0|||
125065139|NCT01253187|449856982|FG001|Period 3|difficulty with blood sampling|1|||
125065140|NCT01253187|449856983|FG002|Period 3|difficulty with blood sampling|0|||
125065141|NCT01253187|449856984|FG003|Period 3|difficulty with blood sampling|0|||
125065142|NCT01253187|449856985|FG004|Period 3|difficulty with blood sampling|0|||
125065143|NCT01253187|449856986|FG005|Period 3|difficulty with blood sampling|0|||
125065144|NCT01253187|449856981|FG000|Period 3|non-compliance|0|||
125065145|NCT01253187|449856982|FG001|Period 3|non-compliance|0|||
125065146|NCT01253187|449856983|FG002|Period 3|non-compliance|0|||
125065147|NCT01253187|449856984|FG003|Period 3|non-compliance|0|||
125065148|NCT01253187|449856985|FG004|Period 3|non-compliance|1|||
125065149|NCT01253187|449856986|FG005|Period 3|non-compliance|0|||
125065150|NCT02680587|449856989|FG000|Overall Study|Withdrawal by Subject|1|||
125065151|NCT02680587|449856990|FG001|Overall Study|Withdrawal by Subject|0|||
125065152|NCT02899377|449856991|FG000|Overall Study|Adverse Event|1|||
125065153|NCT02899377|449856992|FG001|Overall Study|Adverse Event|0|||
125065154|NCT00469209|449856993|FG000|Overall Study|Adverse Event|1|||
125065155|NCT00469209|449856994|FG001|Overall Study|Adverse Event|0|||
125065156|NCT00469209|449856995|FG002|Overall Study|Adverse Event|1|||
125065157|NCT00712933|449856998|FG000|Overall Study|Adverse Event|69|||
125065158|NCT00712933|449856998|FG000|Overall Study|Lack of Efficacy|6|||
125065159|NCT00712933|449856998|FG000|Overall Study|Lost to Follow-up|22|||
125065160|NCT00712933|449856998|FG000|Overall Study|Non-compliance with study drug|13|||
125065161|NCT00712933|449856998|FG000|Overall Study|Other Pregnancy|37|||
125065162|NCT00712933|449856998|FG000|Overall Study|Sponsor decision|14|||
125065163|NCT00712933|449856998|FG000|Overall Study|Withdrew consent|4|||
125065164|NCT00712933|449856998|FG000|Overall Study|Hip replacement surgery|1|||
125065165|NCT00712933|449856998|FG000|Overall Study|Involved in Clinical research|3|||
125065166|NCT00712933|449856998|FG000|Overall Study|Participant hospitalized|1|||
125065167|NCT00712933|449856998|FG000|Overall Study|Participant travelled overseas|2|||
125065168|NCT00712933|449856998|FG000|Overall Study|Death of patient|1|||
125065169|NCT00712933|449856998|FG000|Overall Study|Other Physician decision|1|||
125065170|NCT00712933|449856998|FG000|Overall Study|Not committed to contraception|1|||
125065171|NCT00712933|449856998|FG000|Overall Study|Participant received medication|1|||
125065172|NCT00712933|449856998|FG000|Overall Study|Physician Decision|36|||
125065173|NCT00712933|449856998|FG000|Overall Study|Protocol Violation|4|||
125065174|NCT00712933|449856998|FG000|Overall Study|Withdrawal by Subject|151|||
125065175|NCT00085917|449856999|FG000|Overall Study|Adverse Event|4|||
125065176|NCT00085917|449857000|FG001|Overall Study|Adverse Event|3|||
125065177|NCT01295580|449857001|FG000|Overall Study|Protocol Violation|4|||
125065178|NCT01295580|449857002|FG001|Overall Study|Protocol Violation|2|||
125065179|NCT01295580|449857001|FG000|Overall Study|Withdrawal by Subject|1|||
125065180|NCT01295580|449857002|FG001|Overall Study|Withdrawal by Subject|4|||
125065181|NCT01295580|449857001|FG000|Overall Study|Adverse Event|2|||
125065182|NCT01295580|449857002|FG001|Overall Study|Adverse Event|1|||
125065183|NCT01295580|449857001|FG000|Overall Study|Lost to Follow-up|1|||
125065184|NCT01295580|449857002|FG001|Overall Study|Lost to Follow-up|0|||
125065185|NCT01295580|449857001|FG000|Overall Study|Lack of Efficacy|1|||
125065186|NCT01295580|449857002|FG001|Overall Study|Lack of Efficacy|0|||
125139757|NCT02462837|450134285|FG001|Overall Study|Withdrawal by Subject|0|||
125139758|NCT00958724|450134288|FG000|Overall Study|Disease Progression|6|||
125139759|NCT00840203|450134306|FG000|First Intervention|Protocol Violation|1|||
125065187|NCT01295580|449857001|FG000|Overall Study|Other: inconvenience|1|||
125065188|NCT01295580|449857002|FG001|Overall Study|Other: inconvenience|0|||
125065189|NCT01295580|449857001|FG000|Overall Study|Other: family objection|0|||
125065190|NCT01295580|449857002|FG001|Overall Study|Other: family objection|1|||
125065191|NCT02022033|449857003|FG000|Overall Study|Physician Decision|1|||
125139760|NCT00840203|450134307|FG001|First Intervention|Protocol Violation|1|||
125065192|NCT01429077|449857004|FG000|Overall Study|Lost to Follow-up|0|||
125065193|NCT01429077|449857005|FG001|Overall Study|Lost to Follow-up|3|||
125065194|NCT01103778|449857007|FG000|Overall Study|Lost to Follow-up|1|||
125065195|NCT01103778|449857007|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
125065196|NCT01103778|449857007|FG000|Overall Study|Screen failure|1|||
125139761|NCT00840203|450134306|FG000|Washout|Protocol Violation|1|||
125065197|NCT03067129|449857008|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
125065198|NCT03067129|449857009|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
125065199|NCT03067129|449857010|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
125065200|NCT03067129|449857011|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
125065201|NCT03067129|449857008|FG000|Overall Study|Withdrawal by Subject|0|||
125065202|NCT03067129|449857009|FG001|Overall Study|Withdrawal by Subject|0|||
125065203|NCT03067129|449857010|FG002|Overall Study|Withdrawal by Subject|1|||
125065204|NCT03067129|449857011|FG003|Overall Study|Withdrawal by Subject|2|||
125065205|NCT03067129|449857008|FG000|Overall Study|Lost to Follow-up|5|||
125065206|NCT03067129|449857009|FG001|Overall Study|Lost to Follow-up|5|||
125065207|NCT03067129|449857010|FG002|Overall Study|Lost to Follow-up|4|||
125065208|NCT03067129|449857011|FG003|Overall Study|Lost to Follow-up|3|||
125065209|NCT03986190|449857012|FG000|Overall Study|Withdrawal by Subject|12|||
125065210|NCT03986190|449857013|FG001|Overall Study|Withdrawal by Subject|0|||
125065211|NCT04929613|449857014|FG000|Overall Study|Withdrawal by Subject|12|||
125065212|NCT00865189|449857015|FG000|Overall Study|Other|1|||
125065213|NCT00865189|449857016|FG001|Overall Study|Other|2|||
125065214|NCT00865189|449857015|FG000|Overall Study|Death|4|||
125065215|NCT00865189|449857016|FG001|Overall Study|Death|11|||
125065216|NCT00865189|449857015|FG000|Overall Study|Lost to Follow-up|6|||
125065217|NCT00865189|449857016|FG001|Overall Study|Lost to Follow-up|6|||
125065218|NCT00865189|449857015|FG000|Overall Study|Withdrawal by Subject|1|||
125065219|NCT00865189|449857016|FG001|Overall Study|Withdrawal by Subject|0|||
125065220|NCT01464788|449857030|FG000|Overall Study|Lost to Follow-up|0|||
125065221|NCT01464788|449857031|FG001|Overall Study|Lost to Follow-up|1|||
125065222|NCT01464788|449857032|FG002|Overall Study|Lost to Follow-up|0|||
125065223|NCT01464788|449857030|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
125065224|NCT01464788|449857031|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
125065225|NCT01464788|449857032|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
125065226|NCT00418379|449857035|FG000|Year 1|Adverse Event|9|||
125065227|NCT00418379|449857036|FG001|Year 1|Adverse Event|15|||
125065228|NCT00418379|449857037|FG002|Year 1|Adverse Event|3|||
125065229|NCT00418379|449857035|FG000|Year 1|Withdrawal by Subject|7|||
125065230|NCT00418379|449857036|FG001|Year 1|Withdrawal by Subject|8|||
125065231|NCT00418379|449857037|FG002|Year 1|Withdrawal by Subject|5|||
125065232|NCT00418379|449857035|FG000|Year 1|Any other reason not above-mentioned|2|||
125065233|NCT00418379|449857036|FG001|Year 1|Any other reason not above-mentioned|5|||
125065234|NCT00418379|449857037|FG002|Year 1|Any other reason not above-mentioned|7|||
125065235|NCT00418379|449857035|FG000|Year 2|Adverse Event|5|||
125065236|NCT00418379|449857036|FG001|Year 2|Adverse Event|2|||
125065237|NCT00418379|449857037|FG002|Year 2|Adverse Event|1|||
125065238|NCT00418379|449857035|FG000|Year 2|Withdrawal by Subject|1|||
125065239|NCT00418379|449857036|FG001|Year 2|Withdrawal by Subject|1|||
125065240|NCT00418379|449857037|FG002|Year 2|Withdrawal by Subject|3|||
125065241|NCT00418379|449857035|FG000|Year 2|Any other reason not above-mentioned|2|||
125065242|NCT00418379|449857036|FG001|Year 2|Any other reason not above-mentioned|1|||
125065243|NCT00418379|449857037|FG002|Year 2|Any other reason not above-mentioned|6|||
125065244|NCT00418379|449857035|FG000|Year 3|Withdrawal by Subject|1|||
125065245|NCT00418379|449857036|FG001|Year 3|Withdrawal by Subject|1|||
125065246|NCT00418379|449857037|FG002|Year 3|Withdrawal by Subject|2|||
125065247|NCT00418379|449857035|FG000|Year 3|Any other reason not above-mentioned|2|||
125065248|NCT00418379|449857036|FG001|Year 3|Any other reason not above-mentioned|1|||
125065249|NCT00418379|449857037|FG002|Year 3|Any other reason not above-mentioned|1|||
125065250|NCT00418379|449857035|FG000|Year 4|Adverse Event|0|||
125065251|NCT00418379|449857036|FG001|Year 4|Adverse Event|1|||
125065252|NCT00418379|449857037|FG002|Year 4|Adverse Event|0|||
125065253|NCT00418379|449857035|FG000|Year 4|Withdrawal by Subject|2|||
125065254|NCT00418379|449857036|FG001|Year 4|Withdrawal by Subject|3|||
125065255|NCT00418379|449857037|FG002|Year 4|Withdrawal by Subject|2|||
125065256|NCT00418379|449857035|FG000|Year 4|Any other reason not above-mentioned|1|||
125065257|NCT00418379|449857036|FG001|Year 4|Any other reason not above-mentioned|1|||
125065258|NCT00418379|449857037|FG002|Year 4|Any other reason not above-mentioned|0|||
125065259|NCT00418379|449857035|FG000|Year 5|Adverse Event|0|||
125065260|NCT00418379|449857036|FG001|Year 5|Adverse Event|1|||
125065261|NCT00418379|449857037|FG002|Year 5|Adverse Event|0|||
125065262|NCT00418379|449857035|FG000|Year 5|Any other reason not above-mentioned|2|||
125065263|NCT00418379|449857036|FG001|Year 5|Any other reason not above-mentioned|4|||
125065264|NCT00418379|449857037|FG002|Year 5|Any other reason not above-mentioned|3|||
125139762|NCT00840203|450134307|FG001|Washout|Protocol Violation|0|||
125139763|NCT02121184|450134311|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
125139764|NCT02121184|450134312|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
125139765|NCT02121184|450134311|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
125139766|NCT02121184|450134312|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
125139767|NCT02121184|450134311|FG000|Overall Study|Emergency cesarean section required|0|||
125065265|NCT00565058|449857038|FG000|Overall Study|Adverse Event|1|||
125065266|NCT00565058|449857039|FG001|Overall Study|Adverse Event|0|||
125065267|NCT00830804|449857040|FG000|Overall Study|Lost to Follow-up|4|||
125065268|NCT00830804|449857040|FG000|Overall Study|Death|1|||
125065269|NCT00830804|449857040|FG000|Overall Study|Unable to get to clinic|7|||
125065270|NCT00830804|449857040|FG000|Overall Study|Consent withdrawn|2|||
125065271|NCT00830804|449857040|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
125065272|NCT00510068|449857041|FG000|Double-blind Period|Disease progression|98|||
125065273|NCT00510068|449857042|FG001|Double-blind Period|Disease progression|169|||
125065274|NCT00510068|449857041|FG000|Double-blind Period|Final primary analysis|52|||
125065275|NCT00510068|449857042|FG001|Double-blind Period|Final primary analysis|18|||
125065276|NCT00510068|449857041|FG000|Double-blind Period|Adverse Event|37|||
125065277|NCT00510068|449857042|FG001|Double-blind Period|Adverse Event|7|||
125065278|NCT00510068|449857041|FG000|Double-blind Period|Withdrawal by Subject|8|||
125065279|NCT00510068|449857042|FG001|Double-blind Period|Withdrawal by Subject|6|||
125065280|NCT00510068|449857041|FG000|Double-blind Period|Death|4|||
125065281|NCT00510068|449857042|FG001|Double-blind Period|Death|3|||
125065282|NCT00510068|449857041|FG000|Double-blind Period|Abnormal test result (s)|1|||
125065283|NCT00510068|449857042|FG001|Double-blind Period|Abnormal test result (s)|0|||
125065284|NCT00510068|449857041|FG000|Double-blind Period|Lost to Follow-up|1|||
125065285|NCT00510068|449857042|FG001|Double-blind Period|Lost to Follow-up|0|||
125065286|NCT00510068|449857041|FG000|Double-blind Period|Protocol Violation|6|||
125065287|NCT00510068|449857042|FG001|Double-blind Period|Protocol Violation|0|||
125065288|NCT00510068|449857041|FG000|Open-label Period|Disease Progression|124|||
125065289|NCT00510068|449857042|FG001|Open-label Period|Disease Progression|0|||
125065290|NCT00510068|449857041|FG000|Open-label Period|Adverse Event|46|||
125065291|NCT00510068|449857042|FG001|Open-label Period|Adverse Event|0|||
125065292|NCT00510068|449857041|FG000|Open-label Period|Withdrawal by Subject|21|||
125065293|NCT00510068|449857042|FG001|Open-label Period|Withdrawal by Subject|0|||
125065294|NCT00510068|449857041|FG000|Open-label Period|Administrative problems|17|||
125065295|NCT00510068|449857042|FG001|Open-label Period|Administrative problems|0|||
125065296|NCT00510068|449857041|FG000|Open-label Period|Death|7|||
125065297|NCT00510068|449857042|FG001|Open-label Period|Death|0|||
125065298|NCT00510068|449857041|FG000|Open-label Period|New cancer therapy|7|||
125065299|NCT00510068|449857042|FG001|Open-label Period|New cancer therapy|0|||
125065300|NCT00510068|449857041|FG000|Open-label Period|Protocol Violation|2|||
125065301|NCT00510068|449857042|FG001|Open-label Period|Protocol Violation|0|||
125065302|NCT00510068|449857041|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
125065303|NCT00510068|449857042|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
125065304|NCT02180217|449857043|FG000|Overall Study|Adverse Event|3|||
125065305|NCT02180217|449857044|FG001|Overall Study|Adverse Event|2|||
125065306|NCT02180217|449857045|FG002|Overall Study|Adverse Event|22|||
125065307|NCT02180217|449857043|FG000|Overall Study|Death|1|||
125065308|NCT02180217|449857044|FG001|Overall Study|Death|1|||
125139768|NCT02121184|450134312|FG001|Overall Study|Emergency cesarean section required|2|||
125139769|NCT02121184|450134311|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
125139770|NCT02121184|450134312|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
125139771|NCT05562011|450134313|FG000|Overall Study|Withdrawal by Subject|3|||
125139772|NCT05562011|450134313|FG000|Overall Study|Lost to Follow-up|1|||
125139773|NCT05562011|450134313|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
125139774|NCT05562011|450134313|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
125139775|NCT05562011|450134313|FG000|Overall Study|Device malfunction|13|||
125139776|NCT00487435|450134322|FG000|Overall Study|Adverse Event|146|||
125139777|NCT00487435|450134322|FG000|Overall Study|Death|2|||
125139778|NCT00487435|450134322|FG000|Overall Study|Lack of Efficacy|33|||
125139779|NCT00487435|450134322|FG000|Overall Study|Lost to Follow-up|54|||
125139780|NCT00487435|450134322|FG000|Overall Study|Pregnancy|2|||
125139781|NCT00487435|450134322|FG000|Overall Study|Withdrawal by Subject|132|||
125139782|NCT00487435|450134322|FG000|Overall Study|Resolution Of Pain|1|||
125139783|NCT00487435|450134322|FG000|Overall Study|Study Medication Non-Compliant|32|||
125139784|NCT00487435|450134322|FG000|Overall Study|Other|83|||
125139785|NCT02705716|450134323|FG000|Overall Study|Adverse Event|0|||
125139786|NCT02705716|450134324|FG001|Overall Study|Adverse Event|1|||
125139787|NCT02705716|450134323|FG000|Overall Study|Protocol Violation|3|||
125139788|NCT02705716|450134324|FG001|Overall Study|Protocol Violation|0|||
125139789|NCT02705716|450134323|FG000|Overall Study|Withdrawal of Consent|1|||
125139790|NCT02705716|450134324|FG001|Overall Study|Withdrawal of Consent|1|||
125139791|NCT00562718|450134325|FG000|Overall Study|Death|1|||
125139792|NCT00562718|450134325|FG000|Overall Study|Withdrawal by Subject|3|||
125139793|NCT00562718|450134325|FG000|Overall Study|Adverse Event|4|||
125139794|NCT00562718|450134325|FG000|Overall Study|Lack of Efficacy|2|||
125139795|NCT00562718|450134325|FG000|Overall Study|not stated|1|||
125139796|NCT01868243|450134326|FG000|Overall Study|Death|0|||
125139797|NCT01868243|450134327|FG001|Overall Study|Death|1|||
125139798|NCT02905435|450134329|FG000|Overall Study|Death|2|||
125139799|NCT02905435|450134329|FG000|Overall Study|Physician Decision|1|||
125139800|NCT02905435|450134329|FG000|Overall Study|Lost to Follow-up|4|||
125065309|NCT02180217|449857045|FG002|Overall Study|Death|0|||
125065310|NCT02180217|449857043|FG000|Overall Study|Withdrawal by Subject|1|||
125065311|NCT02180217|449857044|FG001|Overall Study|Withdrawal by Subject|1|||
125065312|NCT02180217|449857045|FG002|Overall Study|Withdrawal by Subject|4|||
125065313|NCT02180217|449857043|FG000|Overall Study|Subject/Guardian decision|5|||
125065314|NCT02180217|449857044|FG001|Overall Study|Subject/Guardian decision|3|||
125065315|NCT02180217|449857045|FG002|Overall Study|Subject/Guardian decision|6|||
125139801|NCT01507662|450134330|FG000|Overall Study|Death|26|||
125139802|NCT01507662|450134331|FG001|Overall Study|Death|18|||
125065316|NCT02180217|449857043|FG000|Overall Study|Physician Decision|1|||
125065317|NCT02180217|449857044|FG001|Overall Study|Physician Decision|1|||
125065318|NCT02180217|449857045|FG002|Overall Study|Physician Decision|6|||
125065319|NCT02180217|449857043|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125065320|NCT02180217|449857044|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125065321|NCT02180217|449857045|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
125065322|NCT00645567|449857046|FG000|Overall Study|Adverse Event|1|||
125065323|NCT04664855|449857047|FG000|Overall Study|Withdrawal by Subject|0|||
125065324|NCT04664855|449857048|FG001|Overall Study|Withdrawal by Subject|2|||
125065325|NCT02219087|449857049|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
125065326|NCT02219087|449857050|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
125065327|NCT03730194|449857056|FG000|First Stage Treatment|Withdrawal by Subject|1|||
125065328|NCT03730194|449857057|FG001|First Stage Treatment|Withdrawal by Subject|1|||
125065329|NCT03730194|449857058|FG002|First Stage Treatment|Withdrawal by Subject|0|||
125139803|NCT01507662|450134330|FG000|Overall Study|Withdrawal by Subject|290|||
125065330|NCT03730194|449857059|FG003|First Stage Treatment|Withdrawal by Subject|0|||
125065331|NCT03730194|449857060|FG004|First Stage Treatment|Withdrawal by Subject|0|||
125065332|NCT03730194|449857061|FG005|First Stage Treatment|Withdrawal by Subject|0|||
125065333|NCT03730194|449857056|FG000|First Stage Treatment|Protocol Violation|3|||
125065334|NCT03730194|449857057|FG001|First Stage Treatment|Protocol Violation|3|||
125065335|NCT03730194|449857058|FG002|First Stage Treatment|Protocol Violation|0|||
125065336|NCT03730194|449857059|FG003|First Stage Treatment|Protocol Violation|0|||
125065337|NCT03730194|449857060|FG004|First Stage Treatment|Protocol Violation|0|||
125065338|NCT03730194|449857061|FG005|First Stage Treatment|Protocol Violation|0|||
125065339|NCT00870818|449857064|FG000|Overall Study|Lost to Follow-up|3|||
125065340|NCT00870818|449857065|FG001|Overall Study|Lost to Follow-up|2|||
125065341|NCT00870818|449857066|FG002|Overall Study|Lost to Follow-up|1|||
125065342|NCT00870818|449857067|FG003|Overall Study|Lost to Follow-up|0|||
125065343|NCT00870818|449857068|FG004|Overall Study|Lost to Follow-up|0|||
125065344|NCT00870818|449857064|FG000|Overall Study|Withdrawal by Subject|0|||
125065345|NCT00870818|449857065|FG001|Overall Study|Withdrawal by Subject|0|||
125065346|NCT00870818|449857066|FG002|Overall Study|Withdrawal by Subject|1|||
125065347|NCT00870818|449857067|FG003|Overall Study|Withdrawal by Subject|2|||
125065348|NCT00870818|449857068|FG004|Overall Study|Withdrawal by Subject|0|||
125065349|NCT00870818|449857064|FG000|Overall Study|Terminated by sponsor|29|||
125065350|NCT00870818|449857065|FG001|Overall Study|Terminated by sponsor|70|||
125065351|NCT00870818|449857066|FG002|Overall Study|Terminated by sponsor|36|||
125065352|NCT00870818|449857067|FG003|Overall Study|Terminated by sponsor|36|||
125065353|NCT00870818|449857068|FG004|Overall Study|Terminated by sponsor|38|||
125065354|NCT00870818|449857064|FG000|Overall Study|Other|0|||
125065355|NCT00870818|449857065|FG001|Overall Study|Other|1|||
125065356|NCT00870818|449857066|FG002|Overall Study|Other|0|||
125065357|NCT00870818|449857067|FG003|Overall Study|Other|0|||
125065358|NCT00870818|449857068|FG004|Overall Study|Other|0|||
125065359|NCT00178464|449857069|FG000|Overall Study|Withdrawal by Subject|1|||
125065360|NCT00178464|449857069|FG000|Overall Study|Physician Decision|1|||
125065361|NCT02227108|449857070|FG000|Overall Study|Did not receive treatment|2|||
125065362|NCT02227108|449857070|FG000|Overall Study|Other|3|||
125065363|NCT02227108|449857070|FG000|Overall Study|Progressive disease|17|||
125065364|NCT02227108|449857070|FG000|Overall Study|Initiation of alternative therapy|2|||
125065365|NCT02227108|449857070|FG000|Overall Study|Investigator discretion|1|||
125065366|NCT02227108|449857070|FG000|Overall Study|Adverse Event|6|||
125065367|NCT04900038|449857071|FG000|Overall Study|Adverse Event|1|||
125065368|NCT04900038|449857072|FG001|Overall Study|Adverse Event|0|||
125065369|NCT04900038|449857073|FG002|Overall Study|Adverse Event|1|||
125065370|NCT04900038|449857074|FG003|Overall Study|Adverse Event|1|||
125139804|NCT01507662|450134331|FG001|Overall Study|Withdrawal by Subject|287|||
125139805|NCT01507662|450134330|FG000|Overall Study|Lost to Follow-up|498|||
125139806|NCT01507662|450134331|FG001|Overall Study|Lost to Follow-up|523|||
125139807|NCT01507662|450134330|FG000|Overall Study|Proxy interview done|2|||
125139808|NCT01507662|450134331|FG001|Overall Study|Proxy interview done|3|||
125139809|NCT01395017|450134332|FG000|Overall Study|Lost to Follow-up|1|||
125139810|NCT01395017|450134333|FG001|Overall Study|Lost to Follow-up|0|||
125139811|NCT01395017|450134332|FG000|Overall Study|Adverse Event|26|||
125139812|NCT01395017|450134333|FG001|Overall Study|Adverse Event|12|||
125065371|NCT04900038|449857071|FG000|Overall Study|Withdrawal by Subject|0|||
125065372|NCT04900038|449857072|FG001|Overall Study|Withdrawal by Subject|1|||
125065373|NCT04900038|449857073|FG002|Overall Study|Withdrawal by Subject|0|||
125065374|NCT04900038|449857074|FG003|Overall Study|Withdrawal by Subject|0|||
125065375|NCT04900038|449857071|FG000|Overall Study|Study terminated by sponsor|18|||
125065376|NCT04900038|449857072|FG001|Overall Study|Study terminated by sponsor|15|||
125065377|NCT04900038|449857073|FG002|Overall Study|Study terminated by sponsor|17|||
125065378|NCT04900038|449857074|FG003|Overall Study|Study terminated by sponsor|14|||
125065379|NCT04900038|449857071|FG000|Overall Study|Protocol Deviation|1|||
125065380|NCT04900038|449857072|FG001|Overall Study|Protocol Deviation|1|||
125065381|NCT04900038|449857073|FG002|Overall Study|Protocol Deviation|0|||
125065382|NCT04900038|449857074|FG003|Overall Study|Protocol Deviation|0|||
125139813|NCT01395017|450134332|FG000|Overall Study|Physician Decision|11|||
125139814|NCT01395017|450134333|FG001|Overall Study|Physician Decision|15|||
125139815|NCT01395017|450134332|FG000|Overall Study|Withdrawal by Subject|14|||
125139816|NCT01395017|450134333|FG001|Overall Study|Withdrawal by Subject|8|||
125139817|NCT01395017|450134332|FG000|Overall Study|Protocol deviation|1|||
125139818|NCT01395017|450134333|FG001|Overall Study|Protocol deviation|2|||
125139819|NCT01395017|450134332|FG000|Overall Study|Death|4|||
125065383|NCT04900038|449857071|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
125065384|NCT04900038|449857072|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
125065385|NCT04900038|449857073|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
125065386|NCT04900038|449857074|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
125065387|NCT04900038|449857071|FG000|Overall Study|Lost to Follow-up|0|||
125065388|NCT04900038|449857072|FG001|Overall Study|Lost to Follow-up|0|||
125065389|NCT04900038|449857073|FG002|Overall Study|Lost to Follow-up|0|||
125065390|NCT04900038|449857074|FG003|Overall Study|Lost to Follow-up|1|||
125065391|NCT02486952|449857075|FG000|Overall Study|Not Started Induction Therapy|3|||
125065392|NCT02486952|449857075|FG000|Overall Study|Adverse Event|1|||
125065393|NCT02486952|449857075|FG000|Overall Study|Death|15|||
125139820|NCT01395017|450134333|FG001|Overall Study|Death|3|||
125139821|NCT01395017|450134332|FG000|Overall Study|Disease progression|42|||
125139822|NCT01395017|450134333|FG001|Overall Study|Disease progression|58|||
125139823|NCT01395017|450134332|FG000|Overall Study|Sponsor discontinued study|1|||
125139824|NCT01395017|450134333|FG001|Overall Study|Sponsor discontinued study|4|||
125139825|NCT03961204|450134336|FG000|Overall Study|Withdrawal by Subject|2|||
125065394|NCT02486952|449857075|FG000|Overall Study|Lack of Efficacy|3|||
125065395|NCT02486952|449857075|FG000|Overall Study|Lost to Follow-up|26|||
125139826|NCT03961204|450134336|FG000|Overall Study|Lost to Follow-up|3|||
125139827|NCT03961204|450134336|FG000|Overall Study|Other|1|||
125139828|NCT03961204|450134336|FG000|Overall Study|Missing|1|||
125139829|NCT01566435|450134340|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
125139830|NCT03684928|450134341|FG000|First Intervention|Lost to Follow-up|0|||
125139831|NCT03684928|450134342|FG001|First Intervention|Lost to Follow-up|1|||
125139832|NCT03684928|450134341|FG000|First Intervention|Withdrawal by Subject|0|||
125139833|NCT03684928|450134342|FG001|First Intervention|Withdrawal by Subject|2|||
125139834|NCT03684928|450134341|FG000|Second Intervention|Soft Tissue Injury|1|||
125139835|NCT03684928|450134342|FG001|Second Intervention|Soft Tissue Injury|0|||
125139836|NCT03733145|450134348|FG000|Overall Study|screenfail|3|||
125139837|NCT03733145|450134349|FG001|Overall Study|screenfail|3|||
125139838|NCT03733145|450134350|FG002|Overall Study|screenfail|2|||
125139839|NCT04236596|450134351|FG000|Overall Study|Withdrawal by Subject|1|||
125139840|NCT04236596|450134351|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
125139841|NCT04236596|450134351|FG000|Overall Study|Participants did not receive implant at all|4|||
125139842|NCT00557245|450135794|FG000|Overall Study|Lost to Follow-up|7|||
125139843|NCT00557245|450135795|FG001|Overall Study|Lost to Follow-up|8|||
125139844|NCT00557245|450135796|FG002|Overall Study|Lost to Follow-up|10|||
125139845|NCT00557245|450135794|FG000|Overall Study|Ineligible|5|||
125139846|NCT00557245|450135795|FG001|Overall Study|Ineligible|4|||
125139847|NCT00557245|450135796|FG002|Overall Study|Ineligible|2|||
125139848|NCT00798603|450135799|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
125139849|NCT00798603|450135799|FG000|Overall Study|Withdrawal by Subject|10|||
125139850|NCT00798603|450135799|FG000|Overall Study|Adverse Event|22|||
125139851|NCT00798603|450135799|FG000|Overall Study|Physician Decision|1|||
125139852|NCT00798603|450135799|FG000|Overall Study|Lack of insurance coverage|1|||
125139853|NCT02316223|450135802|FG000|Overall Study|Lack of Efficacy|0|||
125139854|NCT02316223|450135803|FG001|Overall Study|Lack of Efficacy|1|||
125139855|NCT02316223|450135804|FG002|Overall Study|Lack of Efficacy|1|||
125139856|NCT02316223|450135802|FG000|Overall Study|Lost to Follow-up|27|||
125139857|NCT02316223|450135803|FG001|Overall Study|Lost to Follow-up|34|||
125139858|NCT02316223|450135804|FG002|Overall Study|Lost to Follow-up|36|||
125139859|NCT02316223|450135802|FG000|Overall Study|COPD Diagnosis|3|||
125139860|NCT02316223|450135803|FG001|Overall Study|COPD Diagnosis|2|||
125139861|NCT02316223|450135804|FG002|Overall Study|COPD Diagnosis|3|||
125139862|NCT02316223|450135802|FG000|Overall Study|Reside outside study area|1|||
125139863|NCT02316223|450135803|FG001|Overall Study|Reside outside study area|1|||
125139864|NCT02316223|450135804|FG002|Overall Study|Reside outside study area|1|||
125139865|NCT02316223|450135802|FG000|Overall Study|No asthma|2|||
125065396|NCT02486952|449857075|FG000|Overall Study|Other|2|||
125139866|NCT02316223|450135803|FG001|Overall Study|No asthma|0|||
125139867|NCT02316223|450135804|FG002|Overall Study|No asthma|0|||
125139868|NCT02316223|450135802|FG000|Overall Study|Discontinued by PI|11|||
125139869|NCT02316223|450135803|FG001|Overall Study|Discontinued by PI|19|||
125139870|NCT02316223|450135804|FG002|Overall Study|Discontinued by PI|3|||
125139871|NCT00521586|450135806|FG000|Initial Vaccination (Year 0)|Subject request|8|||
125139872|NCT00521586|450135807|FG001|Initial Vaccination (Year 0)|Subject request|11|||
125139873|NCT00521586|450135806|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
125065397|NCT04111107|449857076|FG000|Overall Study|Withdrawal by Subject|6|||
125065398|NCT04111107|449857076|FG000|Overall Study|Declining Health|5|||
125065399|NCT01928485|449857077|FG000|Overall Study|Physician Decision|0|||
125065400|NCT01928485|449857078|FG001|Overall Study|Physician Decision|1|||
125065401|NCT03814590|449857081|FG000|Overall Study|Adverse Event|0|||
125065402|NCT03814590|449857082|FG001|Overall Study|Adverse Event|0|||
125065403|NCT03814590|449857083|FG002|Overall Study|Adverse Event|0|||
125065404|NCT03814590|449857084|FG003|Overall Study|Adverse Event|0|||
125065405|NCT03814590|449857085|FG004|Overall Study|Adverse Event|0|||
125065406|NCT03814590|449857086|FG005|Overall Study|Adverse Event|1|||
125065407|NCT03814590|449857087|FG006|Overall Study|Adverse Event|1|||
125065408|NCT03814590|449857088|FG007|Overall Study|Adverse Event|1|||
125065409|NCT03814590|449857089|FG008|Overall Study|Adverse Event|0|||
125065410|NCT03814590|449857090|FG009|Overall Study|Adverse Event|0|||
125065411|NCT03814590|449857091|FG010|Overall Study|Adverse Event|1|||
125065412|NCT03814590|449857092|FG011|Overall Study|Adverse Event|0|||
125065413|NCT03814590|449857093|FG012|Overall Study|Adverse Event|3|||
125065414|NCT03814590|449857094|FG013|Overall Study|Adverse Event|0|||
125065415|NCT03814590|449857081|FG000|Overall Study|Lost to Follow-up|0|||
125065416|NCT03814590|449857082|FG001|Overall Study|Lost to Follow-up|2|||
125065417|NCT03814590|449857083|FG002|Overall Study|Lost to Follow-up|1|||
125065418|NCT03814590|449857084|FG003|Overall Study|Lost to Follow-up|0|||
125065419|NCT03814590|449857085|FG004|Overall Study|Lost to Follow-up|1|||
125065420|NCT03814590|449857086|FG005|Overall Study|Lost to Follow-up|1|||
125065421|NCT03814590|449857087|FG006|Overall Study|Lost to Follow-up|1|||
125065422|NCT03814590|449857088|FG007|Overall Study|Lost to Follow-up|1|||
125065423|NCT03814590|449857089|FG008|Overall Study|Lost to Follow-up|0|||
125065424|NCT03814590|449857090|FG009|Overall Study|Lost to Follow-up|0|||
125065425|NCT03814590|449857091|FG010|Overall Study|Lost to Follow-up|1|||
125065426|NCT03814590|449857092|FG011|Overall Study|Lost to Follow-up|0|||
125065427|NCT03814590|449857093|FG012|Overall Study|Lost to Follow-up|0|||
125065428|NCT03814590|449857094|FG013|Overall Study|Lost to Follow-up|1|||
125065429|NCT03814590|449857081|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125065430|NCT03814590|449857082|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125065431|NCT03814590|449857083|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125065432|NCT03814590|449857084|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125065433|NCT03814590|449857085|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125065434|NCT03814590|449857086|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125065435|NCT03814590|449857087|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125065436|NCT03814590|449857088|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125065437|NCT03814590|449857089|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125139874|NCT00521586|450135807|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
125139875|NCT00521586|450135806|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
125139876|NCT00521586|450135807|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
125139877|NCT00521586|450135806|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
125139878|NCT00521586|450135807|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
125139879|NCT00521586|450135806|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
125139880|NCT00521586|450135807|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
125139881|NCT00521586|450135806|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
125139882|NCT00521586|450135807|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
125139883|NCT00521586|450135806|FG000|Initial Vaccination (Year 0)|Death|1|||
125139884|NCT00521586|450135807|FG001|Initial Vaccination (Year 0)|Death|0|||
125139885|NCT00521586|450135806|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
125139886|NCT00521586|450135807|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
125065438|NCT03814590|449857090|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
125065439|NCT03814590|449857091|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125065440|NCT03814590|449857092|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125065441|NCT03814590|449857093|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125065442|NCT03814590|449857094|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125065443|NCT03814590|449857081|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
125065444|NCT03814590|449857082|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
125065445|NCT03814590|449857083|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
125065446|NCT03814590|449857084|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
125065447|NCT03814590|449857085|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
125065448|NCT03814590|449857086|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
125065449|NCT03814590|449857087|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
125065450|NCT03814590|449857088|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
125065451|NCT03814590|449857089|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
125065452|NCT03814590|449857090|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
125065453|NCT03814590|449857091|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
125065454|NCT03814590|449857092|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
125065455|NCT03814590|449857093|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
125065456|NCT03814590|449857094|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
125065457|NCT03814590|449857081|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125065458|NCT03814590|449857082|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125065459|NCT03814590|449857083|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125065460|NCT03814590|449857084|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125065461|NCT03814590|449857085|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125065462|NCT03814590|449857086|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125065463|NCT03814590|449857087|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125065464|NCT03814590|449857088|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125065465|NCT03814590|449857089|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125065466|NCT03814590|449857090|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125065467|NCT03814590|449857091|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125065468|NCT03814590|449857092|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125065469|NCT03814590|449857093|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125065470|NCT03814590|449857094|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125065471|NCT03814590|449857081|FG000|Overall Study|UNKNOWN REASON|0|||
125065472|NCT03814590|449857082|FG001|Overall Study|UNKNOWN REASON|0|||
125065473|NCT03814590|449857083|FG002|Overall Study|UNKNOWN REASON|0|||
125065474|NCT03814590|449857084|FG003|Overall Study|UNKNOWN REASON|0|||
125065475|NCT03814590|449857085|FG004|Overall Study|UNKNOWN REASON|0|||
125065476|NCT03814590|449857086|FG005|Overall Study|UNKNOWN REASON|0|||
125065477|NCT03814590|449857087|FG006|Overall Study|UNKNOWN REASON|0|||
125065478|NCT03814590|449857088|FG007|Overall Study|UNKNOWN REASON|1|||
125065479|NCT03814590|449857089|FG008|Overall Study|UNKNOWN REASON|0|||
125065480|NCT03814590|449857090|FG009|Overall Study|UNKNOWN REASON|0|||
125065481|NCT03814590|449857091|FG010|Overall Study|UNKNOWN REASON|0|||
125065482|NCT03814590|449857092|FG011|Overall Study|UNKNOWN REASON|0|||
125065483|NCT03814590|449857093|FG012|Overall Study|UNKNOWN REASON|0|||
125065484|NCT03814590|449857094|FG013|Overall Study|UNKNOWN REASON|0|||
125065485|NCT00567541|449857096|FG000|Overall Study|Adverse Event|0|||
125065486|NCT00567541|449857097|FG001|Overall Study|Adverse Event|1|||
125065487|NCT03519516|449857100|FG000|Overall Study|Adverse Event|0|||
125222508|NCT03428100|450442766|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222509|NCT03428100|450442767|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222510|NCT03428100|450442768|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222511|NCT03428100|450442769|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222512|NCT03428100|450442770|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222513|NCT03428100|450442771|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125065488|NCT03519516|449857101|FG001|Overall Study|Adverse Event|1|||
125065489|NCT01890512|449857102|FG000|Overall Study|Physician Decision|1|||
125065490|NCT01890512|449857102|FG000|Overall Study|Withdrawal by Subject|1|||
125065491|NCT01890512|449857102|FG000|Overall Study|Protocol Violation|1|||
125065492|NCT01935336|449857103|FG000|Overall Study|Adverse Event|1|||
125139887|NCT00521586|450135806|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
125139888|NCT00521586|450135807|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
125139889|NCT00521586|450135806|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
125139890|NCT00521586|450135807|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
125139891|NCT00521586|450135806|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
125139892|NCT00521586|450135807|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
125222514|NCT03428100|450442772|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222515|NCT03428100|450442754|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
125222516|NCT03428100|450442755|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222517|NCT03428100|450442756|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222518|NCT03428100|450442757|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222519|NCT03428100|450442758|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222520|NCT03428100|450442759|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222521|NCT03428100|450442760|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222522|NCT03428100|450442761|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222523|NCT03428100|450442762|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222524|NCT03428100|450442763|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222525|NCT03428100|450442764|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222526|NCT03428100|450442765|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125065493|NCT01935336|449857104|FG001|Overall Study|Adverse Event|0|||
125065494|NCT01935336|449857105|FG002|Overall Study|Adverse Event|0|||
125065495|NCT01935336|449857106|FG003|Overall Study|Adverse Event|0|||
125065496|NCT01935336|449857103|FG000|Overall Study|Progressive disease|5|||
125065497|NCT01935336|449857104|FG001|Overall Study|Progressive disease|3|||
125065498|NCT01935336|449857105|FG002|Overall Study|Progressive disease|47|||
125065499|NCT01935336|449857106|FG003|Overall Study|Progressive disease|66|||
125065500|NCT01529385|449857107|FG000|Overall Study|Lost to Follow-up|2|||
125065501|NCT01529385|449857108|FG001|Overall Study|Lost to Follow-up|1|||
125222527|NCT03428100|450442766|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222528|NCT03428100|450442767|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222529|NCT03428100|450442768|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222530|NCT03428100|450442769|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222531|NCT03428100|450442770|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222532|NCT03428100|450442771|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222533|NCT03428100|450442772|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222534|NCT03428100|450442754|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222535|NCT03428100|450442755|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
125222536|NCT03428100|450442756|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222537|NCT03428100|450442757|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222538|NCT03428100|450442758|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222539|NCT03428100|450442759|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222540|NCT03428100|450442760|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222541|NCT03428100|450442761|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222542|NCT03428100|450442762|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125065502|NCT00964158|449857111|FG000|Overall Study|Lost to Follow-up|0|||
125065503|NCT00964158|449857112|FG001|Overall Study|Lost to Follow-up|1|||
125065504|NCT00964158|449857113|FG002|Overall Study|Lost to Follow-up|2|||
125065505|NCT00964158|449857111|FG000|Overall Study|Withdrawal by Subject|0|||
125065506|NCT00964158|449857112|FG001|Overall Study|Withdrawal by Subject|0|||
125065507|NCT00964158|449857113|FG002|Overall Study|Withdrawal by Subject|6|||
125065508|NCT01763866|449857122|FG000|Overall Study|Withdrawal by Subject|2|||
125065509|NCT01763866|449857123|FG001|Overall Study|Withdrawal by Subject|1|||
125065510|NCT01763866|449857124|FG002|Overall Study|Withdrawal by Subject|4|||
125065511|NCT01763866|449857125|FG003|Overall Study|Withdrawal by Subject|0|||
125065512|NCT01763866|449857126|FG004|Overall Study|Withdrawal by Subject|0|||
125139893|NCT00521586|450135806|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
125139894|NCT00521586|450135807|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
125139895|NCT00521586|450135806|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
125139896|NCT00521586|450135807|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
125139897|NCT00521586|450135806|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
125139898|NCT00521586|450135807|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
125139899|NCT00521586|450135806|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
125065513|NCT01763866|449857127|FG005|Overall Study|Withdrawal by Subject|3|||
125065514|NCT01763866|449857128|FG006|Overall Study|Withdrawal by Subject|4|||
125065515|NCT01763866|449857129|FG007|Overall Study|Withdrawal by Subject|0|||
125065516|NCT01763866|449857130|FG008|Overall Study|Withdrawal by Subject|1|||
125065517|NCT01763866|449857131|FG009|Overall Study|Withdrawal by Subject|1|||
125065518|NCT01763866|449857132|FG010|Overall Study|Withdrawal by Subject|2|||
125065519|NCT01763866|449857133|FG011|Overall Study|Withdrawal by Subject|2|||
125065520|NCT01763866|449857134|FG012|Overall Study|Withdrawal by Subject|2|||
125065521|NCT01763866|449857135|FG013|Overall Study|Withdrawal by Subject|0|||
125065522|NCT01763866|449857136|FG014|Overall Study|Withdrawal by Subject|6|||
125065523|NCT01763866|449857137|FG015|Overall Study|Withdrawal by Subject|3|||
125065524|NCT01763866|449857138|FG016|Overall Study|Withdrawal by Subject|0|||
125065525|NCT01763866|449857139|FG017|Overall Study|Withdrawal by Subject|1|||
125065526|NCT01763866|449857140|FG018|Overall Study|Withdrawal by Subject|1|||
125065527|NCT01763866|449857141|FG019|Overall Study|Withdrawal by Subject|1|||
125065528|NCT01763866|449857142|FG020|Overall Study|Withdrawal by Subject|2|||
125065529|NCT01763866|449857143|FG021|Overall Study|Withdrawal by Subject|1|||
125065530|NCT01763866|449857144|FG022|Overall Study|Withdrawal by Subject|2|||
125065531|NCT01763866|449857145|FG023|Overall Study|Withdrawal by Subject|1|||
125065532|NCT01763866|449857122|FG000|Overall Study|Decision by sponsor|0|||
125065533|NCT01763866|449857123|FG001|Overall Study|Decision by sponsor|0|||
125065534|NCT01763866|449857124|FG002|Overall Study|Decision by sponsor|1|||
125065535|NCT01763866|449857125|FG003|Overall Study|Decision by sponsor|0|||
125065536|NCT01763866|449857126|FG004|Overall Study|Decision by sponsor|2|||
125065537|NCT01763866|449857127|FG005|Overall Study|Decision by sponsor|0|||
125065538|NCT01763866|449857128|FG006|Overall Study|Decision by sponsor|2|||
125065539|NCT01763866|449857129|FG007|Overall Study|Decision by sponsor|0|||
125065540|NCT01763866|449857130|FG008|Overall Study|Decision by sponsor|2|||
125139900|NCT00521586|450135807|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
125139901|NCT00521586|450135806|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
125139902|NCT00521586|450135807|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
125139903|NCT00521586|450135806|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
125139904|NCT00521586|450135807|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
125139905|NCT00521586|450135806|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
125139906|NCT00521586|450135807|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
125139907|NCT00521586|450135806|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
125139908|NCT00521586|450135807|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
125139909|NCT00529763|450135808|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
125139910|NCT00529763|450135809|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
125139911|NCT00529763|450135810|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
125139912|NCT00529763|450135808|FG000|Overall Study|Death|1|||
125139913|NCT00529763|450135809|FG001|Overall Study|Death|1|||
125139914|NCT00529763|450135810|FG002|Overall Study|Death|1|||
125139915|NCT00529763|450135808|FG000|Overall Study|Disease Progression|10|||
125139916|NCT00529763|450135809|FG001|Overall Study|Disease Progression|16|||
125139917|NCT00529763|450135810|FG002|Overall Study|Disease Progression|11|||
125139918|NCT00529763|450135808|FG000|Overall Study|Lost to Follow-up|1|||
125222543|NCT03428100|450442763|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222544|NCT03428100|450442764|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222545|NCT03428100|450442765|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222546|NCT03428100|450442766|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222547|NCT03428100|450442767|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222548|NCT03428100|450442768|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222549|NCT03428100|450442769|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222550|NCT03428100|450442770|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222551|NCT03428100|450442771|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222552|NCT03428100|450442772|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222553|NCT03428100|450442754|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
125222554|NCT03428100|450442755|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
125222555|NCT03428100|450442756|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
125222556|NCT03428100|450442757|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
125222557|NCT03428100|450442758|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
125222558|NCT03428100|450442759|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
125222559|NCT03428100|450442760|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
125222560|NCT03428100|450442761|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
125222561|NCT03428100|450442762|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
125222562|NCT03428100|450442763|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
125065541|NCT01763866|449857131|FG009|Overall Study|Decision by sponsor|0|||
125065542|NCT01763866|449857132|FG010|Overall Study|Decision by sponsor|6|||
125065543|NCT01763866|449857133|FG011|Overall Study|Decision by sponsor|0|||
125065544|NCT01763866|449857134|FG012|Overall Study|Decision by sponsor|1|||
125065545|NCT01763866|449857135|FG013|Overall Study|Decision by sponsor|0|||
125065546|NCT01763866|449857136|FG014|Overall Study|Decision by sponsor|5|||
125065547|NCT01763866|449857137|FG015|Overall Study|Decision by sponsor|0|||
125065548|NCT01763866|449857138|FG016|Overall Study|Decision by sponsor|0|||
125139919|NCT00529763|450135809|FG001|Overall Study|Lost to Follow-up|2|||
125139920|NCT00529763|450135810|FG002|Overall Study|Lost to Follow-up|3|||
125139921|NCT00529763|450135808|FG000|Overall Study|Stem Cell Transplant|0|||
125139922|NCT00529763|450135809|FG001|Overall Study|Stem Cell Transplant|3|||
125139923|NCT00529763|450135810|FG002|Overall Study|Stem Cell Transplant|1|||
125139924|NCT00529763|450135808|FG000|Overall Study|Study Drug Toxicity|3|||
125139925|NCT00529763|450135809|FG001|Overall Study|Study Drug Toxicity|6|||
125139926|NCT00529763|450135810|FG002|Overall Study|Study Drug Toxicity|4|||
125139927|NCT00529763|450135808|FG000|Overall Study|Participant Withdrew Consent|2|||
125139928|NCT00529763|450135809|FG001|Overall Study|Participant Withdrew Consent|3|||
125139929|NCT00529763|450135810|FG002|Overall Study|Participant Withdrew Consent|4|||
125139930|NCT00529763|450135808|FG000|Overall Study|Other reasons|2|||
125139931|NCT00529763|450135809|FG001|Overall Study|Other reasons|0|||
125139932|NCT00529763|450135810|FG002|Overall Study|Other reasons|2|||
125139933|NCT00529763|450135808|FG000|Overall Study|Participant request to discontinue treatment|1|||
125139934|NCT00529763|450135809|FG001|Overall Study|Participant request to discontinue treatment|1|||
125139935|NCT00529763|450135810|FG002|Overall Study|Participant request to discontinue treatment|3|||
125139936|NCT03669250|450135811|FG000|Overall Study|Adverse Event|0|||
125139937|NCT03669250|450135812|FG001|Overall Study|Adverse Event|0|||
125139938|NCT03669250|450135813|FG002|Overall Study|Adverse Event|0|||
125139939|NCT03669250|450135814|FG003|Overall Study|Adverse Event|0|||
125139940|NCT03669250|450135815|FG004|Overall Study|Adverse Event|1|||
125139941|NCT03669250|450135816|FG005|Overall Study|Adverse Event|0|||
125139942|NCT03669250|450135811|FG000|Overall Study|Withdrawal by Subject|0|||
125139943|NCT03669250|450135812|FG001|Overall Study|Withdrawal by Subject|1|||
125139944|NCT03669250|450135813|FG002|Overall Study|Withdrawal by Subject|0|||
125139945|NCT03669250|450135814|FG003|Overall Study|Withdrawal by Subject|1|||
125139946|NCT03669250|450135815|FG004|Overall Study|Withdrawal by Subject|0|||
125139947|NCT03669250|450135816|FG005|Overall Study|Withdrawal by Subject|0|||
125139948|NCT00828321|450135817|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
125139949|NCT00828321|450135818|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
125139950|NCT00828321|450135817|FG000|Second Intervention|Protocol Violation|0|||
125139951|NCT00828321|450135818|FG001|Second Intervention|Protocol Violation|1|||
125139952|NCT03234907|450135819|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
125139953|NCT03234907|450135820|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
125139954|NCT03234907|450135821|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
125139955|NCT03234907|450135822|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
125139956|NCT03234907|450135823|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
125139957|NCT03234907|450135824|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
125139958|NCT03234907|450135819|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
125139959|NCT03234907|450135820|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
125065549|NCT01763866|449857139|FG017|Overall Study|Decision by sponsor|0|||
125065550|NCT01763866|449857140|FG018|Overall Study|Decision by sponsor|4|||
125065551|NCT01763866|449857141|FG019|Overall Study|Decision by sponsor|0|||
125065552|NCT01763866|449857142|FG020|Overall Study|Decision by sponsor|2|||
125065553|NCT01763866|449857143|FG021|Overall Study|Decision by sponsor|0|||
125065554|NCT01763866|449857144|FG022|Overall Study|Decision by sponsor|1|||
125065555|NCT01763866|449857145|FG023|Overall Study|Decision by sponsor|0|||
125065556|NCT01763866|449857122|FG000|Overall Study|Lost to Follow-up|0|||
125065557|NCT01763866|449857123|FG001|Overall Study|Lost to Follow-up|0|||
125065558|NCT01763866|449857124|FG002|Overall Study|Lost to Follow-up|0|||
125065559|NCT01763866|449857125|FG003|Overall Study|Lost to Follow-up|0|||
125065560|NCT01763866|449857126|FG004|Overall Study|Lost to Follow-up|0|||
125065561|NCT01763866|449857127|FG005|Overall Study|Lost to Follow-up|0|||
125065562|NCT01763866|449857128|FG006|Overall Study|Lost to Follow-up|1|||
125065563|NCT01763866|449857129|FG007|Overall Study|Lost to Follow-up|0|||
125065564|NCT01763866|449857130|FG008|Overall Study|Lost to Follow-up|0|||
125065565|NCT01763866|449857131|FG009|Overall Study|Lost to Follow-up|0|||
125065566|NCT01763866|449857132|FG010|Overall Study|Lost to Follow-up|0|||
125065567|NCT01763866|449857133|FG011|Overall Study|Lost to Follow-up|0|||
125065568|NCT01763866|449857134|FG012|Overall Study|Lost to Follow-up|1|||
125065569|NCT01763866|449857135|FG013|Overall Study|Lost to Follow-up|0|||
125065570|NCT01763866|449857136|FG014|Overall Study|Lost to Follow-up|1|||
125139960|NCT03234907|450135821|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
125139961|NCT03234907|450135822|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
125139962|NCT03234907|450135823|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
125139963|NCT03234907|450135824|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
125139964|NCT03234907|450135819|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
125139965|NCT03234907|450135820|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
125065571|NCT01763866|449857137|FG015|Overall Study|Lost to Follow-up|0|||
125065572|NCT01763866|449857138|FG016|Overall Study|Lost to Follow-up|0|||
125065573|NCT01763866|449857139|FG017|Overall Study|Lost to Follow-up|0|||
125065574|NCT01763866|449857140|FG018|Overall Study|Lost to Follow-up|1|||
125065575|NCT01763866|449857141|FG019|Overall Study|Lost to Follow-up|1|||
125065576|NCT01763866|449857142|FG020|Overall Study|Lost to Follow-up|0|||
125065577|NCT01763866|449857143|FG021|Overall Study|Lost to Follow-up|0|||
125065578|NCT01763866|449857144|FG022|Overall Study|Lost to Follow-up|0|||
125065579|NCT01763866|449857145|FG023|Overall Study|Lost to Follow-up|1|||
125065580|NCT01763866|449857122|FG000|Overall Study|Death|0|||
125065581|NCT01763866|449857123|FG001|Overall Study|Death|0|||
125065582|NCT01763866|449857124|FG002|Overall Study|Death|0|||
125065583|NCT01763866|449857125|FG003|Overall Study|Death|0|||
125065584|NCT01763866|449857126|FG004|Overall Study|Death|0|||
125065585|NCT01763866|449857127|FG005|Overall Study|Death|0|||
125065586|NCT01763866|449857128|FG006|Overall Study|Death|0|||
125065587|NCT01763866|449857129|FG007|Overall Study|Death|0|||
125065588|NCT01763866|449857130|FG008|Overall Study|Death|0|||
125065589|NCT01763866|449857131|FG009|Overall Study|Death|0|||
125065590|NCT01763866|449857132|FG010|Overall Study|Death|0|||
125065591|NCT01763866|449857133|FG011|Overall Study|Death|0|||
125065592|NCT01763866|449857134|FG012|Overall Study|Death|0|||
125065593|NCT01763866|449857135|FG013|Overall Study|Death|0|||
125065594|NCT01763866|449857136|FG014|Overall Study|Death|0|||
125065595|NCT01763866|449857137|FG015|Overall Study|Death|0|||
125065596|NCT01763866|449857138|FG016|Overall Study|Death|1|||
125065597|NCT01763866|449857139|FG017|Overall Study|Death|0|||
125065598|NCT01763866|449857140|FG018|Overall Study|Death|0|||
125065599|NCT01763866|449857141|FG019|Overall Study|Death|0|||
125065600|NCT01763866|449857142|FG020|Overall Study|Death|0|||
125065601|NCT01763866|449857143|FG021|Overall Study|Death|0|||
125065602|NCT01763866|449857144|FG022|Overall Study|Death|0|||
125065603|NCT01763866|449857145|FG023|Overall Study|Death|0|||
125065604|NCT03245723|449857151|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
125065605|NCT03245723|449857152|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
125065606|NCT03245723|449857151|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
125065607|NCT03245723|449857152|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
125065608|NCT03245723|449857151|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
125065609|NCT03245723|449857152|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
125065610|NCT03245723|449857151|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
125065611|NCT03245723|449857152|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
125065612|NCT03337139|449857153|FG000|Phase I|Withdrawal by Subject|10|||
125065613|NCT03337139|449857154|FG001|Phase I|Withdrawal by Subject|0|||
125065614|NCT02554253|449857155|FG000|Overall Study|ineligible after enrollment|1|||
125065615|NCT02554253|449857156|FG001|Overall Study|ineligible after enrollment|0|||
125065616|NCT02554253|449857155|FG000|Overall Study|converted to transcatheter procedure|0|||
125065617|NCT02554253|449857156|FG001|Overall Study|converted to transcatheter procedure|1|||
125065618|NCT02554253|449857155|FG000|Overall Study|received both drugs|0|||
125065619|NCT02554253|449857156|FG001|Overall Study|received both drugs|1|||
125065620|NCT03288493|449857157|FG000|Overall Study|Withdrawal by Subject|4|||
125065621|NCT03288493|449857158|FG001|Overall Study|Withdrawal by Subject|0|||
125065622|NCT03288493|449857159|FG002|Overall Study|Withdrawal by Subject|0|||
125065623|NCT03288493|449857160|FG003|Overall Study|Withdrawal by Subject|0|||
125065624|NCT03288493|449857161|FG004|Overall Study|Withdrawal by Subject|0|||
125065625|NCT03288493|449857162|FG005|Overall Study|Withdrawal by Subject|2|||
125065626|NCT03288493|449857163|FG006|Overall Study|Withdrawal by Subject|0|||
125065627|NCT03288493|449857157|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
125065628|NCT03288493|449857158|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
125065629|NCT03288493|449857159|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
125065630|NCT03288493|449857160|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
125065631|NCT03288493|449857161|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
125065632|NCT03288493|449857162|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
125065633|NCT03288493|449857163|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
125065634|NCT03288493|449857157|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
125139966|NCT03234907|450135821|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
125065635|NCT03288493|449857158|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
125065636|NCT03288493|449857159|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
125065637|NCT03288493|449857160|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
125139967|NCT03234907|450135822|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
125139968|NCT03234907|450135823|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
125139969|NCT03234907|450135824|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
125139970|NCT03234907|450135819|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
125139971|NCT03234907|450135820|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
125139972|NCT03234907|450135821|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
125139973|NCT03234907|450135822|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
125139974|NCT03234907|450135823|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
125139975|NCT03234907|450135824|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
125139976|NCT03234907|450135819|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
125139977|NCT03234907|450135820|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
125065638|NCT03288493|449857161|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
125065639|NCT03288493|449857162|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
125065640|NCT03288493|449857163|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
125065641|NCT03288493|449857157|FG000|Overall Study|Death|2|||
125065642|NCT03288493|449857158|FG001|Overall Study|Death|0|||
125065643|NCT03288493|449857159|FG002|Overall Study|Death|0|||
125065644|NCT03288493|449857160|FG003|Overall Study|Death|0|||
125065645|NCT03288493|449857161|FG004|Overall Study|Death|0|||
125065646|NCT03288493|449857162|FG005|Overall Study|Death|0|||
125065647|NCT03288493|449857163|FG006|Overall Study|Death|0|||
125065648|NCT03288493|449857157|FG000|Overall Study|other reason not listed above|2|||
125065649|NCT03288493|449857158|FG001|Overall Study|other reason not listed above|0|||
125065650|NCT03288493|449857159|FG002|Overall Study|other reason not listed above|0|||
125065651|NCT03288493|449857160|FG003|Overall Study|other reason not listed above|0|||
125065652|NCT03288493|449857161|FG004|Overall Study|other reason not listed above|0|||
125065653|NCT03288493|449857162|FG005|Overall Study|other reason not listed above|0|||
125065654|NCT03288493|449857163|FG006|Overall Study|other reason not listed above|0|||
125065655|NCT01736254|449857165|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
125065656|NCT01736254|449857165|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
125065657|NCT02559206|449857166|FG000|Overall Study|Adverse Event|0|||
125065658|NCT02559206|449857167|FG001|Overall Study|Adverse Event|4|||
125065659|NCT02559206|449857168|FG002|Overall Study|Adverse Event|1|||
125065660|NCT02559206|449857169|FG003|Overall Study|Adverse Event|5|||
125065661|NCT02559206|449857170|FG004|Overall Study|Adverse Event|3|||
125065662|NCT02559206|449857171|FG005|Overall Study|Adverse Event|0|||
125065663|NCT02559206|449857172|FG006|Overall Study|Adverse Event|1|||
125065664|NCT02559206|449857173|FG007|Overall Study|Adverse Event|0|||
125065665|NCT02559206|449857166|FG000|Overall Study|Protocol Violation|1|||
125065666|NCT02559206|449857167|FG001|Overall Study|Protocol Violation|0|||
125065667|NCT02559206|449857168|FG002|Overall Study|Protocol Violation|1|||
125065668|NCT02559206|449857169|FG003|Overall Study|Protocol Violation|0|||
125065669|NCT02559206|449857170|FG004|Overall Study|Protocol Violation|0|||
125065670|NCT02559206|449857171|FG005|Overall Study|Protocol Violation|2|||
125065671|NCT02559206|449857172|FG006|Overall Study|Protocol Violation|0|||
125065672|NCT02559206|449857173|FG007|Overall Study|Protocol Violation|0|||
125065673|NCT02559206|449857166|FG000|Overall Study|Withdrawal by Subject|3|||
125065674|NCT02559206|449857167|FG001|Overall Study|Withdrawal by Subject|3|||
125065675|NCT02559206|449857168|FG002|Overall Study|Withdrawal by Subject|1|||
125065676|NCT02559206|449857169|FG003|Overall Study|Withdrawal by Subject|3|||
125065677|NCT02559206|449857170|FG004|Overall Study|Withdrawal by Subject|5|||
125065678|NCT02559206|449857171|FG005|Overall Study|Withdrawal by Subject|4|||
125065679|NCT02559206|449857172|FG006|Overall Study|Withdrawal by Subject|1|||
125065680|NCT02559206|449857173|FG007|Overall Study|Withdrawal by Subject|2|||
125065681|NCT02559206|449857166|FG000|Overall Study|Lost to Follow-up|3|||
125065682|NCT02559206|449857167|FG001|Overall Study|Lost to Follow-up|5|||
125065683|NCT02559206|449857168|FG002|Overall Study|Lost to Follow-up|3|||
125139978|NCT03234907|450135821|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
125139979|NCT03234907|450135822|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
125139980|NCT03234907|450135823|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
125139981|NCT03234907|450135824|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
125139982|NCT03234907|450135819|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
125139983|NCT03234907|450135820|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
125139984|NCT03234907|450135821|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
125139985|NCT03234907|450135822|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
125065684|NCT02559206|449857169|FG003|Overall Study|Lost to Follow-up|3|||
125065685|NCT02559206|449857170|FG004|Overall Study|Lost to Follow-up|2|||
125065686|NCT02559206|449857171|FG005|Overall Study|Lost to Follow-up|5|||
125065687|NCT02559206|449857172|FG006|Overall Study|Lost to Follow-up|1|||
125065688|NCT02559206|449857173|FG007|Overall Study|Lost to Follow-up|4|||
125065689|NCT02559206|449857166|FG000|Overall Study|Lack of Efficacy|1|||
125065690|NCT02559206|449857167|FG001|Overall Study|Lack of Efficacy|0|||
125065691|NCT02559206|449857168|FG002|Overall Study|Lack of Efficacy|3|||
125065692|NCT02559206|449857169|FG003|Overall Study|Lack of Efficacy|2|||
125065693|NCT02559206|449857170|FG004|Overall Study|Lack of Efficacy|2|||
125065694|NCT02559206|449857171|FG005|Overall Study|Lack of Efficacy|3|||
125065695|NCT02559206|449857172|FG006|Overall Study|Lack of Efficacy|3|||
125065696|NCT02559206|449857173|FG007|Overall Study|Lack of Efficacy|3|||
125065697|NCT02559206|449857166|FG000|Overall Study|Other Not Specified|0|||
125065698|NCT02559206|449857167|FG001|Overall Study|Other Not Specified|0|||
125065699|NCT02559206|449857168|FG002|Overall Study|Other Not Specified|0|||
125065700|NCT02559206|449857169|FG003|Overall Study|Other Not Specified|1|||
125065701|NCT02559206|449857170|FG004|Overall Study|Other Not Specified|0|||
125065702|NCT02559206|449857171|FG005|Overall Study|Other Not Specified|0|||
125065703|NCT02559206|449857172|FG006|Overall Study|Other Not Specified|0|||
125065704|NCT02559206|449857173|FG007|Overall Study|Other Not Specified|0|||
125065705|NCT01561560|449857174|FG000|First Two Weeks of Wear|Time/job conflict|0|||
125065706|NCT01561560|449857175|FG001|First Two Weeks of Wear|Time/job conflict|1|||
125065707|NCT01561560|449857174|FG000|First Two Weeks of Wear|Adverse Event|0|||
125065708|NCT01561560|449857175|FG001|First Two Weeks of Wear|Adverse Event|1|||
125065709|NCT01561560|449857174|FG000|Second Two Weeks of Wear|Adverse Event|0|||
125065710|NCT01561560|449857175|FG001|Second Two Weeks of Wear|Adverse Event|1|||
125065711|NCT00646113|449858741|FG000|Overall Study|Lost to Follow-up|5|||
125065712|NCT00646113|449858741|FG000|Overall Study|Adverse Event|3|||
125065713|NCT02109744|449858742|FG000|Overall Study|Death|1|||
125065714|NCT02109744|449858743|FG001|Overall Study|Death|1|||
125065715|NCT02109744|449858742|FG000|Overall Study|no marrow exam|1|||
125065716|NCT02109744|449858743|FG001|Overall Study|no marrow exam|0|||
125065717|NCT04656418|449858744|FG000|Overall Study|Withdrawal by Subject|1|||
125065718|NCT04656418|449858745|FG001|Overall Study|Withdrawal by Subject|3|||
125065719|NCT03287245|449858746|FG000|Overall Study|Study terminated by sponsor|3|||
125065720|NCT03287245|449858747|FG001|Overall Study|Study terminated by sponsor|0|||
125065721|NCT03287245|449858748|FG002|Overall Study|Study terminated by sponsor|3|||
125065722|NCT03287245|449858749|FG003|Overall Study|Study terminated by sponsor|1|||
125065723|NCT03287245|449858746|FG000|Overall Study|Adverse Event|1|||
125065724|NCT03287245|449858747|FG001|Overall Study|Adverse Event|0|||
125065725|NCT03287245|449858748|FG002|Overall Study|Adverse Event|0|||
125065726|NCT03287245|449858749|FG003|Overall Study|Adverse Event|0|||
125065727|NCT03287245|449858746|FG000|Overall Study|Withdrawal by Subject|8|||
125065728|NCT03287245|449858747|FG001|Overall Study|Withdrawal by Subject|3|||
125065729|NCT03287245|449858748|FG002|Overall Study|Withdrawal by Subject|3|||
125065730|NCT03287245|449858749|FG003|Overall Study|Withdrawal by Subject|0|||
125065731|NCT03287245|449858746|FG000|Overall Study|Physician Decision|3|||
125065732|NCT03287245|449858747|FG001|Overall Study|Physician Decision|2|||
125065733|NCT03287245|449858748|FG002|Overall Study|Physician Decision|0|||
125065734|NCT03287245|449858749|FG003|Overall Study|Physician Decision|0|||
125065735|NCT02701192|449858750|FG000|Overall Study|Protocol Violation|2|||
125065736|NCT02701192|449858750|FG000|Overall Study|Lost to Follow-up|4|||
125065737|NCT02150213|449858752|FG000|Overall Study|Lost to Follow-up|1|||
125139986|NCT03234907|450135823|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
125139987|NCT03234907|450135824|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
125139988|NCT03234907|450135819|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
125139989|NCT03234907|450135820|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
125139990|NCT03234907|450135821|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
125139991|NCT03234907|450135822|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
125139992|NCT03234907|450135823|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
125139993|NCT03234907|450135824|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
125139994|NCT02664415|450135825|FG000|Overall Study|Adverse Event|1|||
125139995|NCT02664415|450135826|FG001|Overall Study|Adverse Event|0|||
125139996|NCT00642993|450135827|FG000|Overall Study|Adverse Event|85|||
125139997|NCT00642993|450135828|FG001|Overall Study|Adverse Event|4|||
125139998|NCT00642993|450135827|FG000|Overall Study|Lost to Follow-up|8|||
125139999|NCT00642993|450135828|FG001|Overall Study|Lost to Follow-up|4|||
125140000|NCT00642993|450135827|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
125140001|NCT00642993|450135828|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
125065738|NCT02150213|449858752|FG000|Overall Study|Withdrawal by Subject|1|||
125140002|NCT00642993|450135827|FG000|Overall Study|Protocol Violation|1|||
125065739|NCT01297309|449858756|FG000|Overall Study|Eligibility failure|2|||
125140003|NCT00642993|450135828|FG001|Overall Study|Protocol Violation|4|||
125222563|NCT03428100|450442764|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
125065740|NCT01297309|449858756|FG000|Overall Study|Screen failure|2|||
125065741|NCT01297309|449858756|FG000|Overall Study|Withdrawal by Subject|5|||
125065742|NCT01297309|449858756|FG000|Overall Study|Adverse Event|1|||
125065743|NCT01297309|449858756|FG000|Overall Study|Investigator Decision|2|||
125065744|NCT01297309|449858756|FG000|Overall Study|Death|1|||
125065745|NCT01297309|449858756|FG000|Overall Study|Participant not entering extensionperiod|1|||
125065746|NCT03039738|449858757|FG000|Overall Study|Incomplete data sets|54|||
125065747|NCT03039738|449858758|FG001|Overall Study|Incomplete data sets|0|||
125065748|NCT02678312|449858759|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
125065749|NCT02678312|449858760|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
125065750|NCT02678312|449858761|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
125065751|NCT02678312|449858762|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
125065752|NCT02678312|449858763|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
125065753|NCT02678312|449858759|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
125065754|NCT02678312|449858760|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
125065755|NCT02678312|449858761|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
125065756|NCT02678312|449858762|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
125065757|NCT02678312|449858763|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
125065758|NCT02678312|449858759|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
125065759|NCT02678312|449858760|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
125065760|NCT02678312|449858761|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
125065761|NCT02678312|449858762|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
125065762|NCT02678312|449858763|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
125065763|NCT02678312|449858759|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
125065764|NCT02678312|449858760|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
125065765|NCT02678312|449858761|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
125065766|NCT02678312|449858762|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
125065767|NCT02678312|449858763|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
125065768|NCT02678312|449858759|FG000|Part 2 Double Blind Epoch|Death|0|||
125065769|NCT02678312|449858760|FG001|Part 2 Double Blind Epoch|Death|0|||
125065770|NCT02678312|449858761|FG002|Part 2 Double Blind Epoch|Death|0|||
125065771|NCT02678312|449858762|FG003|Part 2 Double Blind Epoch|Death|8|||
125065772|NCT02678312|449858763|FG004|Part 2 Double Blind Epoch|Death|12|||
125065773|NCT02678312|449858759|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
125065774|NCT02678312|449858760|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
125065775|NCT02678312|449858761|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
125065776|NCT02678312|449858762|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
125065777|NCT02678312|449858763|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
125065778|NCT02678312|449858759|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
125065779|NCT02678312|449858760|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
125065780|NCT02678312|449858761|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
125065781|NCT02678312|449858762|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
125065782|NCT02678312|449858763|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
125065783|NCT02678312|449858759|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
125065784|NCT02678312|449858760|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
125065785|NCT02678312|449858761|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
125065786|NCT02678312|449858762|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
125065787|NCT02678312|449858763|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
125065788|NCT02716194|449858766|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
125065789|NCT02716194|449858767|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
125065790|NCT02716194|449858768|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
125065791|NCT00971425|449858769|FG000|Overall Study|Adverse Event|1|||
125065792|NCT00971425|449858770|FG001|Overall Study|Adverse Event|1|||
125065793|NCT00971425|449858769|FG000|Overall Study|Withdrawal by Subject|0|||
125065794|NCT00971425|449858770|FG001|Overall Study|Withdrawal by Subject|1|||
125065795|NCT03587584|449858776|FG000|Overall Study|SOC deviations|4|||
125065796|NCT03587584|449858777|FG001|Overall Study|SOC deviations|6|||
125065797|NCT03587584|449858776|FG000|Overall Study|Incomplete data|0|||
125065798|NCT03587584|449858777|FG001|Overall Study|Incomplete data|3|||
125065799|NCT00225147|449858778|FG000|Open-label Phase|Lost to Follow-up|0|||
125065800|NCT00225147|449858779|FG001|Open-label Phase|Lost to Follow-up|0|||
125065801|NCT00225147|449858780|FG002|Open-label Phase|Lost to Follow-up|0|||
125065802|NCT00225147|449858781|FG003|Open-label Phase|Lost to Follow-up|4|||
125065803|NCT00225147|449858778|FG000|Open-label Phase|Withdrawal by Subject|0|||
125065804|NCT00225147|449858779|FG001|Open-label Phase|Withdrawal by Subject|0|||
125065805|NCT00225147|449858780|FG002|Open-label Phase|Withdrawal by Subject|0|||
125065806|NCT00225147|449858781|FG003|Open-label Phase|Withdrawal by Subject|6|||
125065807|NCT02685995|449858784|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
125065808|NCT02685995|449858785|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
125065809|NCT03625141|449858786|FG000|Overall Study|Adverse Event|0|||
125065810|NCT03625141|449858787|FG001|Overall Study|Adverse Event|2|||
125065811|NCT03625141|449858786|FG000|Overall Study|Study Terminated By Sponsor|1|||
125065812|NCT03625141|449858787|FG001|Overall Study|Study Terminated By Sponsor|13|||
125065813|NCT03625141|449858786|FG000|Overall Study|Withdrawal by Subject|3|||
125065814|NCT03625141|449858787|FG001|Overall Study|Withdrawal by Subject|0|||
125065815|NCT03625141|449858786|FG000|Overall Study|Withdrawal Of Consent|0|||
125065816|NCT03625141|449858787|FG001|Overall Study|Withdrawal Of Consent|1|||
125222564|NCT03428100|450442765|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
125222565|NCT03428100|450442766|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
125065817|NCT03625141|449858786|FG000|Overall Study|Death|11|||
125065818|NCT03625141|449858787|FG001|Overall Study|Death|47|||
125065819|NCT03625141|449858786|FG000|Overall Study|Progressive Disease|0|||
125222566|NCT03428100|450442767|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
125140004|NCT00642993|450135827|FG000|Overall Study|Did not meet protocol eligibility|0|||
125065820|NCT03625141|449858787|FG001|Overall Study|Progressive Disease|2|||
125065821|NCT00868166|449858789|FG000|Overall Study|Death|58|||
125065822|NCT00868166|449858790|FG001|Overall Study|Death|65|||
125065823|NCT00868166|449858789|FG000|Overall Study|Withdrawal by Subject|33|||
125065824|NCT00868166|449858790|FG001|Overall Study|Withdrawal by Subject|25|||
125065825|NCT00868166|449858789|FG000|Overall Study|Protocol Violation|1|||
125065826|NCT00868166|449858790|FG001|Overall Study|Protocol Violation|0|||
125065827|NCT00868166|449858789|FG000|Overall Study|Lost to Follow-up|1|||
125065828|NCT00868166|449858790|FG001|Overall Study|Lost to Follow-up|3|||
125065829|NCT00868166|449858789|FG000|Overall Study|Adverse Event|9|||
125065830|NCT00868166|449858790|FG001|Overall Study|Adverse Event|10|||
125065831|NCT00868166|449858789|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
125065832|NCT00868166|449858790|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
125065833|NCT00868166|449858789|FG000|Overall Study|Non-compliance with IMP|1|||
125065834|NCT00868166|449858790|FG001|Overall Study|Non-compliance with IMP|1|||
125065835|NCT03819218|449858795|FG000|Overall Study|Protocol Violation|1|||
125065836|NCT02267278|449858796|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
125065837|NCT02267278|449858796|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
125065838|NCT02267278|449858796|FG000|Overall Study|Developed new cancer diagnoses|2|||
125065839|NCT02267278|449858796|FG000|Overall Study|prescribed prohibited medication|1|||
125065840|NCT00650091|449858797|FG000|Amended Study Design|Withdrawal by Subject|12|||
125065841|NCT00650091|449858798|FG001|Amended Study Design|Withdrawal by Subject|11|||
125065842|NCT00650091|449858799|FG002|Amended Study Design|Withdrawal by Subject|0|||
125065843|NCT00650091|449858797|FG000|Amended Study Design|Physician Decision|5|||
125065844|NCT00650091|449858798|FG001|Amended Study Design|Physician Decision|0|||
125065845|NCT00650091|449858799|FG002|Amended Study Design|Physician Decision|0|||
125065846|NCT00650091|449858797|FG000|Amended Study Design|Adverse Event|1|||
125065847|NCT00650091|449858798|FG001|Amended Study Design|Adverse Event|4|||
125065848|NCT00650091|449858799|FG002|Amended Study Design|Adverse Event|0|||
125065849|NCT00650091|449858797|FG000|Amended Study Design|Lung transplantation|4|||
125065850|NCT00650091|449858798|FG001|Amended Study Design|Lung transplantation|2|||
125065851|NCT00650091|449858799|FG002|Amended Study Design|Lung transplantation|0|||
125065852|NCT00650091|449858797|FG000|Amended Study Design|Other|1|||
125065853|NCT00650091|449858798|FG001|Amended Study Design|Other|3|||
125065854|NCT00650091|449858799|FG002|Amended Study Design|Other|0|||
125140005|NCT00642993|450135828|FG001|Overall Study|Did not meet protocol eligibility|1|||
125140006|NCT00642993|450135827|FG000|Overall Study|Administrative|1|||
125140007|NCT00642993|450135828|FG001|Overall Study|Administrative|0|||
125140008|NCT02986139|450135830|FG000|Overall Study|Sponsor Decision|1|||
125140009|NCT02986139|450135831|FG001|Overall Study|Sponsor Decision|2|||
125140010|NCT02986139|450135830|FG000|Overall Study|Withdrawal by Subject|0|||
125140011|NCT02986139|450135831|FG001|Overall Study|Withdrawal by Subject|1|||
125140012|NCT02986139|450135830|FG000|Overall Study|Lost to Follow-up|0|||
125140013|NCT02986139|450135831|FG001|Overall Study|Lost to Follow-up|1|||
125140014|NCT00414726|450135835|FG000|Overall Study|Withdrawal by Subject|0|||
125140015|NCT00414726|450135836|FG001|Overall Study|Withdrawal by Subject|1|||
125140016|NCT02107196|450135837|FG000|12-week Treatment Period|Adverse Event|6|||
125140017|NCT02107196|450135838|FG001|12-week Treatment Period|Adverse Event|3|||
125140018|NCT02107196|450135837|FG000|12-week Treatment Period|Lack of Efficacy|2|||
125140019|NCT02107196|450135838|FG001|12-week Treatment Period|Lack of Efficacy|1|||
125140020|NCT02107196|450135837|FG000|12-week Treatment Period|Lost to Follow-up|3|||
125140021|NCT02107196|450135838|FG001|12-week Treatment Period|Lost to Follow-up|6|||
125140022|NCT02107196|450135837|FG000|12-week Treatment Period|Physician Decision|0|||
125140023|NCT02107196|450135838|FG001|12-week Treatment Period|Physician Decision|1|||
125140024|NCT02107196|450135837|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
125140025|NCT02107196|450135838|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
125140026|NCT02107196|450135837|FG000|12-week Treatment Period|Protocol Violation|7|||
125140027|NCT02107196|450135838|FG001|12-week Treatment Period|Protocol Violation|8|||
125140028|NCT02107196|450135837|FG000|12-week Treatment Period|Reason Missing|11|||
125065855|NCT01413542|449858805|FG000|Overall Study|Physician Decision|1|||
125065856|NCT01413542|449858806|FG001|Overall Study|Physician Decision|0|||
125065857|NCT01413542|449858807|FG002|Overall Study|Physician Decision|3|||
125065858|NCT01413542|449858808|FG003|Overall Study|Physician Decision|0|||
125065859|NCT01413542|449858805|FG000|Overall Study|Adverse Event|0|||
125140029|NCT02107196|450135838|FG001|12-week Treatment Period|Reason Missing|8|||
125140030|NCT02107196|450135837|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
125065860|NCT01413542|449858806|FG001|Overall Study|Adverse Event|0|||
125065861|NCT01413542|449858807|FG002|Overall Study|Adverse Event|0|||
125222567|NCT03428100|450442768|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
125065862|NCT01413542|449858808|FG003|Overall Study|Adverse Event|1|||
125065863|NCT02505542|449858809|FG000|Part A: Open-Label Period|Adverse Event|31|||
125140031|NCT02107196|450135838|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
125140032|NCT02107196|450135837|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
125140033|NCT02107196|450135838|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
125140034|NCT02107196|450135837|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
125065864|NCT02505542|449858810|FG001|Part A: Open-Label Period|Adverse Event|0|||
125065865|NCT02505542|449858811|FG002|Part A: Open-Label Period|Adverse Event|0|||
125140035|NCT02107196|450135838|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
125140036|NCT02107196|450135837|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
125140037|NCT02107196|450135838|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
125140038|NCT00516295|450135839|FG000|Overall Study|Lack of Efficacy|2|||
125140039|NCT00516295|450135840|FG001|Overall Study|Lack of Efficacy|0|||
125140040|NCT00516295|450135841|FG002|Overall Study|Lack of Efficacy|0|||
125140041|NCT00516295|450135839|FG000|Overall Study|Ineligible|1|||
125140042|NCT00516295|450135840|FG001|Overall Study|Ineligible|0|||
125140043|NCT00516295|450135841|FG002|Overall Study|Ineligible|0|||
125140044|NCT01243151|450135844|FG000|Overall Study|Adverse Event|0|||
125140045|NCT01243151|450135845|FG001|Overall Study|Adverse Event|1|||
125140046|NCT01243151|450135846|FG002|Overall Study|Adverse Event|0|||
125140047|NCT01243151|450135847|FG003|Overall Study|Adverse Event|0|||
125140048|NCT01243151|450135848|FG004|Overall Study|Adverse Event|0|||
125140049|NCT01243151|450135844|FG000|Overall Study|Protocol Violation|0|||
125140050|NCT01243151|450135845|FG001|Overall Study|Protocol Violation|0|||
125140051|NCT01243151|450135846|FG002|Overall Study|Protocol Violation|1|||
125140052|NCT01243151|450135847|FG003|Overall Study|Protocol Violation|0|||
125140053|NCT01243151|450135848|FG004|Overall Study|Protocol Violation|0|||
125140054|NCT01243151|450135844|FG000|Overall Study|Other|0|||
125140055|NCT01243151|450135845|FG001|Overall Study|Other|0|||
125065866|NCT02505542|449858812|FG003|Part A: Open-Label Period|Adverse Event|0|||
125065867|NCT02505542|449858809|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
125065868|NCT02505542|449858810|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
125065869|NCT02505542|449858811|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
125065870|NCT02505542|449858812|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
125065871|NCT02505542|449858809|FG000|Part A: Open-Label Period|Protocol Violation|1|||
125065872|NCT02505542|449858810|FG001|Part A: Open-Label Period|Protocol Violation|0|||
125065873|NCT02505542|449858811|FG002|Part A: Open-Label Period|Protocol Violation|0|||
125065874|NCT02505542|449858812|FG003|Part A: Open-Label Period|Protocol Violation|0|||
125065875|NCT02505542|449858809|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
125065876|NCT02505542|449858810|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
125065877|NCT02505542|449858811|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
125065878|NCT02505542|449858812|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
125065879|NCT02505542|449858809|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
125065880|NCT02505542|449858810|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
125065881|NCT02505542|449858811|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
125065882|NCT02505542|449858812|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
125065883|NCT02505542|449858809|FG000|Part A: Open-Label Period|New medical history available|1|||
125065884|NCT02505542|449858810|FG001|Part A: Open-Label Period|New medical history available|0|||
125065885|NCT02505542|449858811|FG002|Part A: Open-Label Period|New medical history available|0|||
125065886|NCT02505542|449858812|FG003|Part A: Open-Label Period|New medical history available|0|||
125065887|NCT02505542|449858809|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
125065888|NCT02505542|449858810|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
125065889|NCT02505542|449858811|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
125065890|NCT02505542|449858812|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
125065891|NCT02505542|449858809|FG000|Part A: Open-Label Period|Pregnancy|2|||
125065892|NCT02505542|449858810|FG001|Part A: Open-Label Period|Pregnancy|0|||
125065893|NCT02505542|449858811|FG002|Part A: Open-Label Period|Pregnancy|0|||
125065894|NCT02505542|449858812|FG003|Part A: Open-Label Period|Pregnancy|0|||
125065895|NCT02505542|449858809|FG000|Part A: Open-Label Period|Sponsor directive|1|||
125065896|NCT02505542|449858810|FG001|Part A: Open-Label Period|Sponsor directive|0|||
125140056|NCT01243151|450135846|FG002|Overall Study|Other|0|||
125140057|NCT01243151|450135847|FG003|Overall Study|Other|1|||
125140058|NCT01243151|450135848|FG004|Overall Study|Other|0|||
125140059|NCT01243151|450135844|FG000|Overall Study|Randomized but not treated|0|||
125140060|NCT01243151|450135845|FG001|Overall Study|Randomized but not treated|0|||
125140061|NCT01243151|450135846|FG002|Overall Study|Randomized but not treated|0|||
125065897|NCT02505542|449858811|FG002|Part A: Open-Label Period|Sponsor directive|0|||
125065898|NCT02505542|449858812|FG003|Part A: Open-Label Period|Sponsor directive|0|||
125065899|NCT02505542|449858809|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
125065900|NCT02505542|449858810|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
125065901|NCT02505542|449858811|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
125140062|NCT01243151|450135847|FG003|Overall Study|Randomized but not treated|1|||
125140063|NCT01243151|450135848|FG004|Overall Study|Randomized but not treated|0|||
125140064|NCT03119662|450135849|FG000|Overall Study|Withdrawal by Subject|0|||
125140065|NCT03119662|450135850|FG001|Overall Study|Withdrawal by Subject|1|||
125140066|NCT01630616|450135854|FG000|Overall Study|Adverse Event|0|||
125140067|NCT01630616|450135855|FG001|Overall Study|Adverse Event|0|||
125140068|NCT01630616|450135856|FG002|Overall Study|Adverse Event|0|||
125065902|NCT02505542|449858812|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
125065903|NCT02505542|449858809|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
125065904|NCT02505542|449858810|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
125065905|NCT02505542|449858811|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
125065906|NCT02505542|449858812|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
125065907|NCT02505542|449858809|FG000|Part A: Open-Label Period|Non-compliance|1|||
125065908|NCT02505542|449858810|FG001|Part A: Open-Label Period|Non-compliance|0|||
125065909|NCT02505542|449858811|FG002|Part A: Open-Label Period|Non-compliance|0|||
125065910|NCT02505542|449858812|FG003|Part A: Open-Label Period|Non-compliance|0|||
125065911|NCT02505542|449858809|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
125065912|NCT02505542|449858810|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
125065913|NCT02505542|449858811|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
125065914|NCT02505542|449858812|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
125065915|NCT02505542|449858809|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
125065916|NCT02505542|449858810|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
125065917|NCT02505542|449858811|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
125065918|NCT02505542|449858812|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
125065919|NCT02505542|449858809|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
125065920|NCT02505542|449858810|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
125065921|NCT02505542|449858811|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
125065922|NCT02505542|449858812|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
125065923|NCT02505542|449858809|FG000|Part B: Double-Blind Period|Adverse Event|0|||
125065924|NCT02505542|449858810|FG001|Part B: Double-Blind Period|Adverse Event|0|||
125065925|NCT02505542|449858811|FG002|Part B: Double-Blind Period|Adverse Event|1|||
125065926|NCT02505542|449858812|FG003|Part B: Double-Blind Period|Adverse Event|3|||
125065927|NCT02505542|449858809|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
125065928|NCT02505542|449858810|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
125065929|NCT02505542|449858811|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
125065930|NCT02505542|449858812|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
125065931|NCT02505542|449858809|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
125065932|NCT02505542|449858810|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
125065933|NCT02505542|449858811|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
125065934|NCT02505542|449858812|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
125065935|NCT02505542|449858809|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
125065936|NCT02505542|449858810|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
125065937|NCT02505542|449858811|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
125065938|NCT02505542|449858812|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
125065939|NCT02505542|449858809|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
125065940|NCT02505542|449858810|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
125065941|NCT02505542|449858811|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
125065942|NCT02505542|449858812|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
125065943|NCT02505542|449858809|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
125065944|NCT02505542|449858810|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
125065945|NCT02505542|449858811|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
125065946|NCT02505542|449858812|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
125065947|NCT02505542|449858809|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
125065948|NCT02505542|449858810|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
125065949|NCT02505542|449858811|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
125065950|NCT02505542|449858812|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
125065951|NCT02505542|449858809|FG000|Part B: Double-Blind Period|Miscalculation|0|||
125065952|NCT02505542|449858810|FG001|Part B: Double-Blind Period|Miscalculation|1|||
125065953|NCT02505542|449858811|FG002|Part B: Double-Blind Period|Miscalculation|0|||
125140069|NCT01630616|450135857|FG003|Overall Study|Adverse Event|1|||
125140070|NCT01630616|450135858|FG004|Overall Study|Adverse Event|0|||
125140071|NCT01630616|450135859|FG005|Overall Study|Adverse Event|0|||
125140072|NCT01630616|450135854|FG000|Overall Study|Withdrawal by Subject|0|||
125140073|NCT01630616|450135855|FG001|Overall Study|Withdrawal by Subject|0|||
125140074|NCT01630616|450135856|FG002|Overall Study|Withdrawal by Subject|0|||
125140075|NCT01630616|450135857|FG003|Overall Study|Withdrawal by Subject|2|||
125140076|NCT01630616|450135858|FG004|Overall Study|Withdrawal by Subject|0|||
125140077|NCT01630616|450135859|FG005|Overall Study|Withdrawal by Subject|0|||
125065954|NCT02505542|449858812|FG003|Part B: Double-Blind Period|Miscalculation|0|||
125065955|NCT02505542|449858809|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
125065956|NCT02505542|449858810|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
125140078|NCT02218541|450135860|FG000|Overall Study|Lost to Follow-up|2|||
125140079|NCT02218541|450135861|FG001|Overall Study|Lost to Follow-up|1|||
125140080|NCT02218541|450135860|FG000|Overall Study|Implant Failure|4|||
125140081|NCT02218541|450135861|FG001|Overall Study|Implant Failure|1|||
125065957|NCT02505542|449858811|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
125065958|NCT02505542|449858812|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
125065959|NCT03372603|449858813|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
125065960|NCT03372603|449858814|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
125065961|NCT03372603|449858813|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
125065962|NCT03372603|449858814|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
125065963|NCT02806947|449858815|FG000|Overall Study|Withdrawal by Subject|5|||
125065964|NCT02806947|449858816|FG001|Overall Study|Withdrawal by Subject|1|||
125065965|NCT00664209|449858823|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
125065966|NCT00664209|449858823|FG000|Study Treatment Period|Physician Decision|4|||
125065967|NCT00664209|449858823|FG000|Study Treatment Period|Withdrawal by Subject|2|||
125065968|NCT00065442|449858824|FG000|Overall Study|Lost to Follow-up|1|||
125065969|NCT00065442|449858825|FG001|Overall Study|Lost to Follow-up|1|||
125065970|NCT00065442|449858824|FG000|Overall Study|Death|121|||
125065971|NCT00065442|449858825|FG001|Overall Study|Death|210|||
125065972|NCT00065442|449858824|FG000|Overall Study|Withdrawal by Subject|3|||
125065973|NCT00065442|449858825|FG001|Overall Study|Withdrawal by Subject|9|||
125065974|NCT01594333|449858827|FG000|Overall Study|Death|96|||
125065975|NCT01594333|449858828|FG001|Overall Study|Death|83|||
125065976|NCT01594333|449858827|FG000|Overall Study|Lost to Follow-up|5|||
125065977|NCT01594333|449858828|FG001|Overall Study|Lost to Follow-up|5|||
125065978|NCT01594333|449858827|FG000|Overall Study|Withdrawal by Subject|60|||
125065979|NCT01594333|449858828|FG001|Overall Study|Withdrawal by Subject|63|||
125065980|NCT01764256|449858829|FG000|Received All Vaccinations|Adverse Event|1|||
125065981|NCT01764256|449858830|FG001|Received All Vaccinations|Adverse Event|1|||
125065982|NCT01764256|449858831|FG002|Received All Vaccinations|Adverse Event|0|||
125065983|NCT01764256|449858832|FG003|Received All Vaccinations|Adverse Event|0|||
125065984|NCT01764256|449858829|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
125065985|NCT01764256|449858830|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
125065986|NCT01764256|449858831|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
125065987|NCT01764256|449858832|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
125065988|NCT01764256|449858829|FG000|Received All Vaccinations|Lost to Follow-up|1|||
125065989|NCT01764256|449858830|FG001|Received All Vaccinations|Lost to Follow-up|0|||
125065990|NCT01764256|449858831|FG002|Received All Vaccinations|Lost to Follow-up|0|||
125065991|NCT01764256|449858832|FG003|Received All Vaccinations|Lost to Follow-up|0|||
125065992|NCT01764256|449858829|FG000|Completed Study|Lost to Follow-up|0|||
125065993|NCT01764256|449858830|FG001|Completed Study|Lost to Follow-up|0|||
125065994|NCT01764256|449858831|FG002|Completed Study|Lost to Follow-up|0|||
125065995|NCT01764256|449858832|FG003|Completed Study|Lost to Follow-up|1|||
125065996|NCT02029638|449858833|FG000|Overall Study|Death|0|||
125065997|NCT02029638|449858834|FG001|Overall Study|Death|0|||
125065998|NCT02029638|449858835|FG002|Overall Study|Death|1|||
125065999|NCT02029638|449858833|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
125066000|NCT02029638|449858834|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
125066001|NCT02029638|449858835|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
125066002|NCT01153841|449858836|FG000|Overall Study|Adverse Event|1|||
125066003|NCT01153841|449858837|FG001|Overall Study|Adverse Event|0|||
125066004|NCT01153841|449858836|FG000|Overall Study|Withdrawal by Subject|1|||
125066005|NCT01153841|449858837|FG001|Overall Study|Withdrawal by Subject|0|||
125066006|NCT01153841|449858836|FG000|Overall Study|Protocol Violation|2|||
125066007|NCT01153841|449858837|FG001|Overall Study|Protocol Violation|0|||
125066008|NCT01153841|449858836|FG000|Overall Study|Lost to Follow-up|2|||
125066009|NCT01153841|449858837|FG001|Overall Study|Lost to Follow-up|0|||
125066010|NCT03428997|449858847|FG000|Overall Study|Sponsor decision.|1|||
125066011|NCT03428997|449858847|FG000|Overall Study|Withdrawal by Subject|3|||
125066012|NCT03428997|449858847|FG000|Overall Study|Lost to Follow-up|4|||
125066013|NCT02563925|449858851|FG000|Overall Study|Withdrawal by Subject|2|||
125066014|NCT00400712|449858852|FG000|Overall Study|Death|1|||
125066015|NCT00400712|449858853|FG001|Overall Study|Death|0|||
125066016|NCT00400712|449858852|FG000|Overall Study|Withdrawal by Subject|11|||
125140082|NCT01993186|450135862|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
125140083|NCT01993186|450135863|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
125140084|NCT01993186|450135862|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
125140085|NCT01993186|450135863|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
125066017|NCT00400712|449858853|FG001|Overall Study|Withdrawal by Subject|12|||
125066018|NCT00400712|449858852|FG000|Overall Study|Physician Decision|5|||
125066019|NCT00400712|449858853|FG001|Overall Study|Physician Decision|4|||
125066020|NCT02553317|449858857|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
125066021|NCT02553317|449858858|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
125066022|NCT02553317|449858857|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
125066023|NCT02553317|449858858|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
125066024|NCT02553317|449858857|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
125066025|NCT02553317|449858858|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
125066026|NCT02553317|449858857|FG000|Overall Treatment Period + Follow-up|Death|1|||
125066027|NCT02553317|449858858|FG001|Overall Treatment Period + Follow-up|Death|3|||
125066028|NCT02553317|449858857|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
125066029|NCT02553317|449858858|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
125066030|NCT02553317|449858857|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
125066031|NCT02553317|449858858|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
125066032|NCT02553317|449858857|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
125066033|NCT02553317|449858858|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
125066034|NCT02553317|449858857|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
125066035|NCT02553317|449858858|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
125066036|NCT02553317|449858857|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
125066037|NCT02553317|449858858|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
125066038|NCT02553317|449858857|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
125066039|NCT02553317|449858858|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
125066040|NCT03691610|449858859|FG000|Overall Study|Adverse Event|0|||
125066041|NCT03691610|449858860|FG001|Overall Study|Adverse Event|1|||
125066042|NCT03691610|449858861|FG002|Overall Study|Adverse Event|0|||
125066043|NCT03691610|449858862|FG003|Overall Study|Adverse Event|0|||
125066044|NCT03691610|449858859|FG000|Overall Study|Protocol Deviation|15|||
125066045|NCT03691610|449858860|FG001|Overall Study|Protocol Deviation|8|||
125066046|NCT03691610|449858861|FG002|Overall Study|Protocol Deviation|1|||
125066047|NCT03691610|449858862|FG003|Overall Study|Protocol Deviation|2|||
125066048|NCT03691610|449858859|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
125066049|NCT03691610|449858860|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
125066050|NCT03691610|449858861|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
125066051|NCT03691610|449858862|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
125066052|NCT03691610|449858859|FG000|Overall Study|Lost to Follow-up|20|||
125066053|NCT03691610|449858860|FG001|Overall Study|Lost to Follow-up|11|||
125066054|NCT03691610|449858861|FG002|Overall Study|Lost to Follow-up|5|||
125066055|NCT03691610|449858862|FG003|Overall Study|Lost to Follow-up|2|||
125066056|NCT00622869|449858864|FG000|Overall Study|Subject Withdrew Consent|13|||
125066057|NCT00622869|449858865|FG001|Overall Study|Subject Withdrew Consent|17|||
125066058|NCT00622869|449858866|FG002|Overall Study|Subject Withdrew Consent|11|||
125066059|NCT00622869|449858864|FG000|Overall Study|Administrative Problems|11|||
125066060|NCT00622869|449858865|FG001|Overall Study|Administrative Problems|17|||
125066061|NCT00622869|449858866|FG002|Overall Study|Administrative Problems|13|||
125066062|NCT00622869|449858864|FG000|Overall Study|Death|12|||
125066063|NCT00622869|449858865|FG001|Overall Study|Death|15|||
125066064|NCT00622869|449858866|FG002|Overall Study|Death|10|||
125066065|NCT00622869|449858864|FG000|Overall Study|Lost to Follow-up|2|||
125066066|NCT00622869|449858865|FG001|Overall Study|Lost to Follow-up|4|||
125066067|NCT00622869|449858866|FG002|Overall Study|Lost to Follow-up|2|||
125066068|NCT00622869|449858864|FG000|Overall Study|Graft Loss|5|||
125066069|NCT00622869|449858865|FG001|Overall Study|Graft Loss|3|||
125066070|NCT00622869|449858866|FG002|Overall Study|Graft Loss|2|||
125066071|NCT00622869|449858864|FG000|Overall Study|Missing|0|||
125066072|NCT00622869|449858865|FG001|Overall Study|Missing|1|||
125066073|NCT00622869|449858866|FG002|Overall Study|Missing|1|||
125066074|NCT03454412|449858867|FG000|Baseline Assesment|Physician Decision|12|||
125066075|NCT00115765|449858868|FG000|Overall Study|Withdrawal by Subject|22|||
125066076|NCT00115765|449858869|FG001|Overall Study|Withdrawal by Subject|53|||
125066077|NCT00115765|449858870|FG002|Overall Study|Withdrawal by Subject|76|||
125066078|NCT00115765|449858871|FG003|Overall Study|Withdrawal by Subject|15|||
125066079|NCT00115765|449858868|FG000|Overall Study|Physician Decision|4|||
125066080|NCT00115765|449858869|FG001|Overall Study|Physician Decision|15|||
125140086|NCT01993186|450135862|FG000|Open-Label Extension Period|Other, Not Specified|0|||
125140087|NCT01993186|450135863|FG001|Open-Label Extension Period|Other, Not Specified|1|||
125140088|NCT01993186|450135862|FG000|Open-Label Extension Period|Adverse Event|1|||
125140089|NCT01993186|450135863|FG001|Open-Label Extension Period|Adverse Event|0|||
125140090|NCT01993186|450135862|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
125140091|NCT01993186|450135863|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
125140092|NCT01993186|450135862|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
125140093|NCT01993186|450135863|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
125140094|NCT01993186|450135862|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
125066081|NCT00115765|449858870|FG002|Overall Study|Physician Decision|18|||
125066082|NCT00115765|449858871|FG003|Overall Study|Physician Decision|13|||
125066083|NCT00115765|449858868|FG000|Overall Study|Lost to Follow-up|3|||
125066084|NCT00115765|449858869|FG001|Overall Study|Lost to Follow-up|20|||
125066085|NCT00115765|449858870|FG002|Overall Study|Lost to Follow-up|18|||
125066086|NCT00115765|449858871|FG003|Overall Study|Lost to Follow-up|1|||
125066087|NCT00115765|449858868|FG000|Overall Study|Other|6|||
125066088|NCT00115765|449858869|FG001|Overall Study|Other|12|||
125066089|NCT00115765|449858870|FG002|Overall Study|Other|9|||
125066090|NCT00115765|449858871|FG003|Overall Study|Other|2|||
125066091|NCT03543358|449858872|FG000|Overall Study|Death|1|||
125066092|NCT03543358|449858873|FG001|Overall Study|Death|0|||
125066093|NCT03543358|449858872|FG000|Overall Study|Disease Progression|1|||
125066094|NCT03543358|449858873|FG001|Overall Study|Disease Progression|0|||
125066095|NCT03543358|449858872|FG000|Overall Study|Parent Study Closure|1|||
125066096|NCT03543358|449858873|FG001|Overall Study|Parent Study Closure|0|||
125066097|NCT03956225|449858874|FG000|Overall Study|Lack of Efficacy|1|||
125066098|NCT03956225|449858875|FG001|Overall Study|Lack of Efficacy|1|||
125066099|NCT03956225|449858874|FG000|Overall Study|Lost to Follow-up|0|||
125066100|NCT03956225|449858875|FG001|Overall Study|Lost to Follow-up|1|||
125066101|NCT03956225|449858874|FG000|Overall Study|Withdrawal by Subject|2|||
125066102|NCT03956225|449858875|FG001|Overall Study|Withdrawal by Subject|1|||
125066103|NCT03956225|449858874|FG000|Overall Study|Other Reasons|2|||
125066104|NCT03956225|449858875|FG001|Overall Study|Other Reasons|1|||
125066105|NCT04093258|449858876|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
125066106|NCT04093258|449858877|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
125066107|NCT00594204|449858878|FG000|Overall Study|Adverse Event|15|||
125066108|NCT00594204|449858879|FG001|Overall Study|Adverse Event|3|||
125066109|NCT00594204|449858878|FG000|Overall Study|Lost to Follow-up|9|||
125066110|NCT00594204|449858879|FG001|Overall Study|Lost to Follow-up|5|||
125066111|NCT00594204|449858878|FG000|Overall Study|Withdrawal by Subject|23|||
125066112|NCT00594204|449858879|FG001|Overall Study|Withdrawal by Subject|29|||
125066113|NCT00594204|449858878|FG000|Overall Study|Other|4|||
125066114|NCT00594204|449858879|FG001|Overall Study|Other|3|||
125066115|NCT00594204|449858878|FG000|Overall Study|Lack of Efficacy|3|||
125066116|NCT00594204|449858879|FG001|Overall Study|Lack of Efficacy|4|||
125066117|NCT00594204|449858878|FG000|Overall Study|Randomized but not treated|4|||
125066118|NCT00594204|449858879|FG001|Overall Study|Randomized but not treated|1|||
125066119|NCT00986427|449858880|FG000|Overall Study|Lost to Follow-up|2|||
125066120|NCT00986427|449858881|FG001|Overall Study|Lost to Follow-up|0|||
125066121|NCT00986427|449858880|FG000|Overall Study|Lack of Efficacy|1|||
125066122|NCT00986427|449858881|FG001|Overall Study|Lack of Efficacy|0|||
125066123|NCT00986427|449858880|FG000|Overall Study|Withdrawal by Subject|1|||
125066124|NCT00986427|449858881|FG001|Overall Study|Withdrawal by Subject|0|||
125066125|NCT01115738|449858882|FG000|Overall Study|Death|1|||
125066126|NCT01115738|449858883|FG001|Overall Study|Death|0|||
125066127|NCT01115738|449858884|FG002|Overall Study|Death|0|||
125066128|NCT01115738|449858882|FG000|Overall Study|Lost to Follow-up|0|||
125066129|NCT01115738|449858883|FG001|Overall Study|Lost to Follow-up|0|||
125066130|NCT01115738|449858884|FG002|Overall Study|Lost to Follow-up|1|||
125066131|NCT01115738|449858882|FG000|Overall Study|Physician Decision|18|||
125066132|NCT01115738|449858883|FG001|Overall Study|Physician Decision|15|||
125066133|NCT01115738|449858884|FG002|Overall Study|Physician Decision|17|||
125066134|NCT01115738|449858882|FG000|Overall Study|Withdrawal by Subject|6|||
125066135|NCT01115738|449858883|FG001|Overall Study|Withdrawal by Subject|6|||
125066136|NCT01115738|449858884|FG002|Overall Study|Withdrawal by Subject|9|||
125066137|NCT01669811|449858888|FG000|Overall Study|Investigator decision|0|||
125066138|NCT01669811|449858889|FG001|Overall Study|Investigator decision|1|||
125066139|NCT01669811|449858888|FG000|Overall Study|Withdrawal by Subject|1|||
125066140|NCT01669811|449858889|FG001|Overall Study|Withdrawal by Subject|2|||
125066141|NCT01669811|449858888|FG000|Overall Study|Adverse Event|2|||
125066142|NCT01669811|449858889|FG001|Overall Study|Adverse Event|6|||
125066143|NCT01669811|449858888|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
125066144|NCT01669811|449858889|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
125066145|NCT04095442|449860054|FG000|Overall Study|Lost to Follow-up|0|||
125066146|NCT04095442|449860055|FG001|Overall Study|Lost to Follow-up|1|||
125066147|NCT04095442|449860054|FG000|Overall Study|Screen failure|1|||
125066148|NCT04095442|449860055|FG001|Overall Study|Screen failure|0|||
125066149|NCT03947255|449860058|FG000|Overall Study|Study Closure by Sponsor|2|||
125140095|NCT01993186|450135863|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
125140096|NCT01853176|450135865|FG000|Overall Study|Study terminated|4|||
125140097|NCT01853176|450135866|FG001|Overall Study|Study terminated|0|||
125140098|NCT00198133|450135867|FG000|Overall Study|Disease progression|2|||
125140099|NCT00198133|450135868|FG001|Overall Study|Disease progression|5|||
125066150|NCT03947255|449860059|FG001|Overall Study|Study Closure by Sponsor|2|||
125066151|NCT03947255|449860058|FG000|Overall Study|Withdrawal by Subject|2|||
125066152|NCT03947255|449860059|FG001|Overall Study|Withdrawal by Subject|2|||
125140100|NCT00198133|450135867|FG000|Overall Study|Adverse Event|1|||
125066153|NCT03947255|449860058|FG000|Overall Study|Lost to Follow-up|2|||
125066154|NCT03947255|449860059|FG001|Overall Study|Lost to Follow-up|0|||
125066155|NCT03947255|449860058|FG000|Overall Study|Death|0|||
125066156|NCT03947255|449860059|FG001|Overall Study|Death|2|||
125066157|NCT00949910|449860060|FG000|Overall Study|Progressive Disease|3750|||
125066158|NCT00949910|449860060|FG000|Overall Study|Symptomatic Deterioration|1088|||
125066159|NCT00949910|449860060|FG000|Overall Study|Lost to Follow-up|100|||
125066160|NCT00949910|449860060|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
125066161|NCT00949910|449860060|FG000|Overall Study|Participant Refusal|390|||
125066162|NCT00949910|449860060|FG000|Overall Study|Death Due to Malignant Disease|456|||
125140101|NCT00198133|450135868|FG001|Overall Study|Adverse Event|3|||
125140102|NCT00198133|450135867|FG000|Overall Study|Withdrawal by Subject|1|||
125066163|NCT00949910|449860060|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
125066164|NCT00949910|449860060|FG000|Overall Study|Death Due to Adverse Event|115|||
125066165|NCT00949910|449860060|FG000|Overall Study|Death Due to Toxicity|3|||
125066166|NCT00949910|449860060|FG000|Overall Study|Death from Unknown Cause|5|||
125066167|NCT00949910|449860060|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
125066168|NCT00949910|449860060|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
125066169|NCT00949910|449860060|FG000|Overall Study|Switched to Commercial Treatment|4|||
125066170|NCT00949910|449860060|FG000|Overall Study|Violation of Eligibility|23|||
125066171|NCT00949910|449860060|FG000|Overall Study|Logistical Reasons|13|||
125066172|NCT00949910|449860060|FG000|Overall Study|Non-Compliance|10|||
125066173|NCT00949910|449860060|FG000|Overall Study|Prolonged Dosing Interruption|4|||
125066174|NCT00949910|449860060|FG000|Overall Study|Adverse Event|83|||
125066175|NCT00949910|449860060|FG000|Overall Study|Serious Adverse Event|6|||
125066176|NCT00949910|449860060|FG000|Overall Study|Physician/Participant Decision|7|||
125066177|NCT00949910|449860060|FG000|Overall Study|Other|4|||
125066178|NCT00949910|449860060|FG000|Overall Study|No Data|9|||
125066179|NCT03097614|449860061|FG000|Overall Study|Adverse Event|3|||
125066180|NCT02254551|449860065|FG000|Dose Escalation|Physician Decision|1|||
125066181|NCT02254551|449860065|FG000|Dose Escalation|Dose-limiting toxicity|2|||
125066182|NCT02759562|449860073|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
125066183|NCT02759562|449860074|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
125066184|NCT02759562|449860073|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
125066185|NCT02759562|449860074|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
125066186|NCT00387348|449860075|FG000|Overall Study|Death|1|||
125066187|NCT00387348|449860076|FG001|Overall Study|Death|1|||
125066188|NCT00387348|449860077|FG002|Overall Study|Death|0|||
125066189|NCT00387348|449860075|FG000|Overall Study|Physician Decision|1|||
125066190|NCT00387348|449860076|FG001|Overall Study|Physician Decision|0|||
125066191|NCT00387348|449860077|FG002|Overall Study|Physician Decision|1|||
125066192|NCT00387348|449860075|FG000|Overall Study|Withdrawal by Subject|0|||
125066193|NCT00387348|449860076|FG001|Overall Study|Withdrawal by Subject|2|||
125066194|NCT00387348|449860077|FG002|Overall Study|Withdrawal by Subject|2|||
125066195|NCT00387348|449860075|FG000|Overall Study|Adverse Event|1|||
125066196|NCT00387348|449860076|FG001|Overall Study|Adverse Event|0|||
125066197|NCT00387348|449860077|FG002|Overall Study|Adverse Event|1|||
125066198|NCT00505752|449860080|FG000|Overall Study|Adverse Event|1|||
125066199|NCT00505752|449860081|FG001|Overall Study|Adverse Event|0|||
125066200|NCT00505752|449860082|FG002|Overall Study|Adverse Event|1|||
125066201|NCT00505752|449860083|FG003|Overall Study|Adverse Event|0|||
125066202|NCT00505752|449860080|FG000|Overall Study|Lost to Follow-up|1|||
125066203|NCT00505752|449860081|FG001|Overall Study|Lost to Follow-up|0|||
125066204|NCT00505752|449860082|FG002|Overall Study|Lost to Follow-up|0|||
125066205|NCT00505752|449860083|FG003|Overall Study|Lost to Follow-up|0|||
125066206|NCT00505752|449860080|FG000|Overall Study|Lack of ovarian response|1|||
125066207|NCT00505752|449860081|FG001|Overall Study|Lack of ovarian response|3|||
125066208|NCT00505752|449860082|FG002|Overall Study|Lack of ovarian response|0|||
125066209|NCT00505752|449860083|FG003|Overall Study|Lack of ovarian response|0|||
125066210|NCT00505752|449860080|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
125066211|NCT00505752|449860081|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
125066212|NCT00505752|449860082|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
125066213|NCT00505752|449860083|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
125066214|NCT00505752|449860080|FG000|Overall Study|No oocytes retrieved|0|||
125140103|NCT00198133|450135868|FG001|Overall Study|Withdrawal by Subject|0|||
125140104|NCT00198133|450135867|FG000|Overall Study|Physician Decision|1|||
125140105|NCT00198133|450135868|FG001|Overall Study|Physician Decision|0|||
125140106|NCT03827395|450135869|FG000|Overall Study|Lost to Follow-up|1|||
125066215|NCT00505752|449860081|FG001|Overall Study|No oocytes retrieved|2|||
125066216|NCT00505752|449860082|FG002|Overall Study|No oocytes retrieved|0|||
125066217|NCT00505752|449860083|FG003|Overall Study|No oocytes retrieved|1|||
125066218|NCT00505752|449860080|FG000|Overall Study|No Fertilization|1|||
125066219|NCT00505752|449860081|FG001|Overall Study|No Fertilization|1|||
125066220|NCT00505752|449860082|FG002|Overall Study|No Fertilization|2|||
125066221|NCT00505752|449860083|FG003|Overall Study|No Fertilization|1|||
125066222|NCT00505752|449860080|FG000|Overall Study|All embryos/blastocysts discarded|0|||
125140107|NCT03827395|450135870|FG001|Overall Study|Lost to Follow-up|0|||
125140108|NCT03827395|450135869|FG000|Overall Study|Protocol Violation|1|||
125140109|NCT03827395|450135870|FG001|Overall Study|Protocol Violation|0|||
125140110|NCT03827395|450135869|FG000|Overall Study|Became ineligible after enrollment|1|||
125140111|NCT03827395|450135870|FG001|Overall Study|Became ineligible after enrollment|2|||
125140112|NCT00731939|450135871|FG000|Overall Study|Adverse Event|6|||
125140113|NCT00731939|450135871|FG000|Overall Study|Lost to Follow-up|15|||
125140114|NCT00731939|450135871|FG000|Overall Study|Not implanted with study device|9|||
125140115|NCT00731939|450135871|FG000|Overall Study|Withdrawal by Subject|2|||
125140116|NCT00731939|450135871|FG000|Overall Study|Did not meet enrollment criteria|2|||
125140117|NCT02072096|450135874|FG000|Overall Study|Lack of Efficacy|18|||
125140118|NCT02072096|450135875|FG001|Overall Study|Lack of Efficacy|29|||
125140119|NCT02072096|450135874|FG000|Overall Study|Protocol Violation|7|||
125140120|NCT02072096|450135875|FG001|Overall Study|Protocol Violation|7|||
125140121|NCT02072096|450135874|FG000|Overall Study|Withdrawal by Subject|5|||
125140122|NCT02072096|450135875|FG001|Overall Study|Withdrawal by Subject|7|||
125140123|NCT02072096|450135874|FG000|Overall Study|Adverse Event|5|||
125140124|NCT02072096|450135875|FG001|Overall Study|Adverse Event|2|||
125140125|NCT02072096|450135874|FG000|Overall Study|No Reason Provided|4|||
125140126|NCT02072096|450135875|FG001|Overall Study|No Reason Provided|2|||
125140127|NCT02072096|450135874|FG000|Overall Study|Death|2|||
125140128|NCT02072096|450135875|FG001|Overall Study|Death|0|||
125140129|NCT02072096|450135874|FG000|Overall Study|Physician Decision|0|||
125140130|NCT02072096|450135875|FG001|Overall Study|Physician Decision|1|||
125140131|NCT02072096|450135874|FG000|Overall Study|Study Terminated by Sponsor|43|||
125140132|NCT02072096|450135875|FG001|Overall Study|Study Terminated by Sponsor|30|||
125140133|NCT02072096|450135874|FG000|Overall Study|Lost to Follow-up|1|||
125140134|NCT02072096|450135875|FG001|Overall Study|Lost to Follow-up|0|||
125140135|NCT01634139|450135880|FG000|Overall Study|Non compliant with protocol|1|||
125066223|NCT00505752|449860081|FG001|Overall Study|All embryos/blastocysts discarded|0|||
125066224|NCT00505752|449860082|FG002|Overall Study|All embryos/blastocysts discarded|1|||
125066225|NCT00505752|449860083|FG003|Overall Study|All embryos/blastocysts discarded|1|||
125066226|NCT00505752|449860080|FG000|Overall Study|Other|1|||
125066227|NCT00505752|449860081|FG001|Overall Study|Other|2|||
125066228|NCT00505752|449860082|FG002|Overall Study|Other|1|||
125066229|NCT00505752|449860083|FG003|Overall Study|Other|2|||
125066230|NCT01925612|449860086|FG000|Overall Study|Progressive Disease|1|||
125066231|NCT01925612|449860087|FG001|Overall Study|Progressive Disease|1|||
125066232|NCT01925612|449860088|FG002|Overall Study|Progressive Disease|1|||
125066233|NCT01925612|449860089|FG003|Overall Study|Progressive Disease|0|||
125066234|NCT01925612|449860090|FG004|Overall Study|Progressive Disease|0|||
125066235|NCT01925612|449860086|FG000|Overall Study|Adverse Event|3|||
125066236|NCT01925612|449860087|FG001|Overall Study|Adverse Event|3|||
125066237|NCT01925612|449860088|FG002|Overall Study|Adverse Event|0|||
125066238|NCT01925612|449860089|FG003|Overall Study|Adverse Event|1|||
125066239|NCT01925612|449860090|FG004|Overall Study|Adverse Event|2|||
125066240|NCT04624672|449860096|FG000|Overall Study|Early Study Closure|2|||
125066241|NCT04624672|449860097|FG001|Overall Study|Early Study Closure|1|||
125066242|NCT03472040|449860098|FG000|Overall Study|Physician Decision|0|||
125066243|NCT03472040|449860099|FG001|Overall Study|Physician Decision|3|||
125066244|NCT03472040|449860098|FG000|Overall Study|Withdrawal by Subject|10|||
125066245|NCT03472040|449860099|FG001|Overall Study|Withdrawal by Subject|23|||
125066246|NCT03472040|449860098|FG000|Overall Study|Perceived Lack of Efficacy|29|||
125140136|NCT01634139|450135881|FG001|Overall Study|Non compliant with protocol|0|||
125140137|NCT01634139|450135882|FG002|Overall Study|Non compliant with protocol|0|||
125140138|NCT01634139|450135880|FG000|Overall Study|Consent withdrawn not due to AE|4|||
125140139|NCT01634139|450135881|FG001|Overall Study|Consent withdrawn not due to AE|3|||
125140140|NCT01634139|450135882|FG002|Overall Study|Consent withdrawn not due to AE|2|||
125140141|NCT01634139|450135880|FG000|Overall Study|Other|4|||
125140142|NCT01634139|450135881|FG001|Overall Study|Other|0|||
125140143|NCT01634139|450135882|FG002|Overall Study|Other|3|||
125140144|NCT01634139|450135880|FG000|Overall Study|Lost to Follow-up|0|||
125140145|NCT01634139|450135881|FG001|Overall Study|Lost to Follow-up|2|||
125140146|NCT01634139|450135882|FG002|Overall Study|Lost to Follow-up|0|||
125066247|NCT03472040|449860099|FG001|Overall Study|Perceived Lack of Efficacy|30|||
125066248|NCT03472040|449860098|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
125066249|NCT03472040|449860099|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
125066250|NCT03472040|449860098|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
125066251|NCT03472040|449860099|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
125140147|NCT01634139|450135880|FG000|Overall Study|Not treated|1|||
125140148|NCT01634139|450135881|FG001|Overall Study|Not treated|1|||
125140149|NCT01634139|450135882|FG002|Overall Study|Not treated|0|||
125140150|NCT01168856|450135884|FG000|Overall Study|Lost to Follow-up|4|||
125140151|NCT01168856|450135885|FG001|Overall Study|Lost to Follow-up|34|||
125140152|NCT01168856|450135884|FG000|Overall Study|Withdrawal by Subject|6|||
125140153|NCT01168856|450135885|FG001|Overall Study|Withdrawal by Subject|8|||
125140154|NCT01168856|450135884|FG000|Overall Study|Physician Decision|2|||
125066252|NCT03472040|449860098|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
125066253|NCT03472040|449860099|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
125066254|NCT03472040|449860098|FG000|Overall Study|Subject Non-compliance|2|||
125066255|NCT03472040|449860099|FG001|Overall Study|Subject Non-compliance|5|||
125066256|NCT03472040|449860098|FG000|Overall Study|Discontinuation due to Rash|0|||
125066257|NCT03472040|449860099|FG001|Overall Study|Discontinuation due to Rash|1|||
125066258|NCT03472040|449860098|FG000|Overall Study|Subsequent Ineligibility|0|||
125066259|NCT03472040|449860099|FG001|Overall Study|Subsequent Ineligibility|2|||
125066260|NCT03472040|449860098|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
125066261|NCT03472040|449860099|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
125066262|NCT02769832|449860100|FG000|Overall Study|Death|30|||
125066263|NCT01280266|449860121|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
125066264|NCT01280266|449860122|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
125066265|NCT01280266|449860121|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
125066266|NCT01280266|449860122|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
125066267|NCT00881361|449860127|FG000|Overall Study|Terminated prior to surgery|27|||
125066268|NCT00881361|449860128|FG001|Overall Study|Terminated prior to surgery|7|||
125066269|NCT00881361|449860129|FG002|Overall Study|Terminated prior to surgery|0|||
125066270|NCT00881361|449860127|FG000|Overall Study|Ineligible|17|||
125066271|NCT00881361|449860128|FG001|Overall Study|Ineligible|2|||
125066272|NCT00881361|449860129|FG002|Overall Study|Ineligible|2|||
125066273|NCT02988219|449860132|FG000|Overall Study|Lack of Efficacy|1|||
125066274|NCT02988219|449860133|FG001|Overall Study|Lack of Efficacy|1|||
125066275|NCT02988219|449860132|FG000|Overall Study|Withdrawal by Subject|0|||
125066276|NCT02988219|449860133|FG001|Overall Study|Withdrawal by Subject|2|||
125066277|NCT01522443|449860134|FG000|Overall Study|No longer receiving clinical benefit|36|||
125066278|NCT01522443|449860135|FG001|Overall Study|No longer receiving clinical benefit|28|||
125140155|NCT01168856|450135885|FG001|Overall Study|Physician Decision|1|||
125140156|NCT01168856|450135884|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
125140157|NCT01168856|450135885|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
125140158|NCT01168856|450135884|FG000|Overall Study|Participant received anti-HCV treatment|1|||
125140159|NCT01168856|450135885|FG001|Overall Study|Participant received anti-HCV treatment|0|||
125140160|NCT01168856|450135884|FG000|Overall Study|Death|0|||
125140161|NCT01168856|450135885|FG001|Overall Study|Death|2|||
125140162|NCT01168856|450135884|FG000|Overall Study|Other|1|||
125140163|NCT01168856|450135885|FG001|Overall Study|Other|291|||
125222568|NCT03428100|450442769|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
125222569|NCT03428100|450442770|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
125222570|NCT03428100|450442771|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
125222571|NCT03428100|450442772|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
125222572|NCT03428100|450442754|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
125222573|NCT03428100|450442755|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
125222574|NCT03428100|450442756|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
125222575|NCT03428100|450442757|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
125222576|NCT03428100|450442758|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
125222577|NCT03428100|450442759|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
125222578|NCT03428100|450442760|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
125222579|NCT03428100|450442761|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
125222580|NCT03428100|450442762|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
125222581|NCT03428100|450442763|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
125222582|NCT03428100|450442764|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
125222583|NCT03428100|450442765|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
125222584|NCT03428100|450442766|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
125222585|NCT03428100|450442767|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
125222586|NCT03428100|450442768|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
125222587|NCT03428100|450442769|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
125222588|NCT03428100|450442770|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
125222589|NCT03428100|450442771|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
125222590|NCT03428100|450442772|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
125222591|NCT03428100|450442754|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
125222592|NCT03428100|450442755|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
125222593|NCT03428100|450442756|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
125066279|NCT01522443|449860134|FG000|Overall Study|Adverse Event|10|||
125140164|NCT01168856|450135884|FG000|Overall Study|Protocol Violation|4|||
125140165|NCT01168856|450135885|FG001|Overall Study|Protocol Violation|6|||
125222594|NCT03428100|450442757|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
125222595|NCT03428100|450442758|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
125222596|NCT03428100|450442759|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
125222597|NCT03428100|450442760|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
125222598|NCT03428100|450442761|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
125222599|NCT03428100|450442762|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
125066280|NCT01522443|449860135|FG001|Overall Study|Adverse Event|15|||
125066281|NCT01522443|449860134|FG000|Overall Study|Withdrawal by Subject|5|||
125066282|NCT01522443|449860135|FG001|Overall Study|Withdrawal by Subject|8|||
125066283|NCT01522443|449860134|FG000|Overall Study|No study treatment given|1|||
125066284|NCT01522443|449860135|FG001|Overall Study|No study treatment given|1|||
125066285|NCT01522443|449860134|FG000|Overall Study|Other|1|||
125066286|NCT01522443|449860135|FG001|Overall Study|Other|3|||
125066287|NCT05590767|449860136|FG000|Overall Study|Protocol Violation|1|||
125066288|NCT05590767|449860136|FG000|Overall Study|surgery canceled|1|||
125066289|NCT05590767|449860136|FG000|Overall Study|interscalene brachial block not performed|1|||
125066290|NCT00776555|449860137|FG000|Overall Study|Study terminated|3|||
125066291|NCT00776555|449860138|FG001|Overall Study|Study terminated|0|||
125066292|NCT00936117|449860139|FG000|Overall Study|Adverse Event|7|||
125066293|NCT00936117|449860139|FG000|Overall Study|Unable to continue oral medication|3|||
125066294|NCT04685499|449860140|FG000|Overall Study|Study Terminated Early|1|||
125066295|NCT03176277|449860141|FG000|Part A Dose Escalation Study|Adverse Event|1|||
125066296|NCT03176277|449860142|FG001|Part A Dose Escalation Study|Adverse Event|0|||
125066297|NCT03176277|449860143|FG002|Part A Dose Escalation Study|Adverse Event|1|||
125066298|NCT03176277|449860144|FG003|Part A Dose Escalation Study|Adverse Event|0|||
125066299|NCT03176277|449860141|FG000|Part A Dose Escalation Study|Physician Decision|1|||
125066300|NCT03176277|449860142|FG001|Part A Dose Escalation Study|Physician Decision|1|||
125066301|NCT03176277|449860143|FG002|Part A Dose Escalation Study|Physician Decision|2|||
125066302|NCT03176277|449860144|FG003|Part A Dose Escalation Study|Physician Decision|0|||
125066303|NCT03176277|449860141|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
125066304|NCT03176277|449860142|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
125066305|NCT03176277|449860143|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
125066306|NCT03176277|449860144|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
125066307|NCT03176277|449860141|FG000|Part A Dose Escalation Study|Progressive disease|3|||
125066308|NCT03176277|449860142|FG001|Part A Dose Escalation Study|Progressive disease|1|||
125066309|NCT03176277|449860143|FG002|Part A Dose Escalation Study|Progressive disease|3|||
125066310|NCT03176277|449860144|FG003|Part A Dose Escalation Study|Progressive disease|0|||
125066311|NCT00634114|449860145|FG000|Overall Study|Adverse Event|6|||
125066312|NCT00634114|449860146|FG001|Overall Study|Adverse Event|8|||
125066313|NCT00634114|449860147|FG002|Overall Study|Adverse Event|3|||
125066314|NCT00634114|449860145|FG000|Overall Study|Withdrawal by Subject|9|||
125066315|NCT00634114|449860146|FG001|Overall Study|Withdrawal by Subject|6|||
125066316|NCT00634114|449860147|FG002|Overall Study|Withdrawal by Subject|11|||
125066317|NCT00634114|449860145|FG000|Overall Study|Lost to Follow-up|0|||
125066318|NCT00634114|449860146|FG001|Overall Study|Lost to Follow-up|0|||
125066319|NCT00634114|449860147|FG002|Overall Study|Lost to Follow-up|1|||
125066320|NCT00634114|449860145|FG000|Overall Study|Protocol Violation|3|||
125066321|NCT00634114|449860146|FG001|Overall Study|Protocol Violation|3|||
125066322|NCT00634114|449860147|FG002|Overall Study|Protocol Violation|1|||
125066323|NCT00634114|449860145|FG000|Overall Study|Pregnancy|1|||
125066324|NCT00634114|449860146|FG001|Overall Study|Pregnancy|0|||
125066325|NCT00634114|449860147|FG002|Overall Study|Pregnancy|0|||
125066326|NCT00634114|449860145|FG000|Overall Study|Incorrect enrolment|0|||
125066327|NCT00634114|449860146|FG001|Overall Study|Incorrect enrolment|1|||
125222600|NCT03428100|450442763|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
125222601|NCT03428100|450442764|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
125222602|NCT03428100|450442765|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
125222603|NCT03428100|450442766|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
125222604|NCT03428100|450442767|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
125222605|NCT03428100|450442768|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
125222606|NCT03428100|450442769|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
125222607|NCT03428100|450442770|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
125222608|NCT03428100|450442771|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
125222609|NCT03428100|450442772|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
125222610|NCT03428100|450442754|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125222611|NCT03428100|450442755|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125222612|NCT03428100|450442756|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125222613|NCT03428100|450442757|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125222614|NCT03428100|450442758|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125066328|NCT00634114|449860147|FG002|Overall Study|Incorrect enrolment|0|||
125222615|NCT03428100|450442759|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125066329|NCT00634114|449860145|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
125066330|NCT00634114|449860146|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
125066331|NCT00634114|449860147|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
125066332|NCT00634114|449860145|FG000|Overall Study|Difficult to continue|3|||
125066333|NCT00634114|449860146|FG001|Overall Study|Difficult to continue|1|||
125066334|NCT00634114|449860147|FG002|Overall Study|Difficult to continue|1|||
125066335|NCT00634114|449860145|FG000|Overall Study|Other reason|1|||
125066336|NCT00634114|449860146|FG001|Overall Study|Other reason|1|||
125066337|NCT00634114|449860147|FG002|Overall Study|Other reason|1|||
125066338|NCT03699631|449860148|FG000|Overall Study|Adverse Event|3|||
125066339|NCT02940626|449860149|FG000|Overall Study|Death|40|||
125066340|NCT02940626|449860150|FG001|Overall Study|Death|32|||
125066341|NCT02940626|449860149|FG000|Overall Study|Lost to Follow-up|5|||
125066342|NCT02940626|449860150|FG001|Overall Study|Lost to Follow-up|2|||
125066343|NCT02940626|449860149|FG000|Overall Study|Withdrawal by Subject|1|||
125066344|NCT02940626|449860150|FG001|Overall Study|Withdrawal by Subject|0|||
125066345|NCT02940626|449860149|FG000|Overall Study|Transfer to Hospice Care|1|||
125066346|NCT02940626|449860150|FG001|Overall Study|Transfer to Hospice Care|0|||
125066347|NCT02940626|449860149|FG000|Overall Study|Prohibited Concomitant Medication|0|||
125066348|NCT02940626|449860150|FG001|Overall Study|Prohibited Concomitant Medication|1|||
125066349|NCT01996904|449860151|FG000|Overall Study|Lost to Follow-up|38|||
125066350|NCT01996904|449860152|FG001|Overall Study|Lost to Follow-up|27|||
125066351|NCT00585923|449860153|FG000|Overall Study|Physician decided not to continue|31|||
125066352|NCT00585923|449860154|FG001|Overall Study|Physician decided not to continue|33|||
125066353|NCT01324622|449860155|FG000|Overall Study|Lost to Follow-up|7|||
125066354|NCT01324622|449860156|FG001|Overall Study|Lost to Follow-up|7|||
125066355|NCT01324622|449860155|FG000|Overall Study|Death|1|||
125066356|NCT01324622|449860156|FG001|Overall Study|Death|0|||
125066357|NCT01324622|449860155|FG000|Overall Study|Lack of Efficacy|1|||
125066358|NCT01324622|449860156|FG001|Overall Study|Lack of Efficacy|0|||
125066359|NCT00618449|449860157|FG000|Overall Study|Lost to Follow-up|98|||
125066360|NCT00618449|449860158|FG001|Overall Study|Lost to Follow-up|110|||
125066361|NCT05127421|449860159|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
125066362|NCT05127421|449860160|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
125066363|NCT05127421|449860161|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
125066364|NCT05127421|449860162|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
125066365|NCT05127421|449860159|FG000|4-Week Double-Blind Period|Physician Decision|1|||
125066366|NCT05127421|449860160|FG001|4-Week Double-Blind Period|Physician Decision|0|||
125066367|NCT05127421|449860161|FG002|4-Week Double-Blind Period|Physician Decision|0|||
125066368|NCT05127421|449860162|FG003|4-Week Double-Blind Period|Physician Decision|0|||
125066369|NCT05127421|449860159|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
125066370|NCT05127421|449860160|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
125066371|NCT05127421|449860161|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
125066372|NCT05127421|449860162|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
125066373|NCT05127421|449860159|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
125066374|NCT05127421|449860160|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
125066375|NCT05127421|449860161|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
125066376|NCT05127421|449860162|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
125066377|NCT05127421|449860159|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
125066378|NCT05127421|449860160|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
125066379|NCT05127421|449860161|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
125066380|NCT05127421|449860162|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
125066381|NCT05127421|449860159|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
125066382|NCT05127421|449860160|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
125066383|NCT05127421|449860161|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
125066384|NCT05127421|449860162|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
125066385|NCT05127421|449860159|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
125066386|NCT05127421|449860160|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
125066387|NCT05127421|449860161|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
125066388|NCT05127421|449860162|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
125066389|NCT05127421|449860159|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
125066390|NCT05127421|449860160|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
125066391|NCT05127421|449860161|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
125140166|NCT01266902|450135886|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
125140167|NCT01266902|450135887|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
125140168|NCT01266902|450135888|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
125140169|NCT01266902|450135886|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
125140170|NCT01266902|450135887|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
125140171|NCT01266902|450135888|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
125140172|NCT01266902|450135886|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
125140173|NCT01266902|450135887|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
125140174|NCT01266902|450135888|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
125140175|NCT01266902|450135886|FG000|Period 1 (Main Study)|Adverse Event|3|||
125140176|NCT01266902|450135887|FG001|Period 1 (Main Study)|Adverse Event|11|||
125140177|NCT01266902|450135888|FG002|Period 1 (Main Study)|Adverse Event|0|||
125140178|NCT01266902|450135886|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
125140179|NCT01266902|450135887|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
125140180|NCT01266902|450135888|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
125140181|NCT01266902|450135886|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
125140182|NCT01266902|450135887|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
125140183|NCT01266902|450135888|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
125140184|NCT01266902|450135886|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
125140185|NCT01266902|450135887|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
125140186|NCT01266902|450135888|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
125140187|NCT01266902|450135886|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
125140188|NCT01266902|450135887|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
125140189|NCT01266902|450135888|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
125140190|NCT01266902|450135886|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
125140191|NCT01266902|450135887|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
125140192|NCT01266902|450135888|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
125140193|NCT01266902|450135886|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
125140194|NCT01266902|450135887|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
125140195|NCT01266902|450135888|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
125140196|NCT00387153|450135893|FG000|Overall Study|Adverse Event|1|||
125066392|NCT05127421|449860162|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
125066393|NCT01441115|449860163|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
125066394|NCT00138424|449860164|FG000|Overall Study|Physician Decision|0|||
125066395|NCT00138424|449860165|FG001|Overall Study|Physician Decision|1|||
125066396|NCT00138424|449860166|FG002|Overall Study|Physician Decision|0|||
125066397|NCT00138424|449860167|FG003|Overall Study|Physician Decision|0|||
125066398|NCT00574496|449860170|FG000|Overall Study|Withdrawal by Subject|1|||
125066399|NCT02176291|449860171|FG000|Overall Study|Death|1|||
125066400|NCT02176291|449860172|FG001|Overall Study|Death|0|||
125066401|NCT02176291|449860171|FG000|Overall Study|non compliance with protocol|2|||
125066402|NCT02176291|449860172|FG001|Overall Study|non compliance with protocol|0|||
125066403|NCT02176291|449860171|FG000|Overall Study|Withdrawal by Subject|2|||
125066404|NCT02176291|449860172|FG001|Overall Study|Withdrawal by Subject|0|||
125066405|NCT01167582|449860173|FG000|Overall Study|Lost to Follow-up|0|||
125066406|NCT01167582|449860174|FG001|Overall Study|Lost to Follow-up|1|||
125066407|NCT01518244|449860175|FG000|Overall Study|Adverse Event|3|||
125066408|NCT01766817|449860176|FG000|Overall Study|Drug-related adverse event|1|||
125066409|NCT01766817|449860177|FG001|Overall Study|Drug-related adverse event|2|||
125066410|NCT01766817|449860178|FG002|Overall Study|Drug-related adverse event|1|||
125066411|NCT01766817|449860176|FG000|Overall Study|Drug-unrelated adverse event|3|||
125066412|NCT01766817|449860177|FG001|Overall Study|Drug-unrelated adverse event|3|||
125066413|NCT01766817|449860178|FG002|Overall Study|Drug-unrelated adverse event|3|||
125066414|NCT01766817|449860176|FG000|Overall Study|Death|1|||
125066415|NCT01766817|449860177|FG001|Overall Study|Death|1|||
125066416|NCT01766817|449860178|FG002|Overall Study|Death|0|||
125066417|NCT01766817|449860176|FG000|Overall Study|Unable to take study drug|0|||
125066418|NCT01766817|449860177|FG001|Overall Study|Unable to take study drug|1|||
125140197|NCT00387153|450135893|FG000|Overall Study|Disease Progression|3|||
125140198|NCT00387153|450135893|FG000|Overall Study|Lack of Response|4|||
125140199|NCT04567329|450135894|FG000|Overall Study|Withdrawal by Subject|5|||
125066419|NCT01766817|449860178|FG002|Overall Study|Unable to take study drug|0|||
125140200|NCT04567329|450135895|FG001|Overall Study|Withdrawal by Subject|6|||
125222616|NCT03428100|450442760|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125066420|NCT01766817|449860176|FG000|Overall Study|Withdrawal by Subject|2|||
125066421|NCT01766817|449860177|FG001|Overall Study|Withdrawal by Subject|0|||
125066422|NCT01766817|449860178|FG002|Overall Study|Withdrawal by Subject|3|||
125066423|NCT01766817|449860176|FG000|Overall Study|Subject non-compliance|0|||
125066424|NCT01766817|449860177|FG001|Overall Study|Subject non-compliance|1|||
125066425|NCT01766817|449860178|FG002|Overall Study|Subject non-compliance|2|||
125066426|NCT01766817|449860176|FG000|Overall Study|Physician Decision|3|||
125066427|NCT01766817|449860177|FG001|Overall Study|Physician Decision|3|||
125066428|NCT01766817|449860178|FG002|Overall Study|Physician Decision|4|||
125066429|NCT01766817|449860176|FG000|Overall Study|Other|1|||
125066430|NCT01766817|449860177|FG001|Overall Study|Other|0|||
125066431|NCT01766817|449860178|FG002|Overall Study|Other|0|||
125066432|NCT02260648|449860183|FG000|Overall Study|Adverse Event|3|||
125140201|NCT04567329|450135894|FG000|Overall Study|Protocol Violation|2|||
125140202|NCT04567329|450135895|FG001|Overall Study|Protocol Violation|3|||
125140203|NCT04567329|450135894|FG000|Overall Study|Discontinued|2|||
125140204|NCT04567329|450135895|FG001|Overall Study|Discontinued|2|||
125140205|NCT04567329|450135894|FG000|Overall Study|Lost to Follow-up|0|||
125140206|NCT04567329|450135895|FG001|Overall Study|Lost to Follow-up|1|||
125140207|NCT04567329|450135894|FG000|Overall Study|Lack of Efficacy|0|||
125140208|NCT04567329|450135895|FG001|Overall Study|Lack of Efficacy|1|||
125140209|NCT01087502|450135896|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
125140210|NCT01087502|450135897|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
125140211|NCT01087502|450135896|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
125140212|NCT01087502|450135897|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
125140213|NCT01087502|450135896|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
125140214|NCT01087502|450135897|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
125140215|NCT01087502|450135896|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
125140216|NCT01087502|450135897|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
125140217|NCT01087502|450135896|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
125140218|NCT01087502|450135897|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
125140219|NCT01087502|450135896|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
125140220|NCT01087502|450135897|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
125140221|NCT01087502|450135896|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
125140222|NCT01087502|450135897|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
125140223|NCT01087502|450135896|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
125140224|NCT01087502|450135897|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
125140225|NCT01087502|450135896|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
125140226|NCT01087502|450135897|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
125140227|NCT01087502|450135896|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
125140228|NCT01087502|450135897|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
125140229|NCT01087502|450135896|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
125140230|NCT01087502|450135897|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
125140231|NCT01087502|450135896|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
125140232|NCT01087502|450135897|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
125140233|NCT00985751|450135899|FG000|Overall Study|Adverse Event|0|||
125140234|NCT00985751|450135900|FG001|Overall Study|Adverse Event|0|||
125140235|NCT00985751|450135901|FG002|Overall Study|Adverse Event|0|||
125140236|NCT00985751|450135902|FG003|Overall Study|Adverse Event|0|||
125140237|NCT00985751|450135903|FG004|Overall Study|Adverse Event|1|||
125140238|NCT00380588|450135904|FG000|Overall Study|Unequivocal Disease Progression|25|||
125140239|NCT00380588|450135905|FG001|Overall Study|Unequivocal Disease Progression|34|||
125140240|NCT00380588|450135904|FG000|Overall Study|Next Cycle Not Started|4|||
125140241|NCT00380588|450135905|FG001|Overall Study|Next Cycle Not Started|0|||
125140242|NCT00380588|450135904|FG000|Overall Study|Adverse Event|7|||
125140243|NCT00380588|450135905|FG001|Overall Study|Adverse Event|3|||
125140244|NCT00380588|450135904|FG000|Overall Study|Withdrawal by Subject|1|||
125140245|NCT00380588|450135905|FG001|Overall Study|Withdrawal by Subject|3|||
125140246|NCT00380588|450135904|FG000|Overall Study|Physician Decision|2|||
125140247|NCT00380588|450135905|FG001|Overall Study|Physician Decision|0|||
125140248|NCT01451541|450135907|FG000|Overall Study|Adverse Event|4|||
125140249|NCT01451541|450135908|FG001|Overall Study|Adverse Event|3|||
125140250|NCT01451541|450135909|FG002|Overall Study|Adverse Event|6|||
125140251|NCT01451541|450135907|FG000|Overall Study|Lack of Efficacy|2|||
125140252|NCT01451541|450135908|FG001|Overall Study|Lack of Efficacy|0|||
125140253|NCT01451541|450135909|FG002|Overall Study|Lack of Efficacy|0|||
125222617|NCT03428100|450442761|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
125222618|NCT03428100|450442762|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125222619|NCT03428100|450442763|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125222620|NCT03428100|450442764|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125222621|NCT03428100|450442765|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
125066433|NCT02260648|449860184|FG001|Overall Study|Adverse Event|0|||
125066434|NCT02260648|449860185|FG002|Overall Study|Adverse Event|1|||
125066435|NCT02260648|449860183|FG000|Overall Study|Withdrawal by Subject|1|||
125066436|NCT02260648|449860184|FG001|Overall Study|Withdrawal by Subject|1|||
125066437|NCT02260648|449860185|FG002|Overall Study|Withdrawal by Subject|0|||
125066438|NCT02260648|449860183|FG000|Overall Study|Protocol Violation|1|||
125066439|NCT02260648|449860184|FG001|Overall Study|Protocol Violation|0|||
125066440|NCT02260648|449860185|FG002|Overall Study|Protocol Violation|0|||
125066441|NCT02260648|449860183|FG000|Overall Study|Discontinue Due to Study Termination|13|||
125066442|NCT02260648|449860184|FG001|Overall Study|Discontinue Due to Study Termination|12|||
125066443|NCT02260648|449860185|FG002|Overall Study|Discontinue Due to Study Termination|7|||
125066444|NCT01401465|449860186|FG000|Treatment Period 1|Adverse Event|4|||
125066445|NCT01401465|449860187|FG001|Treatment Period 1|Adverse Event|1|||
125066446|NCT01401465|449860186|FG000|Treatment Period 1|Pregnancy|0|||
125066447|NCT01401465|449860187|FG001|Treatment Period 1|Pregnancy|1|||
125066448|NCT01401465|449860186|FG000|Treatment Period 1|Protocol Violation|5|||
125066449|NCT01401465|449860187|FG001|Treatment Period 1|Protocol Violation|0|||
125066450|NCT01401465|449860186|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125066451|NCT01401465|449860187|FG001|Treatment Period 1|Withdrawal by Subject|4|||
125066452|NCT01401465|449860186|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
125066453|NCT01401465|449860187|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
125066454|NCT01401465|449860186|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
125066455|NCT01401465|449860187|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
125066456|NCT01401465|449860186|FG000|Treatment Period 1|Scheduling Difficulties|1|||
125066457|NCT01401465|449860187|FG001|Treatment Period 1|Scheduling Difficulties|1|||
125066458|NCT01401465|449860186|FG000|Treatment Period 2|Lost to Follow-up|0|||
125066459|NCT01401465|449860187|FG001|Treatment Period 2|Lost to Follow-up|1|||
125066460|NCT01401465|449860186|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125066461|NCT01401465|449860187|FG001|Treatment Period 2|Withdrawal by Subject|1|||
125066462|NCT04142216|449860188|FG000|Overall Study|Hospitalization|0|||
125066463|NCT04142216|449860189|FG001|Overall Study|Hospitalization|2|||
125066464|NCT04142216|449860188|FG000|Overall Study|Death|3|||
125066465|NCT04142216|449860189|FG001|Overall Study|Death|1|||
125066466|NCT04142216|449860188|FG000|Overall Study|Referral to another hemodialysis unit|3|||
125066467|NCT04142216|449860189|FG001|Overall Study|Referral to another hemodialysis unit|2|||
125066468|NCT04142216|449860188|FG000|Overall Study|Use of clove|0|||
125066469|NCT04142216|449860189|FG001|Overall Study|Use of clove|1|||
125066470|NCT01054976|449860192|FG000|Overall Study|Adverse Event|16|||
125066471|NCT01054976|449860192|FG000|Overall Study|Uncooperative participations to study|7|||
125066472|NCT01054976|449860192|FG000|Overall Study|Withdrawal by Subject|4|||
125066473|NCT01054976|449860192|FG000|Overall Study|Other|8|||
125066474|NCT01195363|449860193|FG000|Overall Study|Lost to Follow-up|7|||
125066475|NCT01195363|449860194|FG001|Overall Study|Lost to Follow-up|4|||
125066476|NCT01195363|449860193|FG000|Overall Study|Adverse Event|3|||
125066477|NCT01195363|449860194|FG001|Overall Study|Adverse Event|1|||
125066478|NCT01195363|449860193|FG000|Overall Study|Lack of Efficacy|0|||
125066479|NCT01195363|449860194|FG001|Overall Study|Lack of Efficacy|4|||
125066480|NCT01195363|449860193|FG000|Overall Study|incarceration|1|||
125066481|NCT01195363|449860194|FG001|Overall Study|incarceration|0|||
125066482|NCT00077376|449860197|FG000|Overall Study|Adverse Event|8|||
125066483|NCT00077376|449860197|FG000|Overall Study|Withdrawal by Subject|2|||
125066484|NCT00077376|449860197|FG000|Overall Study|Death|1|||
125066485|NCT00077376|449860197|FG000|Overall Study|Physician Decision|1|||
125066486|NCT00077376|449860197|FG000|Overall Study|Alternative therapy|5|||
125066487|NCT00077376|449860197|FG000|Overall Study|Complicating disease|1|||
125066488|NCT00077376|449860197|FG000|Overall Study|Still on treatment|1|||
125066489|NCT00077376|449860197|FG000|Overall Study|Symptomatic deterioration|1|||
125066490|NCT00077376|449860197|FG000|Overall Study|Surgery|1|||
125066491|NCT00077376|449860197|FG000|Overall Study|Insurance ran out|1|||
125066492|NCT05691829|449862348|FG000|Overall Study|Physician Decision|2|||
125066493|NCT05691829|449862348|FG000|Overall Study|Eligibility criteria not met|3|||
125066494|NCT00453180|449862353|FG000|Overall Study|Lost to Follow-up|2|||
125066495|NCT00453180|449862354|FG001|Overall Study|Lost to Follow-up|1|||
125066496|NCT00453180|449862353|FG000|Overall Study|Adverse Event|1|||
125066497|NCT00453180|449862354|FG001|Overall Study|Adverse Event|2|||
125066498|NCT01002742|449862361|FG000|Overall Study|Determined to be ineligible|0|||
125066499|NCT01002742|449862362|FG001|Overall Study|Determined to be ineligible|1|||
125066500|NCT02862548|449862374|FG000|Randomized Phase (Up to Week 48)|Death|0|||
125066501|NCT02862548|449862375|FG001|Randomized Phase (Up to Week 48)|Death|1|||
125066502|NCT02862548|449862374|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
125066503|NCT02862548|449862375|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
125066504|NCT02862548|449862374|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
125066505|NCT02862548|449862375|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
125066506|NCT02862548|449862374|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
125066507|NCT02862548|449862375|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
125066508|NCT00880763|449862376|FG000|Extension Period (Part 2)|Adverse Event|0|||
125066509|NCT00880763|449862377|FG001|Extension Period (Part 2)|Adverse Event|0|||
125066510|NCT00880763|449862378|FG002|Extension Period (Part 2)|Adverse Event|1|||
125066511|NCT00880763|449862379|FG003|Extension Period (Part 2)|Adverse Event|1|||
125066512|NCT00880763|449862376|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
125066513|NCT00880763|449862377|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
125066514|NCT00880763|449862378|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
125066515|NCT00880763|449862379|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
125066516|NCT00880763|449862376|FG000|Extension Period (Part 2)|Physician Decision|0|||
125066517|NCT00880763|449862377|FG001|Extension Period (Part 2)|Physician Decision|1|||
125066518|NCT00880763|449862378|FG002|Extension Period (Part 2)|Physician Decision|1|||
125066519|NCT00880763|449862379|FG003|Extension Period (Part 2)|Physician Decision|0|||
125066520|NCT00880763|449862376|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
125066521|NCT00880763|449862377|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
125066522|NCT00880763|449862378|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
125066523|NCT00880763|449862379|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
125066524|NCT02670928|449862380|FG000|Overall Study|Adverse Event|3|||
125066525|NCT02670928|449862381|FG001|Overall Study|Adverse Event|1|||
125066526|NCT02670928|449862380|FG000|Overall Study|Withdrawal by Subject|4|||
125066527|NCT02670928|449862381|FG001|Overall Study|Withdrawal by Subject|0|||
125066528|NCT02670928|449862380|FG000|Overall Study|Lost to Follow-up|1|||
125066529|NCT02670928|449862381|FG001|Overall Study|Lost to Follow-up|0|||
125066530|NCT02670928|449862380|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
125066531|NCT02670928|449862381|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
125066532|NCT01494987|449862382|FG000|Overall Study|Adverse Event|6|||
125066533|NCT01494987|449862383|FG001|Overall Study|Adverse Event|5|||
125066534|NCT01494987|449862382|FG000|Overall Study|Hyperglycemia|6|||
125066535|NCT01494987|449862383|FG001|Overall Study|Hyperglycemia|4|||
125066536|NCT01494987|449862382|FG000|Overall Study|Investigator's Discretion|1|||
125066537|NCT01494987|449862383|FG001|Overall Study|Investigator's Discretion|2|||
125066538|NCT01494987|449862382|FG000|Overall Study|Lost to Follow-up|1|||
125066539|NCT01494987|449862383|FG001|Overall Study|Lost to Follow-up|1|||
125066540|NCT01494987|449862382|FG000|Overall Study|Protocol Violation|3|||
125066541|NCT01494987|449862383|FG001|Overall Study|Protocol Violation|3|||
125066542|NCT01494987|449862382|FG000|Overall Study|Subject Non-Compliance|9|||
125066543|NCT01494987|449862383|FG001|Overall Study|Subject Non-Compliance|10|||
125066544|NCT01494987|449862382|FG000|Overall Study|Subject Withdrew Consent|2|||
125066545|NCT01494987|449862383|FG001|Overall Study|Subject Withdrew Consent|3|||
125066546|NCT00436982|449862384|FG000|Overall Study|Withdrawal by Subject|3|||
125066547|NCT00436982|449862385|FG001|Overall Study|Withdrawal by Subject|1|||
125066548|NCT00436982|449862384|FG000|Overall Study|Did not receive allocated intervention|0|||
125066549|NCT00436982|449862385|FG001|Overall Study|Did not receive allocated intervention|1|||
125066550|NCT00436982|449862384|FG000|Overall Study|no RSA data|1|||
125066551|NCT00436982|449862385|FG001|Overall Study|no RSA data|2|||
125066552|NCT02215616|449862389|FG000|Overall Study|Sponsor requested to stop study drug|0|||
125066553|NCT02215616|449862390|FG001|Overall Study|Sponsor requested to stop study drug|0|||
125066554|NCT02215616|449862391|FG002|Overall Study|Sponsor requested to stop study drug|1|||
125066555|NCT02215616|449862392|FG003|Overall Study|Sponsor requested to stop study drug|4|||
125066556|NCT02215616|449862389|FG000|Overall Study|Death|1|||
125066557|NCT02215616|449862390|FG001|Overall Study|Death|0|||
125066558|NCT02215616|449862391|FG002|Overall Study|Death|0|||
125066559|NCT02215616|449862392|FG003|Overall Study|Death|0|||
125066560|NCT02215616|449862389|FG000|Overall Study|Adverse Event|7|||
125066561|NCT02215616|449862390|FG001|Overall Study|Adverse Event|4|||
125066562|NCT02215616|449862391|FG002|Overall Study|Adverse Event|9|||
125066563|NCT02215616|449862392|FG003|Overall Study|Adverse Event|2|||
125066564|NCT02215616|449862389|FG000|Overall Study|Withdrawal by Subject|1|||
125066565|NCT02215616|449862390|FG001|Overall Study|Withdrawal by Subject|8|||
125066566|NCT02215616|449862391|FG002|Overall Study|Withdrawal by Subject|2|||
125066567|NCT02215616|449862392|FG003|Overall Study|Withdrawal by Subject|5|||
125222622|NCT03428100|450442766|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
125222623|NCT03428100|450442767|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125066568|NCT02215616|449862389|FG000|Overall Study|Non-compliance|0|||
125066569|NCT02215616|449862390|FG001|Overall Study|Non-compliance|2|||
125066570|NCT02215616|449862391|FG002|Overall Study|Non-compliance|1|||
125066571|NCT02215616|449862392|FG003|Overall Study|Non-compliance|0|||
125066572|NCT02215616|449862389|FG000|Overall Study|Protocol Violation|0|||
125066573|NCT02215616|449862390|FG001|Overall Study|Protocol Violation|2|||
125066574|NCT02215616|449862391|FG002|Overall Study|Protocol Violation|0|||
125066575|NCT02215616|449862392|FG003|Overall Study|Protocol Violation|0|||
125066576|NCT02215616|449862389|FG000|Overall Study|Lost to Follow-up|1|||
125066577|NCT02215616|449862390|FG001|Overall Study|Lost to Follow-up|1|||
125066578|NCT02215616|449862391|FG002|Overall Study|Lost to Follow-up|0|||
125066579|NCT02215616|449862392|FG003|Overall Study|Lost to Follow-up|1|||
125066580|NCT02215616|449862389|FG000|Overall Study|Other than specified|1|||
125066581|NCT02215616|449862390|FG001|Overall Study|Other than specified|0|||
125066582|NCT02215616|449862391|FG002|Overall Study|Other than specified|1|||
125066583|NCT02215616|449862392|FG003|Overall Study|Other than specified|1|||
125140254|NCT01451541|450135907|FG000|Overall Study|Lost to Follow-up|4|||
125140255|NCT01451541|450135908|FG001|Overall Study|Lost to Follow-up|4|||
125140256|NCT01451541|450135909|FG002|Overall Study|Lost to Follow-up|7|||
125140257|NCT01451541|450135907|FG000|Overall Study|Withdrawal by Subject|15|||
125140258|NCT01451541|450135908|FG001|Overall Study|Withdrawal by Subject|8|||
125140259|NCT01451541|450135909|FG002|Overall Study|Withdrawal by Subject|6|||
125140260|NCT01451541|450135907|FG000|Overall Study|randomization error, noncompliance|11|||
125140261|NCT01451541|450135908|FG001|Overall Study|randomization error, noncompliance|10|||
125140262|NCT01451541|450135909|FG002|Overall Study|randomization error, noncompliance|8|||
125140263|NCT03366428|450135911|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
125140264|NCT03366428|450135911|FG000|Overall Study|Adverse Event|12|||
125140265|NCT03366428|450135911|FG000|Overall Study|Clinical progression|2|||
125140266|NCT03366428|450135911|FG000|Overall Study|Withdrawal by Subject|4|||
125140267|NCT00999687|450135918|FG000|First Intervention|Withdrawal by Subject|1|||
125140268|NCT00999687|450135918|FG000|Second Intervention|Withdrawal by Subject|2|||
125140269|NCT00999687|450135918|FG000|Second Intervention|Lack of Efficacy|1|||
125140270|NCT01120028|450135920|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
125140271|NCT01120028|450135921|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
125140272|NCT01120028|450135922|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
125140273|NCT01120028|450135923|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
125140274|NCT01120028|450135920|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
125140275|NCT01120028|450135921|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
125140276|NCT01120028|450135922|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
125140277|NCT01120028|450135923|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
125140278|NCT01253564|450135925|FG000|Overall Study|Disease Progression|22|||
125140279|NCT01253564|450135925|FG000|Overall Study|Withdrawal by Subject|1|||
125140280|NCT01253564|450135925|FG000|Overall Study|Serious Adverse Event|1|||
125140281|NCT02034513|450137568|FG000|Overall Study|Adverse Event|11|||
125140282|NCT02034513|450137569|FG001|Overall Study|Adverse Event|10|||
125140283|NCT02034513|450137568|FG000|Overall Study|Lack of Efficacy|0|||
125140284|NCT02034513|450137569|FG001|Overall Study|Lack of Efficacy|1|||
125140285|NCT02034513|450137568|FG000|Overall Study|Lost to Follow-up|6|||
125140286|NCT02034513|450137569|FG001|Overall Study|Lost to Follow-up|7|||
125140287|NCT02034513|450137568|FG000|Overall Study|Pregnancy|0|||
125140288|NCT02034513|450137569|FG001|Overall Study|Pregnancy|3|||
125140289|NCT02034513|450137568|FG000|Overall Study|Protocol Violation|7|||
125066584|NCT01352845|449862395|FG000|Overall Study|Lost to Follow-up|313|||
125066585|NCT01352845|449862396|FG001|Overall Study|Lost to Follow-up|92|||
125066586|NCT01352845|449862395|FG000|Overall Study|No Longer Willing to Participate|205|||
125066587|NCT01352845|449862396|FG001|Overall Study|No Longer Willing to Participate|58|||
125066588|NCT01352845|449862395|FG000|Overall Study|Withdrawal by Subject|48|||
125066589|NCT01352845|449862396|FG001|Overall Study|Withdrawal by Subject|16|||
125066590|NCT01352845|449862395|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
125066591|NCT01352845|449862396|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
125066592|NCT01352845|449862395|FG000|Overall Study|Pregnancy|27|||
125066593|NCT01352845|449862396|FG001|Overall Study|Pregnancy|7|||
125066594|NCT01352845|449862395|FG000|Overall Study|Adverse Event|22|||
125066595|NCT01352845|449862396|FG001|Overall Study|Adverse Event|6|||
125066596|NCT01352845|449862395|FG000|Overall Study|Other|17|||
125066597|NCT01352845|449862396|FG001|Overall Study|Other|7|||
125066598|NCT01352845|449862395|FG000|Overall Study|Protocol Violation|12|||
125140290|NCT02034513|450137569|FG001|Overall Study|Protocol Violation|10|||
125140291|NCT02034513|450137568|FG000|Overall Study|Withdrawal by Subject|25|||
125140292|NCT02034513|450137569|FG001|Overall Study|Withdrawal by Subject|25|||
125140293|NCT02034513|450137568|FG000|Overall Study|Unclassified|0|||
125140294|NCT02034513|450137569|FG001|Overall Study|Unclassified|1|||
125140295|NCT02308241|450137570|FG000|Overall Study|Withdrawal by Subject|3|||
125140296|NCT04408924|450137571|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
125140297|NCT04408924|450137571|FG000|Overall Study|Lost to Follow-up|3|||
125140298|NCT04408924|450137571|FG000|Overall Study|Withdrawal by Subject|5|||
125066599|NCT01352845|449862396|FG001|Overall Study|Protocol Violation|6|||
125066600|NCT01352845|449862395|FG000|Overall Study|Death|3|||
125066601|NCT01352845|449862396|FG001|Overall Study|Death|0|||
125066602|NCT00433446|449862402|FG000|Overall Study|Adverse Event|4|||
125066603|NCT00433446|449862402|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
125066604|NCT00433446|449862402|FG000|Overall Study|Progression|44|||
125066605|NCT00433446|449862402|FG000|Overall Study|Other - Not Protocol specified|3|||
125066606|NCT00433446|449862402|FG000|Overall Study|Ineligible|9|||
125066607|NCT01188538|449862403|FG000|Overall Study|Lost to Follow-up|0|||
125066608|NCT01188538|449862404|FG001|Overall Study|Lost to Follow-up|1|||
125066609|NCT01231607|449862408|FG000|Overall Study|Adverse Event|0|||
125066610|NCT01231607|449862409|FG001|Overall Study|Adverse Event|8|||
125066611|NCT01231607|449862410|FG002|Overall Study|Adverse Event|4|||
125066612|NCT01231607|449862411|FG003|Overall Study|Adverse Event|4|||
125066613|NCT01231607|449862412|FG004|Overall Study|Adverse Event|5|||
125066614|NCT01231607|449862408|FG000|Overall Study|Lost to Follow-up|13|||
125066615|NCT01231607|449862409|FG001|Overall Study|Lost to Follow-up|11|||
125066616|NCT01231607|449862410|FG002|Overall Study|Lost to Follow-up|10|||
125066617|NCT01231607|449862411|FG003|Overall Study|Lost to Follow-up|10|||
125066618|NCT01231607|449862412|FG004|Overall Study|Lost to Follow-up|4|||
125066619|NCT01231607|449862408|FG000|Overall Study|Physician Decision|4|||
125066620|NCT01231607|449862409|FG001|Overall Study|Physician Decision|4|||
125066621|NCT01231607|449862410|FG002|Overall Study|Physician Decision|3|||
125066622|NCT01231607|449862411|FG003|Overall Study|Physician Decision|5|||
125066623|NCT01231607|449862412|FG004|Overall Study|Physician Decision|4|||
125066624|NCT01231607|449862408|FG000|Overall Study|Protocol Violation|3|||
125066625|NCT01231607|449862409|FG001|Overall Study|Protocol Violation|2|||
125066626|NCT01231607|449862410|FG002|Overall Study|Protocol Violation|0|||
125066627|NCT01231607|449862411|FG003|Overall Study|Protocol Violation|2|||
125066628|NCT01231607|449862412|FG004|Overall Study|Protocol Violation|2|||
125066629|NCT01231607|449862408|FG000|Overall Study|Withdrawal by Subject|9|||
125066630|NCT01231607|449862409|FG001|Overall Study|Withdrawal by Subject|9|||
125066631|NCT01231607|449862410|FG002|Overall Study|Withdrawal by Subject|14|||
125066632|NCT01231607|449862411|FG003|Overall Study|Withdrawal by Subject|17|||
125066633|NCT01231607|449862412|FG004|Overall Study|Withdrawal by Subject|9|||
125066634|NCT02501902|449862413|FG000|Overall Study|Subject Refused Further Follow-up|0|||
125066635|NCT02501902|449862414|FG001|Overall Study|Subject Refused Further Follow-up|0|||
125066636|NCT02501902|449862415|FG002|Overall Study|Subject Refused Further Follow-up|0|||
125066637|NCT02501902|449862416|FG003|Overall Study|Subject Refused Further Follow-up|0|||
125066638|NCT02501902|449862417|FG004|Overall Study|Subject Refused Further Follow-up|0|||
125066639|NCT02501902|449862418|FG005|Overall Study|Subject Refused Further Follow-up|0|||
125066640|NCT02501902|449862419|FG006|Overall Study|Subject Refused Further Follow-up|0|||
125066641|NCT02501902|449862420|FG007|Overall Study|Subject Refused Further Follow-up|1|||
125066642|NCT02501902|449862413|FG000|Overall Study|Study Terminated by Sponsor|0|||
125066643|NCT02501902|449862414|FG001|Overall Study|Study Terminated by Sponsor|3|||
125066644|NCT02501902|449862415|FG002|Overall Study|Study Terminated by Sponsor|0|||
125066645|NCT02501902|449862416|FG003|Overall Study|Study Terminated by Sponsor|1|||
125066646|NCT02501902|449862417|FG004|Overall Study|Study Terminated by Sponsor|1|||
125066647|NCT02501902|449862418|FG005|Overall Study|Study Terminated by Sponsor|0|||
125066648|NCT02501902|449862419|FG006|Overall Study|Study Terminated by Sponsor|2|||
125066649|NCT02501902|449862420|FG007|Overall Study|Study Terminated by Sponsor|4|||
125066650|NCT02501902|449862413|FG000|Overall Study|Death|3|||
125066651|NCT02501902|449862414|FG001|Overall Study|Death|4|||
125066652|NCT02501902|449862415|FG002|Overall Study|Death|4|||
125066653|NCT02501902|449862416|FG003|Overall Study|Death|10|||
125066654|NCT02501902|449862417|FG004|Overall Study|Death|10|||
125066655|NCT02501902|449862418|FG005|Overall Study|Death|11|||
125066656|NCT02501902|449862419|FG006|Overall Study|Death|7|||
125066657|NCT02501902|449862420|FG007|Overall Study|Death|15|||
125066658|NCT02513771|449862421|FG000|Overall Study|Lost to Follow-up|1|||
125066659|NCT02513771|449862422|FG001|Overall Study|Lost to Follow-up|1|||
125066660|NCT02513771|449862421|FG000|Overall Study|Not being able to get to clinic|1|||
125066661|NCT02513771|449862422|FG001|Overall Study|Not being able to get to clinic|0|||
125066662|NCT01797445|449862423|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
125066663|NCT01797445|449862424|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
125066664|NCT01797445|449862423|FG000|Double-Blind Phase|Adverse Event|3|||
125066665|NCT01797445|449862424|FG001|Double-Blind Phase|Adverse Event|0|||
125066666|NCT01797445|449862423|FG000|Double-Blind Phase|Death|5|||
125066667|NCT01797445|449862424|FG001|Double-Blind Phase|Death|4|||
125066668|NCT01797445|449862423|FG000|Double-Blind Phase|Pregnancy|0|||
125066669|NCT01797445|449862424|FG001|Double-Blind Phase|Pregnancy|1|||
125066670|NCT01797445|449862423|FG000|Double-Blind Phase|Lack of Efficacy|1|||
125066671|NCT01797445|449862424|FG001|Double-Blind Phase|Lack of Efficacy|2|||
125222624|NCT03428100|450442768|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
125066672|NCT01797445|449862423|FG000|Double-Blind Phase|Investigator's Discretion|15|||
125066673|NCT01797445|449862424|FG001|Double-Blind Phase|Investigator's Discretion|17|||
125066674|NCT01797445|449862423|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
125066675|NCT01797445|449862424|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
125066676|NCT01797445|449862423|FG000|Double-Blind Phase|Protocol Violation|0|||
125066677|NCT01797445|449862424|FG001|Double-Blind Phase|Protocol Violation|1|||
125066678|NCT01797445|449862423|FG000|Double-Blind Phase|Withdrew Consent|20|||
125066679|NCT01797445|449862424|FG001|Double-Blind Phase|Withdrew Consent|35|||
125066680|NCT01797445|449862423|FG000|Double-Blind Phase|Lost to Follow-up|34|||
125066681|NCT01797445|449862424|FG001|Double-Blind Phase|Lost to Follow-up|26|||
125066682|NCT01797445|449862423|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
125066683|NCT01797445|449862424|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
125066684|NCT01595438|449862425|FG000|Overall Study|Lost to Follow-up|20|||
125066685|NCT01595438|449862426|FG001|Overall Study|Lost to Follow-up|20|||
125066686|NCT01595438|449862425|FG000|Overall Study|Withdrawal by Subject|12|||
125066687|NCT01595438|449862426|FG001|Overall Study|Withdrawal by Subject|12|||
125066688|NCT01595438|449862425|FG000|Overall Study|Other Eligibility criteria|11|||
125066689|NCT01595438|449862426|FG001|Overall Study|Other Eligibility criteria|9|||
125066690|NCT04116073|449862429|FG000|Overall Study|Withdrawal by Subject|2|||
125066691|NCT04116073|449862429|FG000|Overall Study|failed to maintained eligibility|1|||
125066692|NCT04190186|449862436|FG000|Overall Study|ILR is no longer functioning|0|||
125066693|NCT04190186|449862437|FG001|Overall Study|ILR is no longer functioning|1|||
125066694|NCT04190186|449862436|FG000|Overall Study|Lost to Follow-up|0|||
125066695|NCT04190186|449862437|FG001|Overall Study|Lost to Follow-up|1|||
125066696|NCT04190186|449862436|FG000|Overall Study|Withdrawal by Subject|2|||
125066697|NCT04190186|449862437|FG001|Overall Study|Withdrawal by Subject|0|||
125066698|NCT04190186|449862436|FG000|Overall Study|Subject choice to explant|1|||
125066699|NCT04190186|449862437|FG001|Overall Study|Subject choice to explant|0|||
125066700|NCT04190186|449862436|FG000|Overall Study|Physician Decision|0|||
125066701|NCT04190186|449862437|FG001|Overall Study|Physician Decision|1|||
125066702|NCT04190186|449862436|FG000|Overall Study|Study was stopped|4|||
125066703|NCT04190186|449862437|FG001|Overall Study|Study was stopped|5|||
125066704|NCT00618995|449862442|FG000|Period 1|Adverse Event|0|||
125066705|NCT00618995|449862443|FG001|Period 1|Adverse Event|0|||
125066706|NCT00618995|449862444|FG002|Period 1|Adverse Event|1|||
125066707|NCT00618995|449862445|FG003|Period 1|Adverse Event|0|||
125066708|NCT00618995|449862442|FG000|Period 1|Protocol Violation|0|||
125066709|NCT00618995|449862443|FG001|Period 1|Protocol Violation|1|||
125066710|NCT00618995|449862444|FG002|Period 1|Protocol Violation|1|||
125066711|NCT00618995|449862445|FG003|Period 1|Protocol Violation|0|||
125066712|NCT00618995|449862442|FG000|Period 2|Protocol Violation|0|||
125066713|NCT00618995|449862443|FG001|Period 2|Protocol Violation|0|||
125066714|NCT00618995|449862444|FG002|Period 2|Protocol Violation|1|||
125066715|NCT00618995|449862445|FG003|Period 2|Protocol Violation|0|||
125066716|NCT00618995|449862442|FG000|Period 4|Adverse Event|1|||
125066717|NCT00618995|449862443|FG001|Period 4|Adverse Event|0|||
125066718|NCT00618995|449862444|FG002|Period 4|Adverse Event|0|||
125066719|NCT00618995|449862445|FG003|Period 4|Adverse Event|0|||
125066720|NCT02677220|449862457|FG000|Overall Study|Adverse Event|1|||
125066721|NCT00965146|449862458|FG000|Overall Study|Death|7|||
125066722|NCT00965146|449862458|FG000|Overall Study|Lost to Follow-up|22|||
125066723|NCT00965146|449862458|FG000|Overall Study|Withdrawal by Subject|17|||
125066724|NCT00965146|449862458|FG000|Overall Study|Unable to return|1|||
125066725|NCT00965146|449862458|FG000|Overall Study|Unwilling to return|11|||
125066726|NCT00965146|449862458|FG000|Overall Study|Intercurrent illness|1|||
125066727|NCT00965146|449862458|FG000|Overall Study|Revision / Removal of Study Implant|6|||
125066728|NCT00965146|449862458|FG000|Overall Study|Overall Study Termination|145|||
125066729|NCT01181102|449862461|FG000|Overall Study|Adverse Event|28|||
125066730|NCT01181102|449862462|FG001|Overall Study|Adverse Event|26|||
125066731|NCT01181102|449862461|FG000|Overall Study|Lack of Efficacy|3|||
125066732|NCT01181102|449862462|FG001|Overall Study|Lack of Efficacy|1|||
125066733|NCT01181102|449862461|FG000|Overall Study|Lost to Follow-up|2|||
125066734|NCT01181102|449862462|FG001|Overall Study|Lost to Follow-up|0|||
125066735|NCT01181102|449862461|FG000|Overall Study|Physician Decision|3|||
125066736|NCT01181102|449862462|FG001|Overall Study|Physician Decision|1|||
125066737|NCT01181102|449862461|FG000|Overall Study|Protocol Violation|5|||
125066738|NCT01181102|449862462|FG001|Overall Study|Protocol Violation|6|||
125066739|NCT01181102|449862461|FG000|Overall Study|Withdrawal by Subject|10|||
125066740|NCT01181102|449862462|FG001|Overall Study|Withdrawal by Subject|12|||
125066741|NCT01309841|449862471|FG000|Overall Study|Other|0|||
125066742|NCT01309841|449862472|FG001|Overall Study|Other|1|||
125066743|NCT01309841|449862473|FG002|Overall Study|Other|1|||
125066744|NCT01309841|449862471|FG000|Overall Study|Lost to Follow-up|7|||
125066745|NCT01309841|449862472|FG001|Overall Study|Lost to Follow-up|6|||
125066746|NCT01309841|449862473|FG002|Overall Study|Lost to Follow-up|4|||
125066747|NCT01309841|449862471|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
125066748|NCT01309841|449862472|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
125066749|NCT01309841|449862473|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
125066750|NCT01309841|449862471|FG000|Overall Study|Lack of Efficacy|0|||
125066751|NCT01309841|449862472|FG001|Overall Study|Lack of Efficacy|0|||
125066752|NCT01309841|449862473|FG002|Overall Study|Lack of Efficacy|2|||
125066753|NCT01309841|449862471|FG000|Overall Study|Adverse Event|9|||
125066754|NCT01309841|449862472|FG001|Overall Study|Adverse Event|22|||
125066755|NCT01309841|449862473|FG002|Overall Study|Adverse Event|11|||
125140299|NCT04408924|450137571|FG000|Overall Study|Sponsor Decision|2|||
125140300|NCT00691704|450137572|FG000|Induction Therapy|Disease Progression|1|||
125140301|NCT00691704|450137572|FG000|Induction Therapy|Active Hepatitis|1|||
125140302|NCT00691704|450137572|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
125140303|NCT00691704|450137572|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
125140304|NCT00691704|450137572|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
125140305|NCT04661202|450137573|FG000|Overall Study|Withdrawal by Subject|1|||
125140306|NCT04661202|450137574|FG001|Overall Study|Withdrawal by Subject|1|||
125140307|NCT04661202|450137573|FG000|Overall Study|Lack of Efficacy|2|||
125140308|NCT04661202|450137574|FG001|Overall Study|Lack of Efficacy|0|||
125140309|NCT04158687|450137575|FG000|Overall Study|Adverse Event|2|||
125140310|NCT04158687|450137576|FG001|Overall Study|Adverse Event|3|||
125140311|NCT04158687|450137577|FG002|Overall Study|Adverse Event|0|||
125140312|NCT04158687|450137578|FG003|Overall Study|Adverse Event|3|||
125140313|NCT04158687|450137575|FG000|Overall Study|Lost to Follow-up|5|||
125140314|NCT04158687|450137576|FG001|Overall Study|Lost to Follow-up|12|||
125140315|NCT04158687|450137577|FG002|Overall Study|Lost to Follow-up|4|||
125140316|NCT04158687|450137578|FG003|Overall Study|Lost to Follow-up|5|||
125140317|NCT04158687|450137575|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
125140318|NCT04158687|450137576|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
125140319|NCT04158687|450137577|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
125140320|NCT04158687|450137578|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
125140321|NCT04158687|450137575|FG000|Overall Study|Non-Compliance with Study Medication|2|||
125140322|NCT04158687|450137576|FG001|Overall Study|Non-Compliance with Study Medication|2|||
125066756|NCT01309841|449862471|FG000|Overall Study|Death|1|||
125066757|NCT01309841|449862472|FG001|Overall Study|Death|0|||
125066758|NCT01309841|449862473|FG002|Overall Study|Death|0|||
125066759|NCT01309841|449862471|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
125066760|NCT01309841|449862472|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
125066761|NCT01309841|449862473|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
125066762|NCT01309841|449862471|FG000|Overall Study|Withdrawal by Subject|17|||
125066763|NCT01309841|449862472|FG001|Overall Study|Withdrawal by Subject|6|||
125066764|NCT01309841|449862473|FG002|Overall Study|Withdrawal by Subject|13|||
125066765|NCT01309841|449862471|FG000|Overall Study|Did Not Receive Treatment|2|||
125066766|NCT01309841|449862472|FG001|Overall Study|Did Not Receive Treatment|0|||
125066767|NCT01309841|449862473|FG002|Overall Study|Did Not Receive Treatment|1|||
125066768|NCT01309841|449862471|FG000|Overall Study|Severe non-compliance with protocol|0|||
125066769|NCT01309841|449862472|FG001|Overall Study|Severe non-compliance with protocol|5|||
125066770|NCT01309841|449862473|FG002|Overall Study|Severe non-compliance with protocol|2|||
125066771|NCT00050960|449862474|FG000|Overall Study|Progressive Disease|137|||
125066772|NCT00050960|449862475|FG001|Overall Study|Progressive Disease|93|||
125066773|NCT00050960|449862474|FG000|Overall Study|Stable Disease|19|||
125066774|NCT00050960|449862475|FG001|Overall Study|Stable Disease|48|||
125066775|NCT00050960|449862474|FG000|Overall Study|Partial Response|14|||
125066776|NCT00050960|449862475|FG001|Overall Study|Partial Response|19|||
125066777|NCT00050960|449862474|FG000|Overall Study|Complete Response|0|||
125066778|NCT00050960|449862475|FG001|Overall Study|Complete Response|2|||
125066779|NCT00050960|449862474|FG000|Overall Study|Adverse Event|62|||
125066780|NCT00050960|449862475|FG001|Overall Study|Adverse Event|61|||
125066781|NCT00050960|449862474|FG000|Overall Study|Lost to Follow-up|0|||
125066782|NCT00050960|449862475|FG001|Overall Study|Lost to Follow-up|1|||
125066783|NCT00050960|449862474|FG000|Overall Study|Withdrawal by Subject|23|||
125066784|NCT00050960|449862475|FG001|Overall Study|Withdrawal by Subject|18|||
125066785|NCT00050960|449862474|FG000|Overall Study|Administrative|31|||
125066786|NCT00050960|449862475|FG001|Overall Study|Administrative|46|||
125066787|NCT00050960|449862474|FG000|Overall Study|Non-compliance|3|||
125066788|NCT00050960|449862475|FG001|Overall Study|Non-compliance|1|||
125066789|NCT00050960|449862474|FG000|Overall Study|Death|13|||
125066790|NCT00050960|449862475|FG001|Overall Study|Death|15|||
125066791|NCT04311177|449862478|FG000|Overall Study|Adverse Event|3|||
125066792|NCT04311177|449862479|FG001|Overall Study|Adverse Event|1|||
125140323|NCT04158687|450137577|FG002|Overall Study|Non-Compliance with Study Medication|3|||
125140324|NCT04158687|450137578|FG003|Overall Study|Non-Compliance with Study Medication|0|||
125140325|NCT04158687|450137575|FG000|Overall Study|Investigator Decision|0|||
125140326|NCT04158687|450137576|FG001|Overall Study|Investigator Decision|0|||
125140327|NCT04158687|450137577|FG002|Overall Study|Investigator Decision|2|||
125140328|NCT04158687|450137578|FG003|Overall Study|Investigator Decision|0|||
125140329|NCT04158687|450137575|FG000|Overall Study|Protocol Violation|0|||
125140330|NCT04158687|450137576|FG001|Overall Study|Protocol Violation|2|||
125140331|NCT04158687|450137577|FG002|Overall Study|Protocol Violation|1|||
125140332|NCT04158687|450137578|FG003|Overall Study|Protocol Violation|0|||
125140333|NCT04158687|450137575|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
125066793|NCT04311177|449862478|FG000|Overall Study|Physician Decision|4|||
125066794|NCT04311177|449862479|FG001|Overall Study|Physician Decision|3|||
125066795|NCT04311177|449862478|FG000|Overall Study|Withdrawal by Subject|1|||
125066796|NCT04311177|449862479|FG001|Overall Study|Withdrawal by Subject|0|||
125140334|NCT04158687|450137576|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
125140335|NCT04158687|450137577|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
125140336|NCT04158687|450137578|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
125140337|NCT04158687|450137575|FG000|Overall Study|Reason not Specified|3|||
125140338|NCT04158687|450137576|FG001|Overall Study|Reason not Specified|2|||
125140339|NCT04158687|450137577|FG002|Overall Study|Reason not Specified|4|||
125140340|NCT04158687|450137578|FG003|Overall Study|Reason not Specified|4|||
125140341|NCT04102345|450137581|FG000|Overall Study|Withdrawal by Subject|1|||
125140342|NCT04102345|450137582|FG001|Overall Study|Withdrawal by Subject|0|||
125140343|NCT00835666|450137588|FG000|Washout|Protocol Violation|1|||
125140344|NCT00835666|450137589|FG001|Washout|Protocol Violation|0|||
125140345|NCT00835666|450137588|FG000|Washout|Withdrawal by Subject|1|||
125140346|NCT00835666|450137589|FG001|Washout|Withdrawal by Subject|0|||
125140347|NCT03599362|450137590|FG000|Overall Study|Screen Failure|3|||
125140348|NCT03707587|450137594|FG000|Overall Study|Death|0|||
125140349|NCT03707587|450137595|FG001|Overall Study|Death|1|||
125140350|NCT01537887|450137596|FG000|Period 1|Physician Decision|0|||
125140351|NCT01537887|450137597|FG001|Period 1|Physician Decision|0|||
125140352|NCT01537887|450137598|FG002|Period 1|Physician Decision|0|||
125140353|NCT01537887|450137599|FG003|Period 1|Physician Decision|0|||
125140354|NCT01537887|450137600|FG004|Period 1|Physician Decision|1|||
125140355|NCT01537887|450137601|FG005|Period 1|Physician Decision|1|||
125140356|NCT01537887|450137596|FG000|Period 1|Did not receive treatment|0|||
125140357|NCT01537887|450137597|FG001|Period 1|Did not receive treatment|0|||
125140358|NCT01537887|450137598|FG002|Period 1|Did not receive treatment|1|||
125140359|NCT01537887|450137599|FG003|Period 1|Did not receive treatment|0|||
125140360|NCT01537887|450137600|FG004|Period 1|Did not receive treatment|0|||
125140361|NCT01537887|450137601|FG005|Period 1|Did not receive treatment|0|||
125140362|NCT01537887|450137596|FG000|Period 2|Withdrawal by Subject|0|||
125140363|NCT01537887|450137597|FG001|Period 2|Withdrawal by Subject|1|||
125140364|NCT01537887|450137598|FG002|Period 2|Withdrawal by Subject|0|||
125140365|NCT01537887|450137599|FG003|Period 2|Withdrawal by Subject|0|||
125140366|NCT01537887|450137600|FG004|Period 2|Withdrawal by Subject|0|||
125140367|NCT01537887|450137601|FG005|Period 2|Withdrawal by Subject|0|||
125140368|NCT01537887|450137596|FG000|Period 3|Adverse Event|0|||
125140369|NCT01537887|450137597|FG001|Period 3|Adverse Event|0|||
125140370|NCT01537887|450137598|FG002|Period 3|Adverse Event|1|||
125140371|NCT01537887|450137599|FG003|Period 3|Adverse Event|0|||
125140372|NCT01537887|450137600|FG004|Period 3|Adverse Event|0|||
125140373|NCT01537887|450137601|FG005|Period 3|Adverse Event|0|||
125140374|NCT01537887|450137596|FG000|Period 3|Withdrawal by Subject|0|||
125140375|NCT01537887|450137597|FG001|Period 3|Withdrawal by Subject|1|||
125140376|NCT01537887|450137598|FG002|Period 3|Withdrawal by Subject|0|||
125140377|NCT01537887|450137599|FG003|Period 3|Withdrawal by Subject|0|||
125140378|NCT01537887|450137600|FG004|Period 3|Withdrawal by Subject|0|||
125140379|NCT01537887|450137601|FG005|Period 3|Withdrawal by Subject|0|||
125140380|NCT01370083|450137603|FG000|Overall Study|Lost to Follow-up|2|||
125140381|NCT01370083|450137604|FG001|Overall Study|Lost to Follow-up|0|||
125140382|NCT01370083|450137603|FG000|Overall Study|Adverse Event|0|||
125140383|NCT01370083|450137604|FG001|Overall Study|Adverse Event|1|||
125140384|NCT03358147|450137606|FG000|Overall Study|Withdrawal by Subject|13|||
125140385|NCT03358147|450137607|FG001|Overall Study|Withdrawal by Subject|19|||
125140386|NCT03358147|450137608|FG002|Overall Study|Withdrawal by Subject|16|||
125140387|NCT03358147|450137609|FG003|Overall Study|Withdrawal by Subject|10|||
125140388|NCT03358147|450137610|FG004|Overall Study|Withdrawal by Subject|5|||
125140389|NCT03358147|450137606|FG000|Overall Study|Adverse Event|3|||
125140390|NCT03358147|450137607|FG001|Overall Study|Adverse Event|9|||
125140391|NCT03358147|450137608|FG002|Overall Study|Adverse Event|7|||
125140392|NCT03358147|450137609|FG003|Overall Study|Adverse Event|5|||
125140393|NCT03358147|450137610|FG004|Overall Study|Adverse Event|2|||
125140394|NCT03358147|450137606|FG000|Overall Study|Lost to Follow-up|4|||
125140395|NCT03358147|450137607|FG001|Overall Study|Lost to Follow-up|3|||
125140396|NCT03358147|450137608|FG002|Overall Study|Lost to Follow-up|7|||
125140397|NCT03358147|450137609|FG003|Overall Study|Lost to Follow-up|6|||
125140398|NCT03358147|450137610|FG004|Overall Study|Lost to Follow-up|4|||
125140399|NCT03358147|450137606|FG000|Overall Study|Major Protocol Deviation|11|||
125140400|NCT03358147|450137607|FG001|Overall Study|Major Protocol Deviation|3|||
125140401|NCT03358147|450137608|FG002|Overall Study|Major Protocol Deviation|2|||
125140402|NCT03358147|450137609|FG003|Overall Study|Major Protocol Deviation|3|||
125140403|NCT03358147|450137610|FG004|Overall Study|Major Protocol Deviation|1|||
125222625|NCT03428100|450442769|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125140404|NCT03358147|450137606|FG000|Overall Study|Protocol specified criteria|2|||
125140405|NCT03358147|450137607|FG001|Overall Study|Protocol specified criteria|3|||
125140406|NCT03358147|450137608|FG002|Overall Study|Protocol specified criteria|0|||
125140407|NCT03358147|450137609|FG003|Overall Study|Protocol specified criteria|3|||
125140408|NCT03358147|450137610|FG004|Overall Study|Protocol specified criteria|1|||
125140409|NCT03358147|450137606|FG000|Overall Study|Physician Decision|1|||
125140410|NCT03358147|450137607|FG001|Overall Study|Physician Decision|0|||
125140411|NCT03358147|450137608|FG002|Overall Study|Physician Decision|1|||
125066797|NCT00413062|449862482|FG000|Overall Study|Adverse event/serious adverse event|289|||
125066798|NCT00413062|449862483|FG001|Overall Study|Adverse event/serious adverse event|56|||
125066799|NCT00413062|449862482|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
125066800|NCT00413062|449862483|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
125066801|NCT00413062|449862482|FG000|Overall Study|Withdrawal of informed consent|111|||
125066802|NCT00413062|449862483|FG001|Overall Study|Withdrawal of informed consent|36|||
125066803|NCT00413062|449862482|FG000|Overall Study|Pregnancy|15|||
125066804|NCT00413062|449862483|FG001|Overall Study|Pregnancy|5|||
125066805|NCT00413062|449862482|FG000|Overall Study|Pregnancy wish|17|||
125066806|NCT00413062|449862483|FG001|Overall Study|Pregnancy wish|6|||
125066807|NCT00413062|449862482|FG000|Overall Study|Lost to Follow-up|175|||
125066808|NCT00413062|449862483|FG001|Overall Study|Lost to Follow-up|73|||
125066809|NCT00413062|449862482|FG000|Overall Study|Other reason|70|||
125066810|NCT00413062|449862483|FG001|Overall Study|Other reason|34|||
125066811|NCT02815293|449862486|FG000|Overall Study|Study termination by sponsor|10|||
125066812|NCT02815293|449862487|FG001|Overall Study|Study termination by sponsor|7|||
125066813|NCT02815293|449862488|FG002|Overall Study|Study termination by sponsor|0|||
125066814|NCT02815293|449862486|FG000|Overall Study|Participants not randomized|0|||
125066815|NCT02815293|449862487|FG001|Overall Study|Participants not randomized|0|||
125066816|NCT02815293|449862488|FG002|Overall Study|Participants not randomized|18|||
125066817|NCT02815293|449862486|FG000|Overall Study|Adverse Event|0|||
125066818|NCT02815293|449862487|FG001|Overall Study|Adverse Event|1|||
125066819|NCT02815293|449862488|FG002|Overall Study|Adverse Event|0|||
125066820|NCT00006604|449862489|FG000|Overall Study|Met study objective - no further FU|1|||
125066821|NCT00006604|449862490|FG001|Overall Study|Met study objective - no further FU|0|||
125066822|NCT00006604|449862491|FG002|Overall Study|Met study objective - no further FU|0|||
125066823|NCT00006604|449862492|FG003|Overall Study|Met study objective - no further FU|0|||
125066824|NCT00006604|449862493|FG004|Overall Study|Met study objective - no further FU|0|||
125066825|NCT00006604|449862494|FG005|Overall Study|Met study objective - no further FU|0|||
125066826|NCT00006604|449862495|FG006|Overall Study|Met study objective - no further FU|0|||
125066827|NCT00006604|449862496|FG007|Overall Study|Met study objective - no further FU|0|||
125066828|NCT00006604|449862497|FG008|Overall Study|Met study objective - no further FU|0|||
125066829|NCT00006604|449862498|FG009|Overall Study|Met study objective - no further FU|0|||
125066830|NCT00006604|449862499|FG010|Overall Study|Met study objective - no further FU|0|||
125066831|NCT00006604|449862500|FG011|Overall Study|Met study objective - no further FU|0|||
125066832|NCT00006604|449862501|FG012|Overall Study|Met study objective - no further FU|0|||
125066833|NCT00006604|449862502|FG013|Overall Study|Met study objective - no further FU|0|||
125066834|NCT00006604|449862503|FG014|Overall Study|Met study objective - no further FU|1|||
125066835|NCT00006604|449862504|FG015|Overall Study|Met study objective - no further FU|1|||
125066836|NCT00006604|449862505|FG016|Overall Study|Met study objective - no further FU|0|||
125066837|NCT00006604|449862489|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
125066838|NCT00006604|449862490|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
125066839|NCT00006604|449862491|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
125066840|NCT00006604|449862492|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
125066841|NCT00006604|449862493|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
125066842|NCT00006604|449862494|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
125066843|NCT00006604|449862495|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
125066844|NCT00006604|449862496|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
125066845|NCT00006604|449862497|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
125066846|NCT00006604|449862498|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
125066847|NCT00006604|449862499|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
125140412|NCT03358147|450137609|FG003|Overall Study|Physician Decision|6|||
125140413|NCT03358147|450137610|FG004|Overall Study|Physician Decision|1|||
125140414|NCT03358147|450137606|FG000|Overall Study|Administrative reasons|0|||
125140415|NCT03358147|450137607|FG001|Overall Study|Administrative reasons|1|||
125140416|NCT03358147|450137608|FG002|Overall Study|Administrative reasons|0|||
125140417|NCT03358147|450137609|FG003|Overall Study|Administrative reasons|3|||
125140418|NCT03358147|450137610|FG004|Overall Study|Administrative reasons|0|||
125140419|NCT03358147|450137606|FG000|Overall Study|Lack of Efficacy|0|||
125140420|NCT03358147|450137607|FG001|Overall Study|Lack of Efficacy|1|||
125140421|NCT03358147|450137608|FG002|Overall Study|Lack of Efficacy|1|||
125066848|NCT00006604|449862500|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
125066849|NCT00006604|449862501|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
125066850|NCT00006604|449862502|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
125066851|NCT00006604|449862503|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
125140422|NCT03358147|450137609|FG003|Overall Study|Lack of Efficacy|0|||
125140423|NCT03358147|450137610|FG004|Overall Study|Lack of Efficacy|0|||
125066852|NCT00006604|449862504|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
125066853|NCT00006604|449862505|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
125066854|NCT00006604|449862489|FG000|Overall Study|Death|0|||
125066855|NCT00006604|449862490|FG001|Overall Study|Death|0|||
125066856|NCT00006604|449862491|FG002|Overall Study|Death|0|||
125066857|NCT00006604|449862492|FG003|Overall Study|Death|0|||
125066858|NCT00006604|449862493|FG004|Overall Study|Death|0|||
125066859|NCT00006604|449862494|FG005|Overall Study|Death|0|||
125066860|NCT00006604|449862495|FG006|Overall Study|Death|0|||
125066861|NCT00006604|449862496|FG007|Overall Study|Death|0|||
125066862|NCT00006604|449862497|FG008|Overall Study|Death|0|||
125066863|NCT00006604|449862498|FG009|Overall Study|Death|1|||
125066864|NCT00006604|449862499|FG010|Overall Study|Death|1|||
125066865|NCT00006604|449862500|FG011|Overall Study|Death|1|||
125066866|NCT00006604|449862501|FG012|Overall Study|Death|0|||
125066867|NCT00006604|449862502|FG013|Overall Study|Death|0|||
125066868|NCT00006604|449862503|FG014|Overall Study|Death|0|||
125066869|NCT00006604|449862504|FG015|Overall Study|Death|0|||
125066870|NCT00006604|449862505|FG016|Overall Study|Death|0|||
125066871|NCT00006604|449862489|FG000|Overall Study|Severe debilitation, unable to continue|0|||
125066872|NCT00006604|449862490|FG001|Overall Study|Severe debilitation, unable to continue|0|||
125066873|NCT00006604|449862491|FG002|Overall Study|Severe debilitation, unable to continue|0|||
125066874|NCT00006604|449862492|FG003|Overall Study|Severe debilitation, unable to continue|0|||
125066875|NCT00006604|449862493|FG004|Overall Study|Severe debilitation, unable to continue|0|||
125066876|NCT00006604|449862494|FG005|Overall Study|Severe debilitation, unable to continue|0|||
125066877|NCT00006604|449862495|FG006|Overall Study|Severe debilitation, unable to continue|3|||
125066878|NCT00006604|449862496|FG007|Overall Study|Severe debilitation, unable to continue|0|||
125066879|NCT00006604|449862497|FG008|Overall Study|Severe debilitation, unable to continue|0|||
125066880|NCT00006604|449862498|FG009|Overall Study|Severe debilitation, unable to continue|5|||
125066881|NCT00006604|449862499|FG010|Overall Study|Severe debilitation, unable to continue|0|||
125066882|NCT00006604|449862500|FG011|Overall Study|Severe debilitation, unable to continue|2|||
125066883|NCT00006604|449862501|FG012|Overall Study|Severe debilitation, unable to continue|1|||
125066884|NCT00006604|449862502|FG013|Overall Study|Severe debilitation, unable to continue|0|||
125066885|NCT00006604|449862503|FG014|Overall Study|Severe debilitation, unable to continue|2|||
125066886|NCT00006604|449862504|FG015|Overall Study|Severe debilitation, unable to continue|0|||
125066887|NCT00006604|449862505|FG016|Overall Study|Severe debilitation, unable to continue|0|||
125066888|NCT00006604|449862489|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
125066889|NCT00006604|449862490|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
125066890|NCT00006604|449862491|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
125066891|NCT00006604|449862492|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
125066892|NCT00006604|449862493|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
125066893|NCT00006604|449862494|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
125066894|NCT00006604|449862495|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
125066895|NCT00006604|449862496|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
125066896|NCT00006604|449862497|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
125066897|NCT00006604|449862498|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
125066898|NCT00006604|449862499|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
125066899|NCT00006604|449862500|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
125066900|NCT00006604|449862501|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
125066901|NCT00006604|449862502|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
125066902|NCT00006604|449862503|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
125066903|NCT00006604|449862504|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
125066904|NCT00006604|449862505|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
125066905|NCT00006604|449862489|FG000|Overall Study|Site closing|0|||
125066906|NCT00006604|449862490|FG001|Overall Study|Site closing|0|||
125066907|NCT00006604|449862491|FG002|Overall Study|Site closing|1|||
125066908|NCT00006604|449862492|FG003|Overall Study|Site closing|1|||
125066909|NCT00006604|449862493|FG004|Overall Study|Site closing|0|||
125066910|NCT00006604|449862494|FG005|Overall Study|Site closing|0|||
125066911|NCT00006604|449862495|FG006|Overall Study|Site closing|0|||
125066912|NCT00006604|449862496|FG007|Overall Study|Site closing|1|||
125066913|NCT00006604|449862497|FG008|Overall Study|Site closing|0|||
125066914|NCT00006604|449862498|FG009|Overall Study|Site closing|0|||
125066915|NCT00006604|449862499|FG010|Overall Study|Site closing|0|||
125066916|NCT00006604|449862500|FG011|Overall Study|Site closing|1|||
125066917|NCT00006604|449862501|FG012|Overall Study|Site closing|1|||
125066918|NCT00006604|449862502|FG013|Overall Study|Site closing|1|||
125066919|NCT00006604|449862503|FG014|Overall Study|Site closing|0|||
125066920|NCT00006604|449862504|FG015|Overall Study|Site closing|0|||
125066921|NCT00006604|449862505|FG016|Overall Study|Site closing|1|||
125066922|NCT00006604|449862489|FG000|Overall Study|Withdrawal by Subject|1|||
125066923|NCT00006604|449862490|FG001|Overall Study|Withdrawal by Subject|0|||
125066924|NCT00006604|449862491|FG002|Overall Study|Withdrawal by Subject|2|||
125066925|NCT00006604|449862492|FG003|Overall Study|Withdrawal by Subject|0|||
125066926|NCT00006604|449862493|FG004|Overall Study|Withdrawal by Subject|1|||
125066927|NCT00006604|449862494|FG005|Overall Study|Withdrawal by Subject|2|||
125066928|NCT00006604|449862495|FG006|Overall Study|Withdrawal by Subject|2|||
125066929|NCT00006604|449862496|FG007|Overall Study|Withdrawal by Subject|0|||
125066930|NCT00006604|449862497|FG008|Overall Study|Withdrawal by Subject|1|||
125066931|NCT00006604|449862498|FG009|Overall Study|Withdrawal by Subject|3|||
125066932|NCT00006604|449862499|FG010|Overall Study|Withdrawal by Subject|2|||
125066933|NCT00006604|449862500|FG011|Overall Study|Withdrawal by Subject|0|||
125066934|NCT00006604|449862501|FG012|Overall Study|Withdrawal by Subject|1|||
125066935|NCT00006604|449862502|FG013|Overall Study|Withdrawal by Subject|2|||
125066936|NCT00006604|449862503|FG014|Overall Study|Withdrawal by Subject|1|||
125066937|NCT00006604|449862504|FG015|Overall Study|Withdrawal by Subject|0|||
125066938|NCT00006604|449862505|FG016|Overall Study|Withdrawal by Subject|1|||
125066939|NCT00006604|449862489|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
125066940|NCT00006604|449862490|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
125066941|NCT00006604|449862491|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
125066942|NCT00006604|449862492|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
125066943|NCT00006604|449862493|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
125066944|NCT00006604|449862494|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
125066945|NCT00006604|449862495|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
125066946|NCT00006604|449862496|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
125066947|NCT00006604|449862497|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
125066948|NCT00006604|449862498|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
125066949|NCT00006604|449862499|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
125066950|NCT00006604|449862500|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
125066951|NCT00006604|449862501|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
125066952|NCT00006604|449862502|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
125066953|NCT00006604|449862503|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
125066954|NCT00006604|449862504|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
125066955|NCT00006604|449862505|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
125066956|NCT00006604|449862489|FG000|Overall Study|Lost to Follow-up|0|||
125066957|NCT00006604|449862490|FG001|Overall Study|Lost to Follow-up|0|||
125066958|NCT00006604|449862491|FG002|Overall Study|Lost to Follow-up|0|||
125066959|NCT00006604|449862492|FG003|Overall Study|Lost to Follow-up|0|||
125066960|NCT00006604|449862493|FG004|Overall Study|Lost to Follow-up|0|||
125066961|NCT00006604|449862494|FG005|Overall Study|Lost to Follow-up|0|||
125066962|NCT00006604|449862495|FG006|Overall Study|Lost to Follow-up|0|||
125066963|NCT00006604|449862496|FG007|Overall Study|Lost to Follow-up|1|||
125066964|NCT00006604|449862497|FG008|Overall Study|Lost to Follow-up|0|||
125066965|NCT00006604|449862498|FG009|Overall Study|Lost to Follow-up|2|||
125066966|NCT00006604|449862499|FG010|Overall Study|Lost to Follow-up|0|||
125066967|NCT00006604|449862500|FG011|Overall Study|Lost to Follow-up|0|||
125066968|NCT00006604|449862501|FG012|Overall Study|Lost to Follow-up|0|||
125066969|NCT00006604|449862502|FG013|Overall Study|Lost to Follow-up|0|||
125066970|NCT00006604|449862503|FG014|Overall Study|Lost to Follow-up|0|||
125066971|NCT00006604|449862504|FG015|Overall Study|Lost to Follow-up|1|||
125066972|NCT00006604|449862505|FG016|Overall Study|Lost to Follow-up|3|||
125066973|NCT00006604|449862489|FG000|Overall Study|Other Reason|0|||
125066974|NCT00006604|449862490|FG001|Overall Study|Other Reason|0|||
125066975|NCT00006604|449862491|FG002|Overall Study|Other Reason|0|||
125066976|NCT00006604|449862492|FG003|Overall Study|Other Reason|0|||
125066977|NCT00006604|449862493|FG004|Overall Study|Other Reason|0|||
125066978|NCT00006604|449862494|FG005|Overall Study|Other Reason|1|||
125066979|NCT00006604|449862495|FG006|Overall Study|Other Reason|0|||
125066980|NCT00006604|449862496|FG007|Overall Study|Other Reason|0|||
125066981|NCT00006604|449862497|FG008|Overall Study|Other Reason|0|||
125066982|NCT00006604|449862498|FG009|Overall Study|Other Reason|1|||
125066983|NCT00006604|449862499|FG010|Overall Study|Other Reason|0|||
125066984|NCT00006604|449862500|FG011|Overall Study|Other Reason|0|||
125066985|NCT00006604|449862501|FG012|Overall Study|Other Reason|0|||
125066986|NCT00006604|449862502|FG013|Overall Study|Other Reason|0|||
125066987|NCT00006604|449862503|FG014|Overall Study|Other Reason|0|||
125066988|NCT00006604|449862504|FG015|Overall Study|Other Reason|0|||
125066989|NCT00006604|449862505|FG016|Overall Study|Other Reason|0|||
125066990|NCT01056341|449862508|FG000|Overall Study|Treatment Intolerance|0|||
125066991|NCT01056341|449862509|FG001|Overall Study|Treatment Intolerance|2|||
125066992|NCT01056341|449862510|FG002|Overall Study|Treatment Intolerance|0|||
125066993|NCT01056341|449862511|FG003|Overall Study|Treatment Intolerance|2|||
125066994|NCT01056341|449862512|FG004|Overall Study|Treatment Intolerance|0|||
125066995|NCT01056341|449862508|FG000|Overall Study|Lack of Efficacy|32|||
125066996|NCT01056341|449862509|FG001|Overall Study|Lack of Efficacy|30|||
125066997|NCT01056341|449862510|FG002|Overall Study|Lack of Efficacy|7|||
125066998|NCT01056341|449862511|FG003|Overall Study|Lack of Efficacy|25|||
125066999|NCT01056341|449862512|FG004|Overall Study|Lack of Efficacy|9|||
125067000|NCT01056341|449862508|FG000|Overall Study|Other reasons|4|||
125067001|NCT01056341|449862509|FG001|Overall Study|Other reasons|4|||
125067002|NCT01056341|449862510|FG002|Overall Study|Other reasons|8|||
125067003|NCT01056341|449862511|FG003|Overall Study|Other reasons|9|||
125067004|NCT01056341|449862512|FG004|Overall Study|Other reasons|5|||
125067005|NCT01086150|449862513|FG000|Overall Study|Withdrawal by Subject|0|||
125067006|NCT01086150|449862514|FG001|Overall Study|Withdrawal by Subject|4|||
125067007|NCT01086150|449862515|FG002|Overall Study|Withdrawal by Subject|1|||
125067008|NCT01086150|449862513|FG000|Overall Study|Lost to Follow-up|0|||
125067009|NCT01086150|449862514|FG001|Overall Study|Lost to Follow-up|1|||
125067010|NCT01086150|449862515|FG002|Overall Study|Lost to Follow-up|0|||
125067011|NCT01086150|449862513|FG000|Overall Study|Screen Failure|0|||
125067012|NCT01086150|449862514|FG001|Overall Study|Screen Failure|1|||
125067013|NCT01086150|449862515|FG002|Overall Study|Screen Failure|0|||
125067014|NCT01681576|449862518|FG000|Period 1|Adverse Event|1|||
125067015|NCT01681576|449862519|FG001|Period 1|Adverse Event|0|||
125067016|NCT01681576|449862518|FG000|Period 1|Protocol Deviation|1|||
125067017|NCT01681576|449862519|FG001|Period 1|Protocol Deviation|0|||
125067018|NCT01681576|449862518|FG000|Period 2|subject/guardian decision|3|||
125067019|NCT01681576|449862519|FG001|Period 2|subject/guardian decision|1|||
125067020|NCT01681576|449862518|FG000|Period 2|Non-compliance with study treatment|1|||
125067021|NCT01681576|449862519|FG001|Period 2|Non-compliance with study treatment|0|||
125067022|NCT02721251|449862520|FG000|Overall Study|Withdrawal by Subject|8|||
125067023|NCT02721251|449862521|FG001|Overall Study|Withdrawal by Subject|7|||
125067024|NCT02721251|449862522|FG002|Overall Study|Withdrawal by Subject|9|||
125067025|NCT02721251|449862520|FG000|Overall Study|poor adherence|2|||
125067026|NCT02721251|449862521|FG001|Overall Study|poor adherence|2|||
125067027|NCT02721251|449862522|FG002|Overall Study|poor adherence|2|||
125067028|NCT01714817|449862523|FG000|Year 1 Period|Lack of Efficacy|11|||
125067029|NCT01714817|449862524|FG001|Year 1 Period|Lack of Efficacy|9|||
125067030|NCT01714817|449862523|FG000|Year 1 Period|Adverse Event|20|||
125067031|NCT01714817|449862524|FG001|Year 1 Period|Adverse Event|17|||
125067032|NCT01714817|449862523|FG000|Year 1 Period|Withdrawal by Subject|6|||
125067033|NCT01714817|449862524|FG001|Year 1 Period|Withdrawal by Subject|7|||
125067034|NCT01714817|449862523|FG000|Year 1 Period|Death|1|||
125067035|NCT01714817|449862524|FG001|Year 1 Period|Death|1|||
125067036|NCT01714817|449862523|FG000|Year 1 Period|Lost to Follow-up|0|||
125067037|NCT01714817|449862524|FG001|Year 1 Period|Lost to Follow-up|2|||
125067038|NCT01714817|449862523|FG000|Year 1 Period|Poor / non-compliance|0|||
125067039|NCT01714817|449862524|FG001|Year 1 Period|Poor / non-compliance|1|||
125067040|NCT01714817|449862523|FG000|Year 1 Period|Pregnancy|2|||
125067041|NCT01714817|449862524|FG001|Year 1 Period|Pregnancy|0|||
125067042|NCT01714817|449862523|FG000|Year 1 Period|Participant no longer meets criteria|6|||
125067043|NCT01714817|449862524|FG001|Year 1 Period|Participant no longer meets criteria|2|||
125067044|NCT01714817|449862523|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
125067045|NCT01714817|449862524|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
125067046|NCT01714817|449862523|FG000|Year 1 Period|Change in Concomitant Medication|0|||
125067047|NCT01714817|449862524|FG001|Year 1 Period|Change in Concomitant Medication|1|||
125067048|NCT01714817|449862523|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
125067049|NCT01714817|449862524|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
125067050|NCT01714817|449862523|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
125067051|NCT01714817|449862524|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
125067052|NCT01714817|449862523|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
125067053|NCT01714817|449862524|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
125067054|NCT01714817|449862523|FG000|Year 2 Period|Lack of Efficacy|4|||
125067055|NCT01714817|449862524|FG001|Year 2 Period|Lack of Efficacy|12|||
125067056|NCT01714817|449862523|FG000|Year 2 Period|Adverse Event|7|||
125067057|NCT01714817|449862524|FG001|Year 2 Period|Adverse Event|6|||
125067058|NCT01714817|449862523|FG000|Year 2 Period|Participant request to stop treatment|4|||
125067059|NCT01714817|449862524|FG001|Year 2 Period|Participant request to stop treatment|4|||
125067060|NCT01714817|449862523|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
125067061|NCT01714817|449862524|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
125067062|NCT01714817|449862523|FG000|Year 2 Period|Participant withdrew consent|1|||
125067063|NCT01714817|449862524|FG001|Year 2 Period|Participant withdrew consent|5|||
125067064|NCT01714817|449862523|FG000|Year 2 Period|Participant no longer meets criteria|1|||
125067065|NCT01714817|449862524|FG001|Year 2 Period|Participant no longer meets criteria|4|||
125067066|NCT01714817|449862523|FG000|Year 2 Period|Lost to Follow-up|2|||
125067067|NCT01714817|449862524|FG001|Year 2 Period|Lost to Follow-up|0|||
125067068|NCT01714817|449862523|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
125067069|NCT01714817|449862524|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
125067070|NCT01714817|449862523|FG000|Year 2 Period|Pregnancy|1|||
125067071|NCT01714817|449862524|FG001|Year 2 Period|Pregnancy|1|||
125067072|NCT01714817|449862523|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
125067073|NCT01714817|449862524|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
125067074|NCT01714817|449862523|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
125067075|NCT01714817|449862524|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
125067076|NCT01714817|449862523|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
125140424|NCT00425308|450137618|FG000|Overall Study|Adverse Event|2|||
125140425|NCT00425308|450137619|FG001|Overall Study|Adverse Event|1|||
125140426|NCT00425308|450137618|FG000|Overall Study|Withdrawal by Subject|1|||
125140427|NCT00425308|450137619|FG001|Overall Study|Withdrawal by Subject|0|||
125140428|NCT00425308|450137618|FG000|Overall Study|Death|1|||
125140429|NCT00425308|450137619|FG001|Overall Study|Death|0|||
125140430|NCT04442503|450137620|FG000|Overall Study|Adverse Event|1|||
125140431|NCT04442503|450137621|FG001|Overall Study|Adverse Event|1|||
125140432|NCT04442503|450137620|FG000|Overall Study|Lost to Follow-up|8|||
125140433|NCT04442503|450137621|FG001|Overall Study|Lost to Follow-up|6|||
125140434|NCT04442503|450137620|FG000|Overall Study|Physician Decision|0|||
125140435|NCT04442503|450137621|FG001|Overall Study|Physician Decision|2|||
125140436|NCT04442503|450137620|FG000|Overall Study|Withdrawal by Subject|3|||
125140437|NCT04442503|450137621|FG001|Overall Study|Withdrawal by Subject|4|||
125067077|NCT01714817|449862524|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
125140438|NCT04442503|450137620|FG000|Overall Study|Reason not Specified|0|||
125140439|NCT04442503|450137621|FG001|Overall Study|Reason not Specified|1|||
125140440|NCT04442503|450137620|FG000|Overall Study|Randomized but not Treated|3|||
125140441|NCT04442503|450137621|FG001|Overall Study|Randomized but not Treated|1|||
125140442|NCT01945580|450137625|FG000|Overall Study|Withdrawal by Subject|13|||
125140443|NCT01945580|450137626|FG001|Overall Study|Withdrawal by Subject|35|||
125140444|NCT01945580|450137625|FG000|Overall Study|Physician Decision|3|||
125140445|NCT01945580|450137626|FG001|Overall Study|Physician Decision|2|||
125140446|NCT01945580|450137625|FG000|Overall Study|Lost to Follow-up|26|||
125140447|NCT01945580|450137626|FG001|Overall Study|Lost to Follow-up|39|||
125140448|NCT01945580|450137625|FG000|Overall Study|Death|7|||
125140449|NCT01945580|450137626|FG001|Overall Study|Death|2|||
125140450|NCT01945580|450137625|FG000|Overall Study|Patient moved out of state|0|||
125140451|NCT01945580|450137626|FG001|Overall Study|Patient moved out of state|1|||
125140452|NCT01945580|450137625|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
125140453|NCT01945580|450137626|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
125140454|NCT01945580|450137625|FG000|Overall Study|Family illness - unable to return|0|||
125140455|NCT01945580|450137626|FG001|Overall Study|Family illness - unable to return|1|||
125140456|NCT01945580|450137625|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
125140457|NCT01945580|450137626|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
125140458|NCT01945580|450137625|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
125140459|NCT01945580|450137626|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
125140460|NCT01945580|450137625|FG000|Overall Study|Noncompliance with 36 month visit|1|||
125140461|NCT01945580|450137626|FG001|Overall Study|Noncompliance with 36 month visit|0|||
125140462|NCT01945580|450137625|FG000|Overall Study|The patient moved.|1|||
125140463|NCT01945580|450137626|FG001|Overall Study|The patient moved.|0|||
125140464|NCT01945580|450137625|FG000|Overall Study|No data available|0|||
125140465|NCT01945580|450137626|FG001|Overall Study|No data available|2|||
125067078|NCT01714817|449862523|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
125067079|NCT01714817|449862524|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
125067080|NCT01714817|449862523|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
125067081|NCT01714817|449862524|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
125067082|NCT01714817|449862523|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
125067083|NCT01714817|449862524|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
125067084|NCT01714817|449862523|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
125067085|NCT01714817|449862524|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
125067086|NCT01714817|449862523|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
125067087|NCT01714817|449862524|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
125067088|NCT01714817|449862523|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
125067089|NCT01714817|449862524|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
125067090|NCT01714817|449862523|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
125067091|NCT01714817|449862524|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
125067092|NCT01714817|449862523|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
125067093|NCT01714817|449862524|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
125067094|NCT01714817|449862523|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
125067095|NCT01714817|449862524|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
125140466|NCT02933060|450137629|FG000|Overall Study|Withdrawal by Subject|0|||
125140467|NCT02933060|450137630|FG001|Overall Study|Withdrawal by Subject|1|||
125140468|NCT05034874|450137633|FG000|Overall Study|Withdrawal by Subject|6|||
125140469|NCT05034874|450137634|FG001|Overall Study|Withdrawal by Subject|6|||
125140470|NCT05034874|450137633|FG000|Overall Study|Lost to Follow-up|18|||
125140471|NCT05034874|450137634|FG001|Overall Study|Lost to Follow-up|8|||
125140472|NCT05034874|450137633|FG000|Overall Study|Physician Decision|0|||
125067096|NCT01714817|449862523|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
125067097|NCT01714817|449862524|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
125067098|NCT01714817|449862523|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
125067099|NCT01714817|449862524|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
125067100|NCT01714817|449862523|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
125067101|NCT01714817|449862524|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
125067102|NCT01714817|449862523|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
125067103|NCT01714817|449862524|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
125067104|NCT02921763|449862525|FG000|Overall Study|Adverse Event|4|||
125067105|NCT02921763|449862525|FG000|Overall Study|Lost to Follow-up|4|||
125067106|NCT02921763|449862525|FG000|Overall Study|Lack of Efficacy|3|||
125067107|NCT02921763|449862525|FG000|Overall Study|Protocol Violation|2|||
125067108|NCT02921763|449862525|FG000|Overall Study|Withdrawal by Subject|2|||
125067109|NCT02921763|449862525|FG000|Overall Study|Physician Decision|1|||
125067110|NCT02921763|449862525|FG000|Overall Study|No data obtained|2|||
125067111|NCT01582971|449862526|FG000|Overall Study|Death|2|||
125067112|NCT01582971|449862527|FG001|Overall Study|Death|1|||
125067113|NCT01582971|449862526|FG000|Overall Study|Lost to Follow-up|18|||
125067114|NCT01582971|449862527|FG001|Overall Study|Lost to Follow-up|21|||
125067115|NCT01582971|449862526|FG000|Overall Study|Withdrawal by Subject|4|||
125067116|NCT01582971|449862527|FG001|Overall Study|Withdrawal by Subject|2|||
125067117|NCT01582971|449862526|FG000|Overall Study|Other|15|||
125067118|NCT01582971|449862527|FG001|Overall Study|Other|13|||
125067119|NCT02007954|449862528|FG000|Overall Study|Received liver transplant|3|||
125067120|NCT02007954|449862528|FG000|Overall Study|Switch in treatment modality|2|||
125067121|NCT02007954|449862528|FG000|Overall Study|Disease progression and unrelated AE|1|||
125067122|NCT02007954|449862528|FG000|Overall Study|Death|1|||
125067123|NCT01871896|449862537|FG000|Overall Study|Lost to Follow-up|1|||
125067124|NCT06025396|449863901|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
125067125|NCT06025396|449863902|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
125067126|NCT06025396|449863903|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
125067127|NCT06025396|449863904|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
125067128|NCT06025396|449863905|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
125067129|NCT06025396|449863901|FG000|Overall Study|Withdrawal by Subject|0|||
125067130|NCT06025396|449863902|FG001|Overall Study|Withdrawal by Subject|1|||
125067131|NCT06025396|449863903|FG002|Overall Study|Withdrawal by Subject|1|||
125067132|NCT06025396|449863904|FG003|Overall Study|Withdrawal by Subject|0|||
125067133|NCT06025396|449863905|FG004|Overall Study|Withdrawal by Subject|0|||
125067134|NCT06422377|449863911|FG000|Overall Study|Study Terminated by Sponsor|1|||
125067135|NCT02843178|449863912|FG000|Overall Study|Lost to Follow-up|8|||
125067136|NCT02843178|449863913|FG001|Overall Study|Lost to Follow-up|8|||
125067137|NCT02843178|449863914|FG002|Overall Study|Lost to Follow-up|6|||
125067138|NCT02843178|449863915|FG003|Overall Study|Lost to Follow-up|3|||
125067139|NCT02843178|449863912|FG000|Overall Study|Withdrawal by Subject|0|||
125067140|NCT02843178|449863913|FG001|Overall Study|Withdrawal by Subject|0|||
125067141|NCT02843178|449863914|FG002|Overall Study|Withdrawal by Subject|1|||
125067142|NCT02843178|449863915|FG003|Overall Study|Withdrawal by Subject|1|||
125067143|NCT02420795|449863919|FG000|Overall Study|Withdrawal by Subject|1|||
125067144|NCT02420795|449863920|FG001|Overall Study|Withdrawal by Subject|0|||
125067145|NCT02420795|449863921|FG002|Overall Study|Withdrawal by Subject|0|||
125067146|NCT02420795|449863919|FG000|Overall Study|Adverse Event|1|||
125067147|NCT02420795|449863920|FG001|Overall Study|Adverse Event|0|||
125067148|NCT02420795|449863921|FG002|Overall Study|Adverse Event|0|||
125067149|NCT02420795|449863919|FG000|Overall Study|Progressive disease|2|||
125067150|NCT02420795|449863920|FG001|Overall Study|Progressive disease|2|||
125067151|NCT02420795|449863921|FG002|Overall Study|Progressive disease|4|||
125067152|NCT02420795|449863919|FG000|Overall Study|Death|0|||
125067153|NCT02420795|449863920|FG001|Overall Study|Death|0|||
125067154|NCT02420795|449863921|FG002|Overall Study|Death|1|||
125067155|NCT01293006|449863925|FG000|Period 2|Lost to Follow-up|1|||
125067156|NCT01293006|449863926|FG001|Period 2|Lost to Follow-up|0|||
125067157|NCT01293006|449863927|FG002|Period 2|Lost to Follow-up|0|||
125067158|NCT01293006|449863928|FG003|Period 2|Lost to Follow-up|0|||
125067159|NCT00520299|449863931|FG000|Overall Study|Withdrawal by Subject|0|||
125067160|NCT00520299|449863932|FG001|Overall Study|Withdrawal by Subject|0|||
125067161|NCT00520299|449863933|FG002|Overall Study|Withdrawal by Subject|2|||
125067162|NCT00520299|449863931|FG000|Overall Study|Progressive disease|0|||
125222626|NCT03428100|450442770|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125222627|NCT03428100|450442771|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
125222628|NCT03428100|450442772|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125222629|NCT03428100|450442754|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
125222630|NCT03428100|450442755|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
125222631|NCT03428100|450442756|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
125222632|NCT03428100|450442757|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
125222633|NCT03428100|450442758|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
125222634|NCT03428100|450442759|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
125222635|NCT03428100|450442760|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
125222636|NCT03428100|450442761|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
125222637|NCT03428100|450442762|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
125222638|NCT03428100|450442763|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
125222639|NCT03428100|450442764|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
125222640|NCT03428100|450442765|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
125222641|NCT03428100|450442766|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
125222642|NCT03428100|450442767|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
125222643|NCT03428100|450442768|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
125222644|NCT03428100|450442769|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
125222645|NCT03428100|450442770|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
125222646|NCT03428100|450442771|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
125222647|NCT03428100|450442772|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
125222648|NCT03428100|450442754|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222649|NCT03428100|450442755|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222650|NCT03428100|450442756|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222651|NCT03428100|450442757|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222652|NCT03428100|450442758|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222653|NCT03428100|450442759|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222654|NCT03428100|450442760|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
125222655|NCT03428100|450442761|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222656|NCT03428100|450442762|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222657|NCT03428100|450442763|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222658|NCT03428100|450442764|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222659|NCT03428100|450442765|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222660|NCT03428100|450442766|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222661|NCT03428100|450442767|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222662|NCT03428100|450442768|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222663|NCT03428100|450442769|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222664|NCT03428100|450442770|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222665|NCT03428100|450442771|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222666|NCT03428100|450442772|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
125222667|NCT03428100|450442754|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
125222668|NCT03428100|450442755|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
125222669|NCT03428100|450442756|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
125222670|NCT03428100|450442757|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
125222671|NCT03428100|450442758|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
125222672|NCT03428100|450442759|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
125222673|NCT03428100|450442760|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
125222674|NCT03428100|450442761|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
125222675|NCT03428100|450442762|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
125222676|NCT03428100|450442763|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
125222677|NCT03428100|450442764|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
125222678|NCT03428100|450442765|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
125222679|NCT03428100|450442766|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
125222680|NCT03428100|450442767|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
125222681|NCT03428100|450442768|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
125222682|NCT03428100|450442769|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
125222683|NCT03428100|450442770|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
125067163|NCT00520299|449863932|FG001|Overall Study|Progressive disease|3|||
125067164|NCT00520299|449863933|FG002|Overall Study|Progressive disease|4|||
125067165|NCT05905601|449863937|FG000|Overall Study|Lost to Follow-up|1|||
125140473|NCT05034874|450137634|FG001|Overall Study|Physician Decision|1|||
125140474|NCT05034874|450137633|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
125140475|NCT05034874|450137634|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
125140476|NCT00989950|450137635|FG000|Randomized Phase|Protocol Violation|1|||
125140477|NCT00989950|450137636|FG001|Randomized Phase|Protocol Violation|0|||
125140478|NCT00989950|450137637|FG002|Randomized Phase|Protocol Violation|0|||
125140479|NCT00989950|450137638|FG003|Randomized Phase|Protocol Violation|0|||
125140480|NCT00989950|450137635|FG000|Randomized Phase|Adverse Event|0|||
125140481|NCT00989950|450137636|FG001|Randomized Phase|Adverse Event|1|||
125140482|NCT00989950|450137637|FG002|Randomized Phase|Adverse Event|0|||
125140483|NCT00989950|450137638|FG003|Randomized Phase|Adverse Event|0|||
125140484|NCT00101439|450137639|FG000|Period 2|Withdrawal by Subject|0|||
125140485|NCT00101439|450137640|FG001|Period 2|Withdrawal by Subject|2|||
125140486|NCT01867658|450137642|FG000|Overall Study|Withdrawal by Subject|6|||
125140487|NCT01867658|450137642|FG000|Overall Study|Death|2|||
125140488|NCT01867658|450137642|FG000|Overall Study|Subject could not be contacted|1|||
125140489|NCT00840658|450137643|FG000|Overall Study|Death|2|||
125140490|NCT00840658|450137644|FG001|Overall Study|Death|2|||
125140491|NCT00840658|450137645|FG002|Overall Study|Death|3|||
125140492|NCT00840658|450137646|FG003|Overall Study|Death|3|||
125067166|NCT05905601|449863938|FG001|Overall Study|Lost to Follow-up|3|||
125067167|NCT03024255|449863939|FG000|Overall Study|Adverse Event|1|||
125067168|NCT03024255|449863940|FG001|Overall Study|Adverse Event|4|||
125067169|NCT03024255|449863941|FG002|Overall Study|Adverse Event|8|||
125067170|NCT03024255|449863942|FG003|Overall Study|Adverse Event|0|||
125067171|NCT03024255|449863939|FG000|Overall Study|Withdrawal by Subject|3|||
125067172|NCT03024255|449863940|FG001|Overall Study|Withdrawal by Subject|1|||
125067173|NCT03024255|449863941|FG002|Overall Study|Withdrawal by Subject|0|||
125067174|NCT03024255|449863942|FG003|Overall Study|Withdrawal by Subject|3|||
125067175|NCT03024255|449863939|FG000|Overall Study|Protocol Violation|0|||
125067176|NCT03024255|449863940|FG001|Overall Study|Protocol Violation|0|||
125067177|NCT03024255|449863941|FG002|Overall Study|Protocol Violation|2|||
125067178|NCT03024255|449863942|FG003|Overall Study|Protocol Violation|0|||
125067179|NCT03024255|449863939|FG000|Overall Study|Lost to Follow-up|1|||
125067180|NCT03024255|449863940|FG001|Overall Study|Lost to Follow-up|2|||
125067181|NCT03024255|449863941|FG002|Overall Study|Lost to Follow-up|1|||
125067182|NCT03024255|449863942|FG003|Overall Study|Lost to Follow-up|1|||
125067183|NCT03024255|449863939|FG000|Overall Study|Lack of Efficacy|1|||
125067184|NCT03024255|449863940|FG001|Overall Study|Lack of Efficacy|0|||
125067185|NCT03024255|449863941|FG002|Overall Study|Lack of Efficacy|0|||
125067186|NCT03024255|449863942|FG003|Overall Study|Lack of Efficacy|0|||
125067187|NCT03024255|449863939|FG000|Overall Study|Protocol Noncompliance|1|||
125067188|NCT03024255|449863940|FG001|Overall Study|Protocol Noncompliance|1|||
125067189|NCT03024255|449863941|FG002|Overall Study|Protocol Noncompliance|0|||
125067190|NCT03024255|449863942|FG003|Overall Study|Protocol Noncompliance|1|||
125067191|NCT03583606|449863943|FG000|Overall Study|Lost to Follow-up|0|||
125067192|NCT03583606|449863944|FG001|Overall Study|Lost to Follow-up|1|||
125067193|NCT03583606|449863945|FG002|Overall Study|Lost to Follow-up|0|||
125067194|NCT03583606|449863943|FG000|Overall Study|Ineligible at baseline|1|||
125067195|NCT03583606|449863944|FG001|Overall Study|Ineligible at baseline|0|||
125067196|NCT03583606|449863945|FG002|Overall Study|Ineligible at baseline|0|||
125140493|NCT00840658|450137643|FG000|Overall Study|Lost to Follow-up|3|||
125140494|NCT00840658|450137644|FG001|Overall Study|Lost to Follow-up|1|||
125140495|NCT00840658|450137645|FG002|Overall Study|Lost to Follow-up|2|||
125140496|NCT00840658|450137646|FG003|Overall Study|Lost to Follow-up|1|||
125140497|NCT03101358|450137647|FG000|Overall Study|Non-compliance with study schedule|1|||
125067197|NCT00126581|449863950|FG000|Overall Study|Adverse Event|3|||
125067198|NCT00126581|449863951|FG001|Overall Study|Adverse Event|7|||
125067199|NCT00126581|449863950|FG000|Overall Study|Death|3|||
125140498|NCT03101358|450137648|FG001|Overall Study|Non-compliance with study schedule|0|||
125140499|NCT03101358|450137649|FG002|Overall Study|Non-compliance with study schedule|0|||
125140500|NCT03101358|450137650|FG003|Overall Study|Non-compliance with study schedule|1|||
125067200|NCT00126581|449863951|FG001|Overall Study|Death|2|||
125140501|NCT03101358|450137647|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
125140502|NCT03101358|450137648|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
125140503|NCT03101358|450137649|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
125140504|NCT03101358|450137650|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
125067201|NCT00126581|449863950|FG000|Overall Study|Withdrawal by Subject|1|||
125067202|NCT00126581|449863951|FG001|Overall Study|Withdrawal by Subject|4|||
125067203|NCT00126581|449863950|FG000|Overall Study|Alternative therapy|3|||
125067204|NCT00126581|449863951|FG001|Overall Study|Alternative therapy|3|||
125067205|NCT00126581|449863950|FG000|Overall Study|Other illness/MD discretion|3|||
125067206|NCT00126581|449863951|FG001|Overall Study|Other illness/MD discretion|4|||
125067207|NCT03728140|449863953|FG000|Overall Study|Abnormal embryo transfer operation|10|||
125140505|NCT03101358|450137647|FG000|Overall Study|Physician Decision|1|||
125140506|NCT03101358|450137648|FG001|Overall Study|Physician Decision|0|||
125140507|NCT03101358|450137649|FG002|Overall Study|Physician Decision|0|||
125222684|NCT03428100|450442771|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
125067208|NCT03728140|449863954|FG001|Overall Study|Abnormal embryo transfer operation|7|||
125067209|NCT03783442|449863957|FG000|Overall Study|Death|252|||
125067210|NCT03783442|449863958|FG001|Overall Study|Death|268|||
125067211|NCT03783442|449863957|FG000|Overall Study|Withdrawal by Subject|19|||
125067212|NCT03783442|449863958|FG001|Overall Study|Withdrawal by Subject|21|||
125067213|NCT03783442|449863957|FG000|Overall Study|Lost to Follow-up|7|||
125067214|NCT03783442|449863958|FG001|Overall Study|Lost to Follow-up|6|||
125067215|NCT03783442|449863957|FG000|Overall Study|Sponsor Ended Study|48|||
125067216|NCT03783442|449863958|FG001|Overall Study|Sponsor Ended Study|28|||
125067217|NCT01504971|449863959|FG000|Overall Study|Physician Decision|13|||
125067218|NCT03483116|449863960|FG000|Overall Study|Adverse Event|0|||
125067219|NCT03483116|449863961|FG001|Overall Study|Adverse Event|1|||
125067220|NCT03483116|449863962|FG002|Overall Study|Adverse Event|0|||
125067221|NCT03483116|449863963|FG003|Overall Study|Adverse Event|1|||
125067222|NCT03483116|449863960|FG000|Overall Study|Protocol Violation|1|||
125067223|NCT03483116|449863961|FG001|Overall Study|Protocol Violation|0|||
125067224|NCT03483116|449863962|FG002|Overall Study|Protocol Violation|0|||
125067225|NCT03483116|449863963|FG003|Overall Study|Protocol Violation|7|||
125067226|NCT03483116|449863960|FG000|Overall Study|Lost to Follow-up|9|||
125067227|NCT03483116|449863961|FG001|Overall Study|Lost to Follow-up|4|||
125067228|NCT03483116|449863962|FG002|Overall Study|Lost to Follow-up|9|||
125067229|NCT03483116|449863963|FG003|Overall Study|Lost to Follow-up|5|||
125067230|NCT03483116|449863960|FG000|Overall Study|Death|1|||
125067231|NCT03483116|449863961|FG001|Overall Study|Death|0|||
125067232|NCT03483116|449863962|FG002|Overall Study|Death|2|||
125067233|NCT03483116|449863963|FG003|Overall Study|Death|1|||
125067234|NCT03483116|449863960|FG000|Overall Study|Withdrawal by Subject|14|||
125067235|NCT03483116|449863961|FG001|Overall Study|Withdrawal by Subject|16|||
125067236|NCT03483116|449863962|FG002|Overall Study|Withdrawal by Subject|14|||
125067237|NCT03483116|449863963|FG003|Overall Study|Withdrawal by Subject|16|||
125067238|NCT03483116|449863960|FG000|Overall Study|Unknown other reason|3|||
125067239|NCT03483116|449863961|FG001|Overall Study|Unknown other reason|2|||
125067240|NCT03483116|449863962|FG002|Overall Study|Unknown other reason|1|||
125067241|NCT03483116|449863963|FG003|Overall Study|Unknown other reason|1|||
125067242|NCT00426556|449863966|FG000|Phase I - Core Phase|Disease Progression|0|||
125067243|NCT00426556|449863967|FG001|Phase I - Core Phase|Disease Progression|6|||
125067244|NCT00426556|449863968|FG002|Phase I - Core Phase|Disease Progression|2|||
125067245|NCT00426556|449863969|FG003|Phase I - Core Phase|Disease Progression|0|||
125067246|NCT00426556|449863966|FG000|Phase I - Core Phase|Adverse Event|1|||
125067247|NCT00426556|449863967|FG001|Phase I - Core Phase|Adverse Event|3|||
125067248|NCT00426556|449863968|FG002|Phase I - Core Phase|Adverse Event|1|||
125067249|NCT00426556|449863969|FG003|Phase I - Core Phase|Adverse Event|0|||
125067250|NCT00426556|449863966|FG000|Phase I - Core Phase|Death|0|||
125067251|NCT00426556|449863967|FG001|Phase I - Core Phase|Death|1|||
125067252|NCT00426556|449863968|FG002|Phase I - Core Phase|Death|0|||
125067253|NCT00426556|449863969|FG003|Phase I - Core Phase|Death|0|||
125067254|NCT00426556|449863966|FG000|Phase I - Extension Phase|Adverse Event|0|||
125067255|NCT00426556|449863967|FG001|Phase I - Extension Phase|Adverse Event|1|||
125067256|NCT00426556|449863968|FG002|Phase I - Extension Phase|Adverse Event|1|||
125067257|NCT00426556|449863969|FG003|Phase I - Extension Phase|Adverse Event|0|||
125067258|NCT00426556|449863966|FG000|Phase I - Extension Phase|Disease Progression|5|||
125067259|NCT00426556|449863967|FG001|Phase I - Extension Phase|Disease Progression|5|||
125067260|NCT00426556|449863968|FG002|Phase I - Extension Phase|Disease Progression|6|||
125067261|NCT00426556|449863969|FG003|Phase I - Extension Phase|Disease Progression|0|||
125067262|NCT00426556|449863966|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
125067263|NCT00426556|449863967|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
125067264|NCT00426556|449863968|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
125067265|NCT00426556|449863969|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
125067266|NCT00426556|449863966|FG000|Phase II - Core Phase|Disease Progression|0|||
125067267|NCT00426556|449863967|FG001|Phase II - Core Phase|Disease Progression|0|||
125067268|NCT00426556|449863968|FG002|Phase II - Core Phase|Disease Progression|0|||
125067269|NCT00426556|449863969|FG003|Phase II - Core Phase|Disease Progression|16|||
125067270|NCT00426556|449863966|FG000|Phase II - Core Phase|Adverse Event|0|||
125067271|NCT00426556|449863967|FG001|Phase II - Core Phase|Adverse Event|0|||
125067272|NCT00426556|449863968|FG002|Phase II - Core Phase|Adverse Event|0|||
125067273|NCT00426556|449863969|FG003|Phase II - Core Phase|Adverse Event|8|||
125067274|NCT00426556|449863966|FG000|Phase II - Extension Phase|Disease Progression|0|||
125067275|NCT00426556|449863967|FG001|Phase II - Extension Phase|Disease Progression|0|||
125067276|NCT00426556|449863968|FG002|Phase II - Extension Phase|Disease Progression|0|||
125067277|NCT00426556|449863969|FG003|Phase II - Extension Phase|Disease Progression|21|||
125067278|NCT00426556|449863966|FG000|Phase II - Extension Phase|Adverse Event|0|||
125067279|NCT00426556|449863967|FG001|Phase II - Extension Phase|Adverse Event|0|||
125067280|NCT00426556|449863968|FG002|Phase II - Extension Phase|Adverse Event|0|||
125067281|NCT00426556|449863969|FG003|Phase II - Extension Phase|Adverse Event|2|||
125067282|NCT00225212|449863970|FG000|Overall Study|Disease progression|2|||
125067283|NCT00225212|449863970|FG000|Overall Study|Death|1|||
125067284|NCT00225212|449863970|FG000|Overall Study|Adverse Event|2|||
125067285|NCT00225212|449863970|FG000|Overall Study|Intercurrent illness|1|||
125067286|NCT01182337|449863977|FG000|Overall Study|Withdrawal by Subject|3|||
125067287|NCT01182337|449863978|FG001|Overall Study|Withdrawal by Subject|1|||
125067288|NCT01182337|449863977|FG000|Overall Study|Lost to Follow-up|0|||
125067289|NCT01182337|449863978|FG001|Overall Study|Lost to Follow-up|1|||
125067290|NCT03448224|449863979|FG000|Overall Study|Provided same answer to every question|1|||
125067291|NCT03448224|449863980|FG001|Overall Study|Provided same answer to every question|0|||
125067292|NCT03103906|449863981|FG000|Overall Study|Adverse Event|2|||
125067293|NCT03103906|449863982|FG001|Overall Study|Adverse Event|3|||
125067294|NCT03103906|449863981|FG000|Overall Study|Other|2|||
125067295|NCT03103906|449863982|FG001|Overall Study|Other|0|||
125067296|NCT03571256|449863983|FG000|Overall Study|Adverse Event|3|||
125067297|NCT03571256|449863984|FG001|Overall Study|Adverse Event|0|||
125067298|NCT03571256|449863985|FG002|Overall Study|Adverse Event|1|||
125067299|NCT03571256|449863983|FG000|Overall Study|Withdrawal by Subject|3|||
125067300|NCT03571256|449863984|FG001|Overall Study|Withdrawal by Subject|1|||
125067301|NCT03571256|449863985|FG002|Overall Study|Withdrawal by Subject|1|||
125067302|NCT03571256|449863983|FG000|Overall Study|Other than specified|0|||
125067303|NCT03571256|449863984|FG001|Overall Study|Other than specified|1|||
125067304|NCT03571256|449863985|FG002|Overall Study|Other than specified|1|||
125067305|NCT03571256|449863983|FG000|Overall Study|Protocol Violation|0|||
125067306|NCT03571256|449863984|FG001|Overall Study|Protocol Violation|1|||
125067307|NCT03571256|449863985|FG002|Overall Study|Protocol Violation|1|||
125067308|NCT00575094|449863986|FG000|Overall Study|Adverse Event|2|||
125067309|NCT00575094|449863986|FG000|Overall Study|Withdrawal by Subject|1|||
125067310|NCT00772382|449863992|FG000|Overall Study|Adverse Event|19|||
125067311|NCT00772382|449863992|FG000|Overall Study|Death|6|||
125067312|NCT00772382|449863992|FG000|Overall Study|Lack of Efficacy|4|||
125067313|NCT00772382|449863992|FG000|Overall Study|Physician Decision|5|||
125067314|NCT00772382|449863992|FG000|Overall Study|Protocol Violation|1|||
125067315|NCT00772382|449863992|FG000|Overall Study|Withdrawal by Subject|10|||
125067316|NCT00772382|449863992|FG000|Overall Study|Other Reasons|10|||
125067317|NCT00643604|449863995|FG000|Overall Study|Death|1|||
125067318|NCT02702011|449863999|FG000|Overall Study|Withdrawal by Subject|0|||
125067319|NCT02702011|449864000|FG001|Overall Study|Withdrawal by Subject|1|||
125067320|NCT02702011|449864001|FG002|Overall Study|Withdrawal by Subject|0|||
125067321|NCT02702011|449864002|FG003|Overall Study|Withdrawal by Subject|0|||
125067322|NCT01374217|449864004|FG000|Overall Study|Lack of Efficacy|13|||
125067323|NCT01740388|449864005|FG000|Overall Study|Withdrawal by Subject|1|||
125067324|NCT01740388|449864006|FG001|Overall Study|Withdrawal by Subject|2|||
125067325|NCT01740388|449864005|FG000|Overall Study|Lost to Follow-up|2|||
125067326|NCT01740388|449864006|FG001|Overall Study|Lost to Follow-up|0|||
125067327|NCT01740388|449864005|FG000|Overall Study|Physician Decision|2|||
125067328|NCT01740388|449864006|FG001|Overall Study|Physician Decision|6|||
125067329|NCT01740388|449864005|FG000|Overall Study|Subjects missing data, completed|41|||
125067330|NCT01740388|449864006|FG001|Overall Study|Subjects missing data, completed|36|||
125067331|NCT00862121|449864009|FG000|Overall Study|Adverse Event|1|||
125067332|NCT00862121|449864010|FG001|Overall Study|Adverse Event|2|||
125067333|NCT00862121|449864009|FG000|Overall Study|Lack of Efficacy|0|||
125067334|NCT00862121|449864010|FG001|Overall Study|Lack of Efficacy|3|||
125067335|NCT00862121|449864009|FG000|Overall Study|Protocol Violation|0|||
125067336|NCT00862121|449864010|FG001|Overall Study|Protocol Violation|1|||
125067337|NCT00862121|449864009|FG000|Overall Study|Exclusion criterion violation|0|||
125067338|NCT00862121|449864010|FG001|Overall Study|Exclusion criterion violation|1|||
125067339|NCT00862121|449864009|FG000|Overall Study|Incorrect randomisation|0|||
125067340|NCT00862121|449864010|FG001|Overall Study|Incorrect randomisation|1|||
125067341|NCT01641991|449864011|FG000|Overall Study|Physician Decision|0|||
125067342|NCT01641991|449864012|FG001|Overall Study|Physician Decision|1|||
125067343|NCT01641991|449864013|FG002|Overall Study|Physician Decision|7|||
125067344|NCT01641991|449864014|FG003|Overall Study|Physician Decision|5|||
125067345|NCT01641991|449864011|FG000|Overall Study|Withdrawal by Subject|4|||
125067346|NCT01641991|449864012|FG001|Overall Study|Withdrawal by Subject|2|||
125067347|NCT01641991|449864013|FG002|Overall Study|Withdrawal by Subject|1|||
125067348|NCT01641991|449864014|FG003|Overall Study|Withdrawal by Subject|5|||
125067349|NCT01641991|449864011|FG000|Overall Study|Adverse Event|2|||
125067350|NCT01641991|449864012|FG001|Overall Study|Adverse Event|1|||
125222685|NCT03428100|450442772|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
125067351|NCT01641991|449864013|FG002|Overall Study|Adverse Event|2|||
125067352|NCT01641991|449864014|FG003|Overall Study|Adverse Event|1|||
125067353|NCT01641991|449864011|FG000|Overall Study|Lost to Follow-up|0|||
125067354|NCT01641991|449864012|FG001|Overall Study|Lost to Follow-up|2|||
125067355|NCT01641991|449864013|FG002|Overall Study|Lost to Follow-up|3|||
125067356|NCT01641991|449864014|FG003|Overall Study|Lost to Follow-up|1|||
125067357|NCT01641991|449864011|FG000|Overall Study|Protocol Violation|1|||
125067358|NCT01641991|449864012|FG001|Overall Study|Protocol Violation|1|||
125067359|NCT01641991|449864013|FG002|Overall Study|Protocol Violation|3|||
125067360|NCT01641991|449864014|FG003|Overall Study|Protocol Violation|0|||
125067361|NCT01641991|449864011|FG000|Overall Study|Pregnancy|0|||
125067362|NCT01641991|449864012|FG001|Overall Study|Pregnancy|0|||
125067363|NCT01641991|449864013|FG002|Overall Study|Pregnancy|1|||
125067364|NCT01641991|449864014|FG003|Overall Study|Pregnancy|0|||
125067365|NCT01641991|449864011|FG000|Overall Study|no longer eligible|2|||
125067366|NCT01641991|449864012|FG001|Overall Study|no longer eligible|1|||
125067367|NCT01641991|449864013|FG002|Overall Study|no longer eligible|0|||
125067368|NCT01641991|449864014|FG003|Overall Study|no longer eligible|4|||
125067369|NCT01578785|449864019|FG000|Overall Study|Withdrawal by Subject|0|||
125067370|NCT01578785|449864020|FG001|Overall Study|Withdrawal by Subject|1|||
125067371|NCT01578785|449864019|FG000|Overall Study|Study terminated by sponsor|59|||
125067372|NCT01578785|449864020|FG001|Overall Study|Study terminated by sponsor|118|||
125067373|NCT03371732|449864021|FG000|Overall Study|Withdrawal by Subject|9|||
125067374|NCT03371732|449864022|FG001|Overall Study|Withdrawal by Subject|3|||
125067375|NCT03371732|449864021|FG000|Overall Study|Refusal to continue|3|||
125067376|NCT03371732|449864022|FG001|Overall Study|Refusal to continue|4|||
125067377|NCT00171314|449864023|FG000|Overall Study|Adverse Event|44|||
125067378|NCT00171314|449864024|FG001|Overall Study|Adverse Event|41|||
125067379|NCT00171314|449864023|FG000|Overall Study|Lack of Efficacy|19|||
125067380|NCT00171314|449864024|FG001|Overall Study|Lack of Efficacy|14|||
125067381|NCT00171314|449864023|FG000|Overall Study|Withdrawal by Subject|9|||
125067382|NCT00171314|449864024|FG001|Overall Study|Withdrawal by Subject|6|||
125067383|NCT00171314|449864023|FG000|Overall Study|Abnormal Test Procedure Results|9|||
125067384|NCT00171314|449864024|FG001|Overall Study|Abnormal Test Procedure Results|3|||
125067385|NCT00171314|449864023|FG000|Overall Study|Protocol Violation|3|||
125067386|NCT00171314|449864024|FG001|Overall Study|Protocol Violation|7|||
125067387|NCT00171314|449864023|FG000|Overall Study|Administrative Problems|4|||
125067388|NCT00171314|449864024|FG001|Overall Study|Administrative Problems|3|||
125067389|NCT00171314|449864023|FG000|Overall Study|Lost to Follow-up|1|||
125067390|NCT00171314|449864024|FG001|Overall Study|Lost to Follow-up|3|||
125067391|NCT00171314|449864023|FG000|Overall Study|Death|2|||
125067392|NCT00171314|449864024|FG001|Overall Study|Death|1|||
125067393|NCT00475540|449864025|FG000|36 Months|Lost to Follow-up|4|||
125067394|NCT00475540|449864026|FG001|36 Months|Lost to Follow-up|4|||
125067395|NCT00475540|449864025|FG000|36 Months|Death|1|||
125067396|NCT00475540|449864026|FG001|36 Months|Death|2|||
125067397|NCT00475540|449864025|FG000|36 Months|Censored due to reoperation|3|||
125067398|NCT00475540|449864026|FG001|36 Months|Censored due to reoperation|0|||
125067399|NCT00377429|449864027|FG000|Overall Study|Withdrawal by Subject|5|||
125067400|NCT00377429|449864027|FG000|Overall Study|Adverse Event|8|||
125067401|NCT00377429|449864027|FG000|Overall Study|Physician Decision|1|||
125067402|NCT00377429|449864027|FG000|Overall Study|Patient non-compliance|1|||
125067403|NCT01033487|449864033|FG000|Fourth Intervention Period|Adverse Event|0|||
125067404|NCT01033487|449864034|FG001|Fourth Intervention Period|Adverse Event|0|||
125067405|NCT01033487|449864035|FG002|Fourth Intervention Period|Adverse Event|0|||
125067406|NCT01033487|449864036|FG003|Fourth Intervention Period|Adverse Event|0|||
125067407|NCT01033487|449864037|FG004|Fourth Intervention Period|Adverse Event|0|||
125067408|NCT01033487|449864038|FG005|Fourth Intervention Period|Adverse Event|0|||
125067409|NCT01033487|449864039|FG006|Fourth Intervention Period|Adverse Event|0|||
125067410|NCT01033487|449864040|FG007|Fourth Intervention Period|Adverse Event|0|||
125067411|NCT01033487|449864041|FG008|Fourth Intervention Period|Adverse Event|1|||
125067412|NCT01033487|449864042|FG009|Fourth Intervention Period|Adverse Event|0|||
125067413|NCT02939599|449864043|FG000|Overall Study|Adverse Event|1|||
125067414|NCT02939599|449864044|FG001|Overall Study|Adverse Event|0|||
125067415|NCT02939599|449864043|FG000|Overall Study|Study Terminated By Sponsor|2|||
125067416|NCT02939599|449864044|FG001|Overall Study|Study Terminated By Sponsor|2|||
125067417|NCT02148211|449864045|FG000|Overall Study|Lost to Follow-up|352|||
125067418|NCT02726113|449864046|FG000|Total Enrollment|Physician Decision|0|||
125067419|NCT02726113|449864047|FG001|Total Enrollment|Physician Decision|1|||
125067420|NCT02726113|449864046|FG000|Total Enrollment|Protocol Violation|1|||
125067421|NCT02726113|449864047|FG001|Total Enrollment|Protocol Violation|0|||
125067422|NCT02726113|449864046|FG000|Total Enrollment|Withdrawal by Subject|2|||
125067423|NCT02726113|449864047|FG001|Total Enrollment|Withdrawal by Subject|1|||
125067424|NCT02726113|449864046|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
125067425|NCT02726113|449864047|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
125067426|NCT02726113|449864046|FG000|Genomic Analysis|Protocol Violation|1|||
125067427|NCT02726113|449864047|FG001|Genomic Analysis|Protocol Violation|0|||
125067428|NCT02726113|449864046|FG000|Genomic Analysis|Withdrawal by Subject|2|||
125067429|NCT02726113|449864047|FG001|Genomic Analysis|Withdrawal by Subject|1|||
125067430|NCT02726113|449864046|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
125067431|NCT02726113|449864047|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
125067432|NCT01512108|449866145|FG000|Overall Study|Adverse Event|9|||
125067433|NCT01512108|449866146|FG001|Overall Study|Adverse Event|4|||
125067434|NCT01512108|449866145|FG000|Overall Study|Protocol Violation|1|||
125067435|NCT01512108|449866146|FG001|Overall Study|Protocol Violation|2|||
125067436|NCT01512108|449866145|FG000|Overall Study|Withdrawal Criteria|1|||
125067437|NCT01512108|449866146|FG001|Overall Study|Withdrawal Criteria|0|||
125140508|NCT03101358|450137650|FG003|Overall Study|Physician Decision|3|||
125140509|NCT03101358|450137647|FG000|Overall Study|Adverse Event|0|||
125140510|NCT03101358|450137648|FG001|Overall Study|Adverse Event|0|||
125140511|NCT03101358|450137649|FG002|Overall Study|Adverse Event|1|||
125140512|NCT03101358|450137650|FG003|Overall Study|Adverse Event|0|||
125140513|NCT03101358|450137647|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
125140514|NCT03101358|450137648|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
125140515|NCT03101358|450137649|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
125140516|NCT03101358|450137650|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
125140517|NCT03101358|450137647|FG000|Overall Study|Lost to Follow-up|1|||
125140518|NCT03101358|450137648|FG001|Overall Study|Lost to Follow-up|0|||
125140519|NCT03101358|450137649|FG002|Overall Study|Lost to Follow-up|0|||
125140520|NCT03101358|450137650|FG003|Overall Study|Lost to Follow-up|1|||
125140521|NCT00474058|450137651|FG000|Overall Study|Adverse Event|11|||
125140522|NCT00474058|450137652|FG001|Overall Study|Adverse Event|6|||
125140523|NCT00474058|450137651|FG000|Overall Study|Lack of Efficacy|0|||
125140524|NCT00474058|450137652|FG001|Overall Study|Lack of Efficacy|4|||
125140525|NCT00474058|450137651|FG000|Overall Study|Withdrawal by Subject|11|||
125140526|NCT00474058|450137652|FG001|Overall Study|Withdrawal by Subject|7|||
125140527|NCT00474058|450137651|FG000|Overall Study|Other|2|||
125067438|NCT01512108|449866145|FG000|Overall Study|Unclassified|11|||
125067439|NCT01512108|449866146|FG001|Overall Study|Unclassified|3|||
125067440|NCT01824693|449866147|FG000|Overall Study|Death|0|||
125067441|NCT01824693|449866148|FG001|Overall Study|Death|1|||
125067442|NCT01824693|449866149|FG002|Overall Study|Death|0|||
125067443|NCT01824693|449866147|FG000|Overall Study|Physician Decision|1|||
125067444|NCT01824693|449866148|FG001|Overall Study|Physician Decision|1|||
125067445|NCT01824693|449866149|FG002|Overall Study|Physician Decision|1|||
125067446|NCT01824693|449866147|FG000|Overall Study|Withdrawal by Subject|0|||
125067447|NCT01824693|449866148|FG001|Overall Study|Withdrawal by Subject|0|||
125067448|NCT01824693|449866149|FG002|Overall Study|Withdrawal by Subject|1|||
125067449|NCT01824693|449866147|FG000|Overall Study|Progressive Disease|0|||
125067450|NCT01824693|449866148|FG001|Overall Study|Progressive Disease|5|||
125067451|NCT01824693|449866149|FG002|Overall Study|Progressive Disease|0|||
125067452|NCT01824693|449866147|FG000|Overall Study|Ineligible|0|||
125067453|NCT01824693|449866148|FG001|Overall Study|Ineligible|0|||
125067454|NCT01824693|449866149|FG002|Overall Study|Ineligible|3|||
125067455|NCT01824693|449866147|FG000|Overall Study|No Transplant Planned|0|||
125067456|NCT01824693|449866148|FG001|Overall Study|No Transplant Planned|0|||
125067457|NCT01824693|449866149|FG002|Overall Study|No Transplant Planned|10|||
125067458|NCT03287869|449866152|FG000|Overall Study|Adverse Event|14|||
125067459|NCT03287869|449866153|FG001|Overall Study|Adverse Event|12|||
125067460|NCT03287869|449866152|FG000|Overall Study|Lack of Efficacy|1|||
125067461|NCT03287869|449866153|FG001|Overall Study|Lack of Efficacy|0|||
125067462|NCT03287869|449866152|FG000|Overall Study|Lost to Follow-up|13|||
125067463|NCT03287869|449866153|FG001|Overall Study|Lost to Follow-up|19|||
125067464|NCT03287869|449866152|FG000|Overall Study|Non-Compliance With Study Drug|5|||
125067465|NCT03287869|449866153|FG001|Overall Study|Non-Compliance With Study Drug|9|||
125067466|NCT03287869|449866152|FG000|Overall Study|Progressive Disease|1|||
125067467|NCT03287869|449866153|FG001|Overall Study|Progressive Disease|0|||
125067468|NCT03287869|449866152|FG000|Overall Study|Protocol Deviation|2|||
125067469|NCT03287869|449866153|FG001|Overall Study|Protocol Deviation|1|||
125067470|NCT03287869|449866152|FG000|Overall Study|Withdrawal by Subject|36|||
125067471|NCT03287869|449866153|FG001|Overall Study|Withdrawal by Subject|43|||
125067472|NCT03287869|449866152|FG000|Overall Study|Early Closure of the Site|0|||
125067473|NCT03287869|449866153|FG001|Overall Study|Early Closure of the Site|1|||
125067474|NCT03287869|449866152|FG000|Overall Study|Physician Decision|5|||
125067475|NCT03287869|449866153|FG001|Overall Study|Physician Decision|5|||
125067476|NCT03287869|449866152|FG000|Overall Study|Reason not Specified|6|||
125067477|NCT03287869|449866153|FG001|Overall Study|Reason not Specified|3|||
125067478|NCT03488238|449866154|FG000|Overall Study|Equipment malfunction|1|||
125067479|NCT03488238|449866154|FG000|Overall Study|Adverse Event|1|||
125067480|NCT02591238|449866155|FG000|Overall Study|Pregnancy|1|||
125067481|NCT02591238|449866156|FG001|Overall Study|Pregnancy|0|||
125067482|NCT02591238|449866157|FG002|Overall Study|Pregnancy|0|||
125067483|NCT02591238|449866158|FG003|Overall Study|Pregnancy|0|||
125067484|NCT02591238|449866155|FG000|Overall Study|Withdrawal by Subject|0|||
125067485|NCT02591238|449866156|FG001|Overall Study|Withdrawal by Subject|0|||
125067486|NCT02591238|449866157|FG002|Overall Study|Withdrawal by Subject|0|||
125067487|NCT02591238|449866158|FG003|Overall Study|Withdrawal by Subject|1|||
125067488|NCT02591238|449866155|FG000|Overall Study|influenza|0|||
125067489|NCT02591238|449866156|FG001|Overall Study|influenza|0|||
125067490|NCT02591238|449866157|FG002|Overall Study|influenza|0|||
125067491|NCT02591238|449866158|FG003|Overall Study|influenza|1|||
125067492|NCT02591238|449866155|FG000|Overall Study|personal circumstances|0|||
125067493|NCT02591238|449866156|FG001|Overall Study|personal circumstances|0|||
125067494|NCT02591238|449866157|FG002|Overall Study|personal circumstances|0|||
125067495|NCT02591238|449866158|FG003|Overall Study|personal circumstances|1|||
125067496|NCT02591238|449866155|FG000|Overall Study|personal circumstances|0|||
125067497|NCT02591238|449866156|FG001|Overall Study|personal circumstances|1|||
125067498|NCT02591238|449866157|FG002|Overall Study|personal circumstances|0|||
125067499|NCT02591238|449866158|FG003|Overall Study|personal circumstances|0|||
125067500|NCT00656084|449866159|FG000|Overall Study|Adverse Event|4|||
125067501|NCT00656084|449866159|FG000|Overall Study|Withdrawal by Subject|1|||
125067502|NCT00656084|449866159|FG000|Overall Study|Patient Request|1|||
125067503|NCT00656084|449866159|FG000|Overall Study|Investigator Request|1|||
125067504|NCT00953225|449866160|FG000|Overall Study|Withdrawal by Subject|2|||
125067505|NCT00953225|449866161|FG001|Overall Study|Withdrawal by Subject|0|||
125067506|NCT00640146|449866165|FG000|Overall Study|Adverse Event|2|||
125067507|NCT00640146|449866166|FG001|Overall Study|Adverse Event|0|||
125067508|NCT00640146|449866165|FG000|Overall Study|Lost to Follow-up|0|||
125067509|NCT00640146|449866166|FG001|Overall Study|Lost to Follow-up|1|||
125067510|NCT00640146|449866165|FG000|Overall Study|Lack of Efficacy|0|||
125067511|NCT00640146|449866166|FG001|Overall Study|Lack of Efficacy|1|||
125067512|NCT00640146|449866165|FG000|Overall Study|Withdrawal by Subject|1|||
125067513|NCT00640146|449866166|FG001|Overall Study|Withdrawal by Subject|1|||
125140528|NCT00474058|450137652|FG001|Overall Study|Other|0|||
125140529|NCT02426918|450137657|FG000|Overall Study|Adverse Event|2|||
125067514|NCT00640146|449866165|FG000|Overall Study|Randomized but not treated|1|||
125067515|NCT00640146|449866166|FG001|Overall Study|Randomized but not treated|3|||
125067516|NCT01634113|449866167|FG000|Overall Study|Not treated|0|||
125067517|NCT01634113|449866168|FG001|Overall Study|Not treated|0|||
125067518|NCT01634113|449866169|FG002|Overall Study|Not treated|1|||
125067519|NCT01357980|449866172|FG000|Overall Study|Lack of Efficacy|0|||
125067520|NCT01357980|449866173|FG001|Overall Study|Lack of Efficacy|1|||
125067521|NCT01357980|449866174|FG002|Overall Study|Lack of Efficacy|0|||
125067522|NCT01357980|449866175|FG003|Overall Study|Lack of Efficacy|0|||
125067523|NCT01357980|449866172|FG000|Overall Study|Consent withdrawn|0|||
125067524|NCT01357980|449866173|FG001|Overall Study|Consent withdrawn|0|||
125067525|NCT01357980|449866174|FG002|Overall Study|Consent withdrawn|1|||
125067526|NCT01357980|449866175|FG003|Overall Study|Consent withdrawn|0|||
125067527|NCT02528253|449866176|FG000|Overall Study|Adverse Event|3|||
125067528|NCT02528253|449866177|FG001|Overall Study|Adverse Event|4|||
125067529|NCT02528253|449866178|FG002|Overall Study|Adverse Event|4|||
125067530|NCT02528253|449866179|FG003|Overall Study|Adverse Event|8|||
125067531|NCT02528253|449866180|FG004|Overall Study|Adverse Event|18|||
125067532|NCT02528253|449866176|FG000|Overall Study|Death|2|||
125067533|NCT02528253|449866177|FG001|Overall Study|Death|2|||
125067534|NCT02528253|449866178|FG002|Overall Study|Death|1|||
125067535|NCT02528253|449866179|FG003|Overall Study|Death|0|||
125067536|NCT02528253|449866180|FG004|Overall Study|Death|1|||
125067537|NCT02528253|449866176|FG000|Overall Study|Insufficient clinical response|7|||
125067538|NCT02528253|449866177|FG001|Overall Study|Insufficient clinical response|10|||
125067539|NCT02528253|449866178|FG002|Overall Study|Insufficient clinical response|13|||
125067540|NCT02528253|449866179|FG003|Overall Study|Insufficient clinical response|12|||
125067541|NCT02528253|449866180|FG004|Overall Study|Insufficient clinical response|16|||
125067542|NCT02528253|449866176|FG000|Overall Study|Lost to Follow-up|16|||
125067543|NCT02528253|449866177|FG001|Overall Study|Lost to Follow-up|9|||
125067544|NCT02528253|449866178|FG002|Overall Study|Lost to Follow-up|31|||
125067545|NCT02528253|449866179|FG003|Overall Study|Lost to Follow-up|16|||
125067546|NCT02528253|449866180|FG004|Overall Study|Lost to Follow-up|34|||
125067547|NCT02528253|449866176|FG000|Overall Study|Other|21|||
125067548|NCT02528253|449866177|FG001|Overall Study|Other|22|||
125067549|NCT02528253|449866178|FG002|Overall Study|Other|58|||
125067550|NCT02528253|449866179|FG003|Overall Study|Other|52|||
125067551|NCT02528253|449866180|FG004|Overall Study|Other|76|||
125067552|NCT02528253|449866176|FG000|Overall Study|Withdrawal by Subject|25|||
125067553|NCT02528253|449866177|FG001|Overall Study|Withdrawal by Subject|20|||
125067554|NCT02528253|449866178|FG002|Overall Study|Withdrawal by Subject|29|||
125067555|NCT02528253|449866179|FG003|Overall Study|Withdrawal by Subject|48|||
125067556|NCT02528253|449866180|FG004|Overall Study|Withdrawal by Subject|73|||
125067557|NCT02528253|449866176|FG000|Overall Study|Protocol Violation|1|||
125067558|NCT02528253|449866177|FG001|Overall Study|Protocol Violation|2|||
125067559|NCT02528253|449866178|FG002|Overall Study|Protocol Violation|4|||
125067560|NCT02528253|449866179|FG003|Overall Study|Protocol Violation|0|||
125067561|NCT02528253|449866180|FG004|Overall Study|Protocol Violation|4|||
125067562|NCT02528253|449866176|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
125067563|NCT02528253|449866177|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
125067564|NCT02528253|449866178|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
125067565|NCT02528253|449866179|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
125067566|NCT02528253|449866180|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
125067567|NCT02293993|449866182|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
125067568|NCT02293993|449866183|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
125067569|NCT02293993|449866184|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
125067570|NCT02293993|449866185|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
125067571|NCT02293993|449866182|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
125067572|NCT02293993|449866183|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
125067573|NCT02293993|449866184|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
125067574|NCT02293993|449866185|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
125067575|NCT02293993|449866182|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
125067576|NCT02293993|449866183|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
125067577|NCT02293993|449866184|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
125067578|NCT02293993|449866185|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
125067579|NCT02293993|449866182|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
125067580|NCT02293993|449866183|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
125067581|NCT02293993|449866184|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
125067582|NCT02293993|449866185|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
125067583|NCT02293993|449866182|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
125067584|NCT02293993|449866183|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
125140530|NCT02426918|450137658|FG001|Overall Study|Adverse Event|2|||
125067585|NCT02293993|449866184|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
125067586|NCT02293993|449866185|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
125067587|NCT00094835|449866186|FG000|Overall Study|Physician Decision|1|||
125067588|NCT00094835|449866187|FG001|Overall Study|Physician Decision|0|||
125067589|NCT00094835|449866188|FG002|Overall Study|Physician Decision|0|||
125067590|NCT00094835|449866189|FG003|Overall Study|Physician Decision|0|||
125067591|NCT00094835|449866190|FG004|Overall Study|Physician Decision|0|||
125067592|NCT00094835|449866191|FG005|Overall Study|Physician Decision|1|||
125067593|NCT00094835|449866192|FG006|Overall Study|Physician Decision|0|||
125067594|NCT00094835|449866186|FG000|Overall Study|Withdrawal by Subject|0|||
125067595|NCT00094835|449866187|FG001|Overall Study|Withdrawal by Subject|0|||
125067596|NCT00094835|449866188|FG002|Overall Study|Withdrawal by Subject|0|||
125067597|NCT00094835|449866189|FG003|Overall Study|Withdrawal by Subject|0|||
125067598|NCT00094835|449866190|FG004|Overall Study|Withdrawal by Subject|0|||
125067599|NCT00094835|449866191|FG005|Overall Study|Withdrawal by Subject|0|||
125067600|NCT00094835|449866192|FG006|Overall Study|Withdrawal by Subject|1|||
125067601|NCT00094835|449866186|FG000|Overall Study|Lost to Follow-up|0|||
125067602|NCT00094835|449866187|FG001|Overall Study|Lost to Follow-up|0|||
125067603|NCT00094835|449866188|FG002|Overall Study|Lost to Follow-up|0|||
125067604|NCT00094835|449866189|FG003|Overall Study|Lost to Follow-up|0|||
125067605|NCT00094835|449866190|FG004|Overall Study|Lost to Follow-up|1|||
125067606|NCT00094835|449866191|FG005|Overall Study|Lost to Follow-up|0|||
125067607|NCT00094835|449866192|FG006|Overall Study|Lost to Follow-up|0|||
125067608|NCT00094835|449866186|FG000|Overall Study|Death|1|||
125067609|NCT00094835|449866187|FG001|Overall Study|Death|0|||
125067610|NCT00094835|449866188|FG002|Overall Study|Death|0|||
125067611|NCT00094835|449866189|FG003|Overall Study|Death|0|||
125067612|NCT00094835|449866190|FG004|Overall Study|Death|1|||
125067613|NCT00094835|449866191|FG005|Overall Study|Death|0|||
125067614|NCT00094835|449866192|FG006|Overall Study|Death|0|||
125067615|NCT00094835|449866186|FG000|Overall Study|Non-compliance|1|||
125067616|NCT00094835|449866187|FG001|Overall Study|Non-compliance|2|||
125067617|NCT00094835|449866188|FG002|Overall Study|Non-compliance|2|||
125067618|NCT00094835|449866189|FG003|Overall Study|Non-compliance|0|||
125067619|NCT00094835|449866190|FG004|Overall Study|Non-compliance|2|||
125067620|NCT00094835|449866191|FG005|Overall Study|Non-compliance|2|||
125067621|NCT00094835|449866192|FG006|Overall Study|Non-compliance|1|||
125067622|NCT00094835|449866186|FG000|Overall Study|Other|1|||
125067623|NCT00094835|449866187|FG001|Overall Study|Other|1|||
125067624|NCT00094835|449866188|FG002|Overall Study|Other|1|||
125067625|NCT00094835|449866189|FG003|Overall Study|Other|1|||
125067626|NCT00094835|449866190|FG004|Overall Study|Other|0|||
125067627|NCT00094835|449866191|FG005|Overall Study|Other|0|||
125067628|NCT00094835|449866192|FG006|Overall Study|Other|0|||
125067629|NCT02514772|449866193|FG000|Overall Study|Adverse Event|1|||
125067630|NCT02514772|449866194|FG001|Overall Study|Adverse Event|0|||
125067631|NCT02514772|449866193|FG000|Overall Study|Death|0|||
125067632|NCT02514772|449866194|FG001|Overall Study|Death|1|||
125067633|NCT02514772|449866193|FG000|Overall Study|Withdrawal by Subject|2|||
125067634|NCT02514772|449866194|FG001|Overall Study|Withdrawal by Subject|1|||
125067635|NCT00817206|449866195|FG000|Overall Study|Adverse Event|10|||
125067636|NCT00817206|449866196|FG001|Overall Study|Adverse Event|3|||
125067637|NCT00817206|449866195|FG000|Overall Study|Protocol Violation|0|||
125067638|NCT00817206|449866196|FG001|Overall Study|Protocol Violation|2|||
125067639|NCT00817206|449866195|FG000|Overall Study|Lost to Follow-up|0|||
125067640|NCT00817206|449866196|FG001|Overall Study|Lost to Follow-up|1|||
125067641|NCT00817206|449866195|FG000|Overall Study|Death|2|||
125067642|NCT00817206|449866196|FG001|Overall Study|Death|0|||
125067643|NCT00817206|449866195|FG000|Overall Study|Withdrawal by Subject|7|||
125067644|NCT00817206|449866196|FG001|Overall Study|Withdrawal by Subject|3|||
125067645|NCT00817206|449866195|FG000|Overall Study|Physician Decision|2|||
125067646|NCT00817206|449866196|FG001|Overall Study|Physician Decision|0|||
125067647|NCT00793182|449866197|FG000|Overall Study|Adverse Event|0|||
125067648|NCT00793182|449866198|FG001|Overall Study|Adverse Event|1|||
125067649|NCT02197897|449866199|FG000|Overall Study|not eligible|1|||
125067650|NCT02384395|449866200|FG000|Overall Study|Physician Decision|4|||
125067651|NCT02384395|449866200|FG000|Overall Study|Withdrawal by Subject|3|||
125067652|NCT02384395|449866200|FG000|Overall Study|Lost to Follow-up|3|||
125067653|NCT04295356|449866202|FG000|Overall Study|Physician Decision|1|||
125067654|NCT04295356|449866203|FG001|Overall Study|Physician Decision|0|||
125067655|NCT04295356|449866202|FG000|Overall Study|Lost to Follow-up|0|||
125067656|NCT04295356|449866203|FG001|Overall Study|Lost to Follow-up|3|||
125067657|NCT04295356|449866202|FG000|Overall Study|Protocol Violation|0|||
125067658|NCT04295356|449866203|FG001|Overall Study|Protocol Violation|1|||
125067659|NCT01106391|449866204|FG000|Overall Study|Death|12|||
125140531|NCT02426918|450137659|FG002|Overall Study|Adverse Event|0|||
125067660|NCT01106391|449866204|FG000|Overall Study|Withdrawal by Subject|7|||
125067661|NCT04268004|449866205|FG000|Overall Study|Excluded from analyses|0|||
125067662|NCT04268004|449866206|FG001|Overall Study|Excluded from analyses|1|||
125067663|NCT01381718|449866207|FG000|Overall Study|Withdrawal by Subject|2|||
125222686|NCT03428100|450442754|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
125067664|NCT01381718|449866208|FG001|Overall Study|Withdrawal by Subject|5|||
125067665|NCT01381718|449866207|FG000|Overall Study|Lost to Follow-up|3|||
125067666|NCT01381718|449866208|FG001|Overall Study|Lost to Follow-up|5|||
125067667|NCT01381718|449866207|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
125067668|NCT01381718|449866208|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
125067669|NCT02759861|449866209|FG000|Overall Study|Death|1|||
125067670|NCT00992186|449866212|FG000|Overall Study|Withdrawal by Subject|2|||
125067671|NCT00992186|449866212|FG000|Overall Study|Protocol Violation|1|||
125067672|NCT00992186|449866212|FG000|Overall Study|Physician Decision|1|||
125067673|NCT00992186|449866212|FG000|Overall Study|Adverse Event|9|||
125067674|NCT00992186|449866212|FG000|Overall Study|Progressive Disease|30|||
125067675|NCT00992186|449866212|FG000|Overall Study|Refusal To Receive Study Agent|3|||
125067676|NCT00830960|449866213|FG000|Overall Study|Death|5|||
125067677|NCT00830960|449866214|FG001|Overall Study|Death|4|||
125067678|NCT00830960|449866215|FG002|Overall Study|Death|3|||
125067679|NCT00830960|449866216|FG003|Overall Study|Death|2|||
125067680|NCT00830960|449866217|FG004|Overall Study|Death|6|||
125067681|NCT00830960|449866218|FG005|Overall Study|Death|1|||
125067682|NCT00830960|449866213|FG000|Overall Study|Lost to Follow-up|1|||
125067683|NCT00830960|449866214|FG001|Overall Study|Lost to Follow-up|1|||
125067684|NCT00830960|449866215|FG002|Overall Study|Lost to Follow-up|1|||
125067685|NCT00830960|449866216|FG003|Overall Study|Lost to Follow-up|0|||
125067686|NCT00830960|449866217|FG004|Overall Study|Lost to Follow-up|0|||
125067687|NCT00830960|449866218|FG005|Overall Study|Lost to Follow-up|1|||
125067688|NCT00830960|449866213|FG000|Overall Study|Withdrawal by Subject|19|||
125067689|NCT00830960|449866214|FG001|Overall Study|Withdrawal by Subject|19|||
125067690|NCT00830960|449866215|FG002|Overall Study|Withdrawal by Subject|18|||
125067691|NCT00830960|449866216|FG003|Overall Study|Withdrawal by Subject|23|||
125067692|NCT00830960|449866217|FG004|Overall Study|Withdrawal by Subject|16|||
125067693|NCT00830960|449866218|FG005|Overall Study|Withdrawal by Subject|21|||
125067694|NCT00830960|449866213|FG000|Overall Study|Sponsor Decision|1|||
125067695|NCT00830960|449866214|FG001|Overall Study|Sponsor Decision|2|||
125067696|NCT00830960|449866215|FG002|Overall Study|Sponsor Decision|3|||
125067697|NCT00830960|449866216|FG003|Overall Study|Sponsor Decision|4|||
125067698|NCT00830960|449866217|FG004|Overall Study|Sponsor Decision|5|||
125067699|NCT00830960|449866218|FG005|Overall Study|Sponsor Decision|7|||
125067700|NCT00830960|449866213|FG000|Overall Study|No study drug received|7|||
125067701|NCT00830960|449866214|FG001|Overall Study|No study drug received|2|||
125067702|NCT00830960|449866215|FG002|Overall Study|No study drug received|4|||
125067703|NCT00830960|449866216|FG003|Overall Study|No study drug received|3|||
125067704|NCT00830960|449866217|FG004|Overall Study|No study drug received|5|||
125067705|NCT00830960|449866218|FG005|Overall Study|No study drug received|7|||
125067706|NCT02855450|449866219|FG000|Overall Study|Adverse Event|1|||
125067707|NCT02855450|449866220|FG001|Overall Study|Adverse Event|0|||
125067708|NCT02855450|449866219|FG000|Overall Study|Lost to Follow-up|4|||
125067709|NCT02855450|449866220|FG001|Overall Study|Lost to Follow-up|0|||
125067710|NCT05159362|449866223|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
125067711|NCT05159362|449866224|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
125067712|NCT05159362|449866225|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
125067713|NCT01376245|449866226|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
125067714|NCT01376245|449866227|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
125067715|NCT01376245|449866228|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
125067716|NCT01376245|449866229|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
125067717|NCT01376245|449866230|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
125067718|NCT01376245|449866226|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
125067719|NCT01376245|449866227|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
125067720|NCT01376245|449866228|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
125067721|NCT01376245|449866229|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
125067722|NCT01376245|449866230|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
125067723|NCT01376245|449866226|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
125067724|NCT01376245|449866227|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
125067725|NCT01376245|449866228|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
125067726|NCT01376245|449866229|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
125067727|NCT01376245|449866230|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
125067728|NCT01376245|449866226|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
125067729|NCT01376245|449866227|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
125067730|NCT01376245|449866228|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
125067731|NCT01376245|449866229|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
125067732|NCT01376245|449866230|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
125067733|NCT01376245|449866226|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
125067734|NCT01376245|449866227|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
125067735|NCT01376245|449866228|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
125067736|NCT01376245|449866229|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
125067737|NCT01376245|449866230|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
125067738|NCT01376245|449866226|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
125067739|NCT01376245|449866227|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
125067740|NCT01376245|449866228|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
125067741|NCT01376245|449866229|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
125067742|NCT01376245|449866230|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
125067743|NCT01376245|449866226|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
125067744|NCT01376245|449866227|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
125067745|NCT01376245|449866228|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
125067746|NCT01376245|449866229|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
125067747|NCT01376245|449866230|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
125067748|NCT01376245|449866226|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
125067749|NCT01376245|449866227|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
125067750|NCT01376245|449866228|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
125067751|NCT01376245|449866229|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
125067752|NCT01376245|449866230|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
125067753|NCT01376245|449866226|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
125067754|NCT01376245|449866227|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
125067755|NCT01376245|449866228|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
125067756|NCT01376245|449866229|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
125067757|NCT01376245|449866230|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
125067758|NCT01376245|449866226|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125067759|NCT01376245|449866227|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
125067760|NCT01376245|449866228|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125067761|NCT01376245|449866229|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
125140532|NCT02426918|450137657|FG000|Overall Study|Physician Decision|1|||
125140533|NCT02426918|450137658|FG001|Overall Study|Physician Decision|1|||
125140534|NCT02426918|450137659|FG002|Overall Study|Physician Decision|1|||
125140535|NCT02426918|450137657|FG000|Overall Study|Withdrawal by Subject|5|||
125140536|NCT02426918|450137658|FG001|Overall Study|Withdrawal by Subject|5|||
125140537|NCT02426918|450137659|FG002|Overall Study|Withdrawal by Subject|4|||
125140538|NCT02426918|450137657|FG000|Overall Study|Other|9|||
125140539|NCT02426918|450137658|FG001|Overall Study|Other|11|||
125067762|NCT01376245|449866230|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
125067763|NCT01376245|449866226|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
125067764|NCT01376245|449866227|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
125067765|NCT01376245|449866228|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
125067766|NCT01376245|449866229|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
125067767|NCT01376245|449866230|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
125067768|NCT01376245|449866226|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
125067769|NCT01376245|449866227|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
125067770|NCT01376245|449866228|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
125067771|NCT01376245|449866229|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
125067772|NCT01376245|449866230|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
125067773|NCT01335698|449866231|FG000|Treatment Stage 1|Lack of Efficacy|3|||
125067774|NCT01335698|449866232|FG001|Treatment Stage 1|Lack of Efficacy|1|||
125067775|NCT01335698|449866233|FG002|Treatment Stage 1|Lack of Efficacy|3|||
125067776|NCT01335698|449866234|FG003|Treatment Stage 1|Lack of Efficacy|3|||
125067777|NCT01335698|449866235|FG004|Treatment Stage 1|Lack of Efficacy|1|||
125067778|NCT01335698|449866231|FG000|Treatment Stage 1|Adverse Event|1|||
125067779|NCT01335698|449866232|FG001|Treatment Stage 1|Adverse Event|2|||
125067780|NCT01335698|449866233|FG002|Treatment Stage 1|Adverse Event|2|||
125067781|NCT01335698|449866234|FG003|Treatment Stage 1|Adverse Event|1|||
125067782|NCT01335698|449866235|FG004|Treatment Stage 1|Adverse Event|1|||
125067783|NCT01335698|449866231|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
125067784|NCT01335698|449866232|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
125067785|NCT01335698|449866233|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
125067786|NCT01335698|449866234|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
125067787|NCT01335698|449866235|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
125067788|NCT01335698|449866231|FG000|Treatment Stage 1|Lost to Follow-up|1|||
125067789|NCT01335698|449866232|FG001|Treatment Stage 1|Lost to Follow-up|1|||
125067790|NCT01335698|449866233|FG002|Treatment Stage 1|Lost to Follow-up|0|||
125067791|NCT01335698|449866234|FG003|Treatment Stage 1|Lost to Follow-up|0|||
125067792|NCT01335698|449866235|FG004|Treatment Stage 1|Lost to Follow-up|0|||
125067793|NCT01335698|449866231|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
125067794|NCT01335698|449866232|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
125067795|NCT01335698|449866233|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
125067796|NCT01335698|449866234|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
125067797|NCT01335698|449866235|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
125067798|NCT01335698|449866231|FG000|Treatment Stage 1|No longer meets study criteria|1|||
125067799|NCT01335698|449866232|FG001|Treatment Stage 1|No longer meets study criteria|1|||
125067800|NCT01335698|449866233|FG002|Treatment Stage 1|No longer meets study criteria|0|||
125067801|NCT01335698|449866234|FG003|Treatment Stage 1|No longer meets study criteria|1|||
125067802|NCT01335698|449866235|FG004|Treatment Stage 1|No longer meets study criteria|0|||
125067803|NCT01335698|449866231|FG000|Treatment Stage 1|Other|1|||
125067804|NCT01335698|449866232|FG001|Treatment Stage 1|Other|0|||
125067805|NCT01335698|449866233|FG002|Treatment Stage 1|Other|0|||
125067806|NCT01335698|449866234|FG003|Treatment Stage 1|Other|1|||
125067807|NCT01335698|449866235|FG004|Treatment Stage 1|Other|0|||
125067808|NCT01335698|449866231|FG000|Treatment Stage 2|Lack of Efficacy|2|||
125067809|NCT01335698|449866232|FG001|Treatment Stage 2|Lack of Efficacy|1|||
125067810|NCT01335698|449866233|FG002|Treatment Stage 2|Lack of Efficacy|3|||
125067811|NCT01335698|449866234|FG003|Treatment Stage 2|Lack of Efficacy|1|||
125067812|NCT01335698|449866235|FG004|Treatment Stage 2|Lack of Efficacy|0|||
125067813|NCT01335698|449866231|FG000|Treatment Stage 2|Adverse Event|2|||
125067814|NCT01335698|449866232|FG001|Treatment Stage 2|Adverse Event|0|||
125067815|NCT01335698|449866233|FG002|Treatment Stage 2|Adverse Event|0|||
125067816|NCT01335698|449866234|FG003|Treatment Stage 2|Adverse Event|3|||
125067817|NCT01335698|449866235|FG004|Treatment Stage 2|Adverse Event|0|||
125067818|NCT01335698|449866231|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
125067819|NCT01335698|449866232|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
125067820|NCT01335698|449866233|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
125067821|NCT01335698|449866234|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
125067822|NCT01335698|449866235|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
125067823|NCT01335698|449866231|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
125067824|NCT01335698|449866232|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
125067825|NCT01335698|449866233|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
125067826|NCT01335698|449866234|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
125067827|NCT01335698|449866235|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
125067828|NCT01335698|449866231|FG000|Treatment Stage 2|Lost to Follow-up|1|||
125067829|NCT01335698|449866232|FG001|Treatment Stage 2|Lost to Follow-up|0|||
125067830|NCT01335698|449866233|FG002|Treatment Stage 2|Lost to Follow-up|0|||
125067831|NCT01335698|449866234|FG003|Treatment Stage 2|Lost to Follow-up|0|||
125067832|NCT01335698|449866235|FG004|Treatment Stage 2|Lost to Follow-up|0|||
125067833|NCT01335698|449866231|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
125067834|NCT01335698|449866232|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
125067835|NCT01335698|449866233|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
125067836|NCT01335698|449866234|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
125067837|NCT01335698|449866235|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
125067838|NCT01335698|449866231|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
125067839|NCT01335698|449866232|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
125067840|NCT01335698|449866233|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
125067841|NCT01335698|449866234|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
125067842|NCT01335698|449866235|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
125067843|NCT01335698|449866231|FG000|Treatment Stage 2|Switched to another formulation|1|||
125067844|NCT01335698|449866232|FG001|Treatment Stage 2|Switched to another formulation|1|||
125067845|NCT01335698|449866233|FG002|Treatment Stage 2|Switched to another formulation|0|||
125067846|NCT01335698|449866234|FG003|Treatment Stage 2|Switched to another formulation|0|||
125067847|NCT01335698|449866235|FG004|Treatment Stage 2|Switched to another formulation|0|||
125067848|NCT01357889|449866236|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
125067849|NCT01357889|449866237|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
125067850|NCT01357889|449866236|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
125067851|NCT01357889|449866237|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
125067852|NCT01357889|449866236|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
125067853|NCT01357889|449866237|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
125067854|NCT01357889|449866236|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
125067855|NCT01357889|449866237|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
125067856|NCT01357889|449866236|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
125067857|NCT01357889|449866237|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
125067858|NCT01357889|449866236|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
125067859|NCT01357889|449866237|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
125067860|NCT01357889|449866236|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
125067861|NCT01357889|449866237|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
125067862|NCT01357889|449866236|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
125067863|NCT01357889|449866237|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
125067864|NCT01357889|449866236|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
125067865|NCT01357889|449866237|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
125067866|NCT01357889|449866236|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
125067867|NCT01357889|449866237|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
125067868|NCT01357889|449866236|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
125067869|NCT01357889|449866237|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
125067870|NCT01357889|449866236|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
125067871|NCT01357889|449866237|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
125067872|NCT01357889|449866236|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
125067873|NCT01357889|449866237|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
125067874|NCT03970824|449866238|FG000|Overall Study|Withdrawal by Subject|1|||
125067875|NCT03970824|449866239|FG001|Overall Study|Withdrawal by Subject|1|||
125067876|NCT03970824|449866240|FG002|Overall Study|Withdrawal by Subject|3|||
125067877|NCT03970824|449866238|FG000|Overall Study|Lost to Follow-up|0|||
125067878|NCT03970824|449866239|FG001|Overall Study|Lost to Follow-up|2|||
125067879|NCT03970824|449866240|FG002|Overall Study|Lost to Follow-up|1|||
125067880|NCT03970824|449866238|FG000|Overall Study|Adverse Event|1|||
125067881|NCT03970824|449866239|FG001|Overall Study|Adverse Event|0|||
125067882|NCT03970824|449866240|FG002|Overall Study|Adverse Event|0|||
125067883|NCT00416312|449866241|FG000|Overall Study|tumors not visible on imaging|2|||
125067884|NCT02727660|449866244|FG000|Overall Study|Lack of Efficacy|40|||
125067885|NCT02727660|449866245|FG001|Overall Study|Lack of Efficacy|40|||
125222687|NCT03428100|450442755|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
125067886|NCT02727660|449866246|FG002|Overall Study|Lack of Efficacy|70|||
125067887|NCT02727660|449866244|FG000|Overall Study|Adverse Event|28|||
125067888|NCT02727660|449866245|FG001|Overall Study|Adverse Event|21|||
125067889|NCT02727660|449866246|FG002|Overall Study|Adverse Event|32|||
125067890|NCT02727660|449866244|FG000|Overall Study|Withdrawal by Subject|26|||
125067891|NCT02727660|449866245|FG001|Overall Study|Withdrawal by Subject|25|||
125067892|NCT02727660|449866246|FG002|Overall Study|Withdrawal by Subject|30|||
125067893|NCT02727660|449866244|FG000|Overall Study|Physician Decision|3|||
125067894|NCT02727660|449866245|FG001|Overall Study|Physician Decision|8|||
125067895|NCT02727660|449866246|FG002|Overall Study|Physician Decision|14|||
125067896|NCT02727660|449866244|FG000|Overall Study|Lost to Follow-up|5|||
125067897|NCT02727660|449866245|FG001|Overall Study|Lost to Follow-up|9|||
125067898|NCT02727660|449866246|FG002|Overall Study|Lost to Follow-up|8|||
125067899|NCT02727660|449866244|FG000|Overall Study|Protocol Violation|7|||
125067900|NCT02727660|449866245|FG001|Overall Study|Protocol Violation|5|||
125067901|NCT02727660|449866246|FG002|Overall Study|Protocol Violation|5|||
125067902|NCT02727660|449866244|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
125067903|NCT02727660|449866245|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
125067904|NCT02727660|449866246|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
125067905|NCT02727660|449866244|FG000|Overall Study|Administrative Reasons|2|||
125067906|NCT02727660|449866245|FG001|Overall Study|Administrative Reasons|3|||
125067907|NCT02727660|449866246|FG002|Overall Study|Administrative Reasons|4|||
125067908|NCT00305604|449866247|FG000|Overall Study|Adverse Event|6|||
125067909|NCT00305604|449866248|FG001|Overall Study|Adverse Event|3|||
125067910|NCT00305604|449866247|FG000|Overall Study|Lack of Efficacy|11|||
125067911|NCT00305604|449866248|FG001|Overall Study|Lack of Efficacy|18|||
125067912|NCT00305604|449866247|FG000|Overall Study|Lost to Follow-up|0|||
125067913|NCT00305604|449866248|FG001|Overall Study|Lost to Follow-up|4|||
125067914|NCT00305604|449866247|FG000|Overall Study|Protocol Violation|2|||
125067915|NCT00305604|449866248|FG001|Overall Study|Protocol Violation|1|||
125067916|NCT00305604|449866247|FG000|Overall Study|Withdrawal by Subject|12|||
125067917|NCT00305604|449866248|FG001|Overall Study|Withdrawal by Subject|21|||
125067918|NCT00305604|449866247|FG000|Overall Study|Patient moved|1|||
125067919|NCT00305604|449866248|FG001|Overall Study|Patient moved|0|||
125067920|NCT00105560|449866249|FG000|Overall Study|Lost to Follow-up|1|||
125067921|NCT01248364|449866253|FG000|Overall Study|Adverse Event|0|||
125067922|NCT01248364|449866254|FG001|Overall Study|Adverse Event|1|||
125067923|NCT01248364|449866255|FG002|Overall Study|Adverse Event|0|||
125067924|NCT01248364|449866256|FG003|Overall Study|Adverse Event|0|||
125067925|NCT00764946|449866259|FG000|Overall Study|Lack of Efficacy|1|||
125067926|NCT00764946|449866260|FG001|Overall Study|Lack of Efficacy|0|||
125067927|NCT00764946|449866261|FG002|Overall Study|Lack of Efficacy|0|||
125067928|NCT00764946|449866259|FG000|Overall Study|Lost to Follow-up|3|||
125067929|NCT00764946|449866260|FG001|Overall Study|Lost to Follow-up|4|||
125067930|NCT00764946|449866261|FG002|Overall Study|Lost to Follow-up|0|||
125067931|NCT00764946|449866259|FG000|Overall Study|Physician Decision|2|||
125067932|NCT00764946|449866260|FG001|Overall Study|Physician Decision|4|||
125067933|NCT00764946|449866261|FG002|Overall Study|Physician Decision|0|||
125067934|NCT00764946|449866259|FG000|Overall Study|Adverse Event|3|||
125067935|NCT00764946|449866260|FG001|Overall Study|Adverse Event|2|||
125067936|NCT00764946|449866261|FG002|Overall Study|Adverse Event|1|||
125067937|NCT00764946|449866259|FG000|Overall Study|Withdrawal by Subject|3|||
125067938|NCT00764946|449866260|FG001|Overall Study|Withdrawal by Subject|6|||
125067939|NCT00764946|449866261|FG002|Overall Study|Withdrawal by Subject|2|||
125067940|NCT00764946|449866259|FG000|Overall Study|Never Treated|1|||
125067941|NCT00764946|449866260|FG001|Overall Study|Never Treated|1|||
125067942|NCT00764946|449866261|FG002|Overall Study|Never Treated|1|||
125067943|NCT02431468|449866265|FG000|Overall Study|Adverse Event|2|||
125067944|NCT02431468|449866266|FG001|Overall Study|Adverse Event|4|||
125067945|NCT02431468|449866267|FG002|Overall Study|Adverse Event|5|||
125067946|NCT02431468|449866265|FG000|Overall Study|Withdrawal by Subject|4|||
125067947|NCT02431468|449866266|FG001|Overall Study|Withdrawal by Subject|12|||
125067948|NCT02431468|449866267|FG002|Overall Study|Withdrawal by Subject|2|||
125067949|NCT02431468|449866265|FG000|Overall Study|noncompliance, investigator termination,|2|||
125067950|NCT02431468|449866266|FG001|Overall Study|noncompliance, investigator termination,|2|||
125067951|NCT02431468|449866267|FG002|Overall Study|noncompliance, investigator termination,|2|||
125067952|NCT01361919|449866268|FG000|Overall Study|technical issues|10|||
125067953|NCT01361919|449866269|FG001|Overall Study|technical issues|12|||
125067954|NCT01361919|449866270|FG002|Overall Study|technical issues|10|||
125067955|NCT01767519|449866274|FG000|Overall Study|Other Reasons|4|||
125067956|NCT01767519|449866275|FG001|Overall Study|Other Reasons|4|||
125067957|NCT01767519|449866276|FG002|Overall Study|Other Reasons|2|||
125067958|NCT01767519|449866274|FG000|Overall Study|Protocol Violation|0|||
125067959|NCT01767519|449866275|FG001|Overall Study|Protocol Violation|3|||
125067960|NCT01767519|449866276|FG002|Overall Study|Protocol Violation|0|||
125067961|NCT01767519|449866274|FG000|Overall Study|Personal Reasons|1|||
125067962|NCT01767519|449866275|FG001|Overall Study|Personal Reasons|0|||
125067963|NCT01767519|449866276|FG002|Overall Study|Personal Reasons|0|||
125067964|NCT01767519|449866274|FG000|Overall Study|Lost to Follow-up|3|||
125067965|NCT01767519|449866275|FG001|Overall Study|Lost to Follow-up|1|||
125067966|NCT01767519|449866276|FG002|Overall Study|Lost to Follow-up|2|||
125067967|NCT01767519|449866274|FG000|Overall Study|Lack of Efficacy|1|||
125067968|NCT01767519|449866275|FG001|Overall Study|Lack of Efficacy|0|||
125067969|NCT01767519|449866276|FG002|Overall Study|Lack of Efficacy|0|||
125067970|NCT01767519|449866274|FG000|Overall Study|Adverse Event|5|||
125067971|NCT01767519|449866275|FG001|Overall Study|Adverse Event|5|||
125067972|NCT01767519|449866276|FG002|Overall Study|Adverse Event|1|||
125067973|NCT00039741|449866277|FG000|Overall Study|Death|0|||
125067974|NCT00039741|449866278|FG001|Overall Study|Death|1|||
125067975|NCT00039741|449866279|FG002|Overall Study|Death|0|||
125067976|NCT00039741|449866280|FG003|Overall Study|Death|0|||
125067977|NCT00039741|449866277|FG000|Overall Study|Lost to Follow-up|3|||
125067978|NCT00039741|449866278|FG001|Overall Study|Lost to Follow-up|1|||
125067979|NCT00039741|449866279|FG002|Overall Study|Lost to Follow-up|5|||
125067980|NCT00039741|449866280|FG003|Overall Study|Lost to Follow-up|2|||
125067981|NCT00039741|449866277|FG000|Overall Study|Confounding medical condition|1|||
125067982|NCT00039741|449866278|FG001|Overall Study|Confounding medical condition|0|||
125067983|NCT00039741|449866279|FG002|Overall Study|Confounding medical condition|0|||
125067984|NCT00039741|449866280|FG003|Overall Study|Confounding medical condition|0|||
125067985|NCT00039741|449866277|FG000|Overall Study|Not able to get to clinic|5|||
125067986|NCT00039741|449866278|FG001|Overall Study|Not able to get to clinic|2|||
125067987|NCT00039741|449866279|FG002|Overall Study|Not able to get to clinic|0|||
125067988|NCT00039741|449866280|FG003|Overall Study|Not able to get to clinic|3|||
125067989|NCT00039741|449866277|FG000|Overall Study|Moved|3|||
125067990|NCT00039741|449866278|FG001|Overall Study|Moved|2|||
125067991|NCT00039741|449866279|FG002|Overall Study|Moved|3|||
125067992|NCT00039741|449866280|FG003|Overall Study|Moved|6|||
125067993|NCT00039741|449866277|FG000|Overall Study|Non-compliance with protocol|1|||
125067994|NCT00039741|449866278|FG001|Overall Study|Non-compliance with protocol|0|||
125067995|NCT00039741|449866279|FG002|Overall Study|Non-compliance with protocol|1|||
125067996|NCT00039741|449866280|FG003|Overall Study|Non-compliance with protocol|0|||
125067997|NCT00039741|449866277|FG000|Overall Study|Withdrew consent|0|||
125067998|NCT00039741|449866278|FG001|Overall Study|Withdrew consent|5|||
125067999|NCT00039741|449866279|FG002|Overall Study|Withdrew consent|0|||
125068000|NCT00039741|449866280|FG003|Overall Study|Withdrew consent|1|||
125068001|NCT00039741|449866277|FG000|Overall Study|Missed final visit|2|||
125068002|NCT00039741|449866278|FG001|Overall Study|Missed final visit|1|||
125068003|NCT00039741|449866279|FG002|Overall Study|Missed final visit|2|||
125068004|NCT00039741|449866280|FG003|Overall Study|Missed final visit|2|||
125068005|NCT00946881|449866281|FG000|First Treatment|Withdrawal by Subject|1|||
125068006|NCT00946881|449866281|FG000|First Treatment|Patient relocated to another state|1|||
125068007|NCT00946881|449866281|FG000|Retreatment|Withdrawal by Subject|1|||
125068008|NCT00293423|449866282|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
125068009|NCT00293423|449866283|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
125068010|NCT00293423|449866282|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
125068011|NCT00293423|449866283|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
125068012|NCT00293423|449866282|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
125068013|NCT00293423|449866283|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
125068014|NCT00293423|449866282|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
125068015|NCT00293423|449866283|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
125068016|NCT00293423|449866282|FG000|Surgical Resection|processing error during surgical resection|1|||
125068017|NCT00293423|449866283|FG001|Surgical Resection|processing error during surgical resection|0|||
125068018|NCT00293423|449866282|FG000|Surgical Resection|Withdrawal by Subject|4|||
125068019|NCT00293423|449866283|FG001|Surgical Resection|Withdrawal by Subject|0|||
125068020|NCT00293423|449866282|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
125068021|NCT00293423|449866283|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
125068022|NCT00805545|449866284|FG000|Overall Study|Protocol Violation|3|||
125068023|NCT00805545|449866285|FG001|Overall Study|Protocol Violation|2|||
125068024|NCT00805545|449866284|FG000|Overall Study|Protocol Violation|3|||
125068025|NCT00805545|449866285|FG001|Overall Study|Protocol Violation|1|||
125068026|NCT00507416|449866286|FG000|Overall Study|Adverse Event|58|||
125068027|NCT00507416|449866287|FG001|Overall Study|Adverse Event|67|||
125068028|NCT00507416|449866288|FG002|Overall Study|Adverse Event|65|||
125068029|NCT00507416|449866286|FG000|Overall Study|Protocol Violation|1|||
125068030|NCT00507416|449866287|FG001|Overall Study|Protocol Violation|2|||
125068031|NCT00507416|449866288|FG002|Overall Study|Protocol Violation|0|||
125068032|NCT00507416|449866286|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
125068033|NCT00507416|449866287|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
125068034|NCT00507416|449866288|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
125068035|NCT00507416|449866286|FG000|Overall Study|Progressive Disease|20|||
125068036|NCT00507416|449866287|FG001|Overall Study|Progressive Disease|10|||
125068037|NCT00507416|449866288|FG002|Overall Study|Progressive Disease|13|||
125068038|NCT00507416|449866286|FG000|Overall Study|Patient declined further treatment|18|||
125068039|NCT00507416|449866287|FG001|Overall Study|Patient declined further treatment|14|||
125068040|NCT00507416|449866288|FG002|Overall Study|Patient declined further treatment|11|||
125068041|NCT00507416|449866286|FG000|Overall Study|Other|11|||
125068042|NCT00507416|449866287|FG001|Overall Study|Other|16|||
125068043|NCT00507416|449866288|FG002|Overall Study|Other|13|||
125068044|NCT00507416|449866286|FG000|Overall Study|Did not Receive Study Treatment|3|||
125068045|NCT00507416|449866287|FG001|Overall Study|Did not Receive Study Treatment|9|||
125068046|NCT00507416|449866288|FG002|Overall Study|Did not Receive Study Treatment|4|||
125068047|NCT02157506|449866291|FG000|Overall Study|Adverse Event|0|||
125068048|NCT02157506|449866292|FG001|Overall Study|Adverse Event|1|||
125068049|NCT02157506|449866293|FG002|Overall Study|Adverse Event|0|||
125068050|NCT02157506|449866294|FG003|Overall Study|Adverse Event|0|||
125068051|NCT02157506|449866295|FG004|Overall Study|Adverse Event|0|||
125068052|NCT02157506|449866291|FG000|Overall Study|Lost to Follow-up|0|||
125068053|NCT02157506|449866292|FG001|Overall Study|Lost to Follow-up|0|||
125068054|NCT02157506|449866293|FG002|Overall Study|Lost to Follow-up|1|||
125068055|NCT02157506|449866294|FG003|Overall Study|Lost to Follow-up|0|||
125140540|NCT02426918|450137659|FG002|Overall Study|Other|9|||
125140541|NCT02845336|450137660|FG000|Overall Study|Lost to Follow-up|3|||
125140542|NCT02845336|450137661|FG001|Overall Study|Lost to Follow-up|1|||
125140543|NCT02845336|450137660|FG000|Overall Study|Inability to get medication|2|||
125068056|NCT02157506|449866295|FG004|Overall Study|Lost to Follow-up|0|||
125068057|NCT03101514|449866296|FG000|Overall Study|Withdrawal by Subject|4|||
125068058|NCT03101514|449866296|FG000|Overall Study|Protocol Violation|2|||
125068059|NCT03101514|449866296|FG000|Overall Study|patient's information was incomplete|1|||
125068060|NCT01021813|449866297|FG000|DB Treatment Phase|Adverse Event|60|||
125068061|NCT01021813|449866298|FG001|DB Treatment Phase|Adverse Event|22|||
125068062|NCT01021813|449866299|FG002|DB Treatment Phase|Adverse Event|0|||
125068063|NCT01021813|449866300|FG003|DB Treatment Phase|Adverse Event|0|||
125068064|NCT01021813|449866301|FG004|DB Treatment Phase|Adverse Event|0|||
125068065|NCT01021813|449866297|FG000|DB Treatment Phase|Lack of Efficacy|44|||
125068066|NCT01021813|449866298|FG001|DB Treatment Phase|Lack of Efficacy|28|||
125068067|NCT01021813|449866299|FG002|DB Treatment Phase|Lack of Efficacy|0|||
125068068|NCT01021813|449866300|FG003|DB Treatment Phase|Lack of Efficacy|0|||
125068069|NCT01021813|449866301|FG004|DB Treatment Phase|Lack of Efficacy|0|||
125068070|NCT01021813|449866297|FG000|DB Treatment Phase|Lost to Follow-up|14|||
125068071|NCT01021813|449866298|FG001|DB Treatment Phase|Lost to Follow-up|12|||
125068072|NCT01021813|449866299|FG002|DB Treatment Phase|Lost to Follow-up|0|||
125068073|NCT01021813|449866300|FG003|DB Treatment Phase|Lost to Follow-up|0|||
125068074|NCT01021813|449866301|FG004|DB Treatment Phase|Lost to Follow-up|0|||
125068075|NCT01021813|449866297|FG000|DB Treatment Phase|Physician Decision|17|||
125140544|NCT02845336|450137661|FG001|Overall Study|Inability to get medication|0|||
125140545|NCT00654186|450137668|FG000|Overall Study|Withdrawal by Subject|5|||
125140546|NCT05616728|450137669|FG000|Overall Study|Lost to Follow-up|0|||
125140547|NCT05616728|450137670|FG001|Overall Study|Lost to Follow-up|0|||
125140548|NCT05616728|450137671|FG002|Overall Study|Lost to Follow-up|1|||
125140549|NCT05616728|450137669|FG000|Overall Study|Withdrawal by Subject|1|||
125140550|NCT05616728|450137670|FG001|Overall Study|Withdrawal by Subject|1|||
125140551|NCT05616728|450137671|FG002|Overall Study|Withdrawal by Subject|0|||
125140552|NCT05616728|450137669|FG000|Overall Study|Physician Decision|1|||
125140553|NCT05616728|450137670|FG001|Overall Study|Physician Decision|1|||
125140554|NCT05616728|450137671|FG002|Overall Study|Physician Decision|1|||
125140555|NCT05616728|450137669|FG000|Overall Study|Other|0|||
125140556|NCT05616728|450137670|FG001|Overall Study|Other|2|||
125140557|NCT05616728|450137671|FG002|Overall Study|Other|0|||
125140558|NCT01024855|450137674|FG000|Overall Study|Inclusion/exclusion criteria|1|||
125140559|NCT03306277|450137681|FG000|Overall Study|Death|1|||
125068076|NCT01021813|449866298|FG001|DB Treatment Phase|Physician Decision|8|||
125140560|NCT03306277|450137681|FG000|Overall Study|Adverse Event|1|||
125140561|NCT03306277|450137681|FG000|Overall Study|Withdrawal by Subject|1|||
125140562|NCT00674128|450137682|FG000|Overall Study|Withdrawal by Subject|25|||
125222688|NCT03428100|450442756|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
125068077|NCT01021813|449866299|FG002|DB Treatment Phase|Physician Decision|0|||
125068078|NCT01021813|449866300|FG003|DB Treatment Phase|Physician Decision|0|||
125068079|NCT01021813|449866301|FG004|DB Treatment Phase|Physician Decision|0|||
125068080|NCT01021813|449866297|FG000|DB Treatment Phase|Pregnancy|1|||
125068081|NCT01021813|449866298|FG001|DB Treatment Phase|Pregnancy|0|||
125068082|NCT01021813|449866299|FG002|DB Treatment Phase|Pregnancy|0|||
125068083|NCT01021813|449866300|FG003|DB Treatment Phase|Pregnancy|0|||
125140563|NCT00674128|450137683|FG001|Overall Study|Withdrawal by Subject|23|||
125140564|NCT00829452|450137687|FG000|First Intervention|Withdrawal by Subject|0|||
125068084|NCT01021813|449866301|FG004|DB Treatment Phase|Pregnancy|0|||
125068085|NCT01021813|449866297|FG000|DB Treatment Phase|Protocol Violation|4|||
125068086|NCT01021813|449866298|FG001|DB Treatment Phase|Protocol Violation|3|||
125068087|NCT01021813|449866299|FG002|DB Treatment Phase|Protocol Violation|0|||
125068088|NCT01021813|449866300|FG003|DB Treatment Phase|Protocol Violation|0|||
125068089|NCT01021813|449866301|FG004|DB Treatment Phase|Protocol Violation|0|||
125068090|NCT01021813|449866297|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
125068091|NCT01021813|449866298|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
125068092|NCT01021813|449866299|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
125068093|NCT01021813|449866300|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
125068094|NCT01021813|449866301|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
125068095|NCT01021813|449866297|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
125068096|NCT01021813|449866298|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
125068097|NCT01021813|449866299|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
125068098|NCT01021813|449866300|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
125068099|NCT01021813|449866301|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
125068100|NCT01021813|449866297|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
125068101|NCT01021813|449866298|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
125068102|NCT01021813|449866299|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
125068103|NCT01021813|449866300|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
125068104|NCT01021813|449866301|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
125068105|NCT01021813|449866297|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
125068106|NCT01021813|449866298|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
125068107|NCT01021813|449866299|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
125068108|NCT01021813|449866300|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
125068109|NCT01021813|449866301|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
125068110|NCT01021813|449866297|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
125068111|NCT01021813|449866298|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
125068112|NCT01021813|449866299|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
125068113|NCT01021813|449866300|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
125068114|NCT01021813|449866301|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
125068115|NCT01021813|449866297|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
125068116|NCT01021813|449866298|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
125068117|NCT01021813|449866299|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
125068118|NCT01021813|449866300|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
125068119|NCT01021813|449866301|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
125068120|NCT00764478|449866302|FG000|Overall Study|Adverse Event|1|||
125068121|NCT00764478|449866303|FG001|Overall Study|Adverse Event|1|||
125068122|NCT00764478|449866304|FG002|Overall Study|Adverse Event|1|||
125068123|NCT00764478|449866302|FG000|Overall Study|Withdrawal by Subject|7|||
125068124|NCT00764478|449866303|FG001|Overall Study|Withdrawal by Subject|12|||
125068125|NCT00764478|449866304|FG002|Overall Study|Withdrawal by Subject|1|||
125068126|NCT00764478|449866302|FG000|Overall Study|Lost to Follow-up|7|||
125068127|NCT00764478|449866303|FG001|Overall Study|Lost to Follow-up|8|||
125068128|NCT00764478|449866304|FG002|Overall Study|Lost to Follow-up|5|||
125068129|NCT00764478|449866302|FG000|Overall Study|Protocol Violation|0|||
125068130|NCT00764478|449866303|FG001|Overall Study|Protocol Violation|1|||
125068131|NCT00764478|449866304|FG002|Overall Study|Protocol Violation|1|||
125068132|NCT02270684|449866305|FG000|Overall Study|Lost to Follow-up|0|||
125068133|NCT02270684|449866306|FG001|Overall Study|Lost to Follow-up|3|||
125068134|NCT02270684|449866305|FG000|Overall Study|Study terminated|1|||
125068135|NCT02270684|449866306|FG001|Overall Study|Study terminated|0|||
125068136|NCT03498287|449866313|FG000|Overall Study|Withdrawal by Subject|3|||
125068137|NCT03498287|449866314|FG001|Overall Study|Withdrawal by Subject|0|||
125068138|NCT03498287|449866313|FG000|Overall Study|Protocol Violation|0|||
125068139|NCT03498287|449866314|FG001|Overall Study|Protocol Violation|4|||
125068140|NCT03498287|449866313|FG000|Overall Study|Adverse Event|0|||
125068141|NCT03498287|449866314|FG001|Overall Study|Adverse Event|1|||
125068142|NCT02555657|449866317|FG000|Overall Study|Death|274|||
125068143|NCT02555657|449866318|FG001|Overall Study|Death|262|||
125140565|NCT00829452|450137688|FG001|First Intervention|Withdrawal by Subject|1|||
125140566|NCT00829452|450137687|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
125068144|NCT02555657|449866317|FG000|Overall Study|Physician Decision|0|||
125068145|NCT02555657|449866318|FG001|Overall Study|Physician Decision|1|||
125140567|NCT00829452|450137688|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
125222689|NCT03428100|450442757|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
125222690|NCT03428100|450442758|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
125222691|NCT03428100|450442759|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
125222692|NCT03428100|450442760|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
125222693|NCT03428100|450442761|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
125222694|NCT03428100|450442762|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
125222695|NCT03428100|450442763|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
125068146|NCT02555657|449866317|FG000|Overall Study|Sponsor Decision|27|||
125068147|NCT02555657|449866318|FG001|Overall Study|Sponsor Decision|15|||
125068148|NCT02555657|449866317|FG000|Overall Study|Withdrawal by Subject|11|||
125068149|NCT02555657|449866318|FG001|Overall Study|Withdrawal by Subject|32|||
125068150|NCT00966693|449866319|FG000|Overall Study|Adverse Event|0|||
125068151|NCT00966693|449866320|FG001|Overall Study|Adverse Event|0|||
125068152|NCT00966693|449866321|FG002|Overall Study|Adverse Event|1|||
125068153|NCT00966693|449866322|FG003|Overall Study|Adverse Event|2|||
125068154|NCT00966693|449866319|FG000|Overall Study|Death|0|||
125068155|NCT00966693|449866320|FG001|Overall Study|Death|0|||
125068156|NCT00966693|449866321|FG002|Overall Study|Death|1|||
125068157|NCT00966693|449866322|FG003|Overall Study|Death|0|||
125068158|NCT00966693|449866319|FG000|Overall Study|Withdrawal by Subject|1|||
125068159|NCT00966693|449866320|FG001|Overall Study|Withdrawal by Subject|0|||
125068160|NCT00966693|449866321|FG002|Overall Study|Withdrawal by Subject|0|||
125068161|NCT00966693|449866322|FG003|Overall Study|Withdrawal by Subject|5|||
125068162|NCT00966693|449866319|FG000|Overall Study|Disease Progression|0|||
125068163|NCT00966693|449866320|FG001|Overall Study|Disease Progression|0|||
125068164|NCT00966693|449866321|FG002|Overall Study|Disease Progression|1|||
125068165|NCT00966693|449866322|FG003|Overall Study|Disease Progression|16|||
125068166|NCT02581982|449866323|FG000|Overall Study|Lack of Efficacy|12|||
125068167|NCT02581982|449866323|FG000|Overall Study|Adverse Event|3|||
125068168|NCT02581982|449866323|FG000|Overall Study|Physician Decision|1|||
125068169|NCT03479216|449866325|FG000|Overall Study|Withdrawal by Subject|3|||
125068170|NCT03479216|449866326|FG001|Overall Study|Withdrawal by Subject|2|||
125068171|NCT03479216|449866325|FG000|Overall Study|Physician Decision|2|||
125068172|NCT03479216|449866326|FG001|Overall Study|Physician Decision|3|||
125068173|NCT03326869|449867477|FG000|Overall Study|Study data has been lost to natural disa|1|||
125068174|NCT03326869|449867478|FG001|Overall Study|Study data has been lost to natural disa|1|||
125068175|NCT03788967|449867479|FG000|Overall Study|Lost to Follow-up|14|||
125068176|NCT03788967|449867480|FG001|Overall Study|Lost to Follow-up|10|||
125068177|NCT03788967|449867479|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
125068178|NCT03788967|449867480|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
125068179|NCT03788967|449867479|FG000|Overall Study|Participant Withdrawal of Consent|13|||
125068180|NCT03788967|449867480|FG001|Overall Study|Participant Withdrawal of Consent|5|||
125068181|NCT03788967|449867479|FG000|Overall Study|Adverse Event|1|||
125068182|NCT03788967|449867480|FG001|Overall Study|Adverse Event|1|||
125068183|NCT03788967|449867479|FG000|Overall Study|COVID-19|1|||
125068184|NCT03788967|449867480|FG001|Overall Study|COVID-19|2|||
125068185|NCT03927911|449867481|FG000|Overall Study|problems with eDiary|0|||
125068186|NCT03927911|449867482|FG001|Overall Study|problems with eDiary|1|||
125068187|NCT03927911|449867483|FG002|Overall Study|problems with eDiary|0|||
125068188|NCT03927911|449867484|FG003|Overall Study|problems with eDiary|1|||
125068189|NCT03927911|449867485|FG004|Overall Study|problems with eDiary|0|||
125068190|NCT03927911|449867486|FG005|Overall Study|problems with eDiary|4|||
125068191|NCT03927911|449867481|FG000|Overall Study|Adverse Event|0|||
125068192|NCT03927911|449867482|FG001|Overall Study|Adverse Event|0|||
125068193|NCT03927911|449867483|FG002|Overall Study|Adverse Event|0|||
125068194|NCT03927911|449867484|FG003|Overall Study|Adverse Event|0|||
125068195|NCT03927911|449867485|FG004|Overall Study|Adverse Event|0|||
125068196|NCT03927911|449867486|FG005|Overall Study|Adverse Event|1|||
125068197|NCT03927911|449867481|FG000|Overall Study|not treated -study terminated by sponsor|0|||
125068198|NCT03927911|449867482|FG001|Overall Study|not treated -study terminated by sponsor|1|||
125068199|NCT03927911|449867483|FG002|Overall Study|not treated -study terminated by sponsor|0|||
125068200|NCT03927911|449867484|FG003|Overall Study|not treated -study terminated by sponsor|0|||
125068201|NCT03927911|449867485|FG004|Overall Study|not treated -study terminated by sponsor|0|||
125068202|NCT03927911|449867486|FG005|Overall Study|not treated -study terminated by sponsor|0|||
125068203|NCT03927911|449867481|FG000|Overall Study|Surgery cancelled|0|||
125068204|NCT03927911|449867482|FG001|Overall Study|Surgery cancelled|0|||
125068205|NCT03927911|449867483|FG002|Overall Study|Surgery cancelled|0|||
125068206|NCT03927911|449867484|FG003|Overall Study|Surgery cancelled|1|||
125068207|NCT03927911|449867485|FG004|Overall Study|Surgery cancelled|0|||
125068208|NCT03927911|449867486|FG005|Overall Study|Surgery cancelled|1|||
125068209|NCT03927911|449867481|FG000|Overall Study|Protocol Violation|0|||
125068210|NCT03927911|449867482|FG001|Overall Study|Protocol Violation|0|||
125068211|NCT03927911|449867483|FG002|Overall Study|Protocol Violation|0|||
125068212|NCT03927911|449867484|FG003|Overall Study|Protocol Violation|0|||
125068213|NCT03927911|449867485|FG004|Overall Study|Protocol Violation|0|||
125068214|NCT03927911|449867486|FG005|Overall Study|Protocol Violation|1|||
125068215|NCT04432376|449867487|FG000|Double-blind Treatment Period|Adverse Event|2|||
125068216|NCT04432376|449867488|FG001|Double-blind Treatment Period|Adverse Event|6|||
125068217|NCT04432376|449867489|FG002|Double-blind Treatment Period|Adverse Event|0|||
125068218|NCT04432376|449867487|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
125068219|NCT04432376|449867488|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
125068220|NCT04432376|449867489|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
125068221|NCT04432376|449867487|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
125068222|NCT04432376|449867488|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
125068223|NCT04432376|449867489|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
125068224|NCT04432376|449867487|FG000|Double-blind Treatment Period|Protocol Violation|0|||
125068225|NCT04432376|449867488|FG001|Double-blind Treatment Period|Protocol Violation|1|||
125068226|NCT04432376|449867489|FG002|Double-blind Treatment Period|Protocol Violation|0|||
125068227|NCT04432376|449867487|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
125068228|NCT04432376|449867488|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
125068229|NCT04432376|449867489|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
125068230|NCT04058158|449867490|FG000|Period 1|Death|1|||
125068231|NCT04058158|449867491|FG001|Period 1|Death|0|||
125068232|NCT04058158|449867490|FG000|Period 1|Adverse Event|1|||
125068233|NCT04058158|449867491|FG001|Period 1|Adverse Event|1|||
125068234|NCT04058158|449867490|FG000|Period 1|Pregnancy|0|||
125068235|NCT04058158|449867491|FG001|Period 1|Pregnancy|1|||
125068236|NCT04847141|449867492|FG000|Overall Study|Adverse Event|1|||
125222696|NCT03428100|450442764|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
125222697|NCT03428100|450442765|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
125222698|NCT03428100|450442766|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
125222699|NCT03428100|450442767|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
125222700|NCT03428100|450442768|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
125222701|NCT03428100|450442769|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
125222702|NCT03428100|450442770|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
125222703|NCT03428100|450442771|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
125222704|NCT03428100|450442772|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
125222705|NCT04556760|450442773|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
125222706|NCT04556760|450442774|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
125222707|NCT04556760|450442775|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
125222708|NCT04556760|450442776|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
125222709|NCT04556760|450442777|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
125068237|NCT04847141|449867493|FG001|Overall Study|Adverse Event|0|||
125068238|NCT04847141|449867494|FG002|Overall Study|Adverse Event|1|||
125068239|NCT04847141|449867492|FG000|Overall Study|Withdrawal by Subject|2|||
125068240|NCT04847141|449867493|FG001|Overall Study|Withdrawal by Subject|4|||
125068241|NCT04847141|449867494|FG002|Overall Study|Withdrawal by Subject|3|||
125068242|NCT04847141|449867492|FG000|Overall Study|Lost to Follow-up|7|||
125068243|NCT04847141|449867493|FG001|Overall Study|Lost to Follow-up|5|||
125068244|NCT04847141|449867494|FG002|Overall Study|Lost to Follow-up|7|||
125068245|NCT04847141|449867492|FG000|Overall Study|Reason not Specified|0|||
125068246|NCT04847141|449867493|FG001|Overall Study|Reason not Specified|1|||
125222710|NCT04556760|450442778|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
125222711|NCT04556760|450442773|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
125222712|NCT04556760|450442774|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
125222713|NCT04556760|450442775|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
125222714|NCT04556760|450442776|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
125222715|NCT04556760|450442777|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
125222716|NCT04556760|450442778|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
125222717|NCT02221648|450442785|FG000|Overall Study|Withdrawal by Subject|3|||
125222718|NCT02221648|450442786|FG001|Overall Study|Withdrawal by Subject|3|||
125222719|NCT03489343|450442790|FG000|Overall Study|Documented progressive disease|1|||
125222720|NCT03489343|450442791|FG001|Overall Study|Documented progressive disease|0|||
125222721|NCT03489343|450442792|FG002|Overall Study|Documented progressive disease|3|||
125222722|NCT03489343|450442793|FG003|Overall Study|Documented progressive disease|1|||
125222723|NCT03489343|450442794|FG004|Overall Study|Documented progressive disease|3|||
125222724|NCT03489343|450442795|FG005|Overall Study|Documented progressive disease|5|||
125222725|NCT03489343|450442796|FG006|Overall Study|Documented progressive disease|4|||
125140568|NCT00829452|450137687|FG000|Second Intervention|Physician Decision|0|||
125140569|NCT00829452|450137688|FG001|Second Intervention|Physician Decision|1|||
125140570|NCT00881751|450137697|FG000|Overall Study|Physician Decision|0|||
125140571|NCT00881751|450137698|FG001|Overall Study|Physician Decision|1|||
125140572|NCT00881751|450137697|FG000|Overall Study|Adverse Event|0|||
125140573|NCT00881751|450137698|FG001|Overall Study|Adverse Event|2|||
125140574|NCT00881751|450137697|FG000|Overall Study|Withdrawal by Subject|0|||
125140575|NCT00881751|450137698|FG001|Overall Study|Withdrawal by Subject|2|||
125140576|NCT00301964|450137701|FG000|Overall Study|Second primary|2|||
125140577|NCT00301964|450137701|FG000|Overall Study|Wrong primary|1|||
125140578|NCT00301964|450137701|FG000|Overall Study|Inadequate pathology|1|||
125140579|NCT02385708|450137703|FG000|Overall Study|Withdrawal by Subject|0|||
125140580|NCT02385708|450137704|FG001|Overall Study|Withdrawal by Subject|2|||
125140581|NCT02385708|450137703|FG000|Overall Study|Withdrawn - surgery canceled|2|||
125140582|NCT02385708|450137704|FG001|Overall Study|Withdrawn - surgery canceled|5|||
125140583|NCT02385708|450137703|FG000|Overall Study|Investigator decision|5|||
125140584|NCT02385708|450137704|FG001|Overall Study|Investigator decision|7|||
125140585|NCT02385708|450137703|FG000|Overall Study|Protocol Violation|1|||
125140586|NCT02385708|450137704|FG001|Overall Study|Protocol Violation|1|||
125140587|NCT01559363|450137711|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
125140588|NCT01559363|450137712|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
125140589|NCT01559363|450137713|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
125140590|NCT01559363|450137714|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
125140591|NCT01559363|450137715|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
125140592|NCT01559363|450137716|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
125140593|NCT01559363|450137711|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
125140594|NCT01559363|450137712|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
125140595|NCT01559363|450137713|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
125140596|NCT01559363|450137714|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
125140597|NCT01559363|450137715|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
125140598|NCT01559363|450137716|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
125140599|NCT01559363|450137711|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
125140600|NCT01559363|450137712|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
125140601|NCT01559363|450137713|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
125140602|NCT01559363|450137714|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
125140603|NCT01559363|450137715|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
125140604|NCT01559363|450137716|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
125140605|NCT01559363|450137711|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
125140606|NCT01559363|450137712|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
125140607|NCT01559363|450137713|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
125140608|NCT01559363|450137714|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
125140609|NCT01559363|450137715|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
125140610|NCT01559363|450137716|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
125140611|NCT01559363|450137711|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
125140612|NCT01559363|450137712|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
125140613|NCT01559363|450137713|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
125140614|NCT01559363|450137714|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
125140615|NCT01559363|450137715|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
125140616|NCT01559363|450137716|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
125140617|NCT01559363|450137711|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
125140618|NCT01559363|450137712|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
125140619|NCT01559363|450137713|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
125140620|NCT01559363|450137714|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
125140621|NCT01559363|450137715|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
125140622|NCT01559363|450137716|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
125140623|NCT01559363|450137711|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
125140624|NCT01559363|450137712|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
125140625|NCT01559363|450137713|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
125140626|NCT01559363|450137714|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
125140627|NCT01559363|450137715|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
125140628|NCT01559363|450137716|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
125140629|NCT00672984|450137717|FG000|First Intervention|Adverse Event|5|||
125140630|NCT00672984|450137718|FG001|First Intervention|Adverse Event|0|||
125140631|NCT00672984|450137719|FG002|First Intervention|Adverse Event|0|||
125140632|NCT00672984|450137717|FG000|First Intervention|Withdrawal by Subject|1|||
125140633|NCT00672984|450137718|FG001|First Intervention|Withdrawal by Subject|2|||
125140634|NCT00672984|450137719|FG002|First Intervention|Withdrawal by Subject|2|||
125140635|NCT00672984|450137717|FG000|First Intervention|Sponsor decision|3|||
125140636|NCT00672984|450137718|FG001|First Intervention|Sponsor decision|0|||
125140637|NCT00672984|450137719|FG002|First Intervention|Sponsor decision|0|||
125140638|NCT00672984|450137717|FG000|Second Intervention|Non-compliance with facility policies|0|||
125140639|NCT00672984|450137718|FG001|Second Intervention|Non-compliance with facility policies|2|||
125140640|NCT00672984|450137719|FG002|Second Intervention|Non-compliance with facility policies|0|||
125140641|NCT00672984|450137717|FG000|Second Intervention|Withdrawal by Subject|0|||
125140642|NCT00672984|450137718|FG001|Second Intervention|Withdrawal by Subject|3|||
125140643|NCT00672984|450137719|FG002|Second Intervention|Withdrawal by Subject|0|||
125140644|NCT00672984|450137717|FG000|Second Intervention|Protocol Violation|0|||
125140645|NCT00672984|450137718|FG001|Second Intervention|Protocol Violation|1|||
125140646|NCT00672984|450137719|FG002|Second Intervention|Protocol Violation|1|||
125140647|NCT00672984|450137717|FG000|Third Intervention|Adverse Event|1|||
125140648|NCT00672984|450137718|FG001|Third Intervention|Adverse Event|0|||
125140649|NCT00672984|450137719|FG002|Third Intervention|Adverse Event|1|||
125140650|NCT00645853|450137720|FG000|Overall Study|Adverse Event|18|||
125140651|NCT00645853|450137721|FG001|Overall Study|Adverse Event|7|||
125140652|NCT00645853|450137720|FG000|Overall Study|AZ study closure in Hungary|60|||
125140653|NCT00645853|450137721|FG001|Overall Study|AZ study closure in Hungary|40|||
125140654|NCT00645853|450137720|FG000|Overall Study|Withdrawal by Subject|5|||
125140655|NCT00645853|450137721|FG001|Overall Study|Withdrawal by Subject|2|||
125140656|NCT00645853|450137720|FG000|Overall Study|Protocol Violation|0|||
125140657|NCT00645853|450137721|FG001|Overall Study|Protocol Violation|2|||
125140658|NCT00645853|450137720|FG000|Overall Study|Discontinuation criteria|2|||
125140659|NCT00645853|450137721|FG001|Overall Study|Discontinuation criteria|2|||
125140660|NCT00645853|450137720|FG000|Overall Study|recall of ICF, planned operation, death|7|||
125140661|NCT00645853|450137721|FG001|Overall Study|recall of ICF, planned operation, death|4|||
125140662|NCT04060251|450137722|FG000|Overall Study|Study terminated due to low enrollment.|7|||
125140663|NCT04060251|450137723|FG001|Overall Study|Study terminated due to low enrollment.|5|||
125140664|NCT04060251|450137724|FG002|Overall Study|Study terminated due to low enrollment.|7|||
125140665|NCT04060251|450137722|FG000|Overall Study|Adverse Event|1|||
125140666|NCT04060251|450137723|FG001|Overall Study|Adverse Event|1|||
125140667|NCT04060251|450137724|FG002|Overall Study|Adverse Event|0|||
125140668|NCT01151618|450137725|FG000|Overall Study|Adverse Event|2|||
125140669|NCT01151618|450137725|FG000|Overall Study|Withdrawal by Subject|7|||
125140670|NCT01632306|450137726|FG000|Overall Study|Protocol Violation|1|||
125140671|NCT01632306|450137727|FG001|Overall Study|Protocol Violation|0|||
125140672|NCT01632306|450137728|FG002|Overall Study|Protocol Violation|0|||
125140673|NCT00858403|450137735|FG000|Overall Study|Withdrawal by Subject|1|||
125140674|NCT00858403|450137735|FG000|Overall Study|Death|3|||
125140675|NCT00858403|450137735|FG000|Overall Study|Disease Progression|1|||
125140676|NCT03867760|450137736|FG000|Overall Study|Lost to Follow-up|2|||
125140677|NCT03867760|450137737|FG001|Overall Study|Lost to Follow-up|3|||
125140678|NCT03867760|450137736|FG000|Overall Study|Withdrawal by Subject|1|||
125140679|NCT03867760|450137737|FG001|Overall Study|Withdrawal by Subject|2|||
125140680|NCT03867760|450137736|FG000|Overall Study|subject could not meet study logistics|3|||
125140681|NCT03867760|450137737|FG001|Overall Study|subject could not meet study logistics|3|||
125140682|NCT02286466|450137739|FG000|Overall Study|Death|1|||
125140683|NCT02286466|450137740|FG001|Overall Study|Death|3|||
125140684|NCT02286466|450137739|FG000|Overall Study|Withdrawal by Subject|5|||
125140685|NCT02286466|450137740|FG001|Overall Study|Withdrawal by Subject|2|||
125140686|NCT02286466|450137739|FG000|Overall Study|Lost to Follow-up|1|||
125140687|NCT02286466|450137740|FG001|Overall Study|Lost to Follow-up|4|||
125140688|NCT02286466|450137739|FG000|Overall Study|Declined Clinician Assessment|0|||
125140689|NCT02286466|450137740|FG001|Overall Study|Declined Clinician Assessment|1|||
125140690|NCT00874276|450137744|FG000|Overall Study|Withdrawal by Subject|1|||
125140691|NCT00874276|450137745|FG001|Overall Study|Withdrawal by Subject|1|||
125140692|NCT03694197|450137748|FG000|Overall Study|Adverse Event|9|||
125140693|NCT03694197|450137748|FG000|Overall Study|Protocol became inconvenient to participate|1|||
125140694|NCT03694197|450137748|FG000|Overall Study|Physician Decision|4|||
125140695|NCT03694197|450137748|FG000|Overall Study|Study terminated by sponsor|1350|||
125140696|NCT03694197|450137748|FG000|Overall Study|Participant moved|5|||
125140697|NCT03694197|450137748|FG000|Overall Study|Participant withdrew consent|10|||
125140698|NCT03694197|450137748|FG000|Overall Study|Related to IMP administration|1|||
125140699|NCT03694197|450137748|FG000|Overall Study|Not disclosed|5|||
125140700|NCT02957331|450137749|FG000|Overall Study|Protocol Violation|1|||
125140701|NCT02957331|450137750|FG001|Overall Study|Protocol Violation|0|||
125140702|NCT03247686|450139503|FG000|Overall Study|Withdrawal by Subject|1|||
125140703|NCT03247686|450139504|FG001|Overall Study|Withdrawal by Subject|2|||
125140704|NCT02583048|450139512|FG000|Overall Study|Withdrawal by Subject|0|||
125140705|NCT02583048|450139513|FG001|Overall Study|Withdrawal by Subject|1|||
125140706|NCT02583048|450139514|FG002|Overall Study|Withdrawal by Subject|0|||
125222726|NCT03489343|450442790|FG000|Overall Study|Adverse Event|0|||
125140707|NCT02583048|450139512|FG000|Overall Study|Failed to meet eligibility criterion|0|||
125140708|NCT02583048|450139513|FG001|Overall Study|Failed to meet eligibility criterion|0|||
125140709|NCT02583048|450139514|FG002|Overall Study|Failed to meet eligibility criterion|1|||
125140710|NCT01151280|450139517|FG000|Overall Study|Adverse Event|1|||
125140711|NCT01151280|450139517|FG000|Overall Study|Lack of Efficacy|3|||
125140712|NCT00757705|450139518|FG000|Overall Study|Adverse Event|19|||
125222727|NCT03489343|450442791|FG001|Overall Study|Adverse Event|1|||
125068247|NCT04847141|449867494|FG002|Overall Study|Reason not Specified|0|||
125068248|NCT00324740|449867495|FG000|Overall Study|Withdrawal by Subject|1|||
125068249|NCT00324740|449867496|FG001|Overall Study|Withdrawal by Subject|0|||
125068250|NCT00324740|449867497|FG002|Overall Study|Withdrawal by Subject|1|||
125068251|NCT04507776|449867498|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
125068252|NCT03628599|449867499|FG000|Overall Study|Adverse Event|0|||
125068253|NCT03628599|449867500|FG001|Overall Study|Adverse Event|1|||
125068254|NCT01624506|449867501|FG000|Overall Study|Lost to Follow-up|29|||
125068255|NCT01624506|449867502|FG001|Overall Study|Lost to Follow-up|15|||
125068256|NCT01624506|449867501|FG000|Overall Study|Withdrawal by Subject|9|||
125068257|NCT01624506|449867502|FG001|Overall Study|Withdrawal by Subject|2|||
125068258|NCT01624506|449867501|FG000|Overall Study|Death|1|||
125068259|NCT01624506|449867502|FG001|Overall Study|Death|0|||
125068260|NCT01624506|449867501|FG000|Overall Study|LINX explants|23|||
125068261|NCT01624506|449867502|FG001|Overall Study|LINX explants|0|||
125068262|NCT01624506|449867501|FG000|Overall Study|Adverse Event|3|||
125068263|NCT01624506|449867502|FG001|Overall Study|Adverse Event|0|||
125068264|NCT00132314|449867505|FG000|Overall Study|Lost to Follow-up|70|||
125068265|NCT00132314|449867506|FG001|Overall Study|Lost to Follow-up|62|||
125068266|NCT00132314|449867505|FG000|Overall Study|Lacked SSN|1|||
125068267|NCT00132314|449867506|FG001|Overall Study|Lacked SSN|3|||
125068268|NCT00132314|449867505|FG000|Overall Study|Refused intervention at baseline|2|||
125068269|NCT00132314|449867506|FG001|Overall Study|Refused intervention at baseline|7|||
125068270|NCT03250377|449867507|FG000|Overall Study|Adverse Event|2|||
125068271|NCT03250377|449867508|FG001|Overall Study|Adverse Event|4|||
125068272|NCT03250377|449867509|FG002|Overall Study|Adverse Event|0|||
125068273|NCT03250377|449867510|FG003|Overall Study|Adverse Event|4|||
125068274|NCT03250377|449867507|FG000|Overall Study|Lack of Efficacy|5|||
125068275|NCT03250377|449867508|FG001|Overall Study|Lack of Efficacy|14|||
125068276|NCT03250377|449867509|FG002|Overall Study|Lack of Efficacy|1|||
125068277|NCT03250377|449867510|FG003|Overall Study|Lack of Efficacy|3|||
125068278|NCT03250377|449867507|FG000|Overall Study|Protocol Violation|0|||
125068279|NCT03250377|449867508|FG001|Overall Study|Protocol Violation|2|||
125068280|NCT03250377|449867509|FG002|Overall Study|Protocol Violation|0|||
125068281|NCT03250377|449867510|FG003|Overall Study|Protocol Violation|1|||
125068282|NCT03250377|449867507|FG000|Overall Study|Lost to Follow-up|0|||
125068283|NCT03250377|449867508|FG001|Overall Study|Lost to Follow-up|1|||
125068284|NCT03250377|449867509|FG002|Overall Study|Lost to Follow-up|0|||
125068285|NCT03250377|449867510|FG003|Overall Study|Lost to Follow-up|0|||
125068286|NCT03250377|449867507|FG000|Overall Study|Withdrawal by Subject|7|||
125068287|NCT03250377|449867508|FG001|Overall Study|Withdrawal by Subject|7|||
125068288|NCT03250377|449867509|FG002|Overall Study|Withdrawal by Subject|0|||
125068289|NCT03250377|449867510|FG003|Overall Study|Withdrawal by Subject|4|||
125068290|NCT03250377|449867507|FG000|Overall Study|Investigator's Judgment|1|||
125068291|NCT03250377|449867508|FG001|Overall Study|Investigator's Judgment|0|||
125068292|NCT03250377|449867509|FG002|Overall Study|Investigator's Judgment|0|||
125068293|NCT03250377|449867510|FG003|Overall Study|Investigator's Judgment|0|||
125068294|NCT03250377|449867507|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
125068295|NCT03250377|449867508|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
125068296|NCT03250377|449867509|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
125068297|NCT03250377|449867510|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
125068298|NCT03250377|449867507|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
125068299|NCT03250377|449867508|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
125068300|NCT03250377|449867509|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
125068301|NCT03250377|449867510|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
125068302|NCT03250377|449867507|FG000|Overall Study|Epilepsy Surgery|0|||
125068303|NCT03250377|449867508|FG001|Overall Study|Epilepsy Surgery|1|||
125068304|NCT03250377|449867509|FG002|Overall Study|Epilepsy Surgery|2|||
125068305|NCT03250377|449867510|FG003|Overall Study|Epilepsy Surgery|0|||
125068306|NCT03250377|449867507|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
125068307|NCT03250377|449867508|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
125068308|NCT03250377|449867509|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
125068309|NCT03250377|449867510|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
125068310|NCT03250377|449867507|FG000|Overall Study|Request From The Sponsor|0|||
125068311|NCT03250377|449867508|FG001|Overall Study|Request From The Sponsor|1|||
125068312|NCT03250377|449867509|FG002|Overall Study|Request From The Sponsor|0|||
125068313|NCT03250377|449867510|FG003|Overall Study|Request From The Sponsor|0|||
125068314|NCT03250377|449867507|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
125068315|NCT03250377|449867508|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
125068316|NCT03250377|449867509|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
125140713|NCT00757705|450139518|FG000|Overall Study|Lost to Follow-up|16|||
125068317|NCT03250377|449867510|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
125068318|NCT03250377|449867507|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
125140714|NCT00757705|450139518|FG000|Overall Study|Withdrawal by Subject|25|||
125222728|NCT03489343|450442792|FG002|Overall Study|Adverse Event|0|||
125222729|NCT03489343|450442793|FG003|Overall Study|Adverse Event|0|||
125222730|NCT03489343|450442794|FG004|Overall Study|Adverse Event|0|||
125222731|NCT03489343|450442795|FG005|Overall Study|Adverse Event|1|||
125222732|NCT03489343|450442796|FG006|Overall Study|Adverse Event|0|||
125222733|NCT03489343|450442790|FG000|Overall Study|Withdrawal by Subject|0|||
125222734|NCT03489343|450442791|FG001|Overall Study|Withdrawal by Subject|0|||
125222735|NCT03489343|450442792|FG002|Overall Study|Withdrawal by Subject|0|||
125222736|NCT03489343|450442793|FG003|Overall Study|Withdrawal by Subject|1|||
125222737|NCT03489343|450442794|FG004|Overall Study|Withdrawal by Subject|0|||
125222738|NCT03489343|450442795|FG005|Overall Study|Withdrawal by Subject|1|||
125222739|NCT03489343|450442796|FG006|Overall Study|Withdrawal by Subject|1|||
125222740|NCT03489343|450442790|FG000|Overall Study|Clinical progression|0|||
125222741|NCT03489343|450442791|FG001|Overall Study|Clinical progression|0|||
125222742|NCT03489343|450442792|FG002|Overall Study|Clinical progression|0|||
125222743|NCT03489343|450442793|FG003|Overall Study|Clinical progression|1|||
125140715|NCT00757705|450139518|FG000|Overall Study|Insufficient Response|26|||
125222744|NCT03489343|450442794|FG004|Overall Study|Clinical progression|0|||
125222745|NCT03489343|450442795|FG005|Overall Study|Clinical progression|0|||
125222746|NCT03489343|450442796|FG006|Overall Study|Clinical progression|1|||
125222747|NCT01166750|450442800|FG000|Overall Study|Lost to Follow-up|1|||
125222748|NCT01166750|450442801|FG001|Overall Study|Lost to Follow-up|0|||
125222749|NCT01585246|450442802|FG000|Overall Study|Lost to Follow-up|0|||
125222750|NCT01585246|450442803|FG001|Overall Study|Lost to Follow-up|0|||
125222751|NCT01585246|450442804|FG002|Overall Study|Lost to Follow-up|2|||
125222752|NCT01585246|450442805|FG003|Overall Study|Lost to Follow-up|1|||
125222753|NCT01585246|450442806|FG004|Overall Study|Lost to Follow-up|0|||
125222754|NCT01585246|450442802|FG000|Overall Study|Protocol Violation|0|||
125222755|NCT01585246|450442803|FG001|Overall Study|Protocol Violation|0|||
125222756|NCT01585246|450442804|FG002|Overall Study|Protocol Violation|0|||
125222757|NCT01585246|450442805|FG003|Overall Study|Protocol Violation|0|||
125222758|NCT01585246|450442806|FG004|Overall Study|Protocol Violation|1|||
125222759|NCT01585246|450442802|FG000|Overall Study|Withdrawal by Subject|0|||
125222760|NCT01585246|450442803|FG001|Overall Study|Withdrawal by Subject|0|||
125222761|NCT01585246|450442804|FG002|Overall Study|Withdrawal by Subject|1|||
125222762|NCT01585246|450442805|FG003|Overall Study|Withdrawal by Subject|2|||
125222763|NCT01585246|450442806|FG004|Overall Study|Withdrawal by Subject|1|||
125222764|NCT01585246|450442802|FG000|Overall Study|Other|0|||
125222765|NCT01585246|450442803|FG001|Overall Study|Other|1|||
125222766|NCT01585246|450442804|FG002|Overall Study|Other|1|||
125222767|NCT01585246|450442805|FG003|Overall Study|Other|1|||
125222768|NCT01585246|450442806|FG004|Overall Study|Other|0|||
125222769|NCT04396626|450442807|FG000|Overall Study|Premature termination of study|975|||
125222770|NCT02111174|450442810|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
125222771|NCT02111174|450442811|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
125222772|NCT02111174|450442810|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
125222773|NCT02111174|450442811|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
125222774|NCT02111174|450442810|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
125222775|NCT02111174|450442811|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
125222776|NCT02111174|450442810|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
125222777|NCT02111174|450442811|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
125222778|NCT00838097|450442814|FG000|Overall Study|Ineligibility determined|6|||
125222779|NCT00838097|450442814|FG000|Overall Study|Adverse Event|2|||
125222780|NCT00838097|450442814|FG000|Overall Study|Withdrawal by Subject|3|||
125222781|NCT00838097|450442814|FG000|Overall Study|Requirement for alternative therapy|2|||
125222782|NCT00838097|450442814|FG000|Overall Study|Physician Decision|4|||
125222783|NCT00838097|450442814|FG000|Overall Study|Lost to Follow-up|11|||
125222784|NCT00838097|450442814|FG000|Overall Study|Death|6|||
125140716|NCT00757705|450139518|FG000|Overall Study|Ineligible to continue|8|||
125140717|NCT00757705|450139518|FG000|Overall Study|Non-compliant|9|||
125140718|NCT00757705|450139518|FG000|Overall Study|Other|18|||
125140719|NCT02578641|450139522|FG000|Overall Study|Adverse Event|5|||
125140720|NCT02578641|450139523|FG001|Overall Study|Adverse Event|15|||
125140721|NCT02578641|450139522|FG000|Overall Study|Death|16|||
125140722|NCT02578641|450139523|FG001|Overall Study|Death|8|||
125140723|NCT02578641|450139522|FG000|Overall Study|Lost to Follow-up|0|||
125140724|NCT02578641|450139523|FG001|Overall Study|Lost to Follow-up|1|||
125140725|NCT02578641|450139522|FG000|Overall Study|Withdrawal by Subject|14|||
125222785|NCT00838097|450442814|FG000|Overall Study|Protocol-specified criteria|142|||
125140726|NCT02578641|450139523|FG001|Overall Study|Withdrawal by Subject|7|||
125222786|NCT00871234|450442815|FG000|Overall Study|Adverse Event|2|||
125222787|NCT00871234|450442815|FG000|Overall Study|Lost to Follow-up|3|||
125222788|NCT03380377|450442818|FG000|Overall Study|Physician Decision|1|||
125222789|NCT03380377|450442818|FG000|Overall Study|Withdrawal by Subject|1|||
125222790|NCT02600923|450442821|FG000|Overall Study|Death|10|||
125222791|NCT02600923|450442821|FG000|Overall Study|Adverse Event|3|||
125140727|NCT02578641|450139522|FG000|Overall Study|Progressive Disease|69|||
125222792|NCT02600923|450442821|FG000|Overall Study|Global deterioration of health status|2|||
125222793|NCT02600923|450442821|FG000|Overall Study|Insufficient clinical response|6|||
125222794|NCT02600923|450442821|FG000|Overall Study|Lost to Follow-up|1|||
125222795|NCT02600923|450442821|FG000|Overall Study|Withdrawal by Subject|5|||
125222796|NCT02600923|450442821|FG000|Overall Study|Objective progression or relapse|50|||
125222797|NCT02600923|450442821|FG000|Overall Study|Study terminated by Sponsor|53|||
125222798|NCT02600923|450442821|FG000|Overall Study|Not treated|1|||
125222799|NCT00792909|450442822|FG000|Overall Study|Withdrawal by Subject|0|||
125222800|NCT00792909|450442823|FG001|Overall Study|Withdrawal by Subject|1|||
125222801|NCT00792909|450442824|FG002|Overall Study|Withdrawal by Subject|0|||
125222802|NCT00128661|450442827|FG000|Overall Study|Adverse Event|14|||
125222803|NCT00128661|450442828|FG001|Overall Study|Adverse Event|11|||
125222804|NCT00128661|450442827|FG000|Overall Study|Lost to Follow-up|10|||
125222805|NCT00128661|450442828|FG001|Overall Study|Lost to Follow-up|7|||
125222806|NCT00128661|450442827|FG000|Overall Study|Withdrawal by Subject|243|||
125222807|NCT00128661|450442828|FG001|Overall Study|Withdrawal by Subject|232|||
125068319|NCT03250377|449867508|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
125068320|NCT03250377|449867509|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
125068321|NCT03250377|449867510|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
125222808|NCT00128661|450442827|FG000|Overall Study|Other|7|||
125222809|NCT00128661|450442828|FG001|Overall Study|Other|8|||
125222810|NCT01261390|450442830|FG000|Overall Study|Significant Concurrent Illness|1|||
125222811|NCT01261390|450442831|FG001|Overall Study|Significant Concurrent Illness|0|||
125222812|NCT01261390|450442832|FG002|Overall Study|Significant Concurrent Illness|1|||
125222813|NCT01261390|450442833|FG003|Overall Study|Significant Concurrent Illness|0|||
125222814|NCT01261390|450442830|FG000|Overall Study|Dissatisfaction with Treatment|2|||
125222815|NCT01261390|450442831|FG001|Overall Study|Dissatisfaction with Treatment|1|||
125222816|NCT01261390|450442832|FG002|Overall Study|Dissatisfaction with Treatment|1|||
125222817|NCT01261390|450442833|FG003|Overall Study|Dissatisfaction with Treatment|2|||
125222818|NCT01261390|450442830|FG000|Overall Study|Relocation|0|||
125222819|NCT01261390|450442831|FG001|Overall Study|Relocation|1|||
125222820|NCT01261390|450442832|FG002|Overall Study|Relocation|0|||
125222821|NCT01261390|450442833|FG003|Overall Study|Relocation|0|||
125222822|NCT01261390|450442830|FG000|Overall Study|Loss of Interest in the Study|3|||
125222823|NCT01261390|450442831|FG001|Overall Study|Loss of Interest in the Study|1|||
125222824|NCT01261390|450442832|FG002|Overall Study|Loss of Interest in the Study|0|||
125222825|NCT01261390|450442833|FG003|Overall Study|Loss of Interest in the Study|0|||
125222826|NCT01261390|450442830|FG000|Overall Study|Lost to Follow-up|1|||
125222827|NCT01261390|450442831|FG001|Overall Study|Lost to Follow-up|6|||
125222828|NCT01261390|450442832|FG002|Overall Study|Lost to Follow-up|5|||
125222829|NCT01261390|450442833|FG003|Overall Study|Lost to Follow-up|6|||
125222830|NCT00977613|450442834|FG000|Overall Study|Lost to Follow-up|16|||
125222831|NCT04001803|450442839|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
125222832|NCT04001803|450442839|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
125222833|NCT04001803|450442839|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
125222834|NCT04001803|450442839|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
125222835|NCT04001803|450442839|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
125222836|NCT04001803|450442839|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
125222837|NCT04001803|450442839|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
125222838|NCT04001803|450442839|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
125222839|NCT04001803|450442839|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
125222840|NCT04001803|450442839|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
125222841|NCT05404711|450442840|FG000|Completed Study Visit|Withdrawal by Subject|1|||
125222842|NCT05404711|450442840|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
125068322|NCT03250377|449867507|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
125068323|NCT03250377|449867508|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
125068324|NCT03250377|449867509|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
125068325|NCT03250377|449867510|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
125068326|NCT03250377|449867507|FG000|Overall Study|Pregnancy Event|0|||
125068327|NCT03250377|449867508|FG001|Overall Study|Pregnancy Event|1|||
125068328|NCT03250377|449867509|FG002|Overall Study|Pregnancy Event|0|||
125068329|NCT03250377|449867510|FG003|Overall Study|Pregnancy Event|0|||
125222843|NCT05404711|450442840|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
125222844|NCT05404711|450442840|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
125222845|NCT05404711|450442840|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
125222846|NCT05404711|450442840|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
125222847|NCT02346877|450442843|FG000|Overall Study|Adverse Event|1|||
125222848|NCT02346877|450442844|FG001|Overall Study|Adverse Event|0|||
125222849|NCT02346877|450442843|FG000|Overall Study|Administrative Decision|1|||
125068330|NCT03250377|449867507|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
125068331|NCT03250377|449867508|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
125068332|NCT03250377|449867509|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
125068333|NCT03250377|449867510|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
125068334|NCT03250377|449867507|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
125068335|NCT03250377|449867508|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
125068336|NCT03250377|449867509|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
125068337|NCT03250377|449867510|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
125068338|NCT03250377|449867507|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
125068339|NCT03250377|449867508|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
125068340|NCT03250377|449867509|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
125068341|NCT03250377|449867510|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
125068342|NCT03250377|449867507|FG000|Overall Study|Patient requested to change hospital|0|||
125068343|NCT03250377|449867508|FG001|Overall Study|Patient requested to change hospital|0|||
125068344|NCT03250377|449867509|FG002|Overall Study|Patient requested to change hospital|0|||
125068345|NCT03250377|449867510|FG003|Overall Study|Patient requested to change hospital|1|||
125068346|NCT03250377|449867507|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
125068347|NCT03250377|449867508|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
125068348|NCT03250377|449867509|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
125068349|NCT03250377|449867510|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
125068350|NCT03657810|449867511|FG000|Overall Study|Adverse Event|0|||
125068351|NCT03657810|449867512|FG001|Overall Study|Adverse Event|1|||
125068352|NCT03657810|449867513|FG002|Overall Study|Adverse Event|0|||
125068353|NCT03657810|449867511|FG000|Overall Study|Lack of Efficacy|4|||
125068354|NCT03657810|449867512|FG001|Overall Study|Lack of Efficacy|1|||
125068355|NCT03657810|449867513|FG002|Overall Study|Lack of Efficacy|3|||
125068356|NCT03657810|449867511|FG000|Overall Study|Protocol Violation|1|||
125068357|NCT03657810|449867512|FG001|Overall Study|Protocol Violation|0|||
125068358|NCT03657810|449867513|FG002|Overall Study|Protocol Violation|0|||
125068359|NCT03657810|449867511|FG000|Overall Study|Lost to Follow-up|0|||
125068360|NCT03657810|449867512|FG001|Overall Study|Lost to Follow-up|1|||
125068361|NCT03657810|449867513|FG002|Overall Study|Lost to Follow-up|0|||
125068362|NCT03657810|449867511|FG000|Overall Study|Not provided|0|||
125068363|NCT03657810|449867512|FG001|Overall Study|Not provided|1|||
125068364|NCT03657810|449867513|FG002|Overall Study|Not provided|0|||
125068365|NCT03939637|449867522|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
125068366|NCT03939637|449867523|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
125068367|NCT03939637|449867522|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
125068368|NCT03939637|449867523|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
125068369|NCT05224076|449867524|FG000|Overall Study|Lost to Follow-up|24|||
125068370|NCT01082367|449867525|FG000|Double-blind Period|Administrative problems|0|||
125068371|NCT01082367|449867526|FG001|Double-blind Period|Administrative problems|1|||
125068372|NCT01082367|449867525|FG000|Double-blind Period|Lack of Efficacy|5|||
125068373|NCT01082367|449867526|FG001|Double-blind Period|Lack of Efficacy|11|||
125068374|NCT01082367|449867525|FG000|Double-blind Period|Adverse Event|0|||
125068375|NCT01082367|449867526|FG001|Double-blind Period|Adverse Event|1|||
125068376|NCT01082367|449867525|FG000|Follow-up (F-U) Period|Administrative problems|1|||
125068377|NCT01082367|449867526|FG001|Follow-up (F-U) Period|Administrative problems|0|||
125068378|NCT01082367|449867525|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
125068379|NCT01082367|449867526|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
125068380|NCT01082367|449867525|FG000|Follow-up (F-U) Period|Adverse Event|0|||
125068381|NCT01082367|449867526|FG001|Follow-up (F-U) Period|Adverse Event|1|||
125068382|NCT02016898|449867527|FG000|Overall Study|Death|1|||
125068383|NCT02016898|449867528|FG001|Overall Study|Death|1|||
125068384|NCT02016898|449867527|FG000|Overall Study|Lost to Follow-up|4|||
125068385|NCT02016898|449867528|FG001|Overall Study|Lost to Follow-up|4|||
125068386|NCT01665768|449867529|FG000|Overall Study|Adverse Event|3|||
125068387|NCT01665768|449867529|FG000|Overall Study|Lack of Efficacy|19|||
125068388|NCT01665768|449867529|FG000|Overall Study|Withdrawal by Subject|1|||
125068389|NCT01329341|449867530|FG000|Overall Study|Withdrawal by Subject|44|||
125068390|NCT03017846|449867531|FG000|Overall Study|Lost to Follow-up|3|||
125068391|NCT03017846|449867531|FG000|Overall Study|Adverse Event|2|||
125068392|NCT04603391|449867532|FG000|First Intervention (4 Days)|Adverse Event|1|||
125068393|NCT04603391|449867533|FG001|First Intervention (4 Days)|Adverse Event|0|||
125068394|NCT04603391|449867532|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
125068395|NCT04603391|449867533|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
125068396|NCT02151682|449867534|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
125068397|NCT02151682|449867535|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
125068398|NCT02151682|449867536|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
125068399|NCT02151682|449867537|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
125068400|NCT02151682|449867538|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
125068401|NCT02151682|449867539|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
125140728|NCT02578641|450139523|FG001|Overall Study|Progressive Disease|21|||
125140729|NCT02578641|450139522|FG000|Overall Study|No Study Drug|2|||
125140730|NCT02578641|450139523|FG001|Overall Study|No Study Drug|0|||
125140731|NCT02578641|450139522|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
125140732|NCT02578641|450139523|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
125140733|NCT02578641|450139522|FG000|Overall Study|Non-compliance with Study Schedule|1|||
125140734|NCT02578641|450139523|FG001|Overall Study|Non-compliance with Study Schedule|0|||
125140735|NCT02578641|450139522|FG000|Overall Study|Other|1|||
125140736|NCT02578641|450139523|FG001|Overall Study|Other|10|||
125140737|NCT02578641|450139522|FG000|Overall Study|Not treated|1|||
125140738|NCT02578641|450139523|FG001|Overall Study|Not treated|4|||
125140739|NCT02313558|450139524|FG000|Overall Study|Withdrawal by Subject|2|||
125140740|NCT02313558|450139525|FG001|Overall Study|Withdrawal by Subject|0|||
125140741|NCT02313558|450139524|FG000|Overall Study|Lost to Follow-up|4|||
125140742|NCT02313558|450139525|FG001|Overall Study|Lost to Follow-up|4|||
125068402|NCT02151682|449867534|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
125068403|NCT02151682|449867535|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
125068404|NCT02151682|449867536|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
125068405|NCT02151682|449867537|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
125068406|NCT02151682|449867538|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
125068407|NCT02151682|449867539|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
125068408|NCT02151682|449867534|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
125068409|NCT02151682|449867535|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
125068410|NCT02151682|449867536|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
125068411|NCT02151682|449867537|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
125068412|NCT02151682|449867538|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
125068413|NCT02151682|449867539|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
125068414|NCT02151682|449867534|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
125068415|NCT02151682|449867535|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
125068416|NCT02151682|449867536|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
125068417|NCT02151682|449867537|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
125068418|NCT02151682|449867538|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
125068419|NCT02151682|449867539|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
125068420|NCT02151682|449867534|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
125068421|NCT02151682|449867535|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
125068422|NCT02151682|449867536|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
125068423|NCT02151682|449867537|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
125068424|NCT02151682|449867538|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
125068425|NCT02151682|449867539|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
125068426|NCT02151682|449867534|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
125068427|NCT02151682|449867535|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
125068428|NCT02151682|449867536|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
125068429|NCT02151682|449867537|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
125068430|NCT02151682|449867538|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
125068431|NCT02151682|449867539|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
125068432|NCT02151682|449867534|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
125068433|NCT02151682|449867535|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
125068434|NCT02151682|449867536|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
125068435|NCT02151682|449867537|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
125068436|NCT02151682|449867538|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
125068437|NCT02151682|449867539|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
125068438|NCT02151682|449867534|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
125068439|NCT02151682|449867535|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
125068440|NCT02151682|449867536|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
125068441|NCT02151682|449867537|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
125068442|NCT02151682|449867538|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
125068443|NCT02151682|449867539|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
125068444|NCT02151682|449867534|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
125068445|NCT02151682|449867535|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
125068446|NCT02151682|449867536|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
125068447|NCT02151682|449867537|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
125068448|NCT02151682|449867538|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
125068449|NCT02151682|449867539|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
125068450|NCT02151682|449867534|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
125068451|NCT02151682|449867535|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
125222850|NCT02346877|450442844|FG001|Overall Study|Administrative Decision|0|||
125068452|NCT02151682|449867536|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
125068453|NCT02151682|449867537|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
125068454|NCT02151682|449867538|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
125068455|NCT02151682|449867539|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
125068456|NCT02151682|449867534|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
125068457|NCT02151682|449867535|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
125068458|NCT02151682|449867536|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
125068459|NCT02151682|449867537|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
125068460|NCT02151682|449867538|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
125068461|NCT02151682|449867539|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
125068462|NCT02151682|449867534|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
125068463|NCT02151682|449867535|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
125068464|NCT02151682|449867536|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
125068465|NCT02151682|449867537|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
125068466|NCT02151682|449867538|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
125068467|NCT02151682|449867539|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
125068468|NCT02151682|449867534|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
125068469|NCT02151682|449867535|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
125068470|NCT02151682|449867536|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
125068471|NCT02151682|449867537|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
125068472|NCT02151682|449867538|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
125068473|NCT02151682|449867539|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
125068474|NCT02151682|449867534|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
125068475|NCT02151682|449867535|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
125068476|NCT02151682|449867536|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
125068477|NCT02151682|449867537|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
125068478|NCT02151682|449867538|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
125068479|NCT02151682|449867539|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
125068480|NCT02151682|449867534|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
125068481|NCT02151682|449867535|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
125068482|NCT02151682|449867536|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
125068483|NCT02151682|449867537|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
125068484|NCT02151682|449867538|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
125068485|NCT02151682|449867539|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
125068486|NCT02151682|449867534|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
125068487|NCT02151682|449867535|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
125068488|NCT02151682|449867536|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
125068489|NCT02151682|449867537|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
125068490|NCT02151682|449867538|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
125068491|NCT02151682|449867539|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
125068492|NCT02151682|449867534|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
125068493|NCT02151682|449867535|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
125068494|NCT02151682|449867536|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
125068495|NCT02151682|449867537|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
125068496|NCT02151682|449867538|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
125068497|NCT02151682|449867539|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
125068498|NCT02151682|449867534|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
125068499|NCT02151682|449867535|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
125068500|NCT02151682|449867536|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
125068501|NCT02151682|449867537|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
125068502|NCT02151682|449867538|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
125068503|NCT02151682|449867539|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
125068504|NCT01306032|449867540|FG000|First Intervention|Adverse Event|1|||
125068505|NCT01306032|449867541|FG001|First Intervention|Adverse Event|0|||
125068506|NCT01306032|449867542|FG002|First Intervention|Adverse Event|1|||
125068507|NCT01306032|449867543|FG003|First Intervention|Adverse Event|0|||
125068508|NCT01306032|449867544|FG004|First Intervention|Adverse Event|0|||
125068509|NCT01306032|449867545|FG005|First Intervention|Adverse Event|1|||
125068510|NCT01306032|449867540|FG000|First Intervention|Withdrawal by Subject|0|||
125222851|NCT02346877|450442843|FG000|Overall Study|Sponsor Decision|12|||
125222852|NCT02346877|450442844|FG001|Overall Study|Sponsor Decision|0|||
125068511|NCT01306032|449867541|FG001|First Intervention|Withdrawal by Subject|2|||
125068512|NCT01306032|449867542|FG002|First Intervention|Withdrawal by Subject|0|||
125068513|NCT01306032|449867543|FG003|First Intervention|Withdrawal by Subject|1|||
125068514|NCT01306032|449867544|FG004|First Intervention|Withdrawal by Subject|0|||
125222853|NCT02346877|450442843|FG000|Overall Study|Missing|5|||
125068515|NCT01306032|449867545|FG005|First Intervention|Withdrawal by Subject|0|||
125068516|NCT01306032|449867540|FG000|First Intervention|Death|0|||
125068517|NCT01306032|449867541|FG001|First Intervention|Death|0|||
125068518|NCT01306032|449867542|FG002|First Intervention|Death|1|||
125068519|NCT01306032|449867543|FG003|First Intervention|Death|0|||
125068520|NCT01306032|449867544|FG004|First Intervention|Death|0|||
125068521|NCT01306032|449867545|FG005|First Intervention|Death|0|||
125068522|NCT01306032|449867540|FG000|First Intervention|Ineligible|0|||
125068523|NCT01306032|449867541|FG001|First Intervention|Ineligible|0|||
125068524|NCT01306032|449867542|FG002|First Intervention|Ineligible|0|||
125068525|NCT01306032|449867543|FG003|First Intervention|Ineligible|0|||
125068526|NCT01306032|449867544|FG004|First Intervention|Ineligible|0|||
125068527|NCT01306032|449867545|FG005|First Intervention|Ineligible|1|||
125068528|NCT01306032|449867540|FG000|First Intervention|Progressive disease|0|||
125068529|NCT01306032|449867541|FG001|First Intervention|Progressive disease|0|||
125068530|NCT01306032|449867542|FG002|First Intervention|Progressive disease|0|||
125068531|NCT01306032|449867543|FG003|First Intervention|Progressive disease|0|||
125068532|NCT01306032|449867544|FG004|First Intervention|Progressive disease|2|||
125068533|NCT01306032|449867545|FG005|First Intervention|Progressive disease|0|||
125068534|NCT01306032|449867540|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
125068535|NCT01306032|449867541|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
125068536|NCT01306032|449867542|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
125068537|NCT01306032|449867543|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
125068538|NCT01306032|449867544|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
125068539|NCT01306032|449867545|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
125068540|NCT01306032|449867540|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
125068541|NCT01306032|449867541|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
125068542|NCT01306032|449867542|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
125068543|NCT01306032|449867543|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
125140743|NCT01710358|450139527|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
125140744|NCT01710358|450139528|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
125140745|NCT01710358|450139529|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
125140746|NCT01710358|450139527|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
125140747|NCT01710358|450139528|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
125140748|NCT01710358|450139529|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
125140749|NCT01710358|450139527|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
125140750|NCT01710358|450139528|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
125140751|NCT01710358|450139529|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
125140752|NCT01710358|450139527|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
125140753|NCT01710358|450139528|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
125222854|NCT02346877|450442844|FG001|Overall Study|Missing|0|||
125222855|NCT01212094|450444406|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
125222856|NCT01212094|450444407|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
125222857|NCT01212094|450444408|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
125222858|NCT01212094|450444406|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
125068544|NCT01306032|449867544|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
125068545|NCT01306032|449867545|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
125068546|NCT03260894|449867547|FG000|Overall Study|Death|6|||
125068547|NCT03260894|449867548|FG001|Overall Study|Death|8|||
125068548|NCT03260894|449867547|FG000|Overall Study|Withdrawal by Subject|4|||
125068549|NCT03260894|449867548|FG001|Overall Study|Withdrawal by Subject|11|||
125068550|NCT03260894|449867547|FG000|Overall Study|On-going at clinical cut off date|36|||
125068551|NCT03260894|449867548|FG001|Overall Study|On-going at clinical cut off date|31|||
125068552|NCT00168064|449867550|FG000|Overall Study|Adverse Event|26|||
125068553|NCT00168064|449867551|FG001|Overall Study|Adverse Event|22|||
125068554|NCT00168064|449867550|FG000|Overall Study|Withdrawal by Subject|3|||
125068555|NCT00168064|449867551|FG001|Overall Study|Withdrawal by Subject|4|||
125068556|NCT00168064|449867550|FG000|Overall Study|Lack of Efficacy|4|||
125068557|NCT00168064|449867551|FG001|Overall Study|Lack of Efficacy|4|||
125068558|NCT00168064|449867550|FG000|Overall Study|Lost to Follow-up|4|||
125068559|NCT00168064|449867551|FG001|Overall Study|Lost to Follow-up|3|||
125068560|NCT00168064|449867550|FG000|Overall Study|Non-compliance|2|||
125068561|NCT00168064|449867551|FG001|Overall Study|Non-compliance|3|||
125068562|NCT00168064|449867550|FG000|Overall Study|Concurrent Illness|4|||
125068563|NCT00168064|449867551|FG001|Overall Study|Concurrent Illness|3|||
125068564|NCT00168064|449867550|FG000|Overall Study|Subject's Best interest|2|||
125068565|NCT00168064|449867551|FG001|Overall Study|Subject's Best interest|2|||
125068566|NCT00168064|449867550|FG000|Overall Study|Various|4|||
125068567|NCT00168064|449867551|FG001|Overall Study|Various|3|||
125068568|NCT00290589|449867552|FG000|Overall Study|Lost to Follow-up|2|||
125068569|NCT00290589|449867553|FG001|Overall Study|Lost to Follow-up|2|||
125068570|NCT05014542|449867554|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
125068571|NCT05014542|449867555|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
125068572|NCT05014542|449867554|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
125068573|NCT05014542|449867555|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
125068574|NCT05014542|449867554|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
125068575|NCT05014542|449867555|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
125068576|NCT05014542|449867554|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
125068577|NCT05014542|449867555|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
125068578|NCT06000501|449867556|FG000|Overall Study|Screen failure|3|||
125068579|NCT06000501|449867556|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
125068580|NCT06000501|449867556|FG000|Overall Study|Physician Decision|4|||
125068581|NCT06000501|449867556|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
125068582|NCT06000501|449867556|FG000|Overall Study|Scheduling issues|2|||
125068583|NCT00318565|449867557|FG000|Overall Study|Excluded per protocol|24|||
125068584|NCT01896856|449867559|FG000|Overall Study|Transportation issues / Non-compliance|0|||
125068585|NCT01896856|449867560|FG001|Overall Study|Transportation issues / Non-compliance|0|||
125068586|NCT01896856|449867561|FG002|Overall Study|Transportation issues / Non-compliance|1|||
125068587|NCT01896856|449867562|FG003|Overall Study|Transportation issues / Non-compliance|0|||
125068588|NCT01896856|449867563|FG004|Overall Study|Transportation issues / Non-compliance|0|||
125068589|NCT01896856|449867564|FG005|Overall Study|Transportation issues / Non-compliance|0|||
125068590|NCT00282867|449867565|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
125068591|NCT00282867|449867566|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
125068592|NCT00282867|449867567|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
125068593|NCT03589885|449867569|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
125068594|NCT03589885|449867570|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
125068595|NCT03589885|449867571|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
125068596|NCT03589885|449867572|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
125068597|NCT03589885|449867573|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
125068598|NCT03589885|449867569|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
125068599|NCT03589885|449867570|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
125068600|NCT03589885|449867571|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
125068601|NCT03589885|449867572|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
125068602|NCT03589885|449867573|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
125068603|NCT03589885|449867569|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
125068604|NCT03589885|449867570|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
125068605|NCT03589885|449867571|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
125068606|NCT03589885|449867572|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
125068607|NCT03589885|449867573|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
125068608|NCT03589885|449867569|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
125068609|NCT03589885|449867570|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
125068610|NCT03589885|449867571|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
125068611|NCT03589885|449867572|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
125068612|NCT03589885|449867573|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
125068613|NCT03589885|449867569|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
125068614|NCT03589885|449867570|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
125068615|NCT03589885|449867571|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
125068616|NCT03589885|449867572|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
125068617|NCT03589885|449867573|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
125140754|NCT01710358|450139529|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
125068618|NCT03589885|449867569|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
125068619|NCT03589885|449867570|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
125068620|NCT03589885|449867571|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
125068621|NCT03589885|449867572|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
125068622|NCT03589885|449867573|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
125068623|NCT03589885|449867569|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
125068624|NCT03589885|449867570|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
125068625|NCT03589885|449867571|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
125068626|NCT03589885|449867572|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
125140755|NCT01710358|450139527|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
125140756|NCT01710358|450139528|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
125140757|NCT01710358|450139529|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
125140758|NCT01710358|450139527|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
125140759|NCT01710358|450139528|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
125140760|NCT01710358|450139529|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
125140761|NCT01710358|450139527|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
125140762|NCT01710358|450139528|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
125140763|NCT01710358|450139529|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
125140764|NCT01710358|450139527|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
125068627|NCT03589885|449867573|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
125068628|NCT03589885|449867569|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
125068629|NCT03589885|449867570|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
125068630|NCT03589885|449867571|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
125068631|NCT03589885|449867572|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
125068632|NCT03589885|449867573|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
125068633|NCT00493974|449867576|FG000|Overall Study|Death|1|||
125068634|NCT00493974|449867577|FG001|Overall Study|Death|2|||
125068635|NCT00493974|449867576|FG000|Overall Study|Withdrawal by Subject|8|||
125068636|NCT00493974|449867577|FG001|Overall Study|Withdrawal by Subject|6|||
125068637|NCT00493974|449867576|FG000|Overall Study|Lost to Follow-up|4|||
125068638|NCT00493974|449867577|FG001|Overall Study|Lost to Follow-up|6|||
125068639|NCT02807363|449867578|FG000|Dosing Period|Adverse Event|0|||
125068640|NCT02807363|449867579|FG001|Dosing Period|Adverse Event|1|||
125068641|NCT02807363|449867580|FG002|Dosing Period|Adverse Event|0|||
125068642|NCT02807363|449867581|FG003|Dosing Period|Adverse Event|0|||
125068643|NCT02188719|449867582|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
125068644|NCT02188719|449867583|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
125068645|NCT02188719|449867584|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
125068646|NCT02188719|449867585|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
125068647|NCT00599027|449867586|FG000|Overall Study|Withdrawal by Subject|1|||
125068648|NCT00599027|449867587|FG001|Overall Study|Withdrawal by Subject|1|||
125068649|NCT00599027|449867586|FG000|Overall Study|Adverse Event|0|||
125068650|NCT00599027|449867587|FG001|Overall Study|Adverse Event|1|||
125068651|NCT00599027|449867586|FG000|Overall Study|Treatment Failure|0|||
125068652|NCT00599027|449867587|FG001|Overall Study|Treatment Failure|1|||
125068653|NCT00476996|449867588|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
125068654|NCT00476996|449867589|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
125068655|NCT00476996|449867590|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
125068656|NCT00476996|449867591|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
125068657|NCT00476996|449867588|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
125068658|NCT00476996|449867589|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
125140765|NCT01710358|450139528|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
125140766|NCT01710358|450139529|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
125140767|NCT01710358|450139527|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
125140768|NCT01710358|450139528|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
125140769|NCT01710358|450139529|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
125140770|NCT01710358|450139527|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
125222859|NCT01212094|450444407|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
125068659|NCT00476996|449867590|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
125068660|NCT00476996|449867591|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
125068661|NCT00476996|449867588|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
125068662|NCT00476996|449867589|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
125068663|NCT00476996|449867590|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
125222860|NCT01212094|450444408|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
125222861|NCT01212094|450444406|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
125222862|NCT01212094|450444407|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
125068664|NCT00476996|449867591|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
125068665|NCT00476996|449867588|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
125068666|NCT00476996|449867589|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
125068667|NCT00476996|449867590|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
125068668|NCT00476996|449867591|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
125068669|NCT00476996|449867588|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
125068670|NCT00476996|449867589|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
125068671|NCT00476996|449867590|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
125068672|NCT00476996|449867591|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
125068673|NCT00476996|449867588|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
125068674|NCT00476996|449867589|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
125068675|NCT00476996|449867590|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
125068676|NCT00476996|449867591|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
125068677|NCT00476996|449867588|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
125068678|NCT00476996|449867589|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
125068679|NCT00476996|449867590|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
125068680|NCT00476996|449867591|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
125068681|NCT00476996|449867588|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
125068682|NCT00476996|449867589|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
125068683|NCT00476996|449867590|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
125068684|NCT00476996|449867591|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
125068685|NCT00476996|449867588|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
125068686|NCT00476996|449867589|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
125068687|NCT00476996|449867590|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
125068688|NCT00476996|449867591|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
125068689|NCT00476996|449867588|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
125068690|NCT00476996|449867589|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
125068691|NCT00476996|449867590|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
125068692|NCT00476996|449867591|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
125068693|NCT00476996|449867588|FG000|OLE Phase (From Week 48)|Death|0|||
125068694|NCT00476996|449867589|FG001|OLE Phase (From Week 48)|Death|0|||
125068695|NCT00476996|449867590|FG002|OLE Phase (From Week 48)|Death|0|||
125068696|NCT00476996|449867591|FG003|OLE Phase (From Week 48)|Death|7|||
125068697|NCT00476996|449867588|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
125068698|NCT00476996|449867589|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
125068699|NCT00476996|449867590|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
125068700|NCT00476996|449867591|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
125068701|NCT00476996|449867588|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
125068702|NCT00476996|449867589|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
125068703|NCT00476996|449867590|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
125068704|NCT00476996|449867591|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
125068705|NCT00476996|449867588|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
125068706|NCT00476996|449867589|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
125068707|NCT00476996|449867590|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
125140771|NCT01710358|450139528|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
125140772|NCT01710358|450139529|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
125140773|NCT01710358|450139527|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
125140774|NCT01710358|450139528|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
125140775|NCT01710358|450139529|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
125140776|NCT01710358|450139527|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
125140777|NCT01710358|450139528|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
125140778|NCT01710358|450139529|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
125140779|NCT01710358|450139527|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
125140780|NCT01710358|450139528|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
125140781|NCT01710358|450139529|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
125140782|NCT01710358|450139527|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
125140783|NCT01710358|450139528|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
125140784|NCT01710358|450139529|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
125140785|NCT01710358|450139527|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
125140786|NCT01710358|450139528|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
125140787|NCT01710358|450139529|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
125140788|NCT01710358|450139527|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
125140789|NCT01710358|450139528|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
125068708|NCT00476996|449867591|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
125068709|NCT00476996|449867588|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
125068710|NCT00476996|449867589|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
125068711|NCT00476996|449867590|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
125068712|NCT00476996|449867591|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
125068713|NCT01181778|449867602|FG000|Overall Study|Physician Decision|48|||
125068714|NCT01265420|449867603|FG000|Overall Study|Lost to Follow-up|1|||
125068715|NCT02332798|449869475|FG000|Overall Study|Unwilling to Participate in Study|0|||
125068716|NCT02332798|449869476|FG001|Overall Study|Unwilling to Participate in Study|1|||
125068717|NCT02332798|449869477|FG002|Overall Study|Unwilling to Participate in Study|1|||
125068718|NCT02332798|449869475|FG000|Overall Study|Positive Urine Drug Test|0|||
125068719|NCT02332798|449869476|FG001|Overall Study|Positive Urine Drug Test|1|||
125068720|NCT02332798|449869477|FG002|Overall Study|Positive Urine Drug Test|0|||
125068721|NCT02332798|449869475|FG000|Overall Study|Abnormal Laboratory Findings|1|||
125068722|NCT02332798|449869476|FG001|Overall Study|Abnormal Laboratory Findings|0|||
125068723|NCT02332798|449869477|FG002|Overall Study|Abnormal Laboratory Findings|0|||
125068724|NCT05406440|449869478|FG000|Overall Study|Lost to Follow-up|0|||
125068725|NCT05406440|449869479|FG001|Overall Study|Lost to Follow-up|0|||
125068726|NCT05406440|449869480|FG002|Overall Study|Lost to Follow-up|0|||
125068727|NCT05406440|449869481|FG003|Overall Study|Lost to Follow-up|0|||
125068728|NCT05406440|449869482|FG004|Overall Study|Lost to Follow-up|2|||
125068729|NCT05406440|449869483|FG005|Overall Study|Lost to Follow-up|0|||
125068730|NCT05406440|449869484|FG006|Overall Study|Lost to Follow-up|0|||
125068731|NCT05406440|449869478|FG000|Overall Study|Physician Decision|0|||
125068732|NCT05406440|449869479|FG001|Overall Study|Physician Decision|0|||
125068733|NCT05406440|449869480|FG002|Overall Study|Physician Decision|0|||
125068734|NCT05406440|449869481|FG003|Overall Study|Physician Decision|0|||
125068735|NCT05406440|449869482|FG004|Overall Study|Physician Decision|1|||
125068736|NCT05406440|449869483|FG005|Overall Study|Physician Decision|0|||
125068737|NCT05406440|449869484|FG006|Overall Study|Physician Decision|0|||
125068738|NCT05406440|449869478|FG000|Overall Study|Withdrawal by Subject|0|||
125068739|NCT05406440|449869479|FG001|Overall Study|Withdrawal by Subject|0|||
125068740|NCT05406440|449869480|FG002|Overall Study|Withdrawal by Subject|0|||
125068741|NCT05406440|449869481|FG003|Overall Study|Withdrawal by Subject|0|||
125068742|NCT05406440|449869482|FG004|Overall Study|Withdrawal by Subject|0|||
125068743|NCT05406440|449869483|FG005|Overall Study|Withdrawal by Subject|2|||
125068744|NCT05406440|449869484|FG006|Overall Study|Withdrawal by Subject|0|||
125068745|NCT02455388|449869485|FG000|Overall Study|Protocol Violation|1|||
125068746|NCT02455388|449869486|FG001|Overall Study|Protocol Violation|0|||
125068747|NCT02455388|449869487|FG002|Overall Study|Protocol Violation|4|||
125068748|NCT02455388|449869485|FG000|Overall Study|Withdrawal by Subject|0|||
125068749|NCT02455388|449869486|FG001|Overall Study|Withdrawal by Subject|0|||
125068750|NCT02455388|449869487|FG002|Overall Study|Withdrawal by Subject|7|||
125068751|NCT00525785|449869488|FG000|Overall Study|Withdrawal by Subject|1|||
125068752|NCT00525785|449869488|FG000|Overall Study|Lack of Efficacy|1|||
125068753|NCT00525785|449869488|FG000|Overall Study|Physician Decision|1|||
125068754|NCT01316939|449869489|FG000|Overall Study|Study closed/terminated|26|||
125068755|NCT01316939|449869490|FG001|Overall Study|Study closed/terminated|25|||
125068756|NCT01316939|449869491|FG002|Overall Study|Study closed/terminated|23|||
125068757|NCT01316939|449869489|FG000|Overall Study|Lack of Efficacy|24|||
125068758|NCT01316939|449869490|FG001|Overall Study|Lack of Efficacy|25|||
125068759|NCT01316939|449869491|FG002|Overall Study|Lack of Efficacy|25|||
125068760|NCT01316939|449869489|FG000|Overall Study|Adverse Event|9|||
125068761|NCT01316939|449869490|FG001|Overall Study|Adverse Event|12|||
125068762|NCT01316939|449869491|FG002|Overall Study|Adverse Event|11|||
125068763|NCT01316939|449869489|FG000|Overall Study|Withdrawal by Subject|1|||
125068764|NCT01316939|449869490|FG001|Overall Study|Withdrawal by Subject|3|||
125068765|NCT01316939|449869491|FG002|Overall Study|Withdrawal by Subject|6|||
125068766|NCT01316939|449869489|FG000|Overall Study|Physician Decision|2|||
125068767|NCT01316939|449869490|FG001|Overall Study|Physician Decision|2|||
125068768|NCT01316939|449869491|FG002|Overall Study|Physician Decision|1|||
125068769|NCT01316939|449869489|FG000|Overall Study|Lost to Follow-up|0|||
125068770|NCT01316939|449869490|FG001|Overall Study|Lost to Follow-up|0|||
125068771|NCT01316939|449869491|FG002|Overall Study|Lost to Follow-up|2|||
125140790|NCT01710358|450139529|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
125140791|NCT01710358|450139527|FG000|Rescue Period|Adverse Event|0|||
125140792|NCT01710358|450139528|FG001|Rescue Period|Adverse Event|15|||
125068772|NCT01316939|449869489|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
125068773|NCT01316939|449869490|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
125068774|NCT01316939|449869491|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
125068775|NCT01316939|449869489|FG000|Overall Study|Protocol Violation|0|||
125068776|NCT01316939|449869490|FG001|Overall Study|Protocol Violation|1|||
125068777|NCT01316939|449869491|FG002|Overall Study|Protocol Violation|0|||
125068778|NCT00801892|449869492|FG000|Main Study Period|Withdrawal by Subject|0|||
125068779|NCT00801892|449869493|FG001|Main Study Period|Withdrawal by Subject|1|||
125068780|NCT00801892|449869492|FG000|Sham Crossover Period|Lost to Follow-up|0|||
125068781|NCT00801892|449869493|FG001|Sham Crossover Period|Lost to Follow-up|2|||
125068782|NCT01711541|449869502|FG000|Overall Study|Cancel prior to treatment|0|||
125068783|NCT01711541|449869503|FG001|Overall Study|Cancel prior to treatment|0|||
125068784|NCT01711541|449869504|FG002|Overall Study|Cancel prior to treatment|0|||
125068785|NCT01711541|449869505|FG003|Overall Study|Cancel prior to treatment|1|||
125068786|NCT01711541|449869506|FG004|Overall Study|Cancel prior to treatment|0|||
125068787|NCT01711541|449869502|FG000|Overall Study|Ineligible|0|||
125068788|NCT01711541|449869503|FG001|Overall Study|Ineligible|1|||
125068789|NCT01711541|449869504|FG002|Overall Study|Ineligible|0|||
125068790|NCT01711541|449869505|FG003|Overall Study|Ineligible|0|||
125068791|NCT01711541|449869506|FG004|Overall Study|Ineligible|0|||
125068792|NCT00728936|449869507|FG000|Overall Study|Withdrawal by Subject|0|||
125068793|NCT00728936|449869508|FG001|Overall Study|Withdrawal by Subject|0|||
125068794|NCT00728936|449869509|FG002|Overall Study|Withdrawal by Subject|0|||
125068795|NCT00728936|449869510|FG003|Overall Study|Withdrawal by Subject|0|||
125068796|NCT00728936|449869511|FG004|Overall Study|Withdrawal by Subject|0|||
125068797|NCT00728936|449869512|FG005|Overall Study|Withdrawal by Subject|1|||
125068798|NCT00728936|449869513|FG006|Overall Study|Withdrawal by Subject|0|||
125068799|NCT02966353|449869522|FG000|Overall Study|Withdrawal by Subject|7|||
125068800|NCT02966353|449869522|FG000|Overall Study|Adverse Event|4|||
125068801|NCT02966353|449869522|FG000|Overall Study|Death|4|||
125068802|NCT02966353|449869522|FG000|Overall Study|Physician Decision|3|||
125068803|NCT02966353|449869522|FG000|Overall Study|Progressive disease|2|||
125068804|NCT02966353|449869522|FG000|Overall Study|Protocol deviation|2|||
125068805|NCT00093470|449869525|FG000|Overall Study|Disease progression|39|||
125068806|NCT00093470|449869526|FG001|Overall Study|Disease progression|0|||
125068807|NCT00093470|449869525|FG000|Overall Study|Adverse Event|15|||
125068808|NCT00093470|449869526|FG001|Overall Study|Adverse Event|0|||
125068809|NCT00093470|449869525|FG000|Overall Study|Death|2|||
125068810|NCT00093470|449869526|FG001|Overall Study|Death|0|||
125068811|NCT00093470|449869525|FG000|Overall Study|Withdrawal by Subject|8|||
125068812|NCT00093470|449869526|FG001|Overall Study|Withdrawal by Subject|0|||
125068813|NCT00093470|449869525|FG000|Overall Study|Alternative therapy|2|||
125068814|NCT00093470|449869526|FG001|Overall Study|Alternative therapy|0|||
125068815|NCT00093470|449869525|FG000|Overall Study|Other complicating disease|3|||
125068816|NCT00093470|449869526|FG001|Overall Study|Other complicating disease|0|||
125068817|NCT00093470|449869525|FG000|Overall Study|Physician Decision|2|||
125068818|NCT00093470|449869526|FG001|Overall Study|Physician Decision|0|||
125068819|NCT00093470|449869525|FG000|Overall Study|Never started treatment|1|||
125068820|NCT00093470|449869526|FG001|Overall Study|Never started treatment|0|||
125068821|NCT00093470|449869525|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
125068822|NCT00093470|449869526|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
125068823|NCT00877006|449869527|FG000|Treatment Period|Death|2|||
125068824|NCT00877006|449869528|FG001|Treatment Period|Death|1|||
125068825|NCT00877006|449869527|FG000|Treatment Period|Adverse Event|10|||
125068826|NCT00877006|449869528|FG001|Treatment Period|Adverse Event|3|||
125068827|NCT00877006|449869527|FG000|Treatment Period|Withdrawal by Subject|2|||
125068828|NCT00877006|449869528|FG001|Treatment Period|Withdrawal by Subject|3|||
125068829|NCT00877006|449869527|FG000|Treatment Period|Protocol Violation|1|||
125068830|NCT00877006|449869528|FG001|Treatment Period|Protocol Violation|0|||
125068831|NCT00877006|449869527|FG000|Treatment Period|Lost to Follow-up|0|||
125068832|NCT00877006|449869528|FG001|Treatment Period|Lost to Follow-up|1|||
125068833|NCT00877006|449869527|FG000|Treatment Period|Disease Progression|1|||
125068834|NCT00877006|449869528|FG001|Treatment Period|Disease Progression|2|||
125068835|NCT00877006|449869527|FG000|Treatment Period|Started New Treatment Regimen|2|||
125068836|NCT00877006|449869528|FG001|Treatment Period|Started New Treatment Regimen|5|||
125068837|NCT00877006|449869527|FG000|Treatment Period|Other|4|||
125068838|NCT00877006|449869528|FG001|Treatment Period|Other|4|||
125068839|NCT00877006|449869527|FG000|Treatment Period|Randomized but Not Treated|3|||
125068840|NCT00877006|449869528|FG001|Treatment Period|Randomized but Not Treated|8|||
125068841|NCT00877006|449869527|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
125068842|NCT00877006|449869528|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
125068843|NCT00877006|449869527|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
125068844|NCT00877006|449869528|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
125068845|NCT00877006|449869527|FG000|Long-Term Follow-up Period|Death|26|||
125068846|NCT00877006|449869528|FG001|Long-Term Follow-up Period|Death|18|||
125068847|NCT00877006|449869527|FG000|Long-Term Follow-up Period|Other|7|||
125068848|NCT00877006|449869528|FG001|Long-Term Follow-up Period|Other|9|||
125068849|NCT01415908|449869529|FG000|Overall Study|Withdrawal by Subject|1|||
125068850|NCT01415908|449869530|FG001|Overall Study|Withdrawal by Subject|0|||
125068851|NCT02034552|449869531|FG000|Overall Study|Never treated|3|||
125068852|NCT02034552|449869532|FG001|Overall Study|Never treated|2|||
125068853|NCT02034552|449869533|FG002|Overall Study|Never treated|0|||
125068854|NCT02034552|449869531|FG000|Overall Study|Radiological progression|3|||
125068855|NCT02034552|449869532|FG001|Overall Study|Radiological progression|5|||
125068856|NCT02034552|449869533|FG002|Overall Study|Radiological progression|4|||
125068857|NCT02034552|449869531|FG000|Overall Study|AE not assoc. with disease progression|1|||
125068858|NCT02034552|449869532|FG001|Overall Study|AE not assoc. with disease progression|4|||
125068859|NCT02034552|449869533|FG002|Overall Study|AE not assoc. with disease progression|2|||
125068860|NCT02034552|449869531|FG000|Overall Study|AE associated with disease progression|0|||
125068861|NCT02034552|449869532|FG001|Overall Study|AE associated with disease progression|1|||
125068862|NCT02034552|449869533|FG002|Overall Study|AE associated with disease progression|0|||
125068863|NCT02034552|449869531|FG000|Overall Study|Withdrawal by Subject|2|||
125068864|NCT02034552|449869532|FG001|Overall Study|Withdrawal by Subject|1|||
125068865|NCT02034552|449869533|FG002|Overall Study|Withdrawal by Subject|1|||
125068866|NCT02034552|449869531|FG000|Overall Study|Non-compliance with study drug|0|||
125068867|NCT02034552|449869532|FG001|Overall Study|Non-compliance with study drug|0|||
125068868|NCT02034552|449869533|FG002|Overall Study|Non-compliance with study drug|1|||
125068869|NCT02034552|449869531|FG000|Overall Study|Clinical progression|5|||
125068870|NCT02034552|449869532|FG001|Overall Study|Clinical progression|7|||
125068871|NCT02034552|449869533|FG002|Overall Study|Clinical progression|9|||
125068872|NCT01188096|449869535|FG000|Overall Study|progression of disease|4|||
125068873|NCT01188096|449869535|FG000|Overall Study|Withdrawal by Subject|2|||
125068874|NCT00851253|449869539|FG000|Overall Study|Disease Progression|1|||
125068875|NCT00851253|449869540|FG001|Overall Study|Disease Progression|0|||
125068876|NCT02062398|449869541|FG000|Overall Study|Implant removal|1|||
125068877|NCT01779648|449869542|FG000|Overall Study|Protocol Violation|1|||
125068878|NCT01779648|449869543|FG001|Overall Study|Protocol Violation|0|||
125068879|NCT00415519|449869544|FG000|Overall Study|Adverse Event|1|||
125068880|NCT00415519|449869545|FG001|Overall Study|Adverse Event|0|||
125068881|NCT00415519|449869544|FG000|Overall Study|Withdrawal by Subject|2|||
125068882|NCT00415519|449869545|FG001|Overall Study|Withdrawal by Subject|0|||
125068883|NCT00415519|449869544|FG000|Overall Study|Patient's convenience|1|||
125068884|NCT00415519|449869545|FG001|Overall Study|Patient's convenience|0|||
125068885|NCT03485222|449869550|FG000|Overall Study|Death|0|||
125068886|NCT03485222|449869551|FG001|Overall Study|Death|1|||
125068887|NCT03485222|449869550|FG000|Overall Study|Lost to Follow-up|2|||
125068888|NCT03485222|449869551|FG001|Overall Study|Lost to Follow-up|1|||
125068889|NCT03325556|449869555|FG000|Open-label Period|Lack of Response in OL period|70|||
125068890|NCT03325556|449869556|FG001|Open-label Period|Lack of Response in OL period|0|||
125068891|NCT03325556|449869557|FG002|Open-label Period|Lack of Response in OL period|0|||
125068892|NCT03325556|449869555|FG000|Open-label Period|Adverse Event|27|||
125068893|NCT03325556|449869556|FG001|Open-label Period|Adverse Event|0|||
125068894|NCT03325556|449869557|FG002|Open-label Period|Adverse Event|0|||
125068895|NCT03325556|449869555|FG000|Open-label Period|Death|1|||
125068896|NCT03325556|449869556|FG001|Open-label Period|Death|0|||
125068897|NCT03325556|449869557|FG002|Open-label Period|Death|0|||
125068898|NCT03325556|449869555|FG000|Open-label Period|Lost to Follow-up|1|||
125068899|NCT03325556|449869556|FG001|Open-label Period|Lost to Follow-up|0|||
125068900|NCT03325556|449869557|FG002|Open-label Period|Lost to Follow-up|0|||
125068901|NCT03325556|449869555|FG000|Open-label Period|Non-compliance with study drug|5|||
125068902|NCT03325556|449869556|FG001|Open-label Period|Non-compliance with study drug|0|||
125068903|NCT03325556|449869557|FG002|Open-label Period|Non-compliance with study drug|0|||
125068904|NCT03325556|449869555|FG000|Open-label Period|Use of prohibited medication|1|||
125068905|NCT03325556|449869556|FG001|Open-label Period|Use of prohibited medication|0|||
125068906|NCT03325556|449869557|FG002|Open-label Period|Use of prohibited medication|0|||
125068907|NCT03325556|449869555|FG000|Open-label Period|Protocol Violation|4|||
125068908|NCT03325556|449869556|FG001|Open-label Period|Protocol Violation|0|||
125068909|NCT03325556|449869557|FG002|Open-label Period|Protocol Violation|0|||
125068910|NCT03325556|449869555|FG000|Open-label Period|Withdrawal by Subject|17|||
125068911|NCT03325556|449869556|FG001|Open-label Period|Withdrawal by Subject|0|||
125068912|NCT03325556|449869557|FG002|Open-label Period|Withdrawal by Subject|0|||
125068913|NCT03325556|449869555|FG000|Open-label Period|Not otherwise specified|8|||
125068914|NCT03325556|449869556|FG001|Open-label Period|Not otherwise specified|0|||
125068915|NCT03325556|449869557|FG002|Open-label Period|Not otherwise specified|0|||
125068916|NCT03325556|449869555|FG000|Open-label Period|Administrative discont. at study termination|41|||
125068917|NCT03325556|449869556|FG001|Open-label Period|Administrative discont. at study termination|0|||
125068918|NCT03325556|449869557|FG002|Open-label Period|Administrative discont. at study termination|0|||
125068919|NCT03325556|449869555|FG000|Double-blind Period|Relapse|0|||
125068920|NCT03325556|449869556|FG001|Double-blind Period|Relapse|15|||
125068921|NCT03325556|449869557|FG002|Double-blind Period|Relapse|34|||
125068922|NCT03325556|449869555|FG000|Double-blind Period|Adverse Event|0|||
125068923|NCT03325556|449869556|FG001|Double-blind Period|Adverse Event|3|||
125068924|NCT03325556|449869557|FG002|Double-blind Period|Adverse Event|1|||
125068925|NCT03325556|449869555|FG000|Double-blind Period|Noncompliance with study drug|0|||
125068926|NCT03325556|449869556|FG001|Double-blind Period|Noncompliance with study drug|0|||
125068927|NCT03325556|449869557|FG002|Double-blind Period|Noncompliance with study drug|1|||
125068928|NCT03325556|449869555|FG000|Double-blind Period|Use of prohibited medication|0|||
125068929|NCT03325556|449869556|FG001|Double-blind Period|Use of prohibited medication|1|||
125068930|NCT03325556|449869557|FG002|Double-blind Period|Use of prohibited medication|0|||
125068931|NCT03325556|449869555|FG000|Double-blind Period|Physician Decision|0|||
125068932|NCT03325556|449869556|FG001|Double-blind Period|Physician Decision|0|||
125068933|NCT03325556|449869557|FG002|Double-blind Period|Physician Decision|1|||
125068934|NCT03325556|449869555|FG000|Double-blind Period|Withdrawal by Subject|0|||
125068935|NCT03325556|449869556|FG001|Double-blind Period|Withdrawal by Subject|6|||
125068936|NCT03325556|449869557|FG002|Double-blind Period|Withdrawal by Subject|4|||
125068937|NCT03325556|449869555|FG000|Double-blind Period|Not otherwise specified|0|||
125068938|NCT03325556|449869556|FG001|Double-blind Period|Not otherwise specified|1|||
125068939|NCT03325556|449869557|FG002|Double-blind Period|Not otherwise specified|5|||
125068940|NCT03325556|449869555|FG000|Double-blind Period|Administrative discont. at study termination|0|||
125068941|NCT03325556|449869556|FG001|Double-blind Period|Administrative discont. at study termination|35|||
125068942|NCT03325556|449869557|FG002|Double-blind Period|Administrative discont. at study termination|31|||
125068943|NCT01705587|449869560|FG000|Overall Study|Withdrawal by Subject|0|||
125068944|NCT01705587|449869561|FG001|Overall Study|Withdrawal by Subject|1|||
125068945|NCT02119026|449869562|FG000|1st-line Treatment|Adverse Event|9|||
125068946|NCT02119026|449869563|FG001|1st-line Treatment|Adverse Event|14|||
125068947|NCT02119026|449869562|FG000|1st-line Treatment|Physician Decision|3|||
125068948|NCT02119026|449869563|FG001|1st-line Treatment|Physician Decision|8|||
125068949|NCT02119026|449869562|FG000|1st-line Treatment|Withdrawal by Subject|4|||
125068950|NCT02119026|449869563|FG001|1st-line Treatment|Withdrawal by Subject|10|||
125068951|NCT02119026|449869562|FG000|1st-line Treatment|Patient condition or compliance|6|||
125068952|NCT02119026|449869563|FG001|1st-line Treatment|Patient condition or compliance|4|||
125068953|NCT02119026|449869562|FG000|1st-line Treatment|Surgery of metastases|2|||
125068954|NCT02119026|449869563|FG001|1st-line Treatment|Surgery of metastases|1|||
125068955|NCT02119026|449869562|FG000|1st-line Treatment|Death|2|||
125140793|NCT01710358|450139529|FG002|Rescue Period|Adverse Event|0|||
125140794|NCT01710358|450139527|FG000|Rescue Period|Death|0|||
125068956|NCT02119026|449869563|FG001|1st-line Treatment|Death|1|||
125068957|NCT02119026|449869562|FG000|2nd-line Treatment|Lost to Follow-up|2|||
125068958|NCT02119026|449869563|FG001|2nd-line Treatment|Lost to Follow-up|0|||
125068959|NCT02119026|449869562|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
125068960|NCT02119026|449869563|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
125068961|NCT02119026|449869562|FG000|2nd-line Treatment|Adverse Event|4|||
125068962|NCT02119026|449869563|FG001|2nd-line Treatment|Adverse Event|1|||
125068963|NCT01373918|449869564|FG000|Overall Study|Physician Decision|0|||
125068964|NCT01373918|449869565|FG001|Overall Study|Physician Decision|1|||
125068965|NCT00340834|449869567|FG000|Core Phase of Study|Adverse Event|26|||
125068966|NCT00340834|449869568|FG001|Core Phase of Study|Adverse Event|9|||
125068967|NCT00340834|449869569|FG002|Core Phase of Study|Adverse Event|9|||
125068968|NCT00340834|449869570|FG003|Core Phase of Study|Adverse Event|0|||
125068969|NCT00340834|449869571|FG004|Core Phase of Study|Adverse Event|0|||
125068970|NCT00340834|449869567|FG000|Core Phase of Study|Withdrawal by Subject|11|||
125068971|NCT00340834|449869568|FG001|Core Phase of Study|Withdrawal by Subject|9|||
125068972|NCT00340834|449869569|FG002|Core Phase of Study|Withdrawal by Subject|16|||
125068973|NCT00340834|449869570|FG003|Core Phase of Study|Withdrawal by Subject|0|||
125068974|NCT00340834|449869571|FG004|Core Phase of Study|Withdrawal by Subject|0|||
125068975|NCT00340834|449869567|FG000|Core Phase of Study|Administrative Problems|6|||
125068976|NCT00340834|449869568|FG001|Core Phase of Study|Administrative Problems|2|||
125068977|NCT00340834|449869569|FG002|Core Phase of Study|Administrative Problems|7|||
125068978|NCT00340834|449869570|FG003|Core Phase of Study|Administrative Problems|0|||
125068979|NCT00340834|449869571|FG004|Core Phase of Study|Administrative Problems|0|||
125068980|NCT00340834|449869567|FG000|Core Phase of Study|Lack of Efficacy|3|||
125068981|NCT00340834|449869568|FG001|Core Phase of Study|Lack of Efficacy|3|||
125068982|NCT00340834|449869569|FG002|Core Phase of Study|Lack of Efficacy|7|||
125068983|NCT00340834|449869570|FG003|Core Phase of Study|Lack of Efficacy|0|||
125068984|NCT00340834|449869571|FG004|Core Phase of Study|Lack of Efficacy|0|||
125068985|NCT00340834|449869567|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
125068986|NCT00340834|449869568|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
125068987|NCT00340834|449869569|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
125068988|NCT00340834|449869570|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
125068989|NCT00340834|449869571|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
125068990|NCT00340834|449869567|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
125068991|NCT00340834|449869568|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
125068992|NCT00340834|449869569|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
125068993|NCT00340834|449869570|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
125068994|NCT00340834|449869571|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
125068995|NCT00340834|449869567|FG000|Core Phase of Study|Lost to Follow-up|1|||
125068996|NCT00340834|449869568|FG001|Core Phase of Study|Lost to Follow-up|1|||
125068997|NCT00340834|449869569|FG002|Core Phase of Study|Lost to Follow-up|4|||
125068998|NCT00340834|449869570|FG003|Core Phase of Study|Lost to Follow-up|0|||
125068999|NCT00340834|449869571|FG004|Core Phase of Study|Lost to Follow-up|0|||
125069000|NCT00340834|449869567|FG000|Core Phase of Study|Death|2|||
125069001|NCT00340834|449869568|FG001|Core Phase of Study|Death|0|||
125069002|NCT00340834|449869569|FG002|Core Phase of Study|Death|0|||
125069003|NCT00340834|449869570|FG003|Core Phase of Study|Death|0|||
125069004|NCT00340834|449869571|FG004|Core Phase of Study|Death|0|||
125069005|NCT00340834|449869567|FG000|Core Phase of Study|Protocol Violation|0|||
125069006|NCT00340834|449869568|FG001|Core Phase of Study|Protocol Violation|0|||
125069007|NCT00340834|449869569|FG002|Core Phase of Study|Protocol Violation|2|||
125069008|NCT00340834|449869570|FG003|Core Phase of Study|Protocol Violation|0|||
125069009|NCT00340834|449869571|FG004|Core Phase of Study|Protocol Violation|0|||
125069010|NCT00340834|449869567|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
125069011|NCT00340834|449869568|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
125069012|NCT00340834|449869569|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
125069013|NCT00340834|449869570|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
125069014|NCT00340834|449869571|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
125069015|NCT00340834|449869567|FG000|Extension Phase of Study|Subject withdrew consent|26|||
125069016|NCT00340834|449869568|FG001|Extension Phase of Study|Subject withdrew consent|31|||
125069017|NCT00340834|449869569|FG002|Extension Phase of Study|Subject withdrew consent|0|||
125069018|NCT00340834|449869570|FG003|Extension Phase of Study|Subject withdrew consent|12|||
125069019|NCT00340834|449869571|FG004|Extension Phase of Study|Subject withdrew consent|15|||
125069020|NCT00340834|449869567|FG000|Extension Phase of Study|Adverse Event|21|||
125069021|NCT00340834|449869568|FG001|Extension Phase of Study|Adverse Event|22|||
125069022|NCT00340834|449869569|FG002|Extension Phase of Study|Adverse Event|0|||
125069023|NCT00340834|449869570|FG003|Extension Phase of Study|Adverse Event|19|||
125069024|NCT00340834|449869571|FG004|Extension Phase of Study|Adverse Event|7|||
125069025|NCT00340834|449869567|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
125069026|NCT00340834|449869568|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
125069027|NCT00340834|449869569|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
125069028|NCT00340834|449869570|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
125069029|NCT00340834|449869571|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
125069030|NCT00340834|449869567|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
125069031|NCT00340834|449869568|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
125069032|NCT00340834|449869569|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
125069033|NCT00340834|449869570|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
125069034|NCT00340834|449869571|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
125069035|NCT00340834|449869567|FG000|Extension Phase of Study|Lost to Follow-up|1|||
125069036|NCT00340834|449869568|FG001|Extension Phase of Study|Lost to Follow-up|1|||
125069037|NCT00340834|449869569|FG002|Extension Phase of Study|Lost to Follow-up|0|||
125069038|NCT00340834|449869570|FG003|Extension Phase of Study|Lost to Follow-up|2|||
125069039|NCT00340834|449869571|FG004|Extension Phase of Study|Lost to Follow-up|3|||
125069040|NCT00340834|449869567|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
125069041|NCT00340834|449869568|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
125069042|NCT00340834|449869569|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
125069043|NCT00340834|449869570|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
125069044|NCT00340834|449869571|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
125140795|NCT01710358|450139528|FG001|Rescue Period|Death|1|||
125140796|NCT01710358|450139529|FG002|Rescue Period|Death|0|||
125140797|NCT01710358|450139527|FG000|Rescue Period|Lack of Efficacy|0|||
125140798|NCT01710358|450139528|FG001|Rescue Period|Lack of Efficacy|7|||
125140799|NCT01710358|450139529|FG002|Rescue Period|Lack of Efficacy|0|||
125140800|NCT01710358|450139527|FG000|Rescue Period|Withdrawal by Subject|0|||
125140801|NCT01710358|450139528|FG001|Rescue Period|Withdrawal by Subject|8|||
125140802|NCT01710358|450139529|FG002|Rescue Period|Withdrawal by Subject|0|||
125140803|NCT00735696|450139536|FG000|Overall Study|Withdrawal by Subject|1|||
125140804|NCT00735696|450139536|FG000|Overall Study|Enrolled but never Treated|1|||
125140805|NCT00084864|450139537|FG000|Overall Study|Adverse Event|1|||
125140806|NCT00084864|450139538|FG001|Overall Study|Adverse Event|0|||
125140807|NCT00084864|450139539|FG002|Overall Study|Adverse Event|0|||
125140808|NCT00084864|450139540|FG003|Overall Study|Adverse Event|0|||
125140809|NCT04406194|450139541|FG000|Period 1|Withdrawal by Subject|0|||
125140810|NCT04406194|450139542|FG001|Period 1|Withdrawal by Subject|1|||
125140811|NCT01741545|450139543|FG000|Treatment Period|Lack of Efficacy|0|||
125140812|NCT01741545|450139544|FG001|Treatment Period|Lack of Efficacy|1|||
125140813|NCT01741545|450139543|FG000|Treatment Period|Adverse event, non-fatal|1|||
125140814|NCT01741545|450139544|FG001|Treatment Period|Adverse event, non-fatal|3|||
125140815|NCT01741545|450139543|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
125140816|NCT01741545|450139544|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
125140817|NCT01741545|450139543|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
125140818|NCT01741545|450139544|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
125140819|NCT01456962|450139545|FG000|Overall Study|Lost to Follow-up|2|||
125140820|NCT01456962|450139546|FG001|Overall Study|Lost to Follow-up|1|||
125140821|NCT02704091|450139549|FG000|Overall Study|Adverse Event|4|||
125140822|NCT02704091|450139550|FG001|Overall Study|Adverse Event|3|||
125140823|NCT02704091|450139549|FG000|Overall Study|Protocol Violation|5|||
125140824|NCT02704091|450139550|FG001|Overall Study|Protocol Violation|3|||
125140825|NCT02704091|450139549|FG000|Overall Study|Consent withdrawn|4|||
125140826|NCT02704091|450139550|FG001|Overall Study|Consent withdrawn|4|||
125140827|NCT02704091|450139549|FG000|Overall Study|Lost to Follow-up|13|||
125140828|NCT02704091|450139550|FG001|Overall Study|Lost to Follow-up|5|||
125140829|NCT02704091|450139549|FG000|Overall Study|Other|2|||
125140830|NCT02704091|450139550|FG001|Overall Study|Other|8|||
125140831|NCT03073798|450139551|FG000|Overall Study|Adverse Event|1|||
125140832|NCT03073798|450139551|FG000|Overall Study|Withdrawal by Subject|1|||
125140833|NCT01186458|450139552|FG000|Overall Study|Adverse Event|1|||
125140834|NCT01496118|450139553|FG000|Overall Study|Disease progression|3|||
125140835|NCT01496118|450139554|FG001|Overall Study|Disease progression|2|||
125140836|NCT01496118|450139555|FG002|Overall Study|Disease progression|3|||
125140837|NCT01496118|450139556|FG003|Overall Study|Disease progression|1|||
125140838|NCT01496118|450139557|FG004|Overall Study|Disease progression|2|||
125140839|NCT01496118|450139558|FG005|Overall Study|Disease progression|2|||
125140840|NCT01496118|450139559|FG006|Overall Study|Disease progression|14|||
125140841|NCT01496118|450139560|FG007|Overall Study|Disease progression|10|||
125140842|NCT01496118|450139553|FG000|Overall Study|Physician Decision|0|||
125069045|NCT00340834|449869567|FG000|Extension Phase of Study|Administrative problems|3|||
125069046|NCT00340834|449869568|FG001|Extension Phase of Study|Administrative problems|0|||
125140843|NCT01496118|450139554|FG001|Overall Study|Physician Decision|0|||
125140844|NCT01496118|450139555|FG002|Overall Study|Physician Decision|0|||
125140845|NCT01496118|450139556|FG003|Overall Study|Physician Decision|0|||
125069047|NCT00340834|449869569|FG002|Extension Phase of Study|Administrative problems|0|||
125069048|NCT00340834|449869570|FG003|Extension Phase of Study|Administrative problems|1|||
125069049|NCT00340834|449869571|FG004|Extension Phase of Study|Administrative problems|1|||
125069050|NCT00340834|449869567|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
125069051|NCT00340834|449869568|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
125069052|NCT00340834|449869569|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
125069053|NCT00340834|449869570|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
125069054|NCT00340834|449869571|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
125069055|NCT00340834|449869567|FG000|Extension Phase of Study|Protocol Violation|3|||
125069056|NCT00340834|449869568|FG001|Extension Phase of Study|Protocol Violation|0|||
125069057|NCT00340834|449869569|FG002|Extension Phase of Study|Protocol Violation|0|||
125069058|NCT00340834|449869570|FG003|Extension Phase of Study|Protocol Violation|0|||
125069059|NCT00340834|449869571|FG004|Extension Phase of Study|Protocol Violation|0|||
125069060|NCT00340834|449869567|FG000|Extension Phase of Study|Death|0|||
125069061|NCT00340834|449869568|FG001|Extension Phase of Study|Death|0|||
125069062|NCT00340834|449869569|FG002|Extension Phase of Study|Death|0|||
125069063|NCT00340834|449869570|FG003|Extension Phase of Study|Death|0|||
125069064|NCT00340834|449869571|FG004|Extension Phase of Study|Death|1|||
125069065|NCT03004976|449869572|FG000|Overall Study|Lost to Follow-up|7|||
125069066|NCT03004976|449869573|FG001|Overall Study|Lost to Follow-up|5|||
125069067|NCT03004976|449869572|FG000|Overall Study|Physician Decision|1|||
125069068|NCT03004976|449869573|FG001|Overall Study|Physician Decision|0|||
125069069|NCT03004976|449869572|FG000|Overall Study|Withdrawal by Subject|1|||
125069070|NCT03004976|449869573|FG001|Overall Study|Withdrawal by Subject|0|||
125069071|NCT03004976|449869572|FG000|Overall Study|Death|4|||
125069072|NCT03004976|449869573|FG001|Overall Study|Death|1|||
125069073|NCT00291499|449869574|FG000|Overall Study|Adverse Event|3|||
125222863|NCT01212094|450444408|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
125222864|NCT01212094|450444406|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
125222865|NCT01212094|450444407|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
125222866|NCT01212094|450444408|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
125222867|NCT01212094|450444406|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
125222868|NCT01212094|450444407|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
125222869|NCT01212094|450444408|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
125222870|NCT01212094|450444406|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
125222871|NCT01212094|450444407|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
125222872|NCT01212094|450444408|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
125222873|NCT02019550|450444410|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
125222874|NCT02019550|450444411|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
125222875|NCT00823134|450444413|FG000|Overall Study|Invalid measurement|1|||
125222876|NCT02291029|450444417|FG000|Overall Study|Withdrawal by Subject|0|||
125222877|NCT02291029|450444418|FG001|Overall Study|Withdrawal by Subject|0|||
125222878|NCT02291029|450444419|FG002|Overall Study|Withdrawal by Subject|1|||
125222879|NCT02291029|450444420|FG003|Overall Study|Withdrawal by Subject|0|||
125222880|NCT02291029|450444421|FG004|Overall Study|Withdrawal by Subject|0|||
125222881|NCT02291029|450444422|FG005|Overall Study|Withdrawal by Subject|0|||
125222882|NCT02291029|450444417|FG000|Overall Study|Adverse Event|0|||
125222883|NCT02291029|450444418|FG001|Overall Study|Adverse Event|1|||
125222884|NCT02291029|450444419|FG002|Overall Study|Adverse Event|0|||
125222885|NCT02291029|450444420|FG003|Overall Study|Adverse Event|0|||
125222886|NCT02291029|450444421|FG004|Overall Study|Adverse Event|0|||
125222887|NCT02291029|450444422|FG005|Overall Study|Adverse Event|0|||
125222888|NCT02922153|450444423|FG000|Overall Study|Death|8|||
125222889|NCT02922153|450444424|FG001|Overall Study|Death|1|||
125222890|NCT02922153|450444423|FG000|Overall Study|Lost to Follow-up|1|||
125222891|NCT02922153|450444424|FG001|Overall Study|Lost to Follow-up|0|||
125222892|NCT02922153|450444423|FG000|Overall Study|Physician Decision|1|||
125222893|NCT02922153|450444424|FG001|Overall Study|Physician Decision|1|||
125222894|NCT02692586|450444427|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
125069074|NCT00291499|449869575|FG001|Overall Study|Adverse Event|8|||
125069075|NCT00291499|449869574|FG000|Overall Study|Change to other therapy|2|||
125069076|NCT00291499|449869575|FG001|Overall Study|Change to other therapy|1|||
125069077|NCT00291499|449869574|FG000|Overall Study|Intercurrent illness|1|||
125222895|NCT02692586|450444427|FG000|Overall Study|Received adjunctive thrombolytics|2|||
125222896|NCT03316586|450444429|FG000|Overall Study|Adverse Event|2|||
125222897|NCT03316586|450444429|FG000|Overall Study|Physician Decision|3|||
125069078|NCT00291499|449869575|FG001|Overall Study|Intercurrent illness|0|||
125069079|NCT00291499|449869574|FG000|Overall Study|Protocol Violation|2|||
125069080|NCT00291499|449869575|FG001|Overall Study|Protocol Violation|2|||
125069081|NCT00291499|449869574|FG000|Overall Study|Other reasons|1|||
125069082|NCT00291499|449869575|FG001|Overall Study|Other reasons|4|||
125069083|NCT01532570|449869579|FG000|Overall Study|Lack of Efficacy|1|||
125069084|NCT01532570|449869580|FG001|Overall Study|Lack of Efficacy|0|||
125069085|NCT01532570|449869581|FG002|Overall Study|Lack of Efficacy|0|||
125069086|NCT01532570|449869582|FG003|Overall Study|Lack of Efficacy|0|||
125069087|NCT01532570|449869579|FG000|Overall Study|Withdrawal by Subject|0|||
125069088|NCT01532570|449869580|FG001|Overall Study|Withdrawal by Subject|1|||
125069089|NCT01532570|449869581|FG002|Overall Study|Withdrawal by Subject|0|||
125069090|NCT01532570|449869582|FG003|Overall Study|Withdrawal by Subject|0|||
125069091|NCT01807949|449869584|FG000|Overall Study|Adverse Event|1|||
125069092|NCT01807949|449869585|FG001|Overall Study|Adverse Event|2|||
125069093|NCT01807949|449869586|FG002|Overall Study|Adverse Event|2|||
125069094|NCT01807949|449869584|FG000|Overall Study|Withdrawal by Subject|1|||
125069095|NCT01807949|449869585|FG001|Overall Study|Withdrawal by Subject|2|||
125069096|NCT01807949|449869586|FG002|Overall Study|Withdrawal by Subject|2|||
125069097|NCT01807949|449869584|FG000|Overall Study|Non-Compliance|0|||
125069098|NCT01807949|449869585|FG001|Overall Study|Non-Compliance|0|||
125069099|NCT01807949|449869586|FG002|Overall Study|Non-Compliance|1|||
125069100|NCT01807949|449869584|FG000|Overall Study|Undefined|0|||
125069101|NCT01807949|449869585|FG001|Overall Study|Undefined|1|||
125069102|NCT01807949|449869586|FG002|Overall Study|Undefined|2|||
125069103|NCT01807949|449869584|FG000|Overall Study|Randomized But Not Treated|0|||
125069104|NCT01807949|449869585|FG001|Overall Study|Randomized But Not Treated|2|||
125069105|NCT01807949|449869586|FG002|Overall Study|Randomized But Not Treated|2|||
125069106|NCT04325906|449869587|FG000|Overall Study|Withdrawal by Subject|2|||
125069107|NCT04325906|449869588|FG001|Overall Study|Withdrawal by Subject|0|||
125069108|NCT01213264|449869593|FG000|Overall Study|Adverse Event|1|||
125069109|NCT01213264|449869594|FG001|Overall Study|Adverse Event|0|||
125069110|NCT01213264|449869595|FG002|Overall Study|Adverse Event|0|||
125069111|NCT01213264|449869593|FG000|Overall Study|Lost to Follow-up|1|||
125069112|NCT01213264|449869594|FG001|Overall Study|Lost to Follow-up|2|||
125069113|NCT01213264|449869595|FG002|Overall Study|Lost to Follow-up|6|||
125069114|NCT00118911|449869596|FG000|Overall Study|Withdrawal by Subject|2|||
125069115|NCT00118911|449869597|FG001|Overall Study|Withdrawal by Subject|5|||
125069116|NCT05507580|449869598|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
125069117|NCT05507580|449869599|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
125069118|NCT05507580|449869600|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
125069119|NCT05507580|449869601|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
125069120|NCT05507580|449869602|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
125069121|NCT05507580|449869603|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
125069122|NCT05507580|449869598|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
125069123|NCT05507580|449869599|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125069124|NCT05507580|449869600|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125069125|NCT05507580|449869601|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125069126|NCT05507580|449869602|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125069127|NCT05507580|449869603|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125069128|NCT05507580|449869598|FG000|Double-Blind Treatment Period|Other, not specified|5|||
125069129|NCT05507580|449869599|FG001|Double-Blind Treatment Period|Other, not specified|4|||
125069130|NCT05507580|449869600|FG002|Double-Blind Treatment Period|Other, not specified|0|||
125069131|NCT05507580|449869601|FG003|Double-Blind Treatment Period|Other, not specified|0|||
125069132|NCT05507580|449869602|FG004|Double-Blind Treatment Period|Other, not specified|0|||
125069133|NCT05507580|449869603|FG005|Double-Blind Treatment Period|Other, not specified|0|||
125069134|NCT05507580|449869598|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
125069135|NCT05507580|449869599|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
125069136|NCT05507580|449869600|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
125069137|NCT05507580|449869601|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
125069138|NCT05507580|449869602|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
125069139|NCT05507580|449869603|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
125069140|NCT05507580|449869598|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
125069141|NCT05507580|449869599|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
125069142|NCT05507580|449869600|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
125069143|NCT05507580|449869601|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
125069144|NCT05507580|449869602|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
125069145|NCT05507580|449869603|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
125069146|NCT05507580|449869598|FG000|Single-Blind Treatment Period|Other, not specified|0|||
125069147|NCT05507580|449869599|FG001|Single-Blind Treatment Period|Other, not specified|0|||
125069148|NCT05507580|449869600|FG002|Single-Blind Treatment Period|Other, not specified|2|||
125069149|NCT05507580|449869601|FG003|Single-Blind Treatment Period|Other, not specified|7|||
125069150|NCT05507580|449869602|FG004|Single-Blind Treatment Period|Other, not specified|3|||
125069151|NCT05507580|449869603|FG005|Single-Blind Treatment Period|Other, not specified|5|||
125069152|NCT04702984|449869604|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
125069153|NCT03496662|449869605|FG000|Overall Study|Adverse Event|0|||
125069154|NCT03496662|449869606|FG001|Overall Study|Adverse Event|0|||
125069155|NCT03496662|449869607|FG002|Overall Study|Adverse Event|4|||
125069156|NCT03496662|449869605|FG000|Overall Study|Withdrawal by Subject|1|||
125069157|NCT03496662|449869606|FG001|Overall Study|Withdrawal by Subject|0|||
125069158|NCT03496662|449869607|FG002|Overall Study|Withdrawal by Subject|2|||
125069159|NCT03496662|449869605|FG000|Overall Study|Death|0|||
125069160|NCT03496662|449869606|FG001|Overall Study|Death|0|||
125069161|NCT03496662|449869607|FG002|Overall Study|Death|2|||
125069162|NCT03496662|449869605|FG000|Overall Study|Noncompliance|0|||
125069163|NCT03496662|449869606|FG001|Overall Study|Noncompliance|0|||
125069164|NCT03496662|449869607|FG002|Overall Study|Noncompliance|1|||
125069165|NCT03037307|449869608|FG000|Period 1|Did Not Meet Study Criteria|0|||
125069166|NCT03037307|449869609|FG001|Period 1|Did Not Meet Study Criteria|0|||
125069167|NCT03037307|449869610|FG002|Period 1|Did Not Meet Study Criteria|0|||
125069168|NCT03037307|449869611|FG003|Period 1|Did Not Meet Study Criteria|1|||
125069169|NCT03037307|449869612|FG004|Period 1|Did Not Meet Study Criteria|0|||
125069170|NCT03037307|449869613|FG005|Period 1|Did Not Meet Study Criteria|0|||
125069171|NCT00691093|449869614|FG000|Overall Study|Adverse Event|1|||
125069172|NCT00691093|449869614|FG000|Overall Study|Lost to Follow-up|1|||
125069173|NCT00691093|449869614|FG000|Overall Study|Lack of Efficacy|1|||
125069174|NCT00691093|449869614|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
125069175|NCT01588353|449869615|FG000|Step2|Withdrawal by Subject|0|||
125069176|NCT01588353|449869616|FG001|Step2|Withdrawal by Subject|1|||
125069177|NCT01588353|449869617|FG002|Step2|Withdrawal by Subject|0|||
125069178|NCT01588353|449869615|FG000|Step3|Adverse Event|0|||
125069179|NCT01588353|449869616|FG001|Step3|Adverse Event|0|||
125069180|NCT01588353|449869617|FG002|Step3|Adverse Event|2|||
125069181|NCT05489081|449869619|FG000|Overall Study|student left classroom|0|||
125069182|NCT05489081|449869620|FG001|Overall Study|student left classroom|1|||
125069183|NCT05489081|449869619|FG000|Overall Study|teacher left school|0|||
125069184|NCT05489081|449869620|FG001|Overall Study|teacher left school|2|||
125069185|NCT00810810|449869621|FG000|Overall Study|Withdrawal by Subject|0|||
125069186|NCT00810810|449869622|FG001|Overall Study|Withdrawal by Subject|8|||
125069187|NCT00810810|449869623|FG002|Overall Study|Withdrawal by Subject|10|||
125069188|NCT00810810|449869624|FG003|Overall Study|Withdrawal by Subject|8|||
125069189|NCT00810810|449869621|FG000|Overall Study|Physician Decision|0|||
125069190|NCT00810810|449869622|FG001|Overall Study|Physician Decision|3|||
125069191|NCT00810810|449869623|FG002|Overall Study|Physician Decision|1|||
125069192|NCT00810810|449869624|FG003|Overall Study|Physician Decision|5|||
125069193|NCT01700985|449869625|FG000|Overall Study|Incarcerated|0|||
125069194|NCT01700985|449869626|FG001|Overall Study|Incarcerated|1|||
125069195|NCT01409993|449869627|FG000|Overall Study|Adverse Event|4|||
125069196|NCT01409993|449869628|FG001|Overall Study|Adverse Event|4|||
125069197|NCT01409993|449869629|FG002|Overall Study|Adverse Event|3|||
125069198|NCT01409993|449869630|FG003|Overall Study|Adverse Event|1|||
125069199|NCT01409993|449869627|FG000|Overall Study|Withdrawal by Subject|0|||
125069200|NCT01409993|449869628|FG001|Overall Study|Withdrawal by Subject|0|||
125069201|NCT01409993|449869629|FG002|Overall Study|Withdrawal by Subject|0|||
125069202|NCT01409993|449869630|FG003|Overall Study|Withdrawal by Subject|4|||
125069203|NCT01409993|449869627|FG000|Overall Study|Lost to Follow-up|0|||
125069204|NCT01409993|449869628|FG001|Overall Study|Lost to Follow-up|1|||
125069205|NCT01409993|449869629|FG002|Overall Study|Lost to Follow-up|0|||
125069206|NCT01409993|449869630|FG003|Overall Study|Lost to Follow-up|0|||
125069207|NCT05067452|449869631|FG000|Overall Study|Lost to Follow-up|0|||
125140846|NCT01496118|450139557|FG004|Overall Study|Physician Decision|1|||
125140847|NCT01496118|450139558|FG005|Overall Study|Physician Decision|0|||
125140848|NCT01496118|450139559|FG006|Overall Study|Physician Decision|3|||
125140849|NCT01496118|450139560|FG007|Overall Study|Physician Decision|6|||
125140850|NCT01496118|450139553|FG000|Overall Study|Adverse Event|1|||
125140851|NCT01496118|450139554|FG001|Overall Study|Adverse Event|1|||
125140852|NCT01496118|450139555|FG002|Overall Study|Adverse Event|0|||
125140853|NCT01496118|450139556|FG003|Overall Study|Adverse Event|0|||
125140854|NCT01496118|450139557|FG004|Overall Study|Adverse Event|0|||
125140855|NCT01496118|450139558|FG005|Overall Study|Adverse Event|0|||
125140856|NCT01496118|450139559|FG006|Overall Study|Adverse Event|6|||
125140857|NCT01496118|450139560|FG007|Overall Study|Adverse Event|10|||
125069208|NCT05067452|449869632|FG001|Overall Study|Lost to Follow-up|4|||
125069209|NCT03074149|449869633|FG000|Overall Study|Reason unknown|22|||
125069210|NCT03074149|449869634|FG001|Overall Study|Reason unknown|35|||
125069211|NCT03074149|449869633|FG000|Overall Study|Death|10|||
125069212|NCT03074149|449869634|FG001|Overall Study|Death|45|||
125069213|NCT00067470|449869635|FG000|Overall Study|Withdrawal by Subject|0|||
125069214|NCT00067470|449869636|FG001|Overall Study|Withdrawal by Subject|1|||
125069215|NCT00050622|449869639|FG000|Overall Study|Adverse Event|1|||
125069216|NCT01192204|449869640|FG000|Overall Study|could not keep recall appointments|1|||
125069217|NCT01192204|449869641|FG001|Overall Study|could not keep recall appointments|0|||
125069218|NCT02146248|449869642|FG000|Overall Study|Withdrawal by Subject|2|||
125069219|NCT01315847|449869643|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
125069220|NCT01315847|449869644|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
125069221|NCT01315847|449869643|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
125140858|NCT01496118|450139553|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
125069222|NCT01315847|449869644|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
125069223|NCT02247401|449869645|FG000|Overall Study|Adverse Event|1|||
125069224|NCT02247401|449869646|FG001|Overall Study|Adverse Event|0|||
125069225|NCT02247401|449869647|FG002|Overall Study|Adverse Event|0|||
125069226|NCT02247401|449869645|FG000|Overall Study|Withdrawal by Subject|4|||
125069227|NCT02247401|449869646|FG001|Overall Study|Withdrawal by Subject|1|||
125069228|NCT02247401|449869647|FG002|Overall Study|Withdrawal by Subject|1|||
125069229|NCT02247401|449869645|FG000|Overall Study|Lost to Follow-up|1|||
125069230|NCT02247401|449869646|FG001|Overall Study|Lost to Follow-up|1|||
125069231|NCT02247401|449869647|FG002|Overall Study|Lost to Follow-up|1|||
125069232|NCT01117012|449869649|FG000|Overall Study|Adverse Event|0|||
125069233|NCT01117012|449869650|FG001|Overall Study|Adverse Event|1|||
125069234|NCT01117012|449869649|FG000|Overall Study|Death|1|||
125069235|NCT01117012|449869650|FG001|Overall Study|Death|1|||
125069236|NCT01117012|449869649|FG000|Overall Study|Withdrawal by Subject|3|||
125069237|NCT01117012|449869650|FG001|Overall Study|Withdrawal by Subject|0|||
125069238|NCT01117012|449869649|FG000|Overall Study|Undefined|4|||
125069239|NCT01117012|449869650|FG001|Overall Study|Undefined|3|||
125069240|NCT03695393|449869651|FG000|Overall Study|Death|3|||
125069241|NCT03695393|449869652|FG001|Overall Study|Death|1|||
125069242|NCT03695393|449869651|FG000|Overall Study|Lost to Follow-up|0|||
125069243|NCT03695393|449869652|FG001|Overall Study|Lost to Follow-up|1|||
125069244|NCT00673894|449869653|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
125069245|NCT00673894|449869654|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
125069246|NCT00673894|449869653|FG000|First Intervention 4 Weeks|Adverse Event|1|||
125069247|NCT00673894|449869654|FG001|First Intervention 4 Weeks|Adverse Event|0|||
125069248|NCT01164865|449869655|FG000|Overall Study|Lost to Follow-up|2|||
125069249|NCT01164865|449869656|FG001|Overall Study|Lost to Follow-up|1|||
125069250|NCT00405821|449869661|FG000|Overall Study|Death|5|||
125069251|NCT00405821|449869662|FG001|Overall Study|Death|7|||
125069252|NCT00405821|449869661|FG000|Overall Study|Lost to Follow-up|7|||
125069253|NCT00405821|449869662|FG001|Overall Study|Lost to Follow-up|7|||
125069254|NCT00405821|449869661|FG000|Overall Study|Protocol Violation|1|||
125069255|NCT00405821|449869662|FG001|Overall Study|Protocol Violation|0|||
125069256|NCT00405821|449869661|FG000|Overall Study|initiated ART|9|||
125069257|NCT00405821|449869662|FG001|Overall Study|initiated ART|8|||
125069258|NCT01586806|449869664|FG000|Overall Study|Protocol Violation|0|||
125069259|NCT01586806|449869665|FG001|Overall Study|Protocol Violation|1|||
125069260|NCT01586806|449869666|FG002|Overall Study|Protocol Violation|0|||
125069261|NCT01586806|449869664|FG000|Overall Study|Withdrawal by Subject|1|||
125069262|NCT01586806|449869665|FG001|Overall Study|Withdrawal by Subject|0|||
125069263|NCT01586806|449869666|FG002|Overall Study|Withdrawal by Subject|0|||
125069264|NCT01586806|449869664|FG000|Overall Study|Lost to Follow-up|2|||
125069265|NCT01586806|449869665|FG001|Overall Study|Lost to Follow-up|3|||
125069266|NCT01586806|449869666|FG002|Overall Study|Lost to Follow-up|2|||
125069267|NCT01769469|449869668|FG000|Overall Study|Consent Withdrawn|5|||
125069268|NCT01769469|449869668|FG000|Overall Study|Moved Out Of Area|3|||
125069269|NCT01769469|449869668|FG000|Overall Study|Lost to Follow-up|17|||
125069270|NCT01769469|449869668|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
125069271|NCT01769469|449869668|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
125069272|NCT02031432|449869669|FG000|Overall Study|Protocol Violation|1|||
125069273|NCT02031432|449869669|FG000|Overall Study|Lack of Efficacy|5|||
125069274|NCT02031432|449869669|FG000|Overall Study|Cancer Progression|2|||
125069275|NCT02031432|449869669|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
125069276|NCT02031432|449869669|FG000|Overall Study|Adverse Event|8|||
125069277|NCT02031432|449869669|FG000|Overall Study|Withdrawal by Subject|5|||
125069278|NCT02031432|449869669|FG000|Overall Study|Lost to Follow-up|1|||
125140859|NCT01496118|450139554|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
125140860|NCT01496118|450139555|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
125069279|NCT02031432|449869669|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
125069280|NCT02031432|449869669|FG000|Overall Study|Death|10|||
125069281|NCT01617187|449869670|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
125069282|NCT01617187|449869671|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
125069283|NCT01617187|449869672|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
125069284|NCT01617187|449869673|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
125069285|NCT01617187|449869670|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
125069286|NCT01617187|449869671|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
125069287|NCT01617187|449869672|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
125069288|NCT01617187|449869673|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
125069289|NCT01617187|449869670|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
125069290|NCT01617187|449869671|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
125069291|NCT01617187|449869672|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
125069292|NCT01617187|449869673|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
125069293|NCT01617187|449869670|FG000|Treatment Through Study Completion|Adverse Event|1|||
125069294|NCT01617187|449869671|FG001|Treatment Through Study Completion|Adverse Event|1|||
125069295|NCT01617187|449869672|FG002|Treatment Through Study Completion|Adverse Event|0|||
125069296|NCT01617187|449869673|FG003|Treatment Through Study Completion|Adverse Event|1|||
125069297|NCT01617187|449869670|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
125069298|NCT01617187|449869671|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
125069299|NCT01617187|449869672|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
125069300|NCT01617187|449869673|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
125069301|NCT01617187|449869670|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
125069302|NCT01617187|449869671|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
125069303|NCT01617187|449869672|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
125069304|NCT01617187|449869673|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
125069305|NCT01617187|449869670|FG000|Treatment Through Study Completion|Protocol Violation|1|||
125069306|NCT01617187|449869671|FG001|Treatment Through Study Completion|Protocol Violation|0|||
125069307|NCT01617187|449869672|FG002|Treatment Through Study Completion|Protocol Violation|0|||
125069308|NCT01617187|449869673|FG003|Treatment Through Study Completion|Protocol Violation|1|||
125069309|NCT01770145|449871398|FG000|Baseline|Adverse Event|20|||
125069310|NCT01770145|449871398|FG000|Baseline|Withdrawal by Subject|1|||
125069311|NCT01770145|449871398|FG000|Baseline|Lost to Follow-up|1|||
125069312|NCT01770145|449871398|FG000|Baseline|Unable to define optimal dose|4|||
125069313|NCT01770145|449871398|FG000|Treatment|Adverse Event|3|||
125069314|NCT01770145|449871398|FG000|Treatment|Withdrawal by Subject|1|||
125069315|NCT00595868|449871399|FG000|Overall Study|Lost to Follow-up|45|||
125069316|NCT00595868|449871400|FG001|Overall Study|Lost to Follow-up|50|||
125069317|NCT04268303|449871402|FG000|Overall Study|Lost to Follow-up|1|||
125069318|NCT04268303|449871403|FG001|Overall Study|Lost to Follow-up|1|||
125069319|NCT04268303|449871404|FG002|Overall Study|Lost to Follow-up|2|||
125069320|NCT04268303|449871402|FG000|Overall Study|Withdrawal by Subject|0|||
125069321|NCT04268303|449871403|FG001|Overall Study|Withdrawal by Subject|1|||
125069322|NCT04268303|449871404|FG002|Overall Study|Withdrawal by Subject|1|||
125069323|NCT04268303|449871402|FG000|Overall Study|Adverse Event|2|||
125069324|NCT04268303|449871403|FG001|Overall Study|Adverse Event|0|||
125069325|NCT04268303|449871404|FG002|Overall Study|Adverse Event|0|||
125069326|NCT05742841|449871409|FG000|Overall Study|Withdrawal by Subject|1|||
125069327|NCT05742841|449871409|FG000|Overall Study|Lost to Follow-up|1|||
125069328|NCT01175590|449871415|FG000|Overall Study|Lost to Follow-up|1|||
125069329|NCT01175590|449871416|FG001|Overall Study|Lost to Follow-up|0|||
125069330|NCT01175590|449871415|FG000|Overall Study|Withdrawal by Subject|0|||
125069331|NCT01175590|449871416|FG001|Overall Study|Withdrawal by Subject|2|||
125069332|NCT01175590|449871415|FG000|Overall Study|Adverse Event|4|||
125069333|NCT01175590|449871416|FG001|Overall Study|Adverse Event|0|||
125069334|NCT01175590|449871415|FG000|Overall Study|Physician Decision|1|||
125069335|NCT01175590|449871416|FG001|Overall Study|Physician Decision|4|||
125069336|NCT01175590|449871415|FG000|Overall Study|Lack of Efficacy|1|||
125069337|NCT01175590|449871416|FG001|Overall Study|Lack of Efficacy|1|||
125069338|NCT01175590|449871415|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
125069339|NCT01175590|449871416|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
125069340|NCT01175590|449871415|FG000|Overall Study|Treated not as randomized|3|||
125069341|NCT01175590|449871416|FG001|Overall Study|Treated not as randomized|2|||
125069342|NCT01175590|449871415|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
125069343|NCT01175590|449871416|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
125069344|NCT01175590|449871415|FG000|Overall Study|Protocol Violation|0|||
125069345|NCT01175590|449871416|FG001|Overall Study|Protocol Violation|1|||
125069346|NCT00688545|449871419|FG000|Overall Study|Lost to Follow-up|1|||
125069347|NCT00688545|449871420|FG001|Overall Study|Lost to Follow-up|4|||
125069348|NCT00688545|449871419|FG000|Overall Study|Insurance/cost of drug|0|||
125069349|NCT00688545|449871420|FG001|Overall Study|Insurance/cost of drug|1|||
125069350|NCT00688545|449871419|FG000|Overall Study|Withdrawal by Subject|2|||
125069351|NCT00688545|449871420|FG001|Overall Study|Withdrawal by Subject|3|||
125069352|NCT00688545|449871419|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
125069353|NCT00688545|449871420|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
125069354|NCT03911869|449871421|FG000|Safety Lead-in Phase|Death|7|||
125069355|NCT03911869|449871422|FG001|Safety Lead-in Phase|Death|0|||
125069356|NCT03911869|449871423|FG002|Safety Lead-in Phase|Death|0|||
125069357|NCT03911869|449871421|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
125069358|NCT03911869|449871422|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
125069359|NCT03911869|449871423|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
125069360|NCT03911869|449871421|FG000|Safety Lead-in Phase|Other|1|||
125069361|NCT03911869|449871422|FG001|Safety Lead-in Phase|Other|0|||
125069362|NCT03911869|449871423|FG002|Safety Lead-in Phase|Other|0|||
125069363|NCT03911869|449871421|FG000|Phase 2|Death|0|||
125069364|NCT03911869|449871422|FG001|Phase 2|Death|3|||
125069365|NCT03911869|449871423|FG002|Phase 2|Death|0|||
125069366|NCT01878097|449871424|FG000|Baseline|Surveys not fully completed|2497|||
125069367|NCT01878097|449871425|FG001|Baseline|Surveys not fully completed|1800|||
125069368|NCT01878097|449871424|FG000|Implementation Year 1|Surveys not fully completed|3202|||
125069369|NCT01878097|449871425|FG001|Implementation Year 1|Surveys not fully completed|2549|||
125069370|NCT01878097|449871424|FG000|Implementation Year 2|Surveys not fully completed|3281|||
125069371|NCT01878097|449871425|FG001|Implementation Year 2|Surveys not fully completed|2841|||
125069372|NCT01878097|449871424|FG000|Implementation Year 3|Surveys not fully completed|3494|||
125069373|NCT01878097|449871425|FG001|Implementation Year 3|Surveys not fully completed|2980|||
125069374|NCT01878097|449871424|FG000|Implementation Year 4|Surveys not fully completed|3604|||
125069375|NCT01878097|449871425|FG001|Implementation Year 4|Surveys not fully completed|3007|||
125069376|NCT00367341|449871426|FG000|Overall Study|Physician Decision|1|||
125069377|NCT00367341|449871427|FG001|Overall Study|Physician Decision|0|||
125069378|NCT00367341|449871426|FG000|Overall Study|Protocol Violation|1|||
125069379|NCT00367341|449871427|FG001|Overall Study|Protocol Violation|0|||
125069380|NCT02786836|449871431|FG000|Overall Study|Death|1|||
125069381|NCT02786836|449871431|FG000|Overall Study|Lack of Efficacy|2|||
125069382|NCT02786836|449871431|FG000|Overall Study|Protocol Violation|3|||
125069383|NCT02786836|449871431|FG000|Overall Study|Withdrawal by Subject|3|||
125069384|NCT02786836|449871431|FG000|Overall Study|Liver Transplantation|2|||
125069385|NCT02786836|449871431|FG000|Overall Study|Device or Pharmacy Issues|3|||
125069386|NCT01143714|449871433|FG000|Overall Study|Adverse Event|4|||
125069387|NCT01143714|449871434|FG001|Overall Study|Adverse Event|2|||
125069388|NCT01143714|449871433|FG000|Overall Study|Withdrawal by Subject|1|||
125069389|NCT01143714|449871434|FG001|Overall Study|Withdrawal by Subject|0|||
125069390|NCT01143714|449871433|FG000|Overall Study|Subject non-compliance|0|||
125069391|NCT01143714|449871434|FG001|Overall Study|Subject non-compliance|1|||
125069392|NCT01143714|449871433|FG000|Overall Study|wound closed = deemed healed|1|||
125069393|NCT01143714|449871434|FG001|Overall Study|wound closed = deemed healed|0|||
125069394|NCT01143714|449871433|FG000|Overall Study|wound size increased|1|||
125069395|NCT01143714|449871434|FG001|Overall Study|wound size increased|0|||
125069396|NCT01387074|449871435|FG000|Overall Study|Lost to Follow-up|7|||
125069397|NCT01387074|449871435|FG000|Overall Study|Lack of Efficacy|1|||
125069398|NCT03892707|449871441|FG000|Overall Study|Screen failure|6|||
125069399|NCT03892707|449871442|FG001|Overall Study|Screen failure|0|||
125069400|NCT03892707|449871441|FG000|Overall Study|Pain resolution|0|||
125069401|NCT03892707|449871442|FG001|Overall Study|Pain resolution|4|||
125069402|NCT03892707|449871441|FG000|Overall Study|Withdrawal by Subject|0|||
125069403|NCT03892707|449871442|FG001|Overall Study|Withdrawal by Subject|1|||
125069404|NCT03892707|449871441|FG000|Overall Study|Other (long business trip)|0|||
125069405|NCT03892707|449871442|FG001|Overall Study|Other (long business trip)|1|||
125069406|NCT02137837|449871445|FG000|Overall Study|Adverse Event|0|||
125069407|NCT02137837|449871446|FG001|Overall Study|Adverse Event|2|||
125069408|NCT02137837|449871447|FG002|Overall Study|Adverse Event|1|||
125069409|NCT02137837|449871445|FG000|Overall Study|Refusal unrelated to adverse event|2|||
125069410|NCT02137837|449871446|FG001|Overall Study|Refusal unrelated to adverse event|2|||
125069411|NCT02137837|449871447|FG002|Overall Study|Refusal unrelated to adverse event|1|||
125140861|NCT01496118|450139556|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
125140862|NCT01496118|450139557|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
125069412|NCT02137837|449871445|FG000|Overall Study|Progression/relapse|9|||
125069413|NCT02137837|449871446|FG001|Overall Study|Progression/relapse|7|||
125069414|NCT02137837|449871447|FG002|Overall Study|Progression/relapse|7|||
125069415|NCT02137837|449871445|FG000|Overall Study|Not protocol specified|2|||
125069416|NCT02137837|449871446|FG001|Overall Study|Not protocol specified|1|||
125069417|NCT02137837|449871447|FG002|Overall Study|Not protocol specified|3|||
125069418|NCT02141217|449871448|FG000|Overall Study|Adverse Event|1|||
125069419|NCT02141217|449871449|FG001|Overall Study|Adverse Event|2|||
125069420|NCT02141217|449871448|FG000|Overall Study|Protocol Violation|1|||
125069421|NCT02141217|449871449|FG001|Overall Study|Protocol Violation|4|||
125140863|NCT01496118|450139558|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
125222898|NCT03316586|450444429|FG000|Overall Study|Lack of Efficacy|10|||
125069422|NCT02141217|449871448|FG000|Overall Study|Withdrawal by Subject|6|||
125069423|NCT02141217|449871449|FG001|Overall Study|Withdrawal by Subject|0|||
125069424|NCT02141217|449871448|FG000|Overall Study|Lost to Follow-up|1|||
125069425|NCT02141217|449871449|FG001|Overall Study|Lost to Follow-up|1|||
125069426|NCT02141217|449871448|FG000|Overall Study|Physician Decision|1|||
125069427|NCT02141217|449871449|FG001|Overall Study|Physician Decision|0|||
125069428|NCT02141217|449871448|FG000|Overall Study|Surgical Intervention|1|||
125069429|NCT02141217|449871449|FG001|Overall Study|Surgical Intervention|1|||
125069430|NCT01181141|449871452|FG000|Overall Study|Adverse Event|2|||
125069431|NCT01181141|449871453|FG001|Overall Study|Adverse Event|1|||
125069432|NCT01181141|449871452|FG000|Overall Study|Lack of Efficacy|1|||
125069433|NCT01181141|449871453|FG001|Overall Study|Lack of Efficacy|0|||
125069434|NCT01181141|449871452|FG000|Overall Study|Lost to Follow-up|1|||
125069435|NCT01181141|449871453|FG001|Overall Study|Lost to Follow-up|1|||
125069436|NCT01181141|449871452|FG000|Overall Study|Physician Decision|2|||
125069437|NCT01181141|449871453|FG001|Overall Study|Physician Decision|0|||
125069438|NCT01181141|449871452|FG000|Overall Study|Protocol Violation|3|||
125069439|NCT01181141|449871453|FG001|Overall Study|Protocol Violation|1|||
125069440|NCT01181141|449871452|FG000|Overall Study|Withdrawal by Subject|3|||
125069441|NCT01181141|449871453|FG001|Overall Study|Withdrawal by Subject|1|||
125069442|NCT00448760|449871454|FG000|Overall Study|Death|3|||
125069443|NCT01438307|449871462|FG000|Overall Study|Death|1|||
125069444|NCT01438307|449871463|FG001|Overall Study|Death|1|||
125069445|NCT00555568|449871464|FG000|Overall Study|Lost to Follow-up|26|||
125069446|NCT00555568|449871465|FG001|Overall Study|Lost to Follow-up|16|||
125069447|NCT00555568|449871466|FG002|Overall Study|Lost to Follow-up|16|||
125069448|NCT02378883|449871469|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
125069449|NCT02378883|449871469|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
125069450|NCT02378883|449871469|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
125069451|NCT02378883|449871469|FG000|30 Day Follow-Up|Physician Decision|2|||
125069452|NCT02378883|449871469|FG000|30 Day Follow-Up|Missed Visit|2|||
125069453|NCT02378883|449871469|FG000|30 Day Follow-Up|Death|1|||
125069454|NCT02378883|449871469|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
125069455|NCT02378883|449871469|FG000|12 Months Follow-Up|Death|2|||
125069456|NCT03814005|449871473|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
125069457|NCT03814005|449871474|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
125069458|NCT03814005|449871475|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
125069459|NCT03814005|449871473|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
125069460|NCT03814005|449871474|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
125069461|NCT03814005|449871475|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
125069462|NCT03814005|449871473|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
125069463|NCT03814005|449871474|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
125069464|NCT03814005|449871475|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
125069465|NCT03814005|449871473|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
125069466|NCT03814005|449871474|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
125069467|NCT03814005|449871475|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
125069468|NCT03814005|449871473|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
125069469|NCT03814005|449871474|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
125069470|NCT03814005|449871475|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
125069471|NCT03814005|449871473|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
125069472|NCT03814005|449871474|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
125069473|NCT03814005|449871475|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
125069474|NCT01135017|449871479|FG000|Overall Study|Adverse Event|3|||
125069475|NCT01135017|449871480|FG001|Overall Study|Adverse Event|8|||
125069476|NCT01135017|449871479|FG000|Overall Study|Other than above|3|||
125069477|NCT01135017|449871480|FG001|Overall Study|Other than above|4|||
125069478|NCT01170221|449871482|FG000|Overall Study|Lost to Follow-up|22|||
125069479|NCT01170221|449871483|FG001|Overall Study|Lost to Follow-up|21|||
125069480|NCT01170221|449871482|FG000|Overall Study|Withdrawal by Subject|9|||
125069481|NCT01170221|449871483|FG001|Overall Study|Withdrawal by Subject|7|||
125069482|NCT01170221|449871482|FG000|Overall Study|Subject completed only screening and LFU|1|||
125069483|NCT01170221|449871483|FG001|Overall Study|Subject completed only screening and LFU|0|||
125069484|NCT01170221|449871482|FG000|Overall Study|Randomized but not treated|1|||
125069485|NCT01170221|449871483|FG001|Overall Study|Randomized but not treated|0|||
125069486|NCT00432562|449871484|FG000|Overall Study|Death|3|||
125069487|NCT00432562|449871485|FG001|Overall Study|Death|0|||
125069488|NCT02693691|449871486|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
125069489|NCT02693691|449871486|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
125069490|NCT02693691|449871486|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
125069491|NCT02693691|449871486|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
125069492|NCT02693691|449871486|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
125069493|NCT02693691|449871486|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
125069494|NCT02693691|449871486|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
125069495|NCT04169061|449871487|FG000|Overall Study|Adverse Event|2|||
125069496|NCT04169061|449871487|FG000|Overall Study|Death|1|||
125069497|NCT04169061|449871487|FG000|Overall Study|Withdrawal by Subject|1|||
125069498|NCT04169061|449871487|FG000|Overall Study|Protocol Violation|1|||
125069499|NCT05425719|449871491|FG000|Overall Study|Lost to Follow-up|4|||
125069500|NCT05425719|449871492|FG001|Overall Study|Lost to Follow-up|0|||
125069501|NCT05425719|449871491|FG000|Overall Study|Withdrew consent|1|||
125069502|NCT05425719|449871492|FG001|Overall Study|Withdrew consent|1|||
125069503|NCT04682353|449871493|FG000|Overall Study|Lost to Follow-up|0|||
125069504|NCT04682353|449871494|FG001|Overall Study|Lost to Follow-up|1|||
125069505|NCT04682353|449871495|FG002|Overall Study|Lost to Follow-up|0|||
125069506|NCT04682353|449871496|FG003|Overall Study|Lost to Follow-up|1|||
125069507|NCT04682353|449871493|FG000|Overall Study|Personal reasons|0|||
125069508|NCT04682353|449871494|FG001|Overall Study|Personal reasons|1|||
125069509|NCT04682353|449871495|FG002|Overall Study|Personal reasons|0|||
125069510|NCT04682353|449871496|FG003|Overall Study|Personal reasons|0|||
125069511|NCT02394795|449871497|FG000|Overall Study|Adverse Event|92|||
125069512|NCT02394795|449871498|FG001|Overall Study|Adverse Event|70|||
125069513|NCT02394795|449871497|FG000|Overall Study|Lost to Follow-up|0|||
125069514|NCT02394795|449871498|FG001|Overall Study|Lost to Follow-up|1|||
125069515|NCT02394795|449871497|FG000|Overall Study|Withdrawal by Subject|17|||
125069516|NCT02394795|449871498|FG001|Overall Study|Withdrawal by Subject|26|||
125069517|NCT02394795|449871497|FG000|Overall Study|Lack of Efficacy|181|||
125069518|NCT02394795|449871498|FG001|Overall Study|Lack of Efficacy|211|||
125069519|NCT02394795|449871497|FG000|Overall Study|Death|4|||
125069520|NCT02394795|449871498|FG001|Overall Study|Death|5|||
125069521|NCT02394795|449871497|FG000|Overall Study|Physician Decision|109|||
125069522|NCT02394795|449871498|FG001|Overall Study|Physician Decision|93|||
125069523|NCT03505749|449871504|FG000|Overall Study|Lost to Follow-up|7|||
125069524|NCT03505749|449871505|FG001|Overall Study|Lost to Follow-up|11|||
125069525|NCT03505749|449871504|FG000|Overall Study|Withdrawal by Subject|6|||
125069526|NCT03505749|449871505|FG001|Overall Study|Withdrawal by Subject|0|||
125069527|NCT03505749|449871504|FG000|Overall Study|Discharged from treatment|3|||
125069528|NCT03505749|449871505|FG001|Overall Study|Discharged from treatment|6|||
125069529|NCT03846219|449871506|FG000|Overall Study|Withdrawal by Subject|3|||
125069530|NCT03846219|449871507|FG001|Overall Study|Withdrawal by Subject|2|||
125069531|NCT03846219|449871508|FG002|Overall Study|Withdrawal by Subject|2|||
125069532|NCT03846219|449871506|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
125069533|NCT03846219|449871507|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
125069534|NCT03846219|449871508|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
125069535|NCT03846219|449871506|FG000|Overall Study|Physician Decision|0|||
125069536|NCT03846219|449871507|FG001|Overall Study|Physician Decision|0|||
125069537|NCT03846219|449871508|FG002|Overall Study|Physician Decision|2|||
125069538|NCT01688635|449871509|FG000|Washout 1|Withdrawal by Subject|1|||
125069539|NCT01688635|449871510|FG001|Washout 1|Withdrawal by Subject|0|||
125069540|NCT01688635|449871509|FG000|Washout 1|Adverse Event|0|||
125069541|NCT01688635|449871510|FG001|Washout 1|Adverse Event|1|||
125069542|NCT01688635|449871509|FG000|Washout 1|Physician Decision|0|||
125069543|NCT01688635|449871510|FG001|Washout 1|Physician Decision|1|||
125069544|NCT01688635|449871509|FG000|Washout 2|Physician Decision|1|||
125069545|NCT01688635|449871510|FG001|Washout 2|Physician Decision|0|||
125069546|NCT01688635|449871509|FG000|Washout 2|Withdrawal by Subject|1|||
125069547|NCT01688635|449871510|FG001|Washout 2|Withdrawal by Subject|0|||
125069548|NCT01688635|449871509|FG000|Washout 2|Sponsor Decision|1|||
125069549|NCT01688635|449871510|FG001|Washout 2|Sponsor Decision|2|||
125069550|NCT01688635|449871509|FG000|Washout 3|Withdrawal by Subject|1|||
125069551|NCT01688635|449871510|FG001|Washout 3|Withdrawal by Subject|0|||
125069552|NCT00888615|449871511|FG000|Overall Study|No treatment|2|||
125069553|NCT03862131|449871512|FG000|Overall Study|Lost to Follow-up|1|||
125069554|NCT03862131|449871513|FG001|Overall Study|Lost to Follow-up|0|||
125069555|NCT03862131|449871514|FG002|Overall Study|Lost to Follow-up|1|||
125140864|NCT01496118|450139559|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
125140865|NCT01496118|450139560|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
125140866|NCT01496118|450139553|FG000|Overall Study|Death|0|||
125140867|NCT01496118|450139554|FG001|Overall Study|Death|0|||
125140868|NCT01496118|450139555|FG002|Overall Study|Death|0|||
125140869|NCT01496118|450139556|FG003|Overall Study|Death|0|||
125069556|NCT03862131|449871512|FG000|Overall Study|Determined to be ineligible|0|||
125069557|NCT03862131|449871513|FG001|Overall Study|Determined to be ineligible|0|||
125069558|NCT03862131|449871514|FG002|Overall Study|Determined to be ineligible|5|||
125069559|NCT03862131|449871512|FG000|Overall Study|Death|4|||
125069560|NCT03862131|449871513|FG001|Overall Study|Death|4|||
125069561|NCT03862131|449871514|FG002|Overall Study|Death|0|||
125069562|NCT03862131|449871512|FG000|Overall Study|Withdrawal by Subject|5|||
125140870|NCT01496118|450139557|FG004|Overall Study|Death|0|||
125069563|NCT03862131|449871513|FG001|Overall Study|Withdrawal by Subject|3|||
125069564|NCT03862131|449871514|FG002|Overall Study|Withdrawal by Subject|0|||
125069565|NCT03862131|449871512|FG000|Overall Study|Physician Decision|0|||
125069566|NCT03862131|449871513|FG001|Overall Study|Physician Decision|1|||
125069567|NCT03862131|449871514|FG002|Overall Study|Physician Decision|0|||
125069568|NCT02293902|449871515|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
125069569|NCT02293902|449871516|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
125069570|NCT02293902|449871517|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
125069571|NCT02293902|449871518|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
125069572|NCT02293902|449871519|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
125069573|NCT02293902|449871515|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
125069574|NCT02293902|449871516|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
125069575|NCT02293902|449871517|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
125069576|NCT02293902|449871518|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
125069577|NCT02293902|449871519|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
125069578|NCT02293902|449871515|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
125069579|NCT02293902|449871516|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
125069580|NCT02293902|449871517|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
125069581|NCT02293902|449871518|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
125069582|NCT02293902|449871519|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
125069583|NCT02293902|449871515|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
125069584|NCT02293902|449871516|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
125069585|NCT02293902|449871517|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
125069586|NCT02293902|449871518|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
125069587|NCT02293902|449871519|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
125069588|NCT02293902|449871515|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
125069589|NCT02293902|449871516|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
125069590|NCT02293902|449871517|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
125069591|NCT02293902|449871518|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
125069592|NCT02293902|449871519|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
125069593|NCT02947022|449871520|FG000|Overall Study|Study Stopped|1|||
125069594|NCT04671342|449873029|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
125069595|NCT04671342|449873029|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
125069596|NCT04671342|449873029|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
125069597|NCT04671342|449873029|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
125069598|NCT04671342|449873029|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
125069599|NCT04671342|449873029|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
125069600|NCT03351478|449873032|FG000|Overall Study|At the subject's own request|11|||
125069601|NCT03351478|449873033|FG001|Overall Study|At the subject's own request|12|||
125069602|NCT03351478|449873034|FG002|Overall Study|At the subject's own request|5|||
125069603|NCT03351478|449873032|FG000|Overall Study|Adverse Event|1|||
125069604|NCT03351478|449873033|FG001|Overall Study|Adverse Event|2|||
125069605|NCT03351478|449873034|FG002|Overall Study|Adverse Event|1|||
125069606|NCT03351478|449873032|FG000|Overall Study|Poor compliance to protocol|1|||
125069607|NCT03351478|449873033|FG001|Overall Study|Poor compliance to protocol|0|||
125069608|NCT03351478|449873034|FG002|Overall Study|Poor compliance to protocol|0|||
125069609|NCT03351478|449873032|FG000|Overall Study|Reason not Specified|1|||
125069610|NCT03351478|449873033|FG001|Overall Study|Reason not Specified|3|||
125069611|NCT03351478|449873034|FG002|Overall Study|Reason not Specified|0|||
125069612|NCT03351478|449873032|FG000|Overall Study|Lost to Follow-up|0|||
125069613|NCT03351478|449873033|FG001|Overall Study|Lost to Follow-up|0|||
125069614|NCT03351478|449873034|FG002|Overall Study|Lost to Follow-up|1|||
125069615|NCT00510484|449873035|FG000|Wash-out Period|Adverse Event|0|||
125069616|NCT00510484|449873036|FG001|Wash-out Period|Adverse Event|1|||
125069617|NCT00762268|449873039|FG000|Overall Study|Withdrawal by Subject|3|||
125069618|NCT00762268|449873040|FG001|Overall Study|Withdrawal by Subject|3|||
125069619|NCT02533401|449873043|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
125069620|NCT02533401|449873043|FG000|Overall Study|Death|5|||
125069621|NCT02533401|449873043|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
125069622|NCT02533401|449873043|FG000|Overall Study|Lost to Follow-up|1|||
125069623|NCT02533401|449873043|FG000|Overall Study|Violation of Selection Criteria|1|||
125069624|NCT00973622|449873044|FG000|Overall Study|did not attend MRI|14|||
125069625|NCT00973622|449873045|FG001|Overall Study|did not attend MRI|3|||
125069626|NCT00973622|449873044|FG000|Overall Study|did not pass MRI screen|6|||
125069627|NCT00973622|449873045|FG001|Overall Study|did not pass MRI screen|0|||
125069628|NCT00973622|449873044|FG000|Overall Study|did not complete rTMS sessions|11|||
125069629|NCT00973622|449873045|FG001|Overall Study|did not complete rTMS sessions|2|||
125140871|NCT01496118|450139558|FG005|Overall Study|Death|0|||
125140872|NCT01496118|450139559|FG006|Overall Study|Death|1|||
125140873|NCT01496118|450139560|FG007|Overall Study|Death|1|||
125140874|NCT01496118|450139553|FG000|Overall Study|Withdrawal by Subject|0|||
125140875|NCT01496118|450139554|FG001|Overall Study|Withdrawal by Subject|0|||
125140876|NCT01496118|450139555|FG002|Overall Study|Withdrawal by Subject|0|||
125140877|NCT01496118|450139556|FG003|Overall Study|Withdrawal by Subject|2|||
125140878|NCT01496118|450139557|FG004|Overall Study|Withdrawal by Subject|0|||
125140879|NCT01496118|450139558|FG005|Overall Study|Withdrawal by Subject|1|||
125069630|NCT00493467|449873046|FG000|Overall Study|Death|1|||
125069631|NCT03395223|449873049|FG000|Overall Study|Lost to Follow-up|3|||
125069632|NCT03395223|449873049|FG000|Overall Study|Other|1|||
125069633|NCT01855945|449873052|FG000|Overall Study|Adverse Event|0|||
125069634|NCT01855945|449873053|FG001|Overall Study|Adverse Event|0|||
125069635|NCT01855945|449873054|FG002|Overall Study|Adverse Event|0|||
125069636|NCT01855945|449873055|FG003|Overall Study|Adverse Event|0|||
125069637|NCT01855945|449873056|FG004|Overall Study|Adverse Event|0|||
125069638|NCT01855945|449873057|FG005|Overall Study|Adverse Event|0|||
125069639|NCT01855945|449873058|FG006|Overall Study|Adverse Event|1|||
125069640|NCT01855945|449873059|FG007|Overall Study|Adverse Event|0|||
125069641|NCT01855945|449873060|FG008|Overall Study|Adverse Event|0|||
125069642|NCT01855945|449873061|FG009|Overall Study|Adverse Event|0|||
125069643|NCT01855945|449873062|FG010|Overall Study|Adverse Event|0|||
125069644|NCT01855945|449873063|FG011|Overall Study|Adverse Event|0|||
125069645|NCT01855945|449873052|FG000|Overall Study|Death|0|||
125069646|NCT01855945|449873053|FG001|Overall Study|Death|0|||
125069647|NCT01855945|449873054|FG002|Overall Study|Death|0|||
125069648|NCT01855945|449873055|FG003|Overall Study|Death|0|||
125069649|NCT01855945|449873056|FG004|Overall Study|Death|0|||
125069650|NCT01855945|449873057|FG005|Overall Study|Death|0|||
125069651|NCT01855945|449873058|FG006|Overall Study|Death|2|||
125069652|NCT01855945|449873059|FG007|Overall Study|Death|0|||
125069653|NCT01855945|449873060|FG008|Overall Study|Death|0|||
125069654|NCT01855945|449873061|FG009|Overall Study|Death|0|||
125069655|NCT01855945|449873062|FG010|Overall Study|Death|0|||
125069656|NCT01855945|449873063|FG011|Overall Study|Death|0|||
125069657|NCT01855945|449873052|FG000|Overall Study|Lost to Follow-up|11|||
125069658|NCT01855945|449873053|FG001|Overall Study|Lost to Follow-up|10|||
125069659|NCT01855945|449873054|FG002|Overall Study|Lost to Follow-up|7|||
125069660|NCT01855945|449873055|FG003|Overall Study|Lost to Follow-up|3|||
125069661|NCT01855945|449873056|FG004|Overall Study|Lost to Follow-up|0|||
125069662|NCT01855945|449873057|FG005|Overall Study|Lost to Follow-up|3|||
125069663|NCT01855945|449873058|FG006|Overall Study|Lost to Follow-up|4|||
125069664|NCT01855945|449873059|FG007|Overall Study|Lost to Follow-up|7|||
125069665|NCT01855945|449873060|FG008|Overall Study|Lost to Follow-up|2|||
125069666|NCT01855945|449873061|FG009|Overall Study|Lost to Follow-up|0|||
125069667|NCT01855945|449873062|FG010|Overall Study|Lost to Follow-up|0|||
125069668|NCT01855945|449873063|FG011|Overall Study|Lost to Follow-up|2|||
125069669|NCT01855945|449873052|FG000|Overall Study|Other - Unclassified|1|||
125069670|NCT01855945|449873053|FG001|Overall Study|Other - Unclassified|1|||
125069671|NCT01855945|449873054|FG002|Overall Study|Other - Unclassified|1|||
125069672|NCT01855945|449873055|FG003|Overall Study|Other - Unclassified|0|||
125069673|NCT01855945|449873056|FG004|Overall Study|Other - Unclassified|0|||
125069674|NCT01855945|449873057|FG005|Overall Study|Other - Unclassified|0|||
125140880|NCT01496118|450139559|FG006|Overall Study|Withdrawal by Subject|6|||
125140881|NCT01496118|450139560|FG007|Overall Study|Withdrawal by Subject|3|||
125140882|NCT02420353|450139561|FG000|Overall Study|Withdrawal by Subject|0|||
125140883|NCT02420353|450139562|FG001|Overall Study|Withdrawal by Subject|1|||
125140884|NCT01149057|450139563|FG000|Overall Study|Lack of Efficacy|16|||
125140885|NCT01149057|450139563|FG000|Overall Study|Adverse Event|13|||
125140886|NCT01149057|450139563|FG000|Overall Study|Withdrawal by Subject|9|||
125140887|NCT01149057|450139563|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
125140888|NCT01149057|450139563|FG000|Overall Study|B Cell Depletion|4|||
125140889|NCT01149057|450139563|FG000|Overall Study|Participant Non-Compliance|2|||
125140890|NCT01149057|450139563|FG000|Overall Study|Lost to Follow-up|1|||
125140891|NCT01149057|450139563|FG000|Overall Study|High Parathyroid Hormone Value|1|||
125140892|NCT01149057|450139563|FG000|Overall Study|Other|6|||
125140893|NCT04608448|450139564|FG000|Overall Study|Withdrawal by Subject|1|||
125140894|NCT04608448|450139564|FG000|Overall Study|Adverse Event|1|||
125140895|NCT00577655|450139565|FG000|Overall Study|Patient Request|0|||
125069675|NCT01855945|449873058|FG006|Overall Study|Other - Unclassified|2|||
125069676|NCT01855945|449873059|FG007|Overall Study|Other - Unclassified|1|||
125069677|NCT01855945|449873060|FG008|Overall Study|Other - Unclassified|0|||
125069678|NCT01855945|449873061|FG009|Overall Study|Other - Unclassified|0|||
125140896|NCT00577655|450139566|FG001|Overall Study|Patient Request|2|||
125140897|NCT00577655|450139565|FG000|Overall Study|Protocol Violation|0|||
125140898|NCT00577655|450139566|FG001|Overall Study|Protocol Violation|1|||
125069679|NCT01855945|449873062|FG010|Overall Study|Other - Unclassified|1|||
125069680|NCT01855945|449873063|FG011|Overall Study|Other - Unclassified|0|||
125069681|NCT01855945|449873052|FG000|Overall Study|Withdrawal by Subject|4|||
125069682|NCT01855945|449873053|FG001|Overall Study|Withdrawal by Subject|0|||
125069683|NCT01855945|449873054|FG002|Overall Study|Withdrawal by Subject|4|||
125069684|NCT01855945|449873055|FG003|Overall Study|Withdrawal by Subject|1|||
125069685|NCT01855945|449873056|FG004|Overall Study|Withdrawal by Subject|1|||
125069686|NCT01855945|449873057|FG005|Overall Study|Withdrawal by Subject|0|||
125069687|NCT01855945|449873058|FG006|Overall Study|Withdrawal by Subject|1|||
125069688|NCT01855945|449873059|FG007|Overall Study|Withdrawal by Subject|0|||
125069689|NCT01855945|449873060|FG008|Overall Study|Withdrawal by Subject|0|||
125069690|NCT01855945|449873061|FG009|Overall Study|Withdrawal by Subject|2|||
125069691|NCT01855945|449873062|FG010|Overall Study|Withdrawal by Subject|4|||
125069692|NCT01855945|449873063|FG011|Overall Study|Withdrawal by Subject|1|||
125069693|NCT01148693|449873064|FG000|Overall Study|Attempts for cannulation were failed|13|||
125069694|NCT01148693|449873065|FG001|Overall Study|Attempts for cannulation were failed|10|||
125069695|NCT03228394|449873066|FG000|Overall Study|Lost to Follow-up|0|||
125069696|NCT03228394|449873067|FG001|Overall Study|Lost to Follow-up|0|||
125069697|NCT03228394|449873068|FG002|Overall Study|Lost to Follow-up|1|||
125069698|NCT03228394|449873069|FG003|Overall Study|Lost to Follow-up|1|||
125069699|NCT03228394|449873070|FG004|Overall Study|Lost to Follow-up|0|||
125069700|NCT03228394|449873071|FG005|Overall Study|Lost to Follow-up|0|||
125069701|NCT03228394|449873072|FG006|Overall Study|Lost to Follow-up|2|||
125069702|NCT03228394|449873073|FG007|Overall Study|Lost to Follow-up|0|||
125069703|NCT03228394|449873066|FG000|Overall Study|Withdrawal by Subject|0|||
125069704|NCT03228394|449873067|FG001|Overall Study|Withdrawal by Subject|0|||
125069705|NCT03228394|449873068|FG002|Overall Study|Withdrawal by Subject|1|||
125069706|NCT03228394|449873069|FG003|Overall Study|Withdrawal by Subject|0|||
125069707|NCT03228394|449873070|FG004|Overall Study|Withdrawal by Subject|0|||
125069708|NCT03228394|449873071|FG005|Overall Study|Withdrawal by Subject|0|||
125069709|NCT03228394|449873072|FG006|Overall Study|Withdrawal by Subject|1|||
125069710|NCT03228394|449873073|FG007|Overall Study|Withdrawal by Subject|3|||
125069711|NCT03228394|449873066|FG000|Overall Study|Protocol Violation|0|||
125069712|NCT03228394|449873067|FG001|Overall Study|Protocol Violation|0|||
125069713|NCT03228394|449873068|FG002|Overall Study|Protocol Violation|0|||
125069714|NCT03228394|449873069|FG003|Overall Study|Protocol Violation|1|||
125069715|NCT03228394|449873070|FG004|Overall Study|Protocol Violation|0|||
125069716|NCT03228394|449873071|FG005|Overall Study|Protocol Violation|0|||
125069717|NCT03228394|449873072|FG006|Overall Study|Protocol Violation|0|||
125069718|NCT03228394|449873073|FG007|Overall Study|Protocol Violation|0|||
125069719|NCT03228394|449873066|FG000|Overall Study|Physician Decision|0|||
125069720|NCT03228394|449873067|FG001|Overall Study|Physician Decision|0|||
125069721|NCT03228394|449873068|FG002|Overall Study|Physician Decision|0|||
125069722|NCT03228394|449873069|FG003|Overall Study|Physician Decision|0|||
125069723|NCT03228394|449873070|FG004|Overall Study|Physician Decision|0|||
125069724|NCT03228394|449873071|FG005|Overall Study|Physician Decision|0|||
125069725|NCT03228394|449873072|FG006|Overall Study|Physician Decision|1|||
125069726|NCT03228394|449873073|FG007|Overall Study|Physician Decision|0|||
125069727|NCT03228394|449873066|FG000|Overall Study|Noncompliance|0|||
125069728|NCT03228394|449873067|FG001|Overall Study|Noncompliance|0|||
125069729|NCT03228394|449873068|FG002|Overall Study|Noncompliance|0|||
125069730|NCT03228394|449873069|FG003|Overall Study|Noncompliance|0|||
125069731|NCT03228394|449873070|FG004|Overall Study|Noncompliance|0|||
125069732|NCT03228394|449873071|FG005|Overall Study|Noncompliance|0|||
125069733|NCT03228394|449873072|FG006|Overall Study|Noncompliance|1|||
125069734|NCT03228394|449873073|FG007|Overall Study|Noncompliance|0|||
125069735|NCT01162304|449873085|FG000|Overall Study|Beck scale to high|11|||
125069736|NCT00326417|449873088|FG000|Overall Study|Withdrawal by Subject|0|||
125069737|NCT00326417|449873089|FG001|Overall Study|Withdrawal by Subject|0|||
125069738|NCT00326417|449873090|FG002|Overall Study|Withdrawal by Subject|1|||
125069739|NCT00326417|449873091|FG003|Overall Study|Withdrawal by Subject|0|||
125069740|NCT00326417|449873088|FG000|Overall Study|Arm Closed|7|||
125069741|NCT00326417|449873089|FG001|Overall Study|Arm Closed|0|||
125069742|NCT00326417|449873090|FG002|Overall Study|Arm Closed|0|||
125069743|NCT00326417|449873091|FG003|Overall Study|Arm Closed|3|||
125069744|NCT00326417|449873088|FG000|Overall Study|Death|7|||
125069745|NCT00326417|449873089|FG001|Overall Study|Death|0|||
125069746|NCT00326417|449873090|FG002|Overall Study|Death|0|||
125069747|NCT00326417|449873091|FG003|Overall Study|Death|0|||
125069748|NCT00844285|449873092|FG000|Overall Study|Other|0|||
125069749|NCT00844285|449873093|FG001|Overall Study|Other|1|||
125069750|NCT00844285|449873094|FG002|Overall Study|Other|0|||
125069751|NCT00844285|449873092|FG000|Overall Study|Other than specified|95|||
125140899|NCT00577655|450139565|FG000|Overall Study|Lost to Follow-up|1|||
125069752|NCT00844285|449873093|FG001|Overall Study|Other than specified|129|||
125069753|NCT00844285|449873094|FG002|Overall Study|Other than specified|12|||
125069754|NCT00844285|449873092|FG000|Overall Study|Site closure|256|||
125069755|NCT00844285|449873093|FG001|Overall Study|Site closure|450|||
125069756|NCT00844285|449873094|FG002|Overall Study|Site closure|50|||
125069757|NCT00844285|449873092|FG000|Overall Study|Follow-up < 8 years|16|||
125069758|NCT00844285|449873093|FG001|Overall Study|Follow-up < 8 years|23|||
125069759|NCT00844285|449873094|FG002|Overall Study|Follow-up < 8 years|4|||
125069760|NCT00844285|449873092|FG000|Overall Study|Protocol Violation|26|||
125069761|NCT00844285|449873093|FG001|Overall Study|Protocol Violation|28|||
125069762|NCT00844285|449873094|FG002|Overall Study|Protocol Violation|54|||
125069763|NCT00844285|449873092|FG000|Overall Study|Death|22|||
125069764|NCT00844285|449873093|FG001|Overall Study|Death|21|||
125069765|NCT00844285|449873094|FG002|Overall Study|Death|8|||
125069766|NCT00844285|449873092|FG000|Overall Study|Withdrew Consent|344|||
125069767|NCT00844285|449873093|FG001|Overall Study|Withdrew Consent|466|||
125069768|NCT00844285|449873094|FG002|Overall Study|Withdrew Consent|70|||
125069769|NCT00844285|449873092|FG000|Overall Study|Lost to Follow-up|330|||
125069770|NCT00844285|449873093|FG001|Overall Study|Lost to Follow-up|486|||
125069771|NCT00844285|449873094|FG002|Overall Study|Lost to Follow-up|74|||
125069772|NCT00192036|449873095|FG000|Overall Study|Protocol Violation|3|||
125069773|NCT00192036|449873095|FG000|Overall Study|Adverse Event|6|||
125069774|NCT00192036|449873095|FG000|Overall Study|Patient/Physician Perception|1|||
125069775|NCT00192036|449873095|FG000|Overall Study|Objective Tumor Progression|4|||
125069776|NCT00192036|449873095|FG000|Overall Study|Clinical Disease Progression|1|||
125069777|NCT00192036|449873095|FG000|Overall Study|Death|1|||
125140900|NCT00577655|450139566|FG001|Overall Study|Lost to Follow-up|1|||
125140901|NCT00875524|450139567|FG000|Overall Study|Serious adverse event|0|||
125140902|NCT00875524|450139568|FG001|Overall Study|Serious adverse event|1|||
125140903|NCT00875524|450139567|FG000|Overall Study|Protocol Violation|4|||
125140904|NCT00875524|450139568|FG001|Overall Study|Protocol Violation|0|||
125140905|NCT00875524|450139567|FG000|Overall Study|Lost to Follow-up|1|||
125140906|NCT00875524|450139568|FG001|Overall Study|Lost to Follow-up|0|||
125140907|NCT00875524|450139567|FG000|Overall Study|Withdrawal by Subject|3|||
125140908|NCT00875524|450139568|FG001|Overall Study|Withdrawal by Subject|5|||
125140909|NCT01370863|450139569|FG000|Overall Study|Adverse Event|1|||
125140910|NCT01370863|450139570|FG001|Overall Study|Adverse Event|1|||
125140911|NCT01370863|450139569|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
125140912|NCT01370863|450139570|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
125140913|NCT01370863|450139569|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
125140914|NCT01370863|450139570|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
125140915|NCT01143337|450139571|FG000|Overall Study|Adverse Event|3|||
125140916|NCT01143337|450139572|FG001|Overall Study|Adverse Event|9|||
125140917|NCT01143337|450139573|FG002|Overall Study|Adverse Event|5|||
125140918|NCT01143337|450139571|FG000|Overall Study|Lack of Efficacy|6|||
125140919|NCT01143337|450139572|FG001|Overall Study|Lack of Efficacy|2|||
125140920|NCT01143337|450139573|FG002|Overall Study|Lack of Efficacy|1|||
125140921|NCT01143337|450139571|FG000|Overall Study|Protocol Violation|1|||
125140922|NCT01143337|450139572|FG001|Overall Study|Protocol Violation|0|||
125140923|NCT01143337|450139573|FG002|Overall Study|Protocol Violation|0|||
125140924|NCT01143337|450139571|FG000|Overall Study|Withdrawal by Subject|0|||
125140925|NCT01143337|450139572|FG001|Overall Study|Withdrawal by Subject|0|||
125140926|NCT01143337|450139573|FG002|Overall Study|Withdrawal by Subject|1|||
125140927|NCT01143337|450139571|FG000|Overall Study|Other reason|0|||
125140928|NCT01143337|450139572|FG001|Overall Study|Other reason|0|||
125140929|NCT01143337|450139573|FG002|Overall Study|Other reason|5|||
125140930|NCT02761915|450139574|FG000|Overall Study|Death|3|||
125140931|NCT02761915|450139575|FG001|Overall Study|Death|1|||
125069778|NCT00192036|449873095|FG000|Overall Study|Unknown or Not Specified|5|||
125069779|NCT00862654|449873098|FG000|Overall Study|Lack of Efficacy|1|||
125140932|NCT02761915|450139576|FG002|Overall Study|Death|1|||
125069780|NCT00862654|449873099|FG001|Overall Study|Lack of Efficacy|0|||
125069781|NCT00862654|449873100|FG002|Overall Study|Lack of Efficacy|1|||
125069782|NCT00862654|449873101|FG003|Overall Study|Lack of Efficacy|0|||
125069783|NCT00862654|449873098|FG000|Overall Study|Lost to Follow-up|1|||
125069784|NCT00862654|449873099|FG001|Overall Study|Lost to Follow-up|2|||
125069785|NCT00862654|449873100|FG002|Overall Study|Lost to Follow-up|1|||
125069786|NCT00862654|449873101|FG003|Overall Study|Lost to Follow-up|3|||
125069787|NCT00862654|449873098|FG000|Overall Study|Adverse Event|0|||
125069788|NCT00862654|449873099|FG001|Overall Study|Adverse Event|1|||
125069789|NCT00862654|449873100|FG002|Overall Study|Adverse Event|1|||
125069790|NCT00862654|449873101|FG003|Overall Study|Adverse Event|0|||
125069791|NCT00862654|449873098|FG000|Overall Study|Pregnancy|1|||
125069792|NCT00862654|449873099|FG001|Overall Study|Pregnancy|1|||
125069793|NCT00862654|449873100|FG002|Overall Study|Pregnancy|0|||
125069794|NCT00862654|449873101|FG003|Overall Study|Pregnancy|0|||
125069795|NCT00862654|449873098|FG000|Overall Study|Withdrawal by Subject|2|||
125069796|NCT00862654|449873099|FG001|Overall Study|Withdrawal by Subject|2|||
125069797|NCT00862654|449873100|FG002|Overall Study|Withdrawal by Subject|2|||
125069798|NCT00862654|449873101|FG003|Overall Study|Withdrawal by Subject|3|||
125069799|NCT00862654|449873098|FG000|Overall Study|Subject mistake|0|||
125069800|NCT00862654|449873099|FG001|Overall Study|Subject mistake|1|||
125069801|NCT00862654|449873100|FG002|Overall Study|Subject mistake|0|||
125069802|NCT00862654|449873101|FG003|Overall Study|Subject mistake|0|||
125069803|NCT00862654|449873098|FG000|Overall Study|Familly constraint|0|||
125069804|NCT00862654|449873099|FG001|Overall Study|Familly constraint|1|||
125069805|NCT00862654|449873100|FG002|Overall Study|Familly constraint|0|||
125069806|NCT00862654|449873101|FG003|Overall Study|Familly constraint|0|||
125069807|NCT00862654|449873098|FG000|Overall Study|Never used study drugs|1|||
125069808|NCT00862654|449873099|FG001|Overall Study|Never used study drugs|0|||
125069809|NCT00862654|449873100|FG002|Overall Study|Never used study drugs|0|||
125069810|NCT00862654|449873101|FG003|Overall Study|Never used study drugs|0|||
125069811|NCT00862654|449873098|FG000|Overall Study|Included after end of inclusions|0|||
125069812|NCT00862654|449873099|FG001|Overall Study|Included after end of inclusions|0|||
125069813|NCT00862654|449873100|FG002|Overall Study|Included after end of inclusions|1|||
125069814|NCT00862654|449873101|FG003|Overall Study|Included after end of inclusions|0|||
125140933|NCT02761915|450139577|FG003|Overall Study|Death|1|||
125140934|NCT02761915|450139578|FG004|Overall Study|Death|0|||
125140935|NCT02761915|450139579|FG005|Overall Study|Death|1|||
125140936|NCT02761915|450139574|FG000|Overall Study|Withdrawal by Subject|1|||
125140937|NCT02761915|450139575|FG001|Overall Study|Withdrawal by Subject|0|||
125140938|NCT02761915|450139576|FG002|Overall Study|Withdrawal by Subject|0|||
125140939|NCT02761915|450139577|FG003|Overall Study|Withdrawal by Subject|0|||
125140940|NCT02761915|450139578|FG004|Overall Study|Withdrawal by Subject|1|||
125140941|NCT02761915|450139579|FG005|Overall Study|Withdrawal by Subject|2|||
125140942|NCT02761915|450139574|FG000|Overall Study|Disease Progression|0|||
125140943|NCT02761915|450139575|FG001|Overall Study|Disease Progression|0|||
125140944|NCT02761915|450139576|FG002|Overall Study|Disease Progression|0|||
125140945|NCT02761915|450139577|FG003|Overall Study|Disease Progression|2|||
125140946|NCT02761915|450139578|FG004|Overall Study|Disease Progression|2|||
125140947|NCT02761915|450139579|FG005|Overall Study|Disease Progression|2|||
125140948|NCT00819169|450139588|FG000|Overall Study|Withdrawal by Subject|2|||
125140949|NCT00819169|450139589|FG001|Overall Study|Withdrawal by Subject|0|||
125140950|NCT00819169|450139590|FG002|Overall Study|Withdrawal by Subject|0|||
125140951|NCT00819169|450139591|FG003|Overall Study|Withdrawal by Subject|1|||
125140952|NCT00819169|450139592|FG004|Overall Study|Withdrawal by Subject|1|||
125140953|NCT00819169|450139593|FG005|Overall Study|Withdrawal by Subject|1|||
125140954|NCT00819169|450139594|FG006|Overall Study|Withdrawal by Subject|5|||
125140955|NCT00819169|450139595|FG007|Overall Study|Withdrawal by Subject|1|||
125140956|NCT00819169|450139596|FG008|Overall Study|Withdrawal by Subject|4|||
125140957|NCT00819169|450139588|FG000|Overall Study|Lost to Follow-up|0|||
125140958|NCT00819169|450139589|FG001|Overall Study|Lost to Follow-up|2|||
125140959|NCT00819169|450139590|FG002|Overall Study|Lost to Follow-up|0|||
125140960|NCT00819169|450139591|FG003|Overall Study|Lost to Follow-up|1|||
125069815|NCT03219567|449873107|FG000|Overall Study|Withdrawal by Subject|0|||
125069816|NCT03219567|449873108|FG001|Overall Study|Withdrawal by Subject|1|||
125069817|NCT01313208|449873113|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
125069818|NCT01313208|449873114|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
125069819|NCT01313208|449873113|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
125069820|NCT01313208|449873114|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
125069821|NCT01313208|449873113|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
125069822|NCT01313208|449873114|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
125069823|NCT01313208|449873113|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
125069824|NCT01313208|449873114|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
125140961|NCT00819169|450139592|FG004|Overall Study|Lost to Follow-up|0|||
125069825|NCT01313208|449873113|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
125069826|NCT01313208|449873114|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
125069827|NCT01313208|449873113|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
125069828|NCT01313208|449873114|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
125069829|NCT01313208|449873113|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
125069830|NCT01313208|449873114|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
125069831|NCT01313208|449873113|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
125069832|NCT01313208|449873114|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
125069833|NCT01313208|449873113|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
125069834|NCT01313208|449873114|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
125069835|NCT01654523|449873115|FG000|Overall Study|Withdrawal by Subject|1|||
125069836|NCT04377672|449873117|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
125069837|NCT03954444|449873118|FG000|Overall Study|Withdrawal by Subject|5|||
125069838|NCT03954444|449873119|FG001|Overall Study|Withdrawal by Subject|5|||
125069839|NCT03954444|449873120|FG002|Overall Study|Withdrawal by Subject|5|||
125069840|NCT03954444|449873118|FG000|Overall Study|Adverse Event|1|||
125069841|NCT03954444|449873119|FG001|Overall Study|Adverse Event|3|||
125069842|NCT03954444|449873120|FG002|Overall Study|Adverse Event|2|||
125069843|NCT03954444|449873118|FG000|Overall Study|Protocol Violation|0|||
125069844|NCT03954444|449873119|FG001|Overall Study|Protocol Violation|3|||
125069845|NCT03954444|449873120|FG002|Overall Study|Protocol Violation|5|||
125069846|NCT03954444|449873118|FG000|Overall Study|Use of prohibited therapy|1|||
125069847|NCT03954444|449873119|FG001|Overall Study|Use of prohibited therapy|1|||
125069848|NCT03954444|449873120|FG002|Overall Study|Use of prohibited therapy|2|||
125069849|NCT03954444|449873118|FG000|Overall Study|Lost to Follow-up|1|||
125069850|NCT03954444|449873119|FG001|Overall Study|Lost to Follow-up|0|||
125069851|NCT03954444|449873120|FG002|Overall Study|Lost to Follow-up|1|||
125069852|NCT03954444|449873118|FG000|Overall Study|Non-compliant with study drug application|2|||
125069853|NCT03954444|449873119|FG001|Overall Study|Non-compliant with study drug application|2|||
125069854|NCT03954444|449873120|FG002|Overall Study|Non-compliant with study drug application|0|||
125069855|NCT03954444|449873118|FG000|Overall Study|Administrative reasons|0|||
125140962|NCT00819169|450139593|FG005|Overall Study|Lost to Follow-up|6|||
125140963|NCT00819169|450139594|FG006|Overall Study|Lost to Follow-up|2|||
125140964|NCT00819169|450139595|FG007|Overall Study|Lost to Follow-up|2|||
125140965|NCT00819169|450139596|FG008|Overall Study|Lost to Follow-up|1|||
125140966|NCT00819169|450139588|FG000|Overall Study|Death|1|||
125140967|NCT00819169|450139589|FG001|Overall Study|Death|1|||
125140968|NCT00819169|450139590|FG002|Overall Study|Death|3|||
125140969|NCT00819169|450139591|FG003|Overall Study|Death|8|||
125140970|NCT00819169|450139592|FG004|Overall Study|Death|5|||
125140971|NCT00819169|450139593|FG005|Overall Study|Death|7|||
125140972|NCT00819169|450139594|FG006|Overall Study|Death|9|||
125140973|NCT00819169|450139595|FG007|Overall Study|Death|4|||
125140974|NCT00819169|450139596|FG008|Overall Study|Death|7|||
125140975|NCT00819169|450139588|FG000|Overall Study|Ineligibility determined|0|||
125140976|NCT00819169|450139589|FG001|Overall Study|Ineligibility determined|0|||
125140977|NCT00819169|450139590|FG002|Overall Study|Ineligibility determined|0|||
125069856|NCT03954444|449873119|FG001|Overall Study|Administrative reasons|0|||
125069857|NCT03954444|449873120|FG002|Overall Study|Administrative reasons|1|||
125069858|NCT03954444|449873118|FG000|Overall Study|Miscellaneous|3|||
125069859|NCT03954444|449873119|FG001|Overall Study|Miscellaneous|2|||
125069860|NCT03954444|449873120|FG002|Overall Study|Miscellaneous|1|||
125069861|NCT02447458|449873121|FG000|Overall Study|Other|0|||
125069862|NCT02447458|449873122|FG001|Overall Study|Other|0|||
125069863|NCT02447458|449873123|FG002|Overall Study|Other|1|||
125069864|NCT02447458|449873124|FG003|Overall Study|Other|0|||
125069865|NCT02447458|449873125|FG004|Overall Study|Other|0|||
125069866|NCT02447458|449873126|FG005|Overall Study|Other|0|||
125069867|NCT00405652|449873128|FG000|Overall Study|Adverse Event|4|||
125069868|NCT02133742|449873129|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
125069869|NCT02133742|449873129|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
125069870|NCT02133742|449873129|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
125069871|NCT02133742|449873129|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
125140978|NCT00819169|450139591|FG003|Overall Study|Ineligibility determined|2|||
125140979|NCT00819169|450139592|FG004|Overall Study|Ineligibility determined|0|||
125222899|NCT03316586|450444429|FG000|Overall Study|still on treatment|1|||
125069872|NCT02133742|449873129|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
125069873|NCT00435994|449873130|FG000|Overall Study|Lost to Follow-up|7|||
125069874|NCT00435994|449873131|FG001|Overall Study|Lost to Follow-up|0|||
125069875|NCT00435994|449873132|FG002|Overall Study|Lost to Follow-up|0|||
125069876|NCT02472795|449873136|FG000|Overall Study|Adverse Event|0|||
125069877|NCT02472795|449873137|FG001|Overall Study|Adverse Event|1|||
125069878|NCT02472795|449873138|FG002|Overall Study|Adverse Event|0|||
125069879|NCT02472795|449873139|FG003|Overall Study|Adverse Event|0|||
125069880|NCT02472795|449873140|FG004|Overall Study|Adverse Event|2|||
125069881|NCT02472795|449873136|FG000|Overall Study|Withdrawal by Subject|0|||
125069882|NCT02472795|449873137|FG001|Overall Study|Withdrawal by Subject|0|||
125069883|NCT02472795|449873138|FG002|Overall Study|Withdrawal by Subject|0|||
125140980|NCT00819169|450139593|FG005|Overall Study|Ineligibility determined|0|||
125140981|NCT00819169|450139594|FG006|Overall Study|Ineligibility determined|0|||
125069884|NCT02472795|449873139|FG003|Overall Study|Withdrawal by Subject|0|||
125069885|NCT02472795|449873140|FG004|Overall Study|Withdrawal by Subject|1|||
125069886|NCT05109702|449873141|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
125069887|NCT05109702|449873142|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
125069888|NCT05109702|449873143|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
125069889|NCT05109702|449873141|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
125069890|NCT05109702|449873142|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
125069891|NCT05109702|449873143|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
125069892|NCT05109702|449873141|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
125069893|NCT05109702|449873142|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
125069894|NCT05109702|449873143|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
125069895|NCT05109702|449873141|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
125069896|NCT05109702|449873142|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
125069897|NCT05109702|449873143|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
125140982|NCT00819169|450139595|FG007|Overall Study|Ineligibility determined|0|||
125140983|NCT00819169|450139596|FG008|Overall Study|Ineligibility determined|1|||
125140984|NCT00819169|450139588|FG000|Overall Study|Adverse Event|0|||
125140985|NCT00819169|450139589|FG001|Overall Study|Adverse Event|0|||
125140986|NCT00819169|450139590|FG002|Overall Study|Adverse Event|0|||
125140987|NCT00819169|450139591|FG003|Overall Study|Adverse Event|0|||
125140988|NCT00819169|450139592|FG004|Overall Study|Adverse Event|1|||
125140989|NCT00819169|450139593|FG005|Overall Study|Adverse Event|0|||
125140990|NCT00819169|450139594|FG006|Overall Study|Adverse Event|0|||
125140991|NCT00819169|450139595|FG007|Overall Study|Adverse Event|0|||
125140992|NCT00819169|450139596|FG008|Overall Study|Adverse Event|0|||
125140993|NCT00819169|450139588|FG000|Overall Study|Administrative Decision|0|||
125140994|NCT00819169|450139589|FG001|Overall Study|Administrative Decision|0|||
125140995|NCT00819169|450139590|FG002|Overall Study|Administrative Decision|0|||
125140996|NCT00819169|450139591|FG003|Overall Study|Administrative Decision|0|||
125140997|NCT00819169|450139592|FG004|Overall Study|Administrative Decision|1|||
125140998|NCT00819169|450139593|FG005|Overall Study|Administrative Decision|2|||
125140999|NCT00819169|450139594|FG006|Overall Study|Administrative Decision|0|||
125141000|NCT00819169|450139595|FG007|Overall Study|Administrative Decision|2|||
125141001|NCT00819169|450139596|FG008|Overall Study|Administrative Decision|0|||
125141002|NCT00406393|450139597|FG000|Overall Study|Did not undergo transplantation|2|||
125141003|NCT00406393|450139598|FG001|Overall Study|Did not undergo transplantation|1|||
125141004|NCT03277248|450139601|FG000|Overall Study|Adverse Event|3|||
125141005|NCT03277248|450139602|FG001|Overall Study|Adverse Event|1|||
125141006|NCT03277248|450139601|FG000|Overall Study|Subject Withdrawal of Consent|6|||
125141007|NCT03277248|450139602|FG001|Overall Study|Subject Withdrawal of Consent|23|||
125141008|NCT03277248|450139601|FG000|Overall Study|Investigator/Sponsor Decision|2|||
125141009|NCT03277248|450139602|FG001|Overall Study|Investigator/Sponsor Decision|2|||
125141010|NCT03277248|450139601|FG000|Overall Study|Pregnancy|4|||
125141011|NCT03277248|450139602|FG001|Overall Study|Pregnancy|1|||
125141012|NCT03277248|450139601|FG000|Overall Study|Lost to Follow-up|0|||
125141013|NCT03277248|450139602|FG001|Overall Study|Lost to Follow-up|2|||
125141014|NCT03277248|450139601|FG000|Overall Study|Lack of Efficacy|0|||
125141015|NCT03277248|450139602|FG001|Overall Study|Lack of Efficacy|2|||
125141016|NCT03277248|450139601|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
125141017|NCT03277248|450139602|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
125141018|NCT01663896|450139603|FG000|Overall Study|Various reasons|43|||
125141019|NCT00379353|450139607|FG000|Overall Study|Hospitalization|3|||
125141020|NCT00379353|450139608|FG001|Overall Study|Hospitalization|3|||
125141021|NCT00379353|450139607|FG000|Overall Study|Withdrawal by Subject|5|||
125141022|NCT00379353|450139608|FG001|Overall Study|Withdrawal by Subject|2|||
125141023|NCT00379353|450139607|FG000|Overall Study|Death|1|||
125141024|NCT00379353|450139608|FG001|Overall Study|Death|0|||
125141025|NCT00379353|450139607|FG000|Overall Study|Cardiac Tamponade|1|||
125141026|NCT00379353|450139608|FG001|Overall Study|Cardiac Tamponade|0|||
125141027|NCT00379353|450139607|FG000|Overall Study|Non-compliance|1|||
125141028|NCT00379353|450139608|FG001|Overall Study|Non-compliance|0|||
125069898|NCT05109702|449873141|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
125069899|NCT05109702|449873142|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
125069900|NCT05109702|449873143|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
125069901|NCT02322411|449873152|FG000|Overall Study|Lost to Follow-up|4|||
125069902|NCT02322411|449873153|FG001|Overall Study|Lost to Follow-up|7|||
125141029|NCT00379353|450139607|FG000|Overall Study|Conflicting drug treatment|0|||
125141030|NCT00379353|450139608|FG001|Overall Study|Conflicting drug treatment|1|||
125141031|NCT03614728|450139609|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
125141032|NCT03614728|450139610|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
125141033|NCT03614728|450139611|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
125141034|NCT03614728|450139612|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
125141035|NCT03614728|450139609|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
125141036|NCT03614728|450139610|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
125141037|NCT03614728|450139611|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
125069903|NCT02322411|449873152|FG000|Overall Study|Withdrawal by Subject|1|||
125069904|NCT02322411|449873153|FG001|Overall Study|Withdrawal by Subject|0|||
125069905|NCT01392378|449873154|FG000|Infant Series|Adverse Event|0|||
125069906|NCT01392378|449873155|FG001|Infant Series|Adverse Event|0|||
125069907|NCT01392378|449873156|FG002|Infant Series|Adverse Event|0|||
125069908|NCT01392378|449873157|FG003|Infant Series|Adverse Event|1|||
125069909|NCT01392378|449873158|FG004|Infant Series|Adverse Event|0|||
125069910|NCT01392378|449873154|FG000|Infant Series|Lost to Follow-up|0|||
125069911|NCT01392378|449873155|FG001|Infant Series|Lost to Follow-up|0|||
125069912|NCT01392378|449873156|FG002|Infant Series|Lost to Follow-up|0|||
125069913|NCT01392378|449873157|FG003|Infant Series|Lost to Follow-up|1|||
125141038|NCT03614728|450139612|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
125141039|NCT01824576|450139613|FG000|Overall Study|Device deficiency|2|||
125141040|NCT01691612|450139616|FG000|Overall Study|deemed ineligible after 1st visit|6|||
125141041|NCT01691612|450139616|FG000|Overall Study|Adverse Event|1|||
125141042|NCT05315713|450139621|FG000|Overall Study|Death|5|||
125141043|NCT05315713|450139621|FG000|Overall Study|Progressive disease|1|||
125141044|NCT05315713|450139621|FG000|Overall Study|Withdrawal by Subject|1|||
125141045|NCT05315713|450139621|FG000|Overall Study|Study terminated by sponsor|1|||
125141046|NCT00556673|450139622|FG000|Overall Study|Protocol deviation|3|||
125141047|NCT00556673|450139623|FG001|Overall Study|Protocol deviation|2|||
125141048|NCT01131260|450139624|FG000|Overall Study|Randomization error|5|||
125141049|NCT01131260|450139625|FG001|Overall Study|Randomization error|1|||
125141050|NCT01131260|450139624|FG000|Overall Study|Declined to continue participation|8|||
125141051|NCT01131260|450139625|FG001|Overall Study|Declined to continue participation|13|||
125069914|NCT01392378|449873158|FG004|Infant Series|Lost to Follow-up|0|||
125069915|NCT01392378|449873154|FG000|Infant Series|Protocol Violation|0|||
125069916|NCT01392378|449873155|FG001|Infant Series|Protocol Violation|1|||
125069917|NCT01392378|449873156|FG002|Infant Series|Protocol Violation|0|||
125069918|NCT01392378|449873157|FG003|Infant Series|Protocol Violation|0|||
125141052|NCT01131260|450139624|FG000|Overall Study|Physician Decision|22|||
125141053|NCT01131260|450139625|FG001|Overall Study|Physician Decision|24|||
125141054|NCT01131260|450139624|FG000|Overall Study|Technical problems|7|||
125141055|NCT01131260|450139625|FG001|Overall Study|Technical problems|6|||
125141056|NCT01131260|450139624|FG000|Overall Study|Staff error|2|||
125069919|NCT01392378|449873158|FG004|Infant Series|Protocol Violation|0|||
125069920|NCT01392378|449873154|FG000|Infant Series|Withdrawal by Parent|4|||
125069921|NCT01392378|449873155|FG001|Infant Series|Withdrawal by Parent|1|||
125069922|NCT01392378|449873156|FG002|Infant Series|Withdrawal by Parent|0|||
125069923|NCT01392378|449873157|FG003|Infant Series|Withdrawal by Parent|0|||
125069924|NCT01392378|449873158|FG004|Infant Series|Withdrawal by Parent|0|||
125069925|NCT01392378|449873154|FG000|After Infant Series|Lost to Follow-up|0|||
125069926|NCT01392378|449873155|FG001|After Infant Series|Lost to Follow-up|0|||
125069927|NCT01392378|449873156|FG002|After Infant Series|Lost to Follow-up|1|||
125069928|NCT01392378|449873157|FG003|After Infant Series|Lost to Follow-up|0|||
125069929|NCT01392378|449873158|FG004|After Infant Series|Lost to Follow-up|0|||
125069930|NCT01392378|449873154|FG000|After Infant Series|Withdrawal by Parent|0|||
125069931|NCT01392378|449873155|FG001|After Infant Series|Withdrawal by Parent|1|||
125069932|NCT01392378|449873156|FG002|After Infant Series|Withdrawal by Parent|1|||
125069933|NCT01392378|449873157|FG003|After Infant Series|Withdrawal by Parent|0|||
125069934|NCT01392378|449873158|FG004|After Infant Series|Withdrawal by Parent|1|||
125069935|NCT01392378|449873154|FG000|Toddler Dose|Lost to Follow-up|0|||
125069936|NCT01392378|449873155|FG001|Toddler Dose|Lost to Follow-up|0|||
125069937|NCT01392378|449873156|FG002|Toddler Dose|Lost to Follow-up|0|||
125069938|NCT01392378|449873157|FG003|Toddler Dose|Lost to Follow-up|1|||
125069939|NCT01392378|449873158|FG004|Toddler Dose|Lost to Follow-up|0|||
125069940|NCT01392378|449873154|FG000|Toddler Dose|Withdrawal by Parent|0|||
125069941|NCT01392378|449873155|FG001|Toddler Dose|Withdrawal by Parent|1|||
125069942|NCT01392378|449873156|FG002|Toddler Dose|Withdrawal by Parent|0|||
125069943|NCT01392378|449873157|FG003|Toddler Dose|Withdrawal by Parent|1|||
125069944|NCT01392378|449873158|FG004|Toddler Dose|Withdrawal by Parent|1|||
125069945|NCT02261883|449873160|FG000|Overall Study|Death|3|||
125069946|NCT02261883|449873161|FG001|Overall Study|Death|2|||
125069947|NCT02261883|449873160|FG000|Overall Study|Physician Decision|1|||
125069948|NCT02261883|449873161|FG001|Overall Study|Physician Decision|0|||
125069949|NCT02261883|449873160|FG000|Overall Study|Protocol Violation|1|||
125069950|NCT02261883|449873161|FG001|Overall Study|Protocol Violation|0|||
125069951|NCT02261883|449873160|FG000|Overall Study|Withdrawal by Subject|0|||
125069952|NCT02261883|449873161|FG001|Overall Study|Withdrawal by Subject|1|||
125069953|NCT02261883|449873160|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
125069954|NCT02261883|449873161|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
125069955|NCT03549117|449873166|FG000|Overall Study|Withdrawal by Subject|1|||
125069956|NCT03549117|449873167|FG001|Overall Study|Withdrawal by Subject|0|||
125069957|NCT00367432|449873168|FG000|First Period (16 Weeks)|Adverse Event|6|||
125069958|NCT00367432|449873169|FG001|First Period (16 Weeks)|Adverse Event|0|||
125069959|NCT00367432|449873168|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
125069960|NCT00367432|449873169|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
125069961|NCT00367432|449873168|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
125069962|NCT00367432|449873169|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
125069963|NCT00367432|449873168|FG000|First Period (16 Weeks)|Other Reason|2|||
125069964|NCT00367432|449873169|FG001|First Period (16 Weeks)|Other Reason|0|||
125069965|NCT00367432|449873168|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
125069966|NCT00367432|449873169|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
125069967|NCT00367432|449873168|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
125069968|NCT00367432|449873169|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
125069969|NCT00367432|449873168|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
125069970|NCT00367432|449873169|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
125069971|NCT00367432|449873168|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
125069972|NCT00367432|449873169|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
125069973|NCT00367432|449873168|FG000|Second Period (up to 54 Months)|Other Reason|6|||
125069974|NCT00367432|449873169|FG001|Second Period (up to 54 Months)|Other Reason|2|||
125069975|NCT00903370|449873170|FG000|Overall Study|Death|13|||
125069976|NCT00903370|449873171|FG001|Overall Study|Death|10|||
125069977|NCT00903370|449873170|FG000|Overall Study|Withdrawal by Subject|9|||
125069978|NCT00903370|449873171|FG001|Overall Study|Withdrawal by Subject|6|||
125069979|NCT00903370|449873170|FG000|Overall Study|Lost to Follow-up|6|||
125069980|NCT00903370|449873171|FG001|Overall Study|Lost to Follow-up|8|||
125069981|NCT00014911|449873172|FG000|Overall Study|Adverse Event|1|||
125069982|NCT00014911|449873172|FG000|Overall Study|Lost to Follow-up|1|||
125069983|NCT00014911|449873172|FG000|Overall Study|Withdrawal by Subject|6|||
125069984|NCT00014911|449873172|FG000|Overall Study|Unknown Reasons|2|||
125069985|NCT00014911|449873172|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
125069986|NCT01924299|449873173|FG000|Period 2|Withdrawal by Subject|1|||
125069987|NCT01924299|449873174|FG001|Period 2|Withdrawal by Subject|0|||
125069988|NCT01924299|449873173|FG000|Period 2|Adverse Event|0|||
125069989|NCT01924299|449873174|FG001|Period 2|Adverse Event|1|||
125069990|NCT01999946|449873179|FG000|Overall Study|Participant not released from jail|2|||
125069991|NCT01999946|449873180|FG001|Overall Study|Participant not released from jail|2|||
125069992|NCT01999946|449873181|FG002|Overall Study|Participant not released from jail|0|||
125069993|NCT01999946|449873179|FG000|Overall Study|Not included in primary outcome analysis|0|||
125069994|NCT01999946|449873180|FG001|Overall Study|Not included in primary outcome analysis|0|||
125069995|NCT01999946|449873181|FG002|Overall Study|Not included in primary outcome analysis|79|||
125069996|NCT04021706|449875338|FG000|Overall Study|Adverse Event|2|||
125069997|NCT04021706|449875339|FG001|Overall Study|Adverse Event|0|||
125069998|NCT04021706|449875338|FG000|Overall Study|Withdrawal by Subject|1|||
125069999|NCT04021706|449875339|FG001|Overall Study|Withdrawal by Subject|2|||
125070000|NCT04021706|449875338|FG000|Overall Study|Physician Decision|1|||
125070001|NCT04021706|449875339|FG001|Overall Study|Physician Decision|0|||
125070002|NCT00355134|449875342|FG000|Core Phase|Withdrawal by Subject|35|||
125070003|NCT00355134|449875343|FG001|Core Phase|Withdrawal by Subject|24|||
125070004|NCT00355134|449875344|FG002|Core Phase|Withdrawal by Subject|35|||
125070005|NCT00355134|449875345|FG003|Core Phase|Withdrawal by Subject|0|||
125070006|NCT00355134|449875346|FG004|Core Phase|Withdrawal by Subject|0|||
125070007|NCT00355134|449875342|FG000|Core Phase|Adverse Event|28|||
125070008|NCT00355134|449875343|FG001|Core Phase|Adverse Event|22|||
125070009|NCT00355134|449875344|FG002|Core Phase|Adverse Event|16|||
125141057|NCT01131260|450139625|FG001|Overall Study|Staff error|1|||
125141058|NCT01131260|450139624|FG000|Overall Study|Ineligible|0|||
125141059|NCT01131260|450139625|FG001|Overall Study|Ineligible|2|||
125141060|NCT00835081|450139628|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
125141061|NCT00835081|450139629|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
125141062|NCT00421304|450139630|FG000|Overall Study|Lost to Follow-up|5|||
125141063|NCT00421304|450139631|FG001|Overall Study|Lost to Follow-up|2|||
125141064|NCT00421304|450139632|FG002|Overall Study|Lost to Follow-up|5|||
125141065|NCT00421304|450139630|FG000|Overall Study|Withdrawal by Subject|2|||
125141066|NCT00421304|450139631|FG001|Overall Study|Withdrawal by Subject|2|||
125141067|NCT00421304|450139632|FG002|Overall Study|Withdrawal by Subject|2|||
125141068|NCT00421304|450139630|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
125141069|NCT00421304|450139631|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
125141070|NCT00421304|450139632|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
125141071|NCT00421304|450139630|FG000|Overall Study|Did not attend Day 360 visit|0|||
125141072|NCT00421304|450139631|FG001|Overall Study|Did not attend Day 360 visit|0|||
125141073|NCT00421304|450139632|FG002|Overall Study|Did not attend Day 360 visit|1|||
125141074|NCT03196284|450139633|FG000|Main Part|Withdrawal by Subject|0|||
125141075|NCT03196284|450139634|FG001|Main Part|Withdrawal by Subject|1|||
125141076|NCT03196284|450139635|FG002|Main Part|Withdrawal by Subject|0|||
125141077|NCT03196284|450139633|FG000|Extension Part|Lack of Efficacy|0|||
125141078|NCT03196284|450139634|FG001|Extension Part|Lack of Efficacy|0|||
125141079|NCT03196284|450139635|FG002|Extension Part|Lack of Efficacy|1|||
125141080|NCT03196284|450139633|FG000|Extension Part|Withdrawal by Subject|0|||
125141081|NCT03196284|450139634|FG001|Extension Part|Withdrawal by Subject|0|||
125141082|NCT03196284|450139635|FG002|Extension Part|Withdrawal by Subject|1|||
125141083|NCT03196284|450139633|FG000|Extension Part|Physician Decision|0|||
125141084|NCT03196284|450139634|FG001|Extension Part|Physician Decision|0|||
125141085|NCT03196284|450139635|FG002|Extension Part|Physician Decision|1|||
125141086|NCT02535923|450139640|FG000|Overall Study|Lost to Follow-up|5|||
125141087|NCT02535923|450139641|FG001|Overall Study|Lost to Follow-up|5|||
125141088|NCT02535923|450139640|FG000|Overall Study|Withdrawal by Subject|4|||
125141089|NCT02535923|450139641|FG001|Overall Study|Withdrawal by Subject|3|||
125141090|NCT01018862|450139642|FG000|Overall Study|Adverse Event|2|||
125141091|NCT01018862|450139643|FG001|Overall Study|Adverse Event|0|||
125141092|NCT01018862|450139644|FG002|Overall Study|Adverse Event|6|||
125141093|NCT01018862|450139642|FG000|Overall Study|Lack of Efficacy|1|||
125141094|NCT01018862|450139643|FG001|Overall Study|Lack of Efficacy|0|||
125141095|NCT01018862|450139644|FG002|Overall Study|Lack of Efficacy|2|||
125070010|NCT00355134|449875345|FG003|Core Phase|Adverse Event|0|||
125070011|NCT00355134|449875346|FG004|Core Phase|Adverse Event|0|||
125070012|NCT00355134|449875342|FG000|Core Phase|Lost to Follow-up|17|||
125070013|NCT00355134|449875343|FG001|Core Phase|Lost to Follow-up|13|||
125070014|NCT00355134|449875344|FG002|Core Phase|Lost to Follow-up|21|||
125141096|NCT01018862|450139642|FG000|Overall Study|Lost to Follow-up|3|||
125141097|NCT01018862|450139643|FG001|Overall Study|Lost to Follow-up|1|||
125141098|NCT01018862|450139644|FG002|Overall Study|Lost to Follow-up|0|||
125141099|NCT01018862|450139642|FG000|Overall Study|Protocol Violation|1|||
125141100|NCT01018862|450139643|FG001|Overall Study|Protocol Violation|3|||
125141101|NCT01018862|450139644|FG002|Overall Study|Protocol Violation|3|||
125141102|NCT01018862|450139642|FG000|Overall Study|Withdrawal by Subject|1|||
125141103|NCT01018862|450139643|FG001|Overall Study|Withdrawal by Subject|2|||
125141104|NCT01018862|450139644|FG002|Overall Study|Withdrawal by Subject|1|||
125070015|NCT00355134|449875345|FG003|Core Phase|Lost to Follow-up|0|||
125070016|NCT00355134|449875346|FG004|Core Phase|Lost to Follow-up|0|||
125070017|NCT00355134|449875342|FG000|Core Phase|Abnormal laboratory value(s)|19|||
125070018|NCT00355134|449875343|FG001|Core Phase|Abnormal laboratory value(s)|14|||
125070019|NCT00355134|449875344|FG002|Core Phase|Abnormal laboratory value(s)|2|||
125070020|NCT00355134|449875345|FG003|Core Phase|Abnormal laboratory value(s)|0|||
125070021|NCT00355134|449875346|FG004|Core Phase|Abnormal laboratory value(s)|0|||
125070022|NCT00355134|449875342|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
125070023|NCT00355134|449875343|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
125070024|NCT00355134|449875344|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
125070025|NCT00355134|449875345|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
125070026|NCT00355134|449875346|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
125070027|NCT00355134|449875342|FG000|Core Phase|Administrative problems|5|||
125070028|NCT00355134|449875343|FG001|Core Phase|Administrative problems|3|||
125070029|NCT00355134|449875344|FG002|Core Phase|Administrative problems|5|||
125070030|NCT00355134|449875345|FG003|Core Phase|Administrative problems|0|||
125141105|NCT01018862|450139642|FG000|Overall Study|administrative problems|5|||
125141106|NCT01018862|450139643|FG001|Overall Study|administrative problems|4|||
125141107|NCT01018862|450139644|FG002|Overall Study|administrative problems|4|||
125141108|NCT01968031|450139647|FG000|Overall Study|Adverse Event|13|||
125141109|NCT01968031|450139648|FG001|Overall Study|Adverse Event|10|||
125141110|NCT01968031|450139649|FG002|Overall Study|Adverse Event|22|||
125141111|NCT01968031|450139647|FG000|Overall Study|Withdrawal by Subject|3|||
125141112|NCT01968031|450139648|FG001|Overall Study|Withdrawal by Subject|7|||
125141113|NCT01968031|450139649|FG002|Overall Study|Withdrawal by Subject|3|||
125141114|NCT01968031|450139647|FG000|Overall Study|Did not meet entry criteria|1|||
125141115|NCT01968031|450139648|FG001|Overall Study|Did not meet entry criteria|1|||
125222900|NCT03316586|450444429|FG000|Overall Study|Patient needed radiation therapy|1|||
125222901|NCT03316586|450444429|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
125070031|NCT00355134|449875346|FG004|Core Phase|Administrative problems|0|||
125070032|NCT00355134|449875342|FG000|Core Phase|Protocol Violation|3|||
125070033|NCT00355134|449875343|FG001|Core Phase|Protocol Violation|2|||
125070034|NCT00355134|449875344|FG002|Core Phase|Protocol Violation|2|||
125070035|NCT00355134|449875345|FG003|Core Phase|Protocol Violation|0|||
125070036|NCT00355134|449875346|FG004|Core Phase|Protocol Violation|0|||
125070037|NCT00355134|449875342|FG000|Core Phase|Abnormal test procedure result(s)|1|||
125070038|NCT00355134|449875343|FG001|Core Phase|Abnormal test procedure result(s)|2|||
125070039|NCT00355134|449875344|FG002|Core Phase|Abnormal test procedure result(s)|1|||
125070040|NCT00355134|449875345|FG003|Core Phase|Abnormal test procedure result(s)|0|||
125070041|NCT00355134|449875346|FG004|Core Phase|Abnormal test procedure result(s)|0|||
125070042|NCT00355134|449875342|FG000|Core Phase|Condition no longer requires study drug|1|||
125070043|NCT00355134|449875343|FG001|Core Phase|Condition no longer requires study drug|0|||
125070044|NCT00355134|449875344|FG002|Core Phase|Condition no longer requires study drug|1|||
125070045|NCT00355134|449875345|FG003|Core Phase|Condition no longer requires study drug|0|||
125070046|NCT00355134|449875346|FG004|Core Phase|Condition no longer requires study drug|0|||
125070047|NCT00355134|449875342|FG000|Extension Phase|Withdrawal by Subject|7|||
125070048|NCT00355134|449875343|FG001|Extension Phase|Withdrawal by Subject|11|||
125070049|NCT00355134|449875344|FG002|Extension Phase|Withdrawal by Subject|0|||
125141116|NCT01968031|450139649|FG002|Overall Study|Did not meet entry criteria|1|||
125141117|NCT01968031|450139647|FG000|Overall Study|Noncompliance|0|||
125141118|NCT01968031|450139648|FG001|Overall Study|Noncompliance|0|||
125222902|NCT01396083|450444430|FG000|Overall Study|Adverse Event|2|||
125222903|NCT01396083|450444431|FG001|Overall Study|Adverse Event|28|||
125222904|NCT01396083|450444430|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125070050|NCT00355134|449875345|FG003|Extension Phase|Withdrawal by Subject|7|||
125070051|NCT00355134|449875346|FG004|Extension Phase|Withdrawal by Subject|5|||
125070052|NCT00355134|449875342|FG000|Extension Phase|Adverse Event|13|||
125070053|NCT00355134|449875343|FG001|Extension Phase|Adverse Event|9|||
125070054|NCT00355134|449875344|FG002|Extension Phase|Adverse Event|0|||
125070055|NCT00355134|449875345|FG003|Extension Phase|Adverse Event|3|||
125070056|NCT00355134|449875346|FG004|Extension Phase|Adverse Event|5|||
125070057|NCT00355134|449875342|FG000|Extension Phase|Lost to Follow-up|2|||
125070058|NCT00355134|449875343|FG001|Extension Phase|Lost to Follow-up|6|||
125141119|NCT01968031|450139649|FG002|Overall Study|Noncompliance|2|||
125141120|NCT01968031|450139647|FG000|Overall Study|Failed inclusion criteria|0|||
125141121|NCT01968031|450139648|FG001|Overall Study|Failed inclusion criteria|2|||
125141122|NCT01968031|450139649|FG002|Overall Study|Failed inclusion criteria|0|||
125141123|NCT01968031|450139647|FG000|Overall Study|Death|0|||
125070059|NCT00355134|449875344|FG002|Extension Phase|Lost to Follow-up|0|||
125070060|NCT00355134|449875345|FG003|Extension Phase|Lost to Follow-up|2|||
125070061|NCT00355134|449875346|FG004|Extension Phase|Lost to Follow-up|4|||
125070062|NCT00355134|449875342|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
125070063|NCT00355134|449875343|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
125070064|NCT00355134|449875344|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
125070065|NCT00355134|449875345|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
125070066|NCT00355134|449875346|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
125070067|NCT00355134|449875342|FG000|Extension Phase|Administrative problems|2|||
125070068|NCT00355134|449875343|FG001|Extension Phase|Administrative problems|4|||
125070069|NCT00355134|449875344|FG002|Extension Phase|Administrative problems|0|||
125070070|NCT00355134|449875345|FG003|Extension Phase|Administrative problems|1|||
125070071|NCT00355134|449875346|FG004|Extension Phase|Administrative problems|1|||
125070072|NCT00355134|449875342|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
125070073|NCT00355134|449875343|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
125070074|NCT00355134|449875344|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
125070075|NCT00355134|449875345|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
125070076|NCT00355134|449875346|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
125070077|NCT00355134|449875342|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
125070078|NCT00355134|449875343|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
125070079|NCT00355134|449875344|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
125070080|NCT00355134|449875345|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
125070081|NCT00355134|449875346|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
125070082|NCT00355134|449875342|FG000|Extension Phase|Protocol Violation|0|||
125070083|NCT00355134|449875343|FG001|Extension Phase|Protocol Violation|0|||
125070084|NCT00355134|449875344|FG002|Extension Phase|Protocol Violation|0|||
125070085|NCT00355134|449875345|FG003|Extension Phase|Protocol Violation|1|||
125070086|NCT00355134|449875346|FG004|Extension Phase|Protocol Violation|0|||
125070087|NCT01412151|449875347|FG000|Week 0 - 306 - Treatment Period|Death|1|||
125070088|NCT01412151|449875347|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
125070089|NCT01412151|449875347|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
125070090|NCT01412151|449875347|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
125070091|NCT03127852|449875349|FG000|Overall Study|Withdrawal by Subject|4|||
125070092|NCT03127852|449875350|FG001|Overall Study|Withdrawal by Subject|1|||
125070093|NCT03127852|449875349|FG000|Overall Study|Death|1|||
125070094|NCT03127852|449875350|FG001|Overall Study|Death|1|||
125070095|NCT00859573|449875352|FG000|Overall Study|Withdrawal by Subject|4|||
125070096|NCT00859573|449875353|FG001|Overall Study|Withdrawal by Subject|1|||
125070097|NCT00859573|449875352|FG000|Overall Study|Physician Decision|1|||
125070098|NCT00859573|449875353|FG001|Overall Study|Physician Decision|1|||
125070099|NCT01544478|449875354|FG000|Overall Study|Adverse Event|1|||
125070100|NCT01544478|449875354|FG000|Overall Study|Death|1|||
125070101|NCT01544478|449875354|FG000|Overall Study|Lost to Follow-up|48|||
125070102|NCT01544478|449875354|FG000|Overall Study|Physician Decision|15|||
125070103|NCT01544478|449875354|FG000|Overall Study|Pregnancy|1|||
125070104|NCT01544478|449875354|FG000|Overall Study|Withdrawal by Subject|52|||
125141124|NCT01968031|450139648|FG001|Overall Study|Death|0|||
125141125|NCT01968031|450139649|FG002|Overall Study|Death|1|||
125141126|NCT01968031|450139647|FG000|Overall Study|Prohibited concomitant medication|1|||
125141127|NCT01968031|450139648|FG001|Overall Study|Prohibited concomitant medication|0|||
125141128|NCT01968031|450139649|FG002|Overall Study|Prohibited concomitant medication|0|||
125141129|NCT00840879|450139653|FG000|Second Intervention|Withdrawal by Subject|1|||
125141130|NCT00840879|450139654|FG001|Second Intervention|Withdrawal by Subject|0|||
125141131|NCT01109849|450140856|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
125141132|NCT01109849|450140857|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
125141133|NCT01109849|450140858|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
125141134|NCT01109849|450140859|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
125141135|NCT01109849|450140860|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
125070105|NCT02574481|449875355|FG000|Overall Study|Withdrawal by Subject|29|||
125070106|NCT02574481|449875356|FG001|Overall Study|Withdrawal by Subject|15|||
125070107|NCT02574481|449875357|FG002|Overall Study|Withdrawal by Subject|4|||
125070108|NCT02574481|449875358|FG003|Overall Study|Withdrawal by Subject|1|||
125070109|NCT02574481|449875355|FG000|Overall Study|Adverse Event|5|||
125141136|NCT01109849|450140856|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
125141137|NCT01109849|450140857|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
125141138|NCT01109849|450140858|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
125141139|NCT01109849|450140859|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
125141140|NCT01109849|450140860|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
125141141|NCT01109849|450140856|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
125141142|NCT01109849|450140857|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
125141143|NCT01109849|450140858|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
125141144|NCT01109849|450140859|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
125070110|NCT02574481|449875356|FG001|Overall Study|Adverse Event|1|||
125070111|NCT02574481|449875357|FG002|Overall Study|Adverse Event|1|||
125070112|NCT02574481|449875358|FG003|Overall Study|Adverse Event|0|||
125070113|NCT02574481|449875355|FG000|Overall Study|Visit Missed|15|||
125070114|NCT02574481|449875356|FG001|Overall Study|Visit Missed|7|||
125070115|NCT02574481|449875357|FG002|Overall Study|Visit Missed|5|||
125070116|NCT02574481|449875358|FG003|Overall Study|Visit Missed|0|||
125070117|NCT02574481|449875355|FG000|Overall Study|Other|7|||
125070118|NCT02574481|449875356|FG001|Overall Study|Other|2|||
125070119|NCT02574481|449875357|FG002|Overall Study|Other|0|||
125070120|NCT02574481|449875358|FG003|Overall Study|Other|0|||
125070121|NCT02574481|449875355|FG000|Overall Study|Death|48|||
125070122|NCT02574481|449875356|FG001|Overall Study|Death|26|||
125070123|NCT02574481|449875357|FG002|Overall Study|Death|12|||
125070124|NCT02574481|449875358|FG003|Overall Study|Death|4|||
125070125|NCT02574481|449875355|FG000|Overall Study|Physician Decision|5|||
125070126|NCT02574481|449875356|FG001|Overall Study|Physician Decision|2|||
125070127|NCT02574481|449875357|FG002|Overall Study|Physician Decision|0|||
125070128|NCT02574481|449875358|FG003|Overall Study|Physician Decision|0|||
125070129|NCT02574481|449875355|FG000|Overall Study|Lost to Follow-up|5|||
125070130|NCT02574481|449875356|FG001|Overall Study|Lost to Follow-up|1|||
125070131|NCT02574481|449875357|FG002|Overall Study|Lost to Follow-up|3|||
125070132|NCT02574481|449875358|FG003|Overall Study|Lost to Follow-up|0|||
125070133|NCT04134728|449875362|FG000|Overall Study|Adverse Event|3|||
125070134|NCT04134728|449875363|FG001|Overall Study|Adverse Event|2|||
125070135|NCT04134728|449875364|FG002|Overall Study|Adverse Event|9|||
125070136|NCT04134728|449875365|FG003|Overall Study|Adverse Event|0|||
125070137|NCT04134728|449875366|FG004|Overall Study|Adverse Event|0|||
125070138|NCT04134728|449875367|FG005|Overall Study|Adverse Event|0|||
125070139|NCT04134728|449875362|FG000|Overall Study|Lack of Efficacy|3|||
125070140|NCT04134728|449875363|FG001|Overall Study|Lack of Efficacy|3|||
125070141|NCT04134728|449875364|FG002|Overall Study|Lack of Efficacy|1|||
125070142|NCT04134728|449875365|FG003|Overall Study|Lack of Efficacy|2|||
125070143|NCT04134728|449875366|FG004|Overall Study|Lack of Efficacy|0|||
125070144|NCT04134728|449875367|FG005|Overall Study|Lack of Efficacy|0|||
125070145|NCT04134728|449875362|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
125070146|NCT04134728|449875363|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125070147|NCT04134728|449875364|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
125070148|NCT04134728|449875365|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125070149|NCT04134728|449875366|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125070150|NCT04134728|449875367|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125070151|NCT04134728|449875362|FG000|Overall Study|Protocol Deviation|0|||
125070152|NCT04134728|449875363|FG001|Overall Study|Protocol Deviation|0|||
125070153|NCT04134728|449875364|FG002|Overall Study|Protocol Deviation|1|||
125070154|NCT04134728|449875365|FG003|Overall Study|Protocol Deviation|0|||
125070155|NCT04134728|449875366|FG004|Overall Study|Protocol Deviation|0|||
125070156|NCT04134728|449875367|FG005|Overall Study|Protocol Deviation|0|||
125070157|NCT04134728|449875362|FG000|Overall Study|Informed Consent Withdrawn|3|||
125070158|NCT04134728|449875363|FG001|Overall Study|Informed Consent Withdrawn|6|||
125070159|NCT04134728|449875364|FG002|Overall Study|Informed Consent Withdrawn|8|||
125070160|NCT04134728|449875365|FG003|Overall Study|Informed Consent Withdrawn|1|||
125070161|NCT04134728|449875366|FG004|Overall Study|Informed Consent Withdrawn|1|||
125070162|NCT04134728|449875367|FG005|Overall Study|Informed Consent Withdrawn|0|||
125070163|NCT04134728|449875362|FG000|Overall Study|Physician Decision|2|||
125070164|NCT04134728|449875363|FG001|Overall Study|Physician Decision|0|||
125070165|NCT04134728|449875364|FG002|Overall Study|Physician Decision|0|||
125070166|NCT04134728|449875365|FG003|Overall Study|Physician Decision|0|||
125070167|NCT04134728|449875366|FG004|Overall Study|Physician Decision|0|||
125141145|NCT01109849|450140860|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
125141146|NCT01109849|450140856|FG000|Initial Randomization: ADHD Treatment|move away|2|||
125141147|NCT01109849|450140857|FG001|Initial Randomization: ADHD Treatment|move away|7|||
125141148|NCT01109849|450140858|FG002|Initial Randomization: ADHD Treatment|move away|0|||
125141149|NCT01109849|450140859|FG003|Initial Randomization: ADHD Treatment|move away|0|||
125141150|NCT01109849|450140860|FG004|Initial Randomization: ADHD Treatment|move away|0|||
125070168|NCT04134728|449875367|FG005|Overall Study|Physician Decision|0|||
125070169|NCT04134728|449875362|FG000|Overall Study|Lost to Follow-up|1|||
125070170|NCT04134728|449875363|FG001|Overall Study|Lost to Follow-up|2|||
125070171|NCT04134728|449875364|FG002|Overall Study|Lost to Follow-up|1|||
125070172|NCT04134728|449875365|FG003|Overall Study|Lost to Follow-up|0|||
125070173|NCT04134728|449875366|FG004|Overall Study|Lost to Follow-up|0|||
125070174|NCT04134728|449875367|FG005|Overall Study|Lost to Follow-up|1|||
125070175|NCT04134728|449875362|FG000|Overall Study|Investigator Site Closed|0|||
125070176|NCT04134728|449875363|FG001|Overall Study|Investigator Site Closed|1|||
125070177|NCT04134728|449875364|FG002|Overall Study|Investigator Site Closed|1|||
125070178|NCT04134728|449875365|FG003|Overall Study|Investigator Site Closed|0|||
125070179|NCT04134728|449875366|FG004|Overall Study|Investigator Site Closed|0|||
125141151|NCT01109849|450140856|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
125070180|NCT04134728|449875367|FG005|Overall Study|Investigator Site Closed|0|||
125070181|NCT03382262|449875368|FG000|Overall Study|Physician Decision|0|||
125070182|NCT03382262|449875369|FG001|Overall Study|Physician Decision|0|||
125141152|NCT01109849|450140857|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
125141153|NCT01109849|450140858|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
125141154|NCT01109849|450140859|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
125141155|NCT01109849|450140860|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
125141156|NCT01109849|450140856|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
125141157|NCT01109849|450140857|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
125141158|NCT01109849|450140858|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
125141159|NCT01109849|450140859|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
125070183|NCT03382262|449875370|FG002|Overall Study|Physician Decision|1|||
125070184|NCT03382262|449875371|FG003|Overall Study|Physician Decision|0|||
125070185|NCT03382262|449875368|FG000|Overall Study|Withdrawal by Subject|0|||
125070186|NCT03382262|449875369|FG001|Overall Study|Withdrawal by Subject|0|||
125070187|NCT03382262|449875370|FG002|Overall Study|Withdrawal by Subject|0|||
125070188|NCT03382262|449875371|FG003|Overall Study|Withdrawal by Subject|1|||
125070189|NCT02038790|449875373|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
125070190|NCT02038790|449875374|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
125070191|NCT00438464|449875382|FG000|Overall Study|Terminated Early|14|||
125070192|NCT00438464|449875383|FG001|Overall Study|Terminated Early|5|||
125070193|NCT00438464|449875382|FG000|Overall Study|Incomplete data submission|0|||
125070194|NCT00438464|449875383|FG001|Overall Study|Incomplete data submission|2|||
125070195|NCT03943446|449875385|FG000|Overall Study|Lost to Follow-up|0|||
125070196|NCT03943446|449875386|FG001|Overall Study|Lost to Follow-up|0|||
125070197|NCT03943446|449875387|FG002|Overall Study|Lost to Follow-up|1|||
125070198|NCT03943446|449875385|FG000|Overall Study|Withdrawal by Subject|1|||
125070199|NCT03943446|449875386|FG001|Overall Study|Withdrawal by Subject|1|||
125070200|NCT03943446|449875387|FG002|Overall Study|Withdrawal by Subject|2|||
125070201|NCT03943446|449875385|FG000|Overall Study|Study Terminated by Sponsor|1|||
125070202|NCT03943446|449875386|FG001|Overall Study|Study Terminated by Sponsor|2|||
125070203|NCT03943446|449875387|FG002|Overall Study|Study Terminated by Sponsor|1|||
125070204|NCT03943446|449875385|FG000|Overall Study|Reason not Specified|5|||
125070205|NCT03943446|449875386|FG001|Overall Study|Reason not Specified|1|||
125070206|NCT03943446|449875387|FG002|Overall Study|Reason not Specified|3|||
125070207|NCT02905825|449875394|FG000|Overall Study|Protocol Violation|11|||
125070208|NCT02905825|449875394|FG000|Overall Study|Device Malfunction|1|||
125070209|NCT01281189|449875395|FG000|Overall Study|Adverse Event|7|||
125070210|NCT01281189|449875396|FG001|Overall Study|Adverse Event|9|||
125070211|NCT01281189|449875395|FG000|Overall Study|Lost to Follow-up|6|||
125070212|NCT01281189|449875396|FG001|Overall Study|Lost to Follow-up|4|||
125070213|NCT01281189|449875395|FG000|Overall Study|Withdrawal by Subject|21|||
125070214|NCT01281189|449875396|FG001|Overall Study|Withdrawal by Subject|24|||
125070215|NCT01281189|449875395|FG000|Overall Study|Physician Decision|2|||
125070216|NCT01281189|449875396|FG001|Overall Study|Physician Decision|3|||
125070217|NCT01281189|449875395|FG000|Overall Study|Death|103|||
125070218|NCT01281189|449875396|FG001|Overall Study|Death|91|||
125070219|NCT01281189|449875395|FG000|Overall Study|Other|8|||
125070220|NCT01281189|449875396|FG001|Overall Study|Other|12|||
125070221|NCT05355818|449875397|FG000|Overall Study|Adverse Event|1|||
125141160|NCT01109849|450140860|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
125141161|NCT00754052|450140867|FG000|Overall Study|Study terminated by Sponsor|5|||
125141162|NCT00754052|450140868|FG001|Overall Study|Study terminated by Sponsor|3|||
125141163|NCT04364854|450140872|FG000|Overall Study|Withdrawal by Subject|1|||
125141164|NCT04364854|450140873|FG001|Overall Study|Withdrawal by Subject|0|||
125141165|NCT04364854|450140874|FG002|Overall Study|Withdrawal by Subject|1|||
125141166|NCT04364854|450140875|FG003|Overall Study|Withdrawal by Subject|3|||
125141167|NCT04364854|450140872|FG000|Overall Study|Death|1|||
125070222|NCT05355818|449875398|FG001|Overall Study|Adverse Event|1|||
125070223|NCT05355818|449875397|FG000|Overall Study|Lack of Efficacy|2|||
125070224|NCT05355818|449875398|FG001|Overall Study|Lack of Efficacy|1|||
125070225|NCT05355818|449875397|FG000|Overall Study|Lost to Follow-up|0|||
125070226|NCT05355818|449875398|FG001|Overall Study|Lost to Follow-up|1|||
125070227|NCT01136746|449875403|FG000|Overall Study|Lost to Follow-up|0|||
125070228|NCT01136746|449875404|FG001|Overall Study|Lost to Follow-up|2|||
125070229|NCT01136746|449875403|FG000|Overall Study|Protocol Violation|2|||
125070230|NCT01136746|449875404|FG001|Overall Study|Protocol Violation|1|||
125070231|NCT01136746|449875403|FG000|Overall Study|Death|1|||
125070232|NCT01136746|449875404|FG001|Overall Study|Death|0|||
125070233|NCT00092677|449875409|FG000|Overall Study|Lost to Follow-up|0|||
125070234|NCT00092677|449875410|FG001|Overall Study|Lost to Follow-up|2|||
125141168|NCT04364854|450140873|FG001|Overall Study|Death|0|||
125070235|NCT00092677|449875409|FG000|Overall Study|Adminstrative|5|||
125070236|NCT00092677|449875410|FG001|Overall Study|Adminstrative|9|||
125070237|NCT01601704|449875411|FG000|Overall Study|Randomized but not dispensed study med|1|||
125070238|NCT01601704|449875412|FG001|Overall Study|Randomized but not dispensed study med|4|||
125070239|NCT01090102|449875413|FG000|First 12 Weeks|Withdrawal by Subject|1|||
125070240|NCT01090102|449875414|FG001|First 12 Weeks|Withdrawal by Subject|1|||
125070241|NCT01090102|449875413|FG000|First 12 Weeks|Adverse Event|2|||
125070242|NCT01090102|449875414|FG001|First 12 Weeks|Adverse Event|0|||
125070243|NCT01090102|449875413|FG000|First 12 Weeks|Death|1|||
125070244|NCT01090102|449875414|FG001|First 12 Weeks|Death|1|||
125070245|NCT01090102|449875413|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
125070246|NCT01090102|449875414|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
125070247|NCT03518034|449875415|FG000|Overall Study|Not Treated|5|||
125070248|NCT03518034|449875416|FG001|Overall Study|Not Treated|1|||
125070249|NCT03518034|449875415|FG000|Overall Study|Withdrawal by Subject|309|||
125070250|NCT03518034|449875416|FG001|Overall Study|Withdrawal by Subject|351|||
125070251|NCT03518034|449875415|FG000|Overall Study|Lost to Follow-up|446|||
125070252|NCT03518034|449875416|FG001|Overall Study|Lost to Follow-up|458|||
125070253|NCT03518034|449875415|FG000|Overall Study|Adverse Event|138|||
125070254|NCT03518034|449875416|FG001|Overall Study|Adverse Event|130|||
125070255|NCT03518034|449875415|FG000|Overall Study|Lack of Efficacy|11|||
125070256|NCT03518034|449875416|FG001|Overall Study|Lack of Efficacy|23|||
125070257|NCT03518034|449875415|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
125070258|NCT03518034|449875416|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
125070259|NCT03518034|449875415|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
125070260|NCT03518034|449875416|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
125070261|NCT03518034|449875415|FG000|Overall Study|Other, Not Specified|84|||
125070262|NCT03518034|449875416|FG001|Overall Study|Other, Not Specified|53|||
125070263|NCT03518034|449875415|FG000|Overall Study|Reason Missing|2|||
125070264|NCT03518034|449875416|FG001|Overall Study|Reason Missing|3|||
125070265|NCT00010803|449875422|FG000|Overall Study|Withdrawal by Subject|97|||
125070266|NCT00010803|449875423|FG001|Overall Study|Withdrawal by Subject|98|||
125070267|NCT01019252|449875424|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
125070268|NCT01019252|449875425|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
125070269|NCT01019252|449875424|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
125070270|NCT01019252|449875425|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
125070271|NCT01019252|449875424|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
125070272|NCT01019252|449875425|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
125070273|NCT01019252|449875424|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
125070274|NCT01019252|449875425|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
125070275|NCT02273037|449875426|FG000|Overall Study|Lost to Follow-up|1|||
125070276|NCT02273037|449875427|FG001|Overall Study|Lost to Follow-up|0|||
125070277|NCT02273037|449875426|FG000|Overall Study|Delivered before monitoring initiated|1|||
125070278|NCT02273037|449875427|FG001|Overall Study|Delivered before monitoring initiated|3|||
125070279|NCT02273037|449875426|FG000|Overall Study|Breech delivery|2|||
125070280|NCT02273037|449875427|FG001|Overall Study|Breech delivery|3|||
125070281|NCT02273037|449875426|FG000|Overall Study|Multiple delivery|2|||
125070282|NCT02273037|449875427|FG001|Overall Study|Multiple delivery|2|||
125070283|NCT02273037|449875426|FG000|Overall Study|Other complication|2|||
125070284|NCT02273037|449875427|FG001|Overall Study|Other complication|0|||
125070285|NCT00792701|449875434|FG000|Overall Study|Adverse Event|0|||
125070286|NCT00792701|449875435|FG001|Overall Study|Adverse Event|22|||
125070287|NCT00792701|449875434|FG000|Overall Study|Ineligible|1|||
125070288|NCT00792701|449875435|FG001|Overall Study|Ineligible|3|||
125070289|NCT00792701|449875434|FG000|Overall Study|Withdrawal by Subject|1|||
125070290|NCT00792701|449875435|FG001|Overall Study|Withdrawal by Subject|19|||
125070291|NCT00792701|449875434|FG000|Overall Study|Not protocol specified|17|||
125070292|NCT00792701|449875435|FG001|Overall Study|Not protocol specified|0|||
125070293|NCT03862495|449875441|FG000|Overall Study|Lost to Follow-up|37|||
125070294|NCT03862495|449875442|FG001|Overall Study|Lost to Follow-up|35|||
125070295|NCT01467661|449875443|FG000|Overall Study|Adverse Event|16|||
125070296|NCT01467661|449875443|FG000|Overall Study|Withdrawal by Subject|1|||
125070297|NCT01467661|449875443|FG000|Overall Study|Lack of Efficacy|3|||
125070298|NCT01467661|449875443|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
125070299|NCT03673956|449875444|FG000|Overall Study|Lost to Follow-up|1|||
125070300|NCT03673956|449875445|FG001|Overall Study|Lost to Follow-up|0|||
125070301|NCT03673956|449875446|FG002|Overall Study|Lost to Follow-up|0|||
125070302|NCT03673956|449875447|FG003|Overall Study|Lost to Follow-up|0|||
125070303|NCT03673956|449875444|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
125070304|NCT03673956|449875445|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
125070305|NCT03673956|449875446|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
125070306|NCT03673956|449875447|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
125070307|NCT00425113|449875448|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
125070308|NCT00425113|449875449|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
125070309|NCT00425113|449875448|FG000|Overall Study|diagnosis of abdominal TB|0|||
125070310|NCT00425113|449875449|FG001|Overall Study|diagnosis of abdominal TB|1|||
125070311|NCT00425113|449875448|FG000|Overall Study|missing study drug more than 14 days|0|||
125070312|NCT00425113|449875449|FG001|Overall Study|missing study drug more than 14 days|1|||
125070313|NCT00425113|449875448|FG000|Overall Study|Withdrawal by Subject|1|||
125070314|NCT00425113|449875449|FG001|Overall Study|Withdrawal by Subject|0|||
125070315|NCT01074658|449875450|FG000|Overall Study|No implant attempted|19|||
125070316|NCT01342952|449875451|FG000|Overall Study|Adverse Event|0|||
125070317|NCT01342952|449875452|FG001|Overall Study|Adverse Event|5|||
125070318|NCT01342952|449875453|FG002|Overall Study|Adverse Event|1|||
125070319|NCT01342952|449875454|FG003|Overall Study|Adverse Event|0|||
125070320|NCT01342952|449875451|FG000|Overall Study|Lost to Follow-up|0|||
125070321|NCT01342952|449875452|FG001|Overall Study|Lost to Follow-up|2|||
125070322|NCT01342952|449875453|FG002|Overall Study|Lost to Follow-up|0|||
125070323|NCT01342952|449875454|FG003|Overall Study|Lost to Follow-up|0|||
125070324|NCT01342952|449875451|FG000|Overall Study|Withdrawal by Subject|1|||
125070325|NCT01342952|449875452|FG001|Overall Study|Withdrawal by Subject|1|||
125070326|NCT01342952|449875453|FG002|Overall Study|Withdrawal by Subject|0|||
125070327|NCT01342952|449875454|FG003|Overall Study|Withdrawal by Subject|0|||
125070328|NCT01342952|449875451|FG000|Overall Study|Physician Decision|3|||
125070329|NCT01342952|449875452|FG001|Overall Study|Physician Decision|3|||
125070330|NCT01342952|449875453|FG002|Overall Study|Physician Decision|1|||
125070331|NCT01342952|449875454|FG003|Overall Study|Physician Decision|0|||
125070332|NCT02156804|449875455|FG000|Overall Study|Withdrawal by Subject|1|||
125070333|NCT04581863|449875456|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
125070334|NCT04581863|449875457|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
125070335|NCT01803711|449875458|FG000|Overall Study|Adverse Event|1|||
125070336|NCT01803711|449875459|FG001|Overall Study|Adverse Event|1|||
125070337|NCT00636441|449875460|FG000|Overall Study|Adverse Event|0|||
125070338|NCT00636441|449875461|FG001|Overall Study|Adverse Event|1|||
125070339|NCT00636441|449875462|FG002|Overall Study|Adverse Event|1|||
125070340|NCT00636441|449875463|FG003|Overall Study|Adverse Event|0|||
125070341|NCT00636441|449875464|FG004|Overall Study|Adverse Event|0|||
125070342|NCT00636441|449875465|FG005|Overall Study|Adverse Event|1|||
125070343|NCT00636441|449875466|FG006|Overall Study|Adverse Event|0|||
125070344|NCT00636441|449875460|FG000|Overall Study|Late, ineligible|0|||
125070345|NCT00636441|449875461|FG001|Overall Study|Late, ineligible|0|||
125070346|NCT00636441|449875462|FG002|Overall Study|Late, ineligible|0|||
125070347|NCT00636441|449875463|FG003|Overall Study|Late, ineligible|0|||
125070348|NCT00636441|449875464|FG004|Overall Study|Late, ineligible|0|||
125070349|NCT00636441|449875465|FG005|Overall Study|Late, ineligible|0|||
125070350|NCT00636441|449875466|FG006|Overall Study|Late, ineligible|1|||
125070351|NCT00636441|449875460|FG000|Overall Study|Screen Failure|0|||
125070352|NCT00636441|449875461|FG001|Overall Study|Screen Failure|0|||
125070353|NCT00636441|449875462|FG002|Overall Study|Screen Failure|0|||
125070354|NCT00636441|449875463|FG003|Overall Study|Screen Failure|0|||
125070355|NCT00636441|449875464|FG004|Overall Study|Screen Failure|0|||
125070356|NCT00636441|449875465|FG005|Overall Study|Screen Failure|0|||
125070357|NCT00636441|449875466|FG006|Overall Study|Screen Failure|17|||
125070358|NCT03495817|449875470|FG000|26 Week Open Label|Adverse Event|3|||
125070359|NCT03495817|449875470|FG000|26 Week Open Label|Withdrawal by Subject|4|||
125070360|NCT03495817|449875470|FG000|26 Week Open Label|Lost to Follow-up|1|||
125070361|NCT03495817|449875470|FG000|26 Week Extension|Lost to Follow-up|2|||
125070362|NCT04585451|449875474|FG000|Overall Study|Withdrawal by Subject|26|||
125070363|NCT04585451|449875475|FG001|Overall Study|Withdrawal by Subject|0|||
125070364|NCT02849626|449875482|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
125070365|NCT02849626|449875483|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
125070366|NCT02849626|449875484|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
125070367|NCT02849626|449875485|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
125070368|NCT02849626|449875482|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
125070369|NCT02849626|449875483|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
125070370|NCT02849626|449875484|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
125070371|NCT02849626|449875485|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
125070372|NCT02849626|449875482|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
125141169|NCT04364854|450140874|FG002|Overall Study|Death|0|||
125070373|NCT02849626|449875483|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
125070374|NCT02849626|449875484|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
125070375|NCT02849626|449875485|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
125070376|NCT02849626|449875482|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
125070377|NCT02849626|449875483|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
125070378|NCT02849626|449875484|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
125070379|NCT02849626|449875485|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
125070380|NCT02849626|449875482|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
125070381|NCT02849626|449875483|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
125070382|NCT02849626|449875484|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
125070383|NCT02849626|449875485|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
125070384|NCT02849626|449875482|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
125070385|NCT02849626|449875483|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
125070386|NCT02849626|449875484|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
125070387|NCT02849626|449875485|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
125070388|NCT02849626|449875482|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
125070389|NCT02849626|449875483|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
125070390|NCT02849626|449875484|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
125070391|NCT02849626|449875485|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
125070392|NCT02849626|449875482|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
125070393|NCT02849626|449875483|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
125070394|NCT02849626|449875484|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
125070395|NCT02849626|449875485|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
125070396|NCT02849626|449875482|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
125070397|NCT02849626|449875483|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
125070398|NCT02849626|449875484|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
125070399|NCT02849626|449875485|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
125070400|NCT02849626|449875482|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
125070401|NCT02849626|449875483|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
125070402|NCT02849626|449875484|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
125070403|NCT02849626|449875485|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
125070404|NCT02849626|449875482|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
125070405|NCT02849626|449875483|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
125070406|NCT02849626|449875484|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
125070407|NCT02849626|449875485|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
125070408|NCT01957787|449875486|FG000|Overall Study|Death|18|||
125070409|NCT01957787|449875486|FG000|Overall Study|Lost to Follow-up|3|||
125070410|NCT01957787|449875486|FG000|Overall Study|Withdrawal by Subject|3|||
125070411|NCT01957787|449875486|FG000|Overall Study|Entered Hospice or Similar Program|2|||
125070412|NCT01957787|449875486|FG000|Overall Study|Index Tumor(s) Resected|2|||
125070413|NCT01957787|449875486|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
125070414|NCT01957787|449875486|FG000|Overall Study|Local therapy, not cryoablation|6|||
125070415|NCT04176445|449875487|FG000|Overall Study|Adverse Event|0|||
125070416|NCT04176445|449875488|FG001|Overall Study|Adverse Event|1|||
125070417|NCT04176445|449875487|FG000|Overall Study|change plans weaning after first intervention|0|||
125070418|NCT04176445|449875488|FG001|Overall Study|change plans weaning after first intervention|1|||
125070419|NCT02248857|449875489|FG000|3 Month|Withdrawal by Subject|9|||
125070420|NCT02248857|449875490|FG001|3 Month|Withdrawal by Subject|3|||
125070421|NCT02248857|449875491|FG002|3 Month|Withdrawal by Subject|4|||
125070422|NCT02248857|449875489|FG000|3 Month|Unable to reach for 3 month|35|||
125070423|NCT02248857|449875490|FG001|3 Month|Unable to reach for 3 month|29|||
125070424|NCT02248857|449875491|FG002|3 Month|Unable to reach for 3 month|26|||
125070425|NCT02248857|449875489|FG000|3 Month|Partially completed, unable to finish|2|||
125070426|NCT02248857|449875490|FG001|3 Month|Partially completed, unable to finish|2|||
125070427|NCT02248857|449875491|FG002|3 Month|Partially completed, unable to finish|1|||
125070428|NCT02248857|449875489|FG000|6 Month|Lost to Follow-up|27|||
125070429|NCT02248857|449875490|FG001|6 Month|Lost to Follow-up|26|||
125070430|NCT02248857|449875491|FG002|6 Month|Lost to Follow-up|15|||
125070431|NCT02248857|449875489|FG000|6 Month|Partially completed, unable to finish|0|||
125070432|NCT02248857|449875490|FG001|6 Month|Partially completed, unable to finish|1|||
125070433|NCT02248857|449875491|FG002|6 Month|Partially completed, unable to finish|0|||
125070434|NCT02248857|449875489|FG000|6 Month|Withdrawal by Subject|0|||
125070435|NCT02248857|449875490|FG001|6 Month|Withdrawal by Subject|2|||
125070436|NCT02248857|449875491|FG002|6 Month|Withdrawal by Subject|2|||
125070437|NCT02248857|449875489|FG000|6 Month|Death|1|||
125070438|NCT02248857|449875490|FG001|6 Month|Death|0|||
125070439|NCT02248857|449875491|FG002|6 Month|Death|0|||
125070440|NCT01412060|449875492|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
125070441|NCT01412060|449875493|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
125070442|NCT01412060|449875494|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
125070443|NCT01412060|449875492|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
125070444|NCT01412060|449875493|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
125070445|NCT01412060|449875494|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
125070446|NCT01412060|449875492|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
125070447|NCT01412060|449875493|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
125070448|NCT01412060|449875494|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
125070449|NCT01412060|449875492|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
125070450|NCT01412060|449875493|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
125070451|NCT01412060|449875494|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
125070452|NCT01412060|449875492|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
125070453|NCT01412060|449875493|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
125070454|NCT01412060|449875494|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
125070455|NCT01412060|449875492|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
125070456|NCT01412060|449875493|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
125070457|NCT01412060|449875494|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
125070458|NCT01412060|449875492|FG000|Period Between RIP and SP|Adverse Event|4|||
125070459|NCT01412060|449875493|FG001|Period Between RIP and SP|Adverse Event|0|||
125070460|NCT01412060|449875494|FG002|Period Between RIP and SP|Adverse Event|0|||
125070461|NCT01412060|449875492|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
125070462|NCT01412060|449875493|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
125070463|NCT01412060|449875494|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
125070464|NCT01412060|449875492|FG000|Period Between RIP and SP|Protocol Violation|2|||
125070465|NCT01412060|449875493|FG001|Period Between RIP and SP|Protocol Violation|0|||
125070466|NCT01412060|449875494|FG002|Period Between RIP and SP|Protocol Violation|0|||
125070467|NCT01412060|449875492|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
125070468|NCT01412060|449875493|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
125070469|NCT01412060|449875494|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
125070470|NCT01412060|449875492|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
125070471|NCT01412060|449875493|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
125070472|NCT01412060|449875494|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
125070473|NCT01412060|449875492|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
125070474|NCT01412060|449875493|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
125070475|NCT01412060|449875494|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
125070476|NCT01412060|449875492|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
125070477|NCT01412060|449875493|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
125070478|NCT01412060|449875494|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
125070479|NCT01412060|449875492|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
125070480|NCT01412060|449875493|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
125070481|NCT01412060|449875494|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
125070482|NCT01412060|449875492|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
125070483|NCT01412060|449875493|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
125070484|NCT01412060|449875494|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
125070485|NCT01412060|449875492|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
125070486|NCT01412060|449875493|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
125070487|NCT01412060|449875494|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
125070488|NCT01412060|449875492|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
125070489|NCT01412060|449875493|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
125070490|NCT01412060|449875494|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
125070491|NCT01412060|449875492|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
125070492|NCT01412060|449875493|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
125070493|NCT01412060|449875494|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
125070494|NCT01412060|449875492|FG000|Period Between SP and DBP|Protocol Violation|2|||
125070495|NCT01412060|449875493|FG001|Period Between SP and DBP|Protocol Violation|0|||
125070496|NCT01412060|449875494|FG002|Period Between SP and DBP|Protocol Violation|0|||
125070497|NCT01412060|449875492|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
125070498|NCT01412060|449875493|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
125070499|NCT01412060|449875494|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
125070500|NCT01412060|449875492|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
125070501|NCT01412060|449875493|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
125070502|NCT01412060|449875494|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
125070503|NCT01412060|449875492|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
125070504|NCT01412060|449875493|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
125070505|NCT01412060|449875494|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
125070506|NCT01412060|449875492|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
125070507|NCT01412060|449875493|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
125070508|NCT01412060|449875494|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
125070509|NCT01412060|449875492|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
125070510|NCT01412060|449875493|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
125070511|NCT01412060|449875494|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
125070512|NCT01412060|449875492|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
125070513|NCT01412060|449875493|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
125070514|NCT01412060|449875494|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
125070515|NCT01412060|449875492|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
125070516|NCT01412060|449875493|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
125070517|NCT01412060|449875494|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
125070518|NCT01412060|449875492|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
125141170|NCT04364854|450140875|FG003|Overall Study|Death|0|||
125141171|NCT04364854|450140872|FG000|Overall Study|Lost to Follow-up|0|||
125070519|NCT01412060|449875493|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
125070520|NCT01412060|449875494|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
125070521|NCT01412060|449875492|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
125070522|NCT01412060|449875493|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
125070523|NCT01412060|449875494|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
125070524|NCT01412060|449875492|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
125070525|NCT01412060|449875493|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
125070526|NCT01412060|449875494|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
125070527|NCT00004732|449875495|FG000|Overall Study|Withdrawal by Subject|36|||
125070528|NCT00004732|449875496|FG001|Overall Study|Withdrawal by Subject|64|||
125070529|NCT00004732|449875495|FG000|Overall Study|Lost to Follow-up|33|||
125070530|NCT00004732|449875496|FG001|Overall Study|Lost to Follow-up|47|||
125070531|NCT02674685|449875500|FG000|Overall Study|Withdrawal by Subject|4|||
125070532|NCT02713789|449875501|FG000|Overall Study|Lost to Follow-up|0|||
125070533|NCT02713789|449875502|FG001|Overall Study|Lost to Follow-up|1|||
125070534|NCT02713789|449875503|FG002|Overall Study|Lost to Follow-up|1|||
125070535|NCT02091921|449875504|FG000|Overall Study|Adverse Event|3|||
125070536|NCT03307629|449875505|FG000|Overall Study|Withdrawal by Subject|0|||
125070537|NCT03307629|449875506|FG001|Overall Study|Withdrawal by Subject|0|||
125070538|NCT03307629|449875507|FG002|Overall Study|Withdrawal by Subject|0|||
125070539|NCT03307629|449875508|FG003|Overall Study|Withdrawal by Subject|2|||
125070540|NCT03307629|449875505|FG000|Overall Study|Disease Progression|0|||
125070541|NCT03307629|449875506|FG001|Overall Study|Disease Progression|0|||
125070542|NCT03307629|449875507|FG002|Overall Study|Disease Progression|0|||
125070543|NCT03307629|449875508|FG003|Overall Study|Disease Progression|3|||
125070544|NCT03307629|449875505|FG000|Overall Study|Death|0|||
125070545|NCT03307629|449875506|FG001|Overall Study|Death|3|||
125070546|NCT03307629|449875507|FG002|Overall Study|Death|0|||
125070547|NCT03307629|449875508|FG003|Overall Study|Death|1|||
125070548|NCT00719953|449875513|FG000|Overall Study|Adverse Event|4|||
125070549|NCT01626989|449875514|FG000|Screening Period|Screen Failure|15|||
125070550|NCT01626989|449875515|FG001|Screening Period|Screen Failure|0|||
125070551|NCT01626989|449875516|FG002|Screening Period|Screen Failure|0|||
125070552|NCT01626989|449875514|FG000|Screening Period|Withdrawal by Subject|2|||
125070553|NCT01626989|449875515|FG001|Screening Period|Withdrawal by Subject|0|||
125070554|NCT01626989|449875516|FG002|Screening Period|Withdrawal by Subject|0|||
125070555|NCT00642018|449875519|FG000|Overall Study|Adverse Event|11|||
125070556|NCT00642018|449875520|FG001|Overall Study|Adverse Event|36|||
125070557|NCT00642018|449875519|FG000|Overall Study|Withdrawal by Subject|4|||
125070558|NCT00642018|449875520|FG001|Overall Study|Withdrawal by Subject|10|||
125070559|NCT00642018|449875519|FG000|Overall Study|Progressive Disease|13|||
125070560|NCT00642018|449875520|FG001|Overall Study|Progressive Disease|18|||
125070561|NCT00642018|449875519|FG000|Overall Study|Physician Decision|0|||
125070562|NCT00642018|449875520|FG001|Overall Study|Physician Decision|10|||
125070563|NCT00642018|449875519|FG000|Overall Study|Protocol Violation|0|||
125070564|NCT00642018|449875520|FG001|Overall Study|Protocol Violation|1|||
125070565|NCT00642018|449875519|FG000|Overall Study|Death|0|||
125070566|NCT00642018|449875520|FG001|Overall Study|Death|3|||
125070567|NCT00642018|449875519|FG000|Overall Study|Entry Criteria Not Met|0|||
125070568|NCT00642018|449875520|FG001|Overall Study|Entry Criteria Not Met|1|||
125070569|NCT01230749|449875521|FG000|Overall Study|Adverse Event|0|||
125070570|NCT01230749|449875522|FG001|Overall Study|Adverse Event|0|||
125070571|NCT01230749|449875523|FG002|Overall Study|Adverse Event|0|||
125070572|NCT01230749|449875524|FG003|Overall Study|Adverse Event|1|||
125070573|NCT01230749|449875521|FG000|Overall Study|Physician Decision|0|||
125070574|NCT01230749|449875522|FG001|Overall Study|Physician Decision|0|||
125070575|NCT01230749|449875523|FG002|Overall Study|Physician Decision|1|||
125070576|NCT01230749|449875524|FG003|Overall Study|Physician Decision|0|||
125070577|NCT01230749|449875521|FG000|Overall Study|Withdrawal by Subject|0|||
125070578|NCT01230749|449875522|FG001|Overall Study|Withdrawal by Subject|1|||
125070579|NCT01230749|449875523|FG002|Overall Study|Withdrawal by Subject|0|||
125070580|NCT01230749|449875524|FG003|Overall Study|Withdrawal by Subject|0|||
125070581|NCT01230749|449875521|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
125070582|NCT01230749|449875522|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
125070583|NCT01230749|449875523|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
125070584|NCT01230749|449875524|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
125070585|NCT02687711|449877343|FG000|Overall Study|Adverse Event|89|||
125070586|NCT02687711|449877343|FG000|Overall Study|Lack of Efficacy|70|||
125070587|NCT02687711|449877343|FG000|Overall Study|Lost to Follow-up|20|||
125070588|NCT02687711|449877343|FG000|Overall Study|Consent withdrawn|15|||
125070589|NCT02687711|449877343|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
125070590|NCT02687711|449877343|FG000|Overall Study|Too expensive|4|||
125070591|NCT02687711|449877343|FG000|Overall Study|Participant moved abroad|1|||
125070592|NCT02687711|449877343|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
125070593|NCT02687711|449877343|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
125070594|NCT02687711|449877343|FG000|Overall Study|Disliked taste|1|||
125070595|NCT02687711|449877343|FG000|Overall Study|Low mood|1|||
125070596|NCT02687711|449877343|FG000|Overall Study|Side effects|1|||
125070597|NCT02687711|449877343|FG000|Overall Study|Change of Hospital|1|||
125070598|NCT02687711|449877343|FG000|Overall Study|Liver Encephalopathy|1|||
125070599|NCT02687711|449877343|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
125070600|NCT02687711|449877343|FG000|Overall Study|Withdrawn due to intake interruption|1|||
125070601|NCT02687711|449877343|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
125070602|NCT02687711|449877343|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
125070603|NCT02687711|449877343|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
125070604|NCT03621189|449877344|FG000|Overall Study|Withdrawal by Subject|0|||
125070605|NCT03621189|449877345|FG001|Overall Study|Withdrawal by Subject|3|||
125070606|NCT03621189|449877344|FG000|Overall Study|Physician Decision|0|||
125070607|NCT03621189|449877345|FG001|Overall Study|Physician Decision|2|||
125070608|NCT03077243|449877346|FG000|Overall Study|Death|1|||
125070609|NCT03077243|449877347|FG001|Overall Study|Death|2|||
125070610|NCT03077243|449877348|FG002|Overall Study|Death|0|||
125070611|NCT03077243|449877349|FG003|Overall Study|Death|0|||
125070612|NCT03077243|449877346|FG000|Overall Study|Withdrawal by Subject|1|||
125070613|NCT03077243|449877347|FG001|Overall Study|Withdrawal by Subject|3|||
125070614|NCT03077243|449877348|FG002|Overall Study|Withdrawal by Subject|0|||
125070615|NCT03077243|449877349|FG003|Overall Study|Withdrawal by Subject|0|||
125141172|NCT04364854|450140873|FG001|Overall Study|Lost to Follow-up|0|||
125141173|NCT04364854|450140874|FG002|Overall Study|Lost to Follow-up|0|||
125070616|NCT03077243|449877346|FG000|Overall Study|Physician Decision|1|||
125070617|NCT03077243|449877347|FG001|Overall Study|Physician Decision|0|||
125070618|NCT03077243|449877348|FG002|Overall Study|Physician Decision|0|||
125070619|NCT03077243|449877349|FG003|Overall Study|Physician Decision|0|||
125070620|NCT03077243|449877346|FG000|Overall Study|Research at two study sites terminated early|0|||
125070621|NCT03077243|449877347|FG001|Overall Study|Research at two study sites terminated early|0|||
125070622|NCT03077243|449877348|FG002|Overall Study|Research at two study sites terminated early|0|||
125070623|NCT03077243|449877349|FG003|Overall Study|Research at two study sites terminated early|69|||
125141174|NCT04364854|450140875|FG003|Overall Study|Lost to Follow-up|1|||
125141175|NCT02435433|450140876|FG000|Overall Study|Withdrawal by Subject|2|||
125141176|NCT02435433|450140877|FG001|Overall Study|Withdrawal by Subject|3|||
125141177|NCT02435433|450140878|FG002|Overall Study|Withdrawal by Subject|1|||
125141178|NCT02435433|450140879|FG003|Overall Study|Withdrawal by Subject|0|||
125141179|NCT02435433|450140880|FG004|Overall Study|Withdrawal by Subject|0|||
125141180|NCT02435433|450140876|FG000|Overall Study|Lost to Follow-up|2|||
125141181|NCT02435433|450140877|FG001|Overall Study|Lost to Follow-up|2|||
125141182|NCT02435433|450140878|FG002|Overall Study|Lost to Follow-up|4|||
125141183|NCT02435433|450140879|FG003|Overall Study|Lost to Follow-up|1|||
125141184|NCT02435433|450140880|FG004|Overall Study|Lost to Follow-up|0|||
125141185|NCT00659815|450140881|FG000|Overall Study|Study related symptoms and complaints|2|||
125141186|NCT00659815|450140882|FG001|Overall Study|Study related symptoms and complaints|1|||
125222905|NCT01396083|450444431|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
125222906|NCT01396083|450444430|FG000|Overall Study|Consent withdrawn|4|||
125222907|NCT01396083|450444431|FG001|Overall Study|Consent withdrawn|5|||
125222908|NCT01396083|450444430|FG000|Overall Study|Protocol deviation(s)|0|||
125222909|NCT01396083|450444431|FG001|Overall Study|Protocol deviation(s)|1|||
125222910|NCT01396083|450444430|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125222911|NCT01396083|450444431|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125222912|NCT01396083|450444430|FG000|Overall Study|Administrative problems|1|||
125222913|NCT01396083|450444431|FG001|Overall Study|Administrative problems|0|||
125222914|NCT01396083|450444430|FG000|Overall Study|Lost to Follow-up|1|||
125222915|NCT01396083|450444431|FG001|Overall Study|Lost to Follow-up|0|||
125222916|NCT02806713|450444432|FG000|Overall Study|Urethral injury during procedure|1|||
125222917|NCT02806713|450444433|FG001|Overall Study|Urethral injury during procedure|0|||
125222918|NCT02806713|450444432|FG000|Overall Study|cancelled surgery|1|||
125222919|NCT02806713|450444433|FG001|Overall Study|cancelled surgery|2|||
125222920|NCT00735709|450444434|FG000|Overall Study|Adverse Event|2|||
125222921|NCT00735709|450444435|FG001|Overall Study|Adverse Event|3|||
125222922|NCT00735709|450444436|FG002|Overall Study|Adverse Event|1|||
125070624|NCT01432457|449877350|FG000|Overall Study|Adverse Event|7|||
125070625|NCT01432457|449877351|FG001|Overall Study|Adverse Event|10|||
125070626|NCT01432457|449877352|FG002|Overall Study|Adverse Event|16|||
125222923|NCT00735709|450444437|FG003|Overall Study|Adverse Event|5|||
125070627|NCT01432457|449877350|FG000|Overall Study|Lack of Efficacy|2|||
125070628|NCT01432457|449877351|FG001|Overall Study|Lack of Efficacy|1|||
125070629|NCT01432457|449877352|FG002|Overall Study|Lack of Efficacy|1|||
125070630|NCT01432457|449877350|FG000|Overall Study|Lost to Follow-up|11|||
125141187|NCT00659815|450140881|FG000|Overall Study|Inability to maintain wearing schedule|1|||
125141188|NCT00659815|450140882|FG001|Overall Study|Inability to maintain wearing schedule|2|||
125141189|NCT00659815|450140881|FG000|Overall Study|Withdrawal by Subject|1|||
125222924|NCT00735709|450444434|FG000|Overall Study|Lack of Efficacy|8|||
125222925|NCT00735709|450444435|FG001|Overall Study|Lack of Efficacy|4|||
125070631|NCT01432457|449877351|FG001|Overall Study|Lost to Follow-up|15|||
125070632|NCT01432457|449877352|FG002|Overall Study|Lost to Follow-up|20|||
125070633|NCT01432457|449877350|FG000|Overall Study|Protocol Violation|3|||
125070634|NCT01432457|449877351|FG001|Overall Study|Protocol Violation|2|||
125070635|NCT01432457|449877352|FG002|Overall Study|Protocol Violation|6|||
125070636|NCT01432457|449877350|FG000|Overall Study|Withdrawal by Subject|6|||
125070637|NCT01432457|449877351|FG001|Overall Study|Withdrawal by Subject|11|||
125070638|NCT01432457|449877352|FG002|Overall Study|Withdrawal by Subject|9|||
125070639|NCT01432457|449877350|FG000|Overall Study|Reasons not defined|2|||
125070640|NCT01432457|449877351|FG001|Overall Study|Reasons not defined|3|||
125070641|NCT01432457|449877352|FG002|Overall Study|Reasons not defined|4|||
125070642|NCT01432457|449877350|FG000|Overall Study|Did not take study drug|6|||
125070643|NCT01432457|449877351|FG001|Overall Study|Did not take study drug|6|||
125070644|NCT01432457|449877352|FG002|Overall Study|Did not take study drug|3|||
125070645|NCT02848313|449877353|FG000|Overall Study|Adverse Event|1|||
125070646|NCT02848313|449877354|FG001|Overall Study|Adverse Event|2|||
125070647|NCT02848313|449877353|FG000|Overall Study|Lack of Efficacy|0|||
125070648|NCT02848313|449877354|FG001|Overall Study|Lack of Efficacy|1|||
125141190|NCT00659815|450140882|FG001|Overall Study|Withdrawal by Subject|1|||
125141191|NCT02651987|450140883|FG000|Overall Study|Adverse Event|2|||
125141192|NCT02651987|450140884|FG001|Overall Study|Adverse Event|2|||
125141193|NCT02651987|450140883|FG000|Overall Study|Consent Withdrawn|2|||
125141194|NCT02651987|450140884|FG001|Overall Study|Consent Withdrawn|0|||
125141195|NCT02651987|450140883|FG000|Overall Study|Local PD|0|||
125141196|NCT02651987|450140884|FG001|Overall Study|Local PD|2|||
125141197|NCT02651987|450140883|FG000|Overall Study|Investigator Decision|1|||
125141198|NCT02651987|450140884|FG001|Overall Study|Investigator Decision|1|||
125141199|NCT00522041|450140885|FG000|Overall Study|Adverse Event|9|||
125141200|NCT00522041|450140886|FG001|Overall Study|Adverse Event|3|||
125141201|NCT00522041|450140885|FG000|Overall Study|Protocol Violation|2|||
125141202|NCT00522041|450140886|FG001|Overall Study|Protocol Violation|0|||
125141203|NCT00522041|450140885|FG000|Overall Study|Lost to Follow-up|1|||
125141204|NCT00522041|450140886|FG001|Overall Study|Lost to Follow-up|4|||
125141205|NCT00522041|450140885|FG000|Overall Study|Voluntary withdrawal|5|||
125141206|NCT00522041|450140886|FG001|Overall Study|Voluntary withdrawal|4|||
125141207|NCT00522041|450140885|FG000|Overall Study|Did not receive treatment|0|||
125141208|NCT00522041|450140886|FG001|Overall Study|Did not receive treatment|1|||
125141209|NCT03540160|450140887|FG000|Overall Study|Protocol Violation|1|||
125141210|NCT03540160|450140887|FG000|Overall Study|Physician Decision|8|||
125141211|NCT03540160|450140887|FG000|Overall Study|Lack of Efficacy|60|||
125141212|NCT03540160|450140887|FG000|Overall Study|Pregnancy|1|||
125141213|NCT03540160|450140887|FG000|Overall Study|Adverse Event|20|||
125141214|NCT03540160|450140887|FG000|Overall Study|Withdrawal by Subject|68|||
125141215|NCT03540160|450140887|FG000|Overall Study|COVID-19|2|||
125141216|NCT03540160|450140887|FG000|Overall Study|Study Closure|10|||
125141217|NCT03540160|450140887|FG000|Overall Study|Lost to Follow-up|18|||
125141218|NCT03540160|450140887|FG000|Overall Study|Sponsor decision|191|||
125141219|NCT01664039|450140888|FG000|Overall Study|Adverse Event|3|||
125141220|NCT01664039|450140889|FG001|Overall Study|Adverse Event|4|||
125141221|NCT01664039|450140888|FG000|Overall Study|Lost to Follow-up|1|||
125141222|NCT01664039|450140889|FG001|Overall Study|Lost to Follow-up|1|||
125141223|NCT01664039|450140888|FG000|Overall Study|Withdrawal by Subject|1|||
125141224|NCT01664039|450140889|FG001|Overall Study|Withdrawal by Subject|3|||
125141225|NCT01664039|450140888|FG000|Overall Study|Noncompliance|1|||
125141226|NCT01664039|450140889|FG001|Overall Study|Noncompliance|1|||
125141227|NCT02640235|450140895|FG000|Overall Study|Withdrawal by Subject|7|||
125141228|NCT02640235|450140896|FG001|Overall Study|Withdrawal by Subject|6|||
125141229|NCT02640235|450140895|FG000|Overall Study|Lost to Follow-up|4|||
125141230|NCT02640235|450140896|FG001|Overall Study|Lost to Follow-up|3|||
125141231|NCT02640235|450140895|FG000|Overall Study|Death|2|||
125141232|NCT02640235|450140896|FG001|Overall Study|Death|3|||
125141233|NCT02640235|450140895|FG000|Overall Study|Other|1|||
125070649|NCT02848313|449877353|FG000|Overall Study|Withdrawal by Subject|1|||
125070650|NCT02848313|449877354|FG001|Overall Study|Withdrawal by Subject|1|||
125070651|NCT02848313|449877353|FG000|Overall Study|Lost to follow up|1|||
125070652|NCT02848313|449877354|FG001|Overall Study|Lost to follow up|0|||
125141234|NCT02640235|450140896|FG001|Overall Study|Other|2|||
125070653|NCT00247273|449877360|FG000|Overall Study|Adverse Event|85|||
125141235|NCT02372006|450140900|FG000|Overall Study|Progressive disease|8|||
125141236|NCT02372006|450140901|FG001|Overall Study|Progressive disease|7|||
125141237|NCT02372006|450140902|FG002|Overall Study|Progressive disease|34|||
125141238|NCT02372006|450140900|FG000|Overall Study|Dose limiting toxicity|0|||
125141239|NCT02372006|450140901|FG001|Overall Study|Dose limiting toxicity|1|||
125141240|NCT02372006|450140902|FG002|Overall Study|Dose limiting toxicity|0|||
125141241|NCT02372006|450140900|FG000|Overall Study|Adverse Event|0|||
125141242|NCT02372006|450140901|FG001|Overall Study|Adverse Event|0|||
125141243|NCT02372006|450140902|FG002|Overall Study|Adverse Event|3|||
125141244|NCT02372006|450140900|FG000|Overall Study|Withdrawal by Subject|0|||
125141245|NCT02372006|450140901|FG001|Overall Study|Withdrawal by Subject|1|||
125070654|NCT00247273|449877361|FG001|Overall Study|Adverse Event|80|||
125070655|NCT00247273|449877360|FG000|Overall Study|Physician Decision|6|||
125070656|NCT00247273|449877361|FG001|Overall Study|Physician Decision|3|||
125070657|NCT00247273|449877360|FG000|Overall Study|Lost to Follow-up|7|||
125070658|NCT00247273|449877361|FG001|Overall Study|Lost to Follow-up|7|||
125070659|NCT00247273|449877360|FG000|Overall Study|Withdrawal by Subject|46|||
125070660|NCT00247273|449877361|FG001|Overall Study|Withdrawal by Subject|47|||
125070661|NCT00247273|449877360|FG000|Overall Study|Did not take any study drug|2|||
125070662|NCT00247273|449877361|FG001|Overall Study|Did not take any study drug|0|||
125070663|NCT01419015|449877362|FG000|Overall Study|Death|2|||
125070664|NCT04209530|449877363|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
125070665|NCT04209530|449877364|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
125070666|NCT04209530|449877363|FG000|Overall Study|Withdrawal by Subject|0|||
125070667|NCT04209530|449877364|FG001|Overall Study|Withdrawal by Subject|1|||
125070668|NCT02580240|449877377|FG000|Overall Study|Physician Decision|2|||
125070669|NCT02580240|449877378|FG001|Overall Study|Physician Decision|0|||
125070670|NCT00607919|449877379|FG000|Acute Phase|Adverse Event|9|||
125070671|NCT00607919|449877380|FG001|Acute Phase|Adverse Event|2|||
125070672|NCT00607919|449877379|FG000|Acute Phase|Entry Criteria Not Met|1|||
125070673|NCT00607919|449877380|FG001|Acute Phase|Entry Criteria Not Met|1|||
125070674|NCT00607919|449877379|FG000|Acute Phase|Lack of Efficacy|1|||
125070675|NCT00607919|449877380|FG001|Acute Phase|Lack of Efficacy|2|||
125070676|NCT00607919|449877379|FG000|Acute Phase|Lost to Follow-up|9|||
125070677|NCT00607919|449877380|FG001|Acute Phase|Lost to Follow-up|3|||
125070678|NCT00607919|449877379|FG000|Acute Phase|Parent/Caregiver Decision|6|||
125070679|NCT00607919|449877380|FG001|Acute Phase|Parent/Caregiver Decision|4|||
125070680|NCT00607919|449877379|FG000|Acute Phase|Protocol Violation|5|||
125070681|NCT00607919|449877380|FG001|Acute Phase|Protocol Violation|1|||
125070682|NCT00607919|449877379|FG000|Acute Phase|Withdrawal by Subject|3|||
125070683|NCT00607919|449877380|FG001|Acute Phase|Withdrawal by Subject|3|||
125070684|NCT00607919|449877379|FG000|Open-Label Phase|Adverse Event|1|||
125070685|NCT00607919|449877380|FG001|Open-Label Phase|Adverse Event|5|||
125070686|NCT00607919|449877379|FG000|Open-Label Phase|Lost to Follow-up|4|||
125070687|NCT00607919|449877380|FG001|Open-Label Phase|Lost to Follow-up|1|||
125070688|NCT00607919|449877379|FG000|Open-Label Phase|Protocol Violation|2|||
125070689|NCT00607919|449877380|FG001|Open-Label Phase|Protocol Violation|2|||
125070690|NCT00607919|449877379|FG000|Open-Label Phase|Withdrawal by Subject|2|||
125070691|NCT00607919|449877380|FG001|Open-Label Phase|Withdrawal by Subject|2|||
125070692|NCT00607919|449877379|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
125070693|NCT00607919|449877380|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
125070694|NCT01527110|449877383|FG000|Overall Study|Adverse Event|1|||
125070695|NCT02007252|449877384|FG000|Overall Study|Administrative problems|3|||
125070696|NCT02007252|449877385|FG001|Overall Study|Administrative problems|7|||
125070697|NCT02007252|449877384|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125070698|NCT02007252|449877385|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125070699|NCT02007252|449877384|FG000|Overall Study|Adverse Event|7|||
125070700|NCT02007252|449877385|FG001|Overall Study|Adverse Event|4|||
125070701|NCT00985738|449877388|FG000|Overall Study|Study closed prematurely|8|||
125070702|NCT00985738|449877389|FG001|Overall Study|Study closed prematurely|8|||
125070703|NCT02227849|449877391|FG000|Overall Study|Adverse Event|4|||
125070704|NCT02227849|449877391|FG000|Overall Study|Physician Decision|1|||
125070705|NCT02227849|449877391|FG000|Overall Study|Withdrawal by Subject|3|||
125070706|NCT01590212|449877394|FG000|Overall Study|Withdrawal by Subject|2|||
125070707|NCT01590212|449877395|FG001|Overall Study|Withdrawal by Subject|2|||
125070708|NCT01590212|449877396|FG002|Overall Study|Withdrawal by Subject|2|||
125070709|NCT01590212|449877394|FG000|Overall Study|Lost to Follow-up|1|||
125070710|NCT01590212|449877395|FG001|Overall Study|Lost to Follow-up|2|||
125070711|NCT01590212|449877396|FG002|Overall Study|Lost to Follow-up|3|||
125070712|NCT04897594|449877398|FG000|Overall Study|Lost to Follow-up|0|||
125070713|NCT04897594|449877399|FG001|Overall Study|Lost to Follow-up|1|||
125070714|NCT04897594|449877400|FG002|Overall Study|Lost to Follow-up|1|||
125070715|NCT04897594|449877398|FG000|Overall Study|Sponsor Decision|0|||
125070716|NCT04897594|449877399|FG001|Overall Study|Sponsor Decision|0|||
125070717|NCT04897594|449877400|FG002|Overall Study|Sponsor Decision|1|||
125070718|NCT04897594|449877398|FG000|Overall Study|Withdrawal by Subject|1|||
125070719|NCT04897594|449877399|FG001|Overall Study|Withdrawal by Subject|0|||
125070720|NCT04897594|449877400|FG002|Overall Study|Withdrawal by Subject|1|||
125070721|NCT00150345|449877403|FG000|Overall Study|Death|5|||
125070722|NCT00150345|449877404|FG001|Overall Study|Death|2|||
125070723|NCT00150345|449877403|FG000|Overall Study|Adverse Event|8|||
125070724|NCT00150345|449877404|FG001|Overall Study|Adverse Event|6|||
125070725|NCT00150345|449877403|FG000|Overall Study|Lack of Efficacy|5|||
125070726|NCT00150345|449877404|FG001|Overall Study|Lack of Efficacy|4|||
125070727|NCT00150345|449877403|FG000|Overall Study|Withdrawal by Subject|3|||
125070728|NCT00150345|449877404|FG001|Overall Study|Withdrawal by Subject|4|||
125070729|NCT00150345|449877403|FG000|Overall Study|Laboratory abnormality|1|||
125070730|NCT00150345|449877404|FG001|Overall Study|Laboratory abnormality|2|||
125070731|NCT00150345|449877403|FG000|Overall Study|Other|12|||
125070732|NCT00150345|449877404|FG001|Overall Study|Other|14|||
125070733|NCT01457924|449877407|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
125070734|NCT01457924|449877408|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
125070735|NCT01457924|449877409|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
125070736|NCT01457924|449877410|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
125070737|NCT01457924|449877411|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
125070738|NCT01457924|449877407|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
125070739|NCT01457924|449877408|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
125070740|NCT01457924|449877409|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
125070741|NCT01457924|449877410|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
125070742|NCT01457924|449877411|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
125070743|NCT01457924|449877407|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
125070744|NCT01457924|449877408|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
125070745|NCT01457924|449877409|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
125070746|NCT01457924|449877410|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
125070747|NCT01457924|449877411|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
125070748|NCT01457924|449877407|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
125070749|NCT01457924|449877408|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
125070750|NCT01457924|449877409|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
125070751|NCT01457924|449877410|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
125070752|NCT01457924|449877411|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
125070753|NCT01457924|449877407|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
125070754|NCT01457924|449877408|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
125070755|NCT01457924|449877409|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
125070756|NCT01457924|449877410|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
125070757|NCT01457924|449877411|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
125070758|NCT01457924|449877407|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
125070759|NCT01457924|449877408|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
125070760|NCT01457924|449877409|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
125070761|NCT01457924|449877410|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
125070762|NCT01457924|449877411|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
125070763|NCT01457924|449877407|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
125070764|NCT01457924|449877408|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
125070765|NCT01457924|449877409|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
125070766|NCT01457924|449877410|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
125070767|NCT01457924|449877411|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
125070768|NCT01457924|449877407|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
125070769|NCT01457924|449877408|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
125070770|NCT01457924|449877409|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
125070771|NCT01457924|449877410|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
125070772|NCT01457924|449877411|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
125070773|NCT01457924|449877407|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
125070774|NCT01457924|449877408|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
125070775|NCT01457924|449877409|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
125070776|NCT01457924|449877410|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
125070777|NCT01457924|449877411|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
125070778|NCT01457924|449877407|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
125070779|NCT01457924|449877408|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
125070780|NCT01457924|449877409|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
125070781|NCT01457924|449877410|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
125070782|NCT01457924|449877411|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
125070783|NCT01457924|449877407|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
125070784|NCT01457924|449877408|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
125070785|NCT01457924|449877409|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
125070786|NCT01457924|449877410|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
125222926|NCT00735709|450444436|FG002|Overall Study|Lack of Efficacy|2|||
125070787|NCT01457924|449877411|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
125070788|NCT01457924|449877407|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
125070789|NCT01457924|449877408|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
125070790|NCT01457924|449877409|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
125070791|NCT01457924|449877410|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
125070792|NCT01457924|449877411|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
125070793|NCT01457924|449877407|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
125070794|NCT01457924|449877408|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
125070795|NCT01457924|449877409|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
125070796|NCT01457924|449877410|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
125070797|NCT01457924|449877411|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
125070798|NCT02001688|449877412|FG000|Overall Study|Withdrawal by Subject|0|||
125070799|NCT02001688|449877413|FG001|Overall Study|Withdrawal by Subject|0|||
125070800|NCT02001688|449877414|FG002|Overall Study|Withdrawal by Subject|1|||
125070801|NCT02001688|449877412|FG000|Overall Study|Adverse Event|0|||
125070802|NCT02001688|449877413|FG001|Overall Study|Adverse Event|1|||
125070803|NCT02001688|449877414|FG002|Overall Study|Adverse Event|0|||
125070804|NCT01628393|449877415|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
125070805|NCT01628393|449877416|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
125070806|NCT01628393|449877417|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
125070807|NCT01628393|449877418|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
125070808|NCT01628393|449877419|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
125070809|NCT01628393|449877415|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
125070810|NCT01628393|449877416|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
125070811|NCT01628393|449877417|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
125070812|NCT01628393|449877418|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
125070813|NCT01628393|449877419|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
125070814|NCT01628393|449877415|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
125070815|NCT01628393|449877416|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
125070816|NCT01628393|449877417|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
125070817|NCT01628393|449877418|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
125070818|NCT01628393|449877419|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
125070819|NCT01628393|449877415|FG000|Blinded Active Extension Period|Adverse Event|0|||
125070820|NCT01628393|449877416|FG001|Blinded Active Extension Period|Adverse Event|1|||
125070821|NCT01628393|449877417|FG002|Blinded Active Extension Period|Adverse Event|0|||
125070822|NCT01628393|449877418|FG003|Blinded Active Extension Period|Adverse Event|2|||
125070823|NCT01628393|449877419|FG004|Blinded Active Extension Period|Adverse Event|2|||
125070824|NCT01628393|449877415|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
125070825|NCT01628393|449877416|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
125070826|NCT01628393|449877417|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
125070827|NCT01628393|449877418|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
125070828|NCT01628393|449877419|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
125070829|NCT01628393|449877415|FG000|Blinded Active Extension Period|Physician Decision|0|||
125070830|NCT01628393|449877416|FG001|Blinded Active Extension Period|Physician Decision|3|||
125070831|NCT01628393|449877417|FG002|Blinded Active Extension Period|Physician Decision|0|||
125070832|NCT01628393|449877418|FG003|Blinded Active Extension Period|Physician Decision|1|||
125070833|NCT01628393|449877419|FG004|Blinded Active Extension Period|Physician Decision|0|||
125070834|NCT01628393|449877415|FG000|Blinded Active Extension Period|Protocol Violation|0|||
125070835|NCT01628393|449877416|FG001|Blinded Active Extension Period|Protocol Violation|0|||
125070836|NCT01628393|449877417|FG002|Blinded Active Extension Period|Protocol Violation|2|||
125070837|NCT01628393|449877418|FG003|Blinded Active Extension Period|Protocol Violation|1|||
125070838|NCT01628393|449877419|FG004|Blinded Active Extension Period|Protocol Violation|0|||
125070839|NCT01628393|449877415|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
125070840|NCT01628393|449877416|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
125070841|NCT01628393|449877417|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
125070842|NCT01628393|449877418|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
125070843|NCT01628393|449877419|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
125070844|NCT05441540|449877423|FG000|Overall Study|Withdrawal by Subject|2|||
125070845|NCT00813917|449877424|FG000|Overall Study|Adverse Event|0|||
125070846|NCT00813917|449877425|FG001|Overall Study|Adverse Event|1|||
125070847|NCT00813917|449877424|FG000|Overall Study|Withdrawal by Subject|3|||
125070848|NCT00813917|449877425|FG001|Overall Study|Withdrawal by Subject|4|||
125070849|NCT00813917|449877424|FG000|Overall Study|Lost to Follow-up|3|||
125070850|NCT00813917|449877425|FG001|Overall Study|Lost to Follow-up|1|||
125070851|NCT02143141|449877432|FG000|Overall Study|pain scores at 24 hours not collected|1|||
125070852|NCT02143141|449877433|FG001|Overall Study|pain scores at 24 hours not collected|0|||
125070853|NCT00615914|449877434|FG000|Overall Study|Adverse Event|274|||
125070854|NCT00615914|449877434|FG000|Overall Study|Death|20|||
125070855|NCT00615914|449877434|FG000|Overall Study|Lack of Efficacy|59|||
125070856|NCT00615914|449877434|FG000|Overall Study|Lost to Follow-up|187|||
125070857|NCT00615914|449877434|FG000|Overall Study|Withdrawal by Subject|16|||
125070858|NCT00615914|449877434|FG000|Overall Study|Physician Decision|4|||
125070859|NCT00615914|449877434|FG000|Overall Study|No data was collected.|65|||
125070860|NCT00615914|449877434|FG000|Overall Study|No treatment|2|||
125070861|NCT00615914|449877434|FG000|Overall Study|Irregularly enrolled patients|10|||
125070862|NCT00270998|449877435|FG000|3 Month Follow-up|Adverse Event|1|||
125070863|NCT00270998|449877436|FG001|3 Month Follow-up|Adverse Event|0|||
125070864|NCT00270998|449877437|FG002|3 Month Follow-up|Adverse Event|0|||
125070865|NCT00270998|449877435|FG000|3 Month Follow-up|Lack of Efficacy|1|||
125070866|NCT00270998|449877436|FG001|3 Month Follow-up|Lack of Efficacy|2|||
125070867|NCT00270998|449877437|FG002|3 Month Follow-up|Lack of Efficacy|1|||
125070868|NCT00270998|449877435|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
125070869|NCT00270998|449877436|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
125070870|NCT00270998|449877437|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
125070871|NCT00270998|449877435|FG000|3 Month Follow-up|Pessary did not fit|12|||
125070872|NCT00270998|449877436|FG001|3 Month Follow-up|Pessary did not fit|0|||
125070873|NCT00270998|449877437|FG002|3 Month Follow-up|Pessary did not fit|0|||
125070874|NCT00270998|449877435|FG000|3 Month Follow-up|Personal/family health|1|||
125070875|NCT00270998|449877436|FG001|3 Month Follow-up|Personal/family health|1|||
125070876|NCT00270998|449877437|FG002|3 Month Follow-up|Personal/family health|0|||
125070877|NCT00270998|449877435|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
125070878|NCT00270998|449877436|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
125070879|NCT00270998|449877437|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
125070880|NCT00270998|449877435|FG000|12 Month Follow-up|Lack of Efficacy|5|||
125070881|NCT00270998|449877436|FG001|12 Month Follow-up|Lack of Efficacy|4|||
125070882|NCT00270998|449877437|FG002|12 Month Follow-up|Lack of Efficacy|3|||
125070883|NCT00270998|449877435|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
125070884|NCT00270998|449877436|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
125070885|NCT00270998|449877437|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
125070886|NCT00270998|449877435|FG000|12 Month Follow-up|Pessary did not fit|1|||
125070887|NCT00270998|449877436|FG001|12 Month Follow-up|Pessary did not fit|0|||
125070888|NCT00270998|449877437|FG002|12 Month Follow-up|Pessary did not fit|0|||
125070889|NCT00270998|449877435|FG000|12 Month Follow-up|Personal/family health|0|||
125070890|NCT00270998|449877436|FG001|12 Month Follow-up|Personal/family health|5|||
125070891|NCT00270998|449877437|FG002|12 Month Follow-up|Personal/family health|1|||
125070892|NCT00270998|449877435|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
125070893|NCT00270998|449877436|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
125070894|NCT00270998|449877437|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
125070895|NCT00563368|449877438|FG000|Overall Study|Lost to Follow-up|14|||
125070896|NCT00563368|449877439|FG001|Overall Study|Lost to Follow-up|14|||
125070897|NCT00563368|449877440|FG002|Overall Study|Lost to Follow-up|12|||
125070898|NCT00563368|449877441|FG003|Overall Study|Lost to Follow-up|6|||
125070899|NCT00563368|449877442|FG004|Overall Study|Lost to Follow-up|9|||
125070900|NCT00563368|449877443|FG005|Overall Study|Lost to Follow-up|8|||
125070901|NCT00563368|449877444|FG006|Overall Study|Lost to Follow-up|9|||
125070902|NCT00563368|449877438|FG000|Overall Study|Adverse Event|3|||
125070903|NCT00563368|449877439|FG001|Overall Study|Adverse Event|4|||
125070904|NCT00563368|449877440|FG002|Overall Study|Adverse Event|5|||
125070905|NCT00563368|449877441|FG003|Overall Study|Adverse Event|9|||
125070906|NCT00563368|449877442|FG004|Overall Study|Adverse Event|6|||
125070907|NCT00563368|449877443|FG005|Overall Study|Adverse Event|10|||
125070908|NCT00563368|449877444|FG006|Overall Study|Adverse Event|17|||
125070909|NCT00563368|449877438|FG000|Overall Study|Withdrawal by Subject|11|||
125070910|NCT00563368|449877439|FG001|Overall Study|Withdrawal by Subject|6|||
125070911|NCT00563368|449877440|FG002|Overall Study|Withdrawal by Subject|5|||
125070912|NCT00563368|449877441|FG003|Overall Study|Withdrawal by Subject|7|||
125070913|NCT00563368|449877442|FG004|Overall Study|Withdrawal by Subject|8|||
125070914|NCT00563368|449877443|FG005|Overall Study|Withdrawal by Subject|5|||
125070915|NCT00563368|449877444|FG006|Overall Study|Withdrawal by Subject|4|||
125070916|NCT00563368|449877438|FG000|Overall Study|protocol non-compliance|1|||
125070917|NCT00563368|449877439|FG001|Overall Study|protocol non-compliance|1|||
125070918|NCT00563368|449877440|FG002|Overall Study|protocol non-compliance|2|||
125070919|NCT00563368|449877441|FG003|Overall Study|protocol non-compliance|1|||
125070920|NCT00563368|449877442|FG004|Overall Study|protocol non-compliance|0|||
125070921|NCT00563368|449877443|FG005|Overall Study|protocol non-compliance|1|||
125070922|NCT00563368|449877444|FG006|Overall Study|protocol non-compliance|3|||
125070923|NCT00563368|449877438|FG000|Overall Study|Pregnancy|1|||
125070924|NCT00563368|449877439|FG001|Overall Study|Pregnancy|0|||
125070925|NCT00563368|449877440|FG002|Overall Study|Pregnancy|1|||
125070926|NCT00563368|449877441|FG003|Overall Study|Pregnancy|2|||
125070927|NCT00563368|449877442|FG004|Overall Study|Pregnancy|1|||
125070928|NCT00563368|449877443|FG005|Overall Study|Pregnancy|2|||
125070929|NCT00563368|449877444|FG006|Overall Study|Pregnancy|0|||
125070930|NCT00563368|449877438|FG000|Overall Study|requirement for restricted medication|0|||
125070931|NCT00563368|449877439|FG001|Overall Study|requirement for restricted medication|0|||
125070932|NCT00563368|449877440|FG002|Overall Study|requirement for restricted medication|2|||
125070933|NCT00563368|449877441|FG003|Overall Study|requirement for restricted medication|0|||
125070934|NCT00563368|449877442|FG004|Overall Study|requirement for restricted medication|0|||
125070935|NCT00563368|449877443|FG005|Overall Study|requirement for restricted medication|0|||
125070936|NCT00563368|449877444|FG006|Overall Study|requirement for restricted medication|0|||
125070937|NCT00563368|449877438|FG000|Overall Study|Other|5|||
125070938|NCT00563368|449877439|FG001|Overall Study|Other|5|||
125070939|NCT00563368|449877440|FG002|Overall Study|Other|3|||
125070940|NCT00563368|449877441|FG003|Overall Study|Other|4|||
125070941|NCT00563368|449877442|FG004|Overall Study|Other|4|||
125070942|NCT00563368|449877443|FG005|Overall Study|Other|4|||
125070943|NCT00563368|449877444|FG006|Overall Study|Other|0|||
125070944|NCT00879437|449877446|FG000|Overall Study|Protocol Violation|0|||
125070945|NCT00879437|449877447|FG001|Overall Study|Protocol Violation|1|||
125070946|NCT00879437|449877446|FG000|Overall Study|Death|1|||
125070947|NCT00879437|449877447|FG001|Overall Study|Death|0|||
125070948|NCT01611298|449877452|FG000|Overall Study|Relapsed|2|||
125070949|NCT00753623|449877453|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
125070950|NCT00753623|449877454|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
125070951|NCT00753623|449877453|FG000|Phase I (14 Days)|Physician Decision|1|||
125070952|NCT00753623|449877454|FG001|Phase I (14 Days)|Physician Decision|2|||
125070953|NCT00753623|449877453|FG000|Phase I (14 Days)|Adverse Event|0|||
125070954|NCT00753623|449877454|FG001|Phase I (14 Days)|Adverse Event|1|||
125070955|NCT00753623|449877453|FG000|Washout (7 Days)|Physician Decision|1|||
125070956|NCT00753623|449877454|FG001|Washout (7 Days)|Physician Decision|0|||
125070957|NCT00753623|449877453|FG000|Phase II (14 Days)|Physician Decision|0|||
125070958|NCT00753623|449877454|FG001|Phase II (14 Days)|Physician Decision|1|||
125070959|NCT03332303|449877455|FG000|Overall Study|Participant did not dose|1|||
125070960|NCT03332303|449877456|FG001|Overall Study|Participant did not dose|2|||
125070961|NCT03332303|449877457|FG002|Overall Study|Participant did not dose|0|||
125070962|NCT03332303|449877455|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
125070963|NCT03332303|449877456|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
125070964|NCT03332303|449877457|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
125070965|NCT03332303|449877455|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
125070966|NCT03332303|449877456|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
125070967|NCT03332303|449877457|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
125070968|NCT03332303|449877455|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
125141246|NCT02372006|450140902|FG002|Overall Study|Withdrawal by Subject|1|||
125141247|NCT02372006|450140900|FG000|Overall Study|Other reason for not completing|0|||
125141248|NCT02372006|450140901|FG001|Overall Study|Other reason for not completing|0|||
125141249|NCT02372006|450140902|FG002|Overall Study|Other reason for not completing|1|||
125141250|NCT00467597|450140910|FG000|Overall Study|Withdrawal by Subject|2|||
125141251|NCT00467597|450140911|FG001|Overall Study|Withdrawal by Subject|0|||
125141252|NCT01046084|450140914|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
125141253|NCT01046084|450140915|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
125141254|NCT02166606|450140916|FG000|Overall Study|Adverse Event|3|||
125222927|NCT00735709|450444437|FG003|Overall Study|Lack of Efficacy|3|||
125222928|NCT00735709|450444434|FG000|Overall Study|Noncompliance|0|||
125222929|NCT00735709|450444435|FG001|Overall Study|Noncompliance|0|||
125222930|NCT00735709|450444436|FG002|Overall Study|Noncompliance|1|||
125222931|NCT00735709|450444437|FG003|Overall Study|Noncompliance|0|||
125222932|NCT00735709|450444434|FG000|Overall Study|Protocol deviations|1|||
125222933|NCT00735709|450444435|FG001|Overall Study|Protocol deviations|2|||
125222934|NCT00735709|450444436|FG002|Overall Study|Protocol deviations|1|||
125070969|NCT03332303|449877456|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
125070970|NCT03332303|449877457|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
125070971|NCT03332303|449877455|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
125070972|NCT03332303|449877456|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
125070973|NCT03332303|449877457|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
125070974|NCT03332303|449877455|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
125141255|NCT02166606|450140916|FG000|Overall Study|Death|31|||
125141256|NCT02166606|450140916|FG000|Overall Study|Protocol Violation|7|||
125141257|NCT02166606|450140916|FG000|Overall Study|Lost to Follow-up|30|||
125222935|NCT00735709|450444437|FG003|Overall Study|Protocol deviations|1|||
125222936|NCT00735709|450444434|FG000|Overall Study|Voluntary Withdrawal|1|||
125070975|NCT03332303|449877456|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
125070976|NCT03332303|449877457|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
125070977|NCT03332303|449877455|FG000|Overall Study|Participant had a significant protocol deviation|0|||
125070978|NCT03332303|449877456|FG001|Overall Study|Participant had a significant protocol deviation|1|||
125070979|NCT03332303|449877457|FG002|Overall Study|Participant had a significant protocol deviation|0|||
125070980|NCT03639987|449877458|FG000|Overall Study|Study terminated by sponsor|26|||
125070981|NCT03639987|449877459|FG001|Overall Study|Study terminated by sponsor|25|||
125070982|NCT03639987|449877458|FG000|Overall Study|Lost to Follow-up|0|||
125070983|NCT03639987|449877459|FG001|Overall Study|Lost to Follow-up|1|||
125070984|NCT00425100|449877460|FG000|Overall Study|Adverse Event|36|||
125070985|NCT00425100|449877460|FG000|Overall Study|Lack of Efficacy|4|||
125070986|NCT00425100|449877460|FG000|Overall Study|Lost to Follow-up|2|||
125070987|NCT00425100|449877460|FG000|Overall Study|Protocol Violation|4|||
125070988|NCT00425100|449877460|FG000|Overall Study|Withdrawal by Subject|7|||
125070989|NCT00555906|449877461|FG000|Phase 1|Objective Progression or Relapse|3|||
125070990|NCT00555906|449877462|FG001|Phase 1|Objective Progression or Relapse|5|||
125070991|NCT00555906|449877463|FG002|Phase 1|Objective Progression or Relapse|3|||
125070992|NCT00555906|449877464|FG003|Phase 1|Objective Progression or Relapse|1|||
125070993|NCT00555906|449877465|FG004|Phase 1|Objective Progression or Relapse|0|||
125070994|NCT00555906|449877461|FG000|Phase 1|Global Deterioration of Health Status|0|||
125070995|NCT00555906|449877462|FG001|Phase 1|Global Deterioration of Health Status|1|||
125070996|NCT00555906|449877463|FG002|Phase 1|Global Deterioration of Health Status|1|||
125070997|NCT00555906|449877464|FG003|Phase 1|Global Deterioration of Health Status|1|||
125070998|NCT00555906|449877465|FG004|Phase 1|Global Deterioration of Health Status|0|||
125070999|NCT00555906|449877461|FG000|Phase 1|Adverse Event|0|||
125071000|NCT00555906|449877462|FG001|Phase 1|Adverse Event|0|||
125071001|NCT00555906|449877463|FG002|Phase 1|Adverse Event|3|||
125071002|NCT00555906|449877464|FG003|Phase 1|Adverse Event|2|||
125071003|NCT00555906|449877465|FG004|Phase 1|Adverse Event|0|||
125071004|NCT00555906|449877461|FG000|Phase 1|Withdrawal by Subject|0|||
125071005|NCT00555906|449877462|FG001|Phase 1|Withdrawal by Subject|0|||
125071006|NCT00555906|449877463|FG002|Phase 1|Withdrawal by Subject|0|||
125071007|NCT00555906|449877464|FG003|Phase 1|Withdrawal by Subject|1|||
125071008|NCT00555906|449877465|FG004|Phase 1|Withdrawal by Subject|0|||
125071009|NCT00555906|449877461|FG000|Phase 2|Adverse Event|0|||
125071010|NCT00555906|449877462|FG001|Phase 2|Adverse Event|0|||
125071011|NCT00555906|449877463|FG002|Phase 2|Adverse Event|0|||
125071012|NCT00555906|449877464|FG003|Phase 2|Adverse Event|0|||
125071013|NCT00555906|449877465|FG004|Phase 2|Adverse Event|4|||
125071014|NCT00555906|449877461|FG000|Phase 2|Global Deterioration of Health Status|0|||
125071015|NCT00555906|449877462|FG001|Phase 2|Global Deterioration of Health Status|0|||
125071016|NCT00555906|449877463|FG002|Phase 2|Global Deterioration of Health Status|0|||
125071017|NCT00555906|449877464|FG003|Phase 2|Global Deterioration of Health Status|0|||
125071018|NCT00555906|449877465|FG004|Phase 2|Global Deterioration of Health Status|2|||
125071019|NCT00555906|449877461|FG000|Phase 2|Objective Progression or Relapse|0|||
125071020|NCT00555906|449877462|FG001|Phase 2|Objective Progression or Relapse|0|||
125071021|NCT00555906|449877463|FG002|Phase 2|Objective Progression or Relapse|0|||
125071022|NCT00555906|449877464|FG003|Phase 2|Objective Progression or Relapse|0|||
125071023|NCT00555906|449877465|FG004|Phase 2|Objective Progression or Relapse|16|||
125071024|NCT00555906|449877461|FG000|Phase 2|Withdrawal by Subject|0|||
125071025|NCT00555906|449877462|FG001|Phase 2|Withdrawal by Subject|0|||
125071026|NCT00555906|449877463|FG002|Phase 2|Withdrawal by Subject|0|||
125071027|NCT00555906|449877464|FG003|Phase 2|Withdrawal by Subject|0|||
125071028|NCT00555906|449877465|FG004|Phase 2|Withdrawal by Subject|2|||
125222937|NCT00735709|450444435|FG001|Overall Study|Voluntary Withdrawal|3|||
125222938|NCT00735709|450444436|FG002|Overall Study|Voluntary Withdrawal|5|||
125222939|NCT00735709|450444437|FG003|Overall Study|Voluntary Withdrawal|7|||
125222940|NCT00735709|450444434|FG000|Overall Study|Lost to Follow-up|0|||
125222941|NCT00735709|450444435|FG001|Overall Study|Lost to Follow-up|1|||
125071029|NCT00555906|449877461|FG000|Phase 2|Other|0|||
125071030|NCT00555906|449877462|FG001|Phase 2|Other|0|||
125071031|NCT00555906|449877463|FG002|Phase 2|Other|0|||
125071032|NCT00555906|449877464|FG003|Phase 2|Other|0|||
125071033|NCT00555906|449877465|FG004|Phase 2|Other|6|||
125071034|NCT00555906|449877461|FG000|Phase 2|Randomized but not Treated|0|||
125071035|NCT00555906|449877462|FG001|Phase 2|Randomized but not Treated|0|||
125071036|NCT00555906|449877463|FG002|Phase 2|Randomized but not Treated|0|||
125071037|NCT00555906|449877464|FG003|Phase 2|Randomized but not Treated|0|||
125071038|NCT00555906|449877465|FG004|Phase 2|Randomized but not Treated|2|||
125071039|NCT00889681|449877466|FG000|Overall Study|Not meeting qualification Criteria|2|||
125071040|NCT00889681|449877466|FG000|Overall Study|Insurance disapproval|1|||
125071041|NCT00187889|449877469|FG000|Overall Study|Withdrawal by Subject|6|||
125071042|NCT00187889|449877470|FG001|Overall Study|Withdrawal by Subject|4|||
125071043|NCT04046341|449877471|FG000|Overall Study|Lost to Follow-up|2|||
125071044|NCT04046341|449877471|FG000|Overall Study|Withdrawal by Subject|1|||
125071045|NCT03094832|449877472|FG000|Overall Study|Lost to Follow-up|0|||
125071046|NCT03094832|449877473|FG001|Overall Study|Lost to Follow-up|0|||
125071047|NCT03094832|449877474|FG002|Overall Study|Lost to Follow-up|0|||
125071048|NCT03094832|449877475|FG003|Overall Study|Lost to Follow-up|1|||
125071049|NCT03094832|449877476|FG004|Overall Study|Lost to Follow-up|1|||
125071050|NCT03094832|449877472|FG000|Overall Study|Death|1|||
125071051|NCT03094832|449877473|FG001|Overall Study|Death|0|||
125071052|NCT03094832|449877474|FG002|Overall Study|Death|0|||
125071053|NCT03094832|449877475|FG003|Overall Study|Death|0|||
125071054|NCT03094832|449877476|FG004|Overall Study|Death|0|||
125071055|NCT03094832|449877472|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
125071056|NCT03094832|449877473|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125071057|NCT03094832|449877474|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
125071058|NCT03094832|449877475|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
125071059|NCT03094832|449877476|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
125071060|NCT03094832|449877472|FG000|Overall Study|Other|13|||
125071061|NCT03094832|449877473|FG001|Overall Study|Other|20|||
125071062|NCT03094832|449877474|FG002|Overall Study|Other|1|||
125071063|NCT03094832|449877475|FG003|Overall Study|Other|7|||
125071064|NCT03094832|449877476|FG004|Overall Study|Other|1|||
125071065|NCT01575899|449877477|FG000|Overall Study|Lost to Follow-up|3|||
125071066|NCT01575899|449877478|FG001|Overall Study|Lost to Follow-up|4|||
125071067|NCT01575899|449877479|FG002|Overall Study|Lost to Follow-up|2|||
125071068|NCT01575899|449877477|FG000|Overall Study|Protocol Violation|2|||
125071069|NCT01575899|449877478|FG001|Overall Study|Protocol Violation|1|||
125071070|NCT01575899|449877479|FG002|Overall Study|Protocol Violation|0|||
125071071|NCT05567393|449877480|FG000|Overall Study|Voluntary Withdrawal|0|||
125071072|NCT05567393|449877481|FG001|Overall Study|Voluntary Withdrawal|0|||
125071073|NCT05567393|449877482|FG002|Overall Study|Voluntary Withdrawal|0|||
125071074|NCT05567393|449877483|FG003|Overall Study|Voluntary Withdrawal|0|||
125071075|NCT05567393|449877484|FG004|Overall Study|Voluntary Withdrawal|0|||
125071076|NCT05567393|449877485|FG005|Overall Study|Voluntary Withdrawal|0|||
125071077|NCT05567393|449877486|FG006|Overall Study|Voluntary Withdrawal|0|||
125071078|NCT05567393|449877487|FG007|Overall Study|Voluntary Withdrawal|0|||
125071079|NCT05567393|449877488|FG008|Overall Study|Voluntary Withdrawal|0|||
125071080|NCT05567393|449877489|FG009|Overall Study|Voluntary Withdrawal|0|||
125071081|NCT05567393|449877490|FG010|Overall Study|Voluntary Withdrawal|0|||
125071082|NCT05567393|449877491|FG011|Overall Study|Voluntary Withdrawal|0|||
125071083|NCT05567393|449877492|FG012|Overall Study|Voluntary Withdrawal|0|||
125071084|NCT05567393|449877493|FG013|Overall Study|Voluntary Withdrawal|1|||
125071085|NCT05567393|449877494|FG014|Overall Study|Voluntary Withdrawal|0|||
125071086|NCT05567393|449877495|FG015|Overall Study|Voluntary Withdrawal|0|||
125071087|NCT05567393|449877496|FG016|Overall Study|Voluntary Withdrawal|0|||
125071088|NCT05567393|449877497|FG017|Overall Study|Voluntary Withdrawal|0|||
125071089|NCT04199793|449877498|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
125071090|NCT04199793|449877499|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
125071091|NCT04199793|449877498|FG000|Overall Study|Withdrawal by Subject|1|||
125071092|NCT04199793|449877499|FG001|Overall Study|Withdrawal by Subject|1|||
125071093|NCT04186663|449877506|FG000|Overall Study|Lost to Follow-up|1|||
125071094|NCT04186663|449877506|FG000|Overall Study|Unable to complete blood draw|3|||
125071095|NCT01602549|449877512|FG000|Overall Study|Protocol Violation|0|||
125071096|NCT01602549|449877513|FG001|Overall Study|Protocol Violation|1|||
125071097|NCT01602549|449877512|FG000|Overall Study|Withdrawal by Subject|1|||
125071098|NCT01602549|449877513|FG001|Overall Study|Withdrawal by Subject|0|||
125141258|NCT02166606|450140916|FG000|Overall Study|Withdrawal by Subject|1|||
125141259|NCT02166606|450140916|FG000|Overall Study|Physician Decision|1|||
125071099|NCT05200455|449877514|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
125071100|NCT00719862|449877515|FG000|Overall Study|Adverse Event|1|||
125071101|NCT00719862|449877516|FG001|Overall Study|Adverse Event|2|||
125071102|NCT00719862|449877515|FG000|Overall Study|Lack of Efficacy|3|||
125071103|NCT00719862|449877516|FG001|Overall Study|Lack of Efficacy|0|||
125071104|NCT00719862|449877515|FG000|Overall Study|Non-Compliance|1|||
125141260|NCT02166606|450140916|FG000|Overall Study|Device upgrade|1|||
125141261|NCT02166606|450140916|FG000|Overall Study|Enrolled after End of Enrollment|4|||
125071105|NCT00719862|449877516|FG001|Overall Study|Non-Compliance|0|||
125071106|NCT00719862|449877515|FG000|Overall Study|Withdrawal by Subject|1|||
125071107|NCT00719862|449877516|FG001|Overall Study|Withdrawal by Subject|0|||
125071108|NCT00719862|449877515|FG000|Overall Study|Lost to Follow-up|0|||
125071109|NCT00719862|449877516|FG001|Overall Study|Lost to Follow-up|1|||
125071110|NCT00719862|449877515|FG000|Overall Study|Other|2|||
125141262|NCT01958476|450140917|FG000|Overall Study|Parent requested exclusion from analysis|1|||
125071111|NCT00719862|449877516|FG001|Overall Study|Other|3|||
125071112|NCT01184846|449877518|FG000|Overall Study|Adverse Event|2|||
125071113|NCT01184846|449877518|FG000|Overall Study|Insufficient response|1|||
125071114|NCT02483078|449877519|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
125071115|NCT02483078|449877520|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
125071116|NCT02483078|449877519|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
125071117|NCT02483078|449877520|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
125071118|NCT02483078|449877519|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
125071119|NCT02483078|449877520|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
125071120|NCT02483078|449877519|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
125071121|NCT02483078|449877520|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
125071122|NCT02483078|449877519|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
125071123|NCT02483078|449877520|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
125071124|NCT02483078|449877519|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
125071125|NCT02483078|449877520|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
125071126|NCT02853032|449877521|FG000|Overall Study|Adverse Event|4|||
125071127|NCT02853032|449877522|FG001|Overall Study|Adverse Event|0|||
125071128|NCT02853032|449877521|FG000|Overall Study|Withdrawal by Subject|3|||
125071129|NCT02853032|449877522|FG001|Overall Study|Withdrawal by Subject|1|||
125071130|NCT02853032|449877521|FG000|Overall Study|Requested to withdraw from all treatment|2|||
125071131|NCT02853032|449877522|FG001|Overall Study|Requested to withdraw from all treatment|2|||
125071132|NCT03366844|449880009|FG000|Overall Study|Physician Decision|1|||
125071133|NCT03366844|449880009|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
125071134|NCT00107172|449880010|FG000|Overall Study|Withdrawal by Subject|1|||
125071135|NCT00107172|449880011|FG001|Overall Study|Withdrawal by Subject|0|||
125071136|NCT00107172|449880010|FG000|Overall Study|Death|0|||
125071137|NCT00107172|449880011|FG001|Overall Study|Death|2|||
125071138|NCT00107172|449880010|FG000|Overall Study|Other Reason|4|||
125071139|NCT00107172|449880011|FG001|Overall Study|Other Reason|3|||
125071140|NCT01102140|449880014|FG000|Overall Study|Lost to Follow-up|1|||
125071141|NCT01102140|449880015|FG001|Overall Study|Lost to Follow-up|0|||
125071142|NCT01102140|449880014|FG000|Overall Study|Investigator terminated study|2|||
125071143|NCT01102140|449880015|FG001|Overall Study|Investigator terminated study|2|||
125071144|NCT01673490|449880018|FG000|Overall Study|Lost to Follow-up|1|||
125071145|NCT01673490|449880018|FG000|Overall Study|Adverse Event|3|||
125071146|NCT01673490|449880018|FG000|Overall Study|Withdrawal by Subject|3|||
125071147|NCT00379236|449880019|FG000|Double-blind|Adverse Event|11|||
125071148|NCT00379236|449880020|FG001|Double-blind|Adverse Event|6|||
125071149|NCT00379236|449880021|FG002|Double-blind|Adverse Event|0|||
125071150|NCT00379236|449880019|FG000|Double-blind|Protocol Violation|3|||
125071151|NCT00379236|449880020|FG001|Double-blind|Protocol Violation|3|||
125071152|NCT00379236|449880021|FG002|Double-blind|Protocol Violation|0|||
125071153|NCT00379236|449880019|FG000|Double-blind|Withdrawal by Subject|12|||
125071154|NCT00379236|449880020|FG001|Double-blind|Withdrawal by Subject|13|||
125071155|NCT00379236|449880021|FG002|Double-blind|Withdrawal by Subject|0|||
125071156|NCT00379236|449880019|FG000|Double-blind|Lost to Follow-up|4|||
125071157|NCT00379236|449880020|FG001|Double-blind|Lost to Follow-up|3|||
125071158|NCT00379236|449880021|FG002|Double-blind|Lost to Follow-up|0|||
125071159|NCT00379236|449880019|FG000|Double-blind|Use of exclusionary medication|1|||
125071160|NCT00379236|449880020|FG001|Double-blind|Use of exclusionary medication|2|||
125071161|NCT00379236|449880021|FG002|Double-blind|Use of exclusionary medication|0|||
125071162|NCT00379236|449880019|FG000|Double-blind|Other|3|||
125071163|NCT00379236|449880020|FG001|Double-blind|Other|7|||
125071164|NCT00379236|449880021|FG002|Double-blind|Other|0|||
125071165|NCT00379236|449880019|FG000|Double-blind|Data could not be retrieved|2|||
125071166|NCT00379236|449880020|FG001|Double-blind|Data could not be retrieved|2|||
125071167|NCT00379236|449880021|FG002|Double-blind|Data could not be retrieved|0|||
125071168|NCT00379236|449880019|FG000|Open-label Extension|Adverse Event|0|||
125071169|NCT00379236|449880020|FG001|Open-label Extension|Adverse Event|0|||
125071170|NCT00379236|449880021|FG002|Open-label Extension|Adverse Event|13|||
125071171|NCT00379236|449880019|FG000|Open-label Extension|Protocol Violation|0|||
125071172|NCT00379236|449880020|FG001|Open-label Extension|Protocol Violation|0|||
125071173|NCT00379236|449880021|FG002|Open-label Extension|Protocol Violation|7|||
125071174|NCT00379236|449880019|FG000|Open-label Extension|Withdrawal by Subject|0|||
125071175|NCT00379236|449880020|FG001|Open-label Extension|Withdrawal by Subject|0|||
125071176|NCT00379236|449880021|FG002|Open-label Extension|Withdrawal by Subject|13|||
125071177|NCT00379236|449880019|FG000|Open-label Extension|Lost to Follow-up|0|||
125071178|NCT00379236|449880020|FG001|Open-label Extension|Lost to Follow-up|0|||
125071179|NCT00379236|449880021|FG002|Open-label Extension|Lost to Follow-up|12|||
125071180|NCT00379236|449880019|FG000|Open-label Extension|Use of exclusionary medication|0|||
125071181|NCT00379236|449880020|FG001|Open-label Extension|Use of exclusionary medication|0|||
125071182|NCT00379236|449880021|FG002|Open-label Extension|Use of exclusionary medication|3|||
125071183|NCT00379236|449880019|FG000|Open-label Extension|Other|0|||
125071184|NCT00379236|449880020|FG001|Open-label Extension|Other|0|||
125071185|NCT00379236|449880021|FG002|Open-label Extension|Other|7|||
125071186|NCT03276572|449880027|FG000|Overall Study|In follow-up|0|||
125071187|NCT03276572|449880028|FG001|Overall Study|In follow-up|0|||
125071188|NCT03276572|449880029|FG002|Overall Study|In follow-up|0|||
125071189|NCT03276572|449880030|FG003|Overall Study|In follow-up|0|||
125071190|NCT03276572|449880031|FG004|Overall Study|In follow-up|0|||
125071191|NCT03276572|449880032|FG005|Overall Study|In follow-up|1|||
125071192|NCT03276572|449880033|FG006|Overall Study|In follow-up|1|||
125071193|NCT03276572|449880027|FG000|Overall Study|Lost to Follow-up|0|||
125071194|NCT03276572|449880028|FG001|Overall Study|Lost to Follow-up|0|||
125071195|NCT03276572|449880029|FG002|Overall Study|Lost to Follow-up|0|||
125071196|NCT03276572|449880030|FG003|Overall Study|Lost to Follow-up|0|||
125071197|NCT03276572|449880031|FG004|Overall Study|Lost to Follow-up|0|||
125071198|NCT03276572|449880032|FG005|Overall Study|Lost to Follow-up|0|||
125071199|NCT03276572|449880033|FG006|Overall Study|Lost to Follow-up|1|||
125071200|NCT01709708|449880034|FG000|Overall Study|Protocol Violation|1|||
125071201|NCT01709708|449880035|FG001|Overall Study|Protocol Violation|2|||
125071202|NCT00527072|449880036|FG000|Overall Study|Adverse Event|13|||
125071203|NCT00527072|449880036|FG000|Overall Study|Lack of Efficacy|11|||
125071204|NCT00527072|449880036|FG000|Overall Study|Lost to Follow-up|3|||
125071205|NCT00527072|449880036|FG000|Overall Study|Protocol Violation|2|||
125071206|NCT00527072|449880036|FG000|Overall Study|Withdrawal by Subject|7|||
125071207|NCT00810043|449880037|FG000|Overall Study|Withdrawal by Subject|1|||
125071208|NCT00810043|449880038|FG001|Overall Study|Withdrawal by Subject|0|||
125071209|NCT00810043|449880039|FG002|Overall Study|Withdrawal by Subject|2|||
125071210|NCT00810043|449880037|FG000|Overall Study|Lost to Follow-up|1|||
125071211|NCT00810043|449880038|FG001|Overall Study|Lost to Follow-up|0|||
125071212|NCT00810043|449880039|FG002|Overall Study|Lost to Follow-up|0|||
125071213|NCT00810043|449880037|FG000|Overall Study|Physician Decision|0|||
125071214|NCT00810043|449880038|FG001|Overall Study|Physician Decision|0|||
125071215|NCT00810043|449880039|FG002|Overall Study|Physician Decision|2|||
125071216|NCT00810043|449880037|FG000|Overall Study|Death|2|||
125071217|NCT00810043|449880038|FG001|Overall Study|Death|0|||
125071218|NCT00810043|449880039|FG002|Overall Study|Death|0|||
125071219|NCT00810043|449880037|FG000|Overall Study|Unrelated medical problem|0|||
125071220|NCT00810043|449880038|FG001|Overall Study|Unrelated medical problem|1|||
125071221|NCT00810043|449880039|FG002|Overall Study|Unrelated medical problem|0|||
125071222|NCT00810043|449880037|FG000|Overall Study|Non-medical problem|0|||
125071223|NCT00810043|449880038|FG001|Overall Study|Non-medical problem|0|||
125071224|NCT00810043|449880039|FG002|Overall Study|Non-medical problem|1|||
125071225|NCT00810043|449880037|FG000|Overall Study|No longer met enrollment criteria|0|||
125071226|NCT00810043|449880038|FG001|Overall Study|No longer met enrollment criteria|0|||
125071227|NCT00810043|449880039|FG002|Overall Study|No longer met enrollment criteria|3|||
125071228|NCT01989754|449880040|FG000|Overall Study|Withdrawal by Subject|10|||
125071229|NCT01989754|449880041|FG001|Overall Study|Withdrawal by Subject|14|||
125071230|NCT01989754|449880040|FG000|Overall Study|Lost to Follow-up|28|||
125071231|NCT01989754|449880041|FG001|Overall Study|Lost to Follow-up|20|||
125071232|NCT01989754|449880040|FG000|Overall Study|Closed Site|1|||
125071233|NCT01989754|449880041|FG001|Overall Study|Closed Site|1|||
125071234|NCT01369225|449880047|FG000|Overall Study|Withdrawal by Subject|1|||
125071235|NCT01369225|449880048|FG001|Overall Study|Withdrawal by Subject|0|||
125071236|NCT01369225|449880049|FG002|Overall Study|Withdrawal by Subject|2|||
125071237|NCT01369225|449880050|FG003|Overall Study|Withdrawal by Subject|1|||
125071238|NCT01369225|449880051|FG004|Overall Study|Withdrawal by Subject|0|||
125071239|NCT01369225|449880052|FG005|Overall Study|Withdrawal by Subject|0|||
125071240|NCT01369225|449880047|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
125071241|NCT01369225|449880048|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
125071242|NCT01369225|449880049|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
125141263|NCT01958476|450140918|FG001|Overall Study|Parent requested exclusion from analysis|0|||
125141264|NCT05412121|450140921|FG000|Overall Study|Withdrawal by Subject|4|||
125141265|NCT05412121|450140921|FG000|Overall Study|Physician Decision|1|||
125141266|NCT05412121|450140921|FG000|Overall Study|Lost to Follow-up|5|||
125071243|NCT01369225|449880050|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
125071244|NCT01369225|449880051|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
125071245|NCT01369225|449880052|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
125071246|NCT01369225|449880047|FG000|Overall Study|Other|1|||
125071247|NCT01369225|449880048|FG001|Overall Study|Other|0|||
125071248|NCT01369225|449880049|FG002|Overall Study|Other|0|||
125071249|NCT01369225|449880050|FG003|Overall Study|Other|0|||
125071250|NCT01369225|449880051|FG004|Overall Study|Other|1|||
125071251|NCT01369225|449880052|FG005|Overall Study|Other|0|||
125071252|NCT01369225|449880047|FG000|Overall Study|Adverse Event|0|||
125071253|NCT01369225|449880048|FG001|Overall Study|Adverse Event|0|||
125071254|NCT01369225|449880049|FG002|Overall Study|Adverse Event|0|||
125141267|NCT02670551|450140922|FG000|Overall Study|Adverse Event|4|||
125071255|NCT01369225|449880050|FG003|Overall Study|Adverse Event|1|||
125071256|NCT01369225|449880051|FG004|Overall Study|Adverse Event|1|||
125071257|NCT01369225|449880052|FG005|Overall Study|Adverse Event|0|||
125071258|NCT02980692|449880053|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
125071259|NCT02980692|449880054|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
125071260|NCT02980692|449880055|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
125071261|NCT02980692|449880056|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
125071262|NCT02980692|449880057|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
125071263|NCT02980692|449880053|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
125071264|NCT02980692|449880054|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
125071265|NCT02980692|449880055|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
125071266|NCT02980692|449880056|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
125071267|NCT02980692|449880057|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
125071268|NCT02980692|449880053|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
125071269|NCT02980692|449880054|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
125071270|NCT02980692|449880055|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
125071271|NCT02980692|449880056|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
125071272|NCT02980692|449880057|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
125071273|NCT02980692|449880053|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
125071274|NCT02980692|449880054|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
125071275|NCT02980692|449880055|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
125071276|NCT02980692|449880056|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
125071277|NCT02980692|449880057|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
125071278|NCT02980692|449880053|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
125071279|NCT02980692|449880054|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
125071280|NCT02980692|449880055|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
125071281|NCT02980692|449880056|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
125071282|NCT02980692|449880057|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
125071283|NCT02980692|449880053|FG000|Double Blind Placebo Controlled Period|Other|1|||
125071284|NCT02980692|449880054|FG001|Double Blind Placebo Controlled Period|Other|0|||
125071285|NCT02980692|449880055|FG002|Double Blind Placebo Controlled Period|Other|0|||
125071286|NCT02980692|449880056|FG003|Double Blind Placebo Controlled Period|Other|0|||
125071287|NCT02980692|449880057|FG004|Double Blind Placebo Controlled Period|Other|1|||
125071288|NCT02980692|449880053|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
125071289|NCT02980692|449880054|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
125071290|NCT02980692|449880055|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
125071291|NCT02980692|449880056|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
125071292|NCT02980692|449880057|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
125071293|NCT02980692|449880053|FG000|Double-blind Follow-up Period|Adverse Event|0|||
125071294|NCT02980692|449880054|FG001|Double-blind Follow-up Period|Adverse Event|0|||
125071295|NCT02980692|449880055|FG002|Double-blind Follow-up Period|Adverse Event|0|||
125071296|NCT02980692|449880056|FG003|Double-blind Follow-up Period|Adverse Event|1|||
125071297|NCT02980692|449880057|FG004|Double-blind Follow-up Period|Adverse Event|1|||
125071298|NCT02980692|449880053|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
125071299|NCT02980692|449880054|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
125071300|NCT02980692|449880055|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
125071301|NCT02980692|449880056|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
125071302|NCT02980692|449880057|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
125071303|NCT02980692|449880053|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
125071304|NCT02980692|449880054|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
125071305|NCT02980692|449880055|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
125071306|NCT02980692|449880056|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
125071307|NCT02980692|449880057|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
125071308|NCT02980692|449880053|FG000|Double-blind Follow-up Period|Pregnancy|0|||
125071309|NCT02980692|449880054|FG001|Double-blind Follow-up Period|Pregnancy|0|||
125071310|NCT02980692|449880055|FG002|Double-blind Follow-up Period|Pregnancy|1|||
125071311|NCT02980692|449880056|FG003|Double-blind Follow-up Period|Pregnancy|1|||
125071312|NCT02980692|449880057|FG004|Double-blind Follow-up Period|Pregnancy|0|||
125071313|NCT02980692|449880053|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
125141268|NCT02670551|450140923|FG001|Overall Study|Adverse Event|7|||
125141269|NCT02670551|450140924|FG002|Overall Study|Adverse Event|9|||
125141270|NCT02670551|450140922|FG000|Overall Study|Lack of Efficacy|2|||
125141271|NCT02670551|450140923|FG001|Overall Study|Lack of Efficacy|0|||
125141272|NCT02670551|450140924|FG002|Overall Study|Lack of Efficacy|3|||
125141273|NCT02670551|450140922|FG000|Overall Study|Withdrawal of Consent|6|||
125222942|NCT00735709|450444436|FG002|Overall Study|Lost to Follow-up|1|||
125222943|NCT00735709|450444437|FG003|Overall Study|Lost to Follow-up|1|||
125222944|NCT00735709|450444434|FG000|Overall Study|Excluded medication|1|||
125222945|NCT00735709|450444435|FG001|Overall Study|Excluded medication|0|||
125222946|NCT00735709|450444436|FG002|Overall Study|Excluded medication|0|||
125222947|NCT00735709|450444437|FG003|Overall Study|Excluded medication|1|||
125222948|NCT01165307|450444439|FG000|Overall Study|Lost to Follow-up|11|||
125222949|NCT01165307|450444440|FG001|Overall Study|Lost to Follow-up|3|||
125222950|NCT01165307|450444439|FG000|Overall Study|Withdrawal by Subject|2|||
125222951|NCT01165307|450444440|FG001|Overall Study|Withdrawal by Subject|0|||
125222952|NCT01165307|450444439|FG000|Overall Study|Subject not available for contact|1|||
125222953|NCT01165307|450444440|FG001|Overall Study|Subject not available for contact|0|||
125222954|NCT00521365|450444444|FG000|Overall Study|Adverse Event|3|||
125222955|NCT00521365|450444444|FG000|Overall Study|Lost to Follow-up|6|||
125222956|NCT00521365|450444444|FG000|Overall Study|Protocol deviation|2|||
125222957|NCT00521365|450444444|FG000|Overall Study|Drug compliance|3|||
125222958|NCT00521365|450444444|FG000|Overall Study|Usage of not allowed drugs|6|||
125222959|NCT03627832|450444445|FG000|Overall Study|Withdrawal by Subject|10|||
125222960|NCT03627832|450444446|FG001|Overall Study|Withdrawal by Subject|1|||
125222961|NCT03150082|450444447|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
125222962|NCT03150082|450444448|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
125222963|NCT01718483|450444449|FG000|Overall Study|Withdrawal by Subject|14|||
125222964|NCT01718483|450444450|FG001|Overall Study|Withdrawal by Subject|12|||
125222965|NCT01718483|450444449|FG000|Overall Study|Adverse Event|5|||
125222966|NCT01718483|450444450|FG001|Overall Study|Adverse Event|12|||
125222967|NCT01718483|450444449|FG000|Overall Study|Lost to Follow-up|8|||
125222968|NCT01718483|450444450|FG001|Overall Study|Lost to Follow-up|3|||
125222969|NCT01718483|450444449|FG000|Overall Study|Protocol Violation|4|||
125222970|NCT01718483|450444450|FG001|Overall Study|Protocol Violation|2|||
125222971|NCT01718483|450444449|FG000|Overall Study|Other|1|||
125222972|NCT01718483|450444450|FG001|Overall Study|Other|4|||
125222973|NCT01718483|450444449|FG000|Overall Study|Pregnancy|1|||
125222974|NCT01718483|450444450|FG001|Overall Study|Pregnancy|1|||
125222975|NCT01718483|450444449|FG000|Overall Study|Lack of Efficacy|1|||
125222976|NCT01718483|450444450|FG001|Overall Study|Lack of Efficacy|0|||
125222977|NCT01051557|450444453|FG000|Overall Study|Physician Decision|1|||
125222978|NCT01051557|450444454|FG001|Overall Study|Physician Decision|0|||
125222979|NCT01051557|450444455|FG002|Overall Study|Physician Decision|0|||
125222980|NCT01051557|450444456|FG003|Overall Study|Physician Decision|0|||
125222981|NCT01051557|450444457|FG004|Overall Study|Physician Decision|0|||
125222982|NCT01051557|450444458|FG005|Overall Study|Physician Decision|0|||
125222983|NCT01051557|450444459|FG006|Overall Study|Physician Decision|0|||
125071314|NCT02980692|449880054|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
125071315|NCT02980692|449880055|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
125071316|NCT02980692|449880056|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
125071317|NCT02980692|449880057|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
125071318|NCT02980692|449880053|FG000|Double-blind Follow-up Period|Other|0|||
125071319|NCT02980692|449880054|FG001|Double-blind Follow-up Period|Other|0|||
125071320|NCT02980692|449880055|FG002|Double-blind Follow-up Period|Other|1|||
125071321|NCT02980692|449880056|FG003|Double-blind Follow-up Period|Other|1|||
125071322|NCT02980692|449880057|FG004|Double-blind Follow-up Period|Other|3|||
125071323|NCT00064077|449880060|FG000|Overall Study|Improper prior treatment|1|||
125071324|NCT00064077|449880061|FG001|Overall Study|Improper prior treatment|0|||
125071325|NCT00064077|449880062|FG002|Overall Study|Improper prior treatment|0|||
125222984|NCT01051557|450444453|FG000|Overall Study|disease progression|3|||
125071326|NCT00064077|449880063|FG003|Overall Study|Improper prior treatment|0|||
125071327|NCT00064077|449880060|FG000|Overall Study|Poor risk|2|||
125071328|NCT00064077|449880061|FG001|Overall Study|Poor risk|0|||
125071329|NCT00064077|449880062|FG002|Overall Study|Poor risk|1|||
125071330|NCT00064077|449880063|FG003|Overall Study|Poor risk|1|||
125071331|NCT00064077|449880060|FG000|Overall Study|Pathology|10|||
125071332|NCT00064077|449880061|FG001|Overall Study|Pathology|7|||
125071333|NCT00064077|449880062|FG002|Overall Study|Pathology|3|||
125222985|NCT01051557|450444454|FG001|Overall Study|disease progression|3|||
125222986|NCT01051557|450444455|FG002|Overall Study|disease progression|5|||
125071334|NCT00064077|449880063|FG003|Overall Study|Pathology|4|||
125071335|NCT00064077|449880060|FG000|Overall Study|No surgery|0|||
125071336|NCT00064077|449880061|FG001|Overall Study|No surgery|0|||
125071337|NCT00064077|449880062|FG002|Overall Study|No surgery|1|||
125071338|NCT00064077|449880063|FG003|Overall Study|No surgery|0|||
125071339|NCT00064077|449880060|FG000|Overall Study|No tumor|0|||
125222987|NCT01051557|450444456|FG003|Overall Study|disease progression|2|||
125222988|NCT01051557|450444457|FG004|Overall Study|disease progression|4|||
125222989|NCT01051557|450444458|FG005|Overall Study|disease progression|3|||
125222990|NCT01051557|450444459|FG006|Overall Study|disease progression|1|||
125071340|NCT00064077|449880061|FG001|Overall Study|No tumor|0|||
125071341|NCT00064077|449880062|FG002|Overall Study|No tumor|1|||
125071342|NCT00064077|449880063|FG003|Overall Study|No tumor|0|||
125222991|NCT01051557|450444453|FG000|Overall Study|Withdrawal by Subject|0|||
125222992|NCT01051557|450444454|FG001|Overall Study|Withdrawal by Subject|0|||
125071343|NCT00064077|449880060|FG000|Overall Study|Other reasons|2|||
125071344|NCT00064077|449880061|FG001|Overall Study|Other reasons|2|||
125071345|NCT00064077|449880062|FG002|Overall Study|Other reasons|1|||
125071346|NCT00064077|449880063|FG003|Overall Study|Other reasons|2|||
125071347|NCT01112982|449880067|FG000|Overall Study|Withdrawal by Subject|1|||
125071348|NCT01112982|449880067|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
125071349|NCT01001234|449880072|FG000|Overall Study|Withdrawal by Subject|2|||
125071350|NCT01001234|449880073|FG001|Overall Study|Withdrawal by Subject|0|||
125071351|NCT01001234|449880074|FG002|Overall Study|Withdrawal by Subject|3|||
125071352|NCT01001234|449880075|FG003|Overall Study|Withdrawal by Subject|0|||
125071353|NCT01001234|449880076|FG004|Overall Study|Withdrawal by Subject|0|||
125071354|NCT01001234|449880072|FG000|Overall Study|Protocol Violation|34|||
125222993|NCT01051557|450444455|FG002|Overall Study|Withdrawal by Subject|1|||
125222994|NCT01051557|450444456|FG003|Overall Study|Withdrawal by Subject|0|||
125222995|NCT01051557|450444457|FG004|Overall Study|Withdrawal by Subject|2|||
125222996|NCT01051557|450444458|FG005|Overall Study|Withdrawal by Subject|0|||
125222997|NCT01051557|450444459|FG006|Overall Study|Withdrawal by Subject|1|||
125222998|NCT01051557|450444453|FG000|Overall Study|Adverse Event|0|||
125071355|NCT01001234|449880073|FG001|Overall Study|Protocol Violation|3|||
125071356|NCT01001234|449880074|FG002|Overall Study|Protocol Violation|19|||
125071357|NCT01001234|449880075|FG003|Overall Study|Protocol Violation|18|||
125071358|NCT01001234|449880076|FG004|Overall Study|Protocol Violation|0|||
125071359|NCT01001234|449880072|FG000|Overall Study|Lost to Follow-up|0|||
125071360|NCT01001234|449880073|FG001|Overall Study|Lost to Follow-up|0|||
125071361|NCT01001234|449880074|FG002|Overall Study|Lost to Follow-up|1|||
125071362|NCT01001234|449880075|FG003|Overall Study|Lost to Follow-up|2|||
125071363|NCT01001234|449880076|FG004|Overall Study|Lost to Follow-up|0|||
125071364|NCT01001234|449880072|FG000|Overall Study|Physician Decision|1|||
125071365|NCT01001234|449880073|FG001|Overall Study|Physician Decision|0|||
125071366|NCT01001234|449880074|FG002|Overall Study|Physician Decision|0|||
125071367|NCT01001234|449880075|FG003|Overall Study|Physician Decision|0|||
125071368|NCT01001234|449880076|FG004|Overall Study|Physician Decision|0|||
125071369|NCT01001234|449880072|FG000|Overall Study|Not Treated: Adverse Event|1|||
125071370|NCT01001234|449880073|FG001|Overall Study|Not Treated: Adverse Event|0|||
125071371|NCT01001234|449880074|FG002|Overall Study|Not Treated: Adverse Event|0|||
125071372|NCT01001234|449880075|FG003|Overall Study|Not Treated: Adverse Event|0|||
125071373|NCT01001234|449880076|FG004|Overall Study|Not Treated: Adverse Event|0|||
125071374|NCT01001234|449880072|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
125071375|NCT01001234|449880073|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
125071376|NCT01001234|449880074|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
125071377|NCT01001234|449880075|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
125071378|NCT01001234|449880076|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
125071379|NCT01001234|449880072|FG000|Overall Study|Not Treated: Protocol Violation|3|||
125071380|NCT01001234|449880073|FG001|Overall Study|Not Treated: Protocol Violation|0|||
125071381|NCT01001234|449880074|FG002|Overall Study|Not Treated: Protocol Violation|0|||
125071382|NCT01001234|449880075|FG003|Overall Study|Not Treated: Protocol Violation|0|||
125071383|NCT01001234|449880076|FG004|Overall Study|Not Treated: Protocol Violation|0|||
125071384|NCT01001234|449880072|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
125071385|NCT01001234|449880073|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
125071386|NCT01001234|449880074|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
125071387|NCT01001234|449880075|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
125071388|NCT01001234|449880076|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
125071389|NCT01001234|449880072|FG000|Overall Study|Not Treated: Pregnancy|3|||
125071390|NCT01001234|449880073|FG001|Overall Study|Not Treated: Pregnancy|0|||
125071391|NCT01001234|449880074|FG002|Overall Study|Not Treated: Pregnancy|0|||
125071392|NCT01001234|449880075|FG003|Overall Study|Not Treated: Pregnancy|0|||
125071393|NCT01001234|449880076|FG004|Overall Study|Not Treated: Pregnancy|0|||
125071394|NCT01001234|449880072|FG000|Overall Study|Not Treated: Physician Decision|37|||
125071395|NCT01001234|449880073|FG001|Overall Study|Not Treated: Physician Decision|4|||
125071396|NCT01001234|449880074|FG002|Overall Study|Not Treated: Physician Decision|0|||
125071397|NCT01001234|449880075|FG003|Overall Study|Not Treated: Physician Decision|0|||
125071398|NCT01001234|449880076|FG004|Overall Study|Not Treated: Physician Decision|0|||
125071399|NCT01001234|449880072|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
125071400|NCT01001234|449880073|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
125071401|NCT01001234|449880074|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
125071402|NCT01001234|449880075|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
125071403|NCT01001234|449880076|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
125071404|NCT03379376|449880077|FG000|Overall Study|Lost to Follow-up|2|||
125071405|NCT03379376|449880077|FG000|Overall Study|Did not wish to complete follow up|1|||
125071406|NCT03379376|449880077|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
125071407|NCT03379376|449880077|FG000|Overall Study|Death|1|||
125071408|NCT00928512|449880078|FG000|Overall Study|Adverse Event|4|||
125071409|NCT00928512|449880079|FG001|Overall Study|Adverse Event|3|||
125071410|NCT00928512|449880080|FG002|Overall Study|Adverse Event|2|||
125071411|NCT00928512|449880081|FG003|Overall Study|Adverse Event|8|||
125071412|NCT00928512|449880082|FG004|Overall Study|Adverse Event|6|||
125071413|NCT00928512|449880078|FG000|Overall Study|Lack of Efficacy|2|||
125071414|NCT00928512|449880079|FG001|Overall Study|Lack of Efficacy|0|||
125071415|NCT00928512|449880080|FG002|Overall Study|Lack of Efficacy|4|||
125071416|NCT00928512|449880081|FG003|Overall Study|Lack of Efficacy|7|||
125071417|NCT00928512|449880082|FG004|Overall Study|Lack of Efficacy|3|||
125071418|NCT00928512|449880078|FG000|Overall Study|Protocol Violation|0|||
125071419|NCT00928512|449880079|FG001|Overall Study|Protocol Violation|1|||
125071420|NCT00928512|449880080|FG002|Overall Study|Protocol Violation|0|||
125071421|NCT00928512|449880081|FG003|Overall Study|Protocol Violation|1|||
125071422|NCT00928512|449880082|FG004|Overall Study|Protocol Violation|3|||
125071423|NCT00928512|449880078|FG000|Overall Study|Withdrawal by Subject|3|||
125071424|NCT00928512|449880079|FG001|Overall Study|Withdrawal by Subject|0|||
125071425|NCT00928512|449880080|FG002|Overall Study|Withdrawal by Subject|3|||
125071426|NCT00928512|449880081|FG003|Overall Study|Withdrawal by Subject|4|||
125071427|NCT00928512|449880082|FG004|Overall Study|Withdrawal by Subject|0|||
125071428|NCT00928512|449880078|FG000|Overall Study|Lost to Follow-up|1|||
125071429|NCT00928512|449880079|FG001|Overall Study|Lost to Follow-up|1|||
125071430|NCT00928512|449880080|FG002|Overall Study|Lost to Follow-up|2|||
125071431|NCT00928512|449880081|FG003|Overall Study|Lost to Follow-up|1|||
125071432|NCT00928512|449880082|FG004|Overall Study|Lost to Follow-up|3|||
125071433|NCT00928512|449880078|FG000|Overall Study|Administrative Problems|0|||
125071434|NCT00928512|449880079|FG001|Overall Study|Administrative Problems|1|||
125071435|NCT00928512|449880080|FG002|Overall Study|Administrative Problems|0|||
125141274|NCT02670551|450140923|FG001|Overall Study|Withdrawal of Consent|3|||
125141275|NCT02670551|450140924|FG002|Overall Study|Withdrawal of Consent|8|||
125141276|NCT02670551|450140922|FG000|Overall Study|Lost to Follow-up|5|||
125141277|NCT02670551|450140923|FG001|Overall Study|Lost to Follow-up|7|||
125141278|NCT02670551|450140924|FG002|Overall Study|Lost to Follow-up|6|||
125141279|NCT02670551|450140922|FG000|Overall Study|Protocol Violation|1|||
125141280|NCT02670551|450140923|FG001|Overall Study|Protocol Violation|0|||
125141281|NCT02670551|450140924|FG002|Overall Study|Protocol Violation|0|||
125141282|NCT02670551|450140922|FG000|Overall Study|Noncompliance with study drug|3|||
125141283|NCT02670551|450140923|FG001|Overall Study|Noncompliance with study drug|3|||
125141284|NCT02670551|450140924|FG002|Overall Study|Noncompliance with study drug|2|||
125141285|NCT02670551|450140922|FG000|Overall Study|Other Miscellaneous Reasons|2|||
125141286|NCT02670551|450140923|FG001|Overall Study|Other Miscellaneous Reasons|3|||
125141287|NCT02670551|450140924|FG002|Overall Study|Other Miscellaneous Reasons|3|||
125141288|NCT02670551|450140922|FG000|Overall Study|Did Not Receive Treatment|5|||
125141289|NCT02670551|450140923|FG001|Overall Study|Did Not Receive Treatment|3|||
125141290|NCT02670551|450140924|FG002|Overall Study|Did Not Receive Treatment|0|||
125141291|NCT04476277|450140925|FG000|Overall Study|Withdrawal by Subject|0|||
125141292|NCT04476277|450140926|FG001|Overall Study|Withdrawal by Subject|0|||
125141293|NCT04476277|450140927|FG002|Overall Study|Withdrawal by Subject|1|||
125141294|NCT04476277|450140928|FG003|Overall Study|Withdrawal by Subject|0|||
125141295|NCT01962298|450140929|FG000|Overall Study|Protocol Violation|1|||
125141296|NCT01962298|450140930|FG001|Overall Study|Protocol Violation|0|||
125141297|NCT01962298|450140931|FG002|Overall Study|Protocol Violation|1|||
125141298|NCT01962298|450140932|FG003|Overall Study|Protocol Violation|1|||
125141299|NCT01962298|450140933|FG004|Overall Study|Protocol Violation|0|||
125141300|NCT01962298|450140929|FG000|Overall Study|Data quality insufficient|2|||
125141301|NCT01962298|450140930|FG001|Overall Study|Data quality insufficient|0|||
125141302|NCT01962298|450140931|FG002|Overall Study|Data quality insufficient|3|||
125141303|NCT01962298|450140932|FG003|Overall Study|Data quality insufficient|1|||
125141304|NCT01962298|450140933|FG004|Overall Study|Data quality insufficient|4|||
125141305|NCT01962298|450140929|FG000|Overall Study|Insufficient data|0|||
125141306|NCT01962298|450140930|FG001|Overall Study|Insufficient data|2|||
125141307|NCT01962298|450140931|FG002|Overall Study|Insufficient data|1|||
125141308|NCT01962298|450140932|FG003|Overall Study|Insufficient data|0|||
125141309|NCT01962298|450140933|FG004|Overall Study|Insufficient data|1|||
125071436|NCT00928512|449880081|FG003|Overall Study|Administrative Problems|0|||
125141310|NCT01962298|450140929|FG000|Overall Study|Incorrect data recorded|0|||
125071437|NCT00928512|449880082|FG004|Overall Study|Administrative Problems|0|||
125071438|NCT01963780|449880083|FG000|Overall Study|Death|7|||
125071439|NCT04153929|449880084|FG000|Overall Study|Other than listed|2|||
125071440|NCT04153929|449880085|FG001|Overall Study|Other than listed|2|||
125071441|NCT04153929|449880086|FG002|Overall Study|Other than listed|0|||
125071442|NCT04153929|449880087|FG003|Overall Study|Other than listed|1|||
125141311|NCT01962298|450140930|FG001|Overall Study|Incorrect data recorded|1|||
125141312|NCT01962298|450140931|FG002|Overall Study|Incorrect data recorded|0|||
125141313|NCT01962298|450140932|FG003|Overall Study|Incorrect data recorded|0|||
125141314|NCT01962298|450140933|FG004|Overall Study|Incorrect data recorded|0|||
125141315|NCT01962298|450140929|FG000|Overall Study|Physician Decision|0|||
125141316|NCT01962298|450140930|FG001|Overall Study|Physician Decision|1|||
125141317|NCT01962298|450140931|FG002|Overall Study|Physician Decision|0|||
125141318|NCT01962298|450140932|FG003|Overall Study|Physician Decision|0|||
125141319|NCT01962298|450140933|FG004|Overall Study|Physician Decision|1|||
125141320|NCT01971645|450140934|FG000|Overall Study|Adverse Event|1|||
125222999|NCT01051557|450444454|FG001|Overall Study|Adverse Event|0|||
125223000|NCT01051557|450444455|FG002|Overall Study|Adverse Event|0|||
125223001|NCT01051557|450444456|FG003|Overall Study|Adverse Event|1|||
125223002|NCT01051557|450444457|FG004|Overall Study|Adverse Event|1|||
125223003|NCT01051557|450444458|FG005|Overall Study|Adverse Event|3|||
125223004|NCT01051557|450444459|FG006|Overall Study|Adverse Event|4|||
125071443|NCT04153929|449880088|FG004|Overall Study|Other than listed|0|||
125071444|NCT04153929|449880089|FG005|Overall Study|Other than listed|2|||
125071445|NCT04153929|449880090|FG006|Overall Study|Other than listed|2|||
125071446|NCT04153929|449880091|FG007|Overall Study|Other than listed|1|||
125071447|NCT04153929|449880084|FG000|Overall Study|Lost to Follow-up|2|||
125071448|NCT04153929|449880085|FG001|Overall Study|Lost to Follow-up|1|||
125071449|NCT04153929|449880086|FG002|Overall Study|Lost to Follow-up|0|||
125071450|NCT04153929|449880087|FG003|Overall Study|Lost to Follow-up|1|||
125071451|NCT04153929|449880088|FG004|Overall Study|Lost to Follow-up|1|||
125071452|NCT04153929|449880089|FG005|Overall Study|Lost to Follow-up|0|||
125071453|NCT04153929|449880090|FG006|Overall Study|Lost to Follow-up|0|||
125071454|NCT04153929|449880091|FG007|Overall Study|Lost to Follow-up|0|||
125071455|NCT04153929|449880084|FG000|Overall Study|Withdrawal by Subject|3|||
125071456|NCT04153929|449880085|FG001|Overall Study|Withdrawal by Subject|1|||
125071457|NCT04153929|449880086|FG002|Overall Study|Withdrawal by Subject|0|||
125223005|NCT04110314|450444460|FG000|Overall Study|Did not meet inclusion criteria|35255|||
125223006|NCT04110314|450444461|FG001|Overall Study|Did not meet inclusion criteria|35104|||
125223007|NCT04110314|450444462|FG002|Overall Study|Did not meet inclusion criteria|35636|||
125223008|NCT04110314|450444463|FG003|Overall Study|Did not meet inclusion criteria|35135|||
125223009|NCT04110314|450444464|FG004|Overall Study|Did not meet inclusion criteria|35247|||
125223010|NCT04110314|450444465|FG005|Overall Study|Did not meet inclusion criteria|35727|||
125223011|NCT01178125|450444472|FG000|Overall Study|Lost to Follow-up|397|||
125223012|NCT01178125|450444472|FG000|Overall Study|Adverse Event|244|||
125223013|NCT01178125|450444472|FG000|Overall Study|Withdrawal by Subject|209|||
125223014|NCT01178125|450444472|FG000|Overall Study|Noncompliance|184|||
125223015|NCT01178125|450444472|FG000|Overall Study|Pregnancy|55|||
125223016|NCT01178125|450444472|FG000|Overall Study|Other Reason|39|||
125223017|NCT01178125|450444472|FG000|Overall Study|Sponsor Decision|28|||
125223018|NCT01178125|450444472|FG000|Overall Study|Protocol Violation|17|||
125223019|NCT01178125|450444472|FG000|Overall Study|Investigator Decision|5|||
125223020|NCT02948829|450444473|FG000|Overall Study|Lost to Follow-up|2|||
125223021|NCT02948829|450444473|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
125223022|NCT02948829|450444473|FG000|Overall Study|Pregnancy|1|||
125223023|NCT02948829|450444473|FG000|Overall Study|Other: Reason not Specified|8|||
125223024|NCT01004978|450444474|FG000|Overall Study|Disease progression|31|||
125223025|NCT01004978|450444475|FG001|Overall Study|Disease progression|48|||
125223026|NCT01004978|450444474|FG000|Overall Study|Adverse Event|42|||
125223027|NCT01004978|450444475|FG001|Overall Study|Adverse Event|22|||
125223028|NCT01004978|450444474|FG000|Overall Study|Death|3|||
125223029|NCT01004978|450444475|FG001|Overall Study|Death|2|||
125223030|NCT01004978|450444474|FG000|Overall Study|Withdrawal by Subject|16|||
125223031|NCT01004978|450444475|FG001|Overall Study|Withdrawal by Subject|16|||
125223032|NCT01004978|450444474|FG000|Overall Study|Alternative therapy|4|||
125223033|NCT01004978|450444475|FG001|Overall Study|Alternative therapy|8|||
125223034|NCT01004978|450444474|FG000|Overall Study|Physician Decision|6|||
125223035|NCT01004978|450444475|FG001|Overall Study|Physician Decision|3|||
125223036|NCT01004978|450444474|FG000|Overall Study|Other complicating disease|2|||
125223037|NCT01004978|450444475|FG001|Overall Study|Other complicating disease|2|||
125223038|NCT01004978|450444474|FG000|Overall Study|Protocol Violation|2|||
125223039|NCT01004978|450444475|FG001|Overall Study|Protocol Violation|3|||
125223040|NCT01004978|450444474|FG000|Overall Study|Non-compliance|3|||
125223041|NCT01004978|450444475|FG001|Overall Study|Non-compliance|2|||
125223042|NCT01004978|450444474|FG000|Overall Study|Ineligible|1|||
125223043|NCT01004978|450444475|FG001|Overall Study|Ineligible|0|||
125223044|NCT01004978|450444474|FG000|Overall Study|Unblinded|0|||
125223045|NCT01004978|450444475|FG001|Overall Study|Unblinded|1|||
125223046|NCT01004978|450444474|FG000|Overall Study|Performance status worsening|0|||
125223047|NCT01004978|450444475|FG001|Overall Study|Performance status worsening|1|||
125223048|NCT01004978|450444474|FG000|Overall Study|Never started treatment|8|||
125223049|NCT01004978|450444475|FG001|Overall Study|Never started treatment|9|||
125071458|NCT04153929|449880087|FG003|Overall Study|Withdrawal by Subject|3|||
125071459|NCT04153929|449880088|FG004|Overall Study|Withdrawal by Subject|1|||
125071460|NCT04153929|449880089|FG005|Overall Study|Withdrawal by Subject|0|||
125223050|NCT00369915|450444476|FG000|Overall Study|expected side effects|2|||
125223051|NCT00369915|450444477|FG001|Overall Study|expected side effects|1|||
125223052|NCT00369915|450444476|FG000|Overall Study|Withdrawal by Subject|4|||
125223053|NCT00369915|450444477|FG001|Overall Study|Withdrawal by Subject|1|||
125223054|NCT00369915|450444476|FG000|Overall Study|W/drawl by investigators|0|||
125071461|NCT04153929|449880090|FG006|Overall Study|Withdrawal by Subject|1|||
125071462|NCT04153929|449880091|FG007|Overall Study|Withdrawal by Subject|0|||
125223055|NCT00369915|450444477|FG001|Overall Study|W/drawl by investigators|1|||
125223056|NCT01711983|450444478|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
125071463|NCT04153929|449880084|FG000|Overall Study|Protocol Violation|0|||
125071464|NCT04153929|449880085|FG001|Overall Study|Protocol Violation|0|||
125071465|NCT04153929|449880086|FG002|Overall Study|Protocol Violation|0|||
125071466|NCT04153929|449880087|FG003|Overall Study|Protocol Violation|0|||
125071467|NCT04153929|449880088|FG004|Overall Study|Protocol Violation|0|||
125071468|NCT04153929|449880089|FG005|Overall Study|Protocol Violation|0|||
125071469|NCT04153929|449880090|FG006|Overall Study|Protocol Violation|1|||
125071470|NCT04153929|449880091|FG007|Overall Study|Protocol Violation|2|||
125071471|NCT04153929|449880084|FG000|Overall Study|Adverse Event|3|||
125071472|NCT04153929|449880085|FG001|Overall Study|Adverse Event|5|||
125071473|NCT04153929|449880086|FG002|Overall Study|Adverse Event|5|||
125071474|NCT04153929|449880087|FG003|Overall Study|Adverse Event|11|||
125071475|NCT04153929|449880088|FG004|Overall Study|Adverse Event|15|||
125071476|NCT04153929|449880089|FG005|Overall Study|Adverse Event|4|||
125071477|NCT04153929|449880090|FG006|Overall Study|Adverse Event|8|||
125071478|NCT04153929|449880091|FG007|Overall Study|Adverse Event|2|||
125071479|NCT04153929|449880084|FG000|Overall Study|Not treated|1|||
125071480|NCT04153929|449880085|FG001|Overall Study|Not treated|0|||
125071481|NCT04153929|449880086|FG002|Overall Study|Not treated|0|||
125071482|NCT04153929|449880087|FG003|Overall Study|Not treated|0|||
125071483|NCT04153929|449880088|FG004|Overall Study|Not treated|0|||
125071484|NCT04153929|449880089|FG005|Overall Study|Not treated|0|||
125071485|NCT04153929|449880090|FG006|Overall Study|Not treated|1|||
125071486|NCT04153929|449880091|FG007|Overall Study|Not treated|0|||
125071487|NCT03383614|449880092|FG000|Overall Study|Withdrawal by Subject|0|||
125071488|NCT03383614|449880093|FG001|Overall Study|Withdrawal by Subject|1|||
125071489|NCT03383614|449880094|FG002|Overall Study|Withdrawal by Subject|0|||
125071490|NCT03383614|449880095|FG003|Overall Study|Withdrawal by Subject|0|||
125071491|NCT00729326|449880102|FG000|Overall Study|Lost to Follow-up|2|||
125071492|NCT00729326|449880103|FG001|Overall Study|Lost to Follow-up|0|||
125071493|NCT00729326|449880102|FG000|Overall Study|Physician Decision|0|||
125071494|NCT00729326|449880103|FG001|Overall Study|Physician Decision|1|||
125071495|NCT00729326|449880102|FG000|Overall Study|Protocol Violation|3|||
125071496|NCT00729326|449880103|FG001|Overall Study|Protocol Violation|2|||
125071497|NCT00729326|449880102|FG000|Overall Study|Subject Decision|4|||
125071498|NCT00729326|449880103|FG001|Overall Study|Subject Decision|4|||
125071499|NCT00729326|449880102|FG000|Overall Study|Sponsor Decision|1|||
125071500|NCT00729326|449880103|FG001|Overall Study|Sponsor Decision|2|||
125071501|NCT01235728|449880104|FG000|Overall Study|Protocol Violation|0|||
125071502|NCT01235728|449880105|FG001|Overall Study|Protocol Violation|0|||
125071503|NCT01235728|449880106|FG002|Overall Study|Protocol Violation|0|||
125071504|NCT01235728|449880107|FG003|Overall Study|Protocol Violation|1|||
125071505|NCT01235728|449880108|FG004|Overall Study|Protocol Violation|0|||
125071506|NCT01235728|449880109|FG005|Overall Study|Protocol Violation|0|||
125071507|NCT01235728|449880110|FG006|Overall Study|Protocol Violation|0|||
125071508|NCT01235728|449880111|FG007|Overall Study|Protocol Violation|0|||
125071509|NCT02559713|449880112|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
125071510|NCT02193828|449880116|FG000|Overall Study|Withdrawal by Subject|0|||
125071511|NCT02193828|449880117|FG001|Overall Study|Withdrawal by Subject|0|||
125071512|NCT02193828|449880118|FG002|Overall Study|Withdrawal by Subject|1|||
125071513|NCT02193828|449880119|FG003|Overall Study|Withdrawal by Subject|1|||
125071514|NCT01185704|449880120|FG000|Overall Study|Randomized but not treated|3|||
125071515|NCT01185704|449880121|FG001|Overall Study|Randomized but not treated|3|||
125071516|NCT01185704|449880120|FG000|Overall Study|Lack of ovarian response|5|||
125071517|NCT01185704|449880121|FG001|Overall Study|Lack of ovarian response|1|||
125071518|NCT01185704|449880120|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
125141321|NCT01971645|450140935|FG001|Overall Study|Adverse Event|0|||
125141322|NCT01971645|450140936|FG002|Overall Study|Adverse Event|0|||
125141323|NCT01971645|450140934|FG000|Overall Study|Lost to Follow-up|1|||
125141324|NCT01971645|450140935|FG001|Overall Study|Lost to Follow-up|0|||
125141325|NCT01971645|450140936|FG002|Overall Study|Lost to Follow-up|1|||
125071519|NCT01185704|449880121|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
125071520|NCT01185704|449880120|FG000|Overall Study|Ectopic pregnancy|0|||
125071521|NCT01185704|449880121|FG001|Overall Study|Ectopic pregnancy|1|||
125071522|NCT01686958|449880124|FG000|Overall Study|Withdrawal by Subject|1|||
125071523|NCT01151540|449880127|FG000|Overall Study|Other|2|||
125071524|NCT01151540|449880127|FG000|Overall Study|Adverse event, non-fatal|4|||
125071525|NCT01151540|449880127|FG000|Overall Study|Withdrawal by Subject|7|||
125071526|NCT00788697|449880130|FG000|Overall Study|No study drug administered|12|||
125071527|NCT00788697|449880130|FG000|Overall Study|Training Patients|74|||
125071528|NCT00788697|449880130|FG000|Overall Study|no truth standard procedure available|5|||
125071529|NCT00788697|449880130|FG000|Overall Study|Technically inadequate truth standard|1|||
125071530|NCT00788697|449880130|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
125071531|NCT01419080|449880134|FG000|Overall Study|Withdrawal by Subject|75|||
125071532|NCT01419080|449880134|FG000|Overall Study|Death|30|||
125071533|NCT01419080|449880134|FG000|Overall Study|Lost to Follow-up|23|||
125141326|NCT01971645|450140934|FG000|Overall Study|Protocol Violation|0|||
125071534|NCT01419080|449880134|FG000|Overall Study|Too Ill|3|||
125071535|NCT01998880|449880135|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
125071536|NCT01998880|449880136|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
125071537|NCT01998880|449880135|FG000|Overall Study|Disease Progression|1|||
125071538|NCT01998880|449880136|FG001|Overall Study|Disease Progression|8|||
125071539|NCT01998880|449880135|FG000|Overall Study|Withdrew Consent|2|||
125071540|NCT01998880|449880136|FG001|Overall Study|Withdrew Consent|1|||
125071541|NCT01998880|449880135|FG000|Overall Study|Death|3|||
125071542|NCT01998880|449880136|FG001|Overall Study|Death|6|||
125071543|NCT01998880|449880135|FG000|Overall Study|Insufficient Therapeutic Response|1|||
125071544|NCT01998880|449880136|FG001|Overall Study|Insufficient Therapeutic Response|5|||
125071545|NCT01998880|449880135|FG000|Overall Study|Administrative/Other|1|||
125071546|NCT01998880|449880136|FG001|Overall Study|Administrative/Other|1|||
125071547|NCT01998880|449880135|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
125071548|NCT01998880|449880136|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
125071549|NCT01998880|449880135|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
125071550|NCT01998880|449880136|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
125071551|NCT01998880|449880135|FG000|Overall Study|Did Not Receive Treatment|3|||
125071552|NCT01998880|449880136|FG001|Overall Study|Did Not Receive Treatment|2|||
125071553|NCT03199638|449880140|FG000|Overall Study|inability to drink glutamine during regularly|0|||
125071554|NCT03199638|449880141|FG001|Overall Study|inability to drink glutamine during regularly|2|||
125071555|NCT02671461|449880142|FG000|Treatment|Adverse Event|0|||
125071556|NCT02671461|449880143|FG001|Treatment|Adverse Event|0|||
125071557|NCT02671461|449880144|FG002|Treatment|Adverse Event|1|||
125071558|NCT02671461|449880142|FG000|Treatment|Administrative Reason by Sponsor|1|||
125071559|NCT02671461|449880143|FG001|Treatment|Administrative Reason by Sponsor|3|||
125141327|NCT01971645|450140935|FG001|Overall Study|Protocol Violation|0|||
125141328|NCT01971645|450140936|FG002|Overall Study|Protocol Violation|1|||
125141329|NCT00537095|450140937|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
125141330|NCT00537095|450140938|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
125141331|NCT00537095|450140937|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
125141332|NCT00537095|450140938|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
125141333|NCT00537095|450140937|FG000|Randomized Treatment Period (433 Days)|Death|3|||
125141334|NCT00537095|450140938|FG001|Randomized Treatment Period (433 Days)|Death|1|||
125141335|NCT00537095|450140937|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
125141336|NCT00537095|450140938|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
125141337|NCT00537095|450140937|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
125141338|NCT00537095|450140938|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
125141339|NCT00537095|450140937|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
125071560|NCT02671461|449880144|FG002|Treatment|Administrative Reason by Sponsor|4|||
125071561|NCT02671461|449880142|FG000|Treatment|Randomized, not treated|1|||
125071562|NCT02671461|449880143|FG001|Treatment|Randomized, not treated|0|||
125071563|NCT02671461|449880144|FG002|Treatment|Randomized, not treated|0|||
125071564|NCT02671461|449880142|FG000|Follow-up|Withdrawal by Subject|1|||
125071565|NCT02671461|449880143|FG001|Follow-up|Withdrawal by Subject|0|||
125071566|NCT02671461|449880144|FG002|Follow-up|Withdrawal by Subject|0|||
125071567|NCT02671461|449880142|FG000|Follow-up|Lost to Follow-up|0|||
125071568|NCT02671461|449880143|FG001|Follow-up|Lost to Follow-up|0|||
125071569|NCT02671461|449880144|FG002|Follow-up|Lost to Follow-up|1|||
125071570|NCT02671461|449880142|FG000|Follow-up|Administrative Reason by Sponsor|0|||
125071571|NCT02671461|449880143|FG001|Follow-up|Administrative Reason by Sponsor|1|||
125071572|NCT02671461|449880144|FG002|Follow-up|Administrative Reason by Sponsor|0|||
125071573|NCT02807844|449880145|FG000|Overall Study|Physician Decision|0|||
125141340|NCT00537095|450140938|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
125071574|NCT02807844|449880146|FG001|Overall Study|Physician Decision|0|||
125141341|NCT00537095|450140937|FG000|Open-label Period (590 Days)|Adverse Event|2|||
125141342|NCT00537095|450140938|FG001|Open-label Period (590 Days)|Adverse Event|11|||
125141343|NCT00537095|450140937|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
125141344|NCT00537095|450140938|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
125141345|NCT00537095|450140937|FG000|Open-label Period (590 Days)|Death|2|||
125141346|NCT00537095|450140938|FG001|Open-label Period (590 Days)|Death|2|||
125141347|NCT00537095|450140937|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
125141348|NCT00537095|450140938|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
125141349|NCT00537095|450140937|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
125071575|NCT02807844|449880147|FG002|Overall Study|Physician Decision|0|||
125071576|NCT02807844|449880148|FG003|Overall Study|Physician Decision|0|||
125071577|NCT02807844|449880149|FG004|Overall Study|Physician Decision|0|||
125071578|NCT02807844|449880150|FG005|Overall Study|Physician Decision|0|||
125071579|NCT02807844|449880151|FG006|Overall Study|Physician Decision|3|||
125071580|NCT02807844|449880152|FG007|Overall Study|Physician Decision|0|||
125071581|NCT02807844|449880153|FG008|Overall Study|Physician Decision|1|||
125071582|NCT02807844|449880154|FG009|Overall Study|Physician Decision|2|||
125071583|NCT02807844|449880145|FG000|Overall Study|Death|0|||
125071584|NCT02807844|449880146|FG001|Overall Study|Death|0|||
125071585|NCT02807844|449880147|FG002|Overall Study|Death|2|||
125071586|NCT02807844|449880148|FG003|Overall Study|Death|4|||
125071587|NCT02807844|449880149|FG004|Overall Study|Death|1|||
125071588|NCT02807844|449880150|FG005|Overall Study|Death|2|||
125071589|NCT02807844|449880151|FG006|Overall Study|Death|1|||
125071590|NCT02807844|449880152|FG007|Overall Study|Death|2|||
125071591|NCT02807844|449880153|FG008|Overall Study|Death|0|||
125071592|NCT02807844|449880154|FG009|Overall Study|Death|1|||
125071593|NCT02807844|449880145|FG000|Overall Study|Withdrawal by Subject|0|||
125071594|NCT02807844|449880146|FG001|Overall Study|Withdrawal by Subject|0|||
125071595|NCT02807844|449880147|FG002|Overall Study|Withdrawal by Subject|2|||
125071596|NCT02807844|449880148|FG003|Overall Study|Withdrawal by Subject|1|||
125071597|NCT02807844|449880149|FG004|Overall Study|Withdrawal by Subject|1|||
125071598|NCT02807844|449880150|FG005|Overall Study|Withdrawal by Subject|0|||
125071599|NCT02807844|449880151|FG006|Overall Study|Withdrawal by Subject|1|||
125071600|NCT02807844|449880152|FG007|Overall Study|Withdrawal by Subject|0|||
125071601|NCT02807844|449880153|FG008|Overall Study|Withdrawal by Subject|0|||
125071602|NCT02807844|449880154|FG009|Overall Study|Withdrawal by Subject|0|||
125071603|NCT02807844|449880145|FG000|Overall Study|Progressive disease|5|||
125071604|NCT02807844|449880146|FG001|Overall Study|Progressive disease|12|||
125071605|NCT02807844|449880147|FG002|Overall Study|Progressive disease|8|||
125071606|NCT02807844|449880148|FG003|Overall Study|Progressive disease|8|||
125071607|NCT02807844|449880149|FG004|Overall Study|Progressive disease|3|||
125071608|NCT02807844|449880150|FG005|Overall Study|Progressive disease|8|||
125071609|NCT02807844|449880151|FG006|Overall Study|Progressive disease|14|||
125071610|NCT02807844|449880152|FG007|Overall Study|Progressive disease|17|||
125071611|NCT02807844|449880153|FG008|Overall Study|Progressive disease|19|||
125071612|NCT02807844|449880154|FG009|Overall Study|Progressive disease|15|||
125071613|NCT02807844|449880145|FG000|Overall Study|Adverse Event|1|||
125071614|NCT02807844|449880146|FG001|Overall Study|Adverse Event|0|||
125071615|NCT02807844|449880147|FG002|Overall Study|Adverse Event|0|||
125071616|NCT02807844|449880148|FG003|Overall Study|Adverse Event|0|||
125071617|NCT02807844|449880149|FG004|Overall Study|Adverse Event|1|||
125071618|NCT02807844|449880150|FG005|Overall Study|Adverse Event|1|||
125071619|NCT02807844|449880151|FG006|Overall Study|Adverse Event|1|||
125071620|NCT02807844|449880152|FG007|Overall Study|Adverse Event|1|||
125071621|NCT02807844|449880153|FG008|Overall Study|Adverse Event|1|||
125071622|NCT02807844|449880154|FG009|Overall Study|Adverse Event|2|||
125071623|NCT00709124|449880155|FG000|Overall Study|Death|3|||
125071624|NCT00709124|449880156|FG001|Overall Study|Death|1|||
125071625|NCT00709124|449880155|FG000|Overall Study|encephalopathy; can't do assessment|1|||
125071626|NCT00709124|449880156|FG001|Overall Study|encephalopathy; can't do assessment|0|||
125071627|NCT00373490|449880157|FG000|Overall Study|Adverse Event|0|||
125071628|NCT00373490|449880158|FG001|Overall Study|Adverse Event|1|||
125071629|NCT00373490|449880157|FG000|Overall Study|Lack of Efficacy|9|||
125071630|NCT00373490|449880158|FG001|Overall Study|Lack of Efficacy|4|||
125071631|NCT00373490|449880157|FG000|Overall Study|Withdrawal by Subject|0|||
125071632|NCT00373490|449880158|FG001|Overall Study|Withdrawal by Subject|1|||
125071633|NCT04294095|449880159|FG000|Overall Study|Adverse Event|1|||
125071634|NCT04294095|449880160|FG001|Overall Study|Adverse Event|0|||
125071635|NCT00141037|449880170|FG000|Overall Study|Physician Decision|1|||
125071636|NCT00141037|449880171|FG001|Overall Study|Physician Decision|2|||
125071637|NCT00141037|449880170|FG000|Overall Study|Lost to Follow-up|3|||
125071638|NCT00141037|449880171|FG001|Overall Study|Lost to Follow-up|1|||
125071639|NCT00141037|449880170|FG000|Overall Study|Protocol Violation|0|||
125071640|NCT00141037|449880171|FG001|Overall Study|Protocol Violation|2|||
125141350|NCT00537095|450140938|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
125141351|NCT00533507|450140939|FG000|Overall Study|Withdrawal by Subject|1|||
125071641|NCT00141037|449880170|FG000|Overall Study|Withdrawal by Subject|2|||
125071642|NCT00141037|449880171|FG001|Overall Study|Withdrawal by Subject|1|||
125071643|NCT00141037|449880170|FG000|Overall Study|Other|0|||
125071644|NCT00141037|449880171|FG001|Overall Study|Other|1|||
125071645|NCT00141037|449880170|FG000|Overall Study|Moved from area|1|||
125071646|NCT00141037|449880171|FG001|Overall Study|Moved from area|7|||
125141352|NCT01576705|450140940|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
125071647|NCT00141037|449880170|FG000|Overall Study|Graft Failure|3|||
125071648|NCT00141037|449880171|FG001|Overall Study|Graft Failure|4|||
125071649|NCT00260429|449880172|FG000|Overall Study|failure to follow appointments|1|||
125071650|NCT00260429|449880173|FG001|Overall Study|failure to follow appointments|0|||
125071651|NCT00260429|449880172|FG000|Overall Study|scheduled hand surgery|1|||
125071652|NCT00260429|449880173|FG001|Overall Study|scheduled hand surgery|0|||
125071653|NCT00628758|449880174|FG000|Overall Study|Adverse Event|2|||
125071654|NCT00628758|449880175|FG001|Overall Study|Adverse Event|3|||
125071655|NCT00628758|449880174|FG000|Overall Study|Withdrawal by Subject|6|||
125071656|NCT00628758|449880175|FG001|Overall Study|Withdrawal by Subject|3|||
125071657|NCT00628758|449880174|FG000|Overall Study|Death|1|||
125071658|NCT00628758|449880175|FG001|Overall Study|Death|0|||
125071659|NCT00628758|449880174|FG000|Overall Study|Protocol Violation|5|||
125071660|NCT00628758|449880175|FG001|Overall Study|Protocol Violation|1|||
125141353|NCT01576705|450140941|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
125141354|NCT01576705|450140942|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
125141355|NCT01576705|450140943|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
125141356|NCT01576705|450140940|FG000|Overall Study|invalid ICF|0|||
125071661|NCT00628758|449880174|FG000|Overall Study|Lost to Follow-up|25|||
125071662|NCT00628758|449880175|FG001|Overall Study|Lost to Follow-up|31|||
125071663|NCT00628758|449880174|FG000|Overall Study|Pregnancy|2|||
125071664|NCT00628758|449880175|FG001|Overall Study|Pregnancy|2|||
125071665|NCT00628758|449880174|FG000|Overall Study|Investigator Moved|3|||
125071666|NCT00628758|449880175|FG001|Overall Study|Investigator Moved|0|||
125071667|NCT00628758|449880174|FG000|Overall Study|Treatment Failure|0|||
125071668|NCT00628758|449880175|FG001|Overall Study|Treatment Failure|2|||
125071669|NCT04179786|449880176|FG000|Overall Study|Withdrawal by Subject|8|||
125071670|NCT01938001|449880177|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
125071671|NCT01938001|449880178|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
125071672|NCT01938001|449880177|FG000|Pre-Treatment|Death|1|||
125071673|NCT01938001|449880178|FG001|Pre-Treatment|Death|0|||
125071674|NCT01938001|449880177|FG000|Treatment|Death|2|||
125071675|NCT01938001|449880178|FG001|Treatment|Death|0|||
125071676|NCT01938001|449880177|FG000|Treatment|Adverse Event|14|||
125071677|NCT01938001|449880178|FG001|Treatment|Adverse Event|8|||
125071678|NCT01938001|449880177|FG000|Treatment|Progressive Disease|21|||
125071679|NCT01938001|449880178|FG001|Treatment|Progressive Disease|54|||
125071680|NCT01938001|449880177|FG000|Treatment|Withdrawal by Subject|13|||
125071681|NCT01938001|449880178|FG001|Treatment|Withdrawal by Subject|7|||
125071682|NCT01938001|449880177|FG000|Treatment|Other reasons|2|||
125071683|NCT01938001|449880178|FG001|Treatment|Other reasons|1|||
125071684|NCT03310580|449880179|FG000|Overall Study|Adverse Event|0|||
125071685|NCT03310580|449880180|FG001|Overall Study|Adverse Event|1|||
125071686|NCT03310580|449880181|FG002|Overall Study|Adverse Event|0|||
125071687|NCT02762708|449880186|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
125071688|NCT02762708|449880187|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
125071689|NCT02762708|449880188|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
125071690|NCT02762708|449880189|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
125071691|NCT01468701|449880194|FG000|Overall Study|Not eligible|91|||
125071692|NCT01468701|449880195|FG001|Overall Study|Not eligible|140|||
125071693|NCT01468701|449880196|FG002|Overall Study|Not eligible|29|||
125071694|NCT01468701|449880197|FG003|Overall Study|Not eligible|12|||
125071695|NCT01468701|449880198|FG004|Overall Study|Not eligible|22|||
125071696|NCT01468701|449880199|FG005|Overall Study|Not eligible|2|||
125071697|NCT01468701|449880200|FG006|Overall Study|Not eligible|39|||
125071698|NCT01468701|449880201|FG007|Overall Study|Not eligible|1|||
125071699|NCT01468701|449880202|FG008|Overall Study|Not eligible|40|||
125071700|NCT01468701|449880203|FG009|Overall Study|Not eligible|126|||
125071701|NCT01468701|449880204|FG010|Overall Study|Not eligible|39|||
125071702|NCT01468701|449880205|FG011|Overall Study|Not eligible|33|||
125071703|NCT01468701|449880206|FG012|Overall Study|Not eligible|1|||
125071704|NCT01468701|449880207|FG013|Overall Study|Not eligible|19|||
125071705|NCT01468701|449880208|FG014|Overall Study|Not eligible|1|||
125071706|NCT01468701|449880209|FG015|Overall Study|Not eligible|32|||
125071707|NCT01468701|449880210|FG016|Overall Study|Not eligible|0|||
125071708|NCT01468701|449880194|FG000|Overall Study|Lost to Follow-up|306|||
125071709|NCT01468701|449880195|FG001|Overall Study|Lost to Follow-up|0|||
125071710|NCT01468701|449880196|FG002|Overall Study|Lost to Follow-up|0|||
125071711|NCT01468701|449880197|FG003|Overall Study|Lost to Follow-up|0|||
125141357|NCT01576705|450140941|FG001|Overall Study|invalid ICF|1|||
125141358|NCT01576705|450140942|FG002|Overall Study|invalid ICF|0|||
125141359|NCT01576705|450140943|FG003|Overall Study|invalid ICF|0|||
125141360|NCT03727139|450140944|FG000|Overall Study|Protocol Violation|60|||
125071712|NCT01468701|449880198|FG004|Overall Study|Lost to Follow-up|0|||
125071713|NCT01468701|449880199|FG005|Overall Study|Lost to Follow-up|0|||
125071714|NCT01468701|449880200|FG006|Overall Study|Lost to Follow-up|0|||
125071715|NCT01468701|449880201|FG007|Overall Study|Lost to Follow-up|0|||
125071716|NCT01468701|449880202|FG008|Overall Study|Lost to Follow-up|215|||
125071717|NCT01468701|449880203|FG009|Overall Study|Lost to Follow-up|309|||
125071718|NCT01468701|449880204|FG010|Overall Study|Lost to Follow-up|224|||
125071719|NCT01468701|449880205|FG011|Overall Study|Lost to Follow-up|212|||
125141361|NCT00566722|450140945|FG000|Overall Study|Adverse Event|0|||
125071720|NCT01468701|449880206|FG012|Overall Study|Lost to Follow-up|11|||
125071721|NCT01468701|449880207|FG013|Overall Study|Lost to Follow-up|164|||
125071722|NCT01468701|449880208|FG014|Overall Study|Lost to Follow-up|17|||
125071723|NCT01468701|449880209|FG015|Overall Study|Lost to Follow-up|127|||
125071724|NCT01468701|449880210|FG016|Overall Study|Lost to Follow-up|1|||
125071725|NCT01468701|449880194|FG000|Overall Study|Withdrawal by Subject|165|||
125071726|NCT01468701|449880195|FG001|Overall Study|Withdrawal by Subject|0|||
125141362|NCT00566722|450140946|FG001|Overall Study|Adverse Event|1|||
125141363|NCT00566722|450140947|FG002|Overall Study|Adverse Event|0|||
125141364|NCT00566722|450140945|FG000|Overall Study|Withdrawal by Subject|0|||
125071727|NCT01468701|449880196|FG002|Overall Study|Withdrawal by Subject|0|||
125071728|NCT01468701|449880197|FG003|Overall Study|Withdrawal by Subject|0|||
125071729|NCT01468701|449880198|FG004|Overall Study|Withdrawal by Subject|0|||
125071730|NCT01468701|449880199|FG005|Overall Study|Withdrawal by Subject|0|||
125071731|NCT01468701|449880200|FG006|Overall Study|Withdrawal by Subject|0|||
125071732|NCT01468701|449880201|FG007|Overall Study|Withdrawal by Subject|0|||
125071733|NCT01468701|449880202|FG008|Overall Study|Withdrawal by Subject|83|||
125071734|NCT01468701|449880203|FG009|Overall Study|Withdrawal by Subject|88|||
125071735|NCT01468701|449880204|FG010|Overall Study|Withdrawal by Subject|100|||
125071736|NCT01468701|449880205|FG011|Overall Study|Withdrawal by Subject|114|||
125071737|NCT01468701|449880206|FG012|Overall Study|Withdrawal by Subject|9|||
125071738|NCT01468701|449880207|FG013|Overall Study|Withdrawal by Subject|47|||
125071739|NCT01468701|449880208|FG014|Overall Study|Withdrawal by Subject|6|||
125071740|NCT01468701|449880209|FG015|Overall Study|Withdrawal by Subject|31|||
125071741|NCT01468701|449880210|FG016|Overall Study|Withdrawal by Subject|0|||
125071742|NCT01468701|449880194|FG000|Overall Study|Other reasons than listed|437|||
125071743|NCT01468701|449880195|FG001|Overall Study|Other reasons than listed|0|||
125071744|NCT01468701|449880196|FG002|Overall Study|Other reasons than listed|0|||
125071745|NCT01468701|449880197|FG003|Overall Study|Other reasons than listed|0|||
125071746|NCT01468701|449880198|FG004|Overall Study|Other reasons than listed|0|||
125071747|NCT01468701|449880199|FG005|Overall Study|Other reasons than listed|0|||
125071748|NCT01468701|449880200|FG006|Overall Study|Other reasons than listed|0|||
125071749|NCT01468701|449880201|FG007|Overall Study|Other reasons than listed|0|||
125071750|NCT01468701|449880202|FG008|Overall Study|Other reasons than listed|318|||
125071751|NCT01468701|449880203|FG009|Overall Study|Other reasons than listed|658|||
125071752|NCT01468701|449880204|FG010|Overall Study|Other reasons than listed|433|||
125071753|NCT01468701|449880205|FG011|Overall Study|Other reasons than listed|504|||
125071754|NCT01468701|449880206|FG012|Overall Study|Other reasons than listed|28|||
125071755|NCT01468701|449880207|FG013|Overall Study|Other reasons than listed|239|||
125071756|NCT01468701|449880208|FG014|Overall Study|Other reasons than listed|39|||
125071757|NCT01468701|449880209|FG015|Overall Study|Other reasons than listed|172|||
125071758|NCT01468701|449880210|FG016|Overall Study|Other reasons than listed|0|||
125071759|NCT01468701|449880194|FG000|Overall Study|No end of study case report form|0|||
125071760|NCT01468701|449880195|FG001|Overall Study|No end of study case report form|0|||
125071761|NCT01468701|449880196|FG002|Overall Study|No end of study case report form|0|||
125071762|NCT01468701|449880197|FG003|Overall Study|No end of study case report form|0|||
125071763|NCT01468701|449880198|FG004|Overall Study|No end of study case report form|0|||
125071764|NCT01468701|449880199|FG005|Overall Study|No end of study case report form|0|||
125071765|NCT01468701|449880200|FG006|Overall Study|No end of study case report form|0|||
125071766|NCT01468701|449880201|FG007|Overall Study|No end of study case report form|0|||
125071767|NCT01468701|449880202|FG008|Overall Study|No end of study case report form|4|||
125071768|NCT01468701|449880203|FG009|Overall Study|No end of study case report form|1|||
125071769|NCT01468701|449880204|FG010|Overall Study|No end of study case report form|2|||
125071770|NCT01468701|449880205|FG011|Overall Study|No end of study case report form|3|||
125071771|NCT01468701|449880206|FG012|Overall Study|No end of study case report form|0|||
125071772|NCT01468701|449880207|FG013|Overall Study|No end of study case report form|1|||
125071773|NCT01468701|449880208|FG014|Overall Study|No end of study case report form|0|||
125071774|NCT01468701|449880209|FG015|Overall Study|No end of study case report form|0|||
125071775|NCT01468701|449880210|FG016|Overall Study|No end of study case report form|0|||
125071776|NCT01468701|449880194|FG000|Overall Study|Not being followed up|0|||
125071777|NCT01468701|449880195|FG001|Overall Study|Not being followed up|4963|||
125071778|NCT01468701|449880196|FG002|Overall Study|Not being followed up|1755|||
125071779|NCT01468701|449880197|FG003|Overall Study|Not being followed up|703|||
125071780|NCT01468701|449880198|FG004|Overall Study|Not being followed up|1714|||
125071781|NCT01468701|449880199|FG005|Overall Study|Not being followed up|126|||
125071782|NCT01468701|449880200|FG006|Overall Study|Not being followed up|1170|||
125071783|NCT01468701|449880201|FG007|Overall Study|Not being followed up|4|||
125071784|NCT01468701|449880202|FG008|Overall Study|Not being followed up|0|||
125071785|NCT01468701|449880203|FG009|Overall Study|Not being followed up|0|||
125071786|NCT01468701|449880204|FG010|Overall Study|Not being followed up|0|||
125071787|NCT01468701|449880205|FG011|Overall Study|Not being followed up|0|||
125141365|NCT00566722|450140946|FG001|Overall Study|Withdrawal by Subject|0|||
125141366|NCT00566722|450140947|FG002|Overall Study|Withdrawal by Subject|1|||
125141367|NCT00566722|450140945|FG000|Overall Study|Lost to Follow-up|1|||
125141368|NCT00566722|450140946|FG001|Overall Study|Lost to Follow-up|1|||
125071788|NCT01468701|449880206|FG012|Overall Study|Not being followed up|0|||
125141369|NCT00566722|450140947|FG002|Overall Study|Lost to Follow-up|1|||
125071789|NCT01468701|449880207|FG013|Overall Study|Not being followed up|0|||
125071790|NCT01468701|449880208|FG014|Overall Study|Not being followed up|0|||
125071791|NCT01468701|449880209|FG015|Overall Study|Not being followed up|0|||
125071792|NCT01468701|449880210|FG016|Overall Study|Not being followed up|0|||
125141370|NCT00566722|450140945|FG000|Overall Study|Lack of Efficacy|1|||
125141371|NCT00566722|450140946|FG001|Overall Study|Lack of Efficacy|2|||
125071793|NCT01068717|449880211|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
125071794|NCT01068717|449880212|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
125071795|NCT01068717|449880213|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
125071796|NCT01068717|449880214|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
125071797|NCT00892957|449880216|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
125071798|NCT00892957|449880217|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
125071799|NCT00892957|449880216|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
125071800|NCT00892957|449880217|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
125071801|NCT03700736|449880220|FG000|Overall Study|Pregnancy|1|||
125071802|NCT03700736|449880221|FG001|Overall Study|Pregnancy|1|||
125071803|NCT03700736|449880220|FG000|Overall Study|Withdrawal by Subject|2|||
125071804|NCT03700736|449880221|FG001|Overall Study|Withdrawal by Subject|6|||
125071805|NCT01410799|449880222|FG000|Overall Study|PI decision|13|||
125071806|NCT02688153|449882276|FG000|Overall Study|Death|7|||
125071807|NCT02688153|449882277|FG001|Overall Study|Death|5|||
125071808|NCT02688153|449882276|FG000|Overall Study|Withdrawal by Subject|4|||
125071809|NCT02688153|449882277|FG001|Overall Study|Withdrawal by Subject|2|||
125071810|NCT02688153|449882276|FG000|Overall Study|Valve Explant|1|||
125071811|NCT02688153|449882277|FG001|Overall Study|Valve Explant|0|||
125071812|NCT02688153|449882276|FG000|Overall Study|Conversion to Commercial Valve|3|||
125071813|NCT02688153|449882277|FG001|Overall Study|Conversion to Commercial Valve|0|||
125071814|NCT03682055|449882278|FG000|Overall Study|Lack of Efficacy|1|||
125071815|NCT03682055|449882279|FG001|Overall Study|Lack of Efficacy|2|||
125071816|NCT03682055|449882280|FG002|Overall Study|Lack of Efficacy|1|||
125071817|NCT03682055|449882281|FG003|Overall Study|Lack of Efficacy|2|||
125071818|NCT03682055|449882282|FG004|Overall Study|Lack of Efficacy|1|||
125071819|NCT03682055|449882283|FG005|Overall Study|Lack of Efficacy|3|||
125071820|NCT03682055|449882278|FG000|Overall Study|Withdrawal by Subject|0|||
125071821|NCT03682055|449882279|FG001|Overall Study|Withdrawal by Subject|0|||
125071822|NCT03682055|449882280|FG002|Overall Study|Withdrawal by Subject|0|||
125071823|NCT03682055|449882281|FG003|Overall Study|Withdrawal by Subject|0|||
125071824|NCT03682055|449882282|FG004|Overall Study|Withdrawal by Subject|0|||
125071825|NCT03682055|449882283|FG005|Overall Study|Withdrawal by Subject|1|||
125071826|NCT03682055|449882278|FG000|Overall Study|Termination of Study by Sponsor|0|||
125071827|NCT03682055|449882279|FG001|Overall Study|Termination of Study by Sponsor|0|||
125071828|NCT03682055|449882280|FG002|Overall Study|Termination of Study by Sponsor|0|||
125071829|NCT03682055|449882281|FG003|Overall Study|Termination of Study by Sponsor|0|||
125071830|NCT03682055|449882282|FG004|Overall Study|Termination of Study by Sponsor|0|||
125071831|NCT03682055|449882283|FG005|Overall Study|Termination of Study by Sponsor|3|||
125071832|NCT01135394|449882284|FG000|Screening|Lost to Follow-up|2|||
125071833|NCT01135394|449882284|FG000|Screening|Withdrawal by Subject|10|||
125071834|NCT01135394|449882284|FG000|Screening|Screening failure|16|||
125071835|NCT01135394|449882284|FG000|Screening|Physician Decision|5|||
125071836|NCT01135394|449882284|FG000|Baseline Assessment|Withdrawal by Subject|9|||
125071837|NCT01135394|449882284|FG000|Baseline Assessment|Physician Decision|3|||
125071838|NCT01135394|449882284|FG000|Baseline Assessment|Lost to Follow-up|2|||
125071839|NCT01135394|449882284|FG000|Baseline Assessment|Adverse Event|1|||
125071840|NCT01135394|449882284|FG000|Study Treatment|Withdrawal by Subject|1|||
125071841|NCT01135394|449882284|FG000|Study Treatment|Physician Decision|1|||
125071842|NCT01135394|449882284|FG000|Study Treatment|Adverse Event|2|||
125071843|NCT00191386|449882285|FG000|Overall Study|Adverse Event|16|||
125071844|NCT00191386|449882285|FG000|Overall Study|Lost to Follow-up|1|||
125071845|NCT00191386|449882285|FG000|Overall Study|Entry Criteria Exclusion|3|||
125071846|NCT00191386|449882285|FG000|Overall Study|Protocol Violation|18|||
125141372|NCT00566722|450140947|FG002|Overall Study|Lack of Efficacy|4|||
125141373|NCT00566722|450140945|FG000|Overall Study|Did not meet exclusion criteria|0|||
125141374|NCT00566722|450140946|FG001|Overall Study|Did not meet exclusion criteria|0|||
125141375|NCT00566722|450140947|FG002|Overall Study|Did not meet exclusion criteria|2|||
125141376|NCT00566722|450140945|FG000|Overall Study|Serious adverse event|0|||
125071847|NCT00191386|449882285|FG000|Overall Study|Withdrawal by Subject|96|||
125071848|NCT00191386|449882285|FG000|Overall Study|Physician Decision|11|||
125071849|NCT00191386|449882285|FG000|Overall Study|Lack of Efficacy|15|||
125071850|NCT00462488|449882286|FG000|Overall Study|Protocol Violation|1|||
125071851|NCT00462488|449882287|FG001|Overall Study|Protocol Violation|0|||
125071852|NCT00462488|449882286|FG000|Overall Study|Lack of Efficacy|19|||
125071853|NCT00462488|449882287|FG001|Overall Study|Lack of Efficacy|17|||
125071854|NCT01742091|449882292|FG000|Overall Study|Adverse Event|0|||
125071855|NCT01742091|449882293|FG001|Overall Study|Adverse Event|0|||
125071856|NCT01742091|449882294|FG002|Overall Study|Adverse Event|0|||
125071857|NCT01742091|449882295|FG003|Overall Study|Adverse Event|0|||
125071858|NCT01742091|449882296|FG004|Overall Study|Adverse Event|1|||
125071859|NCT01742091|449882297|FG005|Overall Study|Adverse Event|0|||
125071860|NCT01742091|449882292|FG000|Overall Study|Physician Decision|0|||
125071861|NCT01742091|449882293|FG001|Overall Study|Physician Decision|0|||
125071862|NCT01742091|449882294|FG002|Overall Study|Physician Decision|0|||
125141377|NCT00566722|450140946|FG001|Overall Study|Serious adverse event|1|||
125071863|NCT01742091|449882295|FG003|Overall Study|Physician Decision|0|||
125071864|NCT01742091|449882296|FG004|Overall Study|Physician Decision|0|||
125071865|NCT01742091|449882297|FG005|Overall Study|Physician Decision|1|||
125071866|NCT01742091|449882292|FG000|Overall Study|Withdrawal by Subject|0|||
125071867|NCT01742091|449882293|FG001|Overall Study|Withdrawal by Subject|0|||
125071868|NCT01742091|449882294|FG002|Overall Study|Withdrawal by Subject|0|||
125071869|NCT01742091|449882295|FG003|Overall Study|Withdrawal by Subject|1|||
125071870|NCT01742091|449882296|FG004|Overall Study|Withdrawal by Subject|0|||
125071871|NCT01742091|449882297|FG005|Overall Study|Withdrawal by Subject|0|||
125071872|NCT01742091|449882292|FG000|Overall Study|Lost to Follow-up|0|||
125071873|NCT01742091|449882293|FG001|Overall Study|Lost to Follow-up|0|||
125071874|NCT01742091|449882294|FG002|Overall Study|Lost to Follow-up|0|||
125071875|NCT01742091|449882295|FG003|Overall Study|Lost to Follow-up|0|||
125071876|NCT01742091|449882296|FG004|Overall Study|Lost to Follow-up|0|||
125071877|NCT01742091|449882297|FG005|Overall Study|Lost to Follow-up|1|||
125071878|NCT03750240|449882298|FG000|Overall Study|Technical Difficulties|2|||
125071879|NCT03706040|449882299|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
125071880|NCT03706040|449882300|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
125071881|NCT03706040|449882301|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
125071882|NCT03706040|449882302|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
125071883|NCT03706040|449882303|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
125071884|NCT03706040|449882304|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
125071885|NCT03706040|449882305|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
125071886|NCT03706040|449882299|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
125071887|NCT03706040|449882300|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
125071888|NCT03706040|449882301|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
125071889|NCT03706040|449882302|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
125071890|NCT03706040|449882303|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
125071891|NCT03706040|449882304|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
125071892|NCT03706040|449882305|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
125071893|NCT03706040|449882299|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
125071894|NCT03706040|449882300|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
125071895|NCT03706040|449882301|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
125071896|NCT03706040|449882302|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
125071897|NCT03706040|449882303|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
125071898|NCT03706040|449882304|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
125071899|NCT03706040|449882305|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
125071900|NCT03706040|449882299|FG000|Period A (Week 0 to Week 16)|Other|2|||
125071901|NCT03706040|449882300|FG001|Period A (Week 0 to Week 16)|Other|0|||
125071902|NCT03706040|449882301|FG002|Period A (Week 0 to Week 16)|Other|2|||
125071903|NCT03706040|449882302|FG003|Period A (Week 0 to Week 16)|Other|0|||
125071904|NCT03706040|449882303|FG004|Period A (Week 0 to Week 16)|Other|0|||
125071905|NCT03706040|449882304|FG005|Period A (Week 0 to Week 16)|Other|0|||
125071906|NCT03706040|449882305|FG006|Period A (Week 0 to Week 16)|Other|0|||
125071907|NCT03706040|449882299|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
125071908|NCT03706040|449882300|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
125071909|NCT03706040|449882301|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
125071910|NCT03706040|449882302|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
125071911|NCT03706040|449882303|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
125071912|NCT03706040|449882304|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
125071913|NCT03706040|449882305|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
125071914|NCT03706040|449882299|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
125071915|NCT03706040|449882300|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
125071916|NCT03706040|449882301|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
125071917|NCT03706040|449882302|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
125071918|NCT03706040|449882303|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
125071919|NCT03706040|449882304|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
125071920|NCT03706040|449882305|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
125071921|NCT03706040|449882299|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
125071922|NCT03706040|449882300|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
125071923|NCT03706040|449882301|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
125071924|NCT03706040|449882302|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
125071925|NCT03706040|449882303|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
125071926|NCT03706040|449882304|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
125071927|NCT03706040|449882305|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
125071928|NCT03706040|449882299|FG000|Period B (Week 16 to Week 52)|Other|0|||
125071929|NCT03706040|449882300|FG001|Period B (Week 16 to Week 52)|Other|0|||
125071930|NCT03706040|449882301|FG002|Period B (Week 16 to Week 52)|Other|0|||
125071931|NCT03706040|449882302|FG003|Period B (Week 16 to Week 52)|Other|4|||
125071932|NCT03706040|449882303|FG004|Period B (Week 16 to Week 52)|Other|5|||
125071933|NCT03706040|449882304|FG005|Period B (Week 16 to Week 52)|Other|23|||
125071934|NCT03706040|449882305|FG006|Period B (Week 16 to Week 52)|Other|17|||
125223057|NCT01711983|450444478|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
125071935|NCT00927758|449882306|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
125071936|NCT00927758|449882307|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
125223058|NCT01711983|450444478|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
125071937|NCT00927758|449882308|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
125071938|NCT00927758|449882309|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
125071939|NCT00927758|449882310|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
125071940|NCT00927758|449882311|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
125071941|NCT00927758|449882306|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
125071942|NCT00927758|449882307|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
125071943|NCT00927758|449882308|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
125071944|NCT00927758|449882309|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
125071945|NCT00927758|449882310|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
125071946|NCT00927758|449882311|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
125071947|NCT00439725|449882312|FG000|Treatment Period|Withdrawal by Subject|22|||
125071948|NCT00439725|449882313|FG001|Treatment Period|Withdrawal by Subject|19|||
125071949|NCT00439725|449882312|FG000|Treatment Period|Study terminated by sponsor|156|||
125071950|NCT00439725|449882313|FG001|Treatment Period|Study terminated by sponsor|148|||
125071951|NCT00439725|449882312|FG000|Treatment Period|Site closed by investigator|1|||
125071952|NCT00439725|449882313|FG001|Treatment Period|Site closed by investigator|2|||
125071953|NCT00439725|449882312|FG000|Treatment Period|Adverse Event|39|||
125071954|NCT00439725|449882313|FG001|Treatment Period|Adverse Event|18|||
125071955|NCT00439725|449882312|FG000|Treatment Period|Physician Decision|1|||
125071956|NCT00439725|449882313|FG001|Treatment Period|Physician Decision|1|||
125071957|NCT00439725|449882312|FG000|Treatment Period|Protocol Violation|2|||
125071958|NCT00439725|449882313|FG001|Treatment Period|Protocol Violation|1|||
125071959|NCT00439725|449882312|FG000|Treatment Period|Clinical endpoint reached|6|||
125071960|NCT00439725|449882313|FG001|Treatment Period|Clinical endpoint reached|50|||
125071961|NCT00439725|449882312|FG000|Treatment Period|Technical problems|1|||
125071962|NCT00439725|449882313|FG001|Treatment Period|Technical problems|0|||
125071963|NCT00439725|449882312|FG000|Treatment Period|Lost to Follow-up|1|||
125071964|NCT00439725|449882313|FG001|Treatment Period|Lost to Follow-up|1|||
125071965|NCT00439725|449882312|FG000|Treatment Period|Participant convenience|1|||
125071966|NCT00439725|449882313|FG001|Treatment Period|Participant convenience|0|||
125071967|NCT00439725|449882312|FG000|Treatment Period|Protocol driven decision point|1|||
125071968|NCT00439725|449882313|FG001|Treatment Period|Protocol driven decision point|1|||
125071969|NCT00439725|449882312|FG000|Treatment Period|Death|1|||
125071970|NCT00439725|449882313|FG001|Treatment Period|Death|1|||
125071971|NCT00439725|449882312|FG000|Treatment Period|Participant did not receive treatment|4|||
125071972|NCT00439725|449882313|FG001|Treatment Period|Participant did not receive treatment|4|||
125071973|NCT00439725|449882312|FG000|Observational Period|Withdrawal by Subject|2|||
125071974|NCT00439725|449882313|FG001|Observational Period|Withdrawal by Subject|2|||
125071975|NCT00439725|449882312|FG000|Observational Period|Lost to Follow-up|0|||
125071976|NCT00439725|449882313|FG001|Observational Period|Lost to Follow-up|1|||
125071977|NCT00439725|449882312|FG000|Observational Period|Death|0|||
125071978|NCT00439725|449882313|FG001|Observational Period|Death|2|||
125141378|NCT00566722|450140947|FG002|Overall Study|Serious adverse event|0|||
125141379|NCT00566722|450140945|FG000|Overall Study|Noncompliant with drug administration|0|||
125141380|NCT00566722|450140946|FG001|Overall Study|Noncompliant with drug administration|0|||
125141381|NCT00566722|450140947|FG002|Overall Study|Noncompliant with drug administration|1|||
125141382|NCT02896296|450140948|FG000|Overall Study|Adverse Event|1|||
125141383|NCT02896296|450140948|FG000|Overall Study|Lost to Follow-up|19|||
125141384|NCT02896296|450140948|FG000|Overall Study|Pregnancy|1|||
125141385|NCT02896296|450140948|FG000|Overall Study|Physician Decision|2|||
125141386|NCT02896296|450140948|FG000|Overall Study|Withdrawal by Subject|10|||
125141387|NCT02896296|450140948|FG000|Overall Study|Site closing|7|||
125141388|NCT02896296|450140948|FG000|Overall Study|Incarceration|1|||
125141389|NCT02896296|450140948|FG000|Overall Study|Relocation|1|||
125141390|NCT01874535|450140949|FG000|Overall Study|Lost to Follow-up|10|||
125141391|NCT01874535|450140950|FG001|Overall Study|Lost to Follow-up|9|||
125071979|NCT00439725|449882312|FG000|Observational Period|Study termination by sponsor|1|||
125071980|NCT00439725|449882313|FG001|Observational Period|Study termination by sponsor|1|||
125071981|NCT00439725|449882312|FG000|Observational Period|Clinical endpoint reached|3|||
125071982|NCT00439725|449882313|FG001|Observational Period|Clinical endpoint reached|1|||
125071983|NCT00439725|449882312|FG000|Observational Period|Technical problems|1|||
125071984|NCT00439725|449882313|FG001|Observational Period|Technical problems|0|||
125071985|NCT00439725|449882312|FG000|Observational Period|Participant convenience|1|||
125071986|NCT00439725|449882313|FG001|Observational Period|Participant convenience|0|||
125071987|NCT00212758|449882316|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
125141392|NCT01874535|450140949|FG000|Overall Study|incomplete symptom resolution|45|||
125141393|NCT01874535|450140950|FG001|Overall Study|incomplete symptom resolution|35|||
125141394|NCT02597049|450140951|FG000|Overall Study|Lost to Follow-up|0|||
125141395|NCT02597049|450140952|FG001|Overall Study|Lost to Follow-up|3|||
125141396|NCT02597049|450140953|FG002|Overall Study|Lost to Follow-up|2|||
125141397|NCT02597049|450140951|FG000|Overall Study|Withdrawal by Subject|2|||
125141398|NCT02597049|450140952|FG001|Overall Study|Withdrawal by Subject|2|||
125141399|NCT02597049|450140953|FG002|Overall Study|Withdrawal by Subject|1|||
125141400|NCT02597049|450140951|FG000|Overall Study|Adverse Event|2|||
125141401|NCT02597049|450140952|FG001|Overall Study|Adverse Event|0|||
125141402|NCT02597049|450140953|FG002|Overall Study|Adverse Event|0|||
125141403|NCT02597049|450140951|FG000|Overall Study|Death|2|||
125141404|NCT02597049|450140952|FG001|Overall Study|Death|0|||
125141405|NCT02597049|450140953|FG002|Overall Study|Death|0|||
125141406|NCT02597049|450140951|FG000|Overall Study|Noncompliant with Study Visits|1|||
125141407|NCT02597049|450140952|FG001|Overall Study|Noncompliant with Study Visits|0|||
125141408|NCT02597049|450140953|FG002|Overall Study|Noncompliant with Study Visits|0|||
125141409|NCT00243347|450140957|FG000|Overall Study|Lack of Efficacy|4|||
125141410|NCT00243347|450140957|FG000|Overall Study|Adverse Event|2|||
125141411|NCT00243347|450140957|FG000|Overall Study|Death|1|||
125141412|NCT00243347|450140957|FG000|Overall Study|Withdrawal by Subject|5|||
125141413|NCT00243347|450140957|FG000|Overall Study|Condition worsened|7|||
125141414|NCT01044433|450140958|FG000|Overall Study|Lost to Follow-up|3|||
125141415|NCT01044433|450140958|FG000|Overall Study|Withdrawal by Subject|3|||
125141416|NCT05065619|450140960|FG000|Up to Day 42|Lost to Follow-up|1|||
125141417|NCT05065619|450140961|FG001|Up to Day 42|Lost to Follow-up|0|||
125141418|NCT05065619|450140960|FG000|Up to Day 42|Withdrawal by Subject|1|||
125141419|NCT05065619|450140961|FG001|Up to Day 42|Withdrawal by Subject|0|||
125141420|NCT05065619|450140960|FG000|After Day 43|Lost to Follow-up|1|||
125141421|NCT05065619|450140961|FG001|After Day 43|Lost to Follow-up|0|||
125141422|NCT05065619|450140960|FG000|After Day 43|Physician Decision|3|||
125141423|NCT05065619|450140961|FG001|After Day 43|Physician Decision|0|||
125141424|NCT05065619|450140960|FG000|After Day 43|Withdrawal by Subject|1|||
125141425|NCT05065619|450140961|FG001|After Day 43|Withdrawal by Subject|2|||
125141426|NCT05065619|450140960|FG000|After Day 43|Public vaccination|6|||
125141427|NCT05065619|450140961|FG001|After Day 43|Public vaccination|8|||
125141428|NCT05065619|450140960|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
125141429|NCT05065619|450140961|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
125141430|NCT05065619|450140960|FG000|After Day 43|Study Terminated by Sponsor|88|||
125141431|NCT05065619|450140961|FG001|After Day 43|Study Terminated by Sponsor|16|||
125141432|NCT01390948|450140962|FG000|Overall Study|End of Study|1|||
125141433|NCT01390948|450140963|FG001|Overall Study|End of Study|0|||
125141434|NCT01390948|450140964|FG002|Overall Study|End of Study|0|||
125141435|NCT01390948|450140962|FG000|Overall Study|Withdrew consent|2|||
125141436|NCT01390948|450140963|FG001|Overall Study|Withdrew consent|2|||
125141437|NCT01390948|450140964|FG002|Overall Study|Withdrew consent|0|||
125141438|NCT01390948|450140962|FG000|Overall Study|Progressive Disease|2|||
125141439|NCT01390948|450140963|FG001|Overall Study|Progressive Disease|5|||
125141440|NCT01390948|450140964|FG002|Overall Study|Progressive Disease|0|||
125141441|NCT01390948|450140962|FG000|Overall Study|Death during follow-up|10|||
125141442|NCT01390948|450140963|FG001|Overall Study|Death during follow-up|11|||
125141443|NCT01390948|450140964|FG002|Overall Study|Death during follow-up|1|||
125141444|NCT05740098|450140967|FG000|Overall Study|Lost to Follow-up|26|||
125141445|NCT05740098|450140968|FG001|Overall Study|Lost to Follow-up|17|||
125141446|NCT05740098|450140969|FG002|Overall Study|Lost to Follow-up|21|||
125141447|NCT02452463|450140970|FG000|Overall Study|Death|1|||
125141448|NCT02452463|450140971|FG001|Overall Study|Death|0|||
125141449|NCT02452463|450140972|FG002|Overall Study|Death|0|||
125141450|NCT02452463|450140970|FG000|Overall Study|Study Suspended|1|||
125141451|NCT02452463|450140971|FG001|Overall Study|Study Suspended|0|||
125141452|NCT02452463|450140972|FG002|Overall Study|Study Suspended|0|||
125141453|NCT02452463|450140970|FG000|Overall Study|Recommended by DSMB|0|||
125223059|NCT01711983|450444478|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
125223060|NCT00268983|450444479|FG000|Overall Study|Death|3|||
125223061|NCT00268983|450444480|FG001|Overall Study|Death|0|||
125223062|NCT00321906|450444487|FG000|Overall Study|Adverse Event|36|||
125223063|NCT00321906|450444488|FG001|Overall Study|Adverse Event|44|||
125223064|NCT00321906|450444487|FG000|Overall Study|Death|9|||
125223065|NCT00321906|450444488|FG001|Overall Study|Death|6|||
125141454|NCT02452463|450140971|FG001|Overall Study|Recommended by DSMB|1|||
125141455|NCT02452463|450140972|FG002|Overall Study|Recommended by DSMB|0|||
125141456|NCT02452463|450140970|FG000|Overall Study|Withdrawal by Subject|0|||
125141457|NCT02452463|450140971|FG001|Overall Study|Withdrawal by Subject|1|||
125141458|NCT02452463|450140972|FG002|Overall Study|Withdrawal by Subject|0|||
125141459|NCT01528735|450140973|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
125141460|NCT01528735|450140974|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
125141461|NCT01528735|450140973|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
125141462|NCT01528735|450140974|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
125141463|NCT01401062|450140977|FG000|Overall Study|Death|9|||
125141464|NCT01401062|450140978|FG001|Overall Study|Death|7|||
125223066|NCT00321906|450444487|FG000|Overall Study|Lost to Follow-up|1|||
125071988|NCT00212758|449882317|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
125071989|NCT00212758|449882316|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
125071990|NCT00212758|449882317|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
125071991|NCT03510910|449882318|FG000|Overall Study|Incomplete Survey|2|||
125071992|NCT03510910|449882319|FG001|Overall Study|Incomplete Survey|3|||
125071993|NCT02940860|449882325|FG000|Overall Study|Non-serious AE|1|||
125071994|NCT02940860|449882326|FG001|Overall Study|Non-serious AE|2|||
125071995|NCT02940860|449882325|FG000|Overall Study|Serious AE|7|||
125071996|NCT02940860|449882326|FG001|Overall Study|Serious AE|3|||
125071997|NCT02940860|449882325|FG000|Overall Study|Withdrawal by Subject|19|||
125071998|NCT02940860|449882326|FG001|Overall Study|Withdrawal by Subject|9|||
125071999|NCT02940860|449882325|FG000|Overall Study|Lost to Follow-up|13|||
125072000|NCT02940860|449882326|FG001|Overall Study|Lost to Follow-up|7|||
125072001|NCT02940860|449882325|FG000|Overall Study|Physician Decision|5|||
125072002|NCT02940860|449882326|FG001|Overall Study|Physician Decision|3|||
125072003|NCT02940860|449882325|FG000|Overall Study|Sponsor Decision|0|||
125072004|NCT02940860|449882326|FG001|Overall Study|Sponsor Decision|1|||
125072005|NCT02940860|449882325|FG000|Overall Study|Protocol Violation|0|||
125072006|NCT02940860|449882326|FG001|Overall Study|Protocol Violation|2|||
125072007|NCT02940860|449882325|FG000|Overall Study|Death|3|||
125072008|NCT02940860|449882326|FG001|Overall Study|Death|2|||
125072009|NCT02940860|449882325|FG000|Overall Study|Moved, poor venous access, transport|6|||
125072010|NCT02940860|449882326|FG001|Overall Study|Moved, poor venous access, transport|4|||
125072011|NCT02940860|449882325|FG000|Overall Study|Not treated|2|||
125072012|NCT02940860|449882326|FG001|Overall Study|Not treated|2|||
125072013|NCT04914819|449882327|FG000|Overall Study|Pregnancy|3|||
125072014|NCT04914819|449882328|FG001|Overall Study|Pregnancy|1|||
125072015|NCT04914819|449882327|FG000|Overall Study|Discontinued study|4|||
125072016|NCT04914819|449882328|FG001|Overall Study|Discontinued study|1|||
125072017|NCT04914819|449882327|FG000|Overall Study|Lost to Follow-up|7|||
125072018|NCT04914819|449882328|FG001|Overall Study|Lost to Follow-up|0|||
125072019|NCT02715804|449882329|FG000|Overall Study|Death|222|||
125072020|NCT02715804|449882330|FG001|Overall Study|Death|106|||
125072021|NCT02715804|449882329|FG000|Overall Study|Withdrawal by Subject|5|||
125072022|NCT02715804|449882330|FG001|Overall Study|Withdrawal by Subject|4|||
125072023|NCT02715804|449882329|FG000|Overall Study|Other than specified|2|||
125072024|NCT02715804|449882330|FG001|Overall Study|Other than specified|3|||
125072025|NCT04038385|449882331|FG000|Overall Study|Completed baseline assessment only|7|||
125072026|NCT04038385|449882332|FG001|Overall Study|Completed baseline assessment only|4|||
125072027|NCT04038385|449882331|FG000|Overall Study|Moved out of area|4|||
125072028|NCT04038385|449882332|FG001|Overall Study|Moved out of area|2|||
125072029|NCT04038385|449882331|FG000|Overall Study|Discontinued study involvement|6|||
125072030|NCT04038385|449882332|FG001|Overall Study|Discontinued study involvement|1|||
125072031|NCT00948194|449882335|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
125072032|NCT00948194|449882336|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
125072033|NCT00233324|449882337|FG000|Main Study|Death|68|||
125072034|NCT00233324|449882338|FG001|Main Study|Death|60|||
125072035|NCT00233324|449882339|FG002|Main Study|Death|62|||
125072036|NCT00233324|449882340|FG003|Main Study|Death|47|||
125141465|NCT01401062|450140977|FG000|Overall Study|Physician Decision|1|||
125141466|NCT01401062|450140978|FG001|Overall Study|Physician Decision|0|||
125141467|NCT01401062|450140977|FG000|Overall Study|Withdrawal by Subject|1|||
125141468|NCT01401062|450140978|FG001|Overall Study|Withdrawal by Subject|1|||
125141469|NCT00757172|450140979|FG000|Overall Study|Withdrawal by Subject|4|||
125141470|NCT00757172|450140979|FG000|Overall Study|Physician Decision|3|||
125141471|NCT00757172|450140979|FG000|Overall Study|Progression|4|||
125141472|NCT03555695|450140980|FG000|Overall Study|Withdrawal by Subject|1|||
125072037|NCT00233324|449882337|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
125072038|NCT00233324|449882338|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
125072039|NCT00233324|449882339|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
125072040|NCT00233324|449882340|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
125072041|NCT00233324|449882337|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
125072042|NCT00233324|449882338|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
125072043|NCT00233324|449882339|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
125072044|NCT00233324|449882340|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
125072045|NCT00724815|449882350|FG000|Overall Study|Randomized, not treated|31|||
125072046|NCT00724815|449882351|FG001|Overall Study|Randomized, not treated|30|||
125141473|NCT03555695|450140980|FG000|Overall Study|Lost to Follow-up|1|||
125072047|NCT00724815|449882350|FG000|Overall Study|Adverse Event|5|||
125072048|NCT00724815|449882351|FG001|Overall Study|Adverse Event|3|||
125072049|NCT00724815|449882350|FG000|Overall Study|Lost to Follow-up|4|||
125072050|NCT00724815|449882351|FG001|Overall Study|Lost to Follow-up|1|||
125072051|NCT00724815|449882350|FG000|Overall Study|Other Various|3|||
125072052|NCT00724815|449882351|FG001|Overall Study|Other Various|5|||
125072053|NCT00105183|449882356|FG000|Overall Study|Death|19|||
125141474|NCT03555695|450140980|FG000|Overall Study|appendicitis (unrelated)|1|||
125141475|NCT03555695|450140980|FG000|Overall Study|pre-existing sciatica|1|||
125072054|NCT00105183|449882357|FG001|Overall Study|Death|13|||
125072055|NCT00105183|449882358|FG002|Overall Study|Death|15|||
125072056|NCT00105183|449882356|FG000|Overall Study|Withdrawal by Subject|1|||
125072057|NCT00105183|449882357|FG001|Overall Study|Withdrawal by Subject|1|||
125072058|NCT00105183|449882358|FG002|Overall Study|Withdrawal by Subject|4|||
125072059|NCT00105183|449882356|FG000|Overall Study|Physician Decision|1|||
125072060|NCT00105183|449882357|FG001|Overall Study|Physician Decision|2|||
125141476|NCT04194151|450140981|FG000|Overall Study|Physician Decision|1|||
125141477|NCT04194151|450140982|FG001|Overall Study|Physician Decision|1|||
125141478|NCT04194151|450140983|FG002|Overall Study|Physician Decision|1|||
125141479|NCT04194151|450140984|FG003|Overall Study|Physician Decision|1|||
125141480|NCT04194151|450140985|FG004|Overall Study|Physician Decision|0|||
125141481|NCT04194151|450140986|FG005|Overall Study|Physician Decision|1|||
125141482|NCT04194151|450140981|FG000|Overall Study|Monitorization problem|0|||
125141483|NCT04194151|450140982|FG001|Overall Study|Monitorization problem|1|||
125141484|NCT04194151|450140983|FG002|Overall Study|Monitorization problem|0|||
125141485|NCT04194151|450140984|FG003|Overall Study|Monitorization problem|0|||
125141486|NCT04194151|450140985|FG004|Overall Study|Monitorization problem|0|||
125223067|NCT00321906|450444488|FG001|Overall Study|Lost to Follow-up|2|||
125223068|NCT00321906|450444487|FG000|Overall Study|Withdrawal by Subject|0|||
125223069|NCT00321906|450444488|FG001|Overall Study|Withdrawal by Subject|4|||
125141487|NCT04194151|450140986|FG005|Overall Study|Monitorization problem|0|||
125141488|NCT04203823|450140988|FG000|Overall Study|Withdrawal by Subject|2|||
125141489|NCT04203823|450140989|FG001|Overall Study|Withdrawal by Subject|2|||
125141490|NCT04203823|450140988|FG000|Overall Study|Adverse Event|1|||
125141491|NCT04203823|450140989|FG001|Overall Study|Adverse Event|1|||
125141492|NCT04203823|450140988|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125141493|NCT04203823|450140989|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
125141494|NCT01499043|450140990|FG000|Overall Study|Progressive disease (radiographic)|2|||
125141495|NCT01499043|450140990|FG000|Overall Study|Progressive disease (clinical)|1|||
125141496|NCT01499043|450140990|FG000|Overall Study|Withdrawal by Subject|2|||
125141497|NCT01499043|450140990|FG000|Overall Study|Adverse Event|1|||
125141498|NCT00438633|450140991|FG000|Overall Study|Withdrawal by Subject|1|||
125141499|NCT00438633|450140992|FG001|Overall Study|Withdrawal by Subject|0|||
125141500|NCT00438633|450140991|FG000|Overall Study|Lost to Follow-up|15|||
125141501|NCT00438633|450140992|FG001|Overall Study|Lost to Follow-up|17|||
125141502|NCT01912807|450140993|FG000|Overall Study|Did not meet elegibility criteria|6|||
125141503|NCT01912807|450140994|FG001|Overall Study|Did not meet elegibility criteria|4|||
125141504|NCT01912807|450140993|FG000|Overall Study|Lost to Follow-up|36|||
125141505|NCT01912807|450140994|FG001|Overall Study|Lost to Follow-up|37|||
125141506|NCT03506633|450142983|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
125141507|NCT03506633|450142984|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
125141508|NCT01894230|450142985|FG000|Overall Study|Lost to Follow-up|2|||
125141509|NCT01894230|450142986|FG001|Overall Study|Lost to Follow-up|2|||
125141510|NCT01894230|450142985|FG000|Overall Study|Withdrawal by Subject|4|||
125141511|NCT01894230|450142986|FG001|Overall Study|Withdrawal by Subject|4|||
125141512|NCT01894230|450142985|FG000|Overall Study|Non-adherent|0|||
125141513|NCT01894230|450142986|FG001|Overall Study|Non-adherent|1|||
125141514|NCT01894230|450142985|FG000|Overall Study|Death|1|||
125141515|NCT01894230|450142986|FG001|Overall Study|Death|0|||
125141516|NCT00640393|450142988|FG000|Part 1|Lost to Follow-up|2|||
125141517|NCT00640393|450142989|FG001|Part 1|Lost to Follow-up|0|||
125223070|NCT01272908|450444489|FG000|Initial Treatment Period|Adverse Event|1|||
125223071|NCT01272908|450444489|FG000|Initial Treatment Period|Lack of Efficacy|5|||
125223072|NCT01272908|450444489|FG000|Initial Treatment Period|Protocol Violation|1|||
125223073|NCT01272908|450444489|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
125223074|NCT01272908|450444489|FG000|Re-Treatment Period|Adverse Event|2|||
125223075|NCT01272908|450444489|FG000|Re-Treatment Period|Lack of Efficacy|3|||
125072061|NCT00105183|449882358|FG002|Overall Study|Physician Decision|3|||
125072062|NCT00105183|449882356|FG000|Overall Study|Lost to Follow-up|0|||
125072063|NCT00105183|449882357|FG001|Overall Study|Lost to Follow-up|1|||
125141518|NCT00640393|450142990|FG002|Part 1|Lost to Follow-up|0|||
125141519|NCT00640393|450142988|FG000|Part 1|Withdrawal by Subject|3|||
125141520|NCT00640393|450142989|FG001|Part 1|Withdrawal by Subject|0|||
125141521|NCT00640393|450142990|FG002|Part 1|Withdrawal by Subject|0|||
125223076|NCT01272908|450444489|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
125223077|NCT01158261|450444490|FG000|Overall Study|Lost to Follow-up|9|||
125072064|NCT00105183|449882358|FG002|Overall Study|Lost to Follow-up|1|||
125072065|NCT00105183|449882356|FG000|Overall Study|Other reason|1|||
125072066|NCT00105183|449882357|FG001|Overall Study|Other reason|2|||
125223078|NCT01158261|450444490|FG000|Overall Study|Death|7|||
125072067|NCT00105183|449882358|FG002|Overall Study|Other reason|0|||
125072068|NCT01819506|449882359|FG000|Overall Study|Physician Decision|5|||
125141522|NCT00640393|450142988|FG000|Randomization|Withdrawn per protocol|17|||
125141523|NCT00640393|450142989|FG001|Randomization|Withdrawn per protocol|0|||
125141524|NCT00640393|450142990|FG002|Randomization|Withdrawn per protocol|0|||
125141525|NCT00640393|450142988|FG000|Randomization|Never randomized by site|2|||
125141526|NCT00640393|450142989|FG001|Randomization|Never randomized by site|0|||
125072069|NCT01819506|449882360|FG001|Overall Study|Physician Decision|2|||
125072070|NCT01819506|449882359|FG000|Overall Study|Withdrawal by Subject|3|||
125072071|NCT01819506|449882360|FG001|Overall Study|Withdrawal by Subject|3|||
125072072|NCT03000686|449882361|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
125072073|NCT03000686|449882362|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
125072074|NCT03000686|449882363|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
125072075|NCT03000686|449882364|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
125072076|NCT00294684|449882365|FG000|Overall Study|Lost to Follow-up|5|||
125072077|NCT00294684|449882366|FG001|Overall Study|Lost to Follow-up|8|||
125072078|NCT00968708|449882367|FG000|Overall Study|Adverse Event|169|||
125072079|NCT00968708|449882368|FG001|Overall Study|Adverse Event|150|||
125072080|NCT00968708|449882367|FG000|Overall Study|Major Protocol Deviation|0|||
125072081|NCT00968708|449882368|FG001|Overall Study|Major Protocol Deviation|1|||
125072082|NCT00968708|449882367|FG000|Overall Study|Lost to Follow-up|19|||
125072083|NCT00968708|449882368|FG001|Overall Study|Lost to Follow-up|11|||
125072084|NCT00968708|449882367|FG000|Overall Study|Voluntary Withdrawal|104|||
125072085|NCT00968708|449882368|FG001|Overall Study|Voluntary Withdrawal|101|||
125072086|NCT00968708|449882367|FG000|Overall Study|Investigator Discretion|0|||
125072087|NCT00968708|449882368|FG001|Overall Study|Investigator Discretion|1|||
125072088|NCT00968708|449882367|FG000|Overall Study|Other|26|||
125072089|NCT00968708|449882368|FG001|Overall Study|Other|34|||
125072090|NCT00389441|449882369|FG000|Overall Study|Adverse Event|7|||
125072091|NCT00389441|449882369|FG000|Overall Study|Death|4|||
125072092|NCT00389441|449882369|FG000|Overall Study|Lost to Follow-up|2|||
125072093|NCT00389441|449882369|FG000|Overall Study|Withdrawal by Subject|4|||
125072094|NCT00389441|449882369|FG000|Overall Study|Physician Decision|1|||
125072095|NCT00389441|449882369|FG000|Overall Study|Protocol Violation|1|||
125072096|NCT00389441|449882369|FG000|Overall Study|Global deterioration of health status|4|||
125072097|NCT00389441|449882369|FG000|Overall Study|Objective progression or relapse|26|||
125072098|NCT00389441|449882369|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
125072099|NCT00389441|449882369|FG000|Overall Study|Clinical progression|1|||
125072100|NCT01981109|449882370|FG000|Overall Study|Death|36|||
125072101|NCT01981109|449882370|FG000|Overall Study|Withdrawal by Subject|40|||
125072102|NCT01981109|449882370|FG000|Overall Study|Lost to Follow-up|9|||
125072103|NCT01981109|449882370|FG000|Overall Study|No Discontinuation Documentation|37|||
125072104|NCT01981109|449882370|FG000|Overall Study|Study Termination|100|||
125072105|NCT01981109|449882370|FG000|Overall Study|No data available|2|||
125072106|NCT00126672|449882371|FG000|Overall Study|Adverse Event|4|||
125072107|NCT00126672|449882371|FG000|Overall Study|Lost to Follow-up|4|||
125072108|NCT01851863|449882373|FG000|Overall Study|Did not receive study medication|2|||
125072109|NCT01851863|449882374|FG001|Overall Study|Did not receive study medication|5|||
125072110|NCT01851863|449882375|FG002|Overall Study|Did not receive study medication|3|||
125072111|NCT01851863|449882376|FG003|Overall Study|Did not receive study medication|0|||
125072112|NCT01851863|449882373|FG000|Overall Study|Lost to Follow-up|3|||
125072113|NCT01851863|449882374|FG001|Overall Study|Lost to Follow-up|4|||
125072114|NCT01851863|449882375|FG002|Overall Study|Lost to Follow-up|2|||
125072115|NCT01851863|449882376|FG003|Overall Study|Lost to Follow-up|3|||
125072116|NCT04083794|449882377|FG000|Overall Study|Lost to Follow-up|9|||
125072117|NCT03097029|449882380|FG000|Overall Study|Withdrawal by Subject|1|||
125072118|NCT02661464|449882388|FG000|Overall Study|Lost to Follow-up|28|||
125141527|NCT00640393|450142990|FG002|Randomization|Never randomized by site|0|||
125141528|NCT00640393|450142988|FG000|Part 2|Lost to Follow-up|0|||
125141529|NCT00640393|450142989|FG001|Part 2|Lost to Follow-up|2|||
125141530|NCT00640393|450142990|FG002|Part 2|Lost to Follow-up|2|||
125141531|NCT00640393|450142988|FG000|Part 2|Withdrawal by Subject|0|||
125141532|NCT00640393|450142989|FG001|Part 2|Withdrawal by Subject|6|||
125072119|NCT02661464|449882389|FG001|Overall Study|Lost to Follow-up|0|||
125072120|NCT02661464|449882390|FG002|Overall Study|Lost to Follow-up|0|||
125072121|NCT02661464|449882391|FG003|Overall Study|Lost to Follow-up|0|||
125072122|NCT02661464|449882388|FG000|Overall Study|Withdrawal by Subject|3|||
125072123|NCT02661464|449882389|FG001|Overall Study|Withdrawal by Subject|1|||
125072124|NCT02661464|449882390|FG002|Overall Study|Withdrawal by Subject|0|||
125072125|NCT02661464|449882391|FG003|Overall Study|Withdrawal by Subject|0|||
125072126|NCT02661464|449882388|FG000|Overall Study|Participants terminated prematurely|288|||
125072127|NCT02661464|449882389|FG001|Overall Study|Participants terminated prematurely|52|||
125072128|NCT02661464|449882390|FG002|Overall Study|Participants terminated prematurely|1|||
125072129|NCT02661464|449882391|FG003|Overall Study|Participants terminated prematurely|1|||
125072130|NCT02661464|449882388|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
125072131|NCT02661464|449882389|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
125072132|NCT02661464|449882390|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
125072133|NCT02661464|449882391|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
125072134|NCT03148756|449882392|FG000|Overall Study|Study Terminated|0|||
125072135|NCT03148756|449882393|FG001|Overall Study|Study Terminated|1|||
125072136|NCT02177175|449882394|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
125072137|NCT02177175|449882395|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
125141533|NCT00640393|450142990|FG002|Part 2|Withdrawal by Subject|1|||
125072138|NCT03820726|449882400|FG000|Overall Study|Other than listed|23|||
125072139|NCT03820726|449882400|FG000|Overall Study|Withdrawal by Subject|37|||
125072140|NCT03820726|449882400|FG000|Overall Study|Lost to Follow-up|3|||
125072141|NCT03820726|449882400|FG000|Overall Study|Protocol deviation|1|||
125072142|NCT03820726|449882400|FG000|Overall Study|Adverse Event|146|||
125072143|NCT03820726|449882400|FG000|Overall Study|Not treated|1|||
125072144|NCT00345540|449882401|FG000|Overall Study|Withdrawal by Subject|1|||
125072145|NCT01406652|449882402|FG000|Overall Study|Lost-to-follow-up|3|||
125072146|NCT01406652|449882403|FG001|Overall Study|Lost-to-follow-up|4|||
125072147|NCT01406652|449882402|FG000|Overall Study|Withdrawal by Subject|2|||
125072148|NCT01406652|449882403|FG001|Overall Study|Withdrawal by Subject|2|||
125072149|NCT01406652|449882402|FG000|Overall Study|Insufficient follow-up|5|||
125072150|NCT01406652|449882403|FG001|Overall Study|Insufficient follow-up|4|||
125072151|NCT01406652|449882402|FG000|Overall Study|Infection not sure|10|||
125072152|NCT01406652|449882403|FG001|Overall Study|Infection not sure|10|||
125072153|NCT00861380|449882404|FG000|Overall Study|Withdrawal Information not recorded|8427|||
125072154|NCT00861380|449882405|FG001|Overall Study|Withdrawal Information not recorded|9112|||
125072155|NCT00861380|449882406|FG002|Overall Study|Withdrawal Information not recorded|8872|||
125072156|NCT00861380|449882407|FG003|Overall Study|Withdrawal Information not recorded|3689|||
125072157|NCT00861380|449882408|FG004|Overall Study|Withdrawal Information not recorded|1812|||
125072158|NCT00861380|449882409|FG005|Overall Study|Withdrawal Information not recorded|6249|||
125072159|NCT00861380|449882410|FG006|Overall Study|Withdrawal Information not recorded|3020|||
125072160|NCT00637377|449882411|FG000|Overall Study|Adverse Event|2|||
125072161|NCT00637377|449882412|FG001|Overall Study|Adverse Event|6|||
125072162|NCT00637377|449882413|FG002|Overall Study|Adverse Event|8|||
125072163|NCT00637377|449882414|FG003|Overall Study|Adverse Event|9|||
125072164|NCT00637377|449882411|FG000|Overall Study|Death|1|||
125072165|NCT00637377|449882412|FG001|Overall Study|Death|3|||
125072166|NCT00637377|449882413|FG002|Overall Study|Death|2|||
125072167|NCT00637377|449882414|FG003|Overall Study|Death|1|||
125072168|NCT00637377|449882411|FG000|Overall Study|Lack of Efficacy|0|||
125072169|NCT00637377|449882412|FG001|Overall Study|Lack of Efficacy|0|||
125072170|NCT00637377|449882413|FG002|Overall Study|Lack of Efficacy|1|||
125072171|NCT00637377|449882414|FG003|Overall Study|Lack of Efficacy|1|||
125072172|NCT00637377|449882411|FG000|Overall Study|Lost to Follow-up|4|||
125072173|NCT00637377|449882412|FG001|Overall Study|Lost to Follow-up|1|||
125072174|NCT00637377|449882413|FG002|Overall Study|Lost to Follow-up|2|||
125072175|NCT00637377|449882414|FG003|Overall Study|Lost to Follow-up|2|||
125072176|NCT00637377|449882411|FG000|Overall Study|Protocol Violation|2|||
125072177|NCT00637377|449882412|FG001|Overall Study|Protocol Violation|1|||
125072178|NCT00637377|449882413|FG002|Overall Study|Protocol Violation|1|||
125072179|NCT00637377|449882414|FG003|Overall Study|Protocol Violation|0|||
125072180|NCT00637377|449882411|FG000|Overall Study|Withdrawal by Subject|11|||
125072181|NCT00637377|449882412|FG001|Overall Study|Withdrawal by Subject|15|||
125072182|NCT00637377|449882413|FG002|Overall Study|Withdrawal by Subject|13|||
125072183|NCT00637377|449882414|FG003|Overall Study|Withdrawal by Subject|11|||
125072184|NCT00637377|449882411|FG000|Overall Study|Other (no further information available)|7|||
125072185|NCT00637377|449882412|FG001|Overall Study|Other (no further information available)|6|||
125072186|NCT00637377|449882413|FG002|Overall Study|Other (no further information available)|10|||
125072187|NCT00637377|449882414|FG003|Overall Study|Other (no further information available)|5|||
125072188|NCT01822223|449882415|FG000|Overall Study|Death|0|||
125072189|NCT01822223|449882416|FG001|Overall Study|Death|1|||
125072190|NCT00631540|449882421|FG000|Overall Study|Withdrawal by Subject|5|||
125072191|NCT00631540|449882421|FG000|Overall Study|Death|4|||
125072192|NCT00631540|449882421|FG000|Overall Study|Lost to Follow-up|2|||
125072193|NCT00631540|449882421|FG000|Overall Study|Core Lab Data Unavailable|3|||
125072194|NCT03136367|449882423|FG000|T1 Consultation|discontinued mistakenly included|2|||
125072195|NCT03136367|449882424|FG001|T1 Consultation|discontinued mistakenly included|6|||
125072196|NCT03136367|449882425|FG002|T1 Consultation|discontinued mistakenly included|1|||
125072197|NCT03136367|449882423|FG000|T1 Consultation|Discontinued other|0|||
125072198|NCT03136367|449882424|FG001|T1 Consultation|Discontinued other|1|||
125072199|NCT03136367|449882425|FG002|T1 Consultation|Discontinued other|0|||
125072200|NCT03136367|449882423|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
125072201|NCT03136367|449882424|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
125072202|NCT03136367|449882425|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
125072203|NCT03136367|449882423|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
125072204|NCT03136367|449882424|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
125072205|NCT03136367|449882425|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
125072206|NCT03136367|449882423|FG000|T2 Post-consultation|Discontinued other|0|||
125072207|NCT03136367|449882424|FG001|T2 Post-consultation|Discontinued other|2|||
125072208|NCT03136367|449882425|FG002|T2 Post-consultation|Discontinued other|6|||
125072209|NCT03136367|449882423|FG000|T2 Post-consultation|Discontinued transferred care|0|||
125072210|NCT03136367|449882424|FG001|T2 Post-consultation|Discontinued transferred care|0|||
125072211|NCT03136367|449882425|FG002|T2 Post-consultation|Discontinued transferred care|3|||
125072212|NCT03136367|449882423|FG000|T2 Post-consultation|Discontinued lost contact|0|||
125072213|NCT03136367|449882424|FG001|T2 Post-consultation|Discontinued lost contact|1|||
125141534|NCT00640393|450142988|FG000|Part 2|Non-adherence|0|||
125141535|NCT00640393|450142989|FG001|Part 2|Non-adherence|1|||
125141536|NCT00640393|450142990|FG002|Part 2|Non-adherence|0|||
125141537|NCT00640393|450142988|FG000|Part 2|Adverse Event|0|||
125141538|NCT00640393|450142989|FG001|Part 2|Adverse Event|1|||
125141539|NCT00640393|450142990|FG002|Part 2|Adverse Event|0|||
125141540|NCT00396162|450142996|FG000|Overall Study|Withdrawal by Subject|2|||
125141541|NCT00396162|450142997|FG001|Overall Study|Withdrawal by Subject|3|||
125141542|NCT03387462|450143000|FG000|Overall Study|Lost to Follow-up|1|||
125141543|NCT01460628|450143003|FG000|Overall Study|Adverse Event|3|||
125141544|NCT01460628|450143003|FG000|Overall Study|Withdrawal by Subject|2|||
125141545|NCT01944722|450143005|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
125141546|NCT01944722|450143005|FG000|Overall Study|Specimen Shipping Issues|34|||
125141547|NCT01944722|450143005|FG000|Overall Study|Improper Storage/Transport|5|||
125141548|NCT01944722|450143005|FG000|Overall Study|Insufficient Volume for Test|1|||
125141549|NCT01944722|450143005|FG000|Overall Study|Missing Specimens|3|||
125141550|NCT01944722|450143005|FG000|Overall Study|Specimens Mislabeled|2|||
125141551|NCT01944722|450143005|FG000|Overall Study|Withdrawal by Subject|8|||
125141552|NCT01944722|450143005|FG000|Overall Study|NILM Subjects <30 years old|8106|||
125141553|NCT01944722|450143005|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
125141554|NCT01944722|450143005|FG000|Overall Study|>ASCUS Cytology|1122|||
125141555|NCT00210639|450143006|FG000|Overall Study|Lost to Follow-up|37|||
125141556|NCT00210639|450143007|FG001|Overall Study|Lost to Follow-up|29|||
125141557|NCT00210639|450143006|FG000|Overall Study|Withdrawal by Subject|8|||
125141558|NCT00210639|450143007|FG001|Overall Study|Withdrawal by Subject|1|||
125141559|NCT00210639|450143006|FG000|Overall Study|Other|18|||
125141560|NCT00210639|450143007|FG001|Overall Study|Other|12|||
125141561|NCT02854800|450143009|FG000|Overall Study|Protocol Violation|16|||
125141562|NCT02854800|450143010|FG001|Overall Study|Protocol Violation|11|||
125141563|NCT02854800|450143011|FG002|Overall Study|Protocol Violation|3|||
125141564|NCT02854800|450143009|FG000|Overall Study|Withdrawal by Subject|4|||
125141565|NCT02854800|450143010|FG001|Overall Study|Withdrawal by Subject|2|||
125141566|NCT02854800|450143011|FG002|Overall Study|Withdrawal by Subject|3|||
125141567|NCT02627963|450143017|FG000|Overall Study|Randomized but not treated|2|||
125141568|NCT02627963|450143018|FG001|Overall Study|Randomized but not treated|6|||
125141569|NCT00152451|450143021|FG000|Overall Study|Adverse Event|4|||
125141570|NCT00503867|450143024|FG000|Overall Study|Lost to Follow-up|1|||
125141571|NCT00503867|450143024|FG000|Overall Study|Adverse Event|1|||
125141572|NCT04697173|450143027|FG000|Overall Study|Withdrawal by Subject|34|||
125141573|NCT04697173|450143028|FG001|Overall Study|Withdrawal by Subject|38|||
125141574|NCT03807440|450143029|FG000|Overall Study|No documentation of index date 2|320|||
125141575|NCT03807440|450143029|FG000|Overall Study|No informed consent for index date 2|117|||
125141576|NCT00323258|450143030|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
125141577|NCT00323258|450143031|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
125141578|NCT00323258|450143030|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
125141579|NCT00323258|450143031|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
125141580|NCT00323258|450143030|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
125141581|NCT00323258|450143031|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
125141582|NCT00323258|450143030|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
125141583|NCT00323258|450143031|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
125141584|NCT00323258|450143030|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
125141585|NCT00323258|450143031|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
125141586|NCT00323258|450143030|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
125141587|NCT00323258|450143031|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
125141588|NCT00323258|450143030|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
125141589|NCT00323258|450143031|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
125141590|NCT01859598|450143044|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
125141591|NCT00354835|450143045|FG000|Overall Study|Death|1|||
125223079|NCT01158261|450444490|FG000|Overall Study|Withdrawal by Subject|1|||
125223080|NCT03143101|450444491|FG000|Overall Study|Withdrawal by Subject|0|||
125141592|NCT00354835|450143046|FG001|Overall Study|Death|1|||
125223081|NCT03143101|450444492|FG001|Overall Study|Withdrawal by Subject|1|||
125223082|NCT03143101|450444493|FG002|Overall Study|Withdrawal by Subject|0|||
125141593|NCT00354835|450143045|FG000|Overall Study|Physician Decision|8|||
125141594|NCT00354835|450143046|FG001|Overall Study|Physician Decision|13|||
125141595|NCT00354835|450143045|FG000|Overall Study|Withdrawal by Subject|2|||
125141596|NCT00354835|450143046|FG001|Overall Study|Withdrawal by Subject|1|||
125141597|NCT00354835|450143045|FG000|Overall Study|Ineligible|17|||
125141598|NCT00354835|450143046|FG001|Overall Study|Ineligible|16|||
125141599|NCT00354835|450143045|FG000|Overall Study|Disease progression or relapse|15|||
125141600|NCT00354835|450143046|FG001|Overall Study|Disease progression or relapse|22|||
125141601|NCT00354835|450143045|FG000|Overall Study|Adverse Event|6|||
125141602|NCT00354835|450143046|FG001|Overall Study|Adverse Event|0|||
125141603|NCT00354835|450143045|FG000|Overall Study|Refusal of further therapy|3|||
125141604|NCT00354835|450143046|FG001|Overall Study|Refusal of further therapy|8|||
125141605|NCT01968551|450143047|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
125141606|NCT01968551|450143048|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
125141607|NCT01968551|450143049|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
125141608|NCT01968551|450143047|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
125141609|NCT01968551|450143048|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
125141610|NCT01968551|450143049|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
125141611|NCT01968551|450143047|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
125141612|NCT01968551|450143048|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
125141613|NCT01968551|450143049|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
125141614|NCT01968551|450143047|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
125141615|NCT01968551|450143048|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
125141616|NCT01968551|450143049|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
125141617|NCT01968551|450143047|FG000|Extension Phase|Adverse Event|0|||
125141618|NCT01968551|450143048|FG001|Extension Phase|Adverse Event|0|||
125141619|NCT01968551|450143049|FG002|Extension Phase|Adverse Event|2|||
125141620|NCT01968551|450143047|FG000|Extension Phase|Death|0|||
125141621|NCT01968551|450143048|FG001|Extension Phase|Death|1|||
125141622|NCT01968551|450143049|FG002|Extension Phase|Death|0|||
125141623|NCT01968551|450143047|FG000|Extension Phase|Withdrew Consent|0|||
125141624|NCT01968551|450143048|FG001|Extension Phase|Withdrew Consent|0|||
125141625|NCT01968551|450143049|FG002|Extension Phase|Withdrew Consent|1|||
125141626|NCT01968551|450143047|FG000|Extension Phase|Lost to Follow-up|1|||
125141627|NCT01968551|450143048|FG001|Extension Phase|Lost to Follow-up|0|||
125141628|NCT01968551|450143049|FG002|Extension Phase|Lost to Follow-up|1|||
125141629|NCT00573313|450143052|FG000|Overall Study|Protocol Violation|5|||
125141630|NCT00573313|450143053|FG001|Overall Study|Protocol Violation|0|||
125141631|NCT00573313|450143054|FG002|Overall Study|Protocol Violation|6|||
125141632|NCT00573313|450143055|FG003|Overall Study|Protocol Violation|0|||
125141633|NCT03255980|450143056|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
125141634|NCT03255980|450143057|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
125141635|NCT03255980|450143058|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
125141636|NCT03255980|450143059|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
125141637|NCT03255980|450143056|FG000|Overall Study|Adverse Event|1|||
125141638|NCT03255980|450143057|FG001|Overall Study|Adverse Event|1|||
125141639|NCT03255980|450143058|FG002|Overall Study|Adverse Event|0|||
125141640|NCT03255980|450143059|FG003|Overall Study|Adverse Event|1|||
125141641|NCT03255980|450143056|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
125141642|NCT03255980|450143057|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
125141643|NCT03255980|450143058|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
125141644|NCT03255980|450143059|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
125141645|NCT03255980|450143056|FG000|Overall Study|Lost to Follow-up|1|||
125141646|NCT03255980|450143057|FG001|Overall Study|Lost to Follow-up|1|||
125141647|NCT03255980|450143058|FG002|Overall Study|Lost to Follow-up|0|||
125141648|NCT03255980|450143059|FG003|Overall Study|Lost to Follow-up|3|||
125141649|NCT03255980|450143056|FG000|Overall Study|Withdrawal by Subject|0|||
125141650|NCT03255980|450143057|FG001|Overall Study|Withdrawal by Subject|1|||
125141651|NCT03255980|450143058|FG002|Overall Study|Withdrawal by Subject|0|||
125141652|NCT03255980|450143059|FG003|Overall Study|Withdrawal by Subject|3|||
125141653|NCT01597791|450143060|FG000|Overall Study|Physician Decision|2|||
125141654|NCT01597791|450143061|FG001|Overall Study|Physician Decision|1|||
125141655|NCT01597791|450143060|FG000|Overall Study|Cesarean Section|6|||
125141656|NCT01597791|450143061|FG001|Overall Study|Cesarean Section|7|||
125141657|NCT01597791|450143060|FG000|Overall Study|Subject withdrawal|0|||
125141658|NCT01597791|450143061|FG001|Overall Study|Subject withdrawal|1|||
125141659|NCT01597791|450143060|FG000|Overall Study|Protocol Violation|0|||
125141660|NCT01597791|450143061|FG001|Overall Study|Protocol Violation|1|||
125141661|NCT02096705|450143066|FG000|Treatment|Adverse Event|6|||
125141662|NCT02096705|450143067|FG001|Treatment|Adverse Event|3|||
125141663|NCT02096705|450143066|FG000|Treatment|Subject request to discontinue treatment|1|||
125141664|NCT02096705|450143067|FG001|Treatment|Subject request to discontinue treatment|1|||
125141665|NCT02096705|450143066|FG000|Treatment|Withdrawal by Subject|1|||
125141666|NCT02096705|450143067|FG001|Treatment|Withdrawal by Subject|0|||
125141667|NCT02096705|450143066|FG000|Treatment|Other|1|||
125141668|NCT02096705|450143067|FG001|Treatment|Other|1|||
125141669|NCT02096705|450143066|FG000|Follow-up|Withdrawal by Subject|1|||
125141670|NCT02096705|450143067|FG001|Follow-up|Withdrawal by Subject|0|||
125141671|NCT02096705|450143066|FG000|Follow-up|Adverse Event|2|||
125141672|NCT02096705|450143067|FG001|Follow-up|Adverse Event|2|||
125141673|NCT02096705|450143066|FG000|Follow-up|Subjects not reporting status|1|||
125141674|NCT02096705|450143067|FG001|Follow-up|Subjects not reporting status|2|||
125141675|NCT01949532|450143068|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
125141676|NCT01949532|450143069|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
125141677|NCT00884390|450143070|FG000|Overall Study|Adverse Event|0|||
125141678|NCT00884390|450143071|FG001|Overall Study|Adverse Event|1|||
125141679|NCT00884390|450143070|FG000|Overall Study|Lost to Follow-up|0|||
125141680|NCT00884390|450143071|FG001|Overall Study|Lost to Follow-up|1|||
125141681|NCT00884390|450143070|FG000|Overall Study|Physician Decision|2|||
125072214|NCT03136367|449882425|FG002|T2 Post-consultation|Discontinued lost contact|0|||
125072215|NCT03136367|449882423|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
125072216|NCT03136367|449882424|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
125223083|NCT03143101|450444491|FG000|Overall Study|Lost to Follow-up|2|||
125223084|NCT03143101|450444492|FG001|Overall Study|Lost to Follow-up|2|||
125072217|NCT03136367|449882425|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
125072218|NCT03136367|449882423|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
125072219|NCT03136367|449882424|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
125072220|NCT03136367|449882425|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
125072221|NCT03136367|449882423|FG000|T3 1 Week After Surgery|other discontinued|2|||
125072222|NCT03136367|449882424|FG001|T3 1 Week After Surgery|other discontinued|4|||
125072223|NCT03136367|449882425|FG002|T3 1 Week After Surgery|other discontinued|3|||
125072224|NCT03136367|449882423|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
125072225|NCT03136367|449882424|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
125072226|NCT03136367|449882425|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
125072227|NCT03136367|449882423|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
125072228|NCT03136367|449882424|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
125072229|NCT03136367|449882425|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
125072230|NCT03136367|449882423|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
125072231|NCT03136367|449882424|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
125072232|NCT03136367|449882425|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
125072233|NCT03136367|449882423|FG000|T4 12 Weeks After Surgery|Death|0|||
125072234|NCT03136367|449882424|FG001|T4 12 Weeks After Surgery|Death|1|||
125072235|NCT03136367|449882425|FG002|T4 12 Weeks After Surgery|Death|3|||
125072236|NCT03136367|449882423|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
125072237|NCT03136367|449882424|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
125072238|NCT03136367|449882425|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
125072239|NCT03136367|449882423|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
125072240|NCT03136367|449882424|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
125072241|NCT03136367|449882425|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
125072242|NCT03136367|449882423|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
125072243|NCT03136367|449882424|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
125072244|NCT03136367|449882425|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
125072245|NCT03136367|449882423|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
125072246|NCT03136367|449882424|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
125072247|NCT03136367|449882425|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
125072248|NCT03136367|449882423|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
125072249|NCT03136367|449882424|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
125072250|NCT03136367|449882425|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
125072251|NCT03136367|449882423|FG000|T5 1 Year After Surgery|Death|0|||
125072252|NCT03136367|449882424|FG001|T5 1 Year After Surgery|Death|0|||
125072253|NCT03136367|449882425|FG002|T5 1 Year After Surgery|Death|1|||
125141682|NCT00884390|450143071|FG001|Overall Study|Physician Decision|1|||
125141683|NCT00884390|450143070|FG000|Overall Study|Protocol Violation|4|||
125141684|NCT00884390|450143071|FG001|Overall Study|Protocol Violation|1|||
125141685|NCT00884390|450143070|FG000|Overall Study|Withdrawal by Subject|4|||
125141686|NCT00884390|450143071|FG001|Overall Study|Withdrawal by Subject|1|||
125141687|NCT00884390|450143070|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
125141688|NCT00884390|450143071|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
125141689|NCT00884390|450143070|FG000|Overall Study|Other|11|||
125141690|NCT00884390|450143071|FG001|Overall Study|Other|1|||
125141691|NCT02611323|450143075|FG000|Overall Study|Death|3|||
125141692|NCT02611323|450143076|FG001|Overall Study|Death|1|||
125141693|NCT02611323|450143077|FG002|Overall Study|Death|0|||
125141694|NCT02611323|450143078|FG003|Overall Study|Death|0|||
125141695|NCT02611323|450143079|FG004|Overall Study|Death|1|||
125141696|NCT02611323|450143080|FG005|Overall Study|Death|1|||
125141697|NCT02611323|450143081|FG006|Overall Study|Death|8|||
125141698|NCT02611323|450143082|FG007|Overall Study|Death|0|||
125141699|NCT02611323|450143083|FG008|Overall Study|Death|4|||
125141700|NCT02611323|450143084|FG009|Overall Study|Death|6|||
125072254|NCT03136367|449882423|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
125072255|NCT03136367|449882424|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
125141701|NCT02611323|450143085|FG010|Overall Study|Death|26|||
125141702|NCT02611323|450143075|FG000|Overall Study|Lost to Follow-up|1|||
125141703|NCT02611323|450143076|FG001|Overall Study|Lost to Follow-up|0|||
125141704|NCT02611323|450143077|FG002|Overall Study|Lost to Follow-up|0|||
125141705|NCT02611323|450143078|FG003|Overall Study|Lost to Follow-up|0|||
125141706|NCT02611323|450143079|FG004|Overall Study|Lost to Follow-up|0|||
125141707|NCT02611323|450143080|FG005|Overall Study|Lost to Follow-up|0|||
125141708|NCT02611323|450143081|FG006|Overall Study|Lost to Follow-up|3|||
125141709|NCT02611323|450143082|FG007|Overall Study|Lost to Follow-up|0|||
125141710|NCT02611323|450143083|FG008|Overall Study|Lost to Follow-up|0|||
125141711|NCT02611323|450143084|FG009|Overall Study|Lost to Follow-up|0|||
125141712|NCT02611323|450143085|FG010|Overall Study|Lost to Follow-up|2|||
125141713|NCT02611323|450143075|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
125141714|NCT02611323|450143076|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
125141715|NCT02611323|450143077|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
125141716|NCT02611323|450143078|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
125141717|NCT02611323|450143079|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
125141718|NCT02611323|450143080|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
125141719|NCT02611323|450143081|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
125141720|NCT02611323|450143082|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
125141721|NCT02611323|450143083|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
125072256|NCT03136367|449882425|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
125072257|NCT03136367|449882423|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
125072258|NCT03136367|449882424|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
125072259|NCT03136367|449882425|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
125072260|NCT03136367|449882423|FG000|T5 1 Year After Surgery|study ended before due|31|||
125072261|NCT03136367|449882424|FG001|T5 1 Year After Surgery|study ended before due|103|||
125072262|NCT03136367|449882425|FG002|T5 1 Year After Surgery|study ended before due|110|||
125072263|NCT03136367|449882423|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
125072264|NCT03136367|449882424|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
125072265|NCT03136367|449882425|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
125072266|NCT04876599|449882432|FG000|Overall Study|Missed|2|||
125072267|NCT04876599|449882433|FG001|Overall Study|Missed|0|||
125072268|NCT04876599|449882432|FG000|Overall Study|Declined|2|||
125072269|NCT04876599|449882433|FG001|Overall Study|Declined|3|||
125072270|NCT03175562|449882434|FG000|Overall Study|Adverse Event|1|||
125072271|NCT03175562|449882434|FG000|Overall Study|Lost to Follow-up|3|||
125072272|NCT03175562|449882434|FG000|Overall Study|Withdrawal by Subject|7|||
125072273|NCT03175562|449882434|FG000|Overall Study|Other (Not Specified)|5|||
125072274|NCT02146833|449882435|FG000|Overall Study|Death|10|||
125072275|NCT02146833|449882435|FG000|Overall Study|No longer consented to study treatment|1|||
125072276|NCT00676208|449882438|FG000|Overall Study|Lost to Follow-up|0|||
125141722|NCT02611323|450143084|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
125141723|NCT02611323|450143085|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
125141724|NCT02611323|450143075|FG000|Overall Study|Progressive Disease|0|||
125141725|NCT02611323|450143076|FG001|Overall Study|Progressive Disease|0|||
125141726|NCT02611323|450143077|FG002|Overall Study|Progressive Disease|0|||
125141727|NCT02611323|450143078|FG003|Overall Study|Progressive Disease|0|||
125141728|NCT02611323|450143079|FG004|Overall Study|Progressive Disease|0|||
125141729|NCT02611323|450143080|FG005|Overall Study|Progressive Disease|0|||
125141730|NCT02611323|450143081|FG006|Overall Study|Progressive Disease|0|||
125141731|NCT02611323|450143082|FG007|Overall Study|Progressive Disease|0|||
125141732|NCT02611323|450143083|FG008|Overall Study|Progressive Disease|0|||
125141733|NCT02611323|450143084|FG009|Overall Study|Progressive Disease|0|||
125141734|NCT02611323|450143085|FG010|Overall Study|Progressive Disease|1|||
125141735|NCT02611323|450143075|FG000|Overall Study|Withdrawal by Subject|1|||
125141736|NCT02611323|450143076|FG001|Overall Study|Withdrawal by Subject|0|||
125141737|NCT02611323|450143077|FG002|Overall Study|Withdrawal by Subject|0|||
125141738|NCT02611323|450143078|FG003|Overall Study|Withdrawal by Subject|0|||
125141739|NCT02611323|450143079|FG004|Overall Study|Withdrawal by Subject|0|||
125141740|NCT02611323|450143080|FG005|Overall Study|Withdrawal by Subject|0|||
125141741|NCT02611323|450143081|FG006|Overall Study|Withdrawal by Subject|0|||
125141742|NCT02611323|450143082|FG007|Overall Study|Withdrawal by Subject|1|||
125141743|NCT02611323|450143083|FG008|Overall Study|Withdrawal by Subject|0|||
125141744|NCT02611323|450143084|FG009|Overall Study|Withdrawal by Subject|1|||
125141745|NCT02611323|450143085|FG010|Overall Study|Withdrawal by Subject|0|||
125141746|NCT01215721|450143086|FG000|Overall Study|Adverse Event|2|||
125141747|NCT00045162|450143087|FG000|Overall Study|Ineligible|12|||
125072277|NCT00676208|449882439|FG001|Overall Study|Lost to Follow-up|2|||
125072278|NCT00676208|449882438|FG000|Overall Study|Incomplete data|2|||
125072279|NCT00676208|449882439|FG001|Overall Study|Incomplete data|4|||
125072280|NCT04126031|449882442|FG000|Part A|Withdrawal by Subject|0|||
125072281|NCT04126031|449882443|FG001|Part A|Withdrawal by Subject|0|||
125141748|NCT00045162|450143088|FG001|Overall Study|Ineligible|8|||
125141749|NCT00045162|450143087|FG000|Overall Study|Not treated|7|||
125141750|NCT00045162|450143088|FG001|Overall Study|Not treated|2|||
125141751|NCT00045162|450143087|FG000|Overall Study|Adverse Event|55|||
125141752|NCT00045162|450143088|FG001|Overall Study|Adverse Event|50|||
125141753|NCT00045162|450143087|FG000|Overall Study|Lack of Efficacy|32|||
125141754|NCT00045162|450143088|FG001|Overall Study|Lack of Efficacy|29|||
125141755|NCT00045162|450143087|FG000|Overall Study|Death|10|||
125141756|NCT00045162|450143088|FG001|Overall Study|Death|10|||
125141757|NCT00045162|450143087|FG000|Overall Study|Withdrawal by Subject|5|||
125072282|NCT04126031|449882444|FG002|Part A|Withdrawal by Subject|1|||
125072283|NCT04126031|449882445|FG003|Part A|Withdrawal by Subject|0|||
125072284|NCT04126031|449882446|FG004|Part A|Withdrawal by Subject|0|||
125072285|NCT04126031|449882447|FG005|Part A|Withdrawal by Subject|0|||
125072286|NCT04126031|449882442|FG000|Part A|Other|1|||
125072287|NCT04126031|449882443|FG001|Part A|Other|0|||
125072288|NCT04126031|449882444|FG002|Part A|Other|0|||
125072289|NCT04126031|449882445|FG003|Part A|Other|0|||
125072290|NCT04126031|449882446|FG004|Part A|Other|0|||
125072291|NCT04126031|449882447|FG005|Part A|Other|0|||
125072292|NCT04126031|449882442|FG000|Part B|Adverse Event|0|||
125072293|NCT04126031|449882443|FG001|Part B|Adverse Event|0|||
125072294|NCT04126031|449882444|FG002|Part B|Adverse Event|0|||
125072295|NCT04126031|449882445|FG003|Part B|Adverse Event|0|||
125072296|NCT04126031|449882446|FG004|Part B|Adverse Event|0|||
125072297|NCT04126031|449882447|FG005|Part B|Adverse Event|2|||
125072298|NCT04126031|449882442|FG000|Part B|Pre-existing hypertransaminasemia|0|||
125072299|NCT04126031|449882443|FG001|Part B|Pre-existing hypertransaminasemia|0|||
125072300|NCT04126031|449882444|FG002|Part B|Pre-existing hypertransaminasemia|0|||
125072301|NCT04126031|449882445|FG003|Part B|Pre-existing hypertransaminasemia|0|||
125072302|NCT04126031|449882446|FG004|Part B|Pre-existing hypertransaminasemia|1|||
125072303|NCT04126031|449882447|FG005|Part B|Pre-existing hypertransaminasemia|0|||
125072304|NCT00131664|449882448|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
125072305|NCT00131664|449882449|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
125072306|NCT00131664|449882450|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
125072307|NCT00131664|449882451|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
125072308|NCT00131664|449882452|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
125072309|NCT00131664|449882453|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
125072310|NCT00131664|449882448|FG000|First Period (First 6 Months)|Death|0|||
125072311|NCT00131664|449882449|FG001|First Period (First 6 Months)|Death|1|||
125072312|NCT00131664|449882450|FG002|First Period (First 6 Months)|Death|0|||
125072313|NCT00131664|449882451|FG003|First Period (First 6 Months)|Death|0|||
125072314|NCT00131664|449882452|FG004|First Period (First 6 Months)|Death|0|||
125072315|NCT00131664|449882453|FG005|First Period (First 6 Months)|Death|0|||
125072316|NCT00131664|449882448|FG000|First Period (First 6 Months)|Protocol Violation|2|||
125072317|NCT00131664|449882449|FG001|First Period (First 6 Months)|Protocol Violation|2|||
125072318|NCT00131664|449882450|FG002|First Period (First 6 Months)|Protocol Violation|1|||
125072319|NCT00131664|449882451|FG003|First Period (First 6 Months)|Protocol Violation|0|||
125072320|NCT00131664|449882452|FG004|First Period (First 6 Months)|Protocol Violation|0|||
125072321|NCT00131664|449882453|FG005|First Period (First 6 Months)|Protocol Violation|0|||
125072322|NCT00131664|449882448|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
125072323|NCT00131664|449882449|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
125072324|NCT00131664|449882450|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
125072325|NCT00131664|449882451|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
125072326|NCT00131664|449882452|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
125072327|NCT00131664|449882453|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
125072328|NCT00131664|449882448|FG000|First Period (First 6 Months)|Adverse Event|9|||
125072329|NCT00131664|449882449|FG001|First Period (First 6 Months)|Adverse Event|4|||
125072330|NCT00131664|449882450|FG002|First Period (First 6 Months)|Adverse Event|5|||
125072331|NCT00131664|449882451|FG003|First Period (First 6 Months)|Adverse Event|0|||
125072332|NCT00131664|449882452|FG004|First Period (First 6 Months)|Adverse Event|0|||
125072333|NCT00131664|449882453|FG005|First Period (First 6 Months)|Adverse Event|0|||
125072334|NCT00131664|449882448|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
125072335|NCT00131664|449882449|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
125072336|NCT00131664|449882450|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
125072337|NCT00131664|449882451|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
125072338|NCT00131664|449882452|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
125072339|NCT00131664|449882453|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
125072340|NCT00131664|449882448|FG000|First Period (First 6 Months)|Administrative reasons|2|||
125072341|NCT00131664|449882449|FG001|First Period (First 6 Months)|Administrative reasons|0|||
125072342|NCT00131664|449882450|FG002|First Period (First 6 Months)|Administrative reasons|5|||
125072343|NCT00131664|449882451|FG003|First Period (First 6 Months)|Administrative reasons|0|||
125072344|NCT00131664|449882452|FG004|First Period (First 6 Months)|Administrative reasons|0|||
125072345|NCT00131664|449882453|FG005|First Period (First 6 Months)|Administrative reasons|0|||
125072346|NCT00131664|449882448|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
125072347|NCT00131664|449882449|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
125072348|NCT00131664|449882450|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
125072349|NCT00131664|449882451|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
125072350|NCT00131664|449882452|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
125072351|NCT00131664|449882453|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
125072352|NCT00131664|449882448|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
125072353|NCT00131664|449882449|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
125072354|NCT00131664|449882450|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
125072355|NCT00131664|449882451|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
125072356|NCT00131664|449882452|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
125072357|NCT00131664|449882453|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
125072358|NCT00131664|449882448|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
125072359|NCT00131664|449882449|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
125072360|NCT00131664|449882450|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
125072361|NCT00131664|449882451|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
125072362|NCT00131664|449882452|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
125072363|NCT00131664|449882453|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
125072364|NCT00131664|449882448|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
125072365|NCT00131664|449882449|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
125072366|NCT00131664|449882450|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
125072367|NCT00131664|449882451|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
125072368|NCT00131664|449882452|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
125072369|NCT00131664|449882453|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
125072370|NCT00131664|449882448|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
125072371|NCT00131664|449882449|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
125072372|NCT00131664|449882450|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
125072373|NCT00131664|449882451|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
125072374|NCT00131664|449882452|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
125072375|NCT00131664|449882453|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
125072376|NCT00131664|449882448|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
125072377|NCT00131664|449882449|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
125072378|NCT00131664|449882450|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
125072379|NCT00131664|449882451|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
125072380|NCT00131664|449882452|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
125072381|NCT00131664|449882453|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
125072382|NCT00617656|449882454|FG000|Overall Study|Inclusion error|4|||
125072383|NCT00617656|449882455|FG001|Overall Study|Inclusion error|4|||
125072384|NCT00617656|449882456|FG002|Overall Study|Inclusion error|0|||
125072385|NCT00617656|449882457|FG003|Overall Study|Inclusion error|0|||
125072386|NCT00617656|449882454|FG000|Overall Study|Missing data|44|||
125072387|NCT00617656|449882455|FG001|Overall Study|Missing data|30|||
125072388|NCT00617656|449882456|FG002|Overall Study|Missing data|13|||
125072389|NCT00617656|449882457|FG003|Overall Study|Missing data|6|||
125072390|NCT00617656|449882454|FG000|Overall Study|Withdrawal by Subject|0|||
125072391|NCT00617656|449882455|FG001|Overall Study|Withdrawal by Subject|2|||
125072392|NCT00617656|449882456|FG002|Overall Study|Withdrawal by Subject|0|||
125072393|NCT00617656|449882457|FG003|Overall Study|Withdrawal by Subject|0|||
125072394|NCT01105936|449884068|FG000|Period 1|Adverse Event|0|||
125072395|NCT01105936|449884069|FG001|Period 1|Adverse Event|0|||
125072396|NCT01105936|449884070|FG002|Period 1|Adverse Event|0|||
125072397|NCT01105936|449884071|FG003|Period 1|Adverse Event|1|||
125072398|NCT01105936|449884068|FG000|Period 2|Adverse Event|1|||
125072399|NCT01105936|449884069|FG001|Period 2|Adverse Event|0|||
125072400|NCT01105936|449884070|FG002|Period 2|Adverse Event|0|||
125072401|NCT01105936|449884071|FG003|Period 2|Adverse Event|0|||
125072402|NCT01105936|449884068|FG000|Period 3|Protocol Violation|0|||
125072403|NCT01105936|449884069|FG001|Period 3|Protocol Violation|2|||
125072404|NCT01105936|449884070|FG002|Period 3|Protocol Violation|0|||
125072405|NCT01105936|449884071|FG003|Period 3|Protocol Violation|0|||
125072406|NCT02657434|449884074|FG000|Overall Study|Study Terminated By Sponsor|64|||
125072407|NCT02657434|449884075|FG001|Overall Study|Study Terminated By Sponsor|82|||
125072408|NCT02657434|449884074|FG000|Overall Study|Death|189|||
125072409|NCT02657434|449884075|FG001|Overall Study|Death|190|||
125072410|NCT02657434|449884074|FG000|Overall Study|Lost to Follow-up|2|||
125072411|NCT02657434|449884075|FG001|Overall Study|Lost to Follow-up|2|||
125072412|NCT02657434|449884074|FG000|Overall Study|Randomization by Error|2|||
125072413|NCT02657434|449884075|FG001|Overall Study|Randomization by Error|0|||
125072414|NCT02657434|449884074|FG000|Overall Study|Withdrawal by Subject|28|||
125072415|NCT02657434|449884075|FG001|Overall Study|Withdrawal by Subject|17|||
125072416|NCT02657434|449884074|FG000|Overall Study|Protocol Violation|1|||
125072417|NCT02657434|449884075|FG001|Overall Study|Protocol Violation|0|||
125072418|NCT02657434|449884074|FG000|Overall Study|Physician Decision|0|||
125072419|NCT02657434|449884075|FG001|Overall Study|Physician Decision|1|||
125072420|NCT00608881|449884076|FG000|Overall Study|Death|22|||
125072421|NCT00608881|449884077|FG001|Overall Study|Death|13|||
125072422|NCT00608881|449884076|FG000|Overall Study|Adverse Event|5|||
125072423|NCT00608881|449884077|FG001|Overall Study|Adverse Event|3|||
125072424|NCT00608881|449884076|FG000|Overall Study|Lost to Follow-up|28|||
125072425|NCT00608881|449884077|FG001|Overall Study|Lost to Follow-up|14|||
125072426|NCT00608881|449884076|FG000|Overall Study|Withdrawal by Subject|18|||
125072427|NCT00608881|449884077|FG001|Overall Study|Withdrawal by Subject|29|||
125072428|NCT00608881|449884076|FG000|Overall Study|Physician Decision|5|||
125072429|NCT00608881|449884077|FG001|Overall Study|Physician Decision|5|||
125072430|NCT00608881|449884076|FG000|Overall Study|Institutionalized|1|||
125072431|NCT00608881|449884077|FG001|Overall Study|Institutionalized|2|||
125072432|NCT01998958|449884078|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072433|NCT01998958|449884079|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
125072434|NCT01998958|449884080|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072435|NCT01998958|449884081|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072436|NCT01998958|449884082|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072437|NCT01998958|449884083|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072438|NCT01998958|449884084|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072439|NCT01998958|449884085|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072440|NCT01998958|449884086|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072441|NCT01998958|449884087|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072442|NCT01998958|449884088|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072443|NCT01998958|449884089|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072444|NCT01998958|449884090|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072445|NCT01998958|449884091|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072446|NCT01998958|449884092|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072447|NCT01998958|449884093|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072448|NCT01998958|449884094|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072449|NCT01998958|449884095|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072450|NCT01998958|449884096|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072451|NCT01998958|449884097|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072452|NCT01998958|449884098|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072453|NCT01998958|449884099|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072454|NCT01998958|449884100|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072455|NCT01998958|449884101|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072456|NCT01998958|449884102|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072457|NCT01998958|449884103|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072458|NCT01998958|449884104|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072459|NCT01998958|449884105|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072460|NCT01998958|449884106|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072461|NCT01998958|449884107|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072462|NCT01998958|449884108|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072463|NCT01998958|449884109|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125072464|NCT01998958|449884078|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072465|NCT01998958|449884079|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
125072466|NCT01998958|449884080|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072467|NCT01998958|449884081|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072468|NCT01998958|449884082|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072469|NCT01998958|449884083|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072470|NCT01998958|449884084|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072471|NCT01998958|449884085|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072472|NCT01998958|449884086|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072473|NCT01998958|449884087|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072474|NCT01998958|449884088|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072475|NCT01998958|449884089|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072476|NCT01998958|449884090|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072477|NCT01998958|449884091|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072478|NCT01998958|449884092|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072479|NCT01998958|449884093|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072480|NCT01998958|449884094|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072481|NCT01998958|449884095|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072482|NCT01998958|449884096|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072483|NCT01998958|449884097|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072484|NCT01998958|449884098|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072485|NCT01998958|449884099|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072486|NCT01998958|449884100|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072487|NCT01998958|449884101|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072488|NCT01998958|449884102|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072489|NCT01998958|449884103|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072490|NCT01998958|449884104|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072491|NCT01998958|449884105|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125141758|NCT00045162|450143088|FG001|Overall Study|Withdrawal by Subject|3|||
125141759|NCT00045162|450143087|FG000|Overall Study|Other|21|||
125141760|NCT00045162|450143088|FG001|Overall Study|Other|16|||
125141761|NCT01899053|450143089|FG000|Overall Study|Progressive Disease|4|||
125141762|NCT01899053|450143090|FG001|Overall Study|Progressive Disease|0|||
125141763|NCT01899053|450143091|FG002|Overall Study|Progressive Disease|3|||
125141764|NCT01899053|450143092|FG003|Overall Study|Progressive Disease|0|||
125141765|NCT01899053|450143093|FG004|Overall Study|Progressive Disease|3|||
125141766|NCT01899053|450143094|FG005|Overall Study|Progressive Disease|1|||
125141767|NCT01899053|450143095|FG006|Overall Study|Progressive Disease|1|||
125141768|NCT01899053|450143096|FG007|Overall Study|Progressive Disease|1|||
125141769|NCT01899053|450143097|FG008|Overall Study|Progressive Disease|4|||
125141770|NCT01899053|450143098|FG009|Overall Study|Progressive Disease|3|||
125141771|NCT01899053|450143099|FG010|Overall Study|Progressive Disease|12|||
125141772|NCT01899053|450143100|FG011|Overall Study|Progressive Disease|5|||
125141773|NCT01899053|450143101|FG012|Overall Study|Progressive Disease|8|||
125141774|NCT01899053|450143102|FG013|Overall Study|Progressive Disease|17|||
125141775|NCT01899053|450143089|FG000|Overall Study|Adverse Event|1|||
125141776|NCT01899053|450143090|FG001|Overall Study|Adverse Event|1|||
125141777|NCT01899053|450143091|FG002|Overall Study|Adverse Event|1|||
125141778|NCT01899053|450143092|FG003|Overall Study|Adverse Event|3|||
125141779|NCT01899053|450143093|FG004|Overall Study|Adverse Event|1|||
125141780|NCT01899053|450143094|FG005|Overall Study|Adverse Event|1|||
125141781|NCT01899053|450143095|FG006|Overall Study|Adverse Event|1|||
125141782|NCT01899053|450143096|FG007|Overall Study|Adverse Event|0|||
125141783|NCT01899053|450143097|FG008|Overall Study|Adverse Event|2|||
125141784|NCT01899053|450143098|FG009|Overall Study|Adverse Event|0|||
125141785|NCT01899053|450143099|FG010|Overall Study|Adverse Event|3|||
125141786|NCT01899053|450143100|FG011|Overall Study|Adverse Event|1|||
125141787|NCT01899053|450143101|FG012|Overall Study|Adverse Event|2|||
125141788|NCT01899053|450143102|FG013|Overall Study|Adverse Event|2|||
125141789|NCT01899053|450143089|FG000|Overall Study|Reason Not Specified|0|||
125141790|NCT01899053|450143090|FG001|Overall Study|Reason Not Specified|0|||
125141791|NCT01899053|450143091|FG002|Overall Study|Reason Not Specified|0|||
125141792|NCT01899053|450143092|FG003|Overall Study|Reason Not Specified|0|||
125141793|NCT01899053|450143093|FG004|Overall Study|Reason Not Specified|0|||
125141794|NCT01899053|450143094|FG005|Overall Study|Reason Not Specified|0|||
125141795|NCT01899053|450143095|FG006|Overall Study|Reason Not Specified|1|||
125141796|NCT01899053|450143096|FG007|Overall Study|Reason Not Specified|0|||
125141797|NCT01899053|450143097|FG008|Overall Study|Reason Not Specified|0|||
125141798|NCT01899053|450143098|FG009|Overall Study|Reason Not Specified|0|||
125141799|NCT01899053|450143099|FG010|Overall Study|Reason Not Specified|0|||
125141800|NCT01899053|450143100|FG011|Overall Study|Reason Not Specified|0|||
125141801|NCT01899053|450143101|FG012|Overall Study|Reason Not Specified|1|||
125141802|NCT01899053|450143102|FG013|Overall Study|Reason Not Specified|0|||
125141803|NCT01899053|450143089|FG000|Overall Study|Withdrawal by Subject|1|||
125141804|NCT01899053|450143090|FG001|Overall Study|Withdrawal by Subject|1|||
125141805|NCT01899053|450143091|FG002|Overall Study|Withdrawal by Subject|2|||
125141806|NCT01899053|450143092|FG003|Overall Study|Withdrawal by Subject|0|||
125141807|NCT01899053|450143093|FG004|Overall Study|Withdrawal by Subject|2|||
125141808|NCT01899053|450143094|FG005|Overall Study|Withdrawal by Subject|0|||
125141809|NCT01899053|450143095|FG006|Overall Study|Withdrawal by Subject|0|||
125141810|NCT01899053|450143096|FG007|Overall Study|Withdrawal by Subject|1|||
125141811|NCT01899053|450143097|FG008|Overall Study|Withdrawal by Subject|0|||
125141812|NCT01899053|450143098|FG009|Overall Study|Withdrawal by Subject|0|||
125141813|NCT01899053|450143099|FG010|Overall Study|Withdrawal by Subject|0|||
125141814|NCT01899053|450143100|FG011|Overall Study|Withdrawal by Subject|0|||
125141815|NCT01899053|450143101|FG012|Overall Study|Withdrawal by Subject|1|||
125141816|NCT01899053|450143102|FG013|Overall Study|Withdrawal by Subject|1|||
125141817|NCT01899053|450143089|FG000|Overall Study|Protocol Violation|0|||
125141818|NCT01899053|450143090|FG001|Overall Study|Protocol Violation|0|||
125141819|NCT01899053|450143091|FG002|Overall Study|Protocol Violation|1|||
125141820|NCT01899053|450143092|FG003|Overall Study|Protocol Violation|0|||
125141821|NCT01899053|450143093|FG004|Overall Study|Protocol Violation|0|||
125141822|NCT01899053|450143094|FG005|Overall Study|Protocol Violation|0|||
125141823|NCT01899053|450143095|FG006|Overall Study|Protocol Violation|0|||
125141824|NCT01899053|450143096|FG007|Overall Study|Protocol Violation|0|||
125141825|NCT01899053|450143097|FG008|Overall Study|Protocol Violation|0|||
125141826|NCT01899053|450143098|FG009|Overall Study|Protocol Violation|0|||
125141827|NCT01899053|450143099|FG010|Overall Study|Protocol Violation|0|||
125141828|NCT01899053|450143100|FG011|Overall Study|Protocol Violation|0|||
125141829|NCT01899053|450143101|FG012|Overall Study|Protocol Violation|0|||
125141830|NCT01899053|450143102|FG013|Overall Study|Protocol Violation|0|||
125141831|NCT01899053|450143089|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
125141832|NCT01899053|450143090|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
125141833|NCT01899053|450143091|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
125072492|NCT01998958|449884106|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072493|NCT01998958|449884107|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072494|NCT01998958|449884108|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072495|NCT01998958|449884109|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125072496|NCT01998958|449884078|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
125072497|NCT01998958|449884079|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
125072498|NCT01998958|449884080|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
125072499|NCT01998958|449884081|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
125072500|NCT01998958|449884082|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
125072501|NCT01998958|449884083|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
125072502|NCT01998958|449884084|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
125072503|NCT01998958|449884085|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
125072504|NCT01998958|449884086|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
125072505|NCT01998958|449884087|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
125072506|NCT01998958|449884088|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
125072507|NCT01998958|449884089|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
125072508|NCT01998958|449884090|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
125072509|NCT01998958|449884091|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
125072510|NCT01998958|449884092|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
125072511|NCT01998958|449884093|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
125072512|NCT01998958|449884094|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
125072513|NCT01998958|449884095|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
125072514|NCT01998958|449884096|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
125072515|NCT01998958|449884097|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
125072516|NCT01998958|449884098|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
125072517|NCT01998958|449884099|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
125072518|NCT01998958|449884100|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
125072519|NCT01998958|449884101|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
125072520|NCT01998958|449884102|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
125072521|NCT01998958|449884103|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
125072522|NCT01998958|449884104|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
125072523|NCT01998958|449884105|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
125072524|NCT01998958|449884106|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
125072525|NCT01998958|449884107|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
125072526|NCT01998958|449884108|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
125072527|NCT01998958|449884109|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
125072528|NCT01998958|449884078|FG000|Period 1 (Panel A and B)|Other|1|||
125072529|NCT01998958|449884079|FG001|Period 1 (Panel A and B)|Other|0|||
125072530|NCT01998958|449884080|FG002|Period 1 (Panel A and B)|Other|0|||
125072531|NCT01998958|449884081|FG003|Period 1 (Panel A and B)|Other|0|||
125072532|NCT01998958|449884082|FG004|Period 1 (Panel A and B)|Other|0|||
125072533|NCT01998958|449884083|FG005|Period 1 (Panel A and B)|Other|0|||
125072534|NCT01998958|449884084|FG006|Period 1 (Panel A and B)|Other|0|||
125072535|NCT01998958|449884085|FG007|Period 1 (Panel A and B)|Other|0|||
125072536|NCT01998958|449884086|FG008|Period 1 (Panel A and B)|Other|0|||
125072537|NCT01998958|449884087|FG009|Period 1 (Panel A and B)|Other|0|||
125072538|NCT01998958|449884088|FG010|Period 1 (Panel A and B)|Other|0|||
125223085|NCT03143101|450444493|FG002|Overall Study|Lost to Follow-up|0|||
125223086|NCT01630135|450444495|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
125072539|NCT01998958|449884089|FG011|Period 1 (Panel A and B)|Other|0|||
125072540|NCT01998958|449884090|FG012|Period 1 (Panel A and B)|Other|0|||
125072541|NCT01998958|449884091|FG013|Period 1 (Panel A and B)|Other|0|||
125072542|NCT01998958|449884092|FG014|Period 1 (Panel A and B)|Other|0|||
125072543|NCT01998958|449884093|FG015|Period 1 (Panel A and B)|Other|0|||
125072544|NCT01998958|449884094|FG016|Period 1 (Panel A and B)|Other|0|||
125072545|NCT01998958|449884095|FG017|Period 1 (Panel A and B)|Other|0|||
125072546|NCT01998958|449884096|FG018|Period 1 (Panel A and B)|Other|0|||
125072547|NCT01998958|449884097|FG019|Period 1 (Panel A and B)|Other|0|||
125072548|NCT01998958|449884098|FG020|Period 1 (Panel A and B)|Other|0|||
125223087|NCT01630135|450444496|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
125223088|NCT03243305|450444499|FG000|Overall Study|Lost to Follow-up|250|||
125223089|NCT03243305|450444499|FG000|Overall Study|Withdrawal by Subject|170|||
125072549|NCT01998958|449884099|FG021|Period 1 (Panel A and B)|Other|0|||
125072550|NCT01998958|449884100|FG022|Period 1 (Panel A and B)|Other|0|||
125223090|NCT03243305|450444499|FG000|Overall Study|Pregnancy|104|||
125072551|NCT01998958|449884101|FG023|Period 1 (Panel A and B)|Other|0|||
125072552|NCT01998958|449884102|FG024|Period 1 (Panel A and B)|Other|0|||
125072553|NCT01998958|449884103|FG025|Period 1 (Panel A and B)|Other|0|||
125072554|NCT01998958|449884104|FG026|Period 1 (Panel A and B)|Other|0|||
125072555|NCT01998958|449884105|FG027|Period 1 (Panel A and B)|Other|0|||
125072556|NCT01998958|449884106|FG028|Period 1 (Panel A and B)|Other|0|||
125072557|NCT01998958|449884107|FG029|Period 1 (Panel A and B)|Other|0|||
125072558|NCT01998958|449884108|FG030|Period 1 (Panel A and B)|Other|0|||
125072559|NCT01998958|449884109|FG031|Period 1 (Panel A and B)|Other|0|||
125072560|NCT01998958|449884078|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
125072561|NCT01998958|449884079|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
125072562|NCT01998958|449884080|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
125072563|NCT01998958|449884081|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
125072564|NCT01998958|449884082|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
125072565|NCT01998958|449884083|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
125072566|NCT01998958|449884084|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
125072567|NCT01998958|449884085|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
125072568|NCT01998958|449884086|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
125072569|NCT01998958|449884087|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
125072570|NCT01998958|449884088|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
125072571|NCT01998958|449884089|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
125072572|NCT01998958|449884090|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
125072573|NCT01998958|449884091|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
125072574|NCT01998958|449884092|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
125072575|NCT01998958|449884093|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
125072576|NCT01998958|449884094|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
125072577|NCT01998958|449884095|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
125072578|NCT01998958|449884096|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
125072579|NCT01998958|449884097|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
125072580|NCT01998958|449884098|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
125072581|NCT01998958|449884099|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
125072582|NCT01998958|449884100|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
125072583|NCT01998958|449884101|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
125072584|NCT01998958|449884102|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
125072585|NCT01998958|449884103|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
125072586|NCT01998958|449884104|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
125072587|NCT01998958|449884105|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
125072588|NCT01998958|449884106|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
125072589|NCT01998958|449884107|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
125072590|NCT01998958|449884108|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
125072591|NCT01998958|449884109|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
125072592|NCT01998958|449884078|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072593|NCT01998958|449884079|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072594|NCT01998958|449884080|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072595|NCT01998958|449884081|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072596|NCT01998958|449884082|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072597|NCT01998958|449884083|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072598|NCT01998958|449884084|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072599|NCT01998958|449884085|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072600|NCT01998958|449884086|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072601|NCT01998958|449884087|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072602|NCT01998958|449884088|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072603|NCT01998958|449884089|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072604|NCT01998958|449884090|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072605|NCT01998958|449884091|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072606|NCT01998958|449884092|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
125072607|NCT01998958|449884093|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072608|NCT01998958|449884094|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072609|NCT01998958|449884095|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072610|NCT01998958|449884096|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
125072611|NCT01998958|449884097|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072612|NCT01998958|449884098|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072613|NCT01998958|449884099|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072614|NCT01998958|449884100|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072615|NCT01998958|449884101|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072616|NCT01998958|449884102|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072617|NCT01998958|449884103|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072618|NCT01998958|449884104|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072619|NCT01998958|449884105|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072620|NCT01998958|449884106|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072621|NCT01998958|449884107|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072622|NCT01998958|449884108|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072623|NCT01998958|449884109|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125072624|NCT01998958|449884078|FG000|Open Label Phase (Optional)|Adverse Event|0|||
125141834|NCT01899053|450143092|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
125072625|NCT01998958|449884079|FG001|Open Label Phase (Optional)|Adverse Event|0|||
125141835|NCT01899053|450143093|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
125072626|NCT01998958|449884080|FG002|Open Label Phase (Optional)|Adverse Event|0|||
125072627|NCT01998958|449884081|FG003|Open Label Phase (Optional)|Adverse Event|0|||
125072628|NCT01998958|449884082|FG004|Open Label Phase (Optional)|Adverse Event|0|||
125072629|NCT01998958|449884083|FG005|Open Label Phase (Optional)|Adverse Event|0|||
125072630|NCT01998958|449884084|FG006|Open Label Phase (Optional)|Adverse Event|0|||
125072631|NCT01998958|449884085|FG007|Open Label Phase (Optional)|Adverse Event|0|||
125072632|NCT01998958|449884086|FG008|Open Label Phase (Optional)|Adverse Event|0|||
125072633|NCT01998958|449884087|FG009|Open Label Phase (Optional)|Adverse Event|0|||
125072634|NCT01998958|449884088|FG010|Open Label Phase (Optional)|Adverse Event|0|||
125072635|NCT01998958|449884089|FG011|Open Label Phase (Optional)|Adverse Event|0|||
125072636|NCT01998958|449884090|FG012|Open Label Phase (Optional)|Adverse Event|0|||
125072637|NCT01998958|449884091|FG013|Open Label Phase (Optional)|Adverse Event|0|||
125072638|NCT01998958|449884092|FG014|Open Label Phase (Optional)|Adverse Event|0|||
125072639|NCT01998958|449884093|FG015|Open Label Phase (Optional)|Adverse Event|0|||
125072640|NCT01998958|449884094|FG016|Open Label Phase (Optional)|Adverse Event|0|||
125072641|NCT01998958|449884095|FG017|Open Label Phase (Optional)|Adverse Event|0|||
125072642|NCT01998958|449884096|FG018|Open Label Phase (Optional)|Adverse Event|0|||
125072643|NCT01998958|449884097|FG019|Open Label Phase (Optional)|Adverse Event|0|||
125072644|NCT01998958|449884098|FG020|Open Label Phase (Optional)|Adverse Event|0|||
125072645|NCT01998958|449884099|FG021|Open Label Phase (Optional)|Adverse Event|0|||
125072646|NCT01998958|449884100|FG022|Open Label Phase (Optional)|Adverse Event|0|||
125072647|NCT01998958|449884101|FG023|Open Label Phase (Optional)|Adverse Event|1|||
125072648|NCT01998958|449884102|FG024|Open Label Phase (Optional)|Adverse Event|0|||
125072649|NCT01998958|449884103|FG025|Open Label Phase (Optional)|Adverse Event|0|||
125072650|NCT01998958|449884104|FG026|Open Label Phase (Optional)|Adverse Event|0|||
125072651|NCT01998958|449884105|FG027|Open Label Phase (Optional)|Adverse Event|0|||
125072652|NCT01998958|449884106|FG028|Open Label Phase (Optional)|Adverse Event|0|||
125072653|NCT01998958|449884107|FG029|Open Label Phase (Optional)|Adverse Event|0|||
125072654|NCT01998958|449884108|FG030|Open Label Phase (Optional)|Adverse Event|0|||
125072655|NCT01998958|449884109|FG031|Open Label Phase (Optional)|Adverse Event|0|||
125072656|NCT01998958|449884078|FG000|Open Label Phase (Optional)|Other|0|||
125072657|NCT01998958|449884079|FG001|Open Label Phase (Optional)|Other|0|||
125072658|NCT01998958|449884080|FG002|Open Label Phase (Optional)|Other|0|||
125072659|NCT01998958|449884081|FG003|Open Label Phase (Optional)|Other|0|||
125072660|NCT01998958|449884082|FG004|Open Label Phase (Optional)|Other|0|||
125072661|NCT01998958|449884083|FG005|Open Label Phase (Optional)|Other|0|||
125072662|NCT01998958|449884084|FG006|Open Label Phase (Optional)|Other|0|||
125072663|NCT01998958|449884085|FG007|Open Label Phase (Optional)|Other|0|||
125072664|NCT01998958|449884086|FG008|Open Label Phase (Optional)|Other|0|||
125072665|NCT01998958|449884087|FG009|Open Label Phase (Optional)|Other|0|||
125072666|NCT01998958|449884088|FG010|Open Label Phase (Optional)|Other|0|||
125072667|NCT01998958|449884089|FG011|Open Label Phase (Optional)|Other|0|||
125072668|NCT01998958|449884090|FG012|Open Label Phase (Optional)|Other|0|||
125072669|NCT01998958|449884091|FG013|Open Label Phase (Optional)|Other|0|||
125072670|NCT01998958|449884092|FG014|Open Label Phase (Optional)|Other|0|||
125072671|NCT01998958|449884093|FG015|Open Label Phase (Optional)|Other|0|||
125072672|NCT01998958|449884094|FG016|Open Label Phase (Optional)|Other|0|||
125072673|NCT01998958|449884095|FG017|Open Label Phase (Optional)|Other|0|||
125072674|NCT01998958|449884096|FG018|Open Label Phase (Optional)|Other|0|||
125072675|NCT01998958|449884097|FG019|Open Label Phase (Optional)|Other|0|||
125072676|NCT01998958|449884098|FG020|Open Label Phase (Optional)|Other|0|||
125072677|NCT01998958|449884099|FG021|Open Label Phase (Optional)|Other|0|||
125072678|NCT01998958|449884100|FG022|Open Label Phase (Optional)|Other|5|||
125072679|NCT01998958|449884101|FG023|Open Label Phase (Optional)|Other|1|||
125072680|NCT01998958|449884102|FG024|Open Label Phase (Optional)|Other|0|||
125072681|NCT01998958|449884103|FG025|Open Label Phase (Optional)|Other|0|||
125072682|NCT01998958|449884104|FG026|Open Label Phase (Optional)|Other|0|||
125072683|NCT01998958|449884105|FG027|Open Label Phase (Optional)|Other|0|||
125072684|NCT01998958|449884106|FG028|Open Label Phase (Optional)|Other|0|||
125072685|NCT01998958|449884107|FG029|Open Label Phase (Optional)|Other|0|||
125072686|NCT01998958|449884108|FG030|Open Label Phase (Optional)|Other|0|||
125072687|NCT01998958|449884109|FG031|Open Label Phase (Optional)|Other|0|||
125072688|NCT01998958|449884078|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072689|NCT01998958|449884079|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072690|NCT01998958|449884080|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072691|NCT01998958|449884081|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072692|NCT01998958|449884082|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072693|NCT01998958|449884083|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072694|NCT01998958|449884084|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072695|NCT01998958|449884085|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072696|NCT01998958|449884086|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072697|NCT01998958|449884087|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072698|NCT01998958|449884088|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072699|NCT01998958|449884089|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072700|NCT01998958|449884090|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072701|NCT01998958|449884091|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072702|NCT01998958|449884092|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072703|NCT01998958|449884093|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072704|NCT01998958|449884094|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072705|NCT01998958|449884095|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072706|NCT01998958|449884096|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072707|NCT01998958|449884097|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072708|NCT01998958|449884098|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072709|NCT01998958|449884099|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072710|NCT01998958|449884100|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
125072711|NCT01998958|449884101|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072712|NCT01998958|449884102|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072713|NCT01998958|449884103|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072714|NCT01998958|449884104|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072715|NCT01998958|449884105|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072716|NCT01998958|449884106|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072717|NCT01998958|449884107|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072718|NCT01998958|449884108|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072719|NCT01998958|449884109|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
125072720|NCT01998958|449884078|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072721|NCT01998958|449884079|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072722|NCT01998958|449884080|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072723|NCT01998958|449884081|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072724|NCT01998958|449884082|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072725|NCT01998958|449884083|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072726|NCT01998958|449884084|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
125141836|NCT01899053|450143094|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
125141837|NCT01899053|450143095|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
125141838|NCT01899053|450143096|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
125141839|NCT01899053|450143097|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
125141840|NCT01899053|450143098|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
125141841|NCT01899053|450143099|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
125141842|NCT01899053|450143100|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
125141843|NCT01899053|450143101|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
125141844|NCT01899053|450143102|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
125141845|NCT01899053|450143089|FG000|Overall Study|Symptomatic Deterioration|0|||
125141846|NCT01899053|450143090|FG001|Overall Study|Symptomatic Deterioration|0|||
125141847|NCT01899053|450143091|FG002|Overall Study|Symptomatic Deterioration|0|||
125141848|NCT01899053|450143092|FG003|Overall Study|Symptomatic Deterioration|0|||
125141849|NCT01899053|450143093|FG004|Overall Study|Symptomatic Deterioration|0|||
125141850|NCT01899053|450143094|FG005|Overall Study|Symptomatic Deterioration|1|||
125141851|NCT01899053|450143095|FG006|Overall Study|Symptomatic Deterioration|0|||
125141852|NCT01899053|450143096|FG007|Overall Study|Symptomatic Deterioration|1|||
125141853|NCT01899053|450143097|FG008|Overall Study|Symptomatic Deterioration|0|||
125141854|NCT01899053|450143098|FG009|Overall Study|Symptomatic Deterioration|0|||
125141855|NCT01899053|450143099|FG010|Overall Study|Symptomatic Deterioration|0|||
125141856|NCT01899053|450143100|FG011|Overall Study|Symptomatic Deterioration|1|||
125141857|NCT01899053|450143101|FG012|Overall Study|Symptomatic Deterioration|2|||
125141858|NCT01899053|450143102|FG013|Overall Study|Symptomatic Deterioration|0|||
125141859|NCT03105297|450143103|FG000|Baseline Phase (Day 1)|Other|21|||
125141860|NCT03105297|450143103|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
125141861|NCT03105297|450143103|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
125141862|NCT00714051|450143108|FG000|Overall Study|Withdrawal by Subject|1|||
125141863|NCT00714051|450143109|FG001|Overall Study|Withdrawal by Subject|0|||
125141864|NCT00714051|450143108|FG000|Overall Study|Death|0|||
125141865|NCT00714051|450143109|FG001|Overall Study|Death|1|||
125141866|NCT03868631|450143110|FG000|Baseline to Week 6|Adverse Event|0|||
125141867|NCT03868631|450143111|FG001|Baseline to Week 6|Adverse Event|3|||
125141868|NCT03868631|450143110|FG000|Baseline to Week 6|Protocol Violation|1|||
125141869|NCT03868631|450143111|FG001|Baseline to Week 6|Protocol Violation|1|||
125141870|NCT03868631|450143110|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
125141871|NCT03868631|450143111|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
125141872|NCT03868631|450143110|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
125141873|NCT03868631|450143111|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
125141874|NCT03868631|450143110|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
125141875|NCT03868631|450143111|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
125141876|NCT03868631|450143110|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
125141877|NCT03868631|450143111|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
125141878|NCT01929681|450143114|FG000|Overall Study|Withdrawal by Subject|1|||
125141879|NCT01929681|450143115|FG001|Overall Study|Withdrawal by Subject|0|||
125141880|NCT01929681|450143114|FG000|Overall Study|Physician Decision|1|||
125072727|NCT01998958|449884085|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072728|NCT01998958|449884086|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072729|NCT01998958|449884087|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
125141881|NCT01929681|450143115|FG001|Overall Study|Physician Decision|1|||
125072730|NCT01998958|449884088|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
125141882|NCT03250117|450143116|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
125141883|NCT03250117|450143117|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
125072731|NCT01998958|449884089|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072732|NCT01998958|449884090|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072733|NCT01998958|449884091|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072734|NCT01998958|449884092|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072735|NCT01998958|449884093|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072736|NCT01998958|449884094|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072737|NCT01998958|449884095|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072738|NCT01998958|449884096|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072739|NCT01998958|449884097|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072740|NCT01998958|449884098|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072741|NCT01998958|449884099|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
125072742|NCT01998958|449884100|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
125072743|NCT01998958|449884101|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072744|NCT01998958|449884102|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072745|NCT01998958|449884103|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072746|NCT01998958|449884104|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072747|NCT01998958|449884105|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072748|NCT01998958|449884106|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072749|NCT01998958|449884107|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072750|NCT01998958|449884108|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072751|NCT01998958|449884109|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
125072752|NCT01998958|449884078|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072753|NCT01998958|449884079|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072754|NCT01998958|449884080|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072755|NCT01998958|449884081|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072756|NCT01998958|449884082|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072757|NCT01998958|449884083|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072758|NCT01998958|449884084|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072759|NCT01998958|449884085|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072760|NCT01998958|449884086|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072761|NCT01998958|449884087|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072762|NCT01998958|449884088|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072763|NCT01998958|449884089|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072764|NCT01998958|449884090|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072765|NCT01998958|449884091|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072766|NCT01998958|449884092|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072767|NCT01998958|449884093|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072768|NCT01998958|449884094|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072769|NCT01998958|449884095|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072770|NCT01998958|449884096|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072771|NCT01998958|449884097|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072772|NCT01998958|449884098|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072773|NCT01998958|449884099|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
125072774|NCT01998958|449884100|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
125072775|NCT01998958|449884101|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
125072776|NCT01998958|449884102|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072777|NCT01998958|449884103|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072778|NCT01998958|449884104|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072779|NCT01998958|449884105|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072780|NCT01998958|449884106|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072781|NCT01998958|449884107|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072782|NCT01998958|449884108|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072783|NCT01998958|449884109|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125072784|NCT01831804|449884116|FG000|Overall Study|Adverse Event|0|||
125072785|NCT01831804|449884117|FG001|Overall Study|Adverse Event|0|||
125072786|NCT01831804|449884118|FG002|Overall Study|Adverse Event|0|||
125072787|NCT01831804|449884119|FG003|Overall Study|Adverse Event|0|||
125072788|NCT01831804|449884120|FG004|Overall Study|Adverse Event|0|||
125072789|NCT01831804|449884121|FG005|Overall Study|Adverse Event|0|||
125072790|NCT01831804|449884122|FG006|Overall Study|Adverse Event|1|||
125072791|NCT01831804|449884123|FG007|Overall Study|Adverse Event|0|||
125072792|NCT01831804|449884124|FG008|Overall Study|Adverse Event|1|||
125223091|NCT03243305|450444499|FG000|Overall Study|Non-Compliance with Study Drug|38|||
125072793|NCT01831804|449884116|FG000|Overall Study|Protocol Violation|0|||
125072794|NCT01831804|449884117|FG001|Overall Study|Protocol Violation|0|||
125223092|NCT03243305|450444499|FG000|Overall Study|Adverse Event|23|||
125223093|NCT03243305|450444499|FG000|Overall Study|No sexually active|26|||
125223094|NCT03243305|450444499|FG000|Overall Study|Physician Decision|22|||
125072795|NCT01831804|449884118|FG002|Overall Study|Protocol Violation|2|||
125072796|NCT01831804|449884119|FG003|Overall Study|Protocol Violation|0|||
125072797|NCT01831804|449884120|FG004|Overall Study|Protocol Violation|0|||
125072798|NCT01831804|449884121|FG005|Overall Study|Protocol Violation|0|||
125223095|NCT03243305|450444499|FG000|Overall Study|Protocol Violation|22|||
125072799|NCT01831804|449884122|FG006|Overall Study|Protocol Violation|0|||
125072800|NCT01831804|449884123|FG007|Overall Study|Protocol Violation|0|||
125072801|NCT01831804|449884124|FG008|Overall Study|Protocol Violation|0|||
125072802|NCT01831804|449884116|FG000|Overall Study|Protocol defined stopping criteria|1|||
125072803|NCT01831804|449884117|FG001|Overall Study|Protocol defined stopping criteria|1|||
125072804|NCT01831804|449884118|FG002|Overall Study|Protocol defined stopping criteria|3|||
125072805|NCT01831804|449884119|FG003|Overall Study|Protocol defined stopping criteria|0|||
125072806|NCT01831804|449884120|FG004|Overall Study|Protocol defined stopping criteria|1|||
125072807|NCT01831804|449884121|FG005|Overall Study|Protocol defined stopping criteria|0|||
125072808|NCT01831804|449884122|FG006|Overall Study|Protocol defined stopping criteria|0|||
125072809|NCT01831804|449884123|FG007|Overall Study|Protocol defined stopping criteria|0|||
125072810|NCT01831804|449884124|FG008|Overall Study|Protocol defined stopping criteria|0|||
125072811|NCT01831804|449884116|FG000|Overall Study|Lost to Follow-up|0|||
125072812|NCT01831804|449884117|FG001|Overall Study|Lost to Follow-up|0|||
125072813|NCT01831804|449884118|FG002|Overall Study|Lost to Follow-up|1|||
125072814|NCT01831804|449884119|FG003|Overall Study|Lost to Follow-up|0|||
125072815|NCT01831804|449884120|FG004|Overall Study|Lost to Follow-up|0|||
125072816|NCT01831804|449884121|FG005|Overall Study|Lost to Follow-up|0|||
125072817|NCT01831804|449884122|FG006|Overall Study|Lost to Follow-up|0|||
125072818|NCT01831804|449884123|FG007|Overall Study|Lost to Follow-up|0|||
125072819|NCT01831804|449884124|FG008|Overall Study|Lost to Follow-up|1|||
125072820|NCT01831804|449884116|FG000|Overall Study|Investigator discretion|0|||
125072821|NCT01831804|449884117|FG001|Overall Study|Investigator discretion|0|||
125072822|NCT01831804|449884118|FG002|Overall Study|Investigator discretion|0|||
125072823|NCT01831804|449884119|FG003|Overall Study|Investigator discretion|0|||
125072824|NCT01831804|449884120|FG004|Overall Study|Investigator discretion|1|||
125072825|NCT01831804|449884121|FG005|Overall Study|Investigator discretion|0|||
125072826|NCT01831804|449884122|FG006|Overall Study|Investigator discretion|0|||
125072827|NCT01831804|449884123|FG007|Overall Study|Investigator discretion|1|||
125072828|NCT01831804|449884124|FG008|Overall Study|Investigator discretion|0|||
125072829|NCT01831804|449884116|FG000|Overall Study|Withdrew Consent|0|||
125072830|NCT01831804|449884117|FG001|Overall Study|Withdrew Consent|1|||
125072831|NCT01831804|449884118|FG002|Overall Study|Withdrew Consent|0|||
125072832|NCT01831804|449884119|FG003|Overall Study|Withdrew Consent|0|||
125072833|NCT01831804|449884120|FG004|Overall Study|Withdrew Consent|0|||
125072834|NCT01831804|449884121|FG005|Overall Study|Withdrew Consent|0|||
125141884|NCT03250117|450143118|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
125141885|NCT03250117|450143119|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
125141886|NCT01073631|450143122|FG000|Overall Study|Death|82|||
125141887|NCT01073631|450143122|FG000|Overall Study|Adverse Event|24|||
125141888|NCT01073631|450143122|FG000|Overall Study|Other|63|||
125141889|NCT01971554|450143123|FG000|Overall Study|Lost to Follow-up|1|||
125141890|NCT01971554|450143124|FG001|Overall Study|Lost to Follow-up|0|||
125141891|NCT01971554|450143125|FG002|Overall Study|Lost to Follow-up|0|||
125141892|NCT01971554|450143126|FG003|Overall Study|Lost to Follow-up|0|||
125141893|NCT01426854|450143127|FG000|Overall Study|Adverse Event|1|||
125141894|NCT01426854|450143128|FG001|Overall Study|Adverse Event|5|||
125141895|NCT01426854|450143127|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
125141896|NCT01426854|450143128|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
125141897|NCT01426854|450143127|FG000|Overall Study|Lost to Follow-up|3|||
125141898|NCT01426854|450143128|FG001|Overall Study|Lost to Follow-up|0|||
125141899|NCT01426854|450143127|FG000|Overall Study|Noncompliance|0|||
125141900|NCT01426854|450143128|FG001|Overall Study|Noncompliance|1|||
125141901|NCT01426854|450143127|FG000|Overall Study|Treatment Failure|0|||
125141902|NCT01426854|450143128|FG001|Overall Study|Treatment Failure|16|||
125141903|NCT01426854|450143127|FG000|Overall Study|Protocol Deviation|0|||
125141904|NCT01426854|450143128|FG001|Overall Study|Protocol Deviation|1|||
125141905|NCT01426854|450143127|FG000|Overall Study|Other|3|||
125141906|NCT01426854|450143128|FG001|Overall Study|Other|2|||
125072835|NCT01831804|449884122|FG006|Overall Study|Withdrew Consent|0|||
125072836|NCT01831804|449884123|FG007|Overall Study|Withdrew Consent|2|||
125072837|NCT01831804|449884124|FG008|Overall Study|Withdrew Consent|0|||
125072838|NCT00268463|449884125|FG000|Overall Study|study terminated due to low accrual|10|||
125141907|NCT01942135|450143134|FG000|Overall Study|Adverse Event|21|||
125141908|NCT01942135|450143135|FG001|Overall Study|Adverse Event|7|||
125141909|NCT01942135|450143134|FG000|Overall Study|Global Deterioration of Health Status|9|||
125141910|NCT01942135|450143135|FG001|Overall Study|Global Deterioration of Health Status|6|||
125141911|NCT01942135|450143134|FG000|Overall Study|Randomized Not Treated|2|||
125072839|NCT00268463|449884126|FG001|Overall Study|study terminated due to low accrual|12|||
125072840|NCT02920450|449884127|FG000|Overall Study|Death|1|||
125072841|NCT02920450|449884128|FG001|Overall Study|Death|0|||
125072842|NCT02920450|449884129|FG002|Overall Study|Death|0|||
125072843|NCT02920450|449884130|FG003|Overall Study|Death|0|||
125072844|NCT02920450|449884127|FG000|Overall Study|Withdrawal by Subject|1|||
125072845|NCT02920450|449884128|FG001|Overall Study|Withdrawal by Subject|0|||
125141912|NCT01942135|450143135|FG001|Overall Study|Randomized Not Treated|2|||
125141913|NCT01942135|450143134|FG000|Overall Study|Death|2|||
125141914|NCT01942135|450143135|FG001|Overall Study|Death|1|||
125141915|NCT01942135|450143134|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
125072846|NCT02920450|449884129|FG002|Overall Study|Withdrawal by Subject|0|||
125072847|NCT02920450|449884130|FG003|Overall Study|Withdrawal by Subject|0|||
125072848|NCT01732107|449884133|FG000|Overall Study|Adverse Event|2|||
125072849|NCT01732107|449884133|FG000|Overall Study|Disease Progression|8|||
125072850|NCT01732107|449884133|FG000|Overall Study|Physician Decision|1|||
125072851|NCT01732107|449884133|FG000|Overall Study|Withdrawal by Subject|2|||
125072852|NCT03407170|449884134|FG000|Overall Study|Adverse Event|1|||
125072853|NCT00615459|449884136|FG000|Period I|Adverse Event|2|||
125072854|NCT00615459|449884137|FG001|Period I|Adverse Event|0|||
125072855|NCT00615459|449884138|FG002|Period I|Adverse Event|1|||
125072856|NCT00615459|449884139|FG003|Period I|Adverse Event|0|||
125072857|NCT00615459|449884136|FG000|Period I|Subject withdrew consent|1|||
125072858|NCT00615459|449884137|FG001|Period I|Subject withdrew consent|0|||
125072859|NCT00615459|449884138|FG002|Period I|Subject withdrew consent|0|||
125072860|NCT00615459|449884139|FG003|Period I|Subject withdrew consent|1|||
125072861|NCT00615459|449884136|FG000|Period I|Abnormal test procedure results|1|||
125072862|NCT00615459|449884137|FG001|Period I|Abnormal test procedure results|1|||
125072863|NCT00615459|449884138|FG002|Period I|Abnormal test procedure results|1|||
125072864|NCT00615459|449884139|FG003|Period I|Abnormal test procedure results|0|||
125072865|NCT00615459|449884136|FG000|Period II|Adverse Event|1|||
125072866|NCT00615459|449884137|FG001|Period II|Adverse Event|0|||
125072867|NCT00615459|449884138|FG002|Period II|Adverse Event|0|||
125072868|NCT00615459|449884139|FG003|Period II|Adverse Event|0|||
125072869|NCT00615459|449884136|FG000|Period II|Lost to Follow-up|0|||
125072870|NCT00615459|449884137|FG001|Period II|Lost to Follow-up|0|||
125072871|NCT00615459|449884138|FG002|Period II|Lost to Follow-up|0|||
125072872|NCT00615459|449884139|FG003|Period II|Lost to Follow-up|1|||
125072873|NCT00615459|449884136|FG000|Period III|Adverse Event|0|||
125072874|NCT00615459|449884137|FG001|Period III|Adverse Event|1|||
125072875|NCT00615459|449884138|FG002|Period III|Adverse Event|0|||
125072876|NCT00615459|449884139|FG003|Period III|Adverse Event|0|||
125072877|NCT00615459|449884136|FG000|Period III|Administrative problems|0|||
125072878|NCT00615459|449884137|FG001|Period III|Administrative problems|1|||
125072879|NCT00615459|449884138|FG002|Period III|Administrative problems|1|||
125072880|NCT00615459|449884139|FG003|Period III|Administrative problems|0|||
125072881|NCT00615459|449884136|FG000|Period III|Unsatisfactory therapeutic effect|0|||
125072882|NCT00615459|449884137|FG001|Period III|Unsatisfactory therapeutic effect|1|||
125072883|NCT00615459|449884138|FG002|Period III|Unsatisfactory therapeutic effect|0|||
125072884|NCT00615459|449884139|FG003|Period III|Unsatisfactory therapeutic effect|0|||
125072885|NCT02076334|449884142|FG000|Overall Study|Protocol Violation|1|||
125072886|NCT02076334|449884143|FG001|Overall Study|Protocol Violation|0|||
125072887|NCT02076334|449884144|FG002|Overall Study|Protocol Violation|0|||
125072888|NCT02076334|449884145|FG003|Overall Study|Protocol Violation|0|||
125072889|NCT02076334|449884142|FG000|Overall Study|Lost to Follow-up|0|||
125072890|NCT02076334|449884143|FG001|Overall Study|Lost to Follow-up|1|||
125072891|NCT02076334|449884144|FG002|Overall Study|Lost to Follow-up|1|||
125072892|NCT02076334|449884145|FG003|Overall Study|Lost to Follow-up|0|||
125072893|NCT02076334|449884142|FG000|Overall Study|muscle soreness|0|||
125072894|NCT02076334|449884143|FG001|Overall Study|muscle soreness|0|||
125072895|NCT02076334|449884144|FG002|Overall Study|muscle soreness|0|||
125072896|NCT02076334|449884145|FG003|Overall Study|muscle soreness|1|||
125141916|NCT01942135|450143135|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
125141917|NCT01942135|450143134|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
125141918|NCT01942135|450143135|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
125141919|NCT01942135|450143134|FG000|Overall Study|Withdrawal by Subject|4|||
125141920|NCT01942135|450143135|FG001|Overall Study|Withdrawal by Subject|3|||
125141921|NCT01942135|450143134|FG000|Overall Study|Protocol Violation|1|||
125072897|NCT03238352|449884146|FG000|Overall Study|Lost to Follow-up|0|||
125072898|NCT03238352|449884147|FG001|Overall Study|Lost to Follow-up|2|||
125072899|NCT03238352|449884148|FG002|Overall Study|Lost to Follow-up|1|||
125072900|NCT03238352|449884146|FG000|Overall Study|Withdrawal by Subject|0|||
125072901|NCT03238352|449884147|FG001|Overall Study|Withdrawal by Subject|1|||
125072902|NCT03238352|449884148|FG002|Overall Study|Withdrawal by Subject|0|||
125072903|NCT01296698|449884149|FG000|Overall Study|Adverse Event|1|||
125072904|NCT01296698|449884150|FG001|Overall Study|Adverse Event|0|||
125141922|NCT01942135|450143135|FG001|Overall Study|Protocol Violation|0|||
125141923|NCT01942135|450143134|FG000|Overall Study|Other|19|||
125141924|NCT01942135|450143135|FG001|Overall Study|Other|4|||
125072905|NCT01296698|449884149|FG000|Overall Study|Death|1|||
125072906|NCT01296698|449884150|FG001|Overall Study|Death|0|||
125072907|NCT01296698|449884149|FG000|Overall Study|Lost to Follow-up|19|||
125072908|NCT01296698|449884150|FG001|Overall Study|Lost to Follow-up|1|||
125141925|NCT00950300|450143136|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
125072909|NCT01296698|449884149|FG000|Overall Study|Withdrawal by Subject|12|||
125072910|NCT01296698|449884150|FG001|Overall Study|Withdrawal by Subject|0|||
125072911|NCT01296698|449884149|FG000|Overall Study|Difficulty Contacting Subject|2|||
125072912|NCT01296698|449884150|FG001|Overall Study|Difficulty Contacting Subject|0|||
125072913|NCT01296698|449884149|FG000|Overall Study|Study Terminated by Sponsor|209|||
125072914|NCT01296698|449884150|FG001|Overall Study|Study Terminated by Sponsor|12|||
125072915|NCT01975675|449884151|FG000|Overall Study|Death|0|||
125072916|NCT01975675|449884152|FG001|Overall Study|Death|1|||
125072917|NCT01975675|449884153|FG002|Overall Study|Death|0|||
125072918|NCT01975675|449884154|FG003|Overall Study|Death|0|||
125072919|NCT00224003|449884155|FG000|Overall Study|Adverse Event|1|||
125072920|NCT00224003|449884155|FG000|Overall Study|Protocol Violation|2|||
125072921|NCT00224003|449884155|FG000|Overall Study|Withdrawal by Subject|1|||
125072922|NCT00224003|449884155|FG000|Overall Study|unk|3|||
125072923|NCT01202760|449884156|FG000|Overall Study|Entry Criteria Not Met|0|||
125072924|NCT01202760|449884157|FG001|Overall Study|Entry Criteria Not Met|3|||
125072925|NCT01202760|449884158|FG002|Overall Study|Entry Criteria Not Met|1|||
125072926|NCT01202760|449884156|FG000|Overall Study|Adverse Event|11|||
125072927|NCT01202760|449884157|FG001|Overall Study|Adverse Event|9|||
125072928|NCT01202760|449884158|FG002|Overall Study|Adverse Event|10|||
125072929|NCT01202760|449884156|FG000|Overall Study|Death|2|||
125072930|NCT01202760|449884157|FG001|Overall Study|Death|1|||
125072931|NCT01202760|449884158|FG002|Overall Study|Death|0|||
125072932|NCT01202760|449884156|FG000|Overall Study|Lack of Efficacy|6|||
125072933|NCT01202760|449884157|FG001|Overall Study|Lack of Efficacy|8|||
125072934|NCT01202760|449884158|FG002|Overall Study|Lack of Efficacy|7|||
125072935|NCT01202760|449884156|FG000|Overall Study|Lost to Follow-up|0|||
125072936|NCT01202760|449884157|FG001|Overall Study|Lost to Follow-up|2|||
125072937|NCT01202760|449884158|FG002|Overall Study|Lost to Follow-up|1|||
125072938|NCT01202760|449884156|FG000|Overall Study|Parent / Caregiver Decision|0|||
125072939|NCT01202760|449884157|FG001|Overall Study|Parent / Caregiver Decision|1|||
125072940|NCT01202760|449884158|FG002|Overall Study|Parent / Caregiver Decision|0|||
125072941|NCT01202760|449884156|FG000|Overall Study|Withdrawal by Subject|17|||
125072942|NCT01202760|449884157|FG001|Overall Study|Withdrawal by Subject|18|||
125072943|NCT01202760|449884158|FG002|Overall Study|Withdrawal by Subject|14|||
125072944|NCT01202760|449884156|FG000|Overall Study|Physician Decision|0|||
125072945|NCT01202760|449884157|FG001|Overall Study|Physician Decision|1|||
125072946|NCT01202760|449884158|FG002|Overall Study|Physician Decision|0|||
125072947|NCT01202760|449884156|FG000|Overall Study|Protocol Violation|7|||
125072948|NCT01202760|449884157|FG001|Overall Study|Protocol Violation|5|||
125072949|NCT01202760|449884158|FG002|Overall Study|Protocol Violation|2|||
125072950|NCT01202760|449884156|FG000|Overall Study|Sponsor Decision|4|||
125072951|NCT01202760|449884157|FG001|Overall Study|Sponsor Decision|4|||
125072952|NCT01202760|449884158|FG002|Overall Study|Sponsor Decision|0|||
125072953|NCT00871572|449884159|FG000|Overall Study|Adverse Event|0|||
125072954|NCT00871572|449884160|FG001|Overall Study|Adverse Event|2|||
125072955|NCT00871572|449884161|FG002|Overall Study|Adverse Event|0|||
125072956|NCT00871572|449884162|FG003|Overall Study|Adverse Event|3|||
125072957|NCT00871572|449884159|FG000|Overall Study|Investigator Decision|0|||
125072958|NCT00871572|449884160|FG001|Overall Study|Investigator Decision|1|||
125072959|NCT00871572|449884161|FG002|Overall Study|Investigator Decision|0|||
125072960|NCT00871572|449884162|FG003|Overall Study|Investigator Decision|1|||
125072961|NCT00871572|449884159|FG000|Overall Study|Lost to Follow-up|0|||
125072962|NCT00871572|449884160|FG001|Overall Study|Lost to Follow-up|1|||
125072963|NCT00871572|449884161|FG002|Overall Study|Lost to Follow-up|0|||
125072964|NCT00871572|449884162|FG003|Overall Study|Lost to Follow-up|1|||
125072965|NCT00871572|449884159|FG000|Overall Study|Protocol Violation|0|||
125072966|NCT00871572|449884160|FG001|Overall Study|Protocol Violation|0|||
125072967|NCT00871572|449884161|FG002|Overall Study|Protocol Violation|1|||
125072968|NCT00871572|449884162|FG003|Overall Study|Protocol Violation|1|||
125072969|NCT00871572|449884159|FG000|Overall Study|Sponsor Decision|1|||
125072970|NCT00871572|449884160|FG001|Overall Study|Sponsor Decision|0|||
125223096|NCT03243305|450444499|FG000|Overall Study|Study method no longer primary method|12|||
125223097|NCT03243305|450444499|FG000|Overall Study|Study Terminated by Sponsor|1|||
125223098|NCT03243305|450444499|FG000|Overall Study|Early terminations|267|||
125223099|NCT01497067|450444505|FG000|Overall Study|Lost to Follow-up|56|||
125223100|NCT01497067|450444505|FG000|Overall Study|Adverse Event|3|||
125072971|NCT00871572|449884161|FG002|Overall Study|Sponsor Decision|0|||
125072972|NCT00871572|449884162|FG003|Overall Study|Sponsor Decision|0|||
125072973|NCT00871572|449884159|FG000|Overall Study|Withdrawal by Subject|1|||
125072974|NCT00871572|449884160|FG001|Overall Study|Withdrawal by Subject|2|||
125072975|NCT00871572|449884161|FG002|Overall Study|Withdrawal by Subject|3|||
125072976|NCT00871572|449884162|FG003|Overall Study|Withdrawal by Subject|1|||
125072977|NCT00108953|449884170|FG000|Follow-up|Death|18|||
125072978|NCT00108953|449884171|FG001|Follow-up|Death|26|||
125072979|NCT00108953|449884170|FG000|Follow-up|Lost to Follow-up|1|||
125072980|NCT00108953|449884171|FG001|Follow-up|Lost to Follow-up|1|||
125223101|NCT01497067|450444505|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
125072981|NCT00108953|449884170|FG000|Follow-up|Study terminated by sponsor|10|||
125072982|NCT00108953|449884171|FG001|Follow-up|Study terminated by sponsor|6|||
125223102|NCT01497067|450444505|FG000|Overall Study|Other|13|||
125072983|NCT03803202|449884172|FG000|Overall Study|Other|0|||
125072984|NCT03803202|449884173|FG001|Overall Study|Other|1|||
125072985|NCT03803202|449884174|FG002|Overall Study|Other|0|||
125072986|NCT03803202|449884175|FG003|Overall Study|Other|0|||
125072987|NCT03803202|449884176|FG004|Overall Study|Other|0|||
125072988|NCT03803202|449884177|FG005|Overall Study|Other|0|||
125072989|NCT03803202|449884178|FG006|Overall Study|Other|0|||
125072990|NCT03803202|449884179|FG007|Overall Study|Other|0|||
125072991|NCT03803202|449884180|FG008|Overall Study|Other|0|||
125072992|NCT03803202|449884172|FG000|Overall Study|Death|0|||
125072993|NCT03803202|449884173|FG001|Overall Study|Death|0|||
125072994|NCT03803202|449884174|FG002|Overall Study|Death|0|||
125072995|NCT03803202|449884175|FG003|Overall Study|Death|0|||
125072996|NCT03803202|449884176|FG004|Overall Study|Death|0|||
125072997|NCT03803202|449884177|FG005|Overall Study|Death|1|||
125072998|NCT03803202|449884178|FG006|Overall Study|Death|0|||
125072999|NCT03803202|449884179|FG007|Overall Study|Death|0|||
125073000|NCT03803202|449884180|FG008|Overall Study|Death|0|||
125073001|NCT03803202|449884172|FG000|Overall Study|Withdrawal by Subject|0|||
125073002|NCT03803202|449884173|FG001|Overall Study|Withdrawal by Subject|0|||
125073003|NCT03803202|449884174|FG002|Overall Study|Withdrawal by Subject|1|||
125073004|NCT03803202|449884175|FG003|Overall Study|Withdrawal by Subject|0|||
125073005|NCT03803202|449884176|FG004|Overall Study|Withdrawal by Subject|0|||
125073006|NCT03803202|449884177|FG005|Overall Study|Withdrawal by Subject|0|||
125073007|NCT03803202|449884178|FG006|Overall Study|Withdrawal by Subject|0|||
125073008|NCT03803202|449884179|FG007|Overall Study|Withdrawal by Subject|1|||
125073009|NCT03803202|449884180|FG008|Overall Study|Withdrawal by Subject|0|||
125073010|NCT03803202|449884172|FG000|Overall Study|Lost to Follow-up|0|||
125073011|NCT03803202|449884173|FG001|Overall Study|Lost to Follow-up|0|||
125073012|NCT03803202|449884174|FG002|Overall Study|Lost to Follow-up|0|||
125073013|NCT03803202|449884175|FG003|Overall Study|Lost to Follow-up|1|||
125073014|NCT03803202|449884176|FG004|Overall Study|Lost to Follow-up|1|||
125073015|NCT03803202|449884177|FG005|Overall Study|Lost to Follow-up|0|||
125073016|NCT03803202|449884178|FG006|Overall Study|Lost to Follow-up|1|||
125073017|NCT03803202|449884179|FG007|Overall Study|Lost to Follow-up|0|||
125073018|NCT03803202|449884180|FG008|Overall Study|Lost to Follow-up|0|||
125073019|NCT01125293|449884181|FG000|Overall Study|Disease Progression|1|||
125073020|NCT01125293|449884182|FG001|Overall Study|Disease Progression|3|||
125073021|NCT01125293|449884183|FG002|Overall Study|Disease Progression|4|||
125073022|NCT01125293|449884184|FG003|Overall Study|Disease Progression|3|||
125073023|NCT01125293|449884185|FG004|Overall Study|Disease Progression|5|||
125073024|NCT01125293|449884186|FG005|Overall Study|Disease Progression|12|||
125073025|NCT01125293|449884181|FG000|Overall Study|Adverse Event|1|||
125073026|NCT01125293|449884182|FG001|Overall Study|Adverse Event|0|||
125073027|NCT01125293|449884183|FG002|Overall Study|Adverse Event|0|||
125073028|NCT01125293|449884184|FG003|Overall Study|Adverse Event|0|||
125073029|NCT01125293|449884185|FG004|Overall Study|Adverse Event|2|||
125073030|NCT01125293|449884186|FG005|Overall Study|Adverse Event|8|||
125073031|NCT01125293|449884181|FG000|Overall Study|Symptomatic Deterioration|1|||
125073032|NCT01125293|449884182|FG001|Overall Study|Symptomatic Deterioration|0|||
125073033|NCT01125293|449884183|FG002|Overall Study|Symptomatic Deterioration|0|||
125073034|NCT01125293|449884184|FG003|Overall Study|Symptomatic Deterioration|0|||
125073035|NCT01125293|449884185|FG004|Overall Study|Symptomatic Deterioration|0|||
125073036|NCT01125293|449884186|FG005|Overall Study|Symptomatic Deterioration|0|||
125073037|NCT01125293|449884181|FG000|Overall Study|Death|0|||
125073038|NCT01125293|449884182|FG001|Overall Study|Death|0|||
125073039|NCT01125293|449884183|FG002|Overall Study|Death|0|||
125073040|NCT01125293|449884184|FG003|Overall Study|Death|0|||
125073041|NCT01125293|449884185|FG004|Overall Study|Death|1|||
125073042|NCT01125293|449884186|FG005|Overall Study|Death|0|||
125073043|NCT01125293|449884181|FG000|Overall Study|Withdrawal by Subject|0|||
125073044|NCT01125293|449884182|FG001|Overall Study|Withdrawal by Subject|0|||
125073045|NCT01125293|449884183|FG002|Overall Study|Withdrawal by Subject|0|||
125073046|NCT01125293|449884184|FG003|Overall Study|Withdrawal by Subject|0|||
125073047|NCT01125293|449884185|FG004|Overall Study|Withdrawal by Subject|2|||
125073048|NCT01125293|449884186|FG005|Overall Study|Withdrawal by Subject|1|||
125073049|NCT01125293|449884181|FG000|Overall Study|Physician Decision|0|||
125073050|NCT01125293|449884182|FG001|Overall Study|Physician Decision|0|||
125073051|NCT01125293|449884183|FG002|Overall Study|Physician Decision|0|||
125073052|NCT01125293|449884184|FG003|Overall Study|Physician Decision|0|||
125073053|NCT01125293|449884185|FG004|Overall Study|Physician Decision|0|||
125073054|NCT01125293|449884186|FG005|Overall Study|Physician Decision|2|||
125073055|NCT01270958|449884191|FG000|Overall Study|Lost to Follow-up|2|||
125073056|NCT01270958|449884191|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
125073057|NCT00659126|449884196|FG000|Overall Study|Adverse Event|2|||
125073058|NCT00659126|449884197|FG001|Overall Study|Adverse Event|2|||
125073059|NCT00659126|449884196|FG000|Overall Study|Screen failure|1|||
125073060|NCT00659126|449884197|FG001|Overall Study|Screen failure|1|||
125073061|NCT00659126|449884196|FG000|Overall Study|Technical problems with MRI|0|||
125073062|NCT00659126|449884197|FG001|Overall Study|Technical problems with MRI|1|||
125073063|NCT02633046|449884201|FG000|Overall Study|Adverse Event|8|||
125073064|NCT02633046|449884201|FG000|Overall Study|Physician Decision|7|||
125073065|NCT02633046|449884201|FG000|Overall Study|Withdrawal by Subject|8|||
125073066|NCT02633046|449884201|FG000|Overall Study|Increased proteinuria|2|||
125073067|NCT02633046|449884201|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
125073068|NCT02633046|449884201|FG000|Overall Study|Mutual decision patient and physician|1|||
125073069|NCT02925312|449884202|FG000|Overall Study|Lost to Follow-up|25|||
125073070|NCT02925312|449884203|FG001|Overall Study|Lost to Follow-up|0|||
125073071|NCT02925312|449884202|FG000|Overall Study|Adverse Event|2|||
125073072|NCT02925312|449884203|FG001|Overall Study|Adverse Event|0|||
125073073|NCT03205982|449884211|FG000|Overall Study|Lost to Follow-up|20|||
125073074|NCT03205982|449884212|FG001|Overall Study|Lost to Follow-up|19|||
125073075|NCT03205982|449884211|FG000|Overall Study|Withdrawal by Subject|4|||
125073076|NCT03205982|449884212|FG001|Overall Study|Withdrawal by Subject|3|||
125073077|NCT03205982|449884211|FG000|Overall Study|Withdrawal by PI|0|||
125073078|NCT03205982|449884212|FG001|Overall Study|Withdrawal by PI|1|||
125073079|NCT00994162|449884213|FG000|Overall Study|Withdrawal by Subject|1|||
125073080|NCT00994162|449884213|FG000|Overall Study|Lost to Follow-up|2|||
125073081|NCT00994162|449884213|FG000|Overall Study|Product Complaint|1|||
125073082|NCT00994162|449884213|FG000|Overall Study|Poor Compliance|5|||
125073083|NCT00994162|449884213|FG000|Overall Study|Lack of Response|3|||
125073084|NCT00994162|449884213|FG000|Overall Study|Discharged from Hospital|4|||
125073085|NCT00994162|449884213|FG000|Overall Study|Death|2|||
125073086|NCT00994162|449884213|FG000|Overall Study|Care Transferred to Another Physician|2|||
125073087|NCT00994162|449884213|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
125073088|NCT00994162|449884213|FG000|Overall Study|Physician Decision|2|||
125073089|NCT00994162|449884213|FG000|Overall Study|Surrounding Wound Erythematous|1|||
125073090|NCT00994162|449884213|FG000|Overall Study|Machine Losing Vaccum|1|||
125073091|NCT00994162|449884213|FG000|Overall Study|Patient Lived Too Far Away|1|||
125073092|NCT00994162|449884213|FG000|Overall Study|Above Knee Amputation|1|||
125073093|NCT00994162|449884213|FG000|Overall Study|Reason Not Reported By Site|1|||
125073094|NCT01425749|449884214|FG000|Overall Study|progression of melanoma|0|||
125073095|NCT01425749|449884215|FG001|Overall Study|progression of melanoma|1|||
125073096|NCT01293084|449884216|FG000|Overall Study|Physician Decision|3|||
125073097|NCT01293084|449884216|FG000|Overall Study|Withdrawal by Subject|2|||
125073098|NCT02096042|449884217|FG000|Overall Study|Disease Progression|1|||
125073099|NCT02096042|449884218|FG001|Overall Study|Disease Progression|0|||
125073100|NCT02096042|449884219|FG002|Overall Study|Disease Progression|0|||
125073101|NCT02983799|449884220|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
125073102|NCT02983799|449884221|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
125073103|NCT02983799|449884222|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
125073104|NCT02983799|449884223|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
125073105|NCT02983799|449884224|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
125073106|NCT02983799|449884220|FG000|Overall Study|Death|20|||
125073107|NCT02983799|449884221|FG001|Overall Study|Death|5|||
125073108|NCT02983799|449884222|FG002|Overall Study|Death|23|||
125073109|NCT02983799|449884223|FG003|Overall Study|Death|47|||
125073110|NCT02983799|449884224|FG004|Overall Study|Death|7|||
125073111|NCT02983799|449884220|FG000|Overall Study|Withdrawal by Subject|1|||
125073112|NCT02983799|449884221|FG001|Overall Study|Withdrawal by Subject|0|||
125073113|NCT02983799|449884222|FG002|Overall Study|Withdrawal by Subject|3|||
125073114|NCT02983799|449884223|FG003|Overall Study|Withdrawal by Subject|4|||
125073115|NCT02983799|449884224|FG004|Overall Study|Withdrawal by Subject|1|||
125073116|NCT02983799|449884220|FG000|Overall Study|Protocol Violation|0|||
125073117|NCT02983799|449884221|FG001|Overall Study|Protocol Violation|1|||
125073118|NCT02983799|449884222|FG002|Overall Study|Protocol Violation|0|||
125073119|NCT02983799|449884223|FG003|Overall Study|Protocol Violation|0|||
125073120|NCT02983799|449884224|FG004|Overall Study|Protocol Violation|1|||
125073121|NCT02983799|449884220|FG000|Overall Study|Lost to Follow-up|1|||
125073122|NCT02983799|449884221|FG001|Overall Study|Lost to Follow-up|0|||
125073123|NCT02983799|449884222|FG002|Overall Study|Lost to Follow-up|1|||
125073124|NCT02983799|449884223|FG003|Overall Study|Lost to Follow-up|0|||
125073125|NCT02983799|449884224|FG004|Overall Study|Lost to Follow-up|0|||
125073126|NCT01225172|449884231|FG000|Overall Study|Subject decision to stop|1|||
125073127|NCT01225172|449884232|FG001|Overall Study|Subject decision to stop|0|||
125073128|NCT01225172|449884231|FG000|Overall Study|Subject request to discontinue treatment|3|||
125073129|NCT01225172|449884232|FG001|Overall Study|Subject request to discontinue treatment|1|||
125073130|NCT01225172|449884231|FG000|Overall Study|Subject no longer meets study criteria|1|||
125073131|NCT01225172|449884232|FG001|Overall Study|Subject no longer meets study criteria|0|||
125073132|NCT01225172|449884231|FG000|Overall Study|Withdrawal by Subject|1|||
125073133|NCT01225172|449884232|FG001|Overall Study|Withdrawal by Subject|0|||
125073134|NCT00795509|449884234|FG000|Overall Study|Protocol Violation|31|||
125073135|NCT01601470|449884235|FG000|Period 2 - LCZ696|Physician Decision|1|||
125073136|NCT02079519|449884236|FG000|Overall Study|Disease Progression|9|||
125073137|NCT02079519|449884236|FG000|Overall Study|Adverse Event|1|||
125073138|NCT01041404|449884239|FG000|Overall Study|Adverse Event|45|||
125073139|NCT01041404|449884240|FG001|Overall Study|Adverse Event|35|||
125073140|NCT01041404|449884239|FG000|Overall Study|Lack of Efficacy|200|||
125073141|NCT01041404|449884240|FG001|Overall Study|Lack of Efficacy|210|||
125073142|NCT01041404|449884239|FG000|Overall Study|Violation of Selection Criteria|0|||
125073143|NCT01041404|449884240|FG001|Overall Study|Violation of Selection Criteria|1|||
125073144|NCT01041404|449884239|FG000|Overall Study|Protocol Violation|4|||
125073145|NCT01041404|449884240|FG001|Overall Study|Protocol Violation|0|||
125073146|NCT01041404|449884239|FG000|Overall Study|Withdrawal by Subject|29|||
125073147|NCT01041404|449884240|FG001|Overall Study|Withdrawal by Subject|23|||
125073148|NCT01041404|449884239|FG000|Overall Study|Failure to Return|1|||
125073149|NCT01041404|449884240|FG001|Overall Study|Failure to Return|2|||
125073150|NCT01041404|449884239|FG000|Overall Study|Other|11|||
125073151|NCT01041404|449884240|FG001|Overall Study|Other|23|||
125073152|NCT01607073|449884241|FG000|Overall Study|Adverse Event|1|||
125073153|NCT03726333|449884242|FG000|Overall Study|Progressive Disease|0|||
125073154|NCT03726333|449884243|FG001|Overall Study|Progressive Disease|0|||
125073155|NCT03726333|449884244|FG002|Overall Study|Progressive Disease|1|||
125073156|NCT03726333|449884245|FG003|Overall Study|Progressive Disease|0|||
125073157|NCT03726333|449884246|FG004|Overall Study|Progressive Disease|0|||
125073158|NCT01946412|449884247|FG000|Overall Study|Adverse Event|1|||
125073159|NCT01946412|449884247|FG000|Overall Study|Non-Compliance|1|||
125073160|NCT01946412|449884247|FG000|Overall Study|Continued with commercial Kalydeco|2|||
125073161|NCT01946412|449884247|FG000|Overall Study|Difficulty in swallowing|1|||
125073162|NCT02088541|449886297|FG000|Overall Study|Adverse Event|3|||
125073163|NCT02088541|449886298|FG001|Overall Study|Adverse Event|0|||
125073164|NCT02088541|449886299|FG002|Overall Study|Adverse Event|3|||
125073165|NCT02088541|449886300|FG003|Overall Study|Adverse Event|3|||
125073166|NCT02088541|449886301|FG004|Overall Study|Adverse Event|0|||
125073167|NCT02088541|449886297|FG000|Overall Study|Death|51|||
125073168|NCT02088541|449886298|FG001|Overall Study|Death|21|||
125073169|NCT02088541|449886299|FG002|Overall Study|Death|85|||
125073170|NCT02088541|449886300|FG003|Overall Study|Death|28|||
125073171|NCT02088541|449886301|FG004|Overall Study|Death|38|||
125073172|NCT02088541|449886297|FG000|Overall Study|Lost to Follow-up|2|||
125073173|NCT02088541|449886298|FG001|Overall Study|Lost to Follow-up|0|||
125073174|NCT02088541|449886299|FG002|Overall Study|Lost to Follow-up|1|||
125073175|NCT02088541|449886300|FG003|Overall Study|Lost to Follow-up|0|||
125073176|NCT02088541|449886301|FG004|Overall Study|Lost to Follow-up|0|||
125073177|NCT02088541|449886297|FG000|Overall Study|Physician Decision|2|||
125073178|NCT02088541|449886298|FG001|Overall Study|Physician Decision|1|||
125073179|NCT02088541|449886299|FG002|Overall Study|Physician Decision|2|||
125073180|NCT02088541|449886300|FG003|Overall Study|Physician Decision|0|||
125073181|NCT02088541|449886301|FG004|Overall Study|Physician Decision|2|||
125073182|NCT02088541|449886297|FG000|Overall Study|Disease progression|7|||
125073183|NCT02088541|449886298|FG001|Overall Study|Disease progression|1|||
125073184|NCT02088541|449886299|FG002|Overall Study|Disease progression|2|||
125073185|NCT02088541|449886300|FG003|Overall Study|Disease progression|3|||
125073186|NCT02088541|449886301|FG004|Overall Study|Disease progression|1|||
125073187|NCT02088541|449886297|FG000|Overall Study|Study terminated by sponsor|1|||
125073188|NCT02088541|449886298|FG001|Overall Study|Study terminated by sponsor|1|||
125073189|NCT02088541|449886299|FG002|Overall Study|Study terminated by sponsor|12|||
125073190|NCT02088541|449886300|FG003|Overall Study|Study terminated by sponsor|2|||
125073191|NCT02088541|449886301|FG004|Overall Study|Study terminated by sponsor|6|||
125073192|NCT02088541|449886297|FG000|Overall Study|Withdrawal by Subject|3|||
125073193|NCT02088541|449886298|FG001|Overall Study|Withdrawal by Subject|2|||
125073194|NCT02088541|449886299|FG002|Overall Study|Withdrawal by Subject|9|||
125073195|NCT02088541|449886300|FG003|Overall Study|Withdrawal by Subject|7|||
125073196|NCT02088541|449886301|FG004|Overall Study|Withdrawal by Subject|10|||
125073197|NCT02088541|449886297|FG000|Overall Study|Other|2|||
125073198|NCT02088541|449886298|FG001|Overall Study|Other|1|||
125073199|NCT02088541|449886299|FG002|Overall Study|Other|3|||
125073200|NCT02088541|449886300|FG003|Overall Study|Other|1|||
125073201|NCT02088541|449886301|FG004|Overall Study|Other|1|||
125141926|NCT00950300|450143137|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
125141927|NCT00950300|450143136|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
125141928|NCT00950300|450143137|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
125141929|NCT00950300|450143136|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
125141930|NCT00950300|450143137|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
125141931|NCT00950300|450143136|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
125141932|NCT00950300|450143137|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
125141933|NCT00950300|450143136|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
125141934|NCT00950300|450143137|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
125141935|NCT00950300|450143136|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
125141936|NCT00950300|450143137|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
125141937|NCT00950300|450143136|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
125141938|NCT00950300|450143137|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
125141939|NCT00950300|450143136|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
125141940|NCT00950300|450143137|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
125223103|NCT01598610|450444508|FG000|Overall Study|Adverse Event|1|||
125223104|NCT04346199|450444509|FG000|Overall Study|Death|8|||
125223105|NCT04346199|450444510|FG001|Overall Study|Death|9|||
125223106|NCT04346199|450444509|FG000|Overall Study|Lost to Follow-up|0|||
125223107|NCT04346199|450444510|FG001|Overall Study|Lost to Follow-up|1|||
125223108|NCT04346199|450444509|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
125073202|NCT01625611|449886302|FG000|Overall Study|No adlib drinks Lab 1|3|||
125073203|NCT01625611|449886303|FG001|Overall Study|No adlib drinks Lab 1|0|||
125073204|NCT01625611|449886302|FG000|Overall Study|Technical issues with PET|1|||
125073205|NCT01625611|449886303|FG001|Overall Study|Technical issues with PET|0|||
125073206|NCT01625611|449886302|FG000|Overall Study|Unable to complete study procedures|1|||
125073207|NCT01625611|449886303|FG001|Overall Study|Unable to complete study procedures|0|||
125073208|NCT01625611|449886302|FG000|Overall Study|Withdrawal by Subject|3|||
125073209|NCT01625611|449886303|FG001|Overall Study|Withdrawal by Subject|0|||
125073210|NCT02431793|449886304|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
125073211|NCT02431793|449886305|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
125073212|NCT02431793|449886306|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
125073213|NCT02431793|449886304|FG000|Overall Study|Withdrawal by Subject|7|||
125073214|NCT02431793|449886305|FG001|Overall Study|Withdrawal by Subject|5|||
125073215|NCT02431793|449886306|FG002|Overall Study|Withdrawal by Subject|5|||
125073216|NCT02431793|449886304|FG000|Overall Study|Lost to Follow-up|101|||
125073217|NCT02431793|449886305|FG001|Overall Study|Lost to Follow-up|122|||
125073218|NCT02431793|449886306|FG002|Overall Study|Lost to Follow-up|104|||
125073219|NCT03170258|449886310|FG000|Overall Study|Physician Decision|4|||
125073220|NCT03170258|449886311|FG001|Overall Study|Physician Decision|0|||
125073221|NCT03170258|449886310|FG000|Overall Study|Equipment issues|1|||
125073222|NCT03170258|449886311|FG001|Overall Study|Equipment issues|0|||
125073223|NCT03170258|449886310|FG000|Overall Study|Medication|1|||
125073224|NCT03170258|449886311|FG001|Overall Study|Medication|0|||
125073225|NCT03170258|449886310|FG000|Overall Study|Sleep issues|1|||
125073226|NCT03170258|449886311|FG001|Overall Study|Sleep issues|0|||
125073227|NCT01563107|449886312|FG000|Overall Study|Physician Decision|0|||
125073228|NCT01563107|449886313|FG001|Overall Study|Physician Decision|1|||
125073229|NCT01563107|449886314|FG002|Overall Study|Physician Decision|1|||
125073230|NCT01563107|449886315|FG003|Overall Study|Physician Decision|3|||
125073231|NCT01563107|449886312|FG000|Overall Study|Withdrawal by Subject|1|||
125073232|NCT01563107|449886313|FG001|Overall Study|Withdrawal by Subject|2|||
125073233|NCT01563107|449886314|FG002|Overall Study|Withdrawal by Subject|1|||
125073234|NCT01563107|449886315|FG003|Overall Study|Withdrawal by Subject|2|||
125073235|NCT03907969|449886316|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
125073236|NCT03907969|449886317|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
125073237|NCT03907969|449886318|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
125073238|NCT03907969|449886319|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
125073239|NCT03907969|449886320|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
125223109|NCT04346199|450444510|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
125223110|NCT04346199|450444509|FG000|Overall Study|Withdrawal by Subject|5|||
125073240|NCT03907969|449886321|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
125073241|NCT03907969|449886322|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
125073242|NCT03907969|449886323|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
125073243|NCT03907969|449886324|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
125073244|NCT03907969|449886325|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
125073245|NCT03907969|449886326|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
125073246|NCT03907969|449886316|FG000|Monotherapy Part A|Progressive Disease|0|||
125073247|NCT03907969|449886317|FG001|Monotherapy Part A|Progressive Disease|1|||
125223111|NCT04346199|450444510|FG001|Overall Study|Withdrawal by Subject|1|||
125073248|NCT03907969|449886318|FG002|Monotherapy Part A|Progressive Disease|0|||
125073249|NCT03907969|449886319|FG003|Monotherapy Part A|Progressive Disease|0|||
125073250|NCT03907969|449886320|FG004|Monotherapy Part A|Progressive Disease|0|||
125073251|NCT03907969|449886321|FG005|Monotherapy Part A|Progressive Disease|1|||
125073252|NCT03907969|449886322|FG006|Monotherapy Part A|Progressive Disease|2|||
125073253|NCT03907969|449886323|FG007|Monotherapy Part A|Progressive Disease|0|||
125073254|NCT03907969|449886324|FG008|Monotherapy Part A|Progressive Disease|0|||
125073255|NCT03907969|449886325|FG009|Monotherapy Part A|Progressive Disease|0|||
125073256|NCT03907969|449886326|FG010|Monotherapy Part A|Progressive Disease|0|||
125073257|NCT03907969|449886316|FG000|Monotherapy Part A|Death|0|||
125073258|NCT03907969|449886317|FG001|Monotherapy Part A|Death|0|||
125073259|NCT03907969|449886318|FG002|Monotherapy Part A|Death|1|||
125073260|NCT03907969|449886319|FG003|Monotherapy Part A|Death|1|||
125073261|NCT03907969|449886320|FG004|Monotherapy Part A|Death|0|||
125073262|NCT03907969|449886321|FG005|Monotherapy Part A|Death|1|||
125073263|NCT03907969|449886322|FG006|Monotherapy Part A|Death|0|||
125073264|NCT03907969|449886323|FG007|Monotherapy Part A|Death|0|||
125073265|NCT03907969|449886324|FG008|Monotherapy Part A|Death|0|||
125073266|NCT03907969|449886325|FG009|Monotherapy Part A|Death|0|||
125073267|NCT03907969|449886326|FG010|Monotherapy Part A|Death|0|||
125073268|NCT03907969|449886316|FG000|Combination Therapy Part A|Adverse Event|0|||
125073269|NCT03907969|449886317|FG001|Combination Therapy Part A|Adverse Event|0|||
125073270|NCT03907969|449886318|FG002|Combination Therapy Part A|Adverse Event|0|||
125073271|NCT03907969|449886319|FG003|Combination Therapy Part A|Adverse Event|0|||
125073272|NCT03907969|449886320|FG004|Combination Therapy Part A|Adverse Event|0|||
125073273|NCT03907969|449886321|FG005|Combination Therapy Part A|Adverse Event|0|||
125073274|NCT03907969|449886322|FG006|Combination Therapy Part A|Adverse Event|0|||
125073275|NCT03907969|449886323|FG007|Combination Therapy Part A|Adverse Event|0|||
125073276|NCT03907969|449886324|FG008|Combination Therapy Part A|Adverse Event|0|||
125073277|NCT03907969|449886325|FG009|Combination Therapy Part A|Adverse Event|1|||
125073278|NCT03907969|449886326|FG010|Combination Therapy Part A|Adverse Event|1|||
125073279|NCT03907969|449886316|FG000|Combination Therapy Part A|Progressive disease|0|||
125073280|NCT03907969|449886317|FG001|Combination Therapy Part A|Progressive disease|0|||
125073281|NCT03907969|449886318|FG002|Combination Therapy Part A|Progressive disease|0|||
125073282|NCT03907969|449886319|FG003|Combination Therapy Part A|Progressive disease|0|||
125073283|NCT03907969|449886320|FG004|Combination Therapy Part A|Progressive disease|0|||
125073284|NCT03907969|449886321|FG005|Combination Therapy Part A|Progressive disease|0|||
125073285|NCT03907969|449886322|FG006|Combination Therapy Part A|Progressive disease|0|||
125073286|NCT03907969|449886323|FG007|Combination Therapy Part A|Progressive disease|1|||
125073287|NCT03907969|449886324|FG008|Combination Therapy Part A|Progressive disease|0|||
125073288|NCT03907969|449886325|FG009|Combination Therapy Part A|Progressive disease|2|||
125073289|NCT03907969|449886326|FG010|Combination Therapy Part A|Progressive disease|3|||
125073290|NCT03907969|449886316|FG000|Combination Therapy Part A|Death|0|||
125073291|NCT03907969|449886317|FG001|Combination Therapy Part A|Death|0|||
125073292|NCT03907969|449886318|FG002|Combination Therapy Part A|Death|0|||
125073293|NCT03907969|449886319|FG003|Combination Therapy Part A|Death|0|||
125073294|NCT03907969|449886320|FG004|Combination Therapy Part A|Death|0|||
125073295|NCT03907969|449886321|FG005|Combination Therapy Part A|Death|0|||
125073296|NCT03907969|449886322|FG006|Combination Therapy Part A|Death|0|||
125073297|NCT03907969|449886323|FG007|Combination Therapy Part A|Death|0|||
125073298|NCT03907969|449886324|FG008|Combination Therapy Part A|Death|1|||
125073299|NCT03907969|449886325|FG009|Combination Therapy Part A|Death|0|||
125073300|NCT03907969|449886326|FG010|Combination Therapy Part A|Death|1|||
125073301|NCT03907969|449886316|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
125073302|NCT03907969|449886317|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
125073303|NCT03907969|449886318|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
125073304|NCT03907969|449886319|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
125073305|NCT03907969|449886320|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
125073306|NCT03907969|449886321|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
125073307|NCT03907969|449886322|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
125073308|NCT03907969|449886323|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
125073309|NCT03907969|449886324|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
125073310|NCT03907969|449886325|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
125073311|NCT03907969|449886326|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
125073312|NCT03907969|449886316|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
125073313|NCT03907969|449886317|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
125073314|NCT03907969|449886318|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
125073315|NCT03907969|449886319|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
125073316|NCT03907969|449886320|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
125073317|NCT03907969|449886321|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
125073318|NCT03907969|449886322|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
125073319|NCT03907969|449886323|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
125073320|NCT03907969|449886324|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
125073321|NCT03907969|449886325|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
125073322|NCT03907969|449886326|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
125223112|NCT00485069|450444511|FG000|Overall Study|Adverse Event|10|||
125073323|NCT03907969|449886316|FG000|Combination Therapy Part A|Physician Decision|0|||
125073324|NCT03907969|449886317|FG001|Combination Therapy Part A|Physician Decision|0|||
125073325|NCT03907969|449886318|FG002|Combination Therapy Part A|Physician Decision|0|||
125073326|NCT03907969|449886319|FG003|Combination Therapy Part A|Physician Decision|0|||
125073327|NCT03907969|449886320|FG004|Combination Therapy Part A|Physician Decision|0|||
125073328|NCT03907969|449886321|FG005|Combination Therapy Part A|Physician Decision|0|||
125073329|NCT03907969|449886322|FG006|Combination Therapy Part A|Physician Decision|0|||
125073330|NCT03907969|449886323|FG007|Combination Therapy Part A|Physician Decision|1|||
125073331|NCT03907969|449886324|FG008|Combination Therapy Part A|Physician Decision|0|||
125073332|NCT03907969|449886325|FG009|Combination Therapy Part A|Physician Decision|0|||
125073333|NCT03907969|449886326|FG010|Combination Therapy Part A|Physician Decision|1|||
125073334|NCT00666536|449886327|FG000|Overall Study|Adverse Event|9|||
125073335|NCT00666536|449886328|FG001|Overall Study|Adverse Event|19|||
125073336|NCT00666536|449886327|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125073337|NCT00666536|449886328|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125073338|NCT00666536|449886327|FG000|Overall Study|Protocol deviation(s)|8|||
125073339|NCT00666536|449886328|FG001|Overall Study|Protocol deviation(s)|6|||
125073340|NCT00666536|449886327|FG000|Overall Study|Withdrawal by Subject|10|||
125073341|NCT00666536|449886328|FG001|Overall Study|Withdrawal by Subject|9|||
125073342|NCT00666536|449886327|FG000|Overall Study|Lost to Follow-up|4|||
125073343|NCT00666536|449886328|FG001|Overall Study|Lost to Follow-up|3|||
125073344|NCT00511108|449886332|FG000|Overall Study|Adverse Event|2|||
125073345|NCT00511108|449886333|FG001|Overall Study|Adverse Event|0|||
125073346|NCT00511108|449886334|FG002|Overall Study|Adverse Event|1|||
125073347|NCT00511108|449886335|FG003|Overall Study|Adverse Event|2|||
125073348|NCT00511108|449886332|FG000|Overall Study|Lost to Follow-up|0|||
125073349|NCT00511108|449886333|FG001|Overall Study|Lost to Follow-up|2|||
125073350|NCT00511108|449886334|FG002|Overall Study|Lost to Follow-up|1|||
125073351|NCT00511108|449886335|FG003|Overall Study|Lost to Follow-up|0|||
125073352|NCT00511108|449886332|FG000|Overall Study|Physician Decision|0|||
125073353|NCT00511108|449886333|FG001|Overall Study|Physician Decision|0|||
125073354|NCT00511108|449886334|FG002|Overall Study|Physician Decision|0|||
125073355|NCT00511108|449886335|FG003|Overall Study|Physician Decision|1|||
125073356|NCT00511108|449886332|FG000|Overall Study|Withdrawal by Subject|4|||
125073357|NCT00511108|449886333|FG001|Overall Study|Withdrawal by Subject|0|||
125073358|NCT00511108|449886334|FG002|Overall Study|Withdrawal by Subject|3|||
125073359|NCT00511108|449886335|FG003|Overall Study|Withdrawal by Subject|2|||
125073360|NCT02147691|449886338|FG000|Overall Study|Withdrawal by Subject|2|||
125073361|NCT02147691|449886339|FG001|Overall Study|Withdrawal by Subject|0|||
125073362|NCT02147691|449886338|FG000|Overall Study|Adverse Event|2|||
125073363|NCT02147691|449886339|FG001|Overall Study|Adverse Event|0|||
125073364|NCT02147691|449886338|FG000|Overall Study|Lost to Follow-up|0|||
125073365|NCT02147691|449886339|FG001|Overall Study|Lost to Follow-up|1|||
125073366|NCT02954952|449886340|FG000|Overall Study|Withdrawal by Subject|1|||
125073367|NCT02954952|449886341|FG001|Overall Study|Withdrawal by Subject|0|||
125073368|NCT02954952|449886342|FG002|Overall Study|Withdrawal by Subject|0|||
125073369|NCT02954952|449886340|FG000|Overall Study|No data collected|0|||
125073370|NCT02954952|449886341|FG001|Overall Study|No data collected|1|||
125141941|NCT00950300|450143136|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
125141942|NCT00950300|450143137|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
125141943|NCT00950300|450143136|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
125141944|NCT00950300|450143137|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
125141945|NCT00950300|450143136|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
125141946|NCT00950300|450143137|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
125141947|NCT00950300|450143136|FG000|TFFU Period|Death|4|||
125141948|NCT00950300|450143137|FG001|TFFU Period|Death|1|||
125141949|NCT00950300|450143136|FG000|TFFU Period|Refused Treatment|10|||
125141950|NCT00950300|450143137|FG001|TFFU Period|Refused Treatment|11|||
125141951|NCT00950300|450143136|FG000|TFFU Period|Failure to Return|16|||
125141952|NCT00950300|450143137|FG001|TFFU Period|Failure to Return|16|||
125141953|NCT00950300|450143136|FG000|TFFU Period|Recurrence of Disease|63|||
125073371|NCT02954952|449886342|FG002|Overall Study|No data collected|0|||
125073372|NCT01392742|449886345|FG000|Overall Study|Premature study termination|42|||
125073373|NCT01392742|449886345|FG000|Overall Study|Failure to return|35|||
125073374|NCT01392742|449886345|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
125073375|NCT01392742|449886345|FG000|Overall Study|Lost to Follow-up|34|||
125073376|NCT01392742|449886345|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
125141954|NCT00950300|450143137|FG001|TFFU Period|Recurrence of Disease|72|||
125141955|NCT00950300|450143136|FG000|TFFU Period|Other|4|||
125073377|NCT01392742|449886345|FG000|Overall Study|ITR and Protocol deviation|1|||
125073378|NCT01392742|449886345|FG000|Overall Study|Adverse event/intercurrent illness|17|||
125073379|NCT01392742|449886345|FG000|Overall Study|Protocol Violation|14|||
125073380|NCT01392742|449886345|FG000|Overall Study|Other|3|||
125073381|NCT01392742|449886345|FG000|Overall Study|Missing information|13|||
125073382|NCT04179032|449886346|FG000|Part B (Up to Week 52)|Adverse Event|1|||
125073383|NCT04179032|449886346|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
125073384|NCT04179032|449886346|FG000|Access Extension Phase|Ongoing|11|||
125073385|NCT03210220|449886347|FG000|Overall Study|Physician Decision|1|||
125073386|NCT03210220|449886348|FG001|Overall Study|Physician Decision|0|||
125073387|NCT02911519|449886349|FG000|Overall Study|Lost to Follow-up|2|||
125073388|NCT02911519|449886350|FG001|Overall Study|Lost to Follow-up|2|||
125073389|NCT02911519|449886349|FG000|Overall Study|Death|0|||
125073390|NCT02911519|449886350|FG001|Overall Study|Death|2|||
125073391|NCT00839436|449886353|FG000|Overall Study|Developed exclusionary condition|1|||
125073392|NCT00839436|449886354|FG001|Overall Study|Developed exclusionary condition|0|||
125073393|NCT00839436|449886355|FG002|Overall Study|Developed exclusionary condition|0|||
125073394|NCT00839436|449886353|FG000|Overall Study|Withdrawal by Subject|0|||
125073395|NCT00839436|449886354|FG001|Overall Study|Withdrawal by Subject|1|||
125073396|NCT00839436|449886355|FG002|Overall Study|Withdrawal by Subject|0|||
125073397|NCT00839436|449886353|FG000|Overall Study|Study drug no longer available|0|||
125073398|NCT00839436|449886354|FG001|Overall Study|Study drug no longer available|0|||
125073399|NCT00839436|449886355|FG002|Overall Study|Study drug no longer available|1|||
125073400|NCT01444898|449886357|FG000|Overall Study|Withdrawal by Subject|1|||
125073401|NCT02580591|449886359|FG000|Overall Study|Adverse Event|0|||
125073402|NCT02580591|449886360|FG001|Overall Study|Adverse Event|1|||
125073403|NCT02580591|449886361|FG002|Overall Study|Adverse Event|2|||
125073404|NCT02580591|449886362|FG003|Overall Study|Adverse Event|5|||
125073405|NCT02580591|449886359|FG000|Overall Study|Protocol Violation|3|||
125073406|NCT02580591|449886360|FG001|Overall Study|Protocol Violation|2|||
125073407|NCT02580591|449886361|FG002|Overall Study|Protocol Violation|1|||
125073408|NCT02580591|449886362|FG003|Overall Study|Protocol Violation|1|||
125073409|NCT02580591|449886359|FG000|Overall Study|Lost to Follow-up|5|||
125073410|NCT02580591|449886360|FG001|Overall Study|Lost to Follow-up|3|||
125073411|NCT02580591|449886361|FG002|Overall Study|Lost to Follow-up|3|||
125073412|NCT02580591|449886362|FG003|Overall Study|Lost to Follow-up|1|||
125073413|NCT02580591|449886359|FG000|Overall Study|Withdrawal by Subject|6|||
125073414|NCT02580591|449886360|FG001|Overall Study|Withdrawal by Subject|1|||
125073415|NCT02580591|449886361|FG002|Overall Study|Withdrawal by Subject|2|||
125073416|NCT02580591|449886362|FG003|Overall Study|Withdrawal by Subject|3|||
125073417|NCT02580591|449886359|FG000|Overall Study|Not treated|1|||
125073418|NCT02580591|449886360|FG001|Overall Study|Not treated|1|||
125073419|NCT02580591|449886361|FG002|Overall Study|Not treated|0|||
125073420|NCT02580591|449886362|FG003|Overall Study|Not treated|0|||
125073421|NCT02580591|449886359|FG000|Overall Study|Other than specified|3|||
125073422|NCT02580591|449886360|FG001|Overall Study|Other than specified|2|||
125073423|NCT02580591|449886361|FG002|Overall Study|Other than specified|5|||
125073424|NCT02580591|449886362|FG003|Overall Study|Other than specified|2|||
125073425|NCT00561340|449886366|FG000|Overall Study|refused to drink pediasure|6|||
125073426|NCT00561340|449886367|FG001|Overall Study|refused to drink pediasure|0|||
125073427|NCT00445341|449886368|FG000|Overall Study|refused further treatment|1|||
125073428|NCT00445341|449886368|FG000|Overall Study|taken off treatment too early|1|||
125073429|NCT02443805|449886371|FG000|Overall Study|Adverse Event|100|||
125073430|NCT02443805|449886372|FG001|Overall Study|Adverse Event|18|||
125073431|NCT02443805|449886371|FG000|Overall Study|Withdrawal by Subject|73|||
125073432|NCT02443805|449886372|FG001|Overall Study|Withdrawal by Subject|74|||
125073433|NCT02443805|449886371|FG000|Overall Study|Lost to Follow-up|19|||
125073434|NCT02443805|449886372|FG001|Overall Study|Lost to Follow-up|14|||
125073435|NCT02443805|449886371|FG000|Overall Study|Pregnancy|6|||
125073436|NCT02443805|449886372|FG001|Overall Study|Pregnancy|5|||
125073437|NCT02443805|449886371|FG000|Overall Study|Protocol Violation|2|||
125073438|NCT02443805|449886372|FG001|Overall Study|Protocol Violation|4|||
125073439|NCT02443805|449886371|FG000|Overall Study|Lack of Efficacy|1|||
125073440|NCT02443805|449886372|FG001|Overall Study|Lack of Efficacy|1|||
125073441|NCT02443805|449886371|FG000|Overall Study|Non-compliance with study drug|6|||
125073442|NCT02443805|449886372|FG001|Overall Study|Non-compliance with study drug|4|||
125073443|NCT02443805|449886371|FG000|Overall Study|Withdrawal by parent/guardian|3|||
125073444|NCT02443805|449886372|FG001|Overall Study|Withdrawal by parent/guardian|5|||
125073445|NCT02443805|449886371|FG000|Overall Study|Any other reason not above-mentioned|3|||
125073446|NCT02443805|449886372|FG001|Overall Study|Any other reason not above-mentioned|2|||
125073447|NCT04362813|449886373|FG000|Overall Study|Death|12|||
125073448|NCT04362813|449886374|FG001|Overall Study|Death|16|||
125073449|NCT04362813|449886373|FG000|Overall Study|Withdrawal by Subject|3|||
125073450|NCT04362813|449886374|FG001|Overall Study|Withdrawal by Subject|1|||
125073451|NCT04362813|449886373|FG000|Overall Study|Protocol Violation|0|||
125073452|NCT04362813|449886374|FG001|Overall Study|Protocol Violation|3|||
125073453|NCT04362813|449886373|FG000|Overall Study|Lost to Follow-up|1|||
125073454|NCT04362813|449886374|FG001|Overall Study|Lost to Follow-up|1|||
125073455|NCT04362813|449886373|FG000|Overall Study|Enrolled but did not receive treatment|2|||
125073456|NCT04362813|449886374|FG001|Overall Study|Enrolled but did not receive treatment|4|||
125073457|NCT00961116|449886375|FG000|Washout Period of 7 Days|Adverse Event|1|||
125073458|NCT00961116|449886376|FG001|Washout Period of 7 Days|Adverse Event|1|||
125073459|NCT00961116|449886375|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
125073460|NCT00961116|449886376|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
125141956|NCT00950300|450143137|FG001|TFFU Period|Other|3|||
125141957|NCT00950300|450143136|FG000|SFU Period|Death|44|||
125141958|NCT00950300|450143137|FG001|SFU Period|Death|42|||
125141959|NCT00950300|450143136|FG000|SFU Period|Lost to Follow-up|30|||
125141960|NCT00950300|450143137|FG001|SFU Period|Lost to Follow-up|28|||
125073461|NCT00961116|449886375|FG000|Washout Period of 7 Days|Protocol Violation|0|||
125073462|NCT00961116|449886376|FG001|Washout Period of 7 Days|Protocol Violation|1|||
125073463|NCT04354155|449886381|FG000|Overall Study|Withdrawal by Subject|1|||
125073464|NCT04354155|449886381|FG000|Overall Study|Did not meet criteria for study intervention|1|||
125073465|NCT02565615|449886382|FG000|Overall Study|Death|0|||
125073466|NCT02565615|449886383|FG001|Overall Study|Death|1|||
125073467|NCT02565615|449886384|FG002|Overall Study|Death|0|||
125073468|NCT02565615|449886385|FG003|Overall Study|Death|0|||
125073469|NCT02565615|449886386|FG004|Overall Study|Death|4|||
125073470|NCT02565615|449886382|FG000|Overall Study|Not willing to participate in study|2|||
125073471|NCT02565615|449886383|FG001|Overall Study|Not willing to participate in study|21|||
125073472|NCT02565615|449886384|FG002|Overall Study|Not willing to participate in study|0|||
125073473|NCT02565615|449886385|FG003|Overall Study|Not willing to participate in study|1|||
125073474|NCT02565615|449886386|FG004|Overall Study|Not willing to participate in study|169|||
125073475|NCT02565615|449886382|FG000|Overall Study|Lost to Follow-up|0|||
125073476|NCT02565615|449886383|FG001|Overall Study|Lost to Follow-up|4|||
125073477|NCT02565615|449886384|FG002|Overall Study|Lost to Follow-up|0|||
125073478|NCT02565615|449886385|FG003|Overall Study|Lost to Follow-up|1|||
125073479|NCT02565615|449886386|FG004|Overall Study|Lost to Follow-up|765|||
125073480|NCT02565615|449886382|FG000|Overall Study|Not meeting eligibility criteria|0|||
125073481|NCT02565615|449886383|FG001|Overall Study|Not meeting eligibility criteria|7|||
125073482|NCT02565615|449886384|FG002|Overall Study|Not meeting eligibility criteria|0|||
125073483|NCT02565615|449886385|FG003|Overall Study|Not meeting eligibility criteria|0|||
125073484|NCT02565615|449886386|FG004|Overall Study|Not meeting eligibility criteria|25|||
125073485|NCT02565615|449886382|FG000|Overall Study|Reason not defined|0|||
125073486|NCT02565615|449886383|FG001|Overall Study|Reason not defined|2|||
125073487|NCT02565615|449886384|FG002|Overall Study|Reason not defined|0|||
125073488|NCT02565615|449886385|FG003|Overall Study|Reason not defined|1|||
125073489|NCT02565615|449886386|FG004|Overall Study|Reason not defined|62|||
125073490|NCT02565615|449886382|FG000|Overall Study|Adverse Event|1|||
125073491|NCT02565615|449886383|FG001|Overall Study|Adverse Event|1|||
125073492|NCT02565615|449886384|FG002|Overall Study|Adverse Event|0|||
125073493|NCT02565615|449886385|FG003|Overall Study|Adverse Event|0|||
125073494|NCT02565615|449886386|FG004|Overall Study|Adverse Event|9|||
125073495|NCT02565615|449886382|FG000|Overall Study|Untreated|0|||
125073496|NCT02565615|449886383|FG001|Overall Study|Untreated|0|||
125073497|NCT02565615|449886384|FG002|Overall Study|Untreated|0|||
125141961|NCT00950300|450143136|FG000|SFU Period|Withdrawal by Subject|4|||
125141962|NCT00950300|450143137|FG001|SFU Period|Withdrawal by Subject|8|||
125141963|NCT01717040|450143138|FG000|Overall Study|Lost to Follow-up|2|||
125141964|NCT01717040|450143139|FG001|Overall Study|Lost to Follow-up|3|||
125141965|NCT01717040|450143138|FG000|Overall Study|Lack of Efficacy|1|||
125141966|NCT01717040|450143139|FG001|Overall Study|Lack of Efficacy|1|||
125141967|NCT01717040|450143138|FG000|Overall Study|Adverse Event|1|||
125141968|NCT01717040|450143139|FG001|Overall Study|Adverse Event|0|||
125141969|NCT01717040|450143138|FG000|Overall Study|Required Medication Change|0|||
125141970|NCT01717040|450143139|FG001|Overall Study|Required Medication Change|1|||
125141971|NCT01717040|450143138|FG000|Overall Study|New Substance Use Disorder|1|||
125141972|NCT01717040|450143139|FG001|Overall Study|New Substance Use Disorder|0|||
125141973|NCT00494013|450143140|FG000|Overall Study|Adverse Event|0|||
125141974|NCT00494013|450143141|FG001|Overall Study|Adverse Event|1|||
125141975|NCT00494013|450143140|FG000|Overall Study|Entry Criteria Not Met|1|||
125141976|NCT00494013|450143141|FG001|Overall Study|Entry Criteria Not Met|4|||
125141977|NCT00494013|450143140|FG000|Overall Study|Lost to Follow-up|5|||
125141978|NCT00494013|450143141|FG001|Overall Study|Lost to Follow-up|6|||
125141979|NCT00494013|450143140|FG000|Overall Study|Physician Decision|3|||
125141980|NCT00494013|450143141|FG001|Overall Study|Physician Decision|5|||
125141981|NCT00494013|450143140|FG000|Overall Study|Protocol Violation|8|||
125073498|NCT02565615|449886385|FG003|Overall Study|Untreated|0|||
125073499|NCT02565615|449886386|FG004|Overall Study|Untreated|567|||
125073500|NCT00753688|449886389|FG000|Overall Study|Death|102|||
125073501|NCT00753688|449886390|FG001|Overall Study|Death|203|||
125073502|NCT00753688|449886389|FG000|Overall Study|Missing|4|||
125073503|NCT00753688|449886390|FG001|Overall Study|Missing|9|||
125073504|NCT00753688|449886389|FG000|Overall Study|Participant Withdrew Consent|2|||
125073505|NCT00753688|449886390|FG001|Overall Study|Participant Withdrew Consent|2|||
125073506|NCT00753688|449886389|FG000|Overall Study|Ongoing - in Follow-up|15|||
125073507|NCT00753688|449886390|FG001|Overall Study|Ongoing - in Follow-up|31|||
125141982|NCT00494013|450143141|FG001|Overall Study|Protocol Violation|5|||
125141983|NCT00494013|450143140|FG000|Overall Study|Withdrawal by Subject|13|||
125141984|NCT00494013|450143141|FG001|Overall Study|Withdrawal by Subject|14|||
125141985|NCT00494013|450143140|FG000|Overall Study|Sponsor Decision|0|||
125141986|NCT00494013|450143141|FG001|Overall Study|Sponsor Decision|1|||
125223113|NCT00485069|450444512|FG001|Overall Study|Adverse Event|4|||
125223114|NCT00485069|450444511|FG000|Overall Study|Lack of Efficacy|2|||
125223115|NCT00485069|450444512|FG001|Overall Study|Lack of Efficacy|1|||
125223116|NCT00485069|450444511|FG000|Overall Study|Protocol Violation|0|||
125223117|NCT00485069|450444512|FG001|Overall Study|Protocol Violation|1|||
125223118|NCT00485069|450444511|FG000|Overall Study|Withdrawal by Subject|6|||
125073508|NCT00753688|449886389|FG000|Overall Study|Adverse Event|0|||
125073509|NCT00753688|449886390|FG001|Overall Study|Adverse Event|1|||
125073510|NCT02999100|449886394|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
125073511|NCT02999100|449886395|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
125073512|NCT02999100|449886396|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
125073513|NCT02999100|449886397|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
125073514|NCT02999100|449886398|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
125073515|NCT02999100|449886399|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
125073516|NCT02999100|449886394|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
125073517|NCT02999100|449886395|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
125073518|NCT02999100|449886396|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
125073519|NCT02999100|449886397|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
125073520|NCT02999100|449886398|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
125073521|NCT02999100|449886399|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
125073522|NCT02999100|449886394|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
125073523|NCT02999100|449886395|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
125073524|NCT02999100|449886396|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
125073525|NCT02999100|449886397|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
125073526|NCT02999100|449886398|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
125073527|NCT02999100|449886399|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
125073528|NCT00293241|449886403|FG000|Overall Study|Lost to Follow-up|9|||
125073529|NCT00293241|449886404|FG001|Overall Study|Lost to Follow-up|16|||
125073530|NCT00293241|449886403|FG000|Overall Study|Physician Decision|23|||
125073531|NCT00293241|449886404|FG001|Overall Study|Physician Decision|17|||
125073532|NCT00293241|449886403|FG000|Overall Study|Withdrawal by Subject|4|||
125073533|NCT00293241|449886404|FG001|Overall Study|Withdrawal by Subject|8|||
125073534|NCT03595384|449886405|FG000|Overall Study|Other time commitments|8|||
125073535|NCT03595384|449886405|FG000|Overall Study|Changes to session time|7|||
125073536|NCT03595384|449886405|FG000|Overall Study|Relocation out of country|1|||
125073537|NCT02224638|449886406|FG000|Overall Study|Adverse Event|1|||
125073538|NCT02224638|449886407|FG001|Overall Study|Adverse Event|1|||
125073539|NCT01455415|449886419|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
125073540|NCT01455415|449886420|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
125073541|NCT01455415|449886419|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
125073542|NCT01455415|449886420|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
125073543|NCT01455415|449886419|FG000|Period 1|Drug Error not Associated to AE|0|||
125073544|NCT01455415|449886420|FG001|Period 1|Drug Error not Associated to AE|1|||
125073545|NCT01455415|449886419|FG000|Period 1|AE Not Related to Study Drug|2|||
125073546|NCT01455415|449886420|FG001|Period 1|AE Not Related to Study Drug|6|||
125073547|NCT01455415|449886419|FG000|Period 1|Withdrawal by Subject|4|||
125073548|NCT01455415|449886420|FG001|Period 1|Withdrawal by Subject|5|||
125073549|NCT01455415|449886419|FG000|Period 1|Unspecified Reason|1|||
125073550|NCT01455415|449886420|FG001|Period 1|Unspecified Reason|1|||
125073551|NCT01455415|449886419|FG000|Period 1|Protocol Violation|0|||
125073552|NCT01455415|449886420|FG001|Period 1|Protocol Violation|2|||
125073553|NCT01455415|449886419|FG000|Washout|AE Related to Study Drug|2|||
125073554|NCT01455415|449886420|FG001|Washout|AE Related to Study Drug|0|||
125073555|NCT01455415|449886419|FG000|Washout|Lost to Follow-up|1|||
125073556|NCT01455415|449886420|FG001|Washout|Lost to Follow-up|0|||
125073557|NCT01455415|449886419|FG000|Washout|Drug Error not Associated to AE|2|||
125073558|NCT01455415|449886420|FG001|Washout|Drug Error not Associated to AE|1|||
125073559|NCT01455415|449886419|FG000|Washout|AE Not Related to Study Drug|2|||
125073560|NCT01455415|449886420|FG001|Washout|AE Not Related to Study Drug|3|||
125073561|NCT01455415|449886419|FG000|Washout|Unspecified Reason|1|||
125073562|NCT01455415|449886420|FG001|Washout|Unspecified Reason|2|||
125073563|NCT01455415|449886419|FG000|Washout|Protocol Violation|0|||
125073564|NCT01455415|449886420|FG001|Washout|Protocol Violation|1|||
125073565|NCT01455415|449886419|FG000|Period 2|AE Related to Study Drug|1|||
125073566|NCT01455415|449886420|FG001|Period 2|AE Related to Study Drug|2|||
125073567|NCT01455415|449886419|FG000|Period 2|Lost to Follow-up|2|||
125073568|NCT01455415|449886420|FG001|Period 2|Lost to Follow-up|1|||
125073569|NCT01455415|449886419|FG000|Period 2|AE Not Related to Study Drug|2|||
125073570|NCT01455415|449886420|FG001|Period 2|AE Not Related to Study Drug|1|||
125073571|NCT01455415|449886419|FG000|Period 2|Lack of Efficacy|2|||
125223119|NCT00485069|450444512|FG001|Overall Study|Withdrawal by Subject|6|||
125073572|NCT01455415|449886420|FG001|Period 2|Lack of Efficacy|0|||
125073573|NCT01455415|449886419|FG000|Period 2|Withdrawal by Subject|2|||
125073574|NCT01455415|449886420|FG001|Period 2|Withdrawal by Subject|3|||
125073575|NCT01455415|449886419|FG000|Period 2|Unspecified Reason|2|||
125141987|NCT04750239|450143142|FG000|Overall Study|Withdrawal by Subject|2|||
125141988|NCT04750239|450143142|FG000|Overall Study|Trial terminated by sponsor|1|||
125141989|NCT00903877|450143143|FG000|Overall Study|Did not meet study criteria|33|||
125141990|NCT00903877|450143143|FG000|Overall Study|Withdrawal by Subject|3|||
125141991|NCT00903877|450143143|FG000|Overall Study|Adverse Event|2|||
125141992|NCT00903877|450143143|FG000|Overall Study|Lost to Follow-up|1|||
125141993|NCT00903877|450143143|FG000|Overall Study|Participation put on hold|4|||
125141994|NCT00919711|450143144|FG000|Overall Study|Withdrawal by Subject|15|||
125223120|NCT02989402|450444513|FG000|Overall Study|Adverse event, or serious adverse event|4|||
125223121|NCT02989402|450444513|FG000|Overall Study|Death|2|||
125223122|NCT02989402|450444513|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
125223123|NCT02989402|450444513|FG000|Overall Study|Lost to Follow-up|8|||
125223124|NCT02989402|450444513|FG000|Overall Study|Patient no longer on monotherapy|1|||
125223125|NCT02989402|450444513|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
125223126|NCT02989402|450444513|FG000|Overall Study|Withdrawal by Subject|7|||
125223127|NCT02989402|450444513|FG000|Overall Study|Other|2|||
125223128|NCT03066830|450444514|FG000|Overall Study|At the Participant's own Request|16|||
125223129|NCT03066830|450444515|FG001|Overall Study|At the Participant's own Request|17|||
125223130|NCT03066830|450444514|FG000|Overall Study|Other|3|||
125223131|NCT03066830|450444515|FG001|Overall Study|Other|0|||
125223132|NCT03066830|450444514|FG000|Overall Study|Poor Compliance to Protocol|1|||
125223133|NCT03066830|450444515|FG001|Overall Study|Poor Compliance to Protocol|0|||
125223134|NCT03066830|450444514|FG000|Overall Study|Adverse Event|2|||
125223135|NCT03066830|450444515|FG001|Overall Study|Adverse Event|2|||
125223136|NCT03066830|450444514|FG000|Overall Study|Lost to Follow-up|11|||
125223137|NCT03066830|450444515|FG001|Overall Study|Lost to Follow-up|3|||
125223138|NCT02039778|450444517|FG000|Overall Study|Death|2|||
125223139|NCT02039778|450444517|FG000|Overall Study|Withdrawal by Subject|1|||
125223140|NCT02039778|450444517|FG000|Overall Study|Never started the protocol treatment|1|||
125223141|NCT00992017|450444533|FG000|Overall Study|Lost to Follow-up|2|||
125223142|NCT00992017|450444533|FG000|Overall Study|Withdrawal by Subject|2|||
125223143|NCT00992017|450444533|FG000|Overall Study|Unable to get to clinic|5|||
125223144|NCT00992017|450444533|FG000|Overall Study|Not adhere to study requirements|1|||
125223145|NCT02864407|450444534|FG000|Overall Study|Protocol Violation|3|||
125223146|NCT02864407|450444534|FG000|Overall Study|Lost to Follow-up|115|||
125223147|NCT02864407|450444534|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
125073576|NCT01455415|449886420|FG001|Period 2|Unspecified Reason|3|||
125073577|NCT01455415|449886419|FG000|Period 2|Protocol Violation|2|||
125073578|NCT01455415|449886420|FG001|Period 2|Protocol Violation|0|||
125073579|NCT01455415|449886419|FG000|Follow-up|AE Related to Study Drug|0|||
125073580|NCT01455415|449886420|FG001|Follow-up|AE Related to Study Drug|1|||
125073581|NCT01455415|449886419|FG000|Follow-up|Lack of Efficacy|0|||
125073582|NCT01455415|449886420|FG001|Follow-up|Lack of Efficacy|1|||
125073583|NCT01455415|449886419|FG000|Follow-up|Withdrawal by Subject|2|||
125073584|NCT01455415|449886420|FG001|Follow-up|Withdrawal by Subject|0|||
125073585|NCT01455415|449886419|FG000|Follow-up|Unspecified Reason|1|||
125073586|NCT01455415|449886420|FG001|Follow-up|Unspecified Reason|0|||
125073587|NCT00587301|449886421|FG000|Overall Study|Screen Failure|9|||
125073588|NCT00587301|449886421|FG000|Overall Study|Lost to Follow-up|22|||
125073589|NCT00587301|449886421|FG000|Overall Study|Withdrawal by Subject|7|||
125073590|NCT00587301|449886421|FG000|Overall Study|Protocol Violation|7|||
125073591|NCT02758613|449886422|FG000|Treatment|Physician and Sponsor Decision|1|||
125073592|NCT02758613|449886423|FG001|Treatment|Physician and Sponsor Decision|0|||
125141995|NCT00919711|450143145|FG001|Overall Study|Withdrawal by Subject|7|||
125141996|NCT00919711|450143144|FG000|Overall Study|Adverse Event|13|||
125141997|NCT00919711|450143145|FG001|Overall Study|Adverse Event|3|||
125223148|NCT02864407|450444534|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
125073593|NCT02758613|449886424|FG002|Treatment|Physician and Sponsor Decision|0|||
125073594|NCT02758613|449886425|FG003|Treatment|Physician and Sponsor Decision|0|||
125073595|NCT02758613|449886422|FG000|Treatment|Withdrawal by Subject|1|||
125073596|NCT02758613|449886423|FG001|Treatment|Withdrawal by Subject|0|||
125073597|NCT02758613|449886424|FG002|Treatment|Withdrawal by Subject|1|||
125223149|NCT02864407|450444534|FG000|Overall Study|Consent prior to the contract date|1|||
125073598|NCT02758613|449886425|FG003|Treatment|Withdrawal by Subject|0|||
125073599|NCT01496274|449886426|FG000|Overall Study|Protocol Violation|0|||
125141998|NCT00919711|450143144|FG000|Overall Study|Other|1|||
125223150|NCT01827592|450444544|FG000|Overall Study|Adverse Event|11|||
125223151|NCT01827592|450444545|FG001|Overall Study|Adverse Event|9|||
125223152|NCT01827592|450444546|FG002|Overall Study|Adverse Event|2|||
125223153|NCT01827592|450444544|FG000|Overall Study|Physician Decision|0|||
125223154|NCT01827592|450444545|FG001|Overall Study|Physician Decision|2|||
125141999|NCT00919711|450143145|FG001|Overall Study|Other|2|||
125142000|NCT00919711|450143144|FG000|Overall Study|Administrative Decision|0|||
125142001|NCT00919711|450143145|FG001|Overall Study|Administrative Decision|1|||
125142002|NCT00919711|450143144|FG000|Overall Study|Lost to Follow-up|2|||
125142003|NCT00919711|450143145|FG001|Overall Study|Lost to Follow-up|0|||
125142004|NCT00919711|450143144|FG000|Overall Study|Death|1|||
125142005|NCT00919711|450143145|FG001|Overall Study|Death|0|||
125142006|NCT00919711|450143144|FG000|Overall Study|Noncompliance|1|||
125142007|NCT00919711|450143145|FG001|Overall Study|Noncompliance|0|||
125142008|NCT00087529|450143146|FG000|Overall Study|Death|1|||
125142009|NCT00087529|450143147|FG001|Overall Study|Death|0|||
125142010|NCT00087529|450143146|FG000|Overall Study|Adverse Event|0|||
125073600|NCT01496274|449886427|FG001|Overall Study|Protocol Violation|1|||
125073601|NCT01496274|449886426|FG000|Overall Study|Adverse Event|1|||
125073602|NCT01496274|449886427|FG001|Overall Study|Adverse Event|1|||
125073603|NCT01496274|449886426|FG000|Overall Study|Withdrawal by Subject|2|||
125073604|NCT01496274|449886427|FG001|Overall Study|Withdrawal by Subject|0|||
125073605|NCT01496274|449886426|FG000|Overall Study|Lost to Follow-up|0|||
125073606|NCT01496274|449886427|FG001|Overall Study|Lost to Follow-up|3|||
125073607|NCT00351819|449886430|FG000|Overall Study|Lost to Follow-up|4|||
125073608|NCT00351819|449886431|FG001|Overall Study|Lost to Follow-up|4|||
125073609|NCT00351819|449886430|FG000|Overall Study|Withdrawal by Subject|0|||
125073610|NCT00351819|449886431|FG001|Overall Study|Withdrawal by Subject|4|||
125073611|NCT00351819|449886430|FG000|Overall Study|Elevated PSA|1|||
125073612|NCT00351819|449886431|FG001|Overall Study|Elevated PSA|1|||
125073613|NCT00351819|449886430|FG000|Overall Study|Traumatic ankle fracture|1|||
125073614|NCT00351819|449886431|FG001|Overall Study|Traumatic ankle fracture|0|||
125073615|NCT00351819|449886430|FG000|Overall Study|Unprofessional behavior|1|||
125073616|NCT00351819|449886431|FG001|Overall Study|Unprofessional behavior|0|||
125073617|NCT00351819|449886430|FG000|Overall Study|Non-compliance|0|||
125073618|NCT00351819|449886431|FG001|Overall Study|Non-compliance|1|||
125073619|NCT00351819|449886430|FG000|Overall Study|Incarcerated|0|||
125073620|NCT00351819|449886431|FG001|Overall Study|Incarcerated|1|||
125073621|NCT00351819|449886430|FG000|Overall Study|Enrolled in another trial|0|||
125073622|NCT00351819|449886431|FG001|Overall Study|Enrolled in another trial|1|||
125073623|NCT00719537|449886434|FG000|Overall Study|Withdrawal by Subject|1|||
125073624|NCT00719537|449886435|FG001|Overall Study|Withdrawal by Subject|0|||
125073625|NCT00719537|449886434|FG000|Overall Study|Lost to Follow-up|0|||
125073626|NCT00719537|449886435|FG001|Overall Study|Lost to Follow-up|1|||
125073627|NCT01459068|449886436|FG000|Overall Study|Withdrawal by Subject|8|||
125073628|NCT01459068|449886437|FG001|Overall Study|Withdrawal by Subject|18|||
125073629|NCT01459068|449886436|FG000|Overall Study|Lost to Follow-up|31|||
125073630|NCT01459068|449886437|FG001|Overall Study|Lost to Follow-up|15|||
125073631|NCT01459068|449886436|FG000|Overall Study|Death|0|||
125073632|NCT01459068|449886437|FG001|Overall Study|Death|1|||
125073633|NCT00196196|449886440|FG000|Overall Study|Withdrawal by Subject|2|||
125073634|NCT00196196|449886440|FG000|Overall Study|Did not have required condition (hydroce|5|||
125073635|NCT02910219|449886441|FG000|Overall Study|Withdrawal by Subject|1|||
125073636|NCT02910219|449886442|FG001|Overall Study|Withdrawal by Subject|1|||
125073637|NCT00701441|449886443|FG000|Overall Study|failure in cpap compliance|0|||
125073638|NCT00701441|449886444|FG001|Overall Study|failure in cpap compliance|4|||
125073639|NCT01015820|449886445|FG000|Overall Study|Suboptimal measurements|1|||
125073640|NCT01015820|449886446|FG001|Overall Study|Suboptimal measurements|0|||
125073641|NCT01313078|449886452|FG000|Overall Study|Death|1|||
125073642|NCT01313078|449886452|FG000|Overall Study|Discontinued study drug|1|||
125073643|NCT01313078|449886452|FG000|Overall Study|Withdrawal by Subject|1|||
125073644|NCT02679781|449886454|FG000|Overall Study|Lost to Follow-up|1|||
125073645|NCT02679781|449886455|FG001|Overall Study|Lost to Follow-up|2|||
125073646|NCT02679781|449886454|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
125073647|NCT02679781|449886455|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
125073648|NCT04209400|449886456|FG000|Overall Study|Withdrawal by Subject|0|||
125073649|NCT04209400|449886457|FG001|Overall Study|Withdrawal by Subject|1|||
125073650|NCT01203787|449886465|FG000|Overall Study|Death|12|||
125073651|NCT01203787|449886466|FG001|Overall Study|Death|10|||
125073652|NCT01203787|449886465|FG000|Overall Study|Withdrawal by Subject|6|||
125142011|NCT00087529|450143147|FG001|Overall Study|Adverse Event|8|||
125073653|NCT01203787|449886466|FG001|Overall Study|Withdrawal by Subject|2|||
125142012|NCT00087529|450143146|FG000|Overall Study|Pregnancy|0|||
125142013|NCT00087529|450143147|FG001|Overall Study|Pregnancy|1|||
125073654|NCT01203787|449886465|FG000|Overall Study|Lost to Follow-up|2|||
125073655|NCT01203787|449886466|FG001|Overall Study|Lost to Follow-up|0|||
125073656|NCT01203787|449886465|FG000|Overall Study|Adverse Event|11|||
125073657|NCT01203787|449886466|FG001|Overall Study|Adverse Event|15|||
125073658|NCT03404518|449886467|FG000|Overall Study|Lost to Follow-up|28|||
125073659|NCT03404518|449886468|FG001|Overall Study|Lost to Follow-up|30|||
125073660|NCT03404518|449886467|FG000|Overall Study|Protocol Violation|13|||
125073661|NCT03404518|449886468|FG001|Overall Study|Protocol Violation|6|||
125073662|NCT01079195|449886469|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
125073663|NCT01079195|449886469|FG000|Overall Study|No Documentation Available|437|||
125073664|NCT01079195|449886469|FG000|Overall Study|Adverse Event|157|||
125073665|NCT01079195|449886469|FG000|Overall Study|Reason Unknown|39|||
125073666|NCT01079195|449886469|FG000|Overall Study|Withdrawal by Subject|18|||
125073667|NCT01079195|449886469|FG000|Overall Study|Financial Reasons|15|||
125073668|NCT01079195|449886469|FG000|Overall Study|Lack of Effectiveness|12|||
125073669|NCT01079195|449886469|FG000|Overall Study|Physician Decision|4|||
125073670|NCT01079195|449886469|FG000|Overall Study|Improved Status of Participant|4|||
125073671|NCT01079195|449886469|FG000|Overall Study|No Follow-up Documentation Available|4|||
125073672|NCT01079195|449886469|FG000|Overall Study|Non-compliance|2|||
125073673|NCT03693404|449886474|FG000|Overall Study|Withdrawal by Subject|1|||
125073674|NCT03693404|449886475|FG001|Overall Study|Withdrawal by Subject|0|||
125073675|NCT03693404|449886474|FG000|Overall Study|Lost to Follow-up|0|||
125073676|NCT03693404|449886475|FG001|Overall Study|Lost to Follow-up|5|||
125073677|NCT03693404|449886474|FG000|Overall Study|Excluded from Analysis|0|||
125073678|NCT03693404|449886475|FG001|Overall Study|Excluded from Analysis|1|||
125073679|NCT01685203|449886480|FG000|Overall Study|Lost to Follow-up|3|||
125073680|NCT01685203|449886481|FG001|Overall Study|Lost to Follow-up|3|||
125073681|NCT01685203|449886482|FG002|Overall Study|Lost to Follow-up|0|||
125073682|NCT01685203|449886483|FG003|Overall Study|Lost to Follow-up|1|||
125073683|NCT01685203|449886484|FG004|Overall Study|Lost to Follow-up|0|||
125073684|NCT01685203|449886485|FG005|Overall Study|Lost to Follow-up|0|||
125073685|NCT01685203|449886486|FG006|Overall Study|Lost to Follow-up|0|||
125073686|NCT01685203|449886480|FG000|Overall Study|Adverse Event|0|||
125073687|NCT01685203|449886481|FG001|Overall Study|Adverse Event|0|||
125073688|NCT01685203|449886482|FG002|Overall Study|Adverse Event|0|||
125073689|NCT01685203|449886483|FG003|Overall Study|Adverse Event|0|||
125073690|NCT01685203|449886484|FG004|Overall Study|Adverse Event|0|||
125073691|NCT01685203|449886485|FG005|Overall Study|Adverse Event|2|||
125073692|NCT01685203|449886486|FG006|Overall Study|Adverse Event|0|||
125073693|NCT01685203|449886480|FG000|Overall Study|Adverse event and withdrew consent|1|||
125073694|NCT01685203|449886481|FG001|Overall Study|Adverse event and withdrew consent|0|||
125073695|NCT01685203|449886482|FG002|Overall Study|Adverse event and withdrew consent|0|||
125073696|NCT01685203|449886483|FG003|Overall Study|Adverse event and withdrew consent|0|||
125073697|NCT01685203|449886484|FG004|Overall Study|Adverse event and withdrew consent|0|||
125073698|NCT01685203|449886485|FG005|Overall Study|Adverse event and withdrew consent|0|||
125073699|NCT01685203|449886486|FG006|Overall Study|Adverse event and withdrew consent|0|||
125073700|NCT01685203|449886480|FG000|Overall Study|Patient's decision|0|||
125073701|NCT01685203|449886481|FG001|Overall Study|Patient's decision|0|||
125073702|NCT01685203|449886482|FG002|Overall Study|Patient's decision|0|||
125073703|NCT01685203|449886483|FG003|Overall Study|Patient's decision|0|||
125073704|NCT01685203|449886484|FG004|Overall Study|Patient's decision|0|||
125142014|NCT00087529|450143146|FG000|Overall Study|Lost to Follow-up|2|||
125142015|NCT00087529|450143147|FG001|Overall Study|Lost to Follow-up|3|||
125142016|NCT00087529|450143146|FG000|Overall Study|Participant Decision|14|||
125142017|NCT00087529|450143147|FG001|Overall Study|Participant Decision|37|||
125142018|NCT00087529|450143146|FG000|Overall Study|Physician Decision|4|||
125142019|NCT00087529|450143147|FG001|Overall Study|Physician Decision|8|||
125142020|NCT00087529|450143146|FG000|Overall Study|Initiation of Excluded Therapy|0|||
125142021|NCT00087529|450143147|FG001|Overall Study|Initiation of Excluded Therapy|1|||
125142022|NCT00087529|450143146|FG000|Overall Study|Participant Noncompliance|0|||
125073705|NCT01685203|449886485|FG005|Overall Study|Patient's decision|1|||
125073706|NCT01685203|449886486|FG006|Overall Study|Patient's decision|0|||
125073707|NCT01576406|449886488|FG000|Overall Study|Lost to Follow-up|1|||
125073708|NCT01576406|449886489|FG001|Overall Study|Lost to Follow-up|2|||
125142023|NCT00087529|450143147|FG001|Overall Study|Participant Noncompliance|1|||
125223155|NCT01827592|450444546|FG002|Overall Study|Physician Decision|1|||
125073709|NCT01576406|449886490|FG002|Overall Study|Lost to Follow-up|0|||
125073710|NCT01576406|449886491|FG003|Overall Study|Lost to Follow-up|0|||
125073711|NCT01576406|449886492|FG004|Overall Study|Lost to Follow-up|0|||
125073712|NCT01576406|449886493|FG005|Overall Study|Lost to Follow-up|0|||
125142024|NCT00087529|450143146|FG000|Overall Study|Disease Progression|5|||
125142025|NCT00087529|450143147|FG001|Overall Study|Disease Progression|4|||
125223156|NCT01827592|450444544|FG000|Overall Study|Protocol Violation|2|||
125073713|NCT01576406|449886488|FG000|Overall Study|Death|3|||
125073714|NCT01576406|449886489|FG001|Overall Study|Death|4|||
125073715|NCT01576406|449886490|FG002|Overall Study|Death|8|||
125073716|NCT01576406|449886491|FG003|Overall Study|Death|5|||
125073717|NCT01576406|449886492|FG004|Overall Study|Death|7|||
125142026|NCT00087529|450143146|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
125142027|NCT00087529|450143147|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
125142028|NCT00685334|450143150|FG000|Overall Study|Withdrawal by Subject|5|||
125142029|NCT00685334|450143151|FG001|Overall Study|Withdrawal by Subject|6|||
125142030|NCT00685334|450143150|FG000|Overall Study|Lost to Follow-up|4|||
125142031|NCT00685334|450143151|FG001|Overall Study|Lost to Follow-up|0|||
125142032|NCT00685334|450143150|FG000|Overall Study|Chose to enter hospital|1|||
125142033|NCT00685334|450143151|FG001|Overall Study|Chose to enter hospital|1|||
125073718|NCT01576406|449886493|FG005|Overall Study|Death|9|||
125142034|NCT01891357|450143152|FG000|Overall Study|Protocol Violation|3|||
125073719|NCT01576406|449886488|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
125073720|NCT01576406|449886489|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
125073721|NCT01576406|449886490|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
125073722|NCT01576406|449886491|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
125073723|NCT01576406|449886492|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
125073724|NCT01576406|449886493|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
125073725|NCT01576406|449886488|FG000|Overall Study|Withdrawal the consent|2|||
125073726|NCT01576406|449886489|FG001|Overall Study|Withdrawal the consent|2|||
125073727|NCT01576406|449886490|FG002|Overall Study|Withdrawal the consent|5|||
125073728|NCT01576406|449886491|FG003|Overall Study|Withdrawal the consent|1|||
125073729|NCT01576406|449886492|FG004|Overall Study|Withdrawal the consent|1|||
125073730|NCT01576406|449886493|FG005|Overall Study|Withdrawal the consent|3|||
125073731|NCT01576406|449886488|FG000|Overall Study|Other|0|||
125073732|NCT01576406|449886489|FG001|Overall Study|Other|0|||
125073733|NCT01576406|449886490|FG002|Overall Study|Other|2|||
125073734|NCT01576406|449886491|FG003|Overall Study|Other|2|||
125073735|NCT01576406|449886492|FG004|Overall Study|Other|0|||
125073736|NCT01576406|449886493|FG005|Overall Study|Other|0|||
125073737|NCT01375647|449888828|FG000|Overall Study|Lost to Follow-up|3|||
125073738|NCT01375647|449888829|FG001|Overall Study|Lost to Follow-up|3|||
125073739|NCT01375647|449888830|FG002|Overall Study|Lost to Follow-up|7|||
125073740|NCT01375647|449888831|FG003|Overall Study|Lost to Follow-up|10|||
125073741|NCT01375647|449888828|FG000|Overall Study|Death|1|||
125073742|NCT01375647|449888829|FG001|Overall Study|Death|2|||
125073743|NCT01375647|449888830|FG002|Overall Study|Death|1|||
125073744|NCT01375647|449888831|FG003|Overall Study|Death|0|||
125073745|NCT01375647|449888828|FG000|Overall Study|Withdrawal by Subject|17|||
125073746|NCT01375647|449888829|FG001|Overall Study|Withdrawal by Subject|20|||
125073747|NCT01375647|449888830|FG002|Overall Study|Withdrawal by Subject|26|||
125073748|NCT01375647|449888831|FG003|Overall Study|Withdrawal by Subject|14|||
125073749|NCT01375647|449888828|FG000|Overall Study|Physician Decision|1|||
125073750|NCT01375647|449888829|FG001|Overall Study|Physician Decision|0|||
125073751|NCT01375647|449888830|FG002|Overall Study|Physician Decision|0|||
125073752|NCT01375647|449888831|FG003|Overall Study|Physician Decision|0|||
125073753|NCT03984812|449888834|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
125073754|NCT03984812|449888835|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
125073755|NCT03984812|449888836|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
125073756|NCT03984812|449888837|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
125073757|NCT03984812|449888838|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
125073758|NCT03984812|449888839|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
125073759|NCT03984812|449888840|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
125073760|NCT03984812|449888841|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
125073761|NCT03984812|449888842|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
125142035|NCT04573309|450144458|FG000|Overall Study|Protocol Violation|1|||
125142036|NCT04573309|450144459|FG001|Overall Study|Protocol Violation|0|||
125142037|NCT02300987|450144460|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
125142038|NCT02300987|450144461|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
125142039|NCT02300987|450144460|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
125142040|NCT02300987|450144461|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
125223157|NCT01827592|450444545|FG001|Overall Study|Protocol Violation|1|||
125223158|NCT01827592|450444546|FG002|Overall Study|Protocol Violation|0|||
125073762|NCT03984812|449888843|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
125073763|NCT03984812|449888844|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
125073764|NCT03424044|449888846|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
125073765|NCT03424044|449888847|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
125073766|NCT03424044|449888848|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
125073767|NCT03424044|449888849|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
125073768|NCT03424044|449888850|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
125073769|NCT03424044|449888851|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
125142041|NCT02300987|450144460|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
125142042|NCT02300987|450144461|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
125142043|NCT02300987|450144460|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
125073770|NCT03424044|449888852|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
125073771|NCT03424044|449888853|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
125073772|NCT03424044|449888854|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
125073773|NCT03424044|449888846|FG000|First Intervention (76 Hours)|Adverse Event|0|||
125073774|NCT03424044|449888847|FG001|First Intervention (76 Hours)|Adverse Event|0|||
125073775|NCT03424044|449888848|FG002|First Intervention (76 Hours)|Adverse Event|0|||
125073776|NCT03424044|449888849|FG003|First Intervention (76 Hours)|Adverse Event|0|||
125073777|NCT03424044|449888850|FG004|First Intervention (76 Hours)|Adverse Event|1|||
125073778|NCT03424044|449888851|FG005|First Intervention (76 Hours)|Adverse Event|0|||
125073779|NCT03424044|449888852|FG006|First Intervention (76 Hours)|Adverse Event|0|||
125073780|NCT03424044|449888853|FG007|First Intervention (76 Hours)|Adverse Event|0|||
125073781|NCT03424044|449888854|FG008|First Intervention (76 Hours)|Adverse Event|0|||
125073782|NCT03424044|449888846|FG000|First Intervention (76 Hours)|device issues|0|||
125073783|NCT03424044|449888847|FG001|First Intervention (76 Hours)|device issues|0|||
125073784|NCT03424044|449888848|FG002|First Intervention (76 Hours)|device issues|0|||
125073785|NCT03424044|449888849|FG003|First Intervention (76 Hours)|device issues|0|||
125073786|NCT03424044|449888850|FG004|First Intervention (76 Hours)|device issues|0|||
125073787|NCT03424044|449888851|FG005|First Intervention (76 Hours)|device issues|0|||
125073788|NCT03424044|449888852|FG006|First Intervention (76 Hours)|device issues|1|||
125073789|NCT03424044|449888853|FG007|First Intervention (76 Hours)|device issues|1|||
125073790|NCT03424044|449888854|FG008|First Intervention (76 Hours)|device issues|1|||
125073791|NCT03424044|449888846|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
125073792|NCT03424044|449888847|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
125073793|NCT03424044|449888848|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
125073794|NCT03424044|449888849|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
125073795|NCT03424044|449888850|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
125073796|NCT03424044|449888851|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
125073797|NCT03424044|449888852|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
125073798|NCT03424044|449888853|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
125073799|NCT03424044|449888854|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
125073800|NCT03424044|449888846|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
125073801|NCT03424044|449888847|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
125073802|NCT03424044|449888848|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
125073803|NCT03424044|449888849|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
125073804|NCT03424044|449888850|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
125073805|NCT03424044|449888851|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
125073806|NCT03424044|449888852|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
125073807|NCT03424044|449888853|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
125073808|NCT03424044|449888854|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
125073809|NCT02971007|449888855|FG000|Overall Study|Adverse Event|1|||
125073810|NCT02971007|449888856|FG001|Overall Study|Adverse Event|0|||
125073811|NCT02971007|449888857|FG002|Overall Study|Adverse Event|0|||
125073812|NCT02971007|449888855|FG000|Overall Study|Lost to Follow-up|0|||
125073813|NCT02971007|449888856|FG001|Overall Study|Lost to Follow-up|1|||
125073814|NCT02971007|449888857|FG002|Overall Study|Lost to Follow-up|1|||
125073815|NCT02971007|449888855|FG000|Overall Study|Withdrawal by Subject|0|||
125073816|NCT02971007|449888856|FG001|Overall Study|Withdrawal by Subject|1|||
125073817|NCT02971007|449888857|FG002|Overall Study|Withdrawal by Subject|0|||
125073818|NCT02971007|449888855|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
125073819|NCT02971007|449888856|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
125073820|NCT02971007|449888857|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
125073821|NCT02971007|449888855|FG000|Overall Study|Patient discontinued study drug|0|||
125142044|NCT02300987|450144461|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
125142045|NCT02300987|450144460|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
125142046|NCT02300987|450144461|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
125142047|NCT02488109|450144462|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
125142048|NCT02488109|450144463|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
125142049|NCT02488109|450144462|FG000|12-month Follow-Up|Lost to Follow-up|4|||
125142050|NCT02488109|450144463|FG001|12-month Follow-Up|Lost to Follow-up|7|||
125142051|NCT03969641|450144464|FG000|Overall Study|Lost to Follow-up|5|||
125142052|NCT03969641|450144465|FG001|Overall Study|Lost to Follow-up|3|||
125142053|NCT03969641|450144464|FG000|Overall Study|Withdrawal by Subject|1|||
125142054|NCT03969641|450144465|FG001|Overall Study|Withdrawal by Subject|2|||
125142055|NCT03969641|450144464|FG000|Overall Study|Found to be ineligible|1|||
125142056|NCT03969641|450144465|FG001|Overall Study|Found to be ineligible|1|||
125142057|NCT03969641|450144464|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
125073822|NCT02971007|449888856|FG001|Overall Study|Patient discontinued study drug|1|||
125073823|NCT02971007|449888857|FG002|Overall Study|Patient discontinued study drug|0|||
125073824|NCT00402285|449888860|FG000|Overall Study|insufficient RNA quality|7|||
125073825|NCT00402285|449888861|FG001|Overall Study|insufficient RNA quality|6|||
125073826|NCT00402285|449888862|FG002|Overall Study|insufficient RNA quality|2|||
125073827|NCT00784459|449888863|FG000|Overall Study|Adverse Event|0|||
125073828|NCT00784459|449888864|FG001|Overall Study|Adverse Event|2|||
125073829|NCT02707601|449888865|FG000|Overall Study|Death|0|||
125073830|NCT02707601|449888866|FG001|Overall Study|Death|1|||
125073831|NCT02707601|449888865|FG000|Overall Study|Lack of Efficacy|0|||
125073832|NCT02707601|449888866|FG001|Overall Study|Lack of Efficacy|1|||
125073833|NCT02707601|449888865|FG000|Overall Study|Investigator's Discretion|1|||
125073834|NCT02707601|449888866|FG001|Overall Study|Investigator's Discretion|0|||
125073835|NCT02707601|449888865|FG000|Overall Study|Withdrew Consent|0|||
125073836|NCT02707601|449888866|FG001|Overall Study|Withdrew Consent|1|||
125073837|NCT02707601|449888865|FG000|Overall Study|Lost to Follow-up|1|||
125073838|NCT02707601|449888866|FG001|Overall Study|Lost to Follow-up|1|||
125073839|NCT02707601|449888865|FG000|Overall Study|Participants Randomized but Not Treated|2|||
125073840|NCT02707601|449888866|FG001|Overall Study|Participants Randomized but Not Treated|0|||
125073841|NCT02009930|449888867|FG000|Overall Study|withdrawn|5|||
125073842|NCT02959970|449888869|FG000|Overall Study|Adverse Event|1|||
125073843|NCT02959970|449888870|FG001|Overall Study|Adverse Event|0|||
125073844|NCT02959970|449888869|FG000|Overall Study|Withdrawal by Subject|0|||
125073845|NCT02959970|449888870|FG001|Overall Study|Withdrawal by Subject|2|||
125073846|NCT02959970|449888869|FG000|Overall Study|Lost to Follow-up|1|||
125073847|NCT02959970|449888870|FG001|Overall Study|Lost to Follow-up|5|||
125073848|NCT00693420|449888871|FG000|Overall Study|Adverse Event|4|||
125073849|NCT00693420|449888872|FG001|Overall Study|Adverse Event|4|||
125073850|NCT00693420|449888871|FG000|Overall Study|Lost to Follow-up|0|||
125073851|NCT00693420|449888872|FG001|Overall Study|Lost to Follow-up|3|||
125073852|NCT00693420|449888871|FG000|Overall Study|Withdrawal by Subject|1|||
125073853|NCT00693420|449888872|FG001|Overall Study|Withdrawal by Subject|0|||
125073854|NCT00693420|449888871|FG000|Overall Study|Protocol Violation|0|||
125073855|NCT00693420|449888872|FG001|Overall Study|Protocol Violation|2|||
125073856|NCT00693420|449888871|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
125073857|NCT00693420|449888872|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
125073858|NCT00693420|449888871|FG000|Overall Study|Personal Reasons|1|||
125073859|NCT00693420|449888872|FG001|Overall Study|Personal Reasons|4|||
125073860|NCT00063986|449888880|FG000|Overall Study|Withdrawal by Subject|1|||
125073861|NCT00063986|449888880|FG000|Overall Study|Ineligible|1|||
125073862|NCT00063986|449888880|FG000|Overall Study|Intra-operatively ineligible|4|||
125073863|NCT01235338|449888881|FG000|Overall Study|Adverse Event|3|||
125073864|NCT01235338|449888882|FG001|Overall Study|Adverse Event|2|||
125073865|NCT01235338|449888881|FG000|Overall Study|Protocol Violation|1|||
125073866|NCT01235338|449888882|FG001|Overall Study|Protocol Violation|1|||
125073867|NCT01235338|449888881|FG000|Overall Study|Withdrawal by Subject|5|||
125073868|NCT01235338|449888882|FG001|Overall Study|Withdrawal by Subject|0|||
125073869|NCT01235338|449888881|FG000|Overall Study|Exclusion criteria violations|1|||
125073870|NCT01235338|449888882|FG001|Overall Study|Exclusion criteria violations|1|||
125073871|NCT01235338|449888881|FG000|Overall Study|Positive drug screen|0|||
125142058|NCT03969641|450144465|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
125073872|NCT01235338|449888882|FG001|Overall Study|Positive drug screen|1|||
125073873|NCT01235338|449888881|FG000|Overall Study|Prohibited meds|1|||
125073874|NCT01235338|449888882|FG001|Overall Study|Prohibited meds|0|||
125073875|NCT00509028|449888886|FG000|Overall Study|Adverse Event|2|||
125073876|NCT00509028|449888887|FG001|Overall Study|Adverse Event|0|||
125142059|NCT03969641|450144464|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
125142060|NCT03969641|450144465|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
125142061|NCT03969641|450144464|FG000|Overall Study|Elective termination|0|||
125142062|NCT03969641|450144465|FG001|Overall Study|Elective termination|1|||
125142063|NCT01541215|450144466|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
125142064|NCT01541215|450144467|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
125142065|NCT01541215|450144466|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
125142066|NCT01541215|450144467|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
125142067|NCT01541215|450144466|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
125142068|NCT01541215|450144467|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
125142069|NCT01541215|450144466|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
125142070|NCT01541215|450144467|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
125142071|NCT01541215|450144466|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
125142072|NCT01541215|450144467|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
125142073|NCT01541215|450144466|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
125142074|NCT01541215|450144467|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
125073877|NCT00509028|449888886|FG000|Overall Study|Withdrawal by Subject|4|||
125073878|NCT00509028|449888887|FG001|Overall Study|Withdrawal by Subject|3|||
125073879|NCT00509028|449888886|FG000|Overall Study|Lost to Follow-up|0|||
125073880|NCT00509028|449888887|FG001|Overall Study|Lost to Follow-up|1|||
125073881|NCT00509028|449888886|FG000|Overall Study|Protocol Violation|4|||
125073882|NCT00509028|449888887|FG001|Overall Study|Protocol Violation|2|||
125073883|NCT00509028|449888886|FG000|Overall Study|Non-compliance|2|||
125073884|NCT00509028|449888887|FG001|Overall Study|Non-compliance|1|||
125073885|NCT00948428|449888888|FG000|Overall Study|Withdrawal by Subject|6|||
125073886|NCT00948428|449888889|FG001|Overall Study|Withdrawal by Subject|12|||
125073887|NCT00948428|449888890|FG002|Overall Study|Withdrawal by Subject|7|||
125073888|NCT00948428|449888888|FG000|Overall Study|Adverse Event|6|||
125073889|NCT00948428|449888889|FG001|Overall Study|Adverse Event|3|||
125073890|NCT00948428|449888890|FG002|Overall Study|Adverse Event|0|||
125073891|NCT00948428|449888888|FG000|Overall Study|Lost to Follow-up|2|||
125073892|NCT00948428|449888889|FG001|Overall Study|Lost to Follow-up|1|||
125073893|NCT00948428|449888890|FG002|Overall Study|Lost to Follow-up|1|||
125073894|NCT00948428|449888888|FG000|Overall Study|Death|2|||
125073895|NCT00948428|449888889|FG001|Overall Study|Death|0|||
125073896|NCT00948428|449888890|FG002|Overall Study|Death|0|||
125073897|NCT00948428|449888888|FG000|Overall Study|Intercurrent Illness|1|||
125073898|NCT00948428|449888889|FG001|Overall Study|Intercurrent Illness|0|||
125073899|NCT00948428|449888890|FG002|Overall Study|Intercurrent Illness|0|||
125073900|NCT00948428|449888888|FG000|Overall Study|Non-compliance|1|||
125073901|NCT00948428|449888889|FG001|Overall Study|Non-compliance|2|||
125073902|NCT00948428|449888890|FG002|Overall Study|Non-compliance|0|||
125073903|NCT04839393|449888894|FG000|Overall Study|Adverse Event|0|||
125073904|NCT04839393|449888895|FG001|Overall Study|Adverse Event|0|||
125073905|NCT04839393|449888896|FG002|Overall Study|Adverse Event|2|||
125073906|NCT04839393|449888894|FG000|Overall Study|Withdrawal by participant|0|||
125073907|NCT04839393|449888895|FG001|Overall Study|Withdrawal by participant|0|||
125073908|NCT04839393|449888896|FG002|Overall Study|Withdrawal by participant|1|||
125073909|NCT00633893|449888899|FG000|Overall Study|Death|1|||
125073910|NCT00633893|449888900|FG001|Overall Study|Death|3|||
125073911|NCT00633893|449888901|FG002|Overall Study|Death|9|||
125073912|NCT00633893|449888899|FG000|Overall Study|Adverse Event|65|||
125073913|NCT00633893|449888900|FG001|Overall Study|Adverse Event|58|||
125073914|NCT00633893|449888901|FG002|Overall Study|Adverse Event|126|||
125073915|NCT00633893|449888899|FG000|Overall Study|Withdrawal by Subject|7|||
125073916|NCT00633893|449888900|FG001|Overall Study|Withdrawal by Subject|12|||
125073917|NCT00633893|449888901|FG002|Overall Study|Withdrawal by Subject|6|||
125073918|NCT00633893|449888899|FG000|Overall Study|Lost to Follow-up|2|||
125073919|NCT00633893|449888900|FG001|Overall Study|Lost to Follow-up|4|||
125073920|NCT00633893|449888901|FG002|Overall Study|Lost to Follow-up|8|||
125073921|NCT00633893|449888899|FG000|Overall Study|Poor/non-compliance|5|||
125073922|NCT00633893|449888900|FG001|Overall Study|Poor/non-compliance|12|||
125073923|NCT00633893|449888901|FG002|Overall Study|Poor/non-compliance|3|||
125073924|NCT00633893|449888899|FG000|Overall Study|Pregnancy|2|||
125073925|NCT00633893|449888900|FG001|Overall Study|Pregnancy|1|||
125073926|NCT00633893|449888901|FG002|Overall Study|Pregnancy|1|||
125073927|NCT00633893|449888899|FG000|Overall Study|Not meet/no longer meets criteria|4|||
125073928|NCT00633893|449888900|FG001|Overall Study|Not meet/no longer meets criteria|6|||
125073929|NCT00633893|449888901|FG002|Overall Study|Not meet/no longer meets criteria|4|||
125073930|NCT00633893|449888899|FG000|Overall Study|Other|28|||
125073931|NCT00633893|449888900|FG001|Overall Study|Other|33|||
125073932|NCT00633893|449888901|FG002|Overall Study|Other|31|||
125073933|NCT02741310|449888902|FG000|Overall Study|Sponsor Decision|2|||
125073934|NCT02741310|449888903|FG001|Overall Study|Sponsor Decision|2|||
125073935|NCT05091918|449888904|FG000|Overall Study|Adverse Event|1|||
125073936|NCT05091918|449888904|FG000|Overall Study|Withdrawal by Subject|81|||
125073937|NCT00239356|449888905|FG000|Overall Study|Lack of Efficacy|1|||
125073938|NCT00239356|449888906|FG001|Overall Study|Lack of Efficacy|0|||
125073939|NCT00239356|449888905|FG000|Overall Study|Adverse Event|6|||
125073940|NCT00239356|449888906|FG001|Overall Study|Adverse Event|0|||
125073941|NCT00239356|449888905|FG000|Overall Study|Withdrawal by Subject|15|||
125073942|NCT00239356|449888906|FG001|Overall Study|Withdrawal by Subject|6|||
125073943|NCT00239356|449888905|FG000|Overall Study|Lost to Follow-up|3|||
125073944|NCT00239356|449888906|FG001|Overall Study|Lost to Follow-up|0|||
125073945|NCT00239356|449888905|FG000|Overall Study|poor/non-compliance|2|||
125073946|NCT00239356|449888906|FG001|Overall Study|poor/non-compliance|0|||
125073947|NCT00239356|449888905|FG000|Overall Study|Pregnancy|1|||
125142075|NCT02658019|450144476|FG000|Overall Study|Adverse Event|1|||
125142076|NCT00820599|450144477|FG000|Overall Study|Death|129|||
125142077|NCT00820599|450144477|FG000|Overall Study|Withdrawal by Subject|2|||
125142078|NCT01098851|450144478|FG000|Overall Study|Equipment failure|1|||
125142079|NCT01098851|450144479|FG001|Overall Study|Equipment failure|0|||
125142080|NCT00452348|450144481|FG000|Overall Study|Adverse Event|6|||
125073948|NCT00239356|449888906|FG001|Overall Study|Pregnancy|0|||
125073949|NCT00239356|449888905|FG000|Overall Study|Administrative reason|0|||
125073950|NCT00239356|449888906|FG001|Overall Study|Administrative reason|1|||
125073951|NCT00239356|449888905|FG000|Overall Study|Drug available on market|11|||
125073952|NCT00239356|449888906|FG001|Overall Study|Drug available on market|2|||
125073953|NCT02044822|449888907|FG000|Overall Study|Study Terminated by Sponsor|77|||
125073954|NCT02044822|449888907|FG000|Overall Study|Investigator's Discretion|10|||
125073955|NCT02044822|449888907|FG000|Overall Study|Withdrew Consent|3|||
125073956|NCT02044822|449888907|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
125073957|NCT02044822|449888907|FG000|Overall Study|Lost to Follow-up|1|||
125073958|NCT03417505|449888910|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
125073959|NCT03417505|449888911|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
125073960|NCT02432703|449888912|FG000|Overall Study|Adverse Event|1|||
125073961|NCT02432703|449888913|FG001|Overall Study|Adverse Event|4|||
125073962|NCT02432703|449888912|FG000|Overall Study|Lack of Efficacy|1|||
125073963|NCT02432703|449888913|FG001|Overall Study|Lack of Efficacy|0|||
125073964|NCT02432703|449888912|FG000|Overall Study|Lost to Follow-up|5|||
125073965|NCT02432703|449888913|FG001|Overall Study|Lost to Follow-up|3|||
125073966|NCT02432703|449888912|FG000|Overall Study|Withdrawal by Subject|9|||
125073967|NCT02432703|449888913|FG001|Overall Study|Withdrawal by Subject|6|||
125073968|NCT02432703|449888912|FG000|Overall Study|Other|6|||
125073969|NCT02432703|449888913|FG001|Overall Study|Other|5|||
125073970|NCT00653328|449888914|FG000|Overall Study|Withdrawal by Subject|1|||
125073971|NCT00653328|449888914|FG000|Overall Study|Adverse Event|2|||
125073972|NCT00653328|449888914|FG000|Overall Study|Disease progression|10|||
125073973|NCT00653328|449888914|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
125073974|NCT03051217|449888915|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
125073975|NCT03051217|449888916|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125073976|NCT03051217|449888917|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
125073977|NCT03051217|449888918|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125073978|NCT03051217|449888919|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125073979|NCT03051217|449888920|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125073980|NCT03051217|449888921|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125073981|NCT03051217|449888915|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
125073982|NCT03051217|449888916|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
125073983|NCT03051217|449888917|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
125073984|NCT03051217|449888918|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
125073985|NCT03051217|449888919|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
125073986|NCT03051217|449888920|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
125073987|NCT03051217|449888921|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
125073988|NCT03051217|449888915|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
125073989|NCT03051217|449888916|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
125073990|NCT03051217|449888917|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
125073991|NCT03051217|449888918|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125073992|NCT03051217|449888919|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125073993|NCT03051217|449888920|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125073994|NCT03051217|449888921|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125073995|NCT03051217|449888915|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
125073996|NCT03051217|449888916|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
125073997|NCT03051217|449888917|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
125073998|NCT03051217|449888918|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
125073999|NCT03051217|449888919|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
125074000|NCT03051217|449888920|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
125074001|NCT03051217|449888921|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
125074002|NCT03051217|449888915|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
125074003|NCT03051217|449888916|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
125074004|NCT03051217|449888917|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
125074005|NCT03051217|449888918|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
125074006|NCT03051217|449888919|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
125074007|NCT03051217|449888920|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
125142081|NCT00452348|450144482|FG001|Overall Study|Adverse Event|9|||
125142082|NCT00452348|450144481|FG000|Overall Study|Lack of Efficacy|10|||
125142083|NCT00452348|450144482|FG001|Overall Study|Lack of Efficacy|9|||
125142084|NCT00452348|450144481|FG000|Overall Study|Lost to Follow-up|14|||
125142085|NCT00452348|450144482|FG001|Overall Study|Lost to Follow-up|8|||
125074008|NCT03051217|449888921|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
125074009|NCT03051217|449888915|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
125142086|NCT00452348|450144481|FG000|Overall Study|Protocol Violation|22|||
125074010|NCT03051217|449888916|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
125074011|NCT03051217|449888917|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
125074012|NCT03051217|449888918|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
125142087|NCT00452348|450144482|FG001|Overall Study|Protocol Violation|28|||
125142088|NCT00452348|450144481|FG000|Overall Study|Withdrawal by Subject|18|||
125142089|NCT00452348|450144482|FG001|Overall Study|Withdrawal by Subject|21|||
125074013|NCT03051217|449888919|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
125074014|NCT03051217|449888920|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
125074015|NCT03051217|449888921|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
125074016|NCT03051217|449888915|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
125074017|NCT03051217|449888916|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
125074018|NCT03051217|449888917|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
125074019|NCT03051217|449888918|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
125074020|NCT03051217|449888919|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
125074021|NCT03051217|449888920|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
125074022|NCT03051217|449888921|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
125074023|NCT03051217|449888915|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
125074024|NCT03051217|449888916|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
125074025|NCT03051217|449888917|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
125074026|NCT03051217|449888918|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
125074027|NCT03051217|449888919|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
125074028|NCT03051217|449888920|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
125074029|NCT03051217|449888921|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
125074030|NCT00109772|449888922|FG000|Double-blind Treatment|Adverse Event|14|||
125074031|NCT00109772|449888923|FG001|Double-blind Treatment|Adverse Event|5|||
125074032|NCT00109772|449888922|FG000|Double-blind Treatment|Lack of Efficacy|1|||
125074033|NCT00109772|449888923|FG001|Double-blind Treatment|Lack of Efficacy|0|||
125074034|NCT00109772|449888922|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
125074035|NCT00109772|449888923|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
125074036|NCT00109772|449888922|FG000|Double-blind Treatment|Lost to Follow-up|2|||
125074037|NCT00109772|449888923|FG001|Double-blind Treatment|Lost to Follow-up|3|||
125074038|NCT00109772|449888922|FG000|Double-blind Treatment|Protocol Violation|0|||
125074039|NCT00109772|449888923|FG001|Double-blind Treatment|Protocol Violation|1|||
125074040|NCT00109772|449888922|FG000|Double-blind Treatment|Other|0|||
125074041|NCT00109772|449888923|FG001|Double-blind Treatment|Other|4|||
125074042|NCT00109772|449888922|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
125074043|NCT00109772|449888923|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
125074044|NCT00109772|449888922|FG000|Open-label Extension|Adverse Event|10|||
125074045|NCT00109772|449888923|FG001|Open-label Extension|Adverse Event|19|||
125074046|NCT00109772|449888922|FG000|Open-label Extension|Lack of Efficacy|19|||
125074047|NCT00109772|449888923|FG001|Open-label Extension|Lack of Efficacy|11|||
125074048|NCT00109772|449888922|FG000|Open-label Extension|Withdrawal by Subject|9|||
125074049|NCT00109772|449888923|FG001|Open-label Extension|Withdrawal by Subject|6|||
125074050|NCT00109772|449888922|FG000|Open-label Extension|Lost to Follow-up|1|||
125074051|NCT00109772|449888923|FG001|Open-label Extension|Lost to Follow-up|0|||
125074052|NCT00109772|449888922|FG000|Open-label Extension|Death|0|||
125074053|NCT00109772|449888923|FG001|Open-label Extension|Death|1|||
125074054|NCT00109772|449888922|FG000|Open-label Extension|Protocol Violation|2|||
125074055|NCT00109772|449888923|FG001|Open-label Extension|Protocol Violation|2|||
125074056|NCT00109772|449888922|FG000|Open-label Extension|Other|4|||
125074057|NCT00109772|449888923|FG001|Open-label Extension|Other|10|||
125074058|NCT01359046|449888926|FG000|Overall Study|Did not receive allocated intervention|6|||
125074059|NCT01359046|449888927|FG001|Overall Study|Did not receive allocated intervention|6|||
125074060|NCT01359046|449888926|FG000|Overall Study|Physician Decision|1|||
125074061|NCT01359046|449888927|FG001|Overall Study|Physician Decision|11|||
125074062|NCT04539262|449888928|FG000|Overall Study|Adverse Event|0|||
125074063|NCT04539262|449888929|FG001|Overall Study|Adverse Event|0|||
125074064|NCT04539262|449888930|FG002|Overall Study|Adverse Event|1|||
125074065|NCT04539262|449888931|FG003|Overall Study|Adverse Event|0|||
125074066|NCT04539262|449888932|FG004|Overall Study|Adverse Event|0|||
125074067|NCT04539262|449888933|FG005|Overall Study|Adverse Event|0|||
125074068|NCT04539262|449888934|FG006|Overall Study|Adverse Event|0|||
125074069|NCT04539262|449888935|FG007|Overall Study|Adverse Event|0|||
125074070|NCT04539262|449888928|FG000|Overall Study|Withdrew Consent|0|||
125074071|NCT04539262|449888929|FG001|Overall Study|Withdrew Consent|0|||
125074072|NCT04539262|449888930|FG002|Overall Study|Withdrew Consent|0|||
125074073|NCT04539262|449888931|FG003|Overall Study|Withdrew Consent|1|||
125074074|NCT04539262|449888932|FG004|Overall Study|Withdrew Consent|0|||
125074075|NCT04539262|449888933|FG005|Overall Study|Withdrew Consent|0|||
125074076|NCT04539262|449888934|FG006|Overall Study|Withdrew Consent|0|||
125142090|NCT00452348|450144481|FG000|Overall Study|Other|9|||
125142091|NCT00452348|450144482|FG001|Overall Study|Other|9|||
125142092|NCT00960154|450144483|FG000|Overall Study|Study termination|25|||
125142093|NCT00960154|450144484|FG001|Overall Study|Study termination|25|||
125142094|NCT00486434|450144485|FG000|Overall Study|Withdrawal by Subject|34|||
125142095|NCT00486434|450144486|FG001|Overall Study|Withdrawal by Subject|39|||
125142096|NCT00486434|450144485|FG000|Overall Study|Adverse Event|118|||
125142097|NCT00486434|450144486|FG001|Overall Study|Adverse Event|44|||
125142098|NCT00486434|450144485|FG000|Overall Study|Protocol Violation|22|||
125142099|NCT00486434|450144486|FG001|Overall Study|Protocol Violation|21|||
125142100|NCT00486434|450144485|FG000|Overall Study|Lack of Efficacy|12|||
125142101|NCT00486434|450144486|FG001|Overall Study|Lack of Efficacy|19|||
125142102|NCT00486434|450144485|FG000|Overall Study|Lost to Follow-up|2|||
125142103|NCT00486434|450144486|FG001|Overall Study|Lost to Follow-up|3|||
125142104|NCT00486434|450144485|FG000|Overall Study|Death|1|||
125142105|NCT00486434|450144486|FG001|Overall Study|Death|2|||
125142106|NCT00486434|450144485|FG000|Overall Study|Personal reasons|5|||
125142107|NCT00486434|450144486|FG001|Overall Study|Personal reasons|6|||
125142108|NCT00544167|450144487|FG000|Overall Study|Adverse Event|21|||
125142109|NCT00544167|450144487|FG000|Overall Study|Physician Decision|8|||
125142110|NCT02725515|450144488|FG000|Overall Study|Refused infusion (no study treatment)|1|||
125142111|NCT02725515|450144489|FG001|Overall Study|Refused infusion (no study treatment)|0|||
125142112|NCT02725515|450144488|FG000|Overall Study|Loss of Improvement per Protocol|14|||
125142113|NCT02725515|450144489|FG001|Overall Study|Loss of Improvement per Protocol|25|||
125074077|NCT04539262|449888935|FG007|Overall Study|Withdrew Consent|0|||
125074078|NCT04539262|449888928|FG000|Overall Study|Randomized, Not treated|0|||
125074079|NCT04539262|449888929|FG001|Overall Study|Randomized, Not treated|1|||
125074080|NCT04539262|449888930|FG002|Overall Study|Randomized, Not treated|0|||
125074081|NCT04539262|449888931|FG003|Overall Study|Randomized, Not treated|0|||
125074082|NCT04539262|449888932|FG004|Overall Study|Randomized, Not treated|0|||
125074083|NCT04539262|449888933|FG005|Overall Study|Randomized, Not treated|0|||
125074084|NCT04539262|449888934|FG006|Overall Study|Randomized, Not treated|1|||
125074085|NCT04539262|449888935|FG007|Overall Study|Randomized, Not treated|0|||
125074086|NCT03725293|449888938|FG000|Overall Study|Physician Decision|9|||
125074087|NCT03725293|449888939|FG001|Overall Study|Physician Decision|6|||
125074088|NCT03725293|449888938|FG000|Overall Study|alternative vascular access needs|1|||
125074089|NCT03725293|449888939|FG001|Overall Study|alternative vascular access needs|2|||
125074090|NCT03725293|449888938|FG000|Overall Study|venous anatomy screen failures|2|||
125074091|NCT03725293|449888939|FG001|Overall Study|venous anatomy screen failures|1|||
125074092|NCT04397796|449888944|FG000|Overall Study|Death|3|||
125074093|NCT04397796|449888945|FG001|Overall Study|Death|1|||
125074094|NCT00802867|449888946|FG000|Overall Study|Lost to Follow-up|6|||
125074095|NCT00802867|449888946|FG000|Overall Study|Protocol Violation|6|||
125074096|NCT00802867|449888946|FG000|Overall Study|Withdrawal by Subject|1|||
125074097|NCT01061567|449888947|FG000|Overall Study|Adverse Event|32|||
125074098|NCT01061567|449888947|FG000|Overall Study|Death|2|||
125074099|NCT01061567|449888947|FG000|Overall Study|Lack of Efficacy|3|||
125074100|NCT01061567|449888947|FG000|Overall Study|Lost to Follow-up|24|||
125074101|NCT01061567|449888947|FG000|Overall Study|Protocol Violation|1|||
125074102|NCT01061567|449888947|FG000|Overall Study|Withdrawal by Subject|11|||
125074103|NCT01061567|449888947|FG000|Overall Study|Other reason than stated above|3|||
125074104|NCT01156532|449888954|FG000|Overall Study|Family Reasons|1|||
125074105|NCT01156532|449888954|FG000|Overall Study|Lost to Follow-up|1|||
125074106|NCT01484561|449888955|FG000|Overall Study|Lack of Efficacy|3|||
125074107|NCT01484561|449888956|FG001|Overall Study|Lack of Efficacy|1|||
125074108|NCT01484561|449888955|FG000|Overall Study|Lost to Follow-up|1|||
125074109|NCT01484561|449888956|FG001|Overall Study|Lost to Follow-up|0|||
125074110|NCT01484561|449888955|FG000|Overall Study|Withdrawal by Subject|3|||
125074111|NCT01484561|449888956|FG001|Overall Study|Withdrawal by Subject|0|||
125142114|NCT02725515|450144488|FG000|Overall Study|Withdrawal by Subject|2|||
125142115|NCT02725515|450144489|FG001|Overall Study|Withdrawal by Subject|1|||
125142116|NCT02725515|450144488|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125074112|NCT01484561|449888955|FG000|Overall Study|Other|1|||
125074113|NCT01484561|449888956|FG001|Overall Study|Other|1|||
125074114|NCT01484561|449888955|FG000|Overall Study|Adverse Event|1|||
125074115|NCT01484561|449888956|FG001|Overall Study|Adverse Event|4|||
125074116|NCT03371251|449888957|FG000|Overall Study|Withdrawal by Subject|1|||
125074117|NCT03371251|449888958|FG001|Overall Study|Withdrawal by Subject|0|||
125074118|NCT03371251|449888959|FG002|Overall Study|Withdrawal by Subject|1|||
125074119|NCT03371251|449888960|FG003|Overall Study|Withdrawal by Subject|0|||
125142117|NCT02725515|450144489|FG001|Overall Study|Non-Compliance With Study Drug|3|||
125142118|NCT02725515|450144488|FG000|Overall Study|Lost to Follow-up|1|||
125142119|NCT02725515|450144489|FG001|Overall Study|Lost to Follow-up|1|||
125142120|NCT02725515|450144488|FG000|Overall Study|Adverse Event|7|||
125074120|NCT03371251|449888961|FG004|Overall Study|Withdrawal by Subject|2|||
125142121|NCT02725515|450144489|FG001|Overall Study|Adverse Event|2|||
125142122|NCT02725515|450144488|FG000|Overall Study|No Documented Disease Improvement|0|||
125142123|NCT02725515|450144489|FG001|Overall Study|No Documented Disease Improvement|1|||
125223159|NCT01827592|450444544|FG000|Overall Study|Lost to Follow-up|1|||
125223160|NCT01827592|450444545|FG001|Overall Study|Lost to Follow-up|2|||
125223161|NCT01827592|450444546|FG002|Overall Study|Lost to Follow-up|2|||
125223162|NCT01827592|450444544|FG000|Overall Study|Withdrawal by Subject|12|||
125074121|NCT03371251|449888962|FG005|Overall Study|Withdrawal by Subject|2|||
125074122|NCT03371251|449888957|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
125074123|NCT03371251|449888958|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
125074124|NCT03371251|449888959|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
125074125|NCT03371251|449888960|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
125074126|NCT03371251|449888961|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
125074127|NCT03371251|449888962|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
125074128|NCT03371251|449888957|FG000|Overall Study|Adverse Event|0|||
125074129|NCT03371251|449888958|FG001|Overall Study|Adverse Event|0|||
125074130|NCT03371251|449888959|FG002|Overall Study|Adverse Event|0|||
125074131|NCT03371251|449888960|FG003|Overall Study|Adverse Event|0|||
125074132|NCT03371251|449888961|FG004|Overall Study|Adverse Event|1|||
125074133|NCT03371251|449888962|FG005|Overall Study|Adverse Event|0|||
125074134|NCT03371251|449888957|FG000|Overall Study|Decision by Sponsor|0|||
125074135|NCT03371251|449888958|FG001|Overall Study|Decision by Sponsor|0|||
125074136|NCT03371251|449888959|FG002|Overall Study|Decision by Sponsor|0|||
125074137|NCT03371251|449888960|FG003|Overall Study|Decision by Sponsor|0|||
125074138|NCT03371251|449888961|FG004|Overall Study|Decision by Sponsor|2|||
125074139|NCT03371251|449888962|FG005|Overall Study|Decision by Sponsor|0|||
125074140|NCT00114218|449888963|FG000|Overall Study|Wrong Cell Type|2|||
125074141|NCT00114218|449888963|FG000|Overall Study|Wrong Primary|1|||
125074142|NCT00114218|449888963|FG000|Overall Study|Never Treated|1|||
125074143|NCT00291187|449888964|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
125074144|NCT00291187|449888965|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
125074145|NCT00291187|449888966|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
125074146|NCT00291187|449888967|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
125074147|NCT03168555|449888969|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
125074148|NCT03168555|449888969|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
125074149|NCT03168555|449888969|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
125074150|NCT03168555|449888969|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
125074151|NCT01040845|449888970|FG000|Overall Study|Withdrawal by Subject|1|||
125074152|NCT01040845|449888971|FG001|Overall Study|Withdrawal by Subject|1|||
125074153|NCT01040845|449888970|FG000|Overall Study|Physician Decision|1|||
125074154|NCT01040845|449888971|FG001|Overall Study|Physician Decision|0|||
125074155|NCT02708966|449888975|FG000|Overall Study|Lost to Follow-up|2|||
125074156|NCT02708966|449888976|FG001|Overall Study|Lost to Follow-up|2|||
125074157|NCT02959190|449888980|FG000|Open Label|Adverse Event|5|||
125074158|NCT02959190|449888981|FG001|Open Label|Adverse Event|7|||
125074159|NCT02959190|449888982|FG002|Open Label|Adverse Event|3|||
125074160|NCT02959190|449888983|FG003|Open Label|Adverse Event|4|||
125074161|NCT02959190|449888980|FG000|Open Label|Pregnancy|0|||
125074162|NCT02959190|449888981|FG001|Open Label|Pregnancy|1|||
125074163|NCT02959190|449888982|FG002|Open Label|Pregnancy|0|||
125074164|NCT02959190|449888983|FG003|Open Label|Pregnancy|0|||
125074165|NCT02959190|449888980|FG000|Open Label|Withdrawal by Subject|2|||
125074166|NCT02959190|449888981|FG001|Open Label|Withdrawal by Subject|8|||
125074167|NCT02959190|449888982|FG002|Open Label|Withdrawal by Subject|0|||
125074168|NCT02959190|449888983|FG003|Open Label|Withdrawal by Subject|0|||
125074169|NCT02959190|449888980|FG000|Open Label|Physician Decision|0|||
125074170|NCT02959190|449888981|FG001|Open Label|Physician Decision|0|||
125074171|NCT02959190|449888982|FG002|Open Label|Physician Decision|1|||
125074172|NCT02959190|449888983|FG003|Open Label|Physician Decision|0|||
125074173|NCT02959190|449888980|FG000|Open Label|Protocol Violation|0|||
125074174|NCT02959190|449888981|FG001|Open Label|Protocol Violation|0|||
125074175|NCT02959190|449888982|FG002|Open Label|Protocol Violation|0|||
125074176|NCT02959190|449888983|FG003|Open Label|Protocol Violation|2|||
125074177|NCT02959190|449888980|FG000|Post Treatment Follow Up|Adverse Event|1|||
125074178|NCT02959190|449888981|FG001|Post Treatment Follow Up|Adverse Event|1|||
125074179|NCT02959190|449888982|FG002|Post Treatment Follow Up|Adverse Event|0|||
125074180|NCT02959190|449888983|FG003|Post Treatment Follow Up|Adverse Event|0|||
125074181|NCT02959190|449888980|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
125074182|NCT02959190|449888981|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
125074183|NCT02959190|449888982|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
125074184|NCT02959190|449888983|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
125074185|NCT02023268|449888984|FG000|Overall Study|Lack of Efficacy|0|||
125074186|NCT02023268|449888985|FG001|Overall Study|Lack of Efficacy|1|||
125223163|NCT01827592|450444545|FG001|Overall Study|Withdrawal by Subject|11|||
125223164|NCT01827592|450444546|FG002|Overall Study|Withdrawal by Subject|11|||
125074187|NCT02023268|449888984|FG000|Overall Study|Adverse Event|0|||
125074188|NCT02023268|449888985|FG001|Overall Study|Adverse Event|2|||
125223165|NCT01827592|450444544|FG000|Overall Study|Patient's substantial non-compliance|1|||
125074189|NCT02023268|449888984|FG000|Overall Study|Withdrawal by Subject|0|||
125074190|NCT02023268|449888985|FG001|Overall Study|Withdrawal by Subject|1|||
125074191|NCT04445688|449888986|FG000|Washout (One Week)|Adverse Event|2|||
125074192|NCT04445688|449888986|FG000|Washout (One Week)|Withdrawal by Subject|1|||
125074193|NCT01142193|449888995|FG000|Overall Study|Adverse Event|12|||
125074194|NCT01142193|449888996|FG001|Overall Study|Adverse Event|4|||
125074195|NCT01142193|449888995|FG000|Overall Study|Lack of Efficacy|2|||
125074196|NCT01142193|449888996|FG001|Overall Study|Lack of Efficacy|1|||
125074197|NCT01142193|449888995|FG000|Overall Study|Physician Decision|1|||
125074198|NCT01142193|449888996|FG001|Overall Study|Physician Decision|1|||
125074199|NCT01142193|449888995|FG000|Overall Study|Withdrawal by Subject|4|||
125074200|NCT01142193|449888996|FG001|Overall Study|Withdrawal by Subject|3|||
125074201|NCT01142193|449888995|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
125074202|NCT01142193|449888996|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
125074203|NCT01142193|449888995|FG000|Overall Study|Other|1|||
125074204|NCT01142193|449888996|FG001|Overall Study|Other|2|||
125074205|NCT00970268|449888997|FG000|Overall Study|Withdrawal by Subject|12|||
125074206|NCT00970268|449888998|FG001|Overall Study|Withdrawal by Subject|19|||
125074207|NCT00970268|449888997|FG000|Overall Study|Adverse Event|15|||
125074208|NCT00970268|449888998|FG001|Overall Study|Adverse Event|12|||
125074209|NCT00970268|449888997|FG000|Overall Study|Lack of Efficacy|3|||
125074210|NCT00970268|449888998|FG001|Overall Study|Lack of Efficacy|6|||
125074211|NCT00970268|449888997|FG000|Overall Study|Protocol Violation|4|||
125074212|NCT00970268|449888998|FG001|Overall Study|Protocol Violation|7|||
125074213|NCT00970268|449888997|FG000|Overall Study|Other Reason|3|||
125074214|NCT00970268|449888998|FG001|Overall Study|Other Reason|1|||
125074215|NCT00970268|449888997|FG000|Overall Study|COPD Exacerbation|4|||
125074216|NCT00970268|449888998|FG001|Overall Study|COPD Exacerbation|2|||
125074217|NCT00970268|449888997|FG000|Overall Study|Lost to Follow-up|1|||
125074218|NCT00970268|449888998|FG001|Overall Study|Lost to Follow-up|2|||
125074219|NCT00970268|449888997|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
125074220|NCT00970268|449888998|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
125074221|NCT00383708|449888999|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
125074222|NCT00383708|449888999|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
125074223|NCT00383708|449888999|FG000|Run-in Period|Protocol Violation|4|||
125074224|NCT00383708|449888999|FG000|Run-in Period|Adverse Event|2|||
125074225|NCT00383708|449888999|FG000|Run-in Period|Claustrophobia|1|||
125074226|NCT00383708|449888999|FG000|Co-administration Period|Adverse Event|5|||
125074227|NCT00318370|449889000|FG000|Period 1|Lack of Efficacy|5|||
125074228|NCT00318370|449889001|FG001|Period 1|Lack of Efficacy|0|||
125074229|NCT00318370|449889002|FG002|Period 1|Lack of Efficacy|0|||
125074230|NCT00318370|449889000|FG000|Period 1|Physician Decision|1|||
125074231|NCT00318370|449889001|FG001|Period 1|Physician Decision|0|||
125074232|NCT00318370|449889002|FG002|Period 1|Physician Decision|0|||
125074233|NCT00318370|449889000|FG000|Period 1|Withdrawal by Subject|1|||
125074234|NCT00318370|449889001|FG001|Period 1|Withdrawal by Subject|0|||
125074235|NCT00318370|449889002|FG002|Period 1|Withdrawal by Subject|0|||
125074236|NCT00318370|449889000|FG000|Period 2|Adverse Event|0|||
125074237|NCT00318370|449889001|FG001|Period 2|Adverse Event|3|||
125074238|NCT00318370|449889002|FG002|Period 2|Adverse Event|0|||
125074239|NCT00318370|449889000|FG000|Period 2|Lack of Efficacy|0|||
125074240|NCT00318370|449889001|FG001|Period 2|Lack of Efficacy|5|||
125074241|NCT00318370|449889002|FG002|Period 2|Lack of Efficacy|0|||
125074242|NCT00318370|449889000|FG000|Period 2|Physician Decision|0|||
125074243|NCT00318370|449889001|FG001|Period 2|Physician Decision|1|||
125074244|NCT00318370|449889002|FG002|Period 2|Physician Decision|0|||
125074245|NCT00318370|449889000|FG000|Period 2|Withdrawal by Subject|0|||
125074246|NCT00318370|449889001|FG001|Period 2|Withdrawal by Subject|1|||
125223166|NCT01827592|450444545|FG001|Overall Study|Patient's substantial non-compliance|1|||
125074247|NCT00318370|449889002|FG002|Period 2|Withdrawal by Subject|0|||
125074248|NCT00318370|449889000|FG000|Period 2|Other|0|||
125074249|NCT00318370|449889001|FG001|Period 2|Other|1|||
125074250|NCT00318370|449889002|FG002|Period 2|Other|0|||
125074251|NCT00318370|449889000|FG000|Period 3|Adverse Event|0|||
125074252|NCT00318370|449889001|FG001|Period 3|Adverse Event|0|||
125074253|NCT00318370|449889002|FG002|Period 3|Adverse Event|1|||
125074254|NCT00318370|449889000|FG000|Period 3|Lack of Efficacy|0|||
125074255|NCT00318370|449889001|FG001|Period 3|Lack of Efficacy|0|||
125074256|NCT00318370|449889002|FG002|Period 3|Lack of Efficacy|24|||
125074257|NCT00318370|449889000|FG000|Period 3|Death|0|||
125074258|NCT00318370|449889001|FG001|Period 3|Death|0|||
125074259|NCT00318370|449889002|FG002|Period 3|Death|1|||
125074260|NCT00318370|449889000|FG000|Period 3|Physician Decision|0|||
125074261|NCT00318370|449889001|FG001|Period 3|Physician Decision|0|||
125074262|NCT00318370|449889002|FG002|Period 3|Physician Decision|1|||
125074263|NCT00318370|449889000|FG000|Period 3|Withdrawal by Subject|0|||
125074264|NCT00318370|449889001|FG001|Period 3|Withdrawal by Subject|0|||
125074265|NCT00318370|449889002|FG002|Period 3|Withdrawal by Subject|3|||
125074266|NCT00318370|449889000|FG000|Period 3|Other|0|||
125074267|NCT00318370|449889001|FG001|Period 3|Other|0|||
125074268|NCT00318370|449889002|FG002|Period 3|Other|3|||
125074269|NCT01750840|449889003|FG000|Overall Study|Lost to Follow-up|4|||
125074270|NCT00669032|449889004|FG000|Overall Study|Lost to Follow-up|6|||
125074271|NCT00669032|449889005|FG001|Overall Study|Lost to Follow-up|5|||
125074272|NCT00669032|449889004|FG000|Overall Study|Lack of Efficacy|8|||
125074273|NCT00669032|449889005|FG001|Overall Study|Lack of Efficacy|19|||
125074274|NCT00669032|449889004|FG000|Overall Study|Withdrawal by Subject|12|||
125074275|NCT00669032|449889005|FG001|Overall Study|Withdrawal by Subject|13|||
125074276|NCT00669032|449889004|FG000|Overall Study|Adverse Event|12|||
125074277|NCT00669032|449889005|FG001|Overall Study|Adverse Event|16|||
125074278|NCT00669032|449889004|FG000|Overall Study|Physician Decision|1|||
125074279|NCT00669032|449889005|FG001|Overall Study|Physician Decision|1|||
125074280|NCT00669032|449889004|FG000|Overall Study|No fulfilment of the selection criteria|5|||
125074281|NCT00669032|449889005|FG001|Overall Study|No fulfilment of the selection criteria|5|||
125074282|NCT03627494|449889006|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
125074283|NCT03627494|449889007|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
125074284|NCT03627494|449889008|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
125074285|NCT03627494|449889009|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
125074286|NCT03627494|449889010|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
125074287|NCT03627494|449889011|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
125074288|NCT03627494|449889012|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
125074289|NCT03627494|449889013|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
125074290|NCT03627494|449889014|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
125074291|NCT03627494|449889015|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
125074292|NCT03627494|449889016|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
125074293|NCT03627494|449889017|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
125074294|NCT03627494|449889006|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
125074295|NCT03627494|449889007|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
125074296|NCT03627494|449889008|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
125074297|NCT03627494|449889009|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
125074298|NCT03627494|449889010|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
125074299|NCT03627494|449889011|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
125074300|NCT03627494|449889012|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
125074301|NCT03627494|449889013|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
125074302|NCT03627494|449889014|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
125074303|NCT03627494|449889015|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
125074304|NCT03627494|449889016|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
125074305|NCT03627494|449889017|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
125074306|NCT03627494|449889006|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
125074307|NCT03627494|449889007|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
125074308|NCT03627494|449889008|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
125074309|NCT03627494|449889009|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
125074310|NCT03627494|449889010|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
125074311|NCT03627494|449889011|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
125074312|NCT03627494|449889012|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
125074313|NCT03627494|449889013|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
125074314|NCT03627494|449889014|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
125074315|NCT03627494|449889015|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
125074316|NCT03627494|449889016|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
125074317|NCT03627494|449889017|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
125074318|NCT03906136|449891084|FG000|Overall Study|Adverse Event|1|||
125074319|NCT03906136|449891085|FG001|Overall Study|Adverse Event|0|||
125074320|NCT03906136|449891084|FG000|Overall Study|Lost to Follow-up|7|||
125074321|NCT03906136|449891085|FG001|Overall Study|Lost to Follow-up|4|||
125074322|NCT03906136|449891084|FG000|Overall Study|Physician Decision|1|||
125074323|NCT03906136|449891085|FG001|Overall Study|Physician Decision|0|||
125074324|NCT03906136|449891084|FG000|Overall Study|Withdrawal by Subject|3|||
125074325|NCT03906136|449891085|FG001|Overall Study|Withdrawal by Subject|7|||
125074326|NCT00323310|449891086|FG000|Overall Study|Withdrawal by Subject|1|||
125074327|NCT00323310|449891086|FG000|Overall Study|a parent refused blood draw|1|||
125074328|NCT00323310|449891086|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
125074329|NCT00446641|449891087|FG000|Overall Study|Withdrawal by Subject|8|||
125074330|NCT00446641|449891088|FG001|Overall Study|Withdrawal by Subject|3|||
125074331|NCT00446641|449891087|FG000|Overall Study|poor compliance|8|||
125074332|NCT00446641|449891088|FG001|Overall Study|poor compliance|6|||
125074333|NCT00446641|449891087|FG000|Overall Study|Lost to Follow-up|1|||
125074334|NCT00446641|449891088|FG001|Overall Study|Lost to Follow-up|1|||
125074335|NCT03565991|449891090|FG000|Overall Study|Other|11|||
125074336|NCT03565991|449891091|FG001|Overall Study|Other|0|||
125074337|NCT03565991|449891090|FG000|Overall Study|Global deterioration of health status|14|||
125074338|NCT03565991|449891091|FG001|Overall Study|Global deterioration of health status|4|||
125074339|NCT03565991|449891090|FG000|Overall Study|Withdrawal by Subject|2|||
125074340|NCT03565991|449891091|FG001|Overall Study|Withdrawal by Subject|6|||
125074341|NCT03565991|449891090|FG000|Overall Study|Progressive disease|121|||
125074342|NCT03565991|449891091|FG001|Overall Study|Progressive disease|29|||
125074343|NCT03565991|449891090|FG000|Overall Study|Death|3|||
125074344|NCT03565991|449891091|FG001|Overall Study|Death|0|||
125074345|NCT03565991|449891090|FG000|Overall Study|Adverse Event|7|||
125074346|NCT03565991|449891091|FG001|Overall Study|Adverse Event|2|||
125074347|NCT01826448|449891092|FG000|Overall Study|Adverse Event|1|||
125074348|NCT01826448|449891093|FG001|Overall Study|Adverse Event|3|||
125074349|NCT01826448|449891092|FG000|Overall Study|Disease progression|2|||
125074350|NCT01826448|449891093|FG001|Overall Study|Disease progression|4|||
125074351|NCT01826448|449891092|FG000|Overall Study|Withdrawal by Subject|1|||
125074352|NCT01826448|449891093|FG001|Overall Study|Withdrawal by Subject|0|||
125074353|NCT01826448|449891092|FG000|Overall Study|Physician Decision|0|||
125074354|NCT01826448|449891093|FG001|Overall Study|Physician Decision|1|||
125074355|NCT01826448|449891092|FG000|Overall Study|2 active cancers|0|||
125074356|NCT01826448|449891093|FG001|Overall Study|2 active cancers|1|||
125074357|NCT03250624|449891104|FG000|Overall Study|Lack of Efficacy|1|||
125074358|NCT03250624|449891105|FG001|Overall Study|Lack of Efficacy|4|||
125074359|NCT03250624|449891104|FG000|Overall Study|Adverse Event|0|||
125074360|NCT03250624|449891105|FG001|Overall Study|Adverse Event|1|||
125074361|NCT03250624|449891104|FG000|Overall Study|Other|1|||
125074362|NCT03250624|449891105|FG001|Overall Study|Other|2|||
125074363|NCT01510028|449891125|FG000|Overall Study|Lack of Efficacy|1|||
125074364|NCT01510028|449891126|FG001|Overall Study|Lack of Efficacy|0|||
125074365|NCT01510028|449891127|FG002|Overall Study|Lack of Efficacy|0|||
125074366|NCT01510028|449891128|FG003|Overall Study|Lack of Efficacy|0|||
125074367|NCT03235726|449891129|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
125074368|NCT03235726|449891130|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
125074369|NCT03235726|449891131|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
125074370|NCT03235726|449891132|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
125074371|NCT03235726|449891133|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
125074372|NCT03235726|449891134|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
125074373|NCT03235726|449891135|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
125074374|NCT03235726|449891136|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
125074375|NCT03235726|449891137|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
125074376|NCT03235726|449891138|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
125074377|NCT03235726|449891129|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
125074378|NCT03235726|449891130|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
125074379|NCT03235726|449891131|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
125074380|NCT03235726|449891132|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
125074381|NCT03235726|449891133|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
125074382|NCT03235726|449891134|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
125074383|NCT03235726|449891135|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
125074384|NCT03235726|449891136|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
125074385|NCT03235726|449891137|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
125074386|NCT03235726|449891138|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
125074387|NCT00282568|449891150|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
125074388|NCT00282568|449891150|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
125074389|NCT00282568|449891150|FG000|Extended Treatment Period|Adverse Event|17|||
125142124|NCT02725515|450144488|FG000|Overall Study|Completed Study Under Original Protocol|0|||
125142125|NCT02725515|450144489|FG001|Overall Study|Completed Study Under Original Protocol|1|||
125142126|NCT02725515|450144488|FG000|Overall Study|Lack of Response|0|||
125142127|NCT02725515|450144489|FG001|Overall Study|Lack of Response|1|||
125142128|NCT00874549|450144490|FG000|Overall Study|Adverse Event|0|||
125074390|NCT00282568|449891150|FG000|Extended Treatment Period|Non-compliance|4|||
125074391|NCT00282568|449891150|FG000|Extended Treatment Period|Physician Decision|1|||
125074392|NCT00282568|449891150|FG000|Extended Treatment Period|Lost to Follow-up|2|||
125074393|NCT03006926|449891151|FG000|Overall Study|Adverse Event|0|||
125074394|NCT03006926|449891152|FG001|Overall Study|Adverse Event|27|||
125074395|NCT03006926|449891151|FG000|Overall Study|Withdrawal by Subject|0|||
125142129|NCT00874549|450144491|FG001|Overall Study|Adverse Event|0|||
125074396|NCT03006926|449891152|FG001|Overall Study|Withdrawal by Subject|1|||
125142130|NCT00874549|450144492|FG002|Overall Study|Adverse Event|1|||
125142131|NCT00874549|450144493|FG003|Overall Study|Adverse Event|0|||
125142132|NCT00874549|450144490|FG000|Overall Study|Protocol Violation|1|||
125142133|NCT00874549|450144491|FG001|Overall Study|Protocol Violation|0|||
125142134|NCT00874549|450144492|FG002|Overall Study|Protocol Violation|2|||
125142135|NCT00874549|450144493|FG003|Overall Study|Protocol Violation|1|||
125142136|NCT00874549|450144490|FG000|Overall Study|Lost to Follow-up|0|||
125142137|NCT00874549|450144491|FG001|Overall Study|Lost to Follow-up|0|||
125142138|NCT00874549|450144492|FG002|Overall Study|Lost to Follow-up|1|||
125142139|NCT00874549|450144493|FG003|Overall Study|Lost to Follow-up|0|||
125142140|NCT00874549|450144490|FG000|Overall Study|Withdrawal by Subject|0|||
125142141|NCT00874549|450144491|FG001|Overall Study|Withdrawal by Subject|1|||
125142142|NCT00874549|450144492|FG002|Overall Study|Withdrawal by Subject|0|||
125142143|NCT00874549|450144493|FG003|Overall Study|Withdrawal by Subject|1|||
125142144|NCT02998541|450144503|FG000|Overall Study|Adverse Event|4|||
125142145|NCT02998541|450144504|FG001|Overall Study|Adverse Event|5|||
125142146|NCT02998541|450144505|FG002|Overall Study|Adverse Event|1|||
125142147|NCT02998541|450144503|FG000|Overall Study|Protocol Violation|1|||
125142148|NCT02998541|450144504|FG001|Overall Study|Protocol Violation|0|||
125142149|NCT02998541|450144505|FG002|Overall Study|Protocol Violation|0|||
125142150|NCT02998541|450144503|FG000|Overall Study|Withdrawal by Subject|3|||
125142151|NCT02998541|450144504|FG001|Overall Study|Withdrawal by Subject|1|||
125142152|NCT02998541|450144505|FG002|Overall Study|Withdrawal by Subject|0|||
125142153|NCT02998541|450144503|FG000|Overall Study|Lost to Follow-up|0|||
125142154|NCT02998541|450144504|FG001|Overall Study|Lost to Follow-up|3|||
125142155|NCT02998541|450144505|FG002|Overall Study|Lost to Follow-up|1|||
125142156|NCT02998541|450144503|FG000|Overall Study|Physician Decision|0|||
125142157|NCT02998541|450144504|FG001|Overall Study|Physician Decision|0|||
125142158|NCT02998541|450144505|FG002|Overall Study|Physician Decision|3|||
125142159|NCT02998541|450144503|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125142160|NCT02998541|450144504|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125142161|NCT02998541|450144505|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
125142162|NCT01513239|450144506|FG000|Period 1: Main Phase|Adverse Event|1|||
125074397|NCT03006926|449891151|FG000|Overall Study|Radiological Disease Progression|0|||
125074398|NCT03006926|449891152|FG001|Overall Study|Radiological Disease Progression|52|||
125074399|NCT03006926|449891151|FG000|Overall Study|Clinical Disease Progression|0|||
125074400|NCT03006926|449891152|FG001|Overall Study|Clinical Disease Progression|10|||
125074401|NCT03006926|449891151|FG000|Overall Study|Other|0|||
125074402|NCT03006926|449891152|FG001|Overall Study|Other|8|||
125074403|NCT03689972|449891153|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
125074404|NCT03689972|449891154|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
125074405|NCT03689972|449891155|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
125074406|NCT03689972|449891156|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
125074407|NCT03689972|449891157|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
125074408|NCT03689972|449891153|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
125074409|NCT03689972|449891154|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
125074410|NCT03689972|449891155|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
125074411|NCT03689972|449891156|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
125074412|NCT03689972|449891157|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
125074413|NCT03689972|449891153|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
125074414|NCT03689972|449891154|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
125074415|NCT03689972|449891155|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
125074416|NCT03689972|449891156|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
125074417|NCT03689972|449891157|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
125074418|NCT03689972|449891153|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
125074419|NCT03689972|449891154|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
125074420|NCT03689972|449891155|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
125074421|NCT03689972|449891156|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
125074422|NCT03689972|449891157|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
125142163|NCT01513239|450144507|FG001|Period 1: Main Phase|Adverse Event|1|||
125142164|NCT01513239|450144508|FG002|Period 1: Main Phase|Adverse Event|2|||
125223167|NCT01827592|450444546|FG002|Overall Study|Patient's substantial non-compliance|6|||
125074423|NCT03689972|449891153|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
125074424|NCT03689972|449891154|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
125074425|NCT03689972|449891155|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
125142165|NCT01513239|450144509|FG003|Period 1: Main Phase|Adverse Event|0|||
125074426|NCT03689972|449891156|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
125074427|NCT03689972|449891157|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
125142166|NCT01513239|450144510|FG004|Period 1: Main Phase|Adverse Event|0|||
125142167|NCT01513239|450144511|FG005|Period 1: Main Phase|Adverse Event|0|||
125142168|NCT01513239|450144506|FG000|Period 1: Main Phase|Death|29|||
125142169|NCT01513239|450144507|FG001|Period 1: Main Phase|Death|22|||
125142170|NCT01513239|450144508|FG002|Period 1: Main Phase|Death|32|||
125142171|NCT01513239|450144509|FG003|Period 1: Main Phase|Death|0|||
125142172|NCT01513239|450144510|FG004|Period 1: Main Phase|Death|0|||
125142173|NCT01513239|450144511|FG005|Period 1: Main Phase|Death|0|||
125142174|NCT01513239|450144506|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
125142175|NCT01513239|450144507|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
125142176|NCT01513239|450144508|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
125142177|NCT01513239|450144509|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
125142178|NCT01513239|450144510|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
125142179|NCT01513239|450144511|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
125142180|NCT01513239|450144506|FG000|Period 1: Main Phase|Physician Decision|4|||
125142181|NCT01513239|450144507|FG001|Period 1: Main Phase|Physician Decision|4|||
125142182|NCT01513239|450144508|FG002|Period 1: Main Phase|Physician Decision|4|||
125142183|NCT01513239|450144509|FG003|Period 1: Main Phase|Physician Decision|0|||
125142184|NCT01513239|450144510|FG004|Period 1: Main Phase|Physician Decision|0|||
125142185|NCT01513239|450144511|FG005|Period 1: Main Phase|Physician Decision|0|||
125142186|NCT01513239|450144506|FG000|Period 1: Main Phase|Protocol Violation|2|||
125142187|NCT01513239|450144507|FG001|Period 1: Main Phase|Protocol Violation|2|||
125142188|NCT01513239|450144508|FG002|Period 1: Main Phase|Protocol Violation|2|||
125142189|NCT01513239|450144509|FG003|Period 1: Main Phase|Protocol Violation|0|||
125142190|NCT01513239|450144510|FG004|Period 1: Main Phase|Protocol Violation|0|||
125142191|NCT01513239|450144511|FG005|Period 1: Main Phase|Protocol Violation|0|||
125142192|NCT01513239|450144506|FG000|Period 1: Main Phase|Technical Problems|1|||
125142193|NCT01513239|450144507|FG001|Period 1: Main Phase|Technical Problems|2|||
125142194|NCT01513239|450144508|FG002|Period 1: Main Phase|Technical Problems|0|||
125142195|NCT01513239|450144509|FG003|Period 1: Main Phase|Technical Problems|0|||
125142196|NCT01513239|450144510|FG004|Period 1: Main Phase|Technical Problems|0|||
125142197|NCT01513239|450144511|FG005|Period 1: Main Phase|Technical Problems|0|||
125142198|NCT01513239|450144506|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
125142199|NCT01513239|450144507|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
125142200|NCT01513239|450144508|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
125142201|NCT01513239|450144509|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
125142202|NCT01513239|450144510|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
125142203|NCT01513239|450144511|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
125142204|NCT01513239|450144506|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
125142205|NCT01513239|450144507|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
125142206|NCT01513239|450144508|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
125142207|NCT01513239|450144509|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
125142208|NCT01513239|450144510|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
125142209|NCT01513239|450144511|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
125142210|NCT01513239|450144506|FG000|Period 2: 9 Month Extension Phase|Death|0|||
125142211|NCT01513239|450144507|FG001|Period 2: 9 Month Extension Phase|Death|0|||
125142212|NCT01513239|450144508|FG002|Period 2: 9 Month Extension Phase|Death|0|||
125142213|NCT01513239|450144509|FG003|Period 2: 9 Month Extension Phase|Death|2|||
125142214|NCT01513239|450144510|FG004|Period 2: 9 Month Extension Phase|Death|5|||
125142215|NCT01513239|450144511|FG005|Period 2: 9 Month Extension Phase|Death|2|||
125142216|NCT01513239|450144506|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
125142217|NCT01513239|450144507|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
125142218|NCT01513239|450144508|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
125142219|NCT01513239|450144509|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
125142220|NCT01513239|450144510|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
125142221|NCT01513239|450144511|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
125142222|NCT01513239|450144506|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
125142223|NCT01513239|450144507|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
125142224|NCT01513239|450144508|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
125142225|NCT01513239|450144509|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
125142226|NCT01513239|450144510|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
125142227|NCT01513239|450144511|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
125223168|NCT01827592|450444544|FG000|Overall Study|Trial terminated by Sponsor|47|||
125223169|NCT01827592|450444545|FG001|Overall Study|Trial terminated by Sponsor|53|||
125223170|NCT01827592|450444546|FG002|Overall Study|Trial terminated by Sponsor|51|||
125223171|NCT01827592|450444544|FG000|Overall Study|Others|0|||
125223172|NCT01827592|450444545|FG001|Overall Study|Others|1|||
125223173|NCT01827592|450444546|FG002|Overall Study|Others|3|||
125223174|NCT02493517|450444547|FG000|Overall Study|Protocol Violation|1|||
125223175|NCT02493517|450444548|FG001|Overall Study|Protocol Violation|2|||
125223176|NCT02493517|450444547|FG000|Overall Study|Withdrawal by Subject|1|||
125223177|NCT02493517|450444548|FG001|Overall Study|Withdrawal by Subject|2|||
125142228|NCT01513239|450144506|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
125142229|NCT01513239|450144507|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
125142230|NCT01513239|450144508|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
125142231|NCT01513239|450144509|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
125142232|NCT01513239|450144510|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
125223178|NCT02493517|450444547|FG000|Overall Study|Adverse Event|0|||
125142233|NCT01513239|450144511|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
125142234|NCT03167606|450144514|FG000|Overall Study|Lost to Follow-up|73|||
125142235|NCT03167606|450144515|FG001|Overall Study|Lost to Follow-up|64|||
125142236|NCT03167606|450144514|FG000|Overall Study|Withdrawal by Subject|6|||
125142237|NCT03167606|450144515|FG001|Overall Study|Withdrawal by Subject|5|||
125142238|NCT03167606|450144514|FG000|Overall Study|Withdrawal by Investigator|0|||
125142239|NCT03167606|450144515|FG001|Overall Study|Withdrawal by Investigator|2|||
125142240|NCT00059332|450144516|FG000|Overall Study|Withdrawal by Subject|2|||
125142241|NCT00059332|450144517|FG001|Overall Study|Withdrawal by Subject|1|||
125142242|NCT00059332|450144516|FG000|Overall Study|Lost to Follow-up|1|||
125142243|NCT00059332|450144517|FG001|Overall Study|Lost to Follow-up|1|||
125142244|NCT00413049|450144518|FG000|Overall Study|Adverse Event|10|||
125142245|NCT00413049|450144519|FG001|Overall Study|Adverse Event|8|||
125142246|NCT00413049|450144518|FG000|Overall Study|Withdrawal by Subject|7|||
125142247|NCT00413049|450144519|FG001|Overall Study|Withdrawal by Subject|5|||
125142248|NCT00413049|450144518|FG000|Overall Study|Lost to Follow-up|2|||
125142249|NCT00413049|450144519|FG001|Overall Study|Lost to Follow-up|3|||
125142250|NCT00413049|450144518|FG000|Overall Study|Protocol Violation|3|||
125142251|NCT00413049|450144519|FG001|Overall Study|Protocol Violation|1|||
125142252|NCT00413049|450144518|FG000|Overall Study|Subject no longer requires study drug|0|||
125142253|NCT00413049|450144519|FG001|Overall Study|Subject no longer requires study drug|1|||
125142254|NCT00413049|450144518|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125142255|NCT00413049|450144519|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125142256|NCT00413049|450144518|FG000|Overall Study|Lack of Efficacy|1|||
125142257|NCT00413049|450144519|FG001|Overall Study|Lack of Efficacy|0|||
125142258|NCT02587143|450144520|FG000|Overall Study|Adverse Event|1|||
125142259|NCT02587143|450144521|FG001|Overall Study|Adverse Event|0|||
125142260|NCT03314857|450144526|FG000|Overall Study|Death|4|||
125142261|NCT03314857|450144526|FG000|Overall Study|Physician Decision|1|||
125142262|NCT02906917|450144527|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
125142263|NCT02906917|450144528|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
125142264|NCT02906917|450144527|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
125142265|NCT02906917|450144528|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
125142266|NCT02906917|450144527|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
125142267|NCT02906917|450144528|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
125142268|NCT02906917|450144527|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
125142269|NCT02906917|450144528|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
125142270|NCT02906917|450144527|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
125142271|NCT02906917|450144528|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
125142272|NCT02906917|450144527|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
125142273|NCT02906917|450144528|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
125142274|NCT02906917|450144527|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
125142275|NCT02906917|450144528|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
125223179|NCT02493517|450444548|FG001|Overall Study|Adverse Event|2|||
125223180|NCT02493517|450444547|FG000|Overall Study|Missed study visit|0|||
125223181|NCT02493517|450444548|FG001|Overall Study|Missed study visit|1|||
125223182|NCT01817075|450444549|FG000|Overall Study|Adverse Event|7|||
125223183|NCT01817075|450444550|FG001|Overall Study|Adverse Event|5|||
125223184|NCT01817075|450444549|FG000|Overall Study|Physician Decision|9|||
125223185|NCT01817075|450444550|FG001|Overall Study|Physician Decision|12|||
125142276|NCT02906917|450144527|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
125142277|NCT02906917|450144528|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
125142278|NCT00874822|450144531|FG000|Overall Study|excluded by criteria|8|||
125142279|NCT04281472|450144533|FG000|Stage A|Lack of Efficacy|8|||
125142280|NCT04281472|450144534|FG001|Stage A|Lack of Efficacy|0|||
125142281|NCT04281472|450144535|FG002|Stage A|Lack of Efficacy|0|||
125142282|NCT04281472|450144533|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
125223186|NCT01817075|450444549|FG000|Overall Study|Withdrawal by Subject|31|||
125223187|NCT01817075|450444550|FG001|Overall Study|Withdrawal by Subject|15|||
125223188|NCT01817075|450444549|FG000|Overall Study|Received Sorafenib after enrollment|0|||
125142283|NCT04281472|450144534|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
125142284|NCT04281472|450144535|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
125142285|NCT04281472|450144533|FG000|Stage A|Adverse Event|20|||
125142286|NCT04281472|450144534|FG001|Stage A|Adverse Event|0|||
125142287|NCT04281472|450144535|FG002|Stage A|Adverse Event|0|||
125223189|NCT01817075|450444550|FG001|Overall Study|Received Sorafenib after enrollment|1|||
125223190|NCT01817075|450444549|FG000|Overall Study|Ineligible|0|||
125223191|NCT01817075|450444550|FG001|Overall Study|Ineligible|2|||
125223192|NCT00419757|450446130|FG000|Overall Study|Adverse Event|1|||
125142288|NCT04281472|450144533|FG000|Stage A|Death|1|||
125142289|NCT04281472|450144534|FG001|Stage A|Death|0|||
125142290|NCT04281472|450144535|FG002|Stage A|Death|0|||
125223193|NCT00419757|450446131|FG001|Overall Study|Adverse Event|4|||
125142291|NCT04281472|450144533|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
125142292|NCT04281472|450144534|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
125074428|NCT03689972|449891153|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
125074429|NCT03689972|449891154|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
125074430|NCT03689972|449891155|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
125074431|NCT03689972|449891156|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
125074432|NCT03689972|449891157|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
125074433|NCT03689972|449891153|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
125074434|NCT03689972|449891154|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
125074435|NCT03689972|449891155|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
125074436|NCT03689972|449891156|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
125074437|NCT03689972|449891157|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
125074438|NCT03689972|449891153|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
125074439|NCT03689972|449891154|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
125074440|NCT03689972|449891155|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
125074441|NCT03689972|449891156|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
125074442|NCT03689972|449891157|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
125074443|NCT03689972|449891153|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
125074444|NCT03689972|449891154|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
125074445|NCT03689972|449891155|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
125074446|NCT03689972|449891156|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
125074447|NCT03689972|449891157|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
125074448|NCT03689972|449891153|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
125074449|NCT03689972|449891154|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
125074450|NCT03689972|449891155|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
125074451|NCT03689972|449891156|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
125074452|NCT03689972|449891157|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
125074453|NCT03689972|449891153|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
125074454|NCT03689972|449891154|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
125074455|NCT03689972|449891155|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
125074456|NCT03689972|449891156|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
125074457|NCT03689972|449891157|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
125074458|NCT03689972|449891153|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
125074459|NCT03689972|449891154|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
125074460|NCT03689972|449891155|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
125074461|NCT03689972|449891156|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
125074462|NCT03689972|449891157|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
125074463|NCT03689972|449891153|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
125074464|NCT03689972|449891154|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
125074465|NCT03689972|449891155|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
125074466|NCT03689972|449891156|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
125074467|NCT03689972|449891157|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
125074468|NCT03689972|449891153|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
125074469|NCT03689972|449891154|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
125074470|NCT03689972|449891155|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
125074471|NCT03689972|449891156|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
125074472|NCT03689972|449891157|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
125074473|NCT03689972|449891153|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
125074474|NCT03689972|449891154|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
125074475|NCT03689972|449891155|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
125074476|NCT03689972|449891156|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
125074477|NCT03689972|449891157|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
125074478|NCT03689972|449891153|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
125074479|NCT03689972|449891154|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
125074480|NCT03689972|449891155|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
125074481|NCT03689972|449891156|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
125074482|NCT03689972|449891157|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
125074483|NCT03689972|449891153|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
125074484|NCT03689972|449891154|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
125142293|NCT04281472|450144535|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
125142294|NCT04281472|450144533|FG000|Stage A|Lost to Follow-up|2|||
125142295|NCT04281472|450144534|FG001|Stage A|Lost to Follow-up|0|||
125142296|NCT04281472|450144535|FG002|Stage A|Lost to Follow-up|0|||
125142297|NCT04281472|450144533|FG000|Stage A|Non-compliance with study drug|1|||
125142298|NCT04281472|450144534|FG001|Stage A|Non-compliance with study drug|0|||
125142299|NCT04281472|450144535|FG002|Stage A|Non-compliance with study drug|0|||
125142300|NCT04281472|450144533|FG000|Stage A|Physician Decision|1|||
125142301|NCT04281472|450144534|FG001|Stage A|Physician Decision|0|||
125142302|NCT04281472|450144535|FG002|Stage A|Physician Decision|0|||
125142303|NCT04281472|450144533|FG000|Stage A|Prohibited medications|2|||
125142304|NCT04281472|450144534|FG001|Stage A|Prohibited medications|0|||
125142305|NCT04281472|450144535|FG002|Stage A|Prohibited medications|0|||
125142306|NCT04281472|450144533|FG000|Stage A|Withdrawal by Subject|11|||
125142307|NCT04281472|450144534|FG001|Stage A|Withdrawal by Subject|0|||
125142308|NCT04281472|450144535|FG002|Stage A|Withdrawal by Subject|0|||
125142309|NCT04281472|450144533|FG000|Stage A|Other|5|||
125142310|NCT04281472|450144534|FG001|Stage A|Other|0|||
125142311|NCT04281472|450144535|FG002|Stage A|Other|0|||
125142312|NCT04281472|450144533|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
125142313|NCT04281472|450144534|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
125142314|NCT04281472|450144535|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
125142315|NCT04281472|450144533|FG000|Stage B|Adverse Event|0|||
125142316|NCT04281472|450144534|FG001|Stage B|Adverse Event|3|||
125142317|NCT04281472|450144535|FG002|Stage B|Adverse Event|0|||
125223194|NCT00419757|450446130|FG000|Overall Study|Lost to Follow-up|1|||
125223195|NCT00419757|450446131|FG001|Overall Study|Lost to Follow-up|4|||
125223196|NCT00419757|450446130|FG000|Overall Study|Withdrawal by Subject|7|||
125074485|NCT03689972|449891155|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
125074486|NCT03689972|449891156|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
125074487|NCT03689972|449891157|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
125074488|NCT03689972|449891153|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
125074489|NCT03689972|449891154|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
125074490|NCT03689972|449891155|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
125074491|NCT03689972|449891156|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
125074492|NCT03689972|449891157|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
125074493|NCT03689972|449891153|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
125074494|NCT03689972|449891154|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
125074495|NCT03689972|449891155|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
125074496|NCT03689972|449891156|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
125074497|NCT03689972|449891157|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
125074498|NCT01838213|449891158|FG000|Overall Study|Ineligible|166|||
125074499|NCT01838213|449891159|FG001|Overall Study|Ineligible|191|||
125074500|NCT02417064|449891164|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
125074501|NCT02417064|449891165|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
125074502|NCT02417064|449891166|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
125074503|NCT02417064|449891164|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
125074504|NCT02417064|449891165|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
125074505|NCT02417064|449891166|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
125074506|NCT02417064|449891164|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
125074507|NCT02417064|449891165|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
125074508|NCT02417064|449891166|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
125074509|NCT02417064|449891164|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
125074510|NCT02417064|449891165|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
125074511|NCT02417064|449891166|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
125074512|NCT02417064|449891164|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
125074513|NCT02417064|449891165|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
125074514|NCT02417064|449891166|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
125074515|NCT02417064|449891164|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
125074516|NCT02417064|449891165|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
125074517|NCT02417064|449891166|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
125074518|NCT02417064|449891164|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
125074519|NCT02417064|449891165|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
125074520|NCT02417064|449891166|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
125074521|NCT02417064|449891164|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
125074522|NCT02417064|449891165|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
125074523|NCT02417064|449891166|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
125074524|NCT02417064|449891164|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
125074525|NCT02417064|449891165|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
125074526|NCT02417064|449891166|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
125074527|NCT02417064|449891164|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
125142318|NCT04281472|450144533|FG000|Stage B|Death|0|||
125142319|NCT04281472|450144534|FG001|Stage B|Death|0|||
125142320|NCT04281472|450144535|FG002|Stage B|Death|1|||
125223197|NCT00419757|450446131|FG001|Overall Study|Withdrawal by Subject|1|||
125142321|NCT04281472|450144533|FG000|Stage B|Lack of Efficacy|0|||
125142322|NCT04281472|450144534|FG001|Stage B|Lack of Efficacy|0|||
125142323|NCT04281472|450144535|FG002|Stage B|Lack of Efficacy|1|||
125142324|NCT04281472|450144533|FG000|Stage B|Lost to Follow-up|0|||
125142325|NCT04281472|450144534|FG001|Stage B|Lost to Follow-up|0|||
125142326|NCT04281472|450144535|FG002|Stage B|Lost to Follow-up|2|||
125142327|NCT04281472|450144533|FG000|Stage B|Prohibited medications|0|||
125142328|NCT04281472|450144534|FG001|Stage B|Prohibited medications|2|||
125142329|NCT04281472|450144535|FG002|Stage B|Prohibited medications|1|||
125142330|NCT04281472|450144533|FG000|Stage B|Protocol Violation|0|||
125142331|NCT04281472|450144534|FG001|Stage B|Protocol Violation|1|||
125142332|NCT04281472|450144535|FG002|Stage B|Protocol Violation|1|||
125142333|NCT04281472|450144533|FG000|Stage B|Sponsor decision|0|||
125142334|NCT04281472|450144534|FG001|Stage B|Sponsor decision|0|||
125142335|NCT04281472|450144535|FG002|Stage B|Sponsor decision|1|||
125142336|NCT04281472|450144533|FG000|Stage B|Withdrawal by Subject|0|||
125142337|NCT04281472|450144534|FG001|Stage B|Withdrawal by Subject|3|||
125142338|NCT04281472|450144535|FG002|Stage B|Withdrawal by Subject|3|||
125142339|NCT04281472|450144533|FG000|Stage B|Other|0|||
125142340|NCT04281472|450144534|FG001|Stage B|Other|3|||
125142341|NCT04281472|450144535|FG002|Stage B|Other|0|||
125142342|NCT05278858|450144536|FG000|Overall Study|Withdrawal by Subject|1|||
125142343|NCT03504085|450144539|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
125142344|NCT03504085|450144540|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
125142345|NCT03504085|450144539|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
125142346|NCT03504085|450144540|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
125142347|NCT04133311|450144541|FG000|Period 1 Double Masked Treatment Period|Death|1|||
125142348|NCT04133311|450144542|FG001|Period 1 Double Masked Treatment Period|Death|0|||
125142349|NCT04133311|450144543|FG002|Period 1 Double Masked Treatment Period|Death|0|||
125142350|NCT04133311|450144544|FG003|Period 1 Double Masked Treatment Period|Death|0|||
125142351|NCT04133311|450144541|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
125142352|NCT04133311|450144542|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
125142353|NCT04133311|450144543|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
125142354|NCT04133311|450144544|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
125142355|NCT04133311|450144541|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
125142356|NCT04133311|450144542|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
125142357|NCT04133311|450144543|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
125142358|NCT04133311|450144544|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
125142359|NCT04133311|450144541|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
125142360|NCT04133311|450144542|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
125142361|NCT04133311|450144543|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
125142362|NCT04133311|450144544|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
125142363|NCT04133311|450144541|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
125142364|NCT04133311|450144542|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
125142365|NCT04133311|450144543|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
125142366|NCT04133311|450144544|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
125142367|NCT04133311|450144541|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
125142368|NCT04133311|450144542|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
125142369|NCT04133311|450144543|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
125142370|NCT04133311|450144544|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
125142371|NCT04133311|450144541|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
125142372|NCT04133311|450144542|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
125142373|NCT04133311|450144543|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
125142374|NCT04133311|450144544|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
125142375|NCT04133311|450144541|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
125142376|NCT04133311|450144542|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
125142377|NCT04133311|450144543|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
125142378|NCT04133311|450144544|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
125142379|NCT00728754|450144547|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
125142380|NCT00728754|450144548|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
125142381|NCT00728754|450144547|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
125142382|NCT00728754|450144548|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
125142383|NCT00728754|450144547|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
125142384|NCT00728754|450144548|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
125142385|NCT01926119|450144549|FG000|Overall Study|Withdrawal by Subject|1|||
125142386|NCT00009945|450144552|FG000|Overall Study|no follow up data|7|||
125142387|NCT00009945|450144553|FG001|Overall Study|no follow up data|5|||
125142388|NCT00295490|450144556|FG000|Overall Study|Protocol Violation|0|||
125142389|NCT00295490|450144557|FG001|Overall Study|Protocol Violation|0|||
125142390|NCT00295490|450144558|FG002|Overall Study|Protocol Violation|3|||
125142391|NCT00295490|450144559|FG003|Overall Study|Protocol Violation|3|||
125142392|NCT00295490|450144556|FG000|Overall Study|Withdrawal by Subject|0|||
125142393|NCT00295490|450144557|FG001|Overall Study|Withdrawal by Subject|2|||
125223198|NCT00419757|450446130|FG000|Overall Study|Protocol Violation|2|||
125074528|NCT02417064|449891165|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
125074529|NCT02417064|449891166|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
125074530|NCT02417064|449891164|FG000|Follow-up Phase (24 Weeks)|Other|2|||
125074531|NCT02417064|449891165|FG001|Follow-up Phase (24 Weeks)|Other|2|||
125074532|NCT02417064|449891166|FG002|Follow-up Phase (24 Weeks)|Other|3|||
125074533|NCT00990249|449891169|FG000|Overall Study|Disease Progression|8|||
125074534|NCT00990249|449891169|FG000|Overall Study|Non-Compliance|1|||
125074535|NCT00990249|449891169|FG000|Overall Study|Death|2|||
125074536|NCT00990249|449891169|FG000|Overall Study|Not treated|2|||
125074537|NCT01548417|449891170|FG000|Overall Study|Withdrawal by Subject|0|||
125074538|NCT01548417|449891171|FG001|Overall Study|Withdrawal by Subject|2|||
125074539|NCT04583969|449891172|FG000|Overall Study|Death|31|||
125074540|NCT04583969|449891173|FG001|Overall Study|Death|38|||
125074541|NCT04583969|449891172|FG000|Overall Study|Lost to Follow-up|16|||
125074542|NCT04583969|449891173|FG001|Overall Study|Lost to Follow-up|13|||
125074543|NCT04583969|449891172|FG000|Overall Study|Protocol Violation|1|||
125074544|NCT04583969|449891173|FG001|Overall Study|Protocol Violation|0|||
125074545|NCT04583969|449891172|FG000|Overall Study|Withdrawal by Subject|3|||
125074546|NCT04583969|449891173|FG001|Overall Study|Withdrawal by Subject|3|||
125074547|NCT04583969|449891172|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
125074548|NCT04583969|449891173|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
125074549|NCT04583969|449891172|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
125074550|NCT04583969|449891173|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
125074551|NCT04583969|449891172|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
125074552|NCT04583969|449891173|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
125074553|NCT04583969|449891172|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
125074554|NCT04583969|449891173|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
125074555|NCT04583969|449891172|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
125074556|NCT04583969|449891173|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
125074557|NCT01057862|449891174|FG000|Overall Study|Withdrawal by Subject|1|||
125074558|NCT01057862|449891175|FG001|Overall Study|Withdrawal by Subject|2|||
125074559|NCT00415584|449891176|FG000|Overall Study|Withdrawal by Subject|1|||
125074560|NCT02640755|449891177|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
125074561|NCT02640755|449891178|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
125074562|NCT02640755|449891177|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
125074563|NCT02640755|449891178|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
125074564|NCT02640755|449891177|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
125074565|NCT02640755|449891178|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
125074566|NCT03434041|449891179|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
125074567|NCT03434041|449891180|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
125074568|NCT03434041|449891179|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
125074569|NCT03434041|449891180|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
125074570|NCT03434041|449891179|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
125074571|NCT03434041|449891180|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
125074572|NCT03434041|449891179|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
125074573|NCT03434041|449891180|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
125074574|NCT03434041|449891179|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
125074575|NCT03434041|449891180|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
125074576|NCT03434041|449891179|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
125074577|NCT03434041|449891180|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
125074578|NCT03434041|449891179|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
125074579|NCT03434041|449891180|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
125074580|NCT03434041|449891179|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
125074581|NCT03434041|449891180|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
125074582|NCT03434041|449891179|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
125074583|NCT03434041|449891180|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
125074584|NCT03434041|449891179|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
125074585|NCT03434041|449891180|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
125074586|NCT03434041|449891179|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
125142394|NCT00295490|450144558|FG002|Overall Study|Withdrawal by Subject|0|||
125142395|NCT00295490|450144559|FG003|Overall Study|Withdrawal by Subject|1|||
125074587|NCT03434041|449891180|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
125074588|NCT04075396|449891181|FG000|Overall Study|Death|11|||
125074589|NCT04075396|449891182|FG001|Overall Study|Death|9|||
125142396|NCT00295490|450144556|FG000|Overall Study|Lost to Follow-up|0|||
125074590|NCT04075396|449891181|FG000|Overall Study|Withdrawal by Subject|1|||
125074591|NCT04075396|449891182|FG001|Overall Study|Withdrawal by Subject|2|||
125142397|NCT00295490|450144557|FG001|Overall Study|Lost to Follow-up|0|||
125142398|NCT00295490|450144558|FG002|Overall Study|Lost to Follow-up|1|||
125074592|NCT04075396|449891181|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
125074593|NCT04075396|449891182|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
125074594|NCT04075396|449891181|FG000|Overall Study|Enrolled but not-treated|0|||
125074595|NCT04075396|449891182|FG001|Overall Study|Enrolled but not-treated|1|||
125074596|NCT03363165|449891183|FG000|3-month Follow-up|Death|0|||
125074597|NCT03363165|449891184|FG001|3-month Follow-up|Death|1|||
125074598|NCT03363165|449891183|FG000|6-month Follow-up|Death|0|||
125074599|NCT03363165|449891184|FG001|6-month Follow-up|Death|1|||
125074600|NCT03363165|449891183|FG000|6-month Follow-up|Withdrawal by Subject|1|||
125074601|NCT03363165|449891184|FG001|6-month Follow-up|Withdrawal by Subject|1|||
125074602|NCT03363165|449891183|FG000|12-month Follow-up|Death|1|||
125074603|NCT03363165|449891184|FG001|12-month Follow-up|Death|1|||
125074604|NCT03363165|449891183|FG000|12-month Follow-up|Withdrawal by Subject|1|||
125074605|NCT03363165|449891184|FG001|12-month Follow-up|Withdrawal by Subject|1|||
125074606|NCT02255760|449891185|FG000|Overall Study|Lost to Follow-up|0|||
125074607|NCT02255760|449891186|FG001|Overall Study|Lost to Follow-up|1|||
125074608|NCT02255760|449891187|FG002|Overall Study|Lost to Follow-up|0|||
125074609|NCT02255760|449891188|FG003|Overall Study|Lost to Follow-up|0|||
125074610|NCT02255760|449891189|FG004|Overall Study|Lost to Follow-up|0|||
125074611|NCT00003838|449891190|FG000|Overall Study|Death|0|||
125074612|NCT00003838|449891191|FG001|Overall Study|Death|12|||
125074613|NCT00003838|449891192|FG002|Overall Study|Death|7|||
125074614|NCT00003838|449891190|FG000|Overall Study|Lost to Follow-up|0|||
125074615|NCT00003838|449891191|FG001|Overall Study|Lost to Follow-up|1|||
125074616|NCT00003838|449891192|FG002|Overall Study|Lost to Follow-up|1|||
125074617|NCT00003838|449891190|FG000|Overall Study|Disease Progression|0|||
125074618|NCT00003838|449891191|FG001|Overall Study|Disease Progression|12|||
125074619|NCT00003838|449891192|FG002|Overall Study|Disease Progression|0|||
125074620|NCT00618813|449891193|FG000|Overall Study|Lack of Efficacy|1|||
125074621|NCT00618813|449891193|FG000|Overall Study|Physician Decision|2|||
125074622|NCT00618813|449891193|FG000|Overall Study|Withdrawal by Subject|1|||
125074623|NCT01809197|449891194|FG000|Overall Study|Lost to Follow-up|4|||
125142399|NCT00295490|450144559|FG003|Overall Study|Lost to Follow-up|0|||
125142400|NCT00295490|450144556|FG000|Overall Study|Adverse Event|1|||
125142401|NCT00295490|450144557|FG001|Overall Study|Adverse Event|0|||
125142402|NCT00295490|450144558|FG002|Overall Study|Adverse Event|0|||
125142403|NCT00295490|450144559|FG003|Overall Study|Adverse Event|0|||
125142404|NCT00295490|450144556|FG000|Overall Study|Other|0|||
125142405|NCT00295490|450144557|FG001|Overall Study|Other|2|||
125142406|NCT00295490|450144558|FG002|Overall Study|Other|0|||
125142407|NCT00295490|450144559|FG003|Overall Study|Other|1|||
125142408|NCT01196390|450144560|FG000|Overall Study|Protocol Violation|4|||
125142409|NCT01196390|450144561|FG001|Overall Study|Protocol Violation|5|||
125142410|NCT03141151|450144568|FG000|Overall Study|Lost to Follow-up|3|||
125142411|NCT03141151|450144569|FG001|Overall Study|Lost to Follow-up|2|||
125142412|NCT03141151|450144568|FG000|Overall Study|Withdrawal by Subject|3|||
125142413|NCT03141151|450144569|FG001|Overall Study|Withdrawal by Subject|2|||
125142414|NCT02218216|450144581|FG000|Overall Study|Study terminated before completed|6|||
125142415|NCT02218216|450144582|FG001|Overall Study|Study terminated before completed|0|||
125142416|NCT02218216|450144583|FG002|Overall Study|Study terminated before completed|0|||
125142417|NCT01691430|450146064|FG000|Overall Study|Death|17|||
125142418|NCT01691430|450146065|FG001|Overall Study|Death|16|||
125142419|NCT01691430|450146064|FG000|Overall Study|Withdrawal by Subject|5|||
125142420|NCT01691430|450146065|FG001|Overall Study|Withdrawal by Subject|1|||
125142421|NCT01691430|450146064|FG000|Overall Study|Lost to Follow-up|0|||
125142422|NCT01691430|450146065|FG001|Overall Study|Lost to Follow-up|3|||
125142423|NCT00660387|450146069|FG000|Overall Study|Adverse Event|1|||
125142424|NCT00660387|450146070|FG001|Overall Study|Adverse Event|2|||
125142425|NCT00660387|450146069|FG000|Overall Study|Lack of Efficacy|0|||
125142426|NCT00660387|450146070|FG001|Overall Study|Lack of Efficacy|1|||
125142427|NCT00660387|450146069|FG000|Overall Study|Protocol Violation|1|||
125142428|NCT00660387|450146070|FG001|Overall Study|Protocol Violation|0|||
125074624|NCT01809197|449891195|FG001|Overall Study|Lost to Follow-up|2|||
125074625|NCT01809197|449891194|FG000|Overall Study|Adverse Event|2|||
125074626|NCT01809197|449891195|FG001|Overall Study|Adverse Event|3|||
125074627|NCT01809197|449891194|FG000|Overall Study|Failed slit lamp exam|1|||
125074628|NCT01809197|449891195|FG001|Overall Study|Failed slit lamp exam|0|||
125074629|NCT01809197|449891194|FG000|Overall Study|Non-Compliance|1|||
125074630|NCT01809197|449891195|FG001|Overall Study|Non-Compliance|1|||
125142429|NCT04729101|450146073|FG000|Overall Study|Adverse Event|1|||
125142430|NCT04729101|450146074|FG001|Overall Study|Adverse Event|0|||
125142431|NCT04729101|450146073|FG000|Overall Study|Physician Decision|1|||
125074631|NCT01809197|449891194|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
125142432|NCT04729101|450146074|FG001|Overall Study|Physician Decision|0|||
125142433|NCT04729101|450146073|FG000|Overall Study|Withdrawal by Subject|1|||
125142434|NCT04729101|450146074|FG001|Overall Study|Withdrawal by Subject|0|||
125142435|NCT03086135|450146075|FG000|Overall Study|Adverse Event|1|||
125142436|NCT03086135|450146075|FG000|Overall Study|Lost to Follow-up|2|||
125142437|NCT00762411|450146078|FG000|Initial Treatment|Death|7|||
125142438|NCT00762411|450146079|FG001|Initial Treatment|Death|6|||
125142439|NCT00762411|450146078|FG000|Initial Treatment|Adverse Event|132|||
125142440|NCT00762411|450146079|FG001|Initial Treatment|Adverse Event|40|||
125142441|NCT00762411|450146078|FG000|Initial Treatment|Protocol Violation|4|||
125142442|NCT00762411|450146079|FG001|Initial Treatment|Protocol Violation|1|||
125142443|NCT00762411|450146078|FG000|Initial Treatment|Withdrawal by Subject|65|||
125142444|NCT00762411|450146079|FG001|Initial Treatment|Withdrawal by Subject|52|||
125142445|NCT00762411|450146078|FG000|Initial Treatment|Physician Decision|1|||
125142446|NCT00762411|450146079|FG001|Initial Treatment|Physician Decision|0|||
125142447|NCT00762411|450146078|FG000|Initial Treatment|Sponsor Decision|293|||
125142448|NCT00762411|450146079|FG001|Initial Treatment|Sponsor Decision|401|||
125142449|NCT00762411|450146078|FG000|Initial Treatment|Lost to Follow-up|5|||
125142450|NCT00762411|450146079|FG001|Initial Treatment|Lost to Follow-up|0|||
125142451|NCT00762411|450146078|FG000|Initial Treatment|Caregiver Decision|21|||
125142452|NCT00762411|450146079|FG001|Initial Treatment|Caregiver Decision|16|||
125142453|NCT00762411|450146078|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
125142454|NCT00762411|450146079|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
125142455|NCT00762411|450146078|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
125142456|NCT00762411|450146079|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
125142457|NCT00762411|450146078|FG000|Delayed Start|Adverse Event|0|||
125142458|NCT00762411|450146079|FG001|Delayed Start|Adverse Event|4|||
125142459|NCT00762411|450146078|FG000|Delayed Start|Protocol Violation|0|||
125142460|NCT00762411|450146079|FG001|Delayed Start|Protocol Violation|1|||
125142461|NCT00762411|450146078|FG000|Delayed Start|Sponsor Decision|16|||
125142462|NCT00762411|450146079|FG001|Delayed Start|Sponsor Decision|20|||
125142463|NCT00762411|450146078|FG000|Delayed Start|Caregiver Decision|1|||
125142464|NCT00762411|450146079|FG001|Delayed Start|Caregiver Decision|1|||
125142465|NCT00762411|450146078|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
125142466|NCT00762411|450146079|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
125142467|NCT00762411|450146078|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
125142468|NCT00762411|450146079|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
125142469|NCT00762411|450146078|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
125142470|NCT00762411|450146079|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
125142471|NCT00762411|450146078|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
125142472|NCT00762411|450146079|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
125142473|NCT00762411|450146078|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
125142474|NCT00762411|450146079|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
125142475|NCT00762411|450146078|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
125142476|NCT00762411|450146079|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
125142477|NCT01023061|450146080|FG000|Overall Study|Withdrawal prior to treatment|2|||
125142478|NCT02259348|450146084|FG000|Overall Study|Donors|6|||
125142479|NCT02259348|450146084|FG000|Overall Study|Death|4|||
125142480|NCT04812548|450146085|FG000|Overall Study|Adverse Event|2|||
125142481|NCT04812548|450146086|FG001|Overall Study|Adverse Event|7|||
125142482|NCT04812548|450146085|FG000|Overall Study|HSCT Planned|2|||
125142483|NCT04812548|450146086|FG001|Overall Study|HSCT Planned|3|||
125142484|NCT04812548|450146085|FG000|Overall Study|Progressive Disease|0|||
125142485|NCT04812548|450146086|FG001|Overall Study|Progressive Disease|2|||
125142486|NCT04812548|450146085|FG000|Overall Study|Death|0|||
125142487|NCT04812548|450146086|FG001|Overall Study|Death|1|||
125142488|NCT04812548|450146085|FG000|Overall Study|Post Study Access to Treatment|0|||
125142489|NCT04812548|450146086|FG001|Overall Study|Post Study Access to Treatment|1|||
125223199|NCT00419757|450446131|FG001|Overall Study|Protocol Violation|3|||
125223200|NCT00419757|450446130|FG000|Overall Study|Study specific discontinuation criteria|4|||
125223201|NCT00419757|450446131|FG001|Overall Study|Study specific discontinuation criteria|8|||
125223202|NCT00419757|450446130|FG000|Overall Study|Multiple reasons|3|||
125223203|NCT00419757|450446131|FG001|Overall Study|Multiple reasons|1|||
125223204|NCT00327340|450446132|FG000|Overall Study|Withdrawal by Subject|1|||
125223205|NCT00327340|450446133|FG001|Overall Study|Withdrawal by Subject|5|||
125223206|NCT00327340|450446132|FG000|Overall Study|Physician Decision|1|||
125223207|NCT00327340|450446133|FG001|Overall Study|Physician Decision|1|||
125223208|NCT00327340|450446132|FG000|Overall Study|Disease Progression|10|||
125223209|NCT00327340|450446133|FG001|Overall Study|Disease Progression|19|||
125142490|NCT04812548|450146085|FG000|Overall Study|Withdrawal by Subject|0|||
125142491|NCT04812548|450146086|FG001|Overall Study|Withdrawal by Subject|1|||
125142492|NCT04812548|450146085|FG000|Overall Study|Physician Decision|1|||
125142493|NCT04812548|450146086|FG001|Overall Study|Physician Decision|0|||
125223210|NCT00327340|450446132|FG000|Overall Study|Symptomatic Disease|0|||
125223211|NCT00327340|450446133|FG001|Overall Study|Symptomatic Disease|2|||
125223212|NCT00327340|450446132|FG000|Overall Study|Adverse Event|3|||
125142494|NCT04211766|450146087|FG000|Overall Study|Withdrawal by Subject|5|||
125223213|NCT00327340|450446133|FG001|Overall Study|Adverse Event|3|||
125223214|NCT03506438|450446138|FG000|Overall Study|Lost to Follow-up|8|||
125223215|NCT03506438|450446139|FG001|Overall Study|Lost to Follow-up|7|||
125223216|NCT03506438|450446140|FG002|Overall Study|Lost to Follow-up|8|||
125223217|NCT03506438|450446141|FG003|Overall Study|Lost to Follow-up|7|||
125223218|NCT03506438|450446142|FG004|Overall Study|Lost to Follow-up|0|||
125223219|NCT03506438|450446143|FG005|Overall Study|Lost to Follow-up|0|||
125074632|NCT01809197|449891195|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
125074633|NCT01809197|449891194|FG000|Overall Study|Withdrawal by Subject|1|||
125074634|NCT01809197|449891195|FG001|Overall Study|Withdrawal by Subject|1|||
125074635|NCT01809197|449891194|FG000|Overall Study|Product not available|0|||
125074636|NCT01809197|449891195|FG001|Overall Study|Product not available|1|||
125074637|NCT04685538|449891202|FG000|Overall Study|Adverse Event|0|||
125074638|NCT04685538|449891203|FG001|Overall Study|Adverse Event|1|||
125074639|NCT04685538|449891202|FG000|Overall Study|Lost to Follow-up|0|||
125074640|NCT04685538|449891203|FG001|Overall Study|Lost to Follow-up|2|||
125074641|NCT04423757|449891217|FG000|Overall Study|Adverse Event|2|||
125074642|NCT04423757|449891218|FG001|Overall Study|Adverse Event|0|||
125074643|NCT04423757|449891217|FG000|Overall Study|Not treated|1|||
125074644|NCT04423757|449891218|FG001|Overall Study|Not treated|1|||
125074645|NCT02709109|449891219|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
125074646|NCT02709109|449891220|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
125074647|NCT02709109|449891221|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
125074648|NCT02709109|449891222|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
125074649|NCT02709109|449891219|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
125074650|NCT02709109|449891220|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
125074651|NCT02709109|449891221|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
125074652|NCT02709109|449891222|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
125074653|NCT02709109|449891219|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
125074654|NCT02709109|449891220|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
125074655|NCT02709109|449891221|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
125074656|NCT02709109|449891222|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
125074657|NCT02709109|449891219|FG000|Washout Period (28 Days)|Other|2|||
125074658|NCT02709109|449891220|FG001|Washout Period (28 Days)|Other|2|||
125074659|NCT02709109|449891221|FG002|Washout Period (28 Days)|Other|3|||
125074660|NCT02709109|449891222|FG003|Washout Period (28 Days)|Other|0|||
125074661|NCT02709109|449891219|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
125074662|NCT02709109|449891220|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
125074663|NCT02709109|449891221|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
125074664|NCT02709109|449891222|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
125074665|NCT02709109|449891219|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
125074666|NCT02709109|449891220|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
125074667|NCT02709109|449891221|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
125074668|NCT02709109|449891222|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
125074669|NCT02709109|449891219|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
125074670|NCT02709109|449891220|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
125074671|NCT02709109|449891221|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
125074672|NCT02709109|449891222|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
125074673|NCT02709109|449891219|FG000|Treatment Period 2 (28 Days)|Other|0|||
125074674|NCT02709109|449891220|FG001|Treatment Period 2 (28 Days)|Other|0|||
125074675|NCT02709109|449891221|FG002|Treatment Period 2 (28 Days)|Other|1|||
125074676|NCT02709109|449891222|FG003|Treatment Period 2 (28 Days)|Other|0|||
125074677|NCT05563714|449891223|FG000|Overall Study|Death|2|||
125074678|NCT05563714|449891224|FG001|Overall Study|Death|2|||
125074679|NCT05563714|449891225|FG002|Overall Study|Death|0|||
125074680|NCT05563714|449891226|FG003|Overall Study|Death|0|||
125074681|NCT05563714|449891223|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
125074682|NCT05563714|449891224|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
125074683|NCT05563714|449891225|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
125074684|NCT05563714|449891226|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
125074685|NCT05563714|449891223|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
125074686|NCT05563714|449891224|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
125074687|NCT05563714|449891225|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
125074688|NCT05563714|449891226|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
125074689|NCT05563714|449891223|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
125074690|NCT05563714|449891224|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
125074691|NCT05563714|449891225|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
125074692|NCT05563714|449891226|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
125074693|NCT05563714|449891223|FG000|Overall Study|Lost to Follow-up|22|||
125223220|NCT01128296|450446144|FG000|Overall Study|Physician Decision|0|||
125223221|NCT01128296|450446145|FG001|Overall Study|Physician Decision|0|||
125223222|NCT01128296|450446146|FG002|Overall Study|Physician Decision|0|||
125074694|NCT05563714|449891224|FG001|Overall Study|Lost to Follow-up|19|||
125223223|NCT01128296|450446147|FG003|Overall Study|Physician Decision|0|||
125223224|NCT01128296|450446148|FG004|Overall Study|Physician Decision|0|||
125223225|NCT01128296|450446149|FG005|Overall Study|Physician Decision|3|||
125223226|NCT01128296|450446144|FG000|Overall Study|Withdrawal by Subject|0|||
125223227|NCT01128296|450446145|FG001|Overall Study|Withdrawal by Subject|0|||
125223228|NCT01128296|450446146|FG002|Overall Study|Withdrawal by Subject|0|||
125223229|NCT01128296|450446147|FG003|Overall Study|Withdrawal by Subject|0|||
125223230|NCT01128296|450446148|FG004|Overall Study|Withdrawal by Subject|0|||
125223231|NCT01128296|450446149|FG005|Overall Study|Withdrawal by Subject|2|||
125223232|NCT01831427|450446150|FG000|Overall Study|Adverse Event|0|||
125223233|NCT01831427|450446151|FG001|Overall Study|Adverse Event|1|||
125223234|NCT01831427|450446152|FG002|Overall Study|Adverse Event|0|||
125223235|NCT01831427|450446153|FG003|Overall Study|Adverse Event|0|||
125223236|NCT01831427|450446154|FG004|Overall Study|Adverse Event|0|||
125223237|NCT01831427|450446155|FG005|Overall Study|Adverse Event|1|||
125223238|NCT01831427|450446156|FG006|Overall Study|Adverse Event|0|||
125223239|NCT01831427|450446157|FG007|Overall Study|Adverse Event|1|||
125223240|NCT01831427|450446158|FG008|Overall Study|Adverse Event|0|||
125223241|NCT01831427|450446159|FG009|Overall Study|Adverse Event|0|||
125223242|NCT01831427|450446160|FG010|Overall Study|Adverse Event|2|||
125223243|NCT01831427|450446150|FG000|Overall Study|Investigator's Discretion|0|||
125223244|NCT01831427|450446151|FG001|Overall Study|Investigator's Discretion|0|||
125223245|NCT01831427|450446152|FG002|Overall Study|Investigator's Discretion|0|||
125223246|NCT01831427|450446153|FG003|Overall Study|Investigator's Discretion|1|||
125223247|NCT01831427|450446154|FG004|Overall Study|Investigator's Discretion|0|||
125223248|NCT01831427|450446155|FG005|Overall Study|Investigator's Discretion|0|||
125223249|NCT01831427|450446156|FG006|Overall Study|Investigator's Discretion|0|||
125223250|NCT01831427|450446157|FG007|Overall Study|Investigator's Discretion|0|||
125223251|NCT01831427|450446158|FG008|Overall Study|Investigator's Discretion|0|||
125223252|NCT01831427|450446159|FG009|Overall Study|Investigator's Discretion|0|||
125223253|NCT01831427|450446160|FG010|Overall Study|Investigator's Discretion|0|||
125223254|NCT01831427|450446150|FG000|Overall Study|Withdrew Consent|0|||
125223255|NCT01831427|450446151|FG001|Overall Study|Withdrew Consent|0|||
125223256|NCT01831427|450446152|FG002|Overall Study|Withdrew Consent|0|||
125223257|NCT01831427|450446153|FG003|Overall Study|Withdrew Consent|0|||
125223258|NCT01831427|450446154|FG004|Overall Study|Withdrew Consent|0|||
125223259|NCT01831427|450446155|FG005|Overall Study|Withdrew Consent|0|||
125223260|NCT01831427|450446156|FG006|Overall Study|Withdrew Consent|2|||
125223261|NCT01831427|450446157|FG007|Overall Study|Withdrew Consent|0|||
125223262|NCT01831427|450446158|FG008|Overall Study|Withdrew Consent|0|||
125223263|NCT01831427|450446159|FG009|Overall Study|Withdrew Consent|1|||
125223264|NCT01831427|450446160|FG010|Overall Study|Withdrew Consent|1|||
125074695|NCT05563714|449891225|FG002|Overall Study|Lost to Follow-up|0|||
125074696|NCT05563714|449891226|FG003|Overall Study|Lost to Follow-up|0|||
125074697|NCT01815580|449891227|FG000|Overall Study|Lost to Follow-up|4|||
125074698|NCT01815580|449891228|FG001|Overall Study|Lost to Follow-up|7|||
125074699|NCT01815580|449891227|FG000|Overall Study|Withdrawal by Subject|3|||
125074700|NCT01815580|449891228|FG001|Overall Study|Withdrawal by Subject|4|||
125074701|NCT01815580|449891227|FG000|Overall Study|Excluded from analysis|5|||
125074702|NCT01815580|449891228|FG001|Overall Study|Excluded from analysis|4|||
125074703|NCT02228564|449891229|FG000|Overall Study|Withdrawal by Subject|10|||
125074704|NCT02228564|449891229|FG000|Overall Study|Death|11|||
125074705|NCT02228564|449891229|FG000|Overall Study|Physician Decision|5|||
125074706|NCT02228564|449891229|FG000|Overall Study|Lost to Follow-up|17|||
125223265|NCT00536510|450446161|FG000|Overall Study|Adverse Event|27|||
125223266|NCT00536510|450446162|FG001|Overall Study|Adverse Event|4|||
125223267|NCT00536510|450446161|FG000|Overall Study|Lost to Follow-up|11|||
125223268|NCT00536510|450446162|FG001|Overall Study|Lost to Follow-up|8|||
125223269|NCT00536510|450446161|FG000|Overall Study|Protocol Violation|4|||
125223270|NCT00536510|450446162|FG001|Overall Study|Protocol Violation|5|||
125223271|NCT00536510|450446161|FG000|Overall Study|Withdrawal by Subject|16|||
125223272|NCT00536510|450446162|FG001|Overall Study|Withdrawal by Subject|9|||
125223273|NCT00536510|450446161|FG000|Overall Study|Flushing with Product|20|||
125223274|NCT00536510|450446162|FG001|Overall Study|Flushing with Product|0|||
125223275|NCT00536510|450446161|FG000|Overall Study|Laboratory Adverse Event|2|||
125074707|NCT02228564|449891229|FG000|Overall Study|Other|6|||
125074708|NCT01998399|449891230|FG000|Overall Study|Lost to Follow-up|1|||
125074709|NCT01998399|449891231|FG001|Overall Study|Lost to Follow-up|3|||
125074710|NCT01998399|449891230|FG000|Overall Study|Death|4|||
125074711|NCT01998399|449891231|FG001|Overall Study|Death|2|||
125074712|NCT01998399|449891230|FG000|Overall Study|Study stopped before dosing completed|3|||
125074713|NCT01998399|449891231|FG001|Overall Study|Study stopped before dosing completed|3|||
125074714|NCT01998399|449891230|FG000|Overall Study|Withdrawal by Subject|0|||
125074715|NCT01998399|449891231|FG001|Overall Study|Withdrawal by Subject|1|||
125074716|NCT04114539|449891235|FG000|Overall Study|Adverse Event|14|||
125074717|NCT04114539|449891235|FG000|Overall Study|Lost to Follow-up|2|||
125074718|NCT04114539|449891235|FG000|Overall Study|Non-compliance with Protocol|2|||
125074719|NCT04114539|449891235|FG000|Overall Study|Non-compliance with Study Drug|1|||
125074720|NCT04114539|449891235|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
125074721|NCT04114539|449891235|FG000|Overall Study|Withdrew consent|10|||
125074722|NCT04114539|449891235|FG000|Overall Study|Others not specified|5|||
125074723|NCT04114539|449891235|FG000|Overall Study|Investigator Decision|2|||
125074724|NCT00617591|449891236|FG000|Overall Study|Withdrew consent during Induction|4|||
125074725|NCT00617591|449891236|FG000|Overall Study|Withdrew consent during Maintenance|6|||
125074726|NCT00376246|449891237|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
125074727|NCT00376246|449891238|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
125074728|NCT00376246|449891237|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
125074729|NCT00376246|449891238|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
125074730|NCT00376246|449891237|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
125074731|NCT00376246|449891238|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
125074732|NCT01072448|449891243|FG000|Overall Study|Adverse Event|9|||
125074733|NCT01072448|449891244|FG001|Overall Study|Adverse Event|10|||
125074734|NCT01072448|449891243|FG000|Overall Study|Subject withdrew consent|4|||
125074735|NCT01072448|449891244|FG001|Overall Study|Subject withdrew consent|9|||
125074736|NCT01072448|449891243|FG000|Overall Study|Protocol deviation|3|||
125074737|NCT01072448|449891244|FG001|Overall Study|Protocol deviation|4|||
125074738|NCT01072448|449891243|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125074739|NCT01072448|449891244|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125074740|NCT01072448|449891243|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125074741|NCT01072448|449891244|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
125074742|NCT01072448|449891243|FG000|Overall Study|Lost to Follow-up|1|||
125074743|NCT01072448|449891244|FG001|Overall Study|Lost to Follow-up|1|||
125074744|NCT01072448|449891243|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125074745|NCT01072448|449891244|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125074746|NCT01072448|449891243|FG000|Overall Study|Death|0|||
125074747|NCT01072448|449891244|FG001|Overall Study|Death|2|||
125074748|NCT00418717|449891247|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
125074749|NCT00418717|449891247|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
125074750|NCT01400139|449891248|FG000|HYD Core Study|Adverse Event|210|||
125074751|NCT01400139|449891248|FG000|HYD Core Study|Lack of Efficacy|59|||
125074752|NCT01400139|449891248|FG000|HYD Core Study|Withdrawal by Subject|114|||
125074753|NCT01400139|449891248|FG000|HYD Core Study|Lost to Follow-up|39|||
125074754|NCT01400139|449891248|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
125074755|NCT01400139|449891248|FG000|HYD Core Study|Administrative|56|||
125074756|NCT01400139|449891248|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
125074757|NCT01400139|449891248|FG000|HYD Extension Period|Adverse Event|8|||
125074758|NCT01400139|449891248|FG000|HYD Extension Period|Withdrawal by Subject|5|||
125074759|NCT01400139|449891248|FG000|HYD Extension Period|Administrative|10|||
125074760|NCT00249795|449891249|FG000|Overall Study|Not treated|16|||
125074761|NCT00249795|449891250|FG001|Overall Study|Not treated|14|||
125074762|NCT00249795|449891249|FG000|Overall Study|Symptomatic hypotension|127|||
125074763|NCT00249795|449891250|FG001|Overall Study|Symptomatic hypotension|64|||
125074764|NCT00249795|449891249|FG000|Overall Study|Other Serious Adverse Event|84|||
125074765|NCT00249795|449891250|FG001|Overall Study|Other Serious Adverse Event|93|||
125142495|NCT04211766|450146088|FG001|Overall Study|Withdrawal by Subject|1|||
125074766|NCT00249795|449891249|FG000|Overall Study|Qualifying condition not present|26|||
125074767|NCT00249795|449891250|FG001|Overall Study|Qualifying condition not present|29|||
125074768|NCT00249795|449891249|FG000|Overall Study|Withdrawal by Subject|678|||
125074769|NCT00249795|449891250|FG001|Overall Study|Withdrawal by Subject|742|||
125074770|NCT00249795|449891249|FG000|Overall Study|Thromboembolic / outcome event|39|||
125142496|NCT03686215|450146089|FG000|Overall Study|Adverse Event|0|||
125142497|NCT03686215|450146090|FG001|Overall Study|Adverse Event|0|||
125142498|NCT03686215|450146091|FG002|Overall Study|Adverse Event|7|||
125142499|NCT03686215|450146089|FG000|Overall Study|Physician Decision|0|||
125142500|NCT03686215|450146090|FG001|Overall Study|Physician Decision|0|||
125074771|NCT00249795|449891250|FG001|Overall Study|Thromboembolic / outcome event|45|||
125074772|NCT00249795|449891249|FG000|Overall Study|Oral anticoagulant required|2|||
125142501|NCT03686215|450146091|FG002|Overall Study|Physician Decision|1|||
125074773|NCT00249795|449891250|FG001|Overall Study|Oral anticoagulant required|0|||
125074774|NCT00249795|449891249|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
125074775|NCT00249795|449891250|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
125074776|NCT00249795|449891249|FG000|Overall Study|Non-compliance|71|||
125074777|NCT00249795|449891250|FG001|Overall Study|Non-compliance|69|||
125074778|NCT00249795|449891249|FG000|Overall Study|Study drug intolerance|3|||
125074779|NCT00249795|449891250|FG001|Overall Study|Study drug intolerance|3|||
125074780|NCT00249795|449891249|FG000|Overall Study|Other adverse events (non-serious)|188|||
125074781|NCT00249795|449891250|FG001|Overall Study|Other adverse events (non-serious)|159|||
125074782|NCT00249795|449891249|FG000|Overall Study|Physician withdrew consent|71|||
125074783|NCT00249795|449891250|FG001|Overall Study|Physician withdrew consent|63|||
125074784|NCT00249795|449891249|FG000|Overall Study|Surgery / procedure|4|||
125074785|NCT00249795|449891250|FG001|Overall Study|Surgery / procedure|5|||
125074786|NCT00249795|449891249|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
125074787|NCT00249795|449891250|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
125074788|NCT00249795|449891249|FG000|Overall Study|Lightheadedness / dizziness|15|||
125074789|NCT00249795|449891250|FG001|Overall Study|Lightheadedness / dizziness|11|||
125074790|NCT00249795|449891249|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
125074791|NCT00249795|449891250|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
125074792|NCT00249795|449891249|FG000|Overall Study|Other contraindicated medication|1|||
125074793|NCT00249795|449891250|FG001|Overall Study|Other contraindicated medication|1|||
125074794|NCT00249795|449891249|FG000|Overall Study|Event related to cardiac condition|17|||
125074795|NCT00249795|449891250|FG001|Overall Study|Event related to cardiac condition|16|||
125074796|NCT00249795|449891249|FG000|Overall Study|Patient not wish to continue after May08|4|||
125074797|NCT00249795|449891250|FG001|Overall Study|Patient not wish to continue after May08|6|||
125074798|NCT00249795|449891249|FG000|Overall Study|Site not agree to continue after May08|1|||
125074799|NCT00249795|449891250|FG001|Overall Study|Site not agree to continue after May08|1|||
125074800|NCT00249795|449891249|FG000|Overall Study|Lost to Follow-up|0|||
125074801|NCT00249795|449891250|FG001|Overall Study|Lost to Follow-up|2|||
125074802|NCT00249795|449891249|FG000|Overall Study|Missing|0|||
125074803|NCT00249795|449891250|FG001|Overall Study|Missing|1|||
125074804|NCT02460978|449891252|FG000|Overall Study|Adverse Event|17|||
125074805|NCT02460978|449891253|FG001|Overall Study|Adverse Event|11|||
125074806|NCT02460978|449891254|FG002|Overall Study|Adverse Event|11|||
125074807|NCT02460978|449891252|FG000|Overall Study|Withdrawal by Subject|5|||
125074808|NCT02460978|449891253|FG001|Overall Study|Withdrawal by Subject|5|||
125074809|NCT02460978|449891254|FG002|Overall Study|Withdrawal by Subject|14|||
125074810|NCT02460978|449891252|FG000|Overall Study|Lost to Follow-up|2|||
125074811|NCT02460978|449891253|FG001|Overall Study|Lost to Follow-up|3|||
125074812|NCT02460978|449891254|FG002|Overall Study|Lost to Follow-up|1|||
125074813|NCT02460978|449891252|FG000|Overall Study|Protocol Violation|1|||
125074814|NCT02460978|449891253|FG001|Overall Study|Protocol Violation|1|||
125074815|NCT02460978|449891254|FG002|Overall Study|Protocol Violation|1|||
125074816|NCT02460978|449891252|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
125074817|NCT02460978|449891253|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
125074818|NCT02460978|449891254|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
125074819|NCT02460978|449891252|FG000|Overall Study|Pregnancy|0|||
125074820|NCT02460978|449891253|FG001|Overall Study|Pregnancy|0|||
125074821|NCT02460978|449891254|FG002|Overall Study|Pregnancy|2|||
125074822|NCT03549429|449891257|FG000|Overall Study|Protocol Violation|5|||
125074823|NCT03549429|449891258|FG001|Overall Study|Protocol Violation|3|||
125074824|NCT00588523|449891262|FG000|Overall Study|Not treated|3|||
125074825|NCT03032510|449891263|FG000|Overall Study|Adverse Event|5|||
125074826|NCT03032510|449891264|FG001|Overall Study|Adverse Event|2|||
125074827|NCT03032510|449891263|FG000|Overall Study|Lost to Follow-up|8|||
125074828|NCT03032510|449891264|FG001|Overall Study|Lost to Follow-up|7|||
125074829|NCT03032510|449891263|FG000|Overall Study|Withdrawal by Subject|8|||
125074830|NCT03032510|449891264|FG001|Overall Study|Withdrawal by Subject|7|||
125074831|NCT03032510|449891263|FG000|Overall Study|Subject noncompliance|4|||
125074832|NCT03032510|449891264|FG001|Overall Study|Subject noncompliance|2|||
125074833|NCT03032510|449891263|FG000|Overall Study|Physician Decision|2|||
125074834|NCT03032510|449891264|FG001|Overall Study|Physician Decision|0|||
125074835|NCT02431702|449892783|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
125074836|NCT02431702|449892784|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
125074837|NCT02431702|449892785|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
125142502|NCT03686215|450146089|FG000|Overall Study|Protocol Violation|0|||
125142503|NCT03686215|450146090|FG001|Overall Study|Protocol Violation|0|||
125142504|NCT03686215|450146091|FG002|Overall Study|Protocol Violation|4|||
125142505|NCT03686215|450146089|FG000|Overall Study|Device issue|1|||
125142506|NCT03686215|450146090|FG001|Overall Study|Device issue|0|||
125142507|NCT03686215|450146091|FG002|Overall Study|Device issue|2|||
125074838|NCT02431702|449892786|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
125074839|NCT02431702|449892787|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
125074840|NCT02431702|449892788|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
125074841|NCT02431702|449892789|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
125074842|NCT02431702|449892783|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
125074843|NCT02431702|449892784|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
125142508|NCT02485158|450146092|FG000|Overall Study|Withdrawal by Subject|3|||
125142509|NCT02485158|450146092|FG000|Overall Study|expected drug side effect|1|||
125142510|NCT01813435|450146095|FG000|Overall Study|did not finish experimental regimen|1902|||
125142511|NCT01813435|450146096|FG001|Overall Study|did not finish experimental regimen|770|||
125142512|NCT01813435|450146095|FG000|Overall Study|Lost to Follow-up|268|||
125142513|NCT01813435|450146096|FG001|Overall Study|Lost to Follow-up|237|||
125142514|NCT03035890|450146097|FG000|Overall Study|Death|1|||
125223276|NCT00536510|450446162|FG001|Overall Study|Laboratory Adverse Event|1|||
125074844|NCT02431702|449892785|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
125074845|NCT02431702|449892786|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
125074846|NCT02431702|449892787|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
125074847|NCT02431702|449892788|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
125074848|NCT02431702|449892789|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
125074849|NCT02431702|449892783|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
125074850|NCT02431702|449892784|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
125074851|NCT02431702|449892785|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
125074852|NCT02431702|449892786|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
125074853|NCT02431702|449892787|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
125074854|NCT02431702|449892788|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
125074855|NCT02431702|449892789|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
125074856|NCT02431702|449892783|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
125074857|NCT02431702|449892784|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
125074858|NCT02431702|449892785|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
125074859|NCT02431702|449892786|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
125074860|NCT02431702|449892787|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
125074861|NCT02431702|449892788|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
125074862|NCT02431702|449892789|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
125074863|NCT02431702|449892783|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
125074864|NCT02431702|449892784|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
125074865|NCT02431702|449892785|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
125074866|NCT02431702|449892786|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
125074867|NCT02431702|449892787|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
125074868|NCT02431702|449892788|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
125074869|NCT02431702|449892789|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
125074870|NCT02431702|449892783|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
125074871|NCT02431702|449892784|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
125074872|NCT02431702|449892785|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
125074873|NCT02431702|449892786|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
125074874|NCT02431702|449892787|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
125074875|NCT02431702|449892788|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
125074876|NCT02431702|449892789|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
125074877|NCT02431702|449892783|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
125074878|NCT02431702|449892784|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
125074879|NCT02431702|449892785|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
125074880|NCT02431702|449892786|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
125074881|NCT02431702|449892787|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
125074882|NCT02431702|449892788|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
125074883|NCT02431702|449892789|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
125074884|NCT02431702|449892783|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
125074885|NCT02431702|449892784|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
125074886|NCT02431702|449892785|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
125074887|NCT02431702|449892786|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
125074888|NCT02431702|449892787|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
125074889|NCT02431702|449892788|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
125142515|NCT01490190|450146098|FG000|Overall Study|Withdrawal by Subject|9|||
125142516|NCT01490190|450146098|FG000|Overall Study|Adverse Event|17|||
125142517|NCT01490190|450146098|FG000|Overall Study|Protocol Violation|5|||
125142518|NCT01490190|450146098|FG000|Overall Study|Lost to Follow-up|13|||
125223277|NCT00536510|450446161|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
125074890|NCT02431702|449892789|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
125074891|NCT02431702|449892783|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
125074892|NCT02431702|449892784|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
125074893|NCT02431702|449892785|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
125142519|NCT01490190|450146098|FG000|Overall Study|Relocation|1|||
125142520|NCT01490190|450146098|FG000|Overall Study|Inconvenience|1|||
125142521|NCT01490190|450146098|FG000|Overall Study|Ring expulsion|2|||
125074894|NCT02431702|449892786|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
125074895|NCT02431702|449892787|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
125074896|NCT02431702|449892788|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
125074897|NCT02431702|449892789|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
125074898|NCT02431702|449892783|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
125074899|NCT02431702|449892784|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
125074900|NCT02431702|449892785|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
125074901|NCT02431702|449892786|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
125074902|NCT02431702|449892787|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
125074903|NCT02431702|449892788|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
125074904|NCT02431702|449892789|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
125074905|NCT02431702|449892783|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
125074906|NCT02431702|449892784|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
125074907|NCT02431702|449892785|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
125074908|NCT02431702|449892786|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
125074909|NCT02431702|449892787|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
125074910|NCT02431702|449892788|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
125074911|NCT02431702|449892789|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
125074912|NCT02431702|449892783|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
125074913|NCT02431702|449892784|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
125074914|NCT02431702|449892785|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
125074915|NCT02431702|449892786|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
125074916|NCT02431702|449892787|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
125074917|NCT02431702|449892788|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
125074918|NCT02431702|449892789|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
125074919|NCT02431702|449892783|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
125074920|NCT02431702|449892784|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
125074921|NCT02431702|449892785|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
125074922|NCT02431702|449892786|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
125074923|NCT02431702|449892787|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
125074924|NCT02431702|449892788|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
125074925|NCT02431702|449892789|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
125074926|NCT02431702|449892783|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
125074927|NCT02431702|449892784|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
125074928|NCT02431702|449892785|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
125074929|NCT02431702|449892786|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
125074930|NCT02431702|449892787|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
125074931|NCT02431702|449892788|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
125074932|NCT02431702|449892789|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
125074933|NCT02431702|449892783|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
125074934|NCT02431702|449892784|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
125074935|NCT02431702|449892785|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
125074936|NCT02431702|449892786|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
125074937|NCT02431702|449892787|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
125074938|NCT02431702|449892788|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
125074939|NCT02431702|449892789|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
125074940|NCT02809118|449892790|FG000|Overall Study|Withdrawal by Subject|0|||
125074941|NCT02809118|449892791|FG001|Overall Study|Withdrawal by Subject|1|||
125074942|NCT02809118|449892792|FG002|Overall Study|Withdrawal by Subject|1|||
125074943|NCT02408484|449892793|FG000|Overall Study|Withdrawal by Subject|3|||
125074944|NCT02408484|449892793|FG000|Overall Study|Not treated during study period|1|||
125074945|NCT03805971|449892794|FG000|Overall Study|Withdrawal by Subject|1|||
125074946|NCT03805971|449892794|FG000|Overall Study|Protocol Violation|2|||
125074947|NCT00517413|449892795|FG000|Overall Study|Adverse Event|7|||
125074948|NCT00517413|449892795|FG000|Overall Study|Death|13|||
125074949|NCT00517413|449892795|FG000|Overall Study|Protocol Violation|15|||
125074950|NCT00517413|449892795|FG000|Overall Study|Withdrawal by Subject|2|||
125074951|NCT00517413|449892795|FG000|Overall Study|Failure to return|1|||
125074952|NCT00517413|449892795|FG000|Overall Study|Other-Reasons|23|||
125074953|NCT01355497|449892796|FG000|Overall Study|Death|19|||
125074954|NCT01355497|449892797|FG001|Overall Study|Death|18|||
125074955|NCT01355497|449892796|FG000|Overall Study|Lost to Follow-up|3|||
125074956|NCT01355497|449892797|FG001|Overall Study|Lost to Follow-up|0|||
125074957|NCT01355497|449892796|FG000|Overall Study|Protocol Violation|0|||
125074958|NCT01355497|449892797|FG001|Overall Study|Protocol Violation|1|||
125074959|NCT01355497|449892796|FG000|Overall Study|other-not provided|9|||
125074960|NCT01355497|449892797|FG001|Overall Study|other-not provided|4|||
125074961|NCT01355497|449892796|FG000|Overall Study|Withdrawal by Subject|12|||
125074962|NCT01355497|449892797|FG001|Overall Study|Withdrawal by Subject|20|||
125074963|NCT01355497|449892796|FG000|Overall Study|noncompliance|1|||
125142522|NCT02817828|450146104|FG000|Overall Study|Lost to Follow-up|41|||
125142523|NCT02817828|450146104|FG000|Overall Study|Adverse event not related to bleeding|104|||
125142524|NCT02817828|450146104|FG000|Overall Study|Adverse event related to bleeding|53|||
125074964|NCT01355497|449892797|FG001|Overall Study|noncompliance|2|||
125074965|NCT01355497|449892796|FG000|Overall Study|progressive disease|11|||
125074966|NCT01355497|449892797|FG001|Overall Study|progressive disease|8|||
125074967|NCT01355497|449892796|FG000|Overall Study|Adverse Event|11|||
125074968|NCT01355497|449892797|FG001|Overall Study|Adverse Event|10|||
125074969|NCT00441727|449892804|FG000|Overall Study|Protocol Violation|19|||
125074970|NCT00441727|449892805|FG001|Overall Study|Protocol Violation|28|||
125074971|NCT00441727|449892806|FG002|Overall Study|Protocol Violation|32|||
125074972|NCT00441727|449892804|FG000|Overall Study|Adverse Event|26|||
125074973|NCT00441727|449892805|FG001|Overall Study|Adverse Event|33|||
125074974|NCT00441727|449892806|FG002|Overall Study|Adverse Event|28|||
125074975|NCT00441727|449892804|FG000|Overall Study|Lack of Efficacy|7|||
125074976|NCT00441727|449892805|FG001|Overall Study|Lack of Efficacy|8|||
125074977|NCT00441727|449892806|FG002|Overall Study|Lack of Efficacy|48|||
125074978|NCT00441727|449892804|FG000|Overall Study|Withdrawal by Subject|40|||
125074979|NCT00441727|449892805|FG001|Overall Study|Withdrawal by Subject|34|||
125074980|NCT00441727|449892806|FG002|Overall Study|Withdrawal by Subject|47|||
125074981|NCT00441727|449892804|FG000|Overall Study|Lost to Follow-up|5|||
125074982|NCT00441727|449892805|FG001|Overall Study|Lost to Follow-up|6|||
125074983|NCT00441727|449892806|FG002|Overall Study|Lost to Follow-up|5|||
125074984|NCT00441727|449892804|FG000|Overall Study|Safety Reasons|3|||
125074985|NCT00441727|449892805|FG001|Overall Study|Safety Reasons|1|||
125074986|NCT00441727|449892806|FG002|Overall Study|Safety Reasons|3|||
125074987|NCT00441727|449892804|FG000|Overall Study|Various reason specified|6|||
125074988|NCT00441727|449892805|FG001|Overall Study|Various reason specified|8|||
125074989|NCT00441727|449892806|FG002|Overall Study|Various reason specified|5|||
125074990|NCT01237223|449892813|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
125074991|NCT01237223|449892814|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
125074992|NCT01237223|449892815|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
125074993|NCT01237223|449892816|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
125074994|NCT01237223|449892817|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
125074995|NCT01237223|449892818|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
125074996|NCT01237223|449892813|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
125074997|NCT01237223|449892814|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
125074998|NCT01237223|449892815|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
125074999|NCT01237223|449892816|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
125075000|NCT01237223|449892817|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
125075001|NCT01237223|449892818|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
125075002|NCT01237223|449892813|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
125075003|NCT01237223|449892814|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
125075004|NCT01237223|449892815|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
125075005|NCT01237223|449892816|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
125075006|NCT01237223|449892817|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
125075007|NCT01237223|449892818|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
125075008|NCT01237223|449892813|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
125075009|NCT01237223|449892814|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
125075010|NCT01237223|449892815|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
125075011|NCT01237223|449892816|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
125075012|NCT01237223|449892817|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
125075013|NCT01237223|449892818|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
125075014|NCT01237223|449892813|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
125075015|NCT01237223|449892814|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
125075016|NCT01237223|449892815|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
125075017|NCT01237223|449892816|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
125075018|NCT01237223|449892817|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
125075019|NCT01237223|449892818|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
125075020|NCT01237223|449892813|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
125075021|NCT01237223|449892814|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
125075022|NCT01237223|449892815|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
125223278|NCT00536510|450446162|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
125223279|NCT02169505|450446163|FG000|Overall Study|Withdrawal by Subject|1|||
125223280|NCT02326272|450446164|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125223281|NCT02326272|450446165|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
125223282|NCT02326272|450446166|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
125223283|NCT02326272|450446167|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125223284|NCT02326272|450446168|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125223285|NCT02326272|450446169|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125223286|NCT02326272|450446170|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125223287|NCT02326272|450446171|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125223288|NCT02326272|450446172|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125223289|NCT02326272|450446173|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125075023|NCT01237223|449892816|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
125075024|NCT01237223|449892817|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
125075025|NCT01237223|449892818|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
125075026|NCT01237223|449892813|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
125075027|NCT01237223|449892814|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
125075028|NCT01237223|449892815|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
125075029|NCT01237223|449892816|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
125075030|NCT01237223|449892817|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
125075031|NCT01237223|449892818|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
125075032|NCT01237223|449892813|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
125075033|NCT01237223|449892814|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
125075034|NCT01237223|449892815|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
125075035|NCT01237223|449892816|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
125075036|NCT01237223|449892817|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
125075037|NCT01237223|449892818|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
125075038|NCT01237223|449892813|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
125075039|NCT01237223|449892814|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
125075040|NCT01237223|449892815|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
125075041|NCT01237223|449892816|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
125075042|NCT01237223|449892817|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
125075043|NCT01237223|449892818|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
125075044|NCT01237223|449892813|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
125075045|NCT01237223|449892814|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
125075046|NCT01237223|449892815|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
125075047|NCT01237223|449892816|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
125075048|NCT01237223|449892817|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
125075049|NCT01237223|449892818|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
125075050|NCT00407550|449892825|FG000|Overall Study|Adverse Event|0|||
125075051|NCT00407550|449892826|FG001|Overall Study|Adverse Event|1|||
125075052|NCT00407550|449892825|FG000|Overall Study|Withdrawal by Subject|0|||
125075053|NCT00407550|449892826|FG001|Overall Study|Withdrawal by Subject|2|||
125075054|NCT00407550|449892825|FG000|Overall Study|Death|1|||
125075055|NCT00407550|449892826|FG001|Overall Study|Death|0|||
125075056|NCT00407550|449892825|FG000|Overall Study|Insurance or Other medical condition|2|||
125075057|NCT00407550|449892826|FG001|Overall Study|Insurance or Other medical condition|1|||
125075058|NCT00443846|449892827|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
125075059|NCT00443846|449892828|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
125075060|NCT00443846|449892827|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
125075061|NCT00443846|449892828|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
125075062|NCT00443846|449892827|FG000|Overall Study|Adverse Event|0|||
125075063|NCT00443846|449892828|FG001|Overall Study|Adverse Event|1|||
125075064|NCT00443846|449892827|FG000|Overall Study|Personal reason|8|||
125223290|NCT02326272|450446174|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125223291|NCT02326272|450446175|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125223292|NCT02326272|450446176|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125075065|NCT00443846|449892828|FG001|Overall Study|Personal reason|3|||
125075066|NCT00443846|449892827|FG000|Overall Study|Lost to Follow-up|1|||
125075067|NCT00443846|449892828|FG001|Overall Study|Lost to Follow-up|2|||
125075068|NCT00641706|449892830|FG000|Overall Study|Adverse Event|2|||
125075069|NCT00641706|449892831|FG001|Overall Study|Adverse Event|1|||
125075070|NCT00641706|449892830|FG000|Overall Study|Withdrawal by Subject|6|||
125075071|NCT00641706|449892831|FG001|Overall Study|Withdrawal by Subject|1|||
125075072|NCT00641706|449892830|FG000|Overall Study|Clinical Decline|1|||
125075073|NCT00641706|449892831|FG001|Overall Study|Clinical Decline|0|||
125075074|NCT00641706|449892830|FG000|Overall Study|Lead Investigator Decision|0|||
125075075|NCT00641706|449892831|FG001|Overall Study|Lead Investigator Decision|1|||
125075076|NCT01599806|449892834|FG000|Overall Study|Lost to Follow-up|20|||
125075077|NCT01599806|449892835|FG001|Overall Study|Lost to Follow-up|20|||
125075078|NCT01599806|449892834|FG000|Overall Study|Withdrawal by Subject|12|||
125075079|NCT01599806|449892835|FG001|Overall Study|Withdrawal by Subject|12|||
125075080|NCT01599806|449892834|FG000|Overall Study|Other Eligibility criteria|11|||
125075081|NCT01599806|449892835|FG001|Overall Study|Other Eligibility criteria|9|||
125075082|NCT00391807|449892837|FG000|Overall Study|Did not receive study medication|23|||
125075083|NCT00391807|449892837|FG000|Overall Study|Adverse Event|177|||
125075084|NCT00391807|449892837|FG000|Overall Study|Pregnancy|25|||
125075085|NCT00391807|449892837|FG000|Overall Study|Lost to Follow-up|227|||
125075086|NCT00391807|449892837|FG000|Overall Study|Withdrawal by Subject|147|||
125075087|NCT00391807|449892837|FG000|Overall Study|Protocol Violation|20|||
125075088|NCT00391807|449892837|FG000|Overall Study|Various|96|||
125075089|NCT01266070|449892838|FG000|Overall Study|Adverse Event|3|||
125075090|NCT01266070|449892838|FG000|Overall Study|Protocol Violation|1|||
125075091|NCT01585168|449892839|FG000|Overall Study|Lost to Follow-up|3|||
125075092|NCT01585168|449892840|FG001|Overall Study|Lost to Follow-up|1|||
125075093|NCT01585168|449892841|FG002|Overall Study|Lost to Follow-up|1|||
125075094|NCT01585168|449892842|FG003|Overall Study|Lost to Follow-up|1|||
125075095|NCT01194414|449892843|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
125075096|NCT01194414|449892844|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
125075097|NCT01194414|449892845|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
125075098|NCT01194414|449892846|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
125075099|NCT01194414|449892843|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
125075100|NCT01194414|449892844|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
125075101|NCT01194414|449892845|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
125075102|NCT01194414|449892846|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
125075103|NCT01194414|449892843|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
125075104|NCT01194414|449892844|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
125075105|NCT01194414|449892845|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
125075106|NCT01194414|449892846|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
125075107|NCT01194414|449892843|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
125075108|NCT01194414|449892844|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
125075109|NCT01194414|449892845|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
125075110|NCT01194414|449892846|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
125075111|NCT01194414|449892843|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
125075112|NCT01194414|449892844|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
125075113|NCT01194414|449892845|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
125075114|NCT01194414|449892846|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
125075115|NCT01194414|449892843|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
125075116|NCT01194414|449892844|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
125075117|NCT01194414|449892845|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
125075118|NCT01194414|449892846|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
125075119|NCT01194414|449892843|FG000|24 Weeks Double Blind Period|Other|0|||
125075120|NCT01194414|449892844|FG001|24 Weeks Double Blind Period|Other|1|||
125075121|NCT01194414|449892845|FG002|24 Weeks Double Blind Period|Other|0|||
125075122|NCT01194414|449892846|FG003|24 Weeks Double Blind Period|Other|0|||
125075123|NCT01194414|449892843|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
125075124|NCT01194414|449892844|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
125075125|NCT01194414|449892845|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
125075126|NCT01194414|449892846|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
125075127|NCT01194414|449892843|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
125075128|NCT01194414|449892844|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
125223293|NCT02326272|450446177|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125075129|NCT01194414|449892845|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
125075130|NCT01194414|449892846|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
125075131|NCT01194414|449892843|FG000|24 Weeks Double Blind Period|Death|0|||
125075132|NCT01194414|449892844|FG001|24 Weeks Double Blind Period|Death|1|||
125075133|NCT01194414|449892845|FG002|24 Weeks Double Blind Period|Death|0|||
125075134|NCT01194414|449892846|FG003|24 Weeks Double Blind Period|Death|0|||
125075135|NCT01194414|449892843|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
125075136|NCT01194414|449892844|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
125075137|NCT01194414|449892845|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
125075138|NCT01194414|449892846|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
125075139|NCT01194414|449892843|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
125075140|NCT01194414|449892844|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
125075141|NCT01194414|449892845|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
125075142|NCT01194414|449892846|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
125075143|NCT01194414|449892843|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
125075144|NCT01194414|449892844|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
125075145|NCT01194414|449892845|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
125075146|NCT01194414|449892846|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
125075147|NCT01194414|449892843|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
125075148|NCT01194414|449892844|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
125075149|NCT01194414|449892845|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
125075150|NCT01194414|449892846|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
125075151|NCT01194414|449892843|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
125075152|NCT01194414|449892844|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
125075153|NCT01194414|449892845|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
125075154|NCT01194414|449892846|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
125075155|NCT01194414|449892843|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
125075156|NCT01194414|449892844|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
125075157|NCT01194414|449892845|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
125075158|NCT01194414|449892846|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
125075159|NCT01194414|449892843|FG000|72 Weeks Open Label Extension|Other|2|||
125075160|NCT01194414|449892844|FG001|72 Weeks Open Label Extension|Other|1|||
125075161|NCT01194414|449892845|FG002|72 Weeks Open Label Extension|Other|0|||
125075162|NCT01194414|449892846|FG003|72 Weeks Open Label Extension|Other|0|||
125075163|NCT01194414|449892843|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
125075164|NCT01194414|449892844|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
125075165|NCT01194414|449892845|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
125075166|NCT01194414|449892846|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
125075167|NCT01194414|449892843|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
125075168|NCT01194414|449892844|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
125075169|NCT01194414|449892845|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
125075170|NCT01194414|449892846|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
125075171|NCT01194414|449892843|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
125142525|NCT02817828|450146104|FG000|Overall Study|Protocol Violation|11|||
125142526|NCT02817828|450146104|FG000|Overall Study|Pregnancy|7|||
125142527|NCT02817828|450146104|FG000|Overall Study|Pregnancy wish|15|||
125142528|NCT02817828|450146104|FG000|Overall Study|Withdrawal by Subject|78|||
125142529|NCT02817828|450146104|FG000|Overall Study|Other|26|||
125142530|NCT00856349|450146108|FG000|Overall Study|Death|418|||
125142531|NCT00856349|450146108|FG000|Overall Study|Withdrawal by Subject|116|||
125142532|NCT00856349|450146108|FG000|Overall Study|Lost to Follow-up|91|||
125142533|NCT00856349|450146108|FG000|Overall Study|Protocol Violation|38|||
125142534|NCT00856349|450146108|FG000|Overall Study|Physician Decision|13|||
125142535|NCT00856349|450146108|FG000|Overall Study|Subject relocation|104|||
125142536|NCT00856349|450146108|FG000|Overall Study|Device explant|33|||
125142537|NCT00856349|450146108|FG000|Overall Study|Site closure|78|||
125142538|NCT00856349|450146108|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
125142539|NCT05061992|450146109|FG000|Overall Study|Excess bowel movements|1|||
125142540|NCT05061992|450146110|FG001|Overall Study|Excess bowel movements|0|||
125142541|NCT05061992|450146109|FG000|Overall Study|Complications of Medical Care|1|||
125142542|NCT05061992|450146110|FG001|Overall Study|Complications of Medical Care|0|||
125142543|NCT05061992|450146109|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
125142544|NCT05061992|450146110|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
125142545|NCT05061992|450146109|FG000|Overall Study|Withdrawal by Subject|0|||
125142546|NCT05061992|450146110|FG001|Overall Study|Withdrawal by Subject|1|||
125142547|NCT01157234|450146111|FG000|Overall Study|Withdrawal by Subject|1|||
125142548|NCT01157234|450146112|FG001|Overall Study|Withdrawal by Subject|0|||
125142549|NCT00397254|450146121|FG000|Overall Study|Lost to Follow-up|2|||
125142550|NCT00397254|450146122|FG001|Overall Study|Lost to Follow-up|2|||
125142551|NCT02340780|450146123|FG000|Overall Study|Ineligible|1|||
125142552|NCT01055834|450146128|FG000|Treatment Period I|Adverse Event|1|||
125075172|NCT01194414|449892844|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
125075173|NCT01194414|449892845|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
125075174|NCT01194414|449892846|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
125075175|NCT01194414|449892843|FG000|72 Weeks Open Label Extension|Death|1|||
125075176|NCT01194414|449892844|FG001|72 Weeks Open Label Extension|Death|2|||
125075177|NCT01194414|449892845|FG002|72 Weeks Open Label Extension|Death|0|||
125075178|NCT01194414|449892846|FG003|72 Weeks Open Label Extension|Death|2|||
125075179|NCT00770224|449892855|FG000|Step 1: Induction|Adverse Event|3|||
125075180|NCT00770224|449892856|FG001|Step 1: Induction|Adverse Event|0|||
125075181|NCT00770224|449892855|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
125075182|NCT00770224|449892856|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
125075183|NCT00770224|449892855|FG000|Step 1: Induction|Other reason not protocol specified|2|||
125075184|NCT00770224|449892856|FG001|Step 1: Induction|Other reason not protocol specified|0|||
125075185|NCT00770224|449892855|FG000|Step 1: Induction|Ineligible|2|||
125075186|NCT00770224|449892856|FG001|Step 1: Induction|Ineligible|0|||
125075187|NCT00770224|449892855|FG000|Step 1: Induction|No protocol treatment given|1|||
125075188|NCT00770224|449892856|FG001|Step 1: Induction|No protocol treatment given|0|||
125075189|NCT00770224|449892855|FG000|Step 2: Maintenance|Adverse Event|0|||
125075190|NCT00770224|449892856|FG001|Step 2: Maintenance|Adverse Event|10|||
125075191|NCT00770224|449892855|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
125075192|NCT00770224|449892856|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
125075193|NCT00770224|449892855|FG000|Step 2: Maintenance|Progression/relapse|0|||
125075194|NCT00770224|449892856|FG001|Step 2: Maintenance|Progression/relapse|1|||
125075195|NCT00770224|449892855|FG000|Step 2: Maintenance|Death|0|||
125075196|NCT00770224|449892856|FG001|Step 2: Maintenance|Death|2|||
125075197|NCT00770224|449892855|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
125075198|NCT00770224|449892856|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
125075199|NCT00770224|449892855|FG000|Step 2: Maintenance|Ineligible|0|||
125075200|NCT00770224|449892856|FG001|Step 2: Maintenance|Ineligible|2|||
125075201|NCT01505114|449892857|FG000|Overall Study|Withdrawal by Subject|5|||
125075202|NCT01505114|449892858|FG001|Overall Study|Withdrawal by Subject|4|||
125075203|NCT01505114|449892859|FG002|Overall Study|Withdrawal by Subject|4|||
125075204|NCT01505114|449892860|FG003|Overall Study|Withdrawal by Subject|7|||
125075205|NCT01505114|449892857|FG000|Overall Study|Death|1|||
125075206|NCT01505114|449892858|FG001|Overall Study|Death|0|||
125075207|NCT01505114|449892859|FG002|Overall Study|Death|0|||
125075208|NCT01505114|449892860|FG003|Overall Study|Death|1|||
125075209|NCT01505114|449892857|FG000|Overall Study|unable to adhere to visit schedule|3|||
125075210|NCT01505114|449892858|FG001|Overall Study|unable to adhere to visit schedule|2|||
125075211|NCT01505114|449892859|FG002|Overall Study|unable to adhere to visit schedule|3|||
125075212|NCT01505114|449892860|FG003|Overall Study|unable to adhere to visit schedule|3|||
125075213|NCT01505114|449892857|FG000|Overall Study|Lost to Follow-up|11|||
125075214|NCT01505114|449892858|FG001|Overall Study|Lost to Follow-up|5|||
125075215|NCT01505114|449892859|FG002|Overall Study|Lost to Follow-up|8|||
125075216|NCT01505114|449892860|FG003|Overall Study|Lost to Follow-up|7|||
125075217|NCT01505114|449892857|FG000|Overall Study|relocated|4|||
125075218|NCT01505114|449892858|FG001|Overall Study|relocated|2|||
125075219|NCT01505114|449892859|FG002|Overall Study|relocated|2|||
125075220|NCT01505114|449892860|FG003|Overall Study|relocated|3|||
125075221|NCT01505114|449892857|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
125075222|NCT01505114|449892858|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
125075223|NCT01505114|449892859|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
125075224|NCT01505114|449892860|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
125075225|NCT01505114|449892857|FG000|Overall Study|staff safety concerns|0|||
125075226|NCT01505114|449892858|FG001|Overall Study|staff safety concerns|0|||
125075227|NCT01505114|449892859|FG002|Overall Study|staff safety concerns|0|||
125075228|NCT01505114|449892860|FG003|Overall Study|staff safety concerns|1|||
125075229|NCT01505114|449892857|FG000|Overall Study|investigator decision|1|||
125075230|NCT01505114|449892858|FG001|Overall Study|investigator decision|0|||
125142553|NCT01055834|450146129|FG001|Treatment Period I|Adverse Event|0|||
125142554|NCT01717313|450146130|FG000|Phase A (Weeks 0 to 24)|Death|0|||
125142555|NCT01717313|450146131|FG001|Phase A (Weeks 0 to 24)|Death|1|||
125142556|NCT01717313|450146130|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
125142557|NCT01717313|450146131|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
125142558|NCT01717313|450146130|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
125075231|NCT01505114|449892859|FG002|Overall Study|investigator decision|1|||
125075232|NCT01505114|449892860|FG003|Overall Study|investigator decision|0|||
125075233|NCT01235507|449892861|FG000|Overall Study|Adverse Event|1|||
125075234|NCT01235507|449892861|FG000|Overall Study|Withdrawal by Subject|1|||
125075235|NCT01587274|449892865|FG000|Overall Study|Lost to Follow-up|4|||
125075236|NCT01587274|449892866|FG001|Overall Study|Lost to Follow-up|5|||
125142559|NCT01717313|450146131|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
125142560|NCT01717313|450146130|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
125142561|NCT01717313|450146131|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
125075237|NCT01587274|449892867|FG002|Overall Study|Lost to Follow-up|3|||
125075238|NCT02475629|449892868|FG000|Overall Study|Adverse Event|1|||
125075239|NCT02475629|449892868|FG000|Overall Study|Death|4|||
125075240|NCT02475629|449892868|FG000|Overall Study|Physician Decision|1|||
125075241|NCT02475629|449892868|FG000|Overall Study|Withdrawal by Subject|1|||
125075242|NCT02475629|449892868|FG000|Overall Study|Lost to Follow-up|1|||
125075243|NCT02475629|449892868|FG000|Overall Study|Subject non-compliance|1|||
125075244|NCT01641081|449892874|FG000|Period 1|Sponsor request (potential unblinding)|0|||
125075245|NCT01641081|449892875|FG001|Period 1|Sponsor request (potential unblinding)|0|||
125075246|NCT01641081|449892876|FG002|Period 1|Sponsor request (potential unblinding)|0|||
125075247|NCT01641081|449892877|FG003|Period 1|Sponsor request (potential unblinding)|0|||
125075248|NCT01641081|449892878|FG004|Period 1|Sponsor request (potential unblinding)|0|||
125075249|NCT01641081|449892879|FG005|Period 1|Sponsor request (potential unblinding)|0|||
125075250|NCT01641081|449892880|FG006|Period 1|Sponsor request (potential unblinding)|1|||
125075251|NCT01641081|449892881|FG007|Period 1|Sponsor request (potential unblinding)|0|||
125075252|NCT01641081|449892882|FG008|Period 1|Sponsor request (potential unblinding)|0|||
125075253|NCT01641081|449892883|FG009|Period 1|Sponsor request (potential unblinding)|0|||
125075254|NCT01641081|449892874|FG000|Period 1|Protocol Violation|0|||
125075255|NCT01641081|449892875|FG001|Period 1|Protocol Violation|0|||
125075256|NCT01641081|449892876|FG002|Period 1|Protocol Violation|0|||
125075257|NCT01641081|449892877|FG003|Period 1|Protocol Violation|0|||
125075258|NCT01641081|449892878|FG004|Period 1|Protocol Violation|1|||
125075259|NCT01641081|449892879|FG005|Period 1|Protocol Violation|0|||
125075260|NCT01641081|449892880|FG006|Period 1|Protocol Violation|0|||
125075261|NCT01641081|449892881|FG007|Period 1|Protocol Violation|1|||
125075262|NCT01641081|449892882|FG008|Period 1|Protocol Violation|0|||
125075263|NCT01641081|449892883|FG009|Period 1|Protocol Violation|0|||
125075264|NCT01641081|449892874|FG000|Period 1|Adverse Event|1|||
125075265|NCT01641081|449892875|FG001|Period 1|Adverse Event|0|||
125075266|NCT01641081|449892876|FG002|Period 1|Adverse Event|0|||
125075267|NCT01641081|449892877|FG003|Period 1|Adverse Event|0|||
125075268|NCT01641081|449892878|FG004|Period 1|Adverse Event|0|||
125075269|NCT01641081|449892879|FG005|Period 1|Adverse Event|0|||
125142562|NCT01717313|450146130|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
125142563|NCT01717313|450146131|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
125142564|NCT01717313|450146130|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
125142565|NCT01717313|450146131|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
125142566|NCT01717313|450146130|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
125142567|NCT01717313|450146131|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
125142568|NCT01717313|450146130|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
125142569|NCT01717313|450146131|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
125142570|NCT01717313|450146130|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
125142571|NCT01717313|450146131|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
125142572|NCT01617096|450146142|FG000|Overall Study|Withdrawal by Subject|96|||
125142573|NCT01617096|450146143|FG001|Overall Study|Withdrawal by Subject|81|||
125142574|NCT01617096|450146142|FG000|Overall Study|Lost to Follow-up|37|||
125142575|NCT01617096|450146143|FG001|Overall Study|Lost to Follow-up|32|||
125142576|NCT01617096|450146142|FG000|Overall Study|Physician Decision|10|||
125142577|NCT01617096|450146143|FG001|Overall Study|Physician Decision|18|||
125142578|NCT01617096|450146142|FG000|Overall Study|Death|4|||
125142579|NCT01617096|450146143|FG001|Overall Study|Death|3|||
125142580|NCT01617096|450146142|FG000|Overall Study|Other|1|||
125142581|NCT01617096|450146143|FG001|Overall Study|Other|3|||
125142582|NCT04473326|450146146|FG000|Overall Study|Death|0|||
125142583|NCT04473326|450146147|FG001|Overall Study|Death|1|||
125142584|NCT04473326|450146146|FG000|Overall Study|Withdrawal by Subject|1|||
125142585|NCT04473326|450146147|FG001|Overall Study|Withdrawal by Subject|2|||
125142586|NCT02611362|450146148|FG000|Overall Study|Withdrawal by Subject|7|||
125142587|NCT02611362|450146149|FG001|Overall Study|Withdrawal by Subject|2|||
125142588|NCT02611362|450146148|FG000|Overall Study|Lost to Follow-up|2|||
125142589|NCT02611362|450146149|FG001|Overall Study|Lost to Follow-up|4|||
125142590|NCT01155531|450146150|FG000|Overall Study|Adverse Event|0|||
125142591|NCT01155531|450146151|FG001|Overall Study|Adverse Event|0|||
125142592|NCT01155531|450146152|FG002|Overall Study|Adverse Event|1|||
125142593|NCT01155531|450146153|FG003|Overall Study|Adverse Event|0|||
125142594|NCT01155531|450146150|FG000|Overall Study|Lost to Follow-up|0|||
125142595|NCT01155531|450146151|FG001|Overall Study|Lost to Follow-up|0|||
125142596|NCT01155531|450146152|FG002|Overall Study|Lost to Follow-up|0|||
125142597|NCT01155531|450146153|FG003|Overall Study|Lost to Follow-up|1|||
125142598|NCT01155531|450146150|FG000|Overall Study|Withdrawal by Subject|1|||
125142599|NCT01155531|450146151|FG001|Overall Study|Withdrawal by Subject|0|||
125075270|NCT01641081|449892880|FG006|Period 1|Adverse Event|0|||
125142600|NCT01155531|450146152|FG002|Overall Study|Withdrawal by Subject|1|||
125142601|NCT01155531|450146153|FG003|Overall Study|Withdrawal by Subject|0|||
125075271|NCT01641081|449892881|FG007|Period 1|Adverse Event|2|||
125075272|NCT01641081|449892882|FG008|Period 1|Adverse Event|0|||
125142602|NCT00354159|450146154|FG000|Randomized Study Period|Withdrawal by Subject|5|||
125075273|NCT01641081|449892883|FG009|Period 1|Adverse Event|0|||
125075274|NCT01641081|449892874|FG000|Period 2|Adverse Event|0|||
125075275|NCT01641081|449892875|FG001|Period 2|Adverse Event|0|||
125075276|NCT01641081|449892876|FG002|Period 2|Adverse Event|0|||
125075277|NCT01641081|449892877|FG003|Period 2|Adverse Event|0|||
125075278|NCT01641081|449892878|FG004|Period 2|Adverse Event|0|||
125075279|NCT01641081|449892879|FG005|Period 2|Adverse Event|1|||
125075280|NCT01641081|449892880|FG006|Period 2|Adverse Event|0|||
125075281|NCT01641081|449892881|FG007|Period 2|Adverse Event|0|||
125075282|NCT01641081|449892882|FG008|Period 2|Adverse Event|0|||
125142603|NCT00354159|450146155|FG001|Randomized Study Period|Withdrawal by Subject|3|||
125142604|NCT00354159|450146154|FG000|Randomized Study Period|Physician Decision|6|||
125142605|NCT00354159|450146155|FG001|Randomized Study Period|Physician Decision|10|||
125142606|NCT00354159|450146154|FG000|Randomized Study Period|Lost to Follow-up|4|||
125142607|NCT00354159|450146155|FG001|Randomized Study Period|Lost to Follow-up|0|||
125142608|NCT00354159|450146154|FG000|Randomized Study Period|Death|7|||
125142609|NCT00354159|450146155|FG001|Randomized Study Period|Death|9|||
125142610|NCT00354159|450146154|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
125142611|NCT00354159|450146155|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
125142612|NCT00354159|450146154|FG000|Long-term Follow-up|Physician Decision|127|||
125142613|NCT00354159|450146155|FG001|Long-term Follow-up|Physician Decision|122|||
125142614|NCT00354159|450146154|FG000|Long-term Follow-up|Lost to Follow-up|1|||
125142615|NCT00354159|450146155|FG001|Long-term Follow-up|Lost to Follow-up|0|||
125142616|NCT00354159|450146154|FG000|Long-term Follow-up|Death|14|||
125142617|NCT00354159|450146155|FG001|Long-term Follow-up|Death|11|||
125142618|NCT00354159|450146154|FG000|Long-term Follow-up|Study Closed|29|||
125142619|NCT00354159|450146155|FG001|Long-term Follow-up|Study Closed|34|||
125142620|NCT02046122|450146156|FG000|Overall Study|Physician Decision|8|||
125142621|NCT02046122|450146156|FG000|Overall Study|Withdrawal by Subject|1|||
125142622|NCT01653704|450146157|FG000|Overall Study|Technical failure during recording|1|||
125142623|NCT01653704|450146158|FG001|Overall Study|Technical failure during recording|1|||
125142624|NCT01653704|450146157|FG000|Overall Study|Performance not reflective of training|1|||
125142625|NCT01653704|450146158|FG001|Overall Study|Performance not reflective of training|0|||
125142626|NCT01728116|450146161|FG000|Overall Study|Sponsor Terminated Study|106|||
125142627|NCT01728116|450146162|FG001|Overall Study|Sponsor Terminated Study|35|||
125142628|NCT01728116|450146161|FG000|Overall Study|Withdrawal by Subject|16|||
125142629|NCT01728116|450146162|FG001|Overall Study|Withdrawal by Subject|9|||
125142630|NCT01728116|450146161|FG000|Overall Study|Adverse Event|13|||
125142631|NCT01728116|450146162|FG001|Overall Study|Adverse Event|0|||
125142632|NCT01728116|450146161|FG000|Overall Study|Procedure/device failure|7|||
125142633|NCT01728116|450146162|FG001|Overall Study|Procedure/device failure|0|||
125142634|NCT01728116|450146161|FG000|Overall Study|Lost to Follow-up|9|||
125142635|NCT01728116|450146162|FG001|Overall Study|Lost to Follow-up|2|||
125142636|NCT01728116|450146161|FG000|Overall Study|Physician Decision|2|||
125142637|NCT01728116|450146162|FG001|Overall Study|Physician Decision|0|||
125142638|NCT01728116|450146161|FG000|Overall Study|Subject Non-Compliance|2|||
125142639|NCT01728116|450146162|FG001|Overall Study|Subject Non-Compliance|0|||
125142640|NCT01728116|450146161|FG000|Overall Study|Inter-current finding at procedure|1|||
125142641|NCT01728116|450146162|FG001|Overall Study|Inter-current finding at procedure|0|||
125142642|NCT01728116|450146161|FG000|Overall Study|Incorrectly enrolled in Study|0|||
125142643|NCT01728116|450146162|FG001|Overall Study|Incorrectly enrolled in Study|1|||
125142644|NCT01728116|450146161|FG000|Overall Study|various not noted previously|5|||
125142645|NCT01728116|450146162|FG001|Overall Study|various not noted previously|0|||
125142646|NCT01532908|450146163|FG000|Overall Study|Not Transplanted|1|||
125142647|NCT01532908|450146164|FG001|Overall Study|Not Transplanted|0|||
125142648|NCT04610580|450146165|FG000|Two-way Crossover Period|Adverse Event|1|||
125142649|NCT04610580|450146166|FG001|Two-way Crossover Period|Adverse Event|0|||
125142650|NCT04610580|450146167|FG002|Two-way Crossover Period|Adverse Event|0|||
125142651|NCT04610580|450146168|FG003|Two-way Crossover Period|Adverse Event|0|||
125142652|NCT04610580|450146169|FG004|Two-way Crossover Period|Adverse Event|0|||
125142653|NCT04610580|450146170|FG005|Two-way Crossover Period|Adverse Event|0|||
125142654|NCT04610580|450146165|FG000|Two-way Crossover Period|Physician Decision|1|||
125142655|NCT04610580|450146166|FG001|Two-way Crossover Period|Physician Decision|0|||
125142656|NCT04610580|450146167|FG002|Two-way Crossover Period|Physician Decision|0|||
125142657|NCT04610580|450146168|FG003|Two-way Crossover Period|Physician Decision|0|||
125075283|NCT01641081|449892883|FG009|Period 2|Adverse Event|0|||
125142658|NCT04610580|450146169|FG004|Two-way Crossover Period|Physician Decision|0|||
125142659|NCT04610580|450146170|FG005|Two-way Crossover Period|Physician Decision|0|||
125142660|NCT04610580|450146165|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
125142661|NCT04610580|450146166|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
125142662|NCT04610580|450146167|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
125142663|NCT04610580|450146168|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
125142664|NCT04610580|450146169|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
125142665|NCT04610580|450146170|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
125142666|NCT04610580|450146165|FG000|Two-way Crossover Period|Other than specified|0|||
125142667|NCT04610580|450146166|FG001|Two-way Crossover Period|Other than specified|1|||
125142668|NCT04610580|450146167|FG002|Two-way Crossover Period|Other than specified|0|||
125142669|NCT04610580|450146168|FG003|Two-way Crossover Period|Other than specified|0|||
125142670|NCT04610580|450146169|FG004|Two-way Crossover Period|Other than specified|0|||
125142671|NCT04610580|450146170|FG005|Two-way Crossover Period|Other than specified|0|||
125142672|NCT04610580|450146165|FG000|Washout Before Extension Period|Other than specified|0|||
125142673|NCT04610580|450146166|FG001|Washout Before Extension Period|Other than specified|1|||
125142674|NCT04610580|450146167|FG002|Washout Before Extension Period|Other than specified|0|||
125142675|NCT04610580|450146168|FG003|Washout Before Extension Period|Other than specified|0|||
125142676|NCT04610580|450146169|FG004|Washout Before Extension Period|Other than specified|0|||
125142677|NCT04610580|450146170|FG005|Washout Before Extension Period|Other than specified|0|||
125142678|NCT04610580|450146165|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
125142679|NCT04610580|450146166|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
125142680|NCT04610580|450146167|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
125142681|NCT04610580|450146168|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
125142682|NCT04610580|450146169|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
125142683|NCT04610580|450146170|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
125142684|NCT04610580|450146165|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
125142685|NCT04610580|450146166|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
125142686|NCT04610580|450146167|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
125142687|NCT04610580|450146168|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
125142688|NCT04610580|450146169|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
125142689|NCT04610580|450146170|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
125142690|NCT01097694|450146171|FG000|Overall Study|Adverse Event|5|||
125142691|NCT01097694|450146172|FG001|Overall Study|Adverse Event|0|||
125223294|NCT02326272|450446178|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125223295|NCT02326272|450446164|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
125075284|NCT01641081|449892874|FG000|Period 2|Withdrawal by Subject|0|||
125075285|NCT01641081|449892875|FG001|Period 2|Withdrawal by Subject|0|||
125075286|NCT01641081|449892876|FG002|Period 2|Withdrawal by Subject|0|||
125075287|NCT01641081|449892877|FG003|Period 2|Withdrawal by Subject|1|||
125075288|NCT01641081|449892878|FG004|Period 2|Withdrawal by Subject|0|||
125075289|NCT01641081|449892879|FG005|Period 2|Withdrawal by Subject|0|||
125075290|NCT01641081|449892880|FG006|Period 2|Withdrawal by Subject|2|||
125075291|NCT01641081|449892881|FG007|Period 2|Withdrawal by Subject|0|||
125075292|NCT01641081|449892882|FG008|Period 2|Withdrawal by Subject|0|||
125075293|NCT01641081|449892883|FG009|Period 2|Withdrawal by Subject|0|||
125075294|NCT01641081|449892874|FG000|Period 2|Protocol Violation|1|||
125075295|NCT01641081|449892875|FG001|Period 2|Protocol Violation|0|||
125075296|NCT01641081|449892876|FG002|Period 2|Protocol Violation|0|||
125075297|NCT01641081|449892877|FG003|Period 2|Protocol Violation|0|||
125075298|NCT01641081|449892878|FG004|Period 2|Protocol Violation|0|||
125075299|NCT01641081|449892879|FG005|Period 2|Protocol Violation|0|||
125075300|NCT01641081|449892880|FG006|Period 2|Protocol Violation|0|||
125075301|NCT01641081|449892881|FG007|Period 2|Protocol Violation|0|||
125075302|NCT01641081|449892882|FG008|Period 2|Protocol Violation|0|||
125075303|NCT01641081|449892883|FG009|Period 2|Protocol Violation|0|||
125075304|NCT01641081|449892874|FG000|Period 3|Adverse Event|0|||
125075305|NCT01641081|449892875|FG001|Period 3|Adverse Event|0|||
125142692|NCT01097694|450146171|FG000|Overall Study|Lost to Follow-up|0|||
125223296|NCT02326272|450446165|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
125075306|NCT01641081|449892876|FG002|Period 3|Adverse Event|1|||
125075307|NCT01641081|449892877|FG003|Period 3|Adverse Event|0|||
125075308|NCT01641081|449892878|FG004|Period 3|Adverse Event|0|||
125075309|NCT01641081|449892879|FG005|Period 3|Adverse Event|0|||
125075310|NCT01641081|449892880|FG006|Period 3|Adverse Event|0|||
125075311|NCT01641081|449892881|FG007|Period 3|Adverse Event|0|||
125075312|NCT01641081|449892882|FG008|Period 3|Adverse Event|0|||
125142693|NCT01097694|450146172|FG001|Overall Study|Lost to Follow-up|3|||
125142694|NCT01097694|450146171|FG000|Overall Study|Withdrawal by Subject|3|||
125075313|NCT01641081|449892883|FG009|Period 3|Adverse Event|0|||
125075314|NCT01641081|449892874|FG000|Period 3|Withdrawal by Subject|0|||
125223297|NCT02326272|450446166|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125223298|NCT02326272|450446167|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125223299|NCT02326272|450446168|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125223300|NCT02326272|450446169|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125075315|NCT01641081|449892875|FG001|Period 3|Withdrawal by Subject|0|||
125075316|NCT01641081|449892876|FG002|Period 3|Withdrawal by Subject|0|||
125075317|NCT01641081|449892877|FG003|Period 3|Withdrawal by Subject|0|||
125075318|NCT01641081|449892878|FG004|Period 3|Withdrawal by Subject|0|||
125075319|NCT01641081|449892879|FG005|Period 3|Withdrawal by Subject|0|||
125075320|NCT01641081|449892880|FG006|Period 3|Withdrawal by Subject|0|||
125075321|NCT01641081|449892881|FG007|Period 3|Withdrawal by Subject|0|||
125075322|NCT01641081|449892882|FG008|Period 3|Withdrawal by Subject|1|||
125075323|NCT01641081|449892883|FG009|Period 3|Withdrawal by Subject|0|||
125075324|NCT01641081|449892874|FG000|Period 4|Adverse Event|0|||
125075325|NCT01641081|449892875|FG001|Period 4|Adverse Event|1|||
125075326|NCT01641081|449892876|FG002|Period 4|Adverse Event|0|||
125075327|NCT01641081|449892877|FG003|Period 4|Adverse Event|1|||
125075328|NCT01641081|449892878|FG004|Period 4|Adverse Event|0|||
125075329|NCT01641081|449892879|FG005|Period 4|Adverse Event|0|||
125075330|NCT01641081|449892880|FG006|Period 4|Adverse Event|0|||
125075331|NCT01641081|449892881|FG007|Period 4|Adverse Event|0|||
125075332|NCT01641081|449892882|FG008|Period 4|Adverse Event|0|||
125075333|NCT01641081|449892883|FG009|Period 4|Adverse Event|0|||
125075334|NCT01641081|449892874|FG000|Period 5|Adverse Event|0|||
125075335|NCT01641081|449892875|FG001|Period 5|Adverse Event|0|||
125075336|NCT01641081|449892876|FG002|Period 5|Adverse Event|2|||
125075337|NCT01641081|449892877|FG003|Period 5|Adverse Event|0|||
125075338|NCT01641081|449892878|FG004|Period 5|Adverse Event|0|||
125075339|NCT01641081|449892879|FG005|Period 5|Adverse Event|0|||
125075340|NCT01641081|449892880|FG006|Period 5|Adverse Event|0|||
125075341|NCT01641081|449892881|FG007|Period 5|Adverse Event|0|||
125075342|NCT01641081|449892882|FG008|Period 5|Adverse Event|0|||
125075343|NCT01641081|449892883|FG009|Period 5|Adverse Event|0|||
125075344|NCT01749800|449892887|FG000|Overall Study|not meeting inclusion criteria|3|||
125075345|NCT01749800|449892888|FG001|Overall Study|not meeting inclusion criteria|0|||
125075346|NCT01749800|449892889|FG002|Overall Study|not meeting inclusion criteria|0|||
125075347|NCT01749800|449892887|FG000|Overall Study|Withdrawal by Subject|0|||
125075348|NCT01749800|449892888|FG001|Overall Study|Withdrawal by Subject|1|||
125075349|NCT01749800|449892889|FG002|Overall Study|Withdrawal by Subject|0|||
125075350|NCT01000025|449892892|FG000|Overall Study|Adverse Event|43|||
125075351|NCT01000025|449892893|FG001|Overall Study|Adverse Event|2|||
125075352|NCT01000025|449892892|FG000|Overall Study|Withdrawal by Subject|13|||
125075353|NCT01000025|449892893|FG001|Overall Study|Withdrawal by Subject|8|||
125075354|NCT01000025|449892892|FG000|Overall Study|Death|23|||
125075355|NCT01000025|449892893|FG001|Overall Study|Death|13|||
125075356|NCT01000025|449892892|FG000|Overall Study|Lack of Efficacy|363|||
125075357|NCT01000025|449892893|FG001|Overall Study|Lack of Efficacy|208|||
125075358|NCT01000025|449892892|FG000|Overall Study|Intercurrent Illness|26|||
125075359|NCT01000025|449892893|FG001|Overall Study|Intercurrent Illness|7|||
125075360|NCT00422669|449892894|FG000|Overall Study|The study was terminated early.|98|||
125075361|NCT00422669|449892895|FG001|Overall Study|The study was terminated early.|100|||
125075362|NCT00422669|449892896|FG002|Overall Study|The study was terminated early.|7|||
125075363|NCT00996593|449892897|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
125223301|NCT02326272|450446170|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125223302|NCT02326272|450446171|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125223303|NCT02326272|450446172|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125075364|NCT00996593|449892897|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
125075365|NCT00996593|449892897|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
125075366|NCT00996593|449892897|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
125075367|NCT00996593|449892897|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
125223304|NCT02326272|450446173|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125223305|NCT02326272|450446174|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125223306|NCT02326272|450446175|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125075368|NCT00996593|449892897|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
125075369|NCT00996593|449892897|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
125075370|NCT00996593|449892897|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
125075371|NCT00996593|449892897|FG000|Long-Term Follow-Up|Site Closed|1|||
125075372|NCT02738580|449892898|FG000|Overall Study|Adverse Event|1|||
125075373|NCT02738580|449892899|FG001|Overall Study|Adverse Event|0|||
125075374|NCT02738580|449892898|FG000|Overall Study|Lack of Efficacy|3|||
125075375|NCT02738580|449892899|FG001|Overall Study|Lack of Efficacy|2|||
125075376|NCT02738580|449892898|FG000|Overall Study|Withdrawal by Subject|0|||
125075377|NCT02738580|449892899|FG001|Overall Study|Withdrawal by Subject|1|||
125075378|NCT02738580|449892898|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
125075379|NCT02738580|449892899|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
125075380|NCT00741260|449892901|FG000|Overall Study|Disease Progression|3|||
125075381|NCT00741260|449892902|FG001|Overall Study|Disease Progression|5|||
125075382|NCT00741260|449892903|FG002|Overall Study|Disease Progression|3|||
125075383|NCT00741260|449892904|FG003|Overall Study|Disease Progression|3|||
125075384|NCT00741260|449892905|FG004|Overall Study|Disease Progression|5|||
125075385|NCT00741260|449892906|FG005|Overall Study|Disease Progression|37|||
125075386|NCT00741260|449892907|FG006|Overall Study|Disease Progression|4|||
125075387|NCT00741260|449892901|FG000|Overall Study|Death|0|||
125075388|NCT00741260|449892902|FG001|Overall Study|Death|1|||
125075389|NCT00741260|449892903|FG002|Overall Study|Death|0|||
125075390|NCT00741260|449892904|FG003|Overall Study|Death|1|||
125075391|NCT00741260|449892905|FG004|Overall Study|Death|2|||
125075392|NCT00741260|449892906|FG005|Overall Study|Death|2|||
125075393|NCT00741260|449892907|FG006|Overall Study|Death|1|||
125075394|NCT00741260|449892901|FG000|Overall Study|Withdrawal by Subject|0|||
125075395|NCT00741260|449892902|FG001|Overall Study|Withdrawal by Subject|0|||
125075396|NCT00741260|449892903|FG002|Overall Study|Withdrawal by Subject|0|||
125075397|NCT00741260|449892904|FG003|Overall Study|Withdrawal by Subject|0|||
125075398|NCT00741260|449892905|FG004|Overall Study|Withdrawal by Subject|1|||
125075399|NCT00741260|449892906|FG005|Overall Study|Withdrawal by Subject|3|||
125075400|NCT00741260|449892907|FG006|Overall Study|Withdrawal by Subject|1|||
125075401|NCT00741260|449892901|FG000|Overall Study|Physician Decision|1|||
125075402|NCT00741260|449892902|FG001|Overall Study|Physician Decision|1|||
125075403|NCT00741260|449892903|FG002|Overall Study|Physician Decision|0|||
125075404|NCT00741260|449892904|FG003|Overall Study|Physician Decision|0|||
125075405|NCT00741260|449892905|FG004|Overall Study|Physician Decision|0|||
125075406|NCT00741260|449892906|FG005|Overall Study|Physician Decision|0|||
125075407|NCT00741260|449892907|FG006|Overall Study|Physician Decision|0|||
125075408|NCT00741260|449892901|FG000|Overall Study|Other|2|||
125075409|NCT00741260|449892902|FG001|Overall Study|Other|1|||
125075410|NCT00741260|449892903|FG002|Overall Study|Other|1|||
125075411|NCT00741260|449892904|FG003|Overall Study|Other|2|||
125075412|NCT00741260|449892905|FG004|Overall Study|Other|1|||
125075413|NCT00741260|449892906|FG005|Overall Study|Other|3|||
125075414|NCT00741260|449892907|FG006|Overall Study|Other|1|||
125075415|NCT02810951|449892908|FG000|Overall Study|Adverse Event|1|||
125075416|NCT01250756|449892909|FG000|Infant Series|Withdrawal by Subject|4|||
125223307|NCT02326272|450446176|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125223308|NCT02326272|450446177|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125223309|NCT02326272|450446178|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125075417|NCT01250756|449892910|FG001|Infant Series|Withdrawal by Subject|5|||
125075418|NCT01250756|449892909|FG000|Infant Series|Randomized, Not Vaccinated|2|||
125075419|NCT01250756|449892910|FG001|Infant Series|Randomized, Not Vaccinated|2|||
125075420|NCT01250756|449892909|FG000|Infant Series|Other|22|||
125075421|NCT01250756|449892910|FG001|Infant Series|Other|0|||
125075422|NCT01250756|449892909|FG000|After Infant Series|Adverse Event|5|||
125075423|NCT01250756|449892910|FG001|After Infant Series|Adverse Event|2|||
125075424|NCT01250756|449892909|FG000|After Infant Series|Withdrawal by Subject|4|||
125075425|NCT01250756|449892910|FG001|After Infant Series|Withdrawal by Subject|1|||
125075426|NCT01250756|449892909|FG000|After Infant Series|Other|2|||
125075427|NCT01250756|449892910|FG001|After Infant Series|Other|1|||
125075428|NCT01250756|449892909|FG000|Toddler Dose|Adverse Event|0|||
125075429|NCT01250756|449892910|FG001|Toddler Dose|Adverse Event|1|||
125075430|NCT01250756|449892909|FG000|After Toddler Dose|Adverse Event|0|||
125075431|NCT01250756|449892910|FG001|After Toddler Dose|Adverse Event|1|||
125075432|NCT01928082|449892911|FG000|Overall Study|Study terminated.|1|||
125075433|NCT02142504|449892917|FG000|Overall Study|Protocol Violation|2|||
125075434|NCT02142504|449892918|FG001|Overall Study|Protocol Violation|1|||
125075435|NCT02142504|449892919|FG002|Overall Study|Protocol Violation|2|||
125075436|NCT02142504|449892917|FG000|Overall Study|Adverse Event|2|||
125075437|NCT02142504|449892918|FG001|Overall Study|Adverse Event|3|||
125075438|NCT02142504|449892919|FG002|Overall Study|Adverse Event|4|||
125075439|NCT02142504|449892917|FG000|Overall Study|Lost to Follow-up|12|||
125075440|NCT02142504|449892918|FG001|Overall Study|Lost to Follow-up|19|||
125075441|NCT02142504|449892919|FG002|Overall Study|Lost to Follow-up|17|||
125075442|NCT02142504|449892917|FG000|Overall Study|Withdrawal by Subject|7|||
125075443|NCT02142504|449892918|FG001|Overall Study|Withdrawal by Subject|9|||
125075444|NCT02142504|449892919|FG002|Overall Study|Withdrawal by Subject|11|||
125075445|NCT02142504|449892917|FG000|Overall Study|Pregnancy|4|||
125075446|NCT02142504|449892918|FG001|Overall Study|Pregnancy|4|||
125075447|NCT02142504|449892919|FG002|Overall Study|Pregnancy|2|||
125075448|NCT02142504|449892917|FG000|Overall Study|Physician Decision|0|||
125075449|NCT02142504|449892918|FG001|Overall Study|Physician Decision|1|||
125075450|NCT02142504|449892919|FG002|Overall Study|Physician Decision|3|||
125075451|NCT02142504|449892917|FG000|Overall Study|Reason Not Specified|4|||
125075452|NCT02142504|449892918|FG001|Overall Study|Reason Not Specified|5|||
125075453|NCT02142504|449892919|FG002|Overall Study|Reason Not Specified|4|||
125075454|NCT02120352|449892922|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
125075455|NCT02120352|449892923|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
125075456|NCT02120352|449892924|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
125075457|NCT02120352|449892925|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
125075458|NCT02120352|449892926|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
125142695|NCT01097694|450146172|FG001|Overall Study|Withdrawal by Subject|1|||
125142696|NCT04320745|450146173|FG000|Overall Study|Adverse Event|26|||
125142697|NCT04320745|450146173|FG000|Overall Study|Withdrawal by Subject|4|||
125142698|NCT04320745|450146173|FG000|Overall Study|Lost to Follow-up|12|||
125142699|NCT04320745|450146173|FG000|Overall Study|Protocol Deviation|2|||
125142700|NCT04320745|450146173|FG000|Overall Study|Non-compliance With Study Drug|2|||
125142701|NCT04320745|450146173|FG000|Overall Study|Reason Not Specified|1|||
125142702|NCT02004691|450146174|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
125142703|NCT02004691|450146175|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
125142704|NCT02004691|450146174|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
125142705|NCT02004691|450146175|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
125142706|NCT02004691|450146174|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
125142707|NCT02004691|450146175|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
125142708|NCT02004691|450146174|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
125142709|NCT02004691|450146175|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
125142710|NCT02004691|450146174|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
125142711|NCT02004691|450146175|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
125142712|NCT02004691|450146174|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
125142713|NCT02004691|450146175|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
125142714|NCT01320722|450146176|FG000|Overall Study|Did not Receive Intervention|3|||
125142715|NCT01320722|450146177|FG001|Overall Study|Did not Receive Intervention|2|||
125142716|NCT01320722|450146178|FG002|Overall Study|Did not Receive Intervention|1|||
125142717|NCT01320722|450146179|FG003|Overall Study|Did not Receive Intervention|1|||
125142718|NCT01320722|450146180|FG004|Overall Study|Did not Receive Intervention|2|||
125142719|NCT01320722|450146176|FG000|Overall Study|Lost to Follow-up|0|||
125142720|NCT01320722|450146177|FG001|Overall Study|Lost to Follow-up|1|||
125142721|NCT01320722|450146178|FG002|Overall Study|Lost to Follow-up|0|||
125142722|NCT01320722|450146179|FG003|Overall Study|Lost to Follow-up|1|||
125142723|NCT01320722|450146180|FG004|Overall Study|Lost to Follow-up|3|||
125142724|NCT01320722|450146176|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
125142725|NCT01320722|450146177|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
125142726|NCT01320722|450146178|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
125142727|NCT01320722|450146179|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
125142728|NCT01320722|450146180|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
125142729|NCT01320722|450146176|FG000|Overall Study|Participant Developed a Rash|0|||
125142730|NCT01320722|450146177|FG001|Overall Study|Participant Developed a Rash|0|||
125142731|NCT01320722|450146178|FG002|Overall Study|Participant Developed a Rash|2|||
125142732|NCT01320722|450146179|FG003|Overall Study|Participant Developed a Rash|1|||
125142733|NCT01320722|450146180|FG004|Overall Study|Participant Developed a Rash|1|||
125142734|NCT01320722|450146176|FG000|Overall Study|Non-compliant with Medication|0|||
125142735|NCT01320722|450146177|FG001|Overall Study|Non-compliant with Medication|0|||
125142736|NCT01320722|450146178|FG002|Overall Study|Non-compliant with Medication|1|||
125142737|NCT01320722|450146179|FG003|Overall Study|Non-compliant with Medication|0|||
125142738|NCT01320722|450146180|FG004|Overall Study|Non-compliant with Medication|0|||
125142739|NCT01320722|450146176|FG000|Overall Study|Adverse Event|0|||
125142740|NCT01320722|450146177|FG001|Overall Study|Adverse Event|0|||
125142741|NCT01320722|450146178|FG002|Overall Study|Adverse Event|3|||
125142742|NCT01320722|450146179|FG003|Overall Study|Adverse Event|6|||
125142743|NCT01320722|450146180|FG004|Overall Study|Adverse Event|0|||
125142744|NCT01320722|450146176|FG000|Overall Study|Not Compliant with Study Procedures|0|||
125142745|NCT01320722|450146177|FG001|Overall Study|Not Compliant with Study Procedures|0|||
125142746|NCT01320722|450146178|FG002|Overall Study|Not Compliant with Study Procedures|0|||
125142747|NCT01320722|450146179|FG003|Overall Study|Not Compliant with Study Procedures|4|||
125142748|NCT01320722|450146180|FG004|Overall Study|Not Compliant with Study Procedures|0|||
125142749|NCT01320722|450146176|FG000|Overall Study|Pregnancy|0|||
125142750|NCT01320722|450146177|FG001|Overall Study|Pregnancy|0|||
125142751|NCT01320722|450146178|FG002|Overall Study|Pregnancy|0|||
125142752|NCT01320722|450146179|FG003|Overall Study|Pregnancy|1|||
125142753|NCT01320722|450146180|FG004|Overall Study|Pregnancy|0|||
125142754|NCT01320722|450146176|FG000|Overall Study|Started an Exclusionary Medication|0|||
125142755|NCT01320722|450146177|FG001|Overall Study|Started an Exclusionary Medication|0|||
125142756|NCT01320722|450146178|FG002|Overall Study|Started an Exclusionary Medication|0|||
125142757|NCT01320722|450146179|FG003|Overall Study|Started an Exclusionary Medication|0|||
125142758|NCT01320722|450146180|FG004|Overall Study|Started an Exclusionary Medication|1|||
125142759|NCT01320722|450146176|FG000|Overall Study|Withdrew due to Health Condition|0|||
125142760|NCT01320722|450146177|FG001|Overall Study|Withdrew due to Health Condition|0|||
125142761|NCT01320722|450146178|FG002|Overall Study|Withdrew due to Health Condition|0|||
125142762|NCT01320722|450146179|FG003|Overall Study|Withdrew due to Health Condition|0|||
125142763|NCT01320722|450146180|FG004|Overall Study|Withdrew due to Health Condition|1|||
125142764|NCT00021541|450146181|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
125142765|NCT00021541|450146182|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
125142766|NCT00021541|450146181|FG000|Period 1-First Treatment|Adverse Event|2|||
125075459|NCT02120352|449892927|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
125075460|NCT02120352|449892928|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
125075461|NCT02120352|449892922|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
125075462|NCT02120352|449892923|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
125075463|NCT02120352|449892924|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
125075464|NCT02120352|449892925|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
125142767|NCT00021541|450146182|FG001|Period 1-First Treatment|Adverse Event|1|||
125142768|NCT00021541|450146181|FG000|Period 1-First Treatment|non-adherence|3|||
125142769|NCT00021541|450146182|FG001|Period 1-First Treatment|non-adherence|0|||
125142770|NCT00021541|450146181|FG000|Period 1-First Treatment|Death|1|||
125142771|NCT00021541|450146182|FG001|Period 1-First Treatment|Death|0|||
125142772|NCT00021541|450146181|FG000|Period 1-First Treatment|Pts that did not progress|2|||
125142773|NCT00021541|450146182|FG001|Period 1-First Treatment|Pts that did not progress|2|||
125142774|NCT00021541|450146181|FG000|Period 1-First Treatment|Ineligible|0|||
125142775|NCT00021541|450146182|FG001|Period 1-First Treatment|Ineligible|2|||
125142776|NCT00021541|450146181|FG000|Period 2-crossover|refused phase B|2|||
125142777|NCT00021541|450146182|FG001|Period 2-crossover|refused phase B|2|||
125142778|NCT00021541|450146181|FG000|Period 2-crossover|Withdrawal by Subject|3|||
125142779|NCT00021541|450146182|FG001|Period 2-crossover|Withdrawal by Subject|4|||
125142780|NCT00021541|450146181|FG000|Period 2-crossover|Adverse Event|2|||
125142781|NCT00021541|450146182|FG001|Period 2-crossover|Adverse Event|2|||
125142782|NCT00021541|450146181|FG000|Period 2-crossover|non-adherence|1|||
125142783|NCT00021541|450146182|FG001|Period 2-crossover|non-adherence|0|||
125142784|NCT00021541|450146181|FG000|Period 2-crossover|Pts that did not progress|2|||
125142785|NCT00021541|450146182|FG001|Period 2-crossover|Pts that did not progress|3|||
125142786|NCT03407729|450146183|FG000|Overall Study|Lost to Follow-up|2|||
125142787|NCT03407729|450146184|FG001|Overall Study|Lost to Follow-up|0|||
125142788|NCT03407729|450146183|FG000|Overall Study|Unable to schedule|0|||
125142789|NCT03407729|450146184|FG001|Overall Study|Unable to schedule|3|||
125142790|NCT04142658|450146185|FG000|Overall Study|Death|2|||
125142791|NCT04142658|450146186|FG001|Overall Study|Death|1|||
125142792|NCT04142658|450146185|FG000|Overall Study|Lost to Follow-up|4|||
125142793|NCT04142658|450146186|FG001|Overall Study|Lost to Follow-up|13|||
125142794|NCT04142658|450146185|FG000|Overall Study|Withdrawal by Subject|9|||
125142795|NCT04142658|450146186|FG001|Overall Study|Withdrawal by Subject|16|||
125142796|NCT02943096|450146187|FG000|Overall Study|Lack of Efficacy|0|||
125142797|NCT02943096|450146188|FG001|Overall Study|Lack of Efficacy|1|||
125142798|NCT00939523|450146193|FG000|Overall Study|Lack of Efficacy|1|||
125142799|NCT00939523|450146193|FG000|Overall Study|Physician Decision|2|||
125142800|NCT00024258|450146194|FG000|Overall Study|Withdrawal by Subject|1|||
125142801|NCT00024258|450146194|FG000|Overall Study|Disease Progression|8|||
125142802|NCT01050764|450146195|FG000|Overall Study|Death, before HSCT|1|||
125142803|NCT01050764|450146195|FG000|Overall Study|Donor mobilization failure, death|1|||
125142804|NCT01050764|450146195|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
125142805|NCT02119936|450146196|FG000|Overall Study|Lost to Follow-up|10|||
125142806|NCT00570128|450146197|FG000|Overall Study|Adverse Event|1|||
125142807|NCT00570128|450146198|FG001|Overall Study|Adverse Event|0|||
125142808|NCT00570128|450146197|FG000|Overall Study|Lost to Follow-up|1|||
125142809|NCT00570128|450146198|FG001|Overall Study|Lost to Follow-up|0|||
125142810|NCT00570128|450146197|FG000|Overall Study|Withdrawal by Subject|2|||
125142811|NCT00570128|450146198|FG001|Overall Study|Withdrawal by Subject|0|||
125142812|NCT04194008|450146199|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
125142813|NCT04194008|450146199|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
125142814|NCT04194008|450146199|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
125142815|NCT04194008|450146199|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
125142816|NCT04194008|450146199|FG000|Treatment Phase With Nerivio|Missing data|4|||
125142817|NCT04194008|450146199|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
125142818|NCT03193021|450146200|FG000|Overall Study|Lost to Follow-up|1|||
125142819|NCT03193021|450146201|FG001|Overall Study|Lost to Follow-up|1|||
125142820|NCT01139762|450146202|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
125142821|NCT01139762|450146203|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
125142822|NCT01139762|450146204|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
125075465|NCT02120352|449892926|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
125142823|NCT01139762|450146202|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
125142824|NCT01139762|450146203|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
125142825|NCT01139762|450146204|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
125142826|NCT01139762|450146202|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
125142827|NCT01139762|450146203|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
125142828|NCT01139762|450146204|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
125142829|NCT01139762|450146202|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
125142830|NCT01139762|450146203|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
125142831|NCT01139762|450146204|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
125075466|NCT02120352|449892927|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
125075467|NCT02120352|449892928|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
125075468|NCT02120352|449892922|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
125075469|NCT02120352|449892923|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
125075470|NCT02120352|449892924|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
125075471|NCT02120352|449892925|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
125075472|NCT02120352|449892926|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
125075473|NCT02120352|449892927|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
125075474|NCT02120352|449892928|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
125075475|NCT02120352|449892922|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
125075476|NCT02120352|449892923|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
125075477|NCT02120352|449892924|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
125075478|NCT02120352|449892925|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
125075479|NCT02120352|449892926|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
125075480|NCT02120352|449892927|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
125075481|NCT02120352|449892928|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
125075482|NCT02120352|449892922|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
125075483|NCT02120352|449892923|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
125075484|NCT02120352|449892924|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
125075485|NCT02120352|449892925|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
125075486|NCT02120352|449892926|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
125075487|NCT02120352|449892927|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
125075488|NCT02120352|449892928|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
125075489|NCT02120352|449892922|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
125075490|NCT02120352|449892923|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
125075491|NCT02120352|449892924|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
125075492|NCT02120352|449892925|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
125075493|NCT02120352|449892926|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
125075494|NCT02120352|449892927|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
125075495|NCT02120352|449892928|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
125075496|NCT02120352|449892922|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
125075497|NCT02120352|449892923|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
125075498|NCT02120352|449892924|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
125075499|NCT02120352|449892925|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
125075500|NCT02120352|449892926|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
125075501|NCT02120352|449892927|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
125075502|NCT02120352|449892928|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
125075503|NCT02120352|449892922|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
125075504|NCT02120352|449892923|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
125075505|NCT02120352|449892924|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
125075506|NCT02120352|449892925|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
125075507|NCT02120352|449892926|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
125075508|NCT02120352|449892927|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
125075509|NCT02120352|449892928|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
125075510|NCT02120352|449892922|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
125075511|NCT02120352|449892923|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
125075512|NCT02120352|449892924|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
125075513|NCT02120352|449892925|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
125075514|NCT02120352|449892926|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
125075515|NCT02120352|449892927|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
125075516|NCT02120352|449892928|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
125075517|NCT02120352|449892922|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
125075518|NCT02120352|449892923|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
125075519|NCT02120352|449892924|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
125075520|NCT02120352|449892925|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
125075521|NCT02120352|449892926|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
125075522|NCT02120352|449892927|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
125142832|NCT01139762|450146202|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
125142833|NCT01139762|450146203|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
125142834|NCT01139762|450146204|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
125142835|NCT01139762|450146202|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
125142836|NCT01139762|450146203|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
125142837|NCT01139762|450146204|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
125142838|NCT01139762|450146202|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
125075523|NCT02120352|449892928|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
125075524|NCT02120352|449892922|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
125075525|NCT02120352|449892923|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
125075526|NCT02120352|449892924|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
125075527|NCT02120352|449892925|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
125075528|NCT02120352|449892926|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
125075529|NCT02120352|449892927|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
125075530|NCT02120352|449892928|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
125075531|NCT02120352|449892922|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
125075532|NCT02120352|449892923|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
125075533|NCT02120352|449892924|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
125075534|NCT02120352|449892925|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
125075535|NCT02120352|449892926|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
125075536|NCT02120352|449892927|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
125075537|NCT02120352|449892928|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
125075538|NCT02120352|449892922|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
125075539|NCT02120352|449892923|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
125075540|NCT02120352|449892924|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
125075541|NCT02120352|449892925|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
125075542|NCT02120352|449892926|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
125075543|NCT02120352|449892927|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
125075544|NCT02120352|449892928|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
125075545|NCT02120352|449892922|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
125075546|NCT02120352|449892923|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
125075547|NCT02120352|449892924|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
125075548|NCT02120352|449892925|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
125075549|NCT02120352|449892926|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
125075550|NCT02120352|449892927|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
125075551|NCT02120352|449892928|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
125075552|NCT02120352|449892922|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
125075553|NCT02120352|449892923|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
125075554|NCT02120352|449892924|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
125075555|NCT02120352|449892925|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
125075556|NCT02120352|449892926|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
125075557|NCT02120352|449892927|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
125075558|NCT02120352|449892928|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
125075559|NCT02120352|449892922|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
125075560|NCT02120352|449892923|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
125075561|NCT02120352|449892924|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
125075562|NCT02120352|449892925|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
125075563|NCT02120352|449892926|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
125075564|NCT02120352|449892927|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
125075565|NCT02120352|449892928|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
125075566|NCT02120352|449892922|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
125075567|NCT02120352|449892923|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
125075568|NCT02120352|449892924|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
125075569|NCT02120352|449892925|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
125075570|NCT02120352|449892926|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
125075571|NCT02120352|449892927|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
125142839|NCT01139762|450146203|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
125142840|NCT01139762|450146204|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
125142841|NCT01139762|450146202|FG000|Double-Blind Randomized Active Treatment|Death|0|||
125142842|NCT01139762|450146203|FG001|Double-Blind Randomized Active Treatment|Death|1|||
125142843|NCT01139762|450146204|FG002|Double-Blind Randomized Active Treatment|Death|1|||
125142844|NCT01139762|450146202|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
125075572|NCT02120352|449892928|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
125075573|NCT02120352|449892922|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
125075574|NCT02120352|449892923|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
125075575|NCT02120352|449892924|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
125075576|NCT02120352|449892925|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
125075577|NCT02120352|449892926|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
125075578|NCT02120352|449892927|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
125142845|NCT01139762|450146203|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
125142846|NCT01139762|450146204|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
125142847|NCT01139762|450146202|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
125223310|NCT02326272|450446164|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
125223311|NCT02326272|450446165|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
125223312|NCT02326272|450446166|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
125223313|NCT02326272|450446167|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125223314|NCT02326272|450446168|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125223315|NCT02326272|450446169|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125223316|NCT02326272|450446170|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125223317|NCT02326272|450446171|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125223318|NCT02326272|450446172|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125223319|NCT02326272|450446173|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125223320|NCT02326272|450446174|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125223321|NCT02326272|450446175|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125075579|NCT02120352|449892928|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
125075580|NCT02120352|449892922|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
125075581|NCT02120352|449892923|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
125075582|NCT02120352|449892924|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
125075583|NCT02120352|449892925|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
125075584|NCT02120352|449892926|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
125075585|NCT02120352|449892927|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
125075586|NCT02120352|449892928|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
125075587|NCT02120352|449892922|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
125075588|NCT02120352|449892923|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
125075589|NCT02120352|449892924|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
125075590|NCT02120352|449892925|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
125075591|NCT02120352|449892926|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
125075592|NCT02120352|449892927|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
125075593|NCT02120352|449892928|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
125075594|NCT02120352|449892922|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
125075595|NCT02120352|449892923|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
125075596|NCT02120352|449892924|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
125075597|NCT02120352|449892925|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
125075598|NCT02120352|449892926|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
125075599|NCT02120352|449892927|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
125075600|NCT02120352|449892928|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
125075601|NCT02120352|449892922|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
125075602|NCT02120352|449892923|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
125075603|NCT02120352|449892924|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
125075604|NCT02120352|449892925|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
125075605|NCT02120352|449892926|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
125075606|NCT02120352|449892927|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
125075607|NCT02120352|449892928|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
125075608|NCT01610206|449892929|FG000|Overall Study|Adverse Event|10|||
125075609|NCT01610206|449892930|FG001|Overall Study|Adverse Event|30|||
125075610|NCT00166517|449892932|FG000|Overall Study|Lost to Follow-up|1|||
125075611|NCT00166517|449892933|FG001|Overall Study|Lost to Follow-up|0|||
125075612|NCT00166517|449892932|FG000|Overall Study|Protocol Violation|4|||
125075613|NCT00166517|449892933|FG001|Overall Study|Protocol Violation|1|||
125075614|NCT00166517|449892932|FG000|Overall Study|Withdrawal by Subject|0|||
125075615|NCT00166517|449892933|FG001|Overall Study|Withdrawal by Subject|1|||
125075616|NCT02186561|449892934|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
125075617|NCT02186561|449892934|FG000|Enrollment|Enrollment Cap Reached|5|||
125075618|NCT02186561|449892934|FG000|Enrollment|Insurance Denial|2|||
125075619|NCT02186561|449892934|FG000|Enrollment|Withdrawal by Subject|2|||
125075620|NCT02186561|449892934|FG000|Enrollment|Investigator Withdrew Consent|1|||
125075621|NCT02186561|449892934|FG000|30-Day Post Index Procedure Visit|Death|1|||
125075622|NCT02186561|449892934|FG000|1- Year Post Index Procedure Visit|Death|1|||
125075623|NCT02186561|449892934|FG000|1- Year Post Index Procedure Visit|Missed|1|||
125075624|NCT04285853|449892935|FG000|Overall Study|Withdrawal by Subject|1|||
125075625|NCT04285853|449892936|FG001|Overall Study|Withdrawal by Subject|0|||
125075626|NCT04285853|449892935|FG000|Overall Study|Lost to Follow-up|9|||
125075627|NCT04285853|449892936|FG001|Overall Study|Lost to Follow-up|5|||
125075628|NCT01802515|449892940|FG000|Overall Study|Withdrawal by Subject|3|||
125075629|NCT01802515|449892941|FG001|Overall Study|Withdrawal by Subject|0|||
125075630|NCT01802515|449892942|FG002|Overall Study|Withdrawal by Subject|0|||
125075631|NCT02371980|449895123|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
125075632|NCT02371980|449895124|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
125075633|NCT02371980|449895125|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
125075634|NCT02371980|449895126|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
125075635|NCT02371980|449895127|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
125075636|NCT02371980|449895123|FG000|Open-label Period|Significant Protocol Deviation|19|||
125075637|NCT02371980|449895124|FG001|Open-label Period|Significant Protocol Deviation|0|||
125223322|NCT02326272|450446176|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125075638|NCT02371980|449895125|FG002|Open-label Period|Significant Protocol Deviation|0|||
125075639|NCT02371980|449895126|FG003|Open-label Period|Significant Protocol Deviation|0|||
125075640|NCT02371980|449895127|FG004|Open-label Period|Significant Protocol Deviation|0|||
125075641|NCT02371980|449895123|FG000|Open-label Period|Noncompliance with Study Drug|10|||
125075642|NCT02371980|449895124|FG001|Open-label Period|Noncompliance with Study Drug|0|||
125075643|NCT02371980|449895125|FG002|Open-label Period|Noncompliance with Study Drug|0|||
125075644|NCT02371980|449895126|FG003|Open-label Period|Noncompliance with Study Drug|0|||
125075645|NCT02371980|449895127|FG004|Open-label Period|Noncompliance with Study Drug|0|||
125075646|NCT02371980|449895123|FG000|Open-label Period|Lost to Follow-up|55|||
125075647|NCT02371980|449895124|FG001|Open-label Period|Lost to Follow-up|0|||
125075648|NCT02371980|449895125|FG002|Open-label Period|Lost to Follow-up|0|||
125075649|NCT02371980|449895126|FG003|Open-label Period|Lost to Follow-up|0|||
125075650|NCT02371980|449895127|FG004|Open-label Period|Lost to Follow-up|0|||
125075651|NCT02371980|449895123|FG000|Open-label Period|Voluntary Withdrawal|91|||
125075652|NCT02371980|449895124|FG001|Open-label Period|Voluntary Withdrawal|0|||
125075653|NCT02371980|449895125|FG002|Open-label Period|Voluntary Withdrawal|0|||
125075654|NCT02371980|449895126|FG003|Open-label Period|Voluntary Withdrawal|0|||
125075655|NCT02371980|449895127|FG004|Open-label Period|Voluntary Withdrawal|0|||
125075656|NCT02371980|449895123|FG000|Open-label Period|Pregnancy|1|||
125075657|NCT02371980|449895124|FG001|Open-label Period|Pregnancy|0|||
125075658|NCT02371980|449895125|FG002|Open-label Period|Pregnancy|0|||
125075659|NCT02371980|449895126|FG003|Open-label Period|Pregnancy|0|||
125075660|NCT02371980|449895127|FG004|Open-label Period|Pregnancy|0|||
125075661|NCT02371980|449895123|FG000|Open-label Period|Lack of Efficacy|116|||
125075662|NCT02371980|449895124|FG001|Open-label Period|Lack of Efficacy|0|||
125075663|NCT02371980|449895125|FG002|Open-label Period|Lack of Efficacy|0|||
125075664|NCT02371980|449895126|FG003|Open-label Period|Lack of Efficacy|0|||
125075665|NCT02371980|449895127|FG004|Open-label Period|Lack of Efficacy|0|||
125075666|NCT02371980|449895123|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
125075667|NCT02371980|449895124|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
125075668|NCT02371980|449895125|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
125075669|NCT02371980|449895126|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
125075670|NCT02371980|449895127|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
125075671|NCT02371980|449895123|FG000|Open-label Period|Reason not Specified|9|||
125075672|NCT02371980|449895124|FG001|Open-label Period|Reason not Specified|0|||
125075673|NCT02371980|449895125|FG002|Open-label Period|Reason not Specified|0|||
125075674|NCT02371980|449895126|FG003|Open-label Period|Reason not Specified|0|||
125075675|NCT02371980|449895127|FG004|Open-label Period|Reason not Specified|0|||
125075676|NCT02371980|449895123|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
125075677|NCT02371980|449895124|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
125075678|NCT02371980|449895125|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
125075679|NCT02371980|449895126|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
125075680|NCT02371980|449895127|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
125075681|NCT02371980|449895123|FG000|Double-blind Period|Significant Protocol Deviation|0|||
125075682|NCT02371980|449895124|FG001|Double-blind Period|Significant Protocol Deviation|2|||
125075683|NCT02371980|449895125|FG002|Double-blind Period|Significant Protocol Deviation|7|||
125075684|NCT02371980|449895126|FG003|Double-blind Period|Significant Protocol Deviation|3|||
125075685|NCT02371980|449895127|FG004|Double-blind Period|Significant Protocol Deviation|3|||
125142848|NCT01139762|450146203|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
125142849|NCT01139762|450146204|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
125142850|NCT01139762|450146202|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
125142851|NCT01139762|450146203|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
125142852|NCT01139762|450146204|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
125142853|NCT01139762|450146202|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
125142854|NCT01139762|450146203|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
125142855|NCT01139762|450146204|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
125142856|NCT01139762|450146202|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
125142857|NCT01139762|450146203|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
125075686|NCT02371980|449895123|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
125075687|NCT02371980|449895124|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
125075688|NCT02371980|449895125|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
125142858|NCT01139762|450146204|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
125142859|NCT01139762|450146202|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
125142860|NCT01139762|450146203|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
125075689|NCT02371980|449895126|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
125075690|NCT02371980|449895127|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
125075691|NCT02371980|449895123|FG000|Double-blind Period|Lost to Follow-up|0|||
125075692|NCT02371980|449895124|FG001|Double-blind Period|Lost to Follow-up|8|||
125075693|NCT02371980|449895125|FG002|Double-blind Period|Lost to Follow-up|8|||
125075694|NCT02371980|449895126|FG003|Double-blind Period|Lost to Follow-up|6|||
125075695|NCT02371980|449895127|FG004|Double-blind Period|Lost to Follow-up|5|||
125075696|NCT02371980|449895123|FG000|Double-blind Period|Voluntary Withdrawal|0|||
125075697|NCT02371980|449895124|FG001|Double-blind Period|Voluntary Withdrawal|12|||
125075698|NCT02371980|449895125|FG002|Double-blind Period|Voluntary Withdrawal|8|||
125075699|NCT02371980|449895126|FG003|Double-blind Period|Voluntary Withdrawal|9|||
125075700|NCT02371980|449895127|FG004|Double-blind Period|Voluntary Withdrawal|11|||
125075701|NCT02371980|449895123|FG000|Double-blind Period|Relapse|0|||
125075702|NCT02371980|449895124|FG001|Double-blind Period|Relapse|50|||
125075703|NCT02371980|449895125|FG002|Double-blind Period|Relapse|25|||
125223323|NCT02326272|450446177|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125075704|NCT02371980|449895126|FG003|Double-blind Period|Relapse|25|||
125075705|NCT02371980|449895127|FG004|Double-blind Period|Relapse|26|||
125075706|NCT02371980|449895123|FG000|Double-blind Period|Reason not Specified|0|||
125075707|NCT02371980|449895124|FG001|Double-blind Period|Reason not Specified|3|||
125075708|NCT02371980|449895125|FG002|Double-blind Period|Reason not Specified|3|||
125075709|NCT02371980|449895126|FG003|Double-blind Period|Reason not Specified|2|||
125075710|NCT02371980|449895127|FG004|Double-blind Period|Reason not Specified|1|||
125075711|NCT02371980|449895123|FG000|Double-blind Period|Missing|0|||
125075712|NCT02371980|449895124|FG001|Double-blind Period|Missing|1|||
125075713|NCT02371980|449895125|FG002|Double-blind Period|Missing|0|||
125075714|NCT02371980|449895126|FG003|Double-blind Period|Missing|0|||
125075715|NCT02371980|449895127|FG004|Double-blind Period|Missing|0|||
125075716|NCT01731990|449895128|FG000|Overall Study|Adverse Event|1|||
125075717|NCT01731990|449895129|FG001|Overall Study|Adverse Event|5|||
125223324|NCT02326272|450446178|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125223325|NCT02326272|450446164|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223326|NCT02326272|450446165|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223327|NCT02326272|450446166|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
125223328|NCT02326272|450446167|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223329|NCT02326272|450446168|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223330|NCT02326272|450446169|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223331|NCT02326272|450446170|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223332|NCT02326272|450446171|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223333|NCT02326272|450446172|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223334|NCT02326272|450446173|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223335|NCT02326272|450446174|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223336|NCT02326272|450446175|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223337|NCT02326272|450446176|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223338|NCT02326272|450446177|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125075718|NCT01731990|449895128|FG000|Overall Study|Withdrawal by Subject|1|||
125075719|NCT01731990|449895129|FG001|Overall Study|Withdrawal by Subject|1|||
125075720|NCT01731990|449895128|FG000|Overall Study|Protocol deviation|1|||
125075721|NCT01731990|449895129|FG001|Overall Study|Protocol deviation|2|||
125075722|NCT01731990|449895128|FG000|Overall Study|Death|1|||
125075723|NCT01731990|449895129|FG001|Overall Study|Death|0|||
125075724|NCT01280812|449895130|FG000|Overall Study|Withdrawal by Subject|2|||
125075725|NCT01280812|449895131|FG001|Overall Study|Withdrawal by Subject|1|||
125075726|NCT01280812|449895132|FG002|Overall Study|Withdrawal by Subject|0|||
125075727|NCT01280812|449895130|FG000|Overall Study|Lost to Follow-up|1|||
125075728|NCT01280812|449895131|FG001|Overall Study|Lost to Follow-up|1|||
125075729|NCT01280812|449895132|FG002|Overall Study|Lost to Follow-up|1|||
125075730|NCT04483544|449895133|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
125075731|NCT04483544|449895133|FG000|Post-Treatment|Admitted to hospice|2|||
125075732|NCT04483544|449895133|FG000|Post-Treatment|Study terminated|3|||
125075733|NCT01131078|449895136|FG000|Overall Study|Adverse Event|22|||
125075734|NCT01131078|449895137|FG001|Overall Study|Adverse Event|12|||
125075735|NCT01131078|449895138|FG002|Overall Study|Adverse Event|17|||
125075736|NCT01131078|449895136|FG000|Overall Study|Progressive Disease|58|||
125075737|NCT01131078|449895137|FG001|Overall Study|Progressive Disease|77|||
125075738|NCT01131078|449895138|FG002|Overall Study|Progressive Disease|71|||
125075739|NCT01131078|449895136|FG000|Overall Study|Protocol Violation|1|||
125075740|NCT01131078|449895137|FG001|Overall Study|Protocol Violation|0|||
125075741|NCT01131078|449895138|FG002|Overall Study|Protocol Violation|0|||
125075742|NCT01131078|449895136|FG000|Overall Study|Lost to Follow-up|1|||
125075743|NCT01131078|449895137|FG001|Overall Study|Lost to Follow-up|1|||
125075744|NCT01131078|449895138|FG002|Overall Study|Lost to Follow-up|1|||
125075745|NCT01131078|449895136|FG000|Overall Study|Withdrawal by Subject|2|||
125075746|NCT01131078|449895137|FG001|Overall Study|Withdrawal by Subject|4|||
125075747|NCT01131078|449895138|FG002|Overall Study|Withdrawal by Subject|3|||
125075748|NCT01131078|449895136|FG000|Overall Study|Non-compliance|3|||
125075749|NCT01131078|449895137|FG001|Overall Study|Non-compliance|0|||
125075750|NCT01131078|449895138|FG002|Overall Study|Non-compliance|0|||
125075751|NCT01131078|449895136|FG000|Overall Study|Physician Decision|10|||
125075752|NCT01131078|449895137|FG001|Overall Study|Physician Decision|6|||
125075753|NCT01131078|449895138|FG002|Overall Study|Physician Decision|8|||
125075754|NCT01131078|449895136|FG000|Overall Study|Death|4|||
125075755|NCT01131078|449895137|FG001|Overall Study|Death|0|||
125075756|NCT01131078|449895138|FG002|Overall Study|Death|2|||
125075757|NCT01131078|449895136|FG000|Overall Study|Other|0|||
125075758|NCT01131078|449895137|FG001|Overall Study|Other|1|||
125075759|NCT01131078|449895138|FG002|Overall Study|Other|0|||
125075760|NCT00790218|449895140|FG000|Overall Study|Death|1|||
125075761|NCT00790218|449895141|FG001|Overall Study|Death|0|||
125075762|NCT00790218|449895142|FG002|Overall Study|Death|0|||
125075763|NCT00880100|449895143|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
125075764|NCT00880100|449895143|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
125075765|NCT00880100|449895143|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
125075766|NCT02853123|449895146|FG000|Treatment Period 1|Adverse Event|0|||
125075767|NCT02853123|449895147|FG001|Treatment Period 1|Adverse Event|3|||
125075768|NCT02853123|449895146|FG000|Washout Period|Worsening of COPD|0|||
125075769|NCT02853123|449895147|FG001|Washout Period|Worsening of COPD|3|||
125075770|NCT02853123|449895146|FG000|Washout Period|Adverse Event|1|||
125075771|NCT02853123|449895147|FG001|Washout Period|Adverse Event|0|||
125075772|NCT05283499|449895148|FG000|Overall Study|Did not receive intervention|1|||
125075773|NCT05283499|449895149|FG001|Overall Study|Did not receive intervention|2|||
125075774|NCT05516134|449895150|FG000|Overall Study|Lost to Follow-up|1|||
125075775|NCT05516134|449895151|FG001|Overall Study|Lost to Follow-up|0|||
125075776|NCT05516134|449895152|FG002|Overall Study|Lost to Follow-up|0|||
125075777|NCT01094808|449895154|FG000|Overall Study|Withdrawal by Subject|1|||
125075778|NCT01094808|449895155|FG001|Overall Study|Withdrawal by Subject|1|||
125075779|NCT01094808|449895156|FG002|Overall Study|Withdrawal by Subject|0|||
125075780|NCT00369278|449895157|FG000|Overall Study|Adverse Event|14|||
125075781|NCT00369278|449895158|FG001|Overall Study|Adverse Event|11|||
125075782|NCT00369278|449895157|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
125075783|NCT00369278|449895158|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
125075784|NCT00369278|449895157|FG000|Overall Study|Protocol Violation|2|||
125075785|NCT00369278|449895158|FG001|Overall Study|Protocol Violation|1|||
125075786|NCT00369278|449895157|FG000|Overall Study|Withdrawal by Subject|2|||
125075787|NCT00369278|449895158|FG001|Overall Study|Withdrawal by Subject|2|||
125075788|NCT00369278|449895157|FG000|Overall Study|Lost to Follow-up|1|||
125075789|NCT00369278|449895158|FG001|Overall Study|Lost to Follow-up|0|||
125075790|NCT00369278|449895157|FG000|Overall Study|Graft loss|1|||
125075791|NCT00369278|449895158|FG001|Overall Study|Graft loss|2|||
125075792|NCT01224106|449895159|FG000|Double-Blind Treatment Phase|Death|3|||
125075793|NCT01224106|449895160|FG001|Double-Blind Treatment Phase|Death|0|||
125075794|NCT01224106|449895161|FG002|Double-Blind Treatment Phase|Death|0|||
125075795|NCT01224106|449895162|FG003|Double-Blind Treatment Phase|Death|0|||
125075796|NCT01224106|449895163|FG004|Double-Blind Treatment Phase|Death|0|||
125075797|NCT01224106|449895159|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
125075798|NCT01224106|449895160|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
125075799|NCT01224106|449895161|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
125075800|NCT01224106|449895162|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
125075801|NCT01224106|449895163|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
125075802|NCT01224106|449895159|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
125075803|NCT01224106|449895160|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
125075804|NCT01224106|449895161|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
125075805|NCT01224106|449895162|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
125075806|NCT01224106|449895163|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
125075807|NCT01224106|449895159|FG000|Double-Blind Treatment Phase|Other|0|||
125075808|NCT01224106|449895160|FG001|Double-Blind Treatment Phase|Other|0|||
125075809|NCT01224106|449895161|FG002|Double-Blind Treatment Phase|Other|1|||
125075810|NCT01224106|449895162|FG003|Double-Blind Treatment Phase|Other|0|||
125075811|NCT01224106|449895163|FG004|Double-Blind Treatment Phase|Other|0|||
125075812|NCT01224106|449895159|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
125075813|NCT01224106|449895160|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
125075814|NCT01224106|449895161|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
125075815|NCT01224106|449895162|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
125075816|NCT01224106|449895163|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
125142861|NCT01139762|450146204|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
125142862|NCT01139762|450146202|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
125142863|NCT01139762|450146203|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
125142864|NCT01139762|450146204|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
125142865|NCT02614196|450146205|FG000|Double Blind Treatment Phase|Adverse Event|8|||
125142866|NCT02614196|450146206|FG001|Double Blind Treatment Phase|Adverse Event|5|||
125142867|NCT02614196|450146207|FG002|Double Blind Treatment Phase|Adverse Event|9|||
125142868|NCT02614196|450146208|FG003|Double Blind Treatment Phase|Adverse Event|0|||
125142869|NCT02614196|450146209|FG004|Double Blind Treatment Phase|Adverse Event|0|||
125142870|NCT02614196|450146210|FG005|Double Blind Treatment Phase|Adverse Event|0|||
125142871|NCT02614196|450146205|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
125142872|NCT02614196|450146206|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
125142873|NCT02614196|450146207|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
125142874|NCT02614196|450146208|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
125142875|NCT02614196|450146209|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
125142876|NCT02614196|450146210|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
125142877|NCT02614196|450146205|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
125142878|NCT02614196|450146206|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
125142879|NCT02614196|450146207|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
125142880|NCT02614196|450146208|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
125142881|NCT02614196|450146209|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
125142882|NCT02614196|450146210|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
125142883|NCT02614196|450146205|FG000|Double Blind Treatment Phase|Physician Decision|4|||
125142884|NCT02614196|450146206|FG001|Double Blind Treatment Phase|Physician Decision|0|||
125142885|NCT02614196|450146207|FG002|Double Blind Treatment Phase|Physician Decision|2|||
125142886|NCT02614196|450146208|FG003|Double Blind Treatment Phase|Physician Decision|0|||
125142887|NCT02614196|450146209|FG004|Double Blind Treatment Phase|Physician Decision|0|||
125142888|NCT02614196|450146210|FG005|Double Blind Treatment Phase|Physician Decision|0|||
125142889|NCT02614196|450146205|FG000|Double Blind Treatment Phase|Pregnancy|1|||
125142890|NCT02614196|450146206|FG001|Double Blind Treatment Phase|Pregnancy|2|||
125142891|NCT02614196|450146207|FG002|Double Blind Treatment Phase|Pregnancy|0|||
125142892|NCT02614196|450146208|FG003|Double Blind Treatment Phase|Pregnancy|0|||
125142893|NCT02614196|450146209|FG004|Double Blind Treatment Phase|Pregnancy|0|||
125142894|NCT02614196|450146210|FG005|Double Blind Treatment Phase|Pregnancy|0|||
125142895|NCT02614196|450146205|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
125142896|NCT02614196|450146206|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
125142897|NCT02614196|450146207|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
125142898|NCT02614196|450146208|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
125142899|NCT02614196|450146209|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
125142900|NCT02614196|450146210|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
125142901|NCT02614196|450146205|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
125142902|NCT02614196|450146206|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
125142903|NCT02614196|450146207|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
125142904|NCT02614196|450146208|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
125075817|NCT01224106|449895159|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
125075818|NCT01224106|449895160|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
125075819|NCT01224106|449895161|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
125142905|NCT02614196|450146209|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
125142906|NCT02614196|450146210|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
125142907|NCT02614196|450146205|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
125142908|NCT02614196|450146206|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
125142909|NCT02614196|450146207|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
125075820|NCT01224106|449895162|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
125075821|NCT01224106|449895163|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
125075822|NCT01224106|449895159|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
125075823|NCT01224106|449895160|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125075824|NCT01224106|449895161|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
125075825|NCT01224106|449895162|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125075826|NCT01224106|449895163|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125142910|NCT02614196|450146208|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
125142911|NCT02614196|450146209|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
125142912|NCT02614196|450146210|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
125142913|NCT02614196|450146205|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
125142914|NCT02614196|450146206|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
125142915|NCT02614196|450146207|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
125142916|NCT02614196|450146208|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
125142917|NCT02614196|450146209|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
125142918|NCT02614196|450146210|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
125142919|NCT02614196|450146205|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
125142920|NCT02614196|450146206|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
125142921|NCT02614196|450146207|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
125142922|NCT02614196|450146208|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
125142923|NCT02614196|450146209|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
125142924|NCT02614196|450146210|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
125142925|NCT02614196|450146205|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
125142926|NCT02614196|450146206|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
125142927|NCT02614196|450146207|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
125142928|NCT02614196|450146208|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
125142929|NCT02614196|450146209|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
125142930|NCT02614196|450146210|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
125142931|NCT02614196|450146205|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
125142932|NCT02614196|450146206|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
125142933|NCT02614196|450146207|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
125142934|NCT02614196|450146208|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
125142935|NCT02614196|450146209|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
125142936|NCT02614196|450146210|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
125142937|NCT02614196|450146205|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
125075827|NCT01224106|449895159|FG000|Open-Label Extension (OLE) Phase|Death|0|||
125075828|NCT01224106|449895160|FG001|Open-Label Extension (OLE) Phase|Death|0|||
125075829|NCT01224106|449895161|FG002|Open-Label Extension (OLE) Phase|Death|0|||
125075830|NCT01224106|449895162|FG003|Open-Label Extension (OLE) Phase|Death|1|||
125142938|NCT02614196|450146206|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
125142939|NCT02614196|450146207|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
125142940|NCT02614196|450146208|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
125142941|NCT02614196|450146209|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
125075831|NCT01224106|449895163|FG004|Open-Label Extension (OLE) Phase|Death|3|||
125075832|NCT01224106|449895159|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
125142942|NCT02614196|450146210|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
125142943|NCT01539239|450146211|FG000|Overall Study|Death|5|||
125142944|NCT01539239|450146212|FG001|Overall Study|Death|5|||
125142945|NCT01539239|450146211|FG000|Overall Study|Lost to Follow-up|7|||
125142946|NCT01539239|450146212|FG001|Overall Study|Lost to Follow-up|12|||
125142947|NCT00640341|450147870|FG000|Overall Study|Adverse Event|0|||
125075833|NCT01224106|449895160|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
125075834|NCT01224106|449895161|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
125075835|NCT01224106|449895162|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
125075836|NCT01224106|449895163|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
125075837|NCT01224106|449895159|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
125223339|NCT02326272|450446178|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223340|NCT02326272|450446164|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223341|NCT02326272|450446165|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223342|NCT02326272|450446166|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
125223343|NCT02326272|450446167|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223344|NCT02326272|450446168|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223345|NCT02326272|450446169|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223346|NCT02326272|450446170|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223347|NCT02326272|450446171|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223348|NCT02326272|450446172|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223349|NCT02326272|450446173|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223350|NCT02326272|450446174|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223351|NCT02326272|450446175|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223352|NCT02326272|450446176|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223353|NCT02326272|450446177|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223354|NCT02326272|450446178|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223355|NCT02326272|450446164|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223356|NCT02326272|450446165|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223357|NCT02326272|450446166|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
125223358|NCT02326272|450446167|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223359|NCT02326272|450446168|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223360|NCT02326272|450446169|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223361|NCT02326272|450446170|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223362|NCT02326272|450446171|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223363|NCT02326272|450446172|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223364|NCT02326272|450446173|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223365|NCT02326272|450446174|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223366|NCT02326272|450446175|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223367|NCT02326272|450446176|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223368|NCT02326272|450446177|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125075838|NCT01224106|449895160|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
125075839|NCT01224106|449895161|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
125075840|NCT01224106|449895162|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
125075841|NCT01224106|449895163|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
125075842|NCT01224106|449895159|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
125075843|NCT01224106|449895160|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
125075844|NCT01224106|449895161|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
125075845|NCT01224106|449895162|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
125075846|NCT01224106|449895163|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
125075847|NCT01224106|449895159|FG000|Open-Label Extension (OLE) Phase|Other|0|||
125075848|NCT01224106|449895160|FG001|Open-Label Extension (OLE) Phase|Other|0|||
125075849|NCT01224106|449895161|FG002|Open-Label Extension (OLE) Phase|Other|0|||
125075850|NCT01224106|449895162|FG003|Open-Label Extension (OLE) Phase|Other|5|||
125142948|NCT00640341|450147871|FG001|Overall Study|Adverse Event|0|||
125142949|NCT00640341|450147872|FG002|Overall Study|Adverse Event|1|||
125142950|NCT00640341|450147870|FG000|Overall Study|Positive Slit Lamp Findings|0|||
125142951|NCT00640341|450147871|FG001|Overall Study|Positive Slit Lamp Findings|0|||
125142952|NCT00640341|450147872|FG002|Overall Study|Positive Slit Lamp Findings|1|||
125142953|NCT00640341|450147870|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
125142954|NCT00640341|450147871|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
125142955|NCT00640341|450147872|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
125142956|NCT00640341|450147870|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
125142957|NCT00640341|450147871|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
125142958|NCT00640341|450147872|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
125142959|NCT00640341|450147870|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
125142960|NCT00640341|450147871|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
125142961|NCT00640341|450147872|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
125142962|NCT00640341|450147870|FG000|Overall Study|Lost to Follow-up|2|||
125142963|NCT00640341|450147871|FG001|Overall Study|Lost to Follow-up|0|||
125142964|NCT00640341|450147872|FG002|Overall Study|Lost to Follow-up|0|||
125075851|NCT01224106|449895163|FG004|Open-Label Extension (OLE) Phase|Other|3|||
125075852|NCT00446797|449895164|FG000|Overall Study|Lack of Efficacy|0|||
125075853|NCT00446797|449895165|FG001|Overall Study|Lack of Efficacy|2|||
125075854|NCT00446797|449895164|FG000|Overall Study|Lost to Follow-up|5|||
125075855|NCT00446797|449895165|FG001|Overall Study|Lost to Follow-up|3|||
125075856|NCT00446797|449895164|FG000|Overall Study|Withdrawal by Subject|2|||
125075857|NCT00446797|449895165|FG001|Overall Study|Withdrawal by Subject|2|||
125075858|NCT00446797|449895164|FG000|Overall Study|Protocol Violation|1|||
125075859|NCT00446797|449895165|FG001|Overall Study|Protocol Violation|3|||
125075860|NCT00446797|449895164|FG000|Overall Study|subject entered at another site|0|||
125075861|NCT00446797|449895165|FG001|Overall Study|subject entered at another site|1|||
125075862|NCT00446797|449895164|FG000|Overall Study|did not meet entrance criteria|0|||
125075863|NCT00446797|449895165|FG001|Overall Study|did not meet entrance criteria|1|||
125075864|NCT02133001|449895166|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
125075865|NCT02133001|449895167|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
125075866|NCT02133001|449895166|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
125075867|NCT02133001|449895167|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
125075868|NCT02133001|449895166|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
125075869|NCT02133001|449895167|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
125075870|NCT02133001|449895166|FG000|Double Blind (Day 1-25)|Other|2|||
125075871|NCT02133001|449895167|FG001|Double Blind (Day 1-25)|Other|2|||
125075872|NCT02133001|449895166|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
125075873|NCT02133001|449895167|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
125075874|NCT02133001|449895166|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
125075875|NCT02133001|449895167|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
125075876|NCT02133001|449895166|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
125075877|NCT02133001|449895167|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
125142965|NCT00640341|450147870|FG000|Overall Study|Withdrawal by Subject|4|||
125142966|NCT00640341|450147871|FG001|Overall Study|Withdrawal by Subject|0|||
125142967|NCT00640341|450147872|FG002|Overall Study|Withdrawal by Subject|1|||
125142968|NCT00640341|450147870|FG000|Overall Study|Unacceptable Lens Movement|1|||
125142969|NCT00640341|450147871|FG001|Overall Study|Unacceptable Lens Movement|0|||
125142970|NCT00640341|450147872|FG002|Overall Study|Unacceptable Lens Movement|0|||
125142971|NCT00640341|450147870|FG000|Overall Study|Poor fit/Uncomfortable|4|||
125142972|NCT00640341|450147871|FG001|Overall Study|Poor fit/Uncomfortable|0|||
125142973|NCT00640341|450147872|FG002|Overall Study|Poor fit/Uncomfortable|0|||
125142974|NCT00640341|450147870|FG000|Overall Study|Ineligable at Baseline|5|||
125142975|NCT00640341|450147871|FG001|Overall Study|Ineligable at Baseline|3|||
125142976|NCT00640341|450147872|FG002|Overall Study|Ineligable at Baseline|2|||
125142977|NCT00640341|450147870|FG000|Overall Study|Adverse event and positive slit lamp|1|||
125142978|NCT00640341|450147871|FG001|Overall Study|Adverse event and positive slit lamp|0|||
125142979|NCT00640341|450147872|FG002|Overall Study|Adverse event and positive slit lamp|0|||
125142980|NCT01520987|450147875|FG000|Overall Study|Withdrawal by Subject|1|||
125142981|NCT01520987|450147876|FG001|Overall Study|Withdrawal by Subject|0|||
125142982|NCT01520987|450147877|FG002|Overall Study|Withdrawal by Subject|0|||
125142983|NCT01520987|450147878|FG003|Overall Study|Withdrawal by Subject|0|||
125142984|NCT01520987|450147879|FG004|Overall Study|Withdrawal by Subject|0|||
125142985|NCT01520987|450147880|FG005|Overall Study|Withdrawal by Subject|1|||
125142986|NCT01520987|450147881|FG006|Overall Study|Withdrawal by Subject|0|||
125142987|NCT01520987|450147882|FG007|Overall Study|Withdrawal by Subject|0|||
125142988|NCT02005562|450147883|FG000|Overall Study|Death|2|||
125142989|NCT02005562|450147884|FG001|Overall Study|Death|2|||
125142990|NCT02005562|450147883|FG000|Overall Study|Graft loss|7|||
125142991|NCT02005562|450147884|FG001|Overall Study|Graft loss|6|||
125142992|NCT02005562|450147883|FG000|Overall Study|Withdrawal by Subject|2|||
125142993|NCT02005562|450147884|FG001|Overall Study|Withdrawal by Subject|2|||
125223369|NCT02326272|450446178|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223370|NCT02326272|450446164|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125142994|NCT02005562|450147883|FG000|Overall Study|No transplant|1|||
125142995|NCT02005562|450147884|FG001|Overall Study|No transplant|4|||
125075878|NCT02133001|449895166|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
125142996|NCT02005562|450147883|FG000|Overall Study|Physician Decision|0|||
125223371|NCT02326272|450446165|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125142997|NCT02005562|450147884|FG001|Overall Study|Physician Decision|1|||
125142998|NCT02966340|450147887|FG000|Overall Study|Adverse Event|0|||
125075879|NCT02133001|449895167|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
125075880|NCT02498392|449895172|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
125075881|NCT02498392|449895173|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
125075882|NCT02498392|449895172|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
125075883|NCT02498392|449895173|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
125075884|NCT02498392|449895172|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
125075885|NCT02498392|449895173|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
125075886|NCT02498392|449895172|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
125075887|NCT02498392|449895173|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
125075888|NCT02498392|449895172|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
125075889|NCT02498392|449895173|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
125075890|NCT02498392|449895172|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
125075891|NCT02498392|449895173|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
125075892|NCT03135262|449895176|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
125075893|NCT03135262|449895177|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
125075894|NCT03135262|449895178|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
125075895|NCT03135262|449895179|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
125075896|NCT03135262|449895180|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
125075897|NCT03135262|449895176|FG000|Overall Study|Progression of disease|0|||
125075898|NCT03135262|449895177|FG001|Overall Study|Progression of disease|0|||
125075899|NCT03135262|449895178|FG002|Overall Study|Progression of disease|0|||
125075900|NCT03135262|449895179|FG003|Overall Study|Progression of disease|1|||
125075901|NCT03135262|449895180|FG004|Overall Study|Progression of disease|0|||
125075902|NCT03135262|449895176|FG000|Overall Study|Death|6|||
125075903|NCT03135262|449895177|FG001|Overall Study|Death|2|||
125075904|NCT03135262|449895178|FG002|Overall Study|Death|2|||
125075905|NCT03135262|449895179|FG003|Overall Study|Death|2|||
125075906|NCT03135262|449895180|FG004|Overall Study|Death|0|||
125075907|NCT03135262|449895176|FG000|Overall Study|Withdrawal by Subject|0|||
125075908|NCT03135262|449895177|FG001|Overall Study|Withdrawal by Subject|0|||
125075909|NCT03135262|449895178|FG002|Overall Study|Withdrawal by Subject|1|||
125075910|NCT03135262|449895179|FG003|Overall Study|Withdrawal by Subject|0|||
125075911|NCT03135262|449895180|FG004|Overall Study|Withdrawal by Subject|1|||
125075912|NCT03135262|449895176|FG000|Overall Study|Study terminated by sponsor|2|||
125075913|NCT03135262|449895177|FG001|Overall Study|Study terminated by sponsor|4|||
125075914|NCT03135262|449895178|FG002|Overall Study|Study terminated by sponsor|4|||
125075915|NCT03135262|449895179|FG003|Overall Study|Study terminated by sponsor|3|||
125075916|NCT03135262|449895180|FG004|Overall Study|Study terminated by sponsor|0|||
125075917|NCT01675141|449895181|FG000|Overall Study|Lenalidomide outside NIH|3|||
125075918|NCT01675141|449895181|FG000|Overall Study|Withdrawal by Subject|3|||
125075919|NCT01675141|449895181|FG000|Overall Study|Physician Decision|4|||
125075920|NCT01675141|449895181|FG000|Overall Study|No treatment, per protocol|1|||
125075921|NCT03097133|449895184|FG000|Overall Study|Lost to Follow-up|3|||
125075922|NCT03097133|449895185|FG001|Overall Study|Lost to Follow-up|2|||
125075923|NCT03097133|449895184|FG000|Overall Study|Withdrawal by Subject|2|||
125075924|NCT03097133|449895185|FG001|Overall Study|Withdrawal by Subject|5|||
125075925|NCT03097133|449895184|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
125075926|NCT03097133|449895185|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
125075927|NCT03097133|449895184|FG000|Overall Study|Other|3|||
125075928|NCT03097133|449895185|FG001|Overall Study|Other|2|||
125075929|NCT03097133|449895184|FG000|Overall Study|Adverse Event|1|||
125075930|NCT03097133|449895185|FG001|Overall Study|Adverse Event|0|||
125075931|NCT02873208|449895186|FG000|Overall Study|Withdrawal by Subject|36|||
125075932|NCT02873208|449895186|FG000|Overall Study|Lost to Follow-up|22|||
125075933|NCT02873208|449895186|FG000|Overall Study|Adverse Event|15|||
125075934|NCT02873208|449895186|FG000|Overall Study|Non-compliance with study drug|12|||
125075935|NCT02873208|449895186|FG000|Overall Study|Protocol Violation|8|||
125075936|NCT02873208|449895186|FG000|Overall Study|Pregnancy|2|||
125075937|NCT02873208|449895186|FG000|Overall Study|Incarceration|1|||
125075938|NCT02873208|449895186|FG000|Overall Study|Lack of Efficacy|1|||
125075939|NCT02873208|449895186|FG000|Overall Study|Physician Decision|1|||
125075940|NCT04080752|449895187|FG000|Overall Study|Adverse Event|2|||
125075941|NCT04080752|449895188|FG001|Overall Study|Adverse Event|3|||
125075942|NCT04080752|449895187|FG000|Overall Study|Lack of Efficacy|1|||
125075943|NCT04080752|449895188|FG001|Overall Study|Lack of Efficacy|0|||
125075944|NCT04080752|449895187|FG000|Overall Study|Lost to Follow-up|1|||
125075945|NCT04080752|449895188|FG001|Overall Study|Lost to Follow-up|0|||
125142999|NCT02966340|450147888|FG001|Overall Study|Adverse Event|1|||
125143000|NCT02966340|450147887|FG000|Overall Study|Lost to Follow-up|0|||
125075946|NCT04080752|449895187|FG000|Overall Study|Pregnancy|0|||
125075947|NCT04080752|449895188|FG001|Overall Study|Pregnancy|1|||
125075948|NCT04080752|449895187|FG000|Overall Study|Withdrawal by Subject|7|||
125075949|NCT04080752|449895188|FG001|Overall Study|Withdrawal by Subject|0|||
125075950|NCT04080752|449895187|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125075951|NCT04080752|449895188|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125075952|NCT04080752|449895187|FG000|Overall Study|Other|2|||
125075953|NCT04080752|449895188|FG001|Overall Study|Other|1|||
125075954|NCT01192100|449895189|FG000|Overall Study|Withdrawal by Subject|0|||
125075955|NCT01192100|449895190|FG001|Overall Study|Withdrawal by Subject|0|||
125075956|NCT01192100|449895191|FG002|Overall Study|Withdrawal by Subject|0|||
125075957|NCT01192100|449895192|FG003|Overall Study|Withdrawal by Subject|0|||
125075958|NCT01192100|449895193|FG004|Overall Study|Withdrawal by Subject|1|||
125075959|NCT01192100|449895194|FG005|Overall Study|Withdrawal by Subject|0|||
125075960|NCT01192100|449895189|FG000|Overall Study|Protocol Violation|0|||
125075961|NCT01192100|449895190|FG001|Overall Study|Protocol Violation|0|||
125075962|NCT01192100|449895191|FG002|Overall Study|Protocol Violation|0|||
125075963|NCT01192100|449895192|FG003|Overall Study|Protocol Violation|1|||
125075964|NCT01192100|449895193|FG004|Overall Study|Protocol Violation|0|||
125075965|NCT01192100|449895194|FG005|Overall Study|Protocol Violation|0|||
125075966|NCT04737759|449895195|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
125075967|NCT04737759|449895196|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
125075968|NCT04737759|449895195|FG000|Overall Study|Death|2|||
125075969|NCT04737759|449895196|FG001|Overall Study|Death|0|||
125075970|NCT04737759|449895195|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
125075971|NCT04737759|449895196|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
125075972|NCT04737759|449895195|FG000|Overall Study|Lost to Follow-up|4|||
125075973|NCT04737759|449895196|FG001|Overall Study|Lost to Follow-up|12|||
125075974|NCT02260388|449895197|FG000|Overall Study|Lost to Follow-up|2|||
125075975|NCT02260388|449895198|FG001|Overall Study|Lost to Follow-up|8|||
125075976|NCT02260388|449895199|FG002|Overall Study|Lost to Follow-up|3|||
125075977|NCT02260388|449895200|FG003|Overall Study|Lost to Follow-up|4|||
125075978|NCT02017704|449895204|FG000|Overall Study|Withdrawal by Subject|2|||
125075979|NCT02017704|449895205|FG001|Overall Study|Withdrawal by Subject|0|||
125075980|NCT00918346|449895206|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
125075981|NCT00918346|449895207|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
125075982|NCT01421069|449895208|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
125075983|NCT01421069|449895208|FG000|Parent Study|Failed to return|3|||
125075984|NCT01421069|449895208|FG000|Parent Study|Withdrawal by Subject|1|||
125075985|NCT01421069|449895208|FG000|Parent Study|Lost to Follow-up|2|||
125075986|NCT01421069|449895208|FG000|Parent Study|Lack of Efficacy|1|||
125075987|NCT01421069|449895208|FG000|Overall Period for Extension Study|Other|2|||
125075988|NCT01421069|449895208|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
125075989|NCT01421069|449895208|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
125075990|NCT01421069|449895208|FG000|Overall Period for Extension Study|Pregnancy|1|||
125075991|NCT01421069|449895208|FG000|Overall Period for Extension Study|Adverse Event|1|||
125075992|NCT01421069|449895208|FG000|Overall Period for Extension Study|Protocol Violation|1|||
125075993|NCT01421069|449895208|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
125075994|NCT01421069|449895208|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
125075995|NCT01421069|449895208|FG000|Active Treatment Period|Other|1|||
125075996|NCT01421069|449895208|FG000|Active Treatment Period|No longer willing to participate in study|8|||
125075997|NCT01421069|449895208|FG000|Active Treatment Period|Insufficient clinical response|1|||
125075998|NCT01421069|449895208|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
125075999|NCT01421069|449895208|FG000|Active Treatment Period|Pregnancy|1|||
125076000|NCT01421069|449895208|FG000|Active Treatment Period|Adverse Event|1|||
125076001|NCT01421069|449895208|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
125076002|NCT01421069|449895208|FG000|Active Treatment Period|Enrolled in observational period|29|||
125076003|NCT01421069|449895208|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
125076004|NCT01421069|449895208|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
125076005|NCT01421069|449895208|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
125076006|NCT01421069|449895208|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
125076007|NCT01421069|449895208|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
125076008|NCT01421069|449895208|FG000|2b. Retreatment Period|Protocol Violation|1|||
125076009|NCT01421069|449895208|FG000|Observational Period|Other|1|||
125076010|NCT01421069|449895208|FG000|Observational Period|No longer willing to participate in study|4|||
125223372|NCT02326272|450446166|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
125223373|NCT02326272|450446167|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125076011|NCT01421069|449895208|FG000|Observational Period|Lost to Follow-up|3|||
125076012|NCT01095666|449895209|FG000|Overall Study|Lack of Efficacy|0|||
125076013|NCT01095666|449895210|FG001|Overall Study|Lack of Efficacy|0|||
125076014|NCT01095666|449895211|FG002|Overall Study|Lack of Efficacy|1|||
125076015|NCT01095666|449895209|FG000|Overall Study|Adverse Event|2|||
125076016|NCT01095666|449895210|FG001|Overall Study|Adverse Event|1|||
125076017|NCT01095666|449895211|FG002|Overall Study|Adverse Event|3|||
125076018|NCT01095666|449895209|FG000|Overall Study|Lost to Follow-up|2|||
125076019|NCT01095666|449895210|FG001|Overall Study|Lost to Follow-up|2|||
125143001|NCT02966340|450147888|FG001|Overall Study|Lost to Follow-up|1|||
125143002|NCT02966340|450147887|FG000|Overall Study|Withdrawal by Subject|1|||
125143003|NCT02966340|450147888|FG001|Overall Study|Withdrawal by Subject|0|||
125143004|NCT02966340|450147887|FG000|Overall Study|data acquisition error|1|||
125143005|NCT02966340|450147888|FG001|Overall Study|data acquisition error|0|||
125143006|NCT02966340|450147887|FG000|Overall Study|startle non-responder|1|||
125143007|NCT02966340|450147888|FG001|Overall Study|startle non-responder|1|||
125143008|NCT01622660|450147889|FG000|Overall Study|Adverse Event|1|||
125143009|NCT04590781|450147890|FG000|Overall Study|Death|0|||
125143010|NCT04590781|450147891|FG001|Overall Study|Death|2|||
125143011|NCT04590781|450147890|FG000|Overall Study|Withdrawal by Subject|2|||
125143012|NCT04590781|450147891|FG001|Overall Study|Withdrawal by Subject|0|||
125143013|NCT01680016|450147892|FG000|Overall Study|Adverse Event|0|||
125143014|NCT01680016|450147893|FG001|Overall Study|Adverse Event|0|||
125143015|NCT01680016|450147894|FG002|Overall Study|Adverse Event|1|||
125143016|NCT01680016|450147895|FG003|Overall Study|Adverse Event|4|||
125143017|NCT01680016|450147892|FG000|Overall Study|The Subject went out of The Trial|1|||
125143018|NCT01680016|450147893|FG001|Overall Study|The Subject went out of The Trial|0|||
125143019|NCT01680016|450147894|FG002|Overall Study|The Subject went out of The Trial|3|||
125143020|NCT01680016|450147895|FG003|Overall Study|The Subject went out of The Trial|0|||
125143021|NCT01680016|450147892|FG000|Overall Study|Protocol Violation|0|||
125143022|NCT01680016|450147893|FG001|Overall Study|Protocol Violation|1|||
125143023|NCT01680016|450147894|FG002|Overall Study|Protocol Violation|0|||
125143024|NCT01680016|450147895|FG003|Overall Study|Protocol Violation|0|||
125143025|NCT01680016|450147892|FG000|Overall Study|Withdrawal by Subject|5|||
125143026|NCT01680016|450147893|FG001|Overall Study|Withdrawal by Subject|7|||
125143027|NCT01680016|450147894|FG002|Overall Study|Withdrawal by Subject|1|||
125143028|NCT01680016|450147895|FG003|Overall Study|Withdrawal by Subject|1|||
125143029|NCT01120899|450147896|FG000|Overall Study|Withdrawal by Subject|3|||
125143030|NCT00202839|450147899|FG000|Overall Study|Adverse Event|1|||
125143031|NCT00202839|450147900|FG001|Overall Study|Adverse Event|5|||
125143032|NCT00202839|450147899|FG000|Overall Study|Physician Decision|12|||
125143033|NCT00202839|450147900|FG001|Overall Study|Physician Decision|0|||
125143034|NCT00202839|450147899|FG000|Overall Study|Withdrawal by Subject|6|||
125143035|NCT00202839|450147900|FG001|Overall Study|Withdrawal by Subject|2|||
125143036|NCT00202839|450147899|FG000|Overall Study|Protocol Violation|2|||
125143037|NCT00202839|450147900|FG001|Overall Study|Protocol Violation|1|||
125143038|NCT00202839|450147899|FG000|Overall Study|Lost to Follow-up|3|||
125143039|NCT00202839|450147900|FG001|Overall Study|Lost to Follow-up|2|||
125143040|NCT00442351|450147901|FG000|Overall Study|Administrative|6|||
125143041|NCT00442351|450147902|FG001|Overall Study|Administrative|5|||
125143042|NCT00442351|450147901|FG000|Overall Study|Did not meet protocol eligibility|1|||
125143043|NCT00442351|450147902|FG001|Overall Study|Did not meet protocol eligibility|0|||
125143044|NCT00442351|450147901|FG000|Overall Study|Other|0|||
125143045|NCT00442351|450147902|FG001|Overall Study|Other|1|||
125143046|NCT00377156|450147907|FG000|Overall Study|Death|23|||
125143047|NCT00377156|450147908|FG001|Overall Study|Death|19|||
125143048|NCT00377156|450147907|FG000|Overall Study|Withdrawal by Subject|16|||
125143049|NCT00377156|450147908|FG001|Overall Study|Withdrawal by Subject|24|||
125143050|NCT00377156|450147907|FG000|Overall Study|Had follow-up <90 d|3|||
125143051|NCT00377156|450147908|FG001|Overall Study|Had follow-up <90 d|6|||
125143052|NCT00377156|450147907|FG000|Overall Study|Cancellation|1|||
125143053|NCT00377156|450147908|FG001|Overall Study|Cancellation|0|||
125143054|NCT00377156|450147907|FG000|Overall Study|Refused testing|0|||
125143055|NCT00377156|450147908|FG001|Overall Study|Refused testing|1|||
125143056|NCT00377156|450147907|FG000|Overall Study|Ineligible|0|||
125143057|NCT00377156|450147908|FG001|Overall Study|Ineligible|1|||
125143058|NCT00377156|450147907|FG000|Overall Study|Disability or language problem|0|||
125143059|NCT00377156|450147908|FG001|Overall Study|Disability or language problem|1|||
125143060|NCT00377156|450147907|FG000|Overall Study|Other|5|||
125143061|NCT00377156|450147908|FG001|Overall Study|Other|2|||
125143062|NCT00288704|450147909|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
125143063|NCT00288704|450147910|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
125143064|NCT00288704|450147911|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
125143065|NCT00288704|450147909|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
125143066|NCT00288704|450147910|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
125143067|NCT00288704|450147911|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
125143068|NCT00288704|450147909|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
125143069|NCT00288704|450147910|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
125143070|NCT00288704|450147911|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
125143071|NCT00288704|450147909|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
125143072|NCT00288704|450147910|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
125143073|NCT00288704|450147911|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
125143074|NCT00288704|450147909|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
125143075|NCT00288704|450147910|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
125076020|NCT01095666|449895211|FG002|Overall Study|Lost to Follow-up|0|||
125076021|NCT01095666|449895209|FG000|Overall Study|Withdrawal by Subject|6|||
125076022|NCT01095666|449895210|FG001|Overall Study|Withdrawal by Subject|6|||
125076023|NCT01095666|449895211|FG002|Overall Study|Withdrawal by Subject|1|||
125076024|NCT01095666|449895209|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
125076025|NCT01095666|449895210|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
125076026|NCT01095666|449895211|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
125076027|NCT00841672|449895220|FG000|Overall Study|Adverse Event|7|||
125076028|NCT00841672|449895221|FG001|Overall Study|Adverse Event|16|||
125076029|NCT00841672|449895220|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125076030|NCT00841672|449895221|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125076031|NCT00841672|449895220|FG000|Overall Study|Subject withdrew consent|2|||
125076032|NCT00841672|449895221|FG001|Overall Study|Subject withdrew consent|4|||
125076033|NCT00841672|449895220|FG000|Overall Study|Lost to Follow-up|1|||
125076034|NCT00841672|449895221|FG001|Overall Study|Lost to Follow-up|1|||
125076035|NCT00841672|449895220|FG000|Overall Study|Administrative problems|9|||
125076036|NCT00841672|449895221|FG001|Overall Study|Administrative problems|9|||
125076037|NCT00841672|449895220|FG000|Overall Study|Misrandomized|1|||
125076038|NCT00841672|449895221|FG001|Overall Study|Misrandomized|0|||
125076039|NCT00841672|449895220|FG000|Overall Study|Protocol Deviation|0|||
125076040|NCT00841672|449895221|FG001|Overall Study|Protocol Deviation|1|||
125076041|NCT01451398|449895225|FG000|Overall Study|Adverse Event|7|||
125076042|NCT01451398|449895226|FG001|Overall Study|Adverse Event|9|||
125076043|NCT01451398|449895225|FG000|Overall Study|Protocol Violation|1|||
125076044|NCT01451398|449895226|FG001|Overall Study|Protocol Violation|2|||
125076045|NCT01451398|449895225|FG000|Overall Study|Physician Decision|1|||
125076046|NCT01451398|449895226|FG001|Overall Study|Physician Decision|1|||
125076047|NCT01451398|449895225|FG000|Overall Study|Withdrawal by Subject|10|||
125076048|NCT01451398|449895226|FG001|Overall Study|Withdrawal by Subject|14|||
125076049|NCT01451398|449895225|FG000|Overall Study|Lost to Follow-up|6|||
125076050|NCT01451398|449895226|FG001|Overall Study|Lost to Follow-up|4|||
125076051|NCT01451398|449895225|FG000|Overall Study|Non-compliance with study drug|1|||
125076052|NCT01451398|449895226|FG001|Overall Study|Non-compliance with study drug|3|||
125076053|NCT01451398|449895225|FG000|Overall Study|Non-compliance with protocol|1|||
125076054|NCT01451398|449895226|FG001|Overall Study|Non-compliance with protocol|1|||
125076055|NCT01451398|449895225|FG000|Overall Study|Moved out of country|0|||
125076056|NCT01451398|449895226|FG001|Overall Study|Moved out of country|1|||
125076057|NCT01451398|449895225|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
125076058|NCT01451398|449895226|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
125076059|NCT01451398|449895225|FG000|Overall Study|Lack of Efficacy|0|||
125076060|NCT01451398|449895226|FG001|Overall Study|Lack of Efficacy|1|||
125076061|NCT02427100|449895230|FG000|Overall Study|Lost to Follow-up|0|||
125076062|NCT02427100|449895231|FG001|Overall Study|Lost to Follow-up|2|||
125076063|NCT00842361|449895232|FG000|Overall Study|Protocol Violation|1|||
125076064|NCT00842361|449895233|FG001|Overall Study|Protocol Violation|0|||
125076065|NCT00842361|449895232|FG000|Overall Study|Unclassified|0|||
125076066|NCT00842361|449895233|FG001|Overall Study|Unclassified|2|||
125076067|NCT03094611|449895234|FG000|Overall Study|Lack of Efficacy|1|||
125076068|NCT03094611|449895234|FG000|Overall Study|Stem Cell Transplant|1|||
125076069|NCT00924729|449895240|FG000|Overall Study|insufficient volume for analysis|1|||
125076070|NCT00924729|449895241|FG001|Overall Study|insufficient volume for analysis|0|||
125076071|NCT00924729|449895240|FG000|Overall Study|Protocol Violation|1|||
125076072|NCT00924729|449895241|FG001|Overall Study|Protocol Violation|0|||
125076073|NCT00981747|449895244|FG000|Losartan|Withdrawal by Subject|1|||
125076074|NCT00981747|449895244|FG000|Losartan|Death|1|||
125076075|NCT00981747|449895244|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
125076076|NCT01814826|449895245|FG000|Overall Study|Other|3|||
125076077|NCT01814826|449895246|FG001|Overall Study|Other|5|||
125076078|NCT01814826|449895247|FG002|Overall Study|Other|0|||
125076079|NCT01814826|449895245|FG000|Overall Study|Death|29|||
125076080|NCT01814826|449895246|FG001|Overall Study|Death|24|||
125076081|NCT01814826|449895247|FG002|Overall Study|Death|3|||
125076082|NCT02917629|449895248|FG000|Overall Study|Withdrawal by Subject|0|||
125076083|NCT02917629|449895249|FG001|Overall Study|Withdrawal by Subject|1|||
125076084|NCT03339401|449895250|FG000|Overall Study|Death|2|||
125076085|NCT03339401|449895251|FG001|Overall Study|Death|1|||
125076086|NCT03339401|449895250|FG000|Overall Study|Withdrawal by Subject|2|||
125076087|NCT03339401|449895251|FG001|Overall Study|Withdrawal by Subject|0|||
125076088|NCT03339401|449895250|FG000|Overall Study|Study terminated|4|||
125143076|NCT00288704|450147911|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
125076089|NCT03339401|449895251|FG001|Overall Study|Study terminated|3|||
125076090|NCT03339401|449895250|FG000|Overall Study|Investigator Decision|1|||
125076091|NCT03339401|449895251|FG001|Overall Study|Investigator Decision|0|||
125076092|NCT00718523|449895252|FG000|Overall Study|Withdrawal by Subject|5|||
125076093|NCT00718523|449895253|FG001|Overall Study|Withdrawal by Subject|7|||
125076094|NCT00718523|449895252|FG000|Overall Study|Death|13|||
125076095|NCT00718523|449895253|FG001|Overall Study|Death|17|||
125076096|NCT03271307|449895254|FG000|Overall Study|Lost to Follow-up|0|||
125076097|NCT03271307|449895255|FG001|Overall Study|Lost to Follow-up|0|||
125076098|NCT03271307|449895256|FG002|Overall Study|Lost to Follow-up|0|||
125076099|NCT03271307|449895257|FG003|Overall Study|Lost to Follow-up|28|||
125143077|NCT00288704|450147909|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
125143078|NCT00288704|450147910|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
125143079|NCT00288704|450147911|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
125143080|NCT00288704|450147909|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
125143081|NCT00288704|450147910|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
125143082|NCT00288704|450147911|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
125143083|NCT01579006|450147912|FG000|Overall Study|Lack of Efficacy|10|||
125143084|NCT01579006|450147912|FG000|Overall Study|Adverse Event|13|||
125143085|NCT01579006|450147912|FG000|Overall Study|Withdrawal by Subject|5|||
125143086|NCT01579006|450147912|FG000|Overall Study|Non-compliance|3|||
125143087|NCT01579006|450147912|FG000|Overall Study|Due to participant's health fund|1|||
125143088|NCT01579006|450147912|FG000|Overall Study|Scheduled surgery|1|||
125143089|NCT02473393|450147915|FG000|Overall Study|Adverse Event|0|||
125143090|NCT02473393|450147916|FG001|Overall Study|Adverse Event|0|||
125143091|NCT02473393|450147917|FG002|Overall Study|Adverse Event|1|||
125143092|NCT02473393|450147918|FG003|Overall Study|Adverse Event|0|||
125143093|NCT02473393|450147915|FG000|Overall Study|Withdrawal by Subject|0|||
125143094|NCT02473393|450147916|FG001|Overall Study|Withdrawal by Subject|0|||
125143095|NCT02473393|450147917|FG002|Overall Study|Withdrawal by Subject|1|||
125143096|NCT02473393|450147918|FG003|Overall Study|Withdrawal by Subject|1|||
125143097|NCT02697617|450147919|FG000|Overall Study|Withdrawal by Subject|0|||
125143098|NCT02697617|450147920|FG001|Overall Study|Withdrawal by Subject|2|||
125143099|NCT02697617|450147919|FG000|Overall Study|Pregnancy|1|||
125143100|NCT02697617|450147920|FG001|Overall Study|Pregnancy|0|||
125143101|NCT02460835|450147921|FG000|Overall Study|Disease progression prior to treatment|3|||
125143102|NCT02460835|450147921|FG000|Overall Study|Unable to complete planning scans|2|||
125143103|NCT02460835|450147921|FG000|Overall Study|Decrease in performance status|1|||
125143104|NCT02460835|450147921|FG000|Overall Study|Withdrawal by Subject|3|||
125143105|NCT02460835|450147921|FG000|Overall Study|Underwent fractionated RT|10|||
125143106|NCT02460835|450147921|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
125143107|NCT00517192|450147925|FG000|Overall Study|Adverse Event|1|||
125143108|NCT00517192|450147926|FG001|Overall Study|Adverse Event|1|||
125143109|NCT00517192|450147925|FG000|Overall Study|Lost to Follow-up|1|||
125143110|NCT00517192|450147926|FG001|Overall Study|Lost to Follow-up|1|||
125143111|NCT00517192|450147925|FG000|Overall Study|Withdrawal by Subject|1|||
125143112|NCT00517192|450147926|FG001|Overall Study|Withdrawal by Subject|0|||
125143113|NCT00517192|450147925|FG000|Overall Study|Early termination of the trial|16|||
125143114|NCT00517192|450147926|FG001|Overall Study|Early termination of the trial|18|||
125143115|NCT02733627|450147928|FG000|Overall Study|Adverse Event|0|||
125143116|NCT02733627|450147929|FG001|Overall Study|Adverse Event|1|||
125143117|NCT02733627|450147930|FG002|Overall Study|Adverse Event|1|||
125143118|NCT02733627|450147931|FG003|Overall Study|Adverse Event|0|||
125143119|NCT02733627|450147928|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
125143120|NCT02733627|450147929|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
125143121|NCT02733627|450147930|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
125143122|NCT02733627|450147931|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
125143123|NCT00183196|450147932|FG000|Overall Study|Withdrawal by Subject|18|||
125143124|NCT00183196|450147933|FG001|Overall Study|Withdrawal by Subject|11|||
125223374|NCT02326272|450446168|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125223375|NCT02326272|450446169|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125223376|NCT02326272|450446170|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125076100|NCT03271307|449895258|FG004|Overall Study|Lost to Follow-up|91|||
125143125|NCT00183196|450147934|FG002|Overall Study|Withdrawal by Subject|13|||
125143126|NCT00183196|450147932|FG000|Overall Study|Adverse Event|1|||
125143127|NCT00183196|450147933|FG001|Overall Study|Adverse Event|2|||
125143128|NCT00183196|450147934|FG002|Overall Study|Adverse Event|2|||
125143129|NCT00183196|450147932|FG000|Overall Study|Legal event|1|||
125143130|NCT00183196|450147933|FG001|Overall Study|Legal event|1|||
125143131|NCT00183196|450147934|FG002|Overall Study|Legal event|1|||
125076101|NCT03365947|449895259|FG000|Overall Study|Lost to Follow-up|0|||
125143132|NCT00183196|450147932|FG000|Overall Study|Required more intensive care|0|||
125143133|NCT00183196|450147933|FG001|Overall Study|Required more intensive care|1|||
125143134|NCT00183196|450147934|FG002|Overall Study|Required more intensive care|2|||
125143135|NCT01119625|450147935|FG000|Overall Study|Lost to Follow-up|1|||
125143136|NCT01119625|450147936|FG001|Overall Study|Lost to Follow-up|2|||
125143137|NCT01119625|450147935|FG000|Overall Study|Withdrawal by Subject|2|||
125143138|NCT01119625|450147936|FG001|Overall Study|Withdrawal by Subject|1|||
125143139|NCT01119625|450147935|FG000|Overall Study|Other|0|||
125143140|NCT01119625|450147936|FG001|Overall Study|Other|1|||
125143141|NCT01721772|450147941|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
125143142|NCT01721772|450147942|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
125143143|NCT01721772|450147941|FG000|Pre-Treatment|Poor/non-compliance|0|||
125143144|NCT01721772|450147942|FG001|Pre-Treatment|Poor/non-compliance|1|||
125143145|NCT01721772|450147941|FG000|Pre-Treatment|Participant withdrew consent|0|||
125143146|NCT01721772|450147942|FG001|Pre-Treatment|Participant withdrew consent|1|||
125143147|NCT01721772|450147941|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
125143148|NCT01721772|450147942|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
125143149|NCT01721772|450147941|FG000|Treatment|Disease progression|119|||
125143150|NCT01721772|450147942|FG001|Treatment|Disease progression|168|||
125143151|NCT01721772|450147941|FG000|Treatment|Study drug toxicity|19|||
125143152|NCT01721772|450147942|FG001|Treatment|Study drug toxicity|10|||
125143153|NCT01721772|450147941|FG000|Treatment|Adverse event unrelated to study drug|7|||
125143154|NCT01721772|450147942|FG001|Treatment|Adverse event unrelated to study drug|7|||
125143155|NCT01721772|450147941|FG000|Treatment|Maximum clinical benefit|16|||
125143156|NCT01721772|450147942|FG001|Treatment|Maximum clinical benefit|4|||
125143157|NCT01721772|450147941|FG000|Treatment|Other|19|||
125143158|NCT01721772|450147942|FG001|Treatment|Other|2|||
125076102|NCT03365947|449895260|FG001|Overall Study|Lost to Follow-up|0|||
125076103|NCT03365947|449895261|FG002|Overall Study|Lost to Follow-up|0|||
125143159|NCT01721772|450147941|FG000|Treatment|Participant withdrew consent|2|||
125143160|NCT01721772|450147942|FG001|Treatment|Participant withdrew consent|5|||
125143161|NCT01721772|450147941|FG000|Treatment|Participant request to discontinue study treatment|21|||
125143162|NCT01721772|450147942|FG001|Treatment|Participant request to discontinue study treatment|8|||
125143163|NCT01721772|450147941|FG000|Treatment|Death|1|||
125143164|NCT01721772|450147942|FG001|Treatment|Death|0|||
125143165|NCT01721772|450147941|FG000|Treatment|Not reported|1|||
125143166|NCT01721772|450147942|FG001|Treatment|Not reported|0|||
125143167|NCT01721772|450147941|FG000|Treatment|Poor/non-compliance|1|||
125143168|NCT01721772|450147942|FG001|Treatment|Poor/non-compliance|0|||
125143169|NCT01721772|450147941|FG000|Treatment|Lost to Follow-up|0|||
125143170|NCT01721772|450147942|FG001|Treatment|Lost to Follow-up|1|||
125143171|NCT05004649|450147948|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
125143172|NCT05004649|450147948|FG000|Overall Study|Lost to Follow-up|1|||
125143173|NCT05004649|450147948|FG000|Overall Study|Withdrawal by Subject|2|||
125143174|NCT05004649|450147948|FG000|Overall Study|COVID-19|1|||
125143175|NCT01698554|450147949|FG000|Overall Study|Adverse Event|2|||
125143176|NCT01698554|450147950|FG001|Overall Study|Adverse Event|5|||
125143177|NCT01698554|450147951|FG002|Overall Study|Adverse Event|0|||
125143178|NCT01698554|450147952|FG003|Overall Study|Adverse Event|1|||
125143179|NCT01698554|450147949|FG000|Overall Study|Lost to Follow-up|1|||
125143180|NCT01698554|450147950|FG001|Overall Study|Lost to Follow-up|0|||
125223377|NCT02326272|450446171|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125223378|NCT02326272|450446172|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125076104|NCT03365947|449895262|FG003|Overall Study|Lost to Follow-up|0|||
125076105|NCT03365947|449895263|FG004|Overall Study|Lost to Follow-up|0|||
125076106|NCT03365947|449895264|FG005|Overall Study|Lost to Follow-up|1|||
125076107|NCT03365947|449895265|FG006|Overall Study|Lost to Follow-up|0|||
125076108|NCT03365947|449895266|FG007|Overall Study|Lost to Follow-up|0|||
125076109|NCT03365947|449895267|FG008|Overall Study|Lost to Follow-up|0|||
125076110|NCT03365947|449895268|FG009|Overall Study|Lost to Follow-up|0|||
125076111|NCT03365947|449895269|FG010|Overall Study|Lost to Follow-up|0|||
125076112|NCT03365947|449895270|FG011|Overall Study|Lost to Follow-up|0|||
125076113|NCT03365947|449895271|FG012|Overall Study|Lost to Follow-up|0|||
125076114|NCT03365947|449895272|FG013|Overall Study|Lost to Follow-up|0|||
125076115|NCT03365947|449895273|FG014|Overall Study|Lost to Follow-up|0|||
125143181|NCT01698554|450147951|FG002|Overall Study|Lost to Follow-up|0|||
125143182|NCT01698554|450147952|FG003|Overall Study|Lost to Follow-up|0|||
125143183|NCT01698554|450147949|FG000|Overall Study|Personal Reasons|0|||
125143184|NCT01698554|450147950|FG001|Overall Study|Personal Reasons|5|||
125143185|NCT01698554|450147951|FG002|Overall Study|Personal Reasons|1|||
125143186|NCT01698554|450147952|FG003|Overall Study|Personal Reasons|1|||
125143187|NCT01698554|450147949|FG000|Overall Study|Protocol Violation|2|||
125143188|NCT01698554|450147950|FG001|Overall Study|Protocol Violation|0|||
125143189|NCT01698554|450147951|FG002|Overall Study|Protocol Violation|1|||
125076116|NCT03365947|449895274|FG015|Overall Study|Lost to Follow-up|0|||
125143190|NCT01698554|450147952|FG003|Overall Study|Protocol Violation|0|||
125143191|NCT01698554|450147949|FG000|Overall Study|Other Miscellaneous Reasons|1|||
125143192|NCT01698554|450147950|FG001|Overall Study|Other Miscellaneous Reasons|0|||
125143193|NCT01698554|450147951|FG002|Overall Study|Other Miscellaneous Reasons|0|||
125143194|NCT01698554|450147952|FG003|Overall Study|Other Miscellaneous Reasons|0|||
125143195|NCT02654145|450147953|FG000|Overall Study|Lack of Efficacy|1|||
125143196|NCT02654145|450147953|FG000|Overall Study|Protocol Violation|1|||
125143197|NCT02654145|450147953|FG000|Overall Study|Withdrawal by Subject|5|||
125143198|NCT02637141|450147954|FG000|Overall Study|Adverse Event|1|||
125143199|NCT02637141|450147955|FG001|Overall Study|Adverse Event|1|||
125143200|NCT02637141|450147956|FG002|Overall Study|Adverse Event|0|||
125143201|NCT02637141|450147954|FG000|Overall Study|Withdrawal by Subject|1|||
125143202|NCT02637141|450147955|FG001|Overall Study|Withdrawal by Subject|1|||
125143203|NCT02637141|450147956|FG002|Overall Study|Withdrawal by Subject|1|||
125143204|NCT01943435|450147958|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
125143205|NCT01943435|450147959|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
125143206|NCT01943435|450147960|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
125143207|NCT01943435|450147958|FG000|Intervention Period|Withdrawal by Subject|3|||
125143208|NCT01943435|450147959|FG001|Intervention Period|Withdrawal by Subject|3|||
125143209|NCT01943435|450147960|FG002|Intervention Period|Withdrawal by Subject|4|||
125143210|NCT01943435|450147958|FG000|2 Month Follow up|Lost to Follow-up|2|||
125143211|NCT01943435|450147959|FG001|2 Month Follow up|Lost to Follow-up|3|||
125143212|NCT01943435|450147960|FG002|2 Month Follow up|Lost to Follow-up|0|||
125143213|NCT01943435|450147958|FG000|6 Month Follow up|Lost to Follow-up|12|||
125143214|NCT01943435|450147959|FG001|6 Month Follow up|Lost to Follow-up|7|||
125143215|NCT01943435|450147960|FG002|6 Month Follow up|Lost to Follow-up|15|||
125143216|NCT03885934|450147961|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
125143217|NCT03885934|450147962|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
125143218|NCT03885934|450147963|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
125143219|NCT03885934|450147964|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
125143220|NCT03885934|450147965|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
125143221|NCT03885934|450147966|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
125143222|NCT04535986|450147974|FG000|Overall Study|Death|4|||
125143223|NCT04535986|450147975|FG001|Overall Study|Death|5|||
125143224|NCT04535986|450147974|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
125143225|NCT04535986|450147975|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
125143226|NCT04535986|450147974|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
125143227|NCT04535986|450147975|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
125143228|NCT04535986|450147974|FG000|Overall Study|Adverse Event|10|||
125143229|NCT04535986|450147975|FG001|Overall Study|Adverse Event|1|||
125143230|NCT04535986|450147974|FG000|Overall Study|Lack of Efficacy|3|||
125143231|NCT04535986|450147975|FG001|Overall Study|Lack of Efficacy|2|||
125143232|NCT04535986|450147974|FG000|Overall Study|Investigator discretion|3|||
125143233|NCT04535986|450147975|FG001|Overall Study|Investigator discretion|0|||
125143234|NCT04535986|450147974|FG000|Overall Study|Withdrawal by Subject|32|||
125143235|NCT04535986|450147975|FG001|Overall Study|Withdrawal by Subject|14|||
125143236|NCT04535986|450147974|FG000|Overall Study|Lost to Follow-up|5|||
125143237|NCT04535986|450147975|FG001|Overall Study|Lost to Follow-up|3|||
125143238|NCT04535986|450147974|FG000|Overall Study|Other|7|||
125143239|NCT04535986|450147975|FG001|Overall Study|Other|3|||
125143240|NCT01559116|450147978|FG000|Overall Study|Adverse Event|10|||
125143241|NCT01559116|450147978|FG000|Overall Study|Lack of Efficacy|1|||
125143242|NCT01559116|450147978|FG000|Overall Study|Lost to Follow-up|1|||
125143243|NCT01559116|450147978|FG000|Overall Study|Protocol Violation|1|||
125143244|NCT01559116|450147978|FG000|Overall Study|Withdrawal by Subject|4|||
125143245|NCT01559116|450147978|FG000|Overall Study|other than stated above|9|||
125143246|NCT02377349|450147979|FG000|Overall Study|Serious Adverse Event|1|||
125143247|NCT02377349|450147980|FG001|Overall Study|Serious Adverse Event|0|||
125143248|NCT02377349|450147979|FG000|Overall Study|Protocol Violation|3|||
125143249|NCT02377349|450147980|FG001|Overall Study|Protocol Violation|2|||
125143250|NCT02377349|450147979|FG000|Overall Study|Withdrawal by Subject|5|||
125143251|NCT02377349|450147980|FG001|Overall Study|Withdrawal by Subject|3|||
125223379|NCT02326272|450446173|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125143252|NCT02377349|450147979|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
125143253|NCT02377349|450147980|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
125143254|NCT02377349|450147979|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
125143255|NCT02377349|450147980|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
125143256|NCT02377349|450147979|FG000|Overall Study|Other|0|||
125143257|NCT02377349|450147980|FG001|Overall Study|Other|1|||
125143258|NCT03259165|450147981|FG000|Overall Study|COVID 19 pandemic|1|||
125143259|NCT03259165|450147982|FG001|Overall Study|COVID 19 pandemic|1|||
125143260|NCT00550147|450147985|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
125143261|NCT00550147|450147985|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
125143262|NCT00550147|450147985|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
125143263|NCT00550147|450147985|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
125076117|NCT03365947|449895275|FG016|Overall Study|Lost to Follow-up|0|||
125076118|NCT03365947|449895276|FG017|Overall Study|Lost to Follow-up|0|||
125076119|NCT03365947|449895277|FG018|Overall Study|Lost to Follow-up|0|||
125076120|NCT01042938|449895278|FG000|Overall Study|Withdrawal by Subject|1|||
125076121|NCT01042938|449895279|FG001|Overall Study|Withdrawal by Subject|1|||
125076122|NCT01042938|449895278|FG000|Overall Study|Protocol Violation|1|||
125076123|NCT01042938|449895279|FG001|Overall Study|Protocol Violation|1|||
125076124|NCT01042938|449895278|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
125076125|NCT01042938|449895279|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
125076126|NCT03136484|449895280|FG000|Overall Study|Withdrawal by Subject|19|||
125076127|NCT03136484|449895281|FG001|Overall Study|Withdrawal by Subject|14|||
125076128|NCT03136484|449895280|FG000|Overall Study|Lost to Follow-up|7|||
125076129|NCT03136484|449895281|FG001|Overall Study|Lost to Follow-up|8|||
125076130|NCT03136484|449895280|FG000|Overall Study|Death|1|||
125076131|NCT03136484|449895281|FG001|Overall Study|Death|0|||
125076132|NCT03997760|449895286|FG000|Overall Study|Protocol Deviation|0|||
125076133|NCT03997760|449895287|FG001|Overall Study|Protocol Deviation|1|||
125076134|NCT03997760|449895288|FG002|Overall Study|Protocol Deviation|0|||
125076135|NCT03997760|449895289|FG003|Overall Study|Protocol Deviation|0|||
125076136|NCT00856986|449895290|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
125076137|NCT00856986|449895291|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
125076138|NCT00856986|449895292|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
125076139|NCT00856986|449895293|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
125076140|NCT00856986|449895294|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
125076141|NCT00856986|449895290|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
125076142|NCT00856986|449895291|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
125076143|NCT00856986|449895292|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
125076144|NCT00856986|449895293|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
125076145|NCT00856986|449895294|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
125076146|NCT00856986|449895290|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
125076147|NCT00856986|449895291|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
125076148|NCT00856986|449895292|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
125076149|NCT00856986|449895293|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
125076150|NCT00856986|449895294|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
125076151|NCT00856986|449895290|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
125076152|NCT00856986|449895291|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
125076153|NCT00856986|449895292|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
125076154|NCT00856986|449895293|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
125076155|NCT00856986|449895294|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
125076156|NCT00856986|449895290|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
125076157|NCT00856986|449895291|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
125076158|NCT00856986|449895292|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
125076159|NCT00856986|449895293|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
125076160|NCT00856986|449895294|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
125076161|NCT00856986|449895290|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
125076162|NCT00856986|449895291|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
125076163|NCT00856986|449895292|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
125076164|NCT00856986|449895293|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
125076165|NCT00856986|449895294|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
125076166|NCT00856986|449895290|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
125076167|NCT00856986|449895291|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
125076168|NCT00856986|449895292|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
125076169|NCT00856986|449895293|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
125076170|NCT00856986|449895294|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
125076171|NCT00856986|449895290|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
125076172|NCT00856986|449895291|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
125076173|NCT00856986|449895292|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
125076174|NCT00856986|449895293|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
125076175|NCT00856986|449895294|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
125143264|NCT00550147|450147985|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
125143265|NCT01824498|450147986|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
125143266|NCT01824498|450147987|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
125076176|NCT00856986|449895290|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
125076177|NCT00856986|449895291|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
125076178|NCT00856986|449895292|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
125076179|NCT00856986|449895293|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
125076180|NCT00856986|449895294|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
125076181|NCT00856986|449895290|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
125143267|NCT01824498|450147988|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
125143268|NCT01824498|450147989|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
125076182|NCT00856986|449895291|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
125076183|NCT00856986|449895292|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
125076184|NCT00856986|449895293|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
125076185|NCT00856986|449895294|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
125076186|NCT00856986|449895290|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
125076187|NCT00856986|449895291|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
125076188|NCT00856986|449895292|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
125076189|NCT00856986|449895293|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
125076190|NCT00856986|449895294|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
125076191|NCT00856986|449895290|FG000|Main Period, Weeks 0-26|Unclassified|7|||
125076192|NCT00856986|449895291|FG001|Main Period, Weeks 0-26|Unclassified|6|||
125076193|NCT00856986|449895292|FG002|Main Period, Weeks 0-26|Unclassified|7|||
125076194|NCT00856986|449895293|FG003|Main Period, Weeks 0-26|Unclassified|0|||
125076195|NCT00856986|449895294|FG004|Main Period, Weeks 0-26|Unclassified|0|||
125076196|NCT00856986|449895290|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
125076197|NCT00856986|449895291|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
125076198|NCT00856986|449895292|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
125076199|NCT00856986|449895293|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
125076200|NCT00856986|449895294|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
125076201|NCT00856986|449895290|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
125076202|NCT00856986|449895291|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
125076203|NCT00856986|449895292|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
125076204|NCT00856986|449895293|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
125076205|NCT00856986|449895294|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
125076206|NCT00856986|449895290|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
125076207|NCT00856986|449895291|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
125076208|NCT00856986|449895292|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
125076209|NCT00856986|449895293|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
125076210|NCT00856986|449895294|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
125076211|NCT00856986|449895290|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
125076212|NCT00856986|449895291|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
125076213|NCT00856986|449895292|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
125076214|NCT00856986|449895293|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
125076215|NCT00856986|449895294|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
125076216|NCT00856986|449895290|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
125076217|NCT00856986|449895291|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
125076218|NCT00856986|449895292|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
125076219|NCT00856986|449895293|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
125076220|NCT00856986|449895294|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
125076221|NCT00856986|449895290|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
125076222|NCT00856986|449895291|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
125076223|NCT00856986|449895292|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
125076224|NCT00856986|449895293|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
125076225|NCT00856986|449895294|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
125076226|NCT05041062|449895295|FG000|Overall Study|Adverse Event|2|||
125076227|NCT01915095|449895296|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
125076228|NCT01915095|449895297|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
125076229|NCT01915095|449895298|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
125076230|NCT01915095|449895299|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
125076231|NCT01915095|449895300|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
125076232|NCT04018612|449895301|FG000|Overall Study|Withdrawal by Subject|1|||
125076233|NCT04018612|449895302|FG001|Overall Study|Withdrawal by Subject|0|||
125076234|NCT04018612|449895303|FG002|Overall Study|Withdrawal by Subject|1|||
125076235|NCT02671760|449895306|FG000|Overall Study|Lost to Follow-up|0|||
125076236|NCT02671760|449895307|FG001|Overall Study|Lost to Follow-up|1|||
125076237|NCT02671760|449895308|FG002|Overall Study|Lost to Follow-up|0|||
125076238|NCT02999191|449895309|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
125076239|NCT02999191|449895310|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
125076240|NCT02999191|449895311|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
125076241|NCT03038672|449896930|FG000|Initial Treatment|Unacceptable chemistry|0|||
125076242|NCT03038672|449896931|FG001|Initial Treatment|Unacceptable chemistry|1|||
125076243|NCT03038672|449896930|FG000|Initial Treatment|Progression prior to treatment|1|||
125076244|NCT03038672|449896931|FG001|Initial Treatment|Progression prior to treatment|0|||
125076245|NCT03038672|449896930|FG000|Initial Treatment|No treatment per protocol|1|||
125076246|NCT03038672|449896931|FG001|Initial Treatment|No treatment per protocol|0|||
125076247|NCT00959894|449896936|FG000|Overall Study|Lost to Follow-up|10|||
125076248|NCT00959894|449896936|FG000|Overall Study|Adverse Event|3|||
125076249|NCT00959894|449896936|FG000|Overall Study|Withdrawal by Subject|1|||
125076250|NCT00959894|449896936|FG000|Overall Study|Need for contraindicated medication|1|||
125076251|NCT00959894|449896936|FG000|Overall Study|Subject moved out of town|1|||
125076252|NCT00653068|449896937|FG000|Overall Study|Death|9|||
125076253|NCT00653068|449896937|FG000|Overall Study|Lack of Efficacy|34|||
125076254|NCT00653068|449896937|FG000|Overall Study|Physician Decision|4|||
125076255|NCT00653068|449896937|FG000|Overall Study|Withdrawal by Subject|1|||
125076256|NCT00653068|449896937|FG000|Overall Study|Ineligible|2|||
125076257|NCT01305941|449896938|FG000|Overall Study|Adverse Event|6|||
125076258|NCT01305941|449896938|FG000|Overall Study|Clinical decline|2|||
125076259|NCT01305941|449896938|FG000|Overall Study|Withdrawal by Subject|1|||
125076260|NCT01305941|449896938|FG000|Overall Study|Death|1|||
125076261|NCT02892734|449896939|FG000|Treatment on Study|Progressive Disease|2|||
125076262|NCT02892734|449896939|FG000|Follow up for 2 Years|Death|2|||
125076263|NCT02892734|449896939|FG000|Follow up for 2 Years|Study closed early|1|||
125076264|NCT02043509|449896940|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
125076265|NCT02043509|449896941|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
125076266|NCT02043509|449896940|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
125076267|NCT02043509|449896941|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
125076268|NCT02043509|449896940|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
125076269|NCT02043509|449896941|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
125076270|NCT02043509|449896940|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
125076271|NCT02043509|449896941|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
125076272|NCT00608244|449896946|FG000|Overall Study|Adverse Event|1|||
125143269|NCT01824498|450147990|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
125143270|NCT01824498|450147991|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
125143271|NCT01567527|450147992|FG000|Conversion Phase.|Protocol deviation|3|||
125143272|NCT01567527|450147993|FG001|Conversion Phase.|Protocol deviation|0|||
125143273|NCT01567527|450147994|FG002|Conversion Phase.|Protocol deviation|0|||
125143274|NCT01567527|450147995|FG003|Conversion Phase.|Protocol deviation|0|||
125143275|NCT01567527|450147996|FG004|Conversion Phase.|Protocol deviation|0|||
125143276|NCT01567527|450147992|FG000|Conversion Phase.|Met withdrawal criteria|10|||
125143277|NCT01567527|450147993|FG001|Conversion Phase.|Met withdrawal criteria|0|||
125143278|NCT01567527|450147994|FG002|Conversion Phase.|Met withdrawal criteria|0|||
125143279|NCT01567527|450147995|FG003|Conversion Phase.|Met withdrawal criteria|0|||
125143280|NCT01567527|450147996|FG004|Conversion Phase.|Met withdrawal criteria|0|||
125143281|NCT01567527|450147992|FG000|Conversion Phase.|Withdrawal by Subject|32|||
125143282|NCT01567527|450147993|FG001|Conversion Phase.|Withdrawal by Subject|0|||
125143283|NCT01567527|450147994|FG002|Conversion Phase.|Withdrawal by Subject|0|||
125143284|NCT01567527|450147995|FG003|Conversion Phase.|Withdrawal by Subject|0|||
125143285|NCT01567527|450147996|FG004|Conversion Phase.|Withdrawal by Subject|0|||
125143286|NCT01567527|450147992|FG000|Conversion Phase.|Lost to Follow-up|16|||
125143287|NCT01567527|450147993|FG001|Conversion Phase.|Lost to Follow-up|0|||
125143288|NCT01567527|450147994|FG002|Conversion Phase.|Lost to Follow-up|0|||
125143289|NCT01567527|450147995|FG003|Conversion Phase.|Lost to Follow-up|0|||
125143290|NCT01567527|450147996|FG004|Conversion Phase.|Lost to Follow-up|0|||
125143291|NCT01567527|450147992|FG000|Conversion Phase.|Lack of Efficacy|2|||
125143292|NCT01567527|450147993|FG001|Conversion Phase.|Lack of Efficacy|0|||
125143293|NCT01567527|450147994|FG002|Conversion Phase.|Lack of Efficacy|0|||
125143294|NCT01567527|450147995|FG003|Conversion Phase.|Lack of Efficacy|0|||
125143295|NCT01567527|450147996|FG004|Conversion Phase.|Lack of Efficacy|0|||
125143296|NCT01567527|450147992|FG000|Conversion Phase.|Adverse Event|33|||
125143297|NCT01567527|450147993|FG001|Conversion Phase.|Adverse Event|0|||
125143298|NCT01567527|450147994|FG002|Conversion Phase.|Adverse Event|0|||
125143299|NCT01567527|450147995|FG003|Conversion Phase.|Adverse Event|0|||
125143300|NCT01567527|450147996|FG004|Conversion Phase.|Adverse Event|0|||
125143301|NCT01567527|450147992|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
125143302|NCT01567527|450147993|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
125143303|NCT01567527|450147994|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
125143304|NCT01567527|450147995|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
125143305|NCT01567527|450147996|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
125143306|NCT01567527|450147992|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
125143307|NCT01567527|450147993|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
125143308|NCT01567527|450147994|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
125076273|NCT00608244|449896946|FG000|Overall Study|Low trough levels|1|||
125076274|NCT01957215|449896951|FG000|Overall Study|Adverse Event|2|||
125076275|NCT01957215|449896952|FG001|Overall Study|Adverse Event|2|||
125076276|NCT01957215|449896951|FG000|Overall Study|Lost to Follow-up|3|||
125076277|NCT01957215|449896952|FG001|Overall Study|Lost to Follow-up|3|||
125143309|NCT01567527|450147995|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
125143310|NCT01567527|450147996|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
125143311|NCT01567527|450147992|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
125143312|NCT01567527|450147993|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
125143313|NCT01567527|450147994|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
125143314|NCT01567527|450147995|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
125143315|NCT01567527|450147996|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
125143316|NCT01567527|450147992|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
125143317|NCT01567527|450147993|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
125143318|NCT01567527|450147994|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
125143319|NCT01567527|450147995|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
125143320|NCT01567527|450147996|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
125143321|NCT01567527|450147992|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
125143322|NCT01567527|450147993|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
125143323|NCT01567527|450147994|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
125143324|NCT01567527|450147995|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
125143325|NCT01567527|450147996|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
125143326|NCT01567527|450147992|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
125143327|NCT01567527|450147993|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
125143328|NCT01567527|450147994|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
125143329|NCT01567527|450147995|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
125143330|NCT01567527|450147996|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
125143331|NCT01567527|450147992|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
125143332|NCT01567527|450147993|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
125143333|NCT01567527|450147994|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
125143334|NCT01567527|450147995|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
125143335|NCT01567527|450147996|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
125143336|NCT01567527|450147992|FG000|IM Depot Stabilization.|Protocol deviation|0|||
125143337|NCT01567527|450147993|FG001|IM Depot Stabilization.|Protocol deviation|0|||
125143338|NCT01567527|450147994|FG002|IM Depot Stabilization.|Protocol deviation|5|||
125143339|NCT01567527|450147995|FG003|IM Depot Stabilization.|Protocol deviation|0|||
125143340|NCT01567527|450147996|FG004|IM Depot Stabilization.|Protocol deviation|0|||
125143341|NCT01567527|450147992|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
125143342|NCT01567527|450147993|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
125143343|NCT01567527|450147994|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
125143344|NCT01567527|450147995|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
125143345|NCT01567527|450147996|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
125143346|NCT01567527|450147992|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
125143347|NCT01567527|450147993|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
125143348|NCT01567527|450147994|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
125143349|NCT01567527|450147995|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
125143350|NCT01567527|450147996|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
125143351|NCT01567527|450147992|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
125143352|NCT01567527|450147993|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
125143353|NCT01567527|450147994|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
125143354|NCT01567527|450147995|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
125143355|NCT01567527|450147996|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
125143356|NCT01567527|450147992|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
125143357|NCT01567527|450147993|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
125143358|NCT01567527|450147994|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
125143359|NCT01567527|450147995|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
125143360|NCT01567527|450147996|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
125143361|NCT01567527|450147992|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
125143362|NCT01567527|450147993|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
125143363|NCT01567527|450147994|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
125143364|NCT01567527|450147995|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
125143365|NCT01567527|450147996|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
125143366|NCT01567527|450147992|FG000|IM Depot Stabilization.|Adverse Event|0|||
125143367|NCT01567527|450147993|FG001|IM Depot Stabilization.|Adverse Event|0|||
125143368|NCT01567527|450147994|FG002|IM Depot Stabilization.|Adverse Event|37|||
125143369|NCT01567527|450147995|FG003|IM Depot Stabilization.|Adverse Event|0|||
125143370|NCT01567527|450147996|FG004|IM Depot Stabilization.|Adverse Event|0|||
125143371|NCT01567527|450147992|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
125143372|NCT01567527|450147993|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
125143373|NCT01567527|450147994|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
125143374|NCT01567527|450147995|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
125143375|NCT01567527|450147996|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
125143376|NCT01567527|450147992|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
125143377|NCT01567527|450147993|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
125143378|NCT01567527|450147994|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
125143379|NCT01567527|450147995|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
125143380|NCT01567527|450147996|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
125143381|NCT01567527|450147992|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
125076278|NCT01957215|449896951|FG000|Overall Study|Protocol Violation|1|||
125076279|NCT01957215|449896952|FG001|Overall Study|Protocol Violation|2|||
125076280|NCT01957215|449896951|FG000|Overall Study|Withdrawal by Subject|7|||
125076281|NCT01957215|449896952|FG001|Overall Study|Withdrawal by Subject|5|||
125076282|NCT01685060|449896960|FG000|Overall Study|Rollover patients|16|||
125076283|NCT01685060|449896960|FG000|Overall Study|Adverse Event|12|||
125076284|NCT01685060|449896960|FG000|Overall Study|Progressive disease|69|||
125076285|NCT01685060|449896960|FG000|Overall Study|Physician Decision|14|||
125076286|NCT01685060|449896960|FG000|Overall Study|Subject/guardian decision|20|||
125076287|NCT01685060|449896960|FG000|Overall Study|Lost to Follow-up|1|||
125076288|NCT01685060|449896960|FG000|Overall Study|Death|8|||
125076289|NCT03597503|449896961|FG000|Overall Study|Withdrawal by Subject|0|||
125076290|NCT03597503|449896962|FG001|Overall Study|Withdrawal by Subject|2|||
125076291|NCT03597503|449896961|FG000|Overall Study|Lost to Follow-up|1|||
125076292|NCT03597503|449896962|FG001|Overall Study|Lost to Follow-up|2|||
125076293|NCT03597503|449896961|FG000|Overall Study|Protocol Violation|1|||
125076294|NCT03597503|449896962|FG001|Overall Study|Protocol Violation|0|||
125076295|NCT02944513|449896963|FG000|Overall Study|Withdrawal by Subject|4|||
125076296|NCT02944513|449896964|FG001|Overall Study|Withdrawal by Subject|1|||
125076297|NCT00937326|449896968|FG000|Overall Study|Adverse Event|0|||
125076298|NCT00937326|449896969|FG001|Overall Study|Adverse Event|3|||
125076299|NCT00937326|449896970|FG002|Overall Study|Adverse Event|1|||
125076300|NCT00937326|449896971|FG003|Overall Study|Adverse Event|1|||
125076301|NCT00937326|449896972|FG004|Overall Study|Adverse Event|2|||
125076302|NCT00937326|449896968|FG000|Overall Study|Death|0|||
125076303|NCT00937326|449896969|FG001|Overall Study|Death|0|||
125076304|NCT00937326|449896970|FG002|Overall Study|Death|1|||
125076305|NCT00937326|449896971|FG003|Overall Study|Death|0|||
125076306|NCT00937326|449896972|FG004|Overall Study|Death|0|||
125076307|NCT00937326|449896968|FG000|Overall Study|Withdrawal by Subject|3|||
125076308|NCT00937326|449896969|FG001|Overall Study|Withdrawal by Subject|4|||
125076309|NCT00937326|449896970|FG002|Overall Study|Withdrawal by Subject|1|||
125076310|NCT00937326|449896971|FG003|Overall Study|Withdrawal by Subject|4|||
125076311|NCT00937326|449896972|FG004|Overall Study|Withdrawal by Subject|3|||
125076312|NCT00937326|449896968|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
125076313|NCT00937326|449896969|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
125076314|NCT00937326|449896970|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
125076315|NCT00937326|449896971|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
125076316|NCT00937326|449896972|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
125076317|NCT02578992|449896973|FG000|Overall Study|equipment not available or malfunction|3|||
125076318|NCT02578992|449896974|FG001|Overall Study|equipment not available or malfunction|3|||
125076319|NCT00086385|449896977|FG000|Overall Study|Death|2|||
125076320|NCT00086385|449896978|FG001|Overall Study|Death|2|||
125076321|NCT00086385|449896979|FG002|Overall Study|Death|1|||
125076322|NCT00086385|449896980|FG003|Overall Study|Death|1|||
125076323|NCT00405275|449896984|FG000|Overall Study|Death|1|||
125076324|NCT00405275|449896985|FG001|Overall Study|Death|0|||
125076325|NCT00405275|449896984|FG000|Overall Study|Lost to Follow-up|5|||
125076326|NCT00405275|449896985|FG001|Overall Study|Lost to Follow-up|1|||
125076327|NCT00405275|449896984|FG000|Overall Study|Withdrawal by Subject|7|||
125143382|NCT01567527|450147993|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
125143383|NCT01567527|450147994|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
125143384|NCT01567527|450147995|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
125143385|NCT01567527|450147996|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
125143386|NCT01567527|450147992|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
125143387|NCT01567527|450147993|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
125143388|NCT01567527|450147994|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
125143389|NCT01567527|450147995|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
125143390|NCT01567527|450147996|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
125143391|NCT01567527|450147992|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
125143392|NCT01567527|450147993|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
125143393|NCT01567527|450147994|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
125143394|NCT01567527|450147995|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
125076328|NCT00405275|449896985|FG001|Overall Study|Withdrawal by Subject|9|||
125076329|NCT00405275|449896984|FG000|Overall Study|Unwilling to continue|10|||
125076330|NCT00405275|449896985|FG001|Overall Study|Unwilling to continue|9|||
125076331|NCT00731666|449896986|FG000|Overall Study|Adverse Event|2|||
125076332|NCT00731666|449896986|FG000|Overall Study|Lost to Follow-up|8|||
125076333|NCT00731666|449896986|FG000|Overall Study|Withdrawal by Subject|2|||
125076334|NCT02471586|449896989|FG000|Overall Study|Lost to Follow-up|3|||
125076335|NCT02471586|449896990|FG001|Overall Study|Lost to Follow-up|8|||
125076336|NCT02471586|449896991|FG002|Overall Study|Lost to Follow-up|4|||
125076337|NCT02471586|449896989|FG000|Overall Study|Death|2|||
125223380|NCT02326272|450446174|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125223381|NCT02326272|450446175|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125223382|NCT02326272|450446176|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125223383|NCT02326272|450446177|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125076338|NCT02471586|449896990|FG001|Overall Study|Death|2|||
125076339|NCT02471586|449896991|FG002|Overall Study|Death|0|||
125076340|NCT01495689|449896999|FG000|Overall Study|Death|0|||
125076341|NCT01495689|449897000|FG001|Overall Study|Death|1|||
125076342|NCT01495689|449896999|FG000|Overall Study|Withdrawal by Subject|3|||
125076343|NCT01495689|449897000|FG001|Overall Study|Withdrawal by Subject|0|||
125076344|NCT01495689|449896999|FG000|Overall Study|Lost to Follow-up|7|||
125076345|NCT01495689|449897000|FG001|Overall Study|Lost to Follow-up|6|||
125076346|NCT00254163|449897001|FG000|Overall Study|Adverse Event|29|||
125076347|NCT00254163|449897002|FG001|Overall Study|Adverse Event|26|||
125076348|NCT00254163|449897001|FG000|Overall Study|Patient request/withdrew consent|6|||
125076349|NCT00254163|449897002|FG001|Overall Study|Patient request/withdrew consent|4|||
125076350|NCT00254163|449897001|FG000|Overall Study|Investigator request|1|||
125076351|NCT00254163|449897002|FG001|Overall Study|Investigator request|3|||
125076352|NCT00254163|449897001|FG000|Overall Study|Failed entry|1|||
125076353|NCT00254163|449897002|FG001|Overall Study|Failed entry|3|||
125076354|NCT00254163|449897001|FG000|Overall Study|Progressive disease|0|||
125076355|NCT00254163|449897002|FG001|Overall Study|Progressive disease|1|||
125076356|NCT00254163|449897001|FG000|Overall Study|Death|0|||
125076357|NCT00254163|449897002|FG001|Overall Study|Death|1|||
125076358|NCT00254163|449897001|FG000|Overall Study|Other|8|||
125076359|NCT00254163|449897002|FG001|Overall Study|Other|8|||
125076360|NCT00606177|449897005|FG000|Overall Study|Adverse Event|9|||
125076361|NCT00606177|449897006|FG001|Overall Study|Adverse Event|5|||
125076362|NCT00606177|449897005|FG000|Overall Study|Lack of Efficacy|3|||
125076363|NCT00606177|449897006|FG001|Overall Study|Lack of Efficacy|7|||
125076364|NCT00606177|449897005|FG000|Overall Study|Physician Decision|1|||
125076365|NCT00606177|449897006|FG001|Overall Study|Physician Decision|0|||
125076366|NCT00606177|449897005|FG000|Overall Study|Protocol Violation|1|||
125076367|NCT00606177|449897006|FG001|Overall Study|Protocol Violation|4|||
125076368|NCT00606177|449897005|FG000|Overall Study|Withdrawal by Subject|5|||
125076369|NCT00606177|449897006|FG001|Overall Study|Withdrawal by Subject|6|||
125076370|NCT00606177|449897005|FG000|Overall Study|Progression to depressive phase|6|||
125076371|NCT00606177|449897006|FG001|Overall Study|Progression to depressive phase|1|||
125076372|NCT00606177|449897005|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
125076373|NCT00606177|449897006|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
125076374|NCT00606177|449897005|FG000|Overall Study|Change of residence or other commitments|1|||
125076375|NCT00606177|449897006|FG001|Overall Study|Change of residence or other commitments|1|||
125076376|NCT00136357|449897007|FG000|Overall Study|Withdrawal by Subject|3|||
125076377|NCT00136357|449897008|FG001|Overall Study|Withdrawal by Subject|2|||
125076378|NCT00216086|449897013|FG000|Overall Study|Protocol Violation|1|||
125076379|NCT00216086|449897013|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
125076380|NCT00216086|449897013|FG000|Overall Study|Social Reasons|2|||
125076381|NCT01784211|449897017|FG000|Part A (Days 1-15)|Adverse Event|1|||
125076382|NCT01784211|449897018|FG001|Part A (Days 1-15)|Adverse Event|1|||
125076383|NCT01784211|449897019|FG002|Part A (Days 1-15)|Adverse Event|0|||
125076384|NCT01784211|449897020|FG003|Part A (Days 1-15)|Adverse Event|0|||
125076385|NCT01784211|449897021|FG004|Part A (Days 1-15)|Adverse Event|0|||
125076386|NCT01784211|449897022|FG005|Part A (Days 1-15)|Adverse Event|0|||
125076387|NCT01784211|449897017|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
125076388|NCT01784211|449897018|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
125076389|NCT01784211|449897019|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
125076390|NCT01784211|449897020|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
125076391|NCT01784211|449897021|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
125076392|NCT01784211|449897022|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
125076393|NCT01001572|449897023|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
125076394|NCT01001572|449897024|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
125223384|NCT02326272|450446178|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125076395|NCT01001572|449897025|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
125076396|NCT01001572|449897023|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
125076397|NCT01001572|449897024|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
125076398|NCT01001572|449897025|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
125076399|NCT01001572|449897023|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
125076400|NCT01001572|449897024|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
125076401|NCT01001572|449897025|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
125076402|NCT01001572|449897023|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
125076403|NCT01001572|449897024|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
125076404|NCT01001572|449897025|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
125076405|NCT01001572|449897023|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
125143395|NCT01567527|450147996|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
125143396|NCT01567527|450147992|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
125143397|NCT01567527|450147993|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
125143398|NCT01567527|450147994|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
125143399|NCT01567527|450147995|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
125143400|NCT01567527|450147996|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
125143401|NCT01567527|450147992|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
125143402|NCT01567527|450147993|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
125143403|NCT01567527|450147994|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
125143404|NCT01567527|450147995|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
125143405|NCT01567527|450147996|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
125143406|NCT01567527|450147992|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
125143407|NCT01567527|450147993|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
125143408|NCT01567527|450147994|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
125143409|NCT01567527|450147995|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
125143410|NCT01567527|450147996|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
125143411|NCT01567527|450147992|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
125143412|NCT01567527|450147993|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
125143413|NCT01567527|450147994|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
125143414|NCT01567527|450147995|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
125143415|NCT01567527|450147996|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
125143416|NCT02623218|450147997|FG000|Overall Study|Lost to Follow-up|0|||
125143417|NCT02623218|450147998|FG001|Overall Study|Lost to Follow-up|1|||
125143418|NCT02623218|450147999|FG002|Overall Study|Lost to Follow-up|0|||
125143419|NCT02623218|450148000|FG003|Overall Study|Lost to Follow-up|0|||
125143420|NCT02623218|450148001|FG004|Overall Study|Lost to Follow-up|0|||
125143421|NCT01726803|450148002|FG000|Overall Study|Lost to Follow-up|6|||
125143422|NCT01726803|450148003|FG001|Overall Study|Lost to Follow-up|1|||
125143423|NCT01726803|450148002|FG000|Overall Study|Withdrawal by Subject|1|||
125143424|NCT01726803|450148003|FG001|Overall Study|Withdrawal by Subject|0|||
125143425|NCT01547728|450148010|FG000|Overall Study|Change in procedure and equipment|1|||
125143426|NCT01547728|450148010|FG000|Overall Study|Drug not ready for subject|1|||
125143427|NCT01547728|450148010|FG000|Overall Study|Screen failure|39|||
125143428|NCT03828539|450148011|FG000|Overall Study|Adverse Event|3|||
125143429|NCT03828539|450148012|FG001|Overall Study|Adverse Event|12|||
125143430|NCT03828539|450148011|FG000|Overall Study|Patient's/guardian's decision|3|||
125143431|NCT03828539|450148012|FG001|Overall Study|Patient's/guardian's decision|5|||
125143432|NCT03828539|450148011|FG000|Overall Study|Lost to Follow-up|4|||
125143433|NCT03828539|450148012|FG001|Overall Study|Lost to Follow-up|2|||
125143434|NCT03828539|450148011|FG000|Overall Study|Protocol Violation|3|||
125143435|NCT03828539|450148012|FG001|Overall Study|Protocol Violation|2|||
125143436|NCT03828539|450148011|FG000|Overall Study|Withdrawal of informed consent|2|||
125143437|NCT03828539|450148012|FG001|Overall Study|Withdrawal of informed consent|1|||
125143438|NCT03828539|450148011|FG000|Overall Study|New therapy for study indication|1|||
125143439|NCT03828539|450148012|FG001|Overall Study|New therapy for study indication|0|||
125143440|NCT01341405|450148013|FG000|Overall Study|Adverse Event|0|||
125143441|NCT01341405|450148014|FG001|Overall Study|Adverse Event|1|||
125143442|NCT01341405|450148015|FG002|Overall Study|Adverse Event|1|||
125143443|NCT01341405|450148013|FG000|Overall Study|Withdrawal by Subject|3|||
125143444|NCT01341405|450148014|FG001|Overall Study|Withdrawal by Subject|2|||
125143445|NCT01341405|450148015|FG002|Overall Study|Withdrawal by Subject|1|||
125143446|NCT02616380|450148016|FG000|Overall Study|Lost to Follow-up|1|||
125143447|NCT02616380|450148016|FG000|Overall Study|Other|2|||
125143448|NCT00826241|450148017|FG000|Overall Study|Withdrawal from Follow-up|1|||
125143449|NCT00826241|450148017|FG000|Overall Study|Withdrew consent|2|||
125143450|NCT00826241|450148017|FG000|Overall Study|Death|4|||
125143451|NCT00826241|450148017|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
125143452|NCT00826241|450148017|FG000|Overall Study|Non-compliance|1|||
125143453|NCT00826241|450148017|FG000|Overall Study|Progression of disease|1|||
125143454|NCT00826241|450148017|FG000|Overall Study|Patient refused follow-up|3|||
125143455|NCT00826241|450148017|FG000|Overall Study|Lost to Follow-up|9|||
125143456|NCT00826241|450148017|FG000|Overall Study|Could not obtain records|1|||
125143457|NCT00826241|450148017|FG000|Overall Study|Screen failure|2|||
125143458|NCT00826241|450148017|FG000|Overall Study|Pt unable to proceed to registration|1|||
125143459|NCT00826241|450148017|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
125143460|NCT03950674|450148022|FG000|Overall Study|Death|16|||
125143461|NCT03950674|450148023|FG001|Overall Study|Death|15|||
125143462|NCT03950674|450148022|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
125143463|NCT03950674|450148023|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
125143464|NCT00830167|450148026|FG000|Overall Study|Lack of Efficacy|26|||
125143465|NCT00830167|450148027|FG001|Overall Study|Lack of Efficacy|10|||
125076406|NCT01001572|449897024|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
125076407|NCT01001572|449897025|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
125076408|NCT01001572|449897023|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
125076409|NCT01001572|449897024|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
125076410|NCT01001572|449897025|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
125076411|NCT01001572|449897023|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
125076412|NCT01001572|449897024|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
125076413|NCT01001572|449897025|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
125076414|NCT01001572|449897023|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
125076415|NCT01001572|449897024|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
125076416|NCT01001572|449897025|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
125076417|NCT01001572|449897023|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
125076418|NCT01001572|449897024|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
125076419|NCT01001572|449897025|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
125076420|NCT01001572|449897023|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
125076421|NCT01001572|449897024|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
125076422|NCT01001572|449897025|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
125076423|NCT01001572|449897023|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
125076424|NCT01001572|449897024|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
125076425|NCT01001572|449897025|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
125076426|NCT01001572|449897023|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
125076427|NCT01001572|449897024|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
125076428|NCT01001572|449897025|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
125076429|NCT01001572|449897023|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
125076430|NCT01001572|449897024|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
125076431|NCT01001572|449897025|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
125076432|NCT01001572|449897023|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125076433|NCT01001572|449897024|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125076434|NCT01001572|449897025|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
125076435|NCT02025530|449897028|FG000|Overall Study|No longer met elligibility criteria|5|||
125076436|NCT02025530|449897029|FG001|Overall Study|No longer met elligibility criteria|1|||
125076437|NCT03551626|449897030|FG000|Overall Study|Adverse Event|88|||
125076438|NCT03551626|449897030|FG000|Overall Study|Disease relapse|18|||
125076439|NCT03551626|449897030|FG000|Overall Study|Withdrawal of informed consent|6|||
125076440|NCT03551626|449897030|FG000|Overall Study|Patient decision|5|||
125076441|NCT03551626|449897030|FG000|Overall Study|Physician Decision|4|||
125076442|NCT03551626|449897030|FG000|Overall Study|Lost to Follow-up|3|||
125076443|NCT03551626|449897030|FG000|Overall Study|Pregnancy|1|||
125076444|NCT03551626|449897030|FG000|Overall Study|Protocol deviation|1|||
125076445|NCT03551626|449897030|FG000|Overall Study|Technical problems|1|||
125076446|NCT04882072|449897034|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
125076447|NCT04882072|449897035|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
125076448|NCT04882072|449897034|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
125076449|NCT04882072|449897035|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
125076450|NCT04882072|449897034|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
125076451|NCT04882072|449897035|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
125076452|NCT02918318|449897036|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
125076453|NCT02918318|449897037|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
125076454|NCT02918318|449897038|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
125076455|NCT02918318|449897039|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
125076456|NCT02918318|449897040|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
125076457|NCT02918318|449897036|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
125076458|NCT02918318|449897037|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
125076459|NCT02918318|449897038|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
125076460|NCT02918318|449897039|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
125076461|NCT02918318|449897040|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
125076462|NCT02918318|449897036|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
125076463|NCT02918318|449897037|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
125076464|NCT02918318|449897038|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
125076465|NCT02918318|449897039|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
125076466|NCT02918318|449897040|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
125076467|NCT02918318|449897036|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
125076468|NCT02918318|449897037|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
125076469|NCT02918318|449897038|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
125076470|NCT02918318|449897039|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
125143466|NCT00830167|450148026|FG000|Overall Study|Adverse Event|8|||
125143467|NCT00830167|450148027|FG001|Overall Study|Adverse Event|24|||
125143468|NCT00830167|450148026|FG000|Overall Study|Not meeting entrance criteria|2|||
125143469|NCT00830167|450148027|FG001|Overall Study|Not meeting entrance criteria|5|||
125143470|NCT00830167|450148026|FG000|Overall Study|Withdrawal by Subject|2|||
125143471|NCT00830167|450148027|FG001|Overall Study|Withdrawal by Subject|0|||
125143472|NCT00830167|450148026|FG000|Overall Study|Lost to Follow-up|0|||
125143473|NCT00830167|450148027|FG001|Overall Study|Lost to Follow-up|1|||
125143474|NCT00830167|450148026|FG000|Overall Study|Protocol Violation|0|||
125143475|NCT00830167|450148027|FG001|Overall Study|Protocol Violation|1|||
125143476|NCT00830167|450148026|FG000|Overall Study|Other|2|||
125143477|NCT00830167|450148027|FG001|Overall Study|Other|2|||
125143478|NCT02224053|450148028|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
125143479|NCT02224053|450148028|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
125143480|NCT02224053|450148028|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
125143481|NCT02224053|450148028|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
125143482|NCT02224053|450148028|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
125143483|NCT00609154|450148029|FG000|Overall Study|Protocol Violation|1|||
125143484|NCT00609154|450148030|FG001|Overall Study|Protocol Violation|2|||
125143485|NCT00609154|450148029|FG000|Overall Study|Unable to establish IV access|0|||
125143486|NCT00609154|450148030|FG001|Overall Study|Unable to establish IV access|4|||
125143487|NCT00609154|450148029|FG000|Overall Study|Adverse Event|0|||
125143488|NCT00609154|450148030|FG001|Overall Study|Adverse Event|2|||
125143489|NCT00860262|450148035|FG000|Overall Study|Adverse Event|9|||
125143490|NCT00860262|450148036|FG001|Overall Study|Adverse Event|6|||
125143491|NCT00860262|450148037|FG002|Overall Study|Adverse Event|7|||
125143492|NCT00860262|450148035|FG000|Overall Study|Protocol Violation|0|||
125143493|NCT00860262|450148036|FG001|Overall Study|Protocol Violation|1|||
125143494|NCT00860262|450148037|FG002|Overall Study|Protocol Violation|0|||
125143495|NCT00860262|450148035|FG000|Overall Study|Lost to Follow-up|2|||
125143496|NCT00860262|450148036|FG001|Overall Study|Lost to Follow-up|0|||
125143497|NCT00860262|450148037|FG002|Overall Study|Lost to Follow-up|1|||
125143498|NCT00860262|450148035|FG000|Overall Study|Withdrawal by Subject|4|||
125143499|NCT00860262|450148036|FG001|Overall Study|Withdrawal by Subject|8|||
125143500|NCT00860262|450148037|FG002|Overall Study|Withdrawal by Subject|6|||
125143501|NCT00860262|450148035|FG000|Overall Study|Lack of Efficacy|0|||
125143502|NCT00860262|450148036|FG001|Overall Study|Lack of Efficacy|4|||
125143503|NCT00860262|450148037|FG002|Overall Study|Lack of Efficacy|3|||
125143504|NCT00860262|450148035|FG000|Overall Study|Other|5|||
125143505|NCT00860262|450148036|FG001|Overall Study|Other|3|||
125143506|NCT00860262|450148037|FG002|Overall Study|Other|1|||
125143507|NCT00124618|450148038|FG000|Overall Study|Ineligible|1|||
125143508|NCT00593827|450148039|FG000|Overall Study|On Active Treatment/Pending|0|||
125143509|NCT00593827|450148040|FG001|Overall Study|On Active Treatment/Pending|2|||
125143510|NCT01675596|450148041|FG000|Overall Study|Death|6|||
125143511|NCT01675596|450148041|FG000|Overall Study|Exit with other reason|1|||
125143512|NCT01675596|450148041|FG000|Overall Study|Missed Visit|1|||
125143513|NCT01751087|450148042|FG000|Overall Study|Withdrawal by Subject|1|||
125143514|NCT01751087|450148043|FG001|Overall Study|Withdrawal by Subject|0|||
125143515|NCT01751087|450148044|FG002|Overall Study|Withdrawal by Subject|0|||
125143516|NCT01751087|450148042|FG000|Overall Study|Physician Decision|0|||
125143517|NCT01751087|450148043|FG001|Overall Study|Physician Decision|0|||
125143518|NCT01751087|450148044|FG002|Overall Study|Physician Decision|1|||
125143519|NCT02219009|450149435|FG000|Overall Study|Withdrawal by Subject|5|||
125143520|NCT02219009|450149436|FG001|Overall Study|Withdrawal by Subject|1|||
125143521|NCT02219009|450149435|FG000|Overall Study|Adverse Event|2|||
125143522|NCT02219009|450149436|FG001|Overall Study|Adverse Event|4|||
125143523|NCT02219009|450149435|FG000|Overall Study|Lost to Follow-up|2|||
125143524|NCT02219009|450149436|FG001|Overall Study|Lost to Follow-up|2|||
125143525|NCT02219009|450149435|FG000|Overall Study|Protocol deviation|1|||
125143526|NCT02219009|450149436|FG001|Overall Study|Protocol deviation|0|||
125143527|NCT02219009|450149435|FG000|Overall Study|Physician Decision|0|||
125143528|NCT02219009|450149436|FG001|Overall Study|Physician Decision|1|||
125143529|NCT00274625|450149437|FG000|Overall Study|Lost to Follow-up|46|||
125143530|NCT00274625|450149438|FG001|Overall Study|Lost to Follow-up|54|||
125143531|NCT00274625|450149437|FG000|Overall Study|Excluded from analysis|14|||
125143532|NCT00274625|450149438|FG001|Overall Study|Excluded from analysis|8|||
125143533|NCT03087786|450149440|FG000|Overall Study|Withdrawal by Subject|2|||
125143534|NCT03087786|450149441|FG001|Overall Study|Withdrawal by Subject|0|||
125143535|NCT00880334|450149442|FG000|Randomized Phase|Physician Decision|1|||
125143536|NCT00880334|450149443|FG001|Randomized Phase|Physician Decision|0|||
125143537|NCT00880334|450149442|FG000|Randomized Phase|Withdrawal by Subject|2|||
125143538|NCT00880334|450149443|FG001|Randomized Phase|Withdrawal by Subject|1|||
125143539|NCT00880334|450149442|FG000|Randomized Phase|Inadequate Labs|1|||
125143540|NCT00880334|450149443|FG001|Randomized Phase|Inadequate Labs|1|||
125143541|NCT00880334|450149442|FG000|Randomized Phase|Brain Metastasis|0|||
125143542|NCT00880334|450149443|FG001|Randomized Phase|Brain Metastasis|1|||
125143543|NCT00880334|450149442|FG000|Randomized Phase|Crossover Participants|0|||
125143544|NCT00880334|450149443|FG001|Randomized Phase|Crossover Participants|37|||
125143545|NCT02419573|450149451|FG000|Overall Study|Lost to Follow-up|3|||
125143546|NCT02419573|450149452|FG001|Overall Study|Lost to Follow-up|0|||
125143547|NCT02419573|450149451|FG000|Overall Study|Withdrawal by Subject|1|||
125143548|NCT02419573|450149452|FG001|Overall Study|Withdrawal by Subject|0|||
125143549|NCT02229084|450149453|FG000|Overall Study|Adverse Event|1|||
125143550|NCT02229084|450149454|FG001|Overall Study|Adverse Event|0|||
125143551|NCT02229084|450149455|FG002|Overall Study|Adverse Event|0|||
125143552|NCT02229084|450149456|FG003|Overall Study|Adverse Event|0|||
125143553|NCT02229084|450149457|FG004|Overall Study|Adverse Event|0|||
125143554|NCT02229084|450149458|FG005|Overall Study|Adverse Event|0|||
125143555|NCT02229084|450149459|FG006|Overall Study|Adverse Event|0|||
125143556|NCT02229084|450149453|FG000|Overall Study|Lost to Follow-up|0|||
125143557|NCT02229084|450149454|FG001|Overall Study|Lost to Follow-up|0|||
125143558|NCT02229084|450149455|FG002|Overall Study|Lost to Follow-up|1|||
125143559|NCT02229084|450149456|FG003|Overall Study|Lost to Follow-up|1|||
125143560|NCT02229084|450149457|FG004|Overall Study|Lost to Follow-up|0|||
125143561|NCT02229084|450149458|FG005|Overall Study|Lost to Follow-up|0|||
125143562|NCT02229084|450149459|FG006|Overall Study|Lost to Follow-up|1|||
125143563|NCT02229084|450149453|FG000|Overall Study|Physician Decision|0|||
125143564|NCT02229084|450149454|FG001|Overall Study|Physician Decision|0|||
125143565|NCT02229084|450149455|FG002|Overall Study|Physician Decision|0|||
125143566|NCT02229084|450149456|FG003|Overall Study|Physician Decision|1|||
125143567|NCT02229084|450149457|FG004|Overall Study|Physician Decision|3|||
125143568|NCT02229084|450149458|FG005|Overall Study|Physician Decision|0|||
125143569|NCT02229084|450149459|FG006|Overall Study|Physician Decision|1|||
125143570|NCT02229084|450149453|FG000|Overall Study|Withdrawal by Subject|0|||
125143571|NCT02229084|450149454|FG001|Overall Study|Withdrawal by Subject|0|||
125143572|NCT02229084|450149455|FG002|Overall Study|Withdrawal by Subject|1|||
125143573|NCT02229084|450149456|FG003|Overall Study|Withdrawal by Subject|0|||
125143574|NCT02229084|450149457|FG004|Overall Study|Withdrawal by Subject|1|||
125143575|NCT02229084|450149458|FG005|Overall Study|Withdrawal by Subject|1|||
125143576|NCT02229084|450149459|FG006|Overall Study|Withdrawal by Subject|1|||
125143577|NCT02229084|450149453|FG000|Overall Study|Death|0|||
125143578|NCT02229084|450149454|FG001|Overall Study|Death|0|||
125143579|NCT02229084|450149455|FG002|Overall Study|Death|0|||
125143580|NCT02229084|450149456|FG003|Overall Study|Death|0|||
125143581|NCT02229084|450149457|FG004|Overall Study|Death|0|||
125143582|NCT02229084|450149458|FG005|Overall Study|Death|0|||
125143583|NCT02229084|450149459|FG006|Overall Study|Death|1|||
125143584|NCT02179190|450149463|FG000|Enrollment|Exit Prior to Device Attempt|11|||
125143585|NCT02179190|450149463|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
125143586|NCT02179190|450149463|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
125143587|NCT02179190|450149463|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
125143588|NCT02179190|450149463|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
125143589|NCT02179190|450149463|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
125143590|NCT00881569|450149466|FG000|Overall Study|Disease progression|1|||
125143591|NCT00881569|450149467|FG001|Overall Study|Disease progression|1|||
125143592|NCT01993940|450149478|FG000|Overall Study|Adverse Event|16|||
125143593|NCT01993940|450149479|FG001|Overall Study|Adverse Event|11|||
125143594|NCT01993940|450149478|FG000|Overall Study|Withdrawal by Subject|15|||
125143595|NCT01993940|450149479|FG001|Overall Study|Withdrawal by Subject|19|||
125143596|NCT01993940|450149478|FG000|Overall Study|Lost to Follow-up|2|||
125143597|NCT01993940|450149479|FG001|Overall Study|Lost to Follow-up|5|||
125143598|NCT01993940|450149478|FG000|Overall Study|Protocol Violation|5|||
125143599|NCT01993940|450149479|FG001|Overall Study|Protocol Violation|8|||
125143600|NCT01993940|450149478|FG000|Overall Study|Death|1|||
125143601|NCT01993940|450149479|FG001|Overall Study|Death|0|||
125143602|NCT01993940|450149478|FG000|Overall Study|Other - Miscellaneous|1|||
125143603|NCT01993940|450149479|FG001|Overall Study|Other - Miscellaneous|1|||
125143604|NCT04164758|450149480|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
125143605|NCT04164758|450149481|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
125143606|NCT04164758|450149482|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
125143607|NCT04164758|450149480|FG000|Overall Study|Adverse Event|0|||
125143608|NCT04164758|450149481|FG001|Overall Study|Adverse Event|1|||
125143609|NCT04164758|450149482|FG002|Overall Study|Adverse Event|0|||
125143610|NCT02858037|450149489|FG000|Overall Study|Death|1|||
125143611|NCT02858037|450149489|FG000|Overall Study|Withdrawal by Subject|18|||
125143612|NCT02858037|450149489|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
125143613|NCT02858037|450149489|FG000|Overall Study|Lost to Follow-up|3|||
125143614|NCT02858037|450149489|FG000|Overall Study|Other|4|||
125143615|NCT01670097|450149490|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
125143616|NCT01670097|450149491|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
125143617|NCT01670097|450149490|FG000|Overall Study|Study burden|1|||
125143618|NCT01670097|450149491|FG001|Overall Study|Study burden|0|||
125143619|NCT01670097|450149490|FG000|Overall Study|COPD exacerbation|0|||
125143620|NCT01670097|450149491|FG001|Overall Study|COPD exacerbation|1|||
125143621|NCT01670097|450149490|FG000|Overall Study|Neutropenia|0|||
125143622|NCT01670097|450149491|FG001|Overall Study|Neutropenia|1|||
125143623|NCT01670097|450149490|FG000|Overall Study|Clinical deterioration|0|||
125143624|NCT01670097|450149491|FG001|Overall Study|Clinical deterioration|1|||
125143625|NCT01670097|450149490|FG000|Overall Study|Disease progression|0|||
125143626|NCT01670097|450149491|FG001|Overall Study|Disease progression|1|||
125143627|NCT00697827|450149492|FG000|Overall Study|enrolled but not treated|2|||
125143628|NCT00697827|450149493|FG001|Overall Study|enrolled but not treated|1|||
125143629|NCT03732833|450149494|FG000|Overall Study|Adverse Event|0|||
125143630|NCT03732833|450149495|FG001|Overall Study|Adverse Event|3|||
125143631|NCT03732833|450149496|FG002|Overall Study|Adverse Event|1|||
125143632|NCT03732833|450149494|FG000|Overall Study|Withdrawal by Subject|11|||
125143633|NCT03732833|450149495|FG001|Overall Study|Withdrawal by Subject|13|||
125143634|NCT03732833|450149496|FG002|Overall Study|Withdrawal by Subject|8|||
125143635|NCT03732833|450149494|FG000|Overall Study|Lost to Follow-up|3|||
125143636|NCT03732833|450149495|FG001|Overall Study|Lost to Follow-up|5|||
125143637|NCT03732833|450149496|FG002|Overall Study|Lost to Follow-up|4|||
125143638|NCT03732833|450149494|FG000|Overall Study|Pregnancy|0|||
125143639|NCT03732833|450149495|FG001|Overall Study|Pregnancy|2|||
125143640|NCT03732833|450149496|FG002|Overall Study|Pregnancy|0|||
125143641|NCT03732833|450149494|FG000|Overall Study|Physician Decision|2|||
125143642|NCT03732833|450149495|FG001|Overall Study|Physician Decision|3|||
125143643|NCT03732833|450149496|FG002|Overall Study|Physician Decision|1|||
125143644|NCT03732833|450149494|FG000|Overall Study|Covid-19 related and other reasons|2|||
125143645|NCT03732833|450149495|FG001|Overall Study|Covid-19 related and other reasons|7|||
125143646|NCT03732833|450149496|FG002|Overall Study|Covid-19 related and other reasons|3|||
125143647|NCT02311894|450149498|FG000|Overall Study|Discontinued in error|1|||
125143648|NCT02311894|450149498|FG000|Overall Study|Lost to Follow-up|1|||
125143649|NCT02311894|450149498|FG000|Overall Study|Adverse Event|1|||
125143650|NCT02311894|450149498|FG000|Overall Study|Withdrawal by Subject|1|||
125143651|NCT00702507|450149501|FG000|Initial Treatment Phase|Adverse Event|2|||
125143652|NCT00702507|450149501|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
125143653|NCT00702507|450149501|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
125143654|NCT00702507|450149501|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
125143655|NCT00702507|450149501|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
125143656|NCT00702507|450149501|FG000|Follow-up Phase|Protocol Violation|2|||
125143657|NCT00702507|450149501|FG000|Follow-up Phase|Lost to Follow-up|23|||
125143658|NCT00702507|450149501|FG000|Follow-up Phase|Late Enrollment|1|||
125143659|NCT01277510|450149502|FG000|Double-blind Phase|Non-compliance|0|||
125143660|NCT01277510|450149503|FG001|Double-blind Phase|Non-compliance|1|||
125143661|NCT01277510|450149502|FG000|Double-blind Phase|Adverse Event|1|||
125143662|NCT01277510|450149503|FG001|Double-blind Phase|Adverse Event|0|||
125143663|NCT01277510|450149502|FG000|Double-blind Phase|Withdrawal by Subject|2|||
125143664|NCT01277510|450149503|FG001|Double-blind Phase|Withdrawal by Subject|0|||
125143665|NCT01277510|450149502|FG000|Double-blind Phase|Administrative decision|7|||
125143666|NCT01277510|450149503|FG001|Double-blind Phase|Administrative decision|9|||
125143667|NCT01277510|450149502|FG000|Double-blind Phase|Death|0|||
125143668|NCT01277510|450149503|FG001|Double-blind Phase|Death|1|||
125143669|NCT01277510|450149502|FG000|Double-blind Phase|Protocol-specified criteria|2|||
125143670|NCT01277510|450149503|FG001|Double-blind Phase|Protocol-specified criteria|6|||
125143671|NCT01277510|450149502|FG000|Double-blind Phase|Other|1|||
125143672|NCT01277510|450149503|FG001|Double-blind Phase|Other|1|||
125143673|NCT01277510|450149502|FG000|Open-label Phase|Administrative decision|4|||
125143674|NCT01277510|450149503|FG001|Open-label Phase|Administrative decision|3|||
125143675|NCT01277510|450149502|FG000|Open-label Phase|Protocol-specified criteria|1|||
125143676|NCT01277510|450149503|FG001|Open-label Phase|Protocol-specified criteria|0|||
125143677|NCT01277510|450149502|FG000|Open-label Phase|Never received investigational product|2|||
125143678|NCT01277510|450149503|FG001|Open-label Phase|Never received investigational product|0|||
125143679|NCT01685008|450149504|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
125143680|NCT01685008|450149505|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
125143681|NCT01685008|450149506|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
125143682|NCT01685008|450149507|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
125143683|NCT01685008|450149504|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
125143684|NCT01685008|450149505|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
125143685|NCT01685008|450149506|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
125143686|NCT01685008|450149507|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
125143687|NCT01685008|450149504|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
125143688|NCT01685008|450149505|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
125143689|NCT01685008|450149506|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
125143690|NCT01685008|450149507|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
125143691|NCT01685008|450149504|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
125143692|NCT01685008|450149505|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
125143693|NCT01685008|450149506|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
125143694|NCT01685008|450149507|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
125143695|NCT01685008|450149504|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
125143696|NCT01685008|450149505|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
125143697|NCT01685008|450149506|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
125143698|NCT01685008|450149507|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
125143699|NCT00057941|450149519|FG000|Overall Study|Death|1|||
125143700|NCT00057941|450149520|FG001|Overall Study|Death|2|||
125143701|NCT00057941|450149519|FG000|Overall Study|Adverse Event|7|||
125143702|NCT00057941|450149520|FG001|Overall Study|Adverse Event|9|||
125143703|NCT00057941|450149519|FG000|Overall Study|Lack of Efficacy|54|||
125143704|NCT00057941|450149520|FG001|Overall Study|Lack of Efficacy|53|||
125143705|NCT00057941|450149519|FG000|Overall Study|Withdrawal by Subject|6|||
125143706|NCT00057941|450149520|FG001|Overall Study|Withdrawal by Subject|1|||
125143707|NCT00057941|450149519|FG000|Overall Study|still on treatment|3|||
125143708|NCT00057941|450149520|FG001|Overall Study|still on treatment|1|||
125143709|NCT00057941|450149519|FG000|Overall Study|insurance, symptomatic deterioration|1|||
125143710|NCT00057941|450149520|FG001|Overall Study|insurance, symptomatic deterioration|3|||
125143711|NCT00057941|450149519|FG000|Overall Study|Ineligible|2|||
125143712|NCT00057941|450149520|FG001|Overall Study|Ineligible|5|||
125143713|NCT01898598|450149522|FG000|Overall Study|Adverse Event|1|||
125143714|NCT01898598|450149523|FG001|Overall Study|Adverse Event|0|||
125143715|NCT01898598|450149522|FG000|Overall Study|Withdrawal by Subject|3|||
125143716|NCT01898598|450149523|FG001|Overall Study|Withdrawal by Subject|0|||
125143717|NCT01898598|450149522|FG000|Overall Study|Lost to Follow-up|0|||
125143718|NCT01898598|450149523|FG001|Overall Study|Lost to Follow-up|1|||
125143719|NCT01898598|450149522|FG000|Overall Study|Other|0|||
125143720|NCT01898598|450149523|FG001|Overall Study|Other|1|||
125143721|NCT03833427|450149524|FG000|Overall Study|Death|4|||
125143722|NCT03833427|450149525|FG001|Overall Study|Death|2|||
125143723|NCT03833427|450149526|FG002|Overall Study|Death|9|||
125143724|NCT03833427|450149527|FG003|Overall Study|Death|11|||
125143725|NCT03833427|450149528|FG004|Overall Study|Death|0|||
125143726|NCT03833427|450149529|FG005|Overall Study|Death|0|||
125143727|NCT03833427|450149530|FG006|Overall Study|Death|0|||
125143728|NCT03833427|450149524|FG000|Overall Study|Withdrawal by Subject|0|||
125143729|NCT03833427|450149525|FG001|Overall Study|Withdrawal by Subject|1|||
125143730|NCT03833427|450149526|FG002|Overall Study|Withdrawal by Subject|1|||
125143731|NCT03833427|450149527|FG003|Overall Study|Withdrawal by Subject|0|||
125143732|NCT03833427|450149528|FG004|Overall Study|Withdrawal by Subject|0|||
125143733|NCT03833427|450149529|FG005|Overall Study|Withdrawal by Subject|0|||
125143734|NCT03833427|450149530|FG006|Overall Study|Withdrawal by Subject|0|||
125143735|NCT03833427|450149524|FG000|Overall Study|Sponsor Decision|0|||
125143736|NCT03833427|450149525|FG001|Overall Study|Sponsor Decision|0|||
125143737|NCT03833427|450149526|FG002|Overall Study|Sponsor Decision|1|||
125143738|NCT03833427|450149527|FG003|Overall Study|Sponsor Decision|3|||
125143739|NCT03833427|450149528|FG004|Overall Study|Sponsor Decision|0|||
125143740|NCT03833427|450149529|FG005|Overall Study|Sponsor Decision|0|||
125143741|NCT03833427|450149530|FG006|Overall Study|Sponsor Decision|0|||
125143742|NCT01499160|450149532|FG000|Overall Study|Adverse Event|1|||
125143743|NCT01499160|450149532|FG000|Overall Study|Withdrawal by Subject|1|||
125143744|NCT02387762|450149535|FG000|Overall Study|Withdrawal by Subject|1|||
125143745|NCT02387762|450149536|FG001|Overall Study|Withdrawal by Subject|0|||
125143746|NCT01596127|450149537|FG000|Overall Study|Patient Ineligible|1|||
125143747|NCT00688844|450149539|FG000|Overall Study|Lost to Follow-up|10|||
125143748|NCT01374451|450149540|FG000|Overall Study|Administrative problems|1|||
125143749|NCT01374451|450149541|FG001|Overall Study|Administrative problems|0|||
125143750|NCT01223027|450149542|FG000|Overall Study|Adverse Event|20|||
125143751|NCT01223027|450149543|FG001|Overall Study|Adverse Event|10|||
125143752|NCT01223027|450149542|FG000|Overall Study|Death|42|||
125143753|NCT01223027|450149543|FG001|Overall Study|Death|42|||
125143754|NCT01223027|450149542|FG000|Overall Study|Lost to Follow-up|2|||
125143755|NCT01223027|450149543|FG001|Overall Study|Lost to Follow-up|1|||
125143756|NCT01223027|450149542|FG000|Overall Study|Physician Decision|4|||
125143757|NCT01223027|450149543|FG001|Overall Study|Physician Decision|8|||
125143758|NCT01223027|450149542|FG000|Overall Study|Progressive Disease|167|||
125143759|NCT01223027|450149543|FG001|Overall Study|Progressive Disease|183|||
125076471|NCT02918318|449897040|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
125076472|NCT02918318|449897036|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
125076473|NCT02918318|449897037|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
125076474|NCT02918318|449897038|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
125076475|NCT02918318|449897039|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
125076476|NCT02918318|449897040|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
125076477|NCT02918318|449897036|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
125076478|NCT02918318|449897037|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
125076479|NCT02918318|449897038|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
125076480|NCT02918318|449897039|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
125076481|NCT02918318|449897040|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
125076482|NCT02918318|449897036|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
125076483|NCT02918318|449897037|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
125076484|NCT02918318|449897038|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
125076485|NCT02918318|449897039|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
125076486|NCT02918318|449897040|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
125076487|NCT02918318|449897036|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
125076488|NCT02918318|449897037|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
125076489|NCT02918318|449897038|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
125076490|NCT02918318|449897039|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
125076491|NCT02918318|449897040|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
125076492|NCT02918318|449897036|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
125076493|NCT02918318|449897037|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
125076494|NCT02918318|449897038|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
125076495|NCT02918318|449897039|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
125076496|NCT02918318|449897040|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
125076497|NCT02918318|449897036|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
125076498|NCT02918318|449897037|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
125076499|NCT02918318|449897038|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
125076500|NCT02918318|449897039|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
125076501|NCT02918318|449897040|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
125076502|NCT02918318|449897036|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
125076503|NCT02918318|449897037|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
125076504|NCT02918318|449897038|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
125076505|NCT02918318|449897039|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
125076506|NCT02918318|449897040|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
125076507|NCT02918318|449897036|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
125076508|NCT02918318|449897037|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
125076509|NCT02918318|449897038|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
125076510|NCT02918318|449897039|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
125076511|NCT02918318|449897040|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
125076512|NCT00045630|449897044|FG000|Overall Study|Adverse Event|1|||
125076513|NCT00045630|449897044|FG000|Overall Study|Refusal unrelated to adverse event|1|||
125076514|NCT00045630|449897044|FG000|Overall Study|Progression/relapse|1|||
125076515|NCT00045630|449897044|FG000|Overall Study|Death|1|||
125076516|NCT00045630|449897044|FG000|Overall Study|Ineligible|2|||
125076517|NCT02023112|449897049|FG000|Overall Study|Withdrawal by Subject|2|||
125076518|NCT02023112|449897050|FG001|Overall Study|Withdrawal by Subject|1|||
125076519|NCT01906476|449897054|FG000|Overall Study|Lost to Follow-up|17|||
125076520|NCT01906476|449897055|FG001|Overall Study|Lost to Follow-up|16|||
125076521|NCT01176240|449897056|FG000|Study 306A|Lack of Efficacy|2|||
125076522|NCT01176240|449897057|FG001|Study 306A|Lack of Efficacy|1|||
125076523|NCT01176240|449897056|FG000|Study 306A|Protocol Violation|0|||
125076524|NCT01176240|449897057|FG001|Study 306A|Protocol Violation|1|||
125076525|NCT01176240|449897056|FG000|Study 306A|Withdrawal by Subject|0|||
125076526|NCT01176240|449897057|FG001|Study 306A|Withdrawal by Subject|1|||
125076527|NCT01176240|449897056|FG000|Study 306A|Stop due to diverse problems|1|||
125076528|NCT01176240|449897057|FG001|Study 306A|Stop due to diverse problems|0|||
125076529|NCT01176240|449897056|FG000|Study 306B|Lack of Efficacy|5|||
125076530|NCT01176240|449897057|FG001|Study 306B|Lack of Efficacy|3|||
125076531|NCT01176240|449897056|FG000|Study 306B|Adverse Event|10|||
125076532|NCT01176240|449897057|FG001|Study 306B|Adverse Event|5|||
125076533|NCT01176240|449897056|FG000|Study 306B|Protocol Violation|2|||
125076534|NCT01176240|449897057|FG001|Study 306B|Protocol Violation|3|||
125076535|NCT01176240|449897056|FG000|Study 306B|Withdrawal by Subject|4|||
125076536|NCT01176240|449897057|FG001|Study 306B|Withdrawal by Subject|1|||
125076537|NCT01176240|449897056|FG000|Study 306B|Physician Decision|2|||
125076538|NCT01176240|449897057|FG001|Study 306B|Physician Decision|1|||
125076539|NCT01176240|449897056|FG000|Study 306B|Supine Hypertension|1|||
125076540|NCT01176240|449897057|FG001|Study 306B|Supine Hypertension|2|||
125076541|NCT01176240|449897056|FG000|Study 306B|Lost to Follow-up|0|||
125143760|NCT01223027|450149542|FG000|Overall Study|Protocol Violation|2|||
125143761|NCT01223027|450149543|FG001|Overall Study|Protocol Violation|1|||
125076542|NCT01176240|449897057|FG001|Study 306B|Lost to Follow-up|1|||
125076543|NCT01176240|449897056|FG000|Study 306B|withdrew prior to dosing|2|||
125076544|NCT01176240|449897057|FG001|Study 306B|withdrew prior to dosing|1|||
125076545|NCT01931150|449897060|FG000|Overall Study|Withdrawal by Subject|1|||
125076546|NCT01931150|449897061|FG001|Overall Study|Withdrawal by Subject|2|||
125076547|NCT02896192|449897065|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
125076548|NCT02896192|449897065|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
125076549|NCT02896192|449897065|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
125076550|NCT00479167|449897070|FG000|Overall Study|Withdrawal by Subject|1|||
125076551|NCT01390038|449897071|FG000|Overall Study|Death|1|||
125076552|NCT01390038|449897071|FG000|Overall Study|Lost to Follow-up|1|||
125076553|NCT01390038|449897071|FG000|Overall Study|Withdrawal by Subject|4|||
125076554|NCT01390038|449897071|FG000|Overall Study|Simpliciti System Removal|2|||
125076555|NCT03619837|449897077|FG000|Screening|received organs from HCV-negative donors|47|||
125076556|NCT03619837|449897077|FG000|Screening|died on the wait-list|2|||
125076557|NCT03619837|449897077|FG000|Screening|remained on the wait list|40|||
125076558|NCT03619837|449897077|FG000|Screening|didn't meet eligibility criteria|3|||
125076559|NCT03619837|449897077|FG000|Screening|withdrew consent|2|||
125076560|NCT03619837|449897077|FG000|Screening|never listed for HCV-viremic donor|1|||
125076561|NCT03619837|449897077|FG000|Screening|developed exclusion criteria|2|||
125076562|NCT03619837|449897077|FG000|Screening|excluded by the investigator due to non-compliance|1|||
125076563|NCT00807014|449897081|FG000|Overall Study|Participant Considered Disease Cured|13|||
125076564|NCT00807014|449897082|FG001|Overall Study|Participant Considered Disease Cured|2|||
125076565|NCT00807014|449897081|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
125076566|NCT00807014|449897082|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
125076567|NCT00807014|449897081|FG000|Overall Study|Protocol Violation|2|||
125076568|NCT00807014|449897082|FG001|Overall Study|Protocol Violation|8|||
125076569|NCT00807014|449897081|FG000|Overall Study|Adverse Event|0|||
125076570|NCT00807014|449897082|FG001|Overall Study|Adverse Event|2|||
125076571|NCT00807014|449897081|FG000|Overall Study|Lost to Follow-up|9|||
125076572|NCT00807014|449897082|FG001|Overall Study|Lost to Follow-up|7|||
125076573|NCT00807014|449897081|FG000|Overall Study|Recovery|1|||
125076574|NCT00807014|449897082|FG001|Overall Study|Recovery|0|||
125076575|NCT00807014|449897081|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
125076576|NCT00807014|449897082|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
125076577|NCT02650895|449897083|FG000|Overall Study|Withdrawal by Subject|0|||
125076578|NCT02650895|449897084|FG001|Overall Study|Withdrawal by Subject|1|||
125076579|NCT02650895|449897085|FG002|Overall Study|Withdrawal by Subject|0|||
125076580|NCT02650895|449897086|FG003|Overall Study|Withdrawal by Subject|0|||
125076581|NCT02650895|449897087|FG004|Overall Study|Withdrawal by Subject|0|||
125076582|NCT02650895|449897088|FG005|Overall Study|Withdrawal by Subject|0|||
125076583|NCT01696396|449899102|FG000|Overall Study|Withdrawal by Subject|19|||
125076584|NCT01696396|449899103|FG001|Overall Study|Withdrawal by Subject|5|||
125076585|NCT01696396|449899104|FG002|Overall Study|Withdrawal by Subject|19|||
125076586|NCT01696396|449899105|FG003|Overall Study|Withdrawal by Subject|11|||
125076587|NCT01696396|449899102|FG000|Overall Study|Decision by Sponsor|3|||
125076588|NCT01696396|449899103|FG001|Overall Study|Decision by Sponsor|1|||
125076589|NCT01696396|449899104|FG002|Overall Study|Decision by Sponsor|2|||
125076590|NCT01696396|449899105|FG003|Overall Study|Decision by Sponsor|2|||
125076591|NCT01696396|449899102|FG000|Overall Study|Lost to Follow-up|9|||
125076592|NCT01696396|449899103|FG001|Overall Study|Lost to Follow-up|1|||
125076593|NCT01696396|449899104|FG002|Overall Study|Lost to Follow-up|4|||
125076594|NCT01696396|449899105|FG003|Overall Study|Lost to Follow-up|1|||
125076595|NCT01696396|449899102|FG000|Overall Study|Death|0|||
125076596|NCT01696396|449899103|FG001|Overall Study|Death|0|||
125076597|NCT01696396|449899104|FG002|Overall Study|Death|1|||
125076598|NCT01696396|449899105|FG003|Overall Study|Death|0|||
125076599|NCT02712008|449899108|FG000|Baseline (Day 1) up to Week 12|Death|3|||
125076600|NCT02712008|449899109|FG001|Baseline (Day 1) up to Week 12|Death|0|||
125076601|NCT02712008|449899110|FG002|Baseline (Day 1) up to Week 12|Death|0|||
125076602|NCT02712008|449899111|FG003|Baseline (Day 1) up to Week 12|Death|0|||
125076603|NCT02712008|449899112|FG004|Baseline (Day 1) up to Week 12|Death|0|||
125143762|NCT01223027|450149542|FG000|Overall Study|Subject/guardian decicion|18|||
125143763|NCT01223027|450149543|FG001|Overall Study|Subject/guardian decicion|16|||
125143764|NCT01223027|450149542|FG000|Overall Study|New therapy for study indication|17|||
125076604|NCT02712008|449899113|FG005|Baseline (Day 1) up to Week 12|Death|0|||
125076605|NCT02712008|449899114|FG006|Baseline (Day 1) up to Week 12|Death|0|||
125076606|NCT02712008|449899115|FG007|Baseline (Day 1) up to Week 12|Death|0|||
125076607|NCT02712008|449899108|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125076608|NCT02712008|449899109|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
125076609|NCT02712008|449899110|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
125143765|NCT01223027|450149543|FG001|Overall Study|New therapy for study indication|8|||
125076610|NCT02712008|449899111|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125076611|NCT02712008|449899112|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125076612|NCT02712008|449899113|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125076613|NCT02712008|449899114|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125076614|NCT02712008|449899115|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125076615|NCT02712008|449899108|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
125076616|NCT02712008|449899109|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125076617|NCT02712008|449899110|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
125076618|NCT02712008|449899111|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125076619|NCT02712008|449899112|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125076620|NCT02712008|449899113|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125076621|NCT02712008|449899114|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125076622|NCT02712008|449899115|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125076623|NCT02712008|449899108|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
125076624|NCT02712008|449899109|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
125143766|NCT01223027|450149542|FG000|Overall Study|Study terminated by sponsor|2|||
125143767|NCT01223027|450149543|FG001|Overall Study|Study terminated by sponsor|8|||
125143768|NCT03201003|450149547|FG000|Overall Study|Adverse Event|14|||
125143769|NCT03201003|450149548|FG001|Overall Study|Adverse Event|1|||
125143770|NCT03201003|450149547|FG000|Overall Study|Other reasons|5|||
125143771|NCT03201003|450149548|FG001|Overall Study|Other reasons|1|||
125143772|NCT03201003|450149547|FG000|Overall Study|Withdrawal by Subject|4|||
125143773|NCT03201003|450149548|FG001|Overall Study|Withdrawal by Subject|1|||
125143774|NCT03201003|450149547|FG000|Overall Study|Lost to Follow-up|2|||
125143775|NCT03201003|450149548|FG001|Overall Study|Lost to Follow-up|0|||
125143776|NCT03201003|450149547|FG000|Overall Study|Protocol Violation|1|||
125143777|NCT03201003|450149548|FG001|Overall Study|Protocol Violation|0|||
125143778|NCT00834613|450149549|FG000|First Intervention|Protocol Violation|1|||
125143779|NCT00834613|450149550|FG001|First Intervention|Protocol Violation|0|||
125143780|NCT00663234|450149551|FG000|Overall Study|Not willing to adhere to requirements|1|||
125143781|NCT01709903|450149554|FG000|Overall Study|administrative problems|2|||
125143782|NCT01709903|450149555|FG001|Overall Study|administrative problems|6|||
125143783|NCT01709903|450149554|FG000|Overall Study|Abnormal test procedure results|1|||
125143784|NCT01709903|450149555|FG001|Overall Study|Abnormal test procedure results|0|||
125143785|NCT01709903|450149554|FG000|Overall Study|In ability to use device|1|||
125143786|NCT01709903|450149555|FG001|Overall Study|In ability to use device|1|||
125143787|NCT01709903|450149554|FG000|Overall Study|no longer needed study drug|0|||
125143788|NCT01709903|450149555|FG001|Overall Study|no longer needed study drug|1|||
125143789|NCT01709903|450149554|FG000|Overall Study|Lost to Follow-up|0|||
125143790|NCT01709903|450149555|FG001|Overall Study|Lost to Follow-up|2|||
125143791|NCT01709903|450149554|FG000|Overall Study|Death|2|||
125143792|NCT01709903|450149555|FG001|Overall Study|Death|0|||
125143793|NCT01709903|450149554|FG000|Overall Study|Protocol Violation|3|||
125143794|NCT01709903|450149555|FG001|Overall Study|Protocol Violation|2|||
125143795|NCT01709903|450149554|FG000|Overall Study|Lack of Efficacy|3|||
125143796|NCT01709903|450149555|FG001|Overall Study|Lack of Efficacy|3|||
125143797|NCT01709903|450149554|FG000|Overall Study|Withdrawal by Subject|6|||
125143798|NCT01709903|450149555|FG001|Overall Study|Withdrawal by Subject|6|||
125143799|NCT01709903|450149554|FG000|Overall Study|Adverse Event|11|||
125143800|NCT01709903|450149555|FG001|Overall Study|Adverse Event|18|||
125143801|NCT02061280|450149556|FG000|Overall Study|Protocol Violation|12|||
125143802|NCT02061280|450149557|FG001|Overall Study|Protocol Violation|8|||
125143803|NCT02061280|450149556|FG000|Overall Study|moved out of state|0|||
125143804|NCT02061280|450149557|FG001|Overall Study|moved out of state|1|||
125143805|NCT02061280|450149556|FG000|Overall Study|Withdrawal by Subject|1|||
125143806|NCT02061280|450149557|FG001|Overall Study|Withdrawal by Subject|2|||
125143807|NCT02061280|450149556|FG000|Overall Study|Lost to Follow-up|5|||
125143808|NCT02061280|450149557|FG001|Overall Study|Lost to Follow-up|1|||
125143809|NCT00724958|450149571|FG000|Overall Study|Adverse Event|28|||
125143810|NCT00724958|450149571|FG000|Overall Study|Loss of Response|40|||
125143811|NCT00724958|450149571|FG000|Overall Study|No Response|18|||
125143812|NCT00724958|450149571|FG000|Overall Study|Remission|7|||
125143813|NCT00724958|450149571|FG000|Overall Study|Other Reason|76|||
125143814|NCT00724958|450149571|FG000|Overall Study|No documentation for end of therapy|13|||
125143815|NCT00697619|450149572|FG000|Overall Study|Lack of Efficacy|2|||
125143816|NCT00697619|450149573|FG001|Overall Study|Lack of Efficacy|2|||
125143817|NCT00697619|450149572|FG000|Overall Study|Adverse Event|4|||
125143818|NCT00697619|450149573|FG001|Overall Study|Adverse Event|6|||
125223385|NCT02326272|450446164|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125223386|NCT02326272|450446165|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125223387|NCT02326272|450446166|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125223388|NCT02326272|450446167|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125223389|NCT02326272|450446168|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
125223390|NCT02326272|450446169|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
125223391|NCT02326272|450446170|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
125223392|NCT02326272|450446171|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
125076625|NCT02712008|449899110|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
125076626|NCT02712008|449899111|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
125076627|NCT02712008|449899112|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
125076628|NCT02712008|449899113|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
125076629|NCT02712008|449899114|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
125076630|NCT02712008|449899115|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
125076631|NCT02712008|449899108|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
125076632|NCT02712008|449899109|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
125076633|NCT02712008|449899110|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
125076634|NCT02712008|449899111|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
125076635|NCT02712008|449899112|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
125076636|NCT02712008|449899113|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
125076637|NCT02712008|449899114|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
125076638|NCT02712008|449899115|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
125076639|NCT02712008|449899108|FG000|From Week 12 up to Week 36|Adverse Event|0|||
125076640|NCT02712008|449899109|FG001|From Week 12 up to Week 36|Adverse Event|0|||
125076641|NCT02712008|449899110|FG002|From Week 12 up to Week 36|Adverse Event|0|||
125076642|NCT02712008|449899111|FG003|From Week 12 up to Week 36|Adverse Event|0|||
125076643|NCT02712008|449899112|FG004|From Week 12 up to Week 36|Adverse Event|1|||
125076644|NCT02712008|449899113|FG005|From Week 12 up to Week 36|Adverse Event|0|||
125076645|NCT02712008|449899114|FG006|From Week 12 up to Week 36|Adverse Event|0|||
125076646|NCT02712008|449899115|FG007|From Week 12 up to Week 36|Adverse Event|2|||
125076647|NCT02712008|449899108|FG000|From Week 12 up to Week 36|Death|1|||
125076648|NCT02712008|449899109|FG001|From Week 12 up to Week 36|Death|0|||
125076649|NCT02712008|449899110|FG002|From Week 12 up to Week 36|Death|0|||
125076650|NCT02712008|449899111|FG003|From Week 12 up to Week 36|Death|0|||
125076651|NCT02712008|449899112|FG004|From Week 12 up to Week 36|Death|0|||
125076652|NCT02712008|449899113|FG005|From Week 12 up to Week 36|Death|0|||
125076653|NCT02712008|449899114|FG006|From Week 12 up to Week 36|Death|1|||
125076654|NCT02712008|449899115|FG007|From Week 12 up to Week 36|Death|0|||
125076655|NCT02712008|449899108|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
125076656|NCT02712008|449899109|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
125076657|NCT02712008|449899110|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
125076658|NCT02712008|449899111|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
125076659|NCT02712008|449899112|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
125076660|NCT02712008|449899113|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
125076661|NCT02712008|449899114|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
125076662|NCT02712008|449899115|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
125076663|NCT02712008|449899108|FG000|From Week 12 up to Week 36|Physician Decision|0|||
125076664|NCT02712008|449899109|FG001|From Week 12 up to Week 36|Physician Decision|0|||
125076665|NCT02712008|449899110|FG002|From Week 12 up to Week 36|Physician Decision|0|||
125076666|NCT02712008|449899111|FG003|From Week 12 up to Week 36|Physician Decision|1|||
125076667|NCT02712008|449899112|FG004|From Week 12 up to Week 36|Physician Decision|1|||
125076668|NCT02712008|449899113|FG005|From Week 12 up to Week 36|Physician Decision|0|||
125076669|NCT02712008|449899114|FG006|From Week 12 up to Week 36|Physician Decision|0|||
125076670|NCT02712008|449899115|FG007|From Week 12 up to Week 36|Physician Decision|0|||
125076671|NCT02712008|449899108|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
125076672|NCT02712008|449899109|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
125143819|NCT00258856|450151329|FG000|Overall Study|Lost to Follow-up|1|||
125143820|NCT00258856|450151330|FG001|Overall Study|Lost to Follow-up|0|||
125143821|NCT00258856|450151331|FG002|Overall Study|Lost to Follow-up|2|||
125143822|NCT00258856|450151332|FG003|Overall Study|Lost to Follow-up|0|||
125143823|NCT00258856|450151329|FG000|Overall Study|Non-compliance|2|||
125143824|NCT00258856|450151330|FG001|Overall Study|Non-compliance|0|||
125143825|NCT00258856|450151331|FG002|Overall Study|Non-compliance|0|||
125143826|NCT00258856|450151332|FG003|Overall Study|Non-compliance|1|||
125143827|NCT01754376|450151338|FG000|Overall Study|Adverse Event|1|||
125143828|NCT01754376|450151338|FG000|Overall Study|Lack of Efficacy|2|||
125143829|NCT04556734|450151339|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
125143830|NCT04556734|450151340|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
125143831|NCT04556734|450151341|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
125143832|NCT04556734|450151342|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125143833|NCT04556734|450151343|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125143834|NCT04556734|450151344|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125143835|NCT04556734|450151345|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125143836|NCT04556734|450151346|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125143837|NCT04556734|450151339|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
125143838|NCT04556734|450151340|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
125143839|NCT04556734|450151341|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
125143840|NCT04556734|450151342|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
125143841|NCT04556734|450151343|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
125143842|NCT04556734|450151344|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
125076673|NCT02712008|449899110|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
125143843|NCT04556734|450151345|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
125143844|NCT04556734|450151346|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
125143845|NCT04556734|450151339|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
125143846|NCT04556734|450151340|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125143847|NCT04556734|450151341|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
125143848|NCT04556734|450151342|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125143849|NCT04556734|450151343|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125143850|NCT04556734|450151344|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125143851|NCT04556734|450151345|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125143852|NCT04556734|450151346|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125143853|NCT04556734|450151339|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
125143854|NCT04556734|450151340|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
125143855|NCT04556734|450151341|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
125143856|NCT04556734|450151342|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
125143857|NCT04556734|450151343|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
125143858|NCT04556734|450151344|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
125143859|NCT04556734|450151345|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
125143860|NCT04556734|450151346|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
125143861|NCT04556734|450151339|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
125143862|NCT04556734|450151340|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
125143863|NCT04556734|450151341|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
125143864|NCT04556734|450151342|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
125143865|NCT04556734|450151343|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
125143866|NCT04556734|450151344|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
125143867|NCT04556734|450151345|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
125143868|NCT04556734|450151346|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
125143869|NCT04556734|450151339|FG000|OLE Period (28 Weeks)|Not reported|0|||
125143870|NCT04556734|450151340|FG001|OLE Period (28 Weeks)|Not reported|0|||
125143871|NCT04556734|450151341|FG002|OLE Period (28 Weeks)|Not reported|0|||
125143872|NCT04556734|450151342|FG003|OLE Period (28 Weeks)|Not reported|0|||
125143873|NCT04556734|450151343|FG004|OLE Period (28 Weeks)|Not reported|0|||
125143874|NCT04556734|450151344|FG005|OLE Period (28 Weeks)|Not reported|1|||
125143875|NCT04556734|450151345|FG006|OLE Period (28 Weeks)|Not reported|0|||
125143876|NCT04556734|450151346|FG007|OLE Period (28 Weeks)|Not reported|0|||
125143877|NCT04556734|450151339|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
125143878|NCT04556734|450151340|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
125143879|NCT04556734|450151341|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
125143880|NCT04556734|450151342|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
125143881|NCT04556734|450151343|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
125143882|NCT04556734|450151344|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
125143883|NCT04556734|450151345|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
125143884|NCT04556734|450151346|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
125143885|NCT04556734|450151339|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
125143886|NCT04556734|450151340|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
125143887|NCT04556734|450151341|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
125143888|NCT04556734|450151342|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
125143889|NCT04556734|450151343|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
125143890|NCT04556734|450151344|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
125143891|NCT04556734|450151345|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
125143892|NCT04556734|450151346|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
125143893|NCT04556734|450151339|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
125143894|NCT04556734|450151340|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
125143895|NCT04556734|450151341|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
125143896|NCT04556734|450151342|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
125143897|NCT04556734|450151343|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
125143898|NCT04556734|450151344|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
125143899|NCT04556734|450151345|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
125143900|NCT04556734|450151346|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
125143901|NCT04264819|450151347|FG000|Overall Study|Physician Decision|19|||
125143902|NCT04264819|450151347|FG000|Overall Study|Adverse Event|12|||
125143903|NCT04264819|450151347|FG000|Overall Study|Withdrawal by Subject|11|||
125143904|NCT04264819|450151347|FG000|Overall Study|Lost to Follow-up|2|||
125143905|NCT04264819|450151347|FG000|Overall Study|Death|2|||
125143906|NCT01705717|450151353|FG000|Overall Study|Adverse Event|2|||
125143907|NCT01705717|450151354|FG001|Overall Study|Adverse Event|2|||
125143908|NCT01705717|450151353|FG000|Overall Study|Lack of Efficacy|0|||
125143909|NCT01705717|450151354|FG001|Overall Study|Lack of Efficacy|1|||
125143910|NCT01705717|450151353|FG000|Overall Study|Other|0|||
125143911|NCT01705717|450151354|FG001|Overall Study|Other|2|||
125143912|NCT01188226|450151358|FG000|Overall Study|Withdrawal by Subject|4|||
125143913|NCT01662024|450151359|FG000|Overall Study|Pregnancy|2|||
125143914|NCT01662024|450151359|FG000|Overall Study|Withdrawal by Subject|3|||
125076674|NCT02712008|449899111|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
125076675|NCT02712008|449899112|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
125076676|NCT02712008|449899113|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
125076677|NCT02712008|449899114|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
125076678|NCT02712008|449899115|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
125076679|NCT03950440|449899116|FG000|Overall Study|Death|8|||
125076680|NCT03950440|449899117|FG001|Overall Study|Death|2|||
125076681|NCT03950440|449899118|FG002|Overall Study|Death|1|||
125076682|NCT00088595|449899122|FG000|Overall Study|Adverse Event|11|||
125076683|NCT00088595|449899122|FG000|Overall Study|Withdrawal by Subject|8|||
125076684|NCT00088595|449899122|FG000|Overall Study|Ongoing (After Core)|7|||
125076685|NCT00088595|449899122|FG000|Overall Study|New Cancer Therapy|2|||
125076686|NCT00524043|449899132|FG000|Overall Study|Lack of Efficacy|15|||
125076687|NCT00524043|449899133|FG001|Overall Study|Lack of Efficacy|13|||
125076688|NCT00524043|449899134|FG002|Overall Study|Lack of Efficacy|14|||
125076689|NCT00524043|449899132|FG000|Overall Study|Withdrawal by Subject|5|||
125076690|NCT00524043|449899133|FG001|Overall Study|Withdrawal by Subject|7|||
125076691|NCT00524043|449899134|FG002|Overall Study|Withdrawal by Subject|7|||
125076692|NCT00524043|449899132|FG000|Overall Study|Adverse Event|5|||
125076693|NCT00524043|449899133|FG001|Overall Study|Adverse Event|2|||
125076694|NCT00524043|449899134|FG002|Overall Study|Adverse Event|7|||
125076695|NCT00524043|449899132|FG000|Overall Study|Lost to Follow-up|3|||
125076696|NCT00524043|449899133|FG001|Overall Study|Lost to Follow-up|5|||
125076697|NCT00524043|449899134|FG002|Overall Study|Lost to Follow-up|3|||
125076698|NCT00524043|449899132|FG000|Overall Study|Various (eg, incarceration)|2|||
125076699|NCT00524043|449899133|FG001|Overall Study|Various (eg, incarceration)|1|||
125076700|NCT00524043|449899134|FG002|Overall Study|Various (eg, incarceration)|0|||
125076701|NCT00711412|449899135|FG000|Induction Treatment|Death|2|||
125076702|NCT00711412|449899135|FG000|Induction Treatment|Adverse Event|1|||
125076703|NCT00711412|449899135|FG000|Induction Treatment|Other|1|||
125076704|NCT00711412|449899135|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
125076705|NCT00711412|449899135|FG000|Evaluated for Combination Treatment|Death|1|||
125076706|NCT00711412|449899135|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
125076707|NCT00711412|449899135|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
125076708|NCT00711412|449899135|FG000|Combination Treatment|Progressive Disease|1|||
125076709|NCT00711412|449899135|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
125076710|NCT00711412|449899135|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
125076711|NCT00711412|449899135|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
125076712|NCT00711412|449899135|FG000|Evaluation for Response and Surgery|Death|1|||
125076713|NCT00711412|449899135|FG000|Survival Follow up Until Death|Other|12|||
125076714|NCT04211961|449899142|FG000|Overall Study|Death|0|||
125076715|NCT04211961|449899143|FG001|Overall Study|Death|1|||
125076716|NCT04211961|449899142|FG000|Overall Study|Lost to Follow-up|0|||
125076717|NCT04211961|449899143|FG001|Overall Study|Lost to Follow-up|1|||
125076718|NCT04211961|449899142|FG000|Overall Study|Withdrawal by Subject|0|||
125076719|NCT04211961|449899143|FG001|Overall Study|Withdrawal by Subject|1|||
125076720|NCT02062827|449899144|FG000|Overall Study|Death|1|||
125076721|NCT02062827|449899145|FG001|Overall Study|Death|0|||
125076722|NCT02062827|449899146|FG002|Overall Study|Death|0|||
125076723|NCT02062827|449899147|FG003|Overall Study|Death|0|||
125076724|NCT02062827|449899148|FG004|Overall Study|Death|0|||
125076725|NCT02062827|449899149|FG005|Overall Study|Death|0|||
125076726|NCT02062827|449899150|FG006|Overall Study|Death|0|||
125076727|NCT02062827|449899151|FG007|Overall Study|Death|0|||
125076728|NCT02062827|449899144|FG000|Overall Study|Withdrawal by Subject|3|||
125076729|NCT02062827|449899145|FG001|Overall Study|Withdrawal by Subject|1|||
125076730|NCT02062827|449899146|FG002|Overall Study|Withdrawal by Subject|1|||
125076731|NCT02062827|449899147|FG003|Overall Study|Withdrawal by Subject|2|||
125076732|NCT02062827|449899148|FG004|Overall Study|Withdrawal by Subject|6|||
125076733|NCT02062827|449899149|FG005|Overall Study|Withdrawal by Subject|0|||
125076734|NCT02062827|449899150|FG006|Overall Study|Withdrawal by Subject|5|||
125076735|NCT02062827|449899151|FG007|Overall Study|Withdrawal by Subject|0|||
125076736|NCT02062827|449899144|FG000|Overall Study|Screen Fail|0|||
125076737|NCT02062827|449899145|FG001|Overall Study|Screen Fail|0|||
125076738|NCT02062827|449899146|FG002|Overall Study|Screen Fail|0|||
125143915|NCT02846883|450151360|FG000|Overall Study|Death|0|||
125076739|NCT02062827|449899147|FG003|Overall Study|Screen Fail|0|||
125076740|NCT02062827|449899148|FG004|Overall Study|Screen Fail|0|||
125076741|NCT02062827|449899149|FG005|Overall Study|Screen Fail|0|||
125076742|NCT02062827|449899150|FG006|Overall Study|Screen Fail|0|||
125076743|NCT02062827|449899151|FG007|Overall Study|Screen Fail|8|||
125076744|NCT05784129|449899152|FG000|Overall Study|Study terminated by sponsor|2|||
125076745|NCT05784129|449899153|FG001|Overall Study|Study terminated by sponsor|2|||
125076746|NCT01156363|449899154|FG000|Overall Study|Adverse Event|6|||
125076747|NCT01156363|449899154|FG000|Overall Study|Insufficient Therapeutic Response|5|||
125076748|NCT01156363|449899154|FG000|Overall Study|Failure to Return|1|||
125076749|NCT01156363|449899154|FG000|Overall Study|Refused Treatment|4|||
125076750|NCT01156363|449899154|FG000|Overall Study|Other|6|||
125076751|NCT02728206|449899156|FG000|Overall Study|Death|1|||
125223393|NCT02326272|450446172|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
125223394|NCT02326272|450446173|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125223395|NCT02326272|450446174|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125076752|NCT00429572|449899159|FG000|Overall Study|Disease progression|1|||
125076753|NCT02773368|449899160|FG000|Overall Study|Lost to Follow-up|4|||
125076754|NCT02773368|449899161|FG001|Overall Study|Lost to Follow-up|1|||
125076755|NCT02773368|449899160|FG000|Overall Study|Withdrawal by Subject|5|||
125076756|NCT02773368|449899161|FG001|Overall Study|Withdrawal by Subject|1|||
125076757|NCT02773368|449899160|FG000|Overall Study|Unclassified|1|||
125076758|NCT02773368|449899161|FG001|Overall Study|Unclassified|1|||
125076759|NCT02773368|449899160|FG000|Overall Study|Missing|0|||
125076760|NCT02773368|449899161|FG001|Overall Study|Missing|1|||
125076761|NCT01929018|449899165|FG000|Overall Study|Lost to Follow-up|1|||
125076762|NCT01929018|449899166|FG001|Overall Study|Lost to Follow-up|0|||
125076763|NCT01929018|449899165|FG000|Overall Study|Hospitalization|0|||
125076764|NCT01929018|449899166|FG001|Overall Study|Hospitalization|1|||
125076765|NCT01366534|449899169|FG000|Overall Study|Lost to Follow-up|1|||
125076766|NCT01366534|449899170|FG001|Overall Study|Lost to Follow-up|0|||
125076767|NCT01366534|449899171|FG002|Overall Study|Lost to Follow-up|0|||
125076768|NCT01366534|449899169|FG000|Overall Study|Migrated|1|||
125143916|NCT02846883|450151361|FG001|Overall Study|Death|1|||
125143917|NCT02846883|450151362|FG002|Overall Study|Death|1|||
125143918|NCT02846883|450151360|FG000|Overall Study|Lost to Follow-up|0|||
125143919|NCT02846883|450151361|FG001|Overall Study|Lost to Follow-up|0|||
125143920|NCT02846883|450151362|FG002|Overall Study|Lost to Follow-up|1|||
125143921|NCT02846883|450151360|FG000|Overall Study|Withdrawal by Subject|1|||
125143922|NCT02846883|450151361|FG001|Overall Study|Withdrawal by Subject|0|||
125143923|NCT02846883|450151362|FG002|Overall Study|Withdrawal by Subject|0|||
125143924|NCT02846883|450151360|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
125143925|NCT02846883|450151361|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
125143926|NCT02846883|450151362|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
125143927|NCT02846883|450151360|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
125143928|NCT02846883|450151361|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
125143929|NCT02846883|450151362|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
125143930|NCT04768296|450151363|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
125143931|NCT04768296|450151364|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
125143932|NCT01453153|450151371|FG000|Overall Study|Physician Decision|0|||
125143933|NCT01453153|450151372|FG001|Overall Study|Physician Decision|0|||
125143934|NCT01453153|450151373|FG002|Overall Study|Physician Decision|1|||
125143935|NCT01453153|450151371|FG000|Overall Study|Progressive Disease|3|||
125143936|NCT01453153|450151372|FG001|Overall Study|Progressive Disease|2|||
125143937|NCT01453153|450151373|FG002|Overall Study|Progressive Disease|16|||
125143938|NCT01453153|450151371|FG000|Overall Study|Withdrawal by Subject|0|||
125143939|NCT01453153|450151372|FG001|Overall Study|Withdrawal by Subject|1|||
125143940|NCT01453153|450151373|FG002|Overall Study|Withdrawal by Subject|2|||
125143941|NCT01453153|450151371|FG000|Overall Study|Adverse Event|1|||
125143942|NCT01453153|450151372|FG001|Overall Study|Adverse Event|1|||
125143943|NCT01453153|450151373|FG002|Overall Study|Adverse Event|1|||
125143944|NCT01802216|450151378|FG000|4 Month Visit|Participant did not show to visit|3|||
125143945|NCT01802216|450151379|FG001|4 Month Visit|Participant did not show to visit|4|||
125143946|NCT01802216|450151378|FG000|8 Month Visit|Participant did not show to visit|3|||
125143947|NCT01802216|450151379|FG001|8 Month Visit|Participant did not show to visit|5|||
125143948|NCT01802216|450151378|FG000|12 Month Visit|Participant did not show to visit|3|||
125143949|NCT01802216|450151379|FG001|12 Month Visit|Participant did not show to visit|4|||
125143950|NCT00799708|450151380|FG000|Overall Study|non-compliance|1|||
125143951|NCT00799708|450151381|FG001|Overall Study|non-compliance|0|||
125143952|NCT00799708|450151382|FG002|Overall Study|non-compliance|0|||
125143953|NCT03343639|450151383|FG000|Overall Study|Withdrawal by Subject|10|||
125143954|NCT03343639|450151384|FG001|Overall Study|Withdrawal by Subject|6|||
125143955|NCT03343639|450151383|FG000|Overall Study|Lost to Follow-up|4|||
125143956|NCT03343639|450151384|FG001|Overall Study|Lost to Follow-up|5|||
125143957|NCT03343639|450151383|FG000|Overall Study|Protocol Violation|0|||
125143958|NCT03343639|450151384|FG001|Overall Study|Protocol Violation|1|||
125143959|NCT02274558|450151390|FG000|Overall Study|Adverse Event|2|||
125143960|NCT02274558|450151391|FG001|Overall Study|Adverse Event|4|||
125143961|NCT02274558|450151392|FG002|Overall Study|Adverse Event|2|||
125143962|NCT02274558|450151390|FG000|Overall Study|Non-compliance|2|||
125143963|NCT02274558|450151391|FG001|Overall Study|Non-compliance|1|||
125076769|NCT01366534|449899170|FG001|Overall Study|Migrated|1|||
125076770|NCT01366534|449899171|FG002|Overall Study|Migrated|0|||
125076771|NCT01366534|449899169|FG000|Overall Study|Declined challenged|0|||
125076772|NCT01366534|449899170|FG001|Overall Study|Declined challenged|1|||
125076773|NCT01366534|449899171|FG002|Overall Study|Declined challenged|0|||
125076774|NCT02635867|449899176|FG000|Overall Study|Lost to Follow-up|4|||
125076775|NCT02635867|449899177|FG001|Overall Study|Lost to Follow-up|3|||
125076776|NCT02635867|449899178|FG002|Overall Study|Lost to Follow-up|3|||
125143964|NCT02274558|450151392|FG002|Overall Study|Non-compliance|0|||
125143965|NCT02274558|450151390|FG000|Overall Study|Withdrawal by Subject|1|||
125143966|NCT02274558|450151391|FG001|Overall Study|Withdrawal by Subject|5|||
125143967|NCT02274558|450151392|FG002|Overall Study|Withdrawal by Subject|4|||
125143968|NCT02274558|450151390|FG000|Overall Study|Death|0|||
125143969|NCT02274558|450151391|FG001|Overall Study|Death|0|||
125143970|NCT02274558|450151392|FG002|Overall Study|Death|1|||
125143971|NCT02274558|450151390|FG000|Overall Study|Lost to Follow-up|2|||
125143972|NCT02274558|450151391|FG001|Overall Study|Lost to Follow-up|1|||
125143973|NCT02274558|450151392|FG002|Overall Study|Lost to Follow-up|1|||
125143974|NCT02274558|450151390|FG000|Overall Study|Physician Decision|0|||
125143975|NCT02274558|450151391|FG001|Overall Study|Physician Decision|2|||
125143976|NCT02274558|450151392|FG002|Overall Study|Physician Decision|1|||
125143977|NCT02655224|450151393|FG000|Overall Study|Adverse Event|1|||
125143978|NCT02655224|450151394|FG001|Overall Study|Adverse Event|1|||
125143979|NCT04592419|450151397|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
125143980|NCT04592419|450151398|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
125143981|NCT04592419|450151397|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
125143982|NCT04592419|450151398|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
125143983|NCT04592419|450151397|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
125143984|NCT04592419|450151398|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
125143985|NCT04592419|450151397|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
125143986|NCT04592419|450151398|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
125143987|NCT04592419|450151397|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
125143988|NCT04592419|450151398|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
125143989|NCT04592419|450151397|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
125143990|NCT04592419|450151398|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
125143991|NCT04592419|450151397|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
125143992|NCT04592419|450151398|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
125143993|NCT04592419|450151397|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
125143994|NCT04592419|450151398|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
125143995|NCT04592419|450151397|FG000|Open-Label Extension Period|Adverse Event|1|||
125143996|NCT04592419|450151398|FG001|Open-Label Extension Period|Adverse Event|2|||
125143997|NCT04592419|450151397|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
125143998|NCT04592419|450151398|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
125143999|NCT04592419|450151397|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
125144000|NCT04592419|450151398|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
125144001|NCT04592419|450151397|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
125144002|NCT04592419|450151398|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
125144003|NCT04592419|450151397|FG000|Open-Label Extension Period|Sponsor Request|73|||
125144004|NCT04592419|450151398|FG001|Open-Label Extension Period|Sponsor Request|84|||
125144005|NCT05393271|450151403|FG000|Overall Study|Physician Decision|0|||
125144006|NCT05393271|450151404|FG001|Overall Study|Physician Decision|0|||
125144007|NCT05393271|450151405|FG002|Overall Study|Physician Decision|0|||
125144008|NCT05393271|450151406|FG003|Overall Study|Physician Decision|0|||
125144009|NCT05393271|450151407|FG004|Overall Study|Physician Decision|0|||
125144010|NCT05393271|450151408|FG005|Overall Study|Physician Decision|0|||
125144011|NCT05393271|450151409|FG006|Overall Study|Physician Decision|1|||
125144012|NCT05393271|450151410|FG007|Overall Study|Physician Decision|0|||
125144013|NCT05393271|450151411|FG008|Overall Study|Physician Decision|0|||
125144014|NCT05393271|450151412|FG009|Overall Study|Physician Decision|0|||
125144015|NCT05393271|450151413|FG010|Overall Study|Physician Decision|0|||
125144016|NCT02943993|450151414|FG000|Overall Study|Withdrawal by Subject|52|||
125144017|NCT02943993|450151414|FG000|Overall Study|Transfer to another institution|6|||
125144018|NCT02943993|450151414|FG000|Overall Study|Lost to Follow-up|135|||
125144019|NCT02943993|450151414|FG000|Overall Study|Death|98|||
125144020|NCT02943993|450151414|FG000|Overall Study|Other reason for premature termination|32|||
125144021|NCT02943993|450151414|FG000|Overall Study|Missing reason for termination|7|||
125144022|NCT02483416|450151415|FG000|Overall Study|Other reason|0|||
125144023|NCT02483416|450151416|FG001|Overall Study|Other reason|1|||
125144024|NCT02483416|450151415|FG000|Overall Study|Treatment stop|3|||
125144025|NCT02483416|450151416|FG001|Overall Study|Treatment stop|0|||
125144026|NCT04968925|450151417|FG000|Phase I- Period 1|COVID-19 related|0|||
125144027|NCT04968925|450151418|FG001|Phase I- Period 1|COVID-19 related|1|||
125144028|NCT04968925|450151419|FG002|Phase I- Period 1|COVID-19 related|0|||
125144029|NCT04968925|450151420|FG003|Phase I- Period 1|COVID-19 related|0|||
125144030|NCT04968925|450151417|FG000|Phase I- Period 1|Subject enrolled in error|1|||
125144031|NCT04968925|450151418|FG001|Phase I- Period 1|Subject enrolled in error|1|||
125144032|NCT04968925|450151419|FG002|Phase I- Period 1|Subject enrolled in error|0|||
125223396|NCT02326272|450446175|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125144033|NCT04968925|450151420|FG003|Phase I- Period 1|Subject enrolled in error|0|||
125144034|NCT04968925|450151417|FG000|Phase II- Period 1|COVID-19 Related|0|||
125076777|NCT02635867|449899179|FG003|Overall Study|Lost to Follow-up|4|||
125076778|NCT02635867|449899180|FG004|Overall Study|Lost to Follow-up|1|||
125076779|NCT02565576|449899181|FG000|Overall Study|abnormal lab value|2|||
125076780|NCT02565576|449899182|FG001|Overall Study|abnormal lab value|0|||
125076781|NCT02565576|449899181|FG000|Overall Study|subject / guardian decision|1|||
125076782|NCT02565576|449899182|FG001|Overall Study|subject / guardian decision|3|||
125076783|NCT02565576|449899181|FG000|Overall Study|Lost to Follow-up|1|||
125076784|NCT02565576|449899182|FG001|Overall Study|Lost to Follow-up|0|||
125076785|NCT02565576|449899181|FG000|Overall Study|Death|0|||
125076786|NCT02565576|449899182|FG001|Overall Study|Death|2|||
125076787|NCT02565576|449899181|FG000|Overall Study|Adverse Event|1|||
125076788|NCT02565576|449899182|FG001|Overall Study|Adverse Event|0|||
125076789|NCT03377452|449899183|FG000|Overall Study|Refused assessment|0|||
125076790|NCT03377452|449899184|FG001|Overall Study|Refused assessment|2|||
125076791|NCT03377452|449899183|FG000|Overall Study|Lost to Follow-up|5|||
125076792|NCT03377452|449899184|FG001|Overall Study|Lost to Follow-up|4|||
125076793|NCT03345342|449899185|FG000|Open-Label Phase|Adverse Event|30|||
125076794|NCT03345342|449899186|FG001|Open-Label Phase|Adverse Event|0|||
125076795|NCT03345342|449899187|FG002|Open-Label Phase|Adverse Event|0|||
125076796|NCT03345342|449899188|FG003|Open-Label Phase|Adverse Event|0|||
125076797|NCT03345342|449899189|FG004|Open-Label Phase|Adverse Event|0|||
125076798|NCT03345342|449899185|FG000|Open-Label Phase|Death|1|||
125076799|NCT03345342|449899186|FG001|Open-Label Phase|Death|0|||
125076800|NCT03345342|449899187|FG002|Open-Label Phase|Death|0|||
125076801|NCT03345342|449899188|FG003|Open-Label Phase|Death|0|||
125076802|NCT03345342|449899189|FG004|Open-Label Phase|Death|0|||
125076803|NCT03345342|449899185|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
125076804|NCT03345342|449899186|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
125076805|NCT03345342|449899187|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
125076806|NCT03345342|449899188|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
125076807|NCT03345342|449899189|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
125076808|NCT03345342|449899185|FG000|Open-Label Phase|Lack of Efficacy|6|||
125076809|NCT03345342|449899186|FG001|Open-Label Phase|Lack of Efficacy|0|||
125076810|NCT03345342|449899187|FG002|Open-Label Phase|Lack of Efficacy|0|||
125076811|NCT03345342|449899188|FG003|Open-Label Phase|Lack of Efficacy|0|||
125076812|NCT03345342|449899189|FG004|Open-Label Phase|Lack of Efficacy|0|||
125076813|NCT03345342|449899185|FG000|Open-Label Phase|Lost to Follow-up|9|||
125076814|NCT03345342|449899186|FG001|Open-Label Phase|Lost to Follow-up|0|||
125076815|NCT03345342|449899187|FG002|Open-Label Phase|Lost to Follow-up|0|||
125076816|NCT03345342|449899188|FG003|Open-Label Phase|Lost to Follow-up|0|||
125076817|NCT03345342|449899189|FG004|Open-Label Phase|Lost to Follow-up|0|||
125076818|NCT03345342|449899185|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
125076819|NCT03345342|449899186|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
125144035|NCT04968925|450151418|FG001|Phase II- Period 1|COVID-19 Related|0|||
125144036|NCT04968925|450151419|FG002|Phase II- Period 1|COVID-19 Related|6|||
125144037|NCT04968925|450151420|FG003|Phase II- Period 1|COVID-19 Related|6|||
125144038|NCT04968925|450151417|FG000|Phase II- Period 1|Subject enrolled in error|0|||
125144039|NCT04968925|450151418|FG001|Phase II- Period 1|Subject enrolled in error|0|||
125144040|NCT04968925|450151419|FG002|Phase II- Period 1|Subject enrolled in error|1|||
125144041|NCT04968925|450151420|FG003|Phase II- Period 1|Subject enrolled in error|0|||
125144042|NCT04968925|450151417|FG000|Phase II -Period 2|COVID-19 related|0|||
125144043|NCT04968925|450151418|FG001|Phase II -Period 2|COVID-19 related|0|||
125144044|NCT04968925|450151419|FG002|Phase II -Period 2|COVID-19 related|4|||
125144045|NCT04968925|450151420|FG003|Phase II -Period 2|COVID-19 related|3|||
125144046|NCT04968925|450151417|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
125144047|NCT04968925|450151418|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
125223397|NCT02326272|450446176|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125223398|NCT02326272|450446177|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125223399|NCT02326272|450446178|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125076820|NCT03345342|449899187|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
125076821|NCT03345342|449899188|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
125076822|NCT03345342|449899189|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
125076823|NCT03345342|449899185|FG000|Open-Label Phase|Physician Decision|4|||
125076824|NCT03345342|449899186|FG001|Open-Label Phase|Physician Decision|0|||
125076825|NCT03345342|449899187|FG002|Open-Label Phase|Physician Decision|0|||
125076826|NCT03345342|449899188|FG003|Open-Label Phase|Physician Decision|0|||
125076827|NCT03345342|449899189|FG004|Open-Label Phase|Physician Decision|0|||
125076828|NCT03345342|449899185|FG000|Open-Label Phase|Protocol Violation|8|||
125076829|NCT03345342|449899186|FG001|Open-Label Phase|Protocol Violation|0|||
125076830|NCT03345342|449899187|FG002|Open-Label Phase|Protocol Violation|0|||
125076831|NCT03345342|449899188|FG003|Open-Label Phase|Protocol Violation|0|||
125076832|NCT03345342|449899189|FG004|Open-Label Phase|Protocol Violation|0|||
125076833|NCT03345342|449899185|FG000|Open-Label Phase|Withdrawal by Subject|57|||
125076834|NCT03345342|449899186|FG001|Open-Label Phase|Withdrawal by Subject|0|||
125076835|NCT03345342|449899187|FG002|Open-Label Phase|Withdrawal by Subject|0|||
125076836|NCT03345342|449899188|FG003|Open-Label Phase|Withdrawal by Subject|0|||
125076837|NCT03345342|449899189|FG004|Open-Label Phase|Withdrawal by Subject|0|||
125076838|NCT03345342|449899185|FG000|Open-Label Phase|Other|15|||
125076839|NCT03345342|449899186|FG001|Open-Label Phase|Other|0|||
125076840|NCT03345342|449899187|FG002|Open-Label Phase|Other|0|||
125076841|NCT03345342|449899188|FG003|Open-Label Phase|Other|0|||
125076842|NCT03345342|449899189|FG004|Open-Label Phase|Other|0|||
125076843|NCT03345342|449899185|FG000|Double-Blind Phase|Adverse Event|0|||
125076844|NCT03345342|449899186|FG001|Double-Blind Phase|Adverse Event|1|||
125076845|NCT03345342|449899187|FG002|Double-Blind Phase|Adverse Event|6|||
125076846|NCT03345342|449899188|FG003|Double-Blind Phase|Adverse Event|0|||
125076847|NCT03345342|449899189|FG004|Double-Blind Phase|Adverse Event|0|||
125076848|NCT03345342|449899185|FG000|Double-Blind Phase|Death|0|||
125076849|NCT03345342|449899186|FG001|Double-Blind Phase|Death|2|||
125076850|NCT03345342|449899187|FG002|Double-Blind Phase|Death|1|||
125076851|NCT03345342|449899188|FG003|Double-Blind Phase|Death|0|||
125076852|NCT03345342|449899189|FG004|Double-Blind Phase|Death|0|||
125076853|NCT03345342|449899185|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
125076854|NCT03345342|449899186|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
125076855|NCT03345342|449899187|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
125076856|NCT03345342|449899188|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
125076857|NCT03345342|449899189|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
125076858|NCT03345342|449899185|FG000|Double-Blind Phase|Lost to Follow-up|0|||
125076859|NCT03345342|449899186|FG001|Double-Blind Phase|Lost to Follow-up|1|||
125076860|NCT03345342|449899187|FG002|Double-Blind Phase|Lost to Follow-up|7|||
125076861|NCT03345342|449899188|FG003|Double-Blind Phase|Lost to Follow-up|0|||
125076862|NCT03345342|449899189|FG004|Double-Blind Phase|Lost to Follow-up|0|||
125076863|NCT03345342|449899185|FG000|Double-Blind Phase|Physician Decision|0|||
125076864|NCT03345342|449899186|FG001|Double-Blind Phase|Physician Decision|1|||
125076865|NCT03345342|449899187|FG002|Double-Blind Phase|Physician Decision|4|||
125076866|NCT03345342|449899188|FG003|Double-Blind Phase|Physician Decision|0|||
125076867|NCT03345342|449899189|FG004|Double-Blind Phase|Physician Decision|0|||
125076868|NCT03345342|449899185|FG000|Double-Blind Phase|Protocol Violation|0|||
125076869|NCT03345342|449899186|FG001|Double-Blind Phase|Protocol Violation|0|||
125076870|NCT03345342|449899187|FG002|Double-Blind Phase|Protocol Violation|1|||
125076871|NCT03345342|449899188|FG003|Double-Blind Phase|Protocol Violation|0|||
125076872|NCT03345342|449899189|FG004|Double-Blind Phase|Protocol Violation|0|||
125076873|NCT03345342|449899185|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
125076874|NCT03345342|449899186|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
125076875|NCT03345342|449899187|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
125076876|NCT03345342|449899188|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
125076877|NCT03345342|449899189|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
125076878|NCT03345342|449899185|FG000|Double-Blind Phase|Other|0|||
125076879|NCT03345342|449899186|FG001|Double-Blind Phase|Other|1|||
125076880|NCT03345342|449899187|FG002|Double-Blind Phase|Other|3|||
125076881|NCT03345342|449899188|FG003|Double-Blind Phase|Other|0|||
125076882|NCT03345342|449899189|FG004|Double-Blind Phase|Other|0|||
125076883|NCT03345342|449899185|FG000|Follow-Up Phase|Adverse Event|0|||
125076884|NCT03345342|449899186|FG001|Follow-Up Phase|Adverse Event|0|||
125076885|NCT03345342|449899187|FG002|Follow-Up Phase|Adverse Event|0|||
125076886|NCT03345342|449899188|FG003|Follow-Up Phase|Adverse Event|0|||
125076887|NCT03345342|449899189|FG004|Follow-Up Phase|Adverse Event|4|||
125076888|NCT03345342|449899185|FG000|Follow-Up Phase|Lost to Follow-up|0|||
125076889|NCT03345342|449899186|FG001|Follow-Up Phase|Lost to Follow-up|0|||
125076890|NCT03345342|449899187|FG002|Follow-Up Phase|Lost to Follow-up|0|||
125076891|NCT03345342|449899188|FG003|Follow-Up Phase|Lost to Follow-up|0|||
125076892|NCT03345342|449899189|FG004|Follow-Up Phase|Lost to Follow-up|6|||
125076893|NCT03345342|449899185|FG000|Follow-Up Phase|Physician Decision|0|||
125076894|NCT03345342|449899186|FG001|Follow-Up Phase|Physician Decision|0|||
125076895|NCT03345342|449899187|FG002|Follow-Up Phase|Physician Decision|0|||
125076896|NCT03345342|449899188|FG003|Follow-Up Phase|Physician Decision|0|||
125076897|NCT03345342|449899189|FG004|Follow-Up Phase|Physician Decision|5|||
125076898|NCT03345342|449899185|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
125076899|NCT03345342|449899186|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
125076900|NCT03345342|449899187|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
125076901|NCT03345342|449899188|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
125076902|NCT03345342|449899189|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
125076903|NCT03345342|449899185|FG000|Follow-Up Phase|Other|0|||
125076904|NCT03345342|449899186|FG001|Follow-Up Phase|Other|0|||
125076905|NCT03345342|449899187|FG002|Follow-Up Phase|Other|0|||
125076906|NCT03345342|449899188|FG003|Follow-Up Phase|Other|3|||
125076907|NCT03345342|449899189|FG004|Follow-Up Phase|Other|1|||
125076908|NCT02782104|449899194|FG000|Overall Study|Other|215|||
125076909|NCT02782104|449899194|FG000|Overall Study|Induction Day 28 Non Responder|9|||
125076910|NCT02782104|449899194|FG000|Overall Study|Non-Compliance with Study Drug|2|||
125076911|NCT02782104|449899194|FG000|Overall Study|Death|8|||
125076912|NCT02782104|449899194|FG000|Overall Study|Pregnancy|6|||
125076913|NCT02782104|449899194|FG000|Overall Study|Withdrawal by Subject|63|||
125076914|NCT02782104|449899194|FG000|Overall Study|Protocol Violation|7|||
125076915|NCT02782104|449899194|FG000|Overall Study|Lack of Efficacy|61|||
125076916|NCT02782104|449899194|FG000|Overall Study|Lost to Follow-up|23|||
125076917|NCT02782104|449899194|FG000|Overall Study|Adverse Event|74|||
125076918|NCT03185819|449899195|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
125076919|NCT03185819|449899196|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
125076920|NCT03185819|449899197|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
125076921|NCT03185819|449899198|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
125076922|NCT03185819|449899195|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
125076923|NCT03185819|449899196|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
125076924|NCT03185819|449899197|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
125076925|NCT03185819|449899198|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
125076926|NCT03185819|449899195|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
125076927|NCT03185819|449899196|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
125076928|NCT03185819|449899197|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
125076929|NCT03185819|449899198|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
125076930|NCT03185819|449899195|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
125076931|NCT03185819|449899196|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
125076932|NCT03185819|449899197|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
125076933|NCT03185819|449899198|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
125076934|NCT03185819|449899195|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
125076935|NCT03185819|449899196|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
125076936|NCT03185819|449899197|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
125076937|NCT03185819|449899198|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
125076938|NCT03185819|449899195|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
125076939|NCT03185819|449899196|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
125076940|NCT03185819|449899197|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
125076941|NCT03185819|449899198|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
125076942|NCT03185819|449899195|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
125076943|NCT03185819|449899196|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
125076944|NCT03185819|449899197|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
125076945|NCT03185819|449899198|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
125076946|NCT03185819|449899195|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
125076947|NCT03185819|449899196|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
125076948|NCT03185819|449899197|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
125076949|NCT03185819|449899198|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
125076950|NCT03185819|449899195|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
125076951|NCT03185819|449899196|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
125076952|NCT03185819|449899197|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
125076953|NCT03185819|449899198|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
125076954|NCT03185819|449899195|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
125076955|NCT03185819|449899196|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
125076956|NCT03185819|449899197|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
125076957|NCT03185819|449899198|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
125076958|NCT03185819|449899195|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
125076959|NCT03185819|449899196|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
125076960|NCT03185819|449899197|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
125076961|NCT03185819|449899198|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
125076962|NCT03185819|449899195|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
125076963|NCT03185819|449899196|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
125076964|NCT03185819|449899197|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
125076965|NCT03185819|449899198|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
125076966|NCT03185819|449899195|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
125076967|NCT03185819|449899196|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
125076968|NCT03185819|449899197|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
125076969|NCT03185819|449899198|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
125076970|NCT02438787|449899199|FG000|Overall Study|Adverse Event|1|||
125076971|NCT02438787|449899200|FG001|Overall Study|Adverse Event|0|||
125076972|NCT02438787|449899201|FG002|Overall Study|Adverse Event|2|||
125076973|NCT02438787|449899199|FG000|Overall Study|Lack of Efficacy|1|||
125144048|NCT04968925|450151419|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
125144049|NCT04968925|450151420|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
125144050|NCT00876265|450151425|FG000|Overall Study|Miscellaneous reasons|4|||
125144051|NCT00876265|450151425|FG000|Overall Study|Lost to Follow-up|6|||
125144052|NCT00876265|450151425|FG000|Overall Study|Withdrawal by Subject|2|||
125144053|NCT02754492|450151426|FG000|Overall Study|Protocol Violation|2|||
125144054|NCT02754492|450151427|FG001|Overall Study|Protocol Violation|2|||
125144055|NCT02754492|450151428|FG002|Overall Study|Protocol Violation|0|||
125144056|NCT02754492|450151429|FG003|Overall Study|Protocol Violation|1|||
125144057|NCT02754492|450151426|FG000|Overall Study|Withdrawal by Subject|2|||
125144058|NCT02754492|450151427|FG001|Overall Study|Withdrawal by Subject|0|||
125144059|NCT02754492|450151428|FG002|Overall Study|Withdrawal by Subject|0|||
125144060|NCT02754492|450151429|FG003|Overall Study|Withdrawal by Subject|0|||
125144061|NCT02754492|450151426|FG000|Overall Study|Equipment malfuntion|0|||
125144062|NCT02754492|450151427|FG001|Overall Study|Equipment malfuntion|0|||
125144063|NCT02754492|450151428|FG002|Overall Study|Equipment malfuntion|2|||
125144064|NCT02754492|450151429|FG003|Overall Study|Equipment malfuntion|5|||
125144065|NCT02754492|450151426|FG000|Overall Study|Adverse Event|0|||
125144066|NCT02754492|450151427|FG001|Overall Study|Adverse Event|0|||
125144067|NCT02754492|450151428|FG002|Overall Study|Adverse Event|0|||
125144068|NCT02754492|450151429|FG003|Overall Study|Adverse Event|13|||
125144069|NCT02754492|450151426|FG000|Overall Study|Venous access issues not resulting in AE|0|||
125144070|NCT02754492|450151427|FG001|Overall Study|Venous access issues not resulting in AE|0|||
125144071|NCT02754492|450151428|FG002|Overall Study|Venous access issues not resulting in AE|0|||
125144072|NCT02754492|450151429|FG003|Overall Study|Venous access issues not resulting in AE|4|||
125144073|NCT01408888|450151430|FG000|First Intervention|Adverse Event|0|||
125144074|NCT01408888|450151431|FG001|First Intervention|Adverse Event|1|||
125144075|NCT01408888|450151430|FG000|First Intervention|Withdrawal by Subject|0|||
125144076|NCT01408888|450151431|FG001|First Intervention|Withdrawal by Subject|2|||
125144077|NCT01408888|450151430|FG000|Second Intervention|Withdrawal by Subject|1|||
125144078|NCT01408888|450151431|FG001|Second Intervention|Withdrawal by Subject|0|||
125144079|NCT01408888|450151430|FG000|Second Intervention|Adverse Event|1|||
125144080|NCT01408888|450151431|FG001|Second Intervention|Adverse Event|0|||
125144081|NCT00487695|450151434|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
125144082|NCT00487695|450151435|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
125144083|NCT00487695|450151434|FG000|First Procedure|active wheezing (did not have procedure)|1|||
125076974|NCT02438787|449899200|FG001|Overall Study|Lack of Efficacy|2|||
125076975|NCT02438787|449899201|FG002|Overall Study|Lack of Efficacy|0|||
125076976|NCT02438787|449899199|FG000|Overall Study|Lost to Follow-up|0|||
125076977|NCT02438787|449899200|FG001|Overall Study|Lost to Follow-up|1|||
125076978|NCT02438787|449899201|FG002|Overall Study|Lost to Follow-up|0|||
125076979|NCT02438787|449899199|FG000|Overall Study|Protocol Violation|0|||
125076980|NCT02438787|449899200|FG001|Overall Study|Protocol Violation|0|||
125076981|NCT02438787|449899201|FG002|Overall Study|Protocol Violation|1|||
125076982|NCT02438787|449899199|FG000|Overall Study|Withdrawal by Subject|15|||
125076983|NCT02438787|449899200|FG001|Overall Study|Withdrawal by Subject|7|||
125076984|NCT02438787|449899201|FG002|Overall Study|Withdrawal by Subject|10|||
125076985|NCT02438787|449899199|FG000|Overall Study|Study discontinued by sponsor|64|||
125076986|NCT02438787|449899200|FG001|Overall Study|Study discontinued by sponsor|72|||
125076987|NCT02438787|449899201|FG002|Overall Study|Study discontinued by sponsor|69|||
125076988|NCT02438787|449899199|FG000|Overall Study|Other|0|||
125076989|NCT02438787|449899200|FG001|Overall Study|Other|1|||
125076990|NCT02438787|449899201|FG002|Overall Study|Other|0|||
125076991|NCT02438787|449899199|FG000|Overall Study|Site terminated by sponsor|0|||
125076992|NCT02438787|449899200|FG001|Overall Study|Site terminated by sponsor|0|||
125076993|NCT02438787|449899201|FG002|Overall Study|Site terminated by sponsor|1|||
125076994|NCT03375203|449899202|FG000|Overall Study|Protocol Violation|0|||
125076995|NCT03375203|449899203|FG001|Overall Study|Protocol Violation|0|||
125076996|NCT03375203|449899204|FG002|Overall Study|Protocol Violation|1|||
125076997|NCT03375203|449899205|FG003|Overall Study|Protocol Violation|0|||
125076998|NCT03375203|449899206|FG004|Overall Study|Protocol Violation|0|||
125076999|NCT03375203|449899202|FG000|Overall Study|Adverse Event|2|||
125144084|NCT00487695|450151435|FG001|First Procedure|active wheezing (did not have procedure)|0|||
125144085|NCT00487695|450151434|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
125144086|NCT00487695|450151435|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
125144087|NCT00487695|450151434|FG000|Second Procedure|active wheezing|0|||
125144088|NCT00487695|450151435|FG001|Second Procedure|active wheezing|1|||
125144089|NCT00487695|450151434|FG000|Second Procedure|Withdrawal by Subject|1|||
125144090|NCT00487695|450151435|FG001|Second Procedure|Withdrawal by Subject|2|||
125144091|NCT00695110|450151436|FG000|Treatment Period 1|Adverse Event|1|||
125144092|NCT00695110|450151436|FG000|Treatment Period 1|Withdrawal by Subject|2|||
125077000|NCT03375203|449899203|FG001|Overall Study|Adverse Event|3|||
125077001|NCT03375203|449899204|FG002|Overall Study|Adverse Event|0|||
125077002|NCT03375203|449899205|FG003|Overall Study|Adverse Event|2|||
125077003|NCT03375203|449899206|FG004|Overall Study|Adverse Event|2|||
125077004|NCT03375203|449899202|FG000|Overall Study|Withdrawal by Subject|3|||
125077005|NCT03375203|449899203|FG001|Overall Study|Withdrawal by Subject|0|||
125077006|NCT03375203|449899204|FG002|Overall Study|Withdrawal by Subject|1|||
125077007|NCT03375203|449899205|FG003|Overall Study|Withdrawal by Subject|0|||
125077008|NCT03375203|449899206|FG004|Overall Study|Withdrawal by Subject|2|||
125077009|NCT03375203|449899202|FG000|Overall Study|Non-compliance with study drug|1|||
125077010|NCT03375203|449899203|FG001|Overall Study|Non-compliance with study drug|0|||
125077011|NCT03375203|449899204|FG002|Overall Study|Non-compliance with study drug|0|||
125077012|NCT03375203|449899205|FG003|Overall Study|Non-compliance with study drug|0|||
125077013|NCT03375203|449899206|FG004|Overall Study|Non-compliance with study drug|0|||
125077014|NCT03375203|449899202|FG000|Overall Study|Randomized, not treated.|0|||
125077015|NCT03375203|449899203|FG001|Overall Study|Randomized, not treated.|1|||
125077016|NCT03375203|449899204|FG002|Overall Study|Randomized, not treated.|0|||
125077017|NCT03375203|449899205|FG003|Overall Study|Randomized, not treated.|0|||
125077018|NCT03375203|449899206|FG004|Overall Study|Randomized, not treated.|0|||
125077019|NCT03321526|449899207|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
125077020|NCT03321526|449899208|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
125077021|NCT03321526|449899207|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
125077022|NCT03321526|449899208|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
125077023|NCT03321526|449899207|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
125077024|NCT03321526|449899208|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
125077025|NCT03321526|449899207|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
125077026|NCT03321526|449899208|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
125077027|NCT03321526|449899207|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
125077028|NCT03321526|449899208|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
125077029|NCT03321526|449899207|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
125077030|NCT03321526|449899208|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
125077031|NCT03321526|449899207|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
125077032|NCT03321526|449899208|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
125077033|NCT03321526|449899207|FG000|Follow-up Phase (2 Weeks)|Other|24|||
125077034|NCT03321526|449899208|FG001|Follow-up Phase (2 Weeks)|Other|24|||
125077035|NCT00732641|449899209|FG000|Overall Study|Relapse or Progressive Disease|65|||
125077036|NCT00732641|449899210|FG001|Overall Study|Relapse or Progressive Disease|101|||
125077037|NCT00732641|449899209|FG000|Overall Study|Serious Adverse Events|12|||
125077038|NCT00732641|449899210|FG001|Overall Study|Serious Adverse Events|3|||
125077039|NCT00732641|449899209|FG000|Overall Study|Physician Decision|6|||
125077040|NCT00732641|449899210|FG001|Overall Study|Physician Decision|0|||
125077041|NCT00732641|449899209|FG000|Overall Study|Withdrawal by Subject|4|||
125077042|NCT00732641|449899210|FG001|Overall Study|Withdrawal by Subject|2|||
125077043|NCT00732641|449899209|FG000|Overall Study|Unable to Complete|1|||
125077044|NCT00732641|449899210|FG001|Overall Study|Unable to Complete|1|||
125077045|NCT00732641|449899209|FG000|Overall Study|Other|18|||
125077046|NCT00732641|449899210|FG001|Overall Study|Other|5|||
125077047|NCT02910089|449899211|FG000|Overall Study|Lost insurance eligibility|22|||
125077048|NCT02910089|449899212|FG001|Overall Study|Lost insurance eligibility|16|||
125077049|NCT03034057|449899217|FG000|Overall Study|Withdrawal by Subject|10|||
125077050|NCT03034057|449899217|FG000|Overall Study|Protocol Violation|1|||
125077051|NCT03034057|449899217|FG000|Overall Study|Not defined|2|||
125077052|NCT03034057|449899217|FG000|Overall Study|Lost to Follow-up|19|||
125077053|NCT03034057|449899217|FG000|Overall Study|Adverse Event|22|||
125077054|NCT03034057|449899217|FG000|Overall Study|Medication error without associated AE|1|||
125077055|NCT00701103|449899221|FG000|Overall Study|Adverse Event|0|||
125077056|NCT00701103|449899222|FG001|Overall Study|Adverse Event|0|||
125077057|NCT00701103|449899223|FG002|Overall Study|Adverse Event|1|||
125077058|NCT00701103|449899224|FG003|Overall Study|Adverse Event|1|||
125077059|NCT00701103|449899225|FG004|Overall Study|Adverse Event|0|||
125077060|NCT00701103|449899226|FG005|Overall Study|Adverse Event|1|||
125077061|NCT00701103|449899227|FG006|Overall Study|Adverse Event|1|||
125077062|NCT00701103|449899228|FG007|Overall Study|Adverse Event|0|||
125077063|NCT00701103|449899229|FG008|Overall Study|Adverse Event|0|||
125077064|NCT00701103|449899230|FG009|Overall Study|Adverse Event|2|||
125077065|NCT00701103|449899231|FG010|Overall Study|Adverse Event|0|||
125077066|NCT00701103|449899221|FG000|Overall Study|Progressive Disease|5|||
125144093|NCT00695110|450151436|FG000|Treatment Period 3|Withdrawal by Subject|1|||
125144094|NCT00695110|450151436|FG000|Treatment Period 4|Adverse Event|1|||
125077067|NCT00701103|449899222|FG001|Overall Study|Progressive Disease|2|||
125077068|NCT00701103|449899223|FG002|Overall Study|Progressive Disease|6|||
125077069|NCT00701103|449899224|FG003|Overall Study|Progressive Disease|5|||
125077070|NCT00701103|449899225|FG004|Overall Study|Progressive Disease|6|||
125077071|NCT00701103|449899226|FG005|Overall Study|Progressive Disease|5|||
125077072|NCT00701103|449899227|FG006|Overall Study|Progressive Disease|7|||
125077073|NCT00701103|449899228|FG007|Overall Study|Progressive Disease|7|||
125077074|NCT00701103|449899229|FG008|Overall Study|Progressive Disease|8|||
125077075|NCT00701103|449899230|FG009|Overall Study|Progressive Disease|8|||
125077076|NCT00701103|449899231|FG010|Overall Study|Progressive Disease|11|||
125077077|NCT00701103|449899221|FG000|Overall Study|Withdrawal by Subject|0|||
125077078|NCT00701103|449899222|FG001|Overall Study|Withdrawal by Subject|1|||
125077079|NCT00701103|449899223|FG002|Overall Study|Withdrawal by Subject|1|||
125077080|NCT00701103|449899224|FG003|Overall Study|Withdrawal by Subject|0|||
125077081|NCT00701103|449899225|FG004|Overall Study|Withdrawal by Subject|0|||
125077082|NCT00701103|449899226|FG005|Overall Study|Withdrawal by Subject|0|||
125077083|NCT00701103|449899227|FG006|Overall Study|Withdrawal by Subject|0|||
125077084|NCT00701103|449899228|FG007|Overall Study|Withdrawal by Subject|0|||
125077085|NCT00701103|449899229|FG008|Overall Study|Withdrawal by Subject|0|||
125077086|NCT00701103|449899230|FG009|Overall Study|Withdrawal by Subject|0|||
125077087|NCT00701103|449899231|FG010|Overall Study|Withdrawal by Subject|0|||
125077088|NCT00701103|449899221|FG000|Overall Study|Other|0|||
125077089|NCT00701103|449899222|FG001|Overall Study|Other|0|||
125077090|NCT00701103|449899223|FG002|Overall Study|Other|0|||
125077091|NCT00701103|449899224|FG003|Overall Study|Other|0|||
125077092|NCT00701103|449899225|FG004|Overall Study|Other|0|||
125077093|NCT00701103|449899226|FG005|Overall Study|Other|0|||
125077094|NCT00701103|449899227|FG006|Overall Study|Other|0|||
125077095|NCT00701103|449899228|FG007|Overall Study|Other|0|||
125077096|NCT00701103|449899229|FG008|Overall Study|Other|1|||
125077097|NCT00701103|449899230|FG009|Overall Study|Other|1|||
125077098|NCT00701103|449899231|FG010|Overall Study|Other|0|||
125077099|NCT01929707|449899232|FG000|Intervention Period 1|Lost to Follow-up|0|||
125077100|NCT01929707|449899233|FG001|Intervention Period 1|Lost to Follow-up|0|||
125077101|NCT01929707|449899234|FG002|Intervention Period 1|Lost to Follow-up|0|||
125077102|NCT01929707|449899235|FG003|Intervention Period 1|Lost to Follow-up|1|||
125077103|NCT01929707|449899236|FG004|Intervention Period 1|Lost to Follow-up|0|||
125077104|NCT01929707|449899237|FG005|Intervention Period 1|Lost to Follow-up|0|||
125077105|NCT01929707|449899238|FG006|Intervention Period 1|Lost to Follow-up|0|||
125077106|NCT01929707|449899239|FG007|Intervention Period 1|Lost to Follow-up|0|||
125077107|NCT01929707|449899232|FG000|Intervention Period 1|Withdrawal by Subject|0|||
125077108|NCT01929707|449899233|FG001|Intervention Period 1|Withdrawal by Subject|0|||
125077109|NCT01929707|449899234|FG002|Intervention Period 1|Withdrawal by Subject|0|||
125077110|NCT01929707|449899235|FG003|Intervention Period 1|Withdrawal by Subject|2|||
125077111|NCT01929707|449899236|FG004|Intervention Period 1|Withdrawal by Subject|0|||
125077112|NCT01929707|449899237|FG005|Intervention Period 1|Withdrawal by Subject|0|||
125077113|NCT01929707|449899238|FG006|Intervention Period 1|Withdrawal by Subject|0|||
125077114|NCT01929707|449899239|FG007|Intervention Period 1|Withdrawal by Subject|0|||
125077115|NCT01929707|449899232|FG000|Intervention Period 2|Withdrawal by Subject|0|||
125077116|NCT01929707|449899233|FG001|Intervention Period 2|Withdrawal by Subject|0|||
125077117|NCT01929707|449899234|FG002|Intervention Period 2|Withdrawal by Subject|0|||
125077118|NCT01929707|449899235|FG003|Intervention Period 2|Withdrawal by Subject|0|||
125077119|NCT01929707|449899236|FG004|Intervention Period 2|Withdrawal by Subject|0|||
125077120|NCT01929707|449899237|FG005|Intervention Period 2|Withdrawal by Subject|2|||
125077121|NCT01929707|449899238|FG006|Intervention Period 2|Withdrawal by Subject|0|||
125077122|NCT01929707|449899239|FG007|Intervention Period 2|Withdrawal by Subject|0|||
125077123|NCT00179517|449899240|FG000|Overall Study|Withdrawal by Subject|2|||
125077124|NCT00179517|449899241|FG001|Overall Study|Withdrawal by Subject|1|||
125077125|NCT00437203|449899242|FG000|Overall Study|Death|0|||
125077126|NCT00437203|449899243|FG001|Overall Study|Death|0|||
125077127|NCT00437203|449899244|FG002|Overall Study|Death|1|||
125077128|NCT00437203|449899245|FG003|Overall Study|Death|0|||
125077129|NCT00437203|449899246|FG004|Overall Study|Death|0|||
125077130|NCT00437203|449899247|FG005|Overall Study|Death|0|||
125077131|NCT00437203|449899248|FG006|Overall Study|Death|0|||
125144095|NCT04542694|450151437|FG000|Overall Study|The need for prohibited therapy|2|||
125077132|NCT00437203|449899249|FG007|Overall Study|Death|1|||
125077133|NCT00437203|449899250|FG008|Overall Study|Death|0|||
125077134|NCT00437203|449899251|FG009|Overall Study|Death|1|||
125077135|NCT00437203|449899242|FG000|Overall Study|Adverse Event|1|||
125077136|NCT00437203|449899243|FG001|Overall Study|Adverse Event|1|||
125077137|NCT00437203|449899244|FG002|Overall Study|Adverse Event|0|||
125077138|NCT00437203|449899245|FG003|Overall Study|Adverse Event|0|||
125077139|NCT00437203|449899246|FG004|Overall Study|Adverse Event|0|||
125077140|NCT00437203|449899247|FG005|Overall Study|Adverse Event|0|||
125077141|NCT00437203|449899248|FG006|Overall Study|Adverse Event|0|||
125077142|NCT00437203|449899249|FG007|Overall Study|Adverse Event|1|||
125077143|NCT00437203|449899250|FG008|Overall Study|Adverse Event|0|||
125077144|NCT00437203|449899251|FG009|Overall Study|Adverse Event|1|||
125077145|NCT00437203|449899242|FG000|Overall Study|Study terminated by sponsor|0|||
125077146|NCT00437203|449899243|FG001|Overall Study|Study terminated by sponsor|0|||
125077147|NCT00437203|449899244|FG002|Overall Study|Study terminated by sponsor|0|||
125077148|NCT00437203|449899245|FG003|Overall Study|Study terminated by sponsor|0|||
125077149|NCT00437203|449899246|FG004|Overall Study|Study terminated by sponsor|0|||
125077150|NCT00437203|449899247|FG005|Overall Study|Study terminated by sponsor|0|||
125077151|NCT00437203|449899248|FG006|Overall Study|Study terminated by sponsor|0|||
125077152|NCT00437203|449899249|FG007|Overall Study|Study terminated by sponsor|0|||
125077153|NCT00437203|449899250|FG008|Overall Study|Study terminated by sponsor|1|||
125077154|NCT00437203|449899251|FG009|Overall Study|Study terminated by sponsor|0|||
125077155|NCT00437203|449899242|FG000|Overall Study|Objective progression or relapse|5|||
125077156|NCT00437203|449899243|FG001|Overall Study|Objective progression or relapse|6|||
125077157|NCT00437203|449899244|FG002|Overall Study|Objective progression or relapse|2|||
125077158|NCT00437203|449899245|FG003|Overall Study|Objective progression or relapse|3|||
125077159|NCT00437203|449899246|FG004|Overall Study|Objective progression or relapse|3|||
125077160|NCT00437203|449899247|FG005|Overall Study|Objective progression or relapse|3|||
125077161|NCT00437203|449899248|FG006|Overall Study|Objective progression or relapse|6|||
125077162|NCT00437203|449899249|FG007|Overall Study|Objective progression or relapse|1|||
125077163|NCT00437203|449899250|FG008|Overall Study|Objective progression or relapse|2|||
125077164|NCT00437203|449899251|FG009|Overall Study|Objective progression or relapse|2|||
125077165|NCT00437203|449899242|FG000|Overall Study|Other|0|||
125077166|NCT00437203|449899243|FG001|Overall Study|Other|1|||
125077167|NCT00437203|449899244|FG002|Overall Study|Other|0|||
125077168|NCT00437203|449899245|FG003|Overall Study|Other|0|||
125077169|NCT00437203|449899246|FG004|Overall Study|Other|0|||
125077170|NCT00437203|449899247|FG005|Overall Study|Other|0|||
125077171|NCT00437203|449899248|FG006|Overall Study|Other|1|||
125077172|NCT00437203|449899249|FG007|Overall Study|Other|0|||
125077173|NCT00437203|449899250|FG008|Overall Study|Other|0|||
125077174|NCT00437203|449899251|FG009|Overall Study|Other|0|||
125077175|NCT01449955|449899252|FG000|Overall Study|Withdrawal by Subject|1|||
125077176|NCT01449955|449899253|FG001|Overall Study|Withdrawal by Subject|2|||
125077177|NCT02067533|449899260|FG000|Overall Study|Lost to Follow-up|4|||
125077178|NCT02067533|449899261|FG001|Overall Study|Lost to Follow-up|2|||
125077179|NCT02566109|449899262|FG000|Overall Study|Withdrawal by Subject|1|||
125077180|NCT01993667|449899263|FG000|Overall Study|Insufficient data to analyze|16|||
125077181|NCT01993667|449899264|FG001|Overall Study|Insufficient data to analyze|16|||
125077182|NCT01993667|449899263|FG000|Overall Study|Insufficient altitude reached|3|||
125077183|NCT01993667|449899264|FG001|Overall Study|Insufficient altitude reached|1|||
125077184|NCT01993667|449899263|FG000|Overall Study|Lost to Follow-up|2|||
125077185|NCT01993667|449899264|FG001|Overall Study|Lost to Follow-up|2|||
125077186|NCT01997281|449899267|FG000|Overall Study|Withdrawal by Subject|1|||
125077187|NCT01997281|449899268|FG001|Overall Study|Withdrawal by Subject|0|||
125077188|NCT01570309|449899271|FG000|Overall Study|Withdrawal by Subject|3|||
125077189|NCT01570309|449899272|FG001|Overall Study|Withdrawal by Subject|3|||
125077190|NCT00560794|449899273|FG000|Overall Study|Adverse Event|2|||
125077191|NCT00560794|449899273|FG000|Overall Study|Patient was not Compliant|1|||
125077192|NCT00560794|449899273|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
125077193|NCT00560794|449899273|FG000|Overall Study|Hematological Relapse|1|||
125077194|NCT00560794|449899273|FG000|Overall Study|Received Bone Marrow Transplant|6|||
125077195|NCT04857892|449899274|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
125077196|NCT04857892|449899275|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
125077197|NCT04857892|449899276|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
125077198|NCT04857892|449899277|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
125077199|NCT04857892|449899278|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
125077200|NCT04857892|449899274|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
125077201|NCT04857892|449899275|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
125077202|NCT04857892|449899276|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
125077203|NCT04857892|449899277|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
125077204|NCT04857892|449899278|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
125077205|NCT04857892|449899274|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
125077206|NCT04857892|449899275|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
125077207|NCT04857892|449899276|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
125144096|NCT04542694|450151438|FG001|Overall Study|The need for prohibited therapy|0|||
125144097|NCT04542694|450151437|FG000|Overall Study|Adverse Event|1|||
125077208|NCT04857892|449899277|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
125077209|NCT04857892|449899278|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
125077210|NCT00368472|449899283|FG000|Overall Study|Adverse Event|22|||
125077211|NCT00368472|449899283|FG000|Overall Study|Medication non-compliance|4|||
125077212|NCT00368472|449899283|FG000|Overall Study|Protocol Violation|2|||
125077213|NCT00368472|449899283|FG000|Overall Study|Request of Investigator or Sponsor|3|||
125077214|NCT00368472|449899283|FG000|Overall Study|Withdrawal by Subject|40|||
125077215|NCT00368472|449899283|FG000|Overall Study|Diary non-compliance|1|||
125077216|NCT00368472|449899283|FG000|Overall Study|Other|32|||
125077217|NCT00368472|449899283|FG000|Overall Study|Missing Final Disposition Date|1|||
125077218|NCT00981682|449899284|FG000|Overall Study|Adverse Event|48|||
125077219|NCT00981682|449899284|FG000|Overall Study|Withdrawal by Subject|52|||
125077220|NCT00981682|449899284|FG000|Overall Study|Lost to Follow-up|14|||
125144098|NCT04542694|450151438|FG001|Overall Study|Adverse Event|0|||
125144099|NCT04542694|450151437|FG000|Overall Study|Protocol Violation|1|||
125077221|NCT00981682|449899284|FG000|Overall Study|Lack of Efficacy|13|||
125077222|NCT00981682|449899284|FG000|Overall Study|Protocol Violation|6|||
125077223|NCT00981682|449899284|FG000|Overall Study|administrative|9|||
125077224|NCT02384993|449899285|FG000|Overall Study|Adverse Event|0|||
125077225|NCT02384993|449899286|FG001|Overall Study|Adverse Event|1|||
125077226|NCT04095793|449899287|FG000|Overall Study|Adverse Event|3|||
125077227|NCT04095793|449899287|FG000|Overall Study|Study Terminated by Sponsor|103|||
125077228|NCT04095793|449899287|FG000|Overall Study|Withdrawal by Subject|4|||
125077229|NCT00651313|449899288|FG000|Overall Study|Adverse Event|0|||
125077230|NCT00651313|449899289|FG001|Overall Study|Adverse Event|1|||
125077231|NCT00651313|449899288|FG000|Overall Study|Withdrawal by Subject|3|||
125077232|NCT00651313|449899289|FG001|Overall Study|Withdrawal by Subject|1|||
125077233|NCT00651313|449899288|FG000|Overall Study|Lost to Follow-up|1|||
125077234|NCT00651313|449899289|FG001|Overall Study|Lost to Follow-up|1|||
125077235|NCT00651313|449899288|FG000|Overall Study|Adminstrative Discontinuation|2|||
125077236|NCT00651313|449899289|FG001|Overall Study|Adminstrative Discontinuation|3|||
125077237|NCT01199198|449901443|FG000|Overall Study|Adverse Event|3|||
125077238|NCT01199198|449901444|FG001|Overall Study|Adverse Event|0|||
125077239|NCT01199198|449901443|FG000|Overall Study|Lost to Follow-up|1|||
125077240|NCT01199198|449901444|FG001|Overall Study|Lost to Follow-up|5|||
125077241|NCT01199198|449901443|FG000|Overall Study|Withdrawal by Subject|1|||
125077242|NCT01199198|449901444|FG001|Overall Study|Withdrawal by Subject|2|||
125077243|NCT01199198|449901443|FG000|Overall Study|ICU Transfer|1|||
125077244|NCT01199198|449901444|FG001|Overall Study|ICU Transfer|2|||
125077245|NCT01199198|449901443|FG000|Overall Study|Hospice-care transfer|1|||
125077246|NCT01199198|449901444|FG001|Overall Study|Hospice-care transfer|2|||
125077247|NCT00922974|449901445|FG000|Phase II Component|Protocol Violation|2|||
125077248|NCT00922974|449901446|FG001|Phase II Component|Protocol Violation|0|||
125077249|NCT00922974|449901445|FG000|Phase II Component|Not evaluable for treatment review|5|||
125077250|NCT00922974|449901446|FG001|Phase II Component|Not evaluable for treatment review|0|||
125077251|NCT00922974|449901445|FG000|Phase III Component|Protocol Violation|8|||
125077252|NCT00922974|449901446|FG001|Phase III Component|Protocol Violation|6|||
125077253|NCT00430027|449901447|FG000|Overall Study|Study terminated|8|||
125077254|NCT02443155|449901450|FG000|Overall Study|Adverse Event|3|||
125077255|NCT02443155|449901451|FG001|Overall Study|Adverse Event|4|||
125077256|NCT02443155|449901452|FG002|Overall Study|Adverse Event|1|||
125077257|NCT02443155|449901453|FG003|Overall Study|Adverse Event|2|||
125077258|NCT02443155|449901450|FG000|Overall Study|Unclassified|0|||
125077259|NCT02443155|449901451|FG001|Overall Study|Unclassified|0|||
125077260|NCT02443155|449901452|FG002|Overall Study|Unclassified|2|||
125077261|NCT02443155|449901453|FG003|Overall Study|Unclassified|1|||
125077262|NCT02443155|449901450|FG000|Overall Study|Withdrawal by Subject|4|||
125077263|NCT02443155|449901451|FG001|Overall Study|Withdrawal by Subject|7|||
125077264|NCT02443155|449901452|FG002|Overall Study|Withdrawal by Subject|3|||
125077265|NCT02443155|449901453|FG003|Overall Study|Withdrawal by Subject|9|||
125077266|NCT02443155|449901450|FG000|Overall Study|Pregnancy|3|||
125077267|NCT02443155|449901451|FG001|Overall Study|Pregnancy|1|||
125077268|NCT02443155|449901452|FG002|Overall Study|Pregnancy|1|||
125077269|NCT02443155|449901453|FG003|Overall Study|Pregnancy|2|||
125077270|NCT02443155|449901450|FG000|Overall Study|Lost to Follow-up|1|||
125077271|NCT02443155|449901451|FG001|Overall Study|Lost to Follow-up|2|||
125077272|NCT02443155|449901452|FG002|Overall Study|Lost to Follow-up|0|||
125077273|NCT02443155|449901453|FG003|Overall Study|Lost to Follow-up|1|||
125077274|NCT02443155|449901450|FG000|Overall Study|Protocol Violation|1|||
125077275|NCT02443155|449901451|FG001|Overall Study|Protocol Violation|0|||
125077276|NCT02443155|449901452|FG002|Overall Study|Protocol Violation|1|||
125144100|NCT04542694|450151438|FG001|Overall Study|Protocol Violation|0|||
125144101|NCT02167594|450151439|FG000|Overall Study|Withdrawal by Subject|2|||
125144102|NCT02167594|450151440|FG001|Overall Study|Withdrawal by Subject|0|||
125144103|NCT02167594|450151441|FG002|Overall Study|Withdrawal by Subject|0|||
125144104|NCT02167594|450151439|FG000|Overall Study|Death|0|||
125144105|NCT02167594|450151440|FG001|Overall Study|Death|1|||
125144106|NCT02167594|450151441|FG002|Overall Study|Death|0|||
125144107|NCT03433703|450151442|FG000|Overall Study|Study terminated by Sponsor|2|||
125144108|NCT01957150|450151443|FG000|Overall Study|Adverse Event|23|||
125144109|NCT01957150|450151444|FG001|Overall Study|Adverse Event|20|||
125144110|NCT01957150|450151443|FG000|Overall Study|Withdrawal by Subject|13|||
125077277|NCT02443155|449901453|FG003|Overall Study|Protocol Violation|1|||
125144111|NCT01957150|450151444|FG001|Overall Study|Withdrawal by Subject|17|||
125144112|NCT01957150|450151443|FG000|Overall Study|Physician Decision|3|||
125077278|NCT02443155|449901450|FG000|Overall Study|Death|0|||
125144113|NCT01957150|450151444|FG001|Overall Study|Physician Decision|6|||
125077279|NCT02443155|449901451|FG001|Overall Study|Death|0|||
125077280|NCT02443155|449901452|FG002|Overall Study|Death|1|||
125077281|NCT02443155|449901453|FG003|Overall Study|Death|0|||
125077282|NCT02000219|449901454|FG000|14-Week Study Period|Physician Decision|1|||
125077283|NCT02000219|449901454|FG000|14-Week Study Period|Adverse Event|1|||
125144114|NCT01957150|450151443|FG000|Overall Study|Lost to Follow-up|4|||
125077284|NCT02000219|449901454|FG000|14-Week Study Period|Underwent transplantation|1|||
125077285|NCT02000219|449901454|FG000|Continuation Period|Withdrawal by Subject|1|||
125077286|NCT02000219|449901454|FG000|Continuation Period|Had liver transplant|2|||
125077287|NCT02000219|449901454|FG000|Continuation Period|Non-compliance with study drug|2|||
125077288|NCT00634751|449901455|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
125077289|NCT00634751|449901456|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
125077290|NCT00634751|449901457|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
125077291|NCT00634751|449901458|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
125077292|NCT00634751|449901455|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
125077293|NCT00634751|449901456|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
125077294|NCT00634751|449901457|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
125077295|NCT00634751|449901458|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
125077296|NCT00634751|449901455|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
125077297|NCT00634751|449901456|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
125077298|NCT00634751|449901457|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
125077299|NCT00634751|449901458|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
125077300|NCT00608894|449901459|FG000|Overall Study|Withdrawal by Subject|0|||
125077301|NCT00608894|449901460|FG001|Overall Study|Withdrawal by Subject|2|||
125077302|NCT01376388|449901463|FG000|Overall Study|Adverse Event|13|||
125077303|NCT01376388|449901463|FG000|Overall Study|Lack of Efficacy|2|||
125077304|NCT01376388|449901463|FG000|Overall Study|Withdrawal by Subject|3|||
125077305|NCT01473355|449901465|FG000|Overall Study|Protocol Violation|2|||
125077306|NCT01473355|449901465|FG000|Overall Study|Adverse Event|2|||
125077307|NCT01473355|449901465|FG000|Overall Study|Lost to Follow-up|2|||
125077308|NCT00106249|449901466|FG000|Overall Study|Lost to Follow-up|3|||
125077309|NCT00106249|449901467|FG001|Overall Study|Lost to Follow-up|2|||
125077310|NCT01119963|449901468|FG000|Overall Study|Lost to Follow-up|1|||
125077311|NCT01119963|449901469|FG001|Overall Study|Lost to Follow-up|1|||
125077312|NCT01843205|449901474|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
125077313|NCT01843205|449901475|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
125077314|NCT03938636|449901476|FG000|Overall Study|Protocol Violation|0|||
125077315|NCT03938636|449901477|FG001|Overall Study|Protocol Violation|1|||
125077316|NCT03938636|449901478|FG002|Overall Study|Protocol Violation|1|||
125077317|NCT03938636|449901476|FG000|Overall Study|Subject withdrew due to death in family|0|||
125077318|NCT03938636|449901477|FG001|Overall Study|Subject withdrew due to death in family|1|||
125077319|NCT03938636|449901478|FG002|Overall Study|Subject withdrew due to death in family|0|||
125077320|NCT03938636|449901476|FG000|Overall Study|Missed visit|0|||
125077321|NCT03938636|449901477|FG001|Overall Study|Missed visit|1|||
125077322|NCT03938636|449901478|FG002|Overall Study|Missed visit|0|||
125077323|NCT03938636|449901476|FG000|Overall Study|Adverse Event|0|||
125077324|NCT03938636|449901477|FG001|Overall Study|Adverse Event|0|||
125077325|NCT03938636|449901478|FG002|Overall Study|Adverse Event|1|||
125077326|NCT03938636|449901476|FG000|Overall Study|Lost to Follow-up|0|||
125077327|NCT03938636|449901477|FG001|Overall Study|Lost to Follow-up|0|||
125077328|NCT03938636|449901478|FG002|Overall Study|Lost to Follow-up|1|||
125077329|NCT02603172|449901479|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
125077330|NCT02603172|449901480|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
125077331|NCT02603172|449901481|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
125077332|NCT02603172|449901482|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
125077333|NCT02603172|449901483|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
125077334|NCT02603172|449901484|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
125077335|NCT02603172|449901485|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
125077336|NCT02603172|449901486|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
125077337|NCT03285490|449901487|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
125077338|NCT03285490|449901488|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
125077339|NCT03285490|449901487|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
125077340|NCT03285490|449901488|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
125077341|NCT03745989|449901489|FG000|Overall Study|Death|3|||
125144115|NCT01957150|450151444|FG001|Overall Study|Lost to Follow-up|4|||
125144116|NCT01957150|450151443|FG000|Overall Study|Protocol Violation|1|||
125144117|NCT01957150|450151444|FG001|Overall Study|Protocol Violation|0|||
125077342|NCT03745989|449901490|FG001|Overall Study|Death|7|||
125077343|NCT03745989|449901491|FG002|Overall Study|Death|4|||
125077344|NCT03745989|449901489|FG000|Overall Study|Lost to Follow-up|0|||
125077345|NCT03745989|449901490|FG001|Overall Study|Lost to Follow-up|2|||
125077346|NCT03745989|449901491|FG002|Overall Study|Lost to Follow-up|0|||
125077347|NCT03745989|449901489|FG000|Overall Study|Sponsor Decision|0|||
125077348|NCT03745989|449901490|FG001|Overall Study|Sponsor Decision|2|||
125077349|NCT03745989|449901491|FG002|Overall Study|Sponsor Decision|8|||
125077350|NCT03745989|449901489|FG000|Overall Study|Withdrawal by Subject|0|||
125077351|NCT03745989|449901490|FG001|Overall Study|Withdrawal by Subject|1|||
125144118|NCT01957150|450151443|FG000|Overall Study|Lack of Efficacy|11|||
125077352|NCT03745989|449901491|FG002|Overall Study|Withdrawal by Subject|3|||
125077353|NCT01047436|449901492|FG000|Overall Study|Protocol Violation|1|||
125077354|NCT01047436|449901493|FG001|Overall Study|Protocol Violation|0|||
125077355|NCT00939341|449901494|FG000|Overall Study|Adverse Event|15|||
125077356|NCT00939341|449901494|FG000|Overall Study|Pregnancy|1|||
125077357|NCT00939341|449901494|FG000|Overall Study|Lost to Follow-up|23|||
125077358|NCT00939341|449901494|FG000|Overall Study|Withdrawal by Subject|13|||
125077359|NCT00939341|449901494|FG000|Overall Study|Protocol Violation|6|||
125077360|NCT00939341|449901494|FG000|Overall Study|Incorrect enrolment|8|||
125077361|NCT00424099|449901495|FG000|Overall Study|Adverse Event|0|||
125077362|NCT00424099|449901496|FG001|Overall Study|Adverse Event|1|||
125077363|NCT00424099|449901497|FG002|Overall Study|Adverse Event|1|||
125077364|NCT00424099|449901498|FG003|Overall Study|Adverse Event|0|||
125077365|NCT00424099|449901495|FG000|Overall Study|Death|0|||
125077366|NCT00424099|449901496|FG001|Overall Study|Death|1|||
125077367|NCT00424099|449901497|FG002|Overall Study|Death|0|||
125077368|NCT00424099|449901498|FG003|Overall Study|Death|0|||
125077369|NCT00424099|449901495|FG000|Overall Study|Illness|2|||
125077370|NCT00424099|449901496|FG001|Overall Study|Illness|0|||
125077371|NCT00424099|449901497|FG002|Overall Study|Illness|1|||
125077372|NCT00424099|449901498|FG003|Overall Study|Illness|4|||
125077373|NCT00424099|449901495|FG000|Overall Study|Lost to Follow-up|0|||
125144119|NCT01957150|450151444|FG001|Overall Study|Lack of Efficacy|11|||
125144120|NCT02786953|450151449|FG000|Overall Study|Withdrawal by Subject|3|||
125144121|NCT02786953|450151450|FG001|Overall Study|Withdrawal by Subject|0|||
125144122|NCT02786953|450151449|FG000|Overall Study|Physician Decision|0|||
125144123|NCT02786953|450151450|FG001|Overall Study|Physician Decision|1|||
125077374|NCT00424099|449901496|FG001|Overall Study|Lost to Follow-up|0|||
125077375|NCT00424099|449901497|FG002|Overall Study|Lost to Follow-up|3|||
125077376|NCT00424099|449901498|FG003|Overall Study|Lost to Follow-up|0|||
125077377|NCT00424099|449901495|FG000|Overall Study|Hospitalized|1|||
125077378|NCT00424099|449901496|FG001|Overall Study|Hospitalized|2|||
125077379|NCT00424099|449901497|FG002|Overall Study|Hospitalized|1|||
125077380|NCT00424099|449901498|FG003|Overall Study|Hospitalized|3|||
125077381|NCT00424099|449901495|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
125077382|NCT00424099|449901496|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
125077383|NCT00424099|449901497|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
125077384|NCT00424099|449901498|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
125077385|NCT00424099|449901495|FG000|Overall Study|Withdrawal by Subject|1|||
125077386|NCT00424099|449901496|FG001|Overall Study|Withdrawal by Subject|9|||
125144124|NCT01745094|450151453|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
125144125|NCT01745094|450151454|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
125144126|NCT01745094|450151455|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
125144127|NCT01745094|450151456|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
125144128|NCT01745094|450151453|FG000|Overall Study|Adverse Event|0|||
125144129|NCT01745094|450151454|FG001|Overall Study|Adverse Event|0|||
125144130|NCT01745094|450151455|FG002|Overall Study|Adverse Event|3|||
125144131|NCT01745094|450151456|FG003|Overall Study|Adverse Event|0|||
125144132|NCT01745094|450151453|FG000|Overall Study|Withdrawal by Subject|2|||
125144133|NCT01745094|450151454|FG001|Overall Study|Withdrawal by Subject|0|||
125144134|NCT01745094|450151455|FG002|Overall Study|Withdrawal by Subject|1|||
125144135|NCT01745094|450151456|FG003|Overall Study|Withdrawal by Subject|2|||
125077387|NCT00424099|449901497|FG002|Overall Study|Withdrawal by Subject|4|||
125077388|NCT00424099|449901498|FG003|Overall Study|Withdrawal by Subject|6|||
125077389|NCT00424099|449901495|FG000|Overall Study|Physician Decision|0|||
125077390|NCT00424099|449901496|FG001|Overall Study|Physician Decision|0|||
125144136|NCT01745094|450151453|FG000|Overall Study|Protocol Violation|1|||
125144137|NCT01745094|450151454|FG001|Overall Study|Protocol Violation|0|||
125144138|NCT01745094|450151455|FG002|Overall Study|Protocol Violation|3|||
125144139|NCT01745094|450151456|FG003|Overall Study|Protocol Violation|1|||
125144140|NCT01745094|450151453|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
125144141|NCT01745094|450151454|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
125144142|NCT01745094|450151455|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
125144143|NCT01745094|450151456|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
125144144|NCT01745094|450151453|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
125144145|NCT01745094|450151454|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
125144146|NCT01745094|450151455|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
125144147|NCT01745094|450151456|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
125077391|NCT00424099|449901497|FG002|Overall Study|Physician Decision|1|||
125077392|NCT00424099|449901498|FG003|Overall Study|Physician Decision|0|||
125077393|NCT00424099|449901495|FG000|Overall Study|Missing|0|||
125077394|NCT00424099|449901496|FG001|Overall Study|Missing|0|||
125077395|NCT00424099|449901497|FG002|Overall Study|Missing|1|||
125077396|NCT00424099|449901498|FG003|Overall Study|Missing|0|||
125077397|NCT02280096|449901499|FG000|Overall Study|Pregnancy|1|||
125077398|NCT02280096|449901500|FG001|Overall Study|Pregnancy|0|||
125144148|NCT01745094|450151453|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
125077399|NCT02280096|449901499|FG000|Overall Study|Functional neurological disorder|1|||
125077400|NCT02280096|449901500|FG001|Overall Study|Functional neurological disorder|0|||
125077401|NCT02280096|449901499|FG000|Overall Study|Lack of attachment|0|||
125077402|NCT02280096|449901500|FG001|Overall Study|Lack of attachment|1|||
125077403|NCT02939976|449901501|FG000|Overall Study|Lost to Follow-up|7|||
125077404|NCT02939976|449901502|FG001|Overall Study|Lost to Follow-up|1|||
125077405|NCT02939976|449901503|FG002|Overall Study|Lost to Follow-up|1|||
125077406|NCT02939976|449901504|FG003|Overall Study|Lost to Follow-up|2|||
125077407|NCT02939976|449901501|FG000|Overall Study|Withdrawal by Subject|4|||
125077408|NCT02939976|449901502|FG001|Overall Study|Withdrawal by Subject|0|||
125077409|NCT02939976|449901503|FG002|Overall Study|Withdrawal by Subject|2|||
125077410|NCT02939976|449901504|FG003|Overall Study|Withdrawal by Subject|4|||
125077411|NCT02939976|449901501|FG000|Overall Study|Due to early study closure|4|||
125077412|NCT02939976|449901502|FG001|Overall Study|Due to early study closure|3|||
125077413|NCT02939976|449901503|FG002|Overall Study|Due to early study closure|2|||
125077414|NCT02939976|449901504|FG003|Overall Study|Due to early study closure|3|||
125077415|NCT01872897|449901505|FG000|Overall Study|Withdrawal by Subject|1|||
125077416|NCT01872897|449901506|FG001|Overall Study|Withdrawal by Subject|0|||
125077417|NCT02418585|449901507|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
125077418|NCT02418585|449901508|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
125077419|NCT02418585|449901507|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
125077420|NCT02418585|449901508|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
125077421|NCT02418585|449901507|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
125077422|NCT02418585|449901508|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
125077423|NCT02418585|449901507|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
125077424|NCT02418585|449901508|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
125077425|NCT02418585|449901507|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
125077426|NCT02418585|449901508|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
125077427|NCT02418585|449901507|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
125077428|NCT02418585|449901508|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
125077429|NCT02418585|449901507|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
125077430|NCT02418585|449901508|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
125077431|NCT02418585|449901507|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
125077432|NCT02418585|449901508|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
125077433|NCT02418585|449901507|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
125077434|NCT02418585|449901508|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
125077435|NCT02418585|449901507|FG000|Follow-up Phase (24 Weeks)|Other|3|||
125077436|NCT02418585|449901508|FG001|Follow-up Phase (24 Weeks)|Other|2|||
125077437|NCT02040857|449901509|FG000|Overall Study|Adverse Event|14|||
125077438|NCT02040857|449901509|FG000|Overall Study|Physician Decision|5|||
125077439|NCT02040857|449901509|FG000|Overall Study|Withdrawal by Subject|31|||
125077440|NCT02040857|449901509|FG000|Overall Study|patient non-compliance|3|||
125077441|NCT02040857|449901509|FG000|Overall Study|Lost to Follow-up|2|||
125077442|NCT02040857|449901509|FG000|Overall Study|recurrence|4|||
125077443|NCT02040857|449901509|FG000|Overall Study|ineligible|1|||
125077444|NCT04159701|449901510|FG000|Period 1: Treatment Period|Pregnancy|1|||
125077445|NCT04159701|449901511|FG001|Period 1: Treatment Period|Pregnancy|0|||
125077446|NCT04159701|449901510|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
125077447|NCT04159701|449901511|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
125077448|NCT04159701|449901510|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
125077449|NCT04159701|449901511|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
125077450|NCT04159701|449901510|FG000|Washout Period|site terminated by sponsor|0|||
125077451|NCT04159701|449901511|FG001|Washout Period|site terminated by sponsor|1|||
125077452|NCT04159701|449901510|FG000|Washout Period|study terminated by sponsor|10|||
125077453|NCT04159701|449901511|FG001|Washout Period|study terminated by sponsor|3|||
125077454|NCT04159701|449901510|FG000|Washout Period|Withdrawal by Subject|1|||
125077455|NCT04159701|449901511|FG001|Washout Period|Withdrawal by Subject|0|||
125077456|NCT04159701|449901510|FG000|Washout Period|Inadvertent Enrollment|1|||
125077457|NCT04159701|449901511|FG001|Washout Period|Inadvertent Enrollment|0|||
125223400|NCT02326272|450446164|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125077458|NCT04159701|449901510|FG000|Washout Period|Miscellaneous|1|||
125077459|NCT04159701|449901511|FG001|Washout Period|Miscellaneous|0|||
125077460|NCT04159701|449901510|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
125077461|NCT04159701|449901511|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
125077462|NCT04159701|449901510|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
125077463|NCT04159701|449901511|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
125077464|NCT04159701|449901510|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
125077465|NCT04159701|449901511|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
125077466|NCT04159701|449901510|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
125077467|NCT04159701|449901511|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
125077468|NCT04159701|449901510|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
125077469|NCT04159701|449901511|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
125144149|NCT01745094|450151454|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
125144150|NCT01745094|450151455|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
125144151|NCT01745094|450151456|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
125077470|NCT03605836|449901512|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
125077471|NCT03605836|449901513|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
125077472|NCT03605836|449901514|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
125077473|NCT03605836|449901515|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
125077474|NCT03605836|449901512|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
125077475|NCT03605836|449901513|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
125077476|NCT03605836|449901514|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
125077477|NCT03605836|449901515|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
125077478|NCT03605836|449901512|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
125077479|NCT03605836|449901513|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
125077480|NCT03605836|449901514|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
125077481|NCT03605836|449901515|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
125077482|NCT03605836|449901512|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
125077483|NCT03605836|449901513|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
125077484|NCT03605836|449901514|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
125077485|NCT03605836|449901515|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
125077486|NCT03605836|449901512|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
125077487|NCT03605836|449901513|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
125077488|NCT03605836|449901514|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
125077489|NCT03605836|449901515|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
125077490|NCT03605836|449901512|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
125077491|NCT03605836|449901513|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
125077492|NCT03605836|449901514|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
125077493|NCT03605836|449901515|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
125077494|NCT03605836|449901512|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
125077495|NCT03605836|449901513|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
125077496|NCT03605836|449901514|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
125077497|NCT03605836|449901515|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
125077498|NCT03605836|449901512|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
125077499|NCT03605836|449901513|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
125077500|NCT03605836|449901514|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
125077501|NCT03605836|449901515|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
125077502|NCT03605836|449901512|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
125077503|NCT03605836|449901513|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
125077504|NCT03605836|449901514|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
125077505|NCT03605836|449901515|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
125077506|NCT03605836|449901512|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
125077507|NCT03605836|449901513|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
125077508|NCT03605836|449901514|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
125077509|NCT03605836|449901515|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
125077510|NCT03605836|449901512|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
125077511|NCT03605836|449901513|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
125077512|NCT03605836|449901514|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
125077513|NCT03605836|449901515|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
125077514|NCT03605836|449901512|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
125077515|NCT03605836|449901513|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
125077516|NCT03605836|449901514|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
125077517|NCT03605836|449901515|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
125077518|NCT03605836|449901512|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
125077519|NCT03605836|449901513|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
125077520|NCT03605836|449901514|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
125077521|NCT03605836|449901515|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
125077522|NCT03605836|449901512|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
125077523|NCT03605836|449901513|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
125144152|NCT03414034|450151457|FG000|Overall Study|Adverse Event|6|||
125144153|NCT03414034|450151458|FG001|Overall Study|Adverse Event|1|||
125144154|NCT03414034|450151459|FG002|Overall Study|Adverse Event|1|||
125144155|NCT03414034|450151457|FG000|Overall Study|Death|0|||
125077524|NCT03605836|449901514|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
125144156|NCT03414034|450151458|FG001|Overall Study|Death|0|||
125077525|NCT03605836|449901515|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
125077526|NCT03605836|449901512|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
125077527|NCT03605836|449901513|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
125077528|NCT03605836|449901514|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
125077529|NCT03605836|449901515|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
125077530|NCT03605836|449901512|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
125077531|NCT03605836|449901513|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
125077532|NCT03605836|449901514|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
125077533|NCT03605836|449901515|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
125077534|NCT03605836|449901512|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
125077535|NCT03605836|449901513|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
125077536|NCT03605836|449901514|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
125077537|NCT03605836|449901515|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
125077538|NCT03605836|449901512|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
125077539|NCT03605836|449901513|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
125077540|NCT03605836|449901514|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
125077541|NCT03605836|449901515|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
125077542|NCT03605836|449901512|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
125077543|NCT03605836|449901513|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
125077544|NCT03605836|449901514|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
125077545|NCT03605836|449901515|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
125077546|NCT03605836|449901512|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
125077547|NCT03605836|449901513|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
125077548|NCT03605836|449901514|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
125077549|NCT03605836|449901515|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
125077550|NCT03605836|449901512|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
125077551|NCT03605836|449901513|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
125077552|NCT03605836|449901514|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
125077553|NCT03605836|449901515|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
125077554|NCT03605836|449901512|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
125077555|NCT03605836|449901513|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
125077556|NCT03605836|449901514|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
125077557|NCT03605836|449901515|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
125077558|NCT02057068|449901522|FG000|Overall Study|Withdrawal by Subject|2|||
125077559|NCT02057068|449901523|FG001|Overall Study|Withdrawal by Subject|2|||
125077560|NCT02057068|449901522|FG000|Overall Study|Caregiver (CG) Health|0|||
125077561|NCT02057068|449901523|FG001|Overall Study|Caregiver (CG) Health|2|||
125077562|NCT02057068|449901522|FG000|Overall Study|Carepartner (CP) Health|4|||
125077563|NCT02057068|449901523|FG001|Overall Study|Carepartner (CP) Health|2|||
125077564|NCT02057068|449901522|FG000|Overall Study|Lost to Follow-up|2|||
125077565|NCT02057068|449901523|FG001|Overall Study|Lost to Follow-up|2|||
125077566|NCT01782885|449901524|FG000|Overall Study|Lost to Follow-up|4|||
125077567|NCT01782885|449901525|FG001|Overall Study|Lost to Follow-up|6|||
125077568|NCT03447821|449901526|FG000|Overall Study|Withdrawal by Subject|1|||
125077569|NCT03447821|449901527|FG001|Overall Study|Withdrawal by Subject|1|||
125077570|NCT03447821|449901528|FG002|Overall Study|Withdrawal by Subject|0|||
125077571|NCT03447821|449901526|FG000|Overall Study|Lost to Follow-up|0|||
125077572|NCT03447821|449901527|FG001|Overall Study|Lost to Follow-up|0|||
125077573|NCT03447821|449901528|FG002|Overall Study|Lost to Follow-up|1|||
125077574|NCT00329784|449901531|FG000|Overall Study|Lost to Follow-up|0|||
125077575|NCT00329784|449901532|FG001|Overall Study|Lost to Follow-up|1|||
125077576|NCT00329784|449901533|FG002|Overall Study|Lost to Follow-up|0|||
125077577|NCT00329784|449901534|FG003|Overall Study|Lost to Follow-up|0|||
125077578|NCT00329784|449901531|FG000|Overall Study|Withdrawal by Subject|4|||
125077579|NCT00329784|449901532|FG001|Overall Study|Withdrawal by Subject|2|||
125077580|NCT00329784|449901533|FG002|Overall Study|Withdrawal by Subject|0|||
125077581|NCT00329784|449901534|FG003|Overall Study|Withdrawal by Subject|0|||
125077582|NCT00329784|449901531|FG000|Overall Study|Other|1|||
125077583|NCT00329784|449901532|FG001|Overall Study|Other|2|||
125077584|NCT00329784|449901533|FG002|Overall Study|Other|0|||
125077585|NCT00329784|449901534|FG003|Overall Study|Other|0|||
125077586|NCT01098032|449901535|FG000|Overall Study|Withdrawal by Subject|1|||
125077587|NCT01098032|449901536|FG001|Overall Study|Withdrawal by Subject|1|||
125144157|NCT03414034|450151459|FG002|Overall Study|Death|1|||
125144158|NCT03414034|450151457|FG000|Overall Study|Non-compliance With Study Drug|0|||
125077588|NCT00481988|449901537|FG000|Overall Study|Withdrawal by Subject|1|||
125077589|NCT00481988|449901538|FG001|Overall Study|Withdrawal by Subject|1|||
125077590|NCT00654420|449901539|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
125077591|NCT00654420|449901540|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
125077592|NCT00654420|449901541|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
125077593|NCT00654420|449901542|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
125077594|NCT00654420|449901539|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
125077595|NCT00654420|449901540|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
125077596|NCT00654420|449901541|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
125077597|NCT00654420|449901542|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
125077598|NCT00654420|449901539|FG000|Phase II|Adverse Event|0|||
125077599|NCT00654420|449901540|FG001|Phase II|Adverse Event|0|||
125077600|NCT00654420|449901541|FG002|Phase II|Adverse Event|3|||
125077601|NCT00654420|449901542|FG003|Phase II|Adverse Event|3|||
125077602|NCT00654420|449901539|FG000|Phase II|Lost to Follow-up|0|||
125077603|NCT00654420|449901540|FG001|Phase II|Lost to Follow-up|0|||
125077604|NCT00654420|449901541|FG002|Phase II|Lost to Follow-up|0|||
125077605|NCT00654420|449901542|FG003|Phase II|Lost to Follow-up|1|||
125077606|NCT00654420|449901539|FG000|Phase II|Physician Decision|0|||
125077607|NCT00654420|449901540|FG001|Phase II|Physician Decision|0|||
125077608|NCT00654420|449901541|FG002|Phase II|Physician Decision|0|||
125077609|NCT00654420|449901542|FG003|Phase II|Physician Decision|4|||
125077610|NCT00654420|449901539|FG000|Phase II|Progressive Disease|0|||
125077611|NCT00654420|449901540|FG001|Phase II|Progressive Disease|0|||
125077612|NCT00654420|449901541|FG002|Phase II|Progressive Disease|29|||
125077613|NCT00654420|449901542|FG003|Phase II|Progressive Disease|29|||
125077614|NCT00654420|449901539|FG000|Phase II|Withdrawal by Subject|0|||
125077615|NCT00654420|449901540|FG001|Phase II|Withdrawal by Subject|0|||
125077616|NCT00654420|449901541|FG002|Phase II|Withdrawal by Subject|4|||
125077617|NCT00654420|449901542|FG003|Phase II|Withdrawal by Subject|1|||
125077618|NCT00654420|449901539|FG000|Phase II|Missing Disposition Record|0|||
125077619|NCT00654420|449901540|FG001|Phase II|Missing Disposition Record|0|||
125077620|NCT00654420|449901541|FG002|Phase II|Missing Disposition Record|1|||
125077621|NCT00654420|449901542|FG003|Phase II|Missing Disposition Record|0|||
125077622|NCT00471276|449901545|FG000|Overall Study|Death|2|||
125077623|NCT00471276|449901545|FG000|Overall Study|Adverse Event|16|||
125077624|NCT00471276|449901545|FG000|Overall Study|Protocol Violation|1|||
125077625|NCT00471276|449901545|FG000|Overall Study|Objective progression or relapse|54|||
125077626|NCT00471276|449901545|FG000|Overall Study|Global deterioration of health status|1|||
125077627|NCT00471276|449901545|FG000|Overall Study|Other|3|||
125077628|NCT00471276|449901545|FG000|Overall Study|Refused treatment|6|||
125077629|NCT01594411|449901546|FG000|Overall Study|Lost to Follow-up|2|||
125077630|NCT00910728|449901550|FG000|Overall Study|Lack of Efficacy|2|||
125077631|NCT00910728|449901551|FG001|Overall Study|Lack of Efficacy|3|||
125077632|NCT00910728|449901552|FG002|Overall Study|Lack of Efficacy|1|||
125077633|NCT00910728|449901553|FG003|Overall Study|Lack of Efficacy|2|||
125077634|NCT00910728|449901554|FG004|Overall Study|Lack of Efficacy|1|||
125077635|NCT00910728|449901555|FG005|Overall Study|Lack of Efficacy|0|||
125077636|NCT00910728|449901556|FG006|Overall Study|Lack of Efficacy|2|||
125077637|NCT00910728|449901557|FG007|Overall Study|Lack of Efficacy|2|||
125077638|NCT00910728|449901558|FG008|Overall Study|Lack of Efficacy|2|||
125077639|NCT00910728|449901550|FG000|Overall Study|Withdrawal by Subject|0|||
125077640|NCT00910728|449901551|FG001|Overall Study|Withdrawal by Subject|0|||
125077641|NCT00910728|449901552|FG002|Overall Study|Withdrawal by Subject|0|||
125077642|NCT00910728|449901553|FG003|Overall Study|Withdrawal by Subject|0|||
125077643|NCT00910728|449901554|FG004|Overall Study|Withdrawal by Subject|3|||
125077644|NCT00910728|449901555|FG005|Overall Study|Withdrawal by Subject|1|||
125077645|NCT00910728|449901556|FG006|Overall Study|Withdrawal by Subject|2|||
125144159|NCT03414034|450151458|FG001|Overall Study|Non-compliance With Study Drug|0|||
125077646|NCT00910728|449901557|FG007|Overall Study|Withdrawal by Subject|0|||
125077647|NCT00910728|449901558|FG008|Overall Study|Withdrawal by Subject|0|||
125077648|NCT00910728|449901550|FG000|Overall Study|(not specified)|2|||
125077649|NCT00910728|449901551|FG001|Overall Study|(not specified)|0|||
125077650|NCT00910728|449901552|FG002|Overall Study|(not specified)|1|||
125077651|NCT00910728|449901553|FG003|Overall Study|(not specified)|0|||
125077652|NCT00910728|449901554|FG004|Overall Study|(not specified)|1|||
125077653|NCT00910728|449901555|FG005|Overall Study|(not specified)|0|||
125077654|NCT00910728|449901556|FG006|Overall Study|(not specified)|0|||
125077655|NCT00910728|449901557|FG007|Overall Study|(not specified)|0|||
125077656|NCT00910728|449901558|FG008|Overall Study|(not specified)|0|||
125077657|NCT00910728|449901550|FG000|Overall Study|Adverse Event|2|||
125077658|NCT00910728|449901551|FG001|Overall Study|Adverse Event|0|||
125077659|NCT00910728|449901552|FG002|Overall Study|Adverse Event|1|||
125077660|NCT00910728|449901553|FG003|Overall Study|Adverse Event|1|||
125077661|NCT00910728|449901554|FG004|Overall Study|Adverse Event|0|||
125077662|NCT00910728|449901555|FG005|Overall Study|Adverse Event|0|||
125077663|NCT00910728|449901556|FG006|Overall Study|Adverse Event|2|||
125077664|NCT00910728|449901557|FG007|Overall Study|Adverse Event|1|||
125077665|NCT00910728|449901558|FG008|Overall Study|Adverse Event|1|||
125077666|NCT00431496|449901559|FG000|Overall Study|Adverse Event|3|||
125077667|NCT00431496|449901559|FG000|Overall Study|Lost to Follow-up|1|||
125077668|NCT00431496|449901559|FG000|Overall Study|Withdrawal by Subject|2|||
125077669|NCT00431496|449901559|FG000|Overall Study|Protocol-specified criteria|5|||
125077670|NCT00361218|449901560|FG000|Overall Study|Lost to Follow-up|11|||
125077671|NCT00361218|449901560|FG000|Overall Study|Personal Reasons|7|||
125077672|NCT00361218|449901560|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
125077673|NCT00044213|449901564|FG000|Overall Study|Withdrawal by Subject|50|||
125077674|NCT00044213|449901565|FG001|Overall Study|Withdrawal by Subject|65|||
125077675|NCT00044213|449901566|FG002|Overall Study|Withdrawal by Subject|91|||
125077676|NCT00044213|449901567|FG003|Overall Study|Withdrawal by Subject|83|||
125077677|NCT00044213|449901564|FG000|Overall Study|Death|42|||
125077678|NCT00044213|449901565|FG001|Overall Study|Death|42|||
125077679|NCT00044213|449901566|FG002|Overall Study|Death|42|||
125077680|NCT00044213|449901567|FG003|Overall Study|Death|49|||
125077681|NCT00044213|449901564|FG000|Overall Study|Lost to Follow-up|8|||
125077682|NCT00044213|449901565|FG001|Overall Study|Lost to Follow-up|5|||
125077683|NCT00044213|449901566|FG002|Overall Study|Lost to Follow-up|5|||
125077684|NCT00044213|449901567|FG003|Overall Study|Lost to Follow-up|4|||
125077685|NCT01927068|449901568|FG000|Overall Study|Death|37|||
125077686|NCT01927068|449901569|FG001|Overall Study|Death|3|||
125077687|NCT01927068|449901568|FG000|Overall Study|Withdrawal by Subject|50|||
125077688|NCT01927068|449901569|FG001|Overall Study|Withdrawal by Subject|3|||
125077689|NCT01927068|449901568|FG000|Overall Study|Lost to Follow-up|10|||
125077690|NCT01927068|449901569|FG001|Overall Study|Lost to Follow-up|2|||
125077691|NCT01927068|449901568|FG000|Overall Study|Physician Decision|9|||
125144160|NCT03414034|450151459|FG002|Overall Study|Non-compliance With Study Drug|1|||
125144161|NCT03414034|450151457|FG000|Overall Study|Physician Decision|1|||
125144162|NCT03414034|450151458|FG001|Overall Study|Physician Decision|3|||
125077692|NCT01927068|449901569|FG001|Overall Study|Physician Decision|0|||
125077693|NCT01927068|449901568|FG000|Overall Study|Missed last follow-up visit|2|||
125077694|NCT01927068|449901569|FG001|Overall Study|Missed last follow-up visit|0|||
125077695|NCT00880607|449901570|FG000|Overall Study|Physician Decision|2|||
125077696|NCT00880607|449901571|FG001|Overall Study|Physician Decision|2|||
125077697|NCT00880607|449901570|FG000|Overall Study|Protocol Violation|2|||
125077698|NCT00880607|449901571|FG001|Overall Study|Protocol Violation|1|||
125077699|NCT00880607|449901570|FG000|Overall Study|surgery did not extend past L1 level|3|||
125077700|NCT00880607|449901571|FG001|Overall Study|surgery did not extend past L1 level|0|||
125077701|NCT02963766|449901573|FG000|Double-Blind Period|Adverse Event|1|||
125077702|NCT02963766|449901574|FG001|Double-Blind Period|Adverse Event|0|||
125077703|NCT02963766|449901575|FG002|Double-Blind Period|Adverse Event|1|||
125077704|NCT02963766|449901573|FG000|Double-Blind Period|Physician Decision|1|||
125077705|NCT02963766|449901574|FG001|Double-Blind Period|Physician Decision|0|||
125077706|NCT02963766|449901575|FG002|Double-Blind Period|Physician Decision|0|||
125077707|NCT02963766|449901573|FG000|Double-Blind Period|Withdrawal by Subject|1|||
125077708|NCT02963766|449901574|FG001|Double-Blind Period|Withdrawal by Subject|1|||
125077709|NCT02963766|449901575|FG002|Double-Blind Period|Withdrawal by Subject|0|||
125077710|NCT02963766|449901573|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
125144163|NCT03414034|450151459|FG002|Overall Study|Physician Decision|2|||
125077711|NCT02963766|449901574|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
125077712|NCT02963766|449901575|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
125077713|NCT02963766|449901573|FG000|Double-Blind Period|Protocol Violation|1|||
125077714|NCT02963766|449901574|FG001|Double-Blind Period|Protocol Violation|0|||
125077715|NCT02963766|449901575|FG002|Double-Blind Period|Protocol Violation|0|||
125077716|NCT02963766|449901573|FG000|Double-Blind Period|Lost to Follow-up|0|||
125077717|NCT02963766|449901574|FG001|Double-Blind Period|Lost to Follow-up|1|||
125077718|NCT02963766|449901575|FG002|Double-Blind Period|Lost to Follow-up|0|||
125077719|NCT02963766|449901573|FG000|Open Label Extension (OLE)|Physician Decision|1|||
125077720|NCT02963766|449901574|FG001|Open Label Extension (OLE)|Physician Decision|2|||
125077721|NCT02963766|449901575|FG002|Open Label Extension (OLE)|Physician Decision|2|||
125077722|NCT02963766|449901573|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
125077723|NCT02963766|449901574|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
125077724|NCT02963766|449901575|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
125077725|NCT00499460|449901576|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
125077726|NCT00499460|449901577|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
125077727|NCT00499460|449901576|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
125077728|NCT00499460|449901577|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
125077729|NCT00499460|449901576|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
125077730|NCT00499460|449901577|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
125077731|NCT00814307|449901578|FG000|Overall Study|Randomized but not treated|1|||
125077732|NCT00814307|449901579|FG001|Overall Study|Randomized but not treated|0|||
125077733|NCT00814307|449901580|FG002|Overall Study|Randomized but not treated|0|||
125077734|NCT00814307|449901581|FG003|Overall Study|Randomized but not treated|0|||
125077735|NCT00814307|449901578|FG000|Overall Study|Adverse Event|3|||
125077736|NCT00814307|449901579|FG001|Overall Study|Adverse Event|9|||
125077737|NCT00814307|449901580|FG002|Overall Study|Adverse Event|3|||
125077738|NCT00814307|449901581|FG003|Overall Study|Adverse Event|2|||
125077739|NCT00814307|449901578|FG000|Overall Study|Lack of Efficacy|1|||
125077740|NCT00814307|449901579|FG001|Overall Study|Lack of Efficacy|1|||
125077741|NCT00814307|449901580|FG002|Overall Study|Lack of Efficacy|3|||
125077742|NCT00814307|449901581|FG003|Overall Study|Lack of Efficacy|4|||
125077743|NCT00814307|449901578|FG000|Overall Study|Other|1|||
125077744|NCT00814307|449901579|FG001|Overall Study|Other|2|||
125077745|NCT00814307|449901580|FG002|Overall Study|Other|0|||
125077746|NCT00814307|449901581|FG003|Overall Study|Other|1|||
125077747|NCT00814307|449901578|FG000|Overall Study|Protocol Violation|2|||
125077748|NCT00814307|449901579|FG001|Overall Study|Protocol Violation|8|||
125077749|NCT00814307|449901580|FG002|Overall Study|Protocol Violation|1|||
125077750|NCT00814307|449901581|FG003|Overall Study|Protocol Violation|1|||
125077751|NCT00814307|449901578|FG000|Overall Study|Withdrawal by Subject|4|||
125077752|NCT00814307|449901579|FG001|Overall Study|Withdrawal by Subject|6|||
125077753|NCT00814307|449901580|FG002|Overall Study|Withdrawal by Subject|0|||
125077754|NCT00814307|449901581|FG003|Overall Study|Withdrawal by Subject|2|||
125077755|NCT00814307|449901578|FG000|Overall Study|Death|0|||
125077756|NCT00814307|449901579|FG001|Overall Study|Death|1|||
125077757|NCT00814307|449901580|FG002|Overall Study|Death|0|||
125077758|NCT00814307|449901581|FG003|Overall Study|Death|0|||
125077759|NCT02290340|449901583|FG000|Overall Study|Lost to Follow-up|0|||
125077760|NCT02290340|449901584|FG001|Overall Study|Lost to Follow-up|0|||
125077761|NCT02290340|449901585|FG002|Overall Study|Lost to Follow-up|0|||
125077762|NCT02290340|449901586|FG003|Overall Study|Lost to Follow-up|1|||
125077763|NCT02290340|449901583|FG000|Overall Study|Withdrawal by Subject|1|||
125077764|NCT02290340|449901584|FG001|Overall Study|Withdrawal by Subject|0|||
125077765|NCT02290340|449901585|FG002|Overall Study|Withdrawal by Subject|0|||
125077766|NCT02290340|449901586|FG003|Overall Study|Withdrawal by Subject|0|||
125077767|NCT02290340|449901583|FG000|Overall Study|Other|1|||
125077768|NCT02290340|449901584|FG001|Overall Study|Other|0|||
125077769|NCT02290340|449901585|FG002|Overall Study|Other|0|||
125077770|NCT02290340|449901586|FG003|Overall Study|Other|1|||
125077771|NCT03209362|449901590|FG000|Overall Study|Adverse Event|0|||
125077772|NCT03209362|449901591|FG001|Overall Study|Adverse Event|1|||
125077773|NCT03209362|449901590|FG000|Overall Study|Lost to Follow-up|0|||
125077774|NCT03209362|449901591|FG001|Overall Study|Lost to Follow-up|1|||
125077775|NCT03209362|449901590|FG000|Overall Study|Withdrawal by Subject|2|||
125077776|NCT03209362|449901591|FG001|Overall Study|Withdrawal by Subject|0|||
125077777|NCT03209362|449901590|FG000|Overall Study|Other|0|||
125077778|NCT03209362|449901591|FG001|Overall Study|Other|1|||
125077779|NCT01594749|449903843|FG000|Overall Study|Adverse Event|2|||
125077780|NCT01594749|449903844|FG001|Overall Study|Adverse Event|1|||
125077781|NCT01594749|449903843|FG000|Overall Study|Withdrawal by Subject|2|||
125077782|NCT01594749|449903844|FG001|Overall Study|Withdrawal by Subject|2|||
125077783|NCT01594749|449903843|FG000|Overall Study|Protocol Violation|2|||
125077784|NCT01594749|449903844|FG001|Overall Study|Protocol Violation|0|||
125077785|NCT01594749|449903843|FG000|Overall Study|Physician Decision|1|||
125077786|NCT01594749|449903844|FG001|Overall Study|Physician Decision|1|||
125077787|NCT01594749|449903843|FG000|Overall Study|Non-compliance with Protocol|0|||
125077788|NCT01594749|449903844|FG001|Overall Study|Non-compliance with Protocol|1|||
125077789|NCT01594749|449903843|FG000|Overall Study|Lost to Follow-up|1|||
125077790|NCT01594749|449903844|FG001|Overall Study|Lost to Follow-up|0|||
125077791|NCT01594749|449903843|FG000|Overall Study|Death|9|||
125077792|NCT01594749|449903844|FG001|Overall Study|Death|3|||
125077793|NCT01594749|449903843|FG000|Overall Study|Not Treated|4|||
125077794|NCT01594749|449903844|FG001|Overall Study|Not Treated|10|||
125077795|NCT01594749|449903843|FG000|Overall Study|Lost Source Documentation|1|||
125077796|NCT01594749|449903844|FG001|Overall Study|Lost Source Documentation|0|||
125223401|NCT02326272|450446165|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125223402|NCT02326272|450446166|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125223403|NCT02326272|450446167|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125223404|NCT02326272|450446168|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125223405|NCT02326272|450446169|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
125223406|NCT02326272|450446170|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
125223407|NCT02326272|450446171|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125077797|NCT02177786|449903845|FG000|Overall Study|Withdrew Consent|2|||
125077798|NCT02177786|449903846|FG001|Overall Study|Withdrew Consent|6|||
125077799|NCT02177786|449903847|FG002|Overall Study|Withdrew Consent|9|||
125077800|NCT02177786|449903848|FG003|Overall Study|Withdrew Consent|5|||
125077801|NCT02177786|449903845|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
125077802|NCT02177786|449903846|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
125077803|NCT02177786|449903847|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
125077804|NCT02177786|449903848|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
125077805|NCT02177786|449903845|FG000|Overall Study|Adverse Event|1|||
125077806|NCT02177786|449903846|FG001|Overall Study|Adverse Event|1|||
125077807|NCT02177786|449903847|FG002|Overall Study|Adverse Event|2|||
125077808|NCT02177786|449903848|FG003|Overall Study|Adverse Event|3|||
125077809|NCT02177786|449903845|FG000|Overall Study|Death|1|||
125077810|NCT02177786|449903846|FG001|Overall Study|Death|1|||
125077811|NCT02177786|449903847|FG002|Overall Study|Death|1|||
125077812|NCT02177786|449903848|FG003|Overall Study|Death|1|||
125077813|NCT02177786|449903845|FG000|Overall Study|Lost to Follow-up|0|||
125077814|NCT02177786|449903846|FG001|Overall Study|Lost to Follow-up|0|||
125077815|NCT02177786|449903847|FG002|Overall Study|Lost to Follow-up|2|||
125077816|NCT02177786|449903848|FG003|Overall Study|Lost to Follow-up|2|||
125077817|NCT02177786|449903845|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125077818|NCT02177786|449903846|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125077819|NCT02177786|449903847|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125077820|NCT02177786|449903848|FG003|Overall Study|Non-Compliance with Study Drug|1|||
125077821|NCT02177786|449903845|FG000|Overall Study|Protocol Violation|0|||
125077822|NCT02177786|449903846|FG001|Overall Study|Protocol Violation|0|||
125077823|NCT02177786|449903847|FG002|Overall Study|Protocol Violation|2|||
125077824|NCT02177786|449903848|FG003|Overall Study|Protocol Violation|0|||
125144164|NCT03414034|450151457|FG000|Overall Study|Withdrawal of Informed Consent|2|||
125144165|NCT03414034|450151458|FG001|Overall Study|Withdrawal of Informed Consent|1|||
125144166|NCT03414034|450151459|FG002|Overall Study|Withdrawal of Informed Consent|4|||
125144167|NCT03414034|450151457|FG000|Overall Study|Progressive Disease|15|||
125144168|NCT03414034|450151458|FG001|Overall Study|Progressive Disease|15|||
125077825|NCT02177786|449903845|FG000|Overall Study|Progressive Disease|0|||
125077826|NCT02177786|449903846|FG001|Overall Study|Progressive Disease|1|||
125077827|NCT02177786|449903847|FG002|Overall Study|Progressive Disease|0|||
125077828|NCT02177786|449903848|FG003|Overall Study|Progressive Disease|0|||
125223408|NCT02326272|450446172|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
125223409|NCT02326272|450446173|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
125223410|NCT02326272|450446174|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125223411|NCT02326272|450446175|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125223412|NCT02326272|450446176|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125223413|NCT02326272|450446177|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125077829|NCT02177786|449903845|FG000|Overall Study|Missing study completion status|0|||
125077830|NCT02177786|449903846|FG001|Overall Study|Missing study completion status|1|||
125077831|NCT02177786|449903847|FG002|Overall Study|Missing study completion status|0|||
125077832|NCT02177786|449903848|FG003|Overall Study|Missing study completion status|0|||
125077833|NCT00439309|449903849|FG000|Follow-Up|Death|1|||
125077834|NCT00439309|449903850|FG001|Follow-Up|Death|0|||
125144169|NCT03414034|450151459|FG002|Overall Study|Progressive Disease|17|||
125144170|NCT03414034|450151457|FG000|Overall Study|Miscellaneous|0|||
125144171|NCT03414034|450151458|FG001|Overall Study|Miscellaneous|0|||
125144172|NCT03414034|450151459|FG002|Overall Study|Miscellaneous|2|||
125223414|NCT02326272|450446178|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125223415|NCT02326272|450446164|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223416|NCT02326272|450446165|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223417|NCT02326272|450446166|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223418|NCT02326272|450446167|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223419|NCT02326272|450446168|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223420|NCT02326272|450446169|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
125077835|NCT00439309|449903849|FG000|Follow-Up|Lost to Follow-up|2|||
125077836|NCT00439309|449903850|FG001|Follow-Up|Lost to Follow-up|0|||
125077837|NCT00439309|449903849|FG000|Follow-Up|Withdrawal by Subject|0|||
125077838|NCT00439309|449903850|FG001|Follow-Up|Withdrawal by Subject|1|||
125077839|NCT00439309|449903849|FG000|Follow-Up|Late response by subject|0|||
125077840|NCT00439309|449903850|FG001|Follow-Up|Late response by subject|1|||
125077841|NCT01977040|449903851|FG000|Overall Study|Vasa previa not confirmed|2|||
125077842|NCT02204410|449903859|FG000|Overall Study|Lost to Follow-up|5|||
125077843|NCT02204410|449903859|FG000|Overall Study|Physician Decision|2|||
125077844|NCT02204410|449903859|FG000|Overall Study|Protocol Violation|1|||
125077845|NCT02204410|449903859|FG000|Overall Study|Withdrawal by Subject|3|||
125077846|NCT03654560|449903860|FG000|Overall Study|Death|3|||
125077847|NCT03654560|449903861|FG001|Overall Study|Death|1|||
125077848|NCT03654560|449903860|FG000|Overall Study|Lost to Follow-up|1|||
125077849|NCT03654560|449903861|FG001|Overall Study|Lost to Follow-up|0|||
125077850|NCT01100658|449903862|FG000|Overall Study|Withdrawal by Subject|1|||
125077851|NCT00420342|449903866|FG000|Overall Study|Lost to Follow-up|1|||
125077852|NCT00420342|449903867|FG001|Overall Study|Lost to Follow-up|0|||
125077853|NCT00420342|449903868|FG002|Overall Study|Lost to Follow-up|1|||
125077854|NCT00420342|449903866|FG000|Overall Study|Withdrawal by Subject|0|||
125077855|NCT00420342|449903867|FG001|Overall Study|Withdrawal by Subject|2|||
125077856|NCT00420342|449903868|FG002|Overall Study|Withdrawal by Subject|0|||
125077857|NCT01017549|449903869|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
125077858|NCT01017549|449903869|FG000|One-year Follow-up|Lost to Follow-up|2|||
125077859|NCT01017549|449903869|FG000|One-year Follow-up|Withdrawal by Subject|5|||
125077860|NCT01017549|449903869|FG000|5 Year Follow-up|Lost to Follow-up|9|||
125077861|NCT01017549|449903869|FG000|5 Year Follow-up|Mastectomy|3|||
125077862|NCT04072575|449903870|FG000|Overall Study|Physician Decision|1|||
125077863|NCT04072575|449903870|FG000|Overall Study|Adverse Event|7|||
125077864|NCT04072575|449903870|FG000|Overall Study|Withdrawal by Subject|14|||
125077865|NCT04072575|449903870|FG000|Overall Study|Other|2|||
125077866|NCT02473289|449903871|FG000|Overall Study|Adverse Event|2|||
125077867|NCT02473289|449903872|FG001|Overall Study|Adverse Event|3|||
125077868|NCT02473289|449903871|FG000|Overall Study|Lost to Follow-up|1|||
125077869|NCT02473289|449903872|FG001|Overall Study|Lost to Follow-up|1|||
125077870|NCT02473289|449903871|FG000|Overall Study|Protocol Violation|0|||
125077871|NCT02473289|449903872|FG001|Overall Study|Protocol Violation|1|||
125077872|NCT02473289|449903871|FG000|Overall Study|Withdrawal of consent|6|||
125077873|NCT02473289|449903872|FG001|Overall Study|Withdrawal of consent|7|||
125077874|NCT02473289|449903871|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
125077875|NCT02473289|449903872|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
125077876|NCT02473289|449903871|FG000|Overall Study|Other|2|||
125077877|NCT02473289|449903872|FG001|Overall Study|Other|0|||
125077878|NCT02244619|449903873|FG000|Overall Study|Did not receive study intervention|8|||
125077879|NCT02244619|449903874|FG001|Overall Study|Did not receive study intervention|21|||
125077880|NCT01291511|449903876|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
125077881|NCT01291511|449903877|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
125077882|NCT01291511|449903876|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
125077883|NCT01291511|449903877|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
125077884|NCT01291511|449903876|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
125077885|NCT01291511|449903877|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
125077886|NCT01291511|449903876|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
125077887|NCT01291511|449903877|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
125077888|NCT01291511|449903876|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
125077889|NCT01291511|449903877|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
125077890|NCT01291511|449903876|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
125077891|NCT01291511|449903877|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
125077892|NCT01291511|449903876|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
125077893|NCT01291511|449903877|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
125077894|NCT01291511|449903876|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
125077895|NCT01291511|449903877|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
125077896|NCT01291511|449903876|FG000|Cross-Titration and Stabilization Phase|Death|1|||
125077897|NCT01291511|449903877|FG001|Cross-Titration and Stabilization Phase|Death|0|||
125077898|NCT01291511|449903876|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
125077899|NCT01291511|449903877|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
125077900|NCT01291511|449903876|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
125077901|NCT01291511|449903877|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
125077902|NCT01291511|449903876|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
125077903|NCT01291511|449903877|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
125077904|NCT01291511|449903876|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
125077905|NCT01291511|449903877|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
125144173|NCT04010227|450151461|FG000|Overall Study|Death|1|||
125144174|NCT04010227|450151462|FG001|Overall Study|Death|2|||
125077906|NCT01291511|449903876|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
125144175|NCT04010227|450151461|FG000|Overall Study|Medical Reasons|4|||
125144176|NCT04010227|450151462|FG001|Overall Study|Medical Reasons|3|||
125144177|NCT04010227|450151461|FG000|Overall Study|Withdrawal by Subject|2|||
125144178|NCT04010227|450151462|FG001|Overall Study|Withdrawal by Subject|0|||
125223421|NCT02326272|450446170|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223422|NCT02326272|450446171|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
125223423|NCT02326272|450446172|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223424|NCT02326272|450446173|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223425|NCT02326272|450446174|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223426|NCT02326272|450446175|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223427|NCT02326272|450446176|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223428|NCT02326272|450446177|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223429|NCT02326272|450446178|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223430|NCT02326272|450446164|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125223431|NCT02326272|450446165|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125223432|NCT02326272|450446166|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125223433|NCT02326272|450446167|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125223434|NCT02326272|450446168|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125223435|NCT02326272|450446169|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
125223436|NCT02326272|450446170|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125223437|NCT02326272|450446171|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125223438|NCT02326272|450446172|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125223439|NCT02326272|450446173|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125223440|NCT02326272|450446174|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125223441|NCT02326272|450446175|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125223442|NCT02326272|450446176|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125223443|NCT02326272|450446177|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125223444|NCT02326272|450446178|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125223445|NCT02326272|450446164|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125223446|NCT02326272|450446165|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125223447|NCT02326272|450446166|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125223448|NCT02326272|450446167|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125223449|NCT02326272|450446168|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125223450|NCT02326272|450446169|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125223451|NCT02326272|450446170|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125223452|NCT02326272|450446171|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
125223453|NCT02326272|450446172|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125077907|NCT01291511|449903877|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
125077908|NCT01291511|449903876|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
125077909|NCT01291511|449903877|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
125077910|NCT01291511|449903876|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
125077911|NCT01291511|449903877|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
125077912|NCT01291511|449903876|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
125077913|NCT01291511|449903877|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
125077914|NCT01291511|449903876|FG000|Double-blind Relapse Prevention Phase|Death|1|||
125077915|NCT01291511|449903877|FG001|Double-blind Relapse Prevention Phase|Death|0|||
125077916|NCT00047008|449903879|FG000|Overall Study|Withdrawn consent|2|||
125077917|NCT00047008|449903880|FG001|Overall Study|Withdrawn consent|3|||
125077918|NCT00047008|449903879|FG000|Overall Study|Ineligible|9|||
125077919|NCT00047008|449903880|FG001|Overall Study|Ineligible|8|||
125077920|NCT01408732|449903882|FG000|Overall Study|Withdrawal by Subject|2|||
125077921|NCT01408732|449903883|FG001|Overall Study|Withdrawal by Subject|2|||
125077922|NCT00796003|449903885|FG000|Overall Study|Disease Progression|2|||
125077923|NCT00796003|449903886|FG001|Overall Study|Disease Progression|13|||
125077924|NCT00796003|449903885|FG000|Overall Study|Adverse Event|1|||
125077925|NCT00796003|449903886|FG001|Overall Study|Adverse Event|7|||
125077926|NCT00796003|449903885|FG000|Overall Study|Specified organ function not met|0|||
125077927|NCT00796003|449903886|FG001|Overall Study|Specified organ function not met|1|||
125077928|NCT00796003|449903885|FG000|Overall Study|Physician Decision|0|||
125077929|NCT00796003|449903886|FG001|Overall Study|Physician Decision|4|||
125077930|NCT00796003|449903885|FG000|Overall Study|Withdrawal by Subject|0|||
125077931|NCT00796003|449903886|FG001|Overall Study|Withdrawal by Subject|1|||
125077932|NCT00796003|449903885|FG000|Overall Study|Other|0|||
125077933|NCT00796003|449903886|FG001|Overall Study|Other|1|||
125077934|NCT00796003|449903885|FG000|Overall Study|Participants Not treated|0|||
125077935|NCT00796003|449903886|FG001|Overall Study|Participants Not treated|2|||
125077936|NCT05179057|449903887|FG000|Overall Study|Adverse Event|3|||
125077937|NCT05179057|449903888|FG001|Overall Study|Adverse Event|2|||
125077938|NCT05179057|449903887|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
125077939|NCT05179057|449903888|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
125077940|NCT05179057|449903887|FG000|Overall Study|Study terminated|13|||
125077941|NCT05179057|449903888|FG001|Overall Study|Study terminated|7|||
125077942|NCT05179057|449903887|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
125077943|NCT05179057|449903888|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
125077944|NCT05179057|449903887|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
125077945|NCT05179057|449903888|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
125077946|NCT02437162|449903889|FG000|Overall Study|Protocol Violation|0|||
125077947|NCT02437162|449903890|FG001|Overall Study|Protocol Violation|1|||
125077948|NCT02437162|449903891|FG002|Overall Study|Protocol Violation|0|||
125077949|NCT02437162|449903889|FG000|Overall Study|Randomized but not treated|0|||
125077950|NCT02437162|449903890|FG001|Overall Study|Randomized but not treated|0|||
125077951|NCT02437162|449903891|FG002|Overall Study|Randomized but not treated|1|||
125077952|NCT02437162|449903889|FG000|Overall Study|Study discontinued by Sponsor|93|||
125077953|NCT02437162|449903890|FG001|Overall Study|Study discontinued by Sponsor|98|||
125077954|NCT02437162|449903891|FG002|Overall Study|Study discontinued by Sponsor|97|||
125077955|NCT02437162|449903889|FG000|Overall Study|Withdrawal by Subject|13|||
125077956|NCT02437162|449903890|FG001|Overall Study|Withdrawal by Subject|7|||
125077957|NCT02437162|449903891|FG002|Overall Study|Withdrawal by Subject|9|||
125077958|NCT02437162|449903889|FG000|Overall Study|Adverse Event|0|||
125077959|NCT02437162|449903890|FG001|Overall Study|Adverse Event|1|||
125077960|NCT02437162|449903891|FG002|Overall Study|Adverse Event|0|||
125077961|NCT02437162|449903889|FG000|Overall Study|Lost to Follow-up|1|||
125077962|NCT02437162|449903890|FG001|Overall Study|Lost to Follow-up|0|||
125077963|NCT02437162|449903891|FG002|Overall Study|Lost to Follow-up|1|||
125077964|NCT02437162|449903889|FG000|Overall Study|Death|0|||
125077965|NCT02437162|449903890|FG001|Overall Study|Death|1|||
125077966|NCT02437162|449903891|FG002|Overall Study|Death|0|||
125077967|NCT02437162|449903889|FG000|Overall Study|Other|0|||
125077968|NCT02437162|449903890|FG001|Overall Study|Other|0|||
125077969|NCT02437162|449903891|FG002|Overall Study|Other|1|||
125077970|NCT04338321|449903892|FG000|Overall Study|Adverse Event|4|||
125077971|NCT04338321|449903893|FG001|Overall Study|Adverse Event|10|||
125077972|NCT04338321|449903892|FG000|Overall Study|Death|1|||
125077973|NCT04338321|449903893|FG001|Overall Study|Death|1|||
125077974|NCT04338321|449903892|FG000|Overall Study|Lost to Follow-up|4|||
125077975|NCT04338321|449903893|FG001|Overall Study|Lost to Follow-up|9|||
125077976|NCT04338321|449903892|FG000|Overall Study|Withdrawal by Subject|45|||
125077977|NCT04338321|449903893|FG001|Overall Study|Withdrawal by Subject|69|||
125077978|NCT04338321|449903892|FG000|Overall Study|Physician Decision|5|||
125077979|NCT04338321|449903893|FG001|Overall Study|Physician Decision|9|||
125077980|NCT04338321|449903892|FG000|Overall Study|Other|3|||
125077981|NCT04338321|449903893|FG001|Overall Study|Other|10|||
125077982|NCT03107793|449903894|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
125077983|NCT03107793|449903895|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
125077984|NCT03107793|449903896|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
125077985|NCT03107793|449903897|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
125077986|NCT03107793|449903898|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
125077987|NCT03107793|449903894|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
125077988|NCT03107793|449903895|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
125144179|NCT04010227|450151461|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
125144180|NCT04010227|450151462|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
125144181|NCT00640926|450151463|FG000|Overall Study|Adverse Event|2|||
125144182|NCT00640926|450151464|FG001|Overall Study|Adverse Event|3|||
125077989|NCT03107793|449903896|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
125077990|NCT03107793|449903897|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
125077991|NCT03107793|449903898|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
125077992|NCT03107793|449903894|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
125223454|NCT02326272|450446173|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125077993|NCT03107793|449903895|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
125077994|NCT03107793|449903896|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
125077995|NCT03107793|449903897|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
125077996|NCT03107793|449903898|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
125077997|NCT03107793|449903894|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
125077998|NCT03107793|449903895|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125077999|NCT03107793|449903896|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125078000|NCT03107793|449903897|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125078001|NCT03107793|449903898|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125078002|NCT03107793|449903894|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
125078003|NCT03107793|449903895|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
125078004|NCT03107793|449903896|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
125078005|NCT03107793|449903897|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
125078006|NCT03107793|449903898|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
125078007|NCT03107793|449903894|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
125078008|NCT03107793|449903895|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
125078009|NCT03107793|449903896|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
125078010|NCT03107793|449903897|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
125078011|NCT03107793|449903898|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
125078012|NCT03107793|449903894|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
125078013|NCT03107793|449903895|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
125078014|NCT03107793|449903896|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
125078015|NCT03107793|449903897|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
125078016|NCT03107793|449903898|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
125078017|NCT03107793|449903894|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
125078018|NCT03107793|449903895|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
125078019|NCT03107793|449903896|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
125078020|NCT03107793|449903897|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
125078021|NCT03107793|449903898|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
125078022|NCT03107793|449903894|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
125078023|NCT03107793|449903895|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
125078024|NCT03107793|449903896|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
125078025|NCT03107793|449903897|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
125078026|NCT03107793|449903898|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
125078027|NCT03107793|449903894|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
125078028|NCT03107793|449903895|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
125078029|NCT03107793|449903896|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
125078030|NCT03107793|449903897|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
125078031|NCT03107793|449903898|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
125078032|NCT03107793|449903894|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125078033|NCT03107793|449903895|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
125078034|NCT03107793|449903896|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125078035|NCT03107793|449903897|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125078036|NCT03107793|449903898|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125078037|NCT03107793|449903894|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
125078038|NCT03107793|449903895|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
125078039|NCT03107793|449903896|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
125078040|NCT03107793|449903897|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
125078041|NCT03107793|449903898|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
125078042|NCT03107793|449903894|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
125078043|NCT03107793|449903895|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
125078044|NCT03107793|449903896|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
125078045|NCT03107793|449903897|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
125078046|NCT03107793|449903898|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
125078047|NCT03107793|449903894|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
125078048|NCT03107793|449903895|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
125078049|NCT03107793|449903896|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
125078050|NCT03107793|449903897|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
125078051|NCT03107793|449903898|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
125223455|NCT02326272|450446174|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125078052|NCT03107793|449903894|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
125078053|NCT03107793|449903895|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
125078054|NCT03107793|449903896|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
125078055|NCT03107793|449903897|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
125078056|NCT03107793|449903898|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
125078057|NCT03107793|449903894|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
125078058|NCT03107793|449903895|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
125078059|NCT03107793|449903896|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
125078060|NCT03107793|449903897|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
125078061|NCT03107793|449903898|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
125078062|NCT03107793|449903894|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
125078063|NCT03107793|449903895|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
125078064|NCT03107793|449903896|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
125078065|NCT03107793|449903897|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
125078066|NCT03107793|449903898|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
125078067|NCT03107793|449903894|FG000|Extension Period (Week 48- Week 104)|Death|0|||
125078068|NCT03107793|449903895|FG001|Extension Period (Week 48- Week 104)|Death|0|||
125078069|NCT03107793|449903896|FG002|Extension Period (Week 48- Week 104)|Death|0|||
125078070|NCT03107793|449903897|FG003|Extension Period (Week 48- Week 104)|Death|0|||
125078071|NCT03107793|449903898|FG004|Extension Period (Week 48- Week 104)|Death|1|||
125078072|NCT03107793|449903894|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
125078073|NCT03107793|449903895|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
125078074|NCT03107793|449903896|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
125078075|NCT03107793|449903897|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
125078076|NCT03107793|449903898|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
125078077|NCT03107793|449903894|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
125078078|NCT03107793|449903895|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
125078079|NCT03107793|449903896|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
125078080|NCT03107793|449903897|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
125078081|NCT03107793|449903898|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
125078082|NCT03107793|449903894|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
125078083|NCT03107793|449903895|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
125078084|NCT03107793|449903896|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
125078085|NCT03107793|449903897|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
125078086|NCT03107793|449903898|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
125078087|NCT03107793|449903894|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
125078088|NCT03107793|449903895|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
125078089|NCT03107793|449903896|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
125078090|NCT03107793|449903897|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
125078091|NCT03107793|449903898|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
125078092|NCT03107793|449903894|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
125078093|NCT03107793|449903895|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
125078094|NCT03107793|449903896|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
125078095|NCT03107793|449903897|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
125078096|NCT03107793|449903898|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
125078097|NCT03107793|449903894|FG000|Extension Period (Week 48- Week 104)|Other|0|||
125078098|NCT03107793|449903895|FG001|Extension Period (Week 48- Week 104)|Other|0|||
125078099|NCT03107793|449903896|FG002|Extension Period (Week 48- Week 104)|Other|0|||
125078100|NCT03107793|449903897|FG003|Extension Period (Week 48- Week 104)|Other|1|||
125078101|NCT03107793|449903898|FG004|Extension Period (Week 48- Week 104)|Other|3|||
125078102|NCT03107793|449903894|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
125078103|NCT03107793|449903895|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
125078104|NCT03107793|449903896|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
125078105|NCT03107793|449903897|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
125078106|NCT03107793|449903898|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
125078107|NCT01989572|449903902|FG000|Overall Study|Lack of Efficacy|35|||
125078108|NCT01989572|449903903|FG001|Overall Study|Lack of Efficacy|48|||
125078109|NCT01989572|449903904|FG002|Overall Study|Lack of Efficacy|48|||
125078110|NCT01989572|449903905|FG003|Overall Study|Lack of Efficacy|43|||
125078111|NCT01989572|449903906|FG004|Overall Study|Lack of Efficacy|71|||
125078112|NCT01989572|449903907|FG005|Overall Study|Lack of Efficacy|79|||
125078113|NCT01989572|449903902|FG000|Overall Study|Adverse Event|2|||
125078114|NCT01989572|449903903|FG001|Overall Study|Adverse Event|1|||
125078115|NCT01989572|449903904|FG002|Overall Study|Adverse Event|3|||
125078116|NCT01989572|449903905|FG003|Overall Study|Adverse Event|0|||
125078117|NCT01989572|449903906|FG004|Overall Study|Adverse Event|3|||
125078118|NCT01989572|449903907|FG005|Overall Study|Adverse Event|0|||
125078119|NCT01989572|449903902|FG000|Overall Study|Death|0|||
125078120|NCT01989572|449903903|FG001|Overall Study|Death|0|||
125078121|NCT01989572|449903904|FG002|Overall Study|Death|0|||
125078122|NCT01989572|449903905|FG003|Overall Study|Death|0|||
125078123|NCT01989572|449903906|FG004|Overall Study|Death|1|||
125078124|NCT01989572|449903907|FG005|Overall Study|Death|0|||
125078125|NCT01989572|449903902|FG000|Overall Study|Withdrawal by Subject|4|||
125078126|NCT01989572|449903903|FG001|Overall Study|Withdrawal by Subject|1|||
125078127|NCT01989572|449903904|FG002|Overall Study|Withdrawal by Subject|5|||
125078128|NCT01989572|449903905|FG003|Overall Study|Withdrawal by Subject|1|||
125078129|NCT01989572|449903906|FG004|Overall Study|Withdrawal by Subject|12|||
125078130|NCT01989572|449903907|FG005|Overall Study|Withdrawal by Subject|4|||
125078131|NCT01989572|449903902|FG000|Overall Study|complicating disease|1|||
125078132|NCT01989572|449903903|FG001|Overall Study|complicating disease|1|||
125078133|NCT01989572|449903904|FG002|Overall Study|complicating disease|2|||
125078134|NCT01989572|449903905|FG003|Overall Study|complicating disease|0|||
125078135|NCT01989572|449903906|FG004|Overall Study|complicating disease|1|||
125078136|NCT01989572|449903907|FG005|Overall Study|complicating disease|0|||
125078137|NCT01989572|449903902|FG000|Overall Study|error|2|||
125078138|NCT01989572|449903903|FG001|Overall Study|error|1|||
125078139|NCT01989572|449903904|FG002|Overall Study|error|1|||
125078140|NCT01989572|449903905|FG003|Overall Study|error|1|||
125078141|NCT01989572|449903906|FG004|Overall Study|error|1|||
125078142|NCT01989572|449903907|FG005|Overall Study|error|1|||
125078143|NCT01989572|449903902|FG000|Overall Study|maximum dose reached|0|||
125078144|NCT01989572|449903903|FG001|Overall Study|maximum dose reached|1|||
125078145|NCT01989572|449903904|FG002|Overall Study|maximum dose reached|0|||
125078146|NCT01989572|449903905|FG003|Overall Study|maximum dose reached|0|||
125078147|NCT01989572|449903906|FG004|Overall Study|maximum dose reached|1|||
125078148|NCT01989572|449903907|FG005|Overall Study|maximum dose reached|0|||
125078149|NCT01989572|449903902|FG000|Overall Study|unknown/not specify|3|||
125078150|NCT01989572|449903903|FG001|Overall Study|unknown/not specify|4|||
125078151|NCT01989572|449903904|FG002|Overall Study|unknown/not specify|1|||
125078152|NCT01989572|449903905|FG003|Overall Study|unknown/not specify|3|||
125078153|NCT01989572|449903906|FG004|Overall Study|unknown/not specify|3|||
125078154|NCT01989572|449903907|FG005|Overall Study|unknown/not specify|5|||
125078155|NCT01989572|449903902|FG000|Overall Study|not start protocol therapy|5|||
125078156|NCT01989572|449903903|FG001|Overall Study|not start protocol therapy|1|||
125078157|NCT01989572|449903904|FG002|Overall Study|not start protocol therapy|2|||
125078158|NCT01989572|449903905|FG003|Overall Study|not start protocol therapy|3|||
125078159|NCT01989572|449903906|FG004|Overall Study|not start protocol therapy|4|||
125078160|NCT01989572|449903907|FG005|Overall Study|not start protocol therapy|18|||
125078161|NCT01989572|449903902|FG000|Overall Study|alternative therapy|3|||
125078162|NCT01989572|449903903|FG001|Overall Study|alternative therapy|0|||
125078163|NCT01989572|449903904|FG002|Overall Study|alternative therapy|0|||
125078164|NCT01989572|449903905|FG003|Overall Study|alternative therapy|0|||
125078165|NCT01989572|449903906|FG004|Overall Study|alternative therapy|1|||
125078166|NCT01989572|449903907|FG005|Overall Study|alternative therapy|3|||
125078167|NCT00865046|449903908|FG000|Overall Study|Lost to Follow-up|1|||
125078168|NCT00865046|449903909|FG001|Overall Study|Lost to Follow-up|4|||
125078169|NCT00865046|449903910|FG002|Overall Study|Lost to Follow-up|0|||
125078170|NCT00865046|449903908|FG000|Overall Study|Death|0|||
125078171|NCT00865046|449903909|FG001|Overall Study|Death|1|||
125078172|NCT00865046|449903910|FG002|Overall Study|Death|1|||
125078173|NCT00865046|449903908|FG000|Overall Study|Withdrawal by Subject|5|||
125078174|NCT00865046|449903909|FG001|Overall Study|Withdrawal by Subject|0|||
125078175|NCT00865046|449903910|FG002|Overall Study|Withdrawal by Subject|0|||
125078176|NCT01024920|449903913|FG000|Overall Study|Progressive disease|47|||
125078177|NCT01024920|449903914|FG001|Overall Study|Progressive disease|25|||
125078178|NCT01024920|449903913|FG000|Overall Study|Adverse Event|8|||
125078179|NCT01024920|449903914|FG001|Overall Study|Adverse Event|4|||
125078180|NCT01024920|449903913|FG000|Overall Study|Lost to Follow-up|0|||
125078181|NCT01024920|449903914|FG001|Overall Study|Lost to Follow-up|1|||
125078182|NCT01024920|449903913|FG000|Overall Study|Patient refusal to continue|4|||
125078183|NCT01024920|449903914|FG001|Overall Study|Patient refusal to continue|0|||
125078184|NCT01024920|449903913|FG000|Overall Study|Other than listed|5|||
125078185|NCT01024920|449903914|FG001|Overall Study|Other than listed|1|||
125078186|NCT01024920|449903913|FG000|Overall Study|Not treated|3|||
125078187|NCT01024920|449903914|FG001|Overall Study|Not treated|0|||
125078188|NCT01024920|449903913|FG000|Overall Study|Protocol Violation|0|||
125078189|NCT01024920|449903914|FG001|Overall Study|Protocol Violation|1|||
125078190|NCT02977507|449903915|FG000|Overall Study|Protocol Deviation|1|||
125078191|NCT02977507|449903916|FG001|Overall Study|Protocol Deviation|0|||
125078192|NCT02977507|449903915|FG000|Overall Study|Lost to Follow-up|1|||
125078193|NCT02977507|449903916|FG001|Overall Study|Lost to Follow-up|0|||
125078194|NCT00633360|449903917|FG000|Overall Study|Lost to Follow-up|1|||
125078195|NCT00633360|449903918|FG001|Overall Study|Lost to Follow-up|1|||
125078196|NCT00633360|449903917|FG000|Overall Study|Adverse Event|3|||
125078197|NCT00633360|449903918|FG001|Overall Study|Adverse Event|1|||
125078198|NCT00633360|449903917|FG000|Overall Study|Protocol Violation|0|||
125078199|NCT00633360|449903918|FG001|Overall Study|Protocol Violation|1|||
125078200|NCT00621244|449903923|FG000|Overall Study|Withdrawal by Subject|7|||
125078201|NCT00621244|449903924|FG001|Overall Study|Withdrawal by Subject|3|||
125078202|NCT00621244|449903925|FG002|Overall Study|Withdrawal by Subject|3|||
125078203|NCT00621244|449903926|FG003|Overall Study|Withdrawal by Subject|3|||
125078204|NCT00621244|449903923|FG000|Overall Study|Disease progression|44|||
125078205|NCT00621244|449903924|FG001|Overall Study|Disease progression|20|||
125078206|NCT00621244|449903925|FG002|Overall Study|Disease progression|20|||
125078207|NCT00621244|449903926|FG003|Overall Study|Disease progression|15|||
125078208|NCT00621244|449903923|FG000|Overall Study|Death|3|||
125078209|NCT00621244|449903924|FG001|Overall Study|Death|3|||
125078210|NCT00621244|449903925|FG002|Overall Study|Death|1|||
125078211|NCT00621244|449903926|FG003|Overall Study|Death|1|||
125078212|NCT00621244|449903923|FG000|Overall Study|Adverse Event|27|||
125078213|NCT00621244|449903924|FG001|Overall Study|Adverse Event|7|||
125078214|NCT00621244|449903925|FG002|Overall Study|Adverse Event|9|||
125078215|NCT00621244|449903926|FG003|Overall Study|Adverse Event|2|||
125078216|NCT00621244|449903923|FG000|Overall Study|Administrative problems|5|||
125078217|NCT00621244|449903924|FG001|Overall Study|Administrative problems|1|||
125078218|NCT00621244|449903925|FG002|Overall Study|Administrative problems|0|||
125078219|NCT00621244|449903926|FG003|Overall Study|Administrative problems|2|||
125078220|NCT04449276|449903932|FG000|Overall Study|Adverse Event|1|||
125078221|NCT04449276|449903933|FG001|Overall Study|Adverse Event|2|||
125078222|NCT04449276|449903934|FG002|Overall Study|Adverse Event|0|||
125078223|NCT04449276|449903935|FG003|Overall Study|Adverse Event|0|||
125078224|NCT04449276|449903936|FG004|Overall Study|Adverse Event|2|||
125078225|NCT04449276|449903937|FG005|Overall Study|Adverse Event|0|||
125078226|NCT04449276|449903938|FG006|Overall Study|Adverse Event|0|||
125078227|NCT04449276|449903939|FG007|Overall Study|Adverse Event|1|||
125078228|NCT04449276|449903932|FG000|Overall Study|Withdrawal by Subject|2|||
125078229|NCT04449276|449903933|FG001|Overall Study|Withdrawal by Subject|0|||
125078230|NCT04449276|449903934|FG002|Overall Study|Withdrawal by Subject|0|||
125078231|NCT04449276|449903935|FG003|Overall Study|Withdrawal by Subject|1|||
125078232|NCT04449276|449903936|FG004|Overall Study|Withdrawal by Subject|0|||
125078233|NCT04449276|449903937|FG005|Overall Study|Withdrawal by Subject|0|||
125078234|NCT04449276|449903938|FG006|Overall Study|Withdrawal by Subject|0|||
125078235|NCT04449276|449903939|FG007|Overall Study|Withdrawal by Subject|0|||
125078236|NCT04449276|449903932|FG000|Overall Study|Other|0|||
125078237|NCT04449276|449903933|FG001|Overall Study|Other|2|||
125078238|NCT04449276|449903934|FG002|Overall Study|Other|3|||
125078239|NCT04449276|449903935|FG003|Overall Study|Other|2|||
125078240|NCT04449276|449903936|FG004|Overall Study|Other|0|||
125078241|NCT04449276|449903937|FG005|Overall Study|Other|0|||
125078242|NCT04449276|449903938|FG006|Overall Study|Other|0|||
125078243|NCT04449276|449903939|FG007|Overall Study|Other|1|||
125078244|NCT01614795|449903940|FG000|Overall Study|Adverse Event|0|||
125078245|NCT01614795|449903941|FG001|Overall Study|Adverse Event|0|||
125078246|NCT01614795|449903942|FG002|Overall Study|Adverse Event|1|||
125078247|NCT01614795|449903943|FG003|Overall Study|Adverse Event|1|||
125078248|NCT01614795|449903940|FG000|Overall Study|Lack of Efficacy|10|||
125078249|NCT01614795|449903941|FG001|Overall Study|Lack of Efficacy|10|||
125078250|NCT01614795|449903942|FG002|Overall Study|Lack of Efficacy|9|||
125078251|NCT01614795|449903943|FG003|Overall Study|Lack of Efficacy|8|||
125078252|NCT01614795|449903940|FG000|Overall Study|Physician Decision|1|||
125078253|NCT01614795|449903941|FG001|Overall Study|Physician Decision|0|||
125078254|NCT01614795|449903942|FG002|Overall Study|Physician Decision|1|||
125078255|NCT01614795|449903943|FG003|Overall Study|Physician Decision|1|||
125078256|NCT01614795|449903940|FG000|Overall Study|Withdrawal by Subject|0|||
125078257|NCT01614795|449903941|FG001|Overall Study|Withdrawal by Subject|1|||
125078258|NCT01614795|449903942|FG002|Overall Study|Withdrawal by Subject|0|||
125078259|NCT01614795|449903943|FG003|Overall Study|Withdrawal by Subject|2|||
125078260|NCT01614795|449903940|FG000|Overall Study|Ineligible|0|||
125078261|NCT01614795|449903941|FG001|Overall Study|Ineligible|1|||
125078262|NCT01614795|449903942|FG002|Overall Study|Ineligible|0|||
125078263|NCT01614795|449903943|FG003|Overall Study|Ineligible|0|||
125078264|NCT00565812|449903944|FG000|Overall Study|Death|2|||
125144183|NCT00640926|450151465|FG002|Overall Study|Adverse Event|2|||
125078265|NCT00565812|449903945|FG001|Overall Study|Death|1|||
125078266|NCT00565812|449903946|FG002|Overall Study|Death|3|||
125078267|NCT00565812|449903944|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
125144184|NCT00640926|450151463|FG000|Overall Study|Lack of Efficacy|0|||
125078268|NCT00565812|449903945|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
125078269|NCT00565812|449903946|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
125078270|NCT00565812|449903944|FG000|Overall Study|Lost to Follow-up|10|||
125078271|NCT00565812|449903945|FG001|Overall Study|Lost to Follow-up|8|||
125078272|NCT00565812|449903946|FG002|Overall Study|Lost to Follow-up|8|||
125078273|NCT00565812|449903944|FG000|Overall Study|Withdrawal by Subject|58|||
125078274|NCT00565812|449903945|FG001|Overall Study|Withdrawal by Subject|47|||
125078275|NCT00565812|449903946|FG002|Overall Study|Withdrawal by Subject|48|||
125078276|NCT00565812|449903944|FG000|Overall Study|Work Schedule|5|||
125078277|NCT00565812|449903945|FG001|Overall Study|Work Schedule|3|||
125078278|NCT00565812|449903946|FG002|Overall Study|Work Schedule|1|||
125078279|NCT00565812|449903944|FG000|Overall Study|Protocol Violation|2|||
125078280|NCT00565812|449903945|FG001|Overall Study|Protocol Violation|6|||
125078281|NCT00565812|449903946|FG002|Overall Study|Protocol Violation|4|||
125078282|NCT00565812|449903944|FG000|Overall Study|Adverse Event|41|||
125078283|NCT00565812|449903945|FG001|Overall Study|Adverse Event|54|||
125078284|NCT00565812|449903946|FG002|Overall Study|Adverse Event|40|||
125078285|NCT00565812|449903944|FG000|Overall Study|Jury Duty|1|||
125078286|NCT00565812|449903945|FG001|Overall Study|Jury Duty|0|||
125078287|NCT00565812|449903946|FG002|Overall Study|Jury Duty|0|||
125078288|NCT00565812|449903944|FG000|Overall Study|Relocated Out of Area|5|||
125144185|NCT00640926|450151464|FG001|Overall Study|Lack of Efficacy|2|||
125144186|NCT00640926|450151465|FG002|Overall Study|Lack of Efficacy|1|||
125144187|NCT00640926|450151463|FG000|Overall Study|Protocol Violation|2|||
125144188|NCT00640926|450151464|FG001|Overall Study|Protocol Violation|0|||
125078289|NCT00565812|449903945|FG001|Overall Study|Relocated Out of Area|8|||
125078290|NCT00565812|449903946|FG002|Overall Study|Relocated Out of Area|9|||
125078291|NCT00565812|449903944|FG000|Overall Study|Sponsor Decision|1|||
125078292|NCT00565812|449903945|FG001|Overall Study|Sponsor Decision|5|||
125078293|NCT00565812|449903946|FG002|Overall Study|Sponsor Decision|1|||
125078294|NCT00565812|449903944|FG000|Overall Study|Domestic Reasons|7|||
125078295|NCT00565812|449903945|FG001|Overall Study|Domestic Reasons|1|||
125078296|NCT00565812|449903946|FG002|Overall Study|Domestic Reasons|3|||
125078297|NCT00565812|449903944|FG000|Overall Study|Research Site Closure|6|||
125078298|NCT00565812|449903945|FG001|Overall Study|Research Site Closure|1|||
125078299|NCT00565812|449903946|FG002|Overall Study|Research Site Closure|8|||
125078300|NCT00565812|449903944|FG000|Overall Study|Surgical Intervention|0|||
125078301|NCT00565812|449903945|FG001|Overall Study|Surgical Intervention|1|||
125078302|NCT00565812|449903946|FG002|Overall Study|Surgical Intervention|2|||
125078303|NCT00565812|449903944|FG000|Overall Study|Low Compliance|1|||
125078304|NCT00565812|449903945|FG001|Overall Study|Low Compliance|0|||
125078305|NCT00565812|449903946|FG002|Overall Study|Low Compliance|1|||
125078306|NCT00565812|449903944|FG000|Overall Study|Follow-up Visit Not Completed|2|||
125078307|NCT00565812|449903945|FG001|Overall Study|Follow-up Visit Not Completed|0|||
125078308|NCT00565812|449903946|FG002|Overall Study|Follow-up Visit Not Completed|1|||
125144189|NCT00640926|450151465|FG002|Overall Study|Protocol Violation|2|||
125144190|NCT00640926|450151463|FG000|Overall Study|Lost to Follow-up|3|||
125144191|NCT00640926|450151464|FG001|Overall Study|Lost to Follow-up|1|||
125144192|NCT00640926|450151465|FG002|Overall Study|Lost to Follow-up|2|||
125144193|NCT00640926|450151463|FG000|Overall Study|Withdrawal by Subject|1|||
125144194|NCT00640926|450151464|FG001|Overall Study|Withdrawal by Subject|0|||
125144195|NCT00640926|450151465|FG002|Overall Study|Withdrawal by Subject|1|||
125144196|NCT03922750|450151466|FG000|Overall Study|Unclassified|0|||
125223456|NCT02326272|450446175|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125078309|NCT00565812|449903944|FG000|Overall Study|Physician Decision|2|||
125078310|NCT00565812|449903945|FG001|Overall Study|Physician Decision|0|||
125144197|NCT03922750|450151467|FG001|Overall Study|Unclassified|0|||
125144198|NCT03922750|450151468|FG002|Overall Study|Unclassified|1|||
125144199|NCT03922750|450151466|FG000|Overall Study|Adverse Event|0|||
125144200|NCT03922750|450151467|FG001|Overall Study|Adverse Event|1|||
125078311|NCT00565812|449903946|FG002|Overall Study|Physician Decision|0|||
125078312|NCT04968353|449903947|FG000|Overall Study|Non-compliance|1|||
125078313|NCT04968353|449903948|FG001|Overall Study|Non-compliance|0|||
125078314|NCT04968353|449903949|FG002|Overall Study|Non-compliance|2|||
125078315|NCT04968353|449903950|FG003|Overall Study|Non-compliance|0|||
125078316|NCT00845845|449903951|FG000|Overall Study|Lost to Follow-up|0|||
125078317|NCT00845845|449903952|FG001|Overall Study|Lost to Follow-up|4|||
125078318|NCT02033850|449903957|FG000|Overall Study|Death|1|||
125078319|NCT02033850|449903958|FG001|Overall Study|Death|0|||
125078320|NCT02033850|449903957|FG000|Overall Study|unrelated medical reason|1|||
125078321|NCT02033850|449903958|FG001|Overall Study|unrelated medical reason|1|||
125078322|NCT02820038|449903959|FG000|Overall Study|Lost to Follow-up|7|||
125078323|NCT02820038|449903960|FG001|Overall Study|Lost to Follow-up|11|||
125078324|NCT02820038|449903961|FG002|Overall Study|Lost to Follow-up|2|||
125078325|NCT02820038|449903962|FG003|Overall Study|Lost to Follow-up|9|||
125078326|NCT02820038|449903959|FG000|Overall Study|Withdrawal by Subject|3|||
125078327|NCT02820038|449903960|FG001|Overall Study|Withdrawal by Subject|14|||
125078328|NCT02820038|449903961|FG002|Overall Study|Withdrawal by Subject|3|||
125078329|NCT02820038|449903962|FG003|Overall Study|Withdrawal by Subject|13|||
125078330|NCT03148795|449903965|FG000|Overall Study|Progressive Disease|1|||
125078331|NCT00251589|449903971|FG000|Overall Study|Adverse Event|5|||
125078332|NCT00251589|449903972|FG001|Overall Study|Adverse Event|1|||
125078333|NCT00251589|449903973|FG002|Overall Study|Adverse Event|2|||
125078334|NCT00251589|449903974|FG003|Overall Study|Adverse Event|1|||
125078335|NCT00251589|449903971|FG000|Overall Study|Withdrawal by Subject|1|||
125078336|NCT00251589|449903972|FG001|Overall Study|Withdrawal by Subject|1|||
125078337|NCT00251589|449903973|FG002|Overall Study|Withdrawal by Subject|0|||
125078338|NCT00251589|449903974|FG003|Overall Study|Withdrawal by Subject|0|||
125078339|NCT00251589|449903971|FG000|Overall Study|Discontinued due to progressive disease|9|||
125078340|NCT00251589|449903972|FG001|Overall Study|Discontinued due to progressive disease|1|||
125078341|NCT00251589|449903973|FG002|Overall Study|Discontinued due to progressive disease|0|||
125078342|NCT00251589|449903974|FG003|Overall Study|Discontinued due to progressive disease|1|||
125078343|NCT02571972|449903977|FG000|Overall Study|Protocol Violation|2|||
125078344|NCT02571972|449903977|FG000|Overall Study|Withdrawal by Subject|2|||
125078345|NCT03039192|449903978|FG000|Overall Study|Lost to Follow-up|4|||
125078346|NCT03039192|449903979|FG001|Overall Study|Lost to Follow-up|4|||
125078347|NCT03039192|449903978|FG000|Overall Study|Adverse event, serious fatal|0|||
125078348|NCT03039192|449903979|FG001|Overall Study|Adverse event, serious fatal|1|||
125078349|NCT03039192|449903978|FG000|Overall Study|Adverse event, non-fatal|0|||
125078350|NCT03039192|449903979|FG001|Overall Study|Adverse event, non-fatal|2|||
125078351|NCT03039192|449903978|FG000|Overall Study|Withdrawal by Subject|6|||
125078352|NCT03039192|449903979|FG001|Overall Study|Withdrawal by Subject|9|||
125078353|NCT03039192|449903978|FG000|Overall Study|Discontinued from treatment phase|19|||
125078354|NCT03039192|449903979|FG001|Overall Study|Discontinued from treatment phase|12|||
125078355|NCT03039192|449903978|FG000|Overall Study|Other|3|||
125078356|NCT03039192|449903979|FG001|Overall Study|Other|2|||
125078357|NCT02493868|449903980|FG000|Induction Phase: DE Participants|Adverse Event|22|||
125078358|NCT02493868|449903981|FG001|Induction Phase: DE Participants|Adverse Event|0|||
125078359|NCT02493868|449903980|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
125078360|NCT02493868|449903981|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
125078361|NCT02493868|449903980|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
125078362|NCT02493868|449903981|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
125078363|NCT02493868|449903980|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
125078364|NCT02493868|449903981|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
125078365|NCT02493868|449903980|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
125078366|NCT02493868|449903981|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
125078367|NCT02493868|449903980|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
125078368|NCT02493868|449903981|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
125078369|NCT02493868|449903980|FG000|Induction Phase: DE Participants|Other|8|||
125078370|NCT02493868|449903981|FG001|Induction Phase: DE Participants|Other|0|||
125078371|NCT02493868|449903980|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
125078372|NCT02493868|449903981|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
125078373|NCT02493868|449903980|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
125078374|NCT02493868|449903981|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
125078375|NCT02493868|449903980|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
125078376|NCT02493868|449903981|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
125078377|NCT02493868|449903980|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
125078378|NCT02493868|449903981|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
125078379|NCT02493868|449903980|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
125078380|NCT02493868|449903981|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
125078381|NCT02493868|449903980|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
125078382|NCT02493868|449903981|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
125078383|NCT02493868|449903980|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
125078384|NCT02493868|449903981|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
125078385|NCT02493868|449903980|FG000|Optimization Phase: DE+TE Participants|Other|10|||
125078386|NCT02493868|449903981|FG001|Optimization Phase: DE+TE Participants|Other|2|||
125078387|NCT02493868|449903980|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
125144201|NCT03922750|450151468|FG002|Overall Study|Adverse Event|0|||
125078388|NCT02493868|449903981|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
125078389|NCT02493868|449903980|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
125078390|NCT02493868|449903981|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
125078391|NCT02493868|449903980|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
125078392|NCT02493868|449903981|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
125078393|NCT02493868|449903980|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
125078394|NCT02493868|449903981|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
125078395|NCT02493868|449903980|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
125078396|NCT02493868|449903981|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
125078397|NCT02493868|449903980|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
125078398|NCT02493868|449903981|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
125078399|NCT02493868|449903980|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
125078400|NCT02493868|449903981|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
125078401|NCT02493868|449903980|FG000|Follow-up Phase|Lost to Follow-up|1|||
125078402|NCT02493868|449903981|FG001|Follow-up Phase|Lost to Follow-up|0|||
125078403|NCT02493868|449903980|FG000|Follow-up Phase|Withdrawal by Subject|3|||
125078404|NCT02493868|449903981|FG001|Follow-up Phase|Withdrawal by Subject|0|||
125078405|NCT02493868|449903980|FG000|Follow-up Phase|Investigator Decision|5|||
125078406|NCT02493868|449903981|FG001|Follow-up Phase|Investigator Decision|1|||
125078407|NCT02493868|449903980|FG000|Follow-up Phase|Other|2|||
125078408|NCT02493868|449903981|FG001|Follow-up Phase|Other|1|||
125078409|NCT02407236|449903982|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
125078410|NCT02407236|449903983|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
125078411|NCT02407236|449903984|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
125078412|NCT02407236|449903985|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
125078413|NCT02407236|449903986|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
125078414|NCT02407236|449903987|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
125078415|NCT02407236|449903988|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
125078416|NCT02407236|449903989|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
125078417|NCT02407236|449903990|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
125078418|NCT02407236|449903991|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
125078419|NCT02407236|449903992|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
125078420|NCT02407236|449903993|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
125078421|NCT02407236|449903994|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
125078422|NCT02407236|449903982|FG000|Induction Study (8 Weeks)|Death|0|||
125078423|NCT02407236|449903983|FG001|Induction Study (8 Weeks)|Death|0|||
125078424|NCT02407236|449903984|FG002|Induction Study (8 Weeks)|Death|1|||
125078425|NCT02407236|449903985|FG003|Induction Study (8 Weeks)|Death|0|||
125078426|NCT02407236|449903986|FG004|Induction Study (8 Weeks)|Death|0|||
125078427|NCT02407236|449903987|FG005|Induction Study (8 Weeks)|Death|0|||
125078428|NCT02407236|449903988|FG006|Induction Study (8 Weeks)|Death|0|||
125078429|NCT02407236|449903989|FG007|Induction Study (8 Weeks)|Death|0|||
125078430|NCT02407236|449903990|FG008|Induction Study (8 Weeks)|Death|0|||
125078431|NCT02407236|449903991|FG009|Induction Study (8 Weeks)|Death|0|||
125078432|NCT02407236|449903992|FG010|Induction Study (8 Weeks)|Death|0|||
125078433|NCT02407236|449903993|FG011|Induction Study (8 Weeks)|Death|0|||
125078434|NCT02407236|449903994|FG012|Induction Study (8 Weeks)|Death|0|||
125078435|NCT02407236|449903982|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
125078436|NCT02407236|449903983|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
125078437|NCT02407236|449903984|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
125078438|NCT02407236|449903985|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
125078439|NCT02407236|449903986|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
125078440|NCT02407236|449903987|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
125078441|NCT02407236|449903988|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
125078442|NCT02407236|449903989|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
125078443|NCT02407236|449903990|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
125078444|NCT02407236|449903991|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
125078445|NCT02407236|449903992|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
125078446|NCT02407236|449903993|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
125078447|NCT02407236|449903994|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
125078448|NCT02407236|449903982|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125078449|NCT02407236|449903983|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125078450|NCT02407236|449903984|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
125078451|NCT02407236|449903985|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125078452|NCT02407236|449903986|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125078453|NCT02407236|449903987|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125078454|NCT02407236|449903988|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125078455|NCT02407236|449903989|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125078456|NCT02407236|449903990|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125078457|NCT02407236|449903991|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125078458|NCT02407236|449903992|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125078459|NCT02407236|449903993|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125078460|NCT02407236|449903994|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125078461|NCT02407236|449903982|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
125078462|NCT02407236|449903983|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
125078463|NCT02407236|449903984|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
125078464|NCT02407236|449903985|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
125078465|NCT02407236|449903986|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
125078466|NCT02407236|449903987|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
125078467|NCT02407236|449903988|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
125078468|NCT02407236|449903989|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
125078469|NCT02407236|449903990|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
125078470|NCT02407236|449903991|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
125078471|NCT02407236|449903992|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
125078472|NCT02407236|449903993|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
125078473|NCT02407236|449903994|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
125078474|NCT02407236|449903982|FG000|Induction Study (8 Weeks)|Other|2|||
125078475|NCT02407236|449903983|FG001|Induction Study (8 Weeks)|Other|1|||
125078476|NCT02407236|449903984|FG002|Induction Study (8 Weeks)|Other|5|||
125078477|NCT02407236|449903985|FG003|Induction Study (8 Weeks)|Other|0|||
125078478|NCT02407236|449903986|FG004|Induction Study (8 Weeks)|Other|0|||
125078479|NCT02407236|449903987|FG005|Induction Study (8 Weeks)|Other|0|||
125078480|NCT02407236|449903988|FG006|Induction Study (8 Weeks)|Other|0|||
125078481|NCT02407236|449903989|FG007|Induction Study (8 Weeks)|Other|0|||
125078482|NCT02407236|449903990|FG008|Induction Study (8 Weeks)|Other|0|||
125078483|NCT02407236|449903991|FG009|Induction Study (8 Weeks)|Other|0|||
125078484|NCT02407236|449903992|FG010|Induction Study (8 Weeks)|Other|0|||
125078485|NCT02407236|449903993|FG011|Induction Study (8 Weeks)|Other|0|||
125078486|NCT02407236|449903994|FG012|Induction Study (8 Weeks)|Other|0|||
125078487|NCT02407236|449903982|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
125078488|NCT02407236|449903983|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
125078489|NCT02407236|449903984|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
125078490|NCT02407236|449903985|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
125078491|NCT02407236|449903986|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
125078492|NCT02407236|449903987|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
125078493|NCT02407236|449903988|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
125078494|NCT02407236|449903989|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
125078495|NCT02407236|449903990|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
125078496|NCT02407236|449903991|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
125078497|NCT02407236|449903992|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
125078498|NCT02407236|449903993|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
125078499|NCT02407236|449903994|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
125078500|NCT02407236|449903982|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
125078501|NCT02407236|449903983|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
125078502|NCT02407236|449903984|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
125078503|NCT02407236|449903985|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
125078504|NCT02407236|449903986|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
125078505|NCT02407236|449903987|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
125078506|NCT02407236|449903988|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
125078507|NCT02407236|449903989|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
125078508|NCT02407236|449903990|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
125078509|NCT02407236|449903991|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
125078510|NCT02407236|449903992|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
125078511|NCT02407236|449903993|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
125078512|NCT02407236|449903994|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
125078513|NCT02407236|449903982|FG000|Maintenance Study (44 Weeks)|Other|0|||
125078514|NCT02407236|449903983|FG001|Maintenance Study (44 Weeks)|Other|0|||
125078515|NCT02407236|449903984|FG002|Maintenance Study (44 Weeks)|Other|0|||
125078516|NCT02407236|449903985|FG003|Maintenance Study (44 Weeks)|Other|5|||
125078517|NCT02407236|449903986|FG004|Maintenance Study (44 Weeks)|Other|7|||
125078518|NCT02407236|449903987|FG005|Maintenance Study (44 Weeks)|Other|8|||
125078519|NCT02407236|449903988|FG006|Maintenance Study (44 Weeks)|Other|4|||
125078520|NCT02407236|449903989|FG007|Maintenance Study (44 Weeks)|Other|6|||
125078521|NCT02407236|449903990|FG008|Maintenance Study (44 Weeks)|Other|0|||
125078522|NCT02407236|449903991|FG009|Maintenance Study (44 Weeks)|Other|0|||
125078523|NCT02407236|449903992|FG010|Maintenance Study (44 Weeks)|Other|0|||
125078524|NCT02407236|449903993|FG011|Maintenance Study (44 Weeks)|Other|0|||
125078525|NCT02407236|449903994|FG012|Maintenance Study (44 Weeks)|Other|0|||
125078526|NCT02407236|449903982|FG000|Maintenance Study (44 Weeks)|Death|0|||
125078527|NCT02407236|449903983|FG001|Maintenance Study (44 Weeks)|Death|0|||
125078528|NCT02407236|449903984|FG002|Maintenance Study (44 Weeks)|Death|0|||
125144202|NCT02985398|450151469|FG000|Overall Study|Adverse Event|1|||
125078529|NCT02407236|449903985|FG003|Maintenance Study (44 Weeks)|Death|0|||
125078530|NCT02407236|449903986|FG004|Maintenance Study (44 Weeks)|Death|0|||
125078531|NCT02407236|449903987|FG005|Maintenance Study (44 Weeks)|Death|0|||
125078532|NCT02407236|449903988|FG006|Maintenance Study (44 Weeks)|Death|0|||
125078533|NCT02407236|449903989|FG007|Maintenance Study (44 Weeks)|Death|1|||
125078534|NCT02407236|449903990|FG008|Maintenance Study (44 Weeks)|Death|0|||
125078535|NCT02407236|449903991|FG009|Maintenance Study (44 Weeks)|Death|0|||
125078536|NCT02407236|449903992|FG010|Maintenance Study (44 Weeks)|Death|0|||
125078537|NCT02407236|449903993|FG011|Maintenance Study (44 Weeks)|Death|0|||
125078538|NCT02407236|449903994|FG012|Maintenance Study (44 Weeks)|Death|0|||
125078539|NCT02407236|449903982|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
125078540|NCT02407236|449903983|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
125078541|NCT02407236|449903984|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
125078542|NCT02407236|449903985|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
125078543|NCT02407236|449903986|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
125078544|NCT02407236|449903987|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
125078545|NCT02407236|449903988|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
125078546|NCT02407236|449903989|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
125078547|NCT02407236|449903990|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
125078548|NCT02407236|449903991|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
125078549|NCT02407236|449903992|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
125078550|NCT02407236|449903993|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
125078551|NCT02407236|449903994|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
125078552|NCT02407236|449903982|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125078553|NCT02407236|449903983|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125078554|NCT02407236|449903984|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125078555|NCT02407236|449903985|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125078556|NCT02407236|449903986|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125078557|NCT02407236|449903987|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125078558|NCT02407236|449903988|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125078559|NCT02407236|449903989|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125078560|NCT02407236|449903990|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125078561|NCT02407236|449903991|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125078562|NCT02407236|449903992|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
125078563|NCT02407236|449903993|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125078564|NCT02407236|449903994|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125078565|NCT02407236|449903982|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
125078566|NCT02407236|449903983|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
125078567|NCT02407236|449903984|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
125078568|NCT02407236|449903985|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
125078569|NCT02407236|449903986|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
125078570|NCT02407236|449903987|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
125078571|NCT02407236|449903988|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
125078572|NCT02407236|449903989|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
125078573|NCT02407236|449903990|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
125078574|NCT02407236|449903991|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
125078575|NCT02407236|449903992|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
125078576|NCT02407236|449903993|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
125078577|NCT02407236|449903994|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
125078578|NCT02407236|449903982|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
125078579|NCT02407236|449903983|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
125078580|NCT02407236|449903984|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
125078581|NCT02407236|449903985|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
125078582|NCT02407236|449903986|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
125078583|NCT02407236|449903987|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
125078584|NCT02407236|449903988|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
125078585|NCT02407236|449903989|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
125078586|NCT02407236|449903990|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
125078587|NCT02407236|449903991|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
125078588|NCT02407236|449903992|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
125078589|NCT02407236|449903993|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
125078590|NCT02407236|449903994|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
125078591|NCT03074318|449903995|FG000|Overall Study|Adverse Event|0|||
125078592|NCT03074318|449903996|FG001|Overall Study|Adverse Event|1|||
125078593|NCT03074318|449903997|FG002|Overall Study|Adverse Event|1|||
125078594|NCT03074318|449903998|FG003|Overall Study|Adverse Event|1|||
125078595|NCT03074318|449903995|FG000|Overall Study|Death|1|||
125078596|NCT03074318|449903996|FG001|Overall Study|Death|0|||
125078597|NCT03074318|449903997|FG002|Overall Study|Death|0|||
125078598|NCT03074318|449903998|FG003|Overall Study|Death|0|||
125078599|NCT03074318|449903995|FG000|Overall Study|Withdrawal by Subject|1|||
125078600|NCT03074318|449903996|FG001|Overall Study|Withdrawal by Subject|2|||
125144203|NCT02985398|450151469|FG000|Overall Study|Lost to Follow-up|4|||
125078601|NCT03074318|449903997|FG002|Overall Study|Withdrawal by Subject|2|||
125078602|NCT03074318|449903998|FG003|Overall Study|Withdrawal by Subject|4|||
125078603|NCT03074318|449903995|FG000|Overall Study|Trial Closure|2|||
125078604|NCT03074318|449903996|FG001|Overall Study|Trial Closure|2|||
125078605|NCT03074318|449903997|FG002|Overall Study|Trial Closure|3|||
125078606|NCT03074318|449903998|FG003|Overall Study|Trial Closure|11|||
125078607|NCT00643448|449904002|FG000|Overall Study|Lack of Efficacy|2|||
125078608|NCT00643448|449904003|FG001|Overall Study|Lack of Efficacy|0|||
125078609|NCT00643448|449904004|FG002|Overall Study|Lack of Efficacy|4|||
125078610|NCT00643448|449904002|FG000|Overall Study|Adverse Event|2|||
125078611|NCT00643448|449904003|FG001|Overall Study|Adverse Event|2|||
125078612|NCT00643448|449904004|FG002|Overall Study|Adverse Event|2|||
125078613|NCT00643448|449904002|FG000|Overall Study|QTcF>550 ms|0|||
125078614|NCT00643448|449904003|FG001|Overall Study|QTcF>550 ms|3|||
125078615|NCT00643448|449904004|FG002|Overall Study|QTcF>550 ms|0|||
125078616|NCT02177812|449904005|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
125078617|NCT02177812|449904006|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
125078618|NCT02177812|449904007|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
125078619|NCT02177812|449904008|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
125078620|NCT02177812|449904009|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
125078621|NCT02177812|449904010|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
125078622|NCT02177812|449904011|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
125078623|NCT02177812|449904012|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
125078624|NCT02177812|449904013|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
125078625|NCT02177812|449904005|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
125078626|NCT02177812|449904006|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
125078627|NCT02177812|449904007|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
125078628|NCT02177812|449904008|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
125078629|NCT02177812|449904009|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
125078630|NCT02177812|449904010|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
125078631|NCT02177812|449904011|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
125078632|NCT02177812|449904012|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
125078633|NCT02177812|449904013|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
125078634|NCT02177812|449904005|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
125078635|NCT02177812|449904006|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
125078636|NCT02177812|449904007|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
125078637|NCT02177812|449904008|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
125078638|NCT02177812|449904009|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
125078639|NCT02177812|449904010|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
125078640|NCT02177812|449904011|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
125078641|NCT02177812|449904012|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
125078642|NCT02177812|449904013|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
125078643|NCT00089999|449904014|FG000|Overall Study|Adverse Event|4|||
125078644|NCT00089999|449904015|FG001|Overall Study|Adverse Event|7|||
125078645|NCT00089999|449904014|FG000|Overall Study|Withdrawal by Subject|0|||
125078646|NCT00089999|449904015|FG001|Overall Study|Withdrawal by Subject|4|||
125078647|NCT00089999|449904014|FG000|Overall Study|Lost to Follow-up|2|||
125078648|NCT00089999|449904015|FG001|Overall Study|Lost to Follow-up|1|||
125078649|NCT00089999|449904014|FG000|Overall Study|Radiological Progression of Cancer|52|||
125078650|NCT00089999|449904015|FG001|Overall Study|Radiological Progression of Cancer|44|||
125078651|NCT00089999|449904014|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
125078652|NCT00089999|449904015|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
125078653|NCT00089999|449904014|FG000|Overall Study|Death|3|||
125078654|NCT00089999|449904015|FG001|Overall Study|Death|3|||
125078655|NCT00089999|449904014|FG000|Overall Study|Poor General Condition|1|||
125078656|NCT00089999|449904015|FG001|Overall Study|Poor General Condition|0|||
125078657|NCT00089999|449904014|FG000|Overall Study|Clinical Progression|1|||
125078658|NCT00089999|449904015|FG001|Overall Study|Clinical Progression|2|||
125078659|NCT00089999|449904014|FG000|Overall Study|Physician Decision|2|||
125078660|NCT00089999|449904015|FG001|Overall Study|Physician Decision|2|||
125078661|NCT00089999|449904014|FG000|Overall Study|Patient Underwent Surgery|2|||
125078662|NCT00089999|449904015|FG001|Overall Study|Patient Underwent Surgery|0|||
125078663|NCT00089999|449904014|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
125078664|NCT00089999|449904015|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
125078665|NCT01167153|449904016|FG000|Overall Study|Non-effective therapy|1|||
125078666|NCT01167153|449904017|FG001|Overall Study|Non-effective therapy|4|||
125078667|NCT01167153|449904016|FG000|Overall Study|AE including clinical laboratory AE|2|||
125078668|NCT01167153|449904017|FG001|Overall Study|AE including clinical laboratory AE|8|||
125078669|NCT01167153|449904016|FG000|Overall Study|Hypotension|1|||
125078670|NCT01167153|449904017|FG001|Overall Study|Hypotension|0|||
125078671|NCT01167153|449904016|FG000|Overall Study|Lost to Follow-up|7|||
125078672|NCT01167153|449904017|FG001|Overall Study|Lost to Follow-up|9|||
125078673|NCT01167153|449904016|FG000|Overall Study|Non-compliance to concomitant medication|0|||
125078674|NCT01167153|449904017|FG001|Overall Study|Non-compliance to concomitant medication|2|||
125078675|NCT01167153|449904016|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
125078676|NCT01167153|449904017|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
125078677|NCT01167153|449904016|FG000|Overall Study|Withdrawal consent|1|||
125078678|NCT01167153|449904017|FG001|Overall Study|Withdrawal consent|1|||
125078679|NCT01167153|449904016|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
125078680|NCT01167153|449904017|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
125078681|NCT05166603|449904020|FG000|Overall Study|Withdrawal by Subject|68|||
125078682|NCT05166603|449904021|FG001|Overall Study|Withdrawal by Subject|0|||
125078683|NCT04402385|449905630|FG000|Overall Study|Withdrawal by Subject|4|||
125078684|NCT04402385|449905631|FG001|Overall Study|Withdrawal by Subject|4|||
125078685|NCT04402385|449905630|FG000|Overall Study|Lost to Follow-up|1|||
125078686|NCT04402385|449905631|FG001|Overall Study|Lost to Follow-up|1|||
125078687|NCT04402385|449905630|FG000|Overall Study|Physician Decision|0|||
125078688|NCT04402385|449905631|FG001|Overall Study|Physician Decision|1|||
125078689|NCT01308853|449905637|FG000|Overall Study|Adverse Event|1|||
125078690|NCT01308853|449905637|FG000|Overall Study|Lost to Follow-up|2|||
125078691|NCT01308853|449905637|FG000|Overall Study|Insertion of permanent implants|1|||
125078692|NCT04984876|449905640|FG000|Overall Study|Subject decision|2|||
125078693|NCT04984876|449905641|FG001|Overall Study|Subject decision|10|||
125078694|NCT04984876|449905642|FG002|Overall Study|Subject decision|3|||
125078695|NCT04984876|449905643|FG003|Overall Study|Subject decision|3|||
125078696|NCT04984876|449905644|FG004|Overall Study|Subject decision|3|||
125078697|NCT04984876|449905645|FG005|Overall Study|Subject decision|0|||
125078698|NCT04984876|449905640|FG000|Overall Study|Guardian decision|0|||
125078699|NCT04984876|449905641|FG001|Overall Study|Guardian decision|1|||
125078700|NCT04984876|449905642|FG002|Overall Study|Guardian decision|0|||
125078701|NCT04984876|449905643|FG003|Overall Study|Guardian decision|2|||
125078702|NCT04984876|449905644|FG004|Overall Study|Guardian decision|0|||
125078703|NCT04984876|449905645|FG005|Overall Study|Guardian decision|1|||
125078704|NCT04984876|449905640|FG000|Overall Study|Lost to Follow-up|0|||
125223457|NCT02326272|450446176|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125223458|NCT02326272|450446177|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125078705|NCT04984876|449905641|FG001|Overall Study|Lost to Follow-up|0|||
125078706|NCT04984876|449905642|FG002|Overall Study|Lost to Follow-up|1|||
125078707|NCT04984876|449905643|FG003|Overall Study|Lost to Follow-up|1|||
125078708|NCT04984876|449905644|FG004|Overall Study|Lost to Follow-up|0|||
125078709|NCT04984876|449905645|FG005|Overall Study|Lost to Follow-up|0|||
125078710|NCT04984876|449905640|FG000|Overall Study|Physician Decision|1|||
125078711|NCT04984876|449905641|FG001|Overall Study|Physician Decision|0|||
125078712|NCT04984876|449905642|FG002|Overall Study|Physician Decision|0|||
125078713|NCT04984876|449905643|FG003|Overall Study|Physician Decision|1|||
125078714|NCT04984876|449905644|FG004|Overall Study|Physician Decision|0|||
125078715|NCT04984876|449905645|FG005|Overall Study|Physician Decision|0|||
125078716|NCT04984876|449905640|FG000|Overall Study|Adverse Event|0|||
125078717|NCT04984876|449905641|FG001|Overall Study|Adverse Event|0|||
125078718|NCT04984876|449905642|FG002|Overall Study|Adverse Event|1|||
125078719|NCT04984876|449905643|FG003|Overall Study|Adverse Event|0|||
125078720|NCT04984876|449905644|FG004|Overall Study|Adverse Event|0|||
125078721|NCT04984876|449905645|FG005|Overall Study|Adverse Event|0|||
125078722|NCT00209092|449905648|FG000|Overall Study|Progression of disease|7|||
125078723|NCT00209092|449905649|FG001|Overall Study|Progression of disease|1|||
125078724|NCT00209092|449905648|FG000|Overall Study|Adverse Event|0|||
125078725|NCT00209092|449905649|FG001|Overall Study|Adverse Event|1|||
125078726|NCT00209092|449905648|FG000|Overall Study|Withdrawal by Subject|1|||
125078727|NCT00209092|449905649|FG001|Overall Study|Withdrawal by Subject|0|||
125078728|NCT01462045|449905650|FG000|Overall Study|Family matter|0|||
125078729|NCT01462045|449905651|FG001|Overall Study|Family matter|1|||
125078730|NCT01462045|449905652|FG002|Overall Study|Family matter|0|||
125078731|NCT02828644|449905657|FG000|Overall Study|Lost to Follow-up|23|||
125078732|NCT02828644|449905658|FG001|Overall Study|Lost to Follow-up|22|||
125078733|NCT02436915|449905661|FG000|Overall Study|Withdrawal by Subject|0|||
125078734|NCT02436915|449905662|FG001|Overall Study|Withdrawal by Subject|1|||
125078735|NCT01117181|449905669|FG000|Overall Study|Lost to Follow-up|1|||
125078736|NCT01117181|449905670|FG001|Overall Study|Lost to Follow-up|0|||
125078737|NCT01117181|449905669|FG000|Overall Study|Withdrawal by Subject|0|||
125078738|NCT01117181|449905670|FG001|Overall Study|Withdrawal by Subject|2|||
125078739|NCT02158728|449905671|FG000|Overall Study|no procedure according to CIP done|3|||
125078740|NCT02158728|449905671|FG000|Overall Study|no qualified dataset|24|||
125078741|NCT00863317|449905672|FG000|Overall Study|Lost to Follow-up|8|||
125078742|NCT00863317|449905673|FG001|Overall Study|Lost to Follow-up|9|||
125078743|NCT03878160|449905674|FG000|Overall Study|Lost to Follow-up|1|||
125078744|NCT03878160|449905675|FG001|Overall Study|Lost to Follow-up|1|||
125078745|NCT03878160|449905676|FG002|Overall Study|Lost to Follow-up|1|||
125078746|NCT03878160|449905674|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
125078747|NCT03878160|449905675|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
125078748|NCT03878160|449905676|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
125078749|NCT00809614|449905683|FG000|Overall Study|Lack of Efficacy|2|||
125078750|NCT00809614|449905684|FG001|Overall Study|Lack of Efficacy|3|||
125078751|NCT00809614|449905683|FG000|Overall Study|Withdrawal by Subject|1|||
125078752|NCT00809614|449905684|FG001|Overall Study|Withdrawal by Subject|1|||
125078753|NCT01080625|449905685|FG000|Overall Study|Physician Decision|0|||
125078754|NCT01080625|449905686|FG001|Overall Study|Physician Decision|2|||
125078755|NCT01080625|449905687|FG002|Overall Study|Physician Decision|1|||
125078756|NCT00364832|449905691|FG000|Core Period|Early Withdrawals|2|||
125078757|NCT00364832|449905692|FG001|Core Period|Early Withdrawals|2|||
125078758|NCT00364832|449905693|FG002|Core Period|Early Withdrawals|1|||
125078759|NCT00364832|449905694|FG003|Core Period|Early Withdrawals|1|||
125078760|NCT00364832|449905695|FG004|Core Period|Early Withdrawals|0|||
125078761|NCT00364832|449905696|FG005|Core Period|Early Withdrawals|0|||
125078762|NCT00364832|449905697|FG006|Core Period|Early Withdrawals|4|||
125078763|NCT00364832|449905698|FG007|Core Period|Early Withdrawals|1|||
125078764|NCT00364832|449905699|FG008|Core Period|Early Withdrawals|0|||
125078765|NCT00364832|449905700|FG009|Core Period|Early Withdrawals|0|||
125078766|NCT00364832|449905701|FG010|Core Period|Early Withdrawals|0|||
125078767|NCT00364832|449905702|FG011|Core Period|Early Withdrawals|0|||
125078768|NCT00364832|449905691|FG000|Extension Year 1|Early Withdrawals|0|||
125078769|NCT00364832|449905692|FG001|Extension Year 1|Early Withdrawals|0|||
125078770|NCT00364832|449905693|FG002|Extension Year 1|Early Withdrawals|0|||
125078771|NCT00364832|449905694|FG003|Extension Year 1|Early Withdrawals|0|||
125078772|NCT00364832|449905695|FG004|Extension Year 1|Early Withdrawals|0|||
125078773|NCT00364832|449905696|FG005|Extension Year 1|Early Withdrawals|0|||
125078774|NCT00364832|449905697|FG006|Extension Year 1|Early Withdrawals|0|||
125078775|NCT00364832|449905698|FG007|Extension Year 1|Early Withdrawals|0|||
125078776|NCT00364832|449905699|FG008|Extension Year 1|Early Withdrawals|0|||
125078777|NCT00364832|449905700|FG009|Extension Year 1|Early Withdrawals|4|||
125078778|NCT00364832|449905701|FG010|Extension Year 1|Early Withdrawals|2|||
125078779|NCT00364832|449905702|FG011|Extension Year 1|Early Withdrawals|10|||
125078780|NCT00364832|449905691|FG000|Extension Year 2|Early Withdrawals|0|||
125078781|NCT00364832|449905692|FG001|Extension Year 2|Early Withdrawals|0|||
125078782|NCT00364832|449905693|FG002|Extension Year 2|Early Withdrawals|0|||
125078783|NCT00364832|449905694|FG003|Extension Year 2|Early Withdrawals|0|||
125078784|NCT00364832|449905695|FG004|Extension Year 2|Early Withdrawals|0|||
125078785|NCT00364832|449905696|FG005|Extension Year 2|Early Withdrawals|0|||
125078786|NCT00364832|449905697|FG006|Extension Year 2|Early Withdrawals|0|||
125078787|NCT00364832|449905698|FG007|Extension Year 2|Early Withdrawals|0|||
125078788|NCT00364832|449905699|FG008|Extension Year 2|Early Withdrawals|0|||
125078789|NCT00364832|449905700|FG009|Extension Year 2|Early Withdrawals|5|||
125078790|NCT00364832|449905701|FG010|Extension Year 2|Early Withdrawals|5|||
125078791|NCT00364832|449905702|FG011|Extension Year 2|Early Withdrawals|3|||
125078792|NCT02658149|449905706|FG000|Overall Study|Physician Decision|1|||
125078793|NCT02658149|449905707|FG001|Overall Study|Physician Decision|0|||
125078794|NCT01804842|449905713|FG000|Overall Study|Adverse Event|1|||
125078795|NCT01804842|449905714|FG001|Overall Study|Adverse Event|1|||
125078796|NCT01804842|449905715|FG002|Overall Study|Adverse Event|0|||
125078797|NCT01804842|449905713|FG000|Overall Study|Lost to Follow-up|1|||
125078798|NCT01804842|449905714|FG001|Overall Study|Lost to Follow-up|0|||
125078799|NCT01804842|449905715|FG002|Overall Study|Lost to Follow-up|0|||
125078800|NCT01804842|449905713|FG000|Overall Study|Non-Compliance|1|||
125078801|NCT01804842|449905714|FG001|Overall Study|Non-Compliance|1|||
125078802|NCT01804842|449905715|FG002|Overall Study|Non-Compliance|0|||
125078803|NCT01804842|449905713|FG000|Overall Study|Personal Reason|0|||
125078804|NCT01804842|449905714|FG001|Overall Study|Personal Reason|0|||
125078805|NCT01804842|449905715|FG002|Overall Study|Personal Reason|1|||
125078806|NCT01440972|449905716|FG000|Overall Study|Withdrawal by Subject|3|||
125078807|NCT01440972|449905717|FG001|Overall Study|Withdrawal by Subject|2|||
125078808|NCT03933215|449905718|FG000|Overall Study|Other|6|||
125078809|NCT03933215|449905718|FG000|Overall Study|Sponsor decision|5|||
125078810|NCT03933215|449905718|FG000|Overall Study|Protocol Violation|5|||
125078811|NCT03933215|449905718|FG000|Overall Study|Withdrawal by Subject|6|||
125078812|NCT03933215|449905718|FG000|Overall Study|Lost to Follow-up|6|||
125078813|NCT03933215|449905718|FG000|Overall Study|Enrolled but not treated|38|||
125078814|NCT04222673|449905719|FG000|Overall Study|Lost to Follow-up|5|||
125078815|NCT04097028|449905720|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
125078816|NCT04097028|449905720|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
125078817|NCT04097028|449905720|FG000|Overall Study|Disease Progression prior to Surgery|2|||
125078818|NCT04097028|449905720|FG000|Overall Study|Adverse Event prior to Surgery|1|||
125078819|NCT00068822|449905721|FG000|First Randomized Intervention|Lost to Follow-up|1|||
125078820|NCT00068822|449905722|FG001|First Randomized Intervention|Lost to Follow-up|2|||
125078821|NCT00735072|449905726|FG000|Overall Study|interrupted study med during ARV change|1|||
125078822|NCT00735072|449905727|FG001|Overall Study|interrupted study med during ARV change|0|||
125078823|NCT00735072|449905726|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
125078824|NCT00735072|449905727|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
125078825|NCT00911144|449905728|FG000|Overall Study|Withdrawal by Subject|16|||
125078826|NCT00911144|449905729|FG001|Overall Study|Withdrawal by Subject|5|||
125078827|NCT03981744|449905730|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
125078828|NCT03981744|449905731|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
125078829|NCT03981744|449905732|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
125078830|NCT03981744|449905733|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
125078831|NCT03981744|449905730|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
125078832|NCT03981744|449905731|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
125078833|NCT03981744|449905732|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
125078834|NCT03981744|449905733|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
125078835|NCT03981744|449905730|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
125078836|NCT03981744|449905731|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
125078837|NCT03981744|449905732|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
125078838|NCT03981744|449905733|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
125078839|NCT00732238|449905734|FG000|Overall Study|Bacteremia|4|||
125078840|NCT00732238|449905735|FG001|Overall Study|Bacteremia|1|||
125078841|NCT00732238|449905734|FG000|Overall Study|Asymptomatic bacteriuria|1|||
125078842|NCT00732238|449905735|FG001|Overall Study|Asymptomatic bacteriuria|0|||
125078843|NCT00246376|449905738|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
125078844|NCT00246376|449905739|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
125078845|NCT00246376|449905740|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
125078846|NCT00246376|449905741|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
125078847|NCT00246376|449905742|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
125078848|NCT00246376|449905738|FG000|Overall Study|Adverse Event|2|||
125078849|NCT00246376|449905739|FG001|Overall Study|Adverse Event|3|||
125078850|NCT00246376|449905740|FG002|Overall Study|Adverse Event|1|||
125078851|NCT00246376|449905741|FG003|Overall Study|Adverse Event|3|||
125078852|NCT00246376|449905742|FG004|Overall Study|Adverse Event|1|||
125078853|NCT00246376|449905738|FG000|Overall Study|Lost to Follow-up|2|||
125078854|NCT00246376|449905739|FG001|Overall Study|Lost to Follow-up|11|||
125078855|NCT00246376|449905740|FG002|Overall Study|Lost to Follow-up|11|||
125078856|NCT00246376|449905741|FG003|Overall Study|Lost to Follow-up|16|||
125078857|NCT00246376|449905742|FG004|Overall Study|Lost to Follow-up|13|||
125078858|NCT00610207|449905746|FG000|Overall Study|Lost to Follow-up|3|||
125078859|NCT00693693|449905747|FG000|Overall Study|Lost to Follow-up|1|||
125078860|NCT00693693|449905748|FG001|Overall Study|Lost to Follow-up|1|||
125078861|NCT00693693|449905749|FG002|Overall Study|Lost to Follow-up|2|||
125078862|NCT02465489|449905752|FG000|Overall Study|Adverse Event|5|||
125078863|NCT02972593|449905753|FG000|Overall Study|Lost to Follow-up|19|||
125078864|NCT02972593|449905754|FG001|Overall Study|Lost to Follow-up|15|||
125078865|NCT02972593|449905753|FG000|Overall Study|Protocol Violation|1|||
125078866|NCT02972593|449905754|FG001|Overall Study|Protocol Violation|0|||
125078867|NCT04599972|449905755|FG000|Overall Study|Withdrawal by Subject|6|||
125078868|NCT04599972|449905756|FG001|Overall Study|Withdrawal by Subject|1|||
125078869|NCT04599972|449905755|FG000|Overall Study|Adverse Event|1|||
125078870|NCT04599972|449905756|FG001|Overall Study|Adverse Event|1|||
125078871|NCT04599972|449905755|FG000|Overall Study|Lost to Follow-up|1|||
125078872|NCT04599972|449905756|FG001|Overall Study|Lost to Follow-up|6|||
125078873|NCT04599972|449905755|FG000|Overall Study|Protocol Violation|1|||
125078874|NCT04599972|449905756|FG001|Overall Study|Protocol Violation|0|||
125078875|NCT04599972|449905755|FG000|Overall Study|Other reason|1|||
125078876|NCT04599972|449905756|FG001|Overall Study|Other reason|0|||
125078877|NCT00638690|449905759|FG000|Overall Study|Death|655|||
125078878|NCT00638690|449905760|FG001|Overall Study|Death|335|||
125078879|NCT00638690|449905759|FG000|Overall Study|Withdrawal by Subject|22|||
125078880|NCT00638690|449905760|FG001|Overall Study|Withdrawal by Subject|5|||
125078881|NCT00638690|449905759|FG000|Overall Study|Lost to Follow-up|4|||
125078882|NCT00638690|449905760|FG001|Overall Study|Lost to Follow-up|2|||
125078883|NCT01347073|449905764|FG000|Overall Study|Adverse Event|1|||
125078884|NCT01347073|449905764|FG000|Overall Study|Liver Transplant|1|||
125078885|NCT00372489|449905771|FG000|Overall Study|Adverse Event|18|||
125078886|NCT00372489|449905771|FG000|Overall Study|Lack of Efficacy|1|||
125078887|NCT00372489|449905771|FG000|Overall Study|Lost to Follow-up|3|||
125078888|NCT00372489|449905771|FG000|Overall Study|Physician Decision|3|||
125078889|NCT00372489|449905771|FG000|Overall Study|Withdrawal by Subject|5|||
125078890|NCT00372489|449905771|FG000|Overall Study|Patient Relocation|2|||
125078891|NCT00372489|449905771|FG000|Overall Study|Renal transplant|6|||
125078892|NCT00372489|449905771|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
125144204|NCT02985398|450151469|FG000|Overall Study|Withdrawal by Subject|8|||
125144205|NCT02985398|450151469|FG000|Overall Study|Study Burden|9|||
125078893|NCT00552344|449905776|FG000|Overall Study|Lack of Efficacy|55|||
125078894|NCT00552344|449905776|FG000|Overall Study|Loss of efficacy|75|||
125078895|NCT00552344|449905776|FG000|Overall Study|Lost to Follow-up|8|||
125078896|NCT00552344|449905776|FG000|Overall Study|Withdrawal by Subject|48|||
125078897|NCT00552344|449905776|FG000|Overall Study|SAE, non-fatal|6|||
125078898|NCT00552344|449905776|FG000|Overall Study|AE, non-serious non-fatal|38|||
125078899|NCT00552344|449905776|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
125144206|NCT01841073|450151470|FG000|Overall Study|Adverse Event|1|||
125078900|NCT00552344|449905776|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
125078901|NCT00552344|449905776|FG000|Overall Study|Other Reason|22|||
125078902|NCT00023712|449905777|FG000|Overall Study|Not platinum sensitive|1|||
125078903|NCT00023712|449905778|FG001|Overall Study|Not platinum sensitive|0|||
125078904|NCT00023712|449905777|FG000|Overall Study|Never treated|1|||
125078905|NCT00023712|449905778|FG001|Overall Study|Never treated|1|||
125078906|NCT01448707|449905782|FG000|Overall Study|Adverse Event|3|||
125078907|NCT01448707|449905783|FG001|Overall Study|Adverse Event|1|||
125078908|NCT01448707|449905782|FG000|Overall Study|Lost to Follow-up|2|||
125078909|NCT01448707|449905783|FG001|Overall Study|Lost to Follow-up|6|||
125078910|NCT01448707|449905782|FG000|Overall Study|Withdrawal by Subject|6|||
125078911|NCT01448707|449905783|FG001|Overall Study|Withdrawal by Subject|7|||
125078912|NCT01448707|449905782|FG000|Overall Study|Other|7|||
125078913|NCT01448707|449905783|FG001|Overall Study|Other|4|||
125078914|NCT03215667|449905785|FG000|Overall Study|Physician Decision|4|||
125078915|NCT01810380|449905786|FG000|Overall Study|Randomised not treated|2|||
125078916|NCT01810380|449905787|FG001|Overall Study|Randomised not treated|1|||
125078917|NCT01810380|449905788|FG002|Overall Study|Randomised not treated|1|||
125078918|NCT01810380|449905786|FG000|Overall Study|Adverse Event|11|||
125078919|NCT01810380|449905787|FG001|Overall Study|Adverse Event|14|||
125078920|NCT01810380|449905788|FG002|Overall Study|Adverse Event|4|||
125078921|NCT01810380|449905786|FG000|Overall Study|Lack of Efficacy|24|||
125078922|NCT01810380|449905787|FG001|Overall Study|Lack of Efficacy|10|||
125078923|NCT01810380|449905788|FG002|Overall Study|Lack of Efficacy|11|||
125078924|NCT01810380|449905786|FG000|Overall Study|Protocol Violation|1|||
125078925|NCT01810380|449905787|FG001|Overall Study|Protocol Violation|0|||
125078926|NCT01810380|449905788|FG002|Overall Study|Protocol Violation|1|||
125078927|NCT01810380|449905786|FG000|Overall Study|Withdrawal by Subject|6|||
125078928|NCT01810380|449905787|FG001|Overall Study|Withdrawal by Subject|0|||
125078929|NCT01810380|449905788|FG002|Overall Study|Withdrawal by Subject|6|||
125078930|NCT01810380|449905786|FG000|Overall Study|Administrative or other reasons|11|||
125078931|NCT01810380|449905787|FG001|Overall Study|Administrative or other reasons|13|||
125078932|NCT01810380|449905788|FG002|Overall Study|Administrative or other reasons|9|||
125078933|NCT00614991|449905789|FG000|Overall Study|Adverse Event|3|||
125078934|NCT00614991|449905790|FG001|Overall Study|Adverse Event|3|||
125078935|NCT00614991|449905791|FG002|Overall Study|Adverse Event|0|||
125078936|NCT00614991|449905792|FG003|Overall Study|Adverse Event|0|||
125078937|NCT00614991|449905793|FG004|Overall Study|Adverse Event|1|||
125078938|NCT00614991|449905794|FG005|Overall Study|Adverse Event|0|||
125078939|NCT02623699|449905795|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125078940|NCT02623699|449905796|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
125078941|NCT02623699|449905797|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125078942|NCT02623699|449905798|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125078943|NCT02623699|449905799|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125078944|NCT02623699|449905800|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125078945|NCT02623699|449905801|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125078946|NCT02623699|449905802|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125078947|NCT02623699|449905803|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125078948|NCT02623699|449905804|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125078949|NCT02623699|449905805|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125078950|NCT02623699|449905806|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125078951|NCT02623699|449905795|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125078952|NCT02623699|449905796|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125078953|NCT02623699|449905797|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125078954|NCT02623699|449905798|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125078955|NCT02623699|449905799|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125078956|NCT02623699|449905800|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125078957|NCT02623699|449905801|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
125078958|NCT02623699|449905802|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125078959|NCT02623699|449905803|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125078960|NCT02623699|449905804|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125078961|NCT02623699|449905805|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125078962|NCT02623699|449905806|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125078963|NCT02623699|449905795|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125078964|NCT02623699|449905796|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125078965|NCT02623699|449905797|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125078966|NCT02623699|449905798|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125078967|NCT02623699|449905799|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125078968|NCT02623699|449905800|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
125078969|NCT02623699|449905801|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125078970|NCT02623699|449905802|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125078971|NCT02623699|449905803|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125078972|NCT02623699|449905804|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125078973|NCT02623699|449905805|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125078974|NCT02623699|449905806|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125078975|NCT02623699|449905795|FG000|Part B (Up to 289 Days)|Death|0|||
125078976|NCT02623699|449905796|FG001|Part B (Up to 289 Days)|Death|0|||
125078977|NCT02623699|449905797|FG002|Part B (Up to 289 Days)|Death|0|||
125078978|NCT02623699|449905798|FG003|Part B (Up to 289 Days)|Death|0|||
125078979|NCT02623699|449905799|FG004|Part B (Up to 289 Days)|Death|0|||
125078980|NCT02623699|449905800|FG005|Part B (Up to 289 Days)|Death|1|||
125078981|NCT02623699|449905801|FG006|Part B (Up to 289 Days)|Death|1|||
125078982|NCT02623699|449905802|FG007|Part B (Up to 289 Days)|Death|0|||
125078983|NCT02623699|449905803|FG008|Part B (Up to 289 Days)|Death|1|||
125078984|NCT02623699|449905804|FG009|Part B (Up to 289 Days)|Death|0|||
125078985|NCT02623699|449905805|FG010|Part B (Up to 289 Days)|Death|0|||
125078986|NCT02623699|449905806|FG011|Part B (Up to 289 Days)|Death|0|||
125078987|NCT02623699|449905795|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
125078988|NCT02623699|449905796|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
125078989|NCT02623699|449905797|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
125078990|NCT02623699|449905798|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
125078991|NCT02623699|449905799|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
125078992|NCT02623699|449905800|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
125078993|NCT02623699|449905801|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
125078994|NCT02623699|449905802|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
125078995|NCT02623699|449905803|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
125078996|NCT02623699|449905804|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
125078997|NCT02623699|449905805|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
125078998|NCT02623699|449905806|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
125078999|NCT02623699|449905795|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
125079000|NCT02623699|449905796|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
125079001|NCT02623699|449905797|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
125079002|NCT02623699|449905798|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
125079003|NCT02623699|449905799|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
125079004|NCT02623699|449905800|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
125079005|NCT02623699|449905801|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
125079006|NCT02623699|449905802|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
125079007|NCT02623699|449905803|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
125079008|NCT02623699|449905804|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
125079009|NCT02623699|449905805|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
125079010|NCT02623699|449905806|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
125079011|NCT02623699|449905795|FG000|Part C (Up to 236 Days)|Death|0|||
125079012|NCT02623699|449905796|FG001|Part C (Up to 236 Days)|Death|0|||
125079013|NCT02623699|449905797|FG002|Part C (Up to 236 Days)|Death|0|||
125079014|NCT02623699|449905798|FG003|Part C (Up to 236 Days)|Death|0|||
125079015|NCT02623699|449905799|FG004|Part C (Up to 236 Days)|Death|0|||
125079016|NCT02623699|449905800|FG005|Part C (Up to 236 Days)|Death|0|||
125079017|NCT02623699|449905801|FG006|Part C (Up to 236 Days)|Death|0|||
125079018|NCT02623699|449905802|FG007|Part C (Up to 236 Days)|Death|0|||
125079019|NCT02623699|449905803|FG008|Part C (Up to 236 Days)|Death|0|||
125079020|NCT02623699|449905804|FG009|Part C (Up to 236 Days)|Death|0|||
125079021|NCT02623699|449905805|FG010|Part C (Up to 236 Days)|Death|0|||
125079022|NCT02623699|449905806|FG011|Part C (Up to 236 Days)|Death|1|||
125079023|NCT02623699|449905795|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
125079024|NCT02623699|449905796|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
125079025|NCT02623699|449905797|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
125079026|NCT02623699|449905798|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
125079027|NCT02623699|449905799|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
125079028|NCT02623699|449905800|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
125079029|NCT02623699|449905801|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
125079030|NCT02623699|449905802|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
125079031|NCT02623699|449905803|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
125079032|NCT02623699|449905804|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
125079033|NCT02623699|449905805|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
125079034|NCT02623699|449905806|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
125079035|NCT03796195|449905809|FG000|Overall Study|Study closed early|1|||
125079036|NCT00464620|449907578|FG000|Overall Study|Physician Decision|1|||
125079037|NCT00464620|449907579|FG001|Overall Study|Physician Decision|0|||
125079038|NCT00464620|449907580|FG002|Overall Study|Physician Decision|0|||
125079039|NCT00464620|449907578|FG000|Overall Study|Withdrawal by Subject|1|||
125079040|NCT00464620|449907579|FG001|Overall Study|Withdrawal by Subject|0|||
125079041|NCT00464620|449907580|FG002|Overall Study|Withdrawal by Subject|3|||
125079042|NCT00464620|449907578|FG000|Overall Study|Ineligible sarcoma subtype|0|||
125079043|NCT00464620|449907579|FG001|Overall Study|Ineligible sarcoma subtype|2|||
125079044|NCT00464620|449907580|FG002|Overall Study|Ineligible sarcoma subtype|2|||
125079045|NCT00464620|449907578|FG000|Overall Study|Use of prohibited concomitant medication|0|||
125079046|NCT00464620|449907579|FG001|Overall Study|Use of prohibited concomitant medication|0|||
125079047|NCT00464620|449907580|FG002|Overall Study|Use of prohibited concomitant medication|2|||
125079048|NCT01518309|449907581|FG000|Overall Study|Adverse Event|6|||
125079049|NCT01518309|449907581|FG000|Overall Study|Death|6|||
125079050|NCT01518309|449907581|FG000|Overall Study|Lack of Efficacy|7|||
125079051|NCT01518309|449907581|FG000|Overall Study|Withdrawal by Subject|6|||
125079052|NCT01518309|449907581|FG000|Overall Study|Physician Decision|3|||
125079053|NCT01518309|449907581|FG000|Overall Study|Sponsor Decision|2|||
125079054|NCT01518309|449907581|FG000|Overall Study|Not in Predefined Categories|9|||
125079055|NCT02579863|449907582|FG000|Overall Study|Final Disposition Unknown|2|||
125079056|NCT02579863|449907583|FG001|Overall Study|Final Disposition Unknown|1|||
125079057|NCT02579863|449907582|FG000|Overall Study|Adverse Event|18|||
125079058|NCT02579863|449907583|FG001|Overall Study|Adverse Event|11|||
125079059|NCT02579863|449907582|FG000|Overall Study|Death|31|||
125079060|NCT02579863|449907583|FG001|Overall Study|Death|29|||
125079061|NCT02579863|449907582|FG000|Overall Study|Lost to Follow-up|2|||
125079062|NCT02579863|449907583|FG001|Overall Study|Lost to Follow-up|1|||
125079063|NCT02579863|449907582|FG000|Overall Study|Physician Decision|1|||
125079064|NCT02579863|449907583|FG001|Overall Study|Physician Decision|2|||
125079065|NCT02579863|449907582|FG000|Overall Study|Screen Failure|0|||
125079066|NCT02579863|449907583|FG001|Overall Study|Screen Failure|2|||
125079067|NCT02579863|449907582|FG000|Overall Study|Study Terminated at Selected Sites|82|||
125079068|NCT02579863|449907583|FG001|Overall Study|Study Terminated at Selected Sites|88|||
125079069|NCT02579863|449907582|FG000|Overall Study|Withdrawal by Subject|20|||
125079070|NCT02579863|449907583|FG001|Overall Study|Withdrawal by Subject|20|||
125079071|NCT00038142|449907591|FG000|Overall Study|Ineligible|1|||
125079072|NCT00038142|449907592|FG001|Overall Study|Ineligible|0|||
125079073|NCT00038142|449907591|FG000|Overall Study|Progressive Disease|11|||
125079074|NCT00038142|449907592|FG001|Overall Study|Progressive Disease|7|||
125079075|NCT00038142|449907591|FG000|Overall Study|Death|1|||
125079076|NCT00038142|449907592|FG001|Overall Study|Death|0|||
125079077|NCT00038142|449907591|FG000|Overall Study|Adverse Event|1|||
125079078|NCT00038142|449907592|FG001|Overall Study|Adverse Event|0|||
125079079|NCT00038142|449907591|FG000|Overall Study|Unknown Reason|8|||
125079080|NCT00038142|449907592|FG001|Overall Study|Unknown Reason|0|||
125079081|NCT00589602|449907593|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
125079082|NCT02352090|449907601|FG000|Overall Study|general malaise|1|||
125079083|NCT02352090|449907602|FG001|Overall Study|general malaise|0|||
125079084|NCT02352090|449907603|FG002|Overall Study|general malaise|0|||
125079085|NCT02352090|449907601|FG000|Overall Study|non-specified mild side-effects|0|||
125079086|NCT02352090|449907602|FG001|Overall Study|non-specified mild side-effects|0|||
125079087|NCT02352090|449907603|FG002|Overall Study|non-specified mild side-effects|2|||
125079088|NCT01849562|449907604|FG000|Overall Study|Lost to Follow-up|1|||
125079089|NCT01849562|449907605|FG001|Overall Study|Lost to Follow-up|0|||
125079090|NCT01849562|449907606|FG002|Overall Study|Lost to Follow-up|0|||
125079091|NCT01849562|449907604|FG000|Overall Study|Non-compliance with Study Drug|1|||
125079092|NCT01849562|449907605|FG001|Overall Study|Non-compliance with Study Drug|0|||
125079093|NCT01849562|449907606|FG002|Overall Study|Non-compliance with Study Drug|0|||
125079094|NCT03146403|449907607|FG000|Overall Study|Withdrawal by Subject|0|||
125079095|NCT03146403|449907608|FG001|Overall Study|Withdrawal by Subject|3|||
125079096|NCT03146403|449907607|FG000|Overall Study|Lost to Follow-up|2|||
125079097|NCT03146403|449907608|FG001|Overall Study|Lost to Follow-up|0|||
125079098|NCT02182999|449907612|FG000|Overall Study|Adverse Event|4|||
125079099|NCT02182999|449907613|FG001|Overall Study|Adverse Event|3|||
125079100|NCT02182999|449907612|FG000|Overall Study|Physician Decision|1|||
125079101|NCT02182999|449907613|FG001|Overall Study|Physician Decision|0|||
125079102|NCT02252588|449907614|FG000|Overall Study|Withdrawal by Subject|4|||
125079103|NCT02252588|449907615|FG001|Overall Study|Withdrawal by Subject|0|||
125079104|NCT03039790|449907616|FG000|Overall Study|Lost to Follow-up|2|||
125079105|NCT03039790|449907617|FG001|Overall Study|Lost to Follow-up|0|||
125079106|NCT03039790|449907618|FG002|Overall Study|Lost to Follow-up|1|||
125079107|NCT03039790|449907619|FG003|Overall Study|Lost to Follow-up|1|||
125079108|NCT03039790|449907620|FG004|Overall Study|Lost to Follow-up|0|||
125079109|NCT03039790|449907621|FG005|Overall Study|Lost to Follow-up|1|||
125079110|NCT03039790|449907622|FG006|Overall Study|Lost to Follow-up|1|||
125079111|NCT03039790|449907623|FG007|Overall Study|Lost to Follow-up|1|||
125079112|NCT03039790|449907624|FG008|Overall Study|Lost to Follow-up|0|||
125079113|NCT03039790|449907625|FG009|Overall Study|Lost to Follow-up|1|||
125079114|NCT03039790|449907626|FG010|Overall Study|Lost to Follow-up|1|||
125079115|NCT03039790|449907627|FG011|Overall Study|Lost to Follow-up|0|||
125079116|NCT03039790|449907628|FG012|Overall Study|Lost to Follow-up|1|||
125079117|NCT03039790|449907629|FG013|Overall Study|Lost to Follow-up|0|||
125079118|NCT03039790|449907630|FG014|Overall Study|Lost to Follow-up|3|||
125144207|NCT01841073|450151471|FG001|Overall Study|Adverse Event|1|||
125079119|NCT03039790|449907631|FG015|Overall Study|Lost to Follow-up|1|||
125079120|NCT03039790|449907632|FG016|Overall Study|Lost to Follow-up|2|||
125079121|NCT03039790|449907633|FG017|Overall Study|Lost to Follow-up|2|||
125079122|NCT03039790|449907634|FG018|Overall Study|Lost to Follow-up|1|||
125079123|NCT03039790|449907635|FG019|Overall Study|Lost to Follow-up|3|||
125079124|NCT03039790|449907616|FG000|Overall Study|Withdrawal of Consent|1|||
125079125|NCT03039790|449907617|FG001|Overall Study|Withdrawal of Consent|0|||
125144208|NCT01841073|450151470|FG000|Overall Study|Physician Decision|1|||
125079126|NCT03039790|449907618|FG002|Overall Study|Withdrawal of Consent|0|||
125079127|NCT03039790|449907619|FG003|Overall Study|Withdrawal of Consent|1|||
125079128|NCT03039790|449907620|FG004|Overall Study|Withdrawal of Consent|0|||
125144209|NCT01841073|450151471|FG001|Overall Study|Physician Decision|0|||
125079129|NCT03039790|449907621|FG005|Overall Study|Withdrawal of Consent|0|||
125079130|NCT03039790|449907622|FG006|Overall Study|Withdrawal of Consent|0|||
125079131|NCT03039790|449907623|FG007|Overall Study|Withdrawal of Consent|0|||
125079132|NCT03039790|449907624|FG008|Overall Study|Withdrawal of Consent|0|||
125079133|NCT03039790|449907625|FG009|Overall Study|Withdrawal of Consent|1|||
125079134|NCT03039790|449907626|FG010|Overall Study|Withdrawal of Consent|0|||
125079135|NCT03039790|449907627|FG011|Overall Study|Withdrawal of Consent|0|||
125079136|NCT03039790|449907628|FG012|Overall Study|Withdrawal of Consent|2|||
125079137|NCT03039790|449907629|FG013|Overall Study|Withdrawal of Consent|0|||
125079138|NCT03039790|449907630|FG014|Overall Study|Withdrawal of Consent|1|||
125079139|NCT03039790|449907631|FG015|Overall Study|Withdrawal of Consent|5|||
125079140|NCT03039790|449907632|FG016|Overall Study|Withdrawal of Consent|3|||
125079141|NCT03039790|449907633|FG017|Overall Study|Withdrawal of Consent|0|||
125079142|NCT03039790|449907634|FG018|Overall Study|Withdrawal of Consent|2|||
125079143|NCT03039790|449907635|FG019|Overall Study|Withdrawal of Consent|5|||
125079144|NCT03039790|449907616|FG000|Overall Study|Death|0|||
125079145|NCT03039790|449907617|FG001|Overall Study|Death|0|||
125079146|NCT03039790|449907618|FG002|Overall Study|Death|0|||
125079147|NCT03039790|449907619|FG003|Overall Study|Death|0|||
125079148|NCT03039790|449907620|FG004|Overall Study|Death|0|||
125079149|NCT03039790|449907621|FG005|Overall Study|Death|0|||
125079150|NCT03039790|449907622|FG006|Overall Study|Death|0|||
125079151|NCT03039790|449907623|FG007|Overall Study|Death|0|||
125079152|NCT03039790|449907624|FG008|Overall Study|Death|0|||
125079153|NCT03039790|449907625|FG009|Overall Study|Death|0|||
125079154|NCT03039790|449907626|FG010|Overall Study|Death|0|||
125079155|NCT03039790|449907627|FG011|Overall Study|Death|0|||
125079156|NCT03039790|449907628|FG012|Overall Study|Death|0|||
125079157|NCT03039790|449907629|FG013|Overall Study|Death|0|||
125079158|NCT03039790|449907630|FG014|Overall Study|Death|0|||
125079159|NCT03039790|449907631|FG015|Overall Study|Death|1|||
125079160|NCT03039790|449907632|FG016|Overall Study|Death|3|||
125079161|NCT03039790|449907633|FG017|Overall Study|Death|0|||
125079162|NCT03039790|449907634|FG018|Overall Study|Death|2|||
125079163|NCT03039790|449907635|FG019|Overall Study|Death|0|||
125079164|NCT03039790|449907616|FG000|Overall Study|Reason, not Specified|1|||
125079165|NCT03039790|449907617|FG001|Overall Study|Reason, not Specified|0|||
125079166|NCT03039790|449907618|FG002|Overall Study|Reason, not Specified|0|||
125079167|NCT03039790|449907619|FG003|Overall Study|Reason, not Specified|0|||
125079168|NCT03039790|449907620|FG004|Overall Study|Reason, not Specified|0|||
125079169|NCT03039790|449907621|FG005|Overall Study|Reason, not Specified|0|||
125079170|NCT03039790|449907622|FG006|Overall Study|Reason, not Specified|0|||
125079171|NCT03039790|449907623|FG007|Overall Study|Reason, not Specified|0|||
125079172|NCT03039790|449907624|FG008|Overall Study|Reason, not Specified|0|||
125079173|NCT03039790|449907625|FG009|Overall Study|Reason, not Specified|0|||
125079174|NCT03039790|449907626|FG010|Overall Study|Reason, not Specified|0|||
125079175|NCT03039790|449907627|FG011|Overall Study|Reason, not Specified|0|||
125079176|NCT03039790|449907628|FG012|Overall Study|Reason, not Specified|0|||
125079177|NCT03039790|449907629|FG013|Overall Study|Reason, not Specified|0|||
125079178|NCT03039790|449907630|FG014|Overall Study|Reason, not Specified|0|||
125079179|NCT03039790|449907631|FG015|Overall Study|Reason, not Specified|0|||
125079180|NCT03039790|449907632|FG016|Overall Study|Reason, not Specified|2|||
125079181|NCT03039790|449907633|FG017|Overall Study|Reason, not Specified|0|||
125079182|NCT03039790|449907634|FG018|Overall Study|Reason, not Specified|1|||
125079183|NCT03039790|449907635|FG019|Overall Study|Reason, not Specified|0|||
125079184|NCT02266004|449907645|FG000|Overall Study|unrelated adverse event|1|||
125079185|NCT02266004|449907645|FG000|Overall Study|Physician Decision|1|||
125079186|NCT00537771|449907650|FG000|Overall Study|Withdrawal by Subject|6|||
125079187|NCT00537771|449907651|FG001|Overall Study|Withdrawal by Subject|23|||
125079188|NCT00537771|449907650|FG000|Overall Study|Adverse Event|8|||
125079189|NCT00537771|449907651|FG001|Overall Study|Adverse Event|15|||
125079190|NCT00537771|449907650|FG000|Overall Study|Lost to Follow-up|9|||
125079191|NCT00537771|449907651|FG001|Overall Study|Lost to Follow-up|15|||
125079192|NCT00537771|449907650|FG000|Overall Study|Protocol Violation|2|||
125079193|NCT00537771|449907651|FG001|Overall Study|Protocol Violation|6|||
125079194|NCT00537771|449907650|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
125079195|NCT00537771|449907651|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
125079196|NCT02736929|449907655|FG000|Main Study|Lost to Follow-up|7|||
125079197|NCT02736929|449907656|FG001|Main Study|Lost to Follow-up|1|||
125079198|NCT02736929|449907657|FG002|Main Study|Lost to Follow-up|0|||
125079199|NCT02736929|449907655|FG000|Main Study|Withdrawal by Subject|1|||
125079200|NCT02736929|449907656|FG001|Main Study|Withdrawal by Subject|1|||
125079201|NCT02736929|449907657|FG002|Main Study|Withdrawal by Subject|0|||
125079202|NCT02736929|449907655|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
125079203|NCT02736929|449907656|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
125079204|NCT02736929|449907657|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
125079205|NCT01855425|449907666|FG000|Overall Study|Physician Decision|20|||
125079206|NCT01690988|449907673|FG000|Overall Study|Withdrawal by Subject|2|||
125079207|NCT01690988|449907674|FG001|Overall Study|Withdrawal by Subject|2|||
125079208|NCT01690988|449907675|FG002|Overall Study|Withdrawal by Subject|3|||
125079209|NCT01690988|449907673|FG000|Overall Study|Physician Decision|0|||
125079210|NCT01690988|449907674|FG001|Overall Study|Physician Decision|0|||
125079211|NCT01690988|449907675|FG002|Overall Study|Physician Decision|1|||
125079212|NCT01690988|449907673|FG000|Overall Study|Operation Cancelled|1|||
125079213|NCT01690988|449907674|FG001|Overall Study|Operation Cancelled|1|||
125079214|NCT01690988|449907675|FG002|Overall Study|Operation Cancelled|0|||
125079215|NCT01690988|449907673|FG000|Overall Study|Determined ineligible|1|||
125079216|NCT01690988|449907674|FG001|Overall Study|Determined ineligible|0|||
125079217|NCT01690988|449907675|FG002|Overall Study|Determined ineligible|0|||
125079218|NCT01690988|449907673|FG000|Overall Study|Death|1|||
125079219|NCT01690988|449907674|FG001|Overall Study|Death|1|||
125079220|NCT01690988|449907675|FG002|Overall Study|Death|1|||
125079221|NCT01690988|449907673|FG000|Overall Study|Sedated|1|||
125079222|NCT01690988|449907674|FG001|Overall Study|Sedated|1|||
125079223|NCT01690988|449907675|FG002|Overall Study|Sedated|2|||
125079224|NCT01634100|449907678|FG000|Overall Study|Withdrawal by Subject|1|||
125079225|NCT01634100|449907679|FG001|Overall Study|Withdrawal by Subject|0|||
125079226|NCT01634100|449907680|FG002|Overall Study|Withdrawal by Subject|1|||
125079227|NCT01634100|449907681|FG003|Overall Study|Withdrawal by Subject|0|||
125079228|NCT01634100|449907682|FG004|Overall Study|Withdrawal by Subject|0|||
125079229|NCT01634100|449907683|FG005|Overall Study|Withdrawal by Subject|0|||
125079230|NCT01662986|449907687|FG000|Overall Study|Adverse Event|5|||
125079231|NCT01662986|449907688|FG001|Overall Study|Adverse Event|4|||
125079232|NCT01662986|449907687|FG000|Overall Study|Protocol Violation|2|||
125079233|NCT01662986|449907688|FG001|Overall Study|Protocol Violation|3|||
125079234|NCT01662986|449907687|FG000|Overall Study|Lost to Follow-up|5|||
125079235|NCT01662986|449907688|FG001|Overall Study|Lost to Follow-up|4|||
125079236|NCT01662986|449907687|FG000|Overall Study|Withdrawal by Subject|2|||
125079237|NCT01662986|449907688|FG001|Overall Study|Withdrawal by Subject|2|||
125079238|NCT01662986|449907687|FG000|Overall Study|Not Treated|1|||
125079239|NCT01662986|449907688|FG001|Overall Study|Not Treated|0|||
125079240|NCT01662986|449907687|FG000|Overall Study|Other than stated above|3|||
125079241|NCT01662986|449907688|FG001|Overall Study|Other than stated above|0|||
125079242|NCT01512693|449907691|FG000|Overall Study|Withdrawal by Subject|0|||
125079243|NCT01512693|449907692|FG001|Overall Study|Withdrawal by Subject|1|||
125079244|NCT01975376|449907693|FG000|Overall Study|Adverse Event|5|||
125079245|NCT01975376|449907694|FG001|Overall Study|Adverse Event|5|||
125079246|NCT01975376|449907693|FG000|Overall Study|Death|65|||
125079247|NCT01975376|449907694|FG001|Overall Study|Death|72|||
125079248|NCT01975376|449907693|FG000|Overall Study|Lost to Follow-up|70|||
125079249|NCT01975376|449907694|FG001|Overall Study|Lost to Follow-up|66|||
125079250|NCT01975376|449907693|FG000|Overall Study|Withdrew consent|68|||
125079251|NCT01975376|449907694|FG001|Overall Study|Withdrew consent|62|||
125079252|NCT01975376|449907693|FG000|Overall Study|Other|2|||
125079253|NCT01975376|449907694|FG001|Overall Study|Other|4|||
125079254|NCT01975376|449907693|FG000|Overall Study|Randomized, Not Treated|16|||
125079255|NCT01975376|449907694|FG001|Overall Study|Randomized, Not Treated|8|||
125079256|NCT04731922|449907695|FG000|Overall Study|Adverse Event|0|||
125079257|NCT04731922|449907696|FG001|Overall Study|Adverse Event|0|||
125079258|NCT04731922|449907697|FG002|Overall Study|Adverse Event|0|||
125079259|NCT04731922|449907698|FG003|Overall Study|Adverse Event|0|||
125079260|NCT04731922|449907699|FG004|Overall Study|Adverse Event|0|||
125079261|NCT04731922|449907700|FG005|Overall Study|Adverse Event|0|||
125079262|NCT04731922|449907701|FG006|Overall Study|Adverse Event|0|||
125079263|NCT04731922|449907702|FG007|Overall Study|Adverse Event|0|||
125079264|NCT04731922|449907703|FG008|Overall Study|Adverse Event|0|||
125079265|NCT04731922|449907704|FG009|Overall Study|Adverse Event|0|||
125079266|NCT04731922|449907705|FG010|Overall Study|Adverse Event|1|||
125079267|NCT04731922|449907706|FG011|Overall Study|Adverse Event|0|||
125079268|NCT04731922|449907707|FG012|Overall Study|Adverse Event|0|||
125079269|NCT04731922|449907708|FG013|Overall Study|Adverse Event|0|||
125079270|NCT04731922|449907709|FG014|Overall Study|Adverse Event|0|||
125079271|NCT04731922|449907710|FG015|Overall Study|Adverse Event|0|||
125079272|NCT04731922|449907711|FG016|Overall Study|Adverse Event|0|||
125079273|NCT04731922|449907695|FG000|Overall Study|Lost to Follow-up|0|||
125079274|NCT04731922|449907696|FG001|Overall Study|Lost to Follow-up|0|||
125079275|NCT04731922|449907697|FG002|Overall Study|Lost to Follow-up|0|||
125079276|NCT04731922|449907698|FG003|Overall Study|Lost to Follow-up|1|||
125079277|NCT04731922|449907699|FG004|Overall Study|Lost to Follow-up|0|||
125079278|NCT04731922|449907700|FG005|Overall Study|Lost to Follow-up|1|||
125079279|NCT04731922|449907701|FG006|Overall Study|Lost to Follow-up|0|||
125079280|NCT04731922|449907702|FG007|Overall Study|Lost to Follow-up|0|||
125079281|NCT04731922|449907703|FG008|Overall Study|Lost to Follow-up|0|||
125079282|NCT04731922|449907704|FG009|Overall Study|Lost to Follow-up|0|||
125079283|NCT04731922|449907705|FG010|Overall Study|Lost to Follow-up|0|||
125079284|NCT04731922|449907706|FG011|Overall Study|Lost to Follow-up|0|||
125079285|NCT04731922|449907707|FG012|Overall Study|Lost to Follow-up|0|||
125079286|NCT04731922|449907708|FG013|Overall Study|Lost to Follow-up|0|||
125079287|NCT04731922|449907709|FG014|Overall Study|Lost to Follow-up|0|||
125079288|NCT04731922|449907710|FG015|Overall Study|Lost to Follow-up|0|||
125079289|NCT04731922|449907711|FG016|Overall Study|Lost to Follow-up|0|||
125079290|NCT04731922|449907695|FG000|Overall Study|Withdrawal by Subject|1|||
125079291|NCT04731922|449907696|FG001|Overall Study|Withdrawal by Subject|0|||
125079292|NCT04731922|449907697|FG002|Overall Study|Withdrawal by Subject|0|||
125079293|NCT04731922|449907698|FG003|Overall Study|Withdrawal by Subject|0|||
125079294|NCT04731922|449907699|FG004|Overall Study|Withdrawal by Subject|1|||
125079295|NCT04731922|449907700|FG005|Overall Study|Withdrawal by Subject|0|||
125079296|NCT04731922|449907701|FG006|Overall Study|Withdrawal by Subject|1|||
125079297|NCT04731922|449907702|FG007|Overall Study|Withdrawal by Subject|0|||
125079298|NCT04731922|449907703|FG008|Overall Study|Withdrawal by Subject|0|||
125079299|NCT04731922|449907704|FG009|Overall Study|Withdrawal by Subject|0|||
125079300|NCT04731922|449907705|FG010|Overall Study|Withdrawal by Subject|0|||
125079301|NCT04731922|449907706|FG011|Overall Study|Withdrawal by Subject|0|||
125079302|NCT04731922|449907707|FG012|Overall Study|Withdrawal by Subject|0|||
125079303|NCT04731922|449907708|FG013|Overall Study|Withdrawal by Subject|1|||
125079304|NCT04731922|449907709|FG014|Overall Study|Withdrawal by Subject|0|||
125079305|NCT04731922|449907710|FG015|Overall Study|Withdrawal by Subject|0|||
125079306|NCT04731922|449907711|FG016|Overall Study|Withdrawal by Subject|0|||
125079307|NCT04731922|449907695|FG000|Overall Study|Other|0|||
125079308|NCT04731922|449907696|FG001|Overall Study|Other|0|||
125079309|NCT04731922|449907697|FG002|Overall Study|Other|0|||
125079310|NCT04731922|449907698|FG003|Overall Study|Other|0|||
125079311|NCT04731922|449907699|FG004|Overall Study|Other|0|||
125079312|NCT04731922|449907700|FG005|Overall Study|Other|0|||
125079313|NCT04731922|449907701|FG006|Overall Study|Other|1|||
125079314|NCT04731922|449907702|FG007|Overall Study|Other|0|||
125079315|NCT04731922|449907703|FG008|Overall Study|Other|0|||
125079316|NCT04731922|449907704|FG009|Overall Study|Other|0|||
125079317|NCT04731922|449907705|FG010|Overall Study|Other|0|||
125079318|NCT04731922|449907706|FG011|Overall Study|Other|0|||
125079319|NCT04731922|449907707|FG012|Overall Study|Other|0|||
125079320|NCT04731922|449907708|FG013|Overall Study|Other|0|||
125079321|NCT04731922|449907709|FG014|Overall Study|Other|0|||
125079322|NCT04731922|449907710|FG015|Overall Study|Other|0|||
125079323|NCT04731922|449907711|FG016|Overall Study|Other|0|||
125079324|NCT01819194|449907713|FG000|Overall Study|Loss of study articles|2|||
125079325|NCT02343952|449907718|FG000|Study Treatment|Disease Progression|23|||
125079326|NCT02343952|449907718|FG000|Study Treatment|Death|3|||
125079327|NCT02343952|449907718|FG000|Study Treatment|Adverse Event|19|||
125079328|NCT02343952|449907718|FG000|Study Treatment|Withdrawal by Subject|7|||
125079329|NCT02343952|449907718|FG000|Study Treatment|other complicating Diseases|1|||
125079330|NCT02343952|449907718|FG000|Follow up|Withdrawal by Subject|3|||
125079331|NCT02343952|449907718|FG000|Follow up|Death|33|||
125079332|NCT02343952|449907718|FG000|Follow up|Patient does not meet eligibility for study.|1|||
125079333|NCT02343952|449907718|FG000|Follow up|Research department closed by the practice.|5|||
125079334|NCT02343952|449907718|FG000|Follow up|Patient went home to Russia|1|||
125079335|NCT02343952|449907718|FG000|Follow up|Disease Progression|1|||
125079336|NCT02343952|449907718|FG000|Follow up|study terminated|1|||
125079337|NCT00033371|449907722|FG000|Overall Study|Adverse Event|1|||
125144210|NCT01841073|450151470|FG000|Overall Study|Lost to Follow-up|0|||
125144211|NCT01841073|450151471|FG001|Overall Study|Lost to Follow-up|2|||
125144212|NCT00668395|450151472|FG000|Overall Study|Withdrawal by Subject|4|||
125079338|NCT00033371|449907723|FG001|Overall Study|Adverse Event|5|||
125079339|NCT00033371|449907722|FG000|Overall Study|Lost to Follow-up|2|||
125079340|NCT00033371|449907723|FG001|Overall Study|Lost to Follow-up|1|||
125079341|NCT00033371|449907722|FG000|Overall Study|Withdrawal by Subject|3|||
125079342|NCT00033371|449907723|FG001|Overall Study|Withdrawal by Subject|3|||
125079343|NCT00033371|449907722|FG000|Overall Study|Disease Progression|0|||
125079344|NCT00033371|449907723|FG001|Overall Study|Disease Progression|1|||
125079345|NCT00899678|449907724|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
125079346|NCT00899678|449907725|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
125079347|NCT00899678|449907726|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
125079348|NCT00899678|449907724|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
125144213|NCT00668395|450151473|FG001|Overall Study|Withdrawal by Subject|4|||
125079349|NCT00899678|449907725|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
125079350|NCT00899678|449907726|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
125079351|NCT00899678|449907724|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
125079352|NCT00899678|449907725|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
125079353|NCT00899678|449907726|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
125079354|NCT00899678|449907724|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
125079355|NCT00899678|449907725|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
125079356|NCT00899678|449907726|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
125079357|NCT00899678|449907724|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
125079358|NCT00899678|449907725|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
125079359|NCT00899678|449907726|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
125079360|NCT00899678|449907724|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
125079361|NCT00899678|449907725|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
125079362|NCT00899678|449907726|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
125079363|NCT00899678|449907724|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
125079364|NCT00899678|449907725|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
125079365|NCT00899678|449907726|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
125079366|NCT00899678|449907724|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
125079367|NCT00899678|449907725|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
125079368|NCT00899678|449907726|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
125079369|NCT00899678|449907724|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
125079370|NCT00899678|449907725|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
125079371|NCT00899678|449907726|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
125079372|NCT02699125|449907727|FG000|Placebo|Lost to Follow-up|2|||
125079373|NCT02699125|449907728|FG001|Placebo|Lost to Follow-up|0|||
125079374|NCT02699125|449907727|FG000|Placebo|Protocol Violation|1|||
125079375|NCT02699125|449907728|FG001|Placebo|Protocol Violation|0|||
125079376|NCT02699125|449907727|FG000|Placebo|Withdrawal by Subject|0|||
125079377|NCT02699125|449907728|FG001|Placebo|Withdrawal by Subject|4|||
125079378|NCT02699125|449907727|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
125079379|NCT02699125|449907728|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
125079380|NCT03799627|449907733|FG000|Overall Study|Adverse Event|1|||
125079381|NCT03799627|449907734|FG001|Overall Study|Adverse Event|2|||
125079382|NCT03799627|449907735|FG002|Overall Study|Adverse Event|0|||
125079383|NCT03799627|449907736|FG003|Overall Study|Adverse Event|0|||
125079384|NCT03799627|449907737|FG004|Overall Study|Adverse Event|2|||
125079385|NCT03799627|449907738|FG005|Overall Study|Adverse Event|5|||
125079386|NCT03799627|449907739|FG006|Overall Study|Adverse Event|0|||
125079387|NCT03799627|449907740|FG007|Overall Study|Adverse Event|2|||
125079388|NCT03799627|449907741|FG008|Overall Study|Adverse Event|0|||
125079389|NCT03799627|449907733|FG000|Overall Study|Physician Decision|2|||
125079390|NCT03799627|449907734|FG001|Overall Study|Physician Decision|2|||
125079391|NCT03799627|449907735|FG002|Overall Study|Physician Decision|0|||
125079392|NCT03799627|449907736|FG003|Overall Study|Physician Decision|0|||
125079393|NCT03799627|449907737|FG004|Overall Study|Physician Decision|2|||
125079394|NCT03799627|449907738|FG005|Overall Study|Physician Decision|2|||
125079395|NCT03799627|449907739|FG006|Overall Study|Physician Decision|0|||
125079396|NCT03799627|449907740|FG007|Overall Study|Physician Decision|0|||
125079397|NCT03799627|449907741|FG008|Overall Study|Physician Decision|0|||
125079398|NCT03799627|449907733|FG000|Overall Study|Withdrawal by Subject|1|||
125079399|NCT03799627|449907734|FG001|Overall Study|Withdrawal by Subject|1|||
125079400|NCT03799627|449907735|FG002|Overall Study|Withdrawal by Subject|0|||
125079401|NCT03799627|449907736|FG003|Overall Study|Withdrawal by Subject|2|||
125079402|NCT03799627|449907737|FG004|Overall Study|Withdrawal by Subject|0|||
125079403|NCT03799627|449907738|FG005|Overall Study|Withdrawal by Subject|3|||
125079404|NCT03799627|449907739|FG006|Overall Study|Withdrawal by Subject|0|||
125079405|NCT03799627|449907740|FG007|Overall Study|Withdrawal by Subject|0|||
125079406|NCT03799627|449907741|FG008|Overall Study|Withdrawal by Subject|0|||
125079407|NCT03799627|449907733|FG000|Overall Study|Lack of Efficacy|0|||
125079408|NCT03799627|449907734|FG001|Overall Study|Lack of Efficacy|0|||
125079409|NCT03799627|449907735|FG002|Overall Study|Lack of Efficacy|0|||
125079410|NCT03799627|449907736|FG003|Overall Study|Lack of Efficacy|1|||
125079411|NCT03799627|449907737|FG004|Overall Study|Lack of Efficacy|0|||
125079412|NCT03799627|449907738|FG005|Overall Study|Lack of Efficacy|0|||
125079413|NCT03799627|449907739|FG006|Overall Study|Lack of Efficacy|0|||
125079414|NCT03799627|449907740|FG007|Overall Study|Lack of Efficacy|0|||
125079415|NCT03799627|449907741|FG008|Overall Study|Lack of Efficacy|0|||
125079416|NCT03799627|449907733|FG000|Overall Study|Lost to Follow-up|0|||
125144214|NCT00668395|450151474|FG002|Overall Study|Withdrawal by Subject|1|||
125144215|NCT00668395|450151472|FG000|Overall Study|Adverse Event|1|||
125144216|NCT00668395|450151473|FG001|Overall Study|Adverse Event|1|||
125144217|NCT00668395|450151474|FG002|Overall Study|Adverse Event|0|||
125144218|NCT00668395|450151472|FG000|Overall Study|Physician Decision|1|||
125144219|NCT00668395|450151473|FG001|Overall Study|Physician Decision|1|||
125079417|NCT03799627|449907734|FG001|Overall Study|Lost to Follow-up|0|||
125079418|NCT03799627|449907735|FG002|Overall Study|Lost to Follow-up|0|||
125079419|NCT03799627|449907736|FG003|Overall Study|Lost to Follow-up|0|||
125079420|NCT03799627|449907737|FG004|Overall Study|Lost to Follow-up|0|||
125079421|NCT03799627|449907738|FG005|Overall Study|Lost to Follow-up|0|||
125079422|NCT03799627|449907739|FG006|Overall Study|Lost to Follow-up|1|||
125079423|NCT03799627|449907740|FG007|Overall Study|Lost to Follow-up|0|||
125079424|NCT03799627|449907741|FG008|Overall Study|Lost to Follow-up|1|||
125079425|NCT03799627|449907733|FG000|Overall Study|Death|0|||
125079426|NCT03799627|449907734|FG001|Overall Study|Death|0|||
125079427|NCT03799627|449907735|FG002|Overall Study|Death|0|||
125079428|NCT03799627|449907736|FG003|Overall Study|Death|1|||
125079429|NCT03799627|449907737|FG004|Overall Study|Death|0|||
125079430|NCT03799627|449907738|FG005|Overall Study|Death|0|||
125079431|NCT03799627|449907739|FG006|Overall Study|Death|0|||
125079432|NCT03799627|449907740|FG007|Overall Study|Death|0|||
125079433|NCT03799627|449907741|FG008|Overall Study|Death|0|||
125079434|NCT03799627|449907733|FG000|Overall Study|Study Drug Put on Hold|1|||
125079435|NCT03799627|449907734|FG001|Overall Study|Study Drug Put on Hold|0|||
125079436|NCT03799627|449907735|FG002|Overall Study|Study Drug Put on Hold|0|||
125079437|NCT03799627|449907736|FG003|Overall Study|Study Drug Put on Hold|0|||
125079438|NCT03799627|449907737|FG004|Overall Study|Study Drug Put on Hold|0|||
125079439|NCT03799627|449907738|FG005|Overall Study|Study Drug Put on Hold|0|||
125079440|NCT03799627|449907739|FG006|Overall Study|Study Drug Put on Hold|0|||
125079441|NCT03799627|449907740|FG007|Overall Study|Study Drug Put on Hold|0|||
125079442|NCT03799627|449907741|FG008|Overall Study|Study Drug Put on Hold|0|||
125079443|NCT03799627|449907733|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
125079444|NCT03799627|449907734|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
125079445|NCT03799627|449907735|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
125079446|NCT03799627|449907736|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
125079447|NCT03799627|449907737|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
125079448|NCT03799627|449907738|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
125079449|NCT03799627|449907739|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
125079450|NCT03799627|449907740|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
125079451|NCT03799627|449907741|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
125079452|NCT03799627|449907733|FG000|Overall Study|Kidney Transplantation|1|||
125079453|NCT03799627|449907734|FG001|Overall Study|Kidney Transplantation|0|||
125079454|NCT03799627|449907735|FG002|Overall Study|Kidney Transplantation|0|||
125079455|NCT03799627|449907736|FG003|Overall Study|Kidney Transplantation|1|||
125079456|NCT03799627|449907737|FG004|Overall Study|Kidney Transplantation|1|||
125079457|NCT03799627|449907738|FG005|Overall Study|Kidney Transplantation|0|||
125079458|NCT03799627|449907739|FG006|Overall Study|Kidney Transplantation|0|||
125079459|NCT03799627|449907740|FG007|Overall Study|Kidney Transplantation|0|||
125079460|NCT03799627|449907741|FG008|Overall Study|Kidney Transplantation|0|||
125079461|NCT03799627|449907733|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
125079462|NCT03799627|449907734|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
125079463|NCT03799627|449907735|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
125079464|NCT03799627|449907736|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
125079465|NCT03799627|449907737|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
125079466|NCT03799627|449907738|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
125079467|NCT03799627|449907739|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
125079468|NCT03799627|449907740|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
125079469|NCT03799627|449907741|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
125079470|NCT03799627|449907733|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
125079471|NCT03799627|449907734|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
125079472|NCT03799627|449907735|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
125079473|NCT03799627|449907736|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
125079474|NCT03799627|449907737|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
125079475|NCT03799627|449907738|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
125079476|NCT03799627|449907739|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
125079477|NCT03799627|449907740|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
125079478|NCT03799627|449907741|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
125079479|NCT03799627|449907733|FG000|Overall Study|Met Exclusion Criteria|0|||
125079480|NCT03799627|449907734|FG001|Overall Study|Met Exclusion Criteria|0|||
125079481|NCT03799627|449907735|FG002|Overall Study|Met Exclusion Criteria|0|||
125079482|NCT03799627|449907736|FG003|Overall Study|Met Exclusion Criteria|1|||
125079483|NCT03799627|449907737|FG004|Overall Study|Met Exclusion Criteria|0|||
125079484|NCT03799627|449907738|FG005|Overall Study|Met Exclusion Criteria|0|||
125079485|NCT03799627|449907739|FG006|Overall Study|Met Exclusion Criteria|0|||
125079486|NCT03799627|449907740|FG007|Overall Study|Met Exclusion Criteria|0|||
125079487|NCT03799627|449907741|FG008|Overall Study|Met Exclusion Criteria|0|||
125079488|NCT03799627|449907733|FG000|Overall Study|Investigational Product Noncompliance|0|||
125079489|NCT03799627|449907734|FG001|Overall Study|Investigational Product Noncompliance|0|||
125079490|NCT03799627|449907735|FG002|Overall Study|Investigational Product Noncompliance|0|||
125079491|NCT03799627|449907736|FG003|Overall Study|Investigational Product Noncompliance|1|||
125079492|NCT03799627|449907737|FG004|Overall Study|Investigational Product Noncompliance|0|||
125079493|NCT03799627|449907738|FG005|Overall Study|Investigational Product Noncompliance|0|||
125079494|NCT03799627|449907739|FG006|Overall Study|Investigational Product Noncompliance|0|||
125079495|NCT03799627|449907740|FG007|Overall Study|Investigational Product Noncompliance|0|||
125079496|NCT03799627|449907741|FG008|Overall Study|Investigational Product Noncompliance|0|||
125079497|NCT03799627|449907733|FG000|Overall Study|Participant Relocation|0|||
125079498|NCT03799627|449907734|FG001|Overall Study|Participant Relocation|0|||
125079499|NCT03799627|449907735|FG002|Overall Study|Participant Relocation|0|||
125079500|NCT03799627|449907736|FG003|Overall Study|Participant Relocation|1|||
125079501|NCT03799627|449907737|FG004|Overall Study|Participant Relocation|0|||
125079502|NCT03799627|449907738|FG005|Overall Study|Participant Relocation|1|||
125079503|NCT03799627|449907739|FG006|Overall Study|Participant Relocation|0|||
125079504|NCT03799627|449907740|FG007|Overall Study|Participant Relocation|0|||
125079505|NCT03799627|449907741|FG008|Overall Study|Participant Relocation|0|||
125079506|NCT03799627|449907733|FG000|Overall Study|Eurofin Issue|0|||
125079507|NCT03799627|449907734|FG001|Overall Study|Eurofin Issue|0|||
125079508|NCT03799627|449907735|FG002|Overall Study|Eurofin Issue|0|||
125079509|NCT03799627|449907736|FG003|Overall Study|Eurofin Issue|0|||
125079510|NCT03799627|449907737|FG004|Overall Study|Eurofin Issue|1|||
125079511|NCT03799627|449907738|FG005|Overall Study|Eurofin Issue|0|||
125079512|NCT03799627|449907739|FG006|Overall Study|Eurofin Issue|0|||
125079513|NCT03799627|449907740|FG007|Overall Study|Eurofin Issue|0|||
125079514|NCT03799627|449907741|FG008|Overall Study|Eurofin Issue|0|||
125079515|NCT03799627|449907733|FG000|Overall Study|Noncompliance with Site Instructions|0|||
125079516|NCT03799627|449907734|FG001|Overall Study|Noncompliance with Site Instructions|0|||
125079517|NCT03799627|449907735|FG002|Overall Study|Noncompliance with Site Instructions|0|||
125079518|NCT03799627|449907736|FG003|Overall Study|Noncompliance with Site Instructions|0|||
125079519|NCT03799627|449907737|FG004|Overall Study|Noncompliance with Site Instructions|1|||
125079520|NCT03799627|449907738|FG005|Overall Study|Noncompliance with Site Instructions|0|||
125079521|NCT03799627|449907739|FG006|Overall Study|Noncompliance with Site Instructions|0|||
125079522|NCT03799627|449907740|FG007|Overall Study|Noncompliance with Site Instructions|0|||
125079523|NCT03799627|449907741|FG008|Overall Study|Noncompliance with Site Instructions|0|||
125079524|NCT03799627|449907733|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
125079525|NCT03799627|449907734|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
125079526|NCT03799627|449907735|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
125079527|NCT03799627|449907736|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
125079528|NCT03799627|449907737|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
125079529|NCT03799627|449907738|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
125079530|NCT03799627|449907739|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
125079531|NCT03799627|449907740|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
125079532|NCT03799627|449907741|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
125079533|NCT03799627|449907733|FG000|Overall Study|Changes In Hemoglobin Values|1|||
125079534|NCT03799627|449907734|FG001|Overall Study|Changes In Hemoglobin Values|2|||
125079535|NCT03799627|449907735|FG002|Overall Study|Changes In Hemoglobin Values|1|||
125079536|NCT03799627|449907736|FG003|Overall Study|Changes In Hemoglobin Values|0|||
125079537|NCT03799627|449907737|FG004|Overall Study|Changes In Hemoglobin Values|0|||
125079538|NCT03799627|449907738|FG005|Overall Study|Changes In Hemoglobin Values|2|||
125079539|NCT03799627|449907739|FG006|Overall Study|Changes In Hemoglobin Values|1|||
125079540|NCT03799627|449907740|FG007|Overall Study|Changes In Hemoglobin Values|0|||
125079541|NCT03799627|449907741|FG008|Overall Study|Changes In Hemoglobin Values|1|||
125079542|NCT02092324|449907744|FG000|Overall Study|Adverse Event|1|||
125079543|NCT02092324|449907744|FG000|Overall Study|Lack of Efficacy|6|||
125079544|NCT02092324|449907744|FG000|Overall Study|Proceed to Transplant|3|||
125079545|NCT02092324|449907744|FG000|Overall Study|Physician Decision|7|||
125079546|NCT02092324|449907744|FG000|Overall Study|Misdiagnosis|2|||
125079547|NCT01922739|449907751|FG000|Titration/Adjustment Period|Adverse Event|3|||
125079548|NCT01922739|449907751|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
125079549|NCT01922739|449907751|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
125079550|NCT01922739|449907751|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
125079551|NCT01922739|449907751|FG000|Open-label Treatment Period|Adverse Event|6|||
125079552|NCT01922739|449907751|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
125079553|NCT01922739|449907751|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
125079554|NCT01922739|449907751|FG000|Open-label Treatment Period|Protocol Violation|5|||
125079555|NCT01922739|449907751|FG000|Open-label Treatment Period|Pregnancy|1|||
125079556|NCT01922739|449907751|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
125079557|NCT01922739|449907751|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
125079558|NCT01922739|449907751|FG000|Open-label Treatment Period|Physician Decision|1|||
125079559|NCT01922739|449907751|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
125079560|NCT02725268|449907754|FG000|Overall Study|Death|58|||
125079561|NCT02725268|449907755|FG001|Overall Study|Death|59|||
125144220|NCT00668395|450151474|FG002|Overall Study|Physician Decision|0|||
125144221|NCT05665387|450151479|FG000|Overall Study|Withdrawal by Subject|1|||
125144222|NCT05665387|450151480|FG001|Overall Study|Withdrawal by Subject|0|||
125079562|NCT02725268|449907756|FG002|Overall Study|Death|30|||
125079563|NCT02725268|449907757|FG003|Overall Study|Death|16|||
125079564|NCT02725268|449907754|FG000|Overall Study|Lost to Follow-up|4|||
125079565|NCT02725268|449907755|FG001|Overall Study|Lost to Follow-up|3|||
125079566|NCT02725268|449907756|FG002|Overall Study|Lost to Follow-up|0|||
125079567|NCT02725268|449907757|FG003|Overall Study|Lost to Follow-up|1|||
125079568|NCT02725268|449907754|FG000|Overall Study|Site Terminated by Sponsor|0|||
125079569|NCT02725268|449907755|FG001|Overall Study|Site Terminated by Sponsor|1|||
125079570|NCT02725268|449907756|FG002|Overall Study|Site Terminated by Sponsor|0|||
125079571|NCT02725268|449907757|FG003|Overall Study|Site Terminated by Sponsor|0|||
125079572|NCT02725268|449907754|FG000|Overall Study|Withdrawal by Subject|8|||
125079573|NCT02725268|449907755|FG001|Overall Study|Withdrawal by Subject|6|||
125079574|NCT02725268|449907756|FG002|Overall Study|Withdrawal by Subject|8|||
125079575|NCT02725268|449907757|FG003|Overall Study|Withdrawal by Subject|1|||
125079576|NCT02725268|449907754|FG000|Overall Study|Reason not Specified|2|||
125079577|NCT02725268|449907755|FG001|Overall Study|Reason not Specified|1|||
125079578|NCT02725268|449907756|FG002|Overall Study|Reason not Specified|0|||
125079579|NCT02725268|449907757|FG003|Overall Study|Reason not Specified|0|||
125079580|NCT04498468|449907758|FG000|Overall Study|Lost to Follow-up|3|||
125079581|NCT02224274|449907760|FG000|Overall Study|Death|1|||
125079582|NCT02224274|449907761|FG001|Overall Study|Death|0|||
125079583|NCT01976624|449907762|FG000|Overall Study|Participants contraindicated|2|||
125079584|NCT01976624|449907762|FG000|Overall Study|Participants age less than 19 years|12|||
125079585|NCT04350372|449907763|FG000|Overall Study|Death|1|||
125079586|NCT00412113|449907765|FG000|Overall Study|Adverse Event|11|||
125079587|NCT00412113|449907766|FG001|Overall Study|Adverse Event|15|||
125079588|NCT00412113|449907765|FG000|Overall Study|did not receive treatment|1|||
125079589|NCT00412113|449907766|FG001|Overall Study|did not receive treatment|0|||
125079590|NCT01190020|449907769|FG000|Overall Study|Adverse Event|2|||
125079591|NCT01190020|449907770|FG001|Overall Study|Adverse Event|0|||
125079592|NCT01190020|449907769|FG000|Overall Study|Lost to Follow-up|2|||
125079593|NCT01190020|449907770|FG001|Overall Study|Lost to Follow-up|0|||
125079594|NCT01190020|449907769|FG000|Overall Study|Withdrawal by Subject|3|||
125079595|NCT01190020|449907770|FG001|Overall Study|Withdrawal by Subject|0|||
125079596|NCT01627782|449907773|FG000|Overall Study|Adverse Event|1|||
125079597|NCT01627782|449907774|FG001|Overall Study|Adverse Event|2|||
125079598|NCT01627782|449907775|FG002|Overall Study|Adverse Event|0|||
125079599|NCT01627782|449907776|FG003|Overall Study|Adverse Event|1|||
125079600|NCT01627782|449907773|FG000|Overall Study|Lack of Efficacy|11|||
125079601|NCT01627782|449907774|FG001|Overall Study|Lack of Efficacy|1|||
125079602|NCT01627782|449907775|FG002|Overall Study|Lack of Efficacy|15|||
125079603|NCT01627782|449907776|FG003|Overall Study|Lack of Efficacy|2|||
125079604|NCT01627782|449907773|FG000|Overall Study|Protocol Violation|1|||
125079605|NCT01627782|449907774|FG001|Overall Study|Protocol Violation|0|||
125079606|NCT01627782|449907775|FG002|Overall Study|Protocol Violation|0|||
125079607|NCT01627782|449907776|FG003|Overall Study|Protocol Violation|0|||
125079608|NCT01627782|449907773|FG000|Overall Study|Withdrawal by Subject|2|||
125079609|NCT01627782|449907774|FG001|Overall Study|Withdrawal by Subject|1|||
125079610|NCT01627782|449907775|FG002|Overall Study|Withdrawal by Subject|0|||
125079611|NCT01627782|449907776|FG003|Overall Study|Withdrawal by Subject|0|||
125079612|NCT01627782|449907773|FG000|Overall Study|Other|0|||
125079613|NCT01627782|449907774|FG001|Overall Study|Other|2|||
125079614|NCT01627782|449907775|FG002|Overall Study|Other|0|||
125079615|NCT01627782|449907776|FG003|Overall Study|Other|3|||
125079616|NCT01627782|449907773|FG000|Overall Study|Randomized But Not Treated|1|||
125079617|NCT01627782|449907774|FG001|Overall Study|Randomized But Not Treated|0|||
125079618|NCT01627782|449907775|FG002|Overall Study|Randomized But Not Treated|0|||
125079619|NCT01627782|449907776|FG003|Overall Study|Randomized But Not Treated|0|||
125079620|NCT03573401|449907777|FG000|Overall Study|Withdrawal by Subject|2|||
125079621|NCT03573401|449907778|FG001|Overall Study|Withdrawal by Subject|0|||
125079622|NCT03573401|449907777|FG000|Overall Study|Subject non-compliance with study schedule|1|||
125079623|NCT03573401|449907778|FG001|Overall Study|Subject non-compliance with study schedule|0|||
125079624|NCT03573401|449907777|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
125079625|NCT03573401|449907778|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
125079626|NCT03573401|449907777|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
125079627|NCT03573401|449907778|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
125079628|NCT00777257|449909555|FG000|Overall Study|Adverse Event|3|||
125079629|NCT00777257|449909556|FG001|Overall Study|Adverse Event|1|||
125079630|NCT00777257|449909557|FG002|Overall Study|Adverse Event|0|||
125079631|NCT00777257|449909555|FG000|Overall Study|Lost to Follow-up|3|||
125079632|NCT00777257|449909556|FG001|Overall Study|Lost to Follow-up|3|||
125079633|NCT00777257|449909557|FG002|Overall Study|Lost to Follow-up|2|||
125079634|NCT00777257|449909555|FG000|Overall Study|Protocol Violation|2|||
125079635|NCT00777257|449909556|FG001|Overall Study|Protocol Violation|2|||
125079636|NCT00777257|449909557|FG002|Overall Study|Protocol Violation|2|||
125079637|NCT00777257|449909555|FG000|Overall Study|Withdrawal by Subject|3|||
125079638|NCT00777257|449909556|FG001|Overall Study|Withdrawal by Subject|6|||
125079639|NCT00777257|449909557|FG002|Overall Study|Withdrawal by Subject|5|||
125079640|NCT04315298|449909558|FG000|Overall Study|Withdrawal by Subject|0|||
125079641|NCT04315298|449909559|FG001|Overall Study|Withdrawal by Subject|0|||
125079642|NCT04315298|449909560|FG002|Overall Study|Withdrawal by Subject|0|||
125079643|NCT04315298|449909561|FG003|Overall Study|Withdrawal by Subject|2|||
125079644|NCT04315298|449909562|FG004|Overall Study|Withdrawal by Subject|2|||
125079645|NCT04315298|449909563|FG005|Overall Study|Withdrawal by Subject|2|||
125079646|NCT04315298|449909564|FG006|Overall Study|Withdrawal by Subject|0|||
125079647|NCT04315298|449909565|FG007|Overall Study|Withdrawal by Subject|1|||
125079648|NCT04315298|449909566|FG008|Overall Study|Withdrawal by Subject|1|||
125079649|NCT04315298|449909567|FG009|Overall Study|Withdrawal by Subject|1|||
125079650|NCT04315298|449909568|FG010|Overall Study|Withdrawal by Subject|0|||
125079651|NCT04315298|449909569|FG011|Overall Study|Withdrawal by Subject|0|||
125079652|NCT04315298|449909570|FG012|Overall Study|Withdrawal by Subject|0|||
125079653|NCT04315298|449909571|FG013|Overall Study|Withdrawal by Subject|0|||
125079654|NCT04315298|449909572|FG014|Overall Study|Withdrawal by Subject|0|||
125079655|NCT04315298|449909573|FG015|Overall Study|Withdrawal by Subject|0|||
125079656|NCT04315298|449909574|FG016|Overall Study|Withdrawal by Subject|0|||
125079657|NCT04315298|449909575|FG017|Overall Study|Withdrawal by Subject|0|||
125079658|NCT04315298|449909576|FG018|Overall Study|Withdrawal by Subject|0|||
125079659|NCT04315298|449909558|FG000|Overall Study|Physician Decision|0|||
125079660|NCT04315298|449909559|FG001|Overall Study|Physician Decision|0|||
125079661|NCT04315298|449909560|FG002|Overall Study|Physician Decision|0|||
125079662|NCT04315298|449909561|FG003|Overall Study|Physician Decision|0|||
125079663|NCT04315298|449909562|FG004|Overall Study|Physician Decision|1|||
125079664|NCT04315298|449909563|FG005|Overall Study|Physician Decision|0|||
125079665|NCT04315298|449909564|FG006|Overall Study|Physician Decision|0|||
125079666|NCT04315298|449909565|FG007|Overall Study|Physician Decision|0|||
125079667|NCT04315298|449909566|FG008|Overall Study|Physician Decision|0|||
125079668|NCT04315298|449909567|FG009|Overall Study|Physician Decision|0|||
125079669|NCT04315298|449909568|FG010|Overall Study|Physician Decision|0|||
125079670|NCT04315298|449909569|FG011|Overall Study|Physician Decision|0|||
125079671|NCT04315298|449909570|FG012|Overall Study|Physician Decision|0|||
125079672|NCT04315298|449909571|FG013|Overall Study|Physician Decision|0|||
125079673|NCT04315298|449909572|FG014|Overall Study|Physician Decision|0|||
125079674|NCT04315298|449909573|FG015|Overall Study|Physician Decision|0|||
125079675|NCT04315298|449909574|FG016|Overall Study|Physician Decision|0|||
125079676|NCT04315298|449909575|FG017|Overall Study|Physician Decision|0|||
125079677|NCT04315298|449909576|FG018|Overall Study|Physician Decision|0|||
125079678|NCT04315298|449909558|FG000|Overall Study|Lost to Follow-up|5|||
125079679|NCT04315298|449909559|FG001|Overall Study|Lost to Follow-up|10|||
125079680|NCT04315298|449909560|FG002|Overall Study|Lost to Follow-up|6|||
125079681|NCT04315298|449909561|FG003|Overall Study|Lost to Follow-up|8|||
125079682|NCT04315298|449909562|FG004|Overall Study|Lost to Follow-up|12|||
125079683|NCT04315298|449909563|FG005|Overall Study|Lost to Follow-up|13|||
125079684|NCT04315298|449909564|FG006|Overall Study|Lost to Follow-up|9|||
125079685|NCT04315298|449909565|FG007|Overall Study|Lost to Follow-up|16|||
125079686|NCT04315298|449909566|FG008|Overall Study|Lost to Follow-up|14|||
125079687|NCT04315298|449909567|FG009|Overall Study|Lost to Follow-up|0|||
125079688|NCT04315298|449909568|FG010|Overall Study|Lost to Follow-up|2|||
125079689|NCT04315298|449909569|FG011|Overall Study|Lost to Follow-up|1|||
125079690|NCT04315298|449909570|FG012|Overall Study|Lost to Follow-up|0|||
125079691|NCT04315298|449909571|FG013|Overall Study|Lost to Follow-up|0|||
125079692|NCT04315298|449909572|FG014|Overall Study|Lost to Follow-up|0|||
125079693|NCT04315298|449909573|FG015|Overall Study|Lost to Follow-up|2|||
125079694|NCT04315298|449909574|FG016|Overall Study|Lost to Follow-up|0|||
125079695|NCT04315298|449909575|FG017|Overall Study|Lost to Follow-up|0|||
125079696|NCT04315298|449909576|FG018|Overall Study|Lost to Follow-up|0|||
125079697|NCT04315298|449909558|FG000|Overall Study|Death|24|||
125079698|NCT04315298|449909559|FG001|Overall Study|Death|60|||
125079699|NCT04315298|449909560|FG002|Overall Study|Death|49|||
125079700|NCT04315298|449909561|FG003|Overall Study|Death|59|||
125079701|NCT04315298|449909562|FG004|Overall Study|Death|70|||
125079702|NCT04315298|449909563|FG005|Overall Study|Death|114|||
125144223|NCT05665387|450151481|FG002|Overall Study|Withdrawal by Subject|1|||
125079703|NCT04315298|449909564|FG006|Overall Study|Death|9|||
125079704|NCT04315298|449909565|FG007|Overall Study|Death|12|||
125079705|NCT04315298|449909566|FG008|Overall Study|Death|21|||
125079706|NCT04315298|449909567|FG009|Overall Study|Death|16|||
125079707|NCT04315298|449909568|FG010|Overall Study|Death|40|||
125079708|NCT04315298|449909569|FG011|Overall Study|Death|40|||
125079709|NCT04315298|449909570|FG012|Overall Study|Death|3|||
125079710|NCT04315298|449909571|FG013|Overall Study|Death|4|||
125144224|NCT01211262|450151484|FG000|Overall Study|Progressive Disease|18|||
125079711|NCT04315298|449909572|FG014|Overall Study|Death|6|||
125079712|NCT04315298|449909573|FG015|Overall Study|Death|4|||
125079713|NCT04315298|449909574|FG016|Overall Study|Death|3|||
125079714|NCT04315298|449909575|FG017|Overall Study|Death|1|||
125079715|NCT04315298|449909576|FG018|Overall Study|Death|0|||
125079716|NCT00736385|449909577|FG000|Overall Study|Withdrawal by Subject|2|||
125079717|NCT00736385|449909578|FG001|Overall Study|Withdrawal by Subject|2|||
125079718|NCT00736385|449909577|FG000|Overall Study|Adverse Event|0|||
125079719|NCT00736385|449909578|FG001|Overall Study|Adverse Event|1|||
125079720|NCT00098865|449909579|FG000|Overall Study|Progressive Disease|6|||
125079721|NCT00098865|449909579|FG000|Overall Study|Adverse Event|2|||
125079722|NCT00098865|449909579|FG000|Overall Study|Alternative Therapy|1|||
125079723|NCT01183104|449909580|FG000|Overall Study|Adverse Event|8|||
125079724|NCT01183104|449909581|FG001|Overall Study|Adverse Event|6|||
125079725|NCT01183104|449909580|FG000|Overall Study|Death|0|||
125079726|NCT01183104|449909581|FG001|Overall Study|Death|1|||
125079727|NCT01183104|449909580|FG000|Overall Study|Lost to Follow-up|14|||
125079728|NCT01183104|449909581|FG001|Overall Study|Lost to Follow-up|7|||
125079729|NCT01183104|449909580|FG000|Overall Study|Physician Decision|5|||
125079730|NCT01183104|449909581|FG001|Overall Study|Physician Decision|8|||
125079731|NCT01183104|449909580|FG000|Overall Study|Withdrawal by Subject|6|||
125079732|NCT01183104|449909581|FG001|Overall Study|Withdrawal by Subject|11|||
125079733|NCT01183104|449909580|FG000|Overall Study|Nonparticipation in Extension Study|39|||
125079734|NCT01183104|449909581|FG001|Overall Study|Nonparticipation in Extension Study|50|||
125079735|NCT01183104|449909580|FG000|Overall Study|Did not receive study drug|5|||
125079736|NCT01183104|449909581|FG001|Overall Study|Did not receive study drug|9|||
125079737|NCT03267511|449909582|FG000|Overall Study|Lost to Follow-up|0|||
125079738|NCT03267511|449909583|FG001|Overall Study|Lost to Follow-up|0|||
125079739|NCT03267511|449909584|FG002|Overall Study|Lost to Follow-up|0|||
125079740|NCT03267511|449909585|FG003|Overall Study|Lost to Follow-up|1|||
125079741|NCT00364351|449909586|FG000|Overall Study|Adverse Event|90|||
125079742|NCT00364351|449909587|FG001|Overall Study|Adverse Event|44|||
125079743|NCT00364351|449909586|FG000|Overall Study|Condition under investigation worsened|469|||
125079744|NCT00364351|449909587|FG001|Overall Study|Condition under investigation worsened|497|||
125079745|NCT00364351|449909586|FG000|Overall Study|Prohibited concomitant medication|0|||
125079746|NCT00364351|449909587|FG001|Overall Study|Prohibited concomitant medication|2|||
125079747|NCT00364351|449909586|FG000|Overall Study|Lost to Follow-up|1|||
125079748|NCT00364351|449909587|FG001|Overall Study|Lost to Follow-up|1|||
125079749|NCT00364351|449909586|FG000|Overall Study|Withdrawal by Subject|30|||
125079750|NCT00364351|449909587|FG001|Overall Study|Withdrawal by Subject|29|||
125079751|NCT00364351|449909586|FG000|Overall Study|Incorrect enrollment|1|||
125079752|NCT00364351|449909587|FG001|Overall Study|Incorrect enrollment|1|||
125079753|NCT00364351|449909586|FG000|Overall Study|Sponsor decision|1|||
125079754|NCT00364351|449909587|FG001|Overall Study|Sponsor decision|0|||
125079755|NCT00364351|449909586|FG000|Overall Study|Poor treatment compliance|0|||
125079756|NCT00364351|449909587|FG001|Overall Study|Poor treatment compliance|3|||
125079757|NCT00364351|449909586|FG000|Overall Study|Investigator error|0|||
125079758|NCT00364351|449909587|FG001|Overall Study|Investigator error|2|||
125079759|NCT00364351|449909586|FG000|Overall Study|Patient could not travel to site|0|||
125079760|NCT00364351|449909587|FG001|Overall Study|Patient could not travel to site|1|||
125079761|NCT00364351|449909586|FG000|Overall Study|Randomised treatment not started|0|||
125079762|NCT00364351|449909587|FG001|Overall Study|Randomised treatment not started|3|||
125079763|NCT00688623|449909589|FG000|Overall Study|Adverse Event|22|||
125079764|NCT00688623|449909589|FG000|Overall Study|abnormal lab value|1|||
125079765|NCT00688623|449909589|FG000|Overall Study|Withdrawal by Subject|4|||
125079766|NCT00688623|449909589|FG000|Overall Study|Death|3|||
125079767|NCT00688623|449909589|FG000|Overall Study|disease progression|23|||
125079768|NCT00688623|449909589|FG000|Overall Study|Protocol Violation|2|||
125079769|NCT02667236|449909590|FG000|Overall Study|Adverse Event|1|||
125079770|NCT02667236|449909591|FG001|Overall Study|Adverse Event|1|||
125079771|NCT02667236|449909590|FG000|Overall Study|Withdrawal by Subject|2|||
125079772|NCT02667236|449909591|FG001|Overall Study|Withdrawal by Subject|0|||
125079773|NCT03887052|449909594|FG000|Overall Study|Adverse Event|2|||
125079774|NCT03887052|449909594|FG000|Overall Study|Physician Decision|2|||
125079775|NCT03887052|449909594|FG000|Overall Study|Withdrawal by Subject|3|||
125079776|NCT03887052|449909594|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
125079777|NCT03887052|449909594|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
125079778|NCT03687827|449909598|FG000|Treatment Period 1|Death|0|||
125079779|NCT03687827|449909599|FG001|Treatment Period 1|Death|1|||
125079780|NCT03687827|449909598|FG000|Treatment Period 1|Lost to Follow-up|2|||
125079781|NCT03687827|449909599|FG001|Treatment Period 1|Lost to Follow-up|2|||
125079782|NCT03687827|449909598|FG000|Treatment Period 1|Physician Decision|5|||
125079783|NCT03687827|449909599|FG001|Treatment Period 1|Physician Decision|2|||
125079784|NCT03687827|449909598|FG000|Treatment Period 1|Withdrawal by Subject|7|||
125079785|NCT03687827|449909599|FG001|Treatment Period 1|Withdrawal by Subject|3|||
125079786|NCT03687827|449909598|FG000|Treatment Period 2|Physician Decision|4|||
125079787|NCT03687827|449909599|FG001|Treatment Period 2|Physician Decision|1|||
125079788|NCT03687827|449909598|FG000|Treatment Period 2|Withdrawal by Subject|1|||
125079789|NCT03687827|449909599|FG001|Treatment Period 2|Withdrawal by Subject|2|||
125079790|NCT01678313|449909600|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
125079791|NCT01678313|449909601|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
125079792|NCT01678313|449909600|FG000|Completed the 3-month Therapy|Physician Decision|3|||
125144225|NCT01211262|450151485|FG001|Overall Study|Progressive Disease|9|||
125144226|NCT01211262|450151484|FG000|Overall Study|Adverse Event|4|||
125079793|NCT01678313|449909601|FG001|Completed the 3-month Therapy|Physician Decision|4|||
125079794|NCT01678313|449909600|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
125079795|NCT01678313|449909601|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
125079796|NCT01678313|449909600|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
125079797|NCT01678313|449909601|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
125079798|NCT00981292|449909604|FG000|Day 1|Protocol Violation|1|||
125079799|NCT00981292|449909605|FG001|Day 1|Protocol Violation|0|||
125079800|NCT00981292|449909606|FG002|Day 1|Protocol Violation|0|||
125144227|NCT01211262|450151485|FG001|Overall Study|Adverse Event|0|||
125144228|NCT01211262|450151484|FG000|Overall Study|Withdrawal of Consent|1|||
125144229|NCT01211262|450151485|FG001|Overall Study|Withdrawal of Consent|0|||
125144230|NCT01211262|450151484|FG000|Overall Study|Other|0|||
125144231|NCT01211262|450151485|FG001|Overall Study|Other|1|||
125144232|NCT04049097|450151488|FG000|Overall Study|Adverse Event|18|||
125144233|NCT04049097|450151488|FG000|Overall Study|Death|2|||
125144234|NCT04049097|450151488|FG000|Overall Study|Lost to Follow-up|1|||
125144235|NCT04049097|450151488|FG000|Overall Study|Physician Decision|2|||
125144236|NCT04049097|450151488|FG000|Overall Study|Withdrawal by Subject|9|||
125144237|NCT04049097|450151488|FG000|Overall Study|Protocol Violation|2|||
125223459|NCT02326272|450446178|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125223460|NCT02326272|450446164|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125223461|NCT02326272|450446165|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125223462|NCT02326272|450446166|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125079801|NCT00981292|449909607|FG003|Day 1|Protocol Violation|0|||
125079802|NCT00981292|449909608|FG004|Day 1|Protocol Violation|0|||
125079803|NCT00981292|449909609|FG005|Day 1|Protocol Violation|2|||
125079804|NCT00981292|449909604|FG000|Day 2|Protocol Violation|2|||
125079805|NCT00981292|449909605|FG001|Day 2|Protocol Violation|0|||
125079806|NCT00981292|449909606|FG002|Day 2|Protocol Violation|0|||
125079807|NCT00981292|449909607|FG003|Day 2|Protocol Violation|0|||
125079808|NCT00981292|449909608|FG004|Day 2|Protocol Violation|0|||
125079809|NCT00981292|449909609|FG005|Day 2|Protocol Violation|0|||
125079810|NCT00981292|449909604|FG000|Day 3|Protocol Violation|0|||
125079811|NCT00981292|449909605|FG001|Day 3|Protocol Violation|0|||
125079812|NCT00981292|449909606|FG002|Day 3|Protocol Violation|0|||
125079813|NCT00981292|449909607|FG003|Day 3|Protocol Violation|0|||
125079814|NCT00981292|449909608|FG004|Day 3|Protocol Violation|0|||
125079815|NCT00981292|449909609|FG005|Day 3|Protocol Violation|1|||
125079816|NCT01131130|449909610|FG000|Period 1 - Baseline|Pregnancy|1|||
125079817|NCT01131130|449909610|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
125079818|NCT03464136|449909611|FG000|Overall Study|Lost to Follow-up|5|||
125079819|NCT03464136|449909612|FG001|Overall Study|Lost to Follow-up|8|||
125079820|NCT03464136|449909611|FG000|Overall Study|Withdrawal by Subject|16|||
125079821|NCT03464136|449909612|FG001|Overall Study|Withdrawal by Subject|13|||
125079822|NCT03464136|449909611|FG000|Overall Study|Death|1|||
125079823|NCT03464136|449909612|FG001|Overall Study|Death|0|||
125079824|NCT03464136|449909611|FG000|Overall Study|Other|8|||
125079825|NCT03464136|449909612|FG001|Overall Study|Other|4|||
125079826|NCT03412565|449909613|FG000|Overall Study|Lost to Follow-up|0|||
125079827|NCT03412565|449909614|FG001|Overall Study|Lost to Follow-up|0|||
125079828|NCT03412565|449909615|FG002|Overall Study|Lost to Follow-up|1|||
125079829|NCT03412565|449909616|FG003|Overall Study|Lost to Follow-up|0|||
125079830|NCT03412565|449909613|FG000|Overall Study|Physician Decision|0|||
125079831|NCT03412565|449909614|FG001|Overall Study|Physician Decision|0|||
125079832|NCT03412565|449909615|FG002|Overall Study|Physician Decision|0|||
125079833|NCT03412565|449909616|FG003|Overall Study|Physician Decision|1|||
125079834|NCT03412565|449909613|FG000|Overall Study|Withdrawal by Subject|0|||
125079835|NCT03412565|449909614|FG001|Overall Study|Withdrawal by Subject|4|||
125079836|NCT03412565|449909615|FG002|Overall Study|Withdrawal by Subject|5|||
125079837|NCT03412565|449909616|FG003|Overall Study|Withdrawal by Subject|5|||
125079838|NCT03412565|449909613|FG000|Overall Study|Death|1|||
125079839|NCT03412565|449909614|FG001|Overall Study|Death|3|||
125223463|NCT02326272|450446167|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125223464|NCT02326272|450446168|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125223465|NCT02326272|450446169|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125223466|NCT02326272|450446170|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
125223467|NCT02326272|450446171|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125079840|NCT03412565|449909615|FG002|Overall Study|Death|4|||
125223468|NCT02326272|450446172|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125079841|NCT03412565|449909616|FG003|Overall Study|Death|5|||
125079842|NCT03412565|449909613|FG000|Overall Study|Data collection ended|0|||
125079843|NCT03412565|449909614|FG001|Overall Study|Data collection ended|41|||
125144238|NCT04049097|450151488|FG000|Overall Study|Other|1|||
125144239|NCT04049097|450151488|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
125223469|NCT02326272|450446173|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125079844|NCT03412565|449909615|FG002|Overall Study|Data collection ended|41|||
125079845|NCT03412565|449909616|FG003|Overall Study|Data collection ended|40|||
125079846|NCT03277105|449909617|FG000|Overall Study|Death|129|||
125079847|NCT03277105|449909618|FG001|Overall Study|Death|124|||
125079848|NCT03277105|449909617|FG000|Overall Study|Lost to Follow-up|2|||
125079849|NCT03277105|449909618|FG001|Overall Study|Lost to Follow-up|4|||
125079850|NCT03277105|449909617|FG000|Overall Study|Withdrawal by Subject|10|||
125079851|NCT03277105|449909618|FG001|Overall Study|Withdrawal by Subject|10|||
125079852|NCT03277105|449909617|FG000|Overall Study|Other|118|||
125079853|NCT03277105|449909618|FG001|Overall Study|Other|125|||
125079854|NCT00498368|449909625|FG000|Overall Study|Withdrawal by Subject|3|||
125079855|NCT00498368|449909626|FG001|Overall Study|Withdrawal by Subject|2|||
125079856|NCT00285649|449909629|FG000|Overall Study|Lost to Follow-up|6|||
125079857|NCT00285649|449909630|FG001|Overall Study|Lost to Follow-up|4|||
125079858|NCT00285649|449909631|FG002|Overall Study|Lost to Follow-up|4|||
125079859|NCT00285649|449909629|FG000|Overall Study|Withdrawal by Subject|3|||
125079860|NCT00285649|449909630|FG001|Overall Study|Withdrawal by Subject|2|||
125079861|NCT00285649|449909631|FG002|Overall Study|Withdrawal by Subject|2|||
125079862|NCT03342404|449909632|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
125079863|NCT03342404|449909633|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
125079864|NCT03342404|449909632|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
125079865|NCT03342404|449909633|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
125079866|NCT03342404|449909632|FG000|Blinded Treatment Phase|Adverse Event|5|||
125079867|NCT03342404|449909633|FG001|Blinded Treatment Phase|Adverse Event|4|||
125079868|NCT03342404|449909632|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
125079869|NCT03342404|449909633|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
125079870|NCT03342404|449909632|FG000|Blinded Treatment Phase|Other reasons|1|||
125079871|NCT03342404|449909633|FG001|Blinded Treatment Phase|Other reasons|0|||
125079872|NCT03342404|449909632|FG000|Blinded Treatment Phase|Physician Decision|1|||
125079873|NCT03342404|449909633|FG001|Blinded Treatment Phase|Physician Decision|0|||
125079874|NCT03342404|449909632|FG000|Blinded Treatment Phase|Death|1|||
125079875|NCT03342404|449909633|FG001|Blinded Treatment Phase|Death|0|||
125079876|NCT03342404|449909632|FG000|Open-Label Phase|Lost to Follow-up|0|||
125079877|NCT03342404|449909633|FG001|Open-Label Phase|Lost to Follow-up|1|||
125079878|NCT03342404|449909632|FG000|Open-Label Phase|Other reasons|0|||
125079879|NCT03342404|449909633|FG001|Open-Label Phase|Other reasons|1|||
125079880|NCT03342404|449909632|FG000|Open-Label Phase|Adverse Event|0|||
125079881|NCT03342404|449909633|FG001|Open-Label Phase|Adverse Event|3|||
125079882|NCT03342404|449909632|FG000|Open-Label Phase|Withdrawal by Subject|0|||
125079883|NCT03342404|449909633|FG001|Open-Label Phase|Withdrawal by Subject|6|||
125079884|NCT03748420|449909636|FG000|Overall Study|No 12 month medication adherence data available|0|||
125079885|NCT03748420|449909637|FG001|Overall Study|No 12 month medication adherence data available|1|||
125079886|NCT03748420|449909636|FG000|Overall Study|Death|24|||
125079887|NCT03748420|449909637|FG001|Overall Study|Death|28|||
125079888|NCT03748420|449909636|FG000|Overall Study|Lost to Follow-up|231|||
125079889|NCT03748420|449909637|FG001|Overall Study|Lost to Follow-up|230|||
125079890|NCT00373880|449909638|FG000|Overall Study|Physician Decision|3|||
125079891|NCT00373880|449909638|FG000|Overall Study|Arrested|1|||
125079892|NCT00373880|449909638|FG000|Overall Study|Protocol Violation|14|||
125144240|NCT01970592|450151489|FG000|Overall Study|Withdrawal by Subject|4|||
125144241|NCT01970592|450151489|FG000|Overall Study|Physician Decision|1|||
125144242|NCT01970592|450151489|FG000|Overall Study|Adverse Event|1|||
125144243|NCT00160524|450151490|FG000|Overall Study|Adverse Event|119|||
125144244|NCT00160524|450151490|FG000|Overall Study|Adverse Event and Other|94|||
125144245|NCT00160524|450151490|FG000|Overall Study|Protocol Violation|16|||
125144246|NCT00160524|450151490|FG000|Overall Study|Protocol Violation and Other|2|||
125144247|NCT00160524|450151490|FG000|Overall Study|Withdrawal by Subject|141|||
125144248|NCT00160524|450151490|FG000|Overall Study|Withdrawal by Subject and Other|17|||
125144249|NCT00160524|450151490|FG000|Overall Study|Physician Decision|27|||
125144250|NCT00160524|450151490|FG000|Overall Study|Physician Decision and Other|6|||
125144251|NCT00160524|450151490|FG000|Overall Study|Lost to Follow-up|13|||
125144252|NCT00160524|450151490|FG000|Overall Study|Lost to Follow-up and Other|1|||
125144253|NCT00160524|450151490|FG000|Overall Study|Lack of Efficacy|21|||
125144254|NCT00160524|450151490|FG000|Overall Study|Lack of Efficacy and Other|1|||
125144255|NCT00160524|450151490|FG000|Overall Study|Other|20|||
125144256|NCT02661022|450151491|FG000|Overall Study|Withdrawal by Subject|3|||
125144257|NCT02661022|450151492|FG001|Overall Study|Withdrawal by Subject|0|||
125144258|NCT02661022|450151491|FG000|Overall Study|Adverse Event|1|||
125144259|NCT02661022|450151492|FG001|Overall Study|Adverse Event|1|||
125144260|NCT02661022|450151491|FG000|Overall Study|Physician Decision|1|||
125144261|NCT02661022|450151492|FG001|Overall Study|Physician Decision|0|||
125144262|NCT02661022|450151491|FG000|Overall Study|Progressive Disease|2|||
125144263|NCT02661022|450151492|FG001|Overall Study|Progressive Disease|1|||
125079893|NCT00312728|449909646|FG000|Overall Study|Progressive disease|53|||
125144264|NCT03448692|450151493|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
125079894|NCT00312728|449909646|FG000|Overall Study|Adverse Event|32|||
125079895|NCT00312728|449909646|FG000|Overall Study|Withdrawal by Subject|10|||
125079896|NCT00312728|449909646|FG000|Overall Study|Required non-protocol cancer treatment|2|||
125079897|NCT00312728|449909646|FG000|Overall Study|Protocol Violation|2|||
125079898|NCT00312728|449909646|FG000|Overall Study|Other|10|||
125079899|NCT00312728|449909646|FG000|Overall Study|Other|1|||
125079900|NCT00423592|449909650|FG000|Overall Study|Adverse Event (through Week 12)|2|||
125079901|NCT00423592|449909650|FG000|Overall Study|Adverse Event (post Week 12)|5|||
125079902|NCT03446612|449909651|FG000|Overall Study|Protocol defined stopping criteria|0|||
125079903|NCT03446612|449909652|FG001|Overall Study|Protocol defined stopping criteria|1|||
125079904|NCT01437267|449909653|FG000|Overall Study|Withdrawal by Subject|0|||
125079905|NCT01437267|449909654|FG001|Overall Study|Withdrawal by Subject|0|||
125079906|NCT01437267|449909655|FG002|Overall Study|Withdrawal by Subject|0|||
125079907|NCT01437267|449909656|FG003|Overall Study|Withdrawal by Subject|1|||
125079908|NCT01437267|449909657|FG004|Overall Study|Withdrawal by Subject|0|||
125079909|NCT01437267|449909658|FG005|Overall Study|Withdrawal by Subject|0|||
125079910|NCT01437267|449909653|FG000|Overall Study|Protocol Violation|0|||
125079911|NCT01437267|449909654|FG001|Overall Study|Protocol Violation|1|||
125079912|NCT01437267|449909655|FG002|Overall Study|Protocol Violation|0|||
125079913|NCT01437267|449909656|FG003|Overall Study|Protocol Violation|0|||
125079914|NCT01437267|449909657|FG004|Overall Study|Protocol Violation|0|||
125079915|NCT01437267|449909658|FG005|Overall Study|Protocol Violation|0|||
125079916|NCT03934203|449909661|FG000|Overall Study|Adverse Event|0|||
125079917|NCT03934203|449909662|FG001|Overall Study|Adverse Event|0|||
125079918|NCT03934203|449909663|FG002|Overall Study|Adverse Event|1|||
125079919|NCT03934203|449909664|FG003|Overall Study|Adverse Event|0|||
125079920|NCT03934203|449909665|FG004|Overall Study|Adverse Event|1|||
125079921|NCT03934203|449909666|FG005|Overall Study|Adverse Event|0|||
125079922|NCT03934203|449909667|FG006|Overall Study|Adverse Event|2|||
125079923|NCT03934203|449909668|FG007|Overall Study|Adverse Event|0|||
125079924|NCT03934203|449909669|FG008|Overall Study|Adverse Event|0|||
125079925|NCT03934203|449909670|FG009|Overall Study|Adverse Event|0|||
125079926|NCT03934203|449909671|FG010|Overall Study|Adverse Event|0|||
125144265|NCT03448692|450151494|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
125144266|NCT03448692|450151493|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
125144267|NCT03448692|450151494|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
125144268|NCT03448692|450151493|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
125144269|NCT03448692|450151494|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
125144270|NCT03448692|450151493|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
125144271|NCT03448692|450151494|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
125144272|NCT03448692|450151493|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
125144273|NCT03448692|450151494|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
125144274|NCT01598896|450151503|FG000|Overall Study|Withdrawal by Subject|0|||
125144275|NCT01598896|450151504|FG001|Overall Study|Withdrawal by Subject|1|||
125144276|NCT01598896|450151503|FG000|Overall Study|Lack of Efficacy|0|||
125144277|NCT01598896|450151504|FG001|Overall Study|Lack of Efficacy|1|||
125144278|NCT04553406|450151507|FG000|Overall Study|Study Discontinuation|0|||
125144279|NCT04553406|450151508|FG001|Overall Study|Study Discontinuation|1|||
125144280|NCT00772148|450151509|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
125144281|NCT00772148|450151510|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
125144282|NCT00772148|450151509|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
125144283|NCT00772148|450151510|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
125144284|NCT00772148|450151509|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
125144285|NCT00772148|450151510|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
125144286|NCT00772148|450151509|FG000|Maintenance Phase (Week 52)|Death|2|||
125144287|NCT00772148|450151510|FG001|Maintenance Phase (Week 52)|Death|2|||
125144288|NCT00772148|450151509|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
125144289|NCT00772148|450151510|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
125144290|NCT00772148|450151509|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
125144291|NCT00772148|450151510|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
125144292|NCT00772148|450151509|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
125144293|NCT00772148|450151510|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
125144294|NCT00633022|450151513|FG000|Overall Study|Adverse Event|1|||
125144295|NCT00633022|450151514|FG001|Overall Study|Adverse Event|0|||
125144296|NCT00633022|450151515|FG002|Overall Study|Adverse Event|5|||
125144297|NCT00633022|450151513|FG000|Overall Study|Physician Decision|0|||
125144298|NCT00633022|450151514|FG001|Overall Study|Physician Decision|1|||
125144299|NCT00633022|450151515|FG002|Overall Study|Physician Decision|0|||
125144300|NCT03573336|450151516|FG000|Overall Study|Study terminated|2|||
125079927|NCT03934203|449909672|FG011|Overall Study|Adverse Event|0|||
125079928|NCT03934203|449909673|FG012|Overall Study|Adverse Event|0|||
125079929|NCT03934203|449909674|FG013|Overall Study|Adverse Event|1|||
125079930|NCT03934203|449909675|FG014|Overall Study|Adverse Event|0|||
125079931|NCT00608842|449909678|FG000|Overall Study|Participant's Request|0|||
125144301|NCT03573336|450151517|FG001|Overall Study|Study terminated|4|||
125144302|NCT03573336|450151518|FG002|Overall Study|Study terminated|2|||
125144303|NCT04388787|450151519|FG000|Blinded Period|Patient could not follow instructions|1|||
125144304|NCT04388787|450151519|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
125144305|NCT02940522|450153040|FG000|Overall Study|Lost to Follow-up|1|||
125144306|NCT02940522|450153041|FG001|Overall Study|Lost to Follow-up|2|||
125144307|NCT02940522|450153040|FG000|Overall Study|Withdrawal by Subject|1|||
125079932|NCT00608842|449909679|FG001|Overall Study|Participant's Request|1|||
125079933|NCT00608842|449909680|FG002|Overall Study|Participant's Request|2|||
125079934|NCT00608842|449909681|FG003|Overall Study|Participant's Request|1|||
125079935|NCT00608842|449909678|FG000|Overall Study|Lost to Follow-up|1|||
125079936|NCT00608842|449909679|FG001|Overall Study|Lost to Follow-up|0|||
125079937|NCT00608842|449909680|FG002|Overall Study|Lost to Follow-up|0|||
125079938|NCT00608842|449909681|FG003|Overall Study|Lost to Follow-up|0|||
125079939|NCT01039428|449909684|FG000|Overall Study|Protocol Violation|1|||
125079940|NCT01039428|449909685|FG001|Overall Study|Protocol Violation|0|||
125079941|NCT01039428|449909684|FG000|Overall Study|Withdrawal by Subject|1|||
125079942|NCT01039428|449909685|FG001|Overall Study|Withdrawal by Subject|0|||
125079943|NCT00422240|449909688|FG000|Overall Study|Lack of Efficacy|1|||
125079944|NCT00422240|449909689|FG001|Overall Study|Lack of Efficacy|2|||
125079945|NCT00422240|449909690|FG002|Overall Study|Lack of Efficacy|0|||
125079946|NCT00422240|449909691|FG003|Overall Study|Lack of Efficacy|1|||
125079947|NCT00422240|449909688|FG000|Overall Study|Adverse Event|11|||
125079948|NCT00422240|449909689|FG001|Overall Study|Adverse Event|4|||
125079949|NCT00422240|449909690|FG002|Overall Study|Adverse Event|5|||
125079950|NCT00422240|449909691|FG003|Overall Study|Adverse Event|2|||
125079951|NCT00422240|449909688|FG000|Overall Study|Subject request|21|||
125079952|NCT00422240|449909689|FG001|Overall Study|Subject request|17|||
125079953|NCT00422240|449909690|FG002|Overall Study|Subject request|18|||
125079954|NCT00422240|449909691|FG003|Overall Study|Subject request|30|||
125079955|NCT00422240|449909688|FG000|Overall Study|Protocol Violation|0|||
125079956|NCT00422240|449909689|FG001|Overall Study|Protocol Violation|1|||
125079957|NCT00422240|449909690|FG002|Overall Study|Protocol Violation|0|||
125079958|NCT00422240|449909691|FG003|Overall Study|Protocol Violation|1|||
125079959|NCT00422240|449909688|FG000|Overall Study|Lost to Follow-up|31|||
125079960|NCT00422240|449909689|FG001|Overall Study|Lost to Follow-up|32|||
125079961|NCT00422240|449909690|FG002|Overall Study|Lost to Follow-up|19|||
125079962|NCT00422240|449909691|FG003|Overall Study|Lost to Follow-up|34|||
125079963|NCT00422240|449909688|FG000|Overall Study|Other|1|||
125079964|NCT00422240|449909689|FG001|Overall Study|Other|0|||
125079965|NCT00422240|449909690|FG002|Overall Study|Other|0|||
125079966|NCT00422240|449909691|FG003|Overall Study|Other|1|||
125079967|NCT00422240|449909688|FG000|Overall Study|Pregnancy|3|||
125079968|NCT00422240|449909689|FG001|Overall Study|Pregnancy|1|||
125079969|NCT00422240|449909690|FG002|Overall Study|Pregnancy|1|||
125079970|NCT00422240|449909691|FG003|Overall Study|Pregnancy|2|||
125079971|NCT04489940|449909692|FG000|Overall Study|Other|2|||
125079972|NCT04489940|449909692|FG000|Overall Study|Withdrawal by Subject|2|||
125079973|NCT04489940|449909692|FG000|Overall Study|Death|5|||
125079974|NCT04489940|449909692|FG000|Overall Study|Lost to Follow-up|1|||
125079975|NCT01624467|449909693|FG000|Overall Study|Withdrawal by Subject|2|||
125079976|NCT01624467|449909693|FG000|Overall Study|Lost to Follow-up|1|||
125079977|NCT01624467|449909693|FG000|Overall Study|Adverse Event|7|||
125079978|NCT01624467|449909693|FG000|Overall Study|Progressive Disease|19|||
125079979|NCT01624467|449909693|FG000|Overall Study|Per Sponsor Requirement|1|||
125079980|NCT01624467|449909693|FG000|Overall Study|Subject Withdrew from Treatment|1|||
125079981|NCT03964493|449909696|FG000|Overall Study|Withdrawal by Subject|4|||
125079982|NCT03964493|449909697|FG001|Overall Study|Withdrawal by Subject|1|||
125079983|NCT03964493|449909696|FG000|Overall Study|Lost to Follow-up|13|||
125079984|NCT03964493|449909697|FG001|Overall Study|Lost to Follow-up|4|||
125079985|NCT02470429|449909698|FG000|Overall Study|Adverse Event|1|||
125079986|NCT02470429|449909699|FG001|Overall Study|Adverse Event|0|||
125079987|NCT02470429|449909698|FG000|Overall Study|Withdrawal by Subject|1|||
125079988|NCT02470429|449909699|FG001|Overall Study|Withdrawal by Subject|0|||
125079989|NCT00398138|449909700|FG000|Overall Study|Adverse Event|2|||
125079990|NCT01188811|449909703|FG000|Overall Study|Withdrawal by Subject|0|||
125079991|NCT01188811|449909704|FG001|Overall Study|Withdrawal by Subject|2|||
125079992|NCT01188811|449909703|FG000|Overall Study|Adverse Event|6|||
125079993|NCT01188811|449909704|FG001|Overall Study|Adverse Event|0|||
125079994|NCT01602744|449909705|FG000|Overall Study|Death|17|||
125079995|NCT01602744|449909706|FG001|Overall Study|Death|15|||
125079996|NCT01602744|449909705|FG000|Overall Study|Lost to Follow-up|13|||
125079997|NCT01602744|449909706|FG001|Overall Study|Lost to Follow-up|8|||
125079998|NCT03418376|449909707|FG000|Overall Study|Musculoskeletal injury|1|||
125079999|NCT03418376|449909708|FG001|Overall Study|Musculoskeletal injury|2|||
125080000|NCT03418376|449909709|FG002|Overall Study|Musculoskeletal injury|1|||
125080001|NCT03418376|449909710|FG003|Overall Study|Musculoskeletal injury|0|||
125080002|NCT03418376|449909707|FG000|Overall Study|Personal reasons|0|||
125080003|NCT03418376|449909708|FG001|Overall Study|Personal reasons|2|||
125080004|NCT03418376|449909709|FG002|Overall Study|Personal reasons|2|||
125080005|NCT03418376|449909710|FG003|Overall Study|Personal reasons|1|||
125144308|NCT02940522|450153041|FG001|Overall Study|Withdrawal by Subject|0|||
125144309|NCT02710214|450153042|FG000|Overall Study|Lost to Follow-up|1|||
125080006|NCT03418376|449909707|FG000|Overall Study|Exacerbation|0|||
125080007|NCT03418376|449909708|FG001|Overall Study|Exacerbation|1|||
125080008|NCT03418376|449909709|FG002|Overall Study|Exacerbation|0|||
125080009|NCT03418376|449909710|FG003|Overall Study|Exacerbation|0|||
125080010|NCT01387594|449909715|FG000|Overall Study|Withdrawal by Subject|0|||
125080011|NCT01387594|449909716|FG001|Overall Study|Withdrawal by Subject|2|||
125080012|NCT01387594|449909715|FG000|Overall Study|Lost to Follow-up|0|||
125080013|NCT01387594|449909716|FG001|Overall Study|Lost to Follow-up|1|||
125080014|NCT03573804|449909718|FG000|Overall Study|claustrophobia or MRI table problems|10|||
125080015|NCT03050307|449911515|FG000|Overall Study|Adverse Event|4|||
125080016|NCT03050307|449911516|FG001|Overall Study|Adverse Event|2|||
125080017|NCT03050307|449911515|FG000|Overall Study|Significant Protocol Deviation|0|||
125080018|NCT03050307|449911516|FG001|Overall Study|Significant Protocol Deviation|1|||
125080019|NCT03050307|449911515|FG000|Overall Study|Lost to Follow-up|0|||
125080020|NCT03050307|449911516|FG001|Overall Study|Lost to Follow-up|1|||
125080021|NCT03050307|449911515|FG000|Overall Study|Voluntary Withdrawal|3|||
125080022|NCT03050307|449911516|FG001|Overall Study|Voluntary Withdrawal|4|||
125080023|NCT03050307|449911515|FG000|Overall Study|Reason not Specified|1|||
125080024|NCT03050307|449911516|FG001|Overall Study|Reason not Specified|1|||
125080025|NCT01998906|449911517|FG000|Overall Study|Participants ongoing in follow-up|77|||
125080026|NCT01998906|449911518|FG001|Overall Study|Participants ongoing in follow-up|60|||
125080027|NCT01998906|449911519|FG002|Overall Study|Participants ongoing in follow-up|58|||
125080028|NCT01998906|449911517|FG000|Overall Study|Death|21|||
125080029|NCT01998906|449911518|FG001|Overall Study|Death|30|||
125080030|NCT01998906|449911519|FG002|Overall Study|Death|17|||
125080031|NCT01998906|449911517|FG000|Overall Study|Lack of Efficacy|10|||
125080032|NCT01998906|449911518|FG001|Overall Study|Lack of Efficacy|9|||
125080033|NCT01998906|449911519|FG002|Overall Study|Lack of Efficacy|8|||
125144310|NCT02710214|450153043|FG001|Overall Study|Lost to Follow-up|0|||
125144311|NCT02710214|450153042|FG000|Overall Study|Lack of Efficacy|0|||
125144312|NCT02710214|450153043|FG001|Overall Study|Lack of Efficacy|1|||
125144313|NCT02710214|450153042|FG000|Overall Study|Death|0|||
125144314|NCT02710214|450153043|FG001|Overall Study|Death|1|||
125144315|NCT04980456|450153049|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
125080034|NCT01998906|449911517|FG000|Overall Study|Failure to return|0|||
125144316|NCT04980456|450153050|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
125144317|NCT04980456|450153049|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
125144318|NCT04980456|450153050|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
125144319|NCT04980456|450153049|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
125144320|NCT04980456|450153050|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
125144321|NCT04980456|450153049|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
125144322|NCT04980456|450153050|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
125144323|NCT04832971|450153051|FG000|Overall Study|Death|1|||
125144324|NCT04832971|450153052|FG001|Overall Study|Death|0|||
125144325|NCT04832971|450153053|FG002|Overall Study|Death|0|||
125144326|NCT04832971|450153054|FG003|Overall Study|Death|0|||
125144327|NCT04832971|450153051|FG000|Overall Study|Lost to Follow-up|1|||
125144328|NCT04832971|450153052|FG001|Overall Study|Lost to Follow-up|1|||
125144329|NCT04832971|450153053|FG002|Overall Study|Lost to Follow-up|1|||
125144330|NCT04832971|450153054|FG003|Overall Study|Lost to Follow-up|0|||
125144331|NCT04832971|450153051|FG000|Overall Study|Withdrawal by Subject|1|||
125080035|NCT01998906|449911518|FG001|Overall Study|Failure to return|2|||
125080036|NCT01998906|449911519|FG002|Overall Study|Failure to return|4|||
125080037|NCT01998906|449911517|FG000|Overall Study|Violation of Selection Criteria|0|||
125080038|NCT01998906|449911518|FG001|Overall Study|Violation of Selection Criteria|0|||
125144332|NCT04832971|450153052|FG001|Overall Study|Withdrawal by Subject|3|||
125144333|NCT04832971|450153053|FG002|Overall Study|Withdrawal by Subject|2|||
125144334|NCT04832971|450153054|FG003|Overall Study|Withdrawal by Subject|2|||
125223470|NCT02326272|450446174|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125144335|NCT04832971|450153051|FG000|Overall Study|Other, Not Specified|0|||
125144336|NCT04832971|450153052|FG001|Overall Study|Other, Not Specified|0|||
125144337|NCT04832971|450153053|FG002|Overall Study|Other, Not Specified|1|||
125144338|NCT04832971|450153054|FG003|Overall Study|Other, Not Specified|0|||
125144339|NCT00927251|450153055|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
125144340|NCT03687242|450153060|FG000|Overall Study|Adverse Event|1|||
125144341|NCT00969124|450153081|FG000|Overall Study|Protocol Violation|2|||
125144342|NCT00969124|450153081|FG000|Overall Study|Inadequate bowel preparation|15|||
125144343|NCT00969124|450153081|FG000|Overall Study|Inability to reach cecum|9|||
125144344|NCT00969124|450153081|FG000|Overall Study|Previously unrecognized disease|3|||
125144345|NCT00969124|450153081|FG000|Overall Study|Technical error|1|||
125144346|NCT02575339|450153084|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
125144347|NCT02575339|450153085|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
125223471|NCT02326272|450446175|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125223472|NCT02326272|450446176|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125223473|NCT02326272|450446177|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125223474|NCT02326272|450446178|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125223475|NCT02326272|450446164|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125080039|NCT01998906|449911519|FG002|Overall Study|Violation of Selection Criteria|1|||
125080040|NCT01998906|449911517|FG000|Overall Study|Withdrawal by Subject|1|||
125080041|NCT01998906|449911518|FG001|Overall Study|Withdrawal by Subject|4|||
125080042|NCT01998906|449911519|FG002|Overall Study|Withdrawal by Subject|3|||
125223476|NCT02326272|450446165|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223477|NCT02326272|450446166|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223478|NCT02326272|450446167|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223479|NCT02326272|450446168|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223480|NCT02326272|450446169|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223481|NCT02326272|450446170|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223482|NCT02326272|450446171|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223483|NCT02326272|450446172|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
125223484|NCT02326272|450446173|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223485|NCT02326272|450446174|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223486|NCT02326272|450446175|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223487|NCT02326272|450446176|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223488|NCT02326272|450446177|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223489|NCT02326272|450446178|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223490|NCT02326272|450446164|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223491|NCT02326272|450446165|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223492|NCT02326272|450446166|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223493|NCT02326272|450446167|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223494|NCT02326272|450446168|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223495|NCT02326272|450446169|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
125223496|NCT02326272|450446170|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
125223497|NCT02326272|450446171|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
125223498|NCT02326272|450446172|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
125223499|NCT02326272|450446173|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223500|NCT02326272|450446174|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223501|NCT02326272|450446175|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223502|NCT02326272|450446176|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223503|NCT02326272|450446177|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223504|NCT02326272|450446178|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223505|NCT02326272|450446164|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125080043|NCT01998906|449911517|FG000|Overall Study|Administrative/Other|2|||
125080044|NCT01998906|449911518|FG001|Overall Study|Administrative/Other|1|||
125080045|NCT01998906|449911519|FG002|Overall Study|Administrative/Other|3|||
125080046|NCT01998906|449911517|FG000|Overall Study|Other|3|||
125080047|NCT01998906|449911518|FG001|Overall Study|Other|8|||
125080048|NCT01998906|449911519|FG002|Overall Study|Other|4|||
125080049|NCT02996110|449911520|FG000|Pre-Treatment|Other Reasons|0|||
125080050|NCT02996110|449911521|FG001|Pre-Treatment|Other Reasons|1|||
125080051|NCT02996110|449911522|FG002|Pre-Treatment|Other Reasons|0|||
125080052|NCT02996110|449911523|FG003|Pre-Treatment|Other Reasons|0|||
125080053|NCT02996110|449911524|FG004|Pre-Treatment|Other Reasons|1|||
125080054|NCT02996110|449911520|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
125080055|NCT02996110|449911521|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
125080056|NCT02996110|449911522|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
125144348|NCT02575339|450153086|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
125144349|NCT02575339|450153084|FG000|Study Treatment|Disease Progression|5|||
125080057|NCT02996110|449911523|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
125080058|NCT02996110|449911524|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
125080059|NCT02996110|449911520|FG000|Track 1|Disease Progression|15|||
125080060|NCT02996110|449911521|FG001|Track 1|Disease Progression|17|||
125080061|NCT02996110|449911522|FG002|Track 1|Disease Progression|0|||
125080062|NCT02996110|449911523|FG003|Track 1|Disease Progression|0|||
125080063|NCT02996110|449911524|FG004|Track 1|Disease Progression|0|||
125080064|NCT02996110|449911520|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
125080065|NCT02996110|449911521|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
125080066|NCT02996110|449911522|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
125080067|NCT02996110|449911523|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
125080068|NCT02996110|449911524|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
125080069|NCT02996110|449911520|FG000|Track 1|Study Drug Toxicity|5|||
125080070|NCT02996110|449911521|FG001|Track 1|Study Drug Toxicity|3|||
125080071|NCT02996110|449911522|FG002|Track 1|Study Drug Toxicity|0|||
125080072|NCT02996110|449911523|FG003|Track 1|Study Drug Toxicity|0|||
125080073|NCT02996110|449911524|FG004|Track 1|Study Drug Toxicity|0|||
125080074|NCT02996110|449911520|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
125080075|NCT02996110|449911521|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
125080076|NCT02996110|449911522|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
125080077|NCT02996110|449911523|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
125080078|NCT02996110|449911524|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
125080079|NCT02996110|449911520|FG000|Track 1|Administrative Reason by Sponsor|0|||
125080080|NCT02996110|449911521|FG001|Track 1|Administrative Reason by Sponsor|1|||
125080081|NCT02996110|449911522|FG002|Track 1|Administrative Reason by Sponsor|0|||
125080082|NCT02996110|449911523|FG003|Track 1|Administrative Reason by Sponsor|0|||
125080083|NCT02996110|449911524|FG004|Track 1|Administrative Reason by Sponsor|0|||
125080084|NCT02996110|449911520|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
125080085|NCT02996110|449911521|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
125080086|NCT02996110|449911522|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
125080087|NCT02996110|449911523|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
125144350|NCT02575339|450153085|FG001|Study Treatment|Disease Progression|2|||
125144351|NCT02575339|450153086|FG002|Study Treatment|Disease Progression|0|||
125144352|NCT02575339|450153084|FG000|Study Treatment|Adverse Event|1|||
125144353|NCT02575339|450153085|FG001|Study Treatment|Adverse Event|2|||
125144354|NCT02575339|450153086|FG002|Study Treatment|Adverse Event|0|||
125144355|NCT02575339|450153084|FG000|Follow up|Death|6|||
125144356|NCT02575339|450153085|FG001|Follow up|Death|2|||
125144357|NCT02575339|450153086|FG002|Follow up|Death|0|||
125144358|NCT02575339|450153084|FG000|Follow up|Study Terminated|0|||
125144359|NCT02575339|450153085|FG001|Follow up|Study Terminated|2|||
125144360|NCT02575339|450153086|FG002|Follow up|Study Terminated|0|||
125144361|NCT02575339|450153084|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
125144362|NCT02575339|450153085|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
125144363|NCT02575339|450153086|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
125144364|NCT04633642|450153087|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
125144365|NCT04633642|450153088|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
125144366|NCT04675775|450153089|FG000|Overall Study|Withdrawal by Subject|7|||
125144367|NCT02451358|450153094|FG000|Overall Study|Withdrawal by Subject|1|||
125144368|NCT02451358|450153095|FG001|Overall Study|Withdrawal by Subject|1|||
125144369|NCT02451358|450153096|FG002|Overall Study|Withdrawal by Subject|0|||
125144370|NCT02451358|450153097|FG003|Overall Study|Withdrawal by Subject|0|||
125144371|NCT02451358|450153094|FG000|Overall Study|Protocol Violation|0|||
125144372|NCT02451358|450153095|FG001|Overall Study|Protocol Violation|1|||
125080088|NCT02996110|449911524|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
125080089|NCT02996110|449911520|FG000|Track 2|Disease Progression|33|||
125080090|NCT02996110|449911521|FG001|Track 2|Disease Progression|26|||
125080091|NCT02996110|449911522|FG002|Track 2|Disease Progression|19|||
125080092|NCT02996110|449911523|FG003|Track 2|Disease Progression|16|||
125080093|NCT02996110|449911524|FG004|Track 2|Disease Progression|15|||
125080094|NCT02996110|449911520|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
125080095|NCT02996110|449911521|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
125080096|NCT02996110|449911522|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
125080097|NCT02996110|449911523|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
125080098|NCT02996110|449911524|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
125080099|NCT02996110|449911520|FG000|Track 2|Death|0|||
125080100|NCT02996110|449911521|FG001|Track 2|Death|0|||
125080101|NCT02996110|449911522|FG002|Track 2|Death|1|||
125144373|NCT02451358|450153096|FG002|Overall Study|Protocol Violation|1|||
125080102|NCT02996110|449911523|FG003|Track 2|Death|0|||
125080103|NCT02996110|449911524|FG004|Track 2|Death|1|||
125144374|NCT02451358|450153097|FG003|Overall Study|Protocol Violation|0|||
125144375|NCT01344018|450153104|FG000|Overall Study|Death|22|||
125144376|NCT01344018|450153105|FG001|Overall Study|Death|25|||
125144377|NCT01344018|450153104|FG000|Overall Study|Lost to Follow-up|4|||
125080104|NCT02996110|449911520|FG000|Track 2|Study Drug Toxicity|4|||
125080105|NCT02996110|449911521|FG001|Track 2|Study Drug Toxicity|1|||
125080106|NCT02996110|449911522|FG002|Track 2|Study Drug Toxicity|4|||
125080107|NCT02996110|449911523|FG003|Track 2|Study Drug Toxicity|1|||
125080108|NCT02996110|449911524|FG004|Track 2|Study Drug Toxicity|0|||
125080109|NCT02996110|449911520|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
125080110|NCT02996110|449911521|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
125080111|NCT02996110|449911522|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
125080112|NCT02996110|449911523|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
125080113|NCT02996110|449911524|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
125080114|NCT02996110|449911520|FG000|Track 2|Participant Withdrew Consent|1|||
125144378|NCT01344018|450153105|FG001|Overall Study|Lost to Follow-up|7|||
125144379|NCT05070754|450153106|FG000|Overall Study|Withdrawal by Subject|0|||
125144380|NCT05070754|450153107|FG001|Overall Study|Withdrawal by Subject|0|||
125144381|NCT05070754|450153108|FG002|Overall Study|Withdrawal by Subject|0|||
125144382|NCT05070754|450153109|FG003|Overall Study|Withdrawal by Subject|1|||
125144383|NCT05070754|450153106|FG000|Overall Study|Protocol Violation|0|||
125144384|NCT05070754|450153107|FG001|Overall Study|Protocol Violation|0|||
125144385|NCT05070754|450153108|FG002|Overall Study|Protocol Violation|0|||
125144386|NCT05070754|450153109|FG003|Overall Study|Protocol Violation|1|||
125144387|NCT00252564|450153110|FG000|Overall Study|Adverse Event|17|||
125144388|NCT00252564|450153111|FG001|Overall Study|Adverse Event|13|||
125144389|NCT00252564|450153110|FG000|Overall Study|Unrelated Complication|2|||
125144390|NCT00252564|450153111|FG001|Overall Study|Unrelated Complication|1|||
125144391|NCT00252564|450153110|FG000|Overall Study|Disease Progression|14|||
125144392|NCT00252564|450153111|FG001|Overall Study|Disease Progression|20|||
125144393|NCT00252564|450153110|FG000|Overall Study|Death|0|||
125144394|NCT00252564|450153111|FG001|Overall Study|Death|3|||
125144395|NCT00252564|450153110|FG000|Overall Study|Physician Decision|1|||
125144396|NCT00252564|450153111|FG001|Overall Study|Physician Decision|0|||
125144397|NCT00252564|450153110|FG000|Overall Study|Lost to Follow-up|1|||
125144398|NCT00252564|450153111|FG001|Overall Study|Lost to Follow-up|0|||
125144399|NCT00252564|450153110|FG000|Overall Study|Patient Request|4|||
125144400|NCT00252564|450153111|FG001|Overall Study|Patient Request|5|||
125144401|NCT00252564|450153110|FG000|Overall Study|Withdrawal by Subject|0|||
125144402|NCT00252564|450153111|FG001|Overall Study|Withdrawal by Subject|2|||
125144403|NCT04561115|450153113|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
125144404|NCT04561115|450153114|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
125144405|NCT04561115|450153113|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
125144406|NCT04561115|450153114|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
125144407|NCT04561115|450153113|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
125144408|NCT04561115|450153114|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
125144409|NCT00743145|450153115|FG000|Overall Study|Withdrawal by Subject|1|||
125144410|NCT00743145|450153115|FG000|Overall Study|Adverse Event|2|||
125144411|NCT00743145|450153115|FG000|Overall Study|Pregnancy|1|||
125144412|NCT01583530|450153116|FG000|Overall Study|Adverse Event|0|||
125144413|NCT01583530|450153117|FG001|Overall Study|Adverse Event|0|||
125144414|NCT01583530|450153118|FG002|Overall Study|Adverse Event|0|||
125144415|NCT01583530|450153119|FG003|Overall Study|Adverse Event|0|||
125144416|NCT01583530|450153120|FG004|Overall Study|Adverse Event|0|||
125144417|NCT01583530|450153121|FG005|Overall Study|Adverse Event|1|||
125144418|NCT01583530|450153116|FG000|Overall Study|Withdrawal by Subject|0|||
125144419|NCT01583530|450153117|FG001|Overall Study|Withdrawal by Subject|3|||
125144420|NCT01583530|450153118|FG002|Overall Study|Withdrawal by Subject|0|||
125144421|NCT01583530|450153119|FG003|Overall Study|Withdrawal by Subject|1|||
125144422|NCT01583530|450153120|FG004|Overall Study|Withdrawal by Subject|1|||
125144423|NCT01583530|450153121|FG005|Overall Study|Withdrawal by Subject|2|||
125144424|NCT01583530|450153116|FG000|Overall Study|Lost to Follow-up|0|||
125080115|NCT02996110|449911521|FG001|Track 2|Participant Withdrew Consent|2|||
125080116|NCT02996110|449911522|FG002|Track 2|Participant Withdrew Consent|3|||
125080117|NCT02996110|449911523|FG003|Track 2|Participant Withdrew Consent|1|||
125080118|NCT02996110|449911524|FG004|Track 2|Participant Withdrew Consent|1|||
125080119|NCT02996110|449911520|FG000|Track 2|Other Reasons|0|||
125080120|NCT02996110|449911521|FG001|Track 2|Other Reasons|0|||
125144425|NCT01583530|450153117|FG001|Overall Study|Lost to Follow-up|0|||
125144426|NCT01583530|450153118|FG002|Overall Study|Lost to Follow-up|0|||
125144427|NCT01583530|450153119|FG003|Overall Study|Lost to Follow-up|0|||
125080121|NCT02996110|449911522|FG002|Track 2|Other Reasons|1|||
125080122|NCT02996110|449911523|FG003|Track 2|Other Reasons|0|||
125080123|NCT02996110|449911524|FG004|Track 2|Other Reasons|1|||
125080124|NCT01077193|449911525|FG000|Overall Study|Lost to Follow-up|1|||
125080125|NCT01077193|449911525|FG000|Overall Study|Withdrawal by Subject|2|||
125080126|NCT01077193|449911525|FG000|Overall Study|Lack of Efficacy|1|||
125080127|NCT01077193|449911525|FG000|Overall Study|Study Terminated by Sponsor|40|||
125080128|NCT06048809|449911530|FG000|Overall Study|Adverse Event|2|||
125080129|NCT06048809|449911531|FG001|Overall Study|Adverse Event|0|||
125080130|NCT06048809|449911530|FG000|Overall Study|Withdrawal by Subject|1|||
125080131|NCT06048809|449911531|FG001|Overall Study|Withdrawal by Subject|1|||
125080132|NCT02148952|449911539|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
125080133|NCT02148952|449911540|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
125080134|NCT02148952|449911539|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
125080135|NCT02148952|449911540|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
125080136|NCT02148952|449911539|FG000|Follow-Up|Lost to Follow-up|219|||
125080137|NCT02148952|449911540|FG001|Follow-Up|Lost to Follow-up|231|||
125080138|NCT02148952|449911539|FG000|Follow-Up|Withdrawal by Subject|46|||
125080139|NCT02148952|449911540|FG001|Follow-Up|Withdrawal by Subject|48|||
125080140|NCT01600105|449911541|FG000|Total Participants|Withdrawal by Subject|1|||
125080141|NCT01600105|449911542|FG001|Total Participants|Withdrawal by Subject|0|||
125080142|NCT01600105|449911541|FG000|Total Participants|No images in PACS|10|||
125080143|NCT01600105|449911542|FG001|Total Participants|No images in PACS|0|||
125080144|NCT01600105|449911541|FG000|Total Participants|Insufficient image quality|30|||
125080145|NCT01600105|449911542|FG001|Total Participants|Insufficient image quality|10|||
125080146|NCT01600105|449911541|FG000|Sub Study I|Insufficient image quality|0|||
125080147|NCT01600105|449911542|FG001|Sub Study I|Insufficient image quality|10|||
125080148|NCT01600105|449911541|FG000|Sub Study II|Withdrawal by Subject|1|||
125080149|NCT01600105|449911542|FG001|Sub Study II|Withdrawal by Subject|0|||
125080150|NCT01600105|449911541|FG000|Sub Study II|No images in PACS|1|||
125080151|NCT01600105|449911542|FG001|Sub Study II|No images in PACS|0|||
125080152|NCT01600105|449911541|FG000|Sub Study II|Insufficient image quality|3|||
125080153|NCT01600105|449911542|FG001|Sub Study II|Insufficient image quality|0|||
125080154|NCT01600105|449911541|FG000|Sub Study III|Insufficient image quality|5|||
125080155|NCT01600105|449911542|FG001|Sub Study III|Insufficient image quality|0|||
125080156|NCT01600105|449911541|FG000|Sub Study V|Poor Image Quality|2|||
125080157|NCT01600105|449911542|FG001|Sub Study V|Poor Image Quality|0|||
125080158|NCT04007367|449911543|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
125080159|NCT04007367|449911544|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
125080160|NCT04007367|449911545|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
125080161|NCT04007367|449911543|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
125080162|NCT04007367|449911544|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
125080163|NCT04007367|449911545|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
125080164|NCT04007367|449911543|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
125080165|NCT04007367|449911544|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
125223506|NCT02326272|450446165|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125080166|NCT04007367|449911545|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
125080167|NCT04007367|449911543|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
125080168|NCT04007367|449911544|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
125080169|NCT04007367|449911545|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
125080170|NCT04007367|449911543|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
125144428|NCT01583530|450153120|FG004|Overall Study|Lost to Follow-up|3|||
125144429|NCT01583530|450153121|FG005|Overall Study|Lost to Follow-up|0|||
125144430|NCT01583530|450153116|FG000|Overall Study|Lack of compliance|0|||
125144431|NCT01583530|450153117|FG001|Overall Study|Lack of compliance|0|||
125144432|NCT01583530|450153118|FG002|Overall Study|Lack of compliance|0|||
125144433|NCT01583530|450153119|FG003|Overall Study|Lack of compliance|0|||
125144434|NCT01583530|450153120|FG004|Overall Study|Lack of compliance|1|||
125144435|NCT01583530|450153121|FG005|Overall Study|Lack of compliance|0|||
125144436|NCT02416180|450153122|FG000|Overall Study|Withdrawal by Subject|1|||
125144437|NCT03480022|450153127|FG000|Overall Study|Pregnancy|2|||
125144438|NCT03480022|450153128|FG001|Overall Study|Pregnancy|0|||
125144439|NCT03480022|450153127|FG000|Overall Study|Adverse Event|6|||
125144440|NCT03480022|450153128|FG001|Overall Study|Adverse Event|0|||
125144441|NCT03480022|450153127|FG000|Overall Study|Lack of Efficacy|0|||
125080171|NCT04007367|449911544|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
125080172|NCT04007367|449911545|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
125080173|NCT01764022|449911546|FG000|Overall Study|Death|3|||
125080174|NCT01764022|449911547|FG001|Overall Study|Death|5|||
125080175|NCT01764022|449911546|FG000|Overall Study|Withdrawal by Subject|2|||
125080176|NCT01764022|449911547|FG001|Overall Study|Withdrawal by Subject|6|||
125080177|NCT01764022|449911546|FG000|Overall Study|Lack of Efficacy|0|||
125080178|NCT01764022|449911547|FG001|Overall Study|Lack of Efficacy|1|||
125080179|NCT01764022|449911546|FG000|Overall Study|Physician Decision|0|||
125080180|NCT01764022|449911547|FG001|Overall Study|Physician Decision|2|||
125080181|NCT01764022|449911546|FG000|Overall Study|Lost to Follow-up|2|||
125080182|NCT01764022|449911547|FG001|Overall Study|Lost to Follow-up|0|||
125080183|NCT01764022|449911546|FG000|Overall Study|Protocol Violation|1|||
125080184|NCT01764022|449911547|FG001|Overall Study|Protocol Violation|0|||
125080185|NCT01899768|449911549|FG000|Part A|Adverse Event|2|||
125080186|NCT01899768|449911549|FG000|Part A|Withdrawal by Subject|1|||
125080187|NCT01899768|449911549|FG000|Part B|Adverse Event|1|||
125080188|NCT01899768|449911549|FG000|Part B|Withdrawal by Subject|1|||
125080189|NCT02203916|449911550|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
125080190|NCT02203916|449911551|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
125080191|NCT02203916|449911552|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
125080192|NCT02203916|449911550|FG000|Overall Study|Major Protocol Deviation|1|||
125080193|NCT02203916|449911551|FG001|Overall Study|Major Protocol Deviation|1|||
125080194|NCT02203916|449911552|FG002|Overall Study|Major Protocol Deviation|0|||
125080195|NCT02203916|449911550|FG000|Overall Study|Lost to Follow-up|0|||
125080196|NCT02203916|449911551|FG001|Overall Study|Lost to Follow-up|1|||
125080197|NCT02203916|449911552|FG002|Overall Study|Lost to Follow-up|0|||
125080198|NCT02203916|449911550|FG000|Overall Study|Voluntary Withdrawal|3|||
125080199|NCT02203916|449911551|FG001|Overall Study|Voluntary Withdrawal|3|||
125080200|NCT02203916|449911552|FG002|Overall Study|Voluntary Withdrawal|8|||
125080201|NCT02203916|449911550|FG000|Overall Study|Lack of Efficacy|3|||
125080202|NCT02203916|449911551|FG001|Overall Study|Lack of Efficacy|0|||
125080203|NCT02203916|449911552|FG002|Overall Study|Lack of Efficacy|0|||
125080204|NCT02203916|449911550|FG000|Overall Study|Reason Not Specified|0|||
125080205|NCT02203916|449911551|FG001|Overall Study|Reason Not Specified|2|||
125080206|NCT02203916|449911552|FG002|Overall Study|Reason Not Specified|1|||
125080207|NCT04043416|449911554|FG000|Washout|Change in health condition|0|||
125080208|NCT04043416|449911555|FG001|Washout|Change in health condition|1|||
125080209|NCT00414973|449911556|FG000|Overall Study|Withdrawal by Subject|14|||
125080210|NCT00414973|449911557|FG001|Overall Study|Withdrawal by Subject|4|||
125080211|NCT00414973|449911558|FG002|Overall Study|Withdrawal by Subject|1|||
125080212|NCT00414973|449911559|FG003|Overall Study|Withdrawal by Subject|0|||
125144442|NCT03480022|450153128|FG001|Overall Study|Lack of Efficacy|2|||
125080213|NCT00414973|449911556|FG000|Overall Study|Adverse Event|10|||
125080214|NCT00414973|449911557|FG001|Overall Study|Adverse Event|0|||
125080215|NCT00414973|449911558|FG002|Overall Study|Adverse Event|1|||
125080216|NCT00414973|449911559|FG003|Overall Study|Adverse Event|0|||
125080217|NCT00414973|449911556|FG000|Overall Study|Protocol Violation|3|||
125080218|NCT00414973|449911557|FG001|Overall Study|Protocol Violation|4|||
125080219|NCT00414973|449911558|FG002|Overall Study|Protocol Violation|0|||
125080220|NCT00414973|449911559|FG003|Overall Study|Protocol Violation|0|||
125080221|NCT00414973|449911556|FG000|Overall Study|Lost to Follow-up|0|||
125080222|NCT00414973|449911557|FG001|Overall Study|Lost to Follow-up|2|||
125080223|NCT00414973|449911558|FG002|Overall Study|Lost to Follow-up|0|||
125080224|NCT00414973|449911559|FG003|Overall Study|Lost to Follow-up|0|||
125080225|NCT00414973|449911556|FG000|Overall Study|Sponsor Decision|1|||
125080226|NCT00414973|449911557|FG001|Overall Study|Sponsor Decision|0|||
125080227|NCT00414973|449911558|FG002|Overall Study|Sponsor Decision|0|||
125080228|NCT00414973|449911559|FG003|Overall Study|Sponsor Decision|0|||
125080229|NCT00414973|449911556|FG000|Overall Study|Death|0|||
125080230|NCT00414973|449911557|FG001|Overall Study|Death|0|||
125144443|NCT03480022|450153127|FG000|Overall Study|Physician Decision|0|||
125144444|NCT03480022|450153128|FG001|Overall Study|Physician Decision|1|||
125144445|NCT03480022|450153127|FG000|Overall Study|Withdrawal by Subject|2|||
125144446|NCT03480022|450153128|FG001|Overall Study|Withdrawal by Subject|0|||
125080231|NCT00414973|449911558|FG002|Overall Study|Death|1|||
125080232|NCT00414973|449911559|FG003|Overall Study|Death|0|||
125080233|NCT01925014|449911568|FG000|Overall Study|Inappropriate enrollment|4|||
125080234|NCT01925014|449911569|FG001|Overall Study|Inappropriate enrollment|6|||
125080235|NCT01925014|449911568|FG000|Overall Study|Withdrawal by Subject|5|||
125080236|NCT01925014|449911569|FG001|Overall Study|Withdrawal by Subject|13|||
125080237|NCT00850135|449911573|FG000|Overall Study|Physician Decision|1|||
125080238|NCT00744991|449911574|FG000|Overall Study|Progressive Disease|11|||
125080239|NCT00744991|449911574|FG000|Overall Study|Withdrawal by Subject|8|||
125080240|NCT00744991|449911574|FG000|Overall Study|Physician Decision|3|||
125080241|NCT00744991|449911574|FG000|Overall Study|Adverse Event|2|||
125080242|NCT00744991|449911574|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
125080243|NCT01487863|449911575|FG000|Overall Study|Death|19|||
125080244|NCT01487863|449911576|FG001|Overall Study|Death|19|||
125080245|NCT02139280|449911577|FG000|Overall Study|No longer eligible|2|||
125080246|NCT02139280|449911578|FG001|Overall Study|No longer eligible|0|||
125080247|NCT00422903|449911591|FG000|Overall Study|Disease Progression|3|||
125080248|NCT00422903|449911592|FG001|Overall Study|Disease Progression|1|||
125080249|NCT00422903|449911591|FG000|Overall Study|Adverse Event|0|||
125080250|NCT00422903|449911592|FG001|Overall Study|Adverse Event|2|||
125080251|NCT00422903|449911591|FG000|Overall Study|Informed Consent Withdrawn|1|||
125080252|NCT00422903|449911592|FG001|Overall Study|Informed Consent Withdrawn|2|||
125080253|NCT01302691|449911593|FG000|Overall Study|Adverse Event|2|||
125080254|NCT01302691|449911594|FG001|Overall Study|Adverse Event|0|||
125080255|NCT01302691|449911593|FG000|Overall Study|Death|0|||
125080256|NCT01302691|449911594|FG001|Overall Study|Death|1|||
125080257|NCT01302691|449911593|FG000|Overall Study|Lost to Follow-up|1|||
125080258|NCT01302691|449911594|FG001|Overall Study|Lost to Follow-up|0|||
125080259|NCT01302691|449911593|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
125080260|NCT01302691|449911594|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
125080261|NCT01302691|449911593|FG000|Overall Study|Physician Decision|0|||
125080262|NCT01302691|449911594|FG001|Overall Study|Physician Decision|1|||
125080263|NCT01302691|449911593|FG000|Overall Study|Protocol Violation|1|||
125080264|NCT01302691|449911594|FG001|Overall Study|Protocol Violation|0|||
125080265|NCT00441480|449911595|FG000|Overall Study|Protocol Violation|1|||
125080266|NCT00441480|449911596|FG001|Overall Study|Protocol Violation|1|||
125080267|NCT00441480|449911595|FG000|Overall Study|Withdrawal by Subject|2|||
125080268|NCT00441480|449911596|FG001|Overall Study|Withdrawal by Subject|3|||
125080269|NCT00441012|449911597|FG000|Overall Study|Adverse Event|0|||
125080270|NCT00441012|449911598|FG001|Overall Study|Adverse Event|1|||
125080271|NCT00441012|449911597|FG000|Overall Study|Lost to Follow-up|3|||
125080272|NCT00441012|449911598|FG001|Overall Study|Lost to Follow-up|3|||
125080273|NCT00441012|449911597|FG000|Overall Study|Protocol Violation|10|||
125080274|NCT00441012|449911598|FG001|Overall Study|Protocol Violation|9|||
125080275|NCT00441012|449911597|FG000|Overall Study|Withdrawal by Subject|4|||
125080276|NCT00441012|449911598|FG001|Overall Study|Withdrawal by Subject|0|||
125080277|NCT00441012|449911597|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
125080278|NCT00441012|449911598|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
125080279|NCT02201472|449911599|FG000|Overall Study|Lack of Efficacy|2|||
125080280|NCT00262314|449911602|FG000|Overall Study|Changing physicians|38|||
125080281|NCT00262314|449911602|FG000|Overall Study|Death|12|||
125080282|NCT00262314|449911602|FG000|Overall Study|Patient's decision|92|||
125080283|NCT00262314|449911602|FG000|Overall Study|Other|95|||
125080284|NCT00262314|449911602|FG000|Overall Study|Lost to Follow-up|70|||
125080285|NCT00262314|449911602|FG000|Overall Study|Administrative withdrawal|30|||
125080286|NCT05104749|449911603|FG000|Overall Study|Lost to Follow-up|2|||
125080287|NCT05104749|449911604|FG001|Overall Study|Lost to Follow-up|3|||
125080288|NCT01300767|449911605|FG000|Overall Study|Discomfort|2|||
125080289|NCT01300767|449911605|FG000|Overall Study|Biomicroscopy|1|||
125080290|NCT01300767|449911605|FG000|Overall Study|Unacceptable fit|1|||
125080291|NCT00117572|449911606|FG000|Overall Study|Site withdrew before starting treatment|2|||
125080292|NCT00117572|449911607|FG001|Overall Study|Site withdrew before starting treatment|3|||
125080293|NCT00117572|449911606|FG000|Overall Study|Withdrawal by Subject|3|||
125080294|NCT00117572|449911607|FG001|Overall Study|Withdrawal by Subject|3|||
125080295|NCT00117572|449911606|FG000|Overall Study|Protocol Violation|1|||
125080296|NCT00117572|449911607|FG001|Overall Study|Protocol Violation|0|||
125080297|NCT04973085|449911612|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
125080298|NCT04973085|449911613|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
125080299|NCT00887068|449911614|FG000|Overall Study|Withdrawal by Subject|2|||
125080300|NCT00887068|449911615|FG001|Overall Study|Withdrawal by Subject|0|||
125080301|NCT00887068|449911614|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
125080302|NCT00887068|449911615|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
125080303|NCT00796224|449911633|FG000|Overall Study|Adverse Event|1|||
125080304|NCT00796224|449911634|FG001|Overall Study|Adverse Event|0|||
125080305|NCT00796224|449911633|FG000|Overall Study|Protocol Violation|0|||
125080306|NCT00796224|449911634|FG001|Overall Study|Protocol Violation|1|||
125080307|NCT02569398|449911635|FG000|Overall Study|Adverse Event|0|||
125080308|NCT02569398|449911636|FG001|Overall Study|Adverse Event|1|||
125080309|NCT02569398|449911637|FG002|Overall Study|Adverse Event|6|||
125080310|NCT02569398|449911635|FG000|Overall Study|Withdrawal by Subject|43|||
125080311|NCT02569398|449911636|FG001|Overall Study|Withdrawal by Subject|43|||
125080312|NCT02569398|449911637|FG002|Overall Study|Withdrawal by Subject|30|||
125080313|NCT02569398|449911635|FG000|Overall Study|Study terminated by sponsor|130|||
125080314|NCT02569398|449911636|FG001|Overall Study|Study terminated by sponsor|131|||
125080315|NCT02569398|449911637|FG002|Overall Study|Study terminated by sponsor|134|||
125080316|NCT02569398|449911635|FG000|Overall Study|Other|12|||
125080317|NCT02569398|449911636|FG001|Overall Study|Other|14|||
125080318|NCT02569398|449911637|FG002|Overall Study|Other|13|||
125080319|NCT02116361|449911638|FG000|Overall Study|Pregnancy|0|||
125080320|NCT02116361|449911639|FG001|Overall Study|Pregnancy|0|||
125080321|NCT02116361|449911640|FG002|Overall Study|Pregnancy|0|||
125080322|NCT02116361|449911641|FG003|Overall Study|Pregnancy|1|||
125080323|NCT02116361|449911638|FG000|Overall Study|Protocol Violation|1|||
125080324|NCT02116361|449911639|FG001|Overall Study|Protocol Violation|0|||
125080325|NCT02116361|449911640|FG002|Overall Study|Protocol Violation|0|||
125080326|NCT02116361|449911641|FG003|Overall Study|Protocol Violation|2|||
125080327|NCT02116361|449911638|FG000|Overall Study|Physician Decision|2|||
125080328|NCT02116361|449911639|FG001|Overall Study|Physician Decision|3|||
125080329|NCT02116361|449911640|FG002|Overall Study|Physician Decision|0|||
125080330|NCT02116361|449911641|FG003|Overall Study|Physician Decision|0|||
125080331|NCT02116361|449911638|FG000|Overall Study|Adverse Event|1|||
125080332|NCT02116361|449911639|FG001|Overall Study|Adverse Event|0|||
125080333|NCT02116361|449911640|FG002|Overall Study|Adverse Event|0|||
125080334|NCT02116361|449911641|FG003|Overall Study|Adverse Event|3|||
125080335|NCT02116361|449911638|FG000|Overall Study|Other Reasons|3|||
125080336|NCT02116361|449911639|FG001|Overall Study|Other Reasons|3|||
125080337|NCT02116361|449911640|FG002|Overall Study|Other Reasons|3|||
125080338|NCT02116361|449911641|FG003|Overall Study|Other Reasons|3|||
125080339|NCT02116361|449911638|FG000|Overall Study|Lack of Efficacy|5|||
125080340|NCT02116361|449911639|FG001|Overall Study|Lack of Efficacy|7|||
125080341|NCT02116361|449911640|FG002|Overall Study|Lack of Efficacy|4|||
125080342|NCT02116361|449911641|FG003|Overall Study|Lack of Efficacy|3|||
125080343|NCT02116361|449911638|FG000|Overall Study|Lost to Follow-up|4|||
125080344|NCT02116361|449911639|FG001|Overall Study|Lost to Follow-up|5|||
125080345|NCT02116361|449911640|FG002|Overall Study|Lost to Follow-up|7|||
125080346|NCT02116361|449911641|FG003|Overall Study|Lost to Follow-up|5|||
125080347|NCT02116361|449911638|FG000|Overall Study|Personal Reasons|6|||
125144447|NCT03480022|450153127|FG000|Overall Study|Medication concerns|1|||
125144448|NCT03480022|450153128|FG001|Overall Study|Medication concerns|0|||
125144449|NCT03480022|450153127|FG000|Overall Study|Family member COVID exposure|0|||
125080348|NCT02116361|449911639|FG001|Overall Study|Personal Reasons|6|||
125080349|NCT02116361|449911640|FG002|Overall Study|Personal Reasons|4|||
125080350|NCT02116361|449911641|FG003|Overall Study|Personal Reasons|9|||
125080351|NCT02116361|449911638|FG000|Overall Study|Investigator Decision - Relapse|9|||
125080352|NCT02116361|449911639|FG001|Overall Study|Investigator Decision - Relapse|7|||
125080353|NCT02116361|449911640|FG002|Overall Study|Investigator Decision - Relapse|8|||
125080354|NCT02116361|449911641|FG003|Overall Study|Investigator Decision - Relapse|5|||
125080355|NCT03227224|449911642|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
125080356|NCT03227224|449911643|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
125080357|NCT03227224|449911644|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
125080358|NCT03227224|449911645|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
125080359|NCT03227224|449911642|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
125080360|NCT03227224|449911643|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
125080361|NCT03227224|449911644|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
125080362|NCT03227224|449911645|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
125080363|NCT03227224|449911642|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
125080364|NCT03227224|449911643|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
125080365|NCT03227224|449911644|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
125080366|NCT03227224|449911645|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
125144450|NCT03480022|450153128|FG001|Overall Study|Family member COVID exposure|1|||
125144451|NCT00283842|450153129|FG000|Overall Study|Adverse Event|8|||
125080367|NCT03227224|449911642|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
125080368|NCT03227224|449911643|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
125080369|NCT03227224|449911644|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
125080370|NCT03227224|449911645|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
125080371|NCT03227224|449911642|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
125080372|NCT03227224|449911643|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
125080373|NCT03227224|449911644|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
125080374|NCT03227224|449911645|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
125080375|NCT03227224|449911642|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
125080376|NCT03227224|449911643|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
125080377|NCT03227224|449911644|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
125080378|NCT03227224|449911645|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
125080379|NCT03227224|449911642|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
125080380|NCT03227224|449911643|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
125080381|NCT03227224|449911644|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
125080382|NCT03227224|449911645|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
125080383|NCT03227224|449911642|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
125080384|NCT03227224|449911643|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
125080385|NCT03227224|449911644|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
125080386|NCT03227224|449911645|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
125080387|NCT03227224|449911642|FG000|Follow-up Phase (2 Weeks)|Other|4|||
125080388|NCT03227224|449911643|FG001|Follow-up Phase (2 Weeks)|Other|4|||
125080389|NCT03227224|449911644|FG002|Follow-up Phase (2 Weeks)|Other|6|||
125080390|NCT03227224|449911645|FG003|Follow-up Phase (2 Weeks)|Other|3|||
125080391|NCT04195750|449911646|FG000|Overall Study|Death|245|||
125080392|NCT04195750|449911647|FG001|Overall Study|Death|253|||
125080393|NCT04195750|449911648|FG002|Overall Study|Death|5|||
125080394|NCT04195750|449911646|FG000|Overall Study|Physician Decision|0|||
125080395|NCT04195750|449911647|FG001|Overall Study|Physician Decision|1|||
125080396|NCT04195750|449911648|FG002|Overall Study|Physician Decision|0|||
125080397|NCT04195750|449911646|FG000|Overall Study|Withdrawal by Subject|9|||
125080398|NCT04195750|449911647|FG001|Overall Study|Withdrawal by Subject|8|||
125080399|NCT04195750|449911648|FG002|Overall Study|Withdrawal by Subject|0|||
125080400|NCT04195750|449911646|FG000|Overall Study|Ongoing|120|||
125080401|NCT04195750|449911647|FG001|Overall Study|Ongoing|110|||
125080402|NCT04195750|449911648|FG002|Overall Study|Ongoing|4|||
125080403|NCT02406027|449911649|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
125080404|NCT02406027|449911650|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
125080405|NCT02406027|449911651|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
125080406|NCT02406027|449911652|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
125080407|NCT02406027|449911653|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
125080408|NCT02406027|449911654|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
125080409|NCT02406027|449911655|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
125080410|NCT02406027|449911649|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
125080411|NCT02406027|449911650|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
125080412|NCT02406027|449911651|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
125080413|NCT02406027|449911652|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
125080414|NCT02406027|449911653|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
125080415|NCT02406027|449911654|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
125080416|NCT02406027|449911655|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
125080417|NCT02406027|449911649|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
125080418|NCT02406027|449911650|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
125080419|NCT02406027|449911651|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
125080420|NCT02406027|449911652|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
125080421|NCT02406027|449911653|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
125080422|NCT02406027|449911654|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
125080423|NCT02406027|449911655|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
125080424|NCT02406027|449911649|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
125080425|NCT02406027|449911650|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
125080426|NCT02406027|449911651|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
125080427|NCT02406027|449911652|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
125080428|NCT02406027|449911653|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
125080429|NCT02406027|449911654|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
125080430|NCT02406027|449911655|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
125080431|NCT02406027|449911649|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
125144452|NCT00283842|450153130|FG001|Overall Study|Adverse Event|7|||
125144453|NCT00283842|450153131|FG002|Overall Study|Adverse Event|21|||
125144454|NCT00283842|450153132|FG003|Overall Study|Adverse Event|21|||
125144455|NCT00283842|450153133|FG004|Overall Study|Adverse Event|5|||
125144456|NCT00283842|450153129|FG000|Overall Study|Protocol Violation|1|||
125144457|NCT00283842|450153130|FG001|Overall Study|Protocol Violation|5|||
125144458|NCT00283842|450153131|FG002|Overall Study|Protocol Violation|4|||
125144459|NCT00283842|450153132|FG003|Overall Study|Protocol Violation|0|||
125144460|NCT00283842|450153133|FG004|Overall Study|Protocol Violation|0|||
125144461|NCT00283842|450153129|FG000|Overall Study|Protocol deviation|0|||
125144462|NCT00283842|450153130|FG001|Overall Study|Protocol deviation|0|||
125144463|NCT00283842|450153131|FG002|Overall Study|Protocol deviation|0|||
125144464|NCT00283842|450153132|FG003|Overall Study|Protocol deviation|0|||
125144465|NCT00283842|450153133|FG004|Overall Study|Protocol deviation|2|||
125144466|NCT00283842|450153129|FG000|Overall Study|Withdrawal by Subject|2|||
125080432|NCT02406027|449911650|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
125080433|NCT02406027|449911651|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
125080434|NCT02406027|449911652|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
125080435|NCT02406027|449911653|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
125080436|NCT02406027|449911654|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
125080437|NCT02406027|449911655|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
125080438|NCT02406027|449911649|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
125080439|NCT02406027|449911650|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
125144467|NCT00283842|450153130|FG001|Overall Study|Withdrawal by Subject|1|||
125144468|NCT00283842|450153131|FG002|Overall Study|Withdrawal by Subject|1|||
125144469|NCT00283842|450153132|FG003|Overall Study|Withdrawal by Subject|5|||
125080440|NCT02406027|449911651|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
125080441|NCT02406027|449911652|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
125080442|NCT02406027|449911653|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
125080443|NCT02406027|449911654|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
125080444|NCT02406027|449911655|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
125080445|NCT02406027|449911649|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
125080446|NCT02406027|449911650|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
125080447|NCT02406027|449911651|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
125080448|NCT02406027|449911652|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
125080449|NCT02406027|449911653|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
125080450|NCT02406027|449911654|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
125080451|NCT02406027|449911655|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
125080452|NCT02406027|449911649|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
125080453|NCT02406027|449911650|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
125080454|NCT02406027|449911651|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
125080455|NCT02406027|449911652|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
125080456|NCT02406027|449911653|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
125080457|NCT02406027|449911654|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
125080458|NCT02406027|449911655|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
125080459|NCT02406027|449911649|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
125080460|NCT02406027|449911650|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
125080461|NCT02406027|449911651|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
125080462|NCT02406027|449911652|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
125080463|NCT02406027|449911653|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
125080464|NCT02406027|449911654|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
125080465|NCT02406027|449911655|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
125080466|NCT02406027|449911649|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
125080467|NCT02406027|449911650|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
125080468|NCT02406027|449911651|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
125144470|NCT00283842|450153133|FG004|Overall Study|Withdrawal by Subject|4|||
125144471|NCT00283842|450153129|FG000|Overall Study|Lack of Efficacy|1|||
125144472|NCT00283842|450153130|FG001|Overall Study|Lack of Efficacy|3|||
125144473|NCT00283842|450153131|FG002|Overall Study|Lack of Efficacy|1|||
125144474|NCT00283842|450153132|FG003|Overall Study|Lack of Efficacy|0|||
125144475|NCT00283842|450153133|FG004|Overall Study|Lack of Efficacy|3|||
125080469|NCT02406027|449911652|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
125080470|NCT02406027|449911653|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
125080471|NCT02406027|449911654|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
125080472|NCT02406027|449911655|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
125080473|NCT02497287|449911656|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
125080474|NCT02497287|449911656|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
125080475|NCT02497287|449911656|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
125080476|NCT02497287|449911656|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
125080477|NCT02497287|449911656|FG000|Induction Phase (4 Weeks)|Other|13|||
125080478|NCT02497287|449911656|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
125080479|NCT02497287|449911656|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
125080480|NCT02497287|449911656|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
125080481|NCT02497287|449911656|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
125080482|NCT02497287|449911656|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
125080483|NCT02497287|449911656|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
125080484|NCT02497287|449911656|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
125080485|NCT02497287|449911656|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
125080486|NCT02497287|449911656|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
125080487|NCT02497287|449911656|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
125080488|NCT02497287|449911656|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
125080489|NCT02497287|449911656|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
125080490|NCT02497287|449911656|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
125080491|NCT02497287|449911656|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
125080492|NCT02497287|449911656|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
125080493|NCT02497287|449911656|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
125080494|NCT02497287|449911656|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
125080495|NCT02497287|449911656|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
125080496|NCT02497287|449911656|FG000|Follow-up Phase (4 Week)|Other|1|||
125080497|NCT03782376|449911657|FG000|Overall Study|Lost to Follow-up|2|||
125080498|NCT03782376|449911658|FG001|Overall Study|Lost to Follow-up|2|||
125080499|NCT03782376|449911657|FG000|Overall Study|Withdrawal by Subject|7|||
125080500|NCT03782376|449911658|FG001|Overall Study|Withdrawal by Subject|11|||
125080501|NCT03782376|449911657|FG000|Overall Study|Death|1|||
125080502|NCT03782376|449911658|FG001|Overall Study|Death|0|||
125080503|NCT03782376|449911657|FG000|Overall Study|Other|16|||
125080504|NCT03782376|449911658|FG001|Overall Study|Other|17|||
125080505|NCT03559192|449911659|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
125080506|NCT03559192|449911660|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
125080507|NCT03559192|449911661|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
125080508|NCT03559192|449911659|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
125080509|NCT03559192|449911660|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
125080510|NCT03559192|449911661|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
125080511|NCT03559192|449911659|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
125080512|NCT03559192|449911660|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
125080513|NCT03559192|449911661|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
125080514|NCT03559192|449911659|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
125080515|NCT03559192|449911660|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
125080516|NCT03559192|449911661|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
125080517|NCT03559192|449911659|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
125080518|NCT03559192|449911660|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
125080519|NCT03559192|449911661|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
125080520|NCT03559192|449911659|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
125080521|NCT03559192|449911660|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
125080522|NCT03559192|449911661|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
125080523|NCT03559192|449911659|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
125080524|NCT03559192|449911660|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
125080525|NCT03559192|449911661|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
125080526|NCT03559192|449911659|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
125080527|NCT03559192|449911660|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
125080528|NCT03559192|449911661|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
125080529|NCT03559192|449911659|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
125080530|NCT03559192|449911660|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
125080531|NCT03559192|449911661|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
125080532|NCT03517722|449911662|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
125080533|NCT03517722|449911663|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
125080534|NCT03517722|449911662|FG000|Double Blind Period: Week 0-52|Death|0|||
125080535|NCT03517722|449911663|FG001|Double Blind Period: Week 0-52|Death|4|||
125080536|NCT03517722|449911662|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
125080537|NCT03517722|449911663|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
125080538|NCT03517722|449911662|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
125080539|NCT03517722|449911663|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
125080540|NCT03517722|449911662|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
125080541|NCT03517722|449911663|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
125080542|NCT03517722|449911662|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
125080543|NCT03517722|449911663|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
125080544|NCT03517722|449911662|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
125080545|NCT03517722|449911663|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
125080546|NCT03517722|449911662|FG000|Double Blind Period: Week 0-52|Other|4|||
125080547|NCT03517722|449911663|FG001|Double Blind Period: Week 0-52|Other|3|||
125080548|NCT03517722|449911662|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
125080549|NCT03517722|449911663|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
125080550|NCT03517722|449911662|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
125080551|NCT03517722|449911663|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
125080552|NCT03517722|449911662|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
125080553|NCT03517722|449911663|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
125080554|NCT03517722|449911662|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
125080555|NCT03517722|449911663|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
125080556|NCT03517722|449911662|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
125080557|NCT03517722|449911663|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
125080558|NCT03277794|449911668|FG000|Overall Study|Lost to Follow-up|2|||
125080559|NCT03277794|449911669|FG001|Overall Study|Lost to Follow-up|4|||
125080560|NCT03277794|449911668|FG000|Overall Study|Withdrew due to high acuity|1|||
125080561|NCT03277794|449911669|FG001|Overall Study|Withdrew due to high acuity|0|||
125080562|NCT01226472|449911673|FG000|Overall Study|Progressive Disease|1|||
125080563|NCT00952419|449911674|FG000|Overall Study|Adverse Event|2|||
125080564|NCT00952419|449911675|FG001|Overall Study|Adverse Event|0|||
125080565|NCT00952419|449911676|FG002|Overall Study|Adverse Event|0|||
125080566|NCT00952419|449911674|FG000|Overall Study|Protocol Violation|3|||
125080567|NCT00952419|449911675|FG001|Overall Study|Protocol Violation|7|||
125080568|NCT00952419|449911676|FG002|Overall Study|Protocol Violation|0|||
125080569|NCT00952419|449911674|FG000|Overall Study|Withdrawal by Subject|1|||
125080570|NCT00952419|449911675|FG001|Overall Study|Withdrawal by Subject|3|||
125080571|NCT00952419|449911676|FG002|Overall Study|Withdrawal by Subject|0|||
125080572|NCT03399786|449911677|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
125080573|NCT03399786|449911678|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
125080574|NCT03399786|449911679|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
125080575|NCT03399786|449911680|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
125080576|NCT03399786|449911677|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
125080577|NCT03399786|449911678|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
125080578|NCT03399786|449911679|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
125080579|NCT03399786|449911680|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
125080580|NCT03399786|449911677|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
125080581|NCT03399786|449911678|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
125080582|NCT03399786|449911679|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
125080583|NCT03399786|449911680|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
125080584|NCT04507360|449913305|FG000|Week 1|Lost to Follow-up|0|||
125080585|NCT04507360|449913306|FG001|Week 1|Lost to Follow-up|0|||
125080586|NCT04507360|449913307|FG002|Week 1|Lost to Follow-up|0|||
125080587|NCT04507360|449913308|FG003|Week 1|Lost to Follow-up|0|||
125080588|NCT04507360|449913309|FG004|Week 1|Lost to Follow-up|0|||
125080589|NCT04507360|449913310|FG005|Week 1|Lost to Follow-up|0|||
125080590|NCT04507360|449913311|FG006|Week 1|Lost to Follow-up|0|||
125080591|NCT04507360|449913312|FG007|Week 1|Lost to Follow-up|0|||
125080592|NCT04507360|449913313|FG008|Week 1|Lost to Follow-up|72|||
125080593|NCT04507360|449913314|FG009|Week 1|Lost to Follow-up|22|||
125080594|NCT04507360|449913315|FG010|Week 1|Lost to Follow-up|10|||
125080595|NCT04507360|449913305|FG000|Week 2|Lost to Follow-up|0|||
125080596|NCT04507360|449913306|FG001|Week 2|Lost to Follow-up|0|||
125223507|NCT02326272|450446166|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125080597|NCT04507360|449913307|FG002|Week 2|Lost to Follow-up|0|||
125080598|NCT04507360|449913308|FG003|Week 2|Lost to Follow-up|0|||
125080599|NCT04507360|449913309|FG004|Week 2|Lost to Follow-up|0|||
125080600|NCT04507360|449913310|FG005|Week 2|Lost to Follow-up|0|||
125080601|NCT04507360|449913311|FG006|Week 2|Lost to Follow-up|0|||
125080602|NCT04507360|449913312|FG007|Week 2|Lost to Follow-up|0|||
125080603|NCT04507360|449913313|FG008|Week 2|Lost to Follow-up|121|||
125080604|NCT04507360|449913314|FG009|Week 2|Lost to Follow-up|85|||
125080605|NCT04507360|449913315|FG010|Week 2|Lost to Follow-up|82|||
125080606|NCT04507360|449913305|FG000|Week 3|Lost to Follow-up|0|||
125080607|NCT04507360|449913306|FG001|Week 3|Lost to Follow-up|0|||
125080608|NCT04507360|449913307|FG002|Week 3|Lost to Follow-up|0|||
125080609|NCT04507360|449913308|FG003|Week 3|Lost to Follow-up|0|||
125080610|NCT04507360|449913309|FG004|Week 3|Lost to Follow-up|0|||
125080611|NCT04507360|449913310|FG005|Week 3|Lost to Follow-up|0|||
125080612|NCT04507360|449913311|FG006|Week 3|Lost to Follow-up|0|||
125080613|NCT04507360|449913312|FG007|Week 3|Lost to Follow-up|0|||
125080614|NCT04507360|449913313|FG008|Week 3|Lost to Follow-up|123|||
125080615|NCT04507360|449913314|FG009|Week 3|Lost to Follow-up|92|||
125080616|NCT04507360|449913315|FG010|Week 3|Lost to Follow-up|84|||
125080617|NCT04507360|449913305|FG000|Week 4|Lost to Follow-up|0|||
125080618|NCT04507360|449913306|FG001|Week 4|Lost to Follow-up|0|||
125080619|NCT04507360|449913307|FG002|Week 4|Lost to Follow-up|0|||
125080620|NCT04507360|449913308|FG003|Week 4|Lost to Follow-up|0|||
125080621|NCT04507360|449913309|FG004|Week 4|Lost to Follow-up|0|||
125080622|NCT04507360|449913310|FG005|Week 4|Lost to Follow-up|0|||
125080623|NCT04507360|449913311|FG006|Week 4|Lost to Follow-up|0|||
125080624|NCT04507360|449913312|FG007|Week 4|Lost to Follow-up|0|||
125080625|NCT04507360|449913313|FG008|Week 4|Lost to Follow-up|131|||
125080626|NCT04507360|449913314|FG009|Week 4|Lost to Follow-up|115|||
125080627|NCT04507360|449913315|FG010|Week 4|Lost to Follow-up|102|||
125080628|NCT04507360|449913305|FG000|Week 5|Lost to Follow-up|0|||
125080629|NCT04507360|449913306|FG001|Week 5|Lost to Follow-up|0|||
125080630|NCT04507360|449913307|FG002|Week 5|Lost to Follow-up|0|||
125080631|NCT04507360|449913308|FG003|Week 5|Lost to Follow-up|0|||
125080632|NCT04507360|449913309|FG004|Week 5|Lost to Follow-up|0|||
125080633|NCT04507360|449913310|FG005|Week 5|Lost to Follow-up|0|||
125080634|NCT04507360|449913311|FG006|Week 5|Lost to Follow-up|0|||
125080635|NCT04507360|449913312|FG007|Week 5|Lost to Follow-up|0|||
125080636|NCT04507360|449913313|FG008|Week 5|Lost to Follow-up|103|||
125080637|NCT04507360|449913314|FG009|Week 5|Lost to Follow-up|135|||
125080638|NCT04507360|449913315|FG010|Week 5|Lost to Follow-up|143|||
125080639|NCT04507360|449913305|FG000|Week 8|Lost to Follow-up|0|||
125080640|NCT04507360|449913306|FG001|Week 8|Lost to Follow-up|0|||
125080641|NCT04507360|449913307|FG002|Week 8|Lost to Follow-up|0|||
125080642|NCT04507360|449913308|FG003|Week 8|Lost to Follow-up|0|||
125080643|NCT04507360|449913309|FG004|Week 8|Lost to Follow-up|0|||
125080644|NCT04507360|449913310|FG005|Week 8|Lost to Follow-up|0|||
125080645|NCT04507360|449913311|FG006|Week 8|Lost to Follow-up|0|||
125080646|NCT04507360|449913312|FG007|Week 8|Lost to Follow-up|0|||
125080647|NCT04507360|449913313|FG008|Week 8|Lost to Follow-up|139|||
125080648|NCT04507360|449913314|FG009|Week 8|Lost to Follow-up|145|||
125080649|NCT04507360|449913315|FG010|Week 8|Lost to Follow-up|152|||
125080650|NCT00636155|449913316|FG000|Overall Study|Adverse Event|8|||
125080651|NCT00636155|449913316|FG000|Overall Study|Lack of Efficacy|1|||
125080652|NCT00636155|449913316|FG000|Overall Study|Withdrawal by Subject|3|||
125080653|NCT00636155|449913316|FG000|Overall Study|Stem cell transplant|1|||
125080654|NCT00636155|449913316|FG000|Overall Study|Physician Decision|5|||
125080655|NCT01432756|449913317|FG000|Overall Study|Lost to Follow-up|1|||
125080656|NCT01432756|449913318|FG001|Overall Study|Lost to Follow-up|0|||
125080657|NCT01432756|449913319|FG002|Overall Study|Lost to Follow-up|2|||
125080658|NCT01432756|449913320|FG003|Overall Study|Lost to Follow-up|1|||
125080659|NCT01004159|449913328|FG000|Overall Study|Adverse Event|2|||
125080660|NCT01004159|449913328|FG000|Overall Study|Disease Progression|18|||
125080661|NCT02973997|449913329|FG000|Overall Study|Withdrawal by Subject|4|||
125080662|NCT02973997|449913330|FG001|Overall Study|Withdrawal by Subject|0|||
125080663|NCT02973997|449913329|FG000|Overall Study|Adverse Event|4|||
125080664|NCT02973997|449913330|FG001|Overall Study|Adverse Event|1|||
125080665|NCT02973997|449913329|FG000|Overall Study|Disease Progression|11|||
125080666|NCT02973997|449913330|FG001|Overall Study|Disease Progression|20|||
125080667|NCT02973997|449913329|FG000|Overall Study|Alternative Therapy|3|||
125080668|NCT02973997|449913330|FG001|Overall Study|Alternative Therapy|0|||
125080669|NCT02973997|449913329|FG000|Overall Study|Other complicating disease|0|||
125080670|NCT02973997|449913330|FG001|Overall Study|Other complicating disease|1|||
125080671|NCT02973997|449913329|FG000|Overall Study|Death|0|||
125080672|NCT02973997|449913330|FG001|Overall Study|Death|1|||
125080673|NCT00444951|449913331|FG000|Overall Study|Lost to Follow-up|1|||
125080674|NCT00444951|449913332|FG001|Overall Study|Lost to Follow-up|1|||
125080675|NCT00444951|449913333|FG002|Overall Study|Lost to Follow-up|0|||
125080676|NCT00444951|449913331|FG000|Overall Study|Withdrawal by Subject|4|||
125080677|NCT00444951|449913332|FG001|Overall Study|Withdrawal by Subject|5|||
125080678|NCT00444951|449913333|FG002|Overall Study|Withdrawal by Subject|3|||
125080679|NCT00366444|449913335|FG000|Overall Study|Withdrawal by Subject|1|||
125080680|NCT00366444|449913336|FG001|Overall Study|Withdrawal by Subject|1|||
125080681|NCT00366444|449913335|FG000|Overall Study|Lack of Efficacy|0|||
125080682|NCT00366444|449913336|FG001|Overall Study|Lack of Efficacy|1|||
125080683|NCT01320033|449913345|FG000|Overall Study|Lack of Efficacy|0|||
125080684|NCT01320033|449913346|FG001|Overall Study|Lack of Efficacy|0|||
125080685|NCT01320033|449913347|FG002|Overall Study|Lack of Efficacy|1|||
125080686|NCT01320033|449913345|FG000|Overall Study|Adverse Event|9|||
125080687|NCT01320033|449913346|FG001|Overall Study|Adverse Event|7|||
125080688|NCT01320033|449913347|FG002|Overall Study|Adverse Event|8|||
125080689|NCT01320033|449913345|FG000|Overall Study|Withdrawal by Subject|22|||
125080690|NCT01320033|449913346|FG001|Overall Study|Withdrawal by Subject|23|||
125080691|NCT01320033|449913347|FG002|Overall Study|Withdrawal by Subject|23|||
125080692|NCT01320033|449913345|FG000|Overall Study|Protocol Violation|3|||
125080693|NCT01320033|449913346|FG001|Overall Study|Protocol Violation|5|||
125080694|NCT01320033|449913347|FG002|Overall Study|Protocol Violation|3|||
125080695|NCT01320033|449913345|FG000|Overall Study|Lost to Follow-up|22|||
125080696|NCT01320033|449913346|FG001|Overall Study|Lost to Follow-up|26|||
125080697|NCT01320033|449913347|FG002|Overall Study|Lost to Follow-up|17|||
125080698|NCT01320033|449913345|FG000|Overall Study|Other|2|||
125080699|NCT01320033|449913346|FG001|Overall Study|Other|3|||
125080700|NCT01320033|449913347|FG002|Overall Study|Other|1|||
125080701|NCT00963469|449913348|FG000|Overall Study|Adverse Event|15|||
125080702|NCT00963469|449913349|FG001|Overall Study|Adverse Event|11|||
125080703|NCT00963469|449913350|FG002|Overall Study|Adverse Event|1|||
125080704|NCT00963469|449913348|FG000|Overall Study|Lack of Efficacy|10|||
125080705|NCT00963469|449913349|FG001|Overall Study|Lack of Efficacy|7|||
125080706|NCT00963469|449913350|FG002|Overall Study|Lack of Efficacy|2|||
125080707|NCT00963469|449913348|FG000|Overall Study|Lost to Follow-up|1|||
125080708|NCT00963469|449913349|FG001|Overall Study|Lost to Follow-up|1|||
125080709|NCT00963469|449913350|FG002|Overall Study|Lost to Follow-up|0|||
125080710|NCT00963469|449913348|FG000|Overall Study|Protocol Violation|5|||
125080711|NCT00963469|449913349|FG001|Overall Study|Protocol Violation|5|||
125080712|NCT00963469|449913350|FG002|Overall Study|Protocol Violation|3|||
125080713|NCT00963469|449913348|FG000|Overall Study|Withdrawal by Subject|4|||
125080714|NCT00963469|449913349|FG001|Overall Study|Withdrawal by Subject|1|||
125080715|NCT00963469|449913350|FG002|Overall Study|Withdrawal by Subject|1|||
125080716|NCT00963469|449913348|FG000|Overall Study|Pre-randomization Adverse Event|1|||
125080717|NCT00963469|449913349|FG001|Overall Study|Pre-randomization Adverse Event|2|||
125080718|NCT00963469|449913350|FG002|Overall Study|Pre-randomization Adverse Event|0|||
125080719|NCT00963469|449913348|FG000|Overall Study|Moved|1|||
125080720|NCT00963469|449913349|FG001|Overall Study|Moved|0|||
125080721|NCT00963469|449913350|FG002|Overall Study|Moved|0|||
125080722|NCT00963469|449913348|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
125080723|NCT00963469|449913349|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
125080724|NCT00963469|449913350|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
125080725|NCT01938391|449913358|FG000|6 Month Follow up|Withdrawal by Subject|1|||
125080726|NCT01938391|449913358|FG000|12 Month Follow up|Physician Decision|1|||
125080727|NCT01938391|449913358|FG000|12 Month Follow up|Withdrawal by Subject|1|||
125080728|NCT00673816|449913371|FG000|Overall Study|Adverse Event|1|||
125080729|NCT00673816|449913371|FG000|Overall Study|Withdrawal by Subject|1|||
125080730|NCT01536418|449913373|FG000|Overall Study|Protocol Violation|2|||
125080731|NCT01536418|449913374|FG001|Overall Study|Protocol Violation|3|||
125080732|NCT01536418|449913373|FG000|Overall Study|Physician Decision|1|||
125080733|NCT01536418|449913374|FG001|Overall Study|Physician Decision|3|||
125080734|NCT01536418|449913373|FG000|Overall Study|Study closed/terminated|41|||
125080735|NCT01536418|449913374|FG001|Overall Study|Study closed/terminated|37|||
125080736|NCT01536418|449913373|FG000|Overall Study|Lack of Efficacy|10|||
125080737|NCT01536418|449913374|FG001|Overall Study|Lack of Efficacy|16|||
125080738|NCT01536418|449913373|FG000|Overall Study|Adverse Event|9|||
125080739|NCT01536418|449913374|FG001|Overall Study|Adverse Event|4|||
125080740|NCT01536418|449913373|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
125080741|NCT01536418|449913374|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
125080742|NCT01536418|449913373|FG000|Overall Study|Withdrawal by Subject|5|||
125080743|NCT01536418|449913374|FG001|Overall Study|Withdrawal by Subject|3|||
125080744|NCT02234050|449913375|FG000|Overall Study|Lack of Efficacy|38|||
125080745|NCT02234050|449913376|FG001|Overall Study|Lack of Efficacy|22|||
125080746|NCT02234050|449913375|FG000|Overall Study|Adverse Event|13|||
125080747|NCT02234050|449913376|FG001|Overall Study|Adverse Event|1|||
125080748|NCT02234050|449913375|FG000|Overall Study|Withdrawal by Subject|4|||
125080749|NCT02234050|449913376|FG001|Overall Study|Withdrawal by Subject|2|||
125080750|NCT02234050|449913375|FG000|Overall Study|Sponsor's decision|6|||
125080751|NCT02234050|449913376|FG001|Overall Study|Sponsor's decision|0|||
125080752|NCT02365506|449913377|FG000|Overall Study|Investigator's Discretion|0|||
125080753|NCT02365506|449913378|FG001|Overall Study|Investigator's Discretion|0|||
125080754|NCT02365506|449913379|FG002|Overall Study|Investigator's Discretion|1|||
125080755|NCT01680991|449913381|FG000|Overall Study|Adverse Event|1|||
125080756|NCT01680991|449913382|FG001|Overall Study|Adverse Event|0|||
125080757|NCT01680991|449913383|FG002|Overall Study|Adverse Event|0|||
125080758|NCT01680991|449913381|FG000|Overall Study|Death|1|||
125080759|NCT01680991|449913382|FG001|Overall Study|Death|0|||
125080760|NCT01680991|449913383|FG002|Overall Study|Death|1|||
125080761|NCT01680991|449913381|FG000|Overall Study|Protocol Violation|0|||
125080762|NCT01680991|449913382|FG001|Overall Study|Protocol Violation|1|||
125080763|NCT01680991|449913383|FG002|Overall Study|Protocol Violation|0|||
125080764|NCT01680991|449913381|FG000|Overall Study|Withdrawal by Subject|5|||
125080765|NCT01680991|449913382|FG001|Overall Study|Withdrawal by Subject|1|||
125080766|NCT01680991|449913383|FG002|Overall Study|Withdrawal by Subject|0|||
125080767|NCT01680991|449913381|FG000|Overall Study|Progressive disease (PD)|0|||
125080768|NCT01680991|449913382|FG001|Overall Study|Progressive disease (PD)|10|||
125080769|NCT01680991|449913383|FG002|Overall Study|Progressive disease (PD)|0|||
125080770|NCT01680991|449913381|FG000|Overall Study|Physician Decision|0|||
125080771|NCT01680991|449913382|FG001|Overall Study|Physician Decision|7|||
125080772|NCT01680991|449913383|FG002|Overall Study|Physician Decision|2|||
125080773|NCT01680991|449913381|FG000|Overall Study|Bad physical condition|0|||
125080774|NCT01680991|449913382|FG001|Overall Study|Bad physical condition|0|||
125080775|NCT01680991|449913383|FG002|Overall Study|Bad physical condition|1|||
125080776|NCT01680991|449913381|FG000|Overall Study|PD confirmed in other hospital|1|||
125080777|NCT01680991|449913382|FG001|Overall Study|PD confirmed in other hospital|0|||
125080778|NCT01680991|449913383|FG002|Overall Study|PD confirmed in other hospital|0|||
125080779|NCT01852591|449913384|FG000|Overall Study|Withdrawal by Subject|2|||
125080780|NCT01852591|449913384|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
125080781|NCT06073054|449913385|FG000|Overall Study|Withdrawal by Subject|2|||
125080782|NCT05505734|449913390|FG000|Overall Study|Withdrawal by Subject|51|||
125080783|NCT05505734|449913391|FG001|Overall Study|Withdrawal by Subject|64|||
125080784|NCT05505734|449913390|FG000|Overall Study|Adverse Event|6|||
125080785|NCT05505734|449913391|FG001|Overall Study|Adverse Event|20|||
125080786|NCT05505734|449913390|FG000|Overall Study|Protocol Violation|8|||
125080787|NCT05505734|449913391|FG001|Overall Study|Protocol Violation|15|||
125080788|NCT05505734|449913390|FG000|Overall Study|Lack of therapeutic response|0|||
125080789|NCT05505734|449913391|FG001|Overall Study|Lack of therapeutic response|1|||
125080790|NCT05505734|449913390|FG000|Overall Study|Lost to Follow-up|247|||
125080791|NCT05505734|449913391|FG001|Overall Study|Lost to Follow-up|237|||
125080792|NCT05505734|449913390|FG000|Overall Study|Physician Decision|22|||
125080793|NCT05505734|449913391|FG001|Overall Study|Physician Decision|13|||
125080794|NCT05505734|449913390|FG000|Overall Study|Death|2|||
125080795|NCT05505734|449913391|FG001|Overall Study|Death|1|||
125080796|NCT05505734|449913390|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125080797|NCT05505734|449913391|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125080798|NCT05505734|449913390|FG000|Overall Study|Pregnancy|1|||
125080799|NCT05505734|449913391|FG001|Overall Study|Pregnancy|0|||
125080800|NCT05505734|449913390|FG000|Overall Study|Other|17|||
125080801|NCT05505734|449913391|FG001|Overall Study|Other|13|||
125080802|NCT00764322|449913392|FG000|Overall Study|Withdrawal by Subject|11|||
125080803|NCT00764322|449913392|FG000|Overall Study|No CYP2D6 genotyping|9|||
125080804|NCT00976963|449913398|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
125080805|NCT00976963|449913399|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
125080806|NCT00976963|449913398|FG000|Overall Study|administrative error|1|||
125080807|NCT00976963|449913399|FG001|Overall Study|administrative error|0|||
125080808|NCT00976963|449913398|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
125080809|NCT00976963|449913399|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
125080810|NCT02768103|449913404|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
125080811|NCT03369704|449913408|FG000|Treatment Epoch|technical problems|1|||
125080812|NCT03369704|449913409|FG001|Treatment Epoch|technical problems|0|||
125080813|NCT03369704|449913408|FG000|Treatment Epoch|Protocol Violation|1|||
125080814|NCT03369704|449913409|FG001|Treatment Epoch|Protocol Violation|0|||
125080815|NCT03369704|449913408|FG000|Treatment Epoch|Lost to Follow-up|0|||
125080816|NCT03369704|449913409|FG001|Treatment Epoch|Lost to Follow-up|1|||
125080817|NCT03369704|449913408|FG000|Treatment Epoch|Lack of Efficacy|0|||
125080818|NCT03369704|449913409|FG001|Treatment Epoch|Lack of Efficacy|2|||
125080819|NCT03369704|449913408|FG000|Treatment Epoch|Adverse Event|2|||
125080820|NCT03369704|449913409|FG001|Treatment Epoch|Adverse Event|0|||
125080821|NCT03369704|449913408|FG000|Follow-up Epoch|Lost to Follow-up|1|||
125080822|NCT03369704|449913409|FG001|Follow-up Epoch|Lost to Follow-up|0|||
125080823|NCT02348840|449913410|FG000|Overall Study|Withdrawal by Subject|2|||
125080824|NCT02348840|449913411|FG001|Overall Study|Withdrawal by Subject|1|||
125080825|NCT02348840|449913412|FG002|Overall Study|Withdrawal by Subject|0|||
125080826|NCT02348840|449913413|FG003|Overall Study|Withdrawal by Subject|0|||
125080827|NCT01263444|449913414|FG000|Overall Study|Adverse Event|8|||
125080828|NCT01263444|449913414|FG000|Overall Study|Withdrawal by Subject|1|||
125080829|NCT01263444|449913414|FG000|Overall Study|Protocol Violation|1|||
125080830|NCT03236506|449913416|FG000|Overall Study|Death|1|||
125080831|NCT03236506|449913417|FG001|Overall Study|Death|1|||
125080832|NCT03236506|449913418|FG002|Overall Study|Death|1|||
125080833|NCT03236506|449913416|FG000|Overall Study|Withdrawal by Subject|3|||
125080834|NCT03236506|449913417|FG001|Overall Study|Withdrawal by Subject|3|||
125080835|NCT03236506|449913418|FG002|Overall Study|Withdrawal by Subject|4|||
125080836|NCT03236506|449913416|FG000|Overall Study|Did not initiate treatment|2|||
125080837|NCT03236506|449913417|FG001|Overall Study|Did not initiate treatment|1|||
125080838|NCT03236506|449913418|FG002|Overall Study|Did not initiate treatment|2|||
125080839|NCT01466062|449913419|FG000|Overall Study|Adverse Event|1|||
125080840|NCT01466062|449913419|FG000|Overall Study|Withdrawal by Subject|1|||
125080841|NCT02865928|449913420|FG000|Overall Study|Withdrawal by Subject|1|||
125080842|NCT02865928|449913421|FG001|Overall Study|Withdrawal by Subject|0|||
125080843|NCT02865928|449913420|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
125080844|NCT02865928|449913421|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
125144476|NCT00283842|450153129|FG000|Overall Study|Lost to Follow-up|0|||
125144477|NCT00283842|450153130|FG001|Overall Study|Lost to Follow-up|2|||
125144478|NCT00283842|450153131|FG002|Overall Study|Lost to Follow-up|4|||
125144479|NCT00283842|450153132|FG003|Overall Study|Lost to Follow-up|1|||
125144480|NCT00283842|450153133|FG004|Overall Study|Lost to Follow-up|1|||
125144481|NCT02472639|450153136|FG000|Overall Study|Physician Decision|4|||
125144482|NCT02472639|450153137|FG001|Overall Study|Physician Decision|3|||
125144483|NCT00751023|450153139|FG000|Overall Study|Lost to Follow-up|11|||
125144484|NCT00751023|450153140|FG001|Overall Study|Lost to Follow-up|7|||
125144485|NCT02308696|450153142|FG000|Overall Study|Lost to Follow-up|28|||
125144486|NCT02308696|450153143|FG001|Overall Study|Lost to Follow-up|21|||
125144487|NCT02308696|450153142|FG000|Overall Study|Death|8|||
125144488|NCT02308696|450153143|FG001|Overall Study|Death|4|||
125144489|NCT02308696|450153142|FG000|Overall Study|Moved to a Higher Level of Care|17|||
125144490|NCT02308696|450153143|FG001|Overall Study|Moved to a Higher Level of Care|6|||
125144491|NCT04768114|450153144|FG000|Overall Study|Lost to Follow-up|5|||
125144492|NCT04768114|450153145|FG001|Overall Study|Lost to Follow-up|10|||
125144493|NCT04768114|450153144|FG000|Overall Study|Withdrawal by Subject|0|||
125144494|NCT04768114|450153145|FG001|Overall Study|Withdrawal by Subject|1|||
125144495|NCT03980522|450153152|FG000|Treatment Period|Adverse Event|1|||
125144496|NCT03980522|450153153|FG001|Treatment Period|Adverse Event|0|||
125144497|NCT03980522|450153154|FG002|Treatment Period|Adverse Event|0|||
125144498|NCT03980522|450153155|FG003|Treatment Period|Adverse Event|0|||
125144499|NCT03980522|450153156|FG004|Treatment Period|Adverse Event|0|||
125144500|NCT04892147|450153157|FG000|Overall Study|Withdrawal by Subject|2|||
125144501|NCT04892147|450153158|FG001|Overall Study|Withdrawal by Subject|0|||
125144502|NCT05263505|450153159|FG000|Overall Study|Adverse Event|0|||
125144503|NCT05263505|450153160|FG001|Overall Study|Adverse Event|1|||
125144504|NCT01785615|450153167|FG000|Dietary Phase|Lost to Follow-up|0|||
125144505|NCT01785615|450153168|FG001|Dietary Phase|Lost to Follow-up|0|||
125144506|NCT01785615|450153169|FG002|Dietary Phase|Lost to Follow-up|0|||
125144507|NCT01785615|450153170|FG003|Dietary Phase|Lost to Follow-up|24|||
125144508|NCT03428945|450153171|FG000|Overall Study|Lost to Follow-up|5|||
125144509|NCT03428945|450153172|FG001|Overall Study|Lost to Follow-up|3|||
125144510|NCT03428945|450153171|FG000|Overall Study|Withdrawal by Subject|10|||
125144511|NCT03428945|450153172|FG001|Overall Study|Withdrawal by Subject|10|||
125144512|NCT00360490|450153175|FG000|Overall Study|Adverse Event|4|||
125144513|NCT00360490|450153176|FG001|Overall Study|Adverse Event|2|||
125144514|NCT00360490|450153175|FG000|Overall Study|Lost to Follow-up|2|||
125144515|NCT00360490|450153176|FG001|Overall Study|Lost to Follow-up|1|||
125144516|NCT00360490|450153175|FG000|Overall Study|Physician Decision|2|||
125144517|NCT00360490|450153176|FG001|Overall Study|Physician Decision|1|||
125144518|NCT00360490|450153175|FG000|Overall Study|Protocol Violation|0|||
125144519|NCT00360490|450153176|FG001|Overall Study|Protocol Violation|4|||
125144520|NCT00360490|450153175|FG000|Overall Study|Withdrawal by Subject|1|||
125144521|NCT00360490|450153176|FG001|Overall Study|Withdrawal by Subject|3|||
125144522|NCT03294317|450153177|FG000|Overall Study|Physician Decision|1|||
125144523|NCT03294317|450153177|FG000|Overall Study|Withdrawal by Subject|6|||
125144524|NCT03294317|450153177|FG000|Overall Study|Lost to Follow-up|1|||
125144525|NCT03294317|450153177|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
125080845|NCT02865928|449913420|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
125080846|NCT02865928|449913421|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
125080847|NCT03152110|449913422|FG000|Overall Study|Withdrawal by Subject|3|||
125080848|NCT03696576|449913423|FG000|Overall Study|Soreness of throat after therapy|1|||
125080849|NCT03696576|449913424|FG001|Overall Study|Soreness of throat after therapy|1|||
125080850|NCT03696576|449913423|FG000|Overall Study|Lost to Follow-up|2|||
125080851|NCT03696576|449913424|FG001|Overall Study|Lost to Follow-up|4|||
125080852|NCT00338806|449913428|FG000|Acute Phase|Withdrawal by Subject|0|||
125080853|NCT00338806|449913429|FG001|Acute Phase|Withdrawal by Subject|1|||
125080854|NCT00338806|449913428|FG000|Follow-up|Lost to Follow-up|1|||
125080855|NCT00338806|449913429|FG001|Follow-up|Lost to Follow-up|3|||
125080856|NCT04259346|449913436|FG000|Overall Study|Lost to Follow-up|1|||
125080857|NCT04259346|449913437|FG001|Overall Study|Lost to Follow-up|3|||
125080858|NCT04259346|449913436|FG000|Overall Study|Protocol Violation|1|||
125144526|NCT03294317|450153177|FG000|Overall Study|Failed HB lead implant|8|||
125144527|NCT03294317|450153177|FG000|Overall Study|Received CRT instead|1|||
125144528|NCT03294317|450153177|FG000|Overall Study|Exited after lead revision|2|||
125144529|NCT01160640|450153178|FG000|Overall Study|Physician Decision|3|||
125144530|NCT01160640|450153179|FG001|Overall Study|Physician Decision|3|||
125144531|NCT01160640|450153178|FG000|Overall Study|Incarceration|1|||
125144532|NCT01160640|450153179|FG001|Overall Study|Incarceration|0|||
125144533|NCT01160640|450153178|FG000|Overall Study|Withdrawal by Subject|0|||
125144534|NCT01160640|450153179|FG001|Overall Study|Withdrawal by Subject|3|||
125080859|NCT04259346|449913437|FG001|Overall Study|Protocol Violation|0|||
125080860|NCT04259346|449913436|FG000|Overall Study|Withdrawal by Subject|1|||
125144535|NCT00642811|450153184|FG000|Overall Study|Adverse Event|2|||
125144536|NCT00642811|450153185|FG001|Overall Study|Adverse Event|3|||
125144537|NCT00642811|450153186|FG002|Overall Study|Adverse Event|0|||
125144538|NCT00642811|450153187|FG003|Overall Study|Adverse Event|0|||
125144539|NCT00642811|450153188|FG004|Overall Study|Adverse Event|0|||
125144540|NCT00642811|450153189|FG005|Overall Study|Adverse Event|1|||
125080861|NCT04259346|449913437|FG001|Overall Study|Withdrawal by Subject|0|||
125080862|NCT04259346|449913436|FG000|Overall Study|Adverse Event|1|||
125080863|NCT04259346|449913437|FG001|Overall Study|Adverse Event|1|||
125080864|NCT00085644|449913438|FG000|Double-Blind Period|Adverse Event|5|||
125080865|NCT00085644|449913439|FG001|Double-Blind Period|Adverse Event|2|||
125080866|NCT00085644|449913440|FG002|Double-Blind Period|Adverse Event|0|||
125080867|NCT00085644|449913438|FG000|Double-Blind Period|Withdrawal by Subject|3|||
125080868|NCT00085644|449913439|FG001|Double-Blind Period|Withdrawal by Subject|0|||
125080869|NCT00085644|449913440|FG002|Double-Blind Period|Withdrawal by Subject|0|||
125080870|NCT00085644|449913438|FG000|Double-Blind Period|Lost to Follow-up|2|||
125080871|NCT00085644|449913439|FG001|Double-Blind Period|Lost to Follow-up|1|||
125080872|NCT00085644|449913440|FG002|Double-Blind Period|Lost to Follow-up|0|||
125080873|NCT00085644|449913438|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
125080874|NCT00085644|449913439|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
125080875|NCT00085644|449913440|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
125080876|NCT00085644|449913438|FG000|Double-Blind Period|Contemplating pregnancy|1|||
125080877|NCT00085644|449913439|FG001|Double-Blind Period|Contemplating pregnancy|0|||
125080878|NCT00085644|449913440|FG002|Double-Blind Period|Contemplating pregnancy|0|||
125080879|NCT00085644|449913438|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
125080880|NCT00085644|449913439|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
125080881|NCT00085644|449913440|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
125080882|NCT00085644|449913438|FG000|Open-Label Period|Adverse Event|0|||
125080883|NCT00085644|449913439|FG001|Open-Label Period|Adverse Event|0|||
125144541|NCT00642811|450153184|FG000|Overall Study|Developement of discontinuation criteria|0|||
125144542|NCT00642811|450153185|FG001|Overall Study|Developement of discontinuation criteria|0|||
125144543|NCT00642811|450153186|FG002|Overall Study|Developement of discontinuation criteria|0|||
125144544|NCT00642811|450153187|FG003|Overall Study|Developement of discontinuation criteria|0|||
125144545|NCT00642811|450153188|FG004|Overall Study|Developement of discontinuation criteria|1|||
125144546|NCT00642811|450153189|FG005|Overall Study|Developement of discontinuation criteria|0|||
125144547|NCT00642811|450153184|FG000|Overall Study|Severe Non-compliance to protocol|1|||
125144548|NCT00642811|450153185|FG001|Overall Study|Severe Non-compliance to protocol|0|||
125144549|NCT00642811|450153186|FG002|Overall Study|Severe Non-compliance to protocol|0|||
125144550|NCT00642811|450153187|FG003|Overall Study|Severe Non-compliance to protocol|0|||
125144551|NCT00642811|450153188|FG004|Overall Study|Severe Non-compliance to protocol|0|||
125144552|NCT00642811|450153189|FG005|Overall Study|Severe Non-compliance to protocol|0|||
125144553|NCT00642811|450153184|FG000|Overall Study|Other|0|||
125144554|NCT00642811|450153185|FG001|Overall Study|Other|1|||
125144555|NCT00642811|450153186|FG002|Overall Study|Other|0|||
125144556|NCT00642811|450153187|FG003|Overall Study|Other|1|||
125144557|NCT00642811|450153188|FG004|Overall Study|Other|0|||
125144558|NCT00642811|450153189|FG005|Overall Study|Other|0|||
125144559|NCT01562613|450153191|FG000|Overall Study|Lost to Follow-up|2|||
125144560|NCT01562613|450153191|FG000|Overall Study|Withdrawal by Subject|2|||
125144561|NCT02614898|450153192|FG000|Overall Study|Participated until study termination|10|||
125080884|NCT00085644|449913440|FG002|Open-Label Period|Adverse Event|38|||
125080885|NCT00085644|449913438|FG000|Open-Label Period|Withdrawal by Subject|0|||
125080886|NCT00085644|449913439|FG001|Open-Label Period|Withdrawal by Subject|0|||
125080887|NCT00085644|449913440|FG002|Open-Label Period|Withdrawal by Subject|29|||
125080888|NCT00085644|449913438|FG000|Open-Label Period|Lost to Follow-up|0|||
125080889|NCT00085644|449913439|FG001|Open-Label Period|Lost to Follow-up|0|||
125080890|NCT00085644|449913440|FG002|Open-Label Period|Lost to Follow-up|13|||
125080891|NCT00085644|449913438|FG000|Open-Label Period|Lack of Efficacy|0|||
125080892|NCT00085644|449913439|FG001|Open-Label Period|Lack of Efficacy|0|||
125080893|NCT00085644|449913440|FG002|Open-Label Period|Lack of Efficacy|15|||
125144562|NCT02614898|450153193|FG001|Overall Study|Participated until study termination|26|||
125223508|NCT02326272|450446167|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125080894|NCT00085644|449913438|FG000|Open-Label Period|Pregnancy|0|||
125080895|NCT00085644|449913439|FG001|Open-Label Period|Pregnancy|0|||
125080896|NCT00085644|449913440|FG002|Open-Label Period|Pregnancy|3|||
125080897|NCT00085644|449913438|FG000|Open-Label Period|Contemplating pregnancy|0|||
125080898|NCT00085644|449913439|FG001|Open-Label Period|Contemplating pregnancy|0|||
125080899|NCT00085644|449913440|FG002|Open-Label Period|Contemplating pregnancy|3|||
125080900|NCT00085644|449913438|FG000|Open-Label Period|Protocol Violation|0|||
125080901|NCT00085644|449913439|FG001|Open-Label Period|Protocol Violation|0|||
125080902|NCT00085644|449913440|FG002|Open-Label Period|Protocol Violation|4|||
125144563|NCT02614898|450153192|FG000|Overall Study|Lost to Follow-up|0|||
125144564|NCT02614898|450153193|FG001|Overall Study|Lost to Follow-up|2|||
125303056|NCT03100058|450736670|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
125080903|NCT00085644|449913438|FG000|Open-Label Period|Personal reason|0|||
125080904|NCT00085644|449913439|FG001|Open-Label Period|Personal reason|0|||
125144565|NCT02614898|450153192|FG000|Overall Study|Physician Decision|1|||
125144566|NCT02614898|450153193|FG001|Overall Study|Physician Decision|8|||
125144567|NCT02614898|450153192|FG000|Overall Study|Study Terminated by Sponsor|3|||
125144568|NCT02614898|450153193|FG001|Overall Study|Study Terminated by Sponsor|0|||
125144569|NCT02614898|450153192|FG000|Overall Study|Withdrawal by Subject|0|||
125144570|NCT02614898|450153193|FG001|Overall Study|Withdrawal by Subject|2|||
125144571|NCT02614898|450153192|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
125144572|NCT02614898|450153193|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
125144573|NCT02614898|450153192|FG000|Overall Study|Other-Additional Information Unavailable|0|||
125144574|NCT02614898|450153193|FG001|Overall Study|Other-Additional Information Unavailable|11|||
125144575|NCT02614898|450153192|FG000|Overall Study|Missing|0|||
125144576|NCT02614898|450153193|FG001|Overall Study|Missing|1|||
125144577|NCT00239005|450153194|FG000|Overall Study|Adverse Event|6|||
125144578|NCT00239005|450153195|FG001|Overall Study|Adverse Event|6|||
125144579|NCT00239005|450153194|FG000|Overall Study|Withdrawal by Subject|3|||
125144580|NCT00239005|450153195|FG001|Overall Study|Withdrawal by Subject|4|||
125144581|NCT00239005|450153194|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
125144582|NCT00239005|450153195|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
125144583|NCT00239005|450153194|FG000|Overall Study|Protocol Violation|1|||
125144584|NCT00239005|450153195|FG001|Overall Study|Protocol Violation|0|||
125144585|NCT00239005|450153194|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
125144586|NCT00239005|450153195|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
125144587|NCT00239005|450153194|FG000|Overall Study|Lost to Follow-up|0|||
125144588|NCT00239005|450153195|FG001|Overall Study|Lost to Follow-up|1|||
125144589|NCT00787605|450153196|FG000|Overall Study|Administrative Problems|3|||
125144590|NCT00787605|450153197|FG001|Overall Study|Administrative Problems|0|||
125144591|NCT00787605|450153196|FG000|Overall Study|Adverse Event|14|||
125144592|NCT00787605|450153197|FG001|Overall Study|Adverse Event|25|||
125144593|NCT00787605|450153196|FG000|Overall Study|Lost to Follow-up|3|||
125144594|NCT00787605|450153197|FG001|Overall Study|Lost to Follow-up|6|||
125144595|NCT00787605|450153196|FG000|Overall Study|Protocol Violation|7|||
125144596|NCT00787605|450153197|FG001|Overall Study|Protocol Violation|3|||
125144597|NCT00787605|450153196|FG000|Overall Study|Withdrawal by Subject|6|||
125144598|NCT00787605|450153197|FG001|Overall Study|Withdrawal by Subject|13|||
125144599|NCT00787605|450153196|FG000|Overall Study|Lack of Efficacy|13|||
125144600|NCT00787605|450153197|FG001|Overall Study|Lack of Efficacy|9|||
125144601|NCT03108820|450153198|FG000|Overall Study|Lost to Follow-up|30|||
125144602|NCT03108820|450153199|FG001|Overall Study|Lost to Follow-up|28|||
125144603|NCT03108820|450153198|FG000|Overall Study|Withdrawal by Subject|32|||
125144604|NCT03108820|450153199|FG001|Overall Study|Withdrawal by Subject|24|||
125144605|NCT03108820|450153198|FG000|Overall Study|Death|6|||
125144606|NCT03108820|450153199|FG001|Overall Study|Death|11|||
125080905|NCT00085644|449913440|FG002|Open-Label Period|Personal reason|4|||
125080906|NCT03330106|449913441|FG000|Part A|Withdrawal by Subject|1|||
125080907|NCT03330106|449913442|FG001|Part A|Withdrawal by Subject|1|||
125080908|NCT03330106|449913443|FG002|Part A|Withdrawal by Subject|0|||
125080909|NCT03330106|449913444|FG003|Part A|Withdrawal by Subject|0|||
125080910|NCT03330106|449913441|FG000|Part A|Death|2|||
125080911|NCT03330106|449913442|FG001|Part A|Death|1|||
125080912|NCT03330106|449913443|FG002|Part A|Death|0|||
125080913|NCT03330106|449913444|FG003|Part A|Death|0|||
125080914|NCT03330106|449913441|FG000|Part A|Adverse Event|0|||
125080915|NCT03330106|449913442|FG001|Part A|Adverse Event|1|||
125080916|NCT03330106|449913443|FG002|Part A|Adverse Event|0|||
125080917|NCT03330106|449913444|FG003|Part A|Adverse Event|0|||
125080918|NCT03330106|449913441|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
125080919|NCT03330106|449913442|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
125080920|NCT03330106|449913443|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
125080921|NCT03330106|449913444|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
125080922|NCT03330106|449913441|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
125080923|NCT03330106|449913442|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
125080924|NCT03330106|449913443|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
125080925|NCT03330106|449913444|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
125144607|NCT03382041|450153200|FG000|Overall Study|Consent Form Lost|2|||
125144608|NCT03382041|450153201|FG001|Overall Study|Consent Form Lost|1|||
125144609|NCT03382041|450153200|FG000|Overall Study|Withdrawal by Subject|1|||
125144610|NCT03382041|450153201|FG001|Overall Study|Withdrawal by Subject|4|||
125144611|NCT03382041|450153200|FG000|Overall Study|Lost to Follow-up|1|||
125144612|NCT03382041|450153201|FG001|Overall Study|Lost to Follow-up|4|||
125144613|NCT03493919|450153206|FG000|Overall Study|Other|2|||
125144614|NCT03493919|450153207|FG001|Overall Study|Other|0|||
125144615|NCT03493919|450153208|FG002|Overall Study|Other|1|||
125144616|NCT03493919|450153209|FG003|Overall Study|Other|0|||
125144617|NCT03493919|450153206|FG000|Overall Study|Withdrawal by Subject|9|||
125144618|NCT03493919|450153207|FG001|Overall Study|Withdrawal by Subject|3|||
125080926|NCT03330106|449913441|FG000|Part A|Progressive Disease|0|||
125144619|NCT03493919|450153208|FG002|Overall Study|Withdrawal by Subject|1|||
125144620|NCT03493919|450153209|FG003|Overall Study|Withdrawal by Subject|1|||
125144621|NCT03493919|450153206|FG000|Overall Study|Lost to Follow-up|5|||
125080927|NCT03330106|449913442|FG001|Part A|Progressive Disease|1|||
125080928|NCT03330106|449913443|FG002|Part A|Progressive Disease|0|||
125080929|NCT03330106|449913444|FG003|Part A|Progressive Disease|0|||
125080930|NCT03330106|449913441|FG000|Part B|Lost to Follow-up|0|||
125080931|NCT03330106|449913442|FG001|Part B|Lost to Follow-up|0|||
125080932|NCT03330106|449913443|FG002|Part B|Lost to Follow-up|0|||
125080933|NCT03330106|449913444|FG003|Part B|Lost to Follow-up|1|||
125080934|NCT03330106|449913441|FG000|Part B|Withdrawal by Subject|0|||
125080935|NCT03330106|449913442|FG001|Part B|Withdrawal by Subject|0|||
125080936|NCT03330106|449913443|FG002|Part B|Withdrawal by Subject|4|||
125080937|NCT03330106|449913444|FG003|Part B|Withdrawal by Subject|0|||
125080938|NCT03330106|449913441|FG000|Part B|Death|0|||
125080939|NCT03330106|449913442|FG001|Part B|Death|0|||
125080940|NCT03330106|449913443|FG002|Part B|Death|2|||
125080941|NCT03330106|449913444|FG003|Part B|Death|0|||
125080942|NCT03330106|449913441|FG000|Part B|Clinical Progression|0|||
125080943|NCT03330106|449913442|FG001|Part B|Clinical Progression|0|||
125080944|NCT03330106|449913443|FG002|Part B|Clinical Progression|1|||
125080945|NCT03330106|449913444|FG003|Part B|Clinical Progression|1|||
125080946|NCT03330106|449913441|FG000|Part B|Symptomatic Deterioration|0|||
125080947|NCT03330106|449913442|FG001|Part B|Symptomatic Deterioration|0|||
125080948|NCT03330106|449913443|FG002|Part B|Symptomatic Deterioration|0|||
125080949|NCT03330106|449913444|FG003|Part B|Symptomatic Deterioration|1|||
125080950|NCT03330106|449913441|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
125080951|NCT03330106|449913442|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
125080952|NCT03330106|449913443|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
125080953|NCT03330106|449913444|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
125080954|NCT03330106|449913441|FG000|Part B|Progressive Disease|0|||
125080955|NCT03330106|449913442|FG001|Part B|Progressive Disease|0|||
125080956|NCT03330106|449913443|FG002|Part B|Progressive Disease|11|||
125080957|NCT03330106|449913444|FG003|Part B|Progressive Disease|4|||
125080958|NCT00623766|449913446|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
125080959|NCT00623766|449913447|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
125080960|NCT00623766|449913446|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
125080961|NCT00623766|449913447|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
125080962|NCT00623766|449913446|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
125080963|NCT00623766|449913447|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
125080964|NCT00623766|449913446|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
125080965|NCT00623766|449913447|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
125080966|NCT00623766|449913446|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
125080967|NCT00623766|449913447|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
125080968|NCT00486889|449913451|FG000|Overall Study|Death|3|||
125080969|NCT00486889|449913451|FG000|Overall Study|Non-compliant|2|||
125080970|NCT00486889|449913451|FG000|Overall Study|Withdrawal by Subject|6|||
125080971|NCT00893763|449913452|FG000|Overall Study|extubated|110|||
125080972|NCT00893763|449913453|FG001|Overall Study|extubated|110|||
125080973|NCT02324049|449913454|FG000|Part C|Study terminated|11|||
125080974|NCT03198728|449913455|FG000|Overall Study|Adverse Event|10|||
125080975|NCT03198728|449913456|FG001|Overall Study|Adverse Event|5|||
125080976|NCT03198728|449913455|FG000|Overall Study|Lost to Follow-up|21|||
125080977|NCT03198728|449913456|FG001|Overall Study|Lost to Follow-up|7|||
125080978|NCT03198728|449913455|FG000|Overall Study|Physician Decision|7|||
125080979|NCT03198728|449913456|FG001|Overall Study|Physician Decision|2|||
125080980|NCT03198728|449913455|FG000|Overall Study|Withdrawal by Subject|14|||
125080981|NCT03198728|449913456|FG001|Overall Study|Withdrawal by Subject|10|||
125080982|NCT04051944|449913459|FG000|Overall Study|Study ending|1|||
125144622|NCT03493919|450153207|FG001|Overall Study|Lost to Follow-up|0|||
125144623|NCT03493919|450153208|FG002|Overall Study|Lost to Follow-up|0|||
125144624|NCT03493919|450153209|FG003|Overall Study|Lost to Follow-up|3|||
125144625|NCT03493919|450153206|FG000|Overall Study|Adverse Event|0|||
125144626|NCT03493919|450153207|FG001|Overall Study|Adverse Event|1|||
125144627|NCT03493919|450153208|FG002|Overall Study|Adverse Event|0|||
125144628|NCT03493919|450153209|FG003|Overall Study|Adverse Event|0|||
125144629|NCT04640194|450153210|FG000|Overall Study|Adverse Event|3|||
125144630|NCT04640194|450153211|FG001|Overall Study|Adverse Event|7|||
125144631|NCT04640194|450153212|FG002|Overall Study|Adverse Event|0|||
125080983|NCT04051944|449913460|FG001|Overall Study|Study ending|1|||
125080984|NCT04051944|449913459|FG000|Overall Study|Early study termination by participant|1|||
125144632|NCT04640194|450153213|FG003|Overall Study|Adverse Event|5|||
125144633|NCT04640194|450153214|FG004|Overall Study|Adverse Event|0|||
125080985|NCT04051944|449913460|FG001|Overall Study|Early study termination by participant|0|||
125080986|NCT04051944|449913459|FG000|Overall Study|Withdrawal by Subject|2|||
125080987|NCT04051944|449913460|FG001|Overall Study|Withdrawal by Subject|2|||
125080988|NCT04051944|449913459|FG000|Overall Study|Lack of Efficacy|3|||
125080989|NCT04051944|449913460|FG001|Overall Study|Lack of Efficacy|0|||
125144634|NCT04640194|450153215|FG005|Overall Study|Adverse Event|4|||
125144635|NCT04640194|450153216|FG006|Overall Study|Adverse Event|0|||
125080990|NCT04051944|449913459|FG000|Overall Study|Adverse event, non- fatal|1|||
125080991|NCT04051944|449913460|FG001|Overall Study|Adverse event, non- fatal|1|||
125080992|NCT04157751|449913461|FG000|Overall Study|Withdrawal by Subject|12|||
125080993|NCT04157751|449913462|FG001|Overall Study|Withdrawal by Subject|17|||
125080994|NCT04157751|449913461|FG000|Overall Study|Lost to Follow-up|6|||
125080995|NCT04157751|449913462|FG001|Overall Study|Lost to Follow-up|2|||
125080996|NCT04157751|449913461|FG000|Overall Study|Adverse Event|34|||
125080997|NCT04157751|449913462|FG001|Overall Study|Adverse Event|23|||
125080998|NCT04157751|449913461|FG000|Overall Study|Not treated|1|||
125080999|NCT04157751|449913462|FG001|Overall Study|Not treated|5|||
125081000|NCT04157751|449913461|FG000|Overall Study|Other reason not stated above|10|||
125081001|NCT04157751|449913462|FG001|Overall Study|Other reason not stated above|10|||
125081002|NCT02829775|449913472|FG000|Overall Study|Death|1|||
125081003|NCT02829775|449913472|FG000|Overall Study|Withdrawal by Subject|3|||
125081004|NCT02829775|449913472|FG000|Overall Study|Disease remission|1|||
125081005|NCT01249157|449913473|FG000|Overall Study|Withdrawal by Subject|1|||
125081006|NCT00062647|449913474|FG000|Overall Study|Death|2|||
125081007|NCT00062647|449913475|FG001|Overall Study|Death|2|||
125081008|NCT00062647|449913474|FG000|Overall Study|Adverse Event|1|||
125081009|NCT00062647|449913475|FG001|Overall Study|Adverse Event|1|||
125081010|NCT00062647|449913474|FG000|Overall Study|Withdrawal by Subject|2|||
125081011|NCT00062647|449913475|FG001|Overall Study|Withdrawal by Subject|1|||
125081012|NCT00062647|449913474|FG000|Overall Study|Protocol Violation|1|||
125081013|NCT00062647|449913475|FG001|Overall Study|Protocol Violation|0|||
125081014|NCT00062647|449913474|FG000|Overall Study|Lost to Follow-up|1|||
125081015|NCT00062647|449913475|FG001|Overall Study|Lost to Follow-up|2|||
125081016|NCT00062647|449913474|FG000|Overall Study|Failed continuation criteria|4|||
125081017|NCT00062647|449913475|FG001|Overall Study|Failed continuation criteria|2|||
125081018|NCT00062647|449913474|FG000|Overall Study|Other|4|||
125081019|NCT00062647|449913475|FG001|Overall Study|Other|4|||
125081020|NCT00062647|449913474|FG000|Overall Study|Never received study treatment|1|||
125081021|NCT00062647|449913475|FG001|Overall Study|Never received study treatment|1|||
125081022|NCT04445051|449913476|FG000|Overall Study|Adverse Event|0|||
125081023|NCT04445051|449913477|FG001|Overall Study|Adverse Event|0|||
125081024|NCT04445051|449913478|FG002|Overall Study|Adverse Event|1|||
125081025|NCT04445051|449913479|FG003|Overall Study|Adverse Event|0|||
125081026|NCT04445051|449913480|FG004|Overall Study|Adverse Event|0|||
125081027|NCT04445051|449913481|FG005|Overall Study|Adverse Event|0|||
125144636|NCT04640194|450153210|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
125144637|NCT04640194|450153211|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
125144638|NCT04640194|450153212|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
125144639|NCT04640194|450153213|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
125081028|NCT02392468|449913490|FG000|Overall Study|Adverse Event|0|||
125081029|NCT02392468|449913491|FG001|Overall Study|Adverse Event|1|||
125081030|NCT02392468|449913492|FG002|Overall Study|Adverse Event|0|||
125081031|NCT02392468|449913493|FG003|Overall Study|Adverse Event|0|||
125081032|NCT02392468|449913494|FG004|Overall Study|Adverse Event|0|||
125081033|NCT02392468|449913495|FG005|Overall Study|Adverse Event|1|||
125081034|NCT00901394|449913502|FG000|Overall Study|Physician Decision|1|||
125081035|NCT00901394|449913503|FG001|Overall Study|Physician Decision|1|||
125081036|NCT00901394|449913504|FG002|Overall Study|Physician Decision|2|||
125081037|NCT02422186|449913505|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
125081038|NCT02422186|449913506|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
125081039|NCT02422186|449913505|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
125081040|NCT02422186|449913506|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
125081041|NCT02422186|449913505|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
125081042|NCT02422186|449913506|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
125081043|NCT02422186|449913505|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
125081044|NCT02422186|449913506|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
125081045|NCT02422186|449913505|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
125144640|NCT04640194|450153214|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
125144641|NCT04640194|450153215|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
125144642|NCT04640194|450153216|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
125144643|NCT04640194|450153210|FG000|Overall Study|fibrinogen level too low|0|||
125081046|NCT02422186|449913506|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
125081047|NCT02422186|449913505|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
125081048|NCT02422186|449913506|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
125081049|NCT02422186|449913505|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
125081050|NCT02422186|449913506|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
125081051|NCT02422186|449913505|FG000|Follow-up Phase (2 Weeks)|Other|3|||
125081052|NCT02422186|449913506|FG001|Follow-up Phase (2 Weeks)|Other|0|||
125081053|NCT03039569|449913507|FG000|Overall Study|Lost to Follow-up|5|||
125081054|NCT03039569|449913508|FG001|Overall Study|Lost to Follow-up|4|||
125144644|NCT04640194|450153211|FG001|Overall Study|fibrinogen level too low|0|||
125081055|NCT02254304|449913509|FG000|Overall Study|Adverse Event|2|||
125081056|NCT02254304|449913510|FG001|Overall Study|Adverse Event|1|||
125081057|NCT02254304|449913509|FG000|Overall Study|Lost to Follow-up|2|||
125081058|NCT02254304|449913510|FG001|Overall Study|Lost to Follow-up|2|||
125081059|NCT02254304|449913509|FG000|Overall Study|Protocol Violation|1|||
125081060|NCT02254304|449913510|FG001|Overall Study|Protocol Violation|0|||
125081061|NCT02254304|449913509|FG000|Overall Study|Withdrawal by Subject|3|||
125081062|NCT02254304|449913510|FG001|Overall Study|Withdrawal by Subject|0|||
125081063|NCT02254304|449913509|FG000|Overall Study|Injection site pain and Injection fear|1|||
125081064|NCT02254304|449913510|FG001|Overall Study|Injection site pain and Injection fear|0|||
125081065|NCT02254304|449913509|FG000|Overall Study|Personal causes|4|||
125081066|NCT02254304|449913510|FG001|Overall Study|Personal causes|1|||
125081067|NCT02254304|449913509|FG000|Overall Study|Personal decision|1|||
125081068|NCT02254304|449913510|FG001|Overall Study|Personal decision|0|||
125081069|NCT04888507|449915514|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
125081070|NCT00400946|449915515|FG000|Overall Study|Ineligible|0|||
125081071|NCT00400946|449915516|FG001|Overall Study|Ineligible|0|||
125081072|NCT00400946|449915517|FG002|Overall Study|Ineligible|0|||
125081073|NCT00400946|449915518|FG003|Overall Study|Ineligible|5|||
125081074|NCT00400946|449915519|FG004|Overall Study|Ineligible|1|||
125081075|NCT00400946|449915515|FG000|Overall Study|Induction Failure|0|||
125081076|NCT00400946|449915516|FG001|Overall Study|Induction Failure|0|||
125081077|NCT00400946|449915517|FG002|Overall Study|Induction Failure|0|||
125081078|NCT00400946|449915518|FG003|Overall Study|Induction Failure|11|||
125081079|NCT00400946|449915519|FG004|Overall Study|Induction Failure|8|||
125081080|NCT00400946|449915515|FG000|Overall Study|Induction Death|0|||
125081081|NCT00400946|449915516|FG001|Overall Study|Induction Death|0|||
125081082|NCT00400946|449915517|FG002|Overall Study|Induction Death|0|||
125081083|NCT00400946|449915518|FG003|Overall Study|Induction Death|13|||
125081084|NCT00400946|449915519|FG004|Overall Study|Induction Death|3|||
125081085|NCT00400946|449915515|FG000|Overall Study|Lost to Follow-up|1|||
125081086|NCT00400946|449915516|FG001|Overall Study|Lost to Follow-up|1|||
125081087|NCT00400946|449915517|FG002|Overall Study|Lost to Follow-up|0|||
125081088|NCT00400946|449915518|FG003|Overall Study|Lost to Follow-up|0|||
125081089|NCT00400946|449915519|FG004|Overall Study|Lost to Follow-up|1|||
125081090|NCT00400946|449915515|FG000|Overall Study|Remission Death|1|||
125081091|NCT00400946|449915516|FG001|Overall Study|Remission Death|1|||
125081092|NCT00400946|449915517|FG002|Overall Study|Remission Death|0|||
125081093|NCT00400946|449915518|FG003|Overall Study|Remission Death|0|||
125081094|NCT00400946|449915519|FG004|Overall Study|Remission Death|1|||
125081095|NCT00400946|449915515|FG000|Overall Study|Relapse|9|||
125081096|NCT00400946|449915516|FG001|Overall Study|Relapse|2|||
125081097|NCT00400946|449915517|FG002|Overall Study|Relapse|1|||
125081098|NCT00400946|449915518|FG003|Overall Study|Relapse|1|||
125081099|NCT00400946|449915519|FG004|Overall Study|Relapse|5|||
125081100|NCT00400946|449915515|FG000|Overall Study|Transplant in CR1|0|||
125081101|NCT00400946|449915516|FG001|Overall Study|Transplant in CR1|0|||
125081102|NCT00400946|449915517|FG002|Overall Study|Transplant in CR1|0|||
125081103|NCT00400946|449915518|FG003|Overall Study|Transplant in CR1|10|||
125081104|NCT00400946|449915519|FG004|Overall Study|Transplant in CR1|1|||
125081105|NCT00400946|449915515|FG000|Overall Study|Withdrawal by Subject|2|||
125081106|NCT00400946|449915516|FG001|Overall Study|Withdrawal by Subject|5|||
125081107|NCT00400946|449915517|FG002|Overall Study|Withdrawal by Subject|1|||
125081108|NCT00400946|449915518|FG003|Overall Study|Withdrawal by Subject|5|||
125081109|NCT00400946|449915519|FG004|Overall Study|Withdrawal by Subject|8|||
125081110|NCT00400946|449915515|FG000|Overall Study|Clinical|1|||
125081111|NCT00400946|449915516|FG001|Overall Study|Clinical|2|||
125081112|NCT00400946|449915517|FG002|Overall Study|Clinical|0|||
125081113|NCT00400946|449915518|FG003|Overall Study|Clinical|2|||
125081114|NCT00400946|449915519|FG004|Overall Study|Clinical|9|||
125081115|NCT00400946|449915515|FG000|Overall Study|Other|0|||
125081116|NCT00400946|449915516|FG001|Overall Study|Other|0|||
125081117|NCT00400946|449915517|FG002|Overall Study|Other|0|||
125081118|NCT00400946|449915518|FG003|Overall Study|Other|0|||
125081119|NCT00400946|449915519|FG004|Overall Study|Other|1|||
125081120|NCT05643170|449915520|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
125081121|NCT05643170|449915520|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
125081122|NCT01673373|449915522|FG000|Overall Study|Death|2|||
125081123|NCT05426460|449915523|FG000|Overall Study|Protocol Violation|1|||
125081124|NCT05426460|449915524|FG001|Overall Study|Protocol Violation|1|||
125081125|NCT05426460|449915525|FG002|Overall Study|Protocol Violation|1|||
125081126|NCT05426460|449915526|FG003|Overall Study|Protocol Violation|0|||
125081127|NCT01431521|449915532|FG000|Overall Study|Withdrawal by Subject|0|||
125081128|NCT01431521|449915533|FG001|Overall Study|Withdrawal by Subject|0|||
125081129|NCT01431521|449915534|FG002|Overall Study|Withdrawal by Subject|1|||
125081130|NCT01431521|449915535|FG003|Overall Study|Withdrawal by Subject|0|||
125081131|NCT02531633|449915536|FG000|Part A (52 Weeks)|Sponsor request|24|||
125081132|NCT02531633|449915537|FG001|Part A (52 Weeks)|Sponsor request|24|||
125081133|NCT02531633|449915538|FG002|Part A (52 Weeks)|Sponsor request|18|||
125081134|NCT02531633|449915539|FG003|Part A (52 Weeks)|Sponsor request|18|||
125081135|NCT02531633|449915540|FG004|Part A (52 Weeks)|Sponsor request|19|||
125081136|NCT02531633|449915541|FG005|Part A (52 Weeks)|Sponsor request|0|||
125081137|NCT02531633|449915542|FG006|Part A (52 Weeks)|Sponsor request|0|||
125081138|NCT02531633|449915543|FG007|Part A (52 Weeks)|Sponsor request|0|||
125081139|NCT02531633|449915544|FG008|Part A (52 Weeks)|Sponsor request|0|||
125081140|NCT02531633|449915545|FG009|Part A (52 Weeks)|Sponsor request|0|||
125081141|NCT02531633|449915536|FG000|Part A (52 Weeks)|Protocol Violation|1|||
125081142|NCT02531633|449915537|FG001|Part A (52 Weeks)|Protocol Violation|0|||
125081143|NCT02531633|449915538|FG002|Part A (52 Weeks)|Protocol Violation|0|||
125081144|NCT02531633|449915539|FG003|Part A (52 Weeks)|Protocol Violation|0|||
125081145|NCT02531633|449915540|FG004|Part A (52 Weeks)|Protocol Violation|0|||
125081146|NCT02531633|449915541|FG005|Part A (52 Weeks)|Protocol Violation|0|||
125081147|NCT02531633|449915542|FG006|Part A (52 Weeks)|Protocol Violation|0|||
125081148|NCT02531633|449915543|FG007|Part A (52 Weeks)|Protocol Violation|0|||
125081149|NCT02531633|449915544|FG008|Part A (52 Weeks)|Protocol Violation|0|||
125081150|NCT02531633|449915545|FG009|Part A (52 Weeks)|Protocol Violation|0|||
125081151|NCT02531633|449915536|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
125081152|NCT02531633|449915537|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
125081153|NCT02531633|449915538|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
125081154|NCT02531633|449915539|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
125081155|NCT02531633|449915540|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
125081156|NCT02531633|449915541|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
125081157|NCT02531633|449915542|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
125081158|NCT02531633|449915543|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
125081159|NCT02531633|449915544|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
125081160|NCT02531633|449915545|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
125081161|NCT02531633|449915536|FG000|Part A (52 Weeks)|Physician Decision|1|||
125081162|NCT02531633|449915537|FG001|Part A (52 Weeks)|Physician Decision|4|||
125081163|NCT02531633|449915538|FG002|Part A (52 Weeks)|Physician Decision|3|||
125081164|NCT02531633|449915539|FG003|Part A (52 Weeks)|Physician Decision|1|||
125081165|NCT02531633|449915540|FG004|Part A (52 Weeks)|Physician Decision|0|||
125081166|NCT02531633|449915541|FG005|Part A (52 Weeks)|Physician Decision|0|||
125081167|NCT02531633|449915542|FG006|Part A (52 Weeks)|Physician Decision|0|||
125081168|NCT02531633|449915543|FG007|Part A (52 Weeks)|Physician Decision|0|||
125081169|NCT02531633|449915544|FG008|Part A (52 Weeks)|Physician Decision|0|||
125081170|NCT02531633|449915545|FG009|Part A (52 Weeks)|Physician Decision|0|||
125081171|NCT02531633|449915536|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
125081172|NCT02531633|449915537|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
125081173|NCT02531633|449915538|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
125081174|NCT02531633|449915539|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
125081175|NCT02531633|449915540|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
125081176|NCT02531633|449915541|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
125081177|NCT02531633|449915542|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
125081178|NCT02531633|449915543|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
125081179|NCT02531633|449915544|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
125081180|NCT02531633|449915545|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
125081181|NCT02531633|449915536|FG000|Part A (52 Weeks)|Other|2|||
125081182|NCT02531633|449915537|FG001|Part A (52 Weeks)|Other|0|||
125081183|NCT02531633|449915538|FG002|Part A (52 Weeks)|Other|0|||
125081184|NCT02531633|449915539|FG003|Part A (52 Weeks)|Other|0|||
125081185|NCT02531633|449915540|FG004|Part A (52 Weeks)|Other|0|||
125081186|NCT02531633|449915541|FG005|Part A (52 Weeks)|Other|0|||
125081187|NCT02531633|449915542|FG006|Part A (52 Weeks)|Other|0|||
125081188|NCT02531633|449915543|FG007|Part A (52 Weeks)|Other|0|||
125081189|NCT02531633|449915544|FG008|Part A (52 Weeks)|Other|0|||
125081190|NCT02531633|449915545|FG009|Part A (52 Weeks)|Other|0|||
125081191|NCT02531633|449915536|FG000|Part B (104 Weeks)|Sponsor request|0|||
125081192|NCT02531633|449915537|FG001|Part B (104 Weeks)|Sponsor request|0|||
125081193|NCT02531633|449915538|FG002|Part B (104 Weeks)|Sponsor request|0|||
125081194|NCT02531633|449915539|FG003|Part B (104 Weeks)|Sponsor request|0|||
125081195|NCT02531633|449915540|FG004|Part B (104 Weeks)|Sponsor request|0|||
125081196|NCT02531633|449915541|FG005|Part B (104 Weeks)|Sponsor request|8|||
125081197|NCT02531633|449915542|FG006|Part B (104 Weeks)|Sponsor request|5|||
125081198|NCT02531633|449915543|FG007|Part B (104 Weeks)|Sponsor request|3|||
125081199|NCT02531633|449915544|FG008|Part B (104 Weeks)|Sponsor request|5|||
125081200|NCT02531633|449915545|FG009|Part B (104 Weeks)|Sponsor request|4|||
125081201|NCT02531633|449915536|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
125081202|NCT02531633|449915537|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
125081203|NCT02531633|449915538|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
125081204|NCT02531633|449915539|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
125081205|NCT02531633|449915540|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
125081206|NCT02531633|449915541|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
125081207|NCT02531633|449915542|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
125081208|NCT02531633|449915543|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
125081209|NCT02531633|449915544|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
125081210|NCT02531633|449915545|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
125081211|NCT01572844|449915546|FG000|Overall Study|Physician Decision|1|||
125081212|NCT01572844|449915547|FG001|Overall Study|Physician Decision|1|||
125081213|NCT05171816|449915548|FG000|Overall Study|Death|18|||
125081214|NCT05171816|449915549|FG001|Overall Study|Death|16|||
125081215|NCT04667949|449915550|FG000|Overall Study|Adverse Event|0|||
125081216|NCT04667949|449915551|FG001|Overall Study|Adverse Event|2|||
125081217|NCT04667949|449915550|FG000|Overall Study|Lost to Follow-up|0|||
125081218|NCT04667949|449915551|FG001|Overall Study|Lost to Follow-up|1|||
125081219|NCT04667949|449915550|FG000|Overall Study|Physician Decision|0|||
125081220|NCT04667949|449915551|FG001|Overall Study|Physician Decision|2|||
125081221|NCT04667949|449915550|FG000|Overall Study|Subject decision|1|||
125081222|NCT04667949|449915551|FG001|Overall Study|Subject decision|7|||
125081223|NCT02000622|449915552|FG000|Overall Study|Withdrawal by Subject|5|||
125081224|NCT02000622|449915553|FG001|Overall Study|Withdrawal by Subject|7|||
125081225|NCT02000622|449915552|FG000|Overall Study|Lost to Follow-up|4|||
125081226|NCT02000622|449915553|FG001|Overall Study|Lost to Follow-up|0|||
125081227|NCT02000622|449915552|FG000|Overall Study|Death|159|||
125081228|NCT02000622|449915553|FG001|Overall Study|Death|73|||
125081229|NCT02000622|449915552|FG000|Overall Study|Withdrawn due to site closure|1|||
125144645|NCT04640194|450153212|FG002|Overall Study|fibrinogen level too low|0|||
125144646|NCT04640194|450153213|FG003|Overall Study|fibrinogen level too low|1|||
125144647|NCT04640194|450153214|FG004|Overall Study|fibrinogen level too low|0|||
125144648|NCT04640194|450153215|FG005|Overall Study|fibrinogen level too low|0|||
125144649|NCT04640194|450153216|FG006|Overall Study|fibrinogen level too low|0|||
125144650|NCT04640194|450153210|FG000|Overall Study|mild bleeding|0|||
125144651|NCT04640194|450153211|FG001|Overall Study|mild bleeding|0|||
125144652|NCT04640194|450153212|FG002|Overall Study|mild bleeding|0|||
125144653|NCT04640194|450153213|FG003|Overall Study|mild bleeding|1|||
125144654|NCT04640194|450153214|FG004|Overall Study|mild bleeding|0|||
125144655|NCT04640194|450153215|FG005|Overall Study|mild bleeding|0|||
125144656|NCT04640194|450153216|FG006|Overall Study|mild bleeding|0|||
125144657|NCT04640194|450153210|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
125144658|NCT04640194|450153211|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
125144659|NCT04640194|450153212|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
125144660|NCT04640194|450153213|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
125144661|NCT04640194|450153214|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
125144662|NCT04640194|450153215|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
125144663|NCT04640194|450153216|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
125144664|NCT04428645|450153217|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
125144665|NCT04773600|450153222|FG000|Overall Study|Withdrawal by Subject|15|||
125144666|NCT04773600|450153223|FG001|Overall Study|Withdrawal by Subject|9|||
125144667|NCT04773600|450153222|FG000|Overall Study|Lost to Follow-up|10|||
125144668|NCT04773600|450153223|FG001|Overall Study|Lost to Follow-up|6|||
125144669|NCT04773600|450153222|FG000|Overall Study|Adverse Event|8|||
125144670|NCT04773600|450153223|FG001|Overall Study|Adverse Event|2|||
125144671|NCT04773600|450153222|FG000|Overall Study|Lack of Efficacy|2|||
125144672|NCT04773600|450153223|FG001|Overall Study|Lack of Efficacy|3|||
125144673|NCT04773600|450153222|FG000|Overall Study|Noncompliance|2|||
125144674|NCT04773600|450153223|FG001|Overall Study|Noncompliance|0|||
125144675|NCT04773600|450153222|FG000|Overall Study|Protocol Violation|2|||
125144676|NCT04773600|450153223|FG001|Overall Study|Protocol Violation|0|||
125144677|NCT04773600|450153222|FG000|Overall Study|Physician Decision|0|||
125144678|NCT04773600|450153223|FG001|Overall Study|Physician Decision|1|||
125081230|NCT02000622|449915553|FG001|Overall Study|Withdrawn due to site closure|0|||
125144679|NCT04773600|450153222|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
125144680|NCT04773600|450153223|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
125144681|NCT04773600|450153222|FG000|Overall Study|Emergency Travel Out of Country|1|||
125144682|NCT04773600|450153223|FG001|Overall Study|Emergency Travel Out of Country|0|||
125144683|NCT00500318|450155876|FG000|Overall Study|Adverse Event|3|||
125081231|NCT01405027|449915557|FG000|Overall Study|Withdrawn consent|3|||
125081232|NCT01405027|449915558|FG001|Overall Study|Withdrawn consent|0|||
125081233|NCT01405027|449915557|FG000|Overall Study|Lost to Follow-up|16|||
125081234|NCT01405027|449915558|FG001|Overall Study|Lost to Follow-up|24|||
125081235|NCT01405027|449915557|FG000|Overall Study|Investigator judgement|0|||
125081236|NCT01405027|449915558|FG001|Overall Study|Investigator judgement|2|||
125081237|NCT01405027|449915557|FG000|Overall Study|Death|1|||
125144684|NCT00500318|450155877|FG001|Overall Study|Adverse Event|8|||
125144685|NCT00500318|450155876|FG000|Overall Study|Protocol Violation|1|||
125081238|NCT01405027|449915558|FG001|Overall Study|Death|0|||
125081239|NCT01405027|449915557|FG000|Overall Study|Other or Unknown|12|||
125081240|NCT01405027|449915558|FG001|Overall Study|Other or Unknown|25|||
125081241|NCT03728881|449915562|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
125081242|NCT03728881|449915563|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
125081243|NCT03728881|449915562|FG000|Enrolled and Received 1st Vaccination|Death|1|||
125081244|NCT03728881|449915563|FG001|Enrolled and Received 1st Vaccination|Death|1|||
125081245|NCT03728881|449915562|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
125081246|NCT03728881|449915563|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
125081247|NCT03728881|449915562|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
125081248|NCT03728881|449915563|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
125081249|NCT03728881|449915562|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
125081250|NCT03728881|449915563|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
125081251|NCT03728881|449915562|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
125081252|NCT03728881|449915563|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
125081253|NCT03728881|449915562|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
125081254|NCT03728881|449915563|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
125081255|NCT03728881|449915562|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
125081256|NCT03728881|449915563|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
125081257|NCT03728881|449915562|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
125081258|NCT03728881|449915563|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
125081259|NCT03728881|449915562|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
125081260|NCT03728881|449915563|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
125081261|NCT03728881|449915562|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
125081262|NCT03728881|449915563|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
125081263|NCT00413777|449915564|FG000|Fixed-dose Period|Lost to Follow-up|1|||
125081264|NCT00413777|449915565|FG001|Fixed-dose Period|Lost to Follow-up|1|||
125081265|NCT00413777|449915564|FG000|Fixed-dose Period|Adverse Event|2|||
125081266|NCT00413777|449915565|FG001|Fixed-dose Period|Adverse Event|1|||
125081267|NCT00413777|449915564|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
125081268|NCT00413777|449915565|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
125081269|NCT00413777|449915564|FG000|Fixed-dose Period|Withdrew Consent|0|||
125081270|NCT00413777|449915565|FG001|Fixed-dose Period|Withdrew Consent|1|||
125081271|NCT04088331|449915566|FG000|Overall Study|Lost to Follow-up|3|||
125081272|NCT04088331|449915566|FG000|Overall Study|Withdrawal by Subject|7|||
125081273|NCT04088331|449915566|FG000|Overall Study|Adverse Event|4|||
125081274|NCT02155712|449915573|FG000|Overall Study|Death|12|||
125081275|NCT02155712|449915574|FG001|Overall Study|Death|0|||
125081276|NCT02155712|449915573|FG000|Overall Study|Lost to Follow-up|37|||
125081277|NCT02155712|449915574|FG001|Overall Study|Lost to Follow-up|22|||
125081278|NCT02155712|449915573|FG000|Overall Study|Revision of device|4|||
125081279|NCT02155712|449915574|FG001|Overall Study|Revision of device|3|||
125081280|NCT02155712|449915573|FG000|Overall Study|Withdrawal by Subject|39|||
125081281|NCT02155712|449915574|FG001|Overall Study|Withdrawal by Subject|21|||
125081282|NCT02155712|449915573|FG000|Overall Study|Site termination|77|||
125081283|NCT02155712|449915574|FG001|Overall Study|Site termination|19|||
125081284|NCT02155712|449915573|FG000|Overall Study|Sponsor terminated study early|150|||
125081285|NCT02155712|449915574|FG001|Overall Study|Sponsor terminated study early|0|||
125081286|NCT02155712|449915573|FG000|Overall Study|Missed final 5-year protocol visit|0|||
125081287|NCT02155712|449915574|FG001|Overall Study|Missed final 5-year protocol visit|32|||
125081288|NCT02155712|449915573|FG000|Overall Study|Censored because surgery cancelled|6|||
125081289|NCT02155712|449915574|FG001|Overall Study|Censored because surgery cancelled|10|||
125081290|NCT02155712|449915573|FG000|Overall Study|Censored because study device was not implanted|61|||
125081291|NCT02155712|449915574|FG001|Overall Study|Censored because study device was not implanted|66|||
125081292|NCT02155712|449915573|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
125081293|NCT02155712|449915574|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
125081294|NCT02756845|449915578|FG000|Overall Study|Death|12|||
125081295|NCT02756845|449915579|FG001|Overall Study|Death|2|||
125081296|NCT02756845|449915578|FG000|Overall Study|Withdrawal by Subject|1|||
125081297|NCT02756845|449915579|FG001|Overall Study|Withdrawal by Subject|0|||
125081298|NCT01688999|449915580|FG000|Overall Study|Withdrawal by Subject|5|||
125081299|NCT01688999|449915581|FG001|Overall Study|Withdrawal by Subject|1|||
125081300|NCT01688999|449915582|FG002|Overall Study|Withdrawal by Subject|1|||
125081301|NCT01688999|449915580|FG000|Overall Study|Adverse Event|2|||
125081302|NCT01688999|449915581|FG001|Overall Study|Adverse Event|0|||
125081303|NCT01688999|449915582|FG002|Overall Study|Adverse Event|2|||
125081304|NCT01688999|449915580|FG000|Overall Study|Ineligible/Not treated|1|||
125081305|NCT01688999|449915581|FG001|Overall Study|Ineligible/Not treated|0|||
125081306|NCT01688999|449915582|FG002|Overall Study|Ineligible/Not treated|0|||
125081307|NCT01025232|449915599|FG000|Overall Study|Study drug no longer available|3|||
125081308|NCT01025232|449915600|FG001|Overall Study|Study drug no longer available|6|||
125144686|NCT00500318|450155877|FG001|Overall Study|Protocol Violation|3|||
125144687|NCT00500318|450155876|FG000|Overall Study|Withdrawal by Subject|1|||
125081309|NCT00736450|449915603|FG000|Overall Study|Not ABC gene eligible|19|||
125081310|NCT00736450|449915603|FG000|Overall Study|Withdrawal by Subject|5|||
125081311|NCT00736450|449915603|FG000|Overall Study|Physician Decision|1|||
125081312|NCT01313039|449915604|FG000|Overall Study|Physician Decision|1|||
125081313|NCT01313039|449915604|FG000|Overall Study|Adverse Event|1|||
125081314|NCT05083949|449915605|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
125081315|NCT05083949|449915606|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
125081316|NCT05083949|449915605|FG000|Period 1|Adverse Event|1|||
125081317|NCT05083949|449915606|FG001|Period 1|Adverse Event|1|||
125081318|NCT05083949|449915605|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
125081319|NCT05083949|449915606|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
125081320|NCT05083949|449915605|FG000|Period 2|Adverse Event|0|||
125081321|NCT05083949|449915606|FG001|Period 2|Adverse Event|2|||
125081322|NCT04228445|449915613|FG000|Overall Study|Lost to Follow-up|1|||
125081323|NCT04228445|449915614|FG001|Overall Study|Lost to Follow-up|1|||
125081324|NCT04228445|449915613|FG000|Overall Study|Physician Decision|1|||
125081325|NCT04228445|449915614|FG001|Overall Study|Physician Decision|2|||
125081326|NCT04228445|449915613|FG000|Overall Study|Withdrawal by Subject|0|||
125081327|NCT04228445|449915614|FG001|Overall Study|Withdrawal by Subject|1|||
125081328|NCT04228445|449915613|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
125081329|NCT04228445|449915614|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
125081330|NCT01316380|449915620|FG000|Overall Study|Adverse Event|0|||
125081331|NCT01316380|449915621|FG001|Overall Study|Adverse Event|2|||
125081332|NCT01316380|449915622|FG002|Overall Study|Adverse Event|1|||
125081333|NCT01316380|449915620|FG000|Overall Study|Protocol Violation|0|||
125081334|NCT01316380|449915621|FG001|Overall Study|Protocol Violation|0|||
125081335|NCT01316380|449915622|FG002|Overall Study|Protocol Violation|1|||
125081336|NCT01316380|449915620|FG000|Overall Study|Withdrawal by Subject|1|||
125081337|NCT01316380|449915621|FG001|Overall Study|Withdrawal by Subject|2|||
125081338|NCT01316380|449915622|FG002|Overall Study|Withdrawal by Subject|0|||
125081339|NCT01316380|449915620|FG000|Overall Study|Other|0|||
125081340|NCT01316380|449915621|FG001|Overall Study|Other|1|||
125081341|NCT01316380|449915622|FG002|Overall Study|Other|1|||
125081342|NCT01316380|449915620|FG000|Overall Study|Not treated|1|||
125081343|NCT01316380|449915621|FG001|Overall Study|Not treated|0|||
125081344|NCT01316380|449915622|FG002|Overall Study|Not treated|0|||
125081345|NCT01894776|449915623|FG000|Overall Study|Withdrawal by Subject|1|||
125081346|NCT03512275|449915624|FG000|Overall Study|Withdrawal by Subject|1|||
125081347|NCT03512275|449915625|FG001|Overall Study|Withdrawal by Subject|3|||
125081348|NCT03512275|449915624|FG000|Overall Study|Physician Decision|0|||
125081349|NCT03512275|449915625|FG001|Overall Study|Physician Decision|1|||
125081350|NCT03512275|449915624|FG000|Overall Study|Lost to Follow-up|0|||
125081351|NCT03512275|449915625|FG001|Overall Study|Lost to Follow-up|3|||
125081352|NCT03512275|449915624|FG000|Overall Study|Other|1|||
125081353|NCT03512275|449915625|FG001|Overall Study|Other|0|||
125081354|NCT01307046|449915626|FG000|Overall Study|Adverse Event|3|||
125081355|NCT01307046|449915627|FG001|Overall Study|Adverse Event|3|||
125081356|NCT01307046|449915626|FG000|Overall Study|Lack of Efficacy|0|||
125081357|NCT01307046|449915627|FG001|Overall Study|Lack of Efficacy|2|||
125081358|NCT01307046|449915626|FG000|Overall Study|Physician Decision|2|||
125081359|NCT01307046|449915627|FG001|Overall Study|Physician Decision|0|||
125081360|NCT01307046|449915626|FG000|Overall Study|Withdrawal by Subject|1|||
125081361|NCT01307046|449915627|FG001|Overall Study|Withdrawal by Subject|1|||
125081362|NCT01307046|449915626|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
125081363|NCT01307046|449915627|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
125081364|NCT01307046|449915626|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
125081365|NCT01307046|449915627|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
125081366|NCT00609167|449915628|FG000|Overall Study|Withdrawal by Subject|1|||
125144688|NCT00500318|450155877|FG001|Overall Study|Withdrawal by Subject|2|||
125144689|NCT00500318|450155876|FG000|Overall Study|Lack of Efficacy|0|||
125144690|NCT00500318|450155877|FG001|Overall Study|Lack of Efficacy|3|||
125081367|NCT00609167|449915629|FG001|Overall Study|Withdrawal by Subject|0|||
125081368|NCT00609167|449915628|FG000|Overall Study|Lack of Efficacy|1|||
125081369|NCT00609167|449915629|FG001|Overall Study|Lack of Efficacy|0|||
125081370|NCT00609167|449915628|FG000|Overall Study|Adverse Event|5|||
125081371|NCT00609167|449915629|FG001|Overall Study|Adverse Event|1|||
125081372|NCT00609167|449915628|FG000|Overall Study|Disease Progression|1|||
125081373|NCT00609167|449915629|FG001|Overall Study|Disease Progression|0|||
125081374|NCT00609167|449915628|FG000|Overall Study|Stem Cell Transplant|0|||
125081375|NCT00609167|449915629|FG001|Overall Study|Stem Cell Transplant|6|||
125081376|NCT02574520|449915630|FG000|Overall Study|Not dosed|2|||
125081377|NCT02574520|449915631|FG001|Overall Study|Not dosed|0|||
125081378|NCT02574520|449915632|FG002|Overall Study|Not dosed|5|||
125081379|NCT02574520|449915633|FG003|Overall Study|Not dosed|4|||
125081380|NCT02574520|449915630|FG000|Overall Study|Adverse Event|0|||
125081381|NCT02574520|449915631|FG001|Overall Study|Adverse Event|0|||
125081382|NCT02574520|449915632|FG002|Overall Study|Adverse Event|0|||
125081383|NCT02574520|449915633|FG003|Overall Study|Adverse Event|1|||
125081384|NCT02574520|449915630|FG000|Overall Study|Withdrawal by Subject|0|||
125081385|NCT02574520|449915631|FG001|Overall Study|Withdrawal by Subject|0|||
125081386|NCT02574520|449915632|FG002|Overall Study|Withdrawal by Subject|0|||
125081387|NCT02574520|449915633|FG003|Overall Study|Withdrawal by Subject|1|||
125081388|NCT02574520|449915630|FG000|Overall Study|Other|0|||
125081389|NCT02574520|449915631|FG001|Overall Study|Other|0|||
125081390|NCT02574520|449915632|FG002|Overall Study|Other|0|||
125081391|NCT02574520|449915633|FG003|Overall Study|Other|2|||
125081392|NCT01365091|449915636|FG000|Period 1|Adverse Event|1|||
125081393|NCT01365091|449915637|FG001|Period 1|Adverse Event|0|||
125081394|NCT01365091|449915638|FG002|Period 1|Adverse Event|2|||
125081395|NCT01365091|449915639|FG003|Period 1|Adverse Event|3|||
125081396|NCT01365091|449915636|FG000|Period 1|Positive test result for drugs of abuse|1|||
125081397|NCT01365091|449915637|FG001|Period 1|Positive test result for drugs of abuse|0|||
125081398|NCT01365091|449915638|FG002|Period 1|Positive test result for drugs of abuse|0|||
125081399|NCT01365091|449915639|FG003|Period 1|Positive test result for drugs of abuse|0|||
125081400|NCT01365091|449915636|FG000|Period 1|No longer met study criteria|0|||
125081401|NCT01365091|449915637|FG001|Period 1|No longer met study criteria|1|||
125081402|NCT01365091|449915638|FG002|Period 1|No longer met study criteria|0|||
125081403|NCT01365091|449915639|FG003|Period 1|No longer met study criteria|0|||
125081404|NCT01365091|449915636|FG000|Period 1|Withdrawal by Subject|0|||
125081405|NCT01365091|449915637|FG001|Period 1|Withdrawal by Subject|1|||
125081406|NCT01365091|449915638|FG002|Period 1|Withdrawal by Subject|0|||
125081407|NCT01365091|449915639|FG003|Period 1|Withdrawal by Subject|0|||
125081408|NCT01365091|449915636|FG000|Period 1|Personal reasons|0|||
125081409|NCT01365091|449915637|FG001|Period 1|Personal reasons|0|||
125081410|NCT01365091|449915638|FG002|Period 1|Personal reasons|1|||
125081411|NCT01365091|449915639|FG003|Period 1|Personal reasons|0|||
125081412|NCT01365091|449915636|FG000|Period 2|Withdrawal by Subject|1|||
125081413|NCT01365091|449915637|FG001|Period 2|Withdrawal by Subject|0|||
125081414|NCT01365091|449915638|FG002|Period 2|Withdrawal by Subject|0|||
125081415|NCT01365091|449915639|FG003|Period 2|Withdrawal by Subject|0|||
125081416|NCT01365091|449915636|FG000|Period 2|Adverse Event|0|||
125081417|NCT01365091|449915637|FG001|Period 2|Adverse Event|0|||
125081418|NCT01365091|449915638|FG002|Period 2|Adverse Event|1|||
125081419|NCT01365091|449915639|FG003|Period 2|Adverse Event|0|||
125081420|NCT05116683|449915640|FG000|Overall Study|Physician Decision|4|||
125081421|NCT01474889|449915642|FG000|Overall Study|Physician Decision|1|||
125081422|NCT01474889|449915643|FG001|Overall Study|Physician Decision|0|||
125081423|NCT01474889|449915644|FG002|Overall Study|Physician Decision|0|||
125081424|NCT01474889|449915642|FG000|Overall Study|Did not meet inclusion|1|||
125081425|NCT01474889|449915643|FG001|Overall Study|Did not meet inclusion|0|||
125081426|NCT01474889|449915644|FG002|Overall Study|Did not meet inclusion|0|||
125081427|NCT01474889|449915642|FG000|Overall Study|Withdrawal by Subject|0|||
125081428|NCT01474889|449915643|FG001|Overall Study|Withdrawal by Subject|1|||
125081429|NCT01474889|449915644|FG002|Overall Study|Withdrawal by Subject|0|||
125081430|NCT03935594|449915648|FG000|Overall Study|Physician Decision|3|||
125081431|NCT01435122|449915649|FG000|Overall Study|Early withdrawal due to toxicity|8|||
125081432|NCT04412668|449915650|FG000|Overall Study|Death - multiple comorbidities|2|||
125081433|NCT04412668|449915651|FG001|Overall Study|Death - multiple comorbidities|0|||
125081434|NCT04412668|449915652|FG002|Overall Study|Death - multiple comorbidities|0|||
125081435|NCT04412668|449915650|FG000|Overall Study|Withdrawal by Subject|3|||
125081436|NCT04412668|449915651|FG001|Overall Study|Withdrawal by Subject|0|||
125081437|NCT04412668|449915652|FG002|Overall Study|Withdrawal by Subject|0|||
125081438|NCT04412668|449915650|FG000|Overall Study|Other than Specified|2|||
125081439|NCT04412668|449915651|FG001|Overall Study|Other than Specified|0|||
125081440|NCT04412668|449915652|FG002|Overall Study|Other than Specified|0|||
125081441|NCT03864627|449915654|FG000|Overall Study|Adverse Event|0|||
125081442|NCT03864627|449915655|FG001|Overall Study|Adverse Event|1|||
125081443|NCT03864627|449915654|FG000|Overall Study|Lack of Efficacy|0|||
125081444|NCT03864627|449915655|FG001|Overall Study|Lack of Efficacy|1|||
125081445|NCT03864627|449915654|FG000|Overall Study|Lost to Follow-up|0|||
125081446|NCT03864627|449915655|FG001|Overall Study|Lost to Follow-up|1|||
125081447|NCT03864627|449915654|FG000|Overall Study|Withdrawal by Subject|4|||
125081448|NCT03864627|449915655|FG001|Overall Study|Withdrawal by Subject|8|||
125081449|NCT03864627|449915654|FG000|Overall Study|Study terminated by sponsor|0|||
125081450|NCT03864627|449915655|FG001|Overall Study|Study terminated by sponsor|1|||
125303057|NCT03100058|450736671|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
125081451|NCT01388491|449915656|FG000|Overall Study|Adverse Event|10|||
125081452|NCT01388491|449915657|FG001|Overall Study|Adverse Event|9|||
125081453|NCT01388491|449915656|FG000|Overall Study|Sponsor Request|9|||
125081454|NCT01388491|449915657|FG001|Overall Study|Sponsor Request|7|||
125081455|NCT01388491|449915656|FG000|Overall Study|Withdrawal by Subject|6|||
125081456|NCT01388491|449915657|FG001|Overall Study|Withdrawal by Subject|10|||
125081457|NCT01388491|449915656|FG000|Overall Study|Lost to Follow-up|4|||
125081458|NCT01388491|449915657|FG001|Overall Study|Lost to Follow-up|3|||
125081459|NCT01388491|449915656|FG000|Overall Study|Protocol Violation|2|||
125081460|NCT01388491|449915657|FG001|Overall Study|Protocol Violation|0|||
125081461|NCT01388491|449915656|FG000|Overall Study|Noncompliance|2|||
125081462|NCT01388491|449915657|FG001|Overall Study|Noncompliance|0|||
125081463|NCT01388491|449915656|FG000|Overall Study|Pregnancy|1|||
125081464|NCT01388491|449915657|FG001|Overall Study|Pregnancy|0|||
125081465|NCT00397891|449915658|FG000|Overall Study|Withdrawal by Subject|1|||
125081466|NCT00397891|449915659|FG001|Overall Study|Withdrawal by Subject|0|||
125081467|NCT00397891|449915660|FG002|Overall Study|Withdrawal by Subject|0|||
125081468|NCT00397891|449915661|FG003|Overall Study|Withdrawal by Subject|0|||
125081469|NCT00397891|449915662|FG004|Overall Study|Withdrawal by Subject|1|||
125081470|NCT04964557|449915663|FG000|Overall Study|Withdrawal by Subject|3|||
125081471|NCT04964557|449915664|FG001|Overall Study|Withdrawal by Subject|2|||
125081472|NCT04964557|449915663|FG000|Overall Study|Lost to Follow-up|1|||
125081473|NCT04964557|449915664|FG001|Overall Study|Lost to Follow-up|2|||
125081474|NCT04964557|449915663|FG000|Overall Study|Physician Decision|2|||
125081475|NCT04964557|449915664|FG001|Overall Study|Physician Decision|0|||
125081476|NCT04964557|449915663|FG000|Overall Study|Death|3|||
125081477|NCT04964557|449915664|FG001|Overall Study|Death|0|||
125081478|NCT04964557|449915663|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
125081479|NCT04964557|449915664|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
125081480|NCT04924114|449917437|FG000|Overall Study|Withdrawal by Subject|0|||
125081481|NCT04924114|449917438|FG001|Overall Study|Withdrawal by Subject|2|||
125081482|NCT04924114|449917439|FG002|Overall Study|Withdrawal by Subject|2|||
125081483|NCT04924114|449917440|FG003|Overall Study|Withdrawal by Subject|0|||
125081484|NCT04924114|449917441|FG004|Overall Study|Withdrawal by Subject|2|||
125081485|NCT04960202|449917442|FG000|Overall Study|Other|5|||
125081486|NCT04960202|449917443|FG001|Overall Study|Other|0|||
125081487|NCT04960202|449917442|FG000|Overall Study|Withdrawal by Subject|37|||
125081488|NCT04960202|449917443|FG001|Overall Study|Withdrawal by Subject|43|||
125081489|NCT04960202|449917442|FG000|Overall Study|Lost to Follow-up|20|||
125081490|NCT04960202|449917443|FG001|Overall Study|Lost to Follow-up|16|||
125081491|NCT04960202|449917442|FG000|Overall Study|Death|0|||
125081492|NCT04960202|449917443|FG001|Overall Study|Death|15|||
125081493|NCT03558828|449917447|FG000|Overall Study|Lost to Follow-up|4|||
125081494|NCT03558828|449917448|FG001|Overall Study|Lost to Follow-up|3|||
125081495|NCT03558828|449917449|FG002|Overall Study|Lost to Follow-up|3|||
125081496|NCT03558828|449917450|FG003|Overall Study|Lost to Follow-up|5|||
125081497|NCT03558828|449917451|FG004|Overall Study|Lost to Follow-up|2|||
125081498|NCT03558828|449917452|FG005|Overall Study|Lost to Follow-up|3|||
125081499|NCT03558828|449917447|FG000|Overall Study|dropped before the intervention|1|||
125081500|NCT03558828|449917448|FG001|Overall Study|dropped before the intervention|1|||
125081501|NCT03558828|449917449|FG002|Overall Study|dropped before the intervention|0|||
125081502|NCT03558828|449917450|FG003|Overall Study|dropped before the intervention|0|||
125081503|NCT03558828|449917451|FG004|Overall Study|dropped before the intervention|0|||
125081504|NCT03558828|449917452|FG005|Overall Study|dropped before the intervention|0|||
125081505|NCT00378534|449917453|FG000|Overall Study|Participants did not receive transplant|3|||
125081506|NCT00378534|449917454|FG001|Overall Study|Participants did not receive transplant|0|||
125081507|NCT04969900|449917455|FG000|Overall Study|Physician Decision|1|||
125081508|NCT04969900|449917456|FG001|Overall Study|Physician Decision|1|||
125223509|NCT02326272|450446168|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125081509|NCT04969900|449917455|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
125081510|NCT04969900|449917456|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
125081511|NCT03671148|449917462|FG000|Overall Study|Adverse Event|3|||
125081512|NCT03671148|449917463|FG001|Overall Study|Adverse Event|2|||
125223510|NCT02326272|450446169|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
125223511|NCT02326272|450446170|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125223512|NCT02326272|450446171|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125223513|NCT02326272|450446172|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125081513|NCT03671148|449917462|FG000|Overall Study|Withdrawal by Subject|8|||
125081514|NCT03671148|449917463|FG001|Overall Study|Withdrawal by Subject|2|||
125081515|NCT03671148|449917462|FG000|Overall Study|Lost to Follow-up|1|||
125081516|NCT03671148|449917463|FG001|Overall Study|Lost to Follow-up|2|||
125081517|NCT03671148|449917462|FG000|Overall Study|Lack of Efficacy|7|||
125081518|NCT03671148|449917463|FG001|Overall Study|Lack of Efficacy|2|||
125081519|NCT03671148|449917462|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
125081520|NCT03671148|449917463|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
125081521|NCT03671148|449917462|FG000|Overall Study|Other|1|||
125081522|NCT03671148|449917463|FG001|Overall Study|Other|0|||
125081523|NCT03671148|449917462|FG000|Overall Study|Incomplete Randomization Visit|1|||
125081524|NCT03671148|449917463|FG001|Overall Study|Incomplete Randomization Visit|0|||
125081525|NCT04423718|449917464|FG000|Main Study|Adverse Event|9|||
125081526|NCT04423718|449917465|FG001|Main Study|Adverse Event|5|||
125081527|NCT04423718|449917466|FG002|Main Study|Adverse Event|8|||
125081528|NCT04423718|449917464|FG000|Main Study|Physician Decision|3|||
125081529|NCT04423718|449917465|FG001|Main Study|Physician Decision|3|||
125081530|NCT04423718|449917466|FG002|Main Study|Physician Decision|2|||
125081531|NCT04423718|449917464|FG000|Main Study|Protocol Violation|0|||
125081532|NCT04423718|449917465|FG001|Main Study|Protocol Violation|0|||
125081533|NCT04423718|449917466|FG002|Main Study|Protocol Violation|1|||
125081534|NCT04423718|449917464|FG000|Main Study|Lost to Follow-up|3|||
125081535|NCT04423718|449917465|FG001|Main Study|Lost to Follow-up|3|||
125081536|NCT04423718|449917466|FG002|Main Study|Lost to Follow-up|4|||
125081537|NCT04423718|449917464|FG000|Main Study|Lack of Efficacy|2|||
125081538|NCT04423718|449917465|FG001|Main Study|Lack of Efficacy|1|||
125081539|NCT04423718|449917466|FG002|Main Study|Lack of Efficacy|0|||
125081540|NCT04423718|449917464|FG000|Main Study|Withdrawal by Subject|14|||
125081541|NCT04423718|449917465|FG001|Main Study|Withdrawal by Subject|20|||
125081542|NCT04423718|449917466|FG002|Main Study|Withdrawal by Subject|20|||
125081543|NCT04423718|449917464|FG000|Main Study|Death|10|||
125081544|NCT04423718|449917465|FG001|Main Study|Death|7|||
125081545|NCT04423718|449917466|FG002|Main Study|Death|7|||
125081546|NCT04423718|449917464|FG000|Main Study|COVID-19 pandemic|2|||
125081547|NCT04423718|449917465|FG001|Main Study|COVID-19 pandemic|2|||
125081548|NCT04423718|449917466|FG002|Main Study|COVID-19 pandemic|2|||
125081549|NCT04423718|449917464|FG000|Main Study|Other|7|||
125081550|NCT04423718|449917465|FG001|Main Study|Other|3|||
125081551|NCT04423718|449917466|FG002|Main Study|Other|2|||
125081552|NCT04423718|449917464|FG000|Extension Phase|Other|1|||
125081553|NCT04423718|449917465|FG001|Extension Phase|Other|0|||
125081554|NCT04423718|449917466|FG002|Extension Phase|Other|0|||
125081555|NCT04423718|449917464|FG000|Extension Phase|Logistical problems|0|||
125081556|NCT04423718|449917465|FG001|Extension Phase|Logistical problems|1|||
125081557|NCT04423718|449917466|FG002|Extension Phase|Logistical problems|1|||
125081558|NCT04423718|449917464|FG000|Extension Phase|Physician Decision|1|||
125081559|NCT04423718|449917465|FG001|Extension Phase|Physician Decision|0|||
125081560|NCT04423718|449917466|FG002|Extension Phase|Physician Decision|1|||
125081561|NCT04423718|449917464|FG000|Extension Phase|Lack of Efficacy|2|||
125081562|NCT04423718|449917465|FG001|Extension Phase|Lack of Efficacy|0|||
125081563|NCT04423718|449917466|FG002|Extension Phase|Lack of Efficacy|1|||
125081564|NCT04423718|449917464|FG000|Extension Phase|Lost to Follow-up|0|||
125081565|NCT04423718|449917465|FG001|Extension Phase|Lost to Follow-up|2|||
125081566|NCT04423718|449917466|FG002|Extension Phase|Lost to Follow-up|3|||
125081567|NCT04423718|449917464|FG000|Extension Phase|Adverse Event|2|||
125081568|NCT04423718|449917465|FG001|Extension Phase|Adverse Event|3|||
125081569|NCT04423718|449917466|FG002|Extension Phase|Adverse Event|1|||
125081570|NCT04423718|449917464|FG000|Extension Phase|Death|4|||
125081571|NCT04423718|449917465|FG001|Extension Phase|Death|7|||
125081572|NCT04423718|449917466|FG002|Extension Phase|Death|2|||
125081573|NCT04423718|449917464|FG000|Extension Phase|Withdrawal by Subject|11|||
125081574|NCT04423718|449917465|FG001|Extension Phase|Withdrawal by Subject|11|||
125081575|NCT04423718|449917466|FG002|Extension Phase|Withdrawal by Subject|7|||
125081576|NCT00425945|449917467|FG000|Overall Study|Concern about Supplement|2|||
125081577|NCT00425945|449917468|FG001|Overall Study|Concern about Supplement|0|||
125081578|NCT00425945|449917467|FG000|Overall Study|Inconvenience|0|||
125081579|NCT00425945|449917468|FG001|Overall Study|Inconvenience|2|||
125081580|NCT00425945|449917467|FG000|Overall Study|Lost to Follow-up|0|||
125081581|NCT00425945|449917468|FG001|Overall Study|Lost to Follow-up|2|||
125081582|NCT00425945|449917467|FG000|Overall Study|Began hypertension medication|1|||
125081583|NCT00425945|449917468|FG001|Overall Study|Began hypertension medication|0|||
125081584|NCT00425945|449917467|FG000|Overall Study|Began cancer treatments|1|||
125081585|NCT00425945|449917468|FG001|Overall Study|Began cancer treatments|0|||
125081586|NCT00425945|449917467|FG000|Overall Study|Moved from area|0|||
125081587|NCT00425945|449917468|FG001|Overall Study|Moved from area|1|||
125081588|NCT03657576|449917473|FG000|Overall Study|Death|0|||
125081589|NCT03657576|449917474|FG001|Overall Study|Death|1|||
125081590|NCT03657576|449917475|FG002|Overall Study|Death|1|||
125081591|NCT03657576|449917476|FG003|Overall Study|Death|0|||
125081592|NCT03657576|449917477|FG004|Overall Study|Death|0|||
125081593|NCT03657576|449917478|FG005|Overall Study|Death|0|||
125081594|NCT03657576|449917473|FG000|Overall Study|Withdrawal by Subject|0|||
125081595|NCT03657576|449917474|FG001|Overall Study|Withdrawal by Subject|0|||
125081596|NCT03657576|449917475|FG002|Overall Study|Withdrawal by Subject|0|||
125081597|NCT03657576|449917476|FG003|Overall Study|Withdrawal by Subject|1|||
125081598|NCT03657576|449917477|FG004|Overall Study|Withdrawal by Subject|0|||
125081599|NCT03657576|449917478|FG005|Overall Study|Withdrawal by Subject|0|||
125081600|NCT03657576|449917473|FG000|Overall Study|Screen Fail|0|||
125081601|NCT03657576|449917474|FG001|Overall Study|Screen Fail|0|||
125081602|NCT03657576|449917475|FG002|Overall Study|Screen Fail|0|||
125081603|NCT03657576|449917476|FG003|Overall Study|Screen Fail|0|||
125081604|NCT03657576|449917477|FG004|Overall Study|Screen Fail|0|||
125081605|NCT03657576|449917478|FG005|Overall Study|Screen Fail|5|||
125081606|NCT03657576|449917473|FG000|Overall Study|Disease Progression|1|||
125081607|NCT03657576|449917474|FG001|Overall Study|Disease Progression|1|||
125081608|NCT03657576|449917475|FG002|Overall Study|Disease Progression|0|||
125081609|NCT03657576|449917476|FG003|Overall Study|Disease Progression|5|||
125081610|NCT03657576|449917477|FG004|Overall Study|Disease Progression|0|||
125081611|NCT03657576|449917478|FG005|Overall Study|Disease Progression|0|||
125081612|NCT03657576|449917473|FG000|Overall Study|Insurance Coverage|0|||
125081613|NCT03657576|449917474|FG001|Overall Study|Insurance Coverage|0|||
125081614|NCT03657576|449917475|FG002|Overall Study|Insurance Coverage|0|||
125081615|NCT03657576|449917476|FG003|Overall Study|Insurance Coverage|1|||
125081616|NCT03657576|449917477|FG004|Overall Study|Insurance Coverage|0|||
125081617|NCT03657576|449917478|FG005|Overall Study|Insurance Coverage|0|||
125081618|NCT05618808|449917481|FG000|Overall Study|Withdrawal by Subject|3|||
125081619|NCT05618808|449917482|FG001|Overall Study|Withdrawal by Subject|1|||
125081620|NCT05618808|449917483|FG002|Overall Study|Withdrawal by Subject|3|||
125081621|NCT04284787|449917484|FG000|Overall Study|Disease Progression|9|||
125081622|NCT04284787|449917485|FG001|Overall Study|Disease Progression|12|||
125081623|NCT04284787|449917484|FG000|Overall Study|Physician Decision|12|||
125081624|NCT04284787|449917485|FG001|Overall Study|Physician Decision|7|||
125081625|NCT04284787|449917484|FG000|Overall Study|Transplant|5|||
125081626|NCT04284787|449917485|FG001|Overall Study|Transplant|4|||
125081627|NCT04284787|449917484|FG000|Overall Study|Death|1|||
125081628|NCT04284787|449917485|FG001|Overall Study|Death|2|||
125081629|NCT04284787|449917484|FG000|Overall Study|Adverse Event|0|||
125081630|NCT04284787|449917485|FG001|Overall Study|Adverse Event|4|||
125081631|NCT04284787|449917484|FG000|Overall Study|Non-adherence|2|||
125081632|NCT04284787|449917485|FG001|Overall Study|Non-adherence|0|||
125081633|NCT04284787|449917484|FG000|Overall Study|Lack of Efficacy|2|||
125081634|NCT04284787|449917485|FG001|Overall Study|Lack of Efficacy|0|||
125081635|NCT01874353|449917486|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
125081636|NCT01874353|449917487|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
125081637|NCT01874353|449917488|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
125081638|NCT01874353|449917489|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
125081639|NCT01874353|449917486|FG000|Overall Study|Lost to Follow-up|2|||
125081640|NCT01874353|449917487|FG001|Overall Study|Lost to Follow-up|2|||
125081641|NCT01874353|449917488|FG002|Overall Study|Lost to Follow-up|2|||
125081642|NCT01874353|449917489|FG003|Overall Study|Lost to Follow-up|0|||
125081643|NCT01874353|449917486|FG000|Overall Study|Death|110|||
125081644|NCT01874353|449917487|FG001|Overall Study|Death|60|||
125081645|NCT01874353|449917488|FG002|Overall Study|Death|13|||
125081646|NCT01874353|449917489|FG003|Overall Study|Death|7|||
125081647|NCT01874353|449917486|FG000|Overall Study|Withdrawal by Subject|13|||
125081648|NCT01874353|449917487|FG001|Overall Study|Withdrawal by Subject|11|||
125081649|NCT01874353|449917488|FG002|Overall Study|Withdrawal by Subject|0|||
125081650|NCT01874353|449917489|FG003|Overall Study|Withdrawal by Subject|0|||
125081651|NCT04392154|449917490|FG000|Overall Study|Adverse Event|3|||
125081652|NCT04392154|449917491|FG001|Overall Study|Adverse Event|46|||
125081653|NCT04392154|449917490|FG000|Overall Study|Due to epidemic/pandemic|0|||
125081654|NCT04392154|449917491|FG001|Overall Study|Due to epidemic/pandemic|1|||
125081655|NCT04392154|449917490|FG000|Overall Study|Lack of Efficacy|1|||
125081656|NCT04392154|449917491|FG001|Overall Study|Lack of Efficacy|47|||
125081657|NCT04392154|449917490|FG000|Overall Study|Lost to Follow-up|11|||
125081658|NCT04392154|449917491|FG001|Overall Study|Lost to Follow-up|61|||
125081659|NCT04392154|449917490|FG000|Overall Study|Geopolitical conflict|1|||
125081660|NCT04392154|449917491|FG001|Overall Study|Geopolitical conflict|1|||
125081661|NCT04392154|449917490|FG000|Overall Study|Physician Decision|1|||
125081662|NCT04392154|449917491|FG001|Overall Study|Physician Decision|5|||
125081663|NCT04392154|449917490|FG000|Overall Study|Pregnancy|1|||
125081664|NCT04392154|449917491|FG001|Overall Study|Pregnancy|8|||
125081665|NCT04392154|449917490|FG000|Overall Study|Protocol deviation|1|||
125081666|NCT04392154|449917491|FG001|Overall Study|Protocol deviation|12|||
125081667|NCT04392154|449917490|FG000|Overall Study|Withdrawal by Subject|18|||
125081668|NCT04392154|449917491|FG001|Overall Study|Withdrawal by Subject|138|||
125081669|NCT04392154|449917490|FG000|Overall Study|Sponsor Decision|1|||
125081670|NCT04392154|449917491|FG001|Overall Study|Sponsor Decision|14|||
125081671|NCT04392154|449917490|FG000|Overall Study|Site Closure|0|||
125081672|NCT04392154|449917491|FG001|Overall Study|Site Closure|4|||
125081673|NCT04992507|449917494|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
125081674|NCT04992507|449917495|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
125081675|NCT04992507|449917494|FG000|Overall Study|Death|0|||
125081676|NCT04992507|449917495|FG001|Overall Study|Death|1|||
125081677|NCT03774875|449917496|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
125081678|NCT03774875|449917497|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
125081679|NCT03774875|449917496|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
125081680|NCT03774875|449917497|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
125081681|NCT03774875|449917496|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
125081682|NCT03774875|449917497|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
125081683|NCT03774875|449917496|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
125081684|NCT03774875|449917497|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
125081685|NCT03774875|449917496|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
125081686|NCT03774875|449917497|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
125081687|NCT03774875|449917496|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
125081688|NCT03774875|449917497|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
125081689|NCT03774875|449917496|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
125081690|NCT03774875|449917497|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
125144691|NCT00500318|450155876|FG000|Overall Study|Other Reason|0|||
125144692|NCT00500318|450155877|FG001|Overall Study|Other Reason|1|||
125144693|NCT03243396|450155878|FG000|Overall Study|Lost to Follow-up|2|||
125144694|NCT03243396|450155879|FG001|Overall Study|Lost to Follow-up|3|||
125144695|NCT03243396|450155880|FG002|Overall Study|Lost to Follow-up|15|||
125144696|NCT03243396|450155881|FG003|Overall Study|Lost to Follow-up|8|||
125144697|NCT03243396|450155882|FG004|Overall Study|Lost to Follow-up|1|||
125144698|NCT03243396|450155883|FG005|Overall Study|Lost to Follow-up|4|||
125144699|NCT03243396|450155884|FG006|Overall Study|Lost to Follow-up|9|||
125144700|NCT01257581|450155885|FG000|Overall Study|Early Termination|3|||
125144701|NCT01257581|450155886|FG001|Overall Study|Early Termination|1|||
125144702|NCT01257581|450155887|FG002|Overall Study|Early Termination|2|||
125144703|NCT01257581|450155885|FG000|Overall Study|Death|2|||
125144704|NCT01257581|450155886|FG001|Overall Study|Death|2|||
125144705|NCT01257581|450155887|FG002|Overall Study|Death|4|||
125144706|NCT02246764|450155890|FG000|Overall Study|Adverse Event|15|||
125144707|NCT02246764|450155891|FG001|Overall Study|Adverse Event|29|||
125144708|NCT02246764|450155892|FG002|Overall Study|Adverse Event|1|||
125144709|NCT02246764|450155890|FG000|Overall Study|Withdrawal by Subject|0|||
125144710|NCT02246764|450155891|FG001|Overall Study|Withdrawal by Subject|0|||
125144711|NCT02246764|450155892|FG002|Overall Study|Withdrawal by Subject|1|||
125144712|NCT02246764|450155890|FG000|Overall Study|Disallowed Concomitant Medication|1|||
125144713|NCT02246764|450155891|FG001|Overall Study|Disallowed Concomitant Medication|0|||
125144714|NCT02246764|450155892|FG002|Overall Study|Disallowed Concomitant Medication|0|||
125144715|NCT02246764|450155890|FG000|Overall Study|Physician Decision|0|||
125144716|NCT02246764|450155891|FG001|Overall Study|Physician Decision|2|||
125081691|NCT03774875|449917496|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
125081692|NCT03774875|449917497|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
125081693|NCT03774875|449917496|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
125081694|NCT03774875|449917497|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
125081695|NCT03774875|449917496|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
125081696|NCT03774875|449917497|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
125081697|NCT03774875|449917496|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
125081698|NCT03774875|449917497|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
125081699|NCT03774875|449917496|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
125081700|NCT03774875|449917497|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
125081701|NCT03774875|449917496|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
125081702|NCT03774875|449917497|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
125081703|NCT03149029|449917500|FG000|Overall Study|Adverse Event|2|||
125081704|NCT03149029|449917501|FG001|Overall Study|Adverse Event|0|||
125081705|NCT03233308|449917502|FG000|Overall Study|Adverse Event|1|||
125081706|NCT03233308|449917502|FG000|Overall Study|Protocol Violation|1|||
125081707|NCT03287830|449917503|FG000|Overall Study|Withdrawal by Subject|1|||
125081708|NCT03287830|449917504|FG001|Overall Study|Withdrawal by Subject|1|||
125081709|NCT03287830|449917503|FG000|Overall Study|not meeting inclusion criteria|5|||
125081710|NCT03287830|449917504|FG001|Overall Study|not meeting inclusion criteria|12|||
125081711|NCT02974621|449917505|FG000|Overall Study|Didn't receive study treatment|1|||
125081712|NCT02974621|449917506|FG001|Overall Study|Didn't receive study treatment|10|||
125081713|NCT00557323|449917508|FG000|Overall Study|Death|3|||
125144717|NCT02246764|450155892|FG002|Overall Study|Physician Decision|1|||
125144718|NCT02246764|450155890|FG000|Overall Study|Protocol Violation|2|||
125081714|NCT00557323|449917508|FG000|Overall Study|Withdrawal by Subject|2|||
125081715|NCT00557323|449917508|FG000|Overall Study|Administrative change|2|||
125081716|NCT01196091|449917513|FG000|Overall Study|Adverse Event|22|||
125081717|NCT01196091|449917514|FG001|Overall Study|Adverse Event|27|||
125144719|NCT02246764|450155891|FG001|Overall Study|Protocol Violation|1|||
125144720|NCT02246764|450155892|FG002|Overall Study|Protocol Violation|1|||
125144721|NCT04982445|450155893|FG000|Overall Study|Protocol Violation|1|||
125144722|NCT04982445|450155893|FG000|Overall Study|Withdrawal by Subject|4|||
125144723|NCT04982445|450155893|FG000|Overall Study|Lost to Follow-up|1|||
125144724|NCT02161549|450155899|FG000|Overall Study|Physician Decision|6|||
125144725|NCT02161549|450155900|FG001|Overall Study|Physician Decision|2|||
125144726|NCT03223909|450155901|FG000|Overall Study|Protocol Violation|48|||
125144727|NCT03223909|450155902|FG001|Overall Study|Protocol Violation|45|||
125081718|NCT01196091|449917515|FG002|Overall Study|Adverse Event|26|||
125081719|NCT01196091|449917513|FG000|Overall Study|Death|3|||
125081720|NCT01196091|449917514|FG001|Overall Study|Death|2|||
125081721|NCT01196091|449917515|FG002|Overall Study|Death|2|||
125081722|NCT01196091|449917513|FG000|Overall Study|Entry Criteria Not Met|11|||
125081723|NCT01196091|449917514|FG001|Overall Study|Entry Criteria Not Met|11|||
125081724|NCT01196091|449917515|FG002|Overall Study|Entry Criteria Not Met|10|||
125081725|NCT01196091|449917513|FG000|Overall Study|Lack of Efficacy|15|||
125081726|NCT01196091|449917514|FG001|Overall Study|Lack of Efficacy|12|||
125081727|NCT01196091|449917515|FG002|Overall Study|Lack of Efficacy|17|||
125081728|NCT01196091|449917513|FG000|Overall Study|Lost to Follow-up|5|||
125081729|NCT01196091|449917514|FG001|Overall Study|Lost to Follow-up|5|||
125081730|NCT01196091|449917515|FG002|Overall Study|Lost to Follow-up|6|||
125081731|NCT01196091|449917513|FG000|Overall Study|Parent/Caregiver Decision|0|||
125081732|NCT01196091|449917514|FG001|Overall Study|Parent/Caregiver Decision|0|||
125081733|NCT01196091|449917515|FG002|Overall Study|Parent/Caregiver Decision|1|||
125081734|NCT01196091|449917513|FG000|Overall Study|Withdrawal by Subject|16|||
125081735|NCT01196091|449917514|FG001|Overall Study|Withdrawal by Subject|19|||
125081736|NCT01196091|449917515|FG002|Overall Study|Withdrawal by Subject|22|||
125081737|NCT01196091|449917513|FG000|Overall Study|Physician Decision|3|||
125081738|NCT01196091|449917514|FG001|Overall Study|Physician Decision|3|||
125081739|NCT01196091|449917515|FG002|Overall Study|Physician Decision|4|||
125081740|NCT01196091|449917513|FG000|Overall Study|Protocol Violation|1|||
125081741|NCT01196091|449917514|FG001|Overall Study|Protocol Violation|3|||
125081742|NCT01196091|449917515|FG002|Overall Study|Protocol Violation|3|||
125081743|NCT01196091|449917513|FG000|Overall Study|Sponsor Decision|6|||
125081744|NCT01196091|449917514|FG001|Overall Study|Sponsor Decision|5|||
125081745|NCT01196091|449917515|FG002|Overall Study|Sponsor Decision|4|||
125081746|NCT01196091|449917513|FG000|Overall Study|Excluded Site|5|||
125081747|NCT01196091|449917514|FG001|Overall Study|Excluded Site|11|||
125081748|NCT01196091|449917515|FG002|Overall Study|Excluded Site|8|||
125081749|NCT01196091|449917513|FG000|Overall Study|Randomized, No Study Drug Received|1|||
125081750|NCT01196091|449917514|FG001|Overall Study|Randomized, No Study Drug Received|0|||
125081751|NCT01196091|449917515|FG002|Overall Study|Randomized, No Study Drug Received|1|||
125081752|NCT03797144|449917516|FG000|Enrollment|Protocol Violation|4|||
125081753|NCT03797144|449917517|FG001|Enrollment|Protocol Violation|1|||
125081754|NCT03797144|449917516|FG000|Surgery|Protocol Violation|1|||
125081755|NCT03797144|449917517|FG001|Surgery|Protocol Violation|0|||
125081756|NCT03797144|449917516|FG000|3 Month|Early termination cut-off date|2|||
125081757|NCT03797144|449917517|FG001|3 Month|Early termination cut-off date|0|||
125081758|NCT03797144|449917516|FG000|12 Month|Early termination cut-off date|8|||
125081759|NCT03797144|449917517|FG001|12 Month|Early termination cut-off date|9|||
125081760|NCT03797144|449917516|FG000|24 Month|Early termination cut-off date|1|||
125081761|NCT03797144|449917517|FG001|24 Month|Early termination cut-off date|1|||
125081762|NCT03077711|449917518|FG000|Overall Study|Lost to Follow-up|2|||
125081763|NCT03077711|449917519|FG001|Overall Study|Lost to Follow-up|2|||
125081764|NCT03077711|449917518|FG000|Overall Study|noncompliant taking medication|2|||
125081765|NCT03077711|449917519|FG001|Overall Study|noncompliant taking medication|0|||
125081766|NCT00376675|449917520|FG000|Overall Study|Withdrawal by Subject|9|||
125081767|NCT00376675|449917521|FG001|Overall Study|Withdrawal by Subject|2|||
125081768|NCT00376675|449917520|FG000|Overall Study|Adverse Event|10|||
125144728|NCT03223909|450155903|FG002|Overall Study|Protocol Violation|16|||
125144729|NCT01628549|450155906|FG000|Overall Study|Adverse Event|1|||
125081769|NCT00376675|449917521|FG001|Overall Study|Adverse Event|5|||
125081770|NCT00376675|449917520|FG000|Overall Study|Other Reason|1|||
125081771|NCT00376675|449917521|FG001|Overall Study|Other Reason|7|||
125081772|NCT02943668|449917523|FG000|Overall Study|Disease Progression|1|||
125081773|NCT02201251|449917524|FG000|Overall Study|Adverse Event|1|||
125081774|NCT02201251|449917525|FG001|Overall Study|Adverse Event|1|||
125081775|NCT02201251|449917524|FG000|Overall Study|Protocol Violation|1|||
125081776|NCT02201251|449917525|FG001|Overall Study|Protocol Violation|0|||
125081777|NCT02201251|449917524|FG000|Overall Study|Noncompliance with Study Drug|0|||
125081778|NCT02201251|449917525|FG001|Overall Study|Noncompliance with Study Drug|1|||
125081779|NCT02201251|449917524|FG000|Overall Study|Withdrawal by Subject|2|||
125081780|NCT02201251|449917525|FG001|Overall Study|Withdrawal by Subject|1|||
125081781|NCT01332851|449917526|FG000|Overall Study|Withdrawal by Subject|4|||
125081782|NCT01332851|449917527|FG001|Overall Study|Withdrawal by Subject|2|||
125081783|NCT01332851|449917526|FG000|Overall Study|Lost to Follow-up|7|||
125081784|NCT01332851|449917527|FG001|Overall Study|Lost to Follow-up|11|||
125081785|NCT01947894|449917529|FG000|Overall Study|Other|3|||
125081786|NCT01947894|449917530|FG001|Overall Study|Other|4|||
125081787|NCT01947894|449917531|FG002|Overall Study|Other|3|||
125081788|NCT01947894|449917529|FG000|Overall Study|Withdrawal by Subject|12|||
125081789|NCT01947894|449917530|FG001|Overall Study|Withdrawal by Subject|4|||
125081790|NCT01947894|449917531|FG002|Overall Study|Withdrawal by Subject|1|||
125081791|NCT01947894|449917529|FG000|Overall Study|Death|12|||
125081792|NCT01947894|449917530|FG001|Overall Study|Death|1|||
125081793|NCT01947894|449917531|FG002|Overall Study|Death|0|||
125081794|NCT01947894|449917529|FG000|Overall Study|Physician Decision|2|||
125081795|NCT01947894|449917530|FG001|Overall Study|Physician Decision|0|||
125081796|NCT01947894|449917531|FG002|Overall Study|Physician Decision|0|||
125081797|NCT01947894|449917529|FG000|Overall Study|Adverse Event|5|||
125081798|NCT01947894|449917530|FG001|Overall Study|Adverse Event|1|||
125081799|NCT01947894|449917531|FG002|Overall Study|Adverse Event|0|||
125081800|NCT01947894|449917529|FG000|Overall Study|Switched to other growth hormone brand|53|||
125081801|NCT01947894|449917530|FG001|Overall Study|Switched to other growth hormone brand|8|||
125081802|NCT01947894|449917531|FG002|Overall Study|Switched to other growth hormone brand|23|||
125081803|NCT00333970|449917532|FG000|Overall Study|Withdrawal by Subject|13|||
125081804|NCT00333970|449917533|FG001|Overall Study|Withdrawal by Subject|7|||
125081805|NCT01678560|449917539|FG000|Overall Study|Physician Decision|4|||
125081806|NCT01678560|449917540|FG001|Overall Study|Physician Decision|4|||
125081807|NCT01678560|449917539|FG000|Overall Study|Death|0|||
125081808|NCT01678560|449917540|FG001|Overall Study|Death|1|||
125081809|NCT01678560|449917539|FG000|Overall Study|Withdrawal by Subject|0|||
125081810|NCT01678560|449917540|FG001|Overall Study|Withdrawal by Subject|1|||
125081811|NCT00322387|449917544|FG000|Treatment Period|Adverse Event|0|||
125081812|NCT00322387|449917545|FG001|Treatment Period|Adverse Event|1|||
125081813|NCT00322387|449917544|FG000|Follow-up Period|Final assessment not done|1|||
125081814|NCT00322387|449917545|FG001|Follow-up Period|Final assessment not done|3|||
125081815|NCT00322387|449917544|FG000|Follow-up Period|Death|1|||
125081816|NCT00322387|449917545|FG001|Follow-up Period|Death|0|||
125081817|NCT01828567|449917548|FG000|Overall Study|Lost to Follow-up|27|||
125081818|NCT01828567|449917549|FG001|Overall Study|Lost to Follow-up|9|||
125081819|NCT01828567|449917548|FG000|Overall Study|Excluded - did not meet criteria|4|||
125081820|NCT01828567|449917549|FG001|Overall Study|Excluded - did not meet criteria|1|||
125081821|NCT00707486|449917552|FG000|Overall Study|Withdrawal by Subject|1|||
125081822|NCT00090766|449917553|FG000|Overall Study|Nephrectomy Planned|0|||
125081823|NCT00090766|449917554|FG001|Overall Study|Nephrectomy Planned|0|||
125223514|NCT02326272|450446173|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125081824|NCT00090766|449917555|FG002|Overall Study|Nephrectomy Planned|1|||
125081825|NCT00090766|449917553|FG000|Overall Study|Death|1|||
125081826|NCT00090766|449917554|FG001|Overall Study|Death|0|||
125081827|NCT00090766|449917555|FG002|Overall Study|Death|0|||
125081828|NCT00090766|449917553|FG000|Overall Study|Admin|0|||
125081829|NCT00090766|449917554|FG001|Overall Study|Admin|2|||
125081830|NCT00090766|449917555|FG002|Overall Study|Admin|0|||
125081831|NCT00090766|449917553|FG000|Overall Study|Lost to Follow-up|2|||
125081832|NCT00090766|449917554|FG001|Overall Study|Lost to Follow-up|0|||
125081833|NCT00090766|449917555|FG002|Overall Study|Lost to Follow-up|2|||
125081834|NCT00804986|449917556|FG000|Overall Study|Adverse Event|0|||
125081835|NCT00804986|449917557|FG001|Overall Study|Adverse Event|1|||
125081836|NCT00804986|449917558|FG002|Overall Study|Adverse Event|2|||
125081837|NCT00804986|449917559|FG003|Overall Study|Adverse Event|1|||
125081838|NCT00804986|449917560|FG004|Overall Study|Adverse Event|3|||
125081839|NCT00804986|449917561|FG005|Overall Study|Adverse Event|0|||
125081840|NCT00804986|449917556|FG000|Overall Study|Lack of Efficacy|0|||
125081841|NCT00804986|449917557|FG001|Overall Study|Lack of Efficacy|0|||
125081842|NCT00804986|449917558|FG002|Overall Study|Lack of Efficacy|0|||
125081843|NCT00804986|449917559|FG003|Overall Study|Lack of Efficacy|1|||
125081844|NCT00804986|449917560|FG004|Overall Study|Lack of Efficacy|0|||
125081845|NCT00804986|449917561|FG005|Overall Study|Lack of Efficacy|3|||
125081846|NCT00804986|449917556|FG000|Overall Study|Lost to Follow-up|0|||
125081847|NCT00804986|449917557|FG001|Overall Study|Lost to Follow-up|0|||
125081848|NCT00804986|449917558|FG002|Overall Study|Lost to Follow-up|0|||
125081849|NCT00804986|449917559|FG003|Overall Study|Lost to Follow-up|1|||
125081850|NCT00804986|449917560|FG004|Overall Study|Lost to Follow-up|1|||
125081851|NCT00804986|449917561|FG005|Overall Study|Lost to Follow-up|3|||
125081852|NCT00804986|449917556|FG000|Overall Study|Protocol Violation|0|||
125081853|NCT00804986|449917557|FG001|Overall Study|Protocol Violation|1|||
125081854|NCT00804986|449917558|FG002|Overall Study|Protocol Violation|0|||
125081855|NCT00804986|449917559|FG003|Overall Study|Protocol Violation|1|||
125081856|NCT00804986|449917560|FG004|Overall Study|Protocol Violation|0|||
125081857|NCT00804986|449917561|FG005|Overall Study|Protocol Violation|0|||
125223515|NCT02326272|450446174|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125223516|NCT02326272|450446175|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125223517|NCT02326272|450446176|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125223518|NCT02326272|450446177|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125223519|NCT02326272|450446178|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125223520|NCT02326272|450446164|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125081858|NCT00804986|449917556|FG000|Overall Study|Withdrawal by Subject|0|||
125081859|NCT00804986|449917557|FG001|Overall Study|Withdrawal by Subject|3|||
125081860|NCT00804986|449917558|FG002|Overall Study|Withdrawal by Subject|0|||
125081861|NCT00804986|449917559|FG003|Overall Study|Withdrawal by Subject|3|||
125081862|NCT00804986|449917560|FG004|Overall Study|Withdrawal by Subject|5|||
125081863|NCT00804986|449917561|FG005|Overall Study|Withdrawal by Subject|3|||
125081864|NCT00804986|449917556|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
125081865|NCT00804986|449917557|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
125081866|NCT00804986|449917558|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
125081867|NCT00804986|449917559|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
125081868|NCT00804986|449917560|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
125081869|NCT00804986|449917561|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
125081870|NCT00804986|449917556|FG000|Overall Study|Sponsor Decision|0|||
125081871|NCT00804986|449917557|FG001|Overall Study|Sponsor Decision|1|||
125081872|NCT00804986|449917558|FG002|Overall Study|Sponsor Decision|0|||
125081873|NCT00804986|449917559|FG003|Overall Study|Sponsor Decision|0|||
125081874|NCT00804986|449917560|FG004|Overall Study|Sponsor Decision|0|||
125081875|NCT00804986|449917561|FG005|Overall Study|Sponsor Decision|0|||
125081876|NCT00804986|449917556|FG000|Overall Study|Physician Decision|1|||
125081877|NCT00804986|449917557|FG001|Overall Study|Physician Decision|0|||
125081878|NCT00804986|449917558|FG002|Overall Study|Physician Decision|0|||
125081879|NCT00804986|449917559|FG003|Overall Study|Physician Decision|0|||
125081880|NCT00804986|449917560|FG004|Overall Study|Physician Decision|0|||
125081881|NCT00804986|449917561|FG005|Overall Study|Physician Decision|0|||
125081882|NCT00654368|449917562|FG000|Overall Study|Ineligibility determined|6|||
125081883|NCT00654368|449917563|FG001|Overall Study|Ineligibility determined|0|||
125081884|NCT00654368|449917564|FG002|Overall Study|Ineligibility determined|0|||
125081885|NCT00654368|449917562|FG000|Overall Study|Protocol deviation|3|||
125081886|NCT00654368|449917563|FG001|Overall Study|Protocol deviation|2|||
125081887|NCT00654368|449917564|FG002|Overall Study|Protocol deviation|1|||
125081888|NCT00654368|449917562|FG000|Overall Study|Non-compliance|2|||
125081889|NCT00654368|449917563|FG001|Overall Study|Non-compliance|1|||
125081890|NCT00654368|449917564|FG002|Overall Study|Non-compliance|2|||
125081891|NCT00654368|449917562|FG000|Overall Study|Withdrawal by Subject|5|||
125081892|NCT00654368|449917563|FG001|Overall Study|Withdrawal by Subject|2|||
125081893|NCT00654368|449917564|FG002|Overall Study|Withdrawal by Subject|2|||
125081894|NCT00654368|449917562|FG000|Overall Study|Disease progression|21|||
125081895|NCT00654368|449917563|FG001|Overall Study|Disease progression|31|||
125081896|NCT00654368|449917564|FG002|Overall Study|Disease progression|13|||
125081897|NCT00654368|449917562|FG000|Overall Study|Requirement for alternative therapy|1|||
125081898|NCT00654368|449917563|FG001|Overall Study|Requirement for alternative therapy|1|||
125081899|NCT00654368|449917564|FG002|Overall Study|Requirement for alternative therapy|1|||
125081900|NCT00654368|449917562|FG000|Overall Study|Physician Decision|0|||
125081901|NCT00654368|449917563|FG001|Overall Study|Physician Decision|0|||
125081902|NCT00654368|449917564|FG002|Overall Study|Physician Decision|2|||
125081903|NCT00654368|449917562|FG000|Overall Study|Death|1|||
125081904|NCT00654368|449917563|FG001|Overall Study|Death|0|||
125081905|NCT00654368|449917564|FG002|Overall Study|Death|0|||
125081906|NCT00654368|449917562|FG000|Overall Study|Pregnancy|0|||
125081907|NCT00654368|449917563|FG001|Overall Study|Pregnancy|0|||
125081908|NCT00654368|449917564|FG002|Overall Study|Pregnancy|2|||
125081909|NCT00654368|449917562|FG000|Overall Study|Other|0|||
125081910|NCT00654368|449917563|FG001|Overall Study|Other|2|||
125081911|NCT00654368|449917564|FG002|Overall Study|Other|3|||
125081912|NCT00654368|449917562|FG000|Overall Study|Adverse Event|14|||
125081913|NCT00654368|449917563|FG001|Overall Study|Adverse Event|9|||
125081914|NCT00654368|449917564|FG002|Overall Study|Adverse Event|6|||
125081915|NCT00959699|449917571|FG000|Treatment Period|Adverse Event|3|||
125081916|NCT00959699|449917572|FG001|Treatment Period|Adverse Event|13|||
125081917|NCT00959699|449917571|FG000|Treatment Period|Lack of Efficacy|15|||
125081918|NCT00959699|449917572|FG001|Treatment Period|Lack of Efficacy|6|||
125081919|NCT00959699|449917571|FG000|Treatment Period|Lost to Follow-up|0|||
125081920|NCT00959699|449917572|FG001|Treatment Period|Lost to Follow-up|1|||
125081921|NCT00959699|449917571|FG000|Treatment Period|Withdrawal by Subject|1|||
125081922|NCT00959699|449917572|FG001|Treatment Period|Withdrawal by Subject|3|||
125081923|NCT00959699|449917571|FG000|Treatment Period|Non-Compliance with Protocol|0|||
125081924|NCT00959699|449917572|FG001|Treatment Period|Non-Compliance with Protocol|1|||
125081925|NCT00959699|449917571|FG000|Treatment Period|Did not receive treatment|0|||
125081926|NCT00959699|449917572|FG001|Treatment Period|Did not receive treatment|1|||
125081927|NCT00959699|449917571|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
125081928|NCT00959699|449917572|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
125081929|NCT00959699|449917571|FG000|Follow-up Period|Lost to Follow-up|3|||
125081930|NCT00959699|449917572|FG001|Follow-up Period|Lost to Follow-up|2|||
125081931|NCT00959699|449917571|FG000|Follow-up Period|Withdrawal by Subject|3|||
125081932|NCT00959699|449917572|FG001|Follow-up Period|Withdrawal by Subject|4|||
125081933|NCT00606294|449917573|FG000|Overall Study|Withdrawal by Subject|36|||
125081934|NCT00606294|449917574|FG001|Overall Study|Withdrawal by Subject|0|||
125081935|NCT03924427|449917579|FG000|Overall Study|Adverse Event|4|||
125081936|NCT03924427|449917579|FG000|Overall Study|Lack of Efficacy|1|||
125081937|NCT03924427|449917579|FG000|Overall Study|Withdrawal by Subject|1|||
125081938|NCT00126425|449917583|FG000|Overall Study|Withdrawal by Subject|17|||
125081939|NCT00126425|449917584|FG001|Overall Study|Withdrawal by Subject|1|||
125081940|NCT00126425|449917583|FG000|Overall Study|Lost to Follow-up|8|||
125081941|NCT00126425|449917584|FG001|Overall Study|Lost to Follow-up|4|||
125223521|NCT02326272|450446165|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125223522|NCT02326272|450446166|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125223523|NCT02326272|450446167|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125223524|NCT02326272|450446168|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125223525|NCT02326272|450446169|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125081942|NCT00126425|449917583|FG000|Overall Study|Protocol Violation|9|||
125081943|NCT00126425|449917584|FG001|Overall Study|Protocol Violation|6|||
125081944|NCT00126425|449917583|FG000|Overall Study|Adverse Event|1|||
125081945|NCT00126425|449917584|FG001|Overall Study|Adverse Event|0|||
125081946|NCT00126425|449917583|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
125081947|NCT00126425|449917584|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
125081948|NCT00126425|449917583|FG000|Overall Study|Other|5|||
125081949|NCT00126425|449917584|FG001|Overall Study|Other|0|||
125081950|NCT02774291|449917585|FG000|Overall Study|Lost to Follow-up|1|||
125081951|NCT00149890|449917586|FG000|Overall Study|Adverse Event|1|||
125081952|NCT00149890|449917587|FG001|Overall Study|Adverse Event|8|||
125081953|NCT00149890|449917586|FG000|Overall Study|Lack of Efficacy|8|||
125081954|NCT00149890|449917587|FG001|Overall Study|Lack of Efficacy|9|||
125081955|NCT00149890|449917586|FG000|Overall Study|Protocol Violation|1|||
125081956|NCT00149890|449917587|FG001|Overall Study|Protocol Violation|0|||
125081957|NCT00149890|449917586|FG000|Overall Study|Lost to Follow-up|1|||
125081958|NCT00149890|449917587|FG001|Overall Study|Lost to Follow-up|0|||
125081959|NCT00149890|449917586|FG000|Overall Study|Graft Loss|2|||
125081960|NCT00149890|449917587|FG001|Overall Study|Graft Loss|1|||
125081961|NCT02332876|449917588|FG000|Overall Study|Lost to Follow-up|1|||
125081962|NCT02332876|449917589|FG001|Overall Study|Lost to Follow-up|1|||
125081963|NCT02415595|449917591|FG000|Overall Study|Administrative reason by sponsor|39|||
125081964|NCT02415595|449917592|FG001|Overall Study|Administrative reason by sponsor|40|||
125081965|NCT02415595|449917593|FG002|Overall Study|Administrative reason by sponsor|41|||
125081966|NCT02415595|449917594|FG003|Overall Study|Administrative reason by sponsor|39|||
125081967|NCT02415595|449917591|FG000|Overall Study|Adverse Event|1|||
125081968|NCT02415595|449917592|FG001|Overall Study|Adverse Event|3|||
125081969|NCT02415595|449917593|FG002|Overall Study|Adverse Event|5|||
125081970|NCT02415595|449917594|FG003|Overall Study|Adverse Event|10|||
125081971|NCT02415595|449917591|FG000|Overall Study|Lack of Efficacy|4|||
125081972|NCT02415595|449917592|FG001|Overall Study|Lack of Efficacy|4|||
125081973|NCT02415595|449917593|FG002|Overall Study|Lack of Efficacy|0|||
125081974|NCT02415595|449917594|FG003|Overall Study|Lack of Efficacy|0|||
125081975|NCT02415595|449917591|FG000|Overall Study|Lost to Follow-up|1|||
125081976|NCT02415595|449917592|FG001|Overall Study|Lost to Follow-up|3|||
125081977|NCT02415595|449917593|FG002|Overall Study|Lost to Follow-up|1|||
125081978|NCT02415595|449917594|FG003|Overall Study|Lost to Follow-up|1|||
125081979|NCT02415595|449917591|FG000|Overall Study|Poor/Non-compliance|1|||
125081980|NCT02415595|449917592|FG001|Overall Study|Poor/Non-compliance|0|||
125081981|NCT02415595|449917593|FG002|Overall Study|Poor/Non-compliance|1|||
125081982|NCT02415595|449917594|FG003|Overall Study|Poor/Non-compliance|0|||
125081983|NCT02415595|449917591|FG000|Overall Study|Reached stopping criteria|0|||
125144730|NCT01628549|450155907|FG001|Overall Study|Adverse Event|1|||
125144731|NCT01628549|450155908|FG002|Overall Study|Adverse Event|0|||
125144732|NCT01628549|450155909|FG003|Overall Study|Adverse Event|4|||
125144733|NCT01628549|450155906|FG000|Overall Study|Lost to Follow-up|3|||
125144734|NCT01628549|450155907|FG001|Overall Study|Lost to Follow-up|4|||
125144735|NCT01628549|450155908|FG002|Overall Study|Lost to Follow-up|3|||
125144736|NCT01628549|450155909|FG003|Overall Study|Lost to Follow-up|3|||
125144737|NCT01628549|450155906|FG000|Overall Study|Withdrawal by Subject|3|||
125144738|NCT01628549|450155907|FG001|Overall Study|Withdrawal by Subject|4|||
125144739|NCT01628549|450155908|FG002|Overall Study|Withdrawal by Subject|4|||
125144740|NCT01628549|450155909|FG003|Overall Study|Withdrawal by Subject|1|||
125144741|NCT01628549|450155906|FG000|Overall Study|Protocol Violation|2|||
125081984|NCT02415595|449917592|FG001|Overall Study|Reached stopping criteria|1|||
125081985|NCT02415595|449917593|FG002|Overall Study|Reached stopping criteria|1|||
125081986|NCT02415595|449917594|FG003|Overall Study|Reached stopping criteria|0|||
125081987|NCT02415595|449917591|FG000|Overall Study|Withdrawal by Subject|4|||
125081988|NCT02415595|449917592|FG001|Overall Study|Withdrawal by Subject|0|||
125081989|NCT02415595|449917593|FG002|Overall Study|Withdrawal by Subject|1|||
125081990|NCT02415595|449917594|FG003|Overall Study|Withdrawal by Subject|3|||
125081991|NCT02415595|449917591|FG000|Overall Study|Other|0|||
125081992|NCT02415595|449917592|FG001|Overall Study|Other|1|||
125081993|NCT02415595|449917593|FG002|Overall Study|Other|1|||
125081994|NCT02415595|449917594|FG003|Overall Study|Other|0|||
125081995|NCT02614261|449917595|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
125081996|NCT02614261|449917596|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
125081997|NCT02614261|449917597|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
125081998|NCT02614261|449917598|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
125081999|NCT02614261|449917595|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
125082000|NCT02614261|449917596|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
125082001|NCT02614261|449917597|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
125082002|NCT02614261|449917598|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
125082003|NCT02614261|449917595|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
125082004|NCT02614261|449917596|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
125082005|NCT02614261|449917597|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
125082006|NCT02614261|449917598|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125082007|NCT02614261|449917595|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
125082008|NCT02614261|449917596|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
125082009|NCT02614261|449917597|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
125082010|NCT02614261|449917598|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
125082011|NCT02614261|449917595|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
125082012|NCT02614261|449917596|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
125082013|NCT02614261|449917597|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
125082014|NCT02614261|449917598|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
125082015|NCT02614261|449917595|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
125082016|NCT02614261|449917596|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
125082017|NCT02614261|449917597|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
125082018|NCT02614261|449917598|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
125082019|NCT02614261|449917595|FG000|Double-Blind Treatment Phase|Screen failure|0|||
125082020|NCT02614261|449917596|FG001|Double-Blind Treatment Phase|Screen failure|1|||
125082021|NCT02614261|449917597|FG002|Double-Blind Treatment Phase|Screen failure|2|||
125082022|NCT02614261|449917598|FG003|Double-Blind Treatment Phase|Screen failure|0|||
125082023|NCT02614261|449917595|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
125082024|NCT02614261|449917596|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
125082025|NCT02614261|449917597|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
125082026|NCT02614261|449917598|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
125082027|NCT02614261|449917595|FG000|Open-Label Extension Phase|Adverse Event|23|||
125082028|NCT02614261|449917596|FG001|Open-Label Extension Phase|Adverse Event|12|||
125082029|NCT02614261|449917597|FG002|Open-Label Extension Phase|Adverse Event|11|||
125082030|NCT02614261|449917598|FG003|Open-Label Extension Phase|Adverse Event|0|||
125082031|NCT02614261|449917595|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
125082032|NCT02614261|449917596|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
125082033|NCT02614261|449917597|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
125082034|NCT02614261|449917598|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
125082035|NCT02614261|449917595|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
125082036|NCT02614261|449917596|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
125082037|NCT02614261|449917597|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
125082038|NCT02614261|449917598|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
125082039|NCT02614261|449917595|FG000|Open-Label Extension Phase|Physician Decision|2|||
125082040|NCT02614261|449917596|FG001|Open-Label Extension Phase|Physician Decision|0|||
125082041|NCT02614261|449917597|FG002|Open-Label Extension Phase|Physician Decision|0|||
125082042|NCT02614261|449917598|FG003|Open-Label Extension Phase|Physician Decision|0|||
125082043|NCT02614261|449917595|FG000|Open-Label Extension Phase|Pregnancy|1|||
125082044|NCT02614261|449917596|FG001|Open-Label Extension Phase|Pregnancy|2|||
125082045|NCT02614261|449917597|FG002|Open-Label Extension Phase|Pregnancy|1|||
125082046|NCT02614261|449917598|FG003|Open-Label Extension Phase|Pregnancy|0|||
125082047|NCT02614261|449917595|FG000|Open-Label Extension Phase|Protocol Violation|3|||
125082048|NCT02614261|449917596|FG001|Open-Label Extension Phase|Protocol Violation|4|||
125082049|NCT02614261|449917597|FG002|Open-Label Extension Phase|Protocol Violation|1|||
125082050|NCT02614261|449917598|FG003|Open-Label Extension Phase|Protocol Violation|0|||
125082051|NCT02614261|449917595|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
125082052|NCT02614261|449917596|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
125082053|NCT02614261|449917597|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
125082054|NCT02614261|449917598|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
125082055|NCT02614261|449917595|FG000|Follow-up Phase|Adverse Event|2|||
125082056|NCT02614261|449917596|FG001|Follow-up Phase|Adverse Event|0|||
125082057|NCT02614261|449917597|FG002|Follow-up Phase|Adverse Event|1|||
125082058|NCT02614261|449917598|FG003|Follow-up Phase|Adverse Event|0|||
125082059|NCT02614261|449917595|FG000|Follow-up Phase|Lost to Follow-up|12|||
125082060|NCT02614261|449917596|FG001|Follow-up Phase|Lost to Follow-up|5|||
125082061|NCT02614261|449917597|FG002|Follow-up Phase|Lost to Follow-up|2|||
125082062|NCT02614261|449917598|FG003|Follow-up Phase|Lost to Follow-up|0|||
125082063|NCT02614261|449917595|FG000|Follow-up Phase|Physician Decision|5|||
125082064|NCT02614261|449917596|FG001|Follow-up Phase|Physician Decision|1|||
125082065|NCT02614261|449917597|FG002|Follow-up Phase|Physician Decision|0|||
125082066|NCT02614261|449917598|FG003|Follow-up Phase|Physician Decision|0|||
125082067|NCT02614261|449917595|FG000|Follow-up Phase|Pregnancy|0|||
125082068|NCT02614261|449917596|FG001|Follow-up Phase|Pregnancy|1|||
125082069|NCT02614261|449917597|FG002|Follow-up Phase|Pregnancy|0|||
125082070|NCT02614261|449917598|FG003|Follow-up Phase|Pregnancy|0|||
125082071|NCT02614261|449917595|FG000|Follow-up Phase|Protocol Violation|1|||
125082072|NCT02614261|449917596|FG001|Follow-up Phase|Protocol Violation|0|||
125082073|NCT02614261|449917597|FG002|Follow-up Phase|Protocol Violation|0|||
125082074|NCT02614261|449917598|FG003|Follow-up Phase|Protocol Violation|0|||
125082075|NCT02614261|449917595|FG000|Follow-up Phase|Withdrawal by Subject|12|||
125082076|NCT02614261|449917596|FG001|Follow-up Phase|Withdrawal by Subject|4|||
125082077|NCT02614261|449917597|FG002|Follow-up Phase|Withdrawal by Subject|11|||
125082078|NCT02614261|449917598|FG003|Follow-up Phase|Withdrawal by Subject|0|||
125082079|NCT02614261|449917595|FG000|Israel Addendum|Withdrawal by Subject|0|||
125082080|NCT02614261|449917596|FG001|Israel Addendum|Withdrawal by Subject|0|||
125082081|NCT02614261|449917597|FG002|Israel Addendum|Withdrawal by Subject|0|||
125082082|NCT02614261|449917598|FG003|Israel Addendum|Withdrawal by Subject|4|||
125082083|NCT00471315|449917599|FG000|Overall Study|Adverse Event|7|||
125082084|NCT00471315|449917599|FG000|Overall Study|Withdrawal by Subject|1|||
125082085|NCT03695471|449919351|FG000|Overall Study|Cancellation|1|||
125082086|NCT02859558|449919352|FG000|Step 1|Not Eligible|0|||
125082087|NCT02859558|449919353|FG001|Step 1|Not Eligible|0|||
125082088|NCT02859558|449919354|FG002|Step 1|Not Eligible|0|||
125082089|NCT02859558|449919355|FG003|Step 1|Not Eligible|0|||
125082090|NCT02859558|449919356|FG004|Step 1|Not Eligible|3|||
125082091|NCT02859558|449919352|FG000|Step 1|Lost to Follow-up|1|||
125082092|NCT02859558|449919353|FG001|Step 1|Lost to Follow-up|3|||
125082093|NCT02859558|449919354|FG002|Step 1|Lost to Follow-up|3|||
125082094|NCT02859558|449919355|FG003|Step 1|Lost to Follow-up|0|||
125082095|NCT02859558|449919356|FG004|Step 1|Lost to Follow-up|0|||
125082096|NCT02859558|449919352|FG000|Step 1|Did Not Return to Clinic|2|||
125082097|NCT02859558|449919353|FG001|Step 1|Did Not Return to Clinic|3|||
125082098|NCT02859558|449919354|FG002|Step 1|Did Not Return to Clinic|4|||
125082099|NCT02859558|449919355|FG003|Step 1|Did Not Return to Clinic|0|||
125082100|NCT02859558|449919356|FG004|Step 1|Did Not Return to Clinic|0|||
125082101|NCT02859558|449919352|FG000|Step 1|Moved|0|||
125082102|NCT02859558|449919353|FG001|Step 1|Moved|1|||
125082103|NCT02859558|449919354|FG002|Step 1|Moved|1|||
125082104|NCT02859558|449919355|FG003|Step 1|Moved|0|||
125082105|NCT02859558|449919356|FG004|Step 1|Moved|0|||
125082106|NCT02859558|449919352|FG000|Step 1|Withdrawal By Participant|1|||
125082107|NCT02859558|449919353|FG001|Step 1|Withdrawal By Participant|2|||
125082108|NCT02859558|449919354|FG002|Step 1|Withdrawal By Participant|1|||
125082109|NCT02859558|449919355|FG003|Step 1|Withdrawal By Participant|0|||
125082110|NCT02859558|449919356|FG004|Step 1|Withdrawal By Participant|0|||
125082111|NCT02859558|449919352|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
125082112|NCT02859558|449919353|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
125082113|NCT02859558|449919354|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
125082114|NCT02859558|449919355|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
125082115|NCT02859558|449919356|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
125082116|NCT02859558|449919352|FG000|Step 1|Incarceration|0|||
125082117|NCT02859558|449919353|FG001|Step 1|Incarceration|1|||
125082118|NCT02859558|449919354|FG002|Step 1|Incarceration|0|||
125082119|NCT02859558|449919355|FG003|Step 1|Incarceration|0|||
125082120|NCT02859558|449919356|FG004|Step 1|Incarceration|0|||
125082121|NCT02859558|449919352|FG000|Step 1|Non-Adherence to Study Drug|2|||
125082122|NCT02859558|449919353|FG001|Step 1|Non-Adherence to Study Drug|0|||
125082123|NCT02859558|449919354|FG002|Step 1|Non-Adherence to Study Drug|1|||
125082124|NCT02859558|449919355|FG003|Step 1|Non-Adherence to Study Drug|0|||
125082125|NCT02859558|449919356|FG004|Step 1|Non-Adherence to Study Drug|0|||
125082126|NCT02859558|449919352|FG000|Step 1|Non-Adherence to Study Requirements|3|||
125082127|NCT02859558|449919353|FG001|Step 1|Non-Adherence to Study Requirements|1|||
125082128|NCT02859558|449919354|FG002|Step 1|Non-Adherence to Study Requirements|0|||
125082129|NCT02859558|449919355|FG003|Step 1|Non-Adherence to Study Requirements|0|||
125082130|NCT02859558|449919356|FG004|Step 1|Non-Adherence to Study Requirements|0|||
125082131|NCT02859558|449919352|FG000|Step 1|Virologic Failure|2|||
125082132|NCT02859558|449919353|FG001|Step 1|Virologic Failure|1|||
125082133|NCT02859558|449919354|FG002|Step 1|Virologic Failure|1|||
125082134|NCT02859558|449919355|FG003|Step 1|Virologic Failure|0|||
125082135|NCT02859558|449919356|FG004|Step 1|Virologic Failure|0|||
125082136|NCT02859558|449919352|FG000|Step 2|Lost to Follow-up|3|||
125082137|NCT02859558|449919353|FG001|Step 2|Lost to Follow-up|3|||
125082138|NCT02859558|449919354|FG002|Step 2|Lost to Follow-up|1|||
125082139|NCT02859558|449919355|FG003|Step 2|Lost to Follow-up|0|||
125082140|NCT02859558|449919356|FG004|Step 2|Lost to Follow-up|0|||
125082141|NCT02859558|449919352|FG000|Step 2|Withdrawal by Subject|0|||
125082142|NCT02859558|449919353|FG001|Step 2|Withdrawal by Subject|1|||
125082143|NCT02859558|449919354|FG002|Step 2|Withdrawal by Subject|1|||
125082144|NCT02859558|449919355|FG003|Step 2|Withdrawal by Subject|0|||
125082145|NCT02859558|449919356|FG004|Step 2|Withdrawal by Subject|0|||
125082146|NCT02859558|449919352|FG000|Step 2|Unexpected Closure of Site|0|||
125082147|NCT02859558|449919353|FG001|Step 2|Unexpected Closure of Site|1|||
125082148|NCT02859558|449919354|FG002|Step 2|Unexpected Closure of Site|1|||
125082149|NCT02859558|449919355|FG003|Step 2|Unexpected Closure of Site|0|||
125082150|NCT02859558|449919356|FG004|Step 2|Unexpected Closure of Site|0|||
125082151|NCT02859558|449919352|FG000|Step 2|Death|1|||
125082152|NCT02859558|449919353|FG001|Step 2|Death|0|||
125082153|NCT02859558|449919354|FG002|Step 2|Death|0|||
125082154|NCT02859558|449919355|FG003|Step 2|Death|0|||
125082155|NCT02859558|449919356|FG004|Step 2|Death|0|||
125082156|NCT02859558|449919352|FG000|Step 2|Incarceration|0|||
125082157|NCT02859558|449919353|FG001|Step 2|Incarceration|0|||
125082158|NCT02859558|449919354|FG002|Step 2|Incarceration|1|||
125082159|NCT02859558|449919355|FG003|Step 2|Incarceration|0|||
125082160|NCT02859558|449919356|FG004|Step 2|Incarceration|0|||
125082161|NCT05665595|449919357|FG000|Overall Study|Ongoing|692|||
125082162|NCT05665595|449919358|FG001|Overall Study|Ongoing|698|||
125082163|NCT05665595|449919357|FG000|Overall Study|Withdrawal by Subject|2|||
125082164|NCT05665595|449919358|FG001|Overall Study|Withdrawal by Subject|2|||
125082165|NCT05665595|449919357|FG000|Overall Study|Lost to Follow-up|1|||
125082166|NCT05665595|449919358|FG001|Overall Study|Lost to Follow-up|0|||
125082167|NCT05665595|449919357|FG000|Overall Study|Death|6|||
125082168|NCT05665595|449919358|FG001|Overall Study|Death|1|||
125082169|NCT00766142|449919359|FG000|Overall Study|Protocol Violation|4|||
125082170|NCT02358863|449919364|FG000|Overall Study|Physician Decision|3|||
125082171|NCT03793010|449919371|FG000|Overall Study|Withdrawal by Subject|5|||
125082172|NCT03793010|449919372|FG001|Overall Study|Withdrawal by Subject|7|||
125082173|NCT03793010|449919371|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
125082174|NCT03793010|449919372|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
125082175|NCT03793010|449919371|FG000|Overall Study|Lost to Follow-up|1|||
125082176|NCT03793010|449919372|FG001|Overall Study|Lost to Follow-up|2|||
125082177|NCT03793010|449919371|FG000|Overall Study|Patient couldn't sit still for injection|1|||
125082178|NCT03793010|449919372|FG001|Overall Study|Patient couldn't sit still for injection|0|||
125082179|NCT03793010|449919371|FG000|Overall Study|Withdrew to pursue other treatment|1|||
125082180|NCT03793010|449919372|FG001|Overall Study|Withdrew to pursue other treatment|0|||
125082181|NCT03793010|449919371|FG000|Overall Study|Did not meet eligibility criteria|1|||
125082182|NCT03793010|449919372|FG001|Overall Study|Did not meet eligibility criteria|0|||
125082183|NCT05016037|449919373|FG000|Overall Study|Lost to Follow-up|2|||
125082184|NCT00129376|449919378|FG000|Overall Study|Adverse Event|1|||
125082185|NCT00129376|449919378|FG000|Overall Study|Lack of Efficacy|1|||
125082186|NCT03218826|449919380|FG000|Overall Study|Non-compliance with protocol|1|||
125082187|NCT03218826|449919381|FG001|Overall Study|Non-compliance with protocol|0|||
125082188|NCT03218826|449919382|FG002|Overall Study|Non-compliance with protocol|2|||
125082189|NCT03218826|449919383|FG003|Overall Study|Non-compliance with protocol|1|||
125082190|NCT03218826|449919384|FG004|Overall Study|Non-compliance with protocol|1|||
125082191|NCT01426009|449919385|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
125082192|NCT01426009|449919385|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
125082193|NCT01426009|449919385|FG000|Washout 1|Withdrawal by Subject|1|||
125082194|NCT01426009|449919385|FG000|Washout 1|Personal Reasons|1|||
125082195|NCT01426009|449919385|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
125082196|NCT01426009|449919385|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
125082197|NCT01426009|449919385|FG000|Washout 2|electrive surgery|1|||
125082198|NCT01426009|449919385|FG000|Washout 3|personal reasons|1|||
125082199|NCT01426009|449919385|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
125082200|NCT01426009|449919385|FG000|Washout 4|Lost to Follow-up|1|||
125082201|NCT00796549|449919395|FG000|Overall Study|Adverse Event|11|||
125082202|NCT00796549|449919395|FG000|Overall Study|not entered|149|||
125082203|NCT00796549|449919395|FG000|Overall Study|Other|2|||
125082204|NCT00796549|449919395|FG000|Overall Study|Progressive disease|56|||
125144742|NCT01628549|450155907|FG001|Overall Study|Protocol Violation|1|||
125144743|NCT01628549|450155908|FG002|Overall Study|Protocol Violation|1|||
125082205|NCT01878175|449919397|FG000|Overall Study|Developed contraindicated health problem|2|||
125082206|NCT03083470|449919398|FG000|Overall Study|Lost to Follow-up|0|||
125082207|NCT03083470|449919399|FG001|Overall Study|Lost to Follow-up|0|||
125144744|NCT01628549|450155909|FG003|Overall Study|Protocol Violation|0|||
125144745|NCT01628549|450155906|FG000|Overall Study|withdrawn for noncompliance|0|||
125144746|NCT01628549|450155907|FG001|Overall Study|withdrawn for noncompliance|2|||
125082208|NCT03083470|449919400|FG002|Overall Study|Lost to Follow-up|0|||
125082209|NCT03083470|449919401|FG003|Overall Study|Lost to Follow-up|0|||
125082210|NCT03083470|449919402|FG004|Overall Study|Lost to Follow-up|1|||
125082211|NCT03083470|449919398|FG000|Overall Study|Withdrawal by Subject|0|||
125082212|NCT03083470|449919399|FG001|Overall Study|Withdrawal by Subject|0|||
125082213|NCT03083470|449919400|FG002|Overall Study|Withdrawal by Subject|0|||
125082214|NCT03083470|449919401|FG003|Overall Study|Withdrawal by Subject|0|||
125082215|NCT03083470|449919402|FG004|Overall Study|Withdrawal by Subject|1|||
125082216|NCT00606229|449919403|FG000|Overall Study|Adverse Event|11|||
125082217|NCT00606229|449919403|FG000|Overall Study|Lack of Efficacy|1|||
125082218|NCT00606229|449919403|FG000|Overall Study|Withdrawal by Subject|4|||
125082219|NCT00606229|449919403|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
125082220|NCT00606229|449919403|FG000|Overall Study|change of residence or other commitments|2|||
125082221|NCT01526928|449919404|FG000|Overall Study|Progressive Disease|35|||
125082222|NCT01526928|449919405|FG001|Overall Study|Progressive Disease|17|||
125082223|NCT01526928|449919406|FG002|Overall Study|Progressive Disease|150|||
125082224|NCT01526928|449919407|FG003|Overall Study|Progressive Disease|182|||
125082225|NCT01526928|449919408|FG004|Overall Study|Progressive Disease|76|||
125082226|NCT01526928|449919409|FG005|Overall Study|Progressive Disease|4|||
125082227|NCT01526928|449919404|FG000|Overall Study|Adverse Event|2|||
125082228|NCT01526928|449919405|FG001|Overall Study|Adverse Event|1|||
125082229|NCT01526928|449919406|FG002|Overall Study|Adverse Event|29|||
125082230|NCT01526928|449919407|FG003|Overall Study|Adverse Event|40|||
125082231|NCT01526928|449919408|FG004|Overall Study|Adverse Event|13|||
125082232|NCT01526928|449919409|FG005|Overall Study|Adverse Event|2|||
125082233|NCT01526928|449919404|FG000|Overall Study|Death|0|||
125144747|NCT01628549|450155908|FG002|Overall Study|withdrawn for noncompliance|1|||
125144748|NCT01628549|450155909|FG003|Overall Study|withdrawn for noncompliance|0|||
125144749|NCT01628549|450155906|FG000|Overall Study|abnormal laboratory test results|0|||
125144750|NCT01628549|450155907|FG001|Overall Study|abnormal laboratory test results|0|||
125144751|NCT01628549|450155908|FG002|Overall Study|abnormal laboratory test results|1|||
125144752|NCT01628549|450155909|FG003|Overall Study|abnormal laboratory test results|0|||
125144753|NCT01628549|450155906|FG000|Overall Study|positive pregnancy test|0|||
125144754|NCT01628549|450155907|FG001|Overall Study|positive pregnancy test|0|||
125144755|NCT01628549|450155908|FG002|Overall Study|positive pregnancy test|0|||
125144756|NCT01628549|450155909|FG003|Overall Study|positive pregnancy test|1|||
125144757|NCT00177164|450155910|FG000|Overall Study|Protocol Violation|0|||
125082234|NCT01526928|449919405|FG001|Overall Study|Death|0|||
125082235|NCT01526928|449919406|FG002|Overall Study|Death|3|||
125082236|NCT01526928|449919407|FG003|Overall Study|Death|0|||
125082237|NCT01526928|449919408|FG004|Overall Study|Death|0|||
125082238|NCT01526928|449919409|FG005|Overall Study|Death|0|||
125082239|NCT01526928|449919404|FG000|Overall Study|Withdrawal by Subject|1|||
125082240|NCT01526928|449919405|FG001|Overall Study|Withdrawal by Subject|0|||
125082241|NCT01526928|449919406|FG002|Overall Study|Withdrawal by Subject|13|||
125082242|NCT01526928|449919407|FG003|Overall Study|Withdrawal by Subject|11|||
125082243|NCT01526928|449919408|FG004|Overall Study|Withdrawal by Subject|3|||
125082244|NCT01526928|449919409|FG005|Overall Study|Withdrawal by Subject|0|||
125082245|NCT01526928|449919404|FG000|Overall Study|Physician Decision|0|||
125082246|NCT01526928|449919405|FG001|Overall Study|Physician Decision|0|||
125082247|NCT01526928|449919406|FG002|Overall Study|Physician Decision|2|||
125082248|NCT01526928|449919407|FG003|Overall Study|Physician Decision|5|||
125082249|NCT01526928|449919408|FG004|Overall Study|Physician Decision|0|||
125082250|NCT01526928|449919409|FG005|Overall Study|Physician Decision|0|||
125082251|NCT01526928|449919404|FG000|Overall Study|Other Reason|0|||
125082252|NCT01526928|449919405|FG001|Overall Study|Other Reason|1|||
125082253|NCT01526928|449919406|FG002|Overall Study|Other Reason|11|||
125082254|NCT01526928|449919407|FG003|Overall Study|Other Reason|4|||
125082255|NCT01526928|449919408|FG004|Overall Study|Other Reason|1|||
125082256|NCT01526928|449919409|FG005|Overall Study|Other Reason|0|||
125082257|NCT01526928|449919404|FG000|Overall Study|Lost to Follow-up|0|||
125082258|NCT01526928|449919405|FG001|Overall Study|Lost to Follow-up|0|||
125082259|NCT01526928|449919406|FG002|Overall Study|Lost to Follow-up|0|||
125082260|NCT01526928|449919407|FG003|Overall Study|Lost to Follow-up|1|||
125082261|NCT01526928|449919408|FG004|Overall Study|Lost to Follow-up|0|||
125082262|NCT01526928|449919409|FG005|Overall Study|Lost to Follow-up|0|||
125082263|NCT01526928|449919404|FG000|Overall Study|Protocol Deviation|0|||
125082264|NCT01526928|449919405|FG001|Overall Study|Protocol Deviation|0|||
125082265|NCT01526928|449919406|FG002|Overall Study|Protocol Deviation|0|||
125082266|NCT01526928|449919407|FG003|Overall Study|Protocol Deviation|2|||
125144758|NCT00177164|450155911|FG001|Overall Study|Protocol Violation|7|||
125144759|NCT00177164|450155910|FG000|Overall Study|Lost to Follow-up|4|||
125082267|NCT01526928|449919408|FG004|Overall Study|Protocol Deviation|0|||
125082268|NCT01526928|449919409|FG005|Overall Study|Protocol Deviation|0|||
125082269|NCT01526928|449919404|FG000|Overall Study|Missing|0|||
125082270|NCT01526928|449919405|FG001|Overall Study|Missing|0|||
125082271|NCT01526928|449919406|FG002|Overall Study|Missing|1|||
125082272|NCT01526928|449919407|FG003|Overall Study|Missing|0|||
125144760|NCT00177164|450155911|FG001|Overall Study|Lost to Follow-up|5|||
125144761|NCT00177164|450155910|FG000|Overall Study|increase in alcohol and drug use|1|||
125082273|NCT01526928|449919408|FG004|Overall Study|Missing|2|||
125082274|NCT01526928|449919409|FG005|Overall Study|Missing|0|||
125082275|NCT01108068|449919410|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
125082276|NCT01108068|449919411|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
125082277|NCT00836953|449919412|FG000|Overall Study|Withdrawal by Subject|1|||
125082278|NCT00836953|449919412|FG000|Overall Study|Lost to Follow-up|1|||
125082279|NCT02877134|449919416|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
125144762|NCT00177164|450155911|FG001|Overall Study|increase in alcohol and drug use|2|||
125144763|NCT00177164|450155910|FG000|Overall Study|Adverse Event|1|||
125144764|NCT00177164|450155911|FG001|Overall Study|Adverse Event|0|||
125144765|NCT00177164|450155910|FG000|Overall Study|discharge from hospital|1|||
125144766|NCT00177164|450155911|FG001|Overall Study|discharge from hospital|0|||
125144767|NCT00177164|450155910|FG000|Overall Study|Lack of Efficacy|2|||
125144768|NCT00177164|450155911|FG001|Overall Study|Lack of Efficacy|1|||
125144769|NCT00177164|450155910|FG000|Overall Study|Pregnancy|0|||
125144770|NCT00177164|450155911|FG001|Overall Study|Pregnancy|1|||
125223526|NCT02326272|450446170|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
125082280|NCT02877134|449919417|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
125082281|NCT02877134|449919418|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
125082282|NCT02877134|449919419|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
125082283|NCT02877134|449919420|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
125082284|NCT02877134|449919421|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
125082285|NCT02877134|449919422|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
125082286|NCT02877134|449919423|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
125082287|NCT02877134|449919424|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
125082288|NCT02877134|449919425|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
125082289|NCT02877134|449919426|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
125082290|NCT02877134|449919427|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
125082291|NCT02877134|449919416|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
125082292|NCT02877134|449919417|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
125082293|NCT02877134|449919418|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
125082294|NCT02877134|449919419|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
125082295|NCT02877134|449919420|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
125082296|NCT02877134|449919421|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
125082297|NCT02877134|449919422|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
125082298|NCT02877134|449919423|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
125082299|NCT02877134|449919424|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
125082300|NCT02877134|449919425|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
125082301|NCT02877134|449919426|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
125082302|NCT02877134|449919427|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
125082303|NCT02877134|449919416|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
125082304|NCT02877134|449919417|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
125082305|NCT02877134|449919418|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
125082306|NCT02877134|449919419|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
125082307|NCT02877134|449919420|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
125082308|NCT02877134|449919421|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
125082309|NCT02877134|449919422|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
125082310|NCT02877134|449919423|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
125082311|NCT02877134|449919424|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
125082312|NCT02877134|449919425|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
125082313|NCT02877134|449919426|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
125082314|NCT02877134|449919427|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
125082315|NCT02877134|449919416|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
125082316|NCT02877134|449919417|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
125082317|NCT02877134|449919418|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
125082318|NCT02877134|449919419|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
125082319|NCT02877134|449919420|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
125082320|NCT02877134|449919421|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
125082321|NCT02877134|449919422|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
125082322|NCT02877134|449919423|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
125082323|NCT02877134|449919424|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
125082324|NCT02877134|449919425|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
125082325|NCT02877134|449919426|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
125082326|NCT02877134|449919427|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
125082327|NCT02877134|449919416|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125082328|NCT02877134|449919417|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125144771|NCT00965757|450155912|FG000|Double-blind Phase|Progression of concomitant disease|1|||
125144772|NCT00965757|450155913|FG001|Double-blind Phase|Progression of concomitant disease|2|||
125144773|NCT00965757|450155914|FG002|Double-blind Phase|Progression of concomitant disease|0|||
125082329|NCT02877134|449919418|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125082330|NCT02877134|449919419|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125082331|NCT02877134|449919420|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125082332|NCT02877134|449919421|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125082333|NCT02877134|449919422|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125144774|NCT00965757|450155915|FG003|Double-blind Phase|Progression of concomitant disease|0|||
125144775|NCT00965757|450155912|FG000|Double-blind Phase|Adverse drug reaction|2|||
125144776|NCT00965757|450155913|FG001|Double-blind Phase|Adverse drug reaction|1|||
125144777|NCT00965757|450155914|FG002|Double-blind Phase|Adverse drug reaction|0|||
125144778|NCT00965757|450155915|FG003|Double-blind Phase|Adverse drug reaction|0|||
125144779|NCT00965757|450155912|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
125144780|NCT00965757|450155913|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
125144781|NCT00965757|450155914|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
125144782|NCT00965757|450155915|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
125082334|NCT02877134|449919423|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125082335|NCT02877134|449919424|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
125082336|NCT02877134|449919425|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125082337|NCT02877134|449919426|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125082338|NCT02877134|449919427|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125082339|NCT02877134|449919416|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
125082340|NCT02877134|449919417|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
125082341|NCT02877134|449919418|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
125082342|NCT02877134|449919419|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
125082343|NCT02877134|449919420|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
125082344|NCT02877134|449919421|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
125082345|NCT02877134|449919422|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
125082346|NCT02877134|449919423|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
125082347|NCT02877134|449919424|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
125082348|NCT02877134|449919425|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
125082349|NCT02877134|449919426|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
125082350|NCT02877134|449919427|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
125082351|NCT02877134|449919416|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
125082352|NCT02877134|449919417|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
125082353|NCT02877134|449919418|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
125082354|NCT02877134|449919419|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
125082355|NCT02877134|449919420|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
125082356|NCT02877134|449919421|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
125082357|NCT02877134|449919422|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
125082358|NCT02877134|449919423|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
125082359|NCT02877134|449919424|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
125082360|NCT02877134|449919425|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
125082361|NCT02877134|449919426|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
125082362|NCT02877134|449919427|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
125082363|NCT02877134|449919416|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
125082364|NCT02877134|449919417|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
125082365|NCT02877134|449919418|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
125082366|NCT02877134|449919419|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
125144783|NCT00965757|450155912|FG000|Double-blind Phase|Lack of Efficacy|7|||
125144784|NCT00965757|450155913|FG001|Double-blind Phase|Lack of Efficacy|11|||
125082367|NCT02877134|449919420|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
125082368|NCT02877134|449919421|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
125082369|NCT02877134|449919422|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
125082370|NCT02877134|449919423|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
125082371|NCT02877134|449919424|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
125082372|NCT02877134|449919425|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
125082373|NCT02877134|449919426|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
125082374|NCT02877134|449919427|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
125082375|NCT01197794|449919430|FG000|Overall Study|Adverse Event|3|||
125082376|NCT01197794|449919431|FG001|Overall Study|Adverse Event|2|||
125082377|NCT01197794|449919432|FG002|Overall Study|Adverse Event|4|||
125082378|NCT01197794|449919433|FG003|Overall Study|Adverse Event|4|||
125082379|NCT01197794|449919434|FG004|Overall Study|Adverse Event|4|||
125082380|NCT01197794|449919435|FG005|Overall Study|Adverse Event|2|||
125082381|NCT01197794|449919436|FG006|Overall Study|Adverse Event|3|||
125082382|NCT01197794|449919430|FG000|Overall Study|Protocol Violation|0|||
125082383|NCT01197794|449919431|FG001|Overall Study|Protocol Violation|0|||
125082384|NCT01197794|449919432|FG002|Overall Study|Protocol Violation|0|||
125082385|NCT01197794|449919433|FG003|Overall Study|Protocol Violation|0|||
125082386|NCT01197794|449919434|FG004|Overall Study|Protocol Violation|2|||
125082387|NCT01197794|449919435|FG005|Overall Study|Protocol Violation|0|||
125082388|NCT01197794|449919436|FG006|Overall Study|Protocol Violation|1|||
125082389|NCT01197794|449919430|FG000|Overall Study|Development of study withdrawal criteria|3|||
125082390|NCT01197794|449919431|FG001|Overall Study|Development of study withdrawal criteria|0|||
125082391|NCT01197794|449919432|FG002|Overall Study|Development of study withdrawal criteria|0|||
125082392|NCT01197794|449919433|FG003|Overall Study|Development of study withdrawal criteria|1|||
125082393|NCT01197794|449919434|FG004|Overall Study|Development of study withdrawal criteria|0|||
125082394|NCT01197794|449919435|FG005|Overall Study|Development of study withdrawal criteria|0|||
125082395|NCT01197794|449919436|FG006|Overall Study|Development of study withdrawal criteria|1|||
125082396|NCT01197794|449919430|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
125082397|NCT01197794|449919431|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
125082398|NCT01197794|449919432|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
125082399|NCT01197794|449919433|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
125082400|NCT01197794|449919434|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
125082401|NCT01197794|449919435|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
125082402|NCT01197794|449919436|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
125082403|NCT01197794|449919430|FG000|Overall Study|Withdrawal by Subject|3|||
125082404|NCT01197794|449919431|FG001|Overall Study|Withdrawal by Subject|3|||
125082405|NCT01197794|449919432|FG002|Overall Study|Withdrawal by Subject|4|||
125082406|NCT01197794|449919433|FG003|Overall Study|Withdrawal by Subject|1|||
125082407|NCT01197794|449919434|FG004|Overall Study|Withdrawal by Subject|1|||
125082408|NCT01197794|449919435|FG005|Overall Study|Withdrawal by Subject|5|||
125082409|NCT01197794|449919436|FG006|Overall Study|Withdrawal by Subject|6|||
125082410|NCT01197794|449919430|FG000|Overall Study|Lost to Follow-up|1|||
125082411|NCT01197794|449919431|FG001|Overall Study|Lost to Follow-up|1|||
125082412|NCT01197794|449919432|FG002|Overall Study|Lost to Follow-up|0|||
125082413|NCT01197794|449919433|FG003|Overall Study|Lost to Follow-up|1|||
125082414|NCT01197794|449919434|FG004|Overall Study|Lost to Follow-up|0|||
125082415|NCT01197794|449919435|FG005|Overall Study|Lost to Follow-up|1|||
125082416|NCT01197794|449919436|FG006|Overall Study|Lost to Follow-up|0|||
125082417|NCT01197794|449919430|FG000|Overall Study|Other|1|||
125082418|NCT01197794|449919431|FG001|Overall Study|Other|1|||
125082419|NCT01197794|449919432|FG002|Overall Study|Other|3|||
125082420|NCT01197794|449919433|FG003|Overall Study|Other|0|||
125082421|NCT01197794|449919434|FG004|Overall Study|Other|2|||
125082422|NCT01197794|449919435|FG005|Overall Study|Other|2|||
125082423|NCT01197794|449919436|FG006|Overall Study|Other|4|||
125082424|NCT01055457|449919437|FG000|Overall Study|Lost to Follow-up|0|||
125082425|NCT01055457|449919438|FG001|Overall Study|Lost to Follow-up|1|||
125082426|NCT01055457|449919439|FG002|Overall Study|Lost to Follow-up|0|||
125082427|NCT01055457|449919440|FG003|Overall Study|Lost to Follow-up|0|||
125082428|NCT01055457|449919441|FG004|Overall Study|Lost to Follow-up|0|||
125082429|NCT01055457|449919442|FG005|Overall Study|Lost to Follow-up|1|||
125082430|NCT01055457|449919443|FG006|Overall Study|Lost to Follow-up|0|||
125082431|NCT01055457|449919444|FG007|Overall Study|Lost to Follow-up|0|||
125082432|NCT01055457|449919445|FG008|Overall Study|Lost to Follow-up|0|||
125082433|NCT01055457|449919446|FG009|Overall Study|Lost to Follow-up|0|||
125082434|NCT01055457|449919437|FG000|Overall Study|Protocol Violation|0|||
125082435|NCT01055457|449919438|FG001|Overall Study|Protocol Violation|0|||
125082436|NCT01055457|449919439|FG002|Overall Study|Protocol Violation|1|||
125082437|NCT01055457|449919440|FG003|Overall Study|Protocol Violation|1|||
125082438|NCT01055457|449919441|FG004|Overall Study|Protocol Violation|1|||
125082439|NCT01055457|449919442|FG005|Overall Study|Protocol Violation|2|||
125082440|NCT01055457|449919443|FG006|Overall Study|Protocol Violation|1|||
125082441|NCT01055457|449919444|FG007|Overall Study|Protocol Violation|0|||
125082442|NCT01055457|449919445|FG008|Overall Study|Protocol Violation|0|||
125082443|NCT01055457|449919446|FG009|Overall Study|Protocol Violation|1|||
125082444|NCT01055457|449919437|FG000|Overall Study|Subject Disinterest|0|||
125082445|NCT01055457|449919438|FG001|Overall Study|Subject Disinterest|0|||
125082446|NCT01055457|449919439|FG002|Overall Study|Subject Disinterest|0|||
125082447|NCT01055457|449919440|FG003|Overall Study|Subject Disinterest|0|||
125082448|NCT01055457|449919441|FG004|Overall Study|Subject Disinterest|0|||
125082449|NCT01055457|449919442|FG005|Overall Study|Subject Disinterest|0|||
125082450|NCT01055457|449919443|FG006|Overall Study|Subject Disinterest|0|||
125082451|NCT01055457|449919444|FG007|Overall Study|Subject Disinterest|1|||
125082452|NCT01055457|449919445|FG008|Overall Study|Subject Disinterest|0|||
125082453|NCT01055457|449919446|FG009|Overall Study|Subject Disinterest|0|||
125082454|NCT01055457|449919437|FG000|Overall Study|Subject Ineligible|1|||
125082455|NCT01055457|449919438|FG001|Overall Study|Subject Ineligible|0|||
125082456|NCT01055457|449919439|FG002|Overall Study|Subject Ineligible|1|||
125082457|NCT01055457|449919440|FG003|Overall Study|Subject Ineligible|0|||
125082458|NCT01055457|449919441|FG004|Overall Study|Subject Ineligible|1|||
125082459|NCT01055457|449919442|FG005|Overall Study|Subject Ineligible|0|||
125082460|NCT01055457|449919443|FG006|Overall Study|Subject Ineligible|0|||
125082461|NCT01055457|449919444|FG007|Overall Study|Subject Ineligible|0|||
125082462|NCT01055457|449919445|FG008|Overall Study|Subject Ineligible|0|||
125082463|NCT01055457|449919446|FG009|Overall Study|Subject Ineligible|0|||
125082464|NCT01055457|449919437|FG000|Overall Study|Discomfort|0|||
125082465|NCT01055457|449919438|FG001|Overall Study|Discomfort|0|||
125082466|NCT01055457|449919439|FG002|Overall Study|Discomfort|0|||
125082467|NCT01055457|449919440|FG003|Overall Study|Discomfort|0|||
125082468|NCT01055457|449919441|FG004|Overall Study|Discomfort|1|||
125082469|NCT01055457|449919442|FG005|Overall Study|Discomfort|0|||
125082470|NCT01055457|449919443|FG006|Overall Study|Discomfort|0|||
125082471|NCT01055457|449919444|FG007|Overall Study|Discomfort|0|||
125082472|NCT01055457|449919445|FG008|Overall Study|Discomfort|0|||
125082473|NCT01055457|449919446|FG009|Overall Study|Discomfort|0|||
125082474|NCT01055457|449919437|FG000|Overall Study|Pregnancy|0|||
125082475|NCT01055457|449919438|FG001|Overall Study|Pregnancy|0|||
125082476|NCT01055457|449919439|FG002|Overall Study|Pregnancy|0|||
125082477|NCT01055457|449919440|FG003|Overall Study|Pregnancy|1|||
125082478|NCT01055457|449919441|FG004|Overall Study|Pregnancy|0|||
125082479|NCT01055457|449919442|FG005|Overall Study|Pregnancy|0|||
125082480|NCT01055457|449919443|FG006|Overall Study|Pregnancy|0|||
125082481|NCT01055457|449919444|FG007|Overall Study|Pregnancy|0|||
125082482|NCT01055457|449919445|FG008|Overall Study|Pregnancy|0|||
125082483|NCT01055457|449919446|FG009|Overall Study|Pregnancy|0|||
125082484|NCT01055457|449919437|FG000|Overall Study|Adverse Event|0|||
125082485|NCT01055457|449919438|FG001|Overall Study|Adverse Event|0|||
125082486|NCT01055457|449919439|FG002|Overall Study|Adverse Event|0|||
125082487|NCT01055457|449919440|FG003|Overall Study|Adverse Event|1|||
125082488|NCT01055457|449919441|FG004|Overall Study|Adverse Event|0|||
125082489|NCT01055457|449919442|FG005|Overall Study|Adverse Event|0|||
125082490|NCT01055457|449919443|FG006|Overall Study|Adverse Event|0|||
125082491|NCT01055457|449919444|FG007|Overall Study|Adverse Event|0|||
125082492|NCT01055457|449919445|FG008|Overall Study|Adverse Event|0|||
125082493|NCT01055457|449919446|FG009|Overall Study|Adverse Event|0|||
125082494|NCT04055844|449919447|FG000|Overall Study|Adverse Event|12|||
125082495|NCT04055844|449919447|FG000|Overall Study|Poor Performance|1|||
125082496|NCT04055844|449919447|FG000|Overall Study|Death|1|||
125082497|NCT03630016|449919456|FG000|Overall Study|Poor Sensor Placement|1|||
125082498|NCT00255008|449919457|FG000|Overall Study|Adverse Event|1|||
125082499|NCT00255008|449919458|FG001|Overall Study|Adverse Event|1|||
125082500|NCT00255008|449919459|FG002|Overall Study|Adverse Event|2|||
125082501|NCT00255008|449919460|FG003|Overall Study|Adverse Event|0|||
125082502|NCT00255008|449919457|FG000|Overall Study|Lost to Follow-up|1|||
125082503|NCT00255008|449919458|FG001|Overall Study|Lost to Follow-up|0|||
125082504|NCT00255008|449919459|FG002|Overall Study|Lost to Follow-up|1|||
125082505|NCT00255008|449919460|FG003|Overall Study|Lost to Follow-up|2|||
125082506|NCT00255008|449919457|FG000|Overall Study|Did not meet viral reduction criteria|4|||
125082507|NCT00255008|449919458|FG001|Overall Study|Did not meet viral reduction criteria|5|||
125082508|NCT00255008|449919459|FG002|Overall Study|Did not meet viral reduction criteria|0|||
125082509|NCT00255008|449919460|FG003|Overall Study|Did not meet viral reduction criteria|1|||
125082510|NCT00255008|449919457|FG000|Overall Study|Withdrew consent|0|||
125082511|NCT00255008|449919458|FG001|Overall Study|Withdrew consent|0|||
125082512|NCT00255008|449919459|FG002|Overall Study|Withdrew consent|2|||
125082513|NCT00255008|449919460|FG003|Overall Study|Withdrew consent|0|||
125082514|NCT00255008|449919457|FG000|Overall Study|Sponsor request|18|||
125082515|NCT00255008|449919458|FG001|Overall Study|Sponsor request|3|||
125082516|NCT00255008|449919459|FG002|Overall Study|Sponsor request|8|||
125303058|NCT03100058|450736672|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
125082517|NCT00255008|449919460|FG003|Overall Study|Sponsor request|17|||
125082518|NCT00255008|449919457|FG000|Overall Study|Adverse lab experience|1|||
125082519|NCT00255008|449919458|FG001|Overall Study|Adverse lab experience|0|||
125082520|NCT00255008|449919459|FG002|Overall Study|Adverse lab experience|0|||
125082521|NCT00255008|449919460|FG003|Overall Study|Adverse lab experience|0|||
125303059|NCT03100058|450736673|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
125303060|NCT03100058|450736661|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
125303061|NCT03100058|450736662|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
125303062|NCT03100058|450736663|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
125144785|NCT00965757|450155914|FG002|Double-blind Phase|Lack of Efficacy|0|||
125144786|NCT00965757|450155915|FG003|Double-blind Phase|Lack of Efficacy|0|||
125144787|NCT00965757|450155912|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
125144788|NCT00965757|450155913|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
125144789|NCT00965757|450155914|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
125144790|NCT00965757|450155915|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
125144791|NCT00965757|450155912|FG000|Double-blind Phase|Lost to Follow-up|0|||
125144792|NCT00965757|450155913|FG001|Double-blind Phase|Lost to Follow-up|1|||
125144793|NCT00965757|450155914|FG002|Double-blind Phase|Lost to Follow-up|0|||
125144794|NCT00965757|450155915|FG003|Double-blind Phase|Lost to Follow-up|0|||
125144795|NCT00965757|450155912|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
125144796|NCT00965757|450155913|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
125144797|NCT00965757|450155914|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
125144798|NCT00965757|450155915|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
125144799|NCT00965757|450155912|FG000|Double-blind Phase|Other|1|||
125144800|NCT00965757|450155913|FG001|Double-blind Phase|Other|0|||
125144801|NCT00965757|450155914|FG002|Double-blind Phase|Other|0|||
125144802|NCT00965757|450155915|FG003|Double-blind Phase|Other|0|||
125144803|NCT00965757|450155912|FG000|Extension Phase|Progression of concomitant disease|0|||
125144804|NCT00965757|450155913|FG001|Extension Phase|Progression of concomitant disease|0|||
125144805|NCT00965757|450155914|FG002|Extension Phase|Progression of concomitant disease|4|||
125144806|NCT00965757|450155915|FG003|Extension Phase|Progression of concomitant disease|2|||
125144807|NCT00965757|450155912|FG000|Extension Phase|Adverse drug reaction|0|||
125144808|NCT00965757|450155913|FG001|Extension Phase|Adverse drug reaction|0|||
125144809|NCT00965757|450155914|FG002|Extension Phase|Adverse drug reaction|6|||
125144810|NCT00965757|450155915|FG003|Extension Phase|Adverse drug reaction|3|||
125144811|NCT00965757|450155912|FG000|Extension Phase|Abnormal Laboratory Value|0|||
125144812|NCT00965757|450155913|FG001|Extension Phase|Abnormal Laboratory Value|0|||
125144813|NCT00965757|450155914|FG002|Extension Phase|Abnormal Laboratory Value|6|||
125144814|NCT00965757|450155915|FG003|Extension Phase|Abnormal Laboratory Value|1|||
125144815|NCT00965757|450155912|FG000|Extension Phase|Lack of Efficacy|0|||
125144816|NCT00965757|450155913|FG001|Extension Phase|Lack of Efficacy|0|||
125144817|NCT00965757|450155914|FG002|Extension Phase|Lack of Efficacy|8|||
125144818|NCT00965757|450155915|FG003|Extension Phase|Lack of Efficacy|12|||
125144819|NCT00965757|450155912|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
125144820|NCT00965757|450155913|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
125144821|NCT00965757|450155914|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
125144822|NCT00965757|450155915|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
125144823|NCT00965757|450155912|FG000|Extension Phase|Lost to Follow-up|0|||
125144824|NCT00965757|450155913|FG001|Extension Phase|Lost to Follow-up|0|||
125144825|NCT00965757|450155914|FG002|Extension Phase|Lost to Follow-up|0|||
125144826|NCT00965757|450155915|FG003|Extension Phase|Lost to Follow-up|1|||
125144827|NCT00965757|450155912|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
125144828|NCT00965757|450155913|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
125144829|NCT00965757|450155914|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
125144830|NCT00965757|450155915|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
125144831|NCT00965757|450155912|FG000|Extension Phase|Protocol Violation|0|||
125144832|NCT00965757|450155913|FG001|Extension Phase|Protocol Violation|0|||
125144833|NCT00965757|450155914|FG002|Extension Phase|Protocol Violation|0|||
125144834|NCT00965757|450155915|FG003|Extension Phase|Protocol Violation|1|||
125144835|NCT00965757|450155912|FG000|Extension Phase|Other|0|||
125144836|NCT00965757|450155913|FG001|Extension Phase|Other|0|||
125144837|NCT00965757|450155914|FG002|Extension Phase|Other|2|||
125144838|NCT00965757|450155915|FG003|Extension Phase|Other|1|||
125144839|NCT01398787|450155920|FG000|Overall Study|Adverse Event|1|||
125144840|NCT02351167|450155921|FG000|Overall Study|Withdrawal by Subject|19|||
125144841|NCT02351167|450155922|FG001|Overall Study|Withdrawal by Subject|18|||
125144842|NCT02351167|450155923|FG002|Overall Study|Withdrawal by Subject|21|||
125144843|NCT01332968|450155924|FG000|Induction Period|Adverse Event|23|||
125144844|NCT01332968|450155925|FG001|Induction Period|Adverse Event|26|||
125144845|NCT01332968|450155926|FG002|Induction Period|Adverse Event|0|||
125144846|NCT01332968|450155927|FG003|Induction Period|Adverse Event|0|||
125144847|NCT01332968|450155928|FG004|Induction Period|Adverse Event|0|||
125144848|NCT01332968|450155929|FG005|Induction Period|Adverse Event|0|||
125144849|NCT01332968|450155930|FG006|Induction Period|Adverse Event|0|||
125144850|NCT01332968|450155931|FG007|Induction Period|Adverse Event|0|||
125144851|NCT01332968|450155924|FG000|Induction Period|Death|1|||
125144852|NCT01332968|450155925|FG001|Induction Period|Death|4|||
125144853|NCT01332968|450155926|FG002|Induction Period|Death|0|||
125144854|NCT01332968|450155927|FG003|Induction Period|Death|0|||
125144855|NCT01332968|450155928|FG004|Induction Period|Death|0|||
125144856|NCT01332968|450155929|FG005|Induction Period|Death|0|||
125144857|NCT01332968|450155930|FG006|Induction Period|Death|0|||
125144858|NCT01332968|450155931|FG007|Induction Period|Death|0|||
125144859|NCT01332968|450155924|FG000|Induction Period|Non-compliance|1|||
125144860|NCT01332968|450155925|FG001|Induction Period|Non-compliance|0|||
125082522|NCT00255008|449919457|FG000|Overall Study|Other|7|||
125082523|NCT00255008|449919458|FG001|Overall Study|Other|0|||
125082524|NCT00255008|449919459|FG002|Overall Study|Other|3|||
125082525|NCT00255008|449919460|FG003|Overall Study|Other|2|||
125082526|NCT01833806|449919461|FG000|Overall Study|Alternative treatment|2|||
125082527|NCT01833806|449919461|FG000|Overall Study|Death|5|||
125082528|NCT01833806|449919461|FG000|Overall Study|Physician Decision|1|||
125082529|NCT01833806|449919461|FG000|Overall Study|Lost to Follow-up|1|||
125082530|NCT02724111|449919462|FG000|Overall Study|Protocol Violation|2|||
125082531|NCT02724111|449919463|FG001|Overall Study|Protocol Violation|5|||
125082532|NCT02996500|449919464|FG000|Overall Study|Adverse Event|1|||
125082533|NCT02996500|449919465|FG001|Overall Study|Adverse Event|1|||
125082534|NCT02996500|449919466|FG002|Overall Study|Adverse Event|4|||
125082535|NCT02996500|449919467|FG003|Overall Study|Adverse Event|3|||
125082536|NCT02996500|449919468|FG004|Overall Study|Adverse Event|1|||
125082537|NCT02996500|449919469|FG005|Overall Study|Adverse Event|2|||
125082538|NCT02996500|449919464|FG000|Overall Study|Lack of Efficacy|0|||
125082539|NCT02996500|449919465|FG001|Overall Study|Lack of Efficacy|0|||
125082540|NCT02996500|449919466|FG002|Overall Study|Lack of Efficacy|0|||
125082541|NCT02996500|449919467|FG003|Overall Study|Lack of Efficacy|0|||
125082542|NCT02996500|449919468|FG004|Overall Study|Lack of Efficacy|2|||
125082543|NCT02996500|449919469|FG005|Overall Study|Lack of Efficacy|0|||
125082544|NCT02996500|449919464|FG000|Overall Study|Lost to Follow-up|1|||
125082545|NCT02996500|449919465|FG001|Overall Study|Lost to Follow-up|0|||
125082546|NCT02996500|449919466|FG002|Overall Study|Lost to Follow-up|0|||
125082547|NCT02996500|449919467|FG003|Overall Study|Lost to Follow-up|0|||
125082548|NCT02996500|449919468|FG004|Overall Study|Lost to Follow-up|0|||
125082549|NCT02996500|449919469|FG005|Overall Study|Lost to Follow-up|1|||
125082550|NCT02996500|449919464|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
125082551|NCT02996500|449919465|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
125082552|NCT02996500|449919466|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
125082553|NCT02996500|449919467|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
125082554|NCT02996500|449919468|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
125082555|NCT02996500|449919469|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
125082556|NCT02996500|449919464|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125082557|NCT02996500|449919465|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125082558|NCT02996500|449919466|FG002|Overall Study|Non-Compliance With Study Drug|0|||
125082559|NCT02996500|449919467|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125144861|NCT01332968|450155926|FG002|Induction Period|Non-compliance|0|||
125144862|NCT01332968|450155927|FG003|Induction Period|Non-compliance|0|||
125144863|NCT01332968|450155928|FG004|Induction Period|Non-compliance|0|||
125144864|NCT01332968|450155929|FG005|Induction Period|Non-compliance|0|||
125144865|NCT01332968|450155930|FG006|Induction Period|Non-compliance|0|||
125144866|NCT01332968|450155931|FG007|Induction Period|Non-compliance|0|||
125144867|NCT01332968|450155924|FG000|Induction Period|Other|2|||
125144868|NCT01332968|450155925|FG001|Induction Period|Other|2|||
125144869|NCT01332968|450155926|FG002|Induction Period|Other|0|||
125144870|NCT01332968|450155927|FG003|Induction Period|Other|0|||
125144871|NCT01332968|450155928|FG004|Induction Period|Other|0|||
125144872|NCT01332968|450155929|FG005|Induction Period|Other|0|||
125144873|NCT01332968|450155930|FG006|Induction Period|Other|0|||
125144874|NCT01332968|450155931|FG007|Induction Period|Other|0|||
125144875|NCT01332968|450155924|FG000|Induction Period|Physician Decision|6|||
125144876|NCT01332968|450155925|FG001|Induction Period|Physician Decision|1|||
125144877|NCT01332968|450155926|FG002|Induction Period|Physician Decision|0|||
125144878|NCT01332968|450155927|FG003|Induction Period|Physician Decision|0|||
125144879|NCT01332968|450155928|FG004|Induction Period|Physician Decision|0|||
125144880|NCT01332968|450155929|FG005|Induction Period|Physician Decision|0|||
125144881|NCT01332968|450155930|FG006|Induction Period|Physician Decision|0|||
125144882|NCT01332968|450155931|FG007|Induction Period|Physician Decision|0|||
125144883|NCT01332968|450155924|FG000|Induction Period|Progressive Disease|15|||
125144884|NCT01332968|450155925|FG001|Induction Period|Progressive Disease|7|||
125144885|NCT01332968|450155926|FG002|Induction Period|Progressive Disease|0|||
125223527|NCT02326272|450446171|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125223528|NCT02326272|450446172|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125223529|NCT02326272|450446173|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125223530|NCT02326272|450446174|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125144886|NCT01332968|450155927|FG003|Induction Period|Progressive Disease|0|||
125144887|NCT01332968|450155928|FG004|Induction Period|Progressive Disease|0|||
125144888|NCT01332968|450155929|FG005|Induction Period|Progressive Disease|0|||
125144889|NCT01332968|450155930|FG006|Induction Period|Progressive Disease|0|||
125082560|NCT02996500|449919468|FG004|Overall Study|Non-Compliance With Study Drug|0|||
125082561|NCT02996500|449919469|FG005|Overall Study|Non-Compliance With Study Drug|1|||
125082562|NCT02996500|449919464|FG000|Overall Study|Progressive Disease|1|||
125082563|NCT02996500|449919465|FG001|Overall Study|Progressive Disease|0|||
125082564|NCT02996500|449919466|FG002|Overall Study|Progressive Disease|0|||
125082565|NCT02996500|449919467|FG003|Overall Study|Progressive Disease|0|||
125082566|NCT02996500|449919468|FG004|Overall Study|Progressive Disease|0|||
125082567|NCT02996500|449919469|FG005|Overall Study|Progressive Disease|0|||
125082568|NCT02996500|449919464|FG000|Overall Study|Other|2|||
125082569|NCT02996500|449919465|FG001|Overall Study|Other|0|||
125082570|NCT02996500|449919466|FG002|Overall Study|Other|2|||
125082571|NCT02996500|449919467|FG003|Overall Study|Other|0|||
125082572|NCT02996500|449919468|FG004|Overall Study|Other|0|||
125082573|NCT02996500|449919469|FG005|Overall Study|Other|0|||
125082574|NCT02996500|449919464|FG000|Overall Study|Protocol Violation|0|||
125082575|NCT02996500|449919465|FG001|Overall Study|Protocol Violation|0|||
125082576|NCT02996500|449919466|FG002|Overall Study|Protocol Violation|0|||
125082577|NCT02996500|449919467|FG003|Overall Study|Protocol Violation|1|||
125144890|NCT01332968|450155931|FG007|Induction Period|Progressive Disease|0|||
125144891|NCT01332968|450155924|FG000|Induction Period|Protocol Violation|3|||
125144892|NCT01332968|450155925|FG001|Induction Period|Protocol Violation|4|||
125144893|NCT01332968|450155926|FG002|Induction Period|Protocol Violation|0|||
125144894|NCT01332968|450155927|FG003|Induction Period|Protocol Violation|0|||
125144895|NCT01332968|450155928|FG004|Induction Period|Protocol Violation|0|||
125144896|NCT01332968|450155929|FG005|Induction Period|Protocol Violation|0|||
125144897|NCT01332968|450155930|FG006|Induction Period|Protocol Violation|0|||
125144898|NCT01332968|450155931|FG007|Induction Period|Protocol Violation|0|||
125144899|NCT01332968|450155924|FG000|Induction Period|Withdrawal by Subject|3|||
125144900|NCT01332968|450155925|FG001|Induction Period|Withdrawal by Subject|5|||
125144901|NCT01332968|450155926|FG002|Induction Period|Withdrawal by Subject|0|||
125144902|NCT01332968|450155927|FG003|Induction Period|Withdrawal by Subject|0|||
125144903|NCT01332968|450155928|FG004|Induction Period|Withdrawal by Subject|0|||
125144904|NCT01332968|450155929|FG005|Induction Period|Withdrawal by Subject|0|||
125144905|NCT01332968|450155930|FG006|Induction Period|Withdrawal by Subject|0|||
125144906|NCT01332968|450155931|FG007|Induction Period|Withdrawal by Subject|0|||
125144907|NCT01332968|450155924|FG000|Induction Period|Randomised but not treated|4|||
125144908|NCT01332968|450155925|FG001|Induction Period|Randomised but not treated|7|||
125144909|NCT01332968|450155926|FG002|Induction Period|Randomised but not treated|0|||
125144910|NCT01332968|450155927|FG003|Induction Period|Randomised but not treated|0|||
125144911|NCT01332968|450155928|FG004|Induction Period|Randomised but not treated|0|||
125144912|NCT01332968|450155929|FG005|Induction Period|Randomised but not treated|0|||
125082578|NCT02996500|449919468|FG004|Overall Study|Protocol Violation|0|||
125082579|NCT02996500|449919469|FG005|Overall Study|Protocol Violation|0|||
125082580|NCT02996500|449919464|FG000|Overall Study|Withdrawal by Subject|3|||
125082581|NCT02996500|449919465|FG001|Overall Study|Withdrawal by Subject|0|||
125082582|NCT02996500|449919466|FG002|Overall Study|Withdrawal by Subject|3|||
125082583|NCT02996500|449919467|FG003|Overall Study|Withdrawal by Subject|0|||
125082584|NCT02996500|449919468|FG004|Overall Study|Withdrawal by Subject|2|||
125082585|NCT02996500|449919469|FG005|Overall Study|Withdrawal by Subject|0|||
125082586|NCT02485860|449919470|FG000|Overall Study|Lost to Follow-up|4|||
125082587|NCT02485860|449919471|FG001|Overall Study|Lost to Follow-up|1|||
125082588|NCT02485860|449919470|FG000|Overall Study|Physician Decision|1|||
125082589|NCT02485860|449919471|FG001|Overall Study|Physician Decision|2|||
125082590|NCT02485860|449919470|FG000|Overall Study|Health context (COVID-19)|1|||
125082591|NCT02485860|449919471|FG001|Overall Study|Health context (COVID-19)|0|||
125082592|NCT03325010|449919474|FG000|Overall Study|Adverse Event|3|||
125082593|NCT03325010|449919475|FG001|Overall Study|Adverse Event|8|||
125144913|NCT01332968|450155930|FG006|Induction Period|Randomised but not treated|0|||
125144914|NCT01332968|450155931|FG007|Induction Period|Randomised but not treated|0|||
125082594|NCT03325010|449919474|FG000|Overall Study|Protocol Violation|1|||
125082595|NCT03325010|449919475|FG001|Overall Study|Protocol Violation|8|||
125144915|NCT01332968|450155924|FG000|Maintenance/Observation Period|Adverse Event|0|||
125144916|NCT01332968|450155925|FG001|Maintenance/Observation Period|Adverse Event|0|||
125144917|NCT01332968|450155926|FG002|Maintenance/Observation Period|Adverse Event|53|||
125144918|NCT01332968|450155927|FG003|Maintenance/Observation Period|Adverse Event|66|||
125144919|NCT01332968|450155928|FG004|Maintenance/Observation Period|Adverse Event|0|||
125144920|NCT01332968|450155929|FG005|Maintenance/Observation Period|Adverse Event|0|||
125144921|NCT01332968|450155930|FG006|Maintenance/Observation Period|Adverse Event|0|||
125223531|NCT02326272|450446175|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125082596|NCT03325010|449919474|FG000|Overall Study|Withdrawal by Subject|1|||
125082597|NCT03325010|449919475|FG001|Overall Study|Withdrawal by Subject|3|||
125082598|NCT03325010|449919474|FG000|Overall Study|Lost to Follow-up|1|||
125082599|NCT03325010|449919475|FG001|Overall Study|Lost to Follow-up|0|||
125082600|NCT03325010|449919474|FG000|Overall Study|Physician Decision|1|||
125082601|NCT03325010|449919475|FG001|Overall Study|Physician Decision|1|||
125082602|NCT03325010|449919474|FG000|Overall Study|Lack of Efficacy|2|||
125082603|NCT03325010|449919475|FG001|Overall Study|Lack of Efficacy|0|||
125082604|NCT03073200|449919482|FG000|Double Blind Treatment Period|Protocol Violation|1|||
125082605|NCT03073200|449919483|FG001|Double Blind Treatment Period|Protocol Violation|0|||
125082606|NCT03073200|449919484|FG002|Double Blind Treatment Period|Protocol Violation|0|||
125082607|NCT03073200|449919485|FG003|Double Blind Treatment Period|Protocol Violation|0|||
125082608|NCT03073200|449919486|FG004|Double Blind Treatment Period|Protocol Violation|0|||
125082609|NCT03073200|449919487|FG005|Double Blind Treatment Period|Protocol Violation|0|||
125082610|NCT03073200|449919488|FG006|Double Blind Treatment Period|Protocol Violation|0|||
125082611|NCT03073200|449919489|FG007|Double Blind Treatment Period|Protocol Violation|0|||
125082612|NCT03073200|449919490|FG008|Double Blind Treatment Period|Protocol Violation|0|||
125082613|NCT03073200|449919491|FG009|Double Blind Treatment Period|Protocol Violation|0|||
125082614|NCT03073200|449919492|FG010|Double Blind Treatment Period|Protocol Violation|0|||
125082615|NCT03073200|449919493|FG011|Double Blind Treatment Period|Protocol Violation|0|||
125082616|NCT03073200|449919494|FG012|Double Blind Treatment Period|Protocol Violation|0|||
125082617|NCT03073200|449919495|FG013|Double Blind Treatment Period|Protocol Violation|0|||
125082618|NCT03073200|449919496|FG014|Double Blind Treatment Period|Protocol Violation|0|||
125082619|NCT03073200|449919482|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125082620|NCT03073200|449919483|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
125082621|NCT03073200|449919484|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125082622|NCT03073200|449919485|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125082623|NCT03073200|449919486|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125082624|NCT03073200|449919487|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125082625|NCT03073200|449919488|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125082626|NCT03073200|449919489|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125082627|NCT03073200|449919490|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125082628|NCT03073200|449919491|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125082629|NCT03073200|449919492|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125082630|NCT03073200|449919493|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125082631|NCT03073200|449919494|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125082632|NCT03073200|449919495|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125082633|NCT03073200|449919496|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125082634|NCT03073200|449919482|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
125082635|NCT03073200|449919483|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
125082636|NCT03073200|449919484|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
125082637|NCT03073200|449919485|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
125082638|NCT03073200|449919486|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
125082639|NCT03073200|449919487|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
125082640|NCT03073200|449919488|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
125082641|NCT03073200|449919489|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
125082642|NCT03073200|449919490|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
125082643|NCT03073200|449919491|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
125082644|NCT03073200|449919492|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
125082645|NCT03073200|449919493|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
125082646|NCT03073200|449919494|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
125082647|NCT03073200|449919495|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
125082648|NCT03073200|449919496|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
125082649|NCT03073200|449919482|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
125082650|NCT03073200|449919483|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
125082651|NCT03073200|449919484|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
125082652|NCT03073200|449919485|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
125082653|NCT03073200|449919486|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
125082654|NCT03073200|449919487|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
125082655|NCT03073200|449919488|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
125082656|NCT03073200|449919489|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
125082657|NCT03073200|449919490|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
125082658|NCT03073200|449919491|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
125082659|NCT03073200|449919492|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
125082660|NCT03073200|449919493|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
125082661|NCT03073200|449919494|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
125082662|NCT03073200|449919495|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
125082663|NCT03073200|449919496|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
125082664|NCT03073200|449919482|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
125082665|NCT03073200|449919483|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
125082666|NCT03073200|449919484|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
125082667|NCT03073200|449919485|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
125082668|NCT03073200|449919486|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
125082669|NCT03073200|449919487|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
125082670|NCT03073200|449919488|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
125082671|NCT03073200|449919489|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
125082672|NCT03073200|449919490|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
125082673|NCT03073200|449919491|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
125082674|NCT03073200|449919492|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
125082675|NCT03073200|449919493|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
125082676|NCT03073200|449919494|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
125082677|NCT03073200|449919495|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
125082678|NCT03073200|449919496|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
125082679|NCT03073200|449919482|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
125082680|NCT03073200|449919483|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
125082681|NCT03073200|449919484|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
125082682|NCT03073200|449919485|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
125082683|NCT03073200|449919486|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
125082684|NCT03073200|449919487|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
125082685|NCT03073200|449919488|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
125082686|NCT03073200|449919489|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
125082687|NCT03073200|449919490|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
125082688|NCT03073200|449919491|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
125082689|NCT03073200|449919492|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
125082690|NCT03073200|449919493|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
125082691|NCT03073200|449919494|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
125082692|NCT03073200|449919495|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
125082693|NCT03073200|449919496|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
125082694|NCT03073200|449919482|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125082695|NCT03073200|449919483|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125082696|NCT03073200|449919484|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125082697|NCT03073200|449919485|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
125082698|NCT03073200|449919486|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
125082699|NCT03073200|449919487|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125082700|NCT03073200|449919488|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125082701|NCT03073200|449919489|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125082702|NCT03073200|449919490|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125082703|NCT03073200|449919491|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125082704|NCT03073200|449919492|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125082705|NCT03073200|449919493|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125082706|NCT03073200|449919494|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125082707|NCT03073200|449919495|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125082708|NCT03073200|449919496|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125082709|NCT03073200|449919482|FG000|Extension Period|Lost to Follow-up|0|||
125082710|NCT03073200|449919483|FG001|Extension Period|Lost to Follow-up|0|||
125082711|NCT03073200|449919484|FG002|Extension Period|Lost to Follow-up|0|||
125082712|NCT03073200|449919485|FG003|Extension Period|Lost to Follow-up|0|||
125082713|NCT03073200|449919486|FG004|Extension Period|Lost to Follow-up|0|||
125082714|NCT03073200|449919487|FG005|Extension Period|Lost to Follow-up|0|||
125082715|NCT03073200|449919488|FG006|Extension Period|Lost to Follow-up|1|||
125082716|NCT03073200|449919489|FG007|Extension Period|Lost to Follow-up|1|||
125082717|NCT03073200|449919490|FG008|Extension Period|Lost to Follow-up|0|||
125082718|NCT03073200|449919491|FG009|Extension Period|Lost to Follow-up|0|||
125082719|NCT03073200|449919492|FG010|Extension Period|Lost to Follow-up|0|||
125082720|NCT03073200|449919493|FG011|Extension Period|Lost to Follow-up|0|||
125082721|NCT03073200|449919494|FG012|Extension Period|Lost to Follow-up|0|||
125082722|NCT03073200|449919495|FG013|Extension Period|Lost to Follow-up|0|||
125082723|NCT03073200|449919496|FG014|Extension Period|Lost to Follow-up|0|||
125082724|NCT03073200|449919482|FG000|Extension Period|Sponsor Decision|0|||
125303178|NCT03100058|450736662|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
125082725|NCT03073200|449919483|FG001|Extension Period|Sponsor Decision|0|||
125082726|NCT03073200|449919484|FG002|Extension Period|Sponsor Decision|0|||
125082727|NCT03073200|449919485|FG003|Extension Period|Sponsor Decision|0|||
125082728|NCT03073200|449919486|FG004|Extension Period|Sponsor Decision|0|||
125082729|NCT03073200|449919487|FG005|Extension Period|Sponsor Decision|0|||
125082730|NCT03073200|449919488|FG006|Extension Period|Sponsor Decision|0|||
125082731|NCT03073200|449919489|FG007|Extension Period|Sponsor Decision|0|||
125082732|NCT03073200|449919490|FG008|Extension Period|Sponsor Decision|1|||
125082733|NCT03073200|449919491|FG009|Extension Period|Sponsor Decision|0|||
125082734|NCT03073200|449919492|FG010|Extension Period|Sponsor Decision|0|||
125082735|NCT03073200|449919493|FG011|Extension Period|Sponsor Decision|0|||
125082736|NCT03073200|449919494|FG012|Extension Period|Sponsor Decision|0|||
125082737|NCT03073200|449919495|FG013|Extension Period|Sponsor Decision|0|||
125082738|NCT03073200|449919496|FG014|Extension Period|Sponsor Decision|0|||
125082739|NCT03073200|449919482|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
125082740|NCT03073200|449919483|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
125082741|NCT03073200|449919484|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
125082742|NCT03073200|449919485|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
125082743|NCT03073200|449919486|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
125082744|NCT03073200|449919487|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
125082745|NCT03073200|449919488|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
125082746|NCT03073200|449919489|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
125082747|NCT03073200|449919490|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
125082748|NCT03073200|449919491|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
125082749|NCT03073200|449919492|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
125082750|NCT03073200|449919493|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
125082751|NCT03073200|449919494|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
125082752|NCT03073200|449919495|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
125082753|NCT03073200|449919496|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
125082754|NCT03073200|449919482|FG000|Extension Period|Withdrawal by Subject|0|||
125082755|NCT03073200|449919483|FG001|Extension Period|Withdrawal by Subject|0|||
125082756|NCT03073200|449919484|FG002|Extension Period|Withdrawal by Subject|0|||
125082757|NCT03073200|449919485|FG003|Extension Period|Withdrawal by Subject|0|||
125082758|NCT03073200|449919486|FG004|Extension Period|Withdrawal by Subject|0|||
125082759|NCT03073200|449919487|FG005|Extension Period|Withdrawal by Subject|0|||
125082760|NCT03073200|449919488|FG006|Extension Period|Withdrawal by Subject|1|||
125082761|NCT03073200|449919489|FG007|Extension Period|Withdrawal by Subject|2|||
125082762|NCT03073200|449919490|FG008|Extension Period|Withdrawal by Subject|0|||
125082763|NCT03073200|449919491|FG009|Extension Period|Withdrawal by Subject|0|||
125082764|NCT03073200|449919492|FG010|Extension Period|Withdrawal by Subject|0|||
125082765|NCT03073200|449919493|FG011|Extension Period|Withdrawal by Subject|0|||
125082766|NCT03073200|449919494|FG012|Extension Period|Withdrawal by Subject|0|||
125082767|NCT03073200|449919495|FG013|Extension Period|Withdrawal by Subject|0|||
125082768|NCT03073200|449919496|FG014|Extension Period|Withdrawal by Subject|0|||
125082769|NCT03073200|449919482|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
125082770|NCT03073200|449919483|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
125082771|NCT03073200|449919484|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
125082772|NCT03073200|449919485|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
125082773|NCT03073200|449919486|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
125082774|NCT03073200|449919487|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
125082775|NCT03073200|449919488|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
125082776|NCT03073200|449919489|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
125082777|NCT03073200|449919490|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
125082778|NCT03073200|449919491|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
125082779|NCT03073200|449919492|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
125082780|NCT03073200|449919493|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
125082781|NCT03073200|449919494|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
125082782|NCT03073200|449919495|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
125082783|NCT03073200|449919496|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
125082784|NCT03073200|449919482|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125082785|NCT03073200|449919483|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125082786|NCT03073200|449919484|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125082787|NCT03073200|449919485|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125082788|NCT03073200|449919486|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125082789|NCT03073200|449919487|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125082790|NCT03073200|449919488|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125082791|NCT03073200|449919489|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125082792|NCT03073200|449919490|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125082793|NCT03073200|449919491|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125082794|NCT03073200|449919492|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125082795|NCT03073200|449919493|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
125082796|NCT03073200|449919494|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125082797|NCT03073200|449919495|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125082798|NCT03073200|449919496|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125082799|NCT03073200|449919482|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125082800|NCT03073200|449919483|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125082801|NCT03073200|449919484|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125082802|NCT03073200|449919485|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125082803|NCT03073200|449919486|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125082804|NCT03073200|449919487|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125082805|NCT03073200|449919488|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125082806|NCT03073200|449919489|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125082807|NCT03073200|449919490|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125082808|NCT03073200|449919491|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125082809|NCT03073200|449919492|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
125082810|NCT03073200|449919493|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
125082811|NCT03073200|449919494|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125082812|NCT03073200|449919495|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125082813|NCT03073200|449919496|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125082814|NCT03073200|449919482|FG000|Randomized Withdrawal Period|Adverse Event|0|||
125082815|NCT03073200|449919483|FG001|Randomized Withdrawal Period|Adverse Event|0|||
125082816|NCT03073200|449919484|FG002|Randomized Withdrawal Period|Adverse Event|0|||
125082817|NCT03073200|449919485|FG003|Randomized Withdrawal Period|Adverse Event|0|||
125082818|NCT03073200|449919486|FG004|Randomized Withdrawal Period|Adverse Event|0|||
125082819|NCT03073200|449919487|FG005|Randomized Withdrawal Period|Adverse Event|0|||
125082820|NCT03073200|449919488|FG006|Randomized Withdrawal Period|Adverse Event|0|||
125082821|NCT03073200|449919489|FG007|Randomized Withdrawal Period|Adverse Event|0|||
125082822|NCT03073200|449919490|FG008|Randomized Withdrawal Period|Adverse Event|0|||
125082823|NCT03073200|449919491|FG009|Randomized Withdrawal Period|Adverse Event|0|||
125082824|NCT03073200|449919492|FG010|Randomized Withdrawal Period|Adverse Event|1|||
125082825|NCT03073200|449919493|FG011|Randomized Withdrawal Period|Adverse Event|0|||
125082826|NCT03073200|449919494|FG012|Randomized Withdrawal Period|Adverse Event|0|||
125082827|NCT03073200|449919495|FG013|Randomized Withdrawal Period|Adverse Event|0|||
125082828|NCT03073200|449919496|FG014|Randomized Withdrawal Period|Adverse Event|0|||
125082829|NCT03073200|449919482|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
125082830|NCT03073200|449919483|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
125082831|NCT03073200|449919484|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
125082832|NCT03073200|449919485|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
125082833|NCT03073200|449919486|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
125082834|NCT03073200|449919487|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
125082835|NCT03073200|449919488|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
125082836|NCT03073200|449919489|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
125082837|NCT03073200|449919490|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
125082838|NCT03073200|449919491|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
125082839|NCT03073200|449919492|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
125082840|NCT03073200|449919493|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
125082841|NCT03073200|449919494|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
125082842|NCT03073200|449919495|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
125082843|NCT03073200|449919496|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
125082844|NCT03073200|449919482|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125082845|NCT03073200|449919483|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125082846|NCT03073200|449919484|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125082847|NCT03073200|449919485|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125082848|NCT03073200|449919486|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125082849|NCT03073200|449919487|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125082850|NCT03073200|449919488|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125082851|NCT03073200|449919489|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125082852|NCT03073200|449919490|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125082853|NCT03073200|449919491|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125082854|NCT03073200|449919492|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125082855|NCT03073200|449919493|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125082856|NCT03073200|449919494|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125082857|NCT03073200|449919495|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
125082858|NCT03073200|449919496|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125082859|NCT03073200|449919482|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125082860|NCT03073200|449919483|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125082861|NCT03073200|449919484|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125082862|NCT03073200|449919485|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125082863|NCT03073200|449919486|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125082864|NCT03073200|449919487|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125082865|NCT03073200|449919488|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125082866|NCT03073200|449919489|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125144922|NCT01332968|450155931|FG007|Maintenance/Observation Period|Adverse Event|0|||
125082867|NCT03073200|449919490|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125082868|NCT03073200|449919491|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125082869|NCT03073200|449919492|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125082870|NCT03073200|449919493|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125082871|NCT03073200|449919494|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125082872|NCT03073200|449919495|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
125082873|NCT03073200|449919496|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125082874|NCT03073200|449919482|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125082875|NCT03073200|449919483|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125082876|NCT03073200|449919484|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125082877|NCT03073200|449919485|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125082878|NCT03073200|449919486|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125082879|NCT03073200|449919487|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125082880|NCT03073200|449919488|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125082881|NCT03073200|449919489|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125082882|NCT03073200|449919490|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125082883|NCT03073200|449919491|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125082884|NCT03073200|449919492|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125082885|NCT03073200|449919493|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125082886|NCT03073200|449919494|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125082887|NCT03073200|449919495|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
125082888|NCT03073200|449919496|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125082889|NCT03073200|449919482|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125082890|NCT03073200|449919483|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125082891|NCT03073200|449919484|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125082892|NCT03073200|449919485|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125082893|NCT03073200|449919486|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125082894|NCT03073200|449919487|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125082895|NCT03073200|449919488|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125082896|NCT03073200|449919489|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125082897|NCT03073200|449919490|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125082898|NCT03073200|449919491|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125082899|NCT03073200|449919492|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125082900|NCT03073200|449919493|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125082901|NCT03073200|449919494|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125082902|NCT03073200|449919495|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125082903|NCT03073200|449919496|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
125082904|NCT03073200|449919482|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125082905|NCT03073200|449919483|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125082906|NCT03073200|449919484|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125082907|NCT03073200|449919485|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125082908|NCT03073200|449919486|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125082909|NCT03073200|449919487|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125082910|NCT03073200|449919488|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125082911|NCT03073200|449919489|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125082912|NCT03073200|449919490|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125082913|NCT03073200|449919491|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125082914|NCT03073200|449919492|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125082915|NCT03073200|449919493|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125082916|NCT03073200|449919494|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125082917|NCT03073200|449919495|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
125082918|NCT03073200|449919496|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125082919|NCT03073200|449919482|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125082920|NCT03073200|449919483|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125082921|NCT03073200|449919484|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125082922|NCT03073200|449919485|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125082923|NCT03073200|449919486|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125082924|NCT03073200|449919487|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125082925|NCT03073200|449919488|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125082926|NCT03073200|449919489|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125082927|NCT03073200|449919490|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125082928|NCT03073200|449919491|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125223532|NCT02326272|450446176|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125082929|NCT03073200|449919492|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125082930|NCT03073200|449919493|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125082931|NCT03073200|449919494|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125144923|NCT01332968|450155924|FG000|Maintenance/Observation Period|Death|0|||
125144924|NCT01332968|450155925|FG001|Maintenance/Observation Period|Death|0|||
125082932|NCT03073200|449919495|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
125082933|NCT03073200|449919496|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125082934|NCT03073200|449919482|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125082935|NCT03073200|449919483|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125082936|NCT03073200|449919484|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125082937|NCT03073200|449919485|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125082938|NCT03073200|449919486|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125082939|NCT03073200|449919487|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125082940|NCT03073200|449919488|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125082941|NCT03073200|449919489|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125082942|NCT03073200|449919490|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125082943|NCT03073200|449919491|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125082944|NCT03073200|449919492|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125082945|NCT03073200|449919493|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125144925|NCT01332968|450155926|FG002|Maintenance/Observation Period|Death|5|||
125144926|NCT01332968|450155927|FG003|Maintenance/Observation Period|Death|6|||
125144927|NCT01332968|450155928|FG004|Maintenance/Observation Period|Death|0|||
125144928|NCT01332968|450155929|FG005|Maintenance/Observation Period|Death|0|||
125082946|NCT03073200|449919494|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125082947|NCT03073200|449919495|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
125082948|NCT03073200|449919496|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125082949|NCT04757376|449919497|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
125082950|NCT04757376|449919498|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
125082951|NCT04757376|449919499|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
125082952|NCT04757376|449919500|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
125082953|NCT04757376|449919501|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
125082954|NCT04757376|449919497|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
125082955|NCT04757376|449919498|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
125082956|NCT04757376|449919499|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
125082957|NCT04757376|449919500|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
125082958|NCT04757376|449919501|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
125082959|NCT04757376|449919497|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
125082960|NCT04757376|449919498|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
125082961|NCT04757376|449919499|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
125082962|NCT04757376|449919500|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
125082963|NCT04757376|449919501|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
125082964|NCT04757376|449919497|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
125082965|NCT04757376|449919498|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
125082966|NCT04757376|449919499|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
125144929|NCT01332968|450155930|FG006|Maintenance/Observation Period|Death|0|||
125144930|NCT01332968|450155931|FG007|Maintenance/Observation Period|Death|0|||
125144931|NCT01332968|450155924|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
125144932|NCT01332968|450155925|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
125144933|NCT01332968|450155926|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
125144934|NCT01332968|450155927|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
125144935|NCT01332968|450155928|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
125144936|NCT01332968|450155929|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
125082967|NCT04757376|449919500|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
125144937|NCT01332968|450155930|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
125223533|NCT02326272|450446177|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125223534|NCT02326272|450446178|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125082968|NCT04757376|449919501|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
125082969|NCT04757376|449919497|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
125082970|NCT04757376|449919498|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
125082971|NCT04757376|449919499|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
125082972|NCT04757376|449919500|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
125082973|NCT04757376|449919501|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
125082974|NCT04757376|449919497|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
125082975|NCT04757376|449919498|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
125082976|NCT04757376|449919499|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
125082977|NCT04757376|449919500|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
125082978|NCT04757376|449919501|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
125082979|NCT04757376|449919497|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
125082980|NCT04757376|449919498|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
125082981|NCT04757376|449919499|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
125082982|NCT04757376|449919500|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
125082983|NCT04757376|449919501|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
125082984|NCT04757376|449919497|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
125082985|NCT04757376|449919498|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
125082986|NCT04757376|449919499|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
125082987|NCT04757376|449919500|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
125082988|NCT04757376|449919501|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
125082989|NCT04474366|449919502|FG000|Overall Study|Lost to Follow-up|2|||
125082990|NCT04474366|449919503|FG001|Overall Study|Lost to Follow-up|5|||
125082991|NCT04063865|449919504|FG000|Overall Study|Physician Decision|1|||
125082992|NCT04063865|449919505|FG001|Overall Study|Physician Decision|3|||
125082993|NCT04063865|449919504|FG000|Overall Study|Study Closed Prior to Completion|4|||
125082994|NCT04063865|449919505|FG001|Overall Study|Study Closed Prior to Completion|4|||
125082995|NCT04063865|449919504|FG000|Overall Study|Withdrawal by Subject|1|||
125082996|NCT04063865|449919505|FG001|Overall Study|Withdrawal by Subject|1|||
125082997|NCT03898323|449919506|FG000|Overall Study|Physician Decision|1|||
125082998|NCT00320190|449919508|FG000|First 12 Months|Completed but did not enter extension|5|||
125082999|NCT00320190|449919509|FG001|First 12 Months|Completed but did not enter extension|3|||
125083000|NCT00320190|449919508|FG000|First 12 Months|Sponsor terminated study|2|||
125083001|NCT00320190|449919509|FG001|First 12 Months|Sponsor terminated study|2|||
125083002|NCT00320190|449919508|FG000|First 12 Months|Lost to Follow-up|0|||
125083003|NCT00320190|449919509|FG001|First 12 Months|Lost to Follow-up|1|||
125083004|NCT00320190|449919508|FG000|First 12 Months|Enrollment failure|0|||
125083005|NCT00320190|449919509|FG001|First 12 Months|Enrollment failure|1|||
125083006|NCT00320190|449919508|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
125083007|NCT00320190|449919509|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
125083008|NCT00320190|449919508|FG000|First 12 Months|Investigator request|0|||
125083009|NCT00320190|449919509|FG001|First 12 Months|Investigator request|1|||
125083010|NCT00320190|449919508|FG000|First 12 Months|Study drug toxicity|0|||
125083011|NCT00320190|449919509|FG001|First 12 Months|Study drug toxicity|1|||
125083012|NCT00320190|449919508|FG000|First 12 Months|Withdrawal by Subject|0|||
125083013|NCT00320190|449919509|FG001|First 12 Months|Withdrawal by Subject|1|||
125083014|NCT00320190|449919508|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
125083015|NCT00320190|449919509|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
125083016|NCT00320190|449919508|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
125083017|NCT00320190|449919509|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
125083018|NCT00320190|449919508|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
125083019|NCT00320190|449919509|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
125083020|NCT00712270|449919510|FG000|Overall Study|Withdrawal by Subject|11|||
125083021|NCT00712270|449919510|FG000|Overall Study|Screen Failure|3|||
125083022|NCT02875366|449919524|FG000|Overall Study|Adverse Event|0|||
125083023|NCT02875366|449919525|FG001|Overall Study|Adverse Event|2|||
125083024|NCT02875366|449919524|FG000|Overall Study|Noncompliance|0|||
125083025|NCT02875366|449919525|FG001|Overall Study|Noncompliance|1|||
125083026|NCT02141854|449919528|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
125083027|NCT02141854|449919529|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125083028|NCT02141854|449919530|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125083029|NCT02141854|449919531|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125083030|NCT02141854|449919532|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125083031|NCT02141854|449919533|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125083032|NCT02141854|449919528|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
125083033|NCT02141854|449919529|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125083034|NCT02141854|449919530|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125083035|NCT02141854|449919531|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125083036|NCT02141854|449919532|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125083037|NCT02141854|449919533|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125083038|NCT02141854|449919528|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
125083039|NCT02141854|449919529|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125083040|NCT02141854|449919530|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125083041|NCT02141854|449919531|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125083042|NCT02141854|449919532|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125083043|NCT02141854|449919533|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125083044|NCT02141854|449919528|FG000|Run-In Period (Pre-assignment)|Other|14|||
125083045|NCT02141854|449919529|FG001|Run-In Period (Pre-assignment)|Other|0|||
125083046|NCT02141854|449919530|FG002|Run-In Period (Pre-assignment)|Other|0|||
125083047|NCT02141854|449919531|FG003|Run-In Period (Pre-assignment)|Other|0|||
125083048|NCT02141854|449919532|FG004|Run-In Period (Pre-assignment)|Other|0|||
125083049|NCT02141854|449919533|FG005|Run-In Period (Pre-assignment)|Other|0|||
125083050|NCT02141854|449919528|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
125083051|NCT02141854|449919529|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
125083052|NCT02141854|449919530|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
125083053|NCT02141854|449919531|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
125083054|NCT02141854|449919532|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
125083055|NCT02141854|449919533|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
125083056|NCT02141854|449919528|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
125083057|NCT02141854|449919529|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125083058|NCT02141854|449919530|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125083059|NCT02141854|449919531|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125083060|NCT02141854|449919532|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125083061|NCT02141854|449919533|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125083062|NCT02141854|449919528|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
125083063|NCT02141854|449919529|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125083064|NCT02141854|449919530|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125083065|NCT02141854|449919531|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125083066|NCT02141854|449919532|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125083067|NCT02141854|449919533|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125083068|NCT02141854|449919528|FG000|Treatment Period|Protocol Violation|0|||
125083069|NCT02141854|449919529|FG001|Treatment Period|Protocol Violation|1|||
125083070|NCT02141854|449919530|FG002|Treatment Period|Protocol Violation|0|||
125083071|NCT02141854|449919531|FG003|Treatment Period|Protocol Violation|2|||
125083072|NCT02141854|449919532|FG004|Treatment Period|Protocol Violation|2|||
125083073|NCT02141854|449919533|FG005|Treatment Period|Protocol Violation|1|||
125083074|NCT02141854|449919528|FG000|Treatment Period|Noncompliance|0|||
125083075|NCT02141854|449919529|FG001|Treatment Period|Noncompliance|0|||
125083076|NCT02141854|449919530|FG002|Treatment Period|Noncompliance|0|||
125083077|NCT02141854|449919531|FG003|Treatment Period|Noncompliance|1|||
125083078|NCT02141854|449919532|FG004|Treatment Period|Noncompliance|0|||
125083079|NCT02141854|449919533|FG005|Treatment Period|Noncompliance|0|||
125083080|NCT02141854|449919528|FG000|Treatment Period|Lack of Efficacy|0|||
125083081|NCT02141854|449919529|FG001|Treatment Period|Lack of Efficacy|0|||
125083082|NCT02141854|449919530|FG002|Treatment Period|Lack of Efficacy|0|||
125083083|NCT02141854|449919531|FG003|Treatment Period|Lack of Efficacy|1|||
125083084|NCT02141854|449919532|FG004|Treatment Period|Lack of Efficacy|1|||
125083085|NCT02141854|449919533|FG005|Treatment Period|Lack of Efficacy|7|||
125083086|NCT02141854|449919528|FG000|Treatment Period|Pregnancy|0|||
125083087|NCT02141854|449919529|FG001|Treatment Period|Pregnancy|1|||
125083088|NCT02141854|449919530|FG002|Treatment Period|Pregnancy|0|||
125083089|NCT02141854|449919531|FG003|Treatment Period|Pregnancy|0|||
125083090|NCT02141854|449919532|FG004|Treatment Period|Pregnancy|0|||
125083091|NCT02141854|449919533|FG005|Treatment Period|Pregnancy|0|||
125083092|NCT02141854|449919528|FG000|Treatment Period|Other|0|||
125083093|NCT02141854|449919529|FG001|Treatment Period|Other|1|||
125083094|NCT02141854|449919530|FG002|Treatment Period|Other|2|||
125083095|NCT02141854|449919531|FG003|Treatment Period|Other|0|||
125083096|NCT02141854|449919532|FG004|Treatment Period|Other|1|||
125083097|NCT02141854|449919533|FG005|Treatment Period|Other|2|||
125083098|NCT02141854|449919528|FG000|Treatment Period|Adverse Event|0|||
125083099|NCT02141854|449919529|FG001|Treatment Period|Adverse Event|2|||
125083100|NCT02141854|449919530|FG002|Treatment Period|Adverse Event|2|||
125083101|NCT02141854|449919531|FG003|Treatment Period|Adverse Event|0|||
125083102|NCT02141854|449919532|FG004|Treatment Period|Adverse Event|2|||
125083103|NCT02141854|449919533|FG005|Treatment Period|Adverse Event|2|||
125083104|NCT02141854|449919528|FG000|Treatment Period|Withdrawal by Subject|0|||
125083105|NCT02141854|449919529|FG001|Treatment Period|Withdrawal by Subject|2|||
125083106|NCT02141854|449919530|FG002|Treatment Period|Withdrawal by Subject|3|||
125083107|NCT02141854|449919531|FG003|Treatment Period|Withdrawal by Subject|3|||
125083108|NCT02141854|449919532|FG004|Treatment Period|Withdrawal by Subject|4|||
125083109|NCT02141854|449919533|FG005|Treatment Period|Withdrawal by Subject|7|||
125083110|NCT02141854|449919528|FG000|Treatment Period|Disease progression|0|||
125083111|NCT02141854|449919529|FG001|Treatment Period|Disease progression|2|||
125083112|NCT02141854|449919530|FG002|Treatment Period|Disease progression|1|||
125083113|NCT02141854|449919531|FG003|Treatment Period|Disease progression|3|||
125083114|NCT02141854|449919532|FG004|Treatment Period|Disease progression|0|||
125083115|NCT02141854|449919533|FG005|Treatment Period|Disease progression|18|||
125083116|NCT02141854|449919528|FG000|Treatment Period|Lost to Follow-up|0|||
125083117|NCT02141854|449919529|FG001|Treatment Period|Lost to Follow-up|1|||
125083118|NCT02141854|449919530|FG002|Treatment Period|Lost to Follow-up|1|||
125083119|NCT02141854|449919531|FG003|Treatment Period|Lost to Follow-up|1|||
125083120|NCT02141854|449919532|FG004|Treatment Period|Lost to Follow-up|0|||
125083121|NCT02141854|449919533|FG005|Treatment Period|Lost to Follow-up|1|||
125083122|NCT02659098|449919534|FG000|Overall Study|Withdrawal by Subject|7|||
125083123|NCT04363944|449919535|FG000|Overall Study|Withdrawal by Subject|2|||
125083124|NCT04363944|449919536|FG001|Overall Study|Withdrawal by Subject|0|||
125083125|NCT02903966|449920946|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
125083126|NCT02903966|449920947|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
125083127|NCT02903966|449920946|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
125083128|NCT02903966|449920947|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
125083129|NCT02903966|449920946|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
125083130|NCT02903966|449920947|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
125083131|NCT03381274|449920948|FG000|Overall Study|Death|2|||
125083132|NCT03381274|449920949|FG001|Overall Study|Death|9|||
125083133|NCT03381274|449920950|FG002|Overall Study|Death|3|||
125083134|NCT03381274|449920951|FG003|Overall Study|Death|2|||
125083135|NCT03381274|449920952|FG004|Overall Study|Death|3|||
125083136|NCT03381274|449920948|FG000|Overall Study|Lost to Follow-up|0|||
125083137|NCT03381274|449920949|FG001|Overall Study|Lost to Follow-up|0|||
125083138|NCT03381274|449920950|FG002|Overall Study|Lost to Follow-up|0|||
125083139|NCT03381274|449920951|FG003|Overall Study|Lost to Follow-up|1|||
125083140|NCT03381274|449920952|FG004|Overall Study|Lost to Follow-up|0|||
125083141|NCT03381274|449920948|FG000|Overall Study|Withdrawal by Subject|2|||
125083142|NCT03381274|449920949|FG001|Overall Study|Withdrawal by Subject|1|||
125083143|NCT03381274|449920950|FG002|Overall Study|Withdrawal by Subject|3|||
125083144|NCT03381274|449920951|FG003|Overall Study|Withdrawal by Subject|1|||
125083145|NCT03381274|449920952|FG004|Overall Study|Withdrawal by Subject|0|||
125083146|NCT03381274|449920948|FG000|Overall Study|Other|1|||
125083147|NCT03381274|449920949|FG001|Overall Study|Other|11|||
125083148|NCT03381274|449920950|FG002|Overall Study|Other|0|||
125083149|NCT03381274|449920951|FG003|Overall Study|Other|2|||
125083150|NCT03381274|449920952|FG004|Overall Study|Other|2|||
125083151|NCT05298774|449920953|FG000|Overall Study|Physician Decision|3|||
125083152|NCT05298774|449920953|FG000|Overall Study|Withdrawal by Subject|2|||
125083153|NCT05298774|449920953|FG000|Overall Study|Lost to Follow-up|3|||
125083154|NCT05298774|449920953|FG000|Overall Study|Screen failure|1|||
125083155|NCT06048367|449920956|FG000|Overall Study|Withdrawal by Subject|0|||
125083156|NCT06048367|449920957|FG001|Overall Study|Withdrawal by Subject|1|||
125083157|NCT06048367|449920958|FG002|Overall Study|Withdrawal by Subject|0|||
125083158|NCT06048367|449920959|FG003|Overall Study|Withdrawal by Subject|0|||
125083159|NCT06048367|449920960|FG004|Overall Study|Withdrawal by Subject|0|||
125083160|NCT06048367|449920956|FG000|Overall Study|Withdrawal by Subject|0|||
125083161|NCT06048367|449920957|FG001|Overall Study|Withdrawal by Subject|0|||
125083162|NCT06048367|449920958|FG002|Overall Study|Withdrawal by Subject|1|||
125083163|NCT06048367|449920959|FG003|Overall Study|Withdrawal by Subject|0|||
125083164|NCT06048367|449920960|FG004|Overall Study|Withdrawal by Subject|0|||
125083165|NCT06048367|449920956|FG000|Overall Study|Withdrawal by Subject|0|||
125083166|NCT06048367|449920957|FG001|Overall Study|Withdrawal by Subject|0|||
125083167|NCT06048367|449920958|FG002|Overall Study|Withdrawal by Subject|0|||
125083168|NCT06048367|449920959|FG003|Overall Study|Withdrawal by Subject|1|||
125083169|NCT06048367|449920960|FG004|Overall Study|Withdrawal by Subject|0|||
125083170|NCT06048367|449920956|FG000|Overall Study|Withdrawal by Subject|0|||
125083171|NCT06048367|449920957|FG001|Overall Study|Withdrawal by Subject|0|||
125083172|NCT06048367|449920958|FG002|Overall Study|Withdrawal by Subject|0|||
125083173|NCT06048367|449920959|FG003|Overall Study|Withdrawal by Subject|1|||
125083174|NCT06048367|449920960|FG004|Overall Study|Withdrawal by Subject|0|||
125083175|NCT02136134|449920961|FG000|Overall Study|Death|170|||
125083176|NCT02136134|449920962|FG001|Overall Study|Death|148|||
125083177|NCT02136134|449920961|FG000|Overall Study|Withdrawal by Subject|19|||
125083178|NCT02136134|449920962|FG001|Overall Study|Withdrawal by Subject|10|||
125083179|NCT02136134|449920961|FG000|Overall Study|Lost to Follow-up|3|||
125083180|NCT02136134|449920962|FG001|Overall Study|Lost to Follow-up|3|||
125083181|NCT02136134|449920961|FG000|Overall Study|Uspecified|55|||
125083182|NCT02136134|449920962|FG001|Overall Study|Uspecified|90|||
125083183|NCT03070119|449920963|FG000|Overall Study|Adverse Event|0|||
125083184|NCT03070119|449920964|FG001|Overall Study|Adverse Event|0|||
125083185|NCT03070119|449920965|FG002|Overall Study|Adverse Event|1|||
125083186|NCT03070119|449920963|FG000|Overall Study|Lost to Follow-up|0|||
125083187|NCT03070119|449920964|FG001|Overall Study|Lost to Follow-up|1|||
125083188|NCT03070119|449920965|FG002|Overall Study|Lost to Follow-up|0|||
125083189|NCT03070119|449920963|FG000|Overall Study|Consent Withdrawn|6|||
125083190|NCT03070119|449920964|FG001|Overall Study|Consent Withdrawn|5|||
125083191|NCT03070119|449920965|FG002|Overall Study|Consent Withdrawn|3|||
125083192|NCT03070119|449920963|FG000|Overall Study|Investigator Decision|0|||
125083193|NCT03070119|449920964|FG001|Overall Study|Investigator Decision|0|||
125083194|NCT03070119|449920965|FG002|Overall Study|Investigator Decision|1|||
125083195|NCT03070119|449920963|FG000|Overall Study|Death|7|||
125083196|NCT03070119|449920964|FG001|Overall Study|Death|14|||
125083197|NCT03070119|449920965|FG002|Overall Study|Death|5|||
125083198|NCT03070119|449920963|FG000|Overall Study|Disease Progression|5|||
125083199|NCT03070119|449920964|FG001|Overall Study|Disease Progression|7|||
125083200|NCT03070119|449920965|FG002|Overall Study|Disease Progression|7|||
125083201|NCT03070119|449920963|FG000|Overall Study|Reason not Specified|2|||
125083202|NCT03070119|449920964|FG001|Overall Study|Reason not Specified|2|||
125083203|NCT03070119|449920965|FG002|Overall Study|Reason not Specified|1|||
125083204|NCT00732472|449920966|FG000|Overall Study|Adverse Event|0|||
125083205|NCT00732472|449920967|FG001|Overall Study|Adverse Event|1|||
125083206|NCT00732472|449920968|FG002|Overall Study|Adverse Event|1|||
125083207|NCT00732472|449920969|FG003|Overall Study|Adverse Event|1|||
125083208|NCT00732472|449920966|FG000|Overall Study|Protocol Violation|0|||
125083209|NCT00732472|449920967|FG001|Overall Study|Protocol Violation|0|||
125083210|NCT00732472|449920968|FG002|Overall Study|Protocol Violation|0|||
125083211|NCT00732472|449920969|FG003|Overall Study|Protocol Violation|1|||
125083212|NCT00732472|449920966|FG000|Overall Study|Withdrawal by Subject|0|||
125083213|NCT00732472|449920967|FG001|Overall Study|Withdrawal by Subject|2|||
125083214|NCT00732472|449920968|FG002|Overall Study|Withdrawal by Subject|0|||
125083215|NCT00732472|449920969|FG003|Overall Study|Withdrawal by Subject|1|||
125083216|NCT01266876|449920971|FG000|Overall Study|Adverse Event|0|||
125083217|NCT01266876|449920972|FG001|Overall Study|Adverse Event|0|||
125083218|NCT01266876|449920973|FG002|Overall Study|Adverse Event|0|||
125083219|NCT01266876|449920974|FG003|Overall Study|Adverse Event|1|||
125083220|NCT01266876|449920975|FG004|Overall Study|Adverse Event|0|||
125083221|NCT05180721|449920976|FG000|Overall Study|Lost to Follow-up|4|||
125083222|NCT01996865|449920978|FG000|Induction Period|Protocol Violation|1|||
125083223|NCT01996865|449920979|FG001|Induction Period|Protocol Violation|0|||
125083224|NCT01996865|449920980|FG002|Induction Period|Protocol Violation|0|||
125083225|NCT01996865|449920978|FG000|Induction Period|Progressive Disease|4|||
125083226|NCT01996865|449920979|FG001|Induction Period|Progressive Disease|0|||
125083227|NCT01996865|449920980|FG002|Induction Period|Progressive Disease|0|||
125083228|NCT01996865|449920978|FG000|Induction Period|Lost to Follow-up|10|||
125083229|NCT01996865|449920979|FG001|Induction Period|Lost to Follow-up|0|||
125083230|NCT01996865|449920980|FG002|Induction Period|Lost to Follow-up|0|||
125083231|NCT01996865|449920978|FG000|Induction Period|Other Reasons|13|||
125083232|NCT01996865|449920979|FG001|Induction Period|Other Reasons|0|||
125083233|NCT01996865|449920980|FG002|Induction Period|Other Reasons|0|||
125083234|NCT01996865|449920978|FG000|Induction Period|Adverse Event|20|||
125083235|NCT01996865|449920979|FG001|Induction Period|Adverse Event|0|||
125083236|NCT01996865|449920980|FG002|Induction Period|Adverse Event|0|||
125083237|NCT01996865|449920978|FG000|Induction Period|Withdrawal by Subject|60|||
125083238|NCT01996865|449920979|FG001|Induction Period|Withdrawal by Subject|0|||
125083239|NCT01996865|449920980|FG002|Induction Period|Withdrawal by Subject|0|||
125083240|NCT01996865|449920978|FG000|Induction Period|Death|111|||
125083241|NCT01996865|449920979|FG001|Induction Period|Death|0|||
125083242|NCT01996865|449920980|FG002|Induction Period|Death|0|||
125083243|NCT01996865|449920978|FG000|Maintenance Period|Protocol Violation|0|||
125083244|NCT01996865|449920979|FG001|Maintenance Period|Protocol Violation|1|||
125083245|NCT01996865|449920980|FG002|Maintenance Period|Protocol Violation|1|||
125144938|NCT01332968|450155931|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
125144939|NCT01332968|450155924|FG000|Maintenance/Observation Period|Non-compliance|0|||
125144940|NCT01332968|450155925|FG001|Maintenance/Observation Period|Non-compliance|0|||
125144941|NCT01332968|450155926|FG002|Maintenance/Observation Period|Non-compliance|4|||
125144942|NCT01332968|450155927|FG003|Maintenance/Observation Period|Non-compliance|3|||
125144943|NCT01332968|450155928|FG004|Maintenance/Observation Period|Non-compliance|0|||
125144944|NCT01332968|450155929|FG005|Maintenance/Observation Period|Non-compliance|0|||
125144945|NCT01332968|450155930|FG006|Maintenance/Observation Period|Non-compliance|0|||
125144946|NCT01332968|450155931|FG007|Maintenance/Observation Period|Non-compliance|0|||
125083246|NCT01996865|449920978|FG000|Maintenance Period|Other reasons|0|||
125083247|NCT01996865|449920979|FG001|Maintenance Period|Other reasons|8|||
125083248|NCT01996865|449920980|FG002|Maintenance Period|Other reasons|5|||
125083249|NCT01996865|449920978|FG000|Maintenance Period|Progressive Disease|0|||
125083250|NCT01996865|449920979|FG001|Maintenance Period|Progressive Disease|6|||
125083251|NCT01996865|449920980|FG002|Maintenance Period|Progressive Disease|23|||
125083252|NCT01996865|449920978|FG000|Maintenance Period|Withdrawal by Subject|0|||
125083253|NCT01996865|449920979|FG001|Maintenance Period|Withdrawal by Subject|18|||
125083254|NCT01996865|449920980|FG002|Maintenance Period|Withdrawal by Subject|4|||
125083255|NCT01996865|449920978|FG000|Maintenance Period|Adverse Event|0|||
125083256|NCT01996865|449920979|FG001|Maintenance Period|Adverse Event|7|||
125083257|NCT01996865|449920980|FG002|Maintenance Period|Adverse Event|7|||
125083258|NCT01996865|449920978|FG000|Maintenance Period|Death|0|||
125083259|NCT01996865|449920979|FG001|Maintenance Period|Death|15|||
125083260|NCT01996865|449920980|FG002|Maintenance Period|Death|3|||
125083261|NCT01996865|449920978|FG000|Maintenance Period|Lost to Follow-up|0|||
125083262|NCT01996865|449920979|FG001|Maintenance Period|Lost to Follow-up|2|||
125083263|NCT01996865|449920980|FG002|Maintenance Period|Lost to Follow-up|0|||
125083264|NCT03575351|449920981|FG000|Overall Study|Adverse Event|1|||
125083265|NCT03575351|449920982|FG001|Overall Study|Adverse Event|0|||
125083266|NCT03575351|449920981|FG000|Overall Study|Death|2|||
125083267|NCT03575351|449920982|FG001|Overall Study|Death|2|||
125083268|NCT03575351|449920981|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
125083269|NCT03575351|449920982|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
125083270|NCT03575351|449920981|FG000|Overall Study|Lack of Efficacy|28|||
125083271|NCT03575351|449920982|FG001|Overall Study|Lack of Efficacy|0|||
125083272|NCT03575351|449920981|FG000|Overall Study|Withdrawal by Subject|1|||
125083273|NCT03575351|449920982|FG001|Overall Study|Withdrawal by Subject|1|||
125083274|NCT03575351|449920981|FG000|Overall Study|Physician Decision|3|||
125083275|NCT03575351|449920982|FG001|Overall Study|Physician Decision|0|||
125083276|NCT03575351|449920981|FG000|Overall Study|Disease relapse|15|||
125083277|NCT03575351|449920982|FG001|Overall Study|Disease relapse|6|||
125083278|NCT03575351|449920981|FG000|Overall Study|Study drug manufacturing failure|0|||
125083279|NCT03575351|449920982|FG001|Overall Study|Study drug manufacturing failure|1|||
125083280|NCT03575351|449920981|FG000|Overall Study|other reasons|5|||
125083281|NCT03575351|449920982|FG001|Overall Study|other reasons|0|||
125083282|NCT04288089|449920983|FG000|Overall Study|Ongoing Treatment|2|||
125083283|NCT04288089|449920984|FG001|Overall Study|Ongoing Treatment|1|||
125083284|NCT04288089|449920985|FG002|Overall Study|Ongoing Treatment|1|||
125083285|NCT04288089|449920986|FG003|Overall Study|Ongoing Treatment|4|||
125083286|NCT03715205|449920987|FG000|Overall Study|Death|13|||
125083287|NCT03715205|449920987|FG000|Overall Study|Lost to Follow-up|2|||
125083288|NCT03715205|449920987|FG000|Overall Study|Physician Decision|93|||
125083289|NCT03715205|449920987|FG000|Overall Study|Withdrawal by Subject|26|||
125083290|NCT02286089|449920990|FG000|Overall Study|Ongoing in Study|1|||
125083291|NCT02286089|449920991|FG001|Overall Study|Ongoing in Study|1|||
125083292|NCT02286089|449920992|FG002|Overall Study|Ongoing in Study|4|||
125083293|NCT02286089|449920993|FG003|Overall Study|Ongoing in Study|10|||
125083294|NCT02286089|449920990|FG000|Overall Study|Withdrawal by Subject|0|||
125083295|NCT02286089|449920991|FG001|Overall Study|Withdrawal by Subject|0|||
125083296|NCT02286089|449920992|FG002|Overall Study|Withdrawal by Subject|2|||
125083297|NCT02286089|449920993|FG003|Overall Study|Withdrawal by Subject|2|||
125083298|NCT03733249|449920994|FG000|Overall Study|Death|7|||
125083299|NCT03733249|449920994|FG000|Overall Study|Disease relapse|16|||
125083300|NCT03733249|449920994|FG000|Overall Study|Lost to Follow-up|4|||
125083301|NCT03733249|449920994|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
125083302|NCT03733249|449920994|FG000|Overall Study|Withdrawal by Subject|1|||
125083303|NCT04247828|449920995|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
125083304|NCT03299166|449920996|FG000|Overall Study|Adverse Event|9|||
125083305|NCT03299166|449920997|FG001|Overall Study|Adverse Event|4|||
125083306|NCT03299166|449920996|FG000|Overall Study|Withdrawal by Subject|6|||
125144947|NCT01332968|450155924|FG000|Maintenance/Observation Period|Other|0|||
125083307|NCT03299166|449920997|FG001|Overall Study|Withdrawal by Subject|5|||
125083308|NCT03299166|449920996|FG000|Overall Study|Physician Decision|1|||
125083309|NCT03299166|449920997|FG001|Overall Study|Physician Decision|1|||
125083310|NCT03299166|449920996|FG000|Overall Study|Sponsor Decision|3|||
125083311|NCT03299166|449920997|FG001|Overall Study|Sponsor Decision|0|||
125083312|NCT03299166|449920996|FG000|Overall Study|Lost to Follow-up|2|||
125083313|NCT03299166|449920997|FG001|Overall Study|Lost to Follow-up|4|||
125083314|NCT03299166|449920996|FG000|Overall Study|Randomization Error|0|||
125083315|NCT03299166|449920997|FG001|Overall Study|Randomization Error|1|||
125083316|NCT03299166|449920996|FG000|Overall Study|Subject unable to return due to COVID|1|||
125083317|NCT03299166|449920997|FG001|Overall Study|Subject unable to return due to COVID|0|||
125083318|NCT03299166|449920996|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
125083319|NCT03299166|449920997|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
125083320|NCT00572728|449920998|FG000|Overall Study|Withdrawal by Subject|10|||
125083321|NCT00572728|449920998|FG000|Overall Study|Ineligible|3|||
125083322|NCT00572728|449920998|FG000|Overall Study|Enrolled under Amendment 4|5|||
125083323|NCT00572728|449920998|FG000|Overall Study|Offstudy due to complicating disease|1|||
125083324|NCT00572728|449920998|FG000|Overall Study|FLT1 not completed|4|||
125083325|NCT00572728|449920998|FG000|Overall Study|First Chemotherapy not initiated|2|||
125083326|NCT00572728|449920998|FG000|Overall Study|FLT2 not completed|5|||
125083327|NCT00572728|449920998|FG000|Overall Study|Second chemotherapy not initiated|1|||
125083328|NCT00572728|449920998|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
125083329|NCT00572728|449920998|FG000|Overall Study|Pathology missing|1|||
125083330|NCT00002981|449920999|FG000|Overall Study|Inevaluable|6|||
125083331|NCT03457636|449921002|FG000|Overall Study|Lost to Follow-up|2|||
125083332|NCT03954704|449921003|FG000|Overall Study|Death|1|||
125083333|NCT03954704|449921004|FG001|Overall Study|Death|1|||
125083334|NCT03954704|449921005|FG002|Overall Study|Death|1|||
125083335|NCT03954704|449921006|FG003|Overall Study|Death|3|||
125083336|NCT03954704|449921007|FG004|Overall Study|Death|2|||
125083337|NCT03954704|449921008|FG005|Overall Study|Death|2|||
125083338|NCT03954704|449921009|FG006|Overall Study|Death|0|||
125083339|NCT03954704|449921003|FG000|Overall Study|Withdrew Consent|0|||
125083340|NCT03954704|449921004|FG001|Overall Study|Withdrew Consent|0|||
125083341|NCT03954704|449921005|FG002|Overall Study|Withdrew Consent|1|||
125083342|NCT03954704|449921006|FG003|Overall Study|Withdrew Consent|0|||
125083343|NCT03954704|449921007|FG004|Overall Study|Withdrew Consent|0|||
125083344|NCT03954704|449921008|FG005|Overall Study|Withdrew Consent|1|||
125083345|NCT03954704|449921009|FG006|Overall Study|Withdrew Consent|0|||
125083346|NCT03954704|449921003|FG000|Overall Study|Lost to Follow-up|0|||
125083347|NCT03954704|449921004|FG001|Overall Study|Lost to Follow-up|0|||
125083348|NCT03954704|449921005|FG002|Overall Study|Lost to Follow-up|0|||
125083349|NCT03954704|449921006|FG003|Overall Study|Lost to Follow-up|0|||
125083350|NCT03954704|449921007|FG004|Overall Study|Lost to Follow-up|0|||
125083351|NCT03954704|449921008|FG005|Overall Study|Lost to Follow-up|0|||
125083352|NCT03954704|449921009|FG006|Overall Study|Lost to Follow-up|1|||
125083353|NCT03954704|449921003|FG000|Overall Study|Study Terminated by Sponsor|0|||
125083354|NCT03954704|449921004|FG001|Overall Study|Study Terminated by Sponsor|0|||
125083355|NCT03954704|449921005|FG002|Overall Study|Study Terminated by Sponsor|1|||
125083356|NCT03954704|449921006|FG003|Overall Study|Study Terminated by Sponsor|0|||
125083357|NCT03954704|449921007|FG004|Overall Study|Study Terminated by Sponsor|1|||
125083358|NCT03954704|449921008|FG005|Overall Study|Study Terminated by Sponsor|4|||
125083359|NCT03954704|449921009|FG006|Overall Study|Study Terminated by Sponsor|2|||
125083360|NCT03954704|449921003|FG000|Overall Study|Enrolled but not Treated|0|||
125083361|NCT03954704|449921004|FG001|Overall Study|Enrolled but not Treated|0|||
125083362|NCT03954704|449921005|FG002|Overall Study|Enrolled but not Treated|0|||
125083363|NCT03954704|449921006|FG003|Overall Study|Enrolled but not Treated|0|||
125083364|NCT03954704|449921007|FG004|Overall Study|Enrolled but not Treated|0|||
125083365|NCT03954704|449921008|FG005|Overall Study|Enrolled but not Treated|1|||
125083366|NCT03954704|449921009|FG006|Overall Study|Enrolled but not Treated|0|||
125083367|NCT00102804|449921010|FG000|Overall Study|Progressive Disease (PD)|307|||
125083368|NCT00102804|449921011|FG001|Overall Study|Progressive Disease (PD)|196|||
125083369|NCT00102804|449921010|FG000|Overall Study|Withdrawal by Subject|46|||
125083370|NCT00102804|449921011|FG001|Overall Study|Withdrawal by Subject|7|||
125083371|NCT00102804|449921010|FG000|Overall Study|Adverse Event|37|||
125083372|NCT00102804|449921011|FG001|Overall Study|Adverse Event|3|||
125083373|NCT00102804|449921010|FG000|Overall Study|Physician Decision|24|||
125083374|NCT00102804|449921011|FG001|Overall Study|Physician Decision|6|||
125083375|NCT00102804|449921010|FG000|Overall Study|Death|5|||
125083376|NCT00102804|449921011|FG001|Overall Study|Death|6|||
125083377|NCT00102804|449921010|FG000|Overall Study|Enrollment Criteria Not Met|6|||
125083378|NCT00102804|449921011|FG001|Overall Study|Enrollment Criteria Not Met|0|||
125083379|NCT00102804|449921010|FG000|Overall Study|Lost to Follow-up|4|||
125083380|NCT00102804|449921011|FG001|Overall Study|Lost to Follow-up|1|||
125083381|NCT00102804|449921010|FG000|Overall Study|Protocol Violation|2|||
125083382|NCT00102804|449921011|FG001|Overall Study|Protocol Violation|1|||
125083383|NCT00102804|449921010|FG000|Overall Study|Satisfactory Response|2|||
125083384|NCT00102804|449921011|FG001|Overall Study|Satisfactory Response|0|||
125083385|NCT00102804|449921010|FG000|Overall Study|Sponsor Decision|1|||
125083386|NCT00102804|449921011|FG001|Overall Study|Sponsor Decision|0|||
125083387|NCT00102804|449921010|FG000|Overall Study|Alive, Receiving Treatment|7|||
125083388|NCT00102804|449921011|FG001|Overall Study|Alive, Receiving Treatment|2|||
125083389|NCT00374127|449921014|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
125083390|NCT00374127|449921014|FG000|Overall Study|Blood could not be drawn.|2|||
125083391|NCT00374127|449921014|FG000|Overall Study|Protocol Violation|5|||
125083392|NCT00374127|449921014|FG000|Overall Study|Pregnancy|1|||
125083393|NCT04035473|449921019|FG000|Screening/Baseline|Death|0|||
125083394|NCT04035473|449921020|FG001|Screening/Baseline|Death|1|||
125083395|NCT04035473|449921019|FG000|Screening/Baseline|Adverse Event|0|||
125083396|NCT04035473|449921020|FG001|Screening/Baseline|Adverse Event|1|||
125083397|NCT04035473|449921019|FG000|Follow-up Period|Adverse Event|2|||
125083398|NCT04035473|449921020|FG001|Follow-up Period|Adverse Event|0|||
125083399|NCT00112840|449921021|FG000|Overall Study|Physician Decision|1|||
125083400|NCT00112840|449921022|FG001|Overall Study|Physician Decision|0|||
125083401|NCT00112840|449921023|FG002|Overall Study|Physician Decision|0|||
125083402|NCT00112840|449921021|FG000|Overall Study|Withdrawal by Subject|1|||
125083403|NCT00112840|449921022|FG001|Overall Study|Withdrawal by Subject|0|||
125083404|NCT00112840|449921023|FG002|Overall Study|Withdrawal by Subject|1|||
125083405|NCT00112840|449921021|FG000|Overall Study|Protocol Violation|0|||
125083406|NCT00112840|449921022|FG001|Overall Study|Protocol Violation|0|||
125083407|NCT00112840|449921023|FG002|Overall Study|Protocol Violation|5|||
125083408|NCT02299206|449921024|FG000|Overall Study|Lost to Follow-up|1|||
125083409|NCT02299206|449921024|FG000|Overall Study|Withdrawal by Subject|1|||
125083410|NCT00683774|449921025|FG000|Overall Study|Withdrawal by Subject|0|||
125083411|NCT00683774|449921026|FG001|Overall Study|Withdrawal by Subject|1|||
125083412|NCT00683774|449921025|FG000|Overall Study|Physician Decision|3|||
125083413|NCT00683774|449921026|FG001|Overall Study|Physician Decision|0|||
125083414|NCT00691054|449921027|FG000|Overall Study|Withdrawal by Subject|1|||
125083415|NCT03595176|449921028|FG000|Overall Study|Death|0|||
125083416|NCT03595176|449921029|FG001|Overall Study|Death|2|||
125083417|NCT03595176|449921028|FG000|Overall Study|Lost to Follow-up|0|||
125083418|NCT03595176|449921029|FG001|Overall Study|Lost to Follow-up|1|||
125083419|NCT02735044|449921031|FG000|Overall Study|Adverse Event|3|||
125083420|NCT02735044|449921032|FG001|Overall Study|Adverse Event|3|||
125083421|NCT02735044|449921031|FG000|Overall Study|Lack of Efficacy|1|||
125083422|NCT02735044|449921032|FG001|Overall Study|Lack of Efficacy|0|||
125083423|NCT02735044|449921031|FG000|Overall Study|Poor compliance to protocol|7|||
125083424|NCT02735044|449921032|FG001|Overall Study|Poor compliance to protocol|7|||
125083425|NCT02735044|449921031|FG000|Overall Study|Randomized and not treated|0|||
125083426|NCT02735044|449921032|FG001|Overall Study|Randomized and not treated|2|||
125083427|NCT02735044|449921031|FG000|Overall Study|Other, not specified above|5|||
125083428|NCT02735044|449921032|FG001|Overall Study|Other, not specified above|11|||
125083429|NCT01682759|449921034|FG000|Overall Study|Death|2|||
125083430|NCT01682759|449921035|FG001|Overall Study|Death|1|||
125083431|NCT01682759|449921034|FG000|Overall Study|Lost to Follow-up|10|||
125083432|NCT01682759|449921035|FG001|Overall Study|Lost to Follow-up|13|||
125083433|NCT01682759|449921034|FG000|Overall Study|Physician Decision|1|||
125083434|NCT01682759|449921035|FG001|Overall Study|Physician Decision|1|||
125083435|NCT01682759|449921034|FG000|Overall Study|Withdrawal by Subject|56|||
125083436|NCT01682759|449921035|FG001|Overall Study|Withdrawal by Subject|55|||
125083437|NCT01868594|449921038|FG000|Overall Study|Do not meet inclusion criteria|4|||
125083438|NCT01868594|449921039|FG001|Overall Study|Do not meet inclusion criteria|3|||
125083439|NCT01201967|449921042|FG000|Overall Study|Lost to Follow-up|6|||
125083440|NCT01201967|449921043|FG001|Overall Study|Lost to Follow-up|5|||
125083441|NCT03128307|449921051|FG000|Overall Study|Lost to Follow-up|29|||
125083442|NCT03128307|449921051|FG000|Overall Study|Withdrawal by Subject|5|||
125083443|NCT02632344|449922808|FG000|Overall Study|Adverse Event|3|||
125083444|NCT02632344|449922808|FG000|Overall Study|Lack of Efficacy|3|||
125083445|NCT02632344|449922808|FG000|Overall Study|Withdrawal by Subject|2|||
125083446|NCT04076579|449922810|FG000|Overall Study|Adverse Event|2|||
125083447|NCT04076579|449922811|FG001|Overall Study|Adverse Event|0|||
125083448|NCT04076579|449922810|FG000|Overall Study|discontinued due to toxicity|1|||
125083449|NCT04076579|449922811|FG001|Overall Study|discontinued due to toxicity|0|||
125083450|NCT04076579|449922810|FG000|Overall Study|Physician Decision|1|||
125083451|NCT04076579|449922811|FG001|Overall Study|Physician Decision|0|||
125083452|NCT04076579|449922810|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
125083453|NCT04076579|449922811|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
125083454|NCT04076579|449922810|FG000|Overall Study|Noncompliance|0|||
125083455|NCT04076579|449922811|FG001|Overall Study|Noncompliance|1|||
125083456|NCT04076579|449922810|FG000|Overall Study|Withdrawal by Subject|0|||
125083457|NCT04076579|449922811|FG001|Overall Study|Withdrawal by Subject|2|||
125083458|NCT01693562|449922812|FG000|Escalation Phase|Withdrawal by Subject|0|||
125083459|NCT01693562|449922813|FG001|Escalation Phase|Withdrawal by Subject|1|||
125083460|NCT01693562|449922814|FG002|Escalation Phase|Withdrawal by Subject|0|||
125083461|NCT01693562|449922815|FG003|Escalation Phase|Withdrawal by Subject|0|||
125083462|NCT01693562|449922816|FG004|Escalation Phase|Withdrawal by Subject|0|||
125083463|NCT01693562|449922817|FG005|Escalation Phase|Withdrawal by Subject|2|||
125083464|NCT01693562|449922818|FG006|Escalation Phase|Withdrawal by Subject|0|||
125083465|NCT01693562|449922819|FG007|Escalation Phase|Withdrawal by Subject|0|||
125083466|NCT01693562|449922820|FG008|Escalation Phase|Withdrawal by Subject|0|||
125083467|NCT01693562|449922821|FG009|Escalation Phase|Withdrawal by Subject|0|||
125083468|NCT01693562|449922822|FG010|Escalation Phase|Withdrawal by Subject|0|||
125083469|NCT01693562|449922823|FG011|Escalation Phase|Withdrawal by Subject|0|||
125083470|NCT01693562|449922824|FG012|Escalation Phase|Withdrawal by Subject|0|||
125144948|NCT01332968|450155925|FG001|Maintenance/Observation Period|Other|0|||
125144949|NCT01332968|450155926|FG002|Maintenance/Observation Period|Other|4|||
125144950|NCT01332968|450155927|FG003|Maintenance/Observation Period|Other|7|||
125144951|NCT01332968|450155928|FG004|Maintenance/Observation Period|Other|0|||
125144952|NCT01332968|450155929|FG005|Maintenance/Observation Period|Other|0|||
125144953|NCT01332968|450155930|FG006|Maintenance/Observation Period|Other|0|||
125144954|NCT01332968|450155931|FG007|Maintenance/Observation Period|Other|0|||
125144955|NCT01332968|450155924|FG000|Maintenance/Observation Period|Physician Decision|0|||
125144956|NCT01332968|450155925|FG001|Maintenance/Observation Period|Physician Decision|0|||
125144957|NCT01332968|450155926|FG002|Maintenance/Observation Period|Physician Decision|14|||
125144958|NCT01332968|450155927|FG003|Maintenance/Observation Period|Physician Decision|19|||
125144959|NCT01332968|450155928|FG004|Maintenance/Observation Period|Physician Decision|0|||
125144960|NCT01332968|450155929|FG005|Maintenance/Observation Period|Physician Decision|1|||
125144961|NCT01332968|450155930|FG006|Maintenance/Observation Period|Physician Decision|0|||
125144962|NCT01332968|450155931|FG007|Maintenance/Observation Period|Physician Decision|0|||
125144963|NCT01332968|450155924|FG000|Maintenance/Observation Period|Progressive Disease|0|||
125144964|NCT01332968|450155925|FG001|Maintenance/Observation Period|Progressive Disease|0|||
125144965|NCT01332968|450155926|FG002|Maintenance/Observation Period|Progressive Disease|72|||
125144966|NCT01332968|450155927|FG003|Maintenance/Observation Period|Progressive Disease|40|||
125144967|NCT01332968|450155928|FG004|Maintenance/Observation Period|Progressive Disease|0|||
125144968|NCT01332968|450155929|FG005|Maintenance/Observation Period|Progressive Disease|0|||
125144969|NCT01332968|450155930|FG006|Maintenance/Observation Period|Progressive Disease|0|||
125144970|NCT01332968|450155931|FG007|Maintenance/Observation Period|Progressive Disease|0|||
125144971|NCT01332968|450155924|FG000|Maintenance/Observation Period|Protocol Violation|0|||
125144972|NCT01332968|450155925|FG001|Maintenance/Observation Period|Protocol Violation|0|||
125144973|NCT01332968|450155926|FG002|Maintenance/Observation Period|Protocol Violation|1|||
125144974|NCT01332968|450155927|FG003|Maintenance/Observation Period|Protocol Violation|1|||
125144975|NCT01332968|450155928|FG004|Maintenance/Observation Period|Protocol Violation|0|||
125144976|NCT01332968|450155929|FG005|Maintenance/Observation Period|Protocol Violation|0|||
125144977|NCT01332968|450155930|FG006|Maintenance/Observation Period|Protocol Violation|0|||
125144978|NCT01332968|450155931|FG007|Maintenance/Observation Period|Protocol Violation|0|||
125144979|NCT01332968|450155924|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
125144980|NCT01332968|450155925|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
125144981|NCT01332968|450155926|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
125144982|NCT01332968|450155927|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
125144983|NCT01332968|450155928|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
125144984|NCT01332968|450155929|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
125144985|NCT01332968|450155930|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
125144986|NCT01332968|450155931|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
125144987|NCT01332968|450155924|FG000|Follow-Up Period|Adverse Event|0|||
125144988|NCT01332968|450155925|FG001|Follow-Up Period|Adverse Event|0|||
125144989|NCT01332968|450155926|FG002|Follow-Up Period|Adverse Event|0|||
125144990|NCT01332968|450155927|FG003|Follow-Up Period|Adverse Event|0|||
125144991|NCT01332968|450155928|FG004|Follow-Up Period|Adverse Event|0|||
125144992|NCT01332968|450155929|FG005|Follow-Up Period|Adverse Event|0|||
125144993|NCT01332968|450155930|FG006|Follow-Up Period|Adverse Event|0|||
125144994|NCT01332968|450155931|FG007|Follow-Up Period|Adverse Event|4|||
125223535|NCT02326272|450446164|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
125083471|NCT01693562|449922825|FG013|Escalation Phase|Withdrawal by Subject|0|||
125144995|NCT01332968|450155924|FG000|Follow-Up Period|Death|0|||
125144996|NCT01332968|450155925|FG001|Follow-Up Period|Death|0|||
125144997|NCT01332968|450155926|FG002|Follow-Up Period|Death|0|||
125144998|NCT01332968|450155927|FG003|Follow-Up Period|Death|0|||
125144999|NCT01332968|450155928|FG004|Follow-Up Period|Death|0|||
125083472|NCT01693562|449922826|FG014|Escalation Phase|Withdrawal by Subject|0|||
125083473|NCT01693562|449922827|FG015|Escalation Phase|Withdrawal by Subject|0|||
125083474|NCT01693562|449922828|FG016|Escalation Phase|Withdrawal by Subject|0|||
125083475|NCT01693562|449922829|FG017|Escalation Phase|Withdrawal by Subject|0|||
125083476|NCT01693562|449922830|FG018|Escalation Phase|Withdrawal by Subject|0|||
125083477|NCT01693562|449922831|FG019|Escalation Phase|Withdrawal by Subject|0|||
125083478|NCT01693562|449922832|FG020|Escalation Phase|Withdrawal by Subject|0|||
125083479|NCT01693562|449922833|FG021|Escalation Phase|Withdrawal by Subject|0|||
125083480|NCT01693562|449922834|FG022|Escalation Phase|Withdrawal by Subject|0|||
125083481|NCT01693562|449922812|FG000|Escalation Phase|Death|4|||
125083482|NCT01693562|449922813|FG001|Escalation Phase|Death|2|||
125083483|NCT01693562|449922814|FG002|Escalation Phase|Death|0|||
125083484|NCT01693562|449922815|FG003|Escalation Phase|Death|3|||
125083485|NCT01693562|449922816|FG004|Escalation Phase|Death|6|||
125083486|NCT01693562|449922817|FG005|Escalation Phase|Death|4|||
125083487|NCT01693562|449922818|FG006|Escalation Phase|Death|0|||
125083488|NCT01693562|449922819|FG007|Escalation Phase|Death|0|||
125083489|NCT01693562|449922820|FG008|Escalation Phase|Death|0|||
125083490|NCT01693562|449922821|FG009|Escalation Phase|Death|0|||
125083491|NCT01693562|449922822|FG010|Escalation Phase|Death|0|||
125083492|NCT01693562|449922823|FG011|Escalation Phase|Death|0|||
125083493|NCT01693562|449922824|FG012|Escalation Phase|Death|0|||
125083494|NCT01693562|449922825|FG013|Escalation Phase|Death|0|||
125083495|NCT01693562|449922826|FG014|Escalation Phase|Death|0|||
125083496|NCT01693562|449922827|FG015|Escalation Phase|Death|0|||
125083497|NCT01693562|449922828|FG016|Escalation Phase|Death|0|||
125083498|NCT01693562|449922829|FG017|Escalation Phase|Death|0|||
125083499|NCT01693562|449922830|FG018|Escalation Phase|Death|0|||
125083500|NCT01693562|449922831|FG019|Escalation Phase|Death|0|||
125083501|NCT01693562|449922832|FG020|Escalation Phase|Death|0|||
125083502|NCT01693562|449922833|FG021|Escalation Phase|Death|0|||
125083503|NCT01693562|449922834|FG022|Escalation Phase|Death|0|||
125083504|NCT01693562|449922812|FG000|Escalation Phase|Lost to Follow-up|0|||
125083505|NCT01693562|449922813|FG001|Escalation Phase|Lost to Follow-up|1|||
125083506|NCT01693562|449922814|FG002|Escalation Phase|Lost to Follow-up|1|||
125083507|NCT01693562|449922815|FG003|Escalation Phase|Lost to Follow-up|0|||
125083508|NCT01693562|449922816|FG004|Escalation Phase|Lost to Follow-up|0|||
125083509|NCT01693562|449922817|FG005|Escalation Phase|Lost to Follow-up|0|||
125083510|NCT01693562|449922818|FG006|Escalation Phase|Lost to Follow-up|0|||
125083511|NCT01693562|449922819|FG007|Escalation Phase|Lost to Follow-up|0|||
125083512|NCT01693562|449922820|FG008|Escalation Phase|Lost to Follow-up|0|||
125083513|NCT01693562|449922821|FG009|Escalation Phase|Lost to Follow-up|0|||
125083514|NCT01693562|449922822|FG010|Escalation Phase|Lost to Follow-up|0|||
125083515|NCT01693562|449922823|FG011|Escalation Phase|Lost to Follow-up|0|||
125083516|NCT01693562|449922824|FG012|Escalation Phase|Lost to Follow-up|0|||
125083517|NCT01693562|449922825|FG013|Escalation Phase|Lost to Follow-up|0|||
125083518|NCT01693562|449922826|FG014|Escalation Phase|Lost to Follow-up|0|||
125083519|NCT01693562|449922827|FG015|Escalation Phase|Lost to Follow-up|0|||
125083520|NCT01693562|449922828|FG016|Escalation Phase|Lost to Follow-up|0|||
125083521|NCT01693562|449922829|FG017|Escalation Phase|Lost to Follow-up|0|||
125083522|NCT01693562|449922830|FG018|Escalation Phase|Lost to Follow-up|0|||
125083523|NCT01693562|449922831|FG019|Escalation Phase|Lost to Follow-up|0|||
125083524|NCT01693562|449922832|FG020|Escalation Phase|Lost to Follow-up|0|||
125083525|NCT01693562|449922833|FG021|Escalation Phase|Lost to Follow-up|0|||
125083526|NCT01693562|449922834|FG022|Escalation Phase|Lost to Follow-up|0|||
125083527|NCT01693562|449922812|FG000|Escalation Phase|Other|0|||
125083528|NCT01693562|449922813|FG001|Escalation Phase|Other|0|||
125083529|NCT01693562|449922814|FG002|Escalation Phase|Other|2|||
125083530|NCT01693562|449922815|FG003|Escalation Phase|Other|0|||
125083531|NCT01693562|449922816|FG004|Escalation Phase|Other|0|||
125083532|NCT01693562|449922817|FG005|Escalation Phase|Other|1|||
125083533|NCT01693562|449922818|FG006|Escalation Phase|Other|0|||
125083534|NCT01693562|449922819|FG007|Escalation Phase|Other|0|||
125145000|NCT01332968|450155929|FG005|Follow-Up Period|Death|0|||
125145001|NCT01332968|450155930|FG006|Follow-Up Period|Death|27|||
125145002|NCT01332968|450155931|FG007|Follow-Up Period|Death|30|||
125083535|NCT01693562|449922820|FG008|Escalation Phase|Other|0|||
125083536|NCT01693562|449922821|FG009|Escalation Phase|Other|0|||
125083537|NCT01693562|449922822|FG010|Escalation Phase|Other|0|||
125083538|NCT01693562|449922823|FG011|Escalation Phase|Other|0|||
125083539|NCT01693562|449922824|FG012|Escalation Phase|Other|0|||
125083540|NCT01693562|449922825|FG013|Escalation Phase|Other|0|||
125083541|NCT01693562|449922826|FG014|Escalation Phase|Other|0|||
125083542|NCT01693562|449922827|FG015|Escalation Phase|Other|0|||
125145003|NCT01332968|450155924|FG000|Follow-Up Period|Lost to Follow-up|0|||
125083543|NCT01693562|449922828|FG016|Escalation Phase|Other|0|||
125145004|NCT01332968|450155925|FG001|Follow-Up Period|Lost to Follow-up|0|||
125145005|NCT01332968|450155926|FG002|Follow-Up Period|Lost to Follow-up|0|||
125083544|NCT01693562|449922829|FG017|Escalation Phase|Other|0|||
125083545|NCT01693562|449922830|FG018|Escalation Phase|Other|0|||
125083546|NCT01693562|449922831|FG019|Escalation Phase|Other|0|||
125083547|NCT01693562|449922832|FG020|Escalation Phase|Other|0|||
125083548|NCT01693562|449922833|FG021|Escalation Phase|Other|0|||
125083549|NCT01693562|449922834|FG022|Escalation Phase|Other|0|||
125083550|NCT01693562|449922812|FG000|Exploration Phase|Withdrawal by Subject|0|||
125083551|NCT01693562|449922813|FG001|Exploration Phase|Withdrawal by Subject|0|||
125083552|NCT01693562|449922814|FG002|Exploration Phase|Withdrawal by Subject|0|||
125083553|NCT01693562|449922815|FG003|Exploration Phase|Withdrawal by Subject|0|||
125083554|NCT01693562|449922816|FG004|Exploration Phase|Withdrawal by Subject|0|||
125083555|NCT01693562|449922817|FG005|Exploration Phase|Withdrawal by Subject|0|||
125083556|NCT01693562|449922818|FG006|Exploration Phase|Withdrawal by Subject|2|||
125083557|NCT01693562|449922819|FG007|Exploration Phase|Withdrawal by Subject|0|||
125083558|NCT01693562|449922820|FG008|Exploration Phase|Withdrawal by Subject|0|||
125083559|NCT01693562|449922821|FG009|Exploration Phase|Withdrawal by Subject|0|||
125083560|NCT01693562|449922822|FG010|Exploration Phase|Withdrawal by Subject|0|||
125083561|NCT01693562|449922823|FG011|Exploration Phase|Withdrawal by Subject|0|||
125083562|NCT01693562|449922824|FG012|Exploration Phase|Withdrawal by Subject|0|||
125083563|NCT01693562|449922825|FG013|Exploration Phase|Withdrawal by Subject|0|||
125083564|NCT01693562|449922826|FG014|Exploration Phase|Withdrawal by Subject|0|||
125083565|NCT01693562|449922827|FG015|Exploration Phase|Withdrawal by Subject|0|||
125083566|NCT01693562|449922828|FG016|Exploration Phase|Withdrawal by Subject|0|||
125083567|NCT01693562|449922829|FG017|Exploration Phase|Withdrawal by Subject|0|||
125083568|NCT01693562|449922830|FG018|Exploration Phase|Withdrawal by Subject|0|||
125083569|NCT01693562|449922831|FG019|Exploration Phase|Withdrawal by Subject|0|||
125083570|NCT01693562|449922832|FG020|Exploration Phase|Withdrawal by Subject|0|||
125083571|NCT01693562|449922833|FG021|Exploration Phase|Withdrawal by Subject|0|||
125083572|NCT01693562|449922834|FG022|Exploration Phase|Withdrawal by Subject|0|||
125083573|NCT01693562|449922812|FG000|Exploration Phase|Death|0|||
125083574|NCT01693562|449922813|FG001|Exploration Phase|Death|0|||
125083575|NCT01693562|449922814|FG002|Exploration Phase|Death|0|||
125083576|NCT01693562|449922815|FG003|Exploration Phase|Death|0|||
125083577|NCT01693562|449922816|FG004|Exploration Phase|Death|0|||
125083578|NCT01693562|449922817|FG005|Exploration Phase|Death|0|||
125083579|NCT01693562|449922818|FG006|Exploration Phase|Death|17|||
125083580|NCT01693562|449922819|FG007|Exploration Phase|Death|0|||
125083581|NCT01693562|449922820|FG008|Exploration Phase|Death|0|||
125083582|NCT01693562|449922821|FG009|Exploration Phase|Death|0|||
125083583|NCT01693562|449922822|FG010|Exploration Phase|Death|0|||
125083584|NCT01693562|449922823|FG011|Exploration Phase|Death|0|||
125083585|NCT01693562|449922824|FG012|Exploration Phase|Death|0|||
125083586|NCT01693562|449922825|FG013|Exploration Phase|Death|0|||
125083587|NCT01693562|449922826|FG014|Exploration Phase|Death|0|||
125083588|NCT01693562|449922827|FG015|Exploration Phase|Death|0|||
125083589|NCT01693562|449922828|FG016|Exploration Phase|Death|0|||
125083590|NCT01693562|449922829|FG017|Exploration Phase|Death|0|||
125083591|NCT01693562|449922830|FG018|Exploration Phase|Death|0|||
125083592|NCT01693562|449922831|FG019|Exploration Phase|Death|0|||
125083593|NCT01693562|449922832|FG020|Exploration Phase|Death|0|||
125083594|NCT01693562|449922833|FG021|Exploration Phase|Death|0|||
125083595|NCT01693562|449922834|FG022|Exploration Phase|Death|0|||
125083596|NCT01693562|449922812|FG000|Exploration Phase|Other|0|||
125083597|NCT01693562|449922813|FG001|Exploration Phase|Other|0|||
125083598|NCT01693562|449922814|FG002|Exploration Phase|Other|0|||
125083599|NCT01693562|449922815|FG003|Exploration Phase|Other|0|||
125083600|NCT01693562|449922816|FG004|Exploration Phase|Other|0|||
125083601|NCT01693562|449922817|FG005|Exploration Phase|Other|0|||
125083602|NCT01693562|449922818|FG006|Exploration Phase|Other|2|||
125083603|NCT01693562|449922819|FG007|Exploration Phase|Other|0|||
125083604|NCT01693562|449922820|FG008|Exploration Phase|Other|0|||
125083605|NCT01693562|449922821|FG009|Exploration Phase|Other|0|||
125083606|NCT01693562|449922822|FG010|Exploration Phase|Other|0|||
125083607|NCT01693562|449922823|FG011|Exploration Phase|Other|0|||
125083608|NCT01693562|449922824|FG012|Exploration Phase|Other|0|||
125083609|NCT01693562|449922825|FG013|Exploration Phase|Other|0|||
125083610|NCT01693562|449922826|FG014|Exploration Phase|Other|0|||
125083611|NCT01693562|449922827|FG015|Exploration Phase|Other|0|||
125083612|NCT01693562|449922828|FG016|Exploration Phase|Other|0|||
125083613|NCT01693562|449922829|FG017|Exploration Phase|Other|0|||
125083614|NCT01693562|449922830|FG018|Exploration Phase|Other|0|||
125083615|NCT01693562|449922831|FG019|Exploration Phase|Other|0|||
125083616|NCT01693562|449922832|FG020|Exploration Phase|Other|0|||
125083617|NCT01693562|449922833|FG021|Exploration Phase|Other|0|||
125083618|NCT01693562|449922834|FG022|Exploration Phase|Other|0|||
125145006|NCT01332968|450155927|FG003|Follow-Up Period|Lost to Follow-up|0|||
125145007|NCT01332968|450155928|FG004|Follow-Up Period|Lost to Follow-up|0|||
125145008|NCT01332968|450155929|FG005|Follow-Up Period|Lost to Follow-up|0|||
125083619|NCT01693562|449922812|FG000|Expansion Phase|Withdrawal by Subject|0|||
125083620|NCT01693562|449922813|FG001|Expansion Phase|Withdrawal by Subject|0|||
125083621|NCT01693562|449922814|FG002|Expansion Phase|Withdrawal by Subject|0|||
125083622|NCT01693562|449922815|FG003|Expansion Phase|Withdrawal by Subject|0|||
125083623|NCT01693562|449922816|FG004|Expansion Phase|Withdrawal by Subject|0|||
125083624|NCT01693562|449922817|FG005|Expansion Phase|Withdrawal by Subject|0|||
125083625|NCT01693562|449922818|FG006|Expansion Phase|Withdrawal by Subject|0|||
125083626|NCT01693562|449922819|FG007|Expansion Phase|Withdrawal by Subject|16|||
125083627|NCT01693562|449922820|FG008|Expansion Phase|Withdrawal by Subject|2|||
125083628|NCT01693562|449922821|FG009|Expansion Phase|Withdrawal by Subject|54|||
125145009|NCT01332968|450155930|FG006|Follow-Up Period|Lost to Follow-up|11|||
125145010|NCT01332968|450155931|FG007|Follow-Up Period|Lost to Follow-up|15|||
125083629|NCT01693562|449922822|FG010|Expansion Phase|Withdrawal by Subject|2|||
125083630|NCT01693562|449922823|FG011|Expansion Phase|Withdrawal by Subject|2|||
125083631|NCT01693562|449922824|FG012|Expansion Phase|Withdrawal by Subject|3|||
125083632|NCT01693562|449922825|FG013|Expansion Phase|Withdrawal by Subject|5|||
125083633|NCT01693562|449922826|FG014|Expansion Phase|Withdrawal by Subject|16|||
125083634|NCT01693562|449922827|FG015|Expansion Phase|Withdrawal by Subject|7|||
125083635|NCT01693562|449922828|FG016|Expansion Phase|Withdrawal by Subject|40|||
125083636|NCT01693562|449922829|FG017|Expansion Phase|Withdrawal by Subject|4|||
125083637|NCT01693562|449922830|FG018|Expansion Phase|Withdrawal by Subject|8|||
125083638|NCT01693562|449922831|FG019|Expansion Phase|Withdrawal by Subject|3|||
125083639|NCT01693562|449922832|FG020|Expansion Phase|Withdrawal by Subject|1|||
125083640|NCT01693562|449922833|FG021|Expansion Phase|Withdrawal by Subject|8|||
125083641|NCT01693562|449922834|FG022|Expansion Phase|Withdrawal by Subject|1|||
125083642|NCT01693562|449922812|FG000|Expansion Phase|Death|0|||
125083643|NCT01693562|449922813|FG001|Expansion Phase|Death|0|||
125083644|NCT01693562|449922814|FG002|Expansion Phase|Death|0|||
125083645|NCT01693562|449922815|FG003|Expansion Phase|Death|0|||
125083646|NCT01693562|449922816|FG004|Expansion Phase|Death|0|||
125083647|NCT01693562|449922817|FG005|Expansion Phase|Death|0|||
125083648|NCT01693562|449922818|FG006|Expansion Phase|Death|0|||
125083649|NCT01693562|449922819|FG007|Expansion Phase|Death|42|||
125083650|NCT01693562|449922820|FG008|Expansion Phase|Death|17|||
125083651|NCT01693562|449922821|FG009|Expansion Phase|Death|208|||
125083652|NCT01693562|449922822|FG010|Expansion Phase|Death|30|||
125083653|NCT01693562|449922823|FG011|Expansion Phase|Death|8|||
125083654|NCT01693562|449922824|FG012|Expansion Phase|Death|19|||
125083655|NCT01693562|449922825|FG013|Expansion Phase|Death|42|||
125083656|NCT01693562|449922826|FG014|Expansion Phase|Death|23|||
125083657|NCT01693562|449922827|FG015|Expansion Phase|Death|23|||
125083658|NCT01693562|449922828|FG016|Expansion Phase|Death|128|||
125083659|NCT01693562|449922829|FG017|Expansion Phase|Death|16|||
125083660|NCT01693562|449922830|FG018|Expansion Phase|Death|36|||
125083661|NCT01693562|449922831|FG019|Expansion Phase|Death|16|||
125083662|NCT01693562|449922832|FG020|Expansion Phase|Death|17|||
125083663|NCT01693562|449922833|FG021|Expansion Phase|Death|35|||
125083664|NCT01693562|449922834|FG022|Expansion Phase|Death|7|||
125083665|NCT01693562|449922812|FG000|Expansion Phase|Lost to Follow-up|0|||
125083666|NCT01693562|449922813|FG001|Expansion Phase|Lost to Follow-up|0|||
125083667|NCT01693562|449922814|FG002|Expansion Phase|Lost to Follow-up|0|||
125083668|NCT01693562|449922815|FG003|Expansion Phase|Lost to Follow-up|0|||
125083669|NCT01693562|449922816|FG004|Expansion Phase|Lost to Follow-up|0|||
125083670|NCT01693562|449922817|FG005|Expansion Phase|Lost to Follow-up|0|||
125083671|NCT01693562|449922818|FG006|Expansion Phase|Lost to Follow-up|0|||
125083672|NCT01693562|449922819|FG007|Expansion Phase|Lost to Follow-up|1|||
125083673|NCT01693562|449922820|FG008|Expansion Phase|Lost to Follow-up|2|||
125083674|NCT01693562|449922821|FG009|Expansion Phase|Lost to Follow-up|10|||
125083675|NCT01693562|449922822|FG010|Expansion Phase|Lost to Follow-up|4|||
125083676|NCT01693562|449922823|FG011|Expansion Phase|Lost to Follow-up|4|||
125083677|NCT01693562|449922824|FG012|Expansion Phase|Lost to Follow-up|1|||
125083678|NCT01693562|449922825|FG013|Expansion Phase|Lost to Follow-up|3|||
125083679|NCT01693562|449922826|FG014|Expansion Phase|Lost to Follow-up|0|||
125083680|NCT01693562|449922827|FG015|Expansion Phase|Lost to Follow-up|1|||
125083681|NCT01693562|449922828|FG016|Expansion Phase|Lost to Follow-up|1|||
125083682|NCT01693562|449922829|FG017|Expansion Phase|Lost to Follow-up|0|||
125083683|NCT01693562|449922830|FG018|Expansion Phase|Lost to Follow-up|2|||
125083684|NCT01693562|449922831|FG019|Expansion Phase|Lost to Follow-up|1|||
125083685|NCT01693562|449922832|FG020|Expansion Phase|Lost to Follow-up|2|||
125083686|NCT01693562|449922833|FG021|Expansion Phase|Lost to Follow-up|2|||
125083687|NCT01693562|449922834|FG022|Expansion Phase|Lost to Follow-up|1|||
125083688|NCT01693562|449922812|FG000|Expansion Phase|Other|0|||
125083689|NCT01693562|449922813|FG001|Expansion Phase|Other|0|||
125083690|NCT01693562|449922814|FG002|Expansion Phase|Other|0|||
125083691|NCT01693562|449922815|FG003|Expansion Phase|Other|0|||
125083692|NCT01693562|449922816|FG004|Expansion Phase|Other|0|||
125083693|NCT01693562|449922817|FG005|Expansion Phase|Other|0|||
125083694|NCT01693562|449922818|FG006|Expansion Phase|Other|0|||
125083695|NCT01693562|449922819|FG007|Expansion Phase|Other|3|||
125083696|NCT01693562|449922820|FG008|Expansion Phase|Other|1|||
125083697|NCT01693562|449922821|FG009|Expansion Phase|Other|28|||
125083698|NCT01693562|449922822|FG010|Expansion Phase|Other|4|||
125083699|NCT01693562|449922823|FG011|Expansion Phase|Other|7|||
125083700|NCT01693562|449922824|FG012|Expansion Phase|Other|0|||
125083701|NCT01693562|449922825|FG013|Expansion Phase|Other|1|||
125083702|NCT01693562|449922826|FG014|Expansion Phase|Other|1|||
125083703|NCT01693562|449922827|FG015|Expansion Phase|Other|0|||
125083704|NCT01693562|449922828|FG016|Expansion Phase|Other|28|||
125083705|NCT01693562|449922829|FG017|Expansion Phase|Other|0|||
125083706|NCT01693562|449922830|FG018|Expansion Phase|Other|1|||
125083707|NCT01693562|449922831|FG019|Expansion Phase|Other|0|||
125083708|NCT01693562|449922832|FG020|Expansion Phase|Other|1|||
125083709|NCT01693562|449922833|FG021|Expansion Phase|Other|17|||
125083710|NCT01693562|449922834|FG022|Expansion Phase|Other|1|||
125083711|NCT05815758|449922839|FG000|Overall Study|Adverse Event|6|||
125083712|NCT05815758|449922840|FG001|Overall Study|Adverse Event|2|||
125083713|NCT05815758|449922839|FG000|Overall Study|Lost to Follow-up|14|||
125083714|NCT05815758|449922840|FG001|Overall Study|Lost to Follow-up|1|||
125083715|NCT05815758|449922839|FG000|Overall Study|Withdrawal by Subject|6|||
125083716|NCT05815758|449922840|FG001|Overall Study|Withdrawal by Subject|6|||
125083717|NCT05815758|449922839|FG000|Overall Study|Protocol Violation|1|||
125083718|NCT05815758|449922840|FG001|Overall Study|Protocol Violation|1|||
125083719|NCT05815758|449922839|FG000|Overall Study|Discontinued|4|||
125083720|NCT05815758|449922840|FG001|Overall Study|Discontinued|4|||
125083721|NCT02987205|449922841|FG000|Overall Study|Adverse Event|1|||
125083722|NCT02987205|449922841|FG000|Overall Study|Withdrawal by Subject|3|||
125083723|NCT04167514|449922846|FG000|Overall Study|Adverse event, not serious|0|||
125083724|NCT04167514|449922847|FG001|Overall Study|Adverse event, not serious|1|||
125083725|NCT04167514|449922846|FG000|Overall Study|Lost to Follow-up|1|||
125083726|NCT04167514|449922847|FG001|Overall Study|Lost to Follow-up|0|||
125083727|NCT04167514|449922846|FG000|Overall Study|Participant Decision|2|||
125083728|NCT04167514|449922847|FG001|Overall Study|Participant Decision|4|||
125083729|NCT04167514|449922846|FG000|Overall Study|Physician Decision|3|||
125083730|NCT04167514|449922847|FG001|Overall Study|Physician Decision|2|||
125083731|NCT04167514|449922846|FG000|Overall Study|Death|14|||
125083732|NCT04167514|449922847|FG001|Overall Study|Death|18|||
125083733|NCT04167514|449922846|FG000|Overall Study|Enrolled but treatment not administered|2|||
125083734|NCT04167514|449922847|FG001|Overall Study|Enrolled but treatment not administered|0|||
125083735|NCT04167514|449922846|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
125083736|NCT04167514|449922847|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
125083737|NCT04167514|449922846|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
125083738|NCT04167514|449922847|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
125083739|NCT03991936|449922848|FG000|Overall Study|Lost to Follow-up|1|||
125083740|NCT03991936|449922849|FG001|Overall Study|Lost to Follow-up|1|||
125083741|NCT03991936|449922850|FG002|Overall Study|Lost to Follow-up|1|||
125083742|NCT03991936|449922851|FG003|Overall Study|Lost to Follow-up|1|||
125083743|NCT03991936|449922852|FG004|Overall Study|Lost to Follow-up|1|||
125083744|NCT00939055|449922853|FG000|Overall Study|Discontinuation prior to procedure|4|||
125083745|NCT00939055|449922854|FG001|Overall Study|Discontinuation prior to procedure|0|||
125083746|NCT00584987|449922857|FG000|Overall Study|Protocol Violation|1|||
125083747|NCT00584987|449922858|FG001|Overall Study|Protocol Violation|1|||
125083748|NCT00584987|449922859|FG002|Overall Study|Protocol Violation|1|||
125083749|NCT00584987|449922860|FG003|Overall Study|Protocol Violation|0|||
125083750|NCT00584987|449922857|FG000|Overall Study|Adverse Event|0|||
125083751|NCT00584987|449922858|FG001|Overall Study|Adverse Event|0|||
125083752|NCT00584987|449922859|FG002|Overall Study|Adverse Event|0|||
125083753|NCT00584987|449922860|FG003|Overall Study|Adverse Event|1|||
125083754|NCT02881151|449922861|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
125083755|NCT03225833|449922862|FG000|Overall Study|Adverse Event|0|||
125083756|NCT03225833|449922863|FG001|Overall Study|Adverse Event|1|||
125083757|NCT03225833|449922864|FG002|Overall Study|Adverse Event|2|||
125083758|NCT03225833|449922865|FG003|Overall Study|Adverse Event|0|||
125083759|NCT03225833|449922866|FG004|Overall Study|Adverse Event|0|||
125083760|NCT03225833|449922867|FG005|Overall Study|Adverse Event|2|||
125083761|NCT03225833|449922862|FG000|Overall Study|Withdrawal by Subject|1|||
125083762|NCT03225833|449922863|FG001|Overall Study|Withdrawal by Subject|0|||
125083763|NCT03225833|449922864|FG002|Overall Study|Withdrawal by Subject|0|||
125083764|NCT03225833|449922865|FG003|Overall Study|Withdrawal by Subject|0|||
125083765|NCT03225833|449922866|FG004|Overall Study|Withdrawal by Subject|1|||
125083766|NCT03225833|449922867|FG005|Overall Study|Withdrawal by Subject|0|||
125083767|NCT03225833|449922862|FG000|Overall Study|Termination of Study by Sponsor|4|||
125083768|NCT03225833|449922863|FG001|Overall Study|Termination of Study by Sponsor|0|||
125083769|NCT03225833|449922864|FG002|Overall Study|Termination of Study by Sponsor|0|||
125083770|NCT03225833|449922865|FG003|Overall Study|Termination of Study by Sponsor|0|||
125083771|NCT03225833|449922866|FG004|Overall Study|Termination of Study by Sponsor|0|||
125083772|NCT03225833|449922867|FG005|Overall Study|Termination of Study by Sponsor|7|||
125083773|NCT03225833|449922862|FG000|Overall Study|Sponsor Decision|0|||
125083774|NCT03225833|449922863|FG001|Overall Study|Sponsor Decision|0|||
125083775|NCT03225833|449922864|FG002|Overall Study|Sponsor Decision|0|||
125083776|NCT03225833|449922865|FG003|Overall Study|Sponsor Decision|0|||
125083777|NCT03225833|449922866|FG004|Overall Study|Sponsor Decision|0|||
125083778|NCT03225833|449922867|FG005|Overall Study|Sponsor Decision|1|||
125083779|NCT03258593|449922868|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
125083780|NCT03258593|449922869|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
125083781|NCT03258593|449922870|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
125083782|NCT03258593|449922871|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
125083783|NCT03258593|449922868|FG000|Run-In Maintenance Phase|Disease progression|3|||
125083784|NCT03258593|449922869|FG001|Run-In Maintenance Phase|Disease progression|0|||
125083785|NCT03258593|449922870|FG002|Run-In Maintenance Phase|Disease progression|0|||
125083786|NCT03258593|449922871|FG003|Run-In Maintenance Phase|Disease progression|0|||
125083787|NCT03258593|449922868|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
125083788|NCT03258593|449922869|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
125083789|NCT03258593|449922870|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
125083790|NCT03258593|449922871|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
125083791|NCT03258593|449922868|FG000|Expansion Maintenance Phase|Physician Decision|0|||
125083792|NCT03258593|449922869|FG001|Expansion Maintenance Phase|Physician Decision|1|||
125083793|NCT03258593|449922870|FG002|Expansion Maintenance Phase|Physician Decision|0|||
125083794|NCT03258593|449922871|FG003|Expansion Maintenance Phase|Physician Decision|0|||
125083795|NCT05318183|449922872|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
125083796|NCT05318183|449922873|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
125083797|NCT05318183|449922872|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
125083798|NCT05318183|449922873|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
125083799|NCT01263470|449922888|FG000|Overall Study|Adverse Event|2|||
125083800|NCT01263470|449922889|FG001|Overall Study|Adverse Event|2|||
125083801|NCT01263470|449922890|FG002|Overall Study|Adverse Event|1|||
125083802|NCT01263470|449922891|FG003|Overall Study|Adverse Event|1|||
125145011|NCT01332968|450155924|FG000|Follow-Up Period|Non-compliance|0|||
125145012|NCT01332968|450155925|FG001|Follow-Up Period|Non-compliance|0|||
125083803|NCT01263470|449922892|FG004|Overall Study|Adverse Event|2|||
125083804|NCT01263470|449922893|FG005|Overall Study|Adverse Event|2|||
125083805|NCT01263470|449922888|FG000|Overall Study|Protocol Violation|0|||
125083806|NCT01263470|449922889|FG001|Overall Study|Protocol Violation|1|||
125083807|NCT01263470|449922890|FG002|Overall Study|Protocol Violation|0|||
125083808|NCT01263470|449922891|FG003|Overall Study|Protocol Violation|0|||
125083809|NCT01263470|449922892|FG004|Overall Study|Protocol Violation|0|||
125083810|NCT01263470|449922893|FG005|Overall Study|Protocol Violation|1|||
125083811|NCT01263470|449922888|FG000|Overall Study|Withdrawal by Subject|0|||
125145013|NCT01332968|450155926|FG002|Follow-Up Period|Non-compliance|0|||
125083812|NCT01263470|449922889|FG001|Overall Study|Withdrawal by Subject|1|||
125083813|NCT01263470|449922890|FG002|Overall Study|Withdrawal by Subject|1|||
125083814|NCT01263470|449922891|FG003|Overall Study|Withdrawal by Subject|2|||
125145014|NCT01332968|450155927|FG003|Follow-Up Period|Non-compliance|0|||
125145015|NCT01332968|450155928|FG004|Follow-Up Period|Non-compliance|0|||
125083815|NCT01263470|449922892|FG004|Overall Study|Withdrawal by Subject|0|||
125083816|NCT01263470|449922893|FG005|Overall Study|Withdrawal by Subject|2|||
125083817|NCT01263470|449922888|FG000|Overall Study|Lack of Efficacy|0|||
125083818|NCT01263470|449922889|FG001|Overall Study|Lack of Efficacy|0|||
125083819|NCT01263470|449922890|FG002|Overall Study|Lack of Efficacy|2|||
125083820|NCT01263470|449922891|FG003|Overall Study|Lack of Efficacy|0|||
125083821|NCT01263470|449922892|FG004|Overall Study|Lack of Efficacy|0|||
125083822|NCT01263470|449922893|FG005|Overall Study|Lack of Efficacy|0|||
125083823|NCT01263470|449922888|FG000|Overall Study|Participant Unavailability|0|||
125083824|NCT01263470|449922889|FG001|Overall Study|Participant Unavailability|1|||
125083825|NCT01263470|449922890|FG002|Overall Study|Participant Unavailability|0|||
125083826|NCT01263470|449922891|FG003|Overall Study|Participant Unavailability|0|||
125083827|NCT01263470|449922892|FG004|Overall Study|Participant Unavailability|0|||
125083828|NCT01263470|449922893|FG005|Overall Study|Participant Unavailability|0|||
125083829|NCT01263470|449922888|FG000|Overall Study|Study Drug Non-compliance|0|||
125083830|NCT01263470|449922889|FG001|Overall Study|Study Drug Non-compliance|0|||
125083831|NCT01263470|449922890|FG002|Overall Study|Study Drug Non-compliance|0|||
125083832|NCT01263470|449922891|FG003|Overall Study|Study Drug Non-compliance|0|||
125083833|NCT01263470|449922892|FG004|Overall Study|Study Drug Non-compliance|1|||
125083834|NCT01263470|449922893|FG005|Overall Study|Study Drug Non-compliance|0|||
125083835|NCT00610714|449922894|FG000|Overall Study|Adverse Event|3|||
125083836|NCT00610714|449922895|FG001|Overall Study|Adverse Event|1|||
125083837|NCT00610714|449922894|FG000|Overall Study|Death|12|||
125083838|NCT00610714|449922895|FG001|Overall Study|Death|18|||
125083839|NCT00610714|449922894|FG000|Overall Study|Withdrawal by Subject|9|||
125083840|NCT00610714|449922895|FG001|Overall Study|Withdrawal by Subject|3|||
125083841|NCT00610714|449922894|FG000|Overall Study|Study completion at 120 PFS events|2|||
125083842|NCT00610714|449922895|FG001|Overall Study|Study completion at 120 PFS events|2|||
125083843|NCT01327573|449922896|FG000|Overall Study|Physician Decision|3|||
125083844|NCT01327573|449922897|FG001|Overall Study|Physician Decision|1|||
125083845|NCT00712712|449922898|FG000|Overall Study|Protocol Violation|11|||
125083846|NCT00712712|449922898|FG000|Overall Study|Radiofrequency not done|3|||
125083847|NCT00712712|449922898|FG000|Overall Study|Death|8|||
125083848|NCT00712712|449922898|FG000|Overall Study|Withdrawal by Subject|1|||
125083849|NCT01058395|449922902|FG000|Overall Study|Death|2|||
125083850|NCT01058395|449922903|FG001|Overall Study|Death|1|||
125083851|NCT01058395|449922902|FG000|Overall Study|Lost to Follow-up|1|||
125083852|NCT01058395|449922903|FG001|Overall Study|Lost to Follow-up|0|||
125083853|NCT04083781|449922904|FG000|Main Part|Physician Decision|0|||
125083854|NCT04083781|449922905|FG001|Main Part|Physician Decision|1|||
125083855|NCT04083781|449922906|FG002|Main Part|Physician Decision|2|||
125083856|NCT04083781|449922907|FG003|Main Part|Physician Decision|0|||
125083857|NCT04083781|449922904|FG000|Main Part|Death|1|||
125083858|NCT04083781|449922905|FG001|Main Part|Death|3|||
125083859|NCT04083781|449922906|FG002|Main Part|Death|1|||
125083860|NCT04083781|449922907|FG003|Main Part|Death|0|||
125083861|NCT04083781|449922904|FG000|Main Part|Withdrawal by Subject|5|||
125083862|NCT04083781|449922905|FG001|Main Part|Withdrawal by Subject|2|||
125083863|NCT04083781|449922906|FG002|Main Part|Withdrawal by Subject|3|||
125083864|NCT04083781|449922907|FG003|Main Part|Withdrawal by Subject|7|||
125083865|NCT04083781|449922904|FG000|Extension Part|Physician Decision|0|||
125083866|NCT04083781|449922905|FG001|Extension Part|Physician Decision|0|||
125083867|NCT04083781|449922906|FG002|Extension Part|Physician Decision|0|||
125083868|NCT04083781|449922907|FG003|Extension Part|Physician Decision|1|||
125223536|NCT02326272|450446165|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
125223537|NCT02326272|450446166|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
125223538|NCT02326272|450446167|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
125083869|NCT04083781|449922904|FG000|Extension Part|Death|0|||
125083870|NCT04083781|449922905|FG001|Extension Part|Death|1|||
125083871|NCT04083781|449922906|FG002|Extension Part|Death|0|||
125083872|NCT04083781|449922907|FG003|Extension Part|Death|1|||
125083873|NCT04083781|449922904|FG000|Extension Part|Withdrawal by Subject|0|||
125083874|NCT04083781|449922905|FG001|Extension Part|Withdrawal by Subject|1|||
125083875|NCT04083781|449922906|FG002|Extension Part|Withdrawal by Subject|0|||
125083876|NCT04083781|449922907|FG003|Extension Part|Withdrawal by Subject|0|||
125083877|NCT04083781|449922904|FG000|Extension Part|Ongoing|13|||
125083878|NCT04083781|449922905|FG001|Extension Part|Ongoing|25|||
125083879|NCT04083781|449922906|FG002|Extension Part|Ongoing|15|||
125083880|NCT04083781|449922907|FG003|Extension Part|Ongoing|51|||
125083881|NCT01602822|449922916|FG000|Overall Study|Adverse Event|11|||
125083882|NCT05492877|449922917|FG000|Overall Study|Adverse Event|11|||
125083883|NCT05492877|449922918|FG001|Overall Study|Adverse Event|7|||
125083884|NCT05492877|449922917|FG000|Overall Study|Death|1|||
125083885|NCT05492877|449922918|FG001|Overall Study|Death|0|||
125083886|NCT05492877|449922917|FG000|Overall Study|Lost to Follow-up|1|||
125083887|NCT05492877|449922918|FG001|Overall Study|Lost to Follow-up|1|||
125083888|NCT05492877|449922917|FG000|Overall Study|Physician Decision|1|||
125083889|NCT05492877|449922918|FG001|Overall Study|Physician Decision|2|||
125083890|NCT05492877|449922917|FG000|Overall Study|Protocol Violation|1|||
125083891|NCT05492877|449922918|FG001|Overall Study|Protocol Violation|1|||
125083892|NCT05492877|449922917|FG000|Overall Study|Withdrawal by Subject|3|||
125083893|NCT05492877|449922918|FG001|Overall Study|Withdrawal by Subject|7|||
125083894|NCT05492877|449922917|FG000|Overall Study|Reason not specified|6|||
125083895|NCT05492877|449922918|FG001|Overall Study|Reason not specified|4|||
125083896|NCT05333289|449922927|FG000|Overall Study|Other|1|||
125083897|NCT05333289|449922928|FG001|Overall Study|Other|0|||
125083898|NCT05333289|449922929|FG002|Overall Study|Other|0|||
125083899|NCT05333289|449922930|FG003|Overall Study|Other|1|||
125083900|NCT05333289|449922931|FG004|Overall Study|Other|1|||
125083901|NCT05333289|449922932|FG005|Overall Study|Other|2|||
125083902|NCT05333289|449922933|FG006|Overall Study|Other|2|||
125083903|NCT05333289|449922934|FG007|Overall Study|Other|0|||
125083904|NCT05333289|449922927|FG000|Overall Study|Withdrawal by Subject|1|||
125083905|NCT05333289|449922928|FG001|Overall Study|Withdrawal by Subject|2|||
125083906|NCT05333289|449922929|FG002|Overall Study|Withdrawal by Subject|2|||
125083907|NCT05333289|449922930|FG003|Overall Study|Withdrawal by Subject|1|||
125083908|NCT05333289|449922931|FG004|Overall Study|Withdrawal by Subject|1|||
125083909|NCT05333289|449922932|FG005|Overall Study|Withdrawal by Subject|2|||
125083910|NCT05333289|449922933|FG006|Overall Study|Withdrawal by Subject|1|||
125083911|NCT05333289|449922934|FG007|Overall Study|Withdrawal by Subject|3|||
125083912|NCT05333289|449922927|FG000|Overall Study|Protocol Violation|1|||
125083913|NCT05333289|449922928|FG001|Overall Study|Protocol Violation|0|||
125083914|NCT05333289|449922929|FG002|Overall Study|Protocol Violation|0|||
125083915|NCT05333289|449922930|FG003|Overall Study|Protocol Violation|0|||
125083916|NCT05333289|449922931|FG004|Overall Study|Protocol Violation|0|||
125083917|NCT05333289|449922932|FG005|Overall Study|Protocol Violation|0|||
125083918|NCT05333289|449922933|FG006|Overall Study|Protocol Violation|0|||
125083919|NCT05333289|449922934|FG007|Overall Study|Protocol Violation|0|||
125083920|NCT05333289|449922927|FG000|Overall Study|Physician Decision|0|||
125083921|NCT05333289|449922928|FG001|Overall Study|Physician Decision|0|||
125083922|NCT05333289|449922929|FG002|Overall Study|Physician Decision|1|||
125083923|NCT05333289|449922930|FG003|Overall Study|Physician Decision|0|||
125083924|NCT05333289|449922931|FG004|Overall Study|Physician Decision|0|||
125083925|NCT05333289|449922932|FG005|Overall Study|Physician Decision|2|||
125083926|NCT05333289|449922933|FG006|Overall Study|Physician Decision|0|||
125083927|NCT05333289|449922934|FG007|Overall Study|Physician Decision|0|||
125083928|NCT05333289|449922927|FG000|Overall Study|Lost to Follow-up|6|||
125083929|NCT05333289|449922928|FG001|Overall Study|Lost to Follow-up|0|||
125083930|NCT05333289|449922929|FG002|Overall Study|Lost to Follow-up|1|||
125083931|NCT05333289|449922930|FG003|Overall Study|Lost to Follow-up|6|||
125083932|NCT05333289|449922931|FG004|Overall Study|Lost to Follow-up|3|||
125083933|NCT05333289|449922932|FG005|Overall Study|Lost to Follow-up|3|||
125083934|NCT05333289|449922933|FG006|Overall Study|Lost to Follow-up|2|||
125083935|NCT05333289|449922934|FG007|Overall Study|Lost to Follow-up|1|||
125083936|NCT05333289|449922927|FG000|Overall Study|Death|1|||
125083937|NCT05333289|449922928|FG001|Overall Study|Death|0|||
125083938|NCT05333289|449922929|FG002|Overall Study|Death|0|||
125083939|NCT05333289|449922930|FG003|Overall Study|Death|0|||
125083940|NCT05333289|449922931|FG004|Overall Study|Death|0|||
125083941|NCT05333289|449922932|FG005|Overall Study|Death|0|||
125083942|NCT05333289|449922933|FG006|Overall Study|Death|0|||
125083943|NCT05333289|449922934|FG007|Overall Study|Death|0|||
125083944|NCT04476108|449922935|FG000|Overall Study|Adverse Event|4|||
125083945|NCT04476108|449922936|FG001|Overall Study|Adverse Event|1|||
125083946|NCT04476108|449922935|FG000|Overall Study|Lost to Follow-up|1|||
125083947|NCT04476108|449922936|FG001|Overall Study|Lost to Follow-up|0|||
125083948|NCT04476108|449922935|FG000|Overall Study|Inadvertent Enrollment|1|||
125083949|NCT04476108|449922936|FG001|Overall Study|Inadvertent Enrollment|0|||
125083950|NCT04476108|449922935|FG000|Overall Study|Protocol Violation|1|||
125083951|NCT04476108|449922936|FG001|Overall Study|Protocol Violation|1|||
125083952|NCT04476108|449922935|FG000|Overall Study|Withdrawal by Subject|1|||
125083953|NCT04476108|449922936|FG001|Overall Study|Withdrawal by Subject|1|||
125083954|NCT02253992|449922937|FG000|Overall Study|Study drug toxicity|1|||
125083955|NCT02253992|449922938|FG001|Overall Study|Study drug toxicity|0|||
125083956|NCT02253992|449922939|FG002|Overall Study|Study drug toxicity|10|||
125083957|NCT02253992|449922937|FG000|Overall Study|Disease progression|4|||
125083958|NCT02253992|449922938|FG001|Overall Study|Disease progression|3|||
125083959|NCT02253992|449922939|FG002|Overall Study|Disease progression|98|||
125083960|NCT02253992|449922937|FG000|Overall Study|Withdrawal by Subject|0|||
125083961|NCT02253992|449922938|FG001|Overall Study|Withdrawal by Subject|0|||
125083962|NCT02253992|449922939|FG002|Overall Study|Withdrawal by Subject|3|||
125083963|NCT02253992|449922937|FG000|Overall Study|Adverse Event|0|||
125083964|NCT02253992|449922938|FG001|Overall Study|Adverse Event|0|||
125083965|NCT02253992|449922939|FG002|Overall Study|Adverse Event|8|||
125083966|NCT02253992|449922937|FG000|Overall Study|Death|0|||
125083967|NCT02253992|449922938|FG001|Overall Study|Death|0|||
125083968|NCT02253992|449922939|FG002|Overall Study|Death|1|||
125083969|NCT02253992|449922937|FG000|Overall Study|Subject discontinued study drug|1|||
125083970|NCT02253992|449922938|FG001|Overall Study|Subject discontinued study drug|0|||
125083971|NCT02253992|449922939|FG002|Overall Study|Subject discontinued study drug|1|||
125083972|NCT02253992|449922937|FG000|Overall Study|Completed treatment as per protocol|0|||
125083973|NCT02253992|449922938|FG001|Overall Study|Completed treatment as per protocol|1|||
125083974|NCT02253992|449922939|FG002|Overall Study|Completed treatment as per protocol|22|||
125083975|NCT02253992|449922937|FG000|Overall Study|Other|0|||
125083976|NCT02253992|449922938|FG001|Overall Study|Other|0|||
125083977|NCT02253992|449922939|FG002|Overall Study|Other|1|||
125083978|NCT00772889|449922940|FG000|Overall Study|Adverse Event|7|||
125083979|NCT00772889|449922941|FG001|Overall Study|Adverse Event|4|||
125083980|NCT00772889|449922942|FG002|Overall Study|Adverse Event|0|||
125083981|NCT00772889|449922940|FG000|Overall Study|Withdrawal by Subject|9|||
125083982|NCT00772889|449922941|FG001|Overall Study|Withdrawal by Subject|8|||
125083983|NCT00772889|449922942|FG002|Overall Study|Withdrawal by Subject|9|||
125083984|NCT00772889|449922940|FG000|Overall Study|Lost to Follow-up|6|||
125083985|NCT00772889|449922941|FG001|Overall Study|Lost to Follow-up|6|||
125083986|NCT00772889|449922942|FG002|Overall Study|Lost to Follow-up|7|||
125083987|NCT03323086|449922943|FG000|Overall Study|Lost to Follow-up|3|||
125083988|NCT03323086|449922944|FG001|Overall Study|Lost to Follow-up|2|||
125083989|NCT00355615|449922945|FG000|Randomized Double Blind Period|Adverse Event|1|||
125083990|NCT00355615|449922946|FG001|Randomized Double Blind Period|Adverse Event|0|||
125083991|NCT00355615|449922947|FG002|Randomized Double Blind Period|Adverse Event|0|||
125083992|NCT00355615|449922948|FG003|Randomized Double Blind Period|Adverse Event|0|||
125083993|NCT00355615|449922949|FG004|Randomized Double Blind Period|Adverse Event|0|||
125083994|NCT00355615|449922945|FG000|Randomized Double Blind Period|Protocol Violation|0|||
125083995|NCT00355615|449922946|FG001|Randomized Double Blind Period|Protocol Violation|0|||
125083996|NCT00355615|449922947|FG002|Randomized Double Blind Period|Protocol Violation|1|||
125083997|NCT00355615|449922948|FG003|Randomized Double Blind Period|Protocol Violation|1|||
125083998|NCT00355615|449922949|FG004|Randomized Double Blind Period|Protocol Violation|0|||
125083999|NCT00355615|449922945|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
125084000|NCT00355615|449922946|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
125084001|NCT00355615|449922947|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
125084002|NCT00355615|449922948|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
125084003|NCT00355615|449922949|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
125084004|NCT00355615|449922945|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
125084005|NCT00355615|449922946|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
125084006|NCT00355615|449922947|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
125084007|NCT00355615|449922948|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
125084008|NCT00355615|449922949|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
125084009|NCT00355615|449922945|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
125084010|NCT00355615|449922946|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
125084011|NCT00355615|449922947|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
125084012|NCT00355615|449922948|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
125084013|NCT00355615|449922949|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
125084014|NCT00355615|449922945|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
125084015|NCT00355615|449922946|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
125084016|NCT00355615|449922947|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
125084017|NCT00355615|449922948|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
125084018|NCT00355615|449922949|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
125084019|NCT03685643|449922953|FG000|Overall Study|Lost to Follow-up|14|||
125084020|NCT03685643|449922954|FG001|Overall Study|Lost to Follow-up|22|||
125084021|NCT02159365|449922955|FG000|Overall Study|Disease Progression|23|||
125084022|NCT02159365|449922955|FG000|Overall Study|Other reasons|11|||
125084023|NCT02159365|449922955|FG000|Overall Study|Administrative reason by Sponsor|9|||
125084024|NCT02159365|449922955|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
125084025|NCT02159365|449922955|FG000|Overall Study|Study drug toxicity|7|||
125084026|NCT02159365|449922955|FG000|Overall Study|Maximum clinical benefit|3|||
125084027|NCT02159365|449922955|FG000|Overall Study|Subject request to discontinue treatment|3|||
125084028|NCT02159365|449922955|FG000|Overall Study|Subject withdrew consent|3|||
125084029|NCT02159365|449922955|FG000|Overall Study|Death|1|||
125084030|NCT02159365|449922955|FG000|Overall Study|Lost to Follow-up|1|||
125084031|NCT03523715|449922956|FG000|Overall Study|Lost to Follow-up|11|||
125084032|NCT03523715|449922957|FG001|Overall Study|Lost to Follow-up|14|||
125084033|NCT03523715|449922956|FG000|Overall Study|Did not meet inclusion criteria|1|||
125084034|NCT03523715|449922957|FG001|Overall Study|Did not meet inclusion criteria|0|||
125084035|NCT03523715|449922956|FG000|Overall Study|Internally inconsistent reporting|0|||
125084036|NCT03523715|449922957|FG001|Overall Study|Internally inconsistent reporting|2|||
125084037|NCT04430036|449922958|FG000|Safety Run in Phase|Progression of disease|2|||
125084038|NCT01842334|449922959|FG000|Overall Study|Withdrawal by Subject|3|||
125084039|NCT01842334|449922960|FG001|Overall Study|Withdrawal by Subject|3|||
125084040|NCT01842334|449922959|FG000|Overall Study|Moved away mid-study|0|||
125084041|NCT01842334|449922960|FG001|Overall Study|Moved away mid-study|1|||
125084042|NCT01885104|449922964|FG000|Overall Study|Withdrawal of Consent|1|||
125084043|NCT01885104|449922965|FG001|Overall Study|Withdrawal of Consent|0|||
125084044|NCT01885104|449922964|FG000|Overall Study|Lost to Follow-up|0|||
125084045|NCT01885104|449922965|FG001|Overall Study|Lost to Follow-up|1|||
125084046|NCT01885104|449922964|FG000|Overall Study|Physician Decision|1|||
125084047|NCT01885104|449922965|FG001|Overall Study|Physician Decision|0|||
125084048|NCT00113555|449922967|FG000|Overall Study|Baseline Failure|59|||
125084049|NCT00113555|449922967|FG000|Overall Study|Permanently Explanted|7|||
125084050|NCT00113555|449922967|FG000|Overall Study|Death|1|||
125084051|NCT00113555|449922967|FG000|Overall Study|Missed Followup|4|||
125084052|NCT00113555|449922967|FG000|Overall Study|Lost to Follow-up|8|||
125084053|NCT01060124|449922968|FG000|Overall Study|Other|16|||
125084054|NCT01060124|449922968|FG000|Overall Study|Adverse Event|14|||
125084055|NCT01060124|449922968|FG000|Overall Study|Withdrawal by Subject|7|||
125084056|NCT03858686|449922976|FG000|Period 1|Adverse Event|1|||
125084057|NCT03858686|449922977|FG001|Period 1|Adverse Event|1|||
125084058|NCT03858686|449922976|FG000|Period 1|Lack of compliance|0|||
125084059|NCT03858686|449922977|FG001|Period 1|Lack of compliance|1|||
125084060|NCT03858686|449922976|FG000|Period 1|Adverse Event|0|||
125084061|NCT03858686|449922977|FG001|Period 1|Adverse Event|1|||
125084062|NCT03858686|449922976|FG000|Period 2|Adverse Event|0|||
125084063|NCT03858686|449922977|FG001|Period 2|Adverse Event|1|||
125084064|NCT01432938|449922978|FG000|First Intervention|Protocol Violation|1|||
125084065|NCT01432938|449922979|FG001|First Intervention|Protocol Violation|0|||
125084066|NCT01432938|449922978|FG000|First Intervention|Physician Decision|1|||
125084067|NCT01432938|449922979|FG001|First Intervention|Physician Decision|0|||
125084068|NCT01432938|449922978|FG000|Second Intervention|Adverse Event|1|||
125084069|NCT01432938|449922979|FG001|Second Intervention|Adverse Event|0|||
125084070|NCT04191096|449922981|FG000|Overall Study|Death|102|||
125084071|NCT04191096|449922982|FG001|Overall Study|Death|89|||
125084072|NCT04191096|449922981|FG000|Overall Study|Lost to Follow-up|1|||
125084073|NCT04191096|449922982|FG001|Overall Study|Lost to Follow-up|1|||
125084074|NCT04191096|449922981|FG000|Overall Study|Withdrawal by Subject|5|||
125084075|NCT04191096|449922982|FG001|Overall Study|Withdrawal by Subject|5|||
125084076|NCT04191096|449922981|FG000|Overall Study|Participants Ongoing|518|||
125084077|NCT04191096|449922982|FG001|Overall Study|Participants Ongoing|530|||
125084078|NCT02683668|449922984|FG000|Period 2|Withdrawal by Subject|0|||
125084079|NCT02683668|449922985|FG001|Period 2|Withdrawal by Subject|1|||
125084080|NCT02683668|449922986|FG002|Period 2|Withdrawal by Subject|0|||
125084081|NCT04418427|449924686|FG000|Overall Study|Death|0|||
125084082|NCT04418427|449924687|FG001|Overall Study|Death|1|||
125084083|NCT04418427|449924688|FG002|Overall Study|Death|0|||
125084084|NCT04418427|449924686|FG000|Overall Study|Lost to Follow-up|0|||
125084085|NCT04418427|449924687|FG001|Overall Study|Lost to Follow-up|2|||
125084086|NCT04418427|449924688|FG002|Overall Study|Lost to Follow-up|2|||
125084087|NCT04418427|449924686|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
125084088|NCT04418427|449924687|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
125084089|NCT04418427|449924688|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
125084090|NCT04418427|449924686|FG000|Overall Study|Pre-existing medical condition|0|||
125084091|NCT04418427|449924687|FG001|Overall Study|Pre-existing medical condition|1|||
125084092|NCT04418427|449924688|FG002|Overall Study|Pre-existing medical condition|0|||
125084093|NCT01888965|449924691|FG000|Overall Study|Adverse Event|5|||
125084094|NCT01888965|449924691|FG000|Overall Study|Lack of Efficacy|4|||
125084095|NCT04124952|449924693|FG000|Overall Study|Lost to Follow-up|1|||
125084096|NCT01654224|449924694|FG000|Overall Study|Lost to Follow-up|2|||
125084097|NCT01654224|449924695|FG001|Overall Study|Lost to Follow-up|2|||
125084098|NCT01654224|449924694|FG000|Overall Study|Did not receive allocation|1|||
125084099|NCT01654224|449924695|FG001|Overall Study|Did not receive allocation|8|||
125084100|NCT01654224|449924694|FG000|Overall Study|Insufficient blood sample|3|||
125084101|NCT01654224|449924695|FG001|Overall Study|Insufficient blood sample|2|||
125084102|NCT03345849|449924696|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
125084103|NCT03345849|449924697|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
125084104|NCT03345849|449924698|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
125084105|NCT03345849|449924699|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
125084106|NCT03345849|449924696|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
125084107|NCT03345849|449924697|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
125084108|NCT03345849|449924698|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
125084109|NCT03345849|449924699|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
125084110|NCT03345849|449924696|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
125084111|NCT03345849|449924697|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
125084112|NCT03345849|449924698|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
125084113|NCT03345849|449924699|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
125084114|NCT03345849|449924696|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
125084115|NCT03345849|449924697|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
125084116|NCT03345849|449924698|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
125084117|NCT03345849|449924699|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
125084118|NCT03345849|449924696|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
125084119|NCT03345849|449924697|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
125084120|NCT03345849|449924698|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
125145016|NCT01332968|450155929|FG005|Follow-Up Period|Non-compliance|0|||
125084121|NCT03345849|449924699|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
125084122|NCT03345849|449924696|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
125084123|NCT03345849|449924697|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
125084124|NCT03345849|449924698|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
125084125|NCT03345849|449924699|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
125084126|NCT03345849|449924696|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
125084127|NCT03345849|449924697|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
125084128|NCT03345849|449924698|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
125084129|NCT03345849|449924699|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
125084130|NCT03345849|449924696|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
125084131|NCT03345849|449924697|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
125084132|NCT03345849|449924698|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
125084133|NCT03345849|449924699|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
125084134|NCT03345849|449924696|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
125084135|NCT03345849|449924697|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
125084136|NCT03345849|449924698|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
125084137|NCT03345849|449924699|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
125084138|NCT03345849|449924696|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
125084139|NCT03345849|449924697|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
125084140|NCT03345849|449924698|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
125084141|NCT03345849|449924699|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
125084142|NCT03345849|449924696|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
125084143|NCT03345849|449924697|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
125084144|NCT03345849|449924698|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
125084145|NCT03345849|449924699|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
125084146|NCT03261037|449924700|FG000|Overall Study|Withdrawal by Subject|2|||
125084147|NCT03261037|449924701|FG001|Overall Study|Withdrawal by Subject|13|||
125084148|NCT03261037|449924702|FG002|Overall Study|Withdrawal by Subject|0|||
125084149|NCT03261037|449924703|FG003|Overall Study|Withdrawal by Subject|18|||
125084150|NCT03261037|449924700|FG000|Overall Study|Non-compliance with study procedures|0|||
125084151|NCT03261037|449924701|FG001|Overall Study|Non-compliance with study procedures|2|||
125084152|NCT03261037|449924702|FG002|Overall Study|Non-compliance with study procedures|0|||
125084153|NCT03261037|449924703|FG003|Overall Study|Non-compliance with study procedures|6|||
125084154|NCT03261037|449924700|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
125084155|NCT03261037|449924701|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
125084156|NCT03261037|449924702|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
125084157|NCT03261037|449924703|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
125084158|NCT03261037|449924700|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
125084159|NCT03261037|449924701|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
125084160|NCT03261037|449924702|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
125084161|NCT03261037|449924703|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
125084162|NCT03261037|449924700|FG000|Overall Study|Diagnosed but protocol deviation|1|||
125084163|NCT03261037|449924701|FG001|Overall Study|Diagnosed but protocol deviation|0|||
125084164|NCT03261037|449924702|FG002|Overall Study|Diagnosed but protocol deviation|0|||
125084165|NCT03261037|449924703|FG003|Overall Study|Diagnosed but protocol deviation|0|||
125084166|NCT03261037|449924700|FG000|Overall Study|Participant did not want to continue the study|0|||
125084167|NCT03261037|449924701|FG001|Overall Study|Participant did not want to continue the study|1|||
125084168|NCT03261037|449924702|FG002|Overall Study|Participant did not want to continue the study|0|||
125084169|NCT03261037|449924703|FG003|Overall Study|Participant did not want to continue the study|0|||
125084170|NCT03261037|449924700|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
125084171|NCT03261037|449924701|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
125084172|NCT03261037|449924702|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
125084173|NCT03261037|449924703|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
125084174|NCT03261037|449924700|FG000|Overall Study|Participant presented clinical improvement|0|||
125084175|NCT03261037|449924701|FG001|Overall Study|Participant presented clinical improvement|2|||
125084176|NCT03261037|449924702|FG002|Overall Study|Participant presented clinical improvement|0|||
125084177|NCT03261037|449924703|FG003|Overall Study|Participant presented clinical improvement|0|||
125084178|NCT03261037|449924700|FG000|Overall Study|Technical difficulties|0|||
125084179|NCT03261037|449924701|FG001|Overall Study|Technical difficulties|0|||
125084180|NCT03261037|449924702|FG002|Overall Study|Technical difficulties|0|||
125084181|NCT03261037|449924703|FG003|Overall Study|Technical difficulties|1|||
125084182|NCT03261037|449924700|FG000|Overall Study|Equipment failed to work|0|||
125084183|NCT03261037|449924701|FG001|Overall Study|Equipment failed to work|0|||
125084184|NCT03261037|449924702|FG002|Overall Study|Equipment failed to work|0|||
125084185|NCT03261037|449924703|FG003|Overall Study|Equipment failed to work|1|||
125084186|NCT03261037|449924700|FG000|Overall Study|End of study for participant and no follow up|0|||
125084187|NCT03261037|449924701|FG001|Overall Study|End of study for participant and no follow up|0|||
125084188|NCT03261037|449924702|FG002|Overall Study|End of study for participant and no follow up|0|||
125084189|NCT03261037|449924703|FG003|Overall Study|End of study for participant and no follow up|1|||
125084190|NCT03261037|449924700|FG000|Overall Study|Participant was too weak to continue in study|1|||
125145017|NCT01332968|450155930|FG006|Follow-Up Period|Non-compliance|4|||
125145018|NCT01332968|450155931|FG007|Follow-Up Period|Non-compliance|9|||
125145019|NCT01332968|450155924|FG000|Follow-Up Period|Other|0|||
125145020|NCT01332968|450155925|FG001|Follow-Up Period|Other|0|||
125145021|NCT01332968|450155926|FG002|Follow-Up Period|Other|0|||
125145022|NCT01332968|450155927|FG003|Follow-Up Period|Other|0|||
125145023|NCT01332968|450155928|FG004|Follow-Up Period|Other|0|||
125145024|NCT01332968|450155929|FG005|Follow-Up Period|Other|0|||
125145025|NCT01332968|450155930|FG006|Follow-Up Period|Other|18|||
125145026|NCT01332968|450155931|FG007|Follow-Up Period|Other|21|||
125145027|NCT01332968|450155924|FG000|Follow-Up Period|Physician Decision|0|||
125145028|NCT01332968|450155925|FG001|Follow-Up Period|Physician Decision|0|||
125145029|NCT01332968|450155926|FG002|Follow-Up Period|Physician Decision|0|||
125084191|NCT03261037|449924701|FG001|Overall Study|Participant was too weak to continue in study|0|||
125084192|NCT03261037|449924702|FG002|Overall Study|Participant was too weak to continue in study|0|||
125084193|NCT03261037|449924703|FG003|Overall Study|Participant was too weak to continue in study|0|||
125084194|NCT02943577|449924704|FG000|Overall Study|Protocol Violation|0|||
125084195|NCT02943577|449924705|FG001|Overall Study|Protocol Violation|1|||
125084196|NCT02943577|449924704|FG000|Overall Study|Adverse Event|3|||
125084197|NCT02943577|449924705|FG001|Overall Study|Adverse Event|2|||
125084198|NCT02943577|449924704|FG000|Overall Study|Lost to Follow-up|0|||
125084199|NCT02943577|449924705|FG001|Overall Study|Lost to Follow-up|1|||
125084200|NCT02943577|449924704|FG000|Overall Study|Withdrawal by Subject|1|||
125084201|NCT02943577|449924705|FG001|Overall Study|Withdrawal by Subject|1|||
125084202|NCT02943577|449924704|FG000|Overall Study|Pregnancy|1|||
125084203|NCT02943577|449924705|FG001|Overall Study|Pregnancy|0|||
125084204|NCT04437511|449924712|FG000|Overall Study|Adverse Event|50|||
125084205|NCT04437511|449924713|FG001|Overall Study|Adverse Event|21|||
125084206|NCT04437511|449924712|FG000|Overall Study|Death|15|||
125084207|NCT04437511|449924713|FG001|Overall Study|Death|10|||
125084208|NCT04437511|449924712|FG000|Overall Study|Lost to Follow-up|11|||
125084209|NCT04437511|449924713|FG001|Overall Study|Lost to Follow-up|11|||
125084210|NCT04437511|449924712|FG000|Overall Study|Physician Decision|19|||
125084211|NCT04437511|449924713|FG001|Overall Study|Physician Decision|10|||
125084212|NCT04437511|449924712|FG000|Overall Study|Progressive Disease|4|||
125084213|NCT04437511|449924713|FG001|Overall Study|Progressive Disease|7|||
125084214|NCT04437511|449924712|FG000|Overall Study|Withdrawal by Subject|111|||
125084215|NCT04437511|449924713|FG001|Overall Study|Withdrawal by Subject|94|||
125084216|NCT04437511|449924712|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
125084217|NCT04437511|449924713|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
125084218|NCT04437511|449924712|FG000|Overall Study|Continuing Study|7|||
125084219|NCT04437511|449924713|FG001|Overall Study|Continuing Study|5|||
125084220|NCT04654468|449924716|FG000|Overall Study|Death|1|||
125084221|NCT04654468|449924716|FG000|Overall Study|Ongoing in the Study|50|||
125084222|NCT03093350|449924721|FG000|Overall Study|Death|1|||
125084223|NCT03093350|449924721|FG000|Overall Study|Signed consent, never began treartment|1|||
125084224|NCT04564027|449924737|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
125084225|NCT04564027|449924738|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
125084226|NCT04564027|449924739|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
125084227|NCT04564027|449924740|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
125084228|NCT00777036|449924741|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
125084229|NCT00777036|449924742|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
125084230|NCT00777036|449924743|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
125084231|NCT00777036|449924744|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
125084232|NCT00777036|449924741|FG000|On Treatment|Administrative Reason By Sponsor|1|||
125084233|NCT00777036|449924742|FG001|On Treatment|Administrative Reason By Sponsor|0|||
125084234|NCT00777036|449924743|FG002|On Treatment|Administrative Reason By Sponsor|9|||
125084235|NCT00777036|449924744|FG003|On Treatment|Administrative Reason By Sponsor|0|||
125145030|NCT01332968|450155927|FG003|Follow-Up Period|Physician Decision|0|||
125145031|NCT01332968|450155928|FG004|Follow-Up Period|Physician Decision|0|||
125145032|NCT01332968|450155929|FG005|Follow-Up Period|Physician Decision|0|||
125145033|NCT01332968|450155930|FG006|Follow-Up Period|Physician Decision|12|||
125145034|NCT01332968|450155931|FG007|Follow-Up Period|Physician Decision|15|||
125145035|NCT01332968|450155924|FG000|Follow-Up Period|Progressive Disease|0|||
125145036|NCT01332968|450155925|FG001|Follow-Up Period|Progressive Disease|0|||
125084236|NCT00777036|449924741|FG000|On Treatment|Failure to Meet Study Criteria|0|||
125084237|NCT00777036|449924742|FG001|On Treatment|Failure to Meet Study Criteria|1|||
125084238|NCT00777036|449924743|FG002|On Treatment|Failure to Meet Study Criteria|4|||
125084239|NCT00777036|449924744|FG003|On Treatment|Failure to Meet Study Criteria|0|||
125145037|NCT01332968|450155926|FG002|Follow-Up Period|Progressive Disease|0|||
125145038|NCT01332968|450155927|FG003|Follow-Up Period|Progressive Disease|0|||
125145039|NCT01332968|450155928|FG004|Follow-Up Period|Progressive Disease|0|||
125084240|NCT00777036|449924741|FG000|On Treatment|Pregnancy|1|||
125084241|NCT00777036|449924742|FG001|On Treatment|Pregnancy|0|||
125084242|NCT00777036|449924743|FG002|On Treatment|Pregnancy|1|||
125084243|NCT00777036|449924744|FG003|On Treatment|Pregnancy|0|||
125084244|NCT00777036|449924741|FG000|On Treatment|Non-compliance with Study Drug|1|||
125084245|NCT00777036|449924742|FG001|On Treatment|Non-compliance with Study Drug|0|||
125084246|NCT00777036|449924743|FG002|On Treatment|Non-compliance with Study Drug|1|||
125084247|NCT00777036|449924744|FG003|On Treatment|Non-compliance with Study Drug|0|||
125084248|NCT00777036|449924741|FG000|On Treatment|Maximum Clinical Benefit|2|||
125084249|NCT00777036|449924742|FG001|On Treatment|Maximum Clinical Benefit|0|||
125084250|NCT00777036|449924743|FG002|On Treatment|Maximum Clinical Benefit|5|||
125084251|NCT00777036|449924744|FG003|On Treatment|Maximum Clinical Benefit|0|||
125084252|NCT00777036|449924741|FG000|On Treatment|Withdrawal by Subject|0|||
125084253|NCT00777036|449924742|FG001|On Treatment|Withdrawal by Subject|2|||
125084254|NCT00777036|449924743|FG002|On Treatment|Withdrawal by Subject|2|||
125084255|NCT00777036|449924744|FG003|On Treatment|Withdrawal by Subject|0|||
125084256|NCT00777036|449924741|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
125084257|NCT00777036|449924742|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
125084258|NCT00777036|449924743|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
125084259|NCT00777036|449924744|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
125084260|NCT00777036|449924741|FG000|On Treatment|Death|0|||
125084261|NCT00777036|449924742|FG001|On Treatment|Death|2|||
125084262|NCT00777036|449924743|FG002|On Treatment|Death|0|||
125084263|NCT00777036|449924744|FG003|On Treatment|Death|0|||
125084264|NCT00777036|449924741|FG000|On Treatment|Study Drug Toxicity|1|||
125084265|NCT00777036|449924742|FG001|On Treatment|Study Drug Toxicity|0|||
125084266|NCT00777036|449924743|FG002|On Treatment|Study Drug Toxicity|4|||
125084267|NCT00777036|449924744|FG003|On Treatment|Study Drug Toxicity|0|||
125084268|NCT00777036|449924741|FG000|On Treatment|Progressive Disease|6|||
125084269|NCT00777036|449924742|FG001|On Treatment|Progressive Disease|4|||
125084270|NCT00777036|449924743|FG002|On Treatment|Progressive Disease|7|||
125084271|NCT00777036|449924744|FG003|On Treatment|Progressive Disease|0|||
125084272|NCT00777036|449924741|FG000|On Treatment|Not Reported|0|||
125084273|NCT00777036|449924742|FG001|On Treatment|Not Reported|0|||
125084274|NCT00777036|449924743|FG002|On Treatment|Not Reported|2|||
125084275|NCT00777036|449924744|FG003|On Treatment|Not Reported|0|||
125084276|NCT00777036|449924741|FG000|On Treatment|Site Closed|0|||
125084277|NCT00777036|449924742|FG001|On Treatment|Site Closed|1|||
125084278|NCT00777036|449924743|FG002|On Treatment|Site Closed|1|||
125084279|NCT00777036|449924744|FG003|On Treatment|Site Closed|0|||
125084280|NCT00777036|449924741|FG000|Follow-Up|Withdrawal by Subject|0|||
125084281|NCT00777036|449924742|FG001|Follow-Up|Withdrawal by Subject|0|||
125084282|NCT00777036|449924743|FG002|Follow-Up|Withdrawal by Subject|5|||
125084283|NCT00777036|449924744|FG003|Follow-Up|Withdrawal by Subject|0|||
125084284|NCT00777036|449924741|FG000|Follow-Up|Death|1|||
125084285|NCT00777036|449924742|FG001|Follow-Up|Death|9|||
125084286|NCT00777036|449924743|FG002|Follow-Up|Death|0|||
125084287|NCT00777036|449924744|FG003|Follow-Up|Death|0|||
125084288|NCT00777036|449924741|FG000|Follow-Up|Lost to Follow-up|3|||
125084289|NCT00777036|449924742|FG001|Follow-Up|Lost to Follow-up|0|||
125084290|NCT00777036|449924743|FG002|Follow-Up|Lost to Follow-up|0|||
125084291|NCT00777036|449924744|FG003|Follow-Up|Lost to Follow-up|0|||
125084292|NCT00777036|449924741|FG000|Follow-Up|Reason Not Specified|4|||
125084293|NCT00777036|449924742|FG001|Follow-Up|Reason Not Specified|0|||
125084294|NCT00777036|449924743|FG002|Follow-Up|Reason Not Specified|13|||
125084295|NCT00777036|449924744|FG003|Follow-Up|Reason Not Specified|0|||
125084296|NCT00777036|449924741|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
125084297|NCT00777036|449924742|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
125084298|NCT00777036|449924743|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
125084299|NCT00777036|449924744|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
125084300|NCT01267955|449924747|FG000|Stage 1 (6 Months)|Death|3|||
125145040|NCT01332968|450155929|FG005|Follow-Up Period|Progressive Disease|0|||
125145041|NCT01332968|450155930|FG006|Follow-Up Period|Progressive Disease|126|||
125145042|NCT01332968|450155931|FG007|Follow-Up Period|Progressive Disease|106|||
125145043|NCT01332968|450155924|FG000|Follow-Up Period|Protocol Violation|0|||
125145044|NCT01332968|450155925|FG001|Follow-Up Period|Protocol Violation|0|||
125084301|NCT01267955|449924747|FG000|Stage 2 (6 Months)|Death|5|||
125084302|NCT01267955|449924747|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
125084303|NCT05564039|449924752|FG000|Overall Study|Adverse Event|1|||
125084304|NCT05564039|449924753|FG001|Overall Study|Adverse Event|0|||
125084305|NCT05564039|449924752|FG000|Overall Study|Death|1|||
125084306|NCT05564039|449924753|FG001|Overall Study|Death|1|||
125084307|NCT05564039|449924752|FG000|Overall Study|Lost to Follow-up|3|||
125145045|NCT01332968|450155926|FG002|Follow-Up Period|Protocol Violation|0|||
125084308|NCT05564039|449924753|FG001|Overall Study|Lost to Follow-up|2|||
125084309|NCT05564039|449924752|FG000|Overall Study|Withdrawal by Subject|2|||
125084310|NCT05564039|449924753|FG001|Overall Study|Withdrawal by Subject|0|||
125084311|NCT05564039|449924752|FG000|Overall Study|Inadvertent enrollment|3|||
125084312|NCT05564039|449924753|FG001|Overall Study|Inadvertent enrollment|6|||
125084313|NCT04651777|449924754|FG000|Overall Study|Adverse Event|1|||
125084314|NCT04651777|449924754|FG000|Overall Study|Withdrawal by Subject|2|||
125084315|NCT04566445|449924755|FG000|Overall Study|Death|4|||
125145046|NCT01332968|450155927|FG003|Follow-Up Period|Protocol Violation|0|||
125145047|NCT01332968|450155928|FG004|Follow-Up Period|Protocol Violation|0|||
125084316|NCT04566445|449924756|FG001|Overall Study|Death|1|||
125084317|NCT04566445|449924757|FG002|Overall Study|Death|1|||
125084318|NCT04566445|449924755|FG000|Overall Study|Lost to Follow-up|3|||
125084319|NCT04566445|449924756|FG001|Overall Study|Lost to Follow-up|1|||
125145048|NCT01332968|450155929|FG005|Follow-Up Period|Protocol Violation|0|||
125084320|NCT04566445|449924757|FG002|Overall Study|Lost to Follow-up|1|||
125084321|NCT04566445|449924755|FG000|Overall Study|Study terminated by sponsor|11|||
125084322|NCT04566445|449924756|FG001|Overall Study|Study terminated by sponsor|17|||
125084323|NCT04566445|449924757|FG002|Overall Study|Study terminated by sponsor|32|||
125084324|NCT04566445|449924755|FG000|Overall Study|Withdrawal by Subject|12|||
125084325|NCT04566445|449924756|FG001|Overall Study|Withdrawal by Subject|14|||
125084326|NCT04566445|449924757|FG002|Overall Study|Withdrawal by Subject|13|||
125084327|NCT04566445|449924755|FG000|Overall Study|Randomized but not treated due to AE|2|||
125084328|NCT04566445|449924756|FG001|Overall Study|Randomized but not treated due to AE|1|||
125084329|NCT04566445|449924757|FG002|Overall Study|Randomized but not treated due to AE|0|||
125084330|NCT04566445|449924755|FG000|Overall Study|Adverse Event|1|||
125084331|NCT04566445|449924756|FG001|Overall Study|Adverse Event|1|||
125084332|NCT04566445|449924757|FG002|Overall Study|Adverse Event|0|||
125084333|NCT02421939|449924758|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
125084334|NCT02421939|449924759|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
125084335|NCT02421939|449924758|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
125084336|NCT02421939|449924759|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
125084337|NCT02421939|449924758|FG000|Randomization Period: Up to 3 Years|Death|38|||
125084338|NCT02421939|449924759|FG001|Randomization Period: Up to 3 Years|Death|10|||
125084339|NCT02421939|449924758|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
125084340|NCT02421939|449924759|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
125084341|NCT02421939|449924758|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
125084342|NCT02421939|449924759|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
125084343|NCT02421939|449924758|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
125084344|NCT02421939|449924759|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
125084345|NCT02421939|449924758|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
125084346|NCT02421939|449924759|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
125084347|NCT02421939|449924758|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
125084348|NCT02421939|449924759|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
125084349|NCT02421939|449924758|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
125084350|NCT02421939|449924759|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
125084351|NCT02421939|449924758|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
125084352|NCT02421939|449924759|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
125084353|NCT02421939|449924758|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
125084354|NCT02421939|449924759|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
125084355|NCT02421939|449924758|FG000|Long Term Follow up: up to 3 Years|Death|118|||
125084356|NCT02421939|449924759|FG001|Long Term Follow up: up to 3 Years|Death|65|||
125084357|NCT02421939|449924758|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
125084358|NCT02421939|449924759|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
125084359|NCT04785144|449924760|FG000|Overall Study|Withdrawal by Subject|4|||
125084360|NCT04785144|449924761|FG001|Overall Study|Withdrawal by Subject|1|||
125084361|NCT04785144|449924762|FG002|Overall Study|Withdrawal by Subject|0|||
125084362|NCT04785144|449924763|FG003|Overall Study|Withdrawal by Subject|0|||
125084363|NCT04785144|449924764|FG004|Overall Study|Withdrawal by Subject|0|||
125084364|NCT04785144|449924765|FG005|Overall Study|Withdrawal by Subject|2|||
125084365|NCT04785144|449924766|FG006|Overall Study|Withdrawal by Subject|2|||
125084366|NCT04785144|449924767|FG007|Overall Study|Withdrawal by Subject|0|||
125084367|NCT04785144|449924768|FG008|Overall Study|Withdrawal by Subject|1|||
125084368|NCT04785144|449924769|FG009|Overall Study|Withdrawal by Subject|0|||
125084369|NCT04785144|449924760|FG000|Overall Study|Lost to Follow-up|1|||
125084370|NCT04785144|449924761|FG001|Overall Study|Lost to Follow-up|0|||
125084371|NCT04785144|449924762|FG002|Overall Study|Lost to Follow-up|0|||
125084372|NCT04785144|449924763|FG003|Overall Study|Lost to Follow-up|0|||
125084373|NCT04785144|449924764|FG004|Overall Study|Lost to Follow-up|1|||
125084374|NCT04785144|449924765|FG005|Overall Study|Lost to Follow-up|2|||
125084375|NCT04785144|449924766|FG006|Overall Study|Lost to Follow-up|1|||
125084376|NCT04785144|449924767|FG007|Overall Study|Lost to Follow-up|2|||
125084377|NCT04785144|449924768|FG008|Overall Study|Lost to Follow-up|4|||
125084378|NCT04785144|449924769|FG009|Overall Study|Lost to Follow-up|1|||
125084379|NCT04785144|449924760|FG000|Overall Study|Protocol Violation|0|||
125084380|NCT04785144|449924761|FG001|Overall Study|Protocol Violation|0|||
125084381|NCT04785144|449924762|FG002|Overall Study|Protocol Violation|0|||
125084382|NCT04785144|449924763|FG003|Overall Study|Protocol Violation|0|||
125084383|NCT04785144|449924764|FG004|Overall Study|Protocol Violation|0|||
125084384|NCT04785144|449924765|FG005|Overall Study|Protocol Violation|0|||
125084385|NCT04785144|449924766|FG006|Overall Study|Protocol Violation|1|||
125084386|NCT04785144|449924767|FG007|Overall Study|Protocol Violation|0|||
125084387|NCT04785144|449924768|FG008|Overall Study|Protocol Violation|0|||
125084388|NCT04785144|449924769|FG009|Overall Study|Protocol Violation|0|||
125084389|NCT04785144|449924760|FG000|Overall Study|Physician Decision|0|||
125084390|NCT04785144|449924761|FG001|Overall Study|Physician Decision|0|||
125084391|NCT04785144|449924762|FG002|Overall Study|Physician Decision|0|||
125084392|NCT04785144|449924763|FG003|Overall Study|Physician Decision|0|||
125084393|NCT04785144|449924764|FG004|Overall Study|Physician Decision|0|||
125084394|NCT04785144|449924765|FG005|Overall Study|Physician Decision|0|||
125084395|NCT04785144|449924766|FG006|Overall Study|Physician Decision|0|||
125084396|NCT04785144|449924767|FG007|Overall Study|Physician Decision|0|||
125084397|NCT04785144|449924768|FG008|Overall Study|Physician Decision|0|||
125084398|NCT04785144|449924769|FG009|Overall Study|Physician Decision|1|||
125084399|NCT04785144|449924760|FG000|Overall Study|Unable to continue due to work schedule|0|||
125084400|NCT04785144|449924761|FG001|Overall Study|Unable to continue due to work schedule|0|||
125084401|NCT04785144|449924762|FG002|Overall Study|Unable to continue due to work schedule|0|||
125084402|NCT04785144|449924763|FG003|Overall Study|Unable to continue due to work schedule|0|||
125084403|NCT04785144|449924764|FG004|Overall Study|Unable to continue due to work schedule|0|||
125084404|NCT04785144|449924765|FG005|Overall Study|Unable to continue due to work schedule|0|||
125084405|NCT04785144|449924766|FG006|Overall Study|Unable to continue due to work schedule|0|||
125084406|NCT04785144|449924767|FG007|Overall Study|Unable to continue due to work schedule|0|||
125084407|NCT04785144|449924768|FG008|Overall Study|Unable to continue due to work schedule|0|||
125084408|NCT04785144|449924769|FG009|Overall Study|Unable to continue due to work schedule|1|||
125084409|NCT03598140|449924770|FG000|Overall Study|enrolled but didn't start|1|||
125084410|NCT03598140|449924771|FG001|Overall Study|enrolled but didn't start|0|||
125084411|NCT05245071|449924772|FG000|Overall Study|Progressive disease|18|||
125084412|NCT05245071|449924772|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
125084413|NCT05245071|449924772|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
125084414|NCT05304611|449924773|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
125084415|NCT05304611|449924774|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
125084416|NCT05304611|449924775|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
125084417|NCT05304611|449924776|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
125084418|NCT05304611|449924777|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
125084419|NCT05304611|449924778|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
125084420|NCT05304611|449924779|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
125084421|NCT05304611|449924780|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
125084422|NCT05304611|449924781|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
125084423|NCT05304611|449924782|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
125084424|NCT05304611|449924783|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
125084425|NCT05304611|449924784|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
125084426|NCT05304611|449924773|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
125084427|NCT05304611|449924774|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
125084428|NCT05304611|449924775|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
125084429|NCT05304611|449924776|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
125084430|NCT05304611|449924777|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
125084431|NCT05304611|449924778|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
125084432|NCT05304611|449924779|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
125084433|NCT05304611|449924780|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
125084434|NCT05304611|449924781|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
125084435|NCT05304611|449924782|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
125084436|NCT05304611|449924783|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
125084437|NCT05304611|449924784|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
125084438|NCT05304611|449924773|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
125084439|NCT05304611|449924774|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
125084440|NCT05304611|449924775|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
125084441|NCT05304611|449924776|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
125084442|NCT05304611|449924777|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
125084443|NCT05304611|449924778|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
125084444|NCT05304611|449924779|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
125084445|NCT05304611|449924780|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
125084446|NCT05304611|449924781|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
125084447|NCT05304611|449924782|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
125084448|NCT05304611|449924783|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
125084449|NCT05304611|449924784|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
125084450|NCT00963820|449924785|FG000|Dose Escalation Phase|Progressive Disease|3|||
125084451|NCT00963820|449924786|FG001|Dose Escalation Phase|Progressive Disease|3|||
125084452|NCT00963820|449924787|FG002|Dose Escalation Phase|Progressive Disease|3|||
125084453|NCT00963820|449924788|FG003|Dose Escalation Phase|Progressive Disease|3|||
125084454|NCT00963820|449924789|FG004|Dose Escalation Phase|Progressive Disease|4|||
125084455|NCT00963820|449924790|FG005|Dose Escalation Phase|Progressive Disease|3|||
125084456|NCT00963820|449924791|FG006|Dose Escalation Phase|Progressive Disease|3|||
125084457|NCT00963820|449924792|FG007|Dose Escalation Phase|Progressive Disease|2|||
125084458|NCT00963820|449924793|FG008|Dose Escalation Phase|Progressive Disease|0|||
125084459|NCT00963820|449924794|FG009|Dose Escalation Phase|Progressive Disease|0|||
125084460|NCT00963820|449924795|FG010|Dose Escalation Phase|Progressive Disease|0|||
125084461|NCT00963820|449924796|FG011|Dose Escalation Phase|Progressive Disease|0|||
125084462|NCT00963820|449924785|FG000|Dose Escalation Phase|Adverse Event|0|||
125084463|NCT00963820|449924786|FG001|Dose Escalation Phase|Adverse Event|0|||
125084464|NCT00963820|449924787|FG002|Dose Escalation Phase|Adverse Event|0|||
125084465|NCT00963820|449924788|FG003|Dose Escalation Phase|Adverse Event|0|||
125084466|NCT00963820|449924789|FG004|Dose Escalation Phase|Adverse Event|0|||
125084467|NCT00963820|449924790|FG005|Dose Escalation Phase|Adverse Event|0|||
125084468|NCT00963820|449924791|FG006|Dose Escalation Phase|Adverse Event|3|||
125084469|NCT00963820|449924792|FG007|Dose Escalation Phase|Adverse Event|1|||
125084470|NCT00963820|449924793|FG008|Dose Escalation Phase|Adverse Event|0|||
125084471|NCT00963820|449924794|FG009|Dose Escalation Phase|Adverse Event|0|||
125084472|NCT00963820|449924795|FG010|Dose Escalation Phase|Adverse Event|0|||
125084473|NCT00963820|449924796|FG011|Dose Escalation Phase|Adverse Event|0|||
125084474|NCT00963820|449924785|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
125084475|NCT00963820|449924786|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
125084476|NCT00963820|449924787|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
125084477|NCT00963820|449924788|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
125084478|NCT00963820|449924789|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
125084479|NCT00963820|449924790|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
125084480|NCT00963820|449924791|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
125084481|NCT00963820|449924792|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
125084482|NCT00963820|449924793|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
125084483|NCT00963820|449924794|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
125084484|NCT00963820|449924795|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
125084485|NCT00963820|449924796|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
125084486|NCT00963820|449924785|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125084487|NCT00963820|449924786|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125084488|NCT00963820|449924787|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125084489|NCT00963820|449924788|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125084490|NCT00963820|449924789|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125084491|NCT00963820|449924790|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125084492|NCT00963820|449924791|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
125084493|NCT00963820|449924792|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125084494|NCT00963820|449924793|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125084495|NCT00963820|449924794|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125084496|NCT00963820|449924795|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125084497|NCT00963820|449924796|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125084498|NCT00963820|449924785|FG000|Expansion Phase|Progressive Disease|0|||
125084499|NCT00963820|449924786|FG001|Expansion Phase|Progressive Disease|0|||
125084500|NCT00963820|449924787|FG002|Expansion Phase|Progressive Disease|0|||
125084501|NCT00963820|449924788|FG003|Expansion Phase|Progressive Disease|0|||
125084502|NCT00963820|449924789|FG004|Expansion Phase|Progressive Disease|0|||
125084503|NCT00963820|449924790|FG005|Expansion Phase|Progressive Disease|0|||
125084504|NCT00963820|449924791|FG006|Expansion Phase|Progressive Disease|0|||
125084505|NCT00963820|449924792|FG007|Expansion Phase|Progressive Disease|0|||
125084506|NCT00963820|449924793|FG008|Expansion Phase|Progressive Disease|8|||
125084507|NCT00963820|449924794|FG009|Expansion Phase|Progressive Disease|6|||
125084508|NCT00963820|449924795|FG010|Expansion Phase|Progressive Disease|4|||
125084509|NCT00963820|449924796|FG011|Expansion Phase|Progressive Disease|2|||
125084510|NCT00963820|449924785|FG000|Expansion Phase|Adverse Event|0|||
125084511|NCT00963820|449924786|FG001|Expansion Phase|Adverse Event|0|||
125084512|NCT00963820|449924787|FG002|Expansion Phase|Adverse Event|0|||
125084513|NCT00963820|449924788|FG003|Expansion Phase|Adverse Event|0|||
125084514|NCT00963820|449924789|FG004|Expansion Phase|Adverse Event|0|||
125084515|NCT00963820|449924790|FG005|Expansion Phase|Adverse Event|0|||
125084516|NCT00963820|449924791|FG006|Expansion Phase|Adverse Event|0|||
125084517|NCT00963820|449924792|FG007|Expansion Phase|Adverse Event|0|||
125084518|NCT00963820|449924793|FG008|Expansion Phase|Adverse Event|1|||
125084519|NCT00963820|449924794|FG009|Expansion Phase|Adverse Event|3|||
125084520|NCT00963820|449924795|FG010|Expansion Phase|Adverse Event|0|||
125084521|NCT00963820|449924796|FG011|Expansion Phase|Adverse Event|0|||
125084522|NCT00963820|449924785|FG000|Expansion Phase|Withdrawal by Subject|0|||
125084523|NCT00963820|449924786|FG001|Expansion Phase|Withdrawal by Subject|0|||
125084524|NCT00963820|449924787|FG002|Expansion Phase|Withdrawal by Subject|0|||
125084525|NCT00963820|449924788|FG003|Expansion Phase|Withdrawal by Subject|0|||
125084526|NCT00963820|449924789|FG004|Expansion Phase|Withdrawal by Subject|0|||
125084527|NCT00963820|449924790|FG005|Expansion Phase|Withdrawal by Subject|0|||
125084528|NCT00963820|449924791|FG006|Expansion Phase|Withdrawal by Subject|0|||
125084529|NCT00963820|449924792|FG007|Expansion Phase|Withdrawal by Subject|0|||
125084530|NCT00963820|449924793|FG008|Expansion Phase|Withdrawal by Subject|1|||
125084531|NCT00963820|449924794|FG009|Expansion Phase|Withdrawal by Subject|0|||
125084532|NCT00963820|449924795|FG010|Expansion Phase|Withdrawal by Subject|1|||
125084533|NCT00963820|449924796|FG011|Expansion Phase|Withdrawal by Subject|1|||
125084534|NCT00963820|449924785|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125084535|NCT00963820|449924786|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125084536|NCT00963820|449924787|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125084537|NCT00963820|449924788|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125084538|NCT00963820|449924789|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125084539|NCT00963820|449924790|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125084540|NCT00963820|449924791|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125084541|NCT00963820|449924792|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125084542|NCT00963820|449924793|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125084543|NCT00963820|449924794|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125084544|NCT00963820|449924795|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125084545|NCT00963820|449924796|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
125084546|NCT02354690|449924797|FG000|Overall Study|Physician Decision|1|||
125084547|NCT04556175|449924805|FG000|Overall Study|Study terminated due to COVID-19|8|||
125084548|NCT04556175|449924806|FG001|Overall Study|Study terminated due to COVID-19|8|||
125084549|NCT05549505|449924808|FG000|Overall Study|Lost to Follow-up|2|||
125084550|NCT05549505|449924809|FG001|Overall Study|Lost to Follow-up|0|||
125084551|NCT05549505|449924808|FG000|Overall Study|Withdrawal by Subject|3|||
125084552|NCT05549505|449924809|FG001|Overall Study|Withdrawal by Subject|3|||
125084553|NCT05549505|449924808|FG000|Overall Study|Other: Miscellaneous|3|||
125084554|NCT05549505|449924809|FG001|Overall Study|Other: Miscellaneous|6|||
125084555|NCT02871791|449924813|FG000|Phase 1b|Death|0|||
125084556|NCT02871791|449924814|FG001|Phase 1b|Death|1|||
125084557|NCT02871791|449924813|FG000|Phase 1b|progressive disease|6|||
125084558|NCT02871791|449924814|FG001|Phase 1b|progressive disease|2|||
125084559|NCT02871791|449924813|FG000|Phase 2|Death|1|||
125084560|NCT02871791|449924814|FG001|Phase 2|Death|0|||
125084561|NCT02871791|449924813|FG000|Phase 2|Lost to Follow-up|2|||
125084562|NCT02871791|449924814|FG001|Phase 2|Lost to Follow-up|0|||
125084563|NCT04005755|449924815|FG000|Overall Study|Adverse Event|6|||
125084564|NCT04005755|449924815|FG000|Overall Study|Physician Decision|3|||
125084565|NCT04005755|449924815|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
125084566|NCT04005755|449924815|FG000|Overall Study|Withdrawal by Subject|3|||
125084567|NCT04005755|449924815|FG000|Overall Study|Lost to Follow-up|1|||
125084568|NCT02723019|449924816|FG000|Overall Study|Death|17|||
125084569|NCT02723019|449924817|FG001|Overall Study|Death|13|||
125084570|NCT02723019|449924816|FG000|Overall Study|Withdrawal by Subject|11|||
125084571|NCT02723019|449924817|FG001|Overall Study|Withdrawal by Subject|7|||
125084572|NCT02723019|449924816|FG000|Overall Study|Lost to Follow-up|57|||
125084573|NCT02723019|449924817|FG001|Overall Study|Lost to Follow-up|70|||
125084574|NCT00515099|449924819|FG000|Overall Study|Lost to Follow-up|0|||
125084575|NCT00515099|449924820|FG001|Overall Study|Lost to Follow-up|4|||
125084576|NCT00515099|449924819|FG000|Overall Study|Withdrawal by Subject|2|||
125084577|NCT00515099|449924820|FG001|Overall Study|Withdrawal by Subject|0|||
125084578|NCT00515099|449924819|FG000|Overall Study|IRB Recommendation|1|||
125084579|NCT00515099|449924820|FG001|Overall Study|IRB Recommendation|0|||
125084580|NCT00592072|449924821|FG000|Wash Out Period|Lost to Follow-up|1|||
125084581|NCT00592072|449924822|FG001|Wash Out Period|Lost to Follow-up|1|||
125084582|NCT02750501|449924828|FG000|Overall Study|Adverse Event|4|||
125084583|NCT02750501|449924828|FG000|Overall Study|Physician Decision|1|||
125084584|NCT02750501|449924828|FG000|Overall Study|Protocol Violation|1|||
125084585|NCT02750501|449924828|FG000|Overall Study|G-tube came out|1|||
125084586|NCT02750501|449924828|FG000|Overall Study|Non-compliant use of PERT|1|||
125084587|NCT01738594|449924829|FG000|Registration and Treatment Start|Adverse Event|0|||
125084588|NCT01738594|449924830|FG001|Registration and Treatment Start|Adverse Event|1|||
125084589|NCT01738594|449924831|FG002|Registration and Treatment Start|Adverse Event|0|||
125084590|NCT01738594|449924832|FG003|Registration and Treatment Start|Adverse Event|0|||
125084591|NCT01738594|449924833|FG004|Registration and Treatment Start|Adverse Event|0|||
125084592|NCT01738594|449924834|FG005|Registration and Treatment Start|Adverse Event|0|||
125084593|NCT01738594|449924835|FG006|Registration and Treatment Start|Adverse Event|0|||
125084594|NCT01738594|449924836|FG007|Registration and Treatment Start|Adverse Event|0|||
125084595|NCT01738594|449924829|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
125084596|NCT01738594|449924830|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
125084597|NCT01738594|449924831|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
125084598|NCT01738594|449924832|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
125084599|NCT01738594|449924833|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
125084600|NCT01738594|449924834|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
125084601|NCT01738594|449924835|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
125084602|NCT01738594|449924836|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
125084603|NCT01738594|449924829|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
125084604|NCT01738594|449924830|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
125084605|NCT01738594|449924831|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
125084606|NCT01738594|449924832|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
125084607|NCT01738594|449924833|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
125084608|NCT01738594|449924834|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
125084609|NCT01738594|449924835|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
125084610|NCT01738594|449924836|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
125084611|NCT01738594|449924829|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
125084612|NCT01738594|449924830|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
125084613|NCT01738594|449924831|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
125084614|NCT01738594|449924832|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
125084615|NCT01738594|449924833|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
125084616|NCT01738594|449924834|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
125084617|NCT01738594|449924835|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
125084618|NCT01738594|449924836|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
125084619|NCT01738594|449924829|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
125084620|NCT01738594|449924830|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
125084621|NCT01738594|449924831|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
125084622|NCT01738594|449924832|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
125084623|NCT01738594|449924833|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
125084624|NCT01738594|449924834|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
125084625|NCT01738594|449924835|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
125084626|NCT01738594|449924836|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
125084627|NCT01738594|449924829|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
125084628|NCT01738594|449924830|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
125084629|NCT01738594|449924831|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
125084630|NCT01738594|449924832|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
125084631|NCT01738594|449924833|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
125084632|NCT01738594|449924834|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
125084633|NCT01738594|449924835|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
125084634|NCT01738594|449924836|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
125084635|NCT01738594|449924829|FG000|Follow up for 1 Year|Death|0|||
125084636|NCT01738594|449924830|FG001|Follow up for 1 Year|Death|0|||
125084637|NCT01738594|449924831|FG002|Follow up for 1 Year|Death|0|||
125084638|NCT01738594|449924832|FG003|Follow up for 1 Year|Death|0|||
125084639|NCT01738594|449924833|FG004|Follow up for 1 Year|Death|0|||
125084640|NCT01738594|449924834|FG005|Follow up for 1 Year|Death|1|||
125084641|NCT01738594|449924835|FG006|Follow up for 1 Year|Death|0|||
125084642|NCT01738594|449924836|FG007|Follow up for 1 Year|Death|0|||
125084643|NCT01738594|449924829|FG000|Follow up for 1 Year|Other|0|||
125084644|NCT01738594|449924830|FG001|Follow up for 1 Year|Other|0|||
125084645|NCT01738594|449924831|FG002|Follow up for 1 Year|Other|0|||
125084646|NCT01738594|449924832|FG003|Follow up for 1 Year|Other|0|||
125084647|NCT01738594|449924833|FG004|Follow up for 1 Year|Other|0|||
125084648|NCT01738594|449924834|FG005|Follow up for 1 Year|Other|2|||
125084649|NCT01738594|449924835|FG006|Follow up for 1 Year|Other|0|||
125084650|NCT01738594|449924836|FG007|Follow up for 1 Year|Other|0|||
125084651|NCT00403390|449924837|FG000|Overall Study|Withdrawal by Subject|1|||
125084652|NCT00403390|449924838|FG001|Overall Study|Withdrawal by Subject|0|||
125084653|NCT00403390|449924837|FG000|Overall Study|samples lost|1|||
125084654|NCT00403390|449924838|FG001|Overall Study|samples lost|0|||
125084655|NCT00403390|449924837|FG000|Overall Study|non-compliant|1|||
125084656|NCT00403390|449924838|FG001|Overall Study|non-compliant|0|||
125084657|NCT01708915|449924848|FG000|Overall Study|Adverse Event|1|||
125084658|NCT01708915|449924849|FG001|Overall Study|Adverse Event|0|||
125084659|NCT01708915|449924850|FG002|Overall Study|Adverse Event|9|||
125084660|NCT01708915|449924851|FG003|Overall Study|Adverse Event|13|||
125084661|NCT01708915|449924848|FG000|Overall Study|Lack of Efficacy|84|||
125084662|NCT01708915|449924849|FG001|Overall Study|Lack of Efficacy|60|||
125084663|NCT01708915|449924850|FG002|Overall Study|Lack of Efficacy|35|||
125084664|NCT01708915|449924851|FG003|Overall Study|Lack of Efficacy|15|||
125084665|NCT01708915|449924848|FG000|Overall Study|Protocol Violation|0|||
125084666|NCT01708915|449924849|FG001|Overall Study|Protocol Violation|0|||
125084667|NCT01708915|449924850|FG002|Overall Study|Protocol Violation|0|||
125084668|NCT01708915|449924851|FG003|Overall Study|Protocol Violation|1|||
125084669|NCT01708915|449924848|FG000|Overall Study|Withdrawal by Subject|0|||
125084670|NCT01708915|449924849|FG001|Overall Study|Withdrawal by Subject|1|||
125084671|NCT01708915|449924850|FG002|Overall Study|Withdrawal by Subject|2|||
125084672|NCT01708915|449924851|FG003|Overall Study|Withdrawal by Subject|2|||
125084673|NCT01708915|449924848|FG000|Overall Study|Other reasons than stated above|1|||
125084674|NCT01708915|449924849|FG001|Overall Study|Other reasons than stated above|1|||
125084675|NCT01708915|449924850|FG002|Overall Study|Other reasons than stated above|0|||
125084676|NCT01708915|449924851|FG003|Overall Study|Other reasons than stated above|2|||
125084677|NCT03231228|449924852|FG000|Overall Study|Lost to Follow-up|2|||
125084678|NCT03231228|449924853|FG001|Overall Study|Lost to Follow-up|0|||
125084679|NCT03231228|449924852|FG000|Overall Study|Physician Decision|1|||
125084680|NCT03231228|449924853|FG001|Overall Study|Physician Decision|0|||
125084681|NCT02554721|449926542|FG000|Overall Study|Adverse Event|1|||
125084682|NCT02554721|449926543|FG001|Overall Study|Adverse Event|0|||
125084683|NCT02554721|449926544|FG002|Overall Study|Adverse Event|0|||
125084684|NCT02554721|449926545|FG003|Overall Study|Adverse Event|0|||
125084685|NCT02554721|449926546|FG004|Overall Study|Adverse Event|1|||
125084686|NCT02554721|449926542|FG000|Overall Study|Noncompliance|0|||
125084687|NCT02554721|449926543|FG001|Overall Study|Noncompliance|0|||
125084688|NCT02554721|449926544|FG002|Overall Study|Noncompliance|0|||
125084689|NCT02554721|449926545|FG003|Overall Study|Noncompliance|0|||
125084690|NCT02554721|449926546|FG004|Overall Study|Noncompliance|1|||
125084691|NCT00908895|449926548|FG000|Overall Study|Lost to Follow-up|1|||
125084692|NCT00908895|449926549|FG001|Overall Study|Lost to Follow-up|3|||
125084693|NCT00908895|449926548|FG000|Overall Study|algodystrophy|2|||
125084694|NCT00908895|449926549|FG001|Overall Study|algodystrophy|2|||
125084695|NCT00908895|449926548|FG000|Overall Study|Adverse Event|1|||
125084696|NCT00908895|449926549|FG001|Overall Study|Adverse Event|1|||
125084697|NCT03661983|449926550|FG000|Open Label Stabilization Phase|Adverse Event|5|||
125084698|NCT03661983|449926551|FG001|Open Label Stabilization Phase|Adverse Event|0|||
125084699|NCT03661983|449926552|FG002|Open Label Stabilization Phase|Adverse Event|0|||
125084700|NCT03661983|449926553|FG003|Open Label Stabilization Phase|Adverse Event|0|||
125084701|NCT03661983|449926550|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
125084702|NCT03661983|449926551|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
125084703|NCT03661983|449926552|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
125084704|NCT03661983|449926553|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
125084705|NCT03661983|449926550|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
125084706|NCT03661983|449926551|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
125084707|NCT03661983|449926552|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
125084708|NCT03661983|449926553|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
125084709|NCT03661983|449926550|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
125084710|NCT03661983|449926551|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
125084711|NCT03661983|449926552|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
125084712|NCT03661983|449926553|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
125084713|NCT03661983|449926550|FG000|Double-blind Randomized Phase|Adverse Event|0|||
125084714|NCT03661983|449926551|FG001|Double-blind Randomized Phase|Adverse Event|1|||
125084715|NCT03661983|449926552|FG002|Double-blind Randomized Phase|Adverse Event|0|||
125084716|NCT03661983|449926553|FG003|Double-blind Randomized Phase|Adverse Event|0|||
125084717|NCT03661983|449926550|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
125084718|NCT03661983|449926551|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
125084719|NCT03661983|449926552|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
125084720|NCT03661983|449926553|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
125084721|NCT03661983|449926550|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
125084722|NCT03661983|449926551|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
125084723|NCT03661983|449926552|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
125084724|NCT03661983|449926553|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
125084725|NCT03661983|449926550|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
125084726|NCT03661983|449926551|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
125084727|NCT03661983|449926552|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
125084728|NCT03661983|449926553|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
125084729|NCT00166504|449926557|FG000|Overall Study|Adverse Event|3|||
125145049|NCT01332968|450155930|FG006|Follow-Up Period|Protocol Violation|1|||
125145050|NCT01332968|450155931|FG007|Follow-Up Period|Protocol Violation|0|||
125145051|NCT01332968|450155924|FG000|Follow-Up Period|Withdrawal by Subject|0|||
125145052|NCT01332968|450155925|FG001|Follow-Up Period|Withdrawal by Subject|0|||
125145053|NCT01332968|450155926|FG002|Follow-Up Period|Withdrawal by Subject|0|||
125145054|NCT01332968|450155927|FG003|Follow-Up Period|Withdrawal by Subject|0|||
125145055|NCT01332968|450155928|FG004|Follow-Up Period|Withdrawal by Subject|0|||
125145056|NCT01332968|450155929|FG005|Follow-Up Period|Withdrawal by Subject|0|||
125145057|NCT01332968|450155930|FG006|Follow-Up Period|Withdrawal by Subject|29|||
125145058|NCT01332968|450155931|FG007|Follow-Up Period|Withdrawal by Subject|32|||
125145059|NCT01332968|450155924|FG000|Follow-Up Period|No reason provided|0|||
125145060|NCT01332968|450155925|FG001|Follow-Up Period|No reason provided|0|||
125145061|NCT01332968|450155926|FG002|Follow-Up Period|No reason provided|0|||
125145062|NCT01332968|450155927|FG003|Follow-Up Period|No reason provided|0|||
125145063|NCT01332968|450155928|FG004|Follow-Up Period|No reason provided|0|||
125145064|NCT01332968|450155929|FG005|Follow-Up Period|No reason provided|0|||
125145065|NCT01332968|450155930|FG006|Follow-Up Period|No reason provided|2|||
125145066|NCT01332968|450155931|FG007|Follow-Up Period|No reason provided|3|||
125145067|NCT00113919|450155938|FG000|Overall Study|Physician Decision|8|||
125084730|NCT00166504|449926558|FG001|Overall Study|Adverse Event|3|||
125084731|NCT00166504|449926557|FG000|Overall Study|Lost to Follow-up|1|||
125084732|NCT00166504|449926558|FG001|Overall Study|Lost to Follow-up|1|||
125084733|NCT00166504|449926557|FG000|Overall Study|Withdrawal by Subject|1|||
125084734|NCT00166504|449926558|FG001|Overall Study|Withdrawal by Subject|0|||
125084735|NCT02094612|449926559|FG000|Overall Study|Lost to Follow-up|47|||
125084736|NCT02094612|449926560|FG001|Overall Study|Lost to Follow-up|47|||
125084737|NCT02094612|449926559|FG000|Overall Study|Never started ADHD medication|32|||
125084738|NCT02094612|449926560|FG001|Overall Study|Never started ADHD medication|23|||
125084739|NCT01222767|449926561|FG000|Overall Study|Progressive disease|13|||
125084740|NCT01222767|449926561|FG000|Overall Study|Adverse Event|2|||
125084741|NCT01222767|449926561|FG000|Overall Study|Surgical resection|1|||
125084742|NCT01222767|449926561|FG000|Overall Study|Never treated|1|||
125084743|NCT00723489|449926562|FG000|Overall Study|Physician Decision|0|||
125084744|NCT00723489|449926563|FG001|Overall Study|Physician Decision|1|||
125084745|NCT00723489|449926564|FG002|Overall Study|Physician Decision|0|||
125084746|NCT00723489|449926565|FG003|Overall Study|Physician Decision|0|||
125084747|NCT00723489|449926562|FG000|Overall Study|Pregnancy|0|||
125084748|NCT00723489|449926563|FG001|Overall Study|Pregnancy|0|||
125084749|NCT00723489|449926564|FG002|Overall Study|Pregnancy|0|||
125084750|NCT00723489|449926565|FG003|Overall Study|Pregnancy|1|||
125084751|NCT00723489|449926562|FG000|Overall Study|Withdrawal by Subject|0|||
125084752|NCT00723489|449926563|FG001|Overall Study|Withdrawal by Subject|0|||
125145068|NCT00113919|450155938|FG000|Overall Study|Death|6|||
125145069|NCT00715676|450155942|FG000|Overall Study|Adverse Event|3|||
125145070|NCT00715676|450155943|FG001|Overall Study|Adverse Event|5|||
125145071|NCT00715676|450155944|FG002|Overall Study|Adverse Event|21|||
125145072|NCT00715676|450155942|FG000|Overall Study|Withdrawal by Subject|1|||
125084753|NCT00723489|449926564|FG002|Overall Study|Withdrawal by Subject|0|||
125084754|NCT00723489|449926565|FG003|Overall Study|Withdrawal by Subject|1|||
125084755|NCT00723489|449926562|FG000|Overall Study|Seropositive at baseline|1|||
125084756|NCT00723489|449926563|FG001|Overall Study|Seropositive at baseline|0|||
125084757|NCT00723489|449926564|FG002|Overall Study|Seropositive at baseline|0|||
125084758|NCT00723489|449926565|FG003|Overall Study|Seropositive at baseline|0|||
125145073|NCT00715676|450155943|FG001|Overall Study|Withdrawal by Subject|3|||
125084759|NCT00723489|449926562|FG000|Overall Study|Prohibited Medication|0|||
125084760|NCT00723489|449926563|FG001|Overall Study|Prohibited Medication|0|||
125084761|NCT00723489|449926564|FG002|Overall Study|Prohibited Medication|0|||
125145074|NCT00715676|450155944|FG002|Overall Study|Withdrawal by Subject|8|||
125145075|NCT00715676|450155942|FG000|Overall Study|Lost to Follow-up|1|||
125145076|NCT00715676|450155943|FG001|Overall Study|Lost to Follow-up|2|||
125145077|NCT00715676|450155944|FG002|Overall Study|Lost to Follow-up|1|||
125145078|NCT00715676|450155942|FG000|Overall Study|Terminated by Sponsor|1|||
125145079|NCT00715676|450155943|FG001|Overall Study|Terminated by Sponsor|0|||
125145080|NCT00715676|450155944|FG002|Overall Study|Terminated by Sponsor|0|||
125145081|NCT00715676|450155942|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
125145082|NCT00715676|450155943|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
125145083|NCT00715676|450155944|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
125084762|NCT00723489|449926565|FG003|Overall Study|Prohibited Medication|1|||
125084763|NCT00723489|449926562|FG000|Overall Study|Samples Collected Out of Window|0|||
125084764|NCT00723489|449926563|FG001|Overall Study|Samples Collected Out of Window|3|||
125084765|NCT00723489|449926564|FG002|Overall Study|Samples Collected Out of Window|0|||
125084766|NCT00723489|449926565|FG003|Overall Study|Samples Collected Out of Window|0|||
125084767|NCT00081263|449926566|FG000|Overall Study|clerical error|1|||
125084768|NCT00081263|449926567|FG001|Overall Study|clerical error|0|||
125084769|NCT00081263|449926566|FG000|Overall Study|wrong cell type|7|||
125084770|NCT00081263|449926567|FG001|Overall Study|wrong cell type|5|||
125084771|NCT00081263|449926566|FG000|Overall Study|improper pre-protocol therapy|0|||
125084772|NCT00081263|449926567|FG001|Overall Study|improper pre-protocol therapy|1|||
125084773|NCT00081263|449926566|FG000|Overall Study|Inadequate pathology|0|||
125084774|NCT00081263|449926567|FG001|Overall Study|Inadequate pathology|1|||
125084775|NCT00081263|449926566|FG000|Overall Study|Never treated|4|||
125084776|NCT00081263|449926567|FG001|Overall Study|Never treated|5|||
125084777|NCT00081263|449926566|FG000|Overall Study|Inadequate data|5|||
125084778|NCT00081263|449926567|FG001|Overall Study|Inadequate data|10|||
125084779|NCT04517253|449926568|FG000|Primary Treatment Period|Adverse Event|1|||
125084780|NCT04517253|449926569|FG001|Primary Treatment Period|Adverse Event|0|||
125084781|NCT04517253|449926570|FG002|Primary Treatment Period|Adverse Event|0|||
125084782|NCT04517253|449926568|FG000|Primary Treatment Period|Death|0|||
125084783|NCT04517253|449926569|FG001|Primary Treatment Period|Death|1|||
125084784|NCT04517253|449926570|FG002|Primary Treatment Period|Death|0|||
125084785|NCT04517253|449926568|FG000|Maintenance Period|Withdrawal by Subject|1|||
125084786|NCT04517253|449926569|FG001|Maintenance Period|Withdrawal by Subject|0|||
125084787|NCT04517253|449926570|FG002|Maintenance Period|Withdrawal by Subject|0|||
125084788|NCT04517253|449926568|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
125084789|NCT04517253|449926569|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
125084790|NCT04517253|449926570|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
125084791|NCT02559115|449926571|FG000|Overall Study|Withdrawal by Subject|3|||
125084792|NCT02060903|449926574|FG000|Overall Study|Lost to Follow-up|4|||
125084793|NCT02060903|449926575|FG001|Overall Study|Lost to Follow-up|0|||
125084794|NCT02060903|449926574|FG000|Overall Study|Withdrawal by Subject|0|||
125084795|NCT02060903|449926575|FG001|Overall Study|Withdrawal by Subject|7|||
125084796|NCT00958191|449926584|FG000|Overall Study|Death|4|||
125084797|NCT00958191|449926584|FG000|Overall Study|Lost to Follow-up|5|||
125084798|NCT00958191|449926584|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
125084799|NCT00958191|449926584|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
125084800|NCT00958191|449926584|FG000|Overall Study|Revision of study device|4|||
125084801|NCT00958191|449926584|FG000|Overall Study|Site termination|11|||
125084802|NCT00958191|449926584|FG000|Overall Study|No 5 yr x-rays|56|||
125084803|NCT00611767|449926585|FG000|Overall Study|Withdrawal by Subject|4|||
125084804|NCT00611767|449926586|FG001|Overall Study|Withdrawal by Subject|1|||
125084805|NCT00611767|449926585|FG000|Overall Study|Thiopental not available|3|||
125084806|NCT00611767|449926586|FG001|Overall Study|Thiopental not available|0|||
125084807|NCT00611767|449926585|FG000|Overall Study|didn't like the medication|1|||
125084808|NCT00611767|449926586|FG001|Overall Study|didn't like the medication|1|||
125084809|NCT00611767|449926585|FG000|Overall Study|Physician Decision|1|||
125084810|NCT00611767|449926586|FG001|Overall Study|Physician Decision|0|||
125084811|NCT02010567|449926587|FG000|Overall Study|Adverse Event|0|||
125084812|NCT02010567|449926588|FG001|Overall Study|Adverse Event|0|||
125084813|NCT02010567|449926589|FG002|Overall Study|Adverse Event|1|||
125084814|NCT02010567|449926590|FG003|Overall Study|Adverse Event|0|||
125084815|NCT02010567|449926591|FG004|Overall Study|Adverse Event|1|||
125084816|NCT00118040|449926592|FG000|Overall Study|Adverse Event|0|||
125084817|NCT00118040|449926593|FG001|Overall Study|Adverse Event|1|||
125084818|NCT00118040|449926594|FG002|Overall Study|Adverse Event|0|||
125084819|NCT00118040|449926592|FG000|Overall Study|Withdrawal by Subject|0|||
125084820|NCT00118040|449926593|FG001|Overall Study|Withdrawal by Subject|0|||
125084821|NCT00118040|449926594|FG002|Overall Study|Withdrawal by Subject|2|||
125084822|NCT00118040|449926592|FG000|Overall Study|Medical Contraindication|0|||
125084823|NCT00118040|449926593|FG001|Overall Study|Medical Contraindication|0|||
125084824|NCT00118040|449926594|FG002|Overall Study|Medical Contraindication|1|||
125084825|NCT00118040|449926592|FG000|Overall Study|Non-Compliant Participant|1|||
125084826|NCT00118040|449926593|FG001|Overall Study|Non-Compliant Participant|1|||
125084827|NCT00118040|449926594|FG002|Overall Study|Non-Compliant Participant|2|||
125084828|NCT00118040|449926592|FG000|Overall Study|Other|0|||
125084829|NCT00118040|449926593|FG001|Overall Study|Other|0|||
125084830|NCT00118040|449926594|FG002|Overall Study|Other|1|||
125084831|NCT03117309|449926597|FG000|Overall Study|Not meeting inclusion criteria|0|||
125084832|NCT03117309|449926598|FG001|Overall Study|Not meeting inclusion criteria|1|||
125084833|NCT04048876|449926599|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
125084834|NCT04048876|449926600|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
125084835|NCT04048876|449926601|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
125084836|NCT04048876|449926602|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
125084837|NCT04048876|449926599|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
125084838|NCT04048876|449926600|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
125084839|NCT04048876|449926601|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
125084840|NCT04048876|449926602|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
125084841|NCT04048876|449926599|FG000|Placebo Controlled Phase|Adverse Event|0|||
125084842|NCT04048876|449926600|FG001|Placebo Controlled Phase|Adverse Event|1|||
125084843|NCT04048876|449926601|FG002|Placebo Controlled Phase|Adverse Event|0|||
125084844|NCT04048876|449926602|FG003|Placebo Controlled Phase|Adverse Event|0|||
125084845|NCT04048876|449926599|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
125084846|NCT04048876|449926600|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
125084847|NCT04048876|449926601|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
125084848|NCT04048876|449926602|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
125084849|NCT01347840|449926611|FG000|Overall Study|Withdrawal by Subject|1|||
125084850|NCT01010776|449926614|FG000|Main Phase|Withdrawal by Subject|14|||
125084851|NCT01010776|449926614|FG000|Main Phase|Lack of Efficacy|8|||
125084852|NCT01010776|449926614|FG000|Main Phase|Adverse Event|7|||
125084853|NCT01010776|449926614|FG000|Main Phase|Lost to Follow-up|6|||
125084854|NCT01010776|449926614|FG000|Main Phase|Non-compliance to study medication|5|||
125084855|NCT01010776|449926614|FG000|Main Phase|Selection failure|2|||
125084856|NCT01010776|449926614|FG000|Main Phase|Inform consent withdrawal|1|||
125084857|NCT01010776|449926614|FG000|Main Phase|Other|1|||
125084858|NCT01010776|449926614|FG000|Main Phase|Did not received study medication|5|||
125084859|NCT01010776|449926614|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
125084860|NCT01010776|449926614|FG000|Extension Phase|Other|3|||
125084861|NCT01012037|449926616|FG000|Overall Study|Adverse Event|0|||
125084862|NCT01012037|449926617|FG001|Overall Study|Adverse Event|8|||
125084863|NCT01012037|449926618|FG002|Overall Study|Adverse Event|3|||
125084864|NCT01012037|449926616|FG000|Overall Study|Protocol Violation|0|||
125084865|NCT01012037|449926617|FG001|Overall Study|Protocol Violation|3|||
125084866|NCT01012037|449926618|FG002|Overall Study|Protocol Violation|5|||
125084867|NCT01012037|449926616|FG000|Overall Study|Withdrawal by Subject|0|||
125084868|NCT01012037|449926617|FG001|Overall Study|Withdrawal by Subject|4|||
125084869|NCT01012037|449926618|FG002|Overall Study|Withdrawal by Subject|1|||
125084870|NCT01012037|449926616|FG000|Overall Study|Other reason (not specified)|1|||
125084871|NCT01012037|449926617|FG001|Overall Study|Other reason (not specified)|1|||
125084872|NCT01012037|449926618|FG002|Overall Study|Other reason (not specified)|1|||
125084873|NCT02583711|449926619|FG000|Overall Study|Withdrawal by Subject|0|||
125084874|NCT02583711|449926620|FG001|Overall Study|Withdrawal by Subject|10|||
125084875|NCT02583711|449926621|FG002|Overall Study|Withdrawal by Subject|0|||
125084876|NCT00415623|449926623|FG000|Overall Study|Adverse Event|3|||
125084877|NCT00415623|449926624|FG001|Overall Study|Adverse Event|4|||
125084878|NCT00415623|449926623|FG000|Overall Study|Death|1|||
125084879|NCT00415623|449926624|FG001|Overall Study|Death|0|||
125084880|NCT00415623|449926623|FG000|Overall Study|Withdrawal by Subject|1|||
125084881|NCT00415623|449926624|FG001|Overall Study|Withdrawal by Subject|1|||
125084882|NCT05307523|449926625|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
125084883|NCT05307523|449926626|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
125084884|NCT05307523|449926625|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
125084885|NCT05307523|449926626|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
125084886|NCT00542425|449926632|FG000|Initial 24 Weeks|Administrative reasons|0|||
125084887|NCT00542425|449926633|FG001|Initial 24 Weeks|Administrative reasons|0|||
125084888|NCT00542425|449926634|FG002|Initial 24 Weeks|Administrative reasons|1|||
125084889|NCT00542425|449926635|FG003|Initial 24 Weeks|Administrative reasons|1|||
125084890|NCT00542425|449926636|FG004|Initial 24 Weeks|Administrative reasons|0|||
125084891|NCT00542425|449926632|FG000|Initial 24 Weeks|Adverse Event|0|||
125084892|NCT00542425|449926633|FG001|Initial 24 Weeks|Adverse Event|1|||
125084893|NCT00542425|449926634|FG002|Initial 24 Weeks|Adverse Event|1|||
125084894|NCT00542425|449926635|FG003|Initial 24 Weeks|Adverse Event|3|||
125084895|NCT00542425|449926636|FG004|Initial 24 Weeks|Adverse Event|2|||
125084896|NCT00542425|449926632|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
125084897|NCT00542425|449926633|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
125084898|NCT00542425|449926634|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
125084899|NCT00542425|449926635|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
125084900|NCT00542425|449926636|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
125084901|NCT00542425|449926632|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
125084902|NCT00542425|449926633|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
125084903|NCT00542425|449926634|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
125084904|NCT00542425|449926635|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
125084905|NCT00542425|449926636|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
125084906|NCT00542425|449926632|FG000|Initial 24 Weeks|Non-compliance|0|||
125084907|NCT00542425|449926633|FG001|Initial 24 Weeks|Non-compliance|0|||
125084908|NCT00542425|449926634|FG002|Initial 24 Weeks|Non-compliance|0|||
125084909|NCT00542425|449926635|FG003|Initial 24 Weeks|Non-compliance|1|||
125084910|NCT00542425|449926636|FG004|Initial 24 Weeks|Non-compliance|1|||
125084911|NCT00542425|449926632|FG000|Initial 24 Weeks|Protocol Violation|0|||
125084912|NCT00542425|449926633|FG001|Initial 24 Weeks|Protocol Violation|0|||
125084913|NCT00542425|449926634|FG002|Initial 24 Weeks|Protocol Violation|0|||
125084914|NCT00542425|449926635|FG003|Initial 24 Weeks|Protocol Violation|1|||
125084915|NCT00542425|449926636|FG004|Initial 24 Weeks|Protocol Violation|0|||
125084916|NCT00542425|449926632|FG000|Initial 24 Weeks|Refusal of treatment|2|||
125084917|NCT00542425|449926633|FG001|Initial 24 Weeks|Refusal of treatment|2|||
125084918|NCT00542425|449926634|FG002|Initial 24 Weeks|Refusal of treatment|1|||
125084919|NCT00542425|449926635|FG003|Initial 24 Weeks|Refusal of treatment|4|||
125084920|NCT00542425|449926636|FG004|Initial 24 Weeks|Refusal of treatment|1|||
125084921|NCT00542425|449926632|FG000|Initial 24 Weeks|Other|0|||
125084922|NCT00542425|449926633|FG001|Initial 24 Weeks|Other|2|||
125084923|NCT00542425|449926634|FG002|Initial 24 Weeks|Other|1|||
125084924|NCT00542425|449926635|FG003|Initial 24 Weeks|Other|0|||
125084925|NCT00542425|449926636|FG004|Initial 24 Weeks|Other|0|||
125084926|NCT00542425|449926632|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
125084927|NCT00542425|449926633|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
125084928|NCT00542425|449926634|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
125084929|NCT00542425|449926635|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
125084930|NCT00542425|449926636|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
125084931|NCT00542425|449926632|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
125084932|NCT00542425|449926633|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
125084933|NCT00542425|449926634|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
125084934|NCT00542425|449926635|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
125145084|NCT00715676|450155942|FG000|Overall Study|Use of Exclusionary Medication|0|||
125145085|NCT00715676|450155943|FG001|Overall Study|Use of Exclusionary Medication|0|||
125145086|NCT00715676|450155944|FG002|Overall Study|Use of Exclusionary Medication|1|||
125145087|NCT00715676|450155942|FG000|Overall Study|Elevated Blood Glucose|0|||
125145088|NCT00715676|450155943|FG001|Overall Study|Elevated Blood Glucose|1|||
125145089|NCT00715676|450155944|FG002|Overall Study|Elevated Blood Glucose|0|||
125084935|NCT00542425|449926636|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
125084936|NCT00542425|449926632|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
125084937|NCT00542425|449926633|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
125084938|NCT00542425|449926634|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
125145090|NCT00372996|450155945|FG000|Overall Study|Death|11|||
125145091|NCT00372996|450155946|FG001|Overall Study|Death|4|||
125145092|NCT00372996|450155947|FG002|Overall Study|Death|8|||
125145093|NCT00372996|450155948|FG003|Overall Study|Death|7|||
125145094|NCT00372996|450155945|FG000|Overall Study|Lost to Follow-up|0|||
125145095|NCT00372996|450155946|FG001|Overall Study|Lost to Follow-up|2|||
125145096|NCT00372996|450155947|FG002|Overall Study|Lost to Follow-up|0|||
125145097|NCT00372996|450155948|FG003|Overall Study|Lost to Follow-up|1|||
125145098|NCT00372996|450155945|FG000|Overall Study|Withdrawal by Subject|12|||
125145099|NCT00372996|450155946|FG001|Overall Study|Withdrawal by Subject|6|||
125145100|NCT00372996|450155947|FG002|Overall Study|Withdrawal by Subject|9|||
125084939|NCT00542425|449926635|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
125084940|NCT00542425|449926636|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
125084941|NCT00542425|449926632|FG000|Extended 24 Weeks of Treatment|Other|1|||
125084942|NCT00542425|449926633|FG001|Extended 24 Weeks of Treatment|Other|1|||
125084943|NCT00542425|449926634|FG002|Extended 24 Weeks of Treatment|Other|0|||
125084944|NCT00542425|449926635|FG003|Extended 24 Weeks of Treatment|Other|0|||
125084945|NCT00542425|449926636|FG004|Extended 24 Weeks of Treatment|Other|1|||
125084946|NCT02096471|449926637|FG000|Overall Study|Adverse Event|1|||
125084947|NCT02096471|449926637|FG000|Overall Study|Lack of Efficacy|7|||
125084948|NCT02096471|449926637|FG000|Overall Study|Withdrawal by Subject|3|||
125084949|NCT02096471|449926637|FG000|Overall Study|Non-Compliant|2|||
125084950|NCT01610414|449926638|FG000|Study Start - Month 13|Serious Adverse Event|65|||
125084951|NCT01610414|449926639|FG001|Study Start - Month 13|Serious Adverse Event|67|||
125084952|NCT01610414|449926638|FG000|Study Start - Month 13|Adverse Event|14|||
125084953|NCT01610414|449926639|FG001|Study Start - Month 13|Adverse Event|14|||
125084954|NCT01610414|449926638|FG000|Study Start - Month 13|Protocol Violation|3|||
125084955|NCT01610414|449926639|FG001|Study Start - Month 13|Protocol Violation|1|||
125084956|NCT01610414|449926638|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
125084957|NCT01610414|449926639|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
125084958|NCT01610414|449926638|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
125084959|NCT01610414|449926639|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
125084960|NCT01610414|449926638|FG000|Study Start - Month 13|Lost to Follow-up|4|||
125145101|NCT00372996|450155948|FG003|Overall Study|Withdrawal by Subject|5|||
125145102|NCT00372996|450155945|FG000|Overall Study|Study Terminated by Sponsor|4|||
125084961|NCT01610414|449926639|FG001|Study Start - Month 13|Lost to Follow-up|6|||
125145103|NCT00372996|450155946|FG001|Overall Study|Study Terminated by Sponsor|0|||
125145104|NCT00372996|450155947|FG002|Overall Study|Study Terminated by Sponsor|4|||
125145105|NCT00372996|450155948|FG003|Overall Study|Study Terminated by Sponsor|0|||
125084962|NCT01610414|449926638|FG000|Study Start - Month 13|Suspected HZ episode|1|||
125084963|NCT01610414|449926639|FG001|Study Start - Month 13|Suspected HZ episode|3|||
125084964|NCT01610414|449926638|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
125084965|NCT01610414|449926639|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
125145106|NCT00372996|450155945|FG000|Overall Study|Other|10|||
125145107|NCT00372996|450155946|FG001|Overall Study|Other|2|||
125145108|NCT00372996|450155947|FG002|Overall Study|Other|7|||
125145109|NCT00372996|450155948|FG003|Overall Study|Other|7|||
125084966|NCT01610414|449926638|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
125084967|NCT01610414|449926639|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
125084968|NCT01610414|449926638|FG000|Month 13 - Month 25|Adverse Event|8|||
125084969|NCT01610414|449926639|FG001|Month 13 - Month 25|Adverse Event|4|||
125084970|NCT01610414|449926638|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
125084971|NCT01610414|449926639|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
125084972|NCT01610414|449926638|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
125084973|NCT01610414|449926639|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
125084974|NCT01610414|449926638|FG000|Month 13 - Month 25|Protocol Violation|0|||
125084975|NCT01610414|449926639|FG001|Month 13 - Month 25|Protocol Violation|2|||
125084976|NCT01610414|449926638|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
125084977|NCT01610414|449926639|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
125084978|NCT01610414|449926638|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
125084979|NCT01610414|449926639|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
125084980|NCT01610414|449926638|FG000|After Month 25|Study end not reached|48|||
125084981|NCT01610414|449926639|FG001|After Month 25|Study end not reached|53|||
125084982|NCT02736474|449926640|FG000|Overall Study|Lost to Follow-up|0|||
125084983|NCT02736474|449926641|FG001|Overall Study|Lost to Follow-up|1|||
125084984|NCT02483611|449926642|FG000|Overall Study|Protocol Violation|0|||
125084985|NCT02483611|449926643|FG001|Overall Study|Protocol Violation|0|||
125084986|NCT02483611|449926644|FG002|Overall Study|Protocol Violation|1|||
125084987|NCT02382276|449926645|FG000|Overall Study|Withdrawal by Subject|4|||
125084988|NCT02382276|449926646|FG001|Overall Study|Withdrawal by Subject|8|||
125084989|NCT02382276|449926647|FG002|Overall Study|Withdrawal by Subject|5|||
125084990|NCT02382276|449926645|FG000|Overall Study|Adverse Event|7|||
125084991|NCT02382276|449926646|FG001|Overall Study|Adverse Event|2|||
125084992|NCT02382276|449926647|FG002|Overall Study|Adverse Event|32|||
125084993|NCT02382276|449926645|FG000|Overall Study|Physician Decision|0|||
125084994|NCT02382276|449926646|FG001|Overall Study|Physician Decision|0|||
125084995|NCT02382276|449926647|FG002|Overall Study|Physician Decision|2|||
125084996|NCT04223778|449926650|FG000|Overall Study|Death|1|||
125084997|NCT04223778|449926651|FG001|Overall Study|Death|1|||
125084998|NCT04223778|449926650|FG000|Overall Study|Lost to Follow-up|4|||
125084999|NCT04223778|449926651|FG001|Overall Study|Lost to Follow-up|5|||
125085000|NCT04223778|449926650|FG000|Overall Study|Physician Decision|10|||
125085001|NCT04223778|449926651|FG001|Overall Study|Physician Decision|6|||
125085002|NCT04223778|449926650|FG000|Overall Study|Withdrawal by Subject|35|||
125085003|NCT04223778|449926651|FG001|Overall Study|Withdrawal by Subject|17|||
125085004|NCT04223778|449926650|FG000|Overall Study|Not Reported|7|||
125085005|NCT04223778|449926651|FG001|Overall Study|Not Reported|8|||
125085006|NCT03893630|449926652|FG000|Overall Study|Lost to Follow-up|5|||
125085007|NCT03893630|449926653|FG001|Overall Study|Lost to Follow-up|4|||
125085008|NCT03893630|449926654|FG002|Overall Study|Lost to Follow-up|2|||
125085009|NCT03893630|449926652|FG000|Overall Study|Withdrawal by Subject|3|||
125085010|NCT03893630|449926653|FG001|Overall Study|Withdrawal by Subject|6|||
125085011|NCT03893630|449926654|FG002|Overall Study|Withdrawal by Subject|3|||
125085012|NCT03893630|449926652|FG000|Overall Study|Discontinued Intervention|0|||
125085013|NCT03893630|449926653|FG001|Overall Study|Discontinued Intervention|4|||
125085014|NCT03893630|449926654|FG002|Overall Study|Discontinued Intervention|2|||
125085015|NCT01569568|449928143|FG000|Overall Study|Physician Decision|0|||
125085016|NCT01569568|449928144|FG001|Overall Study|Physician Decision|2|||
125085017|NCT01370499|449928145|FG000|Overall Study|Adverse Event|38|||
125085018|NCT01370499|449928146|FG001|Overall Study|Adverse Event|12|||
125085019|NCT01370499|449928145|FG000|Overall Study|Lack of Efficacy|4|||
125085020|NCT01370499|449928146|FG001|Overall Study|Lack of Efficacy|2|||
125085021|NCT01370499|449928145|FG000|Overall Study|Lost to Follow-up|2|||
125085022|NCT01370499|449928146|FG001|Overall Study|Lost to Follow-up|1|||
125085023|NCT01370499|449928145|FG000|Overall Study|Physician Decision|3|||
125085024|NCT01370499|449928146|FG001|Overall Study|Physician Decision|3|||
125085025|NCT01370499|449928145|FG000|Overall Study|Protocol Violation|5|||
125085026|NCT01370499|449928146|FG001|Overall Study|Protocol Violation|4|||
125085027|NCT01370499|449928145|FG000|Overall Study|Withdrawal by Subject|18|||
125085028|NCT01370499|449928146|FG001|Overall Study|Withdrawal by Subject|7|||
125085029|NCT01370499|449928145|FG000|Overall Study|Sponsor Decision|41|||
125085030|NCT01370499|449928146|FG001|Overall Study|Sponsor Decision|15|||
125085031|NCT00887822|449928147|FG000|Overall Study|Insufficient therapeutic response|53|||
125085032|NCT00887822|449928148|FG001|Overall Study|Insufficient therapeutic response|55|||
125223539|NCT02326272|450446168|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
125085033|NCT00887822|449928147|FG000|Overall Study|Adverse Event|14|||
125085034|NCT00887822|449928148|FG001|Overall Study|Adverse Event|17|||
125085035|NCT00887822|449928147|FG000|Overall Study|Failure to return|11|||
125085036|NCT00887822|449928148|FG001|Overall Study|Failure to return|11|||
125085037|NCT00887822|449928147|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
125085038|NCT00887822|449928148|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
125085039|NCT00887822|449928147|FG000|Overall Study|Administrative/Other than specified|5|||
125085040|NCT00887822|449928148|FG001|Overall Study|Administrative/Other than specified|4|||
125085041|NCT00887822|449928147|FG000|Overall Study|Death|2|||
125085042|NCT00887822|449928148|FG001|Overall Study|Death|3|||
125085043|NCT00887822|449928147|FG000|Overall Study|Protocol Violation|0|||
125085044|NCT00887822|449928148|FG001|Overall Study|Protocol Violation|1|||
125085045|NCT00887822|449928147|FG000|Overall Study|Randomized but not treated|0|||
125085046|NCT00887822|449928148|FG001|Overall Study|Randomized but not treated|1|||
125085047|NCT02045979|449928149|FG000|Overall Study|Informed Consent Withdrawn|2|||
125085048|NCT02045979|449928150|FG001|Overall Study|Informed Consent Withdrawn|0|||
125085049|NCT02045979|449928151|FG002|Overall Study|Informed Consent Withdrawn|1|||
125085050|NCT02045979|449928149|FG000|Overall Study|not specified above|0|||
125085051|NCT02045979|449928150|FG001|Overall Study|not specified above|1|||
125085052|NCT02045979|449928151|FG002|Overall Study|not specified above|0|||
125085053|NCT02425891|449928152|FG000|Overall Study|Death|333|||
125085054|NCT02425891|449928153|FG001|Overall Study|Death|314|||
125085055|NCT02425891|449928152|FG000|Overall Study|Lost to Follow-up|4|||
125085056|NCT02425891|449928153|FG001|Overall Study|Lost to Follow-up|6|||
125085057|NCT02425891|449928152|FG000|Overall Study|Non-Compliance|1|||
125085058|NCT02425891|449928153|FG001|Overall Study|Non-Compliance|1|||
125085059|NCT02425891|449928152|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
125085060|NCT02425891|449928153|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
125085061|NCT02425891|449928152|FG000|Overall Study|Physician Decision|0|||
125085062|NCT02425891|449928153|FG001|Overall Study|Physician Decision|1|||
125085063|NCT02425891|449928152|FG000|Overall Study|Protocol Violation|1|||
125085064|NCT02425891|449928153|FG001|Overall Study|Protocol Violation|1|||
125085065|NCT02425891|449928152|FG000|Overall Study|Study Terminated By Sponsor|85|||
125085066|NCT02425891|449928153|FG001|Overall Study|Study Terminated By Sponsor|95|||
125085067|NCT02425891|449928152|FG000|Overall Study|Withdrawal by Subject|27|||
125085068|NCT02425891|449928153|FG001|Overall Study|Withdrawal by Subject|32|||
125085069|NCT01944462|449928155|FG000|PPPP Educational Program|Lost to Follow-up|60|||
125085070|NCT01599585|449928156|FG000|Overall Study|Withdrawal by Subject|16|||
125085071|NCT01599585|449928157|FG001|Overall Study|Withdrawal by Subject|9|||
125085072|NCT01599585|449928156|FG000|Overall Study|Lost to Follow-up|3|||
125085073|NCT01599585|449928157|FG001|Overall Study|Lost to Follow-up|5|||
125085074|NCT01599585|449928156|FG000|Overall Study|randomized did not start treatment|3|||
125085075|NCT01599585|449928157|FG001|Overall Study|randomized did not start treatment|3|||
125085076|NCT05827978|449928158|FG000|Overall Study|Adverse Event|1|||
125085077|NCT05827978|449928159|FG001|Overall Study|Adverse Event|0|||
125085078|NCT05827978|449928160|FG002|Overall Study|Adverse Event|0|||
125085079|NCT05827978|449928161|FG003|Overall Study|Adverse Event|1|||
125085080|NCT05827978|449928162|FG004|Overall Study|Adverse Event|0|||
125085081|NCT05827978|449928163|FG005|Overall Study|Adverse Event|0|||
125085082|NCT05827978|449928158|FG000|Overall Study|Death|1|||
125085083|NCT05827978|449928159|FG001|Overall Study|Death|5|||
125085084|NCT05827978|449928160|FG002|Overall Study|Death|2|||
125085085|NCT05827978|449928161|FG003|Overall Study|Death|3|||
125085086|NCT05827978|449928162|FG004|Overall Study|Death|1|||
125085087|NCT05827978|449928163|FG005|Overall Study|Death|3|||
125085088|NCT05827978|449928158|FG000|Overall Study|Lost to Follow-up|57|||
125085089|NCT05827978|449928159|FG001|Overall Study|Lost to Follow-up|88|||
125085090|NCT05827978|449928160|FG002|Overall Study|Lost to Follow-up|54|||
125085091|NCT05827978|449928161|FG003|Overall Study|Lost to Follow-up|47|||
125085092|NCT05827978|449928162|FG004|Overall Study|Lost to Follow-up|25|||
125085093|NCT05827978|449928163|FG005|Overall Study|Lost to Follow-up|10|||
125085094|NCT05827978|449928158|FG000|Overall Study|Noncompliance with Study Procedures|0|||
125085095|NCT05827978|449928159|FG001|Overall Study|Noncompliance with Study Procedures|1|||
125085096|NCT05827978|449928160|FG002|Overall Study|Noncompliance with Study Procedures|1|||
125085097|NCT05827978|449928161|FG003|Overall Study|Noncompliance with Study Procedures|1|||
125085098|NCT05827978|449928162|FG004|Overall Study|Noncompliance with Study Procedures|1|||
125085099|NCT05827978|449928163|FG005|Overall Study|Noncompliance with Study Procedures|0|||
125085100|NCT05827978|449928158|FG000|Overall Study|Physician Decision|2|||
125085101|NCT05827978|449928159|FG001|Overall Study|Physician Decision|0|||
125085102|NCT05827978|449928160|FG002|Overall Study|Physician Decision|1|||
125085103|NCT05827978|449928161|FG003|Overall Study|Physician Decision|2|||
125085104|NCT05827978|449928162|FG004|Overall Study|Physician Decision|1|||
125085105|NCT05827978|449928163|FG005|Overall Study|Physician Decision|1|||
125085106|NCT05827978|449928158|FG000|Overall Study|Protocol Violation|5|||
125085107|NCT05827978|449928159|FG001|Overall Study|Protocol Violation|2|||
125085108|NCT05827978|449928160|FG002|Overall Study|Protocol Violation|0|||
125085109|NCT05827978|449928161|FG003|Overall Study|Protocol Violation|0|||
125085110|NCT05827978|449928162|FG004|Overall Study|Protocol Violation|0|||
125085111|NCT05827978|449928163|FG005|Overall Study|Protocol Violation|0|||
125085112|NCT05827978|449928158|FG000|Overall Study|Withdrawal by Subject|17|||
125085113|NCT05827978|449928159|FG001|Overall Study|Withdrawal by Subject|16|||
125085114|NCT05827978|449928160|FG002|Overall Study|Withdrawal by Subject|10|||
125085115|NCT05827978|449928161|FG003|Overall Study|Withdrawal by Subject|12|||
125085116|NCT05827978|449928162|FG004|Overall Study|Withdrawal by Subject|10|||
125085117|NCT05827978|449928163|FG005|Overall Study|Withdrawal by Subject|9|||
125085118|NCT05827978|449928158|FG000|Overall Study|Other Than Specified|0|||
125085119|NCT05827978|449928159|FG001|Overall Study|Other Than Specified|0|||
125085120|NCT05827978|449928160|FG002|Overall Study|Other Than Specified|1|||
125085121|NCT05827978|449928161|FG003|Overall Study|Other Than Specified|0|||
125085122|NCT05827978|449928162|FG004|Overall Study|Other Than Specified|2|||
125085123|NCT05827978|449928163|FG005|Overall Study|Other Than Specified|0|||
125085124|NCT00729560|449928164|FG000|Overall Study|Withdrawal by Subject|3|||
125085125|NCT00103207|449928165|FG000|Overall Study|Adverse Event|3|||
125085126|NCT00103207|449928165|FG000|Overall Study|Death|1|||
125085127|NCT00103207|449928165|FG000|Overall Study|Withdrawal by Subject|2|||
125085128|NCT00103207|449928165|FG000|Overall Study|Other complicating disease|1|||
125085129|NCT00103207|449928165|FG000|Overall Study|Ineligible|4|||
125085130|NCT00103207|449928165|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
125085131|NCT03662789|449928166|FG000|Overall Study|Lost to Follow-up|1|||
125085132|NCT03662789|449928167|FG001|Overall Study|Lost to Follow-up|2|||
125085133|NCT03662789|449928166|FG000|Overall Study|Could not perform treadmill test|4|||
125085134|NCT03662789|449928167|FG001|Overall Study|Could not perform treadmill test|4|||
125085135|NCT03662789|449928166|FG000|Overall Study|Death|0|||
125085136|NCT03662789|449928167|FG001|Overall Study|Death|1|||
125085137|NCT01029691|449928168|FG000|Continued APAP to Delivery|Death|0|||
125085138|NCT01029691|449928169|FG001|Continued APAP to Delivery|Death|0|||
125085139|NCT01029691|449928170|FG002|Continued APAP to Delivery|Death|1|||
125085140|NCT01023516|449928171|FG000|Overall Study|Voluntary discontinuation|7|||
125085141|NCT01023516|449928172|FG001|Overall Study|Voluntary discontinuation|5|||
125085142|NCT01023516|449928171|FG000|Overall Study|Adverse Event|9|||
125085143|NCT01023516|449928172|FG001|Overall Study|Adverse Event|6|||
125085144|NCT01023516|449928171|FG000|Overall Study|Safety reason|0|||
125085145|NCT01023516|449928172|FG001|Overall Study|Safety reason|3|||
125085146|NCT01023516|449928171|FG000|Overall Study|Study-specific criteria|4|||
125085147|NCT01023516|449928172|FG001|Overall Study|Study-specific criteria|2|||
125085148|NCT01023516|449928171|FG000|Overall Study|Incorrect enrolment|4|||
125085149|NCT01023516|449928172|FG001|Overall Study|Incorrect enrolment|2|||
125085150|NCT00137267|449928175|FG000|Overall Study|Lost to Follow-up|15|||
125085151|NCT00137267|449928176|FG001|Overall Study|Lost to Follow-up|21|||
125085152|NCT00638989|449928177|FG000|Overall Study|Lost to Follow-up|0|||
125085153|NCT00638989|449928178|FG001|Overall Study|Lost to Follow-up|0|||
125085154|NCT00638989|449928179|FG002|Overall Study|Lost to Follow-up|1|||
125085155|NCT00853112|449928180|FG000|Overall Study|Randomized but not treated|0|||
125085156|NCT00853112|449928181|FG001|Overall Study|Randomized but not treated|1|||
125085157|NCT00853112|449928182|FG002|Overall Study|Randomized but not treated|0|||
125085158|NCT00853112|449928183|FG003|Overall Study|Randomized but not treated|2|||
125085159|NCT00853112|449928184|FG004|Overall Study|Randomized but not treated|0|||
125085160|NCT00853112|449928185|FG005|Overall Study|Randomized but not treated|0|||
125085161|NCT00853112|449928186|FG006|Overall Study|Randomized but not treated|1|||
125085162|NCT01553591|449928187|FG000|Overall Study|Voluntarily withdrew|94|||
125085163|NCT01553591|449928188|FG001|Overall Study|Voluntarily withdrew|79|||
125085164|NCT01553591|449928189|FG002|Overall Study|Voluntarily withdrew|96|||
125085165|NCT01553591|449928187|FG000|Overall Study|Adverse Event|36|||
125085166|NCT01553591|449928188|FG001|Overall Study|Adverse Event|45|||
125085167|NCT01553591|449928189|FG002|Overall Study|Adverse Event|16|||
125085168|NCT01553591|449928187|FG000|Overall Study|Lost to Follow-up|25|||
125085169|NCT01553591|449928188|FG001|Overall Study|Lost to Follow-up|23|||
125085170|NCT01553591|449928189|FG002|Overall Study|Lost to Follow-up|16|||
125085171|NCT01553591|449928187|FG000|Overall Study|Physician decision: other|11|||
125085172|NCT01553591|449928188|FG001|Overall Study|Physician decision: other|14|||
125085173|NCT01553591|449928189|FG002|Overall Study|Physician decision: other|16|||
125085174|NCT01553591|449928187|FG000|Overall Study|Physician decision: lack of efficacy|2|||
125085175|NCT01553591|449928188|FG001|Overall Study|Physician decision: lack of efficacy|3|||
125085176|NCT01553591|449928189|FG002|Overall Study|Physician decision: lack of efficacy|7|||
125085177|NCT01553591|449928187|FG000|Overall Study|Protocol Violation|3|||
125085178|NCT01553591|449928188|FG001|Overall Study|Protocol Violation|4|||
125085179|NCT01553591|449928189|FG002|Overall Study|Protocol Violation|4|||
125085180|NCT01553591|449928187|FG000|Overall Study|Sponsor decision|1|||
125085181|NCT01553591|449928188|FG001|Overall Study|Sponsor decision|0|||
125085182|NCT01553591|449928189|FG002|Overall Study|Sponsor decision|3|||
125085183|NCT01553591|449928187|FG000|Overall Study|Randomized and never dispensed drug|0|||
125085184|NCT01553591|449928188|FG001|Overall Study|Randomized and never dispensed drug|1|||
125085185|NCT01553591|449928189|FG002|Overall Study|Randomized and never dispensed drug|0|||
125085186|NCT01818765|449928190|FG000|Overall Study|Death|2|||
125085187|NCT02005211|449928191|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
125085188|NCT02005211|449928192|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
125085189|NCT02005211|449928193|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
125085190|NCT02005211|449928194|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
125085191|NCT02005211|449928195|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
125085192|NCT02005211|449928196|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
125085193|NCT02005211|449928197|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
125085194|NCT00397631|449928199|FG000|Overall Study|Adverse Event|5|||
125085195|NCT00397631|449928200|FG001|Overall Study|Adverse Event|6|||
125085196|NCT00397631|449928199|FG000|Overall Study|Lack of Efficacy|7|||
125085197|NCT00397631|449928200|FG001|Overall Study|Lack of Efficacy|10|||
125085198|NCT00397631|449928199|FG000|Overall Study|Lost to Follow-up|8|||
125085199|NCT00397631|449928200|FG001|Overall Study|Lost to Follow-up|9|||
125085200|NCT00397631|449928199|FG000|Overall Study|Physician Decision|2|||
125085201|NCT00397631|449928200|FG001|Overall Study|Physician Decision|0|||
125085202|NCT00397631|449928199|FG000|Overall Study|Protocol Violation|0|||
125085203|NCT00397631|449928200|FG001|Overall Study|Protocol Violation|1|||
125085204|NCT00397631|449928199|FG000|Overall Study|Withdrawal by Subject|7|||
125085205|NCT00397631|449928200|FG001|Overall Study|Withdrawal by Subject|14|||
125085206|NCT00397631|449928199|FG000|Overall Study|protocol discontinuation criteria|1|||
125085207|NCT00397631|449928200|FG001|Overall Study|protocol discontinuation criteria|4|||
125085208|NCT02202161|449928201|FG000|Overall Study|Adverse Event|1|||
125085209|NCT02202161|449928202|FG001|Overall Study|Adverse Event|1|||
125085210|NCT02202161|449928203|FG002|Overall Study|Adverse Event|0|||
125085211|NCT02202161|449928204|FG003|Overall Study|Adverse Event|0|||
125085212|NCT02202161|449928205|FG004|Overall Study|Adverse Event|0|||
125085213|NCT02202161|449928206|FG005|Overall Study|Adverse Event|1|||
125085214|NCT02202161|449928207|FG006|Overall Study|Adverse Event|0|||
125085215|NCT02202161|449928208|FG007|Overall Study|Adverse Event|0|||
125085216|NCT02202161|449928201|FG000|Overall Study|Did not meet continuation criteria|0|||
125085217|NCT02202161|449928202|FG001|Overall Study|Did not meet continuation criteria|0|||
125085218|NCT02202161|449928203|FG002|Overall Study|Did not meet continuation criteria|0|||
125085219|NCT02202161|449928204|FG003|Overall Study|Did not meet continuation criteria|0|||
125085220|NCT02202161|449928205|FG004|Overall Study|Did not meet continuation criteria|0|||
125085221|NCT02202161|449928206|FG005|Overall Study|Did not meet continuation criteria|0|||
125085222|NCT02202161|449928207|FG006|Overall Study|Did not meet continuation criteria|0|||
125085223|NCT02202161|449928208|FG007|Overall Study|Did not meet continuation criteria|3|||
125085224|NCT02202161|449928201|FG000|Overall Study|Physician Decision|0|||
125085225|NCT02202161|449928202|FG001|Overall Study|Physician Decision|0|||
125085226|NCT02202161|449928203|FG002|Overall Study|Physician Decision|0|||
125085227|NCT02202161|449928204|FG003|Overall Study|Physician Decision|0|||
125085228|NCT02202161|449928205|FG004|Overall Study|Physician Decision|0|||
125085229|NCT02202161|449928206|FG005|Overall Study|Physician Decision|0|||
125085230|NCT02202161|449928207|FG006|Overall Study|Physician Decision|0|||
125085231|NCT02202161|449928208|FG007|Overall Study|Physician Decision|3|||
125085232|NCT02202161|449928201|FG000|Overall Study|Withdrawal by Subject|0|||
125085233|NCT02202161|449928202|FG001|Overall Study|Withdrawal by Subject|0|||
125085234|NCT02202161|449928203|FG002|Overall Study|Withdrawal by Subject|0|||
125085235|NCT02202161|449928204|FG003|Overall Study|Withdrawal by Subject|0|||
125085236|NCT02202161|449928205|FG004|Overall Study|Withdrawal by Subject|1|||
125085237|NCT02202161|449928206|FG005|Overall Study|Withdrawal by Subject|0|||
125085238|NCT02202161|449928207|FG006|Overall Study|Withdrawal by Subject|0|||
125085239|NCT02202161|449928208|FG007|Overall Study|Withdrawal by Subject|0|||
125085240|NCT00832091|449928209|FG000|Overall Study|Adverse Event|1|||
125085241|NCT00832091|449928210|FG001|Overall Study|Adverse Event|1|||
125085242|NCT00832091|449928209|FG000|Overall Study|Protocol Violation|1|||
125085243|NCT00832091|449928210|FG001|Overall Study|Protocol Violation|0|||
125085244|NCT00832091|449928209|FG000|Overall Study|Withdrawal by Subject|2|||
125085245|NCT00832091|449928210|FG001|Overall Study|Withdrawal by Subject|1|||
125085246|NCT00832091|449928209|FG000|Overall Study|Prohibited Medication|1|||
125085247|NCT00832091|449928210|FG001|Overall Study|Prohibited Medication|0|||
125085248|NCT00942422|449928216|FG000|Overall Study|Withdrawal by Subject|1|||
125085249|NCT00942422|449928216|FG000|Overall Study|Death|1|||
125085250|NCT00942422|449928216|FG000|Overall Study|Progressive diease|1|||
125085251|NCT02711553|449928217|FG000|Overall Study|Withdrawal by Subject|2|||
125085252|NCT02711553|449928218|FG001|Overall Study|Withdrawal by Subject|1|||
125085253|NCT02711553|449928219|FG002|Overall Study|Withdrawal by Subject|1|||
125085254|NCT02711553|449928220|FG003|Overall Study|Withdrawal by Subject|0|||
125085255|NCT02711553|449928217|FG000|Overall Study|Lost to Follow-up|3|||
125085256|NCT02711553|449928218|FG001|Overall Study|Lost to Follow-up|3|||
125085257|NCT02711553|449928219|FG002|Overall Study|Lost to Follow-up|6|||
125085258|NCT02711553|449928220|FG003|Overall Study|Lost to Follow-up|3|||
125085259|NCT02711553|449928217|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
125085260|NCT02711553|449928218|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
125085261|NCT02711553|449928219|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
125085262|NCT02711553|449928220|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
125085263|NCT05559203|449928221|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
125085264|NCT02187224|449928222|FG000|Overall Study|Did not show up for test day|1|||
125085265|NCT02187224|449928223|FG001|Overall Study|Did not show up for test day|0|||
125085266|NCT01700140|449928228|FG000|Overall Study|Use of rescue drugs|3|||
125085267|NCT01700140|449928229|FG001|Overall Study|Use of rescue drugs|3|||
125085268|NCT01700140|449928230|FG002|Overall Study|Use of rescue drugs|1|||
125085269|NCT01700140|449928228|FG000|Overall Study|Discontinuation of radiotherapy|1|||
125085270|NCT01700140|449928229|FG001|Overall Study|Discontinuation of radiotherapy|0|||
125085271|NCT01700140|449928230|FG002|Overall Study|Discontinuation of radiotherapy|0|||
125085272|NCT01700140|449928228|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
125085273|NCT01700140|449928229|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
125085274|NCT01700140|449928230|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
125085275|NCT01700140|449928228|FG000|Overall Study|Aggravation of symptoms|1|||
125085276|NCT01700140|449928229|FG001|Overall Study|Aggravation of symptoms|0|||
125085277|NCT01700140|449928230|FG002|Overall Study|Aggravation of symptoms|0|||
125085278|NCT01700140|449928228|FG000|Overall Study|Adverse Event|0|||
125085279|NCT01700140|449928229|FG001|Overall Study|Adverse Event|1|||
125085280|NCT01700140|449928230|FG002|Overall Study|Adverse Event|0|||
125085281|NCT01700140|449928228|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
125085282|NCT01700140|449928229|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
125085283|NCT01700140|449928230|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
125085284|NCT02573012|449928231|FG000|Overall Study|Adverse Event|5|||
125085285|NCT02573012|449928232|FG001|Overall Study|Adverse Event|5|||
125085286|NCT02573012|449928231|FG000|Overall Study|Lack of Efficacy|5|||
125085287|NCT02573012|449928232|FG001|Overall Study|Lack of Efficacy|4|||
125085288|NCT02573012|449928231|FG000|Overall Study|Non-compliance|1|||
125085289|NCT02573012|449928232|FG001|Overall Study|Non-compliance|2|||
125085290|NCT02573012|449928231|FG000|Overall Study|Withdrawal by Subject|2|||
125085291|NCT02573012|449928232|FG001|Overall Study|Withdrawal by Subject|2|||
125085292|NCT02573012|449928231|FG000|Overall Study|Study Ended per Protocol|1|||
125085293|NCT02573012|449928232|FG001|Overall Study|Study Ended per Protocol|0|||
125085294|NCT02573012|449928231|FG000|Overall Study|Physician Decision|1|||
125085295|NCT02573012|449928232|FG001|Overall Study|Physician Decision|2|||
125085296|NCT01222416|449928233|FG000|Overall Study|ineligible;metastasis|3|||
125085297|NCT01222416|449928234|FG001|Overall Study|ineligible;metastasis|0|||
125085298|NCT01222416|449928233|FG000|Overall Study|Adverse Event|4|||
125085299|NCT01222416|449928234|FG001|Overall Study|Adverse Event|0|||
125085300|NCT01222416|449928233|FG000|Overall Study|Withdrawal by Subject|5|||
125085301|NCT01222416|449928234|FG001|Overall Study|Withdrawal by Subject|0|||
125085302|NCT01222416|449928233|FG000|Overall Study|scheduling|6|||
125085303|NCT01222416|449928234|FG001|Overall Study|scheduling|0|||
125085304|NCT01222416|449928233|FG000|Overall Study|missed view/scan|1|||
125085305|NCT01222416|449928234|FG001|Overall Study|missed view/scan|0|||
125085306|NCT01222416|449928233|FG000|Overall Study|Death|1|||
125085307|NCT01222416|449928234|FG001|Overall Study|Death|0|||
125085308|NCT00518336|449928235|FG000|Year 7|Lost to Follow-up|2|||
125085309|NCT00518336|449928236|FG001|Year 7|Lost to Follow-up|0|||
125085310|NCT00518336|449928235|FG000|Year 7|Could not attend in time|0|||
125085311|NCT00518336|449928236|FG001|Year 7|Could not attend in time|3|||
125085312|NCT00518336|449928235|FG000|Year 8|Lost to Follow-up|1|||
125085313|NCT00518336|449928236|FG001|Year 8|Lost to Follow-up|1|||
125085314|NCT00518336|449928235|FG000|Year 8|Could not attend in time|0|||
125085315|NCT00518336|449928236|FG001|Year 8|Could not attend in time|1|||
125085316|NCT00518336|449928235|FG000|Year 9|Migrated/moved from study area|1|||
125085317|NCT00518336|449928236|FG001|Year 9|Migrated/moved from study area|1|||
125085318|NCT00518336|449928235|FG000|Year 9|Lost to Follow-up|3|||
125085319|NCT00518336|449928236|FG001|Year 9|Lost to Follow-up|0|||
125085320|NCT00518336|449928235|FG000|Year 9|Personal reasons|1|||
125085321|NCT00518336|449928236|FG001|Year 9|Personal reasons|0|||
125085322|NCT00125268|449928237|FG000|Overall Study|Withdrawal by Subject|1|||
125085323|NCT00125268|449928238|FG001|Overall Study|Withdrawal by Subject|1|||
125085324|NCT00286156|449928239|FG000|Overall Study|Missed 12 month visit|0|||
125085325|NCT00286156|449928240|FG001|Overall Study|Missed 12 month visit|0|||
125085326|NCT00286156|449928241|FG002|Overall Study|Missed 12 month visit|1|||
125085327|NCT00286156|449928239|FG000|Overall Study|AE: pulmonary embolus|0|||
125085328|NCT00286156|449928240|FG001|Overall Study|AE: pulmonary embolus|1|||
125085329|NCT00286156|449928241|FG002|Overall Study|AE: pulmonary embolus|0|||
125085330|NCT00286156|449928239|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
125085331|NCT00286156|449928240|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
125085332|NCT00286156|449928241|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
125085333|NCT00286156|449928239|FG000|Overall Study|AE: pneumonia|1|||
125085334|NCT00286156|449928240|FG001|Overall Study|AE: pneumonia|0|||
125085335|NCT00286156|449928241|FG002|Overall Study|AE: pneumonia|0|||
125085336|NCT02449915|449928243|FG000|Overall Study|Exclusion criteria - drug use|1|||
125085337|NCT02449915|449928244|FG001|Overall Study|Exclusion criteria - drug use|0|||
125085338|NCT02449915|449928243|FG000|Overall Study|Withdrawal by Subject|0|||
125085339|NCT02449915|449928244|FG001|Overall Study|Withdrawal by Subject|2|||
125085340|NCT02449915|449928243|FG000|Overall Study|Intraoperative surgical findings|1|||
125085341|NCT02449915|449928244|FG001|Overall Study|Intraoperative surgical findings|1|||
125085342|NCT02449915|449928243|FG000|Overall Study|Abnormal preop lab|0|||
125085343|NCT02449915|449928244|FG001|Overall Study|Abnormal preop lab|1|||
125085344|NCT02059174|449929322|FG000|Period 1|Withdrawal by Subject|0|||
125085345|NCT02059174|449929323|FG001|Period 1|Withdrawal by Subject|2|||
125085346|NCT02059174|449929322|FG000|Period 2|Withdrawal by Subject|0|||
125085347|NCT02059174|449929323|FG001|Period 2|Withdrawal by Subject|2|||
125085348|NCT02059174|449929322|FG000|Period 2|Protocol Violation|1|||
125085349|NCT02059174|449929323|FG001|Period 2|Protocol Violation|0|||
125085350|NCT02059174|449929322|FG000|Period 3|Physician Decision|1|||
125085351|NCT02059174|449929323|FG001|Period 3|Physician Decision|0|||
125085352|NCT02306148|449929324|FG000|Overall Study|Adverse Event|12|||
125085353|NCT02306148|449929325|FG001|Overall Study|Adverse Event|6|||
125085354|NCT02306148|449929324|FG000|Overall Study|Lost to Follow-up|1|||
125085355|NCT02306148|449929325|FG001|Overall Study|Lost to Follow-up|4|||
125085356|NCT00087594|449929330|FG000|Overall Study|Adverse Event|2|||
125085357|NCT00087594|449929331|FG001|Overall Study|Adverse Event|3|||
125085358|NCT00087594|449929330|FG000|Overall Study|Lost to Follow-up|0|||
125085359|NCT00087594|449929331|FG001|Overall Study|Lost to Follow-up|2|||
125085360|NCT00087594|449929330|FG000|Overall Study|Withdrawal by Subject|4|||
125085361|NCT00087594|449929331|FG001|Overall Study|Withdrawal by Subject|2|||
125085362|NCT00087594|449929330|FG000|Overall Study|Lack of Efficacy|2|||
125085363|NCT00087594|449929331|FG001|Overall Study|Lack of Efficacy|5|||
125085364|NCT01952041|449929334|FG000|Overall Study|Lost to Follow-up|9|||
125085365|NCT01952041|449929335|FG001|Overall Study|Lost to Follow-up|16|||
125085366|NCT01952041|449929334|FG000|Overall Study|Withdrawal by Subject|7|||
125085367|NCT01952041|449929335|FG001|Overall Study|Withdrawal by Subject|5|||
125085368|NCT01952041|449929334|FG000|Overall Study|Death|1|||
125085369|NCT01952041|449929335|FG001|Overall Study|Death|0|||
125085370|NCT01736176|449929336|FG000|Overall Study|Adverse Event|3|||
125085371|NCT01736176|449929336|FG000|Overall Study|Withdrawal by Subject|4|||
125085372|NCT01736176|449929336|FG000|Overall Study|Lack of Efficacy|3|||
125085373|NCT01736176|449929336|FG000|Overall Study|Unable to Complete PEG Placement|1|||
125085374|NCT00186121|449929337|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
125085375|NCT00186121|449929337|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
125085376|NCT00186121|449929337|FG000|Overall Study|Not eligible (no treatment)|1|||
125085377|NCT03650387|449929338|FG000|Overall Study|Withdrawal by Subject|13|||
125085378|NCT03650387|449929338|FG000|Overall Study|Lost to Follow-up|12|||
125085379|NCT03650387|449929338|FG000|Overall Study|Adverse Event (Not related)|1|||
125085380|NCT03650387|449929338|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
125085381|NCT00934791|449929339|FG000|Overall Study|Withdrawal by Subject|1|||
125085382|NCT00934791|449929340|FG001|Overall Study|Withdrawal by Subject|0|||
125085383|NCT03763942|449929342|FG000|Overall Study|Lost to Follow-up|114|||
125085384|NCT03763942|449929343|FG001|Overall Study|Lost to Follow-up|54|||
125085385|NCT03763942|449929342|FG000|Overall Study|Protocol Violation|1|||
125085386|NCT03763942|449929343|FG001|Overall Study|Protocol Violation|0|||
125085387|NCT03763942|449929342|FG000|Overall Study|Withdrawal by Subject|2|||
125085388|NCT03763942|449929343|FG001|Overall Study|Withdrawal by Subject|0|||
125085389|NCT03763942|449929342|FG000|Overall Study|Other|2|||
125085390|NCT03763942|449929343|FG001|Overall Study|Other|3|||
125085391|NCT03558503|449929344|FG000|Overall Study|Adverse Event|1|||
125085392|NCT03558503|449929344|FG000|Overall Study|Death|1|||
125085393|NCT03558503|449929344|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
125085394|NCT02145429|449929345|FG000|Overall Study|Death|4|||
125085395|NCT02145429|449929346|FG001|Overall Study|Death|5|||
125085396|NCT02145429|449929345|FG000|Overall Study|Lost to Follow-up|4|||
125085397|NCT02145429|449929346|FG001|Overall Study|Lost to Follow-up|3|||
125085398|NCT02145429|449929345|FG000|Overall Study|Withdrawal by Subject|8|||
125085399|NCT02145429|449929346|FG001|Overall Study|Withdrawal by Subject|3|||
125085400|NCT02646891|449929347|FG000|Overall Study|Adverse Event|0|||
125085401|NCT02646891|449929348|FG001|Overall Study|Adverse Event|1|||
125085402|NCT02646891|449929349|FG002|Overall Study|Adverse Event|0|||
125085403|NCT02646891|449929350|FG003|Overall Study|Adverse Event|0|||
125085404|NCT02646891|449929351|FG004|Overall Study|Adverse Event|0|||
125085405|NCT02646891|449929352|FG005|Overall Study|Adverse Event|0|||
125085406|NCT02646891|449929353|FG006|Overall Study|Adverse Event|0|||
125145110|NCT01091363|450155949|FG000|Overall Study|Withdrawal by Subject|11|||
125085407|NCT02646891|449929354|FG007|Overall Study|Adverse Event|0|||
125085408|NCT02646891|449929355|FG008|Overall Study|Adverse Event|0|||
125085409|NCT02646891|449929356|FG009|Overall Study|Adverse Event|0|||
125085410|NCT02646891|449929347|FG000|Overall Study|Lost to Follow-up|0|||
125085411|NCT02646891|449929348|FG001|Overall Study|Lost to Follow-up|0|||
125085412|NCT02646891|449929349|FG002|Overall Study|Lost to Follow-up|0|||
125085413|NCT02646891|449929350|FG003|Overall Study|Lost to Follow-up|0|||
125085414|NCT02646891|449929351|FG004|Overall Study|Lost to Follow-up|0|||
125085415|NCT02646891|449929352|FG005|Overall Study|Lost to Follow-up|0|||
125085416|NCT02646891|449929353|FG006|Overall Study|Lost to Follow-up|2|||
125085417|NCT02646891|449929354|FG007|Overall Study|Lost to Follow-up|2|||
125085418|NCT02646891|449929355|FG008|Overall Study|Lost to Follow-up|2|||
125085419|NCT02646891|449929356|FG009|Overall Study|Lost to Follow-up|2|||
125085420|NCT02646891|449929347|FG000|Overall Study|Protocol Violation|0|||
125085421|NCT02646891|449929348|FG001|Overall Study|Protocol Violation|0|||
125085422|NCT02646891|449929349|FG002|Overall Study|Protocol Violation|0|||
125085423|NCT02646891|449929350|FG003|Overall Study|Protocol Violation|0|||
125085424|NCT02646891|449929351|FG004|Overall Study|Protocol Violation|0|||
125085425|NCT02646891|449929352|FG005|Overall Study|Protocol Violation|0|||
125085426|NCT02646891|449929353|FG006|Overall Study|Protocol Violation|1|||
125085427|NCT02646891|449929354|FG007|Overall Study|Protocol Violation|1|||
125085428|NCT02646891|449929355|FG008|Overall Study|Protocol Violation|0|||
125085429|NCT02646891|449929356|FG009|Overall Study|Protocol Violation|0|||
125085430|NCT02646891|449929347|FG000|Overall Study|Withdrawal by Subject|2|||
125085431|NCT02646891|449929348|FG001|Overall Study|Withdrawal by Subject|0|||
125085432|NCT02646891|449929349|FG002|Overall Study|Withdrawal by Subject|1|||
125085433|NCT02646891|449929350|FG003|Overall Study|Withdrawal by Subject|0|||
125085434|NCT02646891|449929351|FG004|Overall Study|Withdrawal by Subject|0|||
125085435|NCT02646891|449929352|FG005|Overall Study|Withdrawal by Subject|0|||
125085436|NCT02646891|449929353|FG006|Overall Study|Withdrawal by Subject|5|||
125085437|NCT02646891|449929354|FG007|Overall Study|Withdrawal by Subject|9|||
125085438|NCT02646891|449929355|FG008|Overall Study|Withdrawal by Subject|7|||
125085439|NCT02646891|449929356|FG009|Overall Study|Withdrawal by Subject|3|||
125085440|NCT02646891|449929347|FG000|Overall Study|Death|0|||
125085441|NCT02646891|449929348|FG001|Overall Study|Death|0|||
125085442|NCT02646891|449929349|FG002|Overall Study|Death|0|||
125085443|NCT02646891|449929350|FG003|Overall Study|Death|0|||
125085444|NCT02646891|449929351|FG004|Overall Study|Death|0|||
125085445|NCT02646891|449929352|FG005|Overall Study|Death|0|||
125085446|NCT02646891|449929353|FG006|Overall Study|Death|1|||
125085447|NCT02646891|449929354|FG007|Overall Study|Death|1|||
125085448|NCT02646891|449929355|FG008|Overall Study|Death|1|||
125223540|NCT02326272|450446169|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
125085449|NCT02646891|449929356|FG009|Overall Study|Death|0|||
125085450|NCT02274311|449929357|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
125085451|NCT02477800|449929359|FG000|Placebo-Controlled Period|Adverse Event|16|||
125085452|NCT02477800|449929360|FG001|Placebo-Controlled Period|Adverse Event|25|||
125085453|NCT02477800|449929361|FG002|Placebo-Controlled Period|Adverse Event|28|||
125085454|NCT02477800|449929362|FG003|Placebo-Controlled Period|Adverse Event|0|||
125085455|NCT02477800|449929363|FG004|Placebo-Controlled Period|Adverse Event|0|||
125085456|NCT02477800|449929364|FG005|Placebo-Controlled Period|Adverse Event|0|||
125085457|NCT02477800|449929365|FG006|Placebo-Controlled Period|Adverse Event|0|||
125085458|NCT02477800|449929359|FG000|Placebo-Controlled Period|Change of Treatment|1|||
125085459|NCT02477800|449929360|FG001|Placebo-Controlled Period|Change of Treatment|2|||
125085460|NCT02477800|449929361|FG002|Placebo-Controlled Period|Change of Treatment|1|||
125085461|NCT02477800|449929362|FG003|Placebo-Controlled Period|Change of Treatment|0|||
125085462|NCT02477800|449929363|FG004|Placebo-Controlled Period|Change of Treatment|0|||
125085463|NCT02477800|449929364|FG005|Placebo-Controlled Period|Change of Treatment|0|||
125085464|NCT02477800|449929365|FG006|Placebo-Controlled Period|Change of Treatment|0|||
125085465|NCT02477800|449929359|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
125085466|NCT02477800|449929360|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
125085467|NCT02477800|449929361|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
125085468|NCT02477800|449929362|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
125085469|NCT02477800|449929363|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
125085470|NCT02477800|449929364|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
125085471|NCT02477800|449929365|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
125085472|NCT02477800|449929359|FG000|Placebo-Controlled Period|Death|0|||
125085473|NCT02477800|449929360|FG001|Placebo-Controlled Period|Death|3|||
125085474|NCT02477800|449929361|FG002|Placebo-Controlled Period|Death|2|||
125085475|NCT02477800|449929362|FG003|Placebo-Controlled Period|Death|0|||
125085476|NCT02477800|449929363|FG004|Placebo-Controlled Period|Death|0|||
125085477|NCT02477800|449929364|FG005|Placebo-Controlled Period|Death|0|||
125085478|NCT02477800|449929365|FG006|Placebo-Controlled Period|Death|0|||
125085479|NCT02477800|449929359|FG000|Placebo-Controlled Period|Disease Progression|1|||
125085480|NCT02477800|449929360|FG001|Placebo-Controlled Period|Disease Progression|0|||
125085481|NCT02477800|449929361|FG002|Placebo-Controlled Period|Disease Progression|1|||
125085482|NCT02477800|449929362|FG003|Placebo-Controlled Period|Disease Progression|0|||
125085483|NCT02477800|449929363|FG004|Placebo-Controlled Period|Disease Progression|0|||
125085484|NCT02477800|449929364|FG005|Placebo-Controlled Period|Disease Progression|0|||
125085485|NCT02477800|449929365|FG006|Placebo-Controlled Period|Disease Progression|0|||
125085486|NCT02477800|449929359|FG000|Placebo-Controlled Period|Investigator Decision|3|||
125085487|NCT02477800|449929360|FG001|Placebo-Controlled Period|Investigator Decision|2|||
125085488|NCT02477800|449929361|FG002|Placebo-Controlled Period|Investigator Decision|1|||
125085489|NCT02477800|449929362|FG003|Placebo-Controlled Period|Investigator Decision|0|||
125085490|NCT02477800|449929363|FG004|Placebo-Controlled Period|Investigator Decision|0|||
125085491|NCT02477800|449929364|FG005|Placebo-Controlled Period|Investigator Decision|0|||
125085492|NCT02477800|449929365|FG006|Placebo-Controlled Period|Investigator Decision|0|||
125085493|NCT02477800|449929359|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
125085494|NCT02477800|449929360|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
125085495|NCT02477800|449929361|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
125085496|NCT02477800|449929362|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
125085497|NCT02477800|449929363|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
125085498|NCT02477800|449929364|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
125085499|NCT02477800|449929365|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
125085500|NCT02477800|449929359|FG000|Placebo-Controlled Period|Relocation|2|||
125085501|NCT02477800|449929360|FG001|Placebo-Controlled Period|Relocation|0|||
125085502|NCT02477800|449929361|FG002|Placebo-Controlled Period|Relocation|0|||
125085503|NCT02477800|449929362|FG003|Placebo-Controlled Period|Relocation|0|||
125085504|NCT02477800|449929363|FG004|Placebo-Controlled Period|Relocation|0|||
125085505|NCT02477800|449929364|FG005|Placebo-Controlled Period|Relocation|0|||
125085506|NCT02477800|449929365|FG006|Placebo-Controlled Period|Relocation|0|||
125085507|NCT02477800|449929359|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
125085508|NCT02477800|449929360|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
125085509|NCT02477800|449929361|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
125085510|NCT02477800|449929362|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
125085511|NCT02477800|449929363|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
125085512|NCT02477800|449929364|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
125085513|NCT02477800|449929365|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
125085514|NCT02477800|449929359|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
125085515|NCT02477800|449929360|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
125085516|NCT02477800|449929361|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
125085517|NCT02477800|449929362|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
125085518|NCT02477800|449929363|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
125085519|NCT02477800|449929364|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
125085520|NCT02477800|449929365|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
125085521|NCT02477800|449929359|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
125085522|NCT02477800|449929360|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
125085523|NCT02477800|449929361|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
125085524|NCT02477800|449929362|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
125085525|NCT02477800|449929363|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
125085526|NCT02477800|449929364|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
125085527|NCT02477800|449929365|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
125085528|NCT02477800|449929359|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
125085529|NCT02477800|449929360|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
125085530|NCT02477800|449929361|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
125085531|NCT02477800|449929362|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
125085532|NCT02477800|449929363|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
125085533|NCT02477800|449929364|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
125085534|NCT02477800|449929365|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
125085535|NCT02477800|449929359|FG000|Placebo-Controlled Period|Reason not Specified|161|||
125085536|NCT02477800|449929360|FG001|Placebo-Controlled Period|Reason not Specified|161|||
125085537|NCT02477800|449929361|FG002|Placebo-Controlled Period|Reason not Specified|189|||
125223541|NCT02326272|450446170|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
125085538|NCT02477800|449929362|FG003|Placebo-Controlled Period|Reason not Specified|0|||
125085539|NCT02477800|449929363|FG004|Placebo-Controlled Period|Reason not Specified|0|||
125085540|NCT02477800|449929364|FG005|Placebo-Controlled Period|Reason not Specified|0|||
125085541|NCT02477800|449929365|FG006|Placebo-Controlled Period|Reason not Specified|0|||
125085542|NCT02477800|449929359|FG000|Long Term Extension Period|Adverse Event|0|||
125085543|NCT02477800|449929360|FG001|Long Term Extension Period|Adverse Event|0|||
125085544|NCT02477800|449929361|FG002|Long Term Extension Period|Adverse Event|0|||
125085545|NCT02477800|449929362|FG003|Long Term Extension Period|Adverse Event|6|||
125085546|NCT02477800|449929363|FG004|Long Term Extension Period|Adverse Event|2|||
125085547|NCT02477800|449929364|FG005|Long Term Extension Period|Adverse Event|4|||
125085548|NCT02477800|449929365|FG006|Long Term Extension Period|Adverse Event|3|||
125085549|NCT02477800|449929359|FG000|Long Term Extension Period|Death|0|||
125085550|NCT02477800|449929360|FG001|Long Term Extension Period|Death|0|||
125085551|NCT02477800|449929361|FG002|Long Term Extension Period|Death|0|||
125085552|NCT02477800|449929362|FG003|Long Term Extension Period|Death|1|||
125085553|NCT02477800|449929363|FG004|Long Term Extension Period|Death|1|||
125085554|NCT02477800|449929364|FG005|Long Term Extension Period|Death|1|||
125085555|NCT02477800|449929365|FG006|Long Term Extension Period|Death|2|||
125085556|NCT02477800|449929359|FG000|Long Term Extension Period|Consent Withdrawn|0|||
125085557|NCT02477800|449929360|FG001|Long Term Extension Period|Consent Withdrawn|0|||
125085558|NCT02477800|449929361|FG002|Long Term Extension Period|Consent Withdrawn|0|||
125085559|NCT02477800|449929362|FG003|Long Term Extension Period|Consent Withdrawn|10|||
125085560|NCT02477800|449929363|FG004|Long Term Extension Period|Consent Withdrawn|4|||
125085561|NCT02477800|449929364|FG005|Long Term Extension Period|Consent Withdrawn|13|||
125085562|NCT02477800|449929365|FG006|Long Term Extension Period|Consent Withdrawn|16|||
125085563|NCT02477800|449929359|FG000|Long Term Extension Period|Disease Progression|0|||
125085564|NCT02477800|449929360|FG001|Long Term Extension Period|Disease Progression|0|||
125085565|NCT02477800|449929361|FG002|Long Term Extension Period|Disease Progression|0|||
125085566|NCT02477800|449929362|FG003|Long Term Extension Period|Disease Progression|3|||
125085567|NCT02477800|449929363|FG004|Long Term Extension Period|Disease Progression|1|||
125085568|NCT02477800|449929364|FG005|Long Term Extension Period|Disease Progression|1|||
125085569|NCT02477800|449929365|FG006|Long Term Extension Period|Disease Progression|0|||
125085570|NCT02477800|449929359|FG000|Long Term Extension Period|Investigator Decision|0|||
125085571|NCT02477800|449929360|FG001|Long Term Extension Period|Investigator Decision|0|||
125085572|NCT02477800|449929361|FG002|Long Term Extension Period|Investigator Decision|0|||
125085573|NCT02477800|449929362|FG003|Long Term Extension Period|Investigator Decision|0|||
125085574|NCT02477800|449929363|FG004|Long Term Extension Period|Investigator Decision|0|||
125085575|NCT02477800|449929364|FG005|Long Term Extension Period|Investigator Decision|0|||
125085576|NCT02477800|449929365|FG006|Long Term Extension Period|Investigator Decision|2|||
125085577|NCT02477800|449929359|FG000|Long Term Extension Period|Lost to Follow-up|0|||
125223542|NCT02326272|450446171|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
125223543|NCT02326272|450446172|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
125085578|NCT02477800|449929360|FG001|Long Term Extension Period|Lost to Follow-up|0|||
125085579|NCT02477800|449929361|FG002|Long Term Extension Period|Lost to Follow-up|0|||
125085580|NCT02477800|449929362|FG003|Long Term Extension Period|Lost to Follow-up|0|||
125085581|NCT02477800|449929363|FG004|Long Term Extension Period|Lost to Follow-up|1|||
125223544|NCT02326272|450446173|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
125085582|NCT02477800|449929364|FG005|Long Term Extension Period|Lost to Follow-up|3|||
125085583|NCT02477800|449929365|FG006|Long Term Extension Period|Lost to Follow-up|0|||
125145111|NCT01091363|450155950|FG001|Overall Study|Withdrawal by Subject|15|||
125145112|NCT01091363|450155949|FG000|Overall Study|Lost to Follow-up|2|||
125145113|NCT01091363|450155950|FG001|Overall Study|Lost to Follow-up|2|||
125145114|NCT02760433|450155953|FG000|Overall Study|Lost to Follow-up|1|||
125145115|NCT02760433|450155954|FG001|Overall Study|Lost to Follow-up|0|||
125145116|NCT02760433|450155955|FG002|Overall Study|Lost to Follow-up|1|||
125145117|NCT02760433|450155956|FG003|Overall Study|Lost to Follow-up|0|||
125145118|NCT02760433|450155957|FG004|Overall Study|Lost to Follow-up|0|||
125145119|NCT02760433|450155953|FG000|Overall Study|Withdrawal by Subject|23|||
125145120|NCT02760433|450155954|FG001|Overall Study|Withdrawal by Subject|9|||
125145121|NCT02760433|450155955|FG002|Overall Study|Withdrawal by Subject|0|||
125145122|NCT02760433|450155956|FG003|Overall Study|Withdrawal by Subject|2|||
125145123|NCT02760433|450155957|FG004|Overall Study|Withdrawal by Subject|9|||
125145124|NCT02760433|450155953|FG000|Overall Study|Lack of Response At Week 14|0|||
125145125|NCT02760433|450155954|FG001|Overall Study|Lack of Response At Week 14|0|||
125145126|NCT02760433|450155955|FG002|Overall Study|Lack of Response At Week 14|0|||
125145127|NCT02760433|450155956|FG003|Overall Study|Lack of Response At Week 14|0|||
125145128|NCT02760433|450155957|FG004|Overall Study|Lack of Response At Week 14|1|||
125145129|NCT02760433|450155953|FG000|Overall Study|Subject refused to continue the study|1|||
125145130|NCT02760433|450155954|FG001|Overall Study|Subject refused to continue the study|0|||
125145131|NCT02760433|450155955|FG002|Overall Study|Subject refused to continue the study|0|||
125145132|NCT02760433|450155956|FG003|Overall Study|Subject refused to continue the study|0|||
125145133|NCT02760433|450155957|FG004|Overall Study|Subject refused to continue the study|0|||
125145134|NCT02760433|450155953|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
125145135|NCT02760433|450155954|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
125145136|NCT02760433|450155955|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
125145137|NCT02760433|450155956|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
125145138|NCT02760433|450155957|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
125085584|NCT02477800|449929359|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
125085585|NCT02477800|449929360|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
125085586|NCT02477800|449929361|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
125085587|NCT02477800|449929362|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
125085588|NCT02477800|449929363|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
125085589|NCT02477800|449929364|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
125085590|NCT02477800|449929365|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
125085591|NCT02477800|449929359|FG000|Long Term Extension Period|Study Visit Burden|0|||
125085592|NCT02477800|449929360|FG001|Long Term Extension Period|Study Visit Burden|0|||
125085593|NCT02477800|449929361|FG002|Long Term Extension Period|Study Visit Burden|0|||
125085594|NCT02477800|449929362|FG003|Long Term Extension Period|Study Visit Burden|3|||
125085595|NCT02477800|449929363|FG004|Long Term Extension Period|Study Visit Burden|0|||
125085596|NCT02477800|449929364|FG005|Long Term Extension Period|Study Visit Burden|2|||
125085597|NCT02477800|449929365|FG006|Long Term Extension Period|Study Visit Burden|2|||
125085598|NCT02477800|449929359|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
125085599|NCT02477800|449929360|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
125085600|NCT02477800|449929361|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
125085601|NCT02477800|449929362|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
125085602|NCT02477800|449929363|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
125085603|NCT02477800|449929364|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
125085604|NCT02477800|449929365|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
125085605|NCT02477800|449929359|FG000|Long Term Extension Period|Reason not Specified|0|||
125085606|NCT02477800|449929360|FG001|Long Term Extension Period|Reason not Specified|0|||
125145139|NCT02760433|450155953|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
125145140|NCT02760433|450155954|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
125145141|NCT02760433|450155955|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
125145142|NCT02760433|450155956|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
125145143|NCT02760433|450155957|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
125145144|NCT02151149|450155958|FG000|Treatment Period|Death|2|||
125145145|NCT02151149|450155959|FG001|Treatment Period|Death|3|||
125145146|NCT02151149|450155958|FG000|Treatment Period|Adverse Event|17|||
125145147|NCT02151149|450155959|FG001|Treatment Period|Adverse Event|14|||
125145148|NCT02151149|450155958|FG000|Treatment Period|Progressive Disease|25|||
125085607|NCT02477800|449929361|FG002|Long Term Extension Period|Reason not Specified|0|||
125085608|NCT02477800|449929362|FG003|Long Term Extension Period|Reason not Specified|126|||
125085609|NCT02477800|449929363|FG004|Long Term Extension Period|Reason not Specified|140|||
125085610|NCT02477800|449929364|FG005|Long Term Extension Period|Reason not Specified|270|||
125085611|NCT02477800|449929365|FG006|Long Term Extension Period|Reason not Specified|224|||
125085612|NCT00170846|449929370|FG000|Overall Study|Subject withdrew Informed Consent|5|||
125085613|NCT00170846|449929371|FG001|Overall Study|Subject withdrew Informed Consent|12|||
125085614|NCT00170846|449929372|FG002|Overall Study|Subject withdrew Informed Consent|8|||
125085615|NCT00170846|449929370|FG000|Overall Study|Lost to Follow-up|6|||
125085616|NCT00170846|449929371|FG001|Overall Study|Lost to Follow-up|3|||
125085617|NCT00170846|449929372|FG002|Overall Study|Lost to Follow-up|2|||
125085618|NCT00170846|449929370|FG000|Overall Study|Death|0|||
125085619|NCT00170846|449929371|FG001|Overall Study|Death|3|||
125085620|NCT00170846|449929372|FG002|Overall Study|Death|3|||
125085621|NCT00170846|449929370|FG000|Overall Study|Reason Missing|0|||
125085622|NCT00170846|449929371|FG001|Overall Study|Reason Missing|1|||
125085623|NCT00170846|449929372|FG002|Overall Study|Reason Missing|0|||
125085624|NCT01756833|449929374|FG000|Overall Study|Withdrawal by Subject|4|||
125085625|NCT01756833|449929375|FG001|Overall Study|Withdrawal by Subject|3|||
125085626|NCT00998985|449929379|FG000|Overall Study|Withdrawal by Subject|0|||
125085627|NCT00998985|449929380|FG001|Overall Study|Withdrawal by Subject|0|||
125085628|NCT00998985|449929381|FG002|Overall Study|Withdrawal by Subject|0|||
125085629|NCT00998985|449929382|FG003|Overall Study|Withdrawal by Subject|0|||
125085630|NCT00998985|449929383|FG004|Overall Study|Withdrawal by Subject|0|||
125085631|NCT00998985|449929384|FG005|Overall Study|Withdrawal by Subject|0|||
125085632|NCT00998985|449929385|FG006|Overall Study|Withdrawal by Subject|0|||
125085633|NCT00998985|449929386|FG007|Overall Study|Withdrawal by Subject|0|||
125085634|NCT00998985|449929387|FG008|Overall Study|Withdrawal by Subject|1|||
125085635|NCT00998985|449929388|FG009|Overall Study|Withdrawal by Subject|0|||
125085636|NCT00998985|449929389|FG010|Overall Study|Withdrawal by Subject|0|||
125085637|NCT00998985|449929390|FG011|Overall Study|Withdrawal by Subject|0|||
125085638|NCT00998985|449929391|FG012|Overall Study|Withdrawal by Subject|0|||
125085639|NCT00998985|449929392|FG013|Overall Study|Withdrawal by Subject|0|||
125085640|NCT00998985|449929379|FG000|Overall Study|Protocol Violation|0|||
125085641|NCT00998985|449929380|FG001|Overall Study|Protocol Violation|0|||
125085642|NCT00998985|449929381|FG002|Overall Study|Protocol Violation|0|||
125085643|NCT00998985|449929382|FG003|Overall Study|Protocol Violation|0|||
125085644|NCT00998985|449929383|FG004|Overall Study|Protocol Violation|0|||
125085645|NCT00998985|449929384|FG005|Overall Study|Protocol Violation|1|||
125085646|NCT00998985|449929385|FG006|Overall Study|Protocol Violation|0|||
125085647|NCT00998985|449929386|FG007|Overall Study|Protocol Violation|0|||
125085648|NCT00998985|449929387|FG008|Overall Study|Protocol Violation|0|||
125085649|NCT00998985|449929388|FG009|Overall Study|Protocol Violation|0|||
125085650|NCT00998985|449929389|FG010|Overall Study|Protocol Violation|0|||
125085651|NCT00998985|449929390|FG011|Overall Study|Protocol Violation|0|||
125085652|NCT00998985|449929391|FG012|Overall Study|Protocol Violation|0|||
125085653|NCT00998985|449929392|FG013|Overall Study|Protocol Violation|0|||
125085654|NCT01040728|449929393|FG000|Overall Study|Adverse Event|4|||
125085655|NCT01040728|449929394|FG001|Overall Study|Adverse Event|8|||
125085656|NCT01040728|449929395|FG002|Overall Study|Adverse Event|0|||
125085657|NCT01040728|449929396|FG003|Overall Study|Adverse Event|4|||
125085658|NCT01040728|449929393|FG000|Overall Study|Withdrawal by Subject|0|||
125085659|NCT01040728|449929394|FG001|Overall Study|Withdrawal by Subject|1|||
125085660|NCT01040728|449929395|FG002|Overall Study|Withdrawal by Subject|1|||
125085661|NCT01040728|449929396|FG003|Overall Study|Withdrawal by Subject|0|||
125085662|NCT01040728|449929393|FG000|Overall Study|Protocol Violation|0|||
125085663|NCT01040728|449929394|FG001|Overall Study|Protocol Violation|0|||
125085664|NCT01040728|449929395|FG002|Overall Study|Protocol Violation|0|||
125085665|NCT01040728|449929396|FG003|Overall Study|Protocol Violation|1|||
125085666|NCT01040728|449929393|FG000|Overall Study|Lack of Efficacy|0|||
125085667|NCT01040728|449929394|FG001|Overall Study|Lack of Efficacy|1|||
125085668|NCT01040728|449929395|FG002|Overall Study|Lack of Efficacy|0|||
125085669|NCT01040728|449929396|FG003|Overall Study|Lack of Efficacy|1|||
125085670|NCT01040728|449929393|FG000|Overall Study|Other reasons not listed above|0|||
125085671|NCT01040728|449929394|FG001|Overall Study|Other reasons not listed above|1|||
125085672|NCT01040728|449929395|FG002|Overall Study|Other reasons not listed above|0|||
125085673|NCT01040728|449929396|FG003|Overall Study|Other reasons not listed above|0|||
125085674|NCT01601873|449929398|FG000|Overall Study|Lost to Follow-up|2|||
125085675|NCT01601873|449929399|FG001|Overall Study|Lost to Follow-up|3|||
125085676|NCT01875874|449929400|FG000|Overall Study|Death|3|||
125085677|NCT00590031|449929401|FG000|Overall Study|Adverse Event|3|||
125085678|NCT00590031|449929401|FG000|Overall Study|Withdrawal by Subject|1|||
125085679|NCT00590031|449929401|FG000|Overall Study|Metastatic Disease|1|||
125085680|NCT00590031|449929401|FG000|Overall Study|Admin Hold|1|||
125085681|NCT00826540|449929415|FG000|Overall Study|ineligible|3|||
125085682|NCT00826540|449929415|FG000|Overall Study|Withdrawal by Subject|1|||
125085683|NCT02178592|449929418|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
125085684|NCT02178592|449929419|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
125085685|NCT02178592|449929418|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
125085686|NCT02178592|449929419|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
125085687|NCT02178592|449929418|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
125085688|NCT02178592|449929419|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
125085689|NCT02178592|449929418|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
125085690|NCT02178592|449929419|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
125085691|NCT02178592|449929418|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
125085692|NCT02178592|449929419|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
125085693|NCT02178592|449929418|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
125085694|NCT02178592|449929419|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
125085695|NCT02178592|449929418|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
125085696|NCT02178592|449929419|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
125085697|NCT02178592|449929418|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
125085698|NCT02178592|449929419|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
125085699|NCT02178592|449929418|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
125085700|NCT02178592|449929419|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
125085701|NCT02178592|449929418|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
125085702|NCT02178592|449929419|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
125085703|NCT02178592|449929418|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
125085704|NCT02178592|449929419|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
125085705|NCT02178592|449929418|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
125085706|NCT02178592|449929419|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
125085707|NCT02520141|449929422|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
125085708|NCT00703781|449929423|FG000|Overall Study|Withdrawal by Subject|1|||
125085709|NCT00703781|449929424|FG001|Overall Study|Withdrawal by Subject|2|||
125085710|NCT00703781|449929423|FG000|Overall Study|Cancelled surgery|1|||
125085711|NCT00703781|449929424|FG001|Overall Study|Cancelled surgery|0|||
125085712|NCT03452397|449929425|FG000|Overall Study|Adverse Event|1|||
125085713|NCT03452397|449929426|FG001|Overall Study|Adverse Event|0|||
125085714|NCT03452397|449929427|FG002|Overall Study|Adverse Event|0|||
125085715|NCT03452397|449929428|FG003|Overall Study|Adverse Event|0|||
125085716|NCT03452397|449929425|FG000|Overall Study|Administrative reason|0|||
125085717|NCT03452397|449929426|FG001|Overall Study|Administrative reason|0|||
125085718|NCT03452397|449929427|FG002|Overall Study|Administrative reason|1|||
125085719|NCT03452397|449929428|FG003|Overall Study|Administrative reason|1|||
125085720|NCT03452397|449929425|FG000|Overall Study|Withdrawal by Subject|0|||
125085721|NCT03452397|449929426|FG001|Overall Study|Withdrawal by Subject|0|||
125085722|NCT03452397|449929427|FG002|Overall Study|Withdrawal by Subject|1|||
125085723|NCT03452397|449929428|FG003|Overall Study|Withdrawal by Subject|0|||
125085724|NCT06334055|449929430|FG000|Overall Study|Adverse Event|4|||
125085725|NCT06334055|449929430|FG000|Overall Study|Disqualified|72|||
125085726|NCT02545049|449929431|FG000|Overall Study|Withdrawal by Subject|1|||
125085727|NCT02545049|449929432|FG001|Overall Study|Withdrawal by Subject|7|||
125085728|NCT02545049|449929431|FG000|Overall Study|Lost to Follow-up|4|||
125085729|NCT02545049|449929432|FG001|Overall Study|Lost to Follow-up|6|||
125085730|NCT02545049|449929431|FG000|Overall Study|GCP violations|37|||
125085731|NCT02545049|449929432|FG001|Overall Study|GCP violations|48|||
125085732|NCT01855919|449931623|FG000|Overall Study|Adverse Event|16|||
125085733|NCT01855919|449931624|FG001|Overall Study|Adverse Event|8|||
125085734|NCT01855919|449931623|FG000|Overall Study|Lack of Efficacy|1|||
125085735|NCT01855919|449931624|FG001|Overall Study|Lack of Efficacy|3|||
125085736|NCT01855919|449931623|FG000|Overall Study|Withdrawal by Subject|4|||
125085737|NCT01855919|449931624|FG001|Overall Study|Withdrawal by Subject|10|||
125085738|NCT01855919|449931623|FG000|Overall Study|Entry Criteria Not Met|1|||
125085739|NCT01855919|449931624|FG001|Overall Study|Entry Criteria Not Met|1|||
125085740|NCT01855919|449931623|FG000|Overall Study|Protocol Violation|1|||
125085741|NCT01855919|449931624|FG001|Overall Study|Protocol Violation|4|||
125085742|NCT04459416|449931625|FG000|Overall Study|Lost to Follow-up|2|||
125085743|NCT04459416|449931626|FG001|Overall Study|Lost to Follow-up|0|||
125085744|NCT04459416|449931625|FG000|Overall Study|Withdrawal by Subject|8|||
125085745|NCT04459416|449931626|FG001|Overall Study|Withdrawal by Subject|10|||
125085746|NCT04459416|449931625|FG000|Overall Study|Disease progression|0|||
125085747|NCT04459416|449931626|FG001|Overall Study|Disease progression|3|||
125085748|NCT03455530|449931627|FG000|Overall Study|Withdrawal by Subject|9|||
125085749|NCT03455530|449931628|FG001|Overall Study|Withdrawal by Subject|1|||
125085750|NCT03455530|449931629|FG002|Overall Study|Withdrawal by Subject|3|||
125085751|NCT03455530|449931630|FG003|Overall Study|Withdrawal by Subject|3|||
125085752|NCT01592773|449931631|FG000|Overall Study|Study Terminated by Sponsor|582|||
125085753|NCT01592773|449931631|FG000|Overall Study|Withdrawal by Subject|35|||
125085754|NCT01592773|449931631|FG000|Overall Study|Lost to Follow-up|19|||
125085755|NCT01592773|449931631|FG000|Overall Study|Adverse Event|17|||
125085756|NCT01592773|449931631|FG000|Overall Study|Lack of Efficacy|9|||
125085757|NCT01592773|449931631|FG000|Overall Study|Protocol Violation|2|||
125085758|NCT01592773|449931631|FG000|Overall Study|Inclusion/exclusion not meet|1|||
125085759|NCT01592773|449931631|FG000|Overall Study|Other Reason|1|||
125085760|NCT00740116|449931635|FG000|Overall Study|Withdrawal by Subject|1|||
125085761|NCT00740116|449931636|FG001|Overall Study|Withdrawal by Subject|1|||
125085762|NCT00740116|449931635|FG000|Overall Study|Protocol Violation|1|||
125085763|NCT00740116|449931636|FG001|Overall Study|Protocol Violation|4|||
125085764|NCT03037489|449931637|FG000|Overall Study|Adverse Event|4|||
125085765|NCT03037489|449931638|FG001|Overall Study|Adverse Event|0|||
125085766|NCT03037489|449931637|FG000|Overall Study|Withdrawal by Subject|3|||
125085767|NCT03037489|449931638|FG001|Overall Study|Withdrawal by Subject|0|||
125085768|NCT00621764|449931639|FG000|Overall Study|Protocol Violation|0|||
125085769|NCT00621764|449931640|FG001|Overall Study|Protocol Violation|0|||
125085770|NCT00621764|449931641|FG002|Overall Study|Protocol Violation|0|||
125085771|NCT00621764|449931642|FG003|Overall Study|Protocol Violation|1|||
125085772|NCT00121485|449931643|FG000|Overall Study|Not implanted|1|||
125085773|NCT00121485|449931644|FG001|Overall Study|Not implanted|5|||
125085774|NCT00121485|449931643|FG000|Overall Study|Crossover|0|||
125085775|NCT00121485|449931644|FG001|Overall Study|Crossover|2|||
125085776|NCT00724243|449931647|FG000|Overall Study|Lack of Efficacy|10|||
125085777|NCT00724243|449931647|FG000|Overall Study|Adverse Event|5|||
125085778|NCT03031327|449931650|FG000|Overall Study|Withdrawal by Subject|0|||
125085779|NCT03031327|449931651|FG001|Overall Study|Withdrawal by Subject|1|||
125085780|NCT03031327|449931652|FG002|Overall Study|Withdrawal by Subject|1|||
125085781|NCT00211536|449931653|FG000|Overall Study|Withdrawal by Subject|2|||
125085782|NCT00211536|449931654|FG001|Overall Study|Withdrawal by Subject|2|||
125085783|NCT00211536|449931653|FG000|Overall Study|Physician Decision|0|||
125085784|NCT00211536|449931654|FG001|Overall Study|Physician Decision|5|||
125085785|NCT00211536|449931653|FG000|Overall Study|Adverse Event|2|||
125085786|NCT00211536|449931654|FG001|Overall Study|Adverse Event|0|||
125085787|NCT01004861|449931655|FG000|Overall Study|Disease progression|3|||
125085788|NCT01004861|449931656|FG001|Overall Study|Disease progression|4|||
125085789|NCT01004861|449931657|FG002|Overall Study|Disease progression|5|||
125085790|NCT01004861|449931658|FG003|Overall Study|Disease progression|4|||
125085791|NCT01004861|449931659|FG004|Overall Study|Disease progression|4|||
125085792|NCT01004861|449931660|FG005|Overall Study|Disease progression|4|||
125085793|NCT01004861|449931661|FG006|Overall Study|Disease progression|5|||
125085794|NCT01004861|449931662|FG007|Overall Study|Disease progression|1|||
125085795|NCT01004861|449931663|FG008|Overall Study|Disease progression|4|||
125085796|NCT01004861|449931664|FG009|Overall Study|Disease progression|7|||
125085797|NCT01004861|449931665|FG010|Overall Study|Disease progression|6|||
125145149|NCT02151149|450155959|FG001|Treatment Period|Progressive Disease|24|||
125145150|NCT02151149|450155958|FG000|Treatment Period|Symptomatic Deterioration|2|||
125085798|NCT01004861|449931666|FG011|Overall Study|Disease progression|3|||
125085799|NCT01004861|449931667|FG012|Overall Study|Disease progression|8|||
125085800|NCT01004861|449931655|FG000|Overall Study|Physician Decision|0|||
125085801|NCT01004861|449931656|FG001|Overall Study|Physician Decision|2|||
125085802|NCT01004861|449931657|FG002|Overall Study|Physician Decision|1|||
125085803|NCT01004861|449931658|FG003|Overall Study|Physician Decision|1|||
125085804|NCT01004861|449931659|FG004|Overall Study|Physician Decision|1|||
125085805|NCT01004861|449931660|FG005|Overall Study|Physician Decision|0|||
125085806|NCT01004861|449931661|FG006|Overall Study|Physician Decision|0|||
125085807|NCT01004861|449931662|FG007|Overall Study|Physician Decision|1|||
125085808|NCT01004861|449931663|FG008|Overall Study|Physician Decision|0|||
125085809|NCT01004861|449931664|FG009|Overall Study|Physician Decision|0|||
125085810|NCT01004861|449931665|FG010|Overall Study|Physician Decision|0|||
125085811|NCT01004861|449931666|FG011|Overall Study|Physician Decision|0|||
125085812|NCT01004861|449931667|FG012|Overall Study|Physician Decision|3|||
125085813|NCT01004861|449931655|FG000|Overall Study|Adverse Event|0|||
125085814|NCT01004861|449931656|FG001|Overall Study|Adverse Event|0|||
125085815|NCT01004861|449931657|FG002|Overall Study|Adverse Event|0|||
125085816|NCT01004861|449931658|FG003|Overall Study|Adverse Event|1|||
125085817|NCT01004861|449931659|FG004|Overall Study|Adverse Event|0|||
125085818|NCT01004861|449931660|FG005|Overall Study|Adverse Event|2|||
125085819|NCT01004861|449931661|FG006|Overall Study|Adverse Event|1|||
125085820|NCT01004861|449931662|FG007|Overall Study|Adverse Event|1|||
125085821|NCT01004861|449931663|FG008|Overall Study|Adverse Event|13|||
125085822|NCT01004861|449931664|FG009|Overall Study|Adverse Event|1|||
125085823|NCT01004861|449931665|FG010|Overall Study|Adverse Event|1|||
125085824|NCT01004861|449931666|FG011|Overall Study|Adverse Event|0|||
125085825|NCT01004861|449931667|FG012|Overall Study|Adverse Event|2|||
125085826|NCT01004861|449931655|FG000|Overall Study|Protocol Violation|0|||
125085827|NCT01004861|449931656|FG001|Overall Study|Protocol Violation|0|||
125085828|NCT01004861|449931657|FG002|Overall Study|Protocol Violation|0|||
125085829|NCT01004861|449931658|FG003|Overall Study|Protocol Violation|0|||
125085830|NCT01004861|449931659|FG004|Overall Study|Protocol Violation|1|||
125085831|NCT01004861|449931660|FG005|Overall Study|Protocol Violation|0|||
125085832|NCT01004861|449931661|FG006|Overall Study|Protocol Violation|0|||
125085833|NCT01004861|449931662|FG007|Overall Study|Protocol Violation|0|||
125085834|NCT01004861|449931663|FG008|Overall Study|Protocol Violation|0|||
125085835|NCT01004861|449931664|FG009|Overall Study|Protocol Violation|0|||
125085836|NCT01004861|449931665|FG010|Overall Study|Protocol Violation|0|||
125085837|NCT01004861|449931666|FG011|Overall Study|Protocol Violation|0|||
125085838|NCT01004861|449931667|FG012|Overall Study|Protocol Violation|0|||
125085839|NCT01004861|449931655|FG000|Overall Study|Lost to Follow-up|0|||
125085840|NCT01004861|449931656|FG001|Overall Study|Lost to Follow-up|0|||
125085841|NCT01004861|449931657|FG002|Overall Study|Lost to Follow-up|0|||
125085842|NCT01004861|449931658|FG003|Overall Study|Lost to Follow-up|0|||
125085843|NCT01004861|449931659|FG004|Overall Study|Lost to Follow-up|0|||
125085844|NCT01004861|449931660|FG005|Overall Study|Lost to Follow-up|0|||
125085845|NCT01004861|449931661|FG006|Overall Study|Lost to Follow-up|0|||
125085846|NCT01004861|449931662|FG007|Overall Study|Lost to Follow-up|1|||
125085847|NCT01004861|449931663|FG008|Overall Study|Lost to Follow-up|3|||
125085848|NCT01004861|449931664|FG009|Overall Study|Lost to Follow-up|0|||
125085849|NCT01004861|449931665|FG010|Overall Study|Lost to Follow-up|0|||
125085850|NCT01004861|449931666|FG011|Overall Study|Lost to Follow-up|1|||
125085851|NCT01004861|449931667|FG012|Overall Study|Lost to Follow-up|0|||
125085852|NCT01004861|449931655|FG000|Overall Study|Non-compliance|0|||
125085853|NCT01004861|449931656|FG001|Overall Study|Non-compliance|0|||
125085854|NCT01004861|449931657|FG002|Overall Study|Non-compliance|0|||
125085855|NCT01004861|449931658|FG003|Overall Study|Non-compliance|0|||
125085856|NCT01004861|449931659|FG004|Overall Study|Non-compliance|0|||
125085857|NCT01004861|449931660|FG005|Overall Study|Non-compliance|0|||
125085858|NCT01004861|449931661|FG006|Overall Study|Non-compliance|0|||
125085859|NCT01004861|449931662|FG007|Overall Study|Non-compliance|0|||
125085860|NCT01004861|449931663|FG008|Overall Study|Non-compliance|5|||
125085861|NCT01004861|449931664|FG009|Overall Study|Non-compliance|0|||
125085862|NCT01004861|449931665|FG010|Overall Study|Non-compliance|0|||
125085863|NCT01004861|449931666|FG011|Overall Study|Non-compliance|0|||
125085864|NCT01004861|449931667|FG012|Overall Study|Non-compliance|1|||
125085865|NCT01004861|449931655|FG000|Overall Study|Other|0|||
125085866|NCT01004861|449931656|FG001|Overall Study|Other|0|||
125085867|NCT01004861|449931657|FG002|Overall Study|Other|0|||
125085868|NCT01004861|449931658|FG003|Overall Study|Other|0|||
125085869|NCT01004861|449931659|FG004|Overall Study|Other|0|||
125085870|NCT01004861|449931660|FG005|Overall Study|Other|0|||
125085871|NCT01004861|449931661|FG006|Overall Study|Other|0|||
125085872|NCT01004861|449931662|FG007|Overall Study|Other|0|||
125085873|NCT01004861|449931663|FG008|Overall Study|Other|0|||
125085874|NCT01004861|449931664|FG009|Overall Study|Other|2|||
125085875|NCT01004861|449931665|FG010|Overall Study|Other|1|||
125085876|NCT01004861|449931666|FG011|Overall Study|Other|2|||
125085877|NCT01004861|449931667|FG012|Overall Study|Other|3|||
125085878|NCT01004861|449931655|FG000|Overall Study|Patient decision|0|||
125085879|NCT01004861|449931656|FG001|Overall Study|Patient decision|0|||
125085880|NCT01004861|449931657|FG002|Overall Study|Patient decision|0|||
125145151|NCT02151149|450155959|FG001|Treatment Period|Symptomatic Deterioration|10|||
125085881|NCT01004861|449931658|FG003|Overall Study|Patient decision|0|||
125085882|NCT01004861|449931659|FG004|Overall Study|Patient decision|1|||
125085883|NCT01004861|449931660|FG005|Overall Study|Patient decision|0|||
125085884|NCT01004861|449931661|FG006|Overall Study|Patient decision|1|||
125085885|NCT01004861|449931662|FG007|Overall Study|Patient decision|0|||
125085886|NCT01004861|449931663|FG008|Overall Study|Patient decision|7|||
125085887|NCT01004861|449931664|FG009|Overall Study|Patient decision|1|||
125085888|NCT01004861|449931665|FG010|Overall Study|Patient decision|1|||
125085889|NCT01004861|449931666|FG011|Overall Study|Patient decision|2|||
125085890|NCT01004861|449931667|FG012|Overall Study|Patient decision|3|||
125085891|NCT01004861|449931655|FG000|Overall Study|Transitioned to Phase 4 study|0|||
125085892|NCT01004861|449931656|FG001|Overall Study|Transitioned to Phase 4 study|0|||
125085893|NCT01004861|449931657|FG002|Overall Study|Transitioned to Phase 4 study|0|||
125085894|NCT01004861|449931658|FG003|Overall Study|Transitioned to Phase 4 study|0|||
125145152|NCT02151149|450155958|FG000|Treatment Period|Withdrawal by Subject|13|||
125145153|NCT02151149|450155959|FG001|Treatment Period|Withdrawal by Subject|11|||
125145154|NCT02151149|450155958|FG000|Treatment Period|Miscellaneous|8|||
125145155|NCT02151149|450155959|FG001|Treatment Period|Miscellaneous|7|||
125145156|NCT02151149|450155958|FG000|Treatment Period|Participants randomized but not treated|3|||
125145157|NCT02151149|450155959|FG001|Treatment Period|Participants randomized but not treated|2|||
125145158|NCT02151149|450155958|FG000|Follow-Up Period|Lost to Follow-up|2|||
125145159|NCT02151149|450155959|FG001|Follow-Up Period|Lost to Follow-up|3|||
125145160|NCT02151149|450155958|FG000|Follow-Up Period|Death|37|||
125145161|NCT02151149|450155959|FG001|Follow-Up Period|Death|34|||
125145162|NCT05889039|450155965|FG000|Overall Study|error in completing survey|0|||
125145163|NCT05889039|450155966|FG001|Overall Study|error in completing survey|2|||
125145164|NCT05889039|450155967|FG002|Overall Study|error in completing survey|0|||
125145165|NCT05889039|450155968|FG003|Overall Study|error in completing survey|0|||
125145166|NCT05889039|450155965|FG000|Overall Study|Lost to Follow-up|4|||
125145167|NCT05889039|450155966|FG001|Overall Study|Lost to Follow-up|0|||
125145168|NCT05889039|450155967|FG002|Overall Study|Lost to Follow-up|0|||
125145169|NCT05889039|450155968|FG003|Overall Study|Lost to Follow-up|0|||
125085895|NCT01004861|449931659|FG004|Overall Study|Transitioned to Phase 4 study|0|||
125085896|NCT01004861|449931660|FG005|Overall Study|Transitioned to Phase 4 study|0|||
125085897|NCT01004861|449931661|FG006|Overall Study|Transitioned to Phase 4 study|0|||
125085898|NCT01004861|449931662|FG007|Overall Study|Transitioned to Phase 4 study|0|||
125085899|NCT01004861|449931663|FG008|Overall Study|Transitioned to Phase 4 study|2|||
125085900|NCT01004861|449931664|FG009|Overall Study|Transitioned to Phase 4 study|0|||
125085901|NCT01004861|449931665|FG010|Overall Study|Transitioned to Phase 4 study|0|||
125085902|NCT01004861|449931666|FG011|Overall Study|Transitioned to Phase 4 study|0|||
125085903|NCT01004861|449931667|FG012|Overall Study|Transitioned to Phase 4 study|0|||
125085904|NCT01004861|449931655|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125085905|NCT01004861|449931656|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125085906|NCT01004861|449931657|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125085907|NCT01004861|449931658|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125085908|NCT01004861|449931659|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125085909|NCT01004861|449931660|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125085910|NCT01004861|449931661|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125085911|NCT01004861|449931662|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125085912|NCT01004861|449931663|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
125085913|NCT01004861|449931664|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125085914|NCT01004861|449931665|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125085915|NCT01004861|449931666|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125085916|NCT01004861|449931667|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125085917|NCT01004861|449931655|FG000|Overall Study|Patient withdrew|0|||
125085918|NCT01004861|449931656|FG001|Overall Study|Patient withdrew|0|||
125085919|NCT01004861|449931657|FG002|Overall Study|Patient withdrew|0|||
125085920|NCT01004861|449931658|FG003|Overall Study|Patient withdrew|0|||
125085921|NCT01004861|449931659|FG004|Overall Study|Patient withdrew|0|||
125085922|NCT01004861|449931660|FG005|Overall Study|Patient withdrew|0|||
125085923|NCT01004861|449931661|FG006|Overall Study|Patient withdrew|0|||
125085924|NCT01004861|449931662|FG007|Overall Study|Patient withdrew|0|||
125085925|NCT01004861|449931663|FG008|Overall Study|Patient withdrew|1|||
125085926|NCT01004861|449931664|FG009|Overall Study|Patient withdrew|0|||
125085927|NCT01004861|449931665|FG010|Overall Study|Patient withdrew|0|||
125085928|NCT01004861|449931666|FG011|Overall Study|Patient withdrew|0|||
125085929|NCT01004861|449931667|FG012|Overall Study|Patient withdrew|0|||
125085930|NCT01004861|449931655|FG000|Overall Study|Surgical resection|0|||
125085931|NCT01004861|449931656|FG001|Overall Study|Surgical resection|0|||
125085932|NCT01004861|449931657|FG002|Overall Study|Surgical resection|0|||
125085933|NCT01004861|449931658|FG003|Overall Study|Surgical resection|0|||
125085934|NCT01004861|449931659|FG004|Overall Study|Surgical resection|0|||
125085935|NCT01004861|449931660|FG005|Overall Study|Surgical resection|0|||
125085936|NCT01004861|449931661|FG006|Overall Study|Surgical resection|0|||
125085937|NCT01004861|449931662|FG007|Overall Study|Surgical resection|0|||
125145170|NCT00982228|450155969|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
125145171|NCT00982228|450155970|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
125145172|NCT00982228|450155969|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
125145173|NCT00982228|450155970|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
125085938|NCT01004861|449931663|FG008|Overall Study|Surgical resection|1|||
125085939|NCT01004861|449931664|FG009|Overall Study|Surgical resection|0|||
125085940|NCT01004861|449931665|FG010|Overall Study|Surgical resection|0|||
125085941|NCT01004861|449931666|FG011|Overall Study|Surgical resection|0|||
125085942|NCT01004861|449931667|FG012|Overall Study|Surgical resection|0|||
125085943|NCT01004861|449931655|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125085944|NCT01004861|449931656|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125085945|NCT01004861|449931657|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125085946|NCT01004861|449931658|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125085947|NCT01004861|449931659|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125085948|NCT01004861|449931660|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125085949|NCT01004861|449931661|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125085950|NCT01004861|449931662|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125085951|NCT01004861|449931663|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
125085952|NCT01004861|449931664|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125085953|NCT01004861|449931665|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125085954|NCT01004861|449931666|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125085955|NCT01004861|449931667|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125145174|NCT00982228|450155969|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
125145175|NCT00982228|450155970|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
125145176|NCT00982228|450155969|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
125145177|NCT00982228|450155970|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
125145178|NCT00982228|450155969|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
125145179|NCT00982228|450155970|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
125145180|NCT00982228|450155969|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
125085956|NCT01004861|449931655|FG000|Overall Study|Study termination by Sponsor|0|||
125145181|NCT00982228|450155970|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
125145182|NCT00982228|450155969|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
125145183|NCT00982228|450155970|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
125145184|NCT00982228|450155969|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
125145185|NCT00982228|450155970|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
125145186|NCT00982228|450155969|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
125145187|NCT00982228|450155970|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
125145188|NCT00982228|450155969|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
125145189|NCT00982228|450155970|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
125145190|NCT01438476|450155971|FG000|Overall Study|Protocol Violation|1|||
125145191|NCT01438476|450155972|FG001|Overall Study|Protocol Violation|0|||
125145192|NCT01438476|450155971|FG000|Overall Study|Withdrawal by Subject|1|||
125145193|NCT01438476|450155972|FG001|Overall Study|Withdrawal by Subject|0|||
125145194|NCT01438476|450155971|FG000|Overall Study|No Surgery- Disease|8|||
125145195|NCT01438476|450155972|FG001|Overall Study|No Surgery- Disease|10|||
125145196|NCT01438476|450155971|FG000|Overall Study|Communication barrier|0|||
125085957|NCT01004861|449931656|FG001|Overall Study|Study termination by Sponsor|0|||
125085958|NCT01004861|449931657|FG002|Overall Study|Study termination by Sponsor|0|||
125085959|NCT01004861|449931658|FG003|Overall Study|Study termination by Sponsor|0|||
125085960|NCT01004861|449931659|FG004|Overall Study|Study termination by Sponsor|0|||
125085961|NCT01004861|449931660|FG005|Overall Study|Study termination by Sponsor|0|||
125085962|NCT01004861|449931661|FG006|Overall Study|Study termination by Sponsor|0|||
125085963|NCT01004861|449931662|FG007|Overall Study|Study termination by Sponsor|0|||
125085964|NCT01004861|449931663|FG008|Overall Study|Study termination by Sponsor|1|||
125085965|NCT01004861|449931664|FG009|Overall Study|Study termination by Sponsor|0|||
125085966|NCT01004861|449931665|FG010|Overall Study|Study termination by Sponsor|0|||
125085967|NCT01004861|449931666|FG011|Overall Study|Study termination by Sponsor|0|||
125085968|NCT01004861|449931667|FG012|Overall Study|Study termination by Sponsor|0|||
125085969|NCT00003389|449931668|FG000|Overall Study|Disease progression|6|||
125085970|NCT00003389|449931669|FG001|Overall Study|Disease progression|1|||
125085971|NCT00003389|449931668|FG000|Overall Study|Adverse Event|13|||
125085972|NCT00003389|449931669|FG001|Overall Study|Adverse Event|2|||
125085973|NCT00003389|449931668|FG000|Overall Study|Death|0|||
125085974|NCT00003389|449931669|FG001|Overall Study|Death|3|||
125085975|NCT00003389|449931668|FG000|Overall Study|Withdrawal by Subject|12|||
125085976|NCT00003389|449931669|FG001|Overall Study|Withdrawal by Subject|5|||
125085977|NCT00003389|449931668|FG000|Overall Study|Alternative therapy|2|||
125085978|NCT00003389|449931669|FG001|Overall Study|Alternative therapy|1|||
125145197|NCT01438476|450155972|FG001|Overall Study|Communication barrier|1|||
125085979|NCT00003389|449931668|FG000|Overall Study|Complicating disease|1|||
125085980|NCT00003389|449931669|FG001|Overall Study|Complicating disease|0|||
125085981|NCT00003389|449931668|FG000|Overall Study|Off-treatment reason missing|31|||
125145198|NCT02522780|450155975|FG000|Overall Study|Consent withdrawn by subject|5|||
125145199|NCT02522780|450155976|FG001|Overall Study|Consent withdrawn by subject|7|||
125145200|NCT02522780|450155975|FG000|Overall Study|Protocol deviation|1|||
125145201|NCT02522780|450155976|FG001|Overall Study|Protocol deviation|3|||
125145202|NCT02522780|450155975|FG000|Overall Study|Subject refused endoscopic procedure|0|||
125145203|NCT02522780|450155976|FG001|Overall Study|Subject refused endoscopic procedure|1|||
125145204|NCT02522780|450155975|FG000|Overall Study|Adverse event, non-fatal|11|||
125145205|NCT02522780|450155976|FG001|Overall Study|Adverse event, non-fatal|16|||
125145206|NCT02058160|450155977|FG000|Overall Study|Randomized but not treated|2|||
125145207|NCT02058160|450155978|FG001|Overall Study|Randomized but not treated|4|||
125145208|NCT02058160|450155977|FG000|Overall Study|Poor compliance to protocol|4|||
125145209|NCT02058160|450155978|FG001|Overall Study|Poor compliance to protocol|1|||
125145210|NCT02058160|450155977|FG000|Overall Study|Adverse Event|12|||
125145211|NCT02058160|450155978|FG001|Overall Study|Adverse Event|3|||
125145212|NCT02058160|450155977|FG000|Overall Study|Lost to Follow-up|1|||
125145213|NCT02058160|450155978|FG001|Overall Study|Lost to Follow-up|0|||
125145214|NCT02058160|450155977|FG000|Overall Study|Other than specified above|12|||
125145215|NCT02058160|450155978|FG001|Overall Study|Other than specified above|6|||
125145216|NCT03310619|450155979|FG000|Pre-Treatment Period|Death|1|||
125145217|NCT03310619|450155980|FG001|Pre-Treatment Period|Death|0|||
125145218|NCT03310619|450155981|FG002|Pre-Treatment Period|Death|0|||
125145219|NCT03310619|450155982|FG003|Pre-Treatment Period|Death|0|||
125145220|NCT03310619|450155983|FG004|Pre-Treatment Period|Death|1|||
125145221|NCT03310619|450155984|FG005|Pre-Treatment Period|Death|0|||
125145222|NCT03310619|450155985|FG006|Pre-Treatment Period|Death|0|||
125145223|NCT03310619|450155986|FG007|Pre-Treatment Period|Death|0|||
125145224|NCT03310619|450155979|FG000|Pre-Treatment Period|Other reasons|2|||
125145225|NCT03310619|450155980|FG001|Pre-Treatment Period|Other reasons|1|||
125145226|NCT03310619|450155981|FG002|Pre-Treatment Period|Other reasons|2|||
125145227|NCT03310619|450155982|FG003|Pre-Treatment Period|Other reasons|0|||
125145228|NCT03310619|450155983|FG004|Pre-Treatment Period|Other reasons|0|||
125145229|NCT03310619|450155984|FG005|Pre-Treatment Period|Other reasons|0|||
125145230|NCT03310619|450155985|FG006|Pre-Treatment Period|Other reasons|2|||
125145231|NCT03310619|450155986|FG007|Pre-Treatment Period|Other reasons|0|||
125145232|NCT03310619|450155979|FG000|Treatment Period|Death|1|||
125145233|NCT03310619|450155980|FG001|Treatment Period|Death|2|||
125145234|NCT03310619|450155981|FG002|Treatment Period|Death|0|||
125145235|NCT03310619|450155982|FG003|Treatment Period|Death|0|||
125145236|NCT03310619|450155983|FG004|Treatment Period|Death|1|||
125145237|NCT03310619|450155984|FG005|Treatment Period|Death|0|||
125145238|NCT03310619|450155985|FG006|Treatment Period|Death|2|||
125145239|NCT03310619|450155986|FG007|Treatment Period|Death|0|||
125145240|NCT03310619|450155979|FG000|Treatment Period|Adverse Event|0|||
125145241|NCT03310619|450155980|FG001|Treatment Period|Adverse Event|1|||
125085982|NCT00003389|449931669|FG001|Overall Study|Off-treatment reason missing|21|||
125085983|NCT00003389|449931668|FG000|Overall Study|Ineligible|33|||
125085984|NCT00003389|449931669|FG001|Overall Study|Ineligible|27|||
125085985|NCT00686699|449931670|FG000|Treatment Period 1|Adverse Event|0|||
125085986|NCT00686699|449931671|FG001|Treatment Period 1|Adverse Event|2|||
125085987|NCT04610827|449931672|FG000|Overall Study|Withdrawal by Subject|1|||
125085988|NCT04610827|449931673|FG001|Overall Study|Withdrawal by Subject|1|||
125085989|NCT04610827|449931674|FG002|Overall Study|Withdrawal by Subject|0|||
125145242|NCT03310619|450155981|FG002|Treatment Period|Adverse Event|4|||
125145243|NCT03310619|450155982|FG003|Treatment Period|Adverse Event|1|||
125145244|NCT03310619|450155983|FG004|Treatment Period|Adverse Event|0|||
125145245|NCT03310619|450155984|FG005|Treatment Period|Adverse Event|0|||
125145246|NCT03310619|450155985|FG006|Treatment Period|Adverse Event|0|||
125145247|NCT03310619|450155986|FG007|Treatment Period|Adverse Event|0|||
125145248|NCT03310619|450155979|FG000|Treatment Period|Withdrawal by participant|0|||
125145249|NCT03310619|450155980|FG001|Treatment Period|Withdrawal by participant|0|||
125145250|NCT03310619|450155981|FG002|Treatment Period|Withdrawal by participant|1|||
125145251|NCT03310619|450155982|FG003|Treatment Period|Withdrawal by participant|0|||
125145252|NCT03310619|450155983|FG004|Treatment Period|Withdrawal by participant|0|||
125145253|NCT03310619|450155984|FG005|Treatment Period|Withdrawal by participant|0|||
125145254|NCT03310619|450155985|FG006|Treatment Period|Withdrawal by participant|0|||
125145255|NCT03310619|450155986|FG007|Treatment Period|Withdrawal by participant|0|||
125085990|NCT01997892|449931676|FG000|Overall Study|Physician Decision|2|||
125145256|NCT03310619|450155979|FG000|Treatment Period|Lost to Follow-up|0|||
125145257|NCT03310619|450155980|FG001|Treatment Period|Lost to Follow-up|0|||
125085991|NCT01997892|449931676|FG000|Overall Study|Lost to Follow-up|6|||
125085992|NCT01997892|449931676|FG000|Overall Study|Death|14|||
125085993|NCT01997892|449931676|FG000|Overall Study|Renal transplant|8|||
125085994|NCT01997892|449931676|FG000|Overall Study|Other|3|||
125085995|NCT01997892|449931676|FG000|Overall Study|Study completion data not recorded|35|||
125085996|NCT02608099|449931680|FG000|Overall Study|Ablation procedure not initiated|3|||
125085997|NCT02608099|449931681|FG001|Overall Study|Ablation procedure not initiated|2|||
125085998|NCT04657003|449931685|FG000|Overall Study|Adverse Event|5|||
125085999|NCT04657003|449931686|FG001|Overall Study|Adverse Event|1|||
125086000|NCT04657003|449931687|FG002|Overall Study|Adverse Event|5|||
125086001|NCT04657003|449931685|FG000|Overall Study|Death|0|||
125086002|NCT04657003|449931686|FG001|Overall Study|Death|2|||
125086003|NCT04657003|449931687|FG002|Overall Study|Death|0|||
125086004|NCT04657003|449931685|FG000|Overall Study|Lost to Follow-up|8|||
125086005|NCT04657003|449931686|FG001|Overall Study|Lost to Follow-up|4|||
125086006|NCT04657003|449931687|FG002|Overall Study|Lost to Follow-up|10|||
125086007|NCT04657003|449931685|FG000|Overall Study|Other - As Reported by Investigator|3|||
125086008|NCT04657003|449931686|FG001|Overall Study|Other - As Reported by Investigator|2|||
125086009|NCT04657003|449931687|FG002|Overall Study|Other - As Reported by Investigator|2|||
125086010|NCT04657003|449931685|FG000|Overall Study|Pregnancy|2|||
125086011|NCT04657003|449931686|FG001|Overall Study|Pregnancy|0|||
125086012|NCT04657003|449931687|FG002|Overall Study|Pregnancy|2|||
125086013|NCT04657003|449931685|FG000|Overall Study|Withdrawal by Subject|16|||
125086014|NCT04657003|449931686|FG001|Overall Study|Withdrawal by Subject|7|||
125086015|NCT04657003|449931687|FG002|Overall Study|Withdrawal by Subject|10|||
125086016|NCT00768040|449931690|FG000|Overall Study|Adverse Event|3|||
125086017|NCT00768040|449931691|FG001|Overall Study|Adverse Event|2|||
125086018|NCT00768040|449931690|FG000|Overall Study|Abnormal laboratory value|1|||
125086019|NCT00768040|449931691|FG001|Overall Study|Abnormal laboratory value|1|||
125086020|NCT00417248|449931693|FG000|Overall Study|Study Terminated|6|||
125086021|NCT00417248|449931693|FG000|Overall Study|Death|1|||
125086022|NCT00417248|449931693|FG000|Overall Study|Lack of Efficacy|1|||
125086023|NCT02185040|449931694|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
125086024|NCT02185040|449931695|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
125086025|NCT02185040|449931696|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
125086026|NCT02185040|449931697|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
125086027|NCT02185040|449931698|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
125086028|NCT02185040|449931699|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
125086029|NCT02185040|449931700|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
125086030|NCT02185040|449931694|FG000|Part 1 Treatment Phase|Adverse Event|1|||
125086031|NCT02185040|449931695|FG001|Part 1 Treatment Phase|Adverse Event|0|||
125086032|NCT02185040|449931696|FG002|Part 1 Treatment Phase|Adverse Event|0|||
125086033|NCT02185040|449931697|FG003|Part 1 Treatment Phase|Adverse Event|2|||
125086034|NCT02185040|449931698|FG004|Part 1 Treatment Phase|Adverse Event|3|||
125086035|NCT02185040|449931699|FG005|Part 1 Treatment Phase|Adverse Event|0|||
125086036|NCT02185040|449931700|FG006|Part 1 Treatment Phase|Adverse Event|0|||
125086037|NCT02185040|449931694|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
125086038|NCT02185040|449931695|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
125086039|NCT02185040|449931696|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
125086040|NCT02185040|449931697|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
125086041|NCT02185040|449931698|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
125086042|NCT02185040|449931699|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
125086043|NCT02185040|449931700|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
125086044|NCT02185040|449931694|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
125086045|NCT02185040|449931695|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
125086046|NCT02185040|449931696|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
125086047|NCT02185040|449931697|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
125086048|NCT02185040|449931698|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
125086049|NCT02185040|449931699|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
125086050|NCT02185040|449931700|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
125086051|NCT02185040|449931694|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
125086052|NCT02185040|449931695|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
125086053|NCT02185040|449931696|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
125086054|NCT02185040|449931697|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
125086055|NCT02185040|449931698|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
125086056|NCT02185040|449931699|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
125086057|NCT02185040|449931700|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
125086058|NCT02185040|449931694|FG000|Active Treatment Extension Phase|Adverse Event|0|||
125086059|NCT02185040|449931695|FG001|Active Treatment Extension Phase|Adverse Event|0|||
125086060|NCT02185040|449931696|FG002|Active Treatment Extension Phase|Adverse Event|0|||
125086061|NCT02185040|449931697|FG003|Active Treatment Extension Phase|Adverse Event|0|||
125086062|NCT02185040|449931698|FG004|Active Treatment Extension Phase|Adverse Event|0|||
125086063|NCT02185040|449931699|FG005|Active Treatment Extension Phase|Adverse Event|1|||
125086064|NCT02185040|449931700|FG006|Active Treatment Extension Phase|Adverse Event|4|||
125086065|NCT02185040|449931694|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
125086066|NCT02185040|449931695|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
125086067|NCT02185040|449931696|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
125086068|NCT02185040|449931697|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
125086069|NCT02185040|449931698|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
125086070|NCT02185040|449931699|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
125086071|NCT02185040|449931700|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
125086072|NCT02185040|449931694|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
125086073|NCT02185040|449931695|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
125086074|NCT02185040|449931696|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
125086075|NCT02185040|449931697|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
125086076|NCT02185040|449931698|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
125086077|NCT02185040|449931699|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
125086078|NCT02185040|449931700|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
125086079|NCT03347279|449931701|FG000|Overall Study|Withdrawal by Subject|8|||
125086080|NCT03347279|449931702|FG001|Overall Study|Withdrawal by Subject|15|||
125086081|NCT03347279|449931701|FG000|Overall Study|Death|0|||
125086082|NCT03347279|449931702|FG001|Overall Study|Death|2|||
125086083|NCT03347279|449931701|FG000|Overall Study|Lost to Follow-up|5|||
125086084|NCT03347279|449931702|FG001|Overall Study|Lost to Follow-up|2|||
125086085|NCT03347279|449931701|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
125086086|NCT03347279|449931702|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
125086087|NCT03818399|449931707|FG000|Overall Study|Lost to Follow-up|11|||
125086088|NCT03818399|449931707|FG000|Overall Study|Withdrawal by Subject|1|||
125086089|NCT03818399|449931707|FG000|Overall Study|Protocol Violation|2|||
125086090|NCT03557801|449931710|FG000|Overall Study|Protocol Violation|1|||
125086091|NCT03557801|449931711|FG001|Overall Study|Protocol Violation|0|||
125086092|NCT03557801|449931712|FG002|Overall Study|Protocol Violation|0|||
125086093|NCT03557801|449931710|FG000|Overall Study|Withdrawal by Subject|1|||
125086094|NCT03557801|449931711|FG001|Overall Study|Withdrawal by Subject|0|||
125086095|NCT03557801|449931712|FG002|Overall Study|Withdrawal by Subject|3|||
125086096|NCT03557801|449931710|FG000|Overall Study|Lost to Follow-up|0|||
125086097|NCT03557801|449931711|FG001|Overall Study|Lost to Follow-up|1|||
125086098|NCT03557801|449931712|FG002|Overall Study|Lost to Follow-up|0|||
125086099|NCT00535236|449931713|FG000|Overall Study|Adverse Event|1|||
125086100|NCT00535236|449931714|FG001|Overall Study|Adverse Event|0|||
125086101|NCT00535236|449931715|FG002|Overall Study|Adverse Event|9|||
125086102|NCT00535236|449931716|FG003|Overall Study|Adverse Event|3|||
125086103|NCT00535236|449931717|FG004|Overall Study|Adverse Event|3|||
125086104|NCT00535236|449931718|FG005|Overall Study|Adverse Event|0|||
125145258|NCT03310619|450155981|FG002|Treatment Period|Lost to Follow-up|0|||
125145259|NCT03310619|450155982|FG003|Treatment Period|Lost to Follow-up|0|||
125145260|NCT03310619|450155983|FG004|Treatment Period|Lost to Follow-up|0|||
125145261|NCT03310619|450155984|FG005|Treatment Period|Lost to Follow-up|0|||
125145262|NCT03310619|450155985|FG006|Treatment Period|Lost to Follow-up|0|||
125145263|NCT03310619|450155986|FG007|Treatment Period|Lost to Follow-up|1|||
125145264|NCT03310619|450155979|FG000|Treatment Period|Study terminated by sponsor|0|||
125145265|NCT03310619|450155980|FG001|Treatment Period|Study terminated by sponsor|0|||
125145266|NCT03310619|450155981|FG002|Treatment Period|Study terminated by sponsor|0|||
125145267|NCT03310619|450155982|FG003|Treatment Period|Study terminated by sponsor|0|||
125145268|NCT03310619|450155983|FG004|Treatment Period|Study terminated by sponsor|0|||
125145269|NCT03310619|450155984|FG005|Treatment Period|Study terminated by sponsor|0|||
125145270|NCT03310619|450155985|FG006|Treatment Period|Study terminated by sponsor|0|||
125145271|NCT03310619|450155986|FG007|Treatment Period|Study terminated by sponsor|1|||
125145272|NCT03310619|450155979|FG000|Treatment Period|Physician Decision|0|||
125145273|NCT03310619|450155980|FG001|Treatment Period|Physician Decision|0|||
125086105|NCT00535236|449931719|FG006|Overall Study|Adverse Event|5|||
125086106|NCT00535236|449931720|FG007|Overall Study|Adverse Event|1|||
125086107|NCT00535236|449931721|FG008|Overall Study|Adverse Event|2|||
125086108|NCT00535236|449931722|FG009|Overall Study|Adverse Event|1|||
125086109|NCT00535236|449931713|FG000|Overall Study|Lost to Follow-up|1|||
125086110|NCT00535236|449931714|FG001|Overall Study|Lost to Follow-up|2|||
125086111|NCT00535236|449931715|FG002|Overall Study|Lost to Follow-up|0|||
125086112|NCT00535236|449931716|FG003|Overall Study|Lost to Follow-up|0|||
125086113|NCT00535236|449931717|FG004|Overall Study|Lost to Follow-up|2|||
125086114|NCT00535236|449931718|FG005|Overall Study|Lost to Follow-up|0|||
125086115|NCT00535236|449931719|FG006|Overall Study|Lost to Follow-up|0|||
125086116|NCT00535236|449931720|FG007|Overall Study|Lost to Follow-up|0|||
125086117|NCT00535236|449931721|FG008|Overall Study|Lost to Follow-up|6|||
125086118|NCT00535236|449931722|FG009|Overall Study|Lost to Follow-up|1|||
125086119|NCT00535236|449931713|FG000|Overall Study|Physician Decision|0|||
125086120|NCT00535236|449931714|FG001|Overall Study|Physician Decision|0|||
125086121|NCT00535236|449931715|FG002|Overall Study|Physician Decision|0|||
125086122|NCT00535236|449931716|FG003|Overall Study|Physician Decision|0|||
125086123|NCT00535236|449931717|FG004|Overall Study|Physician Decision|1|||
125086124|NCT00535236|449931718|FG005|Overall Study|Physician Decision|0|||
125086125|NCT00535236|449931719|FG006|Overall Study|Physician Decision|1|||
125086126|NCT00535236|449931720|FG007|Overall Study|Physician Decision|0|||
125086127|NCT00535236|449931721|FG008|Overall Study|Physician Decision|0|||
125086128|NCT00535236|449931722|FG009|Overall Study|Physician Decision|0|||
125086129|NCT00535236|449931713|FG000|Overall Study|Protocol Violation|2|||
125086130|NCT00535236|449931714|FG001|Overall Study|Protocol Violation|0|||
125086131|NCT00535236|449931715|FG002|Overall Study|Protocol Violation|1|||
125086132|NCT00535236|449931716|FG003|Overall Study|Protocol Violation|0|||
125086133|NCT00535236|449931717|FG004|Overall Study|Protocol Violation|0|||
125086134|NCT00535236|449931718|FG005|Overall Study|Protocol Violation|0|||
125086135|NCT00535236|449931719|FG006|Overall Study|Protocol Violation|0|||
125086136|NCT00535236|449931720|FG007|Overall Study|Protocol Violation|0|||
125086137|NCT00535236|449931721|FG008|Overall Study|Protocol Violation|1|||
125086138|NCT00535236|449931722|FG009|Overall Study|Protocol Violation|0|||
125145274|NCT03310619|450155981|FG002|Treatment Period|Physician Decision|0|||
125145275|NCT03310619|450155982|FG003|Treatment Period|Physician Decision|0|||
125145276|NCT03310619|450155983|FG004|Treatment Period|Physician Decision|3|||
125145277|NCT03310619|450155984|FG005|Treatment Period|Physician Decision|0|||
125145278|NCT03310619|450155985|FG006|Treatment Period|Physician Decision|0|||
125145279|NCT03310619|450155986|FG007|Treatment Period|Physician Decision|0|||
125086139|NCT00535236|449931713|FG000|Overall Study|Withdrawal by Subject|3|||
125086140|NCT00535236|449931714|FG001|Overall Study|Withdrawal by Subject|0|||
125086141|NCT00535236|449931715|FG002|Overall Study|Withdrawal by Subject|2|||
125086142|NCT00535236|449931716|FG003|Overall Study|Withdrawal by Subject|1|||
125086143|NCT00535236|449931717|FG004|Overall Study|Withdrawal by Subject|6|||
125086144|NCT00535236|449931718|FG005|Overall Study|Withdrawal by Subject|1|||
125086145|NCT00535236|449931719|FG006|Overall Study|Withdrawal by Subject|5|||
125086146|NCT00535236|449931720|FG007|Overall Study|Withdrawal by Subject|0|||
125086147|NCT00535236|449931721|FG008|Overall Study|Withdrawal by Subject|4|||
125086148|NCT00535236|449931722|FG009|Overall Study|Withdrawal by Subject|2|||
125086149|NCT00141297|449931724|FG000|Overall Study|Adverse Event|0|||
125086150|NCT00141297|449931725|FG001|Overall Study|Adverse Event|0|||
125086151|NCT00141297|449931726|FG002|Overall Study|Adverse Event|1|||
125086152|NCT00141297|449931727|FG003|Overall Study|Adverse Event|0|||
125086153|NCT00141297|449931728|FG004|Overall Study|Adverse Event|1|||
125086154|NCT00141297|449931729|FG005|Overall Study|Adverse Event|1|||
125086155|NCT00141297|449931730|FG006|Overall Study|Adverse Event|0|||
125086156|NCT00141297|449931731|FG007|Overall Study|Adverse Event|1|||
125086157|NCT00141297|449931732|FG008|Overall Study|Adverse Event|1|||
125086158|NCT00141297|449931733|FG009|Overall Study|Adverse Event|0|||
125086159|NCT00141297|449931724|FG000|Overall Study|Death|1|||
125086160|NCT00141297|449931725|FG001|Overall Study|Death|0|||
125086161|NCT00141297|449931726|FG002|Overall Study|Death|0|||
125086162|NCT00141297|449931727|FG003|Overall Study|Death|0|||
125086163|NCT00141297|449931728|FG004|Overall Study|Death|0|||
125086164|NCT00141297|449931729|FG005|Overall Study|Death|0|||
125086165|NCT00141297|449931730|FG006|Overall Study|Death|0|||
125086166|NCT00141297|449931731|FG007|Overall Study|Death|0|||
125086167|NCT00141297|449931732|FG008|Overall Study|Death|1|||
125086168|NCT00141297|449931733|FG009|Overall Study|Death|0|||
125086169|NCT00141297|449931724|FG000|Overall Study|Withdrawal by Subject|0|||
125086170|NCT00141297|449931725|FG001|Overall Study|Withdrawal by Subject|0|||
125086171|NCT00141297|449931726|FG002|Overall Study|Withdrawal by Subject|0|||
125086172|NCT00141297|449931727|FG003|Overall Study|Withdrawal by Subject|0|||
125086173|NCT00141297|449931728|FG004|Overall Study|Withdrawal by Subject|0|||
125086174|NCT00141297|449931729|FG005|Overall Study|Withdrawal by Subject|0|||
125086175|NCT00141297|449931730|FG006|Overall Study|Withdrawal by Subject|0|||
125086176|NCT00141297|449931731|FG007|Overall Study|Withdrawal by Subject|0|||
125086177|NCT00141297|449931732|FG008|Overall Study|Withdrawal by Subject|1|||
125086178|NCT00141297|449931733|FG009|Overall Study|Withdrawal by Subject|0|||
125086179|NCT00141297|449931724|FG000|Overall Study|Other|0|||
125086180|NCT00141297|449931725|FG001|Overall Study|Other|0|||
125086181|NCT00141297|449931726|FG002|Overall Study|Other|0|||
125086182|NCT00141297|449931727|FG003|Overall Study|Other|1|||
125086183|NCT00141297|449931728|FG004|Overall Study|Other|5|||
125086184|NCT00141297|449931729|FG005|Overall Study|Other|0|||
125086185|NCT00141297|449931730|FG006|Overall Study|Other|0|||
125086186|NCT00141297|449931731|FG007|Overall Study|Other|0|||
125086187|NCT00141297|449931732|FG008|Overall Study|Other|2|||
125086188|NCT00141297|449931733|FG009|Overall Study|Other|0|||
125086189|NCT00141297|449931724|FG000|Overall Study|Progressive Disease|2|||
125086190|NCT00141297|449931725|FG001|Overall Study|Progressive Disease|3|||
125086191|NCT00141297|449931726|FG002|Overall Study|Progressive Disease|6|||
125086192|NCT00141297|449931727|FG003|Overall Study|Progressive Disease|2|||
125086193|NCT00141297|449931728|FG004|Overall Study|Progressive Disease|15|||
125086194|NCT00141297|449931729|FG005|Overall Study|Progressive Disease|2|||
125086195|NCT00141297|449931730|FG006|Overall Study|Progressive Disease|3|||
125086196|NCT00141297|449931731|FG007|Overall Study|Progressive Disease|3|||
125086197|NCT00141297|449931732|FG008|Overall Study|Progressive Disease|15|||
125086198|NCT00141297|449931733|FG009|Overall Study|Progressive Disease|6|||
125086199|NCT00141297|449931724|FG000|Overall Study|Transitioned|0|||
125086200|NCT00141297|449931725|FG001|Overall Study|Transitioned|0|||
125086201|NCT00141297|449931726|FG002|Overall Study|Transitioned|0|||
125086202|NCT00141297|449931727|FG003|Overall Study|Transitioned|0|||
125086203|NCT00141297|449931728|FG004|Overall Study|Transitioned|1|||
125086204|NCT00141297|449931729|FG005|Overall Study|Transitioned|0|||
125086205|NCT00141297|449931730|FG006|Overall Study|Transitioned|0|||
125086206|NCT00141297|449931731|FG007|Overall Study|Transitioned|0|||
125086207|NCT00141297|449931732|FG008|Overall Study|Transitioned|0|||
125086208|NCT00141297|449931733|FG009|Overall Study|Transitioned|0|||
125086209|NCT02200510|449931734|FG000|Overall Study|Death|1|||
125086210|NCT02200510|449931735|FG001|Overall Study|Death|1|||
125086211|NCT02200510|449931734|FG000|Overall Study|Protocol Violation|0|||
125086212|NCT02200510|449931735|FG001|Overall Study|Protocol Violation|1|||
125086213|NCT02200510|449931734|FG000|Overall Study|Lost to Follow-up|7|||
125086214|NCT02200510|449931735|FG001|Overall Study|Lost to Follow-up|1|||
125086215|NCT02200510|449931734|FG000|Overall Study|potential COI - joined study team|1|||
125086216|NCT02200510|449931735|FG001|Overall Study|potential COI - joined study team|0|||
125086217|NCT00290355|449931736|FG000|Overall Study|Serious adverse event|7|||
125086218|NCT00290355|449931737|FG001|Overall Study|Serious adverse event|4|||
125086219|NCT00290355|449931736|FG000|Overall Study|Study product reactogenicity|1|||
125086220|NCT00290355|449931737|FG001|Overall Study|Study product reactogenicity|0|||
125086221|NCT00290355|449931736|FG000|Overall Study|Protocol Violation|1|||
125086222|NCT00290355|449931737|FG001|Overall Study|Protocol Violation|0|||
125086223|NCT00290355|449931736|FG000|Overall Study|Withdrawal by Subject|2|||
125086224|NCT00290355|449931737|FG001|Overall Study|Withdrawal by Subject|0|||
125086225|NCT00290355|449931736|FG000|Overall Study|Migrated / moved from the study area|1|||
125086226|NCT00290355|449931737|FG001|Overall Study|Migrated / moved from the study area|0|||
125086227|NCT00290355|449931736|FG000|Overall Study|Lost to Follow-up|3|||
125086228|NCT00290355|449931737|FG001|Overall Study|Lost to Follow-up|1|||
125086229|NCT00290355|449931736|FG000|Overall Study|Other|2|||
125086230|NCT00290355|449931737|FG001|Overall Study|Other|0|||
125086231|NCT01542632|449931738|FG000|Overall Study|Withdrawal of Consent|0|||
125086232|NCT01542632|449931739|FG001|Overall Study|Withdrawal of Consent|0|||
125086233|NCT01542632|449931740|FG002|Overall Study|Withdrawal of Consent|0|||
125086234|NCT01542632|449931741|FG003|Overall Study|Withdrawal of Consent|2|||
125086235|NCT01542632|449931742|FG004|Overall Study|Withdrawal of Consent|3|||
125086236|NCT01542632|449931743|FG005|Overall Study|Withdrawal of Consent|0|||
125086237|NCT01542632|449931738|FG000|Overall Study|Adverse Event|0|||
125086238|NCT01542632|449931739|FG001|Overall Study|Adverse Event|0|||
125086239|NCT01542632|449931740|FG002|Overall Study|Adverse Event|1|||
125086240|NCT01542632|449931741|FG003|Overall Study|Adverse Event|0|||
125086241|NCT01542632|449931742|FG004|Overall Study|Adverse Event|0|||
125086242|NCT01542632|449931743|FG005|Overall Study|Adverse Event|0|||
125086243|NCT01542632|449931738|FG000|Overall Study|Lost to Follow-up|0|||
125086244|NCT01542632|449931739|FG001|Overall Study|Lost to Follow-up|1|||
125086245|NCT01542632|449931740|FG002|Overall Study|Lost to Follow-up|0|||
125086246|NCT01542632|449931741|FG003|Overall Study|Lost to Follow-up|0|||
125086247|NCT01542632|449931742|FG004|Overall Study|Lost to Follow-up|0|||
125086248|NCT01542632|449931743|FG005|Overall Study|Lost to Follow-up|0|||
125086249|NCT01542632|449931738|FG000|Overall Study|Sponsor/Investigator Decision|0|||
125086250|NCT01542632|449931739|FG001|Overall Study|Sponsor/Investigator Decision|0|||
125086251|NCT01542632|449931740|FG002|Overall Study|Sponsor/Investigator Decision|0|||
125086252|NCT01542632|449931741|FG003|Overall Study|Sponsor/Investigator Decision|0|||
125086253|NCT01542632|449931742|FG004|Overall Study|Sponsor/Investigator Decision|1|||
125086254|NCT01542632|449931743|FG005|Overall Study|Sponsor/Investigator Decision|0|||
125086255|NCT00033514|449931744|FG000|Overall Study|Lost to Follow-up|1|||
125086256|NCT00033514|449931745|FG001|Overall Study|Lost to Follow-up|1|||
125086257|NCT00033514|449931744|FG000|Overall Study|Withdrawal by Subject|0|||
125086258|NCT00033514|449931745|FG001|Overall Study|Withdrawal by Subject|3|||
125086259|NCT01108263|449931751|FG000|Overall Study|Adverse Event|0|||
125086260|NCT01108263|449931752|FG001|Overall Study|Adverse Event|1|||
125086261|NCT01685372|449931753|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
125086262|NCT01685372|449931754|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
125086263|NCT01072500|449931755|FG000|Overall Study|Death|2|||
125086264|NCT01072500|449931756|FG001|Overall Study|Death|2|||
125086265|NCT01072500|449931755|FG000|Overall Study|Lost to Follow-up|5|||
125086266|NCT01072500|449931756|FG001|Overall Study|Lost to Follow-up|2|||
125086267|NCT01072500|449931755|FG000|Overall Study|Withdrawal by Subject|17|||
125086268|NCT01072500|449931756|FG001|Overall Study|Withdrawal by Subject|10|||
125145280|NCT03310619|450155979|FG000|Treatment Period|Other reasons|1|||
125086269|NCT00829010|449931757|FG000|Overall Study|Adverse Event|1|||
125086270|NCT00829010|449931758|FG001|Overall Study|Adverse Event|0|||
125086271|NCT00829010|449931759|FG002|Overall Study|Adverse Event|0|||
125086272|NCT00829010|449931760|FG003|Overall Study|Adverse Event|0|||
125086273|NCT00829010|449931761|FG004|Overall Study|Adverse Event|0|||
125145281|NCT03310619|450155980|FG001|Treatment Period|Other reasons|0|||
125086274|NCT00829010|449931757|FG000|Overall Study|Withdrawal by Subject|0|||
125086275|NCT00829010|449931758|FG001|Overall Study|Withdrawal by Subject|1|||
125086276|NCT00829010|449931759|FG002|Overall Study|Withdrawal by Subject|1|||
125086277|NCT00829010|449931760|FG003|Overall Study|Withdrawal by Subject|0|||
125086278|NCT00829010|449931761|FG004|Overall Study|Withdrawal by Subject|2|||
125086279|NCT00829010|449931757|FG000|Overall Study|Lost to Follow-up|1|||
125086280|NCT00829010|449931758|FG001|Overall Study|Lost to Follow-up|0|||
125086281|NCT00829010|449931759|FG002|Overall Study|Lost to Follow-up|2|||
125086282|NCT00829010|449931760|FG003|Overall Study|Lost to Follow-up|0|||
125086283|NCT00829010|449931761|FG004|Overall Study|Lost to Follow-up|0|||
125086284|NCT00829010|449931757|FG000|Overall Study|Fatality|5|||
125086285|NCT00829010|449931758|FG001|Overall Study|Fatality|4|||
125086286|NCT00829010|449931759|FG002|Overall Study|Fatality|0|||
125086287|NCT00829010|449931760|FG003|Overall Study|Fatality|3|||
125086288|NCT00829010|449931761|FG004|Overall Study|Fatality|0|||
125086289|NCT00829010|449931757|FG000|Overall Study|Migrated/Moved from study area|3|||
125086290|NCT00829010|449931758|FG001|Overall Study|Migrated/Moved from study area|4|||
125086291|NCT00829010|449931759|FG002|Overall Study|Migrated/Moved from study area|0|||
125086292|NCT00829010|449931760|FG003|Overall Study|Migrated/Moved from study area|5|||
125086293|NCT00829010|449931761|FG004|Overall Study|Migrated/Moved from study area|0|||
125086294|NCT02061540|449931762|FG000|Overall Study|Adverse Event|2|||
125086295|NCT02061540|449931762|FG000|Overall Study|Withdrawal by Subject|2|||
125086296|NCT02289833|449931763|FG000|Overall Study|Study discontinuation|0|||
125086297|NCT02289833|449931764|FG001|Overall Study|Study discontinuation|1|||
125086298|NCT02289833|449931763|FG000|Overall Study|Lost to Follow-up|4|||
125086299|NCT02289833|449931764|FG001|Overall Study|Lost to Follow-up|0|||
125086300|NCT02289833|449931763|FG000|Overall Study|Death|23|||
125086301|NCT02289833|449931764|FG001|Overall Study|Death|16|||
125086302|NCT01642004|449931765|FG000|Randomization|Adverse Event unrelated to study drug|1|||
125086303|NCT01642004|449931766|FG001|Randomization|Adverse Event unrelated to study drug|0|||
125086304|NCT01642004|449931765|FG000|Randomization|Participant withdrew consent|1|||
125086305|NCT01642004|449931766|FG001|Randomization|Participant withdrew consent|6|||
125086306|NCT01642004|449931765|FG000|Randomization|No longer meets study criteria|2|||
125086307|NCT01642004|449931766|FG001|Randomization|No longer meets study criteria|2|||
125086308|NCT01642004|449931765|FG000|Treatment|Disease progression|95|||
125086309|NCT01642004|449931766|FG001|Treatment|Disease progression|79|||
125086310|NCT01642004|449931765|FG000|Treatment|Study drug toxicity|10|||
125086311|NCT01642004|449931766|FG001|Treatment|Study drug toxicity|13|||
125086312|NCT01642004|449931765|FG000|Treatment|Death|1|||
125086313|NCT01642004|449931766|FG001|Treatment|Death|1|||
125086314|NCT01642004|449931765|FG000|Treatment|Adverse event unrelated to study drug|9|||
125086315|NCT01642004|449931766|FG001|Treatment|Adverse event unrelated to study drug|13|||
125086316|NCT01642004|449931765|FG000|Treatment|Maximum clinical benefit|1|||
125086317|NCT01642004|449931766|FG001|Treatment|Maximum clinical benefit|9|||
125086318|NCT01642004|449931765|FG000|Treatment|Poor/non-compliance|1|||
125086319|NCT01642004|449931766|FG001|Treatment|Poor/non-compliance|0|||
125086320|NCT01642004|449931765|FG000|Treatment|No longer meets study criteria|1|||
125086321|NCT01642004|449931766|FG001|Treatment|No longer meets study criteria|2|||
125086322|NCT01642004|449931765|FG000|Treatment|Other reasons|2|||
125086323|NCT01642004|449931766|FG001|Treatment|Other reasons|0|||
125086324|NCT01642004|449931765|FG000|Treatment|Not reported|0|||
125086325|NCT01642004|449931766|FG001|Treatment|Not reported|3|||
125086326|NCT01642004|449931765|FG000|Treatment|Participant request to discontinue study treatment|6|||
125086327|NCT01642004|449931766|FG001|Treatment|Participant request to discontinue study treatment|4|||
125086328|NCT01642004|449931765|FG000|Treatment|Participant withdrew consent|5|||
125086329|NCT01642004|449931766|FG001|Treatment|Participant withdrew consent|5|||
125086330|NCT00811395|449931769|FG000|Extension Treatment|Adverse Event|1|||
125086331|NCT00811395|449931770|FG001|Extension Treatment|Adverse Event|2|||
125086332|NCT00811395|449931771|FG002|Extension Treatment|Adverse Event|2|||
125086333|NCT00811395|449931772|FG003|Extension Treatment|Adverse Event|2|||
125086334|NCT00811395|449931773|FG004|Extension Treatment|Adverse Event|0|||
125086335|NCT00811395|449931774|FG005|Extension Treatment|Adverse Event|1|||
125086336|NCT00811395|449931769|FG000|Extension Treatment|Progressive disease|1|||
125086337|NCT00811395|449931770|FG001|Extension Treatment|Progressive disease|1|||
125145282|NCT03310619|450155981|FG002|Treatment Period|Other reasons|2|||
125145283|NCT03310619|450155982|FG003|Treatment Period|Other reasons|0|||
125145284|NCT03310619|450155983|FG004|Treatment Period|Other reasons|0|||
125145285|NCT03310619|450155984|FG005|Treatment Period|Other reasons|0|||
125145286|NCT03310619|450155985|FG006|Treatment Period|Other reasons|0|||
125086338|NCT00811395|449931771|FG002|Extension Treatment|Progressive disease|0|||
125086339|NCT00811395|449931772|FG003|Extension Treatment|Progressive disease|0|||
125086340|NCT00811395|449931773|FG004|Extension Treatment|Progressive disease|0|||
125086341|NCT00811395|449931774|FG005|Extension Treatment|Progressive disease|0|||
125086342|NCT00811395|449931769|FG000|Extension Treatment|Participant did not wish to continue|0|||
125086343|NCT00811395|449931770|FG001|Extension Treatment|Participant did not wish to continue|3|||
125086344|NCT00811395|449931771|FG002|Extension Treatment|Participant did not wish to continue|0|||
125145287|NCT03310619|450155986|FG007|Treatment Period|Other reasons|0|||
125145288|NCT01115933|450155987|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
125086345|NCT00811395|449931772|FG003|Extension Treatment|Participant did not wish to continue|1|||
125086346|NCT00811395|449931773|FG004|Extension Treatment|Participant did not wish to continue|0|||
125086347|NCT00811395|449931774|FG005|Extension Treatment|Participant did not wish to continue|1|||
125086348|NCT00811395|449931769|FG000|Extension Treatment|Other than above|0|||
125086349|NCT00811395|449931770|FG001|Extension Treatment|Other than above|0|||
125086350|NCT00811395|449931771|FG002|Extension Treatment|Other than above|1|||
125086351|NCT00811395|449931772|FG003|Extension Treatment|Other than above|0|||
125086352|NCT00811395|449931773|FG004|Extension Treatment|Other than above|0|||
125086353|NCT00811395|449931774|FG005|Extension Treatment|Other than above|0|||
125086354|NCT02607865|449931777|FG000|Overall Study|Lost to Follow-up|9|||
125086355|NCT02607865|449931778|FG001|Overall Study|Lost to Follow-up|7|||
125086356|NCT02607865|449931779|FG002|Overall Study|Lost to Follow-up|7|||
125086357|NCT02607865|449931780|FG003|Overall Study|Lost to Follow-up|5|||
125086358|NCT02607865|449931777|FG000|Overall Study|Withdrawal by Subject|18|||
125086359|NCT02607865|449931778|FG001|Overall Study|Withdrawal by Subject|18|||
125086360|NCT02607865|449931779|FG002|Overall Study|Withdrawal by Subject|17|||
125086361|NCT02607865|449931780|FG003|Overall Study|Withdrawal by Subject|8|||
125086362|NCT02607865|449931777|FG000|Overall Study|Death|5|||
125086363|NCT02607865|449931778|FG001|Overall Study|Death|4|||
125086364|NCT02607865|449931779|FG002|Overall Study|Death|1|||
125086365|NCT02607865|449931780|FG003|Overall Study|Death|3|||
125086366|NCT02607865|449931777|FG000|Overall Study|Unclassified|1|||
125086367|NCT02607865|449931778|FG001|Overall Study|Unclassified|1|||
125086368|NCT02607865|449931779|FG002|Overall Study|Unclassified|2|||
125086369|NCT02607865|449931780|FG003|Overall Study|Unclassified|0|||
125086370|NCT00528840|449931781|FG000|Overall Study|Lost to Follow-up|10|||
125086371|NCT00528840|449931781|FG000|Overall Study|Adverse Event|1|||
125086372|NCT00528840|449931781|FG000|Overall Study|Withdrawal by Subject|17|||
125086373|NCT00528840|449931781|FG000|Overall Study|Death|2|||
125086374|NCT00528840|449931781|FG000|Overall Study|Administrative Reasons|1|||
125086375|NCT00528840|449931781|FG000|Overall Study|Other|2|||
125086376|NCT02447952|449931782|FG000|Overall Study|Adverse Event|2|||
125086377|NCT02447952|449931782|FG000|Overall Study|Physician Decision|1|||
125086378|NCT02447952|449931782|FG000|Overall Study|Withdrawal by Subject|4|||
125086379|NCT01766401|449931787|FG000|Overall Study|Adverse Event|7|||
125086380|NCT01766401|449931788|FG001|Overall Study|Adverse Event|22|||
125086381|NCT01766401|449931787|FG000|Overall Study|Lack of Efficacy|1|||
125086382|NCT01766401|449931788|FG001|Overall Study|Lack of Efficacy|2|||
125086383|NCT01766401|449931787|FG000|Overall Study|Protocol Violation|3|||
125086384|NCT01766401|449931788|FG001|Overall Study|Protocol Violation|8|||
125086385|NCT01766401|449931787|FG000|Overall Study|Withdrawal by Subject|15|||
125086386|NCT01766401|449931788|FG001|Overall Study|Withdrawal by Subject|12|||
125086387|NCT01766401|449931787|FG000|Overall Study|Lost to Follow-up|10|||
125086388|NCT01766401|449931788|FG001|Overall Study|Lost to Follow-up|11|||
125086389|NCT01766401|449931787|FG000|Overall Study|Pregnancy|1|||
125086390|NCT01766401|449931788|FG001|Overall Study|Pregnancy|1|||
125086391|NCT00398086|449931792|FG000|Overall Study|Unacceptable Toxicity|2|||
125086392|NCT00398086|449931793|FG001|Overall Study|Unacceptable Toxicity|8|||
125086393|NCT00398086|449931794|FG002|Overall Study|Unacceptable Toxicity|2|||
125086394|NCT00398086|449931792|FG000|Overall Study|Adverse Event|1|||
125086395|NCT00398086|449931793|FG001|Overall Study|Adverse Event|4|||
125086396|NCT00398086|449931794|FG002|Overall Study|Adverse Event|0|||
125086397|NCT00398086|449931792|FG000|Overall Study|Physician Decision|1|||
125086398|NCT00398086|449931793|FG001|Overall Study|Physician Decision|4|||
125086399|NCT00398086|449931794|FG002|Overall Study|Physician Decision|0|||
125086400|NCT00398086|449931792|FG000|Overall Study|Withdrawal by Subject|5|||
125086401|NCT00398086|449931793|FG001|Overall Study|Withdrawal by Subject|7|||
125086402|NCT00398086|449931794|FG002|Overall Study|Withdrawal by Subject|0|||
125086403|NCT01950364|449931795|FG000|Overall Study|Adverse Event|3|||
125086404|NCT01950364|449931796|FG001|Overall Study|Adverse Event|0|||
125086405|NCT01950364|449931795|FG000|Overall Study|Stem Cell Transplant|2|||
125086406|NCT01950364|449931796|FG001|Overall Study|Stem Cell Transplant|6|||
125086407|NCT01950364|449931795|FG000|Overall Study|Disease Progression|5|||
125086408|NCT01950364|449931796|FG001|Overall Study|Disease Progression|2|||
125086409|NCT01950364|449931795|FG000|Overall Study|Withdrawal by Subject|0|||
125086410|NCT01950364|449931796|FG001|Overall Study|Withdrawal by Subject|1|||
125086411|NCT01950364|449931795|FG000|Overall Study|Protocol Violation|0|||
125086412|NCT01950364|449931796|FG001|Overall Study|Protocol Violation|1|||
125086413|NCT01166386|449931799|FG000|Overall Study|Withdrawal by Subject|3|||
125086414|NCT01166386|449931800|FG001|Overall Study|Withdrawal by Subject|5|||
125086415|NCT02691468|449931803|FG000|Overall Study|Bronchial blocker use|2|||
125086416|NCT02691468|449931804|FG001|Overall Study|Bronchial blocker use|1|||
125086417|NCT02691468|449931803|FG000|Overall Study|Lost to Follow-up|2|||
125086418|NCT02691468|449931804|FG001|Overall Study|Lost to Follow-up|1|||
125086419|NCT02691468|449931803|FG000|Overall Study|Failure to advance FOB|2|||
125086420|NCT02691468|449931804|FG001|Overall Study|Failure to advance FOB|0|||
125086421|NCT02972658|449933244|FG000|Overall Study|Adverse Event|0|||
125086422|NCT02972658|449933245|FG001|Overall Study|Adverse Event|3|||
125086423|NCT02972658|449933246|FG002|Overall Study|Adverse Event|0|||
125086424|NCT02972658|449933247|FG003|Overall Study|Adverse Event|2|||
125086425|NCT02972658|449933244|FG000|Overall Study|Other-determined by Investigator|1|||
125086426|NCT02972658|449933245|FG001|Overall Study|Other-determined by Investigator|1|||
125086427|NCT02972658|449933246|FG002|Overall Study|Other-determined by Investigator|0|||
125086428|NCT02972658|449933247|FG003|Overall Study|Other-determined by Investigator|0|||
125086429|NCT02972658|449933244|FG000|Overall Study|Death|0|||
125086430|NCT02972658|449933245|FG001|Overall Study|Death|0|||
125086431|NCT02972658|449933246|FG002|Overall Study|Death|0|||
125086432|NCT02972658|449933247|FG003|Overall Study|Death|1|||
125086433|NCT02972658|449933244|FG000|Overall Study|Lost to Follow-up|0|||
125086434|NCT02972658|449933245|FG001|Overall Study|Lost to Follow-up|1|||
125086435|NCT02972658|449933246|FG002|Overall Study|Lost to Follow-up|1|||
125086436|NCT02972658|449933247|FG003|Overall Study|Lost to Follow-up|2|||
125086437|NCT02972658|449933244|FG000|Overall Study|Progressive Disease|0|||
125086438|NCT02972658|449933245|FG001|Overall Study|Progressive Disease|1|||
125086439|NCT02972658|449933246|FG002|Overall Study|Progressive Disease|0|||
125086440|NCT02972658|449933247|FG003|Overall Study|Progressive Disease|1|||
125086441|NCT02972658|449933244|FG000|Overall Study|Withdrawal by Subject|4|||
125086442|NCT02972658|449933245|FG001|Overall Study|Withdrawal by Subject|4|||
125086443|NCT02972658|449933246|FG002|Overall Study|Withdrawal by Subject|1|||
125086444|NCT02972658|449933247|FG003|Overall Study|Withdrawal by Subject|6|||
125086445|NCT02972658|449933244|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
125086446|NCT02972658|449933245|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
125086447|NCT02972658|449933246|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
125086448|NCT02972658|449933247|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
125086449|NCT02972658|449933244|FG000|Overall Study|Sponsor Decision|70|||
125086450|NCT02972658|449933245|FG001|Overall Study|Sponsor Decision|127|||
125086451|NCT02972658|449933246|FG002|Overall Study|Sponsor Decision|72|||
125086452|NCT02972658|449933247|FG003|Overall Study|Sponsor Decision|119|||
125086453|NCT03958149|449933248|FG000|Overall Study|Withdrawal by Subject|0|||
125086454|NCT03958149|449933249|FG001|Overall Study|Withdrawal by Subject|1|||
125086455|NCT02785588|449933250|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
125086456|NCT02785588|449933250|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
125086457|NCT02499172|449933252|FG000|Overall Study|Financial reason|0|||
125086458|NCT02499172|449933253|FG001|Overall Study|Financial reason|0|||
125086459|NCT02499172|449933254|FG002|Overall Study|Financial reason|523|||
125086460|NCT02499172|449933255|FG003|Overall Study|Financial reason|436|||
125086461|NCT02499172|449933252|FG000|Overall Study|Lost to Follow-up|65|||
125086462|NCT02499172|449933253|FG001|Overall Study|Lost to Follow-up|64|||
125086463|NCT02499172|449933254|FG002|Overall Study|Lost to Follow-up|0|||
125086464|NCT02499172|449933255|FG003|Overall Study|Lost to Follow-up|0|||
125086465|NCT01293123|449933256|FG000|Overall Study|Lost to Follow-up|0|||
125086466|NCT01293123|449933257|FG001|Overall Study|Lost to Follow-up|1|||
125086467|NCT02710422|449933260|FG000|Overall Study|Termination of study|9|||
125086468|NCT02710422|449933261|FG001|Overall Study|Termination of study|9|||
125086469|NCT01488994|449933270|FG000|Overall Study|Withdrawal by Subject|0|||
125086470|NCT01488994|449933271|FG001|Overall Study|Withdrawal by Subject|1|||
125086471|NCT03798366|449933272|FG000|Overall Study|Lost to Follow-up|0|||
125086472|NCT03798366|449933273|FG001|Overall Study|Lost to Follow-up|1|||
125086473|NCT00474539|449933276|FG000|Infant Series|Withdrawal by Subject|3|||
125086474|NCT00474539|449933277|FG001|Infant Series|Withdrawal by Subject|4|||
125086475|NCT00474539|449933276|FG000|Infant Series|Randomization error|5|||
125086476|NCT00474539|449933277|FG001|Infant Series|Randomization error|0|||
125086477|NCT00474539|449933276|FG000|Infant Series|Lost to Follow-up|2|||
125086478|NCT00474539|449933277|FG001|Infant Series|Lost to Follow-up|1|||
125086479|NCT00474539|449933276|FG000|Infant Series|Protocol Violation|0|||
125086480|NCT00474539|449933277|FG001|Infant Series|Protocol Violation|1|||
125086481|NCT00474539|449933276|FG000|After Infant Series|Lost to Follow-up|3|||
125086482|NCT00474539|449933277|FG001|After Infant Series|Lost to Follow-up|0|||
125086483|NCT00474539|449933276|FG000|After Infant Series|Withdrawal by Subject|1|||
125086484|NCT00474539|449933277|FG001|After Infant Series|Withdrawal by Subject|0|||
125086485|NCT00474539|449933276|FG000|Toddler Dose|Protocol Violation|1|||
125086486|NCT00474539|449933277|FG001|Toddler Dose|Protocol Violation|0|||
125086487|NCT01227252|449933279|FG000|Overall Study|Sponsor Decision|0|||
125086488|NCT01227252|449933280|FG001|Overall Study|Sponsor Decision|1|||
125086489|NCT01227252|449933281|FG002|Overall Study|Sponsor Decision|0|||
125086490|NCT01227252|449933282|FG003|Overall Study|Sponsor Decision|0|||
125086491|NCT01227252|449933279|FG000|Overall Study|Lost to Follow-up|0|||
125086492|NCT01227252|449933280|FG001|Overall Study|Lost to Follow-up|1|||
125086493|NCT01227252|449933281|FG002|Overall Study|Lost to Follow-up|0|||
125086494|NCT01227252|449933282|FG003|Overall Study|Lost to Follow-up|0|||
125086495|NCT01227252|449933279|FG000|Overall Study|Withdrawal by Subject|0|||
125086496|NCT01227252|449933280|FG001|Overall Study|Withdrawal by Subject|1|||
125086497|NCT01227252|449933281|FG002|Overall Study|Withdrawal by Subject|0|||
125086498|NCT01227252|449933282|FG003|Overall Study|Withdrawal by Subject|0|||
125086499|NCT02561273|449933289|FG000|Overall Study|Protocol Violation|1|||
125086500|NCT02561273|449933290|FG001|Overall Study|Protocol Violation|0|||
125086501|NCT03442595|449933291|FG000|Overall Study|Lost to Follow-up|94|||
125086502|NCT03442595|449933292|FG001|Overall Study|Lost to Follow-up|0|||
125086503|NCT02192190|449933301|FG000|Overall Study|Adverse Event|1|||
125086504|NCT02192190|449933302|FG001|Overall Study|Adverse Event|1|||
125086505|NCT02192190|449933303|FG002|Overall Study|Adverse Event|0|||
125086506|NCT02192190|449933304|FG003|Overall Study|Adverse Event|0|||
125086507|NCT02192190|449933305|FG004|Overall Study|Adverse Event|0|||
125086508|NCT02192190|449933306|FG005|Overall Study|Adverse Event|0|||
125086509|NCT02192190|449933301|FG000|Overall Study|Lost to Follow-up|3|||
125086510|NCT02192190|449933302|FG001|Overall Study|Lost to Follow-up|3|||
125086511|NCT02192190|449933303|FG002|Overall Study|Lost to Follow-up|2|||
125086512|NCT02192190|449933304|FG003|Overall Study|Lost to Follow-up|1|||
125086513|NCT02192190|449933305|FG004|Overall Study|Lost to Follow-up|4|||
125086514|NCT02192190|449933306|FG005|Overall Study|Lost to Follow-up|3|||
125086515|NCT02192190|449933301|FG000|Overall Study|Physician Decision|2|||
125086516|NCT02192190|449933302|FG001|Overall Study|Physician Decision|0|||
125086517|NCT02192190|449933303|FG002|Overall Study|Physician Decision|0|||
125086518|NCT02192190|449933304|FG003|Overall Study|Physician Decision|0|||
125086519|NCT02192190|449933305|FG004|Overall Study|Physician Decision|0|||
125086520|NCT02192190|449933306|FG005|Overall Study|Physician Decision|0|||
125086521|NCT02192190|449933301|FG000|Overall Study|Terminated by Sponsor|43|||
125086522|NCT02192190|449933302|FG001|Overall Study|Terminated by Sponsor|23|||
125086523|NCT02192190|449933303|FG002|Overall Study|Terminated by Sponsor|20|||
125086524|NCT02192190|449933304|FG003|Overall Study|Terminated by Sponsor|23|||
125086525|NCT02192190|449933305|FG004|Overall Study|Terminated by Sponsor|21|||
125086526|NCT02192190|449933306|FG005|Overall Study|Terminated by Sponsor|23|||
125086527|NCT02192190|449933301|FG000|Overall Study|Withdrawal by Subject|4|||
125086528|NCT02192190|449933302|FG001|Overall Study|Withdrawal by Subject|1|||
125086529|NCT02192190|449933303|FG002|Overall Study|Withdrawal by Subject|2|||
125086530|NCT02192190|449933304|FG003|Overall Study|Withdrawal by Subject|1|||
125086531|NCT02192190|449933305|FG004|Overall Study|Withdrawal by Subject|5|||
125086532|NCT02192190|449933306|FG005|Overall Study|Withdrawal by Subject|3|||
125086533|NCT02192190|449933301|FG000|Overall Study|Could not Keep Visit Schedule|1|||
125086534|NCT02192190|449933302|FG001|Overall Study|Could not Keep Visit Schedule|0|||
125086535|NCT02192190|449933303|FG002|Overall Study|Could not Keep Visit Schedule|0|||
125086536|NCT02192190|449933304|FG003|Overall Study|Could not Keep Visit Schedule|0|||
125086537|NCT02192190|449933305|FG004|Overall Study|Could not Keep Visit Schedule|0|||
125086538|NCT02192190|449933306|FG005|Overall Study|Could not Keep Visit Schedule|0|||
125086539|NCT02192190|449933301|FG000|Overall Study|Positive Drug Screen|0|||
125086540|NCT02192190|449933302|FG001|Overall Study|Positive Drug Screen|0|||
125086541|NCT02192190|449933303|FG002|Overall Study|Positive Drug Screen|0|||
125086542|NCT02192190|449933304|FG003|Overall Study|Positive Drug Screen|1|||
125086543|NCT02192190|449933305|FG004|Overall Study|Positive Drug Screen|0|||
125086544|NCT02192190|449933306|FG005|Overall Study|Positive Drug Screen|0|||
125086545|NCT02192190|449933301|FG000|Overall Study|Inadequate Pain Relief|0|||
125086546|NCT02192190|449933302|FG001|Overall Study|Inadequate Pain Relief|1|||
125086547|NCT02192190|449933303|FG002|Overall Study|Inadequate Pain Relief|1|||
125086548|NCT02192190|449933304|FG003|Overall Study|Inadequate Pain Relief|0|||
125086549|NCT02192190|449933305|FG004|Overall Study|Inadequate Pain Relief|0|||
125086550|NCT02192190|449933306|FG005|Overall Study|Inadequate Pain Relief|0|||
125086551|NCT03227692|449933307|FG000|Overall Study|Protocol Violation|1|||
125086552|NCT03227692|449933308|FG001|Overall Study|Protocol Violation|1|||
125086553|NCT03227692|449933307|FG000|Overall Study|Lost to Follow-up|4|||
125086554|NCT03227692|449933308|FG001|Overall Study|Lost to Follow-up|2|||
125086555|NCT03227692|449933307|FG000|Overall Study|Adverse Event|0|||
125086556|NCT03227692|449933308|FG001|Overall Study|Adverse Event|2|||
125086557|NCT01657253|449933309|FG000|Overall Study|Lost to Follow-up|6|||
125086558|NCT01657253|449933310|FG001|Overall Study|Lost to Follow-up|5|||
125086559|NCT01657253|449933309|FG000|Overall Study|Withdrawal by Subject|11|||
125086560|NCT01657253|449933310|FG001|Overall Study|Withdrawal by Subject|12|||
125086561|NCT01657253|449933309|FG000|Overall Study|Adverse Event|0|||
125086562|NCT01657253|449933310|FG001|Overall Study|Adverse Event|1|||
125145289|NCT00926367|450155989|FG000|Overall Study|Withdrawal by Subject|0|||
125145290|NCT00926367|450155990|FG001|Overall Study|Withdrawal by Subject|1|||
125086563|NCT01970540|449933313|FG000|Overall Study|Non-treatment-related AE|0|||
125086564|NCT01970540|449933314|FG001|Overall Study|Non-treatment-related AE|0|||
125086565|NCT01970540|449933315|FG002|Overall Study|Non-treatment-related AE|1|||
125086566|NCT01970540|449933313|FG000|Overall Study|Progressive disease|55|||
125086567|NCT01970540|449933314|FG001|Overall Study|Progressive disease|23|||
125086568|NCT01970540|449933315|FG002|Overall Study|Progressive disease|10|||
125086569|NCT01970540|449933313|FG000|Overall Study|Treatment delay over protocol|0|||
125086570|NCT01970540|449933314|FG001|Overall Study|Treatment delay over protocol|0|||
125086571|NCT01970540|449933315|FG002|Overall Study|Treatment delay over protocol|1|||
125086572|NCT01970540|449933313|FG000|Overall Study|Physician Decision|7|||
125086573|NCT01970540|449933314|FG001|Overall Study|Physician Decision|2|||
125086574|NCT01970540|449933315|FG002|Overall Study|Physician Decision|0|||
125145291|NCT00926367|450155989|FG000|Overall Study|Lost to Follow-up|1|||
125145292|NCT00926367|450155990|FG001|Overall Study|Lost to Follow-up|0|||
125145293|NCT00926367|450155989|FG000|Overall Study|Skin Irritation|1|||
125145294|NCT00926367|450155990|FG001|Overall Study|Skin Irritation|2|||
125145295|NCT01517867|450155991|FG000|Overall Study|never started treatment|29|||
125145296|NCT01517867|450155992|FG001|Overall Study|never started treatment|32|||
125145297|NCT01517867|450155991|FG000|Overall Study|Withdrawal by Subject|34|||
125145298|NCT01517867|450155992|FG001|Overall Study|Withdrawal by Subject|30|||
125145299|NCT01517867|450155991|FG000|Overall Study|Still in treatment at study end|0|||
125145300|NCT01517867|450155992|FG001|Overall Study|Still in treatment at study end|3|||
125145301|NCT01266603|450155994|FG000|Overall Study|Adverse Event|1|||
125145302|NCT01266603|450155994|FG000|Overall Study|Lack of Efficacy|14|||
125145303|NCT01266603|450155994|FG000|Overall Study|Withdrawal by Subject|1|||
125145304|NCT01266603|450155994|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
125145305|NCT02725411|450156001|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
125145306|NCT02725411|450156002|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
125145307|NCT02725411|450156003|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
125145308|NCT02725411|450156001|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
125145309|NCT02725411|450156002|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
125145310|NCT02725411|450156003|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
125145311|NCT02725411|450156001|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
125145312|NCT02725411|450156002|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
125145313|NCT02725411|450156003|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
125145314|NCT02725411|450156001|FG000|Treatment Period (56 Weeks)|Other|1|||
125145315|NCT02725411|450156002|FG001|Treatment Period (56 Weeks)|Other|4|||
125145316|NCT02725411|450156003|FG002|Treatment Period (56 Weeks)|Other|5|||
125145317|NCT02725411|450156001|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
125145318|NCT02725411|450156002|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
125145319|NCT02725411|450156003|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
125145320|NCT02725411|450156001|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
125145321|NCT02725411|450156002|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
125145322|NCT02725411|450156003|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
125145323|NCT02725411|450156001|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
125145324|NCT02725411|450156002|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
125145325|NCT02725411|450156003|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
125145326|NCT02725411|450156001|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
125145327|NCT02725411|450156002|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
125145328|NCT02725411|450156003|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
125145329|NCT02725411|450156001|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
125145330|NCT02725411|450156002|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
125145331|NCT02725411|450156003|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
125145332|NCT02725411|450156001|FG000|Follow-up Period (24 Weeks)|Other|1|||
125145333|NCT02725411|450156002|FG001|Follow-up Period (24 Weeks)|Other|4|||
125145334|NCT02725411|450156003|FG002|Follow-up Period (24 Weeks)|Other|2|||
125145335|NCT02725411|450156001|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
125145336|NCT02725411|450156002|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
125086575|NCT01970540|449933313|FG000|Overall Study|Clinical progression|0|||
125086576|NCT01970540|449933314|FG001|Overall Study|Clinical progression|1|||
125086577|NCT01970540|449933315|FG002|Overall Study|Clinical progression|1|||
125086578|NCT01970540|449933313|FG000|Overall Study|End of study|2|||
125086579|NCT01970540|449933314|FG001|Overall Study|End of study|0|||
125086580|NCT01970540|449933315|FG002|Overall Study|End of study|2|||
125086581|NCT01970540|449933313|FG000|Overall Study|Adverse Event|0|||
125086582|NCT01970540|449933314|FG001|Overall Study|Adverse Event|2|||
125086583|NCT01970540|449933315|FG002|Overall Study|Adverse Event|1|||
125086584|NCT01970540|449933313|FG000|Overall Study|Treatment-related AE|4|||
125086585|NCT01970540|449933314|FG001|Overall Study|Treatment-related AE|0|||
125086586|NCT01970540|449933315|FG002|Overall Study|Treatment-related AE|2|||
125086587|NCT01970540|449933313|FG000|Overall Study|Withdrawal by Subject|4|||
125086588|NCT01970540|449933314|FG001|Overall Study|Withdrawal by Subject|0|||
125086589|NCT01970540|449933315|FG002|Overall Study|Withdrawal by Subject|1|||
125086590|NCT01970540|449933313|FG000|Overall Study|Clinical deterioration|1|||
125086591|NCT01970540|449933314|FG001|Overall Study|Clinical deterioration|0|||
125086592|NCT01970540|449933315|FG002|Overall Study|Clinical deterioration|0|||
125086593|NCT01603628|449933316|FG000|Overall Study|Personal Reasons|1|||
125086594|NCT01603628|449933317|FG001|Overall Study|Personal Reasons|1|||
125145337|NCT02725411|450156003|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
125145338|NCT02911935|450156006|FG000|Overall Study|Lost to Follow-up|5|||
125223545|NCT02326272|450446174|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
125086595|NCT01603628|449933318|FG002|Overall Study|Personal Reasons|2|||
125086596|NCT01603628|449933316|FG000|Overall Study|Protocol Violation|1|||
125086597|NCT01603628|449933317|FG001|Overall Study|Protocol Violation|1|||
125086598|NCT01603628|449933318|FG002|Overall Study|Protocol Violation|0|||
125086599|NCT01603628|449933316|FG000|Overall Study|Lost to Follow-up|0|||
125145339|NCT02911935|450156007|FG001|Overall Study|Lost to Follow-up|7|||
125145340|NCT00603512|450156008|FG000|Overall Study|Adverse Event|0|||
125145341|NCT00603512|450156009|FG001|Overall Study|Adverse Event|2|||
125145342|NCT00603512|450156010|FG002|Overall Study|Adverse Event|4|||
125145343|NCT00603512|450156011|FG003|Overall Study|Adverse Event|4|||
125145344|NCT00603512|450156012|FG004|Overall Study|Adverse Event|2|||
125145345|NCT00603512|450156008|FG000|Overall Study|Lack of Efficacy|0|||
125145346|NCT00603512|450156009|FG001|Overall Study|Lack of Efficacy|1|||
125145347|NCT00603512|450156010|FG002|Overall Study|Lack of Efficacy|0|||
125145348|NCT00603512|450156011|FG003|Overall Study|Lack of Efficacy|0|||
125145349|NCT00603512|450156012|FG004|Overall Study|Lack of Efficacy|1|||
125145350|NCT00603512|450156008|FG000|Overall Study|Other|2|||
125145351|NCT00603512|450156009|FG001|Overall Study|Other|1|||
125145352|NCT00603512|450156010|FG002|Overall Study|Other|0|||
125223546|NCT02326272|450446175|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
125145353|NCT00603512|450156011|FG003|Overall Study|Other|1|||
125145354|NCT00603512|450156012|FG004|Overall Study|Other|1|||
125145355|NCT00603512|450156008|FG000|Overall Study|Withdrawal by Subject|0|||
125223547|NCT02326272|450446176|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
125223548|NCT02326272|450446177|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
125223549|NCT02326272|450446178|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
125145356|NCT00603512|450156009|FG001|Overall Study|Withdrawal by Subject|0|||
125086600|NCT01603628|449933317|FG001|Overall Study|Lost to Follow-up|1|||
125086601|NCT01603628|449933318|FG002|Overall Study|Lost to Follow-up|0|||
125086602|NCT01603628|449933316|FG000|Overall Study|Other Miscellaneous Reason|1|||
125086603|NCT01603628|449933317|FG001|Overall Study|Other Miscellaneous Reason|0|||
125086604|NCT01603628|449933318|FG002|Overall Study|Other Miscellaneous Reason|0|||
125086605|NCT00952588|449933320|FG000|Overall Study|Death|28|||
125086606|NCT00952588|449933321|FG001|Overall Study|Death|13|||
125086607|NCT00952588|449933320|FG000|Overall Study|Withdrawal by Subject|2|||
125086608|NCT00952588|449933321|FG001|Overall Study|Withdrawal by Subject|5|||
125086609|NCT00952588|449933320|FG000|Overall Study|Adverse Event|2|||
125086610|NCT00952588|449933321|FG001|Overall Study|Adverse Event|3|||
125086611|NCT00952588|449933320|FG000|Overall Study|Lost to Follow-up|2|||
125086612|NCT00952588|449933321|FG001|Overall Study|Lost to Follow-up|0|||
125086613|NCT00952588|449933320|FG000|Overall Study|Physician Decision|0|||
125086614|NCT00952588|449933321|FG001|Overall Study|Physician Decision|1|||
125086615|NCT00952588|449933320|FG000|Overall Study|Lack of Efficacy|2|||
125086616|NCT00952588|449933321|FG001|Overall Study|Lack of Efficacy|2|||
125086617|NCT01796106|449933322|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
125086618|NCT01796106|449933323|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
125086619|NCT02795182|449933324|FG000|Overall Study|Death|5|||
125086620|NCT02795182|449933325|FG001|Overall Study|Death|4|||
125086621|NCT02795182|449933326|FG002|Overall Study|Death|4|||
125086622|NCT02795182|449933327|FG003|Overall Study|Death|18|||
125086623|NCT02795182|449933324|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
125086624|NCT02795182|449933325|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
125086625|NCT02795182|449933326|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
125086626|NCT02795182|449933327|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
125086627|NCT02795182|449933324|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
125086628|NCT02795182|449933325|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
125086629|NCT02795182|449933326|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
125086630|NCT02795182|449933327|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
125086631|NCT02795182|449933324|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
125086632|NCT02795182|449933325|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
125086633|NCT02795182|449933326|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
125086634|NCT02795182|449933327|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
125086635|NCT02795182|449933324|FG000|Overall Study|Withdrawal by Subject|4|||
125086636|NCT02795182|449933325|FG001|Overall Study|Withdrawal by Subject|0|||
125086637|NCT02795182|449933326|FG002|Overall Study|Withdrawal by Subject|0|||
125086638|NCT02795182|449933327|FG003|Overall Study|Withdrawal by Subject|3|||
125086639|NCT02795182|449933324|FG000|Overall Study|Lost to Follow-up|0|||
125086640|NCT02795182|449933325|FG001|Overall Study|Lost to Follow-up|0|||
125086641|NCT02795182|449933326|FG002|Overall Study|Lost to Follow-up|1|||
125086642|NCT02795182|449933327|FG003|Overall Study|Lost to Follow-up|1|||
125086643|NCT02795182|449933324|FG000|Overall Study|Roll Over to Long Term Extension|3|||
125086644|NCT02795182|449933325|FG001|Overall Study|Roll Over to Long Term Extension|3|||
125086645|NCT02795182|449933326|FG002|Overall Study|Roll Over to Long Term Extension|2|||
125086646|NCT02795182|449933327|FG003|Overall Study|Roll Over to Long Term Extension|5|||
125086647|NCT02795182|449933324|FG000|Overall Study|Progressive Disease|0|||
125086648|NCT02795182|449933325|FG001|Overall Study|Progressive Disease|1|||
125086649|NCT02795182|449933326|FG002|Overall Study|Progressive Disease|0|||
125086650|NCT02795182|449933327|FG003|Overall Study|Progressive Disease|4|||
125086651|NCT02795182|449933324|FG000|Overall Study|Physician Decision|0|||
125086652|NCT02795182|449933325|FG001|Overall Study|Physician Decision|0|||
125086653|NCT02795182|449933326|FG002|Overall Study|Physician Decision|0|||
125086654|NCT02795182|449933327|FG003|Overall Study|Physician Decision|1|||
125086655|NCT04107935|449933328|FG000|Overall Study|Death|1|||
125086656|NCT04107935|449933329|FG001|Overall Study|Death|0|||
125086657|NCT01021553|449933330|FG000|Overall Study|Adverse Event|1|||
125086658|NCT01021553|449933331|FG001|Overall Study|Adverse Event|0|||
125086659|NCT01021553|449933332|FG002|Overall Study|Adverse Event|0|||
125086660|NCT01021553|449933330|FG000|Overall Study|Lack of Efficacy|2|||
125086661|NCT01021553|449933331|FG001|Overall Study|Lack of Efficacy|2|||
125086662|NCT01021553|449933332|FG002|Overall Study|Lack of Efficacy|0|||
125145357|NCT00603512|450156010|FG002|Overall Study|Withdrawal by Subject|0|||
125145358|NCT00603512|450156011|FG003|Overall Study|Withdrawal by Subject|0|||
125145359|NCT00603512|450156012|FG004|Overall Study|Withdrawal by Subject|1|||
125086663|NCT01021553|449933330|FG000|Overall Study|Protocol Violation|0|||
125086664|NCT01021553|449933331|FG001|Overall Study|Protocol Violation|2|||
125086665|NCT01021553|449933332|FG002|Overall Study|Protocol Violation|2|||
125086666|NCT01021553|449933330|FG000|Overall Study|Lost to Follow-up|0|||
125086667|NCT01021553|449933331|FG001|Overall Study|Lost to Follow-up|0|||
125086668|NCT01021553|449933332|FG002|Overall Study|Lost to Follow-up|1|||
125086669|NCT01021553|449933330|FG000|Overall Study|Withdrawal by Subject|1|||
125145360|NCT00603512|450156008|FG000|Overall Study|Randomized but not treated|0|||
125145361|NCT00603512|450156009|FG001|Overall Study|Randomized but not treated|1|||
125145362|NCT00603512|450156010|FG002|Overall Study|Randomized but not treated|1|||
125145363|NCT00603512|450156011|FG003|Overall Study|Randomized but not treated|2|||
125145364|NCT00603512|450156012|FG004|Overall Study|Randomized but not treated|0|||
125145365|NCT00685750|450156013|FG000|Overall Study|Tumor sampling failure|0|||
125145366|NCT00685750|450156014|FG001|Overall Study|Tumor sampling failure|0|||
125145367|NCT00685750|450156015|FG002|Overall Study|Tumor sampling failure|1|||
125145368|NCT00685750|450156016|FG003|Overall Study|Tumor sampling failure|0|||
125145369|NCT00685750|450156017|FG004|Overall Study|Tumor sampling failure|0|||
125145370|NCT00685750|450156018|FG005|Overall Study|Tumor sampling failure|0|||
125145371|NCT00685750|450156019|FG006|Overall Study|Tumor sampling failure|0|||
125145372|NCT00685750|450156013|FG000|Overall Study|Patient didn't receive the treatment|0|||
125145373|NCT00685750|450156014|FG001|Overall Study|Patient didn't receive the treatment|0|||
125145374|NCT00685750|450156015|FG002|Overall Study|Patient didn't receive the treatment|0|||
125145375|NCT00685750|450156016|FG003|Overall Study|Patient didn't receive the treatment|0|||
125145376|NCT00685750|450156017|FG004|Overall Study|Patient didn't receive the treatment|0|||
125145377|NCT00685750|450156018|FG005|Overall Study|Patient didn't receive the treatment|0|||
125145378|NCT00685750|450156019|FG006|Overall Study|Patient didn't receive the treatment|1|||
125145379|NCT00685750|450156013|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125145380|NCT00685750|450156014|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125145381|NCT00685750|450156015|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
125145382|NCT00685750|450156016|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
125145383|NCT00685750|450156017|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
125145384|NCT00685750|450156018|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
125145385|NCT00685750|450156019|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
125145386|NCT04979858|450156020|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
125145387|NCT04979858|450156021|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
125145388|NCT02654015|450156022|FG000|Overall Study|Death|12|||
125145389|NCT02654015|450156022|FG000|Overall Study|Lost to Follow-up|3|||
125145390|NCT01896505|450156025|FG000|Overall Study|Adverse Event|1|||
125145391|NCT01896505|450156026|FG001|Overall Study|Adverse Event|0|||
125145392|NCT01896505|450156027|FG002|Overall Study|Adverse Event|2|||
125145393|NCT01896505|450156028|FG003|Overall Study|Adverse Event|1|||
125145394|NCT01896505|450156029|FG004|Overall Study|Adverse Event|1|||
125145395|NCT01896505|450156030|FG005|Overall Study|Adverse Event|0|||
125145396|NCT01896505|450156025|FG000|Overall Study|Physician Decision|1|||
125145397|NCT01896505|450156026|FG001|Overall Study|Physician Decision|3|||
125145398|NCT01896505|450156027|FG002|Overall Study|Physician Decision|2|||
125145399|NCT01896505|450156028|FG003|Overall Study|Physician Decision|0|||
125145400|NCT01896505|450156029|FG004|Overall Study|Physician Decision|0|||
125145401|NCT01896505|450156030|FG005|Overall Study|Physician Decision|1|||
125145402|NCT01896505|450156025|FG000|Overall Study|Withdrawal by Subject|1|||
125145403|NCT01896505|450156026|FG001|Overall Study|Withdrawal by Subject|0|||
125145404|NCT01896505|450156027|FG002|Overall Study|Withdrawal by Subject|3|||
125145405|NCT01896505|450156028|FG003|Overall Study|Withdrawal by Subject|1|||
125145406|NCT01896505|450156029|FG004|Overall Study|Withdrawal by Subject|0|||
125145407|NCT01896505|450156030|FG005|Overall Study|Withdrawal by Subject|0|||
125145408|NCT01896505|450156025|FG000|Overall Study|Disease Progression|7|||
125145409|NCT01896505|450156026|FG001|Overall Study|Disease Progression|5|||
125145410|NCT01896505|450156027|FG002|Overall Study|Disease Progression|8|||
125145411|NCT01896505|450156028|FG003|Overall Study|Disease Progression|4|||
125145412|NCT01896505|450156029|FG004|Overall Study|Disease Progression|4|||
125145413|NCT01896505|450156030|FG005|Overall Study|Disease Progression|4|||
125145414|NCT01896505|450156025|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
125145415|NCT01896505|450156026|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
125145416|NCT01896505|450156027|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
125145417|NCT01896505|450156028|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
125145418|NCT01896505|450156029|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
125145419|NCT01896505|450156030|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
125145420|NCT01896505|450156025|FG000|Overall Study|Intercurrent illness|0|||
125223550|NCT02326272|450446164|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125145421|NCT01896505|450156026|FG001|Overall Study|Intercurrent illness|1|||
125145422|NCT01896505|450156027|FG002|Overall Study|Intercurrent illness|0|||
125145423|NCT01896505|450156028|FG003|Overall Study|Intercurrent illness|0|||
125145424|NCT01896505|450156029|FG004|Overall Study|Intercurrent illness|0|||
125145425|NCT01896505|450156030|FG005|Overall Study|Intercurrent illness|0|||
125145426|NCT01896505|450156025|FG000|Overall Study|Death|0|||
125145427|NCT01896505|450156026|FG001|Overall Study|Death|0|||
125145428|NCT01896505|450156027|FG002|Overall Study|Death|1|||
125145429|NCT01896505|450156028|FG003|Overall Study|Death|1|||
125145430|NCT01896505|450156029|FG004|Overall Study|Death|0|||
125223551|NCT02326272|450446165|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125086670|NCT01021553|449933331|FG001|Overall Study|Withdrawal by Subject|1|||
125086671|NCT01021553|449933332|FG002|Overall Study|Withdrawal by Subject|0|||
125086672|NCT00033293|449933333|FG000|Overall Study|Death|0|||
125086673|NCT00033293|449933334|FG001|Overall Study|Death|1|||
125086674|NCT00033293|449933333|FG000|Overall Study|Lack of Efficacy|5|||
125086675|NCT00033293|449933334|FG001|Overall Study|Lack of Efficacy|8|||
125086676|NCT00033293|449933333|FG000|Overall Study|Lost to Follow-up|0|||
125086677|NCT00033293|449933334|FG001|Overall Study|Lost to Follow-up|1|||
125086678|NCT00033293|449933333|FG000|Overall Study|Physician Decision|3|||
125086679|NCT00033293|449933334|FG001|Overall Study|Physician Decision|1|||
125086680|NCT00033293|449933333|FG000|Overall Study|Withdrawal by Subject|1|||
125086681|NCT00033293|449933334|FG001|Overall Study|Withdrawal by Subject|0|||
125086682|NCT00033293|449933333|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
125086683|NCT00033293|449933334|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
125086684|NCT00033293|449933333|FG000|Overall Study|Treatment refused|0|||
125086685|NCT00033293|449933334|FG001|Overall Study|Treatment refused|6|||
125086686|NCT00890201|449933335|FG000|Overall Study|Protocol Violation|5|||
125086687|NCT00890201|449933336|FG001|Overall Study|Protocol Violation|56|||
125086688|NCT00935701|449933337|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
125086689|NCT02087241|449933338|FG000|Overall Study|Death|2|||
125086690|NCT02087241|449933339|FG001|Overall Study|Death|1|||
125086691|NCT02087241|449933340|FG002|Overall Study|Death|1|||
125086692|NCT02087241|449933341|FG003|Overall Study|Death|1|||
125086693|NCT02087241|449933338|FG000|Overall Study|Withdrawal by Subject|1|||
125086694|NCT02087241|449933339|FG001|Overall Study|Withdrawal by Subject|0|||
125086695|NCT02087241|449933340|FG002|Overall Study|Withdrawal by Subject|0|||
125086696|NCT02087241|449933341|FG003|Overall Study|Withdrawal by Subject|1|||
125086697|NCT02087241|449933338|FG000|Overall Study|Progressive Disease|0|||
125086698|NCT02087241|449933339|FG001|Overall Study|Progressive Disease|0|||
125086699|NCT02087241|449933340|FG002|Overall Study|Progressive Disease|0|||
125086700|NCT02087241|449933341|FG003|Overall Study|Progressive Disease|1|||
125086701|NCT02087241|449933338|FG000|Overall Study|Study Terminated by Sponsor|0|||
125086702|NCT02087241|449933339|FG001|Overall Study|Study Terminated by Sponsor|2|||
125086703|NCT02087241|449933340|FG002|Overall Study|Study Terminated by Sponsor|0|||
125086704|NCT02087241|449933341|FG003|Overall Study|Study Terminated by Sponsor|4|||
125086705|NCT02181504|449933342|FG000|Overall Study|Adverse Event|1|||
125086706|NCT02181504|449933343|FG001|Overall Study|Adverse Event|1|||
125086707|NCT02181504|449933344|FG002|Overall Study|Adverse Event|1|||
125086708|NCT00545584|449933345|FG000|Overall Study|Only one reason for discontinuation|62|||
125086709|NCT00545584|449933346|FG001|Overall Study|Only one reason for discontinuation|61|||
125086710|NCT00545584|449933347|FG002|Overall Study|Only one reason for discontinuation|48|||
125086711|NCT00545584|449933345|FG000|Overall Study|Two or more reasons for discontinuation|17|||
125086712|NCT00545584|449933346|FG001|Overall Study|Two or more reasons for discontinuation|19|||
125086713|NCT00545584|449933347|FG002|Overall Study|Two or more reasons for discontinuation|8|||
125086714|NCT03525613|449933348|FG000|Overall Study|Adverse Event|11|||
125086715|NCT03525613|449933349|FG001|Overall Study|Adverse Event|8|||
125086716|NCT03525613|449933350|FG002|Overall Study|Adverse Event|3|||
125086717|NCT03525613|449933351|FG003|Overall Study|Adverse Event|3|||
125086718|NCT03525613|449933348|FG000|Overall Study|Lost to Follow-up|4|||
125086719|NCT03525613|449933349|FG001|Overall Study|Lost to Follow-up|5|||
125086720|NCT03525613|449933350|FG002|Overall Study|Lost to Follow-up|3|||
125086721|NCT03525613|449933351|FG003|Overall Study|Lost to Follow-up|2|||
125086722|NCT03525613|449933348|FG000|Overall Study|Physician Decision|0|||
125086723|NCT03525613|449933349|FG001|Overall Study|Physician Decision|1|||
125086724|NCT03525613|449933350|FG002|Overall Study|Physician Decision|0|||
125086725|NCT03525613|449933351|FG003|Overall Study|Physician Decision|1|||
125086726|NCT03525613|449933348|FG000|Overall Study|Consent Withdrawal|25|||
125086727|NCT03525613|449933349|FG001|Overall Study|Consent Withdrawal|16|||
125086728|NCT03525613|449933350|FG002|Overall Study|Consent Withdrawal|12|||
125086729|NCT03525613|449933351|FG003|Overall Study|Consent Withdrawal|9|||
125086730|NCT03525613|449933348|FG000|Overall Study|Death|20|||
125086731|NCT03525613|449933349|FG001|Overall Study|Death|9|||
125086732|NCT03525613|449933350|FG002|Overall Study|Death|7|||
125086733|NCT03525613|449933351|FG003|Overall Study|Death|1|||
125086734|NCT03525613|449933348|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
125086735|NCT03525613|449933349|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
125086736|NCT03525613|449933350|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
125145431|NCT01896505|450156030|FG005|Overall Study|Death|1|||
125086737|NCT03525613|449933351|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
125086738|NCT02584660|449933352|FG000|Overall Study|Adverse Event|4|||
125086739|NCT02584660|449933353|FG001|Overall Study|Adverse Event|0|||
125145432|NCT04974580|450156031|FG000|Overall Study|Lost to Follow-up|33|||
125086740|NCT02584660|449933352|FG000|Overall Study|Lost to Follow-up|3|||
125086741|NCT02584660|449933353|FG001|Overall Study|Lost to Follow-up|4|||
125086742|NCT02584660|449933352|FG000|Overall Study|Protocol Violation|0|||
125145433|NCT04974580|450156032|FG001|Overall Study|Lost to Follow-up|39|||
125223552|NCT02326272|450446166|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125086743|NCT02584660|449933353|FG001|Overall Study|Protocol Violation|1|||
125086744|NCT02584660|449933352|FG000|Overall Study|Withdrawal by Subject|0|||
125086745|NCT02584660|449933353|FG001|Overall Study|Withdrawal by Subject|2|||
125086746|NCT02584660|449933352|FG000|Overall Study|Other|0|||
125086747|NCT02584660|449933353|FG001|Overall Study|Other|1|||
125086748|NCT00461552|449933356|FG000|Overall Study|Drug Dispensing error|0|||
125086749|NCT00461552|449933357|FG001|Overall Study|Drug Dispensing error|2|||
125086750|NCT01289028|449933360|FG000|Overall Study|Progressive Disease|49|||
125086751|NCT01289028|449933360|FG000|Overall Study|Adverse Event|14|||
125086752|NCT01289028|449933360|FG000|Overall Study|Withdrawal by Subject|6|||
125086753|NCT01289028|449933360|FG000|Overall Study|Death|4|||
125086754|NCT01289028|449933360|FG000|Overall Study|Lack of Efficacy|2|||
125086755|NCT01289028|449933360|FG000|Overall Study|No longer required|2|||
125086756|NCT01289028|449933360|FG000|Overall Study|Lost to Follow-up|2|||
125086757|NCT01289028|449933360|FG000|Overall Study|New Cancer Therapy|2|||
125086758|NCT01289028|449933360|FG000|Overall Study|Abnormal Lab Value|1|||
125086759|NCT01289028|449933360|FG000|Overall Study|Missing reason for discon|1|||
125086760|NCT02120469|449933361|FG000|Overall Study|HER-2/neu-amplified|1|||
125086761|NCT02120469|449933362|FG001|Overall Study|HER-2/neu-amplified|0|||
125086762|NCT02120469|449933363|FG002|Overall Study|HER-2/neu-amplified|1|||
125086763|NCT01846208|449933365|FG000|Overall Study|Withdrew prior to treatment|1|||
125086764|NCT01846208|449933366|FG001|Overall Study|Withdrew prior to treatment|1|||
125086765|NCT01846208|449933367|FG002|Overall Study|Withdrew prior to treatment|1|||
125086766|NCT01846208|449933365|FG000|Overall Study|Dosing Symptoms|1|||
125086767|NCT01846208|449933366|FG001|Overall Study|Dosing Symptoms|2|||
125086768|NCT01846208|449933367|FG002|Overall Study|Dosing Symptoms|6|||
125086769|NCT01846208|449933365|FG000|Overall Study|Withdrawal by Subject|5|||
125086770|NCT01846208|449933366|FG001|Overall Study|Withdrawal by Subject|0|||
125086771|NCT01846208|449933367|FG002|Overall Study|Withdrawal by Subject|0|||
125086772|NCT01846208|449933365|FG000|Overall Study|Non-compliance|1|||
125086773|NCT01846208|449933366|FG001|Overall Study|Non-compliance|1|||
125086774|NCT01846208|449933367|FG002|Overall Study|Non-compliance|0|||
125086775|NCT01846208|449933365|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
125086776|NCT01846208|449933366|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
125086777|NCT01846208|449933367|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
125086778|NCT01846208|449933365|FG000|Overall Study|Refused SU OFC|0|||
125086779|NCT01846208|449933366|FG001|Overall Study|Refused SU OFC|0|||
125086780|NCT01846208|449933367|FG002|Overall Study|Refused SU OFC|1|||
125086781|NCT01424306|449933368|FG000|Overall Study|Protocol Violation|0|||
125086782|NCT01424306|449933369|FG001|Overall Study|Protocol Violation|0|||
125086783|NCT01424306|449933370|FG002|Overall Study|Protocol Violation|0|||
125086784|NCT01424306|449933371|FG003|Overall Study|Protocol Violation|0|||
125086785|NCT01424306|449933372|FG004|Overall Study|Protocol Violation|1|||
125086786|NCT01424306|449933373|FG005|Overall Study|Protocol Violation|0|||
125086787|NCT03344562|449933379|FG000|Overall Study|Withdrawal by Subject|2|||
125086788|NCT03344562|449933380|FG001|Overall Study|Withdrawal by Subject|0|||
125086789|NCT02463331|449933382|FG000|Overall Study|Adverse Event|4|||
125086790|NCT02463331|449933383|FG001|Overall Study|Adverse Event|2|||
125086791|NCT02463331|449933382|FG000|Overall Study|Lost to Follow-up|1|||
125086792|NCT02463331|449933383|FG001|Overall Study|Lost to Follow-up|1|||
125086793|NCT02463331|449933382|FG000|Overall Study|Pregnancy|2|||
125086794|NCT02463331|449933383|FG001|Overall Study|Pregnancy|3|||
125086795|NCT02463331|449933382|FG000|Overall Study|Lack of Efficacy|6|||
125086796|NCT02463331|449933383|FG001|Overall Study|Lack of Efficacy|0|||
125086797|NCT02463331|449933382|FG000|Overall Study|Physician Decision|3|||
125086798|NCT02463331|449933383|FG001|Overall Study|Physician Decision|0|||
125086799|NCT02274766|449933384|FG000|Overall Study|Withdrawal by Subject|3|||
125086800|NCT02274766|449933385|FG001|Overall Study|Withdrawal by Subject|6|||
125086801|NCT02274766|449933384|FG000|Overall Study|Did Not Receive Study Drug|1|||
125086802|NCT02274766|449933385|FG001|Overall Study|Did Not Receive Study Drug|1|||
125086803|NCT02274766|449933384|FG000|Overall Study|Subject Unwilling to Proceed|0|||
125086804|NCT02274766|449933385|FG001|Overall Study|Subject Unwilling to Proceed|1|||
125086805|NCT02274766|449933384|FG000|Overall Study|Adverse Event|0|||
125086806|NCT02274766|449933385|FG001|Overall Study|Adverse Event|1|||
125086807|NCT02608892|449933395|FG000|Overall Study|Lost to Follow-up|1|||
125086808|NCT02608892|449933396|FG001|Overall Study|Lost to Follow-up|0|||
125086809|NCT02590406|449933397|FG000|Overall Study|Adverse Event|1|||
125086810|NCT02590406|449933398|FG001|Overall Study|Adverse Event|0|||
125086811|NCT02590406|449933397|FG000|Overall Study|Saturometer malfunction|0|||
125086812|NCT02590406|449933398|FG001|Overall Study|Saturometer malfunction|1|||
125086813|NCT00984009|449933399|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
125086814|NCT02036476|449933402|FG000|Overall Study|Withdrawal by Subject|2|||
125086815|NCT02036476|449933402|FG000|Overall Study|Progressive Disease|4|||
125086816|NCT02036476|449933402|FG000|Overall Study|Unacceptable Toxicity|2|||
125086817|NCT02168816|449933403|FG000|Overall Study|Lost to Follow-up|2|||
125086818|NCT02168816|449933404|FG001|Overall Study|Lost to Follow-up|2|||
125086819|NCT02985684|449933405|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
125086820|NCT02985684|449933405|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
125086821|NCT02985684|449933405|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
125086822|NCT01436357|449933406|FG000|Overall Study|Death|5|||
125086823|NCT01436357|449933407|FG001|Overall Study|Death|1|||
125086824|NCT01436357|449933406|FG000|Overall Study|Enrolled but not vaccinated|1|||
125086825|NCT01436357|449933407|FG001|Overall Study|Enrolled but not vaccinated|1|||
125086826|NCT01436357|449933406|FG000|Overall Study|Incarceration|18|||
125086827|NCT01436357|449933407|FG001|Overall Study|Incarceration|20|||
125086828|NCT01436357|449933406|FG000|Overall Study|Lost to Follow-up|67|||
125086829|NCT01436357|449933407|FG001|Overall Study|Lost to Follow-up|61|||
125086830|NCT01436357|449933406|FG000|Overall Study|Protocol Violation|1|||
125086831|NCT01436357|449933407|FG001|Overall Study|Protocol Violation|0|||
125086832|NCT01436357|449933406|FG000|Overall Study|Withdrawal by Subject|26|||
125086833|NCT01436357|449933407|FG001|Overall Study|Withdrawal by Subject|38|||
125086834|NCT01436357|449933406|FG000|Overall Study|Physician Decision|3|||
125086835|NCT01436357|449933407|FG001|Overall Study|Physician Decision|4|||
125086836|NCT01436357|449933406|FG000|Overall Study|Moved out of area|1|||
125086837|NCT01436357|449933407|FG001|Overall Study|Moved out of area|2|||
125086838|NCT01436357|449933406|FG000|Overall Study|Subject in rehab|0|||
125086839|NCT01436357|449933407|FG001|Overall Study|Subject in rehab|1|||
125086840|NCT05281094|449933408|FG000|Overall Study|Adverse Event|1|||
125086841|NCT05281094|449933409|FG001|Overall Study|Adverse Event|0|||
125086842|NCT05281094|449933408|FG000|Overall Study|Lost to Follow-up|29|||
125086843|NCT05281094|449933409|FG001|Overall Study|Lost to Follow-up|22|||
125086844|NCT05281094|449933408|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
125086845|NCT05281094|449933409|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
125086846|NCT05281094|449933408|FG000|Overall Study|Death|1|||
125086847|NCT05281094|449933409|FG001|Overall Study|Death|2|||
125086848|NCT05281094|449933408|FG000|Overall Study|Not pre-specified reason|8|||
125086849|NCT05281094|449933409|FG001|Overall Study|Not pre-specified reason|5|||
125086850|NCT05315297|449933410|FG000|Overall Study|Lost to Follow-up|6|||
125086851|NCT05315297|449933411|FG001|Overall Study|Lost to Follow-up|4|||
125086852|NCT05315297|449933410|FG000|Overall Study|Withdrawal by Subject|0|||
125086853|NCT05315297|449933411|FG001|Overall Study|Withdrawal by Subject|1|||
125086854|NCT02583399|449935286|FG000|Overall Study|Able to be discharged|3|||
125086855|NCT02583399|449935286|FG000|Overall Study|Wanted to use a restricted medication|3|||
125086856|NCT02759939|449935294|FG000|Overall Study|Missing data on first outcome assessed|11|||
125086857|NCT02759939|449935295|FG001|Overall Study|Missing data on first outcome assessed|2|||
125086858|NCT02759939|449935296|FG002|Overall Study|Missing data on first outcome assessed|5|||
125086859|NCT02759939|449935297|FG003|Overall Study|Missing data on first outcome assessed|2|||
125086860|NCT02759939|449935294|FG000|Overall Study|Ineligible for T2 and T3|310|||
125086861|NCT02759939|449935295|FG001|Overall Study|Ineligible for T2 and T3|179|||
125086862|NCT02759939|449935296|FG002|Overall Study|Ineligible for T2 and T3|366|||
125086863|NCT02759939|449935297|FG003|Overall Study|Ineligible for T2 and T3|391|||
125086864|NCT02759939|449935294|FG000|Overall Study|Lost to Follow-up|735|||
125086865|NCT02759939|449935295|FG001|Overall Study|Lost to Follow-up|791|||
125086866|NCT02759939|449935296|FG002|Overall Study|Lost to Follow-up|783|||
125086867|NCT02759939|449935297|FG003|Overall Study|Lost to Follow-up|650|||
125086868|NCT03288987|449935298|FG000|Overall Study|Protocol Violation|10|||
125086869|NCT03288987|449935299|FG001|Overall Study|Protocol Violation|4|||
125086870|NCT04905563|449935302|FG000|Overall Study|Withdrawal by Subject|1|||
125086871|NCT04905563|449935303|FG001|Overall Study|Withdrawal by Subject|0|||
125086872|NCT04905563|449935302|FG000|Overall Study|Standard of care orders entered by resident|1|||
125086873|NCT04905563|449935303|FG001|Overall Study|Standard of care orders entered by resident|0|||
125086874|NCT04905563|449935302|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
125086875|NCT04905563|449935303|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
125086876|NCT04905563|449935302|FG000|Overall Study|Withdrawal by Subject|0|||
125086877|NCT04905563|449935303|FG001|Overall Study|Withdrawal by Subject|1|||
125086878|NCT04652102|449935315|FG000|Overall Study|Adverse Event|14|||
125086879|NCT04652102|449935316|FG001|Overall Study|Adverse Event|13|||
125086880|NCT04652102|449935315|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
125086881|NCT04652102|449935316|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
125086882|NCT04652102|449935315|FG000|Overall Study|Physician Decision|78|||
125086883|NCT04652102|449935316|FG001|Overall Study|Physician Decision|40|||
125086884|NCT04652102|449935315|FG000|Overall Study|Study Ended by Sponsor|64|||
125086885|NCT04652102|449935316|FG001|Overall Study|Study Ended by Sponsor|17|||
125086886|NCT04652102|449935315|FG000|Overall Study|Withdrawal by Subject|4625|||
125086887|NCT04652102|449935316|FG001|Overall Study|Withdrawal by Subject|5594|||
125086888|NCT04652102|449935315|FG000|Overall Study|Lost to Follow-up|2019|||
125086889|NCT04652102|449935316|FG001|Overall Study|Lost to Follow-up|1082|||
125086890|NCT04652102|449935315|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
125086891|NCT04652102|449935316|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
125086892|NCT04652102|449935315|FG000|Overall Study|Miscellaneous|80|||
125086893|NCT04652102|449935316|FG001|Overall Study|Miscellaneous|64|||
125086894|NCT00696774|449935322|FG000|Period II|Adverse Event|0|||
125086895|NCT00696774|449935323|FG001|Period II|Adverse Event|0|||
125086896|NCT00696774|449935324|FG002|Period II|Adverse Event|15|||
125086897|NCT00696774|449935322|FG000|Period II|Lost to Follow-up|0|||
125086898|NCT00696774|449935323|FG001|Period II|Lost to Follow-up|0|||
125086899|NCT00696774|449935324|FG002|Period II|Lost to Follow-up|4|||
125086900|NCT00696774|449935322|FG000|Period II|Protocol Violation|0|||
125086901|NCT00696774|449935323|FG001|Period II|Protocol Violation|0|||
125086902|NCT00696774|449935324|FG002|Period II|Protocol Violation|11|||
125086903|NCT00696774|449935322|FG000|Period II|Withdrawal by Subject|0|||
125086904|NCT00696774|449935323|FG001|Period II|Withdrawal by Subject|0|||
125086905|NCT00696774|449935324|FG002|Period II|Withdrawal by Subject|4|||
125086906|NCT00696774|449935322|FG000|Period II|Sponsor Decision|0|||
125086907|NCT00696774|449935323|FG001|Period II|Sponsor Decision|0|||
125086908|NCT00696774|449935324|FG002|Period II|Sponsor Decision|0|||
125086909|NCT00696774|449935322|FG000|Period II|Lack of Efficacy|0|||
125086910|NCT00696774|449935323|FG001|Period II|Lack of Efficacy|0|||
125086911|NCT00696774|449935324|FG002|Period II|Lack of Efficacy|2|||
125086912|NCT00696774|449935322|FG000|Period III|Adverse Event|1|||
125086913|NCT00696774|449935323|FG001|Period III|Adverse Event|1|||
125086914|NCT00696774|449935324|FG002|Period III|Adverse Event|0|||
125086915|NCT00696774|449935322|FG000|Period III|Lost to Follow-up|2|||
125086916|NCT00696774|449935323|FG001|Period III|Lost to Follow-up|1|||
125086917|NCT00696774|449935324|FG002|Period III|Lost to Follow-up|0|||
125086918|NCT00696774|449935322|FG000|Period III|Protocol Violation|1|||
125086919|NCT00696774|449935323|FG001|Period III|Protocol Violation|1|||
125086920|NCT00696774|449935324|FG002|Period III|Protocol Violation|0|||
125086921|NCT00696774|449935322|FG000|Period III|Withdrawal by Subject|1|||
125086922|NCT00696774|449935323|FG001|Period III|Withdrawal by Subject|2|||
125086923|NCT00696774|449935324|FG002|Period III|Withdrawal by Subject|0|||
125086924|NCT00696774|449935322|FG000|Period III|Sponsor Decision|2|||
125086925|NCT00696774|449935323|FG001|Period III|Sponsor Decision|0|||
125086926|NCT00696774|449935324|FG002|Period III|Sponsor Decision|0|||
125086927|NCT00696774|449935322|FG000|Period III|Lack of Efficacy|0|||
125086928|NCT00696774|449935323|FG001|Period III|Lack of Efficacy|2|||
125086929|NCT00696774|449935324|FG002|Period III|Lack of Efficacy|0|||
125086930|NCT00887913|449935332|FG000|Overall Study|Withdrawal by Subject|6|||
125086931|NCT02442765|449935335|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
125086932|NCT02442765|449935336|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
125086933|NCT02442765|449935337|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
125086934|NCT02442765|449935338|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
125086935|NCT02442765|449935339|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
125086936|NCT02442765|449935340|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
125086937|NCT02442765|449935341|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
125086938|NCT02442765|449935342|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
125086939|NCT02442765|449935335|FG000|Stage 2- (Days 43 to 85)|Death|0|||
125086940|NCT02442765|449935336|FG001|Stage 2- (Days 43 to 85)|Death|0|||
125086941|NCT02442765|449935337|FG002|Stage 2- (Days 43 to 85)|Death|0|||
125086942|NCT02442765|449935338|FG003|Stage 2- (Days 43 to 85)|Death|1|||
125086943|NCT02442765|449935339|FG004|Stage 2- (Days 43 to 85)|Death|1|||
125086944|NCT02442765|449935340|FG005|Stage 2- (Days 43 to 85)|Death|0|||
125086945|NCT02442765|449935341|FG006|Stage 2- (Days 43 to 85)|Death|2|||
125086946|NCT02442765|449935342|FG007|Stage 2- (Days 43 to 85)|Death|0|||
125086947|NCT02442765|449935335|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
125086948|NCT02442765|449935336|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
125086949|NCT02442765|449935337|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
125086950|NCT02442765|449935338|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
125086951|NCT02442765|449935339|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
125086952|NCT02442765|449935340|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
125086953|NCT02442765|449935341|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
125086954|NCT02442765|449935342|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
125086955|NCT02442765|449935335|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
125086956|NCT02442765|449935336|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
125086957|NCT02442765|449935337|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
125086958|NCT02442765|449935338|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
125086959|NCT02442765|449935339|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
125086960|NCT02442765|449935340|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
125086961|NCT02442765|449935341|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
125086962|NCT02442765|449935342|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
125086963|NCT02442765|449935335|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
125086964|NCT02442765|449935336|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
125086965|NCT02442765|449935337|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
125086966|NCT02442765|449935338|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
125086967|NCT02442765|449935339|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
125086968|NCT02442765|449935340|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
125145434|NCT04974580|450156033|FG002|Overall Study|Lost to Follow-up|30|||
125145435|NCT04974580|450156034|FG003|Overall Study|Lost to Follow-up|29|||
125145436|NCT05317195|450156040|FG000|Randomization|Withdrawal by Subject|1|||
125145437|NCT05317195|450156040|FG000|Randomization|Discontinued|6|||
125145438|NCT05317195|450156040|FG000|Admission|Withdrawal by Subject|2|||
125145439|NCT03919695|450156041|FG000|3-month Follow-up|Death|1|||
125145440|NCT03919695|450156042|FG001|3-month Follow-up|Death|1|||
125145441|NCT03919695|450156041|FG000|3-month Follow-up|unable to contact|0|||
125145442|NCT03919695|450156042|FG001|3-month Follow-up|unable to contact|3|||
125145443|NCT03919695|450156041|FG000|3-month Follow-up|in prison|0|||
125145444|NCT03919695|450156042|FG001|3-month Follow-up|in prison|1|||
125145445|NCT03919695|450156041|FG000|6-month Follow-up|Death|0|||
125145446|NCT03919695|450156042|FG001|6-month Follow-up|Death|1|||
125145447|NCT03919695|450156041|FG000|6-month Follow-up|Lost to Follow-up|1|||
125145448|NCT03919695|450156042|FG001|6-month Follow-up|Lost to Follow-up|2|||
125145449|NCT03919695|450156041|FG000|6-month Follow-up|in prison|0|||
125145450|NCT03919695|450156042|FG001|6-month Follow-up|in prison|2|||
125145451|NCT03919695|450156041|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
125145452|NCT03919695|450156042|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
125086969|NCT02442765|449935341|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
125086970|NCT02442765|449935342|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
125145453|NCT03919695|450156041|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
125145454|NCT03919695|450156042|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
125223553|NCT02326272|450446167|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125086971|NCT02442765|449935335|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
125086972|NCT02442765|449935336|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
125086973|NCT02442765|449935337|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
125145455|NCT02063217|450156044|FG000|Overall Study|Withdrawal by Subject|1|||
125145456|NCT02063217|450156045|FG001|Overall Study|Withdrawal by Subject|0|||
125145457|NCT02063217|450156046|FG002|Overall Study|Withdrawal by Subject|0|||
125145458|NCT01020526|450156047|FG000|Overall Study|Withdrawal by Subject|5|||
125145459|NCT01020526|450156047|FG000|Overall Study|Other reasons|3|||
125145460|NCT01020526|450156047|FG000|Overall Study|Insufficient clinical response|3|||
125145461|NCT01020526|450156047|FG000|Overall Study|Lost to Follow-up|1|||
125145462|NCT01020526|450156047|FG000|Overall Study|Adverse Event|2|||
125086974|NCT02442765|449935338|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
125086975|NCT02442765|449935339|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
125086976|NCT02442765|449935340|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
125086977|NCT02442765|449935341|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
125086978|NCT02442765|449935342|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
125086979|NCT02442765|449935335|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
125086980|NCT02442765|449935336|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
125086981|NCT02442765|449935337|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
125086982|NCT02442765|449935338|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
125086983|NCT02442765|449935339|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
125086984|NCT02442765|449935340|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
125086985|NCT02442765|449935341|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
125086986|NCT02442765|449935342|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
125145463|NCT02212457|450156053|FG000|Overall Study|Adverse Event|1|||
125145464|NCT02212457|450156054|FG001|Overall Study|Adverse Event|2|||
125145465|NCT02212457|450156055|FG002|Overall Study|Adverse Event|2|||
125145466|NCT02212457|450156056|FG003|Overall Study|Adverse Event|2|||
125145467|NCT02212457|450156057|FG004|Overall Study|Adverse Event|0|||
125145468|NCT02212457|450156058|FG005|Overall Study|Adverse Event|1|||
125145469|NCT02212457|450156053|FG000|Overall Study|Withdrawal by Subject|8|||
125145470|NCT02212457|450156054|FG001|Overall Study|Withdrawal by Subject|10|||
125145471|NCT02212457|450156055|FG002|Overall Study|Withdrawal by Subject|8|||
125145472|NCT02212457|450156056|FG003|Overall Study|Withdrawal by Subject|6|||
125145473|NCT02212457|450156057|FG004|Overall Study|Withdrawal by Subject|5|||
125145474|NCT02212457|450156058|FG005|Overall Study|Withdrawal by Subject|4|||
125145475|NCT02212457|450156053|FG000|Overall Study|Lost to Follow-up|6|||
125145476|NCT02212457|450156054|FG001|Overall Study|Lost to Follow-up|7|||
125145477|NCT02212457|450156055|FG002|Overall Study|Lost to Follow-up|4|||
125145478|NCT02212457|450156056|FG003|Overall Study|Lost to Follow-up|1|||
125145479|NCT02212457|450156057|FG004|Overall Study|Lost to Follow-up|8|||
125145480|NCT02212457|450156058|FG005|Overall Study|Lost to Follow-up|4|||
125145481|NCT02212457|450156053|FG000|Overall Study|Protocol Violation|2|||
125145482|NCT02212457|450156054|FG001|Overall Study|Protocol Violation|1|||
125145483|NCT02212457|450156055|FG002|Overall Study|Protocol Violation|0|||
125145484|NCT02212457|450156056|FG003|Overall Study|Protocol Violation|1|||
125145485|NCT02212457|450156057|FG004|Overall Study|Protocol Violation|2|||
125145486|NCT02212457|450156058|FG005|Overall Study|Protocol Violation|3|||
125145487|NCT02212457|450156053|FG000|Overall Study|Other|2|||
125145488|NCT02212457|450156054|FG001|Overall Study|Other|1|||
125145489|NCT02212457|450156055|FG002|Overall Study|Other|2|||
125145490|NCT02212457|450156056|FG003|Overall Study|Other|1|||
125145491|NCT02212457|450156057|FG004|Overall Study|Other|0|||
125145492|NCT02212457|450156058|FG005|Overall Study|Other|1|||
125145493|NCT01120691|450156059|FG000|Overall Study|Adverse Event|59|||
125145494|NCT01120691|450156060|FG001|Overall Study|Adverse Event|67|||
125145495|NCT01120691|450156061|FG002|Overall Study|Adverse Event|47|||
125145496|NCT01120691|450156059|FG000|Overall Study|Subject withdrew consent|33|||
125145497|NCT01120691|450156060|FG001|Overall Study|Subject withdrew consent|50|||
125145498|NCT01120691|450156061|FG002|Overall Study|Subject withdrew consent|44|||
125145499|NCT01120691|450156059|FG000|Overall Study|Death|21|||
125145500|NCT01120691|450156060|FG001|Overall Study|Death|22|||
125145501|NCT01120691|450156061|FG002|Overall Study|Death|24|||
125145502|NCT01120691|450156059|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
125145503|NCT01120691|450156060|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
125145504|NCT01120691|450156061|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
125145505|NCT01120691|450156059|FG000|Overall Study|Administrative problems|15|||
125145506|NCT01120691|450156060|FG001|Overall Study|Administrative problems|8|||
125145507|NCT01120691|450156061|FG002|Overall Study|Administrative problems|9|||
125145508|NCT01120691|450156059|FG000|Overall Study|Protocol deviation|13|||
125145509|NCT01120691|450156060|FG001|Overall Study|Protocol deviation|12|||
125086987|NCT02442765|449935335|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
125145510|NCT01120691|450156061|FG002|Overall Study|Protocol deviation|12|||
125145511|NCT01120691|450156059|FG000|Overall Study|Lost to Follow-up|5|||
125145512|NCT01120691|450156060|FG001|Overall Study|Lost to Follow-up|6|||
125145513|NCT01120691|450156061|FG002|Overall Study|Lost to Follow-up|4|||
125145514|NCT01120691|450156059|FG000|Overall Study|Abnormal test procedure result(s)|3|||
125145515|NCT01120691|450156060|FG001|Overall Study|Abnormal test procedure result(s)|2|||
125145516|NCT01120691|450156061|FG002|Overall Study|Abnormal test procedure result(s)|1|||
125145517|NCT01120691|450156059|FG000|Overall Study|Patient's inability to use the device|3|||
125145518|NCT01120691|450156060|FG001|Overall Study|Patient's inability to use the device|1|||
125145519|NCT01120691|450156061|FG002|Overall Study|Patient's inability to use the device|0|||
125145520|NCT01120691|450156059|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125145521|NCT01120691|450156060|FG001|Overall Study|Abnormal laboratory value(s)|3|||
125145522|NCT01120691|450156061|FG002|Overall Study|Abnormal laboratory value(s)|4|||
125145523|NCT03370510|450156064|FG000|Overall Study|COVID-19|2|||
125145524|NCT03370510|450156065|FG001|Overall Study|COVID-19|0|||
125145525|NCT01525628|450156070|FG000|Overall Study|Adverse Event|1|||
125086988|NCT02442765|449935336|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
125086989|NCT02442765|449935337|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
125086990|NCT02442765|449935338|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
125086991|NCT02442765|449935339|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
125086992|NCT02442765|449935340|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
125086993|NCT02442765|449935341|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
125086994|NCT02442765|449935342|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
125086995|NCT01200758|449935343|FG000|Stage I|Death|0|||
125086996|NCT01200758|449935344|FG001|Stage I|Death|1|||
125086997|NCT01200758|449935345|FG002|Stage I|Death|0|||
125086998|NCT01200758|449935346|FG003|Stage I|Death|0|||
125086999|NCT01200758|449935343|FG000|Stage I|Physician Decision|1|||
125087000|NCT01200758|449935344|FG001|Stage I|Physician Decision|1|||
125087001|NCT01200758|449935345|FG002|Stage I|Physician Decision|0|||
125087002|NCT01200758|449935346|FG003|Stage I|Physician Decision|0|||
125087003|NCT01200758|449935343|FG000|Stage I|Lack of Efficacy|2|||
125087004|NCT01200758|449935344|FG001|Stage I|Lack of Efficacy|1|||
125087005|NCT01200758|449935345|FG002|Stage I|Lack of Efficacy|0|||
125087006|NCT01200758|449935346|FG003|Stage I|Lack of Efficacy|0|||
125087007|NCT01200758|449935343|FG000|Stage I|Adverse Event|5|||
125087008|NCT01200758|449935344|FG001|Stage I|Adverse Event|5|||
125087009|NCT01200758|449935345|FG002|Stage I|Adverse Event|0|||
125087010|NCT01200758|449935346|FG003|Stage I|Adverse Event|0|||
125087011|NCT01200758|449935343|FG000|Stage I|Withdrawal by Subject|1|||
125087012|NCT01200758|449935344|FG001|Stage I|Withdrawal by Subject|2|||
125087013|NCT01200758|449935345|FG002|Stage I|Withdrawal by Subject|0|||
125087014|NCT01200758|449935346|FG003|Stage I|Withdrawal by Subject|0|||
125087015|NCT01200758|449935343|FG000|Stage I|Disease Progression|9|||
125087016|NCT01200758|449935344|FG001|Stage I|Disease Progression|7|||
125087017|NCT01200758|449935345|FG002|Stage I|Disease Progression|0|||
125087018|NCT01200758|449935346|FG003|Stage I|Disease Progression|0|||
125087019|NCT01200758|449935343|FG000|Stage 2|Disease Progression|0|||
125087020|NCT01200758|449935344|FG001|Stage 2|Disease Progression|0|||
125087021|NCT01200758|449935345|FG002|Stage 2|Disease Progression|16|||
125087022|NCT01200758|449935346|FG003|Stage 2|Disease Progression|21|||
125087023|NCT01200758|449935343|FG000|Stage 2|Lack of Efficacy|0|||
125087024|NCT01200758|449935344|FG001|Stage 2|Lack of Efficacy|0|||
125087025|NCT01200758|449935345|FG002|Stage 2|Lack of Efficacy|4|||
125087026|NCT01200758|449935346|FG003|Stage 2|Lack of Efficacy|2|||
125087027|NCT01200758|449935343|FG000|Stage 2|Physician Decision|0|||
125087028|NCT01200758|449935344|FG001|Stage 2|Physician Decision|0|||
125087029|NCT01200758|449935345|FG002|Stage 2|Physician Decision|5|||
125087030|NCT01200758|449935346|FG003|Stage 2|Physician Decision|7|||
125087031|NCT01200758|449935343|FG000|Stage 2|Adverse Event|0|||
125087032|NCT01200758|449935344|FG001|Stage 2|Adverse Event|0|||
125087033|NCT01200758|449935345|FG002|Stage 2|Adverse Event|5|||
125087034|NCT01200758|449935346|FG003|Stage 2|Adverse Event|9|||
125087035|NCT01200758|449935343|FG000|Stage 2|Withdrawal by Subject|0|||
125087036|NCT01200758|449935344|FG001|Stage 2|Withdrawal by Subject|0|||
125087037|NCT01200758|449935345|FG002|Stage 2|Withdrawal by Subject|4|||
125087038|NCT01200758|449935346|FG003|Stage 2|Withdrawal by Subject|1|||
125087039|NCT01200758|449935343|FG000|Stage 2|Lost to Follow-up|0|||
125087040|NCT01200758|449935344|FG001|Stage 2|Lost to Follow-up|0|||
125087041|NCT01200758|449935345|FG002|Stage 2|Lost to Follow-up|3|||
125087042|NCT01200758|449935346|FG003|Stage 2|Lost to Follow-up|1|||
125087043|NCT01200758|449935343|FG000|Stage 2|Protocol Violation|0|||
125087044|NCT01200758|449935344|FG001|Stage 2|Protocol Violation|0|||
125087045|NCT01200758|449935345|FG002|Stage 2|Protocol Violation|1|||
125087046|NCT01200758|449935346|FG003|Stage 2|Protocol Violation|4|||
125087047|NCT01200758|449935343|FG000|Stage 2|Death|0|||
125087048|NCT01200758|449935344|FG001|Stage 2|Death|0|||
125087049|NCT01200758|449935345|FG002|Stage 2|Death|3|||
125087050|NCT01200758|449935346|FG003|Stage 2|Death|5|||
125087051|NCT01371721|449935347|FG000|Overall Study|Adverse Event|5|||
125087052|NCT01371721|449935348|FG001|Overall Study|Adverse Event|4|||
125087053|NCT01371721|449935349|FG002|Overall Study|Adverse Event|5|||
125087054|NCT01371721|449935347|FG000|Overall Study|Protocol Violation|6|||
125087055|NCT01371721|449935348|FG001|Overall Study|Protocol Violation|4|||
125087056|NCT01371721|449935349|FG002|Overall Study|Protocol Violation|5|||
125087057|NCT01371721|449935347|FG000|Overall Study|Lost to Follow-up|8|||
125087058|NCT01371721|449935348|FG001|Overall Study|Lost to Follow-up|2|||
125087059|NCT01371721|449935349|FG002|Overall Study|Lost to Follow-up|6|||
125087060|NCT01371721|449935347|FG000|Overall Study|Withdrawal by Subject|5|||
125087061|NCT01371721|449935348|FG001|Overall Study|Withdrawal by Subject|7|||
125087062|NCT01371721|449935349|FG002|Overall Study|Withdrawal by Subject|11|||
125087063|NCT01371721|449935347|FG000|Overall Study|Other|2|||
125087064|NCT01371721|449935348|FG001|Overall Study|Other|3|||
125087065|NCT01371721|449935349|FG002|Overall Study|Other|0|||
125087066|NCT01371721|449935347|FG000|Overall Study|Lack of Efficacy|2|||
125087067|NCT01371721|449935348|FG001|Overall Study|Lack of Efficacy|4|||
125087068|NCT01371721|449935349|FG002|Overall Study|Lack of Efficacy|3|||
125087069|NCT01371721|449935347|FG000|Overall Study|Randomized but not treated|1|||
125087070|NCT01371721|449935348|FG001|Overall Study|Randomized but not treated|0|||
125087071|NCT01371721|449935349|FG002|Overall Study|Randomized but not treated|0|||
125087072|NCT03267576|449935356|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
125087073|NCT03267576|449935357|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
125087074|NCT03267576|449935356|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
125087075|NCT03267576|449935357|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
125087076|NCT01369069|449935358|FG000|Overall Study|Lost to Follow-up|8|||
125087077|NCT01369069|449935359|FG001|Overall Study|Lost to Follow-up|9|||
125087078|NCT01369069|449935358|FG000|Overall Study|Withdrawal by Subject|9|||
125087079|NCT01369069|449935359|FG001|Overall Study|Withdrawal by Subject|7|||
125087080|NCT00882362|449935360|FG000|Overall Study|Adverse Event|13|||
125087081|NCT00882362|449935361|FG001|Overall Study|Adverse Event|10|||
125145526|NCT01525628|450156071|FG001|Overall Study|Adverse Event|1|||
125145527|NCT01525628|450156072|FG002|Overall Study|Adverse Event|2|||
125145528|NCT01525628|450156073|FG003|Overall Study|Adverse Event|0|||
125145529|NCT01525628|450156074|FG004|Overall Study|Adverse Event|1|||
125145530|NCT01525628|450156070|FG000|Overall Study|Lack of Efficacy|0|||
125145531|NCT01525628|450156071|FG001|Overall Study|Lack of Efficacy|2|||
125145532|NCT01525628|450156072|FG002|Overall Study|Lack of Efficacy|2|||
125145533|NCT01525628|450156073|FG003|Overall Study|Lack of Efficacy|1|||
125087082|NCT00882362|449935360|FG000|Overall Study|Withdrawal by Subject|13|||
125087083|NCT00882362|449935361|FG001|Overall Study|Withdrawal by Subject|10|||
125087084|NCT00882362|449935360|FG000|Overall Study|Lack of Efficacy|3|||
125087085|NCT00882362|449935361|FG001|Overall Study|Lack of Efficacy|0|||
125087086|NCT00882362|449935360|FG000|Overall Study|Protocol Violation|7|||
125087087|NCT00882362|449935361|FG001|Overall Study|Protocol Violation|2|||
125087088|NCT00882362|449935360|FG000|Overall Study|Pregnancy|1|||
125087089|NCT00882362|449935361|FG001|Overall Study|Pregnancy|0|||
125087090|NCT00882362|449935360|FG000|Overall Study|Physician Decision|5|||
125087091|NCT00882362|449935361|FG001|Overall Study|Physician Decision|1|||
125087092|NCT00882362|449935360|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
125087093|NCT00882362|449935361|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
125087094|NCT00882362|449935360|FG000|Overall Study|change of residence or other commitments|5|||
125087095|NCT00882362|449935361|FG001|Overall Study|change of residence or other commitments|0|||
125087096|NCT01268514|449935362|FG000|Overall Study|Adverse Event|20|||
125087097|NCT01268514|449935362|FG000|Overall Study|Death|8|||
125087098|NCT01268514|449935362|FG000|Overall Study|Lost to Follow-up|5|||
125087099|NCT01268514|449935362|FG000|Overall Study|Withdrawal by Subject|3|||
125087100|NCT01268514|449935362|FG000|Overall Study|Withdrawal by Surgeon|5|||
125087101|NCT03196973|449935365|FG000|Overall Study|Adverse Event|1|||
125087102|NCT03196973|449935366|FG001|Overall Study|Adverse Event|1|||
125087103|NCT03196973|449935367|FG002|Overall Study|Adverse Event|2|||
125087104|NCT03196973|449935365|FG000|Overall Study|Lack of Efficacy|2|||
125087105|NCT03196973|449935366|FG001|Overall Study|Lack of Efficacy|6|||
125087106|NCT03196973|449935367|FG002|Overall Study|Lack of Efficacy|1|||
125087107|NCT03196973|449935365|FG000|Overall Study|Lost to Follow-up|4|||
125087108|NCT03196973|449935366|FG001|Overall Study|Lost to Follow-up|3|||
125087109|NCT03196973|449935367|FG002|Overall Study|Lost to Follow-up|2|||
125087110|NCT03196973|449935365|FG000|Overall Study|Consent withdrawn|2|||
125087111|NCT03196973|449935366|FG001|Overall Study|Consent withdrawn|1|||
125087112|NCT03196973|449935367|FG002|Overall Study|Consent withdrawn|0|||
125087113|NCT03196973|449935365|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
125087114|NCT03196973|449935366|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
125087115|NCT03196973|449935367|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
125087116|NCT01809327|449935368|FG000|Overall Study|Lost to Follow-up|5|||
125087117|NCT01809327|449935369|FG001|Overall Study|Lost to Follow-up|2|||
125087118|NCT01809327|449935370|FG002|Overall Study|Lost to Follow-up|4|||
125087119|NCT01809327|449935371|FG003|Overall Study|Lost to Follow-up|2|||
125087120|NCT01809327|449935372|FG004|Overall Study|Lost to Follow-up|3|||
125087121|NCT01809327|449935368|FG000|Overall Study|Withdrawal by Subject|6|||
125087122|NCT01809327|449935369|FG001|Overall Study|Withdrawal by Subject|4|||
125087123|NCT01809327|449935370|FG002|Overall Study|Withdrawal by Subject|4|||
125087124|NCT01809327|449935371|FG003|Overall Study|Withdrawal by Subject|2|||
125087125|NCT01809327|449935372|FG004|Overall Study|Withdrawal by Subject|5|||
125087126|NCT01809327|449935368|FG000|Overall Study|Adverse Event|4|||
125087127|NCT01809327|449935369|FG001|Overall Study|Adverse Event|3|||
125087128|NCT01809327|449935370|FG002|Overall Study|Adverse Event|7|||
125087129|NCT01809327|449935371|FG003|Overall Study|Adverse Event|4|||
125087130|NCT01809327|449935372|FG004|Overall Study|Adverse Event|8|||
125087131|NCT01809327|449935368|FG000|Overall Study|Death|1|||
125087132|NCT01809327|449935369|FG001|Overall Study|Death|0|||
125087133|NCT01809327|449935370|FG002|Overall Study|Death|0|||
125087134|NCT01809327|449935371|FG003|Overall Study|Death|0|||
125087135|NCT01809327|449935372|FG004|Overall Study|Death|0|||
125087136|NCT01809327|449935368|FG000|Overall Study|Protocol Violation|0|||
125087137|NCT01809327|449935369|FG001|Overall Study|Protocol Violation|1|||
125087138|NCT01809327|449935370|FG002|Overall Study|Protocol Violation|0|||
125087139|NCT01809327|449935371|FG003|Overall Study|Protocol Violation|0|||
125087140|NCT01809327|449935372|FG004|Overall Study|Protocol Violation|0|||
125087141|NCT01809327|449935368|FG000|Overall Study|Physician Decision|1|||
125087142|NCT01809327|449935369|FG001|Overall Study|Physician Decision|1|||
125087143|NCT01809327|449935370|FG002|Overall Study|Physician Decision|0|||
125087144|NCT01809327|449935371|FG003|Overall Study|Physician Decision|0|||
125087145|NCT01809327|449935372|FG004|Overall Study|Physician Decision|0|||
125087146|NCT01809327|449935368|FG000|Overall Study|Pregnancy|1|||
125087147|NCT01809327|449935369|FG001|Overall Study|Pregnancy|0|||
125087148|NCT01809327|449935370|FG002|Overall Study|Pregnancy|0|||
125087149|NCT01809327|449935371|FG003|Overall Study|Pregnancy|0|||
125087150|NCT01809327|449935372|FG004|Overall Study|Pregnancy|0|||
125087151|NCT01809327|449935368|FG000|Overall Study|Other|14|||
125087152|NCT01809327|449935369|FG001|Overall Study|Other|15|||
125087153|NCT01809327|449935370|FG002|Overall Study|Other|7|||
125087154|NCT01809327|449935371|FG003|Overall Study|Other|4|||
125087155|NCT01809327|449935372|FG004|Overall Study|Other|9|||
125087156|NCT02390362|449935378|FG000|Overall Study|Withdrawal by Subject|0|||
125087157|NCT02390362|449935379|FG001|Overall Study|Withdrawal by Subject|1|||
125087158|NCT04009824|449935380|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
125087159|NCT04009824|449935381|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
125087160|NCT04009824|449935382|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
125087161|NCT04009824|449935383|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
125087162|NCT04009824|449935384|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
125087163|NCT01142791|449935387|FG000|Overall Study|Alternative Treatment|1|||
125087164|NCT01142791|449935388|FG001|Overall Study|Alternative Treatment|0|||
125087165|NCT01142791|449935387|FG000|Overall Study|Lost to Follow-up|1|||
125087166|NCT01142791|449935388|FG001|Overall Study|Lost to Follow-up|0|||
125087167|NCT01142791|449935387|FG000|Overall Study|Withdrawal by Subject|5|||
125087168|NCT01142791|449935388|FG001|Overall Study|Withdrawal by Subject|0|||
125087169|NCT01142791|449935387|FG000|Overall Study|Received only 1 sonication|0|||
125087170|NCT01142791|449935388|FG001|Overall Study|Received only 1 sonication|6|||
125087171|NCT03032523|449935391|FG000|Overall Study|Withdrawal by Subject|2|||
125087172|NCT03032523|449935392|FG001|Overall Study|Withdrawal by Subject|2|||
125087173|NCT03032523|449935391|FG000|Overall Study|Physician Decision|1|||
125087174|NCT03032523|449935392|FG001|Overall Study|Physician Decision|0|||
125087175|NCT00957723|449935393|FG000|Overall Study|Death|3|||
125087176|NCT00957723|449935393|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
125087177|NCT00957723|449935393|FG000|Overall Study|Lost to Follow-up|8|||
125087178|NCT00957723|449935393|FG000|Overall Study|Withdrawal by Subject|24|||
125087179|NCT00957723|449935393|FG000|Overall Study|Investigative Site Terminated|61|||
125087180|NCT00957723|449935393|FG000|Overall Study|Intercurrent Illness|2|||
125087181|NCT00957723|449935393|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
125087182|NCT00281528|449935394|FG000|Overall Study|Progressive Disease|28|||
125087183|NCT00281528|449935395|FG001|Overall Study|Progressive Disease|18|||
125087184|NCT00281528|449935396|FG002|Overall Study|Progressive Disease|27|||
125087185|NCT00281528|449935394|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
125087186|NCT00281528|449935395|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
125087187|NCT00281528|449935396|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
125087188|NCT00281528|449935394|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
125087189|NCT00281528|449935395|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
125087190|NCT00281528|449935396|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
125087191|NCT00281528|449935394|FG000|Overall Study|Physician Decision|11|||
125087192|NCT00281528|449935395|FG001|Overall Study|Physician Decision|4|||
125087193|NCT00281528|449935396|FG002|Overall Study|Physician Decision|5|||
125087194|NCT00281528|449935394|FG000|Overall Study|Protocol Violation|1|||
125087195|NCT00281528|449935395|FG001|Overall Study|Protocol Violation|0|||
125087196|NCT00281528|449935396|FG002|Overall Study|Protocol Violation|1|||
125087197|NCT00281528|449935394|FG000|Overall Study|Withdrawal by Subject|5|||
125087198|NCT00281528|449935395|FG001|Overall Study|Withdrawal by Subject|5|||
125087199|NCT00281528|449935396|FG002|Overall Study|Withdrawal by Subject|7|||
125087200|NCT00281528|449935394|FG000|Overall Study|Other|6|||
125087201|NCT00281528|449935395|FG001|Overall Study|Other|3|||
125087202|NCT00281528|449935396|FG002|Overall Study|Other|5|||
125087203|NCT01984294|449935404|FG000|Overall Study|Randomized but Never Treated|0|||
125087204|NCT01984294|449935405|FG001|Overall Study|Randomized but Never Treated|0|||
125087205|NCT01984294|449935406|FG002|Overall Study|Randomized but Never Treated|1|||
125087206|NCT01984294|449935404|FG000|Overall Study|Lack of Efficacy|4|||
125087207|NCT01984294|449935405|FG001|Overall Study|Lack of Efficacy|2|||
125087208|NCT01984294|449935406|FG002|Overall Study|Lack of Efficacy|6|||
125087209|NCT01984294|449935404|FG000|Overall Study|Adverse Event|0|||
125087210|NCT01984294|449935405|FG001|Overall Study|Adverse Event|1|||
125087211|NCT01984294|449935406|FG002|Overall Study|Adverse Event|0|||
125087212|NCT01987609|449935407|FG000|Overall Study|Adverse Event|1|||
125087213|NCT02610231|449935408|FG000|Overall Study|Withdrawal by Subject|27|||
125087214|NCT02610231|449935408|FG000|Overall Study|Adverse Event|20|||
125087215|NCT02610231|449935408|FG000|Overall Study|Death|5|||
125087216|NCT02610231|449935408|FG000|Overall Study|Surgery|2|||
125087217|NCT02610231|449935408|FG000|Overall Study|Physician Decision|1|||
125087218|NCT02610231|449935408|FG000|Overall Study|Non Compliance|2|||
125087219|NCT02610231|449935408|FG000|Overall Study|Other|3|||
125087220|NCT00806494|449935409|FG000|Overall Study|Adverse Event|29|||
125087221|NCT00806494|449935409|FG000|Overall Study|Lack of Efficacy|6|||
125087222|NCT00806494|449935409|FG000|Overall Study|Lost to Follow-up|10|||
125087223|NCT00806494|449935409|FG000|Overall Study|Other|30|||
125087224|NCT00806494|449935409|FG000|Overall Study|Withdrawal by Subject|5|||
125087225|NCT01279954|449935410|FG000|Overall Study|Lack of Efficacy|3|||
125087226|NCT01279954|449935411|FG001|Overall Study|Lack of Efficacy|4|||
125087227|NCT02709889|449935412|FG000|Overall Study|Withdrawal by Subject|11|||
125087228|NCT02709889|449935413|FG001|Overall Study|Withdrawal by Subject|10|||
125087229|NCT02709889|449935414|FG002|Overall Study|Withdrawal by Subject|2|||
125087230|NCT02709889|449935415|FG003|Overall Study|Withdrawal by Subject|12|||
125087231|NCT02709889|449935412|FG000|Overall Study|Death|25|||
125087232|NCT02709889|449935413|FG001|Overall Study|Death|38|||
125087233|NCT02709889|449935414|FG002|Overall Study|Death|4|||
125087234|NCT02709889|449935415|FG003|Overall Study|Death|44|||
125087235|NCT02709889|449935412|FG000|Overall Study|Physician Decision|1|||
125087236|NCT02709889|449935413|FG001|Overall Study|Physician Decision|2|||
125087237|NCT02709889|449935414|FG002|Overall Study|Physician Decision|3|||
125087238|NCT02709889|449935415|FG003|Overall Study|Physician Decision|5|||
125087239|NCT02709889|449935412|FG000|Overall Study|Lost to Follow-up|2|||
125087240|NCT02709889|449935413|FG001|Overall Study|Lost to Follow-up|0|||
125087241|NCT02709889|449935414|FG002|Overall Study|Lost to Follow-up|0|||
125087242|NCT02709889|449935415|FG003|Overall Study|Lost to Follow-up|4|||
125087243|NCT02709889|449935412|FG000|Overall Study|Study Terminated by Sponsor|4|||
125087244|NCT02709889|449935413|FG001|Overall Study|Study Terminated by Sponsor|6|||
125087245|NCT02709889|449935414|FG002|Overall Study|Study Terminated by Sponsor|2|||
125087246|NCT02709889|449935415|FG003|Overall Study|Study Terminated by Sponsor|17|||
125087247|NCT02709889|449935412|FG000|Overall Study|Other, Not Specified|0|||
125087248|NCT02709889|449935413|FG001|Overall Study|Other, Not Specified|1|||
125087249|NCT02709889|449935414|FG002|Overall Study|Other, Not Specified|1|||
125087250|NCT02709889|449935415|FG003|Overall Study|Other, Not Specified|6|||
125087251|NCT00537810|449935416|FG000|Overall Study|Withdrawal by Subject|4|||
125087252|NCT00537810|449935417|FG001|Overall Study|Withdrawal by Subject|11|||
125087253|NCT00537810|449935418|FG002|Overall Study|Withdrawal by Subject|4|||
125087254|NCT00537810|449935419|FG003|Overall Study|Withdrawal by Subject|3|||
125087255|NCT00537810|449935416|FG000|Overall Study|Medically withdrawn|2|||
125087256|NCT00537810|449935417|FG001|Overall Study|Medically withdrawn|2|||
125087257|NCT00537810|449935418|FG002|Overall Study|Medically withdrawn|0|||
125087258|NCT00537810|449935419|FG003|Overall Study|Medically withdrawn|1|||
125087259|NCT01066546|449935420|FG000|Overall Study|Study terminated by sponsor|5|||
125087260|NCT03258762|449935421|FG000|Overall Study|Lost to Follow-up|0|||
125087261|NCT03258762|449935422|FG001|Overall Study|Lost to Follow-up|1|||
125087262|NCT01711359|449935423|FG000|Treatment Period|Withdrawal by Subject|18|||
125087263|NCT01711359|449935424|FG001|Treatment Period|Withdrawal by Subject|7|||
125087264|NCT01711359|449935425|FG002|Treatment Period|Withdrawal by Subject|13|||
125087265|NCT01711359|449935423|FG000|Treatment Period|Lack of Efficacy|13|||
125087266|NCT01711359|449935424|FG001|Treatment Period|Lack of Efficacy|2|||
125087267|NCT01711359|449935425|FG002|Treatment Period|Lack of Efficacy|2|||
125087268|NCT01711359|449935423|FG000|Treatment Period|Adverse Event|8|||
125087269|NCT01711359|449935424|FG001|Treatment Period|Adverse Event|10|||
125087270|NCT01711359|449935425|FG002|Treatment Period|Adverse Event|24|||
125087271|NCT01711359|449935423|FG000|Treatment Period|Physician Decision|4|||
125087272|NCT01711359|449935424|FG001|Treatment Period|Physician Decision|3|||
125087273|NCT01711359|449935425|FG002|Treatment Period|Physician Decision|2|||
125087274|NCT01711359|449935423|FG000|Treatment Period|Death|3|||
125087275|NCT01711359|449935424|FG001|Treatment Period|Death|0|||
125087276|NCT01711359|449935425|FG002|Treatment Period|Death|0|||
125087277|NCT01711359|449935423|FG000|Treatment Period|Entry Criteria Not Met|1|||
125087278|NCT01711359|449935424|FG001|Treatment Period|Entry Criteria Not Met|0|||
125087279|NCT01711359|449935425|FG002|Treatment Period|Entry Criteria Not Met|0|||
125087280|NCT01711359|449935423|FG000|Treatment Period|Sponsor Decision|1|||
125087281|NCT01711359|449935424|FG001|Treatment Period|Sponsor Decision|0|||
125087282|NCT01711359|449935425|FG002|Treatment Period|Sponsor Decision|0|||
125087283|NCT01711359|449935423|FG000|Treatment Period|Lost to Follow-up|1|||
125087284|NCT01711359|449935424|FG001|Treatment Period|Lost to Follow-up|1|||
125087285|NCT01711359|449935425|FG002|Treatment Period|Lost to Follow-up|1|||
125087286|NCT01711359|449935423|FG000|Treatment Period|Randomized, Not Treated|3|||
125087287|NCT01711359|449935424|FG001|Treatment Period|Randomized, Not Treated|1|||
125087288|NCT01711359|449935425|FG002|Treatment Period|Randomized, Not Treated|0|||
125087289|NCT02698176|449935426|FG000|Overall Study|Progressive disease|4|||
125087290|NCT02698176|449935427|FG001|Overall Study|Progressive disease|3|||
125087291|NCT02698176|449935428|FG002|Overall Study|Progressive disease|1|||
125087292|NCT02698176|449935429|FG003|Overall Study|Progressive disease|0|||
125087293|NCT02698176|449935426|FG000|Overall Study|Adverse Event|2|||
125087294|NCT02698176|449935427|FG001|Overall Study|Adverse Event|0|||
125087295|NCT02698176|449935428|FG002|Overall Study|Adverse Event|0|||
125087296|NCT02698176|449935429|FG003|Overall Study|Adverse Event|0|||
125087297|NCT02698176|449935426|FG000|Overall Study|Clinical progression|3|||
125087298|NCT02698176|449935427|FG001|Overall Study|Clinical progression|0|||
125087299|NCT02698176|449935428|FG002|Overall Study|Clinical progression|0|||
125087300|NCT02698176|449935429|FG003|Overall Study|Clinical progression|0|||
125087301|NCT02561572|449935436|FG000|Overall Study|Inadequate time before surgery|2|||
125087302|NCT02561572|449935437|FG001|Overall Study|Inadequate time before surgery|1|||
125087303|NCT02561572|449935436|FG000|Overall Study|Protocol Violation|0|||
125087304|NCT02561572|449935437|FG001|Overall Study|Protocol Violation|1|||
125087305|NCT00795717|449935438|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
125087306|NCT00795717|449935439|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
125087307|NCT00795717|449935438|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
125087308|NCT00795717|449935439|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
125087309|NCT00795717|449935438|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
125087310|NCT00795717|449935439|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
125087311|NCT00795717|449935438|FG000|Phase II|too busy|0|||
125223554|NCT02326272|450446168|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125087312|NCT00795717|449935439|FG001|Phase II|too busy|1|||
125087313|NCT00424463|449935446|FG000|Overall Study|Adverse Event|2|||
125087314|NCT00424463|449935447|FG001|Overall Study|Adverse Event|3|||
125087315|NCT00424463|449935448|FG002|Overall Study|Adverse Event|2|||
125087316|NCT00424463|449935446|FG000|Overall Study|Physician Decision|0|||
125087317|NCT00424463|449935447|FG001|Overall Study|Physician Decision|2|||
125087318|NCT00424463|449935448|FG002|Overall Study|Physician Decision|2|||
125087319|NCT00424463|449935446|FG000|Overall Study|Withdrawal by Subject|4|||
125087320|NCT00424463|449935447|FG001|Overall Study|Withdrawal by Subject|2|||
125087321|NCT00424463|449935448|FG002|Overall Study|Withdrawal by Subject|5|||
125087322|NCT00424463|449935446|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
125087323|NCT00424463|449935447|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
125087324|NCT00424463|449935448|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
125087325|NCT00424463|449935446|FG000|Overall Study|Patient's convenience|0|||
125087326|NCT00424463|449935447|FG001|Overall Study|Patient's convenience|0|||
125087327|NCT00424463|449935448|FG002|Overall Study|Patient's convenience|1|||
125087328|NCT04728815|449935456|FG000|Overall Study|Lost to Follow-up|3|||
125087329|NCT04728815|449935457|FG001|Overall Study|Lost to Follow-up|0|||
125087330|NCT04728815|449935458|FG002|Overall Study|Lost to Follow-up|0|||
125087331|NCT04728815|449935459|FG003|Overall Study|Lost to Follow-up|1|||
125087332|NCT04728815|449935460|FG004|Overall Study|Lost to Follow-up|1|||
125087333|NCT04728815|449935461|FG005|Overall Study|Lost to Follow-up|0|||
125087334|NCT04728815|449935462|FG006|Overall Study|Lost to Follow-up|2|||
125087335|NCT04728815|449935463|FG007|Overall Study|Lost to Follow-up|0|||
125087336|NCT04728815|449935456|FG000|Overall Study|Physician Decision|0|||
125087337|NCT04728815|449935457|FG001|Overall Study|Physician Decision|0|||
125145534|NCT01525628|450156074|FG004|Overall Study|Lack of Efficacy|2|||
125145535|NCT01525628|450156070|FG000|Overall Study|Protocol Violation|0|||
125145536|NCT01525628|450156071|FG001|Overall Study|Protocol Violation|0|||
125145537|NCT01525628|450156072|FG002|Overall Study|Protocol Violation|1|||
125145538|NCT01525628|450156073|FG003|Overall Study|Protocol Violation|0|||
125145539|NCT01525628|450156074|FG004|Overall Study|Protocol Violation|0|||
125145540|NCT01525628|450156070|FG000|Overall Study|Lost to Follow-up|1|||
125145541|NCT01525628|450156071|FG001|Overall Study|Lost to Follow-up|1|||
125145542|NCT01525628|450156072|FG002|Overall Study|Lost to Follow-up|0|||
125145543|NCT01525628|450156073|FG003|Overall Study|Lost to Follow-up|0|||
125145544|NCT01525628|450156074|FG004|Overall Study|Lost to Follow-up|0|||
125145545|NCT01525628|450156070|FG000|Overall Study|Withdrawal by Subject|0|||
125145546|NCT01525628|450156071|FG001|Overall Study|Withdrawal by Subject|1|||
125145547|NCT01525628|450156072|FG002|Overall Study|Withdrawal by Subject|0|||
125145548|NCT01525628|450156073|FG003|Overall Study|Withdrawal by Subject|0|||
125145549|NCT01525628|450156074|FG004|Overall Study|Withdrawal by Subject|0|||
125145550|NCT01525628|450156070|FG000|Overall Study|Other reason not defined above|0|||
125145551|NCT01525628|450156071|FG001|Overall Study|Other reason not defined above|0|||
125145552|NCT01525628|450156072|FG002|Overall Study|Other reason not defined above|0|||
125145553|NCT01525628|450156073|FG003|Overall Study|Other reason not defined above|3|||
125145554|NCT01525628|450156074|FG004|Overall Study|Other reason not defined above|0|||
125145555|NCT00089973|450156075|FG000|Overall Study|Adverse Event|3|||
125145556|NCT00089973|450156075|FG000|Overall Study|Withdrawal by Subject|1|||
125145557|NCT00089973|450156075|FG000|Overall Study|Disease progression|45|||
125145558|NCT00089973|450156075|FG000|Overall Study|Death|1|||
125145559|NCT01992094|450156076|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
125145560|NCT01992094|450156077|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
125145561|NCT01992094|450156078|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
125145562|NCT01992094|450156076|FG000|Overall Study|Adverse Event|1|||
125145563|NCT01992094|450156077|FG001|Overall Study|Adverse Event|0|||
125145564|NCT01992094|450156078|FG002|Overall Study|Adverse Event|0|||
125145565|NCT01992094|450156076|FG000|Overall Study|Death|5|||
125145566|NCT01992094|450156077|FG001|Overall Study|Death|5|||
125145567|NCT01992094|450156078|FG002|Overall Study|Death|2|||
125145568|NCT01992094|450156076|FG000|Overall Study|Lost to Follow-up|26|||
125145569|NCT01992094|450156077|FG001|Overall Study|Lost to Follow-up|9|||
125145570|NCT01992094|450156078|FG002|Overall Study|Lost to Follow-up|13|||
125145571|NCT01992094|450156076|FG000|Overall Study|OTHER|4|||
125223555|NCT02326272|450446169|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125223556|NCT02326272|450446170|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125087338|NCT04728815|449935458|FG002|Overall Study|Physician Decision|1|||
125145572|NCT01992094|450156077|FG001|Overall Study|OTHER|0|||
125145573|NCT01992094|450156078|FG002|Overall Study|OTHER|0|||
125145574|NCT01992094|450156076|FG000|Overall Study|Protocol Violation|1|||
125145575|NCT01992094|450156077|FG001|Overall Study|Protocol Violation|0|||
125087339|NCT04728815|449935459|FG003|Overall Study|Physician Decision|0|||
125087340|NCT04728815|449935460|FG004|Overall Study|Physician Decision|0|||
125087341|NCT04728815|449935461|FG005|Overall Study|Physician Decision|0|||
125087342|NCT04728815|449935462|FG006|Overall Study|Physician Decision|0|||
125145576|NCT01992094|450156078|FG002|Overall Study|Protocol Violation|1|||
125145577|NCT01992094|450156076|FG000|Overall Study|Withdrawal by Subject|7|||
125145578|NCT01992094|450156077|FG001|Overall Study|Withdrawal by Subject|3|||
125145579|NCT01992094|450156078|FG002|Overall Study|Withdrawal by Subject|4|||
125145580|NCT01214239|450156079|FG000|Overall Study|Adverse Event|3|||
125145581|NCT01214239|450156080|FG001|Overall Study|Adverse Event|4|||
125145582|NCT01214239|450156079|FG000|Overall Study|Protocol Violation|2|||
125087343|NCT04728815|449935463|FG007|Overall Study|Physician Decision|0|||
125087344|NCT04728815|449935456|FG000|Overall Study|Treatment drop|0|||
125087345|NCT04728815|449935457|FG001|Overall Study|Treatment drop|2|||
125087346|NCT04728815|449935458|FG002|Overall Study|Treatment drop|1|||
125087347|NCT04728815|449935459|FG003|Overall Study|Treatment drop|0|||
125087348|NCT04728815|449935460|FG004|Overall Study|Treatment drop|3|||
125087349|NCT04728815|449935461|FG005|Overall Study|Treatment drop|1|||
125087350|NCT04728815|449935462|FG006|Overall Study|Treatment drop|3|||
125087351|NCT04728815|449935463|FG007|Overall Study|Treatment drop|0|||
125087352|NCT04728815|449935456|FG000|Overall Study|Study drop|0|||
125087353|NCT04728815|449935457|FG001|Overall Study|Study drop|3|||
125087354|NCT04728815|449935458|FG002|Overall Study|Study drop|3|||
125087355|NCT04728815|449935459|FG003|Overall Study|Study drop|0|||
125087356|NCT04728815|449935460|FG004|Overall Study|Study drop|0|||
125087357|NCT04728815|449935461|FG005|Overall Study|Study drop|0|||
125087358|NCT04728815|449935462|FG006|Overall Study|Study drop|7|||
125087359|NCT04728815|449935463|FG007|Overall Study|Study drop|0|||
125087360|NCT00631969|449935464|FG000|Overall Study|Adverse Event|3|||
125087361|NCT00631969|449935465|FG001|Overall Study|Adverse Event|1|||
125087362|NCT00631969|449935464|FG000|Overall Study|Lack of Efficacy|2|||
125087363|NCT00631969|449935465|FG001|Overall Study|Lack of Efficacy|8|||
125087364|NCT00631969|449935464|FG000|Overall Study|Lost to Follow-up|2|||
125087365|NCT00631969|449935465|FG001|Overall Study|Lost to Follow-up|1|||
125087366|NCT00631969|449935464|FG000|Overall Study|Protocol Violation|1|||
125087367|NCT00631969|449935465|FG001|Overall Study|Protocol Violation|1|||
125087368|NCT00631969|449935464|FG000|Overall Study|Consent Withdrawn|5|||
125087369|NCT00631969|449935465|FG001|Overall Study|Consent Withdrawn|7|||
125087370|NCT00631969|449935464|FG000|Overall Study|Noncompliant With Study Medication|0|||
125087371|NCT00631969|449935465|FG001|Overall Study|Noncompliant With Study Medication|1|||
125087372|NCT00631969|449935464|FG000|Overall Study|No Drug Exposure|2|||
125087373|NCT00631969|449935465|FG001|Overall Study|No Drug Exposure|2|||
125087374|NCT00957034|449935466|FG000|Overall Study|Adverse Event|0|||
125087375|NCT00957034|449935467|FG001|Overall Study|Adverse Event|1|||
125087376|NCT00957034|449935468|FG002|Overall Study|Adverse Event|1|||
125087377|NCT00957034|449935466|FG000|Overall Study|Sponsor Terminated Study|6|||
125087378|NCT00957034|449935467|FG001|Overall Study|Sponsor Terminated Study|1|||
125087379|NCT00957034|449935468|FG002|Overall Study|Sponsor Terminated Study|5|||
125087380|NCT00957034|449935466|FG000|Overall Study|Withdrawal by Subject|0|||
125087381|NCT00957034|449935467|FG001|Overall Study|Withdrawal by Subject|2|||
125087382|NCT00957034|449935468|FG002|Overall Study|Withdrawal by Subject|0|||
125087383|NCT03053180|449937011|FG000|Overall Study|Failure to Return|1|||
125087384|NCT01465958|449937014|FG000|Run-in Phase|Protocol Violation|1|||
125087385|NCT01465958|449937015|FG001|Run-in Phase|Protocol Violation|0|||
125087386|NCT01465958|449937014|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
125087387|NCT01465958|449937015|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
125087388|NCT00669240|449937020|FG000|Overall Study|Lack of Efficacy|33|||
125087389|NCT00669240|449937020|FG000|Overall Study|Withdrawal by Subject|42|||
125087390|NCT00669240|449937020|FG000|Overall Study|Lost to Follow-up|34|||
125087391|NCT00669240|449937020|FG000|Overall Study|Adverse Event|21|||
125087392|NCT00669240|449937020|FG000|Overall Study|Other|19|||
125087393|NCT00669240|449937020|FG000|Overall Study|Enrolled but not treated|15|||
125087394|NCT00669240|449937020|FG000|Overall Study|Enrolled but no dosing record|1|||
125087395|NCT00532441|449937023|FG000|Overall Study|Death|1|||
125087396|NCT00532441|449937024|FG001|Overall Study|Death|0|||
125087397|NCT00626327|449937030|FG000|Overall Study|Withdrawal by Subject|21|||
125087398|NCT00626327|449937031|FG001|Overall Study|Withdrawal by Subject|29|||
125087399|NCT00626327|449937032|FG002|Overall Study|Withdrawal by Subject|30|||
125145583|NCT01214239|450156080|FG001|Overall Study|Protocol Violation|1|||
125145584|NCT01214239|450156079|FG000|Overall Study|Lost to Follow-up|1|||
125145585|NCT01214239|450156080|FG001|Overall Study|Lost to Follow-up|1|||
125145586|NCT01214239|450156079|FG000|Overall Study|Withdrawal by Subject|4|||
125087400|NCT00626327|449937030|FG000|Overall Study|Adverse Event|1|||
125087401|NCT00626327|449937031|FG001|Overall Study|Adverse Event|0|||
125087402|NCT00626327|449937032|FG002|Overall Study|Adverse Event|0|||
125087403|NCT00626327|449937030|FG000|Overall Study|Lost to Follow-up|24|||
125087404|NCT00626327|449937031|FG001|Overall Study|Lost to Follow-up|21|||
125087405|NCT00626327|449937032|FG002|Overall Study|Lost to Follow-up|23|||
125087406|NCT00626327|449937030|FG000|Overall Study|Inappropriate enrollment|4|||
125087407|NCT00626327|449937031|FG001|Overall Study|Inappropriate enrollment|5|||
125087408|NCT00626327|449937032|FG002|Overall Study|Inappropriate enrollment|3|||
125087409|NCT00626327|449937030|FG000|Overall Study|Administrative Reason|2|||
125087410|NCT00626327|449937031|FG001|Overall Study|Administrative Reason|0|||
125087411|NCT00626327|449937032|FG002|Overall Study|Administrative Reason|6|||
125087412|NCT00626327|449937030|FG000|Overall Study|Protocol Violation|26|||
125087413|NCT00626327|449937031|FG001|Overall Study|Protocol Violation|4|||
125145587|NCT01214239|450156080|FG001|Overall Study|Withdrawal by Subject|9|||
125087414|NCT00626327|449937032|FG002|Overall Study|Protocol Violation|26|||
125087415|NCT02807376|449937036|FG000|Overall Study|Intra-operative exclusion criteria|3|||
125087416|NCT02807376|449937037|FG001|Overall Study|Intra-operative exclusion criteria|0|||
125145588|NCT01214239|450156079|FG000|Overall Study|Lack of Efficacy|1|||
125087417|NCT02807376|449937036|FG000|Overall Study|Lost to Follow-up|0|||
125087418|NCT02807376|449937037|FG001|Overall Study|Lost to Follow-up|1|||
125087419|NCT00846027|449937038|FG000|Overall Study|Death|3|||
125087420|NCT00846027|449937038|FG000|Overall Study|Disease Progression|30|||
125087421|NCT00846027|449937038|FG000|Overall Study|Toxicity|12|||
125087422|NCT00846027|449937038|FG000|Overall Study|Patient Decision|7|||
125087423|NCT00846027|449937038|FG000|Overall Study|Investigator Discretion|29|||
125087424|NCT00846027|449937038|FG000|Overall Study|Protocol Violation|2|||
125087425|NCT00846027|449937038|FG000|Overall Study|Subject Not Treated|7|||
125087426|NCT01797302|449937039|FG000|Overall Study|Lost to Follow-up|16|||
125087427|NCT01797302|449937040|FG001|Overall Study|Lost to Follow-up|23|||
125087428|NCT01797302|449937041|FG002|Overall Study|Lost to Follow-up|22|||
125087429|NCT01797302|449937039|FG000|Overall Study|Withdrawal by Subject|1|||
125087430|NCT01797302|449937040|FG001|Overall Study|Withdrawal by Subject|3|||
125087431|NCT01797302|449937041|FG002|Overall Study|Withdrawal by Subject|4|||
125087432|NCT03228836|449937042|FG000|Overall Study|Adverse Event|3|||
125087433|NCT03228836|449937042|FG000|Overall Study|Withdrawal by Subject|1|||
125087434|NCT03228836|449937042|FG000|Overall Study|Death|1|||
125087435|NCT03228836|449937042|FG000|Overall Study|Physician Decision|1|||
125087436|NCT03228836|449937042|FG000|Overall Study|Disease Progression|7|||
125087437|NCT03228836|449937042|FG000|Overall Study|Other|4|||
125087438|NCT02176226|449937046|FG000|Overall Study|Lost to Follow-up|3|||
125223557|NCT02326272|450446171|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125087439|NCT02176226|449937046|FG000|Overall Study|Withdrew prior to treatment|6|||
125223558|NCT02326272|450446172|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125087440|NCT02908841|449937051|FG000|Overall Study|Physician Decision|4|||
125087441|NCT02908841|449937052|FG001|Overall Study|Physician Decision|0|||
125087442|NCT01611558|449937053|FG000|Induction Phase|Study drug toxicity|15|||
125087443|NCT01611558|449937053|FG000|Induction Phase|Disease progression|18|||
125087444|NCT01611558|449937053|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
125087445|NCT01611558|449937053|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
125087446|NCT01611558|449937053|FG000|Induction Phase|Death|1|||
125087447|NCT01611558|449937053|FG000|Maintenance Phase|Withdrawal by Subject|1|||
125087448|NCT01611558|449937053|FG000|Maintenance Phase|Elevated Uric acid|1|||
125087449|NCT04005885|449937055|FG000|First Intervention|Withdrawal by Subject|1|||
125087450|NCT04005885|449937056|FG001|First Intervention|Withdrawal by Subject|1|||
125087451|NCT04005885|449937055|FG000|Second Intervention|Withdrawal by Subject|0|||
125087452|NCT04005885|449937056|FG001|Second Intervention|Withdrawal by Subject|2|||
125087453|NCT02718625|449937057|FG000|Overall Study|Adverse Event|0|||
125087454|NCT02718625|449937058|FG001|Overall Study|Adverse Event|1|||
125087455|NCT02718625|449937057|FG000|Overall Study|Termination of Study by Sponsor|0|||
125087456|NCT02718625|449937058|FG001|Overall Study|Termination of Study by Sponsor|1|||
125087457|NCT01947127|449937063|FG000|Overall Study|Protocol Violation|18|||
125087458|NCT01947127|449937064|FG001|Overall Study|Protocol Violation|38|||
125087459|NCT01947127|449937063|FG000|Overall Study|Withdrawal by Subject|1|||
125087460|NCT01947127|449937064|FG001|Overall Study|Withdrawal by Subject|1|||
125087461|NCT01947127|449937063|FG000|Overall Study|Data loss|4|||
125087462|NCT01947127|449937064|FG001|Overall Study|Data loss|4|||
125087463|NCT01836549|449937065|FG000|Overall Study|Did not receive study drug|0|||
125087464|NCT01836549|449937066|FG001|Overall Study|Did not receive study drug|0|||
125087465|NCT01836549|449937067|FG002|Overall Study|Did not receive study drug|1|||
125087466|NCT01836549|449937068|FG003|Overall Study|Did not receive study drug|0|||
125087467|NCT01836549|449937069|FG004|Overall Study|Did not receive study drug|0|||
125087468|NCT01836549|449937070|FG005|Overall Study|Did not receive study drug|0|||
125087469|NCT01836549|449937071|FG006|Overall Study|Did not receive study drug|0|||
125087470|NCT01836549|449937065|FG000|Overall Study|Patient declared ineligible|0|||
125087471|NCT01836549|449937066|FG001|Overall Study|Patient declared ineligible|0|||
125087472|NCT01836549|449937067|FG002|Overall Study|Patient declared ineligible|0|||
125087473|NCT01836549|449937068|FG003|Overall Study|Patient declared ineligible|1|||
125087474|NCT01836549|449937069|FG004|Overall Study|Patient declared ineligible|0|||
125087475|NCT01836549|449937070|FG005|Overall Study|Patient declared ineligible|0|||
125087476|NCT01836549|449937071|FG006|Overall Study|Patient declared ineligible|0|||
125087477|NCT01836549|449937065|FG000|Overall Study|Patient inevaluable to start therapy|0|||
125087478|NCT01836549|449937066|FG001|Overall Study|Patient inevaluable to start therapy|0|||
125087479|NCT01836549|449937067|FG002|Overall Study|Patient inevaluable to start therapy|0|||
125087480|NCT01836549|449937068|FG003|Overall Study|Patient inevaluable to start therapy|0|||
125087481|NCT01836549|449937069|FG004|Overall Study|Patient inevaluable to start therapy|0|||
125087482|NCT01836549|449937070|FG005|Overall Study|Patient inevaluable to start therapy|0|||
125087483|NCT01836549|449937071|FG006|Overall Study|Patient inevaluable to start therapy|1|||
125087484|NCT02516306|449937072|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
125087485|NCT02516306|449937073|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
125087486|NCT00242710|449937077|FG000|Core Study (up to Year 1)|Adverse Event|30|||
125087487|NCT00242710|449937078|FG001|Core Study (up to Year 1)|Adverse Event|25|||
125087488|NCT00242710|449937079|FG002|Core Study (up to Year 1)|Adverse Event|23|||
125087489|NCT00242710|449937080|FG003|Core Study (up to Year 1)|Adverse Event|14|||
125087490|NCT00242710|449937077|FG000|Core Study (up to Year 1)|Death|0|||
125087491|NCT00242710|449937078|FG001|Core Study (up to Year 1)|Death|0|||
125087492|NCT00242710|449937079|FG002|Core Study (up to Year 1)|Death|1|||
125087493|NCT00242710|449937080|FG003|Core Study (up to Year 1)|Death|0|||
125087494|NCT00242710|449937077|FG000|Core Study (up to Year 1)|Physician Decision|0|||
125087495|NCT00242710|449937078|FG001|Core Study (up to Year 1)|Physician Decision|1|||
125087496|NCT00242710|449937079|FG002|Core Study (up to Year 1)|Physician Decision|0|||
125087497|NCT00242710|449937080|FG003|Core Study (up to Year 1)|Physician Decision|1|||
125087498|NCT00242710|449937077|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
125087499|NCT00242710|449937078|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
125087500|NCT00242710|449937079|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
125087501|NCT00242710|449937080|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
125087502|NCT00242710|449937077|FG000|Core Study (up to Year 1)|Other|6|||
125087503|NCT00242710|449937078|FG001|Core Study (up to Year 1)|Other|1|||
125087504|NCT00242710|449937079|FG002|Core Study (up to Year 1)|Other|0|||
125087505|NCT00242710|449937080|FG003|Core Study (up to Year 1)|Other|2|||
125087506|NCT00242710|449937077|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
125087507|NCT00242710|449937078|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
125087508|NCT00242710|449937079|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
125087509|NCT00242710|449937080|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
125087510|NCT00242710|449937077|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
125087511|NCT00242710|449937078|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
125087512|NCT00242710|449937079|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
125087513|NCT00242710|449937080|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
125087514|NCT00242710|449937077|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
125223559|NCT02326272|450446173|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125087515|NCT00242710|449937078|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
125087516|NCT00242710|449937079|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
125087517|NCT00242710|449937080|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
125087518|NCT00242710|449937077|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
125087519|NCT00242710|449937078|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
125087520|NCT00242710|449937079|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
125087521|NCT00242710|449937080|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
125087522|NCT00242710|449937077|FG000|Period Between Core Study and Extension|Adverse Event|2|||
125087523|NCT00242710|449937078|FG001|Period Between Core Study and Extension|Adverse Event|3|||
125087524|NCT00242710|449937079|FG002|Period Between Core Study and Extension|Adverse Event|5|||
125087525|NCT00242710|449937080|FG003|Period Between Core Study and Extension|Adverse Event|2|||
125087526|NCT00242710|449937077|FG000|Period Between Core Study and Extension|Physician Decision|1|||
125087527|NCT00242710|449937078|FG001|Period Between Core Study and Extension|Physician Decision|1|||
125087528|NCT00242710|449937079|FG002|Period Between Core Study and Extension|Physician Decision|0|||
125087529|NCT00242710|449937080|FG003|Period Between Core Study and Extension|Physician Decision|0|||
125087530|NCT00242710|449937077|FG000|Period Between Core Study and Extension|Other|24|||
125087531|NCT00242710|449937078|FG001|Period Between Core Study and Extension|Other|24|||
125087532|NCT00242710|449937079|FG002|Period Between Core Study and Extension|Other|9|||
125087533|NCT00242710|449937080|FG003|Period Between Core Study and Extension|Other|11|||
125087534|NCT00242710|449937077|FG000|Period Between Core Study and Extension|Extension not Available|17|||
125087535|NCT00242710|449937078|FG001|Period Between Core Study and Extension|Extension not Available|21|||
125087536|NCT00242710|449937079|FG002|Period Between Core Study and Extension|Extension not Available|8|||
125087537|NCT00242710|449937080|FG003|Period Between Core Study and Extension|Extension not Available|7|||
125087538|NCT00242710|449937077|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
125087539|NCT00242710|449937078|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
125087540|NCT00242710|449937079|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
125087541|NCT00242710|449937080|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
125087542|NCT00242710|449937077|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
125087543|NCT00242710|449937078|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
125087544|NCT00242710|449937079|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
125087545|NCT00242710|449937080|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
125087546|NCT00242710|449937077|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
125087547|NCT00242710|449937078|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
125087548|NCT00242710|449937079|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
125087549|NCT00242710|449937080|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
125087550|NCT00242710|449937077|FG000|Study Extension (up to Year 2)|Death|0|||
125087551|NCT00242710|449937078|FG001|Study Extension (up to Year 2)|Death|0|||
125087552|NCT00242710|449937079|FG002|Study Extension (up to Year 2)|Death|0|||
125087553|NCT00242710|449937080|FG003|Study Extension (up to Year 2)|Death|1|||
125087554|NCT00242710|449937077|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
125087555|NCT00242710|449937078|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
125087556|NCT00242710|449937079|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
125087557|NCT00242710|449937080|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
125087558|NCT00242710|449937077|FG000|Study Extension (up to Year 2)|Other|3|||
125087559|NCT00242710|449937078|FG001|Study Extension (up to Year 2)|Other|5|||
125087560|NCT00242710|449937079|FG002|Study Extension (up to Year 2)|Other|4|||
125087561|NCT00242710|449937080|FG003|Study Extension (up to Year 2)|Other|3|||
125087562|NCT00242710|449937077|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
125087563|NCT00242710|449937078|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
125087564|NCT00242710|449937079|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
125087565|NCT00242710|449937080|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
125087566|NCT00242710|449937077|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
125087567|NCT00242710|449937078|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
125087568|NCT00242710|449937079|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
125087569|NCT00242710|449937080|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
125087570|NCT00579527|449937081|FG000|Overall Study|Death|4|||
125087571|NCT03961529|449937082|FG000|Overall Study|Adverse Event|13|||
125087572|NCT03961529|449937083|FG001|Overall Study|Adverse Event|5|||
125087573|NCT03961529|449937084|FG002|Overall Study|Adverse Event|2|||
125087574|NCT03961529|449937082|FG000|Overall Study|Withdrawal by Subject|17|||
125087575|NCT03961529|449937083|FG001|Overall Study|Withdrawal by Subject|2|||
125087576|NCT03961529|449937084|FG002|Overall Study|Withdrawal by Subject|1|||
125087577|NCT03961529|449937082|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125087578|NCT03961529|449937083|FG001|Overall Study|Withdrawal by parent/guardian|7|||
125087579|NCT03961529|449937084|FG002|Overall Study|Withdrawal by parent/guardian|0|||
125087580|NCT03961529|449937082|FG000|Overall Study|Physician Decision|2|||
125087581|NCT03961529|449937083|FG001|Overall Study|Physician Decision|1|||
125087582|NCT03961529|449937084|FG002|Overall Study|Physician Decision|1|||
125087583|NCT03961529|449937082|FG000|Overall Study|Lost to Follow-up|2|||
125145589|NCT01214239|450156080|FG001|Overall Study|Lack of Efficacy|2|||
125145590|NCT01214239|450156079|FG000|Overall Study|patient's private reason|1|||
125145591|NCT01214239|450156080|FG001|Overall Study|patient's private reason|1|||
125145592|NCT01049581|450156081|FG000|Overall Study|Lost to Follow-up|2|||
125145593|NCT01049581|450156082|FG001|Overall Study|Lost to Follow-up|1|||
125145594|NCT05068284|450156093|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
125145595|NCT05068284|450156094|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
125145596|NCT05068284|450156095|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
125145597|NCT05068284|450156096|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
125145598|NCT05068284|450156097|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
125145599|NCT05068284|450156098|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
125145600|NCT05068284|450156099|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
125145601|NCT05068284|450156100|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
125145602|NCT05068284|450156093|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
125145603|NCT05068284|450156094|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
125145604|NCT05068284|450156095|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
125145605|NCT05068284|450156096|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
125145606|NCT05068284|450156097|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
125145607|NCT05068284|450156098|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
125145608|NCT05068284|450156099|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
125145609|NCT05068284|450156100|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
125145610|NCT05068284|450156093|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
125145611|NCT05068284|450156094|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
125145612|NCT05068284|450156095|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
125145613|NCT05068284|450156096|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
125145614|NCT05068284|450156097|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
125145615|NCT05068284|450156098|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
125145616|NCT05068284|450156099|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
125145617|NCT05068284|450156100|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
125145618|NCT05068284|450156093|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
125145619|NCT05068284|450156094|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
125145620|NCT05068284|450156095|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
125145621|NCT05068284|450156096|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
125145622|NCT05068284|450156097|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
125145623|NCT05068284|450156098|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
125145624|NCT05068284|450156099|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
125145625|NCT05068284|450156100|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
125145626|NCT05068284|450156093|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
125145627|NCT05068284|450156094|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
125145628|NCT05068284|450156095|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
125145629|NCT05068284|450156096|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
125145630|NCT05068284|450156097|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
125145631|NCT05068284|450156098|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
125145632|NCT05068284|450156099|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
125145633|NCT05068284|450156100|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
125145634|NCT05068284|450156093|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
125145635|NCT05068284|450156094|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
125145636|NCT05068284|450156095|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
125145637|NCT05068284|450156096|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
125145638|NCT05068284|450156097|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
125145639|NCT05068284|450156098|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
125145640|NCT05068284|450156099|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
125145641|NCT05068284|450156100|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
125145642|NCT05068284|450156093|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
125145643|NCT05068284|450156094|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
125145644|NCT05068284|450156095|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
125145645|NCT05068284|450156096|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
125145646|NCT05068284|450156097|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
125145647|NCT05068284|450156098|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
125145648|NCT05068284|450156099|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
125145649|NCT05068284|450156100|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
125145650|NCT05068284|450156093|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
125145651|NCT05068284|450156094|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
125145652|NCT05068284|450156095|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
125145653|NCT05068284|450156096|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
125087584|NCT03961529|449937083|FG001|Overall Study|Lost to Follow-up|1|||
125087585|NCT03961529|449937084|FG002|Overall Study|Lost to Follow-up|0|||
125087586|NCT03961529|449937082|FG000|Overall Study|Lack of Efficacy|2|||
125087587|NCT03961529|449937083|FG001|Overall Study|Lack of Efficacy|0|||
125087588|NCT03961529|449937084|FG002|Overall Study|Lack of Efficacy|1|||
125087589|NCT03961529|449937082|FG000|Overall Study|Other|6|||
125087590|NCT03961529|449937083|FG001|Overall Study|Other|1|||
125087591|NCT03961529|449937084|FG002|Overall Study|Other|0|||
125087592|NCT03644173|449937087|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
125087593|NCT03644173|449937087|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
125087594|NCT03644173|449937087|FG000|Participants at the 1-month Follow up|Death|2|||
125087595|NCT03644173|449937087|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
125087596|NCT00381706|449937088|FG000|Overall Study|Never treated|7|||
125087597|NCT00381706|449937089|FG001|Overall Study|Never treated|2|||
125087598|NCT00381706|449937090|FG002|Overall Study|Never treated|1|||
125087599|NCT04554394|449937091|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
125087600|NCT04554394|449937092|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
125087601|NCT04554394|449937091|FG000|Overall Study|Withdrawal by Subject|2|||
125087602|NCT04554394|449937092|FG001|Overall Study|Withdrawal by Subject|2|||
125087603|NCT04554394|449937091|FG000|Overall Study|Lost to Follow-up|2|||
125087604|NCT04554394|449937092|FG001|Overall Study|Lost to Follow-up|2|||
125087605|NCT04554394|449937091|FG000|Overall Study|Physician Decision|1|||
125087606|NCT04554394|449937092|FG001|Overall Study|Physician Decision|1|||
125087607|NCT00886587|449937096|FG000|Overall Study|Adverse Event|2|||
125087608|NCT00886587|449937097|FG001|Overall Study|Adverse Event|1|||
125087609|NCT00886587|449937096|FG000|Overall Study|Protocol Violation|2|||
125087610|NCT00886587|449937097|FG001|Overall Study|Protocol Violation|0|||
125087611|NCT00886587|449937096|FG000|Overall Study|Withdrawal by Subject|0|||
125087612|NCT00886587|449937097|FG001|Overall Study|Withdrawal by Subject|1|||
125087613|NCT03490734|449937098|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
125087614|NCT03490734|449937099|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
125087615|NCT03490734|449937100|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
125087616|NCT03490734|449937101|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
125087617|NCT03490734|449937098|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
125087618|NCT03490734|449937099|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
125087619|NCT03490734|449937100|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
125087620|NCT03490734|449937101|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
125087621|NCT03490734|449937098|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
125087622|NCT03490734|449937099|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
125087623|NCT03490734|449937100|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
125087624|NCT03490734|449937101|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
125087625|NCT03490734|449937098|FG000|Post-intervention Scan Visit|Adverse Event|2|||
125087626|NCT03490734|449937099|FG001|Post-intervention Scan Visit|Adverse Event|0|||
125087627|NCT03490734|449937100|FG002|Post-intervention Scan Visit|Adverse Event|0|||
125087628|NCT03490734|449937101|FG003|Post-intervention Scan Visit|Adverse Event|0|||
125087629|NCT03490734|449937098|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
125087630|NCT03490734|449937099|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
125087631|NCT03490734|449937100|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
125087632|NCT03490734|449937101|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
125087633|NCT03490734|449937098|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
125087634|NCT03490734|449937099|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
125087635|NCT03490734|449937100|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
125087636|NCT03490734|449937101|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
125087637|NCT00374452|449937105|FG000|Overall Study|Left clinic before intervention started|4|||
125087638|NCT00374452|449937106|FG001|Overall Study|Left clinic before intervention started|1|||
125087639|NCT00374452|449937105|FG000|Overall Study|Change in job role before intervention|0|||
125087640|NCT00374452|449937106|FG001|Overall Study|Change in job role before intervention|1|||
125087641|NCT00374452|449937105|FG000|Overall Study|Left clinic after intervention started|1|||
125087642|NCT00374452|449937106|FG001|Overall Study|Left clinic after intervention started|1|||
125087643|NCT00374452|449937105|FG000|Overall Study|Withdrawal by Subject|0|||
125087644|NCT00374452|449937106|FG001|Overall Study|Withdrawal by Subject|2|||
125087645|NCT00523744|449937107|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
125087646|NCT00523744|449937107|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
125087647|NCT00523744|449937107|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
125087648|NCT00523744|449937107|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
125087649|NCT00523744|449937107|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
125087650|NCT00523744|449937107|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
125087651|NCT03099304|449937110|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
125087652|NCT03099304|449937111|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
125087653|NCT03099304|449937112|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
125087654|NCT03099304|449937113|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
125087655|NCT03099304|449937114|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
125087656|NCT03099304|449937115|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
125087657|NCT03099304|449937110|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
125087658|NCT03099304|449937111|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
125087659|NCT03099304|449937112|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
125087660|NCT03099304|449937113|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
125087661|NCT03099304|449937114|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
125087662|NCT03099304|449937115|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
125087663|NCT03099304|449937110|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
125087664|NCT03099304|449937111|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
125087665|NCT03099304|449937112|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
125087666|NCT03099304|449937113|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
125087667|NCT03099304|449937114|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
125087668|NCT03099304|449937115|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
125087669|NCT03099304|449937110|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
125087670|NCT03099304|449937111|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
125087671|NCT03099304|449937112|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
125087672|NCT03099304|449937113|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
125087673|NCT03099304|449937114|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
125087674|NCT03099304|449937115|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
125087675|NCT03099304|449937110|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
125087676|NCT03099304|449937111|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
125087677|NCT03099304|449937112|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
125087678|NCT03099304|449937113|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
125087679|NCT03099304|449937114|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
125087680|NCT03099304|449937115|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
125087681|NCT03099304|449937110|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
125087682|NCT03099304|449937111|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
125087683|NCT03099304|449937112|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
125087684|NCT03099304|449937113|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
125087685|NCT03099304|449937114|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
125087686|NCT03099304|449937115|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
125087687|NCT03099304|449937110|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
125087688|NCT03099304|449937111|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
125087689|NCT03099304|449937112|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
125087690|NCT03099304|449937113|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
125087691|NCT03099304|449937114|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
125087692|NCT03099304|449937115|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
125087693|NCT03099304|449937110|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
125087694|NCT03099304|449937111|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
125087695|NCT03099304|449937112|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
125087696|NCT03099304|449937113|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
125087697|NCT03099304|449937114|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
125087698|NCT03099304|449937115|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
125087699|NCT03099304|449937110|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
125087700|NCT03099304|449937111|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
125087701|NCT03099304|449937112|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
125087702|NCT03099304|449937113|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
125087703|NCT03099304|449937114|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
125087704|NCT03099304|449937115|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
125087705|NCT03099304|449937110|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
125087706|NCT03099304|449937111|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
125087707|NCT03099304|449937112|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
125145654|NCT05068284|450156097|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
125145655|NCT05068284|450156098|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
125145656|NCT05068284|450156099|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
125145657|NCT05068284|450156100|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
125145658|NCT05068284|450156093|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
125145659|NCT05068284|450156094|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
125145660|NCT05068284|450156095|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
125087708|NCT03099304|449937113|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
125087709|NCT03099304|449937114|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
125087710|NCT03099304|449937115|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
125087711|NCT03099304|449937110|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
125087712|NCT03099304|449937111|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
125087713|NCT03099304|449937112|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
125087714|NCT03099304|449937113|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
125145661|NCT05068284|450156096|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
125223560|NCT02326272|450446174|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
125087715|NCT03099304|449937114|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
125087716|NCT03099304|449937115|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
125087717|NCT03099304|449937110|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
125087718|NCT03099304|449937111|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
125087719|NCT03099304|449937112|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
125087720|NCT03099304|449937113|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
125087721|NCT03099304|449937114|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
125087722|NCT03099304|449937115|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
125087723|NCT03099304|449937110|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
125087724|NCT03099304|449937111|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
125087725|NCT03099304|449937112|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
125087726|NCT03099304|449937113|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
125087727|NCT03099304|449937114|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
125087728|NCT03099304|449937115|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
125087729|NCT03099304|449937110|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
125087730|NCT03099304|449937111|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
125087731|NCT03099304|449937112|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
125087732|NCT03099304|449937113|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
125087733|NCT03099304|449937114|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
125087734|NCT03099304|449937115|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
125087735|NCT03099304|449937110|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
125087736|NCT03099304|449937111|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
125087737|NCT03099304|449937112|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
125087738|NCT03099304|449937113|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
125087739|NCT03099304|449937114|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
125087740|NCT03099304|449937115|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
125087741|NCT03099304|449937110|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
125087742|NCT03099304|449937111|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
125087743|NCT03099304|449937112|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
125087744|NCT03099304|449937113|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
125087745|NCT03099304|449937114|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
125087746|NCT03099304|449937115|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
125087747|NCT03099304|449937110|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
125087748|NCT03099304|449937111|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
125087749|NCT03099304|449937112|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
125087750|NCT03099304|449937113|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
125087751|NCT03099304|449937114|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
125087752|NCT03099304|449937115|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
125087753|NCT00715949|449937118|FG000|Overall Study|could not finish first test|4|||
125087754|NCT01024946|449937119|FG000|Overall Study|Screen Failure|3|||
125087755|NCT01024946|449937119|FG000|Overall Study|Withdrawal by Subject|1|||
125087756|NCT01024946|449937119|FG000|Overall Study|Adverse Event|1|||
125087757|NCT05375838|449937120|FG000|Overall Study|Other|0|||
125087758|NCT05375838|449937121|FG001|Overall Study|Other|0|||
125087759|NCT05375838|449937122|FG002|Overall Study|Other|0|||
125087760|NCT05375838|449937123|FG003|Overall Study|Other|1|||
125087761|NCT05375838|449937124|FG004|Overall Study|Other|1|||
125087762|NCT05375838|449937125|FG005|Overall Study|Other|0|||
125087763|NCT05375838|449937120|FG000|Overall Study|Withdrawal by Subject|2|||
125087764|NCT05375838|449937121|FG001|Overall Study|Withdrawal by Subject|1|||
125087765|NCT05375838|449937122|FG002|Overall Study|Withdrawal by Subject|3|||
125087766|NCT05375838|449937123|FG003|Overall Study|Withdrawal by Subject|2|||
125087767|NCT05375838|449937124|FG004|Overall Study|Withdrawal by Subject|2|||
125087768|NCT05375838|449937125|FG005|Overall Study|Withdrawal by Subject|0|||
125087769|NCT05375838|449937120|FG000|Overall Study|Protocol Violation|0|||
125087770|NCT05375838|449937121|FG001|Overall Study|Protocol Violation|0|||
125087771|NCT05375838|449937122|FG002|Overall Study|Protocol Violation|0|||
125087772|NCT05375838|449937123|FG003|Overall Study|Protocol Violation|0|||
125087773|NCT05375838|449937124|FG004|Overall Study|Protocol Violation|1|||
125087774|NCT05375838|449937125|FG005|Overall Study|Protocol Violation|0|||
125087775|NCT05375838|449937120|FG000|Overall Study|Physician Decision|0|||
125087776|NCT05375838|449937121|FG001|Overall Study|Physician Decision|1|||
125087777|NCT05375838|449937122|FG002|Overall Study|Physician Decision|0|||
125087778|NCT05375838|449937123|FG003|Overall Study|Physician Decision|0|||
125087779|NCT05375838|449937124|FG004|Overall Study|Physician Decision|0|||
125087780|NCT05375838|449937125|FG005|Overall Study|Physician Decision|1|||
125223561|NCT02326272|450446175|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
125223562|NCT02326272|450446176|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
125223563|NCT02326272|450446177|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125087781|NCT05375838|449937120|FG000|Overall Study|Lost to Follow-up|2|||
125087782|NCT05375838|449937121|FG001|Overall Study|Lost to Follow-up|7|||
125087783|NCT05375838|449937122|FG002|Overall Study|Lost to Follow-up|0|||
125145662|NCT05068284|450156097|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
125145663|NCT05068284|450156098|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
125145664|NCT05068284|450156099|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
125145665|NCT05068284|450156100|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
125145666|NCT05068284|450156093|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
125145667|NCT05068284|450156094|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
125145668|NCT05068284|450156095|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
125145669|NCT05068284|450156096|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
125145670|NCT05068284|450156097|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
125145671|NCT05068284|450156098|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
125145672|NCT05068284|450156099|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
125145673|NCT05068284|450156100|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
125145674|NCT05068284|450156093|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
125145675|NCT05068284|450156094|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
125145676|NCT05068284|450156095|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
125145677|NCT05068284|450156096|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
125145678|NCT05068284|450156097|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
125145679|NCT05068284|450156098|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
125145680|NCT05068284|450156099|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
125145681|NCT05068284|450156100|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
125145682|NCT05068284|450156093|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
125145683|NCT05068284|450156094|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
125145684|NCT05068284|450156095|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
125145685|NCT05068284|450156096|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
125145686|NCT05068284|450156097|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
125145687|NCT05068284|450156098|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
125145688|NCT05068284|450156099|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
125145689|NCT05068284|450156100|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
125145690|NCT05068284|450156093|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
125145691|NCT05068284|450156094|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
125145692|NCT05068284|450156095|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
125145693|NCT05068284|450156096|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
125145694|NCT05068284|450156097|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
125145695|NCT05068284|450156098|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
125145696|NCT05068284|450156099|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
125145697|NCT05068284|450156100|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
125145698|NCT05068284|450156093|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
125145699|NCT05068284|450156094|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
125145700|NCT05068284|450156095|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
125145701|NCT05068284|450156096|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
125145702|NCT05068284|450156097|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
125145703|NCT05068284|450156098|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
125145704|NCT05068284|450156099|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
125145705|NCT05068284|450156100|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
125145706|NCT00965731|450156101|FG000|Overall Study|Death|0|||
125145707|NCT00965731|450156102|FG001|Overall Study|Death|4|||
125145708|NCT00965731|450156101|FG000|Overall Study|Withdrawal by Subject|0|||
125145709|NCT00965731|450156102|FG001|Overall Study|Withdrawal by Subject|1|||
125145710|NCT00965731|450156101|FG000|Overall Study|Other|7|||
125145711|NCT00965731|450156102|FG001|Overall Study|Other|15|||
125145712|NCT05135273|450158008|FG000|Overall Study|Recruited into the army|0|||
125145713|NCT05135273|450158009|FG001|Overall Study|Recruited into the army|0|||
125145714|NCT05135273|450158010|FG002|Overall Study|Recruited into the army|0|||
125145715|NCT05135273|450158011|FG003|Overall Study|Recruited into the army|0|||
125145716|NCT05135273|450158012|FG004|Overall Study|Recruited into the army|1|||
125145717|NCT05135273|450158013|FG005|Overall Study|Recruited into the army|0|||
125087784|NCT05375838|449937123|FG003|Overall Study|Lost to Follow-up|4|||
125087785|NCT05375838|449937124|FG004|Overall Study|Lost to Follow-up|2|||
125087786|NCT05375838|449937125|FG005|Overall Study|Lost to Follow-up|3|||
125087787|NCT02993783|449937134|FG000|Overall Study|Reason not Specified|6|||
125087788|NCT02993783|449937135|FG001|Overall Study|Reason not Specified|9|||
125087789|NCT03049852|449937141|FG000|Overall Study|Lost to Follow-up|0|||
125087790|NCT03049852|449937142|FG001|Overall Study|Lost to Follow-up|1|||
125087791|NCT03049852|449937143|FG002|Overall Study|Lost to Follow-up|0|||
125087792|NCT02067104|449937144|FG000|Overall Study|Study termination due to low accrual|4|||
125087793|NCT02067104|449937145|FG001|Overall Study|Study termination due to low accrual|5|||
125087794|NCT00554840|449937159|FG000|Overall Study|Physician Decision|0|||
125087795|NCT00554840|449937160|FG001|Overall Study|Physician Decision|1|||
125087796|NCT01385098|449937161|FG000|Overall Study|Adverse Event|10|||
125087797|NCT01385098|449937161|FG000|Overall Study|Lost to Follow-up|4|||
125087798|NCT00925522|449937162|FG000|Overall Study|study closed -- business decision|20|||
125087799|NCT00410514|449937163|FG000|Overall Study|Adverse Event|2|||
125087800|NCT00410514|449937164|FG001|Overall Study|Adverse Event|2|||
125087801|NCT00410514|449937165|FG002|Overall Study|Adverse Event|2|||
125087802|NCT00410514|449937163|FG000|Overall Study|Protocol Violation|0|||
125087803|NCT00410514|449937164|FG001|Overall Study|Protocol Violation|1|||
125087804|NCT00410514|449937165|FG002|Overall Study|Protocol Violation|1|||
125087805|NCT00410514|449937163|FG000|Overall Study|Lost to Follow-up|0|||
125087806|NCT00410514|449937164|FG001|Overall Study|Lost to Follow-up|0|||
125087807|NCT00410514|449937165|FG002|Overall Study|Lost to Follow-up|2|||
125087808|NCT00410514|449937163|FG000|Overall Study|Non-compliant with study procedures|0|||
125087809|NCT00410514|449937164|FG001|Overall Study|Non-compliant with study procedures|0|||
125087810|NCT00410514|449937165|FG002|Overall Study|Non-compliant with study procedures|2|||
125087811|NCT00656799|449937167|FG000|Overall Study|Death|2|||
125145718|NCT05135273|450158014|FG006|Overall Study|Recruited into the army|0|||
125145719|NCT05135273|450158015|FG007|Overall Study|Recruited into the army|0|||
125145720|NCT05135273|450158008|FG000|Overall Study|Moved away from study site|0|||
125145721|NCT05135273|450158009|FG001|Overall Study|Moved away from study site|0|||
125145722|NCT05135273|450158010|FG002|Overall Study|Moved away from study site|0|||
125145723|NCT05135273|450158011|FG003|Overall Study|Moved away from study site|0|||
125145724|NCT05135273|450158012|FG004|Overall Study|Moved away from study site|0|||
125145725|NCT05135273|450158013|FG005|Overall Study|Moved away from study site|1|||
125145726|NCT05135273|450158014|FG006|Overall Study|Moved away from study site|1|||
125145727|NCT05135273|450158015|FG007|Overall Study|Moved away from study site|0|||
125145728|NCT05135273|450158008|FG000|Overall Study|Travel|0|||
125145729|NCT05135273|450158009|FG001|Overall Study|Travel|0|||
125145730|NCT05135273|450158010|FG002|Overall Study|Travel|0|||
125145731|NCT05135273|450158011|FG003|Overall Study|Travel|0|||
125145732|NCT05135273|450158012|FG004|Overall Study|Travel|0|||
125145733|NCT05135273|450158013|FG005|Overall Study|Travel|0|||
125145734|NCT05135273|450158014|FG006|Overall Study|Travel|0|||
125145735|NCT05135273|450158015|FG007|Overall Study|Travel|1|||
125145736|NCT04129944|450158017|FG000|Overall Study|Death|0|||
125145737|NCT04129944|450158018|FG001|Overall Study|Death|0|||
125145738|NCT04129944|450158019|FG002|Overall Study|Death|0|||
125145739|NCT04129944|450158020|FG003|Overall Study|Death|1|||
125145740|NCT04129944|450158017|FG000|Overall Study|Lost to Follow-up|1|||
125145741|NCT04129944|450158018|FG001|Overall Study|Lost to Follow-up|0|||
125145742|NCT04129944|450158019|FG002|Overall Study|Lost to Follow-up|0|||
125145743|NCT04129944|450158020|FG003|Overall Study|Lost to Follow-up|0|||
125145744|NCT04129944|450158017|FG000|Overall Study|Withdrawal by Subject|1|||
125145745|NCT04129944|450158018|FG001|Overall Study|Withdrawal by Subject|0|||
125145746|NCT04129944|450158019|FG002|Overall Study|Withdrawal by Subject|1|||
125145747|NCT04129944|450158020|FG003|Overall Study|Withdrawal by Subject|2|||
125145748|NCT00493792|450158021|FG000|Overall Study|Death|55|||
125145749|NCT00493792|450158022|FG001|Overall Study|Death|50|||
125145750|NCT00493792|450158021|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
125145751|NCT00493792|450158022|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
125145752|NCT00685035|450158023|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
125223564|NCT02326272|450446178|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
125145753|NCT00685035|450158024|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
125145754|NCT04241133|450158025|FG000|Overall Study|COVID19 Precautions|14|||
125145755|NCT04241133|450158026|FG001|Overall Study|COVID19 Precautions|34|||
125145756|NCT02104817|450158027|FG000|Overall Study|Death|363|||
125145757|NCT02104817|450158028|FG001|Overall Study|Death|330|||
125145758|NCT02104817|450158027|FG000|Overall Study|Lost to Follow-up|3|||
125145759|NCT02104817|450158028|FG001|Overall Study|Lost to Follow-up|2|||
125145760|NCT02104817|450158027|FG000|Overall Study|Protocol Violation|0|||
125145761|NCT02104817|450158028|FG001|Overall Study|Protocol Violation|1|||
125145762|NCT02104817|450158027|FG000|Overall Study|Study terminated by sponsor|5854|||
125145763|NCT02104817|450158028|FG001|Overall Study|Study terminated by sponsor|5901|||
125145764|NCT02104817|450158027|FG000|Overall Study|Withdrawal by Subject|111|||
125145765|NCT02104817|450158028|FG001|Overall Study|Withdrawal by Subject|78|||
125145766|NCT02104817|450158027|FG000|Overall Study|Other reasons|128|||
125145767|NCT02104817|450158028|FG001|Overall Study|Other reasons|135|||
125145768|NCT00611884|450158033|FG000|Overall Study|Adverse Event|1|||
125145769|NCT00611884|450158034|FG001|Overall Study|Adverse Event|0|||
125145770|NCT00611884|450158035|FG002|Overall Study|Adverse Event|0|||
125145771|NCT00611884|450158036|FG003|Overall Study|Adverse Event|1|||
125145772|NCT00611884|450158033|FG000|Overall Study|Non-Compliance|1|||
125145773|NCT00611884|450158034|FG001|Overall Study|Non-Compliance|4|||
125145774|NCT00611884|450158035|FG002|Overall Study|Non-Compliance|2|||
125145775|NCT00611884|450158036|FG003|Overall Study|Non-Compliance|2|||
125145776|NCT00611884|450158033|FG000|Overall Study|Lack of Efficacy|0|||
125145777|NCT00611884|450158034|FG001|Overall Study|Lack of Efficacy|1|||
125145778|NCT00611884|450158035|FG002|Overall Study|Lack of Efficacy|0|||
125145779|NCT00611884|450158036|FG003|Overall Study|Lack of Efficacy|0|||
125145780|NCT00611884|450158033|FG000|Overall Study|Unclassified|7|||
125145781|NCT00611884|450158034|FG001|Overall Study|Unclassified|4|||
125145782|NCT00611884|450158035|FG002|Overall Study|Unclassified|2|||
125145783|NCT00611884|450158036|FG003|Overall Study|Unclassified|3|||
125145784|NCT00981799|450158037|FG000|Overall Study|Adverse Event|1|||
125145785|NCT00981799|450158038|FG001|Overall Study|Adverse Event|1|||
125145786|NCT00981799|450158039|FG002|Overall Study|Adverse Event|0|||
125145787|NCT00981799|450158040|FG003|Overall Study|Adverse Event|0|||
125145788|NCT00348816|450158041|FG000|Overall Study|Noncompliance with radiation treatment|1|||
125145789|NCT00687739|450158042|FG000|Overall Study|Lost to Follow-up|2|||
125145790|NCT00687739|450158043|FG001|Overall Study|Lost to Follow-up|2|||
125145791|NCT00687739|450158044|FG002|Overall Study|Lost to Follow-up|1|||
125145792|NCT00687739|450158045|FG003|Overall Study|Lost to Follow-up|2|||
125145793|NCT00687739|450158042|FG000|Overall Study|Adverse Event|0|||
125145794|NCT00687739|450158043|FG001|Overall Study|Adverse Event|1|||
125145795|NCT00687739|450158044|FG002|Overall Study|Adverse Event|1|||
125145796|NCT00687739|450158045|FG003|Overall Study|Adverse Event|0|||
125145797|NCT01190930|450158046|FG000|Induction|Adverse Event|17|||
125145798|NCT01190930|450158047|FG001|Induction|Adverse Event|0|||
125145799|NCT01190930|450158048|FG002|Induction|Adverse Event|0|||
125145800|NCT01190930|450158049|FG003|Induction|Adverse Event|0|||
125145801|NCT01190930|450158050|FG004|Induction|Adverse Event|0|||
125145802|NCT01190930|450158051|FG005|Induction|Adverse Event|0|||
125145803|NCT01190930|450158052|FG006|Induction|Adverse Event|0|||
125145804|NCT01190930|450158053|FG007|Induction|Adverse Event|0|||
125145805|NCT01190930|450158054|FG008|Induction|Adverse Event|0|||
125145806|NCT01190930|450158055|FG009|Induction|Adverse Event|0|||
125145807|NCT01190930|450158046|FG000|Induction|Death|34|||
125145808|NCT01190930|450158047|FG001|Induction|Death|0|||
125145809|NCT01190930|450158048|FG002|Induction|Death|0|||
125145810|NCT01190930|450158049|FG003|Induction|Death|0|||
125145811|NCT01190930|450158050|FG004|Induction|Death|0|||
125145812|NCT01190930|450158051|FG005|Induction|Death|0|||
125145813|NCT01190930|450158052|FG006|Induction|Death|0|||
125145814|NCT01190930|450158053|FG007|Induction|Death|0|||
125145815|NCT01190930|450158054|FG008|Induction|Death|0|||
125145816|NCT01190930|450158055|FG009|Induction|Death|0|||
125145817|NCT01190930|450158046|FG000|Induction|Lost to Follow-up|1|||
125145818|NCT01190930|450158047|FG001|Induction|Lost to Follow-up|0|||
125145819|NCT01190930|450158048|FG002|Induction|Lost to Follow-up|0|||
125145820|NCT01190930|450158049|FG003|Induction|Lost to Follow-up|0|||
125145821|NCT01190930|450158050|FG004|Induction|Lost to Follow-up|0|||
125145822|NCT01190930|450158051|FG005|Induction|Lost to Follow-up|0|||
125145823|NCT01190930|450158052|FG006|Induction|Lost to Follow-up|0|||
125145824|NCT01190930|450158053|FG007|Induction|Lost to Follow-up|0|||
125145825|NCT01190930|450158054|FG008|Induction|Lost to Follow-up|0|||
125145826|NCT01190930|450158055|FG009|Induction|Lost to Follow-up|0|||
125145827|NCT01190930|450158046|FG000|Induction|Physician Decision|125|||
125145828|NCT01190930|450158047|FG001|Induction|Physician Decision|3|||
125223565|NCT02326272|450446164|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125223566|NCT02326272|450446165|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125223567|NCT02326272|450446166|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125223568|NCT02326272|450446167|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125223569|NCT02326272|450446168|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125223570|NCT02326272|450446169|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125223571|NCT02326272|450446170|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125223572|NCT02326272|450446171|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125145829|NCT01190930|450158048|FG002|Induction|Physician Decision|0|||
125145830|NCT01190930|450158049|FG003|Induction|Physician Decision|0|||
125145831|NCT01190930|450158050|FG004|Induction|Physician Decision|0|||
125145832|NCT01190930|450158051|FG005|Induction|Physician Decision|0|||
125145833|NCT01190930|450158052|FG006|Induction|Physician Decision|0|||
125145834|NCT01190930|450158053|FG007|Induction|Physician Decision|0|||
125145835|NCT01190930|450158054|FG008|Induction|Physician Decision|0|||
125145836|NCT01190930|450158055|FG009|Induction|Physician Decision|0|||
125145837|NCT01190930|450158046|FG000|Induction|Withdrawal by Subject|9|||
125145838|NCT01190930|450158047|FG001|Induction|Withdrawal by Subject|0|||
125145839|NCT01190930|450158048|FG002|Induction|Withdrawal by Subject|0|||
125145840|NCT01190930|450158049|FG003|Induction|Withdrawal by Subject|0|||
125145841|NCT01190930|450158050|FG004|Induction|Withdrawal by Subject|0|||
125145842|NCT01190930|450158051|FG005|Induction|Withdrawal by Subject|0|||
125145843|NCT01190930|450158052|FG006|Induction|Withdrawal by Subject|0|||
125145844|NCT01190930|450158053|FG007|Induction|Withdrawal by Subject|0|||
125145845|NCT01190930|450158054|FG008|Induction|Withdrawal by Subject|0|||
125145846|NCT01190930|450158055|FG009|Induction|Withdrawal by Subject|0|||
125145847|NCT01190930|450158046|FG000|Induction|Refusal|235|||
125223573|NCT02326272|450446172|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125223574|NCT02326272|450446173|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125145848|NCT01190930|450158047|FG001|Induction|Refusal|0|||
125145849|NCT01190930|450158048|FG002|Induction|Refusal|0|||
125145850|NCT01190930|450158049|FG003|Induction|Refusal|0|||
125145851|NCT01190930|450158050|FG004|Induction|Refusal|0|||
125145852|NCT01190930|450158051|FG005|Induction|Refusal|0|||
125145853|NCT01190930|450158052|FG006|Induction|Refusal|0|||
125145854|NCT01190930|450158053|FG007|Induction|Refusal|0|||
125145855|NCT01190930|450158054|FG008|Induction|Refusal|0|||
125145856|NCT01190930|450158055|FG009|Induction|Refusal|0|||
125145857|NCT01190930|450158046|FG000|Induction|Inevaluable|23|||
125145858|NCT01190930|450158047|FG001|Induction|Inevaluable|1|||
125145859|NCT01190930|450158048|FG002|Induction|Inevaluable|0|||
125145860|NCT01190930|450158049|FG003|Induction|Inevaluable|0|||
125145861|NCT01190930|450158050|FG004|Induction|Inevaluable|0|||
125145862|NCT01190930|450158051|FG005|Induction|Inevaluable|0|||
125145863|NCT01190930|450158052|FG006|Induction|Inevaluable|0|||
125145864|NCT01190930|450158053|FG007|Induction|Inevaluable|0|||
125145865|NCT01190930|450158054|FG008|Induction|Inevaluable|0|||
125145866|NCT01190930|450158055|FG009|Induction|Inevaluable|0|||
125145867|NCT01190930|450158046|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
125145868|NCT01190930|450158047|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
125145869|NCT01190930|450158048|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
125145870|NCT01190930|450158049|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
125145871|NCT01190930|450158050|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
125145872|NCT01190930|450158051|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
125145873|NCT01190930|450158052|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
125145874|NCT01190930|450158053|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
125145875|NCT01190930|450158054|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
125145876|NCT01190930|450158055|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
125145877|NCT01190930|450158046|FG000|Induction|High Risk Downs|80|||
125145878|NCT01190930|450158047|FG001|Induction|High Risk Downs|0|||
125145879|NCT01190930|450158048|FG002|Induction|High Risk Downs|0|||
125145880|NCT01190930|450158049|FG003|Induction|High Risk Downs|0|||
125145881|NCT01190930|450158050|FG004|Induction|High Risk Downs|0|||
125145882|NCT01190930|450158051|FG005|Induction|High Risk Downs|0|||
125145883|NCT01190930|450158052|FG006|Induction|High Risk Downs|0|||
125145884|NCT01190930|450158053|FG007|Induction|High Risk Downs|0|||
125145885|NCT01190930|450158054|FG008|Induction|High Risk Downs|0|||
125145886|NCT01190930|450158055|FG009|Induction|High Risk Downs|0|||
125145887|NCT01190930|450158046|FG000|Induction|Enrollment onto another COG Protocol|1|||
125145888|NCT01190930|450158047|FG001|Induction|Enrollment onto another COG Protocol|0|||
125145889|NCT01190930|450158048|FG002|Induction|Enrollment onto another COG Protocol|0|||
125145890|NCT01190930|450158049|FG003|Induction|Enrollment onto another COG Protocol|0|||
125145891|NCT01190930|450158050|FG004|Induction|Enrollment onto another COG Protocol|0|||
125145892|NCT01190930|450158051|FG005|Induction|Enrollment onto another COG Protocol|0|||
125145893|NCT01190930|450158052|FG006|Induction|Enrollment onto another COG Protocol|0|||
125145894|NCT01190930|450158053|FG007|Induction|Enrollment onto another COG Protocol|0|||
125145895|NCT01190930|450158054|FG008|Induction|Enrollment onto another COG Protocol|0|||
125145896|NCT01190930|450158055|FG009|Induction|Enrollment onto another COG Protocol|0|||
125145897|NCT01190930|450158046|FG000|Induction|Average Risk|1847|||
125145898|NCT01190930|450158047|FG001|Induction|Average Risk|0|||
125145899|NCT01190930|450158048|FG002|Induction|Average Risk|0|||
125145900|NCT01190930|450158049|FG003|Induction|Average Risk|0|||
125145901|NCT01190930|450158050|FG004|Induction|Average Risk|0|||
125145902|NCT01190930|450158051|FG005|Induction|Average Risk|0|||
125145903|NCT01190930|450158052|FG006|Induction|Average Risk|0|||
125145904|NCT01190930|450158053|FG007|Induction|Average Risk|0|||
125145905|NCT01190930|450158054|FG008|Induction|Average Risk|0|||
125145906|NCT01190930|450158055|FG009|Induction|Average Risk|0|||
125145907|NCT01190930|450158046|FG000|Induction|High Risk|1227|||
125145908|NCT01190930|450158047|FG001|Induction|High Risk|0|||
125145909|NCT01190930|450158048|FG002|Induction|High Risk|0|||
125145910|NCT01190930|450158049|FG003|Induction|High Risk|0|||
125145911|NCT01190930|450158050|FG004|Induction|High Risk|0|||
125145912|NCT01190930|450158051|FG005|Induction|High Risk|0|||
125145913|NCT01190930|450158052|FG006|Induction|High Risk|0|||
125145914|NCT01190930|450158053|FG007|Induction|High Risk|0|||
125145915|NCT01190930|450158054|FG008|Induction|High Risk|0|||
125145916|NCT01190930|450158055|FG009|Induction|High Risk|0|||
125145917|NCT01190930|450158046|FG000|Induction|Low Risk|443|||
125145918|NCT01190930|450158047|FG001|Induction|Low Risk|0|||
125145919|NCT01190930|450158048|FG002|Induction|Low Risk|0|||
125145920|NCT01190930|450158049|FG003|Induction|Low Risk|0|||
125145921|NCT01190930|450158050|FG004|Induction|Low Risk|0|||
125145922|NCT01190930|450158051|FG005|Induction|Low Risk|0|||
125145923|NCT01190930|450158052|FG006|Induction|Low Risk|0|||
125145924|NCT01190930|450158053|FG007|Induction|Low Risk|0|||
125145925|NCT01190930|450158054|FG008|Induction|Low Risk|0|||
125145926|NCT01190930|450158055|FG009|Induction|Low Risk|0|||
125145927|NCT01190930|450158046|FG000|Induction|Very High Risk|1012|||
125145928|NCT01190930|450158047|FG001|Induction|Very High Risk|0|||
125145929|NCT01190930|450158048|FG002|Induction|Very High Risk|0|||
125145930|NCT01190930|450158049|FG003|Induction|Very High Risk|0|||
125145931|NCT01190930|450158050|FG004|Induction|Very High Risk|0|||
125145932|NCT01190930|450158051|FG005|Induction|Very High Risk|0|||
125145933|NCT01190930|450158052|FG006|Induction|Very High Risk|0|||
125145934|NCT01190930|450158053|FG007|Induction|Very High Risk|0|||
125145935|NCT01190930|450158054|FG008|Induction|Very High Risk|0|||
125145936|NCT01190930|450158055|FG009|Induction|Very High Risk|0|||
125145937|NCT01190930|450158046|FG000|Induction|Philadelphia chromosome-positive|99|||
125145938|NCT01190930|450158047|FG001|Induction|Philadelphia chromosome-positive|0|||
125145939|NCT01190930|450158048|FG002|Induction|Philadelphia chromosome-positive|0|||
125145940|NCT01190930|450158049|FG003|Induction|Philadelphia chromosome-positive|0|||
125145941|NCT01190930|450158050|FG004|Induction|Philadelphia chromosome-positive|0|||
125145942|NCT01190930|450158051|FG005|Induction|Philadelphia chromosome-positive|0|||
125145943|NCT01190930|450158052|FG006|Induction|Philadelphia chromosome-positive|0|||
125145944|NCT01190930|450158053|FG007|Induction|Philadelphia chromosome-positive|0|||
125145945|NCT01190930|450158054|FG008|Induction|Philadelphia chromosome-positive|0|||
125145946|NCT01190930|450158055|FG009|Induction|Philadelphia chromosome-positive|0|||
125145947|NCT01190930|450158046|FG000|Induction|Incomplete Induction data|63|||
125145948|NCT01190930|450158047|FG001|Induction|Incomplete Induction data|0|||
125145949|NCT01190930|450158048|FG002|Induction|Incomplete Induction data|0|||
125145950|NCT01190930|450158049|FG003|Induction|Incomplete Induction data|0|||
125145951|NCT01190930|450158050|FG004|Induction|Incomplete Induction data|0|||
125145952|NCT01190930|450158051|FG005|Induction|Incomplete Induction data|0|||
125145953|NCT01190930|450158052|FG006|Induction|Incomplete Induction data|0|||
125145954|NCT01190930|450158053|FG007|Induction|Incomplete Induction data|0|||
125145955|NCT01190930|450158054|FG008|Induction|Incomplete Induction data|0|||
125145956|NCT01190930|450158055|FG009|Induction|Incomplete Induction data|0|||
125145957|NCT01190930|450158046|FG000|Induction|Progressive disease|0|||
125145958|NCT01190930|450158047|FG001|Induction|Progressive disease|1|||
125145959|NCT01190930|450158048|FG002|Induction|Progressive disease|0|||
125145960|NCT01190930|450158049|FG003|Induction|Progressive disease|0|||
125145961|NCT01190930|450158050|FG004|Induction|Progressive disease|0|||
125145962|NCT01190930|450158051|FG005|Induction|Progressive disease|0|||
125145963|NCT01190930|450158052|FG006|Induction|Progressive disease|0|||
125145964|NCT01190930|450158053|FG007|Induction|Progressive disease|0|||
125145965|NCT01190930|450158054|FG008|Induction|Progressive disease|0|||
125145966|NCT01190930|450158055|FG009|Induction|Progressive disease|0|||
125145967|NCT01190930|450158046|FG000|Induction|No treatment|3|||
125145968|NCT01190930|450158047|FG001|Induction|No treatment|0|||
125145969|NCT01190930|450158048|FG002|Induction|No treatment|0|||
125145970|NCT01190930|450158049|FG003|Induction|No treatment|0|||
125145971|NCT01190930|450158050|FG004|Induction|No treatment|0|||
125145972|NCT01190930|450158051|FG005|Induction|No treatment|0|||
125145973|NCT01190930|450158052|FG006|Induction|No treatment|0|||
125145974|NCT01190930|450158053|FG007|Induction|No treatment|0|||
125145975|NCT01190930|450158054|FG008|Induction|No treatment|0|||
125145976|NCT01190930|450158055|FG009|Induction|No treatment|0|||
125145977|NCT01190930|450158046|FG000|Induction|Ineligible|69|||
125145978|NCT01190930|450158047|FG001|Induction|Ineligible|4|||
125145979|NCT01190930|450158048|FG002|Induction|Ineligible|0|||
125145980|NCT01190930|450158049|FG003|Induction|Ineligible|0|||
125145981|NCT01190930|450158050|FG004|Induction|Ineligible|0|||
125145982|NCT01190930|450158051|FG005|Induction|Ineligible|0|||
125145983|NCT01190930|450158052|FG006|Induction|Ineligible|0|||
125145984|NCT01190930|450158053|FG007|Induction|Ineligible|0|||
125145985|NCT01190930|450158054|FG008|Induction|Ineligible|0|||
125145986|NCT01190930|450158055|FG009|Induction|Ineligible|0|||
125145987|NCT01190930|450158046|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
125145988|NCT01190930|450158047|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
125145989|NCT01190930|450158048|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
125145990|NCT01190930|450158049|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
125145991|NCT01190930|450158050|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
125145992|NCT01190930|450158051|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
125145993|NCT01190930|450158052|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
125145994|NCT01190930|450158053|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
125145995|NCT01190930|450158054|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
125145996|NCT01190930|450158055|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
125145997|NCT01190930|450158046|FG000|Post Induction Pre-Maintenance|Death|0|||
125145998|NCT01190930|450158047|FG001|Post Induction Pre-Maintenance|Death|0|||
125145999|NCT01190930|450158048|FG002|Post Induction Pre-Maintenance|Death|8|||
125146000|NCT01190930|450158049|FG003|Post Induction Pre-Maintenance|Death|4|||
125146001|NCT01190930|450158050|FG004|Post Induction Pre-Maintenance|Death|0|||
125146002|NCT01190930|450158051|FG005|Post Induction Pre-Maintenance|Death|0|||
125146003|NCT01190930|450158052|FG006|Post Induction Pre-Maintenance|Death|0|||
125146004|NCT01190930|450158053|FG007|Post Induction Pre-Maintenance|Death|0|||
125146005|NCT01190930|450158054|FG008|Post Induction Pre-Maintenance|Death|0|||
125146006|NCT01190930|450158055|FG009|Post Induction Pre-Maintenance|Death|0|||
125146007|NCT01190930|450158046|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
125146008|NCT01190930|450158047|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
125146009|NCT01190930|450158048|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
125146010|NCT01190930|450158049|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
125146011|NCT01190930|450158050|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
125146012|NCT01190930|450158051|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
125146013|NCT01190930|450158052|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
125223575|NCT02326272|450446174|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
125146014|NCT01190930|450158053|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
125146015|NCT01190930|450158054|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
125146016|NCT01190930|450158055|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
125146017|NCT01190930|450158046|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
125146018|NCT01190930|450158047|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
125146019|NCT01190930|450158048|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
125146020|NCT01190930|450158049|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
125146021|NCT01190930|450158050|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
125146022|NCT01190930|450158051|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
125146023|NCT01190930|450158052|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
125146024|NCT01190930|450158053|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
125146025|NCT01190930|450158054|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
125146026|NCT01190930|450158055|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
125146027|NCT01190930|450158046|FG000|Post Induction Pre-Maintenance|Refusal|0|||
125146028|NCT01190930|450158047|FG001|Post Induction Pre-Maintenance|Refusal|2|||
125146029|NCT01190930|450158048|FG002|Post Induction Pre-Maintenance|Refusal|694|||
125146030|NCT01190930|450158049|FG003|Post Induction Pre-Maintenance|Refusal|4|||
125146031|NCT01190930|450158050|FG004|Post Induction Pre-Maintenance|Refusal|0|||
125146032|NCT01190930|450158051|FG005|Post Induction Pre-Maintenance|Refusal|3|||
125146033|NCT01190930|450158052|FG006|Post Induction Pre-Maintenance|Refusal|0|||
125146034|NCT01190930|450158053|FG007|Post Induction Pre-Maintenance|Refusal|0|||
125146035|NCT01190930|450158054|FG008|Post Induction Pre-Maintenance|Refusal|0|||
125146036|NCT01190930|450158055|FG009|Post Induction Pre-Maintenance|Refusal|0|||
125146037|NCT01190930|450158046|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
125146038|NCT01190930|450158047|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
125146039|NCT01190930|450158048|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
125146040|NCT01190930|450158049|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
125146041|NCT01190930|450158050|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
125146042|NCT01190930|450158051|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
125146043|NCT01190930|450158052|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
125146044|NCT01190930|450158053|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
125146045|NCT01190930|450158054|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
125146046|NCT01190930|450158055|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
125146047|NCT01190930|450158046|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
125146048|NCT01190930|450158047|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
125146049|NCT01190930|450158048|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
125146050|NCT01190930|450158049|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
125146051|NCT01190930|450158050|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
125146052|NCT01190930|450158051|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
125146053|NCT01190930|450158052|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
125146054|NCT01190930|450158053|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
125146055|NCT01190930|450158054|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
125146056|NCT01190930|450158055|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
125146057|NCT01190930|450158046|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
125146058|NCT01190930|450158047|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
125146059|NCT01190930|450158048|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
125146060|NCT01190930|450158049|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
125146061|NCT01190930|450158050|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
125146062|NCT01190930|450158051|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
125146063|NCT01190930|450158052|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
125146064|NCT01190930|450158053|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
125146065|NCT01190930|450158054|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
125146066|NCT01190930|450158055|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
125146067|NCT01190930|450158046|FG000|Post Induction Pre-Maintenance|Relapse|0|||
125146068|NCT01190930|450158047|FG001|Post Induction Pre-Maintenance|Relapse|0|||
125146069|NCT01190930|450158048|FG002|Post Induction Pre-Maintenance|Relapse|1|||
125146070|NCT01190930|450158049|FG003|Post Induction Pre-Maintenance|Relapse|0|||
125146071|NCT01190930|450158050|FG004|Post Induction Pre-Maintenance|Relapse|0|||
125146072|NCT01190930|450158051|FG005|Post Induction Pre-Maintenance|Relapse|0|||
125146073|NCT01190930|450158052|FG006|Post Induction Pre-Maintenance|Relapse|0|||
125146074|NCT01190930|450158053|FG007|Post Induction Pre-Maintenance|Relapse|0|||
125146075|NCT01190930|450158054|FG008|Post Induction Pre-Maintenance|Relapse|0|||
125146076|NCT01190930|450158055|FG009|Post Induction Pre-Maintenance|Relapse|0|||
125146077|NCT01190930|450158046|FG000|Maintenance|Adverse Event|0|||
125146078|NCT01190930|450158047|FG001|Maintenance|Adverse Event|0|||
125146079|NCT01190930|450158048|FG002|Maintenance|Adverse Event|0|||
125146080|NCT01190930|450158049|FG003|Maintenance|Adverse Event|0|||
125146081|NCT01190930|450158050|FG004|Maintenance|Adverse Event|0|||
125146082|NCT01190930|450158051|FG005|Maintenance|Adverse Event|1|||
125146083|NCT01190930|450158052|FG006|Maintenance|Adverse Event|1|||
125146084|NCT01190930|450158053|FG007|Maintenance|Adverse Event|3|||
125146085|NCT01190930|450158054|FG008|Maintenance|Adverse Event|3|||
125146086|NCT01190930|450158055|FG009|Maintenance|Adverse Event|0|||
125146087|NCT01190930|450158046|FG000|Maintenance|Death|0|||
125146088|NCT01190930|450158047|FG001|Maintenance|Death|0|||
125146089|NCT01190930|450158048|FG002|Maintenance|Death|0|||
125146090|NCT01190930|450158049|FG003|Maintenance|Death|1|||
125146091|NCT01190930|450158050|FG004|Maintenance|Death|0|||
125146092|NCT01190930|450158051|FG005|Maintenance|Death|0|||
125146093|NCT01190930|450158052|FG006|Maintenance|Death|2|||
125146094|NCT01190930|450158053|FG007|Maintenance|Death|2|||
125146095|NCT01190930|450158054|FG008|Maintenance|Death|2|||
125146096|NCT01190930|450158055|FG009|Maintenance|Death|2|||
125146097|NCT01190930|450158046|FG000|Maintenance|Lost to Follow-up|0|||
125146098|NCT01190930|450158047|FG001|Maintenance|Lost to Follow-up|0|||
125146099|NCT01190930|450158048|FG002|Maintenance|Lost to Follow-up|0|||
125146100|NCT01190930|450158049|FG003|Maintenance|Lost to Follow-up|0|||
125146101|NCT01190930|450158050|FG004|Maintenance|Lost to Follow-up|0|||
125146102|NCT01190930|450158051|FG005|Maintenance|Lost to Follow-up|0|||
125146103|NCT01190930|450158052|FG006|Maintenance|Lost to Follow-up|1|||
125146104|NCT01190930|450158053|FG007|Maintenance|Lost to Follow-up|1|||
125146105|NCT01190930|450158054|FG008|Maintenance|Lost to Follow-up|1|||
125146106|NCT01190930|450158055|FG009|Maintenance|Lost to Follow-up|0|||
125146107|NCT01190930|450158046|FG000|Maintenance|Physician Decision|0|||
125146108|NCT01190930|450158047|FG001|Maintenance|Physician Decision|1|||
125146109|NCT01190930|450158048|FG002|Maintenance|Physician Decision|0|||
125146110|NCT01190930|450158049|FG003|Maintenance|Physician Decision|5|||
125146111|NCT01190930|450158050|FG004|Maintenance|Physician Decision|9|||
125146112|NCT01190930|450158051|FG005|Maintenance|Physician Decision|4|||
125146113|NCT01190930|450158052|FG006|Maintenance|Physician Decision|8|||
125146114|NCT01190930|450158053|FG007|Maintenance|Physician Decision|8|||
125146115|NCT01190930|450158054|FG008|Maintenance|Physician Decision|10|||
125146116|NCT01190930|450158055|FG009|Maintenance|Physician Decision|17|||
125146117|NCT01190930|450158046|FG000|Maintenance|Withdrawal by Subject|0|||
125146118|NCT01190930|450158047|FG001|Maintenance|Withdrawal by Subject|0|||
125146119|NCT01190930|450158048|FG002|Maintenance|Withdrawal by Subject|0|||
125146120|NCT01190930|450158049|FG003|Maintenance|Withdrawal by Subject|0|||
125146121|NCT01190930|450158050|FG004|Maintenance|Withdrawal by Subject|0|||
125146122|NCT01190930|450158051|FG005|Maintenance|Withdrawal by Subject|0|||
125146123|NCT01190930|450158052|FG006|Maintenance|Withdrawal by Subject|2|||
125146124|NCT01190930|450158053|FG007|Maintenance|Withdrawal by Subject|1|||
125146125|NCT01190930|450158054|FG008|Maintenance|Withdrawal by Subject|4|||
125146126|NCT01190930|450158055|FG009|Maintenance|Withdrawal by Subject|1|||
125146127|NCT01190930|450158046|FG000|Maintenance|Refusal|0|||
125146128|NCT01190930|450158047|FG001|Maintenance|Refusal|1|||
125146129|NCT01190930|450158048|FG002|Maintenance|Refusal|0|||
125146130|NCT01190930|450158049|FG003|Maintenance|Refusal|2|||
125146131|NCT01190930|450158050|FG004|Maintenance|Refusal|0|||
125146132|NCT01190930|450158051|FG005|Maintenance|Refusal|4|||
125146133|NCT01190930|450158052|FG006|Maintenance|Refusal|5|||
125146134|NCT01190930|450158053|FG007|Maintenance|Refusal|17|||
125146135|NCT01190930|450158054|FG008|Maintenance|Refusal|13|||
125146136|NCT01190930|450158055|FG009|Maintenance|Refusal|6|||
125146137|NCT01190930|450158046|FG000|Maintenance|second malignant neoplasm|0|||
125146138|NCT01190930|450158047|FG001|Maintenance|second malignant neoplasm|0|||
125146139|NCT01190930|450158048|FG002|Maintenance|second malignant neoplasm|0|||
125146140|NCT01190930|450158049|FG003|Maintenance|second malignant neoplasm|1|||
125146141|NCT01190930|450158050|FG004|Maintenance|second malignant neoplasm|0|||
125146142|NCT01190930|450158051|FG005|Maintenance|second malignant neoplasm|1|||
125146143|NCT01190930|450158052|FG006|Maintenance|second malignant neoplasm|0|||
125146144|NCT01190930|450158053|FG007|Maintenance|second malignant neoplasm|0|||
125146145|NCT01190930|450158054|FG008|Maintenance|second malignant neoplasm|1|||
125146146|NCT01190930|450158055|FG009|Maintenance|second malignant neoplasm|0|||
125146147|NCT01190930|450158046|FG000|Maintenance|Inevaluable|0|||
125146148|NCT01190930|450158047|FG001|Maintenance|Inevaluable|0|||
125146149|NCT01190930|450158048|FG002|Maintenance|Inevaluable|0|||
125146150|NCT01190930|450158049|FG003|Maintenance|Inevaluable|0|||
125146151|NCT01190930|450158050|FG004|Maintenance|Inevaluable|0|||
125146152|NCT01190930|450158051|FG005|Maintenance|Inevaluable|1|||
125146153|NCT01190930|450158052|FG006|Maintenance|Inevaluable|1|||
125146154|NCT01190930|450158053|FG007|Maintenance|Inevaluable|1|||
125146155|NCT01190930|450158054|FG008|Maintenance|Inevaluable|0|||
125146156|NCT01190930|450158055|FG009|Maintenance|Inevaluable|0|||
125146157|NCT01190930|450158046|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
125146158|NCT01190930|450158047|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
125146159|NCT01190930|450158048|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
125146160|NCT01190930|450158049|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
125146161|NCT01190930|450158050|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
125146162|NCT01190930|450158051|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
125146163|NCT01190930|450158052|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
125146164|NCT01190930|450158053|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
125146165|NCT01190930|450158054|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
125146166|NCT01190930|450158055|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
125146167|NCT01190930|450158046|FG000|Maintenance|Relapse|0|||
125146168|NCT01190930|450158047|FG001|Maintenance|Relapse|0|||
125146169|NCT01190930|450158048|FG002|Maintenance|Relapse|0|||
125146170|NCT01190930|450158049|FG003|Maintenance|Relapse|2|||
125146171|NCT01190930|450158050|FG004|Maintenance|Relapse|0|||
125146172|NCT01190930|450158051|FG005|Maintenance|Relapse|1|||
125146173|NCT01190930|450158052|FG006|Maintenance|Relapse|6|||
125146174|NCT01190930|450158053|FG007|Maintenance|Relapse|13|||
125146175|NCT01190930|450158054|FG008|Maintenance|Relapse|11|||
125146176|NCT01190930|450158055|FG009|Maintenance|Relapse|11|||
125146177|NCT01190930|450158046|FG000|Maintenance|Still on therapy|0|||
125146178|NCT01190930|450158047|FG001|Maintenance|Still on therapy|8|||
125146179|NCT01190930|450158048|FG002|Maintenance|Still on therapy|0|||
125146180|NCT01190930|450158049|FG003|Maintenance|Still on therapy|29|||
125146181|NCT01190930|450158050|FG004|Maintenance|Still on therapy|0|||
125146182|NCT01190930|450158051|FG005|Maintenance|Still on therapy|0|||
125146183|NCT01190930|450158052|FG006|Maintenance|Still on therapy|0|||
125146184|NCT01190930|450158053|FG007|Maintenance|Still on therapy|0|||
125146185|NCT01190930|450158054|FG008|Maintenance|Still on therapy|0|||
125146186|NCT01190930|450158055|FG009|Maintenance|Still on therapy|0|||
125146187|NCT00046839|450158058|FG000|Overall Study|Ineligible / No protocol treatment|0|||
125146188|NCT00046839|450158059|FG001|Overall Study|Ineligible / No protocol treatment|2|||
125146189|NCT00046839|450158058|FG000|Overall Study|Withdrawal of consent|1|||
125146190|NCT00046839|450158059|FG001|Overall Study|Withdrawal of consent|0|||
125146191|NCT02050321|450158060|FG000|Overall Study|Withdrawal by Subject|1|||
125146192|NCT02050321|450158060|FG000|Overall Study|Adverse Event|1|||
125146193|NCT00766493|450158061|FG000|30 Days Post-Procedure|Discontinued|7|||
125146194|NCT00766493|450158061|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
125146195|NCT00766493|450158061|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
125146196|NCT00721955|450158064|FG000|Overall Study|Adverse Event|0|||
125146197|NCT00721955|450158065|FG001|Overall Study|Adverse Event|0|||
125146198|NCT00721955|450158066|FG002|Overall Study|Adverse Event|2|||
125146199|NCT01292837|450158067|FG000|Overall Study|Adverse Event|1|||
125146200|NCT01292837|450158067|FG000|Overall Study|Further treatment determined|1|||
125146201|NCT04531527|450158070|FG000|Overall Study|Found to be Ineligible|3|||
125146202|NCT01077258|450158079|FG000|Overall Study|Lost to Follow-up|1390|||
125146203|NCT01077258|450158079|FG000|Overall Study|Adverse drug reaction|218|||
125146204|NCT01077258|450158079|FG000|Overall Study|Lack of Efficacy|663|||
125146205|NCT01077258|450158079|FG000|Overall Study|Clinical remission|37|||
125146206|NCT01077258|450158079|FG000|Overall Study|Other reasons|260|||
125146207|NCT00434837|450158080|FG000|Overall Study|Lost to Follow-up|20|||
125146208|NCT00434837|450158081|FG001|Overall Study|Lost to Follow-up|23|||
125146209|NCT00434837|450158082|FG002|Overall Study|Lost to Follow-up|30|||
125146210|NCT00726895|450158084|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
125146211|NCT00726895|450158085|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
125146212|NCT01881737|450158088|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
125146213|NCT01881737|450158088|FG000|Overall Study|Withdrawal by Subject|1|||
125146214|NCT01881737|450158088|FG000|Overall Study|Worsening of baseline behavior|1|||
125146215|NCT02250651|450158101|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
125146216|NCT02250651|450158102|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
125146217|NCT02250651|450158103|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
125146218|NCT02250651|450158101|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
125146219|NCT02250651|450158102|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
125146220|NCT02250651|450158103|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
125146221|NCT02250651|450158101|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
125146222|NCT02250651|450158102|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
125146223|NCT02250651|450158103|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
125146224|NCT02250651|450158101|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
125146225|NCT02250651|450158102|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
125146226|NCT02250651|450158103|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
125146227|NCT02250651|450158101|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
125146228|NCT02250651|450158102|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
125146229|NCT02250651|450158103|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
125146230|NCT02250651|450158101|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
125146231|NCT02250651|450158102|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
125146232|NCT02250651|450158103|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
125146233|NCT02250651|450158101|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
125146234|NCT02250651|450158102|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
125146235|NCT02250651|450158103|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
125146236|NCT02250651|450158101|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
125146237|NCT02250651|450158102|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
125146238|NCT02250651|450158103|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
125146239|NCT02250651|450158101|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
125146240|NCT02250651|450158102|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
125146241|NCT02250651|450158103|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
125146242|NCT02250651|450158101|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
125146243|NCT02250651|450158102|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
125146244|NCT02250651|450158103|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
125146245|NCT02250651|450158101|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
125146246|NCT02250651|450158102|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
125146247|NCT02250651|450158103|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
125146248|NCT02250651|450158101|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
125146249|NCT02250651|450158102|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
125146250|NCT02250651|450158103|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
125146251|NCT02250651|450158101|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
125146252|NCT02250651|450158102|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
125146253|NCT02250651|450158103|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
125146254|NCT02250651|450158101|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
125146255|NCT02250651|450158102|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
125146256|NCT02250651|450158103|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
125146257|NCT02250651|450158101|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
125146258|NCT02250651|450158102|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
125146259|NCT02250651|450158103|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
125146260|NCT03496298|450158104|FG000|Overall Study|Adverse Event|49|||
125146261|NCT03496298|450158105|FG001|Overall Study|Adverse Event|68|||
125146262|NCT03496298|450158106|FG002|Overall Study|Adverse Event|79|||
125146263|NCT03496298|450158104|FG000|Overall Study|Study terminated by Sponsor|1050|||
125146264|NCT03496298|450158105|FG001|Overall Study|Study terminated by Sponsor|1063|||
125146265|NCT03496298|450158106|FG002|Overall Study|Study terminated by Sponsor|1071|||
125146266|NCT03496298|450158104|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
125146267|NCT03496298|450158105|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
125146268|NCT03496298|450158106|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
125146269|NCT03496298|450158104|FG000|Overall Study|Withdrawal by Subject|176|||
125146270|NCT03496298|450158105|FG001|Overall Study|Withdrawal by Subject|154|||
125146271|NCT03496298|450158106|FG002|Overall Study|Withdrawal by Subject|151|||
125146272|NCT03496298|450158104|FG000|Overall Study|Other|29|||
125146273|NCT03496298|450158105|FG001|Overall Study|Other|20|||
125146274|NCT03496298|450158106|FG002|Overall Study|Other|23|||
125146275|NCT03496298|450158104|FG000|Overall Study|Randomized and not treated|1|||
125146276|NCT03496298|450158105|FG001|Overall Study|Randomized and not treated|1|||
125223576|NCT02326272|450446175|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125146277|NCT03496298|450158106|FG002|Overall Study|Randomized and not treated|1|||
125146278|NCT02260635|450158111|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
125146279|NCT02260635|450158112|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
125146280|NCT02260635|450158111|FG000|Open-Label Extension|Study Termination|25|||
125146281|NCT02260635|450158112|FG001|Open-Label Extension|Study Termination|25|||
125146282|NCT02260635|450158111|FG000|Open-Label Extension|Withdrawal by Subject|1|||
125146283|NCT02260635|450158112|FG001|Open-Label Extension|Withdrawal by Subject|0|||
125146284|NCT04106817|450158113|FG000|Overall Study|Lost to Follow-up|1|||
125146285|NCT04106817|450158114|FG001|Overall Study|Lost to Follow-up|0|||
125146286|NCT04106817|450158115|FG002|Overall Study|Lost to Follow-up|0|||
125146287|NCT00152516|450158116|FG000|Overall Study|Adverse Event|18|||
125146288|NCT00152516|450158116|FG000|Overall Study|Lack and Loss of Efficacy|30|||
125146289|NCT00152516|450158116|FG000|Overall Study|Lost to Follow-up|5|||
125146290|NCT00152516|450158116|FG000|Overall Study|Withdrawal by Subject|8|||
125146291|NCT00152516|450158116|FG000|Overall Study|Protocol Violation|3|||
125146292|NCT00152516|450158116|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
125146293|NCT00152516|450158116|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
125146294|NCT00152516|450158116|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
125146295|NCT00152516|450158116|FG000|Overall Study|Other: Non-Compliance|2|||
125146296|NCT00152516|450158116|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
125146297|NCT00152516|450158116|FG000|Overall Study|Other: Moved Out Of State|1|||
125146298|NCT00152516|450158116|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
125146299|NCT00152516|450158116|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
125146300|NCT02427399|450158117|FG000|Overall Study|Protocol Violation|14|||
125146301|NCT02427399|450158118|FG001|Overall Study|Protocol Violation|16|||
125146302|NCT02427399|450158119|FG002|Overall Study|Protocol Violation|12|||
125146303|NCT02427399|450158120|FG003|Overall Study|Protocol Violation|18|||
125146304|NCT02427399|450158121|FG004|Overall Study|Protocol Violation|15|||
125146305|NCT02289820|450158122|FG000|Overall Study|Withdrawal by Subject|2|||
125146306|NCT02289820|450158123|FG001|Overall Study|Withdrawal by Subject|1|||
125146307|NCT02289820|450158124|FG002|Overall Study|Withdrawal by Subject|2|||
125146308|NCT02289820|450158125|FG003|Overall Study|Withdrawal by Subject|1|||
125146309|NCT02289820|450158126|FG004|Overall Study|Withdrawal by Subject|0|||
125146310|NCT02289820|450158127|FG005|Overall Study|Withdrawal by Subject|0|||
125146311|NCT02289820|450158128|FG006|Overall Study|Withdrawal by Subject|1|||
125146312|NCT02289820|450158122|FG000|Overall Study|Death|0|||
125146313|NCT02289820|450158123|FG001|Overall Study|Death|0|||
125146314|NCT02289820|450158124|FG002|Overall Study|Death|1|||
125146315|NCT02289820|450158125|FG003|Overall Study|Death|0|||
125146316|NCT02289820|450158126|FG004|Overall Study|Death|0|||
125146317|NCT02289820|450158127|FG005|Overall Study|Death|0|||
125146318|NCT02289820|450158128|FG006|Overall Study|Death|0|||
125146319|NCT02289820|450158122|FG000|Overall Study|Lost to Follow-up|0|||
125146320|NCT02289820|450158123|FG001|Overall Study|Lost to Follow-up|0|||
125146321|NCT02289820|450158124|FG002|Overall Study|Lost to Follow-up|3|||
125146322|NCT02289820|450158125|FG003|Overall Study|Lost to Follow-up|1|||
125146323|NCT02289820|450158126|FG004|Overall Study|Lost to Follow-up|0|||
125146324|NCT02289820|450158127|FG005|Overall Study|Lost to Follow-up|1|||
125146325|NCT02289820|450158128|FG006|Overall Study|Lost to Follow-up|1|||
125146326|NCT02289820|450158122|FG000|Overall Study|withdrawal of consent|0|||
125146327|NCT02289820|450158123|FG001|Overall Study|withdrawal of consent|1|||
125146328|NCT02289820|450158124|FG002|Overall Study|withdrawal of consent|0|||
125146329|NCT02289820|450158125|FG003|Overall Study|withdrawal of consent|0|||
125146330|NCT02289820|450158126|FG004|Overall Study|withdrawal of consent|0|||
125146331|NCT02289820|450158127|FG005|Overall Study|withdrawal of consent|0|||
125146332|NCT02289820|450158128|FG006|Overall Study|withdrawal of consent|0|||
125146333|NCT03847974|450158131|FG000|Overall Study|relocated out of region|3|||
125146334|NCT03847974|450158131|FG000|Overall Study|Withdrawal by Subject|2|||
125146335|NCT03847974|450158131|FG000|Overall Study|Adverse Event|1|||
125146336|NCT01924364|450158132|FG000|Overall Study|Physician Decision|3|||
125146337|NCT01685216|450158133|FG000|Overall Study|Did not receive study drug|1|||
125146338|NCT00756717|450158134|FG000|Overall Study|Withdrawal by Subject|2|||
125146339|NCT02418754|450158135|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
125146340|NCT02418754|450158136|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
125146341|NCT02418754|450158137|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
125146342|NCT02418754|450158138|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
125146343|NCT02418754|450158139|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
125146344|NCT02418754|450158135|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
125146345|NCT02418754|450158136|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
125146346|NCT02418754|450158137|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
125146347|NCT02418754|450158138|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
125146348|NCT02418754|450158139|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
125146349|NCT02418754|450158135|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
125146350|NCT02418754|450158136|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
125146351|NCT02418754|450158137|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
125146352|NCT02418754|450158138|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
125146353|NCT02418754|450158139|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
125146354|NCT02418754|450158135|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
125146355|NCT02418754|450158136|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
125146356|NCT02418754|450158137|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
125146357|NCT02418754|450158138|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
125146358|NCT02418754|450158139|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
125146359|NCT02418754|450158135|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
125146360|NCT02418754|450158136|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
125146361|NCT02418754|450158137|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
125146362|NCT02418754|450158138|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
125146363|NCT02418754|450158139|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
125146364|NCT02418754|450158135|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
125146365|NCT02418754|450158136|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
125146366|NCT02418754|450158137|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
125146367|NCT02418754|450158138|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
125146368|NCT02418754|450158139|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
125146369|NCT02418754|450158135|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
125146370|NCT02418754|450158136|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
125146371|NCT02418754|450158137|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
125146372|NCT02418754|450158138|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
125146373|NCT02418754|450158139|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
125146374|NCT02418754|450158135|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
125146375|NCT02418754|450158136|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
125146376|NCT02418754|450158137|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
125223577|NCT02326272|450446176|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
125223578|NCT02326272|450446177|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125223579|NCT02326272|450446178|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125223580|NCT02326272|450446164|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223581|NCT02326272|450446165|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223582|NCT02326272|450446166|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223583|NCT02326272|450446167|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223584|NCT02326272|450446168|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223585|NCT02326272|450446169|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223586|NCT02326272|450446170|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223587|NCT02326272|450446171|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223588|NCT02326272|450446172|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223589|NCT02326272|450446173|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223590|NCT02326272|450446174|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223591|NCT02326272|450446175|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
125223592|NCT02326272|450446176|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223593|NCT02326272|450446177|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125146377|NCT02418754|450158138|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
125146378|NCT02418754|450158139|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
125146379|NCT02418754|450158135|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
125146380|NCT02418754|450158136|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
125146381|NCT02418754|450158137|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
125146382|NCT02418754|450158138|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
125146383|NCT02418754|450158139|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
125146384|NCT02418754|450158135|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
125146385|NCT02418754|450158136|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
125146386|NCT02418754|450158137|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
125146387|NCT02418754|450158138|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
125146388|NCT02418754|450158139|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
125146389|NCT02418754|450158135|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
125146390|NCT02418754|450158136|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
125146391|NCT02418754|450158137|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
125146392|NCT02418754|450158138|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
125146393|NCT02418754|450158139|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
125146394|NCT00250705|450158140|FG000|Overall Study|Lack of Efficacy|2|||
125146395|NCT02466386|450158148|FG000|Overall Study|Adverse Event|5|||
125146396|NCT02466386|450158148|FG000|Overall Study|Protocol Violation|2|||
125146397|NCT02466386|450158148|FG000|Overall Study|Withdrawal by Subject|14|||
125146398|NCT02466386|450158148|FG000|Overall Study|Lost to Follow-up|5|||
125146399|NCT02466386|450158148|FG000|Overall Study|Lack of Efficacy|8|||
125146400|NCT02466386|450158148|FG000|Overall Study|Other|10|||
125146401|NCT01688882|450158151|FG000|Overall Study|Adverse Event|1|||
125146402|NCT01688882|450158152|FG001|Overall Study|Adverse Event|0|||
125146403|NCT01688882|450158151|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125146404|NCT01688882|450158152|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125146405|NCT01688882|450158151|FG000|Overall Study|Administrative problems|1|||
125146406|NCT01688882|450158152|FG001|Overall Study|Administrative problems|0|||
125146407|NCT03259789|450158153|FG000|Overall Study|Adverse Event|3|||
125146408|NCT03259789|450158154|FG001|Overall Study|Adverse Event|2|||
125146409|NCT03259789|450158155|FG002|Overall Study|Adverse Event|1|||
125146410|NCT03259789|450158153|FG000|Overall Study|Withdrawal by Subject|9|||
125146411|NCT03259789|450158154|FG001|Overall Study|Withdrawal by Subject|5|||
125146412|NCT03259789|450158155|FG002|Overall Study|Withdrawal by Subject|1|||
125146413|NCT03259789|450158153|FG000|Overall Study|Lost to Follow-up|5|||
125146414|NCT03259789|450158154|FG001|Overall Study|Lost to Follow-up|9|||
125146415|NCT03259789|450158155|FG002|Overall Study|Lost to Follow-up|4|||
125146416|NCT03259789|450158153|FG000|Overall Study|Physician Decision|0|||
125146417|NCT03259789|450158154|FG001|Overall Study|Physician Decision|1|||
125146418|NCT03259789|450158155|FG002|Overall Study|Physician Decision|0|||
125146419|NCT00889252|450158156|FG000|Overall Study|Adverse Event|2|||
125146420|NCT00889252|450158157|FG001|Overall Study|Adverse Event|4|||
125146421|NCT00889252|450158156|FG000|Overall Study|Withdrawal by Subject|3|||
125146422|NCT00889252|450158157|FG001|Overall Study|Withdrawal by Subject|0|||
125146423|NCT00889252|450158156|FG000|Overall Study|Protocol Violation|2|||
125146424|NCT00889252|450158157|FG001|Overall Study|Protocol Violation|0|||
125146425|NCT02416934|450158158|FG000|Overall Study|given steroids|1|||
125146426|NCT02416934|450158159|FG001|Overall Study|given steroids|2|||
125146427|NCT02416934|450158158|FG000|Overall Study|Lost to Follow-up|0|||
125146428|NCT02416934|450158159|FG001|Overall Study|Lost to Follow-up|2|||
125146429|NCT02416934|450158158|FG000|Overall Study|Withdrawal by Subject|1|||
125146430|NCT02416934|450158159|FG001|Overall Study|Withdrawal by Subject|0|||
125146431|NCT02416934|450158158|FG000|Overall Study|recruited during continuing renewal proc|0|||
125146432|NCT02416934|450158159|FG001|Overall Study|recruited during continuing renewal proc|1|||
125146433|NCT02416934|450158158|FG000|Overall Study|Protocol Violation|0|||
125146434|NCT02416934|450158159|FG001|Overall Study|Protocol Violation|1|||
125146435|NCT02416934|450158158|FG000|Overall Study|surgery started late|0|||
125146436|NCT02416934|450158159|FG001|Overall Study|surgery started late|1|||
125146437|NCT02416934|450158158|FG000|Overall Study|re-operation|1|||
125146438|NCT02416934|450158159|FG001|Overall Study|re-operation|0|||
125146439|NCT00398073|450158162|FG000|Overall Study|Withdrawal by Subject|1|||
125146440|NCT00398073|450158163|FG001|Overall Study|Withdrawal by Subject|0|||
125146441|NCT01833169|450158166|FG000|Overall Study|Disease Progression|99|||
125146442|NCT01833169|450158166|FG000|Overall Study|Adverse Event|33|||
125146443|NCT01833169|450158166|FG000|Overall Study|Withdrawal by Subject|9|||
125146444|NCT01833169|450158166|FG000|Overall Study|Death|3|||
125146445|NCT01833169|450158166|FG000|Overall Study|Physician Decision|2|||
125146446|NCT00879684|450158170|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
125146447|NCT00879684|450158171|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
125146448|NCT00879684|450158172|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
125146449|NCT00879684|450158173|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
125146450|NCT00879684|450158174|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
125146451|NCT00879684|450158175|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
125146452|NCT00879684|450158176|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
125146453|NCT00879684|450158170|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
125146454|NCT00879684|450158171|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
125146455|NCT00879684|450158172|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
125146456|NCT00879684|450158173|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
125146457|NCT00879684|450158174|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
125146458|NCT00879684|450158175|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
125146459|NCT00879684|450158176|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
125146460|NCT00879684|450158170|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
125146461|NCT00879684|450158171|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
125146462|NCT00879684|450158172|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
125146463|NCT00879684|450158173|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
125146464|NCT00879684|450158174|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
125146465|NCT00879684|450158175|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
125146466|NCT00879684|450158176|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
125146467|NCT00879684|450158170|FG000|Stage 1: Dose Escalation|Death|0|||
125146468|NCT00879684|450158171|FG001|Stage 1: Dose Escalation|Death|0|||
125146469|NCT00879684|450158172|FG002|Stage 1: Dose Escalation|Death|1|||
125146470|NCT00879684|450158173|FG003|Stage 1: Dose Escalation|Death|0|||
125146471|NCT00879684|450158174|FG004|Stage 1: Dose Escalation|Death|0|||
125146472|NCT00879684|450158175|FG005|Stage 1: Dose Escalation|Death|0|||
125146473|NCT00879684|450158176|FG006|Stage 1: Dose Escalation|Death|0|||
125146474|NCT00879684|450158170|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
125146475|NCT00879684|450158171|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
125146476|NCT00879684|450158172|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
125146477|NCT00879684|450158173|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
125146478|NCT00879684|450158174|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
125146479|NCT00879684|450158175|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
125146480|NCT00879684|450158176|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
125146481|NCT00879684|450158170|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
125146482|NCT00879684|450158171|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
125146483|NCT00879684|450158172|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
125146484|NCT00879684|450158173|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
125146485|NCT00879684|450158174|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
125146486|NCT00879684|450158175|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
125146487|NCT00879684|450158176|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
125146488|NCT00879684|450158170|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
125146489|NCT00879684|450158171|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
125146490|NCT00879684|450158172|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
125146491|NCT00879684|450158173|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
125146492|NCT00879684|450158174|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
125146493|NCT00879684|450158175|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
125146494|NCT00879684|450158176|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
125146495|NCT00127166|450158177|FG000|Period I|Protocol Violation|0|||
125146496|NCT00127166|450158178|FG001|Period I|Protocol Violation|2|||
125146497|NCT00127166|450158177|FG000|Period I|Withdrawal by Subject|2|||
125146498|NCT00127166|450158178|FG001|Period I|Withdrawal by Subject|0|||
125146499|NCT00127166|450158177|FG000|Period I|Patient did not meet inclusion criteria|1|||
125146500|NCT00127166|450158178|FG001|Period I|Patient did not meet inclusion criteria|0|||
125146501|NCT00127166|450158177|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
125146502|NCT00127166|450158178|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
125146503|NCT00127166|450158177|FG000|Period II|Withdrawal by Subject|2|||
125146504|NCT00127166|450158178|FG001|Period II|Withdrawal by Subject|0|||
125146505|NCT00127166|450158177|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
125146506|NCT00127166|450158178|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
125146507|NCT00105157|450158179|FG000|Double-Blind (DB)|Never Treated|1|||
125146508|NCT00105157|450158180|FG001|Double-Blind (DB)|Never Treated|0|||
125146509|NCT00105157|450158181|FG002|Double-Blind (DB)|Never Treated|0|||
125146510|NCT00105157|450158182|FG003|Double-Blind (DB)|Never Treated|0|||
125146511|NCT00105157|450158179|FG000|Double-Blind (DB)|Adverse Event|2|||
125223594|NCT02326272|450446178|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125146512|NCT00105157|450158180|FG001|Double-Blind (DB)|Adverse Event|0|||
125146513|NCT00105157|450158181|FG002|Double-Blind (DB)|Adverse Event|1|||
125146514|NCT00105157|450158182|FG003|Double-Blind (DB)|Adverse Event|1|||
125146515|NCT00105157|450158179|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
125146516|NCT00105157|450158180|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
125146517|NCT00105157|450158181|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
125146518|NCT00105157|450158182|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
125146519|NCT00105157|450158179|FG000|Open-Label Continuation of DB|Adverse Event|3|||
125146520|NCT00105157|450158180|FG001|Open-Label Continuation of DB|Adverse Event|1|||
125146521|NCT00105157|450158181|FG002|Open-Label Continuation of DB|Adverse Event|0|||
125146522|NCT00105157|450158182|FG003|Open-Label Continuation of DB|Adverse Event|0|||
125146523|NCT00105157|450158179|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
125146524|NCT00105157|450158180|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
125146525|NCT00105157|450158181|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
125146526|NCT00105157|450158182|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
125146527|NCT00105157|450158179|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
125146528|NCT00105157|450158180|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
125146529|NCT00105157|450158181|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
125146530|NCT00105157|450158182|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
125146531|NCT00105157|450158179|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
125146532|NCT00105157|450158180|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
125146533|NCT00105157|450158181|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
125146534|NCT00105157|450158182|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
125146535|NCT00105157|450158179|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
125146536|NCT00105157|450158180|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
125146537|NCT00105157|450158181|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
125146538|NCT00105157|450158182|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
125146539|NCT00105157|450158179|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
125146540|NCT00105157|450158180|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
125146541|NCT00105157|450158181|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
125146542|NCT00105157|450158182|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
125146543|NCT00105157|450158179|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
125146544|NCT00105157|450158180|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
125146545|NCT00105157|450158181|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
125146546|NCT00105157|450158182|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
125146547|NCT00105157|450158179|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
125146548|NCT00105157|450158180|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
125146549|NCT00105157|450158181|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
125146550|NCT00105157|450158182|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
125146551|NCT00105157|450158179|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
125146552|NCT00105157|450158180|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
125146553|NCT00105157|450158181|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
125146554|NCT00105157|450158182|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
125146555|NCT00105157|450158179|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
125146556|NCT00105157|450158180|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
125146557|NCT00105157|450158181|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
125146558|NCT00105157|450158182|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
125146559|NCT00105157|450158179|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
125146560|NCT00105157|450158180|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
125146561|NCT00105157|450158181|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
125146562|NCT00105157|450158182|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
125146563|NCT02169336|450158185|FG000|Overall Study|Lack of Efficacy|1|||
125146564|NCT02169336|450158186|FG001|Overall Study|Lack of Efficacy|1|||
125146565|NCT02169336|450158187|FG002|Overall Study|Lack of Efficacy|0|||
125146566|NCT02169336|450158185|FG000|Overall Study|Adverse Event|2|||
125146567|NCT02169336|450158186|FG001|Overall Study|Adverse Event|3|||
125146568|NCT02169336|450158187|FG002|Overall Study|Adverse Event|1|||
125146569|NCT02169336|450158185|FG000|Overall Study|Withdrawal by Subject|1|||
125146570|NCT02169336|450158186|FG001|Overall Study|Withdrawal by Subject|0|||
125146571|NCT02169336|450158187|FG002|Overall Study|Withdrawal by Subject|0|||
125146572|NCT02169336|450158185|FG000|Overall Study|Physician Decision|0|||
125146573|NCT02169336|450158186|FG001|Overall Study|Physician Decision|0|||
125146574|NCT02169336|450158187|FG002|Overall Study|Physician Decision|1|||
125146575|NCT02169336|450158185|FG000|Overall Study|Subject declined to continue dosing|0|||
125146576|NCT02169336|450158186|FG001|Overall Study|Subject declined to continue dosing|0|||
125223595|NCT02326272|450446164|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125223596|NCT02326272|450446165|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125223597|NCT02326272|450446166|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125223598|NCT02326272|450446167|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125223599|NCT02326272|450446168|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125146577|NCT02169336|450158187|FG002|Overall Study|Subject declined to continue dosing|1|||
125146578|NCT01148225|450158188|FG000|Overall Study|Other|185|||
125146579|NCT00393705|450158189|FG000|Overall Study|Adverse Event|0|||
125146580|NCT00393705|450158190|FG001|Overall Study|Adverse Event|2|||
125146581|NCT00393705|450158189|FG000|Overall Study|Death|0|||
125146582|NCT00393705|450158190|FG001|Overall Study|Death|1|||
125146583|NCT00393705|450158189|FG000|Overall Study|Lost to Follow-up|2|||
125146584|NCT00393705|450158190|FG001|Overall Study|Lost to Follow-up|2|||
125146585|NCT00393705|450158189|FG000|Overall Study|Entry Criteria Not Met|10|||
125146586|NCT00393705|450158190|FG001|Overall Study|Entry Criteria Not Met|10|||
125146587|NCT00393705|450158189|FG000|Overall Study|Protocol Violation|4|||
125146588|NCT00393705|450158190|FG001|Overall Study|Protocol Violation|3|||
125146589|NCT00393705|450158189|FG000|Overall Study|Withdrawal by Subject|5|||
125146590|NCT00393705|450158190|FG001|Overall Study|Withdrawal by Subject|3|||
125146591|NCT00393705|450158189|FG000|Overall Study|Physician Decision|2|||
125146592|NCT00393705|450158190|FG001|Overall Study|Physician Decision|2|||
125146593|NCT02490800|450158191|FG000|Overall Study|Adverse Event|0|||
125146594|NCT02490800|450158192|FG001|Overall Study|Adverse Event|0|||
125146595|NCT02490800|450158193|FG002|Overall Study|Adverse Event|0|||
125146596|NCT02490800|450158194|FG003|Overall Study|Adverse Event|2|||
125146597|NCT02490800|450158195|FG004|Overall Study|Adverse Event|3|||
125146598|NCT02490800|450158196|FG005|Overall Study|Adverse Event|2|||
125146599|NCT02490800|450158197|FG006|Overall Study|Adverse Event|0|||
125146600|NCT02490800|450158198|FG007|Overall Study|Adverse Event|0|||
125146601|NCT02490800|450158199|FG008|Overall Study|Adverse Event|0|||
125146602|NCT02490800|450158200|FG009|Overall Study|Adverse Event|0|||
125146603|NCT02490800|450158201|FG010|Overall Study|Adverse Event|0|||
125146604|NCT02490800|450158202|FG011|Overall Study|Adverse Event|2|||
125146605|NCT02490800|450158203|FG012|Overall Study|Adverse Event|2|||
125146606|NCT02490800|450158191|FG000|Overall Study|Withdrawal by Subject|0|||
125146607|NCT02490800|450158192|FG001|Overall Study|Withdrawal by Subject|0|||
125146608|NCT02490800|450158193|FG002|Overall Study|Withdrawal by Subject|0|||
125146609|NCT02490800|450158194|FG003|Overall Study|Withdrawal by Subject|1|||
125146610|NCT02490800|450158195|FG004|Overall Study|Withdrawal by Subject|0|||
125146611|NCT02490800|450158196|FG005|Overall Study|Withdrawal by Subject|0|||
125146612|NCT02490800|450158197|FG006|Overall Study|Withdrawal by Subject|0|||
125146613|NCT02490800|450158198|FG007|Overall Study|Withdrawal by Subject|0|||
125146614|NCT02490800|450158199|FG008|Overall Study|Withdrawal by Subject|1|||
125146615|NCT02490800|450158200|FG009|Overall Study|Withdrawal by Subject|0|||
125146616|NCT02490800|450158201|FG010|Overall Study|Withdrawal by Subject|0|||
125146617|NCT02490800|450158202|FG011|Overall Study|Withdrawal by Subject|0|||
125146618|NCT02490800|450158203|FG012|Overall Study|Withdrawal by Subject|0|||
125146619|NCT02490800|450158191|FG000|Overall Study|Progressive disease|3|||
125146620|NCT02490800|450158192|FG001|Overall Study|Progressive disease|3|||
125146621|NCT02490800|450158193|FG002|Overall Study|Progressive disease|3|||
125146622|NCT02490800|450158194|FG003|Overall Study|Progressive disease|4|||
125146623|NCT02490800|450158195|FG004|Overall Study|Progressive disease|4|||
125146624|NCT02490800|450158196|FG005|Overall Study|Progressive disease|1|||
125146625|NCT02490800|450158197|FG006|Overall Study|Progressive disease|4|||
125146626|NCT02490800|450158198|FG007|Overall Study|Progressive disease|3|||
125146627|NCT02490800|450158199|FG008|Overall Study|Progressive disease|6|||
125146628|NCT02490800|450158200|FG009|Overall Study|Progressive disease|2|||
125146629|NCT02490800|450158201|FG010|Overall Study|Progressive disease|7|||
125146630|NCT02490800|450158202|FG011|Overall Study|Progressive disease|1|||
125146631|NCT02490800|450158203|FG012|Overall Study|Progressive disease|10|||
125146632|NCT02490800|450158191|FG000|Overall Study|Patient enrolled in post-trial access|0|||
125146633|NCT02490800|450158192|FG001|Overall Study|Patient enrolled in post-trial access|0|||
125146634|NCT02490800|450158193|FG002|Overall Study|Patient enrolled in post-trial access|0|||
125146635|NCT02490800|450158194|FG003|Overall Study|Patient enrolled in post-trial access|0|||
125146636|NCT02490800|450158195|FG004|Overall Study|Patient enrolled in post-trial access|0|||
125146637|NCT02490800|450158196|FG005|Overall Study|Patient enrolled in post-trial access|0|||
125146638|NCT02490800|450158197|FG006|Overall Study|Patient enrolled in post-trial access|0|||
125146639|NCT02490800|450158198|FG007|Overall Study|Patient enrolled in post-trial access|0|||
125146640|NCT02490800|450158199|FG008|Overall Study|Patient enrolled in post-trial access|0|||
125146641|NCT02490800|450158200|FG009|Overall Study|Patient enrolled in post-trial access|1|||
125146642|NCT02490800|450158201|FG010|Overall Study|Patient enrolled in post-trial access|1|||
125146643|NCT02490800|450158202|FG011|Overall Study|Patient enrolled in post-trial access|0|||
125146644|NCT02490800|450158203|FG012|Overall Study|Patient enrolled in post-trial access|6|||
125146645|NCT03365791|450158204|FG000|Overall Study|Adverse Event|5|||
125146646|NCT03365791|450158204|FG000|Overall Study|Death|1|||
125146647|NCT03365791|450158204|FG000|Overall Study|Lost to Follow-up|1|||
125146648|NCT03365791|450158204|FG000|Overall Study|Physician Decision|9|||
125146649|NCT03365791|450158204|FG000|Overall Study|Progressive disease|51|||
125146650|NCT03365791|450158204|FG000|Overall Study|Subject/guardian decision|5|||
125146651|NCT03693950|450158205|FG000|Overall Study|Withdrawal by Subject|1|||
125146652|NCT03693950|450158206|FG001|Overall Study|Withdrawal by Subject|0|||
125146653|NCT01475487|450158207|FG000|Overall Study|had to leave early for personal reasons|2|||
125146654|NCT01475487|450158208|FG001|Overall Study|had to leave early for personal reasons|1|||
125146655|NCT03203642|450158209|FG000|Overall Study|Adverse Event|3|||
125146656|NCT03203642|450158210|FG001|Overall Study|Adverse Event|1|||
125146657|NCT03203642|450158209|FG000|Overall Study|Withdrawal by Subject|6|||
125146658|NCT03203642|450158210|FG001|Overall Study|Withdrawal by Subject|6|||
125146659|NCT03203642|450158209|FG000|Overall Study|Lost to Follow-up|2|||
125146660|NCT03203642|450158210|FG001|Overall Study|Lost to Follow-up|1|||
125146661|NCT03203642|450158209|FG000|Overall Study|Termination of the study by sponsor|1|||
125146662|NCT03203642|450158210|FG001|Overall Study|Termination of the study by sponsor|1|||
125146663|NCT03203642|450158209|FG000|Overall Study|Participant moved|0|||
125146664|NCT03203642|450158210|FG001|Overall Study|Participant moved|1|||
125146665|NCT03203642|450158209|FG000|Overall Study|Investigator's decision|3|||
125146666|NCT03203642|450158210|FG001|Overall Study|Investigator's decision|0|||
125146667|NCT03203642|450158209|FG000|Overall Study|Other than above specified|0|||
125146668|NCT03203642|450158210|FG001|Overall Study|Other than above specified|1|||
125146669|NCT00559637|450159711|FG000|Overall Study|Adverse Event|22|||
125146670|NCT00559637|450159711|FG000|Overall Study|Withdrawal by Subject|4|||
125146671|NCT00559637|450159711|FG000|Overall Study|Protocol Violation|6|||
125146672|NCT00559637|450159711|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
125146673|NCT00559637|450159711|FG000|Overall Study|Failure to return|6|||
125146674|NCT00559637|450159711|FG000|Overall Study|Insufficient response|3|||
125146675|NCT00559637|450159711|FG000|Overall Study|Started requiring dialysis after month 7|2|||
125146676|NCT00559637|450159711|FG000|Overall Study|Suspected lung cancer|1|||
125146677|NCT00559637|450159711|FG000|Overall Study|Participation in another study|1|||
125146678|NCT00559637|450159711|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
125146679|NCT00559637|450159711|FG000|Overall Study|Change of center|1|||
125146680|NCT00559637|450159711|FG000|Overall Study|Change of home|1|||
125146681|NCT00559637|450159711|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
125146682|NCT02832167|450159712|FG000|Treatment Period 1|Disease progression|90|||
125146683|NCT02832167|450159712|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
125146684|NCT02832167|450159712|FG000|Treatment Period 1|Death|2|||
125146685|NCT02832167|450159712|FG000|Treatment Period 1|Study Drug Toxicity|6|||
125146686|NCT02832167|450159712|FG000|Treatment Period 1|Participant request to discontinue|9|||
125146687|NCT02832167|450159712|FG000|Treatment Period 1|No longer meet study criteria|1|||
125146688|NCT02832167|450159712|FG000|Treatment Period 1|Participant withdrew consent|3|||
125146689|NCT02832167|450159712|FG000|Treatment Period 1|Other reasons|6|||
125146690|NCT02832167|450159712|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
125146691|NCT02832167|450159712|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
125146692|NCT02832167|450159712|FG000|Transition From Period 1 to Period 2|Death|2|||
125146693|NCT02832167|450159712|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
125146694|NCT02832167|450159712|FG000|Treatment Period 2|Disease progression|69|||
125146695|NCT02832167|450159712|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
125146696|NCT02832167|450159712|FG000|Treatment Period 2|Maximum clinical benefit|1|||
125146697|NCT02832167|450159712|FG000|Treatment Period 2|Study Drug Toxicity|5|||
125146698|NCT02832167|450159712|FG000|Treatment Period 2|Participant request to discontinue|2|||
125146699|NCT02832167|450159712|FG000|Treatment Period 2|Participant withdrew consent|3|||
125146700|NCT02832167|450159712|FG000|Treatment Period 2|Other reasons|3|||
125146701|NCT01958060|450159715|FG000|Overall Study|Not treated|2|||
125146702|NCT01958060|450159716|FG001|Overall Study|Not treated|0|||
125146703|NCT01958060|450159717|FG002|Overall Study|Not treated|0|||
125146704|NCT01958060|450159718|FG003|Overall Study|Not treated|0|||
125146705|NCT01958060|450159719|FG004|Overall Study|Not treated|1|||
125146706|NCT01958060|450159720|FG005|Overall Study|Not treated|0|||
125146707|NCT02293460|450159722|FG000|Overall Study|Protocol Violation|1|||
125146708|NCT02293460|450159722|FG000|Overall Study|Lack of Efficacy|2|||
125146709|NCT02293460|450159722|FG000|Overall Study|Adverse Event|2|||
125146710|NCT02293460|450159722|FG000|Overall Study|Withdrawal by Subject|1|||
125146711|NCT00224484|450159742|FG000|Overall Study|Serious Adverse Event|1|||
125146712|NCT00224484|450159743|FG001|Overall Study|Serious Adverse Event|1|||
125146713|NCT00224484|450159744|FG002|Overall Study|Serious Adverse Event|0|||
125146714|NCT00224484|450159742|FG000|Overall Study|Non-Serious Adverse Event|5|||
125146715|NCT00224484|450159743|FG001|Overall Study|Non-Serious Adverse Event|7|||
125146716|NCT00224484|450159744|FG002|Overall Study|Non-Serious Adverse Event|3|||
125146717|NCT00224484|450159742|FG000|Overall Study|Protocol Violation|2|||
125146718|NCT00224484|450159743|FG001|Overall Study|Protocol Violation|2|||
125146719|NCT00224484|450159744|FG002|Overall Study|Protocol Violation|0|||
125146720|NCT00224484|450159742|FG000|Overall Study|Withdrawal by Subject|49|||
125146721|NCT00224484|450159743|FG001|Overall Study|Withdrawal by Subject|18|||
125146722|NCT00224484|450159744|FG002|Overall Study|Withdrawal by Subject|16|||
125146723|NCT00224484|450159742|FG000|Overall Study|Migrated/moved from study area|18|||
125146724|NCT00224484|450159743|FG001|Overall Study|Migrated/moved from study area|5|||
125146725|NCT00224484|450159744|FG002|Overall Study|Migrated/moved from study area|5|||
125146726|NCT00224484|450159742|FG000|Overall Study|Lost to Follow-up|66|||
125146727|NCT00224484|450159743|FG001|Overall Study|Lost to Follow-up|28|||
125146728|NCT00224484|450159744|FG002|Overall Study|Lost to Follow-up|36|||
125146729|NCT00224484|450159742|FG000|Overall Study|Reason not specified|5|||
125146730|NCT00224484|450159743|FG001|Overall Study|Reason not specified|4|||
125146731|NCT00224484|450159744|FG002|Overall Study|Reason not specified|2|||
125146732|NCT01074008|450159747|FG000|Overall Study|Adverse Event|0|||
125146733|NCT01074008|450159748|FG001|Overall Study|Adverse Event|1|||
125146734|NCT01074008|450159749|FG002|Overall Study|Adverse Event|0|||
125146735|NCT01074008|450159750|FG003|Overall Study|Adverse Event|0|||
125146736|NCT01074008|450159751|FG004|Overall Study|Adverse Event|0|||
125146737|NCT01074008|450159752|FG005|Overall Study|Adverse Event|0|||
125146738|NCT01074008|450159753|FG006|Overall Study|Adverse Event|0|||
125146739|NCT01074008|450159754|FG007|Overall Study|Adverse Event|0|||
125146740|NCT01074008|450159755|FG008|Overall Study|Adverse Event|0|||
125146741|NCT01074008|450159747|FG000|Overall Study|Withdrawal by Subject|1|||
125146742|NCT01074008|450159748|FG001|Overall Study|Withdrawal by Subject|1|||
125146743|NCT01074008|450159749|FG002|Overall Study|Withdrawal by Subject|1|||
125146744|NCT01074008|450159750|FG003|Overall Study|Withdrawal by Subject|0|||
125146745|NCT01074008|450159751|FG004|Overall Study|Withdrawal by Subject|1|||
125146746|NCT01074008|450159752|FG005|Overall Study|Withdrawal by Subject|0|||
125146747|NCT01074008|450159753|FG006|Overall Study|Withdrawal by Subject|0|||
125146748|NCT01074008|450159754|FG007|Overall Study|Withdrawal by Subject|0|||
125146749|NCT01074008|450159755|FG008|Overall Study|Withdrawal by Subject|0|||
125146750|NCT01074008|450159747|FG000|Overall Study|Lost to Follow-up|0|||
125146751|NCT01074008|450159748|FG001|Overall Study|Lost to Follow-up|1|||
125146752|NCT01074008|450159749|FG002|Overall Study|Lost to Follow-up|1|||
125146753|NCT01074008|450159750|FG003|Overall Study|Lost to Follow-up|1|||
125146754|NCT01074008|450159751|FG004|Overall Study|Lost to Follow-up|1|||
125146755|NCT01074008|450159752|FG005|Overall Study|Lost to Follow-up|0|||
125146756|NCT01074008|450159753|FG006|Overall Study|Lost to Follow-up|1|||
125146757|NCT01074008|450159754|FG007|Overall Study|Lost to Follow-up|0|||
125146758|NCT01074008|450159755|FG008|Overall Study|Lost to Follow-up|4|||
125146759|NCT02805309|450159756|FG000|Overall Study|Lost to Follow-up|2|||
125146760|NCT02805309|450159757|FG001|Overall Study|Lost to Follow-up|2|||
125146761|NCT02805309|450159758|FG002|Overall Study|Lost to Follow-up|2|||
125146762|NCT02805309|450159756|FG000|Overall Study|Post-Randomization Exclusion|0|||
125146763|NCT02805309|450159757|FG001|Overall Study|Post-Randomization Exclusion|2|||
125146764|NCT02805309|450159758|FG002|Overall Study|Post-Randomization Exclusion|1|||
125146765|NCT01350934|450159763|FG000|Base Study|Adverse Event|6|||
125146766|NCT01350934|450159764|FG001|Base Study|Adverse Event|0|||
125146767|NCT01350934|450159763|FG000|Base Study|Lost to Follow-up|1|||
125146768|NCT01350934|450159764|FG001|Base Study|Lost to Follow-up|0|||
125146769|NCT01350934|450159763|FG000|Base Study|Protocol Violation|1|||
125146770|NCT01350934|450159764|FG001|Base Study|Protocol Violation|1|||
125146771|NCT01350934|450159763|FG000|Base Study|Withdrawal by Subject|1|||
125146772|NCT01350934|450159764|FG001|Base Study|Withdrawal by Subject|2|||
125146773|NCT01350934|450159763|FG000|Base Study|Non-Compliance With Study Drug|2|||
125146774|NCT01350934|450159764|FG001|Base Study|Non-Compliance With Study Drug|0|||
125146775|NCT01350934|450159763|FG000|Extension Study|Adverse Event|2|||
125146776|NCT01350934|450159764|FG001|Extension Study|Adverse Event|1|||
125146777|NCT01350934|450159763|FG000|Extension Study|Lost to Follow-up|2|||
125146778|NCT01350934|450159764|FG001|Extension Study|Lost to Follow-up|0|||
125146779|NCT01350934|450159763|FG000|Extension Study|Protocol Violation|1|||
125146780|NCT01350934|450159764|FG001|Extension Study|Protocol Violation|1|||
125146781|NCT01350934|450159763|FG000|Extension Study|Lack of Efficacy|0|||
125146782|NCT01350934|450159764|FG001|Extension Study|Lack of Efficacy|1|||
125146783|NCT01350934|450159763|FG000|Extension Study|Withdrawal by Subject|0|||
125146784|NCT01350934|450159764|FG001|Extension Study|Withdrawal by Subject|1|||
125146785|NCT03547635|450159767|FG000|Overall Study|Adverse Event|5|||
125146786|NCT03547635|450159768|FG001|Overall Study|Adverse Event|2|||
125146787|NCT03547635|450159769|FG002|Overall Study|Adverse Event|3|||
125146788|NCT03547635|450159767|FG000|Overall Study|Lost to Follow-up|1|||
125146789|NCT03547635|450159768|FG001|Overall Study|Lost to Follow-up|3|||
125146790|NCT03547635|450159769|FG002|Overall Study|Lost to Follow-up|4|||
125146791|NCT03547635|450159767|FG000|Overall Study|Withdrawal by Subject|1|||
125146792|NCT03547635|450159768|FG001|Overall Study|Withdrawal by Subject|0|||
125146793|NCT03547635|450159769|FG002|Overall Study|Withdrawal by Subject|0|||
125146794|NCT03547635|450159767|FG000|Overall Study|Withdrawal By PI|0|||
125146795|NCT03547635|450159768|FG001|Overall Study|Withdrawal By PI|1|||
125223600|NCT02326272|450446169|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125146796|NCT03547635|450159769|FG002|Overall Study|Withdrawal By PI|0|||
125146797|NCT03547635|450159767|FG000|Overall Study|Withdrawal by Sponsor|0|||
125146798|NCT03547635|450159768|FG001|Overall Study|Withdrawal by Sponsor|0|||
125146799|NCT03547635|450159769|FG002|Overall Study|Withdrawal by Sponsor|1|||
125146800|NCT03547635|450159767|FG000|Overall Study|Errant Randomization before Treatment|0|||
125146801|NCT03547635|450159768|FG001|Overall Study|Errant Randomization before Treatment|1|||
125146802|NCT03547635|450159769|FG002|Overall Study|Errant Randomization before Treatment|0|||
125146803|NCT03547635|450159767|FG000|Overall Study|Withdrawal by Subject|1|||
125146804|NCT03547635|450159768|FG001|Overall Study|Withdrawal by Subject|0|||
125146805|NCT03547635|450159769|FG002|Overall Study|Withdrawal by Subject|0|||
125146806|NCT02415387|450159779|FG000|Overall Study|Withdrawal by Subject|6|||
125146807|NCT02415387|450159780|FG001|Overall Study|Withdrawal by Subject|1|||
125146808|NCT02415387|450159779|FG000|Overall Study|blood draw problem|0|||
125146809|NCT02415387|450159780|FG001|Overall Study|blood draw problem|1|||
125146810|NCT02415387|450159779|FG000|Overall Study|Protocol Violation|1|||
125146811|NCT02415387|450159780|FG001|Overall Study|Protocol Violation|0|||
125146812|NCT00676650|450159784|FG000|Overall Study|Death|45|||
125146813|NCT00676650|450159785|FG001|Overall Study|Death|14|||
125146814|NCT00676650|450159784|FG000|Overall Study|Adverse Event|159|||
125146815|NCT00676650|450159785|FG001|Overall Study|Adverse Event|21|||
125146816|NCT00676650|450159784|FG000|Overall Study|Global deterioration of health status|66|||
125146817|NCT00676650|450159785|FG001|Overall Study|Global deterioration of health status|31|||
125146818|NCT00676650|450159784|FG000|Overall Study|Lost to Follow-up|0|||
125146819|NCT00676650|450159785|FG001|Overall Study|Lost to Follow-up|1|||
125146820|NCT00676650|450159784|FG000|Overall Study|Objective progression or relapse|189|||
125146821|NCT00676650|450159785|FG001|Overall Study|Objective progression or relapse|140|||
125146822|NCT00676650|450159784|FG000|Overall Study|Other|14|||
125146823|NCT00676650|450159785|FG001|Overall Study|Other|10|||
125146824|NCT00676650|450159784|FG000|Overall Study|Protocol Violation|3|||
125146825|NCT00676650|450159785|FG001|Overall Study|Protocol Violation|1|||
125146826|NCT00676650|450159784|FG000|Overall Study|Study terminated by sponsor|57|||
125146827|NCT00676650|450159785|FG001|Overall Study|Study terminated by sponsor|43|||
125146828|NCT00676650|450159784|FG000|Overall Study|Withdrawal by Subject|48|||
125146829|NCT00676650|450159785|FG001|Overall Study|Withdrawal by Subject|24|||
125146830|NCT00676650|450159784|FG000|Overall Study|Randomized but not treated|3|||
125146831|NCT00676650|450159785|FG001|Overall Study|Randomized but not treated|4|||
125146832|NCT00683592|450159786|FG000|Overall Study|Adverse Event|12|||
125146833|NCT00683592|450159787|FG001|Overall Study|Adverse Event|4|||
125146834|NCT00683592|450159786|FG000|Overall Study|Withdrawal by Subject|11|||
125146835|NCT00683592|450159787|FG001|Overall Study|Withdrawal by Subject|11|||
125146836|NCT00683592|450159786|FG000|Overall Study|Lost to Follow-up|17|||
125146837|NCT00683592|450159787|FG001|Overall Study|Lost to Follow-up|17|||
125146838|NCT00683592|450159786|FG000|Overall Study|Lack of Efficacy|3|||
125146839|NCT00683592|450159787|FG001|Overall Study|Lack of Efficacy|7|||
125146840|NCT00683592|450159786|FG000|Overall Study|Physician Decision|0|||
125146841|NCT00683592|450159787|FG001|Overall Study|Physician Decision|1|||
125146842|NCT00683592|450159786|FG000|Overall Study|Non-compliance|3|||
125146843|NCT00683592|450159787|FG001|Overall Study|Non-compliance|5|||
125146844|NCT00683592|450159786|FG000|Overall Study|Other|1|||
125146845|NCT00683592|450159787|FG001|Overall Study|Other|1|||
125146846|NCT03653026|450159788|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
125146847|NCT03653026|450159789|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
125146848|NCT03653026|450159790|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
125146849|NCT03653026|450159791|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
125146850|NCT03653026|450159788|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
125146851|NCT03653026|450159789|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
125146852|NCT03653026|450159790|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
125146853|NCT03653026|450159791|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
125146854|NCT03653026|450159788|FG000|Part 1: Placebo-controlled Period|Other|0|||
125146855|NCT03653026|450159789|FG001|Part 1: Placebo-controlled Period|Other|3|||
125146856|NCT03653026|450159790|FG002|Part 1: Placebo-controlled Period|Other|0|||
125146857|NCT03653026|450159791|FG003|Part 1: Placebo-controlled Period|Other|0|||
125146858|NCT03653026|450159788|FG000|Part 2: Open-label Extension|Adverse Event|0|||
125146859|NCT03653026|450159789|FG001|Part 2: Open-label Extension|Adverse Event|0|||
125146860|NCT03653026|450159790|FG002|Part 2: Open-label Extension|Adverse Event|1|||
125146861|NCT03653026|450159791|FG003|Part 2: Open-label Extension|Adverse Event|1|||
125146862|NCT03653026|450159788|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
125146863|NCT03653026|450159789|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
125146864|NCT03653026|450159790|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
125146865|NCT03653026|450159791|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
125146866|NCT03653026|450159788|FG000|Part 2: Open-label Extension|Other|0|||
125146867|NCT03653026|450159789|FG001|Part 2: Open-label Extension|Other|0|||
125146868|NCT03653026|450159790|FG002|Part 2: Open-label Extension|Other|1|||
125146869|NCT03653026|450159791|FG003|Part 2: Open-label Extension|Other|2|||
125146870|NCT01201759|450159792|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
125146871|NCT01201759|450159793|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
125146872|NCT01201759|450159792|FG000|Visit 3 - Washout|Adverse Event|0|||
125146873|NCT01201759|450159793|FG001|Visit 3 - Washout|Adverse Event|3|||
125146874|NCT01201759|450159792|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
125146875|NCT01201759|450159793|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
125146876|NCT01201759|450159792|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
125146877|NCT01201759|450159793|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
125146878|NCT02005276|450159800|FG000|Overall Study|No longer interested|5|||
125146879|NCT02005276|450159801|FG001|Overall Study|No longer interested|2|||
125146880|NCT02005276|450159802|FG002|Overall Study|No longer interested|3|||
125146881|NCT02005276|450159803|FG003|Overall Study|No longer interested|3|||
125146882|NCT01963260|450159804|FG000|Overall Study|Withdrawal by Subject|2|||
125146883|NCT01963260|450159805|FG001|Overall Study|Withdrawal by Subject|0|||
125146884|NCT01963260|450159806|FG002|Overall Study|Withdrawal by Subject|0|||
125146885|NCT01963260|450159807|FG003|Overall Study|Withdrawal by Subject|1|||
125146886|NCT01963260|450159808|FG004|Overall Study|Withdrawal by Subject|2|||
125146887|NCT01963260|450159809|FG005|Overall Study|Withdrawal by Subject|0|||
125146888|NCT01963260|450159810|FG006|Overall Study|Withdrawal by Subject|0|||
125146889|NCT01963260|450159811|FG007|Overall Study|Withdrawal by Subject|0|||
125146890|NCT01963260|450159812|FG008|Overall Study|Withdrawal by Subject|0|||
125146891|NCT01963260|450159813|FG009|Overall Study|Withdrawal by Subject|0|||
125146892|NCT04994431|450159814|FG000|Overall Study|Adverse Event|1|||
125146893|NCT04994431|450159815|FG001|Overall Study|Adverse Event|0|||
125146894|NCT01067521|450159818|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
125146895|NCT01067521|450159819|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
125146896|NCT01067521|450159818|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
125146897|NCT01067521|450159819|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
125146898|NCT01067521|450159818|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
125146899|NCT01067521|450159819|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
125146900|NCT01067521|450159818|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
125146901|NCT01067521|450159819|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
125146902|NCT01067521|450159818|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
125146903|NCT01067521|450159819|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
125146904|NCT01067521|450159818|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
125146905|NCT01067521|450159819|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
125146906|NCT01067521|450159818|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
125146907|NCT01067521|450159819|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
125146908|NCT01067521|450159818|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
125146909|NCT01067521|450159819|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
125146910|NCT01067521|450159818|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
125146911|NCT01067521|450159819|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
125146912|NCT01067521|450159818|FG000|Open-Label Period|Death|3|||
125146913|NCT01067521|450159819|FG001|Open-Label Period|Death|1|||
125146914|NCT01067521|450159818|FG000|Open-Label Period|Adverse Event|30|||
125146915|NCT01067521|450159819|FG001|Open-Label Period|Adverse Event|28|||
125146916|NCT01067521|450159818|FG000|Open-Label Period|Withdrawal by Subject|160|||
125146917|NCT01067521|450159819|FG001|Open-Label Period|Withdrawal by Subject|88|||
125146918|NCT01067521|450159818|FG000|Open-Label Period|Physician Decision|13|||
125146919|NCT01067521|450159819|FG001|Open-Label Period|Physician Decision|11|||
125146920|NCT01067521|450159818|FG000|Open-Label Period|Non-compliance with study drug|5|||
125146921|NCT01067521|450159819|FG001|Open-Label Period|Non-compliance with study drug|0|||
125146922|NCT01067521|450159818|FG000|Open-Label Period|Protocol Violation|3|||
125146923|NCT01067521|450159819|FG001|Open-Label Period|Protocol Violation|0|||
125146924|NCT01067521|450159818|FG000|Open-Label Period|Pregnancy|14|||
125146925|NCT01067521|450159819|FG001|Open-Label Period|Pregnancy|8|||
125146926|NCT01067521|450159818|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
125146927|NCT01067521|450159819|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
125146928|NCT01067521|450159818|FG000|Open-Label Period|Lost to Follow-up|21|||
125146929|NCT01067521|450159819|FG001|Open-Label Period|Lost to Follow-up|20|||
125146930|NCT03419962|450159822|FG000|Overall Study|Change to other medication|1|||
125146931|NCT03419962|450159822|FG000|Overall Study|Refusal of continuing with trial drug|1|||
125146932|NCT03419962|450159822|FG000|Overall Study|Lost to Follow-up|3|||
125146933|NCT03419962|450159822|FG000|Overall Study|Difficulty in inhaling the doses|1|||
125146934|NCT03419962|450159822|FG000|Overall Study|Missing completion data|31|||
125146935|NCT02914457|450159823|FG000|Overall Study|Withdrawal by Subject|1|||
125146936|NCT02914457|450159823|FG000|Overall Study|Physician Decision|1|||
125146937|NCT02914457|450159823|FG000|Overall Study|No veins available for lead placement|1|||
125146938|NCT02914457|450159823|FG000|Overall Study|Electrical instability of patient|1|||
125146939|NCT02914457|450159823|FG000|Overall Study|ECG acquisition error due to sweating|1|||
125146940|NCT02914457|450159823|FG000|Overall Study|Protocol Violation|1|||
125146941|NCT01098539|450159826|FG000|Overall Study|Adverse Event|26|||
125146942|NCT01098539|450159827|FG001|Overall Study|Adverse Event|26|||
125146943|NCT01098539|450159826|FG000|Overall Study|Protocol Violation|1|||
125146944|NCT01098539|450159827|FG001|Overall Study|Protocol Violation|4|||
125146945|NCT01098539|450159826|FG000|Overall Study|Noncompliance|3|||
125146946|NCT01098539|450159827|FG001|Overall Study|Noncompliance|5|||
125146947|NCT01098539|450159826|FG000|Overall Study|Lost to Follow-up|4|||
125146948|NCT01098539|450159827|FG001|Overall Study|Lost to Follow-up|4|||
125146949|NCT01098539|450159826|FG000|Overall Study|Withdrawal by Subject|12|||
125146950|NCT01098539|450159827|FG001|Overall Study|Withdrawal by Subject|26|||
125146951|NCT01098539|450159826|FG000|Overall Study|Physician Decision|5|||
125146952|NCT01098539|450159827|FG001|Overall Study|Physician Decision|3|||
125146953|NCT01849458|450159828|FG000|Overall Study|Lost to Follow-up|4|||
125146954|NCT01781234|450159829|FG000|Overall Study|Adverse Event|2|||
125146955|NCT01781234|450159830|FG001|Overall Study|Adverse Event|0|||
125146956|NCT01781234|450159829|FG000|Overall Study|Protocol Violation|3|||
125146957|NCT01781234|450159830|FG001|Overall Study|Protocol Violation|0|||
125146958|NCT01781234|450159829|FG000|Overall Study|Withdrawal by Subject|4|||
125146959|NCT01781234|450159830|FG001|Overall Study|Withdrawal by Subject|3|||
125146960|NCT03439085|450159831|FG000|Overall Study|Death|2|||
125146961|NCT03439085|450159831|FG000|Overall Study|Screen Failure|20|||
125146962|NCT01863433|450159832|FG000|Overall Study|Protocol Violation|1|||
125146963|NCT02174276|450159833|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
125146964|NCT02174276|450159834|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
125146965|NCT02174276|450159835|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
125146966|NCT02174276|450159836|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
125146967|NCT02174276|450159833|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
125146968|NCT02174276|450159834|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
125146969|NCT02174276|450159835|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
125146970|NCT02174276|450159836|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
125146971|NCT02174276|450159833|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
125146972|NCT02174276|450159834|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
125146973|NCT02174276|450159835|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
125146974|NCT02174276|450159836|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
125146975|NCT02174276|450159833|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
125146976|NCT02174276|450159834|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
125146977|NCT02174276|450159835|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
125146978|NCT02174276|450159836|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
125146979|NCT02174276|450159833|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
125146980|NCT02174276|450159834|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
125146981|NCT02174276|450159835|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
125146982|NCT02174276|450159836|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
125146983|NCT02174276|450159833|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
125146984|NCT02174276|450159834|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
125146985|NCT02174276|450159835|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
125146986|NCT02174276|450159836|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
125146987|NCT01206439|450159837|FG000|Overall Study|subject did not meet inclusion criteria|1|||
125146988|NCT00515216|450159840|FG000|Overall Study|Withdrawal by Subject|1|||
125146989|NCT02786927|450159841|FG000|Overall Study|Adverse Event|1|||
125146990|NCT02786927|450159841|FG000|Overall Study|Protocol Violation|4|||
125146991|NCT01801917|450159842|FG000|Period 1 - Randomized|Adverse Event|1|||
125146992|NCT01801917|450159843|FG001|Period 1 - Randomized|Adverse Event|0|||
125146993|NCT01801917|450159844|FG002|Period 1 - Randomized|Adverse Event|1|||
125146994|NCT01801917|450159845|FG003|Period 1 - Randomized|Adverse Event|0|||
125146995|NCT04307849|450159846|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
125146996|NCT04307849|450159847|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
125146997|NCT04307849|450159848|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
125146998|NCT04307849|450159849|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
125146999|NCT04307849|450159850|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
125147000|NCT04307849|450159851|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
125147001|NCT04307849|450159846|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
125147002|NCT04307849|450159847|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
125147003|NCT04307849|450159848|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
125147004|NCT04307849|450159849|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
125147005|NCT04307849|450159850|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
125147006|NCT04307849|450159851|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
125147007|NCT04307849|450159846|FG000|Overall Study|Family member did not want them to continue|0|||
125147008|NCT04307849|450159847|FG001|Overall Study|Family member did not want them to continue|0|||
125147009|NCT04307849|450159848|FG002|Overall Study|Family member did not want them to continue|1|||
125147010|NCT04307849|450159849|FG003|Overall Study|Family member did not want them to continue|0|||
125147011|NCT04307849|450159850|FG004|Overall Study|Family member did not want them to continue|0|||
125147012|NCT04307849|450159851|FG005|Overall Study|Family member did not want them to continue|0|||
125147013|NCT04307849|450159846|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
125147014|NCT04307849|450159847|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
125147015|NCT04307849|450159848|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
125147016|NCT04307849|450159849|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
125147017|NCT04307849|450159850|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
125147018|NCT04307849|450159851|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
125147019|NCT05467982|450159852|FG000|Overall Study|Death|0|||
125147020|NCT05467982|450159853|FG001|Overall Study|Death|1|||
125147021|NCT05467982|450159852|FG000|Overall Study|Lost to Follow-up|3|||
125147022|NCT05467982|450159853|FG001|Overall Study|Lost to Follow-up|1|||
125147023|NCT00708682|450159873|FG000|Infant Series|Adverse Event|1|||
125147024|NCT00708682|450159873|FG000|Infant Series|Lost to Follow-up|4|||
125147025|NCT00708682|450159873|FG000|Infant Series|Protocol Violation|1|||
125147026|NCT00708682|450159873|FG000|Infant Series|Parent/legal guardian request|6|||
125147027|NCT00708682|450159873|FG000|Infant Series|Failed to return|2|||
125147028|NCT00708682|450159873|FG000|Infant Series|Other|19|||
125147029|NCT00708682|450159873|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
125147030|NCT00708682|450159873|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
125147031|NCT00708682|450159873|FG000|Toddler Dose|Lost to Follow-up|3|||
125147032|NCT00708682|450159873|FG000|Toddler Dose|Failed to Return|4|||
125147033|NCT00420095|450159874|FG000|Overall Study|Adverse Event|1|||
125147034|NCT00420095|450159875|FG001|Overall Study|Adverse Event|0|||
125147035|NCT00420095|450159874|FG000|Overall Study|Protocol Violation|1|||
125147036|NCT00420095|450159875|FG001|Overall Study|Protocol Violation|1|||
125147037|NCT00420095|450159874|FG000|Overall Study|Lost to Follow-up|1|||
125147038|NCT00420095|450159875|FG001|Overall Study|Lost to Follow-up|0|||
125147039|NCT03185741|450159876|FG000|Baseline|Withdrawal by Subject|1|||
125147040|NCT03185741|450159877|FG001|Baseline|Withdrawal by Subject|3|||
125147041|NCT03185741|450159878|FG002|Baseline|Withdrawal by Subject|2|||
125147042|NCT03185741|450159876|FG000|Baseline|Lost to Follow-up|1|||
125147043|NCT03185741|450159877|FG001|Baseline|Lost to Follow-up|2|||
125147044|NCT03185741|450159878|FG002|Baseline|Lost to Follow-up|3|||
125147045|NCT03185741|450159876|FG000|3Month|Death|1|||
125147046|NCT03185741|450159877|FG001|3Month|Death|1|||
125147047|NCT03185741|450159878|FG002|3Month|Death|2|||
125147048|NCT03185741|450159876|FG000|3Month|Withdrawal by Subject|1|||
125147049|NCT03185741|450159877|FG001|3Month|Withdrawal by Subject|5|||
125147050|NCT03185741|450159878|FG002|3Month|Withdrawal by Subject|1|||
125147051|NCT03185741|450159876|FG000|3Month|Lost to Follow-up|7|||
125147052|NCT03185741|450159877|FG001|3Month|Lost to Follow-up|9|||
125147053|NCT03185741|450159878|FG002|3Month|Lost to Follow-up|8|||
125223601|NCT02326272|450446170|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125147054|NCT03185741|450159876|FG000|3Month|Unavailable for 3Month|11|||
125147055|NCT03185741|450159877|FG001|3Month|Unavailable for 3Month|10|||
125147056|NCT03185741|450159878|FG002|3Month|Unavailable for 3Month|11|||
125147057|NCT03185741|450159876|FG000|3Month|Protocol Violation|0|||
125147058|NCT03185741|450159877|FG001|3Month|Protocol Violation|0|||
125147059|NCT03185741|450159878|FG002|3Month|Protocol Violation|3|||
125147060|NCT03185741|450159876|FG000|6Month|Death|1|||
125147061|NCT03185741|450159877|FG001|6Month|Death|1|||
125147062|NCT03185741|450159878|FG002|6Month|Death|2|||
125147063|NCT03185741|450159876|FG000|6Month|Withdrawal by Subject|2|||
125147064|NCT03185741|450159877|FG001|6Month|Withdrawal by Subject|3|||
125147065|NCT03185741|450159878|FG002|6Month|Withdrawal by Subject|1|||
125147066|NCT03185741|450159876|FG000|6Month|Lost to Follow-up|16|||
125147067|NCT03185741|450159877|FG001|6Month|Lost to Follow-up|15|||
125147068|NCT03185741|450159878|FG002|6Month|Lost to Follow-up|16|||
125147069|NCT01634854|450159879|FG000|Overall Study|Cesarean delivery|2|||
125147070|NCT01634854|450159880|FG001|Overall Study|Cesarean delivery|7|||
125147071|NCT00654641|450159881|FG000|Overall Study|Lost to Follow-up|2|||
125147072|NCT00654641|450159882|FG001|Overall Study|Lost to Follow-up|3|||
125147073|NCT01337596|450159883|FG000|Overall Study|Withdrawal by Subject|0|||
125147074|NCT01337596|450159884|FG001|Overall Study|Withdrawal by Subject|0|||
125147075|NCT01337596|450159885|FG002|Overall Study|Withdrawal by Subject|0|||
125147076|NCT01337596|450159886|FG003|Overall Study|Withdrawal by Subject|0|||
125147077|NCT01337596|450159887|FG004|Overall Study|Withdrawal by Subject|2|||
125147078|NCT01337596|450159888|FG005|Overall Study|Withdrawal by Subject|0|||
125147079|NCT01337596|450159889|FG006|Overall Study|Withdrawal by Subject|0|||
125147080|NCT01337596|450159890|FG007|Overall Study|Withdrawal by Subject|0|||
125147081|NCT01337596|450159891|FG008|Overall Study|Withdrawal by Subject|0|||
125147082|NCT00108628|450161255|FG000|Overall Study|Withdrawal by Subject|17|||
125147083|NCT00108628|450161256|FG001|Overall Study|Withdrawal by Subject|9|||
125147084|NCT00108628|450161255|FG000|Overall Study|Lack of Efficacy|2|||
125147085|NCT00108628|450161256|FG001|Overall Study|Lack of Efficacy|1|||
125147086|NCT00108628|450161255|FG000|Overall Study|Death|1|||
125147087|NCT00108628|450161256|FG001|Overall Study|Death|0|||
125147088|NCT01636934|450161257|FG000|Overall Study|Withdrawal by Subject|3|||
125147089|NCT01636934|450161258|FG001|Overall Study|Withdrawal by Subject|2|||
125147090|NCT01636934|450161257|FG000|Overall Study|Chemo cancel|1|||
125147091|NCT01636934|450161258|FG001|Overall Study|Chemo cancel|0|||
125147092|NCT01636934|450161257|FG000|Overall Study|Too ill to continue|1|||
125147093|NCT01636934|450161258|FG001|Overall Study|Too ill to continue|0|||
125147094|NCT01636934|450161257|FG000|Overall Study|Never started study medication|1|||
125147095|NCT01636934|450161258|FG001|Overall Study|Never started study medication|1|||
125147096|NCT02297841|450161262|FG000|Overall Study|Withdrawal by Subject|1|||
125147097|NCT02297841|450161262|FG000|Overall Study|Protocol Violation|7|||
125147098|NCT03429049|450161263|FG000|Overall Study|Adverse Event|2|||
125147099|NCT03429049|450161264|FG001|Overall Study|Adverse Event|3|||
125147100|NCT03429049|450161263|FG000|Overall Study|Death|0|||
125147101|NCT03429049|450161264|FG001|Overall Study|Death|1|||
125147102|NCT03429049|450161263|FG000|Overall Study|Lack of Efficacy|4|||
125147103|NCT03429049|450161264|FG001|Overall Study|Lack of Efficacy|2|||
125147104|NCT03429049|450161263|FG000|Overall Study|Lost to Follow-up|9|||
125147105|NCT03429049|450161264|FG001|Overall Study|Lost to Follow-up|8|||
125147106|NCT03429049|450161263|FG000|Overall Study|Physician Decision|1|||
125147107|NCT03429049|450161264|FG001|Overall Study|Physician Decision|0|||
125147108|NCT03429049|450161263|FG000|Overall Study|Protocol Violation|3|||
125147109|NCT03429049|450161264|FG001|Overall Study|Protocol Violation|0|||
125147110|NCT03429049|450161263|FG000|Overall Study|Sponsor Decision|2|||
125147111|NCT03429049|450161264|FG001|Overall Study|Sponsor Decision|0|||
125147112|NCT03429049|450161263|FG000|Overall Study|Withdrawal by Subject|4|||
125147113|NCT03429049|450161264|FG001|Overall Study|Withdrawal by Subject|20|||
125147114|NCT03429049|450161263|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
125147115|NCT03429049|450161264|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
125223602|NCT02326272|450446171|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125147116|NCT01841060|450161268|FG000|Overall Study|Protocol Violation|10|||
125147117|NCT01872715|450161272|FG000|Overall Study|Adverse Event|1|||
125147118|NCT01872715|450161272|FG000|Overall Study|Protocol Violation|1|||
125147119|NCT01872715|450161272|FG000|Overall Study|Withdrawal by Subject|2|||
125147120|NCT01765270|450161282|FG000|Overall Study|Physician Decision|1|||
125147121|NCT01765270|450161283|FG001|Overall Study|Physician Decision|0|||
125147122|NCT01765270|450161282|FG000|Overall Study|Withdrawal by Subject|0|||
125147123|NCT01765270|450161283|FG001|Overall Study|Withdrawal by Subject|1|||
125147124|NCT03431337|450161286|FG000|Overall Study|Lost to Follow-up|21|||
125147125|NCT03431337|450161287|FG001|Overall Study|Lost to Follow-up|19|||
125147126|NCT03431337|450161286|FG000|Overall Study|Withdrawal by Subject|8|||
125147127|NCT03431337|450161287|FG001|Overall Study|Withdrawal by Subject|3|||
125147128|NCT00329160|450161288|FG000|Overall Study|Adverse Event|27|||
125147129|NCT00329160|450161288|FG000|Overall Study|Withdrawal by Subject|13|||
125147130|NCT00329160|450161288|FG000|Overall Study|Protocol Violation|2|||
125147131|NCT00329160|450161288|FG000|Overall Study|Did not Receive Study Drug|1|||
125147132|NCT00329160|450161288|FG000|Overall Study|Incomplete IVUS|45|||
125147133|NCT04501094|450161289|FG000|Overall Study|Death (unrelated to research)|1|||
125147134|NCT04501094|450161290|FG001|Overall Study|Death (unrelated to research)|0|||
125147135|NCT00063258|450161294|FG000|Overall Study|Physician Decision|2|||
125147136|NCT00063258|450161295|FG001|Overall Study|Physician Decision|0|||
125147137|NCT00063258|450161294|FG000|Overall Study|Lack of Efficacy|2|||
125147138|NCT00063258|450161295|FG001|Overall Study|Lack of Efficacy|0|||
125147139|NCT00784979|450161298|FG000|Overall Study|incomplete data|6|||
125147140|NCT00894933|450161299|FG000|Overall Study|Lost to Follow-up|2|||
125147141|NCT00894933|450161299|FG000|Overall Study|Cancelled Procedure|1|||
125147142|NCT00894933|450161299|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
125147143|NCT01235715|450161304|FG000|Overall Study|Physician Decision|0|||
125147144|NCT01235715|450161305|FG001|Overall Study|Physician Decision|2|||
125147145|NCT03619876|450161306|FG000|Overall Study|Withdrawal by Subject|1|||
125147146|NCT03619876|450161307|FG001|Overall Study|Withdrawal by Subject|2|||
125147147|NCT03619876|450161306|FG000|Overall Study|Withdrawal due to incidental finding|0|||
125147148|NCT03619876|450161307|FG001|Overall Study|Withdrawal due to incidental finding|2|||
125147149|NCT00396630|450161310|FG000|Overall Study|Lost to Follow-up|1|||
125147150|NCT00396630|450161311|FG001|Overall Study|Lost to Follow-up|1|||
125147151|NCT00396630|450161310|FG000|Overall Study|Withdrawal by Subject|1|||
125147152|NCT00396630|450161311|FG001|Overall Study|Withdrawal by Subject|1|||
125147153|NCT00396630|450161310|FG000|Overall Study|Not vaccinated at Visit 3|3|||
125147154|NCT00396630|450161311|FG001|Overall Study|Not vaccinated at Visit 3|3|||
125147155|NCT00996437|450161314|FG000|Overall Study|Death|1|||
125147156|NCT00996437|450161315|FG001|Overall Study|Death|0|||
125147157|NCT00996437|450161314|FG000|Overall Study|Dropped|2|||
125147158|NCT00996437|450161315|FG001|Overall Study|Dropped|2|||
125147159|NCT00996437|450161314|FG000|Overall Study|Missed|2|||
125147160|NCT00996437|450161315|FG001|Overall Study|Missed|5|||
125147161|NCT02576717|450161318|FG000|Overall Study|Other Reasons|16|||
125147162|NCT02576717|450161319|FG001|Overall Study|Other Reasons|18|||
125147163|NCT02576717|450161320|FG002|Overall Study|Other Reasons|15|||
125147164|NCT02576717|450161318|FG000|Overall Study|Covid-19 Pandemic|0|||
125147165|NCT02576717|450161319|FG001|Overall Study|Covid-19 Pandemic|1|||
125147166|NCT02576717|450161320|FG002|Overall Study|Covid-19 Pandemic|1|||
125147167|NCT02576717|450161318|FG000|Overall Study|Sponsor Decision|0|||
125147168|NCT02576717|450161319|FG001|Overall Study|Sponsor Decision|0|||
125147169|NCT02576717|450161320|FG002|Overall Study|Sponsor Decision|1|||
125147170|NCT02576717|450161318|FG000|Overall Study|Physician Decision|3|||
125147171|NCT02576717|450161319|FG001|Overall Study|Physician Decision|8|||
125147172|NCT02576717|450161320|FG002|Overall Study|Physician Decision|9|||
125147173|NCT02576717|450161318|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
125147174|NCT02576717|450161319|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
125147175|NCT02576717|450161320|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
125147176|NCT02576717|450161318|FG000|Overall Study|Death|3|||
125147177|NCT02576717|450161319|FG001|Overall Study|Death|5|||
125147178|NCT02576717|450161320|FG002|Overall Study|Death|3|||
125147179|NCT02576717|450161318|FG000|Overall Study|Lost to Follow-up|9|||
125147180|NCT02576717|450161319|FG001|Overall Study|Lost to Follow-up|10|||
125147181|NCT02576717|450161320|FG002|Overall Study|Lost to Follow-up|19|||
125147182|NCT02576717|450161318|FG000|Overall Study|Protocol Violation|4|||
125147183|NCT02576717|450161319|FG001|Overall Study|Protocol Violation|0|||
125147184|NCT02576717|450161320|FG002|Overall Study|Protocol Violation|5|||
125147185|NCT02576717|450161318|FG000|Overall Study|Lack of Efficacy|24|||
125147186|NCT02576717|450161319|FG001|Overall Study|Lack of Efficacy|28|||
125147187|NCT02576717|450161320|FG002|Overall Study|Lack of Efficacy|20|||
125147188|NCT02576717|450161318|FG000|Overall Study|Adverse Event|26|||
125147189|NCT02576717|450161319|FG001|Overall Study|Adverse Event|32|||
125147190|NCT02576717|450161320|FG002|Overall Study|Adverse Event|26|||
125147191|NCT01755975|450161321|FG000|Overall Study|Adverse Event|0|||
125147192|NCT01755975|450161322|FG001|Overall Study|Adverse Event|0|||
125147193|NCT01755975|450161323|FG002|Overall Study|Adverse Event|1|||
125147194|NCT01755975|450161324|FG003|Overall Study|Adverse Event|0|||
125147195|NCT01755975|450161325|FG004|Overall Study|Adverse Event|2|||
125147196|NCT00399893|450161326|FG000|Overall Study|Withdrawal by Subject|1|||
125147197|NCT00399893|450161327|FG001|Overall Study|Withdrawal by Subject|0|||
125147198|NCT01729026|450161329|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
125147199|NCT01729026|450161330|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
125147200|NCT01729026|450161329|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
125147201|NCT01729026|450161330|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
125147202|NCT00906373|450161331|FG000|Overall Study|Withdrawal by Subject|0|||
125147203|NCT00906373|450161332|FG001|Overall Study|Withdrawal by Subject|5|||
125147204|NCT00906373|450161331|FG000|Overall Study|Other|0|||
125147205|NCT00906373|450161332|FG001|Overall Study|Other|1|||
125147206|NCT00906373|450161331|FG000|Overall Study|Still on treatment at cutoff date|0|||
125147207|NCT00906373|450161332|FG001|Overall Study|Still on treatment at cutoff date|2|||
125147208|NCT01597479|450161333|FG000|Overall Study|Protocol Violation|1|||
125147209|NCT01597479|450161334|FG001|Overall Study|Protocol Violation|0|||
125147210|NCT01597479|450161333|FG000|Overall Study|Lost to Follow-up|1|||
125147211|NCT01597479|450161334|FG001|Overall Study|Lost to Follow-up|0|||
125147212|NCT00848042|450161335|FG000|Overall Study|Death|1|||
125147213|NCT00848042|450161336|FG001|Overall Study|Death|2|||
125147214|NCT00848042|450161337|FG002|Overall Study|Death|0|||
125147215|NCT00848042|450161335|FG000|Overall Study|Other Therapy|3|||
125147216|NCT00848042|450161336|FG001|Overall Study|Other Therapy|0|||
125147217|NCT00848042|450161337|FG002|Overall Study|Other Therapy|0|||
125147218|NCT00979212|450161340|FG000|Overall Study|Protocol Violation|1|||
125147219|NCT00979212|450161341|FG001|Overall Study|Protocol Violation|8|||
125147220|NCT00979212|450161340|FG000|Overall Study|No protocol therapy received|1|||
125147221|NCT00979212|450161341|FG001|Overall Study|No protocol therapy received|0|||
125147222|NCT04886063|450161344|FG000|Overall Study|Adverse Event|50|||
125147223|NCT04886063|450161344|FG000|Overall Study|Lack of Efficacy|31|||
125147224|NCT04886063|450161344|FG000|Overall Study|Withdrawal by Subject|45|||
125147225|NCT04886063|450161344|FG000|Overall Study|Physician Decision|3|||
125147226|NCT04886063|450161344|FG000|Overall Study|Protocol Violation|3|||
125147227|NCT04886063|450161344|FG000|Overall Study|Site closure|4|||
125147228|NCT04886063|450161344|FG000|Overall Study|Nursing home replacement|3|||
125147229|NCT04886063|450161344|FG000|Overall Study|Lost to Follow-up|5|||
125147230|NCT04886063|450161344|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
125147231|NCT04886063|450161344|FG000|Overall Study|>1 reason|20|||
125147232|NCT00309985|450161345|FG000|Overall Study|Disease progression|12|||
125147233|NCT00309985|450161346|FG001|Overall Study|Disease progression|0|||
125147234|NCT00309985|450161345|FG000|Overall Study|Adverse Event|30|||
125147235|NCT00309985|450161346|FG001|Overall Study|Adverse Event|0|||
125147236|NCT00309985|450161345|FG000|Overall Study|Death|2|||
125147237|NCT00309985|450161346|FG001|Overall Study|Death|0|||
125147238|NCT00309985|450161345|FG000|Overall Study|Withdrawal by Subject|5|||
125147239|NCT00309985|450161346|FG001|Overall Study|Withdrawal by Subject|1|||
125147240|NCT00309985|450161345|FG000|Overall Study|Physician Decision|3|||
125147241|NCT00309985|450161346|FG001|Overall Study|Physician Decision|0|||
125147242|NCT00309985|450161345|FG000|Overall Study|Never started treatment|7|||
125147243|NCT00309985|450161346|FG001|Overall Study|Never started treatment|0|||
125147244|NCT00309985|450161345|FG000|Overall Study|Complicating disease|1|||
125147245|NCT00309985|450161346|FG001|Overall Study|Complicating disease|0|||
125147246|NCT00309985|450161345|FG000|Overall Study|Non-compliance|1|||
125147247|NCT00309985|450161346|FG001|Overall Study|Non-compliance|0|||
125147248|NCT00309985|450161345|FG000|Overall Study|Chemotherapy discontinued only|1|||
125147249|NCT00309985|450161346|FG001|Overall Study|Chemotherapy discontinued only|0|||
125147250|NCT02448563|450161347|FG000|Overall Study|Lost to Follow-up|16|||
125147251|NCT02448563|450161348|FG001|Overall Study|Lost to Follow-up|10|||
125147252|NCT02448563|450161347|FG000|Overall Study|Withdrawal by Subject|0|||
125147253|NCT02448563|450161348|FG001|Overall Study|Withdrawal by Subject|1|||
125147254|NCT02340962|450161350|FG000|Overall Study|Lost to Follow-up|1|||
125147255|NCT02340962|450161351|FG001|Overall Study|Lost to Follow-up|0|||
125147256|NCT01450800|450161352|FG000|Overall Study|Protocol Violation|1|||
125147257|NCT01450800|450161353|FG001|Overall Study|Protocol Violation|3|||
125147258|NCT00265785|450161354|FG000|Overall Study|Adverse Event|4|||
125147259|NCT00265785|450161354|FG000|Overall Study|Withdrawal by Subject|3|||
125147260|NCT00265785|450161354|FG000|Overall Study|Progression/Relapse|15|||
125147261|NCT00265785|450161354|FG000|Overall Study|Not protocol specified|2|||
125223603|NCT02326272|450446172|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125147262|NCT00265785|450161354|FG000|Overall Study|Ineligible|1|||
125147263|NCT00265785|450161354|FG000|Overall Study|Did not receive protocol treatment|2|||
125147264|NCT01294449|450161357|FG000|Overall Study|Death|11|||
125147265|NCT01294449|450161358|FG001|Overall Study|Death|12|||
125147266|NCT01294449|450161357|FG000|Overall Study|Withdrawal by Subject|1|||
125147267|NCT01294449|450161358|FG001|Overall Study|Withdrawal by Subject|3|||
125147268|NCT04291508|450161365|FG000|Overall Study|Withdrawal by Subject|1|||
125147269|NCT04291508|450161366|FG001|Overall Study|Withdrawal by Subject|0|||
125147270|NCT04291508|450161367|FG002|Overall Study|Withdrawal by Subject|1|||
125147271|NCT04291508|450161368|FG003|Overall Study|Withdrawal by Subject|0|||
125147272|NCT04291508|450161365|FG000|Overall Study|lost to follow up|4|||
125147273|NCT04291508|450161366|FG001|Overall Study|lost to follow up|0|||
125147274|NCT04291508|450161367|FG002|Overall Study|lost to follow up|1|||
125147275|NCT04291508|450161368|FG003|Overall Study|lost to follow up|0|||
125147276|NCT02329431|450161369|FG000|Overall Study|Lost to Follow-up|20|||
125147277|NCT02329431|450161370|FG001|Overall Study|Lost to Follow-up|13|||
125147278|NCT02625974|450161371|FG000|Part 1|Lost to Follow-up|9|||
125147279|NCT02625974|450161372|FG001|Part 1|Lost to Follow-up|3|||
125147280|NCT02625974|450161371|FG000|Part 2|Lost to Follow-up|4|||
125147281|NCT02625974|450161372|FG001|Part 2|Lost to Follow-up|6|||
125147282|NCT02625974|450161371|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
125147283|NCT02625974|450161372|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
125147284|NCT01977456|450161373|FG000|Overall Study|Death|5|||
125147285|NCT01142661|450161374|FG000|Overall Study|Adverse Event|2|||
125147286|NCT01142661|450161374|FG000|Overall Study|Withdrawal by Subject|1|||
125147287|NCT01142661|450161374|FG000|Overall Study|Physician Decision|1|||
125147288|NCT00434590|450161375|FG000|Overall Study|Administrative problems|5|||
125147289|NCT00434590|450161376|FG001|Overall Study|Administrative problems|5|||
125147290|NCT02129062|450162870|FG000|Overall Study|Death|1|||
125147291|NCT02129062|450162870|FG000|Overall Study|Disease Progression|2|||
125147292|NCT02722616|450162871|FG000|Overall Study|Sponsor closed study after one month|2|||
125147293|NCT02722616|450162872|FG001|Overall Study|Sponsor closed study after one month|0|||
125147294|NCT02722616|450162873|FG002|Overall Study|Sponsor closed study after one month|0|||
125147295|NCT01923311|450162876|FG000|Overall Study|Pregnancy|1|||
125147296|NCT01923311|450162877|FG001|Overall Study|Pregnancy|0|||
125147297|NCT01923311|450162876|FG000|Overall Study|Investigator's Discretion|1|||
125147298|NCT01923311|450162877|FG001|Overall Study|Investigator's Discretion|0|||
125147299|NCT01923311|450162876|FG000|Overall Study|Non-Compliance with Study Drug|2|||
125147300|NCT01923311|450162877|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125147301|NCT01923311|450162876|FG000|Overall Study|Withdrew Consent|1|||
125147302|NCT01923311|450162877|FG001|Overall Study|Withdrew Consent|0|||
125147303|NCT01923311|450162876|FG000|Overall Study|Study Terminated by Sponsor|12|||
125147304|NCT01923311|450162877|FG001|Overall Study|Study Terminated by Sponsor|0|||
125147305|NCT02031237|450162878|FG000|Overall Study|Death|1|||
125147306|NCT02031237|450162879|FG001|Overall Study|Death|5|||
125147307|NCT02031237|450162880|FG002|Overall Study|Death|0|||
125147308|NCT02031237|450162878|FG000|Overall Study|Physician Decision|0|||
125147309|NCT02031237|450162879|FG001|Overall Study|Physician Decision|1|||
125147310|NCT02031237|450162880|FG002|Overall Study|Physician Decision|0|||
125147311|NCT02031237|450162878|FG000|Overall Study|Withdrawal by Subject|2|||
125147312|NCT02031237|450162879|FG001|Overall Study|Withdrawal by Subject|2|||
125147313|NCT02031237|450162880|FG002|Overall Study|Withdrawal by Subject|0|||
125147314|NCT02031237|450162878|FG000|Overall Study|Protocol Violation|2|||
125147315|NCT02031237|450162879|FG001|Overall Study|Protocol Violation|6|||
125147316|NCT02031237|450162880|FG002|Overall Study|Protocol Violation|0|||
125147317|NCT02031237|450162878|FG000|Overall Study|Alternate Treatment Given|0|||
125147318|NCT02031237|450162879|FG001|Overall Study|Alternate Treatment Given|0|||
125223604|NCT02326272|450446173|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125147319|NCT02031237|450162880|FG002|Overall Study|Alternate Treatment Given|3|||
125147320|NCT01011335|450162883|FG000|Overall Study|Lost to Follow-up|0|||
125147321|NCT01011335|450162884|FG001|Overall Study|Lost to Follow-up|0|||
125147322|NCT01011335|450162885|FG002|Overall Study|Lost to Follow-up|1|||
125147323|NCT01011335|450162886|FG003|Overall Study|Lost to Follow-up|1|||
125147324|NCT01011335|450162887|FG004|Overall Study|Lost to Follow-up|1|||
125147325|NCT01011335|450162888|FG005|Overall Study|Lost to Follow-up|1|||
125147326|NCT01011335|450162889|FG006|Overall Study|Lost to Follow-up|2|||
125147327|NCT01011335|450162890|FG007|Overall Study|Lost to Follow-up|2|||
125147328|NCT01011335|450162891|FG008|Overall Study|Lost to Follow-up|1|||
125147329|NCT01011335|450162892|FG009|Overall Study|Lost to Follow-up|0|||
125147330|NCT01011335|450162893|FG010|Overall Study|Lost to Follow-up|0|||
125147331|NCT01011335|450162894|FG011|Overall Study|Lost to Follow-up|1|||
125147332|NCT01011335|450162895|FG012|Overall Study|Lost to Follow-up|2|||
125147333|NCT01011335|450162883|FG000|Overall Study|Protocol Violation|0|||
125147334|NCT01011335|450162884|FG001|Overall Study|Protocol Violation|1|||
125147335|NCT01011335|450162885|FG002|Overall Study|Protocol Violation|0|||
125147336|NCT01011335|450162886|FG003|Overall Study|Protocol Violation|0|||
125147337|NCT01011335|450162887|FG004|Overall Study|Protocol Violation|0|||
125147338|NCT01011335|450162888|FG005|Overall Study|Protocol Violation|0|||
125147339|NCT01011335|450162889|FG006|Overall Study|Protocol Violation|0|||
125147340|NCT01011335|450162890|FG007|Overall Study|Protocol Violation|0|||
125147341|NCT01011335|450162891|FG008|Overall Study|Protocol Violation|0|||
125147342|NCT01011335|450162892|FG009|Overall Study|Protocol Violation|0|||
125147343|NCT01011335|450162893|FG010|Overall Study|Protocol Violation|0|||
125147344|NCT01011335|450162894|FG011|Overall Study|Protocol Violation|0|||
125147345|NCT01011335|450162895|FG012|Overall Study|Protocol Violation|0|||
125147346|NCT01011335|450162883|FG000|Overall Study|Moved/deployed or no booster|1|||
125147347|NCT01011335|450162884|FG001|Overall Study|Moved/deployed or no booster|0|||
125147348|NCT01011335|450162885|FG002|Overall Study|Moved/deployed or no booster|0|||
125147349|NCT01011335|450162886|FG003|Overall Study|Moved/deployed or no booster|1|||
125147350|NCT01011335|450162887|FG004|Overall Study|Moved/deployed or no booster|0|||
125147351|NCT01011335|450162888|FG005|Overall Study|Moved/deployed or no booster|0|||
125147352|NCT01011335|450162889|FG006|Overall Study|Moved/deployed or no booster|1|||
125147353|NCT01011335|450162890|FG007|Overall Study|Moved/deployed or no booster|0|||
125147354|NCT01011335|450162891|FG008|Overall Study|Moved/deployed or no booster|1|||
125147355|NCT01011335|450162892|FG009|Overall Study|Moved/deployed or no booster|0|||
125147356|NCT01011335|450162893|FG010|Overall Study|Moved/deployed or no booster|2|||
125147357|NCT01011335|450162894|FG011|Overall Study|Moved/deployed or no booster|0|||
125147358|NCT01011335|450162895|FG012|Overall Study|Moved/deployed or no booster|0|||
125147359|NCT01011335|450162883|FG000|Overall Study|Adverse Event|0|||
125147360|NCT01011335|450162884|FG001|Overall Study|Adverse Event|0|||
125147361|NCT01011335|450162885|FG002|Overall Study|Adverse Event|0|||
125147362|NCT01011335|450162886|FG003|Overall Study|Adverse Event|0|||
125147363|NCT01011335|450162887|FG004|Overall Study|Adverse Event|0|||
125147364|NCT01011335|450162888|FG005|Overall Study|Adverse Event|0|||
125147365|NCT01011335|450162889|FG006|Overall Study|Adverse Event|0|||
125147366|NCT01011335|450162890|FG007|Overall Study|Adverse Event|0|||
125147367|NCT01011335|450162891|FG008|Overall Study|Adverse Event|0|||
125147368|NCT01011335|450162892|FG009|Overall Study|Adverse Event|0|||
125147369|NCT01011335|450162893|FG010|Overall Study|Adverse Event|4|||
125147370|NCT01011335|450162894|FG011|Overall Study|Adverse Event|0|||
125147371|NCT01011335|450162895|FG012|Overall Study|Adverse Event|1|||
125147372|NCT01765751|450162902|FG000|Overall Study|Lost to Follow-up|0|||
125147373|NCT01765751|450162903|FG001|Overall Study|Lost to Follow-up|2|||
125147374|NCT01765751|450162904|FG002|Overall Study|Lost to Follow-up|1|||
125147375|NCT02459418|450162905|FG000|Overall Study|Exclusion Criteria|4|||
125147376|NCT02459418|450162906|FG001|Overall Study|Exclusion Criteria|0|||
125147377|NCT02459418|450162905|FG000|Overall Study|Protocol Violation|0|||
125147378|NCT02459418|450162906|FG001|Overall Study|Protocol Violation|2|||
125147379|NCT02459418|450162905|FG000|Overall Study|Physician Decision|0|||
125147380|NCT02459418|450162906|FG001|Overall Study|Physician Decision|2|||
125147381|NCT02459418|450162905|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
125147382|NCT02459418|450162906|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
125147383|NCT02459418|450162905|FG000|Overall Study|Adverse Event|0|||
125147384|NCT02459418|450162906|FG001|Overall Study|Adverse Event|1|||
125147385|NCT02459418|450162905|FG000|Overall Study|Withdrawal by Subject|1|||
125147386|NCT02459418|450162906|FG001|Overall Study|Withdrawal by Subject|1|||
125147387|NCT02459418|450162905|FG000|Overall Study|Elevated Creatine Kinase|1|||
125147388|NCT02459418|450162906|FG001|Overall Study|Elevated Creatine Kinase|0|||
125147389|NCT02459418|450162905|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
125147390|NCT02459418|450162906|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
125147391|NCT05258630|450162907|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
125147392|NCT05258630|450162908|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
125147393|NCT05258630|450162907|FG000|Overall Study|Lost to Follow-up|0|||
125147394|NCT05258630|450162908|FG001|Overall Study|Lost to Follow-up|2|||
125147395|NCT03303417|450162909|FG000|Overall Study|Withdrawal by Subject|1|||
125147396|NCT03303417|450162910|FG001|Overall Study|Withdrawal by Subject|1|||
125147397|NCT01848210|450162911|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
125147398|NCT01848210|450162912|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
125147399|NCT01848210|450162911|FG000|Overall Study|Lost to Follow-up|24|||
125147400|NCT01848210|450162912|FG001|Overall Study|Lost to Follow-up|12|||
125147401|NCT01848210|450162911|FG000|Overall Study|Protocol Violation|3|||
125147402|NCT01848210|450162912|FG001|Overall Study|Protocol Violation|5|||
125147403|NCT01848210|450162911|FG000|Overall Study|Use of Forbidden Drugs|9|||
125147404|NCT01848210|450162912|FG001|Overall Study|Use of Forbidden Drugs|10|||
125147405|NCT01848210|450162911|FG000|Overall Study|Impedition Condition|5|||
125147406|NCT01848210|450162912|FG001|Overall Study|Impedition Condition|9|||
125147407|NCT01848210|450162911|FG000|Overall Study|Adverse Event|7|||
125147408|NCT01848210|450162912|FG001|Overall Study|Adverse Event|9|||
125147409|NCT01848210|450162911|FG000|Overall Study|Discontinuation Criterion|5|||
125147410|NCT01848210|450162912|FG001|Overall Study|Discontinuation Criterion|7|||
125147411|NCT01848210|450162911|FG000|Overall Study|Hypesensitivity|1|||
125147412|NCT01848210|450162912|FG001|Overall Study|Hypesensitivity|0|||
125147413|NCT01848210|450162911|FG000|Overall Study|Hepatic Function Alteration|4|||
125147414|NCT01848210|450162912|FG001|Overall Study|Hepatic Function Alteration|0|||
125147415|NCT01848210|450162911|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
125147416|NCT01848210|450162912|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
125147417|NCT01848210|450162911|FG000|Overall Study|Administrative|1|||
125147418|NCT01848210|450162912|FG001|Overall Study|Administrative|0|||
125147419|NCT02426541|450162916|FG000|Overall Study|Protocol Violation|1|||
125147420|NCT02426541|450162917|FG001|Overall Study|Protocol Violation|0|||
125147421|NCT00631007|450162920|FG000|Overall Study|Adverse Event|0|||
125147422|NCT00631007|450162921|FG001|Overall Study|Adverse Event|2|||
125147423|NCT00631007|450162922|FG002|Overall Study|Adverse Event|0|||
125147424|NCT00631007|450162923|FG003|Overall Study|Adverse Event|2|||
125147425|NCT00631007|450162924|FG004|Overall Study|Adverse Event|3|||
125147426|NCT00631007|450162925|FG005|Overall Study|Adverse Event|2|||
125147427|NCT00631007|450162920|FG000|Overall Study|Lost to Follow-up|2|||
125147428|NCT00631007|450162921|FG001|Overall Study|Lost to Follow-up|1|||
125147429|NCT00631007|450162922|FG002|Overall Study|Lost to Follow-up|2|||
125147430|NCT00631007|450162923|FG003|Overall Study|Lost to Follow-up|4|||
125147431|NCT00631007|450162924|FG004|Overall Study|Lost to Follow-up|5|||
125147432|NCT00631007|450162925|FG005|Overall Study|Lost to Follow-up|3|||
125147433|NCT00631007|450162920|FG000|Overall Study|Physician Decision|1|||
125147434|NCT00631007|450162921|FG001|Overall Study|Physician Decision|0|||
125147435|NCT00631007|450162922|FG002|Overall Study|Physician Decision|1|||
125147436|NCT00631007|450162923|FG003|Overall Study|Physician Decision|0|||
125147437|NCT00631007|450162924|FG004|Overall Study|Physician Decision|0|||
125147438|NCT00631007|450162925|FG005|Overall Study|Physician Decision|2|||
125147439|NCT00631007|450162920|FG000|Overall Study|Persistent Hyperglycemia|2|||
125147440|NCT00631007|450162921|FG001|Overall Study|Persistent Hyperglycemia|2|||
125147441|NCT00631007|450162922|FG002|Overall Study|Persistent Hyperglycemia|5|||
125147442|NCT00631007|450162923|FG003|Overall Study|Persistent Hyperglycemia|1|||
125147443|NCT00631007|450162924|FG004|Overall Study|Persistent Hyperglycemia|2|||
125147444|NCT00631007|450162925|FG005|Overall Study|Persistent Hyperglycemia|5|||
125147445|NCT00631007|450162920|FG000|Overall Study|Withdrawal by Subject|4|||
125147446|NCT00631007|450162921|FG001|Overall Study|Withdrawal by Subject|5|||
125147447|NCT00631007|450162922|FG002|Overall Study|Withdrawal by Subject|2|||
125147448|NCT00631007|450162923|FG003|Overall Study|Withdrawal by Subject|2|||
125147449|NCT00631007|450162924|FG004|Overall Study|Withdrawal by Subject|1|||
125147450|NCT00631007|450162925|FG005|Overall Study|Withdrawal by Subject|3|||
125147451|NCT00631007|450162920|FG000|Overall Study|Other|2|||
125147452|NCT00631007|450162921|FG001|Overall Study|Other|1|||
125147453|NCT00631007|450162922|FG002|Overall Study|Other|0|||
125147454|NCT00631007|450162923|FG003|Overall Study|Other|0|||
125147455|NCT00631007|450162924|FG004|Overall Study|Other|1|||
125147456|NCT00631007|450162925|FG005|Overall Study|Other|0|||
125147457|NCT00683787|450162926|FG000|Overall Study|Progression|3|||
125147458|NCT00683787|450162927|FG001|Overall Study|Progression|3|||
125147459|NCT00683787|450162928|FG002|Overall Study|Progression|0|||
125147460|NCT00683787|450162926|FG000|Overall Study|Adverse Event|0|||
125147461|NCT00683787|450162927|FG001|Overall Study|Adverse Event|0|||
125147462|NCT00683787|450162928|FG002|Overall Study|Adverse Event|2|||
125147463|NCT02674633|450162929|FG000|Overall Study|Lost to Follow-up|3|||
125147464|NCT02674633|450162930|FG001|Overall Study|Lost to Follow-up|2|||
125147465|NCT02674633|450162929|FG000|Overall Study|Physician Decision|1|||
125147466|NCT02674633|450162930|FG001|Overall Study|Physician Decision|0|||
125147467|NCT02674633|450162929|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
125147468|NCT02674633|450162930|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
125223605|NCT02326272|450446174|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
125147469|NCT00460109|450162931|FG000|Overall Study|Death|1|||
125147470|NCT02994394|450162932|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
125147471|NCT02994394|450162933|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
125147472|NCT02994394|450162934|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
125147473|NCT02994394|450162935|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
125147474|NCT02994394|450162936|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
125147475|NCT02994394|450162937|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
125147476|NCT02994394|450162932|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
125147477|NCT02994394|450162933|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
125223606|NCT02326272|450446175|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125147478|NCT02994394|450162934|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
125147479|NCT02994394|450162935|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
125147480|NCT02994394|450162936|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
125147481|NCT02994394|450162937|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
125147482|NCT02327325|450162938|FG000|Overall Study|Withdrawal by Subject|1|||
125147483|NCT02327325|450162939|FG001|Overall Study|Withdrawal by Subject|4|||
125147484|NCT02327325|450162940|FG002|Overall Study|Withdrawal by Subject|4|||
125147485|NCT02327325|450162938|FG000|Overall Study|Excluded by Study Team|0|||
125147486|NCT02327325|450162939|FG001|Overall Study|Excluded by Study Team|0|||
125147487|NCT02327325|450162940|FG002|Overall Study|Excluded by Study Team|1|||
125147488|NCT02457819|450162945|FG000|Overall Study|reason not given|8|||
125147489|NCT02457819|450162945|FG000|Overall Study|Withdrawal by Subject|24|||
125147490|NCT02457819|450162945|FG000|Overall Study|Protocol Violation|1|||
125147491|NCT02457819|450162945|FG000|Overall Study|non compliance with study drug|4|||
125147492|NCT02457819|450162945|FG000|Overall Study|Lost to Follow-up|10|||
125147493|NCT02457819|450162945|FG000|Overall Study|Lack of Efficacy|19|||
125147494|NCT02457819|450162945|FG000|Overall Study|Adverse Event|33|||
125147495|NCT03330236|450162947|FG000|Overall Study|Death|2|||
125147496|NCT03330236|450162948|FG001|Overall Study|Death|1|||
125147497|NCT03330236|450162947|FG000|Overall Study|Withdrawal by Subject|2|||
125147498|NCT03330236|450162948|FG001|Overall Study|Withdrawal by Subject|4|||
125147499|NCT03330236|450162947|FG000|Overall Study|Lost to Follow-up|0|||
125147500|NCT03330236|450162948|FG001|Overall Study|Lost to Follow-up|2|||
125147501|NCT03330236|450162947|FG000|Overall Study|Physician Decision|2|||
125147502|NCT03330236|450162948|FG001|Overall Study|Physician Decision|0|||
125147503|NCT03330236|450162947|FG000|Overall Study|Protocol Violation|4|||
125147504|NCT03330236|450162948|FG001|Overall Study|Protocol Violation|3|||
125147505|NCT03330236|450162947|FG000|Overall Study|SedLine malfunction/blinding|19|||
125147506|NCT03330236|450162948|FG001|Overall Study|SedLine malfunction/blinding|14|||
125147507|NCT03330236|450162947|FG000|Overall Study|Volatile anesthetics used|11|||
125147508|NCT03330236|450162948|FG001|Overall Study|Volatile anesthetics used|8|||
125147509|NCT03330236|450162947|FG000|Overall Study|Surgery aborted/converted to open|60|||
125147510|NCT03330236|450162948|FG001|Overall Study|Surgery aborted/converted to open|52|||
125147511|NCT01901848|450162952|FG000|Randomized and Treated|Lost to Follow-up|3|||
125147512|NCT01901848|450162953|FG001|Randomized and Treated|Lost to Follow-up|6|||
125147513|NCT01901848|450162952|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
125147514|NCT01901848|450162953|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
125147515|NCT00763555|450162954|FG000|Overall Study|Adverse Event|2|||
125147516|NCT00763555|450162955|FG001|Overall Study|Adverse Event|1|||
125147517|NCT00763555|450162954|FG000|Overall Study|Withdrawal by Subject|2|||
125147518|NCT00763555|450162955|FG001|Overall Study|Withdrawal by Subject|6|||
125147519|NCT00763555|450162954|FG000|Overall Study|Lost to Follow-up|0|||
125147520|NCT00763555|450162955|FG001|Overall Study|Lost to Follow-up|3|||
125147521|NCT00852917|450162956|FG000|Overall Study|Adverse Event|13|||
125147522|NCT00852917|450162957|FG001|Overall Study|Adverse Event|20|||
125147523|NCT00852917|450162958|FG002|Overall Study|Adverse Event|35|||
125147524|NCT00852917|450162959|FG003|Overall Study|Adverse Event|17|||
125147525|NCT00852917|450162956|FG000|Overall Study|Lack of Efficacy|21|||
125147526|NCT00852917|450162957|FG001|Overall Study|Lack of Efficacy|11|||
125147527|NCT00852917|450162958|FG002|Overall Study|Lack of Efficacy|11|||
125147528|NCT00852917|450162959|FG003|Overall Study|Lack of Efficacy|47|||
125147529|NCT00852917|450162956|FG000|Overall Study|Withdrawal by Subject|4|||
125147530|NCT00852917|450162957|FG001|Overall Study|Withdrawal by Subject|8|||
125147531|NCT00852917|450162958|FG002|Overall Study|Withdrawal by Subject|10|||
125147532|NCT00852917|450162959|FG003|Overall Study|Withdrawal by Subject|9|||
125147533|NCT00852917|450162956|FG000|Overall Study|Physician Decision|6|||
125147534|NCT00852917|450162957|FG001|Overall Study|Physician Decision|7|||
125147535|NCT00852917|450162958|FG002|Overall Study|Physician Decision|2|||
125147536|NCT00852917|450162959|FG003|Overall Study|Physician Decision|19|||
125147537|NCT00852917|450162956|FG000|Overall Study|Death|0|||
125147538|NCT00852917|450162957|FG001|Overall Study|Death|0|||
125147539|NCT00852917|450162958|FG002|Overall Study|Death|0|||
125147540|NCT00852917|450162959|FG003|Overall Study|Death|1|||
125147541|NCT03710590|450162960|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
125147542|NCT03710590|450162961|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
125147543|NCT02488824|450162962|FG000|Overall Study|Adverse Event|1|||
125147544|NCT02488824|450162963|FG001|Overall Study|Adverse Event|1|||
125147545|NCT01045707|450162966|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
125147546|NCT01045707|450162967|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
125147547|NCT01045707|450162966|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
125147548|NCT01045707|450162967|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
125147549|NCT01045707|450162966|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
125147550|NCT01045707|450162967|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
125147551|NCT01045707|450162966|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
125147552|NCT01045707|450162967|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
125147553|NCT01045707|450162966|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
125147554|NCT01045707|450162967|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
125147555|NCT01045707|450162966|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
125147556|NCT01045707|450162967|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
125147557|NCT01045707|450162966|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
125147558|NCT01045707|450162967|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
125147559|NCT01045707|450162966|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
125147560|NCT01045707|450162967|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
125147561|NCT01045707|450162966|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
125147562|NCT01045707|450162967|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
125147563|NCT04317599|450162971|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
125147564|NCT04317599|450162971|FG000|Overall Study|treatment outside standard of care|4|||
125147565|NCT00809965|450162972|FG000|Overall Study|Death|194|||
125147566|NCT00809965|450162973|FG001|Overall Study|Death|147|||
125147567|NCT00809965|450162974|FG002|Overall Study|Death|196|||
125147568|NCT00809965|450162972|FG000|Overall Study|Lost to Follow-up|17|||
125147569|NCT00809965|450162973|FG001|Overall Study|Lost to Follow-up|10|||
125147570|NCT00809965|450162974|FG002|Overall Study|Lost to Follow-up|18|||
125147571|NCT00809965|450162972|FG000|Overall Study|Withdrawal by Subject|405|||
125147572|NCT00809965|450162973|FG001|Overall Study|Withdrawal by Subject|448|||
125147573|NCT00809965|450162974|FG002|Overall Study|Withdrawal by Subject|441|||
125147574|NCT00809965|450162972|FG000|Overall Study|Other Reason|167|||
125147575|NCT00809965|450162973|FG001|Overall Study|Other Reason|170|||
125147576|NCT00809965|450162974|FG002|Overall Study|Other Reason|189|||
125147577|NCT02315066|450162975|FG000|Overall Study|Lost to Follow-up|0|||
125147578|NCT02315066|450162976|FG001|Overall Study|Lost to Follow-up|1|||
125147579|NCT02315066|450162977|FG002|Overall Study|Lost to Follow-up|1|||
125147580|NCT02315066|450162978|FG003|Overall Study|Lost to Follow-up|0|||
125147581|NCT02315066|450162979|FG004|Overall Study|Lost to Follow-up|1|||
125147582|NCT02315066|450162980|FG005|Overall Study|Lost to Follow-up|0|||
125147583|NCT02315066|450162981|FG006|Overall Study|Lost to Follow-up|2|||
125147584|NCT02315066|450162982|FG007|Overall Study|Lost to Follow-up|1|||
125147585|NCT02315066|450162983|FG008|Overall Study|Lost to Follow-up|0|||
125147586|NCT02315066|450162984|FG009|Overall Study|Lost to Follow-up|0|||
125147587|NCT02315066|450162985|FG010|Overall Study|Lost to Follow-up|1|||
125147588|NCT02315066|450162986|FG011|Overall Study|Lost to Follow-up|2|||
125147589|NCT02315066|450162987|FG012|Overall Study|Lost to Follow-up|0|||
125147590|NCT02315066|450162988|FG013|Overall Study|Lost to Follow-up|4|||
125147591|NCT02315066|450162975|FG000|Overall Study|Death|2|||
125147592|NCT02315066|450162976|FG001|Overall Study|Death|7|||
125147593|NCT02315066|450162977|FG002|Overall Study|Death|6|||
125147594|NCT02315066|450162978|FG003|Overall Study|Death|11|||
125147595|NCT02315066|450162979|FG004|Overall Study|Death|10|||
125147596|NCT02315066|450162980|FG005|Overall Study|Death|3|||
125147597|NCT02315066|450162981|FG006|Overall Study|Death|9|||
125147598|NCT02315066|450162982|FG007|Overall Study|Death|9|||
125147599|NCT02315066|450162983|FG008|Overall Study|Death|10|||
125147600|NCT02315066|450162984|FG009|Overall Study|Death|8|||
125147601|NCT02315066|450162985|FG010|Overall Study|Death|10|||
125147602|NCT02315066|450162986|FG011|Overall Study|Death|7|||
125147603|NCT02315066|450162987|FG012|Overall Study|Death|8|||
125147604|NCT02315066|450162988|FG013|Overall Study|Death|21|||
125147605|NCT02315066|450162975|FG000|Overall Study|Other|0|||
125147606|NCT02315066|450162976|FG001|Overall Study|Other|0|||
125147607|NCT02315066|450162977|FG002|Overall Study|Other|0|||
125147608|NCT02315066|450162978|FG003|Overall Study|Other|0|||
125147609|NCT02315066|450162979|FG004|Overall Study|Other|0|||
125147610|NCT02315066|450162980|FG005|Overall Study|Other|0|||
125147611|NCT02315066|450162981|FG006|Overall Study|Other|0|||
125147612|NCT02315066|450162982|FG007|Overall Study|Other|1|||
125147613|NCT02315066|450162983|FG008|Overall Study|Other|1|||
125147614|NCT02315066|450162984|FG009|Overall Study|Other|2|||
125147615|NCT02315066|450162985|FG010|Overall Study|Other|0|||
125147616|NCT02315066|450162986|FG011|Overall Study|Other|0|||
125147617|NCT02315066|450162987|FG012|Overall Study|Other|0|||
125147618|NCT02315066|450162988|FG013|Overall Study|Other|0|||
125147619|NCT02315066|450162975|FG000|Overall Study|Subject refused further follow-up|0|||
125147620|NCT02315066|450162976|FG001|Overall Study|Subject refused further follow-up|2|||
125147621|NCT02315066|450162977|FG002|Overall Study|Subject refused further follow-up|2|||
125147622|NCT02315066|450162978|FG003|Overall Study|Subject refused further follow-up|0|||
125147623|NCT02315066|450162979|FG004|Overall Study|Subject refused further follow-up|0|||
125147624|NCT02315066|450162980|FG005|Overall Study|Subject refused further follow-up|0|||
125147625|NCT02315066|450162981|FG006|Overall Study|Subject refused further follow-up|2|||
125147626|NCT02315066|450162982|FG007|Overall Study|Subject refused further follow-up|3|||
125147627|NCT02315066|450162983|FG008|Overall Study|Subject refused further follow-up|0|||
125147628|NCT02315066|450162984|FG009|Overall Study|Subject refused further follow-up|1|||
125147629|NCT02315066|450162985|FG010|Overall Study|Subject refused further follow-up|1|||
125147630|NCT02315066|450162986|FG011|Overall Study|Subject refused further follow-up|2|||
125147631|NCT02315066|450162987|FG012|Overall Study|Subject refused further follow-up|2|||
125147632|NCT02315066|450162988|FG013|Overall Study|Subject refused further follow-up|4|||
125147633|NCT02315066|450162975|FG000|Overall Study|Study ongoing at date of cut-off|0|||
125147634|NCT02315066|450162976|FG001|Overall Study|Study ongoing at date of cut-off|0|||
125147635|NCT02315066|450162977|FG002|Overall Study|Study ongoing at date of cut-off|0|||
125147636|NCT02315066|450162978|FG003|Overall Study|Study ongoing at date of cut-off|0|||
125147637|NCT02315066|450162979|FG004|Overall Study|Study ongoing at date of cut-off|0|||
125147638|NCT02315066|450162980|FG005|Overall Study|Study ongoing at date of cut-off|0|||
125147639|NCT02315066|450162981|FG006|Overall Study|Study ongoing at date of cut-off|0|||
125147640|NCT02315066|450162982|FG007|Overall Study|Study ongoing at date of cut-off|0|||
125147641|NCT02315066|450162983|FG008|Overall Study|Study ongoing at date of cut-off|0|||
125147642|NCT02315066|450162984|FG009|Overall Study|Study ongoing at date of cut-off|0|||
125147643|NCT02315066|450162985|FG010|Overall Study|Study ongoing at date of cut-off|0|||
125147644|NCT02315066|450162986|FG011|Overall Study|Study ongoing at date of cut-off|0|||
125147645|NCT02315066|450162987|FG012|Overall Study|Study ongoing at date of cut-off|0|||
125147646|NCT02315066|450162988|FG013|Overall Study|Study ongoing at date of cut-off|1|||
125147647|NCT00112294|450162989|FG000|Overall Study|Still on study|5|||
125147648|NCT00112294|450162990|FG001|Overall Study|Still on study|0|||
125147649|NCT01142908|450162991|FG000|Overall Study|Lost to Follow-up|19|||
125147650|NCT01142908|450162992|FG001|Overall Study|Lost to Follow-up|13|||
125147651|NCT01142908|450162991|FG000|Overall Study|Death|1|||
125147652|NCT01142908|450162992|FG001|Overall Study|Death|4|||
125147653|NCT01142908|450162991|FG000|Overall Study|Excluded - did not meet criteria|9|||
125147654|NCT01142908|450162992|FG001|Overall Study|Excluded - did not meet criteria|5|||
125147655|NCT01142908|450162991|FG000|Overall Study|Withdrawal by Subject|3|||
125147656|NCT01142908|450162992|FG001|Overall Study|Withdrawal by Subject|0|||
125147657|NCT00035555|450162993|FG000|Overall Study|Adverse Event|5|||
125147658|NCT00035555|450162994|FG001|Overall Study|Adverse Event|8|||
125147659|NCT00035555|450162995|FG002|Overall Study|Adverse Event|9|||
125147660|NCT00035555|450162993|FG000|Overall Study|Allograft loss|1|||
125147661|NCT00035555|450162994|FG001|Overall Study|Allograft loss|1|||
125147662|NCT00035555|450162995|FG002|Overall Study|Allograft loss|2|||
125147663|NCT00035555|450162993|FG000|Overall Study|Death|0|||
125147664|NCT00035555|450162994|FG001|Overall Study|Death|0|||
125147665|NCT00035555|450162995|FG002|Overall Study|Death|2|||
125147666|NCT00035555|450162993|FG000|Overall Study|Lost to Follow-up|0|||
125147667|NCT00035555|450162994|FG001|Overall Study|Lost to Follow-up|0|||
125147668|NCT00035555|450162995|FG002|Overall Study|Lost to Follow-up|1|||
125147669|NCT00035555|450162993|FG000|Overall Study|Noncompliance|0|||
125147670|NCT00035555|450162994|FG001|Overall Study|Noncompliance|1|||
125147671|NCT00035555|450162995|FG002|Overall Study|Noncompliance|1|||
125147672|NCT00035555|450162993|FG000|Overall Study|Prohibited medication|1|||
125147673|NCT00035555|450162994|FG001|Overall Study|Prohibited medication|1|||
125147674|NCT00035555|450162995|FG002|Overall Study|Prohibited medication|0|||
125147675|NCT00035555|450162993|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
125147676|NCT00035555|450162994|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
125147677|NCT00035555|450162995|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
125147678|NCT00035555|450162993|FG000|Overall Study|Withdrawal by Subject|2|||
125147679|NCT00035555|450162994|FG001|Overall Study|Withdrawal by Subject|0|||
125147680|NCT00035555|450162995|FG002|Overall Study|Withdrawal by Subject|2|||
125147681|NCT00035555|450162993|FG000|Overall Study|Investigator deemed not a good candidate|0|||
125147682|NCT00035555|450162994|FG001|Overall Study|Investigator deemed not a good candidate|0|||
125147683|NCT00035555|450162995|FG002|Overall Study|Investigator deemed not a good candidate|1|||
125147684|NCT00035555|450162993|FG000|Overall Study|Received cyclosporin in error|0|||
125147685|NCT00035555|450162994|FG001|Overall Study|Received cyclosporin in error|0|||
125147686|NCT00035555|450162995|FG002|Overall Study|Received cyclosporin in error|1|||
125147687|NCT01186016|450162998|FG000|Overall Study|Withdrawal by Subject|46|||
125147688|NCT01186016|450162999|FG001|Overall Study|Withdrawal by Subject|29|||
125147689|NCT01055886|450163001|FG000|Overall Study|Withdrawal by Subject|4|||
125147690|NCT01055886|450163002|FG001|Overall Study|Withdrawal by Subject|9|||
125147691|NCT01055886|450163001|FG000|Overall Study|Lost to Follow-up|1|||
125147692|NCT01055886|450163002|FG001|Overall Study|Lost to Follow-up|1|||
125147693|NCT01055886|450163001|FG000|Overall Study|Withdrawal by PI|0|||
125147694|NCT01055886|450163002|FG001|Overall Study|Withdrawal by PI|1|||
125147695|NCT02972515|450163005|FG000|Overall Study|Lost to Follow-up|78|||
125147696|NCT01086969|450163006|FG000|Overall Study|Withdrawal by Subject|1|||
125147697|NCT01086969|450163007|FG001|Overall Study|Withdrawal by Subject|2|||
125147698|NCT01086969|450163008|FG002|Overall Study|Withdrawal by Subject|0|||
125147699|NCT00585312|450163019|FG000|Overall Study|Adverse Event|3|||
125147700|NCT00585312|450163020|FG001|Overall Study|Adverse Event|0|||
125147701|NCT00585312|450163019|FG000|Overall Study|Lack of Efficacy|6|||
125147702|NCT00585312|450163020|FG001|Overall Study|Lack of Efficacy|11|||
125147703|NCT00585312|450163019|FG000|Overall Study|Lost to Follow-up|1|||
125147704|NCT00585312|450163020|FG001|Overall Study|Lost to Follow-up|1|||
125147705|NCT00585312|450163019|FG000|Overall Study|Reason not specified|2|||
125147706|NCT00585312|450163020|FG001|Overall Study|Reason not specified|0|||
125147707|NCT00585312|450163019|FG000|Overall Study|Withdrawal by Subject|5|||
125147708|NCT00585312|450163020|FG001|Overall Study|Withdrawal by Subject|1|||
125147709|NCT00585312|450163019|FG000|Overall Study|Study terminated by the sponsor|34|||
125147710|NCT00585312|450163020|FG001|Overall Study|Study terminated by the sponsor|31|||
125147711|NCT04203667|450163023|FG000|Overall Study|Withdrawal by Subject|1|||
125147712|NCT04203667|450163023|FG000|Overall Study|Lost to Follow-up|1|||
125147713|NCT04203667|450163023|FG000|Overall Study|Death|1|||
125147714|NCT04203667|450163023|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
125147715|NCT01362296|450163024|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
125147716|NCT01362296|450163025|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
125147717|NCT01362296|450163026|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
125147718|NCT01362296|450163027|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
125147719|NCT01362296|450163024|FG000|Randomized Phase (RP)|Physician Decision|1|||
125147720|NCT01362296|450163025|FG001|Randomized Phase (RP)|Physician Decision|9|||
125147721|NCT01362296|450163026|FG002|Randomized Phase (RP)|Physician Decision|0|||
125147722|NCT01362296|450163027|FG003|Randomized Phase (RP)|Physician Decision|0|||
125147723|NCT01362296|450163024|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
125147724|NCT01362296|450163025|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
125147725|NCT01362296|450163026|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
125147726|NCT01362296|450163027|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
125147727|NCT01362296|450163024|FG000|Randomized Phase (RP)|Adverse Event|20|||
125147728|NCT01362296|450163025|FG001|Randomized Phase (RP)|Adverse Event|4|||
125147729|NCT01362296|450163026|FG002|Randomized Phase (RP)|Adverse Event|0|||
125147730|NCT01362296|450163027|FG003|Randomized Phase (RP)|Adverse Event|0|||
125147731|NCT01362296|450163024|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
125147732|NCT01362296|450163025|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
125147733|NCT01362296|450163026|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
125147734|NCT01362296|450163027|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
125147735|NCT01362296|450163024|FG000|Crossover Phase|PD including Death due to PD|0|||
125147736|NCT01362296|450163025|FG001|Crossover Phase|PD including Death due to PD|0|||
125147737|NCT01362296|450163026|FG002|Crossover Phase|PD including Death due to PD|16|||
125147738|NCT01362296|450163027|FG003|Crossover Phase|PD including Death due to PD|1|||
125147739|NCT01362296|450163024|FG000|Crossover Phase|Withdrawal by Subject|0|||
125147740|NCT01362296|450163025|FG001|Crossover Phase|Withdrawal by Subject|0|||
125147741|NCT01362296|450163026|FG002|Crossover Phase|Withdrawal by Subject|2|||
125147742|NCT01362296|450163027|FG003|Crossover Phase|Withdrawal by Subject|1|||
125147743|NCT01362296|450163024|FG000|Crossover Phase|Adverse Event|0|||
125147744|NCT01362296|450163025|FG001|Crossover Phase|Adverse Event|0|||
125147745|NCT01362296|450163026|FG002|Crossover Phase|Adverse Event|4|||
125147746|NCT01362296|450163027|FG003|Crossover Phase|Adverse Event|0|||
125147747|NCT01362296|450163024|FG000|Crossover Phase|Study Closed/Terminated|0|||
125147748|NCT01362296|450163025|FG001|Crossover Phase|Study Closed/Terminated|0|||
125147749|NCT01362296|450163026|FG002|Crossover Phase|Study Closed/Terminated|1|||
125147750|NCT01362296|450163027|FG003|Crossover Phase|Study Closed/Terminated|0|||
125147751|NCT00653159|450164329|FG000|Overall Study|Adverse Event|4|||
125147752|NCT00653159|450164330|FG001|Overall Study|Adverse Event|1|||
125147753|NCT00653159|450164329|FG000|Overall Study|Lost to Follow-up|1|||
125147754|NCT00653159|450164330|FG001|Overall Study|Lost to Follow-up|2|||
125147755|NCT00109837|450164331|FG000|Overall Study|Adverse Event|2|||
125147756|NCT00109837|450164331|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
125147757|NCT00109837|450164331|FG000|Overall Study|Death|1|||
125147758|NCT00109837|450164331|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
125147759|NCT00109837|450164331|FG000|Overall Study|Not treated|1|||
125147760|NCT00109837|450164331|FG000|Overall Study|Ineligible|1|||
125147761|NCT00381849|450164332|FG000|Wash Out|Withdrawal by Subject|0|||
125147762|NCT00381849|450164333|FG001|Wash Out|Withdrawal by Subject|1|||
125147763|NCT04167618|450164334|FG000|Overall Study|Trial terminated by sponsor|1|||
125147764|NCT04167618|450164335|FG001|Overall Study|Trial terminated by sponsor|1|||
125147765|NCT05996198|450164336|FG000|Overall Study|Withdrawal by Subject|1|||
125147766|NCT05996198|450164337|FG001|Overall Study|Withdrawal by Subject|0|||
125147767|NCT00835796|450164339|FG000|First Intervention|Withdrawal by Subject|0|||
125147768|NCT00835796|450164340|FG001|First Intervention|Withdrawal by Subject|1|||
125147769|NCT00651183|450164343|FG000|Overall Study|Lack of Efficacy|1|||
125147770|NCT00651183|450164344|FG001|Overall Study|Lack of Efficacy|0|||
125147771|NCT00651183|450164343|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
125147772|NCT00651183|450164344|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
125147773|NCT00651183|450164343|FG000|Overall Study|Tolerability insufficient|5|||
125147774|NCT00651183|450164344|FG001|Overall Study|Tolerability insufficient|2|||
125147775|NCT00651183|450164343|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
125147776|NCT00651183|450164344|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
125147777|NCT00651183|450164343|FG000|Overall Study|Withdrawal by Subject|6|||
125147778|NCT00651183|450164344|FG001|Overall Study|Withdrawal by Subject|3|||
125147779|NCT00651183|450164343|FG000|Overall Study|Lost to Follow-up|3|||
125147780|NCT00651183|450164344|FG001|Overall Study|Lost to Follow-up|1|||
125147781|NCT00651183|450164343|FG000|Overall Study|Other reasons|4|||
125147782|NCT00651183|450164344|FG001|Overall Study|Other reasons|2|||
125147783|NCT00651183|450164343|FG000|Overall Study|missing|1|||
125147784|NCT00651183|450164344|FG001|Overall Study|missing|0|||
125147785|NCT01363011|450164346|FG000|Main Study|Adverse Event|2|||
125147786|NCT01363011|450164347|FG001|Main Study|Adverse Event|3|||
125147787|NCT01363011|450164346|FG000|Main Study|Investigator's Discretion|1|||
125147788|NCT01363011|450164347|FG001|Main Study|Investigator's Discretion|1|||
125147789|NCT01363011|450164346|FG000|Main Study|Withdrew Consent|1|||
125147790|NCT01363011|450164347|FG001|Main Study|Withdrew Consent|4|||
125147791|NCT01363011|450164346|FG000|Main Study|Protocol Violation|0|||
125147792|NCT01363011|450164347|FG001|Main Study|Protocol Violation|1|||
125147793|NCT01363011|450164346|FG000|Extension Phase|Adverse Event|1|||
125147794|NCT01363011|450164347|FG001|Extension Phase|Adverse Event|1|||
125147795|NCT01363011|450164346|FG000|Extension Phase|Lack of Efficacy|0|||
125147796|NCT01363011|450164347|FG001|Extension Phase|Lack of Efficacy|1|||
125147797|NCT01363011|450164346|FG000|Extension Phase|Investigator's Discretion|2|||
125147798|NCT01363011|450164347|FG001|Extension Phase|Investigator's Discretion|2|||
125147799|NCT01363011|450164346|FG000|Extension Phase|Withdrew Consent|0|||
125147800|NCT01363011|450164347|FG001|Extension Phase|Withdrew Consent|1|||
125147801|NCT01363011|450164346|FG000|Extension Phase|Lost to Follow-up|0|||
125147802|NCT01363011|450164347|FG001|Extension Phase|Lost to Follow-up|2|||
125147803|NCT01363011|450164346|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
125147804|NCT01363011|450164347|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
125147805|NCT04412057|450164348|FG000|Overall Study|Death|3|||
125147806|NCT04412057|450164349|FG001|Overall Study|Death|7|||
125147807|NCT04412057|450164348|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
125147808|NCT04412057|450164349|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
125147809|NCT01961882|450164353|FG000|Overall Study|Adverse Event|3|||
125147810|NCT01961882|450164354|FG001|Overall Study|Adverse Event|2|||
125147811|NCT01961882|450164353|FG000|Overall Study|Physician Decision|1|||
125147812|NCT01961882|450164354|FG001|Overall Study|Physician Decision|0|||
125147813|NCT01961882|450164353|FG000|Overall Study|Withdrawal by Subject|4|||
125147814|NCT01961882|450164354|FG001|Overall Study|Withdrawal by Subject|1|||
125147815|NCT01961882|450164353|FG000|Overall Study|Relapse of AML|39|||
125147816|NCT01961882|450164354|FG001|Overall Study|Relapse of AML|37|||
125147817|NCT01961882|450164353|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
125147818|NCT01961882|450164354|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
125147819|NCT01961882|450164353|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
125147820|NCT01961882|450164354|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
125147821|NCT00407745|450164355|FG000|Overall Study|Lack of Efficacy|1|||
125147822|NCT00407745|450164356|FG001|Overall Study|Lack of Efficacy|2|||
125147823|NCT00407745|450164355|FG000|Overall Study|Withdrawal by Subject|3|||
125147824|NCT00407745|450164356|FG001|Overall Study|Withdrawal by Subject|3|||
125147825|NCT00407745|450164355|FG000|Overall Study|Protocol Violation|5|||
125147826|NCT00407745|450164356|FG001|Overall Study|Protocol Violation|3|||
125147827|NCT00407745|450164355|FG000|Overall Study|Adverse Event|8|||
125147828|NCT00407745|450164356|FG001|Overall Study|Adverse Event|8|||
125147829|NCT00407745|450164355|FG000|Overall Study|Other|2|||
125147830|NCT00407745|450164356|FG001|Overall Study|Other|0|||
125147831|NCT00407745|450164355|FG000|Overall Study|Randomized, unknown if treated|0|||
125147832|NCT00407745|450164356|FG001|Overall Study|Randomized, unknown if treated|1|||
125147833|NCT00108082|450164357|FG000|Overall Study|Adverse Event|14|||
125147834|NCT00108082|450164358|FG001|Overall Study|Adverse Event|12|||
125147835|NCT00108082|450164359|FG002|Overall Study|Adverse Event|17|||
125223607|NCT02326272|450446176|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
125223608|NCT02326272|450446177|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125223609|NCT02326272|450446178|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
125147836|NCT00108082|450164357|FG000|Overall Study|Lost to Follow-up|6|||
125147837|NCT00108082|450164358|FG001|Overall Study|Lost to Follow-up|3|||
125147838|NCT00108082|450164359|FG002|Overall Study|Lost to Follow-up|7|||
125147839|NCT00108082|450164357|FG000|Overall Study|Consent Withdrawn|3|||
125147840|NCT00108082|450164358|FG001|Overall Study|Consent Withdrawn|3|||
125147841|NCT00108082|450164359|FG002|Overall Study|Consent Withdrawn|5|||
125147842|NCT00108082|450164357|FG000|Overall Study|Protocol Violation|1|||
125147843|NCT00108082|450164358|FG001|Overall Study|Protocol Violation|2|||
125147844|NCT00108082|450164359|FG002|Overall Study|Protocol Violation|0|||
125147845|NCT00108082|450164357|FG000|Overall Study|Lack of Efficacy|3|||
125147846|NCT00108082|450164358|FG001|Overall Study|Lack of Efficacy|1|||
125147847|NCT00108082|450164359|FG002|Overall Study|Lack of Efficacy|2|||
125147848|NCT00108082|450164357|FG000|Overall Study|Amendment 4: > Month 12|5|||
125147849|NCT00108082|450164358|FG001|Overall Study|Amendment 4: > Month 12|7|||
125147850|NCT00108082|450164359|FG002|Overall Study|Amendment 4: > Month 12|5|||
125147851|NCT00108082|450164357|FG000|Overall Study|Woman of Child-bearing Potential|2|||
125147852|NCT00108082|450164358|FG001|Overall Study|Woman of Child-bearing Potential|0|||
125147853|NCT00108082|450164359|FG002|Overall Study|Woman of Child-bearing Potential|2|||
125147854|NCT00108082|450164357|FG000|Overall Study|Incorrectly Randomized|0|||
125147855|NCT00108082|450164358|FG001|Overall Study|Incorrectly Randomized|0|||
125147856|NCT00108082|450164359|FG002|Overall Study|Incorrectly Randomized|2|||
125147857|NCT00108082|450164357|FG000|Overall Study|Non-compliance|1|||
125147858|NCT00108082|450164358|FG001|Overall Study|Non-compliance|0|||
125147859|NCT00108082|450164359|FG002|Overall Study|Non-compliance|2|||
125147860|NCT00108082|450164357|FG000|Overall Study|Stopped Study Medication|0|||
125147861|NCT00108082|450164358|FG001|Overall Study|Stopped Study Medication|0|||
125147862|NCT00108082|450164359|FG002|Overall Study|Stopped Study Medication|1|||
125147863|NCT00108082|450164357|FG000|Overall Study|Site Closed Study|0|||
125147864|NCT00108082|450164358|FG001|Overall Study|Site Closed Study|2|||
125147865|NCT00108082|450164359|FG002|Overall Study|Site Closed Study|0|||
125147866|NCT00108082|450164357|FG000|Overall Study|Protocol Amendment|0|||
125147867|NCT00108082|450164358|FG001|Overall Study|Protocol Amendment|1|||
125147868|NCT00108082|450164359|FG002|Overall Study|Protocol Amendment|0|||
125147869|NCT00108082|450164357|FG000|Overall Study|Study Medication Not Tapered|0|||
125147870|NCT00108082|450164358|FG001|Overall Study|Study Medication Not Tapered|1|||
125147871|NCT00108082|450164359|FG002|Overall Study|Study Medication Not Tapered|0|||
125147872|NCT00108082|450164357|FG000|Overall Study|Subject Left Site Location|1|||
125147873|NCT00108082|450164358|FG001|Overall Study|Subject Left Site Location|0|||
125147874|NCT00108082|450164359|FG002|Overall Study|Subject Left Site Location|0|||
125147875|NCT00108082|450164357|FG000|Overall Study|Investigator Not at Site|1|||
125147876|NCT00108082|450164358|FG001|Overall Study|Investigator Not at Site|0|||
125147877|NCT00108082|450164359|FG002|Overall Study|Investigator Not at Site|0|||
125147878|NCT00108082|450164357|FG000|Overall Study|Blood Pressure Not Controlled|1|||
125147879|NCT00108082|450164358|FG001|Overall Study|Blood Pressure Not Controlled|0|||
125147880|NCT00108082|450164359|FG002|Overall Study|Blood Pressure Not Controlled|0|||
125147881|NCT01563237|450164360|FG000|Overall Study|Lost to Follow-up|6|||
125147882|NCT01563237|450164361|FG001|Overall Study|Lost to Follow-up|0|||
125147883|NCT01563237|450164360|FG000|Overall Study|Withdrawal by Subject|1|||
125147884|NCT01563237|450164361|FG001|Overall Study|Withdrawal by Subject|0|||
125147885|NCT01563237|450164360|FG000|Overall Study|Adverse Event|1|||
125147886|NCT01563237|450164361|FG001|Overall Study|Adverse Event|0|||
125147887|NCT01563237|450164360|FG000|Overall Study|Medical Reasons|1|||
125147888|NCT01563237|450164361|FG001|Overall Study|Medical Reasons|0|||
125147889|NCT01563237|450164360|FG000|Overall Study|Death|1|||
125147890|NCT01563237|450164361|FG001|Overall Study|Death|0|||
125147891|NCT02940730|450164367|FG000|Intervention 2|Physician Decision|7|||
125147892|NCT02940730|450164368|FG001|Intervention 2|Physician Decision|0|||
125147893|NCT03036839|450164370|FG000|Overall Study|Adverse Event|0|||
125147894|NCT03036839|450164371|FG001|Overall Study|Adverse Event|0|||
125147895|NCT03036839|450164372|FG002|Overall Study|Adverse Event|1|||
125147896|NCT03036839|450164370|FG000|Overall Study|Death|3|||
125147897|NCT03036839|450164371|FG001|Overall Study|Death|0|||
125147898|NCT03036839|450164372|FG002|Overall Study|Death|3|||
125147899|NCT03036839|450164370|FG000|Overall Study|Withdrew Consent|0|||
125147900|NCT03036839|450164371|FG001|Overall Study|Withdrew Consent|0|||
125147901|NCT03036839|450164372|FG002|Overall Study|Withdrew Consent|1|||
125147902|NCT00412737|450164373|FG000|Overall Study|Death|1|||
125147903|NCT00412737|450164374|FG001|Overall Study|Death|0|||
125147904|NCT00412737|450164373|FG000|Overall Study|Adverse Event|3|||
125147905|NCT00412737|450164374|FG001|Overall Study|Adverse Event|2|||
125147906|NCT00412737|450164373|FG000|Overall Study|Refused Treatment|6|||
125147907|NCT00412737|450164374|FG001|Overall Study|Refused Treatment|2|||
125147908|NCT00412737|450164373|FG000|Overall Study|Failure to Return|6|||
125147909|NCT00412737|450164374|FG001|Overall Study|Failure to Return|2|||
125147910|NCT01064531|450164376|FG000|Overall Study|Lost to Follow-up|0|||
125147911|NCT01064531|450164377|FG001|Overall Study|Lost to Follow-up|2|||
125147912|NCT01064531|450164376|FG000|Overall Study|Physician Decision|0|||
125147913|NCT01064531|450164377|FG001|Overall Study|Physician Decision|1|||
125147914|NCT01064531|450164376|FG000|Overall Study|Withdrawal by Subject|2|||
125147915|NCT01064531|450164377|FG001|Overall Study|Withdrawal by Subject|2|||
125147916|NCT01064531|450164376|FG000|Overall Study|Revision due to femoral stem loosening|1|||
125147917|NCT01064531|450164377|FG001|Overall Study|Revision due to femoral stem loosening|0|||
125147918|NCT01064531|450164376|FG000|Overall Study|Revision due to dislocation|0|||
125147919|NCT01064531|450164377|FG001|Overall Study|Revision due to dislocation|1|||
125147920|NCT01064531|450164376|FG000|Overall Study|Death|0|||
125147921|NCT01064531|450164377|FG001|Overall Study|Death|1|||
125147922|NCT03449199|450164382|FG000|Overall Study|Lost to Follow-up|1|||
125147923|NCT03449199|450164383|FG001|Overall Study|Lost to Follow-up|1|||
125147924|NCT03449199|450164384|FG002|Overall Study|Lost to Follow-up|0|||
125147925|NCT03449199|450164382|FG000|Overall Study|Protocol Deviation|0|||
125147926|NCT03449199|450164383|FG001|Overall Study|Protocol Deviation|0|||
125147927|NCT03449199|450164384|FG002|Overall Study|Protocol Deviation|1|||
125147928|NCT03449199|450164382|FG000|Overall Study|Withdrawal by Subject|0|||
125147929|NCT03449199|450164383|FG001|Overall Study|Withdrawal by Subject|0|||
125147930|NCT03449199|450164384|FG002|Overall Study|Withdrawal by Subject|1|||
125147931|NCT01091103|450164385|FG000|Overall Study|Adverse Event|1|||
125147932|NCT01091103|450164385|FG000|Overall Study|Progressive Disease|3|||
125147933|NCT01270620|450164386|FG000|Overall Study|Withdrawal by Subject|1|||
125147934|NCT01270620|450164387|FG001|Overall Study|Withdrawal by Subject|3|||
125147935|NCT00684567|450164388|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
125147936|NCT00684567|450164388|FG000|Monotherapy Period|Adverse Event|2|||
125147937|NCT00684567|450164388|FG000|Monotherapy Period|Death|1|||
125147938|NCT00684567|450164388|FG000|Monotherapy Period|Progression of primary disease|11|||
125147939|NCT03136406|450164389|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
125147940|NCT00988208|450164392|FG000|Overall Study|Adverse Event|71|||
125147941|NCT00988208|450164393|FG001|Overall Study|Adverse Event|122|||
125147942|NCT00988208|450164392|FG000|Overall Study|Disease Progression|103|||
125147943|NCT00988208|450164393|FG001|Overall Study|Disease Progression|89|||
125147944|NCT00988208|450164392|FG000|Overall Study|Withdrawal by Subject|50|||
125147945|NCT00988208|450164393|FG001|Overall Study|Withdrawal by Subject|57|||
125147946|NCT00988208|450164392|FG000|Overall Study|Death|9|||
125147947|NCT00988208|450164393|FG001|Overall Study|Death|15|||
125147948|NCT00988208|450164392|FG000|Overall Study|Lost to Follow-up|2|||
125147949|NCT00988208|450164393|FG001|Overall Study|Lost to Follow-up|3|||
125147950|NCT00988208|450164392|FG000|Overall Study|Protocol Violation|9|||
125147951|NCT00988208|450164393|FG001|Overall Study|Protocol Violation|2|||
125147952|NCT00988208|450164392|FG000|Overall Study|Sponsor Decision|102|||
125147953|NCT00988208|450164393|FG001|Overall Study|Sponsor Decision|78|||
125147954|NCT00988208|450164392|FG000|Overall Study|Clinical Progression|17|||
125147955|NCT00988208|450164393|FG001|Overall Study|Clinical Progression|16|||
125147956|NCT00988208|450164392|FG000|Overall Study|Biochemical Progression|21|||
125147957|NCT00988208|450164393|FG001|Overall Study|Biochemical Progression|7|||
125147958|NCT00988208|450164392|FG000|Overall Study|Clinical Deterioration|7|||
125147959|NCT00988208|450164393|FG001|Overall Study|Clinical Deterioration|14|||
125147960|NCT00988208|450164392|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
125147961|NCT00988208|450164393|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
125147962|NCT00988208|450164392|FG000|Overall Study|Other|8|||
125147963|NCT00988208|450164393|FG001|Overall Study|Other|3|||
125147964|NCT02618382|450164401|FG000|Overall Study|Physician Decision|1|||
125147965|NCT02618382|450164401|FG000|Overall Study|Withdrawal by Subject|1|||
125147966|NCT02618382|450164401|FG000|Overall Study|Protocol Violation|1|||
125147967|NCT03843125|450164402|FG000|Overall Study|Adverse Event|17|||
125147968|NCT03843125|450164403|FG001|Overall Study|Adverse Event|13|||
125147969|NCT03843125|450164404|FG002|Overall Study|Adverse Event|5|||
125147970|NCT03843125|450164405|FG003|Overall Study|Adverse Event|9|||
125147971|NCT03843125|450164402|FG000|Overall Study|Death|0|||
125147972|NCT03843125|450164403|FG001|Overall Study|Death|6|||
125147973|NCT03843125|450164404|FG002|Overall Study|Death|2|||
125147974|NCT03843125|450164405|FG003|Overall Study|Death|0|||
125147975|NCT03843125|450164402|FG000|Overall Study|Lack of Efficacy|14|||
125147976|NCT03843125|450164403|FG001|Overall Study|Lack of Efficacy|11|||
125147977|NCT03843125|450164404|FG002|Overall Study|Lack of Efficacy|9|||
125147978|NCT03843125|450164405|FG003|Overall Study|Lack of Efficacy|4|||
125147979|NCT03843125|450164402|FG000|Overall Study|Lost to Follow-up|3|||
125147980|NCT03843125|450164403|FG001|Overall Study|Lost to Follow-up|4|||
125147981|NCT03843125|450164404|FG002|Overall Study|Lost to Follow-up|0|||
125147982|NCT03843125|450164405|FG003|Overall Study|Lost to Follow-up|2|||
125147983|NCT03843125|450164402|FG000|Overall Study|Other|12|||
125147984|NCT03843125|450164403|FG001|Overall Study|Other|14|||
125147985|NCT03843125|450164404|FG002|Overall Study|Other|3|||
125147986|NCT03843125|450164405|FG003|Overall Study|Other|4|||
125147987|NCT03843125|450164402|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
125147988|NCT03843125|450164403|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
125147989|NCT03843125|450164404|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
125147990|NCT03843125|450164405|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
125147991|NCT03843125|450164402|FG000|Overall Study|Study Terminated by Sponsor|318|||
125147992|NCT03843125|450164403|FG001|Overall Study|Study Terminated by Sponsor|318|||
125147993|NCT03843125|450164404|FG002|Overall Study|Study Terminated by Sponsor|163|||
125147994|NCT03843125|450164405|FG003|Overall Study|Study Terminated by Sponsor|163|||
125147995|NCT03843125|450164402|FG000|Overall Study|Withdrawal by Subject|23|||
125147996|NCT03843125|450164403|FG001|Overall Study|Withdrawal by Subject|12|||
125147997|NCT03843125|450164404|FG002|Overall Study|Withdrawal by Subject|6|||
125147998|NCT03843125|450164405|FG003|Overall Study|Withdrawal by Subject|9|||
125147999|NCT03843125|450164402|FG000|Overall Study|Missing data|0|||
125148000|NCT03843125|450164403|FG001|Overall Study|Missing data|1|||
125148001|NCT03843125|450164404|FG002|Overall Study|Missing data|1|||
125148002|NCT03843125|450164405|FG003|Overall Study|Missing data|0|||
125148003|NCT03173560|450164406|FG000|Overall Study|Death|70|||
125148004|NCT03173560|450164407|FG001|Overall Study|Death|60|||
125148005|NCT03173560|450164406|FG000|Overall Study|Lost to Follow-up|1|||
125148006|NCT03173560|450164407|FG001|Overall Study|Lost to Follow-up|4|||
125148007|NCT03173560|450164406|FG000|Overall Study|Withdrawal by Subject|10|||
125148008|NCT03173560|450164407|FG001|Overall Study|Withdrawal by Subject|5|||
125148009|NCT03173560|450164406|FG000|Overall Study|Other|0|||
125148010|NCT03173560|450164407|FG001|Overall Study|Other|1|||
125148011|NCT04254809|450164408|FG000|Overall Study|Lost to Follow-up|5|||
125148012|NCT04254809|450164409|FG001|Overall Study|Lost to Follow-up|10|||
125148013|NCT03023137|450164410|FG000|Overall Study|Multiple pregnancy|2|||
125148014|NCT03023137|450164411|FG001|Overall Study|Multiple pregnancy|4|||
125148015|NCT03023137|450164410|FG000|Overall Study|Lost to Follow-up|1|||
125148016|NCT03023137|450164411|FG001|Overall Study|Lost to Follow-up|1|||
125148017|NCT03023137|450164410|FG000|Overall Study|Protocol Violation|0|||
125148018|NCT03023137|450164411|FG001|Overall Study|Protocol Violation|4|||
125148019|NCT03023137|450164410|FG000|Overall Study|Lost the baby in a car accident|1|||
125148020|NCT03023137|450164411|FG001|Overall Study|Lost the baby in a car accident|0|||
125148021|NCT02608476|450164412|FG000|Overall Study|Withdrawal by Subject|30|||
125148022|NCT02608476|450164413|FG001|Overall Study|Withdrawal by Subject|37|||
125148023|NCT02608476|450164412|FG000|Overall Study|Lost to Follow-up|24|||
125148024|NCT02608476|450164413|FG001|Overall Study|Lost to Follow-up|24|||
125148025|NCT02608476|450164412|FG000|Overall Study|Adverse Event|2|||
125148026|NCT02608476|450164413|FG001|Overall Study|Adverse Event|8|||
125148027|NCT02608476|450164412|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
125148028|NCT02608476|450164413|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
125148029|NCT02608476|450164412|FG000|Overall Study|Noncompliance with treatment|1|||
125148030|NCT02608476|450164413|FG001|Overall Study|Noncompliance with treatment|5|||
125148031|NCT02608476|450164412|FG000|Overall Study|Lack of Efficacy|3|||
125148032|NCT02608476|450164413|FG001|Overall Study|Lack of Efficacy|1|||
125148033|NCT02608476|450164412|FG000|Overall Study|Other|0|||
125148034|NCT02608476|450164413|FG001|Overall Study|Other|1|||
125148035|NCT02608476|450164412|FG000|Overall Study|Physician Decision|1|||
125223610|NCT02326272|450446164|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223611|NCT02326272|450446165|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223612|NCT02326272|450446166|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223613|NCT02326272|450446167|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223614|NCT02326272|450446168|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223615|NCT02326272|450446169|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223616|NCT02326272|450446170|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223617|NCT02326272|450446171|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223618|NCT02326272|450446172|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223619|NCT02326272|450446173|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223620|NCT02326272|450446174|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223621|NCT02326272|450446175|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
125223622|NCT02326272|450446176|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223623|NCT02326272|450446177|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223624|NCT02326272|450446178|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
125223625|NCT02326272|450446164|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223626|NCT02326272|450446165|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223627|NCT02326272|450446166|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223628|NCT02326272|450446167|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223629|NCT02326272|450446168|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223630|NCT02326272|450446169|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223631|NCT02326272|450446170|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125148036|NCT02608476|450164413|FG001|Overall Study|Physician Decision|0|||
125148037|NCT02608476|450164412|FG000|Overall Study|Pregnancy|0|||
125148038|NCT02608476|450164413|FG001|Overall Study|Pregnancy|1|||
125148039|NCT02608476|450164412|FG000|Overall Study|Progressive disease|1|||
125148040|NCT02608476|450164413|FG001|Overall Study|Progressive disease|0|||
125148041|NCT02795676|450164414|FG000|Overall Study|Adverse Event|2|||
125148042|NCT02795676|450164415|FG001|Overall Study|Adverse Event|0|||
125148043|NCT02795676|450164414|FG000|Overall Study|Withdrawal by Subject|3|||
125148044|NCT02795676|450164415|FG001|Overall Study|Withdrawal by Subject|1|||
125148045|NCT00605176|450164416|FG000|Overall Study|Adverse Event|2|||
125148046|NCT00605176|450164417|FG001|Overall Study|Adverse Event|1|||
125148047|NCT00605176|450164418|FG002|Overall Study|Adverse Event|3|||
125148048|NCT00605176|450164416|FG000|Overall Study|Withdrawal by Subject|4|||
125148049|NCT00605176|450164417|FG001|Overall Study|Withdrawal by Subject|2|||
125148050|NCT00605176|450164418|FG002|Overall Study|Withdrawal by Subject|4|||
125148051|NCT00605176|450164416|FG000|Overall Study|Lost to Follow-up|2|||
125148052|NCT00605176|450164417|FG001|Overall Study|Lost to Follow-up|2|||
125148053|NCT00605176|450164418|FG002|Overall Study|Lost to Follow-up|1|||
125148054|NCT00605176|450164416|FG000|Overall Study|Non-complicance with study procedures|1|||
125148055|NCT00605176|450164417|FG001|Overall Study|Non-complicance with study procedures|0|||
125148056|NCT00605176|450164418|FG002|Overall Study|Non-complicance with study procedures|0|||
125148057|NCT00605176|450164416|FG000|Overall Study|Use of concomitant therapy|1|||
125148058|NCT00605176|450164417|FG001|Overall Study|Use of concomitant therapy|0|||
125148059|NCT00605176|450164418|FG002|Overall Study|Use of concomitant therapy|1|||
125148060|NCT00605176|450164416|FG000|Overall Study|Other (not due to AE)|1|||
125148061|NCT00605176|450164417|FG001|Overall Study|Other (not due to AE)|1|||
125148062|NCT00605176|450164418|FG002|Overall Study|Other (not due to AE)|0|||
125148063|NCT04253236|450164434|FG000|Overall Study|Adverse Event|1|||
125148064|NCT04253236|450164435|FG001|Overall Study|Adverse Event|0|||
125148065|NCT04253236|450164434|FG000|Overall Study|Safety Concerns|1|||
125148066|NCT04253236|450164435|FG001|Overall Study|Safety Concerns|0|||
125148067|NCT04253236|450164434|FG000|Overall Study|Study Terminated by Sponsor|1|||
125148068|NCT04253236|450164435|FG001|Overall Study|Study Terminated by Sponsor|0|||
125148069|NCT00587431|450164436|FG000|Overall Study|Adverse Event|1|||
125148070|NCT00587431|450164437|FG001|Overall Study|Adverse Event|0|||
125148071|NCT00587431|450164436|FG000|Overall Study|Withdrawal by Subject|0|||
125148072|NCT00587431|450164437|FG001|Overall Study|Withdrawal by Subject|1|||
125148073|NCT02169791|450164438|FG000|Overall Study|Death|6|||
125148074|NCT02169791|450164438|FG000|Overall Study|patient withdrew consent|1|||
125148075|NCT03566238|450164439|FG000|Overall Study|Adverse Event|0|||
125148076|NCT03566238|450164440|FG001|Overall Study|Adverse Event|1|||
125148077|NCT03566238|450164441|FG002|Overall Study|Adverse Event|0|||
125148078|NCT03566238|450164439|FG000|Overall Study|Lack of Efficacy|4|||
125148079|NCT03566238|450164440|FG001|Overall Study|Lack of Efficacy|2|||
125148080|NCT03566238|450164441|FG002|Overall Study|Lack of Efficacy|5|||
125148081|NCT03566238|450164439|FG000|Overall Study|Other|1|||
125148082|NCT03566238|450164440|FG001|Overall Study|Other|0|||
125148083|NCT03566238|450164441|FG002|Overall Study|Other|0|||
125148084|NCT00373425|450164448|FG000|Overall Study|Relapse of NSCLC|116|||
125148085|NCT00373425|450164449|FG001|Overall Study|Relapse of NSCLC|104|||
125148086|NCT00373425|450164450|FG002|Overall Study|Relapse of NSCLC|19|||
125148087|NCT00373425|450164451|FG003|Overall Study|Relapse of NSCLC|2|||
125148088|NCT00373425|450164452|FG004|Overall Study|Relapse of NSCLC|26|||
125148089|NCT00373425|450164448|FG000|Overall Study|Adverse Event|191|||
125148090|NCT00373425|450164449|FG001|Overall Study|Adverse Event|22|||
125148091|NCT00373425|450164450|FG002|Overall Study|Adverse Event|59|||
125148092|NCT00373425|450164451|FG003|Overall Study|Adverse Event|0|||
125148093|NCT00373425|450164452|FG004|Overall Study|Adverse Event|34|||
125148094|NCT00373425|450164448|FG000|Overall Study|Patient request|35|||
125148095|NCT00373425|450164449|FG001|Overall Study|Patient request|18|||
125148096|NCT00373425|450164450|FG002|Overall Study|Patient request|43|||
125148097|NCT00373425|450164451|FG003|Overall Study|Patient request|6|||
125148098|NCT00373425|450164452|FG004|Overall Study|Patient request|7|||
125148099|NCT00373425|450164448|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
125148100|NCT00373425|450164449|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
125148101|NCT00373425|450164450|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
125148102|NCT00373425|450164451|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
125148103|NCT00373425|450164452|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
125148104|NCT00373425|450164448|FG000|Overall Study|Death|7|||
125148105|NCT00373425|450164449|FG001|Overall Study|Death|0|||
125148106|NCT00373425|450164450|FG002|Overall Study|Death|3|||
125148107|NCT00373425|450164451|FG003|Overall Study|Death|1|||
125148108|NCT00373425|450164452|FG004|Overall Study|Death|0|||
125148109|NCT03942211|450164455|FG000|Overall Study|Death|1|||
125148110|NCT03942211|450164456|FG001|Overall Study|Death|0|||
125223632|NCT02326272|450446171|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223633|NCT02326272|450446172|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223634|NCT02326272|450446173|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223635|NCT02326272|450446174|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223636|NCT02326272|450446175|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
125223637|NCT02326272|450446176|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
125223638|NCT02326272|450446177|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223639|NCT02326272|450446178|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
125223640|NCT02326272|450446164|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223641|NCT02326272|450446165|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223642|NCT02326272|450446166|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223643|NCT02326272|450446167|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223644|NCT02326272|450446168|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223645|NCT02326272|450446169|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125148111|NCT03942211|450164455|FG000|Overall Study|Study terminated by sponsor|5|||
125148112|NCT03942211|450164456|FG001|Overall Study|Study terminated by sponsor|3|||
125148113|NCT03942211|450164455|FG000|Overall Study|Adverse Event|0|||
125148114|NCT03942211|450164456|FG001|Overall Study|Adverse Event|1|||
125148115|NCT01183884|450164457|FG000|Overall Study|Progressive Disease|26|||
125148116|NCT01183884|450164457|FG000|Overall Study|Adverse Event|3|||
125148117|NCT01183884|450164457|FG000|Overall Study|Withdrawal by Subject|1|||
125148118|NCT01183884|450164457|FG000|Overall Study|Other Complicating Disease|3|||
125148119|NCT01183884|450164457|FG000|Overall Study|Not Treated|1|||
125148120|NCT01183884|450164457|FG000|Overall Study|Other|4|||
125148121|NCT01835548|450164463|FG000|Dose Optimization Period|Adverse Event|0|||
125148122|NCT01835548|450164464|FG001|Dose Optimization Period|Adverse Event|0|||
125148123|NCT01835548|450164465|FG002|Dose Optimization Period|Adverse Event|1|||
125148124|NCT01835548|450164463|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
125148125|NCT01835548|450164464|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
125148126|NCT01835548|450164465|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
125148127|NCT01835548|450164463|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125148128|NCT01835548|450164464|FG001|Double-Blind Treatment Period|Adverse Event|1|||
125148129|NCT01835548|450164465|FG002|Double-Blind Treatment Period|Adverse Event|0|||
125148130|NCT01835548|450164463|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125148131|NCT01835548|450164464|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125148132|NCT01835548|450164465|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125148133|NCT01169038|450164466|FG000|Overall Study|Death|1|||
125148134|NCT01169038|450164466|FG000|Overall Study|Adverse Event|5|||
125148135|NCT01169038|450164466|FG000|Overall Study|Required antibiotic administration|1|||
125148136|NCT01488448|450164467|FG000|Overall Study|Withdrawal by Subject|3|||
125148137|NCT01488448|450164468|FG001|Overall Study|Withdrawal by Subject|1|||
125148138|NCT01488448|450164467|FG000|Overall Study|Adverse Event|9|||
125148139|NCT01488448|450164468|FG001|Overall Study|Adverse Event|4|||
125148140|NCT01488448|450164467|FG000|Overall Study|Physician Decision|4|||
125148141|NCT01488448|450164468|FG001|Overall Study|Physician Decision|9|||
125148142|NCT01488448|450164467|FG000|Overall Study|Protocol Violation|4|||
125148143|NCT01488448|450164468|FG001|Overall Study|Protocol Violation|3|||
125148144|NCT00537017|450164469|FG000|Treatment Phase|Adverse Event|19|||
125148145|NCT00537017|450164469|FG000|Treatment Phase|Withdrawal by Subject|13|||
125148146|NCT00537017|450164469|FG000|Treatment Phase|Protocol Violation|2|||
125148147|NCT00537017|450164469|FG000|Follow-up Phase|Withdrawal by Subject|9|||
125148148|NCT03168906|450164472|FG000|Overall Study|Lack of Efficacy|6|||
125148149|NCT03168906|450164473|FG001|Overall Study|Lack of Efficacy|6|||
125148150|NCT02219308|450164476|FG000|Overall Study|Withdrawal by Subject|1|||
125148151|NCT02219308|450164477|FG001|Overall Study|Withdrawal by Subject|2|||
125148152|NCT02839798|450166442|FG000|Overall Study|Withdrawal by Subject|2|||
125148153|NCT02447887|450166443|FG000|Overall Study|Study was terminated|3|||
125148154|NCT00401245|450166444|FG000|Double Blind Titration Phase|Adverse Event|3|||
125148155|NCT00401245|450166445|FG001|Double Blind Titration Phase|Adverse Event|2|||
125148156|NCT00401245|450166446|FG002|Double Blind Titration Phase|Adverse Event|5|||
125148157|NCT00401245|450166447|FG003|Double Blind Titration Phase|Adverse Event|12|||
125148158|NCT00401245|450166448|FG004|Double Blind Titration Phase|Adverse Event|0|||
125148159|NCT00401245|450166449|FG005|Double Blind Titration Phase|Adverse Event|0|||
125148160|NCT00401245|450166450|FG006|Double Blind Titration Phase|Adverse Event|0|||
125148161|NCT00401245|450166451|FG007|Double Blind Titration Phase|Adverse Event|0|||
125148162|NCT00401245|450166444|FG000|Double Blind Titration Phase|Other|0|||
125148163|NCT00401245|450166445|FG001|Double Blind Titration Phase|Other|0|||
125148164|NCT00401245|450166446|FG002|Double Blind Titration Phase|Other|1|||
125148165|NCT00401245|450166447|FG003|Double Blind Titration Phase|Other|0|||
125148166|NCT00401245|450166448|FG004|Double Blind Titration Phase|Other|0|||
125148167|NCT00401245|450166449|FG005|Double Blind Titration Phase|Other|0|||
125148168|NCT00401245|450166450|FG006|Double Blind Titration Phase|Other|0|||
125148169|NCT00401245|450166451|FG007|Double Blind Titration Phase|Other|0|||
125148170|NCT00401245|450166444|FG000|Double Blind Titration Phase|Protocol Violation|0|||
125148171|NCT00401245|450166445|FG001|Double Blind Titration Phase|Protocol Violation|0|||
125148172|NCT00401245|450166446|FG002|Double Blind Titration Phase|Protocol Violation|0|||
125148173|NCT00401245|450166447|FG003|Double Blind Titration Phase|Protocol Violation|1|||
125148174|NCT00401245|450166448|FG004|Double Blind Titration Phase|Protocol Violation|0|||
125148175|NCT00401245|450166449|FG005|Double Blind Titration Phase|Protocol Violation|0|||
125148176|NCT00401245|450166450|FG006|Double Blind Titration Phase|Protocol Violation|0|||
125148177|NCT00401245|450166451|FG007|Double Blind Titration Phase|Protocol Violation|0|||
125148178|NCT00401245|450166444|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
125148179|NCT00401245|450166445|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
125223646|NCT02326272|450446170|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223647|NCT02326272|450446171|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223648|NCT02326272|450446172|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223649|NCT02326272|450446173|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125148180|NCT00401245|450166446|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
125148181|NCT00401245|450166447|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
125148182|NCT00401245|450166448|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
125148183|NCT00401245|450166449|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
125148184|NCT00401245|450166450|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
125148185|NCT00401245|450166451|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
125148186|NCT00401245|450166444|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
125148187|NCT00401245|450166445|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
125148188|NCT00401245|450166446|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
125148189|NCT00401245|450166447|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
125148190|NCT00401245|450166448|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
125148191|NCT00401245|450166449|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
125148192|NCT00401245|450166450|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
125148193|NCT00401245|450166451|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
125148194|NCT00401245|450166444|FG000|Open Label Phase|Adverse Event|5|||
125148195|NCT00401245|450166445|FG001|Open Label Phase|Adverse Event|14|||
125148196|NCT00401245|450166446|FG002|Open Label Phase|Adverse Event|6|||
125148197|NCT00401245|450166447|FG003|Open Label Phase|Adverse Event|7|||
125148198|NCT00401245|450166448|FG004|Open Label Phase|Adverse Event|0|||
125148199|NCT00401245|450166449|FG005|Open Label Phase|Adverse Event|0|||
125148200|NCT00401245|450166450|FG006|Open Label Phase|Adverse Event|0|||
125148201|NCT00401245|450166451|FG007|Open Label Phase|Adverse Event|0|||
125148202|NCT00401245|450166444|FG000|Open Label Phase|Lost to Follow-up|5|||
125148203|NCT00401245|450166445|FG001|Open Label Phase|Lost to Follow-up|7|||
125148204|NCT00401245|450166446|FG002|Open Label Phase|Lost to Follow-up|5|||
125148205|NCT00401245|450166447|FG003|Open Label Phase|Lost to Follow-up|4|||
125148206|NCT00401245|450166448|FG004|Open Label Phase|Lost to Follow-up|0|||
125148207|NCT00401245|450166449|FG005|Open Label Phase|Lost to Follow-up|0|||
125148208|NCT00401245|450166450|FG006|Open Label Phase|Lost to Follow-up|0|||
125148209|NCT00401245|450166451|FG007|Open Label Phase|Lost to Follow-up|0|||
125148210|NCT00401245|450166444|FG000|Open Label Phase|Other|4|||
125148211|NCT00401245|450166445|FG001|Open Label Phase|Other|8|||
125148212|NCT00401245|450166446|FG002|Open Label Phase|Other|7|||
125148213|NCT00401245|450166447|FG003|Open Label Phase|Other|8|||
125148214|NCT00401245|450166448|FG004|Open Label Phase|Other|0|||
125148215|NCT00401245|450166449|FG005|Open Label Phase|Other|0|||
125148216|NCT00401245|450166450|FG006|Open Label Phase|Other|0|||
125148217|NCT00401245|450166451|FG007|Open Label Phase|Other|0|||
125148218|NCT00401245|450166444|FG000|Open Label Phase|Protocol Violation|0|||
125148219|NCT00401245|450166445|FG001|Open Label Phase|Protocol Violation|1|||
125148220|NCT00401245|450166446|FG002|Open Label Phase|Protocol Violation|0|||
125148221|NCT00401245|450166447|FG003|Open Label Phase|Protocol Violation|1|||
125148222|NCT00401245|450166448|FG004|Open Label Phase|Protocol Violation|0|||
125148223|NCT00401245|450166449|FG005|Open Label Phase|Protocol Violation|0|||
125148224|NCT00401245|450166450|FG006|Open Label Phase|Protocol Violation|0|||
125148225|NCT00401245|450166451|FG007|Open Label Phase|Protocol Violation|0|||
125148226|NCT00401245|450166444|FG000|Open Label Phase|Withdrawal by Subject|3|||
125148227|NCT00401245|450166445|FG001|Open Label Phase|Withdrawal by Subject|3|||
125148228|NCT00401245|450166446|FG002|Open Label Phase|Withdrawal by Subject|2|||
125148229|NCT00401245|450166447|FG003|Open Label Phase|Withdrawal by Subject|1|||
125148230|NCT00401245|450166448|FG004|Open Label Phase|Withdrawal by Subject|0|||
125148231|NCT00401245|450166449|FG005|Open Label Phase|Withdrawal by Subject|0|||
125148232|NCT00401245|450166450|FG006|Open Label Phase|Withdrawal by Subject|0|||
125148233|NCT00401245|450166451|FG007|Open Label Phase|Withdrawal by Subject|0|||
125148234|NCT00401245|450166444|FG000|Open Label Phase|Lack of Efficacy|4|||
125148235|NCT00401245|450166445|FG001|Open Label Phase|Lack of Efficacy|2|||
125148236|NCT00401245|450166446|FG002|Open Label Phase|Lack of Efficacy|3|||
125148237|NCT00401245|450166447|FG003|Open Label Phase|Lack of Efficacy|0|||
125148238|NCT00401245|450166448|FG004|Open Label Phase|Lack of Efficacy|0|||
125148239|NCT00401245|450166449|FG005|Open Label Phase|Lack of Efficacy|0|||
125148240|NCT00401245|450166450|FG006|Open Label Phase|Lack of Efficacy|0|||
125148241|NCT00401245|450166451|FG007|Open Label Phase|Lack of Efficacy|0|||
125148242|NCT00401245|450166444|FG000|Double Blind Tapering Phase|Adverse Event|0|||
125148243|NCT00401245|450166445|FG001|Double Blind Tapering Phase|Adverse Event|0|||
125148244|NCT00401245|450166446|FG002|Double Blind Tapering Phase|Adverse Event|0|||
125148245|NCT00401245|450166447|FG003|Double Blind Tapering Phase|Adverse Event|0|||
125148246|NCT00401245|450166448|FG004|Double Blind Tapering Phase|Adverse Event|1|||
125148247|NCT00401245|450166449|FG005|Double Blind Tapering Phase|Adverse Event|1|||
125148248|NCT00401245|450166450|FG006|Double Blind Tapering Phase|Adverse Event|2|||
125223650|NCT02326272|450446174|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223651|NCT02326272|450446175|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
125223652|NCT02326272|450446176|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125148249|NCT00401245|450166451|FG007|Double Blind Tapering Phase|Adverse Event|4|||
125148250|NCT00401245|450166444|FG000|Double Blind Tapering Phase|Investigator request|0|||
125148251|NCT00401245|450166445|FG001|Double Blind Tapering Phase|Investigator request|0|||
125223653|NCT02326272|450446177|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223654|NCT02326272|450446178|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223655|NCT02326272|450446164|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125223656|NCT02326272|450446165|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125148252|NCT00401245|450166446|FG002|Double Blind Tapering Phase|Investigator request|0|||
125148253|NCT00401245|450166447|FG003|Double Blind Tapering Phase|Investigator request|0|||
125148254|NCT00401245|450166448|FG004|Double Blind Tapering Phase|Investigator request|0|||
125148255|NCT00401245|450166449|FG005|Double Blind Tapering Phase|Investigator request|0|||
125148256|NCT00401245|450166450|FG006|Double Blind Tapering Phase|Investigator request|0|||
125148257|NCT00401245|450166451|FG007|Double Blind Tapering Phase|Investigator request|1|||
125148258|NCT00401245|450166444|FG000|Double Blind Tapering Phase|Other|0|||
125148259|NCT00401245|450166445|FG001|Double Blind Tapering Phase|Other|0|||
125148260|NCT00401245|450166446|FG002|Double Blind Tapering Phase|Other|0|||
125148261|NCT00401245|450166447|FG003|Double Blind Tapering Phase|Other|0|||
125148262|NCT00401245|450166448|FG004|Double Blind Tapering Phase|Other|1|||
125148263|NCT00401245|450166449|FG005|Double Blind Tapering Phase|Other|0|||
125148264|NCT00401245|450166450|FG006|Double Blind Tapering Phase|Other|2|||
125148265|NCT00401245|450166451|FG007|Double Blind Tapering Phase|Other|2|||
125148266|NCT00401245|450166444|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
125148267|NCT00401245|450166445|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
125148268|NCT00401245|450166446|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
125148269|NCT00401245|450166447|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
125148270|NCT00401245|450166448|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
125148271|NCT00401245|450166449|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
125148272|NCT00401245|450166450|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
125148273|NCT00401245|450166451|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
125148274|NCT00401245|450166444|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
125148275|NCT00401245|450166445|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
125148276|NCT00401245|450166446|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
125148277|NCT00401245|450166447|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
125148278|NCT00401245|450166448|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
125148279|NCT00401245|450166449|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
125148280|NCT00401245|450166450|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
125148281|NCT00401245|450166451|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
125148282|NCT02344745|450166452|FG000|Overall Study|Data collection sheets were lost|2|||
125148283|NCT02344745|450166453|FG001|Overall Study|Data collection sheets were lost|0|||
125148284|NCT02788513|450166454|FG000|Overall Study|Withdrawal by Subject|3|||
125148285|NCT02788513|450166455|FG001|Overall Study|Withdrawal by Subject|0|||
125148286|NCT02788513|450166456|FG002|Overall Study|Withdrawal by Subject|2|||
125148287|NCT02788513|450166457|FG003|Overall Study|Withdrawal by Subject|3|||
125148288|NCT02788513|450166458|FG004|Overall Study|Withdrawal by Subject|1|||
125148289|NCT02788513|450166454|FG000|Overall Study|Lost to Follow-up|1|||
125148290|NCT02788513|450166455|FG001|Overall Study|Lost to Follow-up|0|||
125148291|NCT02788513|450166456|FG002|Overall Study|Lost to Follow-up|0|||
125148292|NCT02788513|450166457|FG003|Overall Study|Lost to Follow-up|0|||
125148293|NCT02788513|450166458|FG004|Overall Study|Lost to Follow-up|1|||
125148294|NCT02788513|450166454|FG000|Overall Study|Adverse Event|5|||
125148295|NCT02788513|450166455|FG001|Overall Study|Adverse Event|8|||
125148296|NCT02788513|450166456|FG002|Overall Study|Adverse Event|4|||
125148297|NCT02788513|450166457|FG003|Overall Study|Adverse Event|2|||
125148298|NCT02788513|450166458|FG004|Overall Study|Adverse Event|2|||
125148299|NCT02788513|450166454|FG000|Overall Study|Protocol Violation|0|||
125148300|NCT02788513|450166455|FG001|Overall Study|Protocol Violation|0|||
125148301|NCT02788513|450166456|FG002|Overall Study|Protocol Violation|1|||
125148302|NCT02788513|450166457|FG003|Overall Study|Protocol Violation|1|||
125148303|NCT02788513|450166458|FG004|Overall Study|Protocol Violation|0|||
125148304|NCT02788513|450166454|FG000|Overall Study|Subject decided to stop taking treatment|0|||
125148305|NCT02788513|450166455|FG001|Overall Study|Subject decided to stop taking treatment|0|||
125148306|NCT02788513|450166456|FG002|Overall Study|Subject decided to stop taking treatment|1|||
125148307|NCT02788513|450166457|FG003|Overall Study|Subject decided to stop taking treatment|0|||
125148308|NCT02788513|450166458|FG004|Overall Study|Subject decided to stop taking treatment|0|||
125148309|NCT02788513|450166454|FG000|Overall Study|Decision by the study team|0|||
125148310|NCT02788513|450166455|FG001|Overall Study|Decision by the study team|0|||
125148311|NCT02788513|450166456|FG002|Overall Study|Decision by the study team|0|||
125148312|NCT02788513|450166457|FG003|Overall Study|Decision by the study team|0|||
125148313|NCT02788513|450166458|FG004|Overall Study|Decision by the study team|1|||
125148314|NCT02014441|450166460|FG000|Overall Study|Withdrawal by Subject|12|||
125148315|NCT01933919|450166461|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
125148316|NCT01933919|450166462|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
125148317|NCT01933919|450166461|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
125148318|NCT01933919|450166462|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
125223657|NCT02326272|450446166|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125148319|NCT01933919|450166461|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
125148320|NCT01933919|450166462|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
125148321|NCT01933919|450166461|FG000|Open-label Long-term Phase|Adverse Event|2|||
125148322|NCT01933919|450166462|FG001|Open-label Long-term Phase|Adverse Event|0|||
125148323|NCT01933919|450166461|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
125148324|NCT01933919|450166462|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
125148325|NCT01933919|450166461|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
125148326|NCT01933919|450166462|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
125148327|NCT01933919|450166461|FG000|Open-label Long-term Phase|Other|1|||
125148328|NCT01933919|450166462|FG001|Open-label Long-term Phase|Other|2|||
125148329|NCT00991510|450166463|FG000|Period I (Days 1-14)|Adverse Event|1|||
125148330|NCT00991510|450166464|FG001|Period I (Days 1-14)|Adverse Event|0|||
125148331|NCT00991510|450166463|FG000|Period III (Days 29-112)|Adverse Event|1|||
125148332|NCT00991510|450166464|FG001|Period III (Days 29-112)|Adverse Event|1|||
125148333|NCT02356211|450166469|FG000|Overall Study|Withdrawal by Subject|2|||
125148334|NCT02356211|450166470|FG001|Overall Study|Withdrawal by Subject|2|||
125148335|NCT02356211|450166469|FG000|Overall Study|ineligible|1|||
125148336|NCT02356211|450166470|FG001|Overall Study|ineligible|8|||
125148337|NCT02510261|450166475|FG000|Overall Study|Adverse Event|5|||
125148338|NCT02510261|450166476|FG001|Overall Study|Adverse Event|8|||
125148339|NCT02510261|450166477|FG002|Overall Study|Adverse Event|0|||
125148340|NCT02510261|450166475|FG000|Overall Study|Physician Decision|1|||
125148341|NCT02510261|450166476|FG001|Overall Study|Physician Decision|5|||
125148342|NCT02510261|450166477|FG002|Overall Study|Physician Decision|0|||
125148343|NCT02510261|450166475|FG000|Overall Study|Death|19|||
125148344|NCT02510261|450166476|FG001|Overall Study|Death|19|||
125148345|NCT02510261|450166477|FG002|Overall Study|Death|0|||
125148346|NCT02510261|450166475|FG000|Overall Study|Withdrawal by Subject|3|||
125148347|NCT02510261|450166476|FG001|Overall Study|Withdrawal by Subject|10|||
125148348|NCT02510261|450166477|FG002|Overall Study|Withdrawal by Subject|3|||
125148349|NCT02443324|450166481|FG000|Overall Study|Death|4|||
125148350|NCT02443324|450166482|FG001|Overall Study|Death|1|||
125148351|NCT02443324|450166483|FG002|Overall Study|Death|0|||
125148352|NCT02443324|450166484|FG003|Overall Study|Death|3|||
125148353|NCT02443324|450166485|FG004|Overall Study|Death|1|||
125148354|NCT02443324|450166486|FG005|Overall Study|Death|3|||
125148355|NCT02443324|450166487|FG006|Overall Study|Death|2|||
125148356|NCT02443324|450166481|FG000|Overall Study|Lost to Follow-up|0|||
125148357|NCT02443324|450166482|FG001|Overall Study|Lost to Follow-up|0|||
125148358|NCT02443324|450166483|FG002|Overall Study|Lost to Follow-up|0|||
125148359|NCT02443324|450166484|FG003|Overall Study|Lost to Follow-up|1|||
125148360|NCT02443324|450166485|FG004|Overall Study|Lost to Follow-up|0|||
125148361|NCT02443324|450166486|FG005|Overall Study|Lost to Follow-up|1|||
125148362|NCT02443324|450166487|FG006|Overall Study|Lost to Follow-up|0|||
125148363|NCT02443324|450166481|FG000|Overall Study|Physician Decision|0|||
125148364|NCT02443324|450166482|FG001|Overall Study|Physician Decision|3|||
125148365|NCT02443324|450166483|FG002|Overall Study|Physician Decision|5|||
125148366|NCT02443324|450166484|FG003|Overall Study|Physician Decision|1|||
125148367|NCT02443324|450166485|FG004|Overall Study|Physician Decision|1|||
125148368|NCT02443324|450166486|FG005|Overall Study|Physician Decision|0|||
125148369|NCT02443324|450166487|FG006|Overall Study|Physician Decision|2|||
125148370|NCT02443324|450166481|FG000|Overall Study|Progressive Disease|20|||
125148371|NCT02443324|450166482|FG001|Overall Study|Progressive Disease|20|||
125148372|NCT02443324|450166483|FG002|Overall Study|Progressive Disease|13|||
125148373|NCT02443324|450166484|FG003|Overall Study|Progressive Disease|10|||
125148374|NCT02443324|450166485|FG004|Overall Study|Progressive Disease|13|||
125148375|NCT02443324|450166486|FG005|Overall Study|Progressive Disease|17|||
125148376|NCT02443324|450166487|FG006|Overall Study|Progressive Disease|10|||
125148377|NCT02443324|450166481|FG000|Overall Study|Withdrawal by Subject|0|||
125148378|NCT02443324|450166482|FG001|Overall Study|Withdrawal by Subject|0|||
125148379|NCT02443324|450166483|FG002|Overall Study|Withdrawal by Subject|3|||
125148380|NCT02443324|450166484|FG003|Overall Study|Withdrawal by Subject|1|||
125148381|NCT02443324|450166485|FG004|Overall Study|Withdrawal by Subject|1|||
125148382|NCT02443324|450166486|FG005|Overall Study|Withdrawal by Subject|0|||
125148383|NCT02443324|450166487|FG006|Overall Study|Withdrawal by Subject|1|||
125148384|NCT02443324|450166481|FG000|Overall Study|Adverse Event|0|||
125148385|NCT02443324|450166482|FG001|Overall Study|Adverse Event|1|||
125148386|NCT02443324|450166483|FG002|Overall Study|Adverse Event|3|||
125148387|NCT02443324|450166484|FG003|Overall Study|Adverse Event|0|||
125148388|NCT02443324|450166485|FG004|Overall Study|Adverse Event|4|||
125148389|NCT02443324|450166486|FG005|Overall Study|Adverse Event|3|||
125148390|NCT02443324|450166487|FG006|Overall Study|Adverse Event|3|||
125148391|NCT02443324|450166481|FG000|Overall Study|Enrolled but Never Treated|0|||
125148392|NCT02443324|450166482|FG001|Overall Study|Enrolled but Never Treated|0|||
125148393|NCT02443324|450166483|FG002|Overall Study|Enrolled but Never Treated|1|||
125148394|NCT02443324|450166484|FG003|Overall Study|Enrolled but Never Treated|0|||
125148395|NCT02443324|450166485|FG004|Overall Study|Enrolled but Never Treated|1|||
125148396|NCT02443324|450166486|FG005|Overall Study|Enrolled but Never Treated|0|||
125148397|NCT02443324|450166487|FG006|Overall Study|Enrolled but Never Treated|1|||
125148398|NCT02780167|450166498|FG000|Overall Study|Adverse Event|9|||
125148399|NCT02780167|450166499|FG001|Overall Study|Adverse Event|8|||
125148400|NCT02780167|450166500|FG002|Overall Study|Adverse Event|8|||
125148401|NCT02780167|450166501|FG003|Overall Study|Adverse Event|12|||
125148402|NCT02780167|450166502|FG004|Overall Study|Adverse Event|8|||
125148403|NCT02780167|450166498|FG000|Overall Study|Lack of Efficacy|6|||
125148404|NCT02780167|450166499|FG001|Overall Study|Lack of Efficacy|5|||
125148405|NCT02780167|450166500|FG002|Overall Study|Lack of Efficacy|6|||
125148406|NCT02780167|450166501|FG003|Overall Study|Lack of Efficacy|1|||
125148407|NCT02780167|450166502|FG004|Overall Study|Lack of Efficacy|0|||
125148408|NCT02780167|450166498|FG000|Overall Study|Lost to Follow-up|2|||
125148409|NCT02780167|450166499|FG001|Overall Study|Lost to Follow-up|0|||
125148410|NCT02780167|450166500|FG002|Overall Study|Lost to Follow-up|1|||
125148411|NCT02780167|450166501|FG003|Overall Study|Lost to Follow-up|0|||
125148412|NCT02780167|450166502|FG004|Overall Study|Lost to Follow-up|0|||
125148413|NCT02780167|450166498|FG000|Overall Study|Does not meet entrance criteria|0|||
125148414|NCT02780167|450166499|FG001|Overall Study|Does not meet entrance criteria|0|||
125148415|NCT02780167|450166500|FG002|Overall Study|Does not meet entrance criteria|1|||
125148416|NCT02780167|450166501|FG003|Overall Study|Does not meet entrance criteria|0|||
125148417|NCT02780167|450166502|FG004|Overall Study|Does not meet entrance criteria|0|||
125148418|NCT02780167|450166498|FG000|Overall Study|No longer meets eligibility criteria|0|||
125148419|NCT02780167|450166499|FG001|Overall Study|No longer meets eligibility criteria|0|||
125148420|NCT02780167|450166500|FG002|Overall Study|No longer meets eligibility criteria|0|||
125148421|NCT02780167|450166501|FG003|Overall Study|No longer meets eligibility criteria|1|||
125148422|NCT02780167|450166502|FG004|Overall Study|No longer meets eligibility criteria|1|||
125148423|NCT02780167|450166498|FG000|Overall Study|Protocol Violation|5|||
125148424|NCT02780167|450166499|FG001|Overall Study|Protocol Violation|5|||
125148425|NCT02780167|450166500|FG002|Overall Study|Protocol Violation|1|||
125148426|NCT02780167|450166501|FG003|Overall Study|Protocol Violation|1|||
125148427|NCT02780167|450166502|FG004|Overall Study|Protocol Violation|2|||
125148428|NCT02780167|450166498|FG000|Overall Study|Withdrawal by Subject|6|||
125148429|NCT02780167|450166499|FG001|Overall Study|Withdrawal by Subject|4|||
125148430|NCT02780167|450166500|FG002|Overall Study|Withdrawal by Subject|4|||
125148431|NCT02780167|450166501|FG003|Overall Study|Withdrawal by Subject|3|||
125148432|NCT02780167|450166502|FG004|Overall Study|Withdrawal by Subject|4|||
125148433|NCT02780167|450166498|FG000|Overall Study|Other|0|||
125148434|NCT02780167|450166499|FG001|Overall Study|Other|0|||
125148435|NCT02780167|450166500|FG002|Overall Study|Other|3|||
125148436|NCT02780167|450166501|FG003|Overall Study|Other|1|||
125148437|NCT02780167|450166502|FG004|Overall Study|Other|2|||
125148438|NCT03180801|450166503|FG000|Overall Study|Physician Decision|3|||
125148439|NCT03180801|450166504|FG001|Overall Study|Physician Decision|3|||
125148440|NCT03180801|450166505|FG002|Overall Study|Physician Decision|1|||
125148441|NCT03180801|450166503|FG000|Overall Study|Non-compliance|1|||
125148442|NCT03180801|450166504|FG001|Overall Study|Non-compliance|4|||
125148443|NCT03180801|450166505|FG002|Overall Study|Non-compliance|0|||
125148444|NCT03180801|450166503|FG000|Overall Study|Inoculation Target Reached|1|||
125148445|NCT03180801|450166504|FG001|Overall Study|Inoculation Target Reached|1|||
125148446|NCT03180801|450166505|FG002|Overall Study|Inoculation Target Reached|3|||
125148447|NCT03180801|450166503|FG000|Overall Study|Adverse Event|1|||
125148448|NCT03180801|450166504|FG001|Overall Study|Adverse Event|0|||
125148449|NCT03180801|450166505|FG002|Overall Study|Adverse Event|2|||
125148450|NCT03180801|450166503|FG000|Overall Study|Withdrawal by Subject|2|||
125148451|NCT03180801|450166504|FG001|Overall Study|Withdrawal by Subject|2|||
125148452|NCT03180801|450166505|FG002|Overall Study|Withdrawal by Subject|1|||
125148453|NCT03180801|450166503|FG000|Overall Study|Lost to Follow-up|0|||
125148454|NCT03180801|450166504|FG001|Overall Study|Lost to Follow-up|2|||
125148455|NCT03180801|450166505|FG002|Overall Study|Lost to Follow-up|3|||
125148456|NCT03756883|450166506|FG000|Overall Study|Adverse Event|2|||
125148457|NCT03756883|450166507|FG001|Overall Study|Adverse Event|2|||
125148458|NCT03756883|450166508|FG002|Overall Study|Adverse Event|2|||
125148459|NCT03756883|450166506|FG000|Overall Study|Lack of Efficacy|0|||
125148460|NCT03756883|450166507|FG001|Overall Study|Lack of Efficacy|1|||
125148461|NCT03756883|450166508|FG002|Overall Study|Lack of Efficacy|2|||
125148462|NCT03756883|450166506|FG000|Overall Study|Lost to Follow-up|3|||
125148463|NCT03756883|450166507|FG001|Overall Study|Lost to Follow-up|3|||
125148464|NCT03756883|450166508|FG002|Overall Study|Lost to Follow-up|0|||
125148465|NCT03756883|450166506|FG000|Overall Study|Protocol Violation|2|||
125148466|NCT03756883|450166507|FG001|Overall Study|Protocol Violation|0|||
125148467|NCT03756883|450166508|FG002|Overall Study|Protocol Violation|1|||
125148468|NCT03756883|450166506|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
125148469|NCT03756883|450166507|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
125148470|NCT03756883|450166508|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
125148471|NCT03756883|450166506|FG000|Overall Study|Withdrawal by Subject|4|||
125148472|NCT03756883|450166507|FG001|Overall Study|Withdrawal by Subject|1|||
125148473|NCT03756883|450166508|FG002|Overall Study|Withdrawal by Subject|0|||
125148474|NCT03756883|450166506|FG000|Overall Study|Other Reasons|2|||
125148475|NCT03756883|450166507|FG001|Overall Study|Other Reasons|4|||
125148476|NCT03756883|450166508|FG002|Overall Study|Other Reasons|0|||
125148477|NCT03235479|450166511|FG000|Overall Study|Lost to Follow-up|8|||
125148478|NCT03235479|450166512|FG001|Overall Study|Lost to Follow-up|11|||
125148479|NCT03235479|450166511|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
125148480|NCT03235479|450166512|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
125148481|NCT03235479|450166511|FG000|Overall Study|Pregnancy|1|||
125148482|NCT03235479|450166512|FG001|Overall Study|Pregnancy|0|||
125148483|NCT03235479|450166511|FG000|Overall Study|Protocol Deviation|1|||
125148484|NCT03235479|450166512|FG001|Overall Study|Protocol Deviation|3|||
125148485|NCT03235479|450166511|FG000|Overall Study|Technical Problems|3|||
125148486|NCT03235479|450166512|FG001|Overall Study|Technical Problems|2|||
125148487|NCT03235479|450166511|FG000|Overall Study|Withdrawal by Subject|2|||
125148488|NCT03235479|450166512|FG001|Overall Study|Withdrawal by Subject|2|||
125148489|NCT03235479|450166511|FG000|Overall Study|Other Reasons|3|||
125148490|NCT03235479|450166512|FG001|Overall Study|Other Reasons|5|||
125148491|NCT03110380|450166524|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
125148492|NCT03110380|450166525|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
125148493|NCT03110380|450166526|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
125148494|NCT03110380|450166527|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
125148495|NCT03110380|450166524|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
125148496|NCT03110380|450166525|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
125148497|NCT03110380|450166526|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125148498|NCT03110380|450166527|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125148499|NCT03110380|450166524|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
125148500|NCT03110380|450166525|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
125148501|NCT03110380|450166526|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
125148502|NCT03110380|450166527|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
125148503|NCT03110380|450166524|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
125148504|NCT03110380|450166525|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
125148505|NCT03110380|450166526|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
125148506|NCT03110380|450166527|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
125148507|NCT03110380|450166524|FG000|Double-Blind Treatment Phase|Death|2|||
125148508|NCT03110380|450166525|FG001|Double-Blind Treatment Phase|Death|1|||
125148509|NCT03110380|450166526|FG002|Double-Blind Treatment Phase|Death|0|||
125148510|NCT03110380|450166527|FG003|Double-Blind Treatment Phase|Death|0|||
125148511|NCT03110380|450166524|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
125148512|NCT03110380|450166525|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
125148513|NCT03110380|450166526|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
125148514|NCT03110380|450166527|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
125148515|NCT03110380|450166524|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
125148516|NCT03110380|450166525|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
125148517|NCT03110380|450166526|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
125148518|NCT03110380|450166527|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
125148519|NCT03110380|450166524|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
125148520|NCT03110380|450166525|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
125148521|NCT03110380|450166526|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
125148522|NCT03110380|450166527|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
125148523|NCT03110380|450166524|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
125148524|NCT03110380|450166525|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
125148525|NCT03110380|450166526|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
125148526|NCT03110380|450166527|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
125148527|NCT03110380|450166524|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
125148528|NCT03110380|450166525|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
125148529|NCT03110380|450166526|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
125148530|NCT03110380|450166527|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
125148531|NCT03110380|450166524|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
125148532|NCT03110380|450166525|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
125148533|NCT03110380|450166526|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
125148534|NCT03110380|450166527|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
125148535|NCT01355302|450166530|FG000|Phase 1b|Death|4|||
125148536|NCT01355302|450166531|FG001|Phase 1b|Death|0|||
125148537|NCT01355302|450166532|FG002|Phase 1b|Death|0|||
125148538|NCT01355302|450166530|FG000|Phase 1b|Study terminated by sponsor|2|||
125148539|NCT01355302|450166531|FG001|Phase 1b|Study terminated by sponsor|0|||
125148540|NCT01355302|450166532|FG002|Phase 1b|Study terminated by sponsor|0|||
125148541|NCT02531594|450166533|FG000|Overall Study|Withdrawal by Subject|7|||
125148542|NCT02531594|450166534|FG001|Overall Study|Withdrawal by Subject|8|||
125148543|NCT03750695|450166535|FG000|Overall Study|Lost to Follow-up|0|||
125148544|NCT03750695|450166536|FG001|Overall Study|Lost to Follow-up|1|||
125148545|NCT04480307|450166539|FG000|Overall Study|Withdrawal by Subject|0|||
125148546|NCT04480307|450166540|FG001|Overall Study|Withdrawal by Subject|1|||
125148547|NCT04480307|450166541|FG002|Overall Study|Withdrawal by Subject|0|||
125148548|NCT04480307|450166542|FG003|Overall Study|Withdrawal by Subject|0|||
125148549|NCT04480307|450166539|FG000|Overall Study|Adverse Event|0|||
125148550|NCT04480307|450166540|FG001|Overall Study|Adverse Event|0|||
125148551|NCT04480307|450166541|FG002|Overall Study|Adverse Event|0|||
125148552|NCT04480307|450166542|FG003|Overall Study|Adverse Event|1|||
125148553|NCT01203917|450166544|FG000|Overall Study|Death|29|||
125148554|NCT01203917|450166544|FG000|Overall Study|Lost to Follow-up|2|||
125148555|NCT01203917|450166544|FG000|Overall Study|Withdrawal by Subject|3|||
125148556|NCT01203917|450166544|FG000|Overall Study|Due to objective disease progression|1|||
125148557|NCT01203917|450166544|FG000|Overall Study|Due to EGFR M+I patient|1|||
125148558|NCT01264835|450166545|FG000|Overall Study|Lost to Follow-up|1|||
125148559|NCT04660032|450166548|FG000|Overall Study|Protocol Violation|1|||
125148560|NCT04660032|450166549|FG001|Overall Study|Protocol Violation|1|||
125148561|NCT01609582|450166558|FG000|Overall Study|Adverse Event|20|||
125148562|NCT01609582|450166559|FG001|Overall Study|Adverse Event|18|||
125148563|NCT01609582|450166558|FG000|Overall Study|Lost to Follow-up|10|||
125148564|NCT01609582|450166559|FG001|Overall Study|Lost to Follow-up|10|||
125148565|NCT01609582|450166558|FG000|Overall Study|Withdrawal by Subject|21|||
125148566|NCT01609582|450166559|FG001|Overall Study|Withdrawal by Subject|15|||
125148567|NCT01609582|450166558|FG000|Overall Study|Study Terminated by Sponsor|1543|||
125148568|NCT01609582|450166559|FG001|Overall Study|Study Terminated by Sponsor|1548|||
125148569|NCT01609582|450166558|FG000|Overall Study|Other|9|||
125148570|NCT01609582|450166559|FG001|Overall Study|Other|10|||
125148571|NCT01609582|450166558|FG000|Overall Study|Randomized, but not treated|0|||
125148572|NCT01609582|450166559|FG001|Overall Study|Randomized, but not treated|3|||
125148573|NCT00819767|450166560|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125148574|NCT00819767|450166561|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125148575|NCT00808509|450166565|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
125148576|NCT00808509|450166566|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
125148577|NCT00808509|450166565|FG000|Randomized Phase|Reduced methotrexate dose|1|||
125148578|NCT00808509|450166566|FG001|Randomized Phase|Reduced methotrexate dose|2|||
125148579|NCT00808509|450166565|FG000|Randomized Phase|Patient refused rescue therapy|0|||
125148580|NCT00808509|450166566|FG001|Randomized Phase|Patient refused rescue therapy|3|||
125148581|NCT02762994|450166569|FG000|Overall Study|Withdrawal by Subject|0|||
125148582|NCT02762994|450166570|FG001|Overall Study|Withdrawal by Subject|1|||
125148583|NCT02762994|450166571|FG002|Overall Study|Withdrawal by Subject|2|||
125148584|NCT02762994|450166572|FG003|Overall Study|Withdrawal by Subject|0|||
125148585|NCT02762994|450166569|FG000|Overall Study|Protocol Violation|1|||
125148586|NCT02762994|450166570|FG001|Overall Study|Protocol Violation|0|||
125148587|NCT02762994|450166571|FG002|Overall Study|Protocol Violation|0|||
125148588|NCT02762994|450166572|FG003|Overall Study|Protocol Violation|2|||
125148589|NCT05103657|450166575|FG000|Overall Study|Other reasons than listed|9|||
125148590|NCT05103657|450166576|FG001|Overall Study|Other reasons than listed|8|||
125148591|NCT05103657|450166575|FG000|Overall Study|Protocol deviation|2|||
125148592|NCT05103657|450166576|FG001|Overall Study|Protocol deviation|2|||
125148593|NCT05103657|450166575|FG000|Overall Study|No reason available|5|||
125148594|NCT05103657|450166576|FG001|Overall Study|No reason available|4|||
125148595|NCT05103657|450166575|FG000|Overall Study|Burden of study procedures|3|||
125148596|NCT05103657|450166576|FG001|Overall Study|Burden of study procedures|1|||
125148597|NCT05103657|450166575|FG000|Overall Study|Perceived lack of efficacy|1|||
125148598|NCT05103657|450166576|FG001|Overall Study|Perceived lack of efficacy|1|||
125148599|NCT05103657|450166575|FG000|Overall Study|Adverse Event|6|||
125148600|NCT05103657|450166576|FG001|Overall Study|Adverse Event|14|||
125148601|NCT05103657|450166575|FG000|Overall Study|Not Treated|1|||
125148602|NCT05103657|450166576|FG001|Overall Study|Not Treated|1|||
125148603|NCT04234464|450166580|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
125148604|NCT04234464|450166581|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
125148605|NCT03635983|450166582|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
125148606|NCT03635983|450166583|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
125148607|NCT03635983|450166582|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
125148608|NCT03635983|450166583|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125148609|NCT03635983|450166582|FG000|Pre-Treatment Period|Other reasons|0|||
125148610|NCT03635983|450166583|FG001|Pre-Treatment Period|Other reasons|1|||
125148611|NCT03635983|450166582|FG000|Pre-Treatment Period|Disease Progression|0|||
125148612|NCT03635983|450166583|FG001|Pre-Treatment Period|Disease Progression|1|||
125148613|NCT03635983|450166582|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
125148614|NCT03635983|450166583|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
125148615|NCT03635983|450166582|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
125148616|NCT03635983|450166583|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
125148617|NCT03635983|450166582|FG000|Treatment Period|Withdrawal by Subject|3|||
125148618|NCT03635983|450166583|FG001|Treatment Period|Withdrawal by Subject|5|||
125148619|NCT03635983|450166582|FG000|Treatment Period|Death|3|||
125148620|NCT03635983|450166583|FG001|Treatment Period|Death|5|||
125148621|NCT03635983|450166582|FG000|Treatment Period|Poor/Non-compliance|2|||
125148622|NCT03635983|450166583|FG001|Treatment Period|Poor/Non-compliance|1|||
125148623|NCT03635983|450166582|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
125148624|NCT03635983|450166583|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
125148625|NCT03635983|450166582|FG000|Treatment Period|Other reasons|7|||
125148626|NCT03635983|450166583|FG001|Treatment Period|Other reasons|4|||
125148627|NCT03635983|450166582|FG000|Treatment Period|Disease progression|230|||
125148628|NCT03635983|450166583|FG001|Treatment Period|Disease progression|201|||
125148629|NCT03635983|450166582|FG000|Treatment Period|Study drug toxicity|35|||
125148630|NCT03635983|450166583|FG001|Treatment Period|Study drug toxicity|36|||
125148631|NCT03635983|450166582|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
125148632|NCT03635983|450166583|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
125148633|NCT03635983|450166582|FG000|Treatment Period|Maximum clinical benefit|3|||
125148634|NCT03635983|450166583|FG001|Treatment Period|Maximum clinical benefit|5|||
125148635|NCT03635983|450166582|FG000|Treatment Period|Administrative reason by the sponsor|1|||
125148636|NCT03635983|450166583|FG001|Treatment Period|Administrative reason by the sponsor|2|||
125148637|NCT03635983|450166582|FG000|Treatment Period|Lost to Follow-up|0|||
125148638|NCT03635983|450166583|FG001|Treatment Period|Lost to Follow-up|1|||
125148639|NCT01235442|450166585|FG000|Overall Study|Lost to Follow-up|12|||
125148640|NCT01235442|450166586|FG001|Overall Study|Lost to Follow-up|10|||
125148641|NCT01235442|450166585|FG000|Overall Study|Death|0|||
125148642|NCT01235442|450166586|FG001|Overall Study|Death|2|||
125148643|NCT01235442|450166585|FG000|Overall Study|Pregnancy|1|||
125148644|NCT01235442|450166586|FG001|Overall Study|Pregnancy|1|||
125148645|NCT01235442|450166585|FG000|Overall Study|Ineligibility determined|5|||
125148646|NCT01235442|450166586|FG001|Overall Study|Ineligibility determined|4|||
125148647|NCT01235442|450166585|FG000|Overall Study|Protocol Violation|3|||
125148648|NCT01235442|450166586|FG001|Overall Study|Protocol Violation|3|||
125148649|NCT01235442|450166585|FG000|Overall Study|Adverse Event|4|||
125148650|NCT01235442|450166586|FG001|Overall Study|Adverse Event|6|||
125148651|NCT01235442|450166585|FG000|Overall Study|Withdrawal by Subject|15|||
125148652|NCT01235442|450166586|FG001|Overall Study|Withdrawal by Subject|9|||
125148653|NCT01235442|450166585|FG000|Overall Study|Lack of Efficacy|1|||
125148654|NCT01235442|450166586|FG001|Overall Study|Lack of Efficacy|3|||
125148655|NCT01235442|450166585|FG000|Overall Study|Noncompliance|1|||
125148656|NCT01235442|450166586|FG001|Overall Study|Noncompliance|2|||
125148657|NCT01235442|450166585|FG000|Overall Study|Administrative decision|1|||
125148658|NCT01235442|450166586|FG001|Overall Study|Administrative decision|2|||
125148659|NCT01235442|450166585|FG000|Overall Study|Other unspecified|1|||
125148660|NCT01235442|450166586|FG001|Overall Study|Other unspecified|2|||
125148661|NCT01701973|450166589|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
125148662|NCT01701973|450166590|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
125148663|NCT01701973|450166591|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
125148664|NCT01701973|450166592|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
125148665|NCT01701973|450166593|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
125148666|NCT01701973|450166594|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
125148667|NCT01701973|450166595|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
125148668|NCT01701973|450166596|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
125148669|NCT02412722|450166599|FG000|Overall Study|Adverse Event|0|||
125148670|NCT02412722|450166600|FG001|Overall Study|Adverse Event|2|||
125148671|NCT02412722|450166601|FG002|Overall Study|Adverse Event|0|||
125148672|NCT02412722|450166602|FG003|Overall Study|Adverse Event|3|||
125148673|NCT02412722|450166603|FG004|Overall Study|Adverse Event|0|||
125148674|NCT02412722|450166604|FG005|Overall Study|Adverse Event|3|||
125148675|NCT02412722|450166599|FG000|Overall Study|Progressive Disease|6|||
125148676|NCT02412722|450166600|FG001|Overall Study|Progressive Disease|4|||
125148677|NCT02412722|450166601|FG002|Overall Study|Progressive Disease|4|||
125148678|NCT02412722|450166602|FG003|Overall Study|Progressive Disease|9|||
125148679|NCT02412722|450166603|FG004|Overall Study|Progressive Disease|3|||
125148680|NCT02412722|450166604|FG005|Overall Study|Progressive Disease|3|||
125148681|NCT02412722|450166599|FG000|Overall Study|Withdrawal by Subject|2|||
125148682|NCT02412722|450166600|FG001|Overall Study|Withdrawal by Subject|0|||
125148683|NCT02412722|450166601|FG002|Overall Study|Withdrawal by Subject|1|||
125148684|NCT02412722|450166602|FG003|Overall Study|Withdrawal by Subject|2|||
125148685|NCT02412722|450166603|FG004|Overall Study|Withdrawal by Subject|1|||
125148686|NCT02412722|450166604|FG005|Overall Study|Withdrawal by Subject|1|||
125148687|NCT02412722|450166599|FG000|Overall Study|Lost to Follow-up|0|||
125148688|NCT02412722|450166600|FG001|Overall Study|Lost to Follow-up|0|||
125148689|NCT02412722|450166601|FG002|Overall Study|Lost to Follow-up|0|||
125148690|NCT02412722|450166602|FG003|Overall Study|Lost to Follow-up|0|||
125148691|NCT02412722|450166603|FG004|Overall Study|Lost to Follow-up|1|||
125148692|NCT02412722|450166604|FG005|Overall Study|Lost to Follow-up|0|||
125148693|NCT02412722|450166599|FG000|Overall Study|Received drug in run-in and discontinued|0|||
125148694|NCT02412722|450166600|FG001|Overall Study|Received drug in run-in and discontinued|2|||
125148695|NCT02412722|450166601|FG002|Overall Study|Received drug in run-in and discontinued|0|||
125148696|NCT02412722|450166602|FG003|Overall Study|Received drug in run-in and discontinued|0|||
125148697|NCT02412722|450166603|FG004|Overall Study|Received drug in run-in and discontinued|0|||
125148698|NCT02412722|450166604|FG005|Overall Study|Received drug in run-in and discontinued|0|||
125148699|NCT02412722|450166599|FG000|Overall Study|Reason not Specified|3|||
125148700|NCT02412722|450166600|FG001|Overall Study|Reason not Specified|0|||
125148701|NCT02412722|450166601|FG002|Overall Study|Reason not Specified|2|||
125148702|NCT02412722|450166602|FG003|Overall Study|Reason not Specified|1|||
125148703|NCT02412722|450166603|FG004|Overall Study|Reason not Specified|2|||
125148704|NCT02412722|450166604|FG005|Overall Study|Reason not Specified|6|||
125148705|NCT02941523|450166605|FG000|Monotherapy|Withdrawal by Subject|0|||
125148706|NCT02941523|450166606|FG001|Monotherapy|Withdrawal by Subject|1|||
125148707|NCT02941523|450166605|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
125148708|NCT02941523|450166606|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
125148709|NCT02941523|450166605|FG000|Carboplatin Combination Therapy|Death|1|||
125148710|NCT02941523|450166606|FG001|Carboplatin Combination Therapy|Death|2|||
125148711|NCT02941523|450166605|FG000|Carboplatin Combination Therapy|Disease progression|2|||
125148712|NCT02941523|450166606|FG001|Carboplatin Combination Therapy|Disease progression|0|||
125148713|NCT02941523|450166605|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
125148714|NCT02941523|450166606|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
125148715|NCT04449341|450166607|FG000|Overall Study|Protocol Violation|1|||
125148716|NCT04449341|450166608|FG001|Overall Study|Protocol Violation|0|||
125148717|NCT04499482|450166609|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
125148718|NCT04330157|450166610|FG000|Overall Study|Protocol Violation|4|||
125148719|NCT04330157|450166610|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
125148720|NCT01899326|450166612|FG000|Overall Study|Withdrawal by Subject|1|||
125148721|NCT01899326|450166612|FG000|Overall Study|Adverse Event|2|||
125148722|NCT01899326|450166612|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
125148723|NCT01263561|450166613|FG000|Overall Study|Death|1|||
125148724|NCT01263561|450166614|FG001|Overall Study|Death|2|||
125148725|NCT01396421|450166615|FG000|Overall Study|Lost to Follow-up|0|||
125148726|NCT01396421|450166616|FG001|Overall Study|Lost to Follow-up|0|||
125148727|NCT01396421|450166617|FG002|Overall Study|Lost to Follow-up|0|||
125148728|NCT01396421|450166618|FG003|Overall Study|Lost to Follow-up|1|||
125148729|NCT01396421|450166615|FG000|Overall Study|Adverse Event|17|||
125148730|NCT01396421|450166616|FG001|Overall Study|Adverse Event|15|||
125148731|NCT01396421|450166617|FG002|Overall Study|Adverse Event|12|||
125148732|NCT01396421|450166618|FG003|Overall Study|Adverse Event|32|||
125148733|NCT01396421|450166615|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
125148734|NCT01396421|450166616|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
125148735|NCT01396421|450166617|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
125148736|NCT01396421|450166618|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
125148737|NCT01396421|450166615|FG000|Overall Study|Physician Decision|1|||
125148738|NCT01396421|450166616|FG001|Overall Study|Physician Decision|1|||
125148739|NCT01396421|450166617|FG002|Overall Study|Physician Decision|0|||
125148740|NCT01396421|450166618|FG003|Overall Study|Physician Decision|3|||
125148741|NCT01396421|450166615|FG000|Overall Study|Withdrawal by Subject|31|||
125148742|NCT01396421|450166616|FG001|Overall Study|Withdrawal by Subject|24|||
125148743|NCT01396421|450166617|FG002|Overall Study|Withdrawal by Subject|13|||
125148744|NCT01396421|450166618|FG003|Overall Study|Withdrawal by Subject|21|||
125148745|NCT01396421|450166615|FG000|Overall Study|Protocol Deviation|2|||
125148746|NCT01396421|450166616|FG001|Overall Study|Protocol Deviation|1|||
125148747|NCT01396421|450166617|FG002|Overall Study|Protocol Deviation|1|||
125148748|NCT01396421|450166618|FG003|Overall Study|Protocol Deviation|0|||
125148749|NCT01396421|450166615|FG000|Overall Study|Lack of Efficacy|7|||
125148750|NCT01396421|450166616|FG001|Overall Study|Lack of Efficacy|17|||
125148751|NCT01396421|450166617|FG002|Overall Study|Lack of Efficacy|7|||
125148752|NCT01396421|450166618|FG003|Overall Study|Lack of Efficacy|18|||
125148753|NCT03689894|450166623|FG000|Overall Study|Adverse Event|1|||
125148754|NCT01321697|450166629|FG000|Overall Study|Study Terminated|7|||
125148755|NCT00857818|450166630|FG000|Overall Study|Lack of Efficacy|1|||
125148756|NCT00857818|450166631|FG001|Overall Study|Lack of Efficacy|0|||
125148757|NCT00857818|450166630|FG000|Overall Study|Adverse Event|3|||
125148758|NCT00857818|450166631|FG001|Overall Study|Adverse Event|0|||
125148759|NCT00857818|450166630|FG000|Overall Study|Withdrawal by Subject|0|||
125148760|NCT00857818|450166631|FG001|Overall Study|Withdrawal by Subject|4|||
125148761|NCT00857818|450166630|FG000|Overall Study|Sponsor terminated study|6|||
125148762|NCT00857818|450166631|FG001|Overall Study|Sponsor terminated study|4|||
125148763|NCT00857818|450166630|FG000|Overall Study|Investigator decision|1|||
125148764|NCT00857818|450166631|FG001|Overall Study|Investigator decision|0|||
125148765|NCT04149535|450166633|FG000|Overall Study|Death|11|||
125148766|NCT04149535|450166634|FG001|Overall Study|Death|7|||
125148767|NCT04149535|450166633|FG000|Overall Study|Physician Decision|10|||
125148768|NCT04149535|450166634|FG001|Overall Study|Physician Decision|4|||
125148769|NCT04149535|450166633|FG000|Overall Study|Withdrawal by Subject|6|||
125148770|NCT04149535|450166634|FG001|Overall Study|Withdrawal by Subject|7|||
125148771|NCT04149535|450166633|FG000|Overall Study|Not described|2|||
125148772|NCT04149535|450166634|FG001|Overall Study|Not described|0|||
125148773|NCT02175368|450166635|FG000|Overall Study|Lost to Follow-up|1|||
125148774|NCT02875028|450166636|FG000|Washout Period|Withdrawal by Subject|0|||
125148775|NCT02875028|450166637|FG001|Washout Period|Withdrawal by Subject|1|||
125148776|NCT03180528|450168091|FG000|Overall Study|Adverse Event|1|||
125148777|NCT03180528|450168091|FG000|Overall Study|Withdrawal by Subject|1|||
125148778|NCT03180528|450168091|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
125148779|NCT04703855|450168092|FG000|Overall Study|Heart Transplant|1|||
125148780|NCT01989676|450168095|FG000|Overall Study|Death|52|||
125148781|NCT01989676|450168096|FG001|Overall Study|Death|60|||
125148782|NCT01989676|450168095|FG000|Overall Study|Protocol Violation|2|||
125148783|NCT01989676|450168096|FG001|Overall Study|Protocol Violation|1|||
125148784|NCT01989676|450168095|FG000|Overall Study|Lost to Follow-up|8|||
125148785|NCT01989676|450168096|FG001|Overall Study|Lost to Follow-up|18|||
125148786|NCT01989676|450168095|FG000|Overall Study|No longer willing to participate in study|26|||
125148787|NCT01989676|450168096|FG001|Overall Study|No longer willing to participate in study|26|||
125148788|NCT01989676|450168095|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
125148789|NCT01989676|450168096|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
125148790|NCT01989676|450168095|FG000|Overall Study|Other|4|||
125148791|NCT01989676|450168096|FG001|Overall Study|Other|3|||
125148792|NCT03941834|450168097|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
125148793|NCT03941834|450168098|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
125148794|NCT03941834|450168099|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
125148795|NCT03941834|450168097|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
125148796|NCT03941834|450168098|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
125148797|NCT03941834|450168099|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
125148798|NCT03941834|450168097|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
125148799|NCT03941834|450168098|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
125148800|NCT03941834|450168099|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
125148801|NCT03941834|450168097|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
125148802|NCT03941834|450168098|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
125148803|NCT03941834|450168099|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
125148804|NCT03941834|450168097|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
125148805|NCT03941834|450168098|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
125148806|NCT03941834|450168099|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
125148807|NCT03941834|450168097|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
125148808|NCT03941834|450168098|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
125148809|NCT03941834|450168099|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
125148810|NCT01560819|450168103|FG000|Overall Study|Physician Decision|1|||
125148811|NCT01560819|450168104|FG001|Overall Study|Physician Decision|0|||
125148812|NCT00114231|450168105|FG000|Overall Study|No consent|2|||
125148813|NCT00114231|450168106|FG001|Overall Study|No consent|0|||
125148814|NCT00114231|450168105|FG000|Overall Study|QARC requirement not met|1|||
125148815|NCT00114231|450168106|FG001|Overall Study|QARC requirement not met|0|||
125148816|NCT00114231|450168105|FG000|Overall Study|Suspected metastatic disease|1|||
125148817|NCT00114231|450168106|FG001|Overall Study|Suspected metastatic disease|0|||
125148818|NCT00114231|450168105|FG000|Overall Study|No adenocarcinoma|1|||
125148819|NCT00114231|450168106|FG001|Overall Study|No adenocarcinoma|0|||
125148820|NCT00114231|450168105|FG000|Overall Study|Low creatinine clearance|0|||
125148821|NCT00114231|450168106|FG001|Overall Study|Low creatinine clearance|1|||
125148822|NCT00114231|450168105|FG000|Overall Study|Tumor size > 4cm|1|||
125148823|NCT00114231|450168106|FG001|Overall Study|Tumor size > 4cm|0|||
125148824|NCT00114231|450168105|FG000|Overall Study|Tumor fixed on digital exam|0|||
125148825|NCT00114231|450168106|FG001|Overall Study|Tumor fixed on digital exam|1|||
125148826|NCT00114231|450168105|FG000|Overall Study|No Absolute Neutrophil Count|2|||
125148827|NCT00114231|450168106|FG001|Overall Study|No Absolute Neutrophil Count|0|||
125148828|NCT00114231|450168105|FG000|Overall Study|Biopsy done after registration|1|||
125148829|NCT00114231|450168106|FG001|Overall Study|Biopsy done after registration|0|||
125148830|NCT01976728|450168109|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
125148831|NCT01976728|450168110|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
125148832|NCT01976728|450168111|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
125148833|NCT01976728|450168112|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
125148834|NCT00966381|450168114|FG000|Overall Study|Withdrawal by Subject|2|||
125148835|NCT00966381|450168115|FG001|Overall Study|Withdrawal by Subject|2|||
125148836|NCT01124695|450168119|FG000|Overall Study|Disease progression|77|||
125148837|NCT01124695|450168119|FG000|Overall Study|Adverse Event|11|||
125148838|NCT01124695|450168119|FG000|Overall Study|Death|1|||
125148839|NCT01124695|450168119|FG000|Overall Study|Withdrawal by Subject|7|||
125148840|NCT01124695|450168119|FG000|Overall Study|Physician Decision|3|||
125148841|NCT01124695|450168119|FG000|Overall Study|Alternative therapy|9|||
125148842|NCT01124695|450168119|FG000|Overall Study|No documentation that patient went off treatment|4|||
125148843|NCT01124695|450168119|FG000|Overall Study|Ineligible|9|||
125148844|NCT01124695|450168119|FG000|Overall Study|Ineligible and never start treatment|2|||
125148845|NCT02668822|450168120|FG000|Overall Study|Protocol Violation|2|||
125148846|NCT02668822|450168121|FG001|Overall Study|Protocol Violation|0|||
125148847|NCT02668822|450168120|FG000|Overall Study|Study Terminated by Sponsor|7|||
125148848|NCT02668822|450168121|FG001|Overall Study|Study Terminated by Sponsor|9|||
125148849|NCT01522950|450168122|FG000|Overall Study|Withdrawal by Subject|3|||
125148850|NCT01522950|450168123|FG001|Overall Study|Withdrawal by Subject|2|||
125148851|NCT01522950|450168124|FG002|Overall Study|Withdrawal by Subject|1|||
125148852|NCT01522950|450168122|FG000|Overall Study|Adverse Event|3|||
125148853|NCT01522950|450168123|FG001|Overall Study|Adverse Event|1|||
125148854|NCT01522950|450168124|FG002|Overall Study|Adverse Event|1|||
125148855|NCT01522950|450168122|FG000|Overall Study|Protocol Violation|0|||
125148856|NCT01522950|450168123|FG001|Overall Study|Protocol Violation|0|||
125148857|NCT01522950|450168124|FG002|Overall Study|Protocol Violation|2|||
125148858|NCT01522950|450168122|FG000|Overall Study|Death|0|||
125148859|NCT01522950|450168123|FG001|Overall Study|Death|1|||
125148860|NCT01522950|450168124|FG002|Overall Study|Death|1|||
125148861|NCT01522950|450168122|FG000|Overall Study|Study Medication Sensitivity|0|||
125148862|NCT01522950|450168123|FG001|Overall Study|Study Medication Sensitivity|1|||
125148863|NCT01522950|450168124|FG002|Overall Study|Study Medication Sensitivity|0|||
125148864|NCT00298740|450168127|FG000|Overall Study|Lack of Efficacy|6|||
125148865|NCT00298740|450168127|FG000|Overall Study|Withdrawal by Subject|3|||
125148866|NCT01345318|450168129|FG000|Overall Study|Adverse Event|16|||
125148867|NCT01345318|450168129|FG000|Overall Study|Lack of Efficacy|17|||
125148868|NCT01345318|450168129|FG000|Overall Study|Lost to Follow-up|2|||
125148869|NCT01345318|450168129|FG000|Overall Study|Protocol Violation|1|||
125148870|NCT01345318|450168129|FG000|Overall Study|Withdrawal by Subject|41|||
125148871|NCT01345318|450168129|FG000|Overall Study|Other|3|||
125148872|NCT00317642|450168130|FG000|Overall Study|Not Received Either Study Drug|1|||
125148873|NCT00317642|450168131|FG001|Overall Study|Not Received Either Study Drug|3|||
125148874|NCT00317642|450168130|FG000|Overall Study|Physician Decision|15|||
125148875|NCT00317642|450168131|FG001|Overall Study|Physician Decision|7|||
125148876|NCT00317642|450168130|FG000|Overall Study|Participant declined treatment|14|||
125148877|NCT00317642|450168131|FG001|Overall Study|Participant declined treatment|3|||
125148878|NCT00317642|450168130|FG000|Overall Study|Adverse Event|17|||
125148879|NCT00317642|450168131|FG001|Overall Study|Adverse Event|5|||
125148880|NCT00317642|450168130|FG000|Overall Study|Treatment Failure|56|||
125148881|NCT00317642|450168131|FG001|Overall Study|Treatment Failure|102|||
125148882|NCT00317642|450168130|FG000|Overall Study|Disease Recurrence|1|||
125148883|NCT00317642|450168131|FG001|Overall Study|Disease Recurrence|2|||
125148884|NCT00317642|450168130|FG000|Overall Study|Death|14|||
125148885|NCT00317642|450168131|FG001|Overall Study|Death|7|||
125148886|NCT00317642|450168130|FG000|Overall Study|Not Continue to Consolidation|2|||
125148887|NCT00317642|450168131|FG001|Overall Study|Not Continue to Consolidation|0|||
125148888|NCT00317642|450168130|FG000|Overall Study|Withdrawal by Subject|0|||
125148889|NCT00317642|450168131|FG001|Overall Study|Withdrawal by Subject|1|||
125148890|NCT00317642|450168130|FG000|Overall Study|Referred For Transplantation|1|||
125148891|NCT00317642|450168131|FG001|Overall Study|Referred For Transplantation|0|||
125148892|NCT00317642|450168130|FG000|Overall Study|AML Not Centrally Confirmed|1|||
125148893|NCT00317642|450168131|FG001|Overall Study|AML Not Centrally Confirmed|5|||
125148894|NCT01049412|450168133|FG000|Period I|Withdrawal by Subject|4|||
125148895|NCT01049412|450168134|FG001|Period I|Withdrawal by Subject|6|||
125148896|NCT01049412|450168133|FG000|Period I|Lost to Follow-up|2|||
125148897|NCT01049412|450168134|FG001|Period I|Lost to Follow-up|2|||
125148898|NCT01049412|450168133|FG000|Period I|Physician Decision|0|||
125148899|NCT01049412|450168134|FG001|Period I|Physician Decision|3|||
125148900|NCT01049412|450168133|FG000|Period I|Protocol Violation|1|||
125148901|NCT01049412|450168134|FG001|Period I|Protocol Violation|2|||
125148902|NCT01049412|450168133|FG000|Period I|Adverse Event|1|||
125148903|NCT01049412|450168134|FG001|Period I|Adverse Event|0|||
125148904|NCT01049412|450168133|FG000|Period II|Withdrawal by Subject|2|||
125148905|NCT01049412|450168134|FG001|Period II|Withdrawal by Subject|3|||
125148906|NCT01049412|450168133|FG000|Period II|Adverse Event|1|||
125148907|NCT01049412|450168134|FG001|Period II|Adverse Event|0|||
125148908|NCT01049412|450168133|FG000|Period II|Lost to Follow-up|1|||
125148909|NCT01049412|450168134|FG001|Period II|Lost to Follow-up|0|||
125148910|NCT04205162|450168142|FG000|Overall Study|Lost to Follow-up|1|||
125148911|NCT04205162|450168143|FG001|Overall Study|Lost to Follow-up|0|||
125148912|NCT04205162|450168142|FG000|Overall Study|Withdrawal by Subject|2|||
125148913|NCT04205162|450168143|FG001|Overall Study|Withdrawal by Subject|0|||
125148914|NCT04205162|450168142|FG000|Overall Study|University closure due to COVID-19|1|||
125148915|NCT04205162|450168143|FG001|Overall Study|University closure due to COVID-19|0|||
125148916|NCT01011556|450168144|FG000|Overall Study|Adverse Event|1|||
125148917|NCT01011556|450168145|FG001|Overall Study|Adverse Event|3|||
125148918|NCT01011556|450168146|FG002|Overall Study|Adverse Event|2|||
125148919|NCT01011556|450168147|FG003|Overall Study|Adverse Event|1|||
125148920|NCT01011556|450168144|FG000|Overall Study|Lost to Follow-up|1|||
125148921|NCT01011556|450168145|FG001|Overall Study|Lost to Follow-up|0|||
125148922|NCT01011556|450168146|FG002|Overall Study|Lost to Follow-up|0|||
125148923|NCT01011556|450168147|FG003|Overall Study|Lost to Follow-up|0|||
125148924|NCT01011556|450168144|FG000|Overall Study|Physician Decision|1|||
125148925|NCT01011556|450168145|FG001|Overall Study|Physician Decision|0|||
125148926|NCT01011556|450168146|FG002|Overall Study|Physician Decision|0|||
125148927|NCT01011556|450168147|FG003|Overall Study|Physician Decision|1|||
125148928|NCT01011556|450168144|FG000|Overall Study|Protocol Violation|0|||
125148929|NCT01011556|450168145|FG001|Overall Study|Protocol Violation|1|||
125148930|NCT01011556|450168146|FG002|Overall Study|Protocol Violation|0|||
125148931|NCT01011556|450168147|FG003|Overall Study|Protocol Violation|0|||
125148932|NCT01011556|450168144|FG000|Overall Study|Withdrawal by Subject|1|||
125148933|NCT01011556|450168145|FG001|Overall Study|Withdrawal by Subject|2|||
125148934|NCT01011556|450168146|FG002|Overall Study|Withdrawal by Subject|4|||
125148935|NCT01011556|450168147|FG003|Overall Study|Withdrawal by Subject|4|||
125148936|NCT01011556|450168144|FG000|Overall Study|Sponsor decision|0|||
125148937|NCT01011556|450168145|FG001|Overall Study|Sponsor decision|1|||
125148938|NCT01011556|450168146|FG002|Overall Study|Sponsor decision|1|||
125148939|NCT01011556|450168147|FG003|Overall Study|Sponsor decision|2|||
125148940|NCT01011556|450168144|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
125148941|NCT01011556|450168145|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
125148942|NCT01011556|450168146|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
125148943|NCT01011556|450168147|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
125148944|NCT00263887|450168148|FG000|Overall Study|Withdrawal by Subject|1|||
125148945|NCT00263887|450168149|FG001|Overall Study|Withdrawal by Subject|1|||
125148946|NCT00263887|450168148|FG000|Overall Study|Lung transplantation|1|||
125148947|NCT00263887|450168149|FG001|Overall Study|Lung transplantation|2|||
125148948|NCT00263887|450168148|FG000|Overall Study|Too ill to attend visit|1|||
125148949|NCT00263887|450168149|FG001|Overall Study|Too ill to attend visit|0|||
125148950|NCT00263887|450168148|FG000|Overall Study|Adverse Event|0|||
125148951|NCT00263887|450168149|FG001|Overall Study|Adverse Event|2|||
125148952|NCT00263887|450168148|FG000|Overall Study|Disease progression|0|||
125148953|NCT00263887|450168149|FG001|Overall Study|Disease progression|1|||
125148954|NCT00263887|450168148|FG000|Overall Study|Lack of Efficacy|0|||
125148955|NCT00263887|450168149|FG001|Overall Study|Lack of Efficacy|1|||
125148956|NCT00779402|450168150|FG000|Treatment Phase 1|Disease Progression|1|||
125148957|NCT00779402|450168151|FG001|Treatment Phase 1|Disease Progression|0|||
125148958|NCT00779402|450168150|FG000|Treatment Phase 1|Adverse Event|2|||
125148959|NCT00779402|450168151|FG001|Treatment Phase 1|Adverse Event|0|||
125148960|NCT00779402|450168150|FG000|Treatment Phase 1|Protocol Violation|1|||
125148961|NCT00779402|450168151|FG001|Treatment Phase 1|Protocol Violation|0|||
125148962|NCT00779402|450168150|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
125148963|NCT00779402|450168151|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
125148964|NCT00779402|450168150|FG000|Treatment Phase 1|Lost to Follow-up|0|||
125148965|NCT00779402|450168151|FG001|Treatment Phase 1|Lost to Follow-up|1|||
125148966|NCT00779402|450168150|FG000|Treatment Phase 1|Death|0|||
125148967|NCT00779402|450168151|FG001|Treatment Phase 1|Death|1|||
125148968|NCT00779402|450168150|FG000|Treatment Phase 1|Intercurrent Illness|1|||
125148969|NCT00779402|450168151|FG001|Treatment Phase 1|Intercurrent Illness|1|||
125148970|NCT00779402|450168150|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
125148971|NCT00779402|450168151|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
125148972|NCT00779402|450168150|FG000|Treatment Phase 1|Other|4|||
125148973|NCT00779402|450168151|FG001|Treatment Phase 1|Other|2|||
125148974|NCT00779402|450168150|FG000|Treatment Phase 1|Closure of Study|3|||
125148975|NCT00779402|450168151|FG001|Treatment Phase 1|Closure of Study|2|||
125148976|NCT00779402|450168150|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
125148977|NCT00779402|450168151|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
125148978|NCT00779402|450168150|FG000|Surveillance Phase|Protocol Violation|0|||
125148979|NCT00779402|450168151|FG001|Surveillance Phase|Protocol Violation|1|||
125148980|NCT00779402|450168150|FG000|Surveillance Phase|Patient refused to continue|22|||
125148981|NCT00779402|450168151|FG001|Surveillance Phase|Patient refused to continue|14|||
125148982|NCT00779402|450168150|FG000|Surveillance Phase|Lost to Follow-up|2|||
125148983|NCT00779402|450168151|FG001|Surveillance Phase|Lost to Follow-up|1|||
125148984|NCT00779402|450168150|FG000|Surveillance Phase|Death|0|||
125148985|NCT00779402|450168151|FG001|Surveillance Phase|Death|1|||
125148986|NCT00779402|450168150|FG000|Surveillance Phase|Intercurrent Illness|2|||
125148987|NCT00779402|450168151|FG001|Surveillance Phase|Intercurrent Illness|0|||
125148988|NCT00779402|450168150|FG000|Surveillance Phase|Other|5|||
125148989|NCT00779402|450168151|FG001|Surveillance Phase|Other|5|||
125148990|NCT00779402|450168150|FG000|Surveillance Phase|Withdrawal by Subject|4|||
125148991|NCT00779402|450168151|FG001|Surveillance Phase|Withdrawal by Subject|1|||
125148992|NCT00779402|450168150|FG000|Surveillance Phase|Closure of study|5|||
125148993|NCT00779402|450168151|FG001|Surveillance Phase|Closure of study|6|||
125148994|NCT00779402|450168150|FG000|Surveillance Phase|Completed Protocol Visits|3|||
125148995|NCT00779402|450168151|FG001|Surveillance Phase|Completed Protocol Visits|2|||
125148996|NCT00779402|450168150|FG000|Long-term Follow-up|Patient refused to continue|2|||
125148997|NCT00779402|450168151|FG001|Long-term Follow-up|Patient refused to continue|0|||
125148998|NCT00779402|450168150|FG000|Long-term Follow-up|Other|5|||
125148999|NCT00779402|450168151|FG001|Long-term Follow-up|Other|0|||
125149000|NCT00779402|450168150|FG000|Long-term Follow-up|Closure of Study|8|||
125149001|NCT00779402|450168151|FG001|Long-term Follow-up|Closure of Study|4|||
125149002|NCT00779402|450168150|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
125149003|NCT00779402|450168151|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
125149004|NCT00693225|450168152|FG000|Overall Study|Lost to Follow-up|1|||
125149005|NCT00693225|450168153|FG001|Overall Study|Lost to Follow-up|2|||
125149006|NCT00693225|450168152|FG000|Overall Study|Adverse Event|1|||
125149007|NCT00693225|450168153|FG001|Overall Study|Adverse Event|3|||
125149008|NCT01315028|450168154|FG000|Overall Study|Lost to Follow-up|1|||
125149009|NCT01315028|450168155|FG001|Overall Study|Lost to Follow-up|0|||
125149010|NCT01315028|450168154|FG000|Overall Study|Death|0|||
125149011|NCT01315028|450168155|FG001|Overall Study|Death|1|||
125149012|NCT02359864|450168156|FG000|Overall Study|Withdrawal by Subject|1|||
125149013|NCT02359864|450168157|FG001|Overall Study|Withdrawal by Subject|0|||
125149014|NCT00725764|450168158|FG000|Overall Study|Withdrawal by Subject|2|||
125149015|NCT00725764|450168158|FG000|Overall Study|Physician Decision|1|||
125149016|NCT00725764|450168158|FG000|Overall Study|Progressive Disease|7|||
125149017|NCT00725764|450168158|FG000|Overall Study|Lost to Follow-up|1|||
125149018|NCT00725764|450168158|FG000|Overall Study|Death|1|||
125149019|NCT00725764|450168158|FG000|Overall Study|Participant non compliant with protocol|1|||
125149020|NCT00725764|450168158|FG000|Overall Study|Decline in performance status|1|||
125149021|NCT01928615|450168159|FG000|Overall Study|Study Terminated by Sponsor|2|||
125149022|NCT00090753|450168160|FG000|First Treatment Period|Adverse Event|20|||
125149023|NCT00090753|450168161|FG001|First Treatment Period|Adverse Event|8|||
125149024|NCT00090753|450168160|FG000|First Treatment Period|Death|88|||
125149025|NCT00090753|450168161|FG001|First Treatment Period|Death|62|||
125149026|NCT00090753|450168160|FG000|First Treatment Period|Lack of Efficacy|2|||
125149027|NCT00090753|450168161|FG001|First Treatment Period|Lack of Efficacy|1|||
125149028|NCT00090753|450168160|FG000|First Treatment Period|Refused Treatment|32|||
125149029|NCT00090753|450168161|FG001|First Treatment Period|Refused Treatment|25|||
125149030|NCT00090753|450168160|FG000|First Treatment Period|Lost to Follow-up|4|||
125149031|NCT00090753|450168161|FG001|First Treatment Period|Lost to Follow-up|4|||
125149032|NCT00090753|450168160|FG000|First Treatment Period|Renal Transplant|70|||
125149033|NCT00090753|450168161|FG001|First Treatment Period|Renal Transplant|50|||
125149034|NCT00090753|450168160|FG000|First Treatment Period|Mircera Commercialization|1|||
125149035|NCT00090753|450168161|FG001|First Treatment Period|Mircera Commercialization|0|||
125149036|NCT00090753|450168160|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
125149037|NCT00090753|450168161|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
125149038|NCT00090753|450168160|FG000|Extended Treatment Period|Adverse Event|11|||
125149039|NCT00090753|450168161|FG001|Extended Treatment Period|Adverse Event|0|||
125149040|NCT00090753|450168160|FG000|Extended Treatment Period|Death|58|||
125149041|NCT00090753|450168161|FG001|Extended Treatment Period|Death|30|||
125149042|NCT00090753|450168160|FG000|Extended Treatment Period|Lack of Efficacy|1|||
125149043|NCT00090753|450168161|FG001|Extended Treatment Period|Lack of Efficacy|0|||
125149044|NCT00090753|450168160|FG000|Extended Treatment Period|Refused Treatment|18|||
125149045|NCT00090753|450168161|FG001|Extended Treatment Period|Refused Treatment|12|||
125149046|NCT00090753|450168160|FG000|Extended Treatment Period|Lost to Follow-up|3|||
125149047|NCT00090753|450168161|FG001|Extended Treatment Period|Lost to Follow-up|1|||
125149048|NCT00090753|450168160|FG000|Extended Treatment Period|Renal Transplant|15|||
125149049|NCT00090753|450168161|FG001|Extended Treatment Period|Renal Transplant|12|||
125149050|NCT00090753|450168160|FG000|Extended Treatment Period|Mircera Commercialization|188|||
125149051|NCT00090753|450168161|FG001|Extended Treatment Period|Mircera Commercialization|93|||
125149052|NCT00090753|450168160|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
125149053|NCT00090753|450168161|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
125149054|NCT01256060|450168164|FG000|Overall Study|Lost to Follow-up|0|||
125149055|NCT01256060|450168165|FG001|Overall Study|Lost to Follow-up|1|||
125149056|NCT01256060|450168166|FG002|Overall Study|Lost to Follow-up|0|||
125149057|NCT01256060|450168167|FG003|Overall Study|Lost to Follow-up|0|||
125149058|NCT01466036|450168168|FG000|Overall Study|Death|1|||
125149059|NCT01466036|450168169|FG001|Overall Study|Death|1|||
125149060|NCT01466036|450168168|FG000|Overall Study|Physician Decision|0|||
125149061|NCT01466036|450168169|FG001|Overall Study|Physician Decision|4|||
125149062|NCT01466036|450168168|FG000|Overall Study|Adverse Event|2|||
125149063|NCT01466036|450168169|FG001|Overall Study|Adverse Event|6|||
125149064|NCT01466036|450168168|FG000|Overall Study|Withdrawal by Subject|2|||
125149065|NCT01466036|450168169|FG001|Overall Study|Withdrawal by Subject|8|||
125149066|NCT01466036|450168168|FG000|Overall Study|progression/relapse|14|||
125149067|NCT01466036|450168169|FG001|Overall Study|progression/relapse|21|||
125149068|NCT01466036|450168168|FG000|Overall Study|prolonged treatment delay|1|||
125149069|NCT01466036|450168169|FG001|Overall Study|prolonged treatment delay|1|||
125149070|NCT01808248|450168170|FG000|Overall Study|Lack of Efficacy|3|||
125149071|NCT01808248|450168170|FG000|Overall Study|Withdrawal by Subject|1|||
125149072|NCT01808248|450168170|FG000|Overall Study|Lost to Follow-up|1|||
125149073|NCT00761176|450168171|FG000|Overall Study|Death|1|||
125149074|NCT00761176|450168172|FG001|Overall Study|Death|0|||
125149075|NCT00761176|450168171|FG000|Overall Study|Withdrawal by Subject|1|||
125149076|NCT00761176|450168172|FG001|Overall Study|Withdrawal by Subject|1|||
125149077|NCT00109850|450168173|FG000|Overall Study|Adverse Event|1|||
125149078|NCT00109850|450168173|FG000|Overall Study|Death|2|||
125149079|NCT00109850|450168173|FG000|Overall Study|Ineligible|1|||
125149080|NCT00476593|450168174|FG000|Overall Study|Lost to Follow-up|10|||
125149081|NCT00476593|450168175|FG001|Overall Study|Lost to Follow-up|2|||
125149082|NCT00476593|450168176|FG002|Overall Study|Lost to Follow-up|8|||
125149083|NCT00476593|450168177|FG003|Overall Study|Lost to Follow-up|22|||
125149084|NCT03430011|450168178|FG000|Pre-Treatment|Death|1|||
125149085|NCT03430011|450168179|FG001|Pre-Treatment|Death|0|||
125149086|NCT03430011|450168180|FG002|Pre-Treatment|Death|0|||
125149087|NCT03430011|450168181|FG003|Pre-Treatment|Death|0|||
125149088|NCT03430011|450168182|FG004|Pre-Treatment|Death|1|||
125149089|NCT03430011|450168183|FG005|Pre-Treatment|Death|0|||
125149090|NCT03430011|450168184|FG006|Pre-Treatment|Death|1|||
125149091|NCT03430011|450168185|FG007|Pre-Treatment|Death|0|||
125149092|NCT03430011|450168178|FG000|Pre-Treatment|Screen Fail|0|||
125149093|NCT03430011|450168179|FG001|Pre-Treatment|Screen Fail|0|||
125149094|NCT03430011|450168180|FG002|Pre-Treatment|Screen Fail|0|||
125149095|NCT03430011|450168181|FG003|Pre-Treatment|Screen Fail|0|||
125149096|NCT03430011|450168182|FG004|Pre-Treatment|Screen Fail|1|||
125223658|NCT02326272|450446167|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125149097|NCT03430011|450168183|FG005|Pre-Treatment|Screen Fail|0|||
125149098|NCT03430011|450168184|FG006|Pre-Treatment|Screen Fail|0|||
125149099|NCT03430011|450168185|FG007|Pre-Treatment|Screen Fail|0|||
125149100|NCT03430011|450168178|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
125149101|NCT03430011|450168179|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
125149102|NCT03430011|450168180|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
125149103|NCT03430011|450168181|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
125149104|NCT03430011|450168182|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
125149105|NCT03430011|450168183|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
125149106|NCT03430011|450168184|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
125149107|NCT03430011|450168185|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
125149108|NCT03430011|450168178|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
125149109|NCT03430011|450168179|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
125149110|NCT03430011|450168180|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
125149111|NCT03430011|450168181|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
125149112|NCT03430011|450168182|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
125149113|NCT03430011|450168183|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
125149114|NCT03430011|450168184|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
125149115|NCT03430011|450168185|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
125149116|NCT03430011|450168178|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
125149117|NCT03430011|450168179|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
125149118|NCT03430011|450168180|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
125149119|NCT03430011|450168181|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
125149120|NCT03430011|450168182|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
125149121|NCT03430011|450168183|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
125149122|NCT03430011|450168184|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
125149123|NCT03430011|450168185|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
125149124|NCT03430011|450168178|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
125149125|NCT03430011|450168179|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
125149126|NCT03430011|450168180|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
125149127|NCT03430011|450168181|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
125149128|NCT03430011|450168182|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
125149129|NCT03430011|450168183|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
125149130|NCT03430011|450168184|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
125149131|NCT03430011|450168185|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
125149132|NCT03430011|450168178|FG000|JCARH125 Treatment|Death|4|||
125149133|NCT03430011|450168179|FG001|JCARH125 Treatment|Death|19|||
125149134|NCT03430011|450168180|FG002|JCARH125 Treatment|Death|10|||
125149135|NCT03430011|450168181|FG003|JCARH125 Treatment|Death|8|||
125149136|NCT03430011|450168182|FG004|JCARH125 Treatment|Death|5|||
125149137|NCT03430011|450168183|FG005|JCARH125 Treatment|Death|3|||
125149138|NCT03430011|450168184|FG006|JCARH125 Treatment|Death|4|||
125149139|NCT03430011|450168185|FG007|JCARH125 Treatment|Death|2|||
125149140|NCT03430011|450168178|FG000|JCARH125 Treatment|Other reasons|1|||
125149141|NCT03430011|450168179|FG001|JCARH125 Treatment|Other reasons|0|||
125149142|NCT03430011|450168180|FG002|JCARH125 Treatment|Other reasons|4|||
125149143|NCT03430011|450168181|FG003|JCARH125 Treatment|Other reasons|2|||
125149144|NCT03430011|450168182|FG004|JCARH125 Treatment|Other reasons|2|||
125149145|NCT03430011|450168183|FG005|JCARH125 Treatment|Other reasons|1|||
125149146|NCT03430011|450168184|FG006|JCARH125 Treatment|Other reasons|3|||
125149147|NCT03430011|450168185|FG007|JCARH125 Treatment|Other reasons|2|||
125149148|NCT04126343|450168186|FG000|Overall Study|Adverse Event|0|||
125149149|NCT04126343|450168187|FG001|Overall Study|Adverse Event|0|||
125149150|NCT04126343|450168188|FG002|Overall Study|Adverse Event|0|||
125149151|NCT04126343|450168189|FG003|Overall Study|Adverse Event|0|||
125149152|NCT04126343|450168190|FG004|Overall Study|Adverse Event|0|||
125149153|NCT04126343|450168191|FG005|Overall Study|Adverse Event|1|||
125149154|NCT04126343|450168186|FG000|Overall Study|Withdrawal by Subject|0|||
125149155|NCT04126343|450168187|FG001|Overall Study|Withdrawal by Subject|0|||
125149156|NCT04126343|450168188|FG002|Overall Study|Withdrawal by Subject|0|||
125149157|NCT04126343|450168189|FG003|Overall Study|Withdrawal by Subject|1|||
125149158|NCT04126343|450168190|FG004|Overall Study|Withdrawal by Subject|0|||
125149159|NCT04126343|450168191|FG005|Overall Study|Withdrawal by Subject|0|||
125149160|NCT04126343|450168186|FG000|Overall Study|Related to COVID-19 pandemic|3|||
125149161|NCT04126343|450168187|FG001|Overall Study|Related to COVID-19 pandemic|4|||
125149162|NCT04126343|450168188|FG002|Overall Study|Related to COVID-19 pandemic|3|||
125149163|NCT04126343|450168189|FG003|Overall Study|Related to COVID-19 pandemic|3|||
125149164|NCT04126343|450168190|FG004|Overall Study|Related to COVID-19 pandemic|3|||
125149165|NCT04126343|450168191|FG005|Overall Study|Related to COVID-19 pandemic|3|||
125149166|NCT00084799|450168192|FG000|Overall Study|Disease Progression|1|||
125149167|NCT00084799|450168193|FG001|Overall Study|Disease Progression|0|||
125149168|NCT03712124|450168194|FG000|Overall Study|Protocol Violation|1|||
125149169|NCT03712124|450168195|FG001|Overall Study|Protocol Violation|0|||
125149170|NCT04314843|450168197|FG000|Overall Study|Death|2|||
125149171|NCT04314843|450168198|FG001|Overall Study|Death|2|||
125149172|NCT04314843|450168197|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
125149173|NCT04314843|450168198|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
125149174|NCT00551616|450168199|FG000|Overall Study|Lost to Follow-up|48|||
125149175|NCT00551616|450168200|FG001|Overall Study|Lost to Follow-up|40|||
125149176|NCT00569777|450168201|FG000|Overall Study|Withdrawal by Subject|4|||
125223659|NCT02326272|450446168|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125149177|NCT00569777|450168202|FG001|Overall Study|Withdrawal by Subject|0|||
125149178|NCT00569777|450168201|FG000|Overall Study|Adverse Event|3|||
125149179|NCT00569777|450168202|FG001|Overall Study|Adverse Event|0|||
125149180|NCT00569777|450168201|FG000|Overall Study|Lost to Follow-up|1|||
125149181|NCT00569777|450168202|FG001|Overall Study|Lost to Follow-up|0|||
125149182|NCT00569777|450168201|FG000|Overall Study|scheduled eye surgery|0|||
125149183|NCT00569777|450168202|FG001|Overall Study|scheduled eye surgery|1|||
125149184|NCT00569777|450168201|FG000|Overall Study|did not meet exclusion criteria|1|||
125149185|NCT00569777|450168202|FG001|Overall Study|did not meet exclusion criteria|2|||
125149186|NCT00569777|450168201|FG000|Overall Study|pregnant|1|||
125149187|NCT00569777|450168202|FG001|Overall Study|pregnant|0|||
125149188|NCT04718129|450168207|FG000|Overall Study|Lost to Follow-up|6|||
125149189|NCT04718129|450168208|FG001|Overall Study|Lost to Follow-up|7|||
125149190|NCT01378962|450168209|FG000|Overall Study|Death|14|||
125149191|NCT01378962|450168209|FG000|Overall Study|Lost to Follow-up|1|||
125149192|NCT01378962|450168209|FG000|Overall Study|Other|2|||
125149193|NCT02030535|450168210|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
125149194|NCT01588548|450168211|FG000|Overall Study|Withdrawal by Subject|0|||
125149195|NCT01588548|450168212|FG001|Overall Study|Withdrawal by Subject|1|||
125149196|NCT01588548|450168213|FG002|Overall Study|Withdrawal by Subject|1|||
125149197|NCT01588548|450168214|FG003|Overall Study|Withdrawal by Subject|1|||
125149198|NCT01588548|450168215|FG004|Overall Study|Withdrawal by Subject|2|||
125149199|NCT01588548|450168216|FG005|Overall Study|Withdrawal by Subject|3|||
125149200|NCT01588548|450168211|FG000|Overall Study|Adverse Event|0|||
125149201|NCT01588548|450168212|FG001|Overall Study|Adverse Event|0|||
125149202|NCT01588548|450168213|FG002|Overall Study|Adverse Event|1|||
125149203|NCT01588548|450168214|FG003|Overall Study|Adverse Event|2|||
125149204|NCT01588548|450168215|FG004|Overall Study|Adverse Event|1|||
125149205|NCT01588548|450168216|FG005|Overall Study|Adverse Event|0|||
125149206|NCT01588548|450168211|FG000|Overall Study|Condition Under Investigation Worsened|3|||
125149207|NCT01588548|450168212|FG001|Overall Study|Condition Under Investigation Worsened|6|||
125149208|NCT01588548|450168213|FG002|Overall Study|Condition Under Investigation Worsened|4|||
125149209|NCT01588548|450168214|FG003|Overall Study|Condition Under Investigation Worsened|4|||
125149210|NCT01588548|450168215|FG004|Overall Study|Condition Under Investigation Worsened|3|||
125149211|NCT01588548|450168216|FG005|Overall Study|Condition Under Investigation Worsened|3|||
125149212|NCT00292227|450168217|FG000|Patch Period|Adverse Event|1|||
125149213|NCT00292227|450168218|FG001|Patch Period|Adverse Event|0|||
125149214|NCT00292227|450168219|FG002|Patch Period|Adverse Event|2|||
125149215|NCT00292227|450168217|FG000|Patch Period|Withdrawal by Subject|0|||
125149216|NCT00292227|450168218|FG001|Patch Period|Withdrawal by Subject|0|||
125149217|NCT00292227|450168219|FG002|Patch Period|Withdrawal by Subject|1|||
125149218|NCT03257254|450168220|FG000|Overall Study|Withdrawal by Subject|7|||
125149219|NCT03257254|450168220|FG000|Overall Study|Lost to Follow-up|9|||
125149220|NCT03257254|450168220|FG000|Overall Study|Study discontinued by sponsor|5|||
125149221|NCT00442546|450168221|FG000|Overall Study|Adverse Event|11|||
125149222|NCT00442546|450168222|FG001|Overall Study|Adverse Event|17|||
125149223|NCT00442546|450168223|FG002|Overall Study|Adverse Event|13|||
125149224|NCT00442546|450168221|FG000|Overall Study|Lost to Follow-up|1|||
125149225|NCT00442546|450168222|FG001|Overall Study|Lost to Follow-up|2|||
125149226|NCT00442546|450168223|FG002|Overall Study|Lost to Follow-up|1|||
125149227|NCT00442546|450168221|FG000|Overall Study|Other|4|||
125149228|NCT00442546|450168222|FG001|Overall Study|Other|9|||
125149229|NCT00442546|450168223|FG002|Overall Study|Other|6|||
125149230|NCT00442546|450168221|FG000|Overall Study|Withdrawal by Subject|5|||
125149231|NCT00442546|450168222|FG001|Overall Study|Withdrawal by Subject|5|||
125149232|NCT00442546|450168223|FG002|Overall Study|Withdrawal by Subject|7|||
125149233|NCT00442546|450168221|FG000|Overall Study|Randomized But Not Treated|5|||
125149234|NCT00442546|450168222|FG001|Overall Study|Randomized But Not Treated|4|||
125149235|NCT00442546|450168223|FG002|Overall Study|Randomized But Not Treated|6|||
125149236|NCT03840382|450168224|FG000|Overall Study|Lost to Follow-up|11|||
125149237|NCT00802178|450169194|FG000|Overall Study|Lack of Efficacy|36|||
125149238|NCT00802178|450169194|FG000|Overall Study|Insufficient tolerability (IT)|17|||
125149239|NCT00802178|450169194|FG000|Overall Study|Withdrawal by Subject|18|||
125149240|NCT00802178|450169194|FG000|Overall Study|Other|32|||
125149241|NCT00802178|450169194|FG000|Overall Study|Lack of efficacy and patient wish|1|||
125149242|NCT00802178|450169194|FG000|Overall Study|IT and patient wish|8|||
125149243|NCT00802178|450169194|FG000|Overall Study|Patients wish and other reason|1|||
125149244|NCT00097786|450169195|FG000|Overall Study|lost to follow-up for all-cause death|296|||
125149245|NCT00097786|450169196|FG001|Overall Study|lost to follow-up for all-cause death|292|||
125149246|NCT00097786|450169197|FG002|Overall Study|lost to follow-up for all-cause death|313|||
125149247|NCT00097786|450169198|FG003|Overall Study|lost to follow-up for all-cause death|310|||
125149248|NCT02000531|450169199|FG000|Overall Study|Lost to Follow-up|1|||
125149249|NCT02000531|450169200|FG001|Overall Study|Lost to Follow-up|0|||
125149250|NCT02000531|450169199|FG000|Overall Study|Discontinued due to data cut-off|3|||
125149251|NCT02000531|450169200|FG001|Overall Study|Discontinued due to data cut-off|8|||
125149252|NCT01239472|450169203|FG000|Overall Study|Withdrawal by Subject|5|||
125149253|NCT01239472|450169204|FG001|Overall Study|Withdrawal by Subject|1|||
125149254|NCT01239472|450169203|FG000|Overall Study|Adverse Event|0|||
125149255|NCT01239472|450169204|FG001|Overall Study|Adverse Event|1|||
125149256|NCT01239472|450169203|FG000|Overall Study|Lack of Efficacy|0|||
125149257|NCT01239472|450169204|FG001|Overall Study|Lack of Efficacy|1|||
125149258|NCT01280617|450169207|FG000|Overall Study|Adverse Event|0|||
125149259|NCT01280617|450169208|FG001|Overall Study|Adverse Event|1|||
125149260|NCT05966090|450169209|FG000|Overall Study|Lost to Follow-up|6|||
125149261|NCT05966090|450169210|FG001|Overall Study|Lost to Follow-up|6|||
125149262|NCT05966090|450169209|FG000|Overall Study|Adverse Event|1|||
125149263|NCT05966090|450169210|FG001|Overall Study|Adverse Event|1|||
125149264|NCT05966090|450169209|FG000|Overall Study|Withdrawal by Subject|1|||
125149265|NCT05966090|450169210|FG001|Overall Study|Withdrawal by Subject|1|||
125149266|NCT05966090|450169209|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125149267|NCT05966090|450169210|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
125149268|NCT05966090|450169209|FG000|Overall Study|Other|1|||
125149269|NCT05966090|450169210|FG001|Overall Study|Other|1|||
125149270|NCT02001051|450169211|FG000|Overall Study|Deemed not eligible following enrollment|0|||
125149271|NCT02001051|450169212|FG001|Overall Study|Deemed not eligible following enrollment|1|||
125149272|NCT00529217|450169217|FG000|Overall Study|Lack of Efficacy|2|||
125149273|NCT00529217|450169217|FG000|Overall Study|Unable to adhere to study schedule|2|||
125149274|NCT01098110|450169219|FG000|Overall Study|Withdrawal by Subject|14|||
125149275|NCT01098110|450169220|FG001|Overall Study|Withdrawal by Subject|24|||
125149276|NCT01098110|450169221|FG002|Overall Study|Withdrawal by Subject|19|||
125149277|NCT01098110|450169219|FG000|Overall Study|Adverse Event|30|||
125149278|NCT01098110|450169220|FG001|Overall Study|Adverse Event|32|||
125149279|NCT01098110|450169221|FG002|Overall Study|Adverse Event|43|||
125149280|NCT01098110|450169219|FG000|Overall Study|Lack of Efficacy|13|||
125149281|NCT01098110|450169220|FG001|Overall Study|Lack of Efficacy|9|||
125149282|NCT01098110|450169221|FG002|Overall Study|Lack of Efficacy|27|||
125149283|NCT01098110|450169219|FG000|Overall Study|Other|4|||
125149284|NCT01098110|450169220|FG001|Overall Study|Other|7|||
125149285|NCT01098110|450169221|FG002|Overall Study|Other|5|||
125149286|NCT01098110|450169219|FG000|Overall Study|Untreated|1|||
125149287|NCT01098110|450169220|FG001|Overall Study|Untreated|1|||
125149288|NCT01098110|450169221|FG002|Overall Study|Untreated|0|||
125149289|NCT02147587|450169222|FG000|Overall Study|Adverse Event|9|||
125149290|NCT02147587|450169223|FG001|Overall Study|Adverse Event|4|||
125149291|NCT02147587|450169222|FG000|Overall Study|Lack of Efficacy|2|||
125149292|NCT02147587|450169223|FG001|Overall Study|Lack of Efficacy|1|||
125149293|NCT01546519|450169224|FG000|Overall Study|Adverse Event|0|||
125149294|NCT01546519|450169225|FG001|Overall Study|Adverse Event|0|||
125149295|NCT01546519|450169226|FG002|Overall Study|Adverse Event|1|||
125149296|NCT01546519|450169227|FG003|Overall Study|Adverse Event|1|||
125149297|NCT01546519|450169224|FG000|Overall Study|Death|0|||
125149298|NCT01546519|450169225|FG001|Overall Study|Death|1|||
125149299|NCT01546519|450169226|FG002|Overall Study|Death|3|||
125149300|NCT01546519|450169227|FG003|Overall Study|Death|1|||
125149301|NCT01546519|450169224|FG000|Overall Study|related to disease progression|2|||
125149302|NCT01546519|450169225|FG001|Overall Study|related to disease progression|2|||
125149303|NCT01546519|450169226|FG002|Overall Study|related to disease progression|2|||
125149304|NCT01546519|450169227|FG003|Overall Study|related to disease progression|1|||
125149305|NCT01546519|450169224|FG000|Overall Study|Physician Decision|6|||
125149306|NCT01546519|450169225|FG001|Overall Study|Physician Decision|5|||
125149307|NCT01546519|450169226|FG002|Overall Study|Physician Decision|2|||
125149308|NCT01546519|450169227|FG003|Overall Study|Physician Decision|3|||
125149309|NCT01546519|450169224|FG000|Overall Study|Withdrawal by Subject|1|||
125149310|NCT01546519|450169225|FG001|Overall Study|Withdrawal by Subject|0|||
125149311|NCT01546519|450169226|FG002|Overall Study|Withdrawal by Subject|0|||
125149312|NCT01546519|450169227|FG003|Overall Study|Withdrawal by Subject|0|||
125149313|NCT01519947|450169234|FG000|Overall Study|Death|0|||
125149314|NCT01519947|450169235|FG001|Overall Study|Death|0|||
125149315|NCT01519947|450169236|FG002|Overall Study|Death|0|||
125149316|NCT01519947|450169237|FG003|Overall Study|Death|1|||
125149317|NCT01519947|450169234|FG000|Overall Study|Protocol Violation|0|||
125149318|NCT01519947|450169235|FG001|Overall Study|Protocol Violation|0|||
125149319|NCT01519947|450169236|FG002|Overall Study|Protocol Violation|2|||
125149320|NCT01519947|450169237|FG003|Overall Study|Protocol Violation|1|||
125149321|NCT01519947|450169234|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
125149322|NCT01519947|450169235|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
125149323|NCT01519947|450169236|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
125149324|NCT01519947|450169237|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
125149325|NCT01519947|450169234|FG000|Overall Study|Development of Anemia|0|||
125149326|NCT01519947|450169235|FG001|Overall Study|Development of Anemia|1|||
125149327|NCT01519947|450169236|FG002|Overall Study|Development of Anemia|0|||
125149328|NCT01519947|450169237|FG003|Overall Study|Development of Anemia|1|||
125149329|NCT01519947|450169234|FG000|Overall Study|Blood Transfusion|0|||
125149330|NCT01519947|450169235|FG001|Overall Study|Blood Transfusion|1|||
125149331|NCT01519947|450169236|FG002|Overall Study|Blood Transfusion|1|||
125149332|NCT01519947|450169237|FG003|Overall Study|Blood Transfusion|0|||
125149333|NCT01519947|450169234|FG000|Overall Study|Withdrawal by Subject|0|||
125149334|NCT01519947|450169235|FG001|Overall Study|Withdrawal by Subject|1|||
125149335|NCT01519947|450169236|FG002|Overall Study|Withdrawal by Subject|0|||
125149336|NCT01519947|450169237|FG003|Overall Study|Withdrawal by Subject|1|||
125149337|NCT01519947|450169234|FG000|Overall Study|Lost to Follow-up|0|||
125149338|NCT01519947|450169235|FG001|Overall Study|Lost to Follow-up|0|||
125149339|NCT01519947|450169236|FG002|Overall Study|Lost to Follow-up|3|||
125149340|NCT01519947|450169237|FG003|Overall Study|Lost to Follow-up|2|||
125149341|NCT01519947|450169234|FG000|Overall Study|Poor Response|1|||
125149342|NCT01519947|450169235|FG001|Overall Study|Poor Response|0|||
125149343|NCT01519947|450169236|FG002|Overall Study|Poor Response|0|||
125149344|NCT01519947|450169237|FG003|Overall Study|Poor Response|1|||
125149345|NCT01519947|450169234|FG000|Overall Study|Adverse Event|1|||
125149346|NCT01519947|450169235|FG001|Overall Study|Adverse Event|0|||
125149347|NCT01519947|450169236|FG002|Overall Study|Adverse Event|1|||
125149348|NCT01519947|450169237|FG003|Overall Study|Adverse Event|1|||
125149349|NCT02274948|450169244|FG000|Overall Study|Lost to Follow-up|28|||
125149350|NCT02274948|450169245|FG001|Overall Study|Lost to Follow-up|25|||
125149351|NCT02274948|450169244|FG000|Overall Study|Withdrawal by Subject|64|||
125149352|NCT02274948|450169245|FG001|Overall Study|Withdrawal by Subject|58|||
125149353|NCT02274948|450169244|FG000|Overall Study|Stopped on family Practitioner advice|2|||
125149354|NCT02274948|450169245|FG001|Overall Study|Stopped on family Practitioner advice|5|||
125149355|NCT02274948|450169244|FG000|Overall Study|Left the area|4|||
125149356|NCT02274948|450169245|FG001|Overall Study|Left the area|3|||
125149357|NCT00707434|450169246|FG000|Overall Study|Adverse Event|1|||
125149358|NCT00530348|450169248|FG000|Overall Study|Adverse Event|5|||
125149359|NCT00530348|450169249|FG001|Overall Study|Adverse Event|1|||
125149360|NCT00530348|450169248|FG000|Overall Study|Death|0|||
125149361|NCT00530348|450169249|FG001|Overall Study|Death|1|||
125149362|NCT00530348|450169248|FG000|Overall Study|Lack of Efficacy|2|||
125149363|NCT00530348|450169249|FG001|Overall Study|Lack of Efficacy|0|||
125149364|NCT00530348|450169248|FG000|Overall Study|Lost to Follow-up|0|||
125149365|NCT00530348|450169249|FG001|Overall Study|Lost to Follow-up|2|||
125149366|NCT00530348|450169248|FG000|Overall Study|Physician Decision|1|||
125149367|NCT00530348|450169249|FG001|Overall Study|Physician Decision|2|||
125149368|NCT00530348|450169248|FG000|Overall Study|Pregnancy|1|||
125149369|NCT00530348|450169249|FG001|Overall Study|Pregnancy|0|||
125149370|NCT00530348|450169248|FG000|Overall Study|Withdrawal by Subject|12|||
125149371|NCT00530348|450169249|FG001|Overall Study|Withdrawal by Subject|12|||
125149372|NCT00530348|450169248|FG000|Overall Study|Randomised in error|1|||
125149373|NCT00530348|450169249|FG001|Overall Study|Randomised in error|0|||
125149374|NCT00530348|450169248|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
125149375|NCT00530348|450169249|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
125149376|NCT04364763|450169250|FG000|Overall Study|Death|1|||
125149377|NCT04364763|450169251|FG001|Overall Study|Death|2|||
125149378|NCT04364763|450169250|FG000|Overall Study|Lost to Follow-up|1|||
125149379|NCT04364763|450169251|FG001|Overall Study|Lost to Follow-up|0|||
125149380|NCT01386125|450169252|FG000|Overall Study|Lost to Follow-up|3|||
125149381|NCT01386125|450169253|FG001|Overall Study|Lost to Follow-up|9|||
125149382|NCT01386125|450169252|FG000|Overall Study|Physician Decision|0|||
125149383|NCT01386125|450169253|FG001|Overall Study|Physician Decision|1|||
125149384|NCT01386125|450169252|FG000|Overall Study|Protocol Violation|5|||
125149385|NCT01386125|450169253|FG001|Overall Study|Protocol Violation|7|||
125149386|NCT01386125|450169252|FG000|Overall Study|Disease Progress|1|||
125149387|NCT01386125|450169253|FG001|Overall Study|Disease Progress|2|||
125149388|NCT01386125|450169252|FG000|Overall Study|Withdrawal by Subject|13|||
125149389|NCT01386125|450169253|FG001|Overall Study|Withdrawal by Subject|12|||
125149390|NCT01386125|450169252|FG000|Overall Study|Adverse Event|2|||
125149391|NCT01386125|450169253|FG001|Overall Study|Adverse Event|5|||
125149392|NCT01386125|450169252|FG000|Overall Study|Lack of Efficacy|0|||
125149393|NCT01386125|450169253|FG001|Overall Study|Lack of Efficacy|1|||
125149394|NCT01386125|450169252|FG000|Overall Study|Participant Leaving Country|1|||
125149395|NCT01386125|450169253|FG001|Overall Study|Participant Leaving Country|0|||
125149396|NCT00732160|450169258|FG000|Overall Study|Adverse Event|1|||
125149397|NCT00732160|450169259|FG001|Overall Study|Adverse Event|0|||
125149398|NCT00732160|450169260|FG002|Overall Study|Adverse Event|1|||
125149399|NCT00732160|450169261|FG003|Overall Study|Adverse Event|1|||
125149400|NCT00732160|450169258|FG000|Overall Study|scheduling|4|||
125149401|NCT00732160|450169259|FG001|Overall Study|scheduling|4|||
125149402|NCT00732160|450169260|FG002|Overall Study|scheduling|2|||
125149403|NCT00732160|450169261|FG003|Overall Study|scheduling|1|||
125149404|NCT00676494|450169262|FG000|Overall Study|Missed Visit|8|||
125149405|NCT00676494|450169262|FG000|Overall Study|Withdrawal by Subject|6|||
125149406|NCT00985231|450169283|FG000|Overall Study|ineligible|1|||
125149407|NCT00985231|450169284|FG001|Overall Study|ineligible|0|||
125149408|NCT00985231|450169283|FG000|Overall Study|Protocol Violation|1|||
125149409|NCT00985231|450169284|FG001|Overall Study|Protocol Violation|0|||
125149410|NCT00985231|450169283|FG000|Overall Study|Withdrawal by Subject|1|||
125149411|NCT00985231|450169284|FG001|Overall Study|Withdrawal by Subject|0|||
125149412|NCT00985231|450169283|FG000|Overall Study|Lost to Follow-up|0|||
125149413|NCT00985231|450169284|FG001|Overall Study|Lost to Follow-up|1|||
125149414|NCT00985231|450169283|FG000|Overall Study|Study related symptoms & complaints|0|||
125149415|NCT00985231|450169284|FG001|Overall Study|Study related symptoms & complaints|2|||
125149416|NCT01463982|450169285|FG000|Overall Study|Withdrawal by Subject|0|||
125149417|NCT01463982|450169286|FG001|Overall Study|Withdrawal by Subject|1|||
125149418|NCT01463982|450169287|FG002|Overall Study|Withdrawal by Subject|1|||
125149419|NCT01463982|450169288|FG003|Overall Study|Withdrawal by Subject|0|||
125149420|NCT01463982|450169285|FG000|Overall Study|Treatment delay over 5 week|0|||
125149421|NCT01463982|450169286|FG001|Overall Study|Treatment delay over 5 week|0|||
125149422|NCT01463982|450169287|FG002|Overall Study|Treatment delay over 5 week|1|||
125149423|NCT01463982|450169288|FG003|Overall Study|Treatment delay over 5 week|0|||
125149424|NCT04220775|450169289|FG000|Overall Study|Adverse Event|1|||
125149425|NCT04220775|450169290|FG001|Overall Study|Adverse Event|0|||
125149426|NCT04220775|450169289|FG000|Overall Study|Disease Progression|1|||
125149427|NCT04220775|450169290|FG001|Overall Study|Disease Progression|0|||
125149428|NCT00931463|450169291|FG000|Overall Study|Death|8|||
125149429|NCT00931463|450169292|FG001|Overall Study|Death|4|||
125149430|NCT00931463|450169291|FG000|Overall Study|Withdrawal by Subject|5|||
125149431|NCT00931463|450169292|FG001|Overall Study|Withdrawal by Subject|0|||
125149432|NCT00931463|450169291|FG000|Overall Study|Lost to Follow-up|4|||
125149433|NCT00931463|450169292|FG001|Overall Study|Lost to Follow-up|1|||
125149434|NCT00436917|450169293|FG000|Overall Study|Withdrawal by Subject|13|||
125149435|NCT00436917|450169293|FG000|Overall Study|Adverse Event|2|||
125149436|NCT00436917|450169293|FG000|Overall Study|Physician Decision|1|||
125149437|NCT00436917|450169293|FG000|Overall Study|Death|1|||
125149438|NCT00436917|450169293|FG000|Overall Study|Lost to Follow-up|1|||
125149439|NCT00436917|450169293|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
125149440|NCT00436917|450169293|FG000|Overall Study|Increased creatinine|1|||
125149441|NCT00436917|450169293|FG000|Overall Study|Personal conflicts of patient|1|||
125149442|NCT01083680|450169298|FG000|Overall Study|Lost to Follow-up|2758|||
125149443|NCT01083680|450169298|FG000|Overall Study|Withdrawal by Subject|1086|||
125149444|NCT05766787|450169299|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
125149445|NCT05766787|450169300|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
125149446|NCT05766787|450169299|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
125149447|NCT05766787|450169300|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
125149448|NCT05766787|450169299|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
125149449|NCT05766787|450169300|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
125149450|NCT01435928|450169301|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
125149451|NCT01435928|450169302|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
125149452|NCT01435928|450169303|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
125149453|NCT01435928|450169301|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
125149454|NCT01435928|450169302|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
125149455|NCT01435928|450169303|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
125149456|NCT01435928|450169301|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
125149457|NCT01435928|450169302|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
125149458|NCT01435928|450169303|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
125149459|NCT01435928|450169301|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
125149460|NCT01435928|450169302|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
125149461|NCT01435928|450169303|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
125149462|NCT01435928|450169301|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
125149463|NCT01435928|450169302|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
125149464|NCT01435928|450169303|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
125149465|NCT01435928|450169301|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
125149466|NCT01435928|450169302|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
125149467|NCT01435928|450169303|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
125149468|NCT01435928|450169301|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
125149469|NCT01435928|450169302|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
125149470|NCT01435928|450169303|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
125149471|NCT01435928|450169301|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
125149472|NCT01435928|450169302|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
125149473|NCT01435928|450169303|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
125149474|NCT01435928|450169301|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
125149475|NCT01435928|450169302|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
125149476|NCT01435928|450169303|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
125149477|NCT01435928|450169301|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
125149478|NCT01435928|450169302|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
125149479|NCT01435928|450169303|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
125149480|NCT01435928|450169301|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
125149481|NCT01435928|450169302|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
125149482|NCT01435928|450169303|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
125149483|NCT01435928|450169301|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
125149484|NCT01435928|450169302|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
125149485|NCT01435928|450169303|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
125149486|NCT01435928|450169301|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
125149487|NCT01435928|450169302|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
125149488|NCT01435928|450169303|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
125149489|NCT01435928|450169301|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
125223660|NCT02326272|450446169|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125223661|NCT02326272|450446170|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125149490|NCT01435928|450169302|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
125149491|NCT01435928|450169303|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
125149492|NCT01435928|450169301|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
125149493|NCT01435928|450169302|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
125149494|NCT01435928|450169303|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
125149495|NCT01435928|450169301|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
125149496|NCT01435928|450169302|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
125149497|NCT01435928|450169303|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
125149498|NCT01619579|450171236|FG000|Overall Study|Withdrawal by Subject|0|||
125149499|NCT01619579|450171237|FG001|Overall Study|Withdrawal by Subject|3|||
125149500|NCT02124902|450171238|FG000|Overall Study|Adverse Event|7|||
125149501|NCT02124902|450171239|FG001|Overall Study|Adverse Event|2|||
125149502|NCT02124902|450171238|FG000|Overall Study|Went to alternative treatment|4|||
125149503|NCT02124902|450171239|FG001|Overall Study|Went to alternative treatment|0|||
125149504|NCT02124902|450171238|FG000|Overall Study|Withdrawal by Subject|2|||
125149505|NCT02124902|450171239|FG001|Overall Study|Withdrawal by Subject|1|||
125149506|NCT02124902|450171238|FG000|Overall Study|Physician Decision|2|||
125149507|NCT02124902|450171239|FG001|Overall Study|Physician Decision|0|||
125149508|NCT02124902|450171238|FG000|Overall Study|Not eligible|1|||
125149509|NCT02124902|450171239|FG001|Overall Study|Not eligible|0|||
125149510|NCT02124902|450171238|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
125149511|NCT02124902|450171239|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
125149512|NCT02938442|450171240|FG000|Overall Study|Death|0|||
125149513|NCT02938442|450171241|FG001|Overall Study|Death|1|||
125149514|NCT02938442|450171240|FG000|Overall Study|Lost to Follow-up|0|||
125149515|NCT02938442|450171241|FG001|Overall Study|Lost to Follow-up|1|||
125149516|NCT02938442|450171240|FG000|Overall Study|Physician Decision|0|||
125149517|NCT02938442|450171241|FG001|Overall Study|Physician Decision|1|||
125149518|NCT02938442|450171240|FG000|Overall Study|Withdrawal by Subject|2|||
125149519|NCT02938442|450171241|FG001|Overall Study|Withdrawal by Subject|0|||
125149520|NCT04100096|450171244|FG000|Overall Study|Adverse Event|19|||
125149521|NCT04100096|450171245|FG001|Overall Study|Adverse Event|7|||
125149522|NCT04100096|450171244|FG000|Overall Study|Lack of Efficacy|0|||
125149523|NCT04100096|450171245|FG001|Overall Study|Lack of Efficacy|1|||
125149524|NCT04100096|450171244|FG000|Overall Study|Lost to Follow-up|13|||
125149525|NCT04100096|450171245|FG001|Overall Study|Lost to Follow-up|11|||
125149526|NCT04100096|450171244|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125149527|NCT04100096|450171245|FG001|Overall Study|Non-Compliance With Study Drug|3|||
125149528|NCT04100096|450171244|FG000|Overall Study|Protocol Deviation|1|||
125149529|NCT04100096|450171245|FG001|Overall Study|Protocol Deviation|1|||
125149530|NCT04100096|450171244|FG000|Overall Study|Withdrawal by Participant|13|||
125149531|NCT04100096|450171245|FG001|Overall Study|Withdrawal by Participant|15|||
125149532|NCT00831233|450171249|FG000|Overall Study|Adverse Event|0|||
125149533|NCT00831233|450171250|FG001|Overall Study|Adverse Event|1|||
125149534|NCT00831233|450171249|FG000|Overall Study|Protocol Violation|1|||
125149535|NCT00831233|450171250|FG001|Overall Study|Protocol Violation|0|||
125149536|NCT00831233|450171249|FG000|Overall Study|Selection Criteria Not Met|2|||
125149537|NCT00831233|450171250|FG001|Overall Study|Selection Criteria Not Met|0|||
125149538|NCT02211014|450171251|FG000|Overall Study|Adverse Event|0|||
125149539|NCT02211014|450171252|FG001|Overall Study|Adverse Event|2|||
125149540|NCT02211014|450171251|FG000|Overall Study|Physician Decision|1|||
125149541|NCT02211014|450171252|FG001|Overall Study|Physician Decision|2|||
125149542|NCT02211014|450171251|FG000|Overall Study|Started another cancer therapy|1|||
125149543|NCT02211014|450171252|FG001|Overall Study|Started another cancer therapy|0|||
125149544|NCT02211014|450171251|FG000|Overall Study|Withdrawal by Subject|0|||
125149545|NCT02211014|450171252|FG001|Overall Study|Withdrawal by Subject|1|||
125149546|NCT02211014|450171251|FG000|Overall Study|In agreement with patient, no benefit|0|||
125149547|NCT02211014|450171252|FG001|Overall Study|In agreement with patient, no benefit|1|||
125149548|NCT01915940|450171253|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
125149549|NCT01915940|450171254|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
125149550|NCT01915940|450171255|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
125149551|NCT01915940|450171253|FG000|Treatment Period|Decision of Participant|0|||
125149552|NCT01915940|450171254|FG001|Treatment Period|Decision of Participant|1|||
125149553|NCT01915940|450171255|FG002|Treatment Period|Decision of Participant|3|||
125149554|NCT01915940|450171253|FG000|Treatment Period|Adverse Event|0|||
125149555|NCT01915940|450171254|FG001|Treatment Period|Adverse Event|9|||
125149556|NCT01915940|450171255|FG002|Treatment Period|Adverse Event|1|||
125149557|NCT01915940|450171253|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
125149558|NCT01915940|450171254|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
125149559|NCT01915940|450171255|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
125149560|NCT02960438|450171256|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
125149561|NCT02960438|450171257|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
125149562|NCT02960438|450171258|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
125149563|NCT02960438|450171259|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
125149564|NCT02960438|450171256|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
125149565|NCT02960438|450171257|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
125149566|NCT02960438|450171258|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
125149567|NCT02960438|450171259|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
125149568|NCT02960438|450171256|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
125149569|NCT02960438|450171257|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
125149570|NCT02960438|450171258|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
125149571|NCT02960438|450171259|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
125149572|NCT02960438|450171256|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
125149573|NCT02960438|450171257|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
125149574|NCT02960438|450171258|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
125149575|NCT02960438|450171259|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
125149576|NCT02960438|450171256|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
125149577|NCT02960438|450171257|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
125149578|NCT02960438|450171258|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
125149579|NCT02960438|450171259|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
125149580|NCT02960438|450171256|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
125149581|NCT02960438|450171257|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
125149582|NCT02960438|450171258|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
125149583|NCT02960438|450171259|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
125149584|NCT02960438|450171256|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
125149585|NCT02960438|450171257|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
125149586|NCT02960438|450171258|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
125149587|NCT02960438|450171259|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
125149588|NCT02960438|450171256|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
125149589|NCT02960438|450171257|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
125149590|NCT02960438|450171258|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
125149591|NCT02960438|450171259|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
125149592|NCT02960438|450171256|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
125149593|NCT02960438|450171257|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
125149594|NCT02960438|450171258|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
125149595|NCT02960438|450171259|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
125149596|NCT02960438|450171256|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
125149597|NCT02960438|450171257|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
125149598|NCT02960438|450171258|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
125149599|NCT02960438|450171259|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
125149600|NCT02960438|450171256|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
125149601|NCT02960438|450171257|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
125149602|NCT02960438|450171258|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
125149603|NCT02960438|450171259|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
125149604|NCT02960438|450171256|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
125149605|NCT02960438|450171257|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
125149606|NCT02960438|450171258|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
125149607|NCT02960438|450171259|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
125149608|NCT01647711|450171261|FG000|Overall Study|Progressive disease|6|||
125149609|NCT01647711|450171262|FG001|Overall Study|Progressive disease|2|||
125149610|NCT01647711|450171263|FG002|Overall Study|Progressive disease|6|||
125149611|NCT01647711|450171264|FG003|Overall Study|Progressive disease|8|||
125149612|NCT01647711|450171265|FG004|Overall Study|Progressive disease|2|||
125149613|NCT01647711|450171261|FG000|Overall Study|Other adverse event|0|||
125149614|NCT01647711|450171262|FG001|Overall Study|Other adverse event|0|||
125149615|NCT01647711|450171263|FG002|Overall Study|Other adverse event|2|||
125149616|NCT01647711|450171264|FG003|Overall Study|Other adverse event|0|||
125149617|NCT01647711|450171265|FG004|Overall Study|Other adverse event|2|||
125149618|NCT01647711|450171261|FG000|Overall Study|Protocol Violation|0|||
125149619|NCT01647711|450171262|FG001|Overall Study|Protocol Violation|0|||
125149620|NCT01647711|450171263|FG002|Overall Study|Protocol Violation|0|||
125149621|NCT01647711|450171264|FG003|Overall Study|Protocol Violation|0|||
125149622|NCT01647711|450171265|FG004|Overall Study|Protocol Violation|1|||
125149623|NCT01647711|450171261|FG000|Overall Study|Refused to continue taking medication|0|||
125149624|NCT01647711|450171262|FG001|Overall Study|Refused to continue taking medication|0|||
125149625|NCT01647711|450171263|FG002|Overall Study|Refused to continue taking medication|0|||
125149626|NCT01647711|450171264|FG003|Overall Study|Refused to continue taking medication|2|||
125149627|NCT01647711|450171265|FG004|Overall Study|Refused to continue taking medication|1|||
125149628|NCT01647711|450171261|FG000|Overall Study|Other reason not defined|0|||
125149629|NCT01647711|450171262|FG001|Overall Study|Other reason not defined|1|||
125149630|NCT01647711|450171263|FG002|Overall Study|Other reason not defined|1|||
125149631|NCT01647711|450171264|FG003|Overall Study|Other reason not defined|1|||
125149632|NCT01647711|450171265|FG004|Overall Study|Other reason not defined|0|||
125149633|NCT01796964|450171283|FG000|Overall Study|Adverse Event|1|||
125149634|NCT01796964|450171284|FG001|Overall Study|Adverse Event|1|||
125149635|NCT01796964|450171283|FG000|Overall Study|Death|1|||
125149636|NCT01796964|450171284|FG001|Overall Study|Death|0|||
125149637|NCT01796964|450171283|FG000|Overall Study|Protocol Violation|0|||
125149638|NCT01796964|450171284|FG001|Overall Study|Protocol Violation|1|||
125149639|NCT01796964|450171283|FG000|Overall Study|Withdrawal by Subject|1|||
125149640|NCT01796964|450171284|FG001|Overall Study|Withdrawal by Subject|1|||
125149641|NCT04025684|450171285|FG000|Overall Study|Withdrawal by Subject|1|||
125149642|NCT04025684|450171286|FG001|Overall Study|Withdrawal by Subject|1|||
125149643|NCT04025684|450171287|FG002|Overall Study|Withdrawal by Subject|0|||
125149644|NCT04025684|450171288|FG003|Overall Study|Withdrawal by Subject|0|||
125149645|NCT04025684|450171285|FG000|Overall Study|Multiple reasons|1|||
125149646|NCT04025684|450171286|FG001|Overall Study|Multiple reasons|3|||
125149647|NCT04025684|450171287|FG002|Overall Study|Multiple reasons|0|||
125149648|NCT04025684|450171288|FG003|Overall Study|Multiple reasons|1|||
125149649|NCT01844531|450171289|FG000|Overall Study|Withdrawal by Subject|0|||
125149650|NCT01844531|450171290|FG001|Overall Study|Withdrawal by Subject|1|||
125149651|NCT01844531|450171291|FG002|Overall Study|Withdrawal by Subject|0|||
125149652|NCT01844531|450171292|FG003|Overall Study|Withdrawal by Subject|0|||
125149653|NCT02744755|450171293|FG000|Study Period 1|Protocol Violation|2|||
125149654|NCT02744755|450171294|FG001|Study Period 1|Protocol Violation|1|||
125149655|NCT02744755|450171293|FG000|Study Period 1|not defined|0|||
125149656|NCT02744755|450171294|FG001|Study Period 1|not defined|1|||
125149657|NCT02744755|450171293|FG000|Study Period 1|Pregnancy|1|||
125149658|NCT02744755|450171294|FG001|Study Period 1|Pregnancy|0|||
125149659|NCT02744755|450171293|FG000|Study Period 1|Adverse Event|1|||
125149660|NCT02744755|450171294|FG001|Study Period 1|Adverse Event|1|||
125149661|NCT02744755|450171293|FG000|Study Period 1|Lost to Follow-up|1|||
125149662|NCT02744755|450171294|FG001|Study Period 1|Lost to Follow-up|1|||
125149663|NCT02744755|450171293|FG000|Study Period 1|Lack of Efficacy|1|||
125149664|NCT02744755|450171294|FG001|Study Period 1|Lack of Efficacy|0|||
125149665|NCT02744755|450171293|FG000|Study Period 1|Withdrawal by Subject|8|||
125149666|NCT02744755|450171294|FG001|Study Period 1|Withdrawal by Subject|4|||
125149667|NCT02744755|450171293|FG000|Study Period 2|Adverse Event|5|||
125149668|NCT02744755|450171294|FG001|Study Period 2|Adverse Event|0|||
125149669|NCT02744755|450171293|FG000|Study Period 2|Protocol Violation|1|||
125149670|NCT02744755|450171294|FG001|Study Period 2|Protocol Violation|0|||
125149671|NCT02744755|450171293|FG000|Study Period 2|not defined|3|||
125149672|NCT02744755|450171294|FG001|Study Period 2|not defined|2|||
125149673|NCT02744755|450171293|FG000|Study Period 2|Lost to Follow-up|0|||
125149674|NCT02744755|450171294|FG001|Study Period 2|Lost to Follow-up|2|||
125149675|NCT02744755|450171293|FG000|Study Period 2|Withdrawal by Subject|2|||
125149676|NCT02744755|450171294|FG001|Study Period 2|Withdrawal by Subject|2|||
125149677|NCT02744755|450171293|FG000|Study Period 2|Lack of Efficacy|3|||
125149678|NCT02744755|450171294|FG001|Study Period 2|Lack of Efficacy|2|||
125149679|NCT02916693|450171297|FG000|Overall Study|Lost to Follow-up|7|||
125149680|NCT00337428|450171298|FG000|Overall Study|Withdrawal by Subject|1|||
125149681|NCT00337428|450171299|FG001|Overall Study|Withdrawal by Subject|2|||
125149682|NCT00337428|450171298|FG000|Overall Study|Lack of Time|1|||
125149683|NCT00337428|450171299|FG001|Overall Study|Lack of Time|1|||
125149684|NCT00337428|450171298|FG000|Overall Study|Unwilling to Continue|1|||
125149685|NCT00337428|450171299|FG001|Overall Study|Unwilling to Continue|0|||
125149686|NCT00337428|450171298|FG000|Overall Study|Anorexia|1|||
125149687|NCT00337428|450171299|FG001|Overall Study|Anorexia|0|||
125149688|NCT01999894|450171300|FG000|Overall Study|Adverse Event|9|||
125149689|NCT01999894|450171300|FG000|Overall Study|Lack of Efficacy|5|||
125149690|NCT01999894|450171300|FG000|Overall Study|Protocol Violation|1|||
125149691|NCT01999894|450171300|FG000|Overall Study|Withdrawal by Subject|7|||
125149692|NCT01999894|450171300|FG000|Overall Study|Lost to Follow-up|10|||
125149693|NCT01999894|450171300|FG000|Overall Study|Other Reason|3|||
125149694|NCT01999894|450171300|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
125149695|NCT01740791|450171302|FG000|Overall Study|Randomized but never treated|5|||
125149696|NCT01740791|450171303|FG001|Overall Study|Randomized but never treated|3|||
125149697|NCT01740791|450171304|FG002|Overall Study|Randomized but never treated|2|||
125149698|NCT01740791|450171305|FG003|Overall Study|Randomized but never treated|2|||
125149699|NCT01740791|450171306|FG004|Overall Study|Randomized but never treated|1|||
125149700|NCT01740791|450171307|FG005|Overall Study|Randomized but never treated|3|||
125149701|NCT01740791|450171302|FG000|Overall Study|Lost to Follow-up|2|||
125149702|NCT01740791|450171303|FG001|Overall Study|Lost to Follow-up|0|||
125149703|NCT01740791|450171304|FG002|Overall Study|Lost to Follow-up|2|||
125149704|NCT01740791|450171305|FG003|Overall Study|Lost to Follow-up|3|||
125149705|NCT01740791|450171306|FG004|Overall Study|Lost to Follow-up|2|||
125149706|NCT01740791|450171307|FG005|Overall Study|Lost to Follow-up|3|||
125149707|NCT01740791|450171302|FG000|Overall Study|Withdrew Consent|4|||
125149708|NCT01740791|450171303|FG001|Overall Study|Withdrew Consent|0|||
125149709|NCT01740791|450171304|FG002|Overall Study|Withdrew Consent|1|||
125149710|NCT01740791|450171305|FG003|Overall Study|Withdrew Consent|2|||
125149711|NCT01740791|450171306|FG004|Overall Study|Withdrew Consent|0|||
125149712|NCT01740791|450171307|FG005|Overall Study|Withdrew Consent|3|||
125149713|NCT01740791|450171302|FG000|Overall Study|Investigator's discretion|1|||
125149714|NCT01740791|450171303|FG001|Overall Study|Investigator's discretion|0|||
125149715|NCT01740791|450171304|FG002|Overall Study|Investigator's discretion|1|||
125149716|NCT01740791|450171305|FG003|Overall Study|Investigator's discretion|0|||
125149717|NCT01740791|450171306|FG004|Overall Study|Investigator's discretion|0|||
125149718|NCT01740791|450171307|FG005|Overall Study|Investigator's discretion|1|||
125149719|NCT01740791|450171302|FG000|Overall Study|Adverse Event|0|||
125149720|NCT01740791|450171303|FG001|Overall Study|Adverse Event|0|||
125149721|NCT01740791|450171304|FG002|Overall Study|Adverse Event|0|||
125149722|NCT01740791|450171305|FG003|Overall Study|Adverse Event|0|||
125149723|NCT01740791|450171306|FG004|Overall Study|Adverse Event|0|||
125149724|NCT01740791|450171307|FG005|Overall Study|Adverse Event|1|||
125149725|NCT03170869|450171308|FG000|Overall Study|Protocol Violation|5|||
125149726|NCT03170869|450171308|FG000|Overall Study|Early study termination|3|||
125149727|NCT00220727|450171311|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
125149728|NCT00220727|450171312|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
125149729|NCT02020967|450171313|FG000|Overall Study|Withdrawal by Subject|51|||
125149730|NCT03507686|450171314|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
125149731|NCT03507686|450171315|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
125149732|NCT03507686|450171314|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
125149733|NCT03507686|450171315|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
125149734|NCT03507686|450171314|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
125149735|NCT03507686|450171315|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
125149736|NCT03507686|450171314|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
125149737|NCT03507686|450171315|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
125149738|NCT03507686|450171314|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
125149739|NCT03507686|450171315|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
125149740|NCT03507686|450171314|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
125149741|NCT03507686|450171315|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
125223662|NCT02326272|450446171|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125223663|NCT02326272|450446172|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125149742|NCT02508116|450171316|FG000|Overall Study|Lost to Follow-up|2|||
125149743|NCT02508116|450171317|FG001|Overall Study|Lost to Follow-up|3|||
125149744|NCT02508116|450171316|FG000|Overall Study|Withdrawal by Subject|3|||
125149745|NCT02508116|450171317|FG001|Overall Study|Withdrawal by Subject|2|||
125149746|NCT02508116|450171316|FG000|Overall Study|Protocol Violation|1|||
125149747|NCT02508116|450171317|FG001|Overall Study|Protocol Violation|2|||
125149748|NCT02508116|450171316|FG000|Overall Study|Physician Decision|2|||
125149749|NCT02508116|450171317|FG001|Overall Study|Physician Decision|0|||
125149750|NCT00983528|450171320|FG000|Overall Study|Death|4|||
125149751|NCT00983528|450171320|FG000|Overall Study|Lost to Follow-up|1|||
125149752|NCT00983528|450171320|FG000|Overall Study|Study Terminated|1|||
125149753|NCT00575380|450171321|FG000|Overall Study|Withdrawal by Subject|1|||
125149754|NCT00575380|450171322|FG001|Overall Study|Withdrawal by Subject|0|||
125149755|NCT00575380|450171321|FG000|Overall Study|Adverse Event|0|||
125149756|NCT00575380|450171322|FG001|Overall Study|Adverse Event|1|||
125149757|NCT00575380|450171321|FG000|Overall Study|Various|0|||
125149758|NCT00575380|450171322|FG001|Overall Study|Various|2|||
125149759|NCT00559364|450171323|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
125149760|NCT00559364|450171324|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
125149761|NCT00330460|450171331|FG000|Overall Study|Physician Decision|1|||
125149762|NCT00330460|450171332|FG001|Overall Study|Physician Decision|0|||
125149763|NCT00330460|450171331|FG000|Overall Study|Adverse Event|10|||
125149764|NCT00330460|450171332|FG001|Overall Study|Adverse Event|8|||
125149765|NCT00330460|450171331|FG000|Overall Study|Withdrawal by Subject|18|||
125149766|NCT00330460|450171332|FG001|Overall Study|Withdrawal by Subject|17|||
125149767|NCT00330460|450171331|FG000|Overall Study|Death|1|||
125149768|NCT00330460|450171332|FG001|Overall Study|Death|1|||
125149769|NCT00330460|450171331|FG000|Overall Study|Ineligibility determined|1|||
125149770|NCT00330460|450171332|FG001|Overall Study|Ineligibility determined|3|||
125149771|NCT00330460|450171331|FG000|Overall Study|Lost to Follow-up|8|||
125149772|NCT00330460|450171332|FG001|Overall Study|Lost to Follow-up|3|||
125149773|NCT00330460|450171331|FG000|Overall Study|Noncompliance|2|||
125149774|NCT00330460|450171332|FG001|Overall Study|Noncompliance|1|||
125149775|NCT00330460|450171331|FG000|Overall Study|Other|1|||
125149776|NCT00330460|450171332|FG001|Overall Study|Other|0|||
125149777|NCT02663882|450171333|FG000|Overall Study|Lost to Follow-up|4|||
125149778|NCT02663882|450171334|FG001|Overall Study|Lost to Follow-up|2|||
125149779|NCT00388037|450171335|FG000|Overall Study|Protocol Violation|1|||
125149780|NCT02539368|450171342|FG000|Overall Study|Death|4|||
125149781|NCT02539368|450171343|FG001|Overall Study|Death|2|||
125149782|NCT02539368|450171344|FG002|Overall Study|Death|1|||
125149783|NCT02539368|450171345|FG003|Overall Study|Death|0|||
125149784|NCT02539368|450171346|FG004|Overall Study|Death|0|||
125149785|NCT02539368|450171342|FG000|Overall Study|Withdrawal by Subject|44|||
125149786|NCT02539368|450171343|FG001|Overall Study|Withdrawal by Subject|35|||
125149787|NCT02539368|450171344|FG002|Overall Study|Withdrawal by Subject|9|||
125149788|NCT02539368|450171345|FG003|Overall Study|Withdrawal by Subject|1|||
125149789|NCT02539368|450171346|FG004|Overall Study|Withdrawal by Subject|3|||
125149790|NCT02539368|450171342|FG000|Overall Study|Physician Decision|49|||
125149791|NCT02539368|450171343|FG001|Overall Study|Physician Decision|15|||
125149792|NCT02539368|450171344|FG002|Overall Study|Physician Decision|7|||
125149793|NCT02539368|450171345|FG003|Overall Study|Physician Decision|0|||
125149794|NCT02539368|450171346|FG004|Overall Study|Physician Decision|2|||
125149795|NCT02539368|450171342|FG000|Overall Study|Lost to Follow-up|96|||
125149796|NCT02539368|450171343|FG001|Overall Study|Lost to Follow-up|21|||
125149797|NCT02539368|450171344|FG002|Overall Study|Lost to Follow-up|16|||
125149798|NCT02539368|450171345|FG003|Overall Study|Lost to Follow-up|4|||
125149799|NCT02539368|450171346|FG004|Overall Study|Lost to Follow-up|3|||
125149800|NCT02539368|450171342|FG000|Overall Study|Adverse Event|44|||
125149801|NCT02539368|450171343|FG001|Overall Study|Adverse Event|5|||
125149802|NCT02539368|450171344|FG002|Overall Study|Adverse Event|9|||
125149803|NCT02539368|450171345|FG003|Overall Study|Adverse Event|0|||
125149804|NCT02539368|450171346|FG004|Overall Study|Adverse Event|3|||
125149805|NCT02539368|450171342|FG000|Overall Study|Participant Non-compliant|13|||
125149806|NCT02539368|450171343|FG001|Overall Study|Participant Non-compliant|2|||
125149807|NCT02539368|450171344|FG002|Overall Study|Participant Non-compliant|1|||
125149808|NCT02539368|450171345|FG003|Overall Study|Participant Non-compliant|1|||
125149809|NCT02539368|450171346|FG004|Overall Study|Participant Non-compliant|0|||
125149810|NCT02539368|450171342|FG000|Overall Study|Other|145|||
125149811|NCT02539368|450171343|FG001|Overall Study|Other|18|||
125149812|NCT02539368|450171344|FG002|Overall Study|Other|24|||
125149813|NCT02539368|450171345|FG003|Overall Study|Other|1|||
125149814|NCT02539368|450171346|FG004|Overall Study|Other|3|||
125149815|NCT02539368|450171342|FG000|Overall Study|Missing|10|||
125149816|NCT02539368|450171343|FG001|Overall Study|Missing|3|||
125149817|NCT02539368|450171344|FG002|Overall Study|Missing|0|||
125149818|NCT02539368|450171345|FG003|Overall Study|Missing|0|||
125149819|NCT02539368|450171346|FG004|Overall Study|Missing|0|||
125149820|NCT00869440|450171347|FG000|Overall Study|Withdrawal by Subject|1|||
125149821|NCT00869440|450171348|FG001|Overall Study|Withdrawal by Subject|0|||
125149822|NCT00869440|450171349|FG002|Overall Study|Withdrawal by Subject|0|||
125149823|NCT00869440|450171350|FG003|Overall Study|Withdrawal by Subject|0|||
125149824|NCT00869440|450171347|FG000|Overall Study|Physician Decision|1|||
125149825|NCT00869440|450171348|FG001|Overall Study|Physician Decision|1|||
125149826|NCT00869440|450171349|FG002|Overall Study|Physician Decision|0|||
125149827|NCT00869440|450171350|FG003|Overall Study|Physician Decision|0|||
125149828|NCT03558139|450171353|FG000|Overall Study|Consent Withdrawn|1|||
125149829|NCT03558139|450171354|FG001|Overall Study|Consent Withdrawn|1|||
125149830|NCT03558139|450171355|FG002|Overall Study|Consent Withdrawn|4|||
125149831|NCT03558139|450171353|FG000|Overall Study|Death|5|||
125149832|NCT03558139|450171354|FG001|Overall Study|Death|3|||
125149833|NCT03558139|450171355|FG002|Overall Study|Death|8|||
125149834|NCT03558139|450171353|FG000|Overall Study|Lost to Follow-up|0|||
125149835|NCT03558139|450171354|FG001|Overall Study|Lost to Follow-up|0|||
125149836|NCT03558139|450171355|FG002|Overall Study|Lost to Follow-up|3|||
125149837|NCT03558139|450171353|FG000|Overall Study|Study Ended Per Protocol|0|||
125149838|NCT03558139|450171354|FG001|Overall Study|Study Ended Per Protocol|3|||
125149839|NCT03558139|450171355|FG002|Overall Study|Study Ended Per Protocol|6|||
125149840|NCT02752802|450171356|FG000|Overall Study|Contrast Volume Not Collected|1|||
125149841|NCT02752802|450171357|FG001|Overall Study|Contrast Volume Not Collected|0|||
125149842|NCT02808819|450171358|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
125149843|NCT02808819|450171359|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
125149844|NCT02808819|450171358|FG000|Overall Study|Withdrawal by Subject|10|||
125149845|NCT02808819|450171359|FG001|Overall Study|Withdrawal by Subject|13|||
125149846|NCT02808819|450171358|FG000|Overall Study|Site terminated by sponsor|2|||
125149847|NCT02808819|450171359|FG001|Overall Study|Site terminated by sponsor|0|||
125149848|NCT02808819|450171358|FG000|Overall Study|Pregnancy|1|||
125149849|NCT02808819|450171359|FG001|Overall Study|Pregnancy|0|||
125149850|NCT02808819|450171358|FG000|Overall Study|Lost to Follow-up|1|||
125149851|NCT02808819|450171359|FG001|Overall Study|Lost to Follow-up|6|||
125149852|NCT02808819|450171358|FG000|Overall Study|Protocol Violation|0|||
125149853|NCT02808819|450171359|FG001|Overall Study|Protocol Violation|1|||
125149854|NCT02808819|450171358|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
125149855|NCT02808819|450171359|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
125149856|NCT02808819|450171358|FG000|Overall Study|Death|1|||
125149857|NCT02808819|450171359|FG001|Overall Study|Death|0|||
125149858|NCT02808819|450171358|FG000|Overall Study|Adverse Event|3|||
125149859|NCT02808819|450171359|FG001|Overall Study|Adverse Event|4|||
125149860|NCT03573817|450171360|FG000|Overall Study|Adverse Event|0|||
125149861|NCT03573817|450171361|FG001|Overall Study|Adverse Event|2|||
125149862|NCT03573817|450171360|FG000|Overall Study|Protocol Violation|0|||
125149863|NCT03573817|450171361|FG001|Overall Study|Protocol Violation|1|||
125149864|NCT03573817|450171360|FG000|Overall Study|Withdrawal by Subject|1|||
125149865|NCT03573817|450171361|FG001|Overall Study|Withdrawal by Subject|1|||
125149866|NCT02013531|450171362|FG000|Overall Study|Lost to Follow-up|3|||
125149867|NCT02013531|450171362|FG000|Overall Study|Met Withdrawal Criteria|1|||
125149868|NCT02013531|450171362|FG000|Overall Study|Withdrawal by Subject|1|||
125149869|NCT03546647|450171363|FG000|Overall Study|Adverse Event|1|||
125149870|NCT03546647|450171364|FG001|Overall Study|Adverse Event|0|||
125149871|NCT02400476|450171365|FG000|Overall Study|Adverse Event|57|||
125149872|NCT02400476|450171366|FG001|Overall Study|Adverse Event|10|||
125149873|NCT02400476|450171367|FG002|Overall Study|Adverse Event|22|||
125149874|NCT02400476|450171368|FG003|Overall Study|Adverse Event|19|||
125149875|NCT02400476|450171369|FG004|Overall Study|Adverse Event|5|||
125149876|NCT02400476|450171370|FG005|Overall Study|Adverse Event|8|||
125149877|NCT02400476|450171365|FG000|Overall Study|Withdrawal by Subject|4|||
125149878|NCT02400476|450171366|FG001|Overall Study|Withdrawal by Subject|1|||
125149879|NCT02400476|450171367|FG002|Overall Study|Withdrawal by Subject|12|||
125149880|NCT02400476|450171368|FG003|Overall Study|Withdrawal by Subject|7|||
125149881|NCT02400476|450171369|FG004|Overall Study|Withdrawal by Subject|5|||
125149882|NCT02400476|450171370|FG005|Overall Study|Withdrawal by Subject|5|||
125149883|NCT02400476|450171365|FG000|Overall Study|Lost to Follow-up|0|||
125149884|NCT02400476|450171366|FG001|Overall Study|Lost to Follow-up|0|||
125149885|NCT02400476|450171367|FG002|Overall Study|Lost to Follow-up|0|||
125149886|NCT02400476|450171368|FG003|Overall Study|Lost to Follow-up|1|||
125149887|NCT02400476|450171369|FG004|Overall Study|Lost to Follow-up|3|||
125149888|NCT02400476|450171370|FG005|Overall Study|Lost to Follow-up|1|||
125149889|NCT02400476|450171365|FG000|Overall Study|Physician Decision|0|||
125149890|NCT02400476|450171366|FG001|Overall Study|Physician Decision|0|||
125149891|NCT02400476|450171367|FG002|Overall Study|Physician Decision|1|||
125149892|NCT02400476|450171368|FG003|Overall Study|Physician Decision|1|||
125149893|NCT02400476|450171369|FG004|Overall Study|Physician Decision|0|||
125149894|NCT02400476|450171370|FG005|Overall Study|Physician Decision|1|||
125149895|NCT02400476|450171365|FG000|Overall Study|Other, Disease Progression|0|||
125149896|NCT02400476|450171366|FG001|Overall Study|Other, Disease Progression|1|||
125149897|NCT02400476|450171367|FG002|Overall Study|Other, Disease Progression|2|||
125149898|NCT02400476|450171368|FG003|Overall Study|Other, Disease Progression|1|||
125149899|NCT02400476|450171369|FG004|Overall Study|Other, Disease Progression|2|||
125149900|NCT02400476|450171370|FG005|Overall Study|Other, Disease Progression|1|||
125149901|NCT02400476|450171365|FG000|Overall Study|Other, Decreased Quality of Life|0|||
125149902|NCT02400476|450171366|FG001|Overall Study|Other, Decreased Quality of Life|0|||
125149903|NCT02400476|450171367|FG002|Overall Study|Other, Decreased Quality of Life|2|||
125149904|NCT02400476|450171368|FG003|Overall Study|Other, Decreased Quality of Life|0|||
125149905|NCT02400476|450171369|FG004|Overall Study|Other, Decreased Quality of Life|0|||
125149906|NCT02400476|450171370|FG005|Overall Study|Other, Decreased Quality of Life|0|||
125149907|NCT02400476|450171365|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
125149908|NCT02400476|450171366|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
125149909|NCT02400476|450171367|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
125149910|NCT02400476|450171368|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
125149911|NCT02400476|450171369|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
125149912|NCT02400476|450171370|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
125149913|NCT00588731|450171373|FG000|Overall Study|Withdrawal by Subject|3|||
125149914|NCT00588731|450171374|FG001|Overall Study|Withdrawal by Subject|2|||
125149915|NCT00612677|450171377|FG000|Overall Study|study closed before treatment started|1|||
125149916|NCT00613730|450171380|FG000|Overall Study|Disease progression|2|||
125149917|NCT00613730|450171380|FG000|Overall Study|Administrative decision|1|||
125149918|NCT02056652|450171383|FG000|Overall Study|Withdrawal by Subject|1|||
125149919|NCT02056652|450171384|FG001|Overall Study|Withdrawal by Subject|0|||
125149920|NCT02056652|450171383|FG000|Overall Study|Lost to Follow-up|0|||
125149921|NCT02056652|450171384|FG001|Overall Study|Lost to Follow-up|3|||
125149922|NCT02093923|450171385|FG000|Overall Study|Lost to Follow-up|0|||
125223664|NCT02326272|450446173|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125149923|NCT02093923|450171386|FG001|Overall Study|Lost to Follow-up|0|||
125149924|NCT02093923|450171387|FG002|Overall Study|Lost to Follow-up|0|||
125149925|NCT02093923|450171388|FG003|Overall Study|Lost to Follow-up|1|||
125149926|NCT02093923|450171389|FG004|Overall Study|Lost to Follow-up|0|||
125149927|NCT02093923|450171385|FG000|Overall Study|Screen failure after randomization|0|||
125149928|NCT02093923|450171386|FG001|Overall Study|Screen failure after randomization|0|||
125149929|NCT02093923|450171387|FG002|Overall Study|Screen failure after randomization|0|||
125149930|NCT02093923|450171388|FG003|Overall Study|Screen failure after randomization|1|||
125149931|NCT02093923|450171389|FG004|Overall Study|Screen failure after randomization|0|||
125149932|NCT03253094|450171390|FG000|Overall Study|Adverse Event|2|||
125149933|NCT03253094|450171391|FG001|Overall Study|Adverse Event|0|||
125149934|NCT03253094|450171392|FG002|Overall Study|Adverse Event|0|||
125149935|NCT03253094|450171393|FG003|Overall Study|Adverse Event|0|||
125149936|NCT03253094|450171394|FG004|Overall Study|Adverse Event|0|||
125149937|NCT03253094|450171395|FG005|Overall Study|Adverse Event|0|||
125149938|NCT03253094|450171390|FG000|Overall Study|Lack of Efficacy|0|||
125149939|NCT03253094|450171391|FG001|Overall Study|Lack of Efficacy|0|||
125149940|NCT03253094|450171392|FG002|Overall Study|Lack of Efficacy|2|||
125149941|NCT03253094|450171393|FG003|Overall Study|Lack of Efficacy|1|||
125149942|NCT03253094|450171394|FG004|Overall Study|Lack of Efficacy|2|||
125149943|NCT03253094|450171395|FG005|Overall Study|Lack of Efficacy|1|||
125149944|NCT03253094|450171390|FG000|Overall Study|Lost to Follow-up|0|||
125149945|NCT03253094|450171391|FG001|Overall Study|Lost to Follow-up|0|||
125149946|NCT03253094|450171392|FG002|Overall Study|Lost to Follow-up|1|||
125149947|NCT03253094|450171393|FG003|Overall Study|Lost to Follow-up|1|||
125149948|NCT03253094|450171394|FG004|Overall Study|Lost to Follow-up|0|||
125149949|NCT03253094|450171395|FG005|Overall Study|Lost to Follow-up|1|||
125149950|NCT03253094|450171390|FG000|Overall Study|Physician Decision|1|||
125149951|NCT03253094|450171391|FG001|Overall Study|Physician Decision|0|||
125149952|NCT03253094|450171392|FG002|Overall Study|Physician Decision|0|||
125149953|NCT03253094|450171393|FG003|Overall Study|Physician Decision|1|||
125149954|NCT03253094|450171394|FG004|Overall Study|Physician Decision|0|||
125149955|NCT03253094|450171395|FG005|Overall Study|Physician Decision|2|||
125149956|NCT03253094|450171390|FG000|Overall Study|Withdrawal by Subject|1|||
125149957|NCT03253094|450171391|FG001|Overall Study|Withdrawal by Subject|2|||
125149958|NCT03253094|450171392|FG002|Overall Study|Withdrawal by Subject|1|||
125149959|NCT03253094|450171393|FG003|Overall Study|Withdrawal by Subject|0|||
125149960|NCT03253094|450171394|FG004|Overall Study|Withdrawal by Subject|3|||
125149961|NCT03253094|450171395|FG005|Overall Study|Withdrawal by Subject|0|||
125149962|NCT03253094|450171390|FG000|Overall Study|Other|0|||
125149963|NCT03253094|450171391|FG001|Overall Study|Other|1|||
125149964|NCT03253094|450171392|FG002|Overall Study|Other|2|||
125149965|NCT03253094|450171393|FG003|Overall Study|Other|1|||
125149966|NCT03253094|450171394|FG004|Overall Study|Other|0|||
125149967|NCT03253094|450171395|FG005|Overall Study|Other|0|||
125149968|NCT00248170|450171396|FG000|Overall Study|Withdrawal by Subject|71|||
125149969|NCT00248170|450171397|FG001|Overall Study|Withdrawal by Subject|79|||
125149970|NCT00248170|450171396|FG000|Overall Study|Protocol Violation|35|||
125149971|NCT00248170|450171397|FG001|Overall Study|Protocol Violation|30|||
125149972|NCT00248170|450171396|FG000|Overall Study|Lost to Follow-up|28|||
125149973|NCT00248170|450171397|FG001|Overall Study|Lost to Follow-up|35|||
125149974|NCT00248170|450171396|FG000|Overall Study|Disease progression|196|||
125149975|NCT00248170|450171397|FG001|Overall Study|Disease progression|216|||
125149976|NCT00248170|450171396|FG000|Overall Study|Death|28|||
125149977|NCT00248170|450171397|FG001|Overall Study|Death|47|||
125149978|NCT00248170|450171396|FG000|Overall Study|Adverse Event|311|||
125149979|NCT00248170|450171397|FG001|Overall Study|Adverse Event|296|||
125149980|NCT00248170|450171396|FG000|Overall Study|Administrative problems|22|||
125149981|NCT00248170|450171397|FG001|Overall Study|Administrative problems|25|||
125149982|NCT00248170|450171396|FG000|Overall Study|Abnormal test procedure(s) result|49|||
125149983|NCT00248170|450171397|FG001|Overall Study|Abnormal test procedure(s) result|61|||
125149984|NCT00248170|450171396|FG000|Overall Study|Abnormal laboratory values|4|||
125149985|NCT00248170|450171397|FG001|Overall Study|Abnormal laboratory values|0|||
125149986|NCT00248170|450171396|FG000|Overall Study|Protocol deviation|17|||
125149987|NCT00248170|450171397|FG001|Overall Study|Protocol deviation|19|||
125149988|NCT01557582|450171398|FG000|Overall Study|Protocol Violation|4|||
125149989|NCT01557582|450171398|FG000|Overall Study|Operator error|2|||
125149990|NCT02843659|450171402|FG000|Overall Study|Subject Withdrew Consent|0|||
125149991|NCT02843659|450171403|FG001|Overall Study|Subject Withdrew Consent|0|||
125149992|NCT02843659|450171404|FG002|Overall Study|Subject Withdrew Consent|1|||
125149993|NCT02843659|450171402|FG000|Overall Study|Administrative Reason by Sponsor|4|||
125149994|NCT02843659|450171403|FG001|Overall Study|Administrative Reason by Sponsor|5|||
125149995|NCT02843659|450171404|FG002|Overall Study|Administrative Reason by Sponsor|4|||
125149996|NCT02843659|450171402|FG000|Overall Study|Adverse Event|0|||
125149997|NCT02843659|450171403|FG001|Overall Study|Adverse Event|1|||
125149998|NCT02843659|450171404|FG002|Overall Study|Adverse Event|0|||
125149999|NCT02413294|450171405|FG000|Overall Study|Withdrawal by Subject|1|||
125150000|NCT01253317|450171415|FG000|Overall Study|Adverse Event|2|||
125150001|NCT02012452|450174648|FG000|Overall Study|Lost to Follow-up|2|||
125150002|NCT02012452|450174649|FG001|Overall Study|Lost to Follow-up|1|||
125150003|NCT02012452|450174648|FG000|Overall Study|Withdrawal by Subject|4|||
125150004|NCT02012452|450174649|FG001|Overall Study|Withdrawal by Subject|0|||
125150005|NCT02688387|450174650|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150006|NCT02688387|450174651|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150007|NCT02688387|450174652|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
125150008|NCT02688387|450174653|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150009|NCT02688387|450174654|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150010|NCT02688387|450174655|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150011|NCT02688387|450174656|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150012|NCT02688387|450174657|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150013|NCT02688387|450174658|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150014|NCT02688387|450174659|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150015|NCT02688387|450174660|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150016|NCT02688387|450174661|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150017|NCT02688387|450174662|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150018|NCT02688387|450174663|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150019|NCT02688387|450174664|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150020|NCT02688387|450174665|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150021|NCT02688387|450174666|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150022|NCT02688387|450174667|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150023|NCT02688387|450174668|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150024|NCT02688387|450174669|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150025|NCT02688387|450174670|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150026|NCT02688387|450174671|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150027|NCT02688387|450174650|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150028|NCT02688387|450174651|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150029|NCT02688387|450174652|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150030|NCT02688387|450174653|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
125150031|NCT02688387|450174654|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150032|NCT02688387|450174655|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150033|NCT02688387|450174656|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150034|NCT02688387|450174657|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150035|NCT02688387|450174658|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150036|NCT02688387|450174659|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150037|NCT02688387|450174660|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150038|NCT02688387|450174661|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150039|NCT02688387|450174662|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150040|NCT02688387|450174663|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150041|NCT02688387|450174664|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150042|NCT02688387|450174665|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150043|NCT02688387|450174666|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150044|NCT02688387|450174667|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150045|NCT02688387|450174668|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150046|NCT02688387|450174669|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150047|NCT02688387|450174670|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150048|NCT02688387|450174671|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150049|NCT02688387|450174650|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150050|NCT02688387|450174651|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
125150051|NCT02688387|450174652|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150052|NCT02688387|450174653|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150053|NCT02688387|450174654|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150054|NCT02688387|450174655|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150055|NCT02688387|450174656|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150056|NCT02688387|450174657|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150057|NCT02688387|450174658|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150058|NCT02688387|450174659|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150059|NCT02688387|450174660|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150060|NCT02688387|450174661|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150061|NCT02688387|450174662|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150062|NCT02688387|450174663|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150063|NCT02688387|450174664|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150064|NCT02688387|450174665|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150065|NCT02688387|450174666|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150066|NCT02688387|450174667|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150067|NCT02688387|450174668|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150068|NCT02688387|450174669|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150069|NCT02688387|450174670|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150070|NCT02688387|450174671|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150071|NCT02688387|450174650|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150072|NCT02688387|450174651|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150073|NCT02688387|450174652|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
125150074|NCT02688387|450174653|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150075|NCT02688387|450174654|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
125150076|NCT02688387|450174655|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150077|NCT02688387|450174656|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150078|NCT02688387|450174657|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150079|NCT02688387|450174658|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150080|NCT02688387|450174659|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150081|NCT02688387|450174660|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150082|NCT02688387|450174661|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150083|NCT02688387|450174662|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150084|NCT02688387|450174663|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150085|NCT02688387|450174664|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150086|NCT02688387|450174665|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150087|NCT02688387|450174666|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150088|NCT02688387|450174667|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150089|NCT02688387|450174668|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150090|NCT02688387|450174669|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150091|NCT02688387|450174670|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150092|NCT02688387|450174671|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150093|NCT02688387|450174650|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
125150094|NCT02688387|450174651|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150095|NCT02688387|450174652|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150096|NCT02688387|450174653|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150097|NCT02688387|450174654|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150098|NCT02688387|450174655|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150099|NCT02688387|450174656|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150100|NCT02688387|450174657|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150101|NCT02688387|450174658|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150102|NCT02688387|450174659|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150103|NCT02688387|450174660|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150104|NCT02688387|450174661|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150105|NCT02688387|450174662|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150106|NCT02688387|450174663|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150107|NCT02688387|450174664|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150108|NCT02688387|450174665|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150109|NCT02688387|450174666|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150110|NCT02688387|450174667|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150111|NCT02688387|450174668|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150112|NCT02688387|450174669|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150113|NCT02688387|450174670|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150114|NCT02688387|450174671|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150115|NCT02688387|450174650|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150116|NCT02688387|450174651|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150117|NCT02688387|450174652|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150118|NCT02688387|450174653|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150119|NCT02688387|450174654|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150120|NCT02688387|450174655|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150121|NCT02688387|450174656|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150122|NCT02688387|450174657|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150123|NCT02688387|450174658|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150124|NCT02688387|450174659|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150125|NCT02688387|450174660|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
125150126|NCT02688387|450174661|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150127|NCT02688387|450174662|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150128|NCT02688387|450174663|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150129|NCT02688387|450174664|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150130|NCT02688387|450174665|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150131|NCT02688387|450174666|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150132|NCT02688387|450174667|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150133|NCT02688387|450174668|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150134|NCT02688387|450174669|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150135|NCT02688387|450174670|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150136|NCT02688387|450174671|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150137|NCT02688387|450174650|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150138|NCT02688387|450174651|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150139|NCT02688387|450174652|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150140|NCT02688387|450174653|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150141|NCT02688387|450174654|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150142|NCT02688387|450174655|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150143|NCT02688387|450174656|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150144|NCT02688387|450174657|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150145|NCT02688387|450174658|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150146|NCT02688387|450174659|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150147|NCT02688387|450174660|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150148|NCT02688387|450174661|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150149|NCT02688387|450174662|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150150|NCT02688387|450174663|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150151|NCT02688387|450174664|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
125150152|NCT02688387|450174665|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150153|NCT02688387|450174666|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150154|NCT02688387|450174667|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150155|NCT02688387|450174668|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150156|NCT02688387|450174669|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150157|NCT02688387|450174670|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150158|NCT02688387|450174671|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150159|NCT02688387|450174650|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150160|NCT02688387|450174651|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150161|NCT02688387|450174652|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150162|NCT02688387|450174653|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150163|NCT02688387|450174654|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150164|NCT02688387|450174655|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150165|NCT02688387|450174656|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150166|NCT02688387|450174657|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150167|NCT02688387|450174658|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150168|NCT02688387|450174659|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150169|NCT02688387|450174660|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150170|NCT02688387|450174661|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150171|NCT02688387|450174662|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150172|NCT02688387|450174663|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150173|NCT02688387|450174664|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150174|NCT02688387|450174665|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150175|NCT02688387|450174666|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150176|NCT02688387|450174667|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150177|NCT02688387|450174668|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150178|NCT02688387|450174669|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150179|NCT02688387|450174670|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
125150180|NCT02688387|450174671|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150181|NCT02688387|450174650|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150182|NCT02688387|450174651|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150183|NCT02688387|450174652|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150184|NCT02688387|450174653|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150185|NCT02688387|450174654|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150186|NCT02688387|450174655|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150187|NCT02688387|450174656|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150188|NCT02688387|450174657|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150189|NCT02688387|450174658|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150190|NCT02688387|450174659|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150191|NCT02688387|450174660|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150192|NCT02688387|450174661|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150193|NCT02688387|450174662|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150194|NCT02688387|450174663|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150195|NCT02688387|450174664|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150196|NCT02688387|450174665|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150197|NCT02688387|450174666|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150198|NCT02688387|450174667|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150199|NCT02688387|450174668|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
125150200|NCT02688387|450174669|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125223665|NCT02326272|450446174|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125150201|NCT02688387|450174670|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
125150202|NCT02688387|450174671|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150203|NCT02688387|450174650|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150204|NCT02688387|450174651|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150205|NCT02688387|450174652|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150206|NCT02688387|450174653|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150207|NCT02688387|450174654|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150208|NCT02688387|450174655|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150209|NCT02688387|450174656|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150210|NCT02688387|450174657|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150211|NCT02688387|450174658|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150212|NCT02688387|450174659|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150213|NCT02688387|450174660|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150214|NCT02688387|450174661|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150215|NCT02688387|450174662|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150216|NCT02688387|450174663|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150217|NCT02688387|450174664|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150218|NCT02688387|450174665|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150219|NCT02688387|450174666|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150220|NCT02688387|450174667|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150221|NCT02688387|450174668|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150222|NCT02688387|450174669|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
125150223|NCT02688387|450174670|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150224|NCT02688387|450174671|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150225|NCT04403399|450174674|FG000|Period 2|Physician Decision|0|||
125150226|NCT04403399|450174675|FG001|Period 2|Physician Decision|1|||
125150227|NCT01606228|450174676|FG000|Overall Study|Lost to Follow-up|20|||
125150228|NCT01606228|450174676|FG000|Overall Study|Withdrawal by Subject|3|||
125150229|NCT01606228|450174676|FG000|Overall Study|Non-compliant|3|||
125150230|NCT01606228|450174676|FG000|Overall Study|Lack of Efficacy|2|||
125150231|NCT01606228|450174676|FG000|Overall Study|Adverse Event|1|||
125150232|NCT00546910|450174677|FG000|Overall Study|Adverse Event|2|||
125150233|NCT00546910|450174678|FG001|Overall Study|Adverse Event|3|||
125150234|NCT00546910|450174677|FG000|Overall Study|Lack of Efficacy|5|||
125150235|NCT00546910|450174678|FG001|Overall Study|Lack of Efficacy|7|||
125150236|NCT00546910|450174677|FG000|Overall Study|Physician Decision|0|||
125150237|NCT00546910|450174678|FG001|Overall Study|Physician Decision|1|||
125150238|NCT00546910|450174677|FG000|Overall Study|Withdrawal by Subject|2|||
125150239|NCT00546910|450174678|FG001|Overall Study|Withdrawal by Subject|0|||
125150240|NCT01115855|450174679|FG000|Overall Study|Adverse Event|16|||
125150241|NCT01115855|450174680|FG001|Overall Study|Adverse Event|18|||
125150242|NCT01115855|450174679|FG000|Overall Study|Death|6|||
125150243|NCT01115855|450174680|FG001|Overall Study|Death|5|||
125150244|NCT01115855|450174679|FG000|Overall Study|Lab Abnormality|1|||
125150245|NCT01115855|450174680|FG001|Overall Study|Lab Abnormality|1|||
125150246|NCT01115855|450174679|FG000|Overall Study|Protocol Violation|0|||
125150247|NCT01115855|450174680|FG001|Overall Study|Protocol Violation|1|||
125150248|NCT01115855|450174679|FG000|Overall Study|Withdrawal by Subject|5|||
125150249|NCT01115855|450174680|FG001|Overall Study|Withdrawal by Subject|5|||
125150250|NCT01115855|450174679|FG000|Overall Study|Other|8|||
125150251|NCT01115855|450174680|FG001|Overall Study|Other|6|||
125150252|NCT00089076|450174705|FG000|Overall Study|Alternate Therapy|1|||
125150253|NCT00089076|450174705|FG000|Overall Study|Withdrawal by Subject|2|||
125150254|NCT00089076|450174705|FG000|Overall Study|Progression|7|||
125150255|NCT01009515|450174707|FG000|Overall Study|Withdrawal by Subject|3|||
125150256|NCT00983476|450174711|FG000|Overall Study|Did not receive intervention|17|||
125150257|NCT00983476|450174712|FG001|Overall Study|Did not receive intervention|22|||
125150258|NCT00983476|450174713|FG002|Overall Study|Did not receive intervention|0|||
125150259|NCT01175473|450174715|FG000|Overall Study|Adverse Event|2|||
125150260|NCT01175473|450174716|FG001|Overall Study|Adverse Event|2|||
125150261|NCT01857973|450174719|FG000|Overall Study|Subject did not meet required BG range|3|||
125150262|NCT01857973|450174719|FG000|Overall Study|drop out after 3 failed attempts|1|||
125150263|NCT01857973|450174719|FG000|Overall Study|Physician Decision|1|||
125150264|NCT01731886|450174728|FG000|Overall Study|Death|1|||
125150265|NCT01731886|450174729|FG001|Overall Study|Death|0|||
125150266|NCT01731886|450174728|FG000|Overall Study|Never started treatment|0|||
125150267|NCT01731886|450174729|FG001|Overall Study|Never started treatment|1|||
125150268|NCT01731886|450174728|FG000|Overall Study|Non-compliant|1|||
125150269|NCT01731886|450174729|FG001|Overall Study|Non-compliant|0|||
125150270|NCT00271024|450174730|FG000|Overall Study|Lost Interest|3|||
125150271|NCT00271024|450174731|FG001|Overall Study|Lost Interest|4|||
125150272|NCT00271024|450174732|FG002|Overall Study|Lost Interest|2|||
125223666|NCT02326272|450446175|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125223667|NCT02326272|450446176|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
125150273|NCT00271024|450174733|FG003|Overall Study|Lost Interest|3|||
125150274|NCT00271024|450174730|FG000|Overall Study|Unknown/Unspecified|11|||
125150275|NCT00271024|450174731|FG001|Overall Study|Unknown/Unspecified|11|||
125150276|NCT00271024|450174732|FG002|Overall Study|Unknown/Unspecified|8|||
125150277|NCT00271024|450174733|FG003|Overall Study|Unknown/Unspecified|4|||
125150278|NCT00271024|450174730|FG000|Overall Study|Protocol Violation|1|||
125150279|NCT00271024|450174731|FG001|Overall Study|Protocol Violation|6|||
125150280|NCT00271024|450174732|FG002|Overall Study|Protocol Violation|5|||
125150281|NCT00271024|450174733|FG003|Overall Study|Protocol Violation|11|||
125150282|NCT00271024|450174730|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
125150283|NCT00271024|450174731|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
125150284|NCT00271024|450174732|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
125150285|NCT00271024|450174733|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
125150286|NCT00271024|450174730|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
125150287|NCT00271024|450174731|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
125150288|NCT00271024|450174732|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
125150289|NCT00271024|450174733|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
125150290|NCT00129116|450174734|FG000|Primary Phase|Lost to Follow-up|1|||
125150291|NCT00129116|450174735|FG001|Primary Phase|Lost to Follow-up|1|||
125150292|NCT00129116|450174736|FG002|Primary Phase|Lost to Follow-up|0|||
125150293|NCT00129116|450174737|FG003|Primary Phase|Lost to Follow-up|1|||
125150294|NCT00129116|450174738|FG004|Primary Phase|Lost to Follow-up|1|||
125150295|NCT00129116|450174734|FG000|Primary Phase|Protocol Violation|0|||
125150296|NCT00129116|450174735|FG001|Primary Phase|Protocol Violation|1|||
125150297|NCT00129116|450174736|FG002|Primary Phase|Protocol Violation|0|||
125150298|NCT00129116|450174737|FG003|Primary Phase|Protocol Violation|0|||
125150299|NCT00129116|450174738|FG004|Primary Phase|Protocol Violation|0|||
125150300|NCT00129116|450174734|FG000|Primary Phase|Adverse Event|1|||
125150301|NCT00129116|450174735|FG001|Primary Phase|Adverse Event|1|||
125150302|NCT00129116|450174736|FG002|Primary Phase|Adverse Event|0|||
125150303|NCT00129116|450174737|FG003|Primary Phase|Adverse Event|0|||
125150304|NCT00129116|450174738|FG004|Primary Phase|Adverse Event|0|||
125150305|NCT00129116|450174734|FG000|Primary Phase|Withdrawal by Subject|0|||
125150306|NCT00129116|450174735|FG001|Primary Phase|Withdrawal by Subject|1|||
125150307|NCT00129116|450174736|FG002|Primary Phase|Withdrawal by Subject|0|||
125150308|NCT00129116|450174737|FG003|Primary Phase|Withdrawal by Subject|0|||
125150309|NCT00129116|450174738|FG004|Primary Phase|Withdrawal by Subject|0|||
125150310|NCT00129116|450174734|FG000|Primary Phase|Other|0|||
125150311|NCT00129116|450174735|FG001|Primary Phase|Other|0|||
125150312|NCT00129116|450174736|FG002|Primary Phase|Other|1|||
125150313|NCT00129116|450174737|FG003|Primary Phase|Other|0|||
125150314|NCT00129116|450174738|FG004|Primary Phase|Other|0|||
125150315|NCT00129116|450174734|FG000|Booster Phase|Lost to Follow-up|2|||
125150316|NCT00129116|450174735|FG001|Booster Phase|Lost to Follow-up|0|||
125150317|NCT00129116|450174736|FG002|Booster Phase|Lost to Follow-up|0|||
125150318|NCT00129116|450174737|FG003|Booster Phase|Lost to Follow-up|0|||
125150319|NCT00129116|450174738|FG004|Booster Phase|Lost to Follow-up|1|||
125150320|NCT00602537|450174739|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
125150321|NCT00602537|450174740|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
125150322|NCT00602537|450174739|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
125150323|NCT00602537|450174740|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
125150324|NCT00602537|450174739|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
125150325|NCT00602537|450174740|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
125150326|NCT00602537|450174739|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
125150327|NCT00602537|450174740|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
125150328|NCT00602537|450174739|FG000|Follow Up Study Comparison|Adverse Event|1|||
125150329|NCT00602537|450174740|FG001|Follow Up Study Comparison|Adverse Event|0|||
125150330|NCT00602537|450174739|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
125150331|NCT00602537|450174740|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
125150332|NCT00602537|450174739|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
125150333|NCT00602537|450174740|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
125150334|NCT03417830|450174743|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
125150335|NCT03417830|450174744|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
125150336|NCT00823199|450174745|FG000|Overall Study|Withdrawal by Subject|2|||
125150337|NCT00268892|450174746|FG000|Overall Study|Adverse Event|14|||
125150338|NCT00268892|450174747|FG001|Overall Study|Adverse Event|17|||
125150339|NCT00268892|450174748|FG002|Overall Study|Adverse Event|20|||
125150340|NCT00268892|450174746|FG000|Overall Study|Lack of Efficacy|1|||
125150341|NCT00268892|450174747|FG001|Overall Study|Lack of Efficacy|3|||
125150342|NCT00268892|450174748|FG002|Overall Study|Lack of Efficacy|0|||
125150343|NCT00268892|450174746|FG000|Overall Study|Withdrawal by Subject|14|||
125150344|NCT00268892|450174747|FG001|Overall Study|Withdrawal by Subject|15|||
125150345|NCT00268892|450174748|FG002|Overall Study|Withdrawal by Subject|13|||
125150346|NCT00268892|450174746|FG000|Overall Study|Physician Decision|0|||
125150347|NCT00268892|450174747|FG001|Overall Study|Physician Decision|1|||
125150348|NCT00268892|450174748|FG002|Overall Study|Physician Decision|0|||
125150349|NCT00268892|450174746|FG000|Overall Study|Lost to Follow-up|5|||
125150350|NCT00268892|450174747|FG001|Overall Study|Lost to Follow-up|2|||
125150351|NCT00268892|450174748|FG002|Overall Study|Lost to Follow-up|4|||
125150352|NCT00268892|450174746|FG000|Overall Study|Protocol Violation|0|||
125150353|NCT00268892|450174747|FG001|Overall Study|Protocol Violation|1|||
125150354|NCT00268892|450174748|FG002|Overall Study|Protocol Violation|0|||
125150355|NCT00268892|450174746|FG000|Overall Study|Disease Progression|1|||
125150356|NCT00268892|450174747|FG001|Overall Study|Disease Progression|1|||
125150357|NCT00268892|450174748|FG002|Overall Study|Disease Progression|0|||
125150358|NCT00268892|450174746|FG000|Overall Study|Trial Site Closed|4|||
125150359|NCT00268892|450174747|FG001|Overall Study|Trial Site Closed|2|||
125150360|NCT00268892|450174748|FG002|Overall Study|Trial Site Closed|2|||
125150361|NCT01640184|450174755|FG000|Overall Study|Death|1|||
125150362|NCT01640184|450174756|FG001|Overall Study|Death|0|||
125150363|NCT01640184|450174757|FG002|Overall Study|Death|0|||
125150364|NCT01640184|450174755|FG000|Overall Study|Lost to Follow-up|4|||
125150365|NCT01640184|450174756|FG001|Overall Study|Lost to Follow-up|1|||
125150366|NCT01640184|450174757|FG002|Overall Study|Lost to Follow-up|0|||
125150367|NCT01640184|450174755|FG000|Overall Study|Physician Decision|3|||
125150368|NCT01640184|450174756|FG001|Overall Study|Physician Decision|0|||
125150369|NCT01640184|450174757|FG002|Overall Study|Physician Decision|0|||
125150370|NCT01640184|450174755|FG000|Overall Study|Withdrawal by Subject|0|||
125150371|NCT01640184|450174756|FG001|Overall Study|Withdrawal by Subject|1|||
125150372|NCT01640184|450174757|FG002|Overall Study|Withdrawal by Subject|1|||
125150373|NCT01640184|450174755|FG000|Overall Study|Protocol Violation|0|||
125150374|NCT01640184|450174756|FG001|Overall Study|Protocol Violation|0|||
125150375|NCT01640184|450174757|FG002|Overall Study|Protocol Violation|1|||
125150376|NCT01684878|450174761|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
125150377|NCT01684878|450174762|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
125150378|NCT01684878|450174763|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
125150379|NCT01684878|450174764|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
125150380|NCT01684878|450174761|FG000|Part 1: Safety Run in Phase|Death|15|||
125150381|NCT01684878|450174762|FG001|Part 1: Safety Run in Phase|Death|20|||
125150382|NCT01684878|450174763|FG002|Part 1: Safety Run in Phase|Death|0|||
125150383|NCT01684878|450174764|FG003|Part 1: Safety Run in Phase|Death|0|||
125150384|NCT01684878|450174761|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
125150385|NCT01684878|450174762|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
125150386|NCT01684878|450174763|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
125150387|NCT01684878|450174764|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
125150388|NCT01684878|450174761|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
125150389|NCT01684878|450174762|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
125150390|NCT01684878|450174763|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
125150391|NCT01684878|450174764|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
125150392|NCT01684878|450174761|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
125150393|NCT01684878|450174762|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
125150394|NCT01684878|450174763|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
125150395|NCT01684878|450174764|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
125150396|NCT01684878|450174761|FG000|Part 2: Randomized Phase|Death|0|||
125223668|NCT02326272|450446177|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125223669|NCT02326272|450446178|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125223670|NCT00468585|450446182|FG000|Overall Study|Patient not treated|1|||
125223671|NCT00468585|450446183|FG001|Overall Study|Patient not treated|0|||
125223672|NCT00468585|450446184|FG002|Overall Study|Patient not treated|1|||
125223673|NCT00468585|450446185|FG003|Overall Study|Patient not treated|0|||
125223674|NCT00468585|450446182|FG000|Overall Study|Patient found to be ineligible|0|||
125223675|NCT00468585|450446183|FG001|Overall Study|Patient found to be ineligible|0|||
125223676|NCT00468585|450446184|FG002|Overall Study|Patient found to be ineligible|1|||
125223677|NCT00468585|450446185|FG003|Overall Study|Patient found to be ineligible|0|||
125223678|NCT00468585|450446182|FG000|Overall Study|Adverse Event|0|||
125223679|NCT00468585|450446183|FG001|Overall Study|Adverse Event|0|||
125223680|NCT00468585|450446184|FG002|Overall Study|Adverse Event|1|||
125223681|NCT00468585|450446185|FG003|Overall Study|Adverse Event|0|||
125223682|NCT00468585|450446182|FG000|Overall Study|Withdrawal by Subject|0|||
125223683|NCT00468585|450446183|FG001|Overall Study|Withdrawal by Subject|0|||
125223684|NCT00468585|450446184|FG002|Overall Study|Withdrawal by Subject|2|||
125223685|NCT00468585|450446185|FG003|Overall Study|Withdrawal by Subject|1|||
125223686|NCT02154139|450446186|FG000|Overall Study|Injection not administered|2|||
125223687|NCT02154139|450446186|FG000|Overall Study|Other|2|||
125223688|NCT02154139|450446186|FG000|Overall Study|Investigator transferred|3|||
125223689|NCT00809445|450446188|FG000|1 Month Follow-up|Lost contact|1|||
125223690|NCT00809445|450446189|FG001|1 Month Follow-up|Lost contact|2|||
125223691|NCT00809445|450446190|FG002|1 Month Follow-up|Lost contact|1|||
125223692|NCT00809445|450446188|FG000|1 Month Follow-up|Withdrew consent|1|||
125223693|NCT00809445|450446189|FG001|1 Month Follow-up|Withdrew consent|1|||
125223694|NCT00809445|450446190|FG002|1 Month Follow-up|Withdrew consent|1|||
125223695|NCT00809445|450446188|FG000|1 Month Follow-up|Death|0|||
125223696|NCT00809445|450446189|FG001|1 Month Follow-up|Death|1|||
125223697|NCT00809445|450446190|FG002|1 Month Follow-up|Death|1|||
125223698|NCT00809445|450446188|FG000|1 Month Follow-up|Incarcerated|0|||
125223699|NCT00809445|450446189|FG001|1 Month Follow-up|Incarcerated|0|||
125223700|NCT00809445|450446190|FG002|1 Month Follow-up|Incarcerated|1|||
125223701|NCT00809445|450446188|FG000|6 Month Follow-up|Lost contact|16|||
125223702|NCT00809445|450446189|FG001|6 Month Follow-up|Lost contact|14|||
125223703|NCT00809445|450446190|FG002|6 Month Follow-up|Lost contact|14|||
125150397|NCT01684878|450174762|FG001|Part 2: Randomized Phase|Death|0|||
125150398|NCT01684878|450174763|FG002|Part 2: Randomized Phase|Death|62|||
125150399|NCT01684878|450174764|FG003|Part 2: Randomized Phase|Death|68|||
125150400|NCT01684878|450174761|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
125223704|NCT00809445|450446188|FG000|6 Month Follow-up|Death|2|||
125223705|NCT00809445|450446189|FG001|6 Month Follow-up|Death|1|||
125223706|NCT00809445|450446190|FG002|6 Month Follow-up|Death|1|||
125223707|NCT00809445|450446188|FG000|6 Month Follow-up|Incarcerated|6|||
125150401|NCT01684878|450174762|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
125150402|NCT01684878|450174763|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
125150403|NCT01684878|450174764|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
125150404|NCT01684878|450174761|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
125150405|NCT01684878|450174762|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
125150406|NCT01684878|450174763|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
125150407|NCT01684878|450174764|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
125150408|NCT02692482|450174765|FG000|Overall Study|Death|2|||
125150409|NCT02692482|450174766|FG001|Overall Study|Death|2|||
125150410|NCT02692482|450174765|FG000|Overall Study|Withdrawal by Subject|1|||
125150411|NCT02692482|450174766|FG001|Overall Study|Withdrawal by Subject|2|||
125150412|NCT01435031|450174767|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
125150413|NCT01435031|450174767|FG000|ITT at 1 Month|Death|1|||
125150414|NCT01435031|450174767|FG000|ITT at 1 Month|Lost to Follow-up|4|||
125150415|NCT01435031|450174767|FG000|ITT at 6 Months|Death|2|||
125150416|NCT01435031|450174767|FG000|ITT at 6 Months|Lost to Follow-up|3|||
125150417|NCT01435031|450174767|FG000|ITT at 1 Year|Death|1|||
125150418|NCT01435031|450174767|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
125150419|NCT01435031|450174767|FG000|ITT at 1 Year|Lost to Follow-up|6|||
125150420|NCT01435031|450174767|FG000|ITT at 2 Years|Death|7|||
125150421|NCT01435031|450174767|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
125150422|NCT01435031|450174767|FG000|ITT at 2 Years|Lost to Follow-up|4|||
125150423|NCT01435031|450174767|FG000|ITT at 3 Years|Death|5|||
125150424|NCT01435031|450174767|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
125150425|NCT01435031|450174767|FG000|ITT at 3 Years|Lost to Follow-up|4|||
125150426|NCT01435031|450174767|FG000|ITT at 4 Years|Death|4|||
125150427|NCT01435031|450174767|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
125150428|NCT01435031|450174767|FG000|ITT at 4 Years|Lost to Follow-up|1|||
125150429|NCT02927834|450174768|FG000|Overall Study|Lost to Follow-up|1|||
125150430|NCT02927834|450174769|FG001|Overall Study|Lost to Follow-up|2|||
125150431|NCT02927834|450174770|FG002|Overall Study|Lost to Follow-up|2|||
125150432|NCT00479388|450174771|FG000|Overall Study|Adverse Event|90|||
125150433|NCT00479388|450174772|FG001|Overall Study|Adverse Event|45|||
125150434|NCT00479388|450174771|FG000|Overall Study|Lost to Follow-up|0|||
125150435|NCT00479388|450174772|FG001|Overall Study|Lost to Follow-up|2|||
125150436|NCT00479388|450174771|FG000|Overall Study|Protocol Violation|10|||
125150437|NCT00479388|450174772|FG001|Overall Study|Protocol Violation|9|||
125150438|NCT00479388|450174771|FG000|Overall Study|Withdrawal by Subject|32|||
125150439|NCT00479388|450174772|FG001|Overall Study|Withdrawal by Subject|17|||
125150440|NCT01876368|450174775|FG000|Overall Study|Adverse Event|2|||
125150441|NCT01876368|450174776|FG001|Overall Study|Adverse Event|5|||
125150442|NCT01876368|450174775|FG000|Overall Study|Lack of Efficacy|1|||
125150443|NCT01876368|450174776|FG001|Overall Study|Lack of Efficacy|0|||
125150444|NCT01876368|450174775|FG000|Overall Study|Lost to Follow-up|0|||
125150445|NCT01876368|450174776|FG001|Overall Study|Lost to Follow-up|1|||
125150446|NCT01876368|450174775|FG000|Overall Study|Non-compliance with study treatment|0|||
125150447|NCT01876368|450174776|FG001|Overall Study|Non-compliance with study treatment|1|||
125150448|NCT01876368|450174775|FG000|Overall Study|Physician Decision|0|||
125150449|NCT01876368|450174776|FG001|Overall Study|Physician Decision|2|||
125150450|NCT01876368|450174775|FG000|Overall Study|Protocol deviation|3|||
125150451|NCT01876368|450174776|FG001|Overall Study|Protocol deviation|3|||
125150452|NCT01876368|450174775|FG000|Overall Study|Subject/guardian decision|3|||
125150453|NCT01876368|450174776|FG001|Overall Study|Subject/guardian decision|1|||
125150454|NCT01955044|450174777|FG000|Overall Study|Death|1|||
125150455|NCT01955044|450174778|FG001|Overall Study|Death|1|||
125150456|NCT01955044|450174779|FG002|Overall Study|Death|0|||
125223708|NCT00809445|450446189|FG001|6 Month Follow-up|Incarcerated|8|||
125150457|NCT02260258|450174780|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
125150458|NCT02260258|450174781|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
125150459|NCT01644149|450174782|FG000|Overall Study|Withdrawal by Subject|1|||
125150460|NCT01644149|450174783|FG001|Overall Study|Withdrawal by Subject|0|||
125150461|NCT01644149|450174782|FG000|Overall Study|Lost to Follow-up|3|||
125150462|NCT01644149|450174783|FG001|Overall Study|Lost to Follow-up|1|||
125150463|NCT01610063|450174786|FG000|Overall Study|Lost to Follow-up|42|||
125150464|NCT01610063|450174787|FG001|Overall Study|Lost to Follow-up|20|||
125150465|NCT04405739|450174788|FG000|Overall Study|Adverse Event|0|||
125150466|NCT04405739|450174789|FG001|Overall Study|Adverse Event|1|||
125150467|NCT04405739|450174790|FG002|Overall Study|Adverse Event|0|||
125150468|NCT04405739|450174791|FG003|Overall Study|Adverse Event|0|||
125150469|NCT04405739|450174788|FG000|Overall Study|Lost to Follow-up|0|||
125150470|NCT04405739|450174789|FG001|Overall Study|Lost to Follow-up|2|||
125150471|NCT04405739|450174790|FG002|Overall Study|Lost to Follow-up|1|||
125150472|NCT04405739|450174791|FG003|Overall Study|Lost to Follow-up|3|||
125150473|NCT04405739|450174788|FG000|Overall Study|Withdrawal by Subject|0|||
125150474|NCT04405739|450174789|FG001|Overall Study|Withdrawal by Subject|2|||
125150475|NCT04405739|450174790|FG002|Overall Study|Withdrawal by Subject|1|||
125150476|NCT04405739|450174791|FG003|Overall Study|Withdrawal by Subject|1|||
125150477|NCT04405739|450174788|FG000|Overall Study|Death|0|||
125150478|NCT04405739|450174789|FG001|Overall Study|Death|0|||
125150479|NCT04405739|450174790|FG002|Overall Study|Death|1|||
125150480|NCT04405739|450174791|FG003|Overall Study|Death|0|||
125150481|NCT04405739|450174788|FG000|Overall Study|Transferred to rehab|0|||
125150482|NCT04405739|450174789|FG001|Overall Study|Transferred to rehab|0|||
125150483|NCT04405739|450174790|FG002|Overall Study|Transferred to rehab|0|||
125150484|NCT04405739|450174791|FG003|Overall Study|Transferred to rehab|1|||
125150485|NCT04405739|450174788|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
125150486|NCT04405739|450174789|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
125150487|NCT04405739|450174790|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
125150488|NCT04405739|450174791|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
125150489|NCT01436643|450174792|FG000|2-week Pre-treatment|Abnormal test result|0|||
125150490|NCT01436643|450174793|FG001|2-week Pre-treatment|Abnormal test result|0|||
125150491|NCT01436643|450174794|FG002|2-week Pre-treatment|Abnormal test result|0|||
125150492|NCT01436643|450174795|FG003|2-week Pre-treatment|Abnormal test result|1|||
125150493|NCT01436643|450174792|FG000|2-week Pre-treatment|Adverse Event|0|||
125150494|NCT01436643|450174793|FG001|2-week Pre-treatment|Adverse Event|0|||
125150495|NCT01436643|450174794|FG002|2-week Pre-treatment|Adverse Event|0|||
125150496|NCT01436643|450174795|FG003|2-week Pre-treatment|Adverse Event|5|||
125150497|NCT01436643|450174792|FG000|2-week Pre-treatment|Protocol Violation|0|||
125150498|NCT01436643|450174793|FG001|2-week Pre-treatment|Protocol Violation|0|||
125150499|NCT01436643|450174794|FG002|2-week Pre-treatment|Protocol Violation|0|||
125150500|NCT01436643|450174795|FG003|2-week Pre-treatment|Protocol Violation|4|||
125150501|NCT01436643|450174792|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
125150502|NCT01436643|450174793|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
125150503|NCT01436643|450174794|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
125150504|NCT01436643|450174795|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
125150505|NCT01436643|450174792|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
125150506|NCT01436643|450174793|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
125150507|NCT01436643|450174794|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
125150508|NCT01436643|450174795|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
125150509|NCT01436643|450174792|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
125150510|NCT01436643|450174793|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
125150511|NCT01436643|450174794|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
125150512|NCT01436643|450174795|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
125150513|NCT03718117|450174796|FG000|Overall Study|Death|12|||
125150514|NCT03718117|450174797|FG001|Overall Study|Death|11|||
125150515|NCT03718117|450174798|FG002|Overall Study|Death|0|||
125150516|NCT03718117|450174796|FG000|Overall Study|Other|0|||
125150517|NCT03718117|450174797|FG001|Overall Study|Other|1|||
125150518|NCT03718117|450174798|FG002|Overall Study|Other|0|||
125150519|NCT03718117|450174796|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
125150520|NCT03718117|450174797|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
125150521|NCT03718117|450174798|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
125150522|NCT03718117|450174796|FG000|Overall Study|Participant not met eligibility criteria|0|||
125150523|NCT03718117|450174797|FG001|Overall Study|Participant not met eligibility criteria|0|||
125150524|NCT03718117|450174798|FG002|Overall Study|Participant not met eligibility criteria|2|||
125150525|NCT03069417|450174799|FG000|Overall Study|Lost to Follow-up|2|||
125150526|NCT03069417|450174800|FG001|Overall Study|Lost to Follow-up|0|||
125150527|NCT03069417|450174799|FG000|Overall Study|Reason Unknown|4|||
125150528|NCT03069417|450174800|FG001|Overall Study|Reason Unknown|7|||
125150529|NCT01867606|450174801|FG000|Overall Study|Withdrawal by Subject|10|||
125150530|NCT01867606|450174802|FG001|Overall Study|Withdrawal by Subject|14|||
125150531|NCT01867606|450174801|FG000|Overall Study|Protocol Violation|0|||
125150532|NCT01867606|450174802|FG001|Overall Study|Protocol Violation|1|||
125150533|NCT00402025|450174808|FG000|Overall Study|Adverse Event|0|||
125150534|NCT00402025|450174809|FG001|Overall Study|Adverse Event|0|||
125150535|NCT00402025|450174810|FG002|Overall Study|Adverse Event|2|||
125150536|NCT00402025|450174808|FG000|Overall Study|Death|0|||
125150537|NCT00402025|450174809|FG001|Overall Study|Death|1|||
125150538|NCT00402025|450174810|FG002|Overall Study|Death|5|||
125150539|NCT00402025|450174808|FG000|Overall Study|Disease Progression|1|||
125150540|NCT00402025|450174809|FG001|Overall Study|Disease Progression|1|||
125150541|NCT00402025|450174810|FG002|Overall Study|Disease Progression|2|||
125150542|NCT00402025|450174808|FG000|Overall Study|Physician Decision|1|||
125150543|NCT00402025|450174809|FG001|Overall Study|Physician Decision|1|||
125150544|NCT00402025|450174810|FG002|Overall Study|Physician Decision|0|||
125150545|NCT00402025|450174808|FG000|Overall Study|Participant Decision|0|||
125150546|NCT00402025|450174809|FG001|Overall Study|Participant Decision|0|||
125150547|NCT00402025|450174810|FG002|Overall Study|Participant Decision|1|||
125150548|NCT03234608|450174816|FG000|Overall Study|Lost to Follow-up|23|||
125150549|NCT03234608|450174817|FG001|Overall Study|Lost to Follow-up|21|||
125150550|NCT02105701|450174818|FG000|Overall Study|Lost to Follow-up|1|||
125150551|NCT02105701|450174819|FG001|Overall Study|Lost to Follow-up|0|||
125150552|NCT02105701|450174820|FG002|Overall Study|Lost to Follow-up|2|||
125150553|NCT02105701|450174821|FG003|Overall Study|Lost to Follow-up|1|||
125150554|NCT02105701|450174818|FG000|Overall Study|Protocol Violation|0|||
125150555|NCT02105701|450174819|FG001|Overall Study|Protocol Violation|0|||
125150556|NCT02105701|450174820|FG002|Overall Study|Protocol Violation|1|||
125150557|NCT02105701|450174821|FG003|Overall Study|Protocol Violation|0|||
125150558|NCT02105701|450174818|FG000|Overall Study|Withdrawal by Subject|2|||
125150559|NCT02105701|450174819|FG001|Overall Study|Withdrawal by Subject|1|||
125150560|NCT02105701|450174820|FG002|Overall Study|Withdrawal by Subject|0|||
125150561|NCT02105701|450174821|FG003|Overall Study|Withdrawal by Subject|1|||
125150562|NCT02105701|450174818|FG000|Overall Study|Death|1|||
125150563|NCT02105701|450174819|FG001|Overall Study|Death|0|||
125150564|NCT02105701|450174820|FG002|Overall Study|Death|0|||
125150565|NCT02105701|450174821|FG003|Overall Study|Death|0|||
125150566|NCT02148445|450174822|FG000|Overall Study|Death|1|||
125150567|NCT02148445|450174823|FG001|Overall Study|Death|3|||
125150568|NCT03450629|450174824|FG000|Overall Study|Adverse Event|15|||
125150569|NCT03450629|450174825|FG001|Overall Study|Adverse Event|14|||
125150570|NCT03450629|450174824|FG000|Overall Study|Physician Decision|2|||
125150571|NCT03450629|450174825|FG001|Overall Study|Physician Decision|2|||
125150572|NCT03450629|450174824|FG000|Overall Study|Lack of Efficacy|2|||
125150573|NCT03450629|450174825|FG001|Overall Study|Lack of Efficacy|0|||
125150574|NCT03450629|450174824|FG000|Overall Study|Lost to Follow-up|4|||
125150575|NCT03450629|450174825|FG001|Overall Study|Lost to Follow-up|2|||
125150576|NCT03450629|450174824|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
125150577|NCT03450629|450174825|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
125150578|NCT03450629|450174824|FG000|Overall Study|Non-Compliance With Study Drug|2|||
125150579|NCT03450629|450174825|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125150580|NCT03450629|450174824|FG000|Overall Study|Protocol Violation|11|||
125150581|NCT03450629|450174825|FG001|Overall Study|Protocol Violation|8|||
125150582|NCT03450629|450174824|FG000|Overall Study|Withdrawal by Subject|12|||
125150583|NCT03450629|450174825|FG001|Overall Study|Withdrawal by Subject|6|||
125150584|NCT04230876|450174827|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
125150585|NCT04230876|450174828|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
125150586|NCT00739973|450174829|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
125150587|NCT00739973|450174830|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
125150588|NCT00739973|450174831|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
125150589|NCT00739973|450174832|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
125150590|NCT00739973|450174833|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
125150591|NCT00739973|450174834|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
125150592|NCT00739973|450174835|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
125150593|NCT00739973|450174836|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
125150594|NCT00739973|450174837|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
125150595|NCT00739973|450174829|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
125150596|NCT00739973|450174830|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
125150597|NCT00739973|450174831|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
125150598|NCT00739973|450174832|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
125150599|NCT00739973|450174833|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
125150600|NCT00739973|450174834|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
125150601|NCT00739973|450174835|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
125150602|NCT00739973|450174836|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
125150603|NCT00739973|450174837|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
125150604|NCT00739973|450174829|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
125150605|NCT00739973|450174830|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
125150606|NCT00739973|450174831|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
125150607|NCT00739973|450174832|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
125150608|NCT00739973|450174833|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
125150609|NCT00739973|450174834|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
125150610|NCT00739973|450174835|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
125150611|NCT00739973|450174836|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
125150612|NCT00739973|450174837|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
125150613|NCT00739973|450174829|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
125150614|NCT00739973|450174830|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
125150615|NCT00739973|450174831|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
125150616|NCT00739973|450174832|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
125150617|NCT00739973|450174833|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
125150618|NCT00739973|450174834|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
125150619|NCT00739973|450174835|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
125150620|NCT00739973|450174836|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
125150621|NCT00739973|450174837|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
125150622|NCT00739973|450174829|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
125150623|NCT00739973|450174830|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
125150624|NCT00739973|450174831|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
125150625|NCT00739973|450174832|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
125150626|NCT00739973|450174833|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
125150627|NCT00739973|450174834|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
125150628|NCT00739973|450174835|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
125150629|NCT00739973|450174836|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
125150630|NCT00739973|450174837|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
125150631|NCT00739973|450174829|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
125150632|NCT00739973|450174830|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
125150633|NCT00739973|450174831|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
125150634|NCT00739973|450174832|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
125150635|NCT00739973|450174833|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
125150636|NCT00739973|450174834|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
125223709|NCT00809445|450446190|FG002|6 Month Follow-up|Incarcerated|8|||
125223710|NCT00809445|450446188|FG000|6 Month Follow-up|Withdrew consent|0|||
125223711|NCT00809445|450446189|FG001|6 Month Follow-up|Withdrew consent|0|||
125223712|NCT00809445|450446190|FG002|6 Month Follow-up|Withdrew consent|1|||
125223713|NCT00676403|450446191|FG000|Overall Study|Adverse Event|1|||
125150637|NCT00739973|450174835|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
125150638|NCT00739973|450174836|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
125150639|NCT00739973|450174837|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
125150640|NCT00739973|450174829|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
125150641|NCT00739973|450174830|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
125150642|NCT00739973|450174831|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
125150643|NCT00739973|450174832|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
125150644|NCT00739973|450174833|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
125150645|NCT00739973|450174834|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
125150646|NCT00739973|450174835|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
125150647|NCT00739973|450174836|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
125150648|NCT00739973|450174837|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
125150649|NCT00739973|450174829|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
125150650|NCT00739973|450174830|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
125150651|NCT00739973|450174831|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
125150652|NCT00739973|450174832|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
125150653|NCT00739973|450174833|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
125223714|NCT00676403|450446192|FG001|Overall Study|Adverse Event|2|||
125223715|NCT00676403|450446193|FG002|Overall Study|Adverse Event|0|||
125150654|NCT00739973|450174834|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
125150655|NCT00739973|450174835|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
125150656|NCT00739973|450174836|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
125150657|NCT00739973|450174837|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
125150658|NCT00739973|450174829|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
125150659|NCT00739973|450174830|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
125150660|NCT00739973|450174831|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
125150661|NCT00739973|450174832|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
125150662|NCT00739973|450174833|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
125150663|NCT00739973|450174834|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
125150664|NCT00739973|450174835|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
125150665|NCT00739973|450174836|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
125150666|NCT00739973|450174837|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
125150667|NCT00739973|450174829|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
125150668|NCT00739973|450174830|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
125150669|NCT00739973|450174831|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
125150670|NCT00739973|450174832|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
125150671|NCT00739973|450174833|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
125150672|NCT00739973|450174834|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
125150673|NCT00739973|450174835|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
125150674|NCT00739973|450174836|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
125150675|NCT00739973|450174837|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
125150676|NCT00739973|450174829|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
125150677|NCT00739973|450174830|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
125150678|NCT00739973|450174831|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
125150679|NCT00739973|450174832|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
125150680|NCT00739973|450174833|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
125150681|NCT00739973|450174834|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
125150682|NCT00739973|450174835|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
125150683|NCT00739973|450174836|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
125150684|NCT00739973|450174837|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
125150685|NCT00739973|450174829|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
125150686|NCT00739973|450174830|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
125150687|NCT00739973|450174831|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
125150688|NCT00739973|450174832|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
125150689|NCT00739973|450174833|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
125150690|NCT00739973|450174834|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
125150691|NCT00739973|450174835|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
125150692|NCT00739973|450174836|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
125150693|NCT00739973|450174837|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
125150694|NCT00739973|450174829|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
125150695|NCT00739973|450174830|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
125150696|NCT00739973|450174831|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
125150697|NCT00739973|450174832|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
125150698|NCT00739973|450174833|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
125150699|NCT00739973|450174834|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
125150700|NCT00739973|450174835|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
125150701|NCT00739973|450174836|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
125150702|NCT00739973|450174837|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
125150703|NCT00739973|450174829|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
125150704|NCT00739973|450174830|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
125150705|NCT00739973|450174831|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
125150706|NCT00739973|450174832|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
125150707|NCT00739973|450174833|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
125150708|NCT00739973|450174834|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
125150709|NCT00739973|450174835|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
125150710|NCT00739973|450174836|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
125223716|NCT00676403|450446194|FG003|Overall Study|Adverse Event|5|||
125223717|NCT00676403|450446195|FG004|Overall Study|Adverse Event|1|||
125150711|NCT00739973|450174837|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
125150712|NCT00739973|450174829|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
125150713|NCT00739973|450174830|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
125150714|NCT00739973|450174831|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
125150715|NCT00739973|450174832|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
125150716|NCT00739973|450174833|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
125150717|NCT00739973|450174834|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
125150718|NCT00739973|450174835|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
125150719|NCT00739973|450174836|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
125150720|NCT00739973|450174837|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
125150721|NCT00739973|450174829|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
125150722|NCT00739973|450174830|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
125150723|NCT00739973|450174831|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
125150724|NCT00739973|450174832|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
125150725|NCT00739973|450174833|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
125150726|NCT00739973|450174834|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
125150727|NCT00739973|450174835|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
125150728|NCT00739973|450174836|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
125150729|NCT00739973|450174837|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
125150730|NCT00739973|450174829|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
125150731|NCT00739973|450174830|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
125150732|NCT00739973|450174831|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
125150733|NCT00739973|450174832|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
125150734|NCT00739973|450174833|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
125150735|NCT00739973|450174834|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
125150736|NCT00739973|450174835|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
125150737|NCT00739973|450174836|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
125150738|NCT00739973|450174837|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
125150739|NCT01662362|450174838|FG000|Overall Study|Lost to Follow-up|38|||
125150740|NCT01181531|450174839|FG000|Overall Study|Other|17|||
125150741|NCT01181531|450174840|FG001|Overall Study|Other|12|||
125150742|NCT01181531|450174839|FG000|Overall Study|Partial consent by subject withdrawn|0|||
125150743|NCT01181531|450174840|FG001|Overall Study|Partial consent by subject withdrawn|1|||
125150744|NCT01181531|450174839|FG000|Overall Study|Physician Decision|3|||
125150745|NCT01181531|450174840|FG001|Overall Study|Physician Decision|1|||
125150746|NCT01181531|450174839|FG000|Overall Study|Noncompliance|2|||
125150747|NCT01181531|450174840|FG001|Overall Study|Noncompliance|2|||
125150748|NCT01181531|450174839|FG000|Overall Study|Ineligibility determined|1|||
125150749|NCT01181531|450174840|FG001|Overall Study|Ineligibility determined|2|||
125150750|NCT01181531|450174839|FG000|Overall Study|Protocol Specified Criteria|15|||
125150751|NCT01181531|450174840|FG001|Overall Study|Protocol Specified Criteria|8|||
125150752|NCT01181531|450174839|FG000|Overall Study|Pregnancy|0|||
125150753|NCT01181531|450174840|FG001|Overall Study|Pregnancy|1|||
125150754|NCT01181531|450174839|FG000|Overall Study|Withdrawal by Subject|8|||
125150755|NCT01181531|450174840|FG001|Overall Study|Withdrawal by Subject|7|||
125150756|NCT01181531|450174839|FG000|Overall Study|Protocol Violation|6|||
125150757|NCT01181531|450174840|FG001|Overall Study|Protocol Violation|6|||
125150758|NCT01181531|450174839|FG000|Overall Study|Death|9|||
125150759|NCT01181531|450174840|FG001|Overall Study|Death|12|||
125150760|NCT01181531|450174839|FG000|Overall Study|Adverse Event|0|||
125150761|NCT01181531|450174840|FG001|Overall Study|Adverse Event|1|||
125150762|NCT00987831|450174841|FG000|Overall Study|Never flared in 12 months|1|||
125150763|NCT00987831|450174842|FG001|Overall Study|Never flared in 12 months|0|||
125150764|NCT00987831|450174843|FG002|Overall Study|Never flared in 12 months|0|||
125150765|NCT00987831|450174841|FG000|Overall Study|Lost to Follow-up|0|||
125150766|NCT00987831|450174842|FG001|Overall Study|Lost to Follow-up|3|||
125150767|NCT00987831|450174843|FG002|Overall Study|Lost to Follow-up|0|||
125150768|NCT00576303|450174844|FG000|Dose Titration Period|Early withdrawal|17|||
125150769|NCT00576303|450174844|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
125150770|NCT00576303|450174844|FG000|Long Term Safety Period|Early withdrawal|16|||
125150771|NCT00810602|450174845|FG000|Overall Study|Withdrawal by Subject|8|||
125150772|NCT00810602|450174846|FG001|Overall Study|Withdrawal by Subject|3|||
125150773|NCT02792218|450174847|FG000|Overall Study|Patient/guardian decision|15|||
125150774|NCT02792218|450174848|FG001|Overall Study|Patient/guardian decision|42|||
125150775|NCT02792218|450174847|FG000|Overall Study|Adverse Event|15|||
125150776|NCT02792218|450174848|FG001|Overall Study|Adverse Event|14|||
125150777|NCT02792218|450174847|FG000|Overall Study|Lost to Follow-up|10|||
125150778|NCT02792218|450174848|FG001|Overall Study|Lost to Follow-up|5|||
125150779|NCT02792218|450174847|FG000|Overall Study|Lack of Efficacy|1|||
125150780|NCT02792218|450174848|FG001|Overall Study|Lack of Efficacy|12|||
125150781|NCT02792218|450174847|FG000|Overall Study|Physician Decision|4|||
125150782|NCT02792218|450174848|FG001|Overall Study|Physician Decision|4|||
125150783|NCT02792218|450174847|FG000|Overall Study|Protocol deviation|3|||
125150784|NCT02792218|450174848|FG001|Overall Study|Protocol deviation|2|||
125150785|NCT02792218|450174847|FG000|Overall Study|New therapy for study indication|0|||
125150786|NCT02792218|450174848|FG001|Overall Study|New therapy for study indication|1|||
125150787|NCT02792218|450174847|FG000|Overall Study|Non-compliance with study treatment|0|||
125150788|NCT02792218|450174848|FG001|Overall Study|Non-compliance with study treatment|1|||
125150789|NCT02792218|450174847|FG000|Overall Study|Pregnancy|1|||
125150790|NCT02792218|450174848|FG001|Overall Study|Pregnancy|0|||
125150791|NCT00824369|450174849|FG000|Overall Study|Nolonger willing to participate in study|1|||
125150792|NCT00824369|450174850|FG001|Overall Study|Nolonger willing to participate in study|0|||
125150793|NCT00824369|450174851|FG002|Overall Study|Nolonger willing to participate in study|1|||
125150794|NCT00824369|450174852|FG003|Overall Study|Nolonger willing to participate in study|2|||
125150795|NCT00824369|450174853|FG004|Overall Study|Nolonger willing to participate in study|0|||
125150796|NCT00824369|450174854|FG005|Overall Study|Nolonger willing to participate in study|1|||
125150797|NCT00824369|450174849|FG000|Overall Study|Lost to Follow-up|0|||
125150798|NCT00824369|450174850|FG001|Overall Study|Lost to Follow-up|0|||
125150799|NCT00824369|450174851|FG002|Overall Study|Lost to Follow-up|0|||
125150800|NCT00824369|450174852|FG003|Overall Study|Lost to Follow-up|0|||
125150801|NCT00824369|450174853|FG004|Overall Study|Lost to Follow-up|1|||
125150802|NCT00824369|450174854|FG005|Overall Study|Lost to Follow-up|0|||
125150803|NCT00749411|450174864|FG000|Overall Study|Adverse Event|0|||
125150804|NCT00749411|450174865|FG001|Overall Study|Adverse Event|2|||
125150805|NCT00749411|450174864|FG000|Overall Study|Lack of Efficacy|0|||
125150806|NCT00749411|450174865|FG001|Overall Study|Lack of Efficacy|1|||
125150807|NCT00749411|450174864|FG000|Overall Study|Protocol Violation|1|||
125150808|NCT00749411|450174865|FG001|Overall Study|Protocol Violation|1|||
125150809|NCT00749411|450174864|FG000|Overall Study|Protocol-defined stopping criteria|0|||
125150810|NCT00749411|450174865|FG001|Overall Study|Protocol-defined stopping criteria|1|||
125150811|NCT03183141|450174867|FG000|Overall Study|Withdrawal by Subject|2|||
125150812|NCT03183141|450174868|FG001|Overall Study|Withdrawal by Subject|4|||
125150813|NCT03183141|450174867|FG000|Overall Study|Death|0|||
125150814|NCT03183141|450174868|FG001|Overall Study|Death|8|||
125150815|NCT02756637|450174870|FG000|Overall Study|Not eligible for initial SWOG study|10|||
125150816|NCT02756637|450174871|FG001|Overall Study|Not eligible for initial SWOG study|10|||
125150817|NCT02756637|450174870|FG000|Overall Study|No available NLR value|44|||
125150818|NCT02756637|450174871|FG001|Overall Study|No available NLR value|44|||
125150819|NCT02756637|450174870|FG000|Overall Study|Did not complete curative therapy|33|||
125150820|NCT02756637|450174871|FG001|Overall Study|Did not complete curative therapy|0|||
125150821|NCT01507090|450174872|FG000|Overall Study|incomplete dataset|18|||
125150822|NCT04034355|450174891|FG000|Overall Study|Study terminated by Sponsor|10|||
125150823|NCT04034355|450174892|FG001|Overall Study|Study terminated by Sponsor|17|||
125150824|NCT04034355|450174891|FG000|Overall Study|Withdrawal by Subject|12|||
125150825|NCT04034355|450174892|FG001|Overall Study|Withdrawal by Subject|11|||
125150826|NCT04034355|450174891|FG000|Overall Study|Site terminated by Sponsor|4|||
125150827|NCT04034355|450174892|FG001|Overall Study|Site terminated by Sponsor|5|||
125150828|NCT04034355|450174891|FG000|Overall Study|Adverse Event|2|||
125150829|NCT04034355|450174892|FG001|Overall Study|Adverse Event|0|||
125150830|NCT04034355|450174891|FG000|Overall Study|Death|1|||
125150831|NCT04034355|450174892|FG001|Overall Study|Death|1|||
125150832|NCT04034355|450174891|FG000|Overall Study|Not reported|2|||
125150833|NCT04034355|450174892|FG001|Overall Study|Not reported|0|||
125150834|NCT04034355|450174891|FG000|Overall Study|Lost to Follow-up|1|||
125150835|NCT04034355|450174892|FG001|Overall Study|Lost to Follow-up|0|||
125150836|NCT04034355|450174891|FG000|Overall Study|Physician Decision|1|||
125150837|NCT04034355|450174892|FG001|Overall Study|Physician Decision|0|||
125150838|NCT04034355|450174891|FG000|Overall Study|Protocol Violation|0|||
125150839|NCT04034355|450174892|FG001|Overall Study|Protocol Violation|1|||
125150840|NCT04034355|450174891|FG000|Overall Study|Progressive disease|1|||
125150841|NCT04034355|450174892|FG001|Overall Study|Progressive disease|0|||
125150842|NCT02190279|450176530|FG000|Overall Study|Withdrawal consent|1|||
125150843|NCT02190279|450176531|FG001|Overall Study|Withdrawal consent|0|||
125150844|NCT02190279|450176532|FG002|Overall Study|Withdrawal consent|1|||
125150845|NCT02190279|450176530|FG000|Overall Study|Lost to Follow-up|2|||
125150846|NCT02190279|450176531|FG001|Overall Study|Lost to Follow-up|0|||
125150847|NCT02190279|450176532|FG002|Overall Study|Lost to Follow-up|0|||
125150848|NCT02190279|450176530|FG000|Overall Study|Refused further treatment|0|||
125150849|NCT02190279|450176531|FG001|Overall Study|Refused further treatment|0|||
125150850|NCT02190279|450176532|FG002|Overall Study|Refused further treatment|1|||
125150851|NCT02190279|450176530|FG000|Overall Study|Screening failure|0|||
125150852|NCT02190279|450176531|FG001|Overall Study|Screening failure|0|||
125150853|NCT02190279|450176532|FG002|Overall Study|Screening failure|1|||
125150854|NCT01467479|450176533|FG000|Overall Study|No Study Medication|1|||
125150855|NCT01467479|450176534|FG001|Overall Study|No Study Medication|0|||
125150856|NCT01467479|450176535|FG002|Overall Study|No Study Medication|2|||
125150857|NCT01467479|450176533|FG000|Overall Study|Adverse Event|1|||
125150858|NCT01467479|450176534|FG001|Overall Study|Adverse Event|2|||
125150859|NCT01467479|450176535|FG002|Overall Study|Adverse Event|0|||
125150860|NCT01467479|450176533|FG000|Overall Study|Death|0|||
125150861|NCT01467479|450176534|FG001|Overall Study|Death|0|||
125150862|NCT01467479|450176535|FG002|Overall Study|Death|1|||
125150863|NCT01467479|450176533|FG000|Overall Study|Lost to Follow-up|2|||
125150864|NCT01467479|450176534|FG001|Overall Study|Lost to Follow-up|5|||
125150865|NCT01467479|450176535|FG002|Overall Study|Lost to Follow-up|3|||
125150866|NCT01467479|450176533|FG000|Overall Study|Withdrawal of Consent|3|||
125150867|NCT01467479|450176534|FG001|Overall Study|Withdrawal of Consent|7|||
125150868|NCT01467479|450176535|FG002|Overall Study|Withdrawal of Consent|7|||
125150869|NCT01467479|450176533|FG000|Overall Study|Study Terminated by Sponsor|1|||
125150870|NCT01467479|450176534|FG001|Overall Study|Study Terminated by Sponsor|3|||
125150871|NCT01467479|450176535|FG002|Overall Study|Study Terminated by Sponsor|3|||
125150872|NCT01467479|450176533|FG000|Overall Study|Other|1|||
125150873|NCT01467479|450176534|FG001|Overall Study|Other|0|||
125150874|NCT01467479|450176535|FG002|Overall Study|Other|0|||
125150875|NCT01197417|450176541|FG000|Overall Study|Physician Decision|3|||
125150876|NCT01197417|450176542|FG001|Overall Study|Physician Decision|2|||
125150877|NCT01197417|450176541|FG000|Overall Study|Withdrawal by Subject|2|||
125150878|NCT01197417|450176542|FG001|Overall Study|Withdrawal by Subject|4|||
125150879|NCT01197417|450176541|FG000|Overall Study|Site miscommunication|0|||
125150880|NCT01197417|450176542|FG001|Overall Study|Site miscommunication|1|||
125150881|NCT01197417|450176541|FG000|Overall Study|Subject transferred to intensive care|0|||
125150882|NCT01197417|450176542|FG001|Overall Study|Subject transferred to intensive care|1|||
125150883|NCT01197417|450176541|FG000|Overall Study|Not consented in time to receive drug|0|||
125150884|NCT01197417|450176542|FG001|Overall Study|Not consented in time to receive drug|1|||
125150885|NCT01197417|450176541|FG000|Overall Study|Hypotension|1|||
125150886|NCT01197417|450176542|FG001|Overall Study|Hypotension|2|||
125150887|NCT01197417|450176541|FG000|Overall Study|Found to be ineligible|2|||
125150888|NCT01197417|450176542|FG001|Overall Study|Found to be ineligible|5|||
125150889|NCT01197417|450176541|FG000|Overall Study|No 25-hour magnesium level|0|||
125150890|NCT01197417|450176542|FG001|Overall Study|No 25-hour magnesium level|2|||
125150891|NCT01652729|450176543|FG000|Overall Study|Withdrawal by Subject|14|||
125150892|NCT01652729|450176544|FG001|Overall Study|Withdrawal by Subject|7|||
125150893|NCT01652729|450176545|FG002|Overall Study|Withdrawal by Subject|7|||
125150894|NCT01652729|450176543|FG000|Overall Study|Adverse Event|4|||
125150895|NCT01652729|450176544|FG001|Overall Study|Adverse Event|0|||
125150896|NCT01652729|450176545|FG002|Overall Study|Adverse Event|3|||
125150897|NCT01652729|450176543|FG000|Overall Study|Physician Decision|1|||
125150898|NCT01652729|450176544|FG001|Overall Study|Physician Decision|0|||
125150899|NCT01652729|450176545|FG002|Overall Study|Physician Decision|1|||
125150900|NCT01652729|450176543|FG000|Overall Study|Protocol Violation|1|||
125150901|NCT01652729|450176544|FG001|Overall Study|Protocol Violation|0|||
125150902|NCT01652729|450176545|FG002|Overall Study|Protocol Violation|0|||
125150903|NCT01652729|450176543|FG000|Overall Study|Lost to Follow-up|6|||
125150904|NCT01652729|450176544|FG001|Overall Study|Lost to Follow-up|6|||
125150905|NCT01652729|450176545|FG002|Overall Study|Lost to Follow-up|3|||
125150906|NCT01652729|450176543|FG000|Overall Study|Administrative|1|||
125150907|NCT01652729|450176544|FG001|Overall Study|Administrative|0|||
125150908|NCT01652729|450176545|FG002|Overall Study|Administrative|0|||
125150909|NCT01311557|450176546|FG000|Overall Study|Serious adverse event|0|||
125150910|NCT01311557|450176547|FG001|Overall Study|Serious adverse event|1|||
125150911|NCT01311557|450176546|FG000|Overall Study|Protocol Violation|4|||
125150912|NCT01311557|450176547|FG001|Overall Study|Protocol Violation|2|||
125150913|NCT01311557|450176546|FG000|Overall Study|Lost to Follow-up|0|||
125150914|NCT01311557|450176547|FG001|Overall Study|Lost to Follow-up|1|||
125150915|NCT01311557|450176546|FG000|Overall Study|Withdrawal by Subject|1|||
125150916|NCT01311557|450176547|FG001|Overall Study|Withdrawal by Subject|2|||
125150917|NCT01470417|450176550|FG000|Overall Study|Disease progression|0|||
125150918|NCT01470417|450176551|FG001|Overall Study|Disease progression|2|||
125150919|NCT02418455|450176552|FG000|48-Week Treatment Period|Other- Not Specified|1|||
125150920|NCT02418455|450176552|FG000|Continuation Period|Sponsor Decision|7|||
125150921|NCT02973321|450176553|FG000|Overall Study|Other than specified|0|||
125150922|NCT02973321|450176554|FG001|Overall Study|Other than specified|5|||
125150923|NCT02973321|450176555|FG002|Overall Study|Other than specified|3|||
125150924|NCT02973321|450176556|FG003|Overall Study|Other than specified|3|||
125150925|NCT02973321|450176557|FG004|Overall Study|Other than specified|1|||
125150926|NCT02973321|450176553|FG000|Overall Study|Lack of Efficacy|0|||
125150927|NCT02973321|450176554|FG001|Overall Study|Lack of Efficacy|0|||
125150928|NCT02973321|450176555|FG002|Overall Study|Lack of Efficacy|0|||
125150929|NCT02973321|450176556|FG003|Overall Study|Lack of Efficacy|0|||
125150930|NCT02973321|450176557|FG004|Overall Study|Lack of Efficacy|1|||
125150931|NCT02973321|450176553|FG000|Overall Study|Adverse Event|1|||
125150932|NCT02973321|450176554|FG001|Overall Study|Adverse Event|10|||
125150933|NCT02973321|450176555|FG002|Overall Study|Adverse Event|11|||
125150934|NCT02973321|450176556|FG003|Overall Study|Adverse Event|13|||
125223718|NCT00676403|450446196|FG005|Overall Study|Adverse Event|2|||
125150935|NCT02973321|450176557|FG004|Overall Study|Adverse Event|3|||
125150936|NCT00194792|450176564|FG000|Overall Study|Withdrawal by Subject|1|||
125150937|NCT01714739|450176565|FG000|Overall Study|Disease progression|3|||
125150938|NCT01714739|450176566|FG001|Overall Study|Disease progression|5|||
125150939|NCT01714739|450176567|FG002|Overall Study|Disease progression|5|||
125150940|NCT01714739|450176568|FG003|Overall Study|Disease progression|204|||
125150941|NCT01714739|450176569|FG004|Overall Study|Disease progression|1|||
125150942|NCT01714739|450176570|FG005|Overall Study|Disease progression|3|||
125150943|NCT01714739|450176571|FG006|Overall Study|Disease progression|5|||
125150944|NCT01714739|450176565|FG000|Overall Study|Study drug toxicity|1|||
125150945|NCT01714739|450176566|FG001|Overall Study|Study drug toxicity|1|||
125150946|NCT01714739|450176567|FG002|Overall Study|Study drug toxicity|1|||
125150947|NCT01714739|450176568|FG003|Overall Study|Study drug toxicity|15|||
125150948|NCT01714739|450176569|FG004|Overall Study|Study drug toxicity|0|||
125150949|NCT01714739|450176570|FG005|Overall Study|Study drug toxicity|0|||
125150950|NCT01714739|450176571|FG006|Overall Study|Study drug toxicity|5|||
125150951|NCT01714739|450176565|FG000|Overall Study|Death|0|||
125150952|NCT01714739|450176566|FG001|Overall Study|Death|0|||
125150953|NCT01714739|450176567|FG002|Overall Study|Death|0|||
125150954|NCT01714739|450176568|FG003|Overall Study|Death|1|||
125150955|NCT01714739|450176569|FG004|Overall Study|Death|0|||
125150956|NCT01714739|450176570|FG005|Overall Study|Death|0|||
125150957|NCT01714739|450176571|FG006|Overall Study|Death|0|||
125150958|NCT01714739|450176565|FG000|Overall Study|Adverse Event unrelated to drug|0|||
125150959|NCT01714739|450176566|FG001|Overall Study|Adverse Event unrelated to drug|0|||
125150960|NCT01714739|450176567|FG002|Overall Study|Adverse Event unrelated to drug|3|||
125150961|NCT01714739|450176568|FG003|Overall Study|Adverse Event unrelated to drug|21|||
125150962|NCT01714739|450176569|FG004|Overall Study|Adverse Event unrelated to drug|0|||
125150963|NCT01714739|450176570|FG005|Overall Study|Adverse Event unrelated to drug|0|||
125150964|NCT01714739|450176571|FG006|Overall Study|Adverse Event unrelated to drug|0|||
125150965|NCT01714739|450176565|FG000|Overall Study|Participant request to stop therapy|0|||
125150966|NCT01714739|450176566|FG001|Overall Study|Participant request to stop therapy|1|||
125150967|NCT01714739|450176567|FG002|Overall Study|Participant request to stop therapy|0|||
125150968|NCT01714739|450176568|FG003|Overall Study|Participant request to stop therapy|6|||
125150969|NCT01714739|450176569|FG004|Overall Study|Participant request to stop therapy|0|||
125150970|NCT01714739|450176570|FG005|Overall Study|Participant request to stop therapy|0|||
125150971|NCT01714739|450176571|FG006|Overall Study|Participant request to stop therapy|0|||
125150972|NCT01714739|450176565|FG000|Overall Study|Participant withdrew consent|0|||
125150973|NCT01714739|450176566|FG001|Overall Study|Participant withdrew consent|1|||
125150974|NCT01714739|450176567|FG002|Overall Study|Participant withdrew consent|0|||
125150975|NCT01714739|450176568|FG003|Overall Study|Participant withdrew consent|8|||
125150976|NCT01714739|450176569|FG004|Overall Study|Participant withdrew consent|0|||
125150977|NCT01714739|450176570|FG005|Overall Study|Participant withdrew consent|0|||
125150978|NCT01714739|450176571|FG006|Overall Study|Participant withdrew consent|0|||
125150979|NCT01714739|450176565|FG000|Overall Study|Lost to Follow-up|0|||
125150980|NCT01714739|450176566|FG001|Overall Study|Lost to Follow-up|0|||
125150981|NCT01714739|450176567|FG002|Overall Study|Lost to Follow-up|0|||
125150982|NCT01714739|450176568|FG003|Overall Study|Lost to Follow-up|1|||
125150983|NCT01714739|450176569|FG004|Overall Study|Lost to Follow-up|0|||
125150984|NCT01714739|450176570|FG005|Overall Study|Lost to Follow-up|0|||
125150985|NCT01714739|450176571|FG006|Overall Study|Lost to Follow-up|0|||
125150986|NCT01714739|450176565|FG000|Overall Study|Maximum clinical benefit|0|||
125150987|NCT01714739|450176566|FG001|Overall Study|Maximum clinical benefit|1|||
125150988|NCT01714739|450176567|FG002|Overall Study|Maximum clinical benefit|1|||
125150989|NCT01714739|450176568|FG003|Overall Study|Maximum clinical benefit|3|||
125150990|NCT01714739|450176569|FG004|Overall Study|Maximum clinical benefit|0|||
125150991|NCT01714739|450176570|FG005|Overall Study|Maximum clinical benefit|0|||
125150992|NCT01714739|450176571|FG006|Overall Study|Maximum clinical benefit|0|||
125150993|NCT01714739|450176565|FG000|Overall Study|Poor/non-comliance|0|||
125150994|NCT01714739|450176566|FG001|Overall Study|Poor/non-comliance|1|||
125150995|NCT01714739|450176567|FG002|Overall Study|Poor/non-comliance|0|||
125150996|NCT01714739|450176568|FG003|Overall Study|Poor/non-comliance|1|||
125150997|NCT01714739|450176569|FG004|Overall Study|Poor/non-comliance|0|||
125150998|NCT01714739|450176570|FG005|Overall Study|Poor/non-comliance|0|||
125150999|NCT01714739|450176571|FG006|Overall Study|Poor/non-comliance|0|||
125151000|NCT01714739|450176565|FG000|Overall Study|No longer meets study criteria|0|||
125151001|NCT01714739|450176566|FG001|Overall Study|No longer meets study criteria|0|||
125151002|NCT01714739|450176567|FG002|Overall Study|No longer meets study criteria|0|||
125151003|NCT01714739|450176568|FG003|Overall Study|No longer meets study criteria|1|||
125223719|NCT00676403|450446191|FG000|Overall Study|Lost to Follow-up|0|||
125151004|NCT01714739|450176569|FG004|Overall Study|No longer meets study criteria|0|||
125151005|NCT01714739|450176570|FG005|Overall Study|No longer meets study criteria|0|||
125151006|NCT01714739|450176571|FG006|Overall Study|No longer meets study criteria|0|||
125151007|NCT01714739|450176565|FG000|Overall Study|Other reason|0|||
125151008|NCT01714739|450176566|FG001|Overall Study|Other reason|0|||
125223720|NCT00676403|450446192|FG001|Overall Study|Lost to Follow-up|0|||
125151009|NCT01714739|450176567|FG002|Overall Study|Other reason|0|||
125151010|NCT01714739|450176568|FG003|Overall Study|Other reason|3|||
125151011|NCT01714739|450176569|FG004|Overall Study|Other reason|1|||
125151012|NCT01714739|450176570|FG005|Overall Study|Other reason|0|||
125151013|NCT01714739|450176571|FG006|Overall Study|Other reason|0|||
125151014|NCT00865514|450176572|FG000|Overall Study|Infusion cost exceeded funding|2|||
125151015|NCT03920280|450176573|FG000|Overall Study|Adverse Event|2|||
125151016|NCT03920280|450176574|FG001|Overall Study|Adverse Event|3|||
125151017|NCT03920280|450176573|FG000|Overall Study|Lost to Follow-up|0|||
125151018|NCT03920280|450176574|FG001|Overall Study|Lost to Follow-up|1|||
125151019|NCT03920280|450176573|FG000|Overall Study|Withdrawal by Subject|1|||
125151020|NCT03920280|450176574|FG001|Overall Study|Withdrawal by Subject|1|||
125151021|NCT03920280|450176573|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
125151022|NCT03920280|450176574|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
125151023|NCT01557920|450176575|FG000|Overall Study|Withdrawal by Subject|2|||
125151024|NCT01557920|450176576|FG001|Overall Study|Withdrawal by Subject|3|||
125151025|NCT01557920|450176575|FG000|Overall Study|Lack of Efficacy|1|||
125223721|NCT00676403|450446193|FG002|Overall Study|Lost to Follow-up|0|||
125223722|NCT00676403|450446194|FG003|Overall Study|Lost to Follow-up|0|||
125223723|NCT00676403|450446195|FG004|Overall Study|Lost to Follow-up|0|||
125223724|NCT00676403|450446196|FG005|Overall Study|Lost to Follow-up|1|||
125223725|NCT00676403|450446191|FG000|Overall Study|Reason Unspecified|1|||
125223726|NCT00676403|450446192|FG001|Overall Study|Reason Unspecified|0|||
125223727|NCT00676403|450446193|FG002|Overall Study|Reason Unspecified|1|||
125223728|NCT00676403|450446194|FG003|Overall Study|Reason Unspecified|0|||
125223729|NCT00676403|450446195|FG004|Overall Study|Reason Unspecified|0|||
125223730|NCT00676403|450446196|FG005|Overall Study|Reason Unspecified|1|||
125223731|NCT00676403|450446191|FG000|Overall Study|Withdrawal by Subject|0|||
125223732|NCT00676403|450446192|FG001|Overall Study|Withdrawal by Subject|0|||
125223733|NCT00676403|450446193|FG002|Overall Study|Withdrawal by Subject|0|||
125223734|NCT00676403|450446194|FG003|Overall Study|Withdrawal by Subject|0|||
125223735|NCT00676403|450446195|FG004|Overall Study|Withdrawal by Subject|0|||
125223736|NCT00676403|450446196|FG005|Overall Study|Withdrawal by Subject|1|||
125223737|NCT02048722|450446200|FG000|2 Cycles of Treatment|Adverse Event|2|||
125223738|NCT02048722|450446200|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
125223739|NCT02048722|450446200|FG000|2 Cycles of Treatment|Progressive Disease|2|||
125223740|NCT02048722|450446200|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
125223741|NCT02048722|450446200|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
125223742|NCT02048722|450446200|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
125223743|NCT05209880|450446201|FG000|1-Month Follow-up|Spoke with Doctor|5|||
125223744|NCT05209880|450446202|FG001|1-Month Follow-up|Spoke with Doctor|5|||
125223745|NCT05209880|450446201|FG000|1-Month Follow-up|Lost to Follow-up|7|||
125223746|NCT05209880|450446202|FG001|1-Month Follow-up|Lost to Follow-up|9|||
125223747|NCT05209880|450446201|FG000|1-Month Follow-up|Discontinued|0|||
125223748|NCT05209880|450446202|FG001|1-Month Follow-up|Discontinued|1|||
125223749|NCT05209880|450446201|FG000|3-Month Follow-up|Spoke with Doctor|17|||
125223750|NCT05209880|450446202|FG001|3-Month Follow-up|Spoke with Doctor|7|||
125223751|NCT05209880|450446201|FG000|3-Month Follow-up|Lost to Follow-up|8|||
125223752|NCT05209880|450446202|FG001|3-Month Follow-up|Lost to Follow-up|10|||
125223753|NCT05209880|450446201|FG000|3-Month Follow-up|Discontinued|1|||
125223754|NCT05209880|450446202|FG001|3-Month Follow-up|Discontinued|3|||
125223755|NCT05209880|450446201|FG000|6-Month Follow-up|Spoke with Doctor|25|||
125223756|NCT05209880|450446202|FG001|6-Month Follow-up|Spoke with Doctor|14|||
125223757|NCT05209880|450446201|FG000|6-Month Follow-up|Lost to Follow-up|9|||
125223758|NCT05209880|450446202|FG001|6-Month Follow-up|Lost to Follow-up|14|||
125223759|NCT05209880|450446201|FG000|6-Month Follow-up|Discontinued|1|||
125223760|NCT05209880|450446202|FG001|6-Month Follow-up|Discontinued|3|||
125223761|NCT04073303|450446203|FG000|Overall Study|Adverse Event|0|||
125223762|NCT04073303|450446204|FG001|Overall Study|Adverse Event|2|||
125223763|NCT04073303|450446203|FG000|Overall Study|Withdrawal by Subject|16|||
125223764|NCT04073303|450446204|FG001|Overall Study|Withdrawal by Subject|36|||
125151026|NCT01557920|450176576|FG001|Overall Study|Lack of Efficacy|0|||
125223765|NCT04073303|450446203|FG000|Overall Study|Lost to Follow-up|6|||
125223766|NCT04073303|450446204|FG001|Overall Study|Lost to Follow-up|1|||
125223767|NCT04073303|450446203|FG000|Overall Study|Protocol Deviation|0|||
125151027|NCT01857206|450176579|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
125151028|NCT01857206|450176580|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
125151029|NCT01857206|450176579|FG000|Overall Study|Lost to Follow-up|9|||
125223768|NCT04073303|450446204|FG001|Overall Study|Protocol Deviation|4|||
125151030|NCT01857206|450176580|FG001|Overall Study|Lost to Follow-up|6|||
125151031|NCT01857206|450176579|FG000|Overall Study|Unclassified|3|||
125151032|NCT01857206|450176580|FG001|Overall Study|Unclassified|3|||
125151033|NCT01857206|450176579|FG000|Overall Study|Withdrawal by Subject|1|||
125223769|NCT04073303|450446203|FG000|Overall Study|Other|1|||
125223770|NCT04073303|450446204|FG001|Overall Study|Other|1|||
125223771|NCT02899065|450446208|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
125223772|NCT02899065|450446209|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
125223773|NCT02899065|450446208|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
125223774|NCT02899065|450446209|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
125223775|NCT02899065|450446208|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
125223776|NCT02899065|450446209|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
125223777|NCT05227118|450446212|FG000|Overall Study|Adverse Event|0|||
125223778|NCT05227118|450446213|FG001|Overall Study|Adverse Event|0|||
125223779|NCT05227118|450446214|FG002|Overall Study|Adverse Event|1|||
125223780|NCT05227118|450446215|FG003|Overall Study|Adverse Event|0|||
125223781|NCT05227118|450446212|FG000|Overall Study|Withdrawal by Subject|0|||
125223782|NCT05227118|450446213|FG001|Overall Study|Withdrawal by Subject|0|||
125223783|NCT05227118|450446214|FG002|Overall Study|Withdrawal by Subject|2|||
125223784|NCT05227118|450446215|FG003|Overall Study|Withdrawal by Subject|0|||
125223785|NCT02689804|450446216|FG000|Overall Study|Withdrawal by Subject|2|||
125223786|NCT02689804|450446217|FG001|Overall Study|Withdrawal by Subject|0|||
125223787|NCT02417753|450446218|FG000|Overall Study|Death|1|||
125223788|NCT03113968|450446221|FG000|Overall Study|Withdrawal by Subject|31|||
125223789|NCT03113968|450446222|FG001|Overall Study|Withdrawal by Subject|4|||
125223790|NCT04805671|450446223|FG000|Overall Study|Death|2|||
125223791|NCT04805671|450446224|FG001|Overall Study|Death|7|||
125223792|NCT04805671|450446223|FG000|Overall Study|Lost to Follow-up|1|||
125223793|NCT04805671|450446224|FG001|Overall Study|Lost to Follow-up|0|||
125223794|NCT04805671|450446223|FG000|Overall Study|Withdrawal by Subject|9|||
125223795|NCT04805671|450446224|FG001|Overall Study|Withdrawal by Subject|7|||
125223796|NCT04805671|450446223|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
125223797|NCT04805671|450446224|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
125223798|NCT01657162|450446231|FG000|Overall Study|Adverse Event|26|||
125223799|NCT01657162|450446232|FG001|Overall Study|Adverse Event|36|||
125223800|NCT01657162|450446231|FG000|Overall Study|Withdrawal by Subject|13|||
125223801|NCT01657162|450446232|FG001|Overall Study|Withdrawal by Subject|13|||
125223802|NCT01657162|450446231|FG000|Overall Study|Continuing Significant Deterioration|9|||
125223803|NCT01657162|450446232|FG001|Overall Study|Continuing Significant Deterioration|3|||
125223804|NCT01657162|450446231|FG000|Overall Study|Refusal of Treatment|4|||
125223805|NCT01657162|450446232|FG001|Overall Study|Refusal of Treatment|6|||
125223806|NCT01657162|450446231|FG000|Overall Study|Lost to Follow-up|3|||
125223807|NCT01657162|450446232|FG001|Overall Study|Lost to Follow-up|4|||
125223808|NCT01657162|450446231|FG000|Overall Study|Death|2|||
125223809|NCT01657162|450446232|FG001|Overall Study|Death|3|||
125223810|NCT01657162|450446231|FG000|Overall Study|Inability to Complete Study Procedures|1|||
125223811|NCT01657162|450446232|FG001|Overall Study|Inability to Complete Study Procedures|7|||
125223812|NCT01657162|450446231|FG000|Overall Study|Protocol Violation|1|||
125223813|NCT01657162|450446232|FG001|Overall Study|Protocol Violation|0|||
125151034|NCT01857206|450176580|FG001|Overall Study|Withdrawal by Subject|0|||
125151035|NCT00003531|450176584|FG000|Overall Study|Not evaluable|10|||
125151036|NCT02487082|450176585|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
125151037|NCT02487082|450176586|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
125151038|NCT02487082|450176585|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
125151039|NCT02487082|450176586|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
125151040|NCT00251316|450176587|FG000|Overall Study|Physician Decision|2|||
125151041|NCT00251316|450176588|FG001|Overall Study|Physician Decision|3|||
125151042|NCT00346164|450176589|FG000|Overall Study|Adverse Event|0|||
125151043|NCT00346164|450176590|FG001|Overall Study|Adverse Event|0|||
125151044|NCT00346164|450176591|FG002|Overall Study|Adverse Event|0|||
125151045|NCT00346164|450176592|FG003|Overall Study|Adverse Event|1|||
125151046|NCT00346164|450176589|FG000|Overall Study|Lack of Efficacy|0|||
125151047|NCT00346164|450176590|FG001|Overall Study|Lack of Efficacy|1|||
125151048|NCT00346164|450176591|FG002|Overall Study|Lack of Efficacy|7|||
125151049|NCT00346164|450176592|FG003|Overall Study|Lack of Efficacy|25|||
125151050|NCT00346164|450176589|FG000|Overall Study|Physician Decision|0|||
125151051|NCT00346164|450176590|FG001|Overall Study|Physician Decision|1|||
125151052|NCT00346164|450176591|FG002|Overall Study|Physician Decision|2|||
125151053|NCT00346164|450176592|FG003|Overall Study|Physician Decision|27|||
125151054|NCT00346164|450176589|FG000|Overall Study|Protocol Violation|6|||
125151055|NCT00346164|450176590|FG001|Overall Study|Protocol Violation|2|||
125151056|NCT00346164|450176591|FG002|Overall Study|Protocol Violation|10|||
125151057|NCT00346164|450176592|FG003|Overall Study|Protocol Violation|4|||
125151058|NCT00346164|450176589|FG000|Overall Study|Withdrawal by Subject|0|||
125151059|NCT00346164|450176590|FG001|Overall Study|Withdrawal by Subject|0|||
125151060|NCT00346164|450176591|FG002|Overall Study|Withdrawal by Subject|2|||
125151061|NCT00346164|450176592|FG003|Overall Study|Withdrawal by Subject|0|||
125151062|NCT00346164|450176589|FG000|Overall Study|Ineligible|11|||
125151063|NCT00346164|450176590|FG001|Overall Study|Ineligible|2|||
125151064|NCT00346164|450176591|FG002|Overall Study|Ineligible|2|||
125151065|NCT00346164|450176592|FG003|Overall Study|Ineligible|23|||
125223814|NCT01657162|450446231|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
125223815|NCT01657162|450446232|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
125151066|NCT00346164|450176589|FG000|Overall Study|Refusal of further protocol therapy|0|||
125151067|NCT00346164|450176590|FG001|Overall Study|Refusal of further protocol therapy|1|||
125151068|NCT00346164|450176591|FG002|Overall Study|Refusal of further protocol therapy|3|||
125151069|NCT00346164|450176592|FG003|Overall Study|Refusal of further protocol therapy|15|||
125151070|NCT00346164|450176589|FG000|Overall Study|Inability to start week 16 tx on time|0|||
125151071|NCT00346164|450176590|FG001|Overall Study|Inability to start week 16 tx on time|0|||
125151072|NCT00346164|450176591|FG002|Overall Study|Inability to start week 16 tx on time|0|||
125151073|NCT00346164|450176592|FG003|Overall Study|Inability to start week 16 tx on time|11|||
125151074|NCT02039063|450176593|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
125151075|NCT02039063|450176594|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
125151076|NCT02039063|450176595|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
125151077|NCT02039063|450176596|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
125151078|NCT02039063|450176593|FG000|Treatment Phase|Progression of disease|0|||
125151079|NCT02039063|450176594|FG001|Treatment Phase|Progression of disease|0|||
125151080|NCT02039063|450176595|FG002|Treatment Phase|Progression of disease|1|||
125151081|NCT02039063|450176596|FG003|Treatment Phase|Progression of disease|1|||
125151082|NCT02039063|450176593|FG000|Extension Phase|Inadequate therapeutic effect|0|||
125151083|NCT02039063|450176594|FG001|Extension Phase|Inadequate therapeutic effect|1|||
125151084|NCT02039063|450176595|FG002|Extension Phase|Inadequate therapeutic effect|2|||
125151085|NCT02039063|450176596|FG003|Extension Phase|Inadequate therapeutic effect|0|||
125151086|NCT02039063|450176593|FG000|Extension Phase|Progression of disease|0|||
125151087|NCT02039063|450176594|FG001|Extension Phase|Progression of disease|0|||
125151088|NCT02039063|450176595|FG002|Extension Phase|Progression of disease|0|||
125151089|NCT02039063|450176596|FG003|Extension Phase|Progression of disease|1|||
125151090|NCT02039063|450176593|FG000|Extension Phase|Adverse Event|0|||
125151091|NCT02039063|450176594|FG001|Extension Phase|Adverse Event|0|||
125151092|NCT02039063|450176595|FG002|Extension Phase|Adverse Event|1|||
125151093|NCT02039063|450176596|FG003|Extension Phase|Adverse Event|0|||
125151094|NCT00467831|450176598|FG000|Overall Study|Death|2|||
125151095|NCT00467831|450176598|FG000|Overall Study|Withdrawal by Subject|1|||
125151096|NCT01198873|450176599|FG000|Overall Study|Adverse Event|4|||
125151097|NCT01198873|450176600|FG001|Overall Study|Adverse Event|7|||
125151098|NCT01198873|450176599|FG000|Overall Study|Study closure|29|||
125151099|NCT01198873|450176600|FG001|Overall Study|Study closure|23|||
125151100|NCT01198873|450176599|FG000|Overall Study|Other than above|4|||
125151101|NCT01198873|450176600|FG001|Overall Study|Other than above|2|||
125151102|NCT03139240|450176601|FG000|Overall Study|Lost to Follow-up|0|||
125223816|NCT01657162|450446231|FG000|Overall Study|Other than Specified|0|||
125223817|NCT01657162|450446232|FG001|Overall Study|Other than Specified|2|||
125223818|NCT00901342|450446233|FG000|Overall Study|Adverse Event|1|||
125223819|NCT00901342|450446233|FG000|Overall Study|Death|4|||
125223820|NCT00901342|450446233|FG000|Overall Study|Disease progression|1|||
125223821|NCT00901342|450446233|FG000|Overall Study|Withdrawal by Subject|9|||
125223822|NCT03421379|450446235|FG000|Period 1|Withdrawal by Subject|0|||
125223823|NCT03421379|450446236|FG001|Period 1|Withdrawal by Subject|1|||
125223824|NCT03421379|450446235|FG000|Period 1|Physician Decision|1|||
125223825|NCT03421379|450446236|FG001|Period 1|Physician Decision|1|||
125223826|NCT03421379|450446235|FG000|Period 1|Did not receive treatment|1|||
125223827|NCT03421379|450446236|FG001|Period 1|Did not receive treatment|2|||
125223828|NCT02782741|450446237|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
125223829|NCT02782741|450446238|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
125223830|NCT02782741|450446239|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
125223831|NCT02782741|450446237|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
125223832|NCT02782741|450446238|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
125223833|NCT02782741|450446239|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
125223834|NCT02782741|450446237|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
125151103|NCT03139240|450176602|FG001|Overall Study|Lost to Follow-up|1|||
125151104|NCT03139240|450176603|FG002|Overall Study|Lost to Follow-up|1|||
125151105|NCT03139240|450176604|FG003|Overall Study|Lost to Follow-up|0|||
125151106|NCT00171340|450176605|FG000|Overall Study|Adverse Event|46|||
125151107|NCT00171340|450176606|FG001|Overall Study|Adverse Event|42|||
125151108|NCT00171340|450176605|FG000|Overall Study|Lack of Efficacy|29|||
125151109|NCT00171340|450176606|FG001|Overall Study|Lack of Efficacy|41|||
125151110|NCT00171340|450176605|FG000|Overall Study|Protocol Violation|7|||
125151111|NCT00171340|450176606|FG001|Overall Study|Protocol Violation|8|||
125151112|NCT00171340|450176605|FG000|Overall Study|Withdrawal by Subject|22|||
125151113|NCT00171340|450176606|FG001|Overall Study|Withdrawal by Subject|19|||
125151114|NCT00171340|450176605|FG000|Overall Study|Lost to Follow-up|0|||
125151115|NCT00171340|450176606|FG001|Overall Study|Lost to Follow-up|5|||
125151116|NCT00171340|450176605|FG000|Overall Study|Abnormal Laboratory Results|2|||
125151117|NCT00171340|450176606|FG001|Overall Study|Abnormal Laboratory Results|0|||
125151118|NCT00171340|450176605|FG000|Overall Study|Abnormal Test Procedure Results|6|||
125151119|NCT00171340|450176606|FG001|Overall Study|Abnormal Test Procedure Results|11|||
125151120|NCT00171340|450176605|FG000|Overall Study|No Longer Required Study Drug|1|||
125151121|NCT00171340|450176606|FG001|Overall Study|No Longer Required Study Drug|1|||
125151122|NCT00171340|450176605|FG000|Overall Study|Administrative Problems|5|||
125151123|NCT00171340|450176606|FG001|Overall Study|Administrative Problems|2|||
125151124|NCT00171340|450176605|FG000|Overall Study|Death|6|||
125151125|NCT00171340|450176606|FG001|Overall Study|Death|6|||
125151126|NCT01998243|450176607|FG000|Overall Study|Pregnancy|0|||
125151127|NCT01998243|450176608|FG001|Overall Study|Pregnancy|1|||
125151128|NCT01998243|450176607|FG000|Overall Study|Protocol Violation|5|||
125151129|NCT01998243|450176608|FG001|Overall Study|Protocol Violation|2|||
125151130|NCT01998243|450176607|FG000|Overall Study|Withdrawal by Subject|3|||
125151131|NCT01998243|450176608|FG001|Overall Study|Withdrawal by Subject|4|||
125151132|NCT01056640|450176609|FG000|Overall Study|Withdrawal by Subject|11|||
125151133|NCT01056640|450176610|FG001|Overall Study|Withdrawal by Subject|8|||
125151134|NCT01056640|450176609|FG000|Overall Study|Death|15|||
125151135|NCT01056640|450176610|FG001|Overall Study|Death|4|||
125151136|NCT04569786|450176611|FG000|Overall Study|Lost to Follow-up|1|||
125151137|NCT04569786|450176612|FG001|Overall Study|Lost to Follow-up|0|||
125151138|NCT04569786|450176613|FG002|Overall Study|Lost to Follow-up|4|||
125151139|NCT04569786|450176614|FG003|Overall Study|Lost to Follow-up|1|||
125151140|NCT04569786|450176615|FG004|Overall Study|Lost to Follow-up|0|||
125151141|NCT04569786|450176611|FG000|Overall Study|Withdrawal by Subject|0|||
125151142|NCT04569786|450176612|FG001|Overall Study|Withdrawal by Subject|0|||
125151143|NCT04569786|450176613|FG002|Overall Study|Withdrawal by Subject|0|||
125151144|NCT04569786|450176614|FG003|Overall Study|Withdrawal by Subject|5|||
125151145|NCT04569786|450176615|FG004|Overall Study|Withdrawal by Subject|1|||
125151146|NCT04569786|450176611|FG000|Overall Study|Physician Decision|0|||
125151147|NCT04569786|450176612|FG001|Overall Study|Physician Decision|0|||
125151148|NCT04569786|450176613|FG002|Overall Study|Physician Decision|0|||
125151149|NCT04569786|450176614|FG003|Overall Study|Physician Decision|1|||
125151150|NCT04569786|450176615|FG004|Overall Study|Physician Decision|0|||
125151151|NCT02492841|450176616|FG000|Overall Study|Lost to Follow-up|34|||
125151152|NCT02492841|450176617|FG001|Overall Study|Lost to Follow-up|31|||
125151153|NCT02492841|450176618|FG002|Overall Study|Lost to Follow-up|35|||
125151154|NCT02563769|450176628|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
125151155|NCT02563769|450176629|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
125151156|NCT02563769|450176630|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
125151157|NCT00690482|450176631|FG000|Overall Study|Adverse Event|2|||
125151158|NCT00690482|450176632|FG001|Overall Study|Adverse Event|1|||
125151159|NCT00690482|450176631|FG000|Overall Study|Incorrect enrolment|0|||
125151160|NCT00690482|450176632|FG001|Overall Study|Incorrect enrolment|1|||
125151161|NCT00690482|450176631|FG000|Overall Study|Study-specific discontinuation criteria|1|||
125151162|NCT00690482|450176632|FG001|Overall Study|Study-specific discontinuation criteria|0|||
125151163|NCT00690482|450176631|FG000|Overall Study|Intake of prohibited medicine|1|||
125151164|NCT00690482|450176632|FG001|Overall Study|Intake of prohibited medicine|0|||
125151165|NCT00690482|450176631|FG000|Overall Study|withdrew consent at rand.day|0|||
125151166|NCT00690482|450176632|FG001|Overall Study|withdrew consent at rand.day|1|||
125151167|NCT02820740|450176633|FG000|Overall Study|Did not have procedure|2|||
125151168|NCT00925301|450176637|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
125151169|NCT00925301|450176638|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
125151170|NCT00925301|450176639|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
125151171|NCT00925301|450176640|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
125151172|NCT00925301|450176637|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
125151173|NCT00925301|450176638|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
125151174|NCT00925301|450176639|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
125151175|NCT00925301|450176640|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
125151176|NCT00925301|450176637|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
125151177|NCT00925301|450176638|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
125151178|NCT00925301|450176639|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
125151179|NCT00925301|450176640|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
125151180|NCT00925301|450176637|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
125151181|NCT00925301|450176638|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
125151182|NCT00925301|450176639|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
125151183|NCT00925301|450176640|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
125151184|NCT00925301|450176637|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
125151185|NCT00925301|450176638|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
125151186|NCT00925301|450176639|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
125151187|NCT00925301|450176640|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
125151188|NCT00925301|450176637|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
125151189|NCT00925301|450176638|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
125151190|NCT00925301|450176639|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
125151191|NCT00925301|450176640|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
125151192|NCT00925301|450176637|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
125151193|NCT00925301|450176638|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
125151194|NCT00925301|450176639|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
125151195|NCT00925301|450176640|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
125151196|NCT01117987|450176641|FG000|Overall Study|Protocol deviation|0|||
125151197|NCT01117987|450176642|FG001|Overall Study|Protocol deviation|1|||
125151198|NCT01117987|450176641|FG000|Overall Study|Subject no longer requires study drug|1|||
125151199|NCT01117987|450176642|FG001|Overall Study|Subject no longer requires study drug|0|||
125151200|NCT01117987|450176641|FG000|Overall Study|Lost to Follow-up|1|||
125151201|NCT01117987|450176642|FG001|Overall Study|Lost to Follow-up|1|||
125151202|NCT01117987|450176641|FG000|Overall Study|Abnormal test procedure result|2|||
125151203|NCT01117987|450176642|FG001|Overall Study|Abnormal test procedure result|0|||
125151204|NCT01117987|450176641|FG000|Overall Study|Lack of Efficacy|3|||
125151205|NCT01117987|450176642|FG001|Overall Study|Lack of Efficacy|4|||
125151206|NCT01117987|450176641|FG000|Overall Study|Death|5|||
125151207|NCT01117987|450176642|FG001|Overall Study|Death|10|||
125151208|NCT01117987|450176641|FG000|Overall Study|Withdrawal by Subject|5|||
125151209|NCT01117987|450176642|FG001|Overall Study|Withdrawal by Subject|10|||
125151210|NCT01117987|450176641|FG000|Overall Study|Adverse Event|19|||
125151211|NCT01117987|450176642|FG001|Overall Study|Adverse Event|26|||
125151212|NCT01117987|450176641|FG000|Overall Study|Administrative problems|25|||
125151213|NCT01117987|450176642|FG001|Overall Study|Administrative problems|22|||
125151214|NCT04117945|450176643|FG000|Overall Study|Death|1|||
125151215|NCT04117945|450176644|FG001|Overall Study|Death|0|||
125151216|NCT04117945|450176643|FG000|Overall Study|Withdrawal by Subject|3|||
125151217|NCT04117945|450176644|FG001|Overall Study|Withdrawal by Subject|1|||
125151218|NCT04117945|450176643|FG000|Overall Study|Disease Progression|0|||
125151219|NCT04117945|450176644|FG001|Overall Study|Disease Progression|2|||
125151220|NCT04117945|450176643|FG000|Overall Study|Ineligible|8|||
125151221|NCT04117945|450176644|FG001|Overall Study|Ineligible|7|||
125151222|NCT01917968|450176646|FG000|Overall Study|Death|3|||
125151223|NCT01917968|450176647|FG001|Overall Study|Death|2|||
125151224|NCT01917968|450176646|FG000|Overall Study|Lost to Follow-up|21|||
125151225|NCT01917968|450176647|FG001|Overall Study|Lost to Follow-up|39|||
125151226|NCT01917968|450176646|FG000|Overall Study|Physician Decision|1|||
125151227|NCT01917968|450176647|FG001|Overall Study|Physician Decision|2|||
125151228|NCT01917968|450176646|FG000|Overall Study|Withdrawal by Subject|20|||
125151229|NCT01917968|450176647|FG001|Overall Study|Withdrawal by Subject|35|||
125151230|NCT01917968|450176646|FG000|Overall Study|Subject Relocation|5|||
125151231|NCT01917968|450176647|FG001|Overall Study|Subject Relocation|1|||
125151232|NCT01917968|450176646|FG000|Overall Study|36M Missed Visit|3|||
125151233|NCT01917968|450176647|FG001|Overall Study|36M Missed Visit|2|||
125151234|NCT01917968|450176646|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
125151235|NCT01917968|450176647|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
125151236|NCT01917968|450176646|FG000|Overall Study|Change in Family Circumstances|0|||
125151237|NCT01917968|450176647|FG001|Overall Study|Change in Family Circumstances|1|||
125151238|NCT01917968|450176646|FG000|Overall Study|No Data Available|0|||
125151239|NCT01917968|450176647|FG001|Overall Study|No Data Available|2|||
125151240|NCT04232540|450176653|FG000|Overall Study|Lost to Follow-up|1|||
125151241|NCT04232540|450176654|FG001|Overall Study|Lost to Follow-up|0|||
125151242|NCT03438006|450176655|FG000|Overall Study|Adverse Event|1|||
125151243|NCT03438006|450176655|FG000|Overall Study|Lost to Follow-up|67|||
125151244|NCT03438006|450176655|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
125151245|NCT03438006|450176655|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
125151246|NCT03078478|450176674|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
125151247|NCT03078478|450176675|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
125151248|NCT03078478|450176674|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
125151249|NCT03078478|450176675|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
125151250|NCT03078478|450176674|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
125151251|NCT03078478|450176675|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
125151252|NCT03078478|450176674|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
125151253|NCT03078478|450176675|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
125151254|NCT03078478|450176674|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
125151255|NCT03078478|450176675|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
125151256|NCT03078478|450176674|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
125151257|NCT03078478|450176675|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
125151258|NCT03078478|450176674|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
125151259|NCT03078478|450176675|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
125151260|NCT03078478|450176674|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
125151261|NCT03078478|450176675|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
125151262|NCT02339090|450176677|FG000|Overall Study|Adverse Event|1|||
125151263|NCT02339090|450176678|FG001|Overall Study|Adverse Event|0|||
125151264|NCT02339090|450176677|FG000|Overall Study|Lost to Follow-up|0|||
125151265|NCT02339090|450176678|FG001|Overall Study|Lost to Follow-up|1|||
125151266|NCT02339090|450176677|FG000|Overall Study|Non-compliance With Study Drug|0|||
125151267|NCT02339090|450176678|FG001|Overall Study|Non-compliance With Study Drug|1|||
125151268|NCT02339090|450176677|FG000|Overall Study|Withdrawal by Subject|2|||
125151269|NCT02339090|450176678|FG001|Overall Study|Withdrawal by Subject|1|||
125151270|NCT02339090|450176677|FG000|Overall Study|Poor Growth|3|||
125151271|NCT02339090|450176678|FG001|Overall Study|Poor Growth|0|||
125151272|NCT02339090|450176677|FG000|Overall Study|Randomized but not treated|0|||
125151273|NCT02339090|450176678|FG001|Overall Study|Randomized but not treated|2|||
125151274|NCT02737592|450176682|FG000|Overall Study|Withdrawal by Subject|1|||
125151275|NCT00955721|450176684|FG000|Overall Study|Physician Decision|1|||
125151276|NCT00955721|450176685|FG001|Overall Study|Physician Decision|0|||
125151277|NCT00955721|450176684|FG000|Overall Study|Death|1|||
125151278|NCT00955721|450176685|FG001|Overall Study|Death|0|||
125151279|NCT00955721|450176684|FG000|Overall Study|Withdrawal by Subject|1|||
125151280|NCT00955721|450176685|FG001|Overall Study|Withdrawal by Subject|0|||
125151281|NCT03581188|450178098|FG000|Overall Study|Inclusion criteria not met|3|||
125151282|NCT03581188|450178099|FG001|Overall Study|Inclusion criteria not met|2|||
125151283|NCT03581188|450178098|FG000|Overall Study|Lost to Follow-up|5|||
125151284|NCT03581188|450178099|FG001|Overall Study|Lost to Follow-up|5|||
125151285|NCT03581188|450178098|FG000|Overall Study|Discontinued intervention|11|||
125151286|NCT03581188|450178099|FG001|Overall Study|Discontinued intervention|8|||
125151287|NCT03064438|450178100|FG000|Overall Study|Lost to Follow-up|1|||
125151288|NCT03064438|450178101|FG001|Overall Study|Lost to Follow-up|0|||
125151289|NCT03064438|450178100|FG000|Overall Study|Withdrawal by Subject|0|||
125151290|NCT03064438|450178101|FG001|Overall Study|Withdrawal by Subject|1|||
125151291|NCT01937351|450178102|FG000|Overall Study|Withdrawal by Subject|4|||
125151292|NCT01937351|450178103|FG001|Overall Study|Withdrawal by Subject|2|||
125151293|NCT01937351|450178102|FG000|Overall Study|Death|1|||
125151294|NCT01937351|450178103|FG001|Overall Study|Death|0|||
125151295|NCT01937351|450178102|FG000|Overall Study|Not treated w device, per protocol fail|4|||
125151296|NCT01937351|450178103|FG001|Overall Study|Not treated w device, per protocol fail|0|||
125151297|NCT01961687|450178104|FG000|Overall Study|Lost to Follow-up|19|||
125151298|NCT01961687|450178104|FG000|Overall Study|Re-operation|17|||
125151299|NCT01961687|450178104|FG000|Overall Study|Death|7|||
125151300|NCT01961687|450178104|FG000|Overall Study|Withdrawal by Subject|6|||
125151301|NCT01961687|450178104|FG000|Overall Study|Adverse Event|6|||
125151302|NCT01961687|450178104|FG000|Overall Study|Moved to area without study site|2|||
125151303|NCT01961687|450178104|FG000|Overall Study|Sponsor decision|2|||
125151304|NCT01961687|450178104|FG000|Overall Study|Physician Decision|1|||
125151305|NCT01961687|450178104|FG000|Overall Study|Unable to meet follow-up requirements|1|||
125151306|NCT02284347|450178105|FG000|Overall Study|Lost to Follow-up|2|||
125151307|NCT02284347|450178105|FG000|Overall Study|Withdrawn prior to treatment|1|||
125151308|NCT01301482|450178107|FG000|Overall Study|Withdrawal by Subject|1|||
125151309|NCT00480324|450178108|FG000|Overall Study|Adverse Event|1|||
125151310|NCT00480324|450178109|FG001|Overall Study|Adverse Event|1|||
125151311|NCT00480324|450178108|FG000|Overall Study|Protocol Violation|0|||
125151312|NCT00480324|450178109|FG001|Overall Study|Protocol Violation|1|||
125151313|NCT00480324|450178108|FG000|Overall Study|Withdrawal by Subject|14|||
125151314|NCT00480324|450178109|FG001|Overall Study|Withdrawal by Subject|5|||
125151315|NCT00480324|450178108|FG000|Overall Study|Lost to Follow-up|17|||
125151316|NCT00480324|450178109|FG001|Overall Study|Lost to Follow-up|8|||
125151317|NCT00480324|450178108|FG000|Overall Study|Subject's mother pregnant|0|||
125151318|NCT00480324|450178109|FG001|Overall Study|Subject's mother pregnant|1|||
125151319|NCT01552369|450178110|FG000|Overall Study|Did not consent to extended follow up|8|||
125151320|NCT01552369|450178111|FG001|Overall Study|Did not consent to extended follow up|9|||
125151321|NCT01316419|450178112|FG000|Overall Study|Not treated|103|||
125151322|NCT01316419|450178112|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
125151323|NCT01316419|450178112|FG000|Overall Study|Lost to Follow-up|19|||
125151324|NCT02999984|450178113|FG000|Overall Study|Treatment Failure|1|||
125151325|NCT04039919|450178114|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125151326|NCT04039919|450178115|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125151327|NCT04039919|450178116|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125151328|NCT04039919|450178117|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125151329|NCT04039919|450178118|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125151330|NCT04039919|450178114|FG000|Treatment Period 1|Sponsor's decision|0|||
125151331|NCT04039919|450178115|FG001|Treatment Period 1|Sponsor's decision|0|||
125151332|NCT04039919|450178116|FG002|Treatment Period 1|Sponsor's decision|0|||
125151333|NCT04039919|450178117|FG003|Treatment Period 1|Sponsor's decision|0|||
125151334|NCT04039919|450178118|FG004|Treatment Period 1|Sponsor's decision|16|||
125151335|NCT04039919|450178114|FG000|Treatment Period 5|Withdrawal by Subject|1|||
125151336|NCT04039919|450178115|FG001|Treatment Period 5|Withdrawal by Subject|0|||
125151337|NCT04039919|450178116|FG002|Treatment Period 5|Withdrawal by Subject|0|||
125151338|NCT04039919|450178117|FG003|Treatment Period 5|Withdrawal by Subject|0|||
125151339|NCT04039919|450178118|FG004|Treatment Period 5|Withdrawal by Subject|0|||
125151340|NCT00754013|450178119|FG000|Overall Study|Lost to Follow-up|1|||
125151341|NCT00754013|450178120|FG001|Overall Study|Lost to Follow-up|1|||
125151342|NCT00754013|450178119|FG000|Overall Study|didn't return after study termed|3|||
125151343|NCT00754013|450178120|FG001|Overall Study|didn't return after study termed|4|||
125151344|NCT02310789|450178121|FG000|Overall Study|Adverse Event|1|||
125151345|NCT00983918|450178122|FG000|Overall Study|conversion to open cholecystectomy|0|||
125151346|NCT00983918|450178123|FG001|Overall Study|conversion to open cholecystectomy|2|||
125151347|NCT00983918|450178124|FG002|Overall Study|conversion to open cholecystectomy|2|||
125151348|NCT00983918|450178125|FG003|Overall Study|conversion to open cholecystectomy|2|||
125151349|NCT00977548|450178127|FG000|Overall Study|Ineligible|4|||
125151350|NCT00977548|450178127|FG000|Overall Study|Adverse Event|8|||
125151351|NCT00977548|450178127|FG000|Overall Study|Withdrawal by Subject|1|||
125151352|NCT02070757|450178128|FG000|Overall Study|Adverse Event|107|||
125151353|NCT02070757|450178129|FG001|Overall Study|Adverse Event|99|||
125151354|NCT02070757|450178128|FG000|Overall Study|Lost to Follow-up|7|||
125151355|NCT02070757|450178129|FG001|Overall Study|Lost to Follow-up|4|||
125151356|NCT02070757|450178128|FG000|Overall Study|Protocol Violation|0|||
125151357|NCT02070757|450178129|FG001|Overall Study|Protocol Violation|4|||
125151358|NCT02070757|450178128|FG000|Overall Study|Withdrawal by Subject|1|||
125151359|NCT02070757|450178129|FG001|Overall Study|Withdrawal by Subject|3|||
125151360|NCT02070757|450178128|FG000|Overall Study|Investigator Decision|0|||
125151361|NCT02070757|450178129|FG001|Overall Study|Investigator Decision|2|||
125151362|NCT02070757|450178128|FG000|Overall Study|Discharged from Study Hospital|2|||
125151363|NCT02070757|450178129|FG001|Overall Study|Discharged from Study Hospital|2|||
125151364|NCT01546922|450178130|FG000|First Period of 10 Weeks|Protocol Violation|3|||
125151365|NCT01546922|450178131|FG001|First Period of 10 Weeks|Protocol Violation|1|||
125151366|NCT01546922|450178130|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
125151367|NCT01546922|450178131|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
125151368|NCT01546922|450178130|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
125151369|NCT01546922|450178131|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
125151370|NCT01546922|450178130|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
125151371|NCT01546922|450178131|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
125151372|NCT01546922|450178130|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
125151373|NCT01546922|450178131|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
125151374|NCT04086641|450178134|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
125151375|NCT04086641|450178135|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
125151376|NCT01613378|450178138|FG000|Overall Study|Lack of Efficacy|13|||
125151377|NCT01613378|450178138|FG000|Overall Study|Adverse Event|11|||
125151378|NCT01613378|450178138|FG000|Overall Study|Withdrawal by Subject|8|||
125151379|NCT01613378|450178138|FG000|Overall Study|Death|2|||
125151380|NCT01613378|450178138|FG000|Overall Study|Lost to Follow-up|1|||
125151381|NCT01613378|450178138|FG000|Overall Study|Other Reason|4|||
125151382|NCT00794417|450178139|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
125151383|NCT00794417|450178140|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
125151384|NCT00794417|450178141|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
125151385|NCT00794417|450178142|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
125151386|NCT00794417|450178139|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
125151387|NCT00794417|450178140|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
125151388|NCT00794417|450178141|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
125151389|NCT00794417|450178142|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
125151390|NCT00794417|450178139|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
125151391|NCT00794417|450178140|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
125151392|NCT00794417|450178141|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
125151393|NCT00794417|450178142|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
125151394|NCT00794417|450178139|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
125151395|NCT00794417|450178140|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
125151396|NCT00794417|450178141|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
125151397|NCT00794417|450178142|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
125151398|NCT00794417|450178139|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
125151399|NCT00794417|450178140|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
125151400|NCT00794417|450178141|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
125151401|NCT00794417|450178142|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
125151402|NCT00794417|450178139|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
125151403|NCT00794417|450178140|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
125151404|NCT00794417|450178141|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
125151405|NCT00794417|450178142|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
125151406|NCT00792623|450178143|FG000|Overall Study|Adverse Event|2|||
125151407|NCT00792623|450178143|FG000|Overall Study|Withdrawal by Subject|5|||
125151408|NCT00880087|450178151|FG000|Overall Study|Lost to Follow-up|0|||
125151409|NCT00880087|450178152|FG001|Overall Study|Lost to Follow-up|2|||
125151410|NCT02065713|450178153|FG000|Overall Study|Adverse Event|0|||
125151411|NCT02065713|450178154|FG001|Overall Study|Adverse Event|1|||
125151412|NCT02065713|450178153|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125151413|NCT02065713|450178154|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125151414|NCT00483548|450178157|FG000|Overall Study|Randomized; not treated with study drug|1|||
125151415|NCT00483548|450178158|FG001|Overall Study|Randomized; not treated with study drug|3|||
125151416|NCT00483548|450178157|FG000|Overall Study|Adverse Event|25|||
125151417|NCT00483548|450178158|FG001|Overall Study|Adverse Event|14|||
125151418|NCT00483548|450178157|FG000|Overall Study|Laboratory abnormality|1|||
125151419|NCT00483548|450178158|FG001|Overall Study|Laboratory abnormality|2|||
125151420|NCT00483548|450178157|FG000|Overall Study|Lack of Efficacy|4|||
125151421|NCT00483548|450178158|FG001|Overall Study|Lack of Efficacy|8|||
125151422|NCT00483548|450178157|FG000|Overall Study|Protocol Violation|11|||
125151423|NCT00483548|450178158|FG001|Overall Study|Protocol Violation|7|||
125151424|NCT00483548|450178157|FG000|Overall Study|Pregnancy|1|||
125151425|NCT00483548|450178158|FG001|Overall Study|Pregnancy|0|||
125151426|NCT00483548|450178157|FG000|Overall Study|Protocol required discontinuation|6|||
125151427|NCT00483548|450178158|FG001|Overall Study|Protocol required discontinuation|6|||
125151428|NCT00483548|450178157|FG000|Overall Study|Unable to comply with protocol schedule|1|||
125151429|NCT00483548|450178158|FG001|Overall Study|Unable to comply with protocol schedule|0|||
125151430|NCT00483548|450178157|FG000|Overall Study|Non-compliance with medication|2|||
125151431|NCT00483548|450178158|FG001|Overall Study|Non-compliance with medication|0|||
125151432|NCT00483548|450178157|FG000|Overall Study|Lost to Follow-up|3|||
125151433|NCT00483548|450178158|FG001|Overall Study|Lost to Follow-up|4|||
125151434|NCT00483548|450178157|FG000|Overall Study|Withdrawal by Subject|5|||
125151435|NCT00483548|450178158|FG001|Overall Study|Withdrawal by Subject|2|||
125151436|NCT02694549|450178161|FG000|Overall Study|screen failures|2|||
125151437|NCT01534078|450178162|FG000|Overall Study|Death|1|||
125151438|NCT01534078|450178162|FG000|Overall Study|Withdrawal by Subject|1|||
125151439|NCT02459665|450178163|FG000|Overall Study|Withdrawal by Subject|0|||
125151440|NCT02459665|450178164|FG001|Overall Study|Withdrawal by Subject|1|||
125151441|NCT02459665|450178165|FG002|Overall Study|Withdrawal by Subject|1|||
125151442|NCT02459665|450178166|FG003|Overall Study|Withdrawal by Subject|2|||
125151443|NCT01220609|450178167|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
125151444|NCT01220609|450178167|FG000|Overall Study|Ineligible- Wrong cell type|1|||
125151445|NCT01220609|450178167|FG000|Overall Study|Ineligible-Never treated|1|||
125151446|NCT02225665|450178168|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
125151447|NCT02225665|450178169|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
125151448|NCT02225665|450178168|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
125151449|NCT02225665|450178169|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
125151450|NCT00572039|450178170|FG000|Overall Study|Withdrawal by Subject|9|||
125151451|NCT00572039|450178171|FG001|Overall Study|Withdrawal by Subject|6|||
125151452|NCT00572039|450178170|FG000|Overall Study|Death|2|||
125151453|NCT00572039|450178171|FG001|Overall Study|Death|3|||
125151454|NCT00572039|450178170|FG000|Overall Study|Ill|5|||
125151455|NCT00572039|450178171|FG001|Overall Study|Ill|1|||
125151456|NCT01790113|450178176|FG000|Overall Study|Adverse Event|2|||
125151457|NCT01790113|450178177|FG001|Overall Study|Adverse Event|7|||
125151458|NCT01790113|450178176|FG000|Overall Study|Study ended due to FDA clearance|1|||
125151459|NCT01790113|450178177|FG001|Overall Study|Study ended due to FDA clearance|68|||
125151460|NCT03585959|450178178|FG000|Overall Study|Physician Decision|1|||
125151461|NCT03585959|450178178|FG000|Overall Study|Unsuccessful Procedure|2|||
125151462|NCT00614822|450178180|FG000|Overall Study|Adverse Event|3|||
125151463|NCT02674386|450178183|FG000|Overall Study|Lost to Follow-up|0|||
125151464|NCT02674386|450178184|FG001|Overall Study|Lost to Follow-up|1|||
125151465|NCT02674386|450178185|FG002|Overall Study|Lost to Follow-up|1|||
125151466|NCT02674386|450178183|FG000|Overall Study|Withdrawal by Subject|0|||
125151467|NCT02674386|450178184|FG001|Overall Study|Withdrawal by Subject|4|||
125151468|NCT02674386|450178185|FG002|Overall Study|Withdrawal by Subject|0|||
125151469|NCT02674386|450178183|FG000|Overall Study|Other|0|||
125151470|NCT02674386|450178184|FG001|Overall Study|Other|1|||
125151471|NCT02674386|450178185|FG002|Overall Study|Other|0|||
125151472|NCT02674386|450178183|FG000|Overall Study|Enrolled but not evaluated|0|||
125151473|NCT02674386|450178184|FG001|Overall Study|Enrolled but not evaluated|4|||
125151474|NCT02674386|450178185|FG002|Overall Study|Enrolled but not evaluated|0|||
125151475|NCT01439724|450178190|FG000|Overall Study|missing consultation|9|||
125151476|NCT01439724|450178191|FG001|Overall Study|missing consultation|8|||
125151477|NCT01040793|450178196|FG000|Overall Study|Adverse Event|5|||
125151478|NCT01040793|450178197|FG001|Overall Study|Adverse Event|3|||
125151479|NCT01040793|450178198|FG002|Overall Study|Adverse Event|0|||
125151480|NCT01040793|450178199|FG003|Overall Study|Adverse Event|2|||
125151481|NCT01040793|450178200|FG004|Overall Study|Adverse Event|2|||
125151482|NCT01040793|450178201|FG005|Overall Study|Adverse Event|1|||
125151483|NCT01040793|450178196|FG000|Overall Study|Protocol Violation|1|||
125151484|NCT01040793|450178197|FG001|Overall Study|Protocol Violation|1|||
125151485|NCT01040793|450178198|FG002|Overall Study|Protocol Violation|1|||
125151486|NCT01040793|450178199|FG003|Overall Study|Protocol Violation|0|||
125151487|NCT01040793|450178200|FG004|Overall Study|Protocol Violation|1|||
125151488|NCT01040793|450178201|FG005|Overall Study|Protocol Violation|0|||
125151489|NCT01040793|450178196|FG000|Overall Study|Lost to Follow-up|0|||
125151490|NCT01040793|450178197|FG001|Overall Study|Lost to Follow-up|1|||
125151491|NCT01040793|450178198|FG002|Overall Study|Lost to Follow-up|1|||
125151492|NCT01040793|450178199|FG003|Overall Study|Lost to Follow-up|0|||
125151493|NCT01040793|450178200|FG004|Overall Study|Lost to Follow-up|0|||
125151494|NCT01040793|450178201|FG005|Overall Study|Lost to Follow-up|0|||
125151495|NCT01040793|450178196|FG000|Overall Study|Withdrawal by Subject|0|||
125151496|NCT01040793|450178197|FG001|Overall Study|Withdrawal by Subject|0|||
125151497|NCT01040793|450178198|FG002|Overall Study|Withdrawal by Subject|0|||
125151498|NCT01040793|450178199|FG003|Overall Study|Withdrawal by Subject|2|||
125151499|NCT01040793|450178200|FG004|Overall Study|Withdrawal by Subject|0|||
125151500|NCT01040793|450178201|FG005|Overall Study|Withdrawal by Subject|0|||
125151501|NCT01040793|450178196|FG000|Overall Study|Other reasons not listed above|0|||
125151502|NCT01040793|450178197|FG001|Overall Study|Other reasons not listed above|0|||
125151503|NCT01040793|450178198|FG002|Overall Study|Other reasons not listed above|1|||
125151504|NCT01040793|450178199|FG003|Overall Study|Other reasons not listed above|0|||
125151505|NCT01040793|450178200|FG004|Overall Study|Other reasons not listed above|1|||
125151506|NCT01040793|450178201|FG005|Overall Study|Other reasons not listed above|0|||
125151507|NCT00939627|450178206|FG000|Overall Study|Disease Progression|16|||
125151508|NCT00939627|450178207|FG001|Overall Study|Disease Progression|12|||
125151509|NCT00939627|450178208|FG002|Overall Study|Disease Progression|0|||
125151510|NCT00939627|450178206|FG000|Overall Study|Adverse Event|6|||
125151511|NCT00939627|450178207|FG001|Overall Study|Adverse Event|7|||
125151512|NCT00939627|450178208|FG002|Overall Study|Adverse Event|0|||
125151513|NCT00939627|450178206|FG000|Overall Study|Death|0|||
125151514|NCT00939627|450178207|FG001|Overall Study|Death|2|||
125151515|NCT00939627|450178208|FG002|Overall Study|Death|0|||
125151516|NCT00939627|450178206|FG000|Overall Study|Withdrawal by Subject|2|||
125151517|NCT00939627|450178207|FG001|Overall Study|Withdrawal by Subject|4|||
125151518|NCT00939627|450178208|FG002|Overall Study|Withdrawal by Subject|0|||
125151519|NCT00939627|450178206|FG000|Overall Study|Other complicating disease|1|||
125151520|NCT00939627|450178207|FG001|Overall Study|Other complicating disease|1|||
125151521|NCT00939627|450178208|FG002|Overall Study|Other complicating disease|0|||
125151522|NCT00939627|450178206|FG000|Overall Study|Not compliant|2|||
125151523|NCT00939627|450178207|FG001|Overall Study|Not compliant|0|||
125151524|NCT00939627|450178208|FG002|Overall Study|Not compliant|0|||
125151525|NCT00939627|450178206|FG000|Overall Study|No off-tx reason given|0|||
125151526|NCT00939627|450178207|FG001|Overall Study|No off-tx reason given|2|||
125151527|NCT00939627|450178208|FG002|Overall Study|No off-tx reason given|0|||
125151528|NCT03297294|450178209|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
125151529|NCT03297294|450178210|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
125151530|NCT03297294|450178211|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
125151531|NCT03297294|450178212|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
125151532|NCT03297294|450178213|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
125151533|NCT03297294|450178209|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
125151534|NCT03297294|450178210|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
125151535|NCT03297294|450178211|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
125151536|NCT03297294|450178212|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
125151537|NCT03297294|450178213|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
125151538|NCT03297294|450178209|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
125151539|NCT03297294|450178210|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
125151540|NCT03297294|450178211|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
125151541|NCT03297294|450178212|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
125151542|NCT03297294|450178213|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
125151543|NCT03297294|450178209|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
125151544|NCT03297294|450178210|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
125151545|NCT03297294|450178211|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
125151546|NCT03297294|450178212|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
125151547|NCT03297294|450178213|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
125151548|NCT03297294|450178209|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
125151549|NCT03297294|450178210|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
125151550|NCT03297294|450178211|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
125151551|NCT03297294|450178212|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
125151552|NCT03297294|450178213|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
125151553|NCT02776553|450178219|FG000|Overall Study|Lost to Follow-up|1|||
125151554|NCT02776553|450178220|FG001|Overall Study|Lost to Follow-up|0|||
125151555|NCT02776553|450178219|FG000|Overall Study|got liver transplant|1|||
125151556|NCT02776553|450178220|FG001|Overall Study|got liver transplant|2|||
125151557|NCT02776553|450178219|FG000|Overall Study|had other surgery|1|||
125151558|NCT02776553|450178220|FG001|Overall Study|had other surgery|0|||
125151559|NCT02776553|450178219|FG000|Overall Study|Protocol Violation|0|||
125151560|NCT02776553|450178220|FG001|Overall Study|Protocol Violation|1|||
125151561|NCT00104247|450178230|FG000|Overall Study|Withdrawal by Subject|1|||
125151562|NCT00104247|450178231|FG001|Overall Study|Withdrawal by Subject|0|||
125151563|NCT00104247|450178230|FG000|Overall Study|Noncompliant with dosing|0|||
125151564|NCT00104247|450178231|FG001|Overall Study|Noncompliant with dosing|1|||
125151565|NCT00063882|450178234|FG000|Overall Study|Protocol Violation|3|||
125151566|NCT00063882|450178235|FG001|Overall Study|Protocol Violation|3|||
125151567|NCT00063882|450178234|FG000|Overall Study|Withdrawal by Subject|2|||
125151568|NCT00063882|450178235|FG001|Overall Study|Withdrawal by Subject|1|||
125151569|NCT01930175|450178236|FG000|Core Study|Lost to Follow-up|0|||
125151570|NCT01930175|450178237|FG001|Core Study|Lost to Follow-up|1|||
125151571|NCT01930175|450178238|FG002|Core Study|Lost to Follow-up|0|||
125151572|NCT01930175|450178236|FG000|Core Study|Adverse Event|0|||
125151573|NCT01930175|450178237|FG001|Core Study|Adverse Event|0|||
125151574|NCT01930175|450178238|FG002|Core Study|Adverse Event|1|||
125151575|NCT00834899|450178239|FG000|Overall Study|Withdrawal by Subject|1|||
125151576|NCT00834899|450178240|FG001|Overall Study|Withdrawal by Subject|1|||
125151577|NCT03314662|450178243|FG000|Overall Study|Withdrawal by Subject|1|||
125151578|NCT03314662|450178244|FG001|Overall Study|Withdrawal by Subject|1|||
125151579|NCT03314662|450178245|FG002|Overall Study|Withdrawal by Subject|1|||
125151580|NCT03314662|450178243|FG000|Overall Study|Lost to Follow-up|5|||
125151581|NCT03314662|450178244|FG001|Overall Study|Lost to Follow-up|4|||
125151582|NCT03314662|450178245|FG002|Overall Study|Lost to Follow-up|4|||
125151583|NCT03314662|450178243|FG000|Overall Study|Death|2|||
125151584|NCT03314662|450178244|FG001|Overall Study|Death|0|||
125151585|NCT03314662|450178245|FG002|Overall Study|Death|0|||
125151586|NCT01117766|450178250|FG000|First Intervention|Adverse Event|0|||
125151587|NCT01117766|450178251|FG001|First Intervention|Adverse Event|1|||
125151588|NCT01117766|450178250|FG000|First Intervention|Protocol Violation|1|||
125151589|NCT01117766|450178251|FG001|First Intervention|Protocol Violation|0|||
125151590|NCT01117766|450178250|FG000|Washout Period|Protocol Violation|0|||
125151591|NCT01117766|450178251|FG001|Washout Period|Protocol Violation|2|||
125151592|NCT01117766|450178250|FG000|Second Intervention|Lost to Follow-up|1|||
125151593|NCT01117766|450178251|FG001|Second Intervention|Lost to Follow-up|0|||
125151594|NCT01117766|450178250|FG000|Second Intervention|Other|1|||
125151595|NCT01117766|450178251|FG001|Second Intervention|Other|2|||
125151596|NCT01117766|450178250|FG000|Second Intervention|Adverse Event|0|||
125151597|NCT01117766|450178251|FG001|Second Intervention|Adverse Event|2|||
125151598|NCT01117766|450178250|FG000|Second Intervention|Withdrawal by Subject|0|||
125151599|NCT01117766|450178251|FG001|Second Intervention|Withdrawal by Subject|1|||
125151600|NCT00438659|450178252|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
125151601|NCT00438659|450178253|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
125151602|NCT00438659|450178252|FG000|Overall Study|Cancel|5|||
125151603|NCT00438659|450178253|FG001|Overall Study|Cancel|2|||
125151604|NCT02244424|450178254|FG000|Overall Study|Lost to Follow-up|20|||
125151605|NCT02244424|450178255|FG001|Overall Study|Lost to Follow-up|10|||
125151606|NCT03366194|450178259|FG000|Overall Study|Lost to Follow-up|2|||
125151607|NCT01684215|450179458|FG000|Phase 1, Part 1|Adverse Event|1|||
125151608|NCT01684215|450179459|FG001|Phase 1, Part 1|Adverse Event|0|||
125151609|NCT01684215|450179460|FG002|Phase 1, Part 1|Adverse Event|0|||
125151610|NCT01684215|450179461|FG003|Phase 1, Part 1|Adverse Event|0|||
125151611|NCT01684215|450179458|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
125151612|NCT01684215|450179459|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
125151613|NCT01684215|450179460|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
125151614|NCT01684215|450179461|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
125151615|NCT01684215|450179458|FG000|Phase 1, Part 2|Adverse Event|0|||
125151616|NCT01684215|450179459|FG001|Phase 1, Part 2|Adverse Event|0|||
125151617|NCT01684215|450179460|FG002|Phase 1, Part 2|Adverse Event|1|||
125151618|NCT01684215|450179461|FG003|Phase 1, Part 2|Adverse Event|0|||
125151619|NCT01684215|450179458|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
125151620|NCT01684215|450179459|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
125151621|NCT01684215|450179460|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
125151622|NCT01684215|450179461|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
125151623|NCT01684215|450179458|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
125151624|NCT01684215|450179459|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
125151625|NCT01684215|450179460|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
125151626|NCT01684215|450179461|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
125151627|NCT01684215|450179458|FG000|Phase 2|Death|0|||
125151628|NCT01684215|450179459|FG001|Phase 2|Death|0|||
125151629|NCT01684215|450179460|FG002|Phase 2|Death|0|||
125151630|NCT01684215|450179461|FG003|Phase 2|Death|8|||
125151631|NCT01684215|450179458|FG000|Phase 2|Study terminated by sponsor|0|||
125151632|NCT01684215|450179459|FG001|Phase 2|Study terminated by sponsor|0|||
125151633|NCT01684215|450179460|FG002|Phase 2|Study terminated by sponsor|0|||
125151634|NCT01684215|450179461|FG003|Phase 2|Study terminated by sponsor|30|||
125151635|NCT01684215|450179458|FG000|Phase 2|Enrolled but not treated|0|||
125151636|NCT01684215|450179459|FG001|Phase 2|Enrolled but not treated|0|||
125151637|NCT01684215|450179460|FG002|Phase 2|Enrolled but not treated|0|||
125151638|NCT01684215|450179461|FG003|Phase 2|Enrolled but not treated|1|||
125151639|NCT01684215|450179458|FG000|Phase 2|Lost to Follow-up|0|||
125151640|NCT01684215|450179459|FG001|Phase 2|Lost to Follow-up|0|||
125151641|NCT01684215|450179460|FG002|Phase 2|Lost to Follow-up|0|||
125151642|NCT01684215|450179461|FG003|Phase 2|Lost to Follow-up|4|||
125151643|NCT03919448|450179466|FG000|Overall Study|Withdrawal by Subject|1|||
125151644|NCT03919448|450179467|FG001|Overall Study|Withdrawal by Subject|0|||
125151645|NCT03919448|450179468|FG002|Overall Study|Withdrawal by Subject|0|||
125151646|NCT03438539|450179469|FG000|Overall Study|Lost to Follow-up|8|||
125151647|NCT03438539|450179470|FG001|Overall Study|Lost to Follow-up|4|||
125151648|NCT03438539|450179471|FG002|Overall Study|Lost to Follow-up|10|||
125151649|NCT03438539|450179472|FG003|Overall Study|Lost to Follow-up|9|||
125151650|NCT03438539|450179473|FG004|Overall Study|Lost to Follow-up|3|||
125151651|NCT03438539|450179474|FG005|Overall Study|Lost to Follow-up|8|||
125151652|NCT04213209|450179478|FG000|Overall Study|Protocol Violation|1|||
125151653|NCT04213209|450179479|FG001|Overall Study|Protocol Violation|0|||
125151654|NCT04213209|450179480|FG002|Overall Study|Protocol Violation|0|||
125151655|NCT04213209|450179481|FG003|Overall Study|Protocol Violation|0|||
125151656|NCT04213209|450179482|FG004|Overall Study|Protocol Violation|0|||
125151657|NCT04213209|450179483|FG005|Overall Study|Protocol Violation|0|||
125151658|NCT01005329|450179486|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
125151659|NCT01272921|450179489|FG000|Overall Study|Protocol Violation|2|||
125151660|NCT01272921|450179490|FG001|Overall Study|Protocol Violation|1|||
125151661|NCT01132664|450179491|FG000|Phase lb|Adverse Event|0|||
125151662|NCT01132664|450179492|FG001|Phase lb|Adverse Event|1|||
125151663|NCT01132664|450179493|FG002|Phase lb|Adverse Event|0|||
125151664|NCT01132664|450179494|FG003|Phase lb|Adverse Event|0|||
125151665|NCT01132664|450179495|FG004|Phase lb|Adverse Event|0|||
125151666|NCT01132664|450179491|FG000|Phase lb|Withdrawal by Subject|1|||
125151667|NCT01132664|450179492|FG001|Phase lb|Withdrawal by Subject|2|||
125151668|NCT01132664|450179493|FG002|Phase lb|Withdrawal by Subject|0|||
125151669|NCT01132664|450179494|FG003|Phase lb|Withdrawal by Subject|0|||
125151670|NCT01132664|450179495|FG004|Phase lb|Withdrawal by Subject|0|||
125151671|NCT01132664|450179491|FG000|Phase lb|Disease Progression|4|||
125151672|NCT01132664|450179492|FG001|Phase lb|Disease Progression|9|||
125151673|NCT01132664|450179493|FG002|Phase lb|Disease Progression|0|||
125151674|NCT01132664|450179494|FG003|Phase lb|Disease Progression|0|||
125151675|NCT01132664|450179495|FG004|Phase lb|Disease Progression|0|||
125151676|NCT01132664|450179491|FG000|Phase ll|Death|0|||
125151677|NCT01132664|450179492|FG001|Phase ll|Death|0|||
125151678|NCT01132664|450179493|FG002|Phase ll|Death|2|||
125151679|NCT01132664|450179494|FG003|Phase ll|Death|0|||
125151680|NCT01132664|450179495|FG004|Phase ll|Death|0|||
125151681|NCT01132664|450179491|FG000|Phase ll|Adverse Event|0|||
125151682|NCT01132664|450179492|FG001|Phase ll|Adverse Event|0|||
125151683|NCT01132664|450179493|FG002|Phase ll|Adverse Event|10|||
125151684|NCT01132664|450179494|FG003|Phase ll|Adverse Event|0|||
125151685|NCT01132664|450179495|FG004|Phase ll|Adverse Event|0|||
125151686|NCT01132664|450179491|FG000|Phase ll|Withdrawal by Subject|0|||
125151687|NCT01132664|450179492|FG001|Phase ll|Withdrawal by Subject|0|||
125151688|NCT01132664|450179493|FG002|Phase ll|Withdrawal by Subject|3|||
125151689|NCT01132664|450179494|FG003|Phase ll|Withdrawal by Subject|0|||
125151690|NCT01132664|450179495|FG004|Phase ll|Withdrawal by Subject|0|||
125151691|NCT01132664|450179491|FG000|Phase ll|Disease progression|0|||
125151692|NCT01132664|450179492|FG001|Phase ll|Disease progression|0|||
125151693|NCT01132664|450179493|FG002|Phase ll|Disease progression|35|||
125151694|NCT01132664|450179494|FG003|Phase ll|Disease progression|0|||
125151695|NCT01132664|450179495|FG004|Phase ll|Disease progression|0|||
125151696|NCT01132664|450179491|FG000|BM Cohort|Disease progression|0|||
125151697|NCT01132664|450179492|FG001|BM Cohort|Disease progression|0|||
125151698|NCT01132664|450179493|FG002|BM Cohort|Disease progression|0|||
125151699|NCT01132664|450179494|FG003|BM Cohort|Disease progression|3|||
125151700|NCT01132664|450179495|FG004|BM Cohort|Disease progression|4|||
125151701|NCT01132664|450179491|FG000|BM Cohort|Adverse Event|0|||
125151702|NCT01132664|450179492|FG001|BM Cohort|Adverse Event|0|||
125151703|NCT01132664|450179493|FG002|BM Cohort|Adverse Event|0|||
125151704|NCT01132664|450179494|FG003|BM Cohort|Adverse Event|0|||
125151705|NCT01132664|450179495|FG004|BM Cohort|Adverse Event|1|||
125151706|NCT01132664|450179491|FG000|BM Cohort|Withdrawal by Subject|0|||
125151707|NCT01132664|450179492|FG001|BM Cohort|Withdrawal by Subject|0|||
125151708|NCT01132664|450179493|FG002|BM Cohort|Withdrawal by Subject|0|||
125151709|NCT01132664|450179494|FG003|BM Cohort|Withdrawal by Subject|0|||
125151710|NCT01132664|450179495|FG004|BM Cohort|Withdrawal by Subject|1|||
125151711|NCT00126126|450179496|FG000|Overall Study|Lost to Follow-up|0|||
125151712|NCT00126126|450179497|FG001|Overall Study|Lost to Follow-up|2|||
125151713|NCT01567826|450179500|FG000|Overall Study|Lost to Follow-up|3|||
125151714|NCT01567826|450179501|FG001|Overall Study|Lost to Follow-up|2|||
125151715|NCT01223235|450179504|FG000|Overall Study|Withdrawal by Subject|1|||
125151716|NCT04364737|450179508|FG000|Overall Study|Withdrawal by Subject|4|||
125151717|NCT04364737|450179509|FG001|Overall Study|Withdrawal by Subject|9|||
125151718|NCT04364737|450179508|FG000|Overall Study|Lost to Follow-up|1|||
125151719|NCT04364737|450179509|FG001|Overall Study|Lost to Follow-up|1|||
125151720|NCT00868296|450179513|FG000|Overall Study|Adverse Event|0|||
125151721|NCT00868296|450179514|FG001|Overall Study|Adverse Event|2|||
125151722|NCT00868296|450179513|FG000|Overall Study|Withdrawal by Subject|0|||
125151723|NCT00868296|450179514|FG001|Overall Study|Withdrawal by Subject|1|||
125151724|NCT00804141|450179519|FG000|Overall Study|Adverse Event|157|||
125151725|NCT00804141|450179519|FG000|Overall Study|Death|4|||
125151726|NCT00804141|450179519|FG000|Overall Study|Failed to return|96|||
125151727|NCT00804141|450179519|FG000|Overall Study|Investigator request|8|||
125151728|NCT00804141|450179519|FG000|Overall Study|Protocol Violation|85|||
125151729|NCT00804141|450179519|FG000|Overall Study|Withdrawal by Subject|131|||
125151730|NCT00804141|450179519|FG000|Overall Study|Lack of Efficacy|46|||
125151731|NCT00804141|450179519|FG000|Overall Study|Other than specified|30|||
125151732|NCT00804141|450179519|FG000|Overall Study|Enrolled but not treated|6|||
125151733|NCT02075606|450179520|FG000|Overall Study|Adverse Event|5|||
125151734|NCT02075606|450179520|FG000|Overall Study|Withdrawal by Subject|1|||
125151735|NCT02075606|450179520|FG000|Overall Study|Death|1|||
125151736|NCT02075606|450179520|FG000|Overall Study|Investigator's decision|1|||
125151737|NCT02075606|450179520|FG000|Overall Study|Symptom management|1|||
125151738|NCT02075606|450179520|FG000|Overall Study|Increasing Symptoms|1|||
125151739|NCT02462486|450179521|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
125151740|NCT02462486|450179522|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
125151741|NCT02462486|450179523|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
125151742|NCT02462486|450179521|FG000|Overall Study|Adverse Event|53|||
125151743|NCT02462486|450179522|FG001|Overall Study|Adverse Event|48|||
125151744|NCT02462486|450179523|FG002|Overall Study|Adverse Event|21|||
125151745|NCT02462486|450179521|FG000|Overall Study|Lack of Efficacy|6|||
125151746|NCT02462486|450179522|FG001|Overall Study|Lack of Efficacy|12|||
125151747|NCT02462486|450179523|FG002|Overall Study|Lack of Efficacy|3|||
125151748|NCT02462486|450179521|FG000|Overall Study|Lost to Follow-up|3|||
125151749|NCT02462486|450179522|FG001|Overall Study|Lost to Follow-up|4|||
125151750|NCT02462486|450179523|FG002|Overall Study|Lost to Follow-up|2|||
125151751|NCT02462486|450179521|FG000|Overall Study|Withdrawal by Subject|25|||
125151752|NCT02462486|450179522|FG001|Overall Study|Withdrawal by Subject|22|||
125151753|NCT02462486|450179523|FG002|Overall Study|Withdrawal by Subject|19|||
125151754|NCT02462486|450179521|FG000|Overall Study|Protocol Violation|3|||
125151755|NCT02462486|450179522|FG001|Overall Study|Protocol Violation|1|||
125151756|NCT02462486|450179523|FG002|Overall Study|Protocol Violation|1|||
125151757|NCT02462486|450179521|FG000|Overall Study|Reason not Specified|3|||
125151758|NCT02462486|450179522|FG001|Overall Study|Reason not Specified|4|||
125151759|NCT02462486|450179523|FG002|Overall Study|Reason not Specified|3|||
125151760|NCT00941720|450179527|FG000|Overall Study|Withdrawal by Subject|1|||
125151761|NCT00941720|450179527|FG000|Overall Study|Insurance denied participation|11|||
125151762|NCT00941720|450179527|FG000|Overall Study|ineligible|2|||
125151763|NCT01682148|450179528|FG000|Overall Study|Withdrawal by Subject|2|||
125151764|NCT01682148|450179529|FG001|Overall Study|Withdrawal by Subject|0|||
125151765|NCT01682148|450179528|FG000|Overall Study|Lost to Follow-up|1|||
125151766|NCT01682148|450179529|FG001|Overall Study|Lost to Follow-up|2|||
125151767|NCT01682148|450179528|FG000|Overall Study|Protocol Violation|1|||
125151768|NCT01682148|450179529|FG001|Overall Study|Protocol Violation|1|||
125151769|NCT00775528|450179530|FG000|Overall Study|Protocol Violation|1|||
125151770|NCT02087176|450179531|FG000|Overall Study|Withdrawal by Subject|1|||
125151771|NCT02087176|450179531|FG000|Overall Study|Death|10|||
125223835|NCT02782741|450446238|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
125223836|NCT02782741|450446239|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
125223837|NCT02782741|450446237|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
125223838|NCT02782741|450446238|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
125151772|NCT02087176|450179531|FG000|Overall Study|Censored|19|||
125151773|NCT02087176|450179531|FG000|Overall Study|Study Terminated by Sponsor|2|||
125151774|NCT03648879|450179532|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
125151775|NCT03812991|450179535|FG000|Overall Study|Lost to Follow-up|3|||
125151776|NCT03812991|450179536|FG001|Overall Study|Lost to Follow-up|1|||
125151777|NCT04740931|450179537|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
125151778|NCT04740931|450179538|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
125223839|NCT02782741|450446239|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
125223840|NCT02782741|450446237|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
125223841|NCT02782741|450446238|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
125223842|NCT02782741|450446239|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
125151779|NCT04740931|450179537|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
125151780|NCT04740931|450179538|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
125151781|NCT04740931|450179537|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
125151782|NCT04740931|450179538|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
125151783|NCT04740931|450179537|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
125151784|NCT04740931|450179538|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
125151785|NCT04740931|450179537|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
125151786|NCT04740931|450179538|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
125151787|NCT04740931|450179537|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
125151788|NCT04740931|450179538|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
125151789|NCT04740931|450179537|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
125151790|NCT04740931|450179538|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
125151791|NCT04740931|450179537|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
125151792|NCT04740931|450179538|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
125151793|NCT04740931|450179537|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
125151794|NCT04740931|450179538|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
125151795|NCT04740931|450179537|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
125151796|NCT04740931|450179538|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
125151797|NCT04740931|450179537|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
125151798|NCT04740931|450179538|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
125151799|NCT04740931|450179537|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
125151800|NCT04740931|450179538|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
125151801|NCT04740931|450179537|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
125151802|NCT04740931|450179538|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
125151803|NCT04740931|450179537|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
125151804|NCT04740931|450179538|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
125151805|NCT04740931|450179537|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
125151806|NCT04740931|450179538|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
125151807|NCT00895037|450179539|FG000|Overall Study|Death|0|||
125151808|NCT00895037|450179540|FG001|Overall Study|Death|2|||
125151809|NCT00895037|450179541|FG002|Overall Study|Death|1|||
125151810|NCT01029392|450179547|FG000|Overall Study|Withdrawal by Subject|18|||
125151811|NCT01029392|450179548|FG001|Overall Study|Withdrawal by Subject|11|||
125151812|NCT01029392|450179547|FG000|Overall Study|Physician Decision|2|||
125151813|NCT01029392|450179548|FG001|Overall Study|Physician Decision|0|||
125151814|NCT01103479|450179549|FG000|Overall Study|Up to date with CRC screening|1|||
125151815|NCT01103479|450179550|FG001|Overall Study|Up to date with CRC screening|9|||
125151816|NCT01103479|450179551|FG002|Overall Study|Up to date with CRC screening|12|||
125151817|NCT01103479|450179549|FG000|Overall Study|Family history of CRC|1|||
125151818|NCT01103479|450179550|FG001|Overall Study|Family history of CRC|0|||
125151819|NCT01103479|450179551|FG002|Overall Study|Family history of CRC|2|||
125151820|NCT01103479|450179549|FG000|Overall Study|Active cancer|1|||
125151821|NCT01103479|450179550|FG001|Overall Study|Active cancer|0|||
125151822|NCT01103479|450179551|FG002|Overall Study|Active cancer|0|||
125151823|NCT01103479|450179549|FG000|Overall Study|Saw non-study physician|2|||
125151824|NCT01103479|450179550|FG001|Overall Study|Saw non-study physician|0|||
125151825|NCT01103479|450179551|FG002|Overall Study|Saw non-study physician|0|||
125151826|NCT01534637|450179552|FG000|Overall Study|Physician Decision|3|||
125151827|NCT01534637|450179552|FG000|Overall Study|Lack of Efficacy|3|||
125151828|NCT01534637|450179552|FG000|Overall Study|Withdrawal by Subject|1|||
125151829|NCT01534637|450179552|FG000|Overall Study|Adverse Event|1|||
125151830|NCT01534637|450179552|FG000|Overall Study|Liver Mets before treatment|1|||
125151831|NCT00605917|450179553|FG000|Overall Study|Protocol Violation|79|||
125151832|NCT00890552|450179554|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
125151833|NCT00890552|450179554|FG000|On-treatment|Early prog disease/ death|10|||
125151834|NCT00724373|450179555|FG000|Overall Study|Adverse Event|41|||
125151835|NCT00724373|450179555|FG000|Overall Study|Lack of Efficacy|82|||
125151836|NCT00724373|450179555|FG000|Overall Study|Lost to Follow-up|7|||
125151837|NCT00724373|450179555|FG000|Overall Study|Non-compliance|2|||
125151838|NCT00724373|450179555|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
125151839|NCT00724373|450179555|FG000|Overall Study|Participant moved away|1|||
125151840|NCT00724373|450179555|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
125151841|NCT00724373|450179555|FG000|Overall Study|Only to have 24 week regimen|1|||
125151842|NCT00724373|450179555|FG000|Overall Study|Viral Relapse|1|||
125151843|NCT00724373|450179555|FG000|Overall Study|Acute HCV infection|1|||
125151844|NCT00724373|450179555|FG000|Overall Study|Drug Relapse|1|||
125151845|NCT00724373|450179555|FG000|Overall Study|Tolerability|23|||
125151846|NCT02549573|450179556|FG000|Overall Study|Withdrawal by Subject|0|||
125151847|NCT02549573|450179557|FG001|Overall Study|Withdrawal by Subject|2|||
125151848|NCT02549573|450179556|FG000|Overall Study|Protocol Violation|0|||
125151849|NCT02549573|450179557|FG001|Overall Study|Protocol Violation|1|||
125151850|NCT03043560|450179560|FG000|Overall Study|Discontinued Intervention|1|||
125151851|NCT03043560|450179561|FG001|Overall Study|Discontinued Intervention|2|||
125151852|NCT03043560|450179560|FG000|Overall Study|Lost to Follow-up|0|||
125151853|NCT03043560|450179561|FG001|Overall Study|Lost to Follow-up|1|||
125151854|NCT00440115|450179562|FG000|Overall Study|Death|7|||
125151855|NCT00440115|450179563|FG001|Overall Study|Death|9|||
125151856|NCT00440115|450179564|FG002|Overall Study|Death|5|||
125151857|NCT00440115|450179562|FG000|Overall Study|Incarceration|0|||
125151858|NCT00440115|450179563|FG001|Overall Study|Incarceration|2|||
125151859|NCT00440115|450179564|FG002|Overall Study|Incarceration|1|||
125151860|NCT00206102|450179566|FG000|Overall Study|Adverse Event|119|||
125151861|NCT00206102|450179567|FG001|Overall Study|Adverse Event|82|||
125151862|NCT00206102|450179566|FG000|Overall Study|Protocol Violation|0|||
125151863|NCT00206102|450179567|FG001|Overall Study|Protocol Violation|2|||
125151864|NCT00206102|450179566|FG000|Overall Study|Lack of therapeutic response|16|||
125151865|NCT00206102|450179567|FG001|Overall Study|Lack of therapeutic response|11|||
125151866|NCT00206102|450179566|FG000|Overall Study|Lost to Follow-up|95|||
125151867|NCT00206102|450179567|FG001|Overall Study|Lost to Follow-up|66|||
125151868|NCT00206102|450179566|FG000|Overall Study|Withdrawal by Subject|118|||
125151869|NCT00206102|450179567|FG001|Overall Study|Withdrawal by Subject|101|||
125151870|NCT00206102|450179566|FG000|Overall Study|Study-specific discontinuation criteria|18|||
125151871|NCT00206102|450179567|FG001|Overall Study|Study-specific discontinuation criteria|17|||
125151872|NCT00206102|450179566|FG000|Overall Study|None of those categories|42|||
125151873|NCT00206102|450179567|FG001|Overall Study|None of those categories|36|||
125151874|NCT03123783|450179568|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
125151875|NCT03123783|450179569|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
125151876|NCT03123783|450179570|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
125151877|NCT03123783|450179571|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
125151878|NCT03123783|450179572|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
125151879|NCT03123783|450179573|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
125151880|NCT03123783|450179574|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
125151881|NCT03123783|450179568|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
125151882|NCT03123783|450179569|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
125151883|NCT03123783|450179570|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
125151884|NCT03123783|450179571|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
125151885|NCT03123783|450179572|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
125151886|NCT03123783|450179573|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
125151887|NCT03123783|450179574|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
125151888|NCT03123783|450179568|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
125151889|NCT03123783|450179569|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
125151890|NCT03123783|450179570|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
125151891|NCT03123783|450179571|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
125151892|NCT03123783|450179572|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
125151893|NCT03123783|450179573|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
125151894|NCT03123783|450179574|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
125151895|NCT03123783|450179568|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
125151896|NCT03123783|450179569|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
125151897|NCT03123783|450179570|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
125151898|NCT03123783|450179571|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
125151899|NCT03123783|450179572|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
125151900|NCT03123783|450179573|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
125151901|NCT03123783|450179574|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
125151902|NCT02953678|450179577|FG000|Overall Study|Adverse Event|20|||
125151903|NCT02953678|450179577|FG000|Overall Study|Death|7|||
125151904|NCT02953678|450179577|FG000|Overall Study|Physician Decision|23|||
125151905|NCT02953678|450179577|FG000|Overall Study|Progressive Disease of GVHD|7|||
125151906|NCT02953678|450179577|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
125151907|NCT02953678|450179577|FG000|Overall Study|Withdrawal by participant|3|||
125151908|NCT02953678|450179577|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
125151909|NCT02953678|450179577|FG000|Overall Study|Participants were transferred to commercial product.|3|||
125151910|NCT01730040|450181083|FG000|Overall Study|Randomized but not treated|0|||
125151911|NCT01730040|450181084|FG001|Overall Study|Randomized but not treated|0|||
125151912|NCT01730040|450181085|FG002|Overall Study|Randomized but not treated|0|||
125151913|NCT01730040|450181086|FG003|Overall Study|Randomized but not treated|0|||
125151914|NCT01730040|450181087|FG004|Overall Study|Randomized but not treated|0|||
125151915|NCT01730040|450181088|FG005|Overall Study|Randomized but not treated|1|||
125151916|NCT01730040|450181089|FG006|Overall Study|Randomized but not treated|0|||
125151917|NCT01730040|450181083|FG000|Overall Study|Subject moved|0|||
125151918|NCT01730040|450181084|FG001|Overall Study|Subject moved|0|||
125151919|NCT01730040|450181085|FG002|Overall Study|Subject moved|1|||
125151920|NCT01730040|450181086|FG003|Overall Study|Subject moved|0|||
125151921|NCT01730040|450181087|FG004|Overall Study|Subject moved|0|||
125151922|NCT01730040|450181088|FG005|Overall Study|Subject moved|0|||
125151923|NCT01730040|450181089|FG006|Overall Study|Subject moved|1|||
125151924|NCT01730040|450181083|FG000|Overall Study|Physician Decision|0|||
125151925|NCT01730040|450181084|FG001|Overall Study|Physician Decision|0|||
125151926|NCT01730040|450181085|FG002|Overall Study|Physician Decision|0|||
125151927|NCT01730040|450181086|FG003|Overall Study|Physician Decision|0|||
125151928|NCT01730040|450181087|FG004|Overall Study|Physician Decision|0|||
125151929|NCT01730040|450181088|FG005|Overall Study|Physician Decision|1|||
125151930|NCT01730040|450181089|FG006|Overall Study|Physician Decision|1|||
125151931|NCT01730040|450181083|FG000|Overall Study|Other than specified|7|||
125151932|NCT01730040|450181084|FG001|Overall Study|Other than specified|8|||
125151933|NCT01730040|450181085|FG002|Overall Study|Other than specified|5|||
125151934|NCT01730040|450181086|FG003|Overall Study|Other than specified|5|||
125151935|NCT01730040|450181087|FG004|Overall Study|Other than specified|5|||
125151936|NCT01730040|450181088|FG005|Overall Study|Other than specified|4|||
125151937|NCT01730040|450181089|FG006|Overall Study|Other than specified|4|||
125151938|NCT01730040|450181083|FG000|Overall Study|Adverse Event|4|||
125151939|NCT01730040|450181084|FG001|Overall Study|Adverse Event|3|||
125151940|NCT01730040|450181085|FG002|Overall Study|Adverse Event|5|||
125151941|NCT01730040|450181086|FG003|Overall Study|Adverse Event|3|||
125151942|NCT01730040|450181087|FG004|Overall Study|Adverse Event|1|||
125151943|NCT01730040|450181088|FG005|Overall Study|Adverse Event|1|||
125151944|NCT01730040|450181089|FG006|Overall Study|Adverse Event|2|||
125151945|NCT01730040|450181083|FG000|Overall Study|Poor compliance to protocol|2|||
125151946|NCT01730040|450181084|FG001|Overall Study|Poor compliance to protocol|4|||
125151947|NCT01730040|450181085|FG002|Overall Study|Poor compliance to protocol|0|||
125151948|NCT01730040|450181086|FG003|Overall Study|Poor compliance to protocol|0|||
125151949|NCT01730040|450181087|FG004|Overall Study|Poor compliance to protocol|0|||
125151950|NCT01730040|450181088|FG005|Overall Study|Poor compliance to protocol|0|||
125151951|NCT01730040|450181089|FG006|Overall Study|Poor compliance to protocol|1|||
125151952|NCT01042535|450181090|FG000|Overall Study|disease progression prior to treatment|3|||
125151953|NCT01042535|450181090|FG000|Overall Study|disease progression during treatment|3|||
125151954|NCT01042535|450181090|FG000|Overall Study|complications from other disease|2|||
125151955|NCT01546142|450181091|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
125151956|NCT01546142|450181092|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
125151957|NCT01546142|450181091|FG000|Overall Study|Subject Noncompliance|1|||
125151958|NCT01546142|450181092|FG001|Overall Study|Subject Noncompliance|1|||
125151959|NCT01546142|450181091|FG000|Overall Study|Adverse Event|6|||
125151960|NCT01546142|450181092|FG001|Overall Study|Adverse Event|3|||
125151961|NCT01546142|450181091|FG000|Overall Study|Lost to Follow-up|20|||
125151962|NCT01546142|450181092|FG001|Overall Study|Lost to Follow-up|15|||
125151963|NCT01546142|450181091|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
125151964|NCT01546142|450181092|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
125151965|NCT01546142|450181091|FG000|Overall Study|Subject Randomized but Not Treated|1|||
125151966|NCT01546142|450181092|FG001|Overall Study|Subject Randomized but Not Treated|0|||
125151967|NCT01213836|450181095|FG000|Period 1, First Intervention|Adverse Event|2|||
125151968|NCT01213836|450181096|FG001|Period 1, First Intervention|Adverse Event|1|||
125151969|NCT01213836|450181095|FG000|Period 1, First Intervention|Protocol Violation|0|||
125151970|NCT01213836|450181096|FG001|Period 1, First Intervention|Protocol Violation|1|||
125151971|NCT01213836|450181095|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
125151972|NCT01213836|450181096|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
125151973|NCT00255151|450181097|FG000|Overall Study|Adverse Event|10|||
125151974|NCT00255151|450181098|FG001|Overall Study|Adverse Event|6|||
125151975|NCT00255151|450181099|FG002|Overall Study|Adverse Event|9|||
125151976|NCT00255151|450181097|FG000|Overall Study|Lost to Follow-up|4|||
125151977|NCT00255151|450181098|FG001|Overall Study|Lost to Follow-up|3|||
125151978|NCT00255151|450181099|FG002|Overall Study|Lost to Follow-up|4|||
125151979|NCT00255151|450181097|FG000|Overall Study|Withdrawal by Subject|18|||
125151980|NCT00255151|450181098|FG001|Overall Study|Withdrawal by Subject|17|||
125151981|NCT00255151|450181099|FG002|Overall Study|Withdrawal by Subject|8|||
125151982|NCT00255151|450181097|FG000|Overall Study|Noncompliance|0|||
125151983|NCT00255151|450181098|FG001|Overall Study|Noncompliance|1|||
125151984|NCT00255151|450181099|FG002|Overall Study|Noncompliance|2|||
125151985|NCT00255151|450181097|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
125151986|NCT00255151|450181098|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
125151987|NCT00255151|450181099|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
125151988|NCT00255151|450181097|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
125151989|NCT00255151|450181098|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
125151990|NCT00255151|450181099|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
125151991|NCT00255151|450181097|FG000|Overall Study|Possible Barrett's Esophagus|1|||
125151992|NCT00255151|450181098|FG001|Overall Study|Possible Barrett's Esophagus|3|||
125151993|NCT00255151|450181099|FG002|Overall Study|Possible Barrett's Esophagus|8|||
125151994|NCT00255151|450181097|FG000|Overall Study|Esophageal Stricture|0|||
125151995|NCT00255151|450181098|FG001|Overall Study|Esophageal Stricture|0|||
125151996|NCT00255151|450181099|FG002|Overall Study|Esophageal Stricture|1|||
125151997|NCT00255151|450181097|FG000|Overall Study|Therapeutic Failure|11|||
125151998|NCT00255151|450181098|FG001|Overall Study|Therapeutic Failure|2|||
125151999|NCT00255151|450181099|FG002|Overall Study|Therapeutic Failure|3|||
125152000|NCT00107042|450181100|FG000|Overall Study|Lost to Follow-up|9|||
125152001|NCT00107042|450181101|FG001|Overall Study|Lost to Follow-up|7|||
125152002|NCT00107042|450181100|FG000|Overall Study|Withdrawal by Subject|6|||
125152003|NCT00107042|450181101|FG001|Overall Study|Withdrawal by Subject|1|||
125152004|NCT00107042|450181100|FG000|Overall Study|Moved out of area|5|||
125152005|NCT00107042|450181101|FG001|Overall Study|Moved out of area|3|||
125152006|NCT00107042|450181100|FG000|Overall Study|Pregnancy|1|||
125152007|NCT00107042|450181101|FG001|Overall Study|Pregnancy|1|||
125152008|NCT00107042|450181100|FG000|Overall Study|Inadvertent enrollment|0|||
125152009|NCT00107042|450181101|FG001|Overall Study|Inadvertent enrollment|1|||
125152010|NCT00107042|450181100|FG000|Overall Study|vaccinated outside window|1|||
125152011|NCT00107042|450181101|FG001|Overall Study|vaccinated outside window|1|||
125152012|NCT00107042|450181100|FG000|Overall Study|Disallowed medications|0|||
125152013|NCT00107042|450181101|FG001|Overall Study|Disallowed medications|2|||
125152014|NCT01286558|450181104|FG000|Overall Study|Adverse Event|1|||
125152015|NCT01286558|450181105|FG001|Overall Study|Adverse Event|1|||
125152016|NCT01286558|450181104|FG000|Overall Study|Withdrawal by Subject|0|||
125152017|NCT01286558|450181105|FG001|Overall Study|Withdrawal by Subject|1|||
125152018|NCT04109313|450181111|FG000|Overall Study|Pregnancy|1|||
125152019|NCT04109313|450181111|FG000|Overall Study|Adverse Event|11|||
125152020|NCT04109313|450181111|FG000|Overall Study|Lack of Efficacy|11|||
125152021|NCT04109313|450181111|FG000|Overall Study|Lost to Follow-up|1|||
125152022|NCT04109313|450181111|FG000|Overall Study|Physician Decision|2|||
125152023|NCT04109313|450181111|FG000|Overall Study|Subject Decision|13|||
125152024|NCT04109313|450181111|FG000|Overall Study|Covid-19 situation|2|||
125152025|NCT00655850|450181114|FG000|Overall Study|Death|2|||
125152026|NCT00655850|450181114|FG000|Overall Study|Withdrawal by Subject|1|||
125152027|NCT03702049|450181115|FG000|Overall Study|Lost to Follow-up|4|||
125152028|NCT03702049|450181115|FG000|Overall Study|Physician Decision|1|||
125152029|NCT00573170|450181116|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
125152030|NCT00573170|450181117|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
125152031|NCT00573170|450181118|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
125152032|NCT00573170|450181119|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
125152033|NCT00573170|450181120|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
125152034|NCT00573170|450181121|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
125152035|NCT00573170|450181116|FG000|First Washout Period|Adverse Event|1|||
125152036|NCT00573170|450181117|FG001|First Washout Period|Adverse Event|1|||
125152037|NCT00573170|450181118|FG002|First Washout Period|Adverse Event|0|||
125152038|NCT00573170|450181119|FG003|First Washout Period|Adverse Event|0|||
125152039|NCT00573170|450181120|FG004|First Washout Period|Adverse Event|0|||
125152040|NCT00573170|450181121|FG005|First Washout Period|Adverse Event|1|||
125152041|NCT00573170|450181116|FG000|First Washout Period|Lack of Efficacy|0|||
125152042|NCT00573170|450181117|FG001|First Washout Period|Lack of Efficacy|0|||
125152043|NCT00573170|450181118|FG002|First Washout Period|Lack of Efficacy|0|||
125152044|NCT00573170|450181119|FG003|First Washout Period|Lack of Efficacy|0|||
125152045|NCT00573170|450181120|FG004|First Washout Period|Lack of Efficacy|0|||
125152046|NCT00573170|450181121|FG005|First Washout Period|Lack of Efficacy|1|||
125152047|NCT00573170|450181116|FG000|First Washout Period|Lost to Follow-up|1|||
125152048|NCT00573170|450181117|FG001|First Washout Period|Lost to Follow-up|1|||
125152049|NCT00573170|450181118|FG002|First Washout Period|Lost to Follow-up|0|||
125152050|NCT00573170|450181119|FG003|First Washout Period|Lost to Follow-up|2|||
125152051|NCT00573170|450181120|FG004|First Washout Period|Lost to Follow-up|0|||
125152052|NCT00573170|450181121|FG005|First Washout Period|Lost to Follow-up|2|||
125152053|NCT00573170|450181116|FG000|First Washout Period|Withdrawal by Subject|2|||
125152054|NCT00573170|450181117|FG001|First Washout Period|Withdrawal by Subject|0|||
125152055|NCT00573170|450181118|FG002|First Washout Period|Withdrawal by Subject|0|||
125152056|NCT00573170|450181119|FG003|First Washout Period|Withdrawal by Subject|2|||
125152057|NCT00573170|450181120|FG004|First Washout Period|Withdrawal by Subject|3|||
125152058|NCT00573170|450181121|FG005|First Washout Period|Withdrawal by Subject|3|||
125152059|NCT00573170|450181116|FG000|First Washout Period|Other|4|||
125152060|NCT00573170|450181117|FG001|First Washout Period|Other|0|||
125152061|NCT00573170|450181118|FG002|First Washout Period|Other|1|||
125152062|NCT00573170|450181119|FG003|First Washout Period|Other|1|||
125152063|NCT00573170|450181120|FG004|First Washout Period|Other|0|||
125152064|NCT00573170|450181121|FG005|First Washout Period|Other|0|||
125152065|NCT00573170|450181116|FG000|Second Washout Period|Adverse Event|1|||
125152066|NCT00573170|450181117|FG001|Second Washout Period|Adverse Event|0|||
125152067|NCT00573170|450181118|FG002|Second Washout Period|Adverse Event|0|||
125152068|NCT00573170|450181119|FG003|Second Washout Period|Adverse Event|0|||
125152069|NCT00573170|450181120|FG004|Second Washout Period|Adverse Event|1|||
125152070|NCT00573170|450181121|FG005|Second Washout Period|Adverse Event|0|||
125152071|NCT00573170|450181116|FG000|Second Washout Period|Protocol Violation|2|||
125152072|NCT00573170|450181117|FG001|Second Washout Period|Protocol Violation|1|||
125152073|NCT00573170|450181118|FG002|Second Washout Period|Protocol Violation|1|||
125152074|NCT00573170|450181119|FG003|Second Washout Period|Protocol Violation|0|||
125152075|NCT00573170|450181120|FG004|Second Washout Period|Protocol Violation|0|||
125152076|NCT00573170|450181121|FG005|Second Washout Period|Protocol Violation|0|||
125152077|NCT00573170|450181116|FG000|Second Washout Period|Withdrawal by Subject|1|||
125152078|NCT00573170|450181117|FG001|Second Washout Period|Withdrawal by Subject|1|||
125152079|NCT00573170|450181118|FG002|Second Washout Period|Withdrawal by Subject|2|||
125152080|NCT00573170|450181119|FG003|Second Washout Period|Withdrawal by Subject|0|||
125152081|NCT00573170|450181120|FG004|Second Washout Period|Withdrawal by Subject|1|||
125152082|NCT00573170|450181121|FG005|Second Washout Period|Withdrawal by Subject|0|||
125152083|NCT00573170|450181116|FG000|Second Washout Period|Lost to Follow-up|0|||
125152084|NCT00573170|450181117|FG001|Second Washout Period|Lost to Follow-up|0|||
125152085|NCT00573170|450181118|FG002|Second Washout Period|Lost to Follow-up|0|||
125152086|NCT00573170|450181119|FG003|Second Washout Period|Lost to Follow-up|1|||
125152087|NCT00573170|450181120|FG004|Second Washout Period|Lost to Follow-up|0|||
125152088|NCT00573170|450181121|FG005|Second Washout Period|Lost to Follow-up|0|||
125152089|NCT00573170|450181116|FG000|Second Washout Period|Other|1|||
125152090|NCT00573170|450181117|FG001|Second Washout Period|Other|2|||
125152091|NCT00573170|450181118|FG002|Second Washout Period|Other|1|||
125152092|NCT00573170|450181119|FG003|Second Washout Period|Other|4|||
125152093|NCT00573170|450181120|FG004|Second Washout Period|Other|6|||
125152094|NCT00573170|450181121|FG005|Second Washout Period|Other|2|||
125152095|NCT00573170|450181116|FG000|Third Treatment Period|Withdrawal by Subject|1|||
125152096|NCT00573170|450181117|FG001|Third Treatment Period|Withdrawal by Subject|0|||
125152097|NCT00573170|450181118|FG002|Third Treatment Period|Withdrawal by Subject|0|||
125152098|NCT00573170|450181119|FG003|Third Treatment Period|Withdrawal by Subject|0|||
125152099|NCT00573170|450181120|FG004|Third Treatment Period|Withdrawal by Subject|0|||
125152100|NCT00573170|450181121|FG005|Third Treatment Period|Withdrawal by Subject|0|||
125152101|NCT00573170|450181116|FG000|Third Treatment Period|Lost to Follow-up|0|||
125152102|NCT00573170|450181117|FG001|Third Treatment Period|Lost to Follow-up|0|||
125152103|NCT00573170|450181118|FG002|Third Treatment Period|Lost to Follow-up|0|||
125152104|NCT00573170|450181119|FG003|Third Treatment Period|Lost to Follow-up|0|||
125152105|NCT00573170|450181120|FG004|Third Treatment Period|Lost to Follow-up|0|||
125152106|NCT00573170|450181121|FG005|Third Treatment Period|Lost to Follow-up|2|||
125152107|NCT00986570|450181122|FG000|Overall Study|Lost to Follow-up|6|||
125152108|NCT00986570|450181122|FG000|Overall Study|Potential bias for objective assessment|1|||
125152109|NCT00608517|450181124|FG000|Overall Study|Death|1|||
125152110|NCT00608517|450181125|FG001|Overall Study|Death|0|||
125152111|NCT00608517|450181126|FG002|Overall Study|Death|0|||
125152112|NCT01833533|450181128|FG000|Overall Study|Adverse Event|0|||
125152113|NCT01833533|450181129|FG001|Overall Study|Adverse Event|1|||
125152114|NCT01833533|450181128|FG000|Overall Study|Lost to Follow-up|4|||
125152115|NCT01833533|450181129|FG001|Overall Study|Lost to Follow-up|9|||
125152116|NCT01833533|450181128|FG000|Overall Study|To Enter an Extension Study|0|||
125152117|NCT01833533|450181129|FG001|Overall Study|To Enter an Extension Study|4|||
125152118|NCT01833533|450181128|FG000|Overall Study|Other|2|||
125152119|NCT01833533|450181129|FG001|Overall Study|Other|7|||
125152120|NCT02457611|450181131|FG000|Overall Study|Lost to Follow-up|3|||
125152121|NCT00384293|450181132|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
125152122|NCT00384293|450181133|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
125152123|NCT00384293|450181134|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
125152124|NCT00384293|450181132|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
125152125|NCT00384293|450181133|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
125152126|NCT00384293|450181134|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
125152127|NCT00384293|450181132|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
125152128|NCT00384293|450181133|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
125152129|NCT00384293|450181134|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
125152130|NCT00384293|450181132|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
125152131|NCT00384293|450181133|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
125152132|NCT00384293|450181134|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
125152133|NCT00384293|450181132|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
125152134|NCT00384293|450181133|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
125152135|NCT00384293|450181134|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
125152136|NCT00384293|450181132|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
125152137|NCT00384293|450181133|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
125152138|NCT00384293|450181134|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
125152139|NCT00384293|450181132|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
125152140|NCT00384293|450181133|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
125152141|NCT00384293|450181134|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
125152142|NCT00384293|450181132|FG000|Post-randomization Period|Adverse Event|0|||
125152143|NCT00384293|450181133|FG001|Post-randomization Period|Adverse Event|23|||
125152144|NCT00384293|450181134|FG002|Post-randomization Period|Adverse Event|7|||
125152145|NCT00384293|450181132|FG000|Post-randomization Period|Lost to Follow-up|0|||
125152146|NCT00384293|450181133|FG001|Post-randomization Period|Lost to Follow-up|2|||
125152147|NCT00384293|450181134|FG002|Post-randomization Period|Lost to Follow-up|1|||
125152148|NCT00384293|450181132|FG000|Post-randomization Period|Protocol Violation|0|||
125152149|NCT00384293|450181133|FG001|Post-randomization Period|Protocol Violation|1|||
125152150|NCT00384293|450181134|FG002|Post-randomization Period|Protocol Violation|0|||
125152151|NCT00384293|450181132|FG000|Post-randomization Period|Withdrawal by Subject|0|||
125152152|NCT00384293|450181133|FG001|Post-randomization Period|Withdrawal by Subject|8|||
125152153|NCT00384293|450181134|FG002|Post-randomization Period|Withdrawal by Subject|6|||
125152154|NCT00384293|450181132|FG000|Post-randomization Period|Trial Termination|0|||
125152155|NCT00384293|450181133|FG001|Post-randomization Period|Trial Termination|180|||
125152156|NCT00384293|450181134|FG002|Post-randomization Period|Trial Termination|204|||
125152157|NCT00384293|450181132|FG000|Post-randomization Period|Patient Randomized in Error|0|||
125152158|NCT00384293|450181133|FG001|Post-randomization Period|Patient Randomized in Error|0|||
125152159|NCT00384293|450181134|FG002|Post-randomization Period|Patient Randomized in Error|1|||
125152160|NCT00493454|450181135|FG000|Overall Study|Withdrawal by Subject|1|||
125152161|NCT00103038|450181136|FG000|Overall Study|Withdrawal by Subject|8|||
125152162|NCT00103038|450181136|FG000|Overall Study|Screen failure|3|||
125152163|NCT00103038|450181136|FG000|Overall Study|Death|1|||
125152164|NCT00103038|450181136|FG000|Overall Study|Physician Decision|1|||
125152165|NCT02865395|450181143|FG000|Overall Study|Physician Decision|6|||
125152166|NCT02865395|450181144|FG001|Overall Study|Physician Decision|10|||
125152167|NCT02865395|450181145|FG002|Overall Study|Physician Decision|7|||
125152168|NCT01501110|450181146|FG000|Overall Study|Death|0|||
125152169|NCT01501110|450181147|FG001|Overall Study|Death|1|||
125152170|NCT01483625|450181148|FG000|Overall Study|Adverse Event|1|||
125152171|NCT01483625|450181149|FG001|Overall Study|Adverse Event|1|||
125152172|NCT01483625|450181148|FG000|Overall Study|Refused to continue medication|2|||
125152173|NCT01483625|450181149|FG001|Overall Study|Refused to continue medication|1|||
125152174|NCT01483625|450181148|FG000|Overall Study|Due to other reason|1|||
125152175|NCT01483625|450181149|FG001|Overall Study|Due to other reason|0|||
125152176|NCT02310763|450181153|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
125152177|NCT02310763|450181154|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
125152178|NCT02310763|450181155|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
125152179|NCT02310763|450181153|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
125152180|NCT02310763|450181154|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
125152181|NCT02310763|450181155|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
125152182|NCT02310763|450181153|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
125152183|NCT02310763|450181154|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
125152184|NCT02310763|450181155|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
125152185|NCT02310763|450181153|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
125152186|NCT02310763|450181154|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
125152187|NCT02310763|450181155|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
125152188|NCT02310763|450181153|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
125152189|NCT02310763|450181154|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
125152190|NCT02310763|450181155|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
125152191|NCT04019054|450181156|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
125152192|NCT04019054|450181157|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
125152193|NCT04019054|450181156|FG000|Overall Study|Withdrawal by Subject|3|||
125152194|NCT04019054|450181157|FG001|Overall Study|Withdrawal by Subject|1|||
125152195|NCT05444543|450181158|FG000|Overall Study|Withdrawal by Subject|1|||
125152196|NCT05444543|450181159|FG001|Overall Study|Withdrawal by Subject|0|||
125152197|NCT05444543|450181158|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
125152198|NCT05444543|450181159|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
125152199|NCT05444543|450181158|FG000|Overall Study|Adverse Event|0|||
125152200|NCT05444543|450181159|FG001|Overall Study|Adverse Event|1|||
125152201|NCT05444543|450181158|FG000|Overall Study|Family relocating at a distance from study site|0|||
125152202|NCT05444543|450181159|FG001|Overall Study|Family relocating at a distance from study site|1|||
125152203|NCT01261624|450181160|FG000|Week 0 to Week 12|Disease Progression|1|||
125152204|NCT01261624|450181161|FG001|Week 0 to Week 12|Disease Progression|1|||
125152205|NCT01261624|450181160|FG000|Week 0 to Week 12|Insufficient Response|0|||
125152206|NCT01261624|450181161|FG001|Week 0 to Week 12|Insufficient Response|2|||
125152207|NCT01261624|450181160|FG000|Week 13 to Week 24|Insufficient Response|0|||
125152208|NCT01261624|450181161|FG001|Week 13 to Week 24|Insufficient Response|1|||
125152209|NCT02094261|450181164|FG000|Overall Study|Death|24|||
125152210|NCT02094261|450181164|FG000|Overall Study|Lost to Follow-up|1|||
125152211|NCT02094261|450181164|FG000|Overall Study|Withdrawal by Subject|4|||
125152212|NCT02094261|450181164|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
125152213|NCT03877926|450181167|FG000|Overall Study|Adverse Event|1|||
125152214|NCT03877926|450181168|FG001|Overall Study|Adverse Event|0|||
125152215|NCT03877926|450181169|FG002|Overall Study|Adverse Event|0|||
125152216|NCT03877926|450181170|FG003|Overall Study|Adverse Event|0|||
125152217|NCT03877926|450181167|FG000|Overall Study|Death|2|||
125152218|NCT03877926|450181168|FG001|Overall Study|Death|2|||
125152219|NCT03877926|450181169|FG002|Overall Study|Death|2|||
125152220|NCT03877926|450181170|FG003|Overall Study|Death|0|||
125152221|NCT03877926|450181167|FG000|Overall Study|Lost to Follow-up|41|||
125152222|NCT03877926|450181168|FG001|Overall Study|Lost to Follow-up|52|||
125152223|NCT03877926|450181169|FG002|Overall Study|Lost to Follow-up|45|||
125152224|NCT03877926|450181170|FG003|Overall Study|Lost to Follow-up|17|||
125152225|NCT03877926|450181167|FG000|Overall Study|Physician Decision|2|||
125152226|NCT03877926|450181168|FG001|Overall Study|Physician Decision|0|||
125152227|NCT03877926|450181169|FG002|Overall Study|Physician Decision|2|||
125152228|NCT03877926|450181170|FG003|Overall Study|Physician Decision|0|||
125152229|NCT03877926|450181167|FG000|Overall Study|Withdrawal by Subject|18|||
125152230|NCT03877926|450181168|FG001|Overall Study|Withdrawal by Subject|21|||
125152231|NCT03877926|450181169|FG002|Overall Study|Withdrawal by Subject|12|||
125152232|NCT03877926|450181170|FG003|Overall Study|Withdrawal by Subject|4|||
125152233|NCT03877926|450181167|FG000|Overall Study|Other - Various|4|||
125152234|NCT03877926|450181168|FG001|Overall Study|Other - Various|1|||
125152235|NCT03877926|450181169|FG002|Overall Study|Other - Various|1|||
125152236|NCT03877926|450181170|FG003|Overall Study|Other - Various|0|||
125152237|NCT03877926|450181167|FG000|Overall Study|Not Treated|3|||
125152238|NCT03877926|450181168|FG001|Overall Study|Not Treated|1|||
125152239|NCT03877926|450181169|FG002|Overall Study|Not Treated|1|||
125152240|NCT03877926|450181170|FG003|Overall Study|Not Treated|0|||
125152241|NCT03554317|450181171|FG000|Overall Study|Withdrawal by Subject|1|||
125152242|NCT03554317|450181171|FG000|Overall Study|PSA Progression|3|||
125152243|NCT03554317|450181171|FG000|Overall Study|Radiographic Progression|4|||
125152244|NCT00124462|450181174|FG000|Overall Study|Lost to Follow-up|3|||
125152245|NCT00124462|450181175|FG001|Overall Study|Lost to Follow-up|3|||
125152246|NCT00124462|450181174|FG000|Overall Study|Physician Decision|3|||
125152247|NCT00124462|450181175|FG001|Overall Study|Physician Decision|4|||
125152248|NCT00124462|450181174|FG000|Overall Study|Withdrawal by Subject|4|||
125152249|NCT00124462|450181175|FG001|Overall Study|Withdrawal by Subject|5|||
125152250|NCT00124462|450181174|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
125152251|NCT00124462|450181175|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
125152252|NCT00537199|450181176|FG000|Overall Study|Study Terminated|1|||
125152253|NCT00860743|450181179|FG000|Overall Study|Withdrawal by Subject|3|||
125152254|NCT00860743|450181180|FG001|Overall Study|Withdrawal by Subject|0|||
125152255|NCT03827018|450181182|FG000|Overall Study|Adverse Event|1|||
125152256|NCT03827018|450181183|FG001|Overall Study|Adverse Event|0|||
125152257|NCT03827018|450181182|FG000|Overall Study|Withdrawal by Subject|2|||
125152258|NCT03827018|450181183|FG001|Overall Study|Withdrawal by Subject|2|||
125152259|NCT03827018|450181182|FG000|Overall Study|Lack of Efficacy|0|||
125152260|NCT03827018|450181183|FG001|Overall Study|Lack of Efficacy|1|||
125152261|NCT00350402|450181188|FG000|Overall Study|Lost to Follow-up|1|||
125152262|NCT00350402|450181189|FG001|Overall Study|Lost to Follow-up|1|||
125152263|NCT01884688|450181192|FG000|Overall Study|Screen Failure|2|||
125152264|NCT04099641|450181196|FG000|Overall Study|Death|46|||
125152265|NCT04099641|450181197|FG001|Overall Study|Death|12|||
125152266|NCT04099641|450181196|FG000|Overall Study|Lost to Follow-up|1|||
125152267|NCT04099641|450181197|FG001|Overall Study|Lost to Follow-up|0|||
125152268|NCT04099641|450181196|FG000|Overall Study|Withdrawal by Subject|2|||
125152269|NCT04099641|450181197|FG001|Overall Study|Withdrawal by Subject|0|||
125152270|NCT04798482|450181213|FG000|Overall Study|Physician Decision|1|||
125152271|NCT04798482|450181213|FG000|Overall Study|Lost eligibility|1|||
125152272|NCT01192399|450181214|FG000|Overall Study|Lack of Efficacy|2|||
125152273|NCT03903159|450181216|FG000|Overall Study|Discharged with Staff Approval|2|||
125152274|NCT03903159|450181216|FG000|Overall Study|Discharged at Staff Request|2|||
125152275|NCT03903159|450181216|FG000|Overall Study|Discharged Against Staff Advice|1|||
125152276|NCT02443545|450181217|FG000|Overall Study|Adverse Event|1|||
125152277|NCT02443545|450181218|FG001|Overall Study|Adverse Event|1|||
125152278|NCT02443545|450181217|FG000|Overall Study|Lost to Follow-up|0|||
125152279|NCT02443545|450181218|FG001|Overall Study|Lost to Follow-up|2|||
125152280|NCT02443545|450181217|FG000|Overall Study|Physician Decision|3|||
125152281|NCT02443545|450181218|FG001|Overall Study|Physician Decision|0|||
125152282|NCT02443545|450181217|FG000|Overall Study|Protocol Violation|8|||
125152283|NCT02443545|450181218|FG001|Overall Study|Protocol Violation|1|||
125152284|NCT02443545|450181217|FG000|Overall Study|Pregnancy|1|||
125152285|NCT02443545|450181218|FG001|Overall Study|Pregnancy|1|||
125152286|NCT02443545|450181217|FG000|Overall Study|Withdrawal by Subject|6|||
125152287|NCT02443545|450181218|FG001|Overall Study|Withdrawal by Subject|3|||
125152288|NCT02443545|450181217|FG000|Overall Study|Termination of study|20|||
125152289|NCT02443545|450181218|FG001|Overall Study|Termination of study|11|||
125152290|NCT00536484|450181219|FG000|Overall Study|Adverse Event|21|||
125152291|NCT00536484|450181220|FG001|Overall Study|Adverse Event|34|||
125152292|NCT00536484|450181219|FG000|Overall Study|Withdrawal by Subject|11|||
125152293|NCT00536484|450181220|FG001|Overall Study|Withdrawal by Subject|11|||
125152294|NCT00536484|450181219|FG000|Overall Study|Lost to Follow-up|8|||
125152295|NCT00536484|450181220|FG001|Overall Study|Lost to Follow-up|6|||
125152296|NCT00536484|450181219|FG000|Overall Study|Lack of Efficacy|16|||
125152297|NCT00536484|450181220|FG001|Overall Study|Lack of Efficacy|5|||
125152298|NCT00536484|450181219|FG000|Overall Study|Other|4|||
125152299|NCT00536484|450181220|FG001|Overall Study|Other|0|||
125152300|NCT01506908|450181221|FG000|Overall Study|Adverse Event|1|||
125152301|NCT01506908|450181222|FG001|Overall Study|Adverse Event|0|||
125152302|NCT01382251|450181224|FG000|Overall Study|Surgeries cancelled or delayed|16|||
125152303|NCT01382251|450181225|FG001|Overall Study|Surgeries cancelled or delayed|16|||
125152304|NCT01382251|450181224|FG000|Overall Study|Lost to Follow-up|4|||
125152305|NCT01382251|450181225|FG001|Overall Study|Lost to Follow-up|4|||
125152306|NCT01382251|450181224|FG000|Overall Study|Contacted after study closed|1|||
125152307|NCT01382251|450181225|FG001|Overall Study|Contacted after study closed|1|||
125152308|NCT00562120|450181226|FG000|First Intervention Period|Adverse Event|1|||
125152309|NCT00562120|450181227|FG001|First Intervention Period|Adverse Event|0|||
125152310|NCT00562120|450181228|FG002|First Intervention Period|Adverse Event|0|||
125152311|NCT00562120|450181229|FG003|First Intervention Period|Adverse Event|0|||
125152312|NCT00562120|450181226|FG000|First Intervention Period|Randomized but not Treated|1|||
125152313|NCT00562120|450181227|FG001|First Intervention Period|Randomized but not Treated|0|||
125152314|NCT00562120|450181228|FG002|First Intervention Period|Randomized but not Treated|0|||
125152315|NCT00562120|450181229|FG003|First Intervention Period|Randomized but not Treated|0|||
125152316|NCT00545688|450181230|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
125152317|NCT00545688|450181231|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
125152318|NCT00545688|450181232|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
125152319|NCT00545688|450181233|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
125152320|NCT00545688|450181230|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
125152321|NCT00545688|450181231|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
125152322|NCT00545688|450181232|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
125152323|NCT00545688|450181233|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
125152324|NCT00545688|450181230|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
125152325|NCT00545688|450181231|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
125152326|NCT00545688|450181232|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
125152327|NCT00545688|450181233|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
125152328|NCT00545688|450181230|FG000|Neo-Adjuvant Treatment Period|Death|0|||
125152329|NCT00545688|450181231|FG001|Neo-Adjuvant Treatment Period|Death|1|||
125152330|NCT00545688|450181232|FG002|Neo-Adjuvant Treatment Period|Death|0|||
125152331|NCT00545688|450181233|FG003|Neo-Adjuvant Treatment Period|Death|0|||
125152332|NCT00545688|450181230|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
125152333|NCT00545688|450181231|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
125152334|NCT00545688|450181232|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
125152335|NCT00545688|450181233|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
125152336|NCT00545688|450181230|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
125152337|NCT00545688|450181231|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
125152338|NCT00545688|450181232|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
125152339|NCT00545688|450181233|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
125152340|NCT00545688|450181230|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
125152341|NCT00545688|450181231|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
125152342|NCT00545688|450181232|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
125152343|NCT00545688|450181233|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
125152344|NCT00545688|450181230|FG000|Adjuvant Treatment Period|Disease Progression|3|||
125152345|NCT00545688|450181231|FG001|Adjuvant Treatment Period|Disease Progression|3|||
125152346|NCT00545688|450181232|FG002|Adjuvant Treatment Period|Disease Progression|0|||
125152347|NCT00545688|450181233|FG003|Adjuvant Treatment Period|Disease Progression|7|||
125152348|NCT00545688|450181230|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
125152349|NCT00545688|450181231|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
125152350|NCT00545688|450181232|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
125152351|NCT00545688|450181233|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
125152352|NCT00545688|450181230|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
125152353|NCT00545688|450181231|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
125152354|NCT00545688|450181232|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
125152355|NCT00545688|450181233|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
125152356|NCT00545688|450181230|FG000|Adjuvant Treatment Period|Adverse Event|0|||
125152357|NCT00545688|450181231|FG001|Adjuvant Treatment Period|Adverse Event|3|||
125152358|NCT00545688|450181232|FG002|Adjuvant Treatment Period|Adverse Event|2|||
125152359|NCT00545688|450181233|FG003|Adjuvant Treatment Period|Adverse Event|2|||
125152360|NCT00545688|450181230|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
125152361|NCT00545688|450181231|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
125152362|NCT00545688|450181232|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
125152363|NCT00545688|450181233|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
125152364|NCT00545688|450181230|FG000|Follow-Up Period|Death|4|||
125152365|NCT00545688|450181231|FG001|Follow-Up Period|Death|2|||
125152366|NCT00545688|450181232|FG002|Follow-Up Period|Death|2|||
125152367|NCT00545688|450181233|FG003|Follow-Up Period|Death|6|||
125152368|NCT00545688|450181230|FG000|Follow-Up Period|Disease Progression|6|||
125152369|NCT00545688|450181231|FG001|Follow-Up Period|Disease Progression|5|||
125152370|NCT00545688|450181232|FG002|Follow-Up Period|Disease Progression|9|||
125152371|NCT00545688|450181233|FG003|Follow-Up Period|Disease Progression|9|||
125152372|NCT00545688|450181230|FG000|Follow-Up Period|Refused Treatment|6|||
125152373|NCT00545688|450181231|FG001|Follow-Up Period|Refused Treatment|2|||
125152374|NCT00545688|450181232|FG002|Follow-Up Period|Refused Treatment|0|||
125152375|NCT00545688|450181233|FG003|Follow-Up Period|Refused Treatment|2|||
125152376|NCT00545688|450181230|FG000|Follow-Up Period|Lost to Follow-up|3|||
125152377|NCT00545688|450181231|FG001|Follow-Up Period|Lost to Follow-up|3|||
125152378|NCT00545688|450181232|FG002|Follow-Up Period|Lost to Follow-up|3|||
125152379|NCT00545688|450181233|FG003|Follow-Up Period|Lost to Follow-up|1|||
125152380|NCT00545688|450181230|FG000|Follow-Up Period|Unspecified Reason|2|||
125152381|NCT00545688|450181231|FG001|Follow-Up Period|Unspecified Reason|5|||
125152382|NCT00545688|450181232|FG002|Follow-Up Period|Unspecified Reason|6|||
125152383|NCT00545688|450181233|FG003|Follow-Up Period|Unspecified Reason|8|||
125152384|NCT00545688|450181230|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
125152385|NCT00545688|450181231|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
125152386|NCT00545688|450181232|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
125152387|NCT00545688|450181233|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
125152388|NCT04678817|450183209|FG000|Overall Study|Lost to Follow-up|28|||
125152389|NCT04678817|450183210|FG001|Overall Study|Lost to Follow-up|0|||
125152390|NCT04678817|450183211|FG002|Overall Study|Lost to Follow-up|0|||
125152391|NCT01010126|450183220|FG000|Overall Study|Withdrawal by Subject|1|||
125152392|NCT01010126|450183221|FG001|Overall Study|Withdrawal by Subject|0|||
125152393|NCT01010126|450183222|FG002|Overall Study|Withdrawal by Subject|1|||
125152394|NCT01010126|450183223|FG003|Overall Study|Withdrawal by Subject|0|||
125152395|NCT01010126|450183224|FG004|Overall Study|Withdrawal by Subject|3|||
125152396|NCT01010126|450183225|FG005|Overall Study|Withdrawal by Subject|0|||
125152397|NCT00784134|450183235|FG000|Overall Study|Lost to Follow-up|3|||
125152398|NCT00784134|450183236|FG001|Overall Study|Lost to Follow-up|6|||
125152399|NCT03785145|450183237|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
125152400|NCT03785145|450183238|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
125152401|NCT03785145|450183237|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
125152402|NCT03785145|450183238|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
125152403|NCT03785145|450183237|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
125152404|NCT03785145|450183238|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
125152405|NCT03785145|450183237|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
125152406|NCT03785145|450183238|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
125152407|NCT03785145|450183237|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
125152408|NCT03785145|450183238|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
125152409|NCT03785145|450183237|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
125152410|NCT03785145|450183238|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
125152411|NCT03785145|450183237|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
125152412|NCT03785145|450183238|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
125152413|NCT03785145|450183237|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
125152414|NCT03785145|450183238|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
125152415|NCT03785145|450183237|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
125152416|NCT03785145|450183238|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
125152417|NCT03785145|450183237|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
125152418|NCT03785145|450183238|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
125152419|NCT03785145|450183237|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
125152420|NCT03785145|450183238|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
125152421|NCT03250299|450183243|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
125152422|NCT03250299|450183244|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
125152423|NCT03250299|450183245|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
125152424|NCT03250299|450183246|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
125152425|NCT03250299|450183247|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
125152426|NCT03250299|450183243|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
125152427|NCT03250299|450183244|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
125152428|NCT03250299|450183245|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
125152429|NCT03250299|450183246|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
125152430|NCT03250299|450183247|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
125152431|NCT03250299|450183243|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
125152432|NCT03250299|450183244|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
125152433|NCT03250299|450183245|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
125152434|NCT03250299|450183246|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
125152435|NCT03250299|450183247|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
125152436|NCT03250299|450183243|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
125152437|NCT03250299|450183244|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
125152438|NCT03250299|450183245|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
125152439|NCT03250299|450183246|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
125152440|NCT03250299|450183247|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
125152441|NCT03346070|450183248|FG000|Overall Study|Death|0|||
125152442|NCT03346070|450183249|FG001|Overall Study|Death|0|||
125152443|NCT03346070|450183250|FG002|Overall Study|Death|0|||
125152444|NCT03346070|450183251|FG003|Overall Study|Death|0|||
125152445|NCT03346070|450183252|FG004|Overall Study|Death|1|||
125152446|NCT03346070|450183248|FG000|Overall Study|Lost to Follow-up|0|||
125152447|NCT03346070|450183249|FG001|Overall Study|Lost to Follow-up|1|||
125152448|NCT03346070|450183250|FG002|Overall Study|Lost to Follow-up|2|||
125152449|NCT03346070|450183251|FG003|Overall Study|Lost to Follow-up|0|||
125152450|NCT03346070|450183252|FG004|Overall Study|Lost to Follow-up|0|||
125152451|NCT03346070|450183248|FG000|Overall Study|Physician Decision|0|||
125152452|NCT03346070|450183249|FG001|Overall Study|Physician Decision|0|||
125152453|NCT03346070|450183250|FG002|Overall Study|Physician Decision|0|||
125152454|NCT03346070|450183251|FG003|Overall Study|Physician Decision|1|||
125152455|NCT03346070|450183252|FG004|Overall Study|Physician Decision|1|||
125152456|NCT03346070|450183248|FG000|Overall Study|Withdrawal by Subject|1|||
125152457|NCT03346070|450183249|FG001|Overall Study|Withdrawal by Subject|0|||
125152458|NCT03346070|450183250|FG002|Overall Study|Withdrawal by Subject|0|||
125152459|NCT03346070|450183251|FG003|Overall Study|Withdrawal by Subject|1|||
125152460|NCT03346070|450183252|FG004|Overall Study|Withdrawal by Subject|0|||
125152461|NCT03346070|450183248|FG000|Overall Study|Study medication not received as planned|2|||
125152462|NCT03346070|450183249|FG001|Overall Study|Study medication not received as planned|3|||
125152463|NCT03346070|450183250|FG002|Overall Study|Study medication not received as planned|2|||
125152464|NCT03346070|450183251|FG003|Overall Study|Study medication not received as planned|3|||
125152465|NCT03346070|450183252|FG004|Overall Study|Study medication not received as planned|2|||
125152466|NCT03346070|450183248|FG000|Overall Study|Screen Failure|0|||
125152467|NCT03346070|450183249|FG001|Overall Study|Screen Failure|0|||
125152468|NCT03346070|450183250|FG002|Overall Study|Screen Failure|0|||
125152469|NCT03346070|450183251|FG003|Overall Study|Screen Failure|1|||
125152470|NCT03346070|450183252|FG004|Overall Study|Screen Failure|1|||
125152471|NCT01221090|450183263|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
125152472|NCT01221090|450183264|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
125152473|NCT01221090|450183265|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
125152474|NCT01221090|450183266|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
125152475|NCT01221090|450183263|FG000|Overall Study|Withdrawal by Subject|0|||
125152476|NCT01221090|450183264|FG001|Overall Study|Withdrawal by Subject|22|||
125152477|NCT01221090|450183265|FG002|Overall Study|Withdrawal by Subject|27|||
125152478|NCT01221090|450183266|FG003|Overall Study|Withdrawal by Subject|2|||
125152479|NCT00708708|450183267|FG000|Overall Study|Another therapy instead of Enbrel|141|||
125152480|NCT00708708|450183267|FG000|Overall Study|Lost to Follow-up|52|||
125152481|NCT00708708|450183267|FG000|Overall Study|Withdrawal by Subject|51|||
125152482|NCT00708708|450183267|FG000|Overall Study|Intolerance|42|||
125152483|NCT00708708|450183267|FG000|Overall Study|Another therapy along with Enbrel|15|||
125152484|NCT00708708|450183267|FG000|Overall Study|Other unspecified|11|||
125152485|NCT00708708|450183267|FG000|Overall Study|Good effectiveness|9|||
125152486|NCT00708708|450183267|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
125152487|NCT00708708|450183267|FG000|Overall Study|Administrative reasons|7|||
125152488|NCT00708708|450183267|FG000|Overall Study|Lack of effectiveness|4|||
125152489|NCT00708708|450183267|FG000|Overall Study|Lack of compliance|3|||
125152490|NCT00708708|450183267|FG000|Overall Study|Pregnancy|3|||
125152491|NCT00708708|450183267|FG000|Overall Study|Adverse Event|3|||
125152492|NCT00708708|450183267|FG000|Overall Study|Missing values|392|||
125152493|NCT04776746|450183271|FG000|Overall Study|Study terminated by sponsor|61|||
125152494|NCT04776746|450183271|FG000|Overall Study|Adverse Event|5|||
125152495|NCT04776746|450183271|FG000|Overall Study|Death|4|||
125152496|NCT04776746|450183271|FG000|Overall Study|Lack of Efficacy|3|||
125152497|NCT04776746|450183271|FG000|Overall Study|Noncompliance with study drug|2|||
125152498|NCT04776746|450183271|FG000|Overall Study|Not related to COVID-19|2|||
125152499|NCT00440466|450183272|FG000|Overall Study|Death|3|||
125152500|NCT00440466|450183273|FG001|Overall Study|Death|2|||
125152501|NCT00440466|450183274|FG002|Overall Study|Death|9|||
125152502|NCT00440466|450183272|FG000|Overall Study|Adverse Event|3|||
125152503|NCT00440466|450183273|FG001|Overall Study|Adverse Event|4|||
125152504|NCT00440466|450183274|FG002|Overall Study|Adverse Event|11|||
125152505|NCT00440466|450183272|FG000|Overall Study|Lost to Follow-up|1|||
125152506|NCT00440466|450183273|FG001|Overall Study|Lost to Follow-up|0|||
125152507|NCT00440466|450183274|FG002|Overall Study|Lost to Follow-up|2|||
125152508|NCT00440466|450183272|FG000|Overall Study|Physician Decision|2|||
125152509|NCT00440466|450183273|FG001|Overall Study|Physician Decision|0|||
125152510|NCT00440466|450183274|FG002|Overall Study|Physician Decision|1|||
125152511|NCT00440466|450183272|FG000|Overall Study|Protocol Violation|2|||
125152512|NCT00440466|450183273|FG001|Overall Study|Protocol Violation|0|||
125152513|NCT00440466|450183274|FG002|Overall Study|Protocol Violation|4|||
125152514|NCT00440466|450183272|FG000|Overall Study|Withdrawal by Subject|2|||
125152515|NCT00440466|450183273|FG001|Overall Study|Withdrawal by Subject|5|||
125152516|NCT00440466|450183274|FG002|Overall Study|Withdrawal by Subject|9|||
125152517|NCT00440466|450183272|FG000|Overall Study|Began Dialysis|0|||
125152518|NCT00440466|450183273|FG001|Overall Study|Began Dialysis|0|||
125152519|NCT00440466|450183274|FG002|Overall Study|Began Dialysis|1|||
125152520|NCT00440466|450183272|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
125152521|NCT00440466|450183273|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
125152522|NCT00440466|450183274|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
125152523|NCT00418522|450183275|FG000|Overall Study|Adverse Event|7|||
125152524|NCT00418522|450183276|FG001|Overall Study|Adverse Event|1|||
125152525|NCT00418522|450183275|FG000|Overall Study|Lack of Efficacy|1|||
125152526|NCT00418522|450183276|FG001|Overall Study|Lack of Efficacy|3|||
125152527|NCT00418522|450183275|FG000|Overall Study|Lost to Follow-up|10|||
125152528|NCT00418522|450183276|FG001|Overall Study|Lost to Follow-up|4|||
125152529|NCT00418522|450183275|FG000|Overall Study|Withdrawal by Subject|31|||
125152530|NCT00418522|450183276|FG001|Overall Study|Withdrawal by Subject|7|||
125152531|NCT00418522|450183275|FG000|Overall Study|Other|27|||
125152532|NCT00418522|450183276|FG001|Overall Study|Other|23|||
125152533|NCT00418522|450183275|FG000|Overall Study|Randomized but did not receive treatment|7|||
125152534|NCT00418522|450183276|FG001|Overall Study|Randomized but did not receive treatment|4|||
125152535|NCT00892281|450183280|FG000|Overall Study|Adverse Event|65|||
125152536|NCT00892281|450183281|FG001|Overall Study|Adverse Event|8|||
125152537|NCT00892281|450183280|FG000|Overall Study|Lost to Follow-up|81|||
125152538|NCT00892281|450183281|FG001|Overall Study|Lost to Follow-up|8|||
125152539|NCT00892281|450183280|FG000|Overall Study|Pregnancy|1|||
125152540|NCT00892281|450183281|FG001|Overall Study|Pregnancy|0|||
125152541|NCT00892281|450183280|FG000|Overall Study|Protocol Violation|7|||
125152542|NCT00892281|450183281|FG001|Overall Study|Protocol Violation|2|||
125152543|NCT00892281|450183280|FG000|Overall Study|Withdrawal by Subject|86|||
125152544|NCT00892281|450183281|FG001|Overall Study|Withdrawal by Subject|14|||
125152545|NCT00892281|450183280|FG000|Overall Study|Subject failed to return for final visit|2|||
125152546|NCT00892281|450183281|FG001|Overall Study|Subject failed to return for final visit|0|||
125152547|NCT00892281|450183280|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
125152548|NCT00892281|450183281|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
125152549|NCT00892281|450183280|FG000|Overall Study|Final visit completed 4 weeks late|0|||
125152550|NCT00892281|450183281|FG001|Overall Study|Final visit completed 4 weeks late|1|||
125152551|NCT00892281|450183280|FG000|Overall Study|Subject completed day after study closed|1|||
125152552|NCT00892281|450183281|FG001|Overall Study|Subject completed day after study closed|0|||
125152553|NCT00892281|450183280|FG000|Overall Study|Family emergency|1|||
125152554|NCT00892281|450183281|FG001|Overall Study|Family emergency|0|||
125152555|NCT00892281|450183280|FG000|Overall Study|Last visit not done - death in family|1|||
125152556|NCT00892281|450183281|FG001|Overall Study|Last visit not done - death in family|0|||
125152557|NCT00892281|450183280|FG000|Overall Study|Did not meet incl/excl criteria|1|||
125152558|NCT00892281|450183281|FG001|Overall Study|Did not meet incl/excl criteria|0|||
125152559|NCT00892281|450183280|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
125152560|NCT00892281|450183281|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
125152561|NCT00892281|450183280|FG000|Overall Study|Unable to redeem the drug voucher|1|||
125152562|NCT00892281|450183281|FG001|Overall Study|Unable to redeem the drug voucher|0|||
125152563|NCT00892281|450183280|FG000|Overall Study|Subject not good candidate for study|1|||
125152564|NCT00892281|450183281|FG001|Overall Study|Subject not good candidate for study|0|||
125152565|NCT00892281|450183280|FG000|Overall Study|Subject did not return for any visits|1|||
125152566|NCT00892281|450183281|FG001|Overall Study|Subject did not return for any visits|0|||
125152567|NCT00892281|450183280|FG000|Overall Study|Subject missed several visits/lost meds|1|||
125152568|NCT00892281|450183281|FG001|Overall Study|Subject missed several visits/lost meds|0|||
125152569|NCT00892281|450183280|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
125152570|NCT00892281|450183281|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
125152571|NCT00892281|450183280|FG000|Overall Study|Scheduled for knee replacement|0|||
125152572|NCT00892281|450183281|FG001|Overall Study|Scheduled for knee replacement|1|||
125152573|NCT00892281|450183280|FG000|Overall Study|PI complained of inadequate compensation|3|||
125152574|NCT00892281|450183281|FG001|Overall Study|PI complained of inadequate compensation|0|||
125152575|NCT00892281|450183280|FG000|Overall Study|Subject lost interest in program|0|||
125152576|NCT00892281|450183281|FG001|Overall Study|Subject lost interest in program|1|||
125152577|NCT00892281|450183280|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
125152578|NCT00892281|450183281|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
125152579|NCT00892281|450183280|FG000|Overall Study|Death in family|1|||
125152580|NCT00892281|450183281|FG001|Overall Study|Death in family|0|||
125152581|NCT00892281|450183280|FG000|Overall Study|Lack of efficacy of study product|2|||
125152582|NCT00892281|450183281|FG001|Overall Study|Lack of efficacy of study product|0|||
125152583|NCT00892281|450183280|FG000|Overall Study|Subject not seen by PI at final visit|1|||
125152584|NCT00892281|450183281|FG001|Overall Study|Subject not seen by PI at final visit|0|||
125152585|NCT00892281|450183280|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
125152586|NCT00892281|450183281|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
125152587|NCT00892281|450183280|FG000|Overall Study|Missed multiple visits|1|||
125152588|NCT00892281|450183281|FG001|Overall Study|Missed multiple visits|0|||
125152589|NCT00892281|450183280|FG000|Overall Study|Missed visits rescheduled out of window|1|||
125152590|NCT00892281|450183281|FG001|Overall Study|Missed visits rescheduled out of window|0|||
125152591|NCT00892281|450183280|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
125152592|NCT00892281|450183281|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
125152593|NCT00892281|450183280|FG000|Overall Study|Subject had history of drug abuse|1|||
125152594|NCT00892281|450183281|FG001|Overall Study|Subject had history of drug abuse|0|||
125152595|NCT00892281|450183280|FG000|Overall Study|Rash on hand|1|||
125152596|NCT00892281|450183281|FG001|Overall Study|Rash on hand|0|||
125152597|NCT00892281|450183280|FG000|Overall Study|Visit 4 date out of window|1|||
125152598|NCT00892281|450183281|FG001|Overall Study|Visit 4 date out of window|0|||
125152599|NCT00865098|450183284|FG000|Overall Study|Progressive disease|1|||
125152600|NCT01048502|450183291|FG000|Overall Study|Lost to Follow-up|2|||
125152601|NCT01048502|450183292|FG001|Overall Study|Lost to Follow-up|0|||
125152602|NCT01048502|450183293|FG002|Overall Study|Lost to Follow-up|0|||
125152603|NCT01048502|450183294|FG003|Overall Study|Lost to Follow-up|0|||
125152604|NCT01048502|450183291|FG000|Overall Study|Adverse Event|1|||
125152605|NCT01048502|450183292|FG001|Overall Study|Adverse Event|0|||
125152606|NCT01048502|450183293|FG002|Overall Study|Adverse Event|0|||
125152607|NCT01048502|450183294|FG003|Overall Study|Adverse Event|0|||
125152608|NCT01048502|450183291|FG000|Overall Study|Withdrawal by Subject|1|||
125152609|NCT01048502|450183292|FG001|Overall Study|Withdrawal by Subject|4|||
125152610|NCT01048502|450183293|FG002|Overall Study|Withdrawal by Subject|5|||
125152611|NCT01048502|450183294|FG003|Overall Study|Withdrawal by Subject|3|||
125152612|NCT01048502|450183291|FG000|Overall Study|Physician Decision|0|||
125152613|NCT01048502|450183292|FG001|Overall Study|Physician Decision|3|||
125152614|NCT01048502|450183293|FG002|Overall Study|Physician Decision|0|||
125152615|NCT01048502|450183294|FG003|Overall Study|Physician Decision|1|||
125152616|NCT01138826|450183295|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
125152617|NCT01138826|450183296|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
125152618|NCT01138826|450183297|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
125152619|NCT01138826|450183298|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
125152620|NCT01138826|450183299|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
125152621|NCT01138826|450183300|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
125152622|NCT05206448|450183301|FG000|Overall Study|Lost to Follow-up|2|||
125152623|NCT05206448|450183302|FG001|Overall Study|Lost to Follow-up|2|||
125152624|NCT05206448|450183301|FG000|Overall Study|Withdrawal by Subject|2|||
125152625|NCT05206448|450183302|FG001|Overall Study|Withdrawal by Subject|0|||
125152626|NCT05206448|450183301|FG000|Overall Study|found ineligible after randomization|1|||
125152627|NCT05206448|450183302|FG001|Overall Study|found ineligible after randomization|1|||
125152628|NCT05206448|450183301|FG000|Overall Study|unable to complete study due to personal constraints|1|||
125152629|NCT05206448|450183302|FG001|Overall Study|unable to complete study due to personal constraints|0|||
125152630|NCT05206448|450183301|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
125152631|NCT05206448|450183302|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
125152632|NCT01333072|450183306|FG000|Overall Study|Lost to Follow-up|3|||
125152633|NCT01333072|450183307|FG001|Overall Study|Lost to Follow-up|0|||
125152634|NCT01333072|450183306|FG000|Overall Study|Adverse Event|2|||
125152635|NCT01333072|450183307|FG001|Overall Study|Adverse Event|4|||
125152636|NCT01333072|450183306|FG000|Overall Study|Physician Decision|1|||
125152637|NCT01333072|450183307|FG001|Overall Study|Physician Decision|0|||
125152638|NCT00619359|450183308|FG000|Overall Study|Adverse Event|32|||
125152639|NCT00619359|450183309|FG001|Overall Study|Adverse Event|36|||
125152640|NCT00619359|450183308|FG000|Overall Study|Lost to Follow-up|12|||
125152641|NCT00619359|450183309|FG001|Overall Study|Lost to Follow-up|16|||
125152642|NCT00619359|450183308|FG000|Overall Study|Physician Decision|0|||
125152643|NCT00619359|450183309|FG001|Overall Study|Physician Decision|7|||
125152644|NCT00619359|450183308|FG000|Overall Study|Protocol Violation|1|||
125152645|NCT00619359|450183309|FG001|Overall Study|Protocol Violation|1|||
125152646|NCT00619359|450183308|FG000|Overall Study|Withdrawal by Subject|19|||
125152647|NCT00619359|450183309|FG001|Overall Study|Withdrawal by Subject|20|||
125152648|NCT00619359|450183308|FG000|Overall Study|Progressive Disease|3|||
125152649|NCT00619359|450183309|FG001|Overall Study|Progressive Disease|1|||
125152650|NCT02502734|450183310|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
125152651|NCT02502734|450183311|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
125152652|NCT02502734|450183310|FG000|Washout Period|Adverse Event|1|||
125152653|NCT02502734|450183311|FG001|Washout Period|Adverse Event|0|||
125152654|NCT03649412|450183314|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
125152655|NCT03649412|450183315|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
125152656|NCT03649412|450183314|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
125152657|NCT03649412|450183315|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
125152658|NCT03649412|450183314|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
125152659|NCT03649412|450183315|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
125152660|NCT03649412|450183314|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
125152661|NCT03649412|450183315|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
125152662|NCT03649412|450183314|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
125152663|NCT03649412|450183315|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
125152664|NCT03649412|450183314|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
125152665|NCT03649412|450183315|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
125152666|NCT02280187|450183316|FG000|Overall Study|Lost to Follow-up|218|||
125152667|NCT04668274|450183317|FG000|Part 1 Study Period 1|Adverse Event|3|||
125152668|NCT04668274|450183318|FG001|Part 1 Study Period 1|Adverse Event|0|||
125152669|NCT04668274|450183319|FG002|Part 1 Study Period 1|Adverse Event|0|||
125152670|NCT04668274|450183320|FG003|Part 1 Study Period 1|Adverse Event|0|||
125152671|NCT04668274|450183317|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
125152672|NCT04668274|450183318|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
125152673|NCT04668274|450183319|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
125152674|NCT04668274|450183320|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
125152675|NCT04668274|450183317|FG000|Part 1 Study Period 2|Other|0|||
125152676|NCT04668274|450183318|FG001|Part 1 Study Period 2|Other|1|||
125152677|NCT04668274|450183319|FG002|Part 1 Study Period 2|Other|0|||
125152678|NCT04668274|450183320|FG003|Part 1 Study Period 2|Other|0|||
125152679|NCT04668274|450183317|FG000|Part 1 Study Period 3|Adverse Event|0|||
125152680|NCT04668274|450183318|FG001|Part 1 Study Period 3|Adverse Event|0|||
125152681|NCT04668274|450183319|FG002|Part 1 Study Period 3|Adverse Event|1|||
125152682|NCT04668274|450183320|FG003|Part 1 Study Period 3|Adverse Event|0|||
125152683|NCT04668274|450183317|FG000|Part 1 Study Period 3|Other|0|||
125152684|NCT04668274|450183318|FG001|Part 1 Study Period 3|Other|0|||
125152685|NCT04668274|450183319|FG002|Part 1 Study Period 3|Other|2|||
125152686|NCT04668274|450183320|FG003|Part 1 Study Period 3|Other|0|||
125152687|NCT04668274|450183317|FG000|Part 2 Study Period 4|Other|0|||
125152688|NCT04668274|450183318|FG001|Part 2 Study Period 4|Other|0|||
125152689|NCT04668274|450183319|FG002|Part 2 Study Period 4|Other|0|||
125152690|NCT04668274|450183320|FG003|Part 2 Study Period 4|Other|1|||
125152691|NCT02363439|450183321|FG000|Overall Study|Lack of Efficacy|4|||
125152692|NCT00508027|450183330|FG000|Dose Level 1|Lost to Follow-up|4|||
125152693|NCT00508027|450183330|FG000|Dose Level 1|Withdrawal by Subject|2|||
125152694|NCT00508027|450183330|FG000|Dose Level 1|Physician Decision|2|||
125152695|NCT00508027|450183330|FG000|Dose Level 2|Lost to Follow-up|2|||
125152696|NCT00508027|450183330|FG000|Dose Level 2|Withdrawal by Subject|2|||
125152697|NCT01719562|450183331|FG000|Overall Study|Lost to Follow-up|1|||
125152698|NCT01719562|450183332|FG001|Overall Study|Lost to Follow-up|0|||
125152699|NCT01719562|450183331|FG000|Overall Study|Death|1|||
125152700|NCT01719562|450183332|FG001|Overall Study|Death|0|||
125152701|NCT01719562|450183331|FG000|Overall Study|New cancer diagnosis|1|||
125152702|NCT01719562|450183332|FG001|Overall Study|New cancer diagnosis|0|||
125152703|NCT03891329|450183337|FG000|Overall Study|Death|5|||
125152704|NCT03891329|450183337|FG000|Overall Study|Lost to Follow-up|4|||
125152705|NCT03891329|450183337|FG000|Overall Study|Physician Decision|4|||
125152706|NCT03891329|450183337|FG000|Overall Study|Device explanted|3|||
125152707|NCT03891329|450183337|FG000|Overall Study|No study device implanted|3|||
125152708|NCT01832402|450183342|FG000|Overall Study|Lost to Follow-up|2|||
125152709|NCT01832402|450183343|FG001|Overall Study|Lost to Follow-up|0|||
125152710|NCT01832402|450183342|FG000|Overall Study|Withdrawal by Subject|3|||
125152711|NCT01832402|450183343|FG001|Overall Study|Withdrawal by Subject|3|||
125152712|NCT01832402|450183342|FG000|Overall Study|Declining Performance status|2|||
125152713|NCT01832402|450183343|FG001|Overall Study|Declining Performance status|1|||
125152714|NCT01202877|450183344|FG000|Overall Study|Disease Progression|0|||
125152715|NCT01202877|450183345|FG001|Overall Study|Disease Progression|1|||
125152716|NCT01202877|450183346|FG002|Overall Study|Disease Progression|2|||
125152717|NCT01202877|450183344|FG000|Overall Study|Adverse Event|0|||
125152718|NCT01202877|450183345|FG001|Overall Study|Adverse Event|0|||
125152719|NCT01202877|450183346|FG002|Overall Study|Adverse Event|2|||
125152720|NCT01202877|450183344|FG000|Overall Study|Withdrawal by Subject|0|||
125152721|NCT01202877|450183345|FG001|Overall Study|Withdrawal by Subject|0|||
125152722|NCT01202877|450183346|FG002|Overall Study|Withdrawal by Subject|1|||
125152723|NCT01202877|450183344|FG000|Overall Study|Death|0|||
125152724|NCT01202877|450183345|FG001|Overall Study|Death|0|||
125152725|NCT01202877|450183346|FG002|Overall Study|Death|1|||
125152726|NCT00396331|450183347|FG000|Overall Study|Failed to mobilize - no transplant|8|||
125152727|NCT00396331|450183347|FG000|Overall Study|Did not go on to transplant|5|||
125152728|NCT00396331|450183347|FG000|Overall Study|Lost to Follow-up|3|||
125152729|NCT00396331|450183347|FG000|Overall Study|Death|16|||
125152730|NCT01351350|450183348|FG000|Overall Study|Disease Progression|5|||
125152731|NCT01351350|450183349|FG001|Overall Study|Disease Progression|13|||
125152732|NCT01351350|450183350|FG002|Overall Study|Disease Progression|6|||
125152733|NCT01351350|450183351|FG003|Overall Study|Disease Progression|8|||
125152734|NCT01351350|450183352|FG004|Overall Study|Disease Progression|5|||
125152735|NCT01351350|450183348|FG000|Overall Study|Adverse Event|1|||
125152736|NCT01351350|450183349|FG001|Overall Study|Adverse Event|10|||
125152737|NCT01351350|450183350|FG002|Overall Study|Adverse Event|1|||
125152738|NCT01351350|450183351|FG003|Overall Study|Adverse Event|2|||
125152739|NCT01351350|450183352|FG004|Overall Study|Adverse Event|0|||
125152740|NCT01351350|450183348|FG000|Overall Study|Participant Decision|2|||
125152741|NCT01351350|450183349|FG001|Overall Study|Participant Decision|6|||
125152742|NCT01351350|450183350|FG002|Overall Study|Participant Decision|3|||
125152743|NCT01351350|450183351|FG003|Overall Study|Participant Decision|3|||
125152744|NCT01351350|450183352|FG004|Overall Study|Participant Decision|2|||
125152745|NCT01351350|450183348|FG000|Overall Study|Enrolled but not Treated|0|||
125152746|NCT01351350|450183349|FG001|Overall Study|Enrolled but not Treated|0|||
125152747|NCT01351350|450183350|FG002|Overall Study|Enrolled but not Treated|1|||
125152748|NCT01351350|450183351|FG003|Overall Study|Enrolled but not Treated|0|||
125152749|NCT01351350|450183352|FG004|Overall Study|Enrolled but not Treated|0|||
125152750|NCT02339740|450183355|FG000|Overall Study|Death|1|||
125152751|NCT02339740|450183356|FG001|Overall Study|Death|0|||
125152752|NCT02339740|450183355|FG000|Overall Study|Physician Decision|0|||
125152753|NCT02339740|450183356|FG001|Overall Study|Physician Decision|2|||
125152754|NCT02339740|450183355|FG000|Overall Study|Withdrawal by Subject|5|||
125152755|NCT02339740|450183356|FG001|Overall Study|Withdrawal by Subject|1|||
125152756|NCT02339740|450183355|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
125152757|NCT02339740|450183356|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
125152758|NCT02096588|450183357|FG000|Overall Study|Lack of Efficacy|2|||
125152759|NCT02096588|450183358|FG001|Overall Study|Lack of Efficacy|0|||
125152760|NCT02096588|450183357|FG000|Overall Study|Withdrawal by Subject|0|||
125152761|NCT02096588|450183358|FG001|Overall Study|Withdrawal by Subject|1|||
125152762|NCT00303667|450183359|FG000|Overall Study|Death|0|||
125152763|NCT00303667|450183360|FG001|Overall Study|Death|4|||
125152764|NCT02377921|450183363|FG000|Overall Study|Subject non-compliance|1|||
125152765|NCT02377921|450183364|FG001|Overall Study|Subject non-compliance|1|||
125152766|NCT00706355|450183370|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
125152767|NCT00706355|450183371|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
125152768|NCT00706355|450183372|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
125152769|NCT00706355|450183373|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
125152770|NCT00706355|450183370|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
125152771|NCT00706355|450183371|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
125152772|NCT00706355|450183372|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
125152773|NCT00706355|450183373|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
125152774|NCT00706355|450183370|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
125152775|NCT00706355|450183371|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
125152776|NCT00706355|450183372|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
125152777|NCT00706355|450183373|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
125152778|NCT00706355|450183370|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
125152779|NCT00706355|450183371|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
125152780|NCT00706355|450183372|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
125152781|NCT00706355|450183373|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
125152782|NCT00706355|450183370|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
125152783|NCT00706355|450183371|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
125152784|NCT00706355|450183372|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
125152785|NCT00706355|450183373|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
125152786|NCT00706355|450183370|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
125152787|NCT00706355|450183371|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
125152788|NCT00706355|450183372|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
125152789|NCT00706355|450183373|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
125152790|NCT00706355|450183370|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
125152791|NCT00706355|450183371|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
125152792|NCT00706355|450183372|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
125152793|NCT00706355|450183373|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
125152794|NCT00706355|450183370|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
125152795|NCT00706355|450183371|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
125152796|NCT00706355|450183372|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
125152797|NCT00706355|450183373|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
125152798|NCT00706355|450183370|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
125152799|NCT00706355|450183371|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
125152800|NCT00706355|450183372|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
125152801|NCT00706355|450183373|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
125152802|NCT01020799|450183374|FG000|Overall Study|Adverse Event|4|||
125152803|NCT01020799|450183375|FG001|Overall Study|Adverse Event|3|||
125152804|NCT01020799|450183376|FG002|Overall Study|Adverse Event|2|||
125152805|NCT01020799|450183374|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
125152806|NCT01020799|450183375|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
125152807|NCT01020799|450183376|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
125152808|NCT01020799|450183374|FG000|Overall Study|Protocol Violation|3|||
125152809|NCT01020799|450183375|FG001|Overall Study|Protocol Violation|2|||
125152810|NCT01020799|450183376|FG002|Overall Study|Protocol Violation|0|||
125152811|NCT01020799|450183374|FG000|Overall Study|Withdrawal by Subject|2|||
125152812|NCT01020799|450183375|FG001|Overall Study|Withdrawal by Subject|2|||
125152813|NCT01020799|450183376|FG002|Overall Study|Withdrawal by Subject|3|||
125152814|NCT01020799|450183374|FG000|Overall Study|Lost to Follow-up|6|||
125152815|NCT01020799|450183375|FG001|Overall Study|Lost to Follow-up|4|||
125152816|NCT01020799|450183376|FG002|Overall Study|Lost to Follow-up|2|||
125152817|NCT01425528|450183377|FG000|Overall Study|Withdrawal by Subject|1|||
125152818|NCT01425528|450183378|FG001|Overall Study|Withdrawal by Subject|1|||
125152819|NCT00952276|450183383|FG000|Overall Study|Withdrawal by Subject|1|||
125152820|NCT00952276|450183384|FG001|Overall Study|Withdrawal by Subject|0|||
125152821|NCT00952276|450183385|FG002|Overall Study|Withdrawal by Subject|0|||
125152822|NCT00952276|450183386|FG003|Overall Study|Withdrawal by Subject|1|||
125152823|NCT00952276|450183387|FG004|Overall Study|Withdrawal by Subject|0|||
125152824|NCT02985879|450183388|FG000|Overall Study|Adverse Event|7|||
125152825|NCT02985879|450183389|FG001|Overall Study|Adverse Event|9|||
125152826|NCT02985879|450183390|FG002|Overall Study|Adverse Event|7|||
125152827|NCT02985879|450183388|FG000|Overall Study|Withdrew consent|6|||
125152828|NCT02985879|450183389|FG001|Overall Study|Withdrew consent|8|||
125152829|NCT02985879|450183390|FG002|Overall Study|Withdrew consent|10|||
125152830|NCT02985879|450183388|FG000|Overall Study|Lost to Follow-up|1|||
125152831|NCT02985879|450183389|FG001|Overall Study|Lost to Follow-up|0|||
125152832|NCT02985879|450183390|FG002|Overall Study|Lost to Follow-up|2|||
125152833|NCT02985879|450183388|FG000|Overall Study|Other, not specified|62|||
125152834|NCT02985879|450183389|FG001|Overall Study|Other, not specified|58|||
125152835|NCT02985879|450183390|FG002|Overall Study|Other, not specified|58|||
125152836|NCT00595335|450184966|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
125152837|NCT00595335|450184967|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
125152838|NCT00595335|450184966|FG000|Baseline to Six Months|Disease Progression|1|||
125152839|NCT00595335|450184967|FG001|Baseline to Six Months|Disease Progression|1|||
125152840|NCT00595335|450184966|FG000|Baseline to Six Months|Adverse Event|1|||
125152841|NCT00595335|450184967|FG001|Baseline to Six Months|Adverse Event|0|||
125152842|NCT00595335|450184966|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
125152843|NCT00595335|450184967|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
125152844|NCT00595335|450184966|FG000|Six Months to Twelve Months|Disease Progression|1|||
125152845|NCT00595335|450184967|FG001|Six Months to Twelve Months|Disease Progression|0|||
125152846|NCT01647958|450184972|FG000|Initial Study|Lost to Follow-up|2|||
125152847|NCT01647958|450184973|FG001|Initial Study|Lost to Follow-up|3|||
125152848|NCT01647958|450184972|FG000|Continuation Phase|treatment received during Overall Study|39|||
125152849|NCT01647958|450184973|FG001|Continuation Phase|treatment received during Overall Study|0|||
125152850|NCT01647958|450184972|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
125152851|NCT01647958|450184973|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
125152852|NCT00544817|450184974|FG000|Combined Modality|Lack of Efficacy|2|||
125152853|NCT00544817|450184974|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
125152854|NCT00544817|450184974|FG000|Combined Modality|Adverse Event|2|||
125152855|NCT00544817|450184974|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
125152856|NCT00544817|450184974|FG000|No Treatment Interval|Lack of Efficacy|8|||
125152857|NCT00544817|450184974|FG000|No Treatment Interval|Physician Decision|3|||
125152858|NCT00544817|450184974|FG000|No Treatment Interval|Adverse Event|1|||
125152859|NCT00544817|450184974|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
125152860|NCT00544817|450184974|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
125152861|NCT00544817|450184974|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
125152862|NCT01131299|450184975|FG000|Overall Study|Withdrawal by Subject|4|||
125152863|NCT01131299|450184976|FG001|Overall Study|Withdrawal by Subject|7|||
125152864|NCT01885182|450184983|FG000|Overall Study|Adverse Event|11|||
125152865|NCT01885182|450184984|FG001|Overall Study|Adverse Event|13|||
125152866|NCT01885182|450184983|FG000|Overall Study|Withdrawal by Subject|13|||
125152867|NCT01885182|450184984|FG001|Overall Study|Withdrawal by Subject|6|||
125152868|NCT01885182|450184983|FG000|Overall Study|Lost to Follow-up|2|||
125152869|NCT01885182|450184984|FG001|Overall Study|Lost to Follow-up|2|||
125152870|NCT01885182|450184983|FG000|Overall Study|Lack of Efficacy|8|||
125152871|NCT01885182|450184984|FG001|Overall Study|Lack of Efficacy|1|||
125152872|NCT03686150|450184985|FG000|Overall Study|Withdrawal by Subject|1|||
125152873|NCT03686150|450184986|FG001|Overall Study|Withdrawal by Subject|1|||
125152874|NCT03686150|450184987|FG002|Overall Study|Withdrawal by Subject|1|||
125152875|NCT03686150|450184988|FG003|Overall Study|Withdrawal by Subject|0|||
125152876|NCT03686150|450184989|FG004|Overall Study|Withdrawal by Subject|1|||
125152877|NCT03686150|450184990|FG005|Overall Study|Withdrawal by Subject|2|||
125152878|NCT03686150|450184985|FG000|Overall Study|Physician Decision|1|||
125152879|NCT03686150|450184986|FG001|Overall Study|Physician Decision|0|||
125152880|NCT03686150|450184987|FG002|Overall Study|Physician Decision|0|||
125152881|NCT03686150|450184988|FG003|Overall Study|Physician Decision|0|||
125152882|NCT03686150|450184989|FG004|Overall Study|Physician Decision|0|||
125152883|NCT03686150|450184990|FG005|Overall Study|Physician Decision|1|||
125152884|NCT03686150|450184985|FG000|Overall Study|Lost to Follow-up|0|||
125223843|NCT04157088|450446240|FG000|Overall Study|Study terminated by sponsor|23|||
125223844|NCT04157088|450446240|FG000|Overall Study|Withdrawal by Subject|4|||
125152885|NCT03686150|450184986|FG001|Overall Study|Lost to Follow-up|1|||
125152886|NCT03686150|450184987|FG002|Overall Study|Lost to Follow-up|0|||
125152887|NCT03686150|450184988|FG003|Overall Study|Lost to Follow-up|0|||
125152888|NCT03686150|450184989|FG004|Overall Study|Lost to Follow-up|0|||
125152889|NCT03686150|450184990|FG005|Overall Study|Lost to Follow-up|0|||
125152890|NCT01207440|450184991|FG000|Overall Study|Adverse Event|46|||
125152891|NCT01207440|450184992|FG001|Overall Study|Adverse Event|11|||
125152892|NCT01207440|450184993|FG002|Overall Study|Adverse Event|7|||
125152893|NCT01207440|450184994|FG003|Overall Study|Adverse Event|2|||
125152894|NCT01207440|450184995|FG004|Overall Study|Adverse Event|6|||
125152895|NCT01207440|450184996|FG005|Overall Study|Adverse Event|6|||
125152896|NCT01207440|450184997|FG006|Overall Study|Adverse Event|2|||
125152897|NCT01207440|450184991|FG000|Overall Study|Death|6|||
125152898|NCT01207440|450184992|FG001|Overall Study|Death|3|||
125152899|NCT01207440|450184993|FG002|Overall Study|Death|2|||
125152900|NCT01207440|450184994|FG003|Overall Study|Death|2|||
125152901|NCT01207440|450184995|FG004|Overall Study|Death|7|||
125152902|NCT01207440|450184996|FG005|Overall Study|Death|5|||
125152903|NCT01207440|450184997|FG006|Overall Study|Death|1|||
125152904|NCT01207440|450184991|FG000|Overall Study|Lack of Efficacy|13|||
125152905|NCT01207440|450184992|FG001|Overall Study|Lack of Efficacy|2|||
125152906|NCT01207440|450184993|FG002|Overall Study|Lack of Efficacy|5|||
125152907|NCT01207440|450184994|FG003|Overall Study|Lack of Efficacy|1|||
125152908|NCT01207440|450184995|FG004|Overall Study|Lack of Efficacy|2|||
125152909|NCT01207440|450184996|FG005|Overall Study|Lack of Efficacy|3|||
125152910|NCT01207440|450184997|FG006|Overall Study|Lack of Efficacy|0|||
125152911|NCT01207440|450184991|FG000|Overall Study|Lost to Follow-up|0|||
125152912|NCT01207440|450184992|FG001|Overall Study|Lost to Follow-up|0|||
125152913|NCT01207440|450184993|FG002|Overall Study|Lost to Follow-up|2|||
125152914|NCT01207440|450184994|FG003|Overall Study|Lost to Follow-up|1|||
125152915|NCT01207440|450184995|FG004|Overall Study|Lost to Follow-up|0|||
125152916|NCT01207440|450184996|FG005|Overall Study|Lost to Follow-up|0|||
125152917|NCT01207440|450184997|FG006|Overall Study|Lost to Follow-up|0|||
125152918|NCT01207440|450184991|FG000|Overall Study|Non-compliance with Study Drug|3|||
125152919|NCT01207440|450184992|FG001|Overall Study|Non-compliance with Study Drug|0|||
125152920|NCT01207440|450184993|FG002|Overall Study|Non-compliance with Study Drug|1|||
125152921|NCT01207440|450184994|FG003|Overall Study|Non-compliance with Study Drug|0|||
125152922|NCT01207440|450184995|FG004|Overall Study|Non-compliance with Study Drug|0|||
125152923|NCT01207440|450184996|FG005|Overall Study|Non-compliance with Study Drug|0|||
125152924|NCT01207440|450184997|FG006|Overall Study|Non-compliance with Study Drug|0|||
125152925|NCT01207440|450184991|FG000|Overall Study|Physician Decision|6|||
125152926|NCT01207440|450184992|FG001|Overall Study|Physician Decision|5|||
125152927|NCT01207440|450184993|FG002|Overall Study|Physician Decision|5|||
125152928|NCT01207440|450184994|FG003|Overall Study|Physician Decision|0|||
125152929|NCT01207440|450184995|FG004|Overall Study|Physician Decision|1|||
125152930|NCT01207440|450184996|FG005|Overall Study|Physician Decision|0|||
125152931|NCT01207440|450184997|FG006|Overall Study|Physician Decision|0|||
125152932|NCT01207440|450184991|FG000|Overall Study|Progressive Disease|19|||
125152933|NCT01207440|450184992|FG001|Overall Study|Progressive Disease|10|||
125152934|NCT01207440|450184993|FG002|Overall Study|Progressive Disease|19|||
125152935|NCT01207440|450184994|FG003|Overall Study|Progressive Disease|7|||
125152936|NCT01207440|450184995|FG004|Overall Study|Progressive Disease|23|||
125152937|NCT01207440|450184996|FG005|Overall Study|Progressive Disease|27|||
125152938|NCT01207440|450184997|FG006|Overall Study|Progressive Disease|0|||
125152939|NCT01207440|450184991|FG000|Overall Study|Protocol Violation|2|||
125152940|NCT01207440|450184992|FG001|Overall Study|Protocol Violation|0|||
125152941|NCT01207440|450184993|FG002|Overall Study|Protocol Violation|0|||
125152942|NCT01207440|450184994|FG003|Overall Study|Protocol Violation|0|||
125152943|NCT01207440|450184995|FG004|Overall Study|Protocol Violation|0|||
125152944|NCT01207440|450184996|FG005|Overall Study|Protocol Violation|0|||
125152945|NCT01207440|450184997|FG006|Overall Study|Protocol Violation|0|||
125152946|NCT01207440|450184991|FG000|Overall Study|Site Terminated by Sponsor|69|||
125152947|NCT01207440|450184992|FG001|Overall Study|Site Terminated by Sponsor|19|||
125152948|NCT01207440|450184993|FG002|Overall Study|Site Terminated by Sponsor|12|||
125152949|NCT01207440|450184994|FG003|Overall Study|Site Terminated by Sponsor|2|||
125152950|NCT01207440|450184995|FG004|Overall Study|Site Terminated by Sponsor|3|||
125152951|NCT01207440|450184996|FG005|Overall Study|Site Terminated by Sponsor|0|||
125152952|NCT01207440|450184997|FG006|Overall Study|Site Terminated by Sponsor|2|||
125152953|NCT01207440|450184991|FG000|Overall Study|Withdrawal by Subject|29|||
125152954|NCT01207440|450184992|FG001|Overall Study|Withdrawal by Subject|4|||
125152955|NCT01207440|450184993|FG002|Overall Study|Withdrawal by Subject|5|||
125152956|NCT01207440|450184994|FG003|Overall Study|Withdrawal by Subject|3|||
125152957|NCT01207440|450184995|FG004|Overall Study|Withdrawal by Subject|2|||
125152958|NCT01207440|450184996|FG005|Overall Study|Withdrawal by Subject|2|||
125152959|NCT01207440|450184997|FG006|Overall Study|Withdrawal by Subject|0|||
125152960|NCT01207440|450184991|FG000|Overall Study|Reason Not Specified|10|||
125152961|NCT01207440|450184992|FG001|Overall Study|Reason Not Specified|10|||
125152962|NCT01207440|450184993|FG002|Overall Study|Reason Not Specified|7|||
125152963|NCT01207440|450184994|FG003|Overall Study|Reason Not Specified|0|||
125152964|NCT01207440|450184995|FG004|Overall Study|Reason Not Specified|4|||
125152965|NCT01207440|450184996|FG005|Overall Study|Reason Not Specified|3|||
125152966|NCT01207440|450184997|FG006|Overall Study|Reason Not Specified|0|||
125152967|NCT03341000|450184998|FG000|Overall Study|Adverse Event|1|||
125152968|NCT02813421|450185001|FG000|Overall Study|Withdrawal by Subject|1|||
125152969|NCT02813421|450185002|FG001|Overall Study|Withdrawal by Subject|2|||
125152970|NCT02813421|450185001|FG000|Overall Study|Lost to Follow-up|1|||
125152971|NCT02813421|450185002|FG001|Overall Study|Lost to Follow-up|1|||
125152972|NCT03135899|450185003|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
125152973|NCT03135899|450185004|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
125152974|NCT03135899|450185005|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
125152975|NCT03135899|450185006|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
125152976|NCT03135899|450185007|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
125152977|NCT03135899|450185008|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
125152978|NCT03135899|450185009|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
125152979|NCT03135899|450185010|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
125152980|NCT03135899|450185003|FG000|Overall Study|Withdrawal by Subject|0|||
125152981|NCT03135899|450185004|FG001|Overall Study|Withdrawal by Subject|0|||
125152982|NCT03135899|450185005|FG002|Overall Study|Withdrawal by Subject|0|||
125152983|NCT03135899|450185006|FG003|Overall Study|Withdrawal by Subject|0|||
125152984|NCT03135899|450185007|FG004|Overall Study|Withdrawal by Subject|0|||
125152985|NCT03135899|450185008|FG005|Overall Study|Withdrawal by Subject|2|||
125152986|NCT03135899|450185009|FG006|Overall Study|Withdrawal by Subject|0|||
125152987|NCT03135899|450185010|FG007|Overall Study|Withdrawal by Subject|0|||
125152988|NCT04146363|450185011|FG000|Induction Period|Adverse Event|1|||
125152989|NCT04146363|450185012|FG001|Induction Period|Adverse Event|2|||
125152990|NCT04146363|450185013|FG002|Induction Period|Adverse Event|0|||
125152991|NCT04146363|450185014|FG003|Induction Period|Adverse Event|0|||
125152992|NCT04146363|450185015|FG004|Induction Period|Adverse Event|0|||
125152993|NCT04146363|450185016|FG005|Induction Period|Adverse Event|0|||
125152994|NCT04146363|450185017|FG006|Induction Period|Adverse Event|0|||
125152995|NCT04146363|450185018|FG007|Induction Period|Adverse Event|0|||
125152996|NCT04146363|450185019|FG008|Induction Period|Adverse Event|0|||
125152997|NCT04146363|450185020|FG009|Induction Period|Adverse Event|0|||
125152998|NCT04146363|450185021|FG010|Induction Period|Adverse Event|0|||
125152999|NCT04146363|450185011|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
125153000|NCT04146363|450185012|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
125153001|NCT04146363|450185013|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
125153002|NCT04146363|450185014|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
125153003|NCT04146363|450185015|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
125153004|NCT04146363|450185016|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
125153005|NCT04146363|450185017|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
125153006|NCT04146363|450185018|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
125153007|NCT04146363|450185019|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
125153008|NCT04146363|450185020|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
125153009|NCT04146363|450185021|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
125153010|NCT04146363|450185011|FG000|Induction Period|Lack of Efficacy|7|||
125153011|NCT04146363|450185012|FG001|Induction Period|Lack of Efficacy|2|||
125153012|NCT04146363|450185013|FG002|Induction Period|Lack of Efficacy|0|||
125153013|NCT04146363|450185014|FG003|Induction Period|Lack of Efficacy|0|||
125153014|NCT04146363|450185015|FG004|Induction Period|Lack of Efficacy|0|||
125153015|NCT04146363|450185016|FG005|Induction Period|Lack of Efficacy|0|||
125153016|NCT04146363|450185017|FG006|Induction Period|Lack of Efficacy|0|||
125153017|NCT04146363|450185018|FG007|Induction Period|Lack of Efficacy|0|||
125153018|NCT04146363|450185019|FG008|Induction Period|Lack of Efficacy|0|||
125153019|NCT04146363|450185020|FG009|Induction Period|Lack of Efficacy|0|||
125153020|NCT04146363|450185021|FG010|Induction Period|Lack of Efficacy|0|||
125153021|NCT04146363|450185011|FG000|Induction Period|Lost to Follow-up|1|||
125153022|NCT04146363|450185012|FG001|Induction Period|Lost to Follow-up|4|||
125153023|NCT04146363|450185013|FG002|Induction Period|Lost to Follow-up|0|||
125223845|NCT04157088|450446240|FG000|Overall Study|Lost to Follow-up|2|||
125153024|NCT04146363|450185014|FG003|Induction Period|Lost to Follow-up|0|||
125153025|NCT04146363|450185015|FG004|Induction Period|Lost to Follow-up|0|||
125153026|NCT04146363|450185016|FG005|Induction Period|Lost to Follow-up|0|||
125153027|NCT04146363|450185017|FG006|Induction Period|Lost to Follow-up|0|||
125153028|NCT04146363|450185018|FG007|Induction Period|Lost to Follow-up|0|||
125153029|NCT04146363|450185019|FG008|Induction Period|Lost to Follow-up|0|||
125153030|NCT04146363|450185020|FG009|Induction Period|Lost to Follow-up|0|||
125153031|NCT04146363|450185021|FG010|Induction Period|Lost to Follow-up|0|||
125153032|NCT04146363|450185011|FG000|Induction Period|Positive quantiferon test|0|||
125153033|NCT04146363|450185012|FG001|Induction Period|Positive quantiferon test|1|||
125153034|NCT04146363|450185013|FG002|Induction Period|Positive quantiferon test|0|||
125153035|NCT04146363|450185014|FG003|Induction Period|Positive quantiferon test|0|||
125153036|NCT04146363|450185015|FG004|Induction Period|Positive quantiferon test|0|||
125153037|NCT04146363|450185016|FG005|Induction Period|Positive quantiferon test|0|||
125153038|NCT04146363|450185017|FG006|Induction Period|Positive quantiferon test|0|||
125153039|NCT04146363|450185018|FG007|Induction Period|Positive quantiferon test|0|||
125153040|NCT04146363|450185019|FG008|Induction Period|Positive quantiferon test|0|||
125153041|NCT04146363|450185020|FG009|Induction Period|Positive quantiferon test|0|||
125153042|NCT04146363|450185021|FG010|Induction Period|Positive quantiferon test|0|||
125153043|NCT04146363|450185011|FG000|Induction Period|Protocol Deviation|5|||
125153044|NCT04146363|450185012|FG001|Induction Period|Protocol Deviation|6|||
125153045|NCT04146363|450185013|FG002|Induction Period|Protocol Deviation|0|||
125153046|NCT04146363|450185014|FG003|Induction Period|Protocol Deviation|0|||
125153047|NCT04146363|450185015|FG004|Induction Period|Protocol Deviation|0|||
125153048|NCT04146363|450185016|FG005|Induction Period|Protocol Deviation|0|||
125153049|NCT04146363|450185017|FG006|Induction Period|Protocol Deviation|0|||
125153050|NCT04146363|450185018|FG007|Induction Period|Protocol Deviation|0|||
125153051|NCT04146363|450185019|FG008|Induction Period|Protocol Deviation|0|||
125153052|NCT04146363|450185020|FG009|Induction Period|Protocol Deviation|0|||
125153053|NCT04146363|450185021|FG010|Induction Period|Protocol Deviation|0|||
125153054|NCT04146363|450185011|FG000|Induction Period|Withdrawal by Subject|6|||
125153055|NCT04146363|450185012|FG001|Induction Period|Withdrawal by Subject|3|||
125153056|NCT04146363|450185013|FG002|Induction Period|Withdrawal by Subject|0|||
125153057|NCT04146363|450185014|FG003|Induction Period|Withdrawal by Subject|0|||
125153058|NCT04146363|450185015|FG004|Induction Period|Withdrawal by Subject|0|||
125153059|NCT04146363|450185016|FG005|Induction Period|Withdrawal by Subject|0|||
125153060|NCT04146363|450185017|FG006|Induction Period|Withdrawal by Subject|0|||
125153061|NCT04146363|450185018|FG007|Induction Period|Withdrawal by Subject|0|||
125153062|NCT04146363|450185019|FG008|Induction Period|Withdrawal by Subject|0|||
125153063|NCT04146363|450185020|FG009|Induction Period|Withdrawal by Subject|0|||
125153064|NCT04146363|450185021|FG010|Induction Period|Withdrawal by Subject|0|||
125153065|NCT04146363|450185011|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
125153066|NCT04146363|450185012|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
125153067|NCT04146363|450185013|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
125153068|NCT04146363|450185014|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
125153069|NCT04146363|450185015|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
125153070|NCT04146363|450185016|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
125153071|NCT04146363|450185017|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
125153072|NCT04146363|450185018|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
125153073|NCT04146363|450185019|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
125153074|NCT04146363|450185020|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
125153075|NCT04146363|450185021|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
125153076|NCT04146363|450185011|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125153077|NCT04146363|450185012|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125153078|NCT04146363|450185013|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125153079|NCT04146363|450185014|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125153080|NCT04146363|450185015|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125153081|NCT04146363|450185016|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125153082|NCT04146363|450185017|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125153083|NCT04146363|450185018|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
125153084|NCT04146363|450185019|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125153085|NCT04146363|450185020|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125153086|NCT04146363|450185021|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125153087|NCT04146363|450185011|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125153088|NCT04146363|450185012|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125153089|NCT04146363|450185013|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125153090|NCT04146363|450185014|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125153091|NCT04146363|450185015|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125153092|NCT04146363|450185016|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125153093|NCT04146363|450185017|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
125153094|NCT04146363|450185018|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
125153095|NCT04146363|450185019|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125153096|NCT04146363|450185020|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125153097|NCT04146363|450185021|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125153098|NCT04146363|450185011|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
125153099|NCT04146363|450185012|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
125153100|NCT04146363|450185013|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
125153101|NCT04146363|450185014|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
125153102|NCT04146363|450185015|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
125153103|NCT04146363|450185016|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
125153104|NCT04146363|450185017|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
125153105|NCT04146363|450185018|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
125153106|NCT04146363|450185019|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
125153107|NCT04146363|450185020|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
125153108|NCT04146363|450185021|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
125153109|NCT04146363|450185011|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125153110|NCT04146363|450185012|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125153111|NCT04146363|450185013|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125153112|NCT04146363|450185014|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125153113|NCT04146363|450185015|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
125153114|NCT04146363|450185016|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
125153115|NCT04146363|450185017|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
125153116|NCT04146363|450185018|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
125153117|NCT04146363|450185019|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125153118|NCT04146363|450185020|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125153119|NCT04146363|450185021|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125153120|NCT04146363|450185011|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125153121|NCT04146363|450185012|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125153122|NCT04146363|450185013|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
125153123|NCT04146363|450185014|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125153124|NCT04146363|450185015|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125153125|NCT04146363|450185016|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
125153126|NCT04146363|450185017|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
125153127|NCT04146363|450185018|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
125153128|NCT04146363|450185019|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125153129|NCT04146363|450185020|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125153130|NCT04146363|450185021|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125153131|NCT04146363|450185011|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
125153132|NCT04146363|450185012|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
125153133|NCT04146363|450185013|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
125153134|NCT04146363|450185014|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
125153135|NCT04146363|450185015|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
125153136|NCT04146363|450185016|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
125153137|NCT04146363|450185017|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
125153138|NCT04146363|450185018|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
125153139|NCT04146363|450185019|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
125153140|NCT04146363|450185020|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
125153141|NCT04146363|450185021|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
125153142|NCT04146363|450185011|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125153143|NCT04146363|450185012|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125153144|NCT04146363|450185013|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125153145|NCT04146363|450185014|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125153146|NCT04146363|450185015|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125153147|NCT04146363|450185016|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125153148|NCT04146363|450185017|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125153149|NCT04146363|450185018|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125153150|NCT04146363|450185019|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
125153151|NCT04146363|450185020|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
125153152|NCT04146363|450185021|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
125153153|NCT04146363|450185011|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125153154|NCT04146363|450185012|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125153155|NCT04146363|450185013|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125153156|NCT04146363|450185014|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125153157|NCT04146363|450185015|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125153158|NCT04146363|450185016|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125153159|NCT04146363|450185017|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125153160|NCT04146363|450185018|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125153161|NCT04146363|450185019|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
125153162|NCT04146363|450185020|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
125153163|NCT04146363|450185021|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125153164|NCT04146363|450185011|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
125153165|NCT04146363|450185012|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
125153166|NCT04146363|450185013|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
125153167|NCT04146363|450185014|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
125153168|NCT04146363|450185015|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
125153169|NCT04146363|450185016|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
125153170|NCT04146363|450185017|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
125153171|NCT04146363|450185018|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
125153172|NCT04146363|450185019|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
125153173|NCT04146363|450185020|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
125153174|NCT04146363|450185021|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
125153175|NCT04146363|450185011|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125153176|NCT04146363|450185012|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125153177|NCT04146363|450185013|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125153178|NCT04146363|450185014|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125153179|NCT04146363|450185015|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125153180|NCT04146363|450185016|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125153181|NCT04146363|450185017|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125153182|NCT04146363|450185018|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125153183|NCT04146363|450185019|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
125153184|NCT04146363|450185020|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
125153185|NCT04146363|450185021|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
125153186|NCT04146363|450185011|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
125153187|NCT04146363|450185012|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
125153188|NCT04146363|450185013|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
125153189|NCT04146363|450185014|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
125153190|NCT04146363|450185015|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
125153191|NCT04146363|450185016|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
125153192|NCT04146363|450185017|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
125153193|NCT04146363|450185018|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
125153194|NCT04146363|450185019|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
125153195|NCT04146363|450185020|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
125153196|NCT04146363|450185021|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
125153197|NCT04146363|450185011|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
125153198|NCT04146363|450185012|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
125153199|NCT04146363|450185013|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
125153200|NCT04146363|450185014|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
125153201|NCT04146363|450185015|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
125153202|NCT04146363|450185016|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
125153203|NCT04146363|450185017|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
125153204|NCT04146363|450185018|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
125153205|NCT04146363|450185019|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
125153206|NCT04146363|450185020|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
125153207|NCT04146363|450185021|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
125153208|NCT02914236|450185030|FG000|Overall Study|Lost to Follow-up|1|||
125153209|NCT00706095|450185037|FG000|Overall Study|Progressive Disease|4|||
125153210|NCT00706095|450185038|FG001|Overall Study|Progressive Disease|5|||
125153211|NCT00706095|450185039|FG002|Overall Study|Progressive Disease|3|||
125153212|NCT00706095|450185037|FG000|Overall Study|Clinical Progression|1|||
125153213|NCT00706095|450185038|FG001|Overall Study|Clinical Progression|2|||
125153214|NCT00706095|450185039|FG002|Overall Study|Clinical Progression|2|||
125153215|NCT00706095|450185037|FG000|Overall Study|Withdrawal by Subject|1|||
125153216|NCT00706095|450185038|FG001|Overall Study|Withdrawal by Subject|0|||
125153217|NCT00706095|450185039|FG002|Overall Study|Withdrawal by Subject|0|||
125153218|NCT02676284|450185040|FG000|Overall Study|Withdrawal by Subject|1|||
125153219|NCT01685073|450185041|FG000|Overall Study|Lost to Follow-up|6|||
125153220|NCT01685073|450185042|FG001|Overall Study|Lost to Follow-up|8|||
125153221|NCT01685073|450185041|FG000|Overall Study|Withdrawal by Subject|24|||
125153222|NCT01685073|450185042|FG001|Overall Study|Withdrawal by Subject|24|||
125153223|NCT00743509|450185045|FG000|Overall Study|Withdrawal by Subject|2|||
125153224|NCT03768726|450185050|FG000|Treatment Phase|Adverse Event|2|||
125153225|NCT03768726|450185051|FG001|Treatment Phase|Adverse Event|2|||
125153226|NCT03768726|450185050|FG000|Treatment Phase|Lost to Follow-up|1|||
125153227|NCT03768726|450185051|FG001|Treatment Phase|Lost to Follow-up|0|||
125153228|NCT03768726|450185050|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
125153229|NCT03768726|450185051|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
125153230|NCT03768726|450185050|FG000|Treatment Phase|Withdrawal by Subject|3|||
125153231|NCT03768726|450185051|FG001|Treatment Phase|Withdrawal by Subject|1|||
125153232|NCT03768726|450185050|FG000|Follow-Up|Adverse Event|2|||
125153233|NCT03768726|450185051|FG001|Follow-Up|Adverse Event|2|||
125153234|NCT03768726|450185050|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
125153235|NCT03768726|450185051|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
125153236|NCT03768726|450185050|FG000|Follow-Up|Withdrawal by Subject|2|||
125153237|NCT03768726|450185051|FG001|Follow-Up|Withdrawal by Subject|0|||
125153238|NCT03768726|450185050|FG000|Follow-Up|Other|1|||
125153239|NCT03768726|450185051|FG001|Follow-Up|Other|0|||
125153240|NCT01787279|450185052|FG000|Overall Study|Lost to Follow-up|2|||
125153241|NCT01787279|450185052|FG000|Overall Study|Lack of Efficacy|1|||
125153242|NCT02695719|450185053|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
125153243|NCT02695719|450185054|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
125153244|NCT02695719|450185053|FG000|Overall Study|Significant Protocol Deviation|0|||
125153245|NCT02695719|450185054|FG001|Overall Study|Significant Protocol Deviation|1|||
125153246|NCT02695719|450185053|FG000|Overall Study|Voluntary Withdrawal|1|||
125153247|NCT02695719|450185054|FG001|Overall Study|Voluntary Withdrawal|0|||
125153248|NCT00140413|450185055|FG000|Overall Study|Lost to Follow-up|1|||
125153249|NCT00140413|450185056|FG001|Overall Study|Lost to Follow-up|0|||
125153250|NCT00140413|450185055|FG000|Overall Study|Withdrawal by Subject|2|||
125153251|NCT00140413|450185056|FG001|Overall Study|Withdrawal by Subject|0|||
125153252|NCT01360866|450185061|FG000|Overall Study|Lost to Follow-up|11|||
125153253|NCT01360866|450185062|FG001|Overall Study|Lost to Follow-up|28|||
125153254|NCT01360866|450185063|FG002|Overall Study|Lost to Follow-up|41|||
125153255|NCT01360866|450185064|FG003|Overall Study|Lost to Follow-up|0|||
125153256|NCT01360866|450185061|FG000|Overall Study|Adverse Event|56|||
125153257|NCT01360866|450185062|FG001|Overall Study|Adverse Event|61|||
125153258|NCT01360866|450185063|FG002|Overall Study|Adverse Event|134|||
125153259|NCT01360866|450185064|FG003|Overall Study|Adverse Event|6|||
125153260|NCT01360866|450185061|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
125153261|NCT01360866|450185062|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
125153262|NCT01360866|450185063|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
125153263|NCT01360866|450185064|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
125153264|NCT01360866|450185061|FG000|Overall Study|Withdrawn by Investigator|9|||
125153265|NCT01360866|450185062|FG001|Overall Study|Withdrawn by Investigator|8|||
125153266|NCT01360866|450185063|FG002|Overall Study|Withdrawn by Investigator|31|||
125153267|NCT01360866|450185064|FG003|Overall Study|Withdrawn by Investigator|2|||
125153268|NCT01360866|450185061|FG000|Overall Study|Withdrawal by participant|79|||
125153269|NCT01360866|450185062|FG001|Overall Study|Withdrawal by participant|89|||
125153270|NCT01360866|450185063|FG002|Overall Study|Withdrawal by participant|168|||
125153271|NCT01360866|450185064|FG003|Overall Study|Withdrawal by participant|8|||
125153272|NCT01360866|450185061|FG000|Overall Study|Protocol Deviation|25|||
125153273|NCT01360866|450185062|FG001|Overall Study|Protocol Deviation|33|||
125153274|NCT01360866|450185063|FG002|Overall Study|Protocol Deviation|61|||
125153275|NCT01360866|450185064|FG003|Overall Study|Protocol Deviation|2|||
125153276|NCT01360866|450185061|FG000|Overall Study|Lack of Efficacy|30|||
125153277|NCT01360866|450185062|FG001|Overall Study|Lack of Efficacy|40|||
125153278|NCT01360866|450185063|FG002|Overall Study|Lack of Efficacy|30|||
125153279|NCT01360866|450185064|FG003|Overall Study|Lack of Efficacy|4|||
125153280|NCT01304693|450185065|FG000|Overall Study|Adverse Event|0|||
125153281|NCT01304693|450185066|FG001|Overall Study|Adverse Event|0|||
125153282|NCT01304693|450185067|FG002|Overall Study|Adverse Event|0|||
125153283|NCT01304693|450185068|FG003|Overall Study|Adverse Event|0|||
125153284|NCT01304693|450185069|FG004|Overall Study|Adverse Event|1|||
125153285|NCT01304693|450185065|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
125153286|NCT01304693|450185066|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
125153287|NCT01304693|450185067|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
125153288|NCT01304693|450185068|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
125153289|NCT01304693|450185069|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
125153290|NCT02129647|450185070|FG000|Overall Study|Adverse Event|2|||
125153291|NCT02129647|450185070|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
125153292|NCT00918463|450185072|FG000|Overall Study|Death|1|||
125153293|NCT00918463|450185072|FG000|Overall Study|Lack of Efficacy|1|||
125153294|NCT01014624|450185076|FG000|Overall Study|Adverse Event|0|||
125153295|NCT01014624|450185077|FG001|Overall Study|Adverse Event|1|||
125153296|NCT01014624|450185076|FG000|Overall Study|Protocol Violation|1|||
125153297|NCT01014624|450185077|FG001|Overall Study|Protocol Violation|0|||
125153298|NCT01014624|450185076|FG000|Overall Study|Withdrawal by Subject|1|||
125153299|NCT01014624|450185077|FG001|Overall Study|Withdrawal by Subject|0|||
125153300|NCT01715896|450185081|FG000|Overall Study|Lost to Follow-up|0|||
125153301|NCT01715896|450185082|FG001|Overall Study|Lost to Follow-up|2|||
125153302|NCT01715896|450185081|FG000|Overall Study|Withdrawal by Subject|1|||
125153303|NCT01715896|450185082|FG001|Overall Study|Withdrawal by Subject|4|||
125153304|NCT01715896|450185081|FG000|Overall Study|Other|2|||
125153305|NCT01715896|450185082|FG001|Overall Study|Other|5|||
125153306|NCT01173471|450185086|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125153307|NCT01173471|450185087|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125153308|NCT01173471|450185088|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
125153309|NCT01173471|450185089|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
125153310|NCT01173471|450185086|FG000|Overall Study|Condition under investigation worsened|2|||
125153311|NCT01173471|450185087|FG001|Overall Study|Condition under investigation worsened|0|||
125153312|NCT01173471|450185088|FG002|Overall Study|Condition under investigation worsened|0|||
125153313|NCT01173471|450185089|FG003|Overall Study|Condition under investigation worsened|0|||
125153314|NCT01173471|450185086|FG000|Overall Study|Lost to Follow-up|0|||
125153315|NCT01173471|450185087|FG001|Overall Study|Lost to Follow-up|0|||
125153316|NCT01173471|450185088|FG002|Overall Study|Lost to Follow-up|1|||
125153317|NCT01173471|450185089|FG003|Overall Study|Lost to Follow-up|0|||
125153318|NCT01173471|450185086|FG000|Overall Study|Reason given as Other|0|||
125153319|NCT01173471|450185087|FG001|Overall Study|Reason given as Other|0|||
125153320|NCT01173471|450185088|FG002|Overall Study|Reason given as Other|1|||
125153321|NCT01173471|450185089|FG003|Overall Study|Reason given as Other|0|||
125153322|NCT03028740|450185090|FG000|Overall Study|Did not Receive Study Drug|4|||
125153323|NCT03028740|450185091|FG001|Overall Study|Did not Receive Study Drug|5|||
125153324|NCT03028740|450185090|FG000|Overall Study|Adverse Event|8|||
125153325|NCT03028740|450185091|FG001|Overall Study|Adverse Event|26|||
125153326|NCT03028740|450185090|FG000|Overall Study|Lack of Efficacy|0|||
125153327|NCT03028740|450185091|FG001|Overall Study|Lack of Efficacy|1|||
125153328|NCT03028740|450185090|FG000|Overall Study|Withdrawal by Subject|48|||
125153329|NCT03028740|450185091|FG001|Overall Study|Withdrawal by Subject|101|||
125153330|NCT03028740|450185090|FG000|Overall Study|Lost to Follow-up|30|||
125153331|NCT03028740|450185091|FG001|Overall Study|Lost to Follow-up|54|||
125153332|NCT03028740|450185090|FG000|Overall Study|Physician Decision|4|||
125153333|NCT03028740|450185091|FG001|Overall Study|Physician Decision|11|||
125153334|NCT03028740|450185090|FG000|Overall Study|Protocol Violation|4|||
125153335|NCT03028740|450185091|FG001|Overall Study|Protocol Violation|8|||
125153336|NCT03028740|450185090|FG000|Overall Study|Non-compliance with Study Drug|0|||
125153337|NCT03028740|450185091|FG001|Overall Study|Non-compliance with Study Drug|2|||
125153338|NCT03028740|450185090|FG000|Overall Study|Study Terminated by Sponsor|467|||
125153339|NCT03028740|450185091|FG001|Overall Study|Study Terminated by Sponsor|917|||
125153340|NCT03028740|450185090|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
125153341|NCT03028740|450185091|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
125153342|NCT03028740|450185090|FG000|Overall Study|Reason not Specified|1|||
125153343|NCT03028740|450185091|FG001|Overall Study|Reason not Specified|5|||
125153344|NCT03336242|450185097|FG000|Overall Study|Adverse Event|0|||
125153345|NCT03336242|450185098|FG001|Overall Study|Adverse Event|1|||
125153346|NCT02224573|450185100|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
125153347|NCT02224573|450185101|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
125153348|NCT02224573|450185100|FG000|Treatment Phase|Started on Other IMP|1|||
125153349|NCT02224573|450185101|FG001|Treatment Phase|Started on Other IMP|0|||
125153350|NCT02224573|450185100|FG000|Treatment Phase|Participant Discontinued IMP|0|||
125153351|NCT02224573|450185101|FG001|Treatment Phase|Participant Discontinued IMP|1|||
125153352|NCT02224573|450185100|FG000|Treatment Phase|Lack of Efficacy|15|||
125153353|NCT02224573|450185101|FG001|Treatment Phase|Lack of Efficacy|8|||
125153354|NCT02224573|450185100|FG000|Treatment Phase|Began Commercial Product|1|||
125153355|NCT02224573|450185101|FG001|Treatment Phase|Began Commercial Product|0|||
125153356|NCT02224573|450185100|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
125153357|NCT02224573|450185101|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
125153358|NCT02224573|450185100|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
125153359|NCT02224573|450185101|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
125153360|NCT02224573|450185100|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
125153361|NCT02224573|450185101|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
125153362|NCT02224573|450185100|FG000|Treatment Phase|Continued Compassionate Use|1|||
125153363|NCT02224573|450185101|FG001|Treatment Phase|Continued Compassionate Use|0|||
125153364|NCT02224573|450185100|FG000|Treatment Phase|Lack of Efficiency|2|||
125153365|NCT02224573|450185101|FG001|Treatment Phase|Lack of Efficiency|1|||
125153366|NCT02224573|450185100|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
125153367|NCT02224573|450185101|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
125153368|NCT02224573|450185100|FG000|Treatment Phase|Participant Moved|2|||
125153369|NCT02224573|450185101|FG001|Treatment Phase|Participant Moved|0|||
125153370|NCT02224573|450185100|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
125153371|NCT02224573|450185101|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
125153372|NCT02224573|450185100|FG000|Treatment Phase|Refused Medication|1|||
125153373|NCT02224573|450185101|FG001|Treatment Phase|Refused Medication|1|||
125153374|NCT02224573|450185100|FG000|Treatment Phase|Adverse Event|26|||
125153375|NCT02224573|450185101|FG001|Treatment Phase|Adverse Event|38|||
125153376|NCT02224573|450185100|FG000|Treatment Phase|Placed in Group Home|0|||
125153377|NCT02224573|450185101|FG001|Treatment Phase|Placed in Group Home|1|||
125153378|NCT02224573|450185100|FG000|Treatment Phase|Pursued Other Trials|1|||
125153379|NCT02224573|450185101|FG001|Treatment Phase|Pursued Other Trials|0|||
125153380|NCT02224573|450185100|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
125153381|NCT02224573|450185101|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
125153382|NCT02224573|450185100|FG000|Treatment Phase|Lost to Follow-up|2|||
125153383|NCT02224573|450185101|FG001|Treatment Phase|Lost to Follow-up|1|||
125153384|NCT02224573|450185100|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
125153385|NCT02224573|450185101|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
125153386|NCT02224573|450185100|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
125153387|NCT02224573|450185101|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
125153388|NCT02224573|450185100|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
125153389|NCT02224573|450185101|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
125153390|NCT02224573|450185100|FG000|Taper Phase|Adverse Event|1|||
125153391|NCT02224573|450185101|FG001|Taper Phase|Adverse Event|1|||
125153392|NCT02546362|450185102|FG000|4-week Treatment Period|Lost to Follow-up|1|||
125153393|NCT02546362|450185102|FG000|4-week Treatment Period|Change in medication|2|||
125153394|NCT02546362|450185102|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
125153395|NCT02546362|450185102|FG000|12-week Treatment Period|Lost to Follow-up|2|||
125153396|NCT02546362|450185102|FG000|12-week Treatment Period|Change in medication|1|||
125153397|NCT01557842|450185103|FG000|Overall Study|Lost to Follow-up|0|||
125153398|NCT01557842|450185104|FG001|Overall Study|Lost to Follow-up|1|||
125153399|NCT01557842|450185103|FG000|Overall Study|Death|1|||
125153400|NCT01557842|450185104|FG001|Overall Study|Death|0|||
125153401|NCT01557842|450185103|FG000|Overall Study|Lack of Efficacy|0|||
125153402|NCT01557842|450185104|FG001|Overall Study|Lack of Efficacy|1|||
125153403|NCT01557842|450185103|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
125153404|NCT01557842|450185104|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
125153405|NCT01557842|450185103|FG000|Overall Study|Study Terminated by Sponsor|3|||
125153406|NCT01557842|450185104|FG001|Overall Study|Study Terminated by Sponsor|4|||
125153407|NCT01557842|450185103|FG000|Overall Study|Not Ablated|2|||
125153408|NCT01557842|450185104|FG001|Overall Study|Not Ablated|0|||
125153409|NCT03005067|450185108|FG000|Overall Study|Withdrawal by Subject|3|||
125153410|NCT03005067|450185109|FG001|Overall Study|Withdrawal by Subject|2|||
125153411|NCT03005067|450185108|FG000|Overall Study|Adverse Event|4|||
125153412|NCT03005067|450185109|FG001|Overall Study|Adverse Event|3|||
125153413|NCT03005067|450185108|FG000|Overall Study|Other (reason not specified)|3|||
125153414|NCT03005067|450185109|FG001|Overall Study|Other (reason not specified)|1|||
125153415|NCT03005067|450185108|FG000|Overall Study|Protocol Violation|0|||
125153416|NCT03005067|450185109|FG001|Overall Study|Protocol Violation|1|||
125153417|NCT01661881|450185115|FG000|Overall Study|Disease Progression|1|||
125153418|NCT00355472|450185122|FG000|Overall Study|Physician Decision|1|||
125153419|NCT01803269|450185125|FG000|Overall Study|Withdrawal by Subject|3|||
125153420|NCT01803269|450185126|FG001|Overall Study|Withdrawal by Subject|0|||
125153421|NCT01803269|450185127|FG002|Overall Study|Withdrawal by Subject|0|||
125153422|NCT04647383|450185128|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
125153423|NCT04647383|450185129|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
125153424|NCT04647383|450185130|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
125153425|NCT04647383|450185131|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
125153426|NCT00873119|450185132|FG000|Overall Study|Patient request|4|||
125153427|NCT00873119|450185133|FG001|Overall Study|Patient request|2|||
125153428|NCT00873119|450185132|FG000|Overall Study|Adverse Event|8|||
125153429|NCT00873119|450185133|FG001|Overall Study|Adverse Event|0|||
125153430|NCT00873119|450185132|FG000|Overall Study|Progressive disease|26|||
125153431|NCT00873119|450185133|FG001|Overall Study|Progressive disease|18|||
125153432|NCT00873119|450185132|FG000|Overall Study|Death|2|||
125153433|NCT00873119|450185133|FG001|Overall Study|Death|1|||
125153434|NCT00873119|450185132|FG000|Overall Study|Other|2|||
125153435|NCT00873119|450185133|FG001|Overall Study|Other|5|||
125153436|NCT00873119|450185132|FG000|Overall Study|Not treated|2|||
125153437|NCT00873119|450185133|FG001|Overall Study|Not treated|0|||
125153438|NCT01258101|450185136|FG000|Overall Study|Adverse Event|5|||
125153439|NCT01258101|450185137|FG001|Overall Study|Adverse Event|6|||
125153440|NCT01258101|450185138|FG002|Overall Study|Adverse Event|0|||
125153441|NCT01258101|450185139|FG003|Overall Study|Adverse Event|0|||
125153442|NCT01258101|450185136|FG000|Overall Study|Extra exclusion criterion amended|2|||
125153443|NCT01258101|450185137|FG001|Overall Study|Extra exclusion criterion amended|1|||
125153444|NCT01258101|450185138|FG002|Overall Study|Extra exclusion criterion amended|1|||
125153445|NCT01258101|450185139|FG003|Overall Study|Extra exclusion criterion amended|1|||
125153446|NCT01258101|450185136|FG000|Overall Study|Informed consent has been withdrawn|2|||
125153447|NCT01258101|450185137|FG001|Overall Study|Informed consent has been withdrawn|2|||
125153448|NCT01258101|450185138|FG002|Overall Study|Informed consent has been withdrawn|1|||
125153449|NCT01258101|450185139|FG003|Overall Study|Informed consent has been withdrawn|1|||
125153450|NCT01258101|450185136|FG000|Overall Study|Patient is not able to attend visits|8|||
125153451|NCT01258101|450185137|FG001|Overall Study|Patient is not able to attend visits|9|||
125153452|NCT01258101|450185138|FG002|Overall Study|Patient is not able to attend visits|7|||
125153453|NCT01258101|450185139|FG003|Overall Study|Patient is not able to attend visits|6|||
125153454|NCT01258101|450185136|FG000|Overall Study|Patient´s compliance|4|||
125153455|NCT01258101|450185137|FG001|Overall Study|Patient´s compliance|3|||
125153456|NCT01258101|450185138|FG002|Overall Study|Patient´s compliance|1|||
125153457|NCT01258101|450185139|FG003|Overall Study|Patient´s compliance|2|||
125153458|NCT01258101|450185136|FG000|Overall Study|Lost to Follow-up|5|||
125153459|NCT01258101|450185137|FG001|Overall Study|Lost to Follow-up|5|||
125153460|NCT01258101|450185138|FG002|Overall Study|Lost to Follow-up|0|||
125153461|NCT01258101|450185139|FG003|Overall Study|Lost to Follow-up|6|||
125153462|NCT01258101|450185136|FG000|Overall Study|PCR positive at week 24|0|||
125153463|NCT01258101|450185137|FG001|Overall Study|PCR positive at week 24|0|||
125153464|NCT01258101|450185138|FG002|Overall Study|PCR positive at week 24|0|||
125153465|NCT01258101|450185139|FG003|Overall Study|PCR positive at week 24|1|||
125153466|NCT01258101|450185136|FG000|Overall Study|Other reason|7|||
125153467|NCT01258101|450185137|FG001|Overall Study|Other reason|8|||
125153468|NCT01258101|450185138|FG002|Overall Study|Other reason|1|||
125153469|NCT01258101|450185139|FG003|Overall Study|Other reason|8|||
125153470|NCT01807117|450185140|FG000|Overall Study|Physician Decision|2|||
125153471|NCT01807117|450185140|FG000|Overall Study|Disease diagnosis not a study disease|1|||
125223846|NCT04157088|450446240|FG000|Overall Study|Death|1|||
125153472|NCT02243293|450185143|FG000|Overall Study|Adverse Event|1|||
125153473|NCT02243293|450185144|FG001|Overall Study|Adverse Event|0|||
125153474|NCT02243293|450185145|FG002|Overall Study|Adverse Event|0|||
125153475|NCT02243293|450185146|FG003|Overall Study|Adverse Event|0|||
125153476|NCT02243293|450185147|FG004|Overall Study|Adverse Event|0|||
125153477|NCT02243293|450185148|FG005|Overall Study|Adverse Event|0|||
125153478|NCT02243293|450185149|FG006|Overall Study|Adverse Event|0|||
125153479|NCT02243293|450185150|FG007|Overall Study|Adverse Event|0|||
125153480|NCT02243293|450185151|FG008|Overall Study|Adverse Event|0|||
125153481|NCT02243293|450185152|FG009|Overall Study|Adverse Event|0|||
125153482|NCT02243293|450185153|FG010|Overall Study|Adverse Event|0|||
125153483|NCT02243293|450185154|FG011|Overall Study|Adverse Event|0|||
125153484|NCT02243293|450185155|FG012|Overall Study|Adverse Event|0|||
125153485|NCT02243293|450185156|FG013|Overall Study|Adverse Event|0|||
125153486|NCT02243293|450185157|FG014|Overall Study|Adverse Event|0|||
125153487|NCT02243293|450185158|FG015|Overall Study|Adverse Event|1|||
125153488|NCT02243293|450185159|FG016|Overall Study|Adverse Event|0|||
125153489|NCT02243293|450185160|FG017|Overall Study|Adverse Event|0|||
125153490|NCT02243293|450185161|FG018|Overall Study|Adverse Event|0|||
125153491|NCT02243293|450185162|FG019|Overall Study|Adverse Event|0|||
125153492|NCT02243293|450185163|FG020|Overall Study|Adverse Event|1|||
125153493|NCT02243293|450185164|FG021|Overall Study|Adverse Event|0|||
125153494|NCT02243293|450185143|FG000|Overall Study|Withdrawal by Subject|1|||
125153495|NCT02243293|450185144|FG001|Overall Study|Withdrawal by Subject|0|||
125153496|NCT02243293|450185145|FG002|Overall Study|Withdrawal by Subject|0|||
125153497|NCT02243293|450185146|FG003|Overall Study|Withdrawal by Subject|0|||
125153498|NCT02243293|450185147|FG004|Overall Study|Withdrawal by Subject|0|||
125153499|NCT02243293|450185148|FG005|Overall Study|Withdrawal by Subject|0|||
125153500|NCT02243293|450185149|FG006|Overall Study|Withdrawal by Subject|0|||
125153501|NCT02243293|450185150|FG007|Overall Study|Withdrawal by Subject|0|||
125153502|NCT02243293|450185151|FG008|Overall Study|Withdrawal by Subject|0|||
125153503|NCT02243293|450185152|FG009|Overall Study|Withdrawal by Subject|1|||
125153504|NCT02243293|450185153|FG010|Overall Study|Withdrawal by Subject|0|||
125153505|NCT02243293|450185154|FG011|Overall Study|Withdrawal by Subject|1|||
125153506|NCT02243293|450185155|FG012|Overall Study|Withdrawal by Subject|0|||
125153507|NCT02243293|450185156|FG013|Overall Study|Withdrawal by Subject|0|||
125153508|NCT02243293|450185157|FG014|Overall Study|Withdrawal by Subject|0|||
125153509|NCT02243293|450185158|FG015|Overall Study|Withdrawal by Subject|0|||
125153510|NCT02243293|450185159|FG016|Overall Study|Withdrawal by Subject|0|||
125153511|NCT02243293|450185160|FG017|Overall Study|Withdrawal by Subject|0|||
125153512|NCT02243293|450185161|FG018|Overall Study|Withdrawal by Subject|0|||
125153513|NCT02243293|450185162|FG019|Overall Study|Withdrawal by Subject|0|||
125153514|NCT02243293|450185163|FG020|Overall Study|Withdrawal by Subject|0|||
125153515|NCT02243293|450185164|FG021|Overall Study|Withdrawal by Subject|1|||
125153516|NCT02243293|450185143|FG000|Overall Study|Lost to Follow-up|0|||
125153517|NCT02243293|450185144|FG001|Overall Study|Lost to Follow-up|1|||
125153518|NCT02243293|450185145|FG002|Overall Study|Lost to Follow-up|1|||
125153519|NCT02243293|450185146|FG003|Overall Study|Lost to Follow-up|1|||
125153520|NCT02243293|450185147|FG004|Overall Study|Lost to Follow-up|0|||
125153521|NCT02243293|450185148|FG005|Overall Study|Lost to Follow-up|0|||
125153522|NCT02243293|450185149|FG006|Overall Study|Lost to Follow-up|3|||
125153523|NCT02243293|450185150|FG007|Overall Study|Lost to Follow-up|0|||
125153524|NCT02243293|450185151|FG008|Overall Study|Lost to Follow-up|0|||
125153525|NCT02243293|450185152|FG009|Overall Study|Lost to Follow-up|0|||
125153526|NCT02243293|450185153|FG010|Overall Study|Lost to Follow-up|0|||
125153527|NCT02243293|450185154|FG011|Overall Study|Lost to Follow-up|2|||
125153528|NCT02243293|450185155|FG012|Overall Study|Lost to Follow-up|0|||
125153529|NCT02243293|450185156|FG013|Overall Study|Lost to Follow-up|0|||
125153530|NCT02243293|450185157|FG014|Overall Study|Lost to Follow-up|0|||
125153531|NCT02243293|450185158|FG015|Overall Study|Lost to Follow-up|0|||
125153532|NCT02243293|450185159|FG016|Overall Study|Lost to Follow-up|3|||
125153533|NCT02243293|450185160|FG017|Overall Study|Lost to Follow-up|1|||
125153534|NCT02243293|450185161|FG018|Overall Study|Lost to Follow-up|0|||
125153535|NCT02243293|450185162|FG019|Overall Study|Lost to Follow-up|0|||
125153536|NCT02243293|450185163|FG020|Overall Study|Lost to Follow-up|1|||
125153537|NCT02243293|450185164|FG021|Overall Study|Lost to Follow-up|2|||
125153538|NCT02243293|450185143|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
125153539|NCT02243293|450185144|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
125153540|NCT02243293|450185145|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
125153541|NCT02243293|450185146|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
125153542|NCT02243293|450185147|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
125153543|NCT02243293|450185148|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
125153544|NCT02243293|450185149|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
125153545|NCT02243293|450185150|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
125153546|NCT02243293|450185151|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
125153547|NCT02243293|450185152|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
125153548|NCT02243293|450185153|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
125153549|NCT02243293|450185154|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
125153550|NCT02243293|450185155|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
125153551|NCT02243293|450185156|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
125153552|NCT02243293|450185157|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
125153553|NCT02243293|450185158|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
125153554|NCT02243293|450185159|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
125153555|NCT02243293|450185160|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
125153556|NCT02243293|450185161|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
125153557|NCT02243293|450185162|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
125153558|NCT02243293|450185163|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
125153559|NCT02243293|450185164|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
125153560|NCT02243293|450185143|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
125153561|NCT02243293|450185144|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
125153562|NCT02243293|450185145|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
125153563|NCT02243293|450185146|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
125153564|NCT02243293|450185147|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
125153565|NCT02243293|450185148|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
125153566|NCT02243293|450185149|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
125153567|NCT02243293|450185150|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
125153568|NCT02243293|450185151|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
125153569|NCT02243293|450185152|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
125153570|NCT02243293|450185153|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
125153571|NCT02243293|450185154|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
125153572|NCT02243293|450185155|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
125153573|NCT02243293|450185156|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
125153574|NCT02243293|450185157|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
125153575|NCT02243293|450185158|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
125153576|NCT02243293|450185159|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
125153577|NCT02243293|450185160|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
125153578|NCT02243293|450185161|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
125153579|NCT02243293|450185162|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
125153580|NCT02243293|450185163|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
125153581|NCT02243293|450185164|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
125153582|NCT02181296|450185165|FG000|Overall Study|Lost to Follow-up|7|||
125153583|NCT02181296|450185166|FG001|Overall Study|Lost to Follow-up|6|||
125153584|NCT02658487|450186687|FG000|Overall Study|Death|2|||
125153585|NCT02658487|450186687|FG000|Overall Study|Disease progression|10|||
125153586|NCT02658487|450186687|FG000|Overall Study|Alternative therapy|1|||
125153587|NCT02658487|450186687|FG000|Overall Study|Adverse Event|1|||
125153588|NCT02658487|450186687|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
125153589|NCT02658487|450186687|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
125153590|NCT00614926|450186695|FG000|Overall Study|Burden of travel|1|||
125153591|NCT00614926|450186696|FG001|Overall Study|Burden of travel|0|||
125153592|NCT00614926|450186695|FG000|Overall Study|Adverse Event|3|||
125153593|NCT00614926|450186696|FG001|Overall Study|Adverse Event|0|||
125153594|NCT00856830|450186699|FG000|Irinotecan & Bendamustine|Death|0|||
125153595|NCT00856830|450186700|FG001|Irinotecan & Bendamustine|Death|0|||
125153596|NCT00856830|450186701|FG002|Irinotecan & Bendamustine|Death|0|||
125153597|NCT00856830|450186702|FG003|Irinotecan & Bendamustine|Death|2|||
125153598|NCT00856830|450186699|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
125153599|NCT00856830|450186700|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
125153600|NCT00856830|450186701|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
125153601|NCT00856830|450186702|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
125153602|NCT02954159|450186704|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
125153603|NCT02954159|450186705|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
125153604|NCT02954159|450186704|FG000|Overall Study|Withdrawal by Subject|0|||
125153605|NCT02954159|450186705|FG001|Overall Study|Withdrawal by Subject|1|||
125153606|NCT01117337|450186712|FG000|Overall Study|Lost to Follow-up|4|||
125153607|NCT01117337|450186713|FG001|Overall Study|Lost to Follow-up|0|||
125153608|NCT03575871|450186714|FG000|Overall Study|Adverse Event|5|||
125153609|NCT03575871|450186715|FG001|Overall Study|Adverse Event|5|||
125153610|NCT03575871|450186716|FG002|Overall Study|Adverse Event|8|||
125153611|NCT03575871|450186714|FG000|Overall Study|Death|1|||
125153612|NCT03575871|450186715|FG001|Overall Study|Death|0|||
125153613|NCT03575871|450186716|FG002|Overall Study|Death|0|||
125153614|NCT03575871|450186714|FG000|Overall Study|Lack of Efficacy|5|||
125153615|NCT03575871|450186715|FG001|Overall Study|Lack of Efficacy|4|||
125153616|NCT03575871|450186716|FG002|Overall Study|Lack of Efficacy|7|||
125153617|NCT03575871|450186714|FG000|Overall Study|Lost to Follow-up|1|||
125153618|NCT03575871|450186715|FG001|Overall Study|Lost to Follow-up|1|||
125153619|NCT03575871|450186716|FG002|Overall Study|Lost to Follow-up|1|||
125153620|NCT03575871|450186714|FG000|Overall Study|Protocol Deviation|1|||
125153621|NCT03575871|450186715|FG001|Overall Study|Protocol Deviation|1|||
125153622|NCT03575871|450186716|FG002|Overall Study|Protocol Deviation|1|||
125153623|NCT03575871|450186714|FG000|Overall Study|Withdrawal by Subject|6|||
125153624|NCT03575871|450186715|FG001|Overall Study|Withdrawal by Subject|1|||
125153625|NCT03575871|450186716|FG002|Overall Study|Withdrawal by Subject|9|||
125153626|NCT03575871|450186714|FG000|Overall Study|Other than specified|2|||
125153627|NCT03575871|450186715|FG001|Overall Study|Other than specified|2|||
125153628|NCT03575871|450186716|FG002|Overall Study|Other than specified|0|||
125153629|NCT02791893|450186719|FG000|Blinded Phase|Lost to Follow-up|2|||
125153630|NCT02791893|450186720|FG001|Blinded Phase|Lost to Follow-up|2|||
125153631|NCT02791893|450186719|FG000|Blinded Phase|Withdrawal by Subject|1|||
125153632|NCT02791893|450186720|FG001|Blinded Phase|Withdrawal by Subject|2|||
125153633|NCT02791893|450186719|FG000|Open Label Phase|Lost to Follow-up|3|||
125153634|NCT02791893|450186720|FG001|Open Label Phase|Lost to Follow-up|0|||
125153635|NCT02791893|450186719|FG000|Open Label Phase|Withdrawal by Subject|0|||
125153636|NCT02791893|450186720|FG001|Open Label Phase|Withdrawal by Subject|2|||
125153637|NCT01744093|450186724|FG000|Overall Study|Withdrawal by Subject|6|||
125153638|NCT01744093|450186725|FG001|Overall Study|Withdrawal by Subject|1|||
125153639|NCT01570283|450186726|FG000|Cohort 1: Dose Level 1|Death|0|||
125153640|NCT01570283|450186727|FG001|Cohort 1: Dose Level 1|Death|1|||
125153641|NCT01570283|450186728|FG002|Cohort 1: Dose Level 1|Death|0|||
125153642|NCT01570283|450186729|FG003|Cohort 1: Dose Level 1|Death|0|||
125153643|NCT01570283|450186730|FG004|Cohort 1: Dose Level 1|Death|0|||
125153644|NCT01570283|450186731|FG005|Cohort 1: Dose Level 1|Death|0|||
125153645|NCT01570283|450186726|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
125153646|NCT01570283|450186727|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
125153647|NCT01570283|450186728|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
125153648|NCT01570283|450186729|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
125153649|NCT01570283|450186730|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
125153650|NCT01570283|450186731|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
125153651|NCT01570283|450186726|FG000|Cohort 2: Dose Level 2|Death|0|||
125153652|NCT01570283|450186727|FG001|Cohort 2: Dose Level 2|Death|0|||
125153653|NCT01570283|450186728|FG002|Cohort 2: Dose Level 2|Death|1|||
125153654|NCT01570283|450186729|FG003|Cohort 2: Dose Level 2|Death|0|||
125153655|NCT01570283|450186730|FG004|Cohort 2: Dose Level 2|Death|0|||
125153656|NCT01570283|450186731|FG005|Cohort 2: Dose Level 2|Death|0|||
125153657|NCT01570283|450186726|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
125153658|NCT01570283|450186727|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
125153659|NCT01570283|450186728|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
125153660|NCT01570283|450186729|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
125153661|NCT01570283|450186730|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
125153662|NCT01570283|450186731|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
125153663|NCT01570283|450186726|FG000|Cohort 3: Dose Level 3|Death|0|||
125153664|NCT01570283|450186727|FG001|Cohort 3: Dose Level 3|Death|0|||
125153665|NCT01570283|450186728|FG002|Cohort 3: Dose Level 3|Death|0|||
125153666|NCT01570283|450186729|FG003|Cohort 3: Dose Level 3|Death|0|||
125153667|NCT01570283|450186730|FG004|Cohort 3: Dose Level 3|Death|0|||
125153668|NCT01570283|450186731|FG005|Cohort 3: Dose Level 3|Death|1|||
125153669|NCT01570283|450186726|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
125153670|NCT01570283|450186727|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
125153671|NCT01570283|450186728|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
125153672|NCT01570283|450186729|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
125153673|NCT01570283|450186730|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
125153674|NCT01570283|450186731|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
125153675|NCT00685802|450186736|FG000|Washout Period of 7 Days|Protocol Violation|2|||
125153676|NCT00685802|450186737|FG001|Washout Period of 7 Days|Protocol Violation|0|||
125153677|NCT00685802|450186736|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
125153678|NCT00685802|450186737|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
125153679|NCT02025010|450186741|FG000|Overall Study|Symptomatic or radiographic progression|36|||
125153680|NCT02025010|450186741|FG000|Overall Study|Adverse Event|6|||
125153681|NCT02025010|450186741|FG000|Overall Study|Physician Decision|7|||
125153682|NCT02025010|450186741|FG000|Overall Study|Withdrawal by Subject|3|||
125153683|NCT02025010|450186741|FG000|Overall Study|Intercurrent illness|3|||
125153684|NCT02025010|450186741|FG000|Overall Study|Patients still on treatment|3|||
125153685|NCT02025010|450186741|FG000|Overall Study|Never initiate the treatment|2|||
125153686|NCT00949988|450186742|FG000|Overall Study|Withdrawal by Subject|3|||
125153687|NCT05212883|450186746|FG000|Overall Study|Invalid test result|125|||
125153688|NCT03095118|450186750|FG000|Overall Study|Adverse Event|1|||
125153689|NCT03095118|450186750|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
125153690|NCT03847194|450186751|FG000|Overall Study|Lost to Follow-up|2|||
125153691|NCT03847194|450186752|FG001|Overall Study|Lost to Follow-up|5|||
125153692|NCT03847194|450186751|FG000|Overall Study|Withdrawal by Subject|1|||
125153693|NCT03847194|450186752|FG001|Overall Study|Withdrawal by Subject|2|||
125153694|NCT03847194|450186751|FG000|Overall Study|Death|0|||
125153695|NCT03847194|450186752|FG001|Overall Study|Death|1|||
125153696|NCT02408120|450186753|FG000|Overall Study|Withdrawal by Subject|0|||
125153697|NCT02408120|450186754|FG001|Overall Study|Withdrawal by Subject|1|||
125153698|NCT02408120|450186753|FG000|Overall Study|Treatment Refusal|1|||
125153699|NCT02408120|450186754|FG001|Overall Study|Treatment Refusal|0|||
125153700|NCT02408120|450186753|FG000|Overall Study|Received Steroids|1|||
125153701|NCT02408120|450186754|FG001|Overall Study|Received Steroids|1|||
125153702|NCT02408120|450186753|FG000|Overall Study|Discharged same day|1|||
125153703|NCT02408120|450186754|FG001|Overall Study|Discharged same day|1|||
125153704|NCT02408120|450186753|FG000|Overall Study|Did not receive insulin|1|||
125153705|NCT02408120|450186754|FG001|Overall Study|Did not receive insulin|2|||
125153706|NCT01144403|450186755|FG000|Overall Study|Lost to Follow-up|3|||
125153707|NCT01144403|450186755|FG000|Overall Study|Death|1|||
125153708|NCT01144403|450186755|FG000|Overall Study|Adverse Event|1|||
125153709|NCT03176784|450186756|FG000|Overall Study|Lost to Follow-up|77|||
125153710|NCT03176784|450186757|FG001|Overall Study|Lost to Follow-up|79|||
125153711|NCT03176784|450186758|FG002|Overall Study|Lost to Follow-up|79|||
125153712|NCT03176784|450186759|FG003|Overall Study|Lost to Follow-up|49|||
125153713|NCT03176784|450186756|FG000|Overall Study|Withdrawal by Subject|28|||
125153714|NCT03176784|450186757|FG001|Overall Study|Withdrawal by Subject|34|||
125153715|NCT03176784|450186758|FG002|Overall Study|Withdrawal by Subject|34|||
125153716|NCT03176784|450186759|FG003|Overall Study|Withdrawal by Subject|21|||
125153717|NCT01825837|450186760|FG000|PART I|Withdrawal by Subject|0|||
125153718|NCT01825837|450186761|FG001|PART I|Withdrawal by Subject|0|||
125153719|NCT01825837|450186762|FG002|PART I|Withdrawal by Subject|0|||
125153720|NCT01825837|450186763|FG003|PART I|Withdrawal by Subject|6|||
125153721|NCT01825837|450186760|FG000|PART I|Patient non-compliance|0|||
125153722|NCT01825837|450186761|FG001|PART I|Patient non-compliance|0|||
125153723|NCT01825837|450186762|FG002|PART I|Patient non-compliance|0|||
125153724|NCT01825837|450186763|FG003|PART I|Patient non-compliance|1|||
125153725|NCT01825837|450186760|FG000|PART I|Treatment failure|0|||
125153726|NCT01825837|450186761|FG001|PART I|Treatment failure|0|||
125153727|NCT01825837|450186762|FG002|PART I|Treatment failure|0|||
125153728|NCT01825837|450186763|FG003|PART I|Treatment failure|7|||
125153729|NCT01825837|450186760|FG000|PART I|reason unspecified|0|||
125153730|NCT01825837|450186761|FG001|PART I|reason unspecified|0|||
125153731|NCT01825837|450186762|FG002|PART I|reason unspecified|0|||
125153732|NCT01825837|450186763|FG003|PART I|reason unspecified|3|||
125153733|NCT01825837|450186760|FG000|PART II|Withdrawal by Subject|3|||
125153734|NCT01825837|450186761|FG001|PART II|Withdrawal by Subject|3|||
125153735|NCT01825837|450186762|FG002|PART II|Withdrawal by Subject|7|||
125153736|NCT01825837|450186763|FG003|PART II|Withdrawal by Subject|0|||
125153737|NCT01825837|450186760|FG000|PART II|Patient non-compliance|5|||
125153738|NCT01825837|450186761|FG001|PART II|Patient non-compliance|2|||
125153739|NCT01825837|450186762|FG002|PART II|Patient non-compliance|4|||
125153740|NCT01825837|450186763|FG003|PART II|Patient non-compliance|0|||
125153741|NCT01825837|450186760|FG000|PART II|Adverse Event|3|||
125153742|NCT01825837|450186761|FG001|PART II|Adverse Event|3|||
125153743|NCT01825837|450186762|FG002|PART II|Adverse Event|1|||
125153744|NCT01825837|450186763|FG003|PART II|Adverse Event|0|||
125153745|NCT01825837|450186760|FG000|PART II|Treatment failure|6|||
125153746|NCT01825837|450186761|FG001|PART II|Treatment failure|4|||
125153747|NCT01825837|450186762|FG002|PART II|Treatment failure|5|||
125153748|NCT01825837|450186763|FG003|PART II|Treatment failure|0|||
125153749|NCT01825837|450186760|FG000|PART II|reason unspecified|2|||
125153750|NCT01825837|450186761|FG001|PART II|reason unspecified|2|||
125153751|NCT01825837|450186762|FG002|PART II|reason unspecified|2|||
125153752|NCT01825837|450186763|FG003|PART II|reason unspecified|0|||
125153753|NCT00904748|450186764|FG000|Overall Study|Withdrawal by Subject|1|||
125153754|NCT00904748|450186765|FG001|Overall Study|Withdrawal by Subject|1|||
125153755|NCT00904748|450186766|FG002|Overall Study|Withdrawal by Subject|1|||
125153756|NCT00904748|450186767|FG003|Overall Study|Withdrawal by Subject|2|||
125153757|NCT00904748|450186768|FG004|Overall Study|Withdrawal by Subject|0|||
125153758|NCT00904748|450186769|FG005|Overall Study|Withdrawal by Subject|0|||
125153759|NCT00904748|450186764|FG000|Overall Study|Adverse Event|0|||
125153760|NCT00904748|450186765|FG001|Overall Study|Adverse Event|0|||
125153761|NCT00904748|450186766|FG002|Overall Study|Adverse Event|0|||
125153762|NCT00904748|450186767|FG003|Overall Study|Adverse Event|0|||
125153763|NCT00904748|450186768|FG004|Overall Study|Adverse Event|1|||
125153764|NCT00904748|450186769|FG005|Overall Study|Adverse Event|0|||
125153765|NCT00680186|450186775|FG000|Overall Study|Adverse Event|47|||
125153766|NCT00680186|450186776|FG001|Overall Study|Adverse Event|44|||
125153767|NCT00680186|450186775|FG000|Overall Study|Protocol Violation|31|||
125153768|NCT00680186|450186776|FG001|Overall Study|Protocol Violation|26|||
125153769|NCT00680186|450186775|FG000|Overall Study|Lost to Follow-up|11|||
125153770|NCT00680186|450186776|FG001|Overall Study|Lost to Follow-up|6|||
125153771|NCT00680186|450186775|FG000|Overall Study|Withdrawal by Subject|32|||
125153772|NCT00680186|450186776|FG001|Overall Study|Withdrawal by Subject|39|||
125153773|NCT00680186|450186775|FG000|Overall Study|Other|4|||
125153774|NCT00680186|450186776|FG001|Overall Study|Other|1|||
125153775|NCT00285584|450186784|FG000|Month 3|Lost to Follow-up|3|||
125153776|NCT00285584|450186785|FG001|Month 3|Lost to Follow-up|3|||
125153777|NCT00285584|450186784|FG000|Month 3|Withdrawal by Subject|1|||
125153778|NCT00285584|450186785|FG001|Month 3|Withdrawal by Subject|0|||
125153779|NCT00285584|450186784|FG000|Month 6|Lost to Follow-up|0|||
125153780|NCT00285584|450186785|FG001|Month 6|Lost to Follow-up|1|||
125153781|NCT00645944|450186786|FG000|Randomized|Withdrawal by Subject|1|||
125153782|NCT00645944|450186787|FG001|Randomized|Withdrawal by Subject|2|||
125153783|NCT00645944|450186786|FG000|Received Medication|Adverse Event|2|||
125153784|NCT00645944|450186787|FG001|Received Medication|Adverse Event|1|||
125153785|NCT00645944|450186786|FG000|Received Medication|Withdrawal by Subject|1|||
125153786|NCT00645944|450186787|FG001|Received Medication|Withdrawal by Subject|1|||
125153787|NCT00645944|450186786|FG000|Received Medication|Lost to Follow-up|1|||
125153788|NCT00645944|450186787|FG001|Received Medication|Lost to Follow-up|0|||
125153789|NCT00645944|450186786|FG000|Received Medication|Protocol Violation|2|||
125153790|NCT00645944|450186787|FG001|Received Medication|Protocol Violation|1|||
125153791|NCT01523587|450186789|FG000|Overall Study|Other than listed|5|||
125153792|NCT01523587|450186790|FG001|Overall Study|Other than listed|5|||
125153793|NCT01523587|450186789|FG000|Overall Study|Worsening of underlying cancer disease|19|||
125153794|NCT01523587|450186790|FG001|Overall Study|Worsening of underlying cancer disease|34|||
125153795|NCT01523587|450186789|FG000|Overall Study|Adverse Event|68|||
125153796|NCT01523587|450186790|FG001|Overall Study|Adverse Event|52|||
125153797|NCT01523587|450186789|FG000|Overall Study|Protocol Violation|5|||
125153798|NCT01523587|450186790|FG001|Overall Study|Protocol Violation|3|||
125153799|NCT01523587|450186789|FG000|Overall Study|Lost to Follow-up|2|||
125153800|NCT01523587|450186790|FG001|Overall Study|Lost to Follow-up|2|||
125153801|NCT01523587|450186789|FG000|Overall Study|Withdrawal by Subject|28|||
125153802|NCT01523587|450186790|FG001|Overall Study|Withdrawal by Subject|20|||
125153803|NCT01523587|450186789|FG000|Overall Study|Withdrew due to Progressive disease|265|||
125153804|NCT01523587|450186790|FG001|Overall Study|Withdrew due to Progressive disease|279|||
125153805|NCT01523587|450186789|FG000|Overall Study|Randomised but bot treated|6|||
125153806|NCT01523587|450186790|FG001|Overall Study|Randomised but bot treated|2|||
125153807|NCT01298778|450186791|FG000|Overall Study|Lost to Follow-up|2|||
125153808|NCT01298778|450186792|FG001|Overall Study|Lost to Follow-up|3|||
125153809|NCT01298778|450186791|FG000|Overall Study|Incorrect use of VAS|1|||
125153810|NCT01298778|450186792|FG001|Overall Study|Incorrect use of VAS|0|||
125153811|NCT01298778|450186791|FG000|Overall Study|Withdrawal by Subject|0|||
125153812|NCT01298778|450186792|FG001|Overall Study|Withdrawal by Subject|1|||
125153813|NCT01298778|450186791|FG000|Overall Study|Protocol Violation|0|||
125153814|NCT01298778|450186792|FG001|Overall Study|Protocol Violation|1|||
125153815|NCT01298778|450186791|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
125153816|NCT01298778|450186792|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
125153817|NCT04965389|450186793|FG000|Overall Study|Other reasons|1|||
125153818|NCT04965389|450186794|FG001|Overall Study|Other reasons|0|||
125153819|NCT04965389|450186795|FG002|Overall Study|Other reasons|0|||
125153820|NCT04965389|450186796|FG003|Overall Study|Other reasons|0|||
125153821|NCT04965389|450186793|FG000|Overall Study|Participant withdrew consent|0|||
125153822|NCT04965389|450186794|FG001|Overall Study|Participant withdrew consent|1|||
125153823|NCT04965389|450186795|FG002|Overall Study|Participant withdrew consent|0|||
125153824|NCT04965389|450186796|FG003|Overall Study|Participant withdrew consent|0|||
125153825|NCT04965389|450186793|FG000|Overall Study|Poor/Non-compliance|0|||
125153826|NCT04965389|450186794|FG001|Overall Study|Poor/Non-compliance|1|||
125153827|NCT04965389|450186795|FG002|Overall Study|Poor/Non-compliance|0|||
125153828|NCT04965389|450186796|FG003|Overall Study|Poor/Non-compliance|0|||
125153829|NCT02709486|450186799|FG000|Overall Study|Adverse Event|2|||
125153830|NCT02709486|450186800|FG001|Overall Study|Adverse Event|5|||
125153831|NCT02709486|450186801|FG002|Overall Study|Adverse Event|3|||
125153832|NCT02709486|450186799|FG000|Overall Study|Death|0|||
125153833|NCT02709486|450186800|FG001|Overall Study|Death|0|||
125153834|NCT02709486|450186801|FG002|Overall Study|Death|2|||
125153835|NCT02709486|450186799|FG000|Overall Study|Insufficient clinical response|7|||
125153836|NCT02709486|450186800|FG001|Overall Study|Insufficient clinical response|3|||
125153837|NCT02709486|450186801|FG002|Overall Study|Insufficient clinical response|3|||
125153838|NCT02709486|450186799|FG000|Overall Study|Lost to Follow-up|3|||
125153839|NCT02709486|450186800|FG001|Overall Study|Lost to Follow-up|2|||
125153840|NCT02709486|450186801|FG002|Overall Study|Lost to Follow-up|2|||
125153841|NCT02709486|450186799|FG000|Overall Study|Other|0|||
125153842|NCT02709486|450186800|FG001|Overall Study|Other|2|||
125153843|NCT02709486|450186801|FG002|Overall Study|Other|3|||
125153844|NCT02709486|450186799|FG000|Overall Study|Withdrawal by Subject|32|||
125153845|NCT02709486|450186800|FG001|Overall Study|Withdrawal by Subject|22|||
125153846|NCT02709486|450186801|FG002|Overall Study|Withdrawal by Subject|32|||
125153847|NCT01855048|450186811|FG000|Overall Study|Withdrawal by Subject|0|||
125153848|NCT01855048|450186812|FG001|Overall Study|Withdrawal by Subject|1|||
125153849|NCT01855048|450186813|FG002|Overall Study|Withdrawal by Subject|0|||
125153850|NCT01855048|450186814|FG003|Overall Study|Withdrawal by Subject|0|||
125153851|NCT01855048|450186815|FG004|Overall Study|Withdrawal by Subject|1|||
125153852|NCT01855048|450186816|FG005|Overall Study|Withdrawal by Subject|0|||
125153853|NCT02139124|450186817|FG000|Overall Study|Adverse Event|2|||
125153854|NCT02139124|450186818|FG001|Overall Study|Adverse Event|0|||
125153855|NCT02139124|450186819|FG002|Overall Study|Adverse Event|1|||
125153856|NCT02139124|450186820|FG003|Overall Study|Adverse Event|2|||
125153857|NCT02139124|450186821|FG004|Overall Study|Adverse Event|5|||
125153858|NCT02139124|450186817|FG000|Overall Study|Withdrawal by Subject|2|||
125153859|NCT02139124|450186818|FG001|Overall Study|Withdrawal by Subject|2|||
125153860|NCT02139124|450186819|FG002|Overall Study|Withdrawal by Subject|2|||
125153861|NCT02139124|450186820|FG003|Overall Study|Withdrawal by Subject|2|||
125153862|NCT02139124|450186821|FG004|Overall Study|Withdrawal by Subject|3|||
125153863|NCT02139124|450186817|FG000|Overall Study|Protocol Violation|0|||
125153864|NCT02139124|450186818|FG001|Overall Study|Protocol Violation|0|||
125153865|NCT02139124|450186819|FG002|Overall Study|Protocol Violation|0|||
125153866|NCT02139124|450186820|FG003|Overall Study|Protocol Violation|1|||
125153867|NCT02139124|450186821|FG004|Overall Study|Protocol Violation|1|||
125153868|NCT02139124|450186817|FG000|Overall Study|non-compliant|1|||
125153869|NCT02139124|450186818|FG001|Overall Study|non-compliant|0|||
125153870|NCT02139124|450186819|FG002|Overall Study|non-compliant|0|||
125153871|NCT02139124|450186820|FG003|Overall Study|non-compliant|2|||
125153872|NCT02139124|450186821|FG004|Overall Study|non-compliant|0|||
125153873|NCT02139124|450186817|FG000|Overall Study|incarceration|0|||
125153874|NCT02139124|450186818|FG001|Overall Study|incarceration|0|||
125153875|NCT02139124|450186819|FG002|Overall Study|incarceration|1|||
125153876|NCT02139124|450186820|FG003|Overall Study|incarceration|0|||
125153877|NCT02139124|450186821|FG004|Overall Study|incarceration|0|||
125153878|NCT02139124|450186817|FG000|Overall Study|subject moved|1|||
125153879|NCT02139124|450186818|FG001|Overall Study|subject moved|0|||
125153880|NCT02139124|450186819|FG002|Overall Study|subject moved|0|||
125153881|NCT02139124|450186820|FG003|Overall Study|subject moved|0|||
125153882|NCT02139124|450186821|FG004|Overall Study|subject moved|0|||
125153883|NCT02139124|450186817|FG000|Overall Study|Lost to Follow-up|3|||
125153884|NCT02139124|450186818|FG001|Overall Study|Lost to Follow-up|2|||
125153885|NCT02139124|450186819|FG002|Overall Study|Lost to Follow-up|0|||
125153886|NCT02139124|450186820|FG003|Overall Study|Lost to Follow-up|5|||
125153887|NCT02139124|450186821|FG004|Overall Study|Lost to Follow-up|4|||
125153888|NCT02691741|450186822|FG000|Overall Study|Adverse Event|0|||
125153889|NCT02691741|450186823|FG001|Overall Study|Adverse Event|2|||
125153890|NCT02691741|450186822|FG000|Overall Study|Lost to Follow-up|1|||
125153891|NCT02691741|450186823|FG001|Overall Study|Lost to Follow-up|0|||
125153892|NCT02691741|450186822|FG000|Overall Study|Physician Decision|0|||
125153893|NCT02691741|450186823|FG001|Overall Study|Physician Decision|1|||
125153894|NCT02691741|450186822|FG000|Overall Study|Withdrawal by Subject|0|||
125153895|NCT02691741|450186823|FG001|Overall Study|Withdrawal by Subject|4|||
125153896|NCT03465436|450186824|FG000|Period 1|Protocol Violation|0|||
125153897|NCT03465436|450186825|FG001|Period 1|Protocol Violation|0|||
125153898|NCT03465436|450186826|FG002|Period 1|Protocol Violation|1|||
125153899|NCT03465436|450186827|FG003|Period 1|Protocol Violation|0|||
125153900|NCT03465436|450186824|FG000|Period 2|Protocol Violation|0|||
125153901|NCT03465436|450186825|FG001|Period 2|Protocol Violation|1|||
125153902|NCT03465436|450186826|FG002|Period 2|Protocol Violation|0|||
125153903|NCT03465436|450186827|FG003|Period 2|Protocol Violation|0|||
125153904|NCT03465436|450186824|FG000|Period 3|Protocol Violation|1|||
125153905|NCT03465436|450186825|FG001|Period 3|Protocol Violation|1|||
125153906|NCT03465436|450186826|FG002|Period 3|Protocol Violation|0|||
125153907|NCT03465436|450186827|FG003|Period 3|Protocol Violation|0|||
125153908|NCT03465436|450186824|FG000|Period 4|Protocol Violation|0|||
125153909|NCT03465436|450186825|FG001|Period 4|Protocol Violation|0|||
125153910|NCT03465436|450186826|FG002|Period 4|Protocol Violation|1|||
125153911|NCT03465436|450186827|FG003|Period 4|Protocol Violation|0|||
125153912|NCT02697773|450186828|FG000|Overall Study|Adverse Event|2|||
125153913|NCT02697773|450186829|FG001|Overall Study|Adverse Event|1|||
125153914|NCT02697773|450186830|FG002|Overall Study|Adverse Event|2|||
125153915|NCT02697773|450186828|FG000|Overall Study|Death|0|||
125153916|NCT02697773|450186829|FG001|Overall Study|Death|0|||
125153917|NCT02697773|450186830|FG002|Overall Study|Death|2|||
125153918|NCT02697773|450186828|FG000|Overall Study|Lack of Efficacy|4|||
125153919|NCT02697773|450186829|FG001|Overall Study|Lack of Efficacy|6|||
125153920|NCT02697773|450186830|FG002|Overall Study|Lack of Efficacy|6|||
125153921|NCT02697773|450186828|FG000|Overall Study|Lost to Follow-up|5|||
125153922|NCT02697773|450186829|FG001|Overall Study|Lost to Follow-up|5|||
125153923|NCT02697773|450186830|FG002|Overall Study|Lost to Follow-up|7|||
125153924|NCT02697773|450186828|FG000|Overall Study|Other|15|||
125153925|NCT02697773|450186829|FG001|Overall Study|Other|11|||
125223847|NCT02421419|450446241|FG000|Overall Study|Physician Decision|0|||
125153926|NCT02697773|450186830|FG002|Overall Study|Other|10|||
125153927|NCT02697773|450186828|FG000|Overall Study|Protocol Violation|1|||
125153928|NCT02697773|450186829|FG001|Overall Study|Protocol Violation|1|||
125153929|NCT02697773|450186830|FG002|Overall Study|Protocol Violation|0|||
125153930|NCT02697773|450186828|FG000|Overall Study|Withdrawal by Subject|10|||
125153931|NCT02697773|450186829|FG001|Overall Study|Withdrawal by Subject|13|||
125153932|NCT02697773|450186830|FG002|Overall Study|Withdrawal by Subject|13|||
125153933|NCT02697773|450186828|FG000|Overall Study|Randomized but not treated|1|||
125153934|NCT02697773|450186829|FG001|Overall Study|Randomized but not treated|1|||
125153935|NCT02697773|450186830|FG002|Overall Study|Randomized but not treated|0|||
125153936|NCT01118117|450186831|FG000|Overall Study|Death|8|||
125153937|NCT01118117|450186832|FG001|Overall Study|Death|0|||
125153938|NCT01118117|450186831|FG000|Overall Study|Lost to Follow-up|6|||
125153939|NCT01118117|450186832|FG001|Overall Study|Lost to Follow-up|0|||
125153940|NCT01118117|450186831|FG000|Overall Study|Missed 12 Month Visit|7|||
125153941|NCT01118117|450186832|FG001|Overall Study|Missed 12 Month Visit|0|||
125153942|NCT02149121|450186834|FG000|Main Study Period|Lack of Efficacy|2|||
125153943|NCT02149121|450186835|FG001|Main Study Period|Lack of Efficacy|2|||
125153944|NCT02149121|450186836|FG002|Main Study Period|Lack of Efficacy|1|||
125153945|NCT02149121|450186837|FG003|Main Study Period|Lack of Efficacy|0|||
125153946|NCT02149121|450186838|FG004|Main Study Period|Lack of Efficacy|0|||
125153947|NCT02149121|450186839|FG005|Main Study Period|Lack of Efficacy|0|||
125153948|NCT02149121|450186840|FG006|Main Study Period|Lack of Efficacy|0|||
125153949|NCT02149121|450186834|FG000|Main Study Period|Withdrawal by Subject|9|||
125153950|NCT02149121|450186835|FG001|Main Study Period|Withdrawal by Subject|5|||
125153951|NCT02149121|450186836|FG002|Main Study Period|Withdrawal by Subject|1|||
125153952|NCT02149121|450186837|FG003|Main Study Period|Withdrawal by Subject|0|||
125153953|NCT02149121|450186838|FG004|Main Study Period|Withdrawal by Subject|0|||
125153954|NCT02149121|450186839|FG005|Main Study Period|Withdrawal by Subject|0|||
125153955|NCT02149121|450186840|FG006|Main Study Period|Withdrawal by Subject|0|||
125153956|NCT02149121|450186834|FG000|Main Study Period|Adverse Event|2|||
125153957|NCT02149121|450186835|FG001|Main Study Period|Adverse Event|5|||
125153958|NCT02149121|450186836|FG002|Main Study Period|Adverse Event|1|||
125153959|NCT02149121|450186837|FG003|Main Study Period|Adverse Event|0|||
125153960|NCT02149121|450186838|FG004|Main Study Period|Adverse Event|0|||
125153961|NCT02149121|450186839|FG005|Main Study Period|Adverse Event|0|||
125153962|NCT02149121|450186840|FG006|Main Study Period|Adverse Event|0|||
125153963|NCT02149121|450186834|FG000|Main Study Period|Protocol Violation|2|||
125153964|NCT02149121|450186835|FG001|Main Study Period|Protocol Violation|0|||
125153965|NCT02149121|450186836|FG002|Main Study Period|Protocol Violation|0|||
125153966|NCT02149121|450186837|FG003|Main Study Period|Protocol Violation|0|||
125153967|NCT02149121|450186838|FG004|Main Study Period|Protocol Violation|0|||
125153968|NCT02149121|450186839|FG005|Main Study Period|Protocol Violation|0|||
125153969|NCT02149121|450186840|FG006|Main Study Period|Protocol Violation|0|||
125153970|NCT02149121|450186834|FG000|Main Study Period|Lost to Follow-up|2|||
125153971|NCT02149121|450186835|FG001|Main Study Period|Lost to Follow-up|1|||
125153972|NCT02149121|450186836|FG002|Main Study Period|Lost to Follow-up|0|||
125153973|NCT02149121|450186837|FG003|Main Study Period|Lost to Follow-up|0|||
125153974|NCT02149121|450186838|FG004|Main Study Period|Lost to Follow-up|0|||
125153975|NCT02149121|450186839|FG005|Main Study Period|Lost to Follow-up|0|||
125153976|NCT02149121|450186840|FG006|Main Study Period|Lost to Follow-up|0|||
125153977|NCT02149121|450186834|FG000|Main Study Period|Death|1|||
125153978|NCT02149121|450186835|FG001|Main Study Period|Death|0|||
125153979|NCT02149121|450186836|FG002|Main Study Period|Death|0|||
125153980|NCT02149121|450186837|FG003|Main Study Period|Death|0|||
125153981|NCT02149121|450186838|FG004|Main Study Period|Death|0|||
125153982|NCT02149121|450186839|FG005|Main Study Period|Death|0|||
125153983|NCT02149121|450186840|FG006|Main Study Period|Death|0|||
125153984|NCT02149121|450186834|FG000|Main Study Period|Physician Decision|1|||
125153985|NCT02149121|450186835|FG001|Main Study Period|Physician Decision|0|||
125153986|NCT02149121|450186836|FG002|Main Study Period|Physician Decision|0|||
125153987|NCT02149121|450186837|FG003|Main Study Period|Physician Decision|0|||
125153988|NCT02149121|450186838|FG004|Main Study Period|Physician Decision|0|||
125153989|NCT02149121|450186839|FG005|Main Study Period|Physician Decision|0|||
125153990|NCT02149121|450186840|FG006|Main Study Period|Physician Decision|0|||
125153991|NCT02149121|450186834|FG000|Main Study Period|Developed any malignancy|0|||
125153992|NCT02149121|450186835|FG001|Main Study Period|Developed any malignancy|1|||
125153993|NCT02149121|450186836|FG002|Main Study Period|Developed any malignancy|1|||
125153994|NCT02149121|450186837|FG003|Main Study Period|Developed any malignancy|0|||
125153995|NCT02149121|450186838|FG004|Main Study Period|Developed any malignancy|0|||
125153996|NCT02149121|450186839|FG005|Main Study Period|Developed any malignancy|0|||
125153997|NCT02149121|450186840|FG006|Main Study Period|Developed any malignancy|0|||
125153998|NCT02149121|450186834|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
125153999|NCT02149121|450186835|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
125154000|NCT02149121|450186836|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
125154001|NCT02149121|450186837|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
125154002|NCT02149121|450186838|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
125154003|NCT02149121|450186839|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
125154004|NCT02149121|450186840|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
125154005|NCT02149121|450186834|FG000|Main Study Period|Disease progression|0|||
125154006|NCT02149121|450186835|FG001|Main Study Period|Disease progression|1|||
125154007|NCT02149121|450186836|FG002|Main Study Period|Disease progression|0|||
125154008|NCT02149121|450186837|FG003|Main Study Period|Disease progression|0|||
125154009|NCT02149121|450186838|FG004|Main Study Period|Disease progression|0|||
125154010|NCT02149121|450186839|FG005|Main Study Period|Disease progression|0|||
125154011|NCT02149121|450186840|FG006|Main Study Period|Disease progression|0|||
125154012|NCT02149121|450186834|FG000|Extension Study Period|Withdrawal by Subject|0|||
125154013|NCT02149121|450186835|FG001|Extension Study Period|Withdrawal by Subject|0|||
125154014|NCT02149121|450186836|FG002|Extension Study Period|Withdrawal by Subject|0|||
125154015|NCT02149121|450186837|FG003|Extension Study Period|Withdrawal by Subject|1|||
125154016|NCT02149121|450186838|FG004|Extension Study Period|Withdrawal by Subject|0|||
125154017|NCT02149121|450186839|FG005|Extension Study Period|Withdrawal by Subject|2|||
125154018|NCT02149121|450186840|FG006|Extension Study Period|Withdrawal by Subject|0|||
125154019|NCT03166124|450186841|FG000|Treatment Period 1|Adverse Event|0|||
125154020|NCT03166124|450186842|FG001|Treatment Period 1|Adverse Event|0|||
125154021|NCT03166124|450186843|FG002|Treatment Period 1|Adverse Event|1|||
125154022|NCT03166124|450186844|FG003|Treatment Period 1|Adverse Event|0|||
125154023|NCT03166124|450186841|FG000|Wash-out Period|Withdrawal by Subject|0|||
125154024|NCT03166124|450186842|FG001|Wash-out Period|Withdrawal by Subject|1|||
125154025|NCT03166124|450186843|FG002|Wash-out Period|Withdrawal by Subject|0|||
125154026|NCT03166124|450186844|FG003|Wash-out Period|Withdrawal by Subject|1|||
125154027|NCT03166124|450186841|FG000|Wash-out Period|Adverse Event|0|||
125154028|NCT03166124|450186842|FG001|Wash-out Period|Adverse Event|1|||
125154029|NCT03166124|450186843|FG002|Wash-out Period|Adverse Event|1|||
125154030|NCT03166124|450186844|FG003|Wash-out Period|Adverse Event|0|||
125154031|NCT00094094|450186850|FG000|Overall Study|Death|2|||
125154032|NCT00094094|450186850|FG000|Overall Study|Lack of Efficacy|23|||
125154033|NCT00094094|450186850|FG000|Overall Study|Adverse Event|7|||
125154034|NCT04974619|450188806|FG000|Overall Study|Lost to Follow-up|0|||
125154035|NCT04974619|450188807|FG001|Overall Study|Lost to Follow-up|0|||
125154036|NCT04974619|450188808|FG002|Overall Study|Lost to Follow-up|1|||
125154037|NCT04974619|450188806|FG000|Overall Study|Withdrawal by Subject|0|||
125154038|NCT04974619|450188807|FG001|Overall Study|Withdrawal by Subject|0|||
125154039|NCT04974619|450188808|FG002|Overall Study|Withdrawal by Subject|1|||
125154040|NCT04974619|450188806|FG000|Overall Study|Protocol Violation|0|||
125154041|NCT04974619|450188807|FG001|Overall Study|Protocol Violation|1|||
125154042|NCT04974619|450188808|FG002|Overall Study|Protocol Violation|0|||
125154043|NCT00493779|450188809|FG000|Overall Study|Logistical issue at site|1|||
125154044|NCT01475253|450188810|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
125154045|NCT01475253|450188811|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
125154046|NCT01475253|450188812|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
125154047|NCT01475253|450188813|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
125154048|NCT01475253|450188810|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
125154049|NCT01475253|450188811|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
125154050|NCT01475253|450188812|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
125154051|NCT01475253|450188813|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
125154052|NCT02148913|450188815|FG000|Overall Study|Death|0|||
125154053|NCT02148913|450188816|FG001|Overall Study|Death|1|||
125154054|NCT02148913|450188817|FG002|Overall Study|Death|0|||
125154055|NCT02148913|450188818|FG003|Overall Study|Death|0|||
125154056|NCT01045993|450188821|FG000|Overall Study|Treated-later found eligibility not met|0|||
125154057|NCT01045993|450188822|FG001|Overall Study|Treated-later found eligibility not met|1|||
125154058|NCT01045993|450188823|FG002|Overall Study|Treated-later found eligibility not met|0|||
125154059|NCT01045993|450188824|FG003|Overall Study|Treated-later found eligibility not met|0|||
125154060|NCT05506358|450188825|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
125154061|NCT05506358|450188826|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
125154062|NCT05506358|450188827|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
125154063|NCT05506358|450188828|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
125154064|NCT05506358|450188829|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
125154065|NCT05506358|450188825|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
125154066|NCT05506358|450188826|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
125154067|NCT05506358|450188827|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
125154068|NCT05506358|450188828|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
125154069|NCT05506358|450188829|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
125154070|NCT05506358|450188825|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
125154071|NCT05506358|450188826|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
125154072|NCT05506358|450188827|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
125223848|NCT02421419|450446242|FG001|Overall Study|Physician Decision|0|||
125154073|NCT05506358|450188828|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
125154074|NCT05506358|450188829|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
125154075|NCT05506358|450188825|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
125154076|NCT05506358|450188826|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
125154077|NCT05506358|450188827|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
125154078|NCT05506358|450188828|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
125154079|NCT05506358|450188829|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
125154080|NCT05506358|450188825|FG000|Overall Study|HbE trait|0|||
125154081|NCT05506358|450188826|FG001|Overall Study|HbE trait|0|||
125154082|NCT05506358|450188827|FG002|Overall Study|HbE trait|0|||
125154083|NCT05506358|450188828|FG003|Overall Study|HbE trait|1|||
125154084|NCT05506358|450188829|FG004|Overall Study|HbE trait|0|||
125154085|NCT01659736|450188830|FG000|Treatment Period|Adverse Event|1|||
125154086|NCT01659736|450188831|FG001|Treatment Period|Adverse Event|1|||
125154087|NCT01659736|450188830|FG000|Treatment Period|Protocol Violation|3|||
125154088|NCT01659736|450188831|FG001|Treatment Period|Protocol Violation|1|||
125154089|NCT01659736|450188830|FG000|Treatment Period|Withdrawal by Subject|1|||
125154090|NCT01659736|450188831|FG001|Treatment Period|Withdrawal by Subject|0|||
125154091|NCT01659736|450188830|FG000|3-month Follow-up|Lost to Follow-up|0|||
125154092|NCT01659736|450188831|FG001|3-month Follow-up|Lost to Follow-up|1|||
125154093|NCT00262041|450188837|FG000|Overall Study|Withdrawal by Subject|0|||
125154094|NCT00262041|450188838|FG001|Overall Study|Withdrawal by Subject|3|||
125154095|NCT00262041|450188839|FG002|Overall Study|Withdrawal by Subject|1|||
125154096|NCT00262041|450188837|FG000|Overall Study|Lost to Follow-up|1|||
125154097|NCT00262041|450188838|FG001|Overall Study|Lost to Follow-up|1|||
125154098|NCT00262041|450188839|FG002|Overall Study|Lost to Follow-up|5|||
125154099|NCT00262041|450188837|FG000|Overall Study|Unable to classify|1|||
125154100|NCT00262041|450188838|FG001|Overall Study|Unable to classify|0|||
125154101|NCT00262041|450188839|FG002|Overall Study|Unable to classify|0|||
125154102|NCT02384941|450188842|FG000|Overall Study|Adverse Event|11|||
125154103|NCT02384941|450188843|FG001|Overall Study|Adverse Event|13|||
125154104|NCT02384941|450188844|FG002|Overall Study|Adverse Event|17|||
125154105|NCT02384941|450188842|FG000|Overall Study|Lost to Follow-up|3|||
125154106|NCT02384941|450188843|FG001|Overall Study|Lost to Follow-up|2|||
125154107|NCT02384941|450188844|FG002|Overall Study|Lost to Follow-up|1|||
125154108|NCT02384941|450188842|FG000|Overall Study|Non-Compliance With Study Drug|2|||
125154109|NCT02384941|450188843|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125154110|NCT02384941|450188844|FG002|Overall Study|Non-Compliance With Study Drug|1|||
125154111|NCT02384941|450188842|FG000|Overall Study|Physician Decision|1|||
125154112|NCT02384941|450188843|FG001|Overall Study|Physician Decision|1|||
125154113|NCT02384941|450188844|FG002|Overall Study|Physician Decision|0|||
125154114|NCT02384941|450188842|FG000|Overall Study|Protocol Violation|3|||
125154115|NCT02384941|450188843|FG001|Overall Study|Protocol Violation|0|||
125154116|NCT02384941|450188844|FG002|Overall Study|Protocol Violation|0|||
125154117|NCT02384941|450188842|FG000|Overall Study|Withdrawal by Subject|26|||
125154118|NCT02384941|450188843|FG001|Overall Study|Withdrawal by Subject|19|||
125154119|NCT02384941|450188844|FG002|Overall Study|Withdrawal by Subject|20|||
125154120|NCT02384941|450188842|FG000|Overall Study|Pregnancy|0|||
125154121|NCT02384941|450188843|FG001|Overall Study|Pregnancy|0|||
125154122|NCT02384941|450188844|FG002|Overall Study|Pregnancy|1|||
125154123|NCT02384941|450188842|FG000|Overall Study|Other than specified above|4|||
125154124|NCT02384941|450188843|FG001|Overall Study|Other than specified above|0|||
125154125|NCT02384941|450188844|FG002|Overall Study|Other than specified above|1|||
125154126|NCT00252174|450188847|FG000|Overall Study|Withdrawal by Subject|0|||
125154127|NCT00252174|450188848|FG001|Overall Study|Withdrawal by Subject|1|||
125154128|NCT00252174|450188849|FG002|Overall Study|Withdrawal by Subject|0|||
125154129|NCT00484419|450188853|FG000|Overall Study|Adverse Event|3|||
125154130|NCT00484419|450188854|FG001|Overall Study|Adverse Event|0|||
125154131|NCT00484419|450188855|FG002|Overall Study|Adverse Event|0|||
125154132|NCT00484419|450188853|FG000|Overall Study|Lost to Follow-up|1|||
125154133|NCT00484419|450188854|FG001|Overall Study|Lost to Follow-up|0|||
125154134|NCT00484419|450188855|FG002|Overall Study|Lost to Follow-up|2|||
125154135|NCT00484419|450188853|FG000|Overall Study|Withdrawal by Subject|3|||
125154136|NCT00484419|450188854|FG001|Overall Study|Withdrawal by Subject|1|||
125154137|NCT00484419|450188855|FG002|Overall Study|Withdrawal by Subject|1|||
125154138|NCT00484419|450188853|FG000|Overall Study|subject met discontinuation criteria|2|||
125154139|NCT00484419|450188854|FG001|Overall Study|subject met discontinuation criteria|2|||
125154140|NCT00484419|450188855|FG002|Overall Study|subject met discontinuation criteria|4|||
125154141|NCT00484419|450188853|FG000|Overall Study|required restricted medication|1|||
125154142|NCT00484419|450188854|FG001|Overall Study|required restricted medication|0|||
125154143|NCT00484419|450188855|FG002|Overall Study|required restricted medication|1|||
125154144|NCT00484419|450188853|FG000|Overall Study|Physician Decision|1|||
125154145|NCT00484419|450188854|FG001|Overall Study|Physician Decision|1|||
125154146|NCT00484419|450188855|FG002|Overall Study|Physician Decision|1|||
125154147|NCT00484419|450188853|FG000|Overall Study|subject unable to receive medication|1|||
125154148|NCT00484419|450188854|FG001|Overall Study|subject unable to receive medication|0|||
125154149|NCT00484419|450188855|FG002|Overall Study|subject unable to receive medication|0|||
125154150|NCT00484419|450188853|FG000|Overall Study|subject relocated|0|||
125154151|NCT00484419|450188854|FG001|Overall Study|subject relocated|1|||
125154152|NCT00484419|450188855|FG002|Overall Study|subject relocated|0|||
125154153|NCT00484419|450188853|FG000|Overall Study|sponsor decision, randomized in error|0|||
125154154|NCT00484419|450188854|FG001|Overall Study|sponsor decision, randomized in error|0|||
125154155|NCT00484419|450188855|FG002|Overall Study|sponsor decision, randomized in error|2|||
125154156|NCT00102687|450188856|FG000|Initial Period|Withdrawal by Subject|6|||
125154157|NCT00102687|450188857|FG001|Initial Period|Withdrawal by Subject|3|||
125154158|NCT00102687|450188858|FG002|Initial Period|Withdrawal by Subject|5|||
125154159|NCT00102687|450188859|FG003|Initial Period|Withdrawal by Subject|0|||
125154160|NCT00102687|450188860|FG004|Initial Period|Withdrawal by Subject|0|||
125154161|NCT00102687|450188856|FG000|Initial Period|Adverse Event|4|||
125154162|NCT00102687|450188857|FG001|Initial Period|Adverse Event|7|||
125154163|NCT00102687|450188858|FG002|Initial Period|Adverse Event|9|||
125154164|NCT00102687|450188859|FG003|Initial Period|Adverse Event|0|||
125154165|NCT00102687|450188860|FG004|Initial Period|Adverse Event|0|||
125154166|NCT00102687|450188856|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
125154167|NCT00102687|450188857|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
125154168|NCT00102687|450188858|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
125154169|NCT00102687|450188859|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
125154170|NCT00102687|450188860|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
125154171|NCT00102687|450188856|FG000|Initial Period|Protocol Violation|0|||
125154172|NCT00102687|450188857|FG001|Initial Period|Protocol Violation|0|||
125154173|NCT00102687|450188858|FG002|Initial Period|Protocol Violation|2|||
125154174|NCT00102687|450188859|FG003|Initial Period|Protocol Violation|0|||
125154175|NCT00102687|450188860|FG004|Initial Period|Protocol Violation|0|||
125154176|NCT00102687|450188856|FG000|Initial Period|Physician Decision|2|||
125154177|NCT00102687|450188857|FG001|Initial Period|Physician Decision|9|||
125154178|NCT00102687|450188858|FG002|Initial Period|Physician Decision|6|||
125154179|NCT00102687|450188859|FG003|Initial Period|Physician Decision|0|||
125154180|NCT00102687|450188860|FG004|Initial Period|Physician Decision|0|||
125154181|NCT00102687|450188856|FG000|Initial Period|Sponsor's decision|0|||
125154182|NCT00102687|450188857|FG001|Initial Period|Sponsor's decision|1|||
125154183|NCT00102687|450188858|FG002|Initial Period|Sponsor's decision|1|||
125154184|NCT00102687|450188859|FG003|Initial Period|Sponsor's decision|0|||
125154185|NCT00102687|450188860|FG004|Initial Period|Sponsor's decision|0|||
125154186|NCT00102687|450188856|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
125154187|NCT00102687|450188857|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
125154188|NCT00102687|450188858|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
125154189|NCT00102687|450188859|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
125154190|NCT00102687|450188860|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
125154191|NCT00102687|450188856|FG000|Initial Period|Death|1|||
125154192|NCT00102687|450188857|FG001|Initial Period|Death|1|||
125154193|NCT00102687|450188858|FG002|Initial Period|Death|1|||
125154194|NCT00102687|450188859|FG003|Initial Period|Death|0|||
125154195|NCT00102687|450188860|FG004|Initial Period|Death|0|||
125154196|NCT00102687|450188856|FG000|Maintenance Period|Withdrawal by Subject|4|||
125154197|NCT00102687|450188857|FG001|Maintenance Period|Withdrawal by Subject|0|||
125154198|NCT00102687|450188858|FG002|Maintenance Period|Withdrawal by Subject|2|||
125154199|NCT00102687|450188859|FG003|Maintenance Period|Withdrawal by Subject|3|||
125154200|NCT00102687|450188860|FG004|Maintenance Period|Withdrawal by Subject|1|||
125154201|NCT00102687|450188856|FG000|Maintenance Period|Adverse Event|1|||
125154202|NCT00102687|450188857|FG001|Maintenance Period|Adverse Event|0|||
125154203|NCT00102687|450188858|FG002|Maintenance Period|Adverse Event|0|||
125154204|NCT00102687|450188859|FG003|Maintenance Period|Adverse Event|1|||
125154205|NCT00102687|450188860|FG004|Maintenance Period|Adverse Event|3|||
125154206|NCT00102687|450188856|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
125154207|NCT00102687|450188857|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
125154208|NCT00102687|450188858|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
125154209|NCT00102687|450188859|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
125154210|NCT00102687|450188860|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
125154211|NCT00102687|450188856|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
125154212|NCT00102687|450188857|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
125154213|NCT00102687|450188858|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
125154214|NCT00102687|450188859|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
125154215|NCT00102687|450188860|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
125154216|NCT00102687|450188856|FG000|Maintenance Period|Death|0|||
125154217|NCT00102687|450188857|FG001|Maintenance Period|Death|0|||
125154218|NCT00102687|450188858|FG002|Maintenance Period|Death|0|||
125154219|NCT00102687|450188859|FG003|Maintenance Period|Death|1|||
125154220|NCT00102687|450188860|FG004|Maintenance Period|Death|1|||
125154221|NCT00102687|450188856|FG000|Maintenance Period|Physician Decision|1|||
125154222|NCT00102687|450188857|FG001|Maintenance Period|Physician Decision|2|||
125154223|NCT00102687|450188858|FG002|Maintenance Period|Physician Decision|3|||
125154224|NCT00102687|450188859|FG003|Maintenance Period|Physician Decision|0|||
125154225|NCT00102687|450188860|FG004|Maintenance Period|Physician Decision|4|||
125154226|NCT01341587|450188861|FG000|Overall Study|Lost to Follow-up|2|||
125154227|NCT01341587|450188862|FG001|Overall Study|Lost to Follow-up|0|||
125154228|NCT01341587|450188861|FG000|Overall Study|stopped using the meters|2|||
125154229|NCT01341587|450188862|FG001|Overall Study|stopped using the meters|10|||
125154230|NCT03739138|450188864|FG000|Overall Study|Death|0|||
125154231|NCT03739138|450188865|FG001|Overall Study|Death|7|||
125154232|NCT03739138|450188866|FG002|Overall Study|Death|4|||
125154233|NCT03739138|450188867|FG003|Overall Study|Death|13|||
125154234|NCT03739138|450188868|FG004|Overall Study|Death|0|||
125154235|NCT03739138|450188864|FG000|Overall Study|Lost to Follow-up|0|||
125154236|NCT03739138|450188865|FG001|Overall Study|Lost to Follow-up|0|||
125154237|NCT03739138|450188866|FG002|Overall Study|Lost to Follow-up|1|||
125154238|NCT03739138|450188867|FG003|Overall Study|Lost to Follow-up|0|||
125154239|NCT03739138|450188868|FG004|Overall Study|Lost to Follow-up|0|||
125154240|NCT03739138|450188864|FG000|Overall Study|Study Terminated By Sponsor|0|||
125154241|NCT03739138|450188865|FG001|Overall Study|Study Terminated By Sponsor|0|||
125154242|NCT03739138|450188866|FG002|Overall Study|Study Terminated By Sponsor|0|||
125154243|NCT03739138|450188867|FG003|Overall Study|Study Terminated By Sponsor|4|||
125154244|NCT03739138|450188868|FG004|Overall Study|Study Terminated By Sponsor|0|||
125154245|NCT03739138|450188864|FG000|Overall Study|Withdrawal by Subject|0|||
125154246|NCT03739138|450188865|FG001|Overall Study|Withdrawal by Subject|0|||
125154247|NCT03739138|450188866|FG002|Overall Study|Withdrawal by Subject|0|||
125154248|NCT03739138|450188867|FG003|Overall Study|Withdrawal by Subject|1|||
125154249|NCT03739138|450188868|FG004|Overall Study|Withdrawal by Subject|0|||
125154250|NCT00466726|450188869|FG000|Overall Study|Not evaluable for response|14|||
125154251|NCT04403763|450188870|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
125154252|NCT04403763|450188871|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
125154253|NCT04403763|450188872|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
125154254|NCT04403763|450188873|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
125154255|NCT04403763|450188874|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
125154256|NCT04403763|450188875|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
125154257|NCT04403763|450188876|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
125154258|NCT04403763|450188870|FG000|Stage 1|Early termination due to PK tube failure|0|||
125154259|NCT04403763|450188871|FG001|Stage 1|Early termination due to PK tube failure|0|||
125154260|NCT04403763|450188872|FG002|Stage 1|Early termination due to PK tube failure|1|||
125154261|NCT04403763|450188873|FG003|Stage 1|Early termination due to PK tube failure|0|||
125154262|NCT04403763|450188874|FG004|Stage 1|Early termination due to PK tube failure|0|||
125154263|NCT04403763|450188875|FG005|Stage 1|Early termination due to PK tube failure|0|||
125154264|NCT04403763|450188876|FG006|Stage 1|Early termination due to PK tube failure|0|||
125154265|NCT04403763|450188870|FG000|Stage 2A|Adverse Event|0|||
125154266|NCT04403763|450188871|FG001|Stage 2A|Adverse Event|0|||
125154267|NCT04403763|450188872|FG002|Stage 2A|Adverse Event|0|||
125154268|NCT04403763|450188873|FG003|Stage 2A|Adverse Event|0|||
125154269|NCT04403763|450188874|FG004|Stage 2A|Adverse Event|0|||
125154270|NCT04403763|450188875|FG005|Stage 2A|Adverse Event|0|||
125154271|NCT04403763|450188876|FG006|Stage 2A|Adverse Event|1|||
125154272|NCT01376310|450188877|FG000|Overall Study|Study closed/terminated|1|||
125154273|NCT01376310|450188878|FG001|Overall Study|Study closed/terminated|2|||
125154274|NCT01376310|450188877|FG000|Overall Study|Withdrawal by Subject|8|||
125154275|NCT01376310|450188878|FG001|Overall Study|Withdrawal by Subject|2|||
125154276|NCT01376310|450188877|FG000|Overall Study|Physician Decision|26|||
125154277|NCT01376310|450188878|FG001|Overall Study|Physician Decision|7|||
125154278|NCT01376310|450188877|FG000|Overall Study|Lost to Follow-up|1|||
125154279|NCT01376310|450188878|FG001|Overall Study|Lost to Follow-up|0|||
125154280|NCT02470091|450188879|FG000|Overall Study|Withdrawal by Subject|1|||
125154281|NCT02470091|450188880|FG001|Overall Study|Withdrawal by Subject|0|||
125154282|NCT02470091|450188879|FG000|Overall Study|Ineligible|0|||
125154283|NCT02470091|450188880|FG001|Overall Study|Ineligible|2|||
125154284|NCT00767520|450188893|FG000|Overall Study|Participants still on treatment|11|||
125154285|NCT00767520|450188894|FG001|Overall Study|Participants still on treatment|15|||
125154286|NCT00767520|450188893|FG000|Overall Study|Randomized in error and Never treated|0|||
125154287|NCT00767520|450188894|FG001|Overall Study|Randomized in error and Never treated|2|||
125154288|NCT00720226|450188895|FG000|Overall Study|Withdrawal by Subject|7|||
125154289|NCT00720226|450188896|FG001|Overall Study|Withdrawal by Subject|4|||
125154290|NCT00958126|450188897|FG000|Overall Study|Serious Adverse Event|0|||
125154291|NCT00958126|450188898|FG001|Overall Study|Serious Adverse Event|2|||
125154292|NCT00958126|450188899|FG002|Overall Study|Serious Adverse Event|0|||
125154293|NCT00958126|450188900|FG003|Overall Study|Serious Adverse Event|0|||
125154294|NCT00958126|450188901|FG004|Overall Study|Serious Adverse Event|0|||
125154295|NCT00958126|450188902|FG005|Overall Study|Serious Adverse Event|0|||
125154296|NCT00958126|450188903|FG006|Overall Study|Serious Adverse Event|1|||
125154297|NCT00958126|450188904|FG007|Overall Study|Serious Adverse Event|0|||
125154298|NCT00958126|450188897|FG000|Overall Study|Withdrawal by Subject|0|||
125154299|NCT00958126|450188898|FG001|Overall Study|Withdrawal by Subject|2|||
125154300|NCT00958126|450188899|FG002|Overall Study|Withdrawal by Subject|0|||
125154301|NCT00958126|450188900|FG003|Overall Study|Withdrawal by Subject|0|||
125154302|NCT00958126|450188901|FG004|Overall Study|Withdrawal by Subject|0|||
125154303|NCT00958126|450188902|FG005|Overall Study|Withdrawal by Subject|0|||
125154304|NCT00958126|450188903|FG006|Overall Study|Withdrawal by Subject|0|||
125154305|NCT00958126|450188904|FG007|Overall Study|Withdrawal by Subject|0|||
125154306|NCT00958126|450188897|FG000|Overall Study|Moved away from study area|0|||
125154307|NCT00958126|450188898|FG001|Overall Study|Moved away from study area|0|||
125154308|NCT00958126|450188899|FG002|Overall Study|Moved away from study area|1|||
125154309|NCT00958126|450188900|FG003|Overall Study|Moved away from study area|1|||
125154310|NCT00958126|450188901|FG004|Overall Study|Moved away from study area|0|||
125154311|NCT00958126|450188902|FG005|Overall Study|Moved away from study area|0|||
125154312|NCT00958126|450188903|FG006|Overall Study|Moved away from study area|0|||
125154313|NCT00958126|450188904|FG007|Overall Study|Moved away from study area|0|||
125154314|NCT00958126|450188897|FG000|Overall Study|Lost to Follow-up|1|||
125154315|NCT00958126|450188898|FG001|Overall Study|Lost to Follow-up|5|||
125154316|NCT00958126|450188899|FG002|Overall Study|Lost to Follow-up|9|||
125154317|NCT00958126|450188900|FG003|Overall Study|Lost to Follow-up|8|||
125154318|NCT00958126|450188901|FG004|Overall Study|Lost to Follow-up|0|||
125154319|NCT00958126|450188902|FG005|Overall Study|Lost to Follow-up|0|||
125154320|NCT00958126|450188903|FG006|Overall Study|Lost to Follow-up|0|||
125154321|NCT00958126|450188904|FG007|Overall Study|Lost to Follow-up|0|||
125154322|NCT00958126|450188897|FG000|Overall Study|Sponsor/Investigator decision|0|||
125154323|NCT00958126|450188898|FG001|Overall Study|Sponsor/Investigator decision|0|||
125154324|NCT00958126|450188899|FG002|Overall Study|Sponsor/Investigator decision|0|||
125154325|NCT00958126|450188900|FG003|Overall Study|Sponsor/Investigator decision|1|||
125154326|NCT00958126|450188901|FG004|Overall Study|Sponsor/Investigator decision|0|||
125154327|NCT00958126|450188902|FG005|Overall Study|Sponsor/Investigator decision|0|||
125154328|NCT00958126|450188903|FG006|Overall Study|Sponsor/Investigator decision|0|||
125154329|NCT00958126|450188904|FG007|Overall Study|Sponsor/Investigator decision|0|||
125154330|NCT00958126|450188897|FG000|Overall Study|Other Reason|0|||
125154331|NCT00958126|450188898|FG001|Overall Study|Other Reason|0|||
125154332|NCT00958126|450188899|FG002|Overall Study|Other Reason|0|||
125154333|NCT00958126|450188900|FG003|Overall Study|Other Reason|1|||
125154334|NCT00958126|450188901|FG004|Overall Study|Other Reason|0|||
125154335|NCT00958126|450188902|FG005|Overall Study|Other Reason|1|||
125154336|NCT00958126|450188903|FG006|Overall Study|Other Reason|0|||
125154337|NCT00958126|450188904|FG007|Overall Study|Other Reason|0|||
125154338|NCT00733369|450188905|FG000|Overall Study|Lost to Follow-up|2|||
125154339|NCT00733369|450188906|FG001|Overall Study|Lost to Follow-up|1|||
125154340|NCT00733369|450188905|FG000|Overall Study|Adverse Event|4|||
125154341|NCT00733369|450188906|FG001|Overall Study|Adverse Event|4|||
125154342|NCT00733369|450188905|FG000|Overall Study|Protocol Violation|4|||
125154343|NCT00733369|450188906|FG001|Overall Study|Protocol Violation|4|||
125154344|NCT03401073|450188907|FG000|Overall Study|Lost to Follow-up|1|||
125154345|NCT03401073|450188908|FG001|Overall Study|Lost to Follow-up|2|||
125154346|NCT02510014|450188914|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
125154347|NCT02510014|450188915|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
125154348|NCT02510014|450188914|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
125154349|NCT02510014|450188915|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
125154350|NCT02510014|450188914|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
125154351|NCT02510014|450188915|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
125154352|NCT02510014|450188914|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
125154353|NCT02510014|450188915|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
125154354|NCT02510014|450188914|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
125154355|NCT02510014|450188915|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
125223849|NCT02421419|450446243|FG002|Overall Study|Physician Decision|1|||
125154356|NCT02510014|450188914|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
125154357|NCT02510014|450188915|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
125154358|NCT02510014|450188914|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
125154359|NCT02510014|450188915|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
125154360|NCT02510014|450188914|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
125154361|NCT02510014|450188915|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
125154362|NCT02510014|450188914|FG000|Treatment Period|Adverse Event|11|||
125154363|NCT02510014|450188915|FG001|Treatment Period|Adverse Event|4|||
125154364|NCT02510014|450188914|FG000|Treatment Period|Withdrawal symptoms|3|||
125154365|NCT02510014|450188915|FG001|Treatment Period|Withdrawal symptoms|0|||
125154366|NCT02510014|450188914|FG000|Treatment Period|Lost to Follow-up|80|||
125154367|NCT02510014|450188915|FG001|Treatment Period|Lost to Follow-up|19|||
125154368|NCT02510014|450188914|FG000|Treatment Period|Physician Decision|5|||
125154369|NCT02510014|450188915|FG001|Treatment Period|Physician Decision|0|||
125154370|NCT02510014|450188914|FG000|Treatment Period|Withdrawal by Subject|67|||
125154371|NCT02510014|450188915|FG001|Treatment Period|Withdrawal by Subject|24|||
125154372|NCT02510014|450188914|FG000|Treatment Period|Withdrawn by the investigator|7|||
125154373|NCT02510014|450188915|FG001|Treatment Period|Withdrawn by the investigator|1|||
125154374|NCT02510014|450188914|FG000|Treatment Period|Protocol Violation|4|||
125154375|NCT02510014|450188915|FG001|Treatment Period|Protocol Violation|4|||
125154376|NCT02510014|450188914|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
125154377|NCT02510014|450188915|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
125154378|NCT01875471|450188919|FG000|Overall Study|Adverse Event|0|||
125154379|NCT01875471|450188920|FG001|Overall Study|Adverse Event|1|||
125154380|NCT01875471|450188919|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
125154381|NCT01875471|450188920|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
125154382|NCT04179019|450188922|FG000|Overall Study|Lost to Follow-up|2|||
125154383|NCT04179019|450188922|FG000|Overall Study|Physician Decision|2|||
125154384|NCT04179019|450188922|FG000|Overall Study|Withdrawal by Subject|5|||
125154385|NCT04179019|450188922|FG000|Overall Study|Adverse Event|4|||
125154386|NCT02083926|450188923|FG000|Overall Study|Withdrawal by Subject|1|||
125154387|NCT02083926|450188924|FG001|Overall Study|Withdrawal by Subject|0|||
125154388|NCT02610816|450188925|FG000|Phase 1|Withdrawal by Subject|2|||
125154389|NCT02610816|450188926|FG001|Phase 1|Withdrawal by Subject|6|||
125154390|NCT02610816|450188927|FG002|Phase 1|Withdrawal by Subject|0|||
125154391|NCT02610816|450188928|FG003|Phase 1|Withdrawal by Subject|0|||
125154392|NCT02610816|450188925|FG000|Phase 1|Lost to Follow-up|2|||
125154393|NCT02610816|450188926|FG001|Phase 1|Lost to Follow-up|1|||
125154394|NCT02610816|450188927|FG002|Phase 1|Lost to Follow-up|0|||
125154395|NCT02610816|450188928|FG003|Phase 1|Lost to Follow-up|0|||
125154396|NCT02610816|450188925|FG000|Phase 1|Physician Decision|0|||
125154397|NCT02610816|450188926|FG001|Phase 1|Physician Decision|1|||
125154398|NCT02610816|450188927|FG002|Phase 1|Physician Decision|0|||
125154399|NCT02610816|450188928|FG003|Phase 1|Physician Decision|0|||
125154400|NCT02610816|450188925|FG000|Phase 2|Withdrawal by Subject|0|||
125154401|NCT02610816|450188926|FG001|Phase 2|Withdrawal by Subject|0|||
125154402|NCT02610816|450188927|FG002|Phase 2|Withdrawal by Subject|9|||
125154403|NCT02610816|450188928|FG003|Phase 2|Withdrawal by Subject|3|||
125154404|NCT02610816|450188925|FG000|Phase 2|Lost to Follow-up|0|||
125154405|NCT02610816|450188926|FG001|Phase 2|Lost to Follow-up|0|||
125154406|NCT02610816|450188927|FG002|Phase 2|Lost to Follow-up|2|||
125154407|NCT02610816|450188928|FG003|Phase 2|Lost to Follow-up|0|||
125154408|NCT02610816|450188925|FG000|Phase 2|Physician Decision|0|||
125154409|NCT02610816|450188926|FG001|Phase 2|Physician Decision|0|||
125154410|NCT02610816|450188927|FG002|Phase 2|Physician Decision|0|||
125154411|NCT02610816|450188928|FG003|Phase 2|Physician Decision|2|||
125154412|NCT02610816|450188925|FG000|Phase 2|Pregnancy|0|||
125154413|NCT02610816|450188926|FG001|Phase 2|Pregnancy|0|||
125154414|NCT02610816|450188927|FG002|Phase 2|Pregnancy|0|||
125154415|NCT02610816|450188928|FG003|Phase 2|Pregnancy|1|||
125154416|NCT01949116|450188929|FG000|Overall Study|Death|2|||
125154417|NCT01949116|450188930|FG001|Overall Study|Death|0|||
125154418|NCT01949116|450188929|FG000|Overall Study|Lost to Follow-up|1|||
125154419|NCT01949116|450188930|FG001|Overall Study|Lost to Follow-up|3|||
125154420|NCT01949116|450188929|FG000|Overall Study|Withdrawal by Subject|5|||
125154421|NCT01949116|450188930|FG001|Overall Study|Withdrawal by Subject|3|||
125154422|NCT03438227|450188931|FG000|Overall Study|Withdrawal by Subject|10|||
125154423|NCT03438227|450188932|FG001|Overall Study|Withdrawal by Subject|5|||
125154424|NCT00049842|450188934|FG000|Treatment Phase|Adverse Event|47|||
125154425|NCT00049842|450188935|FG001|Treatment Phase|Adverse Event|12|||
125154426|NCT00049842|450188934|FG000|Treatment Phase|Withdrawal by Subject|35|||
125154427|NCT00049842|450188935|FG001|Treatment Phase|Withdrawal by Subject|46|||
125154428|NCT00049842|450188934|FG000|Treatment Phase|Non-compliance with protocol|7|||
125154429|NCT00049842|450188935|FG001|Treatment Phase|Non-compliance with protocol|8|||
125154430|NCT00049842|450188934|FG000|Treatment Phase|Lost to Follow-up|4|||
125154431|NCT00049842|450188935|FG001|Treatment Phase|Lost to Follow-up|8|||
125154432|NCT00049842|450188934|FG000|Treatment Phase|Administrative|0|||
125154433|NCT00049842|450188935|FG001|Treatment Phase|Administrative|3|||
125154434|NCT00049842|450188934|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
125154435|NCT00049842|450188935|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
125154436|NCT00049842|450188934|FG000|Follow-up Phase|Adverse Event|6|||
125154437|NCT00049842|450188935|FG001|Follow-up Phase|Adverse Event|1|||
125154438|NCT00049842|450188934|FG000|Follow-up Phase|Other|1|||
125154439|NCT00049842|450188935|FG001|Follow-up Phase|Other|4|||
125154440|NCT01813071|450188936|FG000|Overall Study|Protocol Violation|0|||
125154441|NCT01813071|450188937|FG001|Overall Study|Protocol Violation|0|||
125154442|NCT01813071|450188938|FG002|Overall Study|Protocol Violation|0|||
125154443|NCT01813071|450188939|FG003|Overall Study|Protocol Violation|0|||
125154444|NCT01813071|450188940|FG004|Overall Study|Protocol Violation|1|||
125154445|NCT01813071|450188941|FG005|Overall Study|Protocol Violation|4|||
125154446|NCT01813071|450188942|FG006|Overall Study|Protocol Violation|2|||
125154447|NCT01813071|450188943|FG007|Overall Study|Protocol Violation|4|||
125154448|NCT01813071|450188944|FG008|Overall Study|Protocol Violation|2|||
125154449|NCT01813071|450188936|FG000|Overall Study|Withdrawal by Subject|0|||
125154450|NCT01813071|450188937|FG001|Overall Study|Withdrawal by Subject|0|||
125154451|NCT01813071|450188938|FG002|Overall Study|Withdrawal by Subject|0|||
125154452|NCT01813071|450188939|FG003|Overall Study|Withdrawal by Subject|0|||
125154453|NCT01813071|450188940|FG004|Overall Study|Withdrawal by Subject|0|||
125154454|NCT01813071|450188941|FG005|Overall Study|Withdrawal by Subject|1|||
125154455|NCT01813071|450188942|FG006|Overall Study|Withdrawal by Subject|0|||
125154456|NCT01813071|450188943|FG007|Overall Study|Withdrawal by Subject|0|||
125154457|NCT01813071|450188944|FG008|Overall Study|Withdrawal by Subject|0|||
125154458|NCT01813071|450188936|FG000|Overall Study|Adverse Event|0|||
125154459|NCT01813071|450188937|FG001|Overall Study|Adverse Event|0|||
125154460|NCT01813071|450188938|FG002|Overall Study|Adverse Event|0|||
125154461|NCT01813071|450188939|FG003|Overall Study|Adverse Event|0|||
125154462|NCT01813071|450188940|FG004|Overall Study|Adverse Event|0|||
125154463|NCT01813071|450188941|FG005|Overall Study|Adverse Event|1|||
125154464|NCT01813071|450188942|FG006|Overall Study|Adverse Event|0|||
125154465|NCT01813071|450188943|FG007|Overall Study|Adverse Event|0|||
125154466|NCT01813071|450188944|FG008|Overall Study|Adverse Event|0|||
125154467|NCT01813071|450188936|FG000|Overall Study|Physician Decision|0|||
125154468|NCT01813071|450188937|FG001|Overall Study|Physician Decision|0|||
125154469|NCT01813071|450188938|FG002|Overall Study|Physician Decision|0|||
125154470|NCT01813071|450188939|FG003|Overall Study|Physician Decision|0|||
125154471|NCT01813071|450188940|FG004|Overall Study|Physician Decision|0|||
125154472|NCT01813071|450188941|FG005|Overall Study|Physician Decision|0|||
125154473|NCT01813071|450188942|FG006|Overall Study|Physician Decision|1|||
125154474|NCT01813071|450188943|FG007|Overall Study|Physician Decision|0|||
125154475|NCT01813071|450188944|FG008|Overall Study|Physician Decision|0|||
125154476|NCT01813071|450188936|FG000|Overall Study|Met inc/exc criteria|0|||
125154477|NCT01813071|450188937|FG001|Overall Study|Met inc/exc criteria|0|||
125154478|NCT01813071|450188938|FG002|Overall Study|Met inc/exc criteria|0|||
125154479|NCT01813071|450188939|FG003|Overall Study|Met inc/exc criteria|0|||
125154480|NCT01813071|450188940|FG004|Overall Study|Met inc/exc criteria|0|||
125154481|NCT01813071|450188941|FG005|Overall Study|Met inc/exc criteria|1|||
125154482|NCT01813071|450188942|FG006|Overall Study|Met inc/exc criteria|0|||
125154483|NCT01813071|450188943|FG007|Overall Study|Met inc/exc criteria|1|||
125154484|NCT01813071|450188944|FG008|Overall Study|Met inc/exc criteria|1|||
125154485|NCT00613834|450188945|FG000|Overall Study|Withdrawal by Subject|0|||
125154486|NCT00613834|450188946|FG001|Overall Study|Withdrawal by Subject|3|||
125154487|NCT00842530|450188947|FG000|Overall Study|Serious adverse event|0|||
125154488|NCT00842530|450188948|FG001|Overall Study|Serious adverse event|6|||
125154489|NCT00842530|450188947|FG000|Overall Study|Other adverse event|6|||
125154490|NCT00842530|450188948|FG001|Overall Study|Other adverse event|1|||
125154491|NCT00842530|450188947|FG000|Overall Study|Protocol Violation|32|||
125154492|NCT00842530|450188948|FG001|Overall Study|Protocol Violation|14|||
125154493|NCT00842530|450188947|FG000|Overall Study|Lost to Follow-up|6|||
125154494|NCT00842530|450188948|FG001|Overall Study|Lost to Follow-up|8|||
125154495|NCT00842530|450188947|FG000|Overall Study|Withdrawal by Subject|73|||
125154496|NCT00842530|450188948|FG001|Overall Study|Withdrawal by Subject|28|||
125154497|NCT02939950|450188951|FG000|Overall Study|Lost to Follow-up|13|||
125154498|NCT02939950|450188952|FG001|Overall Study|Lost to Follow-up|16|||
125154499|NCT02939950|450188951|FG000|Overall Study|Positive slit lamp findings|0|||
125154500|NCT02939950|450188952|FG001|Overall Study|Positive slit lamp findings|1|||
125154501|NCT02939950|450188951|FG000|Overall Study|Chalazion upper lid|0|||
125154502|NCT02939950|450188952|FG001|Overall Study|Chalazion upper lid|1|||
125154503|NCT02939950|450188951|FG000|Overall Study|Lack of motivation|0|||
125154504|NCT02939950|450188952|FG001|Overall Study|Lack of motivation|2|||
125154505|NCT02939950|450188951|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
125154506|NCT02939950|450188952|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
125154507|NCT02939950|450188951|FG000|Overall Study|Military orders|1|||
125154508|NCT02939950|450188952|FG001|Overall Study|Military orders|0|||
125154509|NCT02939950|450188951|FG000|Overall Study|Participant Relocated|5|||
125154510|NCT02939950|450188952|FG001|Overall Study|Participant Relocated|3|||
125154511|NCT02939950|450188951|FG000|Overall Study|Study related symptoms|8|||
125154512|NCT02939950|450188952|FG001|Overall Study|Study related symptoms|8|||
125154513|NCT02939950|450188951|FG000|Overall Study|Unacceptable lens movement|2|||
125154514|NCT02939950|450188952|FG001|Overall Study|Unacceptable lens movement|0|||
125154515|NCT02939950|450188951|FG000|Overall Study|Protocol Violation|6|||
125154516|NCT02939950|450188952|FG001|Overall Study|Protocol Violation|3|||
125154517|NCT02939950|450188951|FG000|Overall Study|Physician Decision|2|||
125154518|NCT02939950|450188952|FG001|Overall Study|Physician Decision|0|||
125154519|NCT02939950|450188951|FG000|Overall Study|Pregnancy|6|||
125154520|NCT02939950|450188952|FG001|Overall Study|Pregnancy|7|||
125154521|NCT02939950|450188951|FG000|Overall Study|Withdrawal by Subject|12|||
125154522|NCT02939950|450188952|FG001|Overall Study|Withdrawal by Subject|28|||
125154523|NCT02939950|450188951|FG000|Overall Study|Adverse Event|7|||
125154524|NCT02939950|450188952|FG001|Overall Study|Adverse Event|3|||
125154525|NCT02939950|450188951|FG000|Overall Study|Randomized, not dispensed|1|||
125154526|NCT02939950|450188952|FG001|Overall Study|Randomized, not dispensed|0|||
125154527|NCT02939950|450188951|FG000|Overall Study|Ineligible at Baseline|2|||
125154528|NCT02939950|450188952|FG001|Overall Study|Ineligible at Baseline|8|||
125154529|NCT01660022|450188956|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
125154530|NCT01660022|450188957|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
125154531|NCT01660022|450188958|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
125154532|NCT01660022|450188959|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
125154533|NCT01660022|450188960|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
125154534|NCT01660022|450188961|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
125154535|NCT01660022|450188956|FG000|First Sequence (7 Days)|Adverse Event|0|||
125154536|NCT01660022|450188957|FG001|First Sequence (7 Days)|Adverse Event|0|||
125154537|NCT01660022|450188958|FG002|First Sequence (7 Days)|Adverse Event|0|||
125154538|NCT01660022|450188959|FG003|First Sequence (7 Days)|Adverse Event|0|||
125154539|NCT01660022|450188960|FG004|First Sequence (7 Days)|Adverse Event|1|||
125154540|NCT01660022|450188961|FG005|First Sequence (7 Days)|Adverse Event|3|||
125154541|NCT01660022|450188956|FG000|First Sequence (7 Days)|Protocol Violation|0|||
125154542|NCT01660022|450188957|FG001|First Sequence (7 Days)|Protocol Violation|0|||
125154543|NCT01660022|450188958|FG002|First Sequence (7 Days)|Protocol Violation|0|||
125154544|NCT01660022|450188959|FG003|First Sequence (7 Days)|Protocol Violation|0|||
125154545|NCT01660022|450188960|FG004|First Sequence (7 Days)|Protocol Violation|0|||
125154546|NCT01660022|450188961|FG005|First Sequence (7 Days)|Protocol Violation|1|||
125154547|NCT00766831|450188966|FG000|Overall Study|Withdrawal by Subject|4|||
125154548|NCT00766831|450188966|FG000|Overall Study|Lost to Follow-up|3|||
125154549|NCT00766831|450188966|FG000|Overall Study|Adverse Event|20|||
125154550|NCT00766831|450188966|FG000|Overall Study|Protocol Violation|15|||
125154551|NCT00766831|450188966|FG000|Overall Study|Physician Decision|5|||
125154552|NCT00766831|450188966|FG000|Overall Study|Withdrawal of consent|26|||
125154553|NCT00766831|450188966|FG000|Overall Study|Non cooperation by participants|14|||
125154554|NCT00766831|450188966|FG000|Overall Study|Other|28|||
125154555|NCT00788593|450188967|FG000|Placebo Run-in Phase|Adverse Event|2|||
125154556|NCT00788593|450188968|FG001|Placebo Run-in Phase|Adverse Event|0|||
125154557|NCT00788593|450188969|FG002|Placebo Run-in Phase|Adverse Event|0|||
125154558|NCT00788593|450188967|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
125154559|NCT00788593|450188968|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
125154560|NCT00788593|450188969|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
125154561|NCT00788593|450188967|FG000|Placebo Run-in Phase|Protocol Violation|2|||
125154562|NCT00788593|450188968|FG001|Placebo Run-in Phase|Protocol Violation|0|||
125154563|NCT00788593|450188969|FG002|Placebo Run-in Phase|Protocol Violation|0|||
125154564|NCT00788593|450188967|FG000|First Intervention Period|Adverse Event|0|||
125154565|NCT00788593|450188968|FG001|First Intervention Period|Adverse Event|1|||
125154566|NCT00788593|450188969|FG002|First Intervention Period|Adverse Event|0|||
125154567|NCT00788593|450188967|FG000|Second Intervention Period|Lost to Follow-up|0|||
125154568|NCT00788593|450188968|FG001|Second Intervention Period|Lost to Follow-up|1|||
125154569|NCT00788593|450188969|FG002|Second Intervention Period|Lost to Follow-up|0|||
125154570|NCT00788593|450188967|FG000|Second Intervention Period|Other|0|||
125154571|NCT00788593|450188968|FG001|Second Intervention Period|Other|0|||
125154572|NCT00788593|450188969|FG002|Second Intervention Period|Other|1|||
125154573|NCT04553913|450188976|FG000|Overall Study|patient's block resolved prior to PACU|1|||
125154574|NCT04553913|450188976|FG000|Overall Study|did not use the device properly|5|||
125154575|NCT00710749|450188977|FG000|First Intervention|Withdrawal by Subject|1|||
125154576|NCT00710749|450188978|FG001|First Intervention|Withdrawal by Subject|0|||
125154577|NCT01000610|450191479|FG000|Overall Study|Adverse Event|1|||
125154578|NCT01000610|450191479|FG000|Overall Study|Lost to Follow-up|4|||
125154579|NCT01000610|450191479|FG000|Overall Study|Treatment failure|1|||
125154580|NCT02631876|450191486|FG000|Overall Study|Death|96|||
125154581|NCT02631876|450191487|FG001|Overall Study|Death|50|||
125154582|NCT02631876|450191486|FG000|Overall Study|Investigator's discretion|1|||
125154583|NCT02631876|450191487|FG001|Overall Study|Investigator's discretion|0|||
125154584|NCT02631876|450191486|FG000|Overall Study|Lost to Follow-up|2|||
125154585|NCT02631876|450191487|FG001|Overall Study|Lost to Follow-up|0|||
125154586|NCT02631876|450191486|FG000|Overall Study|Withdrawal by Subject|16|||
125154587|NCT02631876|450191487|FG001|Overall Study|Withdrawal by Subject|9|||
125154588|NCT02631876|450191486|FG000|Overall Study|Other than specified|4|||
125154589|NCT02631876|450191487|FG001|Overall Study|Other than specified|4|||
125154590|NCT01592721|450191488|FG000|Long-term Follow-up|Death|1|||
125154591|NCT01408563|450191493|FG000|Overall Study|Ineligible after consent/ registration|2|||
125154592|NCT02516410|450191494|FG000|Overall Study|Adverse Event|0|||
125154593|NCT02516410|450191495|FG001|Overall Study|Adverse Event|1|||
125154594|NCT02516410|450191494|FG000|Overall Study|Withdrawal by Subject|0|||
125154595|NCT02516410|450191495|FG001|Overall Study|Withdrawal by Subject|1|||
125154596|NCT01432574|450191496|FG000|Overall Study|Moved|2|||
125154597|NCT01432574|450191496|FG000|Overall Study|Not interested|1|||
125154598|NCT02698865|450191505|FG000|Overall Study|Other|11|||
125154599|NCT02698865|450191506|FG001|Overall Study|Other|11|||
125154600|NCT02698865|450191505|FG000|Overall Study|Withdrawal by Subject|20|||
125154601|NCT02698865|450191506|FG001|Overall Study|Withdrawal by Subject|16|||
125154602|NCT02698865|450191505|FG000|Overall Study|Physician Decision|0|||
125154603|NCT02698865|450191506|FG001|Overall Study|Physician Decision|4|||
125154604|NCT02698865|450191505|FG000|Overall Study|Lost to Follow-up|4|||
125154605|NCT02698865|450191506|FG001|Overall Study|Lost to Follow-up|2|||
125154606|NCT03861481|450191507|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
125154607|NCT03861481|450191508|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
125154608|NCT03861481|450191507|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
125154609|NCT03861481|450191508|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
125154610|NCT03861481|450191507|FG000|Overall Study|Relapse|1|||
125154611|NCT03861481|450191508|FG001|Overall Study|Relapse|0|||
125154612|NCT03861481|450191507|FG000|Overall Study|Withdrawal by Subject|0|||
125154613|NCT03861481|450191508|FG001|Overall Study|Withdrawal by Subject|1|||
125154614|NCT03861481|450191507|FG000|Overall Study|Lack of Efficacy|4|||
125154615|NCT03861481|450191508|FG001|Overall Study|Lack of Efficacy|5|||
125154616|NCT00773734|450191509|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
125154617|NCT00773734|450191510|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
125154618|NCT00773734|450191511|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
125154619|NCT00773734|450191512|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
125154620|NCT00773734|450191513|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
125154621|NCT00773734|450191514|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
125154622|NCT00773734|450191509|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
125154623|NCT00773734|450191510|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
125154624|NCT00773734|450191511|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
125154625|NCT00773734|450191512|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
125154626|NCT00773734|450191513|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
125154627|NCT00773734|450191514|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
125154628|NCT00773734|450191509|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
125154629|NCT00773734|450191510|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
125154630|NCT00773734|450191511|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
125154631|NCT00773734|450191512|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
125154632|NCT00773734|450191513|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
125154633|NCT00773734|450191514|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
125154634|NCT00773734|450191509|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
125154635|NCT00773734|450191510|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
125154636|NCT00773734|450191511|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
125154637|NCT00773734|450191512|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
125154638|NCT00773734|450191513|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
125154639|NCT00773734|450191514|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
125154640|NCT00773734|450191509|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
125154641|NCT00773734|450191510|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
125154642|NCT00773734|450191511|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
125154643|NCT00773734|450191512|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
125154644|NCT00773734|450191513|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
125154645|NCT00773734|450191514|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
125154646|NCT00773734|450191509|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
125154647|NCT00773734|450191510|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
125154648|NCT00773734|450191511|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
125154649|NCT00773734|450191512|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
125154650|NCT00773734|450191513|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
125154651|NCT00773734|450191514|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
125154652|NCT00773734|450191509|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
125154653|NCT00773734|450191510|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
125154654|NCT00773734|450191511|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
125154655|NCT00773734|450191512|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
125154656|NCT00773734|450191513|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
125154657|NCT00773734|450191514|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
125154658|NCT00773734|450191509|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
125154659|NCT00773734|450191510|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
125154660|NCT00773734|450191511|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
125154661|NCT00773734|450191512|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
125154662|NCT00773734|450191513|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
125154663|NCT00773734|450191514|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
125154664|NCT00773734|450191509|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
125154665|NCT00773734|450191510|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
125154666|NCT00773734|450191511|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
125154667|NCT00773734|450191512|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
125154668|NCT00773734|450191513|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
125154669|NCT00773734|450191514|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
125154670|NCT00773734|450191509|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
125154671|NCT00773734|450191510|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
125154672|NCT00773734|450191511|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
125154673|NCT00773734|450191512|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
125154674|NCT00773734|450191513|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
125154675|NCT00773734|450191514|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
125154676|NCT00773734|450191509|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
125154677|NCT00773734|450191510|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
125154678|NCT00773734|450191511|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
125154679|NCT00773734|450191512|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
125154680|NCT00773734|450191513|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
125154681|NCT00773734|450191514|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
125154682|NCT00773734|450191509|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
125154683|NCT00773734|450191510|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
125154684|NCT00773734|450191511|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
125154685|NCT00773734|450191512|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
125154686|NCT00773734|450191513|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
125154687|NCT00773734|450191514|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
125154688|NCT00773734|450191509|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
125154689|NCT00773734|450191510|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
125154690|NCT00773734|450191511|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
125154691|NCT00773734|450191512|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
125154692|NCT00773734|450191513|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
125154693|NCT00773734|450191514|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
125154694|NCT00773734|450191509|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
125154695|NCT00773734|450191510|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
125154696|NCT00773734|450191511|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
125154697|NCT00773734|450191512|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
125154698|NCT00773734|450191513|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
125154699|NCT00773734|450191514|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
125154700|NCT00773734|450191509|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
125154701|NCT00773734|450191510|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
125154702|NCT00773734|450191511|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
125154703|NCT00773734|450191512|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
125154704|NCT00773734|450191513|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
125154705|NCT00773734|450191514|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
125154706|NCT00773734|450191509|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
125154707|NCT00773734|450191510|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
125154708|NCT00773734|450191511|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
125154709|NCT00773734|450191512|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
125154710|NCT00773734|450191513|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
125223850|NCT00196105|450446249|FG000|Overall Study|Lost to Follow-up|4|||
125154711|NCT00773734|450191514|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
125154712|NCT00773734|450191509|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
125154713|NCT00773734|450191510|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
125154714|NCT00773734|450191511|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
125154715|NCT00773734|450191512|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
125154716|NCT00773734|450191513|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
125154717|NCT00773734|450191514|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
125154718|NCT00773734|450191509|FG000|Extension: Active Treatment Week 24-52|Other|0|||
125154719|NCT00773734|450191510|FG001|Extension: Active Treatment Week 24-52|Other|0|||
125154720|NCT00773734|450191511|FG002|Extension: Active Treatment Week 24-52|Other|1|||
125154721|NCT00773734|450191512|FG003|Extension: Active Treatment Week 24-52|Other|2|||
125154722|NCT00773734|450191513|FG004|Extension: Active Treatment Week 24-52|Other|0|||
125154723|NCT00773734|450191514|FG005|Extension: Active Treatment Week 24-52|Other|1|||
125154724|NCT00773734|450191509|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
125154725|NCT00773734|450191510|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
125154726|NCT00773734|450191511|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
125154727|NCT00773734|450191512|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
125154728|NCT00773734|450191513|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
125154729|NCT00773734|450191514|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
125154730|NCT00773734|450191509|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
125154731|NCT00773734|450191510|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
125154732|NCT00773734|450191511|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
125154733|NCT00773734|450191512|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
125154734|NCT00773734|450191513|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
125154735|NCT00773734|450191514|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
125154736|NCT00773734|450191509|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
125154737|NCT00773734|450191510|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
125154738|NCT00773734|450191511|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
125154739|NCT00773734|450191512|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
125154740|NCT00773734|450191513|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
125154741|NCT00773734|450191514|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
125154742|NCT00773734|450191509|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
125154743|NCT00773734|450191510|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
125154744|NCT00773734|450191511|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
125154745|NCT00773734|450191512|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
125154746|NCT00773734|450191513|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
125154747|NCT00773734|450191514|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
125154748|NCT01220297|450191517|FG000|Overall Study|Death|2|||
125154749|NCT01220297|450191517|FG000|Overall Study|Lost to Follow-up|1|||
125154750|NCT01287039|450191518|FG000|Overall Study|Noncompliance with study procedures|0|||
125154751|NCT01287039|450191519|FG001|Overall Study|Noncompliance with study procedures|1|||
125154752|NCT01287039|450191518|FG000|Overall Study|Change of location/residence|0|||
125154753|NCT01287039|450191519|FG001|Overall Study|Change of location/residence|3|||
125154754|NCT01287039|450191518|FG000|Overall Study|Elective surgery|0|||
125154755|NCT01287039|450191519|FG001|Overall Study|Elective surgery|1|||
125154756|NCT01287039|450191518|FG000|Overall Study|Protocol Violation|2|||
125154757|NCT01287039|450191519|FG001|Overall Study|Protocol Violation|3|||
125154758|NCT01287039|450191518|FG000|Overall Study|Excluded medication taken|1|||
125154759|NCT01287039|450191519|FG001|Overall Study|Excluded medication taken|0|||
125154760|NCT01287039|450191518|FG000|Overall Study|Noncompliance with study medication|0|||
125154761|NCT01287039|450191519|FG001|Overall Study|Noncompliance with study medication|1|||
125154762|NCT01287039|450191518|FG000|Overall Study|Problem with travel|0|||
125154763|NCT01287039|450191519|FG001|Overall Study|Problem with travel|1|||
125154764|NCT01287039|450191518|FG000|Overall Study|Death|1|||
125154765|NCT01287039|450191519|FG001|Overall Study|Death|0|||
125154766|NCT01287039|450191518|FG000|Overall Study|Change of residence|1|||
125154767|NCT01287039|450191519|FG001|Overall Study|Change of residence|0|||
125154768|NCT01287039|450191518|FG000|Overall Study|Adverse Event|7|||
125154769|NCT01287039|450191519|FG001|Overall Study|Adverse Event|4|||
125154770|NCT01287039|450191518|FG000|Overall Study|Withdrawal by Subject|14|||
125154771|NCT01287039|450191519|FG001|Overall Study|Withdrawal by Subject|11|||
125154772|NCT01287039|450191518|FG000|Overall Study|Lost to Follow-up|3|||
125154773|NCT01287039|450191519|FG001|Overall Study|Lost to Follow-up|2|||
125154774|NCT00099268|450191520|FG000|Overall Study|Withdrawal by Subject|46|||
125154775|NCT00099268|450191521|FG001|Overall Study|Withdrawal by Subject|28|||
125154776|NCT00099268|450191520|FG000|Overall Study|Adverse Event|19|||
125154777|NCT00099268|450191521|FG001|Overall Study|Adverse Event|19|||
125154778|NCT00099268|450191520|FG000|Overall Study|Protocol Violation|9|||
125154779|NCT00099268|450191521|FG001|Overall Study|Protocol Violation|8|||
125154780|NCT00099268|450191520|FG000|Overall Study|Lost to Follow-up|6|||
125154781|NCT00099268|450191521|FG001|Overall Study|Lost to Follow-up|4|||
125154782|NCT00099268|450191520|FG000|Overall Study|Lack of Efficacy|5|||
125154783|NCT00099268|450191521|FG001|Overall Study|Lack of Efficacy|18|||
125154784|NCT00099268|450191520|FG000|Overall Study|Administrative problems|4|||
125154785|NCT00099268|450191521|FG001|Overall Study|Administrative problems|4|||
125154786|NCT00099268|450191520|FG000|Overall Study|Death|3|||
125154787|NCT00099268|450191521|FG001|Overall Study|Death|1|||
125154788|NCT05016622|450191522|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
125154789|NCT05016622|450191522|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
125154790|NCT02581163|450191524|FG000|Overall Study|Failure to return|15|||
125154791|NCT02581163|450191524|FG000|Overall Study|Insufficient virological response|3|||
125154792|NCT02581163|450191524|FG000|Overall Study|Withdrew consent|1|||
125154793|NCT02581163|450191524|FG000|Overall Study|Death|1|||
125154794|NCT02581163|450191524|FG000|Overall Study|Other, not specified|9|||
125154795|NCT03438396|450191525|FG000|Overall Study|Reason Not Specified|9|||
125154796|NCT03438396|450191525|FG000|Overall Study|Withdrawal by Subject|5|||
125154797|NCT03438396|450191525|FG000|Overall Study|Lost to Follow-up|2|||
125154798|NCT03438396|450191525|FG000|Overall Study|Death|85|||
125154799|NCT03438396|450191525|FG000|Overall Study|Not treated|1|||
125154800|NCT02006628|450191526|FG000|Overall Study|Adverse Event|1|||
125154801|NCT02006628|450191527|FG001|Overall Study|Adverse Event|1|||
125154802|NCT02006628|450191526|FG000|Overall Study|Withdrawal by Subject|2|||
125154803|NCT02006628|450191527|FG001|Overall Study|Withdrawal by Subject|1|||
125154804|NCT01421342|450191528|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
125154805|NCT01421342|450191529|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
125154806|NCT01421342|450191530|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
125154807|NCT01421342|450191528|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
125154808|NCT01421342|450191529|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
125154809|NCT01421342|450191530|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
125154810|NCT01421342|450191528|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
125154811|NCT01421342|450191529|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
125154812|NCT01421342|450191530|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
125154813|NCT01421342|450191528|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
125154814|NCT01421342|450191529|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
125154815|NCT01421342|450191530|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
125154816|NCT01421342|450191528|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
125154817|NCT01421342|450191529|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
125154818|NCT01421342|450191530|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
125154819|NCT01421342|450191528|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
125154820|NCT01421342|450191529|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
125154821|NCT01421342|450191530|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
125154822|NCT01421342|450191528|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
125154823|NCT01421342|450191529|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
125154824|NCT01421342|450191530|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
125154825|NCT01421342|450191528|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
125154826|NCT01421342|450191529|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
125154827|NCT01421342|450191530|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
125154828|NCT01421342|450191528|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
125154829|NCT01421342|450191529|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
125154830|NCT01421342|450191530|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
125154831|NCT01421342|450191528|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
125154832|NCT01421342|450191529|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
125154833|NCT01421342|450191530|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
125154834|NCT01421342|450191528|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
125154835|NCT01421342|450191529|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
125154836|NCT01421342|450191530|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
125154837|NCT01421342|450191528|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
125154838|NCT01421342|450191529|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
125154839|NCT01421342|450191530|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
125154840|NCT01421342|450191528|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
125154841|NCT01421342|450191529|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
125154842|NCT01421342|450191530|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
125154843|NCT01421342|450191528|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
125154844|NCT01421342|450191529|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
125154845|NCT01421342|450191530|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
125154846|NCT01421342|450191528|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
125154847|NCT01421342|450191529|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
125154848|NCT01421342|450191530|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
125154849|NCT01421342|450191528|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
125154850|NCT01421342|450191529|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
125223851|NCT00196105|450446250|FG001|Overall Study|Lost to Follow-up|5|||
125223852|NCT00196105|450446251|FG002|Overall Study|Lost to Follow-up|7|||
125223853|NCT04863872|450446252|FG000|Overall Study|Withdrawal by Subject|4|||
125223854|NCT04863872|450446253|FG001|Overall Study|Withdrawal by Subject|15|||
125223855|NCT04863872|450446252|FG000|Overall Study|Death|5|||
125154851|NCT01421342|450191530|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
125154852|NCT01421342|450191528|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
125154853|NCT01421342|450191529|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
125154854|NCT01421342|450191530|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
125154855|NCT01421342|450191528|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
125154856|NCT01421342|450191529|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
125154857|NCT01421342|450191530|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
125154858|NCT01421342|450191528|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
125154859|NCT01421342|450191529|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
125154860|NCT01421342|450191530|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
125154861|NCT01421342|450191528|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
125154862|NCT01421342|450191529|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
125154863|NCT01421342|450191530|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
125154864|NCT01421342|450191528|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
125154865|NCT01421342|450191529|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
125154866|NCT01421342|450191530|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
125154867|NCT01421342|450191528|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
125154868|NCT01421342|450191529|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
125154869|NCT01421342|450191530|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
125154870|NCT01421342|450191528|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
125154871|NCT01421342|450191529|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
125154872|NCT01421342|450191530|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
125154873|NCT01421342|450191528|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
125154874|NCT01421342|450191529|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
125154875|NCT01421342|450191530|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
125154876|NCT01421342|450191528|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
125154877|NCT01421342|450191529|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
125154878|NCT01421342|450191530|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
125154879|NCT01421342|450191528|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
125154880|NCT01421342|450191529|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
125154881|NCT01421342|450191530|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
125154882|NCT01421342|450191528|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
125154883|NCT01421342|450191529|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
125154884|NCT01421342|450191530|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
125154885|NCT01421342|450191528|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
125154886|NCT01421342|450191529|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
125154887|NCT01421342|450191530|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
125154888|NCT03578237|450191531|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
125154889|NCT03578237|450191532|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
125154890|NCT02488330|450191533|FG000|Overall Study|Adverse Event|1|||
125154891|NCT02488330|450191533|FG000|Overall Study|Physician Decision|2|||
125154892|NCT02488330|450191533|FG000|Overall Study|Death|2|||
125154893|NCT02488330|450191533|FG000|Overall Study|Disease Progression|3|||
125154894|NCT02488330|450191533|FG000|Overall Study|Study Termination by Sponsor|4|||
125154895|NCT01206816|450191535|FG000|Overall Study|Protocol Violation|0|||
125154896|NCT01206816|450191536|FG001|Overall Study|Protocol Violation|0|||
125154897|NCT01206816|450191537|FG002|Overall Study|Protocol Violation|1|||
125154898|NCT01206816|450191538|FG003|Overall Study|Protocol Violation|0|||
125154899|NCT01206816|450191539|FG004|Overall Study|Protocol Violation|0|||
125154900|NCT01206816|450191540|FG005|Overall Study|Protocol Violation|0|||
125154901|NCT01206816|450191541|FG006|Overall Study|Protocol Violation|0|||
125154902|NCT01206816|450191535|FG000|Overall Study|Withdrawal by Subject|0|||
125154903|NCT01206816|450191536|FG001|Overall Study|Withdrawal by Subject|0|||
125154904|NCT01206816|450191537|FG002|Overall Study|Withdrawal by Subject|1|||
125154905|NCT01206816|450191538|FG003|Overall Study|Withdrawal by Subject|0|||
125154906|NCT01206816|450191539|FG004|Overall Study|Withdrawal by Subject|0|||
125154907|NCT01206816|450191540|FG005|Overall Study|Withdrawal by Subject|0|||
125154908|NCT01206816|450191541|FG006|Overall Study|Withdrawal by Subject|0|||
125154909|NCT01206816|450191535|FG000|Overall Study|Progressive disease|3|||
125154910|NCT01206816|450191536|FG001|Overall Study|Progressive disease|3|||
125154911|NCT01206816|450191537|FG002|Overall Study|Progressive disease|13|||
125154912|NCT01206816|450191538|FG003|Overall Study|Progressive disease|3|||
125154913|NCT01206816|450191539|FG004|Overall Study|Progressive disease|3|||
125154914|NCT01206816|450191540|FG005|Overall Study|Progressive disease|16|||
125154915|NCT01206816|450191541|FG006|Overall Study|Progressive disease|3|||
125154916|NCT01206816|450191535|FG000|Overall Study|Other AE|0|||
125154917|NCT01206816|450191536|FG001|Overall Study|Other AE|0|||
125154918|NCT01206816|450191537|FG002|Overall Study|Other AE|4|||
125154919|NCT01206816|450191538|FG003|Overall Study|Other AE|0|||
125154920|NCT01206816|450191539|FG004|Overall Study|Other AE|0|||
125154921|NCT01206816|450191540|FG005|Overall Study|Other AE|3|||
125154922|NCT01206816|450191541|FG006|Overall Study|Other AE|2|||
125154923|NCT01206816|450191535|FG000|Overall Study|other than stated above|0|||
125154924|NCT01206816|450191536|FG001|Overall Study|other than stated above|0|||
125154925|NCT01206816|450191537|FG002|Overall Study|other than stated above|1|||
125154926|NCT01206816|450191538|FG003|Overall Study|other than stated above|0|||
125154927|NCT01206816|450191539|FG004|Overall Study|other than stated above|0|||
125154928|NCT01206816|450191540|FG005|Overall Study|other than stated above|0|||
125154929|NCT01206816|450191541|FG006|Overall Study|other than stated above|1|||
125154930|NCT02493777|450191544|FG000|Overall Study|Lost to Follow-up|0|||
125154931|NCT02493777|450191545|FG001|Overall Study|Lost to Follow-up|1|||
125154932|NCT01642914|450191546|FG000|Overall Study|Adverse Event|11|||
125154933|NCT01642914|450191547|FG001|Overall Study|Adverse Event|7|||
125154934|NCT01642914|450191548|FG002|Overall Study|Adverse Event|15|||
125154935|NCT01642914|450191546|FG000|Overall Study|Lack of Efficacy|9|||
125154936|NCT01642914|450191547|FG001|Overall Study|Lack of Efficacy|4|||
125154937|NCT01642914|450191548|FG002|Overall Study|Lack of Efficacy|2|||
125154938|NCT01642914|450191546|FG000|Overall Study|Protocol Violation|15|||
125154939|NCT01642914|450191547|FG001|Overall Study|Protocol Violation|13|||
125154940|NCT01642914|450191548|FG002|Overall Study|Protocol Violation|6|||
125154941|NCT01642914|450191546|FG000|Overall Study|Withdrawal by Subject|5|||
125154942|NCT01642914|450191547|FG001|Overall Study|Withdrawal by Subject|5|||
125154943|NCT01642914|450191548|FG002|Overall Study|Withdrawal by Subject|10|||
125154944|NCT01642914|450191546|FG000|Overall Study|Lost to Follow-up|5|||
125154945|NCT01642914|450191547|FG001|Overall Study|Lost to Follow-up|3|||
125154946|NCT01642914|450191548|FG002|Overall Study|Lost to Follow-up|7|||
125154947|NCT01642914|450191546|FG000|Overall Study|Other Reason|1|||
125154948|NCT01642914|450191547|FG001|Overall Study|Other Reason|0|||
125154949|NCT01642914|450191548|FG002|Overall Study|Other Reason|0|||
125154950|NCT01705236|450191549|FG000|Overall Study|Lost to Follow-up|1|||
125154951|NCT01705236|450191549|FG000|Overall Study|Administrative problems|2|||
125154952|NCT01705236|450191549|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
125154953|NCT01705236|450191549|FG000|Overall Study|Protocol Violation|3|||
125154954|NCT01705236|450191549|FG000|Overall Study|Abnormal test procedure result(s)|4|||
125154955|NCT01705236|450191549|FG000|Overall Study|Abnormal laboratory value(s)|4|||
125154956|NCT01705236|450191549|FG000|Overall Study|Withdrawal by Subject|5|||
125154957|NCT01705236|450191549|FG000|Overall Study|Adverse Event|5|||
125154958|NCT00171301|450191550|FG000|Overall Study|Death|1|||
125154959|NCT00171301|450191551|FG001|Overall Study|Death|2|||
125154960|NCT00171301|450191550|FG000|Overall Study|Adverse Event|1|||
125154961|NCT00171301|450191551|FG001|Overall Study|Adverse Event|2|||
125154962|NCT00171301|450191550|FG000|Overall Study|Lost to Follow-up|6|||
125154963|NCT00171301|450191551|FG001|Overall Study|Lost to Follow-up|2|||
125154964|NCT00171301|450191550|FG000|Overall Study|Protocol Violation|0|||
125154965|NCT00171301|450191551|FG001|Overall Study|Protocol Violation|2|||
125154966|NCT00171301|450191550|FG000|Overall Study|Withdrawal by Subject|0|||
125154967|NCT00171301|450191551|FG001|Overall Study|Withdrawal by Subject|1|||
125154968|NCT04319159|450191552|FG000|Overall Study|Screening failure|13|||
125154969|NCT04319159|450191552|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
125154970|NCT04319159|450191552|FG000|Overall Study|Withdrawal by Subject|1|||
125154971|NCT02100319|450191553|FG000|Overall Study|Case Report Forms Uncollected|11|||
125154972|NCT02100319|450191553|FG000|Overall Study|Protocol Deviation|5|||
125154973|NCT02370914|450191554|FG000|Overall Study|Protocol Violation|2|||
125154974|NCT00754442|450191555|FG000|Overall Study|Withdrawal by Subject|5|||
125154975|NCT00754442|450191556|FG001|Overall Study|Withdrawal by Subject|3|||
125154976|NCT00296491|450191557|FG000|Overall Study|Low Pollen Counts|18|||
125154977|NCT00296491|450191558|FG001|Overall Study|Low Pollen Counts|26|||
125154978|NCT00296491|450191559|FG002|Overall Study|Low Pollen Counts|25|||
125154979|NCT00296491|450191560|FG003|Overall Study|Low Pollen Counts|16|||
125154980|NCT00296491|450191557|FG000|Overall Study|Protocol Violation|4|||
125154981|NCT00296491|450191558|FG001|Overall Study|Protocol Violation|6|||
125154982|NCT00296491|450191559|FG002|Overall Study|Protocol Violation|2|||
125154983|NCT00296491|450191560|FG003|Overall Study|Protocol Violation|3|||
125154984|NCT00296491|450191557|FG000|Overall Study|Adverse Event|1|||
125154985|NCT00296491|450191558|FG001|Overall Study|Adverse Event|3|||
125154986|NCT00296491|450191559|FG002|Overall Study|Adverse Event|1|||
125154987|NCT00296491|450191560|FG003|Overall Study|Adverse Event|4|||
125154988|NCT00296491|450191557|FG000|Overall Study|Withdrawn due to Asthma|0|||
125154989|NCT00296491|450191558|FG001|Overall Study|Withdrawn due to Asthma|0|||
125154990|NCT00296491|450191559|FG002|Overall Study|Withdrawn due to Asthma|0|||
125154991|NCT00296491|450191560|FG003|Overall Study|Withdrawn due to Asthma|4|||
125154992|NCT00296491|450191557|FG000|Overall Study|Withdrawal by Subject|7|||
125154993|NCT00296491|450191558|FG001|Overall Study|Withdrawal by Subject|3|||
125154994|NCT00296491|450191559|FG002|Overall Study|Withdrawal by Subject|3|||
125154995|NCT00296491|450191560|FG003|Overall Study|Withdrawal by Subject|2|||
125154996|NCT00296491|450191557|FG000|Overall Study|Non-Compliance|12|||
125154997|NCT00296491|450191558|FG001|Overall Study|Non-Compliance|13|||
125154998|NCT00296491|450191559|FG002|Overall Study|Non-Compliance|10|||
125154999|NCT00296491|450191560|FG003|Overall Study|Non-Compliance|14|||
125155000|NCT00296491|450191557|FG000|Overall Study|Lost to Follow-up|0|||
125155001|NCT00296491|450191558|FG001|Overall Study|Lost to Follow-up|2|||
125155002|NCT00296491|450191559|FG002|Overall Study|Lost to Follow-up|2|||
125155003|NCT00296491|450191560|FG003|Overall Study|Lost to Follow-up|0|||
125155004|NCT01300052|450191561|FG000|Overall Study|Adverse Event|3|||
125155005|NCT01300052|450191562|FG001|Overall Study|Adverse Event|0|||
125155006|NCT01300052|450191561|FG000|Overall Study|Withdrawal by Subject|2|||
125155007|NCT01300052|450191562|FG001|Overall Study|Withdrawal by Subject|2|||
125155008|NCT01300052|450191561|FG000|Overall Study|Protocol Violation|1|||
125155009|NCT01300052|450191562|FG001|Overall Study|Protocol Violation|1|||
125155010|NCT01231373|450191563|FG000|Overall Study|Withdrew consent prior to randomization|2|||
125155011|NCT01231373|450191564|FG001|Overall Study|Withdrew consent prior to randomization|1|||
125155012|NCT01231373|450191565|FG002|Overall Study|Withdrew consent prior to randomization|0|||
125155013|NCT01231373|450191566|FG003|Overall Study|Withdrew consent prior to randomization|0|||
125155014|NCT01231373|450191563|FG000|Overall Study|Lost to Follow-up|0|||
125155015|NCT01231373|450191564|FG001|Overall Study|Lost to Follow-up|0|||
125155016|NCT01231373|450191565|FG002|Overall Study|Lost to Follow-up|0|||
125155017|NCT01231373|450191566|FG003|Overall Study|Lost to Follow-up|1|||
125155018|NCT01231373|450191563|FG000|Overall Study|Withdrew Consent|1|||
125155019|NCT01231373|450191564|FG001|Overall Study|Withdrew Consent|0|||
125155020|NCT01231373|450191565|FG002|Overall Study|Withdrew Consent|0|||
125155021|NCT01231373|450191566|FG003|Overall Study|Withdrew Consent|0|||
125155022|NCT03451006|450191567|FG000|Overall Study|Withdrawal by Subject|2|||
125155023|NCT03451006|450191568|FG001|Overall Study|Withdrawal by Subject|2|||
125155024|NCT02547766|450191569|FG000|Overall Study|Withdrawal by Subject|1|||
125155025|NCT01929395|450191570|FG000|Overall Study|Did not complete - non-related toxicity|1|||
125155026|NCT01929395|450191571|FG001|Overall Study|Did not complete - non-related toxicity|0|||
125155027|NCT01929395|450191572|FG002|Overall Study|Did not complete - non-related toxicity|0|||
125155028|NCT01929395|450191570|FG000|Overall Study|Withdrawal by Subject|0|||
125155029|NCT01929395|450191571|FG001|Overall Study|Withdrawal by Subject|1|||
125155030|NCT01929395|450191572|FG002|Overall Study|Withdrawal by Subject|0|||
125155031|NCT01929395|450191570|FG000|Overall Study|Screen Fail|0|||
125155032|NCT01929395|450191571|FG001|Overall Study|Screen Fail|0|||
125155033|NCT01929395|450191572|FG002|Overall Study|Screen Fail|1|||
125155034|NCT03604341|450191573|FG000|Overall Study|Withdrawal by Subject|1|||
125155035|NCT03604341|450191574|FG001|Overall Study|Withdrawal by Subject|1|||
125155036|NCT03604341|450191573|FG000|Overall Study|Adverse Event|1|||
125155037|NCT03604341|450191574|FG001|Overall Study|Adverse Event|0|||
125155038|NCT03604341|450191573|FG000|Overall Study|Protocol Violation|0|||
125155039|NCT03604341|450191574|FG001|Overall Study|Protocol Violation|1|||
125155040|NCT00897949|450191578|FG000|Overall Study|Adverse Event|1|||
125155041|NCT00897949|450191579|FG001|Overall Study|Adverse Event|1|||
125155042|NCT00897949|450191580|FG002|Overall Study|Adverse Event|0|||
125155043|NCT00897949|450191578|FG000|Overall Study|Lost to Follow-up|0|||
125155044|NCT00897949|450191579|FG001|Overall Study|Lost to Follow-up|2|||
125155045|NCT00897949|450191580|FG002|Overall Study|Lost to Follow-up|1|||
125155046|NCT00897949|450191578|FG000|Overall Study|Protocol Violation|6|||
125155047|NCT00897949|450191579|FG001|Overall Study|Protocol Violation|3|||
125155048|NCT00897949|450191580|FG002|Overall Study|Protocol Violation|1|||
125155049|NCT00897949|450191578|FG000|Overall Study|Withdrawal by Subject|1|||
125155050|NCT00897949|450191579|FG001|Overall Study|Withdrawal by Subject|2|||
125155051|NCT00897949|450191580|FG002|Overall Study|Withdrawal by Subject|0|||
125155052|NCT00897949|450191578|FG000|Overall Study|Patient Uncoorperative|0|||
125155053|NCT00897949|450191579|FG001|Overall Study|Patient Uncoorperative|2|||
125155054|NCT00897949|450191580|FG002|Overall Study|Patient Uncoorperative|1|||
125155055|NCT00897949|450191578|FG000|Overall Study|Lost to Follow-up|30|||
125155056|NCT00897949|450191579|FG001|Overall Study|Lost to Follow-up|23|||
125155057|NCT00897949|450191580|FG002|Overall Study|Lost to Follow-up|17|||
125155058|NCT00897949|450191578|FG000|Overall Study|Withdrawal by Subject|24|||
125155059|NCT00897949|450191579|FG001|Overall Study|Withdrawal by Subject|31|||
125155060|NCT00897949|450191580|FG002|Overall Study|Withdrawal by Subject|17|||
125155061|NCT00897949|450191578|FG000|Overall Study|Abnormal Prestudy Labs|2|||
125155062|NCT00897949|450191579|FG001|Overall Study|Abnormal Prestudy Labs|3|||
125155063|NCT00897949|450191580|FG002|Overall Study|Abnormal Prestudy Labs|4|||
125155064|NCT00897949|450191578|FG000|Overall Study|Abnormal Baseline ECG|2|||
125155065|NCT00897949|450191579|FG001|Overall Study|Abnormal Baseline ECG|2|||
125155066|NCT00897949|450191580|FG002|Overall Study|Abnormal Baseline ECG|4|||
125155067|NCT00897949|450191578|FG000|Overall Study|Need for Concom. Med.|0|||
125155068|NCT00897949|450191579|FG001|Overall Study|Need for Concom. Med.|1|||
125155069|NCT00897949|450191580|FG002|Overall Study|Need for Concom. Med.|1|||
125155070|NCT00897949|450191578|FG000|Overall Study|Lack of Migraine Attack|29|||
125155071|NCT00897949|450191579|FG001|Overall Study|Lack of Migraine Attack|30|||
125155072|NCT00897949|450191580|FG002|Overall Study|Lack of Migraine Attack|19|||
125155073|NCT00897949|450191578|FG000|Overall Study|Did not take study drug|9|||
125155074|NCT00897949|450191579|FG001|Overall Study|Did not take study drug|3|||
125155075|NCT00897949|450191580|FG002|Overall Study|Did not take study drug|4|||
125155076|NCT01553747|450191581|FG000|Overall Study|Protocol Violation|0|||
125155077|NCT01553747|450191582|FG001|Overall Study|Protocol Violation|2|||
125155078|NCT01553747|450191583|FG002|Overall Study|Protocol Violation|0|||
125155079|NCT01553747|450191581|FG000|Overall Study|Voluntarily withdrew|70|||
125155080|NCT01553747|450191582|FG001|Overall Study|Voluntarily withdrew|66|||
125155081|NCT01553747|450191583|FG002|Overall Study|Voluntarily withdrew|74|||
125155082|NCT01553747|450191581|FG000|Overall Study|Adverse event or SAE|32|||
125155083|NCT01553747|450191582|FG001|Overall Study|Adverse event or SAE|28|||
125155084|NCT01553747|450191583|FG002|Overall Study|Adverse event or SAE|19|||
125155085|NCT01553747|450191581|FG000|Overall Study|Physician decision: other|10|||
125155086|NCT01553747|450191582|FG001|Overall Study|Physician decision: other|8|||
125155087|NCT01553747|450191583|FG002|Overall Study|Physician decision: other|7|||
125155088|NCT01553747|450191581|FG000|Overall Study|Lost to Follow-up|11|||
125155089|NCT01553747|450191582|FG001|Overall Study|Lost to Follow-up|5|||
125155090|NCT01553747|450191583|FG002|Overall Study|Lost to Follow-up|6|||
125155091|NCT01553747|450191581|FG000|Overall Study|Sponsor decision, specify|7|||
125155092|NCT01553747|450191582|FG001|Overall Study|Sponsor decision, specify|5|||
125155093|NCT01553747|450191583|FG002|Overall Study|Sponsor decision, specify|0|||
125155094|NCT01553747|450191581|FG000|Overall Study|Physician decision: lack of efficacy|1|||
125155095|NCT01553747|450191582|FG001|Overall Study|Physician decision: lack of efficacy|5|||
125155096|NCT01553747|450191583|FG002|Overall Study|Physician decision: lack of efficacy|3|||
125155097|NCT01134627|450191584|FG000|Overall Study|Adverse Event|47|||
125155098|NCT01134627|450191585|FG001|Overall Study|Adverse Event|31|||
125155099|NCT01134627|450191584|FG000|Overall Study|Lost to Follow-up|1|||
125155100|NCT01134627|450191585|FG001|Overall Study|Lost to Follow-up|2|||
125155101|NCT01134627|450191584|FG000|Overall Study|Protocol Violation|3|||
125155102|NCT01134627|450191585|FG001|Overall Study|Protocol Violation|5|||
125155103|NCT01134627|450191584|FG000|Overall Study|Lack of Efficacy|2|||
125155104|NCT01134627|450191585|FG001|Overall Study|Lack of Efficacy|12|||
125155105|NCT01134627|450191584|FG000|Overall Study|Withdrawal by Subject|4|||
125155106|NCT01134627|450191585|FG001|Overall Study|Withdrawal by Subject|3|||
125155107|NCT01134627|450191584|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
125155108|NCT01134627|450191585|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
125155109|NCT01134627|450191584|FG000|Overall Study|Other|11|||
125155110|NCT01134627|450191585|FG001|Overall Study|Other|14|||
125155111|NCT00351351|450191586|FG000|Overall Study|surgical access pbs; device issues|9|||
125155112|NCT00351351|450191587|FG001|Overall Study|surgical access pbs; device issues|4|||
125155113|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
125155114|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
125155115|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
125155116|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
125155117|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
125155118|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
125155119|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
125155120|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
125155121|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
125155122|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
125155123|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
125155124|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
125155125|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
125155126|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
125155127|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
125155128|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
125155129|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
125155130|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
125155131|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
125155132|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
125155133|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
125155134|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
125155135|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
125155136|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
125155137|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
125155138|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
125155139|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
125155140|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
125155141|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Death|0|||
125155142|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Death|1|||
125155143|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Death|0|||
125155144|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Death|0|||
125155145|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
125155146|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
125155147|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
125155148|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
125155149|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
125155150|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
125155151|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
125155152|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
125155153|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Other|1|||
125155154|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Other|3|||
125155155|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Other|0|||
125155156|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Other|0|||
125155157|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
125155158|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
125155159|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
125155160|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
125155161|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Death|1|||
125155162|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Death|0|||
125155163|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Death|0|||
125155164|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Death|0|||
125155165|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
125155166|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
125155167|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
125155168|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
125155169|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
125155170|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
125155171|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
125155172|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
125155173|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
125155174|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
125155175|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
125155176|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
125155177|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
125155178|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
125155179|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
125155180|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
125155181|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
125155182|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
125155183|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
125155184|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
125155185|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
125155186|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
125155187|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
125155188|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
125155189|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
125155190|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
125155191|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
125155192|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
125155193|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
125155194|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
125155195|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
125155196|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
125155197|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
125155198|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
125155199|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
125155200|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
125155201|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Other|3|||
125155202|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Other|0|||
125155203|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Other|4|||
125155204|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Other|1|||
125155205|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
125155206|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
125155207|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
125155208|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
125155209|NCT02990806|450191591|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
125155210|NCT02990806|450191592|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
125155211|NCT02990806|450191593|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
125155212|NCT02990806|450191594|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
125155213|NCT02990806|450191591|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
125155214|NCT02990806|450191592|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
125155215|NCT02990806|450191593|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
125155216|NCT02990806|450191594|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
125155217|NCT02990806|450191591|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
125155218|NCT02990806|450191592|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
125155219|NCT02990806|450191593|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
125155220|NCT02990806|450191594|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
125155221|NCT02990806|450191591|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
125155222|NCT02990806|450191592|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
125155223|NCT02990806|450191593|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
125155224|NCT02990806|450191594|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
125155225|NCT02990806|450191591|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
125155226|NCT02990806|450191592|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
125155227|NCT02990806|450191593|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
125155228|NCT02990806|450191594|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
125155229|NCT02990806|450191591|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
125155230|NCT02990806|450191592|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
125155231|NCT02990806|450191593|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
125155232|NCT02990806|450191594|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
125155233|NCT02990806|450191591|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
125155234|NCT02990806|450191592|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
125155235|NCT02990806|450191593|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
125155236|NCT02990806|450191594|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
125155237|NCT02990806|450191591|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
125155238|NCT02990806|450191592|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
125155239|NCT02990806|450191593|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
125155240|NCT02990806|450191594|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
125155241|NCT02903238|450191595|FG000|Overall Study|Lost to Follow-up|4|||
125155242|NCT00700817|450191596|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
125155243|NCT00700817|450191597|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
125155244|NCT00700817|450191598|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
125155245|NCT00700817|450191599|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
125155246|NCT00700817|450191600|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
125155247|NCT00700817|450191596|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
125155248|NCT00700817|450191597|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
125155249|NCT00700817|450191598|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
125155250|NCT00700817|450191599|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
125155251|NCT00700817|450191600|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
125155252|NCT00700817|450191596|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
125155253|NCT00700817|450191597|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
125155254|NCT00700817|450191598|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
125155255|NCT00700817|450191599|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
125155256|NCT00700817|450191600|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
125155257|NCT00700817|450191596|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
125155258|NCT00700817|450191597|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
125155259|NCT00700817|450191598|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
125155260|NCT00700817|450191599|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
125155261|NCT00700817|450191600|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
125155262|NCT00700817|450191596|FG000|Week 0-26 (Main Period)|Unclassified|14|||
125155263|NCT00700817|450191597|FG001|Week 0-26 (Main Period)|Unclassified|4|||
125155264|NCT00700817|450191598|FG002|Week 0-26 (Main Period)|Unclassified|8|||
125155265|NCT00700817|450191599|FG003|Week 0-26 (Main Period)|Unclassified|0|||
125155266|NCT00700817|450191600|FG004|Week 0-26 (Main Period)|Unclassified|0|||
125155267|NCT00700817|450191596|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
125155268|NCT00700817|450191597|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
125155269|NCT00700817|450191598|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
125155270|NCT00700817|450191599|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
125155271|NCT00700817|450191600|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
125155272|NCT00700817|450191596|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
125155273|NCT00700817|450191597|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
125155274|NCT00700817|450191598|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
125155275|NCT00700817|450191599|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
125155276|NCT00700817|450191600|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
125155277|NCT00700817|450191596|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
125155278|NCT00700817|450191597|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
125155279|NCT00700817|450191598|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
125155280|NCT00700817|450191599|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
125155281|NCT00700817|450191600|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
125155282|NCT00700817|450191596|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
125155283|NCT00700817|450191597|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
125155284|NCT00700817|450191598|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
125155285|NCT00700817|450191599|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
125155286|NCT00700817|450191600|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
125155287|NCT00700817|450191596|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
125155288|NCT00700817|450191597|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
125155289|NCT00700817|450191598|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
125155290|NCT00700817|450191599|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
125155291|NCT00700817|450191600|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
125155292|NCT00700817|450191596|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
125155293|NCT00700817|450191597|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
125155294|NCT00700817|450191598|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
125155295|NCT00700817|450191599|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
125155296|NCT00700817|450191600|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
125155297|NCT00700817|450191596|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
125155298|NCT00700817|450191597|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
125155299|NCT00700817|450191598|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
125155300|NCT00700817|450191599|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
125155301|NCT00700817|450191600|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
125155302|NCT00700817|450191596|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
125155303|NCT00700817|450191597|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
125155304|NCT00700817|450191598|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
125155305|NCT00700817|450191599|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
125155306|NCT00700817|450191600|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
125155307|NCT00700817|450191596|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
125155308|NCT00700817|450191597|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
125155309|NCT00700817|450191598|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
125155310|NCT00700817|450191599|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
125155311|NCT00700817|450191600|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
125155312|NCT00700817|450191596|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
125155313|NCT00700817|450191597|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
125155314|NCT00700817|450191598|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
125155315|NCT00700817|450191599|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
125155316|NCT00700817|450191600|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
125155317|NCT01338987|450191601|FG000|Overall Study|enrolled on new protocol|0|||
125155318|NCT01338987|450191602|FG001|Overall Study|enrolled on new protocol|0|||
125155319|NCT01338987|450191603|FG002|Overall Study|enrolled on new protocol|1|||
125155320|NCT01338987|450191604|FG003|Overall Study|enrolled on new protocol|0|||
125155321|NCT01338987|450191605|FG004|Overall Study|enrolled on new protocol|0|||
125155322|NCT01338987|450191601|FG000|Overall Study|Disease progression on study|2|||
125155323|NCT01338987|450191602|FG001|Overall Study|Disease progression on study|1|||
125155324|NCT01338987|450191603|FG002|Overall Study|Disease progression on study|1|||
125155325|NCT01338987|450191604|FG003|Overall Study|Disease progression on study|0|||
125155326|NCT01338987|450191605|FG004|Overall Study|Disease progression on study|0|||
125155327|NCT00606502|450191608|FG000|Randomization|Randomized but not treated|3|||
125155328|NCT00606502|450191609|FG001|Randomization|Randomized but not treated|0|||
125155329|NCT00606502|450191608|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
125155330|NCT00606502|450191609|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
125155331|NCT01470612|450191618|FG000|Overall Study|Adverse Event|20|||
125155332|NCT01470612|450191619|FG001|Overall Study|Adverse Event|80|||
125155333|NCT01470612|450191618|FG000|Overall Study|Death|0|||
125155334|NCT01470612|450191619|FG001|Overall Study|Death|1|||
125155335|NCT01470612|450191618|FG000|Overall Study|Lack of Efficacy|20|||
125155336|NCT01470612|450191619|FG001|Overall Study|Lack of Efficacy|326|||
125155337|NCT01470612|450191618|FG000|Overall Study|Lost to Follow-up|2|||
125155338|NCT01470612|450191619|FG001|Overall Study|Lost to Follow-up|5|||
125155339|NCT01470612|450191618|FG000|Overall Study|Did not meet entrance criteria|0|||
125155340|NCT01470612|450191619|FG001|Overall Study|Did not meet entrance criteria|1|||
125155341|NCT01470612|450191618|FG000|Overall Study|Pregnancy|2|||
125155342|NCT01470612|450191619|FG001|Overall Study|Pregnancy|10|||
125155343|NCT01470612|450191618|FG000|Overall Study|Protocol Violation|2|||
125155344|NCT01470612|450191619|FG001|Overall Study|Protocol Violation|7|||
125155345|NCT01470612|450191618|FG000|Overall Study|Withdrawal by Subject|24|||
125155346|NCT01470612|450191619|FG001|Overall Study|Withdrawal by Subject|79|||
125155347|NCT01470612|450191618|FG000|Overall Study|Other|14|||
125155348|NCT01470612|450191619|FG001|Overall Study|Other|156|||
125155349|NCT03407118|450191623|FG000|Period 2|Withdrawal by Subject|1|||
125155350|NCT03407118|450191624|FG001|Period 2|Withdrawal by Subject|0|||
125155351|NCT02556307|450191625|FG000|Overall Study|Premature treatment interruption|11|||
125155352|NCT02556307|450191625|FG000|Overall Study|Lost to Follow-up|36|||
125155353|NCT02556307|450191625|FG000|Overall Study|Change to triple therapy|4|||
125155354|NCT02556307|450191625|FG000|Overall Study|Enrolled but not treated|2|||
125155355|NCT00384176|450191628|FG000|Overall Study|Death|239|||
125155356|NCT00384176|450191629|FG001|Overall Study|Death|247|||
125155357|NCT00384176|450191630|FG002|Overall Study|Death|105|||
125155358|NCT00384176|450191628|FG000|Overall Study|Withdrawal by Subject|52|||
125155359|NCT00384176|450191629|FG001|Overall Study|Withdrawal by Subject|48|||
125155360|NCT00384176|450191630|FG002|Overall Study|Withdrawal by Subject|22|||
125155361|NCT00384176|450191628|FG000|Overall Study|Lost to Follow-up|16|||
125155362|NCT00384176|450191629|FG001|Overall Study|Lost to Follow-up|18|||
125155363|NCT00384176|450191630|FG002|Overall Study|Lost to Follow-up|4|||
125155364|NCT00384176|450191628|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
125155365|NCT00384176|450191629|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
125155366|NCT00384176|450191630|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
125155367|NCT00384176|450191628|FG000|Overall Study|Longer QTC as Visit 1|1|||
125155368|NCT00384176|450191629|FG001|Overall Study|Longer QTC as Visit 1|0|||
125155369|NCT00384176|450191630|FG002|Overall Study|Longer QTC as Visit 1|0|||
125155370|NCT00384176|450191628|FG000|Overall Study|Toxicity of treatment|1|||
125155371|NCT00384176|450191629|FG001|Overall Study|Toxicity of treatment|0|||
125155372|NCT00384176|450191630|FG002|Overall Study|Toxicity of treatment|0|||
125155373|NCT00384176|450191628|FG000|Overall Study|Did not receive study treatment|0|||
125155374|NCT00384176|450191629|FG001|Overall Study|Did not receive study treatment|1|||
125155375|NCT00384176|450191630|FG002|Overall Study|Did not receive study treatment|1|||
125155376|NCT00384176|450191628|FG000|Overall Study|Physician Decision|0|||
125155377|NCT00384176|450191629|FG001|Overall Study|Physician Decision|2|||
125155378|NCT00384176|450191630|FG002|Overall Study|Physician Decision|0|||
125155379|NCT00384176|450191628|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
125155380|NCT00384176|450191629|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
125155381|NCT00384176|450191630|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
125155382|NCT00854373|450191631|FG000|Overall Study|Withdrawal by Subject|1|||
125155383|NCT00854373|450191632|FG001|Overall Study|Withdrawal by Subject|3|||
125155384|NCT00854373|450191631|FG000|Overall Study|Forgot to take study drug|1|||
125155385|NCT00854373|450191632|FG001|Overall Study|Forgot to take study drug|1|||
125155386|NCT00307931|450191633|FG000|Overall Study|Adverse Event|1|||
125155387|NCT00515034|450191634|FG000|Overall Study|Adverse Event|2|||
125155388|NCT00515034|450191635|FG001|Overall Study|Adverse Event|0|||
125155389|NCT00515034|450191636|FG002|Overall Study|Adverse Event|1|||
125155390|NCT00515034|450191637|FG003|Overall Study|Adverse Event|0|||
125155391|NCT00515034|450191634|FG000|Overall Study|Death|4|||
125155392|NCT00515034|450191635|FG001|Overall Study|Death|2|||
125155393|NCT00515034|450191636|FG002|Overall Study|Death|1|||
125155394|NCT00515034|450191637|FG003|Overall Study|Death|3|||
125155395|NCT00515034|450191634|FG000|Overall Study|Withdrawal by Subject|1|||
125155396|NCT00515034|450191635|FG001|Overall Study|Withdrawal by Subject|0|||
125155397|NCT00515034|450191636|FG002|Overall Study|Withdrawal by Subject|3|||
125155398|NCT00515034|450191637|FG003|Overall Study|Withdrawal by Subject|0|||
125155399|NCT00515034|450191634|FG000|Overall Study|Physician Decision|0|||
125155400|NCT00515034|450191635|FG001|Overall Study|Physician Decision|0|||
125155401|NCT00515034|450191636|FG002|Overall Study|Physician Decision|1|||
125155402|NCT00515034|450191637|FG003|Overall Study|Physician Decision|1|||
125155403|NCT00515034|450191634|FG000|Overall Study|Other|1|||
125155404|NCT00515034|450191635|FG001|Overall Study|Other|0|||
125155405|NCT00515034|450191636|FG002|Overall Study|Other|2|||
125155406|NCT00515034|450191637|FG003|Overall Study|Other|1|||
125155407|NCT01392326|450191638|FG000|Overall Study|Death|2|||
125155408|NCT01392326|450191639|FG001|Overall Study|Death|0|||
125155409|NCT01392326|450191640|FG002|Overall Study|Death|0|||
125155410|NCT01392326|450191638|FG000|Overall Study|Withdrawal by Subject|12|||
125155411|NCT01392326|450191639|FG001|Overall Study|Withdrawal by Subject|11|||
125155412|NCT01392326|450191640|FG002|Overall Study|Withdrawal by Subject|15|||
125155413|NCT01392326|450191638|FG000|Overall Study|Protocol Violation|2|||
125155414|NCT01392326|450191639|FG001|Overall Study|Protocol Violation|0|||
125155415|NCT01392326|450191640|FG002|Overall Study|Protocol Violation|0|||
125155416|NCT01392326|450191638|FG000|Overall Study|Pregnancy|0|||
125155417|NCT01392326|450191639|FG001|Overall Study|Pregnancy|0|||
125155418|NCT01392326|450191640|FG002|Overall Study|Pregnancy|1|||
125155419|NCT01392326|450191638|FG000|Overall Study|Physician Decision|7|||
125155420|NCT01392326|450191639|FG001|Overall Study|Physician Decision|5|||
125155421|NCT01392326|450191640|FG002|Overall Study|Physician Decision|2|||
125155422|NCT01392326|450191638|FG000|Overall Study|Lost to Follow-up|1|||
125155423|NCT01392326|450191639|FG001|Overall Study|Lost to Follow-up|3|||
125155424|NCT01392326|450191640|FG002|Overall Study|Lost to Follow-up|4|||
125155425|NCT01392326|450191638|FG000|Overall Study|Lack of Efficacy|14|||
125155426|NCT01392326|450191639|FG001|Overall Study|Lack of Efficacy|10|||
125155427|NCT01392326|450191640|FG002|Overall Study|Lack of Efficacy|15|||
125155428|NCT01392326|450191638|FG000|Overall Study|Adverse Event|9|||
125155429|NCT01392326|450191639|FG001|Overall Study|Adverse Event|6|||
125155430|NCT01392326|450191640|FG002|Overall Study|Adverse Event|11|||
125155431|NCT05626803|450194095|FG000|Overall Study|Lost to Follow-up|0|||
125155432|NCT05626803|450194096|FG001|Overall Study|Lost to Follow-up|1|||
125155433|NCT05626803|450194097|FG002|Overall Study|Lost to Follow-up|0|||
125155434|NCT05626803|450194098|FG003|Overall Study|Lost to Follow-up|0|||
125155435|NCT00493246|450194099|FG000|Overall Study|Withdrawal by Subject|0|||
125155436|NCT00493246|450194100|FG001|Overall Study|Withdrawal by Subject|0|||
125155437|NCT00493246|450194101|FG002|Overall Study|Withdrawal by Subject|0|||
125155438|NCT00493246|450194102|FG003|Overall Study|Withdrawal by Subject|0|||
125155439|NCT00493246|450194103|FG004|Overall Study|Withdrawal by Subject|1|||
125155440|NCT00493246|450194104|FG005|Overall Study|Withdrawal by Subject|0|||
125155441|NCT00493246|450194105|FG006|Overall Study|Withdrawal by Subject|0|||
125155442|NCT00493246|450194106|FG007|Overall Study|Withdrawal by Subject|0|||
125155443|NCT00493246|450194099|FG000|Overall Study|No access to draw blood|0|||
125155444|NCT00493246|450194100|FG001|Overall Study|No access to draw blood|0|||
125155445|NCT00493246|450194101|FG002|Overall Study|No access to draw blood|0|||
125155446|NCT00493246|450194102|FG003|Overall Study|No access to draw blood|0|||
125155447|NCT00493246|450194103|FG004|Overall Study|No access to draw blood|0|||
125155448|NCT00493246|450194104|FG005|Overall Study|No access to draw blood|1|||
125155449|NCT00493246|450194105|FG006|Overall Study|No access to draw blood|0|||
125155450|NCT00493246|450194106|FG007|Overall Study|No access to draw blood|0|||
125155451|NCT00493246|450194099|FG000|Overall Study|Lost to Follow-up|0|||
125155452|NCT00493246|450194100|FG001|Overall Study|Lost to Follow-up|0|||
125155453|NCT00493246|450194101|FG002|Overall Study|Lost to Follow-up|0|||
125155454|NCT00493246|450194102|FG003|Overall Study|Lost to Follow-up|0|||
125155455|NCT00493246|450194103|FG004|Overall Study|Lost to Follow-up|0|||
125155456|NCT00493246|450194104|FG005|Overall Study|Lost to Follow-up|0|||
125155457|NCT00493246|450194105|FG006|Overall Study|Lost to Follow-up|1|||
125155458|NCT00493246|450194106|FG007|Overall Study|Lost to Follow-up|0|||
125155459|NCT02054130|450194111|FG000|Overall Study|Withdrawal by Subject|4|||
125155460|NCT02054130|450194112|FG001|Overall Study|Withdrawal by Subject|4|||
125155461|NCT02054130|450194113|FG002|Overall Study|Withdrawal by Subject|7|||
125155462|NCT02054130|450194114|FG003|Overall Study|Withdrawal by Subject|10|||
125155463|NCT02054130|450194111|FG000|Overall Study|Death|0|||
125155464|NCT02054130|450194112|FG001|Overall Study|Death|1|||
125155465|NCT02054130|450194113|FG002|Overall Study|Death|0|||
125155466|NCT02054130|450194114|FG003|Overall Study|Death|0|||
125155467|NCT02054130|450194111|FG000|Overall Study|Lost to Follow-up|0|||
125155468|NCT02054130|450194112|FG001|Overall Study|Lost to Follow-up|0|||
125155469|NCT02054130|450194113|FG002|Overall Study|Lost to Follow-up|1|||
125155470|NCT02054130|450194114|FG003|Overall Study|Lost to Follow-up|2|||
125155471|NCT02054130|450194111|FG000|Overall Study|Missed dose|4|||
125155472|NCT02054130|450194112|FG001|Overall Study|Missed dose|6|||
125155473|NCT02054130|450194113|FG002|Overall Study|Missed dose|7|||
125155474|NCT02054130|450194114|FG003|Overall Study|Missed dose|10|||
125155475|NCT00094458|450194115|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
125155476|NCT00094458|450194116|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
125155477|NCT00094458|450194117|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
125155478|NCT00094458|450194118|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
125155479|NCT00094458|450194119|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
125155480|NCT00094458|450194120|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
125155481|NCT00094458|450194115|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
125155482|NCT00094458|450194116|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
125155483|NCT00094458|450194117|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
125155484|NCT00094458|450194118|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
125155485|NCT00094458|450194119|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
125155486|NCT00094458|450194120|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
125155487|NCT00094458|450194115|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
125155488|NCT00094458|450194116|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
125155489|NCT00094458|450194117|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
125155490|NCT00094458|450194118|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
125155491|NCT00094458|450194119|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
125155492|NCT00094458|450194120|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
125155493|NCT00094458|450194115|FG000|Main Study: Through Week 30|Adverse Event|38|||
125155494|NCT00094458|450194116|FG001|Main Study: Through Week 30|Adverse Event|20|||
125155495|NCT00094458|450194117|FG002|Main Study: Through Week 30|Adverse Event|28|||
125155496|NCT00094458|450194118|FG003|Main Study: Through Week 30|Adverse Event|0|||
125155497|NCT00094458|450194119|FG004|Main Study: Through Week 30|Adverse Event|0|||
125155498|NCT00094458|450194120|FG005|Main Study: Through Week 30|Adverse Event|0|||
125155499|NCT00094458|450194115|FG000|Main Study: Through Week 30|Death|1|||
125155500|NCT00094458|450194116|FG001|Main Study: Through Week 30|Death|0|||
125155501|NCT00094458|450194117|FG002|Main Study: Through Week 30|Death|0|||
125155502|NCT00094458|450194118|FG003|Main Study: Through Week 30|Death|0|||
125155503|NCT00094458|450194119|FG004|Main Study: Through Week 30|Death|0|||
125155504|NCT00094458|450194120|FG005|Main Study: Through Week 30|Death|0|||
125155505|NCT00094458|450194115|FG000|Main Study: Through Week 30|Other|19|||
125155506|NCT00094458|450194116|FG001|Main Study: Through Week 30|Other|16|||
125155507|NCT00094458|450194117|FG002|Main Study: Through Week 30|Other|9|||
125155508|NCT00094458|450194118|FG003|Main Study: Through Week 30|Other|0|||
125155509|NCT00094458|450194119|FG004|Main Study: Through Week 30|Other|0|||
125155510|NCT00094458|450194120|FG005|Main Study: Through Week 30|Other|0|||
125155511|NCT00094458|450194115|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
125155512|NCT00094458|450194116|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
125155513|NCT00094458|450194117|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
125155514|NCT00094458|450194118|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
125155515|NCT00094458|450194119|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
125155516|NCT00094458|450194120|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
125155517|NCT00094458|450194115|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
125155518|NCT00094458|450194116|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
125155519|NCT00094458|450194117|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
125155520|NCT00094458|450194118|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
125155521|NCT00094458|450194119|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
125155522|NCT00094458|450194120|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
125155523|NCT00094458|450194115|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
125155524|NCT00094458|450194116|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
125155525|NCT00094458|450194117|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
125155526|NCT00094458|450194118|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
125155527|NCT00094458|450194119|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
125155528|NCT00094458|450194120|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
125155529|NCT00094458|450194115|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
125155530|NCT00094458|450194116|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
125155531|NCT00094458|450194117|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
125155532|NCT00094458|450194118|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
125155533|NCT00094458|450194119|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
125155534|NCT00094458|450194120|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
125155535|NCT00094458|450194115|FG000|OLE: Open-Label Extension|Adverse Event|0|||
125155536|NCT00094458|450194116|FG001|OLE: Open-Label Extension|Adverse Event|0|||
125155537|NCT00094458|450194117|FG002|OLE: Open-Label Extension|Adverse Event|0|||
125155538|NCT00094458|450194118|FG003|OLE: Open-Label Extension|Adverse Event|0|||
125155539|NCT00094458|450194119|FG004|OLE: Open-Label Extension|Adverse Event|3|||
125155540|NCT00094458|450194120|FG005|OLE: Open-Label Extension|Adverse Event|4|||
125155541|NCT00094458|450194115|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
125155542|NCT00094458|450194116|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
125155543|NCT00094458|450194117|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
125155544|NCT00094458|450194118|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
125155545|NCT00094458|450194119|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
125155546|NCT00094458|450194120|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
125155547|NCT00094458|450194115|FG000|OLE: Open-Label Extension|Patient decision|0|||
125155548|NCT00094458|450194116|FG001|OLE: Open-Label Extension|Patient decision|0|||
125155549|NCT00094458|450194117|FG002|OLE: Open-Label Extension|Patient decision|0|||
125155550|NCT00094458|450194118|FG003|OLE: Open-Label Extension|Patient decision|0|||
125155551|NCT00094458|450194119|FG004|OLE: Open-Label Extension|Patient decision|1|||
125155552|NCT00094458|450194120|FG005|OLE: Open-Label Extension|Patient decision|0|||
125155553|NCT02017860|450194125|FG000|Overall Study|Adverse Event|1|||
125155554|NCT02017860|450194125|FG000|Overall Study|Withdrawal by Subject|1|||
125155555|NCT01829113|450194128|FG000|Overall Study|Disease Progression|37|||
125155556|NCT01829113|450194129|FG001|Overall Study|Disease Progression|48|||
125155557|NCT01829113|450194128|FG000|Overall Study|Adverse Event|14|||
125155558|NCT01829113|450194129|FG001|Overall Study|Adverse Event|10|||
125155559|NCT01829113|450194128|FG000|Overall Study|Withdrawal by Subject|17|||
125155560|NCT01829113|450194129|FG001|Overall Study|Withdrawal by Subject|10|||
125155561|NCT01829113|450194128|FG000|Overall Study|Death|4|||
125155562|NCT01829113|450194129|FG001|Overall Study|Death|6|||
125155563|NCT01829113|450194128|FG000|Overall Study|Sponsor Decision|1|||
125155564|NCT01829113|450194129|FG001|Overall Study|Sponsor Decision|1|||
125155565|NCT01829113|450194128|FG000|Overall Study|No Study Treatment Received|3|||
125155566|NCT01829113|450194129|FG001|Overall Study|No Study Treatment Received|2|||
125155567|NCT01829113|450194128|FG000|Overall Study|Physician Decision|1|||
125155568|NCT01829113|450194129|FG001|Overall Study|Physician Decision|1|||
125155569|NCT02010255|450194136|FG000|Overall Study|Death|0|||
125155570|NCT02010255|450194137|FG001|Overall Study|Death|1|||
125155571|NCT02010255|450194138|FG002|Overall Study|Death|4|||
125155572|NCT02010255|450194139|FG003|Overall Study|Death|4|||
125155573|NCT02010255|450194140|FG004|Overall Study|Death|2|||
125155574|NCT02010255|450194141|FG005|Overall Study|Death|0|||
125155575|NCT02010255|450194142|FG006|Overall Study|Death|1|||
125155576|NCT02010255|450194143|FG007|Overall Study|Death|1|||
125155577|NCT02010255|450194144|FG008|Overall Study|Death|1|||
125155578|NCT02010255|450194145|FG009|Overall Study|Death|0|||
125155579|NCT02010255|450194146|FG010|Overall Study|Death|1|||
125155580|NCT02010255|450194147|FG011|Overall Study|Death|1|||
125155581|NCT02010255|450194148|FG012|Overall Study|Death|0|||
125155582|NCT02010255|450194149|FG013|Overall Study|Death|0|||
125155583|NCT02010255|450194136|FG000|Overall Study|Lack of Efficacy|4|||
125155584|NCT02010255|450194137|FG001|Overall Study|Lack of Efficacy|1|||
125155585|NCT02010255|450194138|FG002|Overall Study|Lack of Efficacy|2|||
125155586|NCT02010255|450194139|FG003|Overall Study|Lack of Efficacy|1|||
125155587|NCT02010255|450194140|FG004|Overall Study|Lack of Efficacy|1|||
125155588|NCT02010255|450194141|FG005|Overall Study|Lack of Efficacy|0|||
125155589|NCT02010255|450194142|FG006|Overall Study|Lack of Efficacy|0|||
125155590|NCT02010255|450194143|FG007|Overall Study|Lack of Efficacy|0|||
125155591|NCT02010255|450194144|FG008|Overall Study|Lack of Efficacy|0|||
125155592|NCT02010255|450194145|FG009|Overall Study|Lack of Efficacy|0|||
125155593|NCT02010255|450194146|FG010|Overall Study|Lack of Efficacy|1|||
125155594|NCT02010255|450194147|FG011|Overall Study|Lack of Efficacy|0|||
125155595|NCT02010255|450194148|FG012|Overall Study|Lack of Efficacy|0|||
125155596|NCT02010255|450194149|FG013|Overall Study|Lack of Efficacy|0|||
125155597|NCT02010255|450194136|FG000|Overall Study|Withdrew Consent|1|||
125155598|NCT02010255|450194137|FG001|Overall Study|Withdrew Consent|0|||
125155599|NCT02010255|450194138|FG002|Overall Study|Withdrew Consent|0|||
125155600|NCT02010255|450194139|FG003|Overall Study|Withdrew Consent|1|||
125155601|NCT02010255|450194140|FG004|Overall Study|Withdrew Consent|0|||
125155602|NCT02010255|450194141|FG005|Overall Study|Withdrew Consent|0|||
125155603|NCT02010255|450194142|FG006|Overall Study|Withdrew Consent|0|||
125155604|NCT02010255|450194143|FG007|Overall Study|Withdrew Consent|0|||
125155605|NCT02010255|450194144|FG008|Overall Study|Withdrew Consent|0|||
125155606|NCT02010255|450194145|FG009|Overall Study|Withdrew Consent|0|||
125155607|NCT02010255|450194146|FG010|Overall Study|Withdrew Consent|0|||
125155608|NCT02010255|450194147|FG011|Overall Study|Withdrew Consent|0|||
125155609|NCT02010255|450194148|FG012|Overall Study|Withdrew Consent|0|||
125155610|NCT02010255|450194149|FG013|Overall Study|Withdrew Consent|0|||
125155611|NCT02010255|450194136|FG000|Overall Study|Adverse Event|1|||
125155612|NCT02010255|450194137|FG001|Overall Study|Adverse Event|0|||
125155613|NCT02010255|450194138|FG002|Overall Study|Adverse Event|0|||
125155614|NCT02010255|450194139|FG003|Overall Study|Adverse Event|0|||
125155615|NCT02010255|450194140|FG004|Overall Study|Adverse Event|0|||
125155616|NCT02010255|450194141|FG005|Overall Study|Adverse Event|0|||
125155617|NCT02010255|450194142|FG006|Overall Study|Adverse Event|0|||
125155618|NCT02010255|450194143|FG007|Overall Study|Adverse Event|0|||
125155619|NCT02010255|450194144|FG008|Overall Study|Adverse Event|0|||
125155620|NCT02010255|450194145|FG009|Overall Study|Adverse Event|0|||
125155621|NCT02010255|450194146|FG010|Overall Study|Adverse Event|0|||
125155622|NCT02010255|450194147|FG011|Overall Study|Adverse Event|0|||
125155623|NCT02010255|450194148|FG012|Overall Study|Adverse Event|0|||
125155624|NCT02010255|450194149|FG013|Overall Study|Adverse Event|0|||
125155625|NCT02010255|450194136|FG000|Overall Study|Lost to Follow-up|0|||
125155626|NCT02010255|450194137|FG001|Overall Study|Lost to Follow-up|0|||
125155627|NCT02010255|450194138|FG002|Overall Study|Lost to Follow-up|1|||
125155628|NCT02010255|450194139|FG003|Overall Study|Lost to Follow-up|0|||
125155629|NCT02010255|450194140|FG004|Overall Study|Lost to Follow-up|1|||
125155630|NCT02010255|450194141|FG005|Overall Study|Lost to Follow-up|0|||
125155631|NCT02010255|450194142|FG006|Overall Study|Lost to Follow-up|0|||
125155632|NCT02010255|450194143|FG007|Overall Study|Lost to Follow-up|0|||
125155633|NCT02010255|450194144|FG008|Overall Study|Lost to Follow-up|0|||
125155634|NCT02010255|450194145|FG009|Overall Study|Lost to Follow-up|0|||
125155635|NCT02010255|450194146|FG010|Overall Study|Lost to Follow-up|0|||
125155636|NCT02010255|450194147|FG011|Overall Study|Lost to Follow-up|0|||
125155637|NCT02010255|450194148|FG012|Overall Study|Lost to Follow-up|0|||
125155638|NCT02010255|450194149|FG013|Overall Study|Lost to Follow-up|0|||
125155639|NCT02010255|450194136|FG000|Overall Study|Randomized but Not Treated|0|||
125155640|NCT02010255|450194137|FG001|Overall Study|Randomized but Not Treated|0|||
125155641|NCT02010255|450194138|FG002|Overall Study|Randomized but Not Treated|0|||
125155642|NCT02010255|450194139|FG003|Overall Study|Randomized but Not Treated|0|||
125155643|NCT02010255|450194140|FG004|Overall Study|Randomized but Not Treated|0|||
125155644|NCT02010255|450194141|FG005|Overall Study|Randomized but Not Treated|0|||
125155645|NCT02010255|450194142|FG006|Overall Study|Randomized but Not Treated|0|||
125155646|NCT02010255|450194143|FG007|Overall Study|Randomized but Not Treated|0|||
125155647|NCT02010255|450194144|FG008|Overall Study|Randomized but Not Treated|0|||
125155648|NCT02010255|450194145|FG009|Overall Study|Randomized but Not Treated|0|||
125155649|NCT02010255|450194146|FG010|Overall Study|Randomized but Not Treated|0|||
125155650|NCT02010255|450194147|FG011|Overall Study|Randomized but Not Treated|0|||
125155651|NCT02010255|450194148|FG012|Overall Study|Randomized but Not Treated|0|||
125155652|NCT02010255|450194149|FG013|Overall Study|Randomized but Not Treated|1|||
125155653|NCT00977431|450194152|FG000|Overall Study|Other than listed|1|||
125155654|NCT00977431|450194153|FG001|Overall Study|Other than listed|0|||
125155655|NCT00977431|450194154|FG002|Overall Study|Other than listed|0|||
125155656|NCT00977431|450194155|FG003|Overall Study|Other than listed|0|||
125155657|NCT00977431|450194156|FG004|Overall Study|Other than listed|2|||
125155658|NCT00977431|450194152|FG000|Overall Study|Protocol Violation|0|||
125155659|NCT00977431|450194153|FG001|Overall Study|Protocol Violation|0|||
125155660|NCT00977431|450194154|FG002|Overall Study|Protocol Violation|1|||
125155661|NCT00977431|450194155|FG003|Overall Study|Protocol Violation|0|||
125155662|NCT00977431|450194156|FG004|Overall Study|Protocol Violation|0|||
125155663|NCT00977431|450194152|FG000|Overall Study|Adverse Event|3|||
125155664|NCT00977431|450194153|FG001|Overall Study|Adverse Event|0|||
125155665|NCT00977431|450194154|FG002|Overall Study|Adverse Event|4|||
125155666|NCT00977431|450194155|FG003|Overall Study|Adverse Event|0|||
125155667|NCT00977431|450194156|FG004|Overall Study|Adverse Event|6|||
125155668|NCT00977431|450194152|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
125155669|NCT00977431|450194153|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
125155670|NCT00977431|450194154|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
125155671|NCT00977431|450194155|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
125155672|NCT00977431|450194156|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
125155673|NCT00977431|450194152|FG000|Overall Study|Progressive disease|2|||
125155674|NCT00977431|450194153|FG001|Overall Study|Progressive disease|6|||
125155675|NCT00977431|450194154|FG002|Overall Study|Progressive disease|1|||
125155676|NCT00977431|450194155|FG003|Overall Study|Progressive disease|3|||
125155677|NCT00977431|450194156|FG004|Overall Study|Progressive disease|5|||
125155678|NCT01010750|450194157|FG000|Second Intervention|Adverse Event|0|||
125155679|NCT01010750|450194158|FG001|Second Intervention|Adverse Event|1|||
125155680|NCT01010750|450194159|FG002|Second Intervention|Adverse Event|0|||
125155681|NCT01010750|450194160|FG003|Second Intervention|Adverse Event|0|||
125155682|NCT01010750|450194161|FG004|Second Intervention|Adverse Event|0|||
125155683|NCT01010750|450194162|FG005|Second Intervention|Adverse Event|0|||
125155684|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
125155685|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
125155686|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
125155687|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
125155688|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
125155689|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
125155690|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
125155691|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
125155692|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
125155693|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
125155694|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Subject decision|1|||
125155695|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Subject decision|1|||
125155696|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
125155697|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
125155698|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
125155699|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
125155700|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
125155701|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
125155702|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
125155703|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
125155704|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
125155705|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
125155706|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
125155707|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
125155708|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
125155709|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
125155710|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
125155711|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
125155712|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
125155713|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
125155714|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
125155715|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
125155716|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
125155717|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
125155718|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
125155719|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
125155720|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
125155721|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
125155722|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
125155723|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
125155724|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
125155725|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
125155726|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
125155727|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
125155728|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
125155729|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
125155730|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
125155731|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
125155732|NCT00567476|450194170|FG000|Overall Study|Adverse Event|2|||
125155733|NCT00567476|450194171|FG001|Overall Study|Adverse Event|0|||
125155734|NCT00567476|450194170|FG000|Overall Study|Pregnancy|1|||
125155735|NCT00567476|450194171|FG001|Overall Study|Pregnancy|0|||
125155736|NCT00567476|450194170|FG000|Overall Study|Protocol Violation|4|||
125155737|NCT00567476|450194171|FG001|Overall Study|Protocol Violation|1|||
125155738|NCT00567476|450194170|FG000|Overall Study|Lost to Follow-up|0|||
125155739|NCT00567476|450194171|FG001|Overall Study|Lost to Follow-up|1|||
125155740|NCT00567476|450194170|FG000|Overall Study|Administrative issues|1|||
125155741|NCT00567476|450194171|FG001|Overall Study|Administrative issues|0|||
125155742|NCT00567476|450194170|FG000|Overall Study|Medical Decision|0|||
125155743|NCT00567476|450194171|FG001|Overall Study|Medical Decision|1|||
125155744|NCT00567476|450194170|FG000|Overall Study|Non-adherence to protocol|0|||
125155745|NCT00567476|450194171|FG001|Overall Study|Non-adherence to protocol|1|||
125155746|NCT02696031|450194172|FG000|Up to Week 24|Adverse Event|2|||
125155747|NCT02696031|450194173|FG001|Up to Week 24|Adverse Event|4|||
125155748|NCT02696031|450194174|FG002|Up to Week 24|Adverse Event|2|||
125155749|NCT02696031|450194175|FG003|Up to Week 24|Adverse Event|0|||
125155750|NCT02696031|450194176|FG004|Up to Week 24|Adverse Event|0|||
125155751|NCT02696031|450194177|FG005|Up to Week 24|Adverse Event|0|||
125155752|NCT02696031|450194172|FG000|Up to Week 24|Lack of Efficacy|2|||
125155753|NCT02696031|450194173|FG001|Up to Week 24|Lack of Efficacy|1|||
125155754|NCT02696031|450194174|FG002|Up to Week 24|Lack of Efficacy|2|||
125155755|NCT02696031|450194175|FG003|Up to Week 24|Lack of Efficacy|0|||
125155756|NCT02696031|450194176|FG004|Up to Week 24|Lack of Efficacy|0|||
125155757|NCT02696031|450194177|FG005|Up to Week 24|Lack of Efficacy|0|||
125155758|NCT02696031|450194172|FG000|Up to Week 24|Lost to Follow-up|0|||
125155759|NCT02696031|450194173|FG001|Up to Week 24|Lost to Follow-up|1|||
125155760|NCT02696031|450194174|FG002|Up to Week 24|Lost to Follow-up|1|||
125155761|NCT02696031|450194175|FG003|Up to Week 24|Lost to Follow-up|0|||
125155762|NCT02696031|450194176|FG004|Up to Week 24|Lost to Follow-up|0|||
125155763|NCT02696031|450194177|FG005|Up to Week 24|Lost to Follow-up|0|||
125155764|NCT02696031|450194172|FG000|Up to Week 24|Physician Decision|1|||
125155765|NCT02696031|450194173|FG001|Up to Week 24|Physician Decision|0|||
125155766|NCT02696031|450194174|FG002|Up to Week 24|Physician Decision|1|||
125155767|NCT02696031|450194175|FG003|Up to Week 24|Physician Decision|0|||
125155768|NCT02696031|450194176|FG004|Up to Week 24|Physician Decision|0|||
125155769|NCT02696031|450194177|FG005|Up to Week 24|Physician Decision|0|||
125155770|NCT02696031|450194172|FG000|Up to Week 24|Protocol Violation|1|||
125155771|NCT02696031|450194173|FG001|Up to Week 24|Protocol Violation|0|||
125155772|NCT02696031|450194174|FG002|Up to Week 24|Protocol Violation|0|||
125155773|NCT02696031|450194175|FG003|Up to Week 24|Protocol Violation|0|||
125155774|NCT02696031|450194176|FG004|Up to Week 24|Protocol Violation|0|||
125155775|NCT02696031|450194177|FG005|Up to Week 24|Protocol Violation|0|||
125155776|NCT02696031|450194172|FG000|Up to Week 24|Withdrawal by Subject|4|||
125155777|NCT02696031|450194173|FG001|Up to Week 24|Withdrawal by Subject|1|||
125155778|NCT02696031|450194174|FG002|Up to Week 24|Withdrawal by Subject|5|||
125155779|NCT02696031|450194175|FG003|Up to Week 24|Withdrawal by Subject|0|||
125155780|NCT02696031|450194176|FG004|Up to Week 24|Withdrawal by Subject|0|||
125155781|NCT02696031|450194177|FG005|Up to Week 24|Withdrawal by Subject|0|||
125155782|NCT02696031|450194172|FG000|Up to Week 52|Adverse Event|4|||
125155783|NCT02696031|450194173|FG001|Up to Week 52|Adverse Event|5|||
125155784|NCT02696031|450194174|FG002|Up to Week 52|Adverse Event|3|||
125155785|NCT02696031|450194175|FG003|Up to Week 52|Adverse Event|0|||
125155786|NCT02696031|450194176|FG004|Up to Week 52|Adverse Event|0|||
125155787|NCT02696031|450194177|FG005|Up to Week 52|Adverse Event|0|||
125155788|NCT02696031|450194172|FG000|Up to Week 52|Lack of Efficacy|10|||
125155789|NCT02696031|450194173|FG001|Up to Week 52|Lack of Efficacy|7|||
125155790|NCT02696031|450194174|FG002|Up to Week 52|Lack of Efficacy|11|||
125155791|NCT02696031|450194175|FG003|Up to Week 52|Lack of Efficacy|0|||
125155792|NCT02696031|450194176|FG004|Up to Week 52|Lack of Efficacy|0|||
125155793|NCT02696031|450194177|FG005|Up to Week 52|Lack of Efficacy|0|||
125155794|NCT02696031|450194172|FG000|Up to Week 52|Lost to Follow-up|1|||
125155795|NCT02696031|450194173|FG001|Up to Week 52|Lost to Follow-up|1|||
125155796|NCT02696031|450194174|FG002|Up to Week 52|Lost to Follow-up|1|||
125155797|NCT02696031|450194175|FG003|Up to Week 52|Lost to Follow-up|0|||
125155798|NCT02696031|450194176|FG004|Up to Week 52|Lost to Follow-up|0|||
125155799|NCT02696031|450194177|FG005|Up to Week 52|Lost to Follow-up|0|||
125155800|NCT02696031|450194172|FG000|Up to Week 52|Physician Decision|1|||
125155801|NCT02696031|450194173|FG001|Up to Week 52|Physician Decision|1|||
125155802|NCT02696031|450194174|FG002|Up to Week 52|Physician Decision|2|||
125155803|NCT02696031|450194175|FG003|Up to Week 52|Physician Decision|0|||
125155804|NCT02696031|450194176|FG004|Up to Week 52|Physician Decision|0|||
125155805|NCT02696031|450194177|FG005|Up to Week 52|Physician Decision|0|||
125155806|NCT02696031|450194172|FG000|Up to Week 52|Pregnancy|0|||
125155807|NCT02696031|450194173|FG001|Up to Week 52|Pregnancy|2|||
125155808|NCT02696031|450194174|FG002|Up to Week 52|Pregnancy|0|||
125155809|NCT02696031|450194175|FG003|Up to Week 52|Pregnancy|0|||
125155810|NCT02696031|450194176|FG004|Up to Week 52|Pregnancy|0|||
125155811|NCT02696031|450194177|FG005|Up to Week 52|Pregnancy|0|||
125155812|NCT02696031|450194172|FG000|Up to Week 52|Protocol Violation|1|||
125155813|NCT02696031|450194173|FG001|Up to Week 52|Protocol Violation|0|||
125155814|NCT02696031|450194174|FG002|Up to Week 52|Protocol Violation|0|||
125155815|NCT02696031|450194175|FG003|Up to Week 52|Protocol Violation|0|||
125155816|NCT02696031|450194176|FG004|Up to Week 52|Protocol Violation|0|||
125155817|NCT02696031|450194177|FG005|Up to Week 52|Protocol Violation|0|||
125155818|NCT02696031|450194172|FG000|Up to Week 52|Withdrawal by Subject|12|||
125155819|NCT02696031|450194173|FG001|Up to Week 52|Withdrawal by Subject|3|||
125155820|NCT02696031|450194174|FG002|Up to Week 52|Withdrawal by Subject|9|||
125155821|NCT02696031|450194175|FG003|Up to Week 52|Withdrawal by Subject|0|||
125155822|NCT02696031|450194176|FG004|Up to Week 52|Withdrawal by Subject|0|||
125155823|NCT02696031|450194177|FG005|Up to Week 52|Withdrawal by Subject|0|||
125155824|NCT02696031|450194172|FG000|Up to Week 104|Pregnancy|0|||
125155825|NCT02696031|450194173|FG001|Up to Week 104|Pregnancy|2|||
125155826|NCT02696031|450194174|FG002|Up to Week 104|Pregnancy|1|||
125155827|NCT02696031|450194175|FG003|Up to Week 104|Pregnancy|0|||
125155828|NCT02696031|450194176|FG004|Up to Week 104|Pregnancy|0|||
125155829|NCT02696031|450194177|FG005|Up to Week 104|Pregnancy|0|||
125155830|NCT02696031|450194172|FG000|Up to Week 104|Withdrawal by Subject|15|||
125155831|NCT02696031|450194173|FG001|Up to Week 104|Withdrawal by Subject|10|||
125155832|NCT02696031|450194174|FG002|Up to Week 104|Withdrawal by Subject|16|||
125155833|NCT02696031|450194175|FG003|Up to Week 104|Withdrawal by Subject|0|||
125155834|NCT02696031|450194176|FG004|Up to Week 104|Withdrawal by Subject|0|||
125155835|NCT02696031|450194177|FG005|Up to Week 104|Withdrawal by Subject|0|||
125155836|NCT02696031|450194172|FG000|Up to Week 104|Protocol Violation|1|||
125155837|NCT02696031|450194173|FG001|Up to Week 104|Protocol Violation|0|||
125155838|NCT02696031|450194174|FG002|Up to Week 104|Protocol Violation|0|||
125155839|NCT02696031|450194175|FG003|Up to Week 104|Protocol Violation|0|||
125155840|NCT02696031|450194176|FG004|Up to Week 104|Protocol Violation|0|||
125155841|NCT02696031|450194177|FG005|Up to Week 104|Protocol Violation|0|||
125155842|NCT02696031|450194172|FG000|Up to Week 104|Physician Decision|1|||
125155843|NCT02696031|450194173|FG001|Up to Week 104|Physician Decision|2|||
125155844|NCT02696031|450194174|FG002|Up to Week 104|Physician Decision|3|||
125155845|NCT02696031|450194175|FG003|Up to Week 104|Physician Decision|0|||
125155846|NCT02696031|450194176|FG004|Up to Week 104|Physician Decision|0|||
125155847|NCT02696031|450194177|FG005|Up to Week 104|Physician Decision|0|||
125155848|NCT02696031|450194172|FG000|Up to Week 104|Lost to Follow-up|2|||
125155849|NCT02696031|450194173|FG001|Up to Week 104|Lost to Follow-up|3|||
125155850|NCT02696031|450194174|FG002|Up to Week 104|Lost to Follow-up|1|||
125155851|NCT02696031|450194175|FG003|Up to Week 104|Lost to Follow-up|0|||
125155852|NCT02696031|450194176|FG004|Up to Week 104|Lost to Follow-up|0|||
125155853|NCT02696031|450194177|FG005|Up to Week 104|Lost to Follow-up|0|||
125155854|NCT02696031|450194172|FG000|Up to Week 104|Lack of Efficacy|13|||
125155855|NCT02696031|450194173|FG001|Up to Week 104|Lack of Efficacy|12|||
125155856|NCT02696031|450194174|FG002|Up to Week 104|Lack of Efficacy|11|||
125155857|NCT02696031|450194175|FG003|Up to Week 104|Lack of Efficacy|0|||
125155858|NCT02696031|450194176|FG004|Up to Week 104|Lack of Efficacy|0|||
125155859|NCT02696031|450194177|FG005|Up to Week 104|Lack of Efficacy|0|||
125155860|NCT02696031|450194172|FG000|Up to Week 104|Adverse Event|7|||
125155861|NCT02696031|450194173|FG001|Up to Week 104|Adverse Event|11|||
125155862|NCT02696031|450194174|FG002|Up to Week 104|Adverse Event|5|||
125155863|NCT02696031|450194175|FG003|Up to Week 104|Adverse Event|0|||
125155864|NCT02696031|450194176|FG004|Up to Week 104|Adverse Event|0|||
125155865|NCT02696031|450194177|FG005|Up to Week 104|Adverse Event|0|||
125155866|NCT02696031|450194172|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
125155867|NCT02696031|450194173|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
125155868|NCT02696031|450194174|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
125155869|NCT02696031|450194175|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
125155870|NCT02696031|450194176|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
125155871|NCT02696031|450194177|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
125155872|NCT02696031|450194172|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
125155873|NCT02696031|450194173|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
125155874|NCT02696031|450194174|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
125155875|NCT02696031|450194175|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
125155876|NCT02696031|450194176|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
125155877|NCT02696031|450194177|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
125155878|NCT02696031|450194172|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
125155879|NCT02696031|450194173|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
125155880|NCT02696031|450194174|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
125155881|NCT02696031|450194175|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
125155882|NCT02696031|450194176|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
125155883|NCT02696031|450194177|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
125155884|NCT02696031|450194172|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
125155885|NCT02696031|450194173|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
125155886|NCT02696031|450194174|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
125155887|NCT02696031|450194175|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
125155888|NCT02696031|450194176|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
125155889|NCT02696031|450194177|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
125155890|NCT02696031|450194172|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
125155891|NCT02696031|450194173|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
125155892|NCT02696031|450194174|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
125155893|NCT02696031|450194175|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
125155894|NCT02696031|450194176|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
125155895|NCT02696031|450194177|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
125155896|NCT02696031|450194172|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
125155897|NCT02696031|450194173|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
125155898|NCT02696031|450194174|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
125155899|NCT02696031|450194175|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
125155900|NCT02696031|450194176|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
125155901|NCT02696031|450194177|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
125155902|NCT02696031|450194172|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
125155903|NCT02696031|450194173|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
125155904|NCT02696031|450194174|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
125155905|NCT02696031|450194175|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
125155906|NCT02696031|450194176|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
125155907|NCT02696031|450194177|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
125155908|NCT02777918|450194178|FG000|Overall Study|Medical reasons|1|||
125155909|NCT02777918|450194179|FG001|Overall Study|Medical reasons|2|||
125155910|NCT02777918|450194178|FG000|Overall Study|Too busy / stressed|1|||
125155911|NCT02777918|450194179|FG001|Overall Study|Too busy / stressed|1|||
125155912|NCT02777918|450194178|FG000|Overall Study|Withdrawal by Subject|1|||
125155913|NCT02777918|450194179|FG001|Overall Study|Withdrawal by Subject|1|||
125155914|NCT00058214|450194180|FG000|Overall Study|Adverse Event|1|||
125155915|NCT03856593|450194184|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
125155916|NCT03856593|450194185|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
125155917|NCT03978091|450194189|FG000|Overall Study|Lost to Follow-up|0|||
125155918|NCT03978091|450194190|FG001|Overall Study|Lost to Follow-up|0|||
125155919|NCT03978091|450194191|FG002|Overall Study|Lost to Follow-up|1|||
125155920|NCT03978091|450194192|FG003|Overall Study|Lost to Follow-up|0|||
125155921|NCT03978091|450194193|FG004|Overall Study|Lost to Follow-up|0|||
125155922|NCT03978091|450194194|FG005|Overall Study|Lost to Follow-up|0|||
125155923|NCT03978091|450194189|FG000|Overall Study|Withdrawal by Subject|0|||
125155924|NCT03978091|450194190|FG001|Overall Study|Withdrawal by Subject|0|||
125155925|NCT03978091|450194191|FG002|Overall Study|Withdrawal by Subject|0|||
125155926|NCT03978091|450194192|FG003|Overall Study|Withdrawal by Subject|1|||
125155927|NCT03978091|450194193|FG004|Overall Study|Withdrawal by Subject|1|||
125155928|NCT03978091|450194194|FG005|Overall Study|Withdrawal by Subject|0|||
125155929|NCT02595008|450194199|FG000|Overall Study|Enrolled In Error|1|||
125155930|NCT02595008|450194200|FG001|Overall Study|Enrolled In Error|0|||
125155931|NCT03078582|450194203|FG000|Overall Study|Adverse Event|0|||
125155932|NCT03078582|450194204|FG001|Overall Study|Adverse Event|8|||
125155933|NCT02972502|450194215|FG000|Overall Study|Lost to Follow-up|3|||
125155934|NCT02972502|450194216|FG001|Overall Study|Lost to Follow-up|1|||
125155935|NCT02972502|450194215|FG000|Overall Study|Withdrawal by Subject|1|||
125155936|NCT02972502|450194216|FG001|Overall Study|Withdrawal by Subject|1|||
125155937|NCT01347866|450194219|FG000|Overall Study|Death|0|||
125155938|NCT01347866|450194220|FG001|Overall Study|Death|0|||
125155939|NCT01347866|450194221|FG002|Overall Study|Death|0|||
125155940|NCT01347866|450194222|FG003|Overall Study|Death|1|||
125155941|NCT01347866|450194223|FG004|Overall Study|Death|2|||
125155942|NCT01347866|450194224|FG005|Overall Study|Death|2|||
125155943|NCT01347866|450194225|FG006|Overall Study|Death|1|||
125155944|NCT01347866|450194226|FG007|Overall Study|Death|0|||
125155945|NCT01347866|450194227|FG008|Overall Study|Death|4|||
125155946|NCT01347866|450194228|FG009|Overall Study|Death|1|||
125155947|NCT01347866|450194229|FG010|Overall Study|Death|3|||
125155948|NCT01347866|450194230|FG011|Overall Study|Death|1|||
125155949|NCT01347866|450194231|FG012|Overall Study|Death|2|||
125155950|NCT01347866|450194232|FG013|Overall Study|Death|0|||
125155951|NCT01347866|450194233|FG014|Overall Study|Death|0|||
125155952|NCT01347866|450194234|FG015|Overall Study|Death|1|||
125155953|NCT01347866|450194235|FG016|Overall Study|Death|0|||
125155954|NCT01347866|450194219|FG000|Overall Study|Lost to Follow-up|0|||
125155955|NCT01347866|450194220|FG001|Overall Study|Lost to Follow-up|0|||
125155956|NCT01347866|450194221|FG002|Overall Study|Lost to Follow-up|0|||
125155957|NCT01347866|450194222|FG003|Overall Study|Lost to Follow-up|0|||
125155958|NCT01347866|450194223|FG004|Overall Study|Lost to Follow-up|0|||
125155959|NCT01347866|450194224|FG005|Overall Study|Lost to Follow-up|0|||
125155960|NCT01347866|450194225|FG006|Overall Study|Lost to Follow-up|0|||
125155961|NCT01347866|450194226|FG007|Overall Study|Lost to Follow-up|1|||
125155962|NCT01347866|450194227|FG008|Overall Study|Lost to Follow-up|1|||
125155963|NCT01347866|450194228|FG009|Overall Study|Lost to Follow-up|0|||
125155964|NCT01347866|450194229|FG010|Overall Study|Lost to Follow-up|0|||
125155965|NCT01347866|450194230|FG011|Overall Study|Lost to Follow-up|0|||
125155966|NCT01347866|450194231|FG012|Overall Study|Lost to Follow-up|0|||
125155967|NCT01347866|450194232|FG013|Overall Study|Lost to Follow-up|0|||
125155968|NCT01347866|450194233|FG014|Overall Study|Lost to Follow-up|0|||
125155969|NCT01347866|450194234|FG015|Overall Study|Lost to Follow-up|0|||
125155970|NCT01347866|450194235|FG016|Overall Study|Lost to Follow-up|0|||
125155971|NCT01347866|450194219|FG000|Overall Study|Other|3|||
125155972|NCT01347866|450194220|FG001|Overall Study|Other|1|||
125155973|NCT01347866|450194221|FG002|Overall Study|Other|1|||
125155974|NCT01347866|450194222|FG003|Overall Study|Other|4|||
125155975|NCT01347866|450194223|FG004|Overall Study|Other|5|||
125155976|NCT01347866|450194224|FG005|Overall Study|Other|0|||
125155977|NCT01347866|450194225|FG006|Overall Study|Other|5|||
125155978|NCT01347866|450194226|FG007|Overall Study|Other|3|||
125155979|NCT01347866|450194227|FG008|Overall Study|Other|22|||
125155980|NCT01347866|450194228|FG009|Overall Study|Other|5|||
125155981|NCT01347866|450194229|FG010|Overall Study|Other|0|||
125155982|NCT01347866|450194230|FG011|Overall Study|Other|3|||
125155983|NCT01347866|450194231|FG012|Overall Study|Other|4|||
125155984|NCT01347866|450194232|FG013|Overall Study|Other|4|||
125155985|NCT01347866|450194233|FG014|Overall Study|Other|2|||
125155986|NCT01347866|450194234|FG015|Overall Study|Other|3|||
125155987|NCT01347866|450194235|FG016|Overall Study|Other|0|||
125155988|NCT01347866|450194219|FG000|Overall Study|Subject refused further follow-up|2|||
125155989|NCT01347866|450194220|FG001|Overall Study|Subject refused further follow-up|0|||
125155990|NCT01347866|450194221|FG002|Overall Study|Subject refused further follow-up|0|||
125155991|NCT01347866|450194222|FG003|Overall Study|Subject refused further follow-up|2|||
125155992|NCT01347866|450194223|FG004|Overall Study|Subject refused further follow-up|0|||
125155993|NCT01347866|450194224|FG005|Overall Study|Subject refused further follow-up|1|||
125155994|NCT01347866|450194225|FG006|Overall Study|Subject refused further follow-up|0|||
125155995|NCT01347866|450194226|FG007|Overall Study|Subject refused further follow-up|0|||
125155996|NCT01347866|450194227|FG008|Overall Study|Subject refused further follow-up|4|||
125155997|NCT01347866|450194228|FG009|Overall Study|Subject refused further follow-up|1|||
125155998|NCT01347866|450194229|FG010|Overall Study|Subject refused further follow-up|0|||
125155999|NCT01347866|450194230|FG011|Overall Study|Subject refused further follow-up|0|||
125156000|NCT01347866|450194231|FG012|Overall Study|Subject refused further follow-up|1|||
125156001|NCT01347866|450194232|FG013|Overall Study|Subject refused further follow-up|3|||
125156002|NCT01347866|450194233|FG014|Overall Study|Subject refused further follow-up|1|||
125156003|NCT01347866|450194234|FG015|Overall Study|Subject refused further follow-up|0|||
125156004|NCT01347866|450194235|FG016|Overall Study|Subject refused further follow-up|2|||
125156005|NCT00869024|450194236|FG000|Overall Study|Death|2|||
125156006|NCT00869024|450194237|FG001|Overall Study|Death|3|||
125156007|NCT00869024|450194236|FG000|Overall Study|Lost to Follow-up|0|||
125156008|NCT00869024|450194237|FG001|Overall Study|Lost to Follow-up|1|||
125156009|NCT00869024|450194236|FG000|Overall Study|Protocol Violation|0|||
125156010|NCT00869024|450194237|FG001|Overall Study|Protocol Violation|1|||
125156011|NCT00293202|450194238|FG000|Overall Study|Withdrawal by Subject|1|||
125156012|NCT00293202|450194239|FG001|Overall Study|Withdrawal by Subject|2|||
125156013|NCT00293202|450194238|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
125156014|NCT00293202|450194239|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
125156015|NCT00293202|450194238|FG000|Overall Study|on-hold due to fistula maturation time|1|||
125156016|NCT00293202|450194239|FG001|Overall Study|on-hold due to fistula maturation time|0|||
125156017|NCT02442271|450194240|FG000|Overall Study|Adverse Event|1|||
125156018|NCT02442271|450194240|FG000|Overall Study|Withdrew Consent|1|||
125156019|NCT02442271|450194240|FG000|Overall Study|Lost to Follow-up|1|||
125156020|NCT02442271|450194240|FG000|Overall Study|Other|1|||
125156021|NCT01560507|450194242|FG000|Overall Study|Lost to Follow-up|3|||
125156022|NCT01560507|450194243|FG001|Overall Study|Lost to Follow-up|1|||
125156023|NCT01560507|450194244|FG002|Overall Study|Lost to Follow-up|2|||
125156024|NCT01560507|450194242|FG000|Overall Study|Withdrawal by Subject|1|||
125156025|NCT01560507|450194243|FG001|Overall Study|Withdrawal by Subject|1|||
125156026|NCT01560507|450194244|FG002|Overall Study|Withdrawal by Subject|0|||
125156027|NCT02080832|450194245|FG000|Overall Study|Excluded from analysis by MRI|9|||
125156028|NCT02080832|450194246|FG001|Overall Study|Excluded from analysis by MRI|10|||
125156029|NCT02080832|450194247|FG002|Overall Study|Excluded from analysis by MRI|14|||
125156030|NCT02080832|450194245|FG000|Overall Study|Lost to Follow-up|0|||
125156031|NCT02080832|450194246|FG001|Overall Study|Lost to Follow-up|2|||
125156032|NCT02080832|450194247|FG002|Overall Study|Lost to Follow-up|2|||
125156033|NCT02427984|450194248|FG000|Overall Study|Lost to Follow-up|13|||
125156034|NCT02427984|450194249|FG001|Overall Study|Lost to Follow-up|5|||
125156035|NCT02427984|450194250|FG002|Overall Study|Lost to Follow-up|18|||
125156036|NCT01491035|450194255|FG000|Overall Study|Lost to Follow-up|0|||
125156037|NCT01491035|450194256|FG001|Overall Study|Lost to Follow-up|0|||
125156038|NCT01491035|450194257|FG002|Overall Study|Lost to Follow-up|0|||
125156039|NCT01491035|450194258|FG003|Overall Study|Lost to Follow-up|0|||
125156040|NCT01491035|450194259|FG004|Overall Study|Lost to Follow-up|1|||
125156041|NCT01491035|450194260|FG005|Overall Study|Lost to Follow-up|0|||
125156042|NCT01491035|450194261|FG006|Overall Study|Lost to Follow-up|0|||
125156043|NCT01491035|450194262|FG007|Overall Study|Lost to Follow-up|0|||
125156044|NCT01277718|450194267|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
125156045|NCT01277718|450194268|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
125156046|NCT01277718|450194267|FG000|Period 2 - Second Intervention|Physician Decision|0|||
125156047|NCT01277718|450194268|FG001|Period 2 - Second Intervention|Physician Decision|2|||
125156048|NCT01524913|450194269|FG000|Overall Study|Lost to Follow-up|4|||
125156049|NCT01524913|450194270|FG001|Overall Study|Lost to Follow-up|0|||
125156050|NCT01524913|450194271|FG002|Overall Study|Lost to Follow-up|0|||
125156051|NCT03351231|450194285|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
125156052|NCT03351231|450194285|FG000|Combination Therapy Period|Disease progression|2|||
125156053|NCT03351231|450194285|FG000|Combination Therapy Period|Study drug toxicity|1|||
125156054|NCT03351231|450194285|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
125156055|NCT03351231|450194285|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
125156056|NCT03351231|450194285|FG000|Safety Follow-Up Period|Other reason|2|||
125156057|NCT02858726|450194286|FG000|Overall Study|Adverse Event|4|||
125156058|NCT02858726|450194287|FG001|Overall Study|Adverse Event|4|||
125156059|NCT02858726|450194288|FG002|Overall Study|Adverse Event|9|||
125156060|NCT02858726|450194289|FG003|Overall Study|Adverse Event|1|||
125156061|NCT02858726|450194286|FG000|Overall Study|Physician Decision|0|||
125156062|NCT02858726|450194287|FG001|Overall Study|Physician Decision|0|||
125156063|NCT02858726|450194288|FG002|Overall Study|Physician Decision|1|||
125156064|NCT02858726|450194289|FG003|Overall Study|Physician Decision|0|||
125156065|NCT02858726|450194286|FG000|Overall Study|Protocol Violation|0|||
125156066|NCT02858726|450194287|FG001|Overall Study|Protocol Violation|0|||
125156067|NCT02858726|450194288|FG002|Overall Study|Protocol Violation|0|||
125156068|NCT02858726|450194289|FG003|Overall Study|Protocol Violation|1|||
125156069|NCT02858726|450194286|FG000|Overall Study|Study Terminated by Sponsor|0|||
125156070|NCT02858726|450194287|FG001|Overall Study|Study Terminated by Sponsor|0|||
125156071|NCT02858726|450194288|FG002|Overall Study|Study Terminated by Sponsor|0|||
125156072|NCT02858726|450194289|FG003|Overall Study|Study Terminated by Sponsor|1|||
125156073|NCT02858726|450194286|FG000|Overall Study|Withdrawal by Subject|1|||
125156074|NCT02858726|450194287|FG001|Overall Study|Withdrawal by Subject|2|||
125156075|NCT02858726|450194288|FG002|Overall Study|Withdrawal by Subject|1|||
125156076|NCT02858726|450194289|FG003|Overall Study|Withdrawal by Subject|0|||
125156077|NCT02858726|450194286|FG000|Overall Study|Noncompliance|0|||
125156078|NCT02858726|450194287|FG001|Overall Study|Noncompliance|1|||
125156079|NCT02858726|450194288|FG002|Overall Study|Noncompliance|0|||
125156080|NCT02858726|450194289|FG003|Overall Study|Noncompliance|0|||
125156081|NCT00233987|450194292|FG000|Overall Study|Withdrawal by Subject|1|||
125156082|NCT00233987|450194292|FG000|Overall Study|Lack of Efficacy|2|||
125156083|NCT00233987|450194292|FG000|Overall Study|Reason Under Review|1|||
125156084|NCT00233987|450194292|FG000|Overall Study|Other - Not Protocol Specified|5|||
125156085|NCT00233987|450194292|FG000|Overall Study|Eligible but No Treatment Received|2|||
125156086|NCT00233987|450194292|FG000|Overall Study|Ineligible|4|||
125156087|NCT00518622|450194295|FG000|Overall Study|Lost to Follow-up|0|||
125156088|NCT00518622|450194296|FG001|Overall Study|Lost to Follow-up|0|||
125156089|NCT00518622|450194297|FG002|Overall Study|Lost to Follow-up|1|||
125156090|NCT00518622|450194298|FG003|Overall Study|Lost to Follow-up|0|||
125156091|NCT00518622|450194299|FG004|Overall Study|Lost to Follow-up|0|||
125156092|NCT00518622|450194300|FG005|Overall Study|Lost to Follow-up|0|||
125156093|NCT00518622|450194301|FG006|Overall Study|Lost to Follow-up|0|||
125156094|NCT00518622|450194302|FG007|Overall Study|Lost to Follow-up|0|||
125156095|NCT00518622|450194295|FG000|Overall Study|Study medication taken incorrectly|0|||
125156096|NCT00518622|450194296|FG001|Overall Study|Study medication taken incorrectly|1|||
125156097|NCT00518622|450194297|FG002|Overall Study|Study medication taken incorrectly|0|||
125156098|NCT00518622|450194298|FG003|Overall Study|Study medication taken incorrectly|0|||
125156099|NCT00518622|450194299|FG004|Overall Study|Study medication taken incorrectly|0|||
125156100|NCT00518622|450194300|FG005|Overall Study|Study medication taken incorrectly|0|||
125156101|NCT00518622|450194301|FG006|Overall Study|Study medication taken incorrectly|0|||
125156102|NCT00518622|450194302|FG007|Overall Study|Study medication taken incorrectly|0|||
125156103|NCT01688726|450194303|FG000|Overall Study|Adverse Event|1|||
125156104|NCT01688726|450194304|FG001|Overall Study|Adverse Event|0|||
125156105|NCT01688726|450194303|FG000|Overall Study|Relocated abroad|0|||
125156106|NCT01688726|450194304|FG001|Overall Study|Relocated abroad|1|||
125156107|NCT02177136|450195823|FG000|DB Phase|Withdrawal by Subject|2|||
125156108|NCT02177136|450195824|FG001|DB Phase|Withdrawal by Subject|0|||
125156109|NCT02177136|450195825|FG002|DB Phase|Withdrawal by Subject|0|||
125156110|NCT02177136|450195826|FG003|DB Phase|Withdrawal by Subject|0|||
125156111|NCT02177136|450195823|FG000|DB Phase|Discontinued Due to Pruritus|1|||
125156112|NCT02177136|450195824|FG001|DB Phase|Discontinued Due to Pruritus|3|||
125156113|NCT02177136|450195825|FG002|DB Phase|Discontinued Due to Pruritus|0|||
125156114|NCT02177136|450195826|FG003|DB Phase|Discontinued Due to Pruritus|0|||
125156115|NCT02177136|450195823|FG000|DB Phase|Adverse Event|3|||
125156116|NCT02177136|450195824|FG001|DB Phase|Adverse Event|2|||
125156117|NCT02177136|450195825|FG002|DB Phase|Adverse Event|3|||
125156118|NCT02177136|450195826|FG003|DB Phase|Adverse Event|0|||
125156119|NCT02177136|450195823|FG000|DB Phase|Protocol Violation|0|||
125156120|NCT02177136|450195824|FG001|DB Phase|Protocol Violation|0|||
125156121|NCT02177136|450195825|FG002|DB Phase|Protocol Violation|1|||
125156122|NCT02177136|450195826|FG003|DB Phase|Protocol Violation|0|||
125156123|NCT02177136|450195823|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
125156124|NCT02177136|450195824|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
125156125|NCT02177136|450195825|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
125156126|NCT02177136|450195826|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
125156127|NCT02177136|450195823|FG000|LTSE Phase|Withdrawal by Subject|0|||
125156128|NCT02177136|450195824|FG001|LTSE Phase|Withdrawal by Subject|0|||
125156129|NCT02177136|450195825|FG002|LTSE Phase|Withdrawal by Subject|0|||
125156130|NCT02177136|450195826|FG003|LTSE Phase|Withdrawal by Subject|6|||
125156131|NCT02177136|450195823|FG000|LTSE Phase|Adverse Event|0|||
125156132|NCT02177136|450195824|FG001|LTSE Phase|Adverse Event|0|||
125156133|NCT02177136|450195825|FG002|LTSE Phase|Adverse Event|0|||
125156134|NCT02177136|450195826|FG003|LTSE Phase|Adverse Event|10|||
125156135|NCT02177136|450195823|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
125156136|NCT02177136|450195824|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
125156137|NCT02177136|450195825|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
125156138|NCT02177136|450195826|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
125156139|NCT02177136|450195823|FG000|LTSE Phase|Physician Decision|0|||
125156140|NCT02177136|450195824|FG001|LTSE Phase|Physician Decision|0|||
125156141|NCT02177136|450195825|FG002|LTSE Phase|Physician Decision|0|||
125156142|NCT02177136|450195826|FG003|LTSE Phase|Physician Decision|2|||
125156143|NCT02177136|450195823|FG000|LTSE Phase|Lost to Follow-up|0|||
125156144|NCT02177136|450195824|FG001|LTSE Phase|Lost to Follow-up|0|||
125156145|NCT02177136|450195825|FG002|LTSE Phase|Lost to Follow-up|0|||
125156146|NCT02177136|450195826|FG003|LTSE Phase|Lost to Follow-up|1|||
125156147|NCT02177136|450195823|FG000|LTSE Phase|Participant Moved|0|||
125156148|NCT02177136|450195824|FG001|LTSE Phase|Participant Moved|0|||
125156149|NCT02177136|450195825|FG002|LTSE Phase|Participant Moved|0|||
125156150|NCT02177136|450195826|FG003|LTSE Phase|Participant Moved|1|||
125156151|NCT01386684|450195827|FG000|Overall Study|Lost to Follow-up|51|||
125156152|NCT01386684|450195827|FG000|Overall Study|Other|51|||
125156153|NCT01386684|450195827|FG000|Overall Study|Death|47|||
125156154|NCT01386684|450195827|FG000|Overall Study|Withdrawal of Consent|44|||
125156155|NCT01386684|450195827|FG000|Overall Study|Alternative Therapy Required|37|||
125156156|NCT01386684|450195827|FG000|Overall Study|Disease Progression|28|||
125156157|NCT01386684|450195827|FG000|Overall Study|Adverse Event|20|||
125156158|NCT01386684|450195827|FG000|Overall Study|Noncompliance|8|||
125156159|NCT01386684|450195827|FG000|Overall Study|Protocol Violation|4|||
125156160|NCT01386684|450195827|FG000|Overall Study|Missing|3|||
125156161|NCT03197558|450195832|FG000|Overall Study|Tubes not placed|1|||
125156162|NCT02072148|450195843|FG000|Overall Study|withdrew prior to surgery|23|||
125156163|NCT02072148|450195844|FG001|Overall Study|withdrew prior to surgery|0|||
125156164|NCT02072148|450195845|FG002|Overall Study|withdrew prior to surgery|0|||
125156165|NCT02072148|450195843|FG000|Overall Study|Death|0|||
125156166|NCT02072148|450195844|FG001|Overall Study|Death|0|||
125156167|NCT02072148|450195845|FG002|Overall Study|Death|1|||
125156168|NCT02072148|450195843|FG000|Overall Study|Withdrawal by Subject|0|||
125156169|NCT02072148|450195844|FG001|Overall Study|Withdrawal by Subject|13|||
125156170|NCT02072148|450195845|FG002|Overall Study|Withdrawal by Subject|12|||
125156171|NCT02528123|450195851|FG000|Overall Study|Lost to Follow-up|1|||
125156172|NCT01892657|450195855|FG000|Overall Study|Withdrawal by Subject|6|||
125156173|NCT01892657|450195855|FG000|Overall Study|Protocol Violation|12|||
125156174|NCT03463993|450195861|FG000|Overall Study|Lost to Follow-up|7|||
125156175|NCT03463993|450195862|FG001|Overall Study|Lost to Follow-up|8|||
125156176|NCT03463993|450195861|FG000|Overall Study|Withdrawal by Subject|2|||
125156177|NCT03463993|450195862|FG001|Overall Study|Withdrawal by Subject|0|||
125156178|NCT03463993|450195861|FG000|Overall Study|Protocol Violation|4|||
125156179|NCT03463993|450195862|FG001|Overall Study|Protocol Violation|1|||
125156180|NCT03463993|450195861|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
125156181|NCT03463993|450195862|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
125156182|NCT03463993|450195861|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
125156183|NCT03463993|450195862|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
125156184|NCT01478828|450195863|FG000|Overall Study|Adverse Event|1|||
125156185|NCT00136318|450195864|FG000|Overall Study|Adverse Event|5|||
125156186|NCT00136318|450195865|FG001|Overall Study|Adverse Event|5|||
125156187|NCT00136318|450195864|FG000|Overall Study|Withdrawal by Subject|2|||
125156188|NCT00136318|450195865|FG001|Overall Study|Withdrawal by Subject|2|||
125223856|NCT04863872|450446253|FG001|Overall Study|Death|2|||
125156189|NCT02654587|450195885|FG000|Overall Study|patient alive at end of study|22|||
125156190|NCT02654587|450195886|FG001|Overall Study|patient alive at end of study|8|||
125156191|NCT02654587|450195885|FG000|Overall Study|Withdrawal by Subject|1|||
125156192|NCT02654587|450195886|FG001|Overall Study|Withdrawal by Subject|7|||
125156193|NCT01843348|450195889|FG000|Overall Study|Withdrawal by Subject|4|||
125156194|NCT01843348|450195890|FG001|Overall Study|Withdrawal by Subject|16|||
125156195|NCT01843348|450195891|FG002|Overall Study|Withdrawal by Subject|18|||
125156196|NCT01843348|450195889|FG000|Overall Study|Lost to Follow-up|5|||
125156197|NCT01843348|450195890|FG001|Overall Study|Lost to Follow-up|4|||
125156198|NCT01843348|450195891|FG002|Overall Study|Lost to Follow-up|2|||
125156199|NCT01843348|450195889|FG000|Overall Study|Death|5|||
125156200|NCT01843348|450195890|FG001|Overall Study|Death|3|||
125156201|NCT01843348|450195891|FG002|Overall Study|Death|4|||
125156202|NCT01843348|450195889|FG000|Overall Study|Graft loss/retransplantation|5|||
125156203|NCT01843348|450195890|FG001|Overall Study|Graft loss/retransplantation|8|||
125156204|NCT01843348|450195891|FG002|Overall Study|Graft loss/retransplantation|11|||
125156205|NCT01843348|450195889|FG000|Overall Study|Various reasons|4|||
125156206|NCT01843348|450195890|FG001|Overall Study|Various reasons|9|||
125156207|NCT01843348|450195891|FG002|Overall Study|Various reasons|6|||
125156208|NCT02039414|450195892|FG000|Overall Study|Delivered|1|||
125156209|NCT02039414|450195893|FG001|Overall Study|Delivered|1|||
125156210|NCT02039414|450195892|FG000|Overall Study|Lost to Follow-up|2|||
125156211|NCT02039414|450195893|FG001|Overall Study|Lost to Follow-up|0|||
125156212|NCT02039414|450195892|FG000|Overall Study|Protocol Violation|3|||
125156213|NCT02039414|450195893|FG001|Overall Study|Protocol Violation|1|||
125156214|NCT00430950|450195894|FG000|Overall Study|Adverse Event|7|||
125156215|NCT00430950|450195895|FG001|Overall Study|Adverse Event|6|||
125156216|NCT00430950|450195894|FG000|Overall Study|Withdrawal by Subject|1|||
125156217|NCT00430950|450195895|FG001|Overall Study|Withdrawal by Subject|0|||
125156218|NCT00430950|450195894|FG000|Overall Study|concomitant medication,etc.|5|||
125156219|NCT00430950|450195895|FG001|Overall Study|concomitant medication,etc.|7|||
125156220|NCT02429934|450195898|FG000|Overall Study|Withdrawal by Subject|0|||
125156221|NCT02429934|450195899|FG001|Overall Study|Withdrawal by Subject|2|||
125156222|NCT02429934|450195898|FG000|Overall Study|Adverse Event|2|||
125156223|NCT02429934|450195899|FG001|Overall Study|Adverse Event|0|||
125156224|NCT02429934|450195898|FG000|Overall Study|Lost to Follow-up|1|||
125156225|NCT02429934|450195899|FG001|Overall Study|Lost to Follow-up|1|||
125156226|NCT02429934|450195898|FG000|Overall Study|Physician Decision|1|||
125156227|NCT02429934|450195899|FG001|Overall Study|Physician Decision|0|||
125156228|NCT00831623|450195903|FG000|Overall Study|Withdrawal by Subject|9|||
125156229|NCT00831623|450195903|FG000|Overall Study|Lost to Follow-up|1|||
125156230|NCT00831623|450195903|FG000|Overall Study|Not 2 years post-treatment|12|||
125156231|NCT01564459|450195907|FG000|Run-In|Adverse Event|7|||
125156232|NCT01564459|450195908|FG001|Run-In|Adverse Event|0|||
125156233|NCT01564459|450195909|FG002|Run-In|Adverse Event|0|||
125156234|NCT01564459|450195907|FG000|Run-In|Lost to Follow-up|1|||
125156235|NCT01564459|450195908|FG001|Run-In|Lost to Follow-up|0|||
125156236|NCT01564459|450195909|FG002|Run-In|Lost to Follow-up|0|||
125156237|NCT01564459|450195907|FG000|Run-In|Non-compliance with study drug|2|||
125156238|NCT01564459|450195908|FG001|Run-In|Non-compliance with study drug|0|||
125156239|NCT01564459|450195909|FG002|Run-In|Non-compliance with study drug|0|||
125156240|NCT01564459|450195907|FG000|Run-In|Protocol Violation|1|||
125156241|NCT01564459|450195908|FG001|Run-In|Protocol Violation|0|||
125156242|NCT01564459|450195909|FG002|Run-In|Protocol Violation|0|||
125156243|NCT01564459|450195907|FG000|Run-In|Withdrawal by Subject|1|||
125156244|NCT01564459|450195908|FG001|Run-In|Withdrawal by Subject|0|||
125156245|NCT01564459|450195909|FG002|Run-In|Withdrawal by Subject|0|||
125156246|NCT01564459|450195907|FG000|Double-blind Treatment|Adverse Event|0|||
125156247|NCT01564459|450195908|FG001|Double-blind Treatment|Adverse Event|0|||
125156248|NCT01564459|450195909|FG002|Double-blind Treatment|Adverse Event|1|||
125156249|NCT00706992|450195915|FG000|Overall Study|Study termination|5|||
125156250|NCT00706992|450195916|FG001|Overall Study|Study termination|5|||
125156251|NCT00706992|450195917|FG002|Overall Study|Study termination|6|||
125156252|NCT00706992|450195918|FG003|Overall Study|Study termination|2|||
125156253|NCT00706992|450195919|FG004|Overall Study|Study termination|3|||
125156254|NCT00706992|450195920|FG005|Overall Study|Study termination|2|||
125156255|NCT00706992|450195921|FG006|Overall Study|Study termination|3|||
125156256|NCT00706992|450195915|FG000|Overall Study|Disease progression before treatment|0|||
125156257|NCT00706992|450195916|FG001|Overall Study|Disease progression before treatment|0|||
125156258|NCT00706992|450195917|FG002|Overall Study|Disease progression before treatment|0|||
125156259|NCT00706992|450195918|FG003|Overall Study|Disease progression before treatment|0|||
125156260|NCT00706992|450195919|FG004|Overall Study|Disease progression before treatment|1|||
125156261|NCT00706992|450195920|FG005|Overall Study|Disease progression before treatment|0|||
125156262|NCT00706992|450195921|FG006|Overall Study|Disease progression before treatment|0|||
125156263|NCT03545191|450195922|FG000|Overall Study|Death|1|||
125156264|NCT03545191|450195923|FG001|Overall Study|Death|0|||
125156265|NCT03545191|450195924|FG002|Overall Study|Death|0|||
125156266|NCT03545191|450195922|FG000|Overall Study|Adverse Event|4|||
125156267|NCT03545191|450195923|FG001|Overall Study|Adverse Event|2|||
125156268|NCT03545191|450195924|FG002|Overall Study|Adverse Event|7|||
125156269|NCT03545191|450195922|FG000|Overall Study|Other reasons|3|||
125156270|NCT03545191|450195923|FG001|Overall Study|Other reasons|11|||
125156271|NCT03545191|450195924|FG002|Overall Study|Other reasons|8|||
125156272|NCT03545191|450195922|FG000|Overall Study|Withdrawal by Subject|13|||
125156273|NCT03545191|450195923|FG001|Overall Study|Withdrawal by Subject|10|||
125156274|NCT03545191|450195924|FG002|Overall Study|Withdrawal by Subject|12|||
125156275|NCT03545191|450195922|FG000|Overall Study|Lost to Follow-up|1|||
125156276|NCT03545191|450195923|FG001|Overall Study|Lost to Follow-up|2|||
125156277|NCT03545191|450195924|FG002|Overall Study|Lost to Follow-up|3|||
125156278|NCT02377063|450195928|FG000|Overall Study|Non-compliance|5|||
125156279|NCT02746627|450195934|FG000|Overall Study|Withdrawal by Subject|1|||
125156280|NCT02746627|450195935|FG001|Overall Study|Withdrawal by Subject|1|||
125156281|NCT02746627|450195936|FG002|Overall Study|Withdrawal by Subject|1|||
125156282|NCT02340221|450195939|FG000|Overall Study|Death|100|||
125156283|NCT02340221|450195940|FG001|Overall Study|Death|197|||
125156284|NCT02340221|450195939|FG000|Overall Study|Withdrawal by Participant|24|||
125156285|NCT02340221|450195940|FG001|Overall Study|Withdrawal by Participant|37|||
125156286|NCT02340221|450195939|FG000|Overall Study|Lost to Follow-up|4|||
125156287|NCT02340221|450195940|FG001|Overall Study|Lost to Follow-up|15|||
125156288|NCT02340221|450195939|FG000|Overall Study|Reason Not Specified|85|||
125156289|NCT02340221|450195940|FG001|Overall Study|Reason Not Specified|165|||
125156290|NCT02340221|450195939|FG000|Overall Study|Study Terminated by Sponsor|1|||
125156291|NCT02340221|450195940|FG001|Overall Study|Study Terminated by Sponsor|3|||
125156292|NCT03499119|450195941|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
125156293|NCT03499119|450195942|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
125156294|NCT03499119|450195943|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
125156295|NCT03499119|450195944|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
125156296|NCT03499119|450195941|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
125156297|NCT03499119|450195942|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
125156298|NCT03499119|450195943|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
125156299|NCT03499119|450195944|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
125156300|NCT03499119|450195941|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
125156301|NCT03499119|450195942|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
125156302|NCT03499119|450195943|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
125156303|NCT03499119|450195944|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
125156304|NCT03499119|450195941|FG000|Optional Extension Phase|Lost to Follow-up|0|||
125156305|NCT03499119|450195942|FG001|Optional Extension Phase|Lost to Follow-up|0|||
125156306|NCT03499119|450195943|FG002|Optional Extension Phase|Lost to Follow-up|0|||
125156307|NCT03499119|450195944|FG003|Optional Extension Phase|Lost to Follow-up|1|||
125156308|NCT03499119|450195941|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
125156309|NCT03499119|450195942|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
125156310|NCT03499119|450195943|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
125156311|NCT03499119|450195944|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
125156312|NCT03499119|450195941|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
125156313|NCT03499119|450195942|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
125156314|NCT03499119|450195943|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
125156315|NCT03499119|450195944|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
125156316|NCT00588640|450195945|FG000|Overall Study|Physician Decision|1|||
125156317|NCT00588640|450195945|FG000|Overall Study|Ineligible Patient|1|||
125156318|NCT00103402|450195946|FG000|Overall Study|Adverse Event|3|||
125156319|NCT00103402|450195947|FG001|Overall Study|Adverse Event|4|||
125156320|NCT00103402|450195946|FG000|Overall Study|Lost to Follow-up|8|||
125156321|NCT00103402|450195947|FG001|Overall Study|Lost to Follow-up|7|||
125156322|NCT00103402|450195946|FG000|Overall Study|Dissatisfied/No longer interested|6|||
125156323|NCT00103402|450195947|FG001|Overall Study|Dissatisfied/No longer interested|6|||
125156324|NCT00103402|450195946|FG000|Overall Study|Personal constraints/Other|5|||
125156325|NCT00103402|450195947|FG001|Overall Study|Personal constraints/Other|0|||
125156326|NCT01393730|450195948|FG000|Overall Study|Withdrawal by Subject|3|||
125156327|NCT01393730|450195948|FG000|Overall Study|Other|2|||
125156328|NCT01393730|450195948|FG000|Overall Study|Adverse Event|1|||
125156329|NCT01481324|450195951|FG000|Overall Study|Missing Data|0|||
125156330|NCT01481324|450195952|FG001|Overall Study|Missing Data|2|||
125156331|NCT01481324|450195953|FG002|Overall Study|Missing Data|2|||
125156332|NCT01172821|450195955|FG000|Overall Study|Adverse Event|5|||
125156333|NCT01172821|450195956|FG001|Overall Study|Adverse Event|2|||
125156334|NCT01172821|450195957|FG002|Overall Study|Adverse Event|2|||
125156335|NCT01172821|450195958|FG003|Overall Study|Adverse Event|7|||
125156336|NCT01172821|450195955|FG000|Overall Study|Protocol Violation|0|||
125156337|NCT01172821|450195956|FG001|Overall Study|Protocol Violation|2|||
125156338|NCT01172821|450195957|FG002|Overall Study|Protocol Violation|1|||
125156339|NCT01172821|450195958|FG003|Overall Study|Protocol Violation|2|||
125156340|NCT01172821|450195955|FG000|Overall Study|Lost to Follow-up|4|||
125156341|NCT01172821|450195956|FG001|Overall Study|Lost to Follow-up|1|||
125156342|NCT01172821|450195957|FG002|Overall Study|Lost to Follow-up|2|||
125156343|NCT01172821|450195958|FG003|Overall Study|Lost to Follow-up|2|||
125156344|NCT01172821|450195955|FG000|Overall Study|Withdrawal by Subject|2|||
125156345|NCT01172821|450195956|FG001|Overall Study|Withdrawal by Subject|3|||
125156346|NCT01172821|450195957|FG002|Overall Study|Withdrawal by Subject|3|||
125156347|NCT01172821|450195958|FG003|Overall Study|Withdrawal by Subject|3|||
125156348|NCT01172821|450195955|FG000|Overall Study|Other|3|||
125156349|NCT01172821|450195956|FG001|Overall Study|Other|4|||
125156350|NCT01172821|450195957|FG002|Overall Study|Other|5|||
125156351|NCT01172821|450195958|FG003|Overall Study|Other|3|||
125156352|NCT00123955|450195959|FG000|Overall Study|Adverse Event|1|||
125156353|NCT00123955|450195960|FG001|Overall Study|Adverse Event|0|||
125156354|NCT00123955|450195959|FG000|Overall Study|Withdrawal by Subject|4|||
125156355|NCT00123955|450195960|FG001|Overall Study|Withdrawal by Subject|3|||
125156356|NCT00123955|450195959|FG000|Overall Study|Death|0|||
125156357|NCT00123955|450195960|FG001|Overall Study|Death|1|||
125156358|NCT01663727|450195962|FG000|Overall Study|Death|161|||
125156359|NCT01663727|450195963|FG001|Overall Study|Death|155|||
125156360|NCT01663727|450195962|FG000|Overall Study|Lost to Follow-up|10|||
125156361|NCT01663727|450195963|FG001|Overall Study|Lost to Follow-up|8|||
125156362|NCT01663727|450195962|FG000|Overall Study|Withdrawal by Subject|18|||
125156363|NCT01663727|450195963|FG001|Overall Study|Withdrawal by Subject|25|||
125156364|NCT01663727|450195962|FG000|Overall Study|Study Terminated|51|||
125156365|NCT01663727|450195963|FG001|Overall Study|Study Terminated|50|||
125156366|NCT01663727|450195962|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
125156367|NCT01663727|450195963|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
125156368|NCT01663727|450195962|FG000|Overall Study|Withdrawal prior to dosing.|1|||
125156369|NCT01663727|450195963|FG001|Overall Study|Withdrawal prior to dosing.|0|||
125156370|NCT00003138|450197678|FG000|Step 1|Reasons off treatment not documented|60|||
125156371|NCT00003138|450197679|FG001|Step 1|Reasons off treatment not documented|57|||
125156372|NCT00003138|450197678|FG000|Step 1|Never started treatment|1|||
125156373|NCT00003138|450197679|FG001|Step 1|Never started treatment|0|||
125156374|NCT00003138|450197678|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
125156375|NCT00003138|450197679|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
125156376|NCT00003138|450197678|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
125156377|NCT00003138|450197679|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
125156378|NCT00003138|450197678|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
125156379|NCT00003138|450197679|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
125156380|NCT00003138|450197678|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
125156381|NCT00003138|450197679|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
125156382|NCT04495283|450197681|FG000|Overall Study|Physician Decision|0|||
125156383|NCT04495283|450197682|FG001|Overall Study|Physician Decision|0|||
125156384|NCT04495283|450197683|FG002|Overall Study|Physician Decision|1|||
125156385|NCT04495283|450197681|FG000|Overall Study|Withdrawal by Subject|0|||
125156386|NCT04495283|450197682|FG001|Overall Study|Withdrawal by Subject|1|||
125156387|NCT04495283|450197683|FG002|Overall Study|Withdrawal by Subject|1|||
125156388|NCT04495283|450197681|FG000|Overall Study|Other|1|||
125156389|NCT04495283|450197682|FG001|Overall Study|Other|0|||
125156390|NCT04495283|450197683|FG002|Overall Study|Other|1|||
125156391|NCT05142566|450197686|FG000|Overall Study|Protocol Violation|1|||
125156392|NCT02246439|450197687|FG000|Overall Study|Adverse Event|3|||
125156393|NCT02246439|450197688|FG001|Overall Study|Adverse Event|0|||
125156394|NCT02246439|450197687|FG000|Overall Study|Lost to Follow-up|7|||
125156395|NCT02246439|450197688|FG001|Overall Study|Lost to Follow-up|5|||
125156396|NCT02246439|450197687|FG000|Overall Study|Protocol Violation|0|||
125156397|NCT02246439|450197688|FG001|Overall Study|Protocol Violation|2|||
125156398|NCT02246439|450197687|FG000|Overall Study|Physician Decision|0|||
125156399|NCT02246439|450197688|FG001|Overall Study|Physician Decision|1|||
125156400|NCT02246439|450197687|FG000|Overall Study|Unkonwn|1|||
125156401|NCT02246439|450197688|FG001|Overall Study|Unkonwn|3|||
125223857|NCT04863872|450446252|FG000|Overall Study|Lost to Follow-up|2|||
125223858|NCT04863872|450446253|FG001|Overall Study|Lost to Follow-up|1|||
125156402|NCT02246439|450197687|FG000|Overall Study|Withdrawal by Subject|1|||
125156403|NCT02246439|450197688|FG001|Overall Study|Withdrawal by Subject|0|||
125156404|NCT01553279|450197689|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
125156405|NCT01553279|450197690|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
125156406|NCT01553279|450197689|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
125156407|NCT01553279|450197690|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
125156408|NCT01553279|450197689|FG000|Interim Period|Withdrawal by Subject|2|||
125156409|NCT01553279|450197690|FG001|Interim Period|Withdrawal by Subject|2|||
125156410|NCT01553279|450197689|FG000|Interim Period|Lost to Follow-up|1|||
125156411|NCT01553279|450197690|FG001|Interim Period|Lost to Follow-up|0|||
125156412|NCT01553279|450197689|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
125156413|NCT01553279|450197690|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
125156414|NCT01553279|450197689|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
125156415|NCT01553279|450197690|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
125156416|NCT00380692|450197691|FG000|Study Period II - Double Blind|Adverse Event|1|||
125156417|NCT00380692|450197692|FG001|Study Period II - Double Blind|Adverse Event|0|||
125156418|NCT00380692|450197691|FG000|Study Period II - Double Blind|Protocol Violation|2|||
125156419|NCT00380692|450197692|FG001|Study Period II - Double Blind|Protocol Violation|2|||
125156420|NCT00380692|450197691|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
125156421|NCT00380692|450197692|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
125156422|NCT00380692|450197691|FG000|Study Period II - Double Blind|Physician Decision|0|||
125156423|NCT00380692|450197692|FG001|Study Period II - Double Blind|Physician Decision|1|||
125156424|NCT00380692|450197691|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
125156425|NCT00380692|450197692|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
125156426|NCT00380692|450197691|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
125156427|NCT00380692|450197692|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
125156428|NCT00380692|450197691|FG000|Study Period III - Open Label|Adverse Event|5|||
125156429|NCT00380692|450197692|FG001|Study Period III - Open Label|Adverse Event|3|||
125156430|NCT00380692|450197691|FG000|Study Period III - Open Label|Protocol Violation|0|||
125156431|NCT00380692|450197692|FG001|Study Period III - Open Label|Protocol Violation|0|||
125156432|NCT00380692|450197691|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
125156433|NCT00380692|450197692|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
125223859|NCT04058028|450446254|FG000|Overall Study|Withdrawal of Consent from Study|12|||
125156434|NCT00380692|450197691|FG000|Study Period III - Open Label|Physician Decision|0|||
125156435|NCT00380692|450197692|FG001|Study Period III - Open Label|Physician Decision|3|||
125156436|NCT00380692|450197691|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
125156437|NCT00380692|450197692|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
125156438|NCT00380692|450197691|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
125156439|NCT00380692|450197692|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
125156440|NCT01388166|450197693|FG000|Overall Study|Adverse Event|16|||
125156441|NCT01388166|450197693|FG000|Overall Study|Lost to Follow-up|30|||
125156442|NCT01388166|450197693|FG000|Overall Study|Others than specified above|13|||
125156443|NCT00158756|450197694|FG000|Overall Study|Withdrawal by Subject|5|||
125156444|NCT00158756|450197695|FG001|Overall Study|Withdrawal by Subject|0|||
125156445|NCT00158756|450197696|FG002|Overall Study|Withdrawal by Subject|6|||
125156446|NCT00158756|450197697|FG003|Overall Study|Withdrawal by Subject|1|||
125156447|NCT00158756|450197698|FG004|Overall Study|Withdrawal by Subject|3|||
125156448|NCT00158756|450197694|FG000|Overall Study|Adverse Event|0|||
125156449|NCT00158756|450197695|FG001|Overall Study|Adverse Event|0|||
125156450|NCT00158756|450197696|FG002|Overall Study|Adverse Event|1|||
125156451|NCT00158756|450197697|FG003|Overall Study|Adverse Event|0|||
125156452|NCT00158756|450197698|FG004|Overall Study|Adverse Event|0|||
125156453|NCT00158756|450197694|FG000|Overall Study|Serious adverse event|0|||
125156454|NCT00158756|450197695|FG001|Overall Study|Serious adverse event|0|||
125156455|NCT00158756|450197696|FG002|Overall Study|Serious adverse event|1|||
125156456|NCT00158756|450197697|FG003|Overall Study|Serious adverse event|0|||
125156457|NCT00158756|450197698|FG004|Overall Study|Serious adverse event|0|||
125156458|NCT01429051|450197699|FG000|Titration Phase|Death|1|||
125156459|NCT01429051|450197699|FG000|Titration Phase|Withdrawal by Subject|7|||
125156460|NCT01429051|450197699|FG000|Titration Phase|Physician Decision|1|||
125156461|NCT01429051|450197699|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
125156462|NCT01429051|450197699|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
125156463|NCT01429051|450197699|FG000|Efficacy Phase|Adverse Event|1|||
125156464|NCT01429051|450197699|FG000|Efficacy Phase|Death|1|||
125156465|NCT01429051|450197699|FG000|Tolerability Phase|Death|5|||
125156466|NCT01429051|450197699|FG000|Tolerability Phase|Adverse Event|2|||
125156467|NCT01429051|450197699|FG000|Tolerability Phase|Withdrawal by Subject|5|||
125156468|NCT01429051|450197699|FG000|Tolerability Phase|Physician Decision|1|||
125156469|NCT01429051|450197699|FG000|Tolerability Phase|Other|2|||
125156470|NCT04132336|450197700|FG000|Overall Study|Investigator Decision|0|||
125156471|NCT04132336|450197701|FG001|Overall Study|Investigator Decision|1|||
125156472|NCT04132336|450197702|FG002|Overall Study|Investigator Decision|0|||
125156473|NCT04132336|450197703|FG003|Overall Study|Investigator Decision|0|||
125156474|NCT04132336|450197704|FG004|Overall Study|Investigator Decision|0|||
125156475|NCT04132336|450197705|FG005|Overall Study|Investigator Decision|0|||
125156476|NCT04132336|450197706|FG006|Overall Study|Investigator Decision|0|||
125156477|NCT01939496|450197707|FG000|Overall Study|Adverse Event|2|||
125156478|NCT01939496|450197708|FG001|Overall Study|Adverse Event|0|||
125156479|NCT01939496|450197709|FG002|Overall Study|Adverse Event|0|||
125156480|NCT01939496|450197707|FG000|Overall Study|Lost to Follow-up|1|||
125156481|NCT01939496|450197708|FG001|Overall Study|Lost to Follow-up|1|||
125156482|NCT01939496|450197709|FG002|Overall Study|Lost to Follow-up|0|||
125156483|NCT01939496|450197707|FG000|Overall Study|Physician Decision|1|||
125156484|NCT01939496|450197708|FG001|Overall Study|Physician Decision|0|||
125156485|NCT01939496|450197709|FG002|Overall Study|Physician Decision|0|||
125156486|NCT01939496|450197707|FG000|Overall Study|Protocol Violation|3|||
125156487|NCT01939496|450197708|FG001|Overall Study|Protocol Violation|0|||
125156488|NCT01939496|450197709|FG002|Overall Study|Protocol Violation|0|||
125156489|NCT01939496|450197707|FG000|Overall Study|Withdrawal by Subject|0|||
125156490|NCT01939496|450197708|FG001|Overall Study|Withdrawal by Subject|1|||
125156491|NCT01939496|450197709|FG002|Overall Study|Withdrawal by Subject|1|||
125156492|NCT01939496|450197707|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
125156493|NCT01939496|450197708|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
125156494|NCT01939496|450197709|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
125156495|NCT01939496|450197707|FG000|Overall Study|Other|2|||
125156496|NCT01939496|450197708|FG001|Overall Study|Other|0|||
125156497|NCT01939496|450197709|FG002|Overall Study|Other|1|||
125156498|NCT03052322|450197710|FG000|Overall Study|Other un-specified|1|||
125156499|NCT03052322|450197711|FG001|Overall Study|Other un-specified|2|||
125156500|NCT03052322|450197710|FG000|Overall Study|Withdrawal by Subject|10|||
125156501|NCT03052322|450197711|FG001|Overall Study|Withdrawal by Subject|9|||
125156502|NCT03052322|450197710|FG000|Overall Study|Death|0|||
125156503|NCT03052322|450197711|FG001|Overall Study|Death|2|||
125156504|NCT03052322|450197710|FG000|Overall Study|Lack of Efficacy|1|||
125156505|NCT03052322|450197711|FG001|Overall Study|Lack of Efficacy|2|||
125156506|NCT03052322|450197710|FG000|Overall Study|Protocol Violation|1|||
125156507|NCT03052322|450197711|FG001|Overall Study|Protocol Violation|0|||
125156508|NCT03052322|450197710|FG000|Overall Study|Lost to Follow-up|2|||
125156509|NCT03052322|450197711|FG001|Overall Study|Lost to Follow-up|4|||
125156510|NCT03052322|450197710|FG000|Overall Study|Adverse Event|6|||
125156511|NCT03052322|450197711|FG001|Overall Study|Adverse Event|13|||
125156512|NCT04920916|450197712|FG000|Phase IIa 60 Day Study|Death|2|||
125156513|NCT04920916|450197713|FG001|Phase IIa 60 Day Study|Death|5|||
125156514|NCT04920916|450197712|FG000|1 Year Follow up (Phone Call)|Death|1|||
125156515|NCT04920916|450197713|FG001|1 Year Follow up (Phone Call)|Death|3|||
125156516|NCT04920916|450197712|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
125156517|NCT04920916|450197713|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
125156518|NCT00973765|450197714|FG000|Overall Study|Lost to Follow-up|8|||
125156519|NCT00973765|450197715|FG001|Overall Study|Lost to Follow-up|14|||
125156520|NCT02011113|450197716|FG000|Overall Study|Adverse Event|4|||
125156521|NCT02011113|450197716|FG000|Overall Study|Disease Progression (DP)|16|||
125156522|NCT02011113|450197716|FG000|Overall Study|Death|1|||
125156523|NCT02011113|450197716|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
125156524|NCT02011113|450197716|FG000|Overall Study|Investigator's judgement- DP|3|||
125156525|NCT02011113|450197716|FG000|Overall Study|Study terminated by sponsor|11|||
125156526|NCT00468728|450197723|FG000|Treatment|criteria for mITT population|4|||
125156527|NCT00468728|450197724|FG001|Treatment|criteria for mITT population|11|||
125156528|NCT00468728|450197723|FG000|Follow-up|mITT failure|34|||
125156529|NCT00468728|450197724|FG001|Follow-up|mITT failure|31|||
125156530|NCT03251963|450197725|FG000|Overall Study|inappropriate Xa level timing|6|||
125156531|NCT03251963|450197726|FG001|Overall Study|inappropriate Xa level timing|3|||
125156532|NCT03251963|450197725|FG000|Overall Study|no peak Xa level drawn|2|||
125156533|NCT03251963|450197726|FG001|Overall Study|no peak Xa level drawn|0|||
125156534|NCT03251963|450197725|FG000|Overall Study|bled prior to Xa level|1|||
125156535|NCT03251963|450197726|FG001|Overall Study|bled prior to Xa level|2|||
125156536|NCT04505293|450197727|FG000|Overall Study|Lost to Follow-up|2|||
125156537|NCT04505293|450197727|FG000|Overall Study|Withdrawal by Subject|6|||
125156538|NCT04505293|450197727|FG000|Overall Study|CT scan unreadable|277|||
125156539|NCT02712333|450197729|FG000|First Period|Withdrawal by Subject|3|||
125156540|NCT02712333|450197730|FG001|First Period|Withdrawal by Subject|2|||
125156541|NCT00775606|450197731|FG000|Overall Study|Study sponsor terminated funding|3|||
125156542|NCT00775606|450197732|FG001|Overall Study|Study sponsor terminated funding|0|||
125156543|NCT02278718|450197733|FG000|Overall Study|Adverse Event|1|||
125156544|NCT02278718|450197734|FG001|Overall Study|Adverse Event|0|||
125156545|NCT02278718|450197733|FG000|Overall Study|Lost to Follow-up|2|||
125156546|NCT02278718|450197734|FG001|Overall Study|Lost to Follow-up|4|||
125156547|NCT02278718|450197733|FG000|Overall Study|Withdrawal by Subject|1|||
125156548|NCT02278718|450197734|FG001|Overall Study|Withdrawal by Subject|4|||
125156549|NCT02278718|450197733|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
125156550|NCT02278718|450197734|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
125156551|NCT02278718|450197733|FG000|Overall Study|Missing|0|||
125156552|NCT02278718|450197734|FG001|Overall Study|Missing|1|||
125156553|NCT01546649|450197735|FG000|Overall Study|Adverse Event|4|||
125156554|NCT01546649|450197736|FG001|Overall Study|Adverse Event|5|||
125156555|NCT01546649|450197735|FG000|Overall Study|Protocol Violation|1|||
125156556|NCT01546649|450197736|FG001|Overall Study|Protocol Violation|0|||
125156557|NCT01546649|450197735|FG000|Overall Study|Lack of Efficacy|1|||
125156558|NCT01546649|450197736|FG001|Overall Study|Lack of Efficacy|0|||
125156559|NCT01546649|450197735|FG000|Overall Study|Recurrence|1|||
125156560|NCT01546649|450197736|FG001|Overall Study|Recurrence|1|||
125156561|NCT01546649|450197735|FG000|Overall Study|Discovery of secondary cancer|0|||
125223860|NCT04058028|450446255|FG001|Overall Study|Withdrawal of Consent from Study|8|||
125223861|NCT04058028|450446256|FG002|Overall Study|Withdrawal of Consent from Study|6|||
125223862|NCT04058028|450446257|FG003|Overall Study|Withdrawal of Consent from Study|7|||
125223863|NCT04058028|450446254|FG000|Overall Study|Decision by Sponsor|13|||
125223864|NCT04058028|450446255|FG001|Overall Study|Decision by Sponsor|4|||
125156562|NCT01546649|450197736|FG001|Overall Study|Discovery of secondary cancer|1|||
125156563|NCT01546649|450197735|FG000|Overall Study|Withdrawal by Subject|1|||
125156564|NCT01546649|450197736|FG001|Overall Study|Withdrawal by Subject|2|||
125156565|NCT04440449|450197737|FG000|Overall Study|Lost to Follow-up|2|||
125223865|NCT04058028|450446256|FG002|Overall Study|Decision by Sponsor|1|||
125223866|NCT04058028|450446257|FG003|Overall Study|Decision by Sponsor|35|||
125223867|NCT04058028|450446254|FG000|Overall Study|Lost to Follow-up|1|||
125223868|NCT04058028|450446255|FG001|Overall Study|Lost to Follow-up|1|||
125223869|NCT04058028|450446256|FG002|Overall Study|Lost to Follow-up|1|||
125223870|NCT04058028|450446257|FG003|Overall Study|Lost to Follow-up|0|||
125223871|NCT04058028|450446254|FG000|Overall Study|Death|0|||
125223872|NCT04058028|450446255|FG001|Overall Study|Death|1|||
125156566|NCT04440449|450197738|FG001|Overall Study|Lost to Follow-up|0|||
125156567|NCT03212794|450197739|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
125156568|NCT03212794|450197740|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
125156569|NCT03212794|450197739|FG000|Overall Study|Lost to Follow-up|5|||
125156570|NCT03212794|450197740|FG001|Overall Study|Lost to Follow-up|6|||
125223873|NCT04058028|450446256|FG002|Overall Study|Death|0|||
125156571|NCT03212794|450197739|FG000|Overall Study|Incarcerated; unable to participate|2|||
125156572|NCT03212794|450197740|FG001|Overall Study|Incarcerated; unable to participate|0|||
125156573|NCT03212794|450197739|FG000|Overall Study|Withdrawal by Subject|1|||
125156574|NCT03212794|450197740|FG001|Overall Study|Withdrawal by Subject|0|||
125156575|NCT03212794|450197739|FG000|Overall Study|Death|0|||
125156576|NCT03212794|450197740|FG001|Overall Study|Death|1|||
125156577|NCT03212794|450197739|FG000|Overall Study|Found to be ineligible after allocation|0|||
125156578|NCT03212794|450197740|FG001|Overall Study|Found to be ineligible after allocation|1|||
125156579|NCT03212794|450197739|FG000|Overall Study|Relocated out of area|2|||
125156580|NCT03212794|450197740|FG001|Overall Study|Relocated out of area|0|||
125156581|NCT01763918|450197741|FG000|Overall Study|Withdrawal by Subject|2|||
125156582|NCT01763918|450197742|FG001|Overall Study|Withdrawal by Subject|1|||
125156583|NCT01763918|450197743|FG002|Overall Study|Withdrawal by Subject|1|||
125156584|NCT01763918|450197744|FG003|Overall Study|Withdrawal by Subject|2|||
125156585|NCT01763918|450197741|FG000|Overall Study|Sponsor Decision|4|||
125156586|NCT01763918|450197742|FG001|Overall Study|Sponsor Decision|0|||
125156587|NCT01763918|450197743|FG002|Overall Study|Sponsor Decision|9|||
125156588|NCT01763918|450197744|FG003|Overall Study|Sponsor Decision|0|||
125156589|NCT03395639|450197745|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
125156590|NCT03395639|450197746|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
125156591|NCT03395639|450197747|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
125156592|NCT03395639|450197745|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
125156593|NCT03395639|450197746|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
125156594|NCT03395639|450197747|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
125156595|NCT03395639|450197745|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
125156596|NCT03395639|450197746|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
125156597|NCT03395639|450197747|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
125156598|NCT03395639|450197745|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
125156599|NCT03395639|450197746|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
125156600|NCT03395639|450197747|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
125156601|NCT03395639|450197745|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
125156602|NCT03395639|450197746|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
125156603|NCT03395639|450197747|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
125156604|NCT00942331|450197748|FG000|Overall Study|Did not start treatment|15|||
125156605|NCT00942331|450197749|FG001|Overall Study|Did not start treatment|22|||
125156606|NCT00597116|450197752|FG000|Overall Study|Adverse Event|2|||
125156607|NCT00597116|450197753|FG001|Overall Study|Adverse Event|1|||
125156608|NCT00597116|450197752|FG000|Overall Study|Withdrawal by Subject|0|||
125156609|NCT00597116|450197753|FG001|Overall Study|Withdrawal by Subject|2|||
125156610|NCT00597116|450197752|FG000|Overall Study|Physician Decision|0|||
125156611|NCT00597116|450197753|FG001|Overall Study|Physician Decision|1|||
125156612|NCT00597116|450197752|FG000|Overall Study|Death|0|||
125156613|NCT00597116|450197753|FG001|Overall Study|Death|1|||
125156614|NCT00597116|450197752|FG000|Overall Study|Lost to Follow-up|1|||
125156615|NCT00597116|450197753|FG001|Overall Study|Lost to Follow-up|0|||
125156616|NCT00597116|450197752|FG000|Overall Study|Progressive disease|11|||
125156617|NCT00597116|450197753|FG001|Overall Study|Progressive disease|6|||
125156618|NCT00757848|450197757|FG000|Overall Study|Voluntary discontinuation|1|||
125156619|NCT00757848|450197758|FG001|Overall Study|Voluntary discontinuation|0|||
125156620|NCT00757848|450197757|FG000|Overall Study|Adverse Event|1|||
125156621|NCT00757848|450197758|FG001|Overall Study|Adverse Event|2|||
125156622|NCT00757848|450197757|FG000|Overall Study|Incorrect enrolment|1|||
125156623|NCT00757848|450197758|FG001|Overall Study|Incorrect enrolment|0|||
125156624|NCT01901874|450197761|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
125156625|NCT01901874|450197761|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
125156626|NCT01901874|450197761|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
125156627|NCT01901874|450197761|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
125156628|NCT01901874|450197761|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
125156629|NCT01901874|450197761|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
125156630|NCT03832738|450197767|FG000|Overall Study|Withdrawal by Subject|6|||
125156631|NCT03832738|450197768|FG001|Overall Study|Withdrawal by Subject|7|||
125156632|NCT03832738|450197769|FG002|Overall Study|Withdrawal by Subject|16|||
125156633|NCT03832738|450197767|FG000|Overall Study|Physician Decision|0|||
125156634|NCT03832738|450197768|FG001|Overall Study|Physician Decision|1|||
125156635|NCT03832738|450197769|FG002|Overall Study|Physician Decision|2|||
125156636|NCT03832738|450197767|FG000|Overall Study|Adverse Event|2|||
125156637|NCT03832738|450197768|FG001|Overall Study|Adverse Event|3|||
125156638|NCT03832738|450197769|FG002|Overall Study|Adverse Event|1|||
125156639|NCT03832738|450197767|FG000|Overall Study|Pregnancy|0|||
125156640|NCT03832738|450197768|FG001|Overall Study|Pregnancy|1|||
125156641|NCT03832738|450197769|FG002|Overall Study|Pregnancy|0|||
125156642|NCT03977701|450197770|FG000|Overall Study|COVID-19 pandemic|0|||
125156643|NCT03977701|450197771|FG001|Overall Study|COVID-19 pandemic|0|||
125156644|NCT03977701|450197772|FG002|Overall Study|COVID-19 pandemic|0|||
125156645|NCT03977701|450197773|FG003|Overall Study|COVID-19 pandemic|0|||
125156646|NCT03977701|450197774|FG004|Overall Study|COVID-19 pandemic|0|||
125156647|NCT03977701|450197775|FG005|Overall Study|COVID-19 pandemic|1|||
125156648|NCT03977701|450197776|FG006|Overall Study|COVID-19 pandemic|0|||
125156649|NCT03977701|450197777|FG007|Overall Study|COVID-19 pandemic|1|||
125156650|NCT03977701|450197778|FG008|Overall Study|COVID-19 pandemic|0|||
125156651|NCT03977701|450197779|FG009|Overall Study|COVID-19 pandemic|0|||
125156652|NCT00702208|450197780|FG000|Overall Study|Lost to Follow-up|28|||
125156653|NCT00702208|450197780|FG000|Overall Study|Did not self-lavage|1|||
125156654|NCT00702208|450197780|FG000|Overall Study|Unsatisfactory colposcopy|2|||
125156655|NCT02025751|450197781|FG000|Overall Study|Lost to Follow-up|1|||
125156656|NCT02025751|450197782|FG001|Overall Study|Lost to Follow-up|0|||
125156657|NCT02025751|450197781|FG000|Overall Study|Adverse Event|0|||
125156658|NCT02025751|450197782|FG001|Overall Study|Adverse Event|1|||
125156659|NCT02025751|450197781|FG000|Overall Study|Physician Decision|0|||
125156660|NCT02025751|450197782|FG001|Overall Study|Physician Decision|1|||
125156661|NCT02025751|450197781|FG000|Overall Study|Withdrawal by Subject|0|||
125156662|NCT02025751|450197782|FG001|Overall Study|Withdrawal by Subject|1|||
125156663|NCT03864042|450197783|FG000|DDI Phase|Adverse Event|2|||
125156664|NCT03864042|450197784|FG001|DDI Phase|Adverse Event|0|||
125156665|NCT03864042|450197785|FG002|DDI Phase|Adverse Event|0|||
125156666|NCT03864042|450197783|FG000|DDI Phase|Physician Decision|1|||
125156667|NCT03864042|450197784|FG001|DDI Phase|Physician Decision|0|||
125156668|NCT03864042|450197785|FG002|DDI Phase|Physician Decision|0|||
125156669|NCT03864042|450197783|FG000|DDI Phase|Progressive Disease|1|||
125156670|NCT03864042|450197784|FG001|DDI Phase|Progressive Disease|0|||
125156671|NCT03864042|450197785|FG002|DDI Phase|Progressive Disease|0|||
125156672|NCT03864042|450197783|FG000|Post-DDI Phase|Adverse Event|5|||
125156673|NCT03864042|450197784|FG001|Post-DDI Phase|Adverse Event|3|||
125156674|NCT03864042|450197785|FG002|Post-DDI Phase|Adverse Event|2|||
125156675|NCT03864042|450197783|FG000|Post-DDI Phase|Progressive Disease|11|||
125156676|NCT03864042|450197784|FG001|Post-DDI Phase|Progressive Disease|6|||
125156677|NCT03864042|450197785|FG002|Post-DDI Phase|Progressive Disease|13|||
125156678|NCT03864042|450197783|FG000|Post-DDI Phase|Discretion of investigator|1|||
125156679|NCT03864042|450197784|FG001|Post-DDI Phase|Discretion of investigator|1|||
125156680|NCT03864042|450197785|FG002|Post-DDI Phase|Discretion of investigator|0|||
125156681|NCT03864042|450197783|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
125156682|NCT03864042|450197784|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
125156683|NCT03864042|450197785|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
125156684|NCT03864042|450197783|FG000|Post-DDI Phase|Withdrawal of consent|1|||
125156685|NCT03864042|450197784|FG001|Post-DDI Phase|Withdrawal of consent|2|||
125156686|NCT03864042|450197785|FG002|Post-DDI Phase|Withdrawal of consent|0|||
125156687|NCT02220725|450197786|FG000|Overall Study|Lost to Follow-up|0|||
125156688|NCT02220725|450197787|FG001|Overall Study|Lost to Follow-up|0|||
125156689|NCT02220725|450197788|FG002|Overall Study|Lost to Follow-up|0|||
125156690|NCT02220725|450197789|FG003|Overall Study|Lost to Follow-up|1|||
125156691|NCT02220725|450197786|FG000|Overall Study|Withdrawal by Subject|0|||
125156692|NCT02220725|450197787|FG001|Overall Study|Withdrawal by Subject|0|||
125156693|NCT02220725|450197788|FG002|Overall Study|Withdrawal by Subject|0|||
125156694|NCT02220725|450197789|FG003|Overall Study|Withdrawal by Subject|1|||
125156695|NCT03487848|450197790|FG000|Overall Study|Lost to Follow-up|1|||
125156696|NCT00731549|450197791|FG000|Overall Study|Lost to Follow-up|19|||
125156697|NCT00731549|450197791|FG000|Overall Study|Met withdrawal criteria|24|||
125156698|NCT00731549|450197791|FG000|Overall Study|Physician Decision|16|||
125156699|NCT00731549|450197791|FG000|Overall Study|Withdrawal by Subject|89|||
125156700|NCT00731549|450197791|FG000|Overall Study|Protocol deviation|1|||
125156701|NCT00731549|450197791|FG000|Overall Study|Adverse Event|31|||
125156702|NCT00731549|450197791|FG000|Overall Study|Lack of efficacy with AE|37|||
125156703|NCT00731549|450197791|FG000|Overall Study|Lack of efficacy without AE|6|||
125156704|NCT02333487|450197792|FG000|Overall Study|Adverse Event|0|||
125156705|NCT02333487|450197793|FG001|Overall Study|Adverse Event|2|||
125156706|NCT02333487|450197794|FG002|Overall Study|Adverse Event|0|||
125156707|NCT01297322|450197795|FG000|Overall Study|Lost to Follow-up|1|||
125156708|NCT01297322|450197796|FG001|Overall Study|Lost to Follow-up|0|||
125156709|NCT01297322|450197795|FG000|Overall Study|Withdrawal by Subject|0|||
125156710|NCT01297322|450197796|FG001|Overall Study|Withdrawal by Subject|1|||
125156711|NCT01297322|450197795|FG000|Overall Study|Protocol Violation|0|||
125156712|NCT01297322|450197796|FG001|Overall Study|Protocol Violation|3|||
125156713|NCT01111019|450197797|FG000|Overall Study|Withdrew Prematurely|2|||
125156714|NCT01111019|450197797|FG000|Overall Study|Other|1|||
125156715|NCT01583218|450197800|FG000|Overall Study|Withdrawal by Subject|43|||
125156716|NCT01583218|450197801|FG001|Overall Study|Withdrawal by Subject|29|||
125156717|NCT01583218|450197800|FG000|Overall Study|Death|206|||
125156718|NCT01583218|450197801|FG001|Overall Study|Death|211|||
125156719|NCT01583218|450197800|FG000|Overall Study|Lost to Follow-up|11|||
125156720|NCT01583218|450197801|FG001|Overall Study|Lost to Follow-up|17|||
125156721|NCT01583218|450197800|FG000|Overall Study|Adverse event or serious adverse event|3|||
125156722|NCT01583218|450197801|FG001|Overall Study|Adverse event or serious adverse event|3|||
125156723|NCT01583218|450197800|FG000|Overall Study|Patient /Family decision|3|||
125156724|NCT01583218|450197801|FG001|Overall Study|Patient /Family decision|0|||
125156725|NCT01583218|450197800|FG000|Overall Study|Cannot contact patient directly|1|||
125156726|NCT01583218|450197801|FG001|Overall Study|Cannot contact patient directly|2|||
125156727|NCT01583218|450197800|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
125156728|NCT01583218|450197801|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
125156729|NCT01583218|450197800|FG000|Overall Study|Patient did not wish to attend visits|0|||
125156730|NCT01583218|450197801|FG001|Overall Study|Patient did not wish to attend visits|1|||
125223874|NCT04058028|450446257|FG003|Overall Study|Death|0|||
125223875|NCT01691378|450446261|FG000|Overall Study|Withdrawal by Subject|2|||
125223876|NCT01691378|450446262|FG001|Overall Study|Withdrawal by Subject|0|||
125223877|NCT01691378|450446261|FG000|Overall Study|Lost to Follow-up|5|||
125156731|NCT01583218|450197800|FG000|Overall Study|Patient randomized but not dosed|17|||
125156732|NCT01583218|450197801|FG001|Overall Study|Patient randomized but not dosed|16|||
125156733|NCT01583218|450197800|FG000|Overall Study|Patient was assessed via phone in person|1|||
125156734|NCT01583218|450197801|FG001|Overall Study|Patient was assessed via phone in person|0|||
125156735|NCT01583218|450197800|FG000|Overall Study|Patient deemed ineligible after random|2|||
125156736|NCT01583218|450197801|FG001|Overall Study|Patient deemed ineligible after random|0|||
125156737|NCT01583218|450197800|FG000|Overall Study|Patient was early terminated from study|0|||
125156738|NCT01583218|450197801|FG001|Overall Study|Patient was early terminated from study|1|||
125156739|NCT01583218|450197800|FG000|Overall Study|Patient was randomized due to mistake|1|||
125156740|NCT01583218|450197801|FG001|Overall Study|Patient was randomized due to mistake|0|||
125156741|NCT01583218|450197800|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
125223878|NCT01691378|450446262|FG001|Overall Study|Lost to Follow-up|2|||
125156742|NCT01583218|450197801|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
125156743|NCT01583218|450197800|FG000|Overall Study|Withdraw of consent on day of random|1|||
125156744|NCT01583218|450197801|FG001|Overall Study|Withdraw of consent on day of random|0|||
125156745|NCT00712985|450197805|FG000|Overall Study|1 withdrew prior to start of drug|1|||
125156746|NCT00712985|450197805|FG000|Overall Study|1 patient moved out of state|1|||
125156747|NCT00712985|450197805|FG000|Overall Study|Lack of Efficacy|3|||
125156748|NCT01299805|450197808|FG000|Overall Study|Adverse Event|2|||
125156749|NCT01299805|450197809|FG001|Overall Study|Adverse Event|0|||
125156750|NCT03334721|450197810|FG000|Overall Study|Withdrawal by Subject|1|||
125156751|NCT03334721|450197811|FG001|Overall Study|Withdrawal by Subject|0|||
125156752|NCT03334721|450197810|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
125156753|NCT03334721|450197811|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
125156754|NCT01902628|450197812|FG000|Overall Study|Withdrawal of participant's consent|7|||
125156755|NCT01902628|450197812|FG000|Overall Study|Adverse Event|41|||
125156756|NCT01902628|450197812|FG000|Overall Study|Lost to Follow-up|35|||
125156757|NCT04969861|450197814|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
125156758|NCT04969861|450197815|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
125156759|NCT02522403|450199202|FG000|Overall Study|Lost to Follow-up|2|||
125156760|NCT02522403|450199203|FG001|Overall Study|Lost to Follow-up|2|||
125156761|NCT02522403|450199202|FG000|Overall Study|Withdrawal by Subject|2|||
125156762|NCT02522403|450199203|FG001|Overall Study|Withdrawal by Subject|4|||
125156763|NCT04718194|450199208|FG000|Overall Study|Withdrawal by Subject|3|||
125156764|NCT04718194|450199209|FG001|Overall Study|Withdrawal by Subject|0|||
125156765|NCT04718194|450199208|FG000|Overall Study|Lost to Follow-up|3|||
125156766|NCT04718194|450199209|FG001|Overall Study|Lost to Follow-up|0|||
125156767|NCT02091141|450199211|FG000|Overall Study|Death|280|||
125156768|NCT02091141|450199212|FG001|Overall Study|Death|118|||
125156769|NCT02091141|450199213|FG002|Overall Study|Death|46|||
125156770|NCT02091141|450199214|FG003|Overall Study|Death|13|||
125156771|NCT02091141|450199215|FG004|Overall Study|Death|31|||
125156772|NCT02091141|450199216|FG005|Overall Study|Death|16|||
125156773|NCT02091141|450199217|FG006|Overall Study|Death|12|||
125156774|NCT02091141|450199211|FG000|Overall Study|Withdrawal by Subject|21|||
125156775|NCT02091141|450199212|FG001|Overall Study|Withdrawal by Subject|13|||
125156776|NCT02091141|450199213|FG002|Overall Study|Withdrawal by Subject|3|||
125156777|NCT02091141|450199214|FG003|Overall Study|Withdrawal by Subject|2|||
125156778|NCT02091141|450199215|FG004|Overall Study|Withdrawal by Subject|2|||
125156779|NCT02091141|450199216|FG005|Overall Study|Withdrawal by Subject|3|||
125156780|NCT02091141|450199217|FG006|Overall Study|Withdrawal by Subject|0|||
125156781|NCT02091141|450199211|FG000|Overall Study|Lost to Follow-up|21|||
125156782|NCT02091141|450199212|FG001|Overall Study|Lost to Follow-up|5|||
125156783|NCT02091141|450199213|FG002|Overall Study|Lost to Follow-up|1|||
125156784|NCT02091141|450199214|FG003|Overall Study|Lost to Follow-up|0|||
125156785|NCT02091141|450199215|FG004|Overall Study|Lost to Follow-up|1|||
125156786|NCT02091141|450199216|FG005|Overall Study|Lost to Follow-up|2|||
125156787|NCT02091141|450199217|FG006|Overall Study|Lost to Follow-up|0|||
125156788|NCT02091141|450199211|FG000|Overall Study|Reason Not Specified|6|||
125156789|NCT02091141|450199212|FG001|Overall Study|Reason Not Specified|5|||
125156790|NCT02091141|450199213|FG002|Overall Study|Reason Not Specified|2|||
125156791|NCT02091141|450199214|FG003|Overall Study|Reason Not Specified|0|||
125156792|NCT02091141|450199215|FG004|Overall Study|Reason Not Specified|0|||
125156793|NCT02091141|450199216|FG005|Overall Study|Reason Not Specified|0|||
125156794|NCT02091141|450199217|FG006|Overall Study|Reason Not Specified|1|||
125156795|NCT02091141|450199211|FG000|Overall Study|Study Ended by Sponsor|1|||
125156796|NCT02091141|450199212|FG001|Overall Study|Study Ended by Sponsor|9|||
125156797|NCT02091141|450199213|FG002|Overall Study|Study Ended by Sponsor|0|||
125156798|NCT02091141|450199214|FG003|Overall Study|Study Ended by Sponsor|0|||
125156799|NCT02091141|450199215|FG004|Overall Study|Study Ended by Sponsor|0|||
125156800|NCT02091141|450199216|FG005|Overall Study|Study Ended by Sponsor|0|||
125156801|NCT02091141|450199217|FG006|Overall Study|Study Ended by Sponsor|0|||
125156802|NCT02091141|450199211|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
125156803|NCT02091141|450199212|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
125156804|NCT02091141|450199213|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
125156805|NCT02091141|450199214|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
125156806|NCT02091141|450199215|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
125156807|NCT02091141|450199216|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
125156808|NCT02091141|450199217|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
125156809|NCT00605865|450199218|FG000|Overall Study|Protocol Violation|115|||
125156810|NCT03955471|450199219|FG000|Overall Study|Death|22|||
125156811|NCT03955471|450199219|FG000|Overall Study|Lost to Follow-up|1|||
125156812|NCT03955471|450199219|FG000|Overall Study|Withdrawal by Subject|6|||
125156813|NCT03955471|450199219|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
125156814|NCT01032018|450199230|FG000|Overall Study|Lost to Follow-up|6|||
125156815|NCT01032018|450199231|FG001|Overall Study|Lost to Follow-up|5|||
125156816|NCT01032018|450199230|FG000|Overall Study|Death|0|||
125156817|NCT01032018|450199231|FG001|Overall Study|Death|1|||
125156818|NCT02119286|450199234|FG000|Overall Study|Adverse Event|9|||
125156819|NCT02119286|450199235|FG001|Overall Study|Adverse Event|7|||
125156820|NCT02119286|450199236|FG002|Overall Study|Adverse Event|2|||
125156821|NCT02119286|450199234|FG000|Overall Study|Lack of Efficacy|11|||
125156822|NCT02119286|450199235|FG001|Overall Study|Lack of Efficacy|3|||
125156823|NCT02119286|450199236|FG002|Overall Study|Lack of Efficacy|4|||
125156824|NCT02119286|450199234|FG000|Overall Study|Lost to Follow-up|2|||
125156825|NCT02119286|450199235|FG001|Overall Study|Lost to Follow-up|0|||
125156826|NCT02119286|450199236|FG002|Overall Study|Lost to Follow-up|1|||
125156827|NCT02119286|450199234|FG000|Overall Study|Withdrawal by Subject|4|||
125156828|NCT02119286|450199235|FG001|Overall Study|Withdrawal by Subject|1|||
125156829|NCT02119286|450199236|FG002|Overall Study|Withdrawal by Subject|0|||
125156830|NCT03247517|450199237|FG000|Overall Study|Adverse Event|0|||
125156831|NCT03247517|450199238|FG001|Overall Study|Adverse Event|4|||
125156832|NCT03247517|450199239|FG002|Overall Study|Adverse Event|2|||
125156833|NCT03247517|450199237|FG000|Overall Study|Lost to Follow-up|2|||
125156834|NCT03247517|450199238|FG001|Overall Study|Lost to Follow-up|6|||
125156835|NCT03247517|450199239|FG002|Overall Study|Lost to Follow-up|4|||
125156836|NCT03247517|450199237|FG000|Overall Study|Consent withdrawn by caregiver|1|||
125156837|NCT03247517|450199238|FG001|Overall Study|Consent withdrawn by caregiver|4|||
125156838|NCT03247517|450199239|FG002|Overall Study|Consent withdrawn by caregiver|7|||
125156839|NCT03247517|450199237|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
125156840|NCT03247517|450199238|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
125156841|NCT03247517|450199239|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
125156842|NCT03247517|450199237|FG000|Overall Study|Protocol Violation|0|||
125156843|NCT03247517|450199238|FG001|Overall Study|Protocol Violation|2|||
125156844|NCT03247517|450199239|FG002|Overall Study|Protocol Violation|0|||
125156845|NCT03247517|450199237|FG000|Overall Study|Multiple reasons|3|||
125156846|NCT03247517|450199238|FG001|Overall Study|Multiple reasons|1|||
125156847|NCT03247517|450199239|FG002|Overall Study|Multiple reasons|0|||
125156848|NCT00619112|450199240|FG000|Overall Study|Adverse Event|1|||
125156849|NCT00619112|450199241|FG001|Overall Study|Adverse Event|2|||
125156850|NCT01996332|450199242|FG000|Overall Study|Adverse Event|117|||
125156851|NCT01996332|450199242|FG000|Overall Study|Lack of Efficacy|1245|||
125156852|NCT01996332|450199242|FG000|Overall Study|Death|264|||
125156853|NCT01996332|450199242|FG000|Overall Study|Protocol Violation|9|||
125156854|NCT01996332|450199242|FG000|Overall Study|Withdrawal by Subject|71|||
125156855|NCT01996332|450199242|FG000|Overall Study|Other|20|||
125156856|NCT01996332|450199242|FG000|Overall Study|Clinical Deterioration|28|||
125156857|NCT01996332|450199242|FG000|Overall Study|Physician Decision|17|||
125156858|NCT01996332|450199242|FG000|Overall Study|Lost to Follow-up|34|||
125156859|NCT02113189|450199243|FG000|Overall Study|Lost to follow up|2|||
125156860|NCT02113189|450199244|FG001|Overall Study|Lost to follow up|1|||
125156861|NCT02113189|450199245|FG002|Overall Study|Lost to follow up|3|||
125156862|NCT03265288|450199246|FG000|Overall Study|Adverse Event|0|||
125156863|NCT03265288|450199247|FG001|Overall Study|Adverse Event|1|||
125156864|NCT03265288|450199246|FG000|Overall Study|Withdrawal by Subject|13|||
125156865|NCT03265288|450199247|FG001|Overall Study|Withdrawal by Subject|5|||
125156866|NCT03265288|450199246|FG000|Overall Study|Drug Withdrawn|3|||
125156867|NCT03265288|450199247|FG001|Overall Study|Drug Withdrawn|3|||
125156868|NCT03265288|450199246|FG000|Overall Study|Any Other Reason|7|||
125156869|NCT03265288|450199247|FG001|Overall Study|Any Other Reason|3|||
125156870|NCT00652028|450199248|FG000|Overall Study|Adverse Event|1|||
125156871|NCT00652028|450199249|FG001|Overall Study|Adverse Event|0|||
125156872|NCT00652028|450199250|FG002|Overall Study|Adverse Event|0|||
125156873|NCT00652028|450199251|FG003|Overall Study|Adverse Event|0|||
125156874|NCT00652028|450199248|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
125156875|NCT00652028|450199249|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
125156876|NCT00652028|450199250|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
125156877|NCT00652028|450199251|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
125156878|NCT00652028|450199248|FG000|Overall Study|Physician Decision|0|||
125156879|NCT00652028|450199249|FG001|Overall Study|Physician Decision|0|||
125156880|NCT00652028|450199250|FG002|Overall Study|Physician Decision|1|||
125156881|NCT00652028|450199251|FG003|Overall Study|Physician Decision|0|||
125156882|NCT00931268|450199255|FG000|Overall Study|Lost to Follow-up|6|||
125156883|NCT00430495|450199256|FG000|Overall Study|Adverse Event|2|||
125156884|NCT00430495|450199257|FG001|Overall Study|Adverse Event|3|||
125156885|NCT00430495|450199258|FG002|Overall Study|Adverse Event|2|||
125156886|NCT00430495|450199259|FG003|Overall Study|Adverse Event|0|||
125156887|NCT00430495|450199256|FG000|Overall Study|Death|0|||
125156888|NCT00430495|450199257|FG001|Overall Study|Death|0|||
125156889|NCT00430495|450199258|FG002|Overall Study|Death|1|||
125156890|NCT00430495|450199259|FG003|Overall Study|Death|0|||
125156891|NCT00430495|450199256|FG000|Overall Study|Lost to Follow-up|0|||
125156892|NCT00430495|450199257|FG001|Overall Study|Lost to Follow-up|1|||
125156893|NCT00430495|450199258|FG002|Overall Study|Lost to Follow-up|4|||
125156894|NCT00430495|450199259|FG003|Overall Study|Lost to Follow-up|0|||
125156895|NCT00430495|450199256|FG000|Overall Study|Protocol Violation|1|||
125156896|NCT00430495|450199257|FG001|Overall Study|Protocol Violation|0|||
125156897|NCT00430495|450199258|FG002|Overall Study|Protocol Violation|1|||
125156898|NCT00430495|450199259|FG003|Overall Study|Protocol Violation|0|||
125156899|NCT00430495|450199256|FG000|Overall Study|Disease Progression|1|||
125156900|NCT00430495|450199257|FG001|Overall Study|Disease Progression|1|||
125156901|NCT00430495|450199258|FG002|Overall Study|Disease Progression|0|||
125156902|NCT00430495|450199259|FG003|Overall Study|Disease Progression|0|||
125156903|NCT00430495|450199256|FG000|Overall Study|Other|8|||
125156904|NCT00430495|450199257|FG001|Overall Study|Other|2|||
125156905|NCT00430495|450199258|FG002|Overall Study|Other|5|||
125156906|NCT00430495|450199259|FG003|Overall Study|Other|4|||
125156907|NCT00430495|450199256|FG000|Overall Study|Randomized but not Treated|2|||
125156908|NCT00430495|450199257|FG001|Overall Study|Randomized but not Treated|0|||
125156909|NCT00430495|450199258|FG002|Overall Study|Randomized but not Treated|0|||
125156910|NCT00430495|450199259|FG003|Overall Study|Randomized but not Treated|0|||
125156911|NCT02751359|450199260|FG000|Overall Study|Lost to Follow-up|1|||
125156912|NCT02400671|450199261|FG000|Overall Study|Death|5|||
125156913|NCT02400671|450199262|FG001|Overall Study|Death|3|||
125156914|NCT02400671|450199263|FG002|Overall Study|Death|4|||
125156915|NCT02400671|450199261|FG000|Overall Study|Lost to Follow-up|20|||
125156916|NCT02400671|450199262|FG001|Overall Study|Lost to Follow-up|27|||
125156917|NCT02400671|450199263|FG002|Overall Study|Lost to Follow-up|24|||
125156918|NCT02400671|450199261|FG000|Overall Study|Withdrawal by Subject|2|||
125156919|NCT02400671|450199262|FG001|Overall Study|Withdrawal by Subject|2|||
125156920|NCT02400671|450199263|FG002|Overall Study|Withdrawal by Subject|0|||
125156921|NCT02145026|450199264|FG000|Overall Study|Adverse Event|2|||
125156922|NCT02145026|450199264|FG000|Overall Study|Death|4|||
125156923|NCT02145026|450199264|FG000|Overall Study|Withdrawal by Subject|2|||
125156924|NCT02145026|450199264|FG000|Overall Study|Physician Decision|4|||
125156925|NCT00857792|450199265|FG000|Overall Study|inadequate image quality for analysis|12|||
125156926|NCT01797835|450199266|FG000|Overall Study|Lost to Follow-up|31|||
125156927|NCT01797835|450199267|FG001|Overall Study|Lost to Follow-up|27|||
125156928|NCT04421586|450199275|FG000|Overall Study|Death|0|||
125156929|NCT04421586|450199276|FG001|Overall Study|Death|1|||
125156930|NCT04421586|450199275|FG000|Overall Study|Lost to Follow-up|2|||
125156931|NCT04421586|450199276|FG001|Overall Study|Lost to Follow-up|2|||
125156932|NCT04421586|450199275|FG000|Overall Study|Withdrawn by PI|1|||
125156933|NCT04421586|450199276|FG001|Overall Study|Withdrawn by PI|0|||
125156934|NCT04421586|450199275|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
125156935|NCT04421586|450199276|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
125156936|NCT00076804|450199278|FG000|Overall Study|Death|9|||
125156937|NCT00076804|450199279|FG001|Overall Study|Death|20|||
125156938|NCT00076804|450199278|FG000|Overall Study|Lost to Follow-up|9|||
125156939|NCT00076804|450199279|FG001|Overall Study|Lost to Follow-up|9|||
125156940|NCT00076804|450199278|FG000|Overall Study|Withdrawal by Subject|10|||
125156941|NCT00076804|450199279|FG001|Overall Study|Withdrawal by Subject|8|||
125156942|NCT00076804|450199278|FG000|Overall Study|Early study Closure|32|||
125156943|NCT00076804|450199279|FG001|Overall Study|Early study Closure|32|||
125156944|NCT04295135|450199281|FG000|Overall Study|Withdrawal by Subject|2|||
125156945|NCT04295135|450199282|FG001|Overall Study|Withdrawal by Subject|1|||
125156946|NCT04295135|450199281|FG000|Overall Study|Subject left organization|8|||
125156947|NCT04295135|450199282|FG001|Overall Study|Subject left organization|4|||
125156948|NCT03484117|450199283|FG000|Overall Study|Lost to Follow-up|1|||
125156949|NCT03484117|450199284|FG001|Overall Study|Lost to Follow-up|3|||
125156950|NCT03484117|450199283|FG000|Overall Study|Declined participation in exit assess|1|||
125156951|NCT03484117|450199284|FG001|Overall Study|Declined participation in exit assess|1|||
125156952|NCT00289874|450199285|FG000|Overall Study|Adverse Event|1|||
125156953|NCT00289874|450199286|FG001|Overall Study|Adverse Event|5|||
125156954|NCT00289874|450199285|FG000|Overall Study|Lost to Follow-up|1|||
125156955|NCT00289874|450199286|FG001|Overall Study|Lost to Follow-up|1|||
125156956|NCT00289874|450199285|FG000|Overall Study|Protocol Violation|3|||
125156957|NCT00289874|450199286|FG001|Overall Study|Protocol Violation|2|||
125156958|NCT00289874|450199285|FG000|Overall Study|Did not meet eligibility|1|||
125156959|NCT00289874|450199286|FG001|Overall Study|Did not meet eligibility|0|||
125156960|NCT03835325|450199287|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
125156961|NCT03835325|450199287|FG000|Overall Study|Selection failure|1|||
125156962|NCT03852459|450199288|FG000|Overall Study|Adverse Event|2|||
125156963|NCT03852459|450199289|FG001|Overall Study|Adverse Event|2|||
125156964|NCT03852459|450199288|FG000|Overall Study|Withdrawal by Subject|1|||
125156965|NCT03852459|450199289|FG001|Overall Study|Withdrawal by Subject|1|||
125156966|NCT00770692|450199291|FG000|Overall Study|Withdrawal by Subject|7|||
125156967|NCT00770692|450199292|FG001|Overall Study|Withdrawal by Subject|9|||
125156968|NCT00770692|450199293|FG002|Overall Study|Withdrawal by Subject|9|||
125156969|NCT00770692|450199294|FG003|Overall Study|Withdrawal by Subject|6|||
125156970|NCT00770692|450199291|FG000|Overall Study|Adverse Event|3|||
125156971|NCT00770692|450199292|FG001|Overall Study|Adverse Event|0|||
125156972|NCT00770692|450199293|FG002|Overall Study|Adverse Event|4|||
125156973|NCT00770692|450199294|FG003|Overall Study|Adverse Event|4|||
125156974|NCT00770692|450199291|FG000|Overall Study|Investigator judgment|2|||
125156975|NCT00770692|450199292|FG001|Overall Study|Investigator judgment|0|||
125156976|NCT00770692|450199293|FG002|Overall Study|Investigator judgment|1|||
125156977|NCT00770692|450199294|FG003|Overall Study|Investigator judgment|1|||
125156978|NCT01138111|450199296|FG000|Overall Study|Withdrawal by Subject|5|||
125156979|NCT01138111|450199296|FG000|Overall Study|Adverse Event|1|||
125156980|NCT01138111|450199296|FG000|Overall Study|Death|1|||
125156981|NCT01138111|450199296|FG000|Overall Study|Lost to Follow-up|2|||
125156982|NCT00560937|450199299|FG000|Overall Study|Withdrawal by Subject|0|||
125156983|NCT00560937|450199300|FG001|Overall Study|Withdrawal by Subject|1|||
125156984|NCT00560937|450199299|FG000|Overall Study|Physician Decision|1|||
125156985|NCT00560937|450199300|FG001|Overall Study|Physician Decision|1|||
125156986|NCT03629028|450199301|FG000|Overall Study|Lost to Follow-up|26|||
125156987|NCT03629028|450199302|FG001|Overall Study|Lost to Follow-up|23|||
125156988|NCT03629028|450199301|FG000|Overall Study|Pregnancy|4|||
125156989|NCT03629028|450199302|FG001|Overall Study|Pregnancy|2|||
125156990|NCT03629028|450199301|FG000|Overall Study|intolerance to examination|2|||
125156991|NCT03629028|450199302|FG001|Overall Study|intolerance to examination|0|||
125156992|NCT02687360|450199307|FG000|Overall Study|Withdrawal by Subject|3|||
125156993|NCT02687360|450199308|FG001|Overall Study|Withdrawal by Subject|0|||
125156994|NCT02989168|450199309|FG000|Overall Study|Withdrawal by Subject|2|||
125156995|NCT02989168|450199310|FG001|Overall Study|Withdrawal by Subject|0|||
125156996|NCT02989168|450199309|FG000|Overall Study|Physician Decision|0|||
125156997|NCT02989168|450199310|FG001|Overall Study|Physician Decision|1|||
125156998|NCT02989168|450199309|FG000|Overall Study|Adverse Event|1|||
125156999|NCT02989168|450199310|FG001|Overall Study|Adverse Event|2|||
125157000|NCT02989168|450199309|FG000|Overall Study|Sponsor stopped study.|1|||
125157001|NCT02989168|450199310|FG001|Overall Study|Sponsor stopped study.|0|||
125157002|NCT01846273|450199311|FG000|Overall Study|Adverse Event|9|||
125157003|NCT01846273|450199312|FG001|Overall Study|Adverse Event|7|||
125157004|NCT01846273|450199313|FG002|Overall Study|Adverse Event|0|||
125157005|NCT01846273|450199311|FG000|Overall Study|Subject withdrew consent|5|||
125157006|NCT01846273|450199312|FG001|Overall Study|Subject withdrew consent|8|||
125157007|NCT01846273|450199313|FG002|Overall Study|Subject withdrew consent|0|||
125157008|NCT01846273|450199311|FG000|Overall Study|Lost to Follow-up|2|||
125157009|NCT01846273|450199312|FG001|Overall Study|Lost to Follow-up|1|||
125157010|NCT01846273|450199313|FG002|Overall Study|Lost to Follow-up|0|||
125157011|NCT01846273|450199311|FG000|Overall Study|Administrative problems|1|||
125157012|NCT01846273|450199312|FG001|Overall Study|Administrative problems|0|||
125157013|NCT01846273|450199313|FG002|Overall Study|Administrative problems|0|||
125157014|NCT01846273|450199311|FG000|Overall Study|Death|2|||
125157015|NCT01846273|450199312|FG001|Overall Study|Death|1|||
125157016|NCT01846273|450199313|FG002|Overall Study|Death|0|||
125157017|NCT01846273|450199311|FG000|Overall Study|Disease Progression|0|||
125157018|NCT01846273|450199312|FG001|Overall Study|Disease Progression|4|||
125157019|NCT01846273|450199313|FG002|Overall Study|Disease Progression|0|||
125157020|NCT01846273|450199311|FG000|Overall Study|Protocol Deviation|2|||
125157021|NCT01846273|450199312|FG001|Overall Study|Protocol Deviation|3|||
125157022|NCT01846273|450199313|FG002|Overall Study|Protocol Deviation|0|||
125157023|NCT01846273|450199311|FG000|Overall Study|Physician Decision|1|||
125157024|NCT01846273|450199312|FG001|Overall Study|Physician Decision|2|||
125157025|NCT01846273|450199313|FG002|Overall Study|Physician Decision|0|||
125157026|NCT00456495|450199316|FG000|Overall Study|Physician Decision|2|||
125157027|NCT02939014|450199317|FG000|Overall Study|Lost to Follow-up|1|||
125157028|NCT02939014|450199318|FG001|Overall Study|Lost to Follow-up|0|||
125157029|NCT02939014|450199317|FG000|Overall Study|Death|4|||
125157030|NCT02939014|450199318|FG001|Overall Study|Death|3|||
125157031|NCT05069155|450199319|FG000|Overall Study|Withdrawal by Subject|1|||
125157032|NCT05069155|450199320|FG001|Overall Study|Withdrawal by Subject|3|||
125157033|NCT02674061|450199321|FG000|Overall Study|Death|229|||
125157034|NCT02674061|450199322|FG001|Overall Study|Death|77|||
125157035|NCT02674061|450199321|FG000|Overall Study|Lost to Follow-up|3|||
125157036|NCT02674061|450199322|FG001|Overall Study|Lost to Follow-up|3|||
125157037|NCT02674061|450199321|FG000|Overall Study|Withdrawal by Subject|9|||
125157038|NCT02674061|450199322|FG001|Overall Study|Withdrawal by Subject|1|||
125157039|NCT02674061|450199321|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
125157040|NCT02674061|450199322|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
125157041|NCT01558297|450199328|FG000|Overall Study|Withdrawal by Subject|2|||
125157042|NCT01558297|450199329|FG001|Overall Study|Withdrawal by Subject|2|||
125157043|NCT01558297|450199330|FG002|Overall Study|Withdrawal by Subject|1|||
125157044|NCT01334710|450199331|FG000|Overall Study|Trial was terminated|3|||
125157045|NCT00375492|450199332|FG000|Overall Study|Adverse Event|4|||
125157046|NCT00375492|450199333|FG001|Overall Study|Adverse Event|5|||
125157047|NCT00375492|450199332|FG000|Overall Study|Entry Criteria Not Met|0|||
125157048|NCT00375492|450199333|FG001|Overall Study|Entry Criteria Not Met|1|||
125157049|NCT00375492|450199332|FG000|Overall Study|Loss of Glucose Control|0|||
125157050|NCT00375492|450199333|FG001|Overall Study|Loss of Glucose Control|1|||
125157051|NCT00375492|450199332|FG000|Overall Study|Lost to Follow-up|10|||
125157052|NCT00375492|450199333|FG001|Overall Study|Lost to Follow-up|5|||
125157053|NCT00375492|450199332|FG000|Overall Study|Physician Decision|0|||
125157054|NCT00375492|450199333|FG001|Overall Study|Physician Decision|4|||
125157055|NCT00375492|450199332|FG000|Overall Study|Protocol Violation|6|||
125157056|NCT00375492|450199333|FG001|Overall Study|Protocol Violation|3|||
125157057|NCT00375492|450199332|FG000|Overall Study|Sponsor Decision|0|||
125157058|NCT00375492|450199333|FG001|Overall Study|Sponsor Decision|1|||
125157059|NCT00375492|450199332|FG000|Overall Study|Withdrawal by Subject|6|||
125157060|NCT00375492|450199333|FG001|Overall Study|Withdrawal by Subject|6|||
125157061|NCT01232491|450199334|FG000|Overall Study|Adverse Event|13|||
125157062|NCT01232491|450199335|FG001|Overall Study|Adverse Event|8|||
125157063|NCT01232491|450199334|FG000|Overall Study|Lack of Efficacy|1|||
125157064|NCT01232491|450199335|FG001|Overall Study|Lack of Efficacy|5|||
125157065|NCT01232491|450199334|FG000|Overall Study|Protocol Violation|13|||
125157066|NCT01232491|450199335|FG001|Overall Study|Protocol Violation|11|||
125157067|NCT01232491|450199334|FG000|Overall Study|Withdrawal Criteria|12|||
125157068|NCT01232491|450199335|FG001|Overall Study|Withdrawal Criteria|21|||
125157069|NCT01232491|450199334|FG000|Overall Study|Other|21|||
125157070|NCT01232491|450199335|FG001|Overall Study|Other|18|||
125157071|NCT03340064|450200742|FG000|First Period|Adverse Event, non-fatal|2|||
125157072|NCT03340064|450200743|FG001|First Period|Adverse Event, non-fatal|0|||
125157073|NCT03340064|450200742|FG000|First Period|Lack of Efficacy|3|||
125157074|NCT03340064|450200743|FG001|First Period|Lack of Efficacy|0|||
125157075|NCT03340064|450200742|FG000|Second Period|Adverse Event, non-fatal|1|||
125157076|NCT03340064|450200743|FG001|Second Period|Adverse Event, non-fatal|1|||
125157077|NCT03340064|450200742|FG000|Second Period|Lack of Efficacy|11|||
125157078|NCT03340064|450200743|FG001|Second Period|Lack of Efficacy|0|||
125157079|NCT03340064|450200742|FG000|Second Period|Physician Decision|3|||
125157080|NCT03340064|450200743|FG001|Second Period|Physician Decision|0|||
125157081|NCT03340064|450200742|FG000|Second Period|Withdrawal by Subject|2|||
125157082|NCT03340064|450200743|FG001|Second Period|Withdrawal by Subject|1|||
125157083|NCT03340064|450200742|FG000|Second Period|Approved Drug Available For Indication|1|||
125157084|NCT03340064|450200743|FG001|Second Period|Approved Drug Available For Indication|0|||
125157085|NCT03340064|450200742|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
125157086|NCT03340064|450200743|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
125157087|NCT00856973|450200746|FG000|Overall Study|Adverse Event|5|||
125157088|NCT00856973|450200747|FG001|Overall Study|Adverse Event|5|||
125157089|NCT00856973|450200748|FG002|Overall Study|Adverse Event|3|||
125157090|NCT00856973|450200746|FG000|Overall Study|Lost to Follow-up|6|||
125157091|NCT00856973|450200747|FG001|Overall Study|Lost to Follow-up|3|||
125157092|NCT00856973|450200748|FG002|Overall Study|Lost to Follow-up|5|||
125157093|NCT00856973|450200746|FG000|Overall Study|Physician Decision|0|||
125157094|NCT00856973|450200747|FG001|Overall Study|Physician Decision|3|||
125157095|NCT00856973|450200748|FG002|Overall Study|Physician Decision|1|||
125157096|NCT00856973|450200746|FG000|Overall Study|Protocol Violation|1|||
125157097|NCT00856973|450200747|FG001|Overall Study|Protocol Violation|2|||
125157098|NCT00856973|450200748|FG002|Overall Study|Protocol Violation|1|||
125157099|NCT00856973|450200746|FG000|Overall Study|Withdrawal by Subject|13|||
125157100|NCT00856973|450200747|FG001|Overall Study|Withdrawal by Subject|16|||
125157101|NCT00856973|450200748|FG002|Overall Study|Withdrawal by Subject|15|||
125157102|NCT00856973|450200746|FG000|Overall Study|Other|11|||
125157103|NCT00856973|450200747|FG001|Overall Study|Other|12|||
125157104|NCT00856973|450200748|FG002|Overall Study|Other|13|||
125157105|NCT03439852|450200750|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
125157106|NCT03439852|450200751|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
125157107|NCT03439852|450200750|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
125157108|NCT03439852|450200751|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
125157109|NCT03439852|450200750|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
125157110|NCT03439852|450200751|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
125157111|NCT04556552|450200754|FG000|Overall Study|Lost to Follow-up|1|||
125157112|NCT04556552|450200755|FG001|Overall Study|Lost to Follow-up|0|||
125157113|NCT04556552|450200754|FG000|Overall Study|Claustrophobia|0|||
125157114|NCT04556552|450200755|FG001|Overall Study|Claustrophobia|1|||
125157115|NCT04556552|450200754|FG000|Overall Study|Inability to continue|0|||
125157116|NCT04556552|450200755|FG001|Overall Study|Inability to continue|1|||
125157117|NCT01215513|450200756|FG000|Overall Study|Not completed CS42|9|||
125157118|NCT01215513|450200756|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
125157119|NCT01215513|450200756|FG000|Overall Study|Adverse event (CS42A)|2|||
125157120|NCT01215513|450200756|FG000|Overall Study|Physician decision (CS42A)|6|||
125157121|NCT01215513|450200756|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
125157122|NCT01215513|450200756|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
125157123|NCT00793780|450200759|FG000|Overall Study|Withdrawal by Subject|2|||
125157124|NCT00793780|450200760|FG001|Overall Study|Withdrawal by Subject|1|||
125157125|NCT02858492|450200761|FG000|Overall Study|Withdrawal by Subject|0|||
125157126|NCT02858492|450200762|FG001|Overall Study|Withdrawal by Subject|1|||
125157127|NCT02858492|450200763|FG002|Overall Study|Withdrawal by Subject|0|||
125157128|NCT02858492|450200764|FG003|Overall Study|Withdrawal by Subject|1|||
125157129|NCT02858492|450200761|FG000|Overall Study|Adverse Event|0|||
125157130|NCT02858492|450200762|FG001|Overall Study|Adverse Event|0|||
125157131|NCT02858492|450200763|FG002|Overall Study|Adverse Event|0|||
125157132|NCT02858492|450200764|FG003|Overall Study|Adverse Event|3|||
125157133|NCT02858492|450200761|FG000|Overall Study|Lack of Efficacy|0|||
125157134|NCT02858492|450200762|FG001|Overall Study|Lack of Efficacy|0|||
125157135|NCT02858492|450200763|FG002|Overall Study|Lack of Efficacy|0|||
125157136|NCT02858492|450200764|FG003|Overall Study|Lack of Efficacy|1|||
125157137|NCT02858492|450200761|FG000|Overall Study|Protocol defined stopping criteria|0|||
125157138|NCT02858492|450200762|FG001|Overall Study|Protocol defined stopping criteria|0|||
125157139|NCT02858492|450200763|FG002|Overall Study|Protocol defined stopping criteria|0|||
125157140|NCT02858492|450200764|FG003|Overall Study|Protocol defined stopping criteria|1|||
125157141|NCT02040779|450200769|FG000|Overall Study|Adverse Event|1|||
125157142|NCT02040779|450200770|FG001|Overall Study|Adverse Event|0|||
125157143|NCT02040779|450200771|FG002|Overall Study|Adverse Event|0|||
125157144|NCT02040779|450200769|FG000|Overall Study|Withdrawal by Subject|4|||
125157145|NCT02040779|450200770|FG001|Overall Study|Withdrawal by Subject|1|||
125157146|NCT02040779|450200771|FG002|Overall Study|Withdrawal by Subject|3|||
125157147|NCT02040779|450200769|FG000|Overall Study|Non-compliance|0|||
125157148|NCT02040779|450200770|FG001|Overall Study|Non-compliance|1|||
125157149|NCT02040779|450200771|FG002|Overall Study|Non-compliance|0|||
125157150|NCT02040779|450200769|FG000|Overall Study|Protocol Violation|2|||
125157151|NCT02040779|450200770|FG001|Overall Study|Protocol Violation|1|||
125157152|NCT02040779|450200771|FG002|Overall Study|Protocol Violation|0|||
125157153|NCT02040779|450200769|FG000|Overall Study|Lost to Follow-up|1|||
125157154|NCT02040779|450200770|FG001|Overall Study|Lost to Follow-up|2|||
125157155|NCT02040779|450200771|FG002|Overall Study|Lost to Follow-up|1|||
125157156|NCT02040779|450200769|FG000|Overall Study|Lack of Efficacy|4|||
125157157|NCT02040779|450200770|FG001|Overall Study|Lack of Efficacy|2|||
125157158|NCT02040779|450200771|FG002|Overall Study|Lack of Efficacy|0|||
125157159|NCT02132637|450200772|FG000|Study Period 1|Withdrawal by Subject|0|||
125157160|NCT02132637|450200773|FG001|Study Period 1|Withdrawal by Subject|4|||
125157161|NCT02132637|450200772|FG000|Study Period 1|Physician Decision|1|||
125157162|NCT02132637|450200773|FG001|Study Period 1|Physician Decision|0|||
125157163|NCT02132637|450200772|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
125157164|NCT02132637|450200773|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
125157165|NCT02132637|450200772|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
125157166|NCT02132637|450200773|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
125157167|NCT00127036|450200781|FG000|Overall Study|Insufficient Data for Analysis|6|||
125157168|NCT00127036|450200782|FG001|Overall Study|Insufficient Data for Analysis|11|||
125157169|NCT00127036|450200781|FG000|Overall Study|Screen Failure|2|||
125157170|NCT00127036|450200782|FG001|Overall Study|Screen Failure|0|||
125157171|NCT03656874|450200785|FG000|Overall Study|Lost to Follow-up|3|||
125157172|NCT03656874|450200786|FG001|Overall Study|Lost to Follow-up|17|||
125157173|NCT00584844|450200787|FG000|Overall Study|Withdrawal by Subject|59|||
125157174|NCT00584844|450200787|FG000|Overall Study|Screen Failure|20|||
125157175|NCT01195103|450200788|FG000|Overall Study|Withdrawal by Subject|1|||
125157176|NCT01195103|450200789|FG001|Overall Study|Withdrawal by Subject|0|||
125157177|NCT01195103|450200790|FG002|Overall Study|Withdrawal by Subject|0|||
125157178|NCT03760250|450200791|FG000|Overall Study|Withdrawal by Subject|1|||
125157179|NCT03760250|450200791|FG000|Overall Study|Physician Decision|1|||
125157180|NCT01615263|450200792|FG000|Overall Study|Post-randomization exclusion|0|||
125157181|NCT01615263|450200793|FG001|Overall Study|Post-randomization exclusion|2|||
125157182|NCT00857259|450200794|FG000|Overall Study|Protocol Violation|1|||
125157183|NCT00857259|450200795|FG001|Overall Study|Protocol Violation|0|||
125157184|NCT00857259|450200796|FG002|Overall Study|Protocol Violation|1|||
125157185|NCT02701413|450200797|FG000|Overall Study|Withdrawal by Subject|7|||
125157186|NCT02701413|450200798|FG001|Overall Study|Withdrawal by Subject|11|||
125157187|NCT01370213|450200799|FG000|Overall Study|Early Death|1|||
125157188|NCT01370213|450200800|FG001|Overall Study|Early Death|0|||
125157189|NCT01370213|450200801|FG002|Overall Study|Early Death|0|||
125157190|NCT01370213|450200799|FG000|Overall Study|Not evaluable|0|||
125157191|NCT01370213|450200800|FG001|Overall Study|Not evaluable|2|||
125157192|NCT01370213|450200801|FG002|Overall Study|Not evaluable|0|||
125157193|NCT01621191|450200807|FG000|Overall Study|Adverse Event|9|||
125157194|NCT01621191|450200807|FG000|Overall Study|Withdrawal by Subject|8|||
125157195|NCT01621191|450200807|FG000|Overall Study|Lack of Efficacy|6|||
125157196|NCT01621191|450200807|FG000|Overall Study|Lost to Follow-up|1|||
125157197|NCT01621191|450200807|FG000|Overall Study|Site Removed From Study|1|||
125157198|NCT01782482|450200812|FG000|Overall Study|Adverse Event|2|||
125157199|NCT01782482|450200813|FG001|Overall Study|Adverse Event|1|||
125157200|NCT01782482|450200812|FG000|Overall Study|Lost to Follow-up|2|||
125157201|NCT01782482|450200813|FG001|Overall Study|Lost to Follow-up|3|||
125157202|NCT01782482|450200812|FG000|Overall Study|Physician Decision|1|||
125157203|NCT01782482|450200813|FG001|Overall Study|Physician Decision|0|||
125157204|NCT01782482|450200812|FG000|Overall Study|Protocol Violation|1|||
125157205|NCT01782482|450200813|FG001|Overall Study|Protocol Violation|0|||
125157206|NCT01782482|450200812|FG000|Overall Study|Withdrawal by Subject|2|||
125157207|NCT01782482|450200813|FG001|Overall Study|Withdrawal by Subject|3|||
125157208|NCT01782482|450200812|FG000|Overall Study|Randomized in Error|2|||
125157209|NCT01782482|450200813|FG001|Overall Study|Randomized in Error|2|||
125157210|NCT01782482|450200812|FG000|Overall Study|Habitually wearing toric lens OS|0|||
125157211|NCT01782482|450200813|FG001|Overall Study|Habitually wearing toric lens OS|1|||
125157212|NCT00038649|450200815|FG000|Overall Study|Adverse Event|9|||
125157213|NCT01321008|450200816|FG000|Overall Study|Early Study Termination|1|||
125157214|NCT02749292|450200821|FG000|Overall Study|Physician Decision|1|||
125157215|NCT02749292|450200822|FG001|Overall Study|Physician Decision|0|||
125157216|NCT02749292|450200821|FG000|Overall Study|Withdrawal by Subject|5|||
125157217|NCT02749292|450200822|FG001|Overall Study|Withdrawal by Subject|7|||
125157218|NCT02749292|450200821|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
125157219|NCT02749292|450200822|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
125157220|NCT02749292|450200821|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
125157221|NCT02749292|450200822|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
125157222|NCT02749292|450200821|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
125157223|NCT02749292|450200822|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
125157224|NCT02749292|450200821|FG000|Overall Study|Adverse Event|4|||
125157225|NCT02749292|450200822|FG001|Overall Study|Adverse Event|1|||
125157226|NCT02749292|450200821|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
125157227|NCT02749292|450200822|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
125157228|NCT02749292|450200821|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
125157229|NCT02749292|450200822|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
125157230|NCT02749292|450200821|FG000|Overall Study|Requiring glucocorticoids|0|||
125157231|NCT02749292|450200822|FG001|Overall Study|Requiring glucocorticoids|3|||
125157232|NCT02749292|450200821|FG000|Overall Study|Cancer|1|||
125157233|NCT02749292|450200822|FG001|Overall Study|Cancer|0|||
125157234|NCT02458092|450200823|FG000|Overall Study|Withdrawal by Subject|1|||
125157235|NCT02458092|450200824|FG001|Overall Study|Withdrawal by Subject|0|||
125157236|NCT00251641|450200827|FG000|Overall Study|Adverse Event|80|||
125157237|NCT00251641|450200828|FG001|Overall Study|Adverse Event|8|||
125157238|NCT00251641|450200827|FG000|Overall Study|Lack of Efficacy|2|||
125157239|NCT00251641|450200828|FG001|Overall Study|Lack of Efficacy|1|||
125157240|NCT00251641|450200827|FG000|Overall Study|Progression of Disease|0|||
125157241|NCT00251641|450200828|FG001|Overall Study|Progression of Disease|2|||
125157242|NCT00251641|450200827|FG000|Overall Study|Lost to Follow-up|3|||
125157243|NCT00251641|450200828|FG001|Overall Study|Lost to Follow-up|3|||
125157244|NCT00251641|450200827|FG000|Overall Study|Withdrawal by Subject|6|||
125157245|NCT00251641|450200828|FG001|Overall Study|Withdrawal by Subject|8|||
125157246|NCT00251641|450200827|FG000|Overall Study|Protocol Violation|10|||
125157247|NCT00251641|450200828|FG001|Overall Study|Protocol Violation|2|||
125157248|NCT00251641|450200827|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
125157249|NCT00251641|450200828|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
125157250|NCT00251641|450200827|FG000|Overall Study|Switched Treatment|9|||
125157251|NCT00251641|450200828|FG001|Overall Study|Switched Treatment|63|||
125157252|NCT02093221|450200831|FG000|Overall Study|Adverse Event|1|||
125157253|NCT02093221|450200832|FG001|Overall Study|Adverse Event|0|||
125157254|NCT02093221|450200833|FG002|Overall Study|Adverse Event|0|||
125157255|NCT02093221|450200834|FG003|Overall Study|Adverse Event|0|||
125157256|NCT02093221|450200835|FG004|Overall Study|Adverse Event|0|||
125157257|NCT02093221|450200831|FG000|Overall Study|Withdrawal by Subject|1|||
125157258|NCT02093221|450200832|FG001|Overall Study|Withdrawal by Subject|1|||
125157259|NCT02093221|450200833|FG002|Overall Study|Withdrawal by Subject|4|||
125157260|NCT02093221|450200834|FG003|Overall Study|Withdrawal by Subject|1|||
125157261|NCT02093221|450200835|FG004|Overall Study|Withdrawal by Subject|1|||
125157262|NCT02093221|450200831|FG000|Overall Study|Lost to Follow-up|2|||
125157263|NCT02093221|450200832|FG001|Overall Study|Lost to Follow-up|0|||
125157264|NCT02093221|450200833|FG002|Overall Study|Lost to Follow-up|1|||
125157265|NCT02093221|450200834|FG003|Overall Study|Lost to Follow-up|1|||
125157266|NCT02093221|450200835|FG004|Overall Study|Lost to Follow-up|0|||
125157267|NCT02093221|450200831|FG000|Overall Study|Death|0|||
125157268|NCT02093221|450200832|FG001|Overall Study|Death|1|||
125157269|NCT02093221|450200833|FG002|Overall Study|Death|0|||
125157270|NCT02093221|450200834|FG003|Overall Study|Death|0|||
125157271|NCT02093221|450200835|FG004|Overall Study|Death|0|||
125157272|NCT02093221|450200831|FG000|Overall Study|Protocol Violation|0|||
125157273|NCT02093221|450200832|FG001|Overall Study|Protocol Violation|1|||
125157274|NCT02093221|450200833|FG002|Overall Study|Protocol Violation|0|||
125157275|NCT02093221|450200834|FG003|Overall Study|Protocol Violation|0|||
125157276|NCT02093221|450200835|FG004|Overall Study|Protocol Violation|0|||
125157277|NCT02093221|450200831|FG000|Overall Study|Study termination|6|||
125157278|NCT02093221|450200832|FG001|Overall Study|Study termination|5|||
125157279|NCT02093221|450200833|FG002|Overall Study|Study termination|4|||
125157280|NCT02093221|450200834|FG003|Overall Study|Study termination|6|||
125157281|NCT02093221|450200835|FG004|Overall Study|Study termination|7|||
125157282|NCT00257920|450200838|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
125157283|NCT00257920|450200839|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
125157284|NCT00257920|450200838|FG000|Period: Second Intervention|Other|2|||
125157285|NCT00257920|450200839|FG001|Period: Second Intervention|Other|1|||
125157286|NCT03097588|450200847|FG000|Overall Study|Adverse Event|1|||
125157287|NCT03456960|450200848|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
125157288|NCT03456960|450200849|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
125157289|NCT03456960|450200850|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
125157290|NCT03456960|450200851|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
125157291|NCT03456960|450200852|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
125157292|NCT03456960|450200853|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
125157293|NCT03456960|450200848|FG000|Period 2 (1 Day)|Adverse Event|1|||
125157294|NCT03456960|450200849|FG001|Period 2 (1 Day)|Adverse Event|0|||
125157295|NCT03456960|450200850|FG002|Period 2 (1 Day)|Adverse Event|0|||
125157296|NCT03456960|450200851|FG003|Period 2 (1 Day)|Adverse Event|1|||
125157297|NCT03456960|450200852|FG004|Period 2 (1 Day)|Adverse Event|0|||
125157298|NCT03456960|450200853|FG005|Period 2 (1 Day)|Adverse Event|0|||
125157299|NCT00653991|450200854|FG000|3 Month Follow-up|Participant would not respond|150|||
125157300|NCT00653991|450200855|FG001|3 Month Follow-up|Participant would not respond|157|||
125157301|NCT00653991|450200854|FG000|6 Month Follow-up|Participant would not respond|133|||
125157302|NCT00653991|450200855|FG001|6 Month Follow-up|Participant would not respond|141|||
125157303|NCT00891839|450200856|FG000|Overall Study|Adverse Event|2|||
125157304|NCT00891839|450200856|FG000|Overall Study|Withdrawal by Subject|2|||
125157305|NCT00891839|450200856|FG000|Overall Study|Disease progression|3|||
125157306|NCT03828448|450200857|FG000|Overall Study|Sponsor's Discretion|34|||
125157307|NCT02037165|450200858|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
125157308|NCT02037165|450200859|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
125157309|NCT02037165|450200860|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
125157310|NCT02037165|450200861|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
125157311|NCT02037165|450200862|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
125157312|NCT00532935|450200863|FG000|Overall Study|Adverse Event|11|||
125157313|NCT00532935|450200864|FG001|Overall Study|Adverse Event|12|||
125157314|NCT00532935|450200863|FG000|Overall Study|Lack of Efficacy|0|||
125157315|NCT00532935|450200864|FG001|Overall Study|Lack of Efficacy|3|||
125157316|NCT00532935|450200863|FG000|Overall Study|Lost to Follow-up|10|||
125157317|NCT00532935|450200864|FG001|Overall Study|Lost to Follow-up|6|||
125157318|NCT00532935|450200863|FG000|Overall Study|Physician Decision|4|||
125157319|NCT00532935|450200864|FG001|Overall Study|Physician Decision|5|||
125157320|NCT00532935|450200863|FG000|Overall Study|Pregnancy|1|||
125157321|NCT00532935|450200864|FG001|Overall Study|Pregnancy|0|||
125157322|NCT00532935|450200863|FG000|Overall Study|Protocol Violation|4|||
125157323|NCT00532935|450200864|FG001|Overall Study|Protocol Violation|2|||
125157324|NCT00532935|450200863|FG000|Overall Study|Withdrawal by Subject|10|||
125157325|NCT00532935|450200864|FG001|Overall Study|Withdrawal by Subject|9|||
125157326|NCT00532935|450200863|FG000|Overall Study|Protocol Specific Criteria|11|||
125157327|NCT00532935|450200864|FG001|Overall Study|Protocol Specific Criteria|15|||
125157328|NCT01300923|450200865|FG000|Overall Study|Physician Decision|0|||
125157329|NCT01300923|450200866|FG001|Overall Study|Physician Decision|2|||
125157330|NCT01568866|450200867|FG000|Overall Study|Disease Progression|208|||
125157331|NCT01568866|450200868|FG001|Overall Study|Disease Progression|183|||
125157332|NCT01568866|450200867|FG000|Overall Study|Adverse Event|94|||
125157333|NCT01568866|450200868|FG001|Overall Study|Adverse Event|96|||
125157334|NCT01568866|450200867|FG000|Overall Study|Patient Request|55|||
125157335|NCT01568866|450200868|FG001|Overall Study|Patient Request|71|||
125157336|NCT01568866|450200867|FG000|Overall Study|Physician Decision|40|||
125157337|NCT01568866|450200868|FG001|Overall Study|Physician Decision|32|||
125157338|NCT01568866|450200867|FG000|Overall Study|Withdrawal by Subject|19|||
125157339|NCT01568866|450200868|FG001|Overall Study|Withdrawal by Subject|11|||
125157340|NCT01568866|450200867|FG000|Overall Study|Death|10|||
125157341|NCT01568866|450200868|FG001|Overall Study|Death|18|||
125157342|NCT01568866|450200867|FG000|Overall Study|Protocol Non-compliance|2|||
125157343|NCT01568866|450200868|FG001|Overall Study|Protocol Non-compliance|4|||
125157344|NCT01568866|450200867|FG000|Overall Study|Lost to Follow-up|1|||
125157345|NCT01568866|450200868|FG001|Overall Study|Lost to Follow-up|0|||
125157346|NCT01568866|450200867|FG000|Overall Study|Randomized but Not Dosed|9|||
125157347|NCT01568866|450200868|FG001|Overall Study|Randomized but Not Dosed|1|||
125157348|NCT01698775|450200869|FG000|Phase A|Adverse Event|2|||
125157349|NCT01698775|450200870|FG001|Phase A|Adverse Event|1|||
125157350|NCT01698775|450200869|FG000|Phase A|Death|1|||
125157351|NCT01698775|450200870|FG001|Phase A|Death|1|||
125157352|NCT01698775|450200869|FG000|Phase A|Lack of Efficacy|1|||
125157353|NCT01698775|450200870|FG001|Phase A|Lack of Efficacy|0|||
125157354|NCT01698775|450200869|FG000|Phase A|Lost to Follow-up|1|||
125157355|NCT01698775|450200870|FG001|Phase A|Lost to Follow-up|2|||
125157356|NCT01698775|450200869|FG000|Phase A|Protocol Violation|1|||
125157357|NCT01698775|450200870|FG001|Phase A|Protocol Violation|0|||
125157358|NCT01698775|450200869|FG000|Phase A|Withdrawal by Subject|3|||
125157359|NCT01698775|450200870|FG001|Phase A|Withdrawal by Subject|4|||
125157360|NCT01698775|450200869|FG000|Phase A|Kidney [transplant]|0|||
125157361|NCT01698775|450200870|FG001|Phase A|Kidney [transplant]|1|||
125157362|NCT01698775|450200869|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
125157363|NCT01698775|450200870|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
125157364|NCT01698775|450200869|FG000|Phase B|Adverse Event|6|||
125157365|NCT01698775|450200870|FG001|Phase B|Adverse Event|3|||
125157366|NCT01698775|450200869|FG000|Phase B|Death|0|||
125157367|NCT01698775|450200870|FG001|Phase B|Death|1|||
125157368|NCT01698775|450200869|FG000|Phase B|Lack of Efficacy|0|||
125157369|NCT01698775|450200870|FG001|Phase B|Lack of Efficacy|1|||
125157370|NCT01698775|450200869|FG000|Phase B|Lost to Follow-up|0|||
125157371|NCT01698775|450200870|FG001|Phase B|Lost to Follow-up|1|||
125157372|NCT01698775|450200869|FG000|Phase B|Physician Decision|1|||
125157373|NCT01698775|450200870|FG001|Phase B|Physician Decision|1|||
125157374|NCT01698775|450200869|FG000|Phase B|Protocol Violation|1|||
125157375|NCT01698775|450200870|FG001|Phase B|Protocol Violation|1|||
125157376|NCT01698775|450200869|FG000|Phase B|Withdrawal by Subject|6|||
125157377|NCT01698775|450200870|FG001|Phase B|Withdrawal by Subject|2|||
125157378|NCT01244061|450200873|FG000|Overall Study|Death|1|||
125157379|NCT01244061|450200874|FG001|Overall Study|Death|0|||
125157380|NCT01244061|450200873|FG000|Overall Study|Did not meet entrance criteria|1|||
125157381|NCT01244061|450200874|FG001|Overall Study|Did not meet entrance criteria|0|||
125157382|NCT01244061|450200873|FG000|Overall Study|Lack of Efficacy|1|||
125157383|NCT01244061|450200874|FG001|Overall Study|Lack of Efficacy|3|||
125157384|NCT01244061|450200873|FG000|Overall Study|Lost to Follow-up|34|||
125157385|NCT01244061|450200874|FG001|Overall Study|Lost to Follow-up|30|||
125157386|NCT01244061|450200873|FG000|Overall Study|Withdrawal by Subject|29|||
125157387|NCT01244061|450200874|FG001|Overall Study|Withdrawal by Subject|46|||
125157388|NCT01244061|450200873|FG000|Overall Study|Other|8|||
125157389|NCT01244061|450200874|FG001|Overall Study|Other|19|||
125157390|NCT01244061|450200873|FG000|Overall Study|Protocol Violation|1|||
125157391|NCT01244061|450200874|FG001|Overall Study|Protocol Violation|1|||
125157392|NCT01244061|450200873|FG000|Overall Study|Adverse Event|5|||
125157393|NCT01244061|450200874|FG001|Overall Study|Adverse Event|2|||
125157394|NCT01244061|450200873|FG000|Overall Study|Randomized but not treated|2|||
125157395|NCT01244061|450200874|FG001|Overall Study|Randomized but not treated|2|||
125157396|NCT02384850|450200877|FG000|Overall Study|Withdrawal by Subject|2|||
125157397|NCT02384850|450200878|FG001|Overall Study|Withdrawal by Subject|2|||
125157398|NCT02013375|450200879|FG000|Overall Study|Did not engraft|1|||
125157399|NCT02013375|450200879|FG000|Overall Study|Did not engraft|1|||
125157421|NCT02932228|450200886|FG000|Overall Study|Death|8|||
125157422|NCT02932228|450200887|FG001|Overall Study|Death|23|||
125157423|NCT02932228|450200886|FG000|Overall Study|not eligible upon chart review|2|||
125157424|NCT02932228|450200887|FG001|Overall Study|not eligible upon chart review|5|||
125157425|NCT00821873|450202621|FG000|Overall Study|Lost to Follow-up|4|||
125157426|NCT03310411|450202622|FG000|Period 1|Adverse Event|0|||
125157427|NCT03310411|450202623|FG001|Period 1|Adverse Event|0|||
125223879|NCT02849080|450446263|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
125223880|NCT02849080|450446264|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
125223881|NCT02849080|450446265|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
125223882|NCT02849080|450446266|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
125223883|NCT02849080|450446263|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
125223884|NCT02849080|450446264|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
125223885|NCT02849080|450446265|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
125223886|NCT02849080|450446266|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
125223887|NCT02849080|450446263|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
125223888|NCT02849080|450446264|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
125223889|NCT02849080|450446265|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
125223890|NCT02849080|450446266|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
125223891|NCT02849080|450446263|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
125223892|NCT02849080|450446264|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
125223893|NCT02849080|450446265|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
125223894|NCT02849080|450446266|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
125223895|NCT02849080|450446263|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
125223896|NCT02849080|450446264|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
125223897|NCT02849080|450446265|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
125223898|NCT02849080|450446266|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
125223899|NCT02849080|450446263|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
125223900|NCT02849080|450446264|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
125223901|NCT02849080|450446265|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
125223902|NCT02849080|450446266|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
125223903|NCT01819727|450446267|FG000|Overall Study|Adverse Event|8|||
125223904|NCT01819727|450446268|FG001|Overall Study|Adverse Event|9|||
125223905|NCT01819727|450446267|FG000|Overall Study|Death|1|||
125223906|NCT01819727|450446268|FG001|Overall Study|Death|0|||
125223907|NCT01819727|450446267|FG000|Overall Study|Lost to Follow-up|1|||
125223908|NCT01819727|450446268|FG001|Overall Study|Lost to Follow-up|1|||
125223909|NCT01819727|450446267|FG000|Overall Study|Physician Decision|3|||
125223910|NCT01819727|450446268|FG001|Overall Study|Physician Decision|2|||
125223911|NCT01819727|450446267|FG000|Overall Study|Pregnancy|1|||
125223912|NCT01819727|450446268|FG001|Overall Study|Pregnancy|0|||
125223913|NCT01819727|450446267|FG000|Overall Study|Protocol Violation|0|||
125223914|NCT01819727|450446268|FG001|Overall Study|Protocol Violation|2|||
125223915|NCT01819727|450446267|FG000|Overall Study|Study Terminated by Sponsor|0|||
125223916|NCT01819727|450446268|FG001|Overall Study|Study Terminated by Sponsor|1|||
125223917|NCT01819727|450446267|FG000|Overall Study|Withdrawal by Subject|6|||
125223918|NCT01819727|450446268|FG001|Overall Study|Withdrawal by Subject|11|||
125223919|NCT01819727|450446267|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
125223920|NCT01819727|450446268|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
125223921|NCT01819727|450446267|FG000|Overall Study|Quit due to lack of health benifits|0|||
125223922|NCT01819727|450446268|FG001|Overall Study|Quit due to lack of health benifits|1|||
125223923|NCT02155985|450446269|FG000|Overall Study|Withdrawal by Subject|0|||
125223924|NCT02155985|450446270|FG001|Overall Study|Withdrawal by Subject|0|||
125223925|NCT02155985|450446271|FG002|Overall Study|Withdrawal by Subject|1|||
125223926|NCT02155985|450446269|FG000|Overall Study|Lost to Follow-up|1|||
125157428|NCT03310411|450202624|FG002|Period 1|Adverse Event|0|||
125157429|NCT03310411|450202625|FG003|Period 1|Adverse Event|1|||
125157430|NCT03623386|450202628|FG000|Overall Study|Protocol Violation|3|||
125157431|NCT03623386|450202629|FG001|Overall Study|Protocol Violation|2|||
125157432|NCT03623386|450202630|FG002|Overall Study|Protocol Violation|0|||
125157433|NCT03623386|450202628|FG000|Overall Study|Physician Decision|1|||
125157434|NCT03623386|450202629|FG001|Overall Study|Physician Decision|1|||
125157435|NCT03623386|450202630|FG002|Overall Study|Physician Decision|0|||
125157436|NCT03623386|450202628|FG000|Overall Study|Lost to Follow-up|0|||
125157437|NCT03623386|450202629|FG001|Overall Study|Lost to Follow-up|2|||
125157438|NCT03623386|450202630|FG002|Overall Study|Lost to Follow-up|0|||
125157439|NCT03623386|450202628|FG000|Overall Study|COVID-19|0|||
125157440|NCT03623386|450202629|FG001|Overall Study|COVID-19|1|||
125157441|NCT03623386|450202630|FG002|Overall Study|COVID-19|0|||
125157442|NCT04271735|450202633|FG000|Overall Study|Physician Decision|2|||
125157443|NCT04271735|450202634|FG001|Overall Study|Physician Decision|0|||
125157444|NCT00515541|450202635|FG000|Overall Study|Physician Decision|0|||
125157445|NCT00515541|450202636|FG001|Overall Study|Physician Decision|2|||
125157446|NCT00515541|450202637|FG002|Overall Study|Physician Decision|0|||
125157447|NCT00515541|450202638|FG003|Overall Study|Physician Decision|1|||
125157448|NCT00515541|450202635|FG000|Overall Study|No show for appointments|0|||
125157449|NCT00515541|450202636|FG001|Overall Study|No show for appointments|1|||
125157450|NCT00515541|450202637|FG002|Overall Study|No show for appointments|0|||
125157451|NCT00515541|450202638|FG003|Overall Study|No show for appointments|2|||
125157452|NCT00515541|450202635|FG000|Overall Study|Withdrawal by Subject|0|||
125157453|NCT00515541|450202636|FG001|Overall Study|Withdrawal by Subject|2|||
125157454|NCT00515541|450202637|FG002|Overall Study|Withdrawal by Subject|0|||
125157455|NCT00515541|450202638|FG003|Overall Study|Withdrawal by Subject|2|||
125157456|NCT00922272|450202639|FG000|Open-label Phase|Adverse Event|5|||
125157457|NCT00922272|450202640|FG001|Open-label Phase|Adverse Event|0|||
125157458|NCT00922272|450202639|FG000|Open-label Phase|Protocol Violation|1|||
125157459|NCT00922272|450202640|FG001|Open-label Phase|Protocol Violation|0|||
125157460|NCT00922272|450202639|FG000|Open-label Phase|Withdrawal by Subject|11|||
125157461|NCT00922272|450202640|FG001|Open-label Phase|Withdrawal by Subject|0|||
125157462|NCT00922272|450202639|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
125157463|NCT00922272|450202640|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
125157464|NCT00922272|450202639|FG000|Open-label Phase|Withdrawal criteria met|5|||
125157465|NCT00922272|450202640|FG001|Open-label Phase|Withdrawal criteria met|0|||
125157466|NCT00922272|450202639|FG000|Double-blind Phase|Adverse Event|1|||
125157467|NCT00922272|450202640|FG001|Double-blind Phase|Adverse Event|1|||
125157468|NCT00922272|450202639|FG000|Double-blind Phase|Withdrawal by Subject|1|||
125157469|NCT00922272|450202640|FG001|Double-blind Phase|Withdrawal by Subject|1|||
125157470|NCT00922272|450202639|FG000|Double-blind Phase|Lost to Follow-up|2|||
125157471|NCT00922272|450202640|FG001|Double-blind Phase|Lost to Follow-up|1|||
125157472|NCT00922272|450202639|FG000|Double-blind Phase|Withdrawal criteria met|1|||
125157473|NCT00922272|450202640|FG001|Double-blind Phase|Withdrawal criteria met|1|||
125157474|NCT00922272|450202639|FG000|Double-blind Phase|Noncompliance|1|||
125157475|NCT00922272|450202640|FG001|Double-blind Phase|Noncompliance|1|||
125157476|NCT00922272|450202639|FG000|Double-blind Phase|Positive urine drug screen|1|||
125157477|NCT00922272|450202640|FG001|Double-blind Phase|Positive urine drug screen|1|||
125157478|NCT02588950|450202641|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
125157479|NCT02588950|450202642|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
125157480|NCT02588950|450202643|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
125157481|NCT02588950|450202644|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
125157482|NCT02588950|450202641|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
125157483|NCT02588950|450202642|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
125157484|NCT02588950|450202643|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
125157485|NCT02588950|450202644|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
125157486|NCT03188718|450202645|FG000|Overall Study|Participant noncompliance|4|||
125157487|NCT03188718|450202645|FG000|Overall Study|Withdrawal by Subject|1|||
125157488|NCT03188718|450202645|FG000|Overall Study|Device failure|3|||
125157489|NCT02072824|450202646|FG000|Overall Study|Insufficient clinical response|1|||
125157490|NCT02072824|450202647|FG001|Overall Study|Insufficient clinical response|0|||
125157491|NCT02072824|450202648|FG002|Overall Study|Insufficient clinical response|1|||
125157492|NCT02072824|450202646|FG000|Overall Study|No longer willing to participate|1|||
125157493|NCT02072824|450202647|FG001|Overall Study|No longer willing to participate|0|||
125157494|NCT02072824|450202648|FG002|Overall Study|No longer willing to participate|1|||
125157495|NCT02072824|450202646|FG000|Overall Study|Medication error|0|||
125157496|NCT02072824|450202647|FG001|Overall Study|Medication error|1|||
125157497|NCT02072824|450202648|FG002|Overall Study|Medication error|0|||
125157498|NCT02072824|450202646|FG000|Overall Study|Adverse Event|0|||
125157499|NCT02072824|450202647|FG001|Overall Study|Adverse Event|0|||
125157500|NCT02072824|450202648|FG002|Overall Study|Adverse Event|1|||
125157501|NCT03084367|450202649|FG000|Overall Study|Lost to Follow-up|32|||
125157502|NCT03084367|450202649|FG000|Overall Study|Withdrawal by Subject|4|||
125157503|NCT03084367|450202649|FG000|Overall Study|Other|1|||
125157504|NCT00841906|450202650|FG000|Overall Study|Withdrawal by Subject|2|||
125157505|NCT00841906|450202651|FG001|Overall Study|Withdrawal by Subject|0|||
125157506|NCT02667288|450202654|FG000|Overall Study|Protocol Violation|5|||
125157507|NCT02667288|450202654|FG000|Overall Study|Lost to Follow-up|3|||
125157508|NCT02667288|450202654|FG000|Overall Study|Withdrawal by Subject|5|||
125157509|NCT00912093|450202655|FG000|The Controlled Phase|Death|0|||
125157510|NCT00912093|450202656|FG001|The Controlled Phase|Death|1|||
125157511|NCT00912093|450202657|FG002|The Controlled Phase|Death|0|||
125157512|NCT00912093|450202658|FG003|The Controlled Phase|Death|0|||
125157513|NCT00912093|450202659|FG004|The Controlled Phase|Death|0|||
125157514|NCT00912093|450202655|FG000|The Controlled Phase|Medical Condition|0|||
125157515|NCT00912093|450202656|FG001|The Controlled Phase|Medical Condition|1|||
125157516|NCT00912093|450202657|FG002|The Controlled Phase|Medical Condition|0|||
125157517|NCT00912093|450202658|FG003|The Controlled Phase|Medical Condition|0|||
125157518|NCT00912093|450202659|FG004|The Controlled Phase|Medical Condition|0|||
125157519|NCT00912093|450202655|FG000|The Controlled Phase|Lost to Follow-up|0|||
125157520|NCT00912093|450202656|FG001|The Controlled Phase|Lost to Follow-up|0|||
125157521|NCT00912093|450202657|FG002|The Controlled Phase|Lost to Follow-up|0|||
125157522|NCT00912093|450202658|FG003|The Controlled Phase|Lost to Follow-up|0|||
125157523|NCT00912093|450202659|FG004|The Controlled Phase|Lost to Follow-up|1|||
125157524|NCT04397445|450202662|FG000|Overall Study|Withdrawal by Subject|1|||
125157525|NCT04397445|450202663|FG001|Overall Study|Withdrawal by Subject|0|||
125157526|NCT04397445|450202664|FG002|Overall Study|Withdrawal by Subject|0|||
125157527|NCT04397445|450202665|FG003|Overall Study|Withdrawal by Subject|0|||
125157528|NCT03921151|450202666|FG000|Overall Study|Withdrawal by Subject|11|||
125157529|NCT03921151|450202667|FG001|Overall Study|Withdrawal by Subject|16|||
125157530|NCT00270257|450202669|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
125157531|NCT00270257|450202670|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
125157532|NCT03001219|450202675|FG000|Proof of Concept|Study Termination by Sponsor|0|||
125157533|NCT03001219|450202676|FG001|Proof of Concept|Study Termination by Sponsor|1|||
125157534|NCT03001219|450202675|FG000|Proof of Concept|Withdrawal by Subject|0|||
125157535|NCT03001219|450202676|FG001|Proof of Concept|Withdrawal by Subject|4|||
125157536|NCT03001219|450202675|FG000|Proof of Concept|Protocol Deviation|0|||
125157537|NCT03001219|450202676|FG001|Proof of Concept|Protocol Deviation|1|||
125157538|NCT03001219|450202675|FG000|Proof of Concept|Adverse Event|1|||
125157539|NCT03001219|450202676|FG001|Proof of Concept|Adverse Event|1|||
125157540|NCT03001219|450202675|FG000|Proof of Concept|Physician Decision|1|||
125157541|NCT03001219|450202676|FG001|Proof of Concept|Physician Decision|0|||
125157542|NCT03001219|450202675|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
125157543|NCT03001219|450202676|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
125157544|NCT03001219|450202675|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
125157545|NCT03001219|450202676|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
125157546|NCT03001219|450202675|FG000|Extension Period Analysis|Physician Decision|0|||
125157547|NCT03001219|450202676|FG001|Extension Period Analysis|Physician Decision|1|||
125157548|NCT03001219|450202675|FG000|Extension Period Analysis|Adverse Event|1|||
125157549|NCT03001219|450202676|FG001|Extension Period Analysis|Adverse Event|1|||
125157550|NCT03001219|450202675|FG000|Extension Period Analysis|Protocol Deviation|0|||
125157551|NCT03001219|450202676|FG001|Extension Period Analysis|Protocol Deviation|1|||
125157552|NCT03001219|450202675|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
125157553|NCT03001219|450202676|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
125157554|NCT03733210|450202677|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
125157555|NCT03733210|450202678|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
125157556|NCT02621034|450202679|FG000|Overall Study|Lost to Follow-up|3|||
125157557|NCT02621034|450202680|FG001|Overall Study|Lost to Follow-up|2|||
125157558|NCT02621034|450202681|FG002|Overall Study|Lost to Follow-up|5|||
125157559|NCT02963441|450202682|FG000|Overall Study|Protocol violation or withdrawn|8|||
125157560|NCT02963441|450202682|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
125157561|NCT02963441|450202682|FG000|Overall Study|IDx-DR insufficient quality|33|||
125157562|NCT02669940|450202685|FG000|Overall Study|Failure to return|0|||
125157563|NCT02669940|450202686|FG001|Overall Study|Failure to return|3|||
125157564|NCT02669940|450202685|FG000|Overall Study|Insufficient follow-up data|1|||
125157565|NCT02669940|450202686|FG001|Overall Study|Insufficient follow-up data|0|||
125157566|NCT00361335|450202687|FG000|IV Period: Baseline to E0|Adverse Event|9|||
125157567|NCT00361335|450202688|FG001|IV Period: Baseline to E0|Adverse Event|4|||
125157568|NCT00361335|450202689|FG002|IV Period: Baseline to E0|Adverse Event|5|||
125157569|NCT00361335|450202690|FG003|IV Period: Baseline to E0|Adverse Event|9|||
125157570|NCT00361335|450202691|FG004|IV Period: Baseline to E0|Adverse Event|8|||
125157571|NCT00361335|450202692|FG005|IV Period: Baseline to E0|Adverse Event|0|||
125157572|NCT00361335|450202693|FG006|IV Period: Baseline to E0|Adverse Event|0|||
125157573|NCT00361335|450202687|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
125157574|NCT00361335|450202688|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
125157575|NCT00361335|450202689|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
125157576|NCT00361335|450202690|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
125157577|NCT00361335|450202691|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
125157578|NCT00361335|450202692|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
125157579|NCT00361335|450202693|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
125157580|NCT00361335|450202687|FG000|IV Period: Baseline to E0|Death|1|||
125157581|NCT00361335|450202688|FG001|IV Period: Baseline to E0|Death|1|||
125157582|NCT00361335|450202689|FG002|IV Period: Baseline to E0|Death|1|||
125157583|NCT00361335|450202690|FG003|IV Period: Baseline to E0|Death|1|||
125157584|NCT00361335|450202691|FG004|IV Period: Baseline to E0|Death|0|||
125157585|NCT00361335|450202692|FG005|IV Period: Baseline to E0|Death|0|||
125157586|NCT00361335|450202693|FG006|IV Period: Baseline to E0|Death|0|||
125157587|NCT00361335|450202687|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
125157588|NCT00361335|450202688|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
125157589|NCT00361335|450202689|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
125157590|NCT00361335|450202690|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
125157591|NCT00361335|450202691|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
125157592|NCT00361335|450202692|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
125157593|NCT00361335|450202693|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
125157594|NCT00361335|450202687|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
125157595|NCT00361335|450202688|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
125157596|NCT00361335|450202689|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
125157597|NCT00361335|450202690|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
125157598|NCT00361335|450202691|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
125157599|NCT00361335|450202692|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
125157600|NCT00361335|450202693|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
125157601|NCT00361335|450202687|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
125157602|NCT00361335|450202688|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
125157603|NCT00361335|450202689|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
125157604|NCT00361335|450202690|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
125157605|NCT00361335|450202691|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
125157606|NCT00361335|450202692|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
125157607|NCT00361335|450202693|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
125157608|NCT00361335|450202687|FG000|IV Period: Baseline to E0|Other|2|||
125157609|NCT00361335|450202688|FG001|IV Period: Baseline to E0|Other|9|||
125157610|NCT00361335|450202689|FG002|IV Period: Baseline to E0|Other|9|||
125157611|NCT00361335|450202690|FG003|IV Period: Baseline to E0|Other|3|||
125157612|NCT00361335|450202691|FG004|IV Period: Baseline to E0|Other|2|||
125157613|NCT00361335|450202692|FG005|IV Period: Baseline to E0|Other|0|||
125157614|NCT00361335|450202693|FG006|IV Period: Baseline to E0|Other|0|||
125157615|NCT00361335|450202687|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
125157616|NCT00361335|450202688|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
125157617|NCT00361335|450202689|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
125157618|NCT00361335|450202690|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
125157619|NCT00361335|450202691|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
125157620|NCT00361335|450202692|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
125157621|NCT00361335|450202693|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
125157622|NCT00361335|450202687|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
125157623|NCT00361335|450202688|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
125157624|NCT00361335|450202689|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
125157625|NCT00361335|450202690|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
125157626|NCT00361335|450202691|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
125157627|NCT00361335|450202692|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
125157628|NCT00361335|450202693|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
125157629|NCT00361335|450202687|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
125157630|NCT00361335|450202688|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
125157631|NCT00361335|450202689|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
125157632|NCT00361335|450202690|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
125157633|NCT00361335|450202691|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
125157634|NCT00361335|450202692|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
125157635|NCT00361335|450202693|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
125157636|NCT00361335|450202687|FG000|SC Period: Week E0 to Week E24|Death|0|||
125157637|NCT00361335|450202688|FG001|SC Period: Week E0 to Week E24|Death|0|||
125157638|NCT00361335|450202689|FG002|SC Period: Week E0 to Week E24|Death|0|||
125157639|NCT00361335|450202690|FG003|SC Period: Week E0 to Week E24|Death|0|||
125157640|NCT00361335|450202691|FG004|SC Period: Week E0 to Week E24|Death|0|||
125157641|NCT00361335|450202692|FG005|SC Period: Week E0 to Week E24|Death|0|||
125157642|NCT00361335|450202693|FG006|SC Period: Week E0 to Week E24|Death|1|||
125157643|NCT00361335|450202687|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
125157644|NCT00361335|450202688|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
125157645|NCT00361335|450202689|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
125157646|NCT00361335|450202690|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
125157647|NCT00361335|450202691|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
125157648|NCT00361335|450202692|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
125157649|NCT00361335|450202693|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
125157650|NCT00361335|450202687|FG000|SC Period: Week E0 to Week E24|Other|1|||
125157651|NCT00361335|450202688|FG001|SC Period: Week E0 to Week E24|Other|0|||
125157652|NCT00361335|450202689|FG002|SC Period: Week E0 to Week E24|Other|0|||
125157653|NCT00361335|450202690|FG003|SC Period: Week E0 to Week E24|Other|1|||
125157654|NCT00361335|450202691|FG004|SC Period: Week E0 to Week E24|Other|0|||
125157655|NCT00361335|450202692|FG005|SC Period: Week E0 to Week E24|Other|1|||
125157656|NCT00361335|450202693|FG006|SC Period: Week E0 to Week E24|Other|2|||
125157657|NCT00361335|450202687|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
125157658|NCT00361335|450202688|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
125157659|NCT00361335|450202689|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
125157660|NCT00361335|450202690|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
125157661|NCT00361335|450202691|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
125157662|NCT00361335|450202692|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
125157663|NCT00361335|450202693|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
125157664|NCT05065983|450202694|FG000|Overall Study|Lost to Follow-up|2|||
125157665|NCT00986180|450202695|FG000|Overall Study|Adverse Event|21|||
125157666|NCT00986180|450202696|FG001|Overall Study|Adverse Event|23|||
125157667|NCT00986180|450202695|FG000|Overall Study|Lack of Efficacy|4|||
125157668|NCT00986180|450202696|FG001|Overall Study|Lack of Efficacy|3|||
125157669|NCT00986180|450202695|FG000|Overall Study|Lost to Follow-up|5|||
125157670|NCT00986180|450202696|FG001|Overall Study|Lost to Follow-up|7|||
125157671|NCT00986180|450202695|FG000|Overall Study|Physician Decision|1|||
125157672|NCT00986180|450202696|FG001|Overall Study|Physician Decision|3|||
125157673|NCT00986180|450202695|FG000|Overall Study|Protocol Violation|2|||
125157674|NCT00986180|450202696|FG001|Overall Study|Protocol Violation|0|||
125157675|NCT00986180|450202695|FG000|Overall Study|Withdrawal by Subject|1|||
125157676|NCT00986180|450202696|FG001|Overall Study|Withdrawal by Subject|9|||
125157677|NCT00986180|450202695|FG000|Overall Study|Miscellanies|10|||
125157678|NCT00986180|450202696|FG001|Overall Study|Miscellanies|11|||
125157679|NCT01765582|450202697|FG000|Overall Study|Other|3|||
125157680|NCT01765582|450202698|FG001|Overall Study|Other|6|||
125157681|NCT01765582|450202699|FG002|Overall Study|Other|9|||
125157682|NCT01765582|450202697|FG000|Overall Study|Lost to Follow-up|2|||
125157683|NCT01765582|450202698|FG001|Overall Study|Lost to Follow-up|2|||
125157684|NCT01765582|450202699|FG002|Overall Study|Lost to Follow-up|1|||
125157685|NCT01765582|450202697|FG000|Overall Study|Death|31|||
125157686|NCT01765582|450202698|FG001|Overall Study|Death|36|||
125157687|NCT01765582|450202699|FG002|Overall Study|Death|33|||
125157688|NCT01765582|450202697|FG000|Overall Study|Sponsor Decision|46|||
125157689|NCT01765582|450202698|FG001|Overall Study|Sponsor Decision|42|||
125157690|NCT01765582|450202699|FG002|Overall Study|Sponsor Decision|42|||
125157691|NCT01765582|450202697|FG000|Overall Study|Withdrawal of Consent|11|||
125157692|NCT01765582|450202698|FG001|Overall Study|Withdrawal of Consent|6|||
125157693|NCT01765582|450202699|FG002|Overall Study|Withdrawal of Consent|10|||
125157694|NCT01691820|450202700|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
125157695|NCT01691820|450202701|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
125157696|NCT01691820|450202700|FG000|Overall Study|Migrated/moved from study area|7|||
125157697|NCT01691820|450202701|FG001|Overall Study|Migrated/moved from study area|4|||
125157698|NCT01691820|450202700|FG000|Overall Study|Lost to Follow-up|6|||
125157699|NCT01691820|450202701|FG001|Overall Study|Lost to Follow-up|17|||
125157700|NCT01691820|450202700|FG000|Overall Study|Other (unspecified)|4|||
125157701|NCT01691820|450202701|FG001|Overall Study|Other (unspecified)|1|||
125157702|NCT00616941|450202706|FG000|Overall Study|Progressive Disease|1|||
125157703|NCT00616941|450202707|FG001|Overall Study|Progressive Disease|2|||
125157704|NCT00616941|450202708|FG002|Overall Study|Progressive Disease|1|||
125157705|NCT00616941|450202706|FG000|Overall Study|Adverse Event|0|||
125157706|NCT00616941|450202707|FG001|Overall Study|Adverse Event|1|||
125157707|NCT00616941|450202708|FG002|Overall Study|Adverse Event|1|||
125157708|NCT00616941|450202706|FG000|Overall Study|Subject Non-compliance|0|||
125157709|NCT00616941|450202707|FG001|Overall Study|Subject Non-compliance|0|||
125157710|NCT00616941|450202708|FG002|Overall Study|Subject Non-compliance|1|||
125157711|NCT00616941|450202706|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
125157712|NCT00616941|450202707|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
125157713|NCT00616941|450202708|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
125157714|NCT00616941|450202706|FG000|Overall Study|Vaccination Suspended|0|||
125157715|NCT00616941|450202707|FG001|Overall Study|Vaccination Suspended|0|||
125157716|NCT00616941|450202708|FG002|Overall Study|Vaccination Suspended|3|||
125157717|NCT00714493|450202709|FG000|Overall Study|Adverse Event|11|||
125157718|NCT00714493|450202709|FG000|Overall Study|Death|3|||
125157719|NCT00714493|450202709|FG000|Overall Study|Lack of Efficacy|10|||
125157720|NCT00714493|450202709|FG000|Overall Study|Lost to Follow-up|3|||
125157721|NCT00714493|450202709|FG000|Overall Study|Protocol Violation|12|||
125157722|NCT00714493|450202709|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
125157723|NCT00714493|450202709|FG000|Overall Study|OTHER|2|||
125157724|NCT02372071|450202710|FG000|Overall Study|Protocol Violation|18|||
125157725|NCT00506129|450202711|FG000|Overall Study|Disease Progression/Relapse|15|||
125157726|NCT00506129|450202711|FG000|Overall Study|Death|7|||
125157727|NCT00557076|450202716|FG000|Overall Study|Unblinding|0|||
125157728|NCT00557076|450202717|FG001|Overall Study|Unblinding|1|||
125157729|NCT02408068|450202719|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
125157730|NCT02408068|450202720|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
125157731|NCT02408068|450202721|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
125157732|NCT02408068|450202722|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
125157733|NCT02408068|450202723|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
125157734|NCT02408068|450202724|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
125157735|NCT02138136|450202733|FG000|Overall Study|Protocol Violation|4|||
125157736|NCT02138136|450202733|FG000|Overall Study|Physician Decision|7|||
125157737|NCT02138136|450202733|FG000|Overall Study|Lack of Efficacy|35|||
125157738|NCT02138136|450202733|FG000|Overall Study|Pregnancy|2|||
125157739|NCT02138136|450202733|FG000|Overall Study|Adverse Event|18|||
125157740|NCT02138136|450202733|FG000|Overall Study|Withdrawal by Subject|36|||
125157741|NCT02138136|450202733|FG000|Overall Study|Lost to Follow-up|32|||
125157742|NCT02138136|450202733|FG000|Overall Study|Withdrawn by Sponsor|5|||
125157743|NCT00706381|450202736|FG000|Overall Study|Lost to Follow-up|0|||
125157744|NCT00706381|450202737|FG001|Overall Study|Lost to Follow-up|1|||
125157745|NCT00706381|450202738|FG002|Overall Study|Lost to Follow-up|1|||
125157746|NCT00706381|450202739|FG003|Overall Study|Lost to Follow-up|0|||
125157747|NCT00995085|450202743|FG000|Overall Study|Withdrawal by Subject|5|||
125157748|NCT03096847|450202749|FG000|Overall Study|Other|2|||
125157749|NCT03096847|450202750|FG001|Overall Study|Other|1|||
125157750|NCT03096847|450202751|FG002|Overall Study|Other|2|||
125157751|NCT03096847|450202749|FG000|Overall Study|Lost to Follow-up|1|||
125157752|NCT03096847|450202750|FG001|Overall Study|Lost to Follow-up|0|||
125157753|NCT03096847|450202751|FG002|Overall Study|Lost to Follow-up|1|||
125157754|NCT03096847|450202749|FG000|Overall Study|Death|6|||
125157755|NCT03096847|450202750|FG001|Overall Study|Death|0|||
125157756|NCT03096847|450202751|FG002|Overall Study|Death|2|||
125157757|NCT03096847|450202749|FG000|Overall Study|Protocol Violation|3|||
125157758|NCT03096847|450202750|FG001|Overall Study|Protocol Violation|0|||
125157759|NCT03096847|450202751|FG002|Overall Study|Protocol Violation|6|||
125157760|NCT03096847|450202749|FG000|Overall Study|Physician Decision|12|||
125157761|NCT03096847|450202750|FG001|Overall Study|Physician Decision|2|||
125157762|NCT03096847|450202751|FG002|Overall Study|Physician Decision|8|||
125157763|NCT03096847|450202749|FG000|Overall Study|Withdrawal by Subject|24|||
125157764|NCT03096847|450202750|FG001|Overall Study|Withdrawal by Subject|1|||
125157765|NCT03096847|450202751|FG002|Overall Study|Withdrawal by Subject|12|||
125157766|NCT03096847|450202749|FG000|Overall Study|Adverse Event|72|||
125157767|NCT03096847|450202750|FG001|Overall Study|Adverse Event|6|||
125157768|NCT03096847|450202751|FG002|Overall Study|Adverse Event|28|||
125157769|NCT03096847|450202749|FG000|Overall Study|Progressive disease|97|||
125157770|NCT03096847|450202750|FG001|Overall Study|Progressive disease|10|||
125157771|NCT03096847|450202751|FG002|Overall Study|Progressive disease|78|||
125157772|NCT03096847|450202749|FG000|Overall Study|Non-compliance with study medication|1|||
125157773|NCT03096847|450202750|FG001|Overall Study|Non-compliance with study medication|0|||
125157774|NCT03096847|450202751|FG002|Overall Study|Non-compliance with study medication|0|||
125157775|NCT03096847|450202749|FG000|Overall Study|New therapy for study indication|1|||
125157776|NCT03096847|450202750|FG001|Overall Study|New therapy for study indication|0|||
125157777|NCT03096847|450202751|FG002|Overall Study|New therapy for study indication|1|||
125157778|NCT01640873|450202752|FG000|Overall Study|Protocol Violation|2|||
125157779|NCT01640873|450202753|FG001|Overall Study|Protocol Violation|1|||
125157780|NCT02192164|450202754|FG000|Overall Study|Other|8|||
125157781|NCT02192164|450202754|FG000|Overall Study|Withdrawal by Subject|1|||
125157782|NCT02192164|450202754|FG000|Overall Study|Physician Decision|4|||
125157783|NCT02192164|450202754|FG000|Overall Study|Did not meet the exclusion criteria|1|||
125157784|NCT00359788|450202757|FG000|Overall Study|Adverse Event|11|||
125157785|NCT00359788|450202758|FG001|Overall Study|Adverse Event|10|||
125157786|NCT00359788|450202757|FG000|Overall Study|Lack of Efficacy|1|||
125157787|NCT00359788|450202758|FG001|Overall Study|Lack of Efficacy|2|||
125157788|NCT00359788|450202757|FG000|Overall Study|Lost to Follow-up|3|||
125157789|NCT00359788|450202758|FG001|Overall Study|Lost to Follow-up|2|||
125157790|NCT00359788|450202757|FG000|Overall Study|Withdrawal by Subject|4|||
125157791|NCT00359788|450202758|FG001|Overall Study|Withdrawal by Subject|1|||
125157792|NCT00359788|450202757|FG000|Overall Study|Protocol Violation|4|||
125157793|NCT00359788|450202758|FG001|Overall Study|Protocol Violation|2|||
125157794|NCT02143583|450202759|FG000|Overall Study|Withdrawal by Subject|1|||
125157795|NCT02143583|450202760|FG001|Overall Study|Withdrawal by Subject|0|||
125157796|NCT02143583|450202761|FG002|Overall Study|Withdrawal by Subject|1|||
125157797|NCT02143583|450202759|FG000|Overall Study|husband illness|0|||
125157798|NCT02143583|450202760|FG001|Overall Study|husband illness|0|||
125157799|NCT02143583|450202761|FG002|Overall Study|husband illness|1|||
125157800|NCT00673933|450202762|FG000|Overall Study|Withdrawal by Subject|2|||
125157801|NCT00673933|450202762|FG000|Overall Study|Lost to Follow-up|1|||
125157802|NCT04932941|450202763|FG000|Overall Study|Lost to Follow-up|3|||
125157803|NCT04932941|450202764|FG001|Overall Study|Lost to Follow-up|1|||
125157804|NCT04932941|450202763|FG000|Overall Study|Withdrawal by Subject|7|||
125157805|NCT04932941|450202764|FG001|Overall Study|Withdrawal by Subject|4|||
125157806|NCT04932941|450202763|FG000|Overall Study|Other|4|||
125157807|NCT04932941|450202764|FG001|Overall Study|Other|2|||
125157808|NCT01929031|450202767|FG000|Overall Study|Adverse Event|3|||
125157809|NCT01929031|450202768|FG001|Overall Study|Adverse Event|1|||
125157810|NCT01929031|450202769|FG002|Overall Study|Adverse Event|1|||
125157811|NCT01929031|450202770|FG003|Overall Study|Adverse Event|0|||
125157812|NCT01929031|450202771|FG004|Overall Study|Adverse Event|0|||
125157813|NCT01929031|450202772|FG005|Overall Study|Adverse Event|0|||
125157814|NCT01929031|450202767|FG000|Overall Study|Protocol Violation|1|||
125157815|NCT01929031|450202768|FG001|Overall Study|Protocol Violation|0|||
125157816|NCT01929031|450202769|FG002|Overall Study|Protocol Violation|0|||
125157817|NCT01929031|450202770|FG003|Overall Study|Protocol Violation|0|||
125157818|NCT01929031|450202771|FG004|Overall Study|Protocol Violation|0|||
125157819|NCT01929031|450202772|FG005|Overall Study|Protocol Violation|1|||
125157820|NCT01929031|450202767|FG000|Overall Study|Reason other than specified above|0|||
125157821|NCT01929031|450202768|FG001|Overall Study|Reason other than specified above|1|||
125157822|NCT01929031|450202769|FG002|Overall Study|Reason other than specified above|0|||
125157823|NCT01929031|450202770|FG003|Overall Study|Reason other than specified above|0|||
125157824|NCT01929031|450202771|FG004|Overall Study|Reason other than specified above|1|||
125157825|NCT01929031|450202772|FG005|Overall Study|Reason other than specified above|0|||
125157826|NCT02394730|450202778|FG000|Overall Study|Lost to Follow-up|1|||
125157827|NCT02394730|450202779|FG001|Overall Study|Lost to Follow-up|0|||
125157828|NCT02394730|450202778|FG000|Overall Study|Withdrawal by Subject|0|||
125157829|NCT02394730|450202779|FG001|Overall Study|Withdrawal by Subject|1|||
125157830|NCT03510182|450202783|FG000|Overall Study|Withdrawal by Subject|2|||
125157831|NCT01195272|450202784|FG000|Overall Study|Adverse Event|1|||
125157832|NCT01195272|450202784|FG000|Overall Study|Lack of Efficacy|3|||
125157833|NCT04905290|450204521|FG000|Overall Study|Adverse Event|4|||
125157834|NCT04905290|450204521|FG000|Overall Study|Death|2|||
125157835|NCT04905290|450204521|FG000|Overall Study|Withdrawal by Subject|4|||
125157836|NCT04905290|450204521|FG000|Overall Study|Physician Decision|2|||
125157837|NCT04905290|450204521|FG000|Overall Study|Lost to Follow-up|2|||
125157838|NCT04905290|450204521|FG000|Overall Study|Screen Failure|2|||
125157839|NCT04905290|450204521|FG000|Overall Study|Unsuccessful Procedure|2|||
125157840|NCT03295318|450204522|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
125157841|NCT03295318|450204523|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
125157842|NCT03295318|450204524|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
125157843|NCT03295318|450204522|FG000|Overall Study|Death|1|||
125157844|NCT03295318|450204523|FG001|Overall Study|Death|1|||
125157845|NCT03295318|450204524|FG002|Overall Study|Death|1|||
125157846|NCT03295318|450204522|FG000|Overall Study|Protocol Violation|4|||
125157847|NCT03295318|450204523|FG001|Overall Study|Protocol Violation|3|||
125157848|NCT03295318|450204524|FG002|Overall Study|Protocol Violation|3|||
125157849|NCT03295318|450204522|FG000|Overall Study|Withdrawal by Subject|0|||
125157850|NCT03295318|450204523|FG001|Overall Study|Withdrawal by Subject|0|||
125157851|NCT03295318|450204524|FG002|Overall Study|Withdrawal by Subject|1|||
125157852|NCT03295318|450204522|FG000|Overall Study|Subject discontinued due to travel|0|||
125157853|NCT03295318|450204523|FG001|Overall Study|Subject discontinued due to travel|1|||
125157854|NCT03295318|450204524|FG002|Overall Study|Subject discontinued due to travel|0|||
125157855|NCT04319718|450204525|FG000|Overall Study|Adverse Event|0|||
125157856|NCT04319718|450204526|FG001|Overall Study|Adverse Event|2|||
125157857|NCT04319718|450204525|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
125157858|NCT04319718|450204526|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
125157859|NCT01288053|450204527|FG000|Overall Study|Death|1|||
125157860|NCT00144781|450204528|FG000|Overall Study|Adverse Event|0|||
125157861|NCT00144781|450204529|FG001|Overall Study|Adverse Event|1|||
125157862|NCT00144781|450204530|FG002|Overall Study|Adverse Event|0|||
125157863|NCT00144781|450204531|FG003|Overall Study|Adverse Event|0|||
125157864|NCT00144781|450204528|FG000|Overall Study|Non-compliant|0|||
125157865|NCT00144781|450204529|FG001|Overall Study|Non-compliant|1|||
125157866|NCT00144781|450204530|FG002|Overall Study|Non-compliant|0|||
125157867|NCT00144781|450204531|FG003|Overall Study|Non-compliant|0|||
125157868|NCT02068092|450204532|FG000|Overall Study|Physician Decision|2|||
125157869|NCT02068092|450204532|FG000|Overall Study|Adverse Event|2|||
125157870|NCT02068092|450204532|FG000|Overall Study|Lost to Follow-up|4|||
125157871|NCT02068092|450204532|FG000|Overall Study|Withdrawal by Subject|2|||
125157872|NCT01045421|450204533|FG000|Phase 1|Progressive Disease|0|||
125157873|NCT01045421|450204534|FG001|Phase 1|Progressive Disease|0|||
125157874|NCT01045421|450204535|FG002|Phase 1|Progressive Disease|0|||
125157875|NCT01045421|450204536|FG003|Phase 1|Progressive Disease|0|||
125157876|NCT01045421|450204537|FG004|Phase 1|Progressive Disease|1|||
125157877|NCT01045421|450204538|FG005|Phase 1|Progressive Disease|0|||
125157878|NCT01045421|450204539|FG006|Phase 1|Progressive Disease|0|||
125157879|NCT01045421|450204540|FG007|Phase 1|Progressive Disease|0|||
125157880|NCT01045421|450204541|FG008|Phase 1|Progressive Disease|0|||
125157881|NCT01045421|450204542|FG009|Phase 1|Progressive Disease|0|||
125157882|NCT01045421|450204543|FG010|Phase 1|Progressive Disease|0|||
125157883|NCT01045421|450204533|FG000|Phase 1|Withdrawal by Subject|0|||
125157884|NCT01045421|450204534|FG001|Phase 1|Withdrawal by Subject|0|||
125157885|NCT01045421|450204535|FG002|Phase 1|Withdrawal by Subject|0|||
125157886|NCT01045421|450204536|FG003|Phase 1|Withdrawal by Subject|1|||
125157887|NCT01045421|450204537|FG004|Phase 1|Withdrawal by Subject|0|||
125157888|NCT01045421|450204538|FG005|Phase 1|Withdrawal by Subject|0|||
125157889|NCT01045421|450204539|FG006|Phase 1|Withdrawal by Subject|0|||
125157890|NCT01045421|450204540|FG007|Phase 1|Withdrawal by Subject|0|||
125157891|NCT01045421|450204541|FG008|Phase 1|Withdrawal by Subject|0|||
125157892|NCT01045421|450204542|FG009|Phase 1|Withdrawal by Subject|0|||
125157893|NCT01045421|450204543|FG010|Phase 1|Withdrawal by Subject|0|||
125157894|NCT01045421|450204533|FG000|Phase 2|Progressive Disease|0|||
125157895|NCT01045421|450204534|FG001|Phase 2|Progressive Disease|0|||
125157896|NCT01045421|450204535|FG002|Phase 2|Progressive Disease|0|||
125157897|NCT01045421|450204536|FG003|Phase 2|Progressive Disease|0|||
125157898|NCT01045421|450204537|FG004|Phase 2|Progressive Disease|0|||
125157899|NCT01045421|450204538|FG005|Phase 2|Progressive Disease|0|||
125157900|NCT01045421|450204539|FG006|Phase 2|Progressive Disease|0|||
125157901|NCT01045421|450204540|FG007|Phase 2|Progressive Disease|1|||
125157902|NCT01045421|450204541|FG008|Phase 2|Progressive Disease|1|||
125157903|NCT01045421|450204542|FG009|Phase 2|Progressive Disease|1|||
125157904|NCT01045421|450204543|FG010|Phase 2|Progressive Disease|1|||
125157905|NCT01045421|450204533|FG000|Phase 2|Death|0|||
125157906|NCT01045421|450204534|FG001|Phase 2|Death|0|||
125157907|NCT01045421|450204535|FG002|Phase 2|Death|0|||
125157908|NCT01045421|450204536|FG003|Phase 2|Death|0|||
125157909|NCT01045421|450204537|FG004|Phase 2|Death|0|||
125157910|NCT01045421|450204538|FG005|Phase 2|Death|0|||
125157911|NCT01045421|450204539|FG006|Phase 2|Death|0|||
125157912|NCT01045421|450204540|FG007|Phase 2|Death|1|||
125157913|NCT01045421|450204541|FG008|Phase 2|Death|1|||
125157914|NCT01045421|450204542|FG009|Phase 2|Death|2|||
125157915|NCT01045421|450204543|FG010|Phase 2|Death|0|||
125157916|NCT01045421|450204533|FG000|Phase 2|Other|0|||
125157917|NCT01045421|450204534|FG001|Phase 2|Other|0|||
125157918|NCT01045421|450204535|FG002|Phase 2|Other|0|||
125157919|NCT01045421|450204536|FG003|Phase 2|Other|0|||
125157920|NCT01045421|450204537|FG004|Phase 2|Other|0|||
125157921|NCT01045421|450204538|FG005|Phase 2|Other|0|||
125157922|NCT01045421|450204539|FG006|Phase 2|Other|0|||
125157923|NCT01045421|450204540|FG007|Phase 2|Other|3|||
125157924|NCT01045421|450204541|FG008|Phase 2|Other|0|||
125157925|NCT01045421|450204542|FG009|Phase 2|Other|0|||
125157926|NCT01045421|450204543|FG010|Phase 2|Other|1|||
125157927|NCT02221037|450204544|FG000|Overall Study|Physician Decision|0|||
125157928|NCT02221037|450204545|FG001|Overall Study|Physician Decision|0|||
125157929|NCT02221037|450204546|FG002|Overall Study|Physician Decision|1|||
125157930|NCT02221037|450204547|FG003|Overall Study|Physician Decision|0|||
125157931|NCT02307266|450204548|FG000|Overall Study|Adverse Event|3|||
125157932|NCT02307266|450204549|FG001|Overall Study|Adverse Event|1|||
125157933|NCT02307266|450204550|FG002|Overall Study|Adverse Event|5|||
125157934|NCT02307266|450204548|FG000|Overall Study|Withdrawal by Subject|2|||
125157935|NCT02307266|450204549|FG001|Overall Study|Withdrawal by Subject|0|||
125157936|NCT02307266|450204550|FG002|Overall Study|Withdrawal by Subject|1|||
125157937|NCT02307266|450204548|FG000|Overall Study|Lost to Follow-up|3|||
125157938|NCT02307266|450204549|FG001|Overall Study|Lost to Follow-up|0|||
125157939|NCT02307266|450204550|FG002|Overall Study|Lost to Follow-up|0|||
125157940|NCT01995266|450204559|FG000|Overall Study|Death|1|||
125157941|NCT01995266|450204559|FG000|Overall Study|Lack of Efficacy|6|||
125157942|NCT01995266|450204559|FG000|Overall Study|Adverse Event|2|||
125157943|NCT03596151|450204563|FG000|Overall Study|Withdrawal by Subject|1|||
125157944|NCT00729248|450204566|FG000|Overall Study|Physician Decision|2|||
125157945|NCT03573505|450204572|FG000|Overall Study|Adverse Event|1|||
125157946|NCT03573505|450204573|FG001|Overall Study|Adverse Event|1|||
125157947|NCT03573505|450204572|FG000|Overall Study|Consent withdrawn|0|||
125157948|NCT03573505|450204573|FG001|Overall Study|Consent withdrawn|1|||
125157949|NCT03573505|450204572|FG000|Overall Study|Disease progression|0|||
125157950|NCT03573505|450204573|FG001|Overall Study|Disease progression|1|||
125157951|NCT03573505|450204572|FG000|Overall Study|Site Terminated by Sponsor|1|||
125157952|NCT03573505|450204573|FG001|Overall Study|Site Terminated by Sponsor|1|||
125157953|NCT03573505|450204572|FG000|Overall Study|Study terminated by sponsor|50|||
125157954|NCT03573505|450204573|FG001|Overall Study|Study terminated by sponsor|45|||
125157955|NCT03573505|450204572|FG000|Overall Study|Reason not specified|0|||
125157956|NCT03573505|450204573|FG001|Overall Study|Reason not specified|1|||
125157957|NCT03573505|450204572|FG000|Overall Study|Death|0|||
125157958|NCT03573505|450204573|FG001|Overall Study|Death|4|||
125157959|NCT03222583|450204574|FG000|Overall Study|Withdrawal by Subject|3|||
125157960|NCT03222583|450204575|FG001|Overall Study|Withdrawal by Subject|3|||
125157961|NCT03222583|450204574|FG000|Overall Study|Lost to Follow-up|1|||
125157962|NCT03222583|450204575|FG001|Overall Study|Lost to Follow-up|0|||
125157963|NCT03222583|450204574|FG000|Overall Study|Other|1|||
125157964|NCT03222583|450204575|FG001|Overall Study|Other|3|||
125157965|NCT04280705|450204576|FG000|Overall Study|Enrolled but not treated|4|||
125157966|NCT04280705|450204577|FG001|Overall Study|Enrolled but not treated|10|||
125157967|NCT04280705|450204576|FG000|Overall Study|Physician Decision|1|||
125157968|NCT04280705|450204577|FG001|Overall Study|Physician Decision|0|||
125157969|NCT04280705|450204576|FG000|Overall Study|Withdrawal by Subject|7|||
125157970|NCT04280705|450204577|FG001|Overall Study|Withdrawal by Subject|9|||
125157971|NCT04280705|450204576|FG000|Overall Study|Adverse Event|0|||
125157972|NCT04280705|450204577|FG001|Overall Study|Adverse Event|4|||
125157973|NCT04280705|450204576|FG000|Overall Study|Transferred to another hospital|1|||
125157974|NCT04280705|450204577|FG001|Overall Study|Transferred to another hospital|1|||
125157975|NCT04268316|450204580|FG000|Overall Study|Withdrawal by Subject|2|||
125157976|NCT04268316|450204581|FG001|Overall Study|Withdrawal by Subject|1|||
125157977|NCT04268316|450204582|FG002|Overall Study|Withdrawal by Subject|0|||
125157978|NCT05855616|450204592|FG000|Overall Study|Lost to Follow-up|1|||
125157979|NCT05855616|450204593|FG001|Overall Study|Lost to Follow-up|2|||
125157980|NCT04032158|450204594|FG000|Overall Study|Study Termination|2|||
125157981|NCT04032158|450204595|FG001|Overall Study|Study Termination|1|||
125157982|NCT00059787|450204596|FG000|Overall Study|Adverse Event|13|||
125157983|NCT00059787|450204596|FG000|Overall Study|disease progression|2|||
125157984|NCT00059787|450204596|FG000|Overall Study|ineligible|1|||
125157985|NCT00059787|450204596|FG000|Overall Study|Other|4|||
125157986|NCT00103311|450204603|FG000|Overall Study|Lost to Follow-up|1|||
125157987|NCT00103311|450204604|FG001|Overall Study|Lost to Follow-up|0|||
125157988|NCT00103311|450204603|FG000|Overall Study|Withdrawal by Subject|2|||
125157989|NCT00103311|450204604|FG001|Overall Study|Withdrawal by Subject|1|||
125157990|NCT00103311|450204603|FG000|Overall Study|Adverse Event|1|||
125157991|NCT00103311|450204604|FG001|Overall Study|Adverse Event|0|||
125157992|NCT01196078|450204605|FG000|Overall Study|Withdrawal by Subject|3|||
125157993|NCT01196078|450204606|FG001|Overall Study|Withdrawal by Subject|5|||
125157994|NCT01196078|450204605|FG000|Overall Study|Adverse Event|4|||
125157995|NCT01196078|450204606|FG001|Overall Study|Adverse Event|4|||
125157996|NCT01196078|450204605|FG000|Overall Study|Protocol Violation|2|||
125157997|NCT01196078|450204606|FG001|Overall Study|Protocol Violation|1|||
125157998|NCT01196078|450204605|FG000|Overall Study|Lack of Efficacy|17|||
125157999|NCT01196078|450204606|FG001|Overall Study|Lack of Efficacy|23|||
125158000|NCT01196078|450204605|FG000|Overall Study|Lost to Follow-up|1|||
125158001|NCT01196078|450204606|FG001|Overall Study|Lost to Follow-up|0|||
125158002|NCT01196078|450204605|FG000|Overall Study|Death|6|||
125158003|NCT01196078|450204606|FG001|Overall Study|Death|4|||
125158004|NCT01403064|450204607|FG000|Overall Study|Death|0|||
125158005|NCT01403064|450204608|FG001|Overall Study|Death|0|||
125158006|NCT01403064|450204609|FG002|Overall Study|Death|1|||
125158007|NCT01403064|450204610|FG003|Overall Study|Death|1|||
125158008|NCT01403064|450204607|FG000|Overall Study|Withdrawal by Subject|0|||
125158009|NCT01403064|450204608|FG001|Overall Study|Withdrawal by Subject|0|||
125158010|NCT01403064|450204609|FG002|Overall Study|Withdrawal by Subject|1|||
125158011|NCT01403064|450204610|FG003|Overall Study|Withdrawal by Subject|1|||
125158012|NCT01403064|450204607|FG000|Overall Study|Other|1|||
125158013|NCT01403064|450204608|FG001|Overall Study|Other|0|||
125158014|NCT01403064|450204609|FG002|Overall Study|Other|2|||
125158015|NCT01403064|450204610|FG003|Overall Study|Other|1|||
125158016|NCT04688931|450204620|FG000|Overall Study|Adverse Event|4|||
125158017|NCT04688931|450204621|FG001|Overall Study|Adverse Event|1|||
125158018|NCT04688931|450204620|FG000|Overall Study|Withdrawal by Subject|5|||
125158019|NCT04688931|450204621|FG001|Overall Study|Withdrawal by Subject|16|||
125158020|NCT04688931|450204620|FG000|Overall Study|Physician Decision|3|||
125158021|NCT04688931|450204621|FG001|Overall Study|Physician Decision|5|||
125158022|NCT04688931|450204620|FG000|Overall Study|Noncompliance|0|||
125158023|NCT04688931|450204621|FG001|Overall Study|Noncompliance|1|||
125158024|NCT04688931|450204620|FG000|Overall Study|Lost to Follow-up|1|||
125158025|NCT04688931|450204621|FG001|Overall Study|Lost to Follow-up|3|||
125158026|NCT04688931|450204620|FG000|Overall Study|Randomization Error|3|||
125158027|NCT04688931|450204621|FG001|Overall Study|Randomization Error|0|||
125158028|NCT04688931|450204620|FG000|Overall Study|Not Eligible|1|||
125158029|NCT04688931|450204621|FG001|Overall Study|Not Eligible|3|||
125158030|NCT04688931|450204620|FG000|Overall Study|Disease Progression|0|||
125158031|NCT04688931|450204621|FG001|Overall Study|Disease Progression|2|||
125158032|NCT04688931|450204620|FG000|Overall Study|Sponsor Requirement|1|||
125158033|NCT04688931|450204621|FG001|Overall Study|Sponsor Requirement|1|||
125158034|NCT04688931|450204620|FG000|Overall Study|Other Reason|1|||
125158035|NCT04688931|450204621|FG001|Overall Study|Other Reason|2|||
125158036|NCT00450619|450204622|FG000|Overall Study|refused treatment after randomization|2|||
125158037|NCT00450619|450204623|FG001|Overall Study|refused treatment after randomization|0|||
125158038|NCT00450619|450204622|FG000|Overall Study|did not progress; refused further trmt|1|||
125158039|NCT00450619|450204623|FG001|Overall Study|did not progress; refused further trmt|1|||
125158040|NCT00450619|450204622|FG000|Overall Study|Adverse Event|1|||
125158041|NCT00450619|450204623|FG001|Overall Study|Adverse Event|0|||
125158042|NCT02034058|450204624|FG000|Overall Study|Death|3|||
125158043|NCT02963311|450204629|FG000|Overall Study|Withdrawal by Subject|1|||
125158044|NCT02963311|450204629|FG000|Overall Study|Screen Failure|4|||
125158045|NCT01968694|450204649|FG000|Washout (1 Month)|Lost to Follow-up|0|||
125158046|NCT01968694|450204650|FG001|Washout (1 Month)|Lost to Follow-up|1|||
125158047|NCT02836496|450204653|FG000|Overall Study|Adverse Event|2|||
125158048|NCT02836496|450204654|FG001|Overall Study|Adverse Event|1|||
125158049|NCT02836496|450204653|FG000|Overall Study|Withdrawal by Subject|0|||
125158050|NCT02836496|450204654|FG001|Overall Study|Withdrawal by Subject|1|||
125158051|NCT00354341|450204655|FG000|Overall Study|Adverse Event|1|||
125158052|NCT00354341|450204656|FG001|Overall Study|Adverse Event|0|||
125158053|NCT00354341|450204655|FG000|Overall Study|Death|0|||
125158054|NCT00354341|450204656|FG001|Overall Study|Death|2|||
125158055|NCT00354341|450204655|FG000|Overall Study|Refused treatment|1|||
125158056|NCT00354341|450204656|FG001|Overall Study|Refused treatment|2|||
125158057|NCT00354341|450204655|FG000|Overall Study|Failure to return|0|||
125158058|NCT00354341|450204656|FG001|Overall Study|Failure to return|1|||
125158059|NCT00354341|450204655|FG000|Overall Study|Other|1|||
125158060|NCT00354341|450204656|FG001|Overall Study|Other|2|||
125158061|NCT01400919|450204657|FG000|Overall Study|Withdrawal by Subject|4|||
125158062|NCT01400919|450204657|FG000|Overall Study|Lost to Follow-up|2|||
125158063|NCT01400919|450204657|FG000|Overall Study|Missed visit|2|||
125158064|NCT00251719|450204658|FG000|Overall Study|Adverse Event|14|||
125158065|NCT00251719|450204659|FG001|Overall Study|Adverse Event|8|||
125158066|NCT00251719|450204660|FG002|Overall Study|Adverse Event|7|||
125158067|NCT00251719|450204658|FG000|Overall Study|Protocol Violation|1|||
125158068|NCT00251719|450204659|FG001|Overall Study|Protocol Violation|1|||
125158069|NCT00251719|450204660|FG002|Overall Study|Protocol Violation|1|||
125158070|NCT00251719|450204658|FG000|Overall Study|Lost to Follow-up|5|||
125158071|NCT00251719|450204659|FG001|Overall Study|Lost to Follow-up|11|||
125158072|NCT00251719|450204660|FG002|Overall Study|Lost to Follow-up|8|||
125158073|NCT00251719|450204658|FG000|Overall Study|Withdrawal by Subject|14|||
125158074|NCT00251719|450204659|FG001|Overall Study|Withdrawal by Subject|12|||
125158075|NCT00251719|450204660|FG002|Overall Study|Withdrawal by Subject|11|||
125158076|NCT00251719|450204658|FG000|Overall Study|Lack of Efficacy|2|||
125158077|NCT00251719|450204659|FG001|Overall Study|Lack of Efficacy|1|||
125158078|NCT00251719|450204660|FG002|Overall Study|Lack of Efficacy|0|||
125158079|NCT00251719|450204658|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
125158080|NCT00251719|450204659|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
125158081|NCT00251719|450204660|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
125158082|NCT00251719|450204658|FG000|Overall Study|Investigator decision|1|||
125158083|NCT00251719|450204659|FG001|Overall Study|Investigator decision|1|||
125158084|NCT00251719|450204660|FG002|Overall Study|Investigator decision|0|||
125158085|NCT00251719|450204658|FG000|Overall Study|Noncompliance|2|||
125158086|NCT00251719|450204659|FG001|Overall Study|Noncompliance|3|||
125158087|NCT00251719|450204660|FG002|Overall Study|Noncompliance|1|||
125158088|NCT00251719|450204658|FG000|Overall Study|Barrett's esophagus|2|||
125158089|NCT00251719|450204659|FG001|Overall Study|Barrett's esophagus|2|||
125158090|NCT00251719|450204660|FG002|Overall Study|Barrett's esophagus|0|||
125158091|NCT03822832|450204661|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
125158092|NCT03822832|450204662|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
125158093|NCT03822832|450204661|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
125158094|NCT03822832|450204662|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
125158095|NCT03822832|450204661|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
125158096|NCT03822832|450204662|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
125158097|NCT03822832|450204661|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
125158098|NCT03822832|450204662|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
125158099|NCT03822832|450204661|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
125158100|NCT03822832|450204662|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
125158101|NCT03822832|450204661|FG000|Re-allocation|Not re-allocated to open label period|2|||
125158102|NCT03822832|450204662|FG001|Re-allocation|Not re-allocated to open label period|6|||
125158103|NCT03822832|450204661|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
125158104|NCT03822832|450204662|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
125158105|NCT03822832|450204661|FG000|Period 2 - Open Label Period|Adverse Event|0|||
125158106|NCT03822832|450204662|FG001|Period 2 - Open Label Period|Adverse Event|3|||
125158107|NCT01732874|450204663|FG000|Overall Study|Withdrawal by Subject|5|||
125158108|NCT01732874|450204664|FG001|Overall Study|Withdrawal by Subject|1|||
125158109|NCT01732874|450204663|FG000|Overall Study|Death of Infant|3|||
125158110|NCT01732874|450204664|FG001|Overall Study|Death of Infant|2|||
125158111|NCT00846521|450204667|FG000|Overall Study|Withdrawal by Subject|5|||
125158112|NCT00846521|450204667|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
125158113|NCT00846521|450204667|FG000|Overall Study|Protocol Violation|1|||
125158114|NCT01246011|450204668|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
125158115|NCT01246011|450204669|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
125158116|NCT01246011|450204670|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
125158117|NCT01246011|450204668|FG000|Overall Study|Withdrawal by Subject|0|||
125158118|NCT01246011|450204669|FG001|Overall Study|Withdrawal by Subject|0|||
125158119|NCT01246011|450204670|FG002|Overall Study|Withdrawal by Subject|1|||
125158120|NCT04392583|450204671|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
125158121|NCT02303041|450204672|FG000|Overall Study|Adverse Event|1|||
125158122|NCT02303041|450204673|FG001|Overall Study|Adverse Event|2|||
125158123|NCT03979820|450204674|FG000|Overall Study|Protocol Violation|1|||
125158124|NCT03979820|450204675|FG001|Overall Study|Protocol Violation|0|||
125158125|NCT03979820|450204676|FG002|Overall Study|Protocol Violation|0|||
125158126|NCT03979820|450204677|FG003|Overall Study|Protocol Violation|0|||
125158127|NCT03979820|450204674|FG000|Overall Study|Withdrawal by Subject|0|||
125158128|NCT03979820|450204675|FG001|Overall Study|Withdrawal by Subject|0|||
125158129|NCT03979820|450204676|FG002|Overall Study|Withdrawal by Subject|1|||
125158130|NCT03979820|450204677|FG003|Overall Study|Withdrawal by Subject|0|||
125158131|NCT03979820|450204674|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
125158132|NCT03979820|450204675|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
125158133|NCT03979820|450204676|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
125158134|NCT03979820|450204677|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
125158135|NCT00160641|450204678|FG000|Overall Study|Adverse Event|102|||
125158136|NCT00160641|450204678|FG000|Overall Study|Withdrawal by Subject|87|||
125158137|NCT00160641|450204678|FG000|Overall Study|Lost to Follow-up|8|||
125158138|NCT00160641|450204678|FG000|Overall Study|Lack of Efficacy|12|||
125158139|NCT00160641|450204678|FG000|Overall Study|Protocol Violation|3|||
125158140|NCT00160641|450204678|FG000|Overall Study|Other|9|||
125158141|NCT05816200|450204692|FG000|Overall Study|Lost to Follow-up|2|||
125158142|NCT05816200|450204693|FG001|Overall Study|Lost to Follow-up|1|||
125158143|NCT01366443|450204694|FG000|Overall Study|Lost to Follow-up|2|||
125158144|NCT01366443|450204694|FG000|Overall Study|Under 18 yo|1|||
125158145|NCT00369382|450204695|FG000|Overall Study|Death|0|||
125158146|NCT00369382|450204696|FG001|Overall Study|Death|2|||
125158147|NCT00369382|450204695|FG000|Overall Study|Physician Decision|2|||
125158148|NCT00369382|450204696|FG001|Overall Study|Physician Decision|1|||
125158149|NCT00369382|450204695|FG000|Overall Study|Withdrawal by Subject|5|||
125158150|NCT00369382|450204696|FG001|Overall Study|Withdrawal by Subject|0|||
125158151|NCT00369382|450204695|FG000|Overall Study|Randomized, not treated|2|||
125158152|NCT00369382|450204696|FG001|Overall Study|Randomized, not treated|0|||
125158153|NCT00369382|450204695|FG000|Overall Study|Other|1|||
125158154|NCT00369382|450204696|FG001|Overall Study|Other|0|||
125158155|NCT01673698|450204699|FG000|Overall Study|Lost to Follow-up|51|||
125158156|NCT01673698|450204700|FG001|Overall Study|Lost to Follow-up|13|||
125158157|NCT00507546|450204701|FG000|Overall Study|Withdrawal by Subject|1|||
125158158|NCT00507546|450204702|FG001|Overall Study|Withdrawal by Subject|0|||
125158159|NCT00507546|450204701|FG000|Overall Study|Protocol Violation|1|||
125158160|NCT00507546|450204702|FG001|Overall Study|Protocol Violation|0|||
125158161|NCT00507546|450204701|FG000|Overall Study|Physician Decision|0|||
125158162|NCT00507546|450204702|FG001|Overall Study|Physician Decision|1|||
125158163|NCT00448136|450204703|FG000|Overall Study|Death|3|||
125158164|NCT00448136|450204704|FG001|Overall Study|Death|8|||
125158165|NCT00448136|450204703|FG000|Overall Study|Investigator's decision (progression)|1|||
125158166|NCT00448136|450204704|FG001|Overall Study|Investigator's decision (progression)|0|||
125158167|NCT00609466|450204705|FG000|Overall Study|Withdrawal by Subject|0|||
125158168|NCT00609466|450204706|FG001|Overall Study|Withdrawal by Subject|1|||
125158169|NCT00609466|450204707|FG002|Overall Study|Withdrawal by Subject|1|||
125158170|NCT00609466|450204705|FG000|Overall Study|Adverse Event|2|||
125158171|NCT00609466|450204706|FG001|Overall Study|Adverse Event|3|||
125158172|NCT00609466|450204707|FG002|Overall Study|Adverse Event|1|||
125158173|NCT00609466|450204705|FG000|Overall Study|Lack of Efficacy|0|||
125158174|NCT00609466|450204706|FG001|Overall Study|Lack of Efficacy|2|||
125158175|NCT00609466|450204707|FG002|Overall Study|Lack of Efficacy|2|||
125158176|NCT03512262|450204708|FG000|Overall Study|Adverse Event|8|||
125158177|NCT03512262|450204709|FG001|Overall Study|Adverse Event|3|||
125158178|NCT03512262|450204708|FG000|Overall Study|Death (non-treatment emergent)|1|||
125158179|NCT03512262|450204709|FG001|Overall Study|Death (non-treatment emergent)|0|||
125158180|NCT03512262|450204708|FG000|Overall Study|Withdrawal by Subject|17|||
125158181|NCT03512262|450204709|FG001|Overall Study|Withdrawal by Subject|9|||
125158182|NCT03512262|450204708|FG000|Overall Study|Lost to Follow-up|7|||
125158183|NCT03512262|450204709|FG001|Overall Study|Lost to Follow-up|1|||
125158184|NCT03512262|450204708|FG000|Overall Study|Other than Specified|2|||
125158185|NCT03512262|450204709|FG001|Overall Study|Other than Specified|2|||
125158186|NCT03407430|450204710|FG000|Washout|Protocol Violation|1|||
125158187|NCT03407430|450204711|FG001|Washout|Protocol Violation|0|||
125158188|NCT03502707|450206211|FG000|Overall Study|Adverse Event|0|||
125158189|NCT03502707|450206212|FG001|Overall Study|Adverse Event|0|||
125158190|NCT03502707|450206213|FG002|Overall Study|Adverse Event|0|||
125158191|NCT03502707|450206214|FG003|Overall Study|Adverse Event|0|||
125158192|NCT03502707|450206215|FG004|Overall Study|Adverse Event|0|||
125158193|NCT03502707|450206216|FG005|Overall Study|Adverse Event|0|||
125158194|NCT03502707|450206217|FG006|Overall Study|Adverse Event|0|||
125158195|NCT03502707|450206218|FG007|Overall Study|Adverse Event|0|||
125158196|NCT03502707|450206219|FG008|Overall Study|Adverse Event|0|||
125158197|NCT03502707|450206220|FG009|Overall Study|Adverse Event|0|||
125158198|NCT03502707|450206221|FG010|Overall Study|Adverse Event|0|||
125158199|NCT03502707|450206222|FG011|Overall Study|Adverse Event|0|||
125158200|NCT03502707|450206223|FG012|Overall Study|Adverse Event|0|||
125158201|NCT03502707|450206224|FG013|Overall Study|Adverse Event|0|||
125158202|NCT03502707|450206225|FG014|Overall Study|Adverse Event|0|||
125158203|NCT03502707|450206226|FG015|Overall Study|Adverse Event|1|||
125158204|NCT03502707|450206227|FG016|Overall Study|Adverse Event|5|||
125158205|NCT03502707|450206228|FG017|Overall Study|Adverse Event|0|||
125158206|NCT03502707|450206211|FG000|Overall Study|Death|0|||
125158207|NCT03502707|450206212|FG001|Overall Study|Death|0|||
125158208|NCT03502707|450206213|FG002|Overall Study|Death|0|||
125158209|NCT03502707|450206214|FG003|Overall Study|Death|1|||
125158210|NCT03502707|450206215|FG004|Overall Study|Death|0|||
125158211|NCT03502707|450206216|FG005|Overall Study|Death|0|||
125158212|NCT03502707|450206217|FG006|Overall Study|Death|0|||
125158213|NCT03502707|450206218|FG007|Overall Study|Death|0|||
125158214|NCT03502707|450206219|FG008|Overall Study|Death|1|||
125158215|NCT03502707|450206220|FG009|Overall Study|Death|1|||
125158216|NCT03502707|450206221|FG010|Overall Study|Death|0|||
125158217|NCT03502707|450206222|FG011|Overall Study|Death|0|||
125158218|NCT03502707|450206223|FG012|Overall Study|Death|1|||
125158219|NCT03502707|450206224|FG013|Overall Study|Death|0|||
125158220|NCT03502707|450206225|FG014|Overall Study|Death|0|||
125158221|NCT03502707|450206226|FG015|Overall Study|Death|1|||
125158222|NCT03502707|450206227|FG016|Overall Study|Death|0|||
125158223|NCT03502707|450206228|FG017|Overall Study|Death|0|||
125158224|NCT03502707|450206211|FG000|Overall Study|Lost to Follow-up|0|||
125158225|NCT03502707|450206212|FG001|Overall Study|Lost to Follow-up|0|||
125158226|NCT03502707|450206213|FG002|Overall Study|Lost to Follow-up|0|||
125158227|NCT03502707|450206214|FG003|Overall Study|Lost to Follow-up|0|||
125158228|NCT03502707|450206215|FG004|Overall Study|Lost to Follow-up|0|||
125158229|NCT03502707|450206216|FG005|Overall Study|Lost to Follow-up|0|||
125158230|NCT03502707|450206217|FG006|Overall Study|Lost to Follow-up|0|||
125158231|NCT03502707|450206218|FG007|Overall Study|Lost to Follow-up|5|||
125158232|NCT03502707|450206219|FG008|Overall Study|Lost to Follow-up|0|||
125158233|NCT03502707|450206220|FG009|Overall Study|Lost to Follow-up|2|||
125158234|NCT03502707|450206221|FG010|Overall Study|Lost to Follow-up|1|||
125158235|NCT03502707|450206222|FG011|Overall Study|Lost to Follow-up|2|||
125158236|NCT03502707|450206223|FG012|Overall Study|Lost to Follow-up|1|||
125158237|NCT03502707|450206224|FG013|Overall Study|Lost to Follow-up|1|||
125158238|NCT03502707|450206225|FG014|Overall Study|Lost to Follow-up|0|||
125158239|NCT03502707|450206226|FG015|Overall Study|Lost to Follow-up|4|||
125158240|NCT03502707|450206227|FG016|Overall Study|Lost to Follow-up|9|||
125158241|NCT03502707|450206228|FG017|Overall Study|Lost to Follow-up|2|||
125158242|NCT03502707|450206211|FG000|Overall Study|Physician Decision|0|||
125158243|NCT03502707|450206212|FG001|Overall Study|Physician Decision|0|||
125158244|NCT03502707|450206213|FG002|Overall Study|Physician Decision|0|||
125158245|NCT03502707|450206214|FG003|Overall Study|Physician Decision|0|||
125158246|NCT03502707|450206215|FG004|Overall Study|Physician Decision|0|||
125158247|NCT03502707|450206216|FG005|Overall Study|Physician Decision|0|||
125158248|NCT03502707|450206217|FG006|Overall Study|Physician Decision|0|||
125158249|NCT03502707|450206218|FG007|Overall Study|Physician Decision|0|||
125158250|NCT03502707|450206219|FG008|Overall Study|Physician Decision|2|||
125158251|NCT03502707|450206220|FG009|Overall Study|Physician Decision|1|||
125158252|NCT03502707|450206221|FG010|Overall Study|Physician Decision|0|||
125158253|NCT03502707|450206222|FG011|Overall Study|Physician Decision|0|||
125158254|NCT03502707|450206223|FG012|Overall Study|Physician Decision|0|||
125158255|NCT03502707|450206224|FG013|Overall Study|Physician Decision|0|||
125158256|NCT03502707|450206225|FG014|Overall Study|Physician Decision|1|||
125158257|NCT03502707|450206226|FG015|Overall Study|Physician Decision|3|||
125158258|NCT03502707|450206227|FG016|Overall Study|Physician Decision|0|||
125158259|NCT03502707|450206228|FG017|Overall Study|Physician Decision|0|||
125158260|NCT03502707|450206211|FG000|Overall Study|Protocol Violation|0|||
125158261|NCT03502707|450206212|FG001|Overall Study|Protocol Violation|0|||
125158262|NCT03502707|450206213|FG002|Overall Study|Protocol Violation|0|||
125158263|NCT03502707|450206214|FG003|Overall Study|Protocol Violation|0|||
125158264|NCT03502707|450206215|FG004|Overall Study|Protocol Violation|0|||
125158265|NCT03502707|450206216|FG005|Overall Study|Protocol Violation|0|||
125158266|NCT03502707|450206217|FG006|Overall Study|Protocol Violation|0|||
125158267|NCT03502707|450206218|FG007|Overall Study|Protocol Violation|0|||
125158268|NCT03502707|450206219|FG008|Overall Study|Protocol Violation|0|||
125158269|NCT03502707|450206220|FG009|Overall Study|Protocol Violation|0|||
125158270|NCT03502707|450206221|FG010|Overall Study|Protocol Violation|0|||
125158271|NCT03502707|450206222|FG011|Overall Study|Protocol Violation|0|||
125158272|NCT03502707|450206223|FG012|Overall Study|Protocol Violation|0|||
125158273|NCT03502707|450206224|FG013|Overall Study|Protocol Violation|0|||
125158274|NCT03502707|450206225|FG014|Overall Study|Protocol Violation|0|||
125158275|NCT03502707|450206226|FG015|Overall Study|Protocol Violation|1|||
125158276|NCT03502707|450206227|FG016|Overall Study|Protocol Violation|0|||
125158277|NCT03502707|450206228|FG017|Overall Study|Protocol Violation|0|||
125158278|NCT03502707|450206211|FG000|Overall Study|Withdrawal by Subject|1|||
125158279|NCT03502707|450206212|FG001|Overall Study|Withdrawal by Subject|1|||
125158280|NCT03502707|450206213|FG002|Overall Study|Withdrawal by Subject|0|||
125158281|NCT03502707|450206214|FG003|Overall Study|Withdrawal by Subject|0|||
125158282|NCT03502707|450206215|FG004|Overall Study|Withdrawal by Subject|0|||
125158283|NCT03502707|450206216|FG005|Overall Study|Withdrawal by Subject|2|||
125158284|NCT03502707|450206217|FG006|Overall Study|Withdrawal by Subject|0|||
125158285|NCT03502707|450206218|FG007|Overall Study|Withdrawal by Subject|3|||
125158286|NCT03502707|450206219|FG008|Overall Study|Withdrawal by Subject|1|||
125158287|NCT03502707|450206220|FG009|Overall Study|Withdrawal by Subject|2|||
125158288|NCT03502707|450206221|FG010|Overall Study|Withdrawal by Subject|12|||
125158289|NCT03502707|450206222|FG011|Overall Study|Withdrawal by Subject|23|||
125158290|NCT03502707|450206223|FG012|Overall Study|Withdrawal by Subject|5|||
125158291|NCT03502707|450206224|FG013|Overall Study|Withdrawal by Subject|3|||
125158292|NCT03502707|450206225|FG014|Overall Study|Withdrawal by Subject|3|||
125158293|NCT03502707|450206226|FG015|Overall Study|Withdrawal by Subject|43|||
125158294|NCT03502707|450206227|FG016|Overall Study|Withdrawal by Subject|44|||
125158295|NCT03502707|450206228|FG017|Overall Study|Withdrawal by Subject|18|||
125158296|NCT03502707|450206211|FG000|Overall Study|Sponsor's Decision|1|||
125158297|NCT03502707|450206212|FG001|Overall Study|Sponsor's Decision|0|||
125158298|NCT03502707|450206213|FG002|Overall Study|Sponsor's Decision|0|||
125158299|NCT03502707|450206214|FG003|Overall Study|Sponsor's Decision|0|||
125158300|NCT03502707|450206215|FG004|Overall Study|Sponsor's Decision|0|||
125158301|NCT03502707|450206216|FG005|Overall Study|Sponsor's Decision|0|||
125158302|NCT03502707|450206217|FG006|Overall Study|Sponsor's Decision|0|||
125158303|NCT03502707|450206218|FG007|Overall Study|Sponsor's Decision|0|||
125158304|NCT03502707|450206219|FG008|Overall Study|Sponsor's Decision|0|||
125158305|NCT03502707|450206220|FG009|Overall Study|Sponsor's Decision|1|||
125158306|NCT03502707|450206221|FG010|Overall Study|Sponsor's Decision|0|||
125158307|NCT03502707|450206222|FG011|Overall Study|Sponsor's Decision|0|||
125158308|NCT03502707|450206223|FG012|Overall Study|Sponsor's Decision|0|||
125158309|NCT03502707|450206224|FG013|Overall Study|Sponsor's Decision|0|||
125158310|NCT03502707|450206225|FG014|Overall Study|Sponsor's Decision|0|||
125158311|NCT03502707|450206226|FG015|Overall Study|Sponsor's Decision|2|||
125158312|NCT03502707|450206227|FG016|Overall Study|Sponsor's Decision|1|||
125158313|NCT03502707|450206228|FG017|Overall Study|Sponsor's Decision|0|||
125158314|NCT03502707|450206211|FG000|Overall Study|Initiated Prohibited Medication|0|||
125158315|NCT03502707|450206212|FG001|Overall Study|Initiated Prohibited Medication|0|||
125158316|NCT03502707|450206213|FG002|Overall Study|Initiated Prohibited Medication|0|||
125158317|NCT03502707|450206214|FG003|Overall Study|Initiated Prohibited Medication|0|||
125158318|NCT03502707|450206215|FG004|Overall Study|Initiated Prohibited Medication|0|||
125158319|NCT03502707|450206216|FG005|Overall Study|Initiated Prohibited Medication|0|||
125158320|NCT03502707|450206217|FG006|Overall Study|Initiated Prohibited Medication|0|||
125158321|NCT03502707|450206218|FG007|Overall Study|Initiated Prohibited Medication|0|||
125158322|NCT03502707|450206219|FG008|Overall Study|Initiated Prohibited Medication|0|||
125158323|NCT03502707|450206220|FG009|Overall Study|Initiated Prohibited Medication|0|||
125158324|NCT03502707|450206221|FG010|Overall Study|Initiated Prohibited Medication|0|||
125158325|NCT03502707|450206222|FG011|Overall Study|Initiated Prohibited Medication|0|||
125158326|NCT03502707|450206223|FG012|Overall Study|Initiated Prohibited Medication|0|||
125158327|NCT03502707|450206224|FG013|Overall Study|Initiated Prohibited Medication|0|||
125158328|NCT03502707|450206225|FG014|Overall Study|Initiated Prohibited Medication|0|||
125158329|NCT03502707|450206226|FG015|Overall Study|Initiated Prohibited Medication|0|||
125158330|NCT03502707|450206227|FG016|Overall Study|Initiated Prohibited Medication|1|||
125158331|NCT03502707|450206228|FG017|Overall Study|Initiated Prohibited Medication|0|||
125158332|NCT03502707|450206211|FG000|Overall Study|Other|0|||
125158333|NCT03502707|450206212|FG001|Overall Study|Other|0|||
125158334|NCT03502707|450206213|FG002|Overall Study|Other|0|||
125158335|NCT03502707|450206214|FG003|Overall Study|Other|0|||
125158336|NCT03502707|450206215|FG004|Overall Study|Other|0|||
125158337|NCT03502707|450206216|FG005|Overall Study|Other|0|||
125158338|NCT03502707|450206217|FG006|Overall Study|Other|0|||
125158339|NCT03502707|450206218|FG007|Overall Study|Other|0|||
125158340|NCT03502707|450206219|FG008|Overall Study|Other|1|||
125158341|NCT03502707|450206220|FG009|Overall Study|Other|1|||
125158342|NCT03502707|450206221|FG010|Overall Study|Other|2|||
125158343|NCT03502707|450206222|FG011|Overall Study|Other|0|||
125158344|NCT03502707|450206223|FG012|Overall Study|Other|0|||
125158345|NCT03502707|450206224|FG013|Overall Study|Other|0|||
125158346|NCT03502707|450206225|FG014|Overall Study|Other|0|||
125158347|NCT03502707|450206226|FG015|Overall Study|Other|4|||
125158348|NCT03502707|450206227|FG016|Overall Study|Other|1|||
125158349|NCT03502707|450206228|FG017|Overall Study|Other|0|||
125158350|NCT03502707|450206211|FG000|Overall Study|Randomized but not vaccinated|0|||
125158351|NCT03502707|450206212|FG001|Overall Study|Randomized but not vaccinated|0|||
125158352|NCT03502707|450206213|FG002|Overall Study|Randomized but not vaccinated|0|||
125158353|NCT03502707|450206214|FG003|Overall Study|Randomized but not vaccinated|0|||
125158354|NCT03502707|450206215|FG004|Overall Study|Randomized but not vaccinated|0|||
125158355|NCT03502707|450206216|FG005|Overall Study|Randomized but not vaccinated|0|||
125158356|NCT03502707|450206217|FG006|Overall Study|Randomized but not vaccinated|0|||
125158357|NCT03502707|450206218|FG007|Overall Study|Randomized but not vaccinated|0|||
125158358|NCT03502707|450206219|FG008|Overall Study|Randomized but not vaccinated|0|||
125158359|NCT03502707|450206220|FG009|Overall Study|Randomized but not vaccinated|0|||
125158360|NCT03502707|450206221|FG010|Overall Study|Randomized but not vaccinated|0|||
125158361|NCT03502707|450206222|FG011|Overall Study|Randomized but not vaccinated|1|||
125158362|NCT03502707|450206223|FG012|Overall Study|Randomized but not vaccinated|0|||
125158363|NCT03502707|450206224|FG013|Overall Study|Randomized but not vaccinated|0|||
125158364|NCT03502707|450206225|FG014|Overall Study|Randomized but not vaccinated|0|||
125158365|NCT03502707|450206226|FG015|Overall Study|Randomized but not vaccinated|0|||
125158366|NCT03502707|450206227|FG016|Overall Study|Randomized but not vaccinated|0|||
125158367|NCT03502707|450206228|FG017|Overall Study|Randomized but not vaccinated|1|||
125158368|NCT04551911|450206229|FG000|Overall Study|Lost to Follow-up|2|||
125158369|NCT04551911|450206230|FG001|Overall Study|Lost to Follow-up|1|||
125158370|NCT04551911|450206229|FG000|Overall Study|Withdrawal by Subject|10|||
125158371|NCT04551911|450206230|FG001|Overall Study|Withdrawal by Subject|10|||
125158372|NCT04551911|450206229|FG000|Overall Study|Did not receive the study drug|3|||
125158373|NCT04551911|450206230|FG001|Overall Study|Did not receive the study drug|4|||
125158374|NCT01030341|450206231|FG000|Overall Study|Withdrawal by Subject|1|||
125158375|NCT01030341|450206231|FG000|Overall Study|Lost to Follow-up|2|||
125158376|NCT01884311|450206232|FG000|Overall Study|Withdrawal by Subject|3|||
125158377|NCT01884311|450206232|FG000|Overall Study|withdrew consent due to AEs|1|||
125158378|NCT01884311|450206232|FG000|Overall Study|Precautionary measure|1|||
125158379|NCT02031458|450206235|FG000|May 8, 2015 to January 11, 2019|Death|89|||
125158380|NCT02031458|450206236|FG001|May 8, 2015 to January 11, 2019|Death|193|||
125158381|NCT02031458|450206237|FG002|May 8, 2015 to January 11, 2019|Death|198|||
125158382|NCT02031458|450206235|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
125158383|NCT02031458|450206236|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
125158384|NCT02031458|450206237|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
125158385|NCT02031458|450206235|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
125158386|NCT02031458|450206236|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
125158387|NCT02031458|450206237|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
125158388|NCT02031458|450206235|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
125158389|NCT02031458|450206236|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
125158390|NCT02031458|450206237|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
125158391|NCT02031458|450206235|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
125158392|NCT02031458|450206236|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
125158393|NCT02031458|450206237|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
125158394|NCT02031458|450206235|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
125158395|NCT02031458|450206236|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
125158396|NCT02031458|450206237|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
125158397|NCT02031458|450206235|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
125158398|NCT02031458|450206236|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
125158399|NCT02031458|450206237|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
125158400|NCT02031458|450206235|FG000|Baseline to May 8, 2015|Death|36|||
125158401|NCT02031458|450206236|FG001|Baseline to May 8, 2015|Death|87|||
125158402|NCT02031458|450206237|FG002|Baseline to May 8, 2015|Death|100|||
125158403|NCT02031458|450206235|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
125158404|NCT02031458|450206236|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
125158405|NCT02031458|450206237|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
125158406|NCT02031458|450206235|FG000|Baseline to May 8, 2015|Physician Decision|0|||
125158407|NCT02031458|450206236|FG001|Baseline to May 8, 2015|Physician Decision|1|||
125158408|NCT02031458|450206237|FG002|Baseline to May 8, 2015|Physician Decision|0|||
125158409|NCT02031458|450206235|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
125158410|NCT02031458|450206236|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
125158411|NCT02031458|450206237|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
125223927|NCT02155985|450446270|FG001|Overall Study|Lost to Follow-up|0|||
125223928|NCT02155985|450446271|FG002|Overall Study|Lost to Follow-up|0|||
125223929|NCT02998151|450446272|FG000|Overall Study|Withdrawal by Subject|3|||
125223930|NCT02998151|450446272|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
125223931|NCT02998151|450446272|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
125223932|NCT02573259|450446275|FG000|Overall Study|Death|1|||
125223933|NCT02573259|450446276|FG001|Overall Study|Death|6|||
125223934|NCT02573259|450446277|FG002|Overall Study|Death|5|||
125223935|NCT02573259|450446278|FG003|Overall Study|Death|6|||
125223936|NCT02573259|450446279|FG004|Overall Study|Death|9|||
125223937|NCT02573259|450446280|FG005|Overall Study|Death|32|||
125223938|NCT02573259|450446281|FG006|Overall Study|Death|21|||
125158412|NCT02031458|450206235|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
125158413|NCT02031458|450206236|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
125158414|NCT02031458|450206237|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
125223939|NCT02573259|450446275|FG000|Overall Study|Lost to Follow-up|0|||
125223940|NCT02573259|450446276|FG001|Overall Study|Lost to Follow-up|0|||
125223941|NCT02573259|450446277|FG002|Overall Study|Lost to Follow-up|0|||
125223942|NCT02573259|450446278|FG003|Overall Study|Lost to Follow-up|0|||
125223943|NCT02573259|450446279|FG004|Overall Study|Lost to Follow-up|0|||
125223944|NCT02573259|450446280|FG005|Overall Study|Lost to Follow-up|2|||
125223945|NCT02573259|450446281|FG006|Overall Study|Lost to Follow-up|1|||
125223946|NCT02573259|450446275|FG000|Overall Study|Participant refused further follow-up|0|||
125223947|NCT02573259|450446276|FG001|Overall Study|Participant refused further follow-up|2|||
125223948|NCT02573259|450446277|FG002|Overall Study|Participant refused further follow-up|1|||
125223949|NCT02573259|450446278|FG003|Overall Study|Participant refused further follow-up|0|||
125223950|NCT02573259|450446279|FG004|Overall Study|Participant refused further follow-up|3|||
125223951|NCT02573259|450446280|FG005|Overall Study|Participant refused further follow-up|20|||
125223952|NCT02573259|450446281|FG006|Overall Study|Participant refused further follow-up|7|||
125223953|NCT02573259|450446275|FG000|Overall Study|Other|0|||
125223954|NCT02573259|450446276|FG001|Overall Study|Other|0|||
125223955|NCT02573259|450446277|FG002|Overall Study|Other|0|||
125223956|NCT02573259|450446278|FG003|Overall Study|Other|0|||
125223957|NCT02573259|450446279|FG004|Overall Study|Other|1|||
125223958|NCT02573259|450446280|FG005|Overall Study|Other|4|||
125223959|NCT02573259|450446281|FG006|Overall Study|Other|5|||
125223960|NCT00751140|450446282|FG000|Overall Study|benign angioma excluded from analysis|1|||
125223961|NCT03718429|450446286|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
125223962|NCT03718429|450446287|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
125223963|NCT03718429|450446288|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
125223964|NCT03718429|450446289|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
125223965|NCT04632225|450446292|FG000|Overall Study|Withdrawal by Subject|2|||
125223966|NCT04632225|450446293|FG001|Overall Study|Withdrawal by Subject|2|||
125158415|NCT02031458|450206235|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
125158416|NCT02031458|450206236|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
125158417|NCT02031458|450206237|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
125158418|NCT02031458|450206235|FG000|Baseline to May 8, 2015|On Treatment|43|||
125158419|NCT02031458|450206236|FG001|Baseline to May 8, 2015|On Treatment|81|||
125158420|NCT02031458|450206237|FG002|Baseline to May 8, 2015|On Treatment|73|||
125158421|NCT02031458|450206235|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
125158422|NCT02031458|450206236|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
125158423|NCT02031458|450206237|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
125158424|NCT00609518|450206239|FG000|Overall Study|Death from Study Disease|32|||
125158425|NCT00609518|450206240|FG001|Overall Study|Death from Study Disease|32|||
125158426|NCT00609518|450206239|FG000|Overall Study|Withdrawal by Subject|5|||
125158427|NCT00609518|450206240|FG001|Overall Study|Withdrawal by Subject|3|||
125158428|NCT00609518|450206239|FG000|Overall Study|Lost to Follow-up|3|||
125158429|NCT00609518|450206240|FG001|Overall Study|Lost to Follow-up|0|||
125158430|NCT00609518|450206239|FG000|Overall Study|Physician Decision|1|||
125158431|NCT00609518|450206240|FG001|Overall Study|Physician Decision|3|||
125158432|NCT00609518|450206239|FG000|Overall Study|Death from Adverse Event|2|||
125223967|NCT00325819|450446294|FG000|Overall Study|Study product lost in mail|2|||
125158433|NCT00609518|450206240|FG001|Overall Study|Death from Adverse Event|2|||
125223968|NCT00325819|450446295|FG001|Overall Study|Study product lost in mail|1|||
125223969|NCT00325819|450446294|FG000|Overall Study|Did not take a dose of study product|4|||
125223970|NCT00325819|450446295|FG001|Overall Study|Did not take a dose of study product|9|||
125223971|NCT00325819|450446294|FG000|Overall Study|Lost to Follow-up|3|||
125223972|NCT00325819|450446295|FG001|Overall Study|Lost to Follow-up|3|||
125158434|NCT00292188|450206244|FG000|Single-Blind|Adverse Event|14|||
125158435|NCT00292188|450206245|FG001|Single-Blind|Adverse Event|0|||
125158436|NCT00292188|450206246|FG002|Single-Blind|Adverse Event|0|||
125158437|NCT00292188|450206244|FG000|Single-Blind|Lack of Efficacy|2|||
125158438|NCT00292188|450206245|FG001|Single-Blind|Lack of Efficacy|0|||
125158439|NCT00292188|450206246|FG002|Single-Blind|Lack of Efficacy|0|||
125158440|NCT00292188|450206244|FG000|Single-Blind|Laboratory Abnormality|5|||
125158441|NCT00292188|450206245|FG001|Single-Blind|Laboratory Abnormality|0|||
125158442|NCT00292188|450206246|FG002|Single-Blind|Laboratory Abnormality|0|||
125158443|NCT00292188|450206244|FG000|Single-Blind|Lost to Follow-up|3|||
125158444|NCT00292188|450206245|FG001|Single-Blind|Lost to Follow-up|0|||
125158445|NCT00292188|450206246|FG002|Single-Blind|Lost to Follow-up|0|||
125158446|NCT00292188|450206244|FG000|Single-Blind|Other|77|||
125158447|NCT00292188|450206245|FG001|Single-Blind|Other|0|||
125158448|NCT00292188|450206246|FG002|Single-Blind|Other|0|||
125158449|NCT00292188|450206244|FG000|Single-Blind|Withdrawal by Subject|12|||
125158450|NCT00292188|450206245|FG001|Single-Blind|Withdrawal by Subject|0|||
125158451|NCT00292188|450206246|FG002|Single-Blind|Withdrawal by Subject|0|||
125158452|NCT00292188|450206244|FG000|Single-Blind|Did not receive treatment|1|||
125158453|NCT00292188|450206245|FG001|Single-Blind|Did not receive treatment|0|||
125158454|NCT00292188|450206246|FG002|Single-Blind|Did not receive treatment|0|||
125158455|NCT00292188|450206244|FG000|Double-Blind|Adverse Event|0|||
125158456|NCT00292188|450206245|FG001|Double-Blind|Adverse Event|25|||
125158457|NCT00292188|450206246|FG002|Double-Blind|Adverse Event|9|||
125158458|NCT00292188|450206244|FG000|Double-Blind|Lack of Efficacy|0|||
125158459|NCT00292188|450206245|FG001|Double-Blind|Lack of Efficacy|2|||
125158460|NCT00292188|450206246|FG002|Double-Blind|Lack of Efficacy|12|||
125158461|NCT00292188|450206244|FG000|Double-Blind|Lost to Follow-up|0|||
125158462|NCT00292188|450206245|FG001|Double-Blind|Lost to Follow-up|1|||
125158463|NCT00292188|450206246|FG002|Double-Blind|Lost to Follow-up|0|||
125158464|NCT00292188|450206244|FG000|Double-Blind|Other|0|||
125158465|NCT00292188|450206245|FG001|Double-Blind|Other|3|||
125158466|NCT00292188|450206246|FG002|Double-Blind|Other|4|||
125158467|NCT00292188|450206244|FG000|Double-Blind|Withdrawal by Subject|0|||
125158468|NCT00292188|450206245|FG001|Double-Blind|Withdrawal by Subject|0|||
125158469|NCT00292188|450206246|FG002|Double-Blind|Withdrawal by Subject|3|||
125158470|NCT00292188|450206244|FG000|Double-Blind|Laboratory Abnormality|0|||
125158471|NCT00292188|450206245|FG001|Double-Blind|Laboratory Abnormality|0|||
125158472|NCT00292188|450206246|FG002|Double-Blind|Laboratory Abnormality|1|||
125158473|NCT00824616|450206247|FG000|Overall Study|Adverse Event|2|||
125158474|NCT00824616|450206248|FG001|Overall Study|Adverse Event|1|||
125158475|NCT00824616|450206247|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
125158476|NCT00824616|450206248|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
125158477|NCT00824616|450206247|FG000|Overall Study|Hyperglycemia|1|||
125158478|NCT00824616|450206248|FG001|Overall Study|Hyperglycemia|1|||
125158479|NCT00824616|450206247|FG000|Overall Study|Lack of Efficacy|2|||
125158480|NCT00824616|450206248|FG001|Overall Study|Lack of Efficacy|1|||
125158481|NCT00824616|450206247|FG000|Overall Study|Lost to Follow-up|0|||
125158482|NCT00824616|450206248|FG001|Overall Study|Lost to Follow-up|1|||
125158483|NCT00824616|450206247|FG000|Overall Study|Withdrawal by Subject|1|||
125158484|NCT00824616|450206248|FG001|Overall Study|Withdrawal by Subject|1|||
125158485|NCT00974974|450206258|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
125158486|NCT00974974|450206259|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
125158487|NCT00974974|450206258|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
125158488|NCT00974974|450206259|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
125158489|NCT00974974|450206258|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
125158490|NCT00974974|450206259|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
125158491|NCT00974974|450206258|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
125158492|NCT00974974|450206259|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
125158493|NCT00974974|450206258|FG000|IR CD-LD Dose Adjustment|Various|0|||
125158494|NCT00974974|450206259|FG001|IR CD-LD Dose Adjustment|Various|9|||
125158495|NCT00974974|450206258|FG000|IPX066 Dose Conversion|Adverse Event|23|||
125158496|NCT00974974|450206259|FG001|IPX066 Dose Conversion|Adverse Event|0|||
125158497|NCT00974974|450206258|FG000|IPX066 Dose Conversion|Death|2|||
125158498|NCT00974974|450206259|FG001|IPX066 Dose Conversion|Death|0|||
125158499|NCT00974974|450206258|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
125158500|NCT00974974|450206259|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
125158501|NCT00974974|450206258|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
125158502|NCT00974974|450206259|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
125158503|NCT00974974|450206258|FG000|IPX066 Dose Conversion|Various|3|||
125158504|NCT00974974|450206259|FG001|IPX066 Dose Conversion|Various|0|||
125158505|NCT00974974|450206258|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
125158506|NCT00974974|450206259|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
125223973|NCT05212168|450446296|FG000|Overall Study|Lost to Follow-up|0|||
125158507|NCT00974974|450206258|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
125158508|NCT00974974|450206259|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
125158509|NCT00974974|450206258|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
125158510|NCT00974974|450206259|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
125158511|NCT00974974|450206258|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
125158512|NCT00974974|450206259|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
125158513|NCT00974974|450206258|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
125158514|NCT00974974|450206259|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
125158515|NCT00974974|450206258|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
125158516|NCT00974974|450206259|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
125158517|NCT00974974|450206258|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
125158518|NCT00974974|450206259|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
125158519|NCT00974974|450206258|FG000|Maintenance - Double Blind Treatment|Various|4|||
125158520|NCT00974974|450206259|FG001|Maintenance - Double Blind Treatment|Various|0|||
125158521|NCT01959035|450206260|FG000|Overall Study|Adverse Event|5|||
125158522|NCT01959035|450206260|FG000|Overall Study|Withdrawal by Subject|4|||
125158523|NCT01959035|450206260|FG000|Overall Study|Lost to Follow-up|1|||
125158524|NCT01959035|450206260|FG000|Overall Study|Other (no primary reason given)|1|||
125158525|NCT03254602|450206261|FG000|Overall Study|Lost to Follow-up|4|||
125158526|NCT00688376|450206265|FG000|Double-Blind Phase|Adverse Event|4|||
125158527|NCT00688376|450206266|FG001|Double-Blind Phase|Adverse Event|4|||
125158528|NCT00688376|450206265|FG000|Double-Blind Phase|Protocol Violation|1|||
125158529|NCT00688376|450206266|FG001|Double-Blind Phase|Protocol Violation|2|||
125158530|NCT00688376|450206265|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
125158531|NCT00688376|450206266|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
125158532|NCT00688376|450206265|FG000|Double-Blind Phase|Not treated|0|||
125158533|NCT00688376|450206266|FG001|Double-Blind Phase|Not treated|1|||
125158534|NCT00688376|450206265|FG000|Blinded Extension Phase|Adverse Event|3|||
125158535|NCT00688376|450206266|FG001|Blinded Extension Phase|Adverse Event|4|||
125158536|NCT00688376|450206265|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
125158537|NCT00688376|450206266|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
125158538|NCT00688376|450206265|FG000|Blinded Extension Phase|Physician Decision|1|||
125158539|NCT00688376|450206266|FG001|Blinded Extension Phase|Physician Decision|0|||
125158540|NCT00688376|450206265|FG000|Blinded Extension Phase|Other|1|||
125158541|NCT00688376|450206266|FG001|Blinded Extension Phase|Other|0|||
125158542|NCT04492020|450206273|FG000|Overall Study|Adverse Event|1|||
125158543|NCT04492020|450206274|FG001|Overall Study|Adverse Event|3|||
125158544|NCT04492020|450206273|FG000|Overall Study|Withdrawal by Subject|4|||
125158545|NCT04492020|450206274|FG001|Overall Study|Withdrawal by Subject|3|||
125158546|NCT04492020|450206273|FG000|Overall Study|Lost to Follow-up|4|||
125158547|NCT04492020|450206274|FG001|Overall Study|Lost to Follow-up|3|||
125158548|NCT04492020|450206273|FG000|Overall Study|Protocol Violation|5|||
125158549|NCT04492020|450206274|FG001|Overall Study|Protocol Violation|2|||
125158550|NCT04492020|450206273|FG000|Overall Study|Lack of Qualifying Event|25|||
125158551|NCT04492020|450206274|FG001|Overall Study|Lack of Qualifying Event|27|||
125158552|NCT04492020|450206273|FG000|Overall Study|Non-compliance with Study Drug|2|||
125158553|NCT04492020|450206274|FG001|Overall Study|Non-compliance with Study Drug|1|||
125158554|NCT02792959|450206279|FG000|Overall Study|Protocol Violation|1|||
125158555|NCT03914950|450206283|FG000|Overall Study|Physician Decision|54|||
125158556|NCT00003875|450206292|FG000|Overall Study|Screen Failed|1|||
125158557|NCT01780987|450206293|FG000|Overall Study|Adverse Event|0|||
125158558|NCT01780987|450206294|FG001|Overall Study|Adverse Event|4|||
125158559|NCT01780987|450206293|FG000|Overall Study|Withdrawal by Subject|2|||
125158560|NCT01780987|450206294|FG001|Overall Study|Withdrawal by Subject|0|||
125158561|NCT01780987|450206293|FG000|Overall Study|Request of Changing Hospital|0|||
125158562|NCT01780987|450206294|FG001|Overall Study|Request of Changing Hospital|1|||
125158563|NCT01780987|450206293|FG000|Overall Study|Changing Residence|1|||
125158564|NCT01780987|450206294|FG001|Overall Study|Changing Residence|0|||
125158565|NCT01780987|450206293|FG000|Overall Study|Not Receiving any Study Medication|0|||
125158566|NCT01780987|450206294|FG001|Overall Study|Not Receiving any Study Medication|1|||
125158567|NCT04168190|450206295|FG000|Overall Study|Lost to Follow-up|0|||
125158568|NCT04168190|450206296|FG001|Overall Study|Lost to Follow-up|1|||
125158569|NCT04168190|450206297|FG002|Overall Study|Lost to Follow-up|0|||
125158570|NCT04168190|450206298|FG003|Overall Study|Lost to Follow-up|7|||
125158571|NCT04168190|450206299|FG004|Overall Study|Lost to Follow-up|5|||
125158572|NCT04168190|450206295|FG000|Overall Study|Withdrawal by Subject|1|||
125158573|NCT04168190|450206296|FG001|Overall Study|Withdrawal by Subject|0|||
125158574|NCT04168190|450206297|FG002|Overall Study|Withdrawal by Subject|0|||
125158575|NCT04168190|450206298|FG003|Overall Study|Withdrawal by Subject|2|||
125158576|NCT04168190|450206299|FG004|Overall Study|Withdrawal by Subject|4|||
125158577|NCT04168190|450206295|FG000|Overall Study|Death|0|||
125158578|NCT04168190|450206296|FG001|Overall Study|Death|0|||
125158579|NCT04168190|450206297|FG002|Overall Study|Death|0|||
125223974|NCT05212168|450446297|FG001|Overall Study|Lost to Follow-up|3|||
125158580|NCT04168190|450206298|FG003|Overall Study|Death|1|||
125158581|NCT04168190|450206299|FG004|Overall Study|Death|0|||
125158582|NCT01070771|450206300|FG000|Overall Study|Adverse Event|2|||
125158583|NCT01070771|450206300|FG000|Overall Study|Protocol Violation|1|||
125158584|NCT00629265|450206301|FG000|Overall Study|Lost to Follow-up|4|||
125158585|NCT00629265|450206302|FG001|Overall Study|Lost to Follow-up|5|||
125158586|NCT00629265|450206301|FG000|Overall Study|Withdrawal by Subject|11|||
125158587|NCT00629265|450206302|FG001|Overall Study|Withdrawal by Subject|8|||
125158588|NCT00629265|450206301|FG000|Overall Study|Death|1|||
125158589|NCT00629265|450206302|FG001|Overall Study|Death|0|||
125158590|NCT00629265|450206301|FG000|Overall Study|Adverse Event|2|||
125158591|NCT00629265|450206302|FG001|Overall Study|Adverse Event|0|||
125158592|NCT00629265|450206301|FG000|Overall Study|HNC Recurrence|4|||
125158593|NCT00629265|450206302|FG001|Overall Study|HNC Recurrence|0|||
125158594|NCT00629265|450206301|FG000|Overall Study|Other CA Requiring Treatment|1|||
125158595|NCT00629265|450206302|FG001|Overall Study|Other CA Requiring Treatment|3|||
125158596|NCT00629265|450206301|FG000|Overall Study|Needed Esophageal Dilation|4|||
125158597|NCT00629265|450206302|FG001|Overall Study|Needed Esophageal Dilation|1|||
125158598|NCT00629265|450206301|FG000|Overall Study|Unrelated Medical Complications|3|||
125158599|NCT00629265|450206302|FG001|Overall Study|Unrelated Medical Complications|1|||
125158600|NCT00629265|450206301|FG000|Overall Study|Unknown Reason|2|||
125158601|NCT00629265|450206302|FG001|Overall Study|Unknown Reason|2|||
125158602|NCT04465630|450206303|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
125158603|NCT04465630|450206303|FG000|Overall Study|Screen failure|8|||
125158604|NCT04465630|450206303|FG000|Overall Study|Baseline failure|16|||
125158605|NCT01169532|450206304|FG000|Overall Study|Withdrawal by Subject|1|||
125158606|NCT04355663|450206309|FG000|Overall Study|Physician Decision|2|||
125158607|NCT04355663|450206310|FG001|Overall Study|Physician Decision|7|||
125158608|NCT04355663|450206311|FG002|Overall Study|Physician Decision|0|||
125158609|NCT04355663|450206309|FG000|Overall Study|Adverse Event|0|||
125158610|NCT04355663|450206310|FG001|Overall Study|Adverse Event|0|||
125158611|NCT04355663|450206311|FG002|Overall Study|Adverse Event|1|||
125158612|NCT04355663|450206309|FG000|Overall Study|Withdrawal by Subject|0|||
125158613|NCT04355663|450206310|FG001|Overall Study|Withdrawal by Subject|8|||
125158614|NCT04355663|450206311|FG002|Overall Study|Withdrawal by Subject|3|||
125158615|NCT00876018|450206314|FG000|Overall Study|Lost to Follow-up|0|||
125158616|NCT00876018|450206315|FG001|Overall Study|Lost to Follow-up|1|||
125158617|NCT00876018|450206316|FG002|Overall Study|Lost to Follow-up|1|||
125158618|NCT00876018|450206314|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
125158619|NCT00876018|450206315|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
125158620|NCT00876018|450206316|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
125158621|NCT01230892|450206317|FG000|Overall Study|Withdrawal by Subject|1|||
125158622|NCT01230892|450206318|FG001|Overall Study|Withdrawal by Subject|1|||
125158623|NCT01230892|450206317|FG000|Overall Study|Lost to Follow-up|2|||
125158624|NCT01230892|450206318|FG001|Overall Study|Lost to Follow-up|0|||
125158625|NCT00679913|450206319|FG000|Overall Study|Protocol Violation|18|||
125158626|NCT00679913|450206320|FG001|Overall Study|Protocol Violation|13|||
125158627|NCT00725621|450206321|FG000|Overall Study|Adverse Event|25|||
125158628|NCT00725621|450206321|FG000|Overall Study|Lack of Efficacy|46|||
125158629|NCT00725621|450206321|FG000|Overall Study|Withdrawal by Subject|57|||
125158630|NCT00725621|450206321|FG000|Overall Study|Physician Decision|19|||
125158631|NCT00725621|450206321|FG000|Overall Study|Lost to Follow-up|52|||
125158632|NCT00725621|450206321|FG000|Overall Study|Non-compliance|8|||
125158633|NCT00725621|450206321|FG000|Overall Study|Continued treatment by other physician|6|||
125158634|NCT00725621|450206321|FG000|Overall Study|Switched to other study|1|||
125158635|NCT00725621|450206321|FG000|Overall Study|Switched to other drug|1|||
125158636|NCT00725621|450206321|FG000|Overall Study|Prepared for elective surgery|1|||
125223975|NCT05212168|450446296|FG000|Overall Study|Study terminated by sponsor|30|||
125223976|NCT05212168|450446297|FG001|Overall Study|Study terminated by sponsor|27|||
125158637|NCT00725621|450206321|FG000|Overall Study|Reason not specified|55|||
125158638|NCT01189500|450206322|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
125158639|NCT01189500|450206322|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
125158640|NCT00062751|450206323|FG000|Overall Study|Disease progression|24|||
125158641|NCT00062751|450206324|FG001|Overall Study|Disease progression|17|||
125158642|NCT00062751|450206325|FG002|Overall Study|Disease progression|24|||
125158643|NCT00062751|450206326|FG003|Overall Study|Disease progression|2|||
125158644|NCT00062751|450206327|FG004|Overall Study|Disease progression|2|||
125158645|NCT00062751|450206323|FG000|Overall Study|Adverse Event|4|||
125158646|NCT00062751|450206324|FG001|Overall Study|Adverse Event|7|||
125158647|NCT00062751|450206325|FG002|Overall Study|Adverse Event|2|||
125158648|NCT00062751|450206326|FG003|Overall Study|Adverse Event|2|||
125158649|NCT00062751|450206327|FG004|Overall Study|Adverse Event|2|||
125158650|NCT00062751|450206323|FG000|Overall Study|Other|2|||
125158651|NCT00062751|450206324|FG001|Overall Study|Other|3|||
125158652|NCT00062751|450206325|FG002|Overall Study|Other|1|||
125158653|NCT00062751|450206326|FG003|Overall Study|Other|0|||
125158654|NCT00062751|450206327|FG004|Overall Study|Other|1|||
125158655|NCT00062751|450206323|FG000|Overall Study|Withdrawal by Subject|1|||
125223977|NCT05212168|450446296|FG000|Overall Study|Other|4|||
125223978|NCT05212168|450446297|FG001|Overall Study|Other|7|||
125223979|NCT03811821|450446298|FG000|Overall Study|Adverse Event|1|||
125223980|NCT03811821|450446299|FG001|Overall Study|Adverse Event|1|||
125223981|NCT03811821|450446298|FG000|Overall Study|Withdrawal by Subject|5|||
125223982|NCT03811821|450446299|FG001|Overall Study|Withdrawal by Subject|4|||
125223983|NCT03811821|450446298|FG000|Overall Study|Lost to Follow-up|2|||
125223984|NCT03811821|450446299|FG001|Overall Study|Lost to Follow-up|2|||
125223985|NCT03811821|450446298|FG000|Overall Study|Contraindication for treatment|0|||
125158656|NCT00062751|450206324|FG001|Overall Study|Withdrawal by Subject|2|||
125158657|NCT00062751|450206325|FG002|Overall Study|Withdrawal by Subject|2|||
125158658|NCT00062751|450206326|FG003|Overall Study|Withdrawal by Subject|1|||
125158659|NCT00062751|450206327|FG004|Overall Study|Withdrawal by Subject|0|||
125158660|NCT00062751|450206323|FG000|Overall Study|Symptomatic deterioration|1|||
125158661|NCT00062751|450206324|FG001|Overall Study|Symptomatic deterioration|1|||
125158662|NCT00062751|450206325|FG002|Overall Study|Symptomatic deterioration|0|||
125158663|NCT00062751|450206326|FG003|Overall Study|Symptomatic deterioration|0|||
125158664|NCT00062751|450206327|FG004|Overall Study|Symptomatic deterioration|1|||
125158665|NCT00062751|450206323|FG000|Overall Study|Death|1|||
125158666|NCT00062751|450206324|FG001|Overall Study|Death|0|||
125158667|NCT00062751|450206325|FG002|Overall Study|Death|1|||
125158668|NCT00062751|450206326|FG003|Overall Study|Death|0|||
125158669|NCT00062751|450206327|FG004|Overall Study|Death|0|||
125158670|NCT01144364|450206330|FG000|Induction Phase|Disease progression|14|||
125158671|NCT01144364|450206331|FG001|Induction Phase|Disease progression|0|||
125158672|NCT01144364|450206332|FG002|Induction Phase|Disease progression|0|||
125158673|NCT01144364|450206330|FG000|Induction Phase|Adverse Event|9|||
125158674|NCT01144364|450206331|FG001|Induction Phase|Adverse Event|0|||
125158675|NCT01144364|450206332|FG002|Induction Phase|Adverse Event|0|||
125158676|NCT01144364|450206330|FG000|Induction Phase|Death|1|||
125158677|NCT01144364|450206331|FG001|Induction Phase|Death|0|||
125158678|NCT01144364|450206332|FG002|Induction Phase|Death|0|||
125158679|NCT01144364|450206330|FG000|Induction Phase|Withdrawal by Subject|1|||
125158680|NCT01144364|450206331|FG001|Induction Phase|Withdrawal by Subject|0|||
125158681|NCT01144364|450206332|FG002|Induction Phase|Withdrawal by Subject|0|||
125158682|NCT01144364|450206330|FG000|Induction Phase|Lost to Follow-up|2|||
125158683|NCT01144364|450206331|FG001|Induction Phase|Lost to Follow-up|0|||
125158684|NCT01144364|450206332|FG002|Induction Phase|Lost to Follow-up|0|||
125158685|NCT01144364|450206330|FG000|Induction Phase|Physician Decision|1|||
125158686|NCT01144364|450206331|FG001|Induction Phase|Physician Decision|0|||
125158687|NCT01144364|450206332|FG002|Induction Phase|Physician Decision|0|||
125158688|NCT01144364|450206330|FG000|Induction Phase|Stable disease|2|||
125158689|NCT01144364|450206331|FG001|Induction Phase|Stable disease|0|||
125158690|NCT01144364|450206332|FG002|Induction Phase|Stable disease|0|||
125158691|NCT01144364|450206330|FG000|Induction Phase|Secondary neoplasia|1|||
125158692|NCT01144364|450206331|FG001|Induction Phase|Secondary neoplasia|0|||
125158693|NCT01144364|450206332|FG002|Induction Phase|Secondary neoplasia|0|||
125158694|NCT01144364|450206330|FG000|Induction Phase|Protocol Violation|1|||
125158695|NCT01144364|450206331|FG001|Induction Phase|Protocol Violation|0|||
125158696|NCT01144364|450206332|FG002|Induction Phase|Protocol Violation|0|||
125158697|NCT01144364|450206330|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
125158698|NCT01144364|450206331|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
125158699|NCT01144364|450206332|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
125158700|NCT01144364|450206330|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
125158701|NCT01144364|450206331|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
125158702|NCT01144364|450206332|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
125158703|NCT01144364|450206330|FG000|Follow-Up/Maintenance Phase|Death|0|||
125158704|NCT01144364|450206331|FG001|Follow-Up/Maintenance Phase|Death|2|||
125158705|NCT01144364|450206332|FG002|Follow-Up/Maintenance Phase|Death|0|||
125158706|NCT01144364|450206330|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
125158707|NCT01144364|450206331|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
125158708|NCT01144364|450206332|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
125158709|NCT01144364|450206330|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
125223986|NCT03811821|450446299|FG001|Overall Study|Contraindication for treatment|1|||
125158710|NCT01144364|450206331|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
125158711|NCT01144364|450206332|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
125158712|NCT01144364|450206330|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
125158713|NCT01144364|450206331|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
125158714|NCT01144364|450206332|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
125158715|NCT01144364|450206330|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
125158716|NCT01144364|450206331|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
125158717|NCT01144364|450206332|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
125223987|NCT03811821|450446298|FG000|Overall Study|Tolerability|0|||
125223988|NCT03811821|450446299|FG001|Overall Study|Tolerability|3|||
125158718|NCT01301508|450206335|FG000|Overall Study|Withdrawal by Subject|1|||
125158719|NCT01301508|450206336|FG001|Overall Study|Withdrawal by Subject|2|||
125158720|NCT01301508|450206335|FG000|Overall Study|Lost to Follow-up|0|||
125158721|NCT01301508|450206336|FG001|Overall Study|Lost to Follow-up|1|||
125158722|NCT00851643|450206337|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
125158723|NCT00851643|450206338|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
125158724|NCT00851643|450206339|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
125158725|NCT00851643|450206340|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
125158726|NCT00851643|450206341|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
125158727|NCT00851643|450206342|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
125158728|NCT00851643|450206337|FG000|Base Study (Up to 12 Months)|Other|0|||
125158729|NCT00851643|450206338|FG001|Base Study (Up to 12 Months)|Other|0|||
125158730|NCT00851643|450206339|FG002|Base Study (Up to 12 Months)|Other|0|||
125158731|NCT00851643|450206340|FG003|Base Study (Up to 12 Months)|Other|0|||
125158732|NCT00851643|450206341|FG004|Base Study (Up to 12 Months)|Other|0|||
125158733|NCT00851643|450206342|FG005|Base Study (Up to 12 Months)|Other|1|||
125158734|NCT00851643|450206337|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
125158735|NCT00851643|450206338|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
125158736|NCT00851643|450206339|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
125158737|NCT00851643|450206340|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
125158738|NCT00851643|450206341|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
125158739|NCT00851643|450206342|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
125158740|NCT00851643|450206337|FG000|Extension Study (Up to 36 Months)|Moved|0|||
125158741|NCT00851643|450206338|FG001|Extension Study (Up to 36 Months)|Moved|2|||
125158742|NCT00851643|450206339|FG002|Extension Study (Up to 36 Months)|Moved|1|||
125158743|NCT00851643|450206340|FG003|Extension Study (Up to 36 Months)|Moved|1|||
125158744|NCT00851643|450206341|FG004|Extension Study (Up to 36 Months)|Moved|0|||
125158745|NCT00851643|450206342|FG005|Extension Study (Up to 36 Months)|Moved|1|||
125158746|NCT02707861|450206345|FG000|Overall Study|Went onto commercial drug|30|||
125158747|NCT02707861|450206346|FG001|Overall Study|Went onto commercial drug|23|||
125158748|NCT02707861|450206345|FG000|Overall Study|Adverse Event|2|||
125158749|NCT02707861|450206346|FG001|Overall Study|Adverse Event|3|||
125158750|NCT02707861|450206345|FG000|Overall Study|Death|5|||
125158751|NCT02707861|450206346|FG001|Overall Study|Death|2|||
125158752|NCT02707861|450206345|FG000|Overall Study|Lack of Efficacy|0|||
125158753|NCT02707861|450206346|FG001|Overall Study|Lack of Efficacy|2|||
125158754|NCT02707861|450206345|FG000|Overall Study|Physician Decision|1|||
125158755|NCT02707861|450206346|FG001|Overall Study|Physician Decision|4|||
125158756|NCT02707861|450206345|FG000|Overall Study|Withdrawal by Subject|2|||
125158757|NCT02707861|450206346|FG001|Overall Study|Withdrawal by Subject|1|||
125158758|NCT02707861|450206345|FG000|Overall Study|Lost to Follow-up|1|||
125158759|NCT02707861|450206346|FG001|Overall Study|Lost to Follow-up|3|||
125158760|NCT01940497|450206347|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
125158761|NCT01940497|450206348|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
125158762|NCT01940497|450206347|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
125158763|NCT01940497|450206348|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
125158764|NCT01940497|450206347|FG000|Overall Study|Violation of Entry Criteria|1|||
125158765|NCT01940497|450206348|FG001|Overall Study|Violation of Entry Criteria|1|||
125158766|NCT01940497|450206347|FG000|Overall Study|Refused Treatment|1|||
125158767|NCT01940497|450206348|FG001|Overall Study|Refused Treatment|3|||
125158768|NCT01940497|450206347|FG000|Overall Study|Withdrew Consent|6|||
125158769|NCT01940497|450206348|FG001|Overall Study|Withdrew Consent|2|||
125158770|NCT01940497|450206347|FG000|Overall Study|Administrative/Other|1|||
125158771|NCT01940497|450206348|FG001|Overall Study|Administrative/Other|1|||
125158772|NCT01641133|450206349|FG000|Overall Study|Protocol Violation|0|||
125158773|NCT01641133|450206350|FG001|Overall Study|Protocol Violation|1|||
125158774|NCT01641133|450206351|FG002|Overall Study|Protocol Violation|1|||
125158775|NCT01641133|450206349|FG000|Overall Study|Migrated/moved from study area|5|||
125158776|NCT01641133|450206350|FG001|Overall Study|Migrated/moved from study area|3|||
125158777|NCT01641133|450206351|FG002|Overall Study|Migrated/moved from study area|1|||
125158778|NCT01641133|450206349|FG000|Overall Study|Adverse Event|0|||
125158779|NCT01641133|450206350|FG001|Overall Study|Adverse Event|0|||
125158780|NCT01641133|450206351|FG002|Overall Study|Adverse Event|1|||
125158781|NCT01641133|450206349|FG000|Overall Study|Withdrawal by Subject|5|||
125158782|NCT01641133|450206350|FG001|Overall Study|Withdrawal by Subject|3|||
125158783|NCT01641133|450206351|FG002|Overall Study|Withdrawal by Subject|3|||
125223989|NCT03811821|450446298|FG000|Overall Study|Comorbidities|0|||
125158784|NCT01641133|450206349|FG000|Overall Study|Lost to Follow-up|0|||
125158785|NCT01641133|450206350|FG001|Overall Study|Lost to Follow-up|2|||
125158786|NCT01641133|450206351|FG002|Overall Study|Lost to Follow-up|2|||
125158787|NCT00444457|450206355|FG000|Infant Series|Other|0|||
125158788|NCT00444457|450206356|FG001|Infant Series|Other|1|||
125158789|NCT00444457|450206357|FG002|Infant Series|Other|0|||
125158790|NCT00444457|450206358|FG003|Infant Series|Other|0|||
125223990|NCT03811821|450446299|FG001|Overall Study|Comorbidities|2|||
125158791|NCT00444457|450206355|FG000|Infant Series|Parent or legal guardian request|18|||
125158792|NCT00444457|450206356|FG001|Infant Series|Parent or legal guardian request|29|||
125158793|NCT00444457|450206357|FG002|Infant Series|Parent or legal guardian request|34|||
125158794|NCT00444457|450206358|FG003|Infant Series|Parent or legal guardian request|14|||
125158795|NCT00444457|450206355|FG000|Infant Series|Lost to Follow-up|10|||
125158796|NCT00444457|450206356|FG001|Infant Series|Lost to Follow-up|11|||
125158797|NCT00444457|450206357|FG002|Infant Series|Lost to Follow-up|7|||
125158798|NCT00444457|450206358|FG003|Infant Series|Lost to Follow-up|6|||
125158799|NCT00444457|450206355|FG000|Infant Series|Protocol Violation|16|||
125158800|NCT00444457|450206356|FG001|Infant Series|Protocol Violation|8|||
125158801|NCT00444457|450206357|FG002|Infant Series|Protocol Violation|6|||
125158802|NCT00444457|450206358|FG003|Infant Series|Protocol Violation|3|||
125158803|NCT00444457|450206355|FG000|Infant Series|Failed to return|5|||
125158804|NCT00444457|450206356|FG001|Infant Series|Failed to return|4|||
125158805|NCT00444457|450206357|FG002|Infant Series|Failed to return|4|||
125158806|NCT00444457|450206358|FG003|Infant Series|Failed to return|2|||
125158807|NCT00444457|450206355|FG000|Infant Series|Investigator request|4|||
125158808|NCT00444457|450206356|FG001|Infant Series|Investigator request|3|||
125158809|NCT00444457|450206357|FG002|Infant Series|Investigator request|3|||
125158810|NCT00444457|450206358|FG003|Infant Series|Investigator request|2|||
125158811|NCT00444457|450206355|FG000|Infant Series|Other|0|||
125158812|NCT00444457|450206356|FG001|Infant Series|Other|2|||
125158813|NCT00444457|450206357|FG002|Infant Series|Other|4|||
125158814|NCT00444457|450206358|FG003|Infant Series|Other|0|||
125158815|NCT00444457|450206355|FG000|Infant Series|Adverse Event|1|||
125158816|NCT00444457|450206356|FG001|Infant Series|Adverse Event|2|||
125158817|NCT00444457|450206357|FG002|Infant Series|Adverse Event|2|||
125158818|NCT00444457|450206358|FG003|Infant Series|Adverse Event|0|||
125158819|NCT00444457|450206355|FG000|Infant Series|Death|0|||
125158820|NCT00444457|450206356|FG001|Infant Series|Death|1|||
125158821|NCT00444457|450206357|FG002|Infant Series|Death|1|||
125158822|NCT00444457|450206358|FG003|Infant Series|Death|1|||
125158823|NCT00444457|450206355|FG000|After Infant Series|Other|0|||
125158824|NCT00444457|450206356|FG001|After Infant Series|Other|1|||
125158825|NCT00444457|450206357|FG002|After Infant Series|Other|1|||
125158826|NCT00444457|450206358|FG003|After Infant Series|Other|1|||
125158827|NCT00444457|450206355|FG000|After Infant Series|Parent or legal guardian request|4|||
125158828|NCT00444457|450206356|FG001|After Infant Series|Parent or legal guardian request|11|||
125158829|NCT00444457|450206357|FG002|After Infant Series|Parent or legal guardian request|6|||
125158830|NCT00444457|450206358|FG003|After Infant Series|Parent or legal guardian request|3|||
125158831|NCT00444457|450206355|FG000|After Infant Series|Failed to return|7|||
125158832|NCT00444457|450206356|FG001|After Infant Series|Failed to return|6|||
125158833|NCT00444457|450206357|FG002|After Infant Series|Failed to return|5|||
125158834|NCT00444457|450206358|FG003|After Infant Series|Failed to return|1|||
125158835|NCT00444457|450206355|FG000|After Infant Series|Lost to Follow-up|5|||
125158836|NCT00444457|450206356|FG001|After Infant Series|Lost to Follow-up|5|||
125158837|NCT00444457|450206357|FG002|After Infant Series|Lost to Follow-up|5|||
125158838|NCT00444457|450206358|FG003|After Infant Series|Lost to Follow-up|2|||
125158839|NCT00444457|450206355|FG000|After Infant Series|Protocol Violation|2|||
125158840|NCT00444457|450206356|FG001|After Infant Series|Protocol Violation|4|||
125158841|NCT00444457|450206357|FG002|After Infant Series|Protocol Violation|2|||
125158842|NCT00444457|450206358|FG003|After Infant Series|Protocol Violation|2|||
125158843|NCT00444457|450206355|FG000|After Infant Series|Adverse Event|2|||
125158844|NCT00444457|450206356|FG001|After Infant Series|Adverse Event|2|||
125158845|NCT00444457|450206357|FG002|After Infant Series|Adverse Event|0|||
125158846|NCT00444457|450206358|FG003|After Infant Series|Adverse Event|0|||
125158847|NCT00444457|450206355|FG000|After Infant Series|Investigator request|0|||
125158848|NCT00444457|450206356|FG001|After Infant Series|Investigator request|0|||
125158849|NCT00444457|450206357|FG002|After Infant Series|Investigator request|0|||
125158850|NCT00444457|450206358|FG003|After Infant Series|Investigator request|1|||
125158851|NCT00444457|450206355|FG000|After Infant Series|Other|0|||
125158852|NCT00444457|450206356|FG001|After Infant Series|Other|1|||
125158853|NCT00444457|450206357|FG002|After Infant Series|Other|0|||
125158854|NCT00444457|450206358|FG003|After Infant Series|Other|0|||
125158855|NCT00444457|450206355|FG000|Toddler Dose|Lost to Follow-up|4|||
125158856|NCT00444457|450206356|FG001|Toddler Dose|Lost to Follow-up|1|||
125158857|NCT00444457|450206357|FG002|Toddler Dose|Lost to Follow-up|1|||
125158858|NCT00444457|450206358|FG003|Toddler Dose|Lost to Follow-up|3|||
125223991|NCT04888494|450446302|FG000|Overall Study|Lost to Follow-up|2|||
125223992|NCT04888494|450446303|FG001|Overall Study|Lost to Follow-up|3|||
125223993|NCT04888494|450446302|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
125223994|NCT04888494|450446303|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
125223995|NCT00611806|450448026|FG000|Overall Study|Withdrawal by Subject|8|||
125223996|NCT00611806|450448027|FG001|Overall Study|Withdrawal by Subject|2|||
125223997|NCT00611806|450448026|FG000|Overall Study|Adverse Event|2|||
125158859|NCT00444457|450206355|FG000|Toddler Dose|Failed to return|2|||
125158860|NCT00444457|450206356|FG001|Toddler Dose|Failed to return|2|||
125158861|NCT00444457|450206357|FG002|Toddler Dose|Failed to return|1|||
125158862|NCT00444457|450206358|FG003|Toddler Dose|Failed to return|3|||
125158863|NCT00444457|450206355|FG000|Toddler Dose|Parent or legal guardian request|0|||
125158864|NCT00444457|450206356|FG001|Toddler Dose|Parent or legal guardian request|3|||
125158865|NCT00444457|450206357|FG002|Toddler Dose|Parent or legal guardian request|2|||
125158866|NCT00444457|450206358|FG003|Toddler Dose|Parent or legal guardian request|1|||
125158867|NCT00444457|450206355|FG000|Toddler Dose|Protocol Violation|1|||
125223998|NCT00611806|450448027|FG001|Overall Study|Adverse Event|1|||
125158868|NCT00444457|450206356|FG001|Toddler Dose|Protocol Violation|0|||
125158869|NCT00444457|450206357|FG002|Toddler Dose|Protocol Violation|0|||
125158870|NCT00444457|450206358|FG003|Toddler Dose|Protocol Violation|1|||
125158871|NCT02518919|450207431|FG000|Overall Study|Protocol Violation|1|||
125158872|NCT02518919|450207432|FG001|Overall Study|Protocol Violation|1|||
125158873|NCT02518919|450207433|FG002|Overall Study|Protocol Violation|2|||
125158874|NCT02227147|450207435|FG000|Controlled Treatment Period|Adverse Event|4|||
125158875|NCT02227147|450207436|FG001|Controlled Treatment Period|Adverse Event|3|||
125158876|NCT02227147|450207435|FG000|Controlled Treatment Period|Other|2|||
125158877|NCT02227147|450207436|FG001|Controlled Treatment Period|Other|0|||
125158878|NCT02227147|450207435|FG000|Follow-up Period|Other|3|||
125158879|NCT02227147|450207436|FG001|Follow-up Period|Other|5|||
125158880|NCT02923674|450207437|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
125223999|NCT00611806|450448026|FG000|Overall Study|Lost to Follow-up|6|||
125158881|NCT02923674|450207438|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
125158882|NCT02923674|450207439|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
125158883|NCT02923674|450207437|FG000|Overall Study|Lost to Follow-up|7|||
125158884|NCT02923674|450207438|FG001|Overall Study|Lost to Follow-up|12|||
125158885|NCT02923674|450207439|FG002|Overall Study|Lost to Follow-up|7|||
125158886|NCT02923674|450207437|FG000|Overall Study|Problem with intervention|2|||
125158887|NCT02923674|450207438|FG001|Overall Study|Problem with intervention|2|||
125158888|NCT02923674|450207439|FG002|Overall Study|Problem with intervention|1|||
125158889|NCT02923674|450207437|FG000|Overall Study|Adverse Event|3|||
125158890|NCT02923674|450207438|FG001|Overall Study|Adverse Event|1|||
125158891|NCT02923674|450207439|FG002|Overall Study|Adverse Event|1|||
125158892|NCT02923674|450207437|FG000|Overall Study|Withdrawal by Subject|2|||
125158893|NCT02923674|450207438|FG001|Overall Study|Withdrawal by Subject|2|||
125158894|NCT02923674|450207439|FG002|Overall Study|Withdrawal by Subject|2|||
125158895|NCT03709823|450207440|FG000|Overall Study|Adverse Event|0|||
125158896|NCT03709823|450207441|FG001|Overall Study|Adverse Event|0|||
125158897|NCT03709823|450207442|FG002|Overall Study|Adverse Event|1|||
125158898|NCT03709823|450207443|FG003|Overall Study|Adverse Event|0|||
125158899|NCT03709823|450207444|FG004|Overall Study|Adverse Event|0|||
125158900|NCT03709823|450207445|FG005|Overall Study|Adverse Event|0|||
125158901|NCT03709823|450207440|FG000|Overall Study|Lost to Follow-up|2|||
125158902|NCT03709823|450207441|FG001|Overall Study|Lost to Follow-up|2|||
125158903|NCT03709823|450207442|FG002|Overall Study|Lost to Follow-up|2|||
125158904|NCT03709823|450207443|FG003|Overall Study|Lost to Follow-up|1|||
125158905|NCT03709823|450207444|FG004|Overall Study|Lost to Follow-up|1|||
125158906|NCT03709823|450207445|FG005|Overall Study|Lost to Follow-up|0|||
125158907|NCT03709823|450207440|FG000|Overall Study|Withdrawal by Subject|1|||
125158908|NCT03709823|450207441|FG001|Overall Study|Withdrawal by Subject|3|||
125158909|NCT03709823|450207442|FG002|Overall Study|Withdrawal by Subject|0|||
125158910|NCT03709823|450207443|FG003|Overall Study|Withdrawal by Subject|0|||
125158911|NCT03709823|450207444|FG004|Overall Study|Withdrawal by Subject|0|||
125158912|NCT03709823|450207445|FG005|Overall Study|Withdrawal by Subject|0|||
125158913|NCT03709823|450207440|FG000|Overall Study|Other, Not Specified|0|||
125158914|NCT03709823|450207441|FG001|Overall Study|Other, Not Specified|0|||
125158915|NCT03709823|450207442|FG002|Overall Study|Other, Not Specified|0|||
125158916|NCT03709823|450207443|FG003|Overall Study|Other, Not Specified|1|||
125158917|NCT03709823|450207444|FG004|Overall Study|Other, Not Specified|0|||
125158918|NCT03709823|450207445|FG005|Overall Study|Other, Not Specified|0|||
125158919|NCT01055132|450207446|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
125158920|NCT01055132|450207447|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
125158921|NCT01055132|450207446|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
125158922|NCT01055132|450207447|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
125158923|NCT00158600|450207448|FG000|Overall Study|unable to commit time to study|0|||
125158924|NCT00158600|450207449|FG001|Overall Study|unable to commit time to study|1|||
125158925|NCT00158600|450207448|FG000|Overall Study|Adverse Event|2|||
125158926|NCT00158600|450207449|FG001|Overall Study|Adverse Event|1|||
125158927|NCT00158600|450207448|FG000|Overall Study|Death|1|||
125158928|NCT00158600|450207449|FG001|Overall Study|Death|0|||
125158929|NCT00158600|450207448|FG000|Overall Study|Withdrawal by Subject|2|||
125158930|NCT00158600|450207449|FG001|Overall Study|Withdrawal by Subject|2|||
125158931|NCT02618408|450207450|FG000|Overall Study|Withdrawal by Subject|1|||
125158932|NCT02618408|450207451|FG001|Overall Study|Withdrawal by Subject|0|||
125158933|NCT02618408|450207452|FG002|Overall Study|Withdrawal by Subject|4|||
125158934|NCT02618408|450207450|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
125158935|NCT02618408|450207451|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
125158936|NCT02618408|450207452|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
125158937|NCT02618408|450207450|FG000|Overall Study|Lost to Follow-up|4|||
125158938|NCT02618408|450207451|FG001|Overall Study|Lost to Follow-up|2|||
125158939|NCT02618408|450207452|FG002|Overall Study|Lost to Follow-up|6|||
125158940|NCT02618408|450207450|FG000|Overall Study|Adverse Event|4|||
125158941|NCT02618408|450207451|FG001|Overall Study|Adverse Event|0|||
125158942|NCT02618408|450207452|FG002|Overall Study|Adverse Event|10|||
125158943|NCT02618408|450207450|FG000|Overall Study|Physician Decision|1|||
125158944|NCT02618408|450207451|FG001|Overall Study|Physician Decision|1|||
125158945|NCT02618408|450207452|FG002|Overall Study|Physician Decision|2|||
125158946|NCT02618408|450207450|FG000|Overall Study|Protocol Violation|1|||
125158947|NCT02618408|450207451|FG001|Overall Study|Protocol Violation|1|||
125158948|NCT02618408|450207452|FG002|Overall Study|Protocol Violation|2|||
125158949|NCT02618408|450207450|FG000|Overall Study|Other, Multiple Categories|0|||
125158950|NCT02618408|450207451|FG001|Overall Study|Other, Multiple Categories|0|||
125158951|NCT02618408|450207452|FG002|Overall Study|Other, Multiple Categories|4|||
125158952|NCT02575911|450207456|FG000|Overall Study|Lost to Follow-up|1|||
125158953|NCT01249365|450207457|FG000|Overall Study|Lost to Follow-up|1|||
125158954|NCT01460901|450207458|FG000|Overall Study|Withdrawal by Subject|2|||
125158955|NCT02566993|450207459|FG000|Overall Study|Randomized but not treated|5|||
125158956|NCT02566993|450207460|FG001|Overall Study|Randomized but not treated|16|||
125158957|NCT02566993|450207459|FG000|Overall Study|Progressive disease|213|||
125158958|NCT02566993|450207460|FG001|Overall Study|Progressive disease|152|||
125158959|NCT02566993|450207459|FG000|Overall Study|Withdrawal by Subject|12|||
125158960|NCT02566993|450207460|FG001|Overall Study|Withdrawal by Subject|28|||
125158961|NCT02566993|450207459|FG000|Overall Study|Death|17|||
125158962|NCT02566993|450207460|FG001|Overall Study|Death|23|||
125158963|NCT02566993|450207459|FG000|Overall Study|Physician Decision|10|||
125158964|NCT02566993|450207460|FG001|Overall Study|Physician Decision|17|||
125158965|NCT02566993|450207459|FG000|Overall Study|Study drug-related adverse event|20|||
125158966|NCT02566993|450207460|FG001|Overall Study|Study drug-related adverse event|41|||
125158967|NCT02566993|450207459|FG000|Overall Study|Non study drug-related adverse event|9|||
125158968|NCT02566993|450207460|FG001|Overall Study|Non study drug-related adverse event|9|||
125158969|NCT02566993|450207459|FG000|Overall Study|Symptomatic deterioration|9|||
125158970|NCT02566993|450207460|FG001|Overall Study|Symptomatic deterioration|16|||
125158971|NCT02566993|450207459|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
125158972|NCT02566993|450207460|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
125158973|NCT02566993|450207459|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
125158974|NCT02566993|450207460|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
125158975|NCT02566993|450207459|FG000|Overall Study|Screening failure|2|||
125158976|NCT02566993|450207460|FG001|Overall Study|Screening failure|0|||
125158977|NCT02566993|450207459|FG000|Overall Study|Lost to Follow-up|0|||
125158978|NCT02566993|450207460|FG001|Overall Study|Lost to Follow-up|1|||
125158979|NCT02566993|450207459|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
125158980|NCT02566993|450207460|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
125158981|NCT03127644|450207470|FG000|Overall Study|Study-specific withdrawal criteria|0|||
125158982|NCT03127644|450207471|FG001|Overall Study|Study-specific withdrawal criteria|0|||
125158983|NCT03127644|450207472|FG002|Overall Study|Study-specific withdrawal criteria|2|||
125158984|NCT02032706|450207473|FG000|Overall Study|Did not qualify|5|||
125158985|NCT02032706|450207473|FG000|Overall Study|Protocol Violation|1|||
125158986|NCT01156142|450207476|FG000|Overall Study|Withdrawal by Subject|8|||
125158987|NCT01156142|450207477|FG001|Overall Study|Withdrawal by Subject|6|||
125158988|NCT01156142|450207476|FG000|Overall Study|Ineligible|0|||
125158989|NCT01156142|450207477|FG001|Overall Study|Ineligible|1|||
125158990|NCT00893737|450207478|FG000|Overall Study|Adverse Event|4|||
125158991|NCT00893737|450207478|FG000|Overall Study|Withdrawal by Subject|2|||
125158992|NCT00893737|450207478|FG000|Overall Study|Lost to Follow-up|6|||
125158993|NCT02140411|450207479|FG000|Overall Study|Adverse Event|1|||
125158994|NCT03981419|450207482|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
125158995|NCT03981419|450207483|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
125158996|NCT01330459|450207488|FG000|Overall Study|Physician Decision|0|||
125158997|NCT01330459|450207489|FG001|Overall Study|Physician Decision|2|||
125158998|NCT00895947|450207490|FG000|Overall Study|Adverse Event|3|||
125158999|NCT00895947|450207491|FG001|Overall Study|Adverse Event|4|||
125159000|NCT00895947|450207490|FG000|Overall Study|Lost to Follow-up|3|||
125159001|NCT00895947|450207491|FG001|Overall Study|Lost to Follow-up|4|||
125159002|NCT00895947|450207490|FG000|Overall Study|Protocol Violation|4|||
125159003|NCT00895947|450207491|FG001|Overall Study|Protocol Violation|2|||
125159004|NCT00895947|450207490|FG000|Overall Study|Withdrawal by Subject|2|||
125159005|NCT00895947|450207491|FG001|Overall Study|Withdrawal by Subject|0|||
125159006|NCT04620135|450207495|FG000|Study Completion|Adverse Event|2|||
125159007|NCT04620135|450207496|FG001|Study Completion|Adverse Event|3|||
125159008|NCT04620135|450207495|FG000|Study Completion|Withdrawal by Subject|2|||
125159009|NCT04620135|450207496|FG001|Study Completion|Withdrawal by Subject|0|||
125159010|NCT02005887|450207505|FG000|Overall Study|Protocol Violation|0|||
125159011|NCT02005887|450207506|FG001|Overall Study|Protocol Violation|2|||
125159012|NCT01550744|450207507|FG000|Open-Label|Lost to Follow-up|7|||
125159013|NCT01550744|450207508|FG001|Open-Label|Lost to Follow-up|0|||
125159014|NCT01550744|450207509|FG002|Open-Label|Lost to Follow-up|0|||
125159015|NCT01550744|450207507|FG000|Open-Label|Withdrawal by Subject|13|||
125159016|NCT01550744|450207508|FG001|Open-Label|Withdrawal by Subject|0|||
125159017|NCT01550744|450207509|FG002|Open-Label|Withdrawal by Subject|0|||
125159018|NCT01550744|450207507|FG000|Open-Label|Adverse Event|11|||
125159019|NCT01550744|450207508|FG001|Open-Label|Adverse Event|0|||
125159020|NCT01550744|450207509|FG002|Open-Label|Adverse Event|0|||
125159021|NCT01550744|450207507|FG000|Open-Label|Lack of Efficacy|4|||
125159022|NCT01550744|450207508|FG001|Open-Label|Lack of Efficacy|0|||
125159023|NCT01550744|450207509|FG002|Open-Label|Lack of Efficacy|0|||
125159024|NCT01550744|450207507|FG000|Open-Label|Protocol Violation|4|||
125159025|NCT01550744|450207508|FG001|Open-Label|Protocol Violation|0|||
125159026|NCT01550744|450207509|FG002|Open-Label|Protocol Violation|0|||
125159027|NCT01550744|450207507|FG000|Open-Label|Not all 3 study drug injections received|2|||
125159028|NCT01550744|450207508|FG001|Open-Label|Not all 3 study drug injections received|0|||
125159029|NCT01550744|450207509|FG002|Open-Label|Not all 3 study drug injections received|0|||
125159030|NCT01550744|450207507|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
125159031|NCT01550744|450207508|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
125159032|NCT01550744|450207509|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
125224000|NCT00611806|450448027|FG001|Overall Study|Lost to Follow-up|0|||
125224001|NCT02317991|450448028|FG000|Overall Study|Adverse Event|12|||
125224002|NCT02317991|450448028|FG000|Overall Study|Death|4|||
125224003|NCT02317991|450448028|FG000|Overall Study|Withdrawal by Subject|8|||
125224004|NCT02317991|450448028|FG000|Overall Study|Progressive Disease|41|||
125224005|NCT01921517|450448029|FG000|Overall Study|Lost to Follow-up|5|||
125224006|NCT01921517|450448030|FG001|Overall Study|Lost to Follow-up|0|||
125224007|NCT01921517|450448029|FG000|Overall Study|Newly diagnosed health concern|2|||
125224008|NCT01921517|450448030|FG001|Overall Study|Newly diagnosed health concern|0|||
125224009|NCT01921517|450448029|FG000|Overall Study|Physician Decision|0|||
125224010|NCT01921517|450448030|FG001|Overall Study|Physician Decision|2|||
125224011|NCT01921517|450448029|FG000|Overall Study|Withdrawal by Subject|7|||
125224012|NCT01921517|450448030|FG001|Overall Study|Withdrawal by Subject|3|||
125159033|NCT01550744|450207507|FG000|Open-Label|Other|1|||
125224013|NCT01921517|450448029|FG000|Overall Study|Subject missed final imaging|1|||
125159034|NCT01550744|450207508|FG001|Open-Label|Other|0|||
125159035|NCT01550744|450207509|FG002|Open-Label|Other|0|||
125159036|NCT01550744|450207507|FG000|Double-Blind|Lost to Follow-up|0|||
125159037|NCT01550744|450207508|FG001|Double-Blind|Lost to Follow-up|6|||
125159038|NCT01550744|450207509|FG002|Double-Blind|Lost to Follow-up|12|||
125159039|NCT01550744|450207507|FG000|Double-Blind|Withdrawal by Subject|0|||
125224014|NCT01921517|450448030|FG001|Overall Study|Subject missed final imaging|4|||
125224015|NCT01325350|450448031|FG000|Overall Study|Adverse Event|3|||
125159040|NCT01550744|450207508|FG001|Double-Blind|Withdrawal by Subject|2|||
125159041|NCT01550744|450207509|FG002|Double-Blind|Withdrawal by Subject|15|||
125159042|NCT01550744|450207507|FG000|Double-Blind|Adverse Event|0|||
125224016|NCT01325350|450448032|FG001|Overall Study|Adverse Event|3|||
125224017|NCT01325350|450448033|FG002|Overall Study|Adverse Event|3|||
125224018|NCT01325350|450448034|FG003|Overall Study|Adverse Event|1|||
125159043|NCT01550744|450207508|FG001|Double-Blind|Adverse Event|4|||
125159044|NCT01550744|450207509|FG002|Double-Blind|Adverse Event|15|||
125159045|NCT01550744|450207507|FG000|Double-Blind|Death|0|||
125159046|NCT01550744|450207508|FG001|Double-Blind|Death|1|||
125159047|NCT01550744|450207509|FG002|Double-Blind|Death|0|||
125159048|NCT01550744|450207507|FG000|Double-Blind|Lack of Efficacy|0|||
125159049|NCT01550744|450207508|FG001|Double-Blind|Lack of Efficacy|2|||
125159050|NCT01550744|450207509|FG002|Double-Blind|Lack of Efficacy|8|||
125159051|NCT01550744|450207507|FG000|Double-Blind|Protocol Violation|0|||
125159052|NCT01550744|450207508|FG001|Double-Blind|Protocol Violation|0|||
125159053|NCT01550744|450207509|FG002|Double-Blind|Protocol Violation|4|||
125159054|NCT01550744|450207507|FG000|Double-Blind|Pregnancy|0|||
125159055|NCT01550744|450207508|FG001|Double-Blind|Pregnancy|0|||
125159056|NCT01550744|450207509|FG002|Double-Blind|Pregnancy|3|||
125159057|NCT01550744|450207507|FG000|Double-Blind|Other|0|||
125159058|NCT01550744|450207508|FG001|Double-Blind|Other|2|||
125159059|NCT01550744|450207509|FG002|Double-Blind|Other|10|||
125159060|NCT01660334|450207510|FG000|Overall Study|Lost to Follow-up|1|||
125159061|NCT00311311|450207511|FG000|Overall Study|Adverse Event|3|||
125159062|NCT00311311|450207512|FG001|Overall Study|Adverse Event|2|||
125159063|NCT00311311|450207511|FG000|Overall Study|Withdrawal by Subject|1|||
125159064|NCT00311311|450207512|FG001|Overall Study|Withdrawal by Subject|1|||
125159065|NCT00311311|450207511|FG000|Overall Study|Noncompliance|0|||
125159066|NCT00311311|450207512|FG001|Overall Study|Noncompliance|1|||
125159067|NCT00311311|450207511|FG000|Overall Study|Study Termination by Sponsor|3|||
125159068|NCT00311311|450207512|FG001|Overall Study|Study Termination by Sponsor|4|||
125159069|NCT00311311|450207511|FG000|Overall Study|Death|1|||
125159070|NCT00311311|450207512|FG001|Overall Study|Death|0|||
125159071|NCT00311311|450207511|FG000|Overall Study|Lack of ancillary assistance|0|||
125159072|NCT00311311|450207512|FG001|Overall Study|Lack of ancillary assistance|1|||
125159073|NCT00988065|450207514|FG000|Overall Study|Adverse Event|4|||
125159074|NCT00988065|450207515|FG001|Overall Study|Adverse Event|10|||
125159075|NCT00988065|450207516|FG002|Overall Study|Adverse Event|2|||
125159076|NCT00988065|450207514|FG000|Overall Study|Lost to Follow-up|1|||
125159077|NCT00988065|450207515|FG001|Overall Study|Lost to Follow-up|2|||
125159078|NCT00988065|450207516|FG002|Overall Study|Lost to Follow-up|2|||
125159079|NCT00988065|450207514|FG000|Overall Study|Subject withdrew consent|3|||
125159080|NCT00988065|450207515|FG001|Overall Study|Subject withdrew consent|5|||
125159081|NCT00988065|450207516|FG002|Overall Study|Subject withdrew consent|2|||
125159082|NCT00988065|450207514|FG000|Overall Study|Noncompliance with protocol|5|||
125159083|NCT00988065|450207515|FG001|Overall Study|Noncompliance with protocol|6|||
125159084|NCT00988065|450207516|FG002|Overall Study|Noncompliance with protocol|9|||
125159085|NCT01229735|450207517|FG000|Overall Study|Lack of Efficacy|8|||
125159086|NCT01229735|450207518|FG001|Overall Study|Lack of Efficacy|8|||
125159087|NCT01229735|450207517|FG000|Overall Study|Protocol Violation|13|||
125159088|NCT01229735|450207518|FG001|Overall Study|Protocol Violation|8|||
125159089|NCT01229735|450207517|FG000|Overall Study|Lost to Follow-up|0|||
125159090|NCT01229735|450207518|FG001|Overall Study|Lost to Follow-up|2|||
125159091|NCT01229735|450207517|FG000|Overall Study|Withdrawal by Subject|18|||
125159092|NCT01229735|450207518|FG001|Overall Study|Withdrawal by Subject|17|||
125159093|NCT01229735|450207517|FG000|Overall Study|Other Reason|13|||
125159094|NCT01229735|450207518|FG001|Overall Study|Other Reason|10|||
125159095|NCT01229735|450207517|FG000|Overall Study|SAE, non-fatal|0|||
125159096|NCT01229735|450207518|FG001|Overall Study|SAE, non-fatal|4|||
125159097|NCT01229735|450207517|FG000|Overall Study|AE, non-serious non-fatal|13|||
125159098|NCT01229735|450207518|FG001|Overall Study|AE, non-serious non-fatal|17|||
125159099|NCT01229735|450207517|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
125159100|NCT01229735|450207518|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
125159101|NCT02685202|450207519|FG000|Overall Study|Lost to Follow-up|9|||
125159102|NCT02787408|450207526|FG000|Overall Study|Death|16|||
125159103|NCT02787408|450207526|FG000|Overall Study|Withdrawal by Subject|1|||
125159104|NCT02787408|450207526|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
125159105|NCT00985712|450207529|FG000|Overall Study|Adverse Event|0|||
125159106|NCT00985712|450207530|FG001|Overall Study|Adverse Event|1|||
125159107|NCT00985712|450207529|FG000|Overall Study|Lost to Follow-up|2|||
125159108|NCT00985712|450207530|FG001|Overall Study|Lost to Follow-up|2|||
125159109|NCT00985712|450207529|FG000|Overall Study|Protocol Violation|0|||
125159110|NCT00985712|450207530|FG001|Overall Study|Protocol Violation|1|||
125159111|NCT00985712|450207529|FG000|Overall Study|Withdrawal by Subject|4|||
125159112|NCT00985712|450207530|FG001|Overall Study|Withdrawal by Subject|1|||
125159113|NCT00985712|450207529|FG000|Overall Study|Sponsor decision|0|||
125159114|NCT00985712|450207530|FG001|Overall Study|Sponsor decision|2|||
125159115|NCT03123861|450207533|FG000|Overall Study|Protocol Violation|1|||
125159116|NCT03123861|450207534|FG001|Overall Study|Protocol Violation|1|||
125159117|NCT03123861|450207533|FG000|Overall Study|Withdrawal by Subject|2|||
125159118|NCT03123861|450207534|FG001|Overall Study|Withdrawal by Subject|2|||
125159119|NCT02206620|450207535|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
125159120|NCT02206620|450207536|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
125159121|NCT02206620|450207535|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
125159122|NCT02206620|450207536|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
125159123|NCT01346774|450207537|FG000|Overall Study|Did not take a single dose|6|||
125159124|NCT01346774|450207538|FG001|Overall Study|Did not take a single dose|4|||
125159125|NCT01346774|450207537|FG000|Overall Study|Lost to Follow-up|3|||
125159126|NCT01346774|450207538|FG001|Overall Study|Lost to Follow-up|4|||
125159127|NCT01346774|450207537|FG000|Overall Study|Withdrawal by Subject|1|||
125159128|NCT01346774|450207538|FG001|Overall Study|Withdrawal by Subject|4|||
125159129|NCT01346774|450207537|FG000|Overall Study|Protocol Violation|2|||
125159130|NCT01346774|450207538|FG001|Overall Study|Protocol Violation|3|||
125159131|NCT01346774|450207537|FG000|Overall Study|Adverse Event|1|||
125159132|NCT01346774|450207538|FG001|Overall Study|Adverse Event|2|||
125159133|NCT00502801|450207539|FG000|Treatment Period|Withdrawal by Subject|3|||
125159134|NCT00502801|450207539|FG000|Treatment Period|Adverse Event|7|||
125159135|NCT00502801|450207539|FG000|Treatment Period|Death|14|||
125159136|NCT00502801|450207539|FG000|Treatment Period|OTHER|30|||
125159137|NCT00502801|450207539|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
125159138|NCT00502801|450207539|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
125159139|NCT00502801|450207539|FG000|End of Therapy to Test of Cure|Death|3|||
125159140|NCT00502801|450207539|FG000|End of Therapy to Test of Cure|OTHER|2|||
125159141|NCT03212521|450207543|FG000|Overall Study|Adverse Event|1|||
125159142|NCT03212521|450207543|FG000|Overall Study|Lost to Follow-up|4|||
125159143|NCT03212521|450207543|FG000|Overall Study|Withdrawal by Subject|1|||
125159144|NCT03212521|450207543|FG000|Overall Study|Other|1|||
125159145|NCT01602965|450207548|FG000|Overall Study|Lost to Follow-up|4|||
125159146|NCT01602965|450207549|FG001|Overall Study|Lost to Follow-up|2|||
125159147|NCT00321737|450207550|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
125159148|NCT00321737|450207551|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
125159149|NCT00321737|450207552|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
125159150|NCT00321737|450207550|FG000|Overall Study|Adverse Event|11|||
125159151|NCT00321737|450207551|FG001|Overall Study|Adverse Event|3|||
125159152|NCT00321737|450207552|FG002|Overall Study|Adverse Event|6|||
125159153|NCT00321737|450207550|FG000|Overall Study|Lost to Follow-up|5|||
125159154|NCT00321737|450207551|FG001|Overall Study|Lost to Follow-up|5|||
125159155|NCT00321737|450207552|FG002|Overall Study|Lost to Follow-up|6|||
125159156|NCT00321737|450207550|FG000|Overall Study|Withdrawal by Subject|19|||
125159157|NCT00321737|450207551|FG001|Overall Study|Withdrawal by Subject|12|||
125159158|NCT00321737|450207552|FG002|Overall Study|Withdrawal by Subject|17|||
125159159|NCT00321737|450207550|FG000|Overall Study|Protocol Violation|0|||
125159160|NCT00321737|450207551|FG001|Overall Study|Protocol Violation|0|||
125159161|NCT00321737|450207552|FG002|Overall Study|Protocol Violation|1|||
125159162|NCT00321737|450207550|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
125159163|NCT00321737|450207551|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
125159164|NCT00321737|450207552|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
125159165|NCT00321737|450207550|FG000|Overall Study|Possible Barrett's Esophagus|2|||
125159166|NCT00321737|450207551|FG001|Overall Study|Possible Barrett's Esophagus|1|||
125159167|NCT00321737|450207552|FG002|Overall Study|Possible Barrett's Esophagus|1|||
125159168|NCT00321737|450207550|FG000|Overall Study|Therapeutic Failure|6|||
125159169|NCT00321737|450207551|FG001|Overall Study|Therapeutic Failure|0|||
125159170|NCT00321737|450207552|FG002|Overall Study|Therapeutic Failure|2|||
125159171|NCT00321737|450207550|FG000|Overall Study|Pregnancy|0|||
125159172|NCT00321737|450207551|FG001|Overall Study|Pregnancy|2|||
125159173|NCT00321737|450207552|FG002|Overall Study|Pregnancy|0|||
125159174|NCT00321737|450207550|FG000|Overall Study|Noncompliance|2|||
125159175|NCT00321737|450207551|FG001|Overall Study|Noncompliance|0|||
125159176|NCT00321737|450207552|FG002|Overall Study|Noncompliance|0|||
125159177|NCT00321737|450207550|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
125159178|NCT00321737|450207551|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
125159179|NCT00321737|450207552|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
125159180|NCT02283294|450207553|FG000|Overall Study|Lost to Follow-up|1|||
125159181|NCT02283294|450207554|FG001|Overall Study|Lost to Follow-up|1|||
125159182|NCT02283294|450207553|FG000|Overall Study|Withdrawal by Subject|1|||
125159183|NCT02283294|450207554|FG001|Overall Study|Withdrawal by Subject|6|||
125159184|NCT02283294|450207553|FG000|Overall Study|Protocol Violation|1|||
125159185|NCT02283294|450207554|FG001|Overall Study|Protocol Violation|0|||
125159186|NCT02283294|450207553|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
125159187|NCT02283294|450207554|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
125159188|NCT01769339|450207555|FG000|Overall Study|Lost to Follow-up|42|||
125159189|NCT01769339|450207555|FG000|Overall Study|Adverse Event|1|||
125159190|NCT00290251|450207556|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
125159191|NCT00290251|450207557|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
125159192|NCT00290251|450207558|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
125159193|NCT00290251|450207559|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
125159194|NCT00290251|450207560|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
125159195|NCT00290251|450207561|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
125159196|NCT00290251|450207556|FG000|Treatment 1 (Months 2-4)|headache|0|||
125159197|NCT00290251|450207557|FG001|Treatment 1 (Months 2-4)|headache|0|||
125159198|NCT00290251|450207558|FG002|Treatment 1 (Months 2-4)|headache|0|||
125159199|NCT00290251|450207559|FG003|Treatment 1 (Months 2-4)|headache|0|||
125159200|NCT00290251|450207560|FG004|Treatment 1 (Months 2-4)|headache|1|||
125159201|NCT00290251|450207561|FG005|Treatment 1 (Months 2-4)|headache|0|||
125159202|NCT00290251|450207556|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
125159203|NCT00290251|450207557|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
125159204|NCT00290251|450207558|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
125159205|NCT00290251|450207559|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
125159206|NCT00290251|450207560|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
125159207|NCT00290251|450207561|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
125159208|NCT04062448|450210026|FG000|Overall Study|Lost to Follow-up|1|||
125159209|NCT04062448|450210026|FG000|Overall Study|Withdrawal by Subject|2|||
125159210|NCT05101486|450210027|FG000|Overall Study|Death|1|||
125159211|NCT05101486|450210028|FG001|Overall Study|Death|0|||
125159212|NCT05101486|450210029|FG002|Overall Study|Death|1|||
125159213|NCT05101486|450210027|FG000|Overall Study|Lost to Follow-up|12|||
125159214|NCT05101486|450210028|FG001|Overall Study|Lost to Follow-up|8|||
125159215|NCT05101486|450210029|FG002|Overall Study|Lost to Follow-up|17|||
125159216|NCT05101486|450210027|FG000|Overall Study|Physician Decision|1|||
125159217|NCT05101486|450210028|FG001|Overall Study|Physician Decision|0|||
125159218|NCT05101486|450210029|FG002|Overall Study|Physician Decision|0|||
125159219|NCT05101486|450210027|FG000|Overall Study|Protocol Violation|0|||
125159220|NCT05101486|450210028|FG001|Overall Study|Protocol Violation|0|||
125159221|NCT05101486|450210029|FG002|Overall Study|Protocol Violation|1|||
125159222|NCT05101486|450210027|FG000|Overall Study|Withdrawal by Subject|5|||
125159223|NCT05101486|450210028|FG001|Overall Study|Withdrawal by Subject|2|||
125159224|NCT05101486|450210029|FG002|Overall Study|Withdrawal by Subject|4|||
125159225|NCT05101486|450210027|FG000|Overall Study|Randomized but not vaccinated|1|||
125159226|NCT05101486|450210028|FG001|Overall Study|Randomized but not vaccinated|1|||
125159227|NCT05101486|450210029|FG002|Overall Study|Randomized but not vaccinated|1|||
125159228|NCT02788045|450210030|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
125159229|NCT02788045|450210031|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
125159230|NCT02788045|450210032|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
125159231|NCT02788045|450210030|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
125159232|NCT02788045|450210031|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
125159233|NCT02788045|450210032|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
125159234|NCT02788045|450210030|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
125159235|NCT02788045|450210031|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
125159236|NCT02788045|450210032|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
125159237|NCT02788045|450210030|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
125159238|NCT02788045|450210031|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
125159239|NCT02788045|450210032|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
125159240|NCT02788045|450210030|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
125159241|NCT02788045|450210031|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
125159242|NCT02788045|450210032|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
125159243|NCT02788045|450210030|FG000|Main Study (Up to Week 72)|Other|3|||
125159244|NCT02788045|450210031|FG001|Main Study (Up to Week 72)|Other|0|||
125159245|NCT02788045|450210032|FG002|Main Study (Up to Week 72)|Other|0|||
125159246|NCT02788045|450210030|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
125159247|NCT02788045|450210031|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
125159248|NCT02788045|450210032|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
125159249|NCT02788045|450210030|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
125159250|NCT02788045|450210031|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
125159251|NCT02788045|450210032|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
125159252|NCT02788045|450210030|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
125159253|NCT02788045|450210031|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
125159254|NCT02788045|450210032|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
125159255|NCT03188666|450210033|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
125159256|NCT03188666|450210034|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
125159257|NCT03188666|450210035|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
125159258|NCT03188666|450210036|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
125159259|NCT03188666|450210033|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
125159260|NCT03188666|450210034|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
125159261|NCT03188666|450210035|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
125159262|NCT03188666|450210036|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
125224019|NCT01325350|450448035|FG004|Overall Study|Adverse Event|2|||
125159263|NCT03188666|450210033|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
125159264|NCT03188666|450210034|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
125159265|NCT03188666|450210035|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
125159266|NCT03188666|450210036|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
125159267|NCT03188666|450210033|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
125159268|NCT03188666|450210034|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
125159269|NCT03188666|450210035|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
125159270|NCT03188666|450210036|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
125159271|NCT03696953|450210037|FG000|Overall Study|Withdrawal by Subject|6|||
125159272|NCT03696953|450210038|FG001|Overall Study|Withdrawal by Subject|1|||
125159273|NCT03696953|450210037|FG000|Overall Study|missed GBS swabs|2|||
125159274|NCT03696953|450210038|FG001|Overall Study|missed GBS swabs|2|||
125159275|NCT03696953|450210037|FG000|Overall Study|lost study bottle containing capsules|2|||
125159276|NCT03696953|450210038|FG001|Overall Study|lost study bottle containing capsules|0|||
125159277|NCT03696953|450210037|FG000|Overall Study|Premature birth|1|||
125159278|NCT03696953|450210038|FG001|Overall Study|Premature birth|4|||
125159279|NCT03696953|450210037|FG000|Overall Study|Gestational hypertension|1|||
125159280|NCT03696953|450210038|FG001|Overall Study|Gestational hypertension|1|||
125159281|NCT03696953|450210037|FG000|Overall Study|Gestational diabetes|2|||
125159282|NCT03696953|450210038|FG001|Overall Study|Gestational diabetes|1|||
125159283|NCT03696953|450210037|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
125159284|NCT03696953|450210038|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
125159285|NCT03696953|450210037|FG000|Overall Study|Changed prenatal provider|1|||
125159286|NCT03696953|450210038|FG001|Overall Study|Changed prenatal provider|1|||
125159287|NCT05104476|450210039|FG000|Overall Study|Randomized But Not Treated|1|||
125159288|NCT05104476|450210040|FG001|Overall Study|Randomized But Not Treated|2|||
125159289|NCT05104476|450210039|FG000|Overall Study|Adverse Event|2|||
125159290|NCT05104476|450210040|FG001|Overall Study|Adverse Event|2|||
125159291|NCT05104476|450210039|FG000|Overall Study|Withdrawal by Subject|3|||
125159292|NCT05104476|450210040|FG001|Overall Study|Withdrawal by Subject|3|||
125159293|NCT05104476|450210039|FG000|Overall Study|Other Than Specified|0|||
125159294|NCT05104476|450210040|FG001|Overall Study|Other Than Specified|3|||
125159295|NCT04908683|450210041|FG000|Overall Study|Failure to meet continuation criteria|34|||
125159296|NCT04908683|450210042|FG001|Overall Study|Failure to meet continuation criteria|22|||
125159297|NCT04908683|450210041|FG000|Overall Study|Initiated prohibited medication|3|||
125159298|NCT04908683|450210042|FG001|Overall Study|Initiated prohibited medication|0|||
125159299|NCT04908683|450210041|FG000|Overall Study|Randomized by mistake|1|||
125159300|NCT04908683|450210042|FG001|Overall Study|Randomized by mistake|0|||
125159301|NCT04908683|450210041|FG000|Overall Study|Lost to Follow-up|679|||
125159302|NCT04908683|450210042|FG001|Overall Study|Lost to Follow-up|341|||
125159303|NCT04908683|450210041|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
125159304|NCT04908683|450210042|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
125159305|NCT04908683|450210041|FG000|Overall Study|Physician Decision|44|||
125159306|NCT04908683|450210042|FG001|Overall Study|Physician Decision|35|||
125159307|NCT04908683|450210041|FG000|Overall Study|Technical problems|12|||
125159308|NCT04908683|450210042|FG001|Overall Study|Technical problems|9|||
125159309|NCT04908683|450210041|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
125159310|NCT04908683|450210042|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
125159311|NCT04908683|450210041|FG000|Overall Study|Protocol Violation|2|||
125159312|NCT04908683|450210042|FG001|Overall Study|Protocol Violation|0|||
125159313|NCT04908683|450210041|FG000|Overall Study|Withdrawal by Subject|1188|||
125159314|NCT04908683|450210042|FG001|Overall Study|Withdrawal by Subject|570|||
125159315|NCT04908683|450210041|FG000|Overall Study|Site Closure by Sponsor|6|||
125159316|NCT04908683|450210042|FG001|Overall Study|Site Closure by Sponsor|3|||
125159317|NCT04908683|450210041|FG000|Overall Study|Adverse Event|21|||
125159318|NCT04908683|450210042|FG001|Overall Study|Adverse Event|11|||
125159319|NCT04908683|450210041|FG000|Overall Study|Death|101|||
125159320|NCT04908683|450210042|FG001|Overall Study|Death|61|||
125159321|NCT04908683|450210041|FG000|Overall Study|Sponsor's decision|14398|||
125159322|NCT04908683|450210042|FG001|Overall Study|Sponsor's decision|7205|||
125159323|NCT04908683|450210041|FG000|Overall Study|Other|92|||
125159324|NCT04908683|450210042|FG001|Overall Study|Other|50|||
125224020|NCT01325350|450448031|FG000|Overall Study|Pregnancy|0|||
125159325|NCT04908683|450210041|FG000|Overall Study|Randomized not vaccinated|108|||
125159326|NCT04908683|450210042|FG001|Overall Study|Randomized not vaccinated|52|||
125159327|NCT03047473|450210044|FG000|Overall Study|Lost to Follow-up|2|||
125159328|NCT06204887|450210045|FG000|Overall Study|Lost to Follow-up|3|||
125159329|NCT06204887|450210046|FG001|Overall Study|Lost to Follow-up|4|||
125159330|NCT06204887|450210047|FG002|Overall Study|Lost to Follow-up|1|||
125159331|NCT06204887|450210048|FG003|Overall Study|Lost to Follow-up|6|||
125159332|NCT02935686|450210049|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
125159333|NCT02935686|450210050|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
125159334|NCT02935686|450210051|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
125159335|NCT02935686|450210052|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
125159336|NCT02935686|450210053|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
125159337|NCT02935686|450210049|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
125159338|NCT02935686|450210050|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
125159339|NCT02935686|450210051|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
125159340|NCT02935686|450210052|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
125159341|NCT02935686|450210053|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
125159342|NCT02935686|450210049|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
125159343|NCT02935686|450210050|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
125159344|NCT02935686|450210051|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
125159345|NCT02935686|450210052|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
125159346|NCT02935686|450210053|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
125159347|NCT02935686|450210049|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
125159348|NCT02935686|450210050|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
125159349|NCT02935686|450210051|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
125159350|NCT02935686|450210052|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
125159351|NCT02935686|450210053|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
125159352|NCT02935686|450210049|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
125159353|NCT02935686|450210050|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
125159354|NCT02935686|450210051|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
125159355|NCT02935686|450210052|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
125159356|NCT02935686|450210053|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
125159357|NCT02935686|450210049|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
125159358|NCT02935686|450210050|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
125159359|NCT02935686|450210051|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
125159360|NCT02935686|450210052|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
125159361|NCT02935686|450210053|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
125159362|NCT02935686|450210049|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
125159363|NCT02935686|450210050|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
125159364|NCT02935686|450210051|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
125159365|NCT02935686|450210052|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
125159366|NCT02935686|450210053|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
125159367|NCT02935686|450210049|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
125159368|NCT02935686|450210050|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
125159369|NCT02935686|450210051|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
125224021|NCT01325350|450448032|FG001|Overall Study|Pregnancy|0|||
125224022|NCT01325350|450448033|FG002|Overall Study|Pregnancy|1|||
125224023|NCT01325350|450448034|FG003|Overall Study|Pregnancy|0|||
125224024|NCT01325350|450448035|FG004|Overall Study|Pregnancy|1|||
125224025|NCT01325350|450448031|FG000|Overall Study|Lost to Follow-up|1|||
125224026|NCT01325350|450448032|FG001|Overall Study|Lost to Follow-up|0|||
125224027|NCT01325350|450448033|FG002|Overall Study|Lost to Follow-up|5|||
125224028|NCT01325350|450448034|FG003|Overall Study|Lost to Follow-up|1|||
125224029|NCT01325350|450448035|FG004|Overall Study|Lost to Follow-up|5|||
125224030|NCT01325350|450448031|FG000|Overall Study|Personal Reasons|2|||
125224031|NCT01325350|450448032|FG001|Overall Study|Personal Reasons|1|||
125224032|NCT01325350|450448033|FG002|Overall Study|Personal Reasons|6|||
125224033|NCT01325350|450448034|FG003|Overall Study|Personal Reasons|5|||
125159370|NCT02935686|450210052|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
125159371|NCT02935686|450210053|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
125159372|NCT02935686|450210049|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
125159373|NCT02935686|450210050|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
125159374|NCT02935686|450210051|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
125159375|NCT02935686|450210052|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
125224034|NCT01325350|450448035|FG004|Overall Study|Personal Reasons|3|||
125224035|NCT01325350|450448031|FG000|Overall Study|Protocol Violation|0|||
125224036|NCT01325350|450448032|FG001|Overall Study|Protocol Violation|0|||
125224037|NCT01325350|450448033|FG002|Overall Study|Protocol Violation|0|||
125224038|NCT01325350|450448034|FG003|Overall Study|Protocol Violation|1|||
125224039|NCT01325350|450448035|FG004|Overall Study|Protocol Violation|0|||
125159376|NCT02935686|450210053|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
125159377|NCT02935686|450210049|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
125159378|NCT02935686|450210050|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
125159379|NCT02935686|450210051|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
125159380|NCT02935686|450210052|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
125159381|NCT02935686|450210053|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
125159382|NCT02935686|450210049|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
125159383|NCT02935686|450210050|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
125159384|NCT02935686|450210051|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
125159385|NCT02935686|450210052|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
125159386|NCT02935686|450210053|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
125159387|NCT00062010|450210055|FG000|Overall Study|Ineligible|3|||
125159388|NCT02856880|450210056|FG000|Overall Study|Withdrawal of consent|1|||
125159389|NCT00573157|450210057|FG000|Overall Study|Adverse Event|3|||
125159390|NCT00573157|450210058|FG001|Overall Study|Adverse Event|1|||
125159391|NCT00573157|450210057|FG000|Overall Study|Other|1|||
125159392|NCT00573157|450210058|FG001|Overall Study|Other|1|||
125159393|NCT02944383|450210059|FG000|Overall Study|Lost to Follow-up|0|||
125159394|NCT02944383|450210060|FG001|Overall Study|Lost to Follow-up|0|||
125159395|NCT02944383|450210061|FG002|Overall Study|Lost to Follow-up|1|||
125159396|NCT02944383|450210059|FG000|Overall Study|Withdrawal by Subject|1|||
125159397|NCT02944383|450210060|FG001|Overall Study|Withdrawal by Subject|0|||
125159398|NCT02944383|450210061|FG002|Overall Study|Withdrawal by Subject|0|||
125159399|NCT01183221|450210064|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
125159400|NCT01183221|450210065|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
125159401|NCT00807248|450210069|FG000|Overall Study|Adverse Event|1|||
125159402|NCT00807248|450210070|FG001|Overall Study|Adverse Event|2|||
125159403|NCT00807248|450210071|FG002|Overall Study|Adverse Event|2|||
125159404|NCT00807248|450210072|FG003|Overall Study|Adverse Event|6|||
125159405|NCT00807248|450210069|FG000|Overall Study|Lack of Efficacy|14|||
125224040|NCT01325350|450448031|FG000|Overall Study|Withdrawal by Subject|0|||
125224041|NCT01325350|450448032|FG001|Overall Study|Withdrawal by Subject|0|||
125224042|NCT01325350|450448033|FG002|Overall Study|Withdrawal by Subject|1|||
125224043|NCT01325350|450448034|FG003|Overall Study|Withdrawal by Subject|1|||
125224044|NCT01325350|450448035|FG004|Overall Study|Withdrawal by Subject|0|||
125224045|NCT01325350|450448031|FG000|Overall Study|Did Not Receive Treatment|0|||
125224046|NCT01325350|450448032|FG001|Overall Study|Did Not Receive Treatment|1|||
125159406|NCT00807248|450210070|FG001|Overall Study|Lack of Efficacy|4|||
125159407|NCT00807248|450210071|FG002|Overall Study|Lack of Efficacy|8|||
125159408|NCT00807248|450210072|FG003|Overall Study|Lack of Efficacy|3|||
125159409|NCT00807248|450210069|FG000|Overall Study|Protocol Violation|0|||
125159410|NCT00807248|450210070|FG001|Overall Study|Protocol Violation|1|||
125159411|NCT00807248|450210071|FG002|Overall Study|Protocol Violation|1|||
125159412|NCT00807248|450210072|FG003|Overall Study|Protocol Violation|0|||
125159413|NCT00807248|450210069|FG000|Overall Study|Withdrawal of Consent|5|||
125159414|NCT00807248|450210070|FG001|Overall Study|Withdrawal of Consent|5|||
125159415|NCT00807248|450210071|FG002|Overall Study|Withdrawal of Consent|5|||
125159416|NCT00807248|450210072|FG003|Overall Study|Withdrawal of Consent|5|||
125159417|NCT00807248|450210069|FG000|Overall Study|Lost to Follow-up|1|||
125159418|NCT00807248|450210070|FG001|Overall Study|Lost to Follow-up|0|||
125159419|NCT00807248|450210071|FG002|Overall Study|Lost to Follow-up|0|||
125159420|NCT00807248|450210072|FG003|Overall Study|Lost to Follow-up|0|||
125159421|NCT00807248|450210069|FG000|Overall Study|Other Reason|0|||
125159422|NCT00807248|450210070|FG001|Overall Study|Other Reason|0|||
125159423|NCT00807248|450210071|FG002|Overall Study|Other Reason|2|||
125159424|NCT00807248|450210072|FG003|Overall Study|Other Reason|0|||
125159425|NCT02504671|450210074|FG000|Overall Study|Withdrawal by Subject|1|||
125159426|NCT02504671|450210075|FG001|Overall Study|Withdrawal by Subject|5|||
125159427|NCT02504671|450210076|FG002|Overall Study|Withdrawal by Subject|4|||
125159428|NCT02504671|450210077|FG003|Overall Study|Withdrawal by Subject|4|||
125159429|NCT02504671|450210078|FG004|Overall Study|Withdrawal by Subject|5|||
125159430|NCT02504671|450210079|FG005|Overall Study|Withdrawal by Subject|3|||
125159431|NCT02504671|450210074|FG000|Overall Study|Lack of Efficacy|1|||
125159432|NCT02504671|450210075|FG001|Overall Study|Lack of Efficacy|3|||
125159433|NCT02504671|450210076|FG002|Overall Study|Lack of Efficacy|1|||
125159434|NCT02504671|450210077|FG003|Overall Study|Lack of Efficacy|0|||
125159435|NCT02504671|450210078|FG004|Overall Study|Lack of Efficacy|4|||
125159436|NCT02504671|450210079|FG005|Overall Study|Lack of Efficacy|4|||
125159437|NCT02504671|450210074|FG000|Overall Study|Adverse Event|1|||
125159438|NCT02504671|450210075|FG001|Overall Study|Adverse Event|1|||
125159439|NCT02504671|450210076|FG002|Overall Study|Adverse Event|0|||
125159440|NCT02504671|450210077|FG003|Overall Study|Adverse Event|1|||
125159441|NCT02504671|450210078|FG004|Overall Study|Adverse Event|0|||
125159442|NCT02504671|450210079|FG005|Overall Study|Adverse Event|2|||
125159443|NCT02504671|450210074|FG000|Overall Study|Protocol Violation|2|||
125159444|NCT02504671|450210075|FG001|Overall Study|Protocol Violation|1|||
125159445|NCT02504671|450210076|FG002|Overall Study|Protocol Violation|0|||
125159446|NCT02504671|450210077|FG003|Overall Study|Protocol Violation|0|||
125159447|NCT02504671|450210078|FG004|Overall Study|Protocol Violation|0|||
125159448|NCT02504671|450210079|FG005|Overall Study|Protocol Violation|1|||
125159449|NCT02504671|450210074|FG000|Overall Study|Lost to Follow-up|0|||
125159450|NCT02504671|450210075|FG001|Overall Study|Lost to Follow-up|0|||
125159451|NCT02504671|450210076|FG002|Overall Study|Lost to Follow-up|2|||
125159452|NCT02504671|450210077|FG003|Overall Study|Lost to Follow-up|0|||
125159453|NCT02504671|450210078|FG004|Overall Study|Lost to Follow-up|0|||
125159454|NCT02504671|450210079|FG005|Overall Study|Lost to Follow-up|1|||
125159455|NCT02504671|450210074|FG000|Overall Study|Protocol defined stopping criteria|7|||
125159456|NCT02504671|450210075|FG001|Overall Study|Protocol defined stopping criteria|4|||
125159457|NCT02504671|450210076|FG002|Overall Study|Protocol defined stopping criteria|3|||
125159458|NCT02504671|450210077|FG003|Overall Study|Protocol defined stopping criteria|5|||
125159459|NCT02504671|450210078|FG004|Overall Study|Protocol defined stopping criteria|3|||
125159460|NCT02504671|450210079|FG005|Overall Study|Protocol defined stopping criteria|3|||
125159461|NCT00210249|450210080|FG000|Overall Study|Lost to Follow-up|5|||
125159462|NCT00210249|450210080|FG000|Overall Study|Protocol Violation|11|||
125159463|NCT00599521|450210081|FG000|Overall Study|Lack of Efficacy|4|||
125159464|NCT00599521|450210082|FG001|Overall Study|Lack of Efficacy|8|||
125159465|NCT00599521|450210081|FG000|Overall Study|Adverse Event|4|||
125159466|NCT00599521|450210082|FG001|Overall Study|Adverse Event|1|||
125159467|NCT00599521|450210081|FG000|Overall Study|Withdrawal by Subject|28|||
125159468|NCT00599521|450210082|FG001|Overall Study|Withdrawal by Subject|34|||
125159469|NCT00599521|450210081|FG000|Overall Study|Protocol Violation|1|||
125159470|NCT00599521|450210082|FG001|Overall Study|Protocol Violation|1|||
125159471|NCT00599521|450210081|FG000|Overall Study|Lost to Follow-up|23|||
125159472|NCT00599521|450210082|FG001|Overall Study|Lost to Follow-up|23|||
125159473|NCT00599521|450210081|FG000|Overall Study|Pregnancy|0|||
125159474|NCT00599521|450210082|FG001|Overall Study|Pregnancy|2|||
125224047|NCT01325350|450448033|FG002|Overall Study|Did Not Receive Treatment|1|||
125159475|NCT01293539|450210083|FG000|Overall Study|Physician Decision|1|||
125159476|NCT01687478|450210086|FG000|Overall Study|Adverse Event|3|||
125159477|NCT01687478|450210087|FG001|Overall Study|Adverse Event|10|||
125159478|NCT01687478|450210086|FG000|Overall Study|Lost to Follow-up|1|||
125159479|NCT01687478|450210087|FG001|Overall Study|Lost to Follow-up|3|||
125159480|NCT01687478|450210086|FG000|Overall Study|Protocol Violation|0|||
125159481|NCT01687478|450210087|FG001|Overall Study|Protocol Violation|2|||
125159482|NCT01687478|450210086|FG000|Overall Study|Withdrawal by Subject|21|||
125159483|NCT01687478|450210087|FG001|Overall Study|Withdrawal by Subject|19|||
125159484|NCT01687478|450210086|FG000|Overall Study|Physician Decision|1|||
125159485|NCT01687478|450210087|FG001|Overall Study|Physician Decision|3|||
125159486|NCT01687478|450210086|FG000|Overall Study|Entry Criteria Not Met|6|||
125159487|NCT01687478|450210087|FG001|Overall Study|Entry Criteria Not Met|2|||
125159488|NCT04322149|450210088|FG000|Overall Study|Adverse Event|1|||
125159489|NCT04322149|450210089|FG001|Overall Study|Adverse Event|1|||
125159490|NCT04322149|450210090|FG002|Overall Study|Adverse Event|0|||
125159491|NCT04322149|450210091|FG003|Overall Study|Adverse Event|0|||
125159492|NCT04322149|450210088|FG000|Overall Study|Withdrawal by Subject|0|||
125159493|NCT04322149|450210089|FG001|Overall Study|Withdrawal by Subject|0|||
125159494|NCT04322149|450210090|FG002|Overall Study|Withdrawal by Subject|0|||
125159495|NCT04322149|450210091|FG003|Overall Study|Withdrawal by Subject|2|||
125159496|NCT04322149|450210088|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
125159497|NCT04322149|450210089|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
125224048|NCT01325350|450448034|FG003|Overall Study|Did Not Receive Treatment|0|||
125159498|NCT04322149|450210090|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
125159499|NCT04322149|450210091|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
125159500|NCT01700049|450210092|FG000|Overall Study|Withdrawal by Subject|1|||
125159501|NCT01206101|450210093|FG000|Overall Study|Adverse Event|1|||
125159502|NCT01206101|450210094|FG001|Overall Study|Adverse Event|0|||
125159503|NCT01206101|450210093|FG000|Overall Study|Physician Decision|0|||
125159504|NCT01206101|450210094|FG001|Overall Study|Physician Decision|1|||
125159505|NCT01206101|450210093|FG000|Overall Study|Unclassified|1|||
125159506|NCT01206101|450210094|FG001|Overall Study|Unclassified|0|||
125159507|NCT01248013|450210095|FG000|Overall Study|Withdrawal by Subject|14|||
125159508|NCT00307034|450210099|FG000|Overall Study|Adverse Event|1|||
125159509|NCT00307034|450210100|FG001|Overall Study|Adverse Event|2|||
125159510|NCT00307034|450210099|FG000|Overall Study|Withdrawal by Subject|1|||
125159511|NCT00307034|450210100|FG001|Overall Study|Withdrawal by Subject|2|||
125159512|NCT00307034|450210099|FG000|Overall Study|Lost to Follow-up|0|||
125159513|NCT00307034|450210100|FG001|Overall Study|Lost to Follow-up|3|||
125159514|NCT00667810|450210101|FG000|Overall Study|Adverse Event|13|||
125159515|NCT00667810|450210102|FG001|Overall Study|Adverse Event|14|||
125159516|NCT00667810|450210103|FG002|Overall Study|Adverse Event|19|||
125159517|NCT00667810|450210104|FG003|Overall Study|Adverse Event|1|||
125159518|NCT00667810|450210101|FG000|Overall Study|Death|1|||
125159519|NCT00667810|450210102|FG001|Overall Study|Death|1|||
125159520|NCT00667810|450210103|FG002|Overall Study|Death|3|||
125159521|NCT00667810|450210104|FG003|Overall Study|Death|0|||
125159522|NCT00667810|450210101|FG000|Overall Study|Lack of Efficacy|1|||
125159523|NCT00667810|450210102|FG001|Overall Study|Lack of Efficacy|0|||
125159524|NCT00667810|450210103|FG002|Overall Study|Lack of Efficacy|2|||
125159525|NCT00667810|450210104|FG003|Overall Study|Lack of Efficacy|0|||
125159526|NCT00667810|450210101|FG000|Overall Study|Lost to Follow-up|1|||
125159527|NCT00667810|450210102|FG001|Overall Study|Lost to Follow-up|4|||
125159528|NCT00667810|450210103|FG002|Overall Study|Lost to Follow-up|2|||
125159529|NCT00667810|450210104|FG003|Overall Study|Lost to Follow-up|0|||
125159530|NCT00667810|450210101|FG000|Overall Study|Physician Decision|1|||
125159531|NCT00667810|450210102|FG001|Overall Study|Physician Decision|1|||
125159532|NCT00667810|450210103|FG002|Overall Study|Physician Decision|2|||
125159533|NCT00667810|450210104|FG003|Overall Study|Physician Decision|0|||
125159534|NCT00667810|450210101|FG000|Overall Study|Protocol Violation|0|||
125159535|NCT00667810|450210102|FG001|Overall Study|Protocol Violation|2|||
125159536|NCT00667810|450210103|FG002|Overall Study|Protocol Violation|0|||
125159537|NCT00667810|450210104|FG003|Overall Study|Protocol Violation|0|||
125159538|NCT00667810|450210101|FG000|Overall Study|Withdrawal by Subject|14|||
125159539|NCT00667810|450210102|FG001|Overall Study|Withdrawal by Subject|20|||
125159540|NCT00667810|450210103|FG002|Overall Study|Withdrawal by Subject|29|||
125159541|NCT00667810|450210104|FG003|Overall Study|Withdrawal by Subject|1|||
125159542|NCT00667810|450210101|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
125159543|NCT00667810|450210102|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
125159544|NCT00667810|450210103|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
125159545|NCT00667810|450210104|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
125159546|NCT00667810|450210101|FG000|Overall Study|Failed to Return|0|||
125159547|NCT00667810|450210102|FG001|Overall Study|Failed to Return|0|||
125159548|NCT00667810|450210103|FG002|Overall Study|Failed to Return|2|||
125159549|NCT00667810|450210104|FG003|Overall Study|Failed to Return|0|||
125159550|NCT00667810|450210101|FG000|Overall Study|Loss of Caregiver|0|||
125159551|NCT00667810|450210102|FG001|Overall Study|Loss of Caregiver|1|||
125159552|NCT00667810|450210103|FG002|Overall Study|Loss of Caregiver|3|||
125159553|NCT00667810|450210104|FG003|Overall Study|Loss of Caregiver|0|||
125159554|NCT00667810|450210101|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
125159555|NCT00667810|450210102|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
125159556|NCT00667810|450210103|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
125159557|NCT00667810|450210104|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
125159558|NCT00667810|450210101|FG000|Overall Study|Other|6|||
125159559|NCT00667810|450210102|FG001|Overall Study|Other|6|||
125159560|NCT00667810|450210103|FG002|Overall Study|Other|5|||
125159561|NCT00667810|450210104|FG003|Overall Study|Other|0|||
125159562|NCT03514641|450210105|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
125159563|NCT03514641|450210106|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
125159564|NCT03514641|450210107|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
125159565|NCT03514641|450210108|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
125159566|NCT03514641|450210105|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
125159567|NCT03514641|450210106|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
125159568|NCT03514641|450210107|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
125159569|NCT03514641|450210108|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
125159570|NCT03514641|450210105|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
125159571|NCT03514641|450210106|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
125159572|NCT03514641|450210107|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
125159573|NCT03514641|450210108|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
125159574|NCT03514641|450210105|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
125159575|NCT03514641|450210106|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
125159576|NCT03514641|450210107|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
125159577|NCT03514641|450210108|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
125159578|NCT03514641|450210105|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
125159579|NCT03514641|450210106|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
125159580|NCT03514641|450210107|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
125159581|NCT03514641|450210108|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
125159582|NCT03514641|450210105|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
125159583|NCT03514641|450210106|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
125159584|NCT03514641|450210107|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
125159585|NCT03514641|450210108|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
125159586|NCT03514641|450210105|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
125159587|NCT03514641|450210106|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
125159588|NCT03514641|450210107|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
125159589|NCT03514641|450210108|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
125159590|NCT03514641|450210105|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
125159591|NCT03514641|450210106|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
125159592|NCT03514641|450210107|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
125159593|NCT03514641|450210108|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
125159594|NCT03514641|450210105|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
125159595|NCT03514641|450210106|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
125159596|NCT03514641|450210107|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
125159597|NCT03514641|450210108|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
125159598|NCT03514641|450210105|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
125159599|NCT03514641|450210106|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
125159600|NCT03514641|450210107|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
125159601|NCT03514641|450210108|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
125159602|NCT03514641|450210105|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
125159603|NCT03514641|450210106|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
125159604|NCT03514641|450210107|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
125159605|NCT03514641|450210108|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
125159606|NCT03514641|450210105|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
125159607|NCT03514641|450210106|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
125159608|NCT03514641|450210107|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
125159609|NCT03514641|450210108|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
125159610|NCT04234984|450210109|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
125159611|NCT04234984|450210109|FG000|Follow-up at the Second Time Point|Death|1|||
125159612|NCT04234984|450210109|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
125159613|NCT02038907|450210110|FG000|Overall Study|Protocol Violation|0|||
125159614|NCT02038907|450210111|FG001|Overall Study|Protocol Violation|0|||
125159615|NCT02038907|450210112|FG002|Overall Study|Protocol Violation|0|||
125159616|NCT02038907|450210113|FG003|Overall Study|Protocol Violation|0|||
125159617|NCT02038907|450210114|FG004|Overall Study|Protocol Violation|0|||
125159618|NCT02038907|450210115|FG005|Overall Study|Protocol Violation|0|||
125159619|NCT02038907|450210116|FG006|Overall Study|Protocol Violation|0|||
125159620|NCT02038907|450210117|FG007|Overall Study|Protocol Violation|0|||
125159621|NCT02038907|450210118|FG008|Overall Study|Protocol Violation|0|||
125159622|NCT02038907|450210119|FG009|Overall Study|Protocol Violation|0|||
125159623|NCT02038907|450210120|FG010|Overall Study|Protocol Violation|1|||
125159624|NCT02038907|450210121|FG011|Overall Study|Protocol Violation|0|||
125159625|NCT02038907|450210122|FG012|Overall Study|Protocol Violation|0|||
125159626|NCT02038907|450210123|FG013|Overall Study|Protocol Violation|0|||
125159627|NCT02038907|450210110|FG000|Overall Study|Withdrawal by Subject|0|||
125159628|NCT02038907|450210111|FG001|Overall Study|Withdrawal by Subject|0|||
125159629|NCT02038907|450210112|FG002|Overall Study|Withdrawal by Subject|0|||
125159630|NCT02038907|450210113|FG003|Overall Study|Withdrawal by Subject|0|||
125159631|NCT02038907|450210114|FG004|Overall Study|Withdrawal by Subject|0|||
125159632|NCT02038907|450210115|FG005|Overall Study|Withdrawal by Subject|0|||
125159633|NCT02038907|450210116|FG006|Overall Study|Withdrawal by Subject|0|||
125159634|NCT02038907|450210117|FG007|Overall Study|Withdrawal by Subject|0|||
125159635|NCT02038907|450210118|FG008|Overall Study|Withdrawal by Subject|0|||
125159636|NCT02038907|450210119|FG009|Overall Study|Withdrawal by Subject|0|||
125159637|NCT02038907|450210120|FG010|Overall Study|Withdrawal by Subject|1|||
125159638|NCT02038907|450210121|FG011|Overall Study|Withdrawal by Subject|0|||
125159639|NCT02038907|450210122|FG012|Overall Study|Withdrawal by Subject|0|||
125159640|NCT02038907|450210123|FG013|Overall Study|Withdrawal by Subject|0|||
125159641|NCT01732484|450210130|FG000|Overall Study|Death|7|||
125159642|NCT01732484|450210130|FG000|Overall Study|Lost to Follow-up|14|||
125159643|NCT01732484|450210130|FG000|Overall Study|chronical illness|5|||
125159644|NCT02272634|450210131|FG000|Overall Study|Adverse Event|1|||
125159645|NCT02272634|450210132|FG001|Overall Study|Adverse Event|0|||
125159646|NCT02272634|450210133|FG002|Overall Study|Adverse Event|0|||
125159647|NCT02272634|450210131|FG000|Overall Study|Protocol Violation|0|||
125159648|NCT02272634|450210132|FG001|Overall Study|Protocol Violation|0|||
125159649|NCT02272634|450210133|FG002|Overall Study|Protocol Violation|1|||
125159650|NCT02272634|450210131|FG000|Overall Study|Withdrawal by Subject|0|||
125159651|NCT02272634|450210132|FG001|Overall Study|Withdrawal by Subject|1|||
125159652|NCT02272634|450210133|FG002|Overall Study|Withdrawal by Subject|0|||
125159653|NCT05070546|450210134|FG000|Overall Study|Death|0|||
125159654|NCT05070546|450210135|FG001|Overall Study|Death|0|||
125159655|NCT05070546|450210136|FG002|Overall Study|Death|0|||
125159656|NCT05070546|450210137|FG003|Overall Study|Death|0|||
125159657|NCT05070546|450210138|FG004|Overall Study|Death|0|||
125159658|NCT05070546|450210139|FG005|Overall Study|Death|1|||
125159659|NCT05070546|450210134|FG000|Overall Study|Lost to Follow-up|8|||
125159660|NCT05070546|450210135|FG001|Overall Study|Lost to Follow-up|2|||
125159661|NCT05070546|450210136|FG002|Overall Study|Lost to Follow-up|7|||
125159662|NCT05070546|450210137|FG003|Overall Study|Lost to Follow-up|1|||
125159663|NCT05070546|450210138|FG004|Overall Study|Lost to Follow-up|2|||
125159664|NCT05070546|450210139|FG005|Overall Study|Lost to Follow-up|0|||
125159665|NCT05070546|450210134|FG000|Overall Study|Withdrawal by Subject|1|||
125159666|NCT05070546|450210135|FG001|Overall Study|Withdrawal by Subject|1|||
125159667|NCT05070546|450210136|FG002|Overall Study|Withdrawal by Subject|3|||
125159668|NCT05070546|450210137|FG003|Overall Study|Withdrawal by Subject|0|||
125224049|NCT01325350|450448035|FG004|Overall Study|Did Not Receive Treatment|1|||
125224050|NCT01716806|450448036|FG000|Overall Study|Patient withdrawal of consent|4|||
125224051|NCT01716806|450448037|FG001|Overall Study|Patient withdrawal of consent|2|||
125224052|NCT01716806|450448038|FG002|Overall Study|Patient withdrawal of consent|4|||
125224053|NCT01716806|450448039|FG003|Overall Study|Patient withdrawal of consent|3|||
125224054|NCT01716806|450448040|FG004|Overall Study|Patient withdrawal of consent|2|||
125224055|NCT01716806|450448041|FG005|Overall Study|Patient withdrawal of consent|0|||
125224056|NCT01716806|450448036|FG000|Overall Study|Lost to Follow-up|3|||
125224057|NCT01716806|450448037|FG001|Overall Study|Lost to Follow-up|3|||
125224058|NCT01716806|450448038|FG002|Overall Study|Lost to Follow-up|0|||
125224059|NCT01716806|450448039|FG003|Overall Study|Lost to Follow-up|2|||
125224060|NCT01716806|450448040|FG004|Overall Study|Lost to Follow-up|1|||
125224061|NCT01716806|450448041|FG005|Overall Study|Lost to Follow-up|0|||
125224062|NCT01716806|450448036|FG000|Overall Study|Death|13|||
125224063|NCT01716806|450448037|FG001|Overall Study|Death|9|||
125224064|NCT01716806|450448038|FG002|Overall Study|Death|12|||
125224065|NCT01716806|450448039|FG003|Overall Study|Death|4|||
125224066|NCT01716806|450448040|FG004|Overall Study|Death|10|||
125224067|NCT01716806|450448041|FG005|Overall Study|Death|5|||
125224068|NCT01716806|450448036|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
125224069|NCT01716806|450448037|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
125224070|NCT01716806|450448038|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
125224071|NCT01716806|450448039|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
125224072|NCT01716806|450448040|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
125224073|NCT01716806|450448041|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
125224074|NCT01716806|450448036|FG000|Overall Study|PI decision|0|||
125224075|NCT01716806|450448037|FG001|Overall Study|PI decision|0|||
125224076|NCT01716806|450448038|FG002|Overall Study|PI decision|0|||
125224077|NCT01716806|450448039|FG003|Overall Study|PI decision|0|||
125224078|NCT01716806|450448040|FG004|Overall Study|PI decision|1|||
125224079|NCT01716806|450448041|FG005|Overall Study|PI decision|0|||
125224080|NCT01716806|450448036|FG000|Overall Study|Change in performance status|1|||
125224081|NCT01716806|450448037|FG001|Overall Study|Change in performance status|0|||
125224082|NCT01716806|450448038|FG002|Overall Study|Change in performance status|0|||
125224083|NCT01716806|450448039|FG003|Overall Study|Change in performance status|0|||
125224084|NCT01716806|450448040|FG004|Overall Study|Change in performance status|0|||
125224085|NCT01716806|450448041|FG005|Overall Study|Change in performance status|0|||
125224086|NCT01716806|450448036|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
125159669|NCT05070546|450210138|FG004|Overall Study|Withdrawal by Subject|0|||
125159670|NCT05070546|450210139|FG005|Overall Study|Withdrawal by Subject|0|||
125159671|NCT05070546|450210134|FG000|Overall Study|Other|0|||
125159672|NCT05070546|450210135|FG001|Overall Study|Other|0|||
125159673|NCT05070546|450210136|FG002|Overall Study|Other|0|||
125159674|NCT05070546|450210137|FG003|Overall Study|Other|0|||
125159675|NCT05070546|450210138|FG004|Overall Study|Other|3|||
125159676|NCT05070546|450210139|FG005|Overall Study|Other|0|||
125159677|NCT05070546|450210134|FG000|Overall Study|Randomized but not vaccinated|1|||
125159678|NCT05070546|450210135|FG001|Overall Study|Randomized but not vaccinated|0|||
125159679|NCT05070546|450210136|FG002|Overall Study|Randomized but not vaccinated|1|||
125159680|NCT05070546|450210137|FG003|Overall Study|Randomized but not vaccinated|1|||
125159681|NCT05070546|450210138|FG004|Overall Study|Randomized but not vaccinated|3|||
125159682|NCT05070546|450210139|FG005|Overall Study|Randomized but not vaccinated|0|||
125159683|NCT01359644|450210140|FG000|Treatment Period|Lack of Efficacy|0|||
125159684|NCT01359644|450210141|FG001|Treatment Period|Lack of Efficacy|1|||
125159685|NCT01359644|450210142|FG002|Treatment Period|Lack of Efficacy|0|||
125159686|NCT01359644|450210143|FG003|Treatment Period|Lack of Efficacy|0|||
125224087|NCT01716806|450448037|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
125224088|NCT01716806|450448038|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
125159687|NCT01359644|450210144|FG004|Treatment Period|Lack of Efficacy|0|||
125159688|NCT01359644|450210145|FG005|Treatment Period|Lack of Efficacy|0|||
125159689|NCT01359644|450210146|FG006|Treatment Period|Lack of Efficacy|0|||
125159690|NCT01359644|450210147|FG007|Treatment Period|Lack of Efficacy|0|||
125159691|NCT01359644|450210148|FG008|Treatment Period|Lack of Efficacy|0|||
125159692|NCT01359644|450210149|FG009|Treatment Period|Lack of Efficacy|0|||
125159693|NCT01359644|450210140|FG000|Treatment Period|Adverse Event|0|||
125159694|NCT01359644|450210141|FG001|Treatment Period|Adverse Event|0|||
125159695|NCT01359644|450210142|FG002|Treatment Period|Adverse Event|1|||
125159696|NCT01359644|450210143|FG003|Treatment Period|Adverse Event|0|||
125159697|NCT01359644|450210144|FG004|Treatment Period|Adverse Event|0|||
125159698|NCT01359644|450210145|FG005|Treatment Period|Adverse Event|1|||
125159699|NCT01359644|450210146|FG006|Treatment Period|Adverse Event|0|||
125159700|NCT01359644|450210147|FG007|Treatment Period|Adverse Event|0|||
125159701|NCT01359644|450210148|FG008|Treatment Period|Adverse Event|0|||
125159702|NCT01359644|450210149|FG009|Treatment Period|Adverse Event|0|||
125159703|NCT01359644|450210140|FG000|Treatment Period|Lost to Follow-up|0|||
125224089|NCT01716806|450448039|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
125224090|NCT01716806|450448040|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
125224091|NCT01716806|450448041|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
125224092|NCT01716806|450448036|FG000|Overall Study|Sponsor direction|7|||
125224093|NCT01716806|450448037|FG001|Overall Study|Sponsor direction|8|||
125224094|NCT01716806|450448038|FG002|Overall Study|Sponsor direction|5|||
125224095|NCT01716806|450448039|FG003|Overall Study|Sponsor direction|12|||
125224096|NCT01716806|450448040|FG004|Overall Study|Sponsor direction|16|||
125224097|NCT01716806|450448041|FG005|Overall Study|Sponsor direction|1|||
125224098|NCT00956839|450448042|FG000|Overall Study|Lost to Follow-up|3|||
125224099|NCT00956839|450448043|FG001|Overall Study|Lost to Follow-up|0|||
125224100|NCT00956839|450448044|FG002|Overall Study|Lost to Follow-up|3|||
125224101|NCT03527277|450448045|FG000|Overall Study|Withdrawal by Subject|5|||
125224102|NCT03527277|450448046|FG001|Overall Study|Withdrawal by Subject|0|||
125224103|NCT03527277|450448045|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
125224104|NCT03527277|450448046|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
125224105|NCT03527277|450448045|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
125224106|NCT03527277|450448046|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
125224107|NCT04155463|450448047|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
125224108|NCT04155463|450448048|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
125224109|NCT01914393|450448053|FG000|Overall Study|Protocol Violation|11|||
125224110|NCT01914393|450448054|FG001|Overall Study|Protocol Violation|3|||
125224111|NCT01914393|450448055|FG002|Overall Study|Protocol Violation|19|||
125224112|NCT01914393|450448053|FG000|Overall Study|Lack of Efficacy|11|||
125224113|NCT01914393|450448054|FG001|Overall Study|Lack of Efficacy|16|||
125224114|NCT01914393|450448055|FG002|Overall Study|Lack of Efficacy|5|||
125224115|NCT01914393|450448053|FG000|Overall Study|no reason given|14|||
125224116|NCT01914393|450448054|FG001|Overall Study|no reason given|8|||
125224117|NCT01914393|450448055|FG002|Overall Study|no reason given|16|||
125224118|NCT01914393|450448053|FG000|Overall Study|Adverse Event|29|||
125224119|NCT01914393|450448054|FG001|Overall Study|Adverse Event|18|||
125224120|NCT01914393|450448055|FG002|Overall Study|Adverse Event|31|||
125224121|NCT01914393|450448053|FG000|Overall Study|Withdrawal by Subject|38|||
125224122|NCT01914393|450448054|FG001|Overall Study|Withdrawal by Subject|20|||
125224123|NCT01914393|450448055|FG002|Overall Study|Withdrawal by Subject|47|||
125224124|NCT01914393|450448053|FG000|Overall Study|Lost to Follow-up|12|||
125224125|NCT01914393|450448054|FG001|Overall Study|Lost to Follow-up|6|||
125224126|NCT01914393|450448055|FG002|Overall Study|Lost to Follow-up|19|||
125224127|NCT01914393|450448053|FG000|Overall Study|subject never dosed|0|||
125224128|NCT01914393|450448054|FG001|Overall Study|subject never dosed|0|||
125224129|NCT01914393|450448055|FG002|Overall Study|subject never dosed|1|||
125224130|NCT01063855|450448056|FG000|Overall Study|Adverse Event|4|||
125224131|NCT01063855|450448057|FG001|Overall Study|Adverse Event|4|||
125224132|NCT01063855|450448056|FG000|Overall Study|Death|0|||
125224133|NCT01063855|450448057|FG001|Overall Study|Death|1|||
125224134|NCT01063855|450448056|FG000|Overall Study|Lost to Follow-up|8|||
125224135|NCT01063855|450448057|FG001|Overall Study|Lost to Follow-up|4|||
125224136|NCT01063855|450448056|FG000|Overall Study|Pregnancy|1|||
125159704|NCT01359644|450210141|FG001|Treatment Period|Lost to Follow-up|0|||
125159705|NCT01359644|450210142|FG002|Treatment Period|Lost to Follow-up|0|||
125159706|NCT01359644|450210143|FG003|Treatment Period|Lost to Follow-up|0|||
125159707|NCT01359644|450210144|FG004|Treatment Period|Lost to Follow-up|0|||
125159708|NCT01359644|450210145|FG005|Treatment Period|Lost to Follow-up|1|||
125159709|NCT01359644|450210146|FG006|Treatment Period|Lost to Follow-up|0|||
125159710|NCT01359644|450210147|FG007|Treatment Period|Lost to Follow-up|0|||
125159711|NCT01359644|450210148|FG008|Treatment Period|Lost to Follow-up|0|||
125159712|NCT01359644|450210149|FG009|Treatment Period|Lost to Follow-up|0|||
125159713|NCT01359644|450210140|FG000|Follow-up Period|Withdrawal by Subject|0|||
125159714|NCT01359644|450210141|FG001|Follow-up Period|Withdrawal by Subject|0|||
125159715|NCT01359644|450210142|FG002|Follow-up Period|Withdrawal by Subject|0|||
125159716|NCT01359644|450210143|FG003|Follow-up Period|Withdrawal by Subject|0|||
125159717|NCT01359644|450210144|FG004|Follow-up Period|Withdrawal by Subject|0|||
125159718|NCT01359644|450210145|FG005|Follow-up Period|Withdrawal by Subject|1|||
125159719|NCT01359644|450210146|FG006|Follow-up Period|Withdrawal by Subject|0|||
125159720|NCT01359644|450210147|FG007|Follow-up Period|Withdrawal by Subject|0|||
125159721|NCT01359644|450210148|FG008|Follow-up Period|Withdrawal by Subject|0|||
125159722|NCT01359644|450210149|FG009|Follow-up Period|Withdrawal by Subject|0|||
125159723|NCT01359644|450210140|FG000|Follow-up Period|Lost to Follow-up|0|||
125159724|NCT01359644|450210141|FG001|Follow-up Period|Lost to Follow-up|0|||
125224137|NCT01063855|450448057|FG001|Overall Study|Pregnancy|0|||
125224138|NCT01063855|450448056|FG000|Overall Study|Lack of Efficacy|0|||
125159725|NCT01359644|450210142|FG002|Follow-up Period|Lost to Follow-up|0|||
125224139|NCT01063855|450448057|FG001|Overall Study|Lack of Efficacy|1|||
125224140|NCT01063855|450448056|FG000|Overall Study|Withdrawal by Subject|11|||
125224141|NCT01063855|450448057|FG001|Overall Study|Withdrawal by Subject|8|||
125159726|NCT01359644|450210143|FG003|Follow-up Period|Lost to Follow-up|0|||
125159727|NCT01359644|450210144|FG004|Follow-up Period|Lost to Follow-up|0|||
125159728|NCT01359644|450210145|FG005|Follow-up Period|Lost to Follow-up|0|||
125159729|NCT01359644|450210146|FG006|Follow-up Period|Lost to Follow-up|1|||
125159730|NCT01359644|450210147|FG007|Follow-up Period|Lost to Follow-up|2|||
125159731|NCT01359644|450210148|FG008|Follow-up Period|Lost to Follow-up|0|||
125159732|NCT01359644|450210149|FG009|Follow-up Period|Lost to Follow-up|0|||
125159733|NCT02130882|450210150|FG000|Overall Study|Withdrawal by Subject|0|||
125159734|NCT02130882|450210151|FG001|Overall Study|Withdrawal by Subject|1|||
125159735|NCT00669071|450210154|FG000|Overall Study|Lost to Follow-up|3|||
125159736|NCT00669071|450210154|FG000|Overall Study|Final visit 40 days out of window|1|||
125159737|NCT01194973|450210155|FG000|Screening Period|Screen Failure|3|||
125159738|NCT01194973|450210155|FG000|26 Week Treatment Period|Adverse Event|1|||
125159739|NCT01194973|450210155|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
125159740|NCT01194973|450210155|FG000|26 Week Treatment Period|Pregnancy|1|||
125159741|NCT00359632|450210158|FG000|Overall Study|Death|2|||
125159742|NCT00359632|450210159|FG001|Overall Study|Death|0|||
125159743|NCT00359632|450210158|FG000|Overall Study|Adverse Event|1|||
125159744|NCT00359632|450210159|FG001|Overall Study|Adverse Event|0|||
125159745|NCT00359632|450210158|FG000|Overall Study|Non-compliance with visit schedule|1|||
125159746|NCT00359632|450210159|FG001|Overall Study|Non-compliance with visit schedule|0|||
125159747|NCT02615171|450210160|FG000|Overall Study|Lost to Follow-up|2|||
125159748|NCT02615171|450210161|FG001|Overall Study|Lost to Follow-up|1|||
125224142|NCT01063855|450448056|FG000|Overall Study|Reason not specified|13|||
125224143|NCT01063855|450448057|FG001|Overall Study|Reason not specified|11|||
125224144|NCT02163395|450448060|FG000|Overall Study|Withdrawal by Subject|1|||
125224145|NCT02163395|450448060|FG000|Overall Study|Lost to Follow-up|3|||
125224146|NCT02163395|450448060|FG000|Overall Study|Adverse Event|1|||
125224147|NCT05137717|450448081|FG000|Overall Study|Death|2|||
125224148|NCT05137717|450448081|FG000|Overall Study|Withdrawal by Subject|6|||
125224149|NCT02035553|450448082|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
125224150|NCT02035553|450448083|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
125224151|NCT02035553|450448082|FG000|Overall Study|Adverse Event|10|||
125224152|NCT02035553|450448083|FG001|Overall Study|Adverse Event|6|||
125224153|NCT02035553|450448082|FG000|Overall Study|Physician Decision|3|||
125224154|NCT02035553|450448083|FG001|Overall Study|Physician Decision|2|||
125224155|NCT02035553|450448082|FG000|Overall Study|Lack of Efficacy|1|||
125224156|NCT02035553|450448083|FG001|Overall Study|Lack of Efficacy|1|||
125224157|NCT02035553|450448082|FG000|Overall Study|Withdrawal by Subject|4|||
125224158|NCT02035553|450448083|FG001|Overall Study|Withdrawal by Subject|7|||
125224159|NCT02035553|450448082|FG000|Overall Study|Non-compliance with Study Drug|0|||
125224160|NCT02035553|450448083|FG001|Overall Study|Non-compliance with Study Drug|1|||
125224161|NCT02035553|450448082|FG000|Overall Study|Lost to Follow-up|0|||
125224162|NCT02035553|450448083|FG001|Overall Study|Lost to Follow-up|1|||
125224163|NCT02035553|450448082|FG000|Overall Study|Other Reason|0|||
125224164|NCT02035553|450448083|FG001|Overall Study|Other Reason|4|||
125224165|NCT02619617|450448084|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
125224166|NCT02619617|450448085|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
125224167|NCT02619617|450448084|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
125224168|NCT02619617|450448085|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
125224169|NCT01854697|450448086|FG000|Overall Study|Adverse Event|1|||
125224170|NCT01854697|450448087|FG001|Overall Study|Adverse Event|0|||
125224171|NCT01854697|450448088|FG002|Overall Study|Adverse Event|0|||
125224172|NCT01854697|450448089|FG003|Overall Study|Adverse Event|0|||
125224173|NCT01854697|450448090|FG004|Overall Study|Adverse Event|1|||
125159749|NCT01000493|450210169|FG000|Overall Study|Adverse Event|3|||
125159750|NCT01000493|450210170|FG001|Overall Study|Adverse Event|6|||
125159751|NCT01000493|450210169|FG000|Overall Study|Lack of Efficacy|1|||
125224174|NCT01854697|450448086|FG000|Overall Study|Lost to Follow-up|4|||
125224175|NCT01854697|450448087|FG001|Overall Study|Lost to Follow-up|1|||
125224176|NCT01854697|450448088|FG002|Overall Study|Lost to Follow-up|1|||
125224177|NCT01854697|450448089|FG003|Overall Study|Lost to Follow-up|2|||
125224178|NCT01854697|450448090|FG004|Overall Study|Lost to Follow-up|0|||
125159752|NCT01000493|450210170|FG001|Overall Study|Lack of Efficacy|1|||
125159753|NCT01000493|450210169|FG000|Overall Study|Protocol Violation|1|||
125159754|NCT01000493|450210170|FG001|Overall Study|Protocol Violation|8|||
125159755|NCT01000493|450210169|FG000|Overall Study|Study closed/terminated|25|||
125159756|NCT01000493|450210170|FG001|Overall Study|Study closed/terminated|23|||
125159757|NCT01000493|450210169|FG000|Overall Study|Lost to Follow-up|5|||
125159758|NCT01000493|450210170|FG001|Overall Study|Lost to Follow-up|9|||
125159759|NCT01000493|450210169|FG000|Overall Study|Physician Decision|1|||
125159760|NCT01000493|450210170|FG001|Overall Study|Physician Decision|1|||
125159761|NCT01000493|450210169|FG000|Overall Study|Withdrawal by Subject|3|||
125159762|NCT01000493|450210170|FG001|Overall Study|Withdrawal by Subject|7|||
125159763|NCT01408628|450210171|FG000|Consented|Withdrawal by Subject|12|||
125159764|NCT01408628|450210171|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
125159765|NCT01408628|450210171|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
125159766|NCT01408628|450210171|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
125159767|NCT01941940|450210172|FG000|Overall Study|Adverse Event|11|||
125159768|NCT01941940|450210172|FG000|Overall Study|Lost to Follow-up|2|||
125159769|NCT01941940|450210172|FG000|Overall Study|Physician Decision|2|||
125159770|NCT01941940|450210172|FG000|Overall Study|Withdrawal by Subject|15|||
125159771|NCT01941940|450210172|FG000|Overall Study|Death|1|||
125159772|NCT01941940|450210172|FG000|Overall Study|Other|1|||
125159773|NCT01941940|450210172|FG000|Overall Study|Other|1|||
125159774|NCT00750308|450210173|FG000|First Treatment|Adverse Event|0|||
125159775|NCT00750308|450210174|FG001|First Treatment|Adverse Event|1|||
125159776|NCT00750308|450210175|FG002|First Treatment|Adverse Event|0|||
125159777|NCT00750308|450210176|FG003|First Treatment|Adverse Event|0|||
125159778|NCT00750308|450210177|FG004|First Treatment|Adverse Event|0|||
125159779|NCT00750308|450210178|FG005|First Treatment|Adverse Event|0|||
125159780|NCT00750308|450210179|FG006|First Treatment|Adverse Event|0|||
125159781|NCT00750308|450210180|FG007|First Treatment|Adverse Event|0|||
125159782|NCT00750308|450210181|FG008|First Treatment|Adverse Event|0|||
125159783|NCT00750308|450210182|FG009|First Treatment|Adverse Event|0|||
125159784|NCT00750308|450210183|FG010|First Treatment|Adverse Event|1|||
125159785|NCT00750308|450210184|FG011|First Treatment|Adverse Event|1|||
125159786|NCT00750308|450210173|FG000|First Treatment|Withdrawal by Subject|0|||
125159787|NCT00750308|450210174|FG001|First Treatment|Withdrawal by Subject|0|||
125159788|NCT00750308|450210175|FG002|First Treatment|Withdrawal by Subject|0|||
125159789|NCT00750308|450210176|FG003|First Treatment|Withdrawal by Subject|1|||
125159790|NCT00750308|450210177|FG004|First Treatment|Withdrawal by Subject|0|||
125159791|NCT00750308|450210178|FG005|First Treatment|Withdrawal by Subject|0|||
125159792|NCT00750308|450210179|FG006|First Treatment|Withdrawal by Subject|0|||
125159793|NCT00750308|450210180|FG007|First Treatment|Withdrawal by Subject|1|||
125159794|NCT00750308|450210181|FG008|First Treatment|Withdrawal by Subject|0|||
125159795|NCT00750308|450210182|FG009|First Treatment|Withdrawal by Subject|0|||
125159796|NCT00750308|450210183|FG010|First Treatment|Withdrawal by Subject|0|||
125159797|NCT00750308|450210184|FG011|First Treatment|Withdrawal by Subject|0|||
125159798|NCT00750308|450210173|FG000|Second Treatment|Adverse Event|0|||
125159799|NCT00750308|450210174|FG001|Second Treatment|Adverse Event|0|||
125159800|NCT00750308|450210175|FG002|Second Treatment|Adverse Event|0|||
125159801|NCT00750308|450210176|FG003|Second Treatment|Adverse Event|0|||
125159802|NCT00750308|450210177|FG004|Second Treatment|Adverse Event|0|||
125159803|NCT00750308|450210178|FG005|Second Treatment|Adverse Event|1|||
125159804|NCT00750308|450210179|FG006|Second Treatment|Adverse Event|0|||
125159805|NCT00750308|450210180|FG007|Second Treatment|Adverse Event|0|||
125159806|NCT00750308|450210181|FG008|Second Treatment|Adverse Event|1|||
125159807|NCT00750308|450210182|FG009|Second Treatment|Adverse Event|0|||
125159808|NCT00750308|450210183|FG010|Second Treatment|Adverse Event|0|||
125159809|NCT00750308|450210184|FG011|Second Treatment|Adverse Event|0|||
125159810|NCT00750308|450210173|FG000|Second Treatment|Withdrawal by Subject|0|||
125159811|NCT00750308|450210174|FG001|Second Treatment|Withdrawal by Subject|0|||
125159812|NCT00750308|450210175|FG002|Second Treatment|Withdrawal by Subject|0|||
125159813|NCT00750308|450210176|FG003|Second Treatment|Withdrawal by Subject|0|||
125159814|NCT00750308|450210177|FG004|Second Treatment|Withdrawal by Subject|1|||
125159815|NCT00750308|450210178|FG005|Second Treatment|Withdrawal by Subject|0|||
125159816|NCT00750308|450210179|FG006|Second Treatment|Withdrawal by Subject|0|||
125159817|NCT00750308|450210180|FG007|Second Treatment|Withdrawal by Subject|0|||
125159818|NCT00750308|450210181|FG008|Second Treatment|Withdrawal by Subject|0|||
125159819|NCT00750308|450210182|FG009|Second Treatment|Withdrawal by Subject|0|||
125159820|NCT00750308|450210183|FG010|Second Treatment|Withdrawal by Subject|0|||
125159821|NCT00750308|450210184|FG011|Second Treatment|Withdrawal by Subject|0|||
125159822|NCT00750308|450210173|FG000|Third Treatment|Withdrawal by Subject|0|||
125159823|NCT00750308|450210174|FG001|Third Treatment|Withdrawal by Subject|1|||
125159824|NCT00750308|450210175|FG002|Third Treatment|Withdrawal by Subject|0|||
125159825|NCT00750308|450210176|FG003|Third Treatment|Withdrawal by Subject|0|||
125159826|NCT00750308|450210177|FG004|Third Treatment|Withdrawal by Subject|0|||
125159827|NCT00750308|450210178|FG005|Third Treatment|Withdrawal by Subject|0|||
125159828|NCT00750308|450210179|FG006|Third Treatment|Withdrawal by Subject|0|||
125159829|NCT00750308|450210180|FG007|Third Treatment|Withdrawal by Subject|0|||
125159830|NCT00750308|450210181|FG008|Third Treatment|Withdrawal by Subject|0|||
125159831|NCT00750308|450210182|FG009|Third Treatment|Withdrawal by Subject|0|||
125159832|NCT00750308|450210183|FG010|Third Treatment|Withdrawal by Subject|0|||
125159833|NCT00750308|450210184|FG011|Third Treatment|Withdrawal by Subject|0|||
125159834|NCT00513682|450210185|FG000|Washout Phase|Adverse Event|2|||
125159835|NCT01121666|450210187|FG000|Overall Study|Protocol Violation|29|||
125159836|NCT01121666|450210188|FG001|Overall Study|Protocol Violation|10|||
125159837|NCT03176459|450210189|FG000|Overall Study|Lost to Follow-up|5|||
125159838|NCT03176459|450210190|FG001|Overall Study|Lost to Follow-up|7|||
125159839|NCT06077487|450212869|FG000|Overall Study|Withdrawal by Subject|0|||
125159840|NCT06077487|450212870|FG001|Overall Study|Withdrawal by Subject|1|||
125159841|NCT00759902|450212873|FG000|Overall Study|Adverse Event|0|||
125159842|NCT00759902|450212874|FG001|Overall Study|Adverse Event|1|||
125159843|NCT02128217|450212879|FG000|Overall Study|Lost to Follow-up|0|||
125159844|NCT02128217|450212880|FG001|Overall Study|Lost to Follow-up|1|||
125159845|NCT05071313|450212881|FG000|Overall Study|Lost to Follow-up|17|||
125159846|NCT05071313|450212882|FG001|Overall Study|Lost to Follow-up|10|||
125159847|NCT05071313|450212881|FG000|Overall Study|Physician Decision|1|||
125159848|NCT05071313|450212882|FG001|Overall Study|Physician Decision|6|||
125159849|NCT05071313|450212881|FG000|Overall Study|Death|1|||
125159850|NCT05071313|450212882|FG001|Overall Study|Death|0|||
125159851|NCT05071313|450212881|FG000|Overall Study|Withdrawal by Subject|10|||
125159852|NCT05071313|450212882|FG001|Overall Study|Withdrawal by Subject|15|||
125159853|NCT05071313|450212881|FG000|Overall Study|Other|1|||
125159854|NCT05071313|450212882|FG001|Overall Study|Other|0|||
125159855|NCT05071313|450212881|FG000|Overall Study|Randomized but not vaccinated|4|||
125159856|NCT05071313|450212882|FG001|Overall Study|Randomized but not vaccinated|2|||
125159857|NCT00541970|450212883|FG000|Month 7|Protocol Violation|9|||
125159858|NCT00541970|450212884|FG001|Month 7|Protocol Violation|13|||
125159859|NCT00541970|450212885|FG002|Month 7|Protocol Violation|11|||
125159860|NCT00541970|450212886|FG003|Month 7|Protocol Violation|5|||
125159861|NCT00541970|450212883|FG000|Month 12|Adverse Event|0|||
125159862|NCT00541970|450212884|FG001|Month 12|Adverse Event|1|||
125159863|NCT00541970|450212885|FG002|Month 12|Adverse Event|1|||
125159864|NCT00541970|450212886|FG003|Month 12|Adverse Event|1|||
125159865|NCT00541970|450212883|FG000|Month 12|Protocol Violation|12|||
125159866|NCT00541970|450212884|FG001|Month 12|Protocol Violation|21|||
125159867|NCT00541970|450212885|FG002|Month 12|Protocol Violation|20|||
125159868|NCT00541970|450212886|FG003|Month 12|Protocol Violation|15|||
125159869|NCT00541970|450212883|FG000|Month 18|Adverse Event|0|||
125159870|NCT00541970|450212884|FG001|Month 18|Adverse Event|1|||
125159871|NCT00541970|450212885|FG002|Month 18|Adverse Event|1|||
125159872|NCT00541970|450212886|FG003|Month 18|Adverse Event|1|||
125159873|NCT00541970|450212883|FG000|Month 18|Protocol Violation|14|||
125159874|NCT00541970|450212884|FG001|Month 18|Protocol Violation|23|||
125159875|NCT00541970|450212885|FG002|Month 18|Protocol Violation|24|||
125159876|NCT00541970|450212886|FG003|Month 18|Protocol Violation|16|||
125159877|NCT00541970|450212883|FG000|Month 24|Adverse Event|0|||
125159878|NCT00541970|450212884|FG001|Month 24|Adverse Event|1|||
125159879|NCT00541970|450212885|FG002|Month 24|Adverse Event|1|||
125159880|NCT00541970|450212886|FG003|Month 24|Adverse Event|1|||
125159881|NCT00541970|450212883|FG000|Month 24|Protocol Violation|29|||
125159882|NCT00541970|450212884|FG001|Month 24|Protocol Violation|31|||
125159883|NCT00541970|450212885|FG002|Month 24|Protocol Violation|31|||
125159884|NCT00541970|450212886|FG003|Month 24|Protocol Violation|21|||
125159885|NCT00541970|450212883|FG000|Month 36|Protocol Violation|61|||
125159886|NCT00541970|450212884|FG001|Month 36|Protocol Violation|66|||
125159887|NCT00541970|450212885|FG002|Month 36|Protocol Violation|66|||
125159888|NCT00541970|450212886|FG003|Month 36|Protocol Violation|60|||
125159889|NCT00541970|450212883|FG000|Month 48|Withdrawal by Subject|2|||
125159890|NCT00541970|450212884|FG001|Month 48|Withdrawal by Subject|4|||
125159891|NCT00541970|450212885|FG002|Month 48|Withdrawal by Subject|4|||
125159892|NCT00541970|450212886|FG003|Month 48|Withdrawal by Subject|2|||
125159893|NCT00541970|450212883|FG000|Month 48|Other|3|||
125159894|NCT00541970|450212884|FG001|Month 48|Other|1|||
125159895|NCT00541970|450212885|FG002|Month 48|Other|1|||
125159896|NCT00541970|450212886|FG003|Month 48|Other|0|||
125159897|NCT00541970|450212883|FG000|Month 48|Lost to Follow-up|66|||
125159898|NCT00541970|450212884|FG001|Month 48|Lost to Follow-up|68|||
125159899|NCT00541970|450212885|FG002|Month 48|Lost to Follow-up|68|||
125159900|NCT00541970|450212886|FG003|Month 48|Lost to Follow-up|73|||
125159901|NCT00541970|450212883|FG000|Month 60|Protocol Violation|78|||
125159902|NCT00541970|450212884|FG001|Month 60|Protocol Violation|77|||
125159903|NCT00541970|450212885|FG002|Month 60|Protocol Violation|82|||
125159904|NCT00541970|450212886|FG003|Month 60|Protocol Violation|72|||
125159905|NCT00321828|450212887|FG000|Overall Study|Ineligible|3|||
125159906|NCT00321828|450212887|FG000|Overall Study|No follow up data|1|||
125159907|NCT00858143|450212892|FG000|Overall Study|Adverse Event|16|||
125159908|NCT00858143|450212892|FG000|Overall Study|Lack of Efficacy|4|||
125159909|NCT00858143|450212892|FG000|Overall Study|Death|7|||
125159910|NCT00858143|450212892|FG000|Overall Study|Other|23|||
125159911|NCT00852969|450212893|FG000|Overall Study|Adverse Event|0|||
125159912|NCT00852969|450212894|FG001|Overall Study|Adverse Event|1|||
125159913|NCT00852969|450212893|FG000|Overall Study|Lost to Follow-up|0|||
125159914|NCT00852969|450212894|FG001|Overall Study|Lost to Follow-up|1|||
125159915|NCT03853148|450212895|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
125159916|NCT03853148|450212896|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
125159917|NCT03853148|450212897|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
125159918|NCT03853148|450212898|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
125159919|NCT00658658|450212901|FG000|Overall Study|Withdrawal by Subject|0|||
125159920|NCT00658658|450212902|FG001|Overall Study|Withdrawal by Subject|1|||
125159921|NCT00658658|450212903|FG002|Overall Study|Withdrawal by Subject|0|||
125159922|NCT00658658|450212904|FG003|Overall Study|Withdrawal by Subject|0|||
125159923|NCT00658658|450212905|FG004|Overall Study|Withdrawal by Subject|0|||
125159924|NCT00658658|450212901|FG000|Overall Study|Death|4|||
125159925|NCT00658658|450212902|FG001|Overall Study|Death|0|||
125159926|NCT00658658|450212903|FG002|Overall Study|Death|0|||
125159927|NCT00658658|450212904|FG003|Overall Study|Death|1|||
125159928|NCT00658658|450212905|FG004|Overall Study|Death|1|||
125159929|NCT00658658|450212901|FG000|Overall Study|Disease Progression|0|||
125159930|NCT00658658|450212902|FG001|Overall Study|Disease Progression|1|||
125159931|NCT00658658|450212903|FG002|Overall Study|Disease Progression|0|||
125159932|NCT00658658|450212904|FG003|Overall Study|Disease Progression|1|||
125159933|NCT00658658|450212905|FG004|Overall Study|Disease Progression|3|||
125159934|NCT00658658|450212901|FG000|Overall Study|Protocol-specified Criteria|1|||
125159935|NCT00658658|450212902|FG001|Overall Study|Protocol-specified Criteria|0|||
125159936|NCT00658658|450212903|FG002|Overall Study|Protocol-specified Criteria|0|||
125159937|NCT00658658|450212904|FG003|Overall Study|Protocol-specified Criteria|0|||
125159938|NCT00658658|450212905|FG004|Overall Study|Protocol-specified Criteria|0|||
125159939|NCT00658658|450212901|FG000|Overall Study|Other|0|||
125159940|NCT00658658|450212902|FG001|Overall Study|Other|0|||
125159941|NCT00658658|450212903|FG002|Overall Study|Other|0|||
125159942|NCT00658658|450212904|FG003|Overall Study|Other|0|||
125159943|NCT00658658|450212905|FG004|Overall Study|Other|1|||
125159944|NCT00678041|450212906|FG000|Overall Study|Physician Decision|5|||
125159945|NCT00678041|450212907|FG001|Overall Study|Physician Decision|5|||
125159946|NCT02358343|450212908|FG000|Screening Intervention|Death|0|||
125159947|NCT02358343|450212909|FG001|Screening Intervention|Death|2|||
125159948|NCT02358343|450212910|FG002|Screening Intervention|Death|0|||
125159949|NCT02358343|450212911|FG003|Screening Intervention|Death|0|||
125159950|NCT02358343|450212912|FG004|Screening Intervention|Death|0|||
125159951|NCT02358343|450212908|FG000|Screening Intervention|Withdrawal by Subject|1|||
125159952|NCT02358343|450212909|FG001|Screening Intervention|Withdrawal by Subject|0|||
125159953|NCT02358343|450212910|FG002|Screening Intervention|Withdrawal by Subject|0|||
125159954|NCT02358343|450212911|FG003|Screening Intervention|Withdrawal by Subject|0|||
125159955|NCT02358343|450212912|FG004|Screening Intervention|Withdrawal by Subject|0|||
125159956|NCT02358343|450212908|FG000|Screening Intervention|Determined Ineligible|5|||
125159957|NCT02358343|450212909|FG001|Screening Intervention|Determined Ineligible|6|||
125159958|NCT02358343|450212910|FG002|Screening Intervention|Determined Ineligible|0|||
125159959|NCT02358343|450212911|FG003|Screening Intervention|Determined Ineligible|0|||
125159960|NCT02358343|450212912|FG004|Screening Intervention|Determined Ineligible|0|||
125159961|NCT02358343|450212908|FG000|Comparative Efficacy Trial / Observation|Death|0|||
125159962|NCT02358343|450212909|FG001|Comparative Efficacy Trial / Observation|Death|0|||
125159963|NCT02358343|450212910|FG002|Comparative Efficacy Trial / Observation|Death|2|||
125159964|NCT02358343|450212911|FG003|Comparative Efficacy Trial / Observation|Death|0|||
125159965|NCT02358343|450212912|FG004|Comparative Efficacy Trial / Observation|Death|0|||
125159966|NCT02358343|450212908|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
125159967|NCT02358343|450212909|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
125159968|NCT02358343|450212910|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
125159969|NCT02358343|450212911|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
125159970|NCT02358343|450212912|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
125159971|NCT02358343|450212908|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
125159972|NCT02358343|450212909|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
125159973|NCT02358343|450212910|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
125159974|NCT02358343|450212911|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
125159975|NCT02358343|450212912|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
125159976|NCT00090610|450212915|FG000|Overall Study|Withdrawal by Subject|1|||
125159977|NCT00090610|450212916|FG001|Overall Study|Withdrawal by Subject|1|||
125159978|NCT02444793|450212917|FG000|Overall Study|Lost to Follow-up|2|||
125159979|NCT02444793|450212918|FG001|Overall Study|Lost to Follow-up|2|||
125159980|NCT02444793|450212919|FG002|Overall Study|Lost to Follow-up|0|||
125159981|NCT02444793|450212920|FG003|Overall Study|Lost to Follow-up|0|||
125159982|NCT02444793|450212917|FG000|Overall Study|Death|0|||
125159983|NCT02444793|450212918|FG001|Overall Study|Death|3|||
125159984|NCT02444793|450212919|FG002|Overall Study|Death|0|||
125224179|NCT01854697|450448086|FG000|Overall Study|To enter another AbbVie study|1|||
125159985|NCT02444793|450212920|FG003|Overall Study|Death|0|||
125159986|NCT02444793|450212917|FG000|Overall Study|Other|0|||
125159987|NCT02444793|450212918|FG001|Overall Study|Other|0|||
125159988|NCT02444793|450212919|FG002|Overall Study|Other|2|||
125159989|NCT02444793|450212920|FG003|Overall Study|Other|0|||
125159990|NCT02444793|450212917|FG000|Overall Study|Objective progression or relapse|9|||
125159991|NCT02444793|450212918|FG001|Overall Study|Objective progression or relapse|1|||
125159992|NCT02444793|450212919|FG002|Overall Study|Objective progression or relapse|2|||
125159993|NCT02444793|450212920|FG003|Overall Study|Objective progression or relapse|3|||
125159994|NCT04498403|450212923|FG000|Overall Study|Adverse Event|1|||
125159995|NCT04498403|450212924|FG001|Overall Study|Adverse Event|0|||
125159996|NCT04498403|450212923|FG000|Overall Study|Study Terminated By Sponsor|29|||
125159997|NCT04498403|450212924|FG001|Overall Study|Study Terminated By Sponsor|10|||
125159998|NCT01951885|450212925|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
125159999|NCT01951885|450212926|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
125160000|NCT01951885|450212925|FG000|Overall Study|Adverse Event|1|||
125160001|NCT01951885|450212926|FG001|Overall Study|Adverse Event|0|||
125160002|NCT01951885|450212925|FG000|Overall Study|Withdrawal by Subject|0|||
125160003|NCT01951885|450212926|FG001|Overall Study|Withdrawal by Subject|1|||
125160004|NCT01951885|450212925|FG000|Overall Study|ineligible due to a change in donor|0|||
125160005|NCT01951885|450212926|FG001|Overall Study|ineligible due to a change in donor|1|||
125160006|NCT01951885|450212925|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
125160007|NCT01951885|450212926|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
125160008|NCT00866658|450212927|FG000|Overall Study|Adverse Event|5|||
125160009|NCT00866658|450212928|FG001|Overall Study|Adverse Event|14|||
125160010|NCT00866658|450212927|FG000|Overall Study|Lack of Efficacy|2|||
125160011|NCT00866658|450212928|FG001|Overall Study|Lack of Efficacy|1|||
125160012|NCT00866658|450212927|FG000|Overall Study|Withdrawal by Subject|1|||
125160013|NCT00866658|450212928|FG001|Overall Study|Withdrawal by Subject|0|||
125160014|NCT00866658|450212927|FG000|Overall Study|Protocol Violation|1|||
125160015|NCT00866658|450212928|FG001|Overall Study|Protocol Violation|1|||
125160016|NCT00866658|450212927|FG000|Overall Study|Familial and Personal Reasons|4|||
125160017|NCT00866658|450212928|FG001|Overall Study|Familial and Personal Reasons|5|||
125160018|NCT01859130|450212931|FG000|Overall Study|Death|4|||
125160019|NCT01859130|450212931|FG000|Overall Study|Lost to Follow-up|16|||
125160020|NCT01859130|450212931|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
125160021|NCT01859130|450212931|FG000|Overall Study|Physician Decision|6|||
125160022|NCT01859130|450212931|FG000|Overall Study|Withdrawal by Subject|17|||
125160023|NCT01859130|450212931|FG000|Overall Study|Adverse Event|11|||
125160024|NCT01462318|450212934|FG000|Main Study / TP-DI Study|Other|2|||
125160025|NCT01462318|450212935|FG001|Main Study / TP-DI Study|Other|0|||
125160026|NCT01462318|450212936|FG002|Main Study / TP-DI Study|Other|0|||
125160027|NCT01462318|450212934|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
125160028|NCT01462318|450212935|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
125160029|NCT01462318|450212936|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
125160030|NCT01462318|450212934|FG000|Main Study / TP-DI Study|Adverse Event|4|||
125160031|NCT01462318|450212935|FG001|Main Study / TP-DI Study|Adverse Event|0|||
125160032|NCT01462318|450212936|FG002|Main Study / TP-DI Study|Adverse Event|0|||
125160033|NCT01462318|450212934|FG000|Extension Phase|Lost to Follow-up|0|||
125160034|NCT01462318|450212935|FG001|Extension Phase|Lost to Follow-up|0|||
125160035|NCT01462318|450212936|FG002|Extension Phase|Lost to Follow-up|1|||
125160036|NCT01462318|450212934|FG000|Extension Phase|Other|0|||
125160037|NCT01462318|450212935|FG001|Extension Phase|Other|0|||
125160038|NCT01462318|450212936|FG002|Extension Phase|Other|1|||
125160039|NCT01462318|450212934|FG000|Extension Phase|Disease Progression|0|||
125160040|NCT01462318|450212935|FG001|Extension Phase|Disease Progression|0|||
125160041|NCT01462318|450212936|FG002|Extension Phase|Disease Progression|1|||
125160042|NCT01462318|450212934|FG000|Extension Phase|Withdrawal by Subject|0|||
125160043|NCT01462318|450212935|FG001|Extension Phase|Withdrawal by Subject|0|||
125160044|NCT01462318|450212936|FG002|Extension Phase|Withdrawal by Subject|15|||
125160045|NCT01462318|450212934|FG000|Extension Phase|Investigator Decision|0|||
125160046|NCT01462318|450212935|FG001|Extension Phase|Investigator Decision|0|||
125160047|NCT01462318|450212936|FG002|Extension Phase|Investigator Decision|5|||
125160048|NCT01462318|450212934|FG000|Extension Phase|Adverse Event|0|||
125160049|NCT01462318|450212935|FG001|Extension Phase|Adverse Event|0|||
125160050|NCT01462318|450212936|FG002|Extension Phase|Adverse Event|22|||
125160051|NCT03827564|450212937|FG000|Overall Study|Discontinued due to Study Termination|1|||
125160052|NCT03827564|450212938|FG001|Overall Study|Discontinued due to Study Termination|0|||
125160053|NCT00891371|450212939|FG000|Pre-assignment|Inclusion/exclusion|5|||
125160054|NCT00891371|450212939|FG000|Pre-assignment|Consent withdrawal|1|||
125160055|NCT00891371|450212939|FG000|Treatment|Lack of Efficacy|5|||
125160056|NCT00891371|450212939|FG000|Treatment|Adverse Event|2|||
125160057|NCT00891371|450212939|FG000|Treatment|Death|1|||
125160058|NCT00891371|450212939|FG000|Treatment|Lost to Follow-up|1|||
125160059|NCT02238626|450212940|FG000|Overall Study|Adverse Event|3|||
125160060|NCT02238626|450212941|FG001|Overall Study|Adverse Event|5|||
125160061|NCT02238626|450212942|FG002|Overall Study|Adverse Event|0|||
125160062|NCT02238626|450212943|FG003|Overall Study|Adverse Event|3|||
125160063|NCT02238626|450212940|FG000|Overall Study|Lost to Follow-up|2|||
125160064|NCT02238626|450212941|FG001|Overall Study|Lost to Follow-up|4|||
125160065|NCT02238626|450212942|FG002|Overall Study|Lost to Follow-up|2|||
125160066|NCT02238626|450212943|FG003|Overall Study|Lost to Follow-up|2|||
125160067|NCT02238626|450212940|FG000|Overall Study|Withdrawal by Subject|0|||
125160068|NCT02238626|450212941|FG001|Overall Study|Withdrawal by Subject|3|||
125160069|NCT02238626|450212942|FG002|Overall Study|Withdrawal by Subject|0|||
125160070|NCT02238626|450212943|FG003|Overall Study|Withdrawal by Subject|1|||
125160071|NCT02238626|450212940|FG000|Overall Study|Death|0|||
125160072|NCT02238626|450212941|FG001|Overall Study|Death|0|||
125160073|NCT02238626|450212942|FG002|Overall Study|Death|1|||
125160074|NCT02238626|450212943|FG003|Overall Study|Death|1|||
125160075|NCT02238626|450212940|FG000|Overall Study|Other|0|||
125160076|NCT02238626|450212941|FG001|Overall Study|Other|2|||
125160077|NCT02238626|450212942|FG002|Overall Study|Other|0|||
125160078|NCT02238626|450212943|FG003|Overall Study|Other|0|||
125160079|NCT02622113|450212946|FG000|Overall Study|Adverse Event|4|||
125160080|NCT02622113|450212947|FG001|Overall Study|Adverse Event|4|||
125160081|NCT02622113|450212946|FG000|Overall Study|Physician Decision|0|||
125160082|NCT02622113|450212947|FG001|Overall Study|Physician Decision|1|||
125160083|NCT02622113|450212946|FG000|Overall Study|Withdrawal by Subject|0|||
125160084|NCT02622113|450212947|FG001|Overall Study|Withdrawal by Subject|2|||
125160085|NCT02622113|450212946|FG000|Overall Study|Stopping Criteria|1|||
125160086|NCT02622113|450212947|FG001|Overall Study|Stopping Criteria|3|||
125160087|NCT04442490|450212954|FG000|Overall Study|Withdrawal by Subject|18|||
125160088|NCT04442490|450212955|FG001|Overall Study|Withdrawal by Subject|10|||
125160089|NCT04442490|450212954|FG000|Overall Study|Lost to Follow-up|7|||
125160090|NCT04442490|450212955|FG001|Overall Study|Lost to Follow-up|7|||
125224180|NCT01854697|450448087|FG001|Overall Study|To enter another AbbVie study|0|||
125160091|NCT04442490|450212954|FG000|Overall Study|Adverse Event|2|||
125160092|NCT04442490|450212955|FG001|Overall Study|Adverse Event|6|||
125160093|NCT04442490|450212954|FG000|Overall Study|Noncompliance|3|||
125160094|NCT04442490|450212955|FG001|Overall Study|Noncompliance|1|||
125160095|NCT04442490|450212954|FG000|Overall Study|Physician Decision|2|||
125160096|NCT04442490|450212955|FG001|Overall Study|Physician Decision|1|||
125160097|NCT04442490|450212954|FG000|Overall Study|Reason not Specified|2|||
125160098|NCT04442490|450212955|FG001|Overall Study|Reason not Specified|1|||
125160099|NCT04442490|450212954|FG000|Overall Study|Randomized but not Treated|3|||
125160100|NCT04442490|450212955|FG001|Overall Study|Randomized but not Treated|3|||
125160101|NCT01449279|450212956|FG000|Overall Study|Lack of Efficacy|5|||
125160102|NCT01449279|450212956|FG000|Overall Study|Toxicity|2|||
125160103|NCT00505375|450212957|FG000|Overall Study|Death|1|||
125160104|NCT00505375|450212958|FG001|Overall Study|Death|0|||
125160105|NCT00505375|450212957|FG000|Overall Study|Withdrawal by Subject|2|||
125160106|NCT00505375|450212958|FG001|Overall Study|Withdrawal by Subject|2|||
125160107|NCT00505375|450212957|FG000|Overall Study|Lost to Follow-up|0|||
125160108|NCT00505375|450212958|FG001|Overall Study|Lost to Follow-up|2|||
125160109|NCT00505375|450212957|FG000|Overall Study|Pregnancy|1|||
125160110|NCT00505375|450212958|FG001|Overall Study|Pregnancy|0|||
125160111|NCT00505375|450212957|FG000|Overall Study|Travel issues|0|||
125160112|NCT00505375|450212958|FG001|Overall Study|Travel issues|1|||
125160113|NCT03347422|450212959|FG000|Part A (26 Weeks)|Adverse Event|3|||
125160114|NCT03347422|450212960|FG001|Part A (26 Weeks)|Adverse Event|0|||
125160115|NCT03347422|450212959|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
125160116|NCT03347422|450212960|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
125160117|NCT03347422|450212959|FG000|Part B (149 Weeks)|Adverse Event|0|||
125160118|NCT03347422|450212960|FG001|Part B (149 Weeks)|Adverse Event|1|||
125160119|NCT03347422|450212959|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
125160120|NCT03347422|450212960|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
125160121|NCT03347422|450212959|FG000|Part B (149 Weeks)|Other|1|||
125160122|NCT03347422|450212960|FG001|Part B (149 Weeks)|Other|0|||
125160123|NCT02746471|450212961|FG000|Overall Study|Death|43|||
125160124|NCT02746471|450212961|FG000|Overall Study|Exited before 36 months|1119|||
125160125|NCT00910091|450212962|FG000|Pre-assignment|Withdrawal by Subject|0|||
125160126|NCT00910091|450212963|FG001|Pre-assignment|Withdrawal by Subject|2|||
125160127|NCT00910091|450212962|FG000|Treatment and Survival|Withdrawal by Subject|3|||
125160128|NCT00910091|450212963|FG001|Treatment and Survival|Withdrawal by Subject|4|||
125160129|NCT00910091|450212962|FG000|Treatment and Survival|Adverse Event|1|||
125160130|NCT00910091|450212963|FG001|Treatment and Survival|Adverse Event|0|||
125160131|NCT04594707|450212967|FG000|Overall Study|Adverse Event|0|||
125160132|NCT04594707|450212968|FG001|Overall Study|Adverse Event|0|||
125160133|NCT04594707|450212969|FG002|Overall Study|Adverse Event|1|||
125160134|NCT04594707|450212967|FG000|Overall Study|Death|0|||
125160135|NCT04594707|450212968|FG001|Overall Study|Death|2|||
125160136|NCT04594707|450212969|FG002|Overall Study|Death|2|||
125160137|NCT04594707|450212967|FG000|Overall Study|Lung Transplant|0|||
125160138|NCT04594707|450212968|FG001|Overall Study|Lung Transplant|0|||
125160139|NCT04594707|450212969|FG002|Overall Study|Lung Transplant|1|||
125160140|NCT04594707|450212967|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
125160141|NCT04594707|450212968|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
125160142|NCT04594707|450212969|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
125160143|NCT04594707|450212967|FG000|Overall Study|Study Terminated By Sponsor|19|||
125160144|NCT04594707|450212968|FG001|Overall Study|Study Terminated By Sponsor|47|||
125224181|NCT01854697|450448088|FG002|Overall Study|To enter another AbbVie study|0|||
125224182|NCT01854697|450448089|FG003|Overall Study|To enter another AbbVie study|0|||
125224183|NCT01854697|450448090|FG004|Overall Study|To enter another AbbVie study|1|||
125224184|NCT01854697|450448086|FG000|Overall Study|Withdrew Consent|0|||
125224185|NCT01854697|450448087|FG001|Overall Study|Withdrew Consent|1|||
125224186|NCT01854697|450448088|FG002|Overall Study|Withdrew Consent|0|||
125224187|NCT01854697|450448089|FG003|Overall Study|Withdrew Consent|1|||
125224188|NCT01854697|450448090|FG004|Overall Study|Withdrew Consent|0|||
125224189|NCT01854697|450448086|FG000|Overall Study|Other|0|||
125224190|NCT01854697|450448087|FG001|Overall Study|Other|1|||
125224191|NCT01854697|450448088|FG002|Overall Study|Other|1|||
125224192|NCT01854697|450448089|FG003|Overall Study|Other|0|||
125224193|NCT01854697|450448090|FG004|Overall Study|Other|0|||
125224194|NCT03713684|450448091|FG000|Overall Study|Adverse Event|1|||
125224195|NCT03713684|450448092|FG001|Overall Study|Adverse Event|3|||
125224196|NCT03713684|450448093|FG002|Overall Study|Adverse Event|1|||
125224197|NCT03713684|450448094|FG003|Overall Study|Adverse Event|0|||
125224198|NCT03713684|450448091|FG000|Overall Study|Poor compliance to protocol|2|||
125160145|NCT04594707|450212969|FG002|Overall Study|Study Terminated By Sponsor|41|||
125160146|NCT04594707|450212967|FG000|Overall Study|Withdrawal by Subject|1|||
125160147|NCT04594707|450212968|FG001|Overall Study|Withdrawal by Subject|0|||
125160148|NCT04594707|450212969|FG002|Overall Study|Withdrawal by Subject|2|||
125160149|NCT01155024|450212970|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
125160150|NCT01155024|450212971|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
125224199|NCT03713684|450448092|FG001|Overall Study|Poor compliance to protocol|1|||
125224200|NCT03713684|450448093|FG002|Overall Study|Poor compliance to protocol|0|||
125160151|NCT01155024|450212970|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
125160152|NCT01155024|450212971|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
125160153|NCT01155024|450212970|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
125160154|NCT01155024|450212971|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
125160155|NCT01593696|450212972|FG000|Dose Escalation|Progressive Disease|2|||
125160156|NCT01593696|450212973|FG001|Dose Escalation|Progressive Disease|0|||
125160157|NCT01593696|450212974|FG002|Dose Escalation|Progressive Disease|0|||
125160158|NCT01593696|450212975|FG003|Dose Escalation|Progressive Disease|0|||
125160159|NCT01593696|450212972|FG000|Dose Expansion|Fungal infection|0|||
125160160|NCT01593696|450212973|FG001|Dose Expansion|Fungal infection|0|||
125160161|NCT01593696|450212974|FG002|Dose Expansion|Fungal infection|1|||
125160162|NCT01593696|450212975|FG003|Dose Expansion|Fungal infection|0|||
125160163|NCT01936623|450212978|FG000|Overall Study|Lost to Follow-up|0|||
125160164|NCT01936623|450212979|FG001|Overall Study|Lost to Follow-up|5|||
125160165|NCT03167723|450212980|FG000|Overall Study|Protocol Violation|4|||
125160166|NCT03167723|450212981|FG001|Overall Study|Protocol Violation|6|||
125160167|NCT01175811|450212983|FG000|Overall Study|Adverse Event|1|||
125160168|NCT01175811|450212984|FG001|Overall Study|Adverse Event|1|||
125160169|NCT01175811|450212983|FG000|Overall Study|Entry criteria not met|3|||
125160170|NCT01175811|450212984|FG001|Overall Study|Entry criteria not met|1|||
125160171|NCT01175811|450212983|FG000|Overall Study|Lack of Efficacy|1|||
125160172|NCT01175811|450212984|FG001|Overall Study|Lack of Efficacy|0|||
125160173|NCT01175811|450212983|FG000|Overall Study|Lost to Follow-up|3|||
125160174|NCT01175811|450212984|FG001|Overall Study|Lost to Follow-up|2|||
125160175|NCT01175811|450212983|FG000|Overall Study|Physician Decision|1|||
125160176|NCT01175811|450212984|FG001|Overall Study|Physician Decision|1|||
125160177|NCT01175811|450212983|FG000|Overall Study|Protocol Violation|1|||
125160178|NCT01175811|450212984|FG001|Overall Study|Protocol Violation|2|||
125160179|NCT01175811|450212983|FG000|Overall Study|Withdrawal by Subject|6|||
125160180|NCT01175811|450212984|FG001|Overall Study|Withdrawal by Subject|7|||
125160181|NCT03579966|450212985|FG000|Overall Study|Adverse Event|6|||
125160182|NCT03579966|450212985|FG000|Overall Study|Lost to Follow-up|4|||
125160183|NCT03579966|450212985|FG000|Overall Study|Physician Decision|10|||
125160184|NCT03579966|450212985|FG000|Overall Study|Pregnancy|1|||
125160185|NCT03579966|450212985|FG000|Overall Study|Withdrawal by Subject|16|||
125160186|NCT03579966|450212985|FG000|Overall Study|Study terminated by Sponsor|22|||
125160187|NCT03579966|450212985|FG000|Overall Study|Protocol Violation|1|||
125160188|NCT01340768|450212988|FG000|Overall Study|Lost to Follow-up|10|||
125160189|NCT01340768|450212989|FG001|Overall Study|Lost to Follow-up|4|||
125160190|NCT01340768|450212988|FG000|Overall Study|Withdrawal by Subject|5|||
125160191|NCT01340768|450212989|FG001|Overall Study|Withdrawal by Subject|1|||
125160192|NCT01340768|450212988|FG000|Overall Study|Other|2|||
125160193|NCT01340768|450212989|FG001|Overall Study|Other|0|||
125160194|NCT03052959|450212990|FG000|Overall Study|Lost to Follow-up|4|||
125160195|NCT03052959|450212991|FG001|Overall Study|Lost to Follow-up|5|||
125160196|NCT00950963|450212992|FG000|Overall Study|Lost to Follow-up|29|||
125160197|NCT00950963|450212993|FG001|Overall Study|Lost to Follow-up|24|||
125160198|NCT00848107|450212994|FG000|Overall Study|Lost to Follow-up|2|||
125160199|NCT00848107|450212994|FG000|Overall Study|Withdrawal by Subject|8|||
125160200|NCT00848107|450212994|FG000|Overall Study|Adverse Event|9|||
125160201|NCT00848107|450212994|FG000|Overall Study|Death|1|||
125160202|NCT00848107|450212994|FG000|Overall Study|Pregnancy|1|||
125160203|NCT00326963|450212995|FG000|Overall Study|Adverse Event|2|||
125160204|NCT00326963|450212995|FG000|Overall Study|Injection site reaction|1|||
125160205|NCT00326963|450212995|FG000|Overall Study|Death|1|||
125160206|NCT00326963|450212995|FG000|Overall Study|Failure to return|10|||
125160207|NCT00326963|450212995|FG000|Overall Study|Withdrawal by Subject|10|||
125160208|NCT00326963|450212995|FG000|Overall Study|Refused treatment / did not cooperate|5|||
125160209|NCT00326963|450212995|FG000|Overall Study|Violation of selection criteria at entry|2|||
125160210|NCT00326963|450212995|FG000|Overall Study|Other protocol violation|1|||
125160211|NCT00326963|450212995|FG000|Overall Study|Administrative / other|1|||
125160212|NCT00859586|450212996|FG000|Overall Study|Donors|4|||
125160213|NCT02992418|450212997|FG000|Overall Study|Withdrawal by Subject|11|||
125160214|NCT02992418|450212998|FG001|Overall Study|Withdrawal by Subject|12|||
125160215|NCT02992418|450212997|FG000|Overall Study|Non-compliance with the protocol|308|||
125160216|NCT02992418|450212998|FG001|Overall Study|Non-compliance with the protocol|308|||
125160217|NCT02992418|450212997|FG000|Overall Study|Lost to Follow-up|27|||
125160218|NCT02992418|450212998|FG001|Overall Study|Lost to Follow-up|22|||
125160219|NCT03246126|450213003|FG000|Overall Study|Withdrawal by Subject|0|||
125160220|NCT03246126|450213004|FG001|Overall Study|Withdrawal by Subject|1|||
125160221|NCT01006135|450213007|FG000|Overall Study|Adverse Event|22|||
125160222|NCT01006135|450213007|FG000|Overall Study|Protocol Violation|14|||
125160223|NCT01006135|450213007|FG000|Overall Study|Lost to Follow-up|32|||
125160224|NCT01006135|450213007|FG000|Overall Study|Other|72|||
125160225|NCT00928707|450213009|FG000|Overall Study|Protocol Violation|1|||
125160226|NCT00928707|450213010|FG001|Overall Study|Protocol Violation|0|||
125160227|NCT00132028|450213011|FG000|Overall Study|Adverse Event|7|||
125160228|NCT00132028|450213011|FG000|Overall Study|Death|2|||
125160229|NCT00132028|450213011|FG000|Overall Study|Lack of Efficacy|11|||
125160230|NCT00132028|450213011|FG000|Overall Study|Withdrawal by Subject|2|||
125160231|NCT00132028|450213011|FG000|Overall Study|not eligible|2|||
125160232|NCT00132028|450213011|FG000|Overall Study|Physician Decision|3|||
125160233|NCT02731326|450213017|FG000|Overall Study|Withdrawal by Subject|4|||
125160234|NCT02731326|450213018|FG001|Overall Study|Withdrawal by Subject|1|||
125160235|NCT02731326|450213017|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
125160236|NCT02731326|450213018|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
125160237|NCT02731326|450213017|FG000|Overall Study|Discharged without AliveCor|10|||
125160238|NCT02731326|450213018|FG001|Overall Study|Discharged without AliveCor|0|||
125160239|NCT02731326|450213017|FG000|Overall Study|Duplicate Participant|1|||
125160240|NCT02731326|450213018|FG001|Overall Study|Duplicate Participant|1|||
125160241|NCT00302081|450213020|FG000|Overall Study|Adverse Event|6|||
125160242|NCT00302081|450213021|FG001|Overall Study|Adverse Event|5|||
125160243|NCT00302081|450213022|FG002|Overall Study|Adverse Event|4|||
125160244|NCT00302081|450213020|FG000|Overall Study|Lost to Follow-up|21|||
125160245|NCT00302081|450213021|FG001|Overall Study|Lost to Follow-up|18|||
125160246|NCT00302081|450213022|FG002|Overall Study|Lost to Follow-up|28|||
125160247|NCT00302081|450213020|FG000|Overall Study|Withdrawal by Subject|8|||
125160248|NCT00302081|450213021|FG001|Overall Study|Withdrawal by Subject|12|||
125160249|NCT00302081|450213022|FG002|Overall Study|Withdrawal by Subject|8|||
125160250|NCT00302081|450213020|FG000|Overall Study|Protocol Violation|5|||
125160251|NCT00302081|450213021|FG001|Overall Study|Protocol Violation|1|||
125160252|NCT00302081|450213022|FG002|Overall Study|Protocol Violation|2|||
125160253|NCT00302081|450213020|FG000|Overall Study|Lack of Efficacy|1|||
125160254|NCT00302081|450213021|FG001|Overall Study|Lack of Efficacy|0|||
125160255|NCT00302081|450213022|FG002|Overall Study|Lack of Efficacy|5|||
125160256|NCT00302081|450213020|FG000|Overall Study|Death|2|||
125160257|NCT00302081|450213021|FG001|Overall Study|Death|1|||
125160258|NCT00302081|450213022|FG002|Overall Study|Death|0|||
125160259|NCT00302081|450213020|FG000|Overall Study|Other|13|||
125160260|NCT00302081|450213021|FG001|Overall Study|Other|6|||
125160261|NCT00302081|450213022|FG002|Overall Study|Other|5|||
125160262|NCT01616953|450213023|FG000|Overall Study|Lost to Follow-up|1|||
125160263|NCT01616953|450213024|FG001|Overall Study|Lost to Follow-up|0|||
125160264|NCT01616953|450213023|FG000|Overall Study|lack of bone and soft tissue|1|||
125160265|NCT01616953|450213024|FG001|Overall Study|lack of bone and soft tissue|0|||
125160266|NCT02500641|450213027|FG000|Overall Study|Adverse Event|0|||
125160267|NCT02500641|450213028|FG001|Overall Study|Adverse Event|2|||
125160268|NCT02500641|450213027|FG000|Overall Study|Withdrawal by Subject|4|||
125160269|NCT02500641|450213028|FG001|Overall Study|Withdrawal by Subject|5|||
125160270|NCT02500641|450213027|FG000|Overall Study|Unable to follow study procedures|3|||
125160271|NCT02500641|450213028|FG001|Overall Study|Unable to follow study procedures|2|||
125160272|NCT02500641|450213027|FG000|Overall Study|Protocol Violation|1|||
125160273|NCT02500641|450213028|FG001|Overall Study|Protocol Violation|2|||
125160274|NCT02500641|450213027|FG000|Overall Study|Lost to Follow-up|1|||
125160275|NCT02500641|450213028|FG001|Overall Study|Lost to Follow-up|0|||
125160276|NCT02500641|450213027|FG000|Overall Study|Sponsor decision|1|||
125160277|NCT02500641|450213028|FG001|Overall Study|Sponsor decision|0|||
125160278|NCT02500641|450213027|FG000|Overall Study|Non compliance to study drug|0|||
125160279|NCT02500641|450213028|FG001|Overall Study|Non compliance to study drug|1|||
125160280|NCT00643565|450213030|FG000|Overall Study|Death|12|||
125160281|NCT00643565|450213031|FG001|Overall Study|Death|11|||
125160282|NCT00643565|450213030|FG000|Overall Study|Withdrawal by Subject|4|||
125160283|NCT00643565|450213031|FG001|Overall Study|Withdrawal by Subject|1|||
125160284|NCT00643565|450213030|FG000|Overall Study|Lost to Follow-up|0|||
125160285|NCT00643565|450213031|FG001|Overall Study|Lost to Follow-up|6|||
125160286|NCT00643565|450213030|FG000|Overall Study|Other|7|||
125160287|NCT00643565|450213031|FG001|Overall Study|Other|8|||
125160288|NCT00643565|450213030|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
125160289|NCT00643565|450213031|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
125160290|NCT00643565|450213030|FG000|Overall Study|Recurrence of Disease|2|||
125160291|NCT00643565|450213031|FG001|Overall Study|Recurrence of Disease|1|||
125160292|NCT00643565|450213030|FG000|Overall Study|Progression of Disease|18|||
125160293|NCT00643565|450213031|FG001|Overall Study|Progression of Disease|14|||
125160294|NCT00643565|450213030|FG000|Overall Study|Protocol Violation|3|||
125160295|NCT00643565|450213031|FG001|Overall Study|Protocol Violation|0|||
125160296|NCT00643565|450213030|FG000|Overall Study|Did Not Cooperate|0|||
125160297|NCT00643565|450213031|FG001|Overall Study|Did Not Cooperate|1|||
125160298|NCT00643565|450213030|FG000|Overall Study|Administrative|22|||
125160299|NCT00643565|450213031|FG001|Overall Study|Administrative|16|||
125160300|NCT00643565|450213030|FG000|Overall Study|Adverse Event|5|||
125160301|NCT00643565|450213031|FG001|Overall Study|Adverse Event|8|||
125160302|NCT02317614|450213032|FG000|Overall Study|Lost to Follow-up|1|||
125160303|NCT02317614|450213033|FG001|Overall Study|Lost to Follow-up|1|||
125160304|NCT02317614|450213032|FG000|Overall Study|Withdrawal by Subject|1|||
125160305|NCT02317614|450213033|FG001|Overall Study|Withdrawal by Subject|0|||
125160306|NCT02317614|450213032|FG000|Overall Study|Death|1|||
125160307|NCT02317614|450213033|FG001|Overall Study|Death|1|||
125160308|NCT01355159|450213034|FG000|Overall Study|Withdrew consent|39|||
125160309|NCT01355159|450213035|FG001|Overall Study|Withdrew consent|47|||
125160310|NCT01355159|450213034|FG000|Overall Study|No primary outcome data|17|||
125160311|NCT01355159|450213035|FG001|Overall Study|No primary outcome data|11|||
125160312|NCT01355159|450213034|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
125160313|NCT01355159|450213035|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
125160314|NCT01355159|450213034|FG000|Overall Study|Early intrauterine fetal death|6|||
125160315|NCT01355159|450213035|FG001|Overall Study|Early intrauterine fetal death|6|||
125160316|NCT04700280|450213036|FG000|Overall Study|Adverse Event|4|||
125160317|NCT04700280|450213037|FG001|Overall Study|Adverse Event|0|||
125160318|NCT04700280|450213036|FG000|Overall Study|Lack of Efficacy|1|||
125160319|NCT04700280|450213037|FG001|Overall Study|Lack of Efficacy|0|||
125160320|NCT04700280|450213036|FG000|Overall Study|Study terminated by sponsor|5|||
125160321|NCT04700280|450213037|FG001|Overall Study|Study terminated by sponsor|3|||
125160322|NCT04700280|450213036|FG000|Overall Study|Other than specified|1|||
125160323|NCT04700280|450213037|FG001|Overall Study|Other than specified|0|||
125160324|NCT00741936|450213041|FG000|Overall Study|Lost to Follow-up|1|||
125160325|NCT00741936|450213042|FG001|Overall Study|Lost to Follow-up|1|||
125160326|NCT00741936|450213041|FG000|Overall Study|Adverse Event|3|||
125160327|NCT00741936|450213042|FG001|Overall Study|Adverse Event|4|||
125160328|NCT00741936|450213041|FG000|Overall Study|Pregnancy|0|||
125160329|NCT00741936|450213042|FG001|Overall Study|Pregnancy|1|||
125160330|NCT00741936|450213041|FG000|Overall Study|Protocol Violation|2|||
125160331|NCT00741936|450213042|FG001|Overall Study|Protocol Violation|0|||
125160332|NCT00741936|450213041|FG000|Overall Study|Lack of Efficacy|0|||
125160333|NCT00741936|450213042|FG001|Overall Study|Lack of Efficacy|2|||
125160334|NCT00741936|450213041|FG000|Overall Study|Low compliance|3|||
125160335|NCT00741936|450213042|FG001|Overall Study|Low compliance|0|||
125160336|NCT02450526|450213043|FG000|DB Period (Cycle 1)|Adverse Event|0|||
125160337|NCT02450526|450213044|FG001|DB Period (Cycle 1)|Adverse Event|0|||
125160338|NCT02450526|450213045|FG002|DB Period (Cycle 1)|Adverse Event|2|||
125160339|NCT02450526|450213046|FG003|DB Period (Cycle 1)|Adverse Event|0|||
125160340|NCT02450526|450213047|FG004|DB Period (Cycle 1)|Adverse Event|0|||
125160341|NCT02450526|450213043|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
125160342|NCT02450526|450213044|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
125160343|NCT02450526|450213045|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
125160344|NCT02450526|450213046|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
125160345|NCT02450526|450213047|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
125160346|NCT02450526|450213043|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
125160347|NCT02450526|450213044|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
125160348|NCT02450526|450213045|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
125160349|NCT02450526|450213046|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
125160350|NCT02450526|450213047|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
125160351|NCT02450526|450213043|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
125160352|NCT02450526|450213044|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
125224201|NCT03713684|450448094|FG003|Overall Study|Poor compliance to protocol|1|||
125224202|NCT03713684|450448091|FG000|Overall Study|Withdrawal by Subject|14|||
125224203|NCT03713684|450448092|FG001|Overall Study|Withdrawal by Subject|6|||
125224204|NCT03713684|450448093|FG002|Overall Study|Withdrawal by Subject|14|||
125160353|NCT02450526|450213045|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
125160354|NCT02450526|450213046|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
125160355|NCT02450526|450213047|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
125160356|NCT02450526|450213043|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
125160357|NCT02450526|450213044|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
125160358|NCT02450526|450213045|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
125160359|NCT02450526|450213046|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
125160360|NCT02450526|450213047|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
125160361|NCT02450526|450213043|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
125160362|NCT02450526|450213044|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
125160363|NCT02450526|450213045|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
125160364|NCT02450526|450213046|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
125160365|NCT02450526|450213047|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
125160366|NCT02450526|450213043|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
125160367|NCT02450526|450213044|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
125160368|NCT02450526|450213045|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
125160369|NCT02450526|450213046|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
125160370|NCT02450526|450213047|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
125160371|NCT02450526|450213043|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
125160372|NCT02450526|450213044|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
125160373|NCT02450526|450213045|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
125160374|NCT02450526|450213046|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
125160375|NCT02450526|450213047|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
125160376|NCT01970865|450213048|FG000|Overall Study|Death|3|||
125160377|NCT01970865|450213049|FG001|Overall Study|Death|2|||
125160378|NCT01970865|450213050|FG002|Overall Study|Death|3|||
125160379|NCT01970865|450213051|FG003|Overall Study|Death|6|||
125160380|NCT01970865|450213052|FG004|Overall Study|Death|9|||
125160381|NCT01970865|450213053|FG005|Overall Study|Death|3|||
125160382|NCT01970865|450213054|FG006|Overall Study|Death|2|||
125160383|NCT01970865|450213055|FG007|Overall Study|Death|3|||
125160384|NCT01970865|450213056|FG008|Overall Study|Death|2|||
125160385|NCT01970865|450213057|FG009|Overall Study|Death|2|||
125160386|NCT01970865|450213058|FG010|Overall Study|Death|8|||
125160387|NCT01970865|450213059|FG011|Overall Study|Death|13|||
125160388|NCT01970865|450213060|FG012|Overall Study|Death|25|||
125160389|NCT01970865|450213061|FG013|Overall Study|Death|46|||
125160390|NCT01970865|450213062|FG014|Overall Study|Death|37|||
125160391|NCT01970865|450213063|FG015|Overall Study|Death|22|||
125160392|NCT01970865|450213064|FG016|Overall Study|Death|1|||
125160393|NCT01970865|450213065|FG017|Overall Study|Death|17|||
125160394|NCT01970865|450213048|FG000|Overall Study|Lost to Follow-up|0|||
125160395|NCT01970865|450213049|FG001|Overall Study|Lost to Follow-up|0|||
125160396|NCT01970865|450213050|FG002|Overall Study|Lost to Follow-up|0|||
125160397|NCT01970865|450213051|FG003|Overall Study|Lost to Follow-up|1|||
125160398|NCT01970865|450213052|FG004|Overall Study|Lost to Follow-up|1|||
125160399|NCT01970865|450213053|FG005|Overall Study|Lost to Follow-up|0|||
125160400|NCT01970865|450213054|FG006|Overall Study|Lost to Follow-up|0|||
125160401|NCT01970865|450213055|FG007|Overall Study|Lost to Follow-up|0|||
125160402|NCT01970865|450213056|FG008|Overall Study|Lost to Follow-up|0|||
125160403|NCT01970865|450213057|FG009|Overall Study|Lost to Follow-up|0|||
125160404|NCT01970865|450213058|FG010|Overall Study|Lost to Follow-up|1|||
125160405|NCT01970865|450213059|FG011|Overall Study|Lost to Follow-up|0|||
125160406|NCT01970865|450213060|FG012|Overall Study|Lost to Follow-up|2|||
125160407|NCT01970865|450213061|FG013|Overall Study|Lost to Follow-up|0|||
125160408|NCT01970865|450213062|FG014|Overall Study|Lost to Follow-up|1|||
125160409|NCT01970865|450213063|FG015|Overall Study|Lost to Follow-up|4|||
125160410|NCT01970865|450213064|FG016|Overall Study|Lost to Follow-up|0|||
125160411|NCT01970865|450213065|FG017|Overall Study|Lost to Follow-up|1|||
125160412|NCT01970865|450213048|FG000|Overall Study|Other|0|||
125160413|NCT01970865|450213049|FG001|Overall Study|Other|1|||
125160414|NCT01970865|450213050|FG002|Overall Study|Other|0|||
125160415|NCT01970865|450213051|FG003|Overall Study|Other|1|||
125160416|NCT01970865|450213052|FG004|Overall Study|Other|1|||
125160417|NCT01970865|450213053|FG005|Overall Study|Other|0|||
125160418|NCT01970865|450213054|FG006|Overall Study|Other|1|||
125160419|NCT01970865|450213055|FG007|Overall Study|Other|0|||
125160420|NCT01970865|450213056|FG008|Overall Study|Other|0|||
125160421|NCT01970865|450213057|FG009|Overall Study|Other|0|||
125160422|NCT01970865|450213058|FG010|Overall Study|Other|2|||
125224205|NCT03713684|450448094|FG003|Overall Study|Withdrawal by Subject|16|||
125160423|NCT01970865|450213059|FG011|Overall Study|Other|3|||
125160424|NCT01970865|450213060|FG012|Overall Study|Other|8|||
125160425|NCT01970865|450213061|FG013|Overall Study|Other|3|||
125160426|NCT01970865|450213062|FG014|Overall Study|Other|2|||
125160427|NCT01970865|450213063|FG015|Overall Study|Other|3|||
125160428|NCT01970865|450213064|FG016|Overall Study|Other|0|||
125160429|NCT01970865|450213065|FG017|Overall Study|Other|2|||
125160430|NCT01970865|450213048|FG000|Overall Study|Participant refused further follow-up|0|||
125160431|NCT01970865|450213049|FG001|Overall Study|Participant refused further follow-up|0|||
125160432|NCT01970865|450213050|FG002|Overall Study|Participant refused further follow-up|0|||
125160433|NCT01970865|450213051|FG003|Overall Study|Participant refused further follow-up|2|||
125160434|NCT01970865|450213052|FG004|Overall Study|Participant refused further follow-up|3|||
125160435|NCT01970865|450213053|FG005|Overall Study|Participant refused further follow-up|0|||
125160436|NCT01970865|450213054|FG006|Overall Study|Participant refused further follow-up|0|||
125160437|NCT01970865|450213055|FG007|Overall Study|Participant refused further follow-up|0|||
125160438|NCT01970865|450213056|FG008|Overall Study|Participant refused further follow-up|0|||
125160439|NCT01970865|450213057|FG009|Overall Study|Participant refused further follow-up|0|||
125160440|NCT01970865|450213058|FG010|Overall Study|Participant refused further follow-up|1|||
125160441|NCT01970865|450213059|FG011|Overall Study|Participant refused further follow-up|4|||
125160442|NCT01970865|450213060|FG012|Overall Study|Participant refused further follow-up|7|||
125160443|NCT01970865|450213061|FG013|Overall Study|Participant refused further follow-up|8|||
125160444|NCT01970865|450213062|FG014|Overall Study|Participant refused further follow-up|3|||
125160445|NCT01970865|450213063|FG015|Overall Study|Participant refused further follow-up|11|||
125160446|NCT01970865|450213064|FG016|Overall Study|Participant refused further follow-up|0|||
125160447|NCT01970865|450213065|FG017|Overall Study|Participant refused further follow-up|6|||
125160448|NCT01855074|450213068|FG000|Overall Study|Adverse Event|1|||
125160449|NCT01855074|450213068|FG000|Overall Study|Lost to Follow-up|4|||
125160450|NCT01855074|450213068|FG000|Overall Study|Withdrawal by Subject|8|||
125160451|NCT01855074|450213068|FG000|Overall Study|Started but not treated|1|||
125160452|NCT01150890|450213069|FG000|Overall Study|Other|0|||
125160453|NCT01150890|450213070|FG001|Overall Study|Other|1|||
125160454|NCT01150890|450213071|FG002|Overall Study|Other|0|||
125160455|NCT01150890|450213072|FG003|Overall Study|Other|2|||
125160456|NCT01150890|450213069|FG000|Overall Study|Pregnancy|0|||
125160457|NCT01150890|450213070|FG001|Overall Study|Pregnancy|0|||
125160458|NCT01150890|450213071|FG002|Overall Study|Pregnancy|0|||
125160459|NCT01150890|450213072|FG003|Overall Study|Pregnancy|1|||
125160460|NCT01150890|450213069|FG000|Overall Study|Administrative Decision|4|||
125160461|NCT01150890|450213070|FG001|Overall Study|Administrative Decision|4|||
125160462|NCT01150890|450213071|FG002|Overall Study|Administrative Decision|5|||
125160463|NCT01150890|450213072|FG003|Overall Study|Administrative Decision|6|||
125160464|NCT01150890|450213069|FG000|Overall Study|Ineligibility determined|0|||
125160465|NCT01150890|450213070|FG001|Overall Study|Ineligibility determined|1|||
125160466|NCT01150890|450213071|FG002|Overall Study|Ineligibility determined|0|||
125160467|NCT01150890|450213072|FG003|Overall Study|Ineligibility determined|0|||
125160468|NCT01150890|450213069|FG000|Overall Study|Adverse Event|0|||
125160469|NCT01150890|450213070|FG001|Overall Study|Adverse Event|0|||
125160470|NCT01150890|450213071|FG002|Overall Study|Adverse Event|2|||
125160471|NCT01150890|450213072|FG003|Overall Study|Adverse Event|0|||
125160472|NCT01150890|450213069|FG000|Overall Study|Withdrawal by Subject|0|||
125160473|NCT01150890|450213070|FG001|Overall Study|Withdrawal by Subject|0|||
125160474|NCT01150890|450213071|FG002|Overall Study|Withdrawal by Subject|2|||
125160475|NCT01150890|450213072|FG003|Overall Study|Withdrawal by Subject|1|||
125160476|NCT01150890|450213069|FG000|Overall Study|Disease progression|0|||
125160477|NCT01150890|450213070|FG001|Overall Study|Disease progression|7|||
125160478|NCT01150890|450213071|FG002|Overall Study|Disease progression|3|||
125160479|NCT01150890|450213072|FG003|Overall Study|Disease progression|7|||
125160480|NCT03071094|450213076|FG000|Overall Study|Death|1|||
125160481|NCT03071094|450213077|FG001|Overall Study|Death|1|||
125160482|NCT03071094|450213076|FG000|Overall Study|Adverse Event|1|||
125160483|NCT03071094|450213077|FG001|Overall Study|Adverse Event|0|||
125160484|NCT02312063|450213078|FG000|Overall Study|Withdrawal by Subject|0|||
125160485|NCT02312063|450213079|FG001|Overall Study|Withdrawal by Subject|1|||
125160486|NCT01079832|450213080|FG000|Overall Study|Withdrawal by Subject|1|||
125160487|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
125160488|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
125160489|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160490|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160491|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160492|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160493|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160494|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160495|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160496|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160497|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160498|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160499|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160500|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160501|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
125160502|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
125160503|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160504|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160505|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160506|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160507|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160508|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160509|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160510|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160511|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160512|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160513|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160514|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160515|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
125160516|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
125160517|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125160518|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125160519|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125160520|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125224206|NCT03713684|450448091|FG000|Overall Study|Other than specified|69|||
125224207|NCT03713684|450448092|FG001|Overall Study|Other than specified|77|||
125160521|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125160522|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125160523|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125160524|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125160525|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125160526|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125160527|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125160528|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125160529|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
125160530|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
125160531|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160532|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160533|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160534|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160535|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160536|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160537|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160538|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160539|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160540|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160541|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160542|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160543|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
125160544|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
125160545|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160546|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160547|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160548|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160549|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160550|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160551|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160552|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160553|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160554|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160555|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160556|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160557|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
125160558|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
125160559|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160560|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160561|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160562|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160563|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160564|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160565|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160566|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160567|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160568|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160569|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160570|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160571|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
125160572|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
125160573|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125160574|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125160575|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125160576|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125160577|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125160578|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125160579|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125160580|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125160581|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125160582|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125160583|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125160584|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125224208|NCT03713684|450448093|FG002|Overall Study|Other than specified|73|||
125224209|NCT03713684|450448094|FG003|Overall Study|Other than specified|70|||
125224210|NCT02185417|450448095|FG000|Overall Study|Death|448|||
125224211|NCT02185417|450448096|FG001|Overall Study|Death|446|||
125224212|NCT02185417|450448097|FG002|Overall Study|Death|0|||
125224213|NCT02185417|450448095|FG000|Overall Study|Withdrawal by Subject|7|||
125224214|NCT02185417|450448096|FG001|Overall Study|Withdrawal by Subject|12|||
125160585|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
125224215|NCT02185417|450448097|FG002|Overall Study|Withdrawal by Subject|0|||
125224216|NCT02595502|450448098|FG000|Period 1|Adverse Event|0|||
125224217|NCT02595502|450448099|FG001|Period 1|Adverse Event|1|||
125224218|NCT02595502|450448098|FG000|Period 1|Withdrawal by Subject|1|||
125224219|NCT02595502|450448099|FG001|Period 1|Withdrawal by Subject|0|||
125224220|NCT02595502|450448098|FG000|Period 1|Lost to Follow-up|0|||
125224221|NCT02595502|450448099|FG001|Period 1|Lost to Follow-up|1|||
125224222|NCT02595502|450448098|FG000|Period 2|Adverse Event|1|||
125224223|NCT02595502|450448099|FG001|Period 2|Adverse Event|1|||
125224224|NCT02595502|450448098|FG000|Period 2|Received incorrect lens at Period 1|0|||
125224225|NCT02595502|450448099|FG001|Period 2|Received incorrect lens at Period 1|1|||
125224226|NCT02595502|450448098|FG000|Period 3|Protocol Violation|0|||
125224227|NCT02595502|450448099|FG001|Period 3|Protocol Violation|1|||
125224228|NCT02595502|450448098|FG000|Period 3|Lost to Follow-up|1|||
125224229|NCT02595502|450448099|FG001|Period 3|Lost to Follow-up|0|||
125224230|NCT02595502|450448098|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
125224231|NCT02595502|450448099|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
125224232|NCT00974311|450448100|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
125224233|NCT00974311|450448101|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
125224234|NCT00974311|450448100|FG000|DB Phase (up to 24 Months)|Death|561|||
125224235|NCT00974311|450448101|FG001|DB Phase (up to 24 Months)|Death|298|||
125224236|NCT00974311|450448100|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
125224237|NCT00974311|450448101|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
125224238|NCT00974311|450448100|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
125224239|NCT00974311|450448101|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
125224240|NCT00974311|450448100|FG000|DB Phase (up to 24 Months)|Other|1|||
125224241|NCT00974311|450448101|FG001|DB Phase (up to 24 Months)|Other|0|||
125224242|NCT00974311|450448100|FG000|OLE Phase (up to 77 Months)|Death|14|||
125224243|NCT00974311|450448101|FG001|OLE Phase (up to 77 Months)|Death|21|||
125224244|NCT00974311|450448100|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
125224245|NCT00974311|450448101|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
125224246|NCT00974311|450448100|FG000|OLE Phase (up to 77 Months)|Other|15|||
125224247|NCT00974311|450448101|FG001|OLE Phase (up to 77 Months)|Other|2|||
125224248|NCT00974311|450448100|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
125224249|NCT00974311|450448101|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
125224250|NCT05556148|450448104|FG000|Overall Study|Early Termination|29|||
125224251|NCT05556148|450448104|FG000|Overall Study|Baseline Tasks Expired|4|||
125224252|NCT05556148|450448104|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
125224253|NCT05556148|450448104|FG000|Overall Study|No Longer Wished to Participate|1|||
125224254|NCT05556148|450448104|FG000|Overall Study|Bacterial Conjunctivitis|1|||
125224255|NCT00458003|450448105|FG000|Overall Study|Non protocol spinal anesthesia|1|||
125224256|NCT00458003|450448106|FG001|Overall Study|Non protocol spinal anesthesia|1|||
125224257|NCT04176939|450448109|FG000|Overall Study|Withdrawal by Subject|5|||
125224258|NCT04176939|450448109|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
125224259|NCT04176939|450448109|FG000|Overall Study|Lost to Follow-up|2|||
125224260|NCT04176939|450448109|FG000|Overall Study|Unspecified reason|4|||
125224261|NCT04176939|450448109|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
125224262|NCT01529606|450448112|FG000|Overall Study|Lost to Follow-up|21|||
125224263|NCT01529606|450448113|FG001|Overall Study|Lost to Follow-up|18|||
125224264|NCT01746862|450448116|FG000|Overall Study|Withdrawal by Subject|1|||
125224265|NCT01746862|450448117|FG001|Overall Study|Withdrawal by Subject|1|||
125224266|NCT01746862|450448116|FG000|Overall Study|Protocol Violation|1|||
125224267|NCT01746862|450448117|FG001|Overall Study|Protocol Violation|0|||
125224268|NCT01746862|450448116|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
125224269|NCT01746862|450448117|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
125224270|NCT01746862|450448116|FG000|Overall Study|Entered puberty during the study|1|||
125224271|NCT01746862|450448117|FG001|Overall Study|Entered puberty during the study|0|||
125224272|NCT04742673|450448118|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
125224273|NCT04742673|450448119|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
125224274|NCT01900444|450448120|FG000|Overall Study|Protocol Violation|2|||
125224275|NCT01900444|450448120|FG000|Overall Study|Lost to Follow-up|1|||
125160586|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
125160587|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160588|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160589|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160590|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160591|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160592|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160593|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160594|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160595|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160596|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160597|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160598|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160599|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
125160600|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
125160601|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160602|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160603|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160604|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160605|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160606|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160607|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160608|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160609|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160610|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160611|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160612|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160613|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
125160614|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
125160615|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160616|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160617|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160618|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160619|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160620|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160621|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160622|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160623|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160624|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160625|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160626|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160627|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
125160628|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
125160629|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160630|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160631|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160632|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160633|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160634|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160635|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160636|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160637|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160638|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160639|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160640|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160641|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
125160642|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
125160643|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160644|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160645|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160646|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160647|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160648|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160649|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160650|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160651|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160652|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160653|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160654|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160655|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160656|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160657|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160658|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
125160659|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160660|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160661|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160662|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160663|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160664|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160665|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160666|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160667|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160668|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160669|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125224276|NCT00072384|450448124|FG000|Overall Study|Physician Decision|1|||
125224277|NCT00072384|450448124|FG000|Overall Study|Ineligible|8|||
125224278|NCT01825200|450448125|FG000|Overall Study|Lost to Follow-up|5|||
125224279|NCT01825200|450448126|FG001|Overall Study|Lost to Follow-up|6|||
125224280|NCT01825200|450448125|FG000|Overall Study|Withdrawal by Subject|0|||
125224281|NCT01825200|450448126|FG001|Overall Study|Withdrawal by Subject|1|||
125224282|NCT00490035|450448127|FG000|Overall Study|AE, non-serious non-fatal|3|||
125224283|NCT00490035|450448128|FG001|Overall Study|AE, non-serious non-fatal|4|||
125224284|NCT00490035|450448129|FG002|Overall Study|AE, non-serious non-fatal|4|||
125224285|NCT00490035|450448130|FG003|Overall Study|AE, non-serious non-fatal|5|||
125224286|NCT00490035|450448127|FG000|Overall Study|Lost to Follow-up|2|||
125224287|NCT00490035|450448128|FG001|Overall Study|Lost to Follow-up|0|||
125224288|NCT00490035|450448129|FG002|Overall Study|Lost to Follow-up|1|||
125224289|NCT00490035|450448130|FG003|Overall Study|Lost to Follow-up|0|||
125224290|NCT00490035|450448127|FG000|Overall Study|Withdrawal by Subject|2|||
125224291|NCT00490035|450448128|FG001|Overall Study|Withdrawal by Subject|1|||
125224292|NCT00490035|450448129|FG002|Overall Study|Withdrawal by Subject|1|||
125224293|NCT00490035|450448130|FG003|Overall Study|Withdrawal by Subject|0|||
125224294|NCT00490035|450448127|FG000|Overall Study|Other reason|0|||
125224295|NCT00490035|450448128|FG001|Overall Study|Other reason|1|||
125224296|NCT00490035|450448129|FG002|Overall Study|Other reason|3|||
125224297|NCT00490035|450448130|FG003|Overall Study|Other reason|1|||
125224298|NCT00490035|450448127|FG000|Overall Study|AE, serious fatal|1|||
125224299|NCT00490035|450448128|FG001|Overall Study|AE, serious fatal|0|||
125224300|NCT00490035|450448129|FG002|Overall Study|AE, serious fatal|0|||
125224301|NCT00490035|450448130|FG003|Overall Study|AE, serious fatal|0|||
125224302|NCT00490035|450448127|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
125224303|NCT00490035|450448128|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
125224304|NCT00490035|450448129|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
125224305|NCT00490035|450448130|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
125224306|NCT00490035|450448127|FG000|Overall Study|AE of unknown type|0|||
125224307|NCT00490035|450448128|FG001|Overall Study|AE of unknown type|0|||
125224308|NCT00490035|450448129|FG002|Overall Study|AE of unknown type|2|||
125224309|NCT00490035|450448130|FG003|Overall Study|AE of unknown type|0|||
125224310|NCT06058390|450448134|FG000|Overall Study|Lost to Follow-up|0|||
125224311|NCT06058390|450448135|FG001|Overall Study|Lost to Follow-up|0|||
125224312|NCT06058390|450448136|FG002|Overall Study|Lost to Follow-up|2|||
125224313|NCT06058390|450448137|FG003|Overall Study|Lost to Follow-up|1|||
125224314|NCT06058390|450448134|FG000|Overall Study|Physician Decision|0|||
125224315|NCT06058390|450448135|FG001|Overall Study|Physician Decision|0|||
125224316|NCT06058390|450448136|FG002|Overall Study|Physician Decision|0|||
125224317|NCT06058390|450448137|FG003|Overall Study|Physician Decision|1|||
125224318|NCT06058390|450448134|FG000|Overall Study|Participants did not receive any study intervention|0|||
125224319|NCT06058390|450448135|FG001|Overall Study|Participants did not receive any study intervention|0|||
125224320|NCT06058390|450448136|FG002|Overall Study|Participants did not receive any study intervention|0|||
125224321|NCT06058390|450448137|FG003|Overall Study|Participants did not receive any study intervention|1|||
125224322|NCT03361306|450448140|FG000|Overall Study|Death|6|||
125224323|NCT04817332|450448143|FG000|Overall Study|Lost to Follow-up|3|||
125224324|NCT04817332|450448144|FG001|Overall Study|Lost to Follow-up|3|||
125224325|NCT04817332|450448143|FG000|Overall Study|Protocol Violation|2|||
125224326|NCT04817332|450448144|FG001|Overall Study|Protocol Violation|0|||
125224327|NCT04795466|450448150|FG000|Overall Study|Adverse Event|3|||
125224328|NCT04795466|450448151|FG001|Overall Study|Adverse Event|1|||
125224329|NCT04795466|450448150|FG000|Overall Study|Physician Decision|1|||
125224330|NCT04795466|450448151|FG001|Overall Study|Physician Decision|0|||
125224331|NCT04795466|450448150|FG000|Overall Study|Withdrawal by Subject|2|||
125224332|NCT04795466|450448151|FG001|Overall Study|Withdrawal by Subject|1|||
125224333|NCT05635045|450448152|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
125160670|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125160671|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
125160672|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125160673|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125160674|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125160675|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125160676|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125160677|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125160678|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125160679|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125160680|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125160681|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125160682|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125160683|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160684|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160685|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
125160686|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160687|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160688|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160689|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160690|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160691|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160692|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160693|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160694|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160695|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160696|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160697|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160698|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160699|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
125160700|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
125160701|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160702|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160703|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160704|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160705|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160706|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160707|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160708|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160709|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160710|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160711|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160712|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160713|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160714|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
125160715|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160716|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160717|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160718|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160719|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160720|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160721|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160722|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160723|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160724|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160725|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160726|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160727|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
125160728|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
125160729|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160730|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160731|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160732|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160733|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160734|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160735|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160736|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160737|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160738|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125224334|NCT05635045|450448153|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
125224335|NCT05635045|450448154|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
125224336|NCT05635045|450448155|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
125224337|NCT02131064|450448163|FG000|Overall Study|Death|5|||
125224338|NCT02131064|450448164|FG001|Overall Study|Death|6|||
125224339|NCT02131064|450448163|FG000|Overall Study|Lost to Follow-up|4|||
125224340|NCT02131064|450448164|FG001|Overall Study|Lost to Follow-up|8|||
125224341|NCT02131064|450448163|FG000|Overall Study|Withdrawal by Subject|14|||
125224342|NCT02131064|450448164|FG001|Overall Study|Withdrawal by Subject|18|||
125224343|NCT02131064|450448163|FG000|Overall Study|Other|2|||
125224344|NCT02131064|450448164|FG001|Overall Study|Other|2|||
125224345|NCT00810069|450448165|FG000|Lead-in Period I|Adverse Event|43|||
125224346|NCT00810069|450448166|FG001|Lead-in Period I|Adverse Event|0|||
125224347|NCT00810069|450448167|FG002|Lead-in Period I|Adverse Event|0|||
125224348|NCT00810069|450448165|FG000|Lead-in Period I|Lack of Efficacy|1|||
125224349|NCT00810069|450448166|FG001|Lead-in Period I|Lack of Efficacy|0|||
125224350|NCT00810069|450448167|FG002|Lead-in Period I|Lack of Efficacy|0|||
125224351|NCT00810069|450448165|FG000|Lead-in Period I|Lost to Follow-up|19|||
125224352|NCT00810069|450448166|FG001|Lead-in Period I|Lost to Follow-up|0|||
125224353|NCT00810069|450448167|FG002|Lead-in Period I|Lost to Follow-up|0|||
125224354|NCT00810069|450448165|FG000|Lead-in Period I|Physician Decision|1|||
125224355|NCT00810069|450448166|FG001|Lead-in Period I|Physician Decision|0|||
125224356|NCT00810069|450448167|FG002|Lead-in Period I|Physician Decision|0|||
125224357|NCT00810069|450448165|FG000|Lead-in Period I|Protocol Violation|1|||
125224358|NCT00810069|450448166|FG001|Lead-in Period I|Protocol Violation|0|||
125224359|NCT00810069|450448167|FG002|Lead-in Period I|Protocol Violation|0|||
125224360|NCT00810069|450448165|FG000|Lead-in Period I|Withdrawal by Subject|46|||
125224361|NCT00810069|450448166|FG001|Lead-in Period I|Withdrawal by Subject|0|||
125224362|NCT00810069|450448167|FG002|Lead-in Period I|Withdrawal by Subject|0|||
125224363|NCT00810069|450448165|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
125224364|NCT00810069|450448166|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
125224365|NCT00810069|450448167|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
125224366|NCT00810069|450448165|FG000|Lead-in Period I|Randomization criteria not met|158|||
125224367|NCT00810069|450448166|FG001|Lead-in Period I|Randomization criteria not met|0|||
125224368|NCT00810069|450448167|FG002|Lead-in Period I|Randomization criteria not met|0|||
125224369|NCT00810069|450448165|FG000|Double-Blind Period II|Adverse Event|0|||
125224370|NCT00810069|450448166|FG001|Double-Blind Period II|Adverse Event|9|||
125224371|NCT00810069|450448167|FG002|Double-Blind Period II|Adverse Event|8|||
125224372|NCT00810069|450448165|FG000|Double-Blind Period II|Lack of Efficacy|0|||
125224373|NCT00810069|450448166|FG001|Double-Blind Period II|Lack of Efficacy|7|||
125224374|NCT00810069|450448167|FG002|Double-Blind Period II|Lack of Efficacy|12|||
125224375|NCT00810069|450448165|FG000|Double-Blind Period II|Lost to Follow-up|0|||
125224376|NCT00810069|450448166|FG001|Double-Blind Period II|Lost to Follow-up|9|||
125224377|NCT00810069|450448167|FG002|Double-Blind Period II|Lost to Follow-up|9|||
125224378|NCT00810069|450448165|FG000|Double-Blind Period II|Physician Decision|0|||
125224379|NCT00810069|450448166|FG001|Double-Blind Period II|Physician Decision|0|||
125224380|NCT00810069|450448167|FG002|Double-Blind Period II|Physician Decision|1|||
125224381|NCT00810069|450448165|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
125224382|NCT00810069|450448166|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
125224383|NCT00810069|450448167|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
125224384|NCT00810069|450448165|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
125224385|NCT00810069|450448166|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
125224386|NCT00810069|450448167|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
125224387|NCT00810069|450448165|FG000|Double-Blind Period II|Clinical relapse|0|||
125224388|NCT00810069|450448166|FG001|Double-Blind Period II|Clinical relapse|3|||
125224389|NCT00810069|450448167|FG002|Double-Blind Period II|Clinical relapse|0|||
125224390|NCT00810069|450448165|FG000|Double-Blind Period II|Protocol Violation|0|||
125224391|NCT00810069|450448166|FG001|Double-Blind Period II|Protocol Violation|7|||
125224392|NCT00810069|450448167|FG002|Double-Blind Period II|Protocol Violation|6|||
125224393|NCT00971867|450448171|FG000|Overall Study|Adverse Event|4|||
125224394|NCT00971867|450448171|FG000|Overall Study|Participant Withdrew Consent|1|||
125224395|NCT00971867|450448171|FG000|Overall Study|Disease Progression|6|||
125224396|NCT04767373|450448172|FG000|Overall Study|Death|6|||
125224397|NCT04767373|450448173|FG001|Overall Study|Death|3|||
125224398|NCT04767373|450448172|FG000|Overall Study|Lost to Follow-up|67|||
125224399|NCT04767373|450448173|FG001|Overall Study|Lost to Follow-up|35|||
125224400|NCT04767373|450448172|FG000|Overall Study|Physician Decision|15|||
125224401|NCT04767373|450448173|FG001|Overall Study|Physician Decision|4|||
125224402|NCT04767373|450448172|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125224403|NCT04767373|450448173|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
125224404|NCT04767373|450448172|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
125224405|NCT04767373|450448173|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
125224406|NCT04767373|450448172|FG000|Overall Study|Other|1|||
125224407|NCT04767373|450448173|FG001|Overall Study|Other|2|||
125224408|NCT00593918|450448175|FG000|Overall Study|Withdrawal by Subject|5|||
125224409|NCT00593918|450448176|FG001|Overall Study|Withdrawal by Subject|24|||
125224410|NCT02983045|450448177|FG000|Overall Study|Withdrawal by Subject|0|||
125224411|NCT02983045|450448178|FG001|Overall Study|Withdrawal by Subject|1|||
125224412|NCT02983045|450448179|FG002|Overall Study|Withdrawal by Subject|0|||
125224413|NCT02983045|450448180|FG003|Overall Study|Withdrawal by Subject|5|||
125224414|NCT02983045|450448181|FG004|Overall Study|Withdrawal by Subject|0|||
125224415|NCT02983045|450448182|FG005|Overall Study|Withdrawal by Subject|72|||
125224416|NCT02983045|450448183|FG006|Overall Study|Withdrawal by Subject|0|||
125224417|NCT02983045|450448184|FG007|Overall Study|Withdrawal by Subject|0|||
125224418|NCT02983045|450448185|FG008|Overall Study|Withdrawal by Subject|0|||
125224419|NCT02983045|450448186|FG009|Overall Study|Withdrawal by Subject|2|||
125224420|NCT02983045|450448177|FG000|Overall Study|Lost to Follow-up|0|||
125224421|NCT02983045|450448178|FG001|Overall Study|Lost to Follow-up|0|||
125224422|NCT02983045|450448179|FG002|Overall Study|Lost to Follow-up|0|||
125224423|NCT02983045|450448180|FG003|Overall Study|Lost to Follow-up|0|||
125224424|NCT02983045|450448181|FG004|Overall Study|Lost to Follow-up|0|||
125224425|NCT02983045|450448182|FG005|Overall Study|Lost to Follow-up|10|||
125224426|NCT02983045|450448183|FG006|Overall Study|Lost to Follow-up|0|||
125224427|NCT02983045|450448184|FG007|Overall Study|Lost to Follow-up|0|||
125224428|NCT02983045|450448185|FG008|Overall Study|Lost to Follow-up|0|||
125224429|NCT02983045|450448186|FG009|Overall Study|Lost to Follow-up|0|||
125224430|NCT02658669|450448187|FG000|Overall Study|Lost to Follow-up|7|||
125160739|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160740|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160741|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160742|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160743|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160744|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160745|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160746|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160747|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
125160748|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160749|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160750|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160751|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160752|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160753|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160754|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160755|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160756|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160757|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160758|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160759|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160760|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125224431|NCT02658669|450448188|FG001|Overall Study|Lost to Follow-up|5|||
125224432|NCT03727841|450448189|FG000|Overall Study|Physician Decision|3|||
125224433|NCT03727841|450448190|FG001|Overall Study|Physician Decision|1|||
125224434|NCT01601496|450448191|FG000|Overall Study|Physician Decision|1|||
125224435|NCT01601496|450448191|FG000|Overall Study|Withdrawal by Subject|1|||
125224436|NCT01601496|450448191|FG000|Overall Study|Lost to Follow-up|6|||
125224437|NCT01601496|450448191|FG000|Overall Study|Death|4|||
125160761|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
125160762|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160763|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160764|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160765|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160766|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160767|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160768|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160769|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160770|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160771|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160772|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160773|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160774|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160775|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
125160776|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160777|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160778|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160779|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160780|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160781|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160782|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160783|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160784|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160785|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160786|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160787|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160788|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160789|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
125160790|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160791|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160792|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160793|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160794|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160795|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160796|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160797|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160798|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160799|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160800|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160801|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160802|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160803|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
125160804|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160805|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160806|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160807|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160808|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160809|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125160810|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125160811|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125160812|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125160813|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125160814|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
125160815|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125160816|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
125160817|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
125160818|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125160819|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125160820|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125160821|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125160822|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125160823|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160824|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160825|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160826|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160827|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160828|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160829|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160830|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160831|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
125160832|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160833|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160834|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160835|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160836|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160837|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160838|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160839|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160840|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160841|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160842|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
125160843|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160844|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
125160845|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
125160846|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160847|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160848|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160849|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160850|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160851|NCT03982199|450213081|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
125224438|NCT01601496|450448191|FG000|Overall Study|Other: patient refusal to continue|3|||
125224439|NCT03771963|450448199|FG000|Overall Study|Lost to Follow-up|22|||
125224440|NCT03771963|450448199|FG000|Overall Study|Withdrawal of Consent|10|||
125224441|NCT03014206|450448200|FG000|Overall Study|Registration Violation|12|||
125224442|NCT05502302|450448201|FG000|Overall Study|Lost to Follow-up|6|||
125224443|NCT05502302|450448201|FG000|Overall Study|Death|2|||
125224444|NCT02358031|450450091|FG000|Overall Study|Death|253|||
125224445|NCT02358031|450450092|FG001|Overall Study|Death|237|||
125224446|NCT02358031|450450093|FG002|Overall Study|Death|266|||
125224447|NCT02358031|450450091|FG000|Overall Study|Lost to Follow-up|1|||
125224448|NCT02358031|450450092|FG001|Overall Study|Lost to Follow-up|1|||
125224449|NCT02358031|450450093|FG002|Overall Study|Lost to Follow-up|0|||
125224450|NCT02358031|450450091|FG000|Overall Study|Withdrawal by Subject|19|||
125224451|NCT02358031|450450092|FG001|Overall Study|Withdrawal by Subject|14|||
125224452|NCT02358031|450450093|FG002|Overall Study|Withdrawal by Subject|18|||
125224453|NCT02358031|450450091|FG000|Overall Study|Sponsor Decision|26|||
125224454|NCT02358031|450450092|FG001|Overall Study|Sponsor Decision|28|||
125224455|NCT02358031|450450093|FG002|Overall Study|Sponsor Decision|16|||
125224456|NCT05664581|450450094|FG000|Overall Study|Withdrawal by Subject|2|||
125224457|NCT03101150|450450097|FG000|Overall Study|Lost to Follow-up|2|||
125224458|NCT03101150|450450098|FG001|Overall Study|Lost to Follow-up|4|||
125224459|NCT03101150|450450097|FG000|Overall Study|Miscarriage|3|||
125224460|NCT03101150|450450098|FG001|Overall Study|Miscarriage|6|||
125224461|NCT03163446|450450099|FG000|Overall Study|Unable to return for Day 180 visit|2|||
125224462|NCT03163446|450450100|FG001|Overall Study|Unable to return for Day 180 visit|0|||
125224463|NCT03163446|450450099|FG000|Overall Study|Withdrawal by Subject|2|||
125224464|NCT03163446|450450100|FG001|Overall Study|Withdrawal by Subject|6|||
125224465|NCT03163446|450450099|FG000|Overall Study|Death|16|||
125224466|NCT03163446|450450100|FG001|Overall Study|Death|5|||
125224467|NCT03163446|450450099|FG000|Overall Study|Lost to Follow-up|6|||
125224468|NCT03163446|450450100|FG001|Overall Study|Lost to Follow-up|5|||
125224469|NCT03163446|450450099|FG000|Overall Study|Physician Decision|1|||
125224470|NCT03163446|450450100|FG001|Overall Study|Physician Decision|1|||
125224471|NCT03163446|450450099|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
125224472|NCT03163446|450450100|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
125224473|NCT01317641|450450101|FG000|Overall Study|Not treated|0|||
125224474|NCT01317641|450450102|FG001|Overall Study|Not treated|0|||
125224475|NCT01317641|450450103|FG002|Overall Study|Not treated|0|||
125224476|NCT01317641|450450104|FG003|Overall Study|Not treated|0|||
125224477|NCT01317641|450450105|FG004|Overall Study|Not treated|0|||
125224478|NCT01317641|450450106|FG005|Overall Study|Not treated|0|||
125224479|NCT01317641|450450107|FG006|Overall Study|Not treated|0|||
125224480|NCT01317641|450450108|FG007|Overall Study|Not treated|1|||
125224481|NCT01317641|450450109|FG008|Overall Study|Not treated|1|||
125224482|NCT01317641|450450101|FG000|Overall Study|Adverse Event|0|||
125224483|NCT01317641|450450102|FG001|Overall Study|Adverse Event|1|||
125224484|NCT01317641|450450103|FG002|Overall Study|Adverse Event|0|||
125224485|NCT01317641|450450104|FG003|Overall Study|Adverse Event|1|||
125224486|NCT01317641|450450105|FG004|Overall Study|Adverse Event|0|||
125224487|NCT01317641|450450106|FG005|Overall Study|Adverse Event|0|||
125224488|NCT01317641|450450107|FG006|Overall Study|Adverse Event|2|||
125224489|NCT01317641|450450108|FG007|Overall Study|Adverse Event|1|||
125224490|NCT01317641|450450109|FG008|Overall Study|Adverse Event|0|||
125224491|NCT01317641|450450101|FG000|Overall Study|Protocol Violation|1|||
125224492|NCT01317641|450450102|FG001|Overall Study|Protocol Violation|0|||
125224493|NCT01317641|450450103|FG002|Overall Study|Protocol Violation|0|||
125224494|NCT01317641|450450104|FG003|Overall Study|Protocol Violation|0|||
125224495|NCT01317641|450450105|FG004|Overall Study|Protocol Violation|0|||
125224496|NCT01317641|450450106|FG005|Overall Study|Protocol Violation|0|||
125224497|NCT01317641|450450107|FG006|Overall Study|Protocol Violation|0|||
125224498|NCT01317641|450450108|FG007|Overall Study|Protocol Violation|0|||
125224499|NCT01317641|450450109|FG008|Overall Study|Protocol Violation|0|||
125224500|NCT01317641|450450101|FG000|Overall Study|Disease progression|0|||
125224501|NCT01317641|450450102|FG001|Overall Study|Disease progression|0|||
125224502|NCT01317641|450450103|FG002|Overall Study|Disease progression|0|||
125224503|NCT01317641|450450104|FG003|Overall Study|Disease progression|0|||
125224504|NCT01317641|450450105|FG004|Overall Study|Disease progression|0|||
125224505|NCT01317641|450450106|FG005|Overall Study|Disease progression|0|||
125224506|NCT01317641|450450107|FG006|Overall Study|Disease progression|0|||
125224507|NCT01317641|450450108|FG007|Overall Study|Disease progression|3|||
125224508|NCT01317641|450450109|FG008|Overall Study|Disease progression|4|||
125224509|NCT01317641|450450101|FG000|Overall Study|Withdrawal by Subject|0|||
125224510|NCT01317641|450450102|FG001|Overall Study|Withdrawal by Subject|0|||
125224511|NCT01317641|450450103|FG002|Overall Study|Withdrawal by Subject|0|||
125224512|NCT01317641|450450104|FG003|Overall Study|Withdrawal by Subject|0|||
125160852|NCT03982199|450213082|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
125160853|NCT03982199|450213083|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
125160854|NCT03982199|450213084|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
125160855|NCT03982199|450213085|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
125160856|NCT03982199|450213086|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
125160857|NCT03982199|450213087|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
125160858|NCT03982199|450213088|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
125160859|NCT03982199|450213089|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
125160860|NCT03982199|450213090|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
125160861|NCT03982199|450213091|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
125160862|NCT03982199|450213092|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
125160863|NCT03982199|450213093|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
125160864|NCT03982199|450213094|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
125160865|NCT03982199|450213081|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160866|NCT03982199|450213082|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160867|NCT03982199|450213083|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160868|NCT03982199|450213084|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160869|NCT03982199|450213085|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160870|NCT03982199|450213086|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160871|NCT03982199|450213087|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160872|NCT03982199|450213088|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160873|NCT03982199|450213089|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160874|NCT03982199|450213090|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
125224513|NCT01317641|450450105|FG004|Overall Study|Withdrawal by Subject|0|||
125224514|NCT01317641|450450106|FG005|Overall Study|Withdrawal by Subject|0|||
125224515|NCT01317641|450450107|FG006|Overall Study|Withdrawal by Subject|1|||
125224516|NCT01317641|450450108|FG007|Overall Study|Withdrawal by Subject|0|||
125224517|NCT01317641|450450109|FG008|Overall Study|Withdrawal by Subject|0|||
125160875|NCT03982199|450213091|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160876|NCT03982199|450213092|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160877|NCT03982199|450213093|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160878|NCT03982199|450213094|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160879|NCT03982199|450213081|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160880|NCT03982199|450213082|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160881|NCT03982199|450213083|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160882|NCT03982199|450213084|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160883|NCT03982199|450213085|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160884|NCT03982199|450213086|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160885|NCT03982199|450213087|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160886|NCT03982199|450213088|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160887|NCT03982199|450213089|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160888|NCT03982199|450213090|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160889|NCT03982199|450213091|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160890|NCT03982199|450213092|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160891|NCT03982199|450213093|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160892|NCT03982199|450213094|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
125160893|NCT03982199|450213081|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160894|NCT03982199|450213082|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160895|NCT03982199|450213083|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160896|NCT03982199|450213084|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160897|NCT03982199|450213085|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160898|NCT03982199|450213086|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160899|NCT03982199|450213087|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160900|NCT03982199|450213088|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160901|NCT03982199|450213089|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160902|NCT03982199|450213090|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160903|NCT03982199|450213091|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
125160904|NCT03982199|450213092|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
125160905|NCT03982199|450213093|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
125160906|NCT03982199|450213094|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160907|NCT03982199|450213081|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160908|NCT03982199|450213082|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160909|NCT03982199|450213083|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160910|NCT03982199|450213084|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160911|NCT03982199|450213085|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160912|NCT03982199|450213086|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160913|NCT03982199|450213087|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160914|NCT03982199|450213088|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160915|NCT03982199|450213089|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160916|NCT03982199|450213090|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160917|NCT03982199|450213091|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160918|NCT03982199|450213092|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160919|NCT03982199|450213093|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160920|NCT03982199|450213094|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
125160921|NCT03982199|450213081|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125160922|NCT03982199|450213082|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125160923|NCT03982199|450213083|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125224518|NCT01228591|450450112|FG000|Baseline|Lack of Efficacy|1|||
125224519|NCT01228591|450450113|FG001|Baseline|Lack of Efficacy|2|||
125224520|NCT01298700|450450114|FG000|Overall Study|Adverse Event|50|||
125224521|NCT01298700|450450115|FG001|Overall Study|Adverse Event|51|||
125224522|NCT01298700|450450114|FG000|Overall Study|Lack of Efficacy|9|||
125224523|NCT01298700|450450115|FG001|Overall Study|Lack of Efficacy|14|||
125224524|NCT01298700|450450114|FG000|Overall Study|Lost to Follow-up|5|||
125224525|NCT01298700|450450115|FG001|Overall Study|Lost to Follow-up|2|||
125224526|NCT01298700|450450114|FG000|Overall Study|Withdrawal by Subject|12|||
125224527|NCT01298700|450450115|FG001|Overall Study|Withdrawal by Subject|9|||
125224528|NCT01298700|450450114|FG000|Overall Study|Protocol Violation|6|||
125224529|NCT01298700|450450115|FG001|Overall Study|Protocol Violation|4|||
125224530|NCT01298700|450450114|FG000|Overall Study|Other Miscellaneous Reasons|16|||
125224531|NCT01298700|450450115|FG001|Overall Study|Other Miscellaneous Reasons|15|||
125224532|NCT01298700|450450114|FG000|Overall Study|Did not Receive Study Drug|3|||
125224533|NCT01298700|450450115|FG001|Overall Study|Did not Receive Study Drug|5|||
125224534|NCT00643760|450450120|FG000|Overall Study|Adverse Event|11|||
125224535|NCT00643760|450450121|FG001|Overall Study|Adverse Event|5|||
125224536|NCT00643760|450450122|FG002|Overall Study|Adverse Event|12|||
125224537|NCT00643760|450450123|FG003|Overall Study|Adverse Event|21|||
125224538|NCT00643760|450450124|FG004|Overall Study|Adverse Event|6|||
125224539|NCT00643760|450450120|FG000|Overall Study|Lack of Efficacy|3|||
125224540|NCT00643760|450450121|FG001|Overall Study|Lack of Efficacy|1|||
125224541|NCT00643760|450450122|FG002|Overall Study|Lack of Efficacy|0|||
125224542|NCT00643760|450450123|FG003|Overall Study|Lack of Efficacy|4|||
125224543|NCT00643760|450450124|FG004|Overall Study|Lack of Efficacy|3|||
125224544|NCT00643760|450450120|FG000|Overall Study|Protocol Violation|7|||
125224545|NCT00643760|450450121|FG001|Overall Study|Protocol Violation|6|||
125224546|NCT00643760|450450122|FG002|Overall Study|Protocol Violation|4|||
125224547|NCT00643760|450450123|FG003|Overall Study|Protocol Violation|4|||
125224548|NCT00643760|450450124|FG004|Overall Study|Protocol Violation|6|||
125224549|NCT00643760|450450120|FG000|Overall Study|Lost to Follow-up|6|||
125224550|NCT00643760|450450121|FG001|Overall Study|Lost to Follow-up|2|||
125224551|NCT00643760|450450122|FG002|Overall Study|Lost to Follow-up|1|||
125224552|NCT00643760|450450123|FG003|Overall Study|Lost to Follow-up|3|||
125224553|NCT00643760|450450124|FG004|Overall Study|Lost to Follow-up|3|||
125224554|NCT00643760|450450120|FG000|Overall Study|Investigator Discretion|0|||
125224555|NCT00643760|450450121|FG001|Overall Study|Investigator Discretion|0|||
125224556|NCT00643760|450450122|FG002|Overall Study|Investigator Discretion|0|||
125224557|NCT00643760|450450123|FG003|Overall Study|Investigator Discretion|2|||
125224558|NCT00643760|450450124|FG004|Overall Study|Investigator Discretion|0|||
125224559|NCT00643760|450450120|FG000|Overall Study|Withdrawal by Subject|3|||
125224560|NCT00643760|450450121|FG001|Overall Study|Withdrawal by Subject|1|||
125224561|NCT00643760|450450122|FG002|Overall Study|Withdrawal by Subject|2|||
125224562|NCT00643760|450450123|FG003|Overall Study|Withdrawal by Subject|4|||
125224563|NCT00643760|450450124|FG004|Overall Study|Withdrawal by Subject|1|||
125224564|NCT03934216|450450125|FG000|Overall Study|Other Reasons|5|||
125224565|NCT03934216|450450126|FG001|Overall Study|Other Reasons|5|||
125224566|NCT03934216|450450125|FG000|Overall Study|Adverse Event|22|||
125224567|NCT03934216|450450126|FG001|Overall Study|Adverse Event|11|||
125224568|NCT03934216|450450125|FG000|Overall Study|Lack of Efficacy|8|||
125224569|NCT03934216|450450126|FG001|Overall Study|Lack of Efficacy|7|||
125224570|NCT03934216|450450125|FG000|Overall Study|Lost to Follow-up|2|||
125224571|NCT03934216|450450126|FG001|Overall Study|Lost to Follow-up|0|||
125224572|NCT03934216|450450125|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125224573|NCT03934216|450450126|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125160924|NCT03982199|450213084|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125160925|NCT03982199|450213085|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125160926|NCT03982199|450213086|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125160927|NCT03982199|450213087|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125160928|NCT03982199|450213088|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125224574|NCT03934216|450450125|FG000|Overall Study|Pregnancy|1|||
125224575|NCT03934216|450450126|FG001|Overall Study|Pregnancy|0|||
125224576|NCT03934216|450450125|FG000|Overall Study|Withdrawal by Subject|18|||
125224577|NCT03934216|450450126|FG001|Overall Study|Withdrawal by Subject|6|||
125224578|NCT03934216|450450125|FG000|Overall Study|Randomized but not treated|1|||
125224579|NCT03934216|450450126|FG001|Overall Study|Randomized but not treated|1|||
125224580|NCT00048035|450450129|FG000|Core Period|Early Withdrawals|4|||
125224581|NCT00048035|450450130|FG001|Core Period|Early Withdrawals|2|||
125224582|NCT00048035|450450131|FG002|Core Period|Early Withdrawals|1|||
125224583|NCT00048035|450450132|FG003|Core Period|Early Withdrawals|1|||
125224584|NCT00048035|450450133|FG004|Core Period|Early Withdrawals|1|||
125224585|NCT00048035|450450134|FG005|Core Period|Early Withdrawals|1|||
125224586|NCT00048035|450450135|FG006|Core Period|Early Withdrawals|0|||
125224587|NCT00048035|450450136|FG007|Core Period|Early Withdrawals|0|||
125224588|NCT00048035|450450129|FG000|Extension Year 1|Early Withdrawals|0|||
125224589|NCT00048035|450450130|FG001|Extension Year 1|Early Withdrawals|0|||
125224590|NCT00048035|450450131|FG002|Extension Year 1|Early Withdrawals|0|||
125224591|NCT00048035|450450132|FG003|Extension Year 1|Early Withdrawals|0|||
125224592|NCT00048035|450450133|FG004|Extension Year 1|Early Withdrawals|0|||
125224593|NCT00048035|450450134|FG005|Extension Year 1|Early Withdrawals|0|||
125224594|NCT00048035|450450135|FG006|Extension Year 1|Early Withdrawals|11|||
125224595|NCT00048035|450450136|FG007|Extension Year 1|Early Withdrawals|11|||
125224596|NCT00048035|450450129|FG000|Extension Year 2|Early Withdrawals|0|||
125224597|NCT00048035|450450130|FG001|Extension Year 2|Early Withdrawals|0|||
125224598|NCT00048035|450450131|FG002|Extension Year 2|Early Withdrawals|0|||
125224599|NCT00048035|450450132|FG003|Extension Year 2|Early Withdrawals|0|||
125224600|NCT00048035|450450133|FG004|Extension Year 2|Early Withdrawals|0|||
125224601|NCT00048035|450450134|FG005|Extension Year 2|Early Withdrawals|0|||
125224602|NCT00048035|450450135|FG006|Extension Year 2|Early Withdrawals|3|||
125224603|NCT00048035|450450136|FG007|Extension Year 2|Early Withdrawals|3|||
125224604|NCT02735980|450450137|FG000|Overall Study|Adverse Event|0|||
125224605|NCT02735980|450450138|FG001|Overall Study|Adverse Event|4|||
125224606|NCT02735980|450450139|FG002|Overall Study|Adverse Event|1|||
125224607|NCT02735980|450450137|FG000|Overall Study|Death|5|||
125224608|NCT02735980|450450138|FG001|Overall Study|Death|4|||
125224609|NCT02735980|450450139|FG002|Overall Study|Death|0|||
125224610|NCT02735980|450450137|FG000|Overall Study|Physician Decision|3|||
125224611|NCT02735980|450450138|FG001|Overall Study|Physician Decision|1|||
125224612|NCT02735980|450450139|FG002|Overall Study|Physician Decision|0|||
125224613|NCT02735980|450450137|FG000|Overall Study|Screen failure|1|||
125224614|NCT02735980|450450138|FG001|Overall Study|Screen failure|0|||
125224615|NCT02735980|450450139|FG002|Overall Study|Screen failure|0|||
125224616|NCT02735980|450450137|FG000|Overall Study|Withdrawal by Subject|1|||
125224617|NCT02735980|450450138|FG001|Overall Study|Withdrawal by Subject|2|||
125224618|NCT02735980|450450139|FG002|Overall Study|Withdrawal by Subject|0|||
125224619|NCT00509899|450450140|FG000|Overall Study|Progressive disease|1|||
125224620|NCT00509899|450450141|FG001|Overall Study|Progressive disease|3|||
125224621|NCT00509899|450450142|FG002|Overall Study|Progressive disease|5|||
125224622|NCT00509899|450450143|FG003|Overall Study|Progressive disease|1|||
125224623|NCT00509899|450450144|FG004|Overall Study|Progressive disease|0|||
125224624|NCT00509899|450450145|FG005|Overall Study|Progressive disease|1|||
125224625|NCT00509899|450450146|FG006|Overall Study|Progressive disease|0|||
125224626|NCT00509899|450450147|FG007|Overall Study|Progressive disease|0|||
125224627|NCT00509899|450450140|FG000|Overall Study|Unacceptable Toxicity|1|||
125224628|NCT00509899|450450141|FG001|Overall Study|Unacceptable Toxicity|0|||
125224629|NCT00509899|450450142|FG002|Overall Study|Unacceptable Toxicity|0|||
125224630|NCT00509899|450450143|FG003|Overall Study|Unacceptable Toxicity|2|||
125224631|NCT00509899|450450144|FG004|Overall Study|Unacceptable Toxicity|0|||
125224632|NCT00509899|450450145|FG005|Overall Study|Unacceptable Toxicity|0|||
125224633|NCT00509899|450450146|FG006|Overall Study|Unacceptable Toxicity|0|||
125224634|NCT00509899|450450147|FG007|Overall Study|Unacceptable Toxicity|0|||
125224635|NCT00509899|450450140|FG000|Overall Study|Withdrawal by Subject|6|||
125224636|NCT00509899|450450141|FG001|Overall Study|Withdrawal by Subject|2|||
125224637|NCT00509899|450450142|FG002|Overall Study|Withdrawal by Subject|3|||
125224638|NCT00509899|450450143|FG003|Overall Study|Withdrawal by Subject|0|||
125224639|NCT00509899|450450144|FG004|Overall Study|Withdrawal by Subject|3|||
125224640|NCT00509899|450450145|FG005|Overall Study|Withdrawal by Subject|2|||
125224641|NCT00509899|450450146|FG006|Overall Study|Withdrawal by Subject|0|||
125224642|NCT00509899|450450147|FG007|Overall Study|Withdrawal by Subject|0|||
125224643|NCT00509899|450450140|FG000|Overall Study|Physician Decision|4|||
125224644|NCT00509899|450450141|FG001|Overall Study|Physician Decision|2|||
125224645|NCT00509899|450450142|FG002|Overall Study|Physician Decision|7|||
125224646|NCT00509899|450450143|FG003|Overall Study|Physician Decision|0|||
125224647|NCT00509899|450450144|FG004|Overall Study|Physician Decision|1|||
125224648|NCT00509899|450450145|FG005|Overall Study|Physician Decision|4|||
125224649|NCT00509899|450450146|FG006|Overall Study|Physician Decision|0|||
125224650|NCT00509899|450450147|FG007|Overall Study|Physician Decision|0|||
125224651|NCT00509899|450450140|FG000|Overall Study|Intercurrent Illness|1|||
125160929|NCT03982199|450213089|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125160930|NCT03982199|450213090|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125160931|NCT03982199|450213091|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125160932|NCT03982199|450213092|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125160933|NCT03982199|450213093|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
125160934|NCT03982199|450213094|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
125160935|NCT03982199|450213081|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160936|NCT03982199|450213082|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160937|NCT03982199|450213083|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160938|NCT03982199|450213084|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160939|NCT03982199|450213085|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160940|NCT03982199|450213086|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160941|NCT03982199|450213087|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160942|NCT03982199|450213088|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160943|NCT03982199|450213089|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160944|NCT03982199|450213090|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160945|NCT03982199|450213091|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160946|NCT03982199|450213092|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160947|NCT03982199|450213093|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
125160948|NCT03982199|450213094|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160949|NCT00594646|450213095|FG000|Overall Study|Withdrawal by Subject|1|||
125160950|NCT00594646|450213095|FG000|Overall Study|Lost to Follow-up|15|||
125160951|NCT03907462|450213098|FG000|Overall Study|Physician Decision|1|||
125160952|NCT03907462|450213099|FG001|Overall Study|Physician Decision|3|||
125160953|NCT03907462|450213100|FG002|Overall Study|Physician Decision|1|||
125160954|NCT03907462|450213098|FG000|Overall Study|Withdrawal by Subject|6|||
125160955|NCT03907462|450213099|FG001|Overall Study|Withdrawal by Subject|3|||
125160956|NCT03907462|450213100|FG002|Overall Study|Withdrawal by Subject|3|||
125160957|NCT03907462|450213098|FG000|Overall Study|Pregnancy|4|||
125160958|NCT03907462|450213099|FG001|Overall Study|Pregnancy|2|||
125160959|NCT03907462|450213100|FG002|Overall Study|Pregnancy|6|||
125160960|NCT03907462|450213098|FG000|Overall Study|Lost to Follow-up|16|||
125160961|NCT03907462|450213099|FG001|Overall Study|Lost to Follow-up|18|||
125160962|NCT03907462|450213100|FG002|Overall Study|Lost to Follow-up|22|||
125160963|NCT03107026|450215280|FG000|Overall Study|Adverse Event|2|||
125160964|NCT03107026|450215281|FG001|Overall Study|Adverse Event|14|||
125160965|NCT03107026|450215282|FG002|Overall Study|Adverse Event|23|||
125160966|NCT03107026|450215280|FG000|Overall Study|Lost to Follow-up|12|||
125160967|NCT03107026|450215281|FG001|Overall Study|Lost to Follow-up|12|||
125160968|NCT03107026|450215282|FG002|Overall Study|Lost to Follow-up|13|||
125160969|NCT03107026|450215280|FG000|Overall Study|Protocol Violation|1|||
125160970|NCT03107026|450215281|FG001|Overall Study|Protocol Violation|2|||
125160971|NCT03107026|450215282|FG002|Overall Study|Protocol Violation|0|||
125160972|NCT03107026|450215280|FG000|Overall Study|Pregnancy|1|||
125160973|NCT03107026|450215281|FG001|Overall Study|Pregnancy|0|||
125160974|NCT03107026|450215282|FG002|Overall Study|Pregnancy|0|||
125160975|NCT03107026|450215280|FG000|Overall Study|Withdrawal by Subject|13|||
125160976|NCT03107026|450215281|FG001|Overall Study|Withdrawal by Subject|5|||
125160977|NCT03107026|450215282|FG002|Overall Study|Withdrawal by Subject|17|||
125160978|NCT03107026|450215280|FG000|Overall Study|non compliance with study visits|1|||
125160979|NCT03107026|450215281|FG001|Overall Study|non compliance with study visits|2|||
125160980|NCT03107026|450215282|FG002|Overall Study|non compliance with study visits|0|||
125160981|NCT03107026|450215280|FG000|Overall Study|non-compliance with study drug|2|||
125160982|NCT03107026|450215281|FG001|Overall Study|non-compliance with study drug|2|||
125160983|NCT03107026|450215282|FG002|Overall Study|non-compliance with study drug|3|||
125160984|NCT03107026|450215280|FG000|Overall Study|Physician Decision|0|||
125160985|NCT03107026|450215281|FG001|Overall Study|Physician Decision|1|||
125160986|NCT03107026|450215282|FG002|Overall Study|Physician Decision|0|||
125160987|NCT02049450|450215283|FG000|Overall Study|Adverse Event|2|||
125160988|NCT02049450|450215283|FG000|Overall Study|Withdrawal by Subject|1|||
125160989|NCT02049450|450215283|FG000|Overall Study|Patients/guardian decision|1|||
125160990|NCT00577395|450215284|FG000|Overall Study|Study was terminated early by Sponsor|7|||
125160991|NCT00577395|450215285|FG001|Overall Study|Study was terminated early by Sponsor|6|||
125160992|NCT00554190|450215288|FG000|Overall Study|Termination forms not completed|10|||
125160993|NCT04709835|450215292|FG000|Overall Study|Withdrawal by Subject|0|||
125160994|NCT04709835|450215293|FG001|Overall Study|Withdrawal by Subject|1|||
125160995|NCT04709835|450215294|FG002|Overall Study|Withdrawal by Subject|0|||
125160996|NCT04325204|450215295|FG000|Overall Study|Death|0|||
125160997|NCT04325204|450215296|FG001|Overall Study|Death|1|||
125160998|NCT04325204|450215295|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
125160999|NCT04325204|450215296|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
125161000|NCT04325204|450215295|FG000|Overall Study|Lost to Follow-up|8|||
125161001|NCT04325204|450215296|FG001|Overall Study|Lost to Follow-up|8|||
125161002|NCT04325204|450215295|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
125161003|NCT04325204|450215296|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
125161004|NCT04711902|450215298|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
125161005|NCT04711902|450215299|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
125161006|NCT04711902|450215300|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
125161007|NCT04711902|450215301|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
125161008|NCT04711902|450215302|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
125161009|NCT04711902|450215303|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
125161010|NCT04710979|450215304|FG000|Overall Study|Lost to Follow-up|2|||
125161011|NCT04710979|450215305|FG001|Overall Study|Lost to Follow-up|4|||
125161012|NCT04710979|450215304|FG000|Overall Study|Withdrawal by Subject|1|||
125161013|NCT04710979|450215305|FG001|Overall Study|Withdrawal by Subject|0|||
125161014|NCT01561430|450215311|FG000|Overall Study|Adverse Event|0|||
125161015|NCT01561430|450215312|FG001|Overall Study|Adverse Event|0|||
125161016|NCT01561430|450215313|FG002|Overall Study|Adverse Event|3|||
125161017|NCT01561430|450215314|FG003|Overall Study|Adverse Event|1|||
125161018|NCT01561430|450215311|FG000|Overall Study|Withdrawal by Subject|0|||
125161019|NCT01561430|450215312|FG001|Overall Study|Withdrawal by Subject|0|||
125161020|NCT01561430|450215313|FG002|Overall Study|Withdrawal by Subject|1|||
125161021|NCT01561430|450215314|FG003|Overall Study|Withdrawal by Subject|0|||
125161022|NCT01561430|450215311|FG000|Overall Study|Physician Decision|0|||
125161023|NCT01561430|450215312|FG001|Overall Study|Physician Decision|1|||
125161024|NCT01561430|450215313|FG002|Overall Study|Physician Decision|0|||
125161025|NCT01561430|450215314|FG003|Overall Study|Physician Decision|0|||
125161026|NCT01561430|450215311|FG000|Overall Study|Sponsor Decision|1|||
125161027|NCT01561430|450215312|FG001|Overall Study|Sponsor Decision|14|||
125161028|NCT01561430|450215313|FG002|Overall Study|Sponsor Decision|13|||
125161029|NCT01561430|450215314|FG003|Overall Study|Sponsor Decision|12|||
125161030|NCT02570113|450215315|FG000|Overall Study|Withdrawal by Subject|3|||
125161031|NCT02564211|450215316|FG000|Overall Study|Adverse Event|4|||
125161032|NCT01908816|450215317|FG000|Overall Study|Subject's no longer requires study drug|0|||
125161033|NCT01908816|450215318|FG001|Overall Study|Subject's no longer requires study drug|0|||
125161034|NCT01908816|450215319|FG002|Overall Study|Subject's no longer requires study drug|0|||
125161035|NCT01908816|450215320|FG003|Overall Study|Subject's no longer requires study drug|1|||
125161036|NCT01908816|450215317|FG000|Overall Study|Protocol deviation|1|||
125161037|NCT01908816|450215318|FG001|Overall Study|Protocol deviation|2|||
125161038|NCT01908816|450215319|FG002|Overall Study|Protocol deviation|1|||
125161039|NCT01908816|450215320|FG003|Overall Study|Protocol deviation|1|||
125161040|NCT01908816|450215317|FG000|Overall Study|Withdrawal by Subject|0|||
125161041|NCT01908816|450215318|FG001|Overall Study|Withdrawal by Subject|4|||
125161042|NCT01908816|450215319|FG002|Overall Study|Withdrawal by Subject|2|||
125161043|NCT01908816|450215320|FG003|Overall Study|Withdrawal by Subject|2|||
125161044|NCT01908816|450215317|FG000|Overall Study|Lost to Follow-up|3|||
125161045|NCT01908816|450215318|FG001|Overall Study|Lost to Follow-up|5|||
125161046|NCT01908816|450215319|FG002|Overall Study|Lost to Follow-up|4|||
125161047|NCT01908816|450215320|FG003|Overall Study|Lost to Follow-up|2|||
125161048|NCT01908816|450215317|FG000|Overall Study|Death|1|||
125161049|NCT01908816|450215318|FG001|Overall Study|Death|0|||
125161050|NCT01908816|450215319|FG002|Overall Study|Death|7|||
125161051|NCT01908816|450215320|FG003|Overall Study|Death|1|||
125161052|NCT01908816|450215317|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125161053|NCT01908816|450215318|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
125161054|NCT01908816|450215319|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
125161055|NCT01908816|450215320|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
125161056|NCT01908816|450215317|FG000|Overall Study|Early termination|87|||
125161057|NCT01908816|450215318|FG001|Overall Study|Early termination|60|||
125161058|NCT01908816|450215319|FG002|Overall Study|Early termination|43|||
125161059|NCT01908816|450215320|FG003|Overall Study|Early termination|28|||
125161060|NCT05183217|450215321|FG000|Overall Study|Withdrawal by Subject|1|||
125161061|NCT05183217|450215322|FG001|Overall Study|Withdrawal by Subject|1|||
125161062|NCT03201250|450215323|FG000|Overall Study|screen failures|3|||
125161063|NCT03201250|450215324|FG001|Overall Study|screen failures|0|||
125161064|NCT03201250|450215325|FG002|Overall Study|screen failures|0|||
125161065|NCT00415194|450215326|FG000|Overall Study|Adverse Event|37|||
125161066|NCT00415194|450215327|FG001|Overall Study|Adverse Event|32|||
125161067|NCT00415194|450215326|FG000|Overall Study|Entry Criteria Not Met|4|||
125161068|NCT00415194|450215327|FG001|Overall Study|Entry Criteria Not Met|8|||
125161069|NCT00415194|450215326|FG000|Overall Study|Lost to Follow-up|1|||
125161070|NCT00415194|450215327|FG001|Overall Study|Lost to Follow-up|0|||
125161071|NCT00415194|450215326|FG000|Overall Study|Physician Decision|10|||
125161072|NCT00415194|450215327|FG001|Overall Study|Physician Decision|16|||
125161073|NCT00415194|450215326|FG000|Overall Study|Progressive Disease|180|||
125161074|NCT00415194|450215327|FG001|Overall Study|Progressive Disease|217|||
125161075|NCT00415194|450215326|FG000|Overall Study|Protocol Violation|4|||
125161076|NCT00415194|450215327|FG001|Overall Study|Protocol Violation|2|||
125161077|NCT00415194|450215326|FG000|Overall Study|Withdrawal by Subject|28|||
125161078|NCT00415194|450215327|FG001|Overall Study|Withdrawal by Subject|21|||
125161079|NCT00415194|450215326|FG000|Overall Study|Death Due to Study Disease|26|||
125161080|NCT00415194|450215327|FG001|Overall Study|Death Due to Study Disease|29|||
125161081|NCT00415194|450215326|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
125161082|NCT00415194|450215327|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
125161083|NCT00415194|450215326|FG000|Overall Study|Death Due to Procedural Related AE|0|||
125161084|NCT00415194|450215327|FG001|Overall Study|Death Due to Procedural Related AE|1|||
125161085|NCT00415194|450215326|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
125161086|NCT00415194|450215327|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
125161087|NCT01297465|450215328|FG000|Overall Study|Lack of Ovarian Response|1|||
125161088|NCT01297465|450215329|FG001|Overall Study|Lack of Ovarian Response|1|||
125161089|NCT01297465|450215328|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
125161090|NCT01297465|450215329|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
125161091|NCT01297465|450215328|FG000|Overall Study|No Oocytes Retrieved|1|||
125161092|NCT01297465|450215329|FG001|Overall Study|No Oocytes Retrieved|1|||
125161093|NCT01297465|450215328|FG000|Overall Study|Poor oocyte quality|0|||
125161094|NCT01297465|450215329|FG001|Overall Study|Poor oocyte quality|1|||
125161095|NCT01297465|450215328|FG000|Overall Study|No Fertilization|6|||
125161096|NCT01297465|450215329|FG001|Overall Study|No Fertilization|4|||
125161097|NCT01297465|450215328|FG000|Overall Study|All Embryos Discarded|0|||
125161098|NCT01297465|450215329|FG001|Overall Study|All Embryos Discarded|1|||
125161099|NCT01297465|450215328|FG000|Overall Study|Intention to Freeze all Embryos|0|||
125161100|NCT01297465|450215329|FG001|Overall Study|Intention to Freeze all Embryos|1|||
125161101|NCT00969540|450215330|FG000|Overall Study|Lost to Follow-up|1|||
125161102|NCT00969540|450215331|FG001|Overall Study|Lost to Follow-up|1|||
125161103|NCT02397408|450215332|FG000|Overall Study|Physician Decision|4|||
125161104|NCT02397408|450215332|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
125161105|NCT00369655|450215333|FG000|Overall Study|Refusal of further treatment|2|||
125161106|NCT01683838|450215334|FG000|Overall Study|Adverse Event|12|||
125161107|NCT01683838|450215335|FG001|Overall Study|Adverse Event|2|||
125161108|NCT01683838|450215334|FG000|Overall Study|Protocol Violation|3|||
125161109|NCT01683838|450215335|FG001|Overall Study|Protocol Violation|1|||
125161110|NCT01683838|450215334|FG000|Overall Study|Withdrawal by Subject|6|||
125161111|NCT01683838|450215335|FG001|Overall Study|Withdrawal by Subject|5|||
125161112|NCT01683838|450215334|FG000|Overall Study|Lost to Follow-up|1|||
125161113|NCT01683838|450215335|FG001|Overall Study|Lost to Follow-up|1|||
125161114|NCT01683838|450215334|FG000|Overall Study|Other|4|||
125161115|NCT01683838|450215335|FG001|Overall Study|Other|3|||
125161116|NCT01646138|450215336|FG000|Overall Study|Lost to Follow-up|0|||
125161117|NCT01646138|450215337|FG001|Overall Study|Lost to Follow-up|0|||
125161118|NCT01646138|450215338|FG002|Overall Study|Lost to Follow-up|0|||
125161119|NCT01646138|450215339|FG003|Overall Study|Lost to Follow-up|0|||
125161120|NCT01646138|450215340|FG004|Overall Study|Lost to Follow-up|2|||
125161121|NCT04049617|450215341|FG000|Overall Study|Adverse Event|0|||
125161122|NCT04049617|450215342|FG001|Overall Study|Adverse Event|0|||
125161123|NCT04049617|450215343|FG002|Overall Study|Adverse Event|0|||
125161124|NCT04049617|450215344|FG003|Overall Study|Adverse Event|1|||
125161125|NCT04049617|450215345|FG004|Overall Study|Adverse Event|0|||
125161126|NCT04049617|450215346|FG005|Overall Study|Adverse Event|0|||
125161127|NCT04049617|450215341|FG000|Overall Study|Death|0|||
125161128|NCT04049617|450215342|FG001|Overall Study|Death|0|||
125161129|NCT04049617|450215343|FG002|Overall Study|Death|0|||
125161130|NCT04049617|450215344|FG003|Overall Study|Death|0|||
125161131|NCT04049617|450215345|FG004|Overall Study|Death|0|||
125161132|NCT04049617|450215346|FG005|Overall Study|Death|1|||
125161133|NCT04049617|450215341|FG000|Overall Study|Lost to Follow-up|0|||
125161134|NCT04049617|450215342|FG001|Overall Study|Lost to Follow-up|0|||
125161135|NCT04049617|450215343|FG002|Overall Study|Lost to Follow-up|0|||
125161136|NCT04049617|450215344|FG003|Overall Study|Lost to Follow-up|1|||
125161137|NCT04049617|450215345|FG004|Overall Study|Lost to Follow-up|0|||
125161138|NCT04049617|450215346|FG005|Overall Study|Lost to Follow-up|0|||
125161139|NCT04049617|450215341|FG000|Overall Study|Withdrew consent|0|||
125161140|NCT04049617|450215342|FG001|Overall Study|Withdrew consent|0|||
125161141|NCT04049617|450215343|FG002|Overall Study|Withdrew consent|1|||
125161142|NCT04049617|450215344|FG003|Overall Study|Withdrew consent|0|||
125161143|NCT04049617|450215345|FG004|Overall Study|Withdrew consent|0|||
125161144|NCT04049617|450215346|FG005|Overall Study|Withdrew consent|0|||
125161145|NCT03551496|450215347|FG000|Overall Study|Death|11|||
125161146|NCT03551496|450215348|FG001|Overall Study|Death|7|||
125161147|NCT03551496|450215347|FG000|Overall Study|Withdrawal by Subject|4|||
125161148|NCT03551496|450215348|FG001|Overall Study|Withdrawal by Subject|3|||
125161149|NCT03551496|450215347|FG000|Overall Study|Other Reasons|1|||
125161150|NCT03551496|450215348|FG001|Overall Study|Other Reasons|0|||
125161151|NCT01524679|450215349|FG000|Overall Study|Lost to Follow-up|1|||
125161152|NCT01524679|450215350|FG001|Overall Study|Lost to Follow-up|4|||
125161153|NCT01524679|450215349|FG000|Overall Study|Withdrawal by Subject|4|||
125161154|NCT01524679|450215350|FG001|Overall Study|Withdrawal by Subject|4|||
125161155|NCT01524679|450215349|FG000|Overall Study|Adverse Event|9|||
125161156|NCT01524679|450215350|FG001|Overall Study|Adverse Event|0|||
125161157|NCT01524679|450215349|FG000|Overall Study|Protocol Violation|1|||
125161158|NCT01524679|450215350|FG001|Overall Study|Protocol Violation|0|||
125161159|NCT01524679|450215349|FG000|Overall Study|Lack of Efficacy|2|||
125161160|NCT01524679|450215350|FG001|Overall Study|Lack of Efficacy|0|||
125161161|NCT01524679|450215349|FG000|Overall Study|e.g.wish for children, relocation|6|||
125161162|NCT01524679|450215350|FG001|Overall Study|e.g.wish for children, relocation|1|||
125161163|NCT00801099|450215351|FG000|Overall Study|Lost to Follow-up|101|||
125161164|NCT00140426|450215354|FG000|Overall Study|Withdrawal by Subject|0|||
125161165|NCT00140426|450215355|FG001|Overall Study|Withdrawal by Subject|3|||
125161166|NCT02149108|450215356|FG000|Overall Study|Not treated|1|||
125161167|NCT02149108|450215357|FG001|Overall Study|Not treated|2|||
125161168|NCT02149108|450215356|FG000|Overall Study|Progressive Disease (PD)|324|||
125161169|NCT02149108|450215357|FG001|Overall Study|Progressive Disease (PD)|318|||
125161170|NCT02149108|450215356|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
125161171|NCT02149108|450215357|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
125161172|NCT02149108|450215356|FG000|Overall Study|Other Adverse Event (AE)|8|||
125161173|NCT02149108|450215357|FG001|Overall Study|Other Adverse Event (AE)|18|||
125161174|NCT02149108|450215356|FG000|Overall Study|Other not defined above|0|||
125161175|NCT02149108|450215357|FG001|Overall Study|Other not defined above|2|||
125161176|NCT02149108|450215356|FG000|Overall Study|Refusal to continue trial medication|15|||
125161177|NCT02149108|450215357|FG001|Overall Study|Refusal to continue trial medication|11|||
125161178|NCT02149108|450215356|FG000|Overall Study|Lost to Follow-up|1|||
125161179|NCT02149108|450215357|FG001|Overall Study|Lost to Follow-up|0|||
125161180|NCT02981303|450215358|FG000|Overall Study|Progressive Disease|17|||
125161181|NCT02981303|450215359|FG001|Overall Study|Progressive Disease|37|||
125161182|NCT02981303|450215358|FG000|Overall Study|Adverse Event|1|||
125161183|NCT02981303|450215359|FG001|Overall Study|Adverse Event|4|||
125161184|NCT02981303|450215358|FG000|Overall Study|Withdrawal by Subject|0|||
125161185|NCT02981303|450215359|FG001|Overall Study|Withdrawal by Subject|1|||
125161186|NCT02393248|450215360|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161187|NCT02393248|450215361|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
125161188|NCT02393248|450215362|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161189|NCT02393248|450215363|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161190|NCT02393248|450215364|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161191|NCT02393248|450215365|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
125161192|NCT02393248|450215366|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
125161193|NCT02393248|450215367|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161194|NCT02393248|450215368|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161195|NCT02393248|450215369|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161196|NCT02393248|450215370|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161197|NCT02393248|450215371|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161198|NCT02393248|450215372|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161199|NCT02393248|450215373|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161200|NCT02393248|450215374|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161201|NCT02393248|450215375|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161202|NCT02393248|450215376|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161203|NCT02393248|450215377|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161204|NCT02393248|450215378|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161205|NCT02393248|450215379|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161206|NCT02393248|450215380|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161207|NCT02393248|450215381|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161208|NCT02393248|450215382|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161209|NCT02393248|450215383|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161210|NCT02393248|450215384|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161211|NCT02393248|450215360|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161212|NCT02393248|450215361|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
125161213|NCT02393248|450215362|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161214|NCT02393248|450215363|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161215|NCT02393248|450215364|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161216|NCT02393248|450215365|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161217|NCT02393248|450215366|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161218|NCT02393248|450215367|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161219|NCT02393248|450215368|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161220|NCT02393248|450215369|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161221|NCT02393248|450215370|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161222|NCT02393248|450215371|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161223|NCT02393248|450215372|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161224|NCT02393248|450215373|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161225|NCT02393248|450215374|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125224652|NCT00509899|450450141|FG001|Overall Study|Intercurrent Illness|0|||
125161226|NCT02393248|450215375|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161227|NCT02393248|450215376|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161228|NCT02393248|450215377|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161229|NCT02393248|450215378|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161230|NCT02393248|450215379|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161231|NCT02393248|450215380|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161232|NCT02393248|450215381|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161233|NCT02393248|450215382|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161234|NCT02393248|450215383|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161235|NCT02393248|450215384|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161236|NCT02393248|450215360|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
125161237|NCT02393248|450215361|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
125161238|NCT02393248|450215362|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
125161239|NCT02393248|450215363|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
125161240|NCT02393248|450215364|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
125161241|NCT02393248|450215365|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
125161242|NCT02393248|450215366|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
125161243|NCT02393248|450215367|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
125161244|NCT02393248|450215368|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
125161245|NCT02393248|450215369|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
125161246|NCT02393248|450215370|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
125161247|NCT02393248|450215371|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
125161248|NCT02393248|450215372|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
125161249|NCT02393248|450215373|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
125161250|NCT02393248|450215374|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
125161251|NCT02393248|450215375|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
125161252|NCT02393248|450215376|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
125161253|NCT02393248|450215377|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
125161254|NCT02393248|450215378|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
125161255|NCT02393248|450215379|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
125161256|NCT02393248|450215380|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
125161257|NCT02393248|450215381|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
125161258|NCT02393248|450215382|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
125161259|NCT02393248|450215383|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
125161260|NCT02393248|450215384|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
125161261|NCT02393248|450215360|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
125161262|NCT02393248|450215361|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161263|NCT02393248|450215362|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161264|NCT02393248|450215363|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161265|NCT02393248|450215364|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161266|NCT02393248|450215365|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161267|NCT02393248|450215366|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161268|NCT02393248|450215367|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161269|NCT02393248|450215368|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161270|NCT02393248|450215369|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161271|NCT02393248|450215370|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161272|NCT02393248|450215371|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161273|NCT02393248|450215372|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161274|NCT02393248|450215373|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161275|NCT02393248|450215374|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161276|NCT02393248|450215375|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161277|NCT02393248|450215376|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125224653|NCT00509899|450450142|FG002|Overall Study|Intercurrent Illness|0|||
125161278|NCT02393248|450215377|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161279|NCT02393248|450215378|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161280|NCT02393248|450215379|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161281|NCT02393248|450215380|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161282|NCT02393248|450215381|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161283|NCT02393248|450215382|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161284|NCT02393248|450215383|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161285|NCT02393248|450215384|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161286|NCT02393248|450215360|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161287|NCT02393248|450215361|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161288|NCT02393248|450215362|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161289|NCT02393248|450215363|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161290|NCT02393248|450215364|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161291|NCT02393248|450215365|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
125161292|NCT02393248|450215366|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
125161293|NCT02393248|450215367|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161294|NCT02393248|450215368|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161295|NCT02393248|450215369|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
125161296|NCT02393248|450215370|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161297|NCT02393248|450215371|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161298|NCT02393248|450215372|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161299|NCT02393248|450215373|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161300|NCT02393248|450215374|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161301|NCT02393248|450215375|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161302|NCT02393248|450215376|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161303|NCT02393248|450215377|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161304|NCT02393248|450215378|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161305|NCT02393248|450215379|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161306|NCT02393248|450215380|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161307|NCT02393248|450215381|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161308|NCT02393248|450215382|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161309|NCT02393248|450215383|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161310|NCT02393248|450215384|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161311|NCT02393248|450215360|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161312|NCT02393248|450215361|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161313|NCT02393248|450215362|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161314|NCT02393248|450215363|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161315|NCT02393248|450215364|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161316|NCT02393248|450215365|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161317|NCT02393248|450215366|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
125161318|NCT02393248|450215367|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161319|NCT02393248|450215368|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161320|NCT02393248|450215369|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161321|NCT02393248|450215370|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161322|NCT02393248|450215371|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161323|NCT02393248|450215372|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161324|NCT02393248|450215373|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161325|NCT02393248|450215374|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161326|NCT02393248|450215375|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161327|NCT02393248|450215376|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161328|NCT02393248|450215377|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161329|NCT02393248|450215378|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161330|NCT02393248|450215379|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161331|NCT02393248|450215380|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161332|NCT02393248|450215381|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161333|NCT02393248|450215382|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161334|NCT02393248|450215383|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161335|NCT02393248|450215384|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161336|NCT02393248|450215360|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161337|NCT02393248|450215361|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161338|NCT02393248|450215362|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161339|NCT02393248|450215363|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161340|NCT02393248|450215364|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161341|NCT02393248|450215365|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161342|NCT02393248|450215366|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161343|NCT02393248|450215367|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161344|NCT02393248|450215368|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161345|NCT02393248|450215369|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161346|NCT02393248|450215370|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161347|NCT02393248|450215371|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
125161348|NCT02393248|450215372|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
125161349|NCT02393248|450215373|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
125161350|NCT02393248|450215374|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
125161351|NCT02393248|450215375|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161352|NCT02393248|450215376|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161353|NCT02393248|450215377|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161354|NCT02393248|450215378|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161355|NCT02393248|450215379|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161356|NCT02393248|450215380|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161357|NCT02393248|450215381|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161358|NCT02393248|450215382|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161359|NCT02393248|450215383|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161360|NCT02393248|450215384|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161361|NCT02393248|450215360|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161362|NCT02393248|450215361|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161363|NCT02393248|450215362|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161364|NCT02393248|450215363|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161365|NCT02393248|450215364|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161366|NCT02393248|450215365|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161367|NCT02393248|450215366|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161368|NCT02393248|450215367|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161369|NCT02393248|450215368|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161370|NCT02393248|450215369|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161371|NCT02393248|450215370|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
125161372|NCT02393248|450215371|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
125161373|NCT02393248|450215372|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161374|NCT02393248|450215373|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161375|NCT02393248|450215374|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161376|NCT02393248|450215375|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161377|NCT02393248|450215376|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161378|NCT02393248|450215377|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161379|NCT02393248|450215378|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161380|NCT02393248|450215379|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161381|NCT02393248|450215380|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161382|NCT02393248|450215381|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161383|NCT02393248|450215382|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161384|NCT02393248|450215383|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161385|NCT02393248|450215384|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161386|NCT02393248|450215360|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
125161387|NCT02393248|450215361|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
125161388|NCT02393248|450215362|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
125161389|NCT02393248|450215363|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
125161390|NCT02393248|450215364|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
125224654|NCT00509899|450450143|FG003|Overall Study|Intercurrent Illness|1|||
125224655|NCT00509899|450450144|FG004|Overall Study|Intercurrent Illness|0|||
125224656|NCT00509899|450450145|FG005|Overall Study|Intercurrent Illness|1|||
125224657|NCT00509899|450450146|FG006|Overall Study|Intercurrent Illness|0|||
125224658|NCT00509899|450450147|FG007|Overall Study|Intercurrent Illness|0|||
125224659|NCT00509899|450450140|FG000|Overall Study|Death|2|||
125224660|NCT00509899|450450141|FG001|Overall Study|Death|2|||
125224661|NCT00509899|450450142|FG002|Overall Study|Death|3|||
125224662|NCT00509899|450450143|FG003|Overall Study|Death|0|||
125224663|NCT00509899|450450144|FG004|Overall Study|Death|1|||
125224664|NCT00509899|450450145|FG005|Overall Study|Death|1|||
125224665|NCT00509899|450450146|FG006|Overall Study|Death|1|||
125224666|NCT00509899|450450147|FG007|Overall Study|Death|1|||
125224667|NCT00509899|450450140|FG000|Overall Study|Lack of Efficacy|1|||
125224668|NCT00509899|450450141|FG001|Overall Study|Lack of Efficacy|0|||
125224669|NCT00509899|450450142|FG002|Overall Study|Lack of Efficacy|2|||
125224670|NCT00509899|450450143|FG003|Overall Study|Lack of Efficacy|0|||
125224671|NCT00509899|450450144|FG004|Overall Study|Lack of Efficacy|0|||
125224672|NCT00509899|450450145|FG005|Overall Study|Lack of Efficacy|1|||
125224673|NCT00509899|450450146|FG006|Overall Study|Lack of Efficacy|0|||
125224674|NCT00509899|450450147|FG007|Overall Study|Lack of Efficacy|0|||
125224675|NCT02087774|450450152|FG000|Overall Study|Were absent day of data collection|8|||
125224676|NCT02087774|450450153|FG001|Overall Study|Were absent day of data collection|20|||
125224677|NCT05081388|450450154|FG000|Overall Study|Adverse Event|1|||
125224678|NCT05081388|450450155|FG001|Overall Study|Adverse Event|0|||
125161391|NCT02393248|450215365|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
125161392|NCT02393248|450215366|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
125161393|NCT02393248|450215367|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
125161394|NCT02393248|450215368|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
125161395|NCT02393248|450215369|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
125161396|NCT02393248|450215370|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
125161397|NCT02393248|450215371|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
125161398|NCT02393248|450215372|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
125161399|NCT02393248|450215373|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
125161400|NCT02393248|450215374|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
125161401|NCT02393248|450215375|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
125161402|NCT02393248|450215376|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
125161403|NCT02393248|450215377|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
125161404|NCT02393248|450215378|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
125161405|NCT02393248|450215379|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
125161406|NCT02393248|450215380|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
125161407|NCT02393248|450215381|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
125161408|NCT02393248|450215382|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
125161409|NCT02393248|450215383|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
125161410|NCT02393248|450215384|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
125161411|NCT02393248|450215360|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161412|NCT02393248|450215361|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161413|NCT02393248|450215362|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161414|NCT02393248|450215363|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161415|NCT02393248|450215364|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161416|NCT02393248|450215365|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161417|NCT02393248|450215366|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161418|NCT02393248|450215367|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161419|NCT02393248|450215368|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161420|NCT02393248|450215369|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161421|NCT02393248|450215370|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161422|NCT02393248|450215371|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
125161423|NCT02393248|450215372|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161424|NCT02393248|450215373|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
125161425|NCT02393248|450215374|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161426|NCT02393248|450215375|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161427|NCT02393248|450215376|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161428|NCT02393248|450215377|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161429|NCT02393248|450215378|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125224679|NCT05081388|450450156|FG002|Overall Study|Adverse Event|0|||
125224680|NCT05081388|450450157|FG003|Overall Study|Adverse Event|0|||
125224681|NCT05081388|450450158|FG004|Overall Study|Adverse Event|0|||
125224682|NCT05081388|450450154|FG000|Overall Study|Lost to Follow-up|0|||
125224683|NCT05081388|450450155|FG001|Overall Study|Lost to Follow-up|1|||
125224684|NCT05081388|450450156|FG002|Overall Study|Lost to Follow-up|0|||
125161430|NCT02393248|450215379|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161431|NCT02393248|450215380|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161432|NCT02393248|450215381|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161433|NCT02393248|450215382|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161434|NCT02393248|450215383|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161435|NCT02393248|450215384|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161436|NCT02393248|450215360|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161437|NCT02393248|450215361|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161438|NCT02393248|450215362|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161439|NCT02393248|450215363|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161440|NCT02393248|450215364|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161441|NCT02393248|450215365|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161442|NCT02393248|450215366|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161443|NCT02393248|450215367|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161444|NCT02393248|450215368|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161445|NCT02393248|450215369|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161446|NCT02393248|450215370|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161447|NCT02393248|450215371|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161448|NCT02393248|450215372|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161449|NCT02393248|450215373|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161450|NCT02393248|450215374|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161451|NCT02393248|450215375|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161452|NCT02393248|450215376|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161453|NCT02393248|450215377|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161454|NCT02393248|450215378|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
125161455|NCT02393248|450215379|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161456|NCT02393248|450215380|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
125161457|NCT02393248|450215381|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
125161458|NCT02393248|450215382|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161459|NCT02393248|450215383|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
125161460|NCT02393248|450215384|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161461|NCT02393248|450215360|FG000|Part 3: Combination Therapy|Death|0|||
125161462|NCT02393248|450215361|FG001|Part 3: Combination Therapy|Death|0|||
125161463|NCT02393248|450215362|FG002|Part 3: Combination Therapy|Death|0|||
125161464|NCT02393248|450215363|FG003|Part 3: Combination Therapy|Death|0|||
125161465|NCT02393248|450215364|FG004|Part 3: Combination Therapy|Death|0|||
125161466|NCT02393248|450215365|FG005|Part 3: Combination Therapy|Death|0|||
125161467|NCT02393248|450215366|FG006|Part 3: Combination Therapy|Death|0|||
125161468|NCT02393248|450215367|FG007|Part 3: Combination Therapy|Death|0|||
125161469|NCT02393248|450215368|FG008|Part 3: Combination Therapy|Death|0|||
125161470|NCT02393248|450215369|FG009|Part 3: Combination Therapy|Death|0|||
125161471|NCT02393248|450215370|FG010|Part 3: Combination Therapy|Death|0|||
125161472|NCT02393248|450215371|FG011|Part 3: Combination Therapy|Death|0|||
125161473|NCT02393248|450215372|FG012|Part 3: Combination Therapy|Death|0|||
125161474|NCT02393248|450215373|FG013|Part 3: Combination Therapy|Death|0|||
125161475|NCT02393248|450215374|FG014|Part 3: Combination Therapy|Death|0|||
125161476|NCT02393248|450215375|FG015|Part 3: Combination Therapy|Death|1|||
125161477|NCT02393248|450215376|FG016|Part 3: Combination Therapy|Death|7|||
125161478|NCT02393248|450215377|FG017|Part 3: Combination Therapy|Death|5|||
125161479|NCT02393248|450215378|FG018|Part 3: Combination Therapy|Death|5|||
125161480|NCT02393248|450215379|FG019|Part 3: Combination Therapy|Death|3|||
125161481|NCT02393248|450215380|FG020|Part 3: Combination Therapy|Death|7|||
125161482|NCT02393248|450215381|FG021|Part 3: Combination Therapy|Death|5|||
125161483|NCT02393248|450215382|FG022|Part 3: Combination Therapy|Death|6|||
125161484|NCT02393248|450215383|FG023|Part 3: Combination Therapy|Death|3|||
125161485|NCT02393248|450215384|FG024|Part 3: Combination Therapy|Death|0|||
125161486|NCT02393248|450215360|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161487|NCT02393248|450215361|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161488|NCT02393248|450215362|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161489|NCT02393248|450215363|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161490|NCT02393248|450215364|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161491|NCT02393248|450215365|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161492|NCT02393248|450215366|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161493|NCT02393248|450215367|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161494|NCT02393248|450215368|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161495|NCT02393248|450215369|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161496|NCT02393248|450215370|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125224685|NCT05081388|450450157|FG003|Overall Study|Lost to Follow-up|0|||
125224686|NCT05081388|450450158|FG004|Overall Study|Lost to Follow-up|0|||
125224687|NCT05081388|450450154|FG000|Overall Study|Subject decision|0|||
125224688|NCT05081388|450450155|FG001|Overall Study|Subject decision|0|||
125224689|NCT05081388|450450156|FG002|Overall Study|Subject decision|0|||
125224690|NCT05081388|450450157|FG003|Overall Study|Subject decision|1|||
125224691|NCT05081388|450450158|FG004|Overall Study|Subject decision|0|||
125224692|NCT02157519|450450167|FG000|Overall Study|Death|3|||
125161497|NCT02393248|450215371|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161498|NCT02393248|450215372|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161499|NCT02393248|450215373|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161500|NCT02393248|450215374|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125224693|NCT02157519|450450168|FG001|Overall Study|Death|1|||
125161501|NCT02393248|450215375|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161502|NCT02393248|450215376|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161503|NCT02393248|450215377|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
125161504|NCT02393248|450215378|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
125161505|NCT02393248|450215379|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161506|NCT02393248|450215380|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
125161507|NCT02393248|450215381|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
125161508|NCT02393248|450215382|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
125161509|NCT02393248|450215383|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
125161510|NCT02393248|450215384|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
125161511|NCT02393248|450215360|FG000|Part 3: Combination Therapy|Disease Progression|0|||
125161512|NCT02393248|450215361|FG001|Part 3: Combination Therapy|Disease Progression|0|||
125161513|NCT02393248|450215362|FG002|Part 3: Combination Therapy|Disease Progression|0|||
125161514|NCT02393248|450215363|FG003|Part 3: Combination Therapy|Disease Progression|0|||
125161515|NCT02393248|450215364|FG004|Part 3: Combination Therapy|Disease Progression|0|||
125161516|NCT02393248|450215365|FG005|Part 3: Combination Therapy|Disease Progression|0|||
125161517|NCT02393248|450215366|FG006|Part 3: Combination Therapy|Disease Progression|0|||
125161518|NCT02393248|450215367|FG007|Part 3: Combination Therapy|Disease Progression|0|||
125161519|NCT02393248|450215368|FG008|Part 3: Combination Therapy|Disease Progression|0|||
125161520|NCT02393248|450215369|FG009|Part 3: Combination Therapy|Disease Progression|0|||
125161521|NCT02393248|450215370|FG010|Part 3: Combination Therapy|Disease Progression|0|||
125161522|NCT02393248|450215371|FG011|Part 3: Combination Therapy|Disease Progression|0|||
125161523|NCT02393248|450215372|FG012|Part 3: Combination Therapy|Disease Progression|0|||
125161524|NCT02393248|450215373|FG013|Part 3: Combination Therapy|Disease Progression|0|||
125161525|NCT02393248|450215374|FG014|Part 3: Combination Therapy|Disease Progression|0|||
125161526|NCT02393248|450215375|FG015|Part 3: Combination Therapy|Disease Progression|0|||
125161527|NCT02393248|450215376|FG016|Part 3: Combination Therapy|Disease Progression|0|||
125161528|NCT02393248|450215377|FG017|Part 3: Combination Therapy|Disease Progression|0|||
125161529|NCT02393248|450215378|FG018|Part 3: Combination Therapy|Disease Progression|0|||
125161530|NCT02393248|450215379|FG019|Part 3: Combination Therapy|Disease Progression|0|||
125161531|NCT02393248|450215380|FG020|Part 3: Combination Therapy|Disease Progression|2|||
125161532|NCT02393248|450215381|FG021|Part 3: Combination Therapy|Disease Progression|1|||
125161533|NCT02393248|450215382|FG022|Part 3: Combination Therapy|Disease Progression|0|||
125161534|NCT02393248|450215383|FG023|Part 3: Combination Therapy|Disease Progression|0|||
125161535|NCT02393248|450215384|FG024|Part 3: Combination Therapy|Disease Progression|0|||
125161536|NCT02393248|450215360|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161537|NCT02393248|450215361|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161538|NCT02393248|450215362|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161539|NCT02393248|450215363|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161540|NCT02393248|450215364|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161541|NCT02393248|450215365|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161542|NCT02393248|450215366|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161543|NCT02393248|450215367|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161544|NCT02393248|450215368|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161545|NCT02393248|450215369|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161546|NCT02393248|450215370|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
125224694|NCT02157519|450450167|FG000|Overall Study|Withdrawal by Subject|7|||
125161547|NCT02393248|450215371|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161548|NCT02393248|450215372|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161549|NCT02393248|450215373|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161550|NCT02393248|450215374|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161551|NCT02393248|450215375|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
125224695|NCT02157519|450450168|FG001|Overall Study|Withdrawal by Subject|0|||
125224696|NCT02157519|450450167|FG000|Overall Study|Lost to Follow-up|1|||
125224697|NCT02157519|450450168|FG001|Overall Study|Lost to Follow-up|0|||
125161552|NCT02393248|450215376|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161553|NCT02393248|450215377|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161554|NCT02393248|450215378|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161555|NCT02393248|450215379|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161556|NCT02393248|450215380|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
125161557|NCT02393248|450215381|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
125161558|NCT02393248|450215382|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161559|NCT02393248|450215383|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161560|NCT02393248|450215384|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161561|NCT02393248|450215360|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161562|NCT02393248|450215361|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161563|NCT02393248|450215362|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161564|NCT02393248|450215363|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161565|NCT02393248|450215364|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161566|NCT02393248|450215365|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161567|NCT02393248|450215366|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161568|NCT02393248|450215367|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161569|NCT02393248|450215368|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161570|NCT02393248|450215369|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161571|NCT02393248|450215370|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161572|NCT02393248|450215371|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161573|NCT02393248|450215372|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161574|NCT02393248|450215373|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161575|NCT02393248|450215374|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161576|NCT02393248|450215375|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161577|NCT02393248|450215376|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161578|NCT02393248|450215377|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161579|NCT02393248|450215378|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161580|NCT02393248|450215379|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161581|NCT02393248|450215380|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
125161582|NCT02393248|450215381|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161583|NCT02393248|450215382|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161584|NCT02393248|450215383|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161585|NCT02393248|450215384|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161586|NCT02393248|450215360|FG000|Part 3: Combination Therapy|Adverse Event|0|||
125161587|NCT02393248|450215361|FG001|Part 3: Combination Therapy|Adverse Event|0|||
125161588|NCT02393248|450215362|FG002|Part 3: Combination Therapy|Adverse Event|0|||
125161589|NCT02393248|450215363|FG003|Part 3: Combination Therapy|Adverse Event|0|||
125161590|NCT02393248|450215364|FG004|Part 3: Combination Therapy|Adverse Event|0|||
125161591|NCT02393248|450215365|FG005|Part 3: Combination Therapy|Adverse Event|0|||
125161592|NCT02393248|450215366|FG006|Part 3: Combination Therapy|Adverse Event|0|||
125161593|NCT02393248|450215367|FG007|Part 3: Combination Therapy|Adverse Event|0|||
125161594|NCT02393248|450215368|FG008|Part 3: Combination Therapy|Adverse Event|0|||
125161595|NCT02393248|450215369|FG009|Part 3: Combination Therapy|Adverse Event|0|||
125161596|NCT02393248|450215370|FG010|Part 3: Combination Therapy|Adverse Event|0|||
125161597|NCT02393248|450215371|FG011|Part 3: Combination Therapy|Adverse Event|0|||
125161598|NCT02393248|450215372|FG012|Part 3: Combination Therapy|Adverse Event|0|||
125161599|NCT02393248|450215373|FG013|Part 3: Combination Therapy|Adverse Event|0|||
125161600|NCT02393248|450215374|FG014|Part 3: Combination Therapy|Adverse Event|0|||
125161601|NCT02393248|450215375|FG015|Part 3: Combination Therapy|Adverse Event|0|||
125161602|NCT02393248|450215376|FG016|Part 3: Combination Therapy|Adverse Event|0|||
125161603|NCT02393248|450215377|FG017|Part 3: Combination Therapy|Adverse Event|0|||
125161604|NCT02393248|450215378|FG018|Part 3: Combination Therapy|Adverse Event|0|||
125161605|NCT02393248|450215379|FG019|Part 3: Combination Therapy|Adverse Event|0|||
125161606|NCT02393248|450215380|FG020|Part 3: Combination Therapy|Adverse Event|0|||
125161607|NCT02393248|450215381|FG021|Part 3: Combination Therapy|Adverse Event|0|||
125161608|NCT02393248|450215382|FG022|Part 3: Combination Therapy|Adverse Event|0|||
125161609|NCT02393248|450215383|FG023|Part 3: Combination Therapy|Adverse Event|1|||
125161610|NCT02393248|450215384|FG024|Part 3: Combination Therapy|Adverse Event|0|||
125224698|NCT01656395|450450169|FG000|Overall Study|Adverse Event|1|||
125224699|NCT01656395|450450170|FG001|Overall Study|Adverse Event|14|||
125224700|NCT01656395|450450171|FG002|Overall Study|Adverse Event|5|||
125224701|NCT01656395|450450172|FG003|Overall Study|Adverse Event|4|||
125224702|NCT01656395|450450173|FG004|Overall Study|Adverse Event|5|||
125224703|NCT01656395|450450174|FG005|Overall Study|Adverse Event|7|||
125224704|NCT01656395|450450175|FG006|Overall Study|Adverse Event|0|||
125224705|NCT01656395|450450176|FG007|Overall Study|Adverse Event|0|||
125224706|NCT01656395|450450169|FG000|Overall Study|Lack of Efficacy|1|||
125224707|NCT01656395|450450170|FG001|Overall Study|Lack of Efficacy|8|||
125224708|NCT01656395|450450171|FG002|Overall Study|Lack of Efficacy|6|||
125224709|NCT01656395|450450172|FG003|Overall Study|Lack of Efficacy|1|||
125224710|NCT01656395|450450173|FG004|Overall Study|Lack of Efficacy|1|||
125224711|NCT01656395|450450174|FG005|Overall Study|Lack of Efficacy|6|||
125224712|NCT01656395|450450175|FG006|Overall Study|Lack of Efficacy|0|||
125224713|NCT01656395|450450176|FG007|Overall Study|Lack of Efficacy|0|||
125224714|NCT01656395|450450169|FG000|Overall Study|Lost to Follow-up|1|||
125224715|NCT01656395|450450170|FG001|Overall Study|Lost to Follow-up|0|||
125161611|NCT02393248|450215360|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161612|NCT02393248|450215361|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161613|NCT02393248|450215362|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161614|NCT02393248|450215363|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161615|NCT02393248|450215364|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161616|NCT02393248|450215365|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161617|NCT02393248|450215366|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161618|NCT02393248|450215367|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161619|NCT02393248|450215368|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161620|NCT02393248|450215369|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161621|NCT02393248|450215370|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161622|NCT02393248|450215371|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161623|NCT02393248|450215372|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161624|NCT02393248|450215373|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161625|NCT02393248|450215374|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161626|NCT02393248|450215375|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161627|NCT02393248|450215376|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161628|NCT02393248|450215377|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161629|NCT02393248|450215378|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161630|NCT02393248|450215379|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161631|NCT02393248|450215380|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161632|NCT02393248|450215381|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161633|NCT02393248|450215382|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161634|NCT02393248|450215383|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
125161635|NCT02393248|450215384|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161636|NCT00987389|450215385|FG000|Overall Study|Ineligible|0|||
125161637|NCT00987389|450215386|FG001|Overall Study|Ineligible|3|||
125161638|NCT00987389|450215387|FG002|Overall Study|Ineligible|0|||
125161639|NCT00987389|450215388|FG003|Overall Study|Ineligible|0|||
125161640|NCT00987389|450215385|FG000|Overall Study|Lost to Follow-up|4|||
125161641|NCT00987389|450215386|FG001|Overall Study|Lost to Follow-up|1|||
125161642|NCT00987389|450215387|FG002|Overall Study|Lost to Follow-up|3|||
125161643|NCT00987389|450215388|FG003|Overall Study|Lost to Follow-up|1|||
125161644|NCT00987389|450215385|FG000|Overall Study|Withdrawal by Subject|4|||
125161645|NCT00987389|450215386|FG001|Overall Study|Withdrawal by Subject|3|||
125161646|NCT00987389|450215387|FG002|Overall Study|Withdrawal by Subject|2|||
125161647|NCT00987389|450215388|FG003|Overall Study|Withdrawal by Subject|1|||
125161648|NCT00987389|450215385|FG000|Overall Study|Withdrawn from Treatment|0|||
125161649|NCT00987389|450215386|FG001|Overall Study|Withdrawn from Treatment|1|||
125161650|NCT00987389|450215387|FG002|Overall Study|Withdrawn from Treatment|0|||
125161651|NCT00987389|450215388|FG003|Overall Study|Withdrawn from Treatment|0|||
125161652|NCT00987389|450215385|FG000|Overall Study|Multiple different reasons|1|||
125161653|NCT00987389|450215386|FG001|Overall Study|Multiple different reasons|0|||
125161654|NCT00987389|450215387|FG002|Overall Study|Multiple different reasons|3|||
125161655|NCT00987389|450215388|FG003|Overall Study|Multiple different reasons|1|||
125161656|NCT00507130|450215389|FG000|Overall Study|Lost to Follow-up|0|||
125161657|NCT00507130|450215390|FG001|Overall Study|Lost to Follow-up|0|||
125161658|NCT00507130|450215391|FG002|Overall Study|Lost to Follow-up|1|||
125161659|NCT00507130|450215392|FG003|Overall Study|Lost to Follow-up|1|||
125161660|NCT00507130|450215389|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
125224716|NCT01656395|450450171|FG002|Overall Study|Lost to Follow-up|0|||
125161661|NCT00507130|450215390|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
125161662|NCT00507130|450215391|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
125161663|NCT00507130|450215392|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
125161664|NCT00080938|450215397|FG000|Overall Study|Adverse Event|3|||
125161665|NCT00080938|450215397|FG000|Overall Study|Withdrawal by Subject|6|||
125224717|NCT01656395|450450172|FG003|Overall Study|Lost to Follow-up|0|||
125161666|NCT00080938|450215397|FG000|Overall Study|Death|2|||
125161667|NCT00080938|450215397|FG000|Overall Study|Lack of Efficacy|7|||
125161668|NCT00080938|450215397|FG000|Overall Study|other disease|1|||
125161669|NCT00080938|450215397|FG000|Overall Study|Not started protocol therapy|1|||
125161670|NCT00080938|450215397|FG000|Overall Study|Ineligible|4|||
125161671|NCT00338455|450215403|FG000|Overall Study|Death|2|||
125161672|NCT00338455|450215404|FG001|Overall Study|Death|1|||
125161673|NCT00338455|450215403|FG000|Overall Study|Physician Decision|1|||
125161674|NCT00338455|450215404|FG001|Overall Study|Physician Decision|0|||
125224718|NCT01656395|450450173|FG004|Overall Study|Lost to Follow-up|0|||
125224719|NCT01656395|450450174|FG005|Overall Study|Lost to Follow-up|0|||
125224720|NCT01656395|450450175|FG006|Overall Study|Lost to Follow-up|0|||
125224721|NCT01656395|450450176|FG007|Overall Study|Lost to Follow-up|0|||
125224722|NCT01656395|450450169|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125224723|NCT01656395|450450170|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125224724|NCT01656395|450450171|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125224725|NCT01656395|450450172|FG003|Overall Study|Non-Compliance with Study Drug|0|||
125224726|NCT01656395|450450173|FG004|Overall Study|Non-Compliance with Study Drug|1|||
125224727|NCT01656395|450450174|FG005|Overall Study|Non-Compliance with Study Drug|1|||
125224728|NCT01656395|450450175|FG006|Overall Study|Non-Compliance with Study Drug|0|||
125224729|NCT01656395|450450176|FG007|Overall Study|Non-Compliance with Study Drug|0|||
125224730|NCT01656395|450450169|FG000|Overall Study|Other|0|||
125224731|NCT01656395|450450170|FG001|Overall Study|Other|0|||
125224732|NCT01656395|450450171|FG002|Overall Study|Other|1|||
125161675|NCT02266134|450215405|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
125161676|NCT02266134|450215406|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
125161677|NCT02266134|450215407|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
125161678|NCT02266134|450215408|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
125161679|NCT02266134|450215405|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
125161680|NCT02266134|450215406|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
125161681|NCT02266134|450215407|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
125161682|NCT02266134|450215408|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
125161683|NCT02266134|450215405|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
125161684|NCT02266134|450215406|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
125161685|NCT02266134|450215407|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
125161686|NCT02266134|450215408|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
125161687|NCT02266134|450215405|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
125161688|NCT02266134|450215406|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
125161689|NCT02266134|450215407|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
125161690|NCT02266134|450215408|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
125161691|NCT02266134|450215405|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
125224733|NCT01656395|450450172|FG003|Overall Study|Other|0|||
125224734|NCT01656395|450450173|FG004|Overall Study|Other|0|||
125224735|NCT01656395|450450174|FG005|Overall Study|Other|1|||
125161692|NCT02266134|450215406|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
125161693|NCT02266134|450215407|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
125224736|NCT01656395|450450175|FG006|Overall Study|Other|0|||
125224737|NCT01656395|450450176|FG007|Overall Study|Other|0|||
125224738|NCT01656395|450450169|FG000|Overall Study|Physician Decision|2|||
125224739|NCT01656395|450450170|FG001|Overall Study|Physician Decision|3|||
125161694|NCT02266134|450215408|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
125161695|NCT02266134|450215405|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
125161696|NCT02266134|450215406|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
125161697|NCT02266134|450215407|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
125161698|NCT02266134|450215408|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
125161699|NCT01437943|450215411|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
125161700|NCT01437943|450215412|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
125161701|NCT01437943|450215411|FG000|Overall Study|Subject expressed pregnancy plans|1|||
125161702|NCT01437943|450215412|FG001|Overall Study|Subject expressed pregnancy plans|0|||
125161703|NCT01437943|450215411|FG000|Overall Study|Adverse Event|2|||
125161704|NCT01437943|450215412|FG001|Overall Study|Adverse Event|0|||
125161705|NCT04647721|450215413|FG000|Overall Study|Withdrawal by Subject|0|||
125161706|NCT04647721|450215414|FG001|Overall Study|Withdrawal by Subject|2|||
125161707|NCT04647721|450215413|FG000|Overall Study|Lost to Follow-up|2|||
125161708|NCT04647721|450215414|FG001|Overall Study|Lost to Follow-up|0|||
125161709|NCT04771403|450215415|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
125161710|NCT04771403|450215416|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
125161711|NCT04771403|450215415|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
125161712|NCT04771403|450215416|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
125161713|NCT04771403|450215415|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
125161714|NCT04771403|450215416|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
125161715|NCT04771403|450215415|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
125161716|NCT04771403|450215416|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
125161717|NCT04771403|450215415|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
125161718|NCT04771403|450215416|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
125161719|NCT04771403|450215415|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
125161720|NCT04771403|450215416|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
125161721|NCT04771403|450215415|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
125161722|NCT04771403|450215416|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
125161723|NCT04771403|450215415|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
125161724|NCT04771403|450215416|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
125161725|NCT05084963|450215417|FG000|Overall Study|Withdrawal by Subject|0|||
125161726|NCT05084963|450215418|FG001|Overall Study|Withdrawal by Subject|0|||
125161727|NCT05084963|450215419|FG002|Overall Study|Withdrawal by Subject|1|||
125161728|NCT05442866|450215420|FG000|Overall Study|Death|1|||
125161729|NCT05442866|450215420|FG000|Overall Study|Lost to Follow-up|9|||
125161730|NCT05442866|450215420|FG000|Overall Study|Protocol Violation|1|||
125161731|NCT03819049|450215421|FG000|Overall Study|Lost to Follow-up|1|||
125161732|NCT03819049|450215422|FG001|Overall Study|Lost to Follow-up|2|||
125161733|NCT03819049|450215423|FG002|Overall Study|Lost to Follow-up|9|||
125161734|NCT03819049|450215424|FG003|Overall Study|Lost to Follow-up|0|||
125161735|NCT03819049|450215425|FG004|Overall Study|Lost to Follow-up|3|||
125161736|NCT03819049|450215426|FG005|Overall Study|Lost to Follow-up|1|||
125161737|NCT03819049|450215427|FG006|Overall Study|Lost to Follow-up|0|||
125161738|NCT03819049|450215421|FG000|Overall Study|Withdrawal by Subject|0|||
125161739|NCT03819049|450215422|FG001|Overall Study|Withdrawal by Subject|0|||
125161740|NCT03819049|450215423|FG002|Overall Study|Withdrawal by Subject|18|||
125161741|NCT03819049|450215424|FG003|Overall Study|Withdrawal by Subject|0|||
125161742|NCT03819049|450215425|FG004|Overall Study|Withdrawal by Subject|10|||
125161743|NCT03819049|450215426|FG005|Overall Study|Withdrawal by Subject|9|||
125161744|NCT03819049|450215427|FG006|Overall Study|Withdrawal by Subject|1|||
125161745|NCT03819049|450215421|FG000|Overall Study|Ongoing|0|||
125161746|NCT03819049|450215422|FG001|Overall Study|Ongoing|0|||
125161747|NCT03819049|450215423|FG002|Overall Study|Ongoing|75|||
125161748|NCT03819049|450215424|FG003|Overall Study|Ongoing|0|||
125161749|NCT03819049|450215425|FG004|Overall Study|Ongoing|41|||
125161750|NCT03819049|450215426|FG005|Overall Study|Ongoing|0|||
125161751|NCT03819049|450215427|FG006|Overall Study|Ongoing|0|||
125161752|NCT03819049|450215421|FG000|Overall Study|Other|0|||
125161753|NCT03819049|450215422|FG001|Overall Study|Other|0|||
125161754|NCT03819049|450215423|FG002|Overall Study|Other|2|||
125161755|NCT03819049|450215424|FG003|Overall Study|Other|0|||
125161756|NCT03819049|450215425|FG004|Overall Study|Other|0|||
125161757|NCT03819049|450215426|FG005|Overall Study|Other|0|||
125161758|NCT03819049|450215427|FG006|Overall Study|Other|0|||
125161759|NCT03819049|450215421|FG000|Overall Study|Randomized but not vaccinated|0|||
125224740|NCT01656395|450450171|FG002|Overall Study|Physician Decision|3|||
125161760|NCT03819049|450215422|FG001|Overall Study|Randomized but not vaccinated|0|||
125161761|NCT03819049|450215423|FG002|Overall Study|Randomized but not vaccinated|0|||
125161762|NCT03819049|450215424|FG003|Overall Study|Randomized but not vaccinated|1|||
125161763|NCT03819049|450215425|FG004|Overall Study|Randomized but not vaccinated|0|||
125161764|NCT03819049|450215426|FG005|Overall Study|Randomized but not vaccinated|2|||
125161765|NCT03819049|450215427|FG006|Overall Study|Randomized but not vaccinated|1|||
125161766|NCT03819049|450215421|FG000|Overall Study|Physician Decision|0|||
125161767|NCT03819049|450215422|FG001|Overall Study|Physician Decision|0|||
125161768|NCT03819049|450215423|FG002|Overall Study|Physician Decision|0|||
125161769|NCT03819049|450215424|FG003|Overall Study|Physician Decision|0|||
125161770|NCT03819049|450215425|FG004|Overall Study|Physician Decision|0|||
125161771|NCT03819049|450215426|FG005|Overall Study|Physician Decision|0|||
125161772|NCT03819049|450215427|FG006|Overall Study|Physician Decision|1|||
125161773|NCT01568320|450215432|FG000|Overall Study|Death|20|||
125161774|NCT01568320|450215432|FG000|Overall Study|Lost to Follow-up|9|||
125161775|NCT01568320|450215432|FG000|Overall Study|Withdrawal by Subject|10|||
125161776|NCT01568320|450215432|FG000|Overall Study|Conversion to open repair|1|||
125161777|NCT01568320|450215432|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
125161778|NCT00816361|450215433|FG000|Overall Study|Withdrawal by Subject|0|||
125161779|NCT00816361|450215434|FG001|Overall Study|Withdrawal by Subject|0|||
125161780|NCT00816361|450215435|FG002|Overall Study|Withdrawal by Subject|0|||
125161781|NCT00816361|450215436|FG003|Overall Study|Withdrawal by Subject|0|||
125161782|NCT00816361|450215437|FG004|Overall Study|Withdrawal by Subject|1|||
125161783|NCT00816361|450215438|FG005|Overall Study|Withdrawal by Subject|2|||
125161784|NCT00816361|450215439|FG006|Overall Study|Withdrawal by Subject|0|||
125161785|NCT00816361|450215440|FG007|Overall Study|Withdrawal by Subject|2|||
125161786|NCT00816361|450215441|FG008|Overall Study|Withdrawal by Subject|1|||
125161787|NCT00816361|450215433|FG000|Overall Study|Death|4|||
125161788|NCT00816361|450215434|FG001|Overall Study|Death|3|||
125161789|NCT00816361|450215435|FG002|Overall Study|Death|3|||
125161790|NCT00816361|450215436|FG003|Overall Study|Death|3|||
125161791|NCT00816361|450215437|FG004|Overall Study|Death|1|||
125161792|NCT00816361|450215438|FG005|Overall Study|Death|1|||
125161793|NCT00816361|450215439|FG006|Overall Study|Death|3|||
125161794|NCT00816361|450215440|FG007|Overall Study|Death|7|||
125161795|NCT00816361|450215441|FG008|Overall Study|Death|8|||
125161796|NCT00816361|450215433|FG000|Overall Study|Other|0|||
125161797|NCT00816361|450215434|FG001|Overall Study|Other|0|||
125161798|NCT00816361|450215435|FG002|Overall Study|Other|0|||
125161799|NCT00816361|450215436|FG003|Overall Study|Other|0|||
125161800|NCT00816361|450215437|FG004|Overall Study|Other|0|||
125161801|NCT00816361|450215438|FG005|Overall Study|Other|0|||
125161802|NCT00816361|450215439|FG006|Overall Study|Other|0|||
125161803|NCT00816361|450215440|FG007|Overall Study|Other|0|||
125161804|NCT00816361|450215441|FG008|Overall Study|Other|1|||
125161805|NCT00546572|450215443|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
125161806|NCT00546572|450215444|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
125161807|NCT00546572|450215443|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
125161808|NCT00546572|450215444|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
125161809|NCT00546572|450215443|FG000|Vax 1 / Year 0|Protocol Violation|3|||
125161810|NCT00546572|450215444|FG001|Vax 1 / Year 0|Protocol Violation|4|||
125161811|NCT00546572|450215443|FG000|Vax 1 / Year 0|Death|2|||
125161812|NCT00546572|450215444|FG001|Vax 1 / Year 0|Death|2|||
125161813|NCT00546572|450215443|FG000|Vax 1 / Year 0|Adverse Event|0|||
125161814|NCT00546572|450215444|FG001|Vax 1 / Year 0|Adverse Event|1|||
125161815|NCT00546572|450215443|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
125161816|NCT00546572|450215444|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
125161817|NCT00546572|450215443|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
125161818|NCT00546572|450215444|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
125161819|NCT00546572|450215443|FG000|Vax 2 / Year 1|Other|1|||
125161820|NCT00546572|450215444|FG001|Vax 2 / Year 1|Other|1|||
125161821|NCT00546572|450215443|FG000|Vax 2 / Year 1|Adverse Event|1|||
125161822|NCT00546572|450215444|FG001|Vax 2 / Year 1|Adverse Event|0|||
125161823|NCT00546572|450215443|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
125161824|NCT00546572|450215444|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
125161825|NCT01394952|450215445|FG000|Overall Study|Lost to Follow-up|0|||
125161826|NCT01394952|450215446|FG001|Overall Study|Lost to Follow-up|5|||
125161827|NCT01394952|450215445|FG000|Overall Study|Withdrawal by Subject|10|||
125161828|NCT01394952|450215446|FG001|Overall Study|Withdrawal by Subject|5|||
125161829|NCT01394952|450215445|FG000|Overall Study|Physician Decision|2|||
125161830|NCT01394952|450215446|FG001|Overall Study|Physician Decision|0|||
125161831|NCT01394952|450215445|FG000|Overall Study|Sponsor Decision|5|||
125161832|NCT01394952|450215446|FG001|Overall Study|Sponsor Decision|7|||
125161833|NCT01986010|450215447|FG000|Overall Study|Adverse Event|0|||
125161834|NCT01986010|450215448|FG001|Overall Study|Adverse Event|1|||
125161835|NCT01986010|450215449|FG002|Overall Study|Adverse Event|0|||
125161836|NCT01986010|450215450|FG003|Overall Study|Adverse Event|0|||
125161837|NCT01986010|450215451|FG004|Overall Study|Adverse Event|0|||
125161838|NCT01986010|450215452|FG005|Overall Study|Adverse Event|0|||
125161839|NCT01986010|450215453|FG006|Overall Study|Adverse Event|0|||
125161840|NCT01986010|450215454|FG007|Overall Study|Adverse Event|0|||
125161841|NCT01986010|450215455|FG008|Overall Study|Adverse Event|0|||
125161842|NCT01986010|450215456|FG009|Overall Study|Adverse Event|0|||
125161843|NCT01986010|450215457|FG010|Overall Study|Adverse Event|0|||
125161844|NCT01986010|450215458|FG011|Overall Study|Adverse Event|0|||
125161845|NCT01986010|450215459|FG012|Overall Study|Adverse Event|0|||
125161846|NCT01986010|450215460|FG013|Overall Study|Adverse Event|0|||
125161847|NCT01986010|450215461|FG014|Overall Study|Adverse Event|0|||
125161848|NCT01986010|450215462|FG015|Overall Study|Adverse Event|1|||
125161849|NCT01986010|450215463|FG016|Overall Study|Adverse Event|0|||
125161850|NCT01986010|450215447|FG000|Overall Study|Lost to Follow-up|2|||
125161851|NCT01986010|450215448|FG001|Overall Study|Lost to Follow-up|1|||
125161852|NCT01986010|450215449|FG002|Overall Study|Lost to Follow-up|2|||
125161853|NCT01986010|450215450|FG003|Overall Study|Lost to Follow-up|2|||
125161854|NCT01986010|450215451|FG004|Overall Study|Lost to Follow-up|2|||
125161855|NCT01986010|450215452|FG005|Overall Study|Lost to Follow-up|2|||
125161856|NCT01986010|450215453|FG006|Overall Study|Lost to Follow-up|0|||
125161857|NCT01986010|450215454|FG007|Overall Study|Lost to Follow-up|0|||
125161858|NCT01986010|450215455|FG008|Overall Study|Lost to Follow-up|4|||
125161859|NCT01986010|450215456|FG009|Overall Study|Lost to Follow-up|2|||
125161860|NCT01986010|450215457|FG010|Overall Study|Lost to Follow-up|0|||
125161861|NCT01986010|450215458|FG011|Overall Study|Lost to Follow-up|1|||
125161862|NCT01986010|450215459|FG012|Overall Study|Lost to Follow-up|1|||
125161863|NCT01986010|450215460|FG013|Overall Study|Lost to Follow-up|1|||
125161864|NCT01986010|450215461|FG014|Overall Study|Lost to Follow-up|2|||
125161865|NCT01986010|450215462|FG015|Overall Study|Lost to Follow-up|0|||
125161866|NCT01986010|450215463|FG016|Overall Study|Lost to Follow-up|0|||
125161867|NCT01986010|450215447|FG000|Overall Study|Physician Decision|0|||
125161868|NCT01986010|450215448|FG001|Overall Study|Physician Decision|0|||
125161869|NCT01986010|450215449|FG002|Overall Study|Physician Decision|0|||
125161870|NCT01986010|450215450|FG003|Overall Study|Physician Decision|0|||
125161871|NCT01986010|450215451|FG004|Overall Study|Physician Decision|0|||
125161872|NCT01986010|450215452|FG005|Overall Study|Physician Decision|0|||
125161873|NCT01986010|450215453|FG006|Overall Study|Physician Decision|0|||
125161874|NCT01986010|450215454|FG007|Overall Study|Physician Decision|0|||
125161875|NCT01986010|450215455|FG008|Overall Study|Physician Decision|0|||
125161876|NCT01986010|450215456|FG009|Overall Study|Physician Decision|0|||
125161877|NCT01986010|450215457|FG010|Overall Study|Physician Decision|0|||
125161878|NCT01986010|450215458|FG011|Overall Study|Physician Decision|0|||
125161879|NCT01986010|450215459|FG012|Overall Study|Physician Decision|0|||
125161880|NCT01986010|450215460|FG013|Overall Study|Physician Decision|0|||
125161881|NCT01986010|450215461|FG014|Overall Study|Physician Decision|1|||
125161882|NCT01986010|450215462|FG015|Overall Study|Physician Decision|0|||
125161883|NCT01986010|450215463|FG016|Overall Study|Physician Decision|0|||
125161884|NCT01986010|450215447|FG000|Overall Study|Withdrawal by Subject|2|||
125161885|NCT01986010|450215448|FG001|Overall Study|Withdrawal by Subject|2|||
125161886|NCT01986010|450215449|FG002|Overall Study|Withdrawal by Subject|3|||
125161887|NCT01986010|450215450|FG003|Overall Study|Withdrawal by Subject|0|||
125161888|NCT01986010|450215451|FG004|Overall Study|Withdrawal by Subject|2|||
125161889|NCT01986010|450215452|FG005|Overall Study|Withdrawal by Subject|4|||
125161890|NCT01986010|450215453|FG006|Overall Study|Withdrawal by Subject|0|||
125161891|NCT01986010|450215454|FG007|Overall Study|Withdrawal by Subject|0|||
125161892|NCT01986010|450215455|FG008|Overall Study|Withdrawal by Subject|0|||
125161893|NCT01986010|450215456|FG009|Overall Study|Withdrawal by Subject|0|||
125161894|NCT01986010|450215457|FG010|Overall Study|Withdrawal by Subject|0|||
125161895|NCT01986010|450215458|FG011|Overall Study|Withdrawal by Subject|2|||
125161896|NCT01986010|450215459|FG012|Overall Study|Withdrawal by Subject|0|||
125161897|NCT01986010|450215460|FG013|Overall Study|Withdrawal by Subject|1|||
125161898|NCT01986010|450215461|FG014|Overall Study|Withdrawal by Subject|2|||
125161899|NCT01986010|450215462|FG015|Overall Study|Withdrawal by Subject|0|||
125161900|NCT01986010|450215463|FG016|Overall Study|Withdrawal by Subject|0|||
125161901|NCT01986010|450215447|FG000|Overall Study|Status Not Recorded|2|||
125161902|NCT01986010|450215448|FG001|Overall Study|Status Not Recorded|4|||
125161903|NCT01986010|450215449|FG002|Overall Study|Status Not Recorded|2|||
125161904|NCT01986010|450215450|FG003|Overall Study|Status Not Recorded|0|||
125161905|NCT01986010|450215451|FG004|Overall Study|Status Not Recorded|1|||
125161906|NCT01986010|450215452|FG005|Overall Study|Status Not Recorded|2|||
125161907|NCT01986010|450215453|FG006|Overall Study|Status Not Recorded|0|||
125161908|NCT01986010|450215454|FG007|Overall Study|Status Not Recorded|0|||
125161909|NCT01986010|450215455|FG008|Overall Study|Status Not Recorded|2|||
125161910|NCT01986010|450215456|FG009|Overall Study|Status Not Recorded|1|||
125161911|NCT01986010|450215457|FG010|Overall Study|Status Not Recorded|7|||
125161912|NCT01986010|450215458|FG011|Overall Study|Status Not Recorded|7|||
125161913|NCT01986010|450215459|FG012|Overall Study|Status Not Recorded|9|||
125161914|NCT01986010|450215460|FG013|Overall Study|Status Not Recorded|9|||
125161915|NCT01986010|450215461|FG014|Overall Study|Status Not Recorded|5|||
125161916|NCT01986010|450215462|FG015|Overall Study|Status Not Recorded|10|||
125161917|NCT01986010|450215463|FG016|Overall Study|Status Not Recorded|4|||
125161918|NCT01335997|450215464|FG000|Period I and II|Adverse Event|63|||
125161919|NCT01335997|450215465|FG001|Period I and II|Adverse Event|43|||
125161920|NCT01335997|450215464|FG000|Period I and II|Noncompliance with Study Drug|1|||
125161921|NCT01335997|450215465|FG001|Period I and II|Noncompliance with Study Drug|1|||
125161922|NCT01335997|450215464|FG000|Period I and II|Lost to Follow-up|3|||
125161923|NCT01335997|450215465|FG001|Period I and II|Lost to Follow-up|5|||
125161924|NCT01335997|450215464|FG000|Period I and II|Withdrawal by Subject|9|||
125161925|NCT01335997|450215465|FG001|Period I and II|Withdrawal by Subject|4|||
125161926|NCT01335997|450215464|FG000|Period I and II|Study Terminated by Sponsor|406|||
125161927|NCT01335997|450215465|FG001|Period I and II|Study Terminated by Sponsor|415|||
125161928|NCT01335997|450215464|FG000|Period I and II|Protocol Violation|9|||
125161929|NCT01335997|450215465|FG001|Period I and II|Protocol Violation|10|||
125161930|NCT01335997|450215464|FG000|Period I and II|Physician Decision|2|||
125161931|NCT01335997|450215465|FG001|Period I and II|Physician Decision|1|||
125161932|NCT01335997|450215464|FG000|Period III|Adverse Event|0|||
125161933|NCT01335997|450215465|FG001|Period III|Adverse Event|2|||
125161934|NCT01335997|450215464|FG000|Period III|Study Terminated by Sponsor|77|||
125161935|NCT01335997|450215465|FG001|Period III|Study Terminated by Sponsor|76|||
125161936|NCT01335997|450215464|FG000|Period III|Protocol Violation|0|||
125161937|NCT01335997|450215465|FG001|Period III|Protocol Violation|1|||
125161938|NCT01335997|450215464|FG000|Period III|Lost to Follow-up|1|||
125161939|NCT01335997|450215465|FG001|Period III|Lost to Follow-up|0|||
125161940|NCT04740814|450215466|FG000|Overall Study|Adverse Event|3|||
125161941|NCT04740814|450215466|FG000|Overall Study|Protocol Violation|2|||
125161942|NCT04740814|450215466|FG000|Overall Study|Lost to Follow-up|2|||
125161943|NCT04740814|450215466|FG000|Overall Study|Withdrawal by Subject|3|||
125161944|NCT01763684|450215467|FG000|Overall Study|Study terminated early due to low enrollment|126|||
125161945|NCT01763684|450215468|FG001|Overall Study|Study terminated early due to low enrollment|127|||
125161946|NCT01763684|450215467|FG000|Overall Study|Study surgery not performed|7|||
125161947|NCT01763684|450215468|FG001|Overall Study|Study surgery not performed|6|||
125161948|NCT04453202|450215473|FG000|Overall Study|Adverse Event|0|||
125161949|NCT04453202|450215474|FG001|Overall Study|Adverse Event|0|||
125161950|NCT04453202|450215475|FG002|Overall Study|Adverse Event|0|||
125161951|NCT04453202|450215476|FG003|Overall Study|Adverse Event|0|||
125161952|NCT04453202|450215477|FG004|Overall Study|Adverse Event|0|||
125161953|NCT04453202|450215478|FG005|Overall Study|Adverse Event|0|||
125161954|NCT04453202|450215479|FG006|Overall Study|Adverse Event|1|||
125161955|NCT04453202|450215480|FG007|Overall Study|Adverse Event|0|||
125161956|NCT04453202|450215481|FG008|Overall Study|Adverse Event|0|||
125161957|NCT04453202|450215482|FG009|Overall Study|Adverse Event|0|||
125161958|NCT04453202|450215483|FG010|Overall Study|Adverse Event|0|||
125161959|NCT04453202|450215473|FG000|Overall Study|Death|0|||
125161960|NCT04453202|450215474|FG001|Overall Study|Death|0|||
125161961|NCT04453202|450215475|FG002|Overall Study|Death|0|||
125161962|NCT04453202|450215476|FG003|Overall Study|Death|0|||
125161963|NCT04453202|450215477|FG004|Overall Study|Death|0|||
125161964|NCT04453202|450215478|FG005|Overall Study|Death|0|||
125161965|NCT04453202|450215479|FG006|Overall Study|Death|0|||
125161966|NCT04453202|450215480|FG007|Overall Study|Death|0|||
125161967|NCT04453202|450215481|FG008|Overall Study|Death|0|||
125161968|NCT04453202|450215482|FG009|Overall Study|Death|1|||
125161969|NCT04453202|450215483|FG010|Overall Study|Death|0|||
125161970|NCT04453202|450215473|FG000|Overall Study|Lost to Follow-up|0|||
125161971|NCT04453202|450215474|FG001|Overall Study|Lost to Follow-up|1|||
125161972|NCT04453202|450215475|FG002|Overall Study|Lost to Follow-up|0|||
125161973|NCT04453202|450215476|FG003|Overall Study|Lost to Follow-up|1|||
125161974|NCT04453202|450215477|FG004|Overall Study|Lost to Follow-up|0|||
125161975|NCT04453202|450215478|FG005|Overall Study|Lost to Follow-up|0|||
125224741|NCT01656395|450450172|FG003|Overall Study|Physician Decision|2|||
125161976|NCT04453202|450215479|FG006|Overall Study|Lost to Follow-up|0|||
125161977|NCT04453202|450215480|FG007|Overall Study|Lost to Follow-up|0|||
125161978|NCT04453202|450215481|FG008|Overall Study|Lost to Follow-up|0|||
125161979|NCT04453202|450215482|FG009|Overall Study|Lost to Follow-up|1|||
125161980|NCT04453202|450215483|FG010|Overall Study|Lost to Follow-up|1|||
125161981|NCT04453202|450215473|FG000|Overall Study|Withdrawal by Subject|1|||
125161982|NCT04453202|450215474|FG001|Overall Study|Withdrawal by Subject|2|||
125161983|NCT04453202|450215475|FG002|Overall Study|Withdrawal by Subject|1|||
125161984|NCT04453202|450215476|FG003|Overall Study|Withdrawal by Subject|2|||
125161985|NCT04453202|450215477|FG004|Overall Study|Withdrawal by Subject|1|||
125161986|NCT04453202|450215478|FG005|Overall Study|Withdrawal by Subject|1|||
125161987|NCT04453202|450215479|FG006|Overall Study|Withdrawal by Subject|0|||
125161988|NCT04453202|450215480|FG007|Overall Study|Withdrawal by Subject|0|||
125161989|NCT04453202|450215481|FG008|Overall Study|Withdrawal by Subject|0|||
125161990|NCT04453202|450215482|FG009|Overall Study|Withdrawal by Subject|1|||
125161991|NCT04453202|450215483|FG010|Overall Study|Withdrawal by Subject|0|||
125161992|NCT04453202|450215473|FG000|Overall Study|Adverse Event|0|||
125161993|NCT04453202|450215474|FG001|Overall Study|Adverse Event|0|||
125161994|NCT04453202|450215475|FG002|Overall Study|Adverse Event|0|||
125161995|NCT04453202|450215476|FG003|Overall Study|Adverse Event|0|||
125161996|NCT04453202|450215477|FG004|Overall Study|Adverse Event|0|||
125224742|NCT01656395|450450173|FG004|Overall Study|Physician Decision|3|||
125224743|NCT01656395|450450174|FG005|Overall Study|Physician Decision|3|||
125224744|NCT01656395|450450175|FG006|Overall Study|Physician Decision|0|||
125224745|NCT01656395|450450176|FG007|Overall Study|Physician Decision|0|||
125224746|NCT01656395|450450169|FG000|Overall Study|Pregnancy|0|||
125224747|NCT01656395|450450170|FG001|Overall Study|Pregnancy|0|||
125224748|NCT01656395|450450171|FG002|Overall Study|Pregnancy|1|||
125224749|NCT01656395|450450172|FG003|Overall Study|Pregnancy|0|||
125224750|NCT01656395|450450173|FG004|Overall Study|Pregnancy|0|||
125224751|NCT01656395|450450174|FG005|Overall Study|Pregnancy|0|||
125224752|NCT01656395|450450175|FG006|Overall Study|Pregnancy|0|||
125224753|NCT01656395|450450176|FG007|Overall Study|Pregnancy|0|||
125224754|NCT01656395|450450169|FG000|Overall Study|Progressive Disease|0|||
125224755|NCT01656395|450450170|FG001|Overall Study|Progressive Disease|0|||
125224756|NCT01656395|450450171|FG002|Overall Study|Progressive Disease|0|||
125224757|NCT01656395|450450172|FG003|Overall Study|Progressive Disease|0|||
125224758|NCT01656395|450450173|FG004|Overall Study|Progressive Disease|0|||
125224759|NCT01656395|450450174|FG005|Overall Study|Progressive Disease|1|||
125224760|NCT01656395|450450175|FG006|Overall Study|Progressive Disease|0|||
125224761|NCT01656395|450450176|FG007|Overall Study|Progressive Disease|0|||
125224762|NCT01656395|450450169|FG000|Overall Study|Protocol Violation|6|||
125224763|NCT01656395|450450170|FG001|Overall Study|Protocol Violation|6|||
125224764|NCT01656395|450450171|FG002|Overall Study|Protocol Violation|9|||
125224765|NCT01656395|450450172|FG003|Overall Study|Protocol Violation|2|||
125224766|NCT01656395|450450173|FG004|Overall Study|Protocol Violation|4|||
125224767|NCT01656395|450450174|FG005|Overall Study|Protocol Violation|10|||
125224768|NCT01656395|450450175|FG006|Overall Study|Protocol Violation|0|||
125224769|NCT01656395|450450176|FG007|Overall Study|Protocol Violation|0|||
125224770|NCT01656395|450450169|FG000|Overall Study|Screen Failure|2|||
125224771|NCT01656395|450450170|FG001|Overall Study|Screen Failure|1|||
125224772|NCT01656395|450450171|FG002|Overall Study|Screen Failure|7|||
125224773|NCT01656395|450450172|FG003|Overall Study|Screen Failure|1|||
125224774|NCT01656395|450450173|FG004|Overall Study|Screen Failure|0|||
125224775|NCT01656395|450450174|FG005|Overall Study|Screen Failure|8|||
125224776|NCT01656395|450450175|FG006|Overall Study|Screen Failure|0|||
125224777|NCT01656395|450450176|FG007|Overall Study|Screen Failure|0|||
125224778|NCT01656395|450450169|FG000|Overall Study|Withdrawal by Subject|3|||
125224779|NCT01656395|450450170|FG001|Overall Study|Withdrawal by Subject|1|||
125224780|NCT01656395|450450171|FG002|Overall Study|Withdrawal by Subject|4|||
125224781|NCT01656395|450450172|FG003|Overall Study|Withdrawal by Subject|2|||
125224782|NCT01656395|450450173|FG004|Overall Study|Withdrawal by Subject|0|||
125224783|NCT01656395|450450174|FG005|Overall Study|Withdrawal by Subject|3|||
125224784|NCT01656395|450450175|FG006|Overall Study|Withdrawal by Subject|0|||
125224785|NCT01656395|450450176|FG007|Overall Study|Withdrawal by Subject|0|||
125224786|NCT03075267|450450177|FG000|Overall Study|Protocol Violation|1|||
125161997|NCT04453202|450215478|FG005|Overall Study|Adverse Event|1|||
125161998|NCT04453202|450215479|FG006|Overall Study|Adverse Event|0|||
125224787|NCT03075267|450450178|FG001|Overall Study|Protocol Violation|0|||
125224788|NCT03075267|450450179|FG002|Overall Study|Protocol Violation|0|||
125224789|NCT00661089|450450182|FG000|Overall Study|1 subject withdrawal|0|||
125161999|NCT04453202|450215480|FG007|Overall Study|Adverse Event|0|||
125224790|NCT00661089|450450183|FG001|Overall Study|1 subject withdrawal|1|||
125224791|NCT00661089|450450182|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
125224792|NCT00661089|450450183|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
125224793|NCT00274742|450450184|FG000|Overall Study|Adverse Event|0|||
125224794|NCT00274742|450450185|FG001|Overall Study|Adverse Event|4|||
125162000|NCT04453202|450215481|FG008|Overall Study|Adverse Event|0|||
125162001|NCT04453202|450215482|FG009|Overall Study|Adverse Event|0|||
125162002|NCT04453202|450215483|FG010|Overall Study|Adverse Event|0|||
125162003|NCT01157897|450215484|FG000|Overall Study|Lost to Follow-up|2|||
125162004|NCT01157897|450215485|FG001|Overall Study|Lost to Follow-up|0|||
125162005|NCT01157897|450215486|FG002|Overall Study|Lost to Follow-up|0|||
125162006|NCT01157897|450215487|FG003|Overall Study|Lost to Follow-up|1|||
125162007|NCT01157897|450215484|FG000|Overall Study|Relocated|0|||
125162008|NCT01157897|450215485|FG001|Overall Study|Relocated|2|||
125162009|NCT01157897|450215486|FG002|Overall Study|Relocated|0|||
125162010|NCT01157897|450215487|FG003|Overall Study|Relocated|0|||
125162011|NCT03276221|450215488|FG000|Overall Study|Lost to Follow-up|6|||
125162012|NCT03276221|450215489|FG001|Overall Study|Lost to Follow-up|2|||
125162013|NCT03276221|450215490|FG002|Overall Study|Lost to Follow-up|0|||
125162014|NCT03276221|450215488|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
125162015|NCT03276221|450215489|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
125162016|NCT03276221|450215490|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
125162017|NCT02912650|450215491|FG000|Overall Study|Withdrawal by Subject|1|||
125162018|NCT02912650|450215492|FG001|Overall Study|Withdrawal by Subject|0|||
125162019|NCT02912650|450215493|FG002|Overall Study|Withdrawal by Subject|1|||
125162020|NCT02912650|450215494|FG003|Overall Study|Withdrawal by Subject|5|||
125162021|NCT02912650|450215491|FG000|Overall Study|Adverse Event|0|||
125162022|NCT02912650|450215492|FG001|Overall Study|Adverse Event|0|||
125162023|NCT02912650|450215493|FG002|Overall Study|Adverse Event|1|||
125162024|NCT02912650|450215494|FG003|Overall Study|Adverse Event|0|||
125162025|NCT02562482|450215496|FG000|Overall Study|Enrolled, but did not receive product|4|||
125162026|NCT02562482|450215497|FG001|Overall Study|Enrolled, but did not receive product|0|||
125162027|NCT02562482|450215496|FG000|Overall Study|Lost to Follow-up|9|||
125162028|NCT02562482|450215497|FG001|Overall Study|Lost to Follow-up|6|||
125162029|NCT02562482|450215496|FG000|Overall Study|Moved from area|2|||
125162030|NCT02562482|450215497|FG001|Overall Study|Moved from area|3|||
125162031|NCT02562482|450215496|FG000|Overall Study|Withdrawal by Subject|5|||
125162032|NCT02562482|450215497|FG001|Overall Study|Withdrawal by Subject|3|||
125162033|NCT02562482|450215496|FG000|Overall Study|Physician Decision|1|||
125162034|NCT02562482|450215497|FG001|Overall Study|Physician Decision|3|||
125162035|NCT02562482|450215496|FG000|Overall Study|Illness/Injury unrelated to product|0|||
125162036|NCT02562482|450215497|FG001|Overall Study|Illness/Injury unrelated to product|1|||
125162037|NCT02435836|450215502|FG000|Overall Study|Lost to Follow-up|21|||
125162038|NCT02435836|450215502|FG000|Overall Study|Lack of Efficacy|1|||
125162039|NCT02435836|450215502|FG000|Overall Study|Withdrawal by Subject|236|||
125162040|NCT02435836|450215502|FG000|Overall Study|Insufficient Clinical Response|26|||
125162041|NCT02435836|450215502|FG000|Overall Study|Adverse Event|44|||
125162042|NCT02435836|450215502|FG000|Overall Study|Sponsor discontinued trial|167|||
125162043|NCT02435836|450215502|FG000|Overall Study|Noncompliance|27|||
125162044|NCT02435836|450215502|FG000|Overall Study|Protocol Violation|6|||
125162045|NCT02435836|450215502|FG000|Overall Study|Met Withdrawal Criteria|7|||
125162046|NCT02435836|450215502|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
125224795|NCT00274742|450450186|FG002|Overall Study|Adverse Event|1|||
125224796|NCT00274742|450450187|FG003|Overall Study|Adverse Event|4|||
125224797|NCT00274742|450450188|FG004|Overall Study|Adverse Event|12|||
125224798|NCT00274742|450450189|FG005|Overall Study|Adverse Event|3|||
125224799|NCT00274742|450450184|FG000|Overall Study|Lost to Follow-up|0|||
125224800|NCT00274742|450450185|FG001|Overall Study|Lost to Follow-up|0|||
125224801|NCT00274742|450450186|FG002|Overall Study|Lost to Follow-up|0|||
125224802|NCT00274742|450450187|FG003|Overall Study|Lost to Follow-up|0|||
125224803|NCT00274742|450450188|FG004|Overall Study|Lost to Follow-up|1|||
125224804|NCT00274742|450450189|FG005|Overall Study|Lost to Follow-up|0|||
125224805|NCT00274742|450450184|FG000|Overall Study|End of Study|0|||
125224806|NCT00274742|450450185|FG001|Overall Study|End of Study|0|||
125224807|NCT00274742|450450186|FG002|Overall Study|End of Study|0|||
125224808|NCT00274742|450450187|FG003|Overall Study|End of Study|1|||
125224809|NCT00274742|450450188|FG004|Overall Study|End of Study|0|||
125224810|NCT00274742|450450189|FG005|Overall Study|End of Study|0|||
125224811|NCT00274742|450450184|FG000|Overall Study|Disease Progression|0|||
125224812|NCT00274742|450450185|FG001|Overall Study|Disease Progression|1|||
125224813|NCT00274742|450450186|FG002|Overall Study|Disease Progression|1|||
125224814|NCT00274742|450450187|FG003|Overall Study|Disease Progression|0|||
125224815|NCT00274742|450450188|FG004|Overall Study|Disease Progression|1|||
125224816|NCT00274742|450450189|FG005|Overall Study|Disease Progression|0|||
125224817|NCT00274742|450450184|FG000|Overall Study|Other|0|||
125224818|NCT00274742|450450185|FG001|Overall Study|Other|3|||
125224819|NCT00274742|450450186|FG002|Overall Study|Other|0|||
125224820|NCT00274742|450450187|FG003|Overall Study|Other|0|||
125224821|NCT00274742|450450188|FG004|Overall Study|Other|2|||
125224822|NCT00274742|450450189|FG005|Overall Study|Other|0|||
125224823|NCT04144322|450450197|FG000|Overall Study|Lack of Efficacy|2|||
125224824|NCT04144322|450450198|FG001|Overall Study|Lack of Efficacy|2|||
125224825|NCT00385918|450450201|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
125224826|NCT00385918|450450202|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
125224827|NCT00385918|450450203|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
125224828|NCT00385918|450450201|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
125224829|NCT00385918|450450202|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
125224830|NCT00385918|450450203|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
125224831|NCT00385918|450450201|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
125224832|NCT00385918|450450202|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
125224833|NCT00385918|450450203|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
125224834|NCT00385918|450450201|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
125224835|NCT00385918|450450202|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
125224836|NCT00385918|450450203|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
125224837|NCT00385918|450450201|FG000|Intervention Phase After Randomization|Physician Decision|1|||
125162047|NCT02041091|450215503|FG000|Treatment|Adverse Event|3|||
125162048|NCT02041091|450215504|FG001|Treatment|Adverse Event|3|||
125162049|NCT02041091|450215503|FG000|Treatment|Withdrawal by Subject|2|||
125162050|NCT02041091|450215504|FG001|Treatment|Withdrawal by Subject|4|||
125162051|NCT02041091|450215503|FG000|Treatment|Physician Decision|1|||
125162052|NCT02041091|450215504|FG001|Treatment|Physician Decision|0|||
125162053|NCT02041091|450215503|FG000|Treatment|Sponsor Decision|15|||
125162054|NCT02041091|450215504|FG001|Treatment|Sponsor Decision|16|||
125162055|NCT02041091|450215503|FG000|Treatment|Lost to Follow-up|1|||
125162056|NCT02041091|450215504|FG001|Treatment|Lost to Follow-up|0|||
125162057|NCT02041091|450215503|FG000|Optional Safety Extension Period|Adverse Event|4|||
125162058|NCT02041091|450215504|FG001|Optional Safety Extension Period|Adverse Event|2|||
125162059|NCT02041091|450215503|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
125162060|NCT02041091|450215504|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
125162061|NCT02041091|450215503|FG000|Optional Safety Extension Period|Protocol Violation|2|||
125162062|NCT02041091|450215504|FG001|Optional Safety Extension Period|Protocol Violation|0|||
125162063|NCT02041091|450215503|FG000|Optional Safety Extension Period|Physician Decision|2|||
125162064|NCT02041091|450215504|FG001|Optional Safety Extension Period|Physician Decision|1|||
125224838|NCT00385918|450450202|FG001|Intervention Phase After Randomization|Physician Decision|0|||
125224839|NCT00385918|450450203|FG002|Intervention Phase After Randomization|Physician Decision|0|||
125224840|NCT00385918|450450201|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
125224841|NCT00385918|450450202|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
125224842|NCT00385918|450450203|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
125224843|NCT01676701|450450204|FG000|Overall Study|Protocol Violation|1|||
125162065|NCT02041091|450215503|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
125162066|NCT02041091|450215504|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
125224844|NCT01676701|450450205|FG001|Overall Study|Protocol Violation|0|||
125224845|NCT01676701|450450204|FG000|Overall Study|Sponsor Decision|3|||
125162067|NCT02041091|450215503|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
125162068|NCT02041091|450215504|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
125224846|NCT01676701|450450205|FG001|Overall Study|Sponsor Decision|4|||
125224847|NCT02155699|450450214|FG000|Overall Study|Withdrawal by Subject|0|||
125224848|NCT02155699|450450215|FG001|Overall Study|Withdrawal by Subject|3|||
125224849|NCT02155699|450450216|FG002|Overall Study|Withdrawal by Subject|6|||
125224850|NCT02155699|450450217|FG003|Overall Study|Withdrawal by Subject|1|||
125224851|NCT02155699|450450214|FG000|Overall Study|Lost to Follow-up|0|||
125224852|NCT02155699|450450215|FG001|Overall Study|Lost to Follow-up|0|||
125224853|NCT02155699|450450216|FG002|Overall Study|Lost to Follow-up|0|||
125224854|NCT02155699|450450217|FG003|Overall Study|Lost to Follow-up|3|||
125224855|NCT02155699|450450214|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
125162069|NCT00922987|450215505|FG000|Overall Study|Insufficient clinical response|1|||
125162070|NCT00922987|450215505|FG000|Overall Study|Protocol Violation|2|||
125162071|NCT00922987|450215505|FG000|Overall Study|Adverse Event|1|||
125162072|NCT05091307|450217717|FG000|Overall Study|Death|0|||
125162073|NCT05091307|450217718|FG001|Overall Study|Death|0|||
125162074|NCT05091307|450217719|FG002|Overall Study|Death|1|||
125162075|NCT05091307|450217720|FG003|Overall Study|Death|0|||
125162076|NCT05091307|450217717|FG000|Overall Study|Lost to Follow-up|33|||
125162077|NCT05091307|450217718|FG001|Overall Study|Lost to Follow-up|33|||
125162078|NCT05091307|450217719|FG002|Overall Study|Lost to Follow-up|2|||
125162079|NCT05091307|450217720|FG003|Overall Study|Lost to Follow-up|0|||
125162080|NCT05091307|450217717|FG000|Overall Study|Physician Decision|1|||
125162081|NCT05091307|450217718|FG001|Overall Study|Physician Decision|0|||
125162082|NCT05091307|450217719|FG002|Overall Study|Physician Decision|0|||
125162083|NCT05091307|450217720|FG003|Overall Study|Physician Decision|0|||
125162084|NCT05091307|450217717|FG000|Overall Study|Protocol Violation|1|||
125162085|NCT05091307|450217718|FG001|Overall Study|Protocol Violation|0|||
125162086|NCT05091307|450217719|FG002|Overall Study|Protocol Violation|0|||
125162087|NCT05091307|450217720|FG003|Overall Study|Protocol Violation|0|||
125162088|NCT05091307|450217717|FG000|Overall Study|Withdrawal by Subject|16|||
125162089|NCT05091307|450217718|FG001|Overall Study|Withdrawal by Subject|16|||
125162090|NCT05091307|450217719|FG002|Overall Study|Withdrawal by Subject|0|||
125162091|NCT05091307|450217720|FG003|Overall Study|Withdrawal by Subject|1|||
125162092|NCT05091307|450217717|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
125162093|NCT05091307|450217718|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
125162094|NCT05091307|450217719|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
125162095|NCT05091307|450217720|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
125162096|NCT05091307|450217717|FG000|Overall Study|Initiated Prohibited Medication|1|||
125162097|NCT05091307|450217718|FG001|Overall Study|Initiated Prohibited Medication|0|||
125162098|NCT05091307|450217719|FG002|Overall Study|Initiated Prohibited Medication|0|||
125162099|NCT05091307|450217720|FG003|Overall Study|Initiated Prohibited Medication|0|||
125162100|NCT05091307|450217717|FG000|Overall Study|Other|4|||
125162101|NCT05091307|450217718|FG001|Overall Study|Other|4|||
125162102|NCT05091307|450217719|FG002|Overall Study|Other|0|||
125162103|NCT05091307|450217720|FG003|Overall Study|Other|0|||
125162104|NCT05091307|450217717|FG000|Overall Study|Randomized but not vaccinated|0|||
125162105|NCT05091307|450217718|FG001|Overall Study|Randomized but not vaccinated|2|||
125162106|NCT05091307|450217719|FG002|Overall Study|Randomized but not vaccinated|0|||
125162107|NCT05091307|450217720|FG003|Overall Study|Randomized but not vaccinated|0|||
125162108|NCT03303625|450217721|FG000|Overall Study|Withdrawal by Subject|2|||
125162109|NCT03303625|450217722|FG001|Overall Study|Withdrawal by Subject|0|||
125162110|NCT03303625|450217723|FG002|Overall Study|Withdrawal by Subject|0|||
125162111|NCT03303625|450217724|FG003|Overall Study|Withdrawal by Subject|0|||
125162112|NCT01167257|450217725|FG000|Overall Study|Lost to Follow-up|2|||
125162113|NCT01167257|450217726|FG001|Overall Study|Lost to Follow-up|2|||
125162114|NCT01167257|450217725|FG000|Overall Study|Withdrew consent|1|||
125162115|NCT01167257|450217726|FG001|Overall Study|Withdrew consent|1|||
125162116|NCT02492880|450217727|FG000|Overall Study|Lost to Follow-up|1|||
125162117|NCT02492880|450217727|FG000|Overall Study|Protocol Violation|1|||
125162118|NCT02771795|450217728|FG000|Overall Study|Withdrawal by Subject|47|||
125162119|NCT02771795|450217729|FG001|Overall Study|Withdrawal by Subject|37|||
125162120|NCT02771795|450217728|FG000|Overall Study|Termination by premature discontinuation of study|168|||
125162121|NCT02771795|450217729|FG001|Overall Study|Termination by premature discontinuation of study|185|||
125162122|NCT02906930|450217730|FG000|Overall Study|Withdrawal by Subject|0|||
125162123|NCT02906930|450217731|FG001|Overall Study|Withdrawal by Subject|5|||
125162124|NCT02906930|450217732|FG002|Overall Study|Withdrawal by Subject|5|||
125162125|NCT02906930|450217733|FG003|Overall Study|Withdrawal by Subject|4|||
125162126|NCT02906930|450217730|FG000|Overall Study|Lost to Follow-up|5|||
125162127|NCT02906930|450217731|FG001|Overall Study|Lost to Follow-up|7|||
125162128|NCT02906930|450217732|FG002|Overall Study|Lost to Follow-up|5|||
125162129|NCT02906930|450217733|FG003|Overall Study|Lost to Follow-up|2|||
125162130|NCT02906930|450217730|FG000|Overall Study|Death|0|||
125162131|NCT02906930|450217731|FG001|Overall Study|Death|0|||
125162132|NCT02906930|450217732|FG002|Overall Study|Death|1|||
125162133|NCT02906930|450217733|FG003|Overall Study|Death|0|||
125162134|NCT02906930|450217730|FG000|Overall Study|Other|1|||
125162135|NCT02906930|450217731|FG001|Overall Study|Other|2|||
125162136|NCT02906930|450217732|FG002|Overall Study|Other|1|||
125162137|NCT02906930|450217733|FG003|Overall Study|Other|2|||
125162138|NCT00622466|450217743|FG000|Overall Study|Death|1|||
125162139|NCT00622466|450217743|FG000|Overall Study|Adverse Event|1|||
125162140|NCT00622466|450217743|FG000|Overall Study|Withdrawal by Subject|2|||
125162141|NCT04585789|450217747|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
125162142|NCT04585789|450217748|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
125162143|NCT04585789|450217749|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
125162144|NCT04585789|450217747|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
125162145|NCT04585789|450217748|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
125162146|NCT04585789|450217749|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
125162147|NCT01383135|450217752|FG000|Overall Study|Not Scanned / Imaged|1|||
125162148|NCT01383135|450217753|FG001|Overall Study|Not Scanned / Imaged|0|||
125162149|NCT01383135|450217754|FG002|Overall Study|Not Scanned / Imaged|1|||
125162150|NCT01383135|450217755|FG003|Overall Study|Not Scanned / Imaged|0|||
125162151|NCT01154816|450217756|FG000|Overall Study|Withdrawal by Subject|1|||
125162152|NCT01154816|450217757|FG001|Overall Study|Withdrawal by Subject|0|||
125162153|NCT01154816|450217758|FG002|Overall Study|Withdrawal by Subject|0|||
125162154|NCT01154816|450217759|FG003|Overall Study|Withdrawal by Subject|1|||
125162155|NCT01154816|450217760|FG004|Overall Study|Withdrawal by Subject|0|||
125162156|NCT01154816|450217761|FG005|Overall Study|Withdrawal by Subject|0|||
125162157|NCT01154816|450217762|FG006|Overall Study|Withdrawal by Subject|0|||
125162158|NCT01154816|450217763|FG007|Overall Study|Withdrawal by Subject|0|||
125162159|NCT01154816|450217764|FG008|Overall Study|Withdrawal by Subject|1|||
125162160|NCT01154816|450217765|FG009|Overall Study|Withdrawal by Subject|3|||
125162161|NCT01154816|450217766|FG010|Overall Study|Withdrawal by Subject|0|||
125162162|NCT01154816|450217767|FG011|Overall Study|Withdrawal by Subject|0|||
125162163|NCT01154816|450217756|FG000|Overall Study|Progressive Disease|13|||
125162164|NCT01154816|450217757|FG001|Overall Study|Progressive Disease|8|||
125162165|NCT01154816|450217758|FG002|Overall Study|Progressive Disease|9|||
125162166|NCT01154816|450217759|FG003|Overall Study|Progressive Disease|9|||
125162167|NCT01154816|450217760|FG004|Overall Study|Progressive Disease|8|||
125162168|NCT01154816|450217761|FG005|Overall Study|Progressive Disease|8|||
125162169|NCT01154816|450217762|FG006|Overall Study|Progressive Disease|5|||
125162170|NCT01154816|450217763|FG007|Overall Study|Progressive Disease|6|||
125162171|NCT01154816|450217764|FG008|Overall Study|Progressive Disease|8|||
125162172|NCT01154816|450217765|FG009|Overall Study|Progressive Disease|6|||
125162173|NCT01154816|450217766|FG010|Overall Study|Progressive Disease|10|||
125162174|NCT01154816|450217767|FG011|Overall Study|Progressive Disease|3|||
125162175|NCT01154816|450217756|FG000|Overall Study|Physician Decision|1|||
125162176|NCT01154816|450217757|FG001|Overall Study|Physician Decision|0|||
125162177|NCT01154816|450217758|FG002|Overall Study|Physician Decision|1|||
125162178|NCT01154816|450217759|FG003|Overall Study|Physician Decision|0|||
125162179|NCT01154816|450217760|FG004|Overall Study|Physician Decision|2|||
125162180|NCT01154816|450217761|FG005|Overall Study|Physician Decision|0|||
125162181|NCT01154816|450217762|FG006|Overall Study|Physician Decision|0|||
125162182|NCT01154816|450217763|FG007|Overall Study|Physician Decision|0|||
125162183|NCT01154816|450217764|FG008|Overall Study|Physician Decision|0|||
125162184|NCT01154816|450217765|FG009|Overall Study|Physician Decision|1|||
125162185|NCT01154816|450217766|FG010|Overall Study|Physician Decision|1|||
125162186|NCT01154816|450217767|FG011|Overall Study|Physician Decision|1|||
125162187|NCT01154816|450217756|FG000|Overall Study|Adverse Event|5|||
125162188|NCT01154816|450217757|FG001|Overall Study|Adverse Event|2|||
125162189|NCT01154816|450217758|FG002|Overall Study|Adverse Event|0|||
125162190|NCT01154816|450217759|FG003|Overall Study|Adverse Event|0|||
125162191|NCT01154816|450217760|FG004|Overall Study|Adverse Event|0|||
125162192|NCT01154816|450217761|FG005|Overall Study|Adverse Event|0|||
125162193|NCT01154816|450217762|FG006|Overall Study|Adverse Event|1|||
125162194|NCT01154816|450217763|FG007|Overall Study|Adverse Event|1|||
125162195|NCT01154816|450217764|FG008|Overall Study|Adverse Event|0|||
125162196|NCT01154816|450217765|FG009|Overall Study|Adverse Event|0|||
125162197|NCT01154816|450217766|FG010|Overall Study|Adverse Event|0|||
125162198|NCT01154816|450217767|FG011|Overall Study|Adverse Event|0|||
125162199|NCT03397771|450217768|FG000|Overall Study|2 erroneously randomized, never treated|3|||
125162200|NCT03397771|450217769|FG001|Overall Study|2 erroneously randomized, never treated|1|||
125162201|NCT03397771|450217768|FG000|Overall Study|Withdrawal by Subject|1|||
125162202|NCT03397771|450217769|FG001|Overall Study|Withdrawal by Subject|3|||
125162203|NCT03397771|450217768|FG000|Overall Study|Protocol Violation|2|||
125162204|NCT03397771|450217769|FG001|Overall Study|Protocol Violation|2|||
125162205|NCT03397771|450217768|FG000|Overall Study|Adverse Event|2|||
125162206|NCT03397771|450217769|FG001|Overall Study|Adverse Event|1|||
125162207|NCT04078126|450217772|FG000|Washout|Study put on hold due to COVID-19|0|||
125162208|NCT04078126|450217773|FG001|Washout|Study put on hold due to COVID-19|2|||
125162209|NCT04078126|450217772|FG000|Period 2|Study put on hold due to COVID-19|1|||
125162210|NCT04078126|450217773|FG001|Period 2|Study put on hold due to COVID-19|1|||
125162211|NCT03321630|450217774|FG000|Overall Study|Adverse Event|1|||
125162212|NCT03321630|450217774|FG000|Overall Study|Investigator Discretion|2|||
125162213|NCT03321630|450217774|FG000|Overall Study|Withdrawal by Subject|1|||
125162214|NCT02669758|450217775|FG000|Overall Study|Withdrawal by Subject|43|||
125162215|NCT02669758|450217775|FG000|Overall Study|Lost to Follow-up|19|||
125162216|NCT02669758|450217775|FG000|Overall Study|Adverse Event|16|||
125162217|NCT02669758|450217775|FG000|Overall Study|Non-Compliance with Study Drug|8|||
125162218|NCT02669758|450217775|FG000|Overall Study|Lack of Efficacy|5|||
125162219|NCT02669758|450217775|FG000|Overall Study|Pregnancy|1|||
125162220|NCT02669758|450217775|FG000|Overall Study|Study noncompliance|1|||
125162221|NCT02669758|450217775|FG000|Overall Study|Protocol Violation|1|||
125162222|NCT02455050|450217776|FG000|Treatment Period 1|Lost to Follow-up|1|||
125162223|NCT02455050|450217777|FG001|Treatment Period 1|Lost to Follow-up|1|||
125162224|NCT02455050|450217778|FG002|Treatment Period 1|Lost to Follow-up|1|||
125162225|NCT02455050|450217779|FG003|Treatment Period 1|Lost to Follow-up|2|||
125162226|NCT02455050|450217776|FG000|Treatment Period 2|Lost to Follow-up|1|||
125162227|NCT02455050|450217777|FG001|Treatment Period 2|Lost to Follow-up|0|||
125162228|NCT02455050|450217778|FG002|Treatment Period 2|Lost to Follow-up|2|||
125162229|NCT02455050|450217779|FG003|Treatment Period 2|Lost to Follow-up|1|||
125162230|NCT02325518|450217780|FG000|Overall Study|Adverse Event|4|||
125162231|NCT02325518|450217781|FG001|Overall Study|Adverse Event|1|||
125162232|NCT02325518|450217780|FG000|Overall Study|Physician Decision|0|||
125162233|NCT02325518|450217781|FG001|Overall Study|Physician Decision|1|||
125162234|NCT02325518|450217780|FG000|Overall Study|Withdrawal by Subject|0|||
125162235|NCT02325518|450217781|FG001|Overall Study|Withdrawal by Subject|1|||
125162236|NCT03393806|450217784|FG000|Overall Study|Physician Decision|1|||
125162237|NCT03393806|450217785|FG001|Overall Study|Physician Decision|0|||
125162238|NCT00886288|450217786|FG000|Overall Study|no respect of the 12 weeks period|657|||
125162239|NCT00886288|450217787|FG001|Overall Study|no respect of the 12 weeks period|227|||
125162240|NCT00886288|450217786|FG000|Overall Study|Lost to Follow-up|86|||
125162241|NCT00886288|450217787|FG001|Overall Study|Lost to Follow-up|0|||
125162242|NCT01675661|450217788|FG000|Overall Study|Lost to Follow-up|22|||
125162243|NCT01675661|450217789|FG001|Overall Study|Lost to Follow-up|23|||
125162244|NCT01675661|450217788|FG000|Overall Study|Practical problems|9|||
125162245|NCT01675661|450217789|FG001|Overall Study|Practical problems|5|||
125162246|NCT01675661|450217788|FG000|Overall Study|Moved away|5|||
125162247|NCT01675661|450217789|FG001|Overall Study|Moved away|6|||
125162248|NCT01675661|450217788|FG000|Overall Study|Withdrawal by Subject|3|||
125162249|NCT01675661|450217789|FG001|Overall Study|Withdrawal by Subject|7|||
125162250|NCT01675661|450217788|FG000|Overall Study|Physician Decision|0|||
125162251|NCT01675661|450217789|FG001|Overall Study|Physician Decision|2|||
125162252|NCT01675661|450217788|FG000|Overall Study|Death|0|||
125162253|NCT01675661|450217789|FG001|Overall Study|Death|1|||
125162254|NCT01675661|450217788|FG000|Overall Study|Other reason|1|||
125162255|NCT01675661|450217789|FG001|Overall Study|Other reason|2|||
125162256|NCT04765384|450217790|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
125162257|NCT04765384|450217791|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
125162258|NCT04765384|450217792|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
125162259|NCT04765384|450217793|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
125162260|NCT04765384|450217794|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
125162261|NCT04765384|450217795|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
125162262|NCT04765384|450217790|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
125162263|NCT04765384|450217791|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
125162264|NCT04765384|450217792|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
125162265|NCT04765384|450217793|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
125162266|NCT04765384|450217794|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
125162267|NCT04765384|450217795|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
125162268|NCT04765384|450217790|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
125162269|NCT04765384|450217791|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
125162270|NCT04765384|450217792|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
125162271|NCT04765384|450217793|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
125162272|NCT04765384|450217794|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
125162273|NCT04765384|450217795|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
125162274|NCT04765384|450217790|FG000|Post-natal: Neonates and Infants|Death|0|||
125162275|NCT04765384|450217791|FG001|Post-natal: Neonates and Infants|Death|0|||
125162276|NCT04765384|450217792|FG002|Post-natal: Neonates and Infants|Death|0|||
125162277|NCT04765384|450217793|FG003|Post-natal: Neonates and Infants|Death|1|||
125162278|NCT04765384|450217794|FG004|Post-natal: Neonates and Infants|Death|0|||
125162279|NCT04765384|450217795|FG005|Post-natal: Neonates and Infants|Death|0|||
125162280|NCT04765384|450217790|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
125162281|NCT04765384|450217791|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
125162282|NCT04765384|450217792|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
125162283|NCT04765384|450217793|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
125162284|NCT04765384|450217794|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
125162285|NCT04765384|450217795|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
125162286|NCT01971970|450217796|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
125162287|NCT01971970|450217797|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
125162288|NCT01971970|450217796|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
125162289|NCT01971970|450217797|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
125162290|NCT01971970|450217796|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
125162291|NCT01971970|450217797|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
125162292|NCT01971970|450217796|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
125162293|NCT01971970|450217797|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
125162294|NCT01971970|450217796|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
125162295|NCT01971970|450217797|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
125162296|NCT01971970|450217796|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
125162297|NCT01971970|450217797|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
125162298|NCT01971970|450217796|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
125162299|NCT01971970|450217797|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
125162300|NCT02335983|450217798|FG000|Overall Study|Sponsor Decision|0|||
125162301|NCT02335983|450217799|FG001|Overall Study|Sponsor Decision|0|||
125162302|NCT02335983|450217800|FG002|Overall Study|Sponsor Decision|1|||
125162303|NCT02335983|450217801|FG003|Overall Study|Sponsor Decision|1|||
125162304|NCT02335983|450217802|FG004|Overall Study|Sponsor Decision|0|||
125162305|NCT02335983|450217803|FG005|Overall Study|Sponsor Decision|1|||
125162306|NCT02335983|450217798|FG000|Overall Study|Withdrawal by Subject|3|||
125162307|NCT02335983|450217799|FG001|Overall Study|Withdrawal by Subject|2|||
125162308|NCT02335983|450217800|FG002|Overall Study|Withdrawal by Subject|2|||
125162309|NCT02335983|450217801|FG003|Overall Study|Withdrawal by Subject|1|||
125162310|NCT02335983|450217802|FG004|Overall Study|Withdrawal by Subject|3|||
125162311|NCT02335983|450217803|FG005|Overall Study|Withdrawal by Subject|9|||
125162312|NCT02335983|450217798|FG000|Overall Study|Death|0|||
125162313|NCT02335983|450217799|FG001|Overall Study|Death|0|||
125162314|NCT02335983|450217800|FG002|Overall Study|Death|2|||
125162315|NCT02335983|450217801|FG003|Overall Study|Death|0|||
125162316|NCT02335983|450217802|FG004|Overall Study|Death|0|||
125162317|NCT02335983|450217803|FG005|Overall Study|Death|0|||
125162318|NCT02335983|450217798|FG000|Overall Study|Lost to Follow-up|0|||
125162319|NCT02335983|450217799|FG001|Overall Study|Lost to Follow-up|0|||
125162320|NCT02335983|450217800|FG002|Overall Study|Lost to Follow-up|0|||
125162321|NCT02335983|450217801|FG003|Overall Study|Lost to Follow-up|0|||
125162322|NCT02335983|450217802|FG004|Overall Study|Lost to Follow-up|0|||
125162323|NCT02335983|450217803|FG005|Overall Study|Lost to Follow-up|1|||
125162324|NCT02335983|450217798|FG000|Overall Study|Protocol Specified Criteria|5|||
125162325|NCT02335983|450217799|FG001|Overall Study|Protocol Specified Criteria|7|||
125162326|NCT02335983|450217800|FG002|Overall Study|Protocol Specified Criteria|27|||
125162327|NCT02335983|450217801|FG003|Overall Study|Protocol Specified Criteria|7|||
125162328|NCT02335983|450217802|FG004|Overall Study|Protocol Specified Criteria|5|||
125162329|NCT02335983|450217803|FG005|Overall Study|Protocol Specified Criteria|21|||
125162330|NCT00655876|450217804|FG000|Overall Study|Protocol Violation|9|||
125162331|NCT00655876|450217805|FG001|Overall Study|Protocol Violation|7|||
125224856|NCT02155699|450450215|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
125162332|NCT01831765|450217806|FG000|Overall Study|Lack of Efficacy|1|||
125162333|NCT01831765|450217807|FG001|Overall Study|Lack of Efficacy|0|||
125162334|NCT01831765|450217808|FG002|Overall Study|Lack of Efficacy|0|||
125162335|NCT01831765|450217806|FG000|Overall Study|Other, sponsor withdrew subject|0|||
125162336|NCT01831765|450217807|FG001|Overall Study|Other, sponsor withdrew subject|1|||
125162337|NCT01831765|450217808|FG002|Overall Study|Other, sponsor withdrew subject|0|||
125162338|NCT01831765|450217806|FG000|Overall Study|Pregnancy|1|||
125162339|NCT01831765|450217807|FG001|Overall Study|Pregnancy|1|||
125162340|NCT01831765|450217808|FG002|Overall Study|Pregnancy|2|||
125162341|NCT01831765|450217806|FG000|Overall Study|Death|0|||
125162342|NCT01831765|450217807|FG001|Overall Study|Death|1|||
125162343|NCT01831765|450217808|FG002|Overall Study|Death|1|||
125162344|NCT01831765|450217806|FG000|Overall Study|Other, site closed|1|||
125162345|NCT01831765|450217807|FG001|Overall Study|Other, site closed|1|||
125162346|NCT01831765|450217808|FG002|Overall Study|Other, site closed|0|||
125162347|NCT01831765|450217806|FG000|Overall Study|Adverse Event|5|||
125162348|NCT01831765|450217807|FG001|Overall Study|Adverse Event|3|||
125162349|NCT01831765|450217808|FG002|Overall Study|Adverse Event|3|||
125162350|NCT01831765|450217806|FG000|Overall Study|Withdrawal by Subject|22|||
125162351|NCT01831765|450217807|FG001|Overall Study|Withdrawal by Subject|7|||
125162352|NCT01831765|450217808|FG002|Overall Study|Withdrawal by Subject|17|||
125162353|NCT01831765|450217806|FG000|Overall Study|Withdrawal criteria|12|||
125162354|NCT01831765|450217807|FG001|Overall Study|Withdrawal criteria|10|||
125162355|NCT01831765|450217808|FG002|Overall Study|Withdrawal criteria|16|||
125162356|NCT01831765|450217806|FG000|Overall Study|Lost to Follow-up|2|||
125162357|NCT01831765|450217807|FG001|Overall Study|Lost to Follow-up|3|||
125162358|NCT01831765|450217808|FG002|Overall Study|Lost to Follow-up|3|||
125162359|NCT00977379|450217811|FG000|Overall Study|Withdrawal by Subject|1|||
125162360|NCT00977379|450217812|FG001|Overall Study|Withdrawal by Subject|1|||
125162361|NCT00977379|450217811|FG000|Overall Study|Death|7|||
125162362|NCT00977379|450217812|FG001|Overall Study|Death|9|||
125162363|NCT00977379|450217811|FG000|Overall Study|Premature Study Termination|4|||
125162364|NCT00977379|450217812|FG001|Overall Study|Premature Study Termination|0|||
125162365|NCT00977379|450217811|FG000|Overall Study|Participant Moving House|0|||
125162366|NCT00977379|450217812|FG001|Overall Study|Participant Moving House|1|||
125162367|NCT00977379|450217811|FG000|Overall Study|Randomization Error|0|||
125162368|NCT00977379|450217812|FG001|Overall Study|Randomization Error|1|||
125162369|NCT00706511|450217815|FG000|Overall Study|Withdrawal by Subject|1|||
125162370|NCT00706511|450217816|FG001|Overall Study|Withdrawal by Subject|0|||
125162371|NCT00706511|450217817|FG002|Overall Study|Withdrawal by Subject|0|||
125162372|NCT00706511|450217818|FG003|Overall Study|Withdrawal by Subject|0|||
125162373|NCT02605993|450217819|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
125162374|NCT02605993|450217820|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
125162375|NCT02605993|450217821|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
125162376|NCT02605993|450217822|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
125162377|NCT02603393|450217823|FG000|Overall Study|Patient/guardian decision|32|||
125162378|NCT02603393|450217824|FG001|Overall Study|Patient/guardian decision|18|||
125162379|NCT02603393|450217823|FG000|Overall Study|Adverse Event|17|||
125162380|NCT02603393|450217824|FG001|Overall Study|Adverse Event|15|||
125162381|NCT02603393|450217823|FG000|Overall Study|Technical problems|4|||
125162382|NCT02603393|450217824|FG001|Overall Study|Technical problems|7|||
125162383|NCT02603393|450217823|FG000|Overall Study|Lack of Efficacy|7|||
125162384|NCT02603393|450217824|FG001|Overall Study|Lack of Efficacy|2|||
125162385|NCT02603393|450217823|FG000|Overall Study|Death|3|||
125162386|NCT02603393|450217824|FG001|Overall Study|Death|4|||
125162387|NCT02603393|450217823|FG000|Overall Study|Physician Decision|3|||
125162388|NCT02603393|450217824|FG001|Overall Study|Physician Decision|3|||
125162389|NCT02603393|450217823|FG000|Overall Study|Protocol deviation|2|||
125162390|NCT02603393|450217824|FG001|Overall Study|Protocol deviation|3|||
125162391|NCT02603393|450217823|FG000|Overall Study|Lost to Follow-up|1|||
125162392|NCT02603393|450217824|FG001|Overall Study|Lost to Follow-up|2|||
125162393|NCT02603393|450217823|FG000|Overall Study|Non-compliance with study treatment|1|||
125162394|NCT02603393|450217824|FG001|Overall Study|Non-compliance with study treatment|0|||
125162395|NCT02603393|450217823|FG000|Overall Study|Sponsor decision|1|||
125162396|NCT02603393|450217824|FG001|Overall Study|Sponsor decision|0|||
125162397|NCT01974440|450217830|FG000|Overall Study|Lost to Follow-up|7|||
125162398|NCT01974440|450217831|FG001|Overall Study|Lost to Follow-up|7|||
125162399|NCT01974440|450217830|FG000|Overall Study|Withdrawal by Subject|24|||
125162400|NCT01974440|450217831|FG001|Overall Study|Withdrawal by Subject|20|||
125162401|NCT01974440|450217830|FG000|Overall Study|Sponsor decision|109|||
125162402|NCT01974440|450217831|FG001|Overall Study|Sponsor decision|110|||
125162403|NCT00762437|450217832|FG000|Overall Study|Lost to Follow-up|7|||
125162404|NCT00762437|450217832|FG000|Overall Study|Missed final study visit|11|||
125162405|NCT00762437|450217832|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
125162406|NCT02387983|450217833|FG000|Overall Study|Adverse Event|4|||
125162407|NCT02387983|450217833|FG000|Overall Study|Protocol Violation|1|||
125162408|NCT02387983|450217833|FG000|Overall Study|Withdrawal by Subject|2|||
125162409|NCT03569228|450217834|FG000|Overall Study|Withdrawal by PI|0|||
125162410|NCT03569228|450217835|FG001|Overall Study|Withdrawal by PI|0|||
125162411|NCT03569228|450217836|FG002|Overall Study|Withdrawal by PI|2|||
125162412|NCT03569228|450217837|FG003|Overall Study|Withdrawal by PI|2|||
125162413|NCT03569228|450217838|FG004|Overall Study|Withdrawal by PI|1|||
125162414|NCT03569228|450217839|FG005|Overall Study|Withdrawal by PI|0|||
125162415|NCT03569228|450217840|FG006|Overall Study|Withdrawal by PI|0|||
125162416|NCT03569228|450217841|FG007|Overall Study|Withdrawal by PI|0|||
125162417|NCT03569228|450217842|FG008|Overall Study|Withdrawal by PI|0|||
125162418|NCT03569228|450217834|FG000|Overall Study|Lost to Follow-up|0|||
125162419|NCT03569228|450217835|FG001|Overall Study|Lost to Follow-up|0|||
125162420|NCT03569228|450217836|FG002|Overall Study|Lost to Follow-up|0|||
125162421|NCT03569228|450217837|FG003|Overall Study|Lost to Follow-up|0|||
125162422|NCT03569228|450217838|FG004|Overall Study|Lost to Follow-up|0|||
125162423|NCT03569228|450217839|FG005|Overall Study|Lost to Follow-up|0|||
125162424|NCT03569228|450217840|FG006|Overall Study|Lost to Follow-up|0|||
125162425|NCT03569228|450217841|FG007|Overall Study|Lost to Follow-up|0|||
125162426|NCT03569228|450217842|FG008|Overall Study|Lost to Follow-up|1|||
125162427|NCT03569228|450217834|FG000|Overall Study|Screen Fail|2|||
125162428|NCT03569228|450217835|FG001|Overall Study|Screen Fail|2|||
125162429|NCT03569228|450217836|FG002|Overall Study|Screen Fail|1|||
125162430|NCT03569228|450217837|FG003|Overall Study|Screen Fail|1|||
125162431|NCT03569228|450217838|FG004|Overall Study|Screen Fail|1|||
125162432|NCT03569228|450217839|FG005|Overall Study|Screen Fail|3|||
125162433|NCT03569228|450217840|FG006|Overall Study|Screen Fail|1|||
125162434|NCT03569228|450217841|FG007|Overall Study|Screen Fail|5|||
125162435|NCT03569228|450217842|FG008|Overall Study|Screen Fail|2|||
125162436|NCT06354998|450217843|FG000|Overall Study|Withdrawal by Subject|3|||
125162437|NCT06354998|450217844|FG001|Overall Study|Withdrawal by Subject|0|||
125162438|NCT02440568|450217845|FG000|Overall Study|Death|1|||
125162439|NCT02440568|450217846|FG001|Overall Study|Death|3|||
125162440|NCT02440568|450217847|FG002|Overall Study|Death|4|||
125162441|NCT02440568|450217848|FG003|Overall Study|Death|2|||
125162442|NCT02440568|450217845|FG000|Overall Study|Lack of Efficacy|2|||
125162443|NCT02440568|450217846|FG001|Overall Study|Lack of Efficacy|0|||
125162444|NCT02440568|450217847|FG002|Overall Study|Lack of Efficacy|1|||
125162445|NCT02440568|450217848|FG003|Overall Study|Lack of Efficacy|0|||
125162446|NCT02440568|450217845|FG000|Overall Study|Lost to Follow-up|1|||
125162447|NCT02440568|450217846|FG001|Overall Study|Lost to Follow-up|0|||
125162448|NCT02440568|450217847|FG002|Overall Study|Lost to Follow-up|0|||
125162449|NCT02440568|450217848|FG003|Overall Study|Lost to Follow-up|0|||
125162450|NCT01103466|450217856|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
125162451|NCT01103466|450217857|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
125162452|NCT01103466|450217858|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
125162453|NCT01103466|450217856|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
125162454|NCT01103466|450217857|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
125162455|NCT01103466|450217858|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
125162456|NCT01103466|450217856|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
125162457|NCT01103466|450217857|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
125162458|NCT01103466|450217858|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
125162459|NCT01103466|450217856|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
125162460|NCT01103466|450217857|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
125162461|NCT01103466|450217858|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
125162462|NCT01103466|450217856|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
125162463|NCT01103466|450217857|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
125162464|NCT01103466|450217858|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
125162465|NCT01103466|450217856|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
125162466|NCT01103466|450217857|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
125224857|NCT02155699|450450216|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
125224858|NCT02155699|450450217|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
125224859|NCT02227784|450450218|FG000|Double-Blind Phase|Adverse Event|3|||
125224860|NCT02227784|450450219|FG001|Double-Blind Phase|Adverse Event|2|||
125224861|NCT02227784|450450220|FG002|Double-Blind Phase|Adverse Event|1|||
125224862|NCT02227784|450450221|FG003|Double-Blind Phase|Adverse Event|3|||
125224863|NCT02227784|450450222|FG004|Double-Blind Phase|Adverse Event|0|||
125224864|NCT02227784|450450218|FG000|Double-Blind Phase|Physician Decision|1|||
125224865|NCT02227784|450450219|FG001|Double-Blind Phase|Physician Decision|0|||
125224866|NCT02227784|450450220|FG002|Double-Blind Phase|Physician Decision|0|||
125224867|NCT02227784|450450221|FG003|Double-Blind Phase|Physician Decision|1|||
125224868|NCT02227784|450450222|FG004|Double-Blind Phase|Physician Decision|0|||
125224869|NCT02227784|450450218|FG000|Double-Blind Phase|Protocol Violation|0|||
125224870|NCT02227784|450450219|FG001|Double-Blind Phase|Protocol Violation|0|||
125224871|NCT02227784|450450220|FG002|Double-Blind Phase|Protocol Violation|1|||
125224872|NCT02227784|450450221|FG003|Double-Blind Phase|Protocol Violation|1|||
125224873|NCT02227784|450450222|FG004|Double-Blind Phase|Protocol Violation|0|||
125224874|NCT02227784|450450218|FG000|Double-Blind Phase|Sponsor Decision|34|||
125224875|NCT02227784|450450219|FG001|Double-Blind Phase|Sponsor Decision|15|||
125224876|NCT02227784|450450220|FG002|Double-Blind Phase|Sponsor Decision|14|||
125224877|NCT02227784|450450221|FG003|Double-Blind Phase|Sponsor Decision|32|||
125224878|NCT02227784|450450222|FG004|Double-Blind Phase|Sponsor Decision|0|||
125224879|NCT02227784|450450218|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
125224880|NCT02227784|450450219|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
125224881|NCT02227784|450450220|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
125224882|NCT02227784|450450221|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
125224883|NCT02227784|450450222|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
125224884|NCT02227784|450450218|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
125224885|NCT02227784|450450219|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
125224886|NCT02227784|450450220|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
125224887|NCT02227784|450450221|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
125224888|NCT02227784|450450222|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
125224889|NCT02227784|450450218|FG000|Open-Label Extension Phase (OLE)|Death|0|||
125224890|NCT02227784|450450219|FG001|Open-Label Extension Phase (OLE)|Death|0|||
125224891|NCT02227784|450450220|FG002|Open-Label Extension Phase (OLE)|Death|0|||
125224892|NCT02227784|450450221|FG003|Open-Label Extension Phase (OLE)|Death|0|||
125224893|NCT02227784|450450222|FG004|Open-Label Extension Phase (OLE)|Death|1|||
125224894|NCT02227784|450450218|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
125224895|NCT02227784|450450219|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
125224896|NCT02227784|450450220|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
125224897|NCT02227784|450450221|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
125224898|NCT02227784|450450222|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
125224899|NCT02227784|450450218|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
125162467|NCT01103466|450217858|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
125162468|NCT02331368|450217861|FG000|Overall Study|Withdrawal by Subject|3|||
125162469|NCT02302859|450217869|FG000|Overall Study|Lost Phone|1|||
125162470|NCT02302859|450217870|FG001|Overall Study|Lost Phone|1|||
125162471|NCT02302859|450217869|FG000|Overall Study|Withdrawal by Subject|0|||
125162472|NCT02302859|450217870|FG001|Overall Study|Withdrawal by Subject|1|||
125162473|NCT03285308|450217873|FG000|Overall Study|Adverse Event|3|||
125162474|NCT03285308|450217874|FG001|Overall Study|Adverse Event|7|||
125162475|NCT03285308|450217873|FG000|Overall Study|Withdrawal by Subject|8|||
125162476|NCT03285308|450217874|FG001|Overall Study|Withdrawal by Subject|9|||
125162477|NCT03285308|450217873|FG000|Overall Study|Lost to Follow-up|3|||
125162478|NCT03285308|450217874|FG001|Overall Study|Lost to Follow-up|1|||
125162479|NCT03285308|450217873|FG000|Overall Study|Protocol Deviation|6|||
125162480|NCT03285308|450217874|FG001|Overall Study|Protocol Deviation|5|||
125162481|NCT03285308|450217873|FG000|Overall Study|Reason not Specified|0|||
125162482|NCT03285308|450217874|FG001|Overall Study|Reason not Specified|1|||
125162483|NCT02283983|450217875|FG000|Overall Study|Inclusion criteria not met|0|||
125162484|NCT02283983|450217876|FG001|Overall Study|Inclusion criteria not met|1|||
125162485|NCT02283983|450217875|FG000|Overall Study|Withdrawal by Subject|4|||
125162486|NCT02283983|450217876|FG001|Overall Study|Withdrawal by Subject|2|||
125162487|NCT02283983|450217875|FG000|Overall Study|Protocol Violation|0|||
125162488|NCT02283983|450217876|FG001|Overall Study|Protocol Violation|4|||
125162489|NCT02283983|450217875|FG000|Overall Study|Physician Decision|2|||
125162490|NCT02283983|450217876|FG001|Overall Study|Physician Decision|4|||
125162491|NCT02283983|450217875|FG000|Overall Study|Death|1|||
125162492|NCT02283983|450217876|FG001|Overall Study|Death|0|||
125162493|NCT02283983|450217875|FG000|Overall Study|Adverse Event|1|||
125162494|NCT02283983|450217876|FG001|Overall Study|Adverse Event|0|||
125162495|NCT02283983|450217875|FG000|Overall Study|Lost to Follow-up|9|||
125162496|NCT02283983|450217876|FG001|Overall Study|Lost to Follow-up|8|||
125162497|NCT02283983|450217875|FG000|Overall Study|Relapse|1|||
125162498|NCT02283983|450217876|FG001|Overall Study|Relapse|0|||
125162499|NCT00424775|450217883|FG000|Overall Study|Adverse Event|2|||
125162500|NCT00424775|450217884|FG001|Overall Study|Adverse Event|0|||
125162501|NCT00424775|450217883|FG000|Overall Study|Lack of Efficacy|1|||
125162502|NCT00424775|450217884|FG001|Overall Study|Lack of Efficacy|0|||
125162503|NCT00681590|450217885|FG000|Overall Study|Withdrawal by Subject|2|||
125162504|NCT00681590|450217886|FG001|Overall Study|Withdrawal by Subject|12|||
125162505|NCT01898650|450217887|FG000|Overall Study|the subject would not lie still for imaging|1|||
125162506|NCT01791153|450217888|FG000|Part 1: Blinded Period|Adverse Event|7|||
125162507|NCT01791153|450217889|FG001|Part 1: Blinded Period|Adverse Event|3|||
125162508|NCT01791153|450217890|FG002|Part 1: Blinded Period|Adverse Event|2|||
125162509|NCT01791153|450217891|FG003|Part 1: Blinded Period|Adverse Event|0|||
125162510|NCT01791153|450217892|FG004|Part 1: Blinded Period|Adverse Event|0|||
125224900|NCT02227784|450450219|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
125162511|NCT01791153|450217893|FG005|Part 1: Blinded Period|Adverse Event|0|||
125162512|NCT01791153|450217894|FG006|Part 1: Blinded Period|Adverse Event|0|||
125162513|NCT01791153|450217895|FG007|Part 1: Blinded Period|Adverse Event|0|||
125162514|NCT01791153|450217888|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
125162515|NCT01791153|450217889|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
125162516|NCT01791153|450217890|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
125162517|NCT01791153|450217891|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
125162518|NCT01791153|450217892|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
125162519|NCT01791153|450217893|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
125162520|NCT01791153|450217894|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
125162521|NCT01791153|450217895|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
125162522|NCT01791153|450217888|FG000|Part 1: Blinded Period|Non-Compliance|1|||
125162523|NCT01791153|450217889|FG001|Part 1: Blinded Period|Non-Compliance|0|||
125162524|NCT01791153|450217890|FG002|Part 1: Blinded Period|Non-Compliance|0|||
125162525|NCT01791153|450217891|FG003|Part 1: Blinded Period|Non-Compliance|0|||
125162526|NCT01791153|450217892|FG004|Part 1: Blinded Period|Non-Compliance|0|||
125162527|NCT01791153|450217893|FG005|Part 1: Blinded Period|Non-Compliance|0|||
125162528|NCT01791153|450217894|FG006|Part 1: Blinded Period|Non-Compliance|0|||
125162529|NCT01791153|450217895|FG007|Part 1: Blinded Period|Non-Compliance|0|||
125162530|NCT01791153|450217888|FG000|Part 1: Blinded Period|Physician Decision|0|||
125162531|NCT01791153|450217889|FG001|Part 1: Blinded Period|Physician Decision|0|||
125162532|NCT01791153|450217890|FG002|Part 1: Blinded Period|Physician Decision|0|||
125162533|NCT01791153|450217891|FG003|Part 1: Blinded Period|Physician Decision|1|||
125162534|NCT01791153|450217892|FG004|Part 1: Blinded Period|Physician Decision|0|||
125162535|NCT01791153|450217893|FG005|Part 1: Blinded Period|Physician Decision|0|||
125162536|NCT01791153|450217894|FG006|Part 1: Blinded Period|Physician Decision|0|||
125162537|NCT01791153|450217895|FG007|Part 1: Blinded Period|Physician Decision|0|||
125162538|NCT01791153|450217888|FG000|Part 1: Blinded Period|Protocol Violation|0|||
125162539|NCT01791153|450217889|FG001|Part 1: Blinded Period|Protocol Violation|0|||
125162540|NCT01791153|450217890|FG002|Part 1: Blinded Period|Protocol Violation|0|||
125162541|NCT01791153|450217891|FG003|Part 1: Blinded Period|Protocol Violation|1|||
125162542|NCT01791153|450217892|FG004|Part 1: Blinded Period|Protocol Violation|0|||
125162543|NCT01791153|450217893|FG005|Part 1: Blinded Period|Protocol Violation|0|||
125162544|NCT01791153|450217894|FG006|Part 1: Blinded Period|Protocol Violation|0|||
125162545|NCT01791153|450217895|FG007|Part 1: Blinded Period|Protocol Violation|0|||
125162546|NCT01791153|450217888|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
125162547|NCT01791153|450217889|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
125162548|NCT01791153|450217890|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
125162549|NCT01791153|450217891|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
125162550|NCT01791153|450217892|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
125162551|NCT01791153|450217893|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
125162552|NCT01791153|450217894|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
125162553|NCT01791153|450217895|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
125162554|NCT01791153|450217888|FG000|Part 2: Open-label Period|Adverse Event|0|||
125162555|NCT01791153|450217889|FG001|Part 2: Open-label Period|Adverse Event|0|||
125162556|NCT01791153|450217890|FG002|Part 2: Open-label Period|Adverse Event|0|||
125162557|NCT01791153|450217891|FG003|Part 2: Open-label Period|Adverse Event|0|||
125162558|NCT01791153|450217892|FG004|Part 2: Open-label Period|Adverse Event|0|||
125162559|NCT01791153|450217893|FG005|Part 2: Open-label Period|Adverse Event|1|||
125162560|NCT01791153|450217894|FG006|Part 2: Open-label Period|Adverse Event|1|||
125162561|NCT01791153|450217895|FG007|Part 2: Open-label Period|Adverse Event|2|||
125162562|NCT01791153|450217888|FG000|Part 2: Open-label Period|Death|0|||
125162563|NCT01791153|450217889|FG001|Part 2: Open-label Period|Death|0|||
125162564|NCT01791153|450217890|FG002|Part 2: Open-label Period|Death|0|||
125162565|NCT01791153|450217891|FG003|Part 2: Open-label Period|Death|0|||
125162566|NCT01791153|450217892|FG004|Part 2: Open-label Period|Death|0|||
125162567|NCT01791153|450217893|FG005|Part 2: Open-label Period|Death|1|||
125162568|NCT01791153|450217894|FG006|Part 2: Open-label Period|Death|1|||
125162569|NCT01791153|450217895|FG007|Part 2: Open-label Period|Death|1|||
125162570|NCT01791153|450217888|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
125162571|NCT01791153|450217889|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
125162572|NCT01791153|450217890|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
125162573|NCT01791153|450217891|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
125162574|NCT01791153|450217892|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
125162575|NCT01791153|450217893|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
125162576|NCT01791153|450217894|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
125162577|NCT01791153|450217895|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
125162578|NCT01791153|450217888|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
125162579|NCT01791153|450217889|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
125162580|NCT01791153|450217890|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
125162581|NCT01791153|450217891|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
125162582|NCT01791153|450217892|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
125162583|NCT01791153|450217893|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
125162584|NCT01791153|450217894|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
125162585|NCT01791153|450217895|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
125162586|NCT01791153|450217888|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
125162587|NCT01791153|450217889|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
125162588|NCT01791153|450217890|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
125162589|NCT01791153|450217891|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
125162590|NCT01791153|450217892|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
125162591|NCT01791153|450217893|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
125162592|NCT01791153|450217894|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
125162593|NCT01791153|450217895|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
125224901|NCT02227784|450450220|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
125224902|NCT02227784|450450221|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
125162594|NCT01791153|450217888|FG000|Part 2: Open-label Period|Physician Decision|0|||
125162595|NCT01791153|450217889|FG001|Part 2: Open-label Period|Physician Decision|0|||
125162596|NCT01791153|450217890|FG002|Part 2: Open-label Period|Physician Decision|0|||
125162597|NCT01791153|450217891|FG003|Part 2: Open-label Period|Physician Decision|0|||
125162598|NCT01791153|450217892|FG004|Part 2: Open-label Period|Physician Decision|1|||
125162599|NCT01791153|450217893|FG005|Part 2: Open-label Period|Physician Decision|1|||
125162600|NCT01791153|450217894|FG006|Part 2: Open-label Period|Physician Decision|0|||
125162601|NCT01791153|450217895|FG007|Part 2: Open-label Period|Physician Decision|0|||
125162602|NCT00975286|450217899|FG000|Overall Study|Adverse Event|9|||
125162603|NCT00975286|450217900|FG001|Overall Study|Adverse Event|19|||
125162604|NCT00975286|450217899|FG000|Overall Study|Protocol Violation|1|||
125162605|NCT00975286|450217900|FG001|Overall Study|Protocol Violation|2|||
125162606|NCT00975286|450217899|FG000|Overall Study|Withdrawal by Subject|0|||
125162607|NCT00975286|450217900|FG001|Overall Study|Withdrawal by Subject|2|||
125162608|NCT00975286|450217899|FG000|Overall Study|Familial and Personal Reasons|2|||
125162609|NCT00975286|450217900|FG001|Overall Study|Familial and Personal Reasons|2|||
125162610|NCT00975286|450217899|FG000|Overall Study|Poor Compliance to Protocol|0|||
125224903|NCT02227784|450450222|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
125224904|NCT03834506|450450226|FG000|Overall Study|Death|336|||
125224905|NCT03834506|450450227|FG001|Overall Study|Death|326|||
125224906|NCT03834506|450450226|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
125224907|NCT03834506|450450227|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
125224908|NCT03834506|450450226|FG000|Overall Study|Withdrawal by Subject|10|||
125224909|NCT03834506|450450227|FG001|Overall Study|Withdrawal by Subject|8|||
125224910|NCT03834506|450450226|FG000|Overall Study|Sponsor decision|165|||
125224911|NCT03834506|450450227|FG001|Overall Study|Sponsor decision|178|||
125224912|NCT03834506|450450226|FG000|Overall Study|Physician Decision|3|||
125162611|NCT00975286|450217900|FG001|Overall Study|Poor Compliance to Protocol|2|||
125162612|NCT00975286|450217899|FG000|Overall Study|Sponsor Decision|0|||
125162613|NCT00975286|450217900|FG001|Overall Study|Sponsor Decision|2|||
125162614|NCT02357342|450217901|FG000|First 6 Months|Death|2|||
125224913|NCT03834506|450450227|FG001|Overall Study|Physician Decision|1|||
125224914|NCT03834506|450450226|FG000|Overall Study|Lost to Follow-up|0|||
125162615|NCT02357342|450217902|FG001|First 6 Months|Death|0|||
125162616|NCT01674647|450217903|FG000|Treatment Period|Death|4|||
125162617|NCT01674647|450217904|FG001|Treatment Period|Death|1|||
125162618|NCT01674647|450217903|FG000|Treatment Period|Efficacy outcome reached|0|||
125162619|NCT01674647|450217904|FG001|Treatment Period|Efficacy outcome reached|1|||
125162620|NCT01674647|450217903|FG000|Treatment Period|Physician Decision|3|||
125162621|NCT01674647|450217904|FG001|Treatment Period|Physician Decision|1|||
125162622|NCT01674647|450217903|FG000|Treatment Period|Adverse Event|60|||
125162623|NCT01674647|450217904|FG001|Treatment Period|Adverse Event|22|||
125162624|NCT01674647|450217903|FG000|Treatment Period|Non-compliance with study drug|3|||
125162625|NCT01674647|450217904|FG001|Treatment Period|Non-compliance with study drug|0|||
125162626|NCT01674647|450217903|FG000|Treatment Period|Lost to Follow-up|1|||
125162627|NCT01674647|450217904|FG001|Treatment Period|Lost to Follow-up|1|||
125162628|NCT01674647|450217903|FG000|Treatment Period|Withdrawal by Subject|19|||
125162629|NCT01674647|450217904|FG001|Treatment Period|Withdrawal by Subject|16|||
125162630|NCT01674647|450217903|FG000|Treatment Period|Switching to other therapy|5|||
125162631|NCT01674647|450217904|FG001|Treatment Period|Switching to other therapy|2|||
125162632|NCT01674647|450217903|FG000|Treatment Period|Logistical difficulties|5|||
125162633|NCT01674647|450217904|FG001|Treatment Period|Logistical difficulties|8|||
125162634|NCT01674647|450217903|FG000|Treatment Period|Treatment failure|0|||
125162635|NCT01674647|450217904|FG001|Treatment Period|Treatment failure|14|||
125162636|NCT01674647|450217903|FG000|Treatment Period|Protocol Violation|56|||
125224915|NCT03834506|450450227|FG001|Overall Study|Lost to Follow-up|1|||
125224916|NCT04577794|450450228|FG000|Overall Study|Adverse Event|1|||
125224917|NCT04577794|450450229|FG001|Overall Study|Adverse Event|1|||
125224918|NCT01628848|450450230|FG000|Overall Study|Adverse Event|9|||
125224919|NCT01628848|450450231|FG001|Overall Study|Adverse Event|7|||
125224920|NCT01628848|450450230|FG000|Overall Study|Lack of Efficacy|0|||
125224921|NCT01628848|450450231|FG001|Overall Study|Lack of Efficacy|4|||
125162637|NCT01674647|450217904|FG001|Treatment Period|Protocol Violation|36|||
125224922|NCT01628848|450450230|FG000|Overall Study|Withdrawal by Subject|0|||
125162638|NCT01674647|450217903|FG000|30-day Safety Follow-up Period|Death|3|||
125162639|NCT01674647|450217904|FG001|30-day Safety Follow-up Period|Death|2|||
125162640|NCT01674647|450217903|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
125162641|NCT01674647|450217904|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
125162642|NCT01674647|450217903|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
125162643|NCT01674647|450217904|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
125162644|NCT01674647|450217903|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
125224923|NCT01628848|450450231|FG001|Overall Study|Withdrawal by Subject|2|||
125224924|NCT01628848|450450230|FG000|Overall Study|Physician Decision|3|||
125224925|NCT01628848|450450231|FG001|Overall Study|Physician Decision|1|||
125224926|NCT00003471|450450232|FG000|Overall Study|Not evaluable|4|||
125224927|NCT02104895|450450233|FG000|Overall Study|Withdrawal by Subject|0|||
125224928|NCT02104895|450450234|FG001|Overall Study|Withdrawal by Subject|14|||
125162645|NCT01674647|450217904|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
125162646|NCT01674647|450217903|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
125162647|NCT01674647|450217904|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
125162648|NCT01674647|450217903|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
125162649|NCT01674647|450217904|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
125162650|NCT01490866|450217905|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
125162651|NCT01490866|450217905|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
125162652|NCT01490866|450217905|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
125162653|NCT01490866|450217905|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
125162654|NCT01490866|450217905|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
125224929|NCT03311945|450450236|FG000|Overall Study|Adverse Event|2|||
125162655|NCT01490866|450217905|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
125162656|NCT01490866|450217905|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
125162657|NCT01490866|450217905|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
125162658|NCT01490866|450217905|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
125162659|NCT01490866|450217905|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
125162660|NCT01490866|450217905|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
125162661|NCT01181271|450217906|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
125162662|NCT01181271|450217906|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
125162663|NCT01181271|450217906|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
125162664|NCT01181271|450217906|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
125162665|NCT04156620|450217907|FG000|Overall Study|Adverse event - TP 1|5|||
125162666|NCT04156620|450217908|FG001|Overall Study|Adverse event - TP 1|2|||
125162667|NCT04156620|450217907|FG000|Overall Study|Lost to follow-up TP 1|1|||
125162668|NCT04156620|450217908|FG001|Overall Study|Lost to follow-up TP 1|1|||
125162669|NCT04156620|450217907|FG000|Overall Study|Progressive disease - TP 1|0|||
125162670|NCT04156620|450217908|FG001|Overall Study|Progressive disease - TP 1|1|||
125162671|NCT04156620|450217907|FG000|Overall Study|Subject decision - TP 1|3|||
125162672|NCT04156620|450217908|FG001|Overall Study|Subject decision - TP 1|5|||
125162673|NCT04156620|450217907|FG000|Overall Study|Adverse event - TP 2|5|||
125162674|NCT04156620|450217908|FG001|Overall Study|Adverse event - TP 2|6|||
125162675|NCT04156620|450217907|FG000|Overall Study|Death - TP 2|1|||
125162676|NCT04156620|450217908|FG001|Overall Study|Death - TP 2|0|||
125162677|NCT04156620|450217907|FG000|Overall Study|Lost to follow-up - TP 2|5|||
125162678|NCT04156620|450217908|FG001|Overall Study|Lost to follow-up - TP 2|2|||
125162679|NCT04156620|450217907|FG000|Overall Study|Physician decision - TP 2|4|||
125162680|NCT04156620|450217908|FG001|Overall Study|Physician decision - TP 2|2|||
125162681|NCT04156620|450217907|FG000|Overall Study|Pregnancy - TP 2|1|||
125162682|NCT04156620|450217908|FG001|Overall Study|Pregnancy - TP 2|1|||
125162683|NCT04156620|450217907|FG000|Overall Study|Subject decision - TP 2|11|||
125162684|NCT04156620|450217908|FG001|Overall Study|Subject decision - TP 2|9|||
125162685|NCT04156620|450217907|FG000|Overall Study|New therapy for study indication - TP 2|1|||
125162686|NCT04156620|450217908|FG001|Overall Study|New therapy for study indication - TP 2|0|||
125162687|NCT02980874|450217909|FG000|Overall Study|Adverse Event|2|||
125162688|NCT02980874|450217910|FG001|Overall Study|Adverse Event|7|||
125162689|NCT02980874|450217909|FG000|Overall Study|Withdrawal by Subject|7|||
125162690|NCT02980874|450217910|FG001|Overall Study|Withdrawal by Subject|2|||
125162691|NCT02980874|450217909|FG000|Overall Study|Lost to Follow-up|5|||
125162692|NCT02980874|450217910|FG001|Overall Study|Lost to Follow-up|5|||
125162693|NCT02980874|450217909|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
125162694|NCT02980874|450217910|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
125162695|NCT02980874|450217909|FG000|Overall Study|Unknown study completion status|1|||
125162696|NCT02980874|450217910|FG001|Overall Study|Unknown study completion status|0|||
125162697|NCT02722148|450217911|FG000|Overall Study|Lost to Follow-up|2|||
125162698|NCT02722148|450217911|FG000|Overall Study|Non compliant with treatment regimen|3|||
125162699|NCT01753336|450217912|FG000|Overall Study|Patient decision|12|||
125162700|NCT01753336|450217912|FG000|Overall Study|Lost to Follow-up|3|||
125162701|NCT01753336|450217912|FG000|Overall Study|Physician Decision|2|||
125162702|NCT01753336|450217912|FG000|Overall Study|Sponsor's decision|2|||
125162703|NCT01753336|450217912|FG000|Overall Study|Withdrawal by Subject|1|||
125162704|NCT00446199|450217916|FG000|Overall Study|Adverse Event|7|||
125162705|NCT00446199|450217917|FG001|Overall Study|Adverse Event|4|||
125162706|NCT00446199|450217918|FG002|Overall Study|Adverse Event|6|||
125162707|NCT00446199|450217919|FG003|Overall Study|Adverse Event|4|||
125162708|NCT00446199|450217916|FG000|Overall Study|Lost to Follow-up|4|||
125162709|NCT00446199|450217917|FG001|Overall Study|Lost to Follow-up|5|||
125162710|NCT00446199|450217918|FG002|Overall Study|Lost to Follow-up|2|||
125162711|NCT00446199|450217919|FG003|Overall Study|Lost to Follow-up|6|||
125162712|NCT00446199|450217916|FG000|Overall Study|Protocol Violation|1|||
125162713|NCT00446199|450217917|FG001|Overall Study|Protocol Violation|2|||
125162714|NCT00446199|450217918|FG002|Overall Study|Protocol Violation|1|||
125162715|NCT00446199|450217919|FG003|Overall Study|Protocol Violation|3|||
125162716|NCT00446199|450217916|FG000|Overall Study|Withdrawal by Subject|2|||
125162717|NCT00446199|450217917|FG001|Overall Study|Withdrawal by Subject|5|||
125162718|NCT00446199|450217918|FG002|Overall Study|Withdrawal by Subject|9|||
125162719|NCT00446199|450217919|FG003|Overall Study|Withdrawal by Subject|10|||
125162720|NCT00446199|450217916|FG000|Overall Study|Site termination|2|||
125162721|NCT00446199|450217917|FG001|Overall Study|Site termination|0|||
125162722|NCT00446199|450217918|FG002|Overall Study|Site termination|0|||
125162723|NCT00446199|450217919|FG003|Overall Study|Site termination|1|||
125162724|NCT00446199|450217916|FG000|Overall Study|Randomization in Error|2|||
125162725|NCT00446199|450217917|FG001|Overall Study|Randomization in Error|0|||
125162726|NCT00446199|450217918|FG002|Overall Study|Randomization in Error|1|||
125162727|NCT00446199|450217919|FG003|Overall Study|Randomization in Error|1|||
125162728|NCT00446199|450217916|FG000|Overall Study|Lack of Efficacy|1|||
125162729|NCT00446199|450217917|FG001|Overall Study|Lack of Efficacy|0|||
125162730|NCT00446199|450217918|FG002|Overall Study|Lack of Efficacy|0|||
125162731|NCT00446199|450217919|FG003|Overall Study|Lack of Efficacy|1|||
125162732|NCT00446199|450217916|FG000|Overall Study|Non-compliant with study drug|1|||
125162733|NCT00446199|450217917|FG001|Overall Study|Non-compliant with study drug|0|||
125162734|NCT00446199|450217918|FG002|Overall Study|Non-compliant with study drug|5|||
125162735|NCT00446199|450217919|FG003|Overall Study|Non-compliant with study drug|0|||
125162736|NCT00446199|450217916|FG000|Overall Study|Non-compliant with visit schedule|1|||
125162737|NCT00446199|450217917|FG001|Overall Study|Non-compliant with visit schedule|1|||
125162738|NCT00446199|450217918|FG002|Overall Study|Non-compliant with visit schedule|1|||
125162739|NCT00446199|450217919|FG003|Overall Study|Non-compliant with visit schedule|2|||
125162740|NCT00446199|450217916|FG000|Overall Study|Hormone fear|0|||
125162741|NCT00446199|450217917|FG001|Overall Study|Hormone fear|0|||
125162742|NCT00446199|450217918|FG002|Overall Study|Hormone fear|0|||
125162743|NCT00446199|450217919|FG003|Overall Study|Hormone fear|1|||
125162744|NCT00446199|450217916|FG000|Overall Study|Lost interest in study participation|0|||
125162745|NCT00446199|450217917|FG001|Overall Study|Lost interest in study participation|1|||
125162746|NCT00446199|450217918|FG002|Overall Study|Lost interest in study participation|0|||
125162747|NCT00446199|450217919|FG003|Overall Study|Lost interest in study participation|0|||
125162748|NCT00446199|450217916|FG000|Overall Study|In-/Exclusion criterion violated|2|||
125162749|NCT00446199|450217917|FG001|Overall Study|In-/Exclusion criterion violated|1|||
125162750|NCT00446199|450217918|FG002|Overall Study|In-/Exclusion criterion violated|2|||
125162751|NCT00446199|450217919|FG003|Overall Study|In-/Exclusion criterion violated|1|||
125162752|NCT00446199|450217916|FG000|Overall Study|Move|0|||
125162753|NCT00446199|450217917|FG001|Overall Study|Move|1|||
125162754|NCT00446199|450217918|FG002|Overall Study|Move|0|||
125162755|NCT00446199|450217919|FG003|Overall Study|Move|0|||
125162756|NCT04188301|450217925|FG000|Month 3|Lost to Follow-up|0|||
125162757|NCT04188301|450217926|FG001|Month 3|Lost to Follow-up|0|||
125162758|NCT04188301|450217927|FG002|Month 3|Lost to Follow-up|1|||
125162759|NCT04188301|450217925|FG000|Month 12|Lost to Follow-up|0|||
125162760|NCT04188301|450217926|FG001|Month 12|Lost to Follow-up|0|||
125162761|NCT04188301|450217927|FG002|Month 12|Lost to Follow-up|2|||
125162762|NCT04188301|450217925|FG000|Month 12|Death|1|||
125162763|NCT04188301|450217926|FG001|Month 12|Death|1|||
125162764|NCT04188301|450217927|FG002|Month 12|Death|0|||
125162765|NCT04188301|450217925|FG000|Month 18|Lost to Follow-up|6|||
125162766|NCT04188301|450217926|FG001|Month 18|Lost to Follow-up|0|||
125162767|NCT04188301|450217927|FG002|Month 18|Lost to Follow-up|0|||
125162768|NCT01104779|450217928|FG000|Overall Study|Protocol Violation|1|||
125162769|NCT01104779|450217929|FG001|Overall Study|Protocol Violation|2|||
125162770|NCT01104779|450217930|FG002|Overall Study|Protocol Violation|2|||
125162771|NCT01104779|450217928|FG000|Overall Study|Lack of Efficacy|26|||
125162772|NCT01104779|450217929|FG001|Overall Study|Lack of Efficacy|12|||
125162773|NCT01104779|450217930|FG002|Overall Study|Lack of Efficacy|13|||
125162774|NCT01104779|450217928|FG000|Overall Study|Adverse Event|13|||
125162775|NCT01104779|450217929|FG001|Overall Study|Adverse Event|14|||
125162776|NCT01104779|450217930|FG002|Overall Study|Adverse Event|13|||
125162777|NCT01104779|450217928|FG000|Overall Study|Did not meet inc/exc criteria|1|||
125162778|NCT01104779|450217929|FG001|Overall Study|Did not meet inc/exc criteria|1|||
125162779|NCT01104779|450217930|FG002|Overall Study|Did not meet inc/exc criteria|1|||
125162780|NCT01104779|450217928|FG000|Overall Study|Other reasons|0|||
125162781|NCT01104779|450217929|FG001|Overall Study|Other reasons|1|||
125162782|NCT01104779|450217930|FG002|Overall Study|Other reasons|0|||
125162783|NCT01104779|450217928|FG000|Overall Study|Lost to Follow-up|2|||
125162784|NCT01104779|450217929|FG001|Overall Study|Lost to Follow-up|0|||
125162785|NCT01104779|450217930|FG002|Overall Study|Lost to Follow-up|1|||
125162786|NCT01104779|450217928|FG000|Overall Study|Withdrawal by Subject|16|||
125162787|NCT01104779|450217929|FG001|Overall Study|Withdrawal by Subject|25|||
125162788|NCT01104779|450217930|FG002|Overall Study|Withdrawal by Subject|32|||
125162789|NCT03548064|450220624|FG000|Overall Study|Withdrawal by Subject|0|||
125162790|NCT03548064|450220625|FG001|Overall Study|Withdrawal by Subject|0|||
125162791|NCT03548064|450220626|FG002|Overall Study|Withdrawal by Subject|0|||
125162792|NCT03548064|450220627|FG003|Overall Study|Withdrawal by Subject|1|||
125162793|NCT03548064|450220628|FG004|Overall Study|Withdrawal by Subject|0|||
125162794|NCT03548064|450220629|FG005|Overall Study|Withdrawal by Subject|0|||
125162795|NCT03548064|450220630|FG006|Overall Study|Withdrawal by Subject|0|||
125162796|NCT03548064|450220631|FG007|Overall Study|Withdrawal by Subject|0|||
125162797|NCT03548064|450220624|FG000|Overall Study|Lost to Follow-up|0|||
125162798|NCT03548064|450220625|FG001|Overall Study|Lost to Follow-up|0|||
125162799|NCT03548064|450220626|FG002|Overall Study|Lost to Follow-up|0|||
125162800|NCT03548064|450220627|FG003|Overall Study|Lost to Follow-up|0|||
125162801|NCT03548064|450220628|FG004|Overall Study|Lost to Follow-up|2|||
125162802|NCT03548064|450220629|FG005|Overall Study|Lost to Follow-up|0|||
125162803|NCT03548064|450220630|FG006|Overall Study|Lost to Follow-up|0|||
125162804|NCT03548064|450220631|FG007|Overall Study|Lost to Follow-up|0|||
125162805|NCT03548064|450220624|FG000|Overall Study|Covid-19 Pandemic|0|||
125162806|NCT03548064|450220625|FG001|Overall Study|Covid-19 Pandemic|0|||
125162807|NCT03548064|450220626|FG002|Overall Study|Covid-19 Pandemic|0|||
125162808|NCT03548064|450220627|FG003|Overall Study|Covid-19 Pandemic|0|||
125162809|NCT03548064|450220628|FG004|Overall Study|Covid-19 Pandemic|10|||
125162810|NCT03548064|450220629|FG005|Overall Study|Covid-19 Pandemic|3|||
125162811|NCT03548064|450220630|FG006|Overall Study|Covid-19 Pandemic|0|||
125162812|NCT03548064|450220631|FG007|Overall Study|Covid-19 Pandemic|0|||
125162813|NCT05011123|450220632|FG000|Overall Study|Withdrawal by Subject|4|||
125162814|NCT05011123|450220633|FG001|Overall Study|Withdrawal by Subject|2|||
125162815|NCT05011123|450220632|FG000|Overall Study|Lost to Follow-up|7|||
125162816|NCT05011123|450220633|FG001|Overall Study|Lost to Follow-up|6|||
125162817|NCT05011123|450220632|FG000|Overall Study|Ongoing at the time of DBL date|36|||
125162818|NCT05011123|450220633|FG001|Overall Study|Ongoing at the time of DBL date|10|||
125162819|NCT05011123|450220632|FG000|Overall Study|Randomized but did not receive vaccination|1|||
125162820|NCT05011123|450220633|FG001|Overall Study|Randomized but did not receive vaccination|0|||
125162821|NCT04221789|450220634|FG000|Overall Study|deviation from protoco|22|||
125162822|NCT04221789|450220635|FG001|Overall Study|deviation from protoco|8|||
125162823|NCT04732221|450220636|FG000|Base Period|Death|2|||
125162824|NCT04732221|450220637|FG001|Base Period|Death|0|||
125162825|NCT04732221|450220638|FG002|Base Period|Death|0|||
125162826|NCT04732221|450220639|FG003|Base Period|Death|0|||
125162827|NCT04732221|450220640|FG004|Base Period|Death|0|||
125162828|NCT04732221|450220641|FG005|Base Period|Death|0|||
125162829|NCT04732221|450220642|FG006|Base Period|Death|0|||
125162830|NCT04732221|450220636|FG000|Base Period|Withdrawal by Subject|0|||
125162831|NCT04732221|450220637|FG001|Base Period|Withdrawal by Subject|1|||
125162832|NCT04732221|450220638|FG002|Base Period|Withdrawal by Subject|1|||
125162833|NCT04732221|450220639|FG003|Base Period|Withdrawal by Subject|0|||
125224930|NCT03311945|450450236|FG000|Overall Study|Lack of Efficacy|1|||
125224931|NCT01107925|450450237|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
125224932|NCT01107925|450450238|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
125224933|NCT01107925|450450239|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
125224934|NCT01107925|450450240|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
125224935|NCT01107925|450450241|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
125224936|NCT01107925|450450242|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
125224937|NCT01107925|450450237|FG000|Period 2|Withdrawal by Subject|0|||
125224938|NCT01107925|450450238|FG001|Period 2|Withdrawal by Subject|1|||
125224939|NCT01107925|450450239|FG002|Period 2|Withdrawal by Subject|0|||
125224940|NCT01107925|450450240|FG003|Period 2|Withdrawal by Subject|0|||
125224941|NCT01107925|450450241|FG004|Period 2|Withdrawal by Subject|0|||
125224942|NCT01107925|450450242|FG005|Period 2|Withdrawal by Subject|1|||
125224943|NCT04877990|450450243|FG000|Treatment|Other reasons|3|||
125224944|NCT04877990|450450244|FG001|Treatment|Other reasons|1|||
125224945|NCT04877990|450450243|FG000|Treatment|Administrative reasons by sponsor|17|||
125224946|NCT04877990|450450244|FG001|Treatment|Administrative reasons by sponsor|33|||
125224947|NCT04877990|450450243|FG000|Treatment|Withdrawal by Subject|2|||
125224948|NCT04877990|450450244|FG001|Treatment|Withdrawal by Subject|6|||
125224949|NCT04877990|450450243|FG000|Treatment|Adverse Event|2|||
125224950|NCT04877990|450450244|FG001|Treatment|Adverse Event|1|||
125224951|NCT01619878|450450245|FG000|6 Week Follow-up Phase|Adverse Event|1|||
125224952|NCT01619878|450450245|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
125224953|NCT01619878|450450245|FG000|Follow-up at 12 Months of Age|Death|2|||
125224954|NCT03839394|450450246|FG000|Overall Study|Lost to Follow-up|6|||
125224955|NCT03839394|450450247|FG001|Overall Study|Lost to Follow-up|8|||
125224956|NCT03839394|450450246|FG000|Overall Study|Withdrawal by Subject|0|||
125224957|NCT03839394|450450247|FG001|Overall Study|Withdrawal by Subject|2|||
125224958|NCT02895295|450450250|FG000|Overall Study|Survey Non-response|71|||
125224959|NCT02895295|450450251|FG001|Overall Study|Survey Non-response|94|||
125224960|NCT02895295|450450252|FG002|Overall Study|Survey Non-response|92|||
125224961|NCT01367249|450450253|FG000|Overall Study|Withdrawal by Subject|6|||
125224962|NCT01367249|450450254|FG001|Overall Study|Withdrawal by Subject|6|||
125224963|NCT01367249|450450253|FG000|Overall Study|Other|3|||
125224964|NCT01367249|450450254|FG001|Overall Study|Other|10|||
125162834|NCT04732221|450220640|FG004|Base Period|Withdrawal by Subject|0|||
125162835|NCT04732221|450220641|FG005|Base Period|Withdrawal by Subject|0|||
125224965|NCT04821830|450450257|FG000|Overall Study|Withdrawal by Subject|1|||
125224966|NCT04821830|450450258|FG001|Overall Study|Withdrawal by Subject|0|||
125224967|NCT00960804|450450264|FG000|Overall Study|Adverse Event|1|||
125224968|NCT00960804|450450265|FG001|Overall Study|Adverse Event|0|||
125224969|NCT00960804|450450266|FG002|Overall Study|Adverse Event|0|||
125224970|NCT00960804|450450264|FG000|Overall Study|Withdrawal by Subject|1|||
125224971|NCT00960804|450450265|FG001|Overall Study|Withdrawal by Subject|0|||
125224972|NCT00960804|450450266|FG002|Overall Study|Withdrawal by Subject|0|||
125162836|NCT04732221|450220642|FG006|Base Period|Withdrawal by Subject|0|||
125162837|NCT04732221|450220636|FG000|Extension Period|Adverse Event|0|||
125162838|NCT04732221|450220637|FG001|Extension Period|Adverse Event|0|||
125162839|NCT04732221|450220638|FG002|Extension Period|Adverse Event|0|||
125162840|NCT04732221|450220639|FG003|Extension Period|Adverse Event|0|||
125162841|NCT04732221|450220640|FG004|Extension Period|Adverse Event|0|||
125162842|NCT04732221|450220641|FG005|Extension Period|Adverse Event|1|||
125162843|NCT04732221|450220642|FG006|Extension Period|Adverse Event|0|||
125162844|NCT04732221|450220636|FG000|Extension Period|Death|0|||
125162845|NCT04732221|450220637|FG001|Extension Period|Death|0|||
125162846|NCT04732221|450220638|FG002|Extension Period|Death|0|||
125162847|NCT04732221|450220639|FG003|Extension Period|Death|0|||
125162848|NCT04732221|450220640|FG004|Extension Period|Death|1|||
125162849|NCT04732221|450220641|FG005|Extension Period|Death|0|||
125162850|NCT04732221|450220642|FG006|Extension Period|Death|2|||
125162851|NCT04732221|450220636|FG000|Extension Period|Pregnancy|0|||
125162852|NCT04732221|450220637|FG001|Extension Period|Pregnancy|0|||
125162853|NCT04732221|450220638|FG002|Extension Period|Pregnancy|0|||
125162854|NCT04732221|450220639|FG003|Extension Period|Pregnancy|0|||
125162855|NCT04732221|450220640|FG004|Extension Period|Pregnancy|1|||
125162856|NCT04732221|450220641|FG005|Extension Period|Pregnancy|0|||
125162857|NCT04732221|450220642|FG006|Extension Period|Pregnancy|0|||
125162858|NCT04732221|450220636|FG000|Extension Period|Sponsors Decision|0|||
125162859|NCT04732221|450220637|FG001|Extension Period|Sponsors Decision|0|||
125162860|NCT04732221|450220638|FG002|Extension Period|Sponsors Decision|0|||
125162861|NCT04732221|450220639|FG003|Extension Period|Sponsors Decision|0|||
125162862|NCT04732221|450220640|FG004|Extension Period|Sponsors Decision|41|||
125162863|NCT04732221|450220641|FG005|Extension Period|Sponsors Decision|40|||
125162864|NCT04732221|450220642|FG006|Extension Period|Sponsors Decision|40|||
125162865|NCT04732221|450220636|FG000|Extension Period|Withdrawal by Subject|0|||
125162866|NCT04732221|450220637|FG001|Extension Period|Withdrawal by Subject|0|||
125162867|NCT04732221|450220638|FG002|Extension Period|Withdrawal by Subject|0|||
125162868|NCT04732221|450220639|FG003|Extension Period|Withdrawal by Subject|0|||
125162869|NCT04732221|450220640|FG004|Extension Period|Withdrawal by Subject|1|||
125162870|NCT04732221|450220641|FG005|Extension Period|Withdrawal by Subject|5|||
125162871|NCT04732221|450220642|FG006|Extension Period|Withdrawal by Subject|2|||
125162872|NCT03747601|450220643|FG000|Overall Study|COVID halt to visits|4|||
125162873|NCT05327816|450220644|FG000|Overall Study|Lost to Follow-up|1|||
125162874|NCT05327816|450220645|FG001|Overall Study|Lost to Follow-up|0|||
125162875|NCT05327816|450220646|FG002|Overall Study|Lost to Follow-up|0|||
125162876|NCT05327816|450220647|FG003|Overall Study|Lost to Follow-up|0|||
125162877|NCT05327816|450220648|FG004|Overall Study|Lost to Follow-up|0|||
125162878|NCT05327816|450220649|FG005|Overall Study|Lost to Follow-up|0|||
125162879|NCT05327816|450220650|FG006|Overall Study|Lost to Follow-up|0|||
125162880|NCT05327816|450220651|FG007|Overall Study|Lost to Follow-up|0|||
125162881|NCT05327816|450220652|FG008|Overall Study|Lost to Follow-up|0|||
125162882|NCT05327816|450220653|FG009|Overall Study|Lost to Follow-up|1|||
125162883|NCT05327816|450220654|FG010|Overall Study|Lost to Follow-up|0|||
125162884|NCT05327816|450220644|FG000|Overall Study|Withdrawal by Subject|0|||
125162885|NCT05327816|450220645|FG001|Overall Study|Withdrawal by Subject|0|||
125224973|NCT00960804|450450264|FG000|Overall Study|Study terminated by the sponsor|5|||
125224974|NCT00960804|450450265|FG001|Overall Study|Study terminated by the sponsor|4|||
125224975|NCT00960804|450450266|FG002|Overall Study|Study terminated by the sponsor|10|||
125224976|NCT00490919|450450267|FG000|Open-label Run-in Period|Adverse Event|239|||
125224977|NCT00490919|450450268|FG001|Open-label Run-in Period|Adverse Event|0|||
125224978|NCT00490919|450450269|FG002|Open-label Run-in Period|Adverse Event|0|||
125224979|NCT00490919|450450267|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
125224980|NCT00490919|450450268|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
125224981|NCT00490919|450450269|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
125224982|NCT00490919|450450267|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
125224983|NCT00490919|450450268|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
125224984|NCT00490919|450450269|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
125224985|NCT00490919|450450267|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
125224986|NCT00490919|450450268|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
125224987|NCT00490919|450450269|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
125162886|NCT05327816|450220646|FG002|Overall Study|Withdrawal by Subject|0|||
125224988|NCT00490919|450450267|FG000|Open-label Run-in Period|Administrative|40|||
125162887|NCT05327816|450220647|FG003|Overall Study|Withdrawal by Subject|0|||
125162888|NCT05327816|450220648|FG004|Overall Study|Withdrawal by Subject|1|||
125162889|NCT05327816|450220649|FG005|Overall Study|Withdrawal by Subject|1|||
125162890|NCT05327816|450220650|FG006|Overall Study|Withdrawal by Subject|0|||
125162891|NCT05327816|450220651|FG007|Overall Study|Withdrawal by Subject|0|||
125162892|NCT05327816|450220652|FG008|Overall Study|Withdrawal by Subject|0|||
125162893|NCT05327816|450220653|FG009|Overall Study|Withdrawal by Subject|0|||
125224989|NCT00490919|450450268|FG001|Open-label Run-in Period|Administrative|0|||
125224990|NCT00490919|450450269|FG002|Open-label Run-in Period|Administrative|0|||
125224991|NCT00490919|450450267|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
125224992|NCT00490919|450450268|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
125224993|NCT00490919|450450269|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
125224994|NCT00490919|450450267|FG000|Double-blind Phase|Adverse Event|0|||
125224995|NCT00490919|450450268|FG001|Double-blind Phase|Adverse Event|40|||
125224996|NCT00490919|450450269|FG002|Double-blind Phase|Adverse Event|20|||
125224997|NCT00490919|450450267|FG000|Double-blind Phase|Withdrawal by Subject|0|||
125224998|NCT00490919|450450268|FG001|Double-blind Phase|Withdrawal by Subject|10|||
125224999|NCT00490919|450450269|FG002|Double-blind Phase|Withdrawal by Subject|11|||
125225000|NCT00490919|450450267|FG000|Double-blind Phase|Lost to Follow-up|0|||
125225001|NCT00490919|450450268|FG001|Double-blind Phase|Lost to Follow-up|8|||
125225002|NCT00490919|450450269|FG002|Double-blind Phase|Lost to Follow-up|11|||
125225003|NCT00490919|450450267|FG000|Double-blind Phase|Lack of Efficacy|0|||
125225004|NCT00490919|450450268|FG001|Double-blind Phase|Lack of Efficacy|22|||
125225005|NCT00490919|450450269|FG002|Double-blind Phase|Lack of Efficacy|36|||
125225006|NCT00490919|450450267|FG000|Double-blind Phase|Administrative|0|||
125225007|NCT00490919|450450268|FG001|Double-blind Phase|Administrative|6|||
125225008|NCT00490919|450450269|FG002|Double-blind Phase|Administrative|6|||
125225009|NCT02787304|450451979|FG000|Overall Study|Adverse Event|9|||
125225010|NCT02787304|450451980|FG001|Overall Study|Adverse Event|3|||
125225011|NCT02787304|450451981|FG002|Overall Study|Adverse Event|8|||
125162894|NCT05327816|450220654|FG010|Overall Study|Withdrawal by Subject|0|||
125162895|NCT05327816|450220644|FG000|Overall Study|Study Terminated by Sponsor|11|||
125162896|NCT05327816|450220645|FG001|Overall Study|Study Terminated by Sponsor|12|||
125162897|NCT05327816|450220646|FG002|Overall Study|Study Terminated by Sponsor|12|||
125162898|NCT05327816|450220647|FG003|Overall Study|Study Terminated by Sponsor|12|||
125162899|NCT05327816|450220648|FG004|Overall Study|Study Terminated by Sponsor|11|||
125162900|NCT05327816|450220649|FG005|Overall Study|Study Terminated by Sponsor|11|||
125162901|NCT05327816|450220650|FG006|Overall Study|Study Terminated by Sponsor|11|||
125162902|NCT05327816|450220651|FG007|Overall Study|Study Terminated by Sponsor|11|||
125162903|NCT05327816|450220652|FG008|Overall Study|Study Terminated by Sponsor|11|||
125162904|NCT05327816|450220653|FG009|Overall Study|Study Terminated by Sponsor|11|||
125162905|NCT05327816|450220654|FG010|Overall Study|Study Terminated by Sponsor|12|||
125162906|NCT05327816|450220644|FG000|Overall Study|Randomized but not treated|0|||
125162907|NCT05327816|450220645|FG001|Overall Study|Randomized but not treated|0|||
125162908|NCT05327816|450220646|FG002|Overall Study|Randomized but not treated|0|||
125162909|NCT05327816|450220647|FG003|Overall Study|Randomized but not treated|0|||
125162910|NCT05327816|450220648|FG004|Overall Study|Randomized but not treated|0|||
125225012|NCT02787304|450451982|FG003|Overall Study|Adverse Event|1|||
125225013|NCT02787304|450451979|FG000|Overall Study|Withdrawal by Subject|1|||
125225014|NCT02787304|450451980|FG001|Overall Study|Withdrawal by Subject|4|||
125225015|NCT02787304|450451981|FG002|Overall Study|Withdrawal by Subject|0|||
125225016|NCT02787304|450451982|FG003|Overall Study|Withdrawal by Subject|0|||
125162911|NCT05327816|450220649|FG005|Overall Study|Randomized but not treated|0|||
125162912|NCT05327816|450220650|FG006|Overall Study|Randomized but not treated|1|||
125162913|NCT05327816|450220651|FG007|Overall Study|Randomized but not treated|1|||
125162914|NCT05327816|450220652|FG008|Overall Study|Randomized but not treated|1|||
125162915|NCT05327816|450220653|FG009|Overall Study|Randomized but not treated|0|||
125225017|NCT02787304|450451979|FG000|Overall Study|Lost to Follow-up|1|||
125225018|NCT02787304|450451980|FG001|Overall Study|Lost to Follow-up|0|||
125225019|NCT02787304|450451981|FG002|Overall Study|Lost to Follow-up|0|||
125225020|NCT02787304|450451982|FG003|Overall Study|Lost to Follow-up|1|||
125225021|NCT02787304|450451979|FG000|Overall Study|Noncompliance with study drug|0|||
125225022|NCT02787304|450451980|FG001|Overall Study|Noncompliance with study drug|0|||
125225023|NCT02787304|450451981|FG002|Overall Study|Noncompliance with study drug|1|||
125225024|NCT02787304|450451982|FG003|Overall Study|Noncompliance with study drug|0|||
125225025|NCT02787304|450451979|FG000|Overall Study|Physician Decision|0|||
125225026|NCT02787304|450451980|FG001|Overall Study|Physician Decision|0|||
125225027|NCT02787304|450451981|FG002|Overall Study|Physician Decision|1|||
125225028|NCT02787304|450451982|FG003|Overall Study|Physician Decision|0|||
125162916|NCT05327816|450220654|FG010|Overall Study|Randomized but not treated|0|||
125162917|NCT00112866|450220655|FG000|Overall Study|Protocol Violation|1|||
125162918|NCT00112866|450220656|FG001|Overall Study|Protocol Violation|0|||
125162919|NCT00112866|450220655|FG000|Overall Study|did not start treatment post-op|1|||
125162920|NCT00112866|450220656|FG001|Overall Study|did not start treatment post-op|2|||
125162921|NCT04305587|450220657|FG000|Overall Study|Withdrawal by Subject|0|||
125225029|NCT02787304|450451979|FG000|Overall Study|Study terminated by sponsor|25|||
125225030|NCT02787304|450451980|FG001|Overall Study|Study terminated by sponsor|31|||
125162922|NCT04305587|450220658|FG001|Overall Study|Withdrawal by Subject|0|||
125162923|NCT04305587|450220659|FG002|Overall Study|Withdrawal by Subject|0|||
125162924|NCT04305587|450220660|FG003|Overall Study|Withdrawal by Subject|1|||
125162925|NCT04305587|450220661|FG004|Overall Study|Withdrawal by Subject|0|||
125162926|NCT04305587|450220662|FG005|Overall Study|Withdrawal by Subject|0|||
125162927|NCT04305587|450220663|FG006|Overall Study|Withdrawal by Subject|0|||
125162928|NCT04305587|450220664|FG007|Overall Study|Withdrawal by Subject|0|||
125162929|NCT04305587|450220665|FG008|Overall Study|Withdrawal by Subject|0|||
125162930|NCT01367665|450220666|FG000|Overall Study|Death|102|||
125162931|NCT01367665|450220667|FG001|Overall Study|Death|19|||
125162932|NCT01367665|450220666|FG000|Overall Study|Lost to Follow-up|222|||
125162933|NCT01367665|450220667|FG001|Overall Study|Lost to Follow-up|22|||
125162934|NCT01367665|450220666|FG000|Overall Study|Not Done|118|||
125162935|NCT01367665|450220667|FG001|Overall Study|Not Done|14|||
125162936|NCT02752906|450220668|FG000|Overall Study|Protocol Violation|2|||
125162937|NCT02752906|450220669|FG001|Overall Study|Protocol Violation|1|||
125162938|NCT02752906|450220668|FG000|Overall Study|Withdrawal by Subject|2|||
125162939|NCT02752906|450220669|FG001|Overall Study|Withdrawal by Subject|2|||
125162940|NCT02752906|450220668|FG000|Overall Study|Lost to Follow-up|3|||
125162941|NCT02752906|450220669|FG001|Overall Study|Lost to Follow-up|2|||
125162942|NCT01345175|450220674|FG000|Overall Study|Physician Decision|0|||
125162943|NCT01345175|450220675|FG001|Overall Study|Physician Decision|1|||
125162944|NCT01345175|450220674|FG000|Overall Study|Withdrawal by Subject|1|||
125162945|NCT01345175|450220675|FG001|Overall Study|Withdrawal by Subject|1|||
125162946|NCT01345175|450220674|FG000|Overall Study|Failed to complete BFI|3|||
125162947|NCT01345175|450220675|FG001|Overall Study|Failed to complete BFI|2|||
125162948|NCT01345175|450220674|FG000|Overall Study|Stopped taking medication|2|||
125162949|NCT01345175|450220675|FG001|Overall Study|Stopped taking medication|2|||
125162950|NCT04112173|450220679|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
125162951|NCT01259115|450220681|FG000|Period 1|Adverse Event|1|||
125162952|NCT01259115|450220682|FG001|Period 1|Adverse Event|0|||
125162953|NCT01259115|450220681|FG000|Period 1|Protocol Violation|2|||
125162954|NCT01259115|450220682|FG001|Period 1|Protocol Violation|0|||
125162955|NCT01259115|450220681|FG000|Period 1|Lost to Follow-up|0|||
125162956|NCT01259115|450220682|FG001|Period 1|Lost to Follow-up|1|||
125162957|NCT01259115|450220681|FG000|Period 2|Adverse Event|1|||
125162958|NCT01259115|450220682|FG001|Period 2|Adverse Event|0|||
125162959|NCT03560986|450220683|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
125162960|NCT03560986|450220684|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
125162961|NCT03560986|450220683|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
125162962|NCT03560986|450220684|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
125162963|NCT03560986|450220683|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
125162964|NCT03560986|450220684|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
125162965|NCT03560986|450220683|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
125162966|NCT03560986|450220684|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
125162967|NCT03560986|450220683|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
125162968|NCT03560986|450220684|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
125162969|NCT03560986|450220683|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
125162970|NCT03560986|450220684|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
125162971|NCT03560986|450220683|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
125162972|NCT03560986|450220684|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
125162973|NCT02524730|450220685|FG000|Overall Study|Lost to Follow-up|5|||
125162974|NCT02524730|450220685|FG000|Overall Study|Withdrawal by Subject|18|||
125162975|NCT02524730|450220685|FG000|Overall Study|Death|10|||
125162976|NCT02524730|450220685|FG000|Overall Study|Adverse Event|8|||
125162977|NCT02524730|450220685|FG000|Overall Study|Protocol Violation|1|||
125162978|NCT02524730|450220685|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
125162979|NCT00593736|450220688|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
125162980|NCT00593736|450220689|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
125162981|NCT00593736|450220690|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
125162982|NCT00593736|450220691|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
125162983|NCT00593736|450220688|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
125162984|NCT00593736|450220689|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
125162985|NCT00593736|450220690|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
125162986|NCT00593736|450220691|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
125162987|NCT00593736|450220688|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
125162988|NCT00593736|450220689|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
125162989|NCT00593736|450220690|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
125162990|NCT00593736|450220691|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
125162991|NCT00593736|450220688|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
125162992|NCT00593736|450220689|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
125162993|NCT00593736|450220690|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
125162994|NCT00593736|450220691|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
125162995|NCT00593736|450220688|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
125162996|NCT00593736|450220689|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
125162997|NCT00593736|450220690|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
125162998|NCT00593736|450220691|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
125162999|NCT00593736|450220688|FG000|Screening Period and Placebo Run-in|Various|0|||
125163000|NCT00593736|450220689|FG001|Screening Period and Placebo Run-in|Various|0|||
125163001|NCT00593736|450220690|FG002|Screening Period and Placebo Run-in|Various|0|||
125163002|NCT00593736|450220691|FG003|Screening Period and Placebo Run-in|Various|25|||
125163003|NCT00593736|450220688|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
125163004|NCT00593736|450220689|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
125163005|NCT00593736|450220690|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
125225031|NCT02787304|450451981|FG002|Overall Study|Study terminated by sponsor|31|||
125163006|NCT00593736|450220691|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
125163007|NCT00593736|450220688|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
125163008|NCT00593736|450220689|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
125163009|NCT00593736|450220690|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
125163010|NCT00593736|450220691|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
125163011|NCT00593736|450220688|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
125163012|NCT00593736|450220689|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
125163013|NCT00593736|450220690|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
125163014|NCT00593736|450220691|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
125163015|NCT00593736|450220688|FG000|Treatment Period and Placebo Run-out|Various|1|||
125163016|NCT00593736|450220689|FG001|Treatment Period and Placebo Run-out|Various|1|||
125163017|NCT00593736|450220690|FG002|Treatment Period and Placebo Run-out|Various|1|||
125163018|NCT00593736|450220691|FG003|Treatment Period and Placebo Run-out|Various|0|||
125163019|NCT01868893|450220692|FG000|Overall Study|Adverse Event|2|||
125163020|NCT01868893|450220692|FG000|Overall Study|Commercial availability of study drug|17|||
125163021|NCT01868893|450220692|FG000|Overall Study|Neutropenia|1|||
125163022|NCT01857271|450220693|FG000|Overall Study|Lost to Follow-up|1|||
125163023|NCT01783548|450220694|FG000|Overall Study|Adverse Event|8|||
125163024|NCT01783548|450220695|FG001|Overall Study|Adverse Event|4|||
125163025|NCT01783548|450220694|FG000|Overall Study|Withdrawal by Subject|11|||
125163026|NCT01783548|450220695|FG001|Overall Study|Withdrawal by Subject|8|||
125163027|NCT01783548|450220694|FG000|Overall Study|Non-compliance|4|||
125163028|NCT01783548|450220695|FG001|Overall Study|Non-compliance|0|||
125163029|NCT01783548|450220694|FG000|Overall Study|Protocol Violation|2|||
125163030|NCT01783548|450220695|FG001|Overall Study|Protocol Violation|2|||
125163031|NCT01783548|450220694|FG000|Overall Study|Lost to Follow-up|8|||
125163032|NCT01783548|450220695|FG001|Overall Study|Lost to Follow-up|3|||
125163033|NCT01783548|450220694|FG000|Overall Study|Lack of Efficacy|1|||
125163034|NCT01783548|450220695|FG001|Overall Study|Lack of Efficacy|1|||
125163035|NCT03493386|450220696|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
125163036|NCT03493386|450220697|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
125163037|NCT03493386|450220698|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
125163038|NCT03493386|450220699|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
125163039|NCT00988442|450220700|FG000|Overall Study|Death|1|||
125163040|NCT00988442|450220701|FG001|Overall Study|Death|2|||
125163041|NCT00988442|450220700|FG000|Overall Study|Lost to Follow-up|0|||
125163042|NCT00988442|450220701|FG001|Overall Study|Lost to Follow-up|1|||
125163043|NCT00988442|450220700|FG000|Overall Study|Early Study Closure|29|||
125163044|NCT00988442|450220701|FG001|Overall Study|Early Study Closure|25|||
125163045|NCT05297578|450220707|FG000|Overall Study|Lost to Follow-up|1|||
125163046|NCT05297578|450220708|FG001|Overall Study|Lost to Follow-up|1|||
125163047|NCT05297578|450220709|FG002|Overall Study|Lost to Follow-up|2|||
125163048|NCT05297578|450220710|FG003|Overall Study|Lost to Follow-up|1|||
125163049|NCT05297578|450220707|FG000|Overall Study|Death|0|||
125163050|NCT05297578|450220708|FG001|Overall Study|Death|1|||
125163051|NCT05297578|450220709|FG002|Overall Study|Death|0|||
125163052|NCT05297578|450220710|FG003|Overall Study|Death|0|||
125163053|NCT05297578|450220707|FG000|Overall Study|Withdrawal by Subject|0|||
125163054|NCT05297578|450220708|FG001|Overall Study|Withdrawal by Subject|0|||
125163055|NCT05297578|450220709|FG002|Overall Study|Withdrawal by Subject|1|||
125163056|NCT05297578|450220710|FG003|Overall Study|Withdrawal by Subject|0|||
125163057|NCT01087489|450220712|FG000|Overall Study|enrolled in another VA study|0|||
125163058|NCT01087489|450220713|FG001|Overall Study|enrolled in another VA study|1|||
125163059|NCT01087489|450220712|FG000|Overall Study|Death|0|||
125163060|NCT01087489|450220713|FG001|Overall Study|Death|1|||
125163061|NCT01087489|450220712|FG000|Overall Study|unable to survey by telephone|0|||
125163062|NCT01087489|450220713|FG001|Overall Study|unable to survey by telephone|1|||
125163063|NCT00117325|450220714|FG000|Overall Study|Adverse Event|3|||
125163064|NCT00117325|450220715|FG001|Overall Study|Adverse Event|3|||
125163065|NCT00117325|450220714|FG000|Overall Study|Lost to Follow-up|1|||
125163066|NCT00117325|450220715|FG001|Overall Study|Lost to Follow-up|1|||
125163067|NCT00117325|450220714|FG000|Overall Study|Protocol Violation|2|||
125163068|NCT00117325|450220715|FG001|Overall Study|Protocol Violation|3|||
125163069|NCT00117325|450220714|FG000|Overall Study|Withdrawal by Subject|3|||
125163070|NCT00117325|450220715|FG001|Overall Study|Withdrawal by Subject|2|||
125163071|NCT00117325|450220714|FG000|Overall Study|Lack of Efficacy|1|||
125163072|NCT00117325|450220715|FG001|Overall Study|Lack of Efficacy|0|||
125163073|NCT00117325|450220714|FG000|Overall Study|Use of prohibited medicine|1|||
125163074|NCT00117325|450220715|FG001|Overall Study|Use of prohibited medicine|2|||
125163075|NCT00117325|450220714|FG000|Overall Study|Early termination|1|||
125163076|NCT00117325|450220715|FG001|Overall Study|Early termination|1|||
125163077|NCT00117325|450220714|FG000|Overall Study|Admisnitrative|1|||
125163078|NCT00117325|450220715|FG001|Overall Study|Admisnitrative|0|||
125163079|NCT01468818|450220718|FG000|Overall Study|Death during treatment|2|||
125163080|NCT01212588|450220720|FG000|Overall Study|Physician Decision|0|||
125163081|NCT01212588|450220721|FG001|Overall Study|Physician Decision|1|||
125163082|NCT01212588|450220720|FG000|Overall Study|Protocol Violation|1|||
125163083|NCT01212588|450220721|FG001|Overall Study|Protocol Violation|1|||
125163084|NCT02338193|450220722|FG000|Overall Study|Withdrawal by Subject|0|||
125163085|NCT02338193|450220723|FG001|Overall Study|Withdrawal by Subject|0|||
125163086|NCT02338193|450220724|FG002|Overall Study|Withdrawal by Subject|2|||
125163087|NCT02338193|450220722|FG000|Overall Study|Pregnancy|0|||
125163088|NCT02338193|450220723|FG001|Overall Study|Pregnancy|1|||
125163089|NCT02338193|450220724|FG002|Overall Study|Pregnancy|1|||
125163090|NCT02338193|450220722|FG000|Overall Study|Noncompliant with visits|2|||
125163091|NCT02338193|450220723|FG001|Overall Study|Noncompliant with visits|2|||
125163092|NCT02338193|450220724|FG002|Overall Study|Noncompliant with visits|7|||
125163093|NCT02338193|450220722|FG000|Overall Study|moved out of state|0|||
125163094|NCT02338193|450220723|FG001|Overall Study|moved out of state|1|||
125163095|NCT02338193|450220724|FG002|Overall Study|moved out of state|0|||
125163096|NCT02338193|450220722|FG000|Overall Study|intolerant of side effects|1|||
125163097|NCT02338193|450220723|FG001|Overall Study|intolerant of side effects|0|||
125163098|NCT02338193|450220724|FG002|Overall Study|intolerant of side effects|0|||
125163099|NCT01735955|450220725|FG000|Overall Study|Administrative problems|1|||
125163100|NCT01735955|450220725|FG000|Overall Study|Patient/guardian decision|1|||
125163101|NCT01735955|450220725|FG000|Overall Study|Patient withdrew consent|2|||
125163102|NCT01735955|450220725|FG000|Overall Study|Physician Decision|4|||
125163103|NCT01735955|450220725|FG000|Overall Study|Disease progression|24|||
125163104|NCT01735955|450220725|FG000|Overall Study|Adverse Event|5|||
125163105|NCT03893565|450220737|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
125163106|NCT03893565|450220738|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
125163107|NCT03893565|450220739|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
125163108|NCT03893565|450220740|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
125163109|NCT03893565|450220741|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
125163110|NCT03893565|450220742|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
125163111|NCT03893565|450220743|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
125163112|NCT03893565|450220744|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
125163113|NCT03893565|450220745|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
125163114|NCT03893565|450220737|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
125163115|NCT03893565|450220738|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
125163116|NCT03893565|450220739|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
125163117|NCT03893565|450220740|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
125163118|NCT03893565|450220741|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
125163119|NCT03893565|450220742|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
125163120|NCT03893565|450220743|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
125163121|NCT03893565|450220744|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
125163122|NCT03893565|450220745|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
125163123|NCT03893565|450220737|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163124|NCT03893565|450220738|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
125163125|NCT03893565|450220739|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163126|NCT03893565|450220740|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
125163127|NCT03893565|450220741|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163128|NCT03893565|450220742|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163129|NCT03893565|450220743|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163130|NCT03893565|450220744|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163131|NCT03893565|450220745|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163132|NCT03893565|450220737|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
125163133|NCT03893565|450220738|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
125163134|NCT03893565|450220739|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
125163135|NCT03893565|450220740|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
125163136|NCT03893565|450220741|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
125163137|NCT03893565|450220742|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
125163138|NCT03893565|450220743|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
125163139|NCT03893565|450220744|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
125163140|NCT03893565|450220745|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
125163141|NCT03893565|450220737|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
125163142|NCT03893565|450220738|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
125163143|NCT03893565|450220739|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
125163144|NCT03893565|450220740|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163145|NCT03893565|450220741|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
125163146|NCT03893565|450220742|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163147|NCT03893565|450220743|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163148|NCT03893565|450220744|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163149|NCT03893565|450220745|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163150|NCT03893565|450220737|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
125163151|NCT03893565|450220738|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
125163152|NCT03893565|450220739|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
125163153|NCT03893565|450220740|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
125163154|NCT03893565|450220741|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
125163155|NCT03893565|450220742|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
125163156|NCT03893565|450220743|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
125163157|NCT03893565|450220744|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
125163158|NCT03893565|450220745|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
125163159|NCT03893565|450220737|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163160|NCT03893565|450220738|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163161|NCT03893565|450220739|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163162|NCT03893565|450220740|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
125163163|NCT03893565|450220741|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163164|NCT03893565|450220742|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163165|NCT03893565|450220743|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163166|NCT03893565|450220744|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163167|NCT03893565|450220745|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163168|NCT03893565|450220737|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
125163169|NCT03893565|450220738|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
125163170|NCT03893565|450220739|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
125163171|NCT03893565|450220740|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
125163172|NCT03893565|450220741|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
125163173|NCT03893565|450220742|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
125163174|NCT03893565|450220743|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
125163175|NCT03893565|450220744|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
125163176|NCT03893565|450220745|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
125163177|NCT03893565|450220737|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
125163178|NCT03893565|450220738|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
125163179|NCT03893565|450220739|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
125163180|NCT03893565|450220740|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
125163181|NCT03893565|450220741|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
125163182|NCT03893565|450220742|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
125163183|NCT03893565|450220743|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
125163184|NCT03893565|450220744|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
125163185|NCT03893565|450220745|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
125163186|NCT03893565|450220737|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
125163187|NCT03893565|450220738|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
125163188|NCT03893565|450220739|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
125163189|NCT03893565|450220740|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
125163190|NCT03893565|450220741|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
125163191|NCT03893565|450220742|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
125163192|NCT03893565|450220743|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
125163193|NCT03893565|450220744|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
125163194|NCT03893565|450220745|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
125163195|NCT03893565|450220737|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
125163196|NCT03893565|450220738|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
125163197|NCT03893565|450220739|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
125163198|NCT03893565|450220740|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
125163199|NCT03893565|450220741|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
125163200|NCT03893565|450220742|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
125163201|NCT03893565|450220743|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
125163202|NCT03893565|450220744|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
125163203|NCT03893565|450220745|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
125163204|NCT03893565|450220737|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
125163205|NCT03893565|450220738|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
125163206|NCT03893565|450220739|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
125163207|NCT03893565|450220740|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
125163208|NCT03893565|450220741|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
125163209|NCT03893565|450220742|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
125163210|NCT03893565|450220743|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
125163211|NCT03893565|450220744|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
125163212|NCT03893565|450220745|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
125163213|NCT03893565|450220737|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163214|NCT03893565|450220738|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163215|NCT03893565|450220739|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163216|NCT03893565|450220740|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163217|NCT03893565|450220741|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163218|NCT03893565|450220742|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163219|NCT03893565|450220743|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163220|NCT03893565|450220744|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
125163221|NCT03893565|450220745|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163222|NCT03893565|450220737|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163223|NCT03893565|450220738|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125225032|NCT02787304|450451982|FG003|Overall Study|Study terminated by sponsor|32|||
125163224|NCT03893565|450220739|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163225|NCT03893565|450220740|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163226|NCT03893565|450220741|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163227|NCT03893565|450220742|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163228|NCT03893565|450220743|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163229|NCT03893565|450220744|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
125163230|NCT03893565|450220745|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163231|NCT03893565|450220737|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163232|NCT03893565|450220738|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163233|NCT03893565|450220739|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163234|NCT03893565|450220740|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163235|NCT03893565|450220741|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163236|NCT03893565|450220742|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163237|NCT03893565|450220743|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163238|NCT03893565|450220744|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
125163239|NCT03893565|450220745|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125225033|NCT01051921|450451986|FG000|Overall Study|Physician Decision|9|||
125163240|NCT03893565|450220737|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
125163241|NCT03893565|450220738|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
125163242|NCT03893565|450220739|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
125163243|NCT03893565|450220740|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
125163244|NCT03893565|450220741|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
125163245|NCT03893565|450220742|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
125163246|NCT03893565|450220743|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
125163247|NCT03893565|450220744|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
125163248|NCT03893565|450220745|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
125163249|NCT05788289|450220751|FG000|Overall Study|Death|3|||
125163250|NCT00085423|450220756|FG000|Overall Study|Withdrawal by Subject|1|||
125163251|NCT00085423|450220756|FG000|Overall Study|screen failure|1|||
125163252|NCT00536263|450220759|FG000|Overall Study|Adverse Event|5|||
125163253|NCT00536263|450220760|FG001|Overall Study|Adverse Event|5|||
125163254|NCT00536263|450220761|FG002|Overall Study|Adverse Event|7|||
125163255|NCT00536263|450220759|FG000|Overall Study|Lost to Follow-up|3|||
125163256|NCT00536263|450220760|FG001|Overall Study|Lost to Follow-up|4|||
125163257|NCT00536263|450220761|FG002|Overall Study|Lost to Follow-up|4|||
125163258|NCT00536263|450220759|FG000|Overall Study|Subject withdrew - not treatment related|2|||
125163259|NCT00536263|450220760|FG001|Overall Study|Subject withdrew - not treatment related|0|||
125163260|NCT00536263|450220761|FG002|Overall Study|Subject withdrew - not treatment related|5|||
125163261|NCT00536263|450220759|FG000|Overall Study|Subject withdrew - treatment related|0|||
125163262|NCT00536263|450220760|FG001|Overall Study|Subject withdrew - treatment related|3|||
125163263|NCT00536263|450220761|FG002|Overall Study|Subject withdrew - treatment related|2|||
125163264|NCT00536263|450220759|FG000|Overall Study|Noncompliance with protocol|0|||
125163265|NCT00536263|450220760|FG001|Overall Study|Noncompliance with protocol|0|||
125163266|NCT00536263|450220761|FG002|Overall Study|Noncompliance with protocol|1|||
125163267|NCT00536263|450220759|FG000|Overall Study|Did not meet protocol eligibility|1|||
125163268|NCT00536263|450220760|FG001|Overall Study|Did not meet protocol eligibility|2|||
125163269|NCT00536263|450220761|FG002|Overall Study|Did not meet protocol eligibility|2|||
125163270|NCT03734666|450220763|FG000|Overall Study|Other|7|||
125163271|NCT03734666|450220764|FG001|Overall Study|Other|4|||
125163272|NCT03734666|450220763|FG000|Overall Study|Lost to Follow-up|12|||
125163273|NCT03734666|450220764|FG001|Overall Study|Lost to Follow-up|12|||
125163274|NCT00914459|450220767|FG000|Overall Study|Protocol Violation|0|||
125163275|NCT00914459|450220768|FG001|Overall Study|Protocol Violation|1|||
125163276|NCT00914459|450220767|FG000|Overall Study|Parent/Legal guardian request|1|||
125163277|NCT00914459|450220768|FG001|Overall Study|Parent/Legal guardian request|0|||
125163278|NCT01661179|450220769|FG000|Overall Study|Death|1|||
125163279|NCT01661179|450220769|FG000|Overall Study|Withdrawal by Subject|1|||
125163280|NCT01661179|450220769|FG000|Overall Study|Other Eligibility criteria|4|||
125163281|NCT01946191|450220770|FG000|Allocation|Did not complete orientation|1|||
125163282|NCT01946191|450220771|FG001|Allocation|Did not complete orientation|1|||
125163283|NCT01946191|450220770|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
125163284|NCT01946191|450220771|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
125163285|NCT01946191|450220770|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
125163286|NCT01946191|450220771|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
125163287|NCT01946191|450220770|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
125163288|NCT01946191|450220771|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
125163289|NCT03118570|450220772|FG000|Overall Study|Adverse Event|2|||
125163290|NCT03118570|450220773|FG001|Overall Study|Adverse Event|0|||
125163291|NCT03118570|450220774|FG002|Overall Study|Adverse Event|0|||
125225034|NCT01051921|450451986|FG000|Overall Study|Adverse Event|8|||
125225035|NCT01051921|450451986|FG000|Overall Study|Withdrawal by Subject|7|||
125225036|NCT01051921|450451986|FG000|Overall Study|Lost to Follow-up|4|||
125225037|NCT01051921|450451986|FG000|Overall Study|virological failure|1|||
125225038|NCT01051921|450451986|FG000|Overall Study|patient moved|1|||
125225039|NCT03110354|450451989|FG000|Overall Study|Death|1|||
125225040|NCT03110354|450451990|FG001|Overall Study|Death|0|||
125225041|NCT03110354|450451991|FG002|Overall Study|Death|0|||
125225042|NCT03110354|450451992|FG003|Overall Study|Death|1|||
125225043|NCT03110354|450451993|FG004|Overall Study|Death|0|||
125225044|NCT03110354|450451989|FG000|Overall Study|Start of new therapy|0|||
125163292|NCT03118570|450220775|FG003|Overall Study|Adverse Event|0|||
125163293|NCT03118570|450220776|FG004|Overall Study|Adverse Event|3|||
125163294|NCT03118570|450220772|FG000|Overall Study|Withdrawal by Subject|0|||
125163295|NCT03118570|450220773|FG001|Overall Study|Withdrawal by Subject|1|||
125163296|NCT03118570|450220774|FG002|Overall Study|Withdrawal by Subject|4|||
125163297|NCT03118570|450220775|FG003|Overall Study|Withdrawal by Subject|0|||
125163298|NCT03118570|450220776|FG004|Overall Study|Withdrawal by Subject|1|||
125163299|NCT03118570|450220772|FG000|Overall Study|Lost to Follow-up|2|||
125163300|NCT03118570|450220773|FG001|Overall Study|Lost to Follow-up|3|||
125163301|NCT03118570|450220774|FG002|Overall Study|Lost to Follow-up|1|||
125225045|NCT03110354|450451990|FG001|Overall Study|Start of new therapy|0|||
125225046|NCT03110354|450451991|FG002|Overall Study|Start of new therapy|0|||
125225047|NCT03110354|450451992|FG003|Overall Study|Start of new therapy|0|||
125225048|NCT03110354|450451993|FG004|Overall Study|Start of new therapy|1|||
125225049|NCT03110354|450451989|FG000|Overall Study|Failure to achieve response|2|||
125225050|NCT03110354|450451990|FG001|Overall Study|Failure to achieve response|3|||
125225051|NCT03110354|450451991|FG002|Overall Study|Failure to achieve response|0|||
125225052|NCT03110354|450451992|FG003|Overall Study|Failure to achieve response|2|||
125225053|NCT03110354|450451993|FG004|Overall Study|Failure to achieve response|1|||
125225054|NCT03110354|450451989|FG000|Overall Study|Progressive disease|1|||
125225055|NCT03110354|450451990|FG001|Overall Study|Progressive disease|1|||
125225056|NCT03110354|450451991|FG002|Overall Study|Progressive disease|3|||
125225057|NCT03110354|450451992|FG003|Overall Study|Progressive disease|4|||
125225058|NCT03110354|450451993|FG004|Overall Study|Progressive disease|2|||
125225059|NCT03110354|450451989|FG000|Overall Study|Adverse Event|0|||
125225060|NCT03110354|450451990|FG001|Overall Study|Adverse Event|0|||
125225061|NCT03110354|450451991|FG002|Overall Study|Adverse Event|0|||
125225062|NCT03110354|450451992|FG003|Overall Study|Adverse Event|2|||
125225063|NCT03110354|450451993|FG004|Overall Study|Adverse Event|2|||
125225064|NCT03110354|450451989|FG000|Overall Study|Other|0|||
125225065|NCT03110354|450451990|FG001|Overall Study|Other|0|||
125225066|NCT03110354|450451991|FG002|Overall Study|Other|0|||
125225067|NCT03110354|450451992|FG003|Overall Study|Other|1|||
125225068|NCT03110354|450451993|FG004|Overall Study|Other|1|||
125225069|NCT00379834|450451994|FG000|Overall Study|Time constraints|2|||
125225070|NCT01775670|450452003|FG000|Overall Study|Lost to Follow-up|1|||
125225071|NCT01775670|450452004|FG001|Overall Study|Lost to Follow-up|1|||
125225072|NCT01001429|450452005|FG000|Overall Study|surgery cancelled|0|||
125225073|NCT01001429|450452006|FG001|Overall Study|surgery cancelled|1|||
125225074|NCT01053741|450452013|FG000|2nd Study Intervention|Physician Decision|0|||
125225075|NCT01053741|450452014|FG001|2nd Study Intervention|Physician Decision|1|||
125225076|NCT02063672|450452015|FG000|Overall Study|Ongoing Follow-up|27|||
125225077|NCT02063672|450452016|FG001|Overall Study|Ongoing Follow-up|14|||
125225078|NCT02063672|450452015|FG000|Overall Study|Death|5|||
125225079|NCT02063672|450452016|FG001|Overall Study|Death|3|||
125225080|NCT02063672|450452015|FG000|Overall Study|Lost to Follow-up|1|||
125225081|NCT02063672|450452016|FG001|Overall Study|Lost to Follow-up|3|||
125225082|NCT02063672|450452015|FG000|Overall Study|Withdrawal by Subject|2|||
125225083|NCT02063672|450452016|FG001|Overall Study|Withdrawal by Subject|2|||
125225084|NCT00619827|450452018|FG000|Overall Study|Adverse Event|1|||
125225085|NCT00619827|450452019|FG001|Overall Study|Adverse Event|2|||
125225086|NCT00619827|450452018|FG000|Overall Study|Withdrawal by Subject|2|||
125163302|NCT03118570|450220775|FG003|Overall Study|Lost to Follow-up|0|||
125163303|NCT03118570|450220776|FG004|Overall Study|Lost to Follow-up|1|||
125163304|NCT03118570|450220772|FG000|Overall Study|Other, Not Specified|1|||
125163305|NCT03118570|450220773|FG001|Overall Study|Other, Not Specified|3|||
125163306|NCT03118570|450220774|FG002|Overall Study|Other, Not Specified|0|||
125163307|NCT03118570|450220775|FG003|Overall Study|Other, Not Specified|0|||
125163308|NCT03118570|450220776|FG004|Overall Study|Other, Not Specified|0|||
125163309|NCT03970837|450220777|FG000|Overall Study|Adverse Event|23|||
125163310|NCT03970837|450220778|FG001|Overall Study|Adverse Event|20|||
125163311|NCT03970837|450220779|FG002|Overall Study|Adverse Event|16|||
125163312|NCT03970837|450220780|FG003|Overall Study|Adverse Event|6|||
125163313|NCT03970837|450220781|FG004|Overall Study|Adverse Event|4|||
125163314|NCT03970837|450220782|FG005|Overall Study|Adverse Event|5|||
125163315|NCT03970837|450220783|FG006|Overall Study|Adverse Event|1|||
125163316|NCT03970837|450220784|FG007|Overall Study|Adverse Event|5|||
125163317|NCT03970837|450220785|FG008|Overall Study|Adverse Event|0|||
125163318|NCT03970837|450220786|FG009|Overall Study|Adverse Event|0|||
125163319|NCT03970837|450220787|FG010|Overall Study|Adverse Event|1|||
125163320|NCT03970837|450220788|FG011|Overall Study|Adverse Event|1|||
125163321|NCT03970837|450220777|FG000|Overall Study|Lack of Efficacy|14|||
125163322|NCT03970837|450220778|FG001|Overall Study|Lack of Efficacy|12|||
125225087|NCT00619827|450452019|FG001|Overall Study|Withdrawal by Subject|2|||
125225088|NCT00104052|450452020|FG000|Overall Study|Adverse Event|1|||
125225089|NCT00104052|450452020|FG000|Overall Study|Lack of Efficacy|26|||
125225090|NCT00104052|450452020|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
125225091|NCT02498678|450452021|FG000|Overall Study|interference from the surgical team|0|||
125225092|NCT02498678|450452022|FG001|Overall Study|interference from the surgical team|2|||
125225093|NCT00239720|450452028|FG000|Overall Study|Adverse Event|1|||
125225094|NCT00239720|450452029|FG001|Overall Study|Adverse Event|0|||
125225095|NCT00239720|450452028|FG000|Overall Study|Lost to Follow-up|0|||
125163323|NCT03970837|450220779|FG002|Overall Study|Lack of Efficacy|1|||
125163324|NCT03970837|450220780|FG003|Overall Study|Lack of Efficacy|2|||
125163325|NCT03970837|450220781|FG004|Overall Study|Lack of Efficacy|3|||
125163326|NCT03970837|450220782|FG005|Overall Study|Lack of Efficacy|4|||
125163327|NCT03970837|450220783|FG006|Overall Study|Lack of Efficacy|6|||
125225096|NCT00239720|450452029|FG001|Overall Study|Lost to Follow-up|1|||
125163328|NCT03970837|450220784|FG007|Overall Study|Lack of Efficacy|1|||
125163329|NCT03970837|450220785|FG008|Overall Study|Lack of Efficacy|1|||
125163330|NCT03970837|450220786|FG009|Overall Study|Lack of Efficacy|0|||
125163331|NCT03970837|450220787|FG010|Overall Study|Lack of Efficacy|0|||
125163332|NCT03970837|450220788|FG011|Overall Study|Lack of Efficacy|0|||
125163333|NCT03970837|450220777|FG000|Overall Study|Lost to Follow-up|6|||
125163334|NCT03970837|450220778|FG001|Overall Study|Lost to Follow-up|5|||
125163335|NCT03970837|450220779|FG002|Overall Study|Lost to Follow-up|5|||
125225097|NCT01484951|450452031|FG000|Overall Study|Adverse Event|3|||
125225098|NCT01484951|450452031|FG000|Overall Study|Personal Reasons|1|||
125225099|NCT01484951|450452031|FG000|Overall Study|Non-Compliance|1|||
125225100|NCT00917124|450452036|FG000|Overall Study|Protocol Violation|4|||
125225101|NCT00917124|450452037|FG001|Overall Study|Protocol Violation|6|||
125225102|NCT00115778|450452038|FG000|Overall Study|Withdrawal by Subject|0|||
125225103|NCT00115778|450452039|FG001|Overall Study|Withdrawal by Subject|1|||
125225104|NCT00528424|450452042|FG000|Overall Study|Lost to Follow-up|13|||
125225105|NCT00528424|450452042|FG000|Overall Study|Withdrew consent|2|||
125225106|NCT00528424|450452042|FG000|Overall Study|Administrative reason|2|||
125225107|NCT00528424|450452042|FG000|Overall Study|Other|12|||
125225108|NCT02515630|450452043|FG000|Overall Study|Withdrawal by Subject|5|||
125225109|NCT02515630|450452043|FG000|Overall Study|Adverse Event|4|||
125225110|NCT02515630|450452043|FG000|Overall Study|Physician Decision|4|||
125225111|NCT02515630|450452043|FG000|Overall Study|Death|2|||
125225112|NCT02515630|450452043|FG000|Overall Study|Disease Progression|1|||
125225113|NCT00483652|450452044|FG000|Double-blind Treatment Period|Protocol Violation|2|||
125225114|NCT00483652|450452045|FG001|Double-blind Treatment Period|Protocol Violation|1|||
125225115|NCT00483652|450452044|FG000|Double-blind Treatment Period|Adverse Event|3|||
125225116|NCT00483652|450452045|FG001|Double-blind Treatment Period|Adverse Event|4|||
125225117|NCT00483652|450452044|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
125225118|NCT00483652|450452045|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
125225119|NCT00483652|450452044|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
125225120|NCT00483652|450452045|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
125225121|NCT00473655|450452050|FG000|Overall Study|Lost to Follow-up|9|||
125225122|NCT00473655|450452051|FG001|Overall Study|Lost to Follow-up|5|||
125225123|NCT00473655|450452052|FG002|Overall Study|Lost to Follow-up|8|||
125225124|NCT02219685|450452053|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
125225125|NCT02219685|450452054|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
125225126|NCT02219685|450452053|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
125225127|NCT02219685|450452054|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
125225128|NCT02869789|450452055|FG000|Overall Study|Disease progression|184|||
125225129|NCT02869789|450452056|FG001|Overall Study|Disease progression|109|||
125225130|NCT02869789|450452057|FG002|Overall Study|Disease progression|260|||
125225131|NCT02869789|450452058|FG003|Overall Study|Disease progression|19|||
125225132|NCT02869789|450452055|FG000|Overall Study|Study drug toxicity|90|||
125225133|NCT02869789|450452056|FG001|Overall Study|Study drug toxicity|32|||
125225134|NCT02869789|450452057|FG002|Overall Study|Study drug toxicity|55|||
125225135|NCT02869789|450452058|FG003|Overall Study|Study drug toxicity|14|||
125225136|NCT02869789|450452055|FG000|Overall Study|Death|7|||
125225137|NCT02869789|450452056|FG001|Overall Study|Death|3|||
125225138|NCT02869789|450452057|FG002|Overall Study|Death|5|||
125225139|NCT02869789|450452058|FG003|Overall Study|Death|1|||
125225140|NCT02869789|450452055|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
125225141|NCT02869789|450452056|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
125225142|NCT02869789|450452057|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
125225143|NCT02869789|450452058|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
125225144|NCT02869789|450452055|FG000|Overall Study|Participant request to discontinue study treatment|10|||
125225145|NCT02869789|450452056|FG001|Overall Study|Participant request to discontinue study treatment|5|||
125225146|NCT02869789|450452057|FG002|Overall Study|Participant request to discontinue study treatment|5|||
125225147|NCT02869789|450452058|FG003|Overall Study|Participant request to discontinue study treatment|3|||
125225148|NCT02869789|450452055|FG000|Overall Study|Withdrawal by Subject|5|||
125225149|NCT02869789|450452056|FG001|Overall Study|Withdrawal by Subject|2|||
125225150|NCT02869789|450452057|FG002|Overall Study|Withdrawal by Subject|7|||
125225151|NCT02869789|450452058|FG003|Overall Study|Withdrawal by Subject|2|||
125225152|NCT02869789|450452055|FG000|Overall Study|Lost to Follow-up|0|||
125225153|NCT02869789|450452056|FG001|Overall Study|Lost to Follow-up|0|||
125225154|NCT02869789|450452057|FG002|Overall Study|Lost to Follow-up|2|||
125225155|NCT02869789|450452058|FG003|Overall Study|Lost to Follow-up|0|||
125225156|NCT02869789|450452055|FG000|Overall Study|Maximum clinical benefit|5|||
125225157|NCT02869789|450452056|FG001|Overall Study|Maximum clinical benefit|2|||
125163336|NCT03970837|450220780|FG003|Overall Study|Lost to Follow-up|1|||
125163337|NCT03970837|450220781|FG004|Overall Study|Lost to Follow-up|0|||
125163338|NCT03970837|450220782|FG005|Overall Study|Lost to Follow-up|2|||
125225158|NCT02869789|450452057|FG002|Overall Study|Maximum clinical benefit|1|||
125225159|NCT02869789|450452058|FG003|Overall Study|Maximum clinical benefit|0|||
125225160|NCT02869789|450452055|FG000|Overall Study|Poor/Non-compliance|0|||
125225161|NCT02869789|450452056|FG001|Overall Study|Poor/Non-compliance|2|||
125225162|NCT02869789|450452057|FG002|Overall Study|Poor/Non-compliance|1|||
125225163|NCT02869789|450452058|FG003|Overall Study|Poor/Non-compliance|0|||
125225164|NCT02869789|450452055|FG000|Overall Study|Participant no longer meets study criteria|0|||
125225165|NCT02869789|450452056|FG001|Overall Study|Participant no longer meets study criteria|1|||
125163339|NCT03970837|450220783|FG006|Overall Study|Lost to Follow-up|0|||
125163340|NCT03970837|450220784|FG007|Overall Study|Lost to Follow-up|0|||
125163341|NCT03970837|450220785|FG008|Overall Study|Lost to Follow-up|0|||
125163342|NCT03970837|450220786|FG009|Overall Study|Lost to Follow-up|0|||
125163343|NCT03970837|450220787|FG010|Overall Study|Lost to Follow-up|0|||
125163344|NCT03970837|450220788|FG011|Overall Study|Lost to Follow-up|0|||
125163345|NCT03970837|450220777|FG000|Overall Study|Protocol Violation|1|||
125163346|NCT03970837|450220778|FG001|Overall Study|Protocol Violation|0|||
125163347|NCT03970837|450220779|FG002|Overall Study|Protocol Violation|0|||
125163348|NCT03970837|450220780|FG003|Overall Study|Protocol Violation|0|||
125163349|NCT03970837|450220781|FG004|Overall Study|Protocol Violation|0|||
125163350|NCT03970837|450220782|FG005|Overall Study|Protocol Violation|0|||
125163351|NCT03970837|450220783|FG006|Overall Study|Protocol Violation|0|||
125225166|NCT02869789|450452057|FG002|Overall Study|Participant no longer meets study criteria|1|||
125225167|NCT02869789|450452058|FG003|Overall Study|Participant no longer meets study criteria|0|||
125163352|NCT03970837|450220784|FG007|Overall Study|Protocol Violation|0|||
125163353|NCT03970837|450220785|FG008|Overall Study|Protocol Violation|0|||
125225168|NCT02869789|450452055|FG000|Overall Study|Administrative reason by sponsor|0|||
125225169|NCT02869789|450452056|FG001|Overall Study|Administrative reason by sponsor|0|||
125225170|NCT02869789|450452057|FG002|Overall Study|Administrative reason by sponsor|1|||
125225171|NCT02869789|450452058|FG003|Overall Study|Administrative reason by sponsor|0|||
125225172|NCT02869789|450452055|FG000|Overall Study|Other reasons|4|||
125163354|NCT03970837|450220786|FG009|Overall Study|Protocol Violation|0|||
125163355|NCT03970837|450220787|FG010|Overall Study|Protocol Violation|0|||
125163356|NCT03970837|450220788|FG011|Overall Study|Protocol Violation|0|||
125163357|NCT03970837|450220777|FG000|Overall Study|Physician Decision|5|||
125163358|NCT03970837|450220778|FG001|Overall Study|Physician Decision|8|||
125163359|NCT03970837|450220779|FG002|Overall Study|Physician Decision|4|||
125163360|NCT03970837|450220780|FG003|Overall Study|Physician Decision|1|||
125163361|NCT03970837|450220781|FG004|Overall Study|Physician Decision|5|||
125163362|NCT03970837|450220782|FG005|Overall Study|Physician Decision|2|||
125163363|NCT03970837|450220783|FG006|Overall Study|Physician Decision|4|||
125163364|NCT03970837|450220784|FG007|Overall Study|Physician Decision|5|||
125163365|NCT03970837|450220785|FG008|Overall Study|Physician Decision|0|||
125163366|NCT03970837|450220786|FG009|Overall Study|Physician Decision|1|||
125163367|NCT03970837|450220787|FG010|Overall Study|Physician Decision|0|||
125163368|NCT03970837|450220788|FG011|Overall Study|Physician Decision|0|||
125163369|NCT03970837|450220777|FG000|Overall Study|Withdrawal by Subject|32|||
125163370|NCT03970837|450220778|FG001|Overall Study|Withdrawal by Subject|35|||
125225173|NCT02869789|450452056|FG001|Overall Study|Other reasons|8|||
125163371|NCT03970837|450220779|FG002|Overall Study|Withdrawal by Subject|12|||
125163372|NCT03970837|450220780|FG003|Overall Study|Withdrawal by Subject|8|||
125163373|NCT03970837|450220781|FG004|Overall Study|Withdrawal by Subject|6|||
125163374|NCT03970837|450220782|FG005|Overall Study|Withdrawal by Subject|8|||
125163375|NCT03970837|450220783|FG006|Overall Study|Withdrawal by Subject|2|||
125163376|NCT03970837|450220784|FG007|Overall Study|Withdrawal by Subject|3|||
125163377|NCT03970837|450220785|FG008|Overall Study|Withdrawal by Subject|0|||
125163378|NCT03970837|450220786|FG009|Overall Study|Withdrawal by Subject|0|||
125163379|NCT03970837|450220787|FG010|Overall Study|Withdrawal by Subject|0|||
125163380|NCT03970837|450220788|FG011|Overall Study|Withdrawal by Subject|1|||
125163381|NCT03970837|450220777|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
125163382|NCT03970837|450220778|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
125163383|NCT03970837|450220779|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
125163384|NCT03970837|450220780|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
125163385|NCT03970837|450220781|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
125163386|NCT03970837|450220782|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
125163387|NCT03970837|450220783|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
125163388|NCT03970837|450220784|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
125163389|NCT03970837|450220785|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
125163390|NCT03970837|450220786|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
125163391|NCT03970837|450220787|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
125163392|NCT03970837|450220788|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
125163393|NCT03970837|450220777|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
125163394|NCT03970837|450220778|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
125163395|NCT03970837|450220779|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
125163396|NCT03970837|450220780|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
125163397|NCT03970837|450220781|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
125163398|NCT03970837|450220782|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
125163399|NCT03970837|450220783|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
125163400|NCT03970837|450220784|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
125163401|NCT03970837|450220785|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
125163402|NCT03970837|450220786|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
125163403|NCT03970837|450220787|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
125163404|NCT03970837|450220788|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
125163405|NCT01425723|450220791|FG000|Overall Study|Lack of Efficacy|0|||
125163406|NCT01425723|450220792|FG001|Overall Study|Lack of Efficacy|1|||
125163407|NCT01425723|450220791|FG000|Overall Study|Withdrawal by Subject|1|||
125163408|NCT01425723|450220792|FG001|Overall Study|Withdrawal by Subject|4|||
125163409|NCT01425723|450220791|FG000|Overall Study|Lost to Follow-up|0|||
125163410|NCT01425723|450220792|FG001|Overall Study|Lost to Follow-up|3|||
125163411|NCT01425723|450220791|FG000|Overall Study|Physician Decision|2|||
125163412|NCT01425723|450220792|FG001|Overall Study|Physician Decision|0|||
125163413|NCT01425723|450220791|FG000|Overall Study|Other|1|||
125163414|NCT01425723|450220792|FG001|Overall Study|Other|10|||
125163415|NCT00186043|450220793|FG000|Overall Study|Lack of Efficacy|1|||
125163416|NCT00186043|450220794|FG001|Overall Study|Lack of Efficacy|3|||
125163417|NCT00186043|450220793|FG000|Overall Study|Lost to Follow-up|4|||
125163418|NCT00186043|450220794|FG001|Overall Study|Lost to Follow-up|6|||
125163419|NCT00186043|450220793|FG000|Overall Study|Withdrawal by Subject|1|||
125163420|NCT00186043|450220794|FG001|Overall Study|Withdrawal by Subject|0|||
125163421|NCT00186043|450220793|FG000|Overall Study|Adverse Event|7|||
125163422|NCT00186043|450220794|FG001|Overall Study|Adverse Event|3|||
125163423|NCT00186043|450220793|FG000|Overall Study|Protocol Violation|2|||
125163424|NCT00186043|450220794|FG001|Overall Study|Protocol Violation|1|||
125163425|NCT04874636|450220795|FG000|Overall Study|Adverse Event|17|||
125163426|NCT04874636|450220796|FG001|Overall Study|Adverse Event|7|||
125163427|NCT04874636|450220795|FG000|Overall Study|Lost to Follow-up|1|||
125163428|NCT04874636|450220796|FG001|Overall Study|Lost to Follow-up|0|||
125163429|NCT04874636|450220795|FG000|Overall Study|Non-Compliance with Study Drug|2|||
125163430|NCT04874636|450220796|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125163431|NCT04874636|450220795|FG000|Overall Study|Physician Decision|1|||
125163432|NCT04874636|450220796|FG001|Overall Study|Physician Decision|0|||
125163433|NCT04874636|450220795|FG000|Overall Study|Withdrawal by Subject|6|||
125163434|NCT04874636|450220796|FG001|Overall Study|Withdrawal by Subject|5|||
125163435|NCT00228423|450220799|FG000|Overall Study|Adverse Event|2|||
125163436|NCT00228423|450220800|FG001|Overall Study|Adverse Event|5|||
125163437|NCT00228423|450220799|FG000|Overall Study|Withdrawal by Subject|7|||
125163438|NCT00228423|450220800|FG001|Overall Study|Withdrawal by Subject|3|||
125163439|NCT00228423|450220799|FG000|Overall Study|Protocol Violation|1|||
125163440|NCT00228423|450220800|FG001|Overall Study|Protocol Violation|3|||
125163441|NCT00228423|450220799|FG000|Overall Study|Physician Decision|0|||
125163442|NCT00228423|450220800|FG001|Overall Study|Physician Decision|1|||
125163443|NCT03845296|450222637|FG000|Overall Study|On Treatment|2|||
125163444|NCT03845296|450222638|FG001|Overall Study|On Treatment|1|||
125163445|NCT03845296|450222637|FG000|Overall Study|Adverse Event|4|||
125163446|NCT03845296|450222638|FG001|Overall Study|Adverse Event|11|||
125163447|NCT03845296|450222637|FG000|Overall Study|Refusal unrelated to adverse event|0|||
125163448|NCT03845296|450222638|FG001|Overall Study|Refusal unrelated to adverse event|1|||
125163449|NCT03845296|450222637|FG000|Overall Study|Progression/relapse|14|||
125163450|NCT03845296|450222638|FG001|Overall Study|Progression/relapse|18|||
125163451|NCT03845296|450222637|FG000|Overall Study|Death|4|||
125163452|NCT03845296|450222638|FG001|Overall Study|Death|0|||
125163453|NCT03845296|450222637|FG000|Overall Study|Other - not protocol specified|1|||
125163454|NCT03845296|450222638|FG001|Overall Study|Other - not protocol specified|3|||
125163455|NCT01200992|450222642|FG000|Overall Study|Study terminated early|35|||
125163456|NCT01200992|450222643|FG001|Overall Study|Study terminated early|41|||
125163457|NCT01200992|450222642|FG000|Overall Study|Randomized but not treated|2|||
125163458|NCT01200992|450222643|FG001|Overall Study|Randomized but not treated|0|||
125163459|NCT02213510|450222652|FG000|Overall Study|Death|0|||
125163460|NCT02213510|450222653|FG001|Overall Study|Death|1|||
125163461|NCT02213510|450222652|FG000|Overall Study|Lost to Follow-up|1|||
125163462|NCT02213510|450222653|FG001|Overall Study|Lost to Follow-up|0|||
125163463|NCT04241315|450222666|FG000|Overall Study|Withdrawal by Subject|0|||
125163464|NCT04241315|450222667|FG001|Overall Study|Withdrawal by Subject|1|||
125163465|NCT00699283|450222668|FG000|Overall Study|Lack of Efficacy|15|||
125163466|NCT00699283|450222669|FG001|Overall Study|Lack of Efficacy|5|||
125163467|NCT00699283|450222668|FG000|Overall Study|Lost to Follow-up|2|||
125225174|NCT02869789|450452057|FG002|Overall Study|Other reasons|6|||
125225175|NCT02869789|450452058|FG003|Overall Study|Other reasons|0|||
125225176|NCT01566604|450452061|FG000|Overall Study|Patient's inability to use the device|1|||
125225177|NCT01566604|450452062|FG001|Overall Study|Patient's inability to use the device|0|||
125225178|NCT01566604|450452061|FG000|Overall Study|Administrative problems|1|||
125225179|NCT01566604|450452062|FG001|Overall Study|Administrative problems|0|||
125225180|NCT01566604|450452061|FG000|Overall Study|Lack of Efficacy|1|||
125225181|NCT01566604|450452062|FG001|Overall Study|Lack of Efficacy|2|||
125225182|NCT01566604|450452061|FG000|Overall Study|Protocol deviation|2|||
125225183|NCT01566604|450452062|FG001|Overall Study|Protocol deviation|0|||
125225184|NCT01566604|450452061|FG000|Overall Study|Abnormal laboratory value|2|||
125225185|NCT01566604|450452062|FG001|Overall Study|Abnormal laboratory value|0|||
125163468|NCT00699283|450222669|FG001|Overall Study|Lost to Follow-up|0|||
125163469|NCT00699283|450222668|FG000|Overall Study|Withdrawal by Subject|1|||
125163470|NCT00699283|450222669|FG001|Overall Study|Withdrawal by Subject|0|||
125163471|NCT00699283|450222668|FG000|Overall Study|Other Reason|5|||
125163472|NCT00699283|450222669|FG001|Overall Study|Other Reason|1|||
125163473|NCT00699283|450222668|FG000|Overall Study|SAE, non-fatal|1|||
125163474|NCT00699283|450222669|FG001|Overall Study|SAE, non-fatal|1|||
125163475|NCT00699283|450222668|FG000|Overall Study|AE, non-serious non-fatal|8|||
125163476|NCT00699283|450222669|FG001|Overall Study|AE, non-serious non-fatal|1|||
125163477|NCT00699283|450222668|FG000|Overall Study|AE of unknown type|1|||
125163478|NCT00699283|450222669|FG001|Overall Study|AE of unknown type|0|||
125163479|NCT00394524|450222670|FG000|Overall Study|Protocol Violation|2|||
125163480|NCT00394524|450222671|FG001|Overall Study|Protocol Violation|3|||
125163481|NCT00394524|450222670|FG000|Overall Study|Death|1|||
125225186|NCT01566604|450452061|FG000|Overall Study|Death|4|||
125225187|NCT01566604|450452062|FG001|Overall Study|Death|1|||
125225188|NCT01566604|450452061|FG000|Overall Study|Adverse Event|4|||
125225189|NCT01566604|450452062|FG001|Overall Study|Adverse Event|2|||
125163482|NCT00394524|450222671|FG001|Overall Study|Death|0|||
125225190|NCT01566604|450452061|FG000|Overall Study|Withdrawal by Subject|9|||
125163483|NCT00394524|450222670|FG000|Overall Study|Withdrawal by Subject|0|||
125163484|NCT00394524|450222671|FG001|Overall Study|Withdrawal by Subject|1|||
125163485|NCT01398514|450222672|FG000|Overall Study|Adverse Event|1|||
125163486|NCT01398514|450222673|FG001|Overall Study|Adverse Event|0|||
125163487|NCT01398514|450222672|FG000|Overall Study|Non-compliance with study procedures|2|||
125163488|NCT01398514|450222673|FG001|Overall Study|Non-compliance with study procedures|0|||
125163489|NCT01398514|450222672|FG000|Overall Study|Physiologic non-responsiveness|1|||
125163490|NCT01398514|450222673|FG001|Overall Study|Physiologic non-responsiveness|3|||
125163491|NCT01398514|450222672|FG000|Overall Study|Failure to show a conditioned response|4|||
125163492|NCT01398514|450222673|FG001|Overall Study|Failure to show a conditioned response|3|||
125163493|NCT03537599|450222674|FG000|Overall Study|Disease Progression|2|||
125163494|NCT03537599|450222675|FG001|Overall Study|Disease Progression|1|||
125163495|NCT03537599|450222674|FG000|Overall Study|Death|0|||
125163496|NCT03537599|450222675|FG001|Overall Study|Death|1|||
125163497|NCT01007942|450222676|FG000|Overall Study|Adverse Event|29|||
125163498|NCT01007942|450222677|FG001|Overall Study|Adverse Event|14|||
125163499|NCT01007942|450222676|FG000|Overall Study|Abnormal test procedure|0|||
125163500|NCT01007942|450222677|FG001|Overall Study|Abnormal test procedure|1|||
125163501|NCT01007942|450222676|FG000|Overall Study|Disease progression|217|||
125163502|NCT01007942|450222677|FG001|Overall Study|Disease progression|242|||
125163503|NCT01007942|450222676|FG000|Overall Study|New cancer therapy|5|||
125163504|NCT01007942|450222677|FG001|Overall Study|New cancer therapy|1|||
125163505|NCT01007942|450222676|FG000|Overall Study|Protocol Violation|1|||
125163506|NCT01007942|450222677|FG001|Overall Study|Protocol Violation|1|||
125163507|NCT01007942|450222676|FG000|Overall Study|Withdrawal by Subject|19|||
125163508|NCT01007942|450222677|FG001|Overall Study|Withdrawal by Subject|14|||
125163509|NCT01007942|450222676|FG000|Overall Study|Lost to Follow-up|1|||
125163510|NCT01007942|450222677|FG001|Overall Study|Lost to Follow-up|0|||
125225191|NCT01566604|450452062|FG001|Overall Study|Withdrawal by Subject|6|||
125225192|NCT03225170|450452063|FG000|Overall Study|Lost to Follow-up|4|||
125225193|NCT03225170|450452064|FG001|Overall Study|Lost to Follow-up|4|||
125225194|NCT03225170|450452065|FG002|Overall Study|Lost to Follow-up|0|||
125225195|NCT03225170|450452063|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
125225196|NCT03225170|450452064|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
125225197|NCT03225170|450452065|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
125225198|NCT00549549|450452089|FG000|Overall Study|Adverse Event|5|||
125225199|NCT00549549|450452090|FG001|Overall Study|Adverse Event|3|||
125225200|NCT00549549|450452091|FG002|Overall Study|Adverse Event|1|||
125225201|NCT00549549|450452092|FG003|Overall Study|Adverse Event|9|||
125225202|NCT00549549|450452089|FG000|Overall Study|Lack of Efficacy|9|||
125225203|NCT00549549|450452090|FG001|Overall Study|Lack of Efficacy|6|||
125225204|NCT00549549|450452091|FG002|Overall Study|Lack of Efficacy|4|||
125225205|NCT00549549|450452092|FG003|Overall Study|Lack of Efficacy|2|||
125225206|NCT00549549|450452089|FG000|Overall Study|Lost to Follow-up|1|||
125225207|NCT00549549|450452090|FG001|Overall Study|Lost to Follow-up|0|||
125225208|NCT00549549|450452091|FG002|Overall Study|Lost to Follow-up|1|||
125225209|NCT00549549|450452092|FG003|Overall Study|Lost to Follow-up|2|||
125225210|NCT00549549|450452089|FG000|Overall Study|Withdrawal by Subject|0|||
125225211|NCT00549549|450452090|FG001|Overall Study|Withdrawal by Subject|4|||
125225212|NCT00549549|450452091|FG002|Overall Study|Withdrawal by Subject|1|||
125225213|NCT00549549|450452092|FG003|Overall Study|Withdrawal by Subject|0|||
125225214|NCT00549549|450452089|FG000|Overall Study|Other|9|||
125225215|NCT00549549|450452090|FG001|Overall Study|Other|9|||
125225216|NCT00549549|450452091|FG002|Overall Study|Other|9|||
125225217|NCT00549549|450452092|FG003|Overall Study|Other|11|||
125225218|NCT00549549|450452089|FG000|Overall Study|Randomized but not treated|0|||
125225219|NCT00549549|450452090|FG001|Overall Study|Randomized but not treated|0|||
125225220|NCT00549549|450452091|FG002|Overall Study|Randomized but not treated|1|||
125225221|NCT00549549|450452092|FG003|Overall Study|Randomized but not treated|1|||
125225222|NCT00248651|450452095|FG000|Overall Study|Withdrawal by Subject|28|||
125225223|NCT00248651|450452096|FG001|Overall Study|Withdrawal by Subject|40|||
125225224|NCT00248651|450452097|FG002|Overall Study|Withdrawal by Subject|32|||
125225225|NCT02688933|450452098|FG000|Overall Study|Adverse Event|3|||
125225226|NCT02688933|450452099|FG001|Overall Study|Adverse Event|1|||
125225227|NCT02688933|450452098|FG000|Overall Study|Lack of Efficacy|2|||
125225228|NCT02688933|450452099|FG001|Overall Study|Lack of Efficacy|2|||
125225229|NCT02688933|450452098|FG000|Overall Study|Poor compliance to protocol|7|||
125225230|NCT02688933|450452099|FG001|Overall Study|Poor compliance to protocol|4|||
125163511|NCT01007942|450222676|FG000|Overall Study|Administrative problems|2|||
125163512|NCT01007942|450222677|FG001|Overall Study|Administrative problems|0|||
125163513|NCT01007942|450222676|FG000|Overall Study|Death|3|||
125163514|NCT01007942|450222677|FG001|Overall Study|Death|2|||
125163515|NCT01007942|450222676|FG000|Overall Study|Patients untreated|4|||
125163516|NCT01007942|450222677|FG001|Overall Study|Patients untreated|3|||
125163517|NCT05083585|450222682|FG000|Overall Study|Death|1|||
125163518|NCT05083585|450222683|FG001|Overall Study|Death|1|||
125163519|NCT05083585|450222682|FG000|Overall Study|Lost to Follow-up|1|||
125163520|NCT05083585|450222683|FG001|Overall Study|Lost to Follow-up|1|||
125163521|NCT05083585|450222682|FG000|Overall Study|Withdrawal by Subject|2|||
125163522|NCT05083585|450222683|FG001|Overall Study|Withdrawal by Subject|0|||
125163523|NCT05083585|450222682|FG000|Overall Study|Randomized but not vaccinated|2|||
125163524|NCT05083585|450222683|FG001|Overall Study|Randomized but not vaccinated|0|||
125163525|NCT03929757|450222684|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
125163526|NCT03929757|450222685|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
125163527|NCT03929757|450222686|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
125163528|NCT03929757|450222684|FG000|Main Study: Up to Day 365|Other|1|||
125163529|NCT03929757|450222685|FG001|Main Study: Up to Day 365|Other|0|||
125163530|NCT03929757|450222686|FG002|Main Study: Up to Day 365|Other|0|||
125163531|NCT03929757|450222684|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
125163532|NCT03929757|450222685|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
125163533|NCT03929757|450222686|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
125163534|NCT00114166|450222688|FG000|Overall Study|Wrong primary|0|||
125163535|NCT00114166|450222689|FG001|Overall Study|Wrong primary|1|||
125163536|NCT00806286|450222695|FG000|Overall Study|Adverse Event|5|||
125163537|NCT00806286|450222696|FG001|Overall Study|Adverse Event|2|||
125163538|NCT00806286|450222697|FG002|Overall Study|Adverse Event|0|||
125163539|NCT00806286|450222695|FG000|Overall Study|Disease progression|31|||
125163540|NCT00806286|450222696|FG001|Overall Study|Disease progression|38|||
125225231|NCT02688933|450452098|FG000|Overall Study|Hypoglycemia|2|||
125225232|NCT02688933|450452099|FG001|Overall Study|Hypoglycemia|0|||
125225233|NCT02688933|450452098|FG000|Overall Study|Other than Specified|14|||
125225234|NCT02688933|450452099|FG001|Overall Study|Other than Specified|25|||
125225235|NCT02688933|450452098|FG000|Overall Study|Lost to Follow-up|1|||
125163541|NCT00806286|450222697|FG002|Overall Study|Disease progression|1|||
125163542|NCT00806286|450222695|FG000|Overall Study|Death|1|||
125163543|NCT00806286|450222696|FG001|Overall Study|Death|6|||
125163544|NCT00806286|450222697|FG002|Overall Study|Death|0|||
125163545|NCT00806286|450222695|FG000|Overall Study|Lost to Follow-up|0|||
125163546|NCT00806286|450222696|FG001|Overall Study|Lost to Follow-up|1|||
125163547|NCT00806286|450222697|FG002|Overall Study|Lost to Follow-up|0|||
125163548|NCT00806286|450222695|FG000|Overall Study|Withdrawal by Subject|8|||
125163549|NCT00806286|450222696|FG001|Overall Study|Withdrawal by Subject|3|||
125163550|NCT00806286|450222697|FG002|Overall Study|Withdrawal by Subject|1|||
125163551|NCT00806286|450222695|FG000|Overall Study|Physician Decision|2|||
125163552|NCT00806286|450222696|FG001|Overall Study|Physician Decision|2|||
125163553|NCT00806286|450222697|FG002|Overall Study|Physician Decision|0|||
125163554|NCT00806286|450222695|FG000|Overall Study|Due to a variety of reasons|7|||
125163555|NCT00806286|450222696|FG001|Overall Study|Due to a variety of reasons|2|||
125163556|NCT00806286|450222697|FG002|Overall Study|Due to a variety of reasons|1|||
125163557|NCT03402750|450222698|FG000|Overall Study|Lost to Follow-up|2|||
125163558|NCT03402750|450222699|FG001|Overall Study|Lost to Follow-up|1|||
125163559|NCT03469336|450222700|FG000|Overall Study|Adverse Event|1|||
125163560|NCT02628743|450222701|FG000|Overall Study|Other|3|||
125163561|NCT02628743|450222701|FG000|Overall Study|Withdrawal by Subject|50|||
125163562|NCT02628743|450222701|FG000|Overall Study|Study Terminated by Sponsor|76|||
125163563|NCT02628743|450222701|FG000|Overall Study|Physician Decision|2|||
125163564|NCT02534844|450222702|FG000|Part B|Withdrawal by Subject|0|||
125163565|NCT02534844|450222703|FG001|Part B|Withdrawal by Subject|0|||
125163566|NCT02534844|450222704|FG002|Part B|Withdrawal by Subject|0|||
125163567|NCT02534844|450222705|FG003|Part B|Withdrawal by Subject|0|||
125163568|NCT02534844|450222706|FG004|Part B|Withdrawal by Subject|2|||
125163569|NCT02534844|450222707|FG005|Part B|Withdrawal by Subject|1|||
125163570|NCT04645966|450222719|FG000|Vaccination Phase|Adverse Event|1|||
125163571|NCT04645966|450222720|FG001|Vaccination Phase|Adverse Event|0|||
125163572|NCT04645966|450222721|FG002|Vaccination Phase|Adverse Event|0|||
125163573|NCT04645966|450222722|FG003|Vaccination Phase|Adverse Event|0|||
125163574|NCT04645966|450222723|FG004|Vaccination Phase|Adverse Event|0|||
125163575|NCT04645966|450222724|FG005|Vaccination Phase|Adverse Event|0|||
125163576|NCT04645966|450222725|FG006|Vaccination Phase|Adverse Event|1|||
125163577|NCT04645966|450222726|FG007|Vaccination Phase|Adverse Event|0|||
125163578|NCT04645966|450222727|FG008|Vaccination Phase|Adverse Event|0|||
125163579|NCT04645966|450222719|FG000|Vaccination Phase|Death|0|||
125163580|NCT04645966|450222720|FG001|Vaccination Phase|Death|0|||
125163581|NCT04645966|450222721|FG002|Vaccination Phase|Death|0|||
125163582|NCT04645966|450222722|FG003|Vaccination Phase|Death|0|||
125163583|NCT04645966|450222723|FG004|Vaccination Phase|Death|0|||
125163584|NCT04645966|450222724|FG005|Vaccination Phase|Death|1|||
125163585|NCT04645966|450222725|FG006|Vaccination Phase|Death|0|||
125163586|NCT04645966|450222726|FG007|Vaccination Phase|Death|0|||
125163587|NCT04645966|450222727|FG008|Vaccination Phase|Death|0|||
125163588|NCT04645966|450222719|FG000|Vaccination Phase|Protocol Violation|0|||
125163589|NCT04645966|450222720|FG001|Vaccination Phase|Protocol Violation|0|||
125163590|NCT04645966|450222721|FG002|Vaccination Phase|Protocol Violation|0|||
125163591|NCT04645966|450222722|FG003|Vaccination Phase|Protocol Violation|0|||
125163592|NCT04645966|450222723|FG004|Vaccination Phase|Protocol Violation|1|||
125163593|NCT04645966|450222724|FG005|Vaccination Phase|Protocol Violation|0|||
125163594|NCT04645966|450222725|FG006|Vaccination Phase|Protocol Violation|0|||
125163595|NCT04645966|450222726|FG007|Vaccination Phase|Protocol Violation|0|||
125163596|NCT04645966|450222727|FG008|Vaccination Phase|Protocol Violation|0|||
125163597|NCT04645966|450222719|FG000|Vaccination Phase|Study terminated by sponsor|0|||
125225236|NCT02688933|450452099|FG001|Overall Study|Lost to Follow-up|5|||
125225237|NCT01275144|450452100|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
125163598|NCT04645966|450222720|FG001|Vaccination Phase|Study terminated by sponsor|0|||
125163599|NCT04645966|450222721|FG002|Vaccination Phase|Study terminated by sponsor|14|||
125163600|NCT04645966|450222722|FG003|Vaccination Phase|Study terminated by sponsor|15|||
125225238|NCT01275144|450452101|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
125225239|NCT00828113|450452102|FG000|Overall Study|Withdrawal by Subject|27|||
125225240|NCT00828113|450452103|FG001|Overall Study|Withdrawal by Subject|26|||
125225241|NCT00828113|450452102|FG000|Overall Study|Lost to Follow-up|3|||
125225242|NCT00828113|450452103|FG001|Overall Study|Lost to Follow-up|5|||
125225243|NCT01365130|450452104|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
125225244|NCT05547386|450452106|FG000|Overall Study|Withdrawal by Subject|7|||
125225245|NCT04622969|450452107|FG000|Overall Study|Withdrawal by Subject|2|||
125225246|NCT04622969|450452108|FG001|Overall Study|Withdrawal by Subject|3|||
125225247|NCT05607576|450452109|FG000|Overall Study|immediate sensor error|2|||
125225248|NCT05607576|450452109|FG000|Overall Study|Physician Decision|2|||
125225249|NCT04467515|450452110|FG000|Overall Study|Lost to Follow-up|1|||
125225250|NCT04467515|450452111|FG001|Overall Study|Lost to Follow-up|0|||
125225251|NCT04467515|450452112|FG002|Overall Study|Lost to Follow-up|0|||
125225252|NCT04467515|450452110|FG000|Overall Study|Withdrawal by Subject|1|||
125225253|NCT04467515|450452111|FG001|Overall Study|Withdrawal by Subject|0|||
125225254|NCT04467515|450452112|FG002|Overall Study|Withdrawal by Subject|1|||
125225255|NCT04467515|450452110|FG000|Overall Study|Progressive Disease|0|||
125225256|NCT04467515|450452111|FG001|Overall Study|Progressive Disease|1|||
125225257|NCT04467515|450452112|FG002|Overall Study|Progressive Disease|3|||
125163601|NCT04645966|450222723|FG004|Vaccination Phase|Study terminated by sponsor|47|||
125163602|NCT04645966|450222724|FG005|Vaccination Phase|Study terminated by sponsor|43|||
125163603|NCT04645966|450222725|FG006|Vaccination Phase|Study terminated by sponsor|29|||
125163604|NCT04645966|450222726|FG007|Vaccination Phase|Study terminated by sponsor|29|||
125163605|NCT04645966|450222727|FG008|Vaccination Phase|Study terminated by sponsor|12|||
125163606|NCT04645966|450222719|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
125163607|NCT04645966|450222720|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
125163608|NCT04645966|450222721|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
125163609|NCT04645966|450222722|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
125163610|NCT04645966|450222723|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
125163611|NCT04645966|450222724|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
125163612|NCT04645966|450222725|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
125163613|NCT04645966|450222726|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
125163614|NCT04645966|450222727|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
125163615|NCT04645966|450222719|FG000|Vaccination Phase|Other|0|||
125163616|NCT04645966|450222720|FG001|Vaccination Phase|Other|0|||
125163617|NCT04645966|450222721|FG002|Vaccination Phase|Other|0|||
125163618|NCT04645966|450222722|FG003|Vaccination Phase|Other|0|||
125163619|NCT04645966|450222723|FG004|Vaccination Phase|Other|0|||
125163620|NCT04645966|450222724|FG005|Vaccination Phase|Other|2|||
125163621|NCT04645966|450222725|FG006|Vaccination Phase|Other|0|||
125163622|NCT04645966|450222726|FG007|Vaccination Phase|Other|0|||
125163623|NCT04645966|450222727|FG008|Vaccination Phase|Other|0|||
125163624|NCT04645966|450222719|FG000|Vaccination Phase|Lost to Follow-up|0|||
125163625|NCT04645966|450222720|FG001|Vaccination Phase|Lost to Follow-up|0|||
125163626|NCT04645966|450222721|FG002|Vaccination Phase|Lost to Follow-up|0|||
125163627|NCT04645966|450222722|FG003|Vaccination Phase|Lost to Follow-up|0|||
125163628|NCT04645966|450222723|FG004|Vaccination Phase|Lost to Follow-up|0|||
125163629|NCT04645966|450222724|FG005|Vaccination Phase|Lost to Follow-up|0|||
125163630|NCT04645966|450222725|FG006|Vaccination Phase|Lost to Follow-up|0|||
125163631|NCT04645966|450222726|FG007|Vaccination Phase|Lost to Follow-up|1|||
125163632|NCT04645966|450222727|FG008|Vaccination Phase|Lost to Follow-up|0|||
125163633|NCT04645966|450222719|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
125163634|NCT04645966|450222720|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
125163635|NCT04645966|450222721|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
125163636|NCT04645966|450222722|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
125163637|NCT04645966|450222723|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
125163638|NCT04645966|450222724|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
125163639|NCT04645966|450222725|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
125163640|NCT04645966|450222726|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
125163641|NCT04645966|450222727|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
125163642|NCT04645966|450222719|FG000|Follow-up Phase|Lost to Follow-up|0|||
125163643|NCT04645966|450222720|FG001|Follow-up Phase|Lost to Follow-up|0|||
125163644|NCT04645966|450222721|FG002|Follow-up Phase|Lost to Follow-up|0|||
125163645|NCT04645966|450222722|FG003|Follow-up Phase|Lost to Follow-up|0|||
125163646|NCT04645966|450222723|FG004|Follow-up Phase|Lost to Follow-up|0|||
125163647|NCT04645966|450222724|FG005|Follow-up Phase|Lost to Follow-up|0|||
125163648|NCT04645966|450222725|FG006|Follow-up Phase|Lost to Follow-up|0|||
125225258|NCT04467515|450452110|FG000|Overall Study|Death|0|||
125163649|NCT04645966|450222726|FG007|Follow-up Phase|Lost to Follow-up|1|||
125163650|NCT04645966|450222727|FG008|Follow-up Phase|Lost to Follow-up|0|||
125163651|NCT03825341|450222728|FG000|Overall Study|Withdrawal by Subject|0|||
125163652|NCT03825341|450222729|FG001|Overall Study|Withdrawal by Subject|1|||
125163653|NCT00289536|450222731|FG000|Period 3|Lost to Follow-up|0|||
125225259|NCT04467515|450452111|FG001|Overall Study|Death|1|||
125225260|NCT04467515|450452112|FG002|Overall Study|Death|0|||
125225261|NCT04391842|450452115|FG000|Overall Study|Withdrawal by Subject|2|||
125163654|NCT00289536|450222732|FG001|Period 3|Lost to Follow-up|0|||
125163655|NCT00289536|450222733|FG002|Period 3|Lost to Follow-up|1|||
125163656|NCT02116608|450222738|FG000|Overall Study|Lost to Follow-up|0|||
125163657|NCT02116608|450222739|FG001|Overall Study|Lost to Follow-up|0|||
125163658|NCT02116608|450222740|FG002|Overall Study|Lost to Follow-up|1|||
125163659|NCT02116608|450222738|FG000|Overall Study|Physician Decision|0|||
125163660|NCT02116608|450222739|FG001|Overall Study|Physician Decision|1|||
125163661|NCT02116608|450222740|FG002|Overall Study|Physician Decision|0|||
125163662|NCT02116608|450222738|FG000|Overall Study|Death|0|||
125163663|NCT02116608|450222739|FG001|Overall Study|Death|1|||
125163664|NCT02116608|450222740|FG002|Overall Study|Death|0|||
125163665|NCT04283500|450222741|FG000|Overall Study|Lost to Follow-up|8|||
125163666|NCT04283500|450222741|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
125163667|NCT02006693|450222745|FG000|Overall Study|No Reason Specified|6|||
125163668|NCT02006693|450222746|FG001|Overall Study|No Reason Specified|8|||
125163669|NCT02006693|450222745|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
125163670|NCT02006693|450222746|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
125225262|NCT00810199|450452116|FG000|Overall Study|Adverse Event|24|||
125163671|NCT02006693|450222745|FG000|Overall Study|XEN Implant Explantation|0|||
125163672|NCT02006693|450222746|FG001|Overall Study|XEN Implant Explantation|1|||
125163673|NCT02006693|450222745|FG000|Overall Study|Death|2|||
125163674|NCT02006693|450222746|FG001|Overall Study|Death|2|||
125163675|NCT02006693|450222745|FG000|Overall Study|Lost to Follow-up|4|||
125163676|NCT02006693|450222746|FG001|Overall Study|Lost to Follow-up|1|||
125163677|NCT02006693|450222745|FG000|Overall Study|Patient Decision|4|||
125163678|NCT02006693|450222746|FG001|Overall Study|Patient Decision|0|||
125163679|NCT01119508|450222749|FG000|Overall Study|Adverse Event|56|||
125163680|NCT01119508|450222749|FG000|Overall Study|Withdrawal by Subject|2|||
125163681|NCT01119508|450222749|FG000|Overall Study|Died before tumor response evaluation|1|||
125163682|NCT00265395|450222750|FG000|Overall Study|Adverse Event|3|||
125163683|NCT00265395|450222751|FG001|Overall Study|Adverse Event|6|||
125163684|NCT00265395|450222750|FG000|Overall Study|Lost to Follow-up|2|||
125163685|NCT00265395|450222751|FG001|Overall Study|Lost to Follow-up|1|||
125163686|NCT00265395|450222750|FG000|Overall Study|Withdrawal by Subject|1|||
125225263|NCT00810199|450452117|FG001|Overall Study|Adverse Event|26|||
125163687|NCT00265395|450222751|FG001|Overall Study|Withdrawal by Subject|6|||
125163688|NCT00265395|450222750|FG000|Overall Study|Protocol Violation|2|||
125163689|NCT00265395|450222751|FG001|Overall Study|Protocol Violation|2|||
125163690|NCT00265395|450222750|FG000|Overall Study|Lack of Efficacy|0|||
125163691|NCT00265395|450222751|FG001|Overall Study|Lack of Efficacy|1|||
125163692|NCT00265395|450222750|FG000|Overall Study|Administrative|0|||
125163693|NCT00265395|450222751|FG001|Overall Study|Administrative|1|||
125163694|NCT04053465|450222754|FG000|Overall Study|Withdrawal by Subject|4|||
125163695|NCT04053465|450222755|FG001|Overall Study|Withdrawal by Subject|4|||
125163696|NCT03317834|450222756|FG000|Overall Study|Death|2|||
125163697|NCT03317834|450222756|FG000|Overall Study|Device Revision|5|||
125163698|NCT03317834|450222756|FG000|Overall Study|Withdrawal by Subject|13|||
125163699|NCT03317834|450222756|FG000|Overall Study|Lost to Follow-up|13|||
125163700|NCT01140503|450222765|FG000|Overall Study|Withdrawal by Subject|1|||
125163701|NCT04135196|450222768|FG000|Overall Study|Lost to Follow-up|8|||
125163702|NCT04135196|450222769|FG001|Overall Study|Lost to Follow-up|7|||
125163703|NCT04135196|450222770|FG002|Overall Study|Lost to Follow-up|8|||
125163704|NCT04135196|450222771|FG003|Overall Study|Lost to Follow-up|9|||
125163705|NCT04135196|450222772|FG004|Overall Study|Lost to Follow-up|1|||
125163706|NCT04135196|450222768|FG000|Overall Study|Pregnancy|0|||
125163707|NCT04135196|450222769|FG001|Overall Study|Pregnancy|0|||
125163708|NCT04135196|450222770|FG002|Overall Study|Pregnancy|1|||
125163709|NCT04135196|450222771|FG003|Overall Study|Pregnancy|0|||
125163710|NCT04135196|450222772|FG004|Overall Study|Pregnancy|0|||
125163711|NCT04135196|450222768|FG000|Overall Study|Withdrawal by Subject|0|||
125163712|NCT04135196|450222769|FG001|Overall Study|Withdrawal by Subject|0|||
125163713|NCT04135196|450222770|FG002|Overall Study|Withdrawal by Subject|0|||
125163714|NCT04135196|450222771|FG003|Overall Study|Withdrawal by Subject|0|||
125163715|NCT04135196|450222772|FG004|Overall Study|Withdrawal by Subject|1|||
125163716|NCT00809159|450222774|FG000|Part 1|Adverse Event|1|||
125163717|NCT00809159|450222775|FG001|Part 1|Adverse Event|1|||
125163718|NCT00809159|450222776|FG002|Part 1|Adverse Event|0|||
125163719|NCT00809159|450222777|FG003|Part 1|Adverse Event|0|||
125163720|NCT00809159|450222778|FG004|Part 1|Adverse Event|0|||
125163721|NCT00809159|450222779|FG005|Part 1|Adverse Event|0|||
125163722|NCT00809159|450222774|FG000|Part 1|Lost to Follow-up|1|||
125163723|NCT00809159|450222775|FG001|Part 1|Lost to Follow-up|0|||
125163724|NCT00809159|450222776|FG002|Part 1|Lost to Follow-up|0|||
125225264|NCT00810199|450452116|FG000|Overall Study|Death|4|||
125225265|NCT00810199|450452117|FG001|Overall Study|Death|6|||
125225266|NCT00810199|450452116|FG000|Overall Study|Withdrew consent|9|||
125225267|NCT00810199|450452117|FG001|Overall Study|Withdrew consent|12|||
125225268|NCT00810199|450452116|FG000|Overall Study|Insufficient therapeutic response|5|||
125225269|NCT00810199|450452117|FG001|Overall Study|Insufficient therapeutic response|14|||
125225270|NCT00810199|450452116|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
125163725|NCT00809159|450222777|FG003|Part 1|Lost to Follow-up|0|||
125163726|NCT00809159|450222778|FG004|Part 1|Lost to Follow-up|0|||
125225271|NCT00810199|450452117|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
125163727|NCT00809159|450222779|FG005|Part 1|Lost to Follow-up|0|||
125163728|NCT00809159|450222774|FG000|Part 1|Withdrawal by Subject|3|||
125163729|NCT00809159|450222775|FG001|Part 1|Withdrawal by Subject|1|||
125163730|NCT00809159|450222776|FG002|Part 1|Withdrawal by Subject|0|||
125163731|NCT00809159|450222777|FG003|Part 1|Withdrawal by Subject|0|||
125163732|NCT00809159|450222778|FG004|Part 1|Withdrawal by Subject|0|||
125163733|NCT00809159|450222779|FG005|Part 1|Withdrawal by Subject|0|||
125163734|NCT00809159|450222774|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
125163735|NCT00809159|450222775|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
125163736|NCT00809159|450222776|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
125163737|NCT00809159|450222777|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
125163738|NCT00809159|450222778|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
125163739|NCT00809159|450222779|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
125163740|NCT00809159|450222774|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
125163741|NCT00809159|450222775|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
125163742|NCT00809159|450222776|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
125163743|NCT00809159|450222777|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
125163744|NCT00809159|450222778|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
125225272|NCT00810199|450452116|FG000|Overall Study|Administrative/Other|5|||
125225273|NCT00810199|450452117|FG001|Overall Study|Administrative/Other|6|||
125225274|NCT00810199|450452116|FG000|Overall Study|Protocol Violation|2|||
125225275|NCT00810199|450452117|FG001|Overall Study|Protocol Violation|6|||
125163745|NCT00809159|450222779|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
125163746|NCT00809159|450222774|FG000|Part 1 and 2|Administrative problems|0|||
125163747|NCT00809159|450222775|FG001|Part 1 and 2|Administrative problems|0|||
125163748|NCT00809159|450222776|FG002|Part 1 and 2|Administrative problems|0|||
125163749|NCT00809159|450222777|FG003|Part 1 and 2|Administrative problems|1|||
125163750|NCT00809159|450222778|FG004|Part 1 and 2|Administrative problems|0|||
125163751|NCT00809159|450222779|FG005|Part 1 and 2|Administrative problems|0|||
125163752|NCT00809159|450222774|FG000|Part 1 and 2|Adverse Event|0|||
125163753|NCT00809159|450222775|FG001|Part 1 and 2|Adverse Event|0|||
125163754|NCT00809159|450222776|FG002|Part 1 and 2|Adverse Event|1|||
125163755|NCT00809159|450222777|FG003|Part 1 and 2|Adverse Event|0|||
125163756|NCT00809159|450222778|FG004|Part 1 and 2|Adverse Event|1|||
125163757|NCT00809159|450222779|FG005|Part 1 and 2|Adverse Event|1|||
125163758|NCT00809159|450222774|FG000|Part 1 and 2|Lost to Follow-up|0|||
125163759|NCT00809159|450222775|FG001|Part 1 and 2|Lost to Follow-up|0|||
125163760|NCT00809159|450222776|FG002|Part 1 and 2|Lost to Follow-up|1|||
125163761|NCT00809159|450222777|FG003|Part 1 and 2|Lost to Follow-up|1|||
125163762|NCT00809159|450222778|FG004|Part 1 and 2|Lost to Follow-up|0|||
125163763|NCT00809159|450222779|FG005|Part 1 and 2|Lost to Follow-up|0|||
125163764|NCT00809159|450222774|FG000|Part 1 and 2|Withdrawal by Subject|0|||
125163765|NCT00809159|450222775|FG001|Part 1 and 2|Withdrawal by Subject|0|||
125163766|NCT00809159|450222776|FG002|Part 1 and 2|Withdrawal by Subject|4|||
125163767|NCT00809159|450222777|FG003|Part 1 and 2|Withdrawal by Subject|0|||
125163768|NCT00809159|450222778|FG004|Part 1 and 2|Withdrawal by Subject|0|||
125163769|NCT00809159|450222779|FG005|Part 1 and 2|Withdrawal by Subject|1|||
125163770|NCT03201211|450222782|FG000|Overall Study|Adverse Event|1|||
125163771|NCT03201211|450222783|FG001|Overall Study|Adverse Event|0|||
125163772|NCT03201211|450222784|FG002|Overall Study|Adverse Event|0|||
125163773|NCT03201211|450222782|FG000|Overall Study|Protocol Violation|1|||
125163774|NCT03201211|450222783|FG001|Overall Study|Protocol Violation|0|||
125163775|NCT03201211|450222784|FG002|Overall Study|Protocol Violation|0|||
125163776|NCT03201211|450222782|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
125163777|NCT03201211|450222783|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
125163778|NCT03201211|450222784|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
125163779|NCT03201211|450222782|FG000|Overall Study|OTHER unknown reasons|0|||
125163780|NCT03201211|450222783|FG001|Overall Study|OTHER unknown reasons|1|||
125163781|NCT03201211|450222784|FG002|Overall Study|OTHER unknown reasons|0|||
125163782|NCT01083810|450222785|FG000|Overall Study|Lost to Follow-up|23|||
125163783|NCT01083810|450222786|FG001|Overall Study|Lost to Follow-up|11|||
125163784|NCT01083810|450222787|FG002|Overall Study|Lost to Follow-up|4|||
125163785|NCT01083810|450222785|FG000|Overall Study|Adverse Event|15|||
125163786|NCT01083810|450222786|FG001|Overall Study|Adverse Event|11|||
125163787|NCT01083810|450222787|FG002|Overall Study|Adverse Event|4|||
125163788|NCT01083810|450222785|FG000|Overall Study|Withdrawal by Subject|7|||
125163789|NCT01083810|450222786|FG001|Overall Study|Withdrawal by Subject|2|||
125163790|NCT01083810|450222787|FG002|Overall Study|Withdrawal by Subject|4|||
125163791|NCT01083810|450222785|FG000|Overall Study|Reason not reported|6|||
125163792|NCT01083810|450222786|FG001|Overall Study|Reason not reported|1|||
125163793|NCT01083810|450222787|FG002|Overall Study|Reason not reported|1|||
125163794|NCT01083810|450222785|FG000|Overall Study|Non-compliance|4|||
125163795|NCT01083810|450222786|FG001|Overall Study|Non-compliance|7|||
125163796|NCT01083810|450222787|FG002|Overall Study|Non-compliance|2|||
125163797|NCT01083810|450222785|FG000|Overall Study|Simplification|4|||
125163798|NCT01083810|450222786|FG001|Overall Study|Simplification|1|||
125163799|NCT01083810|450222787|FG002|Overall Study|Simplification|0|||
125163800|NCT01083810|450222785|FG000|Overall Study|Death|2|||
125163801|NCT01083810|450222786|FG001|Overall Study|Death|2|||
125163802|NCT01083810|450222787|FG002|Overall Study|Death|3|||
125163803|NCT01083810|450222785|FG000|Overall Study|Co-morbidities|1|||
125163804|NCT01083810|450222786|FG001|Overall Study|Co-morbidities|0|||
125163805|NCT01083810|450222787|FG002|Overall Study|Co-morbidities|0|||
125163806|NCT01083810|450222785|FG000|Overall Study|Participation in study|1|||
125163807|NCT01083810|450222786|FG001|Overall Study|Participation in study|0|||
125163808|NCT01083810|450222787|FG002|Overall Study|Participation in study|0|||
125163809|NCT01083810|450222785|FG000|Overall Study|Therapy break|1|||
125163810|NCT01083810|450222786|FG001|Overall Study|Therapy break|2|||
125163811|NCT01083810|450222787|FG002|Overall Study|Therapy break|2|||
125163812|NCT01083810|450222785|FG000|Overall Study|Virologic failure|1|||
125163813|NCT01083810|450222786|FG001|Overall Study|Virologic failure|8|||
125163814|NCT01083810|450222787|FG002|Overall Study|Virologic failure|0|||
125163815|NCT01629966|450222788|FG000|Overall Study|Pregnancy|0|||
125163816|NCT01629966|450222789|FG001|Overall Study|Pregnancy|1|||
125163817|NCT01629966|450222790|FG002|Overall Study|Pregnancy|0|||
125163818|NCT01629966|450222788|FG000|Overall Study|Lost to Follow-up|10|||
125163819|NCT01629966|450222789|FG001|Overall Study|Lost to Follow-up|13|||
125163820|NCT01629966|450222790|FG002|Overall Study|Lost to Follow-up|9|||
125163821|NCT01629966|450222788|FG000|Overall Study|Withdrawal by Subject|8|||
125163822|NCT01629966|450222789|FG001|Overall Study|Withdrawal by Subject|9|||
125163823|NCT01629966|450222790|FG002|Overall Study|Withdrawal by Subject|16|||
125163824|NCT01629966|450222788|FG000|Overall Study|Protocol Violation|7|||
125163825|NCT01629966|450222789|FG001|Overall Study|Protocol Violation|9|||
125163826|NCT01629966|450222790|FG002|Overall Study|Protocol Violation|7|||
125163827|NCT01629966|450222788|FG000|Overall Study|Lack of Efficacy|5|||
125163828|NCT01629966|450222789|FG001|Overall Study|Lack of Efficacy|2|||
125163829|NCT01629966|450222790|FG002|Overall Study|Lack of Efficacy|4|||
125163830|NCT01629966|450222788|FG000|Overall Study|Adverse Event|11|||
125163831|NCT01629966|450222789|FG001|Overall Study|Adverse Event|18|||
125163832|NCT01629966|450222790|FG002|Overall Study|Adverse Event|30|||
125163833|NCT00477295|450222793|FG000|Overall Study|Adverse Event|31|||
125163834|NCT00477295|450222794|FG001|Overall Study|Adverse Event|35|||
125163835|NCT00477295|450222793|FG000|Overall Study|Withdrawal by Subject|35|||
125163836|NCT00477295|450222794|FG001|Overall Study|Withdrawal by Subject|24|||
125163837|NCT00477295|450222793|FG000|Overall Study|Lack of Efficacy|23|||
125163838|NCT00477295|450222794|FG001|Overall Study|Lack of Efficacy|23|||
125163839|NCT00477295|450222793|FG000|Overall Study|Protocol Violation|3|||
125163840|NCT00477295|450222794|FG001|Overall Study|Protocol Violation|8|||
125163841|NCT00477295|450222793|FG000|Overall Study|Physician Decision|4|||
125163842|NCT00477295|450222794|FG001|Overall Study|Physician Decision|5|||
125163843|NCT00477295|450222793|FG000|Overall Study|Lost to Follow-up|21|||
125163844|NCT00477295|450222794|FG001|Overall Study|Lost to Follow-up|11|||
125163845|NCT00477295|450222793|FG000|Overall Study|Other|4|||
125163846|NCT00477295|450222794|FG001|Overall Study|Other|3|||
125163847|NCT04568031|450222795|FG000|Overall Study|Lost to Follow-up|1|||
125163848|NCT04568031|450222796|FG001|Overall Study|Lost to Follow-up|0|||
125163849|NCT04568031|450222797|FG002|Overall Study|Lost to Follow-up|0|||
125163850|NCT04568031|450222798|FG003|Overall Study|Lost to Follow-up|0|||
125163851|NCT04568031|450222795|FG000|Overall Study|Physician Decision|1|||
125163852|NCT04568031|450222796|FG001|Overall Study|Physician Decision|0|||
125163853|NCT04568031|450222797|FG002|Overall Study|Physician Decision|1|||
125163854|NCT04568031|450222798|FG003|Overall Study|Physician Decision|0|||
125163855|NCT04568031|450222795|FG000|Overall Study|Withdrawal by Subject|1|||
125163856|NCT04568031|450222796|FG001|Overall Study|Withdrawal by Subject|0|||
125163857|NCT04568031|450222797|FG002|Overall Study|Withdrawal by Subject|4|||
125163858|NCT04568031|450222798|FG003|Overall Study|Withdrawal by Subject|1|||
125163859|NCT04430855|450222799|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
125163860|NCT04430855|450222800|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
125163861|NCT04430855|450222799|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
125163862|NCT04430855|450222800|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
125163863|NCT04430855|450222799|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
125163864|NCT04430855|450222800|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
125163865|NCT04430855|450222799|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
125163866|NCT04430855|450222800|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
125163867|NCT04430855|450222799|FG000|Period 1 (Weeks 1-12)|Other|0|||
125163868|NCT04430855|450222800|FG001|Period 1 (Weeks 1-12)|Other|1|||
125163869|NCT04430855|450222799|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
125163870|NCT04430855|450222800|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
125163871|NCT04430855|450222799|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
125163872|NCT04430855|450222800|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
125163873|NCT04430855|450222799|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
125163874|NCT04430855|450222800|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
125163875|NCT00390221|450222801|FG000|Overall Study|Lost to Follow-up|0|||
125163876|NCT00390221|450222802|FG001|Overall Study|Lost to Follow-up|3|||
125163877|NCT00390221|450222803|FG002|Overall Study|Lost to Follow-up|0|||
125163878|NCT00390221|450222801|FG000|Overall Study|Adverse Event|1|||
125163879|NCT00390221|450222802|FG001|Overall Study|Adverse Event|4|||
125163880|NCT00390221|450222803|FG002|Overall Study|Adverse Event|3|||
125163881|NCT00390221|450222801|FG000|Overall Study|Investigator Decision|0|||
125163882|NCT00390221|450222802|FG001|Overall Study|Investigator Decision|0|||
125163883|NCT00390221|450222803|FG002|Overall Study|Investigator Decision|1|||
125163884|NCT00390221|450222801|FG000|Overall Study|Withdrawal by Subject|13|||
125163885|NCT00390221|450222802|FG001|Overall Study|Withdrawal by Subject|9|||
125163886|NCT00390221|450222803|FG002|Overall Study|Withdrawal by Subject|7|||
125163887|NCT00390221|450222801|FG000|Overall Study|Subject Non-compliance|1|||
125163888|NCT00390221|450222802|FG001|Overall Study|Subject Non-compliance|0|||
125163889|NCT00390221|450222803|FG002|Overall Study|Subject Non-compliance|2|||
125163890|NCT00390221|450222801|FG000|Overall Study|Other|3|||
125163891|NCT00390221|450222802|FG001|Overall Study|Other|4|||
125163892|NCT00390221|450222803|FG002|Overall Study|Other|2|||
125163893|NCT02533375|450222806|FG000|Overall Study|Lack of Efficacy|3|||
125163894|NCT02533375|450222806|FG000|Overall Study|Adverse Event|2|||
125163895|NCT03258853|450222824|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
125163896|NCT03258853|450222825|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
125163897|NCT03870477|450222826|FG000|Overall Study|Early Study Termination|1|||
125163898|NCT01709838|450222829|FG000|Overall Study|Withdrawal by Subject|21|||
125163899|NCT01709838|450222829|FG000|Overall Study|Lost to Follow-up|16|||
125163900|NCT01709838|450222829|FG000|Overall Study|Pregnancy|10|||
125163901|NCT01709838|450222829|FG000|Overall Study|Subject/guardian decision|8|||
125163902|NCT01709838|450222829|FG000|Overall Study|Adverse Event|4|||
125163903|NCT01709838|450222829|FG000|Overall Study|Physician Decision|4|||
125163904|NCT01709838|450222829|FG000|Overall Study|Death|3|||
125163905|NCT01709838|450222829|FG000|Overall Study|Protocol Violation|1|||
125163906|NCT03753763|450222839|FG000|Overall Study|Adverse Event|2|||
125163907|NCT03753763|450222840|FG001|Overall Study|Adverse Event|0|||
125163908|NCT03753763|450222839|FG000|Overall Study|Withdrawal by Subject|3|||
125163909|NCT03753763|450222840|FG001|Overall Study|Withdrawal by Subject|1|||
125163910|NCT03753763|450222839|FG000|Overall Study|clinical deterioration|1|||
125163911|NCT03753763|450222840|FG001|Overall Study|clinical deterioration|0|||
125163912|NCT00389831|450222841|FG000|Overall Study|Lack of Efficacy|0|||
125163913|NCT00389831|450222842|FG001|Overall Study|Lack of Efficacy|2|||
125163914|NCT00389831|450222841|FG000|Overall Study|Did not receive treatment.|0|||
125163915|NCT00389831|450222842|FG001|Overall Study|Did not receive treatment.|2|||
125163916|NCT00389831|450222841|FG000|Overall Study|Other reasons|0|||
125163917|NCT00389831|450222842|FG001|Overall Study|Other reasons|2|||
125163918|NCT00389831|450222841|FG000|Overall Study|Lost to Follow-up|0|||
125163919|NCT00389831|450222842|FG001|Overall Study|Lost to Follow-up|1|||
125163920|NCT03433755|450222843|FG000|Overall Study|Lost to Follow-up|1|||
125163921|NCT03433755|450222844|FG001|Overall Study|Lost to Follow-up|0|||
125163922|NCT03433755|450222845|FG002|Overall Study|Lost to Follow-up|0|||
125163923|NCT03433755|450222846|FG003|Overall Study|Lost to Follow-up|0|||
125163924|NCT03433755|450222843|FG000|Overall Study|Decision by Sponsor|1|||
125163925|NCT03433755|450222844|FG001|Overall Study|Decision by Sponsor|0|||
125163926|NCT03433755|450222845|FG002|Overall Study|Decision by Sponsor|0|||
125225276|NCT00810199|450452116|FG000|Overall Study|Failure to return|1|||
125225277|NCT00810199|450452117|FG001|Overall Study|Failure to return|4|||
125163927|NCT03433755|450222846|FG003|Overall Study|Decision by Sponsor|0|||
125163928|NCT04941729|450225021|FG000|Overall Study|Death|0|||
125163929|NCT04941729|450225022|FG001|Overall Study|Death|1|||
125163930|NCT04941729|450225021|FG000|Overall Study|Study terminated by sponsor|11|||
125225278|NCT00810199|450452116|FG000|Overall Study|Did not receive study drug|2|||
125163931|NCT04941729|450225022|FG001|Overall Study|Study terminated by sponsor|10|||
125163932|NCT03190330|450225023|FG000|Overall Study|Adverse Event|2|||
125163933|NCT03190330|450225023|FG000|Overall Study|Death|10|||
125163934|NCT03190330|450225023|FG000|Overall Study|Lost to Follow-up|1|||
125163935|NCT03190330|450225023|FG000|Overall Study|Withdrawal by Subject|6|||
125163936|NCT03190330|450225023|FG000|Overall Study|Progressive Disease|1|||
125163937|NCT00006721|450225024|FG000|Overall Study|Adverse Event|0|||
125163938|NCT00006721|450225025|FG001|Overall Study|Adverse Event|4|||
125163939|NCT00006721|450225026|FG002|Overall Study|Adverse Event|4|||
125163940|NCT00006721|450225024|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
125163941|NCT00006721|450225025|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
125163942|NCT00006721|450225026|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
125163943|NCT00006721|450225024|FG000|Overall Study|Progression/Relapse|0|||
125163944|NCT00006721|450225025|FG001|Overall Study|Progression/Relapse|1|||
125163945|NCT00006721|450225026|FG002|Overall Study|Progression/Relapse|2|||
125163946|NCT00006721|450225024|FG000|Overall Study|Death|0|||
125163947|NCT00006721|450225025|FG001|Overall Study|Death|1|||
125163948|NCT00006721|450225026|FG002|Overall Study|Death|2|||
125163949|NCT00006721|450225024|FG000|Overall Study|Other - Not Protocol Specified|0|||
125163950|NCT00006721|450225025|FG001|Overall Study|Other - Not Protocol Specified|7|||
125163951|NCT00006721|450225026|FG002|Overall Study|Other - Not Protocol Specified|7|||
125163952|NCT00006721|450225024|FG000|Overall Study|Ineligible|2|||
125163953|NCT00006721|450225025|FG001|Overall Study|Ineligible|12|||
125163954|NCT00006721|450225026|FG002|Overall Study|Ineligible|10|||
125163955|NCT00006721|450225024|FG000|Overall Study|Eligible but no Treatment Received|1|||
125163956|NCT00006721|450225025|FG001|Overall Study|Eligible but no Treatment Received|0|||
125225279|NCT00810199|450452117|FG001|Overall Study|Did not receive study drug|1|||
125163957|NCT00006721|450225026|FG002|Overall Study|Eligible but no Treatment Received|0|||
125163958|NCT02081209|450225027|FG000|Overall Study|Withdrawal by Subject|1|||
125163959|NCT00191113|450225038|FG000|Core Study|Withdrawal by Subject|25|||
125163960|NCT00191113|450225039|FG001|Core Study|Withdrawal by Subject|9|||
125163961|NCT00191113|450225038|FG000|Core Study|Protocol Violation|6|||
125163962|NCT00191113|450225039|FG001|Core Study|Protocol Violation|2|||
125225280|NCT00715403|450452118|FG000|Overall Study|Progressive disease|0|||
125225281|NCT00715403|450452119|FG001|Overall Study|Progressive disease|1|||
125225282|NCT00715403|450452120|FG002|Overall Study|Progressive disease|3|||
125225283|NCT00715403|450452121|FG003|Overall Study|Progressive disease|9|||
125225284|NCT00715403|450452122|FG004|Overall Study|Progressive disease|5|||
125225285|NCT00715403|450452123|FG005|Overall Study|Progressive disease|14|||
125225286|NCT00715403|450452124|FG006|Overall Study|Progressive disease|1|||
125225287|NCT00715403|450452118|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
125225288|NCT00715403|450452119|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
125225289|NCT00715403|450452120|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
125225290|NCT00715403|450452121|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
125225291|NCT00715403|450452122|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
125225292|NCT00715403|450452123|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
125225293|NCT00715403|450452124|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
125225294|NCT00715403|450452118|FG000|Overall Study|Other Adverse Event than DLT|1|||
125225295|NCT00715403|450452119|FG001|Overall Study|Other Adverse Event than DLT|0|||
125225296|NCT00715403|450452120|FG002|Overall Study|Other Adverse Event than DLT|0|||
125225297|NCT00715403|450452121|FG003|Overall Study|Other Adverse Event than DLT|0|||
125225298|NCT00715403|450452122|FG004|Overall Study|Other Adverse Event than DLT|0|||
125225299|NCT00715403|450452123|FG005|Overall Study|Other Adverse Event than DLT|2|||
125225300|NCT00715403|450452124|FG006|Overall Study|Other Adverse Event than DLT|0|||
125225301|NCT00715403|450452118|FG000|Overall Study|Protocol Violation|0|||
125225302|NCT00715403|450452119|FG001|Overall Study|Protocol Violation|0|||
125225303|NCT00715403|450452120|FG002|Overall Study|Protocol Violation|0|||
125225304|NCT00715403|450452121|FG003|Overall Study|Protocol Violation|0|||
125225305|NCT00715403|450452122|FG004|Overall Study|Protocol Violation|0|||
125225306|NCT00715403|450452123|FG005|Overall Study|Protocol Violation|1|||
125225307|NCT00715403|450452124|FG006|Overall Study|Protocol Violation|0|||
125225308|NCT00715403|450452118|FG000|Overall Study|Other reason not defined above|0|||
125225309|NCT00715403|450452119|FG001|Overall Study|Other reason not defined above|0|||
125225310|NCT00715403|450452120|FG002|Overall Study|Other reason not defined above|1|||
125225311|NCT00715403|450452121|FG003|Overall Study|Other reason not defined above|0|||
125225312|NCT00715403|450452122|FG004|Overall Study|Other reason not defined above|1|||
125225313|NCT00715403|450452123|FG005|Overall Study|Other reason not defined above|1|||
125163963|NCT00191113|450225038|FG000|Core Study|Lost to Follow-up|3|||
125163964|NCT00191113|450225039|FG001|Core Study|Lost to Follow-up|0|||
125163965|NCT00191113|450225038|FG000|Core Study|Adverse Event|0|||
125163966|NCT00191113|450225039|FG001|Core Study|Adverse Event|2|||
125163967|NCT00191113|450225038|FG000|Core Study|Lack of Efficacy|0|||
125163968|NCT00191113|450225039|FG001|Core Study|Lack of Efficacy|2|||
125163969|NCT00191113|450225038|FG000|Core Study|Death|1|||
125163970|NCT00191113|450225039|FG001|Core Study|Death|0|||
125225314|NCT00715403|450452124|FG006|Overall Study|Other reason not defined above|0|||
125225315|NCT02175225|450452125|FG000|Overall Study|Withdrawal by Subject|1|||
125225316|NCT02175225|450452126|FG001|Overall Study|Withdrawal by Subject|2|||
125163971|NCT03786718|450225042|FG000|Overall Study|Lost to Follow-up|3|||
125163972|NCT03786718|450225042|FG000|Overall Study|Withdrawal by Subject|1|||
125163973|NCT03786718|450225042|FG000|Overall Study|Did not use the intervention|2|||
125163974|NCT03786718|450225042|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
125163975|NCT00368979|450225043|FG000|Overall Study|Adverse Event|9|||
125163976|NCT00368979|450225044|FG001|Overall Study|Adverse Event|16|||
125163977|NCT00368979|450225043|FG000|Overall Study|Lack of Efficacy|5|||
125163978|NCT00368979|450225044|FG001|Overall Study|Lack of Efficacy|3|||
125163979|NCT00368979|450225043|FG000|Overall Study|Other|3|||
125163980|NCT00368979|450225044|FG001|Overall Study|Other|1|||
125163981|NCT00368979|450225043|FG000|Overall Study|Lost to Follow-up|1|||
125225317|NCT02175225|450452125|FG000|Overall Study|Lost to Follow-up|6|||
125225318|NCT02175225|450452126|FG001|Overall Study|Lost to Follow-up|7|||
125225319|NCT02175225|450452125|FG000|Overall Study|Study drug not administered|1|||
125163982|NCT00368979|450225044|FG001|Overall Study|Lost to Follow-up|0|||
125163983|NCT00368979|450225043|FG000|Overall Study|Protocol Violation|2|||
125163984|NCT00368979|450225044|FG001|Overall Study|Protocol Violation|1|||
125163985|NCT00368979|450225043|FG000|Overall Study|Withdrawal by Subject|5|||
125225320|NCT02175225|450452126|FG001|Overall Study|Study drug not administered|2|||
125225321|NCT01883895|450452127|FG000|Overall Study|Lost to Follow-up|2|||
125225322|NCT00807365|450452128|FG000|Overall Study|Study Terminated|5|||
125225323|NCT03810456|450452129|FG000|Treatment|Urgent Family Matters|3|||
125225324|NCT03810456|450452130|FG001|Treatment|Urgent Family Matters|0|||
125225325|NCT03810456|450452131|FG002|Treatment|Urgent Family Matters|0|||
125225326|NCT03810456|450452129|FG000|Treatment|Scheduling Conflicts|0|||
125163986|NCT00368979|450225044|FG001|Overall Study|Withdrawal by Subject|9|||
125163987|NCT01570686|450225057|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125163988|NCT01570686|450225058|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125163989|NCT01570686|450225057|FG000|Overall Study|Administrative problems|0|||
125163990|NCT01570686|450225058|FG001|Overall Study|Administrative problems|1|||
125163991|NCT01570686|450225057|FG000|Overall Study|Adverse Event|8|||
125163992|NCT01570686|450225058|FG001|Overall Study|Adverse Event|6|||
125163993|NCT01570686|450225057|FG000|Overall Study|Lost to Follow-up|4|||
125163994|NCT01570686|450225058|FG001|Overall Study|Lost to Follow-up|3|||
125163995|NCT01570686|450225057|FG000|Overall Study|Protocol Deviation|3|||
125163996|NCT01570686|450225058|FG001|Overall Study|Protocol Deviation|0|||
125163997|NCT01570686|450225057|FG000|Overall Study|Withdrawal by Subject|4|||
125163998|NCT01570686|450225058|FG001|Overall Study|Withdrawal by Subject|4|||
125163999|NCT01570686|450225057|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125164000|NCT01570686|450225058|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125164001|NCT01136967|450225062|FG000|Overall Study|Adverse Event|9|||
125164002|NCT01136967|450225063|FG001|Overall Study|Adverse Event|12|||
125164003|NCT01136967|450225062|FG000|Overall Study|Participant Choice|8|||
125164004|NCT01136967|450225063|FG001|Overall Study|Participant Choice|3|||
125164005|NCT01136967|450225062|FG000|Overall Study|Lost to Follow-up|0|||
125164006|NCT01136967|450225063|FG001|Overall Study|Lost to Follow-up|1|||
125164007|NCT01136967|450225062|FG000|Overall Study|Withdrawal by Subject|1|||
125164008|NCT01136967|450225063|FG001|Overall Study|Withdrawal by Subject|2|||
125164009|NCT01136967|450225062|FG000|Overall Study|Clinical Progression|3|||
125164010|NCT01136967|450225063|FG001|Overall Study|Clinical Progression|5|||
125164011|NCT01136967|450225062|FG000|Overall Study|Radiation|1|||
125164012|NCT01136967|450225063|FG001|Overall Study|Radiation|0|||
125164013|NCT01136967|450225062|FG000|Overall Study|Non-compliance|1|||
125164014|NCT01136967|450225063|FG001|Overall Study|Non-compliance|0|||
125164015|NCT01136967|450225062|FG000|Overall Study|Investigator's Choice|1|||
125164016|NCT01136967|450225063|FG001|Overall Study|Investigator's Choice|1|||
125164017|NCT01136967|450225062|FG000|Overall Study|Increase in Lesion Size|0|||
125164018|NCT01136967|450225063|FG001|Overall Study|Increase in Lesion Size|2|||
125164019|NCT01136967|450225062|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
125164020|NCT01136967|450225063|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
125164021|NCT02885181|450225064|FG000|Overall Study|Investigator's Discretion|0|||
125164022|NCT02885181|450225065|FG001|Overall Study|Investigator's Discretion|1|||
125164023|NCT02885181|450225066|FG002|Overall Study|Investigator's Discretion|0|||
125164024|NCT02885181|450225067|FG003|Overall Study|Investigator's Discretion|1|||
125164025|NCT02885181|450225064|FG000|Overall Study|Adverse Event|0|||
125164026|NCT02885181|450225065|FG001|Overall Study|Adverse Event|0|||
125164027|NCT02885181|450225066|FG002|Overall Study|Adverse Event|0|||
125164028|NCT02885181|450225067|FG003|Overall Study|Adverse Event|1|||
125164029|NCT02885181|450225064|FG000|Overall Study|Withdrawal by Subject|0|||
125164030|NCT02885181|450225065|FG001|Overall Study|Withdrawal by Subject|0|||
125164031|NCT02885181|450225066|FG002|Overall Study|Withdrawal by Subject|0|||
125164032|NCT02885181|450225067|FG003|Overall Study|Withdrawal by Subject|1|||
125164033|NCT03327792|450225068|FG000|Overall Study|Adverse Event|4|||
125164034|NCT03327792|450225069|FG001|Overall Study|Adverse Event|0|||
125164035|NCT03327792|450225068|FG000|Overall Study|Family/Personal issues|3|||
125164036|NCT03327792|450225069|FG001|Overall Study|Family/Personal issues|2|||
125164037|NCT03327792|450225068|FG000|Overall Study|Lost to Follow-up|0|||
125164038|NCT03327792|450225069|FG001|Overall Study|Lost to Follow-up|1|||
125164039|NCT00123474|450225079|FG000|Randomized to Treatment|Randomized, never treated|1|||
125164040|NCT00123474|450225080|FG001|Randomized to Treatment|Randomized, never treated|4|||
125164041|NCT00123474|450225081|FG002|Randomized to Treatment|Randomized, never treated|2|||
125164042|NCT00123474|450225082|FG003|Randomized to Treatment|Randomized, never treated|1|||
125164043|NCT00123474|450225079|FG000|As Treated at Study Closure|not reported when site closed|1|||
125225327|NCT03810456|450452130|FG001|Treatment|Scheduling Conflicts|11|||
125225328|NCT03810456|450452131|FG002|Treatment|Scheduling Conflicts|0|||
125225329|NCT03810456|450452129|FG000|Treatment|No Longer Interested|0|||
125225330|NCT03810456|450452130|FG001|Treatment|No Longer Interested|12|||
125225331|NCT03810456|450452131|FG002|Treatment|No Longer Interested|0|||
125225332|NCT03810456|450452129|FG000|Treatment|Transportation Issues|0|||
125225333|NCT03810456|450452130|FG001|Treatment|Transportation Issues|1|||
125225334|NCT03810456|450452131|FG002|Treatment|Transportation Issues|0|||
125225335|NCT03810456|450452129|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
125225336|NCT03810456|450452130|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
125225337|NCT03810456|450452131|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
125225338|NCT03810456|450452129|FG000|1 Month Follow-Up|Relocated to Different State|1|||
125225339|NCT03810456|450452130|FG001|1 Month Follow-Up|Relocated to Different State|0|||
125225340|NCT03810456|450452131|FG002|1 Month Follow-Up|Relocated to Different State|1|||
125225341|NCT03810456|450452129|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
125164044|NCT00123474|450225080|FG001|As Treated at Study Closure|not reported when site closed|0|||
125164045|NCT00123474|450225081|FG002|As Treated at Study Closure|not reported when site closed|1|||
125164046|NCT00123474|450225082|FG003|As Treated at Study Closure|not reported when site closed|0|||
125164047|NCT00123474|450225079|FG000|As Treated at Study Closure|Adverse Event|10|||
125164048|NCT00123474|450225080|FG001|As Treated at Study Closure|Adverse Event|4|||
125164049|NCT00123474|450225081|FG002|As Treated at Study Closure|Adverse Event|10|||
125164050|NCT00123474|450225082|FG003|As Treated at Study Closure|Adverse Event|8|||
125164051|NCT00123474|450225079|FG000|As Treated at Study Closure|Disease Progression|35|||
125164052|NCT00123474|450225080|FG001|As Treated at Study Closure|Disease Progression|42|||
125164053|NCT00123474|450225081|FG002|As Treated at Study Closure|Disease Progression|29|||
125164054|NCT00123474|450225082|FG003|As Treated at Study Closure|Disease Progression|27|||
125164055|NCT00123474|450225079|FG000|As Treated at Study Closure|Investigator Request|12|||
125164056|NCT00123474|450225080|FG001|As Treated at Study Closure|Investigator Request|6|||
125164057|NCT00123474|450225081|FG002|As Treated at Study Closure|Investigator Request|7|||
125164058|NCT00123474|450225082|FG003|As Treated at Study Closure|Investigator Request|5|||
125164059|NCT00123474|450225079|FG000|As Treated at Study Closure|non-specified|54|||
125164060|NCT00123474|450225080|FG001|As Treated at Study Closure|non-specified|47|||
125164061|NCT00123474|450225081|FG002|As Treated at Study Closure|non-specified|57|||
125164062|NCT00123474|450225082|FG003|As Treated at Study Closure|non-specified|60|||
125164063|NCT00123474|450225079|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
125164064|NCT00123474|450225080|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
125164065|NCT00123474|450225081|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
125164066|NCT00123474|450225082|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
125164067|NCT00123474|450225079|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
125164068|NCT00123474|450225080|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
125164069|NCT00123474|450225081|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
125164070|NCT00123474|450225082|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
125164071|NCT01059344|450225083|FG000|Overall Study|Adverse Event|12|||
125164072|NCT01059344|450225084|FG001|Overall Study|Adverse Event|30|||
125164073|NCT01059344|450225083|FG000|Overall Study|Withdrawal by Subject|6|||
125164074|NCT01059344|450225084|FG001|Overall Study|Withdrawal by Subject|9|||
125164075|NCT01059344|450225083|FG000|Overall Study|Lost to Follow-up|1|||
125164076|NCT01059344|450225084|FG001|Overall Study|Lost to Follow-up|1|||
125164077|NCT01059344|450225083|FG000|Overall Study|Other|3|||
125164078|NCT01059344|450225084|FG001|Overall Study|Other|6|||
125164079|NCT00742924|450225085|FG000|Overall Study|Adverse Event|0|||
125164080|NCT00742924|450225086|FG001|Overall Study|Adverse Event|0|||
125164081|NCT00742924|450225087|FG002|Overall Study|Adverse Event|1|||
125164082|NCT00742924|450225088|FG003|Overall Study|Adverse Event|1|||
125164083|NCT00742924|450225085|FG000|Overall Study|Lack of Efficacy|5|||
125164084|NCT00742924|450225086|FG001|Overall Study|Lack of Efficacy|1|||
125164085|NCT00742924|450225087|FG002|Overall Study|Lack of Efficacy|2|||
125164086|NCT00742924|450225088|FG003|Overall Study|Lack of Efficacy|4|||
125164087|NCT00742924|450225085|FG000|Overall Study|Physician Decision|0|||
125164088|NCT00742924|450225086|FG001|Overall Study|Physician Decision|0|||
125164089|NCT00742924|450225087|FG002|Overall Study|Physician Decision|0|||
125164090|NCT00742924|450225088|FG003|Overall Study|Physician Decision|1|||
125164091|NCT00742924|450225085|FG000|Overall Study|Withdrawal by Subject|0|||
125164092|NCT00742924|450225086|FG001|Overall Study|Withdrawal by Subject|1|||
125164093|NCT00742924|450225087|FG002|Overall Study|Withdrawal by Subject|1|||
125164094|NCT00742924|450225088|FG003|Overall Study|Withdrawal by Subject|0|||
125164095|NCT00660400|450225089|FG000|Overall Study|Lack of insurance approval|1|||
125164096|NCT00660400|450225089|FG000|Overall Study|Suboptimal organ function|1|||
125164097|NCT00660400|450225089|FG000|Overall Study|Intracranial hemorrhage|1|||
125164098|NCT00660400|450225089|FG000|Overall Study|Withdrawal by Subject|1|||
125164099|NCT00528411|450225091|FG000|Overall Study|Adverse Event|4|||
125164100|NCT00528411|450225092|FG001|Overall Study|Adverse Event|0|||
125164101|NCT00528411|450225093|FG002|Overall Study|Adverse Event|1|||
125164102|NCT00528411|450225091|FG000|Overall Study|Incorrect Enrolment|1|||
125164103|NCT00528411|450225092|FG001|Overall Study|Incorrect Enrolment|1|||
125164104|NCT00528411|450225093|FG002|Overall Study|Incorrect Enrolment|0|||
125164105|NCT00528411|450225091|FG000|Overall Study|Severe non-compliance to protocol|0|||
125164106|NCT00528411|450225092|FG001|Overall Study|Severe non-compliance to protocol|1|||
125164107|NCT00528411|450225093|FG002|Overall Study|Severe non-compliance to protocol|0|||
125164108|NCT00528411|450225091|FG000|Overall Study|Prior commitment medication|0|||
125164109|NCT00528411|450225092|FG001|Overall Study|Prior commitment medication|1|||
125164110|NCT00528411|450225093|FG002|Overall Study|Prior commitment medication|0|||
125164111|NCT02643355|450225094|FG000|Overall Study|Withdrawal by Subject|1|||
125164112|NCT02643355|450225095|FG001|Overall Study|Withdrawal by Subject|3|||
125164113|NCT02643355|450225094|FG000|Overall Study|Protocol Violation|0|||
125164114|NCT02643355|450225095|FG001|Overall Study|Protocol Violation|2|||
125164115|NCT01715571|450225096|FG000|Overall Study|Lost to Follow-up|8|||
125164116|NCT04524364|450225101|FG000|Overall Study|Physician Decision|3|||
125164117|NCT04524364|450225102|FG001|Overall Study|Physician Decision|6|||
125164118|NCT04524364|450225101|FG000|Overall Study|Adverse Event|0|||
125164119|NCT04524364|450225102|FG001|Overall Study|Adverse Event|1|||
125164120|NCT04524364|450225101|FG000|Overall Study|Investigational device deficiency|0|||
125164121|NCT04524364|450225102|FG001|Overall Study|Investigational device deficiency|1|||
125164122|NCT04524364|450225101|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
125164123|NCT04524364|450225102|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
125164124|NCT04524364|450225101|FG000|Overall Study|Device unavailability|0|||
125164125|NCT04524364|450225102|FG001|Overall Study|Device unavailability|2|||
125164126|NCT04524364|450225101|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
125164127|NCT04524364|450225102|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
125164128|NCT04524364|450225101|FG000|Overall Study|Low International normalized ratio (INR)|1|||
125164129|NCT04524364|450225102|FG001|Overall Study|Low International normalized ratio (INR)|0|||
125164130|NCT00826449|450225103|FG000|Overall Study|Disease Progression|4|||
125164131|NCT00826449|450225103|FG000|Overall Study|Withdrawal by Subject|1|||
125164132|NCT02994940|450225104|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
125164133|NCT02994940|450225105|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
125164134|NCT02994940|450225104|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
125164135|NCT02994940|450225105|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
125164136|NCT02994940|450225104|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
125164137|NCT02994940|450225105|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
125164138|NCT03233230|450225106|FG000|Overall Study|Adverse Event|6|||
125164139|NCT03233230|450225107|FG001|Overall Study|Adverse Event|3|||
125164140|NCT03233230|450225108|FG002|Overall Study|Adverse Event|6|||
125164141|NCT03233230|450225109|FG003|Overall Study|Adverse Event|3|||
125164142|NCT03233230|450225106|FG000|Overall Study|Protocol Violation|1|||
125164143|NCT03233230|450225107|FG001|Overall Study|Protocol Violation|2|||
125164144|NCT03233230|450225108|FG002|Overall Study|Protocol Violation|1|||
125164145|NCT03233230|450225109|FG003|Overall Study|Protocol Violation|1|||
125225342|NCT03810456|450452130|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
125225343|NCT03810456|450452131|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
125225344|NCT03810456|450452129|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
125164146|NCT03233230|450225106|FG000|Overall Study|Lack of Efficacy|1|||
125164147|NCT03233230|450225107|FG001|Overall Study|Lack of Efficacy|0|||
125164148|NCT03233230|450225108|FG002|Overall Study|Lack of Efficacy|0|||
125164149|NCT03233230|450225109|FG003|Overall Study|Lack of Efficacy|0|||
125164150|NCT03233230|450225106|FG000|Overall Study|Other|5|||
125164151|NCT03233230|450225107|FG001|Overall Study|Other|5|||
125164152|NCT03233230|450225108|FG002|Overall Study|Other|5|||
125164153|NCT03233230|450225109|FG003|Overall Study|Other|3|||
125164154|NCT03233230|450225106|FG000|Overall Study|Withdrawal by Subject|2|||
125164155|NCT03233230|450225107|FG001|Overall Study|Withdrawal by Subject|2|||
125164156|NCT03233230|450225108|FG002|Overall Study|Withdrawal by Subject|0|||
125164157|NCT03233230|450225109|FG003|Overall Study|Withdrawal by Subject|1|||
125225345|NCT03810456|450452130|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
125225346|NCT03810456|450452131|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
125225347|NCT03810456|450452129|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
125225348|NCT03810456|450452130|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
125225349|NCT03810456|450452131|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
125225350|NCT03810456|450452129|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
125225351|NCT03810456|450452130|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
125225352|NCT03810456|450452131|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
125225353|NCT03810456|450452129|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
125225354|NCT03810456|450452130|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
125225355|NCT03810456|450452131|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
125225356|NCT01094288|450454231|FG000|Overall Study|Adverse Event|0|||
125225357|NCT01094288|450454232|FG001|Overall Study|Adverse Event|3|||
125164158|NCT03233230|450225106|FG000|Overall Study|Lost to Follow-up|0|||
125164159|NCT03233230|450225107|FG001|Overall Study|Lost to Follow-up|3|||
125164160|NCT03233230|450225108|FG002|Overall Study|Lost to Follow-up|0|||
125164161|NCT03233230|450225109|FG003|Overall Study|Lost to Follow-up|0|||
125164162|NCT02987959|450225114|FG000|Overall Study|Grantor stopped supply of drugs|6|||
125164163|NCT04126213|450225117|FG000|Overall Study|Lost to Follow-up|9|||
125164164|NCT04126213|450225118|FG001|Overall Study|Lost to Follow-up|1|||
125164165|NCT04126213|450225119|FG002|Overall Study|Lost to Follow-up|5|||
125164166|NCT04126213|450225120|FG003|Overall Study|Lost to Follow-up|10|||
125164167|NCT04126213|450225121|FG004|Overall Study|Lost to Follow-up|4|||
125164168|NCT04126213|450225122|FG005|Overall Study|Lost to Follow-up|7|||
125164169|NCT04126213|450225117|FG000|Overall Study|Withdrawal by Subject|3|||
125164170|NCT04126213|450225118|FG001|Overall Study|Withdrawal by Subject|2|||
125164171|NCT04126213|450225119|FG002|Overall Study|Withdrawal by Subject|1|||
125164172|NCT04126213|450225120|FG003|Overall Study|Withdrawal by Subject|1|||
125164173|NCT04126213|450225121|FG004|Overall Study|Withdrawal by Subject|1|||
125164174|NCT04126213|450225122|FG005|Overall Study|Withdrawal by Subject|1|||
125164175|NCT04126213|450225117|FG000|Overall Study|Other|0|||
125164176|NCT04126213|450225118|FG001|Overall Study|Other|0|||
125164177|NCT04126213|450225119|FG002|Overall Study|Other|2|||
125164178|NCT04126213|450225120|FG003|Overall Study|Other|2|||
125164179|NCT04126213|450225121|FG004|Overall Study|Other|0|||
125164180|NCT04126213|450225122|FG005|Overall Study|Other|1|||
125164181|NCT04126213|450225117|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125164182|NCT04126213|450225118|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
125164183|NCT04126213|450225119|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125164184|NCT04126213|450225120|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125164185|NCT04126213|450225121|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125164186|NCT04126213|450225122|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
125164187|NCT02853370|450225123|FG000|Overall Study|Physician Decision|1|||
125164188|NCT02853370|450225123|FG000|Overall Study|Lack of Efficacy|2|||
125164189|NCT02853370|450225123|FG000|Overall Study|Death|1|||
125164190|NCT02853370|450225123|FG000|Overall Study|Adverse Event|4|||
125164191|NCT02853370|450225123|FG000|Overall Study|Withdrawal by Subject|3|||
125225358|NCT01094288|450454233|FG002|Overall Study|Adverse Event|1|||
125225359|NCT01094288|450454234|FG003|Overall Study|Adverse Event|1|||
125164192|NCT02196701|450225124|FG000|Overall Study|Adverse Event|1|||
125164193|NCT02196701|450225124|FG000|Overall Study|Lost to Follow-up|1|||
125164194|NCT02196701|450225124|FG000|Overall Study|Non-adherence to Protocol|1|||
125164195|NCT03275064|450225129|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
125164196|NCT03275064|450225130|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
125164197|NCT03275064|450225131|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
125164198|NCT03275064|450225132|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
125164199|NCT03275064|450225133|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
125164200|NCT03275064|450225129|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
125225360|NCT01094288|450454235|FG004|Overall Study|Adverse Event|0|||
125164201|NCT03275064|450225130|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
125164202|NCT03275064|450225131|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
125164203|NCT03275064|450225132|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
125164204|NCT03275064|450225133|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
125164205|NCT03275064|450225129|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
125164206|NCT03275064|450225130|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
125164207|NCT03275064|450225131|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
125164208|NCT03275064|450225132|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
125164209|NCT03275064|450225133|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
125164210|NCT03275064|450225129|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
125164211|NCT03275064|450225130|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
125164212|NCT03275064|450225131|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
125164213|NCT03275064|450225132|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
125164214|NCT03275064|450225133|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
125164215|NCT03275064|450225129|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
125164216|NCT03275064|450225130|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
125164217|NCT03275064|450225131|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
125164218|NCT03275064|450225132|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
125225361|NCT01094288|450454236|FG005|Overall Study|Adverse Event|0|||
125225362|NCT01094288|450454237|FG006|Overall Study|Adverse Event|0|||
125164219|NCT03275064|450225133|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
125164220|NCT04159935|450225134|FG000|Overall Study|Study terminated due to COVID-19|1|||
125164221|NCT04159935|450225135|FG001|Overall Study|Study terminated due to COVID-19|3|||
125164222|NCT01341782|450225136|FG000|Overall Study|Adverse Event|1|||
125164223|NCT01341782|450225137|FG001|Overall Study|Adverse Event|1|||
125164224|NCT01341782|450225136|FG000|Overall Study|Withdrawal by Subject|6|||
125164225|NCT01341782|450225137|FG001|Overall Study|Withdrawal by Subject|5|||
125164226|NCT01341782|450225136|FG000|Overall Study|Missed 3 consecutive doses|0|||
125164227|NCT01341782|450225137|FG001|Overall Study|Missed 3 consecutive doses|4|||
125164228|NCT01341782|450225136|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
125164229|NCT01341782|450225137|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
125164230|NCT01341782|450225136|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
125164231|NCT01341782|450225137|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
125164232|NCT01341782|450225136|FG000|Overall Study|Other|5|||
125164233|NCT01341782|450225137|FG001|Overall Study|Other|0|||
125164234|NCT00620555|450225138|FG000|Overall Study|Adverse Event|4|||
125164235|NCT00620555|450225138|FG000|Overall Study|Protocol Violation|2|||
125164236|NCT00620555|450225138|FG000|Overall Study|Lack of Efficacy|12|||
125164237|NCT00620555|450225138|FG000|Overall Study|Withdrawal by Subject|1|||
125164238|NCT00620555|450225138|FG000|Overall Study|Choice of other treatment|1|||
125164239|NCT00620555|450225138|FG000|Overall Study|Visit failure against planned|1|||
125164240|NCT00724048|450225139|FG000|Overall Study|Adverse Event|1|||
125164241|NCT00724048|450225140|FG001|Overall Study|Adverse Event|1|||
125164242|NCT00724048|450225141|FG002|Overall Study|Adverse Event|1|||
125164243|NCT00724048|450225142|FG003|Overall Study|Adverse Event|0|||
125164244|NCT00724048|450225139|FG000|Overall Study|Lost to Follow-up|0|||
125164245|NCT00724048|450225140|FG001|Overall Study|Lost to Follow-up|1|||
125164246|NCT00724048|450225141|FG002|Overall Study|Lost to Follow-up|0|||
125164247|NCT00724048|450225142|FG003|Overall Study|Lost to Follow-up|0|||
125164248|NCT00724048|450225139|FG000|Overall Study|Withdrawal by Subject|1|||
125164249|NCT00724048|450225140|FG001|Overall Study|Withdrawal by Subject|2|||
125164250|NCT00724048|450225141|FG002|Overall Study|Withdrawal by Subject|1|||
125164251|NCT00724048|450225142|FG003|Overall Study|Withdrawal by Subject|2|||
125164252|NCT00724048|450225139|FG000|Overall Study|Investigator decision|0|||
125164253|NCT00724048|450225140|FG001|Overall Study|Investigator decision|0|||
125164254|NCT00724048|450225141|FG002|Overall Study|Investigator decision|1|||
125164255|NCT00724048|450225142|FG003|Overall Study|Investigator decision|0|||
125164256|NCT00724048|450225139|FG000|Overall Study|Did not tolerate study drug|0|||
125164257|NCT00724048|450225140|FG001|Overall Study|Did not tolerate study drug|0|||
125164258|NCT00724048|450225141|FG002|Overall Study|Did not tolerate study drug|0|||
125164259|NCT00724048|450225142|FG003|Overall Study|Did not tolerate study drug|1|||
125164260|NCT00724048|450225139|FG000|Overall Study|Other than specified|1|||
125164261|NCT00724048|450225140|FG001|Overall Study|Other than specified|1|||
125164262|NCT00724048|450225141|FG002|Overall Study|Other than specified|0|||
125164263|NCT00724048|450225142|FG003|Overall Study|Other than specified|0|||
125164264|NCT03923530|450225143|FG000|Overall Study|Withdrawal by Subject|1|||
125164265|NCT03923530|450225143|FG000|Overall Study|screen failure|3|||
125164266|NCT00911807|450225144|FG000|Overall Study|Adverse Event|2|||
125164267|NCT00911807|450225145|FG001|Overall Study|Adverse Event|1|||
125164268|NCT00911807|450225146|FG002|Overall Study|Adverse Event|5|||
125164269|NCT00911807|450225144|FG000|Overall Study|Death|0|||
125164270|NCT00911807|450225145|FG001|Overall Study|Death|0|||
125164271|NCT00911807|450225146|FG002|Overall Study|Death|1|||
125164272|NCT00911807|450225144|FG000|Overall Study|Protocol Violation|6|||
125164273|NCT00911807|450225145|FG001|Overall Study|Protocol Violation|4|||
125164274|NCT00911807|450225146|FG002|Overall Study|Protocol Violation|9|||
125164275|NCT00911807|450225144|FG000|Overall Study|Withdrawal by Subject|8|||
125164276|NCT00911807|450225145|FG001|Overall Study|Withdrawal by Subject|10|||
125164277|NCT00911807|450225146|FG002|Overall Study|Withdrawal by Subject|7|||
125164278|NCT00911807|450225144|FG000|Overall Study|Organizational reasons|1|||
125164279|NCT00911807|450225145|FG001|Overall Study|Organizational reasons|3|||
125164280|NCT00911807|450225146|FG002|Overall Study|Organizational reasons|1|||
125164281|NCT02991430|450225149|FG000|Treatment Period 1|Adverse Event|1|||
125164282|NCT02991430|450225150|FG001|Treatment Period 1|Adverse Event|0|||
125164283|NCT02991430|450225151|FG002|Treatment Period 1|Adverse Event|2|||
125164284|NCT02991430|450225149|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125164285|NCT02991430|450225150|FG001|Treatment Period 1|Withdrawal by Subject|4|||
125164286|NCT02991430|450225151|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125164287|NCT02991430|450225149|FG000|Treatment Period 2|Study Termination|6|||
125164288|NCT02991430|450225150|FG001|Treatment Period 2|Study Termination|3|||
125164289|NCT02991430|450225151|FG002|Treatment Period 2|Study Termination|3|||
125164290|NCT02991430|450225149|FG000|Treatment Period 2|Lost to Follow-up|0|||
125164291|NCT02991430|450225150|FG001|Treatment Period 2|Lost to Follow-up|0|||
125164292|NCT02991430|450225151|FG002|Treatment Period 2|Lost to Follow-up|1|||
125164293|NCT02991430|450225149|FG000|Post-treatment Observation Period|Study Termination|3|||
125164294|NCT02991430|450225150|FG001|Post-treatment Observation Period|Study Termination|6|||
125225363|NCT01094288|450454238|FG007|Overall Study|Adverse Event|0|||
125225364|NCT01094288|450454231|FG000|Overall Study|Withdrawal by Subject|0|||
125225365|NCT01094288|450454232|FG001|Overall Study|Withdrawal by Subject|1|||
125225366|NCT01094288|450454233|FG002|Overall Study|Withdrawal by Subject|2|||
125225367|NCT01094288|450454234|FG003|Overall Study|Withdrawal by Subject|0|||
125225368|NCT01094288|450454235|FG004|Overall Study|Withdrawal by Subject|0|||
125225369|NCT01094288|450454236|FG005|Overall Study|Withdrawal by Subject|0|||
125225370|NCT01094288|450454237|FG006|Overall Study|Withdrawal by Subject|0|||
125225371|NCT01094288|450454238|FG007|Overall Study|Withdrawal by Subject|2|||
125225372|NCT01094288|450454231|FG000|Overall Study|Initiation of Alternative Therapy|0|||
125225373|NCT01094288|450454232|FG001|Overall Study|Initiation of Alternative Therapy|0|||
125225374|NCT01094288|450454233|FG002|Overall Study|Initiation of Alternative Therapy|1|||
125225375|NCT01094288|450454234|FG003|Overall Study|Initiation of Alternative Therapy|0|||
125225376|NCT01094288|450454235|FG004|Overall Study|Initiation of Alternative Therapy|0|||
125225377|NCT01094288|450454236|FG005|Overall Study|Initiation of Alternative Therapy|0|||
125225378|NCT01094288|450454237|FG006|Overall Study|Initiation of Alternative Therapy|0|||
125225379|NCT01094288|450454238|FG007|Overall Study|Initiation of Alternative Therapy|0|||
125225380|NCT01094288|450454231|FG000|Overall Study|Reason not Specified|2|||
125225381|NCT01094288|450454232|FG001|Overall Study|Reason not Specified|3|||
125225382|NCT01094288|450454233|FG002|Overall Study|Reason not Specified|0|||
125225383|NCT01094288|450454234|FG003|Overall Study|Reason not Specified|1|||
125225384|NCT01094288|450454235|FG004|Overall Study|Reason not Specified|0|||
125225385|NCT01094288|450454236|FG005|Overall Study|Reason not Specified|0|||
125225386|NCT01094288|450454237|FG006|Overall Study|Reason not Specified|0|||
125225387|NCT01094288|450454238|FG007|Overall Study|Reason not Specified|0|||
125225388|NCT01094288|450454231|FG000|Overall Study|Ongoing Participants|0|||
125225389|NCT01094288|450454232|FG001|Overall Study|Ongoing Participants|3|||
125225390|NCT01094288|450454233|FG002|Overall Study|Ongoing Participants|0|||
125225391|NCT01094288|450454234|FG003|Overall Study|Ongoing Participants|0|||
125225392|NCT01094288|450454235|FG004|Overall Study|Ongoing Participants|0|||
125225393|NCT01094288|450454236|FG005|Overall Study|Ongoing Participants|0|||
125225394|NCT01094288|450454237|FG006|Overall Study|Ongoing Participants|0|||
125225395|NCT01094288|450454238|FG007|Overall Study|Ongoing Participants|0|||
125225396|NCT02611882|450454239|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
125225397|NCT02611882|450454240|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
125225398|NCT02611882|450454241|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
125225399|NCT01317940|450454242|FG000|Overall Study|Death|1|||
125225400|NCT01317940|450454243|FG001|Overall Study|Death|0|||
125225401|NCT01317940|450454244|FG002|Overall Study|Death|1|||
125225402|NCT01317940|450454245|FG003|Overall Study|Death|0|||
125225403|NCT01317940|450454246|FG004|Overall Study|Death|0|||
125225404|NCT01317940|450454247|FG005|Overall Study|Death|0|||
125225405|NCT01317940|450454242|FG000|Overall Study|Lost to Follow-up|0|||
125225406|NCT01317940|450454243|FG001|Overall Study|Lost to Follow-up|0|||
125225407|NCT01317940|450454244|FG002|Overall Study|Lost to Follow-up|1|||
125225408|NCT01317940|450454245|FG003|Overall Study|Lost to Follow-up|1|||
125225409|NCT01317940|450454246|FG004|Overall Study|Lost to Follow-up|1|||
125225410|NCT01317940|450454247|FG005|Overall Study|Lost to Follow-up|0|||
125225411|NCT01317940|450454242|FG000|Overall Study|Change in therapy plan|0|||
125225412|NCT01317940|450454243|FG001|Overall Study|Change in therapy plan|0|||
125225413|NCT01317940|450454244|FG002|Overall Study|Change in therapy plan|3|||
125225414|NCT01317940|450454245|FG003|Overall Study|Change in therapy plan|0|||
125225415|NCT01317940|450454246|FG004|Overall Study|Change in therapy plan|0|||
125225416|NCT01317940|450454247|FG005|Overall Study|Change in therapy plan|0|||
125225417|NCT04152200|450454248|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
125225418|NCT04152200|450454249|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
125225419|NCT04980014|450454250|FG000|Overall Study|Participants who are Duplicated|1|||
125225420|NCT04980014|450454250|FG000|Overall Study|Follow-up Failure|13|||
125225421|NCT04980014|450454250|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
125225422|NCT04980014|450454250|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
125225423|NCT04980014|450454250|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
125225424|NCT00593814|450454251|FG000|Overall Study|Death|7|||
125225425|NCT00593814|450454252|FG001|Overall Study|Death|0|||
125225426|NCT00593814|450454251|FG000|Overall Study|Withdrawal by Subject|7|||
125225427|NCT00593814|450454252|FG001|Overall Study|Withdrawal by Subject|0|||
125225428|NCT00593814|450454251|FG000|Overall Study|Lost to Follow-up|7|||
125225429|NCT00593814|450454252|FG001|Overall Study|Lost to Follow-up|0|||
125225430|NCT00593814|450454251|FG000|Overall Study|Physician Decision|3|||
125225431|NCT00593814|450454252|FG001|Overall Study|Physician Decision|0|||
125225432|NCT00715559|450454253|FG000|Overall Study|medication not tolerated - nausea|1|||
125225433|NCT02699996|450454254|FG000|Overall Study|Withdrawal by Subject|5|||
125225434|NCT02699996|450454255|FG001|Overall Study|Withdrawal by Subject|2|||
125225435|NCT01095835|450454258|FG000|Overall Study|Adverse Event|8|||
125225436|NCT01095835|450454259|FG001|Overall Study|Adverse Event|6|||
125225437|NCT01095835|450454260|FG002|Overall Study|Adverse Event|6|||
125225438|NCT01095835|450454258|FG000|Overall Study|Lack of Efficacy|0|||
125225439|NCT01095835|450454259|FG001|Overall Study|Lack of Efficacy|1|||
125225440|NCT01095835|450454260|FG002|Overall Study|Lack of Efficacy|0|||
125225441|NCT01095835|450454258|FG000|Overall Study|Physician Decision|0|||
125225442|NCT01095835|450454259|FG001|Overall Study|Physician Decision|0|||
125225443|NCT01095835|450454260|FG002|Overall Study|Physician Decision|1|||
125225444|NCT01095835|450454258|FG000|Overall Study|Withdrawal by Subject|1|||
125225445|NCT01095835|450454259|FG001|Overall Study|Withdrawal by Subject|3|||
125225446|NCT01095835|450454260|FG002|Overall Study|Withdrawal by Subject|0|||
125225447|NCT01095835|450454258|FG000|Overall Study|Non study compliance|0|||
125225448|NCT01095835|450454259|FG001|Overall Study|Non study compliance|0|||
125225449|NCT01095835|450454260|FG002|Overall Study|Non study compliance|1|||
125225450|NCT01095835|450454258|FG000|Overall Study|Protocol Violation|1|||
125225451|NCT01095835|450454259|FG001|Overall Study|Protocol Violation|2|||
125225452|NCT01095835|450454260|FG002|Overall Study|Protocol Violation|0|||
125225453|NCT01198002|450454261|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
125225454|NCT01198002|450454262|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
125225455|NCT01198002|450454263|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
125225456|NCT01198002|450454261|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
125225457|NCT01198002|450454262|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
125225458|NCT01198002|450454263|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
125225459|NCT01198002|450454261|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
125225460|NCT01198002|450454262|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
125225461|NCT01198002|450454263|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
125225462|NCT01198002|450454261|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
125225463|NCT01198002|450454262|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
125225464|NCT01198002|450454263|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
125225465|NCT01198002|450454261|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
125225466|NCT01198002|450454262|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
125225467|NCT01198002|450454263|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
125225468|NCT01198002|450454261|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
125225469|NCT01198002|450454262|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
125225470|NCT01198002|450454263|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
125225471|NCT01198002|450454261|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
125225472|NCT01198002|450454262|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
125225473|NCT01198002|450454263|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
125225474|NCT01198002|450454261|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
125225475|NCT01198002|450454262|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
125225476|NCT01198002|450454263|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
125225477|NCT01198002|450454261|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
125225478|NCT01198002|450454262|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
125225479|NCT01198002|450454263|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
125225480|NCT01198002|450454261|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
125225481|NCT01198002|450454262|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
125225482|NCT01198002|450454263|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
125225483|NCT01198002|450454261|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
125225484|NCT01198002|450454262|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
125225485|NCT01198002|450454263|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
125225486|NCT01198002|450454261|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
125225487|NCT01198002|450454262|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
125164295|NCT02991430|450225151|FG002|Post-treatment Observation Period|Study Termination|5|||
125164296|NCT01672970|450225152|FG000|Overall Study|Lack of Efficacy|12|||
125164297|NCT01672970|450225152|FG000|Overall Study|Adverse Event|18|||
125164298|NCT01672970|450225152|FG000|Overall Study|Withdrawal by Subject|2|||
125164299|NCT01672970|450225152|FG000|Overall Study|Lost to Follow-up|5|||
125164300|NCT01672970|450225152|FG000|Overall Study|Other|9|||
125164301|NCT01672970|450225152|FG000|Overall Study|Enrolled but not treated|1|||
125164302|NCT03835221|450225157|FG000|Methafilcon A|Withdrawal by Subject|1|||
125164303|NCT01770392|450225159|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
125164304|NCT04639713|450225162|FG000|Overall Study|Protocol Noncompliance|2|||
125164305|NCT04639713|450225162|FG000|Overall Study|Withdrawal by Subject|1|||
125164306|NCT02582866|450225165|FG000|Overall Study|Death|1|||
125164307|NCT02582866|450225165|FG000|Overall Study|Lack of Efficacy|2|||
125164308|NCT02582866|450225165|FG000|Overall Study|Lost to Follow-up|2|||
125164309|NCT02582866|450225165|FG000|Overall Study|Withdrawal by Subject|7|||
125225488|NCT01198002|450454263|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
125225489|NCT01198002|450454261|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
125225490|NCT01198002|450454262|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
125164310|NCT02582866|450225165|FG000|Overall Study|Investigator decision|5|||
125164311|NCT02582866|450225165|FG000|Overall Study|Participant wants to get pregnant|1|||
125225491|NCT01198002|450454263|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
125225492|NCT01198002|450454261|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
125164312|NCT02582866|450225165|FG000|Overall Study|Pregnancy|2|||
125164313|NCT02582866|450225165|FG000|Overall Study|Sponsor decision|1|||
125164314|NCT02582866|450225165|FG000|Overall Study|Withdrawal due to personal reasons|1|||
125164315|NCT01193127|450225172|FG000|Randomized|Surgery Cancelled|0|||
125164316|NCT01193127|450225173|FG001|Randomized|Surgery Cancelled|0|||
125164317|NCT01193127|450225174|FG002|Randomized|Surgery Cancelled|0|||
125164318|NCT01193127|450225175|FG003|Randomized|Surgery Cancelled|1|||
125164319|NCT01193127|450225172|FG000|Treated|Withdrawal by Subject|0|||
125164320|NCT01193127|450225173|FG001|Treated|Withdrawal by Subject|0|||
125164321|NCT01193127|450225174|FG002|Treated|Withdrawal by Subject|0|||
125164322|NCT01193127|450225175|FG003|Treated|Withdrawal by Subject|1|||
125164323|NCT03246646|450225178|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
125164324|NCT03246646|450225179|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
125164325|NCT03246646|450225178|FG000|Overall Study|Withdrawal by Subject|3|||
125164326|NCT03246646|450225179|FG001|Overall Study|Withdrawal by Subject|0|||
125164327|NCT03246646|450225178|FG000|Overall Study|Lost to Follow-up|7|||
125164328|NCT03246646|450225179|FG001|Overall Study|Lost to Follow-up|0|||
125164329|NCT02352779|450225182|FG000|Overall Study|Personal Issues|1|||
125164330|NCT02352779|450225183|FG001|Overall Study|Personal Issues|1|||
125164331|NCT02352779|450225184|FG002|Overall Study|Personal Issues|0|||
125164332|NCT02352779|450225182|FG000|Overall Study|Too Many Forms|2|||
125164333|NCT02352779|450225183|FG001|Overall Study|Too Many Forms|0|||
125164334|NCT02352779|450225184|FG002|Overall Study|Too Many Forms|0|||
125164335|NCT02352779|450225182|FG000|Overall Study|Feeling Overwhelmed|1|||
125164336|NCT02352779|450225183|FG001|Overall Study|Feeling Overwhelmed|0|||
125164337|NCT02352779|450225184|FG002|Overall Study|Feeling Overwhelmed|0|||
125164338|NCT02352779|450225182|FG000|Overall Study|Disliked Intervention|1|||
125164339|NCT02352779|450225183|FG001|Overall Study|Disliked Intervention|0|||
125164340|NCT02352779|450225184|FG002|Overall Study|Disliked Intervention|0|||
125164341|NCT02352779|450225182|FG000|Overall Study|Changed Mind|1|||
125164342|NCT02352779|450225183|FG001|Overall Study|Changed Mind|0|||
125164343|NCT02352779|450225184|FG002|Overall Study|Changed Mind|0|||
125164344|NCT02352779|450225182|FG000|Overall Study|Study Related Symptoms|1|||
125164345|NCT02352779|450225183|FG001|Overall Study|Study Related Symptoms|0|||
125164346|NCT02352779|450225184|FG002|Overall Study|Study Related Symptoms|0|||
125164347|NCT02352779|450225182|FG000|Overall Study|Absence of Symptoms|1|||
125164348|NCT02352779|450225183|FG001|Overall Study|Absence of Symptoms|0|||
125164349|NCT02352779|450225184|FG002|Overall Study|Absence of Symptoms|0|||
125164350|NCT02352779|450225182|FG000|Overall Study|Other Medical Reason|0|||
125164351|NCT02352779|450225183|FG001|Overall Study|Other Medical Reason|0|||
125164352|NCT02352779|450225184|FG002|Overall Study|Other Medical Reason|1|||
125164353|NCT02352779|450225182|FG000|Overall Study|No Reason|0|||
125164354|NCT02352779|450225183|FG001|Overall Study|No Reason|0|||
125164355|NCT02352779|450225184|FG002|Overall Study|No Reason|1|||
125164356|NCT00871741|450225189|FG000|Overall Study|Premature study termination|9|||
125164357|NCT00871741|450225190|FG001|Overall Study|Premature study termination|7|||
125164358|NCT01565850|450225191|FG000|Overall Study|Adverse Event|0|||
125164359|NCT01565850|450225192|FG001|Overall Study|Adverse Event|1|||
125164360|NCT01565850|450225191|FG000|Overall Study|Lost to Follow-up|12|||
125164361|NCT01565850|450225192|FG001|Overall Study|Lost to Follow-up|4|||
125164362|NCT01565850|450225191|FG000|Overall Study|Investigator's Discretion|2|||
125164363|NCT01565850|450225192|FG001|Overall Study|Investigator's Discretion|1|||
125164364|NCT01565850|450225191|FG000|Overall Study|Participant noncompliance|2|||
125164365|NCT01565850|450225192|FG001|Overall Study|Participant noncompliance|0|||
125164366|NCT01565850|450225191|FG000|Overall Study|Withdrew Consent|4|||
125164367|NCT01565850|450225192|FG001|Overall Study|Withdrew Consent|2|||
125164368|NCT03611543|450227738|FG000|Overall Study|Withdrawal by Subject|4|||
125164369|NCT03611543|450227739|FG001|Overall Study|Withdrawal by Subject|4|||
125164370|NCT03611543|450227738|FG000|Overall Study|Physician Decision|1|||
125164371|NCT03611543|450227739|FG001|Overall Study|Physician Decision|1|||
125164372|NCT03611543|450227738|FG000|Overall Study|Protocol Violation|2|||
125164373|NCT03611543|450227739|FG001|Overall Study|Protocol Violation|2|||
125164374|NCT03611543|450227738|FG000|Overall Study|Device failure|2|||
125164375|NCT03611543|450227739|FG001|Overall Study|Device failure|2|||
125164376|NCT03611543|450227738|FG000|Overall Study|Missing information|5|||
125164377|NCT03611543|450227739|FG001|Overall Study|Missing information|5|||
125164378|NCT04395001|450227740|FG000|Overall Study|Lost to Follow-up|8|||
125164379|NCT04395001|450227741|FG001|Overall Study|Lost to Follow-up|9|||
125164380|NCT04395001|450227742|FG002|Overall Study|Lost to Follow-up|5|||
125164381|NCT04395001|450227740|FG000|Overall Study|Withdrawal by Subject|3|||
125164382|NCT04395001|450227741|FG001|Overall Study|Withdrawal by Subject|1|||
125164383|NCT04395001|450227742|FG002|Overall Study|Withdrawal by Subject|3|||
125164384|NCT04395001|450227740|FG000|Overall Study|missed appointment|7|||
125164385|NCT04395001|450227741|FG001|Overall Study|missed appointment|4|||
125164386|NCT04395001|450227742|FG002|Overall Study|missed appointment|1|||
125164387|NCT02799095|450227743|FG000|Part A|Adverse Event|1|||
125164388|NCT02799095|450227744|FG001|Part A|Adverse Event|0|||
125164389|NCT02799095|450227745|FG002|Part A|Adverse Event|1|||
125164390|NCT02799095|450227746|FG003|Part A|Adverse Event|4|||
125164391|NCT02799095|450227747|FG004|Part A|Adverse Event|1|||
125164392|NCT02799095|450227748|FG005|Part A|Adverse Event|0|||
125164393|NCT02799095|450227749|FG006|Part A|Adverse Event|0|||
125164394|NCT02799095|450227750|FG007|Part A|Adverse Event|0|||
125164395|NCT02799095|450227751|FG008|Part A|Adverse Event|0|||
125164396|NCT02799095|450227752|FG009|Part A|Adverse Event|0|||
125164397|NCT02799095|450227753|FG010|Part A|Adverse Event|0|||
125164398|NCT02799095|450227754|FG011|Part A|Adverse Event|0|||
125164399|NCT02799095|450227755|FG012|Part A|Adverse Event|0|||
125164400|NCT02799095|450227756|FG013|Part A|Adverse Event|0|||
125164401|NCT02799095|450227757|FG014|Part A|Adverse Event|0|||
125164402|NCT02799095|450227758|FG015|Part A|Adverse Event|0|||
125164403|NCT02799095|450227759|FG016|Part A|Adverse Event|0|||
125164404|NCT02799095|450227743|FG000|Part A|Death|0|||
125164405|NCT02799095|450227744|FG001|Part A|Death|0|||
125164406|NCT02799095|450227745|FG002|Part A|Death|0|||
125164407|NCT02799095|450227746|FG003|Part A|Death|0|||
125164408|NCT02799095|450227747|FG004|Part A|Death|0|||
125164409|NCT02799095|450227748|FG005|Part A|Death|0|||
125164410|NCT02799095|450227749|FG006|Part A|Death|3|||
125164411|NCT02799095|450227750|FG007|Part A|Death|0|||
125164412|NCT02799095|450227751|FG008|Part A|Death|0|||
125164413|NCT02799095|450227752|FG009|Part A|Death|0|||
125164414|NCT02799095|450227753|FG010|Part A|Death|0|||
125164415|NCT02799095|450227754|FG011|Part A|Death|0|||
125164416|NCT02799095|450227755|FG012|Part A|Death|0|||
125164417|NCT02799095|450227756|FG013|Part A|Death|0|||
125164418|NCT02799095|450227757|FG014|Part A|Death|0|||
125164419|NCT02799095|450227758|FG015|Part A|Death|0|||
125164420|NCT02799095|450227759|FG016|Part A|Death|0|||
125164421|NCT02799095|450227743|FG000|Part A|Lost to Follow-up|0|||
125164422|NCT02799095|450227744|FG001|Part A|Lost to Follow-up|1|||
125164423|NCT02799095|450227745|FG002|Part A|Lost to Follow-up|0|||
125164424|NCT02799095|450227746|FG003|Part A|Lost to Follow-up|0|||
125164425|NCT02799095|450227747|FG004|Part A|Lost to Follow-up|0|||
125164426|NCT02799095|450227748|FG005|Part A|Lost to Follow-up|0|||
125164427|NCT02799095|450227749|FG006|Part A|Lost to Follow-up|1|||
125164428|NCT02799095|450227750|FG007|Part A|Lost to Follow-up|0|||
125164429|NCT02799095|450227751|FG008|Part A|Lost to Follow-up|0|||
125164430|NCT02799095|450227752|FG009|Part A|Lost to Follow-up|0|||
125164431|NCT02799095|450227753|FG010|Part A|Lost to Follow-up|0|||
125164432|NCT02799095|450227754|FG011|Part A|Lost to Follow-up|0|||
125164433|NCT02799095|450227755|FG012|Part A|Lost to Follow-up|0|||
125164434|NCT02799095|450227756|FG013|Part A|Lost to Follow-up|0|||
125164435|NCT02799095|450227757|FG014|Part A|Lost to Follow-up|0|||
125164436|NCT02799095|450227758|FG015|Part A|Lost to Follow-up|0|||
125164437|NCT02799095|450227759|FG016|Part A|Lost to Follow-up|0|||
125164438|NCT02799095|450227743|FG000|Part A|Progressive Disease|3|||
125164439|NCT02799095|450227744|FG001|Part A|Progressive Disease|3|||
125164440|NCT02799095|450227745|FG002|Part A|Progressive Disease|3|||
125164441|NCT02799095|450227746|FG003|Part A|Progressive Disease|2|||
125164442|NCT02799095|450227747|FG004|Part A|Progressive Disease|2|||
125164443|NCT02799095|450227748|FG005|Part A|Progressive Disease|0|||
125164444|NCT02799095|450227749|FG006|Part A|Progressive Disease|0|||
125164445|NCT02799095|450227750|FG007|Part A|Progressive Disease|0|||
125164446|NCT02799095|450227751|FG008|Part A|Progressive Disease|0|||
125164447|NCT02799095|450227752|FG009|Part A|Progressive Disease|0|||
125164448|NCT02799095|450227753|FG010|Part A|Progressive Disease|0|||
125164449|NCT02799095|450227754|FG011|Part A|Progressive Disease|0|||
125164450|NCT02799095|450227755|FG012|Part A|Progressive Disease|0|||
125164451|NCT02799095|450227756|FG013|Part A|Progressive Disease|0|||
125164452|NCT02799095|450227757|FG014|Part A|Progressive Disease|0|||
125164453|NCT02799095|450227758|FG015|Part A|Progressive Disease|0|||
125164454|NCT02799095|450227759|FG016|Part A|Progressive Disease|0|||
125164455|NCT02799095|450227743|FG000|Part A|Clinical Progression|1|||
125164456|NCT02799095|450227744|FG001|Part A|Clinical Progression|0|||
125164457|NCT02799095|450227745|FG002|Part A|Clinical Progression|2|||
125164458|NCT02799095|450227746|FG003|Part A|Clinical Progression|1|||
125164459|NCT02799095|450227747|FG004|Part A|Clinical Progression|5|||
125164460|NCT02799095|450227748|FG005|Part A|Clinical Progression|0|||
125164461|NCT02799095|450227749|FG006|Part A|Clinical Progression|0|||
125164462|NCT02799095|450227750|FG007|Part A|Clinical Progression|0|||
125164463|NCT02799095|450227751|FG008|Part A|Clinical Progression|0|||
125164464|NCT02799095|450227752|FG009|Part A|Clinical Progression|0|||
125164465|NCT02799095|450227753|FG010|Part A|Clinical Progression|0|||
125164466|NCT02799095|450227754|FG011|Part A|Clinical Progression|0|||
125164467|NCT02799095|450227755|FG012|Part A|Clinical Progression|0|||
125164468|NCT02799095|450227756|FG013|Part A|Clinical Progression|0|||
125164469|NCT02799095|450227757|FG014|Part A|Clinical Progression|0|||
125164470|NCT02799095|450227758|FG015|Part A|Clinical Progression|0|||
125164471|NCT02799095|450227759|FG016|Part A|Clinical Progression|0|||
125164472|NCT02799095|450227743|FG000|Part A|Protocol Deviation|0|||
125164473|NCT02799095|450227744|FG001|Part A|Protocol Deviation|0|||
125164474|NCT02799095|450227745|FG002|Part A|Protocol Deviation|1|||
125164475|NCT02799095|450227746|FG003|Part A|Protocol Deviation|0|||
125164476|NCT02799095|450227747|FG004|Part A|Protocol Deviation|0|||
125164477|NCT02799095|450227748|FG005|Part A|Protocol Deviation|0|||
125164478|NCT02799095|450227749|FG006|Part A|Protocol Deviation|0|||
125164479|NCT02799095|450227750|FG007|Part A|Protocol Deviation|0|||
125164480|NCT02799095|450227751|FG008|Part A|Protocol Deviation|0|||
125164481|NCT02799095|450227752|FG009|Part A|Protocol Deviation|0|||
125164482|NCT02799095|450227753|FG010|Part A|Protocol Deviation|0|||
125164483|NCT02799095|450227754|FG011|Part A|Protocol Deviation|0|||
125164484|NCT02799095|450227755|FG012|Part A|Protocol Deviation|0|||
125164485|NCT02799095|450227756|FG013|Part A|Protocol Deviation|0|||
125164486|NCT02799095|450227757|FG014|Part A|Protocol Deviation|0|||
125164487|NCT02799095|450227758|FG015|Part A|Protocol Deviation|0|||
125164488|NCT02799095|450227759|FG016|Part A|Protocol Deviation|0|||
125164489|NCT02799095|450227743|FG000|Part A|Withdrawal by Subject|0|||
125164490|NCT02799095|450227744|FG001|Part A|Withdrawal by Subject|0|||
125164491|NCT02799095|450227745|FG002|Part A|Withdrawal by Subject|0|||
125164492|NCT02799095|450227746|FG003|Part A|Withdrawal by Subject|1|||
125164493|NCT02799095|450227747|FG004|Part A|Withdrawal by Subject|3|||
125164494|NCT02799095|450227748|FG005|Part A|Withdrawal by Subject|1|||
125164495|NCT02799095|450227749|FG006|Part A|Withdrawal by Subject|1|||
125164496|NCT02799095|450227750|FG007|Part A|Withdrawal by Subject|0|||
125164497|NCT02799095|450227751|FG008|Part A|Withdrawal by Subject|0|||
125164498|NCT02799095|450227752|FG009|Part A|Withdrawal by Subject|0|||
125164499|NCT02799095|450227753|FG010|Part A|Withdrawal by Subject|0|||
125164500|NCT02799095|450227754|FG011|Part A|Withdrawal by Subject|0|||
125164501|NCT02799095|450227755|FG012|Part A|Withdrawal by Subject|0|||
125164502|NCT02799095|450227756|FG013|Part A|Withdrawal by Subject|0|||
125164503|NCT02799095|450227757|FG014|Part A|Withdrawal by Subject|0|||
125164504|NCT02799095|450227758|FG015|Part A|Withdrawal by Subject|0|||
125164505|NCT02799095|450227759|FG016|Part A|Withdrawal by Subject|0|||
125164506|NCT02799095|450227743|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
125164507|NCT02799095|450227744|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
125164508|NCT02799095|450227745|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
125164509|NCT02799095|450227746|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
125164510|NCT02799095|450227747|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
125164511|NCT02799095|450227748|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
125164512|NCT02799095|450227749|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
125164513|NCT02799095|450227750|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
125164514|NCT02799095|450227751|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
125164515|NCT02799095|450227752|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
125164516|NCT02799095|450227753|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
125164517|NCT02799095|450227754|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
125164518|NCT02799095|450227755|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
125164519|NCT02799095|450227756|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
125164520|NCT02799095|450227757|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
125164521|NCT02799095|450227758|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
125164522|NCT02799095|450227759|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
125164523|NCT02799095|450227743|FG000|Part B|Death|0|||
125164524|NCT02799095|450227744|FG001|Part B|Death|0|||
125225493|NCT01198002|450454262|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
125225494|NCT01198002|450454263|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
125225495|NCT01198002|450454261|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
125225496|NCT01198002|450454262|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
125225497|NCT01198002|450454263|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
125225498|NCT00116688|450454267|FG000|Overall Study|Protocol deviation|1|||
125225499|NCT00116688|450454268|FG001|Overall Study|Protocol deviation|0|||
125225500|NCT00116688|450454267|FG000|Overall Study|Noncompliance|3|||
125225501|NCT00116688|450454268|FG001|Overall Study|Noncompliance|1|||
125225502|NCT00116688|450454267|FG000|Overall Study|Adverse Event|11|||
125225503|NCT00116688|450454268|FG001|Overall Study|Adverse Event|0|||
125225504|NCT00116688|450454267|FG000|Overall Study|Withdrawal by Subject|26|||
125225505|NCT00116688|450454268|FG001|Overall Study|Withdrawal by Subject|2|||
125225506|NCT00116688|450454267|FG000|Overall Study|Requirement for alternative therapy|11|||
125225507|NCT00116688|450454268|FG001|Overall Study|Requirement for alternative therapy|1|||
125225508|NCT00116688|450454267|FG000|Overall Study|Physician Decision|7|||
125225509|NCT00116688|450454268|FG001|Overall Study|Physician Decision|0|||
125225510|NCT00116688|450454267|FG000|Overall Study|Lost to Follow-up|3|||
125225511|NCT00116688|450454268|FG001|Overall Study|Lost to Follow-up|0|||
125225512|NCT00116688|450454267|FG000|Overall Study|Death|15|||
125225513|NCT00116688|450454268|FG001|Overall Study|Death|0|||
125225514|NCT00116688|450454267|FG000|Overall Study|Protocol-specified criteria|3|||
125225515|NCT00116688|450454268|FG001|Overall Study|Protocol-specified criteria|0|||
125225516|NCT00116688|450454267|FG000|Overall Study|Pregnancy|1|||
125225517|NCT00116688|450454268|FG001|Overall Study|Pregnancy|0|||
125225518|NCT00116688|450454267|FG000|Overall Study|Other|11|||
125225519|NCT00116688|450454268|FG001|Overall Study|Other|0|||
125164525|NCT02799095|450227745|FG002|Part B|Death|0|||
125164526|NCT02799095|450227746|FG003|Part B|Death|0|||
125164527|NCT02799095|450227747|FG004|Part B|Death|0|||
125164528|NCT02799095|450227748|FG005|Part B|Death|0|||
125164529|NCT02799095|450227749|FG006|Part B|Death|0|||
125164530|NCT02799095|450227750|FG007|Part B|Death|7|||
125164531|NCT02799095|450227751|FG008|Part B|Death|7|||
125164532|NCT02799095|450227752|FG009|Part B|Death|0|||
125164533|NCT02799095|450227753|FG010|Part B|Death|0|||
125164534|NCT02799095|450227754|FG011|Part B|Death|0|||
125164535|NCT02799095|450227755|FG012|Part B|Death|0|||
125164536|NCT02799095|450227756|FG013|Part B|Death|0|||
125164537|NCT02799095|450227757|FG014|Part B|Death|0|||
125164538|NCT02799095|450227758|FG015|Part B|Death|0|||
125164539|NCT02799095|450227759|FG016|Part B|Death|0|||
125164540|NCT02799095|450227743|FG000|Part B|Progressive Disease|0|||
125164541|NCT02799095|450227744|FG001|Part B|Progressive Disease|0|||
125164542|NCT02799095|450227745|FG002|Part B|Progressive Disease|0|||
125164543|NCT02799095|450227746|FG003|Part B|Progressive Disease|0|||
125164544|NCT02799095|450227747|FG004|Part B|Progressive Disease|0|||
125164545|NCT02799095|450227748|FG005|Part B|Progressive Disease|0|||
125164546|NCT02799095|450227749|FG006|Part B|Progressive Disease|0|||
125164547|NCT02799095|450227750|FG007|Part B|Progressive Disease|1|||
125164548|NCT02799095|450227751|FG008|Part B|Progressive Disease|0|||
125164549|NCT02799095|450227752|FG009|Part B|Progressive Disease|0|||
125164550|NCT02799095|450227753|FG010|Part B|Progressive Disease|0|||
125164551|NCT02799095|450227754|FG011|Part B|Progressive Disease|0|||
125164552|NCT02799095|450227755|FG012|Part B|Progressive Disease|0|||
125164553|NCT02799095|450227756|FG013|Part B|Progressive Disease|0|||
125164554|NCT02799095|450227757|FG014|Part B|Progressive Disease|0|||
125164555|NCT02799095|450227758|FG015|Part B|Progressive Disease|0|||
125164556|NCT02799095|450227759|FG016|Part B|Progressive Disease|0|||
125164557|NCT02799095|450227743|FG000|Part B|Withdrawal by Subject|0|||
125164558|NCT02799095|450227744|FG001|Part B|Withdrawal by Subject|0|||
125164559|NCT02799095|450227745|FG002|Part B|Withdrawal by Subject|0|||
125164560|NCT02799095|450227746|FG003|Part B|Withdrawal by Subject|0|||
125164561|NCT02799095|450227747|FG004|Part B|Withdrawal by Subject|0|||
125164562|NCT02799095|450227748|FG005|Part B|Withdrawal by Subject|0|||
125164563|NCT02799095|450227749|FG006|Part B|Withdrawal by Subject|0|||
125225520|NCT04006145|450454270|FG000|Overall Study|Lost to Follow-up|0|||
125225521|NCT04006145|450454271|FG001|Overall Study|Lost to Follow-up|1|||
125225522|NCT04006145|450454270|FG000|Overall Study|Other|1|||
125225523|NCT04006145|450454271|FG001|Overall Study|Other|2|||
125225524|NCT00010257|450454272|FG000|Overall Study|Withdrawal by Subject|1|||
125164564|NCT02799095|450227750|FG007|Part B|Withdrawal by Subject|10|||
125164565|NCT02799095|450227751|FG008|Part B|Withdrawal by Subject|7|||
125164566|NCT02799095|450227752|FG009|Part B|Withdrawal by Subject|0|||
125164567|NCT02799095|450227753|FG010|Part B|Withdrawal by Subject|0|||
125164568|NCT02799095|450227754|FG011|Part B|Withdrawal by Subject|0|||
125164569|NCT02799095|450227755|FG012|Part B|Withdrawal by Subject|0|||
125164570|NCT02799095|450227756|FG013|Part B|Withdrawal by Subject|0|||
125164571|NCT02799095|450227757|FG014|Part B|Withdrawal by Subject|0|||
125164572|NCT02799095|450227758|FG015|Part B|Withdrawal by Subject|0|||
125164573|NCT02799095|450227759|FG016|Part B|Withdrawal by Subject|0|||
125225525|NCT00010257|450454273|FG001|Overall Study|Withdrawal by Subject|0|||
125164574|NCT02799095|450227743|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
125164575|NCT02799095|450227744|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
125164576|NCT02799095|450227745|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
125164577|NCT02799095|450227746|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
125164578|NCT02799095|450227747|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
125164579|NCT02799095|450227748|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
125164580|NCT02799095|450227749|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
125164581|NCT02799095|450227750|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
125164582|NCT02799095|450227751|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
125164583|NCT02799095|450227752|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
125164584|NCT02799095|450227753|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
125164585|NCT02799095|450227754|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
125164586|NCT02799095|450227755|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
125164587|NCT02799095|450227756|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
125164588|NCT02799095|450227757|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
125164589|NCT02799095|450227758|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
125164590|NCT02799095|450227759|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
125164591|NCT02799095|450227743|FG000|Part C|Adverse Event|0|||
125164592|NCT02799095|450227744|FG001|Part C|Adverse Event|0|||
125164593|NCT02799095|450227745|FG002|Part C|Adverse Event|0|||
125164594|NCT02799095|450227746|FG003|Part C|Adverse Event|0|||
125164595|NCT02799095|450227747|FG004|Part C|Adverse Event|0|||
125164596|NCT02799095|450227748|FG005|Part C|Adverse Event|0|||
125164597|NCT02799095|450227749|FG006|Part C|Adverse Event|0|||
125164598|NCT02799095|450227750|FG007|Part C|Adverse Event|0|||
125164599|NCT02799095|450227751|FG008|Part C|Adverse Event|0|||
125164600|NCT02799095|450227752|FG009|Part C|Adverse Event|0|||
125164601|NCT02799095|450227753|FG010|Part C|Adverse Event|3|||
125164602|NCT02799095|450227754|FG011|Part C|Adverse Event|1|||
125164603|NCT02799095|450227755|FG012|Part C|Adverse Event|0|||
125164604|NCT02799095|450227756|FG013|Part C|Adverse Event|1|||
125164605|NCT02799095|450227757|FG014|Part C|Adverse Event|0|||
125164606|NCT02799095|450227758|FG015|Part C|Adverse Event|0|||
125164607|NCT02799095|450227759|FG016|Part C|Adverse Event|0|||
125164608|NCT02799095|450227743|FG000|Part C|Death|0|||
125164609|NCT02799095|450227744|FG001|Part C|Death|0|||
125164610|NCT02799095|450227745|FG002|Part C|Death|0|||
125164611|NCT02799095|450227746|FG003|Part C|Death|0|||
125164612|NCT02799095|450227747|FG004|Part C|Death|0|||
125164613|NCT02799095|450227748|FG005|Part C|Death|0|||
125164614|NCT02799095|450227749|FG006|Part C|Death|0|||
125164615|NCT02799095|450227750|FG007|Part C|Death|0|||
125164616|NCT02799095|450227751|FG008|Part C|Death|0|||
125164617|NCT02799095|450227752|FG009|Part C|Death|0|||
125164618|NCT02799095|450227753|FG010|Part C|Death|7|||
125164619|NCT02799095|450227754|FG011|Part C|Death|5|||
125164620|NCT02799095|450227755|FG012|Part C|Death|6|||
125164621|NCT02799095|450227756|FG013|Part C|Death|8|||
125164622|NCT02799095|450227757|FG014|Part C|Death|1|||
125164623|NCT02799095|450227758|FG015|Part C|Death|8|||
125164624|NCT02799095|450227759|FG016|Part C|Death|1|||
125164625|NCT02799095|450227743|FG000|Part C|Lost to Follow-up|0|||
125164626|NCT02799095|450227744|FG001|Part C|Lost to Follow-up|0|||
125164627|NCT02799095|450227745|FG002|Part C|Lost to Follow-up|0|||
125164628|NCT02799095|450227746|FG003|Part C|Lost to Follow-up|0|||
125164629|NCT02799095|450227747|FG004|Part C|Lost to Follow-up|0|||
125164630|NCT02799095|450227748|FG005|Part C|Lost to Follow-up|0|||
125164631|NCT02799095|450227749|FG006|Part C|Lost to Follow-up|0|||
125164632|NCT02799095|450227750|FG007|Part C|Lost to Follow-up|0|||
125164633|NCT02799095|450227751|FG008|Part C|Lost to Follow-up|0|||
125164634|NCT02799095|450227752|FG009|Part C|Lost to Follow-up|0|||
125164635|NCT02799095|450227753|FG010|Part C|Lost to Follow-up|1|||
125164636|NCT02799095|450227754|FG011|Part C|Lost to Follow-up|1|||
125164637|NCT02799095|450227755|FG012|Part C|Lost to Follow-up|1|||
125164638|NCT02799095|450227756|FG013|Part C|Lost to Follow-up|3|||
125164639|NCT02799095|450227757|FG014|Part C|Lost to Follow-up|0|||
125164640|NCT02799095|450227758|FG015|Part C|Lost to Follow-up|0|||
125164641|NCT02799095|450227759|FG016|Part C|Lost to Follow-up|0|||
125164642|NCT02799095|450227743|FG000|Part C|Progressive Disease|0|||
125164643|NCT02799095|450227744|FG001|Part C|Progressive Disease|0|||
125164644|NCT02799095|450227745|FG002|Part C|Progressive Disease|0|||
125164645|NCT02799095|450227746|FG003|Part C|Progressive Disease|0|||
125164646|NCT02799095|450227747|FG004|Part C|Progressive Disease|0|||
125164647|NCT02799095|450227748|FG005|Part C|Progressive Disease|0|||
125164648|NCT02799095|450227749|FG006|Part C|Progressive Disease|0|||
125164649|NCT02799095|450227750|FG007|Part C|Progressive Disease|0|||
125164650|NCT02799095|450227751|FG008|Part C|Progressive Disease|0|||
125164651|NCT02799095|450227752|FG009|Part C|Progressive Disease|2|||
125164652|NCT02799095|450227753|FG010|Part C|Progressive Disease|13|||
125164653|NCT02799095|450227754|FG011|Part C|Progressive Disease|2|||
125164654|NCT02799095|450227755|FG012|Part C|Progressive Disease|0|||
125164655|NCT02799095|450227756|FG013|Part C|Progressive Disease|1|||
125164656|NCT02799095|450227757|FG014|Part C|Progressive Disease|0|||
125164657|NCT02799095|450227758|FG015|Part C|Progressive Disease|0|||
125164658|NCT02799095|450227759|FG016|Part C|Progressive Disease|0|||
125164659|NCT02799095|450227743|FG000|Part C|Clinical Progression|0|||
125164660|NCT02799095|450227744|FG001|Part C|Clinical Progression|0|||
125164661|NCT02799095|450227745|FG002|Part C|Clinical Progression|0|||
125164662|NCT02799095|450227746|FG003|Part C|Clinical Progression|0|||
125164663|NCT02799095|450227747|FG004|Part C|Clinical Progression|0|||
125164664|NCT02799095|450227748|FG005|Part C|Clinical Progression|0|||
125164665|NCT02799095|450227749|FG006|Part C|Clinical Progression|0|||
125164666|NCT02799095|450227750|FG007|Part C|Clinical Progression|0|||
125164667|NCT02799095|450227751|FG008|Part C|Clinical Progression|0|||
125164668|NCT02799095|450227752|FG009|Part C|Clinical Progression|1|||
125164669|NCT02799095|450227753|FG010|Part C|Clinical Progression|3|||
125164670|NCT02799095|450227754|FG011|Part C|Clinical Progression|0|||
125164671|NCT02799095|450227755|FG012|Part C|Clinical Progression|0|||
125164672|NCT02799095|450227756|FG013|Part C|Clinical Progression|1|||
125164673|NCT02799095|450227757|FG014|Part C|Clinical Progression|0|||
125164674|NCT02799095|450227758|FG015|Part C|Clinical Progression|0|||
125164675|NCT02799095|450227759|FG016|Part C|Clinical Progression|0|||
125164676|NCT02799095|450227743|FG000|Part C|Withdrawal by Subject|0|||
125164677|NCT02799095|450227744|FG001|Part C|Withdrawal by Subject|0|||
125164678|NCT02799095|450227745|FG002|Part C|Withdrawal by Subject|0|||
125164679|NCT02799095|450227746|FG003|Part C|Withdrawal by Subject|0|||
125164680|NCT02799095|450227747|FG004|Part C|Withdrawal by Subject|0|||
125164681|NCT02799095|450227748|FG005|Part C|Withdrawal by Subject|0|||
125164682|NCT02799095|450227749|FG006|Part C|Withdrawal by Subject|0|||
125164683|NCT02799095|450227750|FG007|Part C|Withdrawal by Subject|0|||
125164684|NCT02799095|450227751|FG008|Part C|Withdrawal by Subject|0|||
125164685|NCT02799095|450227752|FG009|Part C|Withdrawal by Subject|0|||
125164686|NCT02799095|450227753|FG010|Part C|Withdrawal by Subject|13|||
125164687|NCT02799095|450227754|FG011|Part C|Withdrawal by Subject|15|||
125164688|NCT02799095|450227755|FG012|Part C|Withdrawal by Subject|13|||
125164689|NCT02799095|450227756|FG013|Part C|Withdrawal by Subject|21|||
125164690|NCT02799095|450227757|FG014|Part C|Withdrawal by Subject|0|||
125164691|NCT02799095|450227758|FG015|Part C|Withdrawal by Subject|12|||
125164692|NCT02799095|450227759|FG016|Part C|Withdrawal by Subject|1|||
125164693|NCT02799095|450227743|FG000|Part C|Physician Decision|0|||
125164694|NCT02799095|450227744|FG001|Part C|Physician Decision|0|||
125164695|NCT02799095|450227745|FG002|Part C|Physician Decision|0|||
125164696|NCT02799095|450227746|FG003|Part C|Physician Decision|0|||
125164697|NCT02799095|450227747|FG004|Part C|Physician Decision|0|||
125164698|NCT02799095|450227748|FG005|Part C|Physician Decision|0|||
125164699|NCT02799095|450227749|FG006|Part C|Physician Decision|0|||
125164700|NCT02799095|450227750|FG007|Part C|Physician Decision|0|||
125164701|NCT02799095|450227751|FG008|Part C|Physician Decision|0|||
125164702|NCT02799095|450227752|FG009|Part C|Physician Decision|0|||
125164703|NCT02799095|450227753|FG010|Part C|Physician Decision|1|||
125164704|NCT02799095|450227754|FG011|Part C|Physician Decision|0|||
125164705|NCT02799095|450227755|FG012|Part C|Physician Decision|0|||
125164706|NCT02799095|450227756|FG013|Part C|Physician Decision|0|||
125164707|NCT02799095|450227757|FG014|Part C|Physician Decision|0|||
125164708|NCT02799095|450227758|FG015|Part C|Physician Decision|0|||
125164709|NCT02799095|450227759|FG016|Part C|Physician Decision|0|||
125164710|NCT02799095|450227743|FG000|Part C|Other|0|||
125164711|NCT02799095|450227744|FG001|Part C|Other|0|||
125164712|NCT02799095|450227745|FG002|Part C|Other|0|||
125164713|NCT02799095|450227746|FG003|Part C|Other|0|||
125164714|NCT02799095|450227747|FG004|Part C|Other|0|||
125164715|NCT02799095|450227748|FG005|Part C|Other|0|||
125164716|NCT02799095|450227749|FG006|Part C|Other|0|||
125164717|NCT02799095|450227750|FG007|Part C|Other|0|||
125164718|NCT02799095|450227751|FG008|Part C|Other|0|||
125164719|NCT02799095|450227752|FG009|Part C|Other|0|||
125164720|NCT02799095|450227753|FG010|Part C|Other|0|||
125164721|NCT02799095|450227754|FG011|Part C|Other|2|||
125164722|NCT02799095|450227755|FG012|Part C|Other|2|||
125164723|NCT02799095|450227756|FG013|Part C|Other|0|||
125164724|NCT02799095|450227757|FG014|Part C|Other|0|||
125164725|NCT02799095|450227758|FG015|Part C|Other|0|||
125164726|NCT02799095|450227759|FG016|Part C|Other|0|||
125164727|NCT04347122|450227760|FG000|Overall Study|Physician Decision|0|||
125164728|NCT04347122|450227761|FG001|Overall Study|Physician Decision|3|||
125164729|NCT04347122|450227762|FG002|Overall Study|Physician Decision|3|||
125164730|NCT04347122|450227763|FG003|Overall Study|Physician Decision|6|||
125164731|NCT04994483|450227764|FG000|Overall Study|Adverse Event|26|||
125164732|NCT04994483|450227765|FG001|Overall Study|Adverse Event|17|||
125164733|NCT04994483|450227764|FG000|Overall Study|Lost to Follow-up|6|||
125164734|NCT04994483|450227765|FG001|Overall Study|Lost to Follow-up|10|||
125164735|NCT04994483|450227764|FG000|Overall Study|Noncompliance with study drug|8|||
125164736|NCT04994483|450227765|FG001|Overall Study|Noncompliance with study drug|5|||
125164737|NCT04994483|450227764|FG000|Overall Study|Physician Decision|5|||
125164738|NCT04994483|450227765|FG001|Overall Study|Physician Decision|0|||
125164739|NCT04994483|450227764|FG000|Overall Study|Withdrawal by Subject|41|||
125164740|NCT04994483|450227765|FG001|Overall Study|Withdrawal by Subject|38|||
125164741|NCT04994483|450227764|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
125164742|NCT04994483|450227765|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
125164743|NCT04994483|450227764|FG000|Overall Study|Met stopping criteria|1|||
125164744|NCT04994483|450227765|FG001|Overall Study|Met stopping criteria|0|||
125164745|NCT04994483|450227764|FG000|Overall Study|Randomized in error, not treated|4|||
125164746|NCT04994483|450227765|FG001|Overall Study|Randomized in error, not treated|3|||
125164747|NCT04994483|450227764|FG000|Overall Study|Lack of a reliable study partner|0|||
125164748|NCT04994483|450227765|FG001|Overall Study|Lack of a reliable study partner|1|||
125164749|NCT04994483|450227764|FG000|Overall Study|Met MRI exclusion criteria|0|||
125164750|NCT04994483|450227765|FG001|Overall Study|Met MRI exclusion criteria|1|||
125164751|NCT03589768|450227770|FG000|Overall Study|Death|1|||
125164752|NCT03589768|450227771|FG001|Overall Study|Death|0|||
125164753|NCT03589768|450227772|FG002|Overall Study|Death|8|||
125164754|NCT03589768|450227773|FG003|Overall Study|Death|3|||
125164755|NCT03589768|450227770|FG000|Overall Study|Withdrawal by Subject|2|||
125164756|NCT03589768|450227771|FG001|Overall Study|Withdrawal by Subject|0|||
125164757|NCT03589768|450227772|FG002|Overall Study|Withdrawal by Subject|0|||
125164758|NCT03589768|450227773|FG003|Overall Study|Withdrawal by Subject|0|||
125164759|NCT03589768|450227770|FG000|Overall Study|Protocol Violation|1|||
125164760|NCT03589768|450227771|FG001|Overall Study|Protocol Violation|0|||
125164761|NCT03589768|450227772|FG002|Overall Study|Protocol Violation|0|||
125164762|NCT03589768|450227773|FG003|Overall Study|Protocol Violation|0|||
125164763|NCT03283319|450227774|FG000|Overall Study|Lost to Follow-up|5|||
125164764|NCT03283319|450227775|FG001|Overall Study|Lost to Follow-up|4|||
125164765|NCT03283319|450227776|FG002|Overall Study|Lost to Follow-up|5|||
125164766|NCT03283319|450227777|FG003|Overall Study|Lost to Follow-up|5|||
125164767|NCT03283319|450227778|FG004|Overall Study|Lost to Follow-up|4|||
125164768|NCT03283319|450227779|FG005|Overall Study|Lost to Follow-up|3|||
125164769|NCT03283319|450227774|FG000|Overall Study|Withdrawal by Subject|2|||
125164770|NCT03283319|450227775|FG001|Overall Study|Withdrawal by Subject|2|||
125164771|NCT03283319|450227776|FG002|Overall Study|Withdrawal by Subject|2|||
125164772|NCT03283319|450227777|FG003|Overall Study|Withdrawal by Subject|1|||
125164773|NCT03283319|450227778|FG004|Overall Study|Withdrawal by Subject|0|||
125164774|NCT03283319|450227779|FG005|Overall Study|Withdrawal by Subject|1|||
125164775|NCT03283319|450227774|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
125164776|NCT03283319|450227775|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
125164777|NCT03283319|450227776|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
125164778|NCT03283319|450227777|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
125164779|NCT03283319|450227778|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
125164780|NCT03283319|450227779|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
125164781|NCT00721630|450227780|FG000|Overall Study|Participant found to be ineligible|1|||
125164782|NCT00792935|450227781|FG000|Overall Study|Adverse Event|2|||
125164783|NCT00792935|450227782|FG001|Overall Study|Adverse Event|1|||
125164784|NCT00792935|450227781|FG000|Overall Study|Lost to Follow-up|0|||
125164785|NCT00792935|450227782|FG001|Overall Study|Lost to Follow-up|1|||
125164786|NCT00792935|450227781|FG000|Overall Study|Protocol Violation|2|||
125164787|NCT00792935|450227782|FG001|Overall Study|Protocol Violation|0|||
125164788|NCT00792935|450227781|FG000|Overall Study|Withdrawal by Subject|0|||
125164789|NCT00792935|450227782|FG001|Overall Study|Withdrawal by Subject|1|||
125164790|NCT03186781|450227783|FG000|Overall Study|Lost to Follow-up|0|||
125164791|NCT03186781|450227784|FG001|Overall Study|Lost to Follow-up|0|||
125164792|NCT03186781|450227785|FG002|Overall Study|Lost to Follow-up|1|||
125164793|NCT03186781|450227786|FG003|Overall Study|Lost to Follow-up|0|||
125164794|NCT03186781|450227787|FG004|Overall Study|Lost to Follow-up|1|||
125164795|NCT03186781|450227788|FG005|Overall Study|Lost to Follow-up|0|||
125164796|NCT03186781|450227783|FG000|Overall Study|Moved from Area|0|||
125164797|NCT03186781|450227784|FG001|Overall Study|Moved from Area|0|||
125164798|NCT03186781|450227785|FG002|Overall Study|Moved from Area|0|||
125164799|NCT03186781|450227786|FG003|Overall Study|Moved from Area|0|||
125164800|NCT03186781|450227787|FG004|Overall Study|Moved from Area|1|||
125164801|NCT03186781|450227788|FG005|Overall Study|Moved from Area|0|||
125164802|NCT03186781|450227783|FG000|Overall Study|Withdrawal by Subject|0|||
125164803|NCT03186781|450227784|FG001|Overall Study|Withdrawal by Subject|0|||
125164804|NCT03186781|450227785|FG002|Overall Study|Withdrawal by Subject|0|||
125164805|NCT03186781|450227786|FG003|Overall Study|Withdrawal by Subject|0|||
125164806|NCT03186781|450227787|FG004|Overall Study|Withdrawal by Subject|1|||
125164807|NCT03186781|450227788|FG005|Overall Study|Withdrawal by Subject|0|||
125164808|NCT04663295|450227789|FG000|Run-in Period|Withdrawal by Subject|3|||
125164809|NCT04663295|450227789|FG000|Overall Study Period|Pregnancy|1|||
125164810|NCT04663295|450227789|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
125164811|NCT03954834|450227790|FG000|Overall Study|Adverse Event|1|||
125164812|NCT03954834|450227791|FG001|Overall Study|Adverse Event|3|||
125164813|NCT03954834|450227792|FG002|Overall Study|Adverse Event|1|||
125164814|NCT03954834|450227793|FG003|Overall Study|Adverse Event|1|||
125164815|NCT03954834|450227790|FG000|Overall Study|Death|0|||
125164816|NCT03954834|450227791|FG001|Overall Study|Death|0|||
125164817|NCT03954834|450227792|FG002|Overall Study|Death|0|||
125164818|NCT03954834|450227793|FG003|Overall Study|Death|1|||
125164819|NCT03954834|450227790|FG000|Overall Study|Physician Decision|0|||
125164820|NCT03954834|450227791|FG001|Overall Study|Physician Decision|1|||
125164821|NCT03954834|450227792|FG002|Overall Study|Physician Decision|0|||
125164822|NCT03954834|450227793|FG003|Overall Study|Physician Decision|2|||
125164823|NCT03954834|450227790|FG000|Overall Study|Protocol Violation|1|||
125164824|NCT03954834|450227791|FG001|Overall Study|Protocol Violation|0|||
125164825|NCT03954834|450227792|FG002|Overall Study|Protocol Violation|0|||
125164826|NCT03954834|450227793|FG003|Overall Study|Protocol Violation|1|||
125164827|NCT03954834|450227790|FG000|Overall Study|Withdrawal by Subject|2|||
125164828|NCT03954834|450227791|FG001|Overall Study|Withdrawal by Subject|3|||
125164829|NCT03954834|450227792|FG002|Overall Study|Withdrawal by Subject|13|||
125164830|NCT03954834|450227793|FG003|Overall Study|Withdrawal by Subject|6|||
125164831|NCT03954834|450227790|FG000|Overall Study|Participant left the country|0|||
125164832|NCT03954834|450227791|FG001|Overall Study|Participant left the country|0|||
125164833|NCT03954834|450227792|FG002|Overall Study|Participant left the country|1|||
125164834|NCT03954834|450227793|FG003|Overall Study|Participant left the country|0|||
125164835|NCT03954834|450227790|FG000|Overall Study|Lost to Follow-up|3|||
125164836|NCT03954834|450227791|FG001|Overall Study|Lost to Follow-up|2|||
125164837|NCT03954834|450227792|FG002|Overall Study|Lost to Follow-up|3|||
125164838|NCT03954834|450227793|FG003|Overall Study|Lost to Follow-up|5|||
125164839|NCT02903030|450227796|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
125225526|NCT01249417|450454279|FG000|Randomised Population|Study treatment not received|0|||
125225527|NCT01249417|450454280|FG001|Randomised Population|Study treatment not received|0|||
125225528|NCT01249417|450454281|FG002|Randomised Population|Study treatment not received|2|||
125225529|NCT01249417|450454279|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
125225530|NCT01249417|450454280|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
125225531|NCT01249417|450454281|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
125225532|NCT01249417|450454279|FG000|Treatment Phase - ITT Population|Other|0|||
125225533|NCT01249417|450454280|FG001|Treatment Phase - ITT Population|Other|0|||
125225534|NCT01249417|450454281|FG002|Treatment Phase - ITT Population|Other|1|||
125225535|NCT01249417|450454279|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
125225536|NCT01249417|450454280|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
125225537|NCT01249417|450454281|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
125225538|NCT01249417|450454279|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
125225539|NCT01249417|450454280|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
125225540|NCT01249417|450454281|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
125225541|NCT01249417|450454279|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
125225542|NCT01249417|450454280|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
125225543|NCT01249417|450454281|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
125225544|NCT00126594|450454283|FG000|Overall Study|Ineligible|2|||
125225545|NCT00126594|450454284|FG001|Overall Study|Ineligible|0|||
125225546|NCT00126594|450454283|FG000|Overall Study|Withdrawal by Subject|0|||
125225547|NCT00126594|450454284|FG001|Overall Study|Withdrawal by Subject|4|||
125225548|NCT00126594|450454283|FG000|Overall Study|Physician Decision|1|||
125225549|NCT00126594|450454284|FG001|Overall Study|Physician Decision|3|||
125225550|NCT00126594|450454283|FG000|Overall Study|Adverse Event|7|||
125225551|NCT00126594|450454284|FG001|Overall Study|Adverse Event|5|||
125225552|NCT00126594|450454283|FG000|Overall Study|Non-compliance|0|||
125225553|NCT00126594|450454284|FG001|Overall Study|Non-compliance|1|||
125225554|NCT00126594|450454283|FG000|Overall Study|Disease Progression|29|||
125225555|NCT00126594|450454284|FG001|Overall Study|Disease Progression|24|||
125225556|NCT03769649|450454285|FG000|Overall Study|Lost to Follow-up|4|||
125225557|NCT01290718|450454288|FG000|Overall Study|Early termination of the study|4|||
125225558|NCT00243919|450454289|FG000|Overall Study|Death|3|||
125225559|NCT00243919|450454290|FG001|Overall Study|Death|4|||
125225560|NCT00243919|450454291|FG002|Overall Study|Death|6|||
125225561|NCT00243919|450454289|FG000|Overall Study|Withdrawal by Subject|6|||
125225562|NCT00243919|450454290|FG001|Overall Study|Withdrawal by Subject|6|||
125225563|NCT00243919|450454291|FG002|Overall Study|Withdrawal by Subject|2|||
125225564|NCT00243919|450454289|FG000|Overall Study|Lost to Follow-up|6|||
125225565|NCT00243919|450454290|FG001|Overall Study|Lost to Follow-up|7|||
125225566|NCT00243919|450454291|FG002|Overall Study|Lost to Follow-up|3|||
125225567|NCT00243919|450454289|FG000|Overall Study|Administrative Error|1|||
125225568|NCT00243919|450454290|FG001|Overall Study|Administrative Error|0|||
125225569|NCT00243919|450454291|FG002|Overall Study|Administrative Error|0|||
125225570|NCT00243919|450454289|FG000|Overall Study|Physician Decision|1|||
125225571|NCT00243919|450454290|FG001|Overall Study|Physician Decision|1|||
125225572|NCT00243919|450454291|FG002|Overall Study|Physician Decision|0|||
125225573|NCT02059239|450454294|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
125225574|NCT02059239|450454295|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
125225575|NCT02059239|450454294|FG000|Overall Study|Physician Decision|1|||
125225576|NCT02059239|450454295|FG001|Overall Study|Physician Decision|0|||
125225577|NCT01268267|450454296|FG000|Overall Study|Protocol Violation|1|||
125225578|NCT04919317|450454301|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
125225579|NCT04919317|450454302|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
125225580|NCT04919317|450454301|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
125225581|NCT04919317|450454302|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
125225582|NCT00230048|450454303|FG000|Overall Study|Lost to Follow-up|13|||
125225583|NCT00230048|450454304|FG001|Overall Study|Lost to Follow-up|18|||
125225584|NCT00731822|450454309|FG000|Overall Study|Adverse Event|2|||
125225585|NCT00731822|450454310|FG001|Overall Study|Adverse Event|1|||
125225586|NCT00731822|450454309|FG000|Overall Study|Protocol Violation|1|||
125225587|NCT00731822|450454310|FG001|Overall Study|Protocol Violation|0|||
125225588|NCT00731822|450454309|FG000|Overall Study|Lost to Follow-up|1|||
125225589|NCT00731822|450454310|FG001|Overall Study|Lost to Follow-up|0|||
125225590|NCT02127658|450454316|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
125225591|NCT02127658|450454317|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
125225592|NCT02127658|450454316|FG000|Overall Study|Withdrawal by Subject|0|||
125225593|NCT02127658|450454317|FG001|Overall Study|Withdrawal by Subject|2|||
125225594|NCT02127658|450454316|FG000|Overall Study|Physician Decision|0|||
125225595|NCT02127658|450454317|FG001|Overall Study|Physician Decision|1|||
125225596|NCT01443858|450454318|FG000|Overall Study|Withdrawal by Subject|9|||
125225597|NCT01443858|450454319|FG001|Overall Study|Withdrawal by Subject|8|||
125225598|NCT01443858|450454320|FG002|Overall Study|Withdrawal by Subject|5|||
125225599|NCT01443858|450454318|FG000|Overall Study|Lack of Efficacy|1|||
125225600|NCT01443858|450454319|FG001|Overall Study|Lack of Efficacy|0|||
125225601|NCT01443858|450454320|FG002|Overall Study|Lack of Efficacy|0|||
125225602|NCT01443858|450454318|FG000|Overall Study|Lost to Follow-up|5|||
125225603|NCT01443858|450454319|FG001|Overall Study|Lost to Follow-up|5|||
125225604|NCT01443858|450454320|FG002|Overall Study|Lost to Follow-up|2|||
125225605|NCT03589807|450454321|FG000|Overall Study|Lost to Follow-up|0|||
125225606|NCT03589807|450454322|FG001|Overall Study|Lost to Follow-up|2|||
125225607|NCT03589807|450454323|FG002|Overall Study|Lost to Follow-up|2|||
125225608|NCT03589807|450454324|FG003|Overall Study|Lost to Follow-up|3|||
125225609|NCT03589807|450454325|FG004|Overall Study|Lost to Follow-up|1|||
125225610|NCT03589807|450454326|FG005|Overall Study|Lost to Follow-up|1|||
125225611|NCT03589807|450454321|FG000|Overall Study|Withdrawal by Subject|0|||
125225612|NCT03589807|450454322|FG001|Overall Study|Withdrawal by Subject|5|||
125225613|NCT03589807|450454323|FG002|Overall Study|Withdrawal by Subject|0|||
125225614|NCT03589807|450454324|FG003|Overall Study|Withdrawal by Subject|0|||
125225615|NCT03589807|450454325|FG004|Overall Study|Withdrawal by Subject|0|||
125225616|NCT03589807|450454326|FG005|Overall Study|Withdrawal by Subject|0|||
125225617|NCT03589807|450454321|FG000|Overall Study|Protocol Violation|0|||
125225618|NCT03589807|450454322|FG001|Overall Study|Protocol Violation|0|||
125225619|NCT03589807|450454323|FG002|Overall Study|Protocol Violation|0|||
125225620|NCT03589807|450454324|FG003|Overall Study|Protocol Violation|1|||
125225621|NCT03589807|450454325|FG004|Overall Study|Protocol Violation|0|||
125225622|NCT03589807|450454326|FG005|Overall Study|Protocol Violation|0|||
125225623|NCT03589807|450454321|FG000|Overall Study|Enrolled but treatment not administered|0|||
125225624|NCT03589807|450454322|FG001|Overall Study|Enrolled but treatment not administered|0|||
125225625|NCT03589807|450454323|FG002|Overall Study|Enrolled but treatment not administered|0|||
125225626|NCT03589807|450454324|FG003|Overall Study|Enrolled but treatment not administered|0|||
125225627|NCT03589807|450454325|FG004|Overall Study|Enrolled but treatment not administered|1|||
125225628|NCT03589807|450454326|FG005|Overall Study|Enrolled but treatment not administered|0|||
125225629|NCT01534273|450454327|FG000|Period 1|Physician Decision|0|||
125225630|NCT01534273|450454328|FG001|Period 1|Physician Decision|0|||
125225631|NCT01534273|450454329|FG002|Period 1|Physician Decision|0|||
125225632|NCT01534273|450454330|FG003|Period 1|Physician Decision|1|||
125225633|NCT01534273|450454331|FG004|Period 1|Physician Decision|0|||
125225634|NCT01534273|450454332|FG005|Period 1|Physician Decision|0|||
125225635|NCT01534273|450454333|FG006|Period 1|Physician Decision|0|||
125225636|NCT03586050|450454334|FG000|Overall Study|Death|3|||
125225637|NCT03586050|450454334|FG000|Overall Study|Withdrawal by Subject|2|||
125225638|NCT01435759|450454336|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
125225639|NCT01435759|450454337|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
125225640|NCT01435759|450454338|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
125225641|NCT01435759|450454339|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
125225642|NCT01435759|450454340|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
125164840|NCT02903030|450227797|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
125164841|NCT01502410|450227798|FG000|Overall Study|Adverse Event|1|||
125164842|NCT01502410|450227799|FG001|Overall Study|Adverse Event|2|||
125164843|NCT01502410|450227800|FG002|Overall Study|Adverse Event|0|||
125164844|NCT01502410|450227801|FG003|Overall Study|Adverse Event|0|||
125164845|NCT01502410|450227798|FG000|Overall Study|Lack of Efficacy|7|||
125164846|NCT01502410|450227799|FG001|Overall Study|Lack of Efficacy|7|||
125164847|NCT01502410|450227800|FG002|Overall Study|Lack of Efficacy|0|||
125164848|NCT01502410|450227801|FG003|Overall Study|Lack of Efficacy|0|||
125164849|NCT01502410|450227798|FG000|Overall Study|Physician Decision|0|||
125164850|NCT01502410|450227799|FG001|Overall Study|Physician Decision|1|||
125164851|NCT01502410|450227800|FG002|Overall Study|Physician Decision|0|||
125164852|NCT01502410|450227801|FG003|Overall Study|Physician Decision|0|||
125164853|NCT01502410|450227798|FG000|Overall Study|Withdrawal by Subject|2|||
125164854|NCT01502410|450227799|FG001|Overall Study|Withdrawal by Subject|0|||
125164855|NCT01502410|450227800|FG002|Overall Study|Withdrawal by Subject|0|||
125164856|NCT01502410|450227801|FG003|Overall Study|Withdrawal by Subject|0|||
125164857|NCT01284361|450227805|FG000|Overall Study|Withdrawal by Subject|1|||
125164858|NCT01284361|450227805|FG000|Overall Study|Protocol Violation|5|||
125164859|NCT01284361|450227805|FG000|Overall Study|Adverse Event|1|||
125164860|NCT01284361|450227805|FG000|Overall Study|Lost to Follow-up|2|||
125164861|NCT00663026|450227806|FG000|Overall Study|Lost to Follow-up|1|||
125164862|NCT00663026|450227807|FG001|Overall Study|Lost to Follow-up|0|||
125164863|NCT00663026|450227808|FG002|Overall Study|Lost to Follow-up|0|||
125164864|NCT00663026|450227806|FG000|Overall Study|Other|1|||
125164865|NCT00663026|450227807|FG001|Overall Study|Other|2|||
125164866|NCT00663026|450227808|FG002|Overall Study|Other|0|||
125164867|NCT00663026|450227806|FG000|Overall Study|Adverse Event|0|||
125164868|NCT00663026|450227807|FG001|Overall Study|Adverse Event|2|||
125164869|NCT00663026|450227808|FG002|Overall Study|Adverse Event|3|||
125164870|NCT00663026|450227806|FG000|Overall Study|Caregiver Request|0|||
125164871|NCT00663026|450227807|FG001|Overall Study|Caregiver Request|2|||
125164872|NCT00663026|450227808|FG002|Overall Study|Caregiver Request|0|||
125164873|NCT00663026|450227806|FG000|Overall Study|Withdrawal by Subject|0|||
125164874|NCT00663026|450227807|FG001|Overall Study|Withdrawal by Subject|0|||
125164875|NCT00663026|450227808|FG002|Overall Study|Withdrawal by Subject|1|||
125164876|NCT00754650|450227809|FG000|Overall Study|Disease Progression|2|||
125164877|NCT00805675|450227810|FG000|Overall Study|Adverse Event|0|||
125164878|NCT00805675|450227811|FG001|Overall Study|Adverse Event|0|||
125164879|NCT00805675|450227812|FG002|Overall Study|Adverse Event|1|||
125164880|NCT00325195|450227814|FG000|Randomized|Not dosed|5|||
125164881|NCT00325195|450227815|FG001|Randomized|Not dosed|5|||
125164882|NCT00325195|450227816|FG002|Randomized|Not dosed|3|||
125164883|NCT00325195|450227814|FG000|Received Intervention: ITT Population|Adverse Event|15|||
125164884|NCT00325195|450227815|FG001|Received Intervention: ITT Population|Adverse Event|17|||
125164885|NCT00325195|450227816|FG002|Received Intervention: ITT Population|Adverse Event|1|||
125164886|NCT00325195|450227814|FG000|Received Intervention: ITT Population|Death|3|||
125164887|NCT00325195|450227815|FG001|Received Intervention: ITT Population|Death|1|||
125164888|NCT00325195|450227816|FG002|Received Intervention: ITT Population|Death|0|||
125164889|NCT00325195|450227814|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
125164890|NCT00325195|450227815|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
125164891|NCT00325195|450227816|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
125164892|NCT00325195|450227814|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
125164893|NCT00325195|450227815|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
125164894|NCT00325195|450227816|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
125164895|NCT00325195|450227814|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
125164896|NCT00325195|450227815|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
125164897|NCT00325195|450227816|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
125164898|NCT00686075|450227818|FG000|Overall Study|Withdrawal by Subject|4|||
125164899|NCT00686075|450227819|FG001|Overall Study|Withdrawal by Subject|3|||
125164900|NCT00686075|450227820|FG002|Overall Study|Withdrawal by Subject|3|||
125164901|NCT00686075|450227821|FG003|Overall Study|Withdrawal by Subject|7|||
125164902|NCT00686075|450227822|FG004|Overall Study|Withdrawal by Subject|1|||
125164903|NCT00686075|450227823|FG005|Overall Study|Withdrawal by Subject|0|||
125164904|NCT00686075|450227824|FG006|Overall Study|Withdrawal by Subject|0|||
125164905|NCT00686075|450227825|FG007|Overall Study|Withdrawal by Subject|2|||
125164906|NCT00686075|450227826|FG008|Overall Study|Withdrawal by Subject|4|||
125164907|NCT00686075|450227827|FG009|Overall Study|Withdrawal by Subject|6|||
125164908|NCT00686075|450227818|FG000|Overall Study|Lost to Follow-up|3|||
125164909|NCT00686075|450227819|FG001|Overall Study|Lost to Follow-up|6|||
125164910|NCT00686075|450227820|FG002|Overall Study|Lost to Follow-up|3|||
125164911|NCT00686075|450227821|FG003|Overall Study|Lost to Follow-up|2|||
125164912|NCT00686075|450227822|FG004|Overall Study|Lost to Follow-up|3|||
125164913|NCT00686075|450227823|FG005|Overall Study|Lost to Follow-up|3|||
125164914|NCT00686075|450227824|FG006|Overall Study|Lost to Follow-up|0|||
125225643|NCT01435759|450454341|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
125225644|NCT01435759|450454336|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
125225645|NCT01435759|450454337|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
125164915|NCT00686075|450227825|FG007|Overall Study|Lost to Follow-up|0|||
125164916|NCT00686075|450227826|FG008|Overall Study|Lost to Follow-up|2|||
125164917|NCT00686075|450227827|FG009|Overall Study|Lost to Follow-up|3|||
125164918|NCT00686075|450227818|FG000|Overall Study|Other|1|||
125164919|NCT00686075|450227819|FG001|Overall Study|Other|1|||
125164920|NCT00686075|450227820|FG002|Overall Study|Other|0|||
125164921|NCT00686075|450227821|FG003|Overall Study|Other|0|||
125164922|NCT00686075|450227822|FG004|Overall Study|Other|0|||
125164923|NCT00686075|450227823|FG005|Overall Study|Other|0|||
125164924|NCT00686075|450227824|FG006|Overall Study|Other|0|||
125164925|NCT00686075|450227825|FG007|Overall Study|Other|0|||
125164926|NCT00686075|450227826|FG008|Overall Study|Other|0|||
125164927|NCT00686075|450227827|FG009|Overall Study|Other|1|||
125164928|NCT04715932|450227828|FG000|Overall Study|Lost to Follow-up|1|||
125164929|NCT04715932|450227829|FG001|Overall Study|Lost to Follow-up|0|||
125164930|NCT02740699|450227840|FG000|Overall Study|Lost to Follow-up|5|||
125164931|NCT02740699|450227840|FG000|Overall Study|Withdrawal by Subject|14|||
125164932|NCT02740699|450227840|FG000|Overall Study|Physician Decision|5|||
125164933|NCT03783039|450227842|FG000|Overall Study|Death|2|||
125164934|NCT03783039|450227843|FG001|Overall Study|Death|1|||
125164935|NCT01682863|450227844|FG000|Overall Study|Subject/guardian decision|19|||
125164936|NCT01682863|450227845|FG001|Overall Study|Subject/guardian decision|12|||
125164937|NCT01682863|450227846|FG002|Overall Study|Subject/guardian decision|10|||
125164938|NCT01682863|450227844|FG000|Overall Study|Lost to Follow-up|5|||
125164939|NCT01682863|450227845|FG001|Overall Study|Lost to Follow-up|1|||
125164940|NCT01682863|450227846|FG002|Overall Study|Lost to Follow-up|6|||
125164941|NCT01682863|450227844|FG000|Overall Study|Death|1|||
125164942|NCT01682863|450227845|FG001|Overall Study|Death|3|||
125164943|NCT01682863|450227846|FG002|Overall Study|Death|4|||
125164944|NCT01682863|450227844|FG000|Overall Study|Protocol deviation|1|||
125164945|NCT01682863|450227845|FG001|Overall Study|Protocol deviation|0|||
125164946|NCT01682863|450227846|FG002|Overall Study|Protocol deviation|1|||
125164947|NCT01682863|450227844|FG000|Overall Study|Technical problems|1|||
125164948|NCT01682863|450227845|FG001|Overall Study|Technical problems|0|||
125164949|NCT01682863|450227846|FG002|Overall Study|Technical problems|0|||
125164950|NCT01682863|450227844|FG000|Overall Study|Adverse Event|0|||
125164951|NCT01682863|450227845|FG001|Overall Study|Adverse Event|1|||
125164952|NCT01682863|450227846|FG002|Overall Study|Adverse Event|2|||
125164953|NCT01682863|450227844|FG000|Overall Study|Physician Decision|0|||
125164954|NCT01682863|450227845|FG001|Overall Study|Physician Decision|0|||
125164955|NCT01682863|450227846|FG002|Overall Study|Physician Decision|1|||
125164956|NCT00918138|450227847|FG000|Overall Study|Subject withdrew consent|1|||
125164957|NCT00918138|450227848|FG001|Overall Study|Subject withdrew consent|1|||
125164958|NCT00918138|450227847|FG000|Overall Study|Death|1|||
125164959|NCT00918138|450227848|FG001|Overall Study|Death|0|||
125164960|NCT00552578|450227852|FG000|Overall Study|Lost to Follow-up|1|||
125164961|NCT00552578|450227853|FG001|Overall Study|Lost to Follow-up|1|||
125164962|NCT01716715|450227854|FG000|Overall Study|Never Treated|2|||
125164963|NCT01716715|450227855|FG001|Overall Study|Never Treated|4|||
125164964|NCT04228783|450227856|FG000|Overall Study|Adverse Event|1|||
125164965|NCT04228783|450227857|FG001|Overall Study|Adverse Event|0|||
125164966|NCT04228783|450227858|FG002|Overall Study|Adverse Event|2|||
125164967|NCT04228783|450227859|FG003|Overall Study|Adverse Event|0|||
125164968|NCT04228783|450227860|FG004|Overall Study|Adverse Event|0|||
125164969|NCT04228783|450227861|FG005|Overall Study|Adverse Event|1|||
125164970|NCT04228783|450227856|FG000|Overall Study|Death|0|||
125164971|NCT04228783|450227857|FG001|Overall Study|Death|0|||
125164972|NCT04228783|450227858|FG002|Overall Study|Death|0|||
125164973|NCT04228783|450227859|FG003|Overall Study|Death|0|||
125164974|NCT04228783|450227860|FG004|Overall Study|Death|1|||
125164975|NCT04228783|450227861|FG005|Overall Study|Death|0|||
125164976|NCT04228783|450227856|FG000|Overall Study|Lost to Follow-up|36|||
125164977|NCT04228783|450227857|FG001|Overall Study|Lost to Follow-up|36|||
125164978|NCT04228783|450227858|FG002|Overall Study|Lost to Follow-up|28|||
125164979|NCT04228783|450227859|FG003|Overall Study|Lost to Follow-up|6|||
125164980|NCT04228783|450227860|FG004|Overall Study|Lost to Follow-up|14|||
125164981|NCT04228783|450227861|FG005|Overall Study|Lost to Follow-up|3|||
125164982|NCT04228783|450227856|FG000|Overall Study|Physician Decision|1|||
125164983|NCT04228783|450227857|FG001|Overall Study|Physician Decision|2|||
125164984|NCT04228783|450227858|FG002|Overall Study|Physician Decision|0|||
125164985|NCT04228783|450227859|FG003|Overall Study|Physician Decision|0|||
125164986|NCT04228783|450227860|FG004|Overall Study|Physician Decision|0|||
125164987|NCT04228783|450227861|FG005|Overall Study|Physician Decision|0|||
125164988|NCT04228783|450227856|FG000|Overall Study|Protocol Violation|0|||
125164989|NCT04228783|450227857|FG001|Overall Study|Protocol Violation|0|||
125164990|NCT04228783|450227858|FG002|Overall Study|Protocol Violation|0|||
125164991|NCT04228783|450227859|FG003|Overall Study|Protocol Violation|1|||
125164992|NCT04228783|450227860|FG004|Overall Study|Protocol Violation|0|||
125164993|NCT04228783|450227861|FG005|Overall Study|Protocol Violation|0|||
125164994|NCT04228783|450227856|FG000|Overall Study|Withdrawal by Subject|6|||
125164995|NCT04228783|450227857|FG001|Overall Study|Withdrawal by Subject|10|||
125164996|NCT04228783|450227858|FG002|Overall Study|Withdrawal by Subject|19|||
125164997|NCT04228783|450227859|FG003|Overall Study|Withdrawal by Subject|1|||
125164998|NCT04228783|450227860|FG004|Overall Study|Withdrawal by Subject|2|||
125164999|NCT04228783|450227861|FG005|Overall Study|Withdrawal by Subject|0|||
125165000|NCT04228783|450227856|FG000|Overall Study|Other|4|||
125165001|NCT04228783|450227857|FG001|Overall Study|Other|3|||
125165002|NCT04228783|450227858|FG002|Overall Study|Other|2|||
125165003|NCT04228783|450227859|FG003|Overall Study|Other|1|||
125165004|NCT04228783|450227860|FG004|Overall Study|Other|0|||
125165005|NCT04228783|450227861|FG005|Overall Study|Other|0|||
125165006|NCT00626392|450227862|FG000|Run-in Period|Adverse Event|0|||
125165007|NCT00626392|450227863|FG001|Run-in Period|Adverse Event|0|||
125165008|NCT00626392|450227864|FG002|Run-in Period|Adverse Event|1|||
125165009|NCT00626392|450227865|FG003|Run-in Period|Adverse Event|0|||
125165010|NCT00626392|450227866|FG004|Run-in Period|Adverse Event|1|||
125165011|NCT00626392|450227867|FG005|Run-in Period|Adverse Event|0|||
125165012|NCT00626392|450227862|FG000|Run-in Period|Withdrawal by Subject|0|||
125165013|NCT00626392|450227863|FG001|Run-in Period|Withdrawal by Subject|1|||
125165014|NCT00626392|450227864|FG002|Run-in Period|Withdrawal by Subject|1|||
125165015|NCT00626392|450227865|FG003|Run-in Period|Withdrawal by Subject|1|||
125165016|NCT00626392|450227866|FG004|Run-in Period|Withdrawal by Subject|3|||
125165017|NCT00626392|450227867|FG005|Run-in Period|Withdrawal by Subject|1|||
125165018|NCT00626392|450227862|FG000|Run-in Period|Noncompliance|1|||
125165019|NCT00626392|450227863|FG001|Run-in Period|Noncompliance|0|||
125165020|NCT00626392|450227864|FG002|Run-in Period|Noncompliance|1|||
125165021|NCT00626392|450227865|FG003|Run-in Period|Noncompliance|0|||
125165022|NCT00626392|450227866|FG004|Run-in Period|Noncompliance|0|||
125165023|NCT00626392|450227867|FG005|Run-in Period|Noncompliance|0|||
125165024|NCT00626392|450227862|FG000|Coadministration Period|Adverse Event|3|||
125165025|NCT00626392|450227863|FG001|Coadministration Period|Adverse Event|1|||
125165026|NCT00626392|450227864|FG002|Coadministration Period|Adverse Event|7|||
125165027|NCT00626392|450227865|FG003|Coadministration Period|Adverse Event|4|||
125165028|NCT00626392|450227866|FG004|Coadministration Period|Adverse Event|3|||
125165029|NCT00626392|450227867|FG005|Coadministration Period|Adverse Event|4|||
125165030|NCT00626392|450227862|FG000|Coadministration Period|Withdrawal by Subject|1|||
125165031|NCT00626392|450227863|FG001|Coadministration Period|Withdrawal by Subject|1|||
125165032|NCT00626392|450227864|FG002|Coadministration Period|Withdrawal by Subject|0|||
125165033|NCT00626392|450227865|FG003|Coadministration Period|Withdrawal by Subject|1|||
125165034|NCT00626392|450227866|FG004|Coadministration Period|Withdrawal by Subject|0|||
125165035|NCT00626392|450227867|FG005|Coadministration Period|Withdrawal by Subject|1|||
125165036|NCT00626392|450227862|FG000|Coadministration Period|Protocol Violation|0|||
125165037|NCT00626392|450227863|FG001|Coadministration Period|Protocol Violation|1|||
125165038|NCT00626392|450227864|FG002|Coadministration Period|Protocol Violation|0|||
125165039|NCT00626392|450227865|FG003|Coadministration Period|Protocol Violation|1|||
125165040|NCT00626392|450227866|FG004|Coadministration Period|Protocol Violation|1|||
125165041|NCT00626392|450227867|FG005|Coadministration Period|Protocol Violation|0|||
125165042|NCT00626392|450227862|FG000|Coadministration Period|Other|0|||
125165043|NCT00626392|450227863|FG001|Coadministration Period|Other|2|||
125165044|NCT00626392|450227864|FG002|Coadministration Period|Other|3|||
125165045|NCT00626392|450227865|FG003|Coadministration Period|Other|1|||
125165046|NCT00626392|450227866|FG004|Coadministration Period|Other|1|||
125165047|NCT00626392|450227867|FG005|Coadministration Period|Other|1|||
125165048|NCT03151811|450227870|FG000|Overall Study|Randomized But Not Treated|18|||
125165049|NCT03151811|450227871|FG001|Overall Study|Randomized But Not Treated|3|||
125165050|NCT03151811|450227870|FG000|Overall Study|Progressive Disease|130|||
125165051|NCT03151811|450227871|FG001|Overall Study|Progressive Disease|170|||
125165052|NCT03151811|450227870|FG000|Overall Study|Adverse Event|49|||
125165053|NCT03151811|450227871|FG001|Overall Study|Adverse Event|40|||
125165054|NCT03151811|450227870|FG000|Overall Study|Lack of Efficacy|6|||
125165055|NCT03151811|450227871|FG001|Overall Study|Lack of Efficacy|8|||
125165056|NCT03151811|450227870|FG000|Overall Study|Physician Decision|21|||
125165057|NCT03151811|450227871|FG001|Overall Study|Physician Decision|9|||
125165058|NCT03151811|450227870|FG000|Overall Study|Withdrawal by Subject|17|||
125165059|NCT03151811|450227871|FG001|Overall Study|Withdrawal by Subject|7|||
125165060|NCT03151811|450227870|FG000|Overall Study|Lost to Follow-up|0|||
125165061|NCT03151811|450227871|FG001|Overall Study|Lost to Follow-up|1|||
125165062|NCT03151811|450227870|FG000|Overall Study|Study Terminated by Sponsor|5|||
125165063|NCT03151811|450227871|FG001|Overall Study|Study Terminated by Sponsor|11|||
125165064|NCT01085734|450227872|FG000|Overall Study|Adverse Event|0|||
125165065|NCT01085734|450227873|FG001|Overall Study|Adverse Event|2|||
125165066|NCT01085734|450227872|FG000|Overall Study|Death|1|||
125165067|NCT01085734|450227873|FG001|Overall Study|Death|0|||
125165068|NCT01085734|450227872|FG000|Overall Study|Lost to Follow-up|0|||
125165069|NCT01085734|450227873|FG001|Overall Study|Lost to Follow-up|1|||
125165070|NCT01085734|450227872|FG000|Overall Study|Withdrawal by Subject|0|||
125165071|NCT01085734|450227873|FG001|Overall Study|Withdrawal by Subject|1|||
125165072|NCT01739348|450227874|FG000|Part I (Base Study)|Adverse Event|41|||
125165073|NCT01739348|450227875|FG001|Part I (Base Study)|Adverse Event|52|||
125165074|NCT01739348|450227876|FG002|Part I (Base Study)|Adverse Event|8|||
125165075|NCT01739348|450227877|FG003|Part I (Base Study)|Adverse Event|33|||
125165076|NCT01739348|450227874|FG000|Part I (Base Study)|Death|10|||
125165077|NCT01739348|450227875|FG001|Part I (Base Study)|Death|7|||
125165078|NCT01739348|450227876|FG002|Part I (Base Study)|Death|2|||
125165079|NCT01739348|450227877|FG003|Part I (Base Study)|Death|8|||
125165080|NCT01739348|450227874|FG000|Part I (Base Study)|Lack of Efficacy|3|||
125165081|NCT01739348|450227875|FG001|Part I (Base Study)|Lack of Efficacy|8|||
125165082|NCT01739348|450227876|FG002|Part I (Base Study)|Lack of Efficacy|0|||
125165083|NCT01739348|450227877|FG003|Part I (Base Study)|Lack of Efficacy|7|||
125165084|NCT01739348|450227874|FG000|Part I (Base Study)|Lost to Follow-up|4|||
125165085|NCT01739348|450227875|FG001|Part I (Base Study)|Lost to Follow-up|2|||
125165086|NCT01739348|450227876|FG002|Part I (Base Study)|Lost to Follow-up|4|||
125165087|NCT01739348|450227877|FG003|Part I (Base Study)|Lost to Follow-up|4|||
125165088|NCT01739348|450227874|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
125165089|NCT01739348|450227875|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
125165090|NCT01739348|450227876|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
125165091|NCT01739348|450227877|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
125165092|NCT01739348|450227874|FG000|Part I (Base Study)|Physician Decision|10|||
125165093|NCT01739348|450227875|FG001|Part I (Base Study)|Physician Decision|7|||
125165094|NCT01739348|450227876|FG002|Part I (Base Study)|Physician Decision|1|||
125165095|NCT01739348|450227877|FG003|Part I (Base Study)|Physician Decision|4|||
125165096|NCT01739348|450227874|FG000|Part I (Base Study)|Protocol Violation|2|||
125165097|NCT01739348|450227875|FG001|Part I (Base Study)|Protocol Violation|0|||
125165098|NCT01739348|450227876|FG002|Part I (Base Study)|Protocol Violation|1|||
125165099|NCT01739348|450227877|FG003|Part I (Base Study)|Protocol Violation|2|||
125165100|NCT01739348|450227874|FG000|Part I (Base Study)|Screen Failure|2|||
125165101|NCT01739348|450227875|FG001|Part I (Base Study)|Screen Failure|0|||
125165102|NCT01739348|450227876|FG002|Part I (Base Study)|Screen Failure|0|||
125165103|NCT01739348|450227877|FG003|Part I (Base Study)|Screen Failure|0|||
125165104|NCT01739348|450227874|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
125165105|NCT01739348|450227875|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
125165106|NCT01739348|450227876|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
125165107|NCT01739348|450227877|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
125165108|NCT01739348|450227874|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
125165109|NCT01739348|450227875|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
125165110|NCT01739348|450227876|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
125165111|NCT01739348|450227877|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
125165112|NCT01739348|450227874|FG000|Part I (Base Study)|Participant Moved|4|||
125165113|NCT01739348|450227875|FG001|Part I (Base Study)|Participant Moved|3|||
125165114|NCT01739348|450227876|FG002|Part I (Base Study)|Participant Moved|1|||
125165115|NCT01739348|450227877|FG003|Part I (Base Study)|Participant Moved|7|||
125225646|NCT01435759|450454338|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
125225647|NCT01435759|450454339|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
125225648|NCT01435759|450454340|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
125225649|NCT01435759|450454341|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
125225650|NCT01435759|450454336|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
125225651|NCT01435759|450454337|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
125225652|NCT01435759|450454338|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
125225653|NCT01435759|450454339|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
125225654|NCT01435759|450454340|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
125225655|NCT01435759|450454341|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
125225656|NCT01435759|450454336|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
125225657|NCT01435759|450454337|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
125225658|NCT01435759|450454338|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
125225659|NCT01435759|450454339|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
125225660|NCT01435759|450454340|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
125225661|NCT01435759|450454341|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
125225662|NCT01435759|450454336|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
125225663|NCT01435759|450454337|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
125225664|NCT01435759|450454338|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
125225665|NCT01435759|450454339|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
125225666|NCT01435759|450454340|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
125225667|NCT01435759|450454341|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
125225668|NCT01435759|450454336|FG000|Antidepressant Lead-in Phase|Other|119|||
125225669|NCT01435759|450454337|FG001|Antidepressant Lead-in Phase|Other|0|||
125225670|NCT01435759|450454338|FG002|Antidepressant Lead-in Phase|Other|0|||
125225671|NCT01435759|450454339|FG003|Antidepressant Lead-in Phase|Other|0|||
125225672|NCT01435759|450454340|FG004|Antidepressant Lead-in Phase|Other|0|||
125225673|NCT01435759|450454341|FG005|Antidepressant Lead-in Phase|Other|0|||
125225674|NCT01435759|450454336|FG000|Double-blind Phase|Adverse Event|7|||
125225675|NCT01435759|450454337|FG001|Double-blind Phase|Adverse Event|0|||
125225676|NCT01435759|450454338|FG002|Double-blind Phase|Adverse Event|1|||
125225677|NCT01435759|450454339|FG003|Double-blind Phase|Adverse Event|1|||
125225678|NCT01435759|450454340|FG004|Double-blind Phase|Adverse Event|1|||
125225679|NCT01435759|450454341|FG005|Double-blind Phase|Adverse Event|3|||
125225680|NCT01435759|450454336|FG000|Double-blind Phase|Protocol Violation|2|||
125225681|NCT01435759|450454337|FG001|Double-blind Phase|Protocol Violation|0|||
125225682|NCT01435759|450454338|FG002|Double-blind Phase|Protocol Violation|1|||
125225683|NCT01435759|450454339|FG003|Double-blind Phase|Protocol Violation|2|||
125225684|NCT01435759|450454340|FG004|Double-blind Phase|Protocol Violation|0|||
125225685|NCT01435759|450454341|FG005|Double-blind Phase|Protocol Violation|1|||
125225686|NCT01435759|450454336|FG000|Double-blind Phase|Withdrawal by Subject|17|||
125225687|NCT01435759|450454337|FG001|Double-blind Phase|Withdrawal by Subject|4|||
125225688|NCT01435759|450454338|FG002|Double-blind Phase|Withdrawal by Subject|3|||
125225689|NCT01435759|450454339|FG003|Double-blind Phase|Withdrawal by Subject|4|||
125225690|NCT01435759|450454340|FG004|Double-blind Phase|Withdrawal by Subject|2|||
125225691|NCT01435759|450454341|FG005|Double-blind Phase|Withdrawal by Subject|2|||
125225692|NCT01435759|450454336|FG000|Double-blind Phase|Lost to Follow-up|31|||
125225693|NCT01435759|450454337|FG001|Double-blind Phase|Lost to Follow-up|1|||
125225694|NCT01435759|450454338|FG002|Double-blind Phase|Lost to Follow-up|2|||
125225695|NCT01435759|450454339|FG003|Double-blind Phase|Lost to Follow-up|0|||
125225696|NCT01435759|450454340|FG004|Double-blind Phase|Lost to Follow-up|3|||
125225697|NCT01435759|450454341|FG005|Double-blind Phase|Lost to Follow-up|3|||
125225698|NCT01435759|450454336|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
125225699|NCT01435759|450454337|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
125225700|NCT01435759|450454338|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
125225701|NCT01435759|450454339|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
125225702|NCT01435759|450454340|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
125225703|NCT01435759|450454341|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
125225704|NCT01435759|450454336|FG000|Double-blind Phase|Other|8|||
125225705|NCT01435759|450454337|FG001|Double-blind Phase|Other|2|||
125225706|NCT01435759|450454338|FG002|Double-blind Phase|Other|0|||
125225707|NCT01435759|450454339|FG003|Double-blind Phase|Other|2|||
125225708|NCT01435759|450454340|FG004|Double-blind Phase|Other|0|||
125225709|NCT01435759|450454341|FG005|Double-blind Phase|Other|0|||
125225710|NCT01211145|450454342|FG000|Overall Study|Reason not specified|3|||
125225711|NCT01211145|450454343|FG001|Overall Study|Reason not specified|2|||
125225712|NCT01211145|450454344|FG002|Overall Study|Reason not specified|2|||
125225713|NCT01211145|450454345|FG003|Overall Study|Reason not specified|1|||
125225714|NCT01211145|450454342|FG000|Overall Study|Lost to Follow-up|3|||
125225715|NCT01211145|450454343|FG001|Overall Study|Lost to Follow-up|2|||
125225716|NCT01211145|450454344|FG002|Overall Study|Lost to Follow-up|1|||
125225717|NCT01211145|450454345|FG003|Overall Study|Lost to Follow-up|2|||
125225718|NCT01211145|450454342|FG000|Overall Study|Study-specific withdrawal criteria|1|||
125165116|NCT01739348|450227874|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
125165117|NCT01739348|450227875|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
125165118|NCT01739348|450227876|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
125165119|NCT01739348|450227877|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
125165120|NCT01739348|450227874|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
125165121|NCT01739348|450227875|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
125165122|NCT01739348|450227876|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
125165123|NCT01739348|450227877|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
125165124|NCT01739348|450227874|FG000|Part II (Extension Study)|Adverse Event|10|||
125165125|NCT01739348|450227875|FG001|Part II (Extension Study)|Adverse Event|11|||
125165126|NCT01739348|450227876|FG002|Part II (Extension Study)|Adverse Event|7|||
125165127|NCT01739348|450227877|FG003|Part II (Extension Study)|Adverse Event|26|||
125165128|NCT01739348|450227874|FG000|Part II (Extension Study)|Death|3|||
125165129|NCT01739348|450227875|FG001|Part II (Extension Study)|Death|3|||
125165130|NCT01739348|450227876|FG002|Part II (Extension Study)|Death|2|||
125165131|NCT01739348|450227877|FG003|Part II (Extension Study)|Death|6|||
125165132|NCT01739348|450227874|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
125165133|NCT01739348|450227875|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
125165134|NCT01739348|450227876|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
125165135|NCT01739348|450227877|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
125165136|NCT01739348|450227874|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
125165137|NCT01739348|450227875|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
125165138|NCT01739348|450227876|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
125165139|NCT01739348|450227877|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
125165140|NCT01739348|450227874|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
125165141|NCT01739348|450227875|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
125165142|NCT01739348|450227876|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
125165143|NCT01739348|450227877|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
125165144|NCT01739348|450227874|FG000|Part II (Extension Study)|Physician Decision|7|||
125165145|NCT01739348|450227875|FG001|Part II (Extension Study)|Physician Decision|11|||
125165146|NCT01739348|450227876|FG002|Part II (Extension Study)|Physician Decision|6|||
125165147|NCT01739348|450227877|FG003|Part II (Extension Study)|Physician Decision|12|||
125165148|NCT01739348|450227874|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
125165149|NCT01739348|450227875|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
125165150|NCT01739348|450227876|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
125165151|NCT01739348|450227877|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
125165152|NCT01739348|450227874|FG000|Part II (Extension Study)|Participant Moved|3|||
125165153|NCT01739348|450227875|FG001|Part II (Extension Study)|Participant Moved|3|||
125165154|NCT01739348|450227876|FG002|Part II (Extension Study)|Participant Moved|0|||
125165155|NCT01739348|450227877|FG003|Part II (Extension Study)|Participant Moved|3|||
125165156|NCT01739348|450227874|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
125165157|NCT01739348|450227875|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
125165158|NCT01739348|450227876|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
125165159|NCT01739348|450227877|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
125165160|NCT01739348|450227874|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
125165161|NCT01739348|450227875|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
125165162|NCT01739348|450227876|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
125165163|NCT01739348|450227877|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
125165164|NCT01447420|450227881|FG000|Overall Study|Adverse Event|2|||
125165165|NCT01447420|450227882|FG001|Overall Study|Adverse Event|4|||
125165166|NCT01447420|450227883|FG002|Overall Study|Adverse Event|2|||
125165167|NCT01447420|450227881|FG000|Overall Study|Protocol Violation|3|||
125165168|NCT01447420|450227882|FG001|Overall Study|Protocol Violation|3|||
125165169|NCT01447420|450227883|FG002|Overall Study|Protocol Violation|0|||
125165170|NCT01447420|450227881|FG000|Overall Study|Withdrawal by Subject|4|||
125165171|NCT01447420|450227882|FG001|Overall Study|Withdrawal by Subject|1|||
125165172|NCT01447420|450227883|FG002|Overall Study|Withdrawal by Subject|0|||
125165173|NCT01447420|450227881|FG000|Overall Study|Lack of Efficacy|1|||
125165174|NCT01447420|450227882|FG001|Overall Study|Lack of Efficacy|19|||
125165175|NCT01447420|450227883|FG002|Overall Study|Lack of Efficacy|8|||
125165176|NCT04562155|450227884|FG000|Overall Study|COVID-19 pandemic|0|||
125165177|NCT04562155|450227885|FG001|Overall Study|COVID-19 pandemic|0|||
125165178|NCT04562155|450227886|FG002|Overall Study|COVID-19 pandemic|0|||
125165179|NCT04562155|450227887|FG003|Overall Study|COVID-19 pandemic|1|||
125165180|NCT04562155|450227884|FG000|Overall Study|Adverse Event|7|||
125165181|NCT04562155|450227885|FG001|Overall Study|Adverse Event|3|||
125165182|NCT04562155|450227886|FG002|Overall Study|Adverse Event|8|||
125165183|NCT04562155|450227887|FG003|Overall Study|Adverse Event|1|||
125165184|NCT04562155|450227884|FG000|Overall Study|Withdrawal by Subject|3|||
125165185|NCT04562155|450227885|FG001|Overall Study|Withdrawal by Subject|6|||
125165186|NCT04562155|450227886|FG002|Overall Study|Withdrawal by Subject|3|||
125165187|NCT04562155|450227887|FG003|Overall Study|Withdrawal by Subject|3|||
125165188|NCT04562155|450227884|FG000|Overall Study|Participant personal reason|1|||
125165189|NCT04562155|450227885|FG001|Overall Study|Participant personal reason|0|||
125165190|NCT04562155|450227886|FG002|Overall Study|Participant personal reason|2|||
125165191|NCT04562155|450227887|FG003|Overall Study|Participant personal reason|1|||
125165192|NCT01268501|450227888|FG000|Overall Study|Lost to Follow-up|1|||
125165193|NCT01268501|450227888|FG000|Overall Study|Withdrawal by Subject|3|||
125165194|NCT01268501|450227888|FG000|Overall Study|Unacceptable Subjective Vision|3|||
125165195|NCT01268501|450227888|FG000|Overall Study|Handling Difficulties|2|||
125165196|NCT05293639|450227889|FG000|Overall Study|Withdrawal by Subject|1|||
125165197|NCT05293639|450227890|FG001|Overall Study|Withdrawal by Subject|1|||
125165198|NCT05293639|450227891|FG002|Overall Study|Withdrawal by Subject|2|||
125165199|NCT05293639|450227889|FG000|Overall Study|Death|0|||
125165200|NCT05293639|450227890|FG001|Overall Study|Death|1|||
125165201|NCT05293639|450227891|FG002|Overall Study|Death|0|||
125165202|NCT05293639|450227889|FG000|Overall Study|Lost to Follow-up|0|||
125165203|NCT05293639|450227890|FG001|Overall Study|Lost to Follow-up|0|||
125165204|NCT05293639|450227891|FG002|Overall Study|Lost to Follow-up|5|||
125165205|NCT05293639|450227889|FG000|Overall Study|Other|0|||
125165206|NCT05293639|450227890|FG001|Overall Study|Other|0|||
125225719|NCT01211145|450454343|FG001|Overall Study|Study-specific withdrawal criteria|0|||
125225720|NCT01211145|450454344|FG002|Overall Study|Study-specific withdrawal criteria|0|||
125165207|NCT05293639|450227891|FG002|Overall Study|Other|1|||
125165208|NCT00827632|450227893|FG000|Overall Study|Lost to Follow-up|8|||
125165209|NCT00827632|450227894|FG001|Overall Study|Lost to Follow-up|12|||
125165210|NCT00827632|450227893|FG000|Overall Study|Early withdrawal|14|||
125165211|NCT00827632|450227894|FG001|Overall Study|Early withdrawal|11|||
125165212|NCT01910389|450227895|FG000|Overall Study|Withdrawal by Subject|2|||
125165213|NCT01910389|450227896|FG001|Overall Study|Withdrawal by Subject|0|||
125165214|NCT01910389|450227895|FG000|Overall Study|Study Closed|13|||
125165215|NCT01910389|450227896|FG001|Overall Study|Study Closed|8|||
125165216|NCT00407758|450227898|FG000|Overall Study|ineligible -improper prior treatment|1|||
125165217|NCT01458106|450227904|FG000|Overall Study|Withdrawal by Subject|2|||
125165218|NCT01458106|450227905|FG001|Overall Study|Withdrawal by Subject|0|||
125165219|NCT01458106|450227904|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
125165220|NCT01458106|450227905|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
125165221|NCT01458106|450227904|FG000|Overall Study|Withdrawn Per Protocol|0|||
125165222|NCT01458106|450227905|FG001|Overall Study|Withdrawn Per Protocol|1|||
125165223|NCT00073021|450227906|FG000|Overall Study|Protocol Violation|2|||
125165224|NCT00073021|450227907|FG001|Overall Study|Protocol Violation|1|||
125165225|NCT00073021|450227906|FG000|Overall Study|Adverse Event|4|||
125165226|NCT00073021|450227907|FG001|Overall Study|Adverse Event|4|||
125165227|NCT00073021|450227906|FG000|Overall Study|Withdrawal by Subject|6|||
125165228|NCT00073021|450227907|FG001|Overall Study|Withdrawal by Subject|5|||
125165229|NCT00073021|450227906|FG000|Overall Study|Physician Decision|3|||
125165230|NCT00073021|450227907|FG001|Overall Study|Physician Decision|1|||
125165231|NCT00073021|450227906|FG000|Overall Study|Lack of Efficacy|11|||
125165232|NCT00073021|450227907|FG001|Overall Study|Lack of Efficacy|5|||
125165233|NCT00855803|450227908|FG000|Overall Study|Death|2|||
125165234|NCT00855803|450227908|FG000|Overall Study|Lost to Follow-up|2|||
125165235|NCT00855803|450227908|FG000|Overall Study|Technical inability to undergo procedure|2|||
125165236|NCT00855803|450227908|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
125165237|NCT00855803|450227908|FG000|Overall Study|Withdrawal by Subject|3|||
125165238|NCT00855803|450227908|FG000|Overall Study|Physician Decision|3|||
125165239|NCT03276780|450227910|FG000|Overall Study|Withdrawal by Subject|5|||
125165240|NCT03276780|450227911|FG001|Overall Study|Withdrawal by Subject|3|||
125165241|NCT03276780|450227910|FG000|Overall Study|Lost to Follow-up|3|||
125165242|NCT03276780|450227911|FG001|Overall Study|Lost to Follow-up|5|||
125165243|NCT03276780|450227910|FG000|Overall Study|Moved out of state|1|||
125165244|NCT03276780|450227911|FG001|Overall Study|Moved out of state|1|||
125165245|NCT03276780|450227910|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
125225721|NCT01211145|450454345|FG003|Overall Study|Study-specific withdrawal criteria|0|||
125165246|NCT03276780|450227911|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
125165247|NCT03276780|450227910|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
125165248|NCT03276780|450227911|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
125165249|NCT03050060|450227912|FG000|Overall Study|Adverse Event|7|||
125165250|NCT03050060|450227912|FG000|Overall Study|Withdrawal by Subject|1|||
125165251|NCT03050060|450227912|FG000|Overall Study|Progression|7|||
125165252|NCT02304458|450227913|FG000|Overall Study|Adverse Event|0|||
125165253|NCT02304458|450227914|FG001|Overall Study|Adverse Event|0|||
125165254|NCT02304458|450227915|FG002|Overall Study|Adverse Event|7|||
125165255|NCT02304458|450227916|FG003|Overall Study|Adverse Event|0|||
125165256|NCT02304458|450227917|FG004|Overall Study|Adverse Event|0|||
125165257|NCT02304458|450227918|FG005|Overall Study|Adverse Event|0|||
125165258|NCT02304458|450227919|FG006|Overall Study|Adverse Event|3|||
125165259|NCT02304458|450227920|FG007|Overall Study|Adverse Event|4|||
125165260|NCT02304458|450227913|FG000|Overall Study|Death|0|||
125165261|NCT02304458|450227914|FG001|Overall Study|Death|0|||
125165262|NCT02304458|450227915|FG002|Overall Study|Death|2|||
125165263|NCT02304458|450227916|FG003|Overall Study|Death|0|||
125165264|NCT02304458|450227917|FG004|Overall Study|Death|0|||
125165265|NCT02304458|450227918|FG005|Overall Study|Death|0|||
125165266|NCT02304458|450227919|FG006|Overall Study|Death|1|||
125165267|NCT02304458|450227920|FG007|Overall Study|Death|0|||
125165268|NCT02304458|450227913|FG000|Overall Study|Lack of Efficacy|4|||
125165269|NCT02304458|450227914|FG001|Overall Study|Lack of Efficacy|6|||
125165270|NCT02304458|450227915|FG002|Overall Study|Lack of Efficacy|38|||
125165271|NCT02304458|450227916|FG003|Overall Study|Lack of Efficacy|5|||
125165272|NCT02304458|450227917|FG004|Overall Study|Lack of Efficacy|6|||
125165273|NCT02304458|450227918|FG005|Overall Study|Lack of Efficacy|6|||
125165274|NCT02304458|450227919|FG006|Overall Study|Lack of Efficacy|21|||
125165275|NCT02304458|450227920|FG007|Overall Study|Lack of Efficacy|4|||
125165276|NCT02304458|450227913|FG000|Overall Study|Physician Decision|2|||
125165277|NCT02304458|450227914|FG001|Overall Study|Physician Decision|0|||
125165278|NCT02304458|450227915|FG002|Overall Study|Physician Decision|16|||
125165279|NCT02304458|450227916|FG003|Overall Study|Physician Decision|1|||
125165280|NCT02304458|450227917|FG004|Overall Study|Physician Decision|0|||
125165281|NCT02304458|450227918|FG005|Overall Study|Physician Decision|0|||
125165282|NCT02304458|450227919|FG006|Overall Study|Physician Decision|3|||
125165283|NCT02304458|450227920|FG007|Overall Study|Physician Decision|0|||
125165284|NCT02304458|450227913|FG000|Overall Study|Protocol Violation|0|||
125165285|NCT02304458|450227914|FG001|Overall Study|Protocol Violation|0|||
125165286|NCT02304458|450227915|FG002|Overall Study|Protocol Violation|1|||
125165287|NCT02304458|450227916|FG003|Overall Study|Protocol Violation|0|||
125165288|NCT02304458|450227917|FG004|Overall Study|Protocol Violation|0|||
125165289|NCT02304458|450227918|FG005|Overall Study|Protocol Violation|0|||
125165290|NCT02304458|450227919|FG006|Overall Study|Protocol Violation|0|||
125165291|NCT02304458|450227920|FG007|Overall Study|Protocol Violation|0|||
125165292|NCT02304458|450227913|FG000|Overall Study|Withdrawal by Subject|1|||
125165293|NCT02304458|450227914|FG001|Overall Study|Withdrawal by Subject|0|||
125165294|NCT02304458|450227915|FG002|Overall Study|Withdrawal by Subject|7|||
125165295|NCT02304458|450227916|FG003|Overall Study|Withdrawal by Subject|0|||
125165296|NCT02304458|450227917|FG004|Overall Study|Withdrawal by Subject|0|||
125165297|NCT02304458|450227918|FG005|Overall Study|Withdrawal by Subject|0|||
125165298|NCT02304458|450227919|FG006|Overall Study|Withdrawal by Subject|1|||
125165299|NCT02304458|450227920|FG007|Overall Study|Withdrawal by Subject|0|||
125165300|NCT03401450|450227921|FG000|Overall Study|Lost to Follow-up|4|||
125165301|NCT03401450|450227922|FG001|Overall Study|Lost to Follow-up|6|||
125165302|NCT03401450|450227921|FG000|Overall Study|Anesthesia plan changed|2|||
125165303|NCT03401450|450227922|FG001|Overall Study|Anesthesia plan changed|2|||
125165304|NCT03401450|450227921|FG000|Overall Study|Did not complete medication diary|4|||
125165305|NCT03401450|450227922|FG001|Overall Study|Did not complete medication diary|2|||
125165306|NCT03401450|450227921|FG000|Overall Study|post surgery medication change|2|||
125165307|NCT03401450|450227922|FG001|Overall Study|post surgery medication change|1|||
125165308|NCT03401450|450227921|FG000|Overall Study|Cancelled surgery|0|||
125165309|NCT03401450|450227922|FG001|Overall Study|Cancelled surgery|2|||
125165310|NCT02823652|450227923|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
125165311|NCT02823652|450227924|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
125165312|NCT02823652|450227925|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
125165313|NCT02823652|450227923|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
125165314|NCT02823652|450227924|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
125165315|NCT02823652|450227925|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
125165316|NCT02823652|450227923|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
125165317|NCT02823652|450227924|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
125165318|NCT02823652|450227925|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
125165319|NCT02823652|450227923|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
125225722|NCT01211145|450454342|FG000|Overall Study|Severe noncompliance to protocol|1|||
125225723|NCT01211145|450454343|FG001|Overall Study|Severe noncompliance to protocol|0|||
125225724|NCT01211145|450454344|FG002|Overall Study|Severe noncompliance to protocol|0|||
125225725|NCT01211145|450454345|FG003|Overall Study|Severe noncompliance to protocol|0|||
125165320|NCT02823652|450227924|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
125165321|NCT02823652|450227925|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
125165322|NCT00633243|450230252|FG000|Overall Study|Withdrawal by Subject|0|||
125165323|NCT00633243|450230253|FG001|Overall Study|Withdrawal by Subject|1|||
125165324|NCT00633243|450230252|FG000|Overall Study|incarceration|0|||
125165325|NCT00633243|450230253|FG001|Overall Study|incarceration|2|||
125165326|NCT00633243|450230252|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
125165327|NCT00633243|450230253|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
125165328|NCT00633243|450230252|FG000|Overall Study|Not comfortable with self-injecting|0|||
125165329|NCT00633243|450230253|FG001|Overall Study|Not comfortable with self-injecting|1|||
125165330|NCT00633243|450230252|FG000|Overall Study|Mental Health--Depression|0|||
125165331|NCT00633243|450230253|FG001|Overall Study|Mental Health--Depression|1|||
125165332|NCT00633243|450230252|FG000|Overall Study|Couldn't tolerate side-effects|1|||
125165333|NCT00633243|450230253|FG001|Overall Study|Couldn't tolerate side-effects|1|||
125165334|NCT02022748|450230254|FG000|Overall Study|Adverse Event|1|||
125165335|NCT02022748|450230255|FG001|Overall Study|Adverse Event|1|||
125165336|NCT02022748|450230256|FG002|Overall Study|Adverse Event|0|||
125165337|NCT02022748|450230254|FG000|Overall Study|Withdrawal by Subject|0|||
125165338|NCT02022748|450230255|FG001|Overall Study|Withdrawal by Subject|1|||
125165339|NCT02022748|450230256|FG002|Overall Study|Withdrawal by Subject|0|||
125165340|NCT03665441|450230257|FG000|Overall Study|survival follow up ongoing|23|||
125165341|NCT03665441|450230258|FG001|Overall Study|survival follow up ongoing|0|||
125165342|NCT03665441|450230257|FG000|Overall Study|Patients ongoing on treatment|9|||
125165343|NCT03665441|450230258|FG001|Overall Study|Patients ongoing on treatment|6|||
125165344|NCT03665441|450230257|FG000|Overall Study|Randomized but not treated|7|||
125165345|NCT03665441|450230258|FG001|Overall Study|Randomized but not treated|11|||
125165346|NCT04345601|450230259|FG000|Overall Study|Death|0|||
125165347|NCT04345601|450230260|FG001|Overall Study|Death|3|||
125165348|NCT04345601|450230261|FG002|Overall Study|Death|2|||
125165349|NCT04345601|450230259|FG000|Overall Study|Lost to Follow-up|0|||
125165350|NCT04345601|450230260|FG001|Overall Study|Lost to Follow-up|0|||
125165351|NCT04345601|450230261|FG002|Overall Study|Lost to Follow-up|2|||
125165352|NCT03700385|450230262|FG000|Overall Study|Lost to Follow-up|1|||
125165353|NCT00372411|450230265|FG000|Overall Study|Withdrawal by Subject|3|||
125165354|NCT00372411|450230266|FG001|Overall Study|Withdrawal by Subject|4|||
125165355|NCT00372411|450230267|FG002|Overall Study|Withdrawal by Subject|1|||
125165356|NCT00372411|450230265|FG000|Overall Study|Death|0|||
125165357|NCT00372411|450230266|FG001|Overall Study|Death|2|||
125165358|NCT00372411|450230267|FG002|Overall Study|Death|1|||
125165359|NCT00372411|450230265|FG000|Overall Study|Lost to Follow-up|1|||
125165360|NCT00372411|450230266|FG001|Overall Study|Lost to Follow-up|1|||
125165361|NCT00372411|450230267|FG002|Overall Study|Lost to Follow-up|1|||
125165362|NCT00372411|450230265|FG000|Overall Study|Adverse Event|1|||
125165363|NCT00372411|450230266|FG001|Overall Study|Adverse Event|1|||
125165364|NCT00372411|450230267|FG002|Overall Study|Adverse Event|0|||
125165365|NCT00631657|450230268|FG000|6-Month Treatment Period|Adverse Event|47|||
125165366|NCT00631657|450230269|FG001|6-Month Treatment Period|Adverse Event|0|||
125165367|NCT00631657|450230270|FG002|6-Month Treatment Period|Adverse Event|7|||
125165368|NCT00631657|450230268|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
125165369|NCT00631657|450230269|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
125165370|NCT00631657|450230270|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
125165371|NCT00631657|450230268|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
125165372|NCT00631657|450230269|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
125165373|NCT00631657|450230270|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
125165374|NCT00631657|450230268|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
125165375|NCT00631657|450230269|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
125165376|NCT00631657|450230270|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
125165377|NCT00631657|450230268|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
125165378|NCT00631657|450230269|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
125165379|NCT00631657|450230270|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
125165380|NCT00631657|450230268|FG000|6-Month Treatment Period|Other|16|||
125225726|NCT01211145|450454342|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
125225727|NCT01211145|450454343|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
125225728|NCT01211145|450454344|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
125225729|NCT01211145|450454345|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
125225730|NCT01211145|450454342|FG000|Overall Study|Patient decision|2|||
125225731|NCT01211145|450454343|FG001|Overall Study|Patient decision|1|||
125225732|NCT01211145|450454344|FG002|Overall Study|Patient decision|0|||
125225733|NCT01211145|450454345|FG003|Overall Study|Patient decision|2|||
125225734|NCT00570401|450454348|FG000|Overall Study|Adverse Event|2|||
125225735|NCT02849587|450454349|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
125225736|NCT02849587|450454350|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
125225737|NCT02849587|450454351|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
125225738|NCT02849587|450454349|FG000|Overall Study|Withdrawal by Subject|0|||
125225739|NCT02849587|450454350|FG001|Overall Study|Withdrawal by Subject|1|||
125225740|NCT02849587|450454351|FG002|Overall Study|Withdrawal by Subject|0|||
125225741|NCT04202497|450454354|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
125225742|NCT04202497|450454355|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
125225743|NCT04202497|450454356|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
125225744|NCT04202497|450454357|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
125225745|NCT02115607|450454358|FG000|Overall Study|Withdrawal by Subject|1|||
125225746|NCT00102596|450454359|FG000|Part A|Screen failures|6|||
125165381|NCT00631657|450230269|FG001|6-Month Treatment Period|Other|0|||
125165382|NCT00631657|450230270|FG002|6-Month Treatment Period|Other|4|||
125165383|NCT00631657|450230268|FG000|6-Month Treatment Period|Not Treated|2|||
125165384|NCT00631657|450230269|FG001|6-Month Treatment Period|Not Treated|0|||
125165385|NCT00631657|450230270|FG002|6-Month Treatment Period|Not Treated|1|||
125165386|NCT00631657|450230268|FG000|7-Day Discontinuation Period|Not Treated|1|||
125165387|NCT00631657|450230269|FG001|7-Day Discontinuation Period|Not Treated|1|||
125165388|NCT00631657|450230270|FG002|7-Day Discontinuation Period|Not Treated|1|||
125165389|NCT00631657|450230268|FG000|7-Day Discontinuation Period|Other|1|||
125165390|NCT00631657|450230269|FG001|7-Day Discontinuation Period|Other|0|||
125165391|NCT00631657|450230270|FG002|7-Day Discontinuation Period|Other|0|||
125165392|NCT00699374|450230272|FG000|Overall Study|Death|93|||
125165393|NCT00699374|450230273|FG001|Overall Study|Death|83|||
125165394|NCT00699374|450230272|FG000|Overall Study|Adverse Event|70|||
125165395|NCT00699374|450230273|FG001|Overall Study|Adverse Event|67|||
125165396|NCT00699374|450230272|FG000|Overall Study|Global deterioration of health status|7|||
125165397|NCT00699374|450230273|FG001|Overall Study|Global deterioration of health status|8|||
125165398|NCT00699374|450230272|FG000|Overall Study|Lost to Follow-up|3|||
125165399|NCT00699374|450230273|FG001|Overall Study|Lost to Follow-up|5|||
125165400|NCT00699374|450230272|FG000|Overall Study|Withdrawal by Subject|34|||
125165401|NCT00699374|450230273|FG001|Overall Study|Withdrawal by Subject|44|||
125165402|NCT00699374|450230272|FG000|Overall Study|Objective progression or relapse|281|||
125165403|NCT00699374|450230273|FG001|Overall Study|Objective progression or relapse|277|||
125165404|NCT00699374|450230272|FG000|Overall Study|Other|18|||
125165405|NCT00699374|450230273|FG001|Overall Study|Other|15|||
125165406|NCT00699374|450230272|FG000|Overall Study|Protocol Violation|2|||
125165407|NCT00699374|450230273|FG001|Overall Study|Protocol Violation|6|||
125165408|NCT00699374|450230272|FG000|Overall Study|Study terminated by sponsor|13|||
125165409|NCT00699374|450230273|FG001|Overall Study|Study terminated by sponsor|28|||
125165410|NCT00699374|450230272|FG000|Overall Study|Randomized but not treated|4|||
125165411|NCT00699374|450230273|FG001|Overall Study|Randomized but not treated|2|||
125165412|NCT00699374|450230272|FG000|Overall Study|Died 28 days after last dose|5|||
125165413|NCT00699374|450230273|FG001|Overall Study|Died 28 days after last dose|9|||
125165414|NCT04091659|450230280|FG000|Overall Study|Protocol Violation|3|||
125165415|NCT04091659|450230281|FG001|Overall Study|Protocol Violation|0|||
125165416|NCT04091659|450230280|FG000|Overall Study|Lost to Follow-up|0|||
125165417|NCT04091659|450230281|FG001|Overall Study|Lost to Follow-up|1|||
125165418|NCT01081834|450230285|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
125165419|NCT01081834|450230286|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
125165420|NCT01081834|450230287|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
125225747|NCT00102596|450454360|FG001|Part A|Screen failures|0|||
125225748|NCT00102596|450454359|FG000|Part A|Adverse Event|1|||
125225749|NCT00102596|450454360|FG001|Part A|Adverse Event|0|||
125225750|NCT00069264|450454361|FG000|Overall Study|Adverse Event|3|||
125165421|NCT01081834|450230288|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
125165422|NCT01081834|450230289|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
125165423|NCT01081834|450230285|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
125165424|NCT01081834|450230286|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
125165425|NCT01081834|450230287|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
125165426|NCT01081834|450230288|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
125165427|NCT01081834|450230289|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
125165428|NCT01081834|450230285|FG000|Core Period: Baseline to Week 26|Death|1|||
125165429|NCT01081834|450230286|FG001|Core Period: Baseline to Week 26|Death|0|||
125225751|NCT00069264|450454361|FG000|Overall Study|Progressive Disease|23|||
125225752|NCT00069264|450454361|FG000|Overall Study|Withdrawal by Subject|3|||
125165430|NCT01081834|450230287|FG002|Core Period: Baseline to Week 26|Death|0|||
125165431|NCT01081834|450230288|FG003|Core Period: Baseline to Week 26|Death|0|||
125165432|NCT01081834|450230289|FG004|Core Period: Baseline to Week 26|Death|0|||
125165433|NCT01081834|450230285|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
125165434|NCT01081834|450230286|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
125165435|NCT01081834|450230287|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
125165436|NCT01081834|450230288|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
125165437|NCT01081834|450230289|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
125165438|NCT01081834|450230285|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
125165439|NCT01081834|450230286|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
125165440|NCT01081834|450230287|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
125165441|NCT01081834|450230288|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
125165442|NCT01081834|450230289|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
125165443|NCT01081834|450230285|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
125165444|NCT01081834|450230286|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
125165445|NCT01081834|450230287|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
125165446|NCT01081834|450230288|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
125165447|NCT01081834|450230289|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
125165448|NCT01081834|450230285|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
125165449|NCT01081834|450230286|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
125165450|NCT01081834|450230287|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
125165451|NCT01081834|450230288|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
125165452|NCT01081834|450230289|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
125165453|NCT01081834|450230285|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
125165454|NCT01081834|450230286|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
125165455|NCT01081834|450230287|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
125165456|NCT01081834|450230288|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
125165457|NCT01081834|450230289|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
125165458|NCT01081834|450230285|FG000|Core Period: Baseline to Week 26|Other|4|||
125165459|NCT01081834|450230286|FG001|Core Period: Baseline to Week 26|Other|4|||
125165460|NCT01081834|450230287|FG002|Core Period: Baseline to Week 26|Other|3|||
125165461|NCT01081834|450230288|FG003|Core Period: Baseline to Week 26|Other|1|||
125165462|NCT01081834|450230289|FG004|Core Period: Baseline to Week 26|Other|0|||
125165463|NCT01081834|450230285|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
125165464|NCT01081834|450230286|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
125165465|NCT01081834|450230287|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
125165466|NCT01081834|450230288|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
125165467|NCT01081834|450230289|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
125165468|NCT01081834|450230285|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
125165469|NCT01081834|450230286|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
125165470|NCT01081834|450230287|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
125165471|NCT01081834|450230288|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
125165472|NCT01081834|450230289|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
125165473|NCT01081834|450230285|FG000|Extension Period: Week 26 to Week 52|Death|1|||
125165474|NCT01081834|450230286|FG001|Extension Period: Week 26 to Week 52|Death|0|||
125165475|NCT01081834|450230287|FG002|Extension Period: Week 26 to Week 52|Death|0|||
125165476|NCT01081834|450230288|FG003|Extension Period: Week 26 to Week 52|Death|0|||
125165477|NCT01081834|450230289|FG004|Extension Period: Week 26 to Week 52|Death|0|||
125165478|NCT01081834|450230285|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
125165479|NCT01081834|450230286|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
125165480|NCT01081834|450230287|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
125165481|NCT01081834|450230288|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
125165482|NCT01081834|450230289|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
125165483|NCT01081834|450230285|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
125165484|NCT01081834|450230286|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
125165485|NCT01081834|450230287|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
125165486|NCT01081834|450230288|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
125165487|NCT01081834|450230289|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
125165488|NCT01081834|450230285|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
125165489|NCT01081834|450230286|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
125225753|NCT00069264|450454361|FG000|Overall Study|Discon Therapy|3|||
125165490|NCT01081834|450230287|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
125165491|NCT01081834|450230288|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
125165492|NCT01081834|450230289|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
125165493|NCT01081834|450230285|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
125165494|NCT01081834|450230286|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
125165495|NCT01081834|450230287|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
125165496|NCT01081834|450230288|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
125165497|NCT01081834|450230289|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
125165498|NCT01081834|450230285|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
125165499|NCT01081834|450230286|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
125165500|NCT01081834|450230287|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
125165501|NCT01081834|450230288|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
125165502|NCT01081834|450230289|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
125165503|NCT01081834|450230285|FG000|Extension Period: Week 26 to Week 52|Other|4|||
125165504|NCT01081834|450230286|FG001|Extension Period: Week 26 to Week 52|Other|5|||
125165505|NCT01081834|450230287|FG002|Extension Period: Week 26 to Week 52|Other|4|||
125165506|NCT01081834|450230288|FG003|Extension Period: Week 26 to Week 52|Other|0|||
125165507|NCT01081834|450230289|FG004|Extension Period: Week 26 to Week 52|Other|0|||
125165508|NCT01081834|450230285|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
125165509|NCT01081834|450230286|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
125165510|NCT01081834|450230287|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
125165511|NCT01081834|450230288|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
125165512|NCT01081834|450230289|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
125165513|NCT01081834|450230285|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
125165514|NCT01081834|450230286|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
125165515|NCT01081834|450230287|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
125165516|NCT01081834|450230288|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
125165517|NCT01081834|450230289|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
125165518|NCT01475097|450230294|FG000|Overall Study|Protocol Violation|1|||
125165519|NCT01475097|450230295|FG001|Overall Study|Protocol Violation|1|||
125165520|NCT01085201|450230306|FG000|Overall Study|Scheduling conflict|1|||
125165521|NCT01085201|450230307|FG001|Overall Study|Scheduling conflict|0|||
125165522|NCT01085201|450230308|FG002|Overall Study|Scheduling conflict|1|||
125165523|NCT01085201|450230309|FG003|Overall Study|Scheduling conflict|0|||
125165524|NCT01085201|450230310|FG004|Overall Study|Scheduling conflict|0|||
125165525|NCT01085201|450230306|FG000|Overall Study|Unknown- no study drug|2|||
125165526|NCT01085201|450230307|FG001|Overall Study|Unknown- no study drug|0|||
125165527|NCT01085201|450230308|FG002|Overall Study|Unknown- no study drug|0|||
125165528|NCT01085201|450230309|FG003|Overall Study|Unknown- no study drug|0|||
125165529|NCT01085201|450230310|FG004|Overall Study|Unknown- no study drug|0|||
125165530|NCT01085201|450230306|FG000|Overall Study|Fond ineligible after consent|0|||
125165531|NCT01085201|450230307|FG001|Overall Study|Fond ineligible after consent|1|||
125165532|NCT01085201|450230308|FG002|Overall Study|Fond ineligible after consent|1|||
125165533|NCT01085201|450230309|FG003|Overall Study|Fond ineligible after consent|0|||
125165534|NCT01085201|450230310|FG004|Overall Study|Fond ineligible after consent|0|||
125165535|NCT00867503|450230315|FG000|Overall Study|Withdrawal by Subject|1|||
125165536|NCT01001988|450230316|FG000|Overall Study|Protocol Violation|84|||
125165537|NCT01001988|450230316|FG000|Overall Study|Withdrawal by Subject|18|||
125165538|NCT01001988|450230316|FG000|Overall Study|Lost to Follow-up|15|||
125165539|NCT01442688|450230319|FG000|First Intervention|Withdrawal by Subject|1|||
125165540|NCT01442688|450230320|FG001|First Intervention|Withdrawal by Subject|0|||
125165541|NCT01442688|450230319|FG000|First Intervention|subject incarcerated|1|||
125165542|NCT01442688|450230320|FG001|First Intervention|subject incarcerated|0|||
125165543|NCT01442688|450230319|FG000|Second Intervention|Adverse Event|1|||
125165544|NCT01442688|450230320|FG001|Second Intervention|Adverse Event|0|||
125165545|NCT00927394|450230321|FG000|Overall Study|Adverse Event|14|||
125165546|NCT00927394|450230322|FG001|Overall Study|Adverse Event|9|||
125165547|NCT00927394|450230321|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
125165548|NCT00927394|450230322|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
125165549|NCT00927394|450230321|FG000|Overall Study|Withdrawal by Subject|20|||
125165550|NCT00927394|450230322|FG001|Overall Study|Withdrawal by Subject|24|||
125165551|NCT00927394|450230321|FG000|Overall Study|Lost to Follow-up|8|||
125165552|NCT00927394|450230322|FG001|Overall Study|Lost to Follow-up|14|||
125165553|NCT00927394|450230321|FG000|Overall Study|Administrative Problem|1|||
125165554|NCT00927394|450230322|FG001|Overall Study|Administrative Problem|0|||
125225754|NCT05067972|450454362|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
125165555|NCT00927394|450230321|FG000|Overall Study|Death|1|||
125165556|NCT00927394|450230322|FG001|Overall Study|Death|1|||
125165557|NCT00927394|450230321|FG000|Overall Study|Protocol deviation|16|||
125165558|NCT00927394|450230322|FG001|Overall Study|Protocol deviation|13|||
125165559|NCT00927394|450230321|FG000|Overall Study|Randomized in error|0|||
125165560|NCT00927394|450230322|FG001|Overall Study|Randomized in error|1|||
125165561|NCT01221363|450230323|FG000|Overall Study|Pregnancy|1|||
125165562|NCT01221363|450230324|FG001|Overall Study|Pregnancy|0|||
125165563|NCT01221363|450230323|FG000|Overall Study|Withdrawal by Subject|11|||
125165564|NCT01221363|450230324|FG001|Overall Study|Withdrawal by Subject|5|||
125165565|NCT02865460|450230325|FG000|Overall Study|Adverse Event|1|||
125165566|NCT02865460|450230326|FG001|Overall Study|Adverse Event|0|||
125165567|NCT02865460|450230325|FG000|Overall Study|Withdrawal by Subject|1|||
125165568|NCT02865460|450230326|FG001|Overall Study|Withdrawal by Subject|1|||
125165569|NCT02865460|450230325|FG000|Overall Study|Lost to Follow-up|7|||
125165570|NCT02865460|450230326|FG001|Overall Study|Lost to Follow-up|4|||
125165571|NCT02865460|450230325|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
125165572|NCT02865460|450230326|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
125165573|NCT02238795|450230327|FG000|Overall Study|Patient without purpura fulminans|1|||
125165574|NCT04480710|450230330|FG000|Overall Study|Adverse Event|0|||
125165575|NCT04480710|450230331|FG001|Overall Study|Adverse Event|2|||
125165576|NCT04480710|450230332|FG002|Overall Study|Adverse Event|0|||
125165577|NCT04480710|450230333|FG003|Overall Study|Adverse Event|0|||
125165578|NCT04480710|450230330|FG000|Overall Study|Withdrawal by Subject|0|||
125165579|NCT04480710|450230331|FG001|Overall Study|Withdrawal by Subject|1|||
125225755|NCT05067972|450454363|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
125225756|NCT05067972|450454364|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
125225757|NCT05067972|450454365|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
125225758|NCT05067972|450454366|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
125225759|NCT05067972|450454367|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
125225760|NCT05067972|450454368|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
125225761|NCT05067972|450454362|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
125225762|NCT05067972|450454363|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
125225763|NCT05067972|450454364|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
125225764|NCT05067972|450454365|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
125225765|NCT05067972|450454366|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
125225766|NCT05067972|450454367|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
125225767|NCT05067972|450454368|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
125225768|NCT05067972|450454362|FG000|Part 1: Treatment|Progressive Disease|3|||
125225769|NCT05067972|450454363|FG001|Part 1: Treatment|Progressive Disease|3|||
125225770|NCT05067972|450454364|FG002|Part 1: Treatment|Progressive Disease|4|||
125225771|NCT05067972|450454365|FG003|Part 1: Treatment|Progressive Disease|2|||
125225772|NCT05067972|450454366|FG004|Part 1: Treatment|Progressive Disease|3|||
125225773|NCT05067972|450454367|FG005|Part 1: Treatment|Progressive Disease|0|||
125225774|NCT05067972|450454368|FG006|Part 1: Treatment|Progressive Disease|2|||
125225775|NCT05067972|450454362|FG000|Part 1: Treatment|Physician Decision|0|||
125225776|NCT05067972|450454363|FG001|Part 1: Treatment|Physician Decision|0|||
125225777|NCT05067972|450454364|FG002|Part 1: Treatment|Physician Decision|0|||
125225778|NCT05067972|450454365|FG003|Part 1: Treatment|Physician Decision|1|||
125225779|NCT05067972|450454366|FG004|Part 1: Treatment|Physician Decision|0|||
125225780|NCT05067972|450454367|FG005|Part 1: Treatment|Physician Decision|0|||
125225781|NCT05067972|450454368|FG006|Part 1: Treatment|Physician Decision|0|||
125225782|NCT05067972|450454362|FG000|Part 1: Treatment|Death|0|||
125225783|NCT05067972|450454363|FG001|Part 1: Treatment|Death|0|||
125225784|NCT05067972|450454364|FG002|Part 1: Treatment|Death|0|||
125225785|NCT05067972|450454365|FG003|Part 1: Treatment|Death|2|||
125225786|NCT05067972|450454366|FG004|Part 1: Treatment|Death|0|||
125225787|NCT05067972|450454367|FG005|Part 1: Treatment|Death|0|||
125225788|NCT05067972|450454368|FG006|Part 1: Treatment|Death|0|||
125225789|NCT05067972|450454362|FG000|Part 1: Treatment|Adverse Event|0|||
125225790|NCT05067972|450454363|FG001|Part 1: Treatment|Adverse Event|0|||
125225791|NCT05067972|450454364|FG002|Part 1: Treatment|Adverse Event|0|||
125225792|NCT05067972|450454365|FG003|Part 1: Treatment|Adverse Event|0|||
125225793|NCT05067972|450454366|FG004|Part 1: Treatment|Adverse Event|0|||
125225794|NCT05067972|450454367|FG005|Part 1: Treatment|Adverse Event|2|||
125225795|NCT05067972|450454368|FG006|Part 1: Treatment|Adverse Event|1|||
125225796|NCT05067972|450454362|FG000|Part 1: Follow-up|Adverse Event|0|||
125225797|NCT05067972|450454363|FG001|Part 1: Follow-up|Adverse Event|0|||
125225798|NCT05067972|450454364|FG002|Part 1: Follow-up|Adverse Event|0|||
125225799|NCT05067972|450454365|FG003|Part 1: Follow-up|Adverse Event|0|||
125225800|NCT05067972|450454366|FG004|Part 1: Follow-up|Adverse Event|0|||
125225801|NCT05067972|450454367|FG005|Part 1: Follow-up|Adverse Event|1|||
125225802|NCT05067972|450454368|FG006|Part 1: Follow-up|Adverse Event|0|||
125225803|NCT05067972|450454362|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
125225804|NCT05067972|450454363|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
125225805|NCT05067972|450454364|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
125225806|NCT05067972|450454365|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
125225807|NCT05067972|450454366|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
125225808|NCT05067972|450454367|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
125225809|NCT05067972|450454368|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
125225810|NCT05067972|450454362|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
125225811|NCT05067972|450454363|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
125225812|NCT05067972|450454364|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
125225813|NCT05067972|450454365|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
125225814|NCT05067972|450454366|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
125225815|NCT05067972|450454367|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
125225816|NCT05067972|450454368|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
125225817|NCT05067972|450454362|FG000|Part 1: Follow-up|Physician Decision|0|||
125225818|NCT05067972|450454363|FG001|Part 1: Follow-up|Physician Decision|0|||
125225819|NCT05067972|450454364|FG002|Part 1: Follow-up|Physician Decision|0|||
125225820|NCT05067972|450454365|FG003|Part 1: Follow-up|Physician Decision|1|||
125225821|NCT05067972|450454366|FG004|Part 1: Follow-up|Physician Decision|0|||
125225822|NCT05067972|450454367|FG005|Part 1: Follow-up|Physician Decision|0|||
125225823|NCT05067972|450454368|FG006|Part 1: Follow-up|Physician Decision|0|||
125225824|NCT05067972|450454362|FG000|Part 1: Follow-up|Death|1|||
125225825|NCT05067972|450454363|FG001|Part 1: Follow-up|Death|2|||
125225826|NCT05067972|450454364|FG002|Part 1: Follow-up|Death|1|||
125225827|NCT05067972|450454365|FG003|Part 1: Follow-up|Death|0|||
125225828|NCT05067972|450454366|FG004|Part 1: Follow-up|Death|1|||
125225829|NCT05067972|450454367|FG005|Part 1: Follow-up|Death|0|||
125225830|NCT05067972|450454368|FG006|Part 1: Follow-up|Death|1|||
125225831|NCT01091246|450454369|FG000|Overall Study|Lost to Follow-up|23|||
125225832|NCT01091246|450454370|FG001|Overall Study|Lost to Follow-up|11|||
125225833|NCT01091246|450454371|FG002|Overall Study|Lost to Follow-up|7|||
125225834|NCT01091246|450454369|FG000|Overall Study|Adverse Event|1|||
125225835|NCT01091246|450454370|FG001|Overall Study|Adverse Event|0|||
125225836|NCT01091246|450454371|FG002|Overall Study|Adverse Event|1|||
125225837|NCT01091246|450454369|FG000|Overall Study|Withdrawal by Subject|9|||
125225838|NCT01091246|450454370|FG001|Overall Study|Withdrawal by Subject|5|||
125225839|NCT01091246|450454371|FG002|Overall Study|Withdrawal by Subject|4|||
125225840|NCT01091246|450454369|FG000|Overall Study|Subject not dosed|2|||
125225841|NCT01091246|450454370|FG001|Overall Study|Subject not dosed|0|||
125225842|NCT01091246|450454371|FG002|Overall Study|Subject not dosed|1|||
125225843|NCT02287038|450454372|FG000|Overall Study|Stopped attending appointments|3|||
125225844|NCT02287038|450454373|FG001|Overall Study|Stopped attending appointments|2|||
125225845|NCT02287038|450454372|FG000|Overall Study|Anxiety after starting medication|0|||
125225846|NCT02287038|450454373|FG001|Overall Study|Anxiety after starting medication|1|||
125225847|NCT02287038|450454372|FG000|Overall Study|Nausea after starting medication|1|||
125225848|NCT02287038|450454373|FG001|Overall Study|Nausea after starting medication|0|||
125225849|NCT02287038|450454372|FG000|Overall Study|Abnormal ECG after starting medication|1|||
125225850|NCT02287038|450454373|FG001|Overall Study|Abnormal ECG after starting medication|0|||
125225851|NCT01676012|450454381|FG000|Overall Study|Adverse Event|2|||
125225852|NCT01676012|450454381|FG000|Overall Study|incomplete set of videos|1|||
125225853|NCT02667301|450454394|FG000|Overall Study|Adverse Event|1|||
125225854|NCT02667301|450454394|FG000|Overall Study|Lack of Efficacy|1|||
125225855|NCT02283658|450454395|FG000|Overall Study|Withdrawal by Subject|1|||
125225856|NCT03528551|450454397|FG000|Overall Study|Lost to Follow-up|0|||
125225857|NCT03528551|450454398|FG001|Overall Study|Lost to Follow-up|1|||
125225858|NCT03528551|450454399|FG002|Overall Study|Lost to Follow-up|0|||
125225859|NCT03528551|450454397|FG000|Overall Study|Transferred to other arm/group|2|||
125225860|NCT03528551|450454398|FG001|Overall Study|Transferred to other arm/group|3|||
125225861|NCT03528551|450454399|FG002|Overall Study|Transferred to other arm/group|0|||
125225862|NCT03528551|450454397|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125225863|NCT03528551|450454398|FG001|Overall Study|Withdrawal by parent/guardian|5|||
125225864|NCT03528551|450454399|FG002|Overall Study|Withdrawal by parent/guardian|0|||
125225865|NCT03528551|450454397|FG000|Overall Study|Protocol Violation|0|||
125225866|NCT03528551|450454398|FG001|Overall Study|Protocol Violation|3|||
125225867|NCT03528551|450454399|FG002|Overall Study|Protocol Violation|0|||
125225868|NCT03528551|450454397|FG000|Overall Study|Withdrawal by Subject|0|||
125225869|NCT03528551|450454398|FG001|Overall Study|Withdrawal by Subject|7|||
125225870|NCT03528551|450454399|FG002|Overall Study|Withdrawal by Subject|0|||
125225871|NCT00846586|450454400|FG000|Overall Study|Adverse Event|20|||
125225872|NCT00846586|450454401|FG001|Overall Study|Adverse Event|10|||
125225873|NCT00846586|450454400|FG000|Overall Study|Subject withdrew consent|8|||
125225874|NCT00846586|450454401|FG001|Overall Study|Subject withdrew consent|10|||
125225875|NCT00846586|450454400|FG000|Overall Study|Administrative problems|5|||
125225876|NCT00846586|450454401|FG001|Overall Study|Administrative problems|4|||
125225877|NCT00846586|450454400|FG000|Overall Study|Death|2|||
125225878|NCT00846586|450454401|FG001|Overall Study|Death|0|||
125225879|NCT00846586|450454400|FG000|Overall Study|Protocol deviation|2|||
125225880|NCT00846586|450454401|FG001|Overall Study|Protocol deviation|6|||
125225881|NCT00846586|450454400|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125225882|NCT00846586|450454401|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125225883|NCT00846586|450454400|FG000|Overall Study|Lost to Follow-up|1|||
125225884|NCT00846586|450454401|FG001|Overall Study|Lost to Follow-up|4|||
125225885|NCT00846586|450454400|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125225886|NCT00846586|450454401|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125225887|NCT00689338|450454402|FG000|Overall Study|Death|65|||
125225888|NCT00689338|450454402|FG000|Overall Study|Adverse Event|13|||
125225889|NCT00689338|450454402|FG000|Overall Study|Insufficient Clinical Response|1|||
125225890|NCT00689338|450454402|FG000|Overall Study|Lack of Efficacy|6|||
125225891|NCT00689338|450454402|FG000|Overall Study|Other|8|||
125225892|NCT00689338|450454402|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
125225893|NCT00689338|450454402|FG000|Overall Study|Lost to Follow-up|5|||
125225894|NCT00689338|450454402|FG000|Overall Study|Withdrawal by Subject|3|||
125225895|NCT00689338|450454402|FG000|Overall Study|Protocol Violation|15|||
125225896|NCT01061606|450454403|FG000|Overall Study|Adverse Event|1|||
125225897|NCT01061606|450454403|FG000|Overall Study|Death|1|||
125225898|NCT01061606|450454403|FG000|Overall Study|Disease Progression|4|||
125225899|NCT01061606|450454403|FG000|Overall Study|alternative therapy|2|||
125225900|NCT00735007|450454404|FG000|Overall Study|Adverse Event|4|||
125225901|NCT00735007|450454404|FG000|Overall Study|Protocol Violation|1|||
125225902|NCT01789047|450454405|FG000|Overall Study|Adverse Event|3|||
125225903|NCT01789047|450454406|FG001|Overall Study|Adverse Event|2|||
125225904|NCT01789047|450454405|FG000|Overall Study|Withdrawal by Subject|1|||
125225905|NCT01789047|450454406|FG001|Overall Study|Withdrawal by Subject|2|||
125225906|NCT03644017|450454407|FG000|Overall Study|Access Abandonment|5|||
125225907|NCT03644017|450454407|FG000|Overall Study|Kidney Transplant|2|||
125225908|NCT02700048|450454408|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
125225909|NCT02700048|450454409|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
125225910|NCT02340000|450454412|FG000|Time Period 1|Withdrawal by Subject|6|||
125225911|NCT02340000|450454413|FG001|Time Period 1|Withdrawal by Subject|8|||
125225912|NCT02340000|450454412|FG000|Time Period 1|Lost to Follow-up|6|||
125225913|NCT02340000|450454413|FG001|Time Period 1|Lost to Follow-up|7|||
125225914|NCT02340000|450454412|FG000|Time Period 2|Withdrawal by Subject|9|||
125225915|NCT02340000|450454413|FG001|Time Period 2|Withdrawal by Subject|7|||
125225916|NCT02340000|450454412|FG000|Time Period 2|Lost to Follow-up|10|||
125225917|NCT02340000|450454413|FG001|Time Period 2|Lost to Follow-up|8|||
125225918|NCT02668640|450454414|FG000|Overall Study|Lost to Follow-up|13|||
125225919|NCT02668640|450454414|FG000|Overall Study|Other, not specified|1|||
125225920|NCT03669588|450454415|FG000|Overall Study|Adverse Event|1|||
125225921|NCT03669588|450454416|FG001|Overall Study|Adverse Event|0|||
125225922|NCT03669588|450454415|FG000|Overall Study|Physician Decision|0|||
125225923|NCT03669588|450454416|FG001|Overall Study|Physician Decision|1|||
125225924|NCT03669588|450454415|FG000|Overall Study|Protocol Violation|1|||
125225925|NCT03669588|450454416|FG001|Overall Study|Protocol Violation|0|||
125225926|NCT03669588|450454415|FG000|Overall Study|Sponsor Decision|1|||
125225927|NCT03669588|450454416|FG001|Overall Study|Sponsor Decision|1|||
125225928|NCT03669588|450454415|FG000|Overall Study|Withdrawal by Subject|1|||
125225929|NCT03669588|450454416|FG001|Overall Study|Withdrawal by Subject|4|||
125225930|NCT03669588|450454415|FG000|Overall Study|Rescue Therapy Needed|0|||
125225931|NCT03669588|450454416|FG001|Overall Study|Rescue Therapy Needed|1|||
125225932|NCT00369343|450454417|FG000|Double-blind Phase|Adverse Event|19|||
125225933|NCT00369343|450454418|FG001|Double-blind Phase|Adverse Event|4|||
125225934|NCT00369343|450454417|FG000|Double-blind Phase|Failed to return|2|||
125225935|NCT00369343|450454418|FG001|Double-blind Phase|Failed to return|0|||
125225936|NCT00369343|450454417|FG000|Double-blind Phase|Lost to Follow-up|9|||
125225937|NCT00369343|450454418|FG001|Double-blind Phase|Lost to Follow-up|2|||
125225938|NCT00369343|450454417|FG000|Double-blind Phase|Protocol Violation|2|||
125225939|NCT00369343|450454418|FG001|Double-blind Phase|Protocol Violation|0|||
125225940|NCT00369343|450454417|FG000|Double-blind Phase|Withdrawal by Subject|8|||
125225941|NCT00369343|450454418|FG001|Double-blind Phase|Withdrawal by Subject|6|||
125225942|NCT00369343|450454417|FG000|Double-blind Phase|Lack of Efficacy|0|||
125225943|NCT00369343|450454418|FG001|Double-blind Phase|Lack of Efficacy|4|||
125225944|NCT00369343|450454417|FG000|Double-blind Phase|Protocol deviation|4|||
125225945|NCT00369343|450454418|FG001|Double-blind Phase|Protocol deviation|0|||
125225946|NCT00369343|450454417|FG000|Open-label Phase|Adverse Event|19|||
125225947|NCT00369343|450454418|FG001|Open-label Phase|Adverse Event|7|||
125225948|NCT00369343|450454417|FG000|Open-label Phase|Failed to return|4|||
125225949|NCT00369343|450454418|FG001|Open-label Phase|Failed to return|0|||
125225950|NCT00369343|450454417|FG000|Open-label Phase|Physician Decision|2|||
125225951|NCT00369343|450454418|FG001|Open-label Phase|Physician Decision|0|||
125225952|NCT00369343|450454417|FG000|Open-label Phase|Lost to Follow-up|5|||
125225953|NCT00369343|450454418|FG001|Open-label Phase|Lost to Follow-up|3|||
125225954|NCT00369343|450454417|FG000|Open-label Phase|inadvertently reported study completers|3|||
125225955|NCT00369343|450454418|FG001|Open-label Phase|inadvertently reported study completers|2|||
125225956|NCT00369343|450454417|FG000|Open-label Phase|Protocol Violation|1|||
125225957|NCT00369343|450454418|FG001|Open-label Phase|Protocol Violation|3|||
125225958|NCT00369343|450454417|FG000|Open-label Phase|Withdrawal by Subject|15|||
125225959|NCT00369343|450454418|FG001|Open-label Phase|Withdrawal by Subject|6|||
125225960|NCT00369343|450454417|FG000|Open-label Phase|Lack of Efficacy|4|||
125225961|NCT00369343|450454418|FG001|Open-label Phase|Lack of Efficacy|3|||
125225962|NCT00369343|450454417|FG000|Open-label Phase|Lack of continuance tolerability|3|||
125225963|NCT00369343|450454418|FG001|Open-label Phase|Lack of continuance tolerability|4|||
125225964|NCT00369343|450454417|FG000|Open-label Phase|did not take study drug|1|||
125225965|NCT00369343|450454418|FG001|Open-label Phase|did not take study drug|2|||
125225966|NCT01100502|450454419|FG000|Overall Study|Withdrawal by Subject|18|||
125225967|NCT01100502|450454420|FG001|Overall Study|Withdrawal by Subject|25|||
125225968|NCT01100502|450454419|FG000|Overall Study|Lost to Follow-up|13|||
125225969|NCT01100502|450454420|FG001|Overall Study|Lost to Follow-up|28|||
125225970|NCT01100502|450454419|FG000|Overall Study|Site request to end participation in study|0|||
125225971|NCT01100502|450454420|FG001|Overall Study|Site request to end participation in study|1|||
125225972|NCT01100502|450454419|FG000|Overall Study|Death|45|||
125225973|NCT01100502|450454420|FG001|Overall Study|Death|40|||
125225974|NCT01190813|450454423|FG000|Overall Study|Lost to Follow-up|1|||
125225975|NCT01190813|450454424|FG001|Overall Study|Lost to Follow-up|2|||
125225976|NCT01190813|450454423|FG000|Overall Study|Withdrawal by Subject|2|||
125225977|NCT01190813|450454424|FG001|Overall Study|Withdrawal by Subject|1|||
125225978|NCT01190813|450454423|FG000|Overall Study|Refused study treatment after randomized|1|||
125225979|NCT01190813|450454424|FG001|Overall Study|Refused study treatment after randomized|0|||
125225980|NCT01190813|450454423|FG000|Overall Study|Adverse Event|0|||
125225981|NCT01190813|450454424|FG001|Overall Study|Adverse Event|1|||
125225982|NCT02481050|450456014|FG000|Overall Study|Adverse Event|1|||
125225983|NCT02481050|450456014|FG000|Overall Study|Disease Progression|47|||
125225984|NCT02481050|450456014|FG000|Overall Study|Withdrawal by Subject|7|||
125225985|NCT02481050|450456014|FG000|Overall Study|Other|3|||
125225986|NCT01386606|450456015|FG000|Overall Study|Adverse Event|0|||
125225987|NCT01386606|450456016|FG001|Overall Study|Adverse Event|1|||
125225988|NCT01386606|450456017|FG002|Overall Study|Adverse Event|0|||
125225989|NCT01386606|450456018|FG003|Overall Study|Adverse Event|0|||
125225990|NCT01386606|450456015|FG000|Overall Study|Withdrawal by Subject|0|||
125225991|NCT01386606|450456016|FG001|Overall Study|Withdrawal by Subject|1|||
125225992|NCT01386606|450456017|FG002|Overall Study|Withdrawal by Subject|1|||
125225993|NCT01386606|450456018|FG003|Overall Study|Withdrawal by Subject|0|||
125225994|NCT01386606|450456015|FG000|Overall Study|Protocol Violation|1|||
125225995|NCT01386606|450456016|FG001|Overall Study|Protocol Violation|0|||
125225996|NCT01386606|450456017|FG002|Overall Study|Protocol Violation|1|||
125225997|NCT01386606|450456018|FG003|Overall Study|Protocol Violation|1|||
125225998|NCT01386606|450456015|FG000|Overall Study|Lost to Follow-up|2|||
125225999|NCT01386606|450456016|FG001|Overall Study|Lost to Follow-up|0|||
125226000|NCT01386606|450456017|FG002|Overall Study|Lost to Follow-up|0|||
125226001|NCT01386606|450456018|FG003|Overall Study|Lost to Follow-up|0|||
125226002|NCT01386606|450456015|FG000|Overall Study|Subject incarcerated|0|||
125226003|NCT01386606|450456016|FG001|Overall Study|Subject incarcerated|1|||
125226004|NCT01386606|450456017|FG002|Overall Study|Subject incarcerated|0|||
125226005|NCT01386606|450456018|FG003|Overall Study|Subject incarcerated|0|||
125226006|NCT01386606|450456015|FG000|Overall Study|Unable to draw PK|1|||
125226007|NCT01386606|450456016|FG001|Overall Study|Unable to draw PK|0|||
125226008|NCT01386606|450456017|FG002|Overall Study|Unable to draw PK|0|||
125226009|NCT01386606|450456018|FG003|Overall Study|Unable to draw PK|0|||
125226010|NCT01386606|450456015|FG000|Overall Study|T levels too high|0|||
125226011|NCT01386606|450456016|FG001|Overall Study|T levels too high|1|||
125226012|NCT01386606|450456017|FG002|Overall Study|T levels too high|1|||
125226013|NCT01386606|450456018|FG003|Overall Study|T levels too high|0|||
125226014|NCT03246347|450456021|FG000|Overall Study|On Study|23|||
125226015|NCT01022203|450456022|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
125226016|NCT01022203|450456023|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
125226017|NCT01022203|450456022|FG000|Post Treatment Assessment|Physician Decision|2|||
125226018|NCT01022203|450456023|FG001|Post Treatment Assessment|Physician Decision|0|||
125226019|NCT01022203|450456022|FG000|Post Treatment Assessment|Adverse Event|0|||
125226020|NCT01022203|450456023|FG001|Post Treatment Assessment|Adverse Event|2|||
125226021|NCT01022203|450456022|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
125226022|NCT01022203|450456023|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
125226023|NCT00903201|450456024|FG000|Overall Study|Adverse Event|1|||
125226024|NCT00903201|450456025|FG001|Overall Study|Adverse Event|4|||
125226025|NCT00903201|450456026|FG002|Overall Study|Adverse Event|0|||
125226026|NCT00903201|450456024|FG000|Overall Study|Protocol Violation|2|||
125226027|NCT00903201|450456025|FG001|Overall Study|Protocol Violation|1|||
125226028|NCT00903201|450456026|FG002|Overall Study|Protocol Violation|0|||
125226029|NCT00903201|450456024|FG000|Overall Study|Lost to Follow-up|0|||
125226030|NCT00903201|450456025|FG001|Overall Study|Lost to Follow-up|1|||
125226031|NCT00903201|450456026|FG002|Overall Study|Lost to Follow-up|0|||
125226032|NCT00903201|450456024|FG000|Overall Study|Physician Decision|1|||
125226033|NCT00903201|450456025|FG001|Overall Study|Physician Decision|0|||
125226034|NCT00903201|450456026|FG002|Overall Study|Physician Decision|1|||
125226035|NCT00903201|450456024|FG000|Overall Study|Withdrawal by Subject|1|||
125226036|NCT00903201|450456025|FG001|Overall Study|Withdrawal by Subject|0|||
125226037|NCT00903201|450456026|FG002|Overall Study|Withdrawal by Subject|1|||
125226038|NCT04069715|450456028|FG000|Overall Study|Lost to Follow-up|1|||
125226039|NCT04069715|450456029|FG001|Overall Study|Lost to Follow-up|1|||
125226040|NCT04069715|450456028|FG000|Overall Study|Physician Decision|1|||
125226041|NCT04069715|450456029|FG001|Overall Study|Physician Decision|1|||
125226042|NCT04069715|450456028|FG000|Overall Study|Withdrawal by Subject|3|||
125226043|NCT04069715|450456029|FG001|Overall Study|Withdrawal by Subject|3|||
125226044|NCT03205150|450456030|FG000|Overall Study|Protocol deviation|1|||
125226045|NCT03205150|450456031|FG001|Overall Study|Protocol deviation|3|||
125226046|NCT03205150|450456032|FG002|Overall Study|Protocol deviation|0|||
125226047|NCT03205150|450456030|FG000|Overall Study|Patient/guardian decision|0|||
125226048|NCT03205150|450456031|FG001|Overall Study|Patient/guardian decision|3|||
125226049|NCT03205150|450456032|FG002|Overall Study|Patient/guardian decision|0|||
125226050|NCT03205150|450456030|FG000|Overall Study|Adverse Event|1|||
125226051|NCT03205150|450456031|FG001|Overall Study|Adverse Event|1|||
125226052|NCT03205150|450456032|FG002|Overall Study|Adverse Event|1|||
125226053|NCT03205150|450456030|FG000|Overall Study|Lost to Follow-up|0|||
125226054|NCT03205150|450456031|FG001|Overall Study|Lost to Follow-up|0|||
125226055|NCT03205150|450456032|FG002|Overall Study|Lost to Follow-up|1|||
125226056|NCT02723188|450456033|FG000|Overall Study|Withdrawal by Subject|1|||
125226057|NCT02723188|450456034|FG001|Overall Study|Withdrawal by Subject|0|||
125226058|NCT02723188|450456035|FG002|Overall Study|Withdrawal by Subject|0|||
125226059|NCT03652818|450456043|FG000|Overall Study|Adverse Event|1|||
125226060|NCT03652818|450456044|FG001|Overall Study|Adverse Event|0|||
125226061|NCT03652818|450456045|FG002|Overall Study|Adverse Event|0|||
125226062|NCT03652818|450456046|FG003|Overall Study|Adverse Event|0|||
125226063|NCT03652818|450456047|FG004|Overall Study|Adverse Event|0|||
125226064|NCT03652818|450456043|FG000|Overall Study|Physician Decision|1|||
125226065|NCT03652818|450456044|FG001|Overall Study|Physician Decision|0|||
125226066|NCT03652818|450456045|FG002|Overall Study|Physician Decision|0|||
125226067|NCT03652818|450456046|FG003|Overall Study|Physician Decision|0|||
125226068|NCT03652818|450456047|FG004|Overall Study|Physician Decision|0|||
125226069|NCT03652818|450456043|FG000|Overall Study|Lost to Follow-up|0|||
125226070|NCT03652818|450456044|FG001|Overall Study|Lost to Follow-up|1|||
125226071|NCT03652818|450456045|FG002|Overall Study|Lost to Follow-up|2|||
125226072|NCT03652818|450456046|FG003|Overall Study|Lost to Follow-up|1|||
125226073|NCT03652818|450456047|FG004|Overall Study|Lost to Follow-up|1|||
125226074|NCT01930539|450456049|FG000|Overall Study|Withdrawal by Subject|2|||
125226075|NCT01930539|450456050|FG001|Overall Study|Withdrawal by Subject|2|||
125226076|NCT01241279|450456051|FG000|Overall Study|Lost to Follow-up|0|||
125226077|NCT01241279|450456052|FG001|Overall Study|Lost to Follow-up|1|||
125226078|NCT00301834|450456055|FG000|Overall Study|Death|1|||
125226079|NCT01811732|450456056|FG000|Overall Study|Lost to Follow-up|24|||
125226080|NCT01811732|450456057|FG001|Overall Study|Lost to Follow-up|30|||
125226081|NCT01811732|450456056|FG000|Overall Study|Withdrawal by Subject|16|||
125226082|NCT01811732|450456057|FG001|Overall Study|Withdrawal by Subject|10|||
125226083|NCT01811732|450456056|FG000|Overall Study|Adverse Event|3|||
125226084|NCT01811732|450456057|FG001|Overall Study|Adverse Event|9|||
125226085|NCT01811732|450456056|FG000|Overall Study|Lack of Efficacy|3|||
125226086|NCT01811732|450456057|FG001|Overall Study|Lack of Efficacy|1|||
125226087|NCT01811732|450456056|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
125226088|NCT01811732|450456057|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
125226089|NCT01811732|450456056|FG000|Overall Study|Physician Decision|2|||
125226090|NCT01811732|450456057|FG001|Overall Study|Physician Decision|0|||
125226091|NCT01811732|450456056|FG000|Overall Study|Death|1|||
125226092|NCT01811732|450456057|FG001|Overall Study|Death|1|||
125226093|NCT01811732|450456056|FG000|Overall Study|Insufficient venous access|0|||
125226094|NCT01811732|450456057|FG001|Overall Study|Insufficient venous access|1|||
125226095|NCT01811732|450456056|FG000|Overall Study|Protocol Violation|0|||
125226096|NCT01811732|450456057|FG001|Overall Study|Protocol Violation|1|||
125226097|NCT01811732|450456056|FG000|Overall Study|Subject incarcerated|1|||
125226098|NCT01811732|450456057|FG001|Overall Study|Subject incarcerated|2|||
125226099|NCT01811732|450456056|FG000|Overall Study|Admitted to another facility|1|||
125226100|NCT01811732|450456057|FG001|Overall Study|Admitted to another facility|0|||
125226101|NCT01811732|450456056|FG000|Overall Study|Correct study drug not available on site|1|||
125226102|NCT01811732|450456057|FG001|Overall Study|Correct study drug not available on site|0|||
125226103|NCT01607593|450456058|FG000|Overall Study|Adverse Event|15|||
125226104|NCT01607593|450456058|FG000|Overall Study|Lack of Efficacy|16|||
125226105|NCT01607593|450456058|FG000|Overall Study|Lost to Follow-up|25|||
125226106|NCT01607593|450456058|FG000|Overall Study|Continuation|33|||
125226107|NCT01607593|450456058|FG000|Overall Study|Other|4|||
125226108|NCT03669549|450456061|FG000|Overall Study|Adverse Event|4|||
125226109|NCT03669549|450456061|FG000|Overall Study|Withdrawal by Subject|1|||
125226110|NCT03669549|450456061|FG000|Overall Study|Study terminated by the Sponsor|1|||
125226111|NCT02974868|450456062|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
125226112|NCT02974868|450456063|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
125226113|NCT02974868|450456064|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
125226114|NCT02974868|450456065|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
125226115|NCT02974868|450456062|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
125226116|NCT02974868|450456063|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
125226117|NCT02974868|450456064|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
125226118|NCT02974868|450456065|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
125226119|NCT02974868|450456062|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
125226120|NCT02974868|450456063|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
125226121|NCT02974868|450456064|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
125226122|NCT02974868|450456065|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
125226123|NCT02974868|450456062|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
125226124|NCT02974868|450456063|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
125226125|NCT02974868|450456064|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
125226126|NCT02974868|450456065|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
125226127|NCT00297648|450456068|FG000|Overall Study|Adverse Event|13|||
125226128|NCT00297648|450456068|FG000|Overall Study|Lack of Efficacy|18|||
125226129|NCT00297648|450456068|FG000|Overall Study|Lost to Follow-up|1|||
125226130|NCT00297648|450456068|FG000|Overall Study|Withdrawal by Subject|3|||
125226131|NCT00297648|450456068|FG000|Overall Study|Other: Incompliance|1|||
125165580|NCT04480710|450230332|FG002|Overall Study|Withdrawal by Subject|0|||
125165581|NCT04480710|450230333|FG003|Overall Study|Withdrawal by Subject|0|||
125165582|NCT04480710|450230330|FG000|Overall Study|Physician Decision|0|||
125165583|NCT04480710|450230331|FG001|Overall Study|Physician Decision|0|||
125226132|NCT03903172|450456069|FG000|Overall Study|screen fail|4|||
125226133|NCT03903172|450456070|FG001|Overall Study|screen fail|1|||
125226134|NCT01545388|450456071|FG000|Overall Study|Adverse Event|2|||
125226135|NCT01545388|450456072|FG001|Overall Study|Adverse Event|4|||
125226136|NCT01545388|450456073|FG002|Overall Study|Adverse Event|1|||
125226137|NCT01545388|450456071|FG000|Overall Study|Lack of Efficacy|3|||
125226138|NCT01545388|450456072|FG001|Overall Study|Lack of Efficacy|2|||
125226139|NCT01545388|450456073|FG002|Overall Study|Lack of Efficacy|5|||
125226140|NCT01545388|450456071|FG000|Overall Study|Participant moved or relocated|1|||
125226141|NCT01545388|450456072|FG001|Overall Study|Participant moved or relocated|0|||
125226142|NCT01545388|450456073|FG002|Overall Study|Participant moved or relocated|0|||
125226143|NCT01545388|450456071|FG000|Overall Study|Withdrawal by Subject|1|||
125226144|NCT01545388|450456072|FG001|Overall Study|Withdrawal by Subject|4|||
125226145|NCT01545388|450456073|FG002|Overall Study|Withdrawal by Subject|2|||
125226146|NCT01545388|450456071|FG000|Overall Study|Other|1|||
125226147|NCT01545388|450456072|FG001|Overall Study|Other|1|||
125226148|NCT01545388|450456073|FG002|Overall Study|Other|0|||
125226149|NCT01701245|450456074|FG000|Overall Study|Protocol Violation|1|||
125226150|NCT01701245|450456075|FG001|Overall Study|Protocol Violation|3|||
125226151|NCT01701245|450456074|FG000|Overall Study|Did not complete the open label period|11|||
125226152|NCT01701245|450456075|FG001|Overall Study|Did not complete the open label period|12|||
125226153|NCT01867008|450456080|FG000|Overall Study|Withdrawal by Subject|1|||
125226154|NCT04613518|450456081|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
125226155|NCT04613518|450456082|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
125226156|NCT04613518|450456083|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
125226157|NCT04613518|450456081|FG000|Double-Blind Treatment Period|Adverse Event|2|||
125226158|NCT04613518|450456082|FG001|Double-Blind Treatment Period|Adverse Event|0|||
125226159|NCT04613518|450456083|FG002|Double-Blind Treatment Period|Adverse Event|1|||
125226160|NCT04613518|450456081|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
125226161|NCT04613518|450456082|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
125226162|NCT04613518|450456083|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
125226163|NCT04613518|450456081|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
125226164|NCT04613518|450456082|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
125226165|NCT04613518|450456083|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
125226166|NCT04613518|450456081|FG000|Double-Blind Treatment Period|Other Reasons|2|||
125226167|NCT04613518|450456082|FG001|Double-Blind Treatment Period|Other Reasons|0|||
125226168|NCT04613518|450456083|FG002|Double-Blind Treatment Period|Other Reasons|0|||
125226169|NCT04613518|450456081|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
125226170|NCT04613518|450456082|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
125226171|NCT04613518|450456083|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
125226172|NCT04613518|450456081|FG000|Open-Label Treatment Period|Adverse Event|1|||
125226173|NCT04613518|450456082|FG001|Open-Label Treatment Period|Adverse Event|0|||
125226174|NCT04613518|450456083|FG002|Open-Label Treatment Period|Adverse Event|3|||
125226175|NCT04613518|450456081|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
125226176|NCT04613518|450456082|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
125226177|NCT04613518|450456083|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
125226178|NCT04613518|450456081|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
125226179|NCT04613518|450456082|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
125226180|NCT04613518|450456083|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
125226181|NCT04613518|450456081|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
125226182|NCT04613518|450456082|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
125226183|NCT04613518|450456083|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
125226184|NCT04613518|450456081|FG000|Open-Label Treatment Period|Other reasons|1|||
125226185|NCT04613518|450456082|FG001|Open-Label Treatment Period|Other reasons|0|||
125226186|NCT04613518|450456083|FG002|Open-Label Treatment Period|Other reasons|0|||
125226187|NCT05616013|450456084|FG000|Overall Study|Adverse Event|6|||
125226188|NCT05616013|450456085|FG001|Overall Study|Adverse Event|12|||
125226189|NCT05616013|450456086|FG002|Overall Study|Adverse Event|8|||
125226190|NCT05616013|450456087|FG003|Overall Study|Adverse Event|4|||
125226191|NCT05616013|450456088|FG004|Overall Study|Adverse Event|6|||
125226192|NCT05616013|450456089|FG005|Overall Study|Adverse Event|8|||
125226193|NCT05616013|450456090|FG006|Overall Study|Adverse Event|3|||
125226194|NCT05616013|450456091|FG007|Overall Study|Adverse Event|6|||
125226195|NCT05616013|450456092|FG008|Overall Study|Adverse Event|1|||
125226196|NCT05616013|450456084|FG000|Overall Study|Lost to Follow-up|5|||
125226197|NCT05616013|450456085|FG001|Overall Study|Lost to Follow-up|4|||
125226198|NCT05616013|450456086|FG002|Overall Study|Lost to Follow-up|3|||
125226199|NCT05616013|450456087|FG003|Overall Study|Lost to Follow-up|2|||
125226200|NCT05616013|450456088|FG004|Overall Study|Lost to Follow-up|0|||
125226201|NCT05616013|450456089|FG005|Overall Study|Lost to Follow-up|5|||
125226202|NCT05616013|450456090|FG006|Overall Study|Lost to Follow-up|2|||
125226203|NCT05616013|450456091|FG007|Overall Study|Lost to Follow-up|1|||
125226204|NCT05616013|450456092|FG008|Overall Study|Lost to Follow-up|2|||
125165584|NCT04480710|450230332|FG002|Overall Study|Physician Decision|1|||
125165585|NCT04480710|450230333|FG003|Overall Study|Physician Decision|0|||
125165586|NCT04480021|450230334|FG000|Overall Study|Lost to Follow-up|3|||
125165587|NCT04480021|450230335|FG001|Overall Study|Lost to Follow-up|4|||
125165588|NCT03384654|450230339|FG000|Overall Study|Withdrawal by Subject|0|||
125165589|NCT03384654|450230340|FG001|Overall Study|Withdrawal by Subject|0|||
125165590|NCT03384654|450230341|FG002|Overall Study|Withdrawal by Subject|1|||
125165591|NCT03384654|450230342|FG003|Overall Study|Withdrawal by Subject|0|||
125165592|NCT00423319|450230343|FG000|Overall Study|Death|2|||
125165593|NCT00423319|450230344|FG001|Overall Study|Death|0|||
125165594|NCT00423319|450230343|FG000|Overall Study|Adverse Event|93|||
125165595|NCT00423319|450230344|FG001|Overall Study|Adverse Event|112|||
125165596|NCT00423319|450230343|FG000|Overall Study|Withdrawal by Subject|86|||
125165597|NCT00423319|450230344|FG001|Overall Study|Withdrawal by Subject|99|||
125165598|NCT00423319|450230343|FG000|Overall Study|Lost to Follow-up|4|||
125165599|NCT00423319|450230344|FG001|Overall Study|Lost to Follow-up|3|||
125165600|NCT00423319|450230343|FG000|Overall Study|Poor compliance or noncompliance|1|||
125165601|NCT00423319|450230344|FG001|Overall Study|Poor compliance or noncompliance|1|||
125165602|NCT00423319|450230343|FG000|Overall Study|No longer meets study criteria|15|||
125165603|NCT00423319|450230344|FG001|Overall Study|No longer meets study criteria|15|||
125165604|NCT00423319|450230343|FG000|Overall Study|Other|23|||
125165605|NCT00423319|450230344|FG001|Overall Study|Other|22|||
125165606|NCT01584843|450230345|FG000|First Treatment Period|Adverse Event|0|||
125165607|NCT01584843|450230346|FG001|First Treatment Period|Adverse Event|0|||
125165608|NCT01584843|450230347|FG002|First Treatment Period|Adverse Event|1|||
125165609|NCT01584843|450230348|FG003|First Treatment Period|Adverse Event|0|||
125165610|NCT01584843|450230349|FG004|First Treatment Period|Adverse Event|0|||
125165611|NCT01584843|450230350|FG005|First Treatment Period|Adverse Event|0|||
125165612|NCT01584843|450230345|FG000|First Treatment Period|Protocol Violation|0|||
125165613|NCT01584843|450230346|FG001|First Treatment Period|Protocol Violation|0|||
125165614|NCT01584843|450230347|FG002|First Treatment Period|Protocol Violation|0|||
125165615|NCT01584843|450230348|FG003|First Treatment Period|Protocol Violation|0|||
125165616|NCT01584843|450230349|FG004|First Treatment Period|Protocol Violation|0|||
125165617|NCT01584843|450230350|FG005|First Treatment Period|Protocol Violation|1|||
125165618|NCT01584843|450230345|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
125165619|NCT01584843|450230346|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
125165620|NCT01584843|450230347|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
125165621|NCT01584843|450230348|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
125165622|NCT01584843|450230349|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
125165623|NCT01584843|450230350|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
125165624|NCT01584843|450230345|FG000|Second Treatment Period|Withdrawal by Subject|0|||
125165625|NCT01584843|450230346|FG001|Second Treatment Period|Withdrawal by Subject|0|||
125165626|NCT01584843|450230347|FG002|Second Treatment Period|Withdrawal by Subject|0|||
125165627|NCT01584843|450230348|FG003|Second Treatment Period|Withdrawal by Subject|0|||
125165628|NCT01584843|450230349|FG004|Second Treatment Period|Withdrawal by Subject|0|||
125165629|NCT01584843|450230350|FG005|Second Treatment Period|Withdrawal by Subject|1|||
125165630|NCT00311402|450230351|FG000|Overall Study|Adverse Event|118|||
125165631|NCT00311402|450230352|FG001|Overall Study|Adverse Event|105|||
125165632|NCT00311402|450230351|FG000|Overall Study|Lost to Follow-up|0|||
125165633|NCT00311402|450230352|FG001|Overall Study|Lost to Follow-up|3|||
125165634|NCT00311402|450230351|FG000|Overall Study|Withdrawal by Subject|17|||
125165635|NCT00311402|450230352|FG001|Overall Study|Withdrawal by Subject|18|||
125165636|NCT00311402|450230351|FG000|Overall Study|Lack of Efficacy|58|||
125165637|NCT00311402|450230352|FG001|Overall Study|Lack of Efficacy|42|||
125165638|NCT00311402|450230351|FG000|Overall Study|Protocol Violation|7|||
125165639|NCT00311402|450230352|FG001|Overall Study|Protocol Violation|6|||
125165640|NCT00311402|450230351|FG000|Overall Study|IRB's rejection etc.|10|||
125165641|NCT00311402|450230352|FG001|Overall Study|IRB's rejection etc.|3|||
125165642|NCT02640053|450230353|FG000|Overall Study|Withdrawal by Subject|2|||
125165643|NCT02640053|450230354|FG001|Overall Study|Withdrawal by Subject|1|||
125165644|NCT02640053|450230353|FG000|Overall Study|Adverse Event|1|||
125165645|NCT02640053|450230354|FG001|Overall Study|Adverse Event|1|||
125165646|NCT02640053|450230353|FG000|Overall Study|Alternative Therapy|1|||
125165647|NCT02640053|450230354|FG001|Overall Study|Alternative Therapy|1|||
125165648|NCT02640053|450230353|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
125165649|NCT02640053|450230354|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
125165650|NCT03283761|450230355|FG000|Study Treatment|Patient Non-Compliance|1|||
125165651|NCT03283761|450230355|FG000|Study Treatment|Alternative Cancer Therapy|7|||
125165652|NCT03283761|450230355|FG000|Study Treatment|Disease progression|21|||
125165653|NCT03283761|450230355|FG000|Study Treatment|Adverse Event|3|||
125165654|NCT03283761|450230355|FG000|Study Treatment|Withdrawal by Subject|4|||
125165655|NCT03283761|450230355|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
125165656|NCT03283761|450230355|FG000|Study Treatment|Symptomatic Deterioration|1|||
125165657|NCT03283761|450230355|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
125226205|NCT05616013|450456084|FG000|Overall Study|Non-compliance with study requirements|2|||
125226206|NCT05616013|450456085|FG001|Overall Study|Non-compliance with study requirements|2|||
125226207|NCT05616013|450456086|FG002|Overall Study|Non-compliance with study requirements|2|||
125226208|NCT05616013|450456087|FG003|Overall Study|Non-compliance with study requirements|3|||
125226209|NCT05616013|450456088|FG004|Overall Study|Non-compliance with study requirements|0|||
125226210|NCT05616013|450456089|FG005|Overall Study|Non-compliance with study requirements|2|||
125226211|NCT05616013|450456090|FG006|Overall Study|Non-compliance with study requirements|1|||
125226212|NCT05616013|450456091|FG007|Overall Study|Non-compliance with study requirements|1|||
125226213|NCT05616013|450456092|FG008|Overall Study|Non-compliance with study requirements|4|||
125226214|NCT05616013|450456084|FG000|Overall Study|Withdrawal by Subject|11|||
125226215|NCT05616013|450456085|FG001|Overall Study|Withdrawal by Subject|9|||
125226216|NCT05616013|450456086|FG002|Overall Study|Withdrawal by Subject|8|||
125226217|NCT05616013|450456087|FG003|Overall Study|Withdrawal by Subject|6|||
125226218|NCT05616013|450456088|FG004|Overall Study|Withdrawal by Subject|3|||
125226219|NCT05616013|450456089|FG005|Overall Study|Withdrawal by Subject|4|||
125226220|NCT05616013|450456090|FG006|Overall Study|Withdrawal by Subject|6|||
125226221|NCT05616013|450456091|FG007|Overall Study|Withdrawal by Subject|5|||
125226222|NCT05616013|450456092|FG008|Overall Study|Withdrawal by Subject|4|||
125226223|NCT05616013|450456084|FG000|Overall Study|Physician Decision|0|||
125226224|NCT05616013|450456085|FG001|Overall Study|Physician Decision|0|||
125226225|NCT05616013|450456086|FG002|Overall Study|Physician Decision|1|||
125226226|NCT05616013|450456087|FG003|Overall Study|Physician Decision|0|||
125226227|NCT05616013|450456088|FG004|Overall Study|Physician Decision|0|||
125226228|NCT05616013|450456089|FG005|Overall Study|Physician Decision|1|||
125226229|NCT05616013|450456090|FG006|Overall Study|Physician Decision|3|||
125226230|NCT05616013|450456091|FG007|Overall Study|Physician Decision|0|||
125226231|NCT05616013|450456092|FG008|Overall Study|Physician Decision|0|||
125226232|NCT05616013|450456084|FG000|Overall Study|Protocol Violation|0|||
125226233|NCT05616013|450456085|FG001|Overall Study|Protocol Violation|0|||
125226234|NCT05616013|450456086|FG002|Overall Study|Protocol Violation|0|||
125226235|NCT05616013|450456087|FG003|Overall Study|Protocol Violation|0|||
125226236|NCT05616013|450456088|FG004|Overall Study|Protocol Violation|0|||
125226237|NCT05616013|450456089|FG005|Overall Study|Protocol Violation|0|||
125226238|NCT05616013|450456090|FG006|Overall Study|Protocol Violation|1|||
125226239|NCT05616013|450456091|FG007|Overall Study|Protocol Violation|0|||
125226240|NCT05616013|450456092|FG008|Overall Study|Protocol Violation|2|||
125226241|NCT05616013|450456084|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
125226242|NCT05616013|450456085|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
125226243|NCT05616013|450456086|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
125226244|NCT05616013|450456087|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
125226245|NCT05616013|450456088|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
125226246|NCT05616013|450456089|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
125226247|NCT05616013|450456090|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
125226248|NCT05616013|450456091|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
125226249|NCT05616013|450456092|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
125226250|NCT05616013|450456084|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
125226251|NCT05616013|450456085|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
125226252|NCT05616013|450456086|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
125226253|NCT05616013|450456087|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
125226254|NCT05616013|450456088|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
125226255|NCT05616013|450456089|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
125226256|NCT05616013|450456090|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
125226257|NCT05616013|450456091|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
125226258|NCT05616013|450456092|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
125226259|NCT05616013|450456084|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
125226260|NCT05616013|450456085|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
125226261|NCT05616013|450456086|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
125226262|NCT05616013|450456087|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
125226263|NCT05616013|450456088|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
125226264|NCT05616013|450456089|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
125226265|NCT05616013|450456090|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
125226266|NCT05616013|450456091|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
125226267|NCT05616013|450456092|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
125226268|NCT05616013|450456084|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
125226269|NCT05616013|450456085|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
125226270|NCT05616013|450456086|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
125226271|NCT05616013|450456087|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
125226272|NCT05616013|450456088|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
125226273|NCT05616013|450456089|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
125226274|NCT05616013|450456090|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
125226275|NCT05616013|450456091|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
125226276|NCT05616013|450456092|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
125226277|NCT05616013|450456084|FG000|Overall Study|Participant Decision, Time Constraints|0|||
125226278|NCT05616013|450456085|FG001|Overall Study|Participant Decision, Time Constraints|1|||
125226279|NCT05616013|450456086|FG002|Overall Study|Participant Decision, Time Constraints|0|||
125226280|NCT05616013|450456087|FG003|Overall Study|Participant Decision, Time Constraints|0|||
125226281|NCT05616013|450456088|FG004|Overall Study|Participant Decision, Time Constraints|0|||
125226282|NCT05616013|450456089|FG005|Overall Study|Participant Decision, Time Constraints|0|||
125226283|NCT05616013|450456090|FG006|Overall Study|Participant Decision, Time Constraints|0|||
125226284|NCT05616013|450456091|FG007|Overall Study|Participant Decision, Time Constraints|0|||
125226285|NCT05616013|450456092|FG008|Overall Study|Participant Decision, Time Constraints|0|||
125226286|NCT05616013|450456084|FG000|Overall Study|Prohibited Concomitant Medication|0|||
125226287|NCT05616013|450456085|FG001|Overall Study|Prohibited Concomitant Medication|0|||
125226288|NCT05616013|450456086|FG002|Overall Study|Prohibited Concomitant Medication|1|||
125226289|NCT05616013|450456087|FG003|Overall Study|Prohibited Concomitant Medication|0|||
125226290|NCT05616013|450456088|FG004|Overall Study|Prohibited Concomitant Medication|0|||
125226291|NCT05616013|450456089|FG005|Overall Study|Prohibited Concomitant Medication|0|||
125226292|NCT05616013|450456090|FG006|Overall Study|Prohibited Concomitant Medication|0|||
125226293|NCT05616013|450456091|FG007|Overall Study|Prohibited Concomitant Medication|0|||
125226294|NCT05616013|450456092|FG008|Overall Study|Prohibited Concomitant Medication|0|||
125226295|NCT05616013|450456084|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
125226296|NCT05616013|450456085|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
125226297|NCT05616013|450456086|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
125226298|NCT05616013|450456087|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
125226299|NCT05616013|450456088|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
125226300|NCT05616013|450456089|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
125226301|NCT05616013|450456090|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
125226302|NCT05616013|450456091|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
125226303|NCT05616013|450456092|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
125226304|NCT05616013|450456084|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
125226305|NCT05616013|450456085|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
125226306|NCT05616013|450456086|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
125226307|NCT05616013|450456087|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
125226308|NCT05616013|450456088|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
125226309|NCT05616013|450456089|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
125226310|NCT05616013|450456090|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
125226311|NCT05616013|450456091|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
125226312|NCT05616013|450456092|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
125226313|NCT05616013|450456084|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
125226314|NCT05616013|450456085|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
125226315|NCT05616013|450456086|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
125226316|NCT05616013|450456087|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
125226317|NCT05616013|450456088|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
125226318|NCT05616013|450456089|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
125226319|NCT05616013|450456090|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
125226320|NCT05616013|450456091|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
125226321|NCT05616013|450456092|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
125226322|NCT05616013|450456084|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
125226323|NCT05616013|450456085|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
125303179|NCT03100058|450736663|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
125303180|NCT03100058|450736664|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
125303181|NCT03100058|450736665|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
125303182|NCT03100058|450736666|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
125226324|NCT05616013|450456086|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
125226325|NCT05616013|450456087|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
125226326|NCT05616013|450456088|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
125226327|NCT05616013|450456089|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
125226328|NCT05616013|450456090|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
125226329|NCT05616013|450456091|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
125226330|NCT05616013|450456092|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
125226331|NCT05616013|450456084|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
125226332|NCT05616013|450456085|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
125226333|NCT05616013|450456086|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
125226334|NCT05616013|450456087|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
125226335|NCT05616013|450456088|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
125226336|NCT05616013|450456089|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
125226337|NCT05616013|450456090|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
125226338|NCT05616013|450456091|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
125226339|NCT05616013|450456092|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
125226340|NCT05116202|450456093|FG000|Overall Study|Study Terminated by Sponsor|21|||
125226341|NCT05116202|450456094|FG001|Overall Study|Study Terminated by Sponsor|38|||
125226342|NCT05116202|450456095|FG002|Overall Study|Study Terminated by Sponsor|17|||
125226343|NCT05116202|450456096|FG003|Overall Study|Study Terminated by Sponsor|18|||
125226344|NCT05116202|450456097|FG004|Overall Study|Study Terminated by Sponsor|0|||
125226345|NCT05116202|450456093|FG000|Overall Study|Withdrawal by Subject|0|||
125226346|NCT05116202|450456094|FG001|Overall Study|Withdrawal by Subject|1|||
125226347|NCT05116202|450456095|FG002|Overall Study|Withdrawal by Subject|1|||
125226348|NCT05116202|450456096|FG003|Overall Study|Withdrawal by Subject|1|||
125226349|NCT05116202|450456097|FG004|Overall Study|Withdrawal by Subject|1|||
125226350|NCT05116202|450456093|FG000|Overall Study|Lost to Follow-up|0|||
125226351|NCT05116202|450456094|FG001|Overall Study|Lost to Follow-up|0|||
125226352|NCT05116202|450456095|FG002|Overall Study|Lost to Follow-up|0|||
125226353|NCT05116202|450456096|FG003|Overall Study|Lost to Follow-up|0|||
125226354|NCT05116202|450456097|FG004|Overall Study|Lost to Follow-up|2|||
125226355|NCT05116202|450456093|FG000|Overall Study|Death|1|||
125226356|NCT05116202|450456094|FG001|Overall Study|Death|1|||
125226357|NCT05116202|450456095|FG002|Overall Study|Death|2|||
125226358|NCT05116202|450456096|FG003|Overall Study|Death|1|||
125226359|NCT05116202|450456097|FG004|Overall Study|Death|5|||
125226360|NCT02322749|450456111|FG000|Period 2|Adverse Event|0|||
125226361|NCT02322749|450456112|FG001|Period 2|Adverse Event|0|||
125226362|NCT02322749|450456113|FG002|Period 2|Adverse Event|0|||
125226363|NCT02322749|450456114|FG003|Period 2|Adverse Event|1|||
125226364|NCT02322749|450456115|FG004|Period 2|Adverse Event|0|||
125226365|NCT02322749|450456116|FG005|Period 2|Adverse Event|0|||
125226366|NCT02322749|450456111|FG000|Period 2|Withdrawal by Subject|0|||
125226367|NCT02322749|450456112|FG001|Period 2|Withdrawal by Subject|0|||
125226368|NCT02322749|450456113|FG002|Period 2|Withdrawal by Subject|0|||
125226369|NCT02322749|450456114|FG003|Period 2|Withdrawal by Subject|1|||
125226370|NCT02322749|450456115|FG004|Period 2|Withdrawal by Subject|0|||
125226371|NCT02322749|450456116|FG005|Period 2|Withdrawal by Subject|0|||
125226372|NCT02322749|450456111|FG000|Period 3|Withdrawal by Subject|0|||
125226373|NCT02322749|450456112|FG001|Period 3|Withdrawal by Subject|0|||
125226374|NCT02322749|450456113|FG002|Period 3|Withdrawal by Subject|1|||
125226375|NCT02322749|450456114|FG003|Period 3|Withdrawal by Subject|0|||
125226376|NCT02322749|450456115|FG004|Period 3|Withdrawal by Subject|0|||
125226377|NCT02322749|450456116|FG005|Period 3|Withdrawal by Subject|0|||
125226378|NCT00073918|450456121|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
125226379|NCT00073918|450456121|FG000|Overall Study|Rapid disease progression|2|||
125226380|NCT00073918|450456121|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
125226381|NCT05158140|450456128|FG000|Overall Study|Death|0|||
125226382|NCT05158140|450456129|FG001|Overall Study|Death|0|||
125226383|NCT05158140|450456130|FG002|Overall Study|Death|0|||
125226384|NCT05158140|450456131|FG003|Overall Study|Death|1|||
125226385|NCT05158140|450456128|FG000|Overall Study|Lost to Follow-up|3|||
125226386|NCT05158140|450456129|FG001|Overall Study|Lost to Follow-up|6|||
125226387|NCT05158140|450456130|FG002|Overall Study|Lost to Follow-up|4|||
125226388|NCT05158140|450456131|FG003|Overall Study|Lost to Follow-up|3|||
125226389|NCT05158140|450456128|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125226390|NCT05158140|450456129|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125226391|NCT05158140|450456130|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
125226392|NCT05158140|450456131|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
125226393|NCT05158140|450456128|FG000|Overall Study|Withdrawal by Subject|3|||
125226394|NCT05158140|450456129|FG001|Overall Study|Withdrawal by Subject|7|||
125226395|NCT05158140|450456130|FG002|Overall Study|Withdrawal by Subject|3|||
125165658|NCT03283761|450230355|FG000|Follow up|Lost to Follow-up|1|||
125165659|NCT03283761|450230355|FG000|Follow up|Symptomatic Deterioration|1|||
125165660|NCT03283761|450230355|FG000|Follow up|Death|29|||
125165661|NCT03283761|450230355|FG000|Follow up|study terminated|4|||
125165662|NCT03283761|450230355|FG000|Follow up|Primary Investigator Withdrawal|1|||
125165663|NCT03283761|450230355|FG000|Follow up|Switched to alternative therapy|1|||
125165664|NCT03283761|450230355|FG000|Follow up|Subject is now in Hospice|1|||
125165665|NCT02036775|450230356|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
125165666|NCT02036775|450230357|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
125165667|NCT02036775|450230358|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
125165668|NCT02036775|450230359|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
125165669|NCT02036775|450230360|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
125165670|NCT02036775|450230361|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
125165671|NCT00678886|450230362|FG000|Overall Study|Withdrawal by Subject|0|||
125165672|NCT00678886|450230363|FG001|Overall Study|Withdrawal by Subject|0|||
125165673|NCT00678886|450230364|FG002|Overall Study|Withdrawal by Subject|4|||
125165674|NCT00678886|450230365|FG003|Overall Study|Withdrawal by Subject|6|||
125165675|NCT00678886|450230362|FG000|Overall Study|Physician Decision|0|||
125165676|NCT00678886|450230363|FG001|Overall Study|Physician Decision|0|||
125165677|NCT00678886|450230364|FG002|Overall Study|Physician Decision|1|||
125165678|NCT00678886|450230365|FG003|Overall Study|Physician Decision|1|||
125165679|NCT00678886|450230362|FG000|Overall Study|Lost to Follow-up|0|||
125165680|NCT00678886|450230363|FG001|Overall Study|Lost to Follow-up|0|||
125165681|NCT00678886|450230364|FG002|Overall Study|Lost to Follow-up|3|||
125165682|NCT00678886|450230365|FG003|Overall Study|Lost to Follow-up|2|||
125165683|NCT00678886|450230362|FG000|Overall Study|Other|0|||
125165684|NCT00678886|450230363|FG001|Overall Study|Other|0|||
125165685|NCT00678886|450230364|FG002|Overall Study|Other|1|||
125165686|NCT00678886|450230365|FG003|Overall Study|Other|0|||
125165687|NCT00206323|450230366|FG000|Overall Study|Lack of Efficacy|4|||
125165688|NCT00206323|450230367|FG001|Overall Study|Lack of Efficacy|1|||
125165689|NCT00206323|450230366|FG000|Overall Study|Adverse Event|1|||
125165690|NCT00206323|450230367|FG001|Overall Study|Adverse Event|1|||
125165691|NCT00206323|450230366|FG000|Overall Study|Lost to Follow-up|1|||
125165692|NCT00206323|450230367|FG001|Overall Study|Lost to Follow-up|1|||
125165693|NCT02329847|450230368|FG000|Overall Study|Death|4|||
125165694|NCT02329847|450230369|FG001|Overall Study|Death|4|||
125165695|NCT02329847|450230370|FG002|Overall Study|Death|22|||
125165696|NCT02329847|450230371|FG003|Overall Study|Death|12|||
125165697|NCT02329847|450230372|FG004|Overall Study|Death|20|||
125165698|NCT02329847|450230373|FG005|Overall Study|Death|13|||
125165699|NCT02329847|450230368|FG000|Overall Study|Lost to Follow-up|0|||
125165700|NCT02329847|450230369|FG001|Overall Study|Lost to Follow-up|0|||
125165701|NCT02329847|450230370|FG002|Overall Study|Lost to Follow-up|2|||
125165702|NCT02329847|450230371|FG003|Overall Study|Lost to Follow-up|3|||
125165703|NCT02329847|450230372|FG004|Overall Study|Lost to Follow-up|0|||
125165704|NCT02329847|450230373|FG005|Overall Study|Lost to Follow-up|1|||
125165705|NCT02329847|450230368|FG000|Overall Study|Physician Decision|0|||
125165706|NCT02329847|450230369|FG001|Overall Study|Physician Decision|0|||
125165707|NCT02329847|450230370|FG002|Overall Study|Physician Decision|0|||
125165708|NCT02329847|450230371|FG003|Overall Study|Physician Decision|0|||
125165709|NCT02329847|450230372|FG004|Overall Study|Physician Decision|1|||
125165710|NCT02329847|450230373|FG005|Overall Study|Physician Decision|0|||
125165711|NCT02329847|450230368|FG000|Overall Study|Withdrawal by Subject|2|||
125165712|NCT02329847|450230369|FG001|Overall Study|Withdrawal by Subject|1|||
125165713|NCT02329847|450230370|FG002|Overall Study|Withdrawal by Subject|5|||
125165714|NCT02329847|450230371|FG003|Overall Study|Withdrawal by Subject|7|||
125165715|NCT02329847|450230372|FG004|Overall Study|Withdrawal by Subject|8|||
125165716|NCT02329847|450230373|FG005|Overall Study|Withdrawal by Subject|3|||
125165717|NCT02329847|450230368|FG000|Overall Study|Other|1|||
125165718|NCT02329847|450230369|FG001|Overall Study|Other|2|||
125165719|NCT02329847|450230370|FG002|Overall Study|Other|6|||
125165720|NCT02329847|450230371|FG003|Overall Study|Other|13|||
125165721|NCT02329847|450230372|FG004|Overall Study|Other|10|||
125165722|NCT02329847|450230373|FG005|Overall Study|Other|3|||
125165723|NCT04669691|450230380|FG000|Overall Study|Death|0|||
125165724|NCT04669691|450230381|FG001|Overall Study|Death|1|||
125165725|NCT04669691|450230382|FG002|Overall Study|Death|0|||
125165726|NCT04669691|450230383|FG003|Overall Study|Death|0|||
125165727|NCT04669691|450230384|FG004|Overall Study|Death|0|||
125165728|NCT04669691|450230385|FG005|Overall Study|Death|0|||
125165729|NCT01822275|450230387|FG000|Overall Study|Withdrawal by Subject|3|||
125165730|NCT01822275|450230387|FG000|Overall Study|Adverse Event|3|||
125165731|NCT01822275|450230387|FG000|Overall Study|Progression|14|||
125165732|NCT01822275|450230387|FG000|Overall Study|Physician Decision|2|||
125165733|NCT02132754|450230388|FG000|Overall Study|Adverse Event|0|||
125165734|NCT02132754|450230389|FG001|Overall Study|Adverse Event|0|||
125165735|NCT02132754|450230390|FG002|Overall Study|Adverse Event|0|||
125165736|NCT02132754|450230391|FG003|Overall Study|Adverse Event|0|||
125165737|NCT02132754|450230392|FG004|Overall Study|Adverse Event|0|||
125165738|NCT02132754|450230393|FG005|Overall Study|Adverse Event|0|||
125165739|NCT02132754|450230394|FG006|Overall Study|Adverse Event|0|||
125165740|NCT02132754|450230395|FG007|Overall Study|Adverse Event|0|||
125165741|NCT02132754|450230396|FG008|Overall Study|Adverse Event|0|||
125165742|NCT02132754|450230397|FG009|Overall Study|Adverse Event|0|||
125165743|NCT02132754|450230398|FG010|Overall Study|Adverse Event|0|||
125165744|NCT02132754|450230399|FG011|Overall Study|Adverse Event|0|||
125165745|NCT02132754|450230400|FG012|Overall Study|Adverse Event|0|||
125165746|NCT02132754|450230401|FG013|Overall Study|Adverse Event|0|||
125165747|NCT02132754|450230402|FG014|Overall Study|Adverse Event|0|||
125165748|NCT02132754|450230403|FG015|Overall Study|Adverse Event|0|||
125165749|NCT02132754|450230404|FG016|Overall Study|Adverse Event|0|||
125165750|NCT02132754|450230405|FG017|Overall Study|Adverse Event|1|||
125165751|NCT02132754|450230406|FG018|Overall Study|Adverse Event|0|||
125165752|NCT02132754|450230407|FG019|Overall Study|Adverse Event|0|||
125165753|NCT02132754|450230408|FG020|Overall Study|Adverse Event|0|||
125165754|NCT02132754|450230409|FG021|Overall Study|Adverse Event|0|||
125226396|NCT05158140|450456131|FG003|Overall Study|Withdrawal by Subject|7|||
125226397|NCT04414787|450456132|FG000|Overall Study|Patient Death|18|||
125226398|NCT04414787|450456133|FG001|Overall Study|Patient Death|18|||
125226399|NCT04414787|450456134|FG002|Overall Study|Patient Death|15|||
125226400|NCT04414787|450456135|FG003|Overall Study|Patient Death|15|||
125226401|NCT04414787|450456132|FG000|Overall Study|Patient Hospitalization|1|||
125226402|NCT04414787|450456133|FG001|Overall Study|Patient Hospitalization|1|||
125226403|NCT04414787|450456134|FG002|Overall Study|Patient Hospitalization|2|||
125226404|NCT04414787|450456135|FG003|Overall Study|Patient Hospitalization|2|||
125226405|NCT04414787|450456132|FG000|Overall Study|Lost to Follow-up|7|||
125226406|NCT04414787|450456133|FG001|Overall Study|Lost to Follow-up|7|||
125226407|NCT04414787|450456134|FG002|Overall Study|Lost to Follow-up|5|||
125226408|NCT04414787|450456135|FG003|Overall Study|Lost to Follow-up|5|||
125226409|NCT04414787|450456132|FG000|Overall Study|Residence in post-acute care facility|3|||
125226410|NCT04414787|450456133|FG001|Overall Study|Residence in post-acute care facility|3|||
125226411|NCT04414787|450456134|FG002|Overall Study|Residence in post-acute care facility|5|||
125226412|NCT04414787|450456135|FG003|Overall Study|Residence in post-acute care facility|5|||
125226413|NCT00919633|450456136|FG000|Overall Study|Adverse Event|1|||
125226414|NCT00919633|450456137|FG001|Overall Study|Adverse Event|9|||
125226415|NCT00919633|450456138|FG002|Overall Study|Adverse Event|12|||
125226416|NCT00919633|450456139|FG003|Overall Study|Adverse Event|10|||
125226417|NCT00919633|450456136|FG000|Overall Study|Death|0|||
125226418|NCT00919633|450456137|FG001|Overall Study|Death|0|||
125226419|NCT00919633|450456138|FG002|Overall Study|Death|2|||
125226420|NCT00919633|450456139|FG003|Overall Study|Death|0|||
125226421|NCT00919633|450456136|FG000|Overall Study|Lack of Efficacy|17|||
125226422|NCT00919633|450456137|FG001|Overall Study|Lack of Efficacy|3|||
125226423|NCT00919633|450456138|FG002|Overall Study|Lack of Efficacy|2|||
125226424|NCT00919633|450456139|FG003|Overall Study|Lack of Efficacy|3|||
125226425|NCT00919633|450456136|FG000|Overall Study|Withdrawal by Subject|1|||
125226426|NCT00919633|450456137|FG001|Overall Study|Withdrawal by Subject|2|||
125226427|NCT00919633|450456138|FG002|Overall Study|Withdrawal by Subject|4|||
125226428|NCT00919633|450456139|FG003|Overall Study|Withdrawal by Subject|3|||
125226429|NCT00919633|450456136|FG000|Overall Study|Lost to Follow-up|3|||
125226430|NCT00919633|450456137|FG001|Overall Study|Lost to Follow-up|1|||
125226431|NCT00919633|450456138|FG002|Overall Study|Lost to Follow-up|0|||
125226432|NCT00919633|450456139|FG003|Overall Study|Lost to Follow-up|2|||
125226433|NCT00919633|450456136|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
125226434|NCT00919633|450456137|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
125226435|NCT00919633|450456138|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
125226436|NCT00919633|450456139|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
125226437|NCT00919633|450456136|FG000|Overall Study|Protocol Violation|0|||
125226438|NCT00919633|450456137|FG001|Overall Study|Protocol Violation|0|||
125226439|NCT00919633|450456138|FG002|Overall Study|Protocol Violation|0|||
125226440|NCT00919633|450456139|FG003|Overall Study|Protocol Violation|1|||
125226441|NCT00919633|450456136|FG000|Overall Study|Physician Decision|0|||
125226442|NCT00919633|450456137|FG001|Overall Study|Physician Decision|0|||
125226443|NCT00919633|450456138|FG002|Overall Study|Physician Decision|0|||
125226444|NCT00919633|450456139|FG003|Overall Study|Physician Decision|1|||
125226445|NCT00919633|450456136|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
125226446|NCT00919633|450456137|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
125226447|NCT00919633|450456138|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
125226448|NCT00919633|450456139|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
125226449|NCT00919633|450456136|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
125226450|NCT00919633|450456137|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
125226451|NCT00919633|450456138|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
125226452|NCT00919633|450456139|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
125226453|NCT01526785|450456140|FG000|Overall Study|Study Terminated by Sponsor|8|||
125226454|NCT01526785|450456140|FG000|Overall Study|Death|2|||
125226455|NCT01526785|450456140|FG000|Overall Study|Physician Decision|1|||
125226456|NCT01526785|450456140|FG000|Overall Study|Withdrawal by Subject|2|||
125226457|NCT01121263|450456141|FG000|Overall Study|Death|3|||
125226458|NCT01121263|450456142|FG001|Overall Study|Death|2|||
125226459|NCT01121263|450456141|FG000|Overall Study|Lost to Follow-up|22|||
125226460|NCT01121263|450456142|FG001|Overall Study|Lost to Follow-up|12|||
125226461|NCT01121263|450456141|FG000|Overall Study|Withdrawal by Subject|0|||
125226462|NCT01121263|450456142|FG001|Overall Study|Withdrawal by Subject|1|||
125226463|NCT02007720|450456143|FG000|Overall Study|Withdrawal by Subject|9|||
125226464|NCT02007720|450456144|FG001|Overall Study|Withdrawal by Subject|11|||
125226465|NCT02007720|450456143|FG000|Overall Study|study terminated by sponsor|58|||
125226466|NCT02007720|450456144|FG001|Overall Study|study terminated by sponsor|54|||
125226467|NCT02007720|450456143|FG000|Overall Study|technical problem|4|||
125226468|NCT02007720|450456144|FG001|Overall Study|technical problem|2|||
125226469|NCT02007720|450456143|FG000|Overall Study|patient followd less than 165 days|11|||
125226470|NCT02007720|450456144|FG001|Overall Study|patient followd less than 165 days|5|||
125226471|NCT04194814|450456147|FG000|Overall Study|Physician Decision|3|||
125165755|NCT02132754|450230410|FG022|Overall Study|Adverse Event|0|||
125165756|NCT02132754|450230411|FG023|Overall Study|Adverse Event|0|||
125165757|NCT02132754|450230412|FG024|Overall Study|Adverse Event|0|||
125165758|NCT02132754|450230413|FG025|Overall Study|Adverse Event|1|||
125165759|NCT02132754|450230414|FG026|Overall Study|Adverse Event|1|||
125165760|NCT02132754|450230415|FG027|Overall Study|Adverse Event|0|||
125165761|NCT02132754|450230416|FG028|Overall Study|Adverse Event|0|||
125165762|NCT02132754|450230417|FG029|Overall Study|Adverse Event|0|||
125165763|NCT02132754|450230418|FG030|Overall Study|Adverse Event|1|||
125165764|NCT02132754|450230419|FG031|Overall Study|Adverse Event|0|||
125165765|NCT02132754|450230420|FG032|Overall Study|Adverse Event|1|||
125165766|NCT02132754|450230421|FG033|Overall Study|Adverse Event|1|||
125165767|NCT02132754|450230388|FG000|Overall Study|Clinical Progression|0|||
125165768|NCT02132754|450230389|FG001|Overall Study|Clinical Progression|0|||
125165769|NCT02132754|450230390|FG002|Overall Study|Clinical Progression|0|||
125165770|NCT02132754|450230391|FG003|Overall Study|Clinical Progression|0|||
125165771|NCT02132754|450230392|FG004|Overall Study|Clinical Progression|0|||
125165772|NCT02132754|450230393|FG005|Overall Study|Clinical Progression|0|||
125165773|NCT02132754|450230394|FG006|Overall Study|Clinical Progression|0|||
125165774|NCT02132754|450230395|FG007|Overall Study|Clinical Progression|0|||
125165775|NCT02132754|450230396|FG008|Overall Study|Clinical Progression|0|||
125165776|NCT02132754|450230397|FG009|Overall Study|Clinical Progression|1|||
125165777|NCT02132754|450230398|FG010|Overall Study|Clinical Progression|0|||
125165778|NCT02132754|450230399|FG011|Overall Study|Clinical Progression|0|||
125165779|NCT02132754|450230400|FG012|Overall Study|Clinical Progression|0|||
125165780|NCT02132754|450230401|FG013|Overall Study|Clinical Progression|0|||
125165781|NCT02132754|450230402|FG014|Overall Study|Clinical Progression|0|||
125165782|NCT02132754|450230403|FG015|Overall Study|Clinical Progression|0|||
125165783|NCT02132754|450230404|FG016|Overall Study|Clinical Progression|1|||
125165784|NCT02132754|450230405|FG017|Overall Study|Clinical Progression|1|||
125165785|NCT02132754|450230406|FG018|Overall Study|Clinical Progression|0|||
125165786|NCT02132754|450230407|FG019|Overall Study|Clinical Progression|1|||
125165787|NCT02132754|450230408|FG020|Overall Study|Clinical Progression|0|||
125165788|NCT02132754|450230409|FG021|Overall Study|Clinical Progression|0|||
125165789|NCT02132754|450230410|FG022|Overall Study|Clinical Progression|1|||
125165790|NCT02132754|450230411|FG023|Overall Study|Clinical Progression|0|||
125165791|NCT02132754|450230412|FG024|Overall Study|Clinical Progression|1|||
125165792|NCT02132754|450230413|FG025|Overall Study|Clinical Progression|1|||
125165793|NCT02132754|450230414|FG026|Overall Study|Clinical Progression|0|||
125165794|NCT02132754|450230415|FG027|Overall Study|Clinical Progression|1|||
125165795|NCT02132754|450230416|FG028|Overall Study|Clinical Progression|1|||
125165796|NCT02132754|450230417|FG029|Overall Study|Clinical Progression|0|||
125165797|NCT02132754|450230418|FG030|Overall Study|Clinical Progression|1|||
125165798|NCT02132754|450230419|FG031|Overall Study|Clinical Progression|0|||
125165799|NCT02132754|450230420|FG032|Overall Study|Clinical Progression|0|||
125165800|NCT02132754|450230421|FG033|Overall Study|Clinical Progression|2|||
125165801|NCT02132754|450230388|FG000|Overall Study|Death|0|||
125165802|NCT02132754|450230389|FG001|Overall Study|Death|0|||
125165803|NCT02132754|450230390|FG002|Overall Study|Death|0|||
125165804|NCT02132754|450230391|FG003|Overall Study|Death|0|||
125165805|NCT02132754|450230392|FG004|Overall Study|Death|0|||
125165806|NCT02132754|450230393|FG005|Overall Study|Death|0|||
125165807|NCT02132754|450230394|FG006|Overall Study|Death|0|||
125165808|NCT02132754|450230395|FG007|Overall Study|Death|0|||
125165809|NCT02132754|450230396|FG008|Overall Study|Death|0|||
125165810|NCT02132754|450230397|FG009|Overall Study|Death|0|||
125165811|NCT02132754|450230398|FG010|Overall Study|Death|0|||
125165812|NCT02132754|450230399|FG011|Overall Study|Death|0|||
125165813|NCT02132754|450230400|FG012|Overall Study|Death|0|||
125165814|NCT02132754|450230401|FG013|Overall Study|Death|0|||
125165815|NCT02132754|450230402|FG014|Overall Study|Death|0|||
125165816|NCT02132754|450230403|FG015|Overall Study|Death|1|||
125165817|NCT02132754|450230404|FG016|Overall Study|Death|0|||
125165818|NCT02132754|450230405|FG017|Overall Study|Death|0|||
125165819|NCT02132754|450230406|FG018|Overall Study|Death|0|||
125165820|NCT02132754|450230407|FG019|Overall Study|Death|1|||
125165821|NCT02132754|450230408|FG020|Overall Study|Death|0|||
125165822|NCT02132754|450230409|FG021|Overall Study|Death|1|||
125165823|NCT02132754|450230410|FG022|Overall Study|Death|0|||
125165824|NCT02132754|450230411|FG023|Overall Study|Death|0|||
125165825|NCT02132754|450230412|FG024|Overall Study|Death|0|||
125165826|NCT02132754|450230413|FG025|Overall Study|Death|0|||
125165827|NCT02132754|450230414|FG026|Overall Study|Death|1|||
125165828|NCT02132754|450230415|FG027|Overall Study|Death|0|||
125165829|NCT02132754|450230416|FG028|Overall Study|Death|0|||
125165830|NCT02132754|450230417|FG029|Overall Study|Death|0|||
125165831|NCT02132754|450230418|FG030|Overall Study|Death|0|||
125165832|NCT02132754|450230419|FG031|Overall Study|Death|0|||
125165833|NCT02132754|450230420|FG032|Overall Study|Death|0|||
125165834|NCT02132754|450230421|FG033|Overall Study|Death|2|||
125165835|NCT02132754|450230388|FG000|Overall Study|Excluded Medication|0|||
125165836|NCT02132754|450230389|FG001|Overall Study|Excluded Medication|0|||
125165837|NCT02132754|450230390|FG002|Overall Study|Excluded Medication|0|||
125165838|NCT02132754|450230391|FG003|Overall Study|Excluded Medication|0|||
125165839|NCT02132754|450230392|FG004|Overall Study|Excluded Medication|0|||
125165840|NCT02132754|450230393|FG005|Overall Study|Excluded Medication|0|||
125165841|NCT02132754|450230394|FG006|Overall Study|Excluded Medication|0|||
125165842|NCT02132754|450230395|FG007|Overall Study|Excluded Medication|0|||
125165843|NCT02132754|450230396|FG008|Overall Study|Excluded Medication|0|||
125165844|NCT02132754|450230397|FG009|Overall Study|Excluded Medication|0|||
125165845|NCT02132754|450230398|FG010|Overall Study|Excluded Medication|0|||
125165846|NCT02132754|450230399|FG011|Overall Study|Excluded Medication|0|||
125165847|NCT02132754|450230400|FG012|Overall Study|Excluded Medication|0|||
125165848|NCT02132754|450230401|FG013|Overall Study|Excluded Medication|0|||
125165849|NCT02132754|450230402|FG014|Overall Study|Excluded Medication|0|||
125165850|NCT02132754|450230403|FG015|Overall Study|Excluded Medication|0|||
125226472|NCT04194814|450456148|FG001|Overall Study|Physician Decision|0|||
125226473|NCT04194814|450456147|FG000|Overall Study|Withdrawal by Subject|0|||
125226474|NCT04194814|450456148|FG001|Overall Study|Withdrawal by Subject|2|||
125226475|NCT00329108|450457936|FG000|Overall Study|Adverse Event|2|||
125226476|NCT00329108|450457937|FG001|Overall Study|Adverse Event|2|||
125226477|NCT00329108|450457936|FG000|Overall Study|Lack of Efficacy|3|||
125226478|NCT00329108|450457937|FG001|Overall Study|Lack of Efficacy|3|||
125226479|NCT00329108|450457936|FG000|Overall Study|Withdrawal by Subject|0|||
125226480|NCT00329108|450457937|FG001|Overall Study|Withdrawal by Subject|2|||
125226481|NCT00329108|450457936|FG000|Overall Study|symptomatic deterioration|1|||
125226482|NCT00329108|450457937|FG001|Overall Study|symptomatic deterioration|1|||
125226483|NCT00329108|450457936|FG000|Overall Study|Subject no longer willing to participate|2|||
125226484|NCT00329108|450457937|FG001|Overall Study|Subject no longer willing to participate|2|||
125226485|NCT00329108|450457936|FG000|Overall Study|study terminated by sponsor|1|||
125226486|NCT00329108|450457937|FG001|Overall Study|study terminated by sponsor|0|||
125226487|NCT00329108|450457936|FG000|Overall Study|withdrew patient after SAE resolved|1|||
125226488|NCT00329108|450457937|FG001|Overall Study|withdrew patient after SAE resolved|0|||
125226489|NCT00329108|450457936|FG000|Overall Study|Protocol Violation|0|||
125226490|NCT00329108|450457937|FG001|Overall Study|Protocol Violation|2|||
125226491|NCT01389232|450457938|FG000|Overall Study|Had scaffold removed|15|||
125226492|NCT01389232|450457938|FG000|Overall Study|Personal reasons|2|||
125226493|NCT01389232|450457938|FG000|Overall Study|Adverse Event|1|||
125226494|NCT01389232|450457938|FG000|Overall Study|Death|1|||
125226495|NCT00789321|450457943|FG000|Overall Study|Adverse Event|0|||
125226496|NCT00789321|450457944|FG001|Overall Study|Adverse Event|1|||
125226497|NCT01162343|450457945|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
125226498|NCT01162343|450457945|FG000|Overall Study|Refused psychiatrist assessment|12|||
125226499|NCT03964207|450457946|FG000|First Treatment|Withdrawal by Subject|1|||
125226500|NCT03964207|450457947|FG001|First Treatment|Withdrawal by Subject|2|||
125226501|NCT03964207|450457946|FG000|First Treatment|Protocol Violation|1|||
125226502|NCT03964207|450457947|FG001|First Treatment|Protocol Violation|0|||
125226503|NCT03964207|450457946|FG000|First Treatment|Lost to Follow-up|1|||
125226504|NCT03964207|450457947|FG001|First Treatment|Lost to Follow-up|0|||
125226505|NCT03964207|450457946|FG000|Second Treatment|Lost to Follow-up|0|||
125226506|NCT03964207|450457947|FG001|Second Treatment|Lost to Follow-up|1|||
125226507|NCT03964207|450457946|FG000|Second Treatment|Adverse Event|1|||
125226508|NCT03964207|450457947|FG001|Second Treatment|Adverse Event|2|||
125226509|NCT01405560|450457950|FG000|Overall Study|Physician Decision|1|||
125226510|NCT01699750|450457954|FG000|Overall Study|Withdrew Consent|0|||
125226511|NCT01699750|450457955|FG001|Overall Study|Withdrew Consent|1|||
125226512|NCT01699750|450457954|FG000|Overall Study|Other|0|||
125226513|NCT01699750|450457955|FG001|Overall Study|Other|2|||
125226514|NCT02737358|450457956|FG000|Overall Study|Withdrawal by Subject|7|||
125226515|NCT02737358|450457957|FG001|Overall Study|Withdrawal by Subject|12|||
125226516|NCT02737358|450457956|FG000|Overall Study|Lost to Follow-up|2|||
125226517|NCT02737358|450457957|FG001|Overall Study|Lost to Follow-up|3|||
125226518|NCT02119299|450457958|FG000|Overall Study|Withdrawal by Subject|7|||
125226519|NCT02119299|450457958|FG000|Overall Study|Lack of Efficacy|1|||
125226520|NCT02119299|450457958|FG000|Overall Study|Pregnancy|1|||
125226521|NCT00744939|450457959|FG000|Overall Study|Withdrawal by Subject|9|||
125226522|NCT00744939|450457959|FG000|Overall Study|Protocol Violation|13|||
125226523|NCT00744939|450457959|FG000|Overall Study|Death|24|||
125165851|NCT02132754|450230404|FG016|Overall Study|Excluded Medication|0|||
125165852|NCT02132754|450230405|FG017|Overall Study|Excluded Medication|0|||
125165853|NCT02132754|450230406|FG018|Overall Study|Excluded Medication|0|||
125165854|NCT02132754|450230407|FG019|Overall Study|Excluded Medication|0|||
125165855|NCT02132754|450230408|FG020|Overall Study|Excluded Medication|1|||
125165856|NCT02132754|450230409|FG021|Overall Study|Excluded Medication|0|||
125165857|NCT02132754|450230410|FG022|Overall Study|Excluded Medication|0|||
125165858|NCT02132754|450230411|FG023|Overall Study|Excluded Medication|0|||
125165859|NCT02132754|450230412|FG024|Overall Study|Excluded Medication|0|||
125165860|NCT02132754|450230413|FG025|Overall Study|Excluded Medication|0|||
125165861|NCT02132754|450230414|FG026|Overall Study|Excluded Medication|0|||
125165862|NCT02132754|450230415|FG027|Overall Study|Excluded Medication|0|||
125165863|NCT02132754|450230416|FG028|Overall Study|Excluded Medication|0|||
125165864|NCT02132754|450230417|FG029|Overall Study|Excluded Medication|0|||
125226524|NCT00744939|450457959|FG000|Overall Study|distance|4|||
125226525|NCT00744939|450457959|FG000|Overall Study|Lost to Follow-up|12|||
125226526|NCT00744939|450457959|FG000|Overall Study|Medical history exclusionary|1|||
125226527|NCT00744939|450457959|FG000|Overall Study|Did not receive Magnevist|7|||
125165865|NCT02132754|450230418|FG030|Overall Study|Excluded Medication|0|||
125165866|NCT02132754|450230419|FG031|Overall Study|Excluded Medication|0|||
125165867|NCT02132754|450230420|FG032|Overall Study|Excluded Medication|0|||
125165868|NCT02132754|450230421|FG033|Overall Study|Excluded Medication|1|||
125165869|NCT02132754|450230388|FG000|Overall Study|Physician Decision|0|||
125165870|NCT02132754|450230389|FG001|Overall Study|Physician Decision|0|||
125165871|NCT02132754|450230390|FG002|Overall Study|Physician Decision|0|||
125165872|NCT02132754|450230391|FG003|Overall Study|Physician Decision|0|||
125165873|NCT02132754|450230392|FG004|Overall Study|Physician Decision|0|||
125165874|NCT02132754|450230393|FG005|Overall Study|Physician Decision|0|||
125165875|NCT02132754|450230394|FG006|Overall Study|Physician Decision|0|||
125165876|NCT02132754|450230395|FG007|Overall Study|Physician Decision|0|||
125165877|NCT02132754|450230396|FG008|Overall Study|Physician Decision|0|||
125165878|NCT02132754|450230397|FG009|Overall Study|Physician Decision|1|||
125165879|NCT02132754|450230398|FG010|Overall Study|Physician Decision|0|||
125165880|NCT02132754|450230399|FG011|Overall Study|Physician Decision|1|||
125165881|NCT02132754|450230400|FG012|Overall Study|Physician Decision|1|||
125165882|NCT02132754|450230401|FG013|Overall Study|Physician Decision|0|||
125165883|NCT02132754|450230402|FG014|Overall Study|Physician Decision|0|||
125165884|NCT02132754|450230403|FG015|Overall Study|Physician Decision|1|||
125165885|NCT02132754|450230404|FG016|Overall Study|Physician Decision|0|||
125165886|NCT02132754|450230405|FG017|Overall Study|Physician Decision|0|||
125165887|NCT02132754|450230406|FG018|Overall Study|Physician Decision|0|||
125165888|NCT02132754|450230407|FG019|Overall Study|Physician Decision|0|||
125165889|NCT02132754|450230408|FG020|Overall Study|Physician Decision|0|||
125165890|NCT02132754|450230409|FG021|Overall Study|Physician Decision|0|||
125165891|NCT02132754|450230410|FG022|Overall Study|Physician Decision|0|||
125165892|NCT02132754|450230411|FG023|Overall Study|Physician Decision|0|||
125165893|NCT02132754|450230412|FG024|Overall Study|Physician Decision|1|||
125165894|NCT02132754|450230413|FG025|Overall Study|Physician Decision|0|||
125165895|NCT02132754|450230414|FG026|Overall Study|Physician Decision|0|||
125165896|NCT02132754|450230415|FG027|Overall Study|Physician Decision|0|||
125165897|NCT02132754|450230416|FG028|Overall Study|Physician Decision|0|||
125165898|NCT02132754|450230417|FG029|Overall Study|Physician Decision|0|||
125165899|NCT02132754|450230418|FG030|Overall Study|Physician Decision|0|||
125165900|NCT02132754|450230419|FG031|Overall Study|Physician Decision|1|||
125165901|NCT02132754|450230420|FG032|Overall Study|Physician Decision|0|||
125165902|NCT02132754|450230421|FG033|Overall Study|Physician Decision|3|||
125165903|NCT02132754|450230388|FG000|Overall Study|Progressive Disease|1|||
125165904|NCT02132754|450230389|FG001|Overall Study|Progressive Disease|1|||
125165905|NCT02132754|450230390|FG002|Overall Study|Progressive Disease|1|||
125165906|NCT02132754|450230391|FG003|Overall Study|Progressive Disease|1|||
125165907|NCT02132754|450230392|FG004|Overall Study|Progressive Disease|1|||
125165908|NCT02132754|450230393|FG005|Overall Study|Progressive Disease|1|||
125165909|NCT02132754|450230394|FG006|Overall Study|Progressive Disease|1|||
125165910|NCT02132754|450230395|FG007|Overall Study|Progressive Disease|1|||
125165911|NCT02132754|450230396|FG008|Overall Study|Progressive Disease|1|||
125165912|NCT02132754|450230397|FG009|Overall Study|Progressive Disease|3|||
125165913|NCT02132754|450230398|FG010|Overall Study|Progressive Disease|3|||
125165914|NCT02132754|450230399|FG011|Overall Study|Progressive Disease|2|||
125165915|NCT02132754|450230400|FG012|Overall Study|Progressive Disease|2|||
125165916|NCT02132754|450230401|FG013|Overall Study|Progressive Disease|3|||
125165917|NCT02132754|450230402|FG014|Overall Study|Progressive Disease|2|||
125165918|NCT02132754|450230403|FG015|Overall Study|Progressive Disease|1|||
125165919|NCT02132754|450230404|FG016|Overall Study|Progressive Disease|2|||
125165920|NCT02132754|450230405|FG017|Overall Study|Progressive Disease|1|||
125165921|NCT02132754|450230406|FG018|Overall Study|Progressive Disease|3|||
125165922|NCT02132754|450230407|FG019|Overall Study|Progressive Disease|1|||
125165923|NCT02132754|450230408|FG020|Overall Study|Progressive Disease|1|||
125165924|NCT02132754|450230409|FG021|Overall Study|Progressive Disease|3|||
125165925|NCT02132754|450230410|FG022|Overall Study|Progressive Disease|2|||
125165926|NCT02132754|450230411|FG023|Overall Study|Progressive Disease|3|||
125165927|NCT02132754|450230412|FG024|Overall Study|Progressive Disease|0|||
125165928|NCT02132754|450230413|FG025|Overall Study|Progressive Disease|1|||
125165929|NCT02132754|450230414|FG026|Overall Study|Progressive Disease|2|||
125165930|NCT02132754|450230415|FG027|Overall Study|Progressive Disease|1|||
125165931|NCT02132754|450230416|FG028|Overall Study|Progressive Disease|2|||
125165932|NCT02132754|450230417|FG029|Overall Study|Progressive Disease|3|||
125165933|NCT02132754|450230418|FG030|Overall Study|Progressive Disease|1|||
125165934|NCT02132754|450230419|FG031|Overall Study|Progressive Disease|1|||
125165935|NCT02132754|450230420|FG032|Overall Study|Progressive Disease|3|||
125165936|NCT02132754|450230421|FG033|Overall Study|Progressive Disease|6|||
125165937|NCT02132754|450230388|FG000|Overall Study|Screen Failure|0|||
125165938|NCT02132754|450230389|FG001|Overall Study|Screen Failure|0|||
125165939|NCT02132754|450230390|FG002|Overall Study|Screen Failure|0|||
125165940|NCT02132754|450230391|FG003|Overall Study|Screen Failure|0|||
125165941|NCT02132754|450230392|FG004|Overall Study|Screen Failure|0|||
125165942|NCT02132754|450230393|FG005|Overall Study|Screen Failure|0|||
125165943|NCT02132754|450230394|FG006|Overall Study|Screen Failure|0|||
125165944|NCT02132754|450230395|FG007|Overall Study|Screen Failure|0|||
125165945|NCT02132754|450230396|FG008|Overall Study|Screen Failure|0|||
125226528|NCT00744939|450457959|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
125226529|NCT00744939|450457959|FG000|Overall Study|coma|1|||
125226530|NCT00744939|450457959|FG000|Overall Study|incorrect race|1|||
125226531|NCT02452047|450457960|FG000|Overall Study|Adverse Event|0|||
125226532|NCT02452047|450457961|FG001|Overall Study|Adverse Event|1|||
125226533|NCT02452047|450457962|FG002|Overall Study|Adverse Event|1|||
125226534|NCT02452047|450457960|FG000|Overall Study|Death|1|||
125226535|NCT02452047|450457961|FG001|Overall Study|Death|3|||
125226536|NCT02452047|450457962|FG002|Overall Study|Death|1|||
125226537|NCT02452047|450457960|FG000|Overall Study|Physician Decision|1|||
125226538|NCT02452047|450457961|FG001|Overall Study|Physician Decision|0|||
125226539|NCT02452047|450457962|FG002|Overall Study|Physician Decision|0|||
125226540|NCT02452047|450457960|FG000|Overall Study|Lost to Follow-up|1|||
125226541|NCT02452047|450457961|FG001|Overall Study|Lost to Follow-up|1|||
125226542|NCT02452047|450457962|FG002|Overall Study|Lost to Follow-up|0|||
125226543|NCT02452047|450457960|FG000|Overall Study|Withdrawal by Subject|1|||
125226544|NCT02452047|450457961|FG001|Overall Study|Withdrawal by Subject|0|||
125226545|NCT02452047|450457962|FG002|Overall Study|Withdrawal by Subject|0|||
125226546|NCT00288912|450457963|FG000|Overall Study|Developed exclusion criterion|4|||
125226547|NCT00288912|450457964|FG001|Overall Study|Developed exclusion criterion|6|||
125226548|NCT00288912|450457965|FG002|Overall Study|Developed exclusion criterion|7|||
125226549|NCT00288912|450457963|FG000|Overall Study|Lost to Follow-up|9|||
125226550|NCT00288912|450457964|FG001|Overall Study|Lost to Follow-up|6|||
125226551|NCT00288912|450457965|FG002|Overall Study|Lost to Follow-up|9|||
125226552|NCT00288912|450457963|FG000|Overall Study|Withdrawal by Subject|4|||
125226553|NCT00288912|450457964|FG001|Overall Study|Withdrawal by Subject|5|||
125226554|NCT00288912|450457965|FG002|Overall Study|Withdrawal by Subject|12|||
125226555|NCT02026141|450457969|FG000|Overall Study|Protocol Violation|0|||
125226556|NCT02026141|450457970|FG001|Overall Study|Protocol Violation|1|||
125226557|NCT01783743|450457975|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
125226558|NCT01783743|450457976|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
125226559|NCT01783743|450457975|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
125226560|NCT01783743|450457976|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
125226561|NCT01783743|450457975|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
125226562|NCT01783743|450457976|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
125226563|NCT02771275|450457977|FG000|Overall Study|Reoperation|3|||
125226564|NCT02771275|450457977|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
125226565|NCT03191799|450457978|FG000|Overall Study|Withdrawal by Subject|4|||
125226566|NCT03191799|450457978|FG000|Overall Study|Physician Decision|2|||
125226567|NCT03191799|450457978|FG000|Overall Study|Lost to Follow-up|1|||
125226568|NCT03191799|450457978|FG000|Overall Study|Death|2|||
125226569|NCT00728494|450457991|FG000|Overall Study|Adverse Event|7|||
125226570|NCT00728494|450457992|FG001|Overall Study|Adverse Event|0|||
125226571|NCT00728494|450457991|FG000|Overall Study|Withdrawal by Subject|0|||
125226572|NCT00728494|450457992|FG001|Overall Study|Withdrawal by Subject|2|||
125226573|NCT00728494|450457991|FG000|Overall Study|Lack of Efficacy|2|||
125226574|NCT00728494|450457992|FG001|Overall Study|Lack of Efficacy|4|||
125226575|NCT00728494|450457991|FG000|Overall Study|No data available|0|||
125226576|NCT00728494|450457992|FG001|Overall Study|No data available|1|||
125226577|NCT03439137|450457993|FG000|Overall Study|Adverse Event|16|||
125226578|NCT03439137|450457994|FG001|Overall Study|Adverse Event|12|||
125226579|NCT03439137|450457993|FG000|Overall Study|Physician Decision|0|||
125226580|NCT03439137|450457994|FG001|Overall Study|Physician Decision|5|||
125226581|NCT03439137|450457993|FG000|Overall Study|Withdrawal by Subject|14|||
125226582|NCT03439137|450457994|FG001|Overall Study|Withdrawal by Subject|4|||
125226583|NCT03439137|450457993|FG000|Overall Study|Conducting rescue therapy|2|||
125226584|NCT03439137|450457994|FG001|Overall Study|Conducting rescue therapy|1|||
125226585|NCT03439137|450457993|FG000|Overall Study|Difficult to control Hb|10|||
125226586|NCT03439137|450457994|FG001|Overall Study|Difficult to control Hb|2|||
125226587|NCT03439137|450457993|FG000|Overall Study|Initiation of a renal transplant|0|||
125226588|NCT03439137|450457994|FG001|Overall Study|Initiation of a renal transplant|2|||
125226589|NCT00748241|450457995|FG000|Overall Study|Implant failure|1|||
125226590|NCT00748241|450457995|FG000|Overall Study|Lost to Follow-up|5|||
125226591|NCT00748241|450457995|FG000|Overall Study|Death|2|||
125226592|NCT01240382|450457996|FG000|Overall Study|Adverse Event|2|||
125226593|NCT01240382|450457997|FG001|Overall Study|Adverse Event|1|||
125165946|NCT02132754|450230397|FG009|Overall Study|Screen Failure|0|||
125165947|NCT02132754|450230398|FG010|Overall Study|Screen Failure|0|||
125165948|NCT02132754|450230399|FG011|Overall Study|Screen Failure|0|||
125165949|NCT02132754|450230400|FG012|Overall Study|Screen Failure|0|||
125165950|NCT02132754|450230401|FG013|Overall Study|Screen Failure|0|||
125165951|NCT02132754|450230402|FG014|Overall Study|Screen Failure|0|||
125165952|NCT02132754|450230403|FG015|Overall Study|Screen Failure|0|||
125165953|NCT02132754|450230404|FG016|Overall Study|Screen Failure|0|||
125165954|NCT02132754|450230405|FG017|Overall Study|Screen Failure|0|||
125165955|NCT02132754|450230406|FG018|Overall Study|Screen Failure|0|||
125165956|NCT02132754|450230407|FG019|Overall Study|Screen Failure|1|||
125165957|NCT02132754|450230408|FG020|Overall Study|Screen Failure|0|||
125165958|NCT02132754|450230409|FG021|Overall Study|Screen Failure|1|||
125165959|NCT02132754|450230410|FG022|Overall Study|Screen Failure|0|||
125165960|NCT02132754|450230411|FG023|Overall Study|Screen Failure|0|||
125165961|NCT02132754|450230412|FG024|Overall Study|Screen Failure|0|||
125165962|NCT02132754|450230413|FG025|Overall Study|Screen Failure|0|||
125165963|NCT02132754|450230414|FG026|Overall Study|Screen Failure|0|||
125165964|NCT02132754|450230415|FG027|Overall Study|Screen Failure|0|||
125165965|NCT02132754|450230416|FG028|Overall Study|Screen Failure|0|||
125165966|NCT02132754|450230417|FG029|Overall Study|Screen Failure|0|||
125165967|NCT02132754|450230418|FG030|Overall Study|Screen Failure|0|||
125165968|NCT02132754|450230419|FG031|Overall Study|Screen Failure|0|||
125165969|NCT02132754|450230420|FG032|Overall Study|Screen Failure|0|||
125165970|NCT02132754|450230421|FG033|Overall Study|Screen Failure|0|||
125165971|NCT02132754|450230388|FG000|Overall Study|Transferred to Extension Study|0|||
125165972|NCT02132754|450230389|FG001|Overall Study|Transferred to Extension Study|0|||
125165973|NCT02132754|450230390|FG002|Overall Study|Transferred to Extension Study|0|||
125165974|NCT02132754|450230391|FG003|Overall Study|Transferred to Extension Study|0|||
125165975|NCT02132754|450230392|FG004|Overall Study|Transferred to Extension Study|0|||
125165976|NCT02132754|450230393|FG005|Overall Study|Transferred to Extension Study|0|||
125226594|NCT01240382|450457996|FG000|Overall Study|Lack of Efficacy|0|||
125226595|NCT01240382|450457997|FG001|Overall Study|Lack of Efficacy|2|||
125226596|NCT01240382|450457996|FG000|Overall Study|Fear of adverse events|0|||
125226597|NCT01240382|450457997|FG001|Overall Study|Fear of adverse events|1|||
125226598|NCT02456727|450458005|FG000|Overall Study|Lost to Follow-up|63|||
125226599|NCT02456727|450458006|FG001|Overall Study|Lost to Follow-up|65|||
125226600|NCT02456727|450458005|FG000|Overall Study|Death|2|||
125226601|NCT02456727|450458006|FG001|Overall Study|Death|1|||
125226602|NCT02456727|450458005|FG000|Overall Study|Withdrawal by Subject|1|||
125226603|NCT02456727|450458006|FG001|Overall Study|Withdrawal by Subject|10|||
125226604|NCT02456727|450458005|FG000|Overall Study|Never Initiated Treatment|43|||
125226605|NCT02456727|450458006|FG001|Overall Study|Never Initiated Treatment|30|||
125226606|NCT02643693|450458010|FG000|Overall Study|Physician Decision|0|||
125226607|NCT02643693|450458011|FG001|Overall Study|Physician Decision|1|||
125226608|NCT02643693|450458012|FG002|Overall Study|Physician Decision|0|||
125226609|NCT02643693|450458013|FG003|Overall Study|Physician Decision|0|||
125226610|NCT02643693|450458014|FG004|Overall Study|Physician Decision|0|||
125226611|NCT02643693|450458015|FG005|Overall Study|Physician Decision|0|||
125226612|NCT02643693|450458010|FG000|Overall Study|Withdrawal by Subject|0|||
125226613|NCT02643693|450458011|FG001|Overall Study|Withdrawal by Subject|1|||
125226614|NCT02643693|450458012|FG002|Overall Study|Withdrawal by Subject|0|||
125226615|NCT02643693|450458013|FG003|Overall Study|Withdrawal by Subject|0|||
125226616|NCT02643693|450458014|FG004|Overall Study|Withdrawal by Subject|0|||
125165977|NCT02132754|450230394|FG006|Overall Study|Transferred to Extension Study|0|||
125165978|NCT02132754|450230395|FG007|Overall Study|Transferred to Extension Study|0|||
125165979|NCT02132754|450230396|FG008|Overall Study|Transferred to Extension Study|0|||
125165980|NCT02132754|450230397|FG009|Overall Study|Transferred to Extension Study|0|||
125165981|NCT02132754|450230398|FG010|Overall Study|Transferred to Extension Study|0|||
125165982|NCT02132754|450230399|FG011|Overall Study|Transferred to Extension Study|0|||
125165983|NCT02132754|450230400|FG012|Overall Study|Transferred to Extension Study|0|||
125165984|NCT02132754|450230401|FG013|Overall Study|Transferred to Extension Study|0|||
125165985|NCT02132754|450230402|FG014|Overall Study|Transferred to Extension Study|0|||
125165986|NCT02132754|450230403|FG015|Overall Study|Transferred to Extension Study|0|||
125165987|NCT02132754|450230404|FG016|Overall Study|Transferred to Extension Study|0|||
125165988|NCT02132754|450230405|FG017|Overall Study|Transferred to Extension Study|0|||
125165989|NCT02132754|450230406|FG018|Overall Study|Transferred to Extension Study|0|||
125165990|NCT02132754|450230407|FG019|Overall Study|Transferred to Extension Study|0|||
125165991|NCT02132754|450230408|FG020|Overall Study|Transferred to Extension Study|0|||
125165992|NCT02132754|450230409|FG021|Overall Study|Transferred to Extension Study|0|||
125226617|NCT02643693|450458015|FG005|Overall Study|Withdrawal by Subject|0|||
125226618|NCT02643693|450458010|FG000|Overall Study|Protocol Adherence Issues|2|||
125226619|NCT02643693|450458011|FG001|Overall Study|Protocol Adherence Issues|0|||
125226620|NCT02643693|450458012|FG002|Overall Study|Protocol Adherence Issues|1|||
125226621|NCT02643693|450458013|FG003|Overall Study|Protocol Adherence Issues|0|||
125165993|NCT02132754|450230410|FG022|Overall Study|Transferred to Extension Study|0|||
125165994|NCT02132754|450230411|FG023|Overall Study|Transferred to Extension Study|0|||
125226622|NCT02643693|450458014|FG004|Overall Study|Protocol Adherence Issues|0|||
125226623|NCT02643693|450458015|FG005|Overall Study|Protocol Adherence Issues|1|||
125165995|NCT02132754|450230412|FG024|Overall Study|Transferred to Extension Study|0|||
125165996|NCT02132754|450230413|FG025|Overall Study|Transferred to Extension Study|0|||
125165997|NCT02132754|450230414|FG026|Overall Study|Transferred to Extension Study|0|||
125165998|NCT02132754|450230415|FG027|Overall Study|Transferred to Extension Study|0|||
125165999|NCT02132754|450230416|FG028|Overall Study|Transferred to Extension Study|0|||
125226624|NCT00492297|450458016|FG000|Treatment|Death|2|||
125226625|NCT00492297|450458016|FG000|Treatment|Study terminated by sponsor|3|||
125226626|NCT00492297|450458016|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
125226627|NCT00492297|450458016|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
125226628|NCT00492297|450458016|FG000|Survival Only Follow-up|Death|46|||
125226629|NCT00492297|450458016|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
125226630|NCT00492297|450458016|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
125226631|NCT01408706|450458017|FG000|Overall Study|Physician Decision|1|||
125226632|NCT01408706|450458018|FG001|Overall Study|Physician Decision|0|||
125226633|NCT00888654|450458020|FG000|Overall Study|Problems swallowing oral meds.|1|||
125226634|NCT00888654|450458020|FG000|Overall Study|Not enough oral meds before surgery|3|||
125226635|NCT00888654|450458020|FG000|Overall Study|Surgery aborted|2|||
125226636|NCT00888654|450458020|FG000|Overall Study|Withdrawal by Subject|1|||
125226637|NCT00888654|450458020|FG000|Overall Study|Inelig. due to contraindication of med|1|||
125226638|NCT00888654|450458020|FG000|Overall Study|Change in surg date|1|||
125226639|NCT00888654|450458020|FG000|Overall Study|Stopped meds due to headaches|1|||
125226640|NCT00698815|450458021|FG000|Overall Study|Death|1|||
125226641|NCT00698815|450458022|FG001|Overall Study|Death|2|||
125226642|NCT00698815|450458023|FG002|Overall Study|Death|4|||
125226643|NCT00698815|450458021|FG000|Overall Study|Withdrawal by Subject|6|||
125226644|NCT00698815|450458022|FG001|Overall Study|Withdrawal by Subject|3|||
125226645|NCT00698815|450458023|FG002|Overall Study|Withdrawal by Subject|2|||
125226646|NCT00698815|450458021|FG000|Overall Study|MD discretion|2|||
125226647|NCT00698815|450458022|FG001|Overall Study|MD discretion|7|||
125226648|NCT00698815|450458023|FG002|Overall Study|MD discretion|2|||
125226649|NCT00698815|450458021|FG000|Overall Study|Did not receive protocol treatment|1|||
125226650|NCT00698815|450458022|FG001|Overall Study|Did not receive protocol treatment|2|||
125226651|NCT00698815|450458023|FG002|Overall Study|Did not receive protocol treatment|2|||
125226652|NCT01663402|450458026|FG000|Overall Study|Randomized but not treated|19|||
125226653|NCT01663402|450458027|FG001|Overall Study|Randomized but not treated|11|||
125226654|NCT01663402|450458026|FG000|Overall Study|Adverse Event|347|||
125226655|NCT01663402|450458027|FG001|Overall Study|Adverse Event|362|||
125226656|NCT01663402|450458026|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
125226657|NCT01663402|450458027|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
125226658|NCT01663402|450458026|FG000|Overall Study|Poor compliance to protocol|529|||
125226659|NCT01663402|450458027|FG001|Overall Study|Poor compliance to protocol|454|||
125226660|NCT01663402|450458026|FG000|Overall Study|Physician Decision|77|||
125226661|NCT01663402|450458027|FG001|Overall Study|Physician Decision|62|||
125226662|NCT01663402|450458026|FG000|Overall Study|Site terminated by sponsor|1|||
125226663|NCT01663402|450458027|FG001|Overall Study|Site terminated by sponsor|3|||
125226664|NCT01663402|450458026|FG000|Overall Study|Participant moved|139|||
125226665|NCT01663402|450458027|FG001|Overall Study|Participant moved|104|||
125226666|NCT01663402|450458026|FG000|Overall Study|Withdrawal by Subject|118|||
125226667|NCT01663402|450458027|FG001|Overall Study|Withdrawal by Subject|91|||
125226668|NCT01663402|450458026|FG000|Overall Study|Related to study drug administration|96|||
125226669|NCT01663402|450458027|FG001|Overall Study|Related to study drug administration|105|||
125226670|NCT01663402|450458026|FG000|Overall Study|Lost to Follow-up|17|||
125226671|NCT01663402|450458027|FG001|Overall Study|Lost to Follow-up|15|||
125226672|NCT01663402|450458026|FG000|Overall Study|Other than specified above|172|||
125226673|NCT01663402|450458027|FG001|Overall Study|Other than specified above|147|||
125166000|NCT02132754|450230417|FG029|Overall Study|Transferred to Extension Study|0|||
125166001|NCT02132754|450230418|FG030|Overall Study|Transferred to Extension Study|0|||
125226674|NCT03575702|450458030|FG000|Overall Study|Withdrawal by Subject|1|||
125226675|NCT03575702|450458031|FG001|Overall Study|Withdrawal by Subject|1|||
125226676|NCT03575702|450458030|FG000|Overall Study|Lost to Follow-up|1|||
125226677|NCT03575702|450458031|FG001|Overall Study|Lost to Follow-up|2|||
125226678|NCT03575702|450458030|FG000|Overall Study|Protocol Violation|0|||
125226679|NCT03575702|450458031|FG001|Overall Study|Protocol Violation|1|||
125226680|NCT03575702|450458030|FG000|Overall Study|Patient non compliance|4|||
125226681|NCT03575702|450458031|FG001|Overall Study|Patient non compliance|0|||
125166002|NCT02132754|450230419|FG031|Overall Study|Transferred to Extension Study|0|||
125166003|NCT02132754|450230420|FG032|Overall Study|Transferred to Extension Study|0|||
125166004|NCT02132754|450230421|FG033|Overall Study|Transferred to Extension Study|6|||
125166005|NCT02132754|450230388|FG000|Overall Study|Withdrawal by Subject|0|||
125166006|NCT02132754|450230389|FG001|Overall Study|Withdrawal by Subject|0|||
125166007|NCT02132754|450230390|FG002|Overall Study|Withdrawal by Subject|0|||
125166008|NCT02132754|450230391|FG003|Overall Study|Withdrawal by Subject|0|||
125166009|NCT02132754|450230392|FG004|Overall Study|Withdrawal by Subject|0|||
125166010|NCT02132754|450230393|FG005|Overall Study|Withdrawal by Subject|0|||
125166011|NCT02132754|450230394|FG006|Overall Study|Withdrawal by Subject|0|||
125166012|NCT02132754|450230395|FG007|Overall Study|Withdrawal by Subject|0|||
125166013|NCT02132754|450230396|FG008|Overall Study|Withdrawal by Subject|0|||
125166014|NCT02132754|450230397|FG009|Overall Study|Withdrawal by Subject|1|||
125166015|NCT02132754|450230398|FG010|Overall Study|Withdrawal by Subject|0|||
125166016|NCT02132754|450230399|FG011|Overall Study|Withdrawal by Subject|0|||
125166017|NCT02132754|450230400|FG012|Overall Study|Withdrawal by Subject|1|||
125166018|NCT02132754|450230401|FG013|Overall Study|Withdrawal by Subject|0|||
125166019|NCT02132754|450230402|FG014|Overall Study|Withdrawal by Subject|1|||
125166020|NCT02132754|450230403|FG015|Overall Study|Withdrawal by Subject|2|||
125166021|NCT02132754|450230404|FG016|Overall Study|Withdrawal by Subject|1|||
125166022|NCT02132754|450230405|FG017|Overall Study|Withdrawal by Subject|0|||
125166023|NCT02132754|450230406|FG018|Overall Study|Withdrawal by Subject|0|||
125166024|NCT02132754|450230407|FG019|Overall Study|Withdrawal by Subject|0|||
125166025|NCT02132754|450230408|FG020|Overall Study|Withdrawal by Subject|1|||
125166026|NCT02132754|450230409|FG021|Overall Study|Withdrawal by Subject|0|||
125166027|NCT02132754|450230410|FG022|Overall Study|Withdrawal by Subject|0|||
125166028|NCT02132754|450230411|FG023|Overall Study|Withdrawal by Subject|0|||
125166029|NCT02132754|450230412|FG024|Overall Study|Withdrawal by Subject|1|||
125166030|NCT02132754|450230413|FG025|Overall Study|Withdrawal by Subject|0|||
125166031|NCT02132754|450230414|FG026|Overall Study|Withdrawal by Subject|0|||
125166032|NCT02132754|450230415|FG027|Overall Study|Withdrawal by Subject|1|||
125166033|NCT02132754|450230416|FG028|Overall Study|Withdrawal by Subject|0|||
125166034|NCT02132754|450230417|FG029|Overall Study|Withdrawal by Subject|0|||
125166035|NCT02132754|450230418|FG030|Overall Study|Withdrawal by Subject|0|||
125166036|NCT02132754|450230419|FG031|Overall Study|Withdrawal by Subject|1|||
125166037|NCT02132754|450230420|FG032|Overall Study|Withdrawal by Subject|0|||
125166038|NCT02132754|450230421|FG033|Overall Study|Withdrawal by Subject|2|||
125166039|NCT02288182|450230424|FG000|Overall Study|Adverse Event|0|||
125166040|NCT02288182|450230425|FG001|Overall Study|Adverse Event|1|||
125166041|NCT02288182|450230424|FG000|Overall Study|Lost to Follow-up|0|||
125166042|NCT02288182|450230425|FG001|Overall Study|Lost to Follow-up|1|||
125166043|NCT03567382|450230427|FG000|Overall Study|Lost to Follow-up|1|||
125166044|NCT03567382|450230428|FG001|Overall Study|Lost to Follow-up|21|||
125166045|NCT03567382|450230429|FG002|Overall Study|Lost to Follow-up|1|||
125166046|NCT03567382|450230430|FG003|Overall Study|Lost to Follow-up|21|||
125166047|NCT03567382|450230427|FG000|Overall Study|Withdrawal by Subject|2|||
125166048|NCT03567382|450230428|FG001|Overall Study|Withdrawal by Subject|14|||
125166049|NCT03567382|450230429|FG002|Overall Study|Withdrawal by Subject|1|||
125166050|NCT03567382|450230430|FG003|Overall Study|Withdrawal by Subject|12|||
125166051|NCT00620659|450230433|FG000|Treatment Period 1|Adverse Event|1|||
125166052|NCT00620659|450230434|FG001|Treatment Period 1|Adverse Event|0|||
125166053|NCT00620659|450230435|FG002|Treatment Period 1|Adverse Event|0|||
125166054|NCT00620659|450230436|FG003|Treatment Period 1|Adverse Event|3|||
125166055|NCT00620659|450230437|FG004|Treatment Period 1|Adverse Event|0|||
125166056|NCT00620659|450230438|FG005|Treatment Period 1|Adverse Event|0|||
125166057|NCT00620659|450230433|FG000|Treatment Period 1|Protocol Violation|1|||
125166058|NCT00620659|450230434|FG001|Treatment Period 1|Protocol Violation|0|||
125166059|NCT00620659|450230435|FG002|Treatment Period 1|Protocol Violation|0|||
125166060|NCT00620659|450230436|FG003|Treatment Period 1|Protocol Violation|0|||
125166061|NCT00620659|450230437|FG004|Treatment Period 1|Protocol Violation|0|||
125166062|NCT00620659|450230438|FG005|Treatment Period 1|Protocol Violation|0|||
125166063|NCT00620659|450230433|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125166064|NCT00620659|450230434|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125166065|NCT00620659|450230435|FG002|Treatment Period 1|Withdrawal by Subject|1|||
125166066|NCT00620659|450230436|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125166067|NCT00620659|450230437|FG004|Treatment Period 1|Withdrawal by Subject|1|||
125166068|NCT00620659|450230438|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125166069|NCT00620659|450230433|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
125166070|NCT00620659|450230434|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
125166071|NCT00620659|450230435|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
125166072|NCT00620659|450230436|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
125166073|NCT00620659|450230437|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
125166074|NCT00620659|450230438|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
125166075|NCT00620659|450230433|FG000|Treatment Period 2|Adverse Event|0|||
125166076|NCT00620659|450230434|FG001|Treatment Period 2|Adverse Event|3|||
125166077|NCT00620659|450230435|FG002|Treatment Period 2|Adverse Event|0|||
125166078|NCT00620659|450230436|FG003|Treatment Period 2|Adverse Event|0|||
125166079|NCT00620659|450230437|FG004|Treatment Period 2|Adverse Event|2|||
125166080|NCT00620659|450230438|FG005|Treatment Period 2|Adverse Event|0|||
125166081|NCT00620659|450230433|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125166082|NCT00620659|450230434|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125166083|NCT00620659|450230435|FG002|Treatment Period 2|Withdrawal by Subject|1|||
125166084|NCT00620659|450230436|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125166085|NCT00620659|450230437|FG004|Treatment Period 2|Withdrawal by Subject|3|||
125166086|NCT00620659|450230438|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125166087|NCT00620659|450230433|FG000|Placebo Washout Period 2|Adverse Event|2|||
125166088|NCT00620659|450230434|FG001|Placebo Washout Period 2|Adverse Event|0|||
125166089|NCT00620659|450230435|FG002|Placebo Washout Period 2|Adverse Event|0|||
125226682|NCT01255163|450458032|FG000|Overall Study|Withdrawal by Subject|1|||
125226683|NCT01255163|450458033|FG001|Overall Study|Withdrawal by Subject|0|||
125226684|NCT01255163|450458032|FG000|Overall Study|Lost to Follow-up|2|||
125226685|NCT01255163|450458033|FG001|Overall Study|Lost to Follow-up|0|||
125226686|NCT01255163|450458032|FG000|Overall Study|Adverse Event|0|||
125226687|NCT01255163|450458033|FG001|Overall Study|Adverse Event|2|||
125226688|NCT01255163|450458032|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
125226689|NCT01255163|450458033|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
125226690|NCT02495389|450458034|FG000|Overall Study|Withdrawal by Subject|40|||
125226691|NCT01802385|450458036|FG000|Overall Study|Death|106|||
125226692|NCT01802385|450458037|FG001|Overall Study|Death|120|||
125226693|NCT03834493|450458038|FG000|Overall Study|Participants Ongoing|311|||
125226694|NCT03834493|450458039|FG001|Overall Study|Participants Ongoing|324|||
125226695|NCT03834493|450458038|FG000|Overall Study|Withdrawal by Subject|20|||
125226696|NCT03834493|450458039|FG001|Overall Study|Withdrawal by Subject|17|||
125226697|NCT03834493|450458038|FG000|Overall Study|Physician Decision|1|||
125226698|NCT03834493|450458039|FG001|Overall Study|Physician Decision|0|||
125226699|NCT03834493|450458038|FG000|Overall Study|Death|289|||
125226700|NCT03834493|450458039|FG001|Overall Study|Death|282|||
125226701|NCT05559905|450458040|FG000|Overall Study|Withdrawal by Subject|1|||
125226702|NCT05559905|450458041|FG001|Overall Study|Withdrawal by Subject|0|||
125226703|NCT05559905|450458042|FG002|Overall Study|Withdrawal by Subject|0|||
125226704|NCT05559905|450458040|FG000|Overall Study|Not Reported|1|||
125226705|NCT05559905|450458041|FG001|Overall Study|Not Reported|0|||
125226706|NCT05559905|450458042|FG002|Overall Study|Not Reported|0|||
125226707|NCT04003103|450458043|FG000|Overall Study|Death|1|||
125226708|NCT04003103|450458044|FG001|Overall Study|Death|0|||
125226709|NCT04003103|450458045|FG002|Overall Study|Death|0|||
125226710|NCT04003103|450458043|FG000|Overall Study|Lost to Follow-up|4|||
125226711|NCT04003103|450458044|FG001|Overall Study|Lost to Follow-up|3|||
125226712|NCT04003103|450458045|FG002|Overall Study|Lost to Follow-up|2|||
125226713|NCT04003103|450458043|FG000|Overall Study|Withdrawal by Subject|10|||
125226714|NCT04003103|450458044|FG001|Overall Study|Withdrawal by Subject|1|||
125226715|NCT04003103|450458045|FG002|Overall Study|Withdrawal by Subject|1|||
125226716|NCT04003103|450458043|FG000|Overall Study|Status not recorded|0|||
125226717|NCT04003103|450458044|FG001|Overall Study|Status not recorded|2|||
125226718|NCT04003103|450458045|FG002|Overall Study|Status not recorded|0|||
125226719|NCT03829462|450458048|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
125226720|NCT03829462|450458049|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
125226721|NCT03829462|450458048|FG000|Overall Study|No treatment due to progression disease|0|||
125226722|NCT03829462|450458049|FG001|Overall Study|No treatment due to progression disease|1|||
125226723|NCT05518539|450458053|FG000|Overall Study|Lost to Follow-up|6|||
125226724|NCT02053493|450458056|FG000|Overall Study|Withdrawal by Subject|1|||
125226725|NCT02053493|450458057|FG001|Overall Study|Withdrawal by Subject|1|||
125226726|NCT01619865|450458062|FG000|Overall Study|Adverse Event|1|||
125226727|NCT01619865|450458062|FG000|Overall Study|Death|2|||
125226728|NCT01619865|450458062|FG000|Overall Study|subject not able to comply|1|||
125226729|NCT01494818|450458063|FG000|Overall Study|Relocation|1|||
125226730|NCT01494818|450458064|FG001|Overall Study|Relocation|2|||
125226731|NCT01494818|450458063|FG000|Overall Study|Lost to Follow-up|1|||
125226732|NCT01494818|450458064|FG001|Overall Study|Lost to Follow-up|0|||
125226733|NCT00791999|450458065|FG000|Overall Study|Protocol planed withdrawal|14|||
125226734|NCT00791999|450458066|FG001|Overall Study|Protocol planed withdrawal|11|||
125226735|NCT00791999|450458067|FG002|Overall Study|Protocol planed withdrawal|11|||
125226736|NCT00791999|450458068|FG003|Overall Study|Protocol planed withdrawal|45|||
125226737|NCT00791999|450458065|FG000|Overall Study|Withdrawal by Subject|0|||
125226738|NCT00791999|450458066|FG001|Overall Study|Withdrawal by Subject|1|||
125226739|NCT00791999|450458067|FG002|Overall Study|Withdrawal by Subject|0|||
125226740|NCT00791999|450458068|FG003|Overall Study|Withdrawal by Subject|2|||
125226741|NCT00791999|450458065|FG000|Overall Study|Protocol Violation|3|||
125226742|NCT00791999|450458066|FG001|Overall Study|Protocol Violation|0|||
125166090|NCT00620659|450230436|FG003|Placebo Washout Period 2|Adverse Event|0|||
125226743|NCT00791999|450458067|FG002|Overall Study|Protocol Violation|1|||
125166091|NCT00620659|450230437|FG004|Placebo Washout Period 2|Adverse Event|0|||
125226744|NCT00791999|450458068|FG003|Overall Study|Protocol Violation|0|||
125226745|NCT00791999|450458065|FG000|Overall Study|Adverse Event|3|||
125226746|NCT00791999|450458066|FG001|Overall Study|Adverse Event|3|||
125226747|NCT00791999|450458067|FG002|Overall Study|Adverse Event|7|||
125226748|NCT00791999|450458068|FG003|Overall Study|Adverse Event|3|||
125226749|NCT00791999|450458065|FG000|Overall Study|Lack of Efficacy|0|||
125226750|NCT00791999|450458066|FG001|Overall Study|Lack of Efficacy|1|||
125226751|NCT00791999|450458067|FG002|Overall Study|Lack of Efficacy|0|||
125226752|NCT00791999|450458068|FG003|Overall Study|Lack of Efficacy|2|||
125226753|NCT00791999|450458065|FG000|Overall Study|Reason other than those above|1|||
125226754|NCT00791999|450458066|FG001|Overall Study|Reason other than those above|0|||
125226755|NCT00791999|450458067|FG002|Overall Study|Reason other than those above|1|||
125226756|NCT00791999|450458068|FG003|Overall Study|Reason other than those above|0|||
125226757|NCT01077323|450458069|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
125226758|NCT01077323|450458070|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
125226759|NCT01077323|450458071|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
125226760|NCT01077323|450458069|FG000|Overall Study|Dispensing of drug in baseline period|0|||
125226761|NCT01077323|450458070|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
125226762|NCT01077323|450458071|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
125226763|NCT01077323|450458069|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
125226764|NCT01077323|450458070|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
125226765|NCT01077323|450458071|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
125226766|NCT01710020|450458072|FG000|Period 1|Protocol Violation|1|||
125226767|NCT00427908|450458073|FG000|Primary Phase|Lost to Follow-up|4|||
125226768|NCT00427908|450458074|FG001|Primary Phase|Lost to Follow-up|0|||
125226769|NCT00427908|450458075|FG002|Primary Phase|Lost to Follow-up|2|||
125226770|NCT00427908|450458076|FG003|Primary Phase|Lost to Follow-up|0|||
125226771|NCT00427908|450458073|FG000|Primary Phase|Withdrawal by Subject|1|||
125226772|NCT00427908|450458074|FG001|Primary Phase|Withdrawal by Subject|2|||
125226773|NCT00427908|450458075|FG002|Primary Phase|Withdrawal by Subject|1|||
125226774|NCT00427908|450458076|FG003|Primary Phase|Withdrawal by Subject|0|||
125226775|NCT00427908|450458073|FG000|Primary Phase|Adverse Event|0|||
125226776|NCT00427908|450458074|FG001|Primary Phase|Adverse Event|1|||
125226777|NCT00427908|450458075|FG002|Primary Phase|Adverse Event|0|||
125226778|NCT00427908|450458076|FG003|Primary Phase|Adverse Event|0|||
125226779|NCT02984982|450458077|FG000|Overall Study|Adverse Event|2|||
125226780|NCT02984982|450458078|FG001|Overall Study|Adverse Event|5|||
125226781|NCT02984982|450458077|FG000|Overall Study|Poor Compliance to Protocol|4|||
125226782|NCT02984982|450458078|FG001|Overall Study|Poor Compliance to Protocol|4|||
125226783|NCT02984982|450458077|FG000|Overall Study|Withdrawal by Subject|2|||
125226784|NCT02984982|450458078|FG001|Overall Study|Withdrawal by Subject|0|||
125226785|NCT02984982|450458077|FG000|Overall Study|Randomized but not treated|0|||
125226786|NCT02984982|450458078|FG001|Overall Study|Randomized but not treated|1|||
125226787|NCT02153918|450458079|FG000|Overall Study|Refused further treatment|1|||
125226788|NCT02616783|450458080|FG000|Overall Study|Randomized but Not Treated|1|||
125226789|NCT02616783|450458081|FG001|Overall Study|Randomized but Not Treated|0|||
125226790|NCT02616783|450458080|FG000|Overall Study|Adverse Event|1|||
125226791|NCT02616783|450458081|FG001|Overall Study|Adverse Event|0|||
125226792|NCT02616783|450458080|FG000|Overall Study|Death|1|||
125226793|NCT02616783|450458081|FG001|Overall Study|Death|0|||
125226794|NCT02616783|450458080|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125226795|NCT02616783|450458081|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125226796|NCT02616783|450458080|FG000|Overall Study|Protocol Violation|1|||
125226797|NCT02616783|450458081|FG001|Overall Study|Protocol Violation|1|||
125226798|NCT02616783|450458080|FG000|Overall Study|Withdrew Consent|1|||
125226799|NCT02616783|450458081|FG001|Overall Study|Withdrew Consent|1|||
125226800|NCT04344301|450458082|FG000|Overall Study|Withdrawal by Subject|1|||
125226801|NCT04344301|450458083|FG001|Overall Study|Withdrawal by Subject|0|||
125226802|NCT04344301|450458082|FG000|Overall Study|Death|0|||
125226803|NCT04344301|450458083|FG001|Overall Study|Death|1|||
125226804|NCT01747499|450458084|FG000|Overall Study|Steroid refractory aGvHD|1|||
125226805|NCT01747499|450458085|FG001|Overall Study|Steroid refractory aGvHD|0|||
125226806|NCT01747499|450458086|FG002|Overall Study|Steroid refractory aGvHD|0|||
125226807|NCT01747499|450458087|FG003|Overall Study|Steroid refractory aGvHD|1|||
125226808|NCT01747499|450458088|FG004|Overall Study|Steroid refractory aGvHD|4|||
125226809|NCT01747499|450458084|FG000|Overall Study|Physician Decision|0|||
125226810|NCT01747499|450458085|FG001|Overall Study|Physician Decision|1|||
125226811|NCT01747499|450458086|FG002|Overall Study|Physician Decision|0|||
125226812|NCT01747499|450458087|FG003|Overall Study|Physician Decision|0|||
125226813|NCT01747499|450458088|FG004|Overall Study|Physician Decision|2|||
125226814|NCT01747499|450458084|FG000|Overall Study|Death|0|||
125226815|NCT01747499|450458085|FG001|Overall Study|Death|0|||
125166092|NCT00620659|450230438|FG005|Placebo Washout Period 2|Adverse Event|0|||
125166093|NCT00620659|450230433|FG000|Treatment Period 3|Adverse Event|0|||
125166094|NCT00620659|450230434|FG001|Treatment Period 3|Adverse Event|2|||
125166095|NCT00620659|450230435|FG002|Treatment Period 3|Adverse Event|0|||
125166096|NCT00620659|450230436|FG003|Treatment Period 3|Adverse Event|0|||
125166097|NCT00620659|450230437|FG004|Treatment Period 3|Adverse Event|0|||
125166098|NCT00620659|450230438|FG005|Treatment Period 3|Adverse Event|0|||
125166099|NCT00620659|450230433|FG000|Treatment Period 3|Withdrawal by Subject|0|||
125166100|NCT00620659|450230434|FG001|Treatment Period 3|Withdrawal by Subject|0|||
125166101|NCT00620659|450230435|FG002|Treatment Period 3|Withdrawal by Subject|0|||
125166102|NCT00620659|450230436|FG003|Treatment Period 3|Withdrawal by Subject|1|||
125166103|NCT00620659|450230437|FG004|Treatment Period 3|Withdrawal by Subject|0|||
125166104|NCT00620659|450230438|FG005|Treatment Period 3|Withdrawal by Subject|0|||
125166105|NCT01214915|450230440|FG000|Overall Study|Adverse Event|8|||
125166106|NCT01214915|450230440|FG000|Overall Study|Lack of Efficacy|3|||
125166107|NCT02056392|450230441|FG000|Overall Study|Lost to Follow-up|0|||
125166108|NCT02056392|450230442|FG001|Overall Study|Lost to Follow-up|1|||
125166109|NCT02056392|450230443|FG002|Overall Study|Lost to Follow-up|2|||
125166110|NCT02056392|450230444|FG003|Overall Study|Lost to Follow-up|0|||
125166111|NCT02056392|450230445|FG004|Overall Study|Lost to Follow-up|0|||
125166112|NCT02056392|450230446|FG005|Overall Study|Lost to Follow-up|0|||
125166113|NCT02056392|450230441|FG000|Overall Study|Protocol Violation|1|||
125166114|NCT02056392|450230442|FG001|Overall Study|Protocol Violation|0|||
125166115|NCT02056392|450230443|FG002|Overall Study|Protocol Violation|1|||
125166116|NCT02056392|450230444|FG003|Overall Study|Protocol Violation|0|||
125166117|NCT02056392|450230445|FG004|Overall Study|Protocol Violation|0|||
125166118|NCT02056392|450230446|FG005|Overall Study|Protocol Violation|0|||
125166119|NCT02056392|450230441|FG000|Overall Study|Withdrawal by Subject|1|||
125166120|NCT02056392|450230442|FG001|Overall Study|Withdrawal by Subject|0|||
125166121|NCT02056392|450230443|FG002|Overall Study|Withdrawal by Subject|0|||
125166122|NCT02056392|450230444|FG003|Overall Study|Withdrawal by Subject|0|||
125166123|NCT02056392|450230445|FG004|Overall Study|Withdrawal by Subject|1|||
125166124|NCT02056392|450230446|FG005|Overall Study|Withdrawal by Subject|0|||
125166125|NCT04555720|450230449|FG000|Overall Study|Lost to Follow-up|2|||
125166126|NCT04555720|450230450|FG001|Overall Study|Lost to Follow-up|0|||
125166127|NCT04555720|450230451|FG002|Overall Study|Lost to Follow-up|0|||
125166128|NCT04555720|450230452|FG003|Overall Study|Lost to Follow-up|0|||
125166129|NCT04555720|450230449|FG000|Overall Study|Withdrawal by Subject|4|||
125166130|NCT04555720|450230450|FG001|Overall Study|Withdrawal by Subject|6|||
125166131|NCT04555720|450230451|FG002|Overall Study|Withdrawal by Subject|0|||
125166132|NCT04555720|450230452|FG003|Overall Study|Withdrawal by Subject|0|||
125166133|NCT00968799|450230453|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
125166134|NCT00719849|450230454|FG000|Overall Study|Death|0|||
125166135|NCT00719849|450230455|FG001|Overall Study|Death|1|||
125166136|NCT01372774|450230458|FG000|Overall Study|Withdrawal prior to treatment|4|||
125166137|NCT01372774|450230459|FG001|Overall Study|Withdrawal prior to treatment|5|||
125166138|NCT02201290|450230460|FG000|Overall Study|Withdrawal by Subject|2|||
125166139|NCT02201290|450230460|FG000|Overall Study|Lack of Efficacy|2|||
125166140|NCT02201290|450230460|FG000|Overall Study|Adverse Event|1|||
125166141|NCT01177059|450230461|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
125166142|NCT01177059|450230461|FG000|Overall Study|Withdrew consent|2|||
125166143|NCT01177059|450230461|FG000|Overall Study|Lost to Follow-up|18|||
125166144|NCT04003896|450232295|FG000|Overall Study|Withdrawal by Subject|3|||
125166145|NCT04003896|450232295|FG000|Overall Study|Physician Decision|1|||
125166146|NCT01957397|450232298|FG000|Test Period 1|sudden leakage/small bag|1|||
125166147|NCT01957397|450232299|FG001|Test Period 1|sudden leakage/small bag|1|||
125166148|NCT01957397|450232298|FG000|Test Period 1|Withdrawal by Subject|1|||
125166149|NCT01957397|450232299|FG001|Test Period 1|Withdrawal by Subject|0|||
125166150|NCT01957397|450232298|FG000|Test Period 2|Adverse Event|0|||
125166151|NCT01957397|450232299|FG001|Test Period 2|Adverse Event|1|||
125166152|NCT01957397|450232298|FG000|Test Period 3|Adverse Event|1|||
125166153|NCT01957397|450232299|FG001|Test Period 3|Adverse Event|2|||
125166154|NCT01957397|450232298|FG000|Test Period 3|the adhesive did not work|1|||
125166155|NCT01957397|450232299|FG001|Test Period 3|the adhesive did not work|0|||
125166156|NCT00324649|450232300|FG000|Overall Study|Adverse Event|1|||
125166157|NCT00324649|450232301|FG001|Overall Study|Adverse Event|4|||
125166158|NCT00324649|450232300|FG000|Overall Study|Withdrawal by Subject|0|||
125166159|NCT00324649|450232301|FG001|Overall Study|Withdrawal by Subject|1|||
125166160|NCT00324649|450232300|FG000|Overall Study|Noncompliance|1|||
125166161|NCT00324649|450232301|FG001|Overall Study|Noncompliance|0|||
125166162|NCT02315196|450232303|FG000|Overall Study|Withdrew consent|9|||
125166163|NCT00470067|450232304|FG000|Overall Study|Death|1|||
125166164|NCT00470067|450232304|FG000|Overall Study|Disease Progression|6|||
125166165|NCT03839823|450232305|FG000|Overall Study|Adverse Event|8|||
125166166|NCT03839823|450232306|FG001|Overall Study|Adverse Event|4|||
125166167|NCT03839823|450232305|FG000|Overall Study|Death|1|||
125226816|NCT01747499|450458086|FG002|Overall Study|Death|0|||
125226817|NCT01747499|450458087|FG003|Overall Study|Death|1|||
125226818|NCT01747499|450458088|FG004|Overall Study|Death|1|||
125226819|NCT01747499|450458084|FG000|Overall Study|Withdrawal by Subject|0|||
125226820|NCT01747499|450458085|FG001|Overall Study|Withdrawal by Subject|0|||
125226821|NCT01747499|450458086|FG002|Overall Study|Withdrawal by Subject|0|||
125226822|NCT01747499|450458087|FG003|Overall Study|Withdrawal by Subject|0|||
125226823|NCT01747499|450458088|FG004|Overall Study|Withdrawal by Subject|6|||
125226824|NCT01747499|450458084|FG000|Overall Study|Developed AML and death|0|||
125226825|NCT01747499|450458085|FG001|Overall Study|Developed AML and death|0|||
125226826|NCT01747499|450458086|FG002|Overall Study|Developed AML and death|0|||
125226827|NCT01747499|450458087|FG003|Overall Study|Developed AML and death|0|||
125226828|NCT01747499|450458088|FG004|Overall Study|Developed AML and death|1|||
125226829|NCT01747499|450458084|FG000|Overall Study|Determined not to be eligible|0|||
125226830|NCT01747499|450458085|FG001|Overall Study|Determined not to be eligible|0|||
125226831|NCT01747499|450458086|FG002|Overall Study|Determined not to be eligible|0|||
125226832|NCT01747499|450458087|FG003|Overall Study|Determined not to be eligible|0|||
125226833|NCT01747499|450458088|FG004|Overall Study|Determined not to be eligible|1|||
125226834|NCT05214118|450458091|FG000|Overall Study|Lost to Follow-up|0|||
125226835|NCT05214118|450458092|FG001|Overall Study|Lost to Follow-up|2|||
125226836|NCT05214118|450458091|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
125226837|NCT05214118|450458092|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
125226838|NCT05214118|450458091|FG000|Overall Study|moved|1|||
125226839|NCT05214118|450458092|FG001|Overall Study|moved|0|||
125226840|NCT04010461|450458093|FG000|Overall Study|COVID based withdrawal|5|||
125226841|NCT04010461|450458093|FG000|Overall Study|Withdrawal by Subject|5|||
125226842|NCT04010461|450458093|FG000|Overall Study|Adverse Event|1|||
125226843|NCT04010461|450458093|FG000|Overall Study|No Motor Threshold obtainable|1|||
125226844|NCT04010461|450458093|FG000|Overall Study|Physician Decision|1|||
125226845|NCT03797898|450458094|FG000|Overall Study|Lost to Follow-up|60|||
125226846|NCT03797898|450458095|FG001|Overall Study|Lost to Follow-up|69|||
125226847|NCT03797898|450458094|FG000|Overall Study|Withdrawal by Subject|9|||
125226848|NCT03797898|450458095|FG001|Overall Study|Withdrawal by Subject|7|||
125226849|NCT03797898|450458094|FG000|Overall Study|Became ineligible|5|||
125226850|NCT03797898|450458095|FG001|Overall Study|Became ineligible|2|||
125226851|NCT00086190|450458096|FG000|Overall Study|Adverse Event|6|||
125226852|NCT00086190|450458097|FG001|Overall Study|Adverse Event|2|||
125226853|NCT00086190|450458098|FG002|Overall Study|Adverse Event|2|||
125226854|NCT00086190|450458096|FG000|Overall Study|Withdrawal by Subject|0|||
125226855|NCT00086190|450458097|FG001|Overall Study|Withdrawal by Subject|2|||
125226856|NCT00086190|450458098|FG002|Overall Study|Withdrawal by Subject|2|||
125226857|NCT00086190|450458096|FG000|Overall Study|Protocol Violation|1|||
125226858|NCT00086190|450458097|FG001|Overall Study|Protocol Violation|0|||
125166168|NCT03839823|450232306|FG001|Overall Study|Death|0|||
125166169|NCT03839823|450232305|FG000|Overall Study|Physician Decision|1|||
125166170|NCT03839823|450232306|FG001|Overall Study|Physician Decision|5|||
125166171|NCT03839823|450232305|FG000|Overall Study|Progressive Disease (PD)|65|||
125166172|NCT03839823|450232306|FG001|Overall Study|Progressive Disease (PD)|65|||
125166173|NCT03839823|450232305|FG000|Overall Study|Subject Decision|2|||
125166174|NCT03839823|450232306|FG001|Overall Study|Subject Decision|9|||
125166175|NCT03839823|450232305|FG000|Overall Study|Not Treated|0|||
125166176|NCT03839823|450232306|FG001|Overall Study|Not Treated|10|||
125166177|NCT01517373|450232308|FG000|Run-in Period|Death|1|||
125166178|NCT01517373|450232309|FG001|Run-in Period|Death|0|||
125166179|NCT01517373|450232310|FG002|Run-in Period|Death|0|||
125166180|NCT01517373|450232311|FG003|Run-in Period|Death|0|||
125166181|NCT01517373|450232312|FG004|Run-in Period|Death|0|||
125166182|NCT01517373|450232313|FG005|Run-in Period|Death|0|||
125166183|NCT01517373|450232308|FG000|Run-in Period|Adverse Event|5|||
125166184|NCT01517373|450232309|FG001|Run-in Period|Adverse Event|0|||
125166185|NCT01517373|450232310|FG002|Run-in Period|Adverse Event|0|||
125166186|NCT01517373|450232311|FG003|Run-in Period|Adverse Event|0|||
125166187|NCT01517373|450232312|FG004|Run-in Period|Adverse Event|0|||
125166188|NCT01517373|450232313|FG005|Run-in Period|Adverse Event|0|||
125166189|NCT01517373|450232308|FG000|Run-in Period|Did not meet eligibility criteria|34|||
125166190|NCT01517373|450232309|FG001|Run-in Period|Did not meet eligibility criteria|0|||
125166191|NCT01517373|450232310|FG002|Run-in Period|Did not meet eligibility criteria|0|||
125166192|NCT01517373|450232311|FG003|Run-in Period|Did not meet eligibility criteria|0|||
125166193|NCT01517373|450232312|FG004|Run-in Period|Did not meet eligibility criteria|0|||
125166194|NCT01517373|450232313|FG005|Run-in Period|Did not meet eligibility criteria|0|||
125166195|NCT01517373|450232308|FG000|Run-in Period|Lost to Follow-up|1|||
125166196|NCT01517373|450232309|FG001|Run-in Period|Lost to Follow-up|0|||
125166197|NCT01517373|450232310|FG002|Run-in Period|Lost to Follow-up|0|||
125166198|NCT01517373|450232311|FG003|Run-in Period|Lost to Follow-up|0|||
125166199|NCT01517373|450232312|FG004|Run-in Period|Lost to Follow-up|0|||
125226859|NCT00086190|450458098|FG002|Overall Study|Protocol Violation|0|||
125226860|NCT00086190|450458096|FG000|Overall Study|Moved|1|||
125226861|NCT00086190|450458097|FG001|Overall Study|Moved|0|||
125226862|NCT00086190|450458098|FG002|Overall Study|Moved|0|||
125166200|NCT01517373|450232313|FG005|Run-in Period|Lost to Follow-up|0|||
125166201|NCT01517373|450232308|FG000|Run-in Period|Withdrawal by Subject|12|||
125166202|NCT01517373|450232309|FG001|Run-in Period|Withdrawal by Subject|0|||
125166203|NCT01517373|450232310|FG002|Run-in Period|Withdrawal by Subject|0|||
125166204|NCT01517373|450232311|FG003|Run-in Period|Withdrawal by Subject|0|||
125166205|NCT01517373|450232312|FG004|Run-in Period|Withdrawal by Subject|0|||
125166206|NCT01517373|450232313|FG005|Run-in Period|Withdrawal by Subject|0|||
125166207|NCT01517373|450232308|FG000|Run-in Period|Sponsor Decision|3|||
125166208|NCT01517373|450232309|FG001|Run-in Period|Sponsor Decision|0|||
125166209|NCT01517373|450232310|FG002|Run-in Period|Sponsor Decision|0|||
125166210|NCT01517373|450232311|FG003|Run-in Period|Sponsor Decision|0|||
125166211|NCT01517373|450232312|FG004|Run-in Period|Sponsor Decision|0|||
125166212|NCT01517373|450232313|FG005|Run-in Period|Sponsor Decision|0|||
125166213|NCT01517373|450232308|FG000|Run-in Period|Other|1|||
125166214|NCT01517373|450232309|FG001|Run-in Period|Other|0|||
125166215|NCT01517373|450232310|FG002|Run-in Period|Other|0|||
125166216|NCT01517373|450232311|FG003|Run-in Period|Other|0|||
125226863|NCT00086190|450458096|FG000|Overall Study|Worsening depression|0|||
125226864|NCT00086190|450458097|FG001|Overall Study|Worsening depression|0|||
125226865|NCT00086190|450458098|FG002|Overall Study|Worsening depression|2|||
125226866|NCT03902613|450458102|FG000|Overall Study|Physician Decision|1|||
125226867|NCT02027025|450458103|FG000|Overall Study|Adverse Event|0|||
125226868|NCT02027025|450458104|FG001|Overall Study|Adverse Event|1|||
125166217|NCT01517373|450232312|FG004|Run-in Period|Other|0|||
125166218|NCT01517373|450232313|FG005|Run-in Period|Other|0|||
125166219|NCT01517373|450232308|FG000|Treatment Period|Adverse Event|0|||
125166220|NCT01517373|450232309|FG001|Treatment Period|Adverse Event|0|||
125166221|NCT01517373|450232310|FG002|Treatment Period|Adverse Event|0|||
125166222|NCT01517373|450232311|FG003|Treatment Period|Adverse Event|0|||
125166223|NCT01517373|450232312|FG004|Treatment Period|Adverse Event|0|||
125166224|NCT01517373|450232313|FG005|Treatment Period|Adverse Event|2|||
125166225|NCT01517373|450232308|FG000|Treatment Period|Lost to Follow-up|0|||
125166226|NCT01517373|450232309|FG001|Treatment Period|Lost to Follow-up|0|||
125166227|NCT01517373|450232310|FG002|Treatment Period|Lost to Follow-up|1|||
125166228|NCT01517373|450232311|FG003|Treatment Period|Lost to Follow-up|1|||
125166229|NCT01517373|450232312|FG004|Treatment Period|Lost to Follow-up|0|||
125166230|NCT01517373|450232313|FG005|Treatment Period|Lost to Follow-up|0|||
125166231|NCT01517373|450232308|FG000|Treatment Period|Withdrawal by Subject|0|||
125166232|NCT01517373|450232309|FG001|Treatment Period|Withdrawal by Subject|3|||
125166233|NCT01517373|450232310|FG002|Treatment Period|Withdrawal by Subject|2|||
125166234|NCT01517373|450232311|FG003|Treatment Period|Withdrawal by Subject|2|||
125166235|NCT01517373|450232312|FG004|Treatment Period|Withdrawal by Subject|2|||
125166236|NCT01517373|450232313|FG005|Treatment Period|Withdrawal by Subject|3|||
125166237|NCT01517373|450232308|FG000|Treatment Period|Other|0|||
125226869|NCT02027025|450458105|FG002|Overall Study|Adverse Event|1|||
125166238|NCT01517373|450232309|FG001|Treatment Period|Other|0|||
125166239|NCT01517373|450232310|FG002|Treatment Period|Other|0|||
125166240|NCT01517373|450232311|FG003|Treatment Period|Other|0|||
125166241|NCT01517373|450232312|FG004|Treatment Period|Other|1|||
125166242|NCT01517373|450232313|FG005|Treatment Period|Other|0|||
125166243|NCT01517373|450232308|FG000|Treatment Period|Protocol Violation|0|||
125166244|NCT01517373|450232309|FG001|Treatment Period|Protocol Violation|0|||
125166245|NCT01517373|450232310|FG002|Treatment Period|Protocol Violation|0|||
125166246|NCT01517373|450232311|FG003|Treatment Period|Protocol Violation|0|||
125166247|NCT01517373|450232312|FG004|Treatment Period|Protocol Violation|1|||
125166248|NCT01517373|450232313|FG005|Treatment Period|Protocol Violation|0|||
125166249|NCT01517373|450232308|FG000|Treatment Period|Lack of Efficacy|0|||
125166250|NCT01517373|450232309|FG001|Treatment Period|Lack of Efficacy|1|||
125166251|NCT01517373|450232310|FG002|Treatment Period|Lack of Efficacy|1|||
125166252|NCT01517373|450232311|FG003|Treatment Period|Lack of Efficacy|3|||
125166253|NCT01517373|450232312|FG004|Treatment Period|Lack of Efficacy|2|||
125166254|NCT01517373|450232313|FG005|Treatment Period|Lack of Efficacy|0|||
125166255|NCT01517373|450232308|FG000|Treatment Period|Medication error without AEs|0|||
125166256|NCT01517373|450232309|FG001|Treatment Period|Medication error without AEs|0|||
125166257|NCT01517373|450232310|FG002|Treatment Period|Medication error without AEs|2|||
125166258|NCT01517373|450232311|FG003|Treatment Period|Medication error without AEs|1|||
125166259|NCT01517373|450232312|FG004|Treatment Period|Medication error without AEs|0|||
125166260|NCT01517373|450232313|FG005|Treatment Period|Medication error without AEs|2|||
125166261|NCT03678285|450232318|FG000|Overall Study|Adverse Event|2|||
125166262|NCT03678285|450232318|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
125166263|NCT03678285|450232318|FG000|Overall Study|Dehydrated prior to start of workout|1|||
125166264|NCT00616629|450232319|FG000|Overall Study|Protocol Violation|1|||
125166265|NCT00616629|450232320|FG001|Overall Study|Protocol Violation|2|||
125166266|NCT00616629|450232321|FG002|Overall Study|Protocol Violation|1|||
125166267|NCT00616629|450232322|FG003|Overall Study|Protocol Violation|0|||
125166268|NCT00616629|450232323|FG004|Overall Study|Protocol Violation|0|||
125166269|NCT00616629|450232319|FG000|Overall Study|AV-block|1|||
125166270|NCT00616629|450232320|FG001|Overall Study|AV-block|0|||
125166271|NCT00616629|450232321|FG002|Overall Study|AV-block|0|||
125166272|NCT00616629|450232322|FG003|Overall Study|AV-block|0|||
125166273|NCT00616629|450232323|FG004|Overall Study|AV-block|0|||
125166274|NCT01777620|450232324|FG000|Overall Study|Subject Withdrawal|1|||
125166275|NCT01777620|450232325|FG001|Overall Study|Subject Withdrawal|0|||
125166276|NCT04516759|450232331|FG000|Overall Study|Withdrawal by Subject|1|||
125166277|NCT04516759|450232332|FG001|Overall Study|Withdrawal by Subject|1|||
125166278|NCT04516759|450232331|FG000|Overall Study|Other|0|||
125166279|NCT04516759|450232332|FG001|Overall Study|Other|1|||
125166280|NCT04005352|450232333|FG000|Overall Study|Adverse Event|4|||
125166281|NCT04005352|450232334|FG001|Overall Study|Adverse Event|5|||
125166282|NCT04005352|450232333|FG000|Overall Study|Death|4|||
125166283|NCT04005352|450232334|FG001|Overall Study|Death|2|||
125166284|NCT04005352|450232333|FG000|Overall Study|Lost to Follow-up|6|||
125166285|NCT04005352|450232334|FG001|Overall Study|Lost to Follow-up|2|||
125166286|NCT04005352|450232333|FG000|Overall Study|Physician Decision|7|||
125166287|NCT04005352|450232334|FG001|Overall Study|Physician Decision|13|||
125166288|NCT04005352|450232333|FG000|Overall Study|Protocol Violation|0|||
125166289|NCT04005352|450232334|FG001|Overall Study|Protocol Violation|1|||
125166290|NCT04005352|450232333|FG000|Overall Study|Withdrawal by Subject|28|||
125166291|NCT04005352|450232334|FG001|Overall Study|Withdrawal by Subject|38|||
125166292|NCT04058067|450232337|FG000|Overall Study|Adverse Event|2|||
125166293|NCT04058067|450232338|FG001|Overall Study|Adverse Event|0|||
125166294|NCT04058067|450232337|FG000|Overall Study|Death|0|||
125166295|NCT04058067|450232338|FG001|Overall Study|Death|1|||
125166296|NCT04058067|450232337|FG000|Overall Study|Physician Decision|3|||
125166297|NCT04058067|450232338|FG001|Overall Study|Physician Decision|1|||
125166298|NCT04058067|450232337|FG000|Overall Study|Protocol Violation|0|||
125166299|NCT04058067|450232338|FG001|Overall Study|Protocol Violation|1|||
125166300|NCT04058067|450232337|FG000|Overall Study|Withdrawal by Subject|7|||
125166301|NCT04058067|450232338|FG001|Overall Study|Withdrawal by Subject|8|||
125166302|NCT00417170|450232339|FG000|Overall Study|Adverse Event|1|||
125166303|NCT00417170|450232340|FG001|Overall Study|Adverse Event|1|||
125166304|NCT00417170|450232339|FG000|Overall Study|Withdrawal by Subject|1|||
125166305|NCT00417170|450232340|FG001|Overall Study|Withdrawal by Subject|1|||
125166306|NCT00417170|450232339|FG000|Overall Study|Lost to Follow-up|0|||
125166307|NCT00417170|450232340|FG001|Overall Study|Lost to Follow-up|1|||
125166308|NCT05005312|450232342|FG000|Overall Study|Enrolled, but not treated|0|||
125166309|NCT05005312|450232343|FG001|Overall Study|Enrolled, but not treated|1|||
125166310|NCT01283035|450232344|FG000|Overall Study|Subject later found ineligible|1|||
125166311|NCT02704403|450232345|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
125166312|NCT02704403|450232346|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
125166313|NCT02704403|450232345|FG000|Overall Study|Administrative reasons by sponsor|1251|||
125166314|NCT02704403|450232346|FG001|Overall Study|Administrative reasons by sponsor|616|||
125226870|NCT02027025|450458103|FG000|Overall Study|Protocol Violation|1|||
125226871|NCT02027025|450458104|FG001|Overall Study|Protocol Violation|0|||
125226872|NCT02027025|450458105|FG002|Overall Study|Protocol Violation|0|||
125226873|NCT02027025|450458103|FG000|Overall Study|Lost to Follow-up|0|||
125226874|NCT02027025|450458104|FG001|Overall Study|Lost to Follow-up|2|||
125226875|NCT02027025|450458105|FG002|Overall Study|Lost to Follow-up|0|||
125226876|NCT02027025|450458103|FG000|Overall Study|Withdrawal by Subject|0|||
125226877|NCT02027025|450458104|FG001|Overall Study|Withdrawal by Subject|1|||
125226878|NCT02027025|450458105|FG002|Overall Study|Withdrawal by Subject|0|||
125226879|NCT02027025|450458103|FG000|Overall Study|Sponsor's decision|0|||
125226880|NCT02027025|450458104|FG001|Overall Study|Sponsor's decision|1|||
125226881|NCT02027025|450458105|FG002|Overall Study|Sponsor's decision|0|||
125226882|NCT01939314|450458106|FG000|Overall Study|Withdrawal by Subject|3|||
125226883|NCT01939314|450458107|FG001|Overall Study|Withdrawal by Subject|1|||
125226884|NCT01939314|450458106|FG000|Overall Study|Protocol Violation|1|||
125226885|NCT01939314|450458107|FG001|Overall Study|Protocol Violation|0|||
125226886|NCT01939314|450458106|FG000|Overall Study|Pregnancy|0|||
125226887|NCT01939314|450458107|FG001|Overall Study|Pregnancy|1|||
125226888|NCT01939314|450458106|FG000|Overall Study|Lost to Follow-up|5|||
125226889|NCT01939314|450458107|FG001|Overall Study|Lost to Follow-up|6|||
125226890|NCT04113694|450460071|FG000|Overall Study|Adverse Event|2|||
125226891|NCT04113694|450460071|FG000|Overall Study|Lost to Follow-up|2|||
125226892|NCT04113694|450460071|FG000|Overall Study|Withdrawal by Subject|6|||
125226893|NCT04113694|450460071|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
125226894|NCT03638128|450460076|FG000|Overall Study|Withdrawal by Subject|1|||
125226895|NCT03638128|450460077|FG001|Overall Study|Withdrawal by Subject|7|||
125226896|NCT03638128|450460078|FG002|Overall Study|Withdrawal by Subject|6|||
125226897|NCT03638128|450460076|FG000|Overall Study|Sponsor Decision|15|||
125166315|NCT02704403|450232345|FG000|Overall Study|Death|4|||
125166316|NCT02704403|450232346|FG001|Overall Study|Death|3|||
125166317|NCT02704403|450232345|FG000|Overall Study|Endpoint event|52|||
125166318|NCT02704403|450232346|FG001|Overall Study|Endpoint event|24|||
125166319|NCT02704403|450232345|FG000|Overall Study|Lost to Follow-up|22|||
125166320|NCT02704403|450232346|FG001|Overall Study|Lost to Follow-up|11|||
125166321|NCT02704403|450232345|FG000|Overall Study|Protocol Violation|15|||
125166322|NCT02704403|450232346|FG001|Overall Study|Protocol Violation|15|||
125166323|NCT02704403|450232345|FG000|Overall Study|Adverse Event|2|||
125166324|NCT02704403|450232346|FG001|Overall Study|Adverse Event|0|||
125166325|NCT02704403|450232345|FG000|Overall Study|Withdrawal by Subject|85|||
125166326|NCT02704403|450232346|FG001|Overall Study|Withdrawal by Subject|45|||
125166327|NCT02704403|450232345|FG000|Overall Study|Investigator decision|1|||
125166328|NCT02704403|450232346|FG001|Overall Study|Investigator decision|1|||
125166329|NCT02704403|450232345|FG000|Overall Study|Follow-up not possible|1|||
125166330|NCT02704403|450232346|FG001|Overall Study|Follow-up not possible|2|||
125166331|NCT00851318|450232347|FG000|Overall Study|Withdrawal by Subject|7|||
125166332|NCT00851318|450232348|FG001|Overall Study|Withdrawal by Subject|1|||
125166333|NCT00851318|450232349|FG002|Overall Study|Withdrawal by Subject|5|||
125166334|NCT00851318|450232350|FG003|Overall Study|Withdrawal by Subject|3|||
125166335|NCT00851318|450232347|FG000|Overall Study|Adverse Event|13|||
125166336|NCT00851318|450232348|FG001|Overall Study|Adverse Event|2|||
125166337|NCT00851318|450232349|FG002|Overall Study|Adverse Event|9|||
125166338|NCT00851318|450232350|FG003|Overall Study|Adverse Event|12|||
125166339|NCT00851318|450232347|FG000|Overall Study|Pregnancy|0|||
125166340|NCT00851318|450232348|FG001|Overall Study|Pregnancy|0|||
125166341|NCT00851318|450232349|FG002|Overall Study|Pregnancy|1|||
125166342|NCT00851318|450232350|FG003|Overall Study|Pregnancy|1|||
125166343|NCT00851318|450232347|FG000|Overall Study|Lack of Efficacy|8|||
125166344|NCT00851318|450232348|FG001|Overall Study|Lack of Efficacy|2|||
125166345|NCT00851318|450232349|FG002|Overall Study|Lack of Efficacy|4|||
125166346|NCT00851318|450232350|FG003|Overall Study|Lack of Efficacy|2|||
125166347|NCT00851318|450232347|FG000|Overall Study|Non-compliance with Study Procedures|2|||
125166348|NCT00851318|450232348|FG001|Overall Study|Non-compliance with Study Procedures|0|||
125166349|NCT00851318|450232349|FG002|Overall Study|Non-compliance with Study Procedures|1|||
125166350|NCT00851318|450232350|FG003|Overall Study|Non-compliance with Study Procedures|0|||
125166351|NCT00851318|450232347|FG000|Overall Study|Physician Decision|0|||
125166352|NCT00851318|450232348|FG001|Overall Study|Physician Decision|0|||
125166353|NCT00851318|450232349|FG002|Overall Study|Physician Decision|1|||
125166354|NCT00851318|450232350|FG003|Overall Study|Physician Decision|1|||
125166355|NCT01844856|450232357|FG000|Overall Study|Lost to Follow-up|15|||
125166356|NCT01844856|450232358|FG001|Overall Study|Lost to Follow-up|3|||
125166357|NCT01844856|450232357|FG000|Overall Study|Adverse Event|3|||
125166358|NCT01844856|450232358|FG001|Overall Study|Adverse Event|6|||
125166359|NCT01844856|450232357|FG000|Overall Study|Withdrawal by Subject|3|||
125166360|NCT01844856|450232358|FG001|Overall Study|Withdrawal by Subject|2|||
125166361|NCT01844856|450232357|FG000|Overall Study|Noncompliance|2|||
125166362|NCT01844856|450232358|FG001|Overall Study|Noncompliance|3|||
125166363|NCT01844856|450232357|FG000|Overall Study|Enterococcus Resistant|0|||
125166364|NCT01844856|450232358|FG001|Overall Study|Enterococcus Resistant|1|||
125166365|NCT01844856|450232357|FG000|Overall Study|Inadvertently Not Scheduled|1|||
125166366|NCT01844856|450232358|FG001|Overall Study|Inadvertently Not Scheduled|0|||
125166367|NCT01844856|450232357|FG000|Overall Study|Randomized but was a Screen Failure|0|||
125166368|NCT01844856|450232358|FG001|Overall Study|Randomized but was a Screen Failure|1|||
125166369|NCT01329549|450232365|FG000|Overall Study|Withdrawal by Subject|1|||
125166370|NCT01329549|450232365|FG000|Overall Study|Adverse Event|1|||
125166371|NCT02695537|450232375|FG000|Overall Study|Adverse Event|3|||
125166372|NCT02695537|450232375|FG000|Overall Study|Lack of Efficacy|28|||
125166373|NCT02695537|450232375|FG000|Overall Study|Withdrawal by Subject|4|||
125166374|NCT02695537|450232375|FG000|Overall Study|Protocol Violation|3|||
125166375|NCT03597529|450232376|FG000|Overall Study|Lost to Follow-up|10|||
125166376|NCT03597529|450232377|FG001|Overall Study|Lost to Follow-up|12|||
125166377|NCT03597529|450232376|FG000|Overall Study|Physician Decision|3|||
125166378|NCT03597529|450232377|FG001|Overall Study|Physician Decision|1|||
125166379|NCT03597529|450232376|FG000|Overall Study|Withdrawal by Subject|6|||
125166380|NCT03597529|450232377|FG001|Overall Study|Withdrawal by Subject|3|||
125166381|NCT03597529|450232376|FG000|Overall Study|Non-compliant with study activities|1|||
125166382|NCT03597529|450232377|FG001|Overall Study|Non-compliant with study activities|2|||
125166383|NCT01755767|450232380|FG000|Overall Study|Progressive Disease|8|||
125166384|NCT01755767|450232381|FG001|Overall Study|Progressive Disease|7|||
125166385|NCT01755767|450232382|FG002|Overall Study|Progressive Disease|91|||
125166386|NCT01755767|450232383|FG003|Overall Study|Progressive Disease|43|||
125166387|NCT01755767|450232380|FG000|Overall Study|Clinical Disease Progression|4|||
125166388|NCT01755767|450232381|FG001|Overall Study|Clinical Disease Progression|2|||
125166389|NCT01755767|450232382|FG002|Overall Study|Clinical Disease Progression|29|||
125166390|NCT01755767|450232383|FG003|Overall Study|Clinical Disease Progression|20|||
125166391|NCT01755767|450232380|FG000|Overall Study|Radiographic Disease Progression|9|||
125166392|NCT01755767|450232381|FG001|Overall Study|Radiographic Disease Progression|4|||
125166393|NCT01755767|450232382|FG002|Overall Study|Radiographic Disease Progression|44|||
125166394|NCT01755767|450232383|FG003|Overall Study|Radiographic Disease Progression|27|||
125166395|NCT01755767|450232380|FG000|Overall Study|Adverse Event|6|||
125166396|NCT01755767|450232381|FG001|Overall Study|Adverse Event|0|||
125166397|NCT01755767|450232382|FG002|Overall Study|Adverse Event|28|||
125166398|NCT01755767|450232383|FG003|Overall Study|Adverse Event|11|||
125166399|NCT01755767|450232380|FG000|Overall Study|Death|1|||
125166400|NCT01755767|450232381|FG001|Overall Study|Death|2|||
125166401|NCT01755767|450232382|FG002|Overall Study|Death|15|||
125166402|NCT01755767|450232383|FG003|Overall Study|Death|4|||
125166403|NCT01755767|450232380|FG000|Overall Study|Subject Decision|0|||
125166404|NCT01755767|450232381|FG001|Overall Study|Subject Decision|0|||
125166405|NCT01755767|450232382|FG002|Overall Study|Subject Decision|10|||
125166406|NCT01755767|450232383|FG003|Overall Study|Subject Decision|3|||
125166407|NCT01755767|450232380|FG000|Overall Study|Withdrawal by Subject|0|||
125166408|NCT01755767|450232381|FG001|Overall Study|Withdrawal by Subject|0|||
125166409|NCT01755767|450232382|FG002|Overall Study|Withdrawal by Subject|2|||
125166410|NCT01755767|450232383|FG003|Overall Study|Withdrawal by Subject|1|||
125166411|NCT01755767|450232380|FG000|Overall Study|Other|0|||
125166412|NCT01755767|450232381|FG001|Overall Study|Other|0|||
125166413|NCT01755767|450232382|FG002|Overall Study|Other|2|||
125166414|NCT01755767|450232383|FG003|Overall Study|Other|3|||
125166415|NCT01755767|450232380|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
125166416|NCT01755767|450232381|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
125166417|NCT01755767|450232382|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
125166418|NCT01755767|450232383|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
125166419|NCT03464630|450232384|FG000|Overall Study|Lost to Follow-up|62|||
125166420|NCT03464630|450232385|FG001|Overall Study|Lost to Follow-up|52|||
125166421|NCT03464630|450232384|FG000|Overall Study|Withdrawal by Subject|16|||
125166422|NCT03464630|450232385|FG001|Overall Study|Withdrawal by Subject|10|||
125166423|NCT03464630|450232384|FG000|Overall Study|Passive Disengagement|8|||
125166424|NCT03464630|450232385|FG001|Overall Study|Passive Disengagement|4|||
125166425|NCT00191165|450232386|FG000|Overall Study|Adverse Event|2|||
125166426|NCT00191165|450232387|FG001|Overall Study|Adverse Event|0|||
125166427|NCT00191165|450232386|FG000|Overall Study|Protocol Violation|0|||
125166428|NCT00191165|450232387|FG001|Overall Study|Protocol Violation|1|||
125166429|NCT00191165|450232386|FG000|Overall Study|Participant Moved Away|0|||
125166430|NCT00191165|450232387|FG001|Overall Study|Participant Moved Away|1|||
125166431|NCT03196635|450232389|FG000|Overall Study|Withdrawal by Subject|1|||
125166432|NCT00998309|450232395|FG000|Overall Study|Protocol Violation|4|||
125166433|NCT00380744|450232397|FG000|Overall Study|Death|0|||
125166434|NCT00380744|450232398|FG001|Overall Study|Death|0|||
125166435|NCT00380744|450232399|FG002|Overall Study|Death|0|||
125166436|NCT00380744|450232400|FG003|Overall Study|Death|0|||
125166437|NCT00380744|450232401|FG004|Overall Study|Death|0|||
125166438|NCT00380744|450232402|FG005|Overall Study|Death|0|||
125166439|NCT00380744|450232403|FG006|Overall Study|Death|1|||
125166440|NCT00380744|450232397|FG000|Overall Study|Withdrawal by Subject|1|||
125166441|NCT00380744|450232398|FG001|Overall Study|Withdrawal by Subject|0|||
125166442|NCT00380744|450232399|FG002|Overall Study|Withdrawal by Subject|0|||
125166443|NCT00380744|450232400|FG003|Overall Study|Withdrawal by Subject|0|||
125166444|NCT00380744|450232401|FG004|Overall Study|Withdrawal by Subject|0|||
125166445|NCT00380744|450232402|FG005|Overall Study|Withdrawal by Subject|0|||
125166446|NCT00380744|450232403|FG006|Overall Study|Withdrawal by Subject|0|||
125166447|NCT02348723|450232417|FG000|Overall Study|No ablation|21|||
125166448|NCT02348723|450232418|FG001|Overall Study|No ablation|20|||
125166449|NCT02348723|450232417|FG000|Overall Study|Non-compliant with Protocol|1|||
125166450|NCT02348723|450232418|FG001|Overall Study|Non-compliant with Protocol|0|||
125166451|NCT02348723|450232417|FG000|Overall Study|Lost to Follow-up|1|||
125166452|NCT02348723|450232418|FG001|Overall Study|Lost to Follow-up|1|||
125166453|NCT02348723|450232417|FG000|Overall Study|Consent withdrawn|1|||
125166454|NCT02348723|450232418|FG001|Overall Study|Consent withdrawn|3|||
125166455|NCT02348723|450232417|FG000|Overall Study|Reason other than specified|1|||
125166456|NCT02348723|450232418|FG001|Overall Study|Reason other than specified|1|||
125166457|NCT02348723|450232417|FG000|Overall Study|Adverse Event|3|||
125166458|NCT02348723|450232418|FG001|Overall Study|Adverse Event|1|||
125166459|NCT02365558|450232419|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
125166460|NCT02365558|450232420|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
125166461|NCT02365558|450232419|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
125166462|NCT02365558|450232420|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
125166463|NCT02828241|450232424|FG000|Overall Study|Adverse Event|7|||
125166464|NCT02828241|450232425|FG001|Overall Study|Adverse Event|2|||
125166465|NCT02828241|450232424|FG000|Overall Study|Protocol Violation|1|||
125166466|NCT02828241|450232425|FG001|Overall Study|Protocol Violation|0|||
125166467|NCT03918109|450232434|FG000|Overall Study|Withdrawal by Subject|0|||
125166468|NCT03918109|450232435|FG001|Overall Study|Withdrawal by Subject|0|||
125166469|NCT03918109|450232436|FG002|Overall Study|Withdrawal by Subject|2|||
125166470|NCT03918109|450232437|FG003|Overall Study|Withdrawal by Subject|1|||
125166471|NCT03918109|450232434|FG000|Overall Study|Lost to Follow-up|0|||
125166472|NCT03918109|450232435|FG001|Overall Study|Lost to Follow-up|0|||
125166473|NCT03918109|450232436|FG002|Overall Study|Lost to Follow-up|0|||
125166474|NCT03918109|450232437|FG003|Overall Study|Lost to Follow-up|1|||
125166475|NCT00861198|450232438|FG000|Overall Study|SpyGlass Failed|5|||
125166476|NCT01197755|450232439|FG000|Overall Study|Adverse Event|8|||
125166477|NCT01197755|450232440|FG001|Overall Study|Adverse Event|10|||
125166478|NCT01197755|450232441|FG002|Overall Study|Adverse Event|10|||
125166479|NCT01197755|450232439|FG000|Overall Study|Study-specific discontinuation criteria|2|||
125166480|NCT01197755|450232440|FG001|Overall Study|Study-specific discontinuation criteria|1|||
125166481|NCT01197755|450232441|FG002|Overall Study|Study-specific discontinuation criteria|0|||
125166482|NCT01197755|450232439|FG000|Overall Study|Entered the long-term extension study|18|||
125166483|NCT01197755|450232440|FG001|Overall Study|Entered the long-term extension study|21|||
125166484|NCT01197755|450232441|FG002|Overall Study|Entered the long-term extension study|35|||
125166485|NCT01197755|450232439|FG000|Overall Study|Lack of therapeutic response|0|||
125166486|NCT01197755|450232440|FG001|Overall Study|Lack of therapeutic response|7|||
125166487|NCT01197755|450232441|FG002|Overall Study|Lack of therapeutic response|4|||
125166488|NCT01197755|450232439|FG000|Overall Study|Severe non-compliance to the protocol|2|||
125166489|NCT01197755|450232440|FG001|Overall Study|Severe non-compliance to the protocol|1|||
125166490|NCT01197755|450232441|FG002|Overall Study|Severe non-compliance to the protocol|2|||
125166491|NCT01197755|450232439|FG000|Overall Study|Withdrawal by Subject|1|||
125166492|NCT01197755|450232440|FG001|Overall Study|Withdrawal by Subject|0|||
125166493|NCT01197755|450232441|FG002|Overall Study|Withdrawal by Subject|0|||
125166494|NCT01197755|450232439|FG000|Overall Study|Lost to Follow-up|0|||
125166495|NCT01197755|450232440|FG001|Overall Study|Lost to Follow-up|0|||
125166496|NCT01197755|450232441|FG002|Overall Study|Lost to Follow-up|1|||
125166497|NCT01197755|450232439|FG000|Overall Study|eg, change in circumstances|7|||
125166498|NCT01197755|450232440|FG001|Overall Study|eg, change in circumstances|3|||
125166499|NCT01197755|450232441|FG002|Overall Study|eg, change in circumstances|2|||
125166500|NCT00499174|450232444|FG000|Overall Study|Physician Decision|78|||
125166501|NCT00499174|450232445|FG001|Overall Study|Physician Decision|9|||
125166502|NCT02269163|450232446|FG000|Overall Study|Lost to Follow-up|1|||
125166503|NCT02269163|450232447|FG001|Overall Study|Lost to Follow-up|0|||
125166504|NCT02269163|450232446|FG000|Overall Study|Major protocol violation|0|||
125166505|NCT02269163|450232447|FG001|Overall Study|Major protocol violation|1|||
125166506|NCT02269163|450232446|FG000|Overall Study|Other|2|||
125166507|NCT02269163|450232447|FG001|Overall Study|Other|2|||
125166508|NCT02269163|450232446|FG000|Overall Study|Withdrawal by Subject|0|||
125166509|NCT02269163|450232447|FG001|Overall Study|Withdrawal by Subject|3|||
125166510|NCT02269163|450232446|FG000|Overall Study|Physician Decision|0|||
125166511|NCT02269163|450232447|FG001|Overall Study|Physician Decision|1|||
125166512|NCT00638027|450232453|FG000|Overall Study|Adverse Event|0|||
125166513|NCT00638027|450232454|FG001|Overall Study|Adverse Event|2|||
125166514|NCT00371397|450232455|FG000|Session 1|Withdrawal by Subject|1|||
125166515|NCT00371397|450232456|FG001|Session 1|Withdrawal by Subject|0|||
125166516|NCT00371397|450232457|FG002|Session 1|Withdrawal by Subject|0|||
125166517|NCT00371397|450232458|FG003|Session 1|Withdrawal by Subject|0|||
125166518|NCT00371397|450232459|FG004|Session 1|Withdrawal by Subject|0|||
125166519|NCT00371397|450232460|FG005|Session 1|Withdrawal by Subject|0|||
125166520|NCT00371397|450232461|FG006|Session 1|Withdrawal by Subject|0|||
125166521|NCT00371397|450232462|FG007|Session 1|Withdrawal by Subject|1|||
125166522|NCT00371397|450232463|FG008|Session 1|Withdrawal by Subject|0|||
125166523|NCT00371397|450232464|FG009|Session 1|Withdrawal by Subject|0|||
125166524|NCT00371397|450232465|FG010|Session 1|Withdrawal by Subject|0|||
125166525|NCT00371397|450232466|FG011|Session 1|Withdrawal by Subject|0|||
125166526|NCT01284621|450232467|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
125166527|NCT01284621|450232468|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
125166528|NCT01284621|450232469|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
125166529|NCT01284621|450232470|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
125166530|NCT01284621|450232471|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
125166531|NCT01284621|450232472|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
125166532|NCT02802631|450232473|FG000|Overall Study|Withdrawal by Subject|1|||
125166533|NCT02802631|450232474|FG001|Overall Study|Withdrawal by Subject|0|||
125166534|NCT02802631|450232475|FG002|Overall Study|Withdrawal by Subject|0|||
125166535|NCT02802631|450232476|FG003|Overall Study|Withdrawal by Subject|0|||
125166536|NCT02802631|450232477|FG004|Overall Study|Withdrawal by Subject|0|||
125166537|NCT02802631|450232478|FG005|Overall Study|Withdrawal by Subject|0|||
125166538|NCT02802631|450232479|FG006|Overall Study|Withdrawal by Subject|0|||
125166539|NCT02802631|450232480|FG007|Overall Study|Withdrawal by Subject|0|||
125166540|NCT02802631|450232473|FG000|Overall Study|Physician Decision|1|||
125166541|NCT02802631|450232474|FG001|Overall Study|Physician Decision|0|||
125166542|NCT02802631|450232475|FG002|Overall Study|Physician Decision|0|||
125166543|NCT02802631|450232476|FG003|Overall Study|Physician Decision|0|||
125226898|NCT03638128|450460077|FG001|Overall Study|Sponsor Decision|12|||
125166544|NCT02802631|450232477|FG004|Overall Study|Physician Decision|0|||
125166545|NCT02802631|450232478|FG005|Overall Study|Physician Decision|0|||
125166546|NCT02802631|450232479|FG006|Overall Study|Physician Decision|1|||
125226899|NCT03638128|450460078|FG002|Overall Study|Sponsor Decision|19|||
125226900|NCT03638128|450460076|FG000|Overall Study|Lost to Follow-up|0|||
125226901|NCT03638128|450460077|FG001|Overall Study|Lost to Follow-up|0|||
125226902|NCT03638128|450460078|FG002|Overall Study|Lost to Follow-up|1|||
125226903|NCT00945243|450460080|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
125226904|NCT02990000|450460081|FG000|Overall Study|Failed to provide data beyond baseline|36|||
125226905|NCT02990000|450460082|FG001|Overall Study|Failed to provide data beyond baseline|34|||
125226906|NCT04969289|450460083|FG000|Overall Study|Lost to Follow-up|13|||
125226907|NCT04969289|450460084|FG001|Overall Study|Lost to Follow-up|9|||
125226908|NCT00557466|450460085|FG000|Overall Study|Adverse Event|3|||
125226909|NCT00557466|450460086|FG001|Overall Study|Adverse Event|1|||
125226910|NCT00557466|450460087|FG002|Overall Study|Adverse Event|4|||
125226911|NCT00557466|450460088|FG003|Overall Study|Adverse Event|1|||
125226912|NCT00557466|450460089|FG004|Overall Study|Adverse Event|2|||
125226913|NCT00557466|450460090|FG005|Overall Study|Adverse Event|4|||
125226914|NCT00557466|450460085|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125226915|NCT00557466|450460086|FG001|Overall Study|Abnormal laboratory value(s)|2|||
125226916|NCT00557466|450460087|FG002|Overall Study|Abnormal laboratory value(s)|0|||
125226917|NCT00557466|450460088|FG003|Overall Study|Abnormal laboratory value(s)|0|||
125226918|NCT00557466|450460089|FG004|Overall Study|Abnormal laboratory value(s)|0|||
125226919|NCT00557466|450460090|FG005|Overall Study|Abnormal laboratory value(s)|0|||
125226920|NCT00557466|450460085|FG000|Overall Study|Protocol deviation|0|||
125226921|NCT00557466|450460086|FG001|Overall Study|Protocol deviation|1|||
125226922|NCT00557466|450460087|FG002|Overall Study|Protocol deviation|0|||
125226923|NCT00557466|450460088|FG003|Overall Study|Protocol deviation|2|||
125226924|NCT00557466|450460089|FG004|Overall Study|Protocol deviation|0|||
125226925|NCT00557466|450460090|FG005|Overall Study|Protocol deviation|0|||
125226926|NCT00557466|450460085|FG000|Overall Study|Subject withdrew consent|0|||
125226927|NCT00557466|450460086|FG001|Overall Study|Subject withdrew consent|0|||
125226928|NCT00557466|450460087|FG002|Overall Study|Subject withdrew consent|0|||
125226929|NCT00557466|450460088|FG003|Overall Study|Subject withdrew consent|0|||
125226930|NCT00557466|450460089|FG004|Overall Study|Subject withdrew consent|1|||
125226931|NCT00557466|450460090|FG005|Overall Study|Subject withdrew consent|2|||
125226932|NCT00557466|450460085|FG000|Overall Study|Administrative problems|0|||
125226933|NCT00557466|450460086|FG001|Overall Study|Administrative problems|1|||
125226934|NCT00557466|450460087|FG002|Overall Study|Administrative problems|1|||
125226935|NCT00557466|450460088|FG003|Overall Study|Administrative problems|0|||
125226936|NCT00557466|450460089|FG004|Overall Study|Administrative problems|0|||
125226937|NCT00557466|450460090|FG005|Overall Study|Administrative problems|0|||
125226938|NCT00557466|450460085|FG000|Overall Study|Abnormal test procedure results|0|||
125226939|NCT00557466|450460086|FG001|Overall Study|Abnormal test procedure results|0|||
125226940|NCT00557466|450460087|FG002|Overall Study|Abnormal test procedure results|1|||
125226941|NCT00557466|450460088|FG003|Overall Study|Abnormal test procedure results|0|||
125226942|NCT00557466|450460089|FG004|Overall Study|Abnormal test procedure results|0|||
125226943|NCT00557466|450460090|FG005|Overall Study|Abnormal test procedure results|0|||
125226944|NCT00557466|450460085|FG000|Overall Study|Lost to Follow-up|0|||
125226945|NCT00557466|450460086|FG001|Overall Study|Lost to Follow-up|0|||
125226946|NCT00557466|450460087|FG002|Overall Study|Lost to Follow-up|0|||
125226947|NCT00557466|450460088|FG003|Overall Study|Lost to Follow-up|1|||
125226948|NCT00557466|450460089|FG004|Overall Study|Lost to Follow-up|0|||
125226949|NCT00557466|450460090|FG005|Overall Study|Lost to Follow-up|0|||
125226950|NCT00496769|450460093|FG000|Double Blind|>=1 reason assigned per patient|558|||
125226951|NCT00496769|450460094|FG001|Double Blind|>=1 reason assigned per patient|649|||
125226952|NCT00496769|450460095|FG002|Double Blind|>=1 reason assigned per patient|0|||
125226953|NCT00496769|450460093|FG000|Open Label|>=1 reason assigned per patient|0|||
125226954|NCT00496769|450460094|FG001|Open Label|>=1 reason assigned per patient|0|||
125226955|NCT00496769|450460095|FG002|Open Label|>=1 reason assigned per patient|1011|||
125226956|NCT02486692|450460096|FG000|Overall Study|did not login for randomization|4|||
125226957|NCT02486692|450460097|FG001|Overall Study|did not login for randomization|7|||
125226958|NCT02812186|450460100|FG000|Period 1|Post randomization screen failure|5|||
125226959|NCT02812186|450460101|FG001|Period 1|Post randomization screen failure|9|||
125226960|NCT02812186|450460100|FG000|Period 1|nonevaluable data sets|6|||
125226961|NCT02812186|450460101|FG001|Period 1|nonevaluable data sets|6|||
125226962|NCT01307787|450460102|FG000|Overall Study|Withdrawal by Subject|2|||
125226963|NCT01307787|450460103|FG001|Overall Study|Withdrawal by Subject|0|||
125226964|NCT01965327|450460110|FG000|Overall Study|Physician Decision|2|||
125226965|NCT03342001|450460111|FG000|Overall Study|Adverse Event|1|||
125226966|NCT03342001|450460111|FG000|Overall Study|Lost to Follow-up|1|||
125226967|NCT04161391|450460116|FG000|Overall Study|Adverse Event|0|||
125226968|NCT04161391|450460117|FG001|Overall Study|Adverse Event|1|||
125226969|NCT04161391|450460118|FG002|Overall Study|Adverse Event|0|||
125226970|NCT04161391|450460119|FG003|Overall Study|Adverse Event|1|||
125226971|NCT04161391|450460120|FG004|Overall Study|Adverse Event|0|||
125226972|NCT04161391|450460121|FG005|Overall Study|Adverse Event|0|||
125226973|NCT04161391|450460122|FG006|Overall Study|Adverse Event|0|||
125226974|NCT04161391|450460123|FG007|Overall Study|Adverse Event|3|||
125166547|NCT02802631|450232480|FG007|Overall Study|Physician Decision|0|||
125166548|NCT02802631|450232473|FG000|Overall Study|Adverse Event|0|||
125166549|NCT02802631|450232474|FG001|Overall Study|Adverse Event|2|||
125166550|NCT02802631|450232475|FG002|Overall Study|Adverse Event|0|||
125166551|NCT02802631|450232476|FG003|Overall Study|Adverse Event|1|||
125166552|NCT02802631|450232477|FG004|Overall Study|Adverse Event|6|||
125166553|NCT02802631|450232478|FG005|Overall Study|Adverse Event|1|||
125166554|NCT02802631|450232479|FG006|Overall Study|Adverse Event|4|||
125166555|NCT02802631|450232480|FG007|Overall Study|Adverse Event|0|||
125166556|NCT02802631|450232473|FG000|Overall Study|Sponsor Decision|0|||
125166557|NCT02802631|450232474|FG001|Overall Study|Sponsor Decision|0|||
125166558|NCT02802631|450232475|FG002|Overall Study|Sponsor Decision|6|||
125166559|NCT02802631|450232476|FG003|Overall Study|Sponsor Decision|0|||
125166560|NCT02802631|450232477|FG004|Overall Study|Sponsor Decision|2|||
125166561|NCT02802631|450232478|FG005|Overall Study|Sponsor Decision|0|||
125166562|NCT02802631|450232479|FG006|Overall Study|Sponsor Decision|0|||
125166563|NCT02802631|450232480|FG007|Overall Study|Sponsor Decision|4|||
125166564|NCT02968849|450232481|FG000|Overall Study|Death|8|||
125166565|NCT02968849|450232482|FG001|Overall Study|Death|10|||
125166566|NCT02968849|450232481|FG000|Overall Study|Lost to Follow-up|31|||
125166567|NCT02968849|450232482|FG001|Overall Study|Lost to Follow-up|29|||
125166568|NCT02968849|450232481|FG000|Overall Study|Withdrawal by Subject|73|||
125166569|NCT02968849|450232482|FG001|Overall Study|Withdrawal by Subject|64|||
125166570|NCT02968849|450232481|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
125166571|NCT02968849|450232482|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
125166572|NCT02968849|450232481|FG000|Overall Study|Physician Decision|6|||
125166573|NCT02968849|450232482|FG001|Overall Study|Physician Decision|9|||
125166574|NCT02968849|450232481|FG000|Overall Study|Other|16|||
125166575|NCT02968849|450232482|FG001|Overall Study|Other|10|||
125166576|NCT02551666|450232483|FG000|Overall Study|Withdrawal by Subject|1|||
125166577|NCT02551666|450232484|FG001|Overall Study|Withdrawal by Subject|3|||
125166578|NCT03395405|450234149|FG000|Overall Study|Death|0|||
125166579|NCT03395405|450234150|FG001|Overall Study|Death|2|||
125166580|NCT03395405|450234149|FG000|Overall Study|Lost to Follow-up|0|||
125166581|NCT03395405|450234150|FG001|Overall Study|Lost to Follow-up|1|||
125166582|NCT03395405|450234149|FG000|Overall Study|Protocol Violation|0|||
125166583|NCT03395405|450234150|FG001|Overall Study|Protocol Violation|1|||
125166584|NCT03395405|450234149|FG000|Overall Study|Withdrawal by Subject|3|||
125166585|NCT03395405|450234150|FG001|Overall Study|Withdrawal by Subject|1|||
125166586|NCT03395405|450234149|FG000|Overall Study|COVID-19 Pandemic|1|||
125166587|NCT03395405|450234150|FG001|Overall Study|COVID-19 Pandemic|0|||
125166588|NCT00461253|450234151|FG000|Overall Study|Death|985|||
125166589|NCT00461253|450234152|FG001|Overall Study|Death|0|||
125166590|NCT00461253|450234151|FG000|Overall Study|Protocol Violation|613|||
125166591|NCT00461253|450234152|FG001|Overall Study|Protocol Violation|236|||
125166592|NCT00461253|450234151|FG000|Overall Study|no response|2609|||
125166593|NCT00461253|450234152|FG001|Overall Study|no response|11789|||
125166594|NCT00461253|450234151|FG000|Overall Study|administrative|773|||
125166595|NCT00461253|450234152|FG001|Overall Study|administrative|7773|||
125166596|NCT03510598|450234153|FG000|Overall Study|Withdrawal by Subject|1|||
125166597|NCT04240392|450234155|FG000|Overall Study|Withdrawal by Subject|13|||
125166598|NCT04240392|450234156|FG001|Overall Study|Withdrawal by Subject|4|||
125166599|NCT04240392|450234155|FG000|Overall Study|Lost to Follow-up|11|||
125166600|NCT04240392|450234156|FG001|Overall Study|Lost to Follow-up|12|||
125166601|NCT05307510|450234157|FG000|Overall Study|Lost to Follow-up|3|||
125166602|NCT05307510|450234158|FG001|Overall Study|Lost to Follow-up|6|||
125166603|NCT05307510|450234157|FG000|Overall Study|Withdrawal by Subject|0|||
125166604|NCT05307510|450234158|FG001|Overall Study|Withdrawal by Subject|1|||
125166605|NCT01555671|450234161|FG000|Overall Study|Physician Decision|20|||
125166606|NCT01555671|450234162|FG001|Overall Study|Physician Decision|25|||
125166607|NCT03047330|450234163|FG000|Sleep Block 1|Withdrawal by Subject|3|||
125166608|NCT04590040|450234164|FG000|Treatment Period|Lost to Follow-up|2|||
125166609|NCT04590040|450234165|FG001|Treatment Period|Lost to Follow-up|5|||
125166610|NCT04590040|450234166|FG002|Treatment Period|Lost to Follow-up|0|||
125166611|NCT04590040|450234164|FG000|Treatment Period|Physician Decision|0|||
125166612|NCT04590040|450234165|FG001|Treatment Period|Physician Decision|0|||
125166613|NCT04590040|450234166|FG002|Treatment Period|Physician Decision|2|||
125166614|NCT00000378|450234170|FG000|Overall Study|Lack of Efficacy|16|||
125166615|NCT00000378|450234171|FG001|Overall Study|Lack of Efficacy|14|||
125166616|NCT00540293|450234174|FG000|Overall Study|Adverse event related to study drug|10|||
125166617|NCT00540293|450234174|FG000|Overall Study|Adverse event not related to study drug|7|||
125166618|NCT00540293|450234174|FG000|Overall Study|Withdrawal by Subject|6|||
125166619|NCT00540293|450234174|FG000|Overall Study|Protocol violation, & subject schedule|12|||
125166620|NCT02585934|450234179|FG000|Overall Study|Lost to Follow-up|2|||
125166621|NCT02585934|450234180|FG001|Overall Study|Lost to Follow-up|2|||
125166622|NCT02585934|450234179|FG000|Overall Study|Protocol Violation|14|||
125166623|NCT02585934|450234180|FG001|Overall Study|Protocol Violation|11|||
125166624|NCT02585934|450234179|FG000|Overall Study|Adverse Event|21|||
125166625|NCT02585934|450234180|FG001|Overall Study|Adverse Event|22|||
125166626|NCT02585934|450234179|FG000|Overall Study|Physician Decision|3|||
125166627|NCT02585934|450234180|FG001|Overall Study|Physician Decision|2|||
125166628|NCT02585934|450234179|FG000|Overall Study|Withdrawal by Subject|7|||
125166629|NCT02585934|450234180|FG001|Overall Study|Withdrawal by Subject|21|||
125166630|NCT02585934|450234179|FG000|Overall Study|Lack of Efficacy|2|||
125166631|NCT02585934|450234180|FG001|Overall Study|Lack of Efficacy|1|||
125166632|NCT02585934|450234179|FG000|Overall Study|Death|2|||
125166633|NCT02585934|450234180|FG001|Overall Study|Death|0|||
125166634|NCT02585934|450234179|FG000|Overall Study|Caregiver Withdrew Consent|7|||
125166635|NCT02585934|450234180|FG001|Overall Study|Caregiver Withdrew Consent|7|||
125166636|NCT02585934|450234179|FG000|Overall Study|Sponsor Termination|1|||
125166637|NCT02585934|450234180|FG001|Overall Study|Sponsor Termination|2|||
125166638|NCT02585934|450234179|FG000|Overall Study|Another Reason|10|||
125166639|NCT02585934|450234180|FG001|Overall Study|Another Reason|5|||
125166640|NCT04713553|450234181|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
125166641|NCT04713553|450234182|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
125166642|NCT04713553|450234183|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
125166643|NCT04713553|450234184|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
125166644|NCT04713553|450234185|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
125166645|NCT04713553|450234186|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
125166646|NCT04713553|450234187|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
125166647|NCT04713553|450234181|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
125166648|NCT04713553|450234182|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
125166649|NCT04713553|450234183|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
125166650|NCT04713553|450234184|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
125166651|NCT04713553|450234185|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
125166652|NCT04713553|450234186|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
125166653|NCT04713553|450234187|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
125166654|NCT04713553|450234181|FG000|Primary Study (2 Months)|Other|1|||
125166655|NCT04713553|450234182|FG001|Primary Study (2 Months)|Other|2|||
125166656|NCT04713553|450234183|FG002|Primary Study (2 Months)|Other|0|||
125166657|NCT04713553|450234184|FG003|Primary Study (2 Months)|Other|0|||
125166658|NCT04713553|450234185|FG004|Primary Study (2 Months)|Other|1|||
125166659|NCT04713553|450234186|FG005|Primary Study (2 Months)|Other|0|||
125166660|NCT04713553|450234187|FG006|Primary Study (2 Months)|Other|0|||
125166661|NCT04713553|450234181|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
125166662|NCT04713553|450234182|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
125166663|NCT04713553|450234183|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
125166664|NCT04713553|450234184|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
125166665|NCT04713553|450234185|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
125166666|NCT04713553|450234186|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
125166667|NCT04713553|450234187|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
125166668|NCT04713553|450234181|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
125226975|NCT04161391|450460124|FG008|Overall Study|Adverse Event|0|||
125166669|NCT04713553|450234182|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
125166670|NCT04713553|450234183|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
125166671|NCT04713553|450234184|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
125166672|NCT04713553|450234185|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
125166673|NCT04713553|450234186|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
125226976|NCT04161391|450460116|FG000|Overall Study|Death|0|||
125166674|NCT04713553|450234187|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
125166675|NCT02448706|450234188|FG000|Overall Study|Withdrawal by Subject|4|||
125166676|NCT02448706|450234189|FG001|Overall Study|Withdrawal by Subject|3|||
125166677|NCT02448706|450234188|FG000|Overall Study|Protocol Violation|1|||
125166678|NCT02448706|450234189|FG001|Overall Study|Protocol Violation|1|||
125166679|NCT01359969|450234193|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
125166680|NCT03972163|450234197|FG000|Overall Study|Death|0|||
125166681|NCT03972163|450234198|FG001|Overall Study|Death|1|||
125166682|NCT01059539|450234200|FG000|Overall Study|Adverse Event|66|||
125166683|NCT01059539|450234200|FG000|Overall Study|Insufficient Therapeutic Response|26|||
125166684|NCT01059539|450234200|FG000|Overall Study|Protocol Violation|55|||
125166685|NCT01059539|450234200|FG000|Overall Study|Withdrawal of Consent|80|||
125166686|NCT01059539|450234200|FG000|Overall Study|Lost to Follow-up|42|||
125166687|NCT01059539|450234200|FG000|Overall Study|Reason Not Specified|2|||
125166688|NCT00537303|450234201|FG000|Overall Study|Adverse Event|1|||
125166689|NCT00537303|450234202|FG001|Overall Study|Adverse Event|4|||
125166690|NCT00537303|450234201|FG000|Overall Study|Lack of Efficacy|6|||
125166691|NCT00537303|450234202|FG001|Overall Study|Lack of Efficacy|7|||
125166692|NCT00537303|450234201|FG000|Overall Study|Protocol Violation|8|||
125166693|NCT00537303|450234202|FG001|Overall Study|Protocol Violation|4|||
125166694|NCT00537303|450234201|FG000|Overall Study|Withdrawal criteria|3|||
125166695|NCT00537303|450234202|FG001|Overall Study|Withdrawal criteria|3|||
125166696|NCT00537303|450234201|FG000|Overall Study|Unclassified|8|||
125166697|NCT00537303|450234202|FG001|Overall Study|Unclassified|7|||
125166698|NCT02085135|450234203|FG000|Overall Study|Adverse Event|4|||
125166699|NCT02085135|450234204|FG001|Overall Study|Adverse Event|7|||
125166700|NCT02085135|450234203|FG000|Overall Study|Lost to Follow-up|2|||
125166701|NCT02085135|450234204|FG001|Overall Study|Lost to Follow-up|2|||
125166702|NCT02085135|450234203|FG000|Overall Study|Withdrawal by Subject|3|||
125166703|NCT02085135|450234204|FG001|Overall Study|Withdrawal by Subject|0|||
125166704|NCT02085135|450234203|FG000|Overall Study|Lack of Efficacy|2|||
125166705|NCT02085135|450234204|FG001|Overall Study|Lack of Efficacy|0|||
125166706|NCT00554606|450234207|FG000|Overall Study|Adverse Event|3|||
125166707|NCT00554606|450234207|FG000|Overall Study|Abnormal laboratory values|1|||
125166708|NCT00554606|450234207|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
125166709|NCT00554606|450234207|FG000|Overall Study|Subject withdrew consent|2|||
125166710|NCT00554606|450234207|FG000|Overall Study|Lost to Follow-up|2|||
125166711|NCT00554606|450234207|FG000|Overall Study|Administrative problems|60|||
125166712|NCT00554606|450234207|FG000|Overall Study|Death|1|||
125166713|NCT00554606|450234207|FG000|Overall Study|Protocol deviation|2|||
125166714|NCT00849186|450234216|FG000|Overall Study|Adverse Event|2|||
125166715|NCT00849186|450234216|FG000|Overall Study|Withdrawal by Subject|1|||
125166716|NCT00849186|450234216|FG000|Overall Study|not treated|6|||
125166717|NCT00849186|450234216|FG000|Overall Study|Other|1|||
125166718|NCT00492024|450234217|FG000|Treatment|Adverse Event|3|||
125166719|NCT00492024|450234218|FG001|Treatment|Adverse Event|1|||
125166720|NCT00492024|450234217|FG000|Treatment|Lack of Efficacy|21|||
125166721|NCT00492024|450234218|FG001|Treatment|Lack of Efficacy|20|||
125166722|NCT00492024|450234217|FG000|Treatment|Lost to Follow-up|3|||
125166723|NCT00492024|450234218|FG001|Treatment|Lost to Follow-up|1|||
125166724|NCT00492024|450234217|FG000|Treatment|Withdrawal by Subject|2|||
125166725|NCT00492024|450234218|FG001|Treatment|Withdrawal by Subject|0|||
125166726|NCT00492024|450234217|FG000|Follow up|Lack of Efficacy|0|||
125166727|NCT00492024|450234218|FG001|Follow up|Lack of Efficacy|1|||
125166728|NCT00492024|450234217|FG000|Follow up|Lost to Follow-up|1|||
125166729|NCT00492024|450234218|FG001|Follow up|Lost to Follow-up|1|||
125166730|NCT03247816|450234219|FG000|Overall Study|Adverse Event|12|||
125166731|NCT03247816|450234219|FG000|Overall Study|Physician Decision|3|||
125166732|NCT03247816|450234219|FG000|Overall Study|Lack of Efficacy|1|||
125166733|NCT03247816|450234219|FG000|Overall Study|Lost to Follow-up|10|||
125166734|NCT03247816|450234219|FG000|Overall Study|Missing Feraccru stop date|3|||
125166735|NCT00936897|450234222|FG000|Overall Study|Withdrawal by Subject|9|||
125166736|NCT00936897|450234223|FG001|Overall Study|Withdrawal by Subject|19|||
125166737|NCT00936897|450234222|FG000|Overall Study|Adverse Event|4|||
125166738|NCT00936897|450234223|FG001|Overall Study|Adverse Event|13|||
125166739|NCT00936897|450234222|FG000|Overall Study|Other|3|||
125166740|NCT00936897|450234223|FG001|Overall Study|Other|9|||
125166741|NCT00936897|450234222|FG000|Overall Study|Lost to Follow-up|1|||
125166742|NCT00936897|450234223|FG001|Overall Study|Lost to Follow-up|10|||
125166743|NCT00936897|450234222|FG000|Overall Study|Administrative Decision|1|||
125166744|NCT00936897|450234223|FG001|Overall Study|Administrative Decision|2|||
125166745|NCT00936897|450234222|FG000|Overall Study|Protocol Violation|1|||
125166746|NCT00936897|450234223|FG001|Overall Study|Protocol Violation|1|||
125166747|NCT00936897|450234222|FG000|Overall Study|Ineligibility Determined|0|||
125166748|NCT00936897|450234223|FG001|Overall Study|Ineligibility Determined|3|||
125166749|NCT00936897|450234222|FG000|Overall Study|Noncompliance|0|||
125166750|NCT00936897|450234223|FG001|Overall Study|Noncompliance|2|||
125166751|NCT00936897|450234222|FG000|Overall Study|Death|0|||
125166752|NCT00936897|450234223|FG001|Overall Study|Death|1|||
125166753|NCT03257865|450234228|FG000|Overall Study|Adverse Event|4|||
125166754|NCT03257865|450234229|FG001|Overall Study|Adverse Event|8|||
125166755|NCT03257865|450234228|FG000|Overall Study|Lack of Efficacy|1|||
125166756|NCT03257865|450234229|FG001|Overall Study|Lack of Efficacy|2|||
125166757|NCT03257865|450234228|FG000|Overall Study|Non-compliance with Study Drug|0|||
125166758|NCT03257865|450234229|FG001|Overall Study|Non-compliance with Study Drug|2|||
125166759|NCT03257865|450234228|FG000|Overall Study|Withdrawal by Subject|23|||
125166760|NCT03257865|450234229|FG001|Overall Study|Withdrawal by Subject|17|||
125166761|NCT03257865|450234228|FG000|Overall Study|Physician Decision|3|||
125166762|NCT03257865|450234229|FG001|Overall Study|Physician Decision|1|||
125166763|NCT03257865|450234228|FG000|Overall Study|Other|0|||
125166764|NCT03257865|450234229|FG001|Overall Study|Other|1|||
125166765|NCT03257865|450234228|FG000|Overall Study|Lost to Follow-up|4|||
125166766|NCT03257865|450234229|FG001|Overall Study|Lost to Follow-up|4|||
125166767|NCT02677714|450234230|FG000|Overall Study|Withdrawal by Subject|2|||
125166768|NCT02677714|450234231|FG001|Overall Study|Withdrawal by Subject|0|||
125166769|NCT02792699|450234232|FG000|Overall Study|Adverse Event|1|||
125166770|NCT02792699|450234233|FG001|Overall Study|Adverse Event|2|||
125166771|NCT02792699|450234234|FG002|Overall Study|Adverse Event|4|||
125166772|NCT02792699|450234232|FG000|Overall Study|Withdrawal by Subject|4|||
125166773|NCT02792699|450234233|FG001|Overall Study|Withdrawal by Subject|4|||
125166774|NCT02792699|450234234|FG002|Overall Study|Withdrawal by Subject|3|||
125166775|NCT02792699|450234232|FG000|Overall Study|Lost to Follow-up|0|||
125166776|NCT02792699|450234233|FG001|Overall Study|Lost to Follow-up|1|||
125166777|NCT02792699|450234234|FG002|Overall Study|Lost to Follow-up|2|||
125166778|NCT02792699|450234232|FG000|Overall Study|Physician Decision|2|||
125166779|NCT02792699|450234233|FG001|Overall Study|Physician Decision|0|||
125166780|NCT02792699|450234234|FG002|Overall Study|Physician Decision|0|||
125166781|NCT02792699|450234232|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
125166782|NCT02792699|450234233|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
125166783|NCT02792699|450234234|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
125166784|NCT02792699|450234232|FG000|Overall Study|Other|1|||
125166785|NCT02792699|450234233|FG001|Overall Study|Other|0|||
125166786|NCT02792699|450234234|FG002|Overall Study|Other|0|||
125166787|NCT02538965|450234235|FG000|Treatment Period|Other = Death due to disease progression|1|||
125166788|NCT02538965|450234235|FG000|Treatment Period|Adverse Event|2|||
125166789|NCT02538965|450234235|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
125166790|NCT02538965|450234235|FG000|Treatment Period|Treatment Failure|9|||
125166791|NCT02538965|450234235|FG000|Treatment Period|Disease Progression|1|||
125166792|NCT02538965|450234235|FG000|Treatment Period|Physician Decision|2|||
125166793|NCT02538965|450234235|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
125166794|NCT02538965|450234235|FG000|Follow-Up Period|Withdrawal by Parent|4|||
125166795|NCT00875797|450234236|FG000|Overall Study|Protocol Violation|6|||
125166796|NCT00875797|450234237|FG001|Overall Study|Protocol Violation|3|||
125166797|NCT01338870|450234241|FG000|Overall Study|Lost to Follow-up|0|||
125166798|NCT01338870|450234242|FG001|Overall Study|Lost to Follow-up|0|||
125166799|NCT01338870|450234243|FG002|Overall Study|Lost to Follow-up|1|||
125166800|NCT01338870|450234244|FG003|Overall Study|Lost to Follow-up|0|||
125166801|NCT01338870|450234245|FG004|Overall Study|Lost to Follow-up|1|||
125166802|NCT01338870|450234246|FG005|Overall Study|Lost to Follow-up|0|||
125166803|NCT01338870|450234241|FG000|Overall Study|Withdrawal by Subject|2|||
125166804|NCT01338870|450234242|FG001|Overall Study|Withdrawal by Subject|3|||
125166805|NCT01338870|450234243|FG002|Overall Study|Withdrawal by Subject|4|||
125166806|NCT01338870|450234244|FG003|Overall Study|Withdrawal by Subject|0|||
125166807|NCT01338870|450234245|FG004|Overall Study|Withdrawal by Subject|0|||
125166808|NCT01338870|450234246|FG005|Overall Study|Withdrawal by Subject|2|||
125166809|NCT01338870|450234241|FG000|Overall Study|Other|3|||
125166810|NCT01338870|450234242|FG001|Overall Study|Other|3|||
125166811|NCT01338870|450234243|FG002|Overall Study|Other|3|||
125166812|NCT01338870|450234244|FG003|Overall Study|Other|2|||
125166813|NCT01338870|450234245|FG004|Overall Study|Other|0|||
125166814|NCT01338870|450234246|FG005|Overall Study|Other|2|||
125166815|NCT01338870|450234241|FG000|Overall Study|Protocol Violation|0|||
125166816|NCT01338870|450234242|FG001|Overall Study|Protocol Violation|2|||
125166817|NCT01338870|450234243|FG002|Overall Study|Protocol Violation|2|||
125166818|NCT01338870|450234244|FG003|Overall Study|Protocol Violation|2|||
125166819|NCT01338870|450234245|FG004|Overall Study|Protocol Violation|1|||
125166820|NCT01338870|450234246|FG005|Overall Study|Protocol Violation|1|||
125166821|NCT01338870|450234241|FG000|Overall Study|Adverse Event|4|||
125166822|NCT01338870|450234242|FG001|Overall Study|Adverse Event|4|||
125166823|NCT01338870|450234243|FG002|Overall Study|Adverse Event|1|||
125166824|NCT01338870|450234244|FG003|Overall Study|Adverse Event|5|||
125166825|NCT01338870|450234245|FG004|Overall Study|Adverse Event|4|||
125166826|NCT01338870|450234246|FG005|Overall Study|Adverse Event|1|||
125166827|NCT02871492|450234249|FG000|Overall Study|Lost to Follow-up|6|||
125166828|NCT02871492|450234250|FG001|Overall Study|Lost to Follow-up|3|||
125166829|NCT02871492|450234251|FG002|Overall Study|Lost to Follow-up|5|||
125166830|NCT02871492|450234249|FG000|Overall Study|Withdrawal by Subject|0|||
125166831|NCT02871492|450234250|FG001|Overall Study|Withdrawal by Subject|0|||
125226977|NCT04161391|450460117|FG001|Overall Study|Death|0|||
125226978|NCT04161391|450460118|FG002|Overall Study|Death|0|||
125226979|NCT04161391|450460119|FG003|Overall Study|Death|0|||
125226980|NCT04161391|450460120|FG004|Overall Study|Death|0|||
125226981|NCT04161391|450460121|FG005|Overall Study|Death|0|||
125226982|NCT04161391|450460122|FG006|Overall Study|Death|0|||
125226983|NCT04161391|450460123|FG007|Overall Study|Death|1|||
125226984|NCT04161391|450460124|FG008|Overall Study|Death|0|||
125226985|NCT04161391|450460116|FG000|Overall Study|Physician Decision|0|||
125226986|NCT04161391|450460117|FG001|Overall Study|Physician Decision|0|||
125226987|NCT04161391|450460118|FG002|Overall Study|Physician Decision|1|||
125226988|NCT04161391|450460119|FG003|Overall Study|Physician Decision|2|||
125226989|NCT04161391|450460120|FG004|Overall Study|Physician Decision|0|||
125226990|NCT04161391|450460121|FG005|Overall Study|Physician Decision|0|||
125226991|NCT04161391|450460122|FG006|Overall Study|Physician Decision|2|||
125226992|NCT04161391|450460123|FG007|Overall Study|Physician Decision|0|||
125226993|NCT04161391|450460124|FG008|Overall Study|Physician Decision|0|||
125166832|NCT02871492|450234251|FG002|Overall Study|Withdrawal by Subject|1|||
125166833|NCT04546724|450234252|FG000|Overall Study|Withdrawal by Subject|145|||
125166834|NCT04546724|450234253|FG001|Overall Study|Withdrawal by Subject|41|||
125166835|NCT04546724|450234252|FG000|Overall Study|Adverse Event|1|||
125166836|NCT04546724|450234253|FG001|Overall Study|Adverse Event|1|||
125166837|NCT04546724|450234252|FG000|Overall Study|Lost to Follow-up|186|||
125166838|NCT04546724|450234253|FG001|Overall Study|Lost to Follow-up|63|||
125166839|NCT04546724|450234252|FG000|Overall Study|Physician Decision|8|||
125166840|NCT04546724|450234253|FG001|Overall Study|Physician Decision|2|||
125166841|NCT04546724|450234252|FG000|Overall Study|Death|2|||
125166842|NCT04546724|450234253|FG001|Overall Study|Death|1|||
125166843|NCT04546724|450234252|FG000|Overall Study|subject has been out of town|1|||
125166844|NCT04546724|450234253|FG001|Overall Study|subject has been out of town|0|||
125166845|NCT04546724|450234252|FG000|Overall Study|subject is incarcerated|2|||
125166846|NCT04546724|450234253|FG001|Overall Study|subject is incarcerated|0|||
125166847|NCT04546724|450234252|FG000|Overall Study|subject is relocating|12|||
125166848|NCT04546724|450234253|FG001|Overall Study|subject is relocating|4|||
125166849|NCT04546724|450234252|FG000|Overall Study|Subject in another study|1|||
125166850|NCT04546724|450234253|FG001|Overall Study|Subject in another study|1|||
125166851|NCT02256436|450234254|FG000|Overall Study|Adverse Event|9|||
125166852|NCT02256436|450234255|FG001|Overall Study|Adverse Event|14|||
125166853|NCT02256436|450234254|FG000|Overall Study|Death|216|||
125166854|NCT02256436|450234255|FG001|Overall Study|Death|208|||
125166855|NCT02256436|450234254|FG000|Overall Study|Lost to Follow-up|1|||
125166856|NCT02256436|450234255|FG001|Overall Study|Lost to Follow-up|2|||
125166857|NCT02256436|450234254|FG000|Overall Study|Physician Decision|1|||
125166858|NCT02256436|450234255|FG001|Overall Study|Physician Decision|0|||
125166859|NCT02256436|450234254|FG000|Overall Study|Protocol Violation|0|||
125166860|NCT02256436|450234255|FG001|Overall Study|Protocol Violation|1|||
125166861|NCT02256436|450234254|FG000|Overall Study|Withdrawal by Subject|26|||
125166862|NCT02256436|450234255|FG001|Overall Study|Withdrawal by Subject|10|||
125166863|NCT02256436|450234254|FG000|Overall Study|Transferred to Extension Study|11|||
125166864|NCT02256436|450234255|FG001|Overall Study|Transferred to Extension Study|23|||
125166865|NCT02256436|450234254|FG000|Overall Study|Did Not Continue on Extension Study|8|||
125166866|NCT02256436|450234255|FG001|Overall Study|Did Not Continue on Extension Study|12|||
125166867|NCT01441947|450234257|FG000|Overall Study|Withdrawal by Subject|3|||
125166868|NCT01441947|450234258|FG001|Overall Study|Withdrawal by Subject|0|||
125166869|NCT00077857|450234260|FG000|Overall Study|Adverse Event|30|||
125166870|NCT00077857|450234261|FG001|Overall Study|Adverse Event|32|||
125166871|NCT00077857|450234260|FG000|Overall Study|Death|7|||
125166872|NCT00077857|450234261|FG001|Overall Study|Death|3|||
125166873|NCT00077857|450234260|FG000|Overall Study|Insufficient therapeutic response|112|||
125166874|NCT00077857|450234261|FG001|Overall Study|Insufficient therapeutic response|128|||
125166875|NCT00077857|450234260|FG000|Overall Study|Violation of selection criteria at entry|3|||
125166876|NCT00077857|450234261|FG001|Overall Study|Violation of selection criteria at entry|1|||
125166877|NCT00077857|450234260|FG000|Overall Study|Other protocol violation|0|||
125166878|NCT00077857|450234261|FG001|Overall Study|Other protocol violation|1|||
125166879|NCT00077857|450234260|FG000|Overall Study|Refused treatment|29|||
125166880|NCT00077857|450234261|FG001|Overall Study|Refused treatment|21|||
125166881|NCT00077857|450234260|FG000|Overall Study|Failure to return|5|||
125226994|NCT04161391|450460116|FG000|Overall Study|Progressive Disease|4|||
125226995|NCT04161391|450460117|FG001|Overall Study|Progressive Disease|3|||
125226996|NCT04161391|450460118|FG002|Overall Study|Progressive Disease|3|||
125226997|NCT04161391|450460119|FG003|Overall Study|Progressive Disease|5|||
125226998|NCT04161391|450460120|FG004|Overall Study|Progressive Disease|3|||
125166882|NCT00077857|450234261|FG001|Overall Study|Failure to return|5|||
125166883|NCT00077857|450234260|FG000|Overall Study|Other|15|||
125166884|NCT00077857|450234261|FG001|Overall Study|Other|13|||
125166885|NCT01292226|450234262|FG000|Overall Study|Adverse Event|5|||
125166886|NCT01292226|450234262|FG000|Overall Study|Death|1|||
125166887|NCT01292226|450234262|FG000|Overall Study|Graft loss|1|||
125226999|NCT04161391|450460121|FG005|Overall Study|Progressive Disease|3|||
125227000|NCT04161391|450460122|FG006|Overall Study|Progressive Disease|5|||
125166888|NCT01292226|450234262|FG000|Overall Study|Protocol Violation|3|||
125166889|NCT01292226|450234262|FG000|Overall Study|Withdrawal by Subject|1|||
125166890|NCT01292226|450234262|FG000|Overall Study|Other|2|||
125166891|NCT01844505|450234263|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
125166892|NCT01844505|450234264|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
125166893|NCT01844505|450234265|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
125166894|NCT01844505|450234263|FG000|Treatment Period|Other Reasons|120|||
125166895|NCT01844505|450234264|FG001|Treatment Period|Other Reasons|136|||
125166896|NCT01844505|450234265|FG002|Treatment Period|Other Reasons|58|||
125166897|NCT01844505|450234263|FG000|Treatment Period|Lost to Follow-up|9|||
125166898|NCT01844505|450234264|FG001|Treatment Period|Lost to Follow-up|11|||
125166899|NCT01844505|450234265|FG002|Treatment Period|Lost to Follow-up|6|||
125166900|NCT01844505|450234263|FG000|Treatment Period|Death|175|||
125166901|NCT01844505|450234264|FG001|Treatment Period|Death|154|||
125166902|NCT01844505|450234265|FG002|Treatment Period|Death|228|||
125166903|NCT00468650|450234266|FG000|Overall Study|Lost to Follow-up|4|||
125166904|NCT00468650|450234266|FG000|Overall Study|Withdrawal by Subject|2|||
125166905|NCT00468650|450234266|FG000|Overall Study|Protocol Violation|1|||
125166906|NCT04874155|450234267|FG000|Overall Study|Lost to Follow-up|1|||
125166907|NCT04874155|450234268|FG001|Overall Study|Lost to Follow-up|1|||
125166908|NCT04874155|450234267|FG000|Overall Study|Withdrawal by Subject|2|||
125166909|NCT04874155|450234268|FG001|Overall Study|Withdrawal by Subject|2|||
125166910|NCT03477903|450234273|FG000|Overall Study|Study Terminated by Sponsor|1|||
125166911|NCT03201965|450234274|FG000|Overall Study|Death|5|||
125166912|NCT03201965|450234275|FG001|Overall Study|Death|27|||
125166913|NCT03201965|450234276|FG002|Overall Study|Death|27|||
125166914|NCT03201965|450234274|FG000|Overall Study|Lost to Follow-up|0|||
125166915|NCT03201965|450234275|FG001|Overall Study|Lost to Follow-up|1|||
125166916|NCT03201965|450234276|FG002|Overall Study|Lost to Follow-up|0|||
125166917|NCT03201965|450234274|FG000|Overall Study|Withdrawal by Subject|3|||
125166918|NCT03201965|450234275|FG001|Overall Study|Withdrawal by Subject|13|||
125166919|NCT03201965|450234276|FG002|Overall Study|Withdrawal by Subject|4|||
125166920|NCT03201965|450234274|FG000|Overall Study|Ongoing|20|||
125166921|NCT03201965|450234275|FG001|Overall Study|Ongoing|152|||
125166922|NCT03201965|450234276|FG002|Overall Study|Ongoing|164|||
125166923|NCT00369317|450234277|FG000|Overall Study|Adverse Event|3|||
125166924|NCT00369317|450234277|FG000|Overall Study|Death|1|||
125166925|NCT00369317|450234277|FG000|Overall Study|Lack of Efficacy|5|||
125166926|NCT00369317|450234277|FG000|Overall Study|Physician Decision|2|||
125166927|NCT00369317|450234277|FG000|Overall Study|Withdrawal by Subject|8|||
125166928|NCT00369317|450234277|FG000|Overall Study|Ineligible|1|||
125166929|NCT00758680|450234286|FG000|Overall Study|Adverse Event|0|||
125166930|NCT00758680|450234287|FG001|Overall Study|Adverse Event|0|||
125166931|NCT00758680|450234288|FG002|Overall Study|Adverse Event|0|||
125166932|NCT00758680|450234289|FG003|Overall Study|Adverse Event|0|||
125166933|NCT00758680|450234290|FG004|Overall Study|Adverse Event|0|||
125166934|NCT00758680|450234291|FG005|Overall Study|Adverse Event|0|||
125166935|NCT00758680|450234292|FG006|Overall Study|Adverse Event|0|||
125166936|NCT00758680|450234293|FG007|Overall Study|Adverse Event|1|||
125166937|NCT00758680|450234294|FG008|Overall Study|Adverse Event|0|||
125166938|NCT00758680|450234295|FG009|Overall Study|Adverse Event|1|||
125166939|NCT00758680|450234286|FG000|Overall Study|Laboratory Adverse Event|0|||
125166940|NCT00758680|450234287|FG001|Overall Study|Laboratory Adverse Event|0|||
125166941|NCT00758680|450234288|FG002|Overall Study|Laboratory Adverse Event|0|||
125166942|NCT00758680|450234289|FG003|Overall Study|Laboratory Adverse Event|0|||
125166943|NCT00758680|450234290|FG004|Overall Study|Laboratory Adverse Event|0|||
125166944|NCT00758680|450234291|FG005|Overall Study|Laboratory Adverse Event|0|||
125166945|NCT00758680|450234292|FG006|Overall Study|Laboratory Adverse Event|0|||
125166946|NCT00758680|450234293|FG007|Overall Study|Laboratory Adverse Event|0|||
125166947|NCT00758680|450234294|FG008|Overall Study|Laboratory Adverse Event|1|||
125166948|NCT00758680|450234295|FG009|Overall Study|Laboratory Adverse Event|0|||
125166949|NCT00758680|450234286|FG000|Overall Study|Withdrawal by Subject|0|||
125166950|NCT00758680|450234287|FG001|Overall Study|Withdrawal by Subject|0|||
125166951|NCT00758680|450234288|FG002|Overall Study|Withdrawal by Subject|0|||
125166952|NCT00758680|450234289|FG003|Overall Study|Withdrawal by Subject|0|||
125166953|NCT00758680|450234290|FG004|Overall Study|Withdrawal by Subject|0|||
125166954|NCT00758680|450234291|FG005|Overall Study|Withdrawal by Subject|0|||
125166955|NCT00758680|450234292|FG006|Overall Study|Withdrawal by Subject|1|||
125166956|NCT00758680|450234293|FG007|Overall Study|Withdrawal by Subject|0|||
125166957|NCT00758680|450234294|FG008|Overall Study|Withdrawal by Subject|1|||
125166958|NCT00758680|450234295|FG009|Overall Study|Withdrawal by Subject|0|||
125166959|NCT00761865|450234296|FG000|Overall Study|Lost to Follow-up|8|||
125166960|NCT00761865|450234297|FG001|Overall Study|Lost to Follow-up|7|||
125166961|NCT00574912|450234298|FG000|Overall Study|Could not place IV lines.|3|||
125166962|NCT00574912|450234298|FG000|Overall Study|scheduling conflicts|3|||
125166963|NCT00574912|450234298|FG000|Overall Study|Physician Decision|2|||
125166964|NCT03866902|450234300|FG000|Overall Study|Lost to Follow-up|98|||
125166965|NCT03866902|450234301|FG001|Overall Study|Lost to Follow-up|82|||
125166966|NCT03866902|450234300|FG000|Overall Study|Pregnancy|18|||
125166967|NCT03866902|450234301|FG001|Overall Study|Pregnancy|24|||
125227001|NCT04161391|450460123|FG007|Overall Study|Progressive Disease|2|||
125227002|NCT04161391|450460124|FG008|Overall Study|Progressive Disease|2|||
125227003|NCT02579629|450460140|FG000|Overall Study|Withdrawal by Subject|0|||
125227004|NCT02579629|450460141|FG001|Overall Study|Withdrawal by Subject|1|||
125227005|NCT02579629|450460142|FG002|Overall Study|Withdrawal by Subject|0|||
125227006|NCT02579629|450460140|FG000|Overall Study|Screen Failure|2|||
125227007|NCT02579629|450460141|FG001|Overall Study|Screen Failure|0|||
125227008|NCT02579629|450460142|FG002|Overall Study|Screen Failure|2|||
125227009|NCT00830219|450460143|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
125227010|NCT00830219|450460144|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
125227011|NCT01294423|450460145|FG000|Overall Study|Adverse Event|1|||
125227012|NCT01294423|450460146|FG001|Overall Study|Adverse Event|2|||
125227013|NCT01294423|450460147|FG002|Overall Study|Adverse Event|3|||
125227014|NCT01294423|450460145|FG000|Overall Study|Withdrawal by Subject|1|||
125227015|NCT01294423|450460146|FG001|Overall Study|Withdrawal by Subject|2|||
125227016|NCT01294423|450460147|FG002|Overall Study|Withdrawal by Subject|2|||
125227017|NCT01294423|450460145|FG000|Overall Study|subject no longer meets study criteria|2|||
125227018|NCT01294423|450460146|FG001|Overall Study|subject no longer meets study criteria|5|||
125227019|NCT01294423|450460147|FG002|Overall Study|subject no longer meets study criteria|2|||
125227020|NCT01294423|450460145|FG000|Overall Study|poor/non-compliance|1|||
125227021|NCT01294423|450460146|FG001|Overall Study|poor/non-compliance|0|||
125227022|NCT01294423|450460147|FG002|Overall Study|poor/non-compliance|1|||
125227023|NCT01145482|450460148|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
125227024|NCT01145482|450460149|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
125227025|NCT04635839|450460150|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
125227026|NCT04635839|450460151|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
125227027|NCT00896493|450460152|FG000|Overall Study|Early disease relapse|3|||
125227028|NCT02870868|450460153|FG000|Overall Study|Withdrawal by Subject|2|||
125227029|NCT02870868|450460154|FG001|Overall Study|Withdrawal by Subject|1|||
125227030|NCT01739335|450460155|FG000|Overall Study|Lost to Follow-up|7|||
125166968|NCT03014180|450234302|FG000|Overall Study|Protocol Violation|2|||
125166969|NCT02377427|450234305|FG000|Part A (Up to Week 20)|Physician Decision|1|||
125166970|NCT02377427|450234306|FG001|Part A (Up to Week 20)|Physician Decision|0|||
125166971|NCT02377427|450234307|FG002|Part A (Up to Week 20)|Physician Decision|0|||
125166972|NCT02377427|450234308|FG003|Part A (Up to Week 20)|Physician Decision|0|||
125166973|NCT02377427|450234309|FG004|Part A (Up to Week 20)|Physician Decision|0|||
125166974|NCT02377427|450234305|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
125166975|NCT02377427|450234306|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
125166976|NCT02377427|450234307|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
125166977|NCT02377427|450234308|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
125166978|NCT02377427|450234309|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
125166979|NCT02377427|450234305|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
125166980|NCT02377427|450234306|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
125166981|NCT02377427|450234307|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
125166982|NCT02377427|450234308|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
125166983|NCT02377427|450234309|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
125166984|NCT02377427|450234305|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
125227031|NCT01739335|450460156|FG001|Overall Study|Lost to Follow-up|4|||
125227032|NCT01739335|450460155|FG000|Overall Study|Ineligible patient randomized|0|||
125227033|NCT01739335|450460156|FG001|Overall Study|Ineligible patient randomized|1|||
125227034|NCT01868646|450460159|FG000|Overall Study|Do not meet inclusion criteria|3|||
125227035|NCT01868646|450460160|FG001|Overall Study|Do not meet inclusion criteria|5|||
125227036|NCT00785356|450460167|FG000|Overall Study|Study prematurely terminated|8|||
125227037|NCT01232790|450460169|FG000|Randomization|Withdrawal by Subject|2|||
125166985|NCT02377427|450234306|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
125227038|NCT01232790|450460170|FG001|Randomization|Withdrawal by Subject|0|||
125227039|NCT01232790|450460169|FG000|Randomization|Protocol Violation|0|||
125227040|NCT01232790|450460170|FG001|Randomization|Protocol Violation|1|||
125227041|NCT01232790|450460169|FG000|Randomization|Physician Decision|0|||
125227042|NCT01232790|450460170|FG001|Randomization|Physician Decision|1|||
125227043|NCT01232790|450460169|FG000|Initial Assessment|Withdrawal by Subject|0|||
125227044|NCT01232790|450460170|FG001|Initial Assessment|Withdrawal by Subject|1|||
125227045|NCT01232790|450460169|FG000|First Crossover|Withdrawal by Subject|1|||
125227046|NCT01232790|450460170|FG001|First Crossover|Withdrawal by Subject|0|||
125227047|NCT01232790|450460169|FG000|Second Crossover|Withdrawal by Subject|1|||
125227048|NCT01232790|450460170|FG001|Second Crossover|Withdrawal by Subject|2|||
125227049|NCT03238417|450460171|FG000|Overall|non-response|955|||
125227050|NCT03238417|450460172|FG001|Overall|non-response|1920|||
125227051|NCT03238417|450460171|FG000|Overall|partial completion|48|||
125227052|NCT03238417|450460172|FG001|Overall|partial completion|68|||
125227053|NCT03238417|450460171|FG000|Baseline|Partial completion|17|||
125227054|NCT03238417|450460172|FG001|Baseline|Partial completion|48|||
125227055|NCT03238417|450460171|FG000|Baseline|non-response|372|||
125227056|NCT03238417|450460172|FG001|Baseline|non-response|669|||
125227057|NCT03238417|450460171|FG000|12-month|non-response|296|||
125227058|NCT03238417|450460172|FG001|12-month|non-response|669|||
125227059|NCT03238417|450460171|FG000|12-month|partial completion|23|||
125227060|NCT03238417|450460172|FG001|12-month|partial completion|37|||
125227061|NCT03238417|450460171|FG000|24-month|non-response|287|||
125227062|NCT03238417|450460172|FG001|24-month|non-response|594|||
125227063|NCT03238417|450460171|FG000|24-month|partial completion|8|||
125227064|NCT03238417|450460172|FG001|24-month|partial completion|31|||
125227065|NCT00083915|450460173|FG000|Overall Study|Death|6|||
125227066|NCT00083915|450460174|FG001|Overall Study|Death|3|||
125227067|NCT00083915|450460173|FG000|Overall Study|Physician Decision|11|||
125227068|NCT00083915|450460174|FG001|Overall Study|Physician Decision|6|||
125227069|NCT00083915|450460173|FG000|Overall Study|Withdrawal by Subject|8|||
125227070|NCT00083915|450460174|FG001|Overall Study|Withdrawal by Subject|3|||
125227071|NCT00083915|450460173|FG000|Overall Study|disease progression|18|||
125227072|NCT00083915|450460174|FG001|Overall Study|disease progression|23|||
125227073|NCT00083915|450460173|FG000|Overall Study|Failure to collect|3|||
125227074|NCT00083915|450460174|FG001|Overall Study|Failure to collect|0|||
125227075|NCT00083915|450460173|FG000|Overall Study|No response|3|||
125227076|NCT00083915|450460174|FG001|Overall Study|No response|1|||
125227077|NCT00083915|450460173|FG000|Overall Study|Insurance issues|1|||
125227078|NCT00083915|450460174|FG001|Overall Study|Insurance issues|1|||
125227079|NCT01239797|450460175|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
125227080|NCT01239797|450460176|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
125227081|NCT01239797|450460175|FG000|Randomized Participants|Participant withdrew consent|1|||
125227082|NCT01239797|450460176|FG001|Randomized Participants|Participant withdrew consent|7|||
125227083|NCT01239797|450460175|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
125227084|NCT01239797|450460176|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
125227085|NCT01239797|450460175|FG000|Treated Participants|Disease progression|185|||
125227086|NCT01239797|450460176|FG001|Treated Participants|Disease progression|185|||
125227087|NCT01239797|450460175|FG000|Treated Participants|Study drug toxicity|39|||
125227088|NCT01239797|450460176|FG001|Treated Participants|Study drug toxicity|45|||
125227089|NCT01239797|450460175|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
125227090|NCT01239797|450460176|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
125227091|NCT01239797|450460175|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
125227092|NCT01239797|450460176|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
125227093|NCT01239797|450460175|FG000|Treated Participants|Administrative reason by sponsor|13|||
125227094|NCT01239797|450460176|FG001|Treated Participants|Administrative reason by sponsor|4|||
125227095|NCT01239797|450460175|FG000|Treated Participants|Other reasons|14|||
125227096|NCT01239797|450460176|FG001|Treated Participants|Other reasons|14|||
125227097|NCT01239797|450460175|FG000|Treated Participants|Participant withdrew consent|6|||
125227098|NCT01239797|450460176|FG001|Treated Participants|Participant withdrew consent|11|||
125227099|NCT01239797|450460175|FG000|Treated Participants|Death|1|||
125227100|NCT01239797|450460176|FG001|Treated Participants|Death|1|||
125227101|NCT01239797|450460175|FG000|Treated Participants|Participant no longer meets study criteria|1|||
125227102|NCT01239797|450460176|FG001|Treated Participants|Participant no longer meets study criteria|1|||
125227103|NCT01239797|450460175|FG000|Treated Participants|Poor/non-compliance|0|||
125227104|NCT01239797|450460176|FG001|Treated Participants|Poor/non-compliance|1|||
125227105|NCT00853762|450460180|FG000|Overall Study|Premature Termination|16|||
125227106|NCT00853762|450460181|FG001|Overall Study|Premature Termination|15|||
125227107|NCT00853762|450460182|FG002|Overall Study|Premature Termination|14|||
125227108|NCT00853762|450460183|FG003|Overall Study|Premature Termination|21|||
125227109|NCT00853762|450460180|FG000|Overall Study|Protocol Violation|0|||
125227110|NCT00853762|450460181|FG001|Overall Study|Protocol Violation|0|||
125227111|NCT00853762|450460182|FG002|Overall Study|Protocol Violation|0|||
125227112|NCT00853762|450460183|FG003|Overall Study|Protocol Violation|1|||
125227113|NCT00853762|450460180|FG000|Overall Study|Withdrawal by Subject|0|||
125227114|NCT00853762|450460181|FG001|Overall Study|Withdrawal by Subject|0|||
125227115|NCT00853762|450460182|FG002|Overall Study|Withdrawal by Subject|1|||
125227116|NCT00853762|450460183|FG003|Overall Study|Withdrawal by Subject|0|||
125227117|NCT00853762|450460180|FG000|Overall Study|Other|0|||
125227118|NCT00853762|450460181|FG001|Overall Study|Other|2|||
125227119|NCT00853762|450460182|FG002|Overall Study|Other|0|||
125227120|NCT00853762|450460183|FG003|Overall Study|Other|0|||
125227121|NCT00853762|450460180|FG000|Overall Study|Randomised but not Treated|0|||
125227122|NCT00853762|450460181|FG001|Overall Study|Randomised but not Treated|2|||
125227123|NCT00853762|450460182|FG002|Overall Study|Randomised but not Treated|2|||
125227124|NCT00853762|450460183|FG003|Overall Study|Randomised but not Treated|0|||
125227125|NCT02000921|450460189|FG000|Overall Study|Withdrawal by Subject|3|||
125227126|NCT02000921|450460190|FG001|Overall Study|Withdrawal by Subject|10|||
125166986|NCT02377427|450234307|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
125166987|NCT02377427|450234308|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
125166988|NCT02377427|450234309|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
125166989|NCT00704730|450234311|FG000|Overall Study|Adverse Event|35|||
125166990|NCT00704730|450234312|FG001|Overall Study|Adverse Event|9|||
125166991|NCT00704730|450234311|FG000|Overall Study|Death|11|||
125166992|NCT00704730|450234312|FG001|Overall Study|Death|5|||
125166993|NCT00704730|450234311|FG000|Overall Study|Physician Decision|2|||
125166994|NCT00704730|450234312|FG001|Overall Study|Physician Decision|0|||
125166995|NCT00704730|450234311|FG000|Overall Study|Did not receive drug|5|||
125166996|NCT00704730|450234312|FG001|Overall Study|Did not receive drug|2|||
125166997|NCT00704730|450234311|FG000|Overall Study|Disease progression per PI|58|||
125166998|NCT00704730|450234312|FG001|Overall Study|Disease progression per PI|67|||
125166999|NCT00704730|450234311|FG000|Overall Study|data unavailable|1|||
125167000|NCT00704730|450234312|FG001|Overall Study|data unavailable|0|||
125167001|NCT00704730|450234311|FG000|Overall Study|Withdrawal by Subject|9|||
125167002|NCT00704730|450234312|FG001|Overall Study|Withdrawal by Subject|13|||
125167003|NCT01523457|450235936|FG000|Overall Study|Withdrawal by Subject|7|||
125167004|NCT01523457|450235937|FG001|Overall Study|Withdrawal by Subject|2|||
125167005|NCT02886624|450235941|FG000|12-week Post Treatment Follow-up|Death|1|||
125167006|NCT02886624|450235941|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
125167007|NCT03400943|450235945|FG000|Treatment Period 1|Adverse Event|0|||
125167008|NCT03400943|450235946|FG001|Treatment Period 1|Adverse Event|0|||
125167009|NCT03400943|450235947|FG002|Treatment Period 1|Adverse Event|0|||
125167010|NCT03400943|450235948|FG003|Treatment Period 1|Adverse Event|1|||
125167011|NCT03400943|450235945|FG000|Treatment Period 1|Lost to Follow-up|1|||
125167012|NCT03400943|450235946|FG001|Treatment Period 1|Lost to Follow-up|0|||
125167013|NCT03400943|450235947|FG002|Treatment Period 1|Lost to Follow-up|0|||
125167014|NCT03400943|450235948|FG003|Treatment Period 1|Lost to Follow-up|0|||
125167015|NCT03400943|450235945|FG000|Treatment Period 1|Protocol Violation|0|||
125167016|NCT03400943|450235946|FG001|Treatment Period 1|Protocol Violation|1|||
125167017|NCT03400943|450235947|FG002|Treatment Period 1|Protocol Violation|1|||
125167018|NCT03400943|450235948|FG003|Treatment Period 1|Protocol Violation|0|||
125167019|NCT03400943|450235945|FG000|Treatment Period 1|Study terminated by sponsor|2|||
125167020|NCT03400943|450235946|FG001|Treatment Period 1|Study terminated by sponsor|0|||
125167021|NCT03400943|450235947|FG002|Treatment Period 1|Study terminated by sponsor|0|||
125167022|NCT03400943|450235948|FG003|Treatment Period 1|Study terminated by sponsor|1|||
125167023|NCT03400943|450235945|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125167024|NCT03400943|450235946|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125167025|NCT03400943|450235947|FG002|Treatment Period 1|Withdrawal by Subject|3|||
125167026|NCT03400943|450235948|FG003|Treatment Period 1|Withdrawal by Subject|1|||
125167027|NCT03400943|450235945|FG000|Treatment Period 1|Other|2|||
125167028|NCT03400943|450235946|FG001|Treatment Period 1|Other|1|||
125167029|NCT03400943|450235947|FG002|Treatment Period 1|Other|2|||
125167030|NCT03400943|450235948|FG003|Treatment Period 1|Other|2|||
125167031|NCT03400943|450235945|FG000|Post-treatment Period 1|Adverse Event|2|||
125167032|NCT03400943|450235946|FG001|Post-treatment Period 1|Adverse Event|0|||
125167033|NCT03400943|450235947|FG002|Post-treatment Period 1|Adverse Event|0|||
125167034|NCT03400943|450235948|FG003|Post-treatment Period 1|Adverse Event|0|||
125167035|NCT03400943|450235945|FG000|Post-treatment Period 1|Protocol Violation|1|||
125167036|NCT03400943|450235946|FG001|Post-treatment Period 1|Protocol Violation|0|||
125167037|NCT03400943|450235947|FG002|Post-treatment Period 1|Protocol Violation|0|||
125167038|NCT03400943|450235948|FG003|Post-treatment Period 1|Protocol Violation|0|||
125167039|NCT03400943|450235945|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
125167040|NCT03400943|450235946|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
125167041|NCT03400943|450235947|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
125167042|NCT03400943|450235948|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
125167043|NCT03400943|450235945|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
125167044|NCT03400943|450235946|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
125167045|NCT03400943|450235947|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
125167046|NCT03400943|450235948|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
125167047|NCT03400943|450235945|FG000|Post-treatment Period 1|Other|2|||
125167048|NCT03400943|450235946|FG001|Post-treatment Period 1|Other|0|||
125167049|NCT03400943|450235947|FG002|Post-treatment Period 1|Other|4|||
125167050|NCT03400943|450235948|FG003|Post-treatment Period 1|Other|5|||
125167051|NCT03400943|450235945|FG000|Treatment Period 2|Study terminated by sponsor|0|||
125167052|NCT03400943|450235946|FG001|Treatment Period 2|Study terminated by sponsor|1|||
125167053|NCT03400943|450235947|FG002|Treatment Period 2|Study terminated by sponsor|0|||
125167054|NCT03400943|450235948|FG003|Treatment Period 2|Study terminated by sponsor|0|||
125167055|NCT03400943|450235945|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125167056|NCT03400943|450235946|FG001|Treatment Period 2|Withdrawal by Subject|1|||
125167057|NCT03400943|450235947|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125167058|NCT03400943|450235948|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125167059|NCT03400943|450235945|FG000|Treatment Period 2|Other|1|||
125167060|NCT03400943|450235946|FG001|Treatment Period 2|Other|6|||
125167061|NCT03400943|450235947|FG002|Treatment Period 2|Other|0|||
125167062|NCT03400943|450235948|FG003|Treatment Period 2|Other|0|||
125167063|NCT03400943|450235945|FG000|Follow-up Period|Withdrawal by Subject|1|||
125167064|NCT03400943|450235946|FG001|Follow-up Period|Withdrawal by Subject|0|||
125167065|NCT03400943|450235947|FG002|Follow-up Period|Withdrawal by Subject|0|||
125167066|NCT03400943|450235948|FG003|Follow-up Period|Withdrawal by Subject|0|||
125167067|NCT02563106|450235949|FG000|Overall Study|Withdrawal by Subject|7|||
125167068|NCT02563106|450235950|FG001|Overall Study|Withdrawal by Subject|8|||
125167069|NCT02563106|450235949|FG000|Overall Study|Adverse Event|17|||
125167070|NCT02563106|450235950|FG001|Overall Study|Adverse Event|15|||
125167071|NCT02563106|450235949|FG000|Overall Study|Protocol Violation|1|||
125167072|NCT02563106|450235950|FG001|Overall Study|Protocol Violation|0|||
125167073|NCT02563106|450235949|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
125167074|NCT02563106|450235950|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
125167075|NCT02563106|450235949|FG000|Overall Study|Lost to Follow-up|3|||
125167076|NCT02563106|450235950|FG001|Overall Study|Lost to Follow-up|2|||
125167077|NCT02563106|450235949|FG000|Overall Study|Physician Decision|3|||
125167078|NCT02563106|450235950|FG001|Overall Study|Physician Decision|1|||
125167079|NCT02563106|450235949|FG000|Overall Study|Other reason - not specified|2|||
125167080|NCT02563106|450235950|FG001|Overall Study|Other reason - not specified|1|||
125167081|NCT04729309|450235951|FG000|Period 1|Subject unable to return for Period 2|3|||
125167082|NCT04729309|450235952|FG001|Period 1|Subject unable to return for Period 2|0|||
125167083|NCT04729309|450235951|FG000|Period 1|Lost to Follow-up|1|||
125167084|NCT04729309|450235952|FG001|Period 1|Lost to Follow-up|0|||
125167085|NCT01664130|450235959|FG000|Overall Study|competing secondary disease|2|||
125167086|NCT01161407|450235961|FG000|Overall Study|Protocol Violation|3|||
125167087|NCT01161407|450235962|FG001|Overall Study|Protocol Violation|1|||
125167088|NCT04746794|450235964|FG000|Overall Study|Did not complete any study assessment|50303|||
125167089|NCT04746794|450235965|FG001|Overall Study|Did not complete any study assessment|44997|||
125167090|NCT04040192|450235966|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
125167091|NCT04040192|450235967|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
125167092|NCT04040192|450235968|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
125167093|NCT04040192|450235966|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
125167094|NCT04040192|450235967|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
125167095|NCT04040192|450235968|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
125167096|NCT04040192|450235966|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
125167097|NCT04040192|450235967|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
125167098|NCT04040192|450235968|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
125167099|NCT04040192|450235966|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
125167100|NCT04040192|450235967|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
125167101|NCT04040192|450235968|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
125167102|NCT04040192|450235966|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
125167103|NCT04040192|450235967|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
125167104|NCT04040192|450235968|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
125167105|NCT04040192|450235966|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
125167106|NCT04040192|450235967|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
125167107|NCT04040192|450235968|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
125167108|NCT04040192|450235966|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
125167109|NCT04040192|450235967|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
125167110|NCT04040192|450235968|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
125167111|NCT04040192|450235966|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
125167112|NCT04040192|450235967|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
125167113|NCT04040192|450235968|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
125167114|NCT04040192|450235966|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
125167115|NCT04040192|450235967|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
125167116|NCT04040192|450235968|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
125167117|NCT04040192|450235966|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
125167118|NCT04040192|450235967|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
125167119|NCT04040192|450235968|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
125167120|NCT04040192|450235966|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
125167121|NCT04040192|450235967|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
125167122|NCT04040192|450235968|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
125167123|NCT04040192|450235966|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
125227127|NCT02000921|450460191|FG002|Overall Study|Withdrawal by Subject|5|||
125227128|NCT02000921|450460189|FG000|Overall Study|Lost to Follow-up|2|||
125227129|NCT02000921|450460190|FG001|Overall Study|Lost to Follow-up|4|||
125227130|NCT02000921|450460191|FG002|Overall Study|Lost to Follow-up|5|||
125227131|NCT02000921|450460189|FG000|Overall Study|Physician Decision|0|||
125227132|NCT02000921|450460190|FG001|Overall Study|Physician Decision|2|||
125227133|NCT02000921|450460191|FG002|Overall Study|Physician Decision|0|||
125227134|NCT02051296|450460196|FG000|Overall Study|Lost to Follow-up|1|||
125227135|NCT02051296|450460197|FG001|Overall Study|Lost to Follow-up|2|||
125227136|NCT02051296|450460196|FG000|Overall Study|withdraw prior to treatment|7|||
125227137|NCT02051296|450460197|FG001|Overall Study|withdraw prior to treatment|7|||
125227138|NCT02631941|450460200|FG000|Overall Study|Physician Decision|0|||
125227139|NCT02631941|450460201|FG001|Overall Study|Physician Decision|1|||
125227140|NCT02631941|450460202|FG002|Overall Study|Physician Decision|0|||
125227141|NCT02631941|450460203|FG003|Overall Study|Physician Decision|0|||
125227142|NCT02631941|450460204|FG004|Overall Study|Physician Decision|0|||
125227143|NCT02631941|450460205|FG005|Overall Study|Physician Decision|0|||
125227144|NCT02631941|450460206|FG006|Overall Study|Physician Decision|0|||
125227145|NCT02631941|450460207|FG007|Overall Study|Physician Decision|0|||
125227146|NCT02631941|450460208|FG008|Overall Study|Physician Decision|0|||
125227147|NCT02631941|450460209|FG009|Overall Study|Physician Decision|0|||
125227148|NCT02631941|450460200|FG000|Overall Study|Adverse Event|0|||
125227149|NCT02631941|450460201|FG001|Overall Study|Adverse Event|1|||
125227150|NCT02631941|450460202|FG002|Overall Study|Adverse Event|0|||
125227151|NCT02631941|450460203|FG003|Overall Study|Adverse Event|0|||
125227152|NCT02631941|450460204|FG004|Overall Study|Adverse Event|0|||
125227153|NCT02631941|450460205|FG005|Overall Study|Adverse Event|0|||
125227154|NCT02631941|450460206|FG006|Overall Study|Adverse Event|0|||
125227155|NCT02631941|450460207|FG007|Overall Study|Adverse Event|0|||
125227156|NCT02631941|450460208|FG008|Overall Study|Adverse Event|0|||
125227157|NCT02631941|450460209|FG009|Overall Study|Adverse Event|0|||
125227158|NCT02631941|450460200|FG000|Overall Study|Withdrawal by Subject|0|||
125227159|NCT02631941|450460201|FG001|Overall Study|Withdrawal by Subject|0|||
125227160|NCT02631941|450460202|FG002|Overall Study|Withdrawal by Subject|0|||
125227161|NCT02631941|450460203|FG003|Overall Study|Withdrawal by Subject|0|||
125227162|NCT02631941|450460204|FG004|Overall Study|Withdrawal by Subject|1|||
125227163|NCT02631941|450460205|FG005|Overall Study|Withdrawal by Subject|0|||
125227164|NCT02631941|450460206|FG006|Overall Study|Withdrawal by Subject|0|||
125227165|NCT02631941|450460207|FG007|Overall Study|Withdrawal by Subject|1|||
125227166|NCT02631941|450460208|FG008|Overall Study|Withdrawal by Subject|0|||
125227167|NCT02631941|450460209|FG009|Overall Study|Withdrawal by Subject|0|||
125227168|NCT02631941|450460200|FG000|Overall Study|Lost to Follow-up|0|||
125227169|NCT02631941|450460201|FG001|Overall Study|Lost to Follow-up|0|||
125227170|NCT02631941|450460202|FG002|Overall Study|Lost to Follow-up|0|||
125227171|NCT02631941|450460203|FG003|Overall Study|Lost to Follow-up|0|||
125227172|NCT02631941|450460204|FG004|Overall Study|Lost to Follow-up|0|||
125227173|NCT02631941|450460205|FG005|Overall Study|Lost to Follow-up|0|||
125227174|NCT02631941|450460206|FG006|Overall Study|Lost to Follow-up|0|||
125227175|NCT02631941|450460207|FG007|Overall Study|Lost to Follow-up|0|||
125227176|NCT02631941|450460208|FG008|Overall Study|Lost to Follow-up|1|||
125227177|NCT02631941|450460209|FG009|Overall Study|Lost to Follow-up|0|||
125227178|NCT02858401|450460211|FG000|Overall Study|Withdrew Consent|0|||
125167124|NCT04040192|450235967|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
125167125|NCT04040192|450235968|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
125167126|NCT04040192|450235966|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
125167127|NCT04040192|450235967|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
125167128|NCT04040192|450235968|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
125167129|NCT04040192|450235966|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
125167130|NCT04040192|450235967|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
125167131|NCT04040192|450235968|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
125167132|NCT04040192|450235966|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
125167133|NCT04040192|450235967|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
125167134|NCT04040192|450235968|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
125227179|NCT02858401|450460212|FG001|Overall Study|Withdrew Consent|0|||
125227180|NCT02858401|450460213|FG002|Overall Study|Withdrew Consent|0|||
125227181|NCT02858401|450460214|FG003|Overall Study|Withdrew Consent|0|||
125227182|NCT02858401|450460215|FG004|Overall Study|Withdrew Consent|0|||
125227183|NCT02858401|450460216|FG005|Overall Study|Withdrew Consent|1|||
125227184|NCT02858401|450460217|FG006|Overall Study|Withdrew Consent|0|||
125227185|NCT02858401|450460211|FG000|Overall Study|Lost to Follow-up|0|||
125227186|NCT02858401|450460212|FG001|Overall Study|Lost to Follow-up|1|||
125227187|NCT02858401|450460213|FG002|Overall Study|Lost to Follow-up|0|||
125227188|NCT02858401|450460214|FG003|Overall Study|Lost to Follow-up|0|||
125227189|NCT02858401|450460215|FG004|Overall Study|Lost to Follow-up|0|||
125227190|NCT02858401|450460216|FG005|Overall Study|Lost to Follow-up|0|||
125227191|NCT02858401|450460217|FG006|Overall Study|Lost to Follow-up|0|||
125227192|NCT03722576|450460218|FG000|Overall Study|Withdrawal by Subject|3|||
125167135|NCT04040192|450235966|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
125227193|NCT03722576|450460218|FG000|Overall Study|Adverse Event|2|||
125227194|NCT03722576|450460218|FG000|Overall Study|Physician Decision|1|||
125227195|NCT03722576|450460218|FG000|Overall Study|Lost to Follow-up|1|||
125227196|NCT02513550|450460221|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
125227197|NCT02513550|450460222|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
125227198|NCT02513550|450460223|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
125227199|NCT02513550|450460224|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
125227200|NCT02513550|450460225|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
125227201|NCT02513550|450460226|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
125227202|NCT02513550|450460221|FG000|Double Blind Treatment Period|Adverse Event|5|||
125227203|NCT02513550|450460222|FG001|Double Blind Treatment Period|Adverse Event|13|||
125227204|NCT02513550|450460223|FG002|Double Blind Treatment Period|Adverse Event|17|||
125227205|NCT02513550|450460224|FG003|Double Blind Treatment Period|Adverse Event|0|||
125227206|NCT02513550|450460225|FG004|Double Blind Treatment Period|Adverse Event|1|||
125227207|NCT02513550|450460226|FG005|Double Blind Treatment Period|Adverse Event|0|||
125227208|NCT02513550|450460221|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
125227209|NCT02513550|450460222|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
125227210|NCT02513550|450460223|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
125227211|NCT02513550|450460224|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
125227212|NCT02513550|450460225|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
125227213|NCT02513550|450460226|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
125227214|NCT02513550|450460221|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
125227215|NCT02513550|450460222|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
125227216|NCT02513550|450460223|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
125227217|NCT02513550|450460224|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
125227218|NCT02513550|450460225|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
125227219|NCT02513550|450460226|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
125167136|NCT04040192|450235967|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
125167137|NCT04040192|450235968|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
125167138|NCT04040192|450235966|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
125167139|NCT04040192|450235967|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
125167140|NCT04040192|450235968|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
125167141|NCT03200912|450235969|FG000|Overall Study|Adverse Event|3|||
125167142|NCT03200912|450235970|FG001|Overall Study|Adverse Event|0|||
125167143|NCT03200912|450235971|FG002|Overall Study|Adverse Event|0|||
125167144|NCT03200912|450235969|FG000|Overall Study|Withdrawal by Subject|1|||
125167145|NCT03200912|450235970|FG001|Overall Study|Withdrawal by Subject|2|||
125167146|NCT03200912|450235971|FG002|Overall Study|Withdrawal by Subject|4|||
125167147|NCT03200912|450235969|FG000|Overall Study|Non-compliance with study drug|0|||
125167148|NCT03200912|450235970|FG001|Overall Study|Non-compliance with study drug|1|||
125167149|NCT03200912|450235971|FG002|Overall Study|Non-compliance with study drug|0|||
125167150|NCT01955083|450235974|FG000|Overall Study|Lost to Follow-up|1|||
125167151|NCT01955083|450235975|FG001|Overall Study|Lost to Follow-up|1|||
125167152|NCT03583086|450235978|FG000|Overall Study|Death|2|||
125167153|NCT03583086|450235979|FG001|Overall Study|Death|6|||
125167154|NCT03583086|450235980|FG002|Overall Study|Death|12|||
125167155|NCT03583086|450235981|FG003|Overall Study|Death|10|||
125167156|NCT03583086|450235982|FG004|Overall Study|Death|14|||
125167157|NCT03583086|450235983|FG005|Overall Study|Death|14|||
125167158|NCT03583086|450235984|FG006|Overall Study|Death|4|||
125167159|NCT03583086|450235978|FG000|Overall Study|Withdrawal by Subject|0|||
125167160|NCT03583086|450235979|FG001|Overall Study|Withdrawal by Subject|0|||
125167161|NCT03583086|450235980|FG002|Overall Study|Withdrawal by Subject|1|||
125167162|NCT03583086|450235981|FG003|Overall Study|Withdrawal by Subject|0|||
125167163|NCT03583086|450235982|FG004|Overall Study|Withdrawal by Subject|0|||
125227220|NCT02513550|450460221|FG000|Double Blind Treatment Period|Protocol Violation|1|||
125227221|NCT02513550|450460222|FG001|Double Blind Treatment Period|Protocol Violation|1|||
125227222|NCT02513550|450460223|FG002|Double Blind Treatment Period|Protocol Violation|4|||
125227223|NCT02513550|450460224|FG003|Double Blind Treatment Period|Protocol Violation|0|||
125227224|NCT02513550|450460225|FG004|Double Blind Treatment Period|Protocol Violation|0|||
125227225|NCT02513550|450460226|FG005|Double Blind Treatment Period|Protocol Violation|0|||
125167164|NCT03583086|450235983|FG005|Overall Study|Withdrawal by Subject|0|||
125167165|NCT03583086|450235984|FG006|Overall Study|Withdrawal by Subject|1|||
125167166|NCT03583086|450235978|FG000|Overall Study|Refused follow-up|0|||
125167167|NCT03583086|450235979|FG001|Overall Study|Refused follow-up|0|||
125167168|NCT03583086|450235980|FG002|Overall Study|Refused follow-up|1|||
125167169|NCT03583086|450235981|FG003|Overall Study|Refused follow-up|0|||
125167170|NCT03583086|450235982|FG004|Overall Study|Refused follow-up|1|||
125167171|NCT03583086|450235983|FG005|Overall Study|Refused follow-up|0|||
125167172|NCT03583086|450235984|FG006|Overall Study|Refused follow-up|0|||
125167173|NCT03583086|450235978|FG000|Overall Study|Declining Performance Status|0|||
125167174|NCT03583086|450235979|FG001|Overall Study|Declining Performance Status|0|||
125167175|NCT03583086|450235980|FG002|Overall Study|Declining Performance Status|1|||
125167176|NCT03583086|450235981|FG003|Overall Study|Declining Performance Status|0|||
125167177|NCT03583086|450235982|FG004|Overall Study|Declining Performance Status|0|||
125167178|NCT03583086|450235983|FG005|Overall Study|Declining Performance Status|0|||
125167179|NCT03583086|450235984|FG006|Overall Study|Declining Performance Status|0|||
125167180|NCT03583086|450235978|FG000|Overall Study|Still on study|0|||
125167181|NCT03583086|450235979|FG001|Overall Study|Still on study|0|||
125167182|NCT03583086|450235980|FG002|Overall Study|Still on study|0|||
125167183|NCT03583086|450235981|FG003|Overall Study|Still on study|1|||
125167184|NCT03583086|450235982|FG004|Overall Study|Still on study|0|||
125167185|NCT03583086|450235983|FG005|Overall Study|Still on study|0|||
125167186|NCT03583086|450235984|FG006|Overall Study|Still on study|1|||
125167187|NCT03583086|450235978|FG000|Overall Study|Disease progression|0|||
125167188|NCT03583086|450235979|FG001|Overall Study|Disease progression|0|||
125167189|NCT03583086|450235980|FG002|Overall Study|Disease progression|0|||
125167190|NCT03583086|450235981|FG003|Overall Study|Disease progression|0|||
125167191|NCT03583086|450235982|FG004|Overall Study|Disease progression|0|||
125167192|NCT03583086|450235983|FG005|Overall Study|Disease progression|0|||
125167193|NCT03583086|450235984|FG006|Overall Study|Disease progression|1|||
125167194|NCT03583086|450235978|FG000|Overall Study|Undergoing radiation therapy|0|||
125167195|NCT03583086|450235979|FG001|Overall Study|Undergoing radiation therapy|0|||
125167196|NCT03583086|450235980|FG002|Overall Study|Undergoing radiation therapy|0|||
125167197|NCT03583086|450235981|FG003|Overall Study|Undergoing radiation therapy|0|||
125167198|NCT03583086|450235982|FG004|Overall Study|Undergoing radiation therapy|0|||
125167199|NCT03583086|450235983|FG005|Overall Study|Undergoing radiation therapy|0|||
125167200|NCT03583086|450235984|FG006|Overall Study|Undergoing radiation therapy|1|||
125167201|NCT03583086|450235978|FG000|Overall Study|Lost to Follow-up|0|||
125167202|NCT03583086|450235979|FG001|Overall Study|Lost to Follow-up|0|||
125227226|NCT02513550|450460221|FG000|Double Blind Treatment Period|Physician Decision|2|||
125227227|NCT02513550|450460222|FG001|Double Blind Treatment Period|Physician Decision|0|||
125227228|NCT02513550|450460223|FG002|Double Blind Treatment Period|Physician Decision|4|||
125227229|NCT02513550|450460224|FG003|Double Blind Treatment Period|Physician Decision|0|||
125227230|NCT02513550|450460225|FG004|Double Blind Treatment Period|Physician Decision|0|||
125227231|NCT02513550|450460226|FG005|Double Blind Treatment Period|Physician Decision|0|||
125227232|NCT02513550|450460221|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
125227233|NCT02513550|450460222|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
125227234|NCT02513550|450460223|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
125227235|NCT02513550|450460224|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
125227236|NCT02513550|450460225|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
125227237|NCT02513550|450460226|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
125227238|NCT02513550|450460221|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
125227239|NCT02513550|450460222|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
125227240|NCT02513550|450460223|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
125227241|NCT02513550|450460224|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
125227242|NCT02513550|450460225|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
125227243|NCT02513550|450460226|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
125227244|NCT02513550|450460221|FG000|Double Blind Treatment Period|Due to personal business|2|||
125227245|NCT02513550|450460222|FG001|Double Blind Treatment Period|Due to personal business|0|||
125227246|NCT02513550|450460223|FG002|Double Blind Treatment Period|Due to personal business|1|||
125227247|NCT02513550|450460224|FG003|Double Blind Treatment Period|Due to personal business|0|||
125167203|NCT03583086|450235980|FG002|Overall Study|Lost to Follow-up|0|||
125167204|NCT03583086|450235981|FG003|Overall Study|Lost to Follow-up|0|||
125167205|NCT03583086|450235982|FG004|Overall Study|Lost to Follow-up|0|||
125167206|NCT03583086|450235983|FG005|Overall Study|Lost to Follow-up|1|||
125167207|NCT03583086|450235984|FG006|Overall Study|Lost to Follow-up|0|||
125167208|NCT03583086|450235978|FG000|Overall Study|Adverse Event|0|||
125167209|NCT03583086|450235979|FG001|Overall Study|Adverse Event|0|||
125167210|NCT03583086|450235980|FG002|Overall Study|Adverse Event|0|||
125167211|NCT03583086|450235981|FG003|Overall Study|Adverse Event|0|||
125167212|NCT03583086|450235982|FG004|Overall Study|Adverse Event|0|||
125167213|NCT03583086|450235983|FG005|Overall Study|Adverse Event|1|||
125167214|NCT03583086|450235984|FG006|Overall Study|Adverse Event|0|||
125167215|NCT00128830|450235986|FG000|Overall Study|Adverse Event|10|||
125167216|NCT00128830|450235986|FG000|Overall Study|Withdrawal by Subject|14|||
125167217|NCT00128830|450235986|FG000|Overall Study|Lost to Follow-up|4|||
125167218|NCT00128830|450235986|FG000|Overall Study|Reached a virologic endpoint|29|||
125167219|NCT00128830|450235986|FG000|Overall Study|Non-compliant|4|||
125167220|NCT00128830|450235986|FG000|Overall Study|Discontinued or ineligible for study|2|||
125167221|NCT00128830|450235986|FG000|Overall Study|Other|9|||
125167222|NCT02927366|450235988|FG000|Overall Study|Adverse Event|1|||
125167223|NCT02927366|450235989|FG001|Overall Study|Adverse Event|0|||
125167224|NCT02927366|450235988|FG000|Overall Study|Patient schedule|1|||
125167225|NCT02927366|450235989|FG001|Overall Study|Patient schedule|0|||
125167226|NCT00426361|450235996|FG000|Overall Study|Lost to Follow-up|3|||
125227248|NCT02513550|450460225|FG004|Double Blind Treatment Period|Due to personal business|0|||
125167227|NCT00426361|450235997|FG001|Overall Study|Lost to Follow-up|2|||
125167228|NCT00426361|450235998|FG002|Overall Study|Lost to Follow-up|5|||
125167229|NCT00426361|450235996|FG000|Overall Study|Withdrawal by Subject|1|||
125167230|NCT00426361|450235997|FG001|Overall Study|Withdrawal by Subject|3|||
125167231|NCT00426361|450235998|FG002|Overall Study|Withdrawal by Subject|0|||
125167232|NCT04642365|450236001|FG000|Overall Study|Death|3|||
125167233|NCT04642365|450236002|FG001|Overall Study|Death|2|||
125167234|NCT04642365|450236003|FG002|Overall Study|Death|4|||
125167235|NCT04642365|450236004|FG003|Overall Study|Death|5|||
125167236|NCT04642365|450236005|FG004|Overall Study|Death|5|||
125227249|NCT02513550|450460226|FG005|Double Blind Treatment Period|Due to personal business|0|||
125167237|NCT04642365|450236006|FG005|Overall Study|Death|3|||
125167238|NCT04642365|450236007|FG006|Overall Study|Death|2|||
125167239|NCT04642365|450236008|FG007|Overall Study|Death|1|||
125167240|NCT04642365|450236001|FG000|Overall Study|Physician Decision|1|||
125167241|NCT04642365|450236002|FG001|Overall Study|Physician Decision|0|||
125167242|NCT04642365|450236003|FG002|Overall Study|Physician Decision|0|||
125167243|NCT04642365|450236004|FG003|Overall Study|Physician Decision|0|||
125167244|NCT04642365|450236005|FG004|Overall Study|Physician Decision|0|||
125167245|NCT04642365|450236006|FG005|Overall Study|Physician Decision|0|||
125227250|NCT02513550|450460221|FG000|Double Blind Treatment Period|Death|1|||
125227251|NCT02513550|450460222|FG001|Double Blind Treatment Period|Death|0|||
125227252|NCT02513550|450460223|FG002|Double Blind Treatment Period|Death|2|||
125167246|NCT04642365|450236007|FG006|Overall Study|Physician Decision|0|||
125167247|NCT04642365|450236008|FG007|Overall Study|Physician Decision|0|||
125167248|NCT04642365|450236001|FG000|Overall Study|Progressive Disease|1|||
125167249|NCT04642365|450236002|FG001|Overall Study|Progressive Disease|1|||
125167250|NCT04642365|450236003|FG002|Overall Study|Progressive Disease|1|||
125227253|NCT02513550|450460224|FG003|Double Blind Treatment Period|Death|0|||
125227254|NCT02513550|450460225|FG004|Double Blind Treatment Period|Death|0|||
125227255|NCT02513550|450460226|FG005|Double Blind Treatment Period|Death|0|||
125227256|NCT02513550|450460221|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
125167251|NCT04642365|450236004|FG003|Overall Study|Progressive Disease|0|||
125167252|NCT04642365|450236005|FG004|Overall Study|Progressive Disease|0|||
125167253|NCT04642365|450236006|FG005|Overall Study|Progressive Disease|0|||
125167254|NCT04642365|450236007|FG006|Overall Study|Progressive Disease|1|||
125167255|NCT04642365|450236008|FG007|Overall Study|Progressive Disease|0|||
125167256|NCT04642365|450236001|FG000|Overall Study|Study Terminated By Sponsor|0|||
125167257|NCT04642365|450236002|FG001|Overall Study|Study Terminated By Sponsor|2|||
125227257|NCT02513550|450460222|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
125227258|NCT02513550|450460223|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
125227259|NCT02513550|450460224|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
125227260|NCT02513550|450460225|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
125227261|NCT02513550|450460226|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
125227262|NCT02513550|450460221|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
125227263|NCT02513550|450460222|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
125227264|NCT02513550|450460223|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
125227265|NCT02513550|450460224|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
125227266|NCT02513550|450460225|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
125227267|NCT02513550|450460226|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
125227268|NCT02513550|450460221|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
125227269|NCT02513550|450460222|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
125227270|NCT02513550|450460223|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
125227271|NCT02513550|450460224|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
125227272|NCT02513550|450460225|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
125227273|NCT02513550|450460226|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
125227274|NCT02513550|450460221|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
125167258|NCT04642365|450236003|FG002|Overall Study|Study Terminated By Sponsor|1|||
125167259|NCT04642365|450236004|FG003|Overall Study|Study Terminated By Sponsor|1|||
125167260|NCT04642365|450236005|FG004|Overall Study|Study Terminated By Sponsor|1|||
125167261|NCT04642365|450236006|FG005|Overall Study|Study Terminated By Sponsor|2|||
125167262|NCT04642365|450236007|FG006|Overall Study|Study Terminated By Sponsor|2|||
125167263|NCT04642365|450236008|FG007|Overall Study|Study Terminated By Sponsor|1|||
125167264|NCT04642365|450236001|FG000|Overall Study|Symptomatic Deterioration|1|||
125167265|NCT04642365|450236002|FG001|Overall Study|Symptomatic Deterioration|1|||
125167266|NCT04642365|450236003|FG002|Overall Study|Symptomatic Deterioration|0|||
125167267|NCT04642365|450236004|FG003|Overall Study|Symptomatic Deterioration|0|||
125167268|NCT04642365|450236005|FG004|Overall Study|Symptomatic Deterioration|0|||
125227275|NCT02513550|450460222|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
125227276|NCT02513550|450460223|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
125227277|NCT02513550|450460224|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
125227278|NCT02513550|450460225|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
125227279|NCT02513550|450460226|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
125167269|NCT04642365|450236006|FG005|Overall Study|Symptomatic Deterioration|1|||
125167270|NCT04642365|450236007|FG006|Overall Study|Symptomatic Deterioration|0|||
125167271|NCT04642365|450236008|FG007|Overall Study|Symptomatic Deterioration|0|||
125167272|NCT04642365|450236001|FG000|Overall Study|Withdrawal by Subject|0|||
125167273|NCT04642365|450236002|FG001|Overall Study|Withdrawal by Subject|0|||
125167274|NCT04642365|450236003|FG002|Overall Study|Withdrawal by Subject|1|||
125167275|NCT04642365|450236004|FG003|Overall Study|Withdrawal by Subject|1|||
125167276|NCT04642365|450236005|FG004|Overall Study|Withdrawal by Subject|0|||
125167277|NCT04642365|450236006|FG005|Overall Study|Withdrawal by Subject|0|||
125167278|NCT04642365|450236007|FG006|Overall Study|Withdrawal by Subject|2|||
125167279|NCT04642365|450236008|FG007|Overall Study|Withdrawal by Subject|0|||
125167280|NCT04642365|450236001|FG000|Overall Study|Adverse Event|0|||
125167281|NCT04642365|450236002|FG001|Overall Study|Adverse Event|0|||
125167282|NCT04642365|450236003|FG002|Overall Study|Adverse Event|0|||
125167283|NCT04642365|450236004|FG003|Overall Study|Adverse Event|0|||
125167284|NCT04642365|450236005|FG004|Overall Study|Adverse Event|0|||
125167285|NCT04642365|450236006|FG005|Overall Study|Adverse Event|0|||
125167286|NCT04642365|450236007|FG006|Overall Study|Adverse Event|0|||
125167287|NCT04642365|450236008|FG007|Overall Study|Adverse Event|1|||
125167288|NCT02478320|450236009|FG000|Overall Study|Adverse Event|2|||
125167289|NCT02478320|450236010|FG001|Overall Study|Adverse Event|0|||
125167290|NCT02478320|450236009|FG000|Overall Study|Death|1|||
125167291|NCT02478320|450236010|FG001|Overall Study|Death|0|||
125167292|NCT02478320|450236009|FG000|Overall Study|Lack of Efficacy|4|||
125167293|NCT02478320|450236010|FG001|Overall Study|Lack of Efficacy|0|||
125167294|NCT02478320|450236009|FG000|Overall Study|Withdrawal by Subject|2|||
125167295|NCT02478320|450236010|FG001|Overall Study|Withdrawal by Subject|0|||
125167296|NCT02478320|450236009|FG000|Overall Study|Screen Failure|3|||
125167297|NCT02478320|450236010|FG001|Overall Study|Screen Failure|0|||
125167298|NCT03185013|450236011|FG000|Overall Study|Withdrawal by Subject|5|||
125167299|NCT03185013|450236012|FG001|Overall Study|Withdrawal by Subject|3|||
125167300|NCT03185013|450236011|FG000|Overall Study|Adverse Event|1|||
125167301|NCT03185013|450236012|FG001|Overall Study|Adverse Event|0|||
125167302|NCT03185013|450236011|FG000|Overall Study|Progressive Disease|1|||
125167303|NCT03185013|450236012|FG001|Overall Study|Progressive Disease|0|||
125167304|NCT03185013|450236011|FG000|Overall Study|Lost to Follow-up|8|||
125167305|NCT03185013|450236012|FG001|Overall Study|Lost to Follow-up|2|||
125167306|NCT03185013|450236011|FG000|Overall Study|Physician Decision|1|||
125167307|NCT03185013|450236012|FG001|Overall Study|Physician Decision|0|||
125167308|NCT03185013|450236011|FG000|Overall Study|Protocol Deviation|2|||
125167309|NCT03185013|450236012|FG001|Overall Study|Protocol Deviation|0|||
125167310|NCT03185013|450236011|FG000|Overall Study|Reason not Specified|3|||
125167311|NCT03185013|450236012|FG001|Overall Study|Reason not Specified|2|||
125167312|NCT03185013|450236011|FG000|Overall Study|Death|1|||
125167313|NCT03185013|450236012|FG001|Overall Study|Death|0|||
125167314|NCT00510289|450236016|FG000|Overall Study|Withdrawal by Subject|7|||
125167315|NCT00510289|450236016|FG000|Overall Study|Refused bone marrow biopsy|2|||
125167316|NCT00510289|450236016|FG000|Overall Study|Lost to Follow-up|1|||
125167317|NCT00510289|450236016|FG000|Overall Study|Progressed prior to starting drug|2|||
125167318|NCT00673387|450236019|FG000|Overall Study|Withdrawal by Subject|15|||
125167319|NCT00673387|450236020|FG001|Overall Study|Withdrawal by Subject|16|||
125167320|NCT00673387|450236021|FG002|Overall Study|Withdrawal by Subject|20|||
125167321|NCT00673387|450236022|FG003|Overall Study|Withdrawal by Subject|16|||
125167322|NCT00673387|450236023|FG004|Overall Study|Withdrawal by Subject|18|||
125167323|NCT00673387|450236024|FG005|Overall Study|Withdrawal by Subject|21|||
125167324|NCT00673387|450236025|FG006|Overall Study|Withdrawal by Subject|15|||
125167325|NCT00673387|450236026|FG007|Overall Study|Withdrawal by Subject|21|||
125167326|NCT00673387|450236019|FG000|Overall Study|Adverse Event|3|||
125167327|NCT00673387|450236020|FG001|Overall Study|Adverse Event|1|||
125167328|NCT00673387|450236021|FG002|Overall Study|Adverse Event|5|||
125167329|NCT00673387|450236022|FG003|Overall Study|Adverse Event|2|||
125167330|NCT00673387|450236023|FG004|Overall Study|Adverse Event|6|||
125167331|NCT00673387|450236024|FG005|Overall Study|Adverse Event|2|||
125167332|NCT00673387|450236025|FG006|Overall Study|Adverse Event|5|||
125167333|NCT00673387|450236026|FG007|Overall Study|Adverse Event|5|||
125167334|NCT00673387|450236019|FG000|Overall Study|Physician Decision|0|||
125167335|NCT00673387|450236020|FG001|Overall Study|Physician Decision|0|||
125167336|NCT00673387|450236021|FG002|Overall Study|Physician Decision|0|||
125167337|NCT00673387|450236022|FG003|Overall Study|Physician Decision|0|||
125167338|NCT00673387|450236023|FG004|Overall Study|Physician Decision|0|||
125167339|NCT00673387|450236024|FG005|Overall Study|Physician Decision|5|||
125167340|NCT00673387|450236025|FG006|Overall Study|Physician Decision|1|||
125167341|NCT00673387|450236026|FG007|Overall Study|Physician Decision|1|||
125167342|NCT00673387|450236019|FG000|Overall Study|Protocol Violation|3|||
125167343|NCT00673387|450236020|FG001|Overall Study|Protocol Violation|0|||
125167344|NCT00673387|450236021|FG002|Overall Study|Protocol Violation|1|||
125167345|NCT00673387|450236022|FG003|Overall Study|Protocol Violation|2|||
125167346|NCT00673387|450236023|FG004|Overall Study|Protocol Violation|0|||
125167347|NCT00673387|450236024|FG005|Overall Study|Protocol Violation|1|||
125167348|NCT00673387|450236025|FG006|Overall Study|Protocol Violation|1|||
125167349|NCT00673387|450236026|FG007|Overall Study|Protocol Violation|3|||
125167350|NCT00673387|450236019|FG000|Overall Study|Lost to Follow-up|8|||
125167351|NCT00673387|450236020|FG001|Overall Study|Lost to Follow-up|6|||
125167352|NCT00673387|450236021|FG002|Overall Study|Lost to Follow-up|5|||
125167353|NCT00673387|450236022|FG003|Overall Study|Lost to Follow-up|6|||
125167354|NCT00673387|450236023|FG004|Overall Study|Lost to Follow-up|6|||
125167355|NCT00673387|450236024|FG005|Overall Study|Lost to Follow-up|5|||
125167356|NCT00673387|450236025|FG006|Overall Study|Lost to Follow-up|8|||
125167357|NCT00673387|450236026|FG007|Overall Study|Lost to Follow-up|5|||
125167358|NCT00960115|450236029|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
125167359|NCT00960115|450236030|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
125167360|NCT04428333|450236031|FG000|Overall Study|Physician Decision|5|||
125167361|NCT04428333|450236032|FG001|Overall Study|Physician Decision|6|||
125167362|NCT04428333|450236031|FG000|Overall Study|Withdrawal by Subject|1|||
125167363|NCT04428333|450236032|FG001|Overall Study|Withdrawal by Subject|3|||
125167364|NCT04428333|450236031|FG000|Overall Study|Study Terminated By Sponsor|14|||
125167365|NCT04428333|450236032|FG001|Overall Study|Study Terminated By Sponsor|16|||
125167366|NCT02351960|450236033|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
125167367|NCT02351960|450236034|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
125167368|NCT02351960|450236033|FG000|Overall Study|Voluntary Withdrawal|5|||
125167369|NCT02351960|450236034|FG001|Overall Study|Voluntary Withdrawal|4|||
125167370|NCT02351960|450236033|FG000|Overall Study|Significant Protocol Deviation|0|||
125167371|NCT02351960|450236034|FG001|Overall Study|Significant Protocol Deviation|5|||
125167372|NCT00319982|450236035|FG000|Overall Study|Withdrawal by Subject|1|||
125167373|NCT00319982|450236036|FG001|Overall Study|Withdrawal by Subject|0|||
125167374|NCT01094886|450236037|FG000|Overall Study|Adverse Event|2|||
125167375|NCT01094886|450236037|FG000|Overall Study|Withdrawal by Subject|5|||
125167376|NCT03480386|450236038|FG000|Overall Study|Did not complete measures at 3-months|17|||
125167377|NCT03480386|450236039|FG001|Overall Study|Did not complete measures at 3-months|14|||
125167378|NCT03480386|450236038|FG000|Overall Study|No baseline measures|11|||
125167379|NCT03480386|450236039|FG001|Overall Study|No baseline measures|14|||
125167380|NCT03480386|450236038|FG000|Overall Study|Death|0|||
125167381|NCT03480386|450236039|FG001|Overall Study|Death|5|||
125167382|NCT03480386|450236038|FG000|Overall Study|Withdrawal by Subject|12|||
125167383|NCT03480386|450236039|FG001|Overall Study|Withdrawal by Subject|8|||
125167384|NCT03480386|450236038|FG000|Overall Study|Lost to Follow-up|2|||
125167385|NCT03480386|450236039|FG001|Overall Study|Lost to Follow-up|1|||
125167386|NCT03480386|450236038|FG000|Overall Study|Complicating disease|0|||
125167387|NCT03480386|450236039|FG001|Overall Study|Complicating disease|1|||
125167388|NCT03480386|450236038|FG000|Overall Study|Disease progression|3|||
125167389|NCT03480386|450236039|FG001|Overall Study|Disease progression|0|||
125167390|NCT03480386|450236038|FG000|Overall Study|Became ineligible|0|||
125167391|NCT03480386|450236039|FG001|Overall Study|Became ineligible|2|||
125167392|NCT04730349|450236041|FG000|Overall Study|Participant withdrew consent|1|||
125167393|NCT04730349|450236042|FG001|Overall Study|Participant withdrew consent|0|||
125167394|NCT04730349|450236041|FG000|Overall Study|Disease progression|6|||
125167395|NCT04730349|450236042|FG001|Overall Study|Disease progression|4|||
125167396|NCT04730349|450236041|FG000|Overall Study|Study drug toxicity|0|||
125167397|NCT04730349|450236042|FG001|Overall Study|Study drug toxicity|1|||
125167398|NCT02013674|450236048|FG000|Overall Study|Death|0|||
125167399|NCT02013674|450236049|FG001|Overall Study|Death|1|||
125167400|NCT02013674|450236048|FG000|Overall Study|Lost to Follow-up|1|||
125167401|NCT02013674|450236049|FG001|Overall Study|Lost to Follow-up|0|||
125167402|NCT00416884|450236051|FG000|Overall Study|Study terminated due to low accrual|1|||
125167403|NCT04051619|450236053|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
125167404|NCT04051619|450236054|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
125167405|NCT04051619|450236053|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
125167406|NCT04051619|450236054|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
125167407|NCT03610516|450237482|FG000|Treatment Epoch|Adverse Event|3|||
125167408|NCT03610516|450237483|FG001|Treatment Epoch|Adverse Event|1|||
125167409|NCT03610516|450237482|FG000|Treatment Epoch|Death|1|||
125167410|NCT03610516|450237483|FG001|Treatment Epoch|Death|0|||
125167411|NCT03610516|450237482|FG000|Treatment Epoch|Lack of Efficacy|0|||
125167412|NCT03610516|450237483|FG001|Treatment Epoch|Lack of Efficacy|1|||
125167413|NCT03610516|450237482|FG000|Treatment Epoch|No longer requires treatment|1|||
125167414|NCT03610516|450237483|FG001|Treatment Epoch|No longer requires treatment|0|||
125167415|NCT03610516|450237482|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
125167416|NCT03610516|450237483|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
125167417|NCT03610516|450237482|FG000|Treatment Epoch|Physician Decision|8|||
125167418|NCT03610516|450237483|FG001|Treatment Epoch|Physician Decision|5|||
125167419|NCT03610516|450237482|FG000|Treatment Epoch|Protocol Deviation|1|||
125167420|NCT03610516|450237483|FG001|Treatment Epoch|Protocol Deviation|0|||
125167421|NCT03610516|450237482|FG000|Treatment Epoch|Withdrawal by Subject|3|||
125167422|NCT03610516|450237483|FG001|Treatment Epoch|Withdrawal by Subject|1|||
125167423|NCT03610516|450237482|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
125167424|NCT03610516|450237483|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
125167425|NCT03610516|450237482|FG000|Post-Treatment Follow-up|Death|1|||
125167426|NCT03610516|450237483|FG001|Post-Treatment Follow-up|Death|0|||
125167427|NCT00660907|450237487|FG000|Overall Study|Incorrect Enrollment|1|||
125167428|NCT00660907|450237488|FG001|Overall Study|Incorrect Enrollment|1|||
125167429|NCT00660907|450237487|FG000|Overall Study|Adverse Event|33|||
125167430|NCT00660907|450237488|FG001|Overall Study|Adverse Event|19|||
125167431|NCT00660907|450237487|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
125167432|NCT00660907|450237488|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
125167433|NCT00660907|450237487|FG000|Overall Study|Withdrawal by Subject|23|||
125167434|NCT00660907|450237488|FG001|Overall Study|Withdrawal by Subject|32|||
125167435|NCT00660907|450237487|FG000|Overall Study|Lost to Follow-up|3|||
125167436|NCT00660907|450237488|FG001|Overall Study|Lost to Follow-up|3|||
125167437|NCT00660907|450237487|FG000|Overall Study|Poor/Non-Compliance|5|||
125167438|NCT00660907|450237488|FG001|Overall Study|Poor/Non-Compliance|1|||
125167439|NCT00660907|450237487|FG000|Overall Study|Safety|1|||
125167440|NCT00660907|450237488|FG001|Overall Study|Safety|0|||
125167441|NCT00660907|450237487|FG000|Overall Study|Death|1|||
125167442|NCT00660907|450237488|FG001|Overall Study|Death|3|||
125167443|NCT00660907|450237487|FG000|Overall Study|Various|11|||
125167444|NCT00660907|450237488|FG001|Overall Study|Various|8|||
125167445|NCT02932306|450237509|FG000|Overall Study|Withdrawal by Subject|16|||
125167446|NCT02932306|450237510|FG001|Overall Study|Withdrawal by Subject|25|||
125167447|NCT02932306|450237509|FG000|Overall Study|Adverse Event|3|||
125167448|NCT02932306|450237510|FG001|Overall Study|Adverse Event|0|||
125167449|NCT02932306|450237509|FG000|Overall Study|Pregnancy|2|||
125167450|NCT02932306|450237510|FG001|Overall Study|Pregnancy|0|||
125167451|NCT02932306|450237509|FG000|Overall Study|Protocol Violation|1|||
125167452|NCT02932306|450237510|FG001|Overall Study|Protocol Violation|1|||
125167453|NCT02932306|450237509|FG000|Overall Study|Noncompliance with Study Drug|1|||
125167454|NCT02932306|450237510|FG001|Overall Study|Noncompliance with Study Drug|1|||
125167455|NCT02932306|450237509|FG000|Overall Study|Lost to Follow-up|36|||
125167456|NCT02932306|450237510|FG001|Overall Study|Lost to Follow-up|40|||
125167457|NCT02932306|450237509|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
125167458|NCT02932306|450237510|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
125167459|NCT02932306|450237509|FG000|Overall Study|Lack of Efficacy|0|||
125167460|NCT02932306|450237510|FG001|Overall Study|Lack of Efficacy|2|||
125167461|NCT02932306|450237509|FG000|Overall Study|Worsening condition|2|||
125167462|NCT02932306|450237510|FG001|Overall Study|Worsening condition|0|||
125167463|NCT02932306|450237509|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
125167464|NCT02932306|450237510|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
125167465|NCT05776862|450237511|FG000|Overall Study|Adverse Event|0|||
125167466|NCT05776862|450237512|FG001|Overall Study|Adverse Event|1|||
125167467|NCT05776862|450237511|FG000|Overall Study|non-compliance|1|||
125167468|NCT05776862|450237512|FG001|Overall Study|non-compliance|0|||
125167469|NCT01199471|450237513|FG000|Overall Study|Protocol Violation|4|||
125167470|NCT01199471|450237513|FG000|Overall Study|Withdrawal by Subject|1|||
125167471|NCT01199471|450237513|FG000|Overall Study|Physician Decision|1|||
125167472|NCT02065700|450237514|FG000|Overall Study|Adverse Event|165|||
125167473|NCT02065700|450237515|FG001|Overall Study|Adverse Event|101|||
125167474|NCT02065700|450237514|FG000|Overall Study|Withdrawal by Subject|90|||
125167475|NCT02065700|450237515|FG001|Overall Study|Withdrawal by Subject|29|||
125167476|NCT02065700|450237514|FG000|Overall Study|Lost to Follow-up|12|||
125167477|NCT02065700|450237515|FG001|Overall Study|Lost to Follow-up|9|||
125167478|NCT02065700|450237514|FG000|Overall Study|Physician Decision|2|||
125167479|NCT02065700|450237515|FG001|Overall Study|Physician Decision|0|||
125167480|NCT02065700|450237514|FG000|Overall Study|Sponsor Request|38|||
125167481|NCT02065700|450237515|FG001|Overall Study|Sponsor Request|15|||
125167482|NCT02065700|450237514|FG000|Overall Study|Treatment Failure|3|||
125167483|NCT02065700|450237515|FG001|Overall Study|Treatment Failure|2|||
125167484|NCT02065700|450237514|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
125167485|NCT02065700|450237515|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
125167486|NCT02065700|450237514|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
125167487|NCT02065700|450237515|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
125167488|NCT02065700|450237514|FG000|Overall Study|Non-compliance with Study Procedures|2|||
125167489|NCT02065700|450237515|FG001|Overall Study|Non-compliance with Study Procedures|0|||
125167490|NCT02065700|450237514|FG000|Overall Study|Not Defined|21|||
125167491|NCT02065700|450237515|FG001|Overall Study|Not Defined|3|||
125167492|NCT01305044|450237520|FG000|Overall Study|Withdrawal by Subject|3|||
125167493|NCT01305044|450237521|FG001|Overall Study|Withdrawal by Subject|6|||
125167494|NCT02278055|450237525|FG000|Overall Study|Adverse Event|1|||
125167495|NCT02278055|450237525|FG000|Overall Study|Lost to Follow-up|1|||
125167496|NCT02278055|450237525|FG000|Overall Study|Withdrawal by Subject|2|||
125167497|NCT02278055|450237525|FG000|Overall Study|Progressive Disease|4|||
125167498|NCT03207243|450237526|FG000|Overall Study|Adverse Event|2|||
125167499|NCT03207243|450237527|FG001|Overall Study|Adverse Event|2|||
125167500|NCT03207243|450237526|FG000|Overall Study|Loss of Asthma Control|47|||
125167501|NCT03207243|450237527|FG001|Overall Study|Loss of Asthma Control|31|||
125167502|NCT03207243|450237526|FG000|Overall Study|Withdrawal by Subject|2|||
125167503|NCT03207243|450237527|FG001|Overall Study|Withdrawal by Subject|4|||
125167504|NCT03207243|450237526|FG000|Overall Study|Physician Decision|1|||
125167505|NCT03207243|450237527|FG001|Overall Study|Physician Decision|1|||
125167506|NCT03207243|450237526|FG000|Overall Study|Lost to Follow-up|0|||
125167507|NCT03207243|450237527|FG001|Overall Study|Lost to Follow-up|1|||
125167508|NCT03207243|450237526|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
125167509|NCT03207243|450237527|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
125167510|NCT03207243|450237526|FG000|Overall Study|Protocol Violation|0|||
125167511|NCT03207243|450237527|FG001|Overall Study|Protocol Violation|3|||
125167512|NCT04015908|450237528|FG000|Overall Study|Lost to Follow-up|0|||
125167513|NCT04015908|450237529|FG001|Overall Study|Lost to Follow-up|1|||
125167514|NCT04623086|450237530|FG000|Overall Study|Withdrawal by Subject|0|||
125167515|NCT04623086|450237531|FG001|Overall Study|Withdrawal by Subject|0|||
125167516|NCT04623086|450237532|FG002|Overall Study|Withdrawal by Subject|10|||
125167517|NCT00715624|450237533|FG000|Overall Study|Adverse Event|12|||
125167518|NCT00715624|450237534|FG001|Overall Study|Adverse Event|37|||
125167519|NCT00715624|450237533|FG000|Overall Study|Lack of Efficacy|11|||
125167520|NCT00715624|450237534|FG001|Overall Study|Lack of Efficacy|11|||
125167521|NCT00715624|450237533|FG000|Overall Study|Lost to Follow-up|1|||
125167522|NCT00715624|450237534|FG001|Overall Study|Lost to Follow-up|2|||
125167523|NCT00715624|450237533|FG000|Overall Study|Protocol Violation|1|||
125167524|NCT00715624|450237534|FG001|Overall Study|Protocol Violation|0|||
125167525|NCT00715624|450237533|FG000|Overall Study|Withdrawal by Subject|11|||
125167526|NCT00715624|450237534|FG001|Overall Study|Withdrawal by Subject|25|||
125167527|NCT00715624|450237533|FG000|Overall Study|Familial and personal reasons|10|||
125167528|NCT00715624|450237534|FG001|Overall Study|Familial and personal reasons|22|||
125167529|NCT00715624|450237533|FG000|Overall Study|Poor compliance|6|||
125167530|NCT00715624|450237534|FG001|Overall Study|Poor compliance|13|||
125167531|NCT00715624|450237533|FG000|Overall Study|Sponsor decision|0|||
125167532|NCT00715624|450237534|FG001|Overall Study|Sponsor decision|4|||
125167533|NCT00715624|450237533|FG000|Overall Study|Incorrect randomization (not treated)|0|||
125167534|NCT00715624|450237534|FG001|Overall Study|Incorrect randomization (not treated)|1|||
125167535|NCT00715624|450237533|FG000|Overall Study|Other|0|||
125167536|NCT00715624|450237534|FG001|Overall Study|Other|1|||
125167537|NCT00229723|450237535|FG000|Concomitant Phase|Adverse Event|4|||
125167538|NCT00229723|450237536|FG001|Concomitant Phase|Adverse Event|2|||
125167539|NCT00229723|450237537|FG002|Concomitant Phase|Adverse Event|5|||
125167540|NCT00229723|450237538|FG003|Concomitant Phase|Adverse Event|2|||
125167541|NCT00229723|450237539|FG004|Concomitant Phase|Adverse Event|0|||
125167542|NCT00229723|450237540|FG005|Concomitant Phase|Adverse Event|1|||
125167543|NCT00229723|450237541|FG006|Concomitant Phase|Adverse Event|2|||
125167544|NCT00229723|450237535|FG000|Concomitant Phase|Objective disease progression|0|||
125167545|NCT00229723|450237536|FG001|Concomitant Phase|Objective disease progression|0|||
125167546|NCT00229723|450237537|FG002|Concomitant Phase|Objective disease progression|0|||
125167547|NCT00229723|450237538|FG003|Concomitant Phase|Objective disease progression|0|||
125167548|NCT00229723|450237539|FG004|Concomitant Phase|Objective disease progression|0|||
125167549|NCT00229723|450237540|FG005|Concomitant Phase|Objective disease progression|0|||
125167550|NCT00229723|450237541|FG006|Concomitant Phase|Objective disease progression|0|||
125167551|NCT00229723|450237535|FG000|Concomitant Phase|Clinical progression|0|||
125167552|NCT00229723|450237536|FG001|Concomitant Phase|Clinical progression|0|||
125167553|NCT00229723|450237537|FG002|Concomitant Phase|Clinical progression|0|||
125167554|NCT00229723|450237538|FG003|Concomitant Phase|Clinical progression|0|||
125167555|NCT00229723|450237539|FG004|Concomitant Phase|Clinical progression|0|||
125167556|NCT00229723|450237540|FG005|Concomitant Phase|Clinical progression|0|||
125167557|NCT00229723|450237541|FG006|Concomitant Phase|Clinical progression|1|||
125167558|NCT00229723|450237535|FG000|Concomitant Phase|Lost to Follow-up|0|||
125167559|NCT00229723|450237536|FG001|Concomitant Phase|Lost to Follow-up|0|||
125167560|NCT00229723|450237537|FG002|Concomitant Phase|Lost to Follow-up|0|||
125167561|NCT00229723|450237538|FG003|Concomitant Phase|Lost to Follow-up|0|||
125167562|NCT00229723|450237539|FG004|Concomitant Phase|Lost to Follow-up|1|||
125167563|NCT00229723|450237540|FG005|Concomitant Phase|Lost to Follow-up|0|||
125167564|NCT00229723|450237541|FG006|Concomitant Phase|Lost to Follow-up|0|||
125167565|NCT00229723|450237535|FG000|Concomitant Phase|Informed consent withdrawn|3|||
125167566|NCT00229723|450237536|FG001|Concomitant Phase|Informed consent withdrawn|2|||
125167567|NCT00229723|450237537|FG002|Concomitant Phase|Informed consent withdrawn|0|||
125167568|NCT00229723|450237538|FG003|Concomitant Phase|Informed consent withdrawn|2|||
125167569|NCT00229723|450237539|FG004|Concomitant Phase|Informed consent withdrawn|0|||
125167570|NCT00229723|450237540|FG005|Concomitant Phase|Informed consent withdrawn|0|||
125167571|NCT00229723|450237541|FG006|Concomitant Phase|Informed consent withdrawn|0|||
125167572|NCT00229723|450237535|FG000|Concomitant Phase|Severe non-compliance|0|||
125167573|NCT00229723|450237536|FG001|Concomitant Phase|Severe non-compliance|1|||
125167574|NCT00229723|450237537|FG002|Concomitant Phase|Severe non-compliance|0|||
125167575|NCT00229723|450237538|FG003|Concomitant Phase|Severe non-compliance|0|||
125167576|NCT00229723|450237539|FG004|Concomitant Phase|Severe non-compliance|1|||
125227280|NCT02513550|450460221|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
125227281|NCT02513550|450460222|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
125227282|NCT02513550|450460223|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
125227283|NCT02513550|450460224|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
125227284|NCT02513550|450460225|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
125227285|NCT02513550|450460226|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
125227286|NCT02513550|450460221|FG000|Post-Treatment Follow-up Period|Death|0|||
125227287|NCT02513550|450460222|FG001|Post-Treatment Follow-up Period|Death|0|||
125227288|NCT02513550|450460223|FG002|Post-Treatment Follow-up Period|Death|1|||
125227289|NCT02513550|450460224|FG003|Post-Treatment Follow-up Period|Death|0|||
125227290|NCT02513550|450460225|FG004|Post-Treatment Follow-up Period|Death|0|||
125167577|NCT00229723|450237540|FG005|Concomitant Phase|Severe non-compliance|0|||
125167578|NCT00229723|450237541|FG006|Concomitant Phase|Severe non-compliance|0|||
125167579|NCT00229723|450237535|FG000|Concomitant Phase|Other|3|||
125167580|NCT00229723|450237536|FG001|Concomitant Phase|Other|0|||
125167581|NCT00229723|450237537|FG002|Concomitant Phase|Other|1|||
125167582|NCT00229723|450237538|FG003|Concomitant Phase|Other|1|||
125167583|NCT00229723|450237539|FG004|Concomitant Phase|Other|0|||
125167584|NCT00229723|450237540|FG005|Concomitant Phase|Other|2|||
125167585|NCT00229723|450237541|FG006|Concomitant Phase|Other|0|||
125167586|NCT00229723|450237535|FG000|Maintenance Phase|Adverse Event|7|||
125167587|NCT00229723|450237536|FG001|Maintenance Phase|Adverse Event|2|||
125167588|NCT00229723|450237537|FG002|Maintenance Phase|Adverse Event|1|||
125167589|NCT00229723|450237538|FG003|Maintenance Phase|Adverse Event|4|||
125167590|NCT00229723|450237539|FG004|Maintenance Phase|Adverse Event|7|||
125167591|NCT00229723|450237540|FG005|Maintenance Phase|Adverse Event|5|||
125167592|NCT00229723|450237541|FG006|Maintenance Phase|Adverse Event|2|||
125167593|NCT00229723|450237535|FG000|Maintenance Phase|Objective disease progression|5|||
125167594|NCT00229723|450237536|FG001|Maintenance Phase|Objective disease progression|5|||
125167595|NCT00229723|450237537|FG002|Maintenance Phase|Objective disease progression|3|||
125167596|NCT00229723|450237538|FG003|Maintenance Phase|Objective disease progression|6|||
125167597|NCT00229723|450237539|FG004|Maintenance Phase|Objective disease progression|2|||
125167598|NCT00229723|450237540|FG005|Maintenance Phase|Objective disease progression|9|||
125167599|NCT00229723|450237541|FG006|Maintenance Phase|Objective disease progression|5|||
125167600|NCT00229723|450237535|FG000|Maintenance Phase|Clinical progression|4|||
125167601|NCT00229723|450237536|FG001|Maintenance Phase|Clinical progression|1|||
125167602|NCT00229723|450237537|FG002|Maintenance Phase|Clinical progression|2|||
125167603|NCT00229723|450237538|FG003|Maintenance Phase|Clinical progression|2|||
125167604|NCT00229723|450237539|FG004|Maintenance Phase|Clinical progression|1|||
125167605|NCT00229723|450237540|FG005|Maintenance Phase|Clinical progression|1|||
125167606|NCT00229723|450237541|FG006|Maintenance Phase|Clinical progression|1|||
125167607|NCT00229723|450237535|FG000|Maintenance Phase|Lost to Follow-up|0|||
125167608|NCT00229723|450237536|FG001|Maintenance Phase|Lost to Follow-up|1|||
125167609|NCT00229723|450237537|FG002|Maintenance Phase|Lost to Follow-up|2|||
125167610|NCT00229723|450237538|FG003|Maintenance Phase|Lost to Follow-up|2|||
125167611|NCT00229723|450237539|FG004|Maintenance Phase|Lost to Follow-up|0|||
125167612|NCT00229723|450237540|FG005|Maintenance Phase|Lost to Follow-up|0|||
125167613|NCT00229723|450237541|FG006|Maintenance Phase|Lost to Follow-up|1|||
125167614|NCT00229723|450237535|FG000|Maintenance Phase|Informed consent withdrawn|1|||
125167615|NCT00229723|450237536|FG001|Maintenance Phase|Informed consent withdrawn|0|||
125167616|NCT00229723|450237537|FG002|Maintenance Phase|Informed consent withdrawn|0|||
125167617|NCT00229723|450237538|FG003|Maintenance Phase|Informed consent withdrawn|1|||
125167618|NCT00229723|450237539|FG004|Maintenance Phase|Informed consent withdrawn|1|||
125167619|NCT00229723|450237540|FG005|Maintenance Phase|Informed consent withdrawn|1|||
125167620|NCT00229723|450237541|FG006|Maintenance Phase|Informed consent withdrawn|0|||
125167621|NCT00229723|450237535|FG000|Maintenance Phase|Severe non-compliance|3|||
125167622|NCT00229723|450237536|FG001|Maintenance Phase|Severe non-compliance|1|||
125167623|NCT00229723|450237537|FG002|Maintenance Phase|Severe non-compliance|0|||
125167624|NCT00229723|450237538|FG003|Maintenance Phase|Severe non-compliance|0|||
125167625|NCT00229723|450237539|FG004|Maintenance Phase|Severe non-compliance|1|||
125167626|NCT00229723|450237540|FG005|Maintenance Phase|Severe non-compliance|0|||
125167627|NCT00229723|450237541|FG006|Maintenance Phase|Severe non-compliance|0|||
125167628|NCT00229723|450237535|FG000|Maintenance Phase|Other|5|||
125167629|NCT00229723|450237536|FG001|Maintenance Phase|Other|4|||
125167630|NCT00229723|450237537|FG002|Maintenance Phase|Other|1|||
125167631|NCT00229723|450237538|FG003|Maintenance Phase|Other|2|||
125167632|NCT00229723|450237539|FG004|Maintenance Phase|Other|3|||
125167633|NCT00229723|450237540|FG005|Maintenance Phase|Other|3|||
125167634|NCT00229723|450237541|FG006|Maintenance Phase|Other|1|||
125167635|NCT03421730|450237549|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167636|NCT03421730|450237550|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
125167637|NCT03421730|450237551|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167638|NCT03421730|450237552|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167639|NCT03421730|450237553|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167640|NCT03421730|450237554|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167641|NCT03421730|450237555|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167642|NCT03421730|450237556|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167643|NCT03421730|450237557|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167644|NCT03421730|450237558|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167645|NCT03421730|450237559|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167646|NCT03421730|450237560|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167647|NCT03421730|450237549|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125167648|NCT03421730|450237550|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125227291|NCT02513550|450460226|FG005|Post-Treatment Follow-up Period|Death|0|||
125227292|NCT02513550|450460221|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
125227293|NCT02513550|450460222|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
125227294|NCT02513550|450460223|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
125227295|NCT02513550|450460224|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
125227296|NCT02513550|450460225|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
125227297|NCT02513550|450460226|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
125227298|NCT02513550|450460221|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
125227299|NCT02513550|450460222|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
125227300|NCT02513550|450460223|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
125227301|NCT02513550|450460224|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
125227302|NCT02513550|450460225|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
125227303|NCT02513550|450460226|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
125227304|NCT02513550|450460221|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
125227305|NCT02513550|450460222|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
125227306|NCT02513550|450460223|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
125227307|NCT02513550|450460224|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
125227308|NCT02513550|450460225|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
125227309|NCT02513550|450460226|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
125227310|NCT02204917|450460228|FG000|Overall Study|Protocol Violation|1|||
125227311|NCT00749398|450460229|FG000|Overall Study|Lack of Efficacy|7|||
125227312|NCT00749398|450460229|FG000|Overall Study|Adverse Event|4|||
125227313|NCT00749398|450460229|FG000|Overall Study|Serious adverse event|11|||
125227314|NCT00749398|450460229|FG000|Overall Study|Withdrawal by Subject|17|||
125227315|NCT00749398|450460229|FG000|Overall Study|Lost to Follow-up|11|||
125227316|NCT00749398|450460229|FG000|Overall Study|Reason not specified|2|||
125227317|NCT00749398|450460229|FG000|Overall Study|Unknown reason|1|||
125227318|NCT02277028|450460233|FG000|Overall Study|Lost to Follow-up|1|||
125227319|NCT02277028|450460234|FG001|Overall Study|Lost to Follow-up|0|||
125227320|NCT02277028|450460233|FG000|Overall Study|Withdrawal by Subject|0|||
125227321|NCT02277028|450460234|FG001|Overall Study|Withdrawal by Subject|1|||
125227322|NCT05002972|450460235|FG000|Overall Study|Withdrawal by Subject|2|||
125227323|NCT02370511|450460239|FG000|Overall Study|Death|10|||
125227324|NCT02370511|450460240|FG001|Overall Study|Death|7|||
125227325|NCT02370511|450460241|FG002|Overall Study|Death|1|||
125227326|NCT02370511|450460239|FG000|Overall Study|Withdrawal by Subject|2|||
125227327|NCT02370511|450460240|FG001|Overall Study|Withdrawal by Subject|0|||
125227328|NCT02370511|450460241|FG002|Overall Study|Withdrawal by Subject|0|||
125227329|NCT02370511|450460239|FG000|Overall Study|Lost to Follow-up|0|||
125227330|NCT02370511|450460240|FG001|Overall Study|Lost to Follow-up|4|||
125227331|NCT02370511|450460241|FG002|Overall Study|Lost to Follow-up|0|||
125227332|NCT03882918|450460245|FG000|Overall Study|Study terminated by sponsor|98|||
125227333|NCT03882918|450460245|FG000|Overall Study|Protocol Violation|1|||
125227334|NCT03882918|450460245|FG000|Overall Study|Other|9|||
125227335|NCT03882918|450460245|FG000|Overall Study|Lack of Efficacy|14|||
125227336|NCT03882918|450460245|FG000|Overall Study|Adverse Event|13|||
125227337|NCT03882918|450460245|FG000|Overall Study|Withdrawal by Subject|5|||
125227338|NCT04350827|450460250|FG000|Overall Study|Lost to Follow-up|1|||
125227339|NCT04350827|450460251|FG001|Overall Study|Lost to Follow-up|2|||
125303063|NCT03100058|450736664|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
125303064|NCT03100058|450736665|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
125303065|NCT03100058|450736666|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
125303066|NCT03100058|450736667|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
125303067|NCT03100058|450736668|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
125303068|NCT03100058|450736669|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
125303069|NCT03100058|450736670|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
125303070|NCT03100058|450736671|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
125303071|NCT03100058|450736672|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
125303072|NCT03100058|450736673|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
125303073|NCT03100058|450736661|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
125303074|NCT03100058|450736662|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
125303075|NCT03100058|450736663|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
125303076|NCT03100058|450736664|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
125303077|NCT03100058|450736665|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
125303078|NCT03100058|450736666|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
125227340|NCT02357459|450462054|FG000|Overall Study|Adverse Event|0|||
125227341|NCT02357459|450462055|FG001|Overall Study|Adverse Event|1|||
125227342|NCT02357459|450462056|FG002|Overall Study|Adverse Event|1|||
125227343|NCT02357459|450462054|FG000|Overall Study|Withdrawal by Subject|5|||
125227344|NCT02357459|450462055|FG001|Overall Study|Withdrawal by Subject|3|||
125227345|NCT02357459|450462056|FG002|Overall Study|Withdrawal by Subject|3|||
125227346|NCT02357459|450462054|FG000|Overall Study|Physician Decision|0|||
125227347|NCT02357459|450462055|FG001|Overall Study|Physician Decision|2|||
125227348|NCT02357459|450462056|FG002|Overall Study|Physician Decision|0|||
125227349|NCT02357459|450462054|FG000|Overall Study|Protocol Violation|1|||
125227350|NCT02357459|450462055|FG001|Overall Study|Protocol Violation|1|||
125227351|NCT02357459|450462056|FG002|Overall Study|Protocol Violation|0|||
125227352|NCT02357459|450462054|FG000|Overall Study|Lost to Follow-up|1|||
125227353|NCT02357459|450462055|FG001|Overall Study|Lost to Follow-up|3|||
125227354|NCT02357459|450462056|FG002|Overall Study|Lost to Follow-up|0|||
125227355|NCT02357459|450462054|FG000|Overall Study|Lack of Efficacy|7|||
125227356|NCT02357459|450462055|FG001|Overall Study|Lack of Efficacy|4|||
125227357|NCT02357459|450462056|FG002|Overall Study|Lack of Efficacy|4|||
125227358|NCT02357459|450462054|FG000|Overall Study|Patient Relocated|2|||
125227359|NCT02357459|450462055|FG001|Overall Study|Patient Relocated|0|||
125227360|NCT02357459|450462056|FG002|Overall Study|Patient Relocated|0|||
125227361|NCT02357459|450462054|FG000|Overall Study|Instruction from PCP|1|||
125227362|NCT02357459|450462055|FG001|Overall Study|Instruction from PCP|0|||
125227363|NCT02357459|450462056|FG002|Overall Study|Instruction from PCP|0|||
125227364|NCT02357459|450462054|FG000|Overall Study|Incarceration|0|||
125227365|NCT02357459|450462055|FG001|Overall Study|Incarceration|0|||
125227366|NCT02357459|450462056|FG002|Overall Study|Incarceration|1|||
125227367|NCT02357459|450462054|FG000|Overall Study|Pre-planned Knee surgery|0|||
125227368|NCT02357459|450462055|FG001|Overall Study|Pre-planned Knee surgery|0|||
125227369|NCT02357459|450462056|FG002|Overall Study|Pre-planned Knee surgery|2|||
125227370|NCT02357459|450462054|FG000|Overall Study|Job Commitments|0|||
125227371|NCT02357459|450462055|FG001|Overall Study|Job Commitments|0|||
125227372|NCT02357459|450462056|FG002|Overall Study|Job Commitments|1|||
125227373|NCT02188160|450462057|FG000|Overall Study|Adverse Event|1|||
125227374|NCT02188160|450462058|FG001|Overall Study|Adverse Event|0|||
125227375|NCT02188160|450462057|FG000|Overall Study|Use of an excluded medication|0|||
125227376|NCT02188160|450462058|FG001|Overall Study|Use of an excluded medication|1|||
125227377|NCT01655901|450462061|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
125227378|NCT01655901|450462062|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
125227379|NCT01655901|450462063|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
125227380|NCT01655901|450462064|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
125227381|NCT01655901|450462065|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
125227382|NCT01655901|450462066|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
125227383|NCT03256578|450462069|FG000|Overall Study|Excluded Post Randomization|66|||
125227384|NCT03256578|450462070|FG001|Overall Study|Excluded Post Randomization|56|||
125227385|NCT02371616|450462071|FG000|Overall Study|Protocol Violation|2|||
125227386|NCT02371616|450462072|FG001|Overall Study|Protocol Violation|1|||
125227387|NCT02371616|450462071|FG000|Overall Study|Adverse Event|0|||
125227388|NCT02371616|450462072|FG001|Overall Study|Adverse Event|1|||
125227389|NCT02371616|450462071|FG000|Overall Study|Withdrawal of Consent|1|||
125227390|NCT02371616|450462072|FG001|Overall Study|Withdrawal of Consent|0|||
125227391|NCT02371616|450462071|FG000|Overall Study|Other (Not specified)|1|||
125227392|NCT02371616|450462072|FG001|Overall Study|Other (Not specified)|5|||
125227393|NCT00754741|450462073|FG000|Overall Study|Died or disenrolled|57|||
125227394|NCT00754741|450462074|FG001|Overall Study|Died or disenrolled|69|||
125227395|NCT00754741|450462075|FG002|Overall Study|Died or disenrolled|54|||
125227396|NCT00922636|450462076|FG000|Overall Study|Adverse Event|3|||
125227397|NCT00922636|450462077|FG001|Overall Study|Adverse Event|3|||
125227398|NCT00922636|450462078|FG002|Overall Study|Adverse Event|2|||
125227399|NCT00922636|450462079|FG003|Overall Study|Adverse Event|3|||
125227400|NCT00922636|450462080|FG004|Overall Study|Adverse Event|2|||
125227401|NCT00922636|450462076|FG000|Overall Study|Lack of Efficacy|1|||
125227402|NCT00922636|450462077|FG001|Overall Study|Lack of Efficacy|7|||
125227403|NCT00922636|450462078|FG002|Overall Study|Lack of Efficacy|3|||
125227404|NCT00922636|450462079|FG003|Overall Study|Lack of Efficacy|2|||
125227405|NCT00922636|450462080|FG004|Overall Study|Lack of Efficacy|4|||
125227406|NCT00922636|450462076|FG000|Overall Study|Sponsor Decision|0|||
125227407|NCT00922636|450462077|FG001|Overall Study|Sponsor Decision|0|||
125227408|NCT00922636|450462078|FG002|Overall Study|Sponsor Decision|2|||
125227409|NCT00922636|450462079|FG003|Overall Study|Sponsor Decision|0|||
125227410|NCT00922636|450462080|FG004|Overall Study|Sponsor Decision|0|||
125227411|NCT00922636|450462076|FG000|Overall Study|Withdrawal by Subject|0|||
125227412|NCT00922636|450462077|FG001|Overall Study|Withdrawal by Subject|0|||
125227413|NCT00922636|450462078|FG002|Overall Study|Withdrawal by Subject|5|||
125227414|NCT00922636|450462079|FG003|Overall Study|Withdrawal by Subject|2|||
125227415|NCT00922636|450462080|FG004|Overall Study|Withdrawal by Subject|4|||
125227416|NCT00922636|450462076|FG000|Overall Study|Protocol Violation|0|||
125227417|NCT00922636|450462077|FG001|Overall Study|Protocol Violation|0|||
125167649|NCT03421730|450237551|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125167650|NCT03421730|450237552|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125167651|NCT03421730|450237553|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
125167652|NCT03421730|450237554|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125167653|NCT03421730|450237555|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125167654|NCT03421730|450237556|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125167655|NCT03421730|450237557|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125167656|NCT03421730|450237558|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125167657|NCT03421730|450237559|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125167658|NCT03421730|450237560|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125167659|NCT03016975|450237567|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
125167660|NCT03016975|450237568|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
125167661|NCT03016975|450237569|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
125167662|NCT03016975|450237567|FG000|At 6 Months Follow-up|Death|2|||
125167663|NCT03016975|450237568|FG001|At 6 Months Follow-up|Death|0|||
125167664|NCT03016975|450237569|FG002|At 6 Months Follow-up|Death|0|||
125167665|NCT03016975|450237567|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
125167666|NCT03016975|450237568|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
125167667|NCT03016975|450237569|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
125167668|NCT03016975|450237567|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
125167669|NCT03016975|450237568|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
125167670|NCT03016975|450237569|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
125167671|NCT03016975|450237567|FG000|At 6 Months Follow-up|Aborted implant|1|||
125167672|NCT03016975|450237568|FG001|At 6 Months Follow-up|Aborted implant|0|||
125167673|NCT03016975|450237569|FG002|At 6 Months Follow-up|Aborted implant|0|||
125167674|NCT03016975|450237567|FG000|At 2 Year Follow-up|Death|1|||
125167675|NCT03016975|450237568|FG001|At 2 Year Follow-up|Death|0|||
125167676|NCT03016975|450237569|FG002|At 2 Year Follow-up|Death|0|||
125167677|NCT03016975|450237567|FG000|At 3 Year Follow-up|Death|1|||
125167678|NCT03016975|450237568|FG001|At 3 Year Follow-up|Death|0|||
125167679|NCT03016975|450237569|FG002|At 3 Year Follow-up|Death|0|||
125167680|NCT03016975|450237567|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
125167681|NCT03016975|450237568|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
125167682|NCT03016975|450237569|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
125167683|NCT03016975|450237567|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
125167684|NCT03016975|450237568|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
125167685|NCT03016975|450237569|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
125167686|NCT01590797|450237570|FG000|Overall Study|Adverse Event|4|||
125167687|NCT01590797|450237571|FG001|Overall Study|Adverse Event|3|||
125167688|NCT01590797|450237570|FG000|Overall Study|Lack of Efficacy|0|||
125167689|NCT01590797|450237571|FG001|Overall Study|Lack of Efficacy|2|||
125167690|NCT01590797|450237570|FG000|Overall Study|Lost to Follow-up|0|||
125167691|NCT01590797|450237571|FG001|Overall Study|Lost to Follow-up|1|||
125167692|NCT01590797|450237570|FG000|Overall Study|Protocol Violation|4|||
125167693|NCT01590797|450237571|FG001|Overall Study|Protocol Violation|1|||
125167694|NCT01590797|450237570|FG000|Overall Study|Withdrawal by Subject|7|||
125167695|NCT01590797|450237571|FG001|Overall Study|Withdrawal by Subject|5|||
125167696|NCT01590797|450237570|FG000|Overall Study|Other Protocol Specified Criteria|2|||
125167697|NCT01590797|450237571|FG001|Overall Study|Other Protocol Specified Criteria|4|||
125167698|NCT02901548|450237572|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
125167699|NCT01696279|450237578|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
125167700|NCT01696279|450237579|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
125167701|NCT01696279|450237580|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
125167702|NCT01696279|450237581|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
125167703|NCT01696279|450237578|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
125167704|NCT01696279|450237579|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
125167705|NCT01696279|450237580|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
125167706|NCT01696279|450237581|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
125167707|NCT01696279|450237578|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
125167708|NCT01696279|450237579|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
125167709|NCT01696279|450237580|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
125167710|NCT01696279|450237581|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
125167711|NCT01696279|450237578|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
125167712|NCT01696279|450237579|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
125167713|NCT01696279|450237580|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
125167714|NCT01696279|450237581|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
125167715|NCT01696279|450237578|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
125167716|NCT01696279|450237579|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
125167717|NCT01696279|450237580|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
125227418|NCT00922636|450462078|FG002|Overall Study|Protocol Violation|2|||
125227419|NCT00922636|450462079|FG003|Overall Study|Protocol Violation|2|||
125227420|NCT00922636|450462080|FG004|Overall Study|Protocol Violation|0|||
125227421|NCT00922636|450462076|FG000|Overall Study|Entry Criteria Not Met|0|||
125227422|NCT00922636|450462077|FG001|Overall Study|Entry Criteria Not Met|0|||
125227423|NCT00922636|450462078|FG002|Overall Study|Entry Criteria Not Met|1|||
125227424|NCT00922636|450462079|FG003|Overall Study|Entry Criteria Not Met|1|||
125227425|NCT00922636|450462080|FG004|Overall Study|Entry Criteria Not Met|0|||
125227426|NCT00922636|450462076|FG000|Overall Study|Parent/Caregiver Decision|2|||
125227427|NCT00922636|450462077|FG001|Overall Study|Parent/Caregiver Decision|4|||
125227428|NCT00922636|450462078|FG002|Overall Study|Parent/Caregiver Decision|3|||
125227429|NCT00922636|450462079|FG003|Overall Study|Parent/Caregiver Decision|5|||
125227430|NCT00922636|450462080|FG004|Overall Study|Parent/Caregiver Decision|2|||
125227431|NCT00922636|450462076|FG000|Overall Study|Lost to Follow-up|1|||
125227432|NCT00922636|450462077|FG001|Overall Study|Lost to Follow-up|2|||
125227433|NCT00922636|450462078|FG002|Overall Study|Lost to Follow-up|2|||
125227434|NCT00922636|450462079|FG003|Overall Study|Lost to Follow-up|2|||
125227435|NCT00922636|450462080|FG004|Overall Study|Lost to Follow-up|4|||
125227436|NCT01251952|450462081|FG000|Overall Study|Adverse Event|1|||
125227437|NCT03028142|450462082|FG000|Overall Study|Adverse Event|1|||
125227438|NCT03028142|450462083|FG001|Overall Study|Adverse Event|1|||
125227439|NCT03028142|450462084|FG002|Overall Study|Adverse Event|0|||
125227440|NCT03028142|450462085|FG003|Overall Study|Adverse Event|0|||
125227441|NCT03028142|450462086|FG004|Overall Study|Adverse Event|0|||
125227442|NCT03028142|450462087|FG005|Overall Study|Adverse Event|1|||
125227443|NCT03028142|450462082|FG000|Overall Study|Withdrawal by Subject|0|||
125227444|NCT03028142|450462083|FG001|Overall Study|Withdrawal by Subject|0|||
125227445|NCT03028142|450462084|FG002|Overall Study|Withdrawal by Subject|0|||
125227446|NCT03028142|450462085|FG003|Overall Study|Withdrawal by Subject|0|||
125227447|NCT03028142|450462086|FG004|Overall Study|Withdrawal by Subject|1|||
125227448|NCT03028142|450462087|FG005|Overall Study|Withdrawal by Subject|0|||
125227449|NCT02810418|450462088|FG000|Arm A Dose Escalation|Adverse Event|2|||
125227450|NCT02810418|450462089|FG001|Arm A Dose Escalation|Adverse Event|1|||
125227451|NCT02810418|450462090|FG002|Arm A Dose Escalation|Adverse Event|0|||
125227452|NCT02810418|450462091|FG003|Arm A Dose Escalation|Adverse Event|0|||
125227453|NCT02810418|450462092|FG004|Arm A Dose Escalation|Adverse Event|0|||
125227454|NCT02810418|450462093|FG005|Arm A Dose Escalation|Adverse Event|0|||
125227455|NCT02810418|450462094|FG006|Arm A Dose Escalation|Adverse Event|0|||
125227456|NCT02810418|450462088|FG000|Dose Expansion|Adverse Event|0|||
125227457|NCT02810418|450462089|FG001|Dose Expansion|Adverse Event|1|||
125227458|NCT02810418|450462090|FG002|Dose Expansion|Adverse Event|1|||
125227459|NCT02810418|450462091|FG003|Dose Expansion|Adverse Event|0|||
125227460|NCT02810418|450462092|FG004|Dose Expansion|Adverse Event|0|||
125227461|NCT02810418|450462093|FG005|Dose Expansion|Adverse Event|0|||
125227462|NCT02810418|450462094|FG006|Dose Expansion|Adverse Event|0|||
125227463|NCT02810418|450462088|FG000|Dose Expansion|Physician Decision|0|||
125227464|NCT02810418|450462089|FG001|Dose Expansion|Physician Decision|0|||
125227465|NCT02810418|450462090|FG002|Dose Expansion|Physician Decision|2|||
125227466|NCT02810418|450462091|FG003|Dose Expansion|Physician Decision|0|||
125227467|NCT02810418|450462092|FG004|Dose Expansion|Physician Decision|0|||
125227468|NCT02810418|450462093|FG005|Dose Expansion|Physician Decision|0|||
125227469|NCT02810418|450462094|FG006|Dose Expansion|Physician Decision|0|||
125227470|NCT02810418|450462088|FG000|Arm B Dose Escalation|Adverse Event|0|||
125227471|NCT02810418|450462089|FG001|Arm B Dose Escalation|Adverse Event|0|||
125227472|NCT02810418|450462090|FG002|Arm B Dose Escalation|Adverse Event|0|||
125227473|NCT02810418|450462091|FG003|Arm B Dose Escalation|Adverse Event|0|||
125227474|NCT02810418|450462092|FG004|Arm B Dose Escalation|Adverse Event|1|||
125227475|NCT02810418|450462093|FG005|Arm B Dose Escalation|Adverse Event|2|||
125227476|NCT02810418|450462094|FG006|Arm B Dose Escalation|Adverse Event|0|||
125167718|NCT01696279|450237581|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
125167719|NCT01696279|450237578|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
125167720|NCT01696279|450237579|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
125167721|NCT01696279|450237580|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
125167722|NCT01696279|450237581|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
125167723|NCT01696279|450237578|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
125167724|NCT01696279|450237579|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
125167725|NCT01696279|450237580|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
125227477|NCT02224625|450462095|FG000|Irritation|Adverse Event|6|||
125227478|NCT02224625|450462095|FG000|Sensitization|Adverse Event|55|||
125227479|NCT01573000|450462098|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
125227480|NCT01573000|450462099|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
125227481|NCT01573000|450462098|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
125227482|NCT01573000|450462099|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
125227483|NCT01573000|450462098|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
125227484|NCT01573000|450462099|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
125167726|NCT01696279|450237581|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
125167727|NCT01696279|450237578|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
125167728|NCT01696279|450237579|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
125167729|NCT01696279|450237580|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
125167730|NCT01696279|450237581|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
125167731|NCT01696279|450237578|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
125167732|NCT01696279|450237579|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
125167733|NCT01696279|450237580|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
125167734|NCT01696279|450237581|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
125167735|NCT01696279|450237578|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
125167736|NCT01696279|450237579|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
125167737|NCT01696279|450237580|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
125167738|NCT01696279|450237581|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
125167739|NCT01696279|450237578|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
125167740|NCT01696279|450237579|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
125167741|NCT01696279|450237580|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
125167742|NCT01696279|450237581|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
125167743|NCT04106661|450237586|FG000|Overall Study|Protocol Violation|3|||
125167744|NCT04106661|450237587|FG001|Overall Study|Protocol Violation|0|||
125167745|NCT04106661|450237586|FG000|Overall Study|Scheduling difficulties|1|||
125167746|NCT04106661|450237587|FG001|Overall Study|Scheduling difficulties|1|||
125167747|NCT03503864|450237588|FG000|Overall Study|Protocol Violation|6|||
125167748|NCT03503864|450237588|FG000|Overall Study|Withdrawal by Subject|7|||
125167749|NCT02639052|450237590|FG000|Overall Study|Lost to Follow-up|1|||
125167750|NCT02730351|450237591|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
125167751|NCT02730351|450237592|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
125167752|NCT02730351|450237591|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
125167753|NCT02730351|450237592|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
125167754|NCT02730351|450237591|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
125167755|NCT02730351|450237592|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
125167756|NCT02730351|450237591|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
125167757|NCT02730351|450237592|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
125167758|NCT02730351|450237591|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
125167759|NCT02730351|450237592|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
125167760|NCT00838435|450237593|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
125167761|NCT00838435|450237593|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
125167762|NCT00838435|450237593|FG000|Part 2 (7 Years)|Adverse Event|2|||
125167763|NCT00838435|450237593|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
125167764|NCT00838435|450237593|FG000|Part 2 (7 Years)|Physician Decision|1|||
125167765|NCT00838435|450237593|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
125167766|NCT00838435|450237593|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
125167767|NCT03796039|450237595|FG000|Overall Study|Death|2|||
125167768|NCT03796039|450237596|FG001|Overall Study|Death|1|||
125167769|NCT03796039|450237595|FG000|Overall Study|Withdrawal by Subject|7|||
125167770|NCT03796039|450237596|FG001|Overall Study|Withdrawal by Subject|4|||
125167771|NCT00530218|450237597|FG000|Overall Study|CMV Not Detected|13|||
125167772|NCT00530218|450237597|FG000|Overall Study|Death|12|||
125167773|NCT02774642|450237600|FG000|Overall Study|Lost to Follow-up|9|||
125167774|NCT02774642|450237601|FG001|Overall Study|Lost to Follow-up|7|||
125167775|NCT01144715|450237602|FG000|Overall Study|Lost to Follow-up|2|||
125167776|NCT01144715|450237603|FG001|Overall Study|Lost to Follow-up|1|||
125167777|NCT01144715|450237602|FG000|Overall Study|Withdrawal by Subject|2|||
125167778|NCT01144715|450237603|FG001|Overall Study|Withdrawal by Subject|1|||
125167779|NCT01144715|450237602|FG000|Overall Study|Adverse Event|0|||
125167780|NCT01144715|450237603|FG001|Overall Study|Adverse Event|1|||
125167781|NCT02011386|450237604|FG000|Overall Study|Non-compliance|2|||
125167782|NCT02011386|450237604|FG000|Overall Study|Lack of Efficacy|3|||
125167783|NCT03255655|450237605|FG000|Overall Study|Lost to Follow-up|7|||
125167784|NCT03255655|450237606|FG001|Overall Study|Lost to Follow-up|4|||
125167785|NCT03365011|450237607|FG000|Overall Study|Withdrawal by Subject|1|||
125167786|NCT03365011|450237608|FG001|Overall Study|Withdrawal by Subject|2|||
125167787|NCT04853992|450237609|FG000|Treatment Period A|Adverse Event|0|||
125167788|NCT04853992|450237610|FG001|Treatment Period A|Adverse Event|1|||
125167789|NCT04853992|450237609|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
125167790|NCT04853992|450237610|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
125167791|NCT03582826|450237611|FG000|Overall Study|Lost to Follow-up|39|||
125167792|NCT03582826|450237612|FG001|Overall Study|Lost to Follow-up|0|||
125167793|NCT03582826|450237611|FG000|Overall Study|Withdrawal by Subject|2|||
125167794|NCT03582826|450237612|FG001|Overall Study|Withdrawal by Subject|0|||
125167795|NCT02099682|450237616|FG000|Overall Study|Data Not Available|51|||
125167796|NCT02099682|450237616|FG000|Overall Study|Lost to Follow-up|31|||
125227485|NCT01573000|450462098|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
125167797|NCT02099682|450237616|FG000|Overall Study|Other|29|||
125167798|NCT02342639|450237617|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
125167799|NCT02342639|450237618|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
125167800|NCT02342639|450237617|FG000|Overall Study|Protocol Violation|0|||
125167801|NCT02342639|450237618|FG001|Overall Study|Protocol Violation|2|||
125167802|NCT02212379|450237619|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
125167803|NCT02212379|450237619|FG000|From Baseline to Week 48|Adverse Event|7|||
125167804|NCT02212379|450237619|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
125167805|NCT02212379|450237619|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
125167806|NCT02212379|450237619|FG000|From Week 48 to Week 96|Adverse Event|1|||
125167807|NCT02212379|450237619|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
125167808|NCT02105974|450237620|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
125167809|NCT02105974|450237621|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
125167810|NCT02105974|450237622|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
125167811|NCT02105974|450237620|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
125167812|NCT02105974|450237621|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
125167813|NCT02105974|450237622|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
125167814|NCT02105974|450237620|FG000|2 Week Run-in Period|Adverse Event|6|||
125167815|NCT02105974|450237621|FG001|2 Week Run-in Period|Adverse Event|0|||
125167816|NCT02105974|450237622|FG002|2 Week Run-in Period|Adverse Event|0|||
125167817|NCT02105974|450237620|FG000|2 Week Run-in Period|Study closed/terminated|1|||
125167818|NCT02105974|450237621|FG001|2 Week Run-in Period|Study closed/terminated|0|||
125167819|NCT02105974|450237622|FG002|2 Week Run-in Period|Study closed/terminated|0|||
125167820|NCT02105974|450237620|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
125167821|NCT02105974|450237621|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
125167822|NCT02105974|450237622|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
125167823|NCT02105974|450237620|FG000|2 Week Run-in Period|Withdrew consent|23|||
125167824|NCT02105974|450237621|FG001|2 Week Run-in Period|Withdrew consent|0|||
125167825|NCT02105974|450237622|FG002|2 Week Run-in Period|Withdrew consent|0|||
125167826|NCT02105974|450237620|FG000|2 Week Run-in Period|Investigator discretion|8|||
125227486|NCT01573000|450462099|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
125227487|NCT01573000|450462098|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
125167827|NCT02105974|450237621|FG001|2 Week Run-in Period|Investigator discretion|0|||
125167828|NCT02105974|450237622|FG002|2 Week Run-in Period|Investigator discretion|0|||
125167829|NCT02105974|450237620|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
125167830|NCT02105974|450237621|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
125167831|NCT02105974|450237622|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
125167832|NCT02105974|450237620|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
125167833|NCT02105974|450237621|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
125167834|NCT02105974|450237622|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
125167835|NCT02105974|450237620|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
125167836|NCT02105974|450237621|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
125167837|NCT02105974|450237622|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
125167838|NCT02105974|450237620|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
125167839|NCT02105974|450237621|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
125167840|NCT02105974|450237622|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
125167841|NCT02105974|450237620|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
125167842|NCT02105974|450237621|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
125167843|NCT02105974|450237622|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
125167844|NCT02105974|450237620|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
125167845|NCT02105974|450237621|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
125167846|NCT02105974|450237622|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
125167847|NCT02105974|450237620|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
125167848|NCT02105974|450237621|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
125167849|NCT02105974|450237622|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
125167850|NCT03155945|450237623|FG000|Overall Study|Lost to Follow-up|0|||
125167851|NCT03155945|450237624|FG001|Overall Study|Lost to Follow-up|1|||
125167852|NCT03155945|450237623|FG000|Overall Study|Withdrawal by Subject|0|||
125167853|NCT03155945|450237624|FG001|Overall Study|Withdrawal by Subject|1|||
125167854|NCT03155945|450237623|FG000|Overall Study|Other Reason|0|||
125167855|NCT03155945|450237624|FG001|Overall Study|Other Reason|1|||
125167856|NCT02203331|450237625|FG000|Overall Study|Pregnancy|1|||
125167857|NCT02203331|450237626|FG001|Overall Study|Pregnancy|0|||
125167858|NCT02203331|450237627|FG002|Overall Study|Pregnancy|0|||
125167859|NCT02203331|450237628|FG003|Overall Study|Pregnancy|0|||
125167860|NCT02203331|450237629|FG004|Overall Study|Pregnancy|2|||
125167861|NCT02203331|450237630|FG005|Overall Study|Pregnancy|0|||
125167862|NCT02203331|450237625|FG000|Overall Study|Withdrawal by Subject|1|||
125167863|NCT02203331|450237626|FG001|Overall Study|Withdrawal by Subject|0|||
125167864|NCT02203331|450237627|FG002|Overall Study|Withdrawal by Subject|1|||
125167865|NCT02203331|450237628|FG003|Overall Study|Withdrawal by Subject|0|||
125167866|NCT02203331|450237629|FG004|Overall Study|Withdrawal by Subject|0|||
125167867|NCT02203331|450237630|FG005|Overall Study|Withdrawal by Subject|3|||
125167868|NCT02203331|450237625|FG000|Overall Study|Adverse Event|4|||
125167869|NCT02203331|450237626|FG001|Overall Study|Adverse Event|8|||
125167870|NCT02203331|450237627|FG002|Overall Study|Adverse Event|3|||
125167871|NCT02203331|450237628|FG003|Overall Study|Adverse Event|4|||
125167872|NCT02203331|450237629|FG004|Overall Study|Adverse Event|3|||
125167873|NCT02203331|450237630|FG005|Overall Study|Adverse Event|3|||
125167874|NCT02203331|450237625|FG000|Overall Study|Other Reasons|1|||
125167875|NCT02203331|450237626|FG001|Overall Study|Other Reasons|2|||
125167876|NCT02203331|450237627|FG002|Overall Study|Other Reasons|0|||
125167877|NCT02203331|450237628|FG003|Overall Study|Other Reasons|2|||
125167878|NCT02203331|450237629|FG004|Overall Study|Other Reasons|0|||
125167879|NCT02203331|450237630|FG005|Overall Study|Other Reasons|0|||
125167880|NCT02203331|450237625|FG000|Overall Study|Lack of Efficacy|0|||
125167881|NCT02203331|450237626|FG001|Overall Study|Lack of Efficacy|2|||
125167882|NCT02203331|450237627|FG002|Overall Study|Lack of Efficacy|1|||
125167883|NCT02203331|450237628|FG003|Overall Study|Lack of Efficacy|0|||
125167884|NCT02203331|450237629|FG004|Overall Study|Lack of Efficacy|0|||
125227488|NCT01573000|450462099|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
125227489|NCT01573000|450462098|FG000|Crossover Phase|Lack of Efficacy|0|||
125227490|NCT01573000|450462099|FG001|Crossover Phase|Lack of Efficacy|13|||
125227491|NCT01573000|450462098|FG000|Crossover Phase|Lost to Follow-up|0|||
125227492|NCT01573000|450462099|FG001|Crossover Phase|Lost to Follow-up|2|||
125167885|NCT02203331|450237630|FG005|Overall Study|Lack of Efficacy|1|||
125227493|NCT01573000|450462098|FG000|Crossover Phase|Death|0|||
125167886|NCT02203331|450237625|FG000|Overall Study|Protocol Violation|0|||
125167887|NCT02203331|450237626|FG001|Overall Study|Protocol Violation|2|||
125167888|NCT02203331|450237627|FG002|Overall Study|Protocol Violation|0|||
125167889|NCT02203331|450237628|FG003|Overall Study|Protocol Violation|1|||
125167890|NCT02203331|450237629|FG004|Overall Study|Protocol Violation|1|||
125167891|NCT02203331|450237630|FG005|Overall Study|Protocol Violation|0|||
125167892|NCT02203331|450237625|FG000|Overall Study|Lost to Follow-up|0|||
125167893|NCT02203331|450237626|FG001|Overall Study|Lost to Follow-up|0|||
125167894|NCT02203331|450237627|FG002|Overall Study|Lost to Follow-up|0|||
125167895|NCT02203331|450237628|FG003|Overall Study|Lost to Follow-up|0|||
125167896|NCT02203331|450237629|FG004|Overall Study|Lost to Follow-up|1|||
125167897|NCT02203331|450237630|FG005|Overall Study|Lost to Follow-up|0|||
125167898|NCT05065567|450237636|FG000|Overall Study|Lost to Follow-up|10|||
125167899|NCT05065567|450237637|FG001|Overall Study|Lost to Follow-up|9|||
125167900|NCT05065567|450237638|FG002|Overall Study|Lost to Follow-up|6|||
125167901|NCT04975191|450238979|FG000|Overall Study|Protocol Violation|1|||
125167902|NCT04975191|450238980|FG001|Overall Study|Protocol Violation|2|||
125167903|NCT04975191|450238981|FG002|Overall Study|Protocol Violation|2|||
125167904|NCT04975191|450238982|FG003|Overall Study|Protocol Violation|2|||
125167905|NCT04975191|450238979|FG000|Overall Study|Lost to Follow-up|13|||
125167906|NCT04975191|450238980|FG001|Overall Study|Lost to Follow-up|3|||
125167907|NCT04975191|450238981|FG002|Overall Study|Lost to Follow-up|8|||
125167908|NCT04975191|450238982|FG003|Overall Study|Lost to Follow-up|8|||
125167909|NCT01056289|450238983|FG000|Open-label Phase|Adverse Event|29|||
125167910|NCT01056289|450238984|FG001|Open-label Phase|Adverse Event|0|||
125167911|NCT01056289|450238985|FG002|Open-label Phase|Adverse Event|0|||
125167912|NCT01056289|450238986|FG003|Open-label Phase|Adverse Event|0|||
125167913|NCT01056289|450238983|FG000|Open-label Phase|Lost to Follow-up|30|||
125167914|NCT01056289|450238984|FG001|Open-label Phase|Lost to Follow-up|0|||
125167915|NCT01056289|450238985|FG002|Open-label Phase|Lost to Follow-up|0|||
125167916|NCT01056289|450238986|FG003|Open-label Phase|Lost to Follow-up|0|||
125167917|NCT01056289|450238983|FG000|Open-label Phase|Other|9|||
125167918|NCT01056289|450238984|FG001|Open-label Phase|Other|0|||
125167919|NCT01056289|450238985|FG002|Open-label Phase|Other|0|||
125167920|NCT01056289|450238986|FG003|Open-label Phase|Other|0|||
125167921|NCT01056289|450238983|FG000|Open-label Phase|Protocol Violation|6|||
125167922|NCT01056289|450238984|FG001|Open-label Phase|Protocol Violation|0|||
125167923|NCT01056289|450238985|FG002|Open-label Phase|Protocol Violation|0|||
125167924|NCT01056289|450238986|FG003|Open-label Phase|Protocol Violation|0|||
125167925|NCT01056289|450238983|FG000|Open-label Phase|Withdrawal by Subject|26|||
125167926|NCT01056289|450238984|FG001|Open-label Phase|Withdrawal by Subject|0|||
125167927|NCT01056289|450238985|FG002|Open-label Phase|Withdrawal by Subject|0|||
125167928|NCT01056289|450238986|FG003|Open-label Phase|Withdrawal by Subject|0|||
125167929|NCT01056289|450238983|FG000|Open-label Phase|Lack of Efficacy|18|||
125167930|NCT01056289|450238984|FG001|Open-label Phase|Lack of Efficacy|0|||
125167931|NCT01056289|450238985|FG002|Open-label Phase|Lack of Efficacy|0|||
125167932|NCT01056289|450238986|FG003|Open-label Phase|Lack of Efficacy|0|||
125167933|NCT01056289|450238983|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
125167934|NCT01056289|450238984|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
125167935|NCT01056289|450238985|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
125167936|NCT01056289|450238986|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
125167937|NCT01056289|450238983|FG000|Double-blind Phase|Adverse Event|0|||
125167938|NCT01056289|450238984|FG001|Double-blind Phase|Adverse Event|1|||
125167939|NCT01056289|450238985|FG002|Double-blind Phase|Adverse Event|2|||
125167940|NCT01056289|450238986|FG003|Double-blind Phase|Adverse Event|1|||
125167941|NCT01056289|450238983|FG000|Double-blind Phase|Lost to Follow-up|0|||
125167942|NCT01056289|450238984|FG001|Double-blind Phase|Lost to Follow-up|2|||
125227494|NCT01573000|450462099|FG001|Crossover Phase|Death|3|||
125167943|NCT01056289|450238985|FG002|Double-blind Phase|Lost to Follow-up|2|||
125167944|NCT01056289|450238986|FG003|Double-blind Phase|Lost to Follow-up|2|||
125167945|NCT01056289|450238983|FG000|Double-blind Phase|Other|0|||
125167946|NCT01056289|450238984|FG001|Double-blind Phase|Other|0|||
125167947|NCT01056289|450238985|FG002|Double-blind Phase|Other|1|||
125167948|NCT01056289|450238986|FG003|Double-blind Phase|Other|2|||
125167949|NCT01056289|450238983|FG000|Double-blind Phase|Protocol Violation|0|||
125167950|NCT01056289|450238984|FG001|Double-blind Phase|Protocol Violation|0|||
125167951|NCT01056289|450238985|FG002|Double-blind Phase|Protocol Violation|1|||
125167952|NCT01056289|450238986|FG003|Double-blind Phase|Protocol Violation|1|||
125167953|NCT01056289|450238983|FG000|Double-blind Phase|Withdrawal by Subject|0|||
125167954|NCT01056289|450238984|FG001|Double-blind Phase|Withdrawal by Subject|0|||
125167955|NCT01056289|450238985|FG002|Double-blind Phase|Withdrawal by Subject|4|||
125227495|NCT01573000|450462098|FG000|Long-Term Follow-Up|Death|3|||
125227496|NCT01573000|450462099|FG001|Long-Term Follow-Up|Death|0|||
125167956|NCT01056289|450238986|FG003|Double-blind Phase|Withdrawal by Subject|2|||
125167957|NCT01056289|450238983|FG000|Double-blind Phase|Discontinuation symptom|0|||
125167958|NCT01056289|450238984|FG001|Double-blind Phase|Discontinuation symptom|1|||
125167959|NCT01056289|450238985|FG002|Double-blind Phase|Discontinuation symptom|2|||
125167960|NCT01056289|450238986|FG003|Double-blind Phase|Discontinuation symptom|2|||
125167961|NCT01056289|450238983|FG000|Double-blind Phase|Physician Decision|0|||
125167962|NCT01056289|450238984|FG001|Double-blind Phase|Physician Decision|0|||
125167963|NCT01056289|450238985|FG002|Double-blind Phase|Physician Decision|1|||
125167964|NCT01056289|450238986|FG003|Double-blind Phase|Physician Decision|0|||
125167965|NCT02618759|450238996|FG000|Overall Study|Lost to Follow-up|0|||
125167966|NCT02618759|450238997|FG001|Overall Study|Lost to Follow-up|1|||
125167967|NCT02618759|450238996|FG000|Overall Study|Withdrawal by Subject|1|||
125167968|NCT02618759|450238997|FG001|Overall Study|Withdrawal by Subject|0|||
125167969|NCT02618759|450238996|FG000|Overall Study|Other Reasons|1|||
125167970|NCT02618759|450238997|FG001|Overall Study|Other Reasons|4|||
125167971|NCT02856555|450239000|FG000|Overall Study|Adverse Event|1|||
125167972|NCT02856555|450239001|FG001|Overall Study|Adverse Event|0|||
125167973|NCT02856555|450239002|FG002|Overall Study|Adverse Event|0|||
125167974|NCT02856555|450239000|FG000|Overall Study|Lost to Follow-up|1|||
125167975|NCT02856555|450239001|FG001|Overall Study|Lost to Follow-up|3|||
125167976|NCT02856555|450239002|FG002|Overall Study|Lost to Follow-up|0|||
125167977|NCT02856555|450239000|FG000|Overall Study|Withdrawal by Subject|3|||
125167978|NCT02856555|450239001|FG001|Overall Study|Withdrawal by Subject|0|||
125167979|NCT02856555|450239002|FG002|Overall Study|Withdrawal by Subject|0|||
125167980|NCT02856555|450239000|FG000|Overall Study|Randomized but Never Treated|0|||
125167981|NCT02856555|450239001|FG001|Overall Study|Randomized but Never Treated|1|||
125167982|NCT02856555|450239002|FG002|Overall Study|Randomized but Never Treated|0|||
125167983|NCT03333941|450239003|FG000|Overall Study|Lost to Follow-up|10|||
125167984|NCT03333941|450239003|FG000|Overall Study|Death|2|||
125227497|NCT01573000|450462098|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
125167985|NCT03333941|450239003|FG000|Overall Study|Adverse Event|1|||
125167986|NCT03323437|450239008|FG000|Overall Study|Withdrawal by Subject|0|||
125167987|NCT03323437|450239009|FG001|Overall Study|Withdrawal by Subject|4|||
125167988|NCT00605540|450239010|FG000|Overall Study|Death|15|||
125167989|NCT00605540|450239010|FG000|Overall Study|Lost to Follow-up|23|||
125227498|NCT01573000|450462099|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
125227499|NCT03353792|450462100|FG000|Overall Study|Lost to Follow-up|1|||
125227500|NCT03353792|450462101|FG001|Overall Study|Lost to Follow-up|0|||
125227501|NCT03353792|450462100|FG000|Overall Study|Participant Unable to Manage Device|1|||
125227502|NCT03353792|450462101|FG001|Overall Study|Participant Unable to Manage Device|0|||
125227503|NCT02351934|450462103|FG000|Allocation|POD weight<pre-op weight|3|||
125227504|NCT02351934|450462104|FG001|Allocation|POD weight<pre-op weight|0|||
125227505|NCT02351934|450462103|FG000|Allocation|Hypotension preventing administration|2|||
125227506|NCT02351934|450462104|FG001|Allocation|Hypotension preventing administration|0|||
125227507|NCT02351934|450462103|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
125227508|NCT02351934|450462104|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
125227509|NCT02351934|450462103|FG000|Follow-Up|POD weight<pre-op weight|3|||
125227510|NCT02351934|450462104|FG001|Follow-Up|POD weight<pre-op weight|0|||
125227511|NCT02351934|450462103|FG000|Follow-Up|Acute Kidney Injury|1|||
125227512|NCT02351934|450462104|FG001|Follow-Up|Acute Kidney Injury|0|||
125227513|NCT02351934|450462103|FG000|Follow-Up|Early dismissal|3|||
125227514|NCT02351934|450462104|FG001|Follow-Up|Early dismissal|0|||
125227515|NCT02351934|450462103|FG000|Follow-Up|Hypotension|3|||
125227516|NCT02351934|450462104|FG001|Follow-Up|Hypotension|0|||
125227517|NCT02351934|450462103|FG000|Follow-Up|No documentation|2|||
125227518|NCT02351934|450462104|FG001|Follow-Up|No documentation|0|||
125227519|NCT02351934|450462103|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
125227520|NCT02351934|450462104|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
125227521|NCT02351934|450462103|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
125227522|NCT02351934|450462104|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
125227523|NCT01225549|450462109|FG000|Period 4 - Washout|Disallowed medication|0|||
125227524|NCT01225549|450462110|FG001|Period 4 - Washout|Disallowed medication|1|||
125227525|NCT01225549|450462111|FG002|Period 4 - Washout|Disallowed medication|0|||
125227526|NCT01225549|450462112|FG003|Period 4 - Washout|Disallowed medication|0|||
125227527|NCT01225549|450462113|FG004|Period 4 - Washout|Disallowed medication|0|||
125227528|NCT01225549|450462114|FG005|Period 4 - Washout|Disallowed medication|0|||
125227529|NCT01225549|450462115|FG006|Period 4 - Washout|Disallowed medication|0|||
125227530|NCT01225549|450462116|FG007|Period 4 - Washout|Disallowed medication|0|||
125227531|NCT01225549|450462117|FG008|Period 4 - Washout|Disallowed medication|0|||
125227532|NCT01225549|450462118|FG009|Period 4 - Washout|Disallowed medication|0|||
125227533|NCT01225549|450462109|FG000|Period 6 - Washout|Disallowed medication|0|||
125227534|NCT01225549|450462110|FG001|Period 6 - Washout|Disallowed medication|0|||
125227535|NCT01225549|450462111|FG002|Period 6 - Washout|Disallowed medication|0|||
125227536|NCT01225549|450462112|FG003|Period 6 - Washout|Disallowed medication|1|||
125227537|NCT01225549|450462113|FG004|Period 6 - Washout|Disallowed medication|0|||
125227538|NCT01225549|450462114|FG005|Period 6 - Washout|Disallowed medication|0|||
125227539|NCT01225549|450462115|FG006|Period 6 - Washout|Disallowed medication|0|||
125227540|NCT01225549|450462116|FG007|Period 6 - Washout|Disallowed medication|0|||
125227541|NCT01225549|450462117|FG008|Period 6 - Washout|Disallowed medication|0|||
125227542|NCT01225549|450462118|FG009|Period 6 - Washout|Disallowed medication|0|||
125227543|NCT00891813|450462120|FG000|Overall Study|Adverse Event|3|||
125227544|NCT00891813|450462120|FG000|Overall Study|Withdrawal by Subject|1|||
125227545|NCT00891813|450462120|FG000|Overall Study|Patient Noncompliance|6|||
125227546|NCT00891813|450462120|FG000|Overall Study|Protocol Violation|2|||
125227547|NCT00192114|450462121|FG000|Overall Study|Objective Tumor Progression|19|||
125227548|NCT00192114|450462121|FG000|Overall Study|Adverse Event|2|||
125227549|NCT00192114|450462121|FG000|Overall Study|Clinical Progression|2|||
125227550|NCT00192114|450462121|FG000|Overall Study|Death|1|||
125227551|NCT02718911|450462124|FG000|Overall Study|Adverse Event|0|||
125227552|NCT02718911|450462125|FG001|Overall Study|Adverse Event|0|||
125227553|NCT02718911|450462126|FG002|Overall Study|Adverse Event|0|||
125227554|NCT02718911|450462127|FG003|Overall Study|Adverse Event|0|||
125227555|NCT02718911|450462128|FG004|Overall Study|Adverse Event|0|||
125227556|NCT02718911|450462129|FG005|Overall Study|Adverse Event|0|||
125227557|NCT02718911|450462130|FG006|Overall Study|Adverse Event|0|||
125227558|NCT02718911|450462131|FG007|Overall Study|Adverse Event|0|||
125227559|NCT02718911|450462132|FG008|Overall Study|Adverse Event|0|||
125227560|NCT02718911|450462133|FG009|Overall Study|Adverse Event|2|||
125227561|NCT02718911|450462124|FG000|Overall Study|Death|2|||
125227562|NCT02718911|450462125|FG001|Overall Study|Death|3|||
125227563|NCT02718911|450462126|FG002|Overall Study|Death|1|||
125227564|NCT02718911|450462127|FG003|Overall Study|Death|0|||
125227565|NCT02718911|450462128|FG004|Overall Study|Death|1|||
125227566|NCT02718911|450462129|FG005|Overall Study|Death|3|||
125227567|NCT02718911|450462130|FG006|Overall Study|Death|1|||
125227568|NCT02718911|450462131|FG007|Overall Study|Death|1|||
125227569|NCT02718911|450462132|FG008|Overall Study|Death|4|||
125227570|NCT02718911|450462133|FG009|Overall Study|Death|3|||
125227571|NCT02718911|450462124|FG000|Overall Study|Lost to Follow-up|0|||
125227572|NCT02718911|450462125|FG001|Overall Study|Lost to Follow-up|0|||
125227573|NCT02718911|450462126|FG002|Overall Study|Lost to Follow-up|0|||
125227574|NCT02718911|450462127|FG003|Overall Study|Lost to Follow-up|0|||
125227575|NCT02718911|450462128|FG004|Overall Study|Lost to Follow-up|0|||
125227576|NCT02718911|450462129|FG005|Overall Study|Lost to Follow-up|0|||
125227577|NCT02718911|450462130|FG006|Overall Study|Lost to Follow-up|0|||
125227578|NCT02718911|450462131|FG007|Overall Study|Lost to Follow-up|0|||
125227579|NCT02718911|450462132|FG008|Overall Study|Lost to Follow-up|1|||
125227580|NCT02718911|450462133|FG009|Overall Study|Lost to Follow-up|0|||
125227581|NCT02718911|450462124|FG000|Overall Study|Physician Decision|2|||
125227582|NCT02718911|450462125|FG001|Overall Study|Physician Decision|0|||
125227583|NCT02718911|450462126|FG002|Overall Study|Physician Decision|1|||
125227584|NCT02718911|450462127|FG003|Overall Study|Physician Decision|1|||
125227585|NCT02718911|450462128|FG004|Overall Study|Physician Decision|0|||
125227586|NCT02718911|450462129|FG005|Overall Study|Physician Decision|0|||
125227587|NCT02718911|450462130|FG006|Overall Study|Physician Decision|0|||
125227588|NCT02718911|450462131|FG007|Overall Study|Physician Decision|1|||
125227589|NCT02718911|450462132|FG008|Overall Study|Physician Decision|2|||
125227590|NCT02718911|450462133|FG009|Overall Study|Physician Decision|1|||
125227591|NCT02718911|450462124|FG000|Overall Study|Withdrawal by Subject|0|||
125227592|NCT02718911|450462125|FG001|Overall Study|Withdrawal by Subject|0|||
125227593|NCT02718911|450462126|FG002|Overall Study|Withdrawal by Subject|0|||
125227594|NCT02718911|450462127|FG003|Overall Study|Withdrawal by Subject|0|||
125227595|NCT02718911|450462128|FG004|Overall Study|Withdrawal by Subject|1|||
125227596|NCT02718911|450462129|FG005|Overall Study|Withdrawal by Subject|0|||
125227597|NCT02718911|450462130|FG006|Overall Study|Withdrawal by Subject|0|||
125227598|NCT02718911|450462131|FG007|Overall Study|Withdrawal by Subject|0|||
125227599|NCT02718911|450462132|FG008|Overall Study|Withdrawal by Subject|1|||
125227600|NCT02718911|450462133|FG009|Overall Study|Withdrawal by Subject|4|||
125227601|NCT02718911|450462124|FG000|Overall Study|Reason Not Collected|0|||
125227602|NCT02718911|450462125|FG001|Overall Study|Reason Not Collected|0|||
125227603|NCT02718911|450462126|FG002|Overall Study|Reason Not Collected|1|||
125167990|NCT00049530|450239012|FG000|Overall Study|Lack of Efficacy|25|||
125167991|NCT00049530|450239012|FG000|Overall Study|Adverse Event|2|||
125167992|NCT00049530|450239012|FG000|Overall Study|Death|1|||
125167993|NCT00049530|450239012|FG000|Overall Study|symptomatic deterioration|1|||
125167994|NCT00049530|450239012|FG000|Overall Study|ineligible|3|||
125167995|NCT02383810|450239013|FG000|Overall Study|Physician Decision|1|||
125167996|NCT02383810|450239014|FG001|Overall Study|Physician Decision|1|||
125167997|NCT02383810|450239015|FG002|Overall Study|Physician Decision|0|||
125167998|NCT02383810|450239016|FG003|Overall Study|Physician Decision|0|||
125167999|NCT02383810|450239017|FG004|Overall Study|Physician Decision|0|||
125168000|NCT02383810|450239018|FG005|Overall Study|Physician Decision|0|||
125168001|NCT02383810|450239019|FG006|Overall Study|Physician Decision|0|||
125168002|NCT02383810|450239020|FG007|Overall Study|Physician Decision|0|||
125168003|NCT02383810|450239013|FG000|Overall Study|Withdrawal by Subject|2|||
125168004|NCT02383810|450239014|FG001|Overall Study|Withdrawal by Subject|3|||
125168005|NCT02383810|450239015|FG002|Overall Study|Withdrawal by Subject|3|||
125168006|NCT02383810|450239016|FG003|Overall Study|Withdrawal by Subject|3|||
125168007|NCT02383810|450239017|FG004|Overall Study|Withdrawal by Subject|0|||
125168008|NCT02383810|450239018|FG005|Overall Study|Withdrawal by Subject|0|||
125168009|NCT02383810|450239019|FG006|Overall Study|Withdrawal by Subject|0|||
125168010|NCT02383810|450239020|FG007|Overall Study|Withdrawal by Subject|0|||
125168011|NCT02383810|450239013|FG000|Overall Study|Adverse Event|0|||
125168012|NCT02383810|450239014|FG001|Overall Study|Adverse Event|2|||
125168013|NCT02383810|450239015|FG002|Overall Study|Adverse Event|4|||
125227604|NCT02718911|450462127|FG003|Overall Study|Reason Not Collected|0|||
125227605|NCT02718911|450462128|FG004|Overall Study|Reason Not Collected|0|||
125227606|NCT02718911|450462129|FG005|Overall Study|Reason Not Collected|0|||
125227607|NCT02718911|450462130|FG006|Overall Study|Reason Not Collected|2|||
125227608|NCT02718911|450462131|FG007|Overall Study|Reason Not Collected|1|||
125168014|NCT02383810|450239016|FG003|Overall Study|Adverse Event|5|||
125227609|NCT02718911|450462132|FG008|Overall Study|Reason Not Collected|4|||
125168015|NCT02383810|450239017|FG004|Overall Study|Adverse Event|0|||
125168016|NCT02383810|450239018|FG005|Overall Study|Adverse Event|1|||
125168017|NCT02383810|450239019|FG006|Overall Study|Adverse Event|1|||
125168018|NCT02383810|450239020|FG007|Overall Study|Adverse Event|0|||
125168019|NCT02383810|450239013|FG000|Overall Study|Lost to Follow-up|0|||
125168020|NCT02383810|450239014|FG001|Overall Study|Lost to Follow-up|1|||
125168021|NCT02383810|450239015|FG002|Overall Study|Lost to Follow-up|0|||
125168022|NCT02383810|450239016|FG003|Overall Study|Lost to Follow-up|1|||
125168023|NCT02383810|450239017|FG004|Overall Study|Lost to Follow-up|0|||
125168024|NCT02383810|450239018|FG005|Overall Study|Lost to Follow-up|0|||
125168025|NCT02383810|450239019|FG006|Overall Study|Lost to Follow-up|0|||
125168026|NCT02383810|450239020|FG007|Overall Study|Lost to Follow-up|0|||
125168027|NCT02383810|450239013|FG000|Overall Study|other|0|||
125168028|NCT02383810|450239014|FG001|Overall Study|other|0|||
125168029|NCT02383810|450239015|FG002|Overall Study|other|0|||
125168030|NCT02383810|450239016|FG003|Overall Study|other|2|||
125168031|NCT02383810|450239017|FG004|Overall Study|other|0|||
125168032|NCT02383810|450239018|FG005|Overall Study|other|0|||
125168033|NCT02383810|450239019|FG006|Overall Study|other|0|||
125168034|NCT02383810|450239020|FG007|Overall Study|other|0|||
125168035|NCT02383810|450239013|FG000|Overall Study|subject did not receive study treatment|0|||
125168036|NCT02383810|450239014|FG001|Overall Study|subject did not receive study treatment|1|||
125168037|NCT02383810|450239015|FG002|Overall Study|subject did not receive study treatment|0|||
125168038|NCT02383810|450239016|FG003|Overall Study|subject did not receive study treatment|0|||
125168039|NCT02383810|450239017|FG004|Overall Study|subject did not receive study treatment|0|||
125168040|NCT02383810|450239018|FG005|Overall Study|subject did not receive study treatment|0|||
125168041|NCT02383810|450239019|FG006|Overall Study|subject did not receive study treatment|0|||
125168042|NCT02383810|450239020|FG007|Overall Study|subject did not receive study treatment|0|||
125168043|NCT01635283|450239023|FG000|Overall Study|Tumor Progression|3|||
125168044|NCT01635283|450239023|FG000|Overall Study|Lost to Follow-up|1|||
125168045|NCT01433549|450239024|FG000|Phase 2: Second Study Product|Adverse Event|0|||
125168046|NCT01433549|450239025|FG001|Phase 2: Second Study Product|Adverse Event|1|||
125168047|NCT03511326|450239028|FG000|Overall Study|Withdrawal by Subject|1|||
125168048|NCT04628793|450239029|FG000|Overall Study|Study terminated by sponsor|0|||
125168049|NCT04628793|450239030|FG001|Overall Study|Study terminated by sponsor|0|||
125168050|NCT04628793|450239031|FG002|Overall Study|Study terminated by sponsor|8|||
125168051|NCT04628793|450239029|FG000|Overall Study|Withdrawal by Subject|2|||
125168052|NCT04628793|450239030|FG001|Overall Study|Withdrawal by Subject|3|||
125168053|NCT04628793|450239031|FG002|Overall Study|Withdrawal by Subject|0|||
125168054|NCT04628793|450239029|FG000|Overall Study|Lost to Follow-up|0|||
125168055|NCT04628793|450239030|FG001|Overall Study|Lost to Follow-up|1|||
125168056|NCT04628793|450239031|FG002|Overall Study|Lost to Follow-up|0|||
125168057|NCT01696058|450239032|FG000|Overall Study|Adverse Event|21|||
125168058|NCT01696058|450239033|FG001|Overall Study|Adverse Event|11|||
125168059|NCT01696058|450239032|FG000|Overall Study|Lack of Efficacy|2|||
125168060|NCT01696058|450239033|FG001|Overall Study|Lack of Efficacy|3|||
125168061|NCT01696058|450239032|FG000|Overall Study|Protocol Violation|9|||
125168062|NCT01696058|450239033|FG001|Overall Study|Protocol Violation|3|||
125168063|NCT01696058|450239032|FG000|Overall Study|Lost to Follow-up|2|||
125168064|NCT01696058|450239033|FG001|Overall Study|Lost to Follow-up|5|||
125227610|NCT02718911|450462133|FG009|Overall Study|Reason Not Collected|9|||
125168065|NCT01696058|450239032|FG000|Overall Study|Withdrawal by Subject|4|||
125168066|NCT01696058|450239033|FG001|Overall Study|Withdrawal by Subject|6|||
125168067|NCT01696058|450239032|FG000|Overall Study|Other reason prematurely discontinued|5|||
125168068|NCT01696058|450239033|FG001|Overall Study|Other reason prematurely discontinued|3|||
125168069|NCT01934335|450239034|FG000|Overall Study|Withdrawal by Subject|1|||
125168070|NCT01934335|450239035|FG001|Overall Study|Withdrawal by Subject|1|||
125168071|NCT05384171|450239036|FG000|Overall Study|Lost to Follow-up|9|||
125168072|NCT05384171|450239037|FG001|Overall Study|Lost to Follow-up|9|||
125168073|NCT05384171|450239036|FG000|Overall Study|Withdrawal by Subject|3|||
125168074|NCT05384171|450239037|FG001|Overall Study|Withdrawal by Subject|0|||
125168075|NCT00106964|450239038|FG000|Overall Study|Lost to Follow-up|8|||
125168076|NCT00106964|450239039|FG001|Overall Study|Lost to Follow-up|6|||
125168077|NCT00106964|450239040|FG002|Overall Study|Lost to Follow-up|2|||
125168078|NCT00106964|450239038|FG000|Overall Study|Pregnancy|2|||
125168079|NCT00106964|450239039|FG001|Overall Study|Pregnancy|3|||
125168080|NCT00106964|450239040|FG002|Overall Study|Pregnancy|2|||
125168081|NCT00106964|450239038|FG000|Overall Study|Death|1|||
125168082|NCT00106964|450239039|FG001|Overall Study|Death|1|||
125168083|NCT00106964|450239040|FG002|Overall Study|Death|0|||
125168084|NCT00106964|450239038|FG000|Overall Study|Incarceration|0|||
125168085|NCT00106964|450239039|FG001|Overall Study|Incarceration|1|||
125168086|NCT00106964|450239040|FG002|Overall Study|Incarceration|0|||
125168087|NCT00106964|450239038|FG000|Overall Study|Site Funding Terminated|0|||
125168088|NCT00106964|450239039|FG001|Overall Study|Site Funding Terminated|1|||
125168089|NCT00106964|450239040|FG002|Overall Study|Site Funding Terminated|1|||
125168090|NCT00106964|450239038|FG000|Overall Study|Failure to adhere|2|||
125168091|NCT00106964|450239039|FG001|Overall Study|Failure to adhere|0|||
125168092|NCT00106964|450239040|FG002|Overall Study|Failure to adhere|0|||
125168093|NCT00106964|450239038|FG000|Overall Study|Did not meet eligibility criteria|0|||
125168094|NCT00106964|450239039|FG001|Overall Study|Did not meet eligibility criteria|2|||
125168095|NCT00106964|450239040|FG002|Overall Study|Did not meet eligibility criteria|2|||
125168096|NCT00106964|450239038|FG000|Overall Study|Required disallowed medication|0|||
125168097|NCT00106964|450239039|FG001|Overall Study|Required disallowed medication|1|||
125168098|NCT00106964|450239040|FG002|Overall Study|Required disallowed medication|0|||
125168099|NCT01422187|450239045|FG000|Overall Study|Personal reason|1|||
125168100|NCT01422187|450239046|FG001|Overall Study|Personal reason|0|||
125168101|NCT01422187|450239047|FG002|Overall Study|Personal reason|0|||
125168102|NCT01422187|450239045|FG000|Overall Study|Lost to Follow-up|0|||
125168103|NCT01422187|450239046|FG001|Overall Study|Lost to Follow-up|1|||
125168104|NCT01422187|450239047|FG002|Overall Study|Lost to Follow-up|0|||
125168105|NCT00168818|450239048|FG000|Overall Study|Adverse Event|23|||
125168106|NCT00168818|450239049|FG001|Overall Study|Adverse Event|29|||
125168107|NCT00168818|450239050|FG002|Overall Study|Adverse Event|31|||
125168108|NCT00168818|450239048|FG000|Overall Study|Protocol Violation|16|||
125168109|NCT00168818|450239049|FG001|Overall Study|Protocol Violation|11|||
125168110|NCT00168818|450239050|FG002|Overall Study|Protocol Violation|11|||
125168111|NCT00168818|450239048|FG000|Overall Study|Lost to Follow-up|13|||
125168112|NCT00168818|450239049|FG001|Overall Study|Lost to Follow-up|4|||
125168113|NCT00168818|450239050|FG002|Overall Study|Lost to Follow-up|15|||
125168114|NCT00168818|450239048|FG000|Overall Study|Withdrawal by Subject|43|||
125168115|NCT00168818|450239049|FG001|Overall Study|Withdrawal by Subject|41|||
125168116|NCT00168818|450239050|FG002|Overall Study|Withdrawal by Subject|37|||
125168117|NCT00168818|450239048|FG000|Overall Study|Other|22|||
125168118|NCT00168818|450239049|FG001|Overall Study|Other|24|||
125168119|NCT00168818|450239050|FG002|Overall Study|Other|30|||
125168120|NCT00168818|450239048|FG000|Treatment|Adverse Event|77|||
125168121|NCT00168818|450239049|FG001|Treatment|Adverse Event|89|||
125168122|NCT00168818|450239050|FG002|Treatment|Adverse Event|68|||
125168123|NCT00168818|450239048|FG000|Treatment|Protocol Violation|8|||
125168124|NCT00168818|450239049|FG001|Treatment|Protocol Violation|11|||
125168125|NCT00168818|450239050|FG002|Treatment|Protocol Violation|11|||
125168126|NCT00168818|450239048|FG000|Treatment|Lost to Follow-up|0|||
125168127|NCT00168818|450239049|FG001|Treatment|Lost to Follow-up|2|||
125168128|NCT00168818|450239050|FG002|Treatment|Lost to Follow-up|1|||
125168129|NCT00168818|450239048|FG000|Treatment|Withdrawal by Subject|25|||
125168130|NCT00168818|450239049|FG001|Treatment|Withdrawal by Subject|20|||
125168131|NCT00168818|450239050|FG002|Treatment|Withdrawal by Subject|22|||
125168132|NCT00168818|450239048|FG000|Treatment|Other|23|||
125168133|NCT00168818|450239049|FG001|Treatment|Other|29|||
125168134|NCT00168818|450239050|FG002|Treatment|Other|31|||
125168135|NCT02227446|450239051|FG000|Overall Study|not eligible post randomization|18|||
125168136|NCT02227446|450239052|FG001|Overall Study|not eligible post randomization|29|||
125168137|NCT02227446|450239051|FG000|Overall Study|Withdrawal by Subject|4|||
125168138|NCT02227446|450239052|FG001|Overall Study|Withdrawal by Subject|5|||
125168139|NCT02309138|450239053|FG000|Overall Study|Withdrawal by Subject|44|||
125168140|NCT02309138|450239054|FG001|Overall Study|Withdrawal by Subject|15|||
125168141|NCT02309138|450239053|FG000|Overall Study|Protocol Violation|4|||
125168142|NCT02309138|450239054|FG001|Overall Study|Protocol Violation|2|||
125168143|NCT02309138|450239053|FG000|Overall Study|delivered before visit 2|0|||
125168144|NCT02309138|450239054|FG001|Overall Study|delivered before visit 2|1|||
125168145|NCT00735397|450239058|FG000|Overall Study|Adverse Event|194|||
125168146|NCT00735397|450239058|FG000|Overall Study|Lost to Follow-up|33|||
125168147|NCT00735397|450239058|FG000|Overall Study|Participant choice|252|||
125168148|NCT00735397|450239058|FG000|Overall Study|Inadequate therapeutic effect|202|||
125168149|NCT00735397|450239058|FG000|Overall Study|Administrative/Other|502|||
125168150|NCT00901576|450239067|FG000|Second Intervention|Withdrawal by Subject|0|||
125168151|NCT00901576|450239068|FG001|Second Intervention|Withdrawal by Subject|0|||
125168152|NCT00901576|450239069|FG002|Second Intervention|Withdrawal by Subject|0|||
125168153|NCT00901576|450239070|FG003|Second Intervention|Withdrawal by Subject|1|||
125168154|NCT00901576|450239071|FG004|Second Intervention|Withdrawal by Subject|0|||
125168155|NCT00901576|450239072|FG005|Second Intervention|Withdrawal by Subject|1|||
125168156|NCT00901576|450239067|FG000|Second Intervention|Physician Decision|1|||
125168157|NCT00901576|450239068|FG001|Second Intervention|Physician Decision|0|||
125168158|NCT00901576|450239069|FG002|Second Intervention|Physician Decision|0|||
125168159|NCT00901576|450239070|FG003|Second Intervention|Physician Decision|0|||
125168160|NCT00901576|450239071|FG004|Second Intervention|Physician Decision|0|||
125168161|NCT00901576|450239072|FG005|Second Intervention|Physician Decision|0|||
125168162|NCT01559389|450239073|FG000|Overall Study|Withdrawal by Subject|20|||
125168163|NCT01559389|450239074|FG001|Overall Study|Withdrawal by Subject|20|||
125168164|NCT01346293|450239075|FG000|Overall Study|Protocol Violation|30|||
125168165|NCT01346293|450239076|FG001|Overall Study|Protocol Violation|9|||
125168166|NCT01346293|450239075|FG000|Overall Study|Lost to Follow-up|21|||
125168167|NCT01346293|450239076|FG001|Overall Study|Lost to Follow-up|8|||
125168168|NCT01346293|450239075|FG000|Overall Study|Withdrawal by Subject|15|||
125168169|NCT01346293|450239076|FG001|Overall Study|Withdrawal by Subject|4|||
125168170|NCT01346293|450239075|FG000|Overall Study|Other|1|||
125168171|NCT01346293|450239076|FG001|Overall Study|Other|0|||
125168172|NCT00587990|450239080|FG000|Overall Study|Death|0|||
125168173|NCT00587990|450239081|FG001|Overall Study|Death|0|||
125168174|NCT00587990|450239082|FG002|Overall Study|Death|1|||
125168175|NCT02754856|450239083|FG000|Overall Study|Withdrawal by Subject|1|||
125168176|NCT01147107|450239087|FG000|Overall Study|Lack of Efficacy|5|||
125168177|NCT01147107|450239088|FG001|Overall Study|Lack of Efficacy|0|||
125168178|NCT01147107|450239087|FG000|Overall Study|Withdrawal by Subject|1|||
125168179|NCT01147107|450239088|FG001|Overall Study|Withdrawal by Subject|1|||
125168180|NCT04693416|450239089|FG000|Overall Study|Lost to Follow-up|13|||
125168181|NCT04693416|450239090|FG001|Overall Study|Lost to Follow-up|0|||
125168182|NCT00474266|450239091|FG000|Overall Study|Withdrawal by Subject|7|||
125168183|NCT00474266|450239092|FG001|Overall Study|Withdrawal by Subject|20|||
125168184|NCT00474266|450239093|FG002|Overall Study|Withdrawal by Subject|4|||
125227611|NCT01172873|450462136|FG000|Overall Study|Withdrawal by Subject|3|||
125227612|NCT01172873|450462137|FG001|Overall Study|Withdrawal by Subject|2|||
125227613|NCT00983372|450462138|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
125227614|NCT00983372|450462138|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
125227615|NCT00983372|450462138|FG000|Diltiazem ER Alone|Adverse Event|1|||
125168185|NCT00474266|450239094|FG003|Overall Study|Withdrawal by Subject|7|||
125227616|NCT00617357|450462145|FG000|Overall Study|Lost to Follow-up|7|||
125168186|NCT00813800|450239097|FG000|Overall Study|Screen Failure after Consent|2|||
125168187|NCT00813800|450239097|FG000|Overall Study|Adverse Event|1|||
125168188|NCT00813800|450239097|FG000|Overall Study|Worsening of depression|2|||
125168189|NCT00813800|450239097|FG000|Overall Study|Physician Decision|1|||
125168190|NCT03456453|450239098|FG000|Overall Study|Withdrawal by Subject|2|||
125168191|NCT03456453|450239099|FG001|Overall Study|Withdrawal by Subject|0|||
125168192|NCT03456453|450239098|FG000|Overall Study|Not released to community|1|||
125168193|NCT03456453|450239099|FG001|Overall Study|Not released to community|5|||
125168194|NCT03456453|450239098|FG000|Overall Study|Lost to Follow-up|0|||
125168195|NCT03456453|450239099|FG001|Overall Study|Lost to Follow-up|2|||
125168196|NCT02369458|450239115|FG000|Overall Study|Determined to be not eligible|1|||
125168197|NCT02369458|450239116|FG001|Overall Study|Determined to be not eligible|0|||
125168198|NCT00121134|450239117|FG000|Overall Study|Progression of Disease|5|||
125168199|NCT00121134|450239118|FG001|Overall Study|Progression of Disease|3|||
125168200|NCT00121134|450239119|FG002|Overall Study|Progression of Disease|4|||
125168201|NCT00121134|450239120|FG003|Overall Study|Progression of Disease|2|||
125168202|NCT00121134|450239117|FG000|Overall Study|Toxicity|4|||
125168203|NCT00121134|450239118|FG001|Overall Study|Toxicity|7|||
125168204|NCT00121134|450239119|FG002|Overall Study|Toxicity|13|||
125168205|NCT00121134|450239120|FG003|Overall Study|Toxicity|5|||
125168206|NCT00121134|450239117|FG000|Overall Study|Physician Decision|6|||
125168207|NCT00121134|450239118|FG001|Overall Study|Physician Decision|4|||
125168208|NCT00121134|450239119|FG002|Overall Study|Physician Decision|4|||
125168209|NCT00121134|450239120|FG003|Overall Study|Physician Decision|1|||
125168210|NCT00121134|450239117|FG000|Overall Study|Treatment Delay|1|||
125168211|NCT00121134|450239118|FG001|Overall Study|Treatment Delay|0|||
125168212|NCT00121134|450239119|FG002|Overall Study|Treatment Delay|0|||
125168213|NCT00121134|450239120|FG003|Overall Study|Treatment Delay|0|||
125168214|NCT00121134|450239117|FG000|Overall Study|Intercurrent Illness|0|||
125168215|NCT00121134|450239118|FG001|Overall Study|Intercurrent Illness|0|||
125168216|NCT00121134|450239119|FG002|Overall Study|Intercurrent Illness|0|||
125168217|NCT00121134|450239120|FG003|Overall Study|Intercurrent Illness|1|||
125168218|NCT00121134|450239117|FG000|Overall Study|Patient Personal Reasons|0|||
125168219|NCT00121134|450239118|FG001|Overall Study|Patient Personal Reasons|1|||
125168220|NCT00121134|450239119|FG002|Overall Study|Patient Personal Reasons|0|||
125168221|NCT00121134|450239120|FG003|Overall Study|Patient Personal Reasons|0|||
125168222|NCT00857584|450239132|FG000|Overall Study|Lack of Efficacy|1|||
125168223|NCT00857584|450239133|FG001|Overall Study|Lack of Efficacy|2|||
125168224|NCT00857584|450239132|FG000|Overall Study|Adverse Event|2|||
125168225|NCT00857584|450239133|FG001|Overall Study|Adverse Event|2|||
125168226|NCT00857584|450239132|FG000|Overall Study|Physician Decision|1|||
125168227|NCT00857584|450239133|FG001|Overall Study|Physician Decision|1|||
125168228|NCT00259272|450239134|FG000|Overall Study|Adverse Event|2|||
125168229|NCT00259272|450239135|FG001|Overall Study|Adverse Event|1|||
125168230|NCT00259272|450239136|FG002|Overall Study|Adverse Event|0|||
125168231|NCT00259272|450239137|FG003|Overall Study|Adverse Event|3|||
125168232|NCT00259272|450239134|FG000|Overall Study|Lack of Efficacy|5|||
125168233|NCT00259272|450239135|FG001|Overall Study|Lack of Efficacy|1|||
125168234|NCT00259272|450239136|FG002|Overall Study|Lack of Efficacy|2|||
125168235|NCT00259272|450239137|FG003|Overall Study|Lack of Efficacy|6|||
125168236|NCT00259272|450239134|FG000|Overall Study|Physician Decision|1|||
125168237|NCT00259272|450239135|FG001|Overall Study|Physician Decision|2|||
125168238|NCT00259272|450239136|FG002|Overall Study|Physician Decision|1|||
125168239|NCT00259272|450239137|FG003|Overall Study|Physician Decision|3|||
125168240|NCT00259272|450239134|FG000|Overall Study|Protocol Violation|2|||
125168241|NCT00259272|450239135|FG001|Overall Study|Protocol Violation|0|||
125168242|NCT00259272|450239136|FG002|Overall Study|Protocol Violation|0|||
125168243|NCT00259272|450239137|FG003|Overall Study|Protocol Violation|1|||
125168244|NCT00259272|450239134|FG000|Overall Study|Sponsor Decision|0|||
125168245|NCT00259272|450239135|FG001|Overall Study|Sponsor Decision|1|||
125168246|NCT00259272|450239136|FG002|Overall Study|Sponsor Decision|0|||
125168247|NCT00259272|450239137|FG003|Overall Study|Sponsor Decision|0|||
125168248|NCT00259272|450239134|FG000|Overall Study|Withdrawal by Subject|4|||
125168249|NCT00259272|450239135|FG001|Overall Study|Withdrawal by Subject|2|||
125168250|NCT00259272|450239136|FG002|Overall Study|Withdrawal by Subject|2|||
125168251|NCT00259272|450239137|FG003|Overall Study|Withdrawal by Subject|7|||
125168252|NCT00259272|450239134|FG000|Overall Study|Lost to Follow-up|1|||
125168253|NCT00259272|450239135|FG001|Overall Study|Lost to Follow-up|0|||
125168254|NCT00259272|450239136|FG002|Overall Study|Lost to Follow-up|0|||
125168255|NCT00259272|450239137|FG003|Overall Study|Lost to Follow-up|1|||
125168256|NCT00805467|450241068|FG000|Overall Study|Lack of Efficacy|0|||
125168257|NCT00805467|450241069|FG001|Overall Study|Lack of Efficacy|8|||
125168258|NCT00805467|450241070|FG002|Overall Study|Lack of Efficacy|13|||
125168259|NCT00805467|450241071|FG003|Overall Study|Lack of Efficacy|86|||
125168260|NCT00805467|450241068|FG000|Overall Study|Lost to Follow-up|0|||
125168261|NCT00805467|450241069|FG001|Overall Study|Lost to Follow-up|1|||
125168262|NCT00805467|450241070|FG002|Overall Study|Lost to Follow-up|7|||
125168263|NCT00805467|450241071|FG003|Overall Study|Lost to Follow-up|21|||
125168264|NCT00805467|450241068|FG000|Overall Study|Withdrawal by Subject|0|||
125168265|NCT00805467|450241069|FG001|Overall Study|Withdrawal by Subject|6|||
125168266|NCT00805467|450241070|FG002|Overall Study|Withdrawal by Subject|45|||
125168267|NCT00805467|450241071|FG003|Overall Study|Withdrawal by Subject|50|||
125168268|NCT00805467|450241068|FG000|Overall Study|Protocol Violation|0|||
125168269|NCT00805467|450241069|FG001|Overall Study|Protocol Violation|3|||
125168270|NCT00805467|450241070|FG002|Overall Study|Protocol Violation|0|||
125168271|NCT00805467|450241071|FG003|Overall Study|Protocol Violation|5|||
125168272|NCT00805467|450241068|FG000|Overall Study|Adverse Event|0|||
125227617|NCT00617357|450462145|FG000|Overall Study|Death|5|||
125227618|NCT00617357|450462145|FG000|Overall Study|insurance concerns|2|||
125168273|NCT00805467|450241069|FG001|Overall Study|Adverse Event|13|||
125168274|NCT00805467|450241070|FG002|Overall Study|Adverse Event|26|||
125168275|NCT00805467|450241071|FG003|Overall Study|Adverse Event|57|||
125168276|NCT00805467|450241068|FG000|Overall Study|Death|0|||
125168277|NCT00805467|450241069|FG001|Overall Study|Death|2|||
125168278|NCT00805467|450241070|FG002|Overall Study|Death|7|||
125168279|NCT00805467|450241071|FG003|Overall Study|Death|5|||
125168280|NCT00805467|450241068|FG000|Overall Study|Physician Decision|0|||
125168281|NCT00805467|450241069|FG001|Overall Study|Physician Decision|1|||
125168282|NCT00805467|450241070|FG002|Overall Study|Physician Decision|2|||
125168283|NCT00805467|450241071|FG003|Overall Study|Physician Decision|6|||
125168284|NCT00805467|450241068|FG000|Overall Study|Not reported|0|||
125168285|NCT00805467|450241069|FG001|Overall Study|Not reported|0|||
125168286|NCT00805467|450241070|FG002|Overall Study|Not reported|3|||
125168287|NCT00805467|450241071|FG003|Overall Study|Not reported|7|||
125168288|NCT01908907|450241072|FG000|Overall Study|Physician Decision|1|||
125168289|NCT01908907|450241073|FG001|Overall Study|Physician Decision|0|||
125168290|NCT01908907|450241072|FG000|Overall Study|Protocol Violation|1|||
125168291|NCT01908907|450241073|FG001|Overall Study|Protocol Violation|0|||
125168292|NCT00761657|450241074|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
125168293|NCT00761657|450241075|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
125168294|NCT00761657|450241076|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
125168295|NCT00761657|450241077|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
125168296|NCT00761657|450241078|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
125168297|NCT00761657|450241079|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
125168298|NCT00761657|450241080|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
125168299|NCT00761657|450241081|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
125168300|NCT00761657|450241082|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
125168301|NCT00761657|450241074|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
125168302|NCT00761657|450241075|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
125168303|NCT00761657|450241076|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
125168304|NCT00761657|450241077|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
125168305|NCT00761657|450241078|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
125168306|NCT00761657|450241079|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
125168307|NCT00761657|450241080|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
125168308|NCT00761657|450241081|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
125168309|NCT00761657|450241082|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
125168310|NCT00761657|450241074|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
125168311|NCT00761657|450241075|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
125168312|NCT00761657|450241076|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
125168313|NCT00761657|450241077|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
125168314|NCT00761657|450241078|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
125168315|NCT00761657|450241079|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
125168316|NCT00761657|450241080|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
125168317|NCT00761657|450241081|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
125168318|NCT00761657|450241082|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
125168319|NCT00761657|450241074|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
125168320|NCT00761657|450241075|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
125168321|NCT00761657|450241076|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
125168322|NCT00761657|450241077|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
125168323|NCT00761657|450241078|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
125168324|NCT00761657|450241079|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
125168325|NCT00761657|450241080|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
125168326|NCT00761657|450241081|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
125168327|NCT00761657|450241082|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
125168328|NCT00270855|450241090|FG000|Overall Study|Withdrawal by Subject|8|||
125227619|NCT00617357|450462145|FG000|Overall Study|Withdrawal by Subject|1|||
125227620|NCT00617357|450462145|FG000|Overall Study|Physician Decision|1|||
125168329|NCT00270855|450241091|FG001|Overall Study|Withdrawal by Subject|8|||
125168330|NCT02152605|450241094|FG000|Overall Study|Adverse Event|6|||
125168331|NCT02152605|450241095|FG001|Overall Study|Adverse Event|8|||
125168332|NCT02152605|450241094|FG000|Overall Study|Lack of Efficacy|7|||
125168333|NCT02152605|450241095|FG001|Overall Study|Lack of Efficacy|4|||
125168334|NCT02152605|450241094|FG000|Overall Study|Protocol deviation|1|||
125168335|NCT02152605|450241095|FG001|Overall Study|Protocol deviation|4|||
125168336|NCT02152605|450241094|FG000|Overall Study|Lost to Follow-up|1|||
125168337|NCT02152605|450241095|FG001|Overall Study|Lost to Follow-up|0|||
125168338|NCT02152605|450241094|FG000|Overall Study|Withdrew consent|4|||
125168339|NCT02152605|450241095|FG001|Overall Study|Withdrew consent|2|||
125168340|NCT03151408|450241096|FG000|Overall Study|Adverse Event|24|||
125168341|NCT03151408|450241097|FG001|Overall Study|Adverse Event|23|||
125168342|NCT03151408|450241096|FG000|Overall Study|Death|46|||
125168343|NCT03151408|450241097|FG001|Overall Study|Death|26|||
125168344|NCT03151408|450241096|FG000|Overall Study|Physician Decision|13|||
125168345|NCT03151408|450241097|FG001|Overall Study|Physician Decision|19|||
125168346|NCT03151408|450241096|FG000|Overall Study|Withdrawal by Subject|16|||
125168347|NCT03151408|450241097|FG001|Overall Study|Withdrawal by Subject|20|||
125168348|NCT03151408|450241096|FG000|Overall Study|Progressive disease|45|||
125168349|NCT03151408|450241097|FG001|Overall Study|Progressive disease|61|||
125168350|NCT03151408|450241096|FG000|Overall Study|non-compliance by patient|1|||
125168351|NCT03151408|450241097|FG001|Overall Study|non-compliance by patient|0|||
125168352|NCT03151408|450241096|FG000|Overall Study|other reasons|56|||
125168353|NCT03151408|450241097|FG001|Overall Study|other reasons|52|||
125168354|NCT03151408|450241096|FG000|Overall Study|randomized and not treated|2|||
125168355|NCT03151408|450241097|FG001|Overall Study|randomized and not treated|2|||
125168356|NCT00837473|450241098|FG000|Overall Study|Lost to Follow-up|1|||
125168357|NCT00837473|450241098|FG000|Overall Study|Withdrawal by Subject|2|||
125168358|NCT01724489|450241099|FG000|Overall Study|Adverse Event|8|||
125168359|NCT01724489|450241100|FG001|Overall Study|Adverse Event|3|||
125168360|NCT01724489|450241099|FG000|Overall Study|Surgery, medication|1|||
125168361|NCT01724489|450241100|FG001|Overall Study|Surgery, medication|1|||
125168362|NCT01724489|450241099|FG000|Overall Study|Lost to Follow-up|1|||
125168363|NCT01724489|450241100|FG001|Overall Study|Lost to Follow-up|2|||
125168364|NCT01724489|450241099|FG000|Overall Study|Withdrawal by Subject|6|||
125168365|NCT01724489|450241100|FG001|Overall Study|Withdrawal by Subject|6|||
125168366|NCT04576923|450241101|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
125168367|NCT00923273|450241104|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
125168368|NCT00923273|450241105|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
125168369|NCT00923273|450241106|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
125168370|NCT00923273|450241107|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
125168371|NCT00923273|450241108|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
125168372|NCT00923273|450241104|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
125168373|NCT00923273|450241105|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
125168374|NCT00923273|450241106|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
125168375|NCT00923273|450241107|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
125168376|NCT00923273|450241108|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
125168377|NCT01473524|450241111|FG000|DB Phase|Adverse Event|4|||
125168378|NCT01473524|450241112|FG001|DB Phase|Adverse Event|8|||
125168379|NCT01473524|450241113|FG002|DB Phase|Adverse Event|2|||
125168380|NCT01473524|450241114|FG003|DB Phase|Adverse Event|0|||
125168381|NCT01473524|450241115|FG004|DB Phase|Adverse Event|0|||
125168382|NCT01473524|450241116|FG005|DB Phase|Adverse Event|0|||
125168383|NCT01473524|450241111|FG000|DB Phase|Death|1|||
125168384|NCT01473524|450241112|FG001|DB Phase|Death|0|||
125168385|NCT01473524|450241113|FG002|DB Phase|Death|0|||
125168386|NCT01473524|450241114|FG003|DB Phase|Death|0|||
125168387|NCT01473524|450241115|FG004|DB Phase|Death|0|||
125168388|NCT01473524|450241116|FG005|DB Phase|Death|0|||
125168389|NCT01473524|450241111|FG000|DB Phase|Withdrawal by Subject|2|||
125168390|NCT01473524|450241112|FG001|DB Phase|Withdrawal by Subject|1|||
125168391|NCT01473524|450241113|FG002|DB Phase|Withdrawal by Subject|1|||
125168392|NCT01473524|450241114|FG003|DB Phase|Withdrawal by Subject|0|||
125168393|NCT01473524|450241115|FG004|DB Phase|Withdrawal by Subject|0|||
125168394|NCT01473524|450241116|FG005|DB Phase|Withdrawal by Subject|0|||
125168395|NCT01473524|450241111|FG000|LTSE Phase|Withdrawal by Subject|0|||
125168396|NCT01473524|450241112|FG001|LTSE Phase|Withdrawal by Subject|0|||
125168397|NCT01473524|450241113|FG002|LTSE Phase|Withdrawal by Subject|0|||
125168398|NCT01473524|450241114|FG003|LTSE Phase|Withdrawal by Subject|3|||
125168399|NCT01473524|450241115|FG004|LTSE Phase|Withdrawal by Subject|3|||
125168400|NCT01473524|450241116|FG005|LTSE Phase|Withdrawal by Subject|6|||
125168401|NCT01473524|450241111|FG000|LTSE Phase|Death|0|||
125227621|NCT01764841|450462146|FG000|Overall Study|Logistical Difficulties|0|||
125168402|NCT01473524|450241112|FG001|LTSE Phase|Death|0|||
125168403|NCT01473524|450241113|FG002|LTSE Phase|Death|0|||
125168404|NCT01473524|450241114|FG003|LTSE Phase|Death|0|||
125168405|NCT01473524|450241115|FG004|LTSE Phase|Death|1|||
125168406|NCT01473524|450241116|FG005|LTSE Phase|Death|0|||
125168407|NCT01473524|450241111|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
125168408|NCT01473524|450241112|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
125168409|NCT01473524|450241113|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
125168410|NCT01473524|450241114|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
125168411|NCT01473524|450241115|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
125168412|NCT01473524|450241116|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
125168413|NCT01473524|450241111|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
125168414|NCT01473524|450241112|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
125168415|NCT01473524|450241113|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
125168416|NCT01473524|450241114|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
125168417|NCT01473524|450241115|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
125168418|NCT01473524|450241116|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
125168419|NCT01473524|450241111|FG000|LTSE Phase|Lost to Follow-up|0|||
125168420|NCT01473524|450241112|FG001|LTSE Phase|Lost to Follow-up|0|||
125168421|NCT01473524|450241113|FG002|LTSE Phase|Lost to Follow-up|0|||
125168422|NCT01473524|450241114|FG003|LTSE Phase|Lost to Follow-up|1|||
125168423|NCT01473524|450241115|FG004|LTSE Phase|Lost to Follow-up|3|||
125168424|NCT01473524|450241116|FG005|LTSE Phase|Lost to Follow-up|2|||
125168425|NCT01473524|450241111|FG000|LTSE Phase|Principal Investigator Decision|0|||
125168426|NCT01473524|450241112|FG001|LTSE Phase|Principal Investigator Decision|0|||
125168427|NCT01473524|450241113|FG002|LTSE Phase|Principal Investigator Decision|0|||
125168428|NCT01473524|450241114|FG003|LTSE Phase|Principal Investigator Decision|1|||
125168429|NCT01473524|450241115|FG004|LTSE Phase|Principal Investigator Decision|1|||
125168430|NCT01473524|450241116|FG005|LTSE Phase|Principal Investigator Decision|3|||
125168431|NCT01473524|450241111|FG000|LTSE Phase|Liver Transplantation|0|||
125168432|NCT01473524|450241112|FG001|LTSE Phase|Liver Transplantation|0|||
125168433|NCT01473524|450241113|FG002|LTSE Phase|Liver Transplantation|0|||
125168434|NCT01473524|450241114|FG003|LTSE Phase|Liver Transplantation|0|||
125168435|NCT01473524|450241115|FG004|LTSE Phase|Liver Transplantation|0|||
125168436|NCT01473524|450241116|FG005|LTSE Phase|Liver Transplantation|1|||
125168437|NCT01473524|450241111|FG000|LTSE Phase|Pregnancy|0|||
125168438|NCT01473524|450241112|FG001|LTSE Phase|Pregnancy|0|||
125168439|NCT01473524|450241113|FG002|LTSE Phase|Pregnancy|0|||
125168440|NCT01473524|450241114|FG003|LTSE Phase|Pregnancy|1|||
125168441|NCT01473524|450241115|FG004|LTSE Phase|Pregnancy|0|||
125168442|NCT01473524|450241116|FG005|LTSE Phase|Pregnancy|0|||
125168443|NCT01473524|450241111|FG000|LTSE Phase|Protocol Violation|0|||
125168444|NCT01473524|450241112|FG001|LTSE Phase|Protocol Violation|0|||
125168445|NCT01473524|450241113|FG002|LTSE Phase|Protocol Violation|0|||
125168446|NCT01473524|450241114|FG003|LTSE Phase|Protocol Violation|0|||
125168447|NCT01473524|450241115|FG004|LTSE Phase|Protocol Violation|0|||
125168448|NCT01473524|450241116|FG005|LTSE Phase|Protocol Violation|1|||
125168449|NCT01544179|450241117|FG000|Overall Study|Death|50|||
125168450|NCT01544179|450241118|FG001|Overall Study|Death|37|||
125168451|NCT01544179|450241117|FG000|Overall Study|Lost to Follow-up|0|||
125168452|NCT01544179|450241118|FG001|Overall Study|Lost to Follow-up|1|||
125168453|NCT01544179|450241117|FG000|Overall Study|Adverse Event|0|||
125168454|NCT01544179|450241118|FG001|Overall Study|Adverse Event|1|||
125168455|NCT01544179|450241117|FG000|Overall Study|Withdrawal by Subject|12|||
125168456|NCT01544179|450241118|FG001|Overall Study|Withdrawal by Subject|7|||
125168457|NCT01544179|450241117|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
125168458|NCT01544179|450241118|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125168459|NCT00282919|450241121|FG000|Overall Study|Lack of Efficacy|4|||
125168460|NCT00282919|450241121|FG000|Overall Study|Withdrawal by Subject|1|||
125168461|NCT00282919|450241121|FG000|Overall Study|Asymptomatic Parasitemia|2|||
125168462|NCT01438996|450241122|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
125168463|NCT01438996|450241123|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
125168464|NCT01438996|450241124|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
125168465|NCT02540850|450241125|FG000|Overall Study|Lost to Follow-up|69|||
125168466|NCT02540850|450241126|FG001|Overall Study|Lost to Follow-up|66|||
125168467|NCT02540850|450241127|FG002|Overall Study|Lost to Follow-up|34|||
125168468|NCT02861014|450241128|FG000|Primary Analysis|Adverse Event|7|||
125168469|NCT02861014|450241128|FG000|Primary Analysis|Death|1|||
125168470|NCT02861014|450241128|FG000|Primary Analysis|Lack of Efficacy|3|||
125168471|NCT02861014|450241128|FG000|Primary Analysis|Physician Decision|2|||
125168472|NCT02861014|450241128|FG000|Primary Analysis|Pregnancy|4|||
125168473|NCT02861014|450241128|FG000|Primary Analysis|Protocol Violation|2|||
125168474|NCT02861014|450241128|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
125227622|NCT01764841|450462147|FG001|Overall Study|Logistical Difficulties|1|||
125168475|NCT02861014|450241128|FG000|Primary Analysis|Withdrawal by Subject|14|||
125168476|NCT02861014|450241128|FG000|Primary Analysis|Commercial ocrelizumab|3|||
125168477|NCT02861014|450241128|FG000|Safety Follow-up|Adverse Event|1|||
125168478|NCT02861014|450241128|FG000|Safety Follow-up|Pregnancy|1|||
125227623|NCT01764841|450462148|FG002|Overall Study|Logistical Difficulties|0|||
125168479|NCT02861014|450241128|FG000|Safety Follow-up|Withdrawal by Subject|9|||
125168480|NCT02861014|450241128|FG000|Safety Follow-up|Study terminated by sponsor|1|||
125168481|NCT02861014|450241128|FG000|Safety Follow-up|Physician Decision|1|||
125168482|NCT02861014|450241128|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
125168483|NCT02861014|450241128|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
125168484|NCT01756079|450241134|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
125168485|NCT01756079|450241134|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
125168486|NCT01756079|450241134|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
125168487|NCT01756079|450241134|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
125227624|NCT01764841|450462149|FG003|Overall Study|Logistical Difficulties|0|||
125227625|NCT01764841|450462146|FG000|Overall Study|Death|3|||
125227626|NCT01764841|450462147|FG001|Overall Study|Death|0|||
125227627|NCT01764841|450462148|FG002|Overall Study|Death|1|||
125227628|NCT01764841|450462149|FG003|Overall Study|Death|4|||
125227629|NCT01764841|450462146|FG000|Overall Study|No Follow Up|1|||
125227630|NCT01764841|450462147|FG001|Overall Study|No Follow Up|0|||
125227631|NCT01764841|450462148|FG002|Overall Study|No Follow Up|1|||
125227632|NCT01764841|450462149|FG003|Overall Study|No Follow Up|0|||
125227633|NCT01764841|450462146|FG000|Overall Study|Protocol Violation|0|||
125227634|NCT01764841|450462147|FG001|Overall Study|Protocol Violation|1|||
125227635|NCT01764841|450462148|FG002|Overall Study|Protocol Violation|0|||
125227636|NCT01764841|450462149|FG003|Overall Study|Protocol Violation|0|||
125227637|NCT01764841|450462146|FG000|Overall Study|Withdrawal by Subject|16|||
125227638|NCT01764841|450462147|FG001|Overall Study|Withdrawal by Subject|24|||
125227639|NCT01764841|450462148|FG002|Overall Study|Withdrawal by Subject|11|||
125227640|NCT01764841|450462149|FG003|Overall Study|Withdrawal by Subject|15|||
125227641|NCT01764841|450462146|FG000|Overall Study|Lost to Follow-up|3|||
125227642|NCT01764841|450462147|FG001|Overall Study|Lost to Follow-up|0|||
125227643|NCT01764841|450462148|FG002|Overall Study|Lost to Follow-up|1|||
125168488|NCT01756079|450241134|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
125168489|NCT02794246|450241135|FG000|Overall Study|Withdrawal by Subject|2|||
125168490|NCT02794246|450241135|FG000|Overall Study|Physician Decision|4|||
125168491|NCT01994291|450241136|FG000|Overall Study|Adverse Event|4|||
125168492|NCT01994291|450241137|FG001|Overall Study|Adverse Event|1|||
125168493|NCT01994291|450241138|FG002|Overall Study|Adverse Event|3|||
125168494|NCT01994291|450241136|FG000|Overall Study|Lost to Follow-up|1|||
125168495|NCT01994291|450241137|FG001|Overall Study|Lost to Follow-up|1|||
125168496|NCT01994291|450241138|FG002|Overall Study|Lost to Follow-up|0|||
125168497|NCT01994291|450241136|FG000|Overall Study|Does not meet entrance criteria|1|||
125168498|NCT01994291|450241137|FG001|Overall Study|Does not meet entrance criteria|0|||
125168499|NCT01994291|450241138|FG002|Overall Study|Does not meet entrance criteria|0|||
125168500|NCT01994291|450241136|FG000|Overall Study|Medication error without associated AE|1|||
125168501|NCT01994291|450241137|FG001|Overall Study|Medication error without associated AE|0|||
125168502|NCT01994291|450241138|FG002|Overall Study|Medication error without associated AE|1|||
125168503|NCT01994291|450241136|FG000|Overall Study|Protocol Violation|1|||
125168504|NCT01994291|450241137|FG001|Overall Study|Protocol Violation|0|||
125168505|NCT01994291|450241138|FG002|Overall Study|Protocol Violation|0|||
125168506|NCT01994291|450241136|FG000|Overall Study|Withdrawal by Subject|6|||
125168507|NCT01994291|450241137|FG001|Overall Study|Withdrawal by Subject|3|||
125168508|NCT01994291|450241138|FG002|Overall Study|Withdrawal by Subject|5|||
125168509|NCT01994291|450241136|FG000|Overall Study|Other|1|||
125168510|NCT01994291|450241137|FG001|Overall Study|Other|2|||
125168511|NCT01994291|450241138|FG002|Overall Study|Other|0|||
125168512|NCT00856375|450241141|FG000|Overall Study|Other|0|||
125168513|NCT00856375|450241142|FG001|Overall Study|Other|1|||
125168514|NCT00856375|450241141|FG000|Overall Study|Death|32|||
125168515|NCT00856375|450241142|FG001|Overall Study|Death|30|||
125168516|NCT00856375|450241141|FG000|Overall Study|Sponsor Terminated Study|7|||
125168517|NCT00856375|450241142|FG001|Overall Study|Sponsor Terminated Study|7|||
125168518|NCT00856375|450241141|FG000|Overall Study|Withdrawal by Subject|2|||
125168519|NCT00856375|450241142|FG001|Overall Study|Withdrawal by Subject|1|||
125168520|NCT00856375|450241141|FG000|Overall Study|Lost to Follow-up|1|||
125168521|NCT00856375|450241142|FG001|Overall Study|Lost to Follow-up|2|||
125168522|NCT03201445|450241149|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
125168523|NCT03201445|450241150|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
125168524|NCT03201445|450241149|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
125168525|NCT03201445|450241150|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
125168526|NCT03201445|450241149|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
125168527|NCT03201445|450241150|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
125168528|NCT03201445|450241149|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
125168529|NCT03201445|450241150|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
125168530|NCT03201445|450241149|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
125168531|NCT03201445|450241150|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
125168532|NCT03201445|450241149|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
125168533|NCT03201445|450241150|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
125168534|NCT03201445|450241149|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
125168535|NCT03201445|450241150|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
125168536|NCT03201445|450241149|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
125168537|NCT03201445|450241150|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
125168538|NCT03201445|450241149|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
125168539|NCT03201445|450241150|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
125168540|NCT03201445|450241149|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
125168541|NCT03201445|450241150|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
125168542|NCT03201445|450241149|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
125227644|NCT01764841|450462149|FG003|Overall Study|Lost to Follow-up|0|||
125227645|NCT01791985|450462151|FG000|Overall Study|Adverse Event|7|||
125227646|NCT01791985|450462151|FG000|Overall Study|Withdrawal by Subject|1|||
125227647|NCT01103323|450462152|FG000|Without/Before Drug Switch|Adverse Event|50|||
125168543|NCT03201445|450241150|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
125168544|NCT03201445|450241149|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
125168545|NCT03201445|450241150|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
125168546|NCT03201445|450241149|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
125227648|NCT01103323|450462153|FG001|Without/Before Drug Switch|Adverse Event|7|||
125227649|NCT01103323|450462152|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
125227650|NCT01103323|450462153|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
125227651|NCT01103323|450462152|FG000|Without/Before Drug Switch|Protocol Violation|2|||
125227652|NCT01103323|450462153|FG001|Without/Before Drug Switch|Protocol Violation|0|||
125227653|NCT01103323|450462152|FG000|Without/Before Drug Switch|Physician Decision|2|||
125227654|NCT01103323|450462153|FG001|Without/Before Drug Switch|Physician Decision|0|||
125227655|NCT01103323|450462152|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
125227656|NCT01103323|450462153|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
125227657|NCT01103323|450462152|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
125227658|NCT01103323|450462153|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
125227659|NCT01103323|450462152|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
125227660|NCT01103323|450462153|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
125227661|NCT00372424|450462154|FG000|Overall Study|Adverse Event|2|||
125227662|NCT00372424|450462154|FG000|Overall Study|Withdrawal by Subject|1|||
125227663|NCT00372424|450462154|FG000|Overall Study|Death|1|||
125227664|NCT00372424|450462154|FG000|Overall Study|Objective Progression or Relapse|14|||
125227665|NCT00372424|450462154|FG000|Overall Study|Other|7|||
125227666|NCT00372424|450462154|FG000|Overall Study|Enrolled, Not Treated|1|||
125227667|NCT00072410|450462155|FG000|Overall Study|Progressive disease|0|||
125227668|NCT00072410|450462156|FG001|Overall Study|Progressive disease|3|||
125227669|NCT02314728|450462162|FG000|Overall Study|Protocol Violation|1|||
125227670|NCT02314728|450462163|FG001|Overall Study|Protocol Violation|0|||
125227671|NCT02314728|450462162|FG000|Overall Study|Lost to Follow-up|0|||
125227672|NCT02314728|450462163|FG001|Overall Study|Lost to Follow-up|1|||
125227673|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
125227674|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
125227675|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
125227676|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
125227677|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
125227678|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
125227679|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
125168547|NCT03201445|450241150|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
125168548|NCT03201445|450241149|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
125168549|NCT03201445|450241150|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
125168550|NCT03201445|450241149|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
125168551|NCT03201445|450241150|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
125168552|NCT03201445|450241149|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
125168553|NCT03201445|450241150|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
125168554|NCT03201445|450241149|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
125168555|NCT03201445|450241150|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
125168556|NCT03201445|450241149|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
125168557|NCT03201445|450241150|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
125168558|NCT03201445|450241149|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
125168559|NCT03201445|450241150|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
125168560|NCT03201445|450241149|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
125168561|NCT03201445|450241150|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
125168562|NCT03201445|450241149|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
125227680|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
125227681|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
125227682|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
125227683|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
125227684|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
125227685|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
125227686|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
125227687|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
125227688|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
125227689|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
125227690|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
125227691|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
125227692|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
125227693|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
125227694|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
125227695|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
125227696|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
125227697|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
125227698|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
125227699|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
125227700|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
125227701|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
125227702|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
125227703|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
125227704|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
125227705|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
125168563|NCT03201445|450241150|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
125168564|NCT01228019|450241151|FG000|Overall Study|Dose Violation|70|||
125168565|NCT01228019|450241151|FG000|Overall Study|Duplicate enrollment|1|||
125168566|NCT01228019|450241151|FG000|Overall Study|Missing pre-treatment data|72|||
125168567|NCT01228019|450241151|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
125168568|NCT01228019|450241151|FG000|Overall Study|Violation of Entry Criterion|9|||
125168569|NCT02087189|450241154|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
125168570|NCT01189487|450241159|FG000|Overall Study|Lack of Efficacy|2|||
125168571|NCT01189487|450241159|FG000|Overall Study|Adverse Event|1|||
125168572|NCT04630158|450241160|FG000|Overall Study|Adverse Event|1|||
125168573|NCT04630158|450241161|FG001|Overall Study|Adverse Event|1|||
125168574|NCT04630158|450241162|FG002|Overall Study|Adverse Event|1|||
125168575|NCT04630158|450241160|FG000|Overall Study|Physician Decision|0|||
125168576|NCT04630158|450241161|FG001|Overall Study|Physician Decision|2|||
125168577|NCT04630158|450241162|FG002|Overall Study|Physician Decision|0|||
125168578|NCT04630158|450241160|FG000|Overall Study|Protocol Violation|1|||
125168579|NCT04630158|450241161|FG001|Overall Study|Protocol Violation|0|||
125168580|NCT04630158|450241162|FG002|Overall Study|Protocol Violation|1|||
125168581|NCT04630158|450241160|FG000|Overall Study|Withdrawal by Subject|2|||
125168582|NCT04630158|450241161|FG001|Overall Study|Withdrawal by Subject|1|||
125168583|NCT04630158|450241162|FG002|Overall Study|Withdrawal by Subject|2|||
125168584|NCT03136965|450241167|FG000|Overall Study|Lost to Follow-up|0|||
125168585|NCT03136965|450241168|FG001|Overall Study|Lost to Follow-up|1|||
125168586|NCT03136965|450241169|FG002|Overall Study|Lost to Follow-up|0|||
125168587|NCT03485365|450241170|FG000|Overall Study|Protocol Violation|0|||
125168588|NCT03485365|450241171|FG001|Overall Study|Protocol Violation|0|||
125168589|NCT03485365|450241172|FG002|Overall Study|Protocol Violation|0|||
125168590|NCT03485365|450241173|FG003|Overall Study|Protocol Violation|1|||
125168591|NCT03485365|450241174|FG004|Overall Study|Protocol Violation|0|||
125168592|NCT03485365|450241175|FG005|Overall Study|Protocol Violation|0|||
125168593|NCT03485365|450241176|FG006|Overall Study|Protocol Violation|1|||
125168594|NCT03485365|450241177|FG007|Overall Study|Protocol Violation|0|||
125168595|NCT03485365|450241178|FG008|Overall Study|Protocol Violation|0|||
125168596|NCT04868968|450241179|FG000|Overall Study|Lost to Follow-up|1|||
125168597|NCT02910063|450241186|FG000|Phase 2|Withdrawal by Subject|3|||
125168598|NCT02910063|450241187|FG001|Phase 2|Withdrawal by Subject|0|||
125168599|NCT02910063|450241188|FG002|Phase 2|Withdrawal by Subject|0|||
125168600|NCT02910063|450241186|FG000|Phase 2|Lost to Follow-up|1|||
125168601|NCT02910063|450241187|FG001|Phase 2|Lost to Follow-up|0|||
125168602|NCT02910063|450241188|FG002|Phase 2|Lost to Follow-up|0|||
125168603|NCT02910063|450241186|FG000|Phase 2|Death|24|||
125168604|NCT02910063|450241187|FG001|Phase 2|Death|0|||
125168605|NCT02910063|450241188|FG002|Phase 2|Death|0|||
125168606|NCT02752087|450241189|FG000|Washout|Physician Decision|1|||
125168607|NCT02752087|450241190|FG001|Washout|Physician Decision|0|||
125168608|NCT00843635|450241191|FG000|Overall Study|Adverse Event|2|||
125168609|NCT00843635|450241192|FG001|Overall Study|Adverse Event|2|||
125168610|NCT00843635|450241193|FG002|Overall Study|Adverse Event|0|||
125227706|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
125168611|NCT01547130|450241194|FG000|Overall Study|Lost to Follow-up|9|||
125168612|NCT01547130|450241195|FG001|Overall Study|Lost to Follow-up|5|||
125168613|NCT03496610|450241196|FG000|Overall Study|Lost to Follow-up|3|||
125168614|NCT03496610|450241197|FG001|Overall Study|Lost to Follow-up|2|||
125168615|NCT03496610|450241196|FG000|Overall Study|Physician Decision|1|||
125168616|NCT03496610|450241197|FG001|Overall Study|Physician Decision|0|||
125168617|NCT03496610|450241196|FG000|Overall Study|Withdrawal by Subject|1|||
125168618|NCT03496610|450241197|FG001|Overall Study|Withdrawal by Subject|0|||
125168619|NCT04435184|450241198|FG000|Overall Study|follow-up blood draws missing|3|||
125168620|NCT04435184|450241199|FG001|Overall Study|follow-up blood draws missing|5|||
125168621|NCT02714426|450241200|FG000|Overall Study|Withdrawal by Subject|2|||
125168622|NCT02714426|450241201|FG001|Overall Study|Withdrawal by Subject|2|||
125168623|NCT04762277|450241205|FG000|Overall Study|Withdrawal by Subject|0|||
125168624|NCT04762277|450241206|FG001|Overall Study|Withdrawal by Subject|2|||
125168625|NCT04762277|450241205|FG000|Overall Study|Protocol Violation|0|||
125168626|NCT04762277|450241206|FG001|Overall Study|Protocol Violation|1|||
125168627|NCT04762277|450241205|FG000|Overall Study|Adverse Event|1|||
125168628|NCT04762277|450241206|FG001|Overall Study|Adverse Event|0|||
125168629|NCT01860677|450241207|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
125168630|NCT01860677|450241208|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
125168631|NCT00642278|450241209|FG000|Overall Study|Adverse Event|2|||
125168632|NCT00642278|450241210|FG001|Overall Study|Adverse Event|1|||
125168633|NCT00642278|450241211|FG002|Overall Study|Adverse Event|3|||
125168634|NCT00642278|450241212|FG003|Overall Study|Adverse Event|1|||
125168635|NCT00642278|450241213|FG004|Overall Study|Adverse Event|2|||
125168636|NCT00642278|450241214|FG005|Overall Study|Adverse Event|2|||
125168637|NCT00642278|450241215|FG006|Overall Study|Adverse Event|0|||
125168638|NCT00642278|450241209|FG000|Overall Study|Lack of Efficacy|0|||
125168639|NCT00642278|450241210|FG001|Overall Study|Lack of Efficacy|1|||
125168640|NCT00642278|450241211|FG002|Overall Study|Lack of Efficacy|0|||
125168641|NCT00642278|450241212|FG003|Overall Study|Lack of Efficacy|0|||
125168642|NCT00642278|450241213|FG004|Overall Study|Lack of Efficacy|0|||
125168643|NCT00642278|450241214|FG005|Overall Study|Lack of Efficacy|0|||
125168644|NCT00642278|450241215|FG006|Overall Study|Lack of Efficacy|0|||
125168645|NCT00642278|450241209|FG000|Overall Study|Lost to Follow-up|5|||
125168646|NCT00642278|450241210|FG001|Overall Study|Lost to Follow-up|1|||
125168647|NCT00642278|450241211|FG002|Overall Study|Lost to Follow-up|0|||
125168648|NCT00642278|450241212|FG003|Overall Study|Lost to Follow-up|1|||
125168649|NCT00642278|450241213|FG004|Overall Study|Lost to Follow-up|0|||
125168650|NCT00642278|450241214|FG005|Overall Study|Lost to Follow-up|1|||
125168651|NCT00642278|450241215|FG006|Overall Study|Lost to Follow-up|1|||
125168652|NCT00642278|450241209|FG000|Overall Study|Physician Decision|0|||
125168653|NCT00642278|450241210|FG001|Overall Study|Physician Decision|0|||
125168654|NCT00642278|450241211|FG002|Overall Study|Physician Decision|0|||
125168655|NCT00642278|450241212|FG003|Overall Study|Physician Decision|1|||
125168656|NCT00642278|450241213|FG004|Overall Study|Physician Decision|0|||
125168657|NCT00642278|450241214|FG005|Overall Study|Physician Decision|0|||
125168658|NCT00642278|450241215|FG006|Overall Study|Physician Decision|0|||
125168659|NCT00642278|450241209|FG000|Overall Study|Protocol Violation|0|||
125168660|NCT00642278|450241210|FG001|Overall Study|Protocol Violation|0|||
125168661|NCT00642278|450241211|FG002|Overall Study|Protocol Violation|1|||
125168662|NCT00642278|450241212|FG003|Overall Study|Protocol Violation|1|||
125168663|NCT00642278|450241213|FG004|Overall Study|Protocol Violation|0|||
125168664|NCT00642278|450241214|FG005|Overall Study|Protocol Violation|1|||
125168665|NCT00642278|450241215|FG006|Overall Study|Protocol Violation|2|||
125168666|NCT00642278|450241209|FG000|Overall Study|Withdrawal by Subject|1|||
125168667|NCT00642278|450241210|FG001|Overall Study|Withdrawal by Subject|1|||
125168668|NCT00642278|450241211|FG002|Overall Study|Withdrawal by Subject|1|||
125168669|NCT00642278|450241212|FG003|Overall Study|Withdrawal by Subject|3|||
125168670|NCT00642278|450241213|FG004|Overall Study|Withdrawal by Subject|6|||
125168671|NCT00642278|450241214|FG005|Overall Study|Withdrawal by Subject|2|||
125168672|NCT00642278|450241215|FG006|Overall Study|Withdrawal by Subject|2|||
125168673|NCT00642278|450241209|FG000|Overall Study|Noncompliance with study drug regimen|0|||
125168674|NCT00642278|450241210|FG001|Overall Study|Noncompliance with study drug regimen|0|||
125168675|NCT00642278|450241211|FG002|Overall Study|Noncompliance with study drug regimen|0|||
125168676|NCT00642278|450241212|FG003|Overall Study|Noncompliance with study drug regimen|1|||
125168677|NCT00642278|450241213|FG004|Overall Study|Noncompliance with study drug regimen|0|||
125168678|NCT00642278|450241214|FG005|Overall Study|Noncompliance with study drug regimen|0|||
125168679|NCT00642278|450241215|FG006|Overall Study|Noncompliance with study drug regimen|0|||
125168680|NCT00642278|450241209|FG000|Overall Study|Other|2|||
125168681|NCT00642278|450241210|FG001|Overall Study|Other|1|||
125168682|NCT00642278|450241211|FG002|Overall Study|Other|0|||
125168683|NCT00642278|450241212|FG003|Overall Study|Other|1|||
125168684|NCT00642278|450241213|FG004|Overall Study|Other|0|||
125168685|NCT00642278|450241214|FG005|Overall Study|Other|1|||
125168686|NCT00642278|450241215|FG006|Overall Study|Other|0|||
125168687|NCT00090363|450241216|FG000|Overall Study|Lost to Follow-up|1|||
125168688|NCT00090363|450241217|FG001|Overall Study|Lost to Follow-up|2|||
125168689|NCT00090363|450241218|FG002|Overall Study|Lost to Follow-up|1|||
125168690|NCT00090363|450241216|FG000|Overall Study|Withdrawal by Subject|7|||
125168691|NCT00090363|450241217|FG001|Overall Study|Withdrawal by Subject|7|||
125168692|NCT00090363|450241218|FG002|Overall Study|Withdrawal by Subject|6|||
125168693|NCT00090363|450241216|FG000|Overall Study|Study-specific discontinuation criteria|75|||
125168694|NCT00090363|450241217|FG001|Overall Study|Study-specific discontinuation criteria|74|||
125168695|NCT00090363|450241218|FG002|Overall Study|Study-specific discontinuation criteria|62|||
125168696|NCT00090363|450241216|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125168697|NCT00090363|450241217|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125168698|NCT00090363|450241218|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
125168699|NCT00090363|450241216|FG000|Overall Study|Consent expired|7|||
125168700|NCT00090363|450241217|FG001|Overall Study|Consent expired|10|||
125168701|NCT00090363|450241218|FG002|Overall Study|Consent expired|9|||
125168702|NCT00090363|450241216|FG000|Overall Study|Reasons not specified|2|||
125168703|NCT00090363|450241217|FG001|Overall Study|Reasons not specified|1|||
125168704|NCT00090363|450241218|FG002|Overall Study|Reasons not specified|1|||
125168705|NCT00090363|450241216|FG000|Overall Study|Continuing on study off treatment|14|||
125168706|NCT00090363|450241217|FG001|Overall Study|Continuing on study off treatment|13|||
125168707|NCT00090363|450241218|FG002|Overall Study|Continuing on study off treatment|16|||
125168708|NCT03713619|450241219|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
125168709|NCT03713619|450241220|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
125168710|NCT03713619|450241221|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
125168711|NCT03713619|450241222|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
125168712|NCT03713619|450241223|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
125168713|NCT03713619|450241219|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
125168714|NCT03713619|450241220|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
125168715|NCT03713619|450241221|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
125168716|NCT03713619|450241222|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
125168717|NCT03713619|450241223|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
125168718|NCT03713619|450241219|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
125168719|NCT03713619|450241220|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
125168720|NCT03713619|450241221|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
125168721|NCT03713619|450241222|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
125168722|NCT03713619|450241223|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
125168723|NCT03713619|450241219|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
125168724|NCT03713619|450241220|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
125168725|NCT03713619|450241221|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
125168726|NCT03713619|450241222|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
125168727|NCT03713619|450241223|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
125168728|NCT03713619|450241219|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
125168729|NCT03713619|450241220|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
125168730|NCT03713619|450241221|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
125168731|NCT03713619|450241222|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
125168732|NCT03713619|450241223|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
125168733|NCT03713619|450241219|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
125168734|NCT03713619|450241220|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
125168735|NCT03713619|450241221|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
125168736|NCT03713619|450241222|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
125168737|NCT03713619|450241223|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
125168738|NCT03713619|450241219|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
125168739|NCT03713619|450241220|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
125168740|NCT03713619|450241221|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
125168741|NCT03713619|450241222|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
125168742|NCT03713619|450241223|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
125168743|NCT03713619|450241219|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
125168744|NCT03713619|450241220|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
125168745|NCT03713619|450241221|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
125168746|NCT03713619|450241222|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
125168747|NCT03713619|450241223|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
125168748|NCT03713619|450241219|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
125168749|NCT03713619|450241220|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
125168750|NCT03713619|450241221|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
125168751|NCT03713619|450241222|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
125168752|NCT03713619|450241223|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
125168753|NCT03713619|450241219|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
125168754|NCT03713619|450241220|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
125168755|NCT03713619|450241221|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
125168756|NCT03713619|450241222|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
125168757|NCT03713619|450241223|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
125168758|NCT03713619|450241219|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
125168759|NCT03713619|450241220|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
125168760|NCT03713619|450241221|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
125168761|NCT03713619|450241222|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
125168762|NCT03713619|450241223|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
125168763|NCT03713619|450241219|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
125168764|NCT03713619|450241220|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
125168765|NCT03713619|450241221|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
125168766|NCT03713619|450241222|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
125168767|NCT03713619|450241223|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
125168768|NCT03713619|450241219|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
125168769|NCT03713619|450241220|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
125168770|NCT03713619|450241221|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
125168771|NCT03713619|450241222|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
125168772|NCT03713619|450241223|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
125168773|NCT06281171|450241224|FG000|Timepoint 2|Lost to Follow-up|6|||
125168774|NCT06281171|450241225|FG001|Timepoint 2|Lost to Follow-up|4|||
125168775|NCT06281171|450241224|FG000|Timepoint 3|Lost to Follow-up|0|||
125168776|NCT06281171|450241225|FG001|Timepoint 3|Lost to Follow-up|5|||
125168777|NCT02552212|450241226|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
125168778|NCT02552212|450241227|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
125168779|NCT02552212|450241228|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
125168780|NCT02552212|450241226|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
125168781|NCT02552212|450241227|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
125168782|NCT02552212|450241228|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
125168783|NCT02552212|450241226|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
125168784|NCT02552212|450241227|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
125168785|NCT02552212|450241228|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
125168786|NCT02552212|450241226|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
125168787|NCT02552212|450241227|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
125168788|NCT02552212|450241228|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
125168789|NCT02552212|450241226|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
125168790|NCT02552212|450241227|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
125168791|NCT02552212|450241228|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
125168792|NCT02552212|450241226|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
125168793|NCT02552212|450241227|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
125168794|NCT02552212|450241228|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
125168795|NCT02552212|450241226|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
125168796|NCT02552212|450241227|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
125168797|NCT02552212|450241228|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
125168798|NCT02552212|450241226|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
125168799|NCT02552212|450241227|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
125168800|NCT02552212|450241228|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
125168801|NCT02552212|450241226|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
125168802|NCT02552212|450241227|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
125168803|NCT02552212|450241228|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
125168804|NCT02552212|450241226|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
125168805|NCT02552212|450241227|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
125168806|NCT02552212|450241228|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
125168807|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
125168808|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
125168809|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
125168810|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
125168811|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
125168812|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
125168813|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
125168814|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
125168815|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
125168816|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
125168817|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
125168818|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
125168819|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
125168820|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
125168821|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
125168822|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
125168823|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
125168824|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
125168825|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
125168826|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
125168827|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
125168828|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
125168829|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
125168830|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
125168831|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
125168832|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
125168833|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
125168834|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
125168835|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
125168836|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
125168837|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
125168838|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
125168839|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
125168840|NCT04572893|450241231|FG000|Part A|Adverse Event|1|||
125168841|NCT04572893|450241232|FG001|Part A|Adverse Event|0|||
125168842|NCT04572893|450241233|FG002|Part A|Adverse Event|0|||
125168843|NCT04572893|450241234|FG003|Part A|Adverse Event|0|||
125168844|NCT04572893|450241235|FG004|Part A|Adverse Event|0|||
125168845|NCT04572893|450241236|FG005|Part A|Adverse Event|0|||
125168846|NCT04572893|450241237|FG006|Part A|Adverse Event|0|||
125168847|NCT04572893|450241231|FG000|Part B|Withdrawal by Subject|0|||
125168848|NCT04572893|450241232|FG001|Part B|Withdrawal by Subject|0|||
125168849|NCT04572893|450241233|FG002|Part B|Withdrawal by Subject|0|||
125168850|NCT04572893|450241234|FG003|Part B|Withdrawal by Subject|0|||
125168851|NCT04572893|450241235|FG004|Part B|Withdrawal by Subject|0|||
125168852|NCT04572893|450241236|FG005|Part B|Withdrawal by Subject|1|||
125168853|NCT04572893|450241237|FG006|Part B|Withdrawal by Subject|0|||
125168854|NCT04572893|450241231|FG000|Part B|Study terminated by sponsor|0|||
125168855|NCT04572893|450241232|FG001|Part B|Study terminated by sponsor|0|||
125168856|NCT04572893|450241233|FG002|Part B|Study terminated by sponsor|0|||
125168857|NCT04572893|450241234|FG003|Part B|Study terminated by sponsor|0|||
125168858|NCT04572893|450241235|FG004|Part B|Study terminated by sponsor|7|||
125168859|NCT04572893|450241236|FG005|Part B|Study terminated by sponsor|5|||
125168860|NCT04572893|450241237|FG006|Part B|Study terminated by sponsor|3|||
125168861|NCT04572893|450241231|FG000|Part B|Lost to Follow-up|0|||
125168862|NCT04572893|450241232|FG001|Part B|Lost to Follow-up|0|||
125168863|NCT04572893|450241233|FG002|Part B|Lost to Follow-up|0|||
125168864|NCT04572893|450241234|FG003|Part B|Lost to Follow-up|0|||
125168865|NCT04572893|450241235|FG004|Part B|Lost to Follow-up|0|||
125168866|NCT04572893|450241236|FG005|Part B|Lost to Follow-up|0|||
125168867|NCT04572893|450241237|FG006|Part B|Lost to Follow-up|1|||
125168868|NCT04572893|450241231|FG000|Part B|Adverse Event|0|||
125168869|NCT04572893|450241232|FG001|Part B|Adverse Event|0|||
125168870|NCT04572893|450241233|FG002|Part B|Adverse Event|0|||
125168871|NCT04572893|450241234|FG003|Part B|Adverse Event|0|||
125168872|NCT04572893|450241235|FG004|Part B|Adverse Event|1|||
125168873|NCT04572893|450241236|FG005|Part B|Adverse Event|1|||
125168874|NCT04572893|450241237|FG006|Part B|Adverse Event|0|||
125168875|NCT00197496|450241238|FG000|Baseline to Discharge|not interested|1|||
125168876|NCT00197496|450241239|FG001|Baseline to Discharge|not interested|0|||
125168877|NCT00197496|450241238|FG000|Baseline to Discharge|MRSA|1|||
125168878|NCT00197496|450241239|FG001|Baseline to Discharge|MRSA|0|||
125168879|NCT00197496|450241238|FG000|Baseline to Discharge|Physician Decision|0|||
125168880|NCT00197496|450241239|FG001|Baseline to Discharge|Physician Decision|1|||
125168881|NCT00197496|450241238|FG000|Baseline to Discharge|Protocol Violation|0|||
125168882|NCT00197496|450241239|FG001|Baseline to Discharge|Protocol Violation|1|||
125168883|NCT00197496|450241238|FG000|Follow-up|Lost to Follow-up|2|||
125168884|NCT00197496|450241239|FG001|Follow-up|Lost to Follow-up|1|||
125168885|NCT00418821|450241240|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
125168886|NCT00103610|450241241|FG000|Overall Study|Entered Rescue Procedure|10|||
125168887|NCT00103610|450241242|FG001|Overall Study|Entered Rescue Procedure|52|||
125168888|NCT00103610|450241241|FG000|Overall Study|Death|16|||
125168889|NCT00103610|450241242|FG001|Overall Study|Death|12|||
125168890|NCT00103610|450241241|FG000|Overall Study|Elective Withdrawal|4|||
125168891|NCT00103610|450241242|FG001|Overall Study|Elective Withdrawal|0|||
125168892|NCT00103610|450241241|FG000|Overall Study|Lost to Follow-up|3|||
125168893|NCT00103610|450241242|FG001|Overall Study|Lost to Follow-up|1|||
125168894|NCT00103610|450241241|FG000|Overall Study|Adverse Event|2|||
125168895|NCT00103610|450241242|FG001|Overall Study|Adverse Event|2|||
125168896|NCT00103610|450241241|FG000|Overall Study|Other|2|||
125168897|NCT00103610|450241242|FG001|Overall Study|Other|7|||
125168898|NCT00103610|450241241|FG000|Overall Study|Failed mobilization|1|||
125168899|NCT00103610|450241242|FG001|Overall Study|Failed mobilization|5|||
125168900|NCT00103610|450241241|FG000|Overall Study|Noncompliance|0|||
125168901|NCT00103610|450241242|FG001|Overall Study|Noncompliance|1|||
125168902|NCT04042376|450241255|FG000|Overall Study|Withdrawal by Subject|1|||
125168903|NCT04042376|450241255|FG000|Overall Study|Death|3|||
125168904|NCT00213135|450242979|FG000|Overall Study|Adverse Event|9|||
125168905|NCT00213135|450242980|FG001|Overall Study|Adverse Event|5|||
125168906|NCT00213135|450242981|FG002|Overall Study|Adverse Event|5|||
125168907|NCT00213135|450242979|FG000|Overall Study|Lost to Follow-up|11|||
125168908|NCT00213135|450242980|FG001|Overall Study|Lost to Follow-up|8|||
125168909|NCT00213135|450242981|FG002|Overall Study|Lost to Follow-up|4|||
125168910|NCT00213135|450242979|FG000|Overall Study|Protocol Violation|4|||
125168911|NCT00213135|450242980|FG001|Overall Study|Protocol Violation|4|||
125168912|NCT00213135|450242981|FG002|Overall Study|Protocol Violation|10|||
125168913|NCT00213135|450242979|FG000|Overall Study|Death|1|||
125168914|NCT00213135|450242980|FG001|Overall Study|Death|1|||
125168915|NCT00213135|450242981|FG002|Overall Study|Death|2|||
125168916|NCT00213135|450242979|FG000|Overall Study|Disease progression|4|||
125168917|NCT00213135|450242980|FG001|Overall Study|Disease progression|5|||
125168918|NCT00213135|450242981|FG002|Overall Study|Disease progression|21|||
125168919|NCT00213135|450242979|FG000|Overall Study|Other|21|||
125168920|NCT00213135|450242980|FG001|Overall Study|Other|12|||
125168921|NCT00213135|450242981|FG002|Overall Study|Other|15|||
125168922|NCT00359801|450242982|FG000|Overall Study|Lost to Follow-up|72|||
125168923|NCT00359801|450242983|FG001|Overall Study|Lost to Follow-up|58|||
125168924|NCT00359801|450242982|FG000|Overall Study|Withdrawal by Subject|143|||
125168925|NCT00359801|450242983|FG001|Overall Study|Withdrawal by Subject|96|||
125168926|NCT00359801|450242982|FG000|Overall Study|Other|66|||
125168927|NCT00359801|450242983|FG001|Overall Study|Other|46|||
125168928|NCT00359801|450242982|FG000|Overall Study|Final Status Unknown: missing data|7|||
125168929|NCT00359801|450242983|FG001|Overall Study|Final Status Unknown: missing data|4|||
125168930|NCT00359801|450242982|FG000|Overall Study|Sponsor Decision|17|||
125168931|NCT00359801|450242983|FG001|Overall Study|Sponsor Decision|16|||
125168932|NCT01396512|450242985|FG000|Overall Study|Withdrawal by Subject|0|||
125168933|NCT01396512|450242986|FG001|Overall Study|Withdrawal by Subject|1|||
125168934|NCT02500043|450242989|FG000|Overall Study|Randomized, but not Treated|2|||
125168935|NCT02500043|450242990|FG001|Overall Study|Randomized, but not Treated|2|||
125168936|NCT02500043|450242989|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
125168937|NCT02500043|450242990|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
125168938|NCT02500043|450242989|FG000|Overall Study|Adverse Event|33|||
125168939|NCT02500043|450242990|FG001|Overall Study|Adverse Event|11|||
125168940|NCT02500043|450242989|FG000|Overall Study|Clinical Progression|54|||
125168941|NCT02500043|450242990|FG001|Overall Study|Clinical Progression|35|||
125168942|NCT02500043|450242989|FG000|Overall Study|Radiological Progression|192|||
125168943|NCT02500043|450242990|FG001|Overall Study|Radiological Progression|110|||
125168944|NCT02500043|450242989|FG000|Overall Study|Physician's Decision|11|||
125168945|NCT02500043|450242990|FG001|Overall Study|Physician's Decision|3|||
125168946|NCT02500043|450242989|FG000|Overall Study|Withdrawal by Subject|14|||
125168947|NCT02500043|450242990|FG001|Overall Study|Withdrawal by Subject|4|||
125168948|NCT02500043|450242989|FG000|Overall Study|Death|11|||
125168949|NCT02500043|450242990|FG001|Overall Study|Death|2|||
125168950|NCT02500043|450242989|FG000|Overall Study|Protocol Deviation|1|||
125168951|NCT02500043|450242990|FG001|Overall Study|Protocol Deviation|0|||
125168952|NCT02094417|450242991|FG000|Overall Study|Adverse Event|0|||
125168953|NCT02094417|450242992|FG001|Overall Study|Adverse Event|0|||
125168954|NCT02094417|450242993|FG002|Overall Study|Adverse Event|0|||
125168955|NCT02094417|450242994|FG003|Overall Study|Adverse Event|1|||
125168956|NCT02094417|450242991|FG000|Overall Study|Eligibility criteria|0|||
125168957|NCT02094417|450242992|FG001|Overall Study|Eligibility criteria|1|||
125168958|NCT02094417|450242993|FG002|Overall Study|Eligibility criteria|0|||
125168959|NCT02094417|450242994|FG003|Overall Study|Eligibility criteria|0|||
125168960|NCT02094417|450242991|FG000|Overall Study|No responder|4|||
125168961|NCT02094417|450242992|FG001|Overall Study|No responder|4|||
125168962|NCT02094417|450242993|FG002|Overall Study|No responder|4|||
125168963|NCT02094417|450242994|FG003|Overall Study|No responder|3|||
125168964|NCT02094417|450242991|FG000|Overall Study|Unable to conduct observations or assess|0|||
125168965|NCT02094417|450242992|FG001|Overall Study|Unable to conduct observations or assess|1|||
125168966|NCT02094417|450242993|FG002|Overall Study|Unable to conduct observations or assess|0|||
125168967|NCT02094417|450242994|FG003|Overall Study|Unable to conduct observations or assess|0|||
125168968|NCT02094417|450242991|FG000|Overall Study|Withdrawal by Subject|1|||
125168969|NCT02094417|450242992|FG001|Overall Study|Withdrawal by Subject|2|||
125168970|NCT02094417|450242993|FG002|Overall Study|Withdrawal by Subject|1|||
125168971|NCT02094417|450242994|FG003|Overall Study|Withdrawal by Subject|3|||
125168972|NCT03301649|450242997|FG000|Overall Study|Need alternate therapy due to live lice|17|||
125168973|NCT03301649|450242998|FG001|Overall Study|Need alternate therapy due to live lice|25|||
125168974|NCT03301649|450242999|FG002|Overall Study|Need alternate therapy due to live lice|81|||
125168975|NCT03301649|450242997|FG000|Overall Study|Lost to Follow-up|11|||
125168976|NCT03301649|450242998|FG001|Overall Study|Lost to Follow-up|11|||
125168977|NCT03301649|450242999|FG002|Overall Study|Lost to Follow-up|3|||
125168978|NCT03301649|450242997|FG000|Overall Study|Protocol Violation|0|||
125168979|NCT03301649|450242998|FG001|Overall Study|Protocol Violation|1|||
125168980|NCT03301649|450242999|FG002|Overall Study|Protocol Violation|1|||
125168981|NCT03301649|450242997|FG000|Overall Study|Withdrawal by Subject|10|||
125168982|NCT03301649|450242998|FG001|Overall Study|Withdrawal by Subject|4|||
125168983|NCT03301649|450242999|FG002|Overall Study|Withdrawal by Subject|0|||
125227707|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
125168984|NCT03301649|450242997|FG000|Overall Study|Other than specified|5|||
125168985|NCT03301649|450242998|FG001|Overall Study|Other than specified|3|||
125227708|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
125168986|NCT03301649|450242999|FG002|Overall Study|Other than specified|0|||
125168987|NCT01564537|450243000|FG000|Overall Study|Site Terminated by Sponsor|1|||
125168988|NCT01564537|450243001|FG001|Overall Study|Site Terminated by Sponsor|0|||
125168989|NCT01564537|450243000|FG000|Overall Study|Withdrawal by Subject|12|||
125168990|NCT01564537|450243001|FG001|Overall Study|Withdrawal by Subject|14|||
125168991|NCT01564537|450243000|FG000|Overall Study|Lost to Follow-up|7|||
125168992|NCT01564537|450243001|FG001|Overall Study|Lost to Follow-up|3|||
125168993|NCT01564537|450243000|FG000|Overall Study|Reason not specified|81|||
125168994|NCT01564537|450243001|FG001|Overall Study|Reason not specified|82|||
125168995|NCT01635218|450243002|FG000|Overall Study|Lost to Follow-up|3|||
125168996|NCT01635218|450243003|FG001|Overall Study|Lost to Follow-up|7|||
125168997|NCT01635218|450243004|FG002|Overall Study|Lost to Follow-up|6|||
125168998|NCT03559400|450243005|FG000|Overall Study|Lost to Follow-up|9|||
125168999|NCT03559400|450243006|FG001|Overall Study|Lost to Follow-up|7|||
125169000|NCT03559400|450243005|FG000|Overall Study|Death|0|||
125169001|NCT03559400|450243006|FG001|Overall Study|Death|2|||
125169002|NCT03262038|450243007|FG000|Overall Study|Withdrawal by Subject|0|||
125169003|NCT03262038|450243008|FG001|Overall Study|Withdrawal by Subject|1|||
125169004|NCT02679235|450243009|FG000|Overall Study|Withdrawal by Subject|3|||
125169005|NCT02679235|450243009|FG000|Overall Study|Adverse Event|1|||
125169006|NCT00094861|450243010|FG000|Overall Study|Adverse Event|5|||
125169007|NCT00094861|450243011|FG001|Overall Study|Adverse Event|2|||
125169008|NCT00094861|450243010|FG000|Overall Study|Withdrawal by Subject|5|||
125169009|NCT00094861|450243011|FG001|Overall Study|Withdrawal by Subject|3|||
125169010|NCT00094861|450243010|FG000|Overall Study|Physician Decision|1|||
125169011|NCT00094861|450243011|FG001|Overall Study|Physician Decision|1|||
125169012|NCT00094861|450243010|FG000|Overall Study|Lost to Follow-up|0|||
125169013|NCT00094861|450243011|FG001|Overall Study|Lost to Follow-up|1|||
125169014|NCT00094861|450243010|FG000|Overall Study|Death|4|||
125169015|NCT00094861|450243011|FG001|Overall Study|Death|2|||
125169016|NCT00094861|450243010|FG000|Overall Study|Other|3|||
125169017|NCT00094861|450243011|FG001|Overall Study|Other|0|||
125169018|NCT02549027|450243013|FG000|Washout After Period 4|Withdrawal by Subject|0|||
125169019|NCT02549027|450243014|FG001|Washout After Period 4|Withdrawal by Subject|1|||
125169020|NCT02549027|450243015|FG002|Washout After Period 4|Withdrawal by Subject|1|||
125169021|NCT02549027|450243016|FG003|Washout After Period 4|Withdrawal by Subject|1|||
125169022|NCT02549027|450243017|FG004|Washout After Period 4|Withdrawal by Subject|0|||
125169023|NCT02549027|450243018|FG005|Washout After Period 4|Withdrawal by Subject|0|||
125169024|NCT02549027|450243013|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
125169025|NCT02549027|450243014|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
125169026|NCT02549027|450243015|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
125169027|NCT02549027|450243016|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
125169028|NCT02549027|450243017|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
125169029|NCT02549027|450243018|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
125169030|NCT01421511|450243024|FG000|Overall Study|Lost to Follow-up|11|||
125169031|NCT01421511|450243025|FG001|Overall Study|Lost to Follow-up|14|||
125169032|NCT01421511|450243024|FG000|Overall Study|Randomized but didn't receive study drug|1|||
125169033|NCT01421511|450243025|FG001|Overall Study|Randomized but didn't receive study drug|7|||
125169034|NCT01421511|450243024|FG000|Overall Study|Physician Decision|0|||
125227709|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
125227710|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
125227711|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
125227712|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
125227713|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
125227714|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
125227715|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
125169035|NCT01421511|450243025|FG001|Overall Study|Physician Decision|1|||
125169036|NCT01421511|450243024|FG000|Overall Study|Withdrawal by Subject|6|||
125169037|NCT01421511|450243025|FG001|Overall Study|Withdrawal by Subject|5|||
125169038|NCT01421511|450243024|FG000|Overall Study|Death|1|||
125169039|NCT01421511|450243025|FG001|Overall Study|Death|1|||
125169040|NCT04581369|450243026|FG000|Overall Study|Death|7|||
125169041|NCT04581369|450243027|FG001|Overall Study|Death|6|||
125169042|NCT04581369|450243028|FG002|Overall Study|Death|0|||
125169043|NCT04581369|450243026|FG000|Overall Study|Lost to Follow-up|7|||
125169044|NCT04581369|450243027|FG001|Overall Study|Lost to Follow-up|3|||
125169045|NCT04581369|450243028|FG002|Overall Study|Lost to Follow-up|0|||
125169046|NCT04581369|450243026|FG000|Overall Study|liver transplant|2|||
125169047|NCT04581369|450243027|FG001|Overall Study|liver transplant|2|||
125169048|NCT04581369|450243028|FG002|Overall Study|liver transplant|0|||
125169049|NCT04581369|450243026|FG000|Overall Study|transitioned to hospice care|0|||
125169050|NCT04581369|450243027|FG001|Overall Study|transitioned to hospice care|5|||
125169051|NCT04581369|450243028|FG002|Overall Study|transitioned to hospice care|0|||
125169052|NCT00780910|450243029|FG000|Overall Study|Adverse Event|2|||
125169053|NCT01111825|450243030|FG000|Overall Study|Withdrawal by Subject|0|||
125169054|NCT01111825|450243031|FG001|Overall Study|Withdrawal by Subject|0|||
125169055|NCT01111825|450243032|FG002|Overall Study|Withdrawal by Subject|1|||
125227716|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
125169056|NCT01111825|450243033|FG003|Overall Study|Withdrawal by Subject|0|||
125227717|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
125227718|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
125227719|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
125227720|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
125227721|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
125227722|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
125227723|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
125227724|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
125227725|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
125227726|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
125227727|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
125227728|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
125227729|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
125227730|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
125227731|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
125227732|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
125227733|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
125227734|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
125227735|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
125227736|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
125227737|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
125227738|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
125227739|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
125227740|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
125227741|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
125227742|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
125227743|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
125227744|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
125227745|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
125227746|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
125227747|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
125227748|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
125227749|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
125227750|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
125227751|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
125227752|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
125227753|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
125169057|NCT01111825|450243030|FG000|Overall Study|Lost to Follow-up|0|||
125169058|NCT01111825|450243031|FG001|Overall Study|Lost to Follow-up|0|||
125169059|NCT01111825|450243032|FG002|Overall Study|Lost to Follow-up|3|||
125169060|NCT01111825|450243033|FG003|Overall Study|Lost to Follow-up|1|||
125169061|NCT01111825|450243030|FG000|Overall Study|Adverse Event|2|||
125169062|NCT01111825|450243031|FG001|Overall Study|Adverse Event|1|||
125169063|NCT01111825|450243032|FG002|Overall Study|Adverse Event|4|||
125169064|NCT01111825|450243033|FG003|Overall Study|Adverse Event|0|||
125169065|NCT01111825|450243030|FG000|Overall Study|Disease Progression|1|||
125169066|NCT01111825|450243031|FG001|Overall Study|Disease Progression|0|||
125169067|NCT01111825|450243032|FG002|Overall Study|Disease Progression|0|||
125169068|NCT01111825|450243033|FG003|Overall Study|Disease Progression|0|||
125169069|NCT01111825|450243030|FG000|Overall Study|Discontinuation by Sponsor|0|||
125169070|NCT01111825|450243031|FG001|Overall Study|Discontinuation by Sponsor|0|||
125169071|NCT01111825|450243032|FG002|Overall Study|Discontinuation by Sponsor|0|||
125169072|NCT01111825|450243033|FG003|Overall Study|Discontinuation by Sponsor|20|||
125169073|NCT02552303|450243041|FG000|Allocation|Withdrawal by Subject|2|||
125169074|NCT02552303|450243042|FG001|Allocation|Withdrawal by Subject|1|||
125169075|NCT02552303|450243043|FG002|Allocation|Withdrawal by Subject|1|||
125169076|NCT02552303|450243044|FG003|Allocation|Withdrawal by Subject|1|||
125169077|NCT02552303|450243041|FG000|Allocation|ineligible|1|||
125169078|NCT02552303|450243042|FG001|Allocation|ineligible|1|||
125169079|NCT02552303|450243043|FG002|Allocation|ineligible|0|||
125169080|NCT02552303|450243044|FG003|Allocation|ineligible|0|||
125169081|NCT02552303|450243041|FG000|Follow-Up|Lost to Follow-up|0|||
125169082|NCT02552303|450243042|FG001|Follow-Up|Lost to Follow-up|0|||
125169083|NCT02552303|450243043|FG002|Follow-Up|Lost to Follow-up|1|||
125169084|NCT02552303|450243044|FG003|Follow-Up|Lost to Follow-up|0|||
125169085|NCT02552303|450243041|FG000|Follow-Up|ineligible|0|||
125169086|NCT02552303|450243042|FG001|Follow-Up|ineligible|2|||
125169087|NCT02552303|450243043|FG002|Follow-Up|ineligible|0|||
125169088|NCT02552303|450243044|FG003|Follow-Up|ineligible|0|||
125169089|NCT01377987|450243045|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
125169090|NCT01377987|450243046|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
125169091|NCT01775189|450243047|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125169092|NCT01775189|450243048|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
125169093|NCT01775189|450243049|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125169094|NCT01775189|450243050|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125169095|NCT01775189|450243051|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125169096|NCT01775189|450243052|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125169097|NCT01775189|450243053|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125169098|NCT01775189|450243047|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125169099|NCT01775189|450243048|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
125169100|NCT01775189|450243049|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125169101|NCT01775189|450243050|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125169102|NCT01775189|450243051|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125169103|NCT01775189|450243052|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125169104|NCT01775189|450243053|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125169105|NCT01775189|450243047|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
125169106|NCT01775189|450243048|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
125169107|NCT01775189|450243049|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
125169108|NCT01775189|450243050|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
125169109|NCT01775189|450243051|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
125169110|NCT01775189|450243052|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
125169111|NCT01775189|450243053|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
125169112|NCT01775189|450243047|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
125169113|NCT01775189|450243048|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
125169114|NCT01775189|450243049|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
125169115|NCT01775189|450243050|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
125169116|NCT01775189|450243051|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
125169117|NCT01775189|450243052|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
125169118|NCT01775189|450243053|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
125169119|NCT01775189|450243047|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
125169120|NCT01775189|450243048|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
125169121|NCT01775189|450243049|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
125169122|NCT01775189|450243050|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
125169123|NCT01775189|450243051|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
125169124|NCT01775189|450243052|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
125169125|NCT01775189|450243053|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
125169126|NCT01775189|450243047|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
125169127|NCT01775189|450243048|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
125169128|NCT01775189|450243049|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
125169129|NCT01775189|450243050|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
125169130|NCT01775189|450243051|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
125169131|NCT01775189|450243052|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
125169132|NCT01775189|450243053|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
125169133|NCT02121392|450243056|FG000|Prior to Intervention|Protocol Violation|40|||
125169134|NCT02121392|450243057|FG001|Prior to Intervention|Protocol Violation|35|||
125169135|NCT02121392|450243056|FG000|Prior to Intervention|Withdrawal by Subject|8|||
125169136|NCT02121392|450243057|FG001|Prior to Intervention|Withdrawal by Subject|6|||
125169137|NCT02121392|450243056|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
125169138|NCT02121392|450243057|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
125169139|NCT02121392|450243056|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
125169140|NCT02121392|450243057|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
125169141|NCT00741286|450243058|FG000|Overall Study|Lost to Follow-up|15|||
125169142|NCT00741286|450243059|FG001|Overall Study|Lost to Follow-up|10|||
125169143|NCT00741286|450243058|FG000|Overall Study|Adverse Event|1|||
125169144|NCT00741286|450243059|FG001|Overall Study|Adverse Event|6|||
125169145|NCT00741286|450243058|FG000|Overall Study|Protocol Violation|3|||
125169146|NCT00741286|450243059|FG001|Overall Study|Protocol Violation|2|||
125169147|NCT00741286|450243058|FG000|Overall Study|Primary Outcome|1|||
125169148|NCT00741286|450243059|FG001|Overall Study|Primary Outcome|1|||
125169149|NCT01352416|450243060|FG000|Overall Study|Physician Decision|1|||
125169150|NCT01352416|450243061|FG001|Overall Study|Physician Decision|2|||
125169151|NCT01352416|450243062|FG002|Overall Study|Physician Decision|2|||
125169152|NCT01352416|450243063|FG003|Overall Study|Physician Decision|1|||
125169153|NCT01831258|450243064|FG000|Overall Study|Withdrawal by Subject|2|||
125169154|NCT01831258|450243065|FG001|Overall Study|Withdrawal by Subject|1|||
125169155|NCT01831258|450243064|FG000|Overall Study|Lost to Follow-up|3|||
125169156|NCT01831258|450243065|FG001|Overall Study|Lost to Follow-up|2|||
125227754|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
125227755|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
125227756|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
125227757|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
125227758|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
125227759|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
125227760|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
125227761|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
125227762|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
125227763|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
125227764|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
125227765|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
125227766|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
125227767|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
125227768|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
125227769|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
125227770|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
125227771|NCT01791595|450462164|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
125227772|NCT01791595|450462165|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
125227773|NCT01791595|450462166|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
125227774|NCT01791595|450462167|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
125227775|NCT01791595|450462168|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
125227776|NCT01791595|450462169|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
125227777|NCT01791595|450462170|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
125227778|NCT01791595|450462164|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
125227779|NCT01791595|450462165|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
125227780|NCT01791595|450462166|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
125227781|NCT01791595|450462167|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
125227782|NCT01791595|450462168|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
125227783|NCT01791595|450462169|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
125227784|NCT01791595|450462170|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
125227785|NCT01791595|450462164|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
125227786|NCT01791595|450462165|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
125227787|NCT01791595|450462166|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
125227788|NCT01791595|450462167|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
125227789|NCT01791595|450462168|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
125227790|NCT01791595|450462169|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
125227791|NCT01791595|450462170|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
125227792|NCT01791595|450462164|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
125227793|NCT01791595|450462165|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
125227794|NCT01791595|450462166|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
125227795|NCT01791595|450462167|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
125227796|NCT01791595|450462168|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
125227797|NCT01791595|450462169|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
125227798|NCT01791595|450462170|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
125227799|NCT03118934|450462171|FG000|Overall Study|Adverse Event|0|||
125227800|NCT03118934|450462172|FG001|Overall Study|Adverse Event|0|||
125227801|NCT03118934|450462173|FG002|Overall Study|Adverse Event|0|||
125227802|NCT03118934|450462174|FG003|Overall Study|Adverse Event|0|||
125227803|NCT03118934|450462175|FG004|Overall Study|Adverse Event|0|||
125227804|NCT03118934|450462176|FG005|Overall Study|Adverse Event|1|||
125227805|NCT03118934|450462171|FG000|Overall Study|Physician Decision|0|||
125227806|NCT03118934|450462172|FG001|Overall Study|Physician Decision|0|||
125227807|NCT03118934|450462173|FG002|Overall Study|Physician Decision|0|||
125227808|NCT03118934|450462174|FG003|Overall Study|Physician Decision|0|||
125227809|NCT03118934|450462175|FG004|Overall Study|Physician Decision|0|||
125227810|NCT03118934|450462176|FG005|Overall Study|Physician Decision|1|||
125227811|NCT03118934|450462171|FG000|Overall Study|Discontinued prior to exposure|0|||
125227812|NCT03118934|450462172|FG001|Overall Study|Discontinued prior to exposure|1|||
125227813|NCT03118934|450462173|FG002|Overall Study|Discontinued prior to exposure|1|||
125227814|NCT03118934|450462174|FG003|Overall Study|Discontinued prior to exposure|1|||
125227815|NCT03118934|450462175|FG004|Overall Study|Discontinued prior to exposure|2|||
125227816|NCT03118934|450462176|FG005|Overall Study|Discontinued prior to exposure|0|||
125227817|NCT02895347|450462177|FG000|Overall Study|Withdrawal by Subject|3|||
125227818|NCT02895347|450462178|FG001|Overall Study|Withdrawal by Subject|1|||
125227819|NCT03177148|450462182|FG000|Overall Study|Lost to Follow-up|50|||
125227820|NCT03177148|450462183|FG001|Overall Study|Lost to Follow-up|1|||
125227821|NCT03177148|450462182|FG000|Overall Study|Death|1|||
125169157|NCT00811928|450243074|FG000|Overall Study|AEs and SAEs Including Death|7|||
125169158|NCT00811928|450243075|FG001|Overall Study|AEs and SAEs Including Death|11|||
125169159|NCT00811928|450243074|FG000|Overall Study|Withdrawal by Subject|18|||
125169160|NCT00811928|450243075|FG001|Overall Study|Withdrawal by Subject|12|||
125169161|NCT00811928|450243074|FG000|Overall Study|Did Not Take Study Drug|3|||
125169162|NCT00811928|450243075|FG001|Overall Study|Did Not Take Study Drug|0|||
125169163|NCT00811928|450243074|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
125169164|NCT00811928|450243075|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
125169165|NCT00811928|450243074|FG000|Overall Study|Investigator Decision|2|||
125169166|NCT00811928|450243075|FG001|Overall Study|Investigator Decision|1|||
125169167|NCT00811928|450243074|FG000|Overall Study|Poor Compliance|2|||
125169168|NCT00811928|450243075|FG001|Overall Study|Poor Compliance|5|||
125169169|NCT00171951|450243076|FG000|Overall Study|Adverse Event|1|||
125169170|NCT00171951|450243076|FG000|Overall Study|Abnormal Laboratory Values|2|||
125169171|NCT00171951|450243076|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
125169172|NCT00171951|450243076|FG000|Overall Study|Participants Withdrew Consent|3|||
125169173|NCT00171951|450243076|FG000|Overall Study|New Cancer Therapy|5|||
125169174|NCT00171951|450243076|FG000|Overall Study|Reason not Specified|2|||
125227822|NCT03177148|450462183|FG001|Overall Study|Death|0|||
125227823|NCT01419314|450462186|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
125227824|NCT01419314|450462187|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
125227825|NCT01419314|450462186|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
125227826|NCT01419314|450462187|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
125227827|NCT01419314|450462186|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
125227828|NCT01419314|450462187|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
125227829|NCT00732069|450462191|FG000|Washout After First Study Drug|Adverse Event|1|||
125227830|NCT00732069|450462192|FG001|Washout After First Study Drug|Adverse Event|0|||
125227831|NCT00732069|450462193|FG002|Washout After First Study Drug|Adverse Event|0|||
125227832|NCT00732069|450462194|FG003|Washout After First Study Drug|Adverse Event|0|||
125227833|NCT00732069|450462195|FG004|Washout After First Study Drug|Adverse Event|0|||
125227834|NCT00732069|450462196|FG005|Washout After First Study Drug|Adverse Event|0|||
125227835|NCT00577317|450462197|FG000|Overall Study|Study Terminated|0|||
125227836|NCT00577317|450462198|FG001|Overall Study|Study Terminated|2|||
125227837|NCT04460326|450462199|FG000|Completed at Least 4 Meals|Early discharge|5|||
125227838|NCT04460326|450462200|FG001|Completed at Least 4 Meals|Early discharge|5|||
125227839|NCT04460326|450462199|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
125227840|NCT04460326|450462200|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
125227841|NCT04460326|450462199|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
125227842|NCT04460326|450462200|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
125227843|NCT04460326|450462199|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
125227844|NCT04460326|450462200|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
125227845|NCT04460326|450462199|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
125227846|NCT04460326|450462200|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
125227847|NCT04460326|450462199|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
125227848|NCT04460326|450462200|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
125227849|NCT03160716|450462201|FG000|Overall Study|Lost to Follow-up|1|||
125227850|NCT04794751|450462203|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
125227851|NCT04794751|450462204|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
125227852|NCT04794751|450462203|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
125227853|NCT04794751|450462204|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
125227854|NCT04794751|450462203|FG000|Period 1|Protocol Violation|0|||
125227855|NCT04794751|450462204|FG001|Period 1|Protocol Violation|2|||
125227856|NCT04794751|450462203|FG000|Period 1|Withdrawal by Subject|0|||
125227857|NCT04794751|450462204|FG001|Period 1|Withdrawal by Subject|1|||
125227858|NCT04794751|450462203|FG000|Period 2|Withdrawal by Subject|0|||
125227859|NCT04794751|450462204|FG001|Period 2|Withdrawal by Subject|1|||
125227860|NCT04794751|450462203|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
125227861|NCT04794751|450462204|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
125227862|NCT04794751|450462203|FG000|Period 2|Protocol Violation|1|||
125227863|NCT04794751|450462204|FG001|Period 2|Protocol Violation|0|||
125227864|NCT00875810|450462208|FG000|Overall Study|Withdrawal by Subject|1|||
125227865|NCT00875810|450462208|FG000|Overall Study|Physician Decision|3|||
125169175|NCT00396812|450243077|FG000|Overall Study|Physician Decision|1|||
125227866|NCT00875810|450462208|FG000|Overall Study|Lost to Follow-up|39|||
125227867|NCT00875810|450462208|FG000|Overall Study|Patient enroled but not implanted|2|||
125227868|NCT00875810|450462208|FG000|Overall Study|Device explanted|1|||
125227869|NCT00780975|450462211|FG000|Overall Study|Progressive disease|3|||
125227870|NCT00780975|450462211|FG000|Overall Study|Toxicity|5|||
125227871|NCT03044314|450462213|FG000|Overall Study|Physician Decision|2|||
125227872|NCT03044314|450462213|FG000|Overall Study|Withdrawal by Subject|1|||
125169176|NCT02015065|450243078|FG000|Overall Study|Death on study|1|||
125169177|NCT02015065|450243079|FG001|Overall Study|Death on study|2|||
125227873|NCT03044314|450462213|FG000|Overall Study|Connector tubing not available|1|||
125169178|NCT02015065|450243080|FG002|Overall Study|Death on study|1|||
125169179|NCT00233402|450243113|FG000|Overall Study|No pathology data|12|||
125169180|NCT00233402|450243114|FG001|Overall Study|No pathology data|9|||
125169181|NCT00233402|450243113|FG000|Overall Study|No Ta/T1|89|||
125169182|NCT00233402|450243114|FG001|Overall Study|No Ta/T1|94|||
125169183|NCT00233402|450243113|FG000|Overall Study|Lost to follow up etc|3|||
125169184|NCT00233402|450243114|FG001|Overall Study|Lost to follow up etc|21|||
125169185|NCT00896480|450243120|FG000|Overall Study|Disease progression/recurrence|21|||
125169186|NCT03553576|450243124|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
125169187|NCT03553576|450243125|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
125169188|NCT03553576|450243124|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
125169189|NCT03553576|450243125|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
125169190|NCT03553576|450243124|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
125169191|NCT03553576|450243125|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
125169192|NCT03553576|450243124|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
125169193|NCT03553576|450243125|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
125169194|NCT03553576|450243124|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
125169195|NCT03553576|450243125|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
125169196|NCT03553576|450243124|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
125169197|NCT03553576|450243125|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
125169198|NCT03553576|450243124|FG000|Overall Study|Physician Decision|2|||
125169199|NCT03553576|450243125|FG001|Overall Study|Physician Decision|5|||
125169200|NCT00205803|450243126|FG000|Infant Series|Lost to Follow-up|10|||
125169201|NCT00205803|450243127|FG001|Infant Series|Lost to Follow-up|4|||
125169202|NCT00205803|450243126|FG000|Infant Series|Withdrawal by Subject|2|||
125169203|NCT00205803|450243127|FG001|Infant Series|Withdrawal by Subject|5|||
125169204|NCT00205803|450243126|FG000|Infant Series|Physician Decision|3|||
125169205|NCT00205803|450243127|FG001|Infant Series|Physician Decision|1|||
125169206|NCT00205803|450243126|FG000|Infant Series|Protocol Violation|1|||
125169207|NCT00205803|450243127|FG001|Infant Series|Protocol Violation|0|||
125169208|NCT00205803|450243126|FG000|Infant Series|Lost Kaiser coverage|0|||
125169209|NCT00205803|450243127|FG001|Infant Series|Lost Kaiser coverage|1|||
125169210|NCT00205803|450243126|FG000|Infant Series|Non-compliant|1|||
125169211|NCT00205803|450243127|FG001|Infant Series|Non-compliant|0|||
125169212|NCT00205803|450243126|FG000|Infant Series|Sponsor request|1|||
125169213|NCT00205803|450243127|FG001|Infant Series|Sponsor request|0|||
125169214|NCT00205803|450243126|FG000|After Infant Series|Adverse Event|1|||
125169215|NCT00205803|450243127|FG001|After Infant Series|Adverse Event|1|||
125169216|NCT00205803|450243126|FG000|After Infant Series|Protocol Violation|1|||
125169217|NCT00205803|450243127|FG001|After Infant Series|Protocol Violation|1|||
125169218|NCT00205803|450243126|FG000|After Infant Series|Lost to Follow-up|2|||
125169219|NCT00205803|450243127|FG001|After Infant Series|Lost to Follow-up|1|||
125169220|NCT00205803|450243126|FG000|After Infant Series|Physician Decision|3|||
125169221|NCT00205803|450243127|FG001|After Infant Series|Physician Decision|2|||
125169222|NCT00205803|450243126|FG000|After Infant Series|Withdrawal by Subject|1|||
125169223|NCT00205803|450243127|FG001|After Infant Series|Withdrawal by Subject|4|||
125169224|NCT00205803|450243126|FG000|After Infant Series|Other|10|||
125169225|NCT00205803|450243127|FG001|After Infant Series|Other|4|||
125169226|NCT00205803|450243126|FG000|Toddler Dose|Lost to Follow-up|2|||
125169227|NCT00205803|450243127|FG001|Toddler Dose|Lost to Follow-up|3|||
125169228|NCT05038800|450243129|FG000|Overall Study|Death|1|||
125169229|NCT05038800|450243130|FG001|Overall Study|Death|1|||
125169230|NCT05038800|450243131|FG002|Overall Study|Death|5|||
125169231|NCT05038800|450243132|FG003|Overall Study|Death|3|||
125169232|NCT05038800|450243133|FG004|Overall Study|Death|1|||
125169233|NCT05038800|450243129|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125169234|NCT05038800|450243130|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125169235|NCT05038800|450243131|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125169236|NCT05038800|450243132|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125169237|NCT05038800|450243133|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
125169238|NCT05038800|450243129|FG000|Overall Study|Lack of Efficacy|0|||
125227874|NCT00969228|450462216|FG000|Overall Study|Adverse Event|1|||
125227875|NCT00969228|450462217|FG001|Overall Study|Adverse Event|0|||
125227876|NCT00969228|450462216|FG000|Overall Study|Withdrawal by Subject|4|||
125227877|NCT00969228|450462217|FG001|Overall Study|Withdrawal by Subject|0|||
125227878|NCT00969228|450462216|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
125169239|NCT05038800|450243130|FG001|Overall Study|Lack of Efficacy|0|||
125169240|NCT05038800|450243131|FG002|Overall Study|Lack of Efficacy|0|||
125169241|NCT05038800|450243132|FG003|Overall Study|Lack of Efficacy|0|||
125169242|NCT05038800|450243133|FG004|Overall Study|Lack of Efficacy|1|||
125169243|NCT01104792|450243136|FG000|Overall Study|Adverse Event|77|||
125169244|NCT01104792|450243136|FG000|Overall Study|Insufficient Therapeutic Response|22|||
125169245|NCT01104792|450243136|FG000|Overall Study|Protocol Violation|45|||
125169246|NCT01104792|450243136|FG000|Overall Study|Withdrawal of Consent|179|||
125169247|NCT01104792|450243136|FG000|Overall Study|Lost to Follow-up|43|||
125169248|NCT01104792|450243136|FG000|Overall Study|Reasons Not Specified|27|||
125169249|NCT01104792|450243136|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
125169250|NCT01102374|450243137|FG000|Overall Study|Death|9|||
125169251|NCT01102374|450243138|FG001|Overall Study|Death|13|||
125169252|NCT01102374|450243137|FG000|Overall Study|Lost to Follow-up|7|||
125169253|NCT01102374|450243138|FG001|Overall Study|Lost to Follow-up|6|||
125169254|NCT02071849|450243139|FG000|6-month Primary Endpoint|Did not receive device|4|||
125169255|NCT02071849|450243139|FG000|6-month Primary Endpoint|Adverse Event|1|||
125169256|NCT02071849|450243139|FG000|2-year Extended Follow-up|Adverse Event|1|||
125169257|NCT04619992|450243140|FG000|Overall Study|Withdrawal by Subject|1|||
125169258|NCT04619992|450243141|FG001|Overall Study|Withdrawal by Subject|0|||
125169259|NCT03301623|450243145|FG000|Overall Study|Death|3|||
125169260|NCT03301623|450243146|FG001|Overall Study|Death|1|||
125169261|NCT03301623|450243145|FG000|Overall Study|Withdrawal by Subject|11|||
125169262|NCT03301623|450243146|FG001|Overall Study|Withdrawal by Subject|13|||
125169263|NCT03301623|450243145|FG000|Overall Study|Lost to Follow-up|3|||
125169264|NCT03301623|450243146|FG001|Overall Study|Lost to Follow-up|1|||
125169265|NCT00658021|450243147|FG000|28-Week Treatment Period|Adverse Event|3|||
125169266|NCT00658021|450243148|FG001|28-Week Treatment Period|Adverse Event|1|||
125169267|NCT00658021|450243149|FG002|28-Week Treatment Period|Adverse Event|0|||
125169268|NCT00658021|450243147|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
125169269|NCT00658021|450243148|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
125169270|NCT00658021|450243149|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
125169271|NCT00658021|450243147|FG000|28-Week Treatment Period|Protocol Violation|0|||
125169272|NCT00658021|450243148|FG001|28-Week Treatment Period|Protocol Violation|2|||
125169273|NCT00658021|450243149|FG002|28-Week Treatment Period|Protocol Violation|1|||
125169274|NCT00658021|450243147|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
125169275|NCT00658021|450243148|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
125169276|NCT00658021|450243149|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
125169277|NCT00658021|450243147|FG000|28-Week Treatment Period|Physician Decision|1|||
125169278|NCT00658021|450243148|FG001|28-Week Treatment Period|Physician Decision|2|||
125169279|NCT00658021|450243149|FG002|28-Week Treatment Period|Physician Decision|1|||
125169280|NCT00658021|450243147|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
125169281|NCT00658021|450243148|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
125169282|NCT00658021|450243149|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
125169283|NCT00658021|450243147|FG000|28-Week Treatment Period|Loss of glucose control|1|||
125169284|NCT00658021|450243148|FG001|28-Week Treatment Period|Loss of glucose control|1|||
125169285|NCT00658021|450243149|FG002|28-Week Treatment Period|Loss of glucose control|10|||
125169286|NCT00658021|450243147|FG000|28-Week Treatment Period|Other|2|||
125169287|NCT00658021|450243148|FG001|28-Week Treatment Period|Other|3|||
125169288|NCT00658021|450243149|FG002|28-Week Treatment Period|Other|1|||
125169289|NCT00658021|450243147|FG000|28-Week Treatment Period|Did not receive treatment|2|||
125169290|NCT00658021|450243148|FG001|28-Week Treatment Period|Did not receive treatment|0|||
125169291|NCT00658021|450243149|FG002|28-Week Treatment Period|Did not receive treatment|0|||
125169292|NCT00658021|450243147|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
125169293|NCT00658021|450243148|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
125169294|NCT00658021|450243149|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
125169295|NCT00658021|450243147|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
125169296|NCT00658021|450243148|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
125169297|NCT00658021|450243149|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
125169298|NCT02092467|450243152|FG000|Overall Study|Death|49|||
125169299|NCT02092467|450243153|FG001|Overall Study|Death|66|||
125169300|NCT02092467|450243154|FG002|Overall Study|Death|38|||
125169301|NCT02092467|450243152|FG000|Overall Study|Lost to Follow-up|38|||
125169302|NCT02092467|450243153|FG001|Overall Study|Lost to Follow-up|35|||
125169303|NCT02092467|450243154|FG002|Overall Study|Lost to Follow-up|40|||
125169304|NCT02092467|450243152|FG000|Overall Study|Global Deterioration of Health Status|1|||
125169305|NCT02092467|450243153|FG001|Overall Study|Global Deterioration of Health Status|0|||
125169306|NCT02092467|450243154|FG002|Overall Study|Global Deterioration of Health Status|0|||
125169307|NCT02092467|450243152|FG000|Overall Study|Other|32|||
125169308|NCT02092467|450243153|FG001|Overall Study|Other|30|||
125169309|NCT02092467|450243154|FG002|Overall Study|Other|24|||
125169310|NCT02092467|450243152|FG000|Overall Study|Withdrawal by Subject|282|||
125169311|NCT02092467|450243153|FG001|Overall Study|Withdrawal by Subject|327|||
125169312|NCT02092467|450243154|FG002|Overall Study|Withdrawal by Subject|289|||
125169313|NCT02092467|450243152|FG000|Overall Study|Randomized but not treated|2|||
125169314|NCT02092467|450243153|FG001|Overall Study|Randomized but not treated|1|||
125169315|NCT02092467|450243154|FG002|Overall Study|Randomized but not treated|7|||
125169316|NCT02952898|450243160|FG000|Overall Study|Withdrawal by Subject|10|||
125227879|NCT00969228|450462217|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
125227880|NCT02563899|450462218|FG000|Overall Study|Protocol Violation|1|||
125227881|NCT02563899|450462219|FG001|Overall Study|Protocol Violation|0|||
125227882|NCT02563899|450462220|FG002|Overall Study|Protocol Violation|0|||
125227883|NCT02563899|450462221|FG003|Overall Study|Protocol Violation|0|||
125227884|NCT02563899|450462218|FG000|Overall Study|Withdrawal by Subject|0|||
125227885|NCT02563899|450462219|FG001|Overall Study|Withdrawal by Subject|0|||
125227886|NCT02563899|450462220|FG002|Overall Study|Withdrawal by Subject|1|||
125227887|NCT02563899|450462221|FG003|Overall Study|Withdrawal by Subject|0|||
125227888|NCT00794664|450462227|FG000|Treatment Period|Withdrawal by Subject|0|||
125227889|NCT00794664|450462228|FG001|Treatment Period|Withdrawal by Subject|2|||
125227890|NCT00794664|450462227|FG000|Treatment Period|Protocol non-compliance|0|||
125227891|NCT00794664|450462228|FG001|Treatment Period|Protocol non-compliance|1|||
125227892|NCT00794664|450462227|FG000|Treatment Period|Other|0|||
125227893|NCT00794664|450462228|FG001|Treatment Period|Other|1|||
125227894|NCT00794664|450462227|FG000|Treatment Period|Adverse Event|1|||
125227895|NCT00794664|450462228|FG001|Treatment Period|Adverse Event|8|||
125227896|NCT00794664|450462227|FG000|Follow-up Period|Other|1|||
125227897|NCT00794664|450462228|FG001|Follow-up Period|Other|2|||
125227898|NCT00794664|450462227|FG000|Follow-up Period|Withdrawal by Subject|0|||
125227899|NCT00794664|450462228|FG001|Follow-up Period|Withdrawal by Subject|2|||
125227900|NCT00794664|450462227|FG000|Follow-up Period|Protocol non-compliance|0|||
125227901|NCT00794664|450462228|FG001|Follow-up Period|Protocol non-compliance|1|||
125227902|NCT01305564|450462233|FG000|Overall Study|Death|21|||
125227903|NCT01305564|450462233|FG000|Overall Study|Lost to Follow-up|12|||
125227904|NCT01305564|450462233|FG000|Overall Study|Withdrawal by Subject|1|||
125227905|NCT01305564|450462233|FG000|Overall Study|Physician Decision|3|||
125227906|NCT01419535|450462235|FG000|Overall Study|could not maintain iv line|1|||
125227907|NCT01419535|450462236|FG001|Overall Study|could not maintain iv line|1|||
125227908|NCT01419535|450462235|FG000|Overall Study|Withdrawal by Subject|0|||
125227909|NCT01419535|450462236|FG001|Overall Study|Withdrawal by Subject|1|||
125227910|NCT01814007|450462244|FG000|Overall Study|Withdrawal by Subject|1|||
125227911|NCT02100124|450462245|FG000|Overall Study|Lost to Follow-up|5|||
125227912|NCT02100124|450462246|FG001|Overall Study|Lost to Follow-up|11|||
125227913|NCT02100124|450462247|FG002|Overall Study|Lost to Follow-up|3|||
125227914|NCT02100124|450462245|FG000|Overall Study|Withdrawal by Subject|1|||
125227915|NCT02100124|450462246|FG001|Overall Study|Withdrawal by Subject|0|||
125227916|NCT02100124|450462247|FG002|Overall Study|Withdrawal by Subject|0|||
125227917|NCT00916578|450464091|FG000|Overall Study|Physician Decision|2|||
125227918|NCT00916578|450464091|FG000|Overall Study|Withdrawal by Subject|3|||
125227919|NCT00916578|450464091|FG000|Overall Study|Insurance Denial|2|||
125227920|NCT01433159|450464096|FG000|Overall Study|Adverse Event|1|||
125227921|NCT01433159|450464097|FG001|Overall Study|Adverse Event|0|||
125227922|NCT01433159|450464096|FG000|Overall Study|Physician Decision|1|||
125227923|NCT01433159|450464097|FG001|Overall Study|Physician Decision|0|||
125227924|NCT01433159|450464096|FG000|Overall Study|Protocol Violation|0|||
125227925|NCT01433159|450464097|FG001|Overall Study|Protocol Violation|1|||
125227926|NCT01100853|450464098|FG000|Overall Study|Lost to Follow-up|11|||
125227927|NCT01100853|450464099|FG001|Overall Study|Lost to Follow-up|6|||
125227928|NCT01100853|450464098|FG000|Overall Study|Received <4 study injections|10|||
125227929|NCT01100853|450464099|FG001|Overall Study|Received <4 study injections|13|||
125227930|NCT01100853|450464098|FG000|Overall Study|Withdrawal by Subject|6|||
125227931|NCT01100853|450464099|FG001|Overall Study|Withdrawal by Subject|4|||
125227932|NCT01190891|450464100|FG000|Overall Study|Protocol Violation|1|||
125227933|NCT01190891|450464101|FG001|Overall Study|Protocol Violation|0|||
125227934|NCT01190891|450464100|FG000|Overall Study|Withdrawal by Subject|5|||
125227935|NCT01190891|450464101|FG001|Overall Study|Withdrawal by Subject|0|||
125227936|NCT00266708|450464102|FG000|Overall Study|No renal function|1|||
125227937|NCT00266708|450464103|FG001|Overall Study|No renal function|1|||
125227938|NCT00266708|450464102|FG000|Overall Study|Refused biopsy|3|||
125227939|NCT00266708|450464103|FG001|Overall Study|Refused biopsy|6|||
125227940|NCT00266708|450464102|FG000|Overall Study|Asthma|0|||
125227941|NCT00266708|450464103|FG001|Overall Study|Asthma|2|||
125227942|NCT01926028|450464104|FG000|Overall Study|Lost to Follow-up|7|||
125227943|NCT01926028|450464105|FG001|Overall Study|Lost to Follow-up|6|||
125227944|NCT01926028|450464106|FG002|Overall Study|Lost to Follow-up|0|||
125227945|NCT01926028|450464104|FG000|Overall Study|Physician Decision|1|||
125227946|NCT01926028|450464105|FG001|Overall Study|Physician Decision|5|||
125227947|NCT01926028|450464106|FG002|Overall Study|Physician Decision|0|||
125227948|NCT01926028|450464104|FG000|Overall Study|Withdrawal by Subject|9|||
125227949|NCT01926028|450464105|FG001|Overall Study|Withdrawal by Subject|9|||
125227950|NCT01926028|450464106|FG002|Overall Study|Withdrawal by Subject|2|||
125227951|NCT01926028|450464104|FG000|Overall Study|Non compliance or other reasons|4|||
125227952|NCT01926028|450464105|FG001|Overall Study|Non compliance or other reasons|2|||
125227953|NCT01926028|450464106|FG002|Overall Study|Non compliance or other reasons|0|||
125227954|NCT01130272|450464107|FG000|Overall Study|Adverse Event|2|||
125227955|NCT01130272|450464108|FG001|Overall Study|Adverse Event|5|||
125227956|NCT01130272|450464109|FG002|Overall Study|Adverse Event|6|||
125169317|NCT02952898|450243161|FG001|Overall Study|Withdrawal by Subject|8|||
125169318|NCT02952898|450243162|FG002|Overall Study|Withdrawal by Subject|8|||
125169319|NCT02952898|450243160|FG000|Overall Study|Adverse Event|8|||
125169320|NCT02952898|450243161|FG001|Overall Study|Adverse Event|8|||
125169321|NCT02952898|450243162|FG002|Overall Study|Adverse Event|3|||
125169322|NCT02952898|450243160|FG000|Overall Study|Lost to Follow-up|3|||
125169323|NCT02952898|450243161|FG001|Overall Study|Lost to Follow-up|2|||
125169324|NCT02952898|450243162|FG002|Overall Study|Lost to Follow-up|2|||
125169325|NCT02952898|450243160|FG000|Overall Study|Non-compliance with study drug|1|||
125169326|NCT02952898|450243161|FG001|Overall Study|Non-compliance with study drug|1|||
125169327|NCT02952898|450243162|FG002|Overall Study|Non-compliance with study drug|2|||
125169328|NCT04400682|450243167|FG000|Period 1|Withdrawal by Subject|1|||
125169329|NCT04400682|450243168|FG001|Period 1|Withdrawal by Subject|4|||
125169330|NCT02293863|450243169|FG000|Overall Study|Death|4|||
125169331|NCT02293863|450243170|FG001|Overall Study|Death|6|||
125169332|NCT02293863|450243171|FG002|Overall Study|Death|4|||
125169333|NCT02293863|450243169|FG000|Overall Study|Lost to Follow-up|2|||
125169334|NCT02293863|450243170|FG001|Overall Study|Lost to Follow-up|2|||
125169335|NCT02293863|450243171|FG002|Overall Study|Lost to Follow-up|2|||
125227957|NCT01130272|450464110|FG003|Overall Study|Adverse Event|22|||
125169336|NCT02293863|450243169|FG000|Overall Study|Withdrawal by Subject|3|||
125169337|NCT02293863|450243170|FG001|Overall Study|Withdrawal by Subject|3|||
125169338|NCT02293863|450243171|FG002|Overall Study|Withdrawal by Subject|1|||
125169339|NCT02293863|450243169|FG000|Overall Study|Reason Not Specified|0|||
125169340|NCT02293863|450243170|FG001|Overall Study|Reason Not Specified|2|||
125169341|NCT02293863|450243171|FG002|Overall Study|Reason Not Specified|2|||
125169342|NCT03462459|450243172|FG000|Overall Study|Death|1|||
125169343|NCT03462459|450243173|FG001|Overall Study|Death|0|||
125169344|NCT03462459|450243172|FG000|Overall Study|Lack of Efficacy|2|||
125169345|NCT03462459|450243173|FG001|Overall Study|Lack of Efficacy|4|||
125169346|NCT03462459|450243172|FG000|Overall Study|Lost to Follow-up|1|||
125169347|NCT03462459|450243173|FG001|Overall Study|Lost to Follow-up|3|||
125169348|NCT03462459|450243172|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
125169349|NCT03462459|450243173|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
125169350|NCT03462459|450243172|FG000|Overall Study|Withdrawal by Subject|3|||
125227958|NCT01130272|450464111|FG004|Overall Study|Adverse Event|7|||
125227959|NCT01130272|450464107|FG000|Overall Study|IVRS-confirmed constipation|0|||
125227960|NCT01130272|450464108|FG001|Overall Study|IVRS-confirmed constipation|1|||
125227961|NCT01130272|450464109|FG002|Overall Study|IVRS-confirmed constipation|1|||
125227962|NCT01130272|450464110|FG003|Overall Study|IVRS-confirmed constipation|2|||
125227963|NCT01130272|450464111|FG004|Overall Study|IVRS-confirmed constipation|0|||
125227964|NCT01130272|450464107|FG000|Overall Study|Rescue medications due to diarrhea|3|||
125227965|NCT01130272|450464108|FG001|Overall Study|Rescue medications due to diarrhea|5|||
125227966|NCT01130272|450464109|FG002|Overall Study|Rescue medications due to diarrhea|8|||
125169351|NCT03462459|450243173|FG001|Overall Study|Withdrawal by Subject|2|||
125169352|NCT03462459|450243172|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
125169353|NCT03462459|450243173|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
125169354|NCT02929056|450244739|FG000|Overall Study|Lost to Follow-up|0|||
125169355|NCT02929056|450244740|FG001|Overall Study|Lost to Follow-up|1|||
125169356|NCT03132155|450244741|FG000|Overall Study|Lack of Efficacy|6|||
125169357|NCT03132155|450244741|FG000|Overall Study|Lost to Follow-up|1|||
125169358|NCT03132155|450244741|FG000|Overall Study|Withdrawal by Subject|1|||
125169359|NCT02925403|450244745|FG000|Overall Study|Lost to Follow-up|0|||
125169360|NCT02925403|450244746|FG001|Overall Study|Lost to Follow-up|1|||
125169361|NCT00459043|450244747|FG000|Overall Study|Withdrawal by Subject|1|||
125169362|NCT00459043|450244748|FG001|Overall Study|Withdrawal by Subject|0|||
125169363|NCT02899195|450244751|FG000|Concurrent Durvalumab|Adverse Event|4|||
125169364|NCT02899195|450244751|FG000|Concurrent Durvalumab|Physician Decision|1|||
125169365|NCT02899195|450244751|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
125169366|NCT02899195|450244751|FG000|Concurrent Durvalumab|Progressive Disease|5|||
125169367|NCT02899195|450244751|FG000|Maintenance Durvalumab|Adverse Event|1|||
125169368|NCT02899195|450244751|FG000|Maintenance Durvalumab|Physician Decision|1|||
125169369|NCT02899195|450244751|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
125169370|NCT02899195|450244751|FG000|Maintenance Durvalumab|Progressive Disease|31|||
125169371|NCT03156504|450244752|FG000|Overall Study|Withdrawal by Subject|1|||
125227967|NCT01130272|450464110|FG003|Overall Study|Rescue medications due to diarrhea|8|||
125227968|NCT01130272|450464111|FG004|Overall Study|Rescue medications due to diarrhea|6|||
125227969|NCT01130272|450464107|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
125169372|NCT00450801|450244753|FG000|Overall Study|Death|1|||
125169373|NCT03452137|450244754|FG000|Overall Study|Death|67|||
125169374|NCT03452137|450244755|FG001|Overall Study|Death|70|||
125169375|NCT03452137|450244754|FG000|Overall Study|Lost to Follow-up|4|||
125169376|NCT03452137|450244755|FG001|Overall Study|Lost to Follow-up|2|||
125169377|NCT03452137|450244754|FG000|Overall Study|Physician Decision|0|||
125169378|NCT03452137|450244755|FG001|Overall Study|Physician Decision|1|||
125169379|NCT03452137|450244754|FG000|Overall Study|Study Terminated by Sponsor|120|||
125169380|NCT03452137|450244755|FG001|Overall Study|Study Terminated by Sponsor|121|||
125169381|NCT03452137|450244754|FG000|Overall Study|Withdrawal by Subject|12|||
125169382|NCT03452137|450244755|FG001|Overall Study|Withdrawal by Subject|9|||
125169383|NCT00261443|450244756|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
125169384|NCT00261443|450244757|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
125169385|NCT00261443|450244758|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
125169386|NCT00261443|450244756|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
125169387|NCT00261443|450244757|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
125169388|NCT00261443|450244758|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
125169389|NCT00261443|450244756|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
125169390|NCT00261443|450244757|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
125169391|NCT00261443|450244758|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
125169392|NCT00261443|450244756|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
125169393|NCT00261443|450244757|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
125169394|NCT00261443|450244758|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
125169395|NCT00261443|450244756|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
125169396|NCT00261443|450244757|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
125169397|NCT00261443|450244758|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
125169398|NCT00261443|450244756|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
125169399|NCT00261443|450244757|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
125169400|NCT00261443|450244758|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
125169401|NCT00261443|450244756|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
125169402|NCT00261443|450244757|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
125169403|NCT00261443|450244758|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
125169404|NCT00261443|450244756|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
125169405|NCT00261443|450244757|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
125169406|NCT00261443|450244758|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
125169407|NCT00261443|450244756|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
125169408|NCT00261443|450244757|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
125169409|NCT00261443|450244758|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
125169410|NCT00261443|450244756|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
125169411|NCT00261443|450244757|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
125169412|NCT00261443|450244758|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
125169413|NCT00261443|450244756|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
125169414|NCT00261443|450244757|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
125169415|NCT00261443|450244758|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
125169416|NCT00261443|450244756|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
125169417|NCT00261443|450244757|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
125169418|NCT00261443|450244758|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
125169419|NCT00261443|450244756|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
125169420|NCT00261443|450244757|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
125169421|NCT00261443|450244758|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
125169422|NCT00261443|450244756|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
125169423|NCT00261443|450244757|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
125169424|NCT00261443|450244758|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
125169425|NCT00261443|450244756|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
125169426|NCT00261443|450244757|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
125169427|NCT00261443|450244758|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
125169428|NCT00261443|450244756|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
125169429|NCT00261443|450244757|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
125169430|NCT00261443|450244758|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
125169431|NCT00261443|450244756|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
125169432|NCT00261443|450244757|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
125169433|NCT00261443|450244758|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
125169434|NCT00261443|450244756|FG000|3: Assessment of Relapse|Adverse Event|0|||
125169435|NCT00261443|450244757|FG001|3: Assessment of Relapse|Adverse Event|15|||
125169436|NCT00261443|450244758|FG002|3: Assessment of Relapse|Adverse Event|19|||
125169437|NCT00261443|450244756|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
125169438|NCT00261443|450244757|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
125169439|NCT00261443|450244758|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
125169440|NCT00261443|450244756|FG000|3: Assessment of Relapse|Death|0|||
125169441|NCT00261443|450244757|FG001|3: Assessment of Relapse|Death|0|||
125169442|NCT00261443|450244758|FG002|3: Assessment of Relapse|Death|1|||
125169443|NCT00261443|450244756|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
125169444|NCT00261443|450244757|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
125169445|NCT00261443|450244758|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
125169446|NCT00261443|450244756|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
125169447|NCT00261443|450244757|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
125169448|NCT00261443|450244758|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
125169449|NCT00261443|450244756|FG000|3: Assessment of Relapse|Pregnancy|0|||
125169450|NCT00261443|450244757|FG001|3: Assessment of Relapse|Pregnancy|2|||
125169451|NCT00261443|450244758|FG002|3: Assessment of Relapse|Pregnancy|1|||
125169452|NCT00261443|450244756|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
125169453|NCT00261443|450244757|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
125169454|NCT00261443|450244758|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
125169455|NCT00261443|450244756|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
125169456|NCT00261443|450244757|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
125169457|NCT00261443|450244758|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
125169458|NCT00261443|450244756|FG000|3: Assessment of Relapse|Other Reasons|0|||
125169459|NCT00261443|450244757|FG001|3: Assessment of Relapse|Other Reasons|4|||
125169460|NCT00261443|450244758|FG002|3: Assessment of Relapse|Other Reasons|3|||
125169461|NCT00261443|450244756|FG000|4: Extension Phase|Adverse Event|0|||
125169462|NCT00261443|450244757|FG001|4: Extension Phase|Adverse Event|1|||
125169463|NCT00261443|450244758|FG002|4: Extension Phase|Adverse Event|0|||
125169464|NCT00261443|450244756|FG000|4: Extension Phase|Withdrawal by Subject|0|||
125169465|NCT00261443|450244757|FG001|4: Extension Phase|Withdrawal by Subject|1|||
125169466|NCT00261443|450244758|FG002|4: Extension Phase|Withdrawal by Subject|2|||
125169467|NCT00261443|450244756|FG000|4: Extension Phase|Lost to Follow-up|0|||
125169468|NCT00261443|450244757|FG001|4: Extension Phase|Lost to Follow-up|1|||
125169469|NCT00261443|450244758|FG002|4: Extension Phase|Lost to Follow-up|0|||
125169470|NCT02755649|450244759|FG000|Overall Study|Transitioned into OLE study|99|||
125169471|NCT02755649|450244760|FG001|Overall Study|Transitioned into OLE study|98|||
125169472|NCT02755649|450244761|FG002|Overall Study|Transitioned into OLE study|100|||
125169473|NCT02755649|450244759|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
125169474|NCT02755649|450244760|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
125169475|NCT02755649|450244761|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
125169476|NCT02755649|450244759|FG000|Overall Study|Physician Decision|0|||
125169477|NCT02755649|450244760|FG001|Overall Study|Physician Decision|0|||
125169478|NCT02755649|450244761|FG002|Overall Study|Physician Decision|2|||
125169479|NCT02755649|450244759|FG000|Overall Study|Withdrawal by Subject|0|||
125169480|NCT02755649|450244760|FG001|Overall Study|Withdrawal by Subject|1|||
125169481|NCT02755649|450244761|FG002|Overall Study|Withdrawal by Subject|0|||
125169482|NCT02755649|450244759|FG000|Overall Study|Undecided|1|||
125169483|NCT02755649|450244760|FG001|Overall Study|Undecided|0|||
125169484|NCT02755649|450244761|FG002|Overall Study|Undecided|0|||
125169485|NCT01286753|450244762|FG000|Overall Study|Adverse Event|7|||
125169486|NCT01286753|450244763|FG001|Overall Study|Adverse Event|6|||
125169487|NCT01286753|450244762|FG000|Overall Study|Progression|11|||
125169488|NCT01286753|450244763|FG001|Overall Study|Progression|13|||
125169489|NCT01286753|450244762|FG000|Overall Study|Refused Treatment|1|||
125169490|NCT01286753|450244763|FG001|Overall Study|Refused Treatment|0|||
125169491|NCT01286753|450244762|FG000|Overall Study|Withdrawal of Consent|0|||
125169492|NCT01286753|450244763|FG001|Overall Study|Withdrawal of Consent|2|||
125169493|NCT01286753|450244762|FG000|Overall Study|Discontinued to Join Extension Study|6|||
125169494|NCT01286753|450244763|FG001|Overall Study|Discontinued to Join Extension Study|4|||
125169495|NCT01286753|450244762|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
125169496|NCT01286753|450244763|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
125169497|NCT04933968|450244766|FG000|Overall Study|Adverse Event|0|||
125169498|NCT04933968|450244767|FG001|Overall Study|Adverse Event|0|||
125169499|NCT04933968|450244768|FG002|Overall Study|Adverse Event|1|||
125169500|NCT04933968|450244769|FG003|Overall Study|Adverse Event|1|||
125169501|NCT04933968|450244770|FG004|Overall Study|Adverse Event|0|||
125169502|NCT04933968|450244771|FG005|Overall Study|Adverse Event|0|||
125169503|NCT04933968|450244766|FG000|Overall Study|Lost to Follow-up|1|||
125169504|NCT04933968|450244767|FG001|Overall Study|Lost to Follow-up|0|||
125169505|NCT04933968|450244768|FG002|Overall Study|Lost to Follow-up|1|||
125169506|NCT04933968|450244769|FG003|Overall Study|Lost to Follow-up|0|||
125169507|NCT04933968|450244770|FG004|Overall Study|Lost to Follow-up|0|||
125169508|NCT04933968|450244771|FG005|Overall Study|Lost to Follow-up|0|||
125169509|NCT04933968|450244766|FG000|Overall Study|Randomized not treated|1|||
125169510|NCT04933968|450244767|FG001|Overall Study|Randomized not treated|0|||
125169511|NCT04933968|450244768|FG002|Overall Study|Randomized not treated|0|||
125169512|NCT04933968|450244769|FG003|Overall Study|Randomized not treated|0|||
125169513|NCT04933968|450244770|FG004|Overall Study|Randomized not treated|0|||
125169514|NCT04933968|450244771|FG005|Overall Study|Randomized not treated|0|||
125169515|NCT04933968|450244766|FG000|Overall Study|Sponsor terminated study|0|||
125169516|NCT04933968|450244767|FG001|Overall Study|Sponsor terminated study|0|||
125169517|NCT04933968|450244768|FG002|Overall Study|Sponsor terminated study|0|||
125169518|NCT04933968|450244769|FG003|Overall Study|Sponsor terminated study|1|||
125169519|NCT04933968|450244770|FG004|Overall Study|Sponsor terminated study|2|||
125169520|NCT04933968|450244771|FG005|Overall Study|Sponsor terminated study|0|||
125169521|NCT04933968|450244766|FG000|Overall Study|Other|0|||
125169522|NCT04933968|450244767|FG001|Overall Study|Other|0|||
125169523|NCT04933968|450244768|FG002|Overall Study|Other|0|||
125169524|NCT04933968|450244769|FG003|Overall Study|Other|1|||
125169525|NCT04933968|450244770|FG004|Overall Study|Other|0|||
125169526|NCT04933968|450244771|FG005|Overall Study|Other|0|||
125169527|NCT04933968|450244766|FG000|Overall Study|Missing|1|||
125169528|NCT04933968|450244767|FG001|Overall Study|Missing|3|||
125227970|NCT01130272|450464108|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
125227971|NCT01130272|450464109|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
125227972|NCT01130272|450464110|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
125227973|NCT01130272|450464111|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
125169529|NCT04933968|450244768|FG002|Overall Study|Missing|2|||
125169530|NCT04933968|450244769|FG003|Overall Study|Missing|1|||
125169531|NCT04933968|450244770|FG004|Overall Study|Missing|1|||
125169532|NCT04933968|450244771|FG005|Overall Study|Missing|0|||
125169533|NCT02119819|450244772|FG000|Overall Study|Adverse Event|3|||
125169534|NCT02119819|450244773|FG001|Overall Study|Adverse Event|1|||
125169535|NCT02119819|450244774|FG002|Overall Study|Adverse Event|2|||
125169536|NCT02119819|450244775|FG003|Overall Study|Adverse Event|3|||
125169537|NCT02119819|450244776|FG004|Overall Study|Adverse Event|0|||
125169538|NCT02119819|450244777|FG005|Overall Study|Adverse Event|1|||
125169539|NCT02119819|450244772|FG000|Overall Study|Lack of Efficacy|0|||
125169540|NCT02119819|450244773|FG001|Overall Study|Lack of Efficacy|0|||
125169541|NCT02119819|450244774|FG002|Overall Study|Lack of Efficacy|0|||
125169542|NCT02119819|450244775|FG003|Overall Study|Lack of Efficacy|0|||
125169543|NCT02119819|450244776|FG004|Overall Study|Lack of Efficacy|0|||
125169544|NCT02119819|450244777|FG005|Overall Study|Lack of Efficacy|1|||
125169545|NCT02119819|450244772|FG000|Overall Study|Lost to Follow-up|0|||
125169546|NCT02119819|450244773|FG001|Overall Study|Lost to Follow-up|0|||
125169547|NCT02119819|450244774|FG002|Overall Study|Lost to Follow-up|1|||
125169548|NCT02119819|450244775|FG003|Overall Study|Lost to Follow-up|2|||
125169549|NCT02119819|450244776|FG004|Overall Study|Lost to Follow-up|1|||
125169550|NCT02119819|450244777|FG005|Overall Study|Lost to Follow-up|2|||
125169551|NCT02119819|450244772|FG000|Overall Study|Physician Decision|1|||
125169552|NCT02119819|450244773|FG001|Overall Study|Physician Decision|1|||
125169553|NCT02119819|450244774|FG002|Overall Study|Physician Decision|0|||
125169554|NCT02119819|450244775|FG003|Overall Study|Physician Decision|0|||
125169555|NCT02119819|450244776|FG004|Overall Study|Physician Decision|0|||
125169556|NCT02119819|450244777|FG005|Overall Study|Physician Decision|1|||
125169557|NCT02119819|450244772|FG000|Overall Study|Withdrawal by Subject|5|||
125169558|NCT02119819|450244773|FG001|Overall Study|Withdrawal by Subject|3|||
125169559|NCT02119819|450244774|FG002|Overall Study|Withdrawal by Subject|0|||
125169560|NCT02119819|450244775|FG003|Overall Study|Withdrawal by Subject|0|||
125169561|NCT02119819|450244776|FG004|Overall Study|Withdrawal by Subject|6|||
125169562|NCT02119819|450244777|FG005|Overall Study|Withdrawal by Subject|10|||
125169563|NCT02119819|450244772|FG000|Overall Study|Jury Duty|0|||
125169564|NCT02119819|450244773|FG001|Overall Study|Jury Duty|0|||
125169565|NCT02119819|450244774|FG002|Overall Study|Jury Duty|1|||
125169566|NCT02119819|450244775|FG003|Overall Study|Jury Duty|0|||
125227974|NCT01130272|450464107|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
125227975|NCT01130272|450464108|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
125227976|NCT01130272|450464109|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
125227977|NCT01130272|450464110|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
125227978|NCT01130272|450464111|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
125227979|NCT01130272|450464107|FG000|Overall Study|Protocol Violation|0|||
125227980|NCT01130272|450464108|FG001|Overall Study|Protocol Violation|0|||
125227981|NCT01130272|450464109|FG002|Overall Study|Protocol Violation|3|||
125227982|NCT01130272|450464110|FG003|Overall Study|Protocol Violation|5|||
125227983|NCT01130272|450464111|FG004|Overall Study|Protocol Violation|5|||
125169567|NCT02119819|450244776|FG004|Overall Study|Jury Duty|0|||
125169568|NCT02119819|450244777|FG005|Overall Study|Jury Duty|0|||
125169569|NCT02119819|450244772|FG000|Overall Study|Protocol Violation|0|||
125169570|NCT02119819|450244773|FG001|Overall Study|Protocol Violation|0|||
125169571|NCT02119819|450244774|FG002|Overall Study|Protocol Violation|0|||
125227984|NCT01130272|450464107|FG000|Overall Study|Lost to Follow-up|4|||
125227985|NCT01130272|450464108|FG001|Overall Study|Lost to Follow-up|3|||
125227986|NCT01130272|450464109|FG002|Overall Study|Lost to Follow-up|4|||
125169572|NCT02119819|450244775|FG003|Overall Study|Protocol Violation|1|||
125169573|NCT02119819|450244776|FG004|Overall Study|Protocol Violation|0|||
125169574|NCT02119819|450244777|FG005|Overall Study|Protocol Violation|0|||
125169575|NCT02119819|450244772|FG000|Overall Study|Left the city to get a job|0|||
125169576|NCT02119819|450244773|FG001|Overall Study|Left the city to get a job|0|||
125169577|NCT02119819|450244774|FG002|Overall Study|Left the city to get a job|0|||
125169578|NCT02119819|450244775|FG003|Overall Study|Left the city to get a job|1|||
125169579|NCT02119819|450244776|FG004|Overall Study|Left the city to get a job|0|||
125169580|NCT02119819|450244777|FG005|Overall Study|Left the city to get a job|0|||
125169581|NCT02699684|450244778|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
125169582|NCT02699684|450244779|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
125169583|NCT04839692|450244780|FG000|Overall Study|Withdrawal by Subject|0|||
125169584|NCT04839692|450244781|FG001|Overall Study|Withdrawal by Subject|3|||
125169585|NCT04839692|450244780|FG000|Overall Study|Physician Decision|1|||
125169586|NCT04839692|450244781|FG001|Overall Study|Physician Decision|0|||
125169587|NCT03146962|450244782|FG000|Overall Study|Lost to Follow-up|1|||
125169588|NCT03146962|450244783|FG001|Overall Study|Lost to Follow-up|1|||
125169589|NCT03146962|450244784|FG002|Overall Study|Lost to Follow-up|0|||
125169590|NCT03146962|450244785|FG003|Overall Study|Lost to Follow-up|0|||
125169591|NCT03146962|450244786|FG004|Overall Study|Lost to Follow-up|0|||
125169592|NCT03146962|450244787|FG005|Overall Study|Lost to Follow-up|0|||
125169593|NCT03146962|450244788|FG006|Overall Study|Lost to Follow-up|0|||
125169594|NCT03146962|450244789|FG007|Overall Study|Lost to Follow-up|0|||
125169595|NCT03146962|450244790|FG008|Overall Study|Lost to Follow-up|0|||
125169596|NCT03146962|450244791|FG009|Overall Study|Lost to Follow-up|0|||
125169597|NCT03146962|450244782|FG000|Overall Study|Adverse Event|0|||
125169598|NCT03146962|450244783|FG001|Overall Study|Adverse Event|3|||
125169599|NCT03146962|450244784|FG002|Overall Study|Adverse Event|0|||
125169600|NCT03146962|450244785|FG003|Overall Study|Adverse Event|0|||
125169601|NCT03146962|450244786|FG004|Overall Study|Adverse Event|0|||
125169602|NCT03146962|450244787|FG005|Overall Study|Adverse Event|0|||
125169603|NCT03146962|450244788|FG006|Overall Study|Adverse Event|0|||
125169604|NCT03146962|450244789|FG007|Overall Study|Adverse Event|1|||
125169605|NCT03146962|450244790|FG008|Overall Study|Adverse Event|0|||
125169606|NCT03146962|450244791|FG009|Overall Study|Adverse Event|0|||
125169607|NCT03146962|450244782|FG000|Overall Study|Withdrawal by Subject|0|||
125169608|NCT03146962|450244783|FG001|Overall Study|Withdrawal by Subject|0|||
125169609|NCT03146962|450244784|FG002|Overall Study|Withdrawal by Subject|0|||
125169610|NCT03146962|450244785|FG003|Overall Study|Withdrawal by Subject|0|||
125169611|NCT03146962|450244786|FG004|Overall Study|Withdrawal by Subject|1|||
125169612|NCT03146962|450244787|FG005|Overall Study|Withdrawal by Subject|0|||
125169613|NCT03146962|450244788|FG006|Overall Study|Withdrawal by Subject|0|||
125169614|NCT03146962|450244789|FG007|Overall Study|Withdrawal by Subject|0|||
125169615|NCT03146962|450244790|FG008|Overall Study|Withdrawal by Subject|0|||
125169616|NCT03146962|450244791|FG009|Overall Study|Withdrawal by Subject|0|||
125169617|NCT03146962|450244782|FG000|Overall Study|Death|0|||
125169618|NCT03146962|450244783|FG001|Overall Study|Death|1|||
125169619|NCT03146962|450244784|FG002|Overall Study|Death|0|||
125169620|NCT03146962|450244785|FG003|Overall Study|Death|0|||
125169621|NCT03146962|450244786|FG004|Overall Study|Death|0|||
125169622|NCT03146962|450244787|FG005|Overall Study|Death|0|||
125169623|NCT03146962|450244788|FG006|Overall Study|Death|0|||
125169624|NCT03146962|450244789|FG007|Overall Study|Death|0|||
125169625|NCT03146962|450244790|FG008|Overall Study|Death|0|||
125169626|NCT03146962|450244791|FG009|Overall Study|Death|0|||
125169627|NCT03146962|450244782|FG000|Overall Study|COVID Precautions|1|||
125169628|NCT03146962|450244783|FG001|Overall Study|COVID Precautions|0|||
125169629|NCT03146962|450244784|FG002|Overall Study|COVID Precautions|0|||
125169630|NCT03146962|450244785|FG003|Overall Study|COVID Precautions|0|||
125169631|NCT03146962|450244786|FG004|Overall Study|COVID Precautions|0|||
125169632|NCT03146962|450244787|FG005|Overall Study|COVID Precautions|0|||
125169633|NCT03146962|450244788|FG006|Overall Study|COVID Precautions|0|||
125169634|NCT03146962|450244789|FG007|Overall Study|COVID Precautions|0|||
125169635|NCT03146962|450244790|FG008|Overall Study|COVID Precautions|0|||
125169636|NCT03146962|450244791|FG009|Overall Study|COVID Precautions|0|||
125169637|NCT03146962|450244782|FG000|Overall Study|Physician Decision|0|||
125169638|NCT03146962|450244783|FG001|Overall Study|Physician Decision|0|||
125169639|NCT03146962|450244784|FG002|Overall Study|Physician Decision|0|||
125169640|NCT03146962|450244785|FG003|Overall Study|Physician Decision|0|||
125169641|NCT03146962|450244786|FG004|Overall Study|Physician Decision|0|||
125169642|NCT03146962|450244787|FG005|Overall Study|Physician Decision|0|||
125169643|NCT03146962|450244788|FG006|Overall Study|Physician Decision|0|||
125169644|NCT03146962|450244789|FG007|Overall Study|Physician Decision|0|||
125169645|NCT03146962|450244790|FG008|Overall Study|Physician Decision|0|||
125169646|NCT03146962|450244791|FG009|Overall Study|Physician Decision|1|||
125169647|NCT03146962|450244782|FG000|Overall Study|Started New Treatment|0|||
125169648|NCT03146962|450244783|FG001|Overall Study|Started New Treatment|1|||
125169649|NCT03146962|450244784|FG002|Overall Study|Started New Treatment|0|||
125169650|NCT03146962|450244785|FG003|Overall Study|Started New Treatment|0|||
125169651|NCT03146962|450244786|FG004|Overall Study|Started New Treatment|0|||
125169652|NCT03146962|450244787|FG005|Overall Study|Started New Treatment|0|||
125169653|NCT03146962|450244788|FG006|Overall Study|Started New Treatment|0|||
125169654|NCT03146962|450244789|FG007|Overall Study|Started New Treatment|0|||
125169655|NCT03146962|450244790|FG008|Overall Study|Started New Treatment|0|||
125169656|NCT03146962|450244791|FG009|Overall Study|Started New Treatment|0|||
125169657|NCT00926783|450244793|FG000|Overall Study|Incomplete CFAE Procedures|3|||
125169658|NCT00926783|450244794|FG001|Overall Study|Incomplete CFAE Procedures|3|||
125169659|NCT02186834|450244797|FG000|Dose Escalation|Death|0|||
125169660|NCT02186834|450244798|FG001|Dose Escalation|Death|0|||
125169661|NCT02186834|450244799|FG002|Dose Escalation|Death|0|||
125169662|NCT02186834|450244800|FG003|Dose Escalation|Death|1|||
125169663|NCT02186834|450244801|FG004|Dose Escalation|Death|0|||
125227987|NCT01130272|450464110|FG003|Overall Study|Lost to Follow-up|7|||
125227988|NCT01130272|450464111|FG004|Overall Study|Lost to Follow-up|6|||
125227989|NCT01130272|450464107|FG000|Overall Study|Withdrawal by Subject|4|||
125227990|NCT01130272|450464108|FG001|Overall Study|Withdrawal by Subject|11|||
125227991|NCT01130272|450464109|FG002|Overall Study|Withdrawal by Subject|10|||
125227992|NCT01130272|450464110|FG003|Overall Study|Withdrawal by Subject|9|||
125227993|NCT01130272|450464111|FG004|Overall Study|Withdrawal by Subject|8|||
125227994|NCT01130272|450464107|FG000|Overall Study|Physician Decision|1|||
125227995|NCT01130272|450464108|FG001|Overall Study|Physician Decision|1|||
125227996|NCT01130272|450464109|FG002|Overall Study|Physician Decision|0|||
125227997|NCT01130272|450464110|FG003|Overall Study|Physician Decision|1|||
125227998|NCT01130272|450464111|FG004|Overall Study|Physician Decision|2|||
125227999|NCT01130272|450464107|FG000|Overall Study|Sponsor decision|6|||
125228000|NCT01130272|450464108|FG001|Overall Study|Sponsor decision|15|||
125228001|NCT01130272|450464109|FG002|Overall Study|Sponsor decision|16|||
125228002|NCT01130272|450464110|FG003|Overall Study|Sponsor decision|13|||
125228003|NCT01130272|450464111|FG004|Overall Study|Sponsor decision|16|||
125228004|NCT01130272|450464107|FG000|Overall Study|Study arm discontinued|38|||
125228005|NCT01130272|450464108|FG001|Overall Study|Study arm discontinued|0|||
125228006|NCT01130272|450464109|FG002|Overall Study|Study arm discontinued|0|||
125228007|NCT01130272|450464110|FG003|Overall Study|Study arm discontinued|0|||
125228008|NCT01130272|450464111|FG004|Overall Study|Study arm discontinued|0|||
125228009|NCT01548404|450464112|FG000|Overall Study|Adverse Event|3|||
125228010|NCT01548404|450464113|FG001|Overall Study|Adverse Event|1|||
125228011|NCT01548404|450464112|FG000|Overall Study|Physician Decision|2|||
125228012|NCT01548404|450464113|FG001|Overall Study|Physician Decision|1|||
125228013|NCT01548404|450464112|FG000|Overall Study|Inadequate response to study treatment|23|||
125228014|NCT01548404|450464113|FG001|Overall Study|Inadequate response to study treatment|7|||
125228015|NCT01548404|450464112|FG000|Overall Study|Lost to Follow-up|2|||
125228016|NCT01548404|450464113|FG001|Overall Study|Lost to Follow-up|0|||
125228017|NCT01548404|450464112|FG000|Overall Study|Withdrawal by Subject|0|||
125228018|NCT01548404|450464113|FG001|Overall Study|Withdrawal by Subject|3|||
125228019|NCT01548404|450464112|FG000|Overall Study|Other than specified above|0|||
125228020|NCT01548404|450464113|FG001|Overall Study|Other than specified above|2|||
125228021|NCT00641056|450464114|FG000|Overall Study|Adverse Event|12|||
125228022|NCT00641056|450464115|FG001|Overall Study|Adverse Event|2|||
125228023|NCT00641056|450464114|FG000|Overall Study|Lost to Follow-up|2|||
125228024|NCT00641056|450464115|FG001|Overall Study|Lost to Follow-up|1|||
125228025|NCT00641056|450464114|FG000|Overall Study|Physician Decision|3|||
125228026|NCT00641056|450464115|FG001|Overall Study|Physician Decision|1|||
125228027|NCT00641056|450464114|FG000|Overall Study|Protocol Violation|2|||
125228028|NCT00641056|450464115|FG001|Overall Study|Protocol Violation|0|||
125228029|NCT00641056|450464114|FG000|Overall Study|Entry Criteria Not Met|3|||
125228030|NCT00641056|450464115|FG001|Overall Study|Entry Criteria Not Met|0|||
125228031|NCT00641056|450464114|FG000|Overall Study|Subject Decision|6|||
125228032|NCT00641056|450464115|FG001|Overall Study|Subject Decision|19|||
125228033|NCT00641056|450464114|FG000|Overall Study|Sponsor Decision|1|||
125228034|NCT00641056|450464115|FG001|Overall Study|Sponsor Decision|2|||
125228035|NCT00737048|450464116|FG000|Overall Study|Physician Decision|0|||
125228036|NCT00737048|450464117|FG001|Overall Study|Physician Decision|0|||
125228037|NCT00737048|450464118|FG002|Overall Study|Physician Decision|1|||
125228038|NCT00737048|450464116|FG000|Overall Study|Adverse Event|0|||
125228039|NCT00737048|450464117|FG001|Overall Study|Adverse Event|1|||
125228040|NCT00737048|450464118|FG002|Overall Study|Adverse Event|0|||
125228041|NCT00737048|450464116|FG000|Overall Study|Worsening of the symptoms|3|||
125228042|NCT00737048|450464117|FG001|Overall Study|Worsening of the symptoms|5|||
125228043|NCT00737048|450464118|FG002|Overall Study|Worsening of the symptoms|3|||
125228044|NCT04040439|450464120|FG000|Overall Study|Invalid registration|11|||
125228045|NCT04040439|450464120|FG000|Overall Study|No IC* on publication of study results|2|||
125228046|NCT01309386|450464121|FG000|Overall Study|Other|2|||
125228047|NCT01309386|450464122|FG001|Overall Study|Other|0|||
125228048|NCT01309386|450464121|FG000|Overall Study|Withdrawal by Subject|2|||
125228049|NCT01309386|450464122|FG001|Overall Study|Withdrawal by Subject|0|||
125228050|NCT01309386|450464121|FG000|Overall Study|Progressive disease|9|||
125228051|NCT01309386|450464122|FG001|Overall Study|Progressive disease|11|||
125228052|NCT01309386|450464121|FG000|Overall Study|Physician Decision|1|||
125228053|NCT01309386|450464122|FG001|Overall Study|Physician Decision|1|||
125228054|NCT01309386|450464121|FG000|Overall Study|Lack of Efficacy|3|||
125228055|NCT01309386|450464122|FG001|Overall Study|Lack of Efficacy|1|||
125228056|NCT01309386|450464121|FG000|Overall Study|Adverse Event|5|||
125228057|NCT01309386|450464122|FG001|Overall Study|Adverse Event|8|||
125228058|NCT02062437|450464123|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
125228059|NCT02062437|450464123|FG000|Overall Study|Patient not available for the 2y visit|18|||
125228060|NCT02062437|450464123|FG000|Overall Study|Death|2|||
125228061|NCT02062437|450464123|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
125228062|NCT01674725|450464124|FG000|Overall Study|Adverse Event|1|||
125228063|NCT01674725|450464125|FG001|Overall Study|Adverse Event|0|||
125228064|NCT01674725|450464124|FG000|Overall Study|Did not receive study drug|1|||
125228065|NCT01674725|450464125|FG001|Overall Study|Did not receive study drug|0|||
125228066|NCT01674725|450464124|FG000|Overall Study|Withdrawal by Subject|1|||
125228067|NCT01674725|450464125|FG001|Overall Study|Withdrawal by Subject|0|||
125228068|NCT01674725|450464124|FG000|Overall Study|Lost to Follow-up|0|||
125228069|NCT01674725|450464125|FG001|Overall Study|Lost to Follow-up|1|||
125228070|NCT02900352|450464126|FG000|Overall Study|Lost to Follow-up|28|||
125228071|NCT02900352|450464127|FG001|Overall Study|Lost to Follow-up|17|||
125228072|NCT03074695|450464128|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
125228073|NCT03074695|450464129|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
125228074|NCT03074695|450464128|FG000|Overall Study|Research staff not available|1|||
125228075|NCT03074695|450464129|FG001|Overall Study|Research staff not available|2|||
125228076|NCT03074695|450464128|FG000|Overall Study|Did not receive neuraxial block|2|||
125228077|NCT03074695|450464129|FG001|Overall Study|Did not receive neuraxial block|2|||
125228078|NCT01774981|450464130|FG000|Overall Study|Adverse Event|0|||
125228079|NCT01774981|450464131|FG001|Overall Study|Adverse Event|0|||
125228080|NCT01774981|450464132|FG002|Overall Study|Adverse Event|0|||
125228081|NCT01774981|450464133|FG003|Overall Study|Adverse Event|0|||
125228082|NCT01774981|450464134|FG004|Overall Study|Adverse Event|0|||
125228083|NCT01774981|450464135|FG005|Overall Study|Adverse Event|1|||
125228084|NCT01774981|450464136|FG006|Overall Study|Adverse Event|0|||
125228085|NCT01774981|450464137|FG007|Overall Study|Adverse Event|0|||
125228086|NCT01774981|450464130|FG000|Overall Study|Withdrawal by Subject|0|||
125228087|NCT01774981|450464131|FG001|Overall Study|Withdrawal by Subject|0|||
125228088|NCT01774981|450464132|FG002|Overall Study|Withdrawal by Subject|0|||
125228089|NCT01774981|450464133|FG003|Overall Study|Withdrawal by Subject|0|||
125228090|NCT01774981|450464134|FG004|Overall Study|Withdrawal by Subject|0|||
125228091|NCT01774981|450464135|FG005|Overall Study|Withdrawal by Subject|0|||
125228092|NCT01774981|450464136|FG006|Overall Study|Withdrawal by Subject|0|||
125228093|NCT01774981|450464137|FG007|Overall Study|Withdrawal by Subject|1|||
125228094|NCT01774981|450464130|FG000|Overall Study|Death|0|||
125228095|NCT01774981|450464131|FG001|Overall Study|Death|0|||
125228096|NCT01774981|450464132|FG002|Overall Study|Death|0|||
125228097|NCT01774981|450464133|FG003|Overall Study|Death|0|||
125228098|NCT01774981|450464134|FG004|Overall Study|Death|1|||
125228099|NCT01774981|450464135|FG005|Overall Study|Death|0|||
125228100|NCT01774981|450464136|FG006|Overall Study|Death|0|||
125228101|NCT01774981|450464137|FG007|Overall Study|Death|0|||
125228102|NCT00960193|450464138|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
125228103|NCT01324102|450464141|FG000|Overall Study|illness|1|||
125228104|NCT01324102|450464142|FG001|Overall Study|illness|6|||
125228105|NCT00386334|450464145|FG000|Double Blind Period|Adverse Event|9|||
125228106|NCT00386334|450464146|FG001|Double Blind Period|Adverse Event|14|||
125228107|NCT00386334|450464145|FG000|Double Blind Period|Protocol Violation|1|||
125228108|NCT00386334|450464146|FG001|Double Blind Period|Protocol Violation|1|||
125228109|NCT00386334|450464145|FG000|Double Blind Period|Withdrawal by Subject|9|||
125228110|NCT00386334|450464146|FG001|Double Blind Period|Withdrawal by Subject|13|||
125228111|NCT00386334|450464145|FG000|Double Blind Period|Lack of Efficacy|20|||
125228112|NCT00386334|450464146|FG001|Double Blind Period|Lack of Efficacy|11|||
125228113|NCT00386334|450464145|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
125228114|NCT00386334|450464146|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
125228115|NCT00386334|450464145|FG000|Double Blind Period|Other|3|||
125228116|NCT00386334|450464146|FG001|Double Blind Period|Other|3|||
125228117|NCT00386334|450464145|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
125228118|NCT00386334|450464146|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
125228119|NCT00902577|450464147|FG000|Overall Study|Withdrawal by Subject|6|||
125228120|NCT00902577|450464147|FG000|Overall Study|FMISO production failure|2|||
125228121|NCT00106002|450464148|FG000|Overall Study|Did not take any study drug|1|||
125228122|NCT00106002|450464148|FG000|Overall Study|Ineligible after Registration|1|||
125228123|NCT01249131|450464155|FG000|Washout Period of 10 Days|Adverse Event|0|||
125228124|NCT01249131|450464156|FG001|Washout Period of 10 Days|Adverse Event|0|||
125228125|NCT01249131|450464157|FG002|Washout Period of 10 Days|Adverse Event|0|||
125228126|NCT01249131|450464158|FG003|Washout Period of 10 Days|Adverse Event|0|||
125228127|NCT01249131|450464159|FG004|Washout Period of 10 Days|Adverse Event|1|||
125228128|NCT01249131|450464160|FG005|Washout Period of 10 Days|Adverse Event|0|||
125228129|NCT01245101|450464161|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
125228130|NCT01245101|450464162|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
125228131|NCT01245101|450464161|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
125228132|NCT01245101|450464162|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
125228133|NCT01245101|450464161|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
125228134|NCT01245101|450464162|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
125228135|NCT04456686|450464163|FG000|Overall Study|Adverse Event|2|||
125228136|NCT04456686|450464164|FG001|Overall Study|Adverse Event|1|||
125228137|NCT04456686|450464163|FG000|Overall Study|Lack of Efficacy|3|||
125228138|NCT04456686|450464164|FG001|Overall Study|Lack of Efficacy|1|||
125228139|NCT04456686|450464163|FG000|Overall Study|Withdrew consent|3|||
125228140|NCT04456686|450464164|FG001|Overall Study|Withdrew consent|1|||
125228141|NCT04456686|450464163|FG000|Overall Study|Physician Decision|2|||
125228142|NCT04456686|450464164|FG001|Overall Study|Physician Decision|2|||
125228143|NCT04456686|450464163|FG000|Overall Study|Withdrawal by Subject|5|||
125228144|NCT04456686|450464164|FG001|Overall Study|Withdrawal by Subject|1|||
125228145|NCT04456686|450464163|FG000|Overall Study|Protocol Violation|0|||
125228146|NCT04456686|450464164|FG001|Overall Study|Protocol Violation|1|||
125228147|NCT00473083|450464171|FG000|Overall Study|Adverse Event|1|||
125228148|NCT00473083|450464172|FG001|Overall Study|Adverse Event|0|||
125228149|NCT00473083|450464173|FG002|Overall Study|Adverse Event|0|||
125228150|NCT02915835|450464174|FG000|Overall Study|Physician Decision|1|||
125228151|NCT02915835|450464175|FG001|Overall Study|Physician Decision|0|||
125228152|NCT02915835|450464174|FG000|Overall Study|Withdrawal by Subject|0|||
125228153|NCT02915835|450464175|FG001|Overall Study|Withdrawal by Subject|1|||
125228154|NCT00113607|450464176|FG000|Overall Study|Adverse Event|40|||
125228155|NCT00113607|450464177|FG001|Overall Study|Adverse Event|71|||
125228156|NCT00113607|450464176|FG000|Overall Study|Death|8|||
125228157|NCT00113607|450464177|FG001|Overall Study|Death|8|||
125228158|NCT00113607|450464176|FG000|Overall Study|Withdrawal by Subject|50|||
125228159|NCT00113607|450464177|FG001|Overall Study|Withdrawal by Subject|58|||
125228160|NCT00113607|450464176|FG000|Overall Study|Lost to Follow-up|0|||
125228161|NCT00113607|450464177|FG001|Overall Study|Lost to Follow-up|2|||
125228162|NCT00113607|450464176|FG000|Overall Study|Disease Progression|180|||
125228163|NCT00113607|450464177|FG001|Overall Study|Disease Progression|142|||
125228164|NCT00113607|450464176|FG000|Overall Study|Complete Response (Confirmed)|14|||
125228165|NCT00113607|450464177|FG001|Overall Study|Complete Response (Confirmed)|24|||
125228166|NCT00113607|450464176|FG000|Overall Study|Other|43|||
125228167|NCT00113607|450464177|FG001|Overall Study|Other|32|||
125228168|NCT01222104|450464178|FG000|Overall Study|Lost to Follow-up|37|||
125228169|NCT01222104|450464178|FG000|Overall Study|Death|10|||
125228170|NCT01418339|450464179|FG000|Overall Study|Adverse Event|5|||
125228171|NCT01418339|450464180|FG001|Overall Study|Adverse Event|2|||
125228172|NCT01418339|450464179|FG000|Overall Study|Subject Withdrew Consent|1|||
125228173|NCT01418339|450464180|FG001|Overall Study|Subject Withdrew Consent|2|||
125228174|NCT01418339|450464179|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
125228175|NCT01418339|450464180|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
125228176|NCT03885908|450464181|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
125228177|NCT03885908|450464182|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
125228178|NCT03885908|450464181|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
125228179|NCT03885908|450464182|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
125228180|NCT03885908|450464181|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
125228181|NCT03885908|450464182|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
125228182|NCT03885908|450464181|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
125228183|NCT03885908|450464182|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
125228184|NCT00909844|450464183|FG000|Overall Study|Adverse Event|1|||
125228185|NCT00909844|450464183|FG000|Overall Study|Withdrawal by Subject|1|||
125228186|NCT00909844|450464183|FG000|Overall Study|Lost to Follow-up|2|||
125228187|NCT00706004|450464184|FG000|Overall Study|Did not meet eligibility criteria|2|||
125228188|NCT01064479|450464185|FG000|Overall Study|Death|10|||
125228189|NCT01064479|450464186|FG001|Overall Study|Death|11|||
125228190|NCT01064479|450464185|FG000|Overall Study|Withdrawal by Subject|2|||
125228191|NCT01064479|450464186|FG001|Overall Study|Withdrawal by Subject|2|||
125228192|NCT01064479|450464185|FG000|Overall Study|Disease progression|1|||
125228193|NCT01064479|450464186|FG001|Overall Study|Disease progression|1|||
125228194|NCT01064479|450464185|FG000|Overall Study|Toxicity|1|||
125228195|NCT01064479|450464186|FG001|Overall Study|Toxicity|1|||
125228196|NCT01064479|450464185|FG000|Overall Study|Other|1|||
125228197|NCT01064479|450464186|FG001|Overall Study|Other|2|||
125228198|NCT03093181|450464189|FG000|Overall Study|Withdrawal by Subject|2|||
125228199|NCT03093181|450464190|FG001|Overall Study|Withdrawal by Subject|1|||
125228200|NCT03093181|450464191|FG002|Overall Study|Withdrawal by Subject|2|||
125228201|NCT03093181|450464189|FG000|Overall Study|Other (Not specified)|1|||
125228202|NCT03093181|450464190|FG001|Overall Study|Other (Not specified)|0|||
125228203|NCT03093181|450464191|FG002|Overall Study|Other (Not specified)|0|||
125228204|NCT03093181|450464189|FG000|Overall Study|Adverse Event|0|||
125228205|NCT03093181|450464190|FG001|Overall Study|Adverse Event|1|||
125228206|NCT03093181|450464191|FG002|Overall Study|Adverse Event|0|||
125228207|NCT03093181|450464189|FG000|Overall Study|Other (Protocol violation)|0|||
125228208|NCT03093181|450464190|FG001|Overall Study|Other (Protocol violation)|0|||
125228209|NCT03093181|450464191|FG002|Overall Study|Other (Protocol violation)|1|||
125228210|NCT04210986|450464192|FG000|Overall Study|Lost to Follow-up|5|||
125228211|NCT04210986|450464193|FG001|Overall Study|Lost to Follow-up|2|||
125228212|NCT04210986|450464192|FG000|Overall Study|Withdrawal by Subject|3|||
125228213|NCT04210986|450464193|FG001|Overall Study|Withdrawal by Subject|1|||
125228214|NCT04210986|450464192|FG000|Overall Study|Protocol Violation|1|||
125228215|NCT04210986|450464193|FG001|Overall Study|Protocol Violation|1|||
125169664|NCT02186834|450244802|FG005|Dose Escalation|Death|0|||
125169665|NCT02186834|450244797|FG000|Treatment at RP2D|Died prior to treatment|0|||
125169666|NCT02186834|450244798|FG001|Treatment at RP2D|Died prior to treatment|0|||
125169667|NCT02186834|450244799|FG002|Treatment at RP2D|Died prior to treatment|0|||
125169668|NCT02186834|450244800|FG003|Treatment at RP2D|Died prior to treatment|0|||
125169669|NCT02186834|450244801|FG004|Treatment at RP2D|Died prior to treatment|0|||
125169670|NCT02186834|450244802|FG005|Treatment at RP2D|Died prior to treatment|1|||
125169671|NCT00749892|450244803|FG000|Overall Study|Withdrawal by Subject|3|||
125169672|NCT01191944|450244806|FG000|Overall Study|Adverse Event|11|||
125169673|NCT01191944|450244807|FG001|Overall Study|Adverse Event|12|||
125169674|NCT01191944|450244806|FG000|Overall Study|Protocol Violation|1|||
125169675|NCT01191944|450244807|FG001|Overall Study|Protocol Violation|2|||
125169676|NCT01191944|450244806|FG000|Overall Study|Withdrawal by Subject|4|||
125169677|NCT01191944|450244807|FG001|Overall Study|Withdrawal by Subject|2|||
125169678|NCT01191944|450244806|FG000|Overall Study|Other|1|||
125169679|NCT01191944|450244807|FG001|Overall Study|Other|3|||
125169680|NCT00469144|450244812|FG000|Overall Study|Death|0|||
125169681|NCT00469144|450244813|FG001|Overall Study|Death|1|||
125169682|NCT00469144|450244812|FG000|Overall Study|No Response|5|||
125169683|NCT00469144|450244813|FG001|Overall Study|No Response|5|||
125169684|NCT00469144|450244812|FG000|Overall Study|Progressive Disease|1|||
125169685|NCT00469144|450244813|FG001|Overall Study|Progressive Disease|0|||
125169686|NCT04602546|450244814|FG000|Overall Study|Training|2|||
125169687|NCT04602546|450244815|FG001|Overall Study|Training|2|||
125169688|NCT04602546|450244816|FG002|Overall Study|Training|1|||
125169689|NCT04602546|450244817|FG003|Overall Study|Training|2|||
125169690|NCT04602546|450244818|FG004|Overall Study|Training|0|||
125169691|NCT04602546|450244814|FG000|Overall Study|Randomized with disqualified data|2|||
125169692|NCT04602546|450244815|FG001|Overall Study|Randomized with disqualified data|0|||
125169693|NCT04602546|450244816|FG002|Overall Study|Randomized with disqualified data|2|||
125169694|NCT04602546|450244817|FG003|Overall Study|Randomized with disqualified data|5|||
125169695|NCT04602546|450244818|FG004|Overall Study|Randomized with disqualified data|3|||
125169696|NCT00253448|450244822|FG000|Overall Study|Withdrawal by Subject|1|||
125169697|NCT02564887|450244823|FG000|Overall Study|Lost to Follow-up|6|||
125169698|NCT02564887|450244824|FG001|Overall Study|Lost to Follow-up|0|||
125169699|NCT00000620|450244825|FG000|Overall Study|Death|86|||
125169700|NCT00000620|450244826|FG001|Overall Study|Death|67|||
125169701|NCT00000620|450244827|FG002|Overall Study|Death|112|||
125169702|NCT00000620|450244828|FG003|Overall Study|Death|126|||
125169703|NCT00000620|450244829|FG004|Overall Study|Death|64|||
125169704|NCT00000620|450244830|FG005|Overall Study|Death|77|||
125169705|NCT00000620|450244831|FG006|Overall Study|Death|91|||
125169706|NCT00000620|450244832|FG007|Overall Study|Death|95|||
125169707|NCT00000620|450244825|FG000|Overall Study|Lost to Follow-up|14|||
125169708|NCT00000620|450244826|FG001|Overall Study|Lost to Follow-up|14|||
125169709|NCT00000620|450244827|FG002|Overall Study|Lost to Follow-up|14|||
125169710|NCT00000620|450244828|FG003|Overall Study|Lost to Follow-up|14|||
125169711|NCT00000620|450244829|FG004|Overall Study|Lost to Follow-up|15|||
125169712|NCT00000620|450244830|FG005|Overall Study|Lost to Follow-up|15|||
125169713|NCT00000620|450244831|FG006|Overall Study|Lost to Follow-up|13|||
125169714|NCT00000620|450244832|FG007|Overall Study|Lost to Follow-up|14|||
125169715|NCT00000620|450244825|FG000|Overall Study|Withdrawal by Subject|40|||
125169716|NCT00000620|450244826|FG001|Overall Study|Withdrawal by Subject|27|||
125169717|NCT00000620|450244827|FG002|Overall Study|Withdrawal by Subject|28|||
125169718|NCT00000620|450244828|FG003|Overall Study|Withdrawal by Subject|27|||
125169719|NCT00000620|450244829|FG004|Overall Study|Withdrawal by Subject|30|||
125169720|NCT00000620|450244830|FG005|Overall Study|Withdrawal by Subject|32|||
125169721|NCT00000620|450244831|FG006|Overall Study|Withdrawal by Subject|32|||
125169722|NCT00000620|450244832|FG007|Overall Study|Withdrawal by Subject|21|||
125169723|NCT00000620|450244825|FG000|Overall Study|missed closeout visit|22|||
125169724|NCT00000620|450244826|FG001|Overall Study|missed closeout visit|28|||
125169725|NCT00000620|450244827|FG002|Overall Study|missed closeout visit|16|||
125169726|NCT00000620|450244828|FG003|Overall Study|missed closeout visit|11|||
125169727|NCT00000620|450244829|FG004|Overall Study|missed closeout visit|26|||
125169728|NCT00000620|450244830|FG005|Overall Study|missed closeout visit|28|||
125169729|NCT00000620|450244831|FG006|Overall Study|missed closeout visit|13|||
125169730|NCT00000620|450244832|FG007|Overall Study|missed closeout visit|16|||
125169731|NCT01199016|450244833|FG000|Overall Study|No longer meets eligibility criteria|4|||
125169732|NCT01199016|450244833|FG000|Overall Study|Entrance criteria|5|||
125169733|NCT01199016|450244833|FG000|Overall Study|Protocol Violation|9|||
125169734|NCT01199016|450244833|FG000|Overall Study|Other|13|||
125169735|NCT01199016|450244833|FG000|Overall Study|Withdrawal by Subject|21|||
125169736|NCT01199016|450244833|FG000|Overall Study|Lost to Follow-up|25|||
125169737|NCT00314951|450244842|FG000|Treatment|Didn't meet criteria for mITT population|16|||
125169738|NCT00314951|450244843|FG001|Treatment|Didn't meet criteria for mITT population|11|||
125169739|NCT00314951|450244842|FG000|Follow-up|mITT failure|44|||
125169740|NCT00314951|450244843|FG001|Follow-up|mITT failure|34|||
125169741|NCT05320887|450244846|FG000|Overall Study|Lost to Follow-up|0|||
125169742|NCT05320887|450244847|FG001|Overall Study|Lost to Follow-up|3|||
125228216|NCT04210986|450464192|FG000|Overall Study|Physician Decision|0|||
125228217|NCT04210986|450464193|FG001|Overall Study|Physician Decision|1|||
125228218|NCT02378662|450464194|FG000|Overall Study|Early Discontinuation|2|||
125228219|NCT02378662|450464195|FG001|Overall Study|Early Discontinuation|0|||
125228220|NCT01159574|450464196|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
125228221|NCT01159574|450464196|FG000|Treatment Phase|Adverse Event|3|||
125228222|NCT01159574|450464196|FG000|Treatment Phase|Death|6|||
125228223|NCT01159574|450464196|FG000|Treatment Phase|Physician Decision|2|||
125228224|NCT01159574|450464196|FG000|Treatment Phase|Withdrawal by Subject|7|||
125228225|NCT01159574|450464196|FG000|Treatment Phase|still on treatment|2|||
125228226|NCT01159574|450464196|FG000|Follow Up Phase|Lost to Follow-up|2|||
125228227|NCT01159574|450464196|FG000|Follow Up Phase|still being followed for overall surviva|18|||
125228228|NCT02666222|450464198|FG000|Overall Study|Death|2|||
125228229|NCT01474486|450464200|FG000|Overall Study|Death|2|||
125228230|NCT01474486|450464200|FG000|Overall Study|Withdrawal by Subject|4|||
125228231|NCT01474486|450464200|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
125228232|NCT03504917|450464201|FG000|Blinded Treatment Period|Protocol Violation|1|||
125228233|NCT03504917|450464202|FG001|Blinded Treatment Period|Protocol Violation|0|||
125228234|NCT03504917|450464201|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
125228235|NCT03504917|450464202|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
125228236|NCT03504917|450464201|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
125228237|NCT03504917|450464202|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
125228238|NCT03504917|450464201|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
125228239|NCT03504917|450464202|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
125228240|NCT03504917|450464201|FG000|Blinded Treatment Period|Adverse Event|4|||
125228241|NCT03504917|450464202|FG001|Blinded Treatment Period|Adverse Event|4|||
125228242|NCT03504917|450464201|FG000|Blinded Treatment Period|Physician Decision|1|||
125228243|NCT03504917|450464202|FG001|Blinded Treatment Period|Physician Decision|0|||
125228244|NCT03504917|450464201|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
125228245|NCT03504917|450464202|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
125228246|NCT03504917|450464201|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
125228247|NCT03504917|450464202|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
125228248|NCT03504917|450464201|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
125228249|NCT03504917|450464202|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
125228250|NCT03504917|450464201|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
125228251|NCT03504917|450464202|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
125228252|NCT03504917|450464201|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
125228253|NCT03504917|450464202|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
125228254|NCT03504917|450464201|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
125228255|NCT03504917|450464202|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
125228256|NCT03504917|450464201|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
125228257|NCT03504917|450464202|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
125228258|NCT03504917|450464201|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
125228259|NCT03504917|450464202|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
125228260|NCT03504917|450464201|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
125228261|NCT03504917|450464202|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
125228262|NCT03504917|450464201|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
125228263|NCT03504917|450464202|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
125228264|NCT04219189|450464203|FG000|Overall Study|Withdrawal by Subject|1|||
125228265|NCT04219189|450464204|FG001|Overall Study|Withdrawal by Subject|2|||
125228266|NCT04219189|450464203|FG000|Overall Study|Protocol Violation|0|||
125228267|NCT04219189|450464204|FG001|Overall Study|Protocol Violation|1|||
125228268|NCT04219189|450464203|FG000|Overall Study|Lost to Follow-up|0|||
125228269|NCT04219189|450464204|FG001|Overall Study|Lost to Follow-up|1|||
125228270|NCT04219189|450464203|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
125228271|NCT04219189|450464204|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
125228272|NCT03101020|450464205|FG000|Overall Study|Lack of time to participate|1|||
125228273|NCT03101020|450464206|FG001|Overall Study|Lack of time to participate|0|||
125228274|NCT03101020|450464205|FG000|Overall Study|Ran over by a car|0|||
125228275|NCT03101020|450464206|FG001|Overall Study|Ran over by a car|1|||
125228276|NCT03101020|450464205|FG000|Overall Study|Withdrawal by Subject|0|||
125228277|NCT03101020|450464206|FG001|Overall Study|Withdrawal by Subject|2|||
125228278|NCT04233879|450464207|FG000|Overall Study|Death|2|||
125228279|NCT04233879|450464208|FG001|Overall Study|Death|0|||
125228280|NCT04233879|450464207|FG000|Overall Study|Lost to Follow-up|3|||
125228281|NCT04233879|450464208|FG001|Overall Study|Lost to Follow-up|8|||
125228282|NCT04233879|450464207|FG000|Overall Study|Physician Decision|4|||
125228283|NCT04233879|450464208|FG001|Overall Study|Physician Decision|4|||
125228284|NCT04233879|450464207|FG000|Overall Study|Withdrawal by Subject|7|||
125228285|NCT04233879|450464208|FG001|Overall Study|Withdrawal by Subject|10|||
125228286|NCT04233879|450464207|FG000|Overall Study|Other|281|||
125228287|NCT04233879|450464208|FG001|Overall Study|Other|279|||
125228288|NCT03585270|450464211|FG000|Overall Study|Withdrawal by Subject|2|||
125228289|NCT03585270|450464212|FG001|Overall Study|Withdrawal by Subject|6|||
125228290|NCT03585270|450464211|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
125228291|NCT03585270|450464212|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
125228292|NCT03585270|450464211|FG000|Overall Study|Adverse Event|5|||
125228293|NCT03585270|450464212|FG001|Overall Study|Adverse Event|2|||
125228294|NCT03585270|450464211|FG000|Overall Study|Lost to Follow-up|1|||
125228295|NCT03585270|450464212|FG001|Overall Study|Lost to Follow-up|4|||
125228296|NCT03585270|450464211|FG000|Overall Study|Death|5|||
125228297|NCT03585270|450464212|FG001|Overall Study|Death|3|||
125228298|NCT03585270|450464211|FG000|Overall Study|Other reasons|2|||
125228299|NCT03585270|450464212|FG001|Overall Study|Other reasons|2|||
125228300|NCT03292016|450464213|FG000|Second Washout|Adverse Event|0|||
125228301|NCT03292016|450464214|FG001|Second Washout|Adverse Event|1|||
125228302|NCT03292016|450464215|FG002|Second Washout|Adverse Event|0|||
125228303|NCT03292016|450464216|FG003|Second Washout|Adverse Event|0|||
125228304|NCT03292016|450464217|FG004|Second Washout|Adverse Event|0|||
125228305|NCT03292016|450464218|FG005|Second Washout|Adverse Event|0|||
125228306|NCT01038687|450464223|FG000|Overall Study|Adverse Event|0|||
125228307|NCT01038687|450464224|FG001|Overall Study|Adverse Event|2|||
125228308|NCT01038687|450464225|FG002|Overall Study|Adverse Event|1|||
125228309|NCT01076543|450464227|FG000|Overall Study|Withdrawal by Subject|2|||
125228310|NCT01076543|450464228|FG001|Overall Study|Withdrawal by Subject|0|||
125228311|NCT01076543|450464229|FG002|Overall Study|Withdrawal by Subject|0|||
125169743|NCT05320887|450244848|FG002|Overall Study|Lost to Follow-up|0|||
125169744|NCT05320887|450244849|FG003|Overall Study|Lost to Follow-up|0|||
125169745|NCT01671332|450244854|FG000|Overall Study|Withdrawal by Subject|1|||
125169746|NCT01671332|450244855|FG001|Overall Study|Withdrawal by Subject|1|||
125169747|NCT02728843|450244856|FG000|Overall Study|Adverse Event|0|||
125169748|NCT02728843|450244857|FG001|Overall Study|Adverse Event|2|||
125169749|NCT02728843|450244858|FG002|Overall Study|Adverse Event|3|||
125169750|NCT02728843|450244859|FG003|Overall Study|Adverse Event|1|||
125169751|NCT02728843|450244860|FG004|Overall Study|Adverse Event|2|||
125169752|NCT02728843|450244856|FG000|Overall Study|Lack of Efficacy|0|||
125169753|NCT02728843|450244857|FG001|Overall Study|Lack of Efficacy|1|||
125169754|NCT02728843|450244858|FG002|Overall Study|Lack of Efficacy|1|||
125169755|NCT02728843|450244859|FG003|Overall Study|Lack of Efficacy|0|||
125169756|NCT02728843|450244860|FG004|Overall Study|Lack of Efficacy|0|||
125169757|NCT02728843|450244856|FG000|Overall Study|Protocol Violation|2|||
125169758|NCT02728843|450244857|FG001|Overall Study|Protocol Violation|0|||
125169759|NCT02728843|450244858|FG002|Overall Study|Protocol Violation|4|||
125169760|NCT02728843|450244859|FG003|Overall Study|Protocol Violation|2|||
125169761|NCT02728843|450244860|FG004|Overall Study|Protocol Violation|2|||
125169762|NCT02728843|450244856|FG000|Overall Study|Withdrawal by Subject|1|||
125169763|NCT02728843|450244857|FG001|Overall Study|Withdrawal by Subject|0|||
125169764|NCT02728843|450244858|FG002|Overall Study|Withdrawal by Subject|0|||
125169765|NCT02728843|450244859|FG003|Overall Study|Withdrawal by Subject|1|||
125169766|NCT02728843|450244860|FG004|Overall Study|Withdrawal by Subject|0|||
125169767|NCT02728843|450244856|FG000|Overall Study|Use of rescue medication|0|||
125169768|NCT02728843|450244857|FG001|Overall Study|Use of rescue medication|2|||
125169769|NCT02728843|450244858|FG002|Overall Study|Use of rescue medication|0|||
125169770|NCT02728843|450244859|FG003|Overall Study|Use of rescue medication|2|||
125169771|NCT02728843|450244860|FG004|Overall Study|Use of rescue medication|1|||
125169772|NCT01806506|450244862|FG000|Overall Study|Lost to Follow-up|2|||
125169773|NCT01806506|450244863|FG001|Overall Study|Lost to Follow-up|1|||
125169774|NCT04844762|450244868|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169775|NCT04844762|450244869|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169776|NCT04844762|450244870|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
125169777|NCT04844762|450244871|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169778|NCT04844762|450244872|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169779|NCT04844762|450244873|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125228312|NCT01076543|450464230|FG003|Overall Study|Withdrawal by Subject|0|||
125228313|NCT01076543|450464231|FG004|Overall Study|Withdrawal by Subject|0|||
125228314|NCT01076543|450464232|FG005|Overall Study|Withdrawal by Subject|0|||
125228315|NCT00338741|450464233|FG000|Overall Study|Lost to Follow-up|2|||
125228316|NCT00338741|450464234|FG001|Overall Study|Lost to Follow-up|0|||
125169780|NCT04844762|450244868|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
125169781|NCT04844762|450244869|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
125169782|NCT04844762|450244870|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
125169783|NCT04844762|450244871|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
125169784|NCT04844762|450244872|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
125169785|NCT04844762|450244873|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
125169786|NCT04844762|450244868|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169787|NCT04844762|450244869|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125228317|NCT05222880|450464235|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
125228318|NCT05222880|450464235|FG000|Overall Study|Withdrew Consent during Study|1|||
125228319|NCT05222880|450464235|FG000|Overall Study|COVID-19 Related|1|||
125228320|NCT01673178|450464249|FG000|Overall Study|Lost to Follow-up|0|||
125228321|NCT01673178|450464250|FG001|Overall Study|Lost to Follow-up|1|||
125228322|NCT01673178|450464251|FG002|Overall Study|Lost to Follow-up|0|||
125228323|NCT01673178|450464252|FG003|Overall Study|Lost to Follow-up|0|||
125228324|NCT01673178|450464253|FG004|Overall Study|Lost to Follow-up|0|||
125228325|NCT01673178|450464249|FG000|Overall Study|Withdrawal by Subject|0|||
125228326|NCT01673178|450464250|FG001|Overall Study|Withdrawal by Subject|0|||
125228327|NCT01673178|450464251|FG002|Overall Study|Withdrawal by Subject|1|||
125228328|NCT01673178|450464252|FG003|Overall Study|Withdrawal by Subject|4|||
125228329|NCT01673178|450464253|FG004|Overall Study|Withdrawal by Subject|2|||
125169788|NCT04844762|450244870|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
125169789|NCT04844762|450244871|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
125169790|NCT04844762|450244872|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169791|NCT04844762|450244873|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
125169792|NCT04844762|450244868|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169793|NCT04844762|450244869|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169794|NCT04844762|450244870|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
125169795|NCT04844762|450244871|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
125169796|NCT04844762|450244872|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
125169797|NCT04844762|450244873|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169798|NCT04844762|450244868|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
125169799|NCT04844762|450244869|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
125169800|NCT04844762|450244870|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
125169801|NCT04844762|450244871|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
125169802|NCT04844762|450244872|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
125169803|NCT04844762|450244873|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
125169804|NCT04844762|450244868|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
125169805|NCT04844762|450244869|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169806|NCT04844762|450244870|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169807|NCT04844762|450244871|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169808|NCT04844762|450244872|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169809|NCT04844762|450244873|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169810|NCT04844762|450244868|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169811|NCT04844762|450244869|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169812|NCT04844762|450244870|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169813|NCT04844762|450244871|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169814|NCT04844762|450244872|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
125169815|NCT04844762|450244873|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169816|NCT04844762|450244868|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
125169817|NCT04844762|450244869|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
125169818|NCT04844762|450244870|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
125169819|NCT04844762|450244871|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
125169820|NCT04844762|450244872|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
125169821|NCT04844762|450244873|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
125169822|NCT04844762|450244868|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
125169823|NCT04844762|450244869|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169824|NCT04844762|450244870|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169825|NCT04844762|450244871|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169826|NCT04844762|450244872|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169827|NCT04844762|450244873|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
125169828|NCT04844762|450244868|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
125169829|NCT04844762|450244869|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
125169830|NCT04844762|450244870|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
125169831|NCT04844762|450244871|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
125169832|NCT04844762|450244872|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
125169833|NCT04844762|450244873|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
125169834|NCT04844762|450244868|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
125169835|NCT04844762|450244869|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
125169836|NCT04844762|450244870|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
125169837|NCT04844762|450244871|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
125169838|NCT04844762|450244872|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
125169839|NCT04844762|450244873|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
125228330|NCT01673178|450464249|FG000|Overall Study|Protocol Violation|1|||
125228331|NCT01673178|450464250|FG001|Overall Study|Protocol Violation|1|||
125228332|NCT01673178|450464251|FG002|Overall Study|Protocol Violation|0|||
125228333|NCT01673178|450464252|FG003|Overall Study|Protocol Violation|1|||
125228334|NCT01673178|450464253|FG004|Overall Study|Protocol Violation|0|||
125228335|NCT01673178|450464249|FG000|Overall Study|Adverse Event|1|||
125228336|NCT01673178|450464250|FG001|Overall Study|Adverse Event|0|||
125228337|NCT01673178|450464251|FG002|Overall Study|Adverse Event|0|||
125228338|NCT01673178|450464252|FG003|Overall Study|Adverse Event|2|||
125228339|NCT01673178|450464253|FG004|Overall Study|Adverse Event|0|||
125228340|NCT01673178|450464249|FG000|Overall Study|Other|1|||
125228341|NCT01673178|450464250|FG001|Overall Study|Other|0|||
125228342|NCT01673178|450464251|FG002|Overall Study|Other|2|||
125228343|NCT01673178|450464252|FG003|Overall Study|Other|1|||
125228344|NCT01673178|450464253|FG004|Overall Study|Other|0|||
125228345|NCT00449163|450464258|FG000|Overall Study|Physician Decision|3|||
125228346|NCT00606307|450464259|FG000|Overall Study|Adverse Event|2|||
125228347|NCT00606307|450464259|FG000|Overall Study|Withdrawal by Subject|2|||
125228348|NCT00606307|450464259|FG000|Overall Study|Disease progression|6|||
125228349|NCT00606307|450464259|FG000|Overall Study|QTc prolongation|1|||
125228350|NCT04386902|450464267|FG000|Overall Study|Withdrawal by Subject|5|||
125228351|NCT04386902|450464267|FG000|Overall Study|Technical problems in the recording|5|||
125228352|NCT00828711|450464268|FG000|Overall Study|Lost to Follow-up|1|||
125228353|NCT00828711|450464269|FG001|Overall Study|Lost to Follow-up|0|||
125228354|NCT00828711|450464270|FG002|Overall Study|Lost to Follow-up|0|||
125228355|NCT02033759|450464272|FG000|Overall Study|Withdrawal by Subject|2|||
125228356|NCT02033759|450464273|FG001|Overall Study|Withdrawal by Subject|1|||
125228357|NCT02033759|450464272|FG000|Overall Study|Protocol Violation|1|||
125228358|NCT02033759|450464273|FG001|Overall Study|Protocol Violation|1|||
125228359|NCT01548599|450465662|FG000|Overall Study|Lost to Follow-up|0|||
125228360|NCT01548599|450465663|FG001|Overall Study|Lost to Follow-up|1|||
125228361|NCT01548599|450465662|FG000|Overall Study|Withdrawal by Subject|4|||
125228362|NCT01548599|450465663|FG001|Overall Study|Withdrawal by Subject|0|||
125228363|NCT01548599|450465662|FG000|Overall Study|Death|2|||
125228364|NCT01548599|450465663|FG001|Overall Study|Death|1|||
125228365|NCT05630196|450465664|FG000|Overall Study|Adverse Event|2|||
125228366|NCT05630196|450465665|FG001|Overall Study|Adverse Event|1|||
125228367|NCT05630196|450465664|FG000|Overall Study|Lost to Follow-up|1|||
125228368|NCT05630196|450465665|FG001|Overall Study|Lost to Follow-up|1|||
125228369|NCT05630196|450465664|FG000|Overall Study|Protocol Violation|2|||
125228370|NCT05630196|450465665|FG001|Overall Study|Protocol Violation|3|||
125228371|NCT05630196|450465664|FG000|Overall Study|Physician Decision|1|||
125228372|NCT05630196|450465665|FG001|Overall Study|Physician Decision|0|||
125228373|NCT05630196|450465664|FG000|Overall Study|Withdrawal by Subject|3|||
125228374|NCT05630196|450465665|FG001|Overall Study|Withdrawal by Subject|4|||
125228375|NCT00352118|450465667|FG000|Overall Study|Physician Decision|4|||
125228376|NCT02308046|450465668|FG000|Overall Study|Negative yeast culture at Baseline|32|||
125228377|NCT02308046|450465669|FG001|Overall Study|Negative yeast culture at Baseline|33|||
125228378|NCT02308046|450465668|FG000|Overall Study|Positive for STD at Baseline|1|||
125228379|NCT02308046|450465669|FG001|Overall Study|Positive for STD at Baseline|2|||
125228380|NCT02308046|450465668|FG000|Overall Study|Lost to Follow-up|1|||
125228381|NCT02308046|450465669|FG001|Overall Study|Lost to Follow-up|3|||
125228382|NCT01587885|450465672|FG000|Treatment Period 1|Failure to Return|0|||
125228383|NCT01587885|450465673|FG001|Treatment Period 1|Failure to Return|1|||
125228384|NCT01587885|450465672|FG000|Treatment Period 1|Protocol Violation|0|||
125228385|NCT01587885|450465673|FG001|Treatment Period 1|Protocol Violation|2|||
125228386|NCT00958074|450465674|FG000|Overall Study|Withdrawal by Subject|0|||
125228387|NCT00958074|450465675|FG001|Overall Study|Withdrawal by Subject|1|||
125228388|NCT03102762|450465676|FG000|Overall Study|Lost to Follow-up|1|||
125228389|NCT03102762|450465677|FG001|Overall Study|Lost to Follow-up|0|||
125228390|NCT00752089|450465682|FG000|Overall Study|Adverse Event|1|||
125228391|NCT00752089|450465682|FG000|Overall Study|Protocol Deviation|2|||
125228392|NCT00752089|450465682|FG000|Overall Study|Could not attend visit 9|1|||
125228393|NCT00752089|450465682|FG000|Overall Study|Not capable of wearing partial denture|1|||
125228394|NCT00752089|450465682|FG000|Overall Study|Cannot continue the study|1|||
125228395|NCT00001566|450465683|FG000|Overall Study|patients' choice to discontinue protocol|3|||
125228396|NCT00001566|450465683|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
125228397|NCT00001566|450465683|FG000|Overall Study|Death|13|||
125228398|NCT00001566|450465683|FG000|Overall Study|Lost to Follow-up|1|||
125228399|NCT00001566|450465683|FG000|Overall Study|unable to complete initial apheresis|1|||
125228400|NCT02914834|450465684|FG000|Overall Study|Study halted due to COVID|1|||
125228401|NCT02914834|450465685|FG001|Overall Study|Study halted due to COVID|1|||
125228402|NCT02914834|450465684|FG000|Overall Study|1 subject withdrew|0|||
125228403|NCT02914834|450465685|FG001|Overall Study|1 subject withdrew|1|||
125228404|NCT00975416|450465688|FG000|Overall Study|early discharge from tx|3|||
125228405|NCT00975416|450465689|FG001|Overall Study|early discharge from tx|5|||
125228406|NCT03555149|450465694|FG000|Overall Study|Death|18|||
125228407|NCT03555149|450465695|FG001|Overall Study|Death|15|||
125228408|NCT03555149|450465696|FG002|Overall Study|Death|15|||
125228409|NCT03555149|450465697|FG003|Overall Study|Death|4|||
125228410|NCT03555149|450465698|FG004|Overall Study|Death|4|||
125228411|NCT03555149|450465699|FG005|Overall Study|Death|11|||
125228412|NCT03555149|450465700|FG006|Overall Study|Death|12|||
125228413|NCT03555149|450465701|FG007|Overall Study|Death|1|||
125228414|NCT03555149|450465694|FG000|Overall Study|Lost to Follow-up|1|||
125169840|NCT00477633|450244874|FG000|Overall Study|Did not receive treatment|23|||
125169841|NCT00477633|450244874|FG000|Overall Study|Adverse Event|143|||
125169842|NCT00477633|450244874|FG000|Overall Study|Pregnancy|23|||
125169843|NCT00477633|450244874|FG000|Overall Study|Lost to Follow-up|271|||
125169844|NCT00477633|450244874|FG000|Overall Study|Withdrawal by Subject|149|||
125169845|NCT00477633|450244874|FG000|Overall Study|Protocol Violation|25|||
125169846|NCT00477633|450244874|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
125169847|NCT04123561|450244880|FG000|Overall Study|Lost to Follow-up|20|||
125169848|NCT04123561|450244881|FG001|Overall Study|Lost to Follow-up|12|||
125169849|NCT04123561|450244882|FG002|Overall Study|Lost to Follow-up|5|||
125169850|NCT04123561|450244880|FG000|Overall Study|Withdrawal by Subject|9|||
125169851|NCT04123561|450244881|FG001|Overall Study|Withdrawal by Subject|7|||
125169852|NCT04123561|450244882|FG002|Overall Study|Withdrawal by Subject|9|||
125169853|NCT04123561|450244880|FG000|Overall Study|Lack of Efficacy|7|||
125169854|NCT04123561|450244881|FG001|Overall Study|Lack of Efficacy|8|||
125169855|NCT04123561|450244882|FG002|Overall Study|Lack of Efficacy|6|||
125169856|NCT04123561|450244880|FG000|Overall Study|Adverse Event|5|||
125169857|NCT04123561|450244881|FG001|Overall Study|Adverse Event|2|||
125169858|NCT04123561|450244882|FG002|Overall Study|Adverse Event|3|||
125169859|NCT04123561|450244880|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
125169860|NCT04123561|450244881|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
125169861|NCT04123561|450244882|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
125169862|NCT04123561|450244880|FG000|Overall Study|Death|0|||
125169863|NCT04123561|450244881|FG001|Overall Study|Death|0|||
125169864|NCT04123561|450244882|FG002|Overall Study|Death|1|||
125169865|NCT04123561|450244880|FG000|Overall Study|Protocol Violation|0|||
125169866|NCT04123561|450244881|FG001|Overall Study|Protocol Violation|1|||
125169867|NCT04123561|450244882|FG002|Overall Study|Protocol Violation|0|||
125169868|NCT01374269|450244890|FG000|Overall Study|Withdrawal by Subject|4|||
125169869|NCT01374269|450244891|FG001|Overall Study|Withdrawal by Subject|0|||
125169870|NCT01374269|450244890|FG000|Overall Study|Lost to Follow-up|1|||
125169871|NCT01374269|450244891|FG001|Overall Study|Lost to Follow-up|3|||
125169872|NCT01374269|450244890|FG000|Overall Study|closed research|1|||
125169873|NCT01374269|450244891|FG001|Overall Study|closed research|2|||
125169874|NCT00278889|450244892|FG000|Overall Study|Withdrawal by Subject|0|||
125169875|NCT00278889|450244893|FG001|Overall Study|Withdrawal by Subject|5|||
125169876|NCT00278889|450244894|FG002|Overall Study|Withdrawal by Subject|3|||
125169877|NCT00278889|450244892|FG000|Overall Study|Lost to Follow-up|1|||
125169878|NCT00278889|450244893|FG001|Overall Study|Lost to Follow-up|1|||
125169879|NCT00278889|450244894|FG002|Overall Study|Lost to Follow-up|0|||
125169880|NCT00278889|450244892|FG000|Overall Study|Death|24|||
125169881|NCT00278889|450244893|FG001|Overall Study|Death|21|||
125169882|NCT00278889|450244894|FG002|Overall Study|Death|17|||
125169883|NCT01987479|450244895|FG000|Overall Study|Protocol Violation|1|||
125169884|NCT01987479|450244895|FG000|Overall Study|Physician Decision|2|||
125169885|NCT01987479|450244895|FG000|Overall Study|Participant/legal guardian decision|1|||
125169886|NCT01987479|450244895|FG000|Overall Study|Other|5|||
125169887|NCT01987479|450244895|FG000|Overall Study|Lost to Follow-up|1|||
125169888|NCT01987479|450244895|FG000|Overall Study|Adverse Event|7|||
125169889|NCT04998851|450247565|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
125169890|NCT04998851|450247566|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
125169891|NCT04998851|450247565|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
125169892|NCT04998851|450247566|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
125169893|NCT00478244|450247569|FG000|Overall Study|Did not receive transplant|1|||
125169894|NCT00509366|450247576|FG000|Overall Study|Not Treated (Screen Failure)|1|||
125169895|NCT00509366|450247577|FG001|Overall Study|Not Treated (Screen Failure)|1|||
125169896|NCT00509366|450247578|FG002|Overall Study|Not Treated (Screen Failure)|1|||
125169897|NCT00509366|450247579|FG003|Overall Study|Not Treated (Screen Failure)|0|||
125228415|NCT03555149|450465695|FG001|Overall Study|Lost to Follow-up|0|||
125228416|NCT03555149|450465696|FG002|Overall Study|Lost to Follow-up|0|||
125228417|NCT03555149|450465697|FG003|Overall Study|Lost to Follow-up|0|||
125228418|NCT03555149|450465698|FG004|Overall Study|Lost to Follow-up|0|||
125228419|NCT03555149|450465699|FG005|Overall Study|Lost to Follow-up|1|||
125169898|NCT00509366|450247580|FG004|Overall Study|Not Treated (Screen Failure)|0|||
125169899|NCT02906358|450247581|FG000|Overall Study|Withdrawal by Subject|10|||
125169900|NCT02906358|450247582|FG001|Overall Study|Withdrawal by Subject|7|||
125169901|NCT02906358|450247581|FG000|Overall Study|Lost to Follow-up|12|||
125169902|NCT02906358|450247582|FG001|Overall Study|Lost to Follow-up|15|||
125169903|NCT01145508|450247584|FG000|Overall Study|Adverse Event|1|||
125228420|NCT03555149|450465700|FG006|Overall Study|Lost to Follow-up|0|||
125228421|NCT03555149|450465701|FG007|Overall Study|Lost to Follow-up|0|||
125228422|NCT03555149|450465694|FG000|Overall Study|Physician Decision|1|||
125228423|NCT03555149|450465695|FG001|Overall Study|Physician Decision|0|||
125169904|NCT01145508|450247585|FG001|Overall Study|Adverse Event|0|||
125169905|NCT01145508|450247584|FG000|Overall Study|Death|1|||
125169906|NCT01145508|450247585|FG001|Overall Study|Death|0|||
125169907|NCT01145508|450247584|FG000|Overall Study|Physician Decision|2|||
125169908|NCT01145508|450247585|FG001|Overall Study|Physician Decision|1|||
125169909|NCT01145508|450247584|FG000|Overall Study|Never started treatment|1|||
125169910|NCT01145508|450247585|FG001|Overall Study|Never started treatment|1|||
125169911|NCT02045147|450247586|FG000|Overall Study|Withdrawal by Subject|2|||
125169912|NCT02045147|450247587|FG001|Overall Study|Withdrawal by Subject|0|||
125169913|NCT02045147|450247588|FG002|Overall Study|Withdrawal by Subject|0|||
125169914|NCT02045147|450247589|FG003|Overall Study|Withdrawal by Subject|0|||
125169915|NCT02045147|450247590|FG004|Overall Study|Withdrawal by Subject|0|||
125169916|NCT02045147|450247591|FG005|Overall Study|Withdrawal by Subject|0|||
125169917|NCT02045147|450247592|FG006|Overall Study|Withdrawal by Subject|0|||
125169918|NCT02045147|450247593|FG007|Overall Study|Withdrawal by Subject|1|||
125169919|NCT02045147|450247586|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
125169920|NCT02045147|450247587|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
125169921|NCT02045147|450247588|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
125169922|NCT02045147|450247589|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
125169923|NCT02045147|450247590|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
125169924|NCT02045147|450247591|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
125169925|NCT02045147|450247592|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
125169926|NCT02045147|450247593|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
125169927|NCT00264550|450247594|FG000|Overall Study|Death|0|||
125169928|NCT00264550|450247595|FG001|Overall Study|Death|3|||
125169929|NCT00264550|450247596|FG002|Overall Study|Death|0|||
125169930|NCT00264550|450247597|FG003|Overall Study|Death|0|||
125169931|NCT00264550|450247594|FG000|Overall Study|Lost to Follow-up|3|||
125169932|NCT00264550|450247595|FG001|Overall Study|Lost to Follow-up|1|||
125169933|NCT00264550|450247596|FG002|Overall Study|Lost to Follow-up|1|||
125169934|NCT00264550|450247597|FG003|Overall Study|Lost to Follow-up|1|||
125169935|NCT00264550|450247594|FG000|Overall Study|Adverse Event|23|||
125169936|NCT00264550|450247595|FG001|Overall Study|Adverse Event|18|||
125169937|NCT00264550|450247596|FG002|Overall Study|Adverse Event|9|||
125169938|NCT00264550|450247597|FG003|Overall Study|Adverse Event|14|||
125169939|NCT00264550|450247594|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
125169940|NCT00264550|450247595|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
125169941|NCT00264550|450247596|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
125169942|NCT00264550|450247597|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
125169943|NCT00264550|450247594|FG000|Overall Study|Discontinued oral study agent|0|||
125169944|NCT00264550|450247595|FG001|Overall Study|Discontinued oral study agent|1|||
125169945|NCT00264550|450247596|FG002|Overall Study|Discontinued oral study agent|0|||
125169946|NCT00264550|450247597|FG003|Overall Study|Discontinued oral study agent|0|||
125169947|NCT00264550|450247594|FG000|Overall Study|Other|13|||
125169948|NCT00264550|450247595|FG001|Overall Study|Other|7|||
125169949|NCT00264550|450247596|FG002|Overall Study|Other|3|||
125169950|NCT00264550|450247597|FG003|Overall Study|Other|9|||
125169951|NCT02246114|450247598|FG000|Overall Study|miscarriage|1|||
125169952|NCT02246114|450247599|FG001|Overall Study|miscarriage|0|||
125169953|NCT01439009|450247605|FG000|Overall Study|Physician Decision|5|||
125169954|NCT01439009|450247606|FG001|Overall Study|Physician Decision|3|||
125169955|NCT01439009|450247605|FG000|Overall Study|Protocol Violation|2|||
125169956|NCT01439009|450247606|FG001|Overall Study|Protocol Violation|0|||
125169957|NCT01439009|450247605|FG000|Overall Study|Deviation of exclusion criteria|1|||
125169958|NCT01439009|450247606|FG001|Overall Study|Deviation of exclusion criteria|0|||
125169959|NCT00696787|450247608|FG000|Overall Study|Adverse Event|1|||
125169960|NCT00696787|450247609|FG001|Overall Study|Adverse Event|0|||
125169961|NCT00696787|450247610|FG002|Overall Study|Adverse Event|6|||
125169962|NCT00696787|450247608|FG000|Overall Study|Discontinuation by Sponsor|9|||
125169963|NCT00696787|450247609|FG001|Overall Study|Discontinuation by Sponsor|13|||
125169964|NCT00696787|450247610|FG002|Overall Study|Discontinuation by Sponsor|14|||
125228424|NCT03555149|450465696|FG002|Overall Study|Physician Decision|0|||
125228425|NCT03555149|450465697|FG003|Overall Study|Physician Decision|0|||
125169965|NCT00696787|450247608|FG000|Overall Study|Lack of Efficacy|0|||
125169966|NCT00696787|450247609|FG001|Overall Study|Lack of Efficacy|1|||
125169967|NCT00696787|450247610|FG002|Overall Study|Lack of Efficacy|0|||
125169968|NCT00696787|450247608|FG000|Overall Study|Lost to Follow-up|4|||
125169969|NCT00696787|450247609|FG001|Overall Study|Lost to Follow-up|0|||
125169970|NCT00696787|450247610|FG002|Overall Study|Lost to Follow-up|3|||
125169971|NCT00696787|450247608|FG000|Overall Study|Withdrawal by Subject|0|||
125169972|NCT00696787|450247609|FG001|Overall Study|Withdrawal by Subject|3|||
125169973|NCT00696787|450247610|FG002|Overall Study|Withdrawal by Subject|2|||
125169974|NCT00696787|450247608|FG000|Overall Study|Failed to return|1|||
125169975|NCT00696787|450247609|FG001|Overall Study|Failed to return|3|||
125169976|NCT00696787|450247610|FG002|Overall Study|Failed to return|1|||
125169977|NCT00129389|450247615|FG000|Overall Study|Adverse Event|19|||
125169978|NCT00129389|450247616|FG001|Overall Study|Adverse Event|87|||
125169979|NCT00129389|450247615|FG000|Overall Study|Death|0|||
125169980|NCT00129389|450247616|FG001|Overall Study|Death|1|||
125169981|NCT00129389|450247615|FG000|Overall Study|Lost to Follow-up|2|||
125169982|NCT00129389|450247616|FG001|Overall Study|Lost to Follow-up|1|||
125169983|NCT00129389|450247615|FG000|Overall Study|Physician Decision|0|||
125169984|NCT00129389|450247616|FG001|Overall Study|Physician Decision|4|||
125169985|NCT00129389|450247615|FG000|Overall Study|Protocol Violation|0|||
125169986|NCT00129389|450247616|FG001|Overall Study|Protocol Violation|6|||
125169987|NCT00129389|450247615|FG000|Overall Study|Withdrawal by Subject|9|||
125169988|NCT00129389|450247616|FG001|Overall Study|Withdrawal by Subject|23|||
125169989|NCT00129389|450247615|FG000|Overall Study|Relapse|1|||
125169990|NCT00129389|450247616|FG001|Overall Study|Relapse|0|||
125169991|NCT00129389|450247615|FG000|Overall Study|Not eligible|1|||
125169992|NCT00129389|450247616|FG001|Overall Study|Not eligible|2|||
125169993|NCT00129389|450247615|FG000|Overall Study|Crossed to the other arm|1|||
125169994|NCT00129389|450247616|FG001|Overall Study|Crossed to the other arm|16|||
125169995|NCT00603837|450247619|FG000|Overall Study|Physician Decision|3|||
125169996|NCT00603837|450247620|FG001|Overall Study|Physician Decision|0|||
125169997|NCT04611529|450247622|FG000|2-day Follow up|Lost to Follow-up|5|||
125169998|NCT04611529|450247623|FG001|2-day Follow up|Lost to Follow-up|6|||
125169999|NCT04611529|450247624|FG002|2-day Follow up|Lost to Follow-up|3|||
125170000|NCT00425373|450247688|FG000|Overall Study|Adverse Event|2|||
125170001|NCT00425373|450247689|FG001|Overall Study|Adverse Event|2|||
125170002|NCT00425373|450247690|FG002|Overall Study|Adverse Event|0|||
125170003|NCT00425373|450247691|FG003|Overall Study|Adverse Event|1|||
125170004|NCT00425373|450247692|FG004|Overall Study|Adverse Event|4|||
125170005|NCT00425373|450247693|FG005|Overall Study|Adverse Event|6|||
125170006|NCT00425373|450247694|FG006|Overall Study|Adverse Event|2|||
125170007|NCT00425373|450247695|FG007|Overall Study|Adverse Event|3|||
125170008|NCT00425373|450247696|FG008|Overall Study|Adverse Event|8|||
125170009|NCT00425373|450247688|FG000|Overall Study|Lost to Follow-up|0|||
125170010|NCT00425373|450247689|FG001|Overall Study|Lost to Follow-up|1|||
125170011|NCT00425373|450247690|FG002|Overall Study|Lost to Follow-up|0|||
125170012|NCT00425373|450247691|FG003|Overall Study|Lost to Follow-up|0|||
125170013|NCT00425373|450247692|FG004|Overall Study|Lost to Follow-up|1|||
125170014|NCT00425373|450247693|FG005|Overall Study|Lost to Follow-up|0|||
125170015|NCT00425373|450247694|FG006|Overall Study|Lost to Follow-up|0|||
125170016|NCT00425373|450247695|FG007|Overall Study|Lost to Follow-up|0|||
125170017|NCT00425373|450247696|FG008|Overall Study|Lost to Follow-up|0|||
125170018|NCT00425373|450247688|FG000|Overall Study|Protocol Violation|1|||
125170019|NCT00425373|450247689|FG001|Overall Study|Protocol Violation|0|||
125170020|NCT00425373|450247690|FG002|Overall Study|Protocol Violation|1|||
125170021|NCT00425373|450247691|FG003|Overall Study|Protocol Violation|0|||
125170022|NCT00425373|450247692|FG004|Overall Study|Protocol Violation|0|||
125170023|NCT00425373|450247693|FG005|Overall Study|Protocol Violation|0|||
125170024|NCT00425373|450247694|FG006|Overall Study|Protocol Violation|0|||
125170025|NCT00425373|450247695|FG007|Overall Study|Protocol Violation|5|||
125170026|NCT00425373|450247696|FG008|Overall Study|Protocol Violation|3|||
125170027|NCT00425373|450247688|FG000|Overall Study|Withdrawal by Subject|2|||
125170028|NCT00425373|450247689|FG001|Overall Study|Withdrawal by Subject|0|||
125170029|NCT00425373|450247690|FG002|Overall Study|Withdrawal by Subject|2|||
125170030|NCT00425373|450247691|FG003|Overall Study|Withdrawal by Subject|1|||
125170031|NCT00425373|450247692|FG004|Overall Study|Withdrawal by Subject|4|||
125170032|NCT00425373|450247693|FG005|Overall Study|Withdrawal by Subject|0|||
125170033|NCT00425373|450247694|FG006|Overall Study|Withdrawal by Subject|2|||
125170034|NCT00425373|450247695|FG007|Overall Study|Withdrawal by Subject|2|||
125170035|NCT00425373|450247696|FG008|Overall Study|Withdrawal by Subject|2|||
125170036|NCT00425373|450247688|FG000|Overall Study|Lack of Efficacy|0|||
125170037|NCT00425373|450247689|FG001|Overall Study|Lack of Efficacy|0|||
125170038|NCT00425373|450247690|FG002|Overall Study|Lack of Efficacy|0|||
125170039|NCT00425373|450247691|FG003|Overall Study|Lack of Efficacy|0|||
125170040|NCT00425373|450247692|FG004|Overall Study|Lack of Efficacy|1|||
125170041|NCT00425373|450247693|FG005|Overall Study|Lack of Efficacy|3|||
125170042|NCT00425373|450247694|FG006|Overall Study|Lack of Efficacy|3|||
125170043|NCT00425373|450247695|FG007|Overall Study|Lack of Efficacy|0|||
125170044|NCT00425373|450247696|FG008|Overall Study|Lack of Efficacy|5|||
125170045|NCT02052011|450247697|FG000|Overall Study|Lost to Follow-up|3|||
125170046|NCT02052011|450247698|FG001|Overall Study|Lost to Follow-up|0|||
125170047|NCT02052011|450247697|FG000|Overall Study|Withdrawal by Subject|1|||
125170048|NCT02052011|450247698|FG001|Overall Study|Withdrawal by Subject|2|||
125170049|NCT01851330|450247699|FG000|Overall Study|Lack of Efficacy|10|||
125170050|NCT01851330|450247700|FG001|Overall Study|Lack of Efficacy|9|||
125170051|NCT01851330|450247701|FG002|Overall Study|Lack of Efficacy|2|||
125170052|NCT01851330|450247699|FG000|Overall Study|Lost to Follow-up|1|||
125170053|NCT01851330|450247700|FG001|Overall Study|Lost to Follow-up|6|||
125170054|NCT01851330|450247701|FG002|Overall Study|Lost to Follow-up|9|||
125170055|NCT01851330|450247699|FG000|Overall Study|Withdrew Consent|2|||
125170056|NCT01851330|450247700|FG001|Overall Study|Withdrew Consent|1|||
125170057|NCT01851330|450247701|FG002|Overall Study|Withdrew Consent|0|||
125228426|NCT03555149|450465698|FG004|Overall Study|Physician Decision|0|||
125228427|NCT03555149|450465699|FG005|Overall Study|Physician Decision|0|||
125228428|NCT03555149|450465700|FG006|Overall Study|Physician Decision|0|||
125228429|NCT03555149|450465701|FG007|Overall Study|Physician Decision|0|||
125228430|NCT03555149|450465694|FG000|Overall Study|Study Terminated By Sponsor|1|||
125228431|NCT03555149|450465695|FG001|Overall Study|Study Terminated By Sponsor|0|||
125228432|NCT03555149|450465696|FG002|Overall Study|Study Terminated By Sponsor|0|||
125228433|NCT03555149|450465697|FG003|Overall Study|Study Terminated By Sponsor|0|||
125228434|NCT03555149|450465698|FG004|Overall Study|Study Terminated By Sponsor|0|||
125228435|NCT03555149|450465699|FG005|Overall Study|Study Terminated By Sponsor|2|||
125228436|NCT03555149|450465700|FG006|Overall Study|Study Terminated By Sponsor|3|||
125228437|NCT03555149|450465701|FG007|Overall Study|Study Terminated By Sponsor|1|||
125228438|NCT03555149|450465694|FG000|Overall Study|Withdrawal by Subject|3|||
125228439|NCT03555149|450465695|FG001|Overall Study|Withdrawal by Subject|0|||
125228440|NCT03555149|450465696|FG002|Overall Study|Withdrawal by Subject|0|||
125228441|NCT03555149|450465697|FG003|Overall Study|Withdrawal by Subject|2|||
125228442|NCT03555149|450465698|FG004|Overall Study|Withdrawal by Subject|0|||
125228443|NCT03555149|450465699|FG005|Overall Study|Withdrawal by Subject|1|||
125228444|NCT03555149|450465700|FG006|Overall Study|Withdrawal by Subject|0|||
125228445|NCT03555149|450465701|FG007|Overall Study|Withdrawal by Subject|0|||
125228446|NCT03863353|450465705|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
125228447|NCT03863353|450465706|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
125228448|NCT05817669|450465707|FG000|Overall Study|Prohibited medication used|1|||
125228449|NCT05817669|450465708|FG001|Overall Study|Prohibited medication used|2|||
125228450|NCT05817669|450465707|FG000|Overall Study|Adverse Event|1|||
125228451|NCT05817669|450465708|FG001|Overall Study|Adverse Event|0|||
125228452|NCT05817669|450465707|FG000|Overall Study|Withdrawal by Subject|1|||
125228453|NCT05817669|450465708|FG001|Overall Study|Withdrawal by Subject|2|||
125170058|NCT01851330|450247699|FG000|Overall Study|Investigator's Discretion|0|||
125170059|NCT01851330|450247700|FG001|Overall Study|Investigator's Discretion|0|||
125170060|NCT01851330|450247701|FG002|Overall Study|Investigator's Discretion|1|||
125170061|NCT02960490|450247703|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
125170062|NCT02960490|450247704|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
125170063|NCT02960490|450247705|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
125170064|NCT02960490|450247706|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
125170065|NCT02960490|450247707|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
125170066|NCT02960490|450247708|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
125170067|NCT02960490|450247709|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
125170068|NCT02960490|450247710|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
125170069|NCT02960490|450247711|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
125170070|NCT02960490|450247712|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
125170071|NCT02960490|450247703|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
125170072|NCT02960490|450247704|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
125170073|NCT02960490|450247705|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
125170074|NCT02960490|450247706|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
125170075|NCT02960490|450247707|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
125170076|NCT02960490|450247708|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
125170077|NCT02960490|450247709|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
125170078|NCT02960490|450247710|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
125170079|NCT02960490|450247711|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
125170080|NCT02960490|450247712|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
125170081|NCT02960490|450247703|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
125170082|NCT02960490|450247704|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
125170083|NCT02960490|450247705|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
125170084|NCT02960490|450247706|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
125170085|NCT02960490|450247707|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
125170086|NCT02960490|450247708|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
125170087|NCT02960490|450247709|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
125170088|NCT02960490|450247710|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
125170089|NCT02960490|450247711|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
125170090|NCT02960490|450247712|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
125170091|NCT02960490|450247703|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
125170092|NCT02960490|450247704|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
125170093|NCT02960490|450247705|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
125170094|NCT02960490|450247706|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
125228454|NCT03810183|450465709|FG000|Overall Study|Study terminated by Sponsor|2|||
125228455|NCT03810183|450465710|FG001|Overall Study|Study terminated by Sponsor|1|||
125228456|NCT00323063|450465712|FG000|Overall Study|Adverse Event|1|||
125228457|NCT00323063|450465713|FG001|Overall Study|Adverse Event|0|||
125170095|NCT02960490|450247707|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
125170096|NCT02960490|450247708|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
125170097|NCT02960490|450247709|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
125170098|NCT02960490|450247710|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
125170099|NCT02960490|450247711|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
125170100|NCT02960490|450247712|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
125170101|NCT02960490|450247703|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
125170102|NCT02960490|450247704|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
125170103|NCT02960490|450247705|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
125170104|NCT02960490|450247706|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
125170105|NCT02960490|450247707|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
125170106|NCT02960490|450247708|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
125170107|NCT02960490|450247709|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
125170108|NCT02960490|450247710|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
125170109|NCT02960490|450247711|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
125170110|NCT02960490|450247712|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
125170111|NCT02960490|450247703|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
125170112|NCT02960490|450247704|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
125170113|NCT02960490|450247705|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
125170114|NCT02960490|450247706|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
125170115|NCT02960490|450247707|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
125170116|NCT02960490|450247708|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
125170117|NCT02960490|450247709|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
125170118|NCT02960490|450247710|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
125170119|NCT02960490|450247711|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
125170120|NCT02960490|450247712|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
125170121|NCT02960490|450247703|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
125170122|NCT02960490|450247704|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
125170123|NCT02960490|450247705|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
125170124|NCT02960490|450247706|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
125170125|NCT02960490|450247707|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
125170126|NCT02960490|450247708|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
125170127|NCT02960490|450247709|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
125170128|NCT02960490|450247710|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
125170129|NCT02960490|450247711|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
125170130|NCT02960490|450247712|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
125170131|NCT02960490|450247703|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
125170132|NCT02960490|450247704|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
125170133|NCT02960490|450247705|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
125170134|NCT02960490|450247706|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
125170135|NCT02960490|450247707|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
125170136|NCT02960490|450247708|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
125170137|NCT02960490|450247709|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
125170138|NCT02960490|450247710|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
125170139|NCT02960490|450247711|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
125170140|NCT02960490|450247712|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
125170141|NCT02960490|450247703|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
125170142|NCT02960490|450247704|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
125170143|NCT02960490|450247705|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
125170144|NCT02960490|450247706|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
125170145|NCT02960490|450247707|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
125170146|NCT02960490|450247708|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
125170147|NCT02960490|450247709|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
125170148|NCT02960490|450247710|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
125170149|NCT02960490|450247711|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
125170150|NCT02960490|450247712|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
125170151|NCT02960490|450247703|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
125170152|NCT02960490|450247704|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
125170153|NCT02960490|450247705|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
125170154|NCT02960490|450247706|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
125170155|NCT02960490|450247707|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
125170156|NCT02960490|450247708|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
125170157|NCT02960490|450247709|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
125170158|NCT02960490|450247710|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
125170159|NCT02960490|450247711|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
125170160|NCT02960490|450247712|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
125170161|NCT02960490|450247703|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
125170162|NCT02960490|450247704|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
125170163|NCT02960490|450247705|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
125170164|NCT02960490|450247706|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
125170165|NCT02960490|450247707|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
125170166|NCT02960490|450247708|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
125170167|NCT02960490|450247709|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
125170168|NCT02960490|450247710|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
125170169|NCT02960490|450247711|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
125170170|NCT02960490|450247712|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
125170171|NCT02960490|450247703|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
125170172|NCT02960490|450247704|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
125170173|NCT02960490|450247705|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
125170174|NCT02960490|450247706|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
125170175|NCT02960490|450247707|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
125170176|NCT02960490|450247708|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
125170177|NCT02960490|450247709|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
125170178|NCT02960490|450247710|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
125170179|NCT02960490|450247711|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
125170180|NCT02960490|450247712|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
125170181|NCT02368314|450247715|FG000|Overall Study|Withdrawal by Subject|2|||
125170182|NCT02368314|450247716|FG001|Overall Study|Withdrawal by Subject|1|||
125170183|NCT02368314|450247715|FG000|Overall Study|Adverse Event|1|||
125170184|NCT02368314|450247716|FG001|Overall Study|Adverse Event|2|||
125170185|NCT01333397|450247717|FG000|Overall Study|Lost to Follow-up|1|||
125170186|NCT01333397|450247718|FG001|Overall Study|Lost to Follow-up|0|||
125170187|NCT01333397|450247719|FG002|Overall Study|Lost to Follow-up|0|||
125170188|NCT01333397|450247720|FG003|Overall Study|Lost to Follow-up|1|||
125170189|NCT01333397|450247721|FG004|Overall Study|Lost to Follow-up|0|||
125170190|NCT01085357|450247722|FG000|Overall Study|Adverse Event|1|||
125170191|NCT01085357|450247723|FG001|Overall Study|Adverse Event|1|||
125170192|NCT01085357|450247722|FG000|Overall Study|Subject Decision|4|||
125170193|NCT01085357|450247723|FG001|Overall Study|Subject Decision|3|||
125170194|NCT01085357|450247722|FG000|Overall Study|Investigator Decision|1|||
125170195|NCT01085357|450247723|FG001|Overall Study|Investigator Decision|1|||
125170196|NCT01085357|450247722|FG000|Overall Study|Death|11|||
125170197|NCT01085357|450247723|FG001|Overall Study|Death|1|||
125170198|NCT01085357|450247722|FG000|Overall Study|Lost to Follow-up|2|||
125170199|NCT01085357|450247723|FG001|Overall Study|Lost to Follow-up|0|||
125170200|NCT02289456|450247733|FG000|Induction Period|Death|2|||
125170201|NCT02289456|450247733|FG000|Induction Period|Adverse Event|11|||
125170202|NCT02289456|450247733|FG000|Induction Period|Progressive Disease (PD)|4|||
125170203|NCT02289456|450247733|FG000|Induction Period|Symptomatic Deterioration|4|||
125170204|NCT02289456|450247733|FG000|Induction Period|Withdrawal by Subject|2|||
125170205|NCT02289456|450247733|FG000|Induction Period|Miscellaneous|1|||
125170206|NCT02289456|450247733|FG000|Monotherapy Period|Death|1|||
125170207|NCT02289456|450247733|FG000|Monotherapy Period|Adverse Event|1|||
125170208|NCT02289456|450247733|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
125170209|NCT02289456|450247733|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
125170210|NCT02289456|450247733|FG000|Monotherapy Period|Withdrawal by Subject|2|||
125170211|NCT02289456|450247733|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
125170212|NCT02289456|450247733|FG000|Monotherapy Period|Miscellaneous|1|||
125170213|NCT00920790|450247736|FG000|Overall Study|aggravation of general condition|14|||
125170214|NCT01661062|450247737|FG000|Overall Study|Completed Treatment Off Study|3|||
125170215|NCT01661062|450247737|FG000|Overall Study|Withdrawal by Subject|2|||
125170216|NCT04411914|450247738|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
125228458|NCT00323063|450465712|FG000|Overall Study|brain mets discovered prior to treatment|1|||
125228459|NCT00323063|450465713|FG001|Overall Study|brain mets discovered prior to treatment|0|||
125228460|NCT03786380|450465714|FG000|Overall Study|Adverse Event|1|||
125228461|NCT03786380|450465715|FG001|Overall Study|Adverse Event|0|||
125170217|NCT04411914|450247739|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
125170218|NCT00895414|450247745|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
125170219|NCT00895414|450247746|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
125170220|NCT00895414|450247745|FG000|First Intervention (14 Days)|Physician Decision|0|||
125170221|NCT00895414|450247746|FG001|First Intervention (14 Days)|Physician Decision|1|||
125170222|NCT00252239|450247747|FG000|Overall Study|Withdrawal by Subject|1|||
125170223|NCT00252239|450247748|FG001|Overall Study|Withdrawal by Subject|0|||
125170224|NCT00252239|450247749|FG002|Overall Study|Withdrawal by Subject|0|||
125170225|NCT00252239|450247750|FG003|Overall Study|Withdrawal by Subject|1|||
125170226|NCT00252239|450247747|FG000|Overall Study|Lost to Follow-up|0|||
125170227|NCT00252239|450247748|FG001|Overall Study|Lost to Follow-up|0|||
125170228|NCT00252239|450247749|FG002|Overall Study|Lost to Follow-up|2|||
125228462|NCT03786380|450465716|FG002|Overall Study|Adverse Event|0|||
125170229|NCT00252239|450247750|FG003|Overall Study|Lost to Follow-up|0|||
125170230|NCT00478426|450247751|FG000|Overall Study|Withdrawal by Subject|1|||
125170231|NCT03489109|450247758|FG000|Overall Study|Lost to Follow-up|1|||
125170232|NCT03489109|450247759|FG001|Overall Study|Lost to Follow-up|2|||
125170233|NCT02181790|450247760|FG000|Overall Study|study terminated|2|||
125170234|NCT02181790|450247761|FG001|Overall Study|study terminated|0|||
125170235|NCT00025259|450247763|FG000|Overall Study|Death|1|||
125170236|NCT00025259|450247764|FG001|Overall Study|Death|3|||
125170237|NCT00025259|450247765|FG002|Overall Study|Death|0|||
125170238|NCT00025259|450247766|FG003|Overall Study|Death|3|||
125170239|NCT00025259|450247767|FG004|Overall Study|Death|0|||
125170240|NCT00025259|450247768|FG005|Overall Study|Death|1|||
125170241|NCT00025259|450247769|FG006|Overall Study|Death|2|||
125170242|NCT00025259|450247763|FG000|Overall Study|Lack of Efficacy|2|||
125170243|NCT00025259|450247764|FG001|Overall Study|Lack of Efficacy|46|||
125170244|NCT00025259|450247765|FG002|Overall Study|Lack of Efficacy|60|||
125170245|NCT00025259|450247766|FG003|Overall Study|Lack of Efficacy|78|||
125170246|NCT00025259|450247767|FG004|Overall Study|Lack of Efficacy|11|||
125170247|NCT00025259|450247768|FG005|Overall Study|Lack of Efficacy|30|||
125170248|NCT00025259|450247769|FG006|Overall Study|Lack of Efficacy|38|||
125170249|NCT00025259|450247763|FG000|Overall Study|Lost to Follow-up|2|||
125170250|NCT00025259|450247764|FG001|Overall Study|Lost to Follow-up|9|||
125170251|NCT00025259|450247765|FG002|Overall Study|Lost to Follow-up|13|||
125170252|NCT00025259|450247766|FG003|Overall Study|Lost to Follow-up|13|||
125170253|NCT00025259|450247767|FG004|Overall Study|Lost to Follow-up|1|||
125170254|NCT00025259|450247768|FG005|Overall Study|Lost to Follow-up|3|||
125170255|NCT00025259|450247769|FG006|Overall Study|Lost to Follow-up|1|||
125170256|NCT00025259|450247763|FG000|Overall Study|Physician Decision|12|||
125170257|NCT00025259|450247764|FG001|Overall Study|Physician Decision|1|||
125170258|NCT00025259|450247765|FG002|Overall Study|Physician Decision|0|||
125170259|NCT00025259|450247766|FG003|Overall Study|Physician Decision|5|||
125170260|NCT00025259|450247767|FG004|Overall Study|Physician Decision|4|||
125170261|NCT00025259|450247768|FG005|Overall Study|Physician Decision|2|||
125170262|NCT00025259|450247769|FG006|Overall Study|Physician Decision|1|||
125170263|NCT00025259|450247763|FG000|Overall Study|Protocol Violation|3|||
125170264|NCT00025259|450247764|FG001|Overall Study|Protocol Violation|2|||
125228463|NCT03786380|450465717|FG003|Overall Study|Adverse Event|3|||
125228464|NCT03786380|450465718|FG004|Overall Study|Adverse Event|1|||
125170265|NCT00025259|450247765|FG002|Overall Study|Protocol Violation|2|||
125170266|NCT00025259|450247766|FG003|Overall Study|Protocol Violation|1|||
125170267|NCT00025259|450247767|FG004|Overall Study|Protocol Violation|2|||
125228465|NCT03786380|450465714|FG000|Overall Study|Lack of Efficacy|0|||
125228466|NCT03786380|450465715|FG001|Overall Study|Lack of Efficacy|0|||
125228467|NCT03786380|450465716|FG002|Overall Study|Lack of Efficacy|0|||
125228468|NCT03786380|450465717|FG003|Overall Study|Lack of Efficacy|0|||
125228469|NCT03786380|450465718|FG004|Overall Study|Lack of Efficacy|1|||
125228470|NCT03786380|450465714|FG000|Overall Study|Withdrawal by Subject|1|||
125228471|NCT03786380|450465715|FG001|Overall Study|Withdrawal by Subject|2|||
125228472|NCT03786380|450465716|FG002|Overall Study|Withdrawal by Subject|2|||
125228473|NCT03786380|450465717|FG003|Overall Study|Withdrawal by Subject|1|||
125228474|NCT03786380|450465718|FG004|Overall Study|Withdrawal by Subject|2|||
125170268|NCT00025259|450247768|FG005|Overall Study|Protocol Violation|1|||
125170269|NCT00025259|450247769|FG006|Overall Study|Protocol Violation|3|||
125170270|NCT00025259|450247763|FG000|Overall Study|Withdrawal by Subject|9|||
125170271|NCT00025259|450247764|FG001|Overall Study|Withdrawal by Subject|27|||
125170272|NCT00025259|450247765|FG002|Overall Study|Withdrawal by Subject|6|||
125170273|NCT00025259|450247766|FG003|Overall Study|Withdrawal by Subject|14|||
125170274|NCT00025259|450247767|FG004|Overall Study|Withdrawal by Subject|11|||
125170275|NCT00025259|450247768|FG005|Overall Study|Withdrawal by Subject|8|||
125170276|NCT00025259|450247769|FG006|Overall Study|Withdrawal by Subject|3|||
125170277|NCT00025259|450247763|FG000|Overall Study|Ineligible|14|||
125170278|NCT00025259|450247764|FG001|Overall Study|Ineligible|1|||
125170279|NCT00025259|450247765|FG002|Overall Study|Ineligible|0|||
125170280|NCT00025259|450247766|FG003|Overall Study|Ineligible|0|||
125228475|NCT03786380|450465714|FG000|Overall Study|Lost to Follow-up|3|||
125170281|NCT00025259|450247767|FG004|Overall Study|Ineligible|6|||
125170282|NCT00025259|450247768|FG005|Overall Study|Ineligible|0|||
125170283|NCT00025259|450247769|FG006|Overall Study|Ineligible|1|||
125170284|NCT00025259|450247763|FG000|Overall Study|Randomization error|1|||
125170285|NCT00025259|450247764|FG001|Overall Study|Randomization error|0|||
125170286|NCT00025259|450247765|FG002|Overall Study|Randomization error|0|||
125170287|NCT00025259|450247766|FG003|Overall Study|Randomization error|0|||
125170288|NCT00025259|450247767|FG004|Overall Study|Randomization error|1|||
125228476|NCT03786380|450465715|FG001|Overall Study|Lost to Follow-up|0|||
125228477|NCT03786380|450465716|FG002|Overall Study|Lost to Follow-up|1|||
125228478|NCT03786380|450465717|FG003|Overall Study|Lost to Follow-up|2|||
125170289|NCT00025259|450247768|FG005|Overall Study|Randomization error|7|||
125170290|NCT00025259|450247769|FG006|Overall Study|Randomization error|2|||
125170291|NCT00025259|450247763|FG000|Overall Study|Adverse Event|1|||
125170292|NCT00025259|450247764|FG001|Overall Study|Adverse Event|0|||
125170293|NCT00025259|450247765|FG002|Overall Study|Adverse Event|0|||
125228479|NCT03786380|450465718|FG004|Overall Study|Lost to Follow-up|0|||
125228480|NCT03786380|450465714|FG000|Overall Study|Physician Decision|0|||
125228481|NCT03786380|450465715|FG001|Overall Study|Physician Decision|0|||
125228482|NCT03786380|450465716|FG002|Overall Study|Physician Decision|1|||
125228483|NCT03786380|450465717|FG003|Overall Study|Physician Decision|0|||
125228484|NCT03786380|450465718|FG004|Overall Study|Physician Decision|0|||
125228485|NCT03786380|450465714|FG000|Overall Study|Study Terminated by the Sponsor|30|||
125228486|NCT03786380|450465715|FG001|Overall Study|Study Terminated by the Sponsor|20|||
125228487|NCT03786380|450465716|FG002|Overall Study|Study Terminated by the Sponsor|50|||
125228488|NCT03786380|450465717|FG003|Overall Study|Study Terminated by the Sponsor|57|||
125228489|NCT03786380|450465718|FG004|Overall Study|Study Terminated by the Sponsor|23|||
125228490|NCT03786380|450465714|FG000|Overall Study|Reason Not Specified|0|||
125228491|NCT03786380|450465715|FG001|Overall Study|Reason Not Specified|0|||
125228492|NCT03786380|450465716|FG002|Overall Study|Reason Not Specified|0|||
125228493|NCT03786380|450465717|FG003|Overall Study|Reason Not Specified|0|||
125228494|NCT03786380|450465718|FG004|Overall Study|Reason Not Specified|1|||
125228495|NCT01664091|450465719|FG000|Overall Study|Death|1|||
125228496|NCT01664091|450465719|FG000|Overall Study|Disease Progression|2|||
125228497|NCT01664091|450465719|FG000|Overall Study|Lost to Follow-up|2|||
125228498|NCT01664091|450465719|FG000|Overall Study|Withdrawal by Subject|1|||
125228499|NCT00726609|450465722|FG000|Overall Study|Adverse Event|10|||
125228500|NCT00726609|450465722|FG000|Overall Study|Withdrawal by Subject|2|||
125228501|NCT00726609|450465722|FG000|Overall Study|Lack of Efficacy|25|||
125228502|NCT00726609|450465722|FG000|Overall Study|Other|16|||
125228503|NCT00726609|450465722|FG000|Overall Study|Missing|42|||
125228504|NCT00726609|450465722|FG000|Overall Study|Other|3|||
125228505|NCT03327324|450465729|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228506|NCT03327324|450465730|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
125228507|NCT03327324|450465731|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228508|NCT03327324|450465732|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
125228509|NCT03327324|450465733|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228510|NCT03327324|450465734|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
125228511|NCT03327324|450465729|FG000|Baseline (Month 0-Month 3)|Refused|0|||
125228512|NCT03327324|450465730|FG001|Baseline (Month 0-Month 3)|Refused|0|||
125228513|NCT03327324|450465731|FG002|Baseline (Month 0-Month 3)|Refused|0|||
125228514|NCT03327324|450465732|FG003|Baseline (Month 0-Month 3)|Refused|0|||
125228515|NCT03327324|450465733|FG004|Baseline (Month 0-Month 3)|Refused|1|||
125228516|NCT03327324|450465734|FG005|Baseline (Month 0-Month 3)|Refused|0|||
125228517|NCT03327324|450465729|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
125228518|NCT03327324|450465730|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
125228519|NCT03327324|450465731|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
125228520|NCT03327324|450465732|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
125228521|NCT03327324|450465733|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
125228522|NCT03327324|450465734|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
125228523|NCT03327324|450465729|FG000|Baseline (Month 0-Month 3)|Death|0|||
125228524|NCT03327324|450465730|FG001|Baseline (Month 0-Month 3)|Death|0|||
125228525|NCT03327324|450465731|FG002|Baseline (Month 0-Month 3)|Death|0|||
125228526|NCT03327324|450465732|FG003|Baseline (Month 0-Month 3)|Death|0|||
125228527|NCT03327324|450465733|FG004|Baseline (Month 0-Month 3)|Death|1|||
125228528|NCT03327324|450465734|FG005|Baseline (Month 0-Month 3)|Death|0|||
125228529|NCT03327324|450465729|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125170294|NCT00025259|450247766|FG003|Overall Study|Adverse Event|0|||
125170295|NCT00025259|450247767|FG004|Overall Study|Adverse Event|0|||
125170296|NCT00025259|450247768|FG005|Overall Study|Adverse Event|0|||
125170297|NCT00025259|450247769|FG006|Overall Study|Adverse Event|0|||
125170298|NCT00863772|450247770|FG000|Overall Study|Adverse Event|1|||
125170299|NCT00863772|450247771|FG001|Overall Study|Adverse Event|4|||
125170300|NCT00863772|450247772|FG002|Overall Study|Adverse Event|0|||
125170301|NCT00863772|450247770|FG000|Overall Study|Lack of Efficacy|4|||
125170302|NCT00863772|450247771|FG001|Overall Study|Lack of Efficacy|2|||
125170303|NCT00863772|450247772|FG002|Overall Study|Lack of Efficacy|4|||
125170304|NCT00863772|450247770|FG000|Overall Study|Lost to Follow-up|5|||
125170305|NCT00863772|450247771|FG001|Overall Study|Lost to Follow-up|1|||
125170306|NCT00863772|450247772|FG002|Overall Study|Lost to Follow-up|1|||
125170307|NCT00863772|450247770|FG000|Overall Study|Protocol Violation|2|||
125228530|NCT03327324|450465730|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125170308|NCT00863772|450247771|FG001|Overall Study|Protocol Violation|0|||
125170309|NCT00863772|450247772|FG002|Overall Study|Protocol Violation|2|||
125170310|NCT00863772|450247770|FG000|Overall Study|Withdrawal by Subject|4|||
125228531|NCT03327324|450465731|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125170311|NCT00863772|450247771|FG001|Overall Study|Withdrawal by Subject|7|||
125170312|NCT00863772|450247772|FG002|Overall Study|Withdrawal by Subject|5|||
125228532|NCT03327324|450465732|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125228533|NCT03327324|450465733|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125228534|NCT03327324|450465734|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
125228535|NCT03327324|450465729|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228536|NCT03327324|450465730|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228537|NCT03327324|450465731|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
125228538|NCT03327324|450465732|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228539|NCT03327324|450465733|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228540|NCT03327324|450465734|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228541|NCT03327324|450465729|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
125228542|NCT03327324|450465730|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
125228543|NCT03327324|450465731|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
125228544|NCT03327324|450465732|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
125228545|NCT03327324|450465733|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
125228546|NCT03327324|450465734|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
125228547|NCT03327324|450465729|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
125228548|NCT03327324|450465730|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
125228549|NCT03327324|450465731|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
125228550|NCT03327324|450465732|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
125228551|NCT03327324|450465733|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
125170313|NCT00863772|450247770|FG000|Overall Study|Study terminated by sponsor|44|||
125228552|NCT03327324|450465734|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
125228553|NCT03327324|450465729|FG000|Intervention (Month 3-Month 6)|Death|1|||
125228554|NCT03327324|450465730|FG001|Intervention (Month 3-Month 6)|Death|0|||
125228555|NCT03327324|450465731|FG002|Intervention (Month 3-Month 6)|Death|1|||
125228556|NCT03327324|450465732|FG003|Intervention (Month 3-Month 6)|Death|1|||
125228557|NCT03327324|450465733|FG004|Intervention (Month 3-Month 6)|Death|1|||
125228558|NCT03327324|450465734|FG005|Intervention (Month 3-Month 6)|Death|0|||
125228559|NCT03327324|450465729|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125228560|NCT03327324|450465730|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125228561|NCT03327324|450465731|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125170314|NCT00863772|450247771|FG001|Overall Study|Study terminated by sponsor|45|||
125170315|NCT00863772|450247772|FG002|Overall Study|Study terminated by sponsor|36|||
125170316|NCT00863772|450247770|FG000|Overall Study|Entered extension study|6|||
125170317|NCT00863772|450247771|FG001|Overall Study|Entered extension study|4|||
125170318|NCT00863772|450247772|FG002|Overall Study|Entered extension study|9|||
125170319|NCT00863772|450247770|FG000|Overall Study|Other|1|||
125170320|NCT00863772|450247771|FG001|Overall Study|Other|2|||
125170321|NCT00863772|450247772|FG002|Overall Study|Other|4|||
125170322|NCT00863772|450247770|FG000|Overall Study|Randomized but not Treated|1|||
125170323|NCT00863772|450247771|FG001|Overall Study|Randomized but not Treated|0|||
125170324|NCT00863772|450247772|FG002|Overall Study|Randomized but not Treated|0|||
125170325|NCT01449370|450247773|FG000|Overall Study|Disease Progression|5|||
125170326|NCT01449370|450247774|FG001|Overall Study|Disease Progression|4|||
125170327|NCT01449370|450247775|FG002|Overall Study|Disease Progression|8|||
125170328|NCT01449370|450247776|FG003|Overall Study|Disease Progression|3|||
125170329|NCT01449370|450247777|FG004|Overall Study|Disease Progression|3|||
125170330|NCT01449370|450247778|FG005|Overall Study|Disease Progression|3|||
125170331|NCT01449370|450247779|FG006|Overall Study|Disease Progression|3|||
125170332|NCT01449370|450247780|FG007|Overall Study|Disease Progression|2|||
125170333|NCT01449370|450247781|FG008|Overall Study|Disease Progression|9|||
125170334|NCT01449370|450247782|FG009|Overall Study|Disease Progression|1|||
125170335|NCT01449370|450247783|FG010|Overall Study|Disease Progression|3|||
125170336|NCT01449370|450247784|FG011|Overall Study|Disease Progression|3|||
125170337|NCT01449370|450247785|FG012|Overall Study|Disease Progression|2|||
125170338|NCT01449370|450247786|FG013|Overall Study|Disease Progression|8|||
125170339|NCT01449370|450247787|FG014|Overall Study|Disease Progression|3|||
125170340|NCT01449370|450247788|FG015|Overall Study|Disease Progression|1|||
125170341|NCT01449370|450247789|FG016|Overall Study|Disease Progression|4|||
125170342|NCT01449370|450247790|FG017|Overall Study|Disease Progression|3|||
125170343|NCT01449370|450247791|FG018|Overall Study|Disease Progression|1|||
125170344|NCT01449370|450247792|FG019|Overall Study|Disease Progression|2|||
125170345|NCT01449370|450247793|FG020|Overall Study|Disease Progression|5|||
125170346|NCT01449370|450247794|FG021|Overall Study|Disease Progression|2|||
125170347|NCT01449370|450247795|FG022|Overall Study|Disease Progression|3|||
125170348|NCT01449370|450247796|FG023|Overall Study|Disease Progression|7|||
125170349|NCT01449370|450247797|FG024|Overall Study|Disease Progression|3|||
125170350|NCT01449370|450247773|FG000|Overall Study|Adverse Event|1|||
125170351|NCT01449370|450247774|FG001|Overall Study|Adverse Event|2|||
125170352|NCT01449370|450247775|FG002|Overall Study|Adverse Event|0|||
125170353|NCT01449370|450247776|FG003|Overall Study|Adverse Event|1|||
125170354|NCT01449370|450247777|FG004|Overall Study|Adverse Event|0|||
125170355|NCT01449370|450247778|FG005|Overall Study|Adverse Event|0|||
125170356|NCT01449370|450247779|FG006|Overall Study|Adverse Event|0|||
125170357|NCT01449370|450247780|FG007|Overall Study|Adverse Event|0|||
125170358|NCT01449370|450247781|FG008|Overall Study|Adverse Event|1|||
125170359|NCT01449370|450247782|FG009|Overall Study|Adverse Event|1|||
125170360|NCT01449370|450247783|FG010|Overall Study|Adverse Event|0|||
125170361|NCT01449370|450247784|FG011|Overall Study|Adverse Event|0|||
125170362|NCT01449370|450247785|FG012|Overall Study|Adverse Event|0|||
125170363|NCT01449370|450247786|FG013|Overall Study|Adverse Event|2|||
125170364|NCT01449370|450247787|FG014|Overall Study|Adverse Event|0|||
125170365|NCT01449370|450247788|FG015|Overall Study|Adverse Event|1|||
125170366|NCT01449370|450247789|FG016|Overall Study|Adverse Event|0|||
125170367|NCT01449370|450247790|FG017|Overall Study|Adverse Event|0|||
125170368|NCT01449370|450247791|FG018|Overall Study|Adverse Event|1|||
125170369|NCT01449370|450247792|FG019|Overall Study|Adverse Event|1|||
125170370|NCT01449370|450247793|FG020|Overall Study|Adverse Event|0|||
125170371|NCT01449370|450247794|FG021|Overall Study|Adverse Event|1|||
125170372|NCT01449370|450247795|FG022|Overall Study|Adverse Event|0|||
125170373|NCT01449370|450247796|FG023|Overall Study|Adverse Event|1|||
125170374|NCT01449370|450247797|FG024|Overall Study|Adverse Event|3|||
125170375|NCT01449370|450247773|FG000|Overall Study|Participant Decision|0|||
125170376|NCT01449370|450247774|FG001|Overall Study|Participant Decision|0|||
125170377|NCT01449370|450247775|FG002|Overall Study|Participant Decision|0|||
125170378|NCT01449370|450247776|FG003|Overall Study|Participant Decision|0|||
125170379|NCT01449370|450247777|FG004|Overall Study|Participant Decision|0|||
125170380|NCT01449370|450247778|FG005|Overall Study|Participant Decision|0|||
125170381|NCT01449370|450247779|FG006|Overall Study|Participant Decision|0|||
125170382|NCT01449370|450247780|FG007|Overall Study|Participant Decision|1|||
125170383|NCT01449370|450247781|FG008|Overall Study|Participant Decision|1|||
125170384|NCT01449370|450247782|FG009|Overall Study|Participant Decision|0|||
125170385|NCT01449370|450247783|FG010|Overall Study|Participant Decision|0|||
125170386|NCT01449370|450247784|FG011|Overall Study|Participant Decision|0|||
125170387|NCT01449370|450247785|FG012|Overall Study|Participant Decision|1|||
125170388|NCT01449370|450247786|FG013|Overall Study|Participant Decision|1|||
125170389|NCT01449370|450247787|FG014|Overall Study|Participant Decision|0|||
125170390|NCT01449370|450247788|FG015|Overall Study|Participant Decision|1|||
125170391|NCT01449370|450247789|FG016|Overall Study|Participant Decision|3|||
125170392|NCT01449370|450247790|FG017|Overall Study|Participant Decision|0|||
125170393|NCT01449370|450247791|FG018|Overall Study|Participant Decision|1|||
125170394|NCT01449370|450247792|FG019|Overall Study|Participant Decision|0|||
125170395|NCT01449370|450247793|FG020|Overall Study|Participant Decision|0|||
125170396|NCT01449370|450247794|FG021|Overall Study|Participant Decision|1|||
125170397|NCT01449370|450247795|FG022|Overall Study|Participant Decision|0|||
125170398|NCT01449370|450247796|FG023|Overall Study|Participant Decision|0|||
125170399|NCT01449370|450247797|FG024|Overall Study|Participant Decision|1|||
125170400|NCT01449370|450247773|FG000|Overall Study|Lost to Follow-up|0|||
125170401|NCT01449370|450247774|FG001|Overall Study|Lost to Follow-up|0|||
125170402|NCT01449370|450247775|FG002|Overall Study|Lost to Follow-up|0|||
125170403|NCT01449370|450247776|FG003|Overall Study|Lost to Follow-up|0|||
125170404|NCT01449370|450247777|FG004|Overall Study|Lost to Follow-up|0|||
125170405|NCT01449370|450247778|FG005|Overall Study|Lost to Follow-up|0|||
125170406|NCT01449370|450247779|FG006|Overall Study|Lost to Follow-up|0|||
125170407|NCT01449370|450247780|FG007|Overall Study|Lost to Follow-up|0|||
125170408|NCT01449370|450247781|FG008|Overall Study|Lost to Follow-up|0|||
125170409|NCT01449370|450247782|FG009|Overall Study|Lost to Follow-up|0|||
125170410|NCT01449370|450247783|FG010|Overall Study|Lost to Follow-up|0|||
125170411|NCT01449370|450247784|FG011|Overall Study|Lost to Follow-up|0|||
125170412|NCT01449370|450247785|FG012|Overall Study|Lost to Follow-up|0|||
125170413|NCT01449370|450247786|FG013|Overall Study|Lost to Follow-up|0|||
125170414|NCT01449370|450247787|FG014|Overall Study|Lost to Follow-up|0|||
125170415|NCT01449370|450247788|FG015|Overall Study|Lost to Follow-up|0|||
125170416|NCT01449370|450247789|FG016|Overall Study|Lost to Follow-up|0|||
125170417|NCT01449370|450247790|FG017|Overall Study|Lost to Follow-up|0|||
125170418|NCT01449370|450247791|FG018|Overall Study|Lost to Follow-up|0|||
125170419|NCT01449370|450247792|FG019|Overall Study|Lost to Follow-up|0|||
125170420|NCT01449370|450247793|FG020|Overall Study|Lost to Follow-up|1|||
125170421|NCT01449370|450247794|FG021|Overall Study|Lost to Follow-up|0|||
125170422|NCT01449370|450247795|FG022|Overall Study|Lost to Follow-up|0|||
125170423|NCT01449370|450247796|FG023|Overall Study|Lost to Follow-up|0|||
125170424|NCT01449370|450247797|FG024|Overall Study|Lost to Follow-up|0|||
125170425|NCT01449370|450247773|FG000|Overall Study|Other|0|||
125170426|NCT01449370|450247774|FG001|Overall Study|Other|0|||
125170427|NCT01449370|450247775|FG002|Overall Study|Other|0|||
125170428|NCT01449370|450247776|FG003|Overall Study|Other|0|||
125170429|NCT01449370|450247777|FG004|Overall Study|Other|0|||
125170430|NCT01449370|450247778|FG005|Overall Study|Other|0|||
125170431|NCT01449370|450247779|FG006|Overall Study|Other|0|||
125170432|NCT01449370|450247780|FG007|Overall Study|Other|0|||
125170433|NCT01449370|450247781|FG008|Overall Study|Other|1|||
125170434|NCT01449370|450247782|FG009|Overall Study|Other|1|||
125170435|NCT01449370|450247783|FG010|Overall Study|Other|0|||
125170436|NCT01449370|450247784|FG011|Overall Study|Other|0|||
125170437|NCT01449370|450247785|FG012|Overall Study|Other|0|||
125170438|NCT01449370|450247786|FG013|Overall Study|Other|0|||
125170439|NCT01449370|450247787|FG014|Overall Study|Other|0|||
125170440|NCT01449370|450247788|FG015|Overall Study|Other|0|||
125170441|NCT01449370|450247789|FG016|Overall Study|Other|0|||
125228562|NCT03327324|450465732|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125170442|NCT01449370|450247790|FG017|Overall Study|Other|0|||
125170443|NCT01449370|450247791|FG018|Overall Study|Other|0|||
125170444|NCT01449370|450247792|FG019|Overall Study|Other|0|||
125170445|NCT01449370|450247793|FG020|Overall Study|Other|0|||
125170446|NCT01449370|450247794|FG021|Overall Study|Other|0|||
125170447|NCT01449370|450247795|FG022|Overall Study|Other|1|||
125170448|NCT01449370|450247796|FG023|Overall Study|Other|1|||
125170449|NCT01449370|450247797|FG024|Overall Study|Other|0|||
125170450|NCT01449370|450247773|FG000|Overall Study|Medication Prohibited by Protocol|0|||
125170451|NCT01449370|450247774|FG001|Overall Study|Medication Prohibited by Protocol|0|||
125170452|NCT01449370|450247775|FG002|Overall Study|Medication Prohibited by Protocol|0|||
125170453|NCT01449370|450247776|FG003|Overall Study|Medication Prohibited by Protocol|0|||
125170454|NCT01449370|450247777|FG004|Overall Study|Medication Prohibited by Protocol|0|||
125170455|NCT01449370|450247778|FG005|Overall Study|Medication Prohibited by Protocol|0|||
125170456|NCT01449370|450247779|FG006|Overall Study|Medication Prohibited by Protocol|0|||
125170457|NCT01449370|450247780|FG007|Overall Study|Medication Prohibited by Protocol|0|||
125170458|NCT01449370|450247781|FG008|Overall Study|Medication Prohibited by Protocol|0|||
125170459|NCT01449370|450247782|FG009|Overall Study|Medication Prohibited by Protocol|0|||
125170460|NCT01449370|450247783|FG010|Overall Study|Medication Prohibited by Protocol|0|||
125170461|NCT01449370|450247784|FG011|Overall Study|Medication Prohibited by Protocol|0|||
125170462|NCT01449370|450247785|FG012|Overall Study|Medication Prohibited by Protocol|0|||
125228563|NCT03327324|450465733|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125228564|NCT03327324|450465734|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
125228565|NCT03327324|450465729|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
125228566|NCT03327324|450465730|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228567|NCT03327324|450465731|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228568|NCT03327324|450465732|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228569|NCT03327324|450465733|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228570|NCT03327324|450465734|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228571|NCT03327324|450465729|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
125228572|NCT03327324|450465730|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
125228573|NCT03327324|450465731|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
125228574|NCT03327324|450465732|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
125170463|NCT01449370|450247786|FG013|Overall Study|Medication Prohibited by Protocol|0|||
125170464|NCT01449370|450247787|FG014|Overall Study|Medication Prohibited by Protocol|0|||
125170465|NCT01449370|450247788|FG015|Overall Study|Medication Prohibited by Protocol|0|||
125170466|NCT01449370|450247789|FG016|Overall Study|Medication Prohibited by Protocol|0|||
125170467|NCT01449370|450247790|FG017|Overall Study|Medication Prohibited by Protocol|0|||
125170468|NCT01449370|450247791|FG018|Overall Study|Medication Prohibited by Protocol|0|||
125170469|NCT01449370|450247792|FG019|Overall Study|Medication Prohibited by Protocol|0|||
125170470|NCT01449370|450247793|FG020|Overall Study|Medication Prohibited by Protocol|0|||
125170471|NCT01449370|450247794|FG021|Overall Study|Medication Prohibited by Protocol|0|||
125170472|NCT01449370|450247795|FG022|Overall Study|Medication Prohibited by Protocol|0|||
125170473|NCT01449370|450247796|FG023|Overall Study|Medication Prohibited by Protocol|1|||
125170474|NCT01449370|450247797|FG024|Overall Study|Medication Prohibited by Protocol|0|||
125170475|NCT01449370|450247773|FG000|Overall Study|Death|0|||
125228575|NCT03327324|450465733|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
125228576|NCT03327324|450465734|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
125228577|NCT03327324|450465729|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
125228578|NCT03327324|450465730|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
125228579|NCT03327324|450465731|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
125228580|NCT03327324|450465732|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
125170476|NCT01449370|450247774|FG001|Overall Study|Death|0|||
125170477|NCT01449370|450247775|FG002|Overall Study|Death|0|||
125170478|NCT01449370|450247776|FG003|Overall Study|Death|0|||
125170479|NCT01449370|450247777|FG004|Overall Study|Death|0|||
125170480|NCT01449370|450247778|FG005|Overall Study|Death|0|||
125170481|NCT01449370|450247779|FG006|Overall Study|Death|0|||
125170482|NCT01449370|450247780|FG007|Overall Study|Death|0|||
125170483|NCT01449370|450247781|FG008|Overall Study|Death|0|||
125170484|NCT01449370|450247782|FG009|Overall Study|Death|0|||
125170485|NCT01449370|450247783|FG010|Overall Study|Death|0|||
125170486|NCT01449370|450247784|FG011|Overall Study|Death|0|||
125170487|NCT01449370|450247785|FG012|Overall Study|Death|0|||
125170488|NCT01449370|450247786|FG013|Overall Study|Death|0|||
125170489|NCT01449370|450247787|FG014|Overall Study|Death|0|||
125170490|NCT01449370|450247788|FG015|Overall Study|Death|0|||
125170491|NCT01449370|450247789|FG016|Overall Study|Death|0|||
125170492|NCT01449370|450247790|FG017|Overall Study|Death|0|||
125170493|NCT01449370|450247791|FG018|Overall Study|Death|0|||
125170494|NCT01449370|450247792|FG019|Overall Study|Death|0|||
125170495|NCT01449370|450247793|FG020|Overall Study|Death|0|||
125170496|NCT01449370|450247794|FG021|Overall Study|Death|0|||
125170497|NCT01449370|450247795|FG022|Overall Study|Death|0|||
125170498|NCT01449370|450247796|FG023|Overall Study|Death|0|||
125170499|NCT01449370|450247797|FG024|Overall Study|Death|1|||
125170500|NCT00908310|450247798|FG000|Overall Study|Death|37|||
125170501|NCT00908310|450247798|FG000|Overall Study|Withdrawal by Subject|7|||
125170502|NCT00908310|450247798|FG000|Overall Study|Lost to Follow-up|7|||
125170503|NCT00908310|450247798|FG000|Overall Study|Screening failure|5|||
125170504|NCT00908310|450247798|FG000|Overall Study|Other reasons|4|||
125228581|NCT03327324|450465733|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
125228582|NCT03327324|450465734|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
125228583|NCT03327324|450465729|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125228584|NCT03327324|450465730|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125228585|NCT03327324|450465731|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125228586|NCT03327324|450465732|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
125228587|NCT03327324|450465733|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
125228588|NCT03327324|450465734|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125228589|NCT03327324|450465729|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
125228590|NCT03327324|450465730|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
125228591|NCT03327324|450465731|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
125228592|NCT03327324|450465732|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
125228593|NCT03327324|450465733|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
125228594|NCT03327324|450465734|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
125228595|NCT03327324|450465729|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
125228596|NCT03327324|450465730|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
125228597|NCT03327324|450465731|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
125228598|NCT03327324|450465732|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
125228599|NCT03327324|450465733|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
125228600|NCT03327324|450465734|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
125228601|NCT03080935|450465737|FG000|Overall Study|Death|34|||
125228602|NCT03080935|450465738|FG001|Overall Study|Death|50|||
125228603|NCT03080935|450465737|FG000|Overall Study|Lost to Follow-up|5|||
125228604|NCT03080935|450465738|FG001|Overall Study|Lost to Follow-up|4|||
125228605|NCT03080935|450465737|FG000|Overall Study|Withdrawal by Subject|11|||
125228606|NCT03080935|450465738|FG001|Overall Study|Withdrawal by Subject|15|||
125228607|NCT01614470|450465739|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
125170505|NCT00534404|450247801|FG000|Overall Study|Death|0|||
125170506|NCT00534404|450247802|FG001|Overall Study|Death|0|||
125170507|NCT00534404|450247803|FG002|Overall Study|Death|2|||
125170508|NCT00534404|450247801|FG000|Overall Study|Withdrawal by Subject|8|||
125170509|NCT00534404|450247802|FG001|Overall Study|Withdrawal by Subject|2|||
125170510|NCT00534404|450247803|FG002|Overall Study|Withdrawal by Subject|38|||
125170511|NCT00534404|450247801|FG000|Overall Study|Removed by study staff|2|||
125170512|NCT00534404|450247802|FG001|Overall Study|Removed by study staff|3|||
125170513|NCT00534404|450247803|FG002|Overall Study|Removed by study staff|1|||
125170514|NCT00534404|450247801|FG000|Overall Study|Lost to Follow-up|170|||
125170515|NCT00534404|450247802|FG001|Overall Study|Lost to Follow-up|138|||
125228608|NCT01614470|450465740|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
125228609|NCT01614470|450465741|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
125228610|NCT01614470|450465739|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
125228611|NCT01614470|450465740|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
125228612|NCT01614470|450465741|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
125170516|NCT00534404|450247803|FG002|Overall Study|Lost to Follow-up|201|||
125170517|NCT02785952|450247807|FG000|Overall Study|Adverse Event|31|||
125170518|NCT02785952|450247808|FG001|Overall Study|Adverse Event|19|||
125170519|NCT02785952|450247807|FG000|Overall Study|Refusal unrelated to adverse events|10|||
125170520|NCT02785952|450247808|FG001|Overall Study|Refusal unrelated to adverse events|5|||
125170521|NCT02785952|450247807|FG000|Overall Study|Disease progression/relapse|61|||
125170522|NCT02785952|450247808|FG001|Overall Study|Disease progression/relapse|89|||
125170523|NCT02785952|450247807|FG000|Overall Study|Death|11|||
125170524|NCT02785952|450247808|FG001|Overall Study|Death|7|||
125170525|NCT02785952|450247807|FG000|Overall Study|Other- not protocol specified|6|||
125170526|NCT02785952|450247808|FG001|Overall Study|Other- not protocol specified|4|||
125170527|NCT02785952|450247807|FG000|Overall Study|On protocol treatment|6|||
125170528|NCT02785952|450247808|FG001|Overall Study|On protocol treatment|3|||
125170529|NCT00351533|450247810|FG000|Overall Study|Extubated before first BAL|1|||
125170530|NCT00351533|450247811|FG001|Overall Study|Extubated before first BAL|0|||
125170531|NCT00351533|450247810|FG000|Overall Study|Lost to Follow-up|1|||
125170532|NCT00351533|450247811|FG001|Overall Study|Lost to Follow-up|3|||
125170533|NCT00351533|450247810|FG000|Overall Study|Physician Decision|0|||
125170534|NCT00351533|450247811|FG001|Overall Study|Physician Decision|1|||
125170535|NCT00351533|450247810|FG000|Overall Study|Withdrawal by Subject|0|||
125170536|NCT00351533|450247811|FG001|Overall Study|Withdrawal by Subject|1|||
125170537|NCT00315731|450247812|FG000|Overall Study|Lost to Follow-up|1|||
125170538|NCT00315731|450247812|FG000|Overall Study|Death|5|||
125170539|NCT04614246|450247813|FG000|Overall Study|Adverse Event|0|||
125170540|NCT04614246|450247814|FG001|Overall Study|Adverse Event|1|||
125170541|NCT04614246|450247815|FG002|Overall Study|Adverse Event|1|||
125170542|NCT04614246|450247816|FG003|Overall Study|Adverse Event|2|||
125170543|NCT04614246|450247817|FG004|Overall Study|Adverse Event|1|||
125228613|NCT02175121|450465742|FG000|Overall Study|Lack of Efficacy|1|||
125228614|NCT02175121|450465743|FG001|Overall Study|Lack of Efficacy|0|||
125228615|NCT02175121|450465744|FG002|Overall Study|Lack of Efficacy|0|||
125228616|NCT02175121|450465745|FG003|Overall Study|Lack of Efficacy|0|||
125228617|NCT02175121|450465746|FG004|Overall Study|Lack of Efficacy|0|||
125228618|NCT02175121|450465742|FG000|Overall Study|Lost to Follow-up|0|||
125228619|NCT02175121|450465743|FG001|Overall Study|Lost to Follow-up|1|||
125228620|NCT02175121|450465744|FG002|Overall Study|Lost to Follow-up|0|||
125228621|NCT02175121|450465745|FG003|Overall Study|Lost to Follow-up|1|||
125228622|NCT02175121|450465746|FG004|Overall Study|Lost to Follow-up|0|||
125228623|NCT02175121|450465742|FG000|Overall Study|Personal emergency|0|||
125228624|NCT02175121|450465743|FG001|Overall Study|Personal emergency|0|||
125228625|NCT02175121|450465744|FG002|Overall Study|Personal emergency|0|||
125228626|NCT02175121|450465745|FG003|Overall Study|Personal emergency|0|||
125228627|NCT02175121|450465746|FG004|Overall Study|Personal emergency|1|||
125228628|NCT02175121|450465742|FG000|Overall Study|Schedule conflict|0|||
125228629|NCT02175121|450465743|FG001|Overall Study|Schedule conflict|0|||
125228630|NCT02175121|450465744|FG002|Overall Study|Schedule conflict|1|||
125228631|NCT02175121|450465745|FG003|Overall Study|Schedule conflict|0|||
125228632|NCT02175121|450465746|FG004|Overall Study|Schedule conflict|0|||
125228633|NCT02175121|450465742|FG000|Overall Study|Time issues|0|||
125228634|NCT02175121|450465743|FG001|Overall Study|Time issues|0|||
125228635|NCT02175121|450465744|FG002|Overall Study|Time issues|1|||
125228636|NCT02175121|450465745|FG003|Overall Study|Time issues|0|||
125228637|NCT02175121|450465746|FG004|Overall Study|Time issues|0|||
125228638|NCT02557399|450465747|FG000|Overall Study|Adverse Event|6|||
125228639|NCT02557399|450465748|FG001|Overall Study|Adverse Event|5|||
125228640|NCT02557399|450465747|FG000|Overall Study|Protocol Violation|0|||
125228641|NCT02557399|450465748|FG001|Overall Study|Protocol Violation|1|||
125228642|NCT02557399|450465747|FG000|Overall Study|Protocol-defined stopping criteria|0|||
125228643|NCT02557399|450465748|FG001|Overall Study|Protocol-defined stopping criteria|1|||
125228644|NCT02557399|450465747|FG000|Overall Study|Withdrawal by Subject|1|||
125228645|NCT02557399|450465748|FG001|Overall Study|Withdrawal by Subject|1|||
125228646|NCT02848664|450465749|FG000|Overall Study|Withdrawal by Subject|2|||
125228647|NCT02848664|450465749|FG000|Overall Study|Adverse Event|1|||
125228648|NCT02848664|450465749|FG000|Overall Study|no assistance for device training|1|||
125228649|NCT00402727|450465750|FG000|Overall Study|Adverse Event|10|||
125170544|NCT04614246|450247813|FG000|Overall Study|Lost to Follow-up|0|||
125228650|NCT00402727|450465751|FG001|Overall Study|Adverse Event|6|||
125170545|NCT04614246|450247814|FG001|Overall Study|Lost to Follow-up|1|||
125170546|NCT04614246|450247815|FG002|Overall Study|Lost to Follow-up|0|||
125228651|NCT00402727|450465750|FG000|Overall Study|Death|1|||
125170547|NCT04614246|450247816|FG003|Overall Study|Lost to Follow-up|1|||
125170548|NCT04614246|450247817|FG004|Overall Study|Lost to Follow-up|3|||
125228652|NCT00402727|450465751|FG001|Overall Study|Death|0|||
125228653|NCT00402727|450465750|FG000|Overall Study|Lack of Efficacy|1|||
125228654|NCT00402727|450465751|FG001|Overall Study|Lack of Efficacy|3|||
125228655|NCT00402727|450465750|FG000|Overall Study|Lost to Follow-up|24|||
125228656|NCT00402727|450465751|FG001|Overall Study|Lost to Follow-up|11|||
125228657|NCT00402727|450465750|FG000|Overall Study|Physician Decision|1|||
125228658|NCT00402727|450465751|FG001|Overall Study|Physician Decision|1|||
125228659|NCT00402727|450465750|FG000|Overall Study|Protocol Violation|0|||
125228660|NCT00402727|450465751|FG001|Overall Study|Protocol Violation|4|||
125228661|NCT00402727|450465750|FG000|Overall Study|Withdrawal by Subject|3|||
125228662|NCT00402727|450465751|FG001|Overall Study|Withdrawal by Subject|7|||
125228663|NCT00402727|450465750|FG000|Overall Study|supply problems|2|||
125228664|NCT00402727|450465751|FG001|Overall Study|supply problems|1|||
125228665|NCT00402727|450465750|FG000|Overall Study|non-compliance|0|||
125228666|NCT00402727|450465751|FG001|Overall Study|non-compliance|1|||
125228667|NCT01405898|450465752|FG000|Overall Study|Withdrawal by Subject|2|||
125228668|NCT01405898|450465753|FG001|Overall Study|Withdrawal by Subject|2|||
125228669|NCT01687218|450465754|FG000|Overall Study|Withdrawal by Subject|2|||
125228670|NCT01687218|450465755|FG001|Overall Study|Withdrawal by Subject|3|||
125228671|NCT01687218|450465756|FG002|Overall Study|Withdrawal by Subject|0|||
125228672|NCT01687218|450465757|FG003|Overall Study|Withdrawal by Subject|1|||
125228673|NCT01687218|450465758|FG004|Overall Study|Withdrawal by Subject|1|||
125228674|NCT01687218|450465759|FG005|Overall Study|Withdrawal by Subject|0|||
125228675|NCT01687218|450465754|FG000|Overall Study|Relocated, no follow-up planned|1|||
125228676|NCT01687218|450465755|FG001|Overall Study|Relocated, no follow-up planned|0|||
125228677|NCT01687218|450465756|FG002|Overall Study|Relocated, no follow-up planned|1|||
125228678|NCT01687218|450465757|FG003|Overall Study|Relocated, no follow-up planned|1|||
125228679|NCT01687218|450465758|FG004|Overall Study|Relocated, no follow-up planned|0|||
125228680|NCT01687218|450465759|FG005|Overall Study|Relocated, no follow-up planned|0|||
125228681|NCT00887484|450465772|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
125228682|NCT00887484|450465772|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
125228683|NCT00887484|450465772|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
125228684|NCT01204671|450465773|FG000|Overall Study|Adverse Event|4|||
125228685|NCT01204671|450465774|FG001|Overall Study|Adverse Event|3|||
125228686|NCT01204671|450465775|FG002|Overall Study|Adverse Event|3|||
125228687|NCT01204671|450465776|FG003|Overall Study|Adverse Event|3|||
125228688|NCT01204671|450465777|FG004|Overall Study|Adverse Event|1|||
125228689|NCT01204671|450465773|FG000|Overall Study|Withdrawal by Subject|2|||
125228690|NCT01204671|450465774|FG001|Overall Study|Withdrawal by Subject|3|||
125228691|NCT01204671|450465775|FG002|Overall Study|Withdrawal by Subject|4|||
125228692|NCT01204671|450465776|FG003|Overall Study|Withdrawal by Subject|5|||
125228693|NCT01204671|450465777|FG004|Overall Study|Withdrawal by Subject|3|||
125228694|NCT01204671|450465773|FG000|Overall Study|Lost to Follow-up|7|||
125228695|NCT01204671|450465774|FG001|Overall Study|Lost to Follow-up|8|||
125228696|NCT01204671|450465775|FG002|Overall Study|Lost to Follow-up|6|||
125228697|NCT01204671|450465776|FG003|Overall Study|Lost to Follow-up|4|||
125228698|NCT01204671|450465777|FG004|Overall Study|Lost to Follow-up|0|||
125228699|NCT01204671|450465773|FG000|Overall Study|Unknown Completion Status|1|||
125228700|NCT01204671|450465774|FG001|Overall Study|Unknown Completion Status|1|||
125228701|NCT01204671|450465775|FG002|Overall Study|Unknown Completion Status|0|||
125228702|NCT01204671|450465776|FG003|Overall Study|Unknown Completion Status|0|||
125228703|NCT01204671|450465777|FG004|Overall Study|Unknown Completion Status|0|||
125228704|NCT01204671|450465773|FG000|Overall Study|Physician Decision|0|||
125228705|NCT01204671|450465774|FG001|Overall Study|Physician Decision|0|||
125228706|NCT01204671|450465775|FG002|Overall Study|Physician Decision|0|||
125228707|NCT01204671|450465776|FG003|Overall Study|Physician Decision|1|||
125228708|NCT01204671|450465777|FG004|Overall Study|Physician Decision|0|||
125228709|NCT01316224|450465778|FG000|Overall Study|Protocol Violation|3|||
125228710|NCT01316224|450465778|FG000|Overall Study|Adverse Event|3|||
125228711|NCT01316224|450465778|FG000|Overall Study|Lack of Efficacy|1|||
125228712|NCT01316224|450465778|FG000|Overall Study|Withdrawal by Subject|1|||
125228713|NCT01316224|450465778|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
125228714|NCT01316224|450465778|FG000|Overall Study|Other|1|||
125228715|NCT00264147|450465779|FG000|Treatment I Period|Adverse Event|3|||
125228716|NCT00264147|450465780|FG001|Treatment I Period|Adverse Event|6|||
125228717|NCT00264147|450465781|FG002|Treatment I Period|Adverse Event|3|||
125228718|NCT00264147|450465782|FG003|Treatment I Period|Adverse Event|5|||
125228719|NCT00264147|450465783|FG004|Treatment I Period|Adverse Event|7|||
125228720|NCT00264147|450465784|FG005|Treatment I Period|Adverse Event|0|||
125228721|NCT00264147|450465779|FG000|Treatment I Period|Laboratory Adverse Event|0|||
125228722|NCT00264147|450465780|FG001|Treatment I Period|Laboratory Adverse Event|0|||
125228723|NCT00264147|450465781|FG002|Treatment I Period|Laboratory Adverse Event|0|||
125228724|NCT00264147|450465782|FG003|Treatment I Period|Laboratory Adverse Event|1|||
125228725|NCT00264147|450465783|FG004|Treatment I Period|Laboratory Adverse Event|0|||
125228726|NCT00264147|450465784|FG005|Treatment I Period|Laboratory Adverse Event|0|||
125228727|NCT00264147|450465779|FG000|Treatment I Period|Lack of Efficacy|6|||
125228728|NCT00264147|450465780|FG001|Treatment I Period|Lack of Efficacy|2|||
125228729|NCT00264147|450465781|FG002|Treatment I Period|Lack of Efficacy|8|||
125170549|NCT04614246|450247813|FG000|Overall Study|Other reason|0|||
125170550|NCT04614246|450247814|FG001|Overall Study|Other reason|1|||
125170551|NCT04614246|450247815|FG002|Overall Study|Other reason|2|||
125170552|NCT04614246|450247816|FG003|Overall Study|Other reason|0|||
125170553|NCT04614246|450247817|FG004|Overall Study|Other reason|0|||
125170554|NCT04614246|450247813|FG000|Overall Study|Withdrawal by Subject|4|||
125170555|NCT04614246|450247814|FG001|Overall Study|Withdrawal by Subject|2|||
125170556|NCT04614246|450247815|FG002|Overall Study|Withdrawal by Subject|4|||
125170557|NCT04614246|450247816|FG003|Overall Study|Withdrawal by Subject|3|||
125170558|NCT04614246|450247817|FG004|Overall Study|Withdrawal by Subject|4|||
125170559|NCT04614246|450247813|FG000|Overall Study|Physician Decision|0|||
125170560|NCT04614246|450247814|FG001|Overall Study|Physician Decision|2|||
125170561|NCT04614246|450247815|FG002|Overall Study|Physician Decision|1|||
125170562|NCT04614246|450247816|FG003|Overall Study|Physician Decision|0|||
125170563|NCT04614246|450247817|FG004|Overall Study|Physician Decision|0|||
125170564|NCT04614246|450247813|FG000|Overall Study|Study terminated by sponsor|10|||
125170565|NCT04614246|450247814|FG001|Overall Study|Study terminated by sponsor|15|||
125170566|NCT04614246|450247815|FG002|Overall Study|Study terminated by sponsor|12|||
125170567|NCT04614246|450247816|FG003|Overall Study|Study terminated by sponsor|13|||
125170568|NCT04614246|450247817|FG004|Overall Study|Study terminated by sponsor|9|||
125170569|NCT04614246|450247813|FG000|Overall Study|Pregnancy|2|||
125170570|NCT04614246|450247814|FG001|Overall Study|Pregnancy|0|||
125170571|NCT04614246|450247815|FG002|Overall Study|Pregnancy|1|||
125170572|NCT04614246|450247816|FG003|Overall Study|Pregnancy|0|||
125170573|NCT04614246|450247817|FG004|Overall Study|Pregnancy|0|||
125170574|NCT01680497|450247818|FG000|Overall Study|Lost to Follow-up|2|||
125170575|NCT00725205|450247819|FG000|Overall Study|Adverse Event|22|||
125170576|NCT00725205|450247819|FG000|Overall Study|Investigator Discontinued|1|||
125170577|NCT00725205|450247819|FG000|Overall Study|Non-compliance With Protocol|14|||
125170578|NCT00725205|450247819|FG000|Overall Study|Other|8|||
125170579|NCT00725205|450247819|FG000|Overall Study|Protocol Defined Clinical Event|1|||
125170580|NCT00725205|450247819|FG000|Overall Study|Treatment Failure|41|||
125170581|NCT00996892|450247821|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
125170582|NCT00996892|450247822|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
125170583|NCT00996892|450247823|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
125170584|NCT00996892|450247824|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
125170585|NCT00996892|450247825|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
125170586|NCT00996892|450247826|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
125170587|NCT00996892|450247827|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
125170588|NCT00996892|450247828|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
125228730|NCT00264147|450465782|FG003|Treatment I Period|Lack of Efficacy|0|||
125228731|NCT00264147|450465783|FG004|Treatment I Period|Lack of Efficacy|1|||
125228732|NCT00264147|450465784|FG005|Treatment I Period|Lack of Efficacy|0|||
125228733|NCT00264147|450465779|FG000|Treatment I Period|Lost to Follow-up|1|||
125228734|NCT00264147|450465780|FG001|Treatment I Period|Lost to Follow-up|0|||
125228735|NCT00264147|450465781|FG002|Treatment I Period|Lost to Follow-up|0|||
125228736|NCT00264147|450465782|FG003|Treatment I Period|Lost to Follow-up|1|||
125228737|NCT00264147|450465783|FG004|Treatment I Period|Lost to Follow-up|1|||
125228738|NCT00264147|450465784|FG005|Treatment I Period|Lost to Follow-up|0|||
125228739|NCT00264147|450465779|FG000|Treatment I Period|Protocol Violation|2|||
125228740|NCT00264147|450465780|FG001|Treatment I Period|Protocol Violation|2|||
125228741|NCT00264147|450465781|FG002|Treatment I Period|Protocol Violation|0|||
125228742|NCT00264147|450465782|FG003|Treatment I Period|Protocol Violation|0|||
125228743|NCT00264147|450465783|FG004|Treatment I Period|Protocol Violation|0|||
125228744|NCT00264147|450465784|FG005|Treatment I Period|Protocol Violation|0|||
125228745|NCT00264147|450465779|FG000|Treatment I Period|Withdrawal by Subject|2|||
125228746|NCT00264147|450465780|FG001|Treatment I Period|Withdrawal by Subject|0|||
125228747|NCT00264147|450465781|FG002|Treatment I Period|Withdrawal by Subject|0|||
125228748|NCT00264147|450465782|FG003|Treatment I Period|Withdrawal by Subject|2|||
125228749|NCT00264147|450465783|FG004|Treatment I Period|Withdrawal by Subject|2|||
125228750|NCT00264147|450465784|FG005|Treatment I Period|Withdrawal by Subject|0|||
125228751|NCT00264147|450465779|FG000|Treatment I Period|Patient out of town for an extended time|0|||
125228752|NCT00264147|450465780|FG001|Treatment I Period|Patient out of town for an extended time|1|||
125228753|NCT00264147|450465781|FG002|Treatment I Period|Patient out of town for an extended time|0|||
125228754|NCT00264147|450465782|FG003|Treatment I Period|Patient out of town for an extended time|0|||
125228755|NCT00264147|450465783|FG004|Treatment I Period|Patient out of town for an extended time|0|||
125228756|NCT00264147|450465784|FG005|Treatment I Period|Patient out of town for an extended time|0|||
125170589|NCT00996892|450247829|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
125170590|NCT00996892|450247830|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
125170591|NCT00996892|450247831|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
125170592|NCT00996892|450247832|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
125170593|NCT00996892|450247833|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
125170594|NCT00996892|450247834|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
125170595|NCT00996892|450247835|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
125170596|NCT00996892|450247836|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
125228757|NCT00264147|450465779|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
125228758|NCT00264147|450465780|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
125228759|NCT00264147|450465781|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
125228760|NCT00264147|450465782|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
125228761|NCT00264147|450465783|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
125228762|NCT00264147|450465784|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
125228763|NCT00264147|450465779|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
125228764|NCT00264147|450465780|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
125228765|NCT00264147|450465781|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
125228766|NCT00264147|450465782|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
125228767|NCT00264147|450465783|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
125228768|NCT00264147|450465784|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
125228769|NCT00264147|450465779|FG000|Treatment II Period|Adverse Event|0|||
125228770|NCT00264147|450465780|FG001|Treatment II Period|Adverse Event|0|||
125228771|NCT00264147|450465781|FG002|Treatment II Period|Adverse Event|0|||
125228772|NCT00264147|450465782|FG003|Treatment II Period|Adverse Event|0|||
125228773|NCT00264147|450465783|FG004|Treatment II Period|Adverse Event|9|||
125228774|NCT00264147|450465784|FG005|Treatment II Period|Adverse Event|9|||
125228775|NCT00264147|450465779|FG000|Treatment II Period|Laboratory Adverse Event|0|||
125228776|NCT00264147|450465780|FG001|Treatment II Period|Laboratory Adverse Event|0|||
125228777|NCT00264147|450465781|FG002|Treatment II Period|Laboratory Adverse Event|0|||
125228778|NCT00264147|450465782|FG003|Treatment II Period|Laboratory Adverse Event|0|||
125228779|NCT00264147|450465783|FG004|Treatment II Period|Laboratory Adverse Event|0|||
125228780|NCT00264147|450465784|FG005|Treatment II Period|Laboratory Adverse Event|1|||
125228781|NCT00264147|450465779|FG000|Treatment II Period|Lack of Efficacy|0|||
125228782|NCT00264147|450465780|FG001|Treatment II Period|Lack of Efficacy|0|||
125228783|NCT00264147|450465781|FG002|Treatment II Period|Lack of Efficacy|0|||
125228784|NCT00264147|450465782|FG003|Treatment II Period|Lack of Efficacy|0|||
125228785|NCT00264147|450465783|FG004|Treatment II Period|Lack of Efficacy|20|||
125228786|NCT00264147|450465784|FG005|Treatment II Period|Lack of Efficacy|19|||
125228787|NCT00264147|450465779|FG000|Treatment II Period|Lost to Follow-up|0|||
125228788|NCT00264147|450465780|FG001|Treatment II Period|Lost to Follow-up|0|||
125228789|NCT00264147|450465781|FG002|Treatment II Period|Lost to Follow-up|0|||
125228790|NCT00264147|450465782|FG003|Treatment II Period|Lost to Follow-up|0|||
125228791|NCT00264147|450465783|FG004|Treatment II Period|Lost to Follow-up|1|||
125228792|NCT00264147|450465784|FG005|Treatment II Period|Lost to Follow-up|1|||
125228793|NCT00264147|450465779|FG000|Treatment II Period|Withdrawal by Subject|0|||
125228794|NCT00264147|450465780|FG001|Treatment II Period|Withdrawal by Subject|0|||
125228795|NCT00264147|450465781|FG002|Treatment II Period|Withdrawal by Subject|0|||
125228796|NCT00264147|450465782|FG003|Treatment II Period|Withdrawal by Subject|0|||
125228797|NCT00264147|450465783|FG004|Treatment II Period|Withdrawal by Subject|3|||
125228798|NCT00264147|450465784|FG005|Treatment II Period|Withdrawal by Subject|2|||
125228799|NCT00264147|450465779|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
125228800|NCT00264147|450465780|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
125228801|NCT00264147|450465781|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
125228802|NCT00264147|450465782|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
125228803|NCT00264147|450465783|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
125228804|NCT00264147|450465784|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
125228805|NCT03234465|450465785|FG000|Overall Study|Adverse Event|4|||
125228806|NCT03234465|450465786|FG001|Overall Study|Adverse Event|2|||
125228807|NCT03234465|450465785|FG000|Overall Study|Death|0|||
125228808|NCT03234465|450465786|FG001|Overall Study|Death|1|||
125228809|NCT03234465|450465785|FG000|Overall Study|Lost to Follow-up|1|||
125228810|NCT03234465|450465786|FG001|Overall Study|Lost to Follow-up|1|||
125228811|NCT03234465|450465785|FG000|Overall Study|Withdrawal by Subject|12|||
125228812|NCT03234465|450465786|FG001|Overall Study|Withdrawal by Subject|27|||
125228813|NCT03234465|450465785|FG000|Overall Study|Symptomatic deterioration|0|||
125228814|NCT03234465|450465786|FG001|Overall Study|Symptomatic deterioration|1|||
125228815|NCT03234465|450465785|FG000|Overall Study|Non-compliance|2|||
125228816|NCT03234465|450465786|FG001|Overall Study|Non-compliance|0|||
125228817|NCT03234465|450465785|FG000|Overall Study|Other|14|||
125228818|NCT03234465|450465786|FG001|Overall Study|Other|8|||
125228819|NCT03106077|450465787|FG000|Overall Study|Screen Failure|94|||
125228820|NCT03106077|450465788|FG001|Overall Study|Screen Failure|0|||
125228821|NCT01274533|450465791|FG000|Overall Study|Withdrawal by Subject|1|||
125228822|NCT01274533|450465791|FG000|Overall Study|Non-compliance|1|||
125228823|NCT01274533|450465791|FG000|Overall Study|Disease progression|2|||
125228824|NCT02008526|450465793|FG000|Overall Study|Death|0|||
125228825|NCT02008526|450465794|FG001|Overall Study|Death|2|||
125228826|NCT02008526|450465795|FG002|Overall Study|Death|1|||
125228827|NCT02008526|450465793|FG000|Overall Study|Withdrawal by Subject|3|||
125228828|NCT02008526|450465794|FG001|Overall Study|Withdrawal by Subject|3|||
125228829|NCT02008526|450465795|FG002|Overall Study|Withdrawal by Subject|2|||
125228830|NCT02008526|450465793|FG000|Overall Study|Lost to Follow-up|5|||
125170597|NCT00996892|450247837|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
125170598|NCT00996892|450247838|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
125170599|NCT00996892|450247839|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
125170600|NCT00996892|450247840|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
125170601|NCT00996892|450247821|FG000|Dose-Escalation Stage 1|Death|1|||
125170602|NCT00996892|450247822|FG001|Dose-Escalation Stage 1|Death|0|||
125170603|NCT00996892|450247823|FG002|Dose-Escalation Stage 1|Death|0|||
125170604|NCT00996892|450247824|FG003|Dose-Escalation Stage 1|Death|0|||
125170605|NCT00996892|450247825|FG004|Dose-Escalation Stage 1|Death|0|||
125170606|NCT00996892|450247826|FG005|Dose-Escalation Stage 1|Death|1|||
125170607|NCT00996892|450247827|FG006|Dose-Escalation Stage 1|Death|0|||
125170608|NCT00996892|450247828|FG007|Dose-Escalation Stage 1|Death|0|||
125170609|NCT00996892|450247829|FG008|Dose-Escalation Stage 1|Death|0|||
125170610|NCT00996892|450247830|FG009|Dose-Escalation Stage 1|Death|0|||
125170611|NCT00996892|450247831|FG010|Dose-Escalation Stage 1|Death|0|||
125170612|NCT00996892|450247832|FG011|Dose-Escalation Stage 1|Death|0|||
125170613|NCT00996892|450247833|FG012|Dose-Escalation Stage 1|Death|0|||
125170614|NCT00996892|450247834|FG013|Dose-Escalation Stage 1|Death|0|||
125170615|NCT00996892|450247835|FG014|Dose-Escalation Stage 1|Death|0|||
125170616|NCT00996892|450247836|FG015|Dose-Escalation Stage 1|Death|0|||
125170617|NCT00996892|450247837|FG016|Dose-Escalation Stage 1|Death|0|||
125170618|NCT00996892|450247838|FG017|Dose-Escalation Stage 1|Death|0|||
125170619|NCT00996892|450247839|FG018|Dose-Escalation Stage 1|Death|0|||
125170620|NCT00996892|450247840|FG019|Dose-Escalation Stage 1|Death|0|||
125170621|NCT00996892|450247821|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
125170622|NCT00996892|450247822|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
125170623|NCT00996892|450247823|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
125170624|NCT00996892|450247824|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
125170625|NCT00996892|450247825|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
125170626|NCT00996892|450247826|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
125170627|NCT00996892|450247827|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
125170628|NCT00996892|450247828|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
125170629|NCT00996892|450247829|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
125170630|NCT00996892|450247830|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
125170631|NCT00996892|450247831|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
125170632|NCT00996892|450247832|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
125170633|NCT00996892|450247833|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
125170634|NCT00996892|450247834|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
125170635|NCT00996892|450247835|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
125170636|NCT00996892|450247836|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
125170637|NCT00996892|450247837|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
125170638|NCT00996892|450247838|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
125170639|NCT00996892|450247839|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
125170640|NCT00996892|450247840|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
125170641|NCT00996892|450247821|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170642|NCT00996892|450247822|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
125170643|NCT00996892|450247823|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170644|NCT00996892|450247824|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
125170645|NCT00996892|450247825|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
125170646|NCT00996892|450247826|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
125170647|NCT00996892|450247827|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
125170648|NCT00996892|450247828|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170649|NCT00996892|450247829|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170650|NCT00996892|450247830|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170651|NCT00996892|450247831|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170652|NCT00996892|450247832|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170653|NCT00996892|450247833|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170654|NCT00996892|450247834|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170655|NCT00996892|450247835|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170656|NCT00996892|450247836|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170657|NCT00996892|450247837|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170658|NCT00996892|450247838|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170659|NCT00996892|450247839|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170660|NCT00996892|450247840|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170661|NCT00996892|450247821|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
125170662|NCT00996892|450247822|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
125170663|NCT00996892|450247823|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
125170664|NCT00996892|450247824|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
125170665|NCT00996892|450247825|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
125170666|NCT00996892|450247826|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
125170667|NCT00996892|450247827|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
125170668|NCT00996892|450247828|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
125170669|NCT00996892|450247829|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
125228831|NCT02008526|450465794|FG001|Overall Study|Lost to Follow-up|9|||
125170670|NCT00996892|450247830|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
125170671|NCT00996892|450247831|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
125170672|NCT00996892|450247832|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
125170673|NCT00996892|450247833|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
125170674|NCT00996892|450247834|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
125170675|NCT00996892|450247835|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
125170676|NCT00996892|450247836|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
125170677|NCT00996892|450247837|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
125170678|NCT00996892|450247838|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
125170679|NCT00996892|450247839|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
125170680|NCT00996892|450247840|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
125170681|NCT00996892|450247821|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
125170682|NCT00996892|450247822|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
125170683|NCT00996892|450247823|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
125170684|NCT00996892|450247824|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
125170685|NCT00996892|450247825|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
125170686|NCT00996892|450247826|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
125170687|NCT00996892|450247827|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
125170688|NCT00996892|450247828|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
125170689|NCT00996892|450247829|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
125170690|NCT00996892|450247830|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
125170691|NCT00996892|450247831|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
125170692|NCT00996892|450247832|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
125170693|NCT00996892|450247833|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
125170694|NCT00996892|450247834|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
125170695|NCT00996892|450247835|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
125170696|NCT00996892|450247836|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
125170697|NCT00996892|450247837|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
125170698|NCT00996892|450247838|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
125170699|NCT00996892|450247839|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
125170700|NCT00996892|450247840|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
125170701|NCT00996892|450247821|FG000|Dose-Escalation Stage 1A|Death|0|||
125170702|NCT00996892|450247822|FG001|Dose-Escalation Stage 1A|Death|0|||
125170703|NCT00996892|450247823|FG002|Dose-Escalation Stage 1A|Death|0|||
125170704|NCT00996892|450247824|FG003|Dose-Escalation Stage 1A|Death|0|||
125170705|NCT00996892|450247825|FG004|Dose-Escalation Stage 1A|Death|0|||
125170706|NCT00996892|450247826|FG005|Dose-Escalation Stage 1A|Death|0|||
125170707|NCT00996892|450247827|FG006|Dose-Escalation Stage 1A|Death|0|||
125170708|NCT00996892|450247828|FG007|Dose-Escalation Stage 1A|Death|0|||
125170709|NCT00996892|450247829|FG008|Dose-Escalation Stage 1A|Death|0|||
125170710|NCT00996892|450247830|FG009|Dose-Escalation Stage 1A|Death|2|||
125170711|NCT00996892|450247831|FG010|Dose-Escalation Stage 1A|Death|0|||
125170712|NCT00996892|450247832|FG011|Dose-Escalation Stage 1A|Death|1|||
125170713|NCT00996892|450247833|FG012|Dose-Escalation Stage 1A|Death|1|||
125170714|NCT00996892|450247834|FG013|Dose-Escalation Stage 1A|Death|0|||
125170715|NCT00996892|450247835|FG014|Dose-Escalation Stage 1A|Death|0|||
125170716|NCT00996892|450247836|FG015|Dose-Escalation Stage 1A|Death|0|||
125170717|NCT00996892|450247837|FG016|Dose-Escalation Stage 1A|Death|0|||
125170718|NCT00996892|450247838|FG017|Dose-Escalation Stage 1A|Death|0|||
125170719|NCT00996892|450247839|FG018|Dose-Escalation Stage 1A|Death|0|||
125170720|NCT00996892|450247840|FG019|Dose-Escalation Stage 1A|Death|0|||
125170721|NCT00996892|450247821|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
125170722|NCT00996892|450247822|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
125170723|NCT00996892|450247823|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
125170724|NCT00996892|450247824|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
125170725|NCT00996892|450247825|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
125170726|NCT00996892|450247826|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
125170727|NCT00996892|450247827|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
125170728|NCT00996892|450247828|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
125170729|NCT00996892|450247829|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
125170730|NCT00996892|450247830|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
125170731|NCT00996892|450247831|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
125170732|NCT00996892|450247832|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
125170733|NCT00996892|450247833|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
125170734|NCT00996892|450247834|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
125170735|NCT00996892|450247835|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
125170736|NCT00996892|450247836|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
125170737|NCT00996892|450247837|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
125170738|NCT00996892|450247838|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
125170739|NCT00996892|450247839|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
125170740|NCT00996892|450247840|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
125170741|NCT00996892|450247821|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170742|NCT00996892|450247822|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125228832|NCT02008526|450465795|FG002|Overall Study|Lost to Follow-up|6|||
125228833|NCT01118052|450465796|FG000|Overall Study|Never treated|2|||
125228834|NCT02949947|450465797|FG000|Overall Study|Non Compliance|0|||
125228835|NCT02949947|450465798|FG001|Overall Study|Non Compliance|1|||
125228836|NCT02949947|450465797|FG000|Overall Study|Insurance change|1|||
125228837|NCT02949947|450465798|FG001|Overall Study|Insurance change|0|||
125228838|NCT00492726|450465800|FG000|Overall Study|Adverse Event|10|||
125228839|NCT00492726|450465801|FG001|Overall Study|Adverse Event|6|||
125228840|NCT00492726|450465800|FG000|Overall Study|Death|7|||
125228841|NCT00492726|450465801|FG001|Overall Study|Death|2|||
125228842|NCT00492726|450465800|FG000|Overall Study|Lack of Efficacy|0|||
125228843|NCT00492726|450465801|FG001|Overall Study|Lack of Efficacy|2|||
125228844|NCT00492726|450465800|FG000|Overall Study|Lost to Follow-up|27|||
125228845|NCT00492726|450465801|FG001|Overall Study|Lost to Follow-up|19|||
125228846|NCT00492726|450465800|FG000|Overall Study|Physician Decision|0|||
125228847|NCT00492726|450465801|FG001|Overall Study|Physician Decision|1|||
125228848|NCT00492726|450465800|FG000|Overall Study|Withdrawal by Subject|6|||
125228849|NCT00492726|450465801|FG001|Overall Study|Withdrawal by Subject|3|||
125228850|NCT00492726|450465800|FG000|Overall Study|Non compliant with study medication|0|||
125228851|NCT00492726|450465801|FG001|Overall Study|Non compliant with study medication|3|||
125228852|NCT02230891|450465802|FG000|Baseline|Did not meet inclusion|0|||
125228853|NCT02230891|450465803|FG001|Baseline|Did not meet inclusion|1|||
125228854|NCT02230891|450465804|FG002|Baseline|Did not meet inclusion|1|||
125228855|NCT02230891|450465802|FG000|2 Week|Withdrawal by Subject|2|||
125228856|NCT02230891|450465803|FG001|2 Week|Withdrawal by Subject|2|||
125228857|NCT02230891|450465804|FG002|2 Week|Withdrawal by Subject|0|||
125228858|NCT02230891|450465802|FG000|2 Week|Consent withdrawn|1|||
125228859|NCT02230891|450465803|FG001|2 Week|Consent withdrawn|0|||
125228860|NCT02230891|450465804|FG002|2 Week|Consent withdrawn|0|||
125228861|NCT02230891|450465802|FG000|6 Month|Withdrawal by Subject|1|||
125228862|NCT02230891|450465803|FG001|6 Month|Withdrawal by Subject|1|||
125228863|NCT02230891|450465804|FG002|6 Month|Withdrawal by Subject|1|||
125228864|NCT02230891|450465802|FG000|6 Month|Physician Decision|0|||
125228865|NCT02230891|450465803|FG001|6 Month|Physician Decision|2|||
125228866|NCT02230891|450465804|FG002|6 Month|Physician Decision|0|||
125228867|NCT02230891|450465802|FG000|12 Month|Death|1|||
125228868|NCT02230891|450465803|FG001|12 Month|Death|0|||
125228869|NCT02230891|450465804|FG002|12 Month|Death|0|||
125228870|NCT02230891|450465802|FG000|12 Month|Lost to Follow-up|0|||
125228871|NCT02230891|450465803|FG001|12 Month|Lost to Follow-up|1|||
125228872|NCT02230891|450465804|FG002|12 Month|Lost to Follow-up|0|||
125228873|NCT02230891|450465802|FG000|12 Month|Withdrawal by Subject|0|||
125228874|NCT02230891|450465803|FG001|12 Month|Withdrawal by Subject|2|||
125228875|NCT02230891|450465804|FG002|12 Month|Withdrawal by Subject|0|||
125228876|NCT02230891|450465802|FG000|18 Month End of Study|Death|0|||
125228877|NCT02230891|450465803|FG001|18 Month End of Study|Death|0|||
125228878|NCT02230891|450465804|FG002|18 Month End of Study|Death|1|||
125228879|NCT02230891|450465802|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
125228880|NCT02230891|450465803|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
125228881|NCT02230891|450465804|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
125228882|NCT02404545|450465805|FG000|Overall Study|Sponsor Termination|6|||
125228883|NCT02404545|450465806|FG001|Overall Study|Sponsor Termination|6|||
125228884|NCT03141359|450465815|FG000|Overall Study|Death|32|||
125228885|NCT03141359|450465815|FG000|Overall Study|Still On Study (in follow up)|29|||
125228886|NCT01081626|450465816|FG000|Overall Study|Dosing error|1|||
125228887|NCT01081626|450465817|FG001|Overall Study|Dosing error|1|||
125228888|NCT01081626|450465816|FG000|Overall Study|Missing Estradiol|25|||
125228889|NCT01081626|450465817|FG001|Overall Study|Missing Estradiol|28|||
125228890|NCT01081626|450465816|FG000|Overall Study|Low antral follicle count|1|||
125228891|NCT01081626|450465817|FG001|Overall Study|Low antral follicle count|0|||
125228892|NCT01081626|450465816|FG000|Overall Study|Overstimulation|0|||
125228893|NCT01081626|450465817|FG001|Overall Study|Overstimulation|1|||
125228894|NCT01081626|450465816|FG000|Overall Study|Lost to Follow-up|0|||
125228895|NCT01081626|450465817|FG001|Overall Study|Lost to Follow-up|1|||
125228896|NCT01081626|450465816|FG000|Overall Study|Other|33|||
125228897|NCT01081626|450465817|FG001|Overall Study|Other|30|||
125228898|NCT00870727|450467870|FG000|Overall Study|Lost to Follow-up|0|||
125228899|NCT00870727|450467871|FG001|Overall Study|Lost to Follow-up|1|||
125228900|NCT00870727|450467870|FG000|Overall Study|Lack of Efficacy|1|||
125228901|NCT00870727|450467871|FG001|Overall Study|Lack of Efficacy|3|||
125228902|NCT00870727|450467870|FG000|Overall Study|Adverse Event|0|||
125228903|NCT00870727|450467871|FG001|Overall Study|Adverse Event|1|||
125228904|NCT00720278|450467872|FG000|Overall Study|Adverse Event|5|||
125228905|NCT00720278|450467873|FG001|Overall Study|Adverse Event|3|||
125228906|NCT00720278|450467874|FG002|Overall Study|Adverse Event|4|||
125228907|NCT00720278|450467872|FG000|Overall Study|Withdrawal by Subject|0|||
125228908|NCT00720278|450467873|FG001|Overall Study|Withdrawal by Subject|1|||
125228909|NCT00720278|450467874|FG002|Overall Study|Withdrawal by Subject|0|||
125228910|NCT00720278|450467872|FG000|Overall Study|Lost to Follow-up|0|||
125228911|NCT00720278|450467873|FG001|Overall Study|Lost to Follow-up|0|||
125228912|NCT00720278|450467874|FG002|Overall Study|Lost to Follow-up|1|||
125228913|NCT00720278|450467872|FG000|Overall Study|Non-compliance|1|||
125228914|NCT00720278|450467873|FG001|Overall Study|Non-compliance|0|||
125228915|NCT00720278|450467874|FG002|Overall Study|Non-compliance|0|||
125228916|NCT00720278|450467872|FG000|Overall Study|eligibility criteria violation|1|||
125228917|NCT00720278|450467873|FG001|Overall Study|eligibility criteria violation|0|||
125228918|NCT00720278|450467874|FG002|Overall Study|eligibility criteria violation|1|||
125228919|NCT01712516|450467875|FG000|Overall Study|Technical problems|0|||
125228920|NCT01712516|450467876|FG001|Overall Study|Technical problems|0|||
125228921|NCT01712516|450467877|FG002|Overall Study|Technical problems|0|||
125228922|NCT01712516|450467878|FG003|Overall Study|Technical problems|2|||
125228923|NCT01712516|450467875|FG000|Overall Study|Lost to Follow-up|0|||
125228924|NCT01712516|450467876|FG001|Overall Study|Lost to Follow-up|0|||
125228925|NCT01712516|450467877|FG002|Overall Study|Lost to Follow-up|2|||
125228926|NCT01712516|450467878|FG003|Overall Study|Lost to Follow-up|1|||
125228927|NCT01712516|450467875|FG000|Overall Study|Death|0|||
125228928|NCT01712516|450467876|FG001|Overall Study|Death|1|||
125228929|NCT01712516|450467877|FG002|Overall Study|Death|0|||
125228930|NCT01712516|450467878|FG003|Overall Study|Death|0|||
125228931|NCT01712516|450467875|FG000|Overall Study|Protocol deviation|1|||
125228932|NCT01712516|450467876|FG001|Overall Study|Protocol deviation|0|||
125228933|NCT01712516|450467877|FG002|Overall Study|Protocol deviation|1|||
125228934|NCT01712516|450467878|FG003|Overall Study|Protocol deviation|0|||
125228935|NCT01712516|450467875|FG000|Overall Study|Physician Decision|2|||
125228936|NCT01712516|450467876|FG001|Overall Study|Physician Decision|0|||
125228937|NCT01712516|450467877|FG002|Overall Study|Physician Decision|0|||
125228938|NCT01712516|450467878|FG003|Overall Study|Physician Decision|1|||
125228939|NCT01712516|450467875|FG000|Overall Study|Withdrawal by Subject|3|||
125228940|NCT01712516|450467876|FG001|Overall Study|Withdrawal by Subject|9|||
125228941|NCT01712516|450467877|FG002|Overall Study|Withdrawal by Subject|3|||
125228942|NCT01712516|450467878|FG003|Overall Study|Withdrawal by Subject|9|||
125228943|NCT01181167|450467882|FG000|Overall Study|Adverse Event|11|||
125170743|NCT00996892|450247823|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170744|NCT00996892|450247824|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170745|NCT00996892|450247825|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170746|NCT00996892|450247826|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170747|NCT00996892|450247827|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170748|NCT00996892|450247828|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170749|NCT00996892|450247829|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170750|NCT00996892|450247830|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
125170751|NCT00996892|450247831|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
125170752|NCT00996892|450247832|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
125170753|NCT00996892|450247833|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
125170754|NCT00996892|450247834|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125228944|NCT01181167|450467883|FG001|Overall Study|Adverse Event|21|||
125228945|NCT01181167|450467882|FG000|Overall Study|Lost to Follow-up|1|||
125228946|NCT01181167|450467883|FG001|Overall Study|Lost to Follow-up|0|||
125228947|NCT01181167|450467882|FG000|Overall Study|Physician Decision|2|||
125228948|NCT01181167|450467883|FG001|Overall Study|Physician Decision|3|||
125228949|NCT01181167|450467882|FG000|Overall Study|Protocol Violation|3|||
125228950|NCT01181167|450467883|FG001|Overall Study|Protocol Violation|0|||
125228951|NCT01181167|450467882|FG000|Overall Study|Withdrawal by Subject|6|||
125228952|NCT01181167|450467883|FG001|Overall Study|Withdrawal by Subject|8|||
125228953|NCT00161213|450467884|FG000|Overall Study|Withdrawal by Subject|1|||
125228954|NCT00161213|450467884|FG000|Overall Study|Evaluable for toxicity but not response|1|||
125228955|NCT03103503|450467885|FG000|Overall Study|Death|64|||
125228956|NCT03103503|450467885|FG000|Overall Study|Physician Decision|57|||
125228957|NCT03103503|450467885|FG000|Overall Study|Withdrawal by Subject|10|||
125228958|NCT03103503|450467885|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
125228959|NCT03103503|450467885|FG000|Overall Study|Lost to Follow-up|3|||
125228960|NCT03103503|450467885|FG000|Overall Study|Study Closure|757|||
125170755|NCT00996892|450247835|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125228961|NCT01384877|450467886|FG000|Treatment 2|Lost to Follow-up|2|||
125228962|NCT01384877|450467887|FG001|Treatment 2|Lost to Follow-up|2|||
125228963|NCT03630393|450467888|FG000|Overall Study|Death|1|||
125170756|NCT00996892|450247836|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125228964|NCT03630393|450467889|FG001|Overall Study|Death|0|||
125228965|NCT00408499|450467890|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
125228966|NCT00408499|450467891|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
125228967|NCT00408499|450467892|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
125228968|NCT00408499|450467893|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
125228969|NCT00408499|450467894|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
125228970|NCT00408499|450467890|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
125170757|NCT00996892|450247837|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170758|NCT00996892|450247838|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170759|NCT00996892|450247839|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125228971|NCT00408499|450467891|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
125228972|NCT00408499|450467892|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
125228973|NCT00408499|450467893|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
125228974|NCT00408499|450467894|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
125228975|NCT00408499|450467890|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
125228976|NCT00408499|450467891|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
125228977|NCT00408499|450467892|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
125228978|NCT00408499|450467893|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
125228979|NCT00408499|450467894|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
125228980|NCT00408499|450467890|FG000|Phase II- MTD Expansion|Adverse Event|0|||
125228981|NCT00408499|450467891|FG001|Phase II- MTD Expansion|Adverse Event|0|||
125228982|NCT00408499|450467892|FG002|Phase II- MTD Expansion|Adverse Event|0|||
125228983|NCT00408499|450467893|FG003|Phase II- MTD Expansion|Adverse Event|0|||
125228984|NCT00408499|450467894|FG004|Phase II- MTD Expansion|Adverse Event|9|||
125228985|NCT00408499|450467890|FG000|Phase II- MTD Expansion|Death|0|||
125228986|NCT00408499|450467891|FG001|Phase II- MTD Expansion|Death|0|||
125228987|NCT00408499|450467892|FG002|Phase II- MTD Expansion|Death|0|||
125228988|NCT00408499|450467893|FG003|Phase II- MTD Expansion|Death|0|||
125228989|NCT00408499|450467894|FG004|Phase II- MTD Expansion|Death|2|||
125228990|NCT00408499|450467890|FG000|Phase II- MTD Expansion|Physician Decision|0|||
125228991|NCT00408499|450467891|FG001|Phase II- MTD Expansion|Physician Decision|0|||
125228992|NCT00408499|450467892|FG002|Phase II- MTD Expansion|Physician Decision|0|||
125228993|NCT00408499|450467893|FG003|Phase II- MTD Expansion|Physician Decision|0|||
125228994|NCT00408499|450467894|FG004|Phase II- MTD Expansion|Physician Decision|1|||
125228995|NCT00408499|450467890|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
125228996|NCT00408499|450467891|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
125228997|NCT00408499|450467892|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
125228998|NCT00408499|450467893|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
125228999|NCT00408499|450467894|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
125229000|NCT00408499|450467890|FG000|Phase II- MTD Expansion|treatment delay|0|||
125229001|NCT00408499|450467891|FG001|Phase II- MTD Expansion|treatment delay|0|||
125229002|NCT00408499|450467892|FG002|Phase II- MTD Expansion|treatment delay|0|||
125229003|NCT00408499|450467893|FG003|Phase II- MTD Expansion|treatment delay|0|||
125229004|NCT00408499|450467894|FG004|Phase II- MTD Expansion|treatment delay|3|||
125229005|NCT01586195|450467898|FG000|Overall Study|Death|11|||
125229006|NCT01586195|450467898|FG000|Overall Study|Withdrawal of Consent|5|||
125229007|NCT01586195|450467898|FG000|Overall Study|Started new anti-melanoma therapy|1|||
125229008|NCT01586195|450467898|FG000|Overall Study|Reason not specified|9|||
125229009|NCT00997334|450467899|FG000|Overall Study|still on therapy|12|||
125229010|NCT00997334|450467899|FG000|Overall Study|Adverse Event|3|||
125229011|NCT00997334|450467899|FG000|Overall Study|Patient non-compliance|1|||
125229012|NCT00997334|450467899|FG000|Overall Study|Withdrawal by Subject|3|||
125229013|NCT00997334|450467899|FG000|Overall Study|Death|2|||
125229014|NCT00997334|450467899|FG000|Overall Study|Urgent Palliative Care|2|||
125229015|NCT00997334|450467899|FG000|Overall Study|No lesion amenable|1|||
125229016|NCT00997334|450467899|FG000|Overall Study|Ineligible|1|||
125229017|NCT02683109|450467901|FG000|Overall Study|Adverse Event|1|||
125229018|NCT02683109|450467902|FG001|Overall Study|Adverse Event|0|||
125170760|NCT00996892|450247840|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170761|NCT00996892|450247821|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
125170762|NCT00996892|450247822|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
125170763|NCT00996892|450247823|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
125170764|NCT00996892|450247824|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
125170765|NCT00996892|450247825|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
125170766|NCT00996892|450247826|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
125170767|NCT00996892|450247827|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
125170768|NCT00996892|450247828|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
125170769|NCT00996892|450247829|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
125170770|NCT00996892|450247830|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
125170771|NCT00996892|450247831|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
125170772|NCT00996892|450247832|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
125170773|NCT00996892|450247833|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
125170774|NCT00996892|450247834|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
125170775|NCT00996892|450247835|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
125170776|NCT00996892|450247836|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
125170777|NCT00996892|450247837|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
125170778|NCT00996892|450247838|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
125170779|NCT00996892|450247839|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
125170780|NCT00996892|450247840|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
125170781|NCT00996892|450247821|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
125170782|NCT00996892|450247822|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
125170783|NCT00996892|450247823|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
125170784|NCT00996892|450247824|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
125170785|NCT00996892|450247825|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
125170786|NCT00996892|450247826|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
125229019|NCT00183430|450467903|FG000|Overall Study|Adverse Event|1|||
125229020|NCT00183430|450467904|FG001|Overall Study|Adverse Event|0|||
125229021|NCT00183430|450467903|FG000|Overall Study|Lost to Follow-up|3|||
125229022|NCT00183430|450467904|FG001|Overall Study|Lost to Follow-up|0|||
125229023|NCT00183430|450467903|FG000|Overall Study|did not meet inclusion criteria|1|||
125229024|NCT00183430|450467904|FG001|Overall Study|did not meet inclusion criteria|0|||
125229025|NCT00183430|450467903|FG000|Overall Study|Withdrawal by Subject|1|||
125170787|NCT00996892|450247827|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
125170788|NCT00996892|450247828|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
125229026|NCT00183430|450467904|FG001|Overall Study|Withdrawal by Subject|0|||
125229027|NCT00883181|450467905|FG000|Overall Study|Hematological Adverse Event|26|||
125229028|NCT00883181|450467905|FG000|Overall Study|Non-hematological Adverse Event|55|||
125229029|NCT00883181|450467905|FG000|Overall Study|Disease Progression|94|||
125229030|NCT00883181|450467905|FG000|Overall Study|Administrative Reason|24|||
125229031|NCT00883181|450467905|FG000|Overall Study|Withdrawal by Subject|4|||
125229032|NCT00883181|450467905|FG000|Overall Study|Death|31|||
125229033|NCT00883181|450467905|FG000|Overall Study|Other|38|||
125229034|NCT00883181|450467905|FG000|Overall Study|Protocol Deviation|3|||
125229035|NCT00883181|450467905|FG000|Overall Study|Noncompliance|3|||
125229036|NCT00426270|450467910|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
125229037|NCT00426270|450467910|FG000|Overall Study|Adverse Event|5|||
125229038|NCT01450813|450467911|FG000|Overall Study|Physician Decision|1|||
125229039|NCT01450813|450467912|FG001|Overall Study|Physician Decision|1|||
125229040|NCT01450813|450467913|FG002|Overall Study|Physician Decision|0|||
125229041|NCT01450813|450467914|FG003|Overall Study|Physician Decision|3|||
125229042|NCT02709746|450467915|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
125229043|NCT02709746|450467916|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
125229044|NCT02709746|450467917|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
125229045|NCT02709746|450467918|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
125229046|NCT02709746|450467919|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
125229047|NCT02709746|450467915|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
125229048|NCT02709746|450467916|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
125229049|NCT02709746|450467917|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
125229050|NCT02709746|450467918|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
125229051|NCT02709746|450467919|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
125229052|NCT02709746|450467915|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
125229053|NCT02709746|450467916|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
125229054|NCT02709746|450467917|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
125229055|NCT02709746|450467918|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
125229056|NCT02709746|450467919|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
125229057|NCT02709746|450467915|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
125229058|NCT02709746|450467916|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
125229059|NCT02709746|450467917|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
125229060|NCT02709746|450467918|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
125229061|NCT02709746|450467919|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
125229062|NCT02709746|450467915|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
125229063|NCT02709746|450467916|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
125229064|NCT02709746|450467917|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
125229065|NCT02709746|450467918|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
125229066|NCT02709746|450467919|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
125229067|NCT02709746|450467915|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
125170789|NCT00996892|450247829|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
125170790|NCT00996892|450247830|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
125170791|NCT00996892|450247831|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
125170792|NCT00996892|450247832|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
125170793|NCT00996892|450247833|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
125170794|NCT00996892|450247834|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
125229068|NCT02709746|450467916|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
125229069|NCT02709746|450467917|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
125229070|NCT02709746|450467918|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
125229071|NCT02709746|450467919|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
125229072|NCT02709746|450467915|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
125229073|NCT02709746|450467916|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
125229074|NCT02709746|450467917|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
125170795|NCT00996892|450247835|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
125170796|NCT00996892|450247836|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
125170797|NCT00996892|450247837|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
125170798|NCT00996892|450247838|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
125170799|NCT00996892|450247839|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
125170800|NCT00996892|450247840|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
125170801|NCT00996892|450247821|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
125170802|NCT00996892|450247822|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
125170803|NCT00996892|450247823|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
125170804|NCT00996892|450247824|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
125170805|NCT00996892|450247825|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
125170806|NCT00996892|450247826|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
125170807|NCT00996892|450247827|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
125170808|NCT00996892|450247828|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
125229075|NCT02709746|450467918|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
125229076|NCT02709746|450467919|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
125229077|NCT02709746|450467915|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
125229078|NCT02709746|450467916|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
125229079|NCT02709746|450467917|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
125229080|NCT02709746|450467918|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
125229081|NCT02709746|450467919|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
125229082|NCT02709746|450467915|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
125229083|NCT02709746|450467916|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
125229084|NCT02709746|450467917|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
125229085|NCT02709746|450467918|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
125229086|NCT02709746|450467919|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
125229087|NCT02709746|450467915|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
125229088|NCT02709746|450467916|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
125229089|NCT02709746|450467917|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
125229090|NCT02709746|450467918|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
125229091|NCT02709746|450467919|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
125229092|NCT02709746|450467915|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
125229093|NCT02709746|450467916|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
125229094|NCT02709746|450467917|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
125229095|NCT02709746|450467918|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
125229096|NCT02709746|450467919|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
125229097|NCT02709746|450467915|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
125229098|NCT02709746|450467916|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
125229099|NCT02709746|450467917|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
125229100|NCT02709746|450467918|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
125229101|NCT02709746|450467919|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
125229102|NCT02709746|450467915|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
125229103|NCT02709746|450467916|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
125229104|NCT02709746|450467917|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
125229105|NCT02709746|450467918|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
125229106|NCT02709746|450467919|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
125229107|NCT02709746|450467915|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
125229108|NCT02709746|450467916|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
125229109|NCT02709746|450467917|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
125229110|NCT02709746|450467918|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
125229111|NCT02709746|450467919|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
125229112|NCT02709746|450467915|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
125229113|NCT02709746|450467916|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
125229114|NCT02709746|450467917|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
125229115|NCT02709746|450467918|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
125229116|NCT02709746|450467919|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
125229117|NCT02709746|450467915|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
125229118|NCT02709746|450467916|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
125229119|NCT02709746|450467917|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
125229120|NCT02709746|450467918|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
125229121|NCT02709746|450467919|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
125229122|NCT02709746|450467915|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
125229123|NCT02709746|450467916|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
125229124|NCT02709746|450467917|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
125229125|NCT02709746|450467918|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
125170809|NCT00996892|450247829|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
125170810|NCT00996892|450247830|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
125170811|NCT00996892|450247831|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
125170812|NCT00996892|450247832|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
125170813|NCT00996892|450247833|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
125170814|NCT00996892|450247834|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
125170815|NCT00996892|450247835|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
125170816|NCT00996892|450247836|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
125170817|NCT00996892|450247837|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
125170818|NCT00996892|450247838|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
125170819|NCT00996892|450247839|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
125170820|NCT00996892|450247840|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
125170821|NCT00996892|450247821|FG000|Expansion Stage 2|Adverse Event|0|||
125170822|NCT00996892|450247822|FG001|Expansion Stage 2|Adverse Event|0|||
125170823|NCT00996892|450247823|FG002|Expansion Stage 2|Adverse Event|0|||
125170824|NCT00996892|450247824|FG003|Expansion Stage 2|Adverse Event|0|||
125170825|NCT00996892|450247825|FG004|Expansion Stage 2|Adverse Event|0|||
125170826|NCT00996892|450247826|FG005|Expansion Stage 2|Adverse Event|0|||
125170827|NCT00996892|450247827|FG006|Expansion Stage 2|Adverse Event|0|||
125170828|NCT00996892|450247828|FG007|Expansion Stage 2|Adverse Event|0|||
125170829|NCT00996892|450247829|FG008|Expansion Stage 2|Adverse Event|0|||
125170830|NCT00996892|450247830|FG009|Expansion Stage 2|Adverse Event|0|||
125170831|NCT00996892|450247831|FG010|Expansion Stage 2|Adverse Event|0|||
125170832|NCT00996892|450247832|FG011|Expansion Stage 2|Adverse Event|0|||
125170833|NCT00996892|450247833|FG012|Expansion Stage 2|Adverse Event|0|||
125170834|NCT00996892|450247834|FG013|Expansion Stage 2|Adverse Event|0|||
125170835|NCT00996892|450247835|FG014|Expansion Stage 2|Adverse Event|0|||
125170836|NCT00996892|450247836|FG015|Expansion Stage 2|Adverse Event|0|||
125170837|NCT00996892|450247837|FG016|Expansion Stage 2|Adverse Event|0|||
125170838|NCT00996892|450247838|FG017|Expansion Stage 2|Adverse Event|0|||
125170839|NCT00996892|450247839|FG018|Expansion Stage 2|Adverse Event|3|||
125170840|NCT00996892|450247840|FG019|Expansion Stage 2|Adverse Event|0|||
125170841|NCT00996892|450247821|FG000|Expansion Stage 2|Death|0|||
125170842|NCT00996892|450247822|FG001|Expansion Stage 2|Death|0|||
125170843|NCT00996892|450247823|FG002|Expansion Stage 2|Death|0|||
125170844|NCT00996892|450247824|FG003|Expansion Stage 2|Death|0|||
125170845|NCT00996892|450247825|FG004|Expansion Stage 2|Death|0|||
125170846|NCT00996892|450247826|FG005|Expansion Stage 2|Death|0|||
125170847|NCT00996892|450247827|FG006|Expansion Stage 2|Death|0|||
125170848|NCT00996892|450247828|FG007|Expansion Stage 2|Death|0|||
125170849|NCT00996892|450247829|FG008|Expansion Stage 2|Death|0|||
125170850|NCT00996892|450247830|FG009|Expansion Stage 2|Death|0|||
125170851|NCT00996892|450247831|FG010|Expansion Stage 2|Death|0|||
125170852|NCT00996892|450247832|FG011|Expansion Stage 2|Death|0|||
125170853|NCT00996892|450247833|FG012|Expansion Stage 2|Death|0|||
125170854|NCT00996892|450247834|FG013|Expansion Stage 2|Death|0|||
125170855|NCT00996892|450247835|FG014|Expansion Stage 2|Death|0|||
125170856|NCT00996892|450247836|FG015|Expansion Stage 2|Death|0|||
125170857|NCT00996892|450247837|FG016|Expansion Stage 2|Death|0|||
125170858|NCT00996892|450247838|FG017|Expansion Stage 2|Death|0|||
125170859|NCT00996892|450247839|FG018|Expansion Stage 2|Death|2|||
125170860|NCT00996892|450247840|FG019|Expansion Stage 2|Death|0|||
125170861|NCT00996892|450247821|FG000|Expansion Stage 2|Physician Decision|0|||
125170862|NCT00996892|450247822|FG001|Expansion Stage 2|Physician Decision|0|||
125170863|NCT00996892|450247823|FG002|Expansion Stage 2|Physician Decision|0|||
125170864|NCT00996892|450247824|FG003|Expansion Stage 2|Physician Decision|0|||
125170865|NCT00996892|450247825|FG004|Expansion Stage 2|Physician Decision|0|||
125170866|NCT00996892|450247826|FG005|Expansion Stage 2|Physician Decision|0|||
125170867|NCT00996892|450247827|FG006|Expansion Stage 2|Physician Decision|0|||
125170868|NCT00996892|450247828|FG007|Expansion Stage 2|Physician Decision|0|||
125170869|NCT00996892|450247829|FG008|Expansion Stage 2|Physician Decision|0|||
125170870|NCT00996892|450247830|FG009|Expansion Stage 2|Physician Decision|0|||
125170871|NCT00996892|450247831|FG010|Expansion Stage 2|Physician Decision|0|||
125170872|NCT00996892|450247832|FG011|Expansion Stage 2|Physician Decision|0|||
125170873|NCT00996892|450247833|FG012|Expansion Stage 2|Physician Decision|0|||
125170874|NCT00996892|450247834|FG013|Expansion Stage 2|Physician Decision|0|||
125170875|NCT00996892|450247835|FG014|Expansion Stage 2|Physician Decision|0|||
125170876|NCT00996892|450247836|FG015|Expansion Stage 2|Physician Decision|0|||
125170877|NCT00996892|450247837|FG016|Expansion Stage 2|Physician Decision|0|||
125170878|NCT00996892|450247838|FG017|Expansion Stage 2|Physician Decision|0|||
125170879|NCT00996892|450247839|FG018|Expansion Stage 2|Physician Decision|1|||
125170880|NCT00996892|450247840|FG019|Expansion Stage 2|Physician Decision|0|||
125170881|NCT00996892|450247821|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
125170882|NCT00996892|450247822|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
125170883|NCT00996892|450247823|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
125170884|NCT00996892|450247824|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
125170885|NCT00996892|450247825|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
125170886|NCT00996892|450247826|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
125170887|NCT00996892|450247827|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
125170888|NCT00996892|450247828|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
125170889|NCT00996892|450247829|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
125170890|NCT00996892|450247830|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
125170891|NCT00996892|450247831|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
125170892|NCT00996892|450247832|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
125170893|NCT00996892|450247833|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
125170894|NCT00996892|450247834|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
125170895|NCT00996892|450247835|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
125170896|NCT00996892|450247836|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
125170897|NCT00996892|450247837|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
125170898|NCT00996892|450247838|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
125170899|NCT00996892|450247839|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
125170900|NCT00996892|450247840|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
125170901|NCT00996892|450247821|FG000|Expansion Stage 2|Disease Progression|0|||
125170902|NCT00996892|450247822|FG001|Expansion Stage 2|Disease Progression|0|||
125170903|NCT00996892|450247823|FG002|Expansion Stage 2|Disease Progression|0|||
125170904|NCT00996892|450247824|FG003|Expansion Stage 2|Disease Progression|0|||
125170905|NCT00996892|450247825|FG004|Expansion Stage 2|Disease Progression|0|||
125170906|NCT00996892|450247826|FG005|Expansion Stage 2|Disease Progression|0|||
125170907|NCT00996892|450247827|FG006|Expansion Stage 2|Disease Progression|0|||
125170908|NCT00996892|450247828|FG007|Expansion Stage 2|Disease Progression|0|||
125170909|NCT00996892|450247829|FG008|Expansion Stage 2|Disease Progression|0|||
125170910|NCT00996892|450247830|FG009|Expansion Stage 2|Disease Progression|0|||
125170911|NCT00996892|450247831|FG010|Expansion Stage 2|Disease Progression|0|||
125170912|NCT00996892|450247832|FG011|Expansion Stage 2|Disease Progression|0|||
125170913|NCT00996892|450247833|FG012|Expansion Stage 2|Disease Progression|0|||
125170914|NCT00996892|450247834|FG013|Expansion Stage 2|Disease Progression|0|||
125170915|NCT00996892|450247835|FG014|Expansion Stage 2|Disease Progression|0|||
125170916|NCT00996892|450247836|FG015|Expansion Stage 2|Disease Progression|0|||
125170917|NCT00996892|450247837|FG016|Expansion Stage 2|Disease Progression|0|||
125170918|NCT00996892|450247838|FG017|Expansion Stage 2|Disease Progression|0|||
125170919|NCT00996892|450247839|FG018|Expansion Stage 2|Disease Progression|28|||
125170920|NCT00996892|450247840|FG019|Expansion Stage 2|Disease Progression|0|||
125170921|NCT00996892|450247821|FG000|Expansion Stage 2A|Adverse Event|0|||
125170922|NCT00996892|450247822|FG001|Expansion Stage 2A|Adverse Event|0|||
125170923|NCT00996892|450247823|FG002|Expansion Stage 2A|Adverse Event|0|||
125170924|NCT00996892|450247824|FG003|Expansion Stage 2A|Adverse Event|0|||
125170925|NCT00996892|450247825|FG004|Expansion Stage 2A|Adverse Event|0|||
125170926|NCT00996892|450247826|FG005|Expansion Stage 2A|Adverse Event|0|||
125170927|NCT00996892|450247827|FG006|Expansion Stage 2A|Adverse Event|0|||
125170928|NCT00996892|450247828|FG007|Expansion Stage 2A|Adverse Event|0|||
125170929|NCT00996892|450247829|FG008|Expansion Stage 2A|Adverse Event|0|||
125170930|NCT00996892|450247830|FG009|Expansion Stage 2A|Adverse Event|0|||
125170931|NCT00996892|450247831|FG010|Expansion Stage 2A|Adverse Event|0|||
125170932|NCT00996892|450247832|FG011|Expansion Stage 2A|Adverse Event|0|||
125170933|NCT00996892|450247833|FG012|Expansion Stage 2A|Adverse Event|0|||
125170934|NCT00996892|450247834|FG013|Expansion Stage 2A|Adverse Event|0|||
125170935|NCT00996892|450247835|FG014|Expansion Stage 2A|Adverse Event|0|||
125170936|NCT00996892|450247836|FG015|Expansion Stage 2A|Adverse Event|0|||
125170937|NCT00996892|450247837|FG016|Expansion Stage 2A|Adverse Event|0|||
125170938|NCT00996892|450247838|FG017|Expansion Stage 2A|Adverse Event|0|||
125170939|NCT00996892|450247839|FG018|Expansion Stage 2A|Adverse Event|0|||
125170940|NCT00996892|450247840|FG019|Expansion Stage 2A|Adverse Event|8|||
125170941|NCT00996892|450247821|FG000|Expansion Stage 2A|Physician Decision|0|||
125170942|NCT00996892|450247822|FG001|Expansion Stage 2A|Physician Decision|0|||
125170943|NCT00996892|450247823|FG002|Expansion Stage 2A|Physician Decision|0|||
125170944|NCT00996892|450247824|FG003|Expansion Stage 2A|Physician Decision|0|||
125170945|NCT00996892|450247825|FG004|Expansion Stage 2A|Physician Decision|0|||
125170946|NCT00996892|450247826|FG005|Expansion Stage 2A|Physician Decision|0|||
125170947|NCT00996892|450247827|FG006|Expansion Stage 2A|Physician Decision|0|||
125170948|NCT00996892|450247828|FG007|Expansion Stage 2A|Physician Decision|0|||
125170949|NCT00996892|450247829|FG008|Expansion Stage 2A|Physician Decision|0|||
125170950|NCT00996892|450247830|FG009|Expansion Stage 2A|Physician Decision|0|||
125170951|NCT00996892|450247831|FG010|Expansion Stage 2A|Physician Decision|0|||
125170952|NCT00996892|450247832|FG011|Expansion Stage 2A|Physician Decision|0|||
125170953|NCT00996892|450247833|FG012|Expansion Stage 2A|Physician Decision|0|||
125170954|NCT00996892|450247834|FG013|Expansion Stage 2A|Physician Decision|0|||
125170955|NCT00996892|450247835|FG014|Expansion Stage 2A|Physician Decision|0|||
125170956|NCT00996892|450247836|FG015|Expansion Stage 2A|Physician Decision|0|||
125170957|NCT00996892|450247837|FG016|Expansion Stage 2A|Physician Decision|0|||
125170958|NCT00996892|450247838|FG017|Expansion Stage 2A|Physician Decision|0|||
125170959|NCT00996892|450247839|FG018|Expansion Stage 2A|Physician Decision|0|||
125170960|NCT00996892|450247840|FG019|Expansion Stage 2A|Physician Decision|2|||
125170961|NCT00996892|450247821|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
125170962|NCT00996892|450247822|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
125229126|NCT02709746|450467919|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
125229127|NCT01483118|450467922|FG000|Overall Study|Lost to Follow-up|12|||
125229128|NCT01483118|450467923|FG001|Overall Study|Lost to Follow-up|16|||
125229129|NCT02089347|450467929|FG000|Overall Study|Protocol Violation|1|||
125229130|NCT02089347|450467930|FG001|Overall Study|Protocol Violation|0|||
125170963|NCT00996892|450247823|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
125170964|NCT00996892|450247824|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
125170965|NCT00996892|450247825|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
125170966|NCT00996892|450247826|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
125170967|NCT00996892|450247827|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
125170968|NCT00996892|450247828|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
125170969|NCT00996892|450247829|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
125170970|NCT00996892|450247830|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
125170971|NCT00996892|450247831|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
125170972|NCT00996892|450247832|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
125170973|NCT00996892|450247833|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
125170974|NCT00996892|450247834|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
125170975|NCT00996892|450247835|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
125170976|NCT00996892|450247836|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
125170977|NCT00996892|450247837|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
125170978|NCT00996892|450247838|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
125170979|NCT00996892|450247839|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
125170980|NCT00996892|450247840|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
125170981|NCT00996892|450247821|FG000|Expansion Stage 2A|Disease Progression|0|||
125170982|NCT00996892|450247822|FG001|Expansion Stage 2A|Disease Progression|0|||
125170983|NCT00996892|450247823|FG002|Expansion Stage 2A|Disease Progression|0|||
125170984|NCT00996892|450247824|FG003|Expansion Stage 2A|Disease Progression|0|||
125170985|NCT00996892|450247825|FG004|Expansion Stage 2A|Disease Progression|0|||
125170986|NCT00996892|450247826|FG005|Expansion Stage 2A|Disease Progression|0|||
125170987|NCT00996892|450247827|FG006|Expansion Stage 2A|Disease Progression|0|||
125170988|NCT00996892|450247828|FG007|Expansion Stage 2A|Disease Progression|0|||
125170989|NCT00996892|450247829|FG008|Expansion Stage 2A|Disease Progression|0|||
125170990|NCT00996892|450247830|FG009|Expansion Stage 2A|Disease Progression|0|||
125170991|NCT00996892|450247831|FG010|Expansion Stage 2A|Disease Progression|0|||
125170992|NCT00996892|450247832|FG011|Expansion Stage 2A|Disease Progression|0|||
125170993|NCT00996892|450247833|FG012|Expansion Stage 2A|Disease Progression|0|||
125170994|NCT00996892|450247834|FG013|Expansion Stage 2A|Disease Progression|0|||
125170995|NCT00996892|450247835|FG014|Expansion Stage 2A|Disease Progression|0|||
125170996|NCT00996892|450247836|FG015|Expansion Stage 2A|Disease Progression|0|||
125170997|NCT00996892|450247837|FG016|Expansion Stage 2A|Disease Progression|0|||
125170998|NCT00996892|450247838|FG017|Expansion Stage 2A|Disease Progression|0|||
125170999|NCT00996892|450247839|FG018|Expansion Stage 2A|Disease Progression|0|||
125171000|NCT00996892|450247840|FG019|Expansion Stage 2A|Disease Progression|31|||
125171001|NCT01653912|450247841|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
125171002|NCT01653912|450247842|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
125171003|NCT01653912|450247843|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
125171004|NCT01653912|450247844|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
125171005|NCT01653912|450247845|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
125171006|NCT01653912|450247846|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
125171007|NCT01653912|450247841|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
125229131|NCT02783066|450467931|FG000|Overall Study|Withdrawal by Subject|13|||
125229132|NCT00551369|450467932|FG000|Overall Study|Protocol Violation|5|||
125229133|NCT00551369|450467932|FG000|Overall Study|Withdrawal by Subject|1|||
125229134|NCT00551369|450467932|FG000|Overall Study|Not treated per protocol and re|1|||
125229135|NCT00719901|450467933|FG000|Overall Study|Adverse Event|5|||
125229136|NCT00719901|450467933|FG000|Overall Study|Withdrawal by Subject|1|||
125229137|NCT00719901|450467933|FG000|Overall Study|Alternate Treatment|1|||
125229138|NCT00719901|450467933|FG000|Overall Study|Disease Progression|3|||
125229139|NCT00719901|450467933|FG000|Overall Study|Availability of Study Drug|1|||
125229140|NCT01122173|450467934|FG000|Overall Study|Lost to Follow-up|3|||
125229141|NCT01122173|450467934|FG000|Overall Study|Withdrawal by Subject|3|||
125229142|NCT01122173|450467934|FG000|Overall Study|Left study for other reasons|3|||
125229143|NCT01184872|450467935|FG000|Overall Study|Adverse Event|3|||
125229144|NCT01184872|450467936|FG001|Overall Study|Adverse Event|4|||
125229145|NCT01184872|450467935|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
125171008|NCT01653912|450247842|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
125171009|NCT01653912|450247843|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
125171010|NCT01653912|450247844|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
125171011|NCT01653912|450247845|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
125171012|NCT01653912|450247846|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
125171013|NCT01653912|450247841|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
125229146|NCT01184872|450467936|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125229147|NCT01184872|450467935|FG000|Overall Study|Withdrawal by Subject|2|||
125229148|NCT01184872|450467936|FG001|Overall Study|Withdrawal by Subject|0|||
125229149|NCT01184872|450467935|FG000|Overall Study|Lost to Follow-up|0|||
125229150|NCT01184872|450467936|FG001|Overall Study|Lost to Follow-up|1|||
125229151|NCT01184872|450467935|FG000|Overall Study|Administrative problems|1|||
125229152|NCT01184872|450467936|FG001|Overall Study|Administrative problems|1|||
125229153|NCT01184872|450467935|FG000|Overall Study|Protocol deviation|1|||
125229154|NCT01184872|450467936|FG001|Overall Study|Protocol deviation|0|||
125229155|NCT03426345|450467937|FG000|Overall Study|Adverse Event|4|||
125229156|NCT03426345|450467938|FG001|Overall Study|Adverse Event|4|||
125229157|NCT03426345|450467937|FG000|Overall Study|Lack of Efficacy|1|||
125229158|NCT03426345|450467938|FG001|Overall Study|Lack of Efficacy|0|||
125229159|NCT03426345|450467937|FG000|Overall Study|Withdrawal by Subject|5|||
125229160|NCT03426345|450467938|FG001|Overall Study|Withdrawal by Subject|6|||
125229161|NCT03426345|450467937|FG000|Overall Study|Lost to Follow-up|3|||
125229162|NCT03426345|450467938|FG001|Overall Study|Lost to Follow-up|1|||
125229163|NCT03426345|450467937|FG000|Overall Study|Protocol Deviation|3|||
125229164|NCT03426345|450467938|FG001|Overall Study|Protocol Deviation|4|||
125229165|NCT03426345|450467937|FG000|Overall Study|Reason Not Specified|1|||
125229166|NCT03426345|450467938|FG001|Overall Study|Reason Not Specified|2|||
125229167|NCT03426345|450467937|FG000|Overall Study|Missing Completion Status|1|||
125229168|NCT03426345|450467938|FG001|Overall Study|Missing Completion Status|0|||
125229169|NCT00116142|450467939|FG000|Overall Study|Adverse Event|8|||
125229170|NCT00116142|450467940|FG001|Overall Study|Adverse Event|7|||
125229171|NCT00116142|450467939|FG000|Overall Study|Protocol Violation|2|||
125229172|NCT00116142|450467940|FG001|Overall Study|Protocol Violation|1|||
125229173|NCT00116142|450467939|FG000|Overall Study|Withdrawal by Subject|5|||
125229174|NCT00116142|450467940|FG001|Overall Study|Withdrawal by Subject|5|||
125229175|NCT00116142|450467939|FG000|Overall Study|Physician Decision|3|||
125229176|NCT00116142|450467940|FG001|Overall Study|Physician Decision|1|||
125229177|NCT00116142|450467939|FG000|Overall Study|Delayed Radiation Therapy|1|||
125229178|NCT00116142|450467940|FG001|Overall Study|Delayed Radiation Therapy|0|||
125229179|NCT00116142|450467939|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
125229180|NCT00116142|450467940|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
125229181|NCT00116142|450467939|FG000|Overall Study|Patient stopped due to depression|0|||
125229182|NCT00116142|450467940|FG001|Overall Study|Patient stopped due to depression|1|||
125229183|NCT00116142|450467939|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
125229184|NCT00116142|450467940|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
125229185|NCT00116142|450467939|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
125171014|NCT01653912|450247842|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
125171015|NCT01653912|450247843|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
125171016|NCT01653912|450247844|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
125171017|NCT01653912|450247845|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
125171018|NCT01653912|450247846|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
125171019|NCT01653912|450247841|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
125171020|NCT01653912|450247842|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
125171021|NCT01653912|450247843|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
125171022|NCT01653912|450247844|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
125171023|NCT01653912|450247845|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
125171024|NCT01653912|450247846|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
125171025|NCT01653912|450247841|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
125171026|NCT01653912|450247842|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
125171027|NCT01653912|450247843|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
125171028|NCT01653912|450247844|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
125171029|NCT01653912|450247845|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
125171030|NCT01653912|450247846|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
125171031|NCT01653912|450247841|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
125171032|NCT01653912|450247842|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
125171033|NCT01653912|450247843|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
125171034|NCT01653912|450247844|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
125229186|NCT00116142|450467940|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
125229187|NCT00116142|450467939|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
125171035|NCT01653912|450247845|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
125171036|NCT01653912|450247846|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
125171037|NCT01653912|450247841|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
125229188|NCT00116142|450467940|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
125171038|NCT01653912|450247842|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
125229189|NCT00644059|450467941|FG000|Overall Study|Lost to Follow-up|37|||
125171039|NCT01653912|450247843|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
125171040|NCT01653912|450247844|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
125171041|NCT01653912|450247845|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
125229190|NCT00644059|450467942|FG001|Overall Study|Lost to Follow-up|34|||
125229191|NCT00644059|450467943|FG002|Overall Study|Lost to Follow-up|16|||
125229192|NCT00644059|450467941|FG000|Overall Study|Withdrawal by Subject|52|||
125171042|NCT01653912|450247846|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
125171043|NCT00602641|450249420|FG000|Overall Study|Never started protocol therapy|6|||
125171044|NCT00602641|450249421|FG001|Overall Study|Never started protocol therapy|2|||
125171045|NCT00602641|450249420|FG000|Overall Study|Still on treatment at time of analysis|8|||
125171046|NCT00602641|450249421|FG001|Overall Study|Still on treatment at time of analysis|15|||
125171047|NCT00602641|450249420|FG000|Overall Study|Adverse Event|62|||
125171048|NCT00602641|450249421|FG001|Overall Study|Adverse Event|53|||
125171049|NCT00602641|450249420|FG000|Overall Study|Disease progression|38|||
125171050|NCT00602641|450249421|FG001|Overall Study|Disease progression|55|||
125171051|NCT00602641|450249420|FG000|Overall Study|Death|6|||
125171052|NCT00602641|450249421|FG001|Overall Study|Death|5|||
125171053|NCT00602641|450249420|FG000|Overall Study|Withdrawal by Subject|15|||
125171054|NCT00602641|450249421|FG001|Overall Study|Withdrawal by Subject|12|||
125229193|NCT00644059|450467942|FG001|Overall Study|Withdrawal by Subject|60|||
125229194|NCT00644059|450467943|FG002|Overall Study|Withdrawal by Subject|30|||
125229195|NCT00644059|450467941|FG000|Overall Study|Adverse Event|8|||
125229196|NCT00644059|450467942|FG001|Overall Study|Adverse Event|5|||
125229197|NCT00644059|450467943|FG002|Overall Study|Adverse Event|1|||
125229198|NCT00644059|450467941|FG000|Overall Study|Inappropriate Enrollment|1|||
125229199|NCT00644059|450467942|FG001|Overall Study|Inappropriate Enrollment|3|||
125229200|NCT00644059|450467943|FG002|Overall Study|Inappropriate Enrollment|0|||
125229201|NCT00644059|450467941|FG000|Overall Study|Protocol Deviation/violation|20|||
125229202|NCT00644059|450467942|FG001|Overall Study|Protocol Deviation/violation|19|||
125229203|NCT00644059|450467943|FG002|Overall Study|Protocol Deviation/violation|15|||
125229204|NCT00644059|450467941|FG000|Overall Study|Unable to classify|6|||
125229205|NCT00644059|450467942|FG001|Overall Study|Unable to classify|2|||
125229206|NCT00644059|450467943|FG002|Overall Study|Unable to classify|3|||
125229207|NCT02133508|450467944|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
125229208|NCT02133508|450467944|FG000|Overall Study|Death|12|||
125229209|NCT02133508|450467944|FG000|Overall Study|Lost to Follow-up|2|||
125229210|NCT02497469|450467951|FG000|Overall Study|Randomized but not Treated|0|||
125229211|NCT02497469|450467952|FG001|Overall Study|Randomized but not Treated|2|||
125229212|NCT02497469|450467951|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
125229213|NCT02497469|450467952|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
125229214|NCT02497469|450467951|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
125229215|NCT02497469|450467952|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
125229216|NCT02497469|450467951|FG000|Overall Study|Significant Protocol Deviation|4|||
125229217|NCT02497469|450467952|FG001|Overall Study|Significant Protocol Deviation|5|||
125229218|NCT02497469|450467951|FG000|Overall Study|Lost to Follow-up|14|||
125229219|NCT02497469|450467952|FG001|Overall Study|Lost to Follow-up|4|||
125229220|NCT02497469|450467951|FG000|Overall Study|Voluntary Withdrawal|39|||
125229221|NCT02497469|450467952|FG001|Overall Study|Voluntary Withdrawal|41|||
125229222|NCT02497469|450467951|FG000|Overall Study|Pregnancy|1|||
125229223|NCT02497469|450467952|FG001|Overall Study|Pregnancy|1|||
125229224|NCT02497469|450467951|FG000|Overall Study|Lack of Efficacy|86|||
125229225|NCT02497469|450467952|FG001|Overall Study|Lack of Efficacy|40|||
125229226|NCT02497469|450467951|FG000|Overall Study|Reason not Specified|6|||
125229227|NCT02497469|450467952|FG001|Overall Study|Reason not Specified|6|||
125229228|NCT04076917|450467954|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
125229229|NCT04076917|450467954|FG000|Overall Study|Study closure|13|||
125229230|NCT04076917|450467954|FG000|Overall Study|Physician Decision|3|||
125229231|NCT04076917|450467954|FG000|Overall Study|Death|1|||
125229232|NCT04076917|450467954|FG000|Overall Study|Lost to Follow-up|1|||
125229233|NCT04076917|450467954|FG000|Overall Study|Withdrawal by Subject|1|||
125229234|NCT04076917|450467954|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
125229235|NCT01774591|450467957|FG000|Overall Study|Physician Decision|1|||
125229236|NCT01774591|450467958|FG001|Overall Study|Physician Decision|1|||
125229237|NCT01774591|450467957|FG000|Overall Study|Withdrawal by Subject|0|||
125229238|NCT01774591|450467958|FG001|Overall Study|Withdrawal by Subject|1|||
125229239|NCT01774591|450467957|FG000|Overall Study|Adverse Event|0|||
125229240|NCT01774591|450467958|FG001|Overall Study|Adverse Event|2|||
125229241|NCT01787552|450467959|FG000|Overall Study|Withdrawal by Subject|2|||
125229242|NCT01787552|450467960|FG001|Overall Study|Withdrawal by Subject|0|||
125229243|NCT01787552|450467961|FG002|Overall Study|Withdrawal by Subject|0|||
125229244|NCT01787552|450467962|FG003|Overall Study|Withdrawal by Subject|4|||
125229245|NCT01787552|450467959|FG000|Overall Study|Physician Decision|2|||
125229246|NCT01787552|450467960|FG001|Overall Study|Physician Decision|2|||
125229247|NCT01787552|450467961|FG002|Overall Study|Physician Decision|1|||
125229248|NCT01787552|450467962|FG003|Overall Study|Physician Decision|2|||
125229249|NCT01787552|450467959|FG000|Overall Study|Death|0|||
125229250|NCT01787552|450467960|FG001|Overall Study|Death|0|||
125171055|NCT00602641|450249420|FG000|Overall Study|Alternative therapy|5|||
125229251|NCT01787552|450467961|FG002|Overall Study|Death|0|||
125229252|NCT01787552|450467962|FG003|Overall Study|Death|1|||
125229253|NCT01787552|450467959|FG000|Overall Study|Adverse Event|2|||
125229254|NCT01787552|450467960|FG001|Overall Study|Adverse Event|5|||
125229255|NCT01787552|450467961|FG002|Overall Study|Adverse Event|2|||
125229256|NCT01787552|450467962|FG003|Overall Study|Adverse Event|16|||
125229257|NCT01787552|450467959|FG000|Overall Study|Study terminated by Sponsor|0|||
125229258|NCT01787552|450467960|FG001|Overall Study|Study terminated by Sponsor|0|||
125229259|NCT01787552|450467961|FG002|Overall Study|Study terminated by Sponsor|1|||
125229260|NCT01787552|450467962|FG003|Overall Study|Study terminated by Sponsor|3|||
125229261|NCT01787552|450467959|FG000|Overall Study|Progressive Disease|2|||
125229262|NCT01787552|450467960|FG001|Overall Study|Progressive Disease|2|||
125229263|NCT01787552|450467961|FG002|Overall Study|Progressive Disease|1|||
125229264|NCT01787552|450467962|FG003|Overall Study|Progressive Disease|1|||
125229265|NCT03055936|450467968|FG000|Overall Study|Adverse Event|0|||
125171056|NCT00602641|450249421|FG001|Overall Study|Alternative therapy|2|||
125171057|NCT00602641|450249420|FG000|Overall Study|Other Complicating Disease|5|||
125171058|NCT00602641|450249421|FG001|Overall Study|Other Complicating Disease|2|||
125171059|NCT00602641|450249420|FG000|Overall Study|Physician Decision|5|||
125171060|NCT00602641|450249421|FG001|Overall Study|Physician Decision|4|||
125171061|NCT00602641|450249420|FG000|Overall Study|Administrative Closure|1|||
125171062|NCT00602641|450249421|FG001|Overall Study|Administrative Closure|1|||
125171063|NCT00602641|450249420|FG000|Overall Study|Other|3|||
125171064|NCT00602641|450249421|FG001|Overall Study|Other|1|||
125171065|NCT03408639|450249427|FG000|Overall Study|Death|5|||
125171066|NCT03408639|450249428|FG001|Overall Study|Death|5|||
125171067|NCT03408639|450249427|FG000|Overall Study|Lost to Follow-up|1|||
125171068|NCT03408639|450249428|FG001|Overall Study|Lost to Follow-up|4|||
125171069|NCT03408639|450249427|FG000|Overall Study|Withdrawal by Subject|2|||
125171070|NCT03408639|450249428|FG001|Overall Study|Withdrawal by Subject|7|||
125171071|NCT03408639|450249427|FG000|Overall Study|Physician Decision|3|||
125171072|NCT03408639|450249428|FG001|Overall Study|Physician Decision|6|||
125171073|NCT00070499|450249429|FG000|Overall Study|Adverse Event|6|||
125171074|NCT00070499|450249430|FG001|Overall Study|Adverse Event|6|||
125171075|NCT00070499|450249431|FG002|Overall Study|Adverse Event|19|||
125171076|NCT00070499|450249432|FG003|Overall Study|Adverse Event|15|||
125171077|NCT00070499|450249429|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
125171078|NCT00070499|450249430|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
125171079|NCT00070499|450249431|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
125171080|NCT00070499|450249432|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
125171081|NCT00070499|450249429|FG000|Overall Study|Progression/relapse|4|||
125171082|NCT00070499|450249430|FG001|Overall Study|Progression/relapse|2|||
125171083|NCT00070499|450249431|FG002|Overall Study|Progression/relapse|1|||
125171084|NCT00070499|450249432|FG003|Overall Study|Progression/relapse|4|||
125171085|NCT00070499|450249429|FG000|Overall Study|Death|1|||
125171086|NCT00070499|450249430|FG001|Overall Study|Death|1|||
125171087|NCT00070499|450249431|FG002|Overall Study|Death|1|||
125171088|NCT00070499|450249432|FG003|Overall Study|Death|2|||
125171089|NCT00070499|450249429|FG000|Overall Study|Other - not protocol specified|7|||
125171090|NCT00070499|450249430|FG001|Overall Study|Other - not protocol specified|3|||
125171091|NCT00070499|450249431|FG002|Overall Study|Other - not protocol specified|12|||
125171092|NCT00070499|450249432|FG003|Overall Study|Other - not protocol specified|20|||
125171093|NCT00070499|450249429|FG000|Overall Study|Still on protocol treatment|10|||
125171094|NCT00070499|450249430|FG001|Overall Study|Still on protocol treatment|4|||
125171095|NCT00070499|450249431|FG002|Overall Study|Still on protocol treatment|79|||
125171096|NCT00070499|450249432|FG003|Overall Study|Still on protocol treatment|57|||
125171097|NCT00070499|450249429|FG000|Overall Study|Did not start treatment|1|||
125171098|NCT00070499|450249430|FG001|Overall Study|Did not start treatment|0|||
125171099|NCT00070499|450249431|FG002|Overall Study|Did not start treatment|0|||
125171100|NCT00070499|450249432|FG003|Overall Study|Did not start treatment|2|||
125171101|NCT00070499|450249429|FG000|Overall Study|Not eligible|2|||
125171102|NCT00070499|450249430|FG001|Overall Study|Not eligible|5|||
125171103|NCT00070499|450249431|FG002|Overall Study|Not eligible|3|||
125171104|NCT00070499|450249432|FG003|Overall Study|Not eligible|2|||
125171105|NCT00587860|450249440|FG000|Overall Study|Lost to Follow-up|2|||
125171106|NCT00587860|450249441|FG001|Overall Study|Lost to Follow-up|2|||
125171107|NCT00587860|450249440|FG000|Overall Study|Withdrawal by Subject|3|||
125171108|NCT00587860|450249441|FG001|Overall Study|Withdrawal by Subject|3|||
125171109|NCT01371747|450249444|FG000|Overall Study|Adverse Event|4|||
125171110|NCT01371747|450249445|FG001|Overall Study|Adverse Event|2|||
125171111|NCT01371747|450249446|FG002|Overall Study|Adverse Event|7|||
125171112|NCT01371747|450249447|FG003|Overall Study|Adverse Event|2|||
125229266|NCT03055936|450467969|FG001|Overall Study|Adverse Event|1|||
125171113|NCT01371747|450249448|FG004|Overall Study|Adverse Event|2|||
125171114|NCT01371747|450249449|FG005|Overall Study|Adverse Event|2|||
125171115|NCT01371747|450249444|FG000|Overall Study|Death|1|||
125171116|NCT01371747|450249445|FG001|Overall Study|Death|0|||
125171117|NCT01371747|450249446|FG002|Overall Study|Death|4|||
125171118|NCT01371747|450249447|FG003|Overall Study|Death|1|||
125171119|NCT01371747|450249448|FG004|Overall Study|Death|2|||
125171120|NCT01371747|450249449|FG005|Overall Study|Death|0|||
125171121|NCT01371747|450249444|FG000|Overall Study|Abnormal Renal Function|0|||
125171122|NCT01371747|450249445|FG001|Overall Study|Abnormal Renal Function|2|||
125229267|NCT03055936|450467970|FG002|Overall Study|Adverse Event|1|||
125229268|NCT03055936|450467971|FG003|Overall Study|Adverse Event|1|||
125229269|NCT03055936|450467968|FG000|Overall Study|Personal reason|2|||
125229270|NCT03055936|450467969|FG001|Overall Study|Personal reason|0|||
125229271|NCT03055936|450467970|FG002|Overall Study|Personal reason|1|||
125229272|NCT03055936|450467971|FG003|Overall Study|Personal reason|0|||
125229273|NCT03167242|450467972|FG000|Overall Study|Patient/Guardian Decision|0|||
125229274|NCT03167242|450467973|FG001|Overall Study|Patient/Guardian Decision|1|||
125229275|NCT03167242|450467974|FG002|Overall Study|Patient/Guardian Decision|2|||
125229276|NCT03167242|450467975|FG003|Overall Study|Patient/Guardian Decision|1|||
125229277|NCT03167242|450467976|FG004|Overall Study|Patient/Guardian Decision|1|||
125229278|NCT03167242|450467977|FG005|Overall Study|Patient/Guardian Decision|1|||
125229279|NCT03167242|450467978|FG006|Overall Study|Patient/Guardian Decision|0|||
125229280|NCT03167242|450467979|FG007|Overall Study|Patient/Guardian Decision|0|||
125229281|NCT03167242|450467980|FG008|Overall Study|Patient/Guardian Decision|0|||
125229282|NCT03167242|450467981|FG009|Overall Study|Patient/Guardian Decision|0|||
125229283|NCT03167242|450467982|FG010|Overall Study|Patient/Guardian Decision|1|||
125229284|NCT03167242|450467983|FG011|Overall Study|Patient/Guardian Decision|0|||
125229285|NCT03167242|450467972|FG000|Overall Study|Lost to Follow-up|0|||
125229286|NCT03167242|450467973|FG001|Overall Study|Lost to Follow-up|0|||
125229287|NCT03167242|450467974|FG002|Overall Study|Lost to Follow-up|1|||
125229288|NCT03167242|450467975|FG003|Overall Study|Lost to Follow-up|0|||
125229289|NCT03167242|450467976|FG004|Overall Study|Lost to Follow-up|0|||
125229290|NCT03167242|450467977|FG005|Overall Study|Lost to Follow-up|1|||
125229291|NCT03167242|450467978|FG006|Overall Study|Lost to Follow-up|2|||
125229292|NCT03167242|450467979|FG007|Overall Study|Lost to Follow-up|1|||
125229293|NCT03167242|450467980|FG008|Overall Study|Lost to Follow-up|0|||
125229294|NCT03167242|450467981|FG009|Overall Study|Lost to Follow-up|0|||
125229295|NCT03167242|450467982|FG010|Overall Study|Lost to Follow-up|1|||
125229296|NCT03167242|450467983|FG011|Overall Study|Lost to Follow-up|1|||
125229297|NCT03167242|450467972|FG000|Overall Study|Reason not provided|0|||
125229298|NCT03167242|450467973|FG001|Overall Study|Reason not provided|0|||
125229299|NCT03167242|450467974|FG002|Overall Study|Reason not provided|0|||
125229300|NCT03167242|450467975|FG003|Overall Study|Reason not provided|0|||
125229301|NCT03167242|450467976|FG004|Overall Study|Reason not provided|0|||
125229302|NCT03167242|450467977|FG005|Overall Study|Reason not provided|0|||
125229303|NCT03167242|450467978|FG006|Overall Study|Reason not provided|0|||
125229304|NCT03167242|450467979|FG007|Overall Study|Reason not provided|0|||
125229305|NCT03167242|450467980|FG008|Overall Study|Reason not provided|1|||
125229306|NCT03167242|450467981|FG009|Overall Study|Reason not provided|0|||
125229307|NCT03167242|450467982|FG010|Overall Study|Reason not provided|0|||
125229308|NCT03167242|450467983|FG011|Overall Study|Reason not provided|0|||
125229309|NCT01909804|450467984|FG000|Overall Study|Randomized but Never Treated|0|||
125229310|NCT01909804|450467985|FG001|Overall Study|Randomized but Never Treated|0|||
125229311|NCT01909804|450467986|FG002|Overall Study|Randomized but Never Treated|0|||
125229312|NCT01909804|450467987|FG003|Overall Study|Randomized but Never Treated|0|||
125229313|NCT01909804|450467988|FG004|Overall Study|Randomized but Never Treated|0|||
125229314|NCT01909804|450467989|FG005|Overall Study|Randomized but Never Treated|0|||
125229315|NCT01909804|450467990|FG006|Overall Study|Randomized but Never Treated|1|||
125229316|NCT01909804|450467991|FG007|Overall Study|Randomized but Never Treated|0|||
125229317|NCT01909804|450467992|FG008|Overall Study|Randomized but Never Treated|0|||
125229318|NCT01909804|450467993|FG009|Overall Study|Randomized but Never Treated|0|||
125229319|NCT01909804|450467994|FG010|Overall Study|Randomized but Never Treated|0|||
125229320|NCT01909804|450467995|FG011|Overall Study|Randomized but Never Treated|1|||
125229321|NCT01909804|450467984|FG000|Overall Study|Death|0|||
125171123|NCT01371747|450249446|FG002|Overall Study|Abnormal Renal Function|0|||
125171124|NCT01371747|450249447|FG003|Overall Study|Abnormal Renal Function|1|||
125171125|NCT01371747|450249448|FG004|Overall Study|Abnormal Renal Function|0|||
125171126|NCT01371747|450249449|FG005|Overall Study|Abnormal Renal Function|1|||
125171127|NCT01371747|450249444|FG000|Overall Study|High Serum Potassium Results|1|||
125171128|NCT01371747|450249445|FG001|Overall Study|High Serum Potassium Results|1|||
125171129|NCT01371747|450249446|FG002|Overall Study|High Serum Potassium Results|1|||
125171130|NCT01371747|450249447|FG003|Overall Study|High Serum Potassium Results|2|||
125171131|NCT01371747|450249448|FG004|Overall Study|High Serum Potassium Results|0|||
125171132|NCT01371747|450249449|FG005|Overall Study|High Serum Potassium Results|2|||
125171133|NCT01371747|450249444|FG000|Overall Study|Low Serum Potassium Results|1|||
125171134|NCT01371747|450249445|FG001|Overall Study|Low Serum Potassium Results|1|||
125171135|NCT01371747|450249446|FG002|Overall Study|Low Serum Potassium Results|1|||
125229322|NCT01909804|450467985|FG001|Overall Study|Death|0|||
125229323|NCT01909804|450467986|FG002|Overall Study|Death|0|||
125229324|NCT01909804|450467987|FG003|Overall Study|Death|0|||
125229325|NCT01909804|450467988|FG004|Overall Study|Death|0|||
125171136|NCT01371747|450249447|FG003|Overall Study|Low Serum Potassium Results|1|||
125229326|NCT01909804|450467989|FG005|Overall Study|Death|0|||
125229327|NCT01909804|450467990|FG006|Overall Study|Death|0|||
125229328|NCT01909804|450467991|FG007|Overall Study|Death|0|||
125229329|NCT01909804|450467992|FG008|Overall Study|Death|0|||
125171137|NCT01371747|450249448|FG004|Overall Study|Low Serum Potassium Results|0|||
125171138|NCT01371747|450249449|FG005|Overall Study|Low Serum Potassium Results|3|||
125171139|NCT01371747|450249444|FG000|Overall Study|Protocol Violation|0|||
125171140|NCT01371747|450249445|FG001|Overall Study|Protocol Violation|0|||
125171141|NCT01371747|450249446|FG002|Overall Study|Protocol Violation|1|||
125171142|NCT01371747|450249447|FG003|Overall Study|Protocol Violation|0|||
125171143|NCT01371747|450249448|FG004|Overall Study|Protocol Violation|0|||
125171144|NCT01371747|450249449|FG005|Overall Study|Protocol Violation|0|||
125171145|NCT01371747|450249444|FG000|Overall Study|Non-Compliance|3|||
125171146|NCT01371747|450249445|FG001|Overall Study|Non-Compliance|4|||
125171147|NCT01371747|450249446|FG002|Overall Study|Non-Compliance|3|||
125171148|NCT01371747|450249447|FG003|Overall Study|Non-Compliance|0|||
125171149|NCT01371747|450249448|FG004|Overall Study|Non-Compliance|0|||
125171150|NCT01371747|450249449|FG005|Overall Study|Non-Compliance|1|||
125171151|NCT01371747|450249444|FG000|Overall Study|Physician Decision|0|||
125171152|NCT01371747|450249445|FG001|Overall Study|Physician Decision|0|||
125171153|NCT01371747|450249446|FG002|Overall Study|Physician Decision|0|||
125171154|NCT01371747|450249447|FG003|Overall Study|Physician Decision|0|||
125171155|NCT01371747|450249448|FG004|Overall Study|Physician Decision|1|||
125171156|NCT01371747|450249449|FG005|Overall Study|Physician Decision|0|||
125171157|NCT01371747|450249444|FG000|Overall Study|Withdrawal by Subject|6|||
125171158|NCT01371747|450249445|FG001|Overall Study|Withdrawal by Subject|12|||
125171159|NCT01371747|450249446|FG002|Overall Study|Withdrawal by Subject|5|||
125171160|NCT01371747|450249447|FG003|Overall Study|Withdrawal by Subject|2|||
125171161|NCT01371747|450249448|FG004|Overall Study|Withdrawal by Subject|2|||
125171162|NCT01371747|450249449|FG005|Overall Study|Withdrawal by Subject|4|||
125171163|NCT01371747|450249444|FG000|Overall Study|Other Reasons|2|||
125171164|NCT01371747|450249445|FG001|Overall Study|Other Reasons|1|||
125171165|NCT01371747|450249446|FG002|Overall Study|Other Reasons|2|||
125171166|NCT01371747|450249447|FG003|Overall Study|Other Reasons|0|||
125171167|NCT01371747|450249448|FG004|Overall Study|Other Reasons|0|||
125171168|NCT01371747|450249449|FG005|Overall Study|Other Reasons|1|||
125171169|NCT03092219|450249450|FG000|Overall Study|Protocol Violation|7|||
125171170|NCT03092219|450249451|FG001|Overall Study|Protocol Violation|4|||
125171171|NCT01443728|450249452|FG000|Overall Study|Lost to Follow-up|2|||
125171172|NCT01443728|450249453|FG001|Overall Study|Lost to Follow-up|0|||
125171173|NCT01443728|450249452|FG000|Overall Study|Withdrawal by Subject|1|||
125171174|NCT01443728|450249453|FG001|Overall Study|Withdrawal by Subject|1|||
125171175|NCT01443728|450249452|FG000|Overall Study|Adverse Event|0|||
125171176|NCT01443728|450249453|FG001|Overall Study|Adverse Event|2|||
125171177|NCT01403051|450249454|FG000|Overall Study|Protocol Violation|2|||
125171178|NCT01403051|450249455|FG001|Overall Study|Protocol Violation|0|||
125171179|NCT01403051|450249454|FG000|Overall Study|Death|1|||
125171180|NCT01403051|450249455|FG001|Overall Study|Death|0|||
125171181|NCT01403051|450249454|FG000|Overall Study|Withdrawal by Subject|2|||
125171182|NCT01403051|450249455|FG001|Overall Study|Withdrawal by Subject|1|||
125171183|NCT01403051|450249454|FG000|Overall Study|Lost to Follow-up|5|||
125171184|NCT01403051|450249455|FG001|Overall Study|Lost to Follow-up|5|||
125171185|NCT04497948|450249463|FG000|Overall Study|Death|2|||
125171186|NCT02242045|450249464|FG000|Overall Study|Investigator's Discretion|1|||
125171187|NCT02242045|450249464|FG000|Overall Study|Progressive Disease|2|||
125171188|NCT02242045|450249464|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
125171189|NCT02242045|450249464|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
125171190|NCT03760185|450249465|FG000|Overall Study|Lost to Follow-up|1|||
125171191|NCT03760185|450249466|FG001|Overall Study|Lost to Follow-up|1|||
125171192|NCT02473523|450249467|FG000|Overall Study|Death|1|||
125171193|NCT02473523|450249467|FG000|Overall Study|Lost to Follow-up|1|||
125171194|NCT00976911|450249470|FG000|Overall Study|Withdrawal by Subject|4|||
125171195|NCT00976911|450249471|FG001|Overall Study|Withdrawal by Subject|6|||
125171196|NCT00976911|450249470|FG000|Overall Study|Death|138|||
125171197|NCT00976911|450249471|FG001|Overall Study|Death|126|||
125171198|NCT00976911|450249470|FG000|Overall Study|Adverse Event|0|||
125171199|NCT00976911|450249471|FG001|Overall Study|Adverse Event|1|||
125171200|NCT00976911|450249470|FG000|Overall Study|Protocol Violation|2|||
125171201|NCT00976911|450249471|FG001|Overall Study|Protocol Violation|0|||
125171202|NCT00976911|450249470|FG000|Overall Study|Other|8|||
125171203|NCT00976911|450249471|FG001|Overall Study|Other|9|||
125171204|NCT00976911|450249470|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
125171205|NCT00976911|450249471|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
125171206|NCT02954991|450249472|FG000|Overall Study|Death|92|||
125171207|NCT02954991|450249473|FG001|Overall Study|Death|11|||
125171208|NCT02954991|450249474|FG002|Overall Study|Death|2|||
125171209|NCT02954991|450249472|FG000|Overall Study|Lost to Follow-up|3|||
125171210|NCT02954991|450249473|FG001|Overall Study|Lost to Follow-up|2|||
125171211|NCT02954991|450249474|FG002|Overall Study|Lost to Follow-up|0|||
125171212|NCT02954991|450249472|FG000|Overall Study|Withdrawal by Subject|9|||
125171213|NCT02954991|450249473|FG001|Overall Study|Withdrawal by Subject|8|||
125171214|NCT02954991|450249474|FG002|Overall Study|Withdrawal by Subject|1|||
125171215|NCT02954991|450249472|FG000|Overall Study|Study Terminated by Sponsor|18|||
125171216|NCT02954991|450249473|FG001|Overall Study|Study Terminated by Sponsor|10|||
125229330|NCT01909804|450467993|FG009|Overall Study|Death|0|||
125171217|NCT02954991|450249474|FG002|Overall Study|Study Terminated by Sponsor|1|||
125171218|NCT02954991|450249472|FG000|Overall Study|Miscellaneous|2|||
125171219|NCT02954991|450249473|FG001|Overall Study|Miscellaneous|1|||
125171220|NCT02954991|450249474|FG002|Overall Study|Miscellaneous|1|||
125171221|NCT00576316|450249475|FG000|Overall Study|Adverse Event|9|||
125171222|NCT00576316|450249475|FG000|Overall Study|Withdrawal by Subject|2|||
125171223|NCT00576316|450249475|FG000|Overall Study|Protocol Violation|9|||
125171224|NCT02648932|450249477|FG000|Overall Study|No transplant|3|||
125171225|NCT02648932|450249478|FG001|Overall Study|No transplant|1|||
125171226|NCT01434810|450249479|FG000|Overall Study|Did not receive treatment|11|||
125171227|NCT01434810|450249480|FG001|Overall Study|Did not receive treatment|3|||
125171228|NCT01434810|450249479|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
125171229|NCT01434810|450249480|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
125171230|NCT04893018|450249483|FG000|Overall Study|Lost to Follow-up|1|||
125171231|NCT04893018|450249484|FG001|Overall Study|Lost to Follow-up|0|||
125171232|NCT04893018|450249483|FG000|Overall Study|Withdrawal by Subject|2|||
125171233|NCT04893018|450249484|FG001|Overall Study|Withdrawal by Subject|0|||
125171234|NCT04893018|450249483|FG000|Overall Study|Study Terminated|1|||
125171235|NCT04893018|450249484|FG001|Overall Study|Study Terminated|2|||
125171236|NCT01307111|450249487|FG000|IUD Insertion|Lost to Follow-up|2|||
125171237|NCT01307111|450249488|FG001|IUD Insertion|Lost to Follow-up|0|||
125171238|NCT01307111|450249487|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
125171239|NCT01307111|450249488|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
125171240|NCT02842073|450249497|FG000|Overall Study|Withdrawal by Subject|1|||
125171241|NCT00195338|450249498|FG000|Overall Study|Lost to Follow-up|2|||
125171242|NCT00195338|450249498|FG000|Overall Study|Adverse Event|5|||
125171243|NCT00195338|450249498|FG000|Overall Study|Lack of Efficacy|1|||
125171244|NCT00195338|450249498|FG000|Overall Study|Early closure of the site|4|||
125171245|NCT02252406|450249499|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
125171246|NCT02252406|450249500|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
125171247|NCT02252406|450249499|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
125171248|NCT02252406|450249500|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
125171249|NCT02252406|450249499|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
125171250|NCT02252406|450249500|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
125171251|NCT02252406|450249499|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
125171252|NCT02252406|450249500|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
125171253|NCT02252406|450249499|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
125171254|NCT02252406|450249500|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
125171255|NCT00447876|450249503|FG000|Overall Study|Withdrawal by Subject|1|||
125171256|NCT00447876|450249504|FG001|Overall Study|Withdrawal by Subject|4|||
125171257|NCT00447876|450249503|FG000|Overall Study|Lost to Follow-up|1|||
125171258|NCT00447876|450249504|FG001|Overall Study|Lost to Follow-up|0|||
125171259|NCT00447876|450249503|FG000|Overall Study|Deterioration of symptomology|1|||
125171260|NCT00447876|450249504|FG001|Overall Study|Deterioration of symptomology|0|||
125171261|NCT02533180|450249505|FG000|Overall Study|Death|0|||
125171262|NCT02533180|450249506|FG001|Overall Study|Death|2|||
125171263|NCT02533180|450249505|FG000|Overall Study|Lost to Follow-up|0|||
125171264|NCT02533180|450249506|FG001|Overall Study|Lost to Follow-up|1|||
125171265|NCT02533180|450249505|FG000|Overall Study|Physician Decision|0|||
125171266|NCT02533180|450249506|FG001|Overall Study|Physician Decision|1|||
125171267|NCT02533180|450249505|FG000|Overall Study|Withdrawal by Subject|2|||
125171268|NCT02533180|450249506|FG001|Overall Study|Withdrawal by Subject|5|||
125171269|NCT02533180|450249505|FG000|Overall Study|Screen Failure|37|||
125171270|NCT02533180|450249506|FG001|Overall Study|Screen Failure|0|||
125171271|NCT02533180|450249505|FG000|Overall Study|Protocol Deviation|0|||
125171272|NCT02533180|450249506|FG001|Overall Study|Protocol Deviation|1|||
125171273|NCT02533180|450249505|FG000|Overall Study|Non-compliance|0|||
125171274|NCT02533180|450249506|FG001|Overall Study|Non-compliance|1|||
125171275|NCT01609023|450249509|FG000|Overall Study|Lack of Efficacy|3|||
125171276|NCT01609023|450249509|FG000|Overall Study|Withdrawal by Subject|4|||
125171277|NCT01609023|450249509|FG000|Overall Study|Lost to Follow-up|8|||
125171278|NCT01609023|450249509|FG000|Overall Study|Toxicity|3|||
125171279|NCT01609023|450249509|FG000|Overall Study|Disease progression|10|||
125171280|NCT01609023|450249509|FG000|Overall Study|Physician Decision|2|||
125171281|NCT01609023|450249509|FG000|Overall Study|Death|2|||
125171282|NCT01609023|450249509|FG000|Overall Study|Personal reasons|1|||
125171283|NCT02047734|450249511|FG000|Overall Study|Adverse Event|18|||
125171284|NCT02047734|450249512|FG001|Overall Study|Adverse Event|13|||
125171285|NCT02047734|450249513|FG002|Overall Study|Adverse Event|13|||
125229331|NCT01909804|450467994|FG010|Overall Study|Death|1|||
125171286|NCT02047734|450249511|FG000|Overall Study|Lack of Efficacy|4|||
125171287|NCT02047734|450249512|FG001|Overall Study|Lack of Efficacy|5|||
125171288|NCT02047734|450249513|FG002|Overall Study|Lack of Efficacy|1|||
125171289|NCT02047734|450249511|FG000|Overall Study|Protocol Violation|3|||
125171290|NCT02047734|450249512|FG001|Overall Study|Protocol Violation|1|||
125171291|NCT02047734|450249513|FG002|Overall Study|Protocol Violation|1|||
125171292|NCT02047734|450249511|FG000|Overall Study|Lost to Follow-up|1|||
125171293|NCT02047734|450249512|FG001|Overall Study|Lost to Follow-up|4|||
125171294|NCT02047734|450249513|FG002|Overall Study|Lost to Follow-up|0|||
125171295|NCT02047734|450249511|FG000|Overall Study|Death|0|||
125171296|NCT02047734|450249512|FG001|Overall Study|Death|1|||
125171297|NCT02047734|450249513|FG002|Overall Study|Death|0|||
125171298|NCT02047734|450249511|FG000|Overall Study|Withdrawal by Subject|30|||
125171299|NCT02047734|450249512|FG001|Overall Study|Withdrawal by Subject|31|||
125171300|NCT02047734|450249513|FG002|Overall Study|Withdrawal by Subject|19|||
125171301|NCT02047734|450249511|FG000|Overall Study|Physician Decision|7|||
125171302|NCT02047734|450249512|FG001|Overall Study|Physician Decision|6|||
125171303|NCT02047734|450249513|FG002|Overall Study|Physician Decision|5|||
125171304|NCT02047734|450249511|FG000|Overall Study|Miscellaneous|2|||
125171305|NCT02047734|450249512|FG001|Overall Study|Miscellaneous|4|||
125171306|NCT02047734|450249513|FG002|Overall Study|Miscellaneous|6|||
125229332|NCT01909804|450467995|FG011|Overall Study|Death|0|||
125229333|NCT01909804|450467984|FG000|Overall Study|Lack of Efficacy|4|||
125229334|NCT01909804|450467985|FG001|Overall Study|Lack of Efficacy|1|||
125229335|NCT01909804|450467986|FG002|Overall Study|Lack of Efficacy|0|||
125229336|NCT01909804|450467987|FG003|Overall Study|Lack of Efficacy|0|||
125229337|NCT01909804|450467988|FG004|Overall Study|Lack of Efficacy|7|||
125229338|NCT01909804|450467989|FG005|Overall Study|Lack of Efficacy|3|||
125229339|NCT01909804|450467990|FG006|Overall Study|Lack of Efficacy|1|||
125229340|NCT01909804|450467991|FG007|Overall Study|Lack of Efficacy|1|||
125229341|NCT01909804|450467992|FG008|Overall Study|Lack of Efficacy|0|||
125229342|NCT01909804|450467993|FG009|Overall Study|Lack of Efficacy|1|||
125229343|NCT01909804|450467994|FG010|Overall Study|Lack of Efficacy|0|||
125229344|NCT01909804|450467995|FG011|Overall Study|Lack of Efficacy|1|||
125229345|NCT01909804|450467984|FG000|Overall Study|Withdrew Consent|0|||
125229346|NCT01909804|450467985|FG001|Overall Study|Withdrew Consent|0|||
125229347|NCT01909804|450467986|FG002|Overall Study|Withdrew Consent|0|||
125229348|NCT01909804|450467987|FG003|Overall Study|Withdrew Consent|0|||
125229349|NCT01909804|450467988|FG004|Overall Study|Withdrew Consent|1|||
125229350|NCT01909804|450467989|FG005|Overall Study|Withdrew Consent|1|||
125229351|NCT01909804|450467990|FG006|Overall Study|Withdrew Consent|0|||
125229352|NCT01909804|450467991|FG007|Overall Study|Withdrew Consent|0|||
125229353|NCT01909804|450467992|FG008|Overall Study|Withdrew Consent|0|||
125229354|NCT01909804|450467993|FG009|Overall Study|Withdrew Consent|0|||
125229355|NCT01909804|450467994|FG010|Overall Study|Withdrew Consent|0|||
125229356|NCT01909804|450467995|FG011|Overall Study|Withdrew Consent|0|||
125229357|NCT01909804|450467984|FG000|Overall Study|Protocol Violation|0|||
125229358|NCT01909804|450467985|FG001|Overall Study|Protocol Violation|0|||
125229359|NCT01909804|450467986|FG002|Overall Study|Protocol Violation|0|||
125229360|NCT01909804|450467987|FG003|Overall Study|Protocol Violation|0|||
125229361|NCT01909804|450467988|FG004|Overall Study|Protocol Violation|0|||
125229362|NCT01909804|450467989|FG005|Overall Study|Protocol Violation|0|||
125229363|NCT01909804|450467990|FG006|Overall Study|Protocol Violation|0|||
125229364|NCT01909804|450467991|FG007|Overall Study|Protocol Violation|0|||
125229365|NCT01909804|450467992|FG008|Overall Study|Protocol Violation|0|||
125229366|NCT01909804|450467993|FG009|Overall Study|Protocol Violation|0|||
125229367|NCT01909804|450467994|FG010|Overall Study|Protocol Violation|0|||
125229368|NCT01909804|450467995|FG011|Overall Study|Protocol Violation|1|||
125229369|NCT02144701|450467997|FG000|Overall Study|development of relapse, GVHD or death|9|||
125229370|NCT02144701|450467998|FG001|Overall Study|development of relapse, GVHD or death|3|||
125229371|NCT03217591|450467999|FG000|Overall Study|Adverse Event|1|||
125229372|NCT03217591|450468000|FG001|Overall Study|Adverse Event|2|||
125229373|NCT03217591|450468001|FG002|Overall Study|Adverse Event|6|||
125229374|NCT03217591|450467999|FG000|Overall Study|Withdrawal by Subject|0|||
125229375|NCT03217591|450468000|FG001|Overall Study|Withdrawal by Subject|1|||
125229376|NCT03217591|450468001|FG002|Overall Study|Withdrawal by Subject|3|||
125229377|NCT03217591|450467999|FG000|Overall Study|Lost to Follow-up|1|||
125229378|NCT03217591|450468000|FG001|Overall Study|Lost to Follow-up|0|||
125229379|NCT03217591|450468001|FG002|Overall Study|Lost to Follow-up|0|||
125229380|NCT03217591|450467999|FG000|Overall Study|Protocol Violation|1|||
125229381|NCT03217591|450468000|FG001|Overall Study|Protocol Violation|0|||
125229382|NCT03217591|450468001|FG002|Overall Study|Protocol Violation|1|||
125229383|NCT00249834|450468002|FG000|Overall Study|Ovarian stimulation failed|1|||
125229384|NCT00249834|450468003|FG001|Overall Study|Ovarian stimulation failed|0|||
125229385|NCT00249834|450468004|FG002|Overall Study|Ovarian stimulation failed|0|||
125229386|NCT00249834|450468005|FG003|Overall Study|Ovarian stimulation failed|0|||
125229387|NCT00249834|450468006|FG004|Overall Study|Ovarian stimulation failed|0|||
125229388|NCT00249834|450468007|FG005|Overall Study|Ovarian stimulation failed|0|||
125229389|NCT00249834|450468008|FG006|Overall Study|Ovarian stimulation failed|0|||
125229390|NCT00249834|450468009|FG007|Overall Study|Ovarian stimulation failed|0|||
125229391|NCT00249834|450468002|FG000|Overall Study|Failure of down-regulation|0|||
125229392|NCT00249834|450468003|FG001|Overall Study|Failure of down-regulation|0|||
125229393|NCT00249834|450468004|FG002|Overall Study|Failure of down-regulation|0|||
125171307|NCT02047734|450249511|FG000|Overall Study|Did Not Receive Study Drug|2|||
125171308|NCT02047734|450249512|FG001|Overall Study|Did Not Receive Study Drug|4|||
125171309|NCT02047734|450249513|FG002|Overall Study|Did Not Receive Study Drug|1|||
125171310|NCT02952586|450249519|FG000|Lead-In Phase (7 Days)|Death|0|||
125171311|NCT02952586|450249520|FG001|Lead-In Phase (7 Days)|Death|1|||
125171312|NCT02952586|450249519|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
125171313|NCT02952586|450249520|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
125171314|NCT02952586|450249519|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
125171315|NCT02952586|450249520|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
125171316|NCT02952586|450249519|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
125171317|NCT02952586|450249520|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
125171318|NCT02952586|450249519|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
125171319|NCT02952586|450249520|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
125171320|NCT02952586|450249519|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
125171321|NCT02952586|450249520|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
125171322|NCT02952586|450249519|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
125171323|NCT02952586|450249520|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
125171324|NCT02952586|450249519|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
125171325|NCT02952586|450249520|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
125171326|NCT02952586|450249519|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
125171327|NCT02952586|450249520|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
125171328|NCT02952586|450249519|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
125171329|NCT02952586|450249520|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
125171330|NCT02952586|450249519|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
125171331|NCT02952586|450249520|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
125171332|NCT02952586|450249519|FG000|CRT for Cisplatin (63 Days)|Death|3|||
125171333|NCT02952586|450249520|FG001|CRT for Cisplatin (63 Days)|Death|8|||
125171334|NCT02952586|450249519|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
125171335|NCT02952586|450249520|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
125171336|NCT02952586|450249519|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
125171337|NCT02952586|450249520|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
125171338|NCT02952586|450249519|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
125171339|NCT02952586|450249520|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
125171340|NCT02952586|450249519|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
125171341|NCT02952586|450249520|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
125171342|NCT02952586|450249519|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
125171343|NCT02952586|450249520|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
125171344|NCT02952586|450249519|FG000|CRT for Cisplatin (63 Days)|Other|1|||
125171345|NCT02952586|450249520|FG001|CRT for Cisplatin (63 Days)|Other|1|||
125171346|NCT02952586|450249519|FG000|CRT for IMRT (63 Days)|Death|5|||
125171347|NCT02952586|450249520|FG001|CRT for IMRT (63 Days)|Death|8|||
125171348|NCT02952586|450249519|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
125171349|NCT02952586|450249520|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
125171350|NCT02952586|450249519|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
125171351|NCT02952586|450249520|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
125171352|NCT02952586|450249519|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
125171353|NCT02952586|450249520|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
125171354|NCT02952586|450249519|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
125171355|NCT02952586|450249520|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
125229394|NCT00249834|450468005|FG003|Overall Study|Failure of down-regulation|0|||
125229395|NCT00249834|450468006|FG004|Overall Study|Failure of down-regulation|0|||
125229396|NCT00249834|450468007|FG005|Overall Study|Failure of down-regulation|0|||
125229397|NCT00249834|450468008|FG006|Overall Study|Failure of down-regulation|1|||
125229398|NCT00249834|450468009|FG007|Overall Study|Failure of down-regulation|0|||
125229399|NCT00249834|450468002|FG000|Overall Study|Protocol Violation|0|||
125229400|NCT00249834|450468003|FG001|Overall Study|Protocol Violation|19|||
125229401|NCT00249834|450468004|FG002|Overall Study|Protocol Violation|14|||
125229402|NCT00249834|450468005|FG003|Overall Study|Protocol Violation|8|||
125229403|NCT00249834|450468006|FG004|Overall Study|Protocol Violation|5|||
125229404|NCT00249834|450468007|FG005|Overall Study|Protocol Violation|2|||
125229405|NCT00249834|450468008|FG006|Overall Study|Protocol Violation|0|||
125229406|NCT00249834|450468009|FG007|Overall Study|Protocol Violation|0|||
125229407|NCT00269152|450468013|FG000|Overall Study|Adverse Event|9|||
125229408|NCT00269152|450468014|FG001|Overall Study|Adverse Event|3|||
125229409|NCT00269152|450468013|FG000|Overall Study|Withdrawal by Subject|7|||
125229410|NCT00269152|450468014|FG001|Overall Study|Withdrawal by Subject|3|||
125229411|NCT00269152|450468013|FG000|Overall Study|Physician Decision|2|||
125229412|NCT00269152|450468014|FG001|Overall Study|Physician Decision|3|||
125229413|NCT00269152|450468013|FG000|Overall Study|Protocol Violation|0|||
125229414|NCT00269152|450468014|FG001|Overall Study|Protocol Violation|1|||
125229415|NCT04249427|450468015|FG000|Overall Study|Adverse Event|3|||
125229416|NCT04249427|450468016|FG001|Overall Study|Adverse Event|1|||
125229417|NCT04249427|450468015|FG000|Overall Study|Lack of Efficacy|0|||
125171356|NCT02952586|450249519|FG000|CRT for IMRT (63 Days)|Other|1|||
125229418|NCT04249427|450468016|FG001|Overall Study|Lack of Efficacy|1|||
125229419|NCT04249427|450468015|FG000|Overall Study|Withdrawal by Subject|1|||
125171357|NCT02952586|450249520|FG001|CRT for IMRT (63 Days)|Other|0|||
125171358|NCT02952586|450249519|FG000|Maintenance Phase (12 Months)|Death|17|||
125171359|NCT02952586|450249520|FG001|Maintenance Phase (12 Months)|Death|11|||
125171360|NCT02952586|450249519|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
125171361|NCT02952586|450249520|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
125171362|NCT02952586|450249519|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
125171363|NCT02952586|450249520|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
125171364|NCT02952586|450249519|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
125171365|NCT02952586|450249520|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
125171366|NCT02952586|450249519|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
125171367|NCT02952586|450249520|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
125171368|NCT02952586|450249519|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
125171369|NCT02952586|450249520|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
125171370|NCT02952586|450249519|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
125171371|NCT02952586|450249520|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
125171372|NCT02952586|450249519|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
125171373|NCT02952586|450249520|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
125171374|NCT02952586|450249519|FG000|Maintenance Phase (12 Months)|Other|2|||
125171375|NCT02952586|450249520|FG001|Maintenance Phase (12 Months)|Other|1|||
125171376|NCT02952586|450249519|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
125171377|NCT02952586|450249520|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
125171378|NCT02952586|450249519|FG000|Follow-Up Phase (90 Days)|Death|12|||
125171379|NCT02952586|450249520|FG001|Follow-Up Phase (90 Days)|Death|10|||
125171380|NCT02952586|450249519|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
125171381|NCT02952586|450249520|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
125171382|NCT02952586|450249519|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
125171383|NCT02952586|450249520|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
125171384|NCT02952586|450249519|FG000|Follow-Up Phase (90 Days)|Other|7|||
125171385|NCT02952586|450249520|FG001|Follow-Up Phase (90 Days)|Other|5|||
125171386|NCT02952586|450249519|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
125171387|NCT02952586|450249520|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
125171388|NCT02952586|450249519|FG000|LT Follow-up (up to 45 Months)|Death|51|||
125171389|NCT02952586|450249520|FG001|LT Follow-up (up to 45 Months)|Death|31|||
125171390|NCT02952586|450249519|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
125171391|NCT02952586|450249520|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
125171392|NCT02952586|450249519|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
125171393|NCT02952586|450249520|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
125171394|NCT02952586|450249519|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
125171395|NCT02952586|450249520|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
125171396|NCT00492778|450249521|FG000|Overall Study|Ineligible by Pathology Review|8|||
125171397|NCT00492778|450249522|FG001|Overall Study|Ineligible by Pathology Review|1|||
125171398|NCT00789035|450249523|FG000|Overall Study|Adverse Event|0|||
125171399|NCT00789035|450249524|FG001|Overall Study|Adverse Event|2|||
125171400|NCT00789035|450249525|FG002|Overall Study|Adverse Event|0|||
125171401|NCT00789035|450249526|FG003|Overall Study|Adverse Event|1|||
125171402|NCT00789035|450249527|FG004|Overall Study|Adverse Event|3|||
125171403|NCT00789035|450249523|FG000|Overall Study|Lack of Efficacy|3|||
125171404|NCT00789035|450249524|FG001|Overall Study|Lack of Efficacy|0|||
125171405|NCT00789035|450249525|FG002|Overall Study|Lack of Efficacy|0|||
125171406|NCT00789035|450249526|FG003|Overall Study|Lack of Efficacy|0|||
125171407|NCT00789035|450249527|FG004|Overall Study|Lack of Efficacy|2|||
125171408|NCT00789035|450249523|FG000|Overall Study|Protocol Violation|1|||
125171409|NCT00789035|450249524|FG001|Overall Study|Protocol Violation|0|||
125171410|NCT00789035|450249525|FG002|Overall Study|Protocol Violation|0|||
125171411|NCT00789035|450249526|FG003|Overall Study|Protocol Violation|0|||
125171412|NCT00789035|450249527|FG004|Overall Study|Protocol Violation|0|||
125171413|NCT00789035|450249523|FG000|Overall Study|Withdrawal by Subject|0|||
125171414|NCT00789035|450249524|FG001|Overall Study|Withdrawal by Subject|2|||
125171415|NCT00789035|450249525|FG002|Overall Study|Withdrawal by Subject|0|||
125171416|NCT00789035|450249526|FG003|Overall Study|Withdrawal by Subject|0|||
125171417|NCT00789035|450249527|FG004|Overall Study|Withdrawal by Subject|0|||
125171418|NCT00789035|450249523|FG000|Overall Study|Other reason not defined above|2|||
125171419|NCT00789035|450249524|FG001|Overall Study|Other reason not defined above|3|||
125171420|NCT00789035|450249525|FG002|Overall Study|Other reason not defined above|1|||
125171421|NCT00789035|450249526|FG003|Overall Study|Other reason not defined above|0|||
125171422|NCT00789035|450249527|FG004|Overall Study|Other reason not defined above|1|||
125171423|NCT01118975|450249528|FG000|Overall Study|Adverse Event|0|||
125171424|NCT01118975|450249529|FG001|Overall Study|Adverse Event|1|||
125171425|NCT00789737|450249540|FG000|Overall Study|Withdrawal by Subject|13|||
125171426|NCT00789737|450249541|FG001|Overall Study|Withdrawal by Subject|22|||
125171427|NCT00789737|450249540|FG000|Overall Study|Lost to Follow-up|10|||
125171428|NCT00789737|450249541|FG001|Overall Study|Lost to Follow-up|14|||
125171429|NCT00789737|450249540|FG000|Overall Study|Adverse Event|8|||
125171430|NCT00789737|450249541|FG001|Overall Study|Adverse Event|8|||
125171431|NCT00789737|450249540|FG000|Overall Study|Protocol Violation|3|||
125171432|NCT00789737|450249541|FG001|Overall Study|Protocol Violation|0|||
125171433|NCT00789737|450249540|FG000|Overall Study|Lack of Efficacy|3|||
125171434|NCT00789737|450249541|FG001|Overall Study|Lack of Efficacy|0|||
125171435|NCT00789737|450249540|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
125171436|NCT00789737|450249541|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
125171437|NCT00789737|450249540|FG000|Overall Study|Other|11|||
125171438|NCT00789737|450249541|FG001|Overall Study|Other|7|||
125171439|NCT00384930|450249542|FG000|Overall Study|Adverse Event|5|||
125171440|NCT00384930|450249543|FG001|Overall Study|Adverse Event|4|||
125171441|NCT00384930|450249544|FG002|Overall Study|Adverse Event|12|||
125171442|NCT00384930|450249545|FG003|Overall Study|Adverse Event|11|||
125171443|NCT00384930|450249546|FG004|Overall Study|Adverse Event|14|||
125171444|NCT00384930|450249542|FG000|Overall Study|Entry Criteria Not Met|2|||
125171445|NCT00384930|450249543|FG001|Overall Study|Entry Criteria Not Met|6|||
125171446|NCT00384930|450249544|FG002|Overall Study|Entry Criteria Not Met|7|||
125171447|NCT00384930|450249545|FG003|Overall Study|Entry Criteria Not Met|8|||
125171448|NCT00384930|450249546|FG004|Overall Study|Entry Criteria Not Met|4|||
125229420|NCT04249427|450468016|FG001|Overall Study|Withdrawal by Subject|2|||
125171449|NCT00384930|450249542|FG000|Overall Study|Lack of Efficacy|1|||
125171450|NCT00384930|450249543|FG001|Overall Study|Lack of Efficacy|1|||
125171451|NCT00384930|450249544|FG002|Overall Study|Lack of Efficacy|2|||
125171452|NCT00384930|450249545|FG003|Overall Study|Lack of Efficacy|1|||
125171453|NCT00384930|450249546|FG004|Overall Study|Lack of Efficacy|2|||
125229421|NCT03886272|450468017|FG000|Period 1|Withdrawal by Subject|0|||
125229422|NCT03886272|450468018|FG001|Period 1|Withdrawal by Subject|0|||
125229423|NCT03886272|450468019|FG002|Period 1|Withdrawal by Subject|0|||
125229424|NCT03886272|450468020|FG003|Period 1|Withdrawal by Subject|0|||
125229425|NCT03886272|450468021|FG004|Period 1|Withdrawal by Subject|0|||
125229426|NCT03886272|450468022|FG005|Period 1|Withdrawal by Subject|1|||
125229427|NCT03886272|450468023|FG006|Period 1|Withdrawal by Subject|0|||
125171454|NCT00384930|450249542|FG000|Overall Study|Lost to Follow-up|5|||
125171455|NCT00384930|450249543|FG001|Overall Study|Lost to Follow-up|3|||
125171456|NCT00384930|450249544|FG002|Overall Study|Lost to Follow-up|0|||
125171457|NCT00384930|450249545|FG003|Overall Study|Lost to Follow-up|4|||
125171458|NCT00384930|450249546|FG004|Overall Study|Lost to Follow-up|6|||
125171459|NCT00384930|450249542|FG000|Overall Study|Physician Decision|0|||
125171460|NCT00384930|450249543|FG001|Overall Study|Physician Decision|1|||
125171461|NCT00384930|450249544|FG002|Overall Study|Physician Decision|1|||
125171462|NCT00384930|450249545|FG003|Overall Study|Physician Decision|0|||
125171463|NCT00384930|450249546|FG004|Overall Study|Physician Decision|1|||
125171464|NCT00384930|450249542|FG000|Overall Study|Protocol Violation|1|||
125171465|NCT00384930|450249543|FG001|Overall Study|Protocol Violation|0|||
125171466|NCT00384930|450249544|FG002|Overall Study|Protocol Violation|1|||
125171467|NCT00384930|450249545|FG003|Overall Study|Protocol Violation|6|||
125171468|NCT00384930|450249546|FG004|Overall Study|Protocol Violation|4|||
125171469|NCT00384930|450249542|FG000|Overall Study|Sponsor Decision|3|||
125171470|NCT00384930|450249543|FG001|Overall Study|Sponsor Decision|4|||
125171471|NCT00384930|450249544|FG002|Overall Study|Sponsor Decision|0|||
125171472|NCT00384930|450249545|FG003|Overall Study|Sponsor Decision|5|||
125171473|NCT00384930|450249546|FG004|Overall Study|Sponsor Decision|0|||
125171474|NCT00384930|450249542|FG000|Overall Study|Withdrawal by Subject|9|||
125171475|NCT00384930|450249543|FG001|Overall Study|Withdrawal by Subject|7|||
125171476|NCT00384930|450249544|FG002|Overall Study|Withdrawal by Subject|7|||
125171477|NCT00384930|450249545|FG003|Overall Study|Withdrawal by Subject|6|||
125171478|NCT00384930|450249546|FG004|Overall Study|Withdrawal by Subject|16|||
125171479|NCT00384930|450249542|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
125229428|NCT00931632|450468024|FG000|Overall Study|Withdrawal by Subject|2|||
125171480|NCT00384930|450249543|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
125171481|NCT00384930|450249544|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
125171482|NCT00384930|450249545|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
125229429|NCT00931632|450468025|FG001|Overall Study|Withdrawal by Subject|3|||
125229430|NCT00931632|450468024|FG000|Overall Study|Adverse Event|19|||
125171483|NCT00384930|450249546|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
125171484|NCT04988087|450249549|FG000|Overall Study|Adverse Event|4|||
125171485|NCT04988087|450249550|FG001|Overall Study|Adverse Event|0|||
125171486|NCT04988087|450249551|FG002|Overall Study|Adverse Event|0|||
125171487|NCT04988087|450249552|FG003|Overall Study|Adverse Event|0|||
125171488|NCT04988087|450249549|FG000|Overall Study|Withdrawal by Subject|1|||
125171489|NCT04988087|450249550|FG001|Overall Study|Withdrawal by Subject|1|||
125171490|NCT04988087|450249551|FG002|Overall Study|Withdrawal by Subject|0|||
125229431|NCT00931632|450468025|FG001|Overall Study|Adverse Event|15|||
125229432|NCT03372798|450468028|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
125229433|NCT03372798|450468029|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
125229434|NCT03372798|450468028|FG000|Overall Study|Failure of imaging probe|0|||
125171491|NCT04988087|450249552|FG003|Overall Study|Withdrawal by Subject|0|||
125171492|NCT04988087|450249549|FG000|Overall Study|Technical problems|7|||
125171493|NCT04988087|450249550|FG001|Overall Study|Technical problems|9|||
125171494|NCT04988087|450249551|FG002|Overall Study|Technical problems|1|||
125171495|NCT04988087|450249552|FG003|Overall Study|Technical problems|2|||
125171496|NCT02613182|450249553|FG000|Overall Study|Death|6|||
125171497|NCT02613182|450249553|FG000|Overall Study|Physician Decision|1|||
125171498|NCT02613182|450249553|FG000|Overall Study|Study Terminated by Sponsor|21|||
125171499|NCT02613182|450249553|FG000|Overall Study|Withdrawal by Subject|6|||
125171500|NCT03968978|450249554|FG000|Overall Study|Adverse Event|1|||
125171501|NCT03968978|450249555|FG001|Overall Study|Adverse Event|0|||
125229435|NCT03372798|450468029|FG001|Overall Study|Failure of imaging probe|1|||
125229436|NCT03188055|450468030|FG000|Overall Study|Unavailable for training|0|||
125229437|NCT03188055|450468031|FG001|Overall Study|Unavailable for training|0|||
125229438|NCT03188055|450468032|FG002|Overall Study|Unavailable for training|19|||
125229439|NCT03188055|450468033|FG003|Overall Study|Unavailable for training|0|||
125229440|NCT03188055|450468034|FG004|Overall Study|Unavailable for training|0|||
125229441|NCT03188055|450468035|FG005|Overall Study|Unavailable for training|0|||
125229442|NCT03188055|450468030|FG000|Overall Study|Lost to Follow-up|0|||
125229443|NCT03188055|450468031|FG001|Overall Study|Lost to Follow-up|18|||
125229444|NCT03188055|450468032|FG002|Overall Study|Lost to Follow-up|0|||
125229445|NCT03188055|450468033|FG003|Overall Study|Lost to Follow-up|11|||
125229446|NCT03188055|450468034|FG004|Overall Study|Lost to Follow-up|0|||
125229447|NCT03188055|450468035|FG005|Overall Study|Lost to Follow-up|0|||
125229448|NCT03188055|450468030|FG000|Overall Study|Withdrawal by Subject|0|||
125229449|NCT03188055|450468031|FG001|Overall Study|Withdrawal by Subject|1|||
125229450|NCT03188055|450468032|FG002|Overall Study|Withdrawal by Subject|0|||
125229451|NCT03188055|450468033|FG003|Overall Study|Withdrawal by Subject|1|||
125229452|NCT03188055|450468034|FG004|Overall Study|Withdrawal by Subject|0|||
125229453|NCT03188055|450468035|FG005|Overall Study|Withdrawal by Subject|0|||
125229454|NCT03139552|450468037|FG000|Overall Study|unable to attend tasting due to schedule|3|||
125229455|NCT02247466|450468046|FG000|Overall Study|Procedure changed to open surgery|0|||
125229456|NCT02247466|450468047|FG001|Overall Study|Procedure changed to open surgery|3|||
125229457|NCT01618968|450468048|FG000|Overall Study|Adverse Event|1|||
125229458|NCT01618968|450468049|FG001|Overall Study|Adverse Event|0|||
125229459|NCT01618968|450468050|FG002|Overall Study|Adverse Event|0|||
125229460|NCT01618968|450468051|FG003|Overall Study|Adverse Event|0|||
125229461|NCT01618968|450468048|FG000|Overall Study|Death|0|||
125229462|NCT01618968|450468049|FG001|Overall Study|Death|0|||
125229463|NCT01618968|450468050|FG002|Overall Study|Death|0|||
125229464|NCT01618968|450468051|FG003|Overall Study|Death|1|||
125229465|NCT00721799|450468052|FG000|Overall Study|Withdrawal by Subject|7|||
125229466|NCT00721799|450468052|FG000|Overall Study|withdraw by subject after scan 1|1|||
125229467|NCT04356937|450468055|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
125229468|NCT04356937|450468056|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
125229469|NCT03533751|450468057|FG000|Overall Study|Withdrawal by Subject|12|||
125229470|NCT03533751|450468058|FG001|Overall Study|Withdrawal by Subject|6|||
125229471|NCT03533751|450468059|FG002|Overall Study|Withdrawal by Subject|11|||
125229472|NCT03533751|450468060|FG003|Overall Study|Withdrawal by Subject|9|||
125229473|NCT03533751|450468061|FG004|Overall Study|Withdrawal by Subject|10|||
125229474|NCT03533751|450468057|FG000|Overall Study|Adverse Event|4|||
125229475|NCT03533751|450468058|FG001|Overall Study|Adverse Event|7|||
125229476|NCT03533751|450468059|FG002|Overall Study|Adverse Event|2|||
125229477|NCT03533751|450468060|FG003|Overall Study|Adverse Event|4|||
125229478|NCT03533751|450468061|FG004|Overall Study|Adverse Event|5|||
125229479|NCT03533751|450468057|FG000|Overall Study|Physician Decision|0|||
125229480|NCT03533751|450468058|FG001|Overall Study|Physician Decision|2|||
125229481|NCT03533751|450468059|FG002|Overall Study|Physician Decision|1|||
125229482|NCT03533751|450468060|FG003|Overall Study|Physician Decision|2|||
125229483|NCT03533751|450468061|FG004|Overall Study|Physician Decision|1|||
125229484|NCT03533751|450468057|FG000|Overall Study|Sponsor Decision|0|||
125229485|NCT03533751|450468058|FG001|Overall Study|Sponsor Decision|0|||
125229486|NCT03533751|450468059|FG002|Overall Study|Sponsor Decision|1|||
125229487|NCT03533751|450468060|FG003|Overall Study|Sponsor Decision|1|||
125229488|NCT03533751|450468061|FG004|Overall Study|Sponsor Decision|0|||
125229489|NCT03533751|450468057|FG000|Overall Study|Lost to Follow-up|3|||
125229490|NCT03533751|450468058|FG001|Overall Study|Lost to Follow-up|7|||
125229491|NCT03533751|450468059|FG002|Overall Study|Lost to Follow-up|6|||
125229492|NCT03533751|450468060|FG003|Overall Study|Lost to Follow-up|4|||
125229493|NCT03533751|450468061|FG004|Overall Study|Lost to Follow-up|3|||
125229494|NCT03533751|450468057|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
125229495|NCT03533751|450468058|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
125229496|NCT03533751|450468059|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
125229497|NCT03533751|450468060|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
125229498|NCT03533751|450468061|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
125229499|NCT03533751|450468057|FG000|Overall Study|Other|0|||
125229500|NCT03533751|450468058|FG001|Overall Study|Other|2|||
125229501|NCT03533751|450468059|FG002|Overall Study|Other|1|||
125229502|NCT03533751|450468060|FG003|Overall Study|Other|0|||
125229503|NCT03533751|450468061|FG004|Overall Study|Other|3|||
125171502|NCT01200069|450251357|FG000|Overall Study|Withdrawal by Subject|0|||
125171503|NCT01200069|450251358|FG001|Overall Study|Withdrawal by Subject|1|||
125171504|NCT02883049|450251359|FG000|Induction|Adverse Event|52|||
125171505|NCT02883049|450251360|FG001|Induction|Adverse Event|2|||
125171506|NCT02883049|450251361|FG002|Induction|Adverse Event|0|||
125171507|NCT02883049|450251362|FG003|Induction|Adverse Event|0|||
125171508|NCT02883049|450251363|FG004|Induction|Adverse Event|0|||
125171509|NCT02883049|450251364|FG005|Induction|Adverse Event|0|||
125171510|NCT02883049|450251365|FG006|Induction|Adverse Event|0|||
125171511|NCT02883049|450251366|FG007|Induction|Adverse Event|0|||
125171512|NCT02883049|450251367|FG008|Induction|Adverse Event|0|||
125171513|NCT02883049|450251368|FG009|Induction|Adverse Event|0|||
125171514|NCT02883049|450251369|FG010|Induction|Adverse Event|0|||
125171515|NCT02883049|450251370|FG011|Induction|Adverse Event|0|||
125171516|NCT02883049|450251371|FG012|Induction|Adverse Event|0|||
125171517|NCT02883049|450251372|FG013|Induction|Adverse Event|0|||
125171518|NCT02883049|450251373|FG014|Induction|Adverse Event|0|||
125171519|NCT02883049|450251374|FG015|Induction|Adverse Event|0|||
125171520|NCT02883049|450251359|FG000|Induction|Death|76|||
125171521|NCT02883049|450251360|FG001|Induction|Death|8|||
125171522|NCT02883049|450251361|FG002|Induction|Death|0|||
125171523|NCT02883049|450251362|FG003|Induction|Death|0|||
125171524|NCT02883049|450251363|FG004|Induction|Death|0|||
125171525|NCT02883049|450251364|FG005|Induction|Death|0|||
125171526|NCT02883049|450251365|FG006|Induction|Death|0|||
125171527|NCT02883049|450251366|FG007|Induction|Death|0|||
125171528|NCT02883049|450251367|FG008|Induction|Death|0|||
125171529|NCT02883049|450251368|FG009|Induction|Death|0|||
125171530|NCT02883049|450251369|FG010|Induction|Death|0|||
125171531|NCT02883049|450251370|FG011|Induction|Death|0|||
125171532|NCT02883049|450251371|FG012|Induction|Death|0|||
125171533|NCT02883049|450251372|FG013|Induction|Death|0|||
125171534|NCT02883049|450251373|FG014|Induction|Death|0|||
125171535|NCT02883049|450251374|FG015|Induction|Death|0|||
125171536|NCT02883049|450251359|FG000|Induction|Lost to Follow-up|2|||
125171537|NCT02883049|450251360|FG001|Induction|Lost to Follow-up|0|||
125171538|NCT02883049|450251361|FG002|Induction|Lost to Follow-up|0|||
125171539|NCT02883049|450251362|FG003|Induction|Lost to Follow-up|0|||
125171540|NCT02883049|450251363|FG004|Induction|Lost to Follow-up|0|||
125171541|NCT02883049|450251364|FG005|Induction|Lost to Follow-up|0|||
125171542|NCT02883049|450251365|FG006|Induction|Lost to Follow-up|0|||
125171543|NCT02883049|450251366|FG007|Induction|Lost to Follow-up|0|||
125171544|NCT02883049|450251367|FG008|Induction|Lost to Follow-up|0|||
125171545|NCT02883049|450251368|FG009|Induction|Lost to Follow-up|0|||
125171546|NCT02883049|450251369|FG010|Induction|Lost to Follow-up|0|||
125171547|NCT02883049|450251370|FG011|Induction|Lost to Follow-up|0|||
125171548|NCT02883049|450251371|FG012|Induction|Lost to Follow-up|0|||
125171549|NCT02883049|450251372|FG013|Induction|Lost to Follow-up|0|||
125171550|NCT02883049|450251373|FG014|Induction|Lost to Follow-up|0|||
125171551|NCT02883049|450251374|FG015|Induction|Lost to Follow-up|0|||
125171552|NCT02883049|450251359|FG000|Induction|Physician Decision|1407|||
125171553|NCT02883049|450251360|FG001|Induction|Physician Decision|8|||
125171554|NCT02883049|450251361|FG002|Induction|Physician Decision|0|||
125171555|NCT02883049|450251362|FG003|Induction|Physician Decision|0|||
125171556|NCT02883049|450251363|FG004|Induction|Physician Decision|0|||
125171557|NCT02883049|450251364|FG005|Induction|Physician Decision|0|||
125171558|NCT02883049|450251365|FG006|Induction|Physician Decision|0|||
125171559|NCT02883049|450251366|FG007|Induction|Physician Decision|0|||
125171560|NCT02883049|450251367|FG008|Induction|Physician Decision|0|||
125171561|NCT02883049|450251368|FG009|Induction|Physician Decision|0|||
125171562|NCT02883049|450251369|FG010|Induction|Physician Decision|0|||
125171563|NCT02883049|450251370|FG011|Induction|Physician Decision|0|||
125171564|NCT02883049|450251371|FG012|Induction|Physician Decision|0|||
125171565|NCT02883049|450251372|FG013|Induction|Physician Decision|0|||
125171566|NCT02883049|450251373|FG014|Induction|Physician Decision|0|||
125171567|NCT02883049|450251374|FG015|Induction|Physician Decision|0|||
125171568|NCT02883049|450251359|FG000|Induction|Protocol Violation|6|||
125171569|NCT02883049|450251360|FG001|Induction|Protocol Violation|0|||
125171570|NCT02883049|450251361|FG002|Induction|Protocol Violation|0|||
125229504|NCT05117060|450468062|FG000|Overall Study|Adverse Event|3|||
125171571|NCT02883049|450251362|FG003|Induction|Protocol Violation|0|||
125171572|NCT02883049|450251363|FG004|Induction|Protocol Violation|0|||
125171573|NCT02883049|450251364|FG005|Induction|Protocol Violation|0|||
125171574|NCT02883049|450251365|FG006|Induction|Protocol Violation|0|||
125171575|NCT02883049|450251366|FG007|Induction|Protocol Violation|0|||
125171576|NCT02883049|450251367|FG008|Induction|Protocol Violation|0|||
125171577|NCT02883049|450251368|FG009|Induction|Protocol Violation|0|||
125171578|NCT02883049|450251369|FG010|Induction|Protocol Violation|0|||
125171579|NCT02883049|450251370|FG011|Induction|Protocol Violation|0|||
125171580|NCT02883049|450251371|FG012|Induction|Protocol Violation|0|||
125229505|NCT05117060|450468063|FG001|Overall Study|Adverse Event|5|||
125229506|NCT05117060|450468064|FG002|Overall Study|Adverse Event|6|||
125229507|NCT05117060|450468065|FG003|Overall Study|Adverse Event|1|||
125229508|NCT05117060|450468062|FG000|Overall Study|Lost to Follow-up|0|||
125229509|NCT05117060|450468063|FG001|Overall Study|Lost to Follow-up|0|||
125229510|NCT05117060|450468064|FG002|Overall Study|Lost to Follow-up|0|||
125229511|NCT05117060|450468065|FG003|Overall Study|Lost to Follow-up|1|||
125229512|NCT05117060|450468062|FG000|Overall Study|Lack of Efficacy|4|||
125229513|NCT05117060|450468063|FG001|Overall Study|Lack of Efficacy|5|||
125229514|NCT05117060|450468064|FG002|Overall Study|Lack of Efficacy|2|||
125229515|NCT05117060|450468065|FG003|Overall Study|Lack of Efficacy|6|||
125229516|NCT05117060|450468062|FG000|Overall Study|Withdrawal by Subject|8|||
125229517|NCT05117060|450468063|FG001|Overall Study|Withdrawal by Subject|5|||
125229518|NCT05117060|450468064|FG002|Overall Study|Withdrawal by Subject|5|||
125229519|NCT05117060|450468065|FG003|Overall Study|Withdrawal by Subject|6|||
125229520|NCT05117060|450468062|FG000|Overall Study|Other|2|||
125229521|NCT05117060|450468063|FG001|Overall Study|Other|1|||
125229522|NCT05117060|450468064|FG002|Overall Study|Other|3|||
125229523|NCT05117060|450468065|FG003|Overall Study|Other|1|||
125229524|NCT04158219|450468066|FG000|Overall Study|Lost to Follow-up|1|||
125229525|NCT05965752|450468067|FG000|Overall Study|Adverse Event|0|||
125229526|NCT05965752|450468068|FG001|Overall Study|Adverse Event|1|||
125229527|NCT05965752|450468069|FG002|Overall Study|Adverse Event|0|||
125171581|NCT02883049|450251372|FG013|Induction|Protocol Violation|0|||
125171582|NCT02883049|450251373|FG014|Induction|Protocol Violation|0|||
125229528|NCT05965752|450468070|FG003|Overall Study|Adverse Event|1|||
125229529|NCT05965752|450468071|FG004|Overall Study|Adverse Event|3|||
125229530|NCT05965752|450468067|FG000|Overall Study|Lost to Follow-up|2|||
125229531|NCT05965752|450468068|FG001|Overall Study|Lost to Follow-up|0|||
125229532|NCT05965752|450468069|FG002|Overall Study|Lost to Follow-up|1|||
125229533|NCT05965752|450468070|FG003|Overall Study|Lost to Follow-up|1|||
125229534|NCT05965752|450468071|FG004|Overall Study|Lost to Follow-up|1|||
125229535|NCT05965752|450468067|FG000|Overall Study|Withdrawal by Subject|2|||
125229536|NCT05965752|450468068|FG001|Overall Study|Withdrawal by Subject|2|||
125229537|NCT05965752|450468069|FG002|Overall Study|Withdrawal by Subject|1|||
125229538|NCT05965752|450468070|FG003|Overall Study|Withdrawal by Subject|5|||
125229539|NCT05965752|450468071|FG004|Overall Study|Withdrawal by Subject|0|||
125229540|NCT05965752|450468067|FG000|Overall Study|Disease Relapse|1|||
125229541|NCT05965752|450468068|FG001|Overall Study|Disease Relapse|0|||
125229542|NCT05965752|450468069|FG002|Overall Study|Disease Relapse|1|||
125229543|NCT05965752|450468070|FG003|Overall Study|Disease Relapse|0|||
125229544|NCT05965752|450468071|FG004|Overall Study|Disease Relapse|0|||
125229545|NCT05965752|450468067|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
125229546|NCT05965752|450468068|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
125171583|NCT02883049|450251374|FG015|Induction|Protocol Violation|0|||
125171584|NCT02883049|450251359|FG000|Induction|Withdrawal by Subject|6|||
125171585|NCT02883049|450251360|FG001|Induction|Withdrawal by Subject|0|||
125171586|NCT02883049|450251361|FG002|Induction|Withdrawal by Subject|0|||
125171587|NCT02883049|450251362|FG003|Induction|Withdrawal by Subject|0|||
125171588|NCT02883049|450251363|FG004|Induction|Withdrawal by Subject|0|||
125171589|NCT02883049|450251364|FG005|Induction|Withdrawal by Subject|0|||
125171590|NCT02883049|450251365|FG006|Induction|Withdrawal by Subject|0|||
125171591|NCT02883049|450251366|FG007|Induction|Withdrawal by Subject|0|||
125171592|NCT02883049|450251367|FG008|Induction|Withdrawal by Subject|0|||
125171593|NCT02883049|450251368|FG009|Induction|Withdrawal by Subject|0|||
125229547|NCT05965752|450468069|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
125229548|NCT05965752|450468070|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
125229549|NCT05965752|450468071|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
125229550|NCT05965752|450468067|FG000|Overall Study|Unable to Return for Study Visits|0|||
125229551|NCT05965752|450468068|FG001|Overall Study|Unable to Return for Study Visits|1|||
125229552|NCT05965752|450468069|FG002|Overall Study|Unable to Return for Study Visits|0|||
125229553|NCT05965752|450468070|FG003|Overall Study|Unable to Return for Study Visits|3|||
125229554|NCT05965752|450468071|FG004|Overall Study|Unable to Return for Study Visits|1|||
125229555|NCT05965752|450468067|FG000|Overall Study|Early Termination|0|||
125229556|NCT05965752|450468068|FG001|Overall Study|Early Termination|0|||
125229557|NCT05965752|450468069|FG002|Overall Study|Early Termination|1|||
125229558|NCT05965752|450468070|FG003|Overall Study|Early Termination|0|||
125229559|NCT05965752|450468071|FG004|Overall Study|Early Termination|0|||
125229560|NCT05965752|450468067|FG000|Overall Study|Reported Unwanted Symptoms|0|||
125171594|NCT02883049|450251369|FG010|Induction|Withdrawal by Subject|0|||
125229561|NCT05965752|450468068|FG001|Overall Study|Reported Unwanted Symptoms|0|||
125229562|NCT05965752|450468069|FG002|Overall Study|Reported Unwanted Symptoms|0|||
125229563|NCT05965752|450468070|FG003|Overall Study|Reported Unwanted Symptoms|0|||
125171595|NCT02883049|450251370|FG011|Induction|Withdrawal by Subject|0|||
125171596|NCT02883049|450251371|FG012|Induction|Withdrawal by Subject|0|||
125171597|NCT02883049|450251372|FG013|Induction|Withdrawal by Subject|0|||
125171598|NCT02883049|450251373|FG014|Induction|Withdrawal by Subject|0|||
125171599|NCT02883049|450251374|FG015|Induction|Withdrawal by Subject|0|||
125171600|NCT02883049|450251359|FG000|Induction|Ineligible|35|||
125171601|NCT02883049|450251360|FG001|Induction|Ineligible|1|||
125171602|NCT02883049|450251361|FG002|Induction|Ineligible|0|||
125171603|NCT02883049|450251362|FG003|Induction|Ineligible|0|||
125171604|NCT02883049|450251363|FG004|Induction|Ineligible|0|||
125171605|NCT02883049|450251364|FG005|Induction|Ineligible|0|||
125171606|NCT02883049|450251365|FG006|Induction|Ineligible|0|||
125171607|NCT02883049|450251366|FG007|Induction|Ineligible|0|||
125171608|NCT02883049|450251367|FG008|Induction|Ineligible|0|||
125171609|NCT02883049|450251368|FG009|Induction|Ineligible|0|||
125171610|NCT02883049|450251369|FG010|Induction|Ineligible|0|||
125171611|NCT02883049|450251370|FG011|Induction|Ineligible|0|||
125171612|NCT02883049|450251371|FG012|Induction|Ineligible|0|||
125171613|NCT02883049|450251372|FG013|Induction|Ineligible|0|||
125171614|NCT02883049|450251373|FG014|Induction|Ineligible|0|||
125171615|NCT02883049|450251374|FG015|Induction|Ineligible|0|||
125171616|NCT02883049|450251359|FG000|Induction|Refusal of further protocol therapy|466|||
125171617|NCT02883049|450251360|FG001|Induction|Refusal of further protocol therapy|2|||
125171618|NCT02883049|450251361|FG002|Induction|Refusal of further protocol therapy|0|||
125171619|NCT02883049|450251362|FG003|Induction|Refusal of further protocol therapy|0|||
125171620|NCT02883049|450251363|FG004|Induction|Refusal of further protocol therapy|0|||
125171621|NCT02883049|450251364|FG005|Induction|Refusal of further protocol therapy|0|||
125171622|NCT02883049|450251365|FG006|Induction|Refusal of further protocol therapy|0|||
125171623|NCT02883049|450251366|FG007|Induction|Refusal of further protocol therapy|0|||
125171624|NCT02883049|450251367|FG008|Induction|Refusal of further protocol therapy|0|||
125171625|NCT02883049|450251368|FG009|Induction|Refusal of further protocol therapy|0|||
125171626|NCT02883049|450251369|FG010|Induction|Refusal of further protocol therapy|0|||
125171627|NCT02883049|450251370|FG011|Induction|Refusal of further protocol therapy|0|||
125171628|NCT02883049|450251371|FG012|Induction|Refusal of further protocol therapy|0|||
125171629|NCT02883049|450251372|FG013|Induction|Refusal of further protocol therapy|0|||
125171630|NCT02883049|450251373|FG014|Induction|Refusal of further protocol therapy|0|||
125171631|NCT02883049|450251374|FG015|Induction|Refusal of further protocol therapy|0|||
125171632|NCT02883049|450251359|FG000|Induction|Identified as Ph+ patients|279|||
125171633|NCT02883049|450251360|FG001|Induction|Identified as Ph+ patients|1|||
125171634|NCT02883049|450251361|FG002|Induction|Identified as Ph+ patients|0|||
125171635|NCT02883049|450251362|FG003|Induction|Identified as Ph+ patients|0|||
125171636|NCT02883049|450251363|FG004|Induction|Identified as Ph+ patients|0|||
125171637|NCT02883049|450251364|FG005|Induction|Identified as Ph+ patients|0|||
125171638|NCT02883049|450251365|FG006|Induction|Identified as Ph+ patients|0|||
125171639|NCT02883049|450251366|FG007|Induction|Identified as Ph+ patients|0|||
125171640|NCT02883049|450251367|FG008|Induction|Identified as Ph+ patients|0|||
125171641|NCT02883049|450251368|FG009|Induction|Identified as Ph+ patients|0|||
125171642|NCT02883049|450251369|FG010|Induction|Identified as Ph+ patients|0|||
125171643|NCT02883049|450251370|FG011|Induction|Identified as Ph+ patients|0|||
125171644|NCT02883049|450251371|FG012|Induction|Identified as Ph+ patients|0|||
125171645|NCT02883049|450251372|FG013|Induction|Identified as Ph+ patients|0|||
125171646|NCT02883049|450251373|FG014|Induction|Identified as Ph+ patients|0|||
125171647|NCT02883049|450251374|FG015|Induction|Identified as Ph+ patients|0|||
125171648|NCT02883049|450251359|FG000|Induction|M3 Marrow at Day29|8|||
125171649|NCT02883049|450251360|FG001|Induction|M3 Marrow at Day29|1|||
125171650|NCT02883049|450251361|FG002|Induction|M3 Marrow at Day29|0|||
125171651|NCT02883049|450251362|FG003|Induction|M3 Marrow at Day29|0|||
125171652|NCT02883049|450251363|FG004|Induction|M3 Marrow at Day29|0|||
125229564|NCT05965752|450468071|FG004|Overall Study|Reported Unwanted Symptoms|1|||
125229565|NCT05965752|450468067|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
125229566|NCT05965752|450468068|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
125229567|NCT05965752|450468069|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
125229568|NCT05965752|450468070|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
125229569|NCT05965752|450468071|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
125229570|NCT02074514|450468072|FG000|Overall Study|Lack of Efficacy|3|||
125229571|NCT02074514|450468073|FG001|Overall Study|Lack of Efficacy|2|||
125229572|NCT02074514|450468072|FG000|Overall Study|Lost to Follow-up|0|||
125229573|NCT02074514|450468073|FG001|Overall Study|Lost to Follow-up|1|||
125229574|NCT02074514|450468072|FG000|Overall Study|Withdrew Consent|0|||
125229575|NCT02074514|450468073|FG001|Overall Study|Withdrew Consent|1|||
125229576|NCT01274351|450468074|FG000|Overall Study|Lost to Follow-up|1|||
125229577|NCT01274351|450468074|FG000|Overall Study|patient not compliant with the protocol|1|||
125229578|NCT01274351|450468074|FG000|Overall Study|Pregnancy|1|||
125229579|NCT01274351|450468074|FG000|Overall Study|Death|2|||
125229580|NCT01274351|450468074|FG000|Overall Study|Withdrawal by Subject|3|||
125229581|NCT01274351|450468074|FG000|Overall Study|Adverse Event|8|||
125229582|NCT01274351|450468074|FG000|Overall Study|progression of disease|3|||
125171653|NCT02883049|450251364|FG005|Induction|M3 Marrow at Day29|0|||
125171654|NCT02883049|450251365|FG006|Induction|M3 Marrow at Day29|0|||
125171655|NCT02883049|450251366|FG007|Induction|M3 Marrow at Day29|0|||
125171656|NCT02883049|450251367|FG008|Induction|M3 Marrow at Day29|0|||
125171657|NCT02883049|450251368|FG009|Induction|M3 Marrow at Day29|0|||
125171658|NCT02883049|450251369|FG010|Induction|M3 Marrow at Day29|0|||
125171659|NCT02883049|450251370|FG011|Induction|M3 Marrow at Day29|0|||
125171660|NCT02883049|450251371|FG012|Induction|M3 Marrow at Day29|0|||
125171661|NCT02883049|450251372|FG013|Induction|M3 Marrow at Day29|0|||
125171662|NCT02883049|450251373|FG014|Induction|M3 Marrow at Day29|0|||
125171663|NCT02883049|450251374|FG015|Induction|M3 Marrow at Day29|0|||
125229583|NCT01274351|450468074|FG000|Overall Study|hospitalization|1|||
125229584|NCT03312738|450469947|FG000|Overall Study|Progressive disease|58|||
125229585|NCT03312738|450469948|FG001|Overall Study|Progressive disease|67|||
125229586|NCT03312738|450469947|FG000|Overall Study|Patient/guardian decision|13|||
125229587|NCT03312738|450469948|FG001|Overall Study|Patient/guardian decision|5|||
125229588|NCT03312738|450469947|FG000|Overall Study|Adverse Event|5|||
125229589|NCT03312738|450469948|FG001|Overall Study|Adverse Event|3|||
125229590|NCT03312738|450469947|FG000|Overall Study|Protocol deviation|2|||
125229591|NCT03312738|450469948|FG001|Overall Study|Protocol deviation|0|||
125229592|NCT03312738|450469947|FG000|Overall Study|Technical problems|0|||
125229593|NCT03312738|450469948|FG001|Overall Study|Technical problems|1|||
125229594|NCT03312738|450469947|FG000|Overall Study|Physician Decision|2|||
125229595|NCT03312738|450469948|FG001|Overall Study|Physician Decision|3|||
125229596|NCT02466399|450469955|FG000|Overall Study|Adverse Event|1|||
125229597|NCT02466399|450469956|FG001|Overall Study|Adverse Event|0|||
125229598|NCT02466399|450469955|FG000|Overall Study|Early exit due to family emergency|1|||
125229599|NCT02466399|450469956|FG001|Overall Study|Early exit due to family emergency|0|||
125229600|NCT03408899|450469957|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
125229601|NCT00606008|450469958|FG000|Overall Study|Adverse Event|1|||
125229602|NCT00606008|450469958|FG000|Overall Study|Withdrawal by Subject|4|||
125229603|NCT02014272|450469959|FG000|Intervention Period 1|Withdrawal by Subject|1|||
125229604|NCT02014272|450469960|FG001|Intervention Period 1|Withdrawal by Subject|0|||
125229605|NCT02014272|450469959|FG000|Intervention Period 1|Adverse Event|0|||
125229606|NCT02014272|450469960|FG001|Intervention Period 1|Adverse Event|1|||
125229607|NCT01863771|450469961|FG000|Induction Phase|Adverse Event|9|||
125229608|NCT01863771|450469962|FG001|Induction Phase|Adverse Event|0|||
125229609|NCT01863771|450469963|FG002|Induction Phase|Adverse Event|0|||
125229610|NCT01863771|450469964|FG003|Induction Phase|Adverse Event|0|||
125229611|NCT01863771|450469961|FG000|Induction Phase|Lack of Efficacy|10|||
125229612|NCT01863771|450469962|FG001|Induction Phase|Lack of Efficacy|0|||
125229613|NCT01863771|450469963|FG002|Induction Phase|Lack of Efficacy|0|||
125229614|NCT01863771|450469964|FG003|Induction Phase|Lack of Efficacy|0|||
125229615|NCT01863771|450469961|FG000|Induction Phase|Withdrawal by Subject|2|||
125229616|NCT01863771|450469962|FG001|Induction Phase|Withdrawal by Subject|0|||
125229617|NCT01863771|450469963|FG002|Induction Phase|Withdrawal by Subject|0|||
125229618|NCT01863771|450469964|FG003|Induction Phase|Withdrawal by Subject|0|||
125171664|NCT02883049|450251359|FG000|Induction|Inevaluable|33|||
125171665|NCT02883049|450251360|FG001|Induction|Inevaluable|1|||
125171666|NCT02883049|450251361|FG002|Induction|Inevaluable|0|||
125171667|NCT02883049|450251362|FG003|Induction|Inevaluable|0|||
125171668|NCT02883049|450251363|FG004|Induction|Inevaluable|0|||
125171669|NCT02883049|450251364|FG005|Induction|Inevaluable|0|||
125171670|NCT02883049|450251365|FG006|Induction|Inevaluable|0|||
125171671|NCT02883049|450251366|FG007|Induction|Inevaluable|0|||
125171672|NCT02883049|450251367|FG008|Induction|Inevaluable|0|||
125171673|NCT02883049|450251368|FG009|Induction|Inevaluable|0|||
125171674|NCT02883049|450251369|FG010|Induction|Inevaluable|0|||
125171675|NCT02883049|450251370|FG011|Induction|Inevaluable|0|||
125171676|NCT02883049|450251371|FG012|Induction|Inevaluable|0|||
125171677|NCT02883049|450251372|FG013|Induction|Inevaluable|0|||
125171678|NCT02883049|450251373|FG014|Induction|Inevaluable|0|||
125171679|NCT02883049|450251374|FG015|Induction|Inevaluable|0|||
125171680|NCT02883049|450251359|FG000|Induction|Identified as VHR at end of Induction|244|||
125171681|NCT02883049|450251360|FG001|Induction|Identified as VHR at end of Induction|0|||
125171682|NCT02883049|450251361|FG002|Induction|Identified as VHR at end of Induction|0|||
125171683|NCT02883049|450251362|FG003|Induction|Identified as VHR at end of Induction|0|||
125171684|NCT02883049|450251363|FG004|Induction|Identified as VHR at end of Induction|0|||
125171685|NCT02883049|450251364|FG005|Induction|Identified as VHR at end of Induction|0|||
125229619|NCT01863771|450469961|FG000|Maintenance Phase|Adverse Event|0|||
125229620|NCT01863771|450469962|FG001|Maintenance Phase|Adverse Event|0|||
125229621|NCT01863771|450469963|FG002|Maintenance Phase|Adverse Event|1|||
125229622|NCT01863771|450469964|FG003|Maintenance Phase|Adverse Event|1|||
125171686|NCT02883049|450251365|FG006|Induction|Identified as VHR at end of Induction|0|||
125171687|NCT02883049|450251366|FG007|Induction|Identified as VHR at end of Induction|0|||
125171688|NCT02883049|450251367|FG008|Induction|Identified as VHR at end of Induction|0|||
125171689|NCT02883049|450251368|FG009|Induction|Identified as VHR at end of Induction|0|||
125229623|NCT01863771|450469961|FG000|Maintenance Phase|Lack of Efficacy|0|||
125229624|NCT01863771|450469962|FG001|Maintenance Phase|Lack of Efficacy|3|||
125171690|NCT02883049|450251369|FG010|Induction|Identified as VHR at end of Induction|0|||
125171691|NCT02883049|450251370|FG011|Induction|Identified as VHR at end of Induction|0|||
125171692|NCT02883049|450251371|FG012|Induction|Identified as VHR at end of Induction|0|||
125171693|NCT02883049|450251372|FG013|Induction|Identified as VHR at end of Induction|0|||
125171694|NCT02883049|450251373|FG014|Induction|Identified as VHR at end of Induction|0|||
125171695|NCT02883049|450251374|FG015|Induction|Identified as VHR at end of Induction|0|||
125171696|NCT02883049|450251359|FG000|Induction|Moved to another non-COG institution|3|||
125171697|NCT02883049|450251360|FG001|Induction|Moved to another non-COG institution|0|||
125171698|NCT02883049|450251361|FG002|Induction|Moved to another non-COG institution|0|||
125171699|NCT02883049|450251362|FG003|Induction|Moved to another non-COG institution|0|||
125171700|NCT02883049|450251363|FG004|Induction|Moved to another non-COG institution|0|||
125171701|NCT02883049|450251364|FG005|Induction|Moved to another non-COG institution|0|||
125171702|NCT02883049|450251365|FG006|Induction|Moved to another non-COG institution|0|||
125171703|NCT02883049|450251366|FG007|Induction|Moved to another non-COG institution|0|||
125171704|NCT02883049|450251367|FG008|Induction|Moved to another non-COG institution|0|||
125171705|NCT02883049|450251368|FG009|Induction|Moved to another non-COG institution|0|||
125171706|NCT02883049|450251369|FG010|Induction|Moved to another non-COG institution|0|||
125171707|NCT02883049|450251370|FG011|Induction|Moved to another non-COG institution|0|||
125171708|NCT02883049|450251371|FG012|Induction|Moved to another non-COG institution|0|||
125171709|NCT02883049|450251372|FG013|Induction|Moved to another non-COG institution|0|||
125171710|NCT02883049|450251373|FG014|Induction|Moved to another non-COG institution|0|||
125171711|NCT02883049|450251374|FG015|Induction|Moved to another non-COG institution|0|||
125171712|NCT02883049|450251359|FG000|Induction|Randomization closed|41|||
125171713|NCT02883049|450251360|FG001|Induction|Randomization closed|0|||
125171714|NCT02883049|450251361|FG002|Induction|Randomization closed|0|||
125171715|NCT02883049|450251362|FG003|Induction|Randomization closed|0|||
125171716|NCT02883049|450251363|FG004|Induction|Randomization closed|0|||
125171717|NCT02883049|450251364|FG005|Induction|Randomization closed|0|||
125171718|NCT02883049|450251365|FG006|Induction|Randomization closed|0|||
125171719|NCT02883049|450251366|FG007|Induction|Randomization closed|0|||
125171720|NCT02883049|450251367|FG008|Induction|Randomization closed|0|||
125171721|NCT02883049|450251368|FG009|Induction|Randomization closed|0|||
125171722|NCT02883049|450251369|FG010|Induction|Randomization closed|0|||
125171723|NCT02883049|450251370|FG011|Induction|Randomization closed|0|||
125171724|NCT02883049|450251371|FG012|Induction|Randomization closed|0|||
125171725|NCT02883049|450251372|FG013|Induction|Randomization closed|0|||
125171726|NCT02883049|450251373|FG014|Induction|Randomization closed|0|||
125171727|NCT02883049|450251374|FG015|Induction|Randomization closed|0|||
125171728|NCT02883049|450251359|FG000|Induction|MRD negative|36|||
125171729|NCT02883049|450251360|FG001|Induction|MRD negative|0|||
125171730|NCT02883049|450251361|FG002|Induction|MRD negative|0|||
125171731|NCT02883049|450251362|FG003|Induction|MRD negative|0|||
125171732|NCT02883049|450251363|FG004|Induction|MRD negative|0|||
125171733|NCT02883049|450251364|FG005|Induction|MRD negative|0|||
125171734|NCT02883049|450251365|FG006|Induction|MRD negative|0|||
125171735|NCT02883049|450251366|FG007|Induction|MRD negative|0|||
125171736|NCT02883049|450251367|FG008|Induction|MRD negative|0|||
125171737|NCT02883049|450251368|FG009|Induction|MRD negative|0|||
125171738|NCT02883049|450251369|FG010|Induction|MRD negative|0|||
125171739|NCT02883049|450251370|FG011|Induction|MRD negative|0|||
125171740|NCT02883049|450251371|FG012|Induction|MRD negative|0|||
125171741|NCT02883049|450251372|FG013|Induction|MRD negative|0|||
125171742|NCT02883049|450251373|FG014|Induction|MRD negative|0|||
125171743|NCT02883049|450251374|FG015|Induction|MRD negative|0|||
125171744|NCT02883049|450251359|FG000|Induction|Identified as HR patients|165|||
125171745|NCT02883049|450251360|FG001|Induction|Identified as HR patients|0|||
125171746|NCT02883049|450251361|FG002|Induction|Identified as HR patients|0|||
125171747|NCT02883049|450251362|FG003|Induction|Identified as HR patients|0|||
125171748|NCT02883049|450251363|FG004|Induction|Identified as HR patients|0|||
125171749|NCT02883049|450251364|FG005|Induction|Identified as HR patients|0|||
125171750|NCT02883049|450251365|FG006|Induction|Identified as HR patients|0|||
125171751|NCT02883049|450251366|FG007|Induction|Identified as HR patients|0|||
125171752|NCT02883049|450251367|FG008|Induction|Identified as HR patients|0|||
125171753|NCT02883049|450251368|FG009|Induction|Identified as HR patients|0|||
125171754|NCT02883049|450251369|FG010|Induction|Identified as HR patients|0|||
125171755|NCT02883049|450251370|FG011|Induction|Identified as HR patients|0|||
125171756|NCT02883049|450251371|FG012|Induction|Identified as HR patients|0|||
125171757|NCT02883049|450251372|FG013|Induction|Identified as HR patients|0|||
125171758|NCT02883049|450251373|FG014|Induction|Identified as HR patients|0|||
125171759|NCT02883049|450251374|FG015|Induction|Identified as HR patients|0|||
125171760|NCT02883049|450251359|FG000|Induction|Developed SMN|0|||
125171761|NCT02883049|450251360|FG001|Induction|Developed SMN|1|||
125171762|NCT02883049|450251361|FG002|Induction|Developed SMN|0|||
125171763|NCT02883049|450251362|FG003|Induction|Developed SMN|0|||
125171764|NCT02883049|450251363|FG004|Induction|Developed SMN|0|||
125171765|NCT02883049|450251364|FG005|Induction|Developed SMN|0|||
125171766|NCT02883049|450251365|FG006|Induction|Developed SMN|0|||
125171767|NCT02883049|450251366|FG007|Induction|Developed SMN|0|||
125171768|NCT02883049|450251367|FG008|Induction|Developed SMN|0|||
125171769|NCT02883049|450251368|FG009|Induction|Developed SMN|0|||
125171770|NCT02883049|450251369|FG010|Induction|Developed SMN|0|||
125171771|NCT02883049|450251370|FG011|Induction|Developed SMN|0|||
125171772|NCT02883049|450251371|FG012|Induction|Developed SMN|0|||
125171773|NCT02883049|450251372|FG013|Induction|Developed SMN|0|||
125171774|NCT02883049|450251373|FG014|Induction|Developed SMN|0|||
125171775|NCT02883049|450251374|FG015|Induction|Developed SMN|0|||
125171776|NCT02883049|450251359|FG000|Induction|Enrolled onto another COG study|72|||
125171777|NCT02883049|450251360|FG001|Induction|Enrolled onto another COG study|0|||
125171778|NCT02883049|450251361|FG002|Induction|Enrolled onto another COG study|0|||
125171779|NCT02883049|450251362|FG003|Induction|Enrolled onto another COG study|0|||
125171780|NCT02883049|450251363|FG004|Induction|Enrolled onto another COG study|0|||
125171781|NCT02883049|450251364|FG005|Induction|Enrolled onto another COG study|0|||
125171782|NCT02883049|450251365|FG006|Induction|Enrolled onto another COG study|0|||
125171783|NCT02883049|450251366|FG007|Induction|Enrolled onto another COG study|0|||
125171784|NCT02883049|450251367|FG008|Induction|Enrolled onto another COG study|0|||
125171785|NCT02883049|450251368|FG009|Induction|Enrolled onto another COG study|0|||
125171786|NCT02883049|450251369|FG010|Induction|Enrolled onto another COG study|0|||
125171787|NCT02883049|450251370|FG011|Induction|Enrolled onto another COG study|0|||
125171788|NCT02883049|450251371|FG012|Induction|Enrolled onto another COG study|0|||
125171789|NCT02883049|450251372|FG013|Induction|Enrolled onto another COG study|0|||
125171790|NCT02883049|450251373|FG014|Induction|Enrolled onto another COG study|0|||
125171791|NCT02883049|450251374|FG015|Induction|Enrolled onto another COG study|0|||
125171792|NCT02883049|450251359|FG000|Induction|Incomplete induction data|17|||
125171793|NCT02883049|450251360|FG001|Induction|Incomplete induction data|0|||
125171794|NCT02883049|450251361|FG002|Induction|Incomplete induction data|0|||
125171795|NCT02883049|450251362|FG003|Induction|Incomplete induction data|0|||
125171796|NCT02883049|450251363|FG004|Induction|Incomplete induction data|0|||
125171797|NCT02883049|450251364|FG005|Induction|Incomplete induction data|0|||
125171798|NCT02883049|450251365|FG006|Induction|Incomplete induction data|0|||
125171799|NCT02883049|450251366|FG007|Induction|Incomplete induction data|0|||
125171800|NCT02883049|450251367|FG008|Induction|Incomplete induction data|0|||
125171801|NCT02883049|450251368|FG009|Induction|Incomplete induction data|0|||
125171802|NCT02883049|450251369|FG010|Induction|Incomplete induction data|0|||
125171803|NCT02883049|450251370|FG011|Induction|Incomplete induction data|0|||
125171804|NCT02883049|450251371|FG012|Induction|Incomplete induction data|0|||
125171805|NCT02883049|450251372|FG013|Induction|Incomplete induction data|0|||
125171806|NCT02883049|450251373|FG014|Induction|Incomplete induction data|0|||
125171807|NCT02883049|450251374|FG015|Induction|Incomplete induction data|0|||
125171808|NCT02883049|450251359|FG000|Post Induction|Adverse Event|0|||
125171809|NCT02883049|450251360|FG001|Post Induction|Adverse Event|0|||
125171810|NCT02883049|450251361|FG002|Post Induction|Adverse Event|0|||
125171811|NCT02883049|450251362|FG003|Post Induction|Adverse Event|7|||
125171812|NCT02883049|450251363|FG004|Post Induction|Adverse Event|8|||
125171813|NCT02883049|450251364|FG005|Post Induction|Adverse Event|3|||
125171814|NCT02883049|450251365|FG006|Post Induction|Adverse Event|4|||
125171815|NCT02883049|450251366|FG007|Post Induction|Adverse Event|5|||
125171816|NCT02883049|450251367|FG008|Post Induction|Adverse Event|6|||
125171817|NCT02883049|450251368|FG009|Post Induction|Adverse Event|7|||
125171818|NCT02883049|450251369|FG010|Post Induction|Adverse Event|2|||
125171819|NCT02883049|450251370|FG011|Post Induction|Adverse Event|2|||
125171820|NCT02883049|450251371|FG012|Post Induction|Adverse Event|0|||
125171821|NCT02883049|450251372|FG013|Post Induction|Adverse Event|0|||
125171822|NCT02883049|450251373|FG014|Post Induction|Adverse Event|5|||
125171823|NCT02883049|450251374|FG015|Post Induction|Adverse Event|2|||
125171824|NCT02883049|450251359|FG000|Post Induction|Death|0|||
125171825|NCT02883049|450251360|FG001|Post Induction|Death|0|||
125171826|NCT02883049|450251361|FG002|Post Induction|Death|0|||
125171827|NCT02883049|450251362|FG003|Post Induction|Death|9|||
125171828|NCT02883049|450251363|FG004|Post Induction|Death|9|||
125171829|NCT02883049|450251364|FG005|Post Induction|Death|0|||
125171830|NCT02883049|450251365|FG006|Post Induction|Death|1|||
125171831|NCT02883049|450251366|FG007|Post Induction|Death|6|||
125171832|NCT02883049|450251367|FG008|Post Induction|Death|5|||
125171833|NCT02883049|450251368|FG009|Post Induction|Death|3|||
125171834|NCT02883049|450251369|FG010|Post Induction|Death|1|||
125171835|NCT02883049|450251370|FG011|Post Induction|Death|0|||
125171836|NCT02883049|450251371|FG012|Post Induction|Death|1|||
125171837|NCT02883049|450251372|FG013|Post Induction|Death|1|||
125171838|NCT02883049|450251373|FG014|Post Induction|Death|10|||
125171839|NCT02883049|450251374|FG015|Post Induction|Death|2|||
125171840|NCT02883049|450251359|FG000|Post Induction|Lost to Follow-up|0|||
125171841|NCT02883049|450251360|FG001|Post Induction|Lost to Follow-up|0|||
125171842|NCT02883049|450251361|FG002|Post Induction|Lost to Follow-up|0|||
125171843|NCT02883049|450251362|FG003|Post Induction|Lost to Follow-up|0|||
125171844|NCT02883049|450251363|FG004|Post Induction|Lost to Follow-up|1|||
125171845|NCT02883049|450251364|FG005|Post Induction|Lost to Follow-up|1|||
125171846|NCT02883049|450251365|FG006|Post Induction|Lost to Follow-up|0|||
125171847|NCT02883049|450251366|FG007|Post Induction|Lost to Follow-up|0|||
125171848|NCT02883049|450251367|FG008|Post Induction|Lost to Follow-up|3|||
125171849|NCT02883049|450251368|FG009|Post Induction|Lost to Follow-up|0|||
125171850|NCT02883049|450251369|FG010|Post Induction|Lost to Follow-up|1|||
125171851|NCT02883049|450251370|FG011|Post Induction|Lost to Follow-up|0|||
125171852|NCT02883049|450251371|FG012|Post Induction|Lost to Follow-up|0|||
125171853|NCT02883049|450251372|FG013|Post Induction|Lost to Follow-up|0|||
125171854|NCT02883049|450251373|FG014|Post Induction|Lost to Follow-up|0|||
125171855|NCT02883049|450251374|FG015|Post Induction|Lost to Follow-up|0|||
125171856|NCT02883049|450251359|FG000|Post Induction|Physician Decision|0|||
125171857|NCT02883049|450251360|FG001|Post Induction|Physician Decision|0|||
125171858|NCT02883049|450251361|FG002|Post Induction|Physician Decision|0|||
125171859|NCT02883049|450251362|FG003|Post Induction|Physician Decision|27|||
125171860|NCT02883049|450251363|FG004|Post Induction|Physician Decision|27|||
125171861|NCT02883049|450251364|FG005|Post Induction|Physician Decision|23|||
125171862|NCT02883049|450251365|FG006|Post Induction|Physician Decision|30|||
125171863|NCT02883049|450251366|FG007|Post Induction|Physician Decision|56|||
125171864|NCT02883049|450251367|FG008|Post Induction|Physician Decision|85|||
125171865|NCT02883049|450251368|FG009|Post Induction|Physician Decision|12|||
125171866|NCT02883049|450251369|FG010|Post Induction|Physician Decision|5|||
125171867|NCT02883049|450251370|FG011|Post Induction|Physician Decision|14|||
125171868|NCT02883049|450251371|FG012|Post Induction|Physician Decision|1|||
125171869|NCT02883049|450251372|FG013|Post Induction|Physician Decision|11|||
125171870|NCT02883049|450251373|FG014|Post Induction|Physician Decision|19|||
125229625|NCT01863771|450469963|FG002|Maintenance Phase|Lack of Efficacy|7|||
125229626|NCT01863771|450469964|FG003|Maintenance Phase|Lack of Efficacy|38|||
125229627|NCT01863771|450469961|FG000|Maintenance Phase|Physician Decision|0|||
125229628|NCT01863771|450469962|FG001|Maintenance Phase|Physician Decision|0|||
125229629|NCT01863771|450469963|FG002|Maintenance Phase|Physician Decision|2|||
125229630|NCT01863771|450469964|FG003|Maintenance Phase|Physician Decision|1|||
125229631|NCT01863771|450469961|FG000|Maintenance Phase|Pregnancy|0|||
125229632|NCT01863771|450469962|FG001|Maintenance Phase|Pregnancy|1|||
125229633|NCT01863771|450469963|FG002|Maintenance Phase|Pregnancy|0|||
125229634|NCT01863771|450469964|FG003|Maintenance Phase|Pregnancy|0|||
125229635|NCT01863771|450469961|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125229636|NCT01863771|450469962|FG001|Maintenance Phase|Withdrawal by Subject|1|||
125229637|NCT01863771|450469963|FG002|Maintenance Phase|Withdrawal by Subject|2|||
125229638|NCT01863771|450469964|FG003|Maintenance Phase|Withdrawal by Subject|3|||
125229639|NCT01218308|450469965|FG000|Overall Study|Adverse Event|1|||
125229640|NCT01218308|450469966|FG001|Overall Study|Adverse Event|2|||
125229641|NCT01218308|450469965|FG000|Overall Study|Protocol Violation|0|||
125229642|NCT01218308|450469966|FG001|Overall Study|Protocol Violation|2|||
125229643|NCT01218308|450469965|FG000|Overall Study|Withdrawal by Subject|61|||
125229644|NCT01218308|450469966|FG001|Overall Study|Withdrawal by Subject|64|||
125229645|NCT01218308|450469965|FG000|Overall Study|Lost to Follow-up|27|||
125229646|NCT01218308|450469966|FG001|Overall Study|Lost to Follow-up|31|||
125229647|NCT01218308|450469965|FG000|Overall Study|Other|14|||
125229648|NCT01218308|450469966|FG001|Overall Study|Other|21|||
125229649|NCT00547339|450469967|FG000|Overall Study|Physician Decision|0|||
125229650|NCT00547339|450469968|FG001|Overall Study|Physician Decision|0|||
125229651|NCT00547339|450469969|FG002|Overall Study|Physician Decision|1|||
125229652|NCT00547339|450469970|FG003|Overall Study|Physician Decision|0|||
125229653|NCT01248455|450469971|FG000|Overall Study|switched to alternate treatment|1|||
125229654|NCT01117870|450469972|FG000|Overall Study|Inability to place needle|1|||
125229655|NCT01117870|450469973|FG001|Overall Study|Inability to place needle|0|||
125229656|NCT01065818|450469974|FG000|Overall Study|Withdrawal by Subject|1|||
125229657|NCT01065818|450469974|FG000|Overall Study|Not a candidate for surgery|1|||
125229658|NCT00095979|450469980|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
125229659|NCT01079780|450469982|FG000|Overall Study|Disease progression|43|||
125229660|NCT01079780|450469983|FG001|Overall Study|Disease progression|7|||
125229661|NCT01079780|450469984|FG002|Overall Study|Disease progression|31|||
125229662|NCT01079780|450469982|FG000|Overall Study|Adverse Event|13|||
125229663|NCT01079780|450469983|FG001|Overall Study|Adverse Event|5|||
125229664|NCT01079780|450469984|FG002|Overall Study|Adverse Event|7|||
125229665|NCT01079780|450469982|FG000|Overall Study|Death|2|||
125229666|NCT01079780|450469983|FG001|Overall Study|Death|0|||
125229667|NCT01079780|450469984|FG002|Overall Study|Death|2|||
125229668|NCT01079780|450469982|FG000|Overall Study|Withdrawal by Subject|6|||
125229669|NCT01079780|450469983|FG001|Overall Study|Withdrawal by Subject|4|||
125229670|NCT01079780|450469984|FG002|Overall Study|Withdrawal by Subject|4|||
125229671|NCT01079780|450469982|FG000|Overall Study|Alternative therapy|2|||
125229672|NCT01079780|450469983|FG001|Overall Study|Alternative therapy|0|||
125229673|NCT01079780|450469984|FG002|Overall Study|Alternative therapy|2|||
125229674|NCT01079780|450469982|FG000|Overall Study|Physician Decision|1|||
125229675|NCT01079780|450469983|FG001|Overall Study|Physician Decision|0|||
125171871|NCT02883049|450251374|FG015|Post Induction|Physician Decision|5|||
125171872|NCT02883049|450251359|FG000|Post Induction|Protocol Violation|0|||
125171873|NCT02883049|450251360|FG001|Post Induction|Protocol Violation|0|||
125171874|NCT02883049|450251361|FG002|Post Induction|Protocol Violation|0|||
125171875|NCT02883049|450251362|FG003|Post Induction|Protocol Violation|0|||
125171876|NCT02883049|450251363|FG004|Post Induction|Protocol Violation|0|||
125171877|NCT02883049|450251364|FG005|Post Induction|Protocol Violation|0|||
125171878|NCT02883049|450251365|FG006|Post Induction|Protocol Violation|0|||
125229676|NCT01079780|450469984|FG002|Overall Study|Physician Decision|1|||
125229677|NCT01079780|450469982|FG000|Overall Study|Error made in lesion measurement|1|||
125229678|NCT01079780|450469983|FG001|Overall Study|Error made in lesion measurement|0|||
125229679|NCT01079780|450469984|FG002|Overall Study|Error made in lesion measurement|0|||
125229680|NCT01079780|450469982|FG000|Overall Study|Patient had surgery|1|||
125171879|NCT02883049|450251366|FG007|Post Induction|Protocol Violation|1|||
125171880|NCT02883049|450251367|FG008|Post Induction|Protocol Violation|0|||
125171881|NCT02883049|450251368|FG009|Post Induction|Protocol Violation|0|||
125171882|NCT02883049|450251369|FG010|Post Induction|Protocol Violation|0|||
125171883|NCT02883049|450251370|FG011|Post Induction|Protocol Violation|0|||
125171884|NCT02883049|450251371|FG012|Post Induction|Protocol Violation|0|||
125171885|NCT02883049|450251372|FG013|Post Induction|Protocol Violation|0|||
125171886|NCT02883049|450251373|FG014|Post Induction|Protocol Violation|0|||
125171887|NCT02883049|450251374|FG015|Post Induction|Protocol Violation|0|||
125171888|NCT02883049|450251359|FG000|Post Induction|Withdrawal by Subject|0|||
125171889|NCT02883049|450251360|FG001|Post Induction|Withdrawal by Subject|0|||
125171890|NCT02883049|450251361|FG002|Post Induction|Withdrawal by Subject|0|||
125171891|NCT02883049|450251362|FG003|Post Induction|Withdrawal by Subject|5|||
125171892|NCT02883049|450251363|FG004|Post Induction|Withdrawal by Subject|2|||
125171893|NCT02883049|450251364|FG005|Post Induction|Withdrawal by Subject|1|||
125171894|NCT02883049|450251365|FG006|Post Induction|Withdrawal by Subject|0|||
125171895|NCT02883049|450251366|FG007|Post Induction|Withdrawal by Subject|0|||
125171896|NCT02883049|450251367|FG008|Post Induction|Withdrawal by Subject|2|||
125171897|NCT02883049|450251368|FG009|Post Induction|Withdrawal by Subject|0|||
125171898|NCT02883049|450251369|FG010|Post Induction|Withdrawal by Subject|1|||
125171899|NCT02883049|450251370|FG011|Post Induction|Withdrawal by Subject|1|||
125171900|NCT02883049|450251371|FG012|Post Induction|Withdrawal by Subject|0|||
125171901|NCT02883049|450251372|FG013|Post Induction|Withdrawal by Subject|0|||
125171902|NCT02883049|450251373|FG014|Post Induction|Withdrawal by Subject|1|||
125171903|NCT02883049|450251374|FG015|Post Induction|Withdrawal by Subject|0|||
125171904|NCT02883049|450251359|FG000|Post Induction|Ineligible|0|||
125171905|NCT02883049|450251360|FG001|Post Induction|Ineligible|0|||
125171906|NCT02883049|450251361|FG002|Post Induction|Ineligible|2|||
125171907|NCT02883049|450251362|FG003|Post Induction|Ineligible|0|||
125171908|NCT02883049|450251363|FG004|Post Induction|Ineligible|0|||
125171909|NCT02883049|450251364|FG005|Post Induction|Ineligible|0|||
125171910|NCT02883049|450251365|FG006|Post Induction|Ineligible|1|||
125171911|NCT02883049|450251366|FG007|Post Induction|Ineligible|0|||
125171912|NCT02883049|450251367|FG008|Post Induction|Ineligible|0|||
125171913|NCT02883049|450251368|FG009|Post Induction|Ineligible|0|||
125171914|NCT02883049|450251369|FG010|Post Induction|Ineligible|1|||
125171915|NCT02883049|450251370|FG011|Post Induction|Ineligible|0|||
125171916|NCT02883049|450251371|FG012|Post Induction|Ineligible|0|||
125171917|NCT02883049|450251372|FG013|Post Induction|Ineligible|0|||
125171918|NCT02883049|450251373|FG014|Post Induction|Ineligible|0|||
125171919|NCT02883049|450251374|FG015|Post Induction|Ineligible|1|||
125171920|NCT02883049|450251359|FG000|Post Induction|Refusal of further protocol therapy|0|||
125171921|NCT02883049|450251360|FG001|Post Induction|Refusal of further protocol therapy|0|||
125171922|NCT02883049|450251361|FG002|Post Induction|Refusal of further protocol therapy|0|||
125171923|NCT02883049|450251362|FG003|Post Induction|Refusal of further protocol therapy|11|||
125171924|NCT02883049|450251363|FG004|Post Induction|Refusal of further protocol therapy|15|||
125171925|NCT02883049|450251364|FG005|Post Induction|Refusal of further protocol therapy|9|||
125171926|NCT02883049|450251365|FG006|Post Induction|Refusal of further protocol therapy|13|||
125171927|NCT02883049|450251366|FG007|Post Induction|Refusal of further protocol therapy|5|||
125171928|NCT02883049|450251367|FG008|Post Induction|Refusal of further protocol therapy|21|||
125171929|NCT02883049|450251368|FG009|Post Induction|Refusal of further protocol therapy|7|||
125229681|NCT01079780|450469983|FG001|Overall Study|Patient had surgery|0|||
125229682|NCT01079780|450469984|FG002|Overall Study|Patient had surgery|0|||
125229683|NCT01079780|450469982|FG000|Overall Study|Treatment cycle delay|0|||
125229684|NCT01079780|450469983|FG001|Overall Study|Treatment cycle delay|0|||
125229685|NCT01079780|450469984|FG002|Overall Study|Treatment cycle delay|1|||
125229686|NCT01079780|450469982|FG000|Overall Study|Never started treatment|1|||
125229687|NCT01079780|450469983|FG001|Overall Study|Never started treatment|0|||
125229688|NCT01079780|450469984|FG002|Overall Study|Never started treatment|2|||
125229689|NCT03322293|450469985|FG000|Overall Study|Lost to Follow-up|0|||
125229690|NCT03322293|450469986|FG001|Overall Study|Lost to Follow-up|0|||
125229691|NCT03322293|450469987|FG002|Overall Study|Lost to Follow-up|1|||
125171930|NCT02883049|450251369|FG010|Post Induction|Refusal of further protocol therapy|0|||
125171931|NCT02883049|450251370|FG011|Post Induction|Refusal of further protocol therapy|7|||
125171932|NCT02883049|450251371|FG012|Post Induction|Refusal of further protocol therapy|3|||
125171933|NCT02883049|450251372|FG013|Post Induction|Refusal of further protocol therapy|0|||
125171934|NCT02883049|450251373|FG014|Post Induction|Refusal of further protocol therapy|4|||
125171935|NCT02883049|450251374|FG015|Post Induction|Refusal of further protocol therapy|1|||
125229692|NCT03435055|450469988|FG000|Screening|Physician Decision|2|||
125229693|NCT03435055|450469988|FG000|Received Intervention|Did not complete nitrous administration|3|||
125171936|NCT02883049|450251359|FG000|Post Induction|Inevaluable|0|||
125171937|NCT02883049|450251360|FG001|Post Induction|Inevaluable|0|||
125171938|NCT02883049|450251361|FG002|Post Induction|Inevaluable|0|||
125171939|NCT02883049|450251362|FG003|Post Induction|Inevaluable|1|||
125171940|NCT02883049|450251363|FG004|Post Induction|Inevaluable|1|||
125171941|NCT02883049|450251364|FG005|Post Induction|Inevaluable|2|||
125171942|NCT02883049|450251365|FG006|Post Induction|Inevaluable|7|||
125171943|NCT02883049|450251366|FG007|Post Induction|Inevaluable|6|||
125171944|NCT02883049|450251367|FG008|Post Induction|Inevaluable|4|||
125171945|NCT02883049|450251368|FG009|Post Induction|Inevaluable|4|||
125171946|NCT02883049|450251369|FG010|Post Induction|Inevaluable|1|||
125171947|NCT02883049|450251370|FG011|Post Induction|Inevaluable|1|||
125171948|NCT02883049|450251371|FG012|Post Induction|Inevaluable|2|||
125171949|NCT02883049|450251372|FG013|Post Induction|Inevaluable|0|||
125171950|NCT02883049|450251373|FG014|Post Induction|Inevaluable|0|||
125171951|NCT02883049|450251374|FG015|Post Induction|Inevaluable|1|||
125171952|NCT02883049|450251359|FG000|Post Induction|Moved to another non-COG institution|0|||
125171953|NCT02883049|450251360|FG001|Post Induction|Moved to another non-COG institution|0|||
125171954|NCT02883049|450251361|FG002|Post Induction|Moved to another non-COG institution|0|||
125171955|NCT02883049|450251362|FG003|Post Induction|Moved to another non-COG institution|0|||
125171956|NCT02883049|450251363|FG004|Post Induction|Moved to another non-COG institution|0|||
125171957|NCT02883049|450251364|FG005|Post Induction|Moved to another non-COG institution|0|||
125171958|NCT02883049|450251365|FG006|Post Induction|Moved to another non-COG institution|0|||
125171959|NCT02883049|450251366|FG007|Post Induction|Moved to another non-COG institution|2|||
125171960|NCT02883049|450251367|FG008|Post Induction|Moved to another non-COG institution|2|||
125171961|NCT02883049|450251368|FG009|Post Induction|Moved to another non-COG institution|0|||
125171962|NCT02883049|450251369|FG010|Post Induction|Moved to another non-COG institution|0|||
125171963|NCT02883049|450251370|FG011|Post Induction|Moved to another non-COG institution|1|||
125171964|NCT02883049|450251371|FG012|Post Induction|Moved to another non-COG institution|0|||
125171965|NCT02883049|450251372|FG013|Post Induction|Moved to another non-COG institution|0|||
125171966|NCT02883049|450251373|FG014|Post Induction|Moved to another non-COG institution|0|||
125171967|NCT02883049|450251374|FG015|Post Induction|Moved to another non-COG institution|0|||
125171968|NCT02883049|450251359|FG000|Post Induction|Randomization closed|0|||
125171969|NCT02883049|450251360|FG001|Post Induction|Randomization closed|0|||
125171970|NCT02883049|450251361|FG002|Post Induction|Randomization closed|0|||
125171971|NCT02883049|450251362|FG003|Post Induction|Randomization closed|0|||
125171972|NCT02883049|450251363|FG004|Post Induction|Randomization closed|0|||
125171973|NCT02883049|450251364|FG005|Post Induction|Randomization closed|0|||
125171974|NCT02883049|450251365|FG006|Post Induction|Randomization closed|0|||
125171975|NCT02883049|450251366|FG007|Post Induction|Randomization closed|20|||
125171976|NCT02883049|450251367|FG008|Post Induction|Randomization closed|0|||
125171977|NCT02883049|450251368|FG009|Post Induction|Randomization closed|0|||
125171978|NCT02883049|450251369|FG010|Post Induction|Randomization closed|0|||
125171979|NCT02883049|450251370|FG011|Post Induction|Randomization closed|0|||
125171980|NCT02883049|450251371|FG012|Post Induction|Randomization closed|0|||
125171981|NCT02883049|450251372|FG013|Post Induction|Randomization closed|0|||
125171982|NCT02883049|450251373|FG014|Post Induction|Randomization closed|0|||
125171983|NCT02883049|450251374|FG015|Post Induction|Randomization closed|0|||
125171984|NCT02883049|450251359|FG000|Post Induction|MRD negative|0|||
125171985|NCT02883049|450251360|FG001|Post Induction|MRD negative|0|||
125171986|NCT02883049|450251361|FG002|Post Induction|MRD negative|0|||
125171987|NCT02883049|450251362|FG003|Post Induction|MRD negative|0|||
125171988|NCT02883049|450251363|FG004|Post Induction|MRD negative|0|||
125171989|NCT02883049|450251364|FG005|Post Induction|MRD negative|0|||
125171990|NCT02883049|450251365|FG006|Post Induction|MRD negative|0|||
125171991|NCT02883049|450251366|FG007|Post Induction|MRD negative|11|||
125171992|NCT02883049|450251367|FG008|Post Induction|MRD negative|0|||
125171993|NCT02883049|450251368|FG009|Post Induction|MRD negative|0|||
125171994|NCT02883049|450251369|FG010|Post Induction|MRD negative|0|||
125171995|NCT02883049|450251370|FG011|Post Induction|MRD negative|0|||
125171996|NCT02883049|450251371|FG012|Post Induction|MRD negative|0|||
125171997|NCT02883049|450251372|FG013|Post Induction|MRD negative|0|||
125171998|NCT02883049|450251373|FG014|Post Induction|MRD negative|0|||
125171999|NCT02883049|450251374|FG015|Post Induction|MRD negative|0|||
125172000|NCT02883049|450251359|FG000|Post Induction|Developed SMN|0|||
125172001|NCT02883049|450251360|FG001|Post Induction|Developed SMN|0|||
125172002|NCT02883049|450251361|FG002|Post Induction|Developed SMN|0|||
125172003|NCT02883049|450251362|FG003|Post Induction|Developed SMN|0|||
125172004|NCT02883049|450251363|FG004|Post Induction|Developed SMN|1|||
125172005|NCT02883049|450251364|FG005|Post Induction|Developed SMN|0|||
125172006|NCT02883049|450251365|FG006|Post Induction|Developed SMN|1|||
125172007|NCT02883049|450251366|FG007|Post Induction|Developed SMN|0|||
125172008|NCT02883049|450251367|FG008|Post Induction|Developed SMN|0|||
125172009|NCT02883049|450251368|FG009|Post Induction|Developed SMN|0|||
125172010|NCT02883049|450251369|FG010|Post Induction|Developed SMN|1|||
125172011|NCT02883049|450251370|FG011|Post Induction|Developed SMN|1|||
125172012|NCT02883049|450251371|FG012|Post Induction|Developed SMN|0|||
125172013|NCT02883049|450251372|FG013|Post Induction|Developed SMN|0|||
125172014|NCT02883049|450251373|FG014|Post Induction|Developed SMN|1|||
125172015|NCT02883049|450251374|FG015|Post Induction|Developed SMN|0|||
125172016|NCT02883049|450251359|FG000|Post Induction|Enrolled onto another COG study|0|||
125172017|NCT02883049|450251360|FG001|Post Induction|Enrolled onto another COG study|0|||
125172018|NCT02883049|450251361|FG002|Post Induction|Enrolled onto another COG study|0|||
125172019|NCT02883049|450251362|FG003|Post Induction|Enrolled onto another COG study|1|||
125172020|NCT02883049|450251363|FG004|Post Induction|Enrolled onto another COG study|1|||
125172021|NCT02883049|450251364|FG005|Post Induction|Enrolled onto another COG study|0|||
125172022|NCT02883049|450251365|FG006|Post Induction|Enrolled onto another COG study|0|||
125172023|NCT02883049|450251366|FG007|Post Induction|Enrolled onto another COG study|4|||
125172024|NCT02883049|450251367|FG008|Post Induction|Enrolled onto another COG study|0|||
125172025|NCT02883049|450251368|FG009|Post Induction|Enrolled onto another COG study|0|||
125172026|NCT02883049|450251369|FG010|Post Induction|Enrolled onto another COG study|0|||
125172027|NCT02883049|450251370|FG011|Post Induction|Enrolled onto another COG study|2|||
125172028|NCT02883049|450251371|FG012|Post Induction|Enrolled onto another COG study|0|||
125172029|NCT02883049|450251372|FG013|Post Induction|Enrolled onto another COG study|1|||
125172030|NCT02883049|450251373|FG014|Post Induction|Enrolled onto another COG study|0|||
125172031|NCT02883049|450251374|FG015|Post Induction|Enrolled onto another COG study|0|||
125172032|NCT02883049|450251359|FG000|Post Induction|Recurrent leukemia|0|||
125172033|NCT02883049|450251360|FG001|Post Induction|Recurrent leukemia|0|||
125172034|NCT02883049|450251361|FG002|Post Induction|Recurrent leukemia|0|||
125172035|NCT02883049|450251362|FG003|Post Induction|Recurrent leukemia|17|||
125172036|NCT02883049|450251363|FG004|Post Induction|Recurrent leukemia|12|||
125172037|NCT02883049|450251364|FG005|Post Induction|Recurrent leukemia|4|||
125172038|NCT02883049|450251365|FG006|Post Induction|Recurrent leukemia|1|||
125172039|NCT02883049|450251366|FG007|Post Induction|Recurrent leukemia|13|||
125172040|NCT02883049|450251367|FG008|Post Induction|Recurrent leukemia|27|||
125172041|NCT02883049|450251368|FG009|Post Induction|Recurrent leukemia|5|||
125172042|NCT02883049|450251369|FG010|Post Induction|Recurrent leukemia|3|||
125172043|NCT02883049|450251370|FG011|Post Induction|Recurrent leukemia|12|||
125172044|NCT02883049|450251371|FG012|Post Induction|Recurrent leukemia|1|||
125172045|NCT02883049|450251372|FG013|Post Induction|Recurrent leukemia|1|||
125172046|NCT02883049|450251373|FG014|Post Induction|Recurrent leukemia|9|||
125172047|NCT02883049|450251374|FG015|Post Induction|Recurrent leukemia|3|||
125172048|NCT02883049|450251359|FG000|Post Induction|Induction Failure|0|||
125172049|NCT02883049|450251360|FG001|Post Induction|Induction Failure|0|||
125172050|NCT02883049|450251361|FG002|Post Induction|Induction Failure|0|||
125172051|NCT02883049|450251362|FG003|Post Induction|Induction Failure|0|||
125172052|NCT02883049|450251363|FG004|Post Induction|Induction Failure|0|||
125172053|NCT02883049|450251364|FG005|Post Induction|Induction Failure|0|||
125172054|NCT02883049|450251365|FG006|Post Induction|Induction Failure|0|||
125172055|NCT02883049|450251366|FG007|Post Induction|Induction Failure|2|||
125172056|NCT02883049|450251367|FG008|Post Induction|Induction Failure|2|||
125172057|NCT02883049|450251368|FG009|Post Induction|Induction Failure|0|||
125172058|NCT02883049|450251369|FG010|Post Induction|Induction Failure|0|||
125172059|NCT02883049|450251370|FG011|Post Induction|Induction Failure|0|||
125172060|NCT02883049|450251371|FG012|Post Induction|Induction Failure|0|||
125172061|NCT02883049|450251372|FG013|Post Induction|Induction Failure|2|||
125172062|NCT02883049|450251373|FG014|Post Induction|Induction Failure|0|||
125172063|NCT02883049|450251374|FG015|Post Induction|Induction Failure|0|||
125172064|NCT01924754|450251378|FG000|Overall Study|Lost to Follow-up|1|||
125172065|NCT01924754|450251379|FG001|Overall Study|Lost to Follow-up|2|||
125172066|NCT01924754|450251380|FG002|Overall Study|Lost to Follow-up|1|||
125172067|NCT01924754|450251378|FG000|Overall Study|Pregnancy|0|||
125172068|NCT01924754|450251379|FG001|Overall Study|Pregnancy|1|||
125172069|NCT01924754|450251380|FG002|Overall Study|Pregnancy|2|||
125172070|NCT02245412|450251383|FG000|Treatment Period|Death|1|||
125172071|NCT02245412|450251384|FG001|Treatment Period|Death|1|||
125172072|NCT02245412|450251385|FG002|Treatment Period|Death|0|||
125172073|NCT02245412|450251383|FG000|Treatment Period|Physician Decision|1|||
125172074|NCT02245412|450251384|FG001|Treatment Period|Physician Decision|1|||
125172075|NCT02245412|450251385|FG002|Treatment Period|Physician Decision|0|||
125172076|NCT02245412|450251383|FG000|Treatment Period|Withdrawal by Subject|2|||
125172077|NCT02245412|450251384|FG001|Treatment Period|Withdrawal by Subject|1|||
125172078|NCT02245412|450251385|FG002|Treatment Period|Withdrawal by Subject|0|||
125172079|NCT02245412|450251383|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
125172080|NCT02245412|450251384|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
125229694|NCT01178294|450469989|FG000|Overall Study|Adverse Event|4|||
125229695|NCT01178294|450469989|FG000|Overall Study|Lost to Follow-up|2|||
125172081|NCT02245412|450251385|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
125172082|NCT02245412|450251383|FG000|Follow-Up Period|Death|4|||
125172083|NCT02245412|450251384|FG001|Follow-Up Period|Death|2|||
125172084|NCT02245412|450251385|FG002|Follow-Up Period|Death|1|||
125172085|NCT02245412|450251383|FG000|Follow-Up Period|Physician Decision|1|||
125172086|NCT02245412|450251384|FG001|Follow-Up Period|Physician Decision|0|||
125172087|NCT02245412|450251385|FG002|Follow-Up Period|Physician Decision|0|||
125172088|NCT02245412|450251383|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
125172089|NCT02245412|450251384|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
125172090|NCT02245412|450251385|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
125172091|NCT01392963|450251386|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
125172092|NCT01392963|450251387|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
125172093|NCT01392963|450251386|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
125172094|NCT01392963|450251387|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
125172095|NCT01392963|450251386|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
125172096|NCT01392963|450251387|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
125172097|NCT00369486|450251388|FG000|4-Week Visit|Missed visit|2|||
125172098|NCT00369486|450251389|FG001|4-Week Visit|Missed visit|2|||
125172099|NCT00369486|450251390|FG002|4-Week Visit|Missed visit|0|||
125172100|NCT00369486|450251391|FG003|4-Week Visit|Missed visit|2|||
125172101|NCT00369486|450251392|FG004|4-Week Visit|Missed visit|1|||
125172102|NCT00369486|450251388|FG000|4-Week Visit|Dropped|0|||
125172103|NCT00369486|450251389|FG001|4-Week Visit|Dropped|0|||
125229696|NCT01178294|450469989|FG000|Overall Study|Lack of Efficacy|1|||
125229697|NCT01178294|450469989|FG000|Overall Study|Death|1|||
125229698|NCT01178294|450469989|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
125229699|NCT01178294|450469989|FG000|Overall Study|Subject status is terminal|1|||
125229700|NCT01178294|450469989|FG000|Overall Study|Completion status could not be verified|1|||
125229701|NCT03712280|450469991|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
125229702|NCT03712280|450469992|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
125229703|NCT03712280|450469993|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
125229704|NCT03712280|450469994|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
125229705|NCT03712280|450469991|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
125229706|NCT03712280|450469992|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
125229707|NCT03712280|450469993|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
125229708|NCT03712280|450469994|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
125229709|NCT03712280|450469991|FG000|Overall Study|Adverse Event|0|||
125229710|NCT03712280|450469992|FG001|Overall Study|Adverse Event|0|||
125229711|NCT03712280|450469993|FG002|Overall Study|Adverse Event|1|||
125229712|NCT03712280|450469994|FG003|Overall Study|Adverse Event|0|||
125229713|NCT05379920|450469998|FG000|Overall Study|Lost to Follow-up|0|||
125229714|NCT05379920|450469999|FG001|Overall Study|Lost to Follow-up|5|||
125229715|NCT05379920|450470000|FG002|Overall Study|Lost to Follow-up|0|||
125229716|NCT05379920|450470001|FG003|Overall Study|Lost to Follow-up|0|||
125229717|NCT03176771|450470004|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
125229718|NCT03176771|450470005|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
125229719|NCT03176771|450470006|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
125229720|NCT03176771|450470007|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
125229721|NCT03176771|450470008|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
125229722|NCT03176771|450470004|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
125229723|NCT03176771|450470005|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
125229724|NCT03176771|450470006|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
125229725|NCT03176771|450470007|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
125229726|NCT03176771|450470008|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
125229727|NCT03176771|450470004|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
125229728|NCT03176771|450470005|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
125229729|NCT03176771|450470006|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
125229730|NCT03176771|450470007|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
125229731|NCT03176771|450470008|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
125229732|NCT03176771|450470004|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
125229733|NCT03176771|450470005|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
125229734|NCT03176771|450470006|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
125229735|NCT03176771|450470007|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
125229736|NCT03176771|450470008|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
125229737|NCT03176771|450470004|FG000|Double-Blind Extension Period|Adverse Event|0|||
125229738|NCT03176771|450470005|FG001|Double-Blind Extension Period|Adverse Event|0|||
125229739|NCT03176771|450470006|FG002|Double-Blind Extension Period|Adverse Event|0|||
125229740|NCT03176771|450470007|FG003|Double-Blind Extension Period|Adverse Event|15|||
125229741|NCT03176771|450470008|FG004|Double-Blind Extension Period|Adverse Event|18|||
125229742|NCT03176771|450470004|FG000|Double-Blind Extension Period|Death|0|||
125172104|NCT00369486|450251390|FG002|4-Week Visit|Dropped|1|||
125172105|NCT00369486|450251391|FG003|4-Week Visit|Dropped|0|||
125172106|NCT00369486|450251392|FG004|4-Week Visit|Dropped|0|||
125172107|NCT00369486|450251388|FG000|8-Week Visit|Missed visit|0|||
125172108|NCT00369486|450251389|FG001|8-Week Visit|Missed visit|1|||
125172109|NCT00369486|450251390|FG002|8-Week Visit|Missed visit|0|||
125172110|NCT00369486|450251391|FG003|8-Week Visit|Missed visit|0|||
125172111|NCT00369486|450251392|FG004|8-Week Visit|Missed visit|1|||
125172112|NCT00369486|450251388|FG000|8-Week Visit|Dropped|0|||
125172113|NCT00369486|450251389|FG001|8-Week Visit|Dropped|0|||
125172114|NCT00369486|450251390|FG002|8-Week Visit|Dropped|0|||
125172115|NCT00369486|450251391|FG003|8-Week Visit|Dropped|1|||
125172116|NCT00369486|450251392|FG004|8-Week Visit|Dropped|0|||
125172117|NCT00369486|450251388|FG000|17-Week Visit|Missed visit|0|||
125172118|NCT00369486|450251389|FG001|17-Week Visit|Missed visit|0|||
125172119|NCT00369486|450251390|FG002|17-Week Visit|Missed visit|1|||
125172120|NCT00369486|450251391|FG003|17-Week Visit|Missed visit|1|||
125172121|NCT00369486|450251392|FG004|17-Week Visit|Missed visit|1|||
125172122|NCT00369486|450251388|FG000|34-Week Visit|Dropped|0|||
125172123|NCT00369486|450251389|FG001|34-Week Visit|Dropped|1|||
125172124|NCT00369486|450251390|FG002|34-Week Visit|Dropped|1|||
125172125|NCT00369486|450251391|FG003|34-Week Visit|Dropped|3|||
125172126|NCT00369486|450251392|FG004|34-Week Visit|Dropped|3|||
125172127|NCT00402116|450251393|FG000|Overall Study|Jaw infection after surgery-other|1|||
125172128|NCT00402116|450251394|FG001|Overall Study|Jaw infection after surgery-other|0|||
125172129|NCT00402116|450251395|FG002|Overall Study|Jaw infection after surgery-other|0|||
125172130|NCT00402116|450251393|FG000|Overall Study|Withdrawal by Subject|1|||
125172131|NCT00402116|450251394|FG001|Overall Study|Withdrawal by Subject|0|||
125172132|NCT00402116|450251395|FG002|Overall Study|Withdrawal by Subject|5|||
125172133|NCT00402116|450251393|FG000|Overall Study|Treatment completed per protocol|1|||
125172134|NCT00402116|450251394|FG001|Overall Study|Treatment completed per protocol|1|||
125172135|NCT00402116|450251395|FG002|Overall Study|Treatment completed per protocol|2|||
125172136|NCT00402116|450251393|FG000|Overall Study|other complicating disease|0|||
125172137|NCT00402116|450251394|FG001|Overall Study|other complicating disease|0|||
125172138|NCT00402116|450251395|FG002|Overall Study|other complicating disease|2|||
125172139|NCT00402116|450251393|FG000|Overall Study|Disease Progression|0|||
125172140|NCT00402116|450251394|FG001|Overall Study|Disease Progression|4|||
125172141|NCT00402116|450251395|FG002|Overall Study|Disease Progression|38|||
125172142|NCT00402116|450251393|FG000|Overall Study|mistaken thrombocytopenia|0|||
125172143|NCT00402116|450251394|FG001|Overall Study|mistaken thrombocytopenia|0|||
125172144|NCT00402116|450251395|FG002|Overall Study|mistaken thrombocytopenia|1|||
125172145|NCT00402116|450251393|FG000|Overall Study|decline related hyponatremia/tumor|0|||
125172146|NCT00402116|450251394|FG001|Overall Study|decline related hyponatremia/tumor|0|||
125172147|NCT00402116|450251395|FG002|Overall Study|decline related hyponatremia/tumor|1|||
125172148|NCT00402116|450251393|FG000|Overall Study|Adverse Event|0|||
125172149|NCT00402116|450251394|FG001|Overall Study|Adverse Event|1|||
125172150|NCT00402116|450251395|FG002|Overall Study|Adverse Event|6|||
125172151|NCT04778904|450251396|FG000|Overall Study|Protocol Violation|1|||
125172152|NCT04778904|450251397|FG001|Overall Study|Protocol Violation|0|||
125172153|NCT04778904|450251398|FG002|Overall Study|Protocol Violation|0|||
125172154|NCT04778904|450251399|FG003|Overall Study|Protocol Violation|0|||
125172155|NCT04778904|450251396|FG000|Overall Study|Withdrawal by Subject|0|||
125172156|NCT04778904|450251397|FG001|Overall Study|Withdrawal by Subject|0|||
125172157|NCT04778904|450251398|FG002|Overall Study|Withdrawal by Subject|1|||
125229743|NCT03176771|450470005|FG001|Double-Blind Extension Period|Death|0|||
125229744|NCT03176771|450470006|FG002|Double-Blind Extension Period|Death|0|||
125229745|NCT03176771|450470007|FG003|Double-Blind Extension Period|Death|3|||
125229746|NCT03176771|450470008|FG004|Double-Blind Extension Period|Death|4|||
125229747|NCT03176771|450470004|FG000|Double-Blind Extension Period|Physician Decision|0|||
125229748|NCT03176771|450470005|FG001|Double-Blind Extension Period|Physician Decision|0|||
125229749|NCT03176771|450470006|FG002|Double-Blind Extension Period|Physician Decision|0|||
125229750|NCT03176771|450470007|FG003|Double-Blind Extension Period|Physician Decision|3|||
125229751|NCT03176771|450470008|FG004|Double-Blind Extension Period|Physician Decision|1|||
125229752|NCT03176771|450470004|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
125229753|NCT03176771|450470005|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
125229754|NCT03176771|450470006|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
125229755|NCT03176771|450470007|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
125229756|NCT03176771|450470008|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
125229757|NCT02732639|450470010|FG000|Overall Study|Lost to Follow-up|1|||
125229758|NCT02662569|450470012|FG000|Overall Study|Withdrawal by Subject|6|||
125172158|NCT04778904|450251399|FG003|Overall Study|Withdrawal by Subject|0|||
125172159|NCT01810302|450251406|FG000|Overall Study|Death|1|||
125229759|NCT02662569|450470013|FG001|Overall Study|Withdrawal by Subject|1|||
125229760|NCT02662569|450470014|FG002|Overall Study|Withdrawal by Subject|6|||
125229761|NCT02662569|450470015|FG003|Overall Study|Withdrawal by Subject|4|||
125172160|NCT01810302|450251407|FG001|Overall Study|Death|0|||
125172161|NCT01810302|450251406|FG000|Overall Study|Physician Decision|0|||
125172162|NCT01810302|450251407|FG001|Overall Study|Physician Decision|1|||
125172163|NCT04138043|450251408|FG000|Overall Study|Withdrawal by Subject|0|||
125172164|NCT04138043|450251409|FG001|Overall Study|Withdrawal by Subject|1|||
125172165|NCT02856802|450251410|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
125229762|NCT02662569|450470012|FG000|Overall Study|Lost to Follow-up|1|||
125172166|NCT02856802|450251411|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
125172167|NCT02856802|450251410|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
125172168|NCT02856802|450251411|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
125172169|NCT02856802|450251410|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
125172170|NCT02856802|450251411|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
125172171|NCT02856802|450251410|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
125172172|NCT02856802|450251411|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
125172173|NCT02856802|450251410|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
125172174|NCT02856802|450251411|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
125172175|NCT02856802|450251410|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
125172176|NCT02856802|450251411|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
125172177|NCT03772717|450251412|FG000|Overall Study|Withdrawal by Subject|2|||
125172178|NCT03278626|450251418|FG000|Overall Study|Death|2|||
125172179|NCT03278626|450251418|FG000|Overall Study|Toxicity|1|||
125172180|NCT03278626|450251418|FG000|Overall Study|Disease Progression|2|||
125172181|NCT00580788|450251419|FG000|Overall Study|Adverse Event|0|||
125172182|NCT00580788|450251420|FG001|Overall Study|Adverse Event|0|||
125172183|NCT00580788|450251421|FG002|Overall Study|Adverse Event|0|||
125172184|NCT00580788|450251422|FG003|Overall Study|Adverse Event|1|||
125172185|NCT04971187|450251423|FG000|Overall Study|Screen failures|2|||
125172186|NCT03743415|450251429|FG000|Overall Study|Death|5|||
125172187|NCT03743415|450251430|FG001|Overall Study|Death|3|||
125172188|NCT03743415|450251431|FG002|Overall Study|Death|1|||
125172189|NCT03743415|450251432|FG003|Overall Study|Death|4|||
125172190|NCT03743415|450251433|FG004|Overall Study|Death|0|||
125172191|NCT03743415|450251434|FG005|Overall Study|Death|0|||
125172192|NCT03743415|450251435|FG006|Overall Study|Death|0|||
125172193|NCT03743415|450251436|FG007|Overall Study|Death|0|||
125172194|NCT03743415|450251437|FG008|Overall Study|Death|1|||
125172195|NCT03743415|450251438|FG009|Overall Study|Death|0|||
125172196|NCT03743415|450251429|FG000|Overall Study|Withdrawal by Subject|1|||
125172197|NCT03743415|450251430|FG001|Overall Study|Withdrawal by Subject|0|||
125172198|NCT03743415|450251431|FG002|Overall Study|Withdrawal by Subject|4|||
125172199|NCT03743415|450251432|FG003|Overall Study|Withdrawal by Subject|5|||
125172200|NCT03743415|450251433|FG004|Overall Study|Withdrawal by Subject|5|||
125172201|NCT03743415|450251434|FG005|Overall Study|Withdrawal by Subject|2|||
125172202|NCT03743415|450251435|FG006|Overall Study|Withdrawal by Subject|2|||
125172203|NCT03743415|450251436|FG007|Overall Study|Withdrawal by Subject|5|||
125172204|NCT03743415|450251437|FG008|Overall Study|Withdrawal by Subject|9|||
125172205|NCT03743415|450251438|FG009|Overall Study|Withdrawal by Subject|10|||
125172206|NCT03743415|450251429|FG000|Overall Study|Lost to Follow-up|2|||
125172207|NCT03743415|450251430|FG001|Overall Study|Lost to Follow-up|0|||
125172208|NCT03743415|450251431|FG002|Overall Study|Lost to Follow-up|2|||
125172209|NCT03743415|450251432|FG003|Overall Study|Lost to Follow-up|1|||
125172210|NCT03743415|450251433|FG004|Overall Study|Lost to Follow-up|1|||
125172211|NCT03743415|450251434|FG005|Overall Study|Lost to Follow-up|0|||
125172212|NCT03743415|450251435|FG006|Overall Study|Lost to Follow-up|1|||
125172213|NCT03743415|450251436|FG007|Overall Study|Lost to Follow-up|4|||
125172214|NCT03743415|450251437|FG008|Overall Study|Lost to Follow-up|13|||
125172215|NCT03743415|450251438|FG009|Overall Study|Lost to Follow-up|13|||
125172216|NCT01266031|450251442|FG000|Overall Study|Not treated|0|||
125172217|NCT01266031|450251443|FG001|Overall Study|Not treated|3|||
125172218|NCT01266031|450251444|FG002|Overall Study|Not treated|2|||
125172219|NCT00005957|450251449|FG000|Overall Study|No treated|3|||
125172220|NCT00005957|450251450|FG001|Overall Study|No treated|9|||
125172221|NCT00005957|450251449|FG000|Overall Study|Crossover to the other arm|5|||
125172222|NCT00005957|450251450|FG001|Overall Study|Crossover to the other arm|19|||
125172223|NCT00799825|450251451|FG000|Overall Study|Adverse Event|1|||
125172224|NCT00799825|450251451|FG000|Overall Study|Withdrawal by Subject|6|||
125172225|NCT00799825|450251451|FG000|Overall Study|Lost to Follow-up|38|||
125172226|NCT00799825|450251451|FG000|Overall Study|Pregnancy|3|||
125172227|NCT00582010|450251452|FG000|Overall Study|Death|0|||
125172228|NCT00582010|450251453|FG001|Overall Study|Death|1|||
125172229|NCT02439970|450251454|FG000|Overall Study|Study Terminated|2|||
125172230|NCT02439970|450251455|FG001|Overall Study|Study Terminated|3|||
125229763|NCT02662569|450470013|FG001|Overall Study|Lost to Follow-up|0|||
125172231|NCT03717012|450251456|FG000|Overall Study|Due to trial termination|1|||
125172232|NCT03717012|450251457|FG001|Overall Study|Due to trial termination|2|||
125172233|NCT03717012|450251456|FG000|Overall Study|Protocol Violation|0|||
125172234|NCT03717012|450251457|FG001|Overall Study|Protocol Violation|2|||
125172235|NCT03717012|450251456|FG000|Overall Study|Adverse Event|0|||
125172236|NCT03717012|450251457|FG001|Overall Study|Adverse Event|1|||
125172237|NCT03717012|450251456|FG000|Overall Study|Lung transplant|0|||
125172238|NCT03717012|450251457|FG001|Overall Study|Lung transplant|1|||
125172239|NCT02640690|450251458|FG000|Overall Study|Lost to Follow-up|7|||
125172240|NCT02640690|450251459|FG001|Overall Study|Lost to Follow-up|7|||
125172241|NCT02640690|450251458|FG000|Overall Study|Withdrawal by Subject|16|||
125172242|NCT02640690|450251459|FG001|Overall Study|Withdrawal by Subject|20|||
125172243|NCT02640690|450251458|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
125172244|NCT02640690|450251459|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
125172245|NCT01520870|450251460|FG000|Overall Study|Withdrawal by Subject|2|||
125172246|NCT02910011|450251463|FG000|Overall Study|Physician Decision|2|||
125172247|NCT02463357|450251464|FG000|Overall Study|Withdrawal by Subject|1|||
125172248|NCT02463357|450251465|FG001|Overall Study|Withdrawal by Subject|0|||
125172249|NCT02463357|450251466|FG002|Overall Study|Withdrawal by Subject|0|||
125172250|NCT02463357|450251467|FG003|Overall Study|Withdrawal by Subject|0|||
125172251|NCT02463357|450251468|FG004|Overall Study|Withdrawal by Subject|0|||
125172252|NCT02463357|450251464|FG000|Overall Study|Withdrawal by Subject|0|||
125172253|NCT02463357|450251465|FG001|Overall Study|Withdrawal by Subject|0|||
125172254|NCT02463357|450251466|FG002|Overall Study|Withdrawal by Subject|0|||
125172255|NCT02463357|450251467|FG003|Overall Study|Withdrawal by Subject|0|||
125172256|NCT02463357|450251468|FG004|Overall Study|Withdrawal by Subject|1|||
125172257|NCT01399658|450251471|FG000|Overall Study|Ineligible|1|||
125172258|NCT01399658|450251471|FG000|Overall Study|Machine Technical Issue|3|||
125172259|NCT01399658|450251471|FG000|Overall Study|Alternative therapy|1|||
125172260|NCT01399658|450251471|FG000|Overall Study|No reason given|1|||
125172261|NCT02460679|450251472|FG000|Overall Study|Investigator Decision|1|||
125172262|NCT02460679|450251472|FG000|Overall Study|Withdrawal by Subject|4|||
125172263|NCT02620579|450251473|FG000|Overall Study|Physician Decision|0|||
125172264|NCT02620579|450251474|FG001|Overall Study|Physician Decision|0|||
125172265|NCT02620579|450251475|FG002|Overall Study|Physician Decision|0|||
125172266|NCT02620579|450251476|FG003|Overall Study|Physician Decision|1|||
125172267|NCT02620579|450251473|FG000|Overall Study|Withdrawal by Subject|0|||
125172268|NCT02620579|450251474|FG001|Overall Study|Withdrawal by Subject|1|||
125172269|NCT02620579|450251475|FG002|Overall Study|Withdrawal by Subject|1|||
125172270|NCT02620579|450251476|FG003|Overall Study|Withdrawal by Subject|0|||
125172271|NCT00796107|450251482|FG000|Overall Study|Lack of Efficacy|1|||
125172272|NCT00796107|450251482|FG000|Overall Study|Progressive Disease|5|||
125172273|NCT01721317|450251484|FG000|Overall Study|Study Closed / Terminated|2|||
125172274|NCT01721317|450251485|FG001|Overall Study|Study Closed / Terminated|2|||
125172275|NCT01721317|450251484|FG000|Overall Study|Physician Decision|0|||
125172276|NCT01721317|450251485|FG001|Overall Study|Physician Decision|1|||
125172277|NCT01721317|450251484|FG000|Overall Study|Withdrawal by Subject|0|||
125172278|NCT01721317|450251485|FG001|Overall Study|Withdrawal by Subject|1|||
125172279|NCT03713632|450251495|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
125172280|NCT03713632|450251496|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
125172281|NCT03713632|450251497|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
125172282|NCT03713632|450251498|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
125172283|NCT03713632|450251499|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
125172284|NCT03713632|450251495|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
125172285|NCT03713632|450251496|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
125172286|NCT03713632|450251497|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
125172287|NCT03713632|450251498|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
125172288|NCT03713632|450251499|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
125172289|NCT03713632|450251495|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
125172290|NCT03713632|450251496|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
125172291|NCT03713632|450251497|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
125172292|NCT03713632|450251498|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
125172293|NCT03713632|450251499|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
125172294|NCT03713632|450251495|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
125229764|NCT02662569|450470014|FG002|Overall Study|Lost to Follow-up|0|||
125229765|NCT02662569|450470015|FG003|Overall Study|Lost to Follow-up|0|||
125229766|NCT00630916|450470019|FG000|Overall Study|Death|110|||
125172295|NCT03713632|450251496|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
125172296|NCT03713632|450251497|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
125172297|NCT03713632|450251498|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
125229767|NCT00630916|450470019|FG000|Overall Study|Explant|8|||
125229768|NCT00630916|450470019|FG000|Overall Study|Lost to Follow-up|5|||
125172298|NCT03713632|450251499|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
125229769|NCT00630916|450470019|FG000|Overall Study|Withdrawal by Subject|30|||
125229770|NCT00630916|450470019|FG000|Overall Study|Protocol Violation|7|||
125229771|NCT00630916|450470019|FG000|Overall Study|Physician Decision|47|||
125229772|NCT00630916|450470019|FG000|Overall Study|Lack of Efficacy|3|||
125229773|NCT01299584|450470026|FG000|Overall Study|Protocol Violation|9|||
125172299|NCT03713632|450251495|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
125172300|NCT03713632|450251496|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
125172301|NCT03713632|450251497|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
125172302|NCT03713632|450251498|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
125172303|NCT03713632|450251499|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
125172304|NCT03713632|450251495|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
125172305|NCT03713632|450251496|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
125172306|NCT03713632|450251497|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
125172307|NCT03713632|450251498|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
125172308|NCT03713632|450251499|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
125172309|NCT03713632|450251495|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
125172310|NCT03713632|450251496|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
125172311|NCT03713632|450251497|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
125172312|NCT03713632|450251498|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
125172313|NCT03713632|450251499|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
125172314|NCT03713632|450251495|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
125172315|NCT03713632|450251496|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
125172316|NCT03713632|450251497|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
125172317|NCT03713632|450251498|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
125172318|NCT03713632|450251499|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
125172319|NCT03713632|450251495|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
125172320|NCT03713632|450251496|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
125172321|NCT03713632|450251497|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
125172322|NCT03713632|450251498|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
125172323|NCT03713632|450251499|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
125172324|NCT03713632|450251495|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
125172325|NCT03713632|450251496|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
125172326|NCT03713632|450251497|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
125172327|NCT03713632|450251498|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
125172328|NCT03713632|450251499|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
125172329|NCT03713632|450251495|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
125172330|NCT03713632|450251496|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
125172331|NCT03713632|450251497|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
125172332|NCT03713632|450251498|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
125172333|NCT03713632|450251499|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
125172334|NCT03713632|450251495|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
125172335|NCT03713632|450251496|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
125172336|NCT03713632|450251497|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
125172337|NCT03713632|450251498|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
125172338|NCT03713632|450251499|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
125172339|NCT03713632|450251495|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
125172340|NCT03713632|450251496|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
125172341|NCT03713632|450251497|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
125172342|NCT03713632|450251498|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
125172343|NCT03713632|450251499|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
125172344|NCT03713632|450251495|FG000|Treatment Period 2 (After Week 16)|Death|0|||
125172345|NCT03713632|450251496|FG001|Treatment Period 2 (After Week 16)|Death|1|||
125172346|NCT03713632|450251497|FG002|Treatment Period 2 (After Week 16)|Death|0|||
125172347|NCT03713632|450251498|FG003|Treatment Period 2 (After Week 16)|Death|0|||
125172348|NCT03713632|450251499|FG004|Treatment Period 2 (After Week 16)|Death|0|||
125172349|NCT03713632|450251495|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
125172350|NCT03713632|450251496|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
125172351|NCT03713632|450251497|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
125172352|NCT03713632|450251498|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
125172353|NCT03713632|450251499|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
125172354|NCT02806024|450251500|FG000|Overall Study|Night Delivery|1|||
125172355|NCT02806024|450251501|FG001|Overall Study|Night Delivery|1|||
125172356|NCT02806024|450251500|FG000|Overall Study|DVT during antepartum admission|0|||
125172357|NCT02806024|450251501|FG001|Overall Study|DVT during antepartum admission|1|||
125172358|NCT02892149|450251502|FG000|Overall Study|Death|262|||
125172359|NCT02892149|450251503|FG001|Overall Study|Death|278|||
125172360|NCT02892149|450251502|FG000|Overall Study|Withdrawal by Subject|53|||
125172361|NCT02892149|450251503|FG001|Overall Study|Withdrawal by Subject|47|||
125172362|NCT02892149|450251502|FG000|Overall Study|Lost to Follow-up|37|||
125172363|NCT02892149|450251503|FG001|Overall Study|Lost to Follow-up|31|||
125172364|NCT01994850|450251504|FG000|Overall Study|Physician Decision|1|||
125172365|NCT01994850|450251504|FG000|Overall Study|Withdrawal by Subject|1|||
125172366|NCT00442962|450251505|FG000|Overall Study|Pregnancy|1|||
125172367|NCT00442962|450251505|FG000|Overall Study|Lost to Follow-up|7|||
125172368|NCT02756208|450251509|FG000|Overall Study|Withdrawal by Subject|1|||
125172369|NCT02756208|450251510|FG001|Overall Study|Withdrawal by Subject|0|||
125172370|NCT02756208|450251511|FG002|Overall Study|Withdrawal by Subject|1|||
125172371|NCT02756208|450251512|FG003|Overall Study|Withdrawal by Subject|3|||
125172372|NCT02756208|450251509|FG000|Overall Study|Lost to Follow-up|3|||
125172373|NCT02756208|450251510|FG001|Overall Study|Lost to Follow-up|1|||
125172374|NCT02756208|450251511|FG002|Overall Study|Lost to Follow-up|1|||
125172375|NCT02756208|450251512|FG003|Overall Study|Lost to Follow-up|1|||
125172376|NCT02756208|450251509|FG000|Overall Study|Physician Decision|1|||
125172377|NCT02756208|450251510|FG001|Overall Study|Physician Decision|0|||
125172378|NCT02756208|450251511|FG002|Overall Study|Physician Decision|0|||
125172379|NCT02756208|450251512|FG003|Overall Study|Physician Decision|0|||
125229774|NCT04079790|450470027|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
125229775|NCT04079790|450470028|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
125229776|NCT04079790|450470029|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
125229777|NCT04079790|450470030|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
125229778|NCT04079790|450470027|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
125172380|NCT02756208|450251509|FG000|Overall Study|Protocol Violation|0|||
125172381|NCT02756208|450251510|FG001|Overall Study|Protocol Violation|1|||
125172382|NCT02756208|450251511|FG002|Overall Study|Protocol Violation|0|||
125172383|NCT02756208|450251512|FG003|Overall Study|Protocol Violation|0|||
125172384|NCT04841577|450251514|FG000|Overall Study|Adverse Event|5|||
125172385|NCT04841577|450251515|FG001|Overall Study|Adverse Event|10|||
125172386|NCT04841577|450251514|FG000|Overall Study|Lost to Follow-up|8|||
125172387|NCT04841577|450251515|FG001|Overall Study|Lost to Follow-up|7|||
125172388|NCT04841577|450251514|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
125172389|NCT04841577|450251515|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
125172390|NCT04841577|450251514|FG000|Overall Study|Other|0|||
125172391|NCT04841577|450251515|FG001|Overall Study|Other|1|||
125172392|NCT01420965|450251520|FG000|Overall Study|Withdrawal by Subject|1|||
125172393|NCT01420965|450251521|FG001|Overall Study|Withdrawal by Subject|0|||
125172394|NCT01420965|450251522|FG002|Overall Study|Withdrawal by Subject|0|||
125172395|NCT01420965|450251520|FG000|Overall Study|Adverse Event|0|||
125172396|NCT01420965|450251521|FG001|Overall Study|Adverse Event|1|||
125172397|NCT01420965|450251522|FG002|Overall Study|Adverse Event|0|||
125172398|NCT00339144|450251527|FG000|Overall Study|Disease progression|5|||
125172399|NCT00339144|450251528|FG001|Overall Study|Disease progression|2|||
125172400|NCT00339144|450251529|FG002|Overall Study|Disease progression|2|||
125172401|NCT00339144|450251527|FG000|Overall Study|Study drug toxicity|3|||
125172402|NCT00339144|450251528|FG001|Overall Study|Study drug toxicity|1|||
125172403|NCT00339144|450251529|FG002|Overall Study|Study drug toxicity|1|||
125172404|NCT00339144|450251527|FG000|Overall Study|Participant's request to discontinuation|1|||
125172405|NCT00339144|450251528|FG001|Overall Study|Participant's request to discontinuation|0|||
125172406|NCT00339144|450251529|FG002|Overall Study|Participant's request to discontinuation|1|||
125172407|NCT03280381|450251530|FG000|Overall Study|Physician Decision|0|||
125172408|NCT03280381|450251531|FG001|Overall Study|Physician Decision|2|||
125172409|NCT02257385|450251532|FG000|Overall Study|Adverse Event|12|||
125172410|NCT02257385|450251533|FG001|Overall Study|Adverse Event|8|||
125172411|NCT02257385|450251532|FG000|Overall Study|Lack of Efficacy|1|||
125172412|NCT02257385|450251533|FG001|Overall Study|Lack of Efficacy|2|||
125172413|NCT02257385|450251532|FG000|Overall Study|Protocol Violation|5|||
125172414|NCT02257385|450251533|FG001|Overall Study|Protocol Violation|7|||
125172415|NCT02257385|450251532|FG000|Overall Study|Lost to Follow-up|0|||
125172416|NCT02257385|450251533|FG001|Overall Study|Lost to Follow-up|1|||
125172417|NCT02257385|450251532|FG000|Overall Study|Withdrawal by Subject|4|||
125172418|NCT02257385|450251533|FG001|Overall Study|Withdrawal by Subject|4|||
125172419|NCT03279692|450251534|FG000|Overall Study|Withdrawal by Subject|1|||
125172420|NCT02458287|450251536|FG000|Overall Study|Adverse Event|0|||
125172421|NCT02458287|450251537|FG001|Overall Study|Adverse Event|0|||
125172422|NCT02458287|450251538|FG002|Overall Study|Adverse Event|0|||
125172423|NCT02458287|450251539|FG003|Overall Study|Adverse Event|1|||
125229779|NCT04079790|450470028|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
125229780|NCT04079790|450470029|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
125229781|NCT04079790|450470030|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
125229782|NCT04079790|450470027|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
125229783|NCT04079790|450470028|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
125229784|NCT04079790|450470029|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
125229785|NCT04079790|450470030|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
125229786|NCT00390689|450470031|FG000|Overall Study|Adverse Event|2|||
125172424|NCT02458287|450251536|FG000|Overall Study|Lost to Follow-up|0|||
125229787|NCT00390689|450470032|FG001|Overall Study|Adverse Event|5|||
125229788|NCT00390689|450470033|FG002|Overall Study|Adverse Event|2|||
125172425|NCT02458287|450251537|FG001|Overall Study|Lost to Follow-up|1|||
125172426|NCT02458287|450251538|FG002|Overall Study|Lost to Follow-up|1|||
125172427|NCT02458287|450251539|FG003|Overall Study|Lost to Follow-up|0|||
125172428|NCT02458287|450251536|FG000|Overall Study|Protocol Violation|0|||
125172429|NCT02458287|450251537|FG001|Overall Study|Protocol Violation|1|||
125172430|NCT02458287|450251538|FG002|Overall Study|Protocol Violation|0|||
125172431|NCT02458287|450251539|FG003|Overall Study|Protocol Violation|0|||
125172432|NCT02458287|450251536|FG000|Overall Study|Withdrawal by Subject|0|||
125172433|NCT02458287|450251537|FG001|Overall Study|Withdrawal by Subject|2|||
125172434|NCT02458287|450251538|FG002|Overall Study|Withdrawal by Subject|2|||
125172435|NCT02458287|450251539|FG003|Overall Study|Withdrawal by Subject|1|||
125172436|NCT02458287|450251536|FG000|Overall Study|Relocated Out of State|0|||
125172437|NCT02458287|450251537|FG001|Overall Study|Relocated Out of State|0|||
125172438|NCT02458287|450251538|FG002|Overall Study|Relocated Out of State|0|||
125172439|NCT02458287|450251539|FG003|Overall Study|Relocated Out of State|1|||
125172440|NCT02800642|450251542|FG000|Overall Study|Death|3|||
125172441|NCT02800642|450251542|FG000|Overall Study|Other|10|||
125172442|NCT02800642|450251542|FG000|Overall Study|Physician Decision|2|||
125172443|NCT02800642|450251542|FG000|Overall Study|Adverse Event|6|||
125172444|NCT02800642|450251542|FG000|Overall Study|Withdrawal by Subject|3|||
125172445|NCT02800642|450251542|FG000|Overall Study|Lost to Follow-up|1|||
125172446|NCT02027428|450251543|FG000|Induction|Never treated|7|||
125172447|NCT02027428|450251544|FG001|Induction|Never treated|0|||
125172448|NCT02027428|450251545|FG002|Induction|Never treated|0|||
125172449|NCT02027428|450251543|FG000|Induction|Progressive disease|77|||
125172450|NCT02027428|450251544|FG001|Induction|Progressive disease|0|||
125172451|NCT02027428|450251545|FG002|Induction|Progressive disease|0|||
125172452|NCT02027428|450251543|FG000|Induction|Adverse Event|51|||
125172453|NCT02027428|450251544|FG001|Induction|Adverse Event|0|||
125172454|NCT02027428|450251545|FG002|Induction|Adverse Event|0|||
125172455|NCT02027428|450251543|FG000|Induction|Withdrawal by Subject|22|||
125172456|NCT02027428|450251544|FG001|Induction|Withdrawal by Subject|0|||
125172457|NCT02027428|450251545|FG002|Induction|Withdrawal by Subject|0|||
125172458|NCT02027428|450251543|FG000|Induction|Death|21|||
125172459|NCT02027428|450251544|FG001|Induction|Death|0|||
125172460|NCT02027428|450251545|FG002|Induction|Death|0|||
125172461|NCT02027428|450251543|FG000|Induction|Symptomatic deterioration|16|||
125172462|NCT02027428|450251544|FG001|Induction|Symptomatic deterioration|0|||
125172463|NCT02027428|450251545|FG002|Induction|Symptomatic deterioration|0|||
125172464|NCT02027428|450251543|FG000|Induction|Study terminated by sponsor|12|||
125172465|NCT02027428|450251544|FG001|Induction|Study terminated by sponsor|0|||
125172466|NCT02027428|450251545|FG002|Induction|Study terminated by sponsor|0|||
125172467|NCT02027428|450251543|FG000|Induction|Protocol Violation|1|||
125172468|NCT02027428|450251544|FG001|Induction|Protocol Violation|0|||
125172469|NCT02027428|450251545|FG002|Induction|Protocol Violation|0|||
125172470|NCT02027428|450251543|FG000|Induction|Miscellaneous|14|||
125172471|NCT02027428|450251544|FG001|Induction|Miscellaneous|0|||
125172472|NCT02027428|450251545|FG002|Induction|Miscellaneous|0|||
125172473|NCT02027428|450251543|FG000|Induction|Induction Treatment Ongoing|4|||
125172474|NCT02027428|450251544|FG001|Induction|Induction Treatment Ongoing|0|||
125172475|NCT02027428|450251545|FG002|Induction|Induction Treatment Ongoing|0|||
125172476|NCT02027428|450251543|FG000|Maintenance|Death|0|||
125172477|NCT02027428|450251544|FG001|Maintenance|Death|3|||
125172478|NCT02027428|450251545|FG002|Maintenance|Death|2|||
125172479|NCT02027428|450251543|FG000|Maintenance|Adverse Event|0|||
125172480|NCT02027428|450251544|FG001|Maintenance|Adverse Event|21|||
125172481|NCT02027428|450251545|FG002|Maintenance|Adverse Event|1|||
125172482|NCT02027428|450251543|FG000|Maintenance|Progressive disease|0|||
125172483|NCT02027428|450251544|FG001|Maintenance|Progressive disease|84|||
125172484|NCT02027428|450251545|FG002|Maintenance|Progressive disease|47|||
125172485|NCT02027428|450251543|FG000|Maintenance|Symptomatic deterioration|0|||
125172486|NCT02027428|450251544|FG001|Maintenance|Symptomatic deterioration|4|||
125172487|NCT02027428|450251545|FG002|Maintenance|Symptomatic deterioration|1|||
125172488|NCT02027428|450251543|FG000|Maintenance|Withdrawal by Subject|0|||
125172489|NCT02027428|450251544|FG001|Maintenance|Withdrawal by Subject|6|||
125172490|NCT02027428|450251545|FG002|Maintenance|Withdrawal by Subject|5|||
125172491|NCT02027428|450251543|FG000|Maintenance|Protocol Violation|0|||
125172492|NCT02027428|450251544|FG001|Maintenance|Protocol Violation|0|||
125172493|NCT02027428|450251545|FG002|Maintenance|Protocol Violation|1|||
125172494|NCT02027428|450251543|FG000|Maintenance|Other|0|||
125172495|NCT02027428|450251544|FG001|Maintenance|Other|6|||
125229789|NCT00390689|450470031|FG000|Overall Study|Lack of Efficacy|0|||
125172496|NCT02027428|450251545|FG002|Maintenance|Other|3|||
125172497|NCT02027428|450251543|FG000|Survival Follow-up|Death|0|||
125172498|NCT02027428|450251544|FG001|Survival Follow-up|Death|78|||
125172499|NCT02027428|450251545|FG002|Survival Follow-up|Death|45|||
125172500|NCT02027428|450251543|FG000|Survival Follow-up|Lost to Follow-up|0|||
125172501|NCT02027428|450251544|FG001|Survival Follow-up|Lost to Follow-up|1|||
125172502|NCT02027428|450251545|FG002|Survival Follow-up|Lost to Follow-up|1|||
125172503|NCT03371459|450251548|FG000|Washout|Lost to Follow-up|0|||
125172504|NCT03371459|450251549|FG001|Washout|Lost to Follow-up|1|||
125172505|NCT01589497|450251550|FG000|Overall Study|Withdrawal by Subject|0|||
125172506|NCT01589497|450251551|FG001|Overall Study|Withdrawal by Subject|1|||
125172507|NCT01589497|450251552|FG002|Overall Study|Withdrawal by Subject|0|||
125172508|NCT01589497|450251553|FG003|Overall Study|Withdrawal by Subject|1|||
125172509|NCT01589497|450251550|FG000|Overall Study|Death|1|||
125172510|NCT01589497|450251551|FG001|Overall Study|Death|0|||
125172511|NCT01589497|450251552|FG002|Overall Study|Death|0|||
125172512|NCT01589497|450251553|FG003|Overall Study|Death|0|||
125172513|NCT01589497|450251550|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
125172514|NCT01589497|450251551|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
125172515|NCT01589497|450251552|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
125172516|NCT01589497|450251553|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
125172517|NCT02542605|450251560|FG000|Part B: Challenge Phase|Sponsor decision|1|||
125172518|NCT02542605|450251561|FG001|Part B: Challenge Phase|Sponsor decision|0|||
125172519|NCT02542605|450251562|FG002|Part B: Challenge Phase|Sponsor decision|0|||
125172520|NCT02542605|450251560|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
125172521|NCT02542605|450251561|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
125172522|NCT02542605|450251562|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
125172523|NCT02682927|450251563|FG000|Overall Study|Adverse Event|0|||
125172524|NCT02682927|450251564|FG001|Overall Study|Adverse Event|0|||
125172525|NCT02682927|450251565|FG002|Overall Study|Adverse Event|5|||
125172526|NCT02682927|450251566|FG003|Overall Study|Adverse Event|1|||
125172527|NCT02682927|450251567|FG004|Overall Study|Adverse Event|0|||
125172528|NCT02682927|450251568|FG005|Overall Study|Adverse Event|2|||
125172529|NCT02682927|450251563|FG000|Overall Study|Death|0|||
125172530|NCT02682927|450251564|FG001|Overall Study|Death|0|||
125172531|NCT02682927|450251565|FG002|Overall Study|Death|0|||
125172532|NCT02682927|450251566|FG003|Overall Study|Death|1|||
125172533|NCT02682927|450251567|FG004|Overall Study|Death|0|||
125172534|NCT02682927|450251568|FG005|Overall Study|Death|0|||
125172535|NCT02682927|450251563|FG000|Overall Study|Lack of Efficacy|1|||
125172536|NCT02682927|450251564|FG001|Overall Study|Lack of Efficacy|0|||
125172537|NCT02682927|450251565|FG002|Overall Study|Lack of Efficacy|0|||
125172538|NCT02682927|450251566|FG003|Overall Study|Lack of Efficacy|1|||
125172539|NCT02682927|450251567|FG004|Overall Study|Lack of Efficacy|0|||
125172540|NCT02682927|450251568|FG005|Overall Study|Lack of Efficacy|0|||
125172541|NCT02682927|450251563|FG000|Overall Study|Other|0|||
125172542|NCT02682927|450251564|FG001|Overall Study|Other|0|||
125172543|NCT02682927|450251565|FG002|Overall Study|Other|0|||
125172544|NCT02682927|450251566|FG003|Overall Study|Other|2|||
125172545|NCT02682927|450251567|FG004|Overall Study|Other|0|||
125172546|NCT02682927|450251568|FG005|Overall Study|Other|0|||
125172547|NCT02682927|450251563|FG000|Overall Study|Withdrawal by Subject|2|||
125172548|NCT02682927|450251564|FG001|Overall Study|Withdrawal by Subject|0|||
125172549|NCT02682927|450251565|FG002|Overall Study|Withdrawal by Subject|1|||
125172550|NCT02682927|450251566|FG003|Overall Study|Withdrawal by Subject|0|||
125172551|NCT02682927|450251567|FG004|Overall Study|Withdrawal by Subject|1|||
125172552|NCT02682927|450251568|FG005|Overall Study|Withdrawal by Subject|1|||
125172553|NCT02766283|450251574|FG000|Overall Study|Lost to Follow-up|27|||
125172554|NCT04007991|450251575|FG000|Overall Study|Withdrawal by Subject|1|||
125172555|NCT04007991|450251576|FG001|Overall Study|Withdrawal by Subject|1|||
125172556|NCT04007991|450251575|FG000|Overall Study|Physician Decision|1|||
125172557|NCT04007991|450251576|FG001|Overall Study|Physician Decision|1|||
125172558|NCT04007991|450251575|FG000|Overall Study|Non-compliance with Study Drug|0|||
125172559|NCT04007991|450251576|FG001|Overall Study|Non-compliance with Study Drug|1|||
125172560|NCT04007991|450251575|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
125172561|NCT04007991|450251576|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
125172562|NCT04007991|450251575|FG000|Overall Study|Adverse event, non-fatal|5|||
125172563|NCT04007991|450251576|FG001|Overall Study|Adverse event, non-fatal|0|||
125172564|NCT04007991|450251575|FG000|Overall Study|Lost to Follow-up|2|||
125172565|NCT04007991|450251576|FG001|Overall Study|Lost to Follow-up|1|||
125172566|NCT05314816|450251577|FG000|Overall Study|Lost to Follow-up|5|||
125172567|NCT05314816|450251578|FG001|Overall Study|Lost to Follow-up|0|||
125172568|NCT05314816|450251579|FG002|Overall Study|Lost to Follow-up|1|||
125172569|NCT05314816|450251577|FG000|Overall Study|Protocol Violation|13|||
125172570|NCT05314816|450251578|FG001|Overall Study|Protocol Violation|8|||
125172571|NCT05314816|450251579|FG002|Overall Study|Protocol Violation|0|||
125172572|NCT05048329|450253334|FG000|Overall Study|Withdrawal by Subject|1|||
125172573|NCT05048329|450253334|FG000|Overall Study|Screenfail|1|||
125172574|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #1|24|||
125172575|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #1|0|||
125172576|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
125172577|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
125172578|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
125172579|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
125172580|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
125172581|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
125172582|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
125172583|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
125172584|NCT03888066|450253335|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
125172585|NCT03888066|450253336|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
125172586|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
125172587|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
125172588|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
125172589|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
125172590|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
125172591|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
125172592|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
125172593|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
125172594|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #2|5|||
125172595|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #2|0|||
125172596|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
125172597|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
125172598|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
125172599|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
125172600|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
125172601|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
125172602|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #3|11|||
125172603|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #3|0|||
125172604|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
125172605|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
125172606|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
125172607|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
125172608|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
125172609|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
125172610|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #4|3|||
125172611|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #4|0|||
125172612|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
125172613|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
125172614|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
125172615|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
125172616|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
125172617|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
125172618|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
125172619|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
125172620|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
125172621|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
125172622|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
125172623|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
125172624|NCT03888066|450253335|FG000|Run-in Phase|AE (Adverse Event)|17|||
125172625|NCT03888066|450253336|FG001|Run-in Phase|AE (Adverse Event)|0|||
125172626|NCT03888066|450253335|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
125172627|NCT03888066|450253336|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
125172628|NCT03888066|450253335|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
125172629|NCT03888066|450253336|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
125172630|NCT03888066|450253335|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
125172631|NCT03888066|450253336|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
125172632|NCT03888066|450253335|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
125172633|NCT03888066|450253336|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
125229790|NCT00390689|450470032|FG001|Overall Study|Lack of Efficacy|0|||
125229791|NCT00390689|450470033|FG002|Overall Study|Lack of Efficacy|1|||
125229792|NCT00390689|450470031|FG000|Overall Study|Protocol Violation|1|||
125229793|NCT00390689|450470032|FG001|Overall Study|Protocol Violation|0|||
125229794|NCT00390689|450470033|FG002|Overall Study|Protocol Violation|0|||
125229795|NCT00390689|450470031|FG000|Overall Study|Investigator's judgement|2|||
125229796|NCT00390689|450470032|FG001|Overall Study|Investigator's judgement|0|||
125172634|NCT03888066|450253335|FG000|Run-in Phase|Withdrawal by Subject|43|||
125172635|NCT03888066|450253336|FG001|Run-in Phase|Withdrawal by Subject|0|||
125172636|NCT03888066|450253335|FG000|Run-in Phase|AE; Physician Decision|1|||
125172637|NCT03888066|450253336|FG001|Run-in Phase|AE; Physician Decision|0|||
125172638|NCT03888066|450253335|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
125229797|NCT00390689|450470033|FG002|Overall Study|Investigator's judgement|0|||
125229798|NCT01253161|450470034|FG000|Overall Study|Adverse Event|1|||
125229799|NCT01924533|450470036|FG000|Overall Study|Death|181|||
125172639|NCT03888066|450253336|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
125172640|NCT03888066|450253335|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
125172641|NCT03888066|450253336|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
125172642|NCT03888066|450253335|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
125172643|NCT03888066|450253336|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
125172644|NCT03888066|450253335|FG000|Run-in Phase|Death|1|||
125172645|NCT03888066|450253336|FG001|Run-in Phase|Death|0|||
125172646|NCT03888066|450253335|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
125172647|NCT03888066|450253336|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
125172648|NCT03888066|450253335|FG000|Run-in Phase|Physician Decision|1|||
125172649|NCT03888066|450253336|FG001|Run-in Phase|Physician Decision|0|||
125172650|NCT03888066|450253335|FG000|Run-in Phase|Protocol Violation|13|||
125172651|NCT03888066|450253336|FG001|Run-in Phase|Protocol Violation|0|||
125172652|NCT03888066|450253335|FG000|Run-in Phase|Sponsor Request|34|||
125172653|NCT03888066|450253336|FG001|Run-in Phase|Sponsor Request|0|||
125172654|NCT03888066|450253335|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
125172655|NCT03888066|450253336|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
125172656|NCT03888066|450253335|FG000|Run-in Phase|Withdrawal Of Consent|1|||
125172657|NCT03888066|450253336|FG001|Run-in Phase|Withdrawal Of Consent|0|||
125172658|NCT03888066|450253335|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
125172659|NCT03888066|450253336|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
125172660|NCT03888066|450253335|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
125172661|NCT03888066|450253336|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
125172662|NCT03888066|450253335|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
125172663|NCT03888066|450253336|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
125172664|NCT03888066|450253335|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
125172665|NCT03888066|450253336|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
125172666|NCT03888066|450253335|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
125172667|NCT03888066|450253336|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
125172668|NCT03888066|450253335|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
125172669|NCT03888066|450253336|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
125172670|NCT03888066|450253335|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
125172671|NCT03888066|450253336|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
125172672|NCT03888066|450253335|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
125172673|NCT03888066|450253336|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
125172674|NCT03888066|450253335|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
125172675|NCT03888066|450253336|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
125172676|NCT03888066|450253335|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
125172677|NCT03888066|450253336|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
125172678|NCT03888066|450253335|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
125172679|NCT03888066|450253336|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
125172680|NCT03888066|450253335|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
125172681|NCT03888066|450253336|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
125172682|NCT05013008|450253338|FG000|Overall Study|Exclusion from mBFAS|5|||
125172683|NCT05013008|450253339|FG001|Overall Study|Exclusion from mBFAS|25|||
125172684|NCT04981717|450253340|FG000|Overall Study|Protocol Violation|0|||
125172685|NCT04981717|450253341|FG001|Overall Study|Protocol Violation|3|||
125172686|NCT04981717|450253340|FG000|Overall Study|Adverse Event|1|||
125172687|NCT04981717|450253341|FG001|Overall Study|Adverse Event|3|||
125172688|NCT04981717|450253340|FG000|Overall Study|Pregnancy|1|||
125172689|NCT04981717|450253341|FG001|Overall Study|Pregnancy|0|||
125172690|NCT04981717|450253340|FG000|Overall Study|Physician Decision|1|||
125172691|NCT04981717|450253341|FG001|Overall Study|Physician Decision|0|||
125172692|NCT04981717|450253340|FG000|Overall Study|Sponsor Request|157|||
125172693|NCT04981717|450253341|FG001|Overall Study|Sponsor Request|172|||
125172694|NCT04981717|450253340|FG000|Overall Study|Lost to Follow-up|4|||
125172695|NCT04981717|450253341|FG001|Overall Study|Lost to Follow-up|5|||
125172696|NCT04981717|450253340|FG000|Overall Study|Withdrawal by Subject|50|||
125172697|NCT04981717|450253341|FG001|Overall Study|Withdrawal by Subject|37|||
125172698|NCT02207634|450253345|FG000|Overall Study|Withdrawal by Subject|21|||
125172699|NCT02207634|450253346|FG001|Overall Study|Withdrawal by Subject|31|||
125172700|NCT02207634|450253345|FG000|Overall Study|Lost to Follow-up|1|||
125172701|NCT02207634|450253346|FG001|Overall Study|Lost to Follow-up|0|||
125172702|NCT00887289|450253347|FG000|Overall Study|Lack of Efficacy|14|||
125172703|NCT00887289|450253347|FG000|Overall Study|Adverse Event|27|||
125172704|NCT00887289|450253347|FG000|Overall Study|Withdrawal by Subject|26|||
125172705|NCT00887289|450253347|FG000|Overall Study|Lost to Follow-up|8|||
125172706|NCT00887289|450253347|FG000|Overall Study|Other|20|||
125172707|NCT00591773|450253350|FG000|Overall Study|Adverse Event|9|||
125172708|NCT00591773|450253351|FG001|Overall Study|Adverse Event|9|||
125172709|NCT00591773|450253352|FG002|Overall Study|Adverse Event|6|||
125172710|NCT00591773|450253350|FG000|Overall Study|Protocol Violation|2|||
125172711|NCT00591773|450253351|FG001|Overall Study|Protocol Violation|3|||
125172712|NCT00591773|450253352|FG002|Overall Study|Protocol Violation|0|||
125172713|NCT00591773|450253350|FG000|Overall Study|Lost to Follow-up|1|||
125172714|NCT00591773|450253351|FG001|Overall Study|Lost to Follow-up|4|||
125172715|NCT00591773|450253352|FG002|Overall Study|Lost to Follow-up|1|||
125172716|NCT00591773|450253350|FG000|Overall Study|Withdrawal by Subject|2|||
125172717|NCT00591773|450253351|FG001|Overall Study|Withdrawal by Subject|5|||
125172718|NCT00591773|450253352|FG002|Overall Study|Withdrawal by Subject|3|||
125172719|NCT00591773|450253350|FG000|Overall Study|Lack of Efficacy|1|||
125172720|NCT00591773|450253351|FG001|Overall Study|Lack of Efficacy|2|||
125172721|NCT00591773|450253352|FG002|Overall Study|Lack of Efficacy|2|||
125172722|NCT00591773|450253350|FG000|Overall Study|Other|1|||
125172723|NCT00591773|450253351|FG001|Overall Study|Other|1|||
125172724|NCT00591773|450253352|FG002|Overall Study|Other|4|||
125172725|NCT00459355|450253353|FG000|Overall Study|Subject no longer met inc criteria|20|||
125172726|NCT00459355|450253354|FG001|Overall Study|Subject no longer met inc criteria|18|||
125172727|NCT00287586|450253355|FG000|Overall Study|Withdrew Consent|19|||
125172728|NCT00287586|450253356|FG001|Overall Study|Withdrew Consent|30|||
125172729|NCT00287586|450253355|FG000|Overall Study|Lost to Follow-up|5|||
125172730|NCT00287586|450253356|FG001|Overall Study|Lost to Follow-up|4|||
125172731|NCT00287586|450253355|FG000|Overall Study|Death|2|||
125172732|NCT00287586|450253356|FG001|Overall Study|Death|3|||
125172733|NCT00287586|450253355|FG000|Overall Study|Elevated Hematocrit|3|||
125172734|NCT00287586|450253356|FG001|Overall Study|Elevated Hematocrit|0|||
125172735|NCT00287586|450253355|FG000|Overall Study|Rash|3|||
125172736|NCT00287586|450253356|FG001|Overall Study|Rash|0|||
125172737|NCT00287586|450253355|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
125172738|NCT00287586|450253356|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
125172739|NCT00287586|450253355|FG000|Overall Study|Stroke|2|||
125172740|NCT00287586|450253356|FG001|Overall Study|Stroke|0|||
125172741|NCT00287586|450253355|FG000|Overall Study|Myocardial Infarction|1|||
125172742|NCT00287586|450253356|FG001|Overall Study|Myocardial Infarction|0|||
125172743|NCT00287586|450253355|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
125172744|NCT00287586|450253356|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
125172745|NCT00287586|450253355|FG000|Overall Study|Cognitive Impairment|1|||
125172746|NCT00287586|450253356|FG001|Overall Study|Cognitive Impairment|0|||
125172747|NCT00287586|450253355|FG000|Overall Study|Pancreatic Cancer|1|||
125172748|NCT00287586|450253356|FG001|Overall Study|Pancreatic Cancer|3|||
125172749|NCT00287586|450253355|FG000|Overall Study|Sleep Apnea|1|||
125172750|NCT00287586|450253356|FG001|Overall Study|Sleep Apnea|0|||
125172751|NCT00287586|450253355|FG000|Overall Study|Shoulder Pain|1|||
125172752|NCT00287586|450253356|FG001|Overall Study|Shoulder Pain|0|||
125172753|NCT00287586|450253355|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
125172754|NCT00287586|450253356|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
125172755|NCT00287586|450253355|FG000|Overall Study|Nonadherence|1|||
125172756|NCT00287586|450253356|FG001|Overall Study|Nonadherence|1|||
125172757|NCT00287586|450253355|FG000|Overall Study|Enrolled in Another Study|1|||
125172758|NCT00287586|450253356|FG001|Overall Study|Enrolled in Another Study|0|||
125172759|NCT00287586|450253355|FG000|Overall Study|Major Depression|0|||
125172760|NCT00287586|450253356|FG001|Overall Study|Major Depression|2|||
125172761|NCT00287586|450253355|FG000|Overall Study|Lung Cancer|0|||
125172762|NCT00287586|450253356|FG001|Overall Study|Lung Cancer|2|||
125172763|NCT00287586|450253355|FG000|Overall Study|Elevated IPSS Score|0|||
125172764|NCT00287586|450253356|FG001|Overall Study|Elevated IPSS Score|1|||
125172765|NCT00287586|450253355|FG000|Overall Study|Retroperitoneal Cancer|0|||
125172766|NCT00287586|450253356|FG001|Overall Study|Retroperitoneal Cancer|1|||
125172767|NCT00287586|450253355|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
125172768|NCT00287586|450253356|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
125172769|NCT00287586|450253355|FG000|Overall Study|Mood Swings and Irritability|0|||
125172770|NCT00287586|450253356|FG001|Overall Study|Mood Swings and Irritability|1|||
125172771|NCT00287586|450253355|FG000|Overall Study|Bradycardia|0|||
125172772|NCT00287586|450253356|FG001|Overall Study|Bradycardia|1|||
125172773|NCT00287586|450253355|FG000|Overall Study|Itchy Swollen Eyes|0|||
125172774|NCT00287586|450253356|FG001|Overall Study|Itchy Swollen Eyes|1|||
125172775|NCT00287586|450253355|FG000|Overall Study|Recurrent Melanoma|0|||
125172776|NCT00287586|450253356|FG001|Overall Study|Recurrent Melanoma|1|||
125172777|NCT02135614|450253357|FG000|Overall Study|Randomized but Not Treated|2|||
125172778|NCT02135614|450253358|FG001|Overall Study|Randomized but Not Treated|1|||
125172779|NCT02135614|450253357|FG000|Overall Study|Adverse Event|0|||
125172780|NCT02135614|450253358|FG001|Overall Study|Adverse Event|1|||
125172781|NCT02135614|450253357|FG000|Overall Study|Death|1|||
125172782|NCT02135614|450253358|FG001|Overall Study|Death|0|||
125172783|NCT02135614|450253357|FG000|Overall Study|Investigator's Discretion|0|||
125172784|NCT02135614|450253358|FG001|Overall Study|Investigator's Discretion|1|||
125172785|NCT02135614|450253357|FG000|Overall Study|Withdrew Consent|2|||
125172786|NCT02135614|450253358|FG001|Overall Study|Withdrew Consent|2|||
125172787|NCT02135614|450253357|FG000|Overall Study|Lost to Follow-up|3|||
125172788|NCT02135614|450253358|FG001|Overall Study|Lost to Follow-up|0|||
125172789|NCT03106987|450253364|FG000|Overall Study|Death|37|||
125172790|NCT03106987|450253365|FG001|Overall Study|Death|22|||
125172791|NCT03106987|450253366|FG002|Overall Study|Death|12|||
125172792|NCT03106987|450253367|FG003|Overall Study|Death|8|||
125172793|NCT03106987|450253364|FG000|Overall Study|Lost to Follow-up|2|||
125172794|NCT03106987|450253365|FG001|Overall Study|Lost to Follow-up|0|||
125172795|NCT03106987|450253366|FG002|Overall Study|Lost to Follow-up|2|||
125172796|NCT03106987|450253367|FG003|Overall Study|Lost to Follow-up|2|||
125172797|NCT03106987|450253364|FG000|Overall Study|Withdrawal by Subject|5|||
125172798|NCT03106987|450253365|FG001|Overall Study|Withdrawal by Subject|1|||
125172799|NCT03106987|450253366|FG002|Overall Study|Withdrawal by Subject|4|||
125172800|NCT03106987|450253367|FG003|Overall Study|Withdrawal by Subject|1|||
125172801|NCT02114385|450253368|FG000|Overall Study|Withdrawal by Subject|3|||
125172802|NCT02114385|450253369|FG001|Overall Study|Withdrawal by Subject|2|||
125172803|NCT02114385|450253368|FG000|Overall Study|Lost to Follow-up|0|||
125172804|NCT02114385|450253369|FG001|Overall Study|Lost to Follow-up|6|||
125172805|NCT01275729|450253370|FG000|Overall Study|Death|3|||
125172806|NCT01275729|450253370|FG000|Overall Study|Withdrawal by Subject|1|||
125172807|NCT02681510|450253373|FG000|Overall Study|Withdrawal by Subject|1|||
125172808|NCT02681510|450253373|FG000|Overall Study|Lost to Follow-up|9|||
125172809|NCT04315506|450253374|FG000|Overall Study|Lost to Follow-up|74|||
125172810|NCT04315506|450253375|FG001|Overall Study|Lost to Follow-up|82|||
125172811|NCT04315506|450253374|FG000|Overall Study|Withdrawal by Subject|8|||
125172812|NCT04315506|450253375|FG001|Overall Study|Withdrawal by Subject|8|||
125172813|NCT04315506|450253374|FG000|Overall Study|Physician Decision|0|||
125172814|NCT04315506|450253375|FG001|Overall Study|Physician Decision|1|||
125172815|NCT00958893|450253376|FG000|Overall Study|Study prematurely terminated|4|||
125172816|NCT00741338|450253377|FG000|Overall Study|Adverse Event|0|||
125172817|NCT00741338|450253378|FG001|Overall Study|Adverse Event|1|||
125172818|NCT03593395|450253379|FG000|Overall Study|Lost to Follow-up|48|||
125172819|NCT03593395|450253380|FG001|Overall Study|Lost to Follow-up|3|||
125172820|NCT03593395|450253379|FG000|Overall Study|Withdrawal by Subject|5|||
125172821|NCT03593395|450253380|FG001|Overall Study|Withdrawal by Subject|24|||
125172822|NCT03593395|450253379|FG000|Overall Study|Death|2|||
125172823|NCT03593395|450253380|FG001|Overall Study|Death|3|||
125172824|NCT03593395|450253379|FG000|Overall Study|Physician Decision|0|||
125172825|NCT03593395|450253380|FG001|Overall Study|Physician Decision|6|||
125172826|NCT03593395|450253379|FG000|Overall Study|Participant Relocated|19|||
125172827|NCT03593395|450253380|FG001|Overall Study|Participant Relocated|3|||
125172828|NCT03593395|450253379|FG000|Overall Study|No Information|1|||
125172829|NCT03593395|450253380|FG001|Overall Study|No Information|7|||
125172830|NCT01098474|450253383|FG000|Active Phase|Other|0|||
125172831|NCT01098474|450253384|FG001|Active Phase|Other|0|||
125172832|NCT01098474|450253385|FG002|Active Phase|Other|3|||
125172833|NCT01098474|450253386|FG003|Active Phase|Other|0|||
125172834|NCT01098474|450253387|FG004|Active Phase|Other|0|||
125172835|NCT01098474|450253388|FG005|Active Phase|Other|0|||
125172836|NCT01098474|450253383|FG000|Active Phase|Withdrawal by Subject|1|||
125172837|NCT01098474|450253384|FG001|Active Phase|Withdrawal by Subject|1|||
125172838|NCT01098474|450253385|FG002|Active Phase|Withdrawal by Subject|2|||
125172839|NCT01098474|450253386|FG003|Active Phase|Withdrawal by Subject|0|||
125172840|NCT01098474|450253387|FG004|Active Phase|Withdrawal by Subject|0|||
125172841|NCT01098474|450253388|FG005|Active Phase|Withdrawal by Subject|0|||
125172842|NCT01098474|450253383|FG000|Active Phase|Lost to Follow-up|1|||
125172843|NCT01098474|450253384|FG001|Active Phase|Lost to Follow-up|0|||
125172844|NCT01098474|450253385|FG002|Active Phase|Lost to Follow-up|0|||
125172845|NCT01098474|450253386|FG003|Active Phase|Lost to Follow-up|0|||
125172846|NCT01098474|450253387|FG004|Active Phase|Lost to Follow-up|0|||
125172847|NCT01098474|450253388|FG005|Active Phase|Lost to Follow-up|0|||
125172848|NCT01098474|450253383|FG000|Follow Up Phase|Travelled out of study area|0|||
125172849|NCT01098474|450253384|FG001|Follow Up Phase|Travelled out of study area|0|||
125172850|NCT01098474|450253385|FG002|Follow Up Phase|Travelled out of study area|0|||
125172851|NCT01098474|450253386|FG003|Follow Up Phase|Travelled out of study area|0|||
125172852|NCT01098474|450253387|FG004|Follow Up Phase|Travelled out of study area|1|||
125172853|NCT01098474|450253388|FG005|Follow Up Phase|Travelled out of study area|0|||
125172854|NCT01098474|450253383|FG000|Follow Up Phase|Other|0|||
125172855|NCT01098474|450253384|FG001|Follow Up Phase|Other|0|||
125172856|NCT01098474|450253385|FG002|Follow Up Phase|Other|0|||
125172857|NCT01098474|450253386|FG003|Follow Up Phase|Other|0|||
125172858|NCT01098474|450253387|FG004|Follow Up Phase|Other|0|||
125172859|NCT01098474|450253388|FG005|Follow Up Phase|Other|4|||
125172860|NCT01098474|450253383|FG000|Follow Up Phase|Withdrawal by Subject|0|||
125172861|NCT01098474|450253384|FG001|Follow Up Phase|Withdrawal by Subject|0|||
125172862|NCT01098474|450253385|FG002|Follow Up Phase|Withdrawal by Subject|0|||
125172863|NCT01098474|450253386|FG003|Follow Up Phase|Withdrawal by Subject|2|||
125172864|NCT01098474|450253387|FG004|Follow Up Phase|Withdrawal by Subject|0|||
125172865|NCT01098474|450253388|FG005|Follow Up Phase|Withdrawal by Subject|1|||
125172866|NCT01098474|450253383|FG000|Follow Up Phase|Lost to Follow-up|0|||
125172867|NCT01098474|450253384|FG001|Follow Up Phase|Lost to Follow-up|0|||
125172868|NCT01098474|450253385|FG002|Follow Up Phase|Lost to Follow-up|0|||
125172869|NCT01098474|450253386|FG003|Follow Up Phase|Lost to Follow-up|0|||
125172870|NCT01098474|450253387|FG004|Follow Up Phase|Lost to Follow-up|1|||
125172871|NCT01098474|450253388|FG005|Follow Up Phase|Lost to Follow-up|0|||
125172872|NCT00704132|450253399|FG000|Overall Study|Clinical Adverse Experience|1|||
125172873|NCT00704132|450253400|FG001|Overall Study|Clinical Adverse Experience|0|||
125172874|NCT00704132|450253399|FG000|Overall Study|Lack of Efficacy|0|||
125172875|NCT00704132|450253400|FG001|Overall Study|Lack of Efficacy|1|||
125172876|NCT00704132|450253399|FG000|Overall Study|Withdrawal by Subject|0|||
125172877|NCT00704132|450253400|FG001|Overall Study|Withdrawal by Subject|1|||
125172878|NCT00182325|450253401|FG000|Overall Study|Lost to Follow-up|7|||
125172879|NCT00182325|450253402|FG001|Overall Study|Lost to Follow-up|7|||
125172880|NCT00182325|450253401|FG000|Overall Study|Miscarriage|5|||
125172881|NCT00182325|450253402|FG001|Overall Study|Miscarriage|3|||
125172882|NCT00182325|450253401|FG000|Overall Study|Did not complete survey|22|||
125172883|NCT00182325|450253402|FG001|Overall Study|Did not complete survey|43|||
125172884|NCT00652340|450253405|FG000|Overall Study|Had not progressed.|4|||
125172885|NCT00652340|450253406|FG001|Overall Study|Had not progressed.|3|||
125172886|NCT03682107|450253407|FG000|Overall Study|Withdrawal by Subject|0|||
125172887|NCT03682107|450253408|FG001|Overall Study|Withdrawal by Subject|1|||
125172888|NCT03682107|450253409|FG002|Overall Study|Withdrawal by Subject|0|||
125172889|NCT03682107|450253410|FG003|Overall Study|Withdrawal by Subject|0|||
125172890|NCT03682107|450253411|FG004|Overall Study|Withdrawal by Subject|0|||
125172891|NCT00214383|450253412|FG000|Overall Study|Lost to Follow-up|16|||
125172892|NCT00214383|450253413|FG001|Overall Study|Lost to Follow-up|26|||
125172893|NCT03607487|450253414|FG000|Overall Study|Withdrawal by Subject|2|||
125172894|NCT03607487|450253415|FG001|Overall Study|Withdrawal by Subject|0|||
125172895|NCT03607487|450253416|FG002|Overall Study|Withdrawal by Subject|0|||
125172896|NCT03607487|450253417|FG003|Overall Study|Withdrawal by Subject|1|||
125172897|NCT01890434|450253418|FG000|Overall Study|Adverse Event|8|||
125172898|NCT01890434|450253418|FG000|Overall Study|PCI at external hospital|1|||
125172899|NCT01890434|450253418|FG000|Overall Study|Assessment discrepancy|1|||
125172900|NCT01890434|450253418|FG000|Overall Study|CRC didn't contact participant for FU|1|||
125172901|NCT01890434|450253418|FG000|Overall Study|Could not get whole set of images|1|||
125172902|NCT01890434|450253418|FG000|Overall Study|Decline to return for GSPECT|1|||
125172903|NCT01890434|450253418|FG000|Overall Study|GSPECT at rest was not done|1|||
125172904|NCT01890434|450253418|FG000|Overall Study|Participant didn't complete MRI|1|||
125172905|NCT01890434|450253418|FG000|Overall Study|Uncontactable by phone|1|||
125172906|NCT01890434|450253418|FG000|Overall Study|Moved out of position|1|||
125172907|NCT01890434|450253418|FG000|Overall Study|Unable to contact|1|||
125172908|NCT01890434|450253418|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
125172909|NCT01141205|450253422|FG000|Overall Study|Physician Decision|1|||
125172910|NCT01141205|450253423|FG001|Overall Study|Physician Decision|1|||
125172911|NCT01141205|450253422|FG000|Overall Study|Lost to Follow-up|1|||
125172912|NCT01141205|450253423|FG001|Overall Study|Lost to Follow-up|0|||
125172913|NCT01141205|450253422|FG000|Overall Study|Withdrawal by Subject|1|||
125172914|NCT01141205|450253423|FG001|Overall Study|Withdrawal by Subject|1|||
125172915|NCT02655666|450253427|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
125172916|NCT01822366|450253428|FG000|Overall Study|Lost to Follow-up|5|||
125172917|NCT01822366|450253429|FG001|Overall Study|Lost to Follow-up|1|||
125172918|NCT01822366|450253430|FG002|Overall Study|Lost to Follow-up|5|||
125172919|NCT01822366|450253431|FG003|Overall Study|Lost to Follow-up|1|||
125172920|NCT01822366|450253428|FG000|Overall Study|Withdrawal by Subject|0|||
125172921|NCT01822366|450253429|FG001|Overall Study|Withdrawal by Subject|6|||
125172922|NCT01822366|450253430|FG002|Overall Study|Withdrawal by Subject|0|||
125172923|NCT01822366|450253431|FG003|Overall Study|Withdrawal by Subject|6|||
125172924|NCT01822366|450253428|FG000|Overall Study|Partial Intervention Completion|0|||
125172925|NCT01822366|450253429|FG001|Overall Study|Partial Intervention Completion|15|||
125172926|NCT01822366|450253430|FG002|Overall Study|Partial Intervention Completion|0|||
125172927|NCT01822366|450253431|FG003|Overall Study|Partial Intervention Completion|15|||
125172928|NCT05199090|450253432|FG000|Overall Study|Adverse Event|1|||
125172929|NCT05199090|450253433|FG001|Overall Study|Adverse Event|4|||
125172930|NCT05199090|450253434|FG002|Overall Study|Adverse Event|0|||
125172931|NCT05199090|450253435|FG003|Overall Study|Adverse Event|0|||
125172932|NCT05199090|450253436|FG004|Overall Study|Adverse Event|0|||
125172933|NCT05199090|450253437|FG005|Overall Study|Adverse Event|0|||
125172934|NCT05199090|450253432|FG000|Overall Study|Lost to Follow-up|1|||
125172935|NCT05199090|450253433|FG001|Overall Study|Lost to Follow-up|0|||
125172936|NCT05199090|450253434|FG002|Overall Study|Lost to Follow-up|1|||
125172937|NCT05199090|450253435|FG003|Overall Study|Lost to Follow-up|4|||
125172938|NCT05199090|450253436|FG004|Overall Study|Lost to Follow-up|0|||
125172939|NCT05199090|450253437|FG005|Overall Study|Lost to Follow-up|5|||
125172940|NCT05199090|450253432|FG000|Overall Study|Physician Decision|0|||
125172941|NCT05199090|450253433|FG001|Overall Study|Physician Decision|0|||
125172942|NCT05199090|450253434|FG002|Overall Study|Physician Decision|0|||
125172943|NCT05199090|450253435|FG003|Overall Study|Physician Decision|0|||
125172944|NCT05199090|450253436|FG004|Overall Study|Physician Decision|0|||
125229800|NCT01924533|450470037|FG001|Overall Study|Death|200|||
125229801|NCT01924533|450470036|FG000|Overall Study|Lost to Follow-up|0|||
125229802|NCT01924533|450470037|FG001|Overall Study|Lost to Follow-up|1|||
125172945|NCT05199090|450253437|FG005|Overall Study|Physician Decision|1|||
125172946|NCT05199090|450253432|FG000|Overall Study|Study terminated by sponsor|0|||
125172947|NCT05199090|450253433|FG001|Overall Study|Study terminated by sponsor|6|||
125172948|NCT05199090|450253434|FG002|Overall Study|Study terminated by sponsor|0|||
125172949|NCT05199090|450253435|FG003|Overall Study|Study terminated by sponsor|0|||
125172950|NCT05199090|450253436|FG004|Overall Study|Study terminated by sponsor|0|||
125172951|NCT05199090|450253437|FG005|Overall Study|Study terminated by sponsor|5|||
125172952|NCT05199090|450253432|FG000|Overall Study|Subject decision|0|||
125172953|NCT05199090|450253433|FG001|Overall Study|Subject decision|4|||
125172954|NCT05199090|450253434|FG002|Overall Study|Subject decision|0|||
125172955|NCT05199090|450253435|FG003|Overall Study|Subject decision|2|||
125172956|NCT05199090|450253436|FG004|Overall Study|Subject decision|5|||
125172957|NCT05199090|450253437|FG005|Overall Study|Subject decision|2|||
125172958|NCT03276078|450253438|FG000|Overall Study|Adverse Event|1|||
125172959|NCT02552732|450253439|FG000|Overall Study|Lost to Follow-up|2|||
125172960|NCT02552732|450253439|FG000|Overall Study|Physician Decision|1|||
125172961|NCT02552732|450253439|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
125172962|NCT02552732|450253439|FG000|Overall Study|Withdrawal by Subject|6|||
125172963|NCT02290223|450253440|FG000|6 Months|Lost to Follow-up|9|||
125172964|NCT02290223|450253441|FG001|6 Months|Lost to Follow-up|6|||
125172965|NCT02290223|450253440|FG000|6 Months|Withdrawal by Subject|5|||
125172966|NCT02290223|450253441|FG001|6 Months|Withdrawal by Subject|0|||
125172967|NCT02290223|450253440|FG000|6 Months|deceased (not related to study)|2|||
125172968|NCT02290223|450253441|FG001|6 Months|deceased (not related to study)|0|||
125172969|NCT02290223|450253440|FG000|12 Months|Lost to Follow-up|16|||
125172970|NCT02290223|450253441|FG001|12 Months|Lost to Follow-up|10|||
125172971|NCT02290223|450253440|FG000|12 Months|Refusal|0|||
125172972|NCT02290223|450253441|FG001|12 Months|Refusal|1|||
125172973|NCT01004003|450253447|FG000|Overall Study|Progressive disease|2|||
125172974|NCT01004003|450253448|FG001|Overall Study|Progressive disease|1|||
125172975|NCT01004003|450253449|FG002|Overall Study|Progressive disease|1|||
125172976|NCT01004003|450253450|FG003|Overall Study|Progressive disease|0|||
125172977|NCT01004003|450253451|FG004|Overall Study|Progressive disease|2|||
125172978|NCT01004003|450253452|FG005|Overall Study|Progressive disease|1|||
125172979|NCT01004003|450253453|FG006|Overall Study|Progressive disease|1|||
125172980|NCT01004003|450253454|FG007|Overall Study|Progressive disease|39|||
125172981|NCT01004003|450253455|FG008|Overall Study|Progressive disease|22|||
125172982|NCT01004003|450253447|FG000|Overall Study|Adverse Event|4|||
125172983|NCT01004003|450253448|FG001|Overall Study|Adverse Event|2|||
125172984|NCT01004003|450253449|FG002|Overall Study|Adverse Event|3|||
125172985|NCT01004003|450253450|FG003|Overall Study|Adverse Event|3|||
125172986|NCT01004003|450253451|FG004|Overall Study|Adverse Event|2|||
125172987|NCT01004003|450253452|FG005|Overall Study|Adverse Event|2|||
125172988|NCT01004003|450253453|FG006|Overall Study|Adverse Event|7|||
125172989|NCT01004003|450253454|FG007|Overall Study|Adverse Event|21|||
125172990|NCT01004003|450253455|FG008|Overall Study|Adverse Event|6|||
125172991|NCT01004003|450253447|FG000|Overall Study|Refused to continue taking trial med.|0|||
125172992|NCT01004003|450253448|FG001|Overall Study|Refused to continue taking trial med.|0|||
125172993|NCT01004003|450253449|FG002|Overall Study|Refused to continue taking trial med.|0|||
125172994|NCT01004003|450253450|FG003|Overall Study|Refused to continue taking trial med.|0|||
125172995|NCT01004003|450253451|FG004|Overall Study|Refused to continue taking trial med.|0|||
125172996|NCT01004003|450253452|FG005|Overall Study|Refused to continue taking trial med.|0|||
125172997|NCT01004003|450253453|FG006|Overall Study|Refused to continue taking trial med.|0|||
125172998|NCT01004003|450253454|FG007|Overall Study|Refused to continue taking trial med.|0|||
125172999|NCT01004003|450253455|FG008|Overall Study|Refused to continue taking trial med.|2|||
125173000|NCT01004003|450253447|FG000|Overall Study|Other|0|||
125173001|NCT01004003|450253448|FG001|Overall Study|Other|0|||
125173002|NCT01004003|450253449|FG002|Overall Study|Other|0|||
125173003|NCT01004003|450253450|FG003|Overall Study|Other|0|||
125173004|NCT01004003|450253451|FG004|Overall Study|Other|0|||
125173005|NCT01004003|450253452|FG005|Overall Study|Other|1|||
125173006|NCT01004003|450253453|FG006|Overall Study|Other|0|||
125173007|NCT01004003|450253454|FG007|Overall Study|Other|0|||
125173008|NCT01004003|450253455|FG008|Overall Study|Other|0|||
125173009|NCT05819203|450253458|FG000|Overall Study|Protocol Violation|1|||
125173010|NCT05819203|450253459|FG001|Overall Study|Protocol Violation|2|||
125173011|NCT05819203|450253458|FG000|Overall Study|Withdrawal by Subject|1|||
125173012|NCT05819203|450253459|FG001|Overall Study|Withdrawal by Subject|0|||
125229803|NCT01924533|450470036|FG000|Overall Study|Withdrawal by Subject|7|||
125173013|NCT02185053|450253460|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
125173014|NCT02185053|450253461|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
125173015|NCT02185053|450253462|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
125173016|NCT02185053|450253460|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
125173017|NCT02185053|450253461|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
125173018|NCT02185053|450253462|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
125173019|NCT02185053|450253460|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
125173020|NCT02185053|450253461|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
125173021|NCT02185053|450253462|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
125173022|NCT02185053|450253460|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
125173023|NCT02185053|450253461|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
125173024|NCT02185053|450253462|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
125173025|NCT02185053|450253460|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
125173026|NCT02185053|450253461|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
125173027|NCT02185053|450253462|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
125173028|NCT02185053|450253460|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
125173029|NCT02185053|450253461|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
125173030|NCT02185053|450253462|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
125173031|NCT02185053|450253460|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
125173032|NCT02185053|450253461|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
125173033|NCT02185053|450253462|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
125173034|NCT02185053|450253460|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
125173035|NCT02185053|450253461|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
125173036|NCT02185053|450253462|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
125173037|NCT02521376|450253465|FG000|Overall Study|Enrolled, But Not Treated|1|||
125173038|NCT02521376|450253466|FG001|Overall Study|Enrolled, But Not Treated|0|||
125173039|NCT02521376|450253467|FG002|Overall Study|Enrolled, But Not Treated|0|||
125173040|NCT02521376|450253468|FG003|Overall Study|Enrolled, But Not Treated|0|||
125173041|NCT03597464|450253474|FG000|Overall Study|Withdrawal by Subject|4|||
125173042|NCT03597464|450253475|FG001|Overall Study|Withdrawal by Subject|5|||
125173043|NCT03597464|450253474|FG000|Overall Study|Lost to Follow-up|3|||
125173044|NCT03597464|450253475|FG001|Overall Study|Lost to Follow-up|1|||
125173045|NCT03597464|450253474|FG000|Overall Study|Pregnancy|3|||
125173046|NCT03597464|450253475|FG001|Overall Study|Pregnancy|1|||
125173047|NCT03597464|450253474|FG000|Overall Study|Lack of Efficacy|2|||
125173048|NCT03597464|450253475|FG001|Overall Study|Lack of Efficacy|0|||
125173049|NCT03597464|450253474|FG000|Overall Study|Physician Decision|2|||
125173050|NCT03597464|450253475|FG001|Overall Study|Physician Decision|2|||
125173051|NCT03597464|450253474|FG000|Overall Study|Protocol Violation|1|||
125173052|NCT03597464|450253475|FG001|Overall Study|Protocol Violation|1|||
125173053|NCT03597464|450253474|FG000|Overall Study|Adverse Event|0|||
125173054|NCT03597464|450253475|FG001|Overall Study|Adverse Event|2|||
125173055|NCT03597464|450253474|FG000|Overall Study|Death|0|||
125173056|NCT03597464|450253475|FG001|Overall Study|Death|3|||
125173057|NCT00143247|450253480|FG000|Overall Study|Death|8|||
125173058|NCT00143247|450253480|FG000|Overall Study|Adverse Event|19|||
125173059|NCT00143247|450253480|FG000|Overall Study|Lack of Efficacy|3|||
125173060|NCT00143247|450253480|FG000|Overall Study|Withdrawal by Subject|55|||
125173061|NCT00143247|450253480|FG000|Overall Study|Study terminated by sponsor|31|||
125173062|NCT00143247|450253480|FG000|Overall Study|Protocol Violation|15|||
125173063|NCT00143247|450253480|FG000|Overall Study|Lost to Follow-up|12|||
125173064|NCT00143247|450253480|FG000|Overall Study|following inaccurate lab adverse event|1|||
125173065|NCT00143247|450253480|FG000|Overall Study|Other|12|||
125173066|NCT00340678|450253481|FG000|Overall Study|Lost to Follow-up|1|||
125173067|NCT00340678|450253482|FG001|Overall Study|Lost to Follow-up|0|||
125173068|NCT00340678|450253483|FG002|Overall Study|Lost to Follow-up|0|||
125173069|NCT00340678|450253484|FG003|Overall Study|Lost to Follow-up|0|||
125173070|NCT01762800|450254836|FG000|Overall Study|Adverse Event|8|||
125173071|NCT01762800|450254837|FG001|Overall Study|Adverse Event|13|||
125173072|NCT01762800|450254836|FG000|Overall Study|Lack of Efficacy|3|||
125173073|NCT01762800|450254837|FG001|Overall Study|Lack of Efficacy|2|||
125173074|NCT01762800|450254836|FG000|Overall Study|Study Closed/Terminated|0|||
125173075|NCT01762800|450254837|FG001|Overall Study|Study Closed/Terminated|1|||
125173076|NCT01762800|450254836|FG000|Overall Study|Physician Decision|1|||
125173077|NCT01762800|450254837|FG001|Overall Study|Physician Decision|1|||
125173078|NCT01762800|450254836|FG000|Overall Study|Withdrawal by Subject|7|||
125173079|NCT01762800|450254837|FG001|Overall Study|Withdrawal by Subject|4|||
125173080|NCT02111603|450254839|FG000|Overall Study|Withdrawal by Subject|1|||
125173081|NCT01753297|450254842|FG000|Overall Study|Lost to Follow-up|7|||
125173082|NCT01753297|450254843|FG001|Overall Study|Lost to Follow-up|2|||
125173083|NCT01753297|450254842|FG000|Overall Study|Withdrawal by Subject|26|||
125173084|NCT01753297|450254843|FG001|Overall Study|Withdrawal by Subject|23|||
125173085|NCT01753297|450254842|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
125173086|NCT01753297|450254843|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
125173087|NCT01753297|450254842|FG000|Overall Study|Death|0|||
125173088|NCT01753297|450254843|FG001|Overall Study|Death|2|||
125173089|NCT01753297|450254842|FG000|Overall Study|Did not attend end of study visit|7|||
125173090|NCT01753297|450254843|FG001|Overall Study|Did not attend end of study visit|8|||
125173091|NCT01174043|450254846|FG000|Overall Study|Disease progression|5|||
125173092|NCT01174043|450254846|FG000|Overall Study|Adverse Event|3|||
125173093|NCT01174043|450254846|FG000|Overall Study|Death|1|||
125173094|NCT01174043|450254846|FG000|Overall Study|Withdrawal by Subject|2|||
125173095|NCT01645787|450254852|FG000|Washout (2 Weeks)|Adverse Event|1|||
125173096|NCT01645787|450254853|FG001|Washout (2 Weeks)|Adverse Event|0|||
125173097|NCT01371539|450254854|FG000|Period One: One Week|Lost to Follow-up|0|||
125173098|NCT01371539|450254855|FG001|Period One: One Week|Lost to Follow-up|1|||
125173099|NCT01371539|450254854|FG000|Period Two: One Week|Lost to Follow-up|0|||
125173100|NCT01371539|450254855|FG001|Period Two: One Week|Lost to Follow-up|1|||
125173101|NCT01371539|450254854|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
125173102|NCT01371539|450254855|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
125173103|NCT01371539|450254854|FG000|Period Two: One Week|Time/job conflict|0|||
125173104|NCT01371539|450254855|FG001|Period Two: One Week|Time/job conflict|1|||
125173105|NCT01524978|450254872|FG000|Overall Study|Other|16|||
125173106|NCT01524978|450254873|FG001|Overall Study|Other|2|||
125173107|NCT01524978|450254874|FG002|Overall Study|Other|1|||
125173108|NCT01524978|450254875|FG003|Overall Study|Other|2|||
125173109|NCT01524978|450254876|FG004|Overall Study|Other|1|||
125173110|NCT01524978|450254877|FG005|Overall Study|Other|3|||
125173111|NCT01524978|450254878|FG006|Overall Study|Other|17|||
125173112|NCT01524978|450254879|FG007|Overall Study|Other|1|||
125173113|NCT01524978|450254880|FG008|Overall Study|Other|2|||
125173114|NCT01524978|450254881|FG009|Overall Study|Other|2|||
125173115|NCT01524978|450254882|FG010|Overall Study|Other|5|||
125173116|NCT01524978|450254872|FG000|Overall Study|Withdrawal by Subject|12|||
125173117|NCT01524978|450254873|FG001|Overall Study|Withdrawal by Subject|0|||
125173118|NCT01524978|450254874|FG002|Overall Study|Withdrawal by Subject|1|||
125173119|NCT01524978|450254875|FG003|Overall Study|Withdrawal by Subject|1|||
125173120|NCT01524978|450254876|FG004|Overall Study|Withdrawal by Subject|3|||
125173121|NCT01524978|450254877|FG005|Overall Study|Withdrawal by Subject|1|||
125173122|NCT01524978|450254878|FG006|Overall Study|Withdrawal by Subject|6|||
125173123|NCT01524978|450254879|FG007|Overall Study|Withdrawal by Subject|2|||
125173124|NCT01524978|450254880|FG008|Overall Study|Withdrawal by Subject|4|||
125173125|NCT01524978|450254881|FG009|Overall Study|Withdrawal by Subject|0|||
125173126|NCT01524978|450254882|FG010|Overall Study|Withdrawal by Subject|5|||
125173127|NCT01524978|450254872|FG000|Overall Study|Lost to Follow-up|0|||
125173128|NCT01524978|450254873|FG001|Overall Study|Lost to Follow-up|0|||
125173129|NCT01524978|450254874|FG002|Overall Study|Lost to Follow-up|3|||
125173130|NCT01524978|450254875|FG003|Overall Study|Lost to Follow-up|0|||
125173131|NCT01524978|450254876|FG004|Overall Study|Lost to Follow-up|1|||
125173132|NCT01524978|450254877|FG005|Overall Study|Lost to Follow-up|1|||
125173133|NCT01524978|450254878|FG006|Overall Study|Lost to Follow-up|2|||
125229804|NCT01924533|450470037|FG001|Overall Study|Withdrawal by Subject|3|||
125229805|NCT01924533|450470036|FG000|Overall Study|Other Eligibility criteria|1|||
125229806|NCT01924533|450470037|FG001|Overall Study|Other Eligibility criteria|1|||
125229807|NCT02747927|450470038|FG000|Overall Study|Adverse Event|5|||
125229808|NCT02747927|450470039|FG001|Overall Study|Adverse Event|14|||
125229809|NCT02747927|450470038|FG000|Overall Study|Lost to Follow-up|22|||
125229810|NCT02747927|450470039|FG001|Overall Study|Lost to Follow-up|43|||
125229811|NCT02747927|450470038|FG000|Overall Study|Pregnancy|34|||
125229812|NCT02747927|450470039|FG001|Overall Study|Pregnancy|66|||
125229813|NCT02747927|450470038|FG000|Overall Study|Protocol Violation|2|||
125229814|NCT02747927|450470039|FG001|Overall Study|Protocol Violation|4|||
125229815|NCT02747927|450470038|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
125173134|NCT01524978|450254879|FG007|Overall Study|Lost to Follow-up|0|||
125173135|NCT01524978|450254880|FG008|Overall Study|Lost to Follow-up|1|||
125173136|NCT01524978|450254881|FG009|Overall Study|Lost to Follow-up|1|||
125173137|NCT01524978|450254882|FG010|Overall Study|Lost to Follow-up|1|||
125173138|NCT01524978|450254872|FG000|Overall Study|Death|34|||
125173139|NCT01524978|450254873|FG001|Overall Study|Death|2|||
125173140|NCT01524978|450254874|FG002|Overall Study|Death|5|||
125173141|NCT01524978|450254875|FG003|Overall Study|Death|24|||
125173142|NCT01524978|450254876|FG004|Overall Study|Death|4|||
125173143|NCT01524978|450254877|FG005|Overall Study|Death|4|||
125173144|NCT01524978|450254878|FG006|Overall Study|Death|1|||
125173145|NCT01524978|450254879|FG007|Overall Study|Death|9|||
125173146|NCT01524978|450254880|FG008|Overall Study|Death|5|||
125173147|NCT01524978|450254881|FG009|Overall Study|Death|6|||
125173148|NCT01524978|450254882|FG010|Overall Study|Death|17|||
125229816|NCT02747927|450470039|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
125173149|NCT02165735|450254885|FG000|Overall Study|Lost to Follow-up|12|||
125173150|NCT02165735|450254886|FG001|Overall Study|Lost to Follow-up|10|||
125173151|NCT02165735|450254885|FG000|Overall Study|Withdrawal by Subject|3|||
125229817|NCT02747927|450470038|FG000|Overall Study|Reason not Specified|11|||
125229818|NCT02747927|450470039|FG001|Overall Study|Reason not Specified|27|||
125173152|NCT02165735|450254886|FG001|Overall Study|Withdrawal by Subject|0|||
125173153|NCT02165735|450254885|FG000|Overall Study|Participant indicated lack of time|1|||
125173154|NCT02165735|450254886|FG001|Overall Study|Participant indicated lack of time|3|||
125173155|NCT02165735|450254885|FG000|Overall Study|Protocol Violation|0|||
125173156|NCT02165735|450254886|FG001|Overall Study|Protocol Violation|1|||
125173157|NCT03066258|450254887|FG000|Overall Study|Death|1|||
125173158|NCT03066258|450254888|FG001|Overall Study|Death|0|||
125173159|NCT03066258|450254889|FG002|Overall Study|Death|0|||
125173160|NCT03066258|450254890|FG003|Overall Study|Death|0|||
125173161|NCT03066258|450254891|FG004|Overall Study|Death|1|||
125173162|NCT02784795|450254892|FG000|Overall Study|Progressive Disease|2|||
125173163|NCT02784795|450254893|FG001|Overall Study|Progressive Disease|1|||
125173164|NCT02784795|450254894|FG002|Overall Study|Progressive Disease|1|||
125173165|NCT02784795|450254895|FG003|Overall Study|Progressive Disease|0|||
125173166|NCT02784795|450254896|FG004|Overall Study|Progressive Disease|2|||
125173167|NCT02784795|450254897|FG005|Overall Study|Progressive Disease|0|||
125173168|NCT02784795|450254898|FG006|Overall Study|Progressive Disease|2|||
125173169|NCT02784795|450254899|FG007|Overall Study|Progressive Disease|0|||
125173170|NCT02784795|450254900|FG008|Overall Study|Progressive Disease|0|||
125173171|NCT02784795|450254901|FG009|Overall Study|Progressive Disease|0|||
125173172|NCT02784795|450254902|FG010|Overall Study|Progressive Disease|1|||
125173173|NCT02784795|450254903|FG011|Overall Study|Progressive Disease|0|||
125173174|NCT02784795|450254892|FG000|Overall Study|Adverse Event|1|||
125173175|NCT02784795|450254893|FG001|Overall Study|Adverse Event|0|||
125173176|NCT02784795|450254894|FG002|Overall Study|Adverse Event|0|||
125173177|NCT02784795|450254895|FG003|Overall Study|Adverse Event|1|||
125173178|NCT02784795|450254896|FG004|Overall Study|Adverse Event|0|||
125173179|NCT02784795|450254897|FG005|Overall Study|Adverse Event|0|||
125173180|NCT02784795|450254898|FG006|Overall Study|Adverse Event|1|||
125173181|NCT02784795|450254899|FG007|Overall Study|Adverse Event|0|||
125173182|NCT02784795|450254900|FG008|Overall Study|Adverse Event|0|||
125173183|NCT02784795|450254901|FG009|Overall Study|Adverse Event|0|||
125173184|NCT02784795|450254902|FG010|Overall Study|Adverse Event|0|||
125173185|NCT02784795|450254903|FG011|Overall Study|Adverse Event|2|||
125173186|NCT02784795|450254892|FG000|Overall Study|Withdrawal by Subject|1|||
125173187|NCT02784795|450254893|FG001|Overall Study|Withdrawal by Subject|0|||
125173188|NCT02784795|450254894|FG002|Overall Study|Withdrawal by Subject|2|||
125173189|NCT02784795|450254895|FG003|Overall Study|Withdrawal by Subject|1|||
125173190|NCT02784795|450254896|FG004|Overall Study|Withdrawal by Subject|3|||
125173191|NCT02784795|450254897|FG005|Overall Study|Withdrawal by Subject|0|||
125173192|NCT02784795|450254898|FG006|Overall Study|Withdrawal by Subject|0|||
125173193|NCT02784795|450254899|FG007|Overall Study|Withdrawal by Subject|1|||
125173194|NCT02784795|450254900|FG008|Overall Study|Withdrawal by Subject|0|||
125173195|NCT02784795|450254901|FG009|Overall Study|Withdrawal by Subject|0|||
125173196|NCT02784795|450254902|FG010|Overall Study|Withdrawal by Subject|0|||
125173197|NCT02784795|450254903|FG011|Overall Study|Withdrawal by Subject|2|||
125173198|NCT02784795|450254892|FG000|Overall Study|Death|0|||
125173199|NCT02784795|450254893|FG001|Overall Study|Death|0|||
125173200|NCT02784795|450254894|FG002|Overall Study|Death|0|||
125173201|NCT02784795|450254895|FG003|Overall Study|Death|0|||
125173202|NCT02784795|450254896|FG004|Overall Study|Death|1|||
125173203|NCT02784795|450254897|FG005|Overall Study|Death|0|||
125173204|NCT02784795|450254898|FG006|Overall Study|Death|0|||
125173205|NCT02784795|450254899|FG007|Overall Study|Death|0|||
125173206|NCT02784795|450254900|FG008|Overall Study|Death|0|||
125173207|NCT02784795|450254901|FG009|Overall Study|Death|0|||
125173208|NCT02784795|450254902|FG010|Overall Study|Death|0|||
125173209|NCT02784795|450254903|FG011|Overall Study|Death|0|||
125173210|NCT02784795|450254892|FG000|Overall Study|Physician Decision|0|||
125173211|NCT02784795|450254893|FG001|Overall Study|Physician Decision|0|||
125173212|NCT02784795|450254894|FG002|Overall Study|Physician Decision|0|||
125173213|NCT02784795|450254895|FG003|Overall Study|Physician Decision|0|||
125173214|NCT02784795|450254896|FG004|Overall Study|Physician Decision|0|||
125173215|NCT02784795|450254897|FG005|Overall Study|Physician Decision|0|||
125173216|NCT02784795|450254898|FG006|Overall Study|Physician Decision|1|||
125173217|NCT02784795|450254899|FG007|Overall Study|Physician Decision|0|||
125173218|NCT02784795|450254900|FG008|Overall Study|Physician Decision|0|||
125173219|NCT02784795|450254901|FG009|Overall Study|Physician Decision|0|||
125173220|NCT02784795|450254902|FG010|Overall Study|Physician Decision|0|||
125173221|NCT02784795|450254903|FG011|Overall Study|Physician Decision|0|||
125173222|NCT00595309|450254906|FG000|Overall Study|Lost to Follow-up|1|||
125173223|NCT00595309|450254906|FG000|Overall Study|planned vaccination against yellow fever|1|||
125229819|NCT05412134|450470040|FG000|Overall Study|Lost to Follow-up|2|||
125173224|NCT00595309|450254906|FG000|Overall Study|acute infection after V0|1|||
125173225|NCT00595309|450254906|FG000|Overall Study|personal reason|1|||
125173226|NCT00626561|450254907|FG000|Overall Study|Withdrawal by Subject|2|||
125173227|NCT00626561|450254907|FG000|Overall Study|Disease Progression|2|||
125173228|NCT00101283|450254908|FG000|Overall Study|Withdrawal by Subject|0|||
125173229|NCT00101283|450254909|FG001|Overall Study|Withdrawal by Subject|1|||
125173230|NCT00101283|450254908|FG000|Overall Study|Insurance Refusal|0|||
125173231|NCT00101283|450254909|FG001|Overall Study|Insurance Refusal|1|||
125173232|NCT00101283|450254908|FG000|Overall Study|Prostate Cancer Recurrence|0|||
125173233|NCT00101283|450254909|FG001|Overall Study|Prostate Cancer Recurrence|1|||
125173234|NCT00185588|450254910|FG000|Overall Study|Adverse Event|3|||
125173235|NCT00185588|450254911|FG001|Overall Study|Adverse Event|1|||
125229820|NCT05412134|450470041|FG001|Overall Study|Lost to Follow-up|0|||
125173236|NCT00185588|450254912|FG002|Overall Study|Adverse Event|4|||
125173237|NCT00185588|450254913|FG003|Overall Study|Adverse Event|2|||
125173238|NCT00185588|450254910|FG000|Overall Study|Lost to Follow-up|0|||
125173239|NCT00185588|450254911|FG001|Overall Study|Lost to Follow-up|0|||
125229821|NCT04275336|450470043|FG000|Overall Study|First venipuncture failed|4|||
125229822|NCT04275336|450470044|FG001|Overall Study|First venipuncture failed|6|||
125229823|NCT04275336|450470045|FG002|Overall Study|First venipuncture failed|5|||
125229824|NCT04275336|450470043|FG000|Overall Study|Unscheduled venipuncture|9|||
125229825|NCT04275336|450470044|FG001|Overall Study|Unscheduled venipuncture|13|||
125229826|NCT04275336|450470045|FG002|Overall Study|Unscheduled venipuncture|7|||
125229827|NCT04275336|450470043|FG000|Overall Study|Failed specimen of saliva|4|||
125229828|NCT04275336|450470044|FG001|Overall Study|Failed specimen of saliva|3|||
125229829|NCT04275336|450470045|FG002|Overall Study|Failed specimen of saliva|4|||
125229830|NCT00423046|450470052|FG000|Overall Study|Other|340|||
125229831|NCT00423046|450470053|FG001|Overall Study|Other|345|||
125229832|NCT00830128|450470054|FG000|Overall Study|Adverse Event|5|||
125229833|NCT00830128|450470054|FG000|Overall Study|Lack of Efficacy|7|||
125229834|NCT00830128|450470054|FG000|Overall Study|Protocol Violation|1|||
125229835|NCT00830128|450470054|FG000|Overall Study|Withdrawal by Subject|2|||
125229836|NCT00830128|450470054|FG000|Overall Study|Family obligation|1|||
125229837|NCT00830128|450470054|FG000|Overall Study|Relocation|1|||
125229838|NCT00830128|450470054|FG000|Overall Study|Work obligation|1|||
125229839|NCT00830128|450470054|FG000|Overall Study|Operating a vehicle|1|||
125229840|NCT05401565|450470055|FG000|Overall Study|Lost to Follow-up|1|||
125229841|NCT05401565|450470056|FG001|Overall Study|Lost to Follow-up|0|||
125229842|NCT05401565|450470055|FG000|Overall Study|Adverse Event|2|||
125229843|NCT05401565|450470056|FG001|Overall Study|Adverse Event|0|||
125229844|NCT01218802|450470065|FG000|Overall Study|Lost to Follow-up|5|||
125229845|NCT01218802|450470066|FG001|Overall Study|Lost to Follow-up|6|||
125229846|NCT01218802|450470065|FG000|Overall Study|Withdrawal by Subject|3|||
125229847|NCT01218802|450470066|FG001|Overall Study|Withdrawal by Subject|10|||
125229848|NCT01218802|450470065|FG000|Overall Study|Adverse Event|0|||
125229849|NCT01218802|450470066|FG001|Overall Study|Adverse Event|2|||
125229850|NCT01218802|450470065|FG000|Overall Study|Incarcerated|2|||
125229851|NCT01218802|450470066|FG001|Overall Study|Incarcerated|0|||
125229852|NCT03329885|450470067|FG000|Overall Study|Sponsor discontinued the study early|0|||
125229853|NCT03329885|450470068|FG001|Overall Study|Sponsor discontinued the study early|0|||
125229854|NCT03329885|450470069|FG002|Overall Study|Sponsor discontinued the study early|0|||
125229855|NCT03329885|450470070|FG003|Overall Study|Sponsor discontinued the study early|0|||
125229856|NCT03329885|450470071|FG004|Overall Study|Sponsor discontinued the study early|0|||
125229857|NCT03329885|450470072|FG005|Overall Study|Sponsor discontinued the study early|0|||
125229858|NCT03329885|450470073|FG006|Overall Study|Sponsor discontinued the study early|1|||
125229859|NCT03329885|450470074|FG007|Overall Study|Sponsor discontinued the study early|1|||
125229860|NCT03329885|450470075|FG008|Overall Study|Sponsor discontinued the study early|0|||
125229861|NCT03368807|450470080|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
125229862|NCT03368807|450470080|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
125229863|NCT03368807|450470080|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
125229864|NCT03368807|450470080|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
125229865|NCT00843492|450470081|FG000|Overall Study|Adverse Event|0|||
125229866|NCT00843492|450470082|FG001|Overall Study|Adverse Event|3|||
125229867|NCT00843492|450470081|FG000|Overall Study|Lost to Follow-up|4|||
125229868|NCT00843492|450470082|FG001|Overall Study|Lost to Follow-up|4|||
125229869|NCT00843492|450470081|FG000|Overall Study|Withdrawal by Subject|0|||
125229870|NCT00843492|450470082|FG001|Overall Study|Withdrawal by Subject|4|||
125229871|NCT00843492|450470081|FG000|Overall Study|Immobilization Stopped|1|||
125229872|NCT00843492|450470082|FG001|Overall Study|Immobilization Stopped|0|||
125229873|NCT00843492|450470081|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
125229874|NCT00843492|450470082|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
125229875|NCT00843492|450470081|FG000|Overall Study|Orthopedic Surgery|0|||
125229876|NCT00843492|450470082|FG001|Overall Study|Orthopedic Surgery|2|||
125229877|NCT00843492|450470081|FG000|Overall Study|Visit Not Performed|1|||
125229878|NCT00843492|450470082|FG001|Overall Study|Visit Not Performed|0|||
125229879|NCT00843492|450470081|FG000|Overall Study|Deep-vein Thrombosis|1|||
125229880|NCT00843492|450470082|FG001|Overall Study|Deep-vein Thrombosis|0|||
125229881|NCT01677741|450470084|FG000|Overall Study|Death|0|||
125229882|NCT01677741|450470085|FG001|Overall Study|Death|0|||
125229883|NCT01677741|450470086|FG002|Overall Study|Death|0|||
125229884|NCT01677741|450470087|FG003|Overall Study|Death|1|||
125229885|NCT01677741|450470088|FG004|Overall Study|Death|0|||
125229886|NCT01677741|450470089|FG005|Overall Study|Death|1|||
125229887|NCT01677741|450470090|FG006|Overall Study|Death|0|||
125229888|NCT01677741|450470091|FG007|Overall Study|Death|0|||
125229889|NCT01677741|450470084|FG000|Overall Study|Withdrawal by Subject|2|||
125229890|NCT01677741|450470085|FG001|Overall Study|Withdrawal by Subject|7|||
125229891|NCT01677741|450470086|FG002|Overall Study|Withdrawal by Subject|5|||
125229892|NCT01677741|450470087|FG003|Overall Study|Withdrawal by Subject|4|||
125229893|NCT01677741|450470088|FG004|Overall Study|Withdrawal by Subject|11|||
125229894|NCT01677741|450470089|FG005|Overall Study|Withdrawal by Subject|20|||
125229895|NCT01677741|450470090|FG006|Overall Study|Withdrawal by Subject|4|||
125229896|NCT01677741|450470091|FG007|Overall Study|Withdrawal by Subject|2|||
125229897|NCT01677741|450470084|FG000|Overall Study|Enrolled in a rollover study|0|||
125229898|NCT01677741|450470085|FG001|Overall Study|Enrolled in a rollover study|3|||
125229899|NCT01677741|450470086|FG002|Overall Study|Enrolled in a rollover study|2|||
125229900|NCT01677741|450470087|FG003|Overall Study|Enrolled in a rollover study|1|||
125229901|NCT01677741|450470088|FG004|Overall Study|Enrolled in a rollover study|6|||
125229902|NCT01677741|450470089|FG005|Overall Study|Enrolled in a rollover study|6|||
125229903|NCT01677741|450470090|FG006|Overall Study|Enrolled in a rollover study|7|||
125229904|NCT01677741|450470091|FG007|Overall Study|Enrolled in a rollover study|0|||
125229905|NCT01677741|450470084|FG000|Overall Study|Progressive disease|1|||
125229906|NCT01677741|450470085|FG001|Overall Study|Progressive disease|0|||
125229907|NCT01677741|450470086|FG002|Overall Study|Progressive disease|1|||
125229908|NCT01677741|450470087|FG003|Overall Study|Progressive disease|0|||
125229909|NCT01677741|450470088|FG004|Overall Study|Progressive disease|0|||
125229910|NCT01677741|450470089|FG005|Overall Study|Progressive disease|1|||
125229911|NCT01677741|450470090|FG006|Overall Study|Progressive disease|0|||
125229912|NCT01677741|450470091|FG007|Overall Study|Progressive disease|0|||
125229913|NCT01973218|450470092|FG000|Overall Study|Adverse Event|1|||
125229914|NCT01973218|450470093|FG001|Overall Study|Adverse Event|0|||
125229915|NCT01973218|450470092|FG000|Overall Study|Withdrawal by Subject|1|||
125229916|NCT01973218|450470093|FG001|Overall Study|Withdrawal by Subject|0|||
125229917|NCT01441973|450470098|FG000|Overall Study|Disease progression|8|||
125229918|NCT01441973|450470099|FG001|Overall Study|Disease progression|6|||
125229919|NCT01441973|450470098|FG000|Overall Study|Adverse event unrelated to study drug|3|||
125229920|NCT01441973|450470099|FG001|Overall Study|Adverse event unrelated to study drug|2|||
125229921|NCT01441973|450470098|FG000|Overall Study|Participant request to discontinue|1|||
125229922|NCT01441973|450470099|FG001|Overall Study|Participant request to discontinue|1|||
125229923|NCT01441973|450470098|FG000|Overall Study|Poor compliance/noncompliance|0|||
125229924|NCT01441973|450470099|FG001|Overall Study|Poor compliance/noncompliance|1|||
125229925|NCT01441973|450470098|FG000|Overall Study|Administrative reason by sponsor|3|||
125229926|NCT01441973|450470099|FG001|Overall Study|Administrative reason by sponsor|5|||
125229927|NCT01441973|450470098|FG000|Overall Study|Participant withdrew consent|0|||
125229928|NCT01441973|450470099|FG001|Overall Study|Participant withdrew consent|1|||
125229929|NCT01149655|450470100|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
125229930|NCT01149655|450470101|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
125229931|NCT01149655|450470102|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
125229932|NCT01149655|450470103|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
125173240|NCT00185588|450254912|FG002|Overall Study|Lost to Follow-up|1|||
125173241|NCT00185588|450254913|FG003|Overall Study|Lost to Follow-up|2|||
125173242|NCT00185588|450254910|FG000|Overall Study|Withdrawal by Subject|0|||
125173243|NCT00185588|450254911|FG001|Overall Study|Withdrawal by Subject|1|||
125173244|NCT00185588|450254912|FG002|Overall Study|Withdrawal by Subject|0|||
125173245|NCT00185588|450254913|FG003|Overall Study|Withdrawal by Subject|0|||
125173246|NCT00185588|450254910|FG000|Overall Study|Physician Decision|0|||
125173247|NCT00185588|450254911|FG001|Overall Study|Physician Decision|0|||
125173248|NCT00185588|450254912|FG002|Overall Study|Physician Decision|1|||
125173249|NCT00185588|450254913|FG003|Overall Study|Physician Decision|0|||
125173250|NCT02604407|450254914|FG000|Overall Study|Adverse Event|0|||
125173251|NCT02604407|450254915|FG001|Overall Study|Adverse Event|7|||
125173252|NCT02604407|450254916|FG002|Overall Study|Adverse Event|5|||
125173253|NCT02604407|450254914|FG000|Overall Study|Protocol Violation|2|||
125173254|NCT02604407|450254915|FG001|Overall Study|Protocol Violation|0|||
125173255|NCT02604407|450254916|FG002|Overall Study|Protocol Violation|0|||
125173256|NCT02604407|450254914|FG000|Overall Study|Withdrawal by Subject|3|||
125173257|NCT02604407|450254915|FG001|Overall Study|Withdrawal by Subject|3|||
125173258|NCT02604407|450254916|FG002|Overall Study|Withdrawal by Subject|5|||
125173259|NCT02604407|450254914|FG000|Overall Study|Lost to Follow-up|2|||
125173260|NCT02604407|450254915|FG001|Overall Study|Lost to Follow-up|1|||
125173261|NCT02604407|450254916|FG002|Overall Study|Lost to Follow-up|2|||
125173262|NCT02604407|450254914|FG000|Overall Study|Lack of Efficacy|1|||
125173263|NCT02604407|450254915|FG001|Overall Study|Lack of Efficacy|0|||
125173264|NCT02604407|450254916|FG002|Overall Study|Lack of Efficacy|0|||
125173265|NCT02604407|450254914|FG000|Overall Study|Other|3|||
125173266|NCT02604407|450254915|FG001|Overall Study|Other|1|||
125173267|NCT02604407|450254916|FG002|Overall Study|Other|4|||
125173268|NCT00398866|450254918|FG000|Overall Study|Adverse Event|1|||
125173269|NCT00398866|450254919|FG001|Overall Study|Adverse Event|0|||
125173270|NCT00398866|450254920|FG002|Overall Study|Adverse Event|0|||
125229933|NCT01149655|450470100|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
125229934|NCT01149655|450470101|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
125173271|NCT00398866|450254918|FG000|Overall Study|Lack of Efficacy|0|||
125173272|NCT00398866|450254919|FG001|Overall Study|Lack of Efficacy|0|||
125173273|NCT00398866|450254920|FG002|Overall Study|Lack of Efficacy|1|||
125173274|NCT00398866|450254918|FG000|Overall Study|Lost to Follow-up|7|||
125173275|NCT00398866|450254919|FG001|Overall Study|Lost to Follow-up|6|||
125173276|NCT00398866|450254920|FG002|Overall Study|Lost to Follow-up|4|||
125173277|NCT00398866|450254918|FG000|Overall Study|Withdrawal by Subject|5|||
125173278|NCT00398866|450254919|FG001|Overall Study|Withdrawal by Subject|1|||
125173279|NCT00398866|450254920|FG002|Overall Study|Withdrawal by Subject|2|||
125173280|NCT00398866|450254918|FG000|Overall Study|Unable to complete requirements of study|1|||
125173281|NCT00398866|450254919|FG001|Overall Study|Unable to complete requirements of study|1|||
125173282|NCT00398866|450254920|FG002|Overall Study|Unable to complete requirements of study|1|||
125173283|NCT00606632|450254921|FG000|Overall Study|Withdrawal by Subject|13|||
125173284|NCT00606632|450254921|FG000|Overall Study|Miscellaneous reasons|9|||
125173285|NCT00191191|450254924|FG000|Overall Study|Entry Criteria Exclusion|2|||
125173286|NCT00191191|450254925|FG001|Overall Study|Entry Criteria Exclusion|0|||
125173287|NCT00191191|450254924|FG000|Overall Study|Treated with Another Systemic Agent|1|||
125173288|NCT00191191|450254925|FG001|Overall Study|Treated with Another Systemic Agent|1|||
125173289|NCT00191191|450254924|FG000|Overall Study|Adverse Event|11|||
125173290|NCT00191191|450254925|FG001|Overall Study|Adverse Event|21|||
125173291|NCT00191191|450254924|FG000|Overall Study|Progressive Disease|84|||
125173292|NCT00191191|450254925|FG001|Overall Study|Progressive Disease|72|||
125173293|NCT00191191|450254924|FG000|Overall Study|Toxicity After Dose Reduction|7|||
125173294|NCT00191191|450254925|FG001|Overall Study|Toxicity After Dose Reduction|8|||
125173295|NCT00191191|450254924|FG000|Overall Study|Family/Caregiver Decision|5|||
125173296|NCT00191191|450254925|FG001|Overall Study|Family/Caregiver Decision|7|||
125173297|NCT00191191|450254924|FG000|Overall Study|Lost to Follow-up|1|||
125173298|NCT00191191|450254925|FG001|Overall Study|Lost to Follow-up|0|||
125173299|NCT00191191|450254924|FG000|Overall Study|Physician Decision|3|||
125173300|NCT00191191|450254925|FG001|Overall Study|Physician Decision|2|||
125173301|NCT00191191|450254924|FG000|Overall Study|Good Clinical Practice Violation|0|||
125173302|NCT00191191|450254925|FG001|Overall Study|Good Clinical Practice Violation|1|||
125173303|NCT05445492|450254926|FG000|Overall Study|Physician Decision|1|||
125173304|NCT03633825|450254927|FG000|Enrollment|Did not post on network|5066|||
125173305|NCT03633825|450254928|FG001|Enrollment|Did not post on network|5080|||
125173306|NCT03633825|450254927|FG000|Enrollment|Post not classified as crisis|13967|||
125173307|NCT03633825|450254928|FG001|Enrollment|Post not classified as crisis|13757|||
125173308|NCT03633825|450254927|FG000|Follow up|Lost to Follow-up|478|||
125173309|NCT03633825|450254928|FG001|Follow up|Lost to Follow-up|450|||
125173310|NCT03348163|450254929|FG000|Overall Study|Withdrawal by Subject|2|||
125173311|NCT03348163|450254930|FG001|Overall Study|Withdrawal by Subject|0|||
125173312|NCT01267994|450254931|FG000|Overall Study|Adverse Event|2|||
125173313|NCT03837743|450254932|FG000|Overall Study|Adverse Event|1|||
125173314|NCT03837743|450254932|FG000|Overall Study|Withdrawal by Subject|2|||
125173315|NCT01275430|450254934|FG000|Overall Study|Adverse Event|1|||
125173316|NCT01275430|450254934|FG000|Overall Study|No Contrast Injection|6|||
125173317|NCT01275430|450254934|FG000|Overall Study|Device Malfunction|1|||
125173318|NCT01275430|450254934|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
125173319|NCT04759768|450254935|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
125173320|NCT04759768|450254936|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
125173321|NCT04759768|450254935|FG000|Washout (7 Days)|Physician Decision|0|||
125173322|NCT04759768|450254936|FG001|Washout (7 Days)|Physician Decision|1|||
125173323|NCT02996487|450254937|FG000|Overall Study|Lost to Follow-up|1|||
125173324|NCT02996487|450254938|FG001|Overall Study|Lost to Follow-up|1|||
125173325|NCT02996487|450254939|FG002|Overall Study|Lost to Follow-up|0|||
125173326|NCT02996487|450254937|FG000|Overall Study|Death|0|||
125173327|NCT02996487|450254938|FG001|Overall Study|Death|1|||
125173328|NCT02996487|450254939|FG002|Overall Study|Death|0|||
125173329|NCT02996487|450254937|FG000|Overall Study|Withdrawal by Subject|2|||
125173330|NCT02996487|450254938|FG001|Overall Study|Withdrawal by Subject|3|||
125173331|NCT02996487|450254939|FG002|Overall Study|Withdrawal by Subject|0|||
125173332|NCT01130597|450254940|FG000|Overall Study|Protocol-specified (High K+)|1|||
125173333|NCT01130597|450254940|FG000|Overall Study|Adverse Event|4|||
125173334|NCT01130597|450254940|FG000|Overall Study|Death|1|||
125173335|NCT01130597|450254940|FG000|Overall Study|Protocol Violation|1|||
125173336|NCT01301729|450254941|FG000|Overall Study|Withdrawal by Subject|2|||
125173337|NCT01301729|450254941|FG000|Overall Study|Participant did not Return for Treatment|1|||
125173338|NCT01301729|450254941|FG000|Overall Study|Violated Selection Criteria|1|||
125173339|NCT04873934|450254942|FG000|Overall Study|Adverse Event|0|||
125173340|NCT04873934|450254943|FG001|Overall Study|Adverse Event|1|||
125173341|NCT04873934|450254942|FG000|Overall Study|Death|0|||
125173342|NCT04873934|450254943|FG001|Overall Study|Death|2|||
125173343|NCT04873934|450254942|FG000|Overall Study|Lost to Follow-up|13|||
125173344|NCT04873934|450254943|FG001|Overall Study|Lost to Follow-up|9|||
125173345|NCT04873934|450254942|FG000|Overall Study|Physician Decision|1|||
125173346|NCT04873934|450254943|FG001|Overall Study|Physician Decision|1|||
125173347|NCT04873934|450254942|FG000|Overall Study|Protocol deviation|2|||
125173348|NCT04873934|450254943|FG001|Overall Study|Protocol deviation|1|||
125173349|NCT04873934|450254942|FG000|Overall Study|Subject decision|1|||
125229935|NCT01149655|450470102|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
125173350|NCT04873934|450254943|FG001|Overall Study|Subject decision|8|||
125173351|NCT04873934|450254942|FG000|Overall Study|Withdrew consent|0|||
125173352|NCT04873934|450254943|FG001|Overall Study|Withdrew consent|4|||
125173353|NCT04873934|450254942|FG000|Overall Study|Missing|1|||
125173354|NCT04873934|450254943|FG001|Overall Study|Missing|0|||
125173355|NCT05794503|450254944|FG000|Overall Study|Operation Cancelled|2|||
125173356|NCT05794503|450254945|FG001|Overall Study|Operation Cancelled|0|||
125173357|NCT05794503|450254944|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
125173358|NCT05794503|450254945|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
125173359|NCT05794503|450254944|FG000|Overall Study|Protocol Violation|1|||
125173360|NCT05794503|450254945|FG001|Overall Study|Protocol Violation|0|||
125173361|NCT01464931|450254947|FG000|Overall Study|Withdrawal by Subject|1|||
125173362|NCT01464931|450254948|FG001|Overall Study|Withdrawal by Subject|0|||
125173363|NCT00338728|450254951|FG000|Overall Study|Screen Failure|14|||
125173364|NCT04102189|450254952|FG000|Overall Study|Withdrawal by Subject|1|||
125173365|NCT04102189|450254953|FG001|Overall Study|Withdrawal by Subject|2|||
125173366|NCT04102189|450254952|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125173367|NCT04102189|450254953|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125173368|NCT04102189|450254952|FG000|Overall Study|Lost to Follow-up|1|||
125173369|NCT04102189|450254953|FG001|Overall Study|Lost to Follow-up|0|||
125173370|NCT02933255|450254956|FG000|Overall Study|Discontinued due to study closure.|1|||
125173371|NCT02933255|450254957|FG001|Overall Study|Discontinued due to study closure.|0|||
125173372|NCT04803305|450254960|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
125173373|NCT04803305|450254961|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
125173374|NCT04803305|450254960|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
125173375|NCT04803305|450254961|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
125173376|NCT04803305|450254960|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
125173377|NCT04803305|450254961|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
125173378|NCT04803305|450254960|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
125173379|NCT04803305|450254961|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
125173380|NCT04803305|450254960|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
125173381|NCT04803305|450254961|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
125173382|NCT04803305|450254960|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
125173383|NCT04803305|450254961|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
125173384|NCT04803305|450254960|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
125173385|NCT04803305|450254961|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
125173386|NCT04803305|450254960|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
125173387|NCT04803305|450254961|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
125173388|NCT00708227|450254966|FG000|Overall Study|Physician Decision|0|||
125173389|NCT00708227|450254967|FG001|Overall Study|Physician Decision|3|||
125173390|NCT00708227|450254968|FG002|Overall Study|Physician Decision|1|||
125173391|NCT00708227|450254969|FG003|Overall Study|Physician Decision|2|||
125173392|NCT00708227|450254966|FG000|Overall Study|Withdrawal by Subject|1|||
125173393|NCT00708227|450254967|FG001|Overall Study|Withdrawal by Subject|2|||
125173394|NCT00708227|450254968|FG002|Overall Study|Withdrawal by Subject|0|||
125173395|NCT00708227|450254969|FG003|Overall Study|Withdrawal by Subject|1|||
125173396|NCT03654599|450254971|FG000|Overall Study|Lost to Follow-up|14|||
125173397|NCT03654599|450254972|FG001|Overall Study|Lost to Follow-up|12|||
125173398|NCT03654599|450254971|FG000|Overall Study|Death|8|||
125173399|NCT03654599|450254972|FG001|Overall Study|Death|6|||
125173400|NCT03654599|450254971|FG000|Overall Study|Withdrawal by Subject|6|||
125173401|NCT03654599|450254972|FG001|Overall Study|Withdrawal by Subject|4|||
125173402|NCT02017015|450257130|FG000|Overall Study|Adverse Event|9|||
125173403|NCT02017015|450257130|FG000|Overall Study|Withdrawal by Subject|21|||
125173404|NCT02017015|450257130|FG000|Overall Study|Death|4|||
125173405|NCT02017015|450257130|FG000|Overall Study|Progressive Disease|31|||
125173406|NCT02017015|450257130|FG000|Overall Study|Non-compliance with study drug|2|||
125173407|NCT02017015|450257130|FG000|Overall Study|Physician Decision|2|||
125173408|NCT02291510|450257138|FG000|Overall Study|Adverse Event|0|||
125173409|NCT02291510|450257139|FG001|Overall Study|Adverse Event|0|||
125173410|NCT02291510|450257140|FG002|Overall Study|Adverse Event|0|||
125173411|NCT02291510|450257141|FG003|Overall Study|Adverse Event|1|||
125173412|NCT03765788|450257142|FG000|Overall Study|Subject decision|2|||
125173413|NCT03765788|450257143|FG001|Overall Study|Subject decision|3|||
125173414|NCT03765788|450257142|FG000|Overall Study|Physician Decision|2|||
125173415|NCT03765788|450257143|FG001|Overall Study|Physician Decision|4|||
125173416|NCT03765788|450257142|FG000|Overall Study|Death|0|||
125173417|NCT03765788|450257143|FG001|Overall Study|Death|1|||
125173418|NCT03765788|450257142|FG000|Overall Study|Lost to Follow-up|1|||
125173419|NCT03765788|450257143|FG001|Overall Study|Lost to Follow-up|0|||
125173420|NCT03203850|450257144|FG000|Overall Study|Subject/guardian decision|4|||
125173421|NCT03203850|450257145|FG001|Overall Study|Subject/guardian decision|3|||
125173422|NCT03203850|450257144|FG000|Overall Study|Adverse Event|3|||
125173423|NCT03203850|450257145|FG001|Overall Study|Adverse Event|0|||
125173424|NCT03203850|450257144|FG000|Overall Study|Death|1|||
125173425|NCT03203850|450257145|FG001|Overall Study|Death|0|||
125173426|NCT01659125|450257146|FG000|Overall Study|Withdrawal by Subject|2|||
125173427|NCT01659125|450257146|FG000|Overall Study|Lost to Follow-up|7|||
125173428|NCT01659125|450257146|FG000|Overall Study|Technical Problem|1|||
125173429|NCT01659125|450257146|FG000|Overall Study|Time Constraints|2|||
125229936|NCT01149655|450470103|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
125173430|NCT01659125|450257146|FG000|Overall Study|Failed to Start Treatment|2|||
125173431|NCT02126826|450257147|FG000|Overall Study|Withdrawal by Subject|0|||
125173432|NCT02126826|450257148|FG001|Overall Study|Withdrawal by Subject|0|||
125173433|NCT02126826|450257149|FG002|Overall Study|Withdrawal by Subject|0|||
125173434|NCT02126826|450257150|FG003|Overall Study|Withdrawal by Subject|1|||
125173435|NCT02126826|450257151|FG004|Overall Study|Withdrawal by Subject|0|||
125173436|NCT02126826|450257152|FG005|Overall Study|Withdrawal by Subject|0|||
125173437|NCT02126826|450257153|FG006|Overall Study|Withdrawal by Subject|0|||
125173438|NCT02640482|450257154|FG000|Overall Study|Lost to Follow-up|3|||
125173439|NCT02640482|450257155|FG001|Overall Study|Lost to Follow-up|0|||
125173440|NCT01173120|450257156|FG000|Overall Study|Lack of Efficacy|2|||
125173441|NCT01173120|450257156|FG000|Overall Study|Lost to Follow-up|1|||
125173442|NCT01173120|450257156|FG000|Overall Study|Participant Decision|2|||
125173443|NCT01173120|450257156|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
125173444|NCT01173120|450257156|FG000|Overall Study|Switch-Participant Decision|12|||
125173445|NCT01173120|450257156|FG000|Overall Study|Switch-Difficulty With Device|12|||
125173446|NCT00517881|450257157|FG000|Overall Study|Protocol Violation|2|||
125173447|NCT00517881|450257157|FG000|Overall Study|Adverse Event|1|||
125173448|NCT00517881|450257157|FG000|Overall Study|Renal transplantation|2|||
125173449|NCT00113763|450257158|FG000|Overall Study|Adverse Event|5|||
125173450|NCT00113763|450257159|FG001|Overall Study|Adverse Event|2|||
125173451|NCT00113763|450257158|FG000|Overall Study|Disease Progression|28|||
125173452|NCT00113763|450257159|FG001|Overall Study|Disease Progression|14|||
125173453|NCT00113763|450257158|FG000|Overall Study|Lost to Follow-up|10|||
125173454|NCT00113763|450257159|FG001|Overall Study|Lost to Follow-up|0|||
125173455|NCT00113763|450257158|FG000|Overall Study|Withdrawal by Subject|1|||
125173456|NCT00113763|450257159|FG001|Overall Study|Withdrawal by Subject|4|||
125173457|NCT00113763|450257158|FG000|Overall Study|Other|27|||
125173458|NCT00113763|450257159|FG001|Overall Study|Other|6|||
125173459|NCT00113763|450257158|FG000|Overall Study|Non-compliance|1|||
125173460|NCT00113763|450257159|FG001|Overall Study|Non-compliance|0|||
125173461|NCT00113763|450257158|FG000|Overall Study|Ongoing|1|||
125173462|NCT00113763|450257159|FG001|Overall Study|Ongoing|0|||
125173463|NCT01383707|450257160|FG000|Overall Study|Consent withdrawal|6|||
125173464|NCT01383707|450257160|FG000|Overall Study|Death|19|||
125173465|NCT01383707|450257160|FG000|Overall Study|Other|8|||
125173466|NCT01383707|450257160|FG000|Overall Study|Sponsor's decision|2|||
125173467|NCT01383707|450257160|FG000|Overall Study|Adverse Event|14|||
125173468|NCT01383707|450257160|FG000|Overall Study|Progressive disease|23|||
125173469|NCT02013817|450257161|FG000|Overall Study|Adverse Event|12|||
125173470|NCT02013817|450257161|FG000|Overall Study|Withdrawal by Subject|4|||
125173471|NCT02013817|450257161|FG000|Overall Study|Death|2|||
125173472|NCT02013817|450257161|FG000|Overall Study|Other|9|||
125173473|NCT02129608|450257162|FG000|Overall Study|Lost to Follow-up|0|||
125173474|NCT02129608|450257163|FG001|Overall Study|Lost to Follow-up|1|||
125173475|NCT02129608|450257164|FG002|Overall Study|Lost to Follow-up|1|||
125173476|NCT02129608|450257162|FG000|Overall Study|Withdrawal by Subject|0|||
125173477|NCT02129608|450257163|FG001|Overall Study|Withdrawal by Subject|0|||
125173478|NCT02129608|450257164|FG002|Overall Study|Withdrawal by Subject|2|||
125173479|NCT00451204|450257171|FG000|Overall Study|Adverse Event|4|||
125173480|NCT00451204|450257172|FG001|Overall Study|Adverse Event|6|||
125173481|NCT00451204|450257171|FG000|Overall Study|Lack of Efficacy|4|||
125173482|NCT00451204|450257172|FG001|Overall Study|Lack of Efficacy|4|||
125173483|NCT00451204|450257171|FG000|Overall Study|Lost to Follow-up|4|||
125173484|NCT00451204|450257172|FG001|Overall Study|Lost to Follow-up|4|||
125173485|NCT00451204|450257171|FG000|Overall Study|Protocol Violation|1|||
125173486|NCT00451204|450257172|FG001|Overall Study|Protocol Violation|0|||
125173487|NCT00451204|450257171|FG000|Overall Study|Patient refusal|8|||
125173488|NCT00451204|450257172|FG001|Overall Study|Patient refusal|4|||
125173489|NCT00451204|450257171|FG000|Overall Study|Other|1|||
125229937|NCT01149655|450470100|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
125173490|NCT00451204|450257172|FG001|Overall Study|Other|2|||
125173491|NCT03055624|450257173|FG000|Overall Study|Study closed|9|||
125173492|NCT01582152|450257174|FG000|Overall Study|Disease Progression|4|||
125229938|NCT01149655|450470101|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
125229939|NCT01149655|450470102|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
125229940|NCT01149655|450470103|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
125229941|NCT01149655|450470100|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
125173493|NCT01582152|450257175|FG001|Overall Study|Disease Progression|5|||
125173494|NCT01582152|450257174|FG000|Overall Study|Adverse Event|2|||
125173495|NCT01582152|450257175|FG001|Overall Study|Adverse Event|1|||
125173496|NCT02794870|450257181|FG000|Overall Study|Withdrawal by Subject|2|||
125173497|NCT02794870|450257182|FG001|Overall Study|Withdrawal by Subject|0|||
125173498|NCT03336528|450257183|FG000|Overall Study|Protocol Violation|1|||
125173499|NCT03336528|450257184|FG001|Overall Study|Protocol Violation|1|||
125173500|NCT03336528|450257183|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
125173501|NCT03336528|450257184|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
125173502|NCT03336528|450257183|FG000|Overall Study|Did not receive study medication|1|||
125229942|NCT01149655|450470101|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
125229943|NCT01149655|450470102|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
125229944|NCT01149655|450470103|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
125229945|NCT01149655|450470100|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
125229946|NCT01149655|450470101|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
125229947|NCT01149655|450470102|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
125229948|NCT01149655|450470103|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
125229949|NCT01149655|450470100|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
125229950|NCT01149655|450470101|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
125229951|NCT01149655|450470102|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
125229952|NCT01149655|450470103|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
125229953|NCT01149655|450470100|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
125229954|NCT01149655|450470101|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
125229955|NCT01149655|450470102|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
125229956|NCT01149655|450470103|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
125229957|NCT01149655|450470100|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
125229958|NCT01149655|450470101|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
125229959|NCT01149655|450470102|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
125229960|NCT01149655|450470103|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
125229961|NCT01149655|450470100|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
125229962|NCT01149655|450470101|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
125229963|NCT01149655|450470102|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
125229964|NCT01149655|450470103|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
125229965|NCT01149655|450470100|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
125229966|NCT01149655|450470101|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
125229967|NCT01149655|450470102|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
125229968|NCT01149655|450470103|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
125229969|NCT01149655|450470100|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
125229970|NCT01149655|450470101|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
125229971|NCT01149655|450470102|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
125229972|NCT01149655|450470103|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
125229973|NCT01149655|450470100|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
125229974|NCT01149655|450470101|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
125229975|NCT01149655|450470102|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
125173503|NCT03336528|450257184|FG001|Overall Study|Did not receive study medication|2|||
125173504|NCT02437903|450257187|FG000|Overall Study|Adverse Event|1|||
125173505|NCT02437903|450257187|FG000|Overall Study|Withdrawal by Subject|1|||
125173506|NCT02437903|450257187|FG000|Overall Study|Lost to Follow-up|3|||
125173507|NCT00230178|450257190|FG000|Overall Study|Adverse Event|1|||
125173508|NCT00230178|450257191|FG001|Overall Study|Adverse Event|5|||
125173509|NCT00230178|450257192|FG002|Overall Study|Adverse Event|2|||
125173510|NCT00230178|450257190|FG000|Overall Study|Withdrawal by Subject|0|||
125173511|NCT00230178|450257191|FG001|Overall Study|Withdrawal by Subject|0|||
125173512|NCT00230178|450257192|FG002|Overall Study|Withdrawal by Subject|1|||
125173513|NCT00230178|450257190|FG000|Overall Study|Various other reasons|3|||
125173514|NCT00230178|450257191|FG001|Overall Study|Various other reasons|2|||
125173515|NCT00230178|450257192|FG002|Overall Study|Various other reasons|4|||
125173516|NCT04172597|450257200|FG000|Overall Study|Disease Progression|0|||
125173517|NCT04172597|450257201|FG001|Overall Study|Disease Progression|0|||
125173518|NCT04172597|450257202|FG002|Overall Study|Disease Progression|0|||
125173519|NCT04172597|450257203|FG003|Overall Study|Disease Progression|0|||
125173520|NCT04172597|450257204|FG004|Overall Study|Disease Progression|1|||
125173521|NCT00794339|450257205|FG000|Overall Study|Withdrawal by Subject|3|||
125173522|NCT00794339|450257205|FG000|Overall Study|Ineligible|4|||
125173523|NCT00794339|450257205|FG000|Overall Study|Tx prior to ATSM|3|||
125173524|NCT00794339|450257205|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
125173525|NCT00794339|450257205|FG000|Overall Study|Tx not per protocol|1|||
125173526|NCT01611857|450257206|FG000|Overall Study|Withdrawal by Subject|0|||
125173527|NCT01611857|450257207|FG001|Overall Study|Withdrawal by Subject|2|||
125173528|NCT00616421|450257220|FG000|Overall Study|Withdrawal by Subject|9|||
125173529|NCT00616421|450257221|FG001|Overall Study|Withdrawal by Subject|11|||
125173530|NCT00616421|450257222|FG002|Overall Study|Withdrawal by Subject|8|||
125173531|NCT00616421|450257220|FG000|Overall Study|Lost to Follow-up|12|||
125229976|NCT01149655|450470103|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
125229977|NCT01149655|450470100|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
125173532|NCT00616421|450257221|FG001|Overall Study|Lost to Follow-up|26|||
125173533|NCT00616421|450257222|FG002|Overall Study|Lost to Follow-up|30|||
125229978|NCT01149655|450470101|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
125173534|NCT00616421|450257220|FG000|Overall Study|Inappropriate enrollment|3|||
125173535|NCT00616421|450257221|FG001|Overall Study|Inappropriate enrollment|0|||
125229979|NCT01149655|450470102|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
125229980|NCT01149655|450470103|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
125229981|NCT01149655|450470100|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
125229982|NCT01149655|450470101|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
125229983|NCT01149655|450470102|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
125229984|NCT01149655|450470103|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
125229985|NCT01149655|450470100|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
125229986|NCT01149655|450470101|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
125229987|NCT01149655|450470102|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
125229988|NCT01149655|450470103|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
125229989|NCT01149655|450470100|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
125229990|NCT01149655|450470101|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
125229991|NCT01149655|450470102|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
125229992|NCT01149655|450470103|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
125229993|NCT04030598|450470104|FG000|Overall Study|Voluntary Withdrawal|0|||
125229994|NCT04030598|450470105|FG001|Overall Study|Voluntary Withdrawal|1|||
125229995|NCT04030598|450470106|FG002|Overall Study|Voluntary Withdrawal|0|||
125229996|NCT05079321|450470107|FG000|Overall Study|Withdrawal by Subject|2|||
125229997|NCT05079321|450470108|FG001|Overall Study|Withdrawal by Subject|2|||
125229998|NCT05079321|450470107|FG000|Overall Study|Lost to Follow-up|0|||
125229999|NCT05079321|450470108|FG001|Overall Study|Lost to Follow-up|1|||
125230000|NCT02003144|450470109|FG000|Open Label Maintenance Phase|Other than specified|2|||
125230001|NCT02003144|450470110|FG001|Open Label Maintenance Phase|Other than specified|4|||
125230002|NCT02003144|450470109|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
125230003|NCT02003144|450470110|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
125230004|NCT02003144|450470109|FG000|Open Label Maintenance Phase|Pregnancy|0|||
125230005|NCT02003144|450470110|FG001|Open Label Maintenance Phase|Pregnancy|2|||
125230006|NCT02003144|450470109|FG000|Open Label Maintenance Phase|Physician Decision|1|||
125230007|NCT02003144|450470110|FG001|Open Label Maintenance Phase|Physician Decision|1|||
125230008|NCT02003144|450470109|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
125230009|NCT02003144|450470110|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
125230010|NCT02003144|450470109|FG000|Open Label Maintenance Phase|Adverse Event|2|||
125230011|NCT02003144|450470110|FG001|Open Label Maintenance Phase|Adverse Event|1|||
125230012|NCT01324947|450470111|FG000|Overall Study|Adverse Event|7|||
125230013|NCT01324947|450470111|FG000|Overall Study|Death|10|||
125230014|NCT01324947|450470111|FG000|Overall Study|Other|3|||
125230015|NCT01324947|450470111|FG000|Overall Study|Progressive Disease|50|||
125230016|NCT01324947|450470111|FG000|Overall Study|Withdrawal by Subject|3|||
125230017|NCT01324947|450470111|FG000|Overall Study|1 discontinued before starting drug|1|||
125230018|NCT02873689|450471464|FG000|Overall Study|Lack of Efficacy|1|||
125230019|NCT02873689|450471465|FG001|Overall Study|Lack of Efficacy|0|||
125230020|NCT02873689|450471464|FG000|Overall Study|Withdrawal by Subject|2|||
125230021|NCT02873689|450471465|FG001|Overall Study|Withdrawal by Subject|2|||
125230022|NCT02873689|450471464|FG000|Overall Study|Protocol Violation|1|||
125230023|NCT02873689|450471465|FG001|Overall Study|Protocol Violation|0|||
125230024|NCT02873689|450471464|FG000|Overall Study|Adverse Event|2|||
125230025|NCT02873689|450471465|FG001|Overall Study|Adverse Event|2|||
125230026|NCT02873689|450471464|FG000|Overall Study|Randomized but not Treated|1|||
125230027|NCT02873689|450471465|FG001|Overall Study|Randomized but not Treated|1|||
125230028|NCT00350545|450471466|FG000|Overall Study|Withdrawal by Subject|2|||
125230029|NCT02997163|450471473|FG000|Overall Study|Adverse Event|1|||
125230030|NCT02997163|450471474|FG001|Overall Study|Adverse Event|0|||
125230031|NCT02997163|450471475|FG002|Overall Study|Adverse Event|0|||
125230032|NCT02997163|450471476|FG003|Overall Study|Adverse Event|1|||
125230033|NCT02337764|450471477|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
125230034|NCT02337764|450471477|FG000|Overall Study|Voluntary Withdrawal|12|||
125230035|NCT02337764|450471477|FG000|Overall Study|Lack of Efficacy|2|||
125230036|NCT01855958|450471489|FG000|Overall Study|Withdrawal by Subject|1|||
125230037|NCT01855958|450471490|FG001|Overall Study|Withdrawal by Subject|0|||
125230038|NCT00368251|450471491|FG000|Overall Study|SAE, non-fatal|1|||
125230039|NCT00368251|450471492|FG001|Overall Study|SAE, non-fatal|0|||
125230040|NCT00368251|450471493|FG002|Overall Study|SAE, non-fatal|0|||
125230041|NCT00368251|450471491|FG000|Overall Study|AE, non-serious non-fatal|0|||
125230042|NCT00368251|450471492|FG001|Overall Study|AE, non-serious non-fatal|0|||
125230043|NCT00368251|450471493|FG002|Overall Study|AE, non-serious non-fatal|1|||
125230044|NCT00607893|450471495|FG000|Overall Study|Lost to Follow-up|4|||
125230045|NCT00607893|450471496|FG001|Overall Study|Lost to Follow-up|0|||
125230046|NCT00607893|450471495|FG000|Overall Study|withdrew due to loss of interest|0|||
125230047|NCT00607893|450471496|FG001|Overall Study|withdrew due to loss of interest|1|||
125230048|NCT00607893|450471495|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
125230049|NCT00607893|450471496|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
125230050|NCT00607893|450471495|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
125230051|NCT00607893|450471496|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
125173536|NCT00616421|450257222|FG002|Overall Study|Inappropriate enrollment|1|||
125173537|NCT00616421|450257220|FG000|Overall Study|Administrative reason|1|||
125173538|NCT00616421|450257221|FG001|Overall Study|Administrative reason|0|||
125173539|NCT00616421|450257222|FG002|Overall Study|Administrative reason|0|||
125173540|NCT00616421|450257220|FG000|Overall Study|Protocol Violation|0|||
125173541|NCT00616421|450257221|FG001|Overall Study|Protocol Violation|1|||
125173542|NCT00616421|450257222|FG002|Overall Study|Protocol Violation|2|||
125173543|NCT00616421|450257220|FG000|Overall Study|Unable to classify|1|||
125173544|NCT00616421|450257221|FG001|Overall Study|Unable to classify|0|||
125173545|NCT00616421|450257222|FG002|Overall Study|Unable to classify|0|||
125173546|NCT02481869|450257223|FG000|Overall Study|Lost to Follow-up|3|||
125173547|NCT02481869|450257224|FG001|Overall Study|Lost to Follow-up|4|||
125173548|NCT02481869|450257223|FG000|Overall Study|Withdrawal by Subject|2|||
125173549|NCT02481869|450257224|FG001|Overall Study|Withdrawal by Subject|0|||
125173550|NCT00711880|450257225|FG000|Overall Study|Adverse Event|11|||
125173551|NCT00711880|450257226|FG001|Overall Study|Adverse Event|2|||
125173552|NCT00711880|450257225|FG000|Overall Study|Patient non-compliance|1|||
125173553|NCT00711880|450257226|FG001|Overall Study|Patient non-compliance|0|||
125173554|NCT00711880|450257225|FG000|Overall Study|Lack of Efficacy|1|||
125173555|NCT00711880|450257226|FG001|Overall Study|Lack of Efficacy|5|||
125173556|NCT03908437|450257229|FG000|Overall Study|Death|0|||
125173557|NCT03908437|450257230|FG001|Overall Study|Death|1|||
125173558|NCT03908437|450257229|FG000|Overall Study|Lost to Follow-up|31|||
125173559|NCT03908437|450257230|FG001|Overall Study|Lost to Follow-up|24|||
125173560|NCT02370238|450257231|FG000|Overall Study|Death|42|||
125173561|NCT02370238|450257232|FG001|Overall Study|Death|35|||
125173562|NCT02370238|450257231|FG000|Overall Study|Lost to Follow-up|1|||
125173563|NCT02370238|450257232|FG001|Overall Study|Lost to Follow-up|3|||
125173564|NCT02370238|450257231|FG000|Overall Study|Withdrawal by Subject|2|||
125173565|NCT02370238|450257232|FG001|Overall Study|Withdrawal by Subject|6|||
125173566|NCT02370238|450257231|FG000|Overall Study|Other|2|||
125173567|NCT02370238|450257232|FG001|Overall Study|Other|1|||
125173568|NCT04342819|450257235|FG000|Overall Study|Declined|4|||
125173569|NCT04342819|450257235|FG000|Overall Study|Not meeeting selection criteria|1|||
125173570|NCT01569295|450257236|FG000|Overall Study|Progressive Disease|75|||
125173571|NCT01569295|450257237|FG001|Overall Study|Progressive Disease|139|||
125173572|NCT01569295|450257236|FG000|Overall Study|Adverse Event|39|||
125173573|NCT01569295|450257237|FG001|Overall Study|Adverse Event|14|||
125173574|NCT01569295|450257236|FG000|Overall Study|Withdrawal by Subject|25|||
125173575|NCT01569295|450257237|FG001|Overall Study|Withdrawal by Subject|12|||
125173576|NCT01569295|450257236|FG000|Overall Study|Death|19|||
125173577|NCT01569295|450257237|FG001|Overall Study|Death|15|||
125173578|NCT01569295|450257236|FG000|Overall Study|Physician Decision|13|||
125173579|NCT01569295|450257237|FG001|Overall Study|Physician Decision|18|||
125173580|NCT01569295|450257236|FG000|Overall Study|Study Terminated by Sponsor|24|||
125173581|NCT01569295|450257237|FG001|Overall Study|Study Terminated by Sponsor|2|||
125173582|NCT01569295|450257236|FG000|Overall Study|Other Reason not Specified|3|||
125173583|NCT01569295|450257237|FG001|Overall Study|Other Reason not Specified|5|||
125173584|NCT01569295|450257236|FG000|Overall Study|Non-Compliance with Study Drug|6|||
125173585|NCT01569295|450257237|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125173586|NCT01569295|450257236|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
125173587|NCT01569295|450257237|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
125173588|NCT01569295|450257236|FG000|Overall Study|Lost to Follow-up|1|||
125173589|NCT01569295|450257237|FG001|Overall Study|Lost to Follow-up|1|||
125173590|NCT03597295|450257238|FG000|Overall Study|Death|70|||
125173591|NCT03597295|450257238|FG000|Overall Study|Lost to Follow-up|7|||
125173592|NCT00879411|450257239|FG000|Overall Study|lost to follow-up (non-AE)|162|||
125173593|NCT01884337|450257240|FG000|Treatment|Adverse Event|2|||
125173594|NCT01884337|450257241|FG001|Treatment|Adverse Event|2|||
125173595|NCT01884337|450257240|FG000|Treatment|Subj. request to discont. treatment|2|||
125173596|NCT01884337|450257241|FG001|Treatment|Subj. request to discont. treatment|0|||
125173597|NCT01884337|450257240|FG000|Follow-up Period|Lost to Follow-up|1|||
125173598|NCT01884337|450257241|FG001|Follow-up Period|Lost to Follow-up|1|||
125173599|NCT02455518|450257242|FG000|Overall Study|Protocol Violation|0|||
125173600|NCT02455518|450257243|FG001|Overall Study|Protocol Violation|1|||
125173601|NCT02455518|450257244|FG002|Overall Study|Protocol Violation|1|||
125173602|NCT02455518|450257245|FG003|Overall Study|Protocol Violation|3|||
125173603|NCT00428116|450257246|FG000|Overall Study|Death|1|||
125173604|NCT00428116|450257247|FG001|Overall Study|Death|0|||
125173605|NCT00428116|450257246|FG000|Overall Study|Withdrawal by Subject|1|||
125173606|NCT00428116|450257247|FG001|Overall Study|Withdrawal by Subject|0|||
125173607|NCT00428116|450257246|FG000|Overall Study|Lost to Follow-up|1|||
125173608|NCT00428116|450257247|FG001|Overall Study|Lost to Follow-up|0|||
125173609|NCT01038297|450257248|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
125173610|NCT01038297|450257249|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
125173611|NCT01038297|450257250|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
125173612|NCT02508935|450257251|FG000|Overall Study|Withdrawal by Subject|1|||
125173613|NCT02508935|450257251|FG000|Overall Study|Withdrawal by Caregiver|8|||
125173614|NCT02508935|450257251|FG000|Overall Study|Pain Score <4|1|||
125173615|NCT02508935|450257251|FG000|Overall Study|Emesis|3|||
125173616|NCT02508935|450257251|FG000|Overall Study|Adverse Event|3|||
125173617|NCT02508935|450257251|FG000|Overall Study|Protocol Violation|1|||
125173618|NCT02508935|450257251|FG000|Overall Study|Physician Decision|1|||
125173619|NCT02508935|450257251|FG000|Overall Study|Trial terminated by sponsor|5|||
125173620|NCT02125877|450257252|FG000|Overall Study|Physician Decision|1|||
125173621|NCT02125877|450257253|FG001|Overall Study|Physician Decision|0|||
125173622|NCT02125877|450257252|FG000|Overall Study|Death|0|||
125173623|NCT02125877|450257253|FG001|Overall Study|Death|1|||
125173624|NCT02125877|450257252|FG000|Overall Study|Administrative problems|0|||
125173625|NCT02125877|450257253|FG001|Overall Study|Administrative problems|1|||
125173626|NCT02125877|450257252|FG000|Overall Study|Participant/guardian decision|0|||
125173627|NCT02125877|450257253|FG001|Overall Study|Participant/guardian decision|2|||
125173628|NCT02125877|450257252|FG000|Overall Study|Withdrawal by Subject|2|||
125173629|NCT02125877|450257253|FG001|Overall Study|Withdrawal by Subject|1|||
125173630|NCT02125877|450257252|FG000|Overall Study|Protocol deviation|4|||
125173631|NCT02125877|450257253|FG001|Overall Study|Protocol deviation|1|||
125173632|NCT02125877|450257252|FG000|Overall Study|Adverse Event|6|||
125173633|NCT02125877|450257253|FG001|Overall Study|Adverse Event|4|||
125173634|NCT01973595|450257254|FG000|Washout|Withdrawal by Subject|1|||
125173635|NCT01973595|450257255|FG001|Washout|Withdrawal by Subject|0|||
125173636|NCT01973595|450257256|FG002|Washout|Withdrawal by Subject|1|||
125173637|NCT01973595|450257257|FG003|Washout|Withdrawal by Subject|0|||
125173638|NCT01210612|450257268|FG000|Overall Study|Withdrawal by Subject|0|||
125173639|NCT01210612|450257269|FG001|Overall Study|Withdrawal by Subject|2|||
125173640|NCT00710866|450257272|FG000|Overall Study|Protocol Violation|5|||
125173641|NCT00710866|450257273|FG001|Overall Study|Protocol Violation|4|||
125173642|NCT00710866|450257272|FG000|Overall Study|Withdrawal by Subject|2|||
125173643|NCT00710866|450257273|FG001|Overall Study|Withdrawal by Subject|1|||
125173644|NCT00710866|450257272|FG000|Overall Study|Lost to Follow-up|1|||
125173645|NCT00710866|450257273|FG001|Overall Study|Lost to Follow-up|0|||
125173646|NCT00710866|450257272|FG000|Overall Study|Failed to meet eligibility|1|||
125173647|NCT00710866|450257273|FG001|Overall Study|Failed to meet eligibility|1|||
125173648|NCT00086281|450257274|FG000|Phase 1|Adverse Event|0|||
125173649|NCT00086281|450257275|FG001|Phase 1|Adverse Event|0|||
125173650|NCT00086281|450257276|FG002|Phase 1|Adverse Event|0|||
125173651|NCT00086281|450257277|FG003|Phase 1|Adverse Event|0|||
125173652|NCT00086281|450257278|FG004|Phase 1|Adverse Event|0|||
125173653|NCT00086281|450257279|FG005|Phase 1|Adverse Event|0|||
125173654|NCT00086281|450257280|FG006|Phase 1|Adverse Event|0|||
125173655|NCT00086281|450257281|FG007|Phase 1|Adverse Event|0|||
125173656|NCT00086281|450257282|FG008|Phase 1|Adverse Event|0|||
125173657|NCT00086281|450257283|FG009|Phase 1|Adverse Event|1|||
125173658|NCT00086281|450257284|FG010|Phase 1|Adverse Event|2|||
125173659|NCT00086281|450257285|FG011|Phase 1|Adverse Event|1|||
125173660|NCT00086281|450257286|FG012|Phase 1|Adverse Event|1|||
125173661|NCT00086281|450257287|FG013|Phase 1|Adverse Event|1|||
125173662|NCT00086281|450257288|FG014|Phase 1|Adverse Event|2|||
125173663|NCT00086281|450257274|FG000|Phase 1|Protocol Violation|0|||
125173664|NCT00086281|450257275|FG001|Phase 1|Protocol Violation|0|||
125173665|NCT00086281|450257276|FG002|Phase 1|Protocol Violation|0|||
125173666|NCT00086281|450257277|FG003|Phase 1|Protocol Violation|0|||
125173667|NCT00086281|450257278|FG004|Phase 1|Protocol Violation|0|||
125173668|NCT00086281|450257279|FG005|Phase 1|Protocol Violation|0|||
125173669|NCT00086281|450257280|FG006|Phase 1|Protocol Violation|0|||
125173670|NCT00086281|450257281|FG007|Phase 1|Protocol Violation|0|||
125173671|NCT00086281|450257282|FG008|Phase 1|Protocol Violation|0|||
125173672|NCT00086281|450257283|FG009|Phase 1|Protocol Violation|0|||
125173673|NCT00086281|450257284|FG010|Phase 1|Protocol Violation|1|||
125173674|NCT00086281|450257285|FG011|Phase 1|Protocol Violation|0|||
125173675|NCT00086281|450257286|FG012|Phase 1|Protocol Violation|0|||
125173676|NCT00086281|450257287|FG013|Phase 1|Protocol Violation|0|||
125173677|NCT00086281|450257288|FG014|Phase 1|Protocol Violation|0|||
125173678|NCT00086281|450257274|FG000|Phase 1|Serious Adverse Event|0|||
125173679|NCT00086281|450257275|FG001|Phase 1|Serious Adverse Event|0|||
125173680|NCT00086281|450257276|FG002|Phase 1|Serious Adverse Event|0|||
125173681|NCT00086281|450257277|FG003|Phase 1|Serious Adverse Event|0|||
125173682|NCT00086281|450257278|FG004|Phase 1|Serious Adverse Event|0|||
125173683|NCT00086281|450257279|FG005|Phase 1|Serious Adverse Event|0|||
125173684|NCT00086281|450257280|FG006|Phase 1|Serious Adverse Event|0|||
125173685|NCT00086281|450257281|FG007|Phase 1|Serious Adverse Event|0|||
125173686|NCT00086281|450257282|FG008|Phase 1|Serious Adverse Event|0|||
125173687|NCT00086281|450257283|FG009|Phase 1|Serious Adverse Event|0|||
125173688|NCT00086281|450257284|FG010|Phase 1|Serious Adverse Event|0|||
125173689|NCT00086281|450257285|FG011|Phase 1|Serious Adverse Event|0|||
125173690|NCT00086281|450257286|FG012|Phase 1|Serious Adverse Event|0|||
125173691|NCT00086281|450257287|FG013|Phase 1|Serious Adverse Event|0|||
125173692|NCT00086281|450257288|FG014|Phase 1|Serious Adverse Event|1|||
125173693|NCT00086281|450257274|FG000|Phase 2|Adverse Event|0|||
125173694|NCT00086281|450257275|FG001|Phase 2|Adverse Event|0|||
125173695|NCT00086281|450257276|FG002|Phase 2|Adverse Event|0|||
125230052|NCT00607893|450471495|FG000|Overall Study|Declined to be treated|1|||
125230053|NCT00607893|450471496|FG001|Overall Study|Declined to be treated|0|||
125230054|NCT00607893|450471495|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
125230055|NCT00607893|450471496|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
125230056|NCT02669849|450471497|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
125230057|NCT02669849|450471498|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
125230058|NCT02669849|450471499|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
125230059|NCT02669849|450471497|FG000|Overall Study|Lost to Follow-up|1|||
125230060|NCT02669849|450471498|FG001|Overall Study|Lost to Follow-up|0|||
125230061|NCT02669849|450471499|FG002|Overall Study|Lost to Follow-up|3|||
125230062|NCT02669849|450471497|FG000|Overall Study|Death|1|||
125230063|NCT02669849|450471498|FG001|Overall Study|Death|1|||
125230064|NCT02669849|450471499|FG002|Overall Study|Death|2|||
125230065|NCT02669849|450471497|FG000|Overall Study|Study terminated by sponsor|16|||
125230066|NCT02669849|450471498|FG001|Overall Study|Study terminated by sponsor|1|||
125230067|NCT02669849|450471499|FG002|Overall Study|Study terminated by sponsor|14|||
125230068|NCT02669849|450471497|FG000|Overall Study|Other|0|||
125230069|NCT02669849|450471498|FG001|Overall Study|Other|0|||
125230070|NCT02669849|450471499|FG002|Overall Study|Other|2|||
125230071|NCT04745351|450471502|FG000|Overall Study|Death|51|||
125230072|NCT04745351|450471503|FG001|Overall Study|Death|25|||
125230073|NCT04745351|450471502|FG000|Overall Study|Lost to Follow-up|9|||
125230074|NCT04745351|450471503|FG001|Overall Study|Lost to Follow-up|3|||
125230075|NCT04745351|450471502|FG000|Overall Study|Randomized but Never Treated|3|||
125230076|NCT04745351|450471503|FG001|Overall Study|Randomized but Never Treated|3|||
125230077|NCT04745351|450471502|FG000|Overall Study|Adverse Event|4|||
125230078|NCT04745351|450471503|FG001|Overall Study|Adverse Event|0|||
125230079|NCT04745351|450471502|FG000|Overall Study|Withdrew Consent|1|||
125230080|NCT04745351|450471503|FG001|Overall Study|Withdrew Consent|2|||
125230081|NCT04745351|450471502|FG000|Overall Study|Investigator's Discretion|2|||
125230082|NCT04745351|450471503|FG001|Overall Study|Investigator's Discretion|0|||
125230083|NCT04745351|450471502|FG000|Overall Study|Protocol Violation|1|||
125230084|NCT04745351|450471503|FG001|Overall Study|Protocol Violation|0|||
125230085|NCT03499795|450471509|FG000|Overall Study|Adverse Event|1|||
125230086|NCT03499795|450471509|FG000|Overall Study|Lost to Follow-up|1|||
125230087|NCT03636256|450471512|FG000|Overall Study|Lost to Follow-up|3|||
125230088|NCT03636256|450471513|FG001|Overall Study|Lost to Follow-up|0|||
125230089|NCT03636256|450471514|FG002|Overall Study|Lost to Follow-up|2|||
125230090|NCT03636256|450471515|FG003|Overall Study|Lost to Follow-up|1|||
125230091|NCT03636256|450471516|FG004|Overall Study|Lost to Follow-up|0|||
125230092|NCT03636256|450471517|FG005|Overall Study|Lost to Follow-up|4|||
125230093|NCT03636256|450471518|FG006|Overall Study|Lost to Follow-up|2|||
125230094|NCT03636256|450471519|FG007|Overall Study|Lost to Follow-up|0|||
125230095|NCT03636256|450471520|FG008|Overall Study|Lost to Follow-up|4|||
125230096|NCT03636256|450471512|FG000|Overall Study|Withdrawal by Subject|0|||
125230097|NCT03636256|450471513|FG001|Overall Study|Withdrawal by Subject|0|||
125230098|NCT03636256|450471514|FG002|Overall Study|Withdrawal by Subject|0|||
125230099|NCT03636256|450471515|FG003|Overall Study|Withdrawal by Subject|0|||
125230100|NCT03636256|450471516|FG004|Overall Study|Withdrawal by Subject|0|||
125230101|NCT03636256|450471517|FG005|Overall Study|Withdrawal by Subject|0|||
125230102|NCT03636256|450471518|FG006|Overall Study|Withdrawal by Subject|0|||
125230103|NCT03636256|450471519|FG007|Overall Study|Withdrawal by Subject|0|||
125230104|NCT03636256|450471520|FG008|Overall Study|Withdrawal by Subject|1|||
125230105|NCT01516216|450471523|FG000|Overall Study|Adverse Event|2|||
125230106|NCT01516216|450471524|FG001|Overall Study|Adverse Event|4|||
125230107|NCT01516216|450471523|FG000|Overall Study|Disease Progression|38|||
125230108|NCT01516216|450471524|FG001|Overall Study|Disease Progression|34|||
125230109|NCT01516216|450471523|FG000|Overall Study|Withdrawal by Subject|9|||
125230110|NCT01516216|450471524|FG001|Overall Study|Withdrawal by Subject|11|||
125230111|NCT01516216|450471523|FG000|Overall Study|Potentially Curative Resection|6|||
125230112|NCT01516216|450471524|FG001|Overall Study|Potentially Curative Resection|12|||
125230113|NCT01516216|450471523|FG000|Overall Study|Nonadherence|2|||
125230114|NCT01516216|450471524|FG001|Overall Study|Nonadherence|3|||
125230115|NCT01516216|450471523|FG000|Overall Study|Physician Decision|6|||
125230116|NCT01516216|450471524|FG001|Overall Study|Physician Decision|3|||
125230117|NCT01516216|450471523|FG000|Overall Study|Prolonged Treatment Delay|5|||
125230118|NCT01516216|450471524|FG001|Overall Study|Prolonged Treatment Delay|1|||
125230119|NCT01516216|450471523|FG000|Overall Study|Intercurrent Illness|1|||
125230120|NCT01516216|450471524|FG001|Overall Study|Intercurrent Illness|0|||
125230121|NCT01516216|450471523|FG000|Overall Study|Death|1|||
125230122|NCT01516216|450471524|FG001|Overall Study|Death|1|||
125230123|NCT01603602|450471527|FG000|Overall Study|Adverse Event|1|||
125230124|NCT01603602|450471528|FG001|Overall Study|Adverse Event|0|||
125230125|NCT01603602|450471529|FG002|Overall Study|Adverse Event|0|||
125230126|NCT01603602|450471527|FG000|Overall Study|Personal Reasons|1|||
125230127|NCT01603602|450471528|FG001|Overall Study|Personal Reasons|0|||
125230128|NCT01603602|450471529|FG002|Overall Study|Personal Reasons|1|||
125230129|NCT04748718|450471533|FG000|Overall Study|Lost to Follow-up|50|||
125230130|NCT01935089|450471534|FG000|Overall Study|Adverse Event|2|||
125230131|NCT01935089|450471534|FG000|Overall Study|Withdrawal by Subject|1|||
125230132|NCT00723229|450471535|FG000|First Intervention|Lost to Follow-up|7|||
125230133|NCT00723229|450471536|FG001|First Intervention|Lost to Follow-up|3|||
125230134|NCT02337491|450471537|FG000|Overall Study|Death|1|||
125230135|NCT02337491|450471538|FG001|Overall Study|Death|1|||
125230136|NCT02337491|450471537|FG000|Overall Study|Adverse Event|0|||
125230137|NCT02337491|450471538|FG001|Overall Study|Adverse Event|1|||
125230138|NCT02337491|450471537|FG000|Overall Study|Withdrawal by Subject|3|||
125230139|NCT02337491|450471538|FG001|Overall Study|Withdrawal by Subject|0|||
125230140|NCT02337491|450471537|FG000|Overall Study|Progressive Disease|44|||
125230141|NCT02337491|450471538|FG001|Overall Study|Progressive Disease|28|||
125230142|NCT02337491|450471537|FG000|Overall Study|On Treatment|2|||
125230143|NCT02337491|450471538|FG001|Overall Study|On Treatment|0|||
125230144|NCT03530293|450471543|FG000|Pre-randomization|Adverse Event|12|||
125230145|NCT03530293|450471544|FG001|Pre-randomization|Adverse Event|0|||
125230146|NCT03530293|450471545|FG002|Pre-randomization|Adverse Event|0|||
125230147|NCT03530293|450471543|FG000|Pre-randomization|Protocol Violation|2|||
125230148|NCT03530293|450471544|FG001|Pre-randomization|Protocol Violation|0|||
125230149|NCT03530293|450471545|FG002|Pre-randomization|Protocol Violation|0|||
125230150|NCT03530293|450471543|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
125230151|NCT03530293|450471544|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
125230152|NCT03530293|450471545|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
125230153|NCT03530293|450471543|FG000|Pre-randomization|Withdrawal by Subject|5|||
125230154|NCT03530293|450471544|FG001|Pre-randomization|Withdrawal by Subject|0|||
125230155|NCT03530293|450471545|FG002|Pre-randomization|Withdrawal by Subject|0|||
125230156|NCT03530293|450471543|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
125230157|NCT03530293|450471544|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
125230158|NCT03530293|450471545|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
125230159|NCT03530293|450471543|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
125230160|NCT03530293|450471544|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
125230161|NCT03530293|450471545|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
125230162|NCT03530293|450471543|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
125230163|NCT03530293|450471544|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
125230164|NCT03530293|450471545|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
125230165|NCT03530293|450471543|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
125230166|NCT03530293|450471544|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
125230167|NCT03530293|450471545|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
125230168|NCT03530293|450471543|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
125230169|NCT03530293|450471544|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
125230170|NCT03530293|450471545|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
125230171|NCT01668797|450471546|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
125230172|NCT01668797|450471547|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
125230173|NCT01668797|450471548|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
125230174|NCT01668797|450471549|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
125230175|NCT01668797|450471546|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
125230176|NCT01668797|450471547|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
125230177|NCT01668797|450471548|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
125230178|NCT01668797|450471549|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
125230179|NCT01668797|450471546|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
125230180|NCT01668797|450471547|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
125230181|NCT01668797|450471548|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
125230182|NCT01668797|450471549|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
125230183|NCT01668797|450471546|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
125230184|NCT01668797|450471547|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
125230185|NCT01668797|450471548|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
125230186|NCT01668797|450471549|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
125230187|NCT01668797|450471546|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
125173696|NCT00086281|450257277|FG003|Phase 2|Adverse Event|0|||
125173697|NCT00086281|450257278|FG004|Phase 2|Adverse Event|0|||
125173698|NCT00086281|450257279|FG005|Phase 2|Adverse Event|0|||
125173699|NCT00086281|450257280|FG006|Phase 2|Adverse Event|0|||
125173700|NCT00086281|450257281|FG007|Phase 2|Adverse Event|0|||
125173701|NCT00086281|450257282|FG008|Phase 2|Adverse Event|0|||
125173702|NCT00086281|450257283|FG009|Phase 2|Adverse Event|0|||
125173703|NCT00086281|450257284|FG010|Phase 2|Adverse Event|0|||
125173704|NCT00086281|450257285|FG011|Phase 2|Adverse Event|0|||
125173705|NCT00086281|450257286|FG012|Phase 2|Adverse Event|1|||
125173706|NCT00086281|450257287|FG013|Phase 2|Adverse Event|1|||
125173707|NCT00086281|450257288|FG014|Phase 2|Adverse Event|0|||
125173708|NCT03071276|450257290|FG000|Overall Study|Adverse Event|1|||
125173709|NCT03071276|450257290|FG000|Overall Study|Lack of Efficacy|14|||
125173710|NCT03390426|450257291|FG000|Overall Study|Protocol Violation|0|||
125173711|NCT03390426|450257292|FG001|Overall Study|Protocol Violation|1|||
125173712|NCT02516553|450257297|FG000|Overall Study|Progressive disease|2|||
125173713|NCT02516553|450257298|FG001|Overall Study|Progressive disease|2|||
125173714|NCT02516553|450257299|FG002|Overall Study|Progressive disease|3|||
125173715|NCT02516553|450257300|FG003|Overall Study|Progressive disease|5|||
125173716|NCT02516553|450257301|FG004|Overall Study|Progressive disease|3|||
125173717|NCT02516553|450257302|FG005|Overall Study|Progressive disease|0|||
125173718|NCT02516553|450257303|FG006|Overall Study|Progressive disease|5|||
125173719|NCT02516553|450257304|FG007|Overall Study|Progressive disease|5|||
125173720|NCT02516553|450257305|FG008|Overall Study|Progressive disease|11|||
125173721|NCT02516553|450257306|FG009|Overall Study|Progressive disease|3|||
125173722|NCT02516553|450257307|FG010|Overall Study|Progressive disease|10|||
125173723|NCT02516553|450257308|FG011|Overall Study|Progressive disease|8|||
125173724|NCT02516553|450257309|FG012|Overall Study|Progressive disease|8|||
125173725|NCT02516553|450257310|FG013|Overall Study|Progressive disease|2|||
125173726|NCT02516553|450257311|FG014|Overall Study|Progressive disease|2|||
125173727|NCT02516553|450257312|FG015|Overall Study|Progressive disease|2|||
125173728|NCT02516553|450257313|FG016|Overall Study|Progressive disease|1|||
125173729|NCT02516553|450257314|FG017|Overall Study|Progressive disease|9|||
125173730|NCT02516553|450257315|FG018|Overall Study|Progressive disease|12|||
125173731|NCT02516553|450257316|FG019|Overall Study|Progressive disease|7|||
125173732|NCT02516553|450257317|FG020|Overall Study|Progressive disease|16|||
125173733|NCT02516553|450257318|FG021|Overall Study|Progressive disease|18|||
125173734|NCT02516553|450257297|FG000|Overall Study|Dose limiting toxicity|0|||
125230188|NCT01668797|450471547|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
125230189|NCT01668797|450471548|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
125230190|NCT01668797|450471549|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
125230191|NCT01668797|450471546|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
125230192|NCT01668797|450471547|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
125230193|NCT01668797|450471548|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
125230194|NCT01668797|450471549|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
125230195|NCT01668797|450471546|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
125230196|NCT01668797|450471547|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
125230197|NCT01668797|450471548|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
125230198|NCT01668797|450471549|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
125230199|NCT01668797|450471546|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
125230200|NCT01668797|450471547|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
125230201|NCT01668797|450471548|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
125173735|NCT02516553|450257298|FG001|Overall Study|Dose limiting toxicity|0|||
125173736|NCT02516553|450257299|FG002|Overall Study|Dose limiting toxicity|0|||
125173737|NCT02516553|450257300|FG003|Overall Study|Dose limiting toxicity|0|||
125173738|NCT02516553|450257301|FG004|Overall Study|Dose limiting toxicity|3|||
125173739|NCT02516553|450257302|FG005|Overall Study|Dose limiting toxicity|1|||
125173740|NCT02516553|450257303|FG006|Overall Study|Dose limiting toxicity|1|||
125173741|NCT02516553|450257304|FG007|Overall Study|Dose limiting toxicity|0|||
125173742|NCT02516553|450257305|FG008|Overall Study|Dose limiting toxicity|1|||
125230202|NCT01668797|450471549|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
125230203|NCT01668797|450471546|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
125173743|NCT02516553|450257306|FG009|Overall Study|Dose limiting toxicity|0|||
125173744|NCT02516553|450257307|FG010|Overall Study|Dose limiting toxicity|0|||
125173745|NCT02516553|450257308|FG011|Overall Study|Dose limiting toxicity|1|||
125173746|NCT02516553|450257309|FG012|Overall Study|Dose limiting toxicity|0|||
125173747|NCT02516553|450257310|FG013|Overall Study|Dose limiting toxicity|1|||
125173748|NCT02516553|450257311|FG014|Overall Study|Dose limiting toxicity|0|||
125173749|NCT02516553|450257312|FG015|Overall Study|Dose limiting toxicity|0|||
125173750|NCT02516553|450257313|FG016|Overall Study|Dose limiting toxicity|1|||
125173751|NCT02516553|450257314|FG017|Overall Study|Dose limiting toxicity|1|||
125173752|NCT02516553|450257315|FG018|Overall Study|Dose limiting toxicity|0|||
125173753|NCT02516553|450257316|FG019|Overall Study|Dose limiting toxicity|2|||
125173754|NCT02516553|450257317|FG020|Overall Study|Dose limiting toxicity|0|||
125173755|NCT02516553|450257318|FG021|Overall Study|Dose limiting toxicity|0|||
125173756|NCT02516553|450257297|FG000|Overall Study|Other Adverse Events|0|||
125173757|NCT02516553|450257298|FG001|Overall Study|Other Adverse Events|0|||
125173758|NCT02516553|450257299|FG002|Overall Study|Other Adverse Events|0|||
125173759|NCT02516553|450257300|FG003|Overall Study|Other Adverse Events|1|||
125173760|NCT02516553|450257301|FG004|Overall Study|Other Adverse Events|0|||
125173761|NCT02516553|450257302|FG005|Overall Study|Other Adverse Events|1|||
125173762|NCT02516553|450257303|FG006|Overall Study|Other Adverse Events|0|||
125173763|NCT02516553|450257304|FG007|Overall Study|Other Adverse Events|0|||
125173764|NCT02516553|450257305|FG008|Overall Study|Other Adverse Events|0|||
125173765|NCT02516553|450257306|FG009|Overall Study|Other Adverse Events|1|||
125173766|NCT02516553|450257307|FG010|Overall Study|Other Adverse Events|3|||
125173767|NCT02516553|450257308|FG011|Overall Study|Other Adverse Events|2|||
125173768|NCT02516553|450257309|FG012|Overall Study|Other Adverse Events|0|||
125173769|NCT02516553|450257310|FG013|Overall Study|Other Adverse Events|1|||
125173770|NCT02516553|450257311|FG014|Overall Study|Other Adverse Events|0|||
125173771|NCT02516553|450257312|FG015|Overall Study|Other Adverse Events|0|||
125173772|NCT02516553|450257313|FG016|Overall Study|Other Adverse Events|0|||
125173773|NCT02516553|450257314|FG017|Overall Study|Other Adverse Events|2|||
125173774|NCT02516553|450257315|FG018|Overall Study|Other Adverse Events|1|||
125230204|NCT01668797|450471547|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
125230205|NCT01668797|450471548|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
125230206|NCT01668797|450471549|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
125230207|NCT01668797|450471546|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
125230208|NCT01668797|450471547|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
125230209|NCT01668797|450471548|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
125230210|NCT01668797|450471549|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
125230211|NCT01668797|450471546|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
125230212|NCT01668797|450471547|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
125230213|NCT01668797|450471548|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
125230214|NCT01668797|450471549|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
125230215|NCT01668797|450471546|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
125230216|NCT01668797|450471547|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
125230217|NCT01668797|450471548|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
125230218|NCT01668797|450471549|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
125230219|NCT01668797|450471546|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
125230220|NCT01668797|450471547|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
125230221|NCT01668797|450471548|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
125230222|NCT01668797|450471549|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
125230223|NCT01668797|450471546|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
125230224|NCT01668797|450471547|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
125230225|NCT01668797|450471548|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
125230226|NCT01668797|450471549|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
125230227|NCT01668797|450471546|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
125230228|NCT01668797|450471547|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
125230229|NCT01668797|450471548|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
125230230|NCT01668797|450471549|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
125230231|NCT01668797|450471546|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
125230232|NCT01668797|450471547|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
125230233|NCT01668797|450471548|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
125230234|NCT01668797|450471549|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
125230235|NCT01668797|450471546|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
125230236|NCT01668797|450471547|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
125230237|NCT01668797|450471548|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
125230238|NCT01668797|450471549|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
125230239|NCT01668797|450471546|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
125230240|NCT01668797|450471547|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
125230241|NCT01668797|450471548|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
125173775|NCT02516553|450257316|FG019|Overall Study|Other Adverse Events|2|||
125173776|NCT02516553|450257317|FG020|Overall Study|Other Adverse Events|2|||
125173777|NCT02516553|450257318|FG021|Overall Study|Other Adverse Events|1|||
125173778|NCT02516553|450257297|FG000|Overall Study|Refused to continue trial medication|0|||
125173779|NCT02516553|450257298|FG001|Overall Study|Refused to continue trial medication|0|||
125173780|NCT02516553|450257299|FG002|Overall Study|Refused to continue trial medication|0|||
125173781|NCT02516553|450257300|FG003|Overall Study|Refused to continue trial medication|0|||
125173782|NCT02516553|450257301|FG004|Overall Study|Refused to continue trial medication|0|||
125173783|NCT02516553|450257302|FG005|Overall Study|Refused to continue trial medication|0|||
125173784|NCT02516553|450257303|FG006|Overall Study|Refused to continue trial medication|0|||
125173785|NCT02516553|450257304|FG007|Overall Study|Refused to continue trial medication|0|||
125173786|NCT02516553|450257305|FG008|Overall Study|Refused to continue trial medication|0|||
125173787|NCT02516553|450257306|FG009|Overall Study|Refused to continue trial medication|0|||
125173788|NCT02516553|450257307|FG010|Overall Study|Refused to continue trial medication|1|||
125173789|NCT02516553|450257308|FG011|Overall Study|Refused to continue trial medication|0|||
125173790|NCT02516553|450257309|FG012|Overall Study|Refused to continue trial medication|0|||
125173791|NCT02516553|450257310|FG013|Overall Study|Refused to continue trial medication|0|||
125173792|NCT02516553|450257311|FG014|Overall Study|Refused to continue trial medication|0|||
125173793|NCT02516553|450257312|FG015|Overall Study|Refused to continue trial medication|0|||
125173794|NCT02516553|450257313|FG016|Overall Study|Refused to continue trial medication|0|||
125173795|NCT02516553|450257314|FG017|Overall Study|Refused to continue trial medication|0|||
125173796|NCT02516553|450257315|FG018|Overall Study|Refused to continue trial medication|1|||
125230242|NCT01668797|450471549|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
125230243|NCT01668797|450471546|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
125230244|NCT01668797|450471547|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
125230245|NCT01668797|450471548|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
125230246|NCT01668797|450471549|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
125230247|NCT01668797|450471546|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
125230248|NCT01668797|450471547|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
125230249|NCT01668797|450471548|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
125230250|NCT01668797|450471549|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
125230251|NCT01668797|450471546|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
125230252|NCT01668797|450471547|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
125230253|NCT01668797|450471548|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
125230254|NCT01668797|450471549|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
125230255|NCT01668797|450471546|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
125230256|NCT01668797|450471547|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
125230257|NCT01668797|450471548|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
125230258|NCT01668797|450471549|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
125230259|NCT01668797|450471546|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
125230260|NCT01668797|450471547|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
125230261|NCT01668797|450471548|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
125230262|NCT01668797|450471549|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
125230263|NCT01668797|450471546|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
125230264|NCT01668797|450471547|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
125230265|NCT01668797|450471548|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
125230266|NCT01668797|450471549|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
125230267|NCT01668797|450471546|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
125230268|NCT01668797|450471547|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
125230269|NCT01668797|450471548|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
125230270|NCT01668797|450471549|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
125230271|NCT02530385|450471550|FG000|Overall Study|Withdrawal by Subject|0|||
125230272|NCT02530385|450471551|FG001|Overall Study|Withdrawal by Subject|1|||
125230273|NCT01569022|450471553|FG000|First Intervention|Lost to Follow-up|2|||
125230274|NCT01569022|450471554|FG001|First Intervention|Lost to Follow-up|1|||
125230275|NCT01569022|450471553|FG000|Second Intervention|Lost to Follow-up|2|||
125230276|NCT01569022|450471554|FG001|Second Intervention|Lost to Follow-up|2|||
125230277|NCT00433836|450471559|FG000|Overall Study|Adverse Event|7|||
125230278|NCT00433836|450471560|FG001|Overall Study|Adverse Event|0|||
125230279|NCT00433836|450471559|FG000|Overall Study|Lost to Follow-up|3|||
125230280|NCT00433836|450471560|FG001|Overall Study|Lost to Follow-up|0|||
125230281|NCT00433836|450471559|FG000|Overall Study|Withdrawal by Subject|2|||
125230282|NCT00433836|450471560|FG001|Overall Study|Withdrawal by Subject|1|||
125230283|NCT00433836|450471559|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125230284|NCT00433836|450471560|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125230285|NCT00433836|450471559|FG000|Overall Study|Protocol Violation|0|||
125230286|NCT00433836|450471560|FG001|Overall Study|Protocol Violation|2|||
125230287|NCT00433836|450471559|FG000|Overall Study|Condition no longer requires study drug|0|||
125230288|NCT00433836|450471560|FG001|Overall Study|Condition no longer requires study drug|1|||
125230289|NCT00433836|450471559|FG000|Overall Study|Abnormal laboratory values|0|||
125230290|NCT00433836|450471560|FG001|Overall Study|Abnormal laboratory values|1|||
125230291|NCT02446691|450471561|FG000|Overall Study|Withdrawal by Subject|2|||
125230292|NCT02446691|450471561|FG000|Overall Study|Lost to Follow-up|8|||
125230293|NCT02446691|450471561|FG000|Overall Study|Protocol Violation|1|||
125230294|NCT00472420|450471562|FG000|Induction Treatment Period|Physician Decision|9|||
125230295|NCT00472420|450471562|FG000|Induction Treatment Period|Adverse Event|3|||
125230296|NCT00472420|450471562|FG000|Induction Treatment Period|Non-compliance|1|||
125230297|NCT00472420|450471562|FG000|Induction Treatment Period|Death|3|||
125230298|NCT00472420|450471562|FG000|Follow-up Period|Death|5|||
125230299|NCT00472420|450471562|FG000|Follow-up Period|Physician Decision|9|||
125230300|NCT00472420|450471562|FG000|Follow-up Period|Lost to Follow-up|2|||
125230301|NCT00472420|450471562|FG000|Follow-up Period|Protocol Violation|1|||
125230302|NCT00686972|450471563|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
125230303|NCT01026493|450471566|FG000|Overall Study|Protocol Violation|0|||
125230304|NCT01026493|450471567|FG001|Overall Study|Protocol Violation|1|||
125230305|NCT01026493|450471568|FG002|Overall Study|Protocol Violation|0|||
125230306|NCT01026493|450471569|FG003|Overall Study|Protocol Violation|0|||
125230307|NCT01026493|450471570|FG004|Overall Study|Protocol Violation|2|||
125230308|NCT01026493|450471571|FG005|Overall Study|Protocol Violation|3|||
125230309|NCT01026493|450471572|FG006|Overall Study|Protocol Violation|4|||
125173797|NCT02516553|450257316|FG019|Overall Study|Refused to continue trial medication|0|||
125173798|NCT02516553|450257317|FG020|Overall Study|Refused to continue trial medication|0|||
125173799|NCT02516553|450257318|FG021|Overall Study|Refused to continue trial medication|1|||
125173800|NCT02516553|450257297|FG000|Overall Study|other reasons than listed|0|||
125230310|NCT01026493|450471573|FG007|Overall Study|Protocol Violation|1|||
125230311|NCT02674516|450471574|FG000|Overall Study|Lost to Follow-up|3|||
125230312|NCT02674516|450471575|FG001|Overall Study|Lost to Follow-up|0|||
125230313|NCT02674516|450471574|FG000|Overall Study|Protocol Violation|0|||
125230314|NCT02674516|450471575|FG001|Overall Study|Protocol Violation|4|||
125230315|NCT02674516|450471574|FG000|Overall Study|Knowledge of study hypothesis|1|||
125230316|NCT02674516|450471575|FG001|Overall Study|Knowledge of study hypothesis|0|||
125230317|NCT02295644|450471578|FG000|Overall Study|Did not meet inclusion criterion|0|||
125230318|NCT02295644|450471579|FG001|Overall Study|Did not meet inclusion criterion|0|||
125230319|NCT02295644|450471580|FG002|Overall Study|Did not meet inclusion criterion|1|||
125230320|NCT02295644|450471581|FG003|Overall Study|Did not meet inclusion criterion|2|||
125230321|NCT00324155|450471582|FG000|Enrolled and Randomized|No longer met study criteria|3|||
125230322|NCT00324155|450471583|FG001|Enrolled and Randomized|No longer met study criteria|0|||
125230323|NCT00324155|450471582|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
125230324|NCT00324155|450471583|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
125230325|NCT00324155|450471582|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
125230326|NCT00324155|450471583|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
125230327|NCT00324155|450471582|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
125230328|NCT00324155|450471583|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
125230329|NCT00324155|450471582|FG000|Received Treatment in Induction Phase|Death|8|||
125230330|NCT00324155|450471583|FG001|Received Treatment in Induction Phase|Death|15|||
125230331|NCT00324155|450471582|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
125230332|NCT00324155|450471583|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
125230333|NCT00324155|450471582|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
125230334|NCT00324155|450471583|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
125230335|NCT00324155|450471582|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
125230336|NCT00324155|450471583|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
125230337|NCT00324155|450471582|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
125230338|NCT00324155|450471583|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
125173801|NCT02516553|450257298|FG001|Overall Study|other reasons than listed|0|||
125173802|NCT02516553|450257299|FG002|Overall Study|other reasons than listed|0|||
125173803|NCT02516553|450257300|FG003|Overall Study|other reasons than listed|0|||
125173804|NCT02516553|450257301|FG004|Overall Study|other reasons than listed|0|||
125173805|NCT02516553|450257302|FG005|Overall Study|other reasons than listed|0|||
125173806|NCT02516553|450257303|FG006|Overall Study|other reasons than listed|0|||
125173807|NCT02516553|450257304|FG007|Overall Study|other reasons than listed|1|||
125173808|NCT02516553|450257305|FG008|Overall Study|other reasons than listed|1|||
125173809|NCT02516553|450257306|FG009|Overall Study|other reasons than listed|0|||
125173810|NCT02516553|450257307|FG010|Overall Study|other reasons than listed|1|||
125173811|NCT02516553|450257308|FG011|Overall Study|other reasons than listed|1|||
125173812|NCT02516553|450257309|FG012|Overall Study|other reasons than listed|0|||
125173813|NCT02516553|450257310|FG013|Overall Study|other reasons than listed|0|||
125173814|NCT02516553|450257311|FG014|Overall Study|other reasons than listed|0|||
125173815|NCT02516553|450257312|FG015|Overall Study|other reasons than listed|0|||
125173816|NCT02516553|450257313|FG016|Overall Study|other reasons than listed|0|||
125173817|NCT02516553|450257314|FG017|Overall Study|other reasons than listed|0|||
125173818|NCT02516553|450257315|FG018|Overall Study|other reasons than listed|0|||
125173819|NCT02516553|450257316|FG019|Overall Study|other reasons than listed|0|||
125173820|NCT02516553|450257317|FG020|Overall Study|other reasons than listed|2|||
125173821|NCT02516553|450257318|FG021|Overall Study|other reasons than listed|2|||
125173822|NCT02924727|450257323|FG000|Overall Study|Withdrawal by Subject|2|||
125173823|NCT02924727|450257324|FG001|Overall Study|Withdrawal by Subject|4|||
125173824|NCT02924727|450257323|FG000|Overall Study|Lost to Follow-up|2|||
125173825|NCT02924727|450257324|FG001|Overall Study|Lost to Follow-up|5|||
125173826|NCT02924727|450257323|FG000|Overall Study|Death|221|||
125173827|NCT02924727|450257324|FG001|Overall Study|Death|247|||
125173828|NCT02924727|450257323|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
125230339|NCT00324155|450471582|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
125230340|NCT00324155|450471583|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
125230341|NCT00324155|450471582|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
125230342|NCT00324155|450471583|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
125173829|NCT02924727|450257324|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
125173830|NCT03052127|450257325|FG000|Overall Study|Withdrawal by Subject|0|||
125173831|NCT03052127|450257326|FG001|Overall Study|Withdrawal by Subject|0|||
125173832|NCT03052127|450257327|FG002|Overall Study|Withdrawal by Subject|0|||
125173833|NCT03052127|450257328|FG003|Overall Study|Withdrawal by Subject|0|||
125173834|NCT03052127|450257329|FG004|Overall Study|Withdrawal by Subject|0|||
125173835|NCT03052127|450257330|FG005|Overall Study|Withdrawal by Subject|0|||
125173836|NCT03052127|450257331|FG006|Overall Study|Withdrawal by Subject|0|||
125173837|NCT03052127|450257332|FG007|Overall Study|Withdrawal by Subject|1|||
125173838|NCT03052127|450257333|FG008|Overall Study|Withdrawal by Subject|1|||
125173839|NCT03052127|450257334|FG009|Overall Study|Withdrawal by Subject|1|||
125173840|NCT03052127|450257335|FG010|Overall Study|Withdrawal by Subject|0|||
125173841|NCT03052127|450257336|FG011|Overall Study|Withdrawal by Subject|0|||
125173842|NCT03052127|450257325|FG000|Overall Study|Discontinuation by Sponsor|0|||
125173843|NCT03052127|450257326|FG001|Overall Study|Discontinuation by Sponsor|0|||
125173844|NCT03052127|450257327|FG002|Overall Study|Discontinuation by Sponsor|0|||
125173845|NCT03052127|450257328|FG003|Overall Study|Discontinuation by Sponsor|0|||
125173846|NCT03052127|450257329|FG004|Overall Study|Discontinuation by Sponsor|0|||
125173847|NCT03052127|450257330|FG005|Overall Study|Discontinuation by Sponsor|0|||
125173848|NCT03052127|450257331|FG006|Overall Study|Discontinuation by Sponsor|0|||
125173849|NCT03052127|450257332|FG007|Overall Study|Discontinuation by Sponsor|0|||
125173850|NCT03052127|450257333|FG008|Overall Study|Discontinuation by Sponsor|4|||
125173851|NCT03052127|450257334|FG009|Overall Study|Discontinuation by Sponsor|2|||
125173852|NCT03052127|450257335|FG010|Overall Study|Discontinuation by Sponsor|5|||
125173853|NCT03052127|450257336|FG011|Overall Study|Discontinuation by Sponsor|13|||
125173854|NCT03052127|450257325|FG000|Overall Study|Inability to comply with trial requirements|0|||
125173855|NCT03052127|450257326|FG001|Overall Study|Inability to comply with trial requirements|0|||
125173856|NCT03052127|450257327|FG002|Overall Study|Inability to comply with trial requirements|1|||
125173857|NCT03052127|450257328|FG003|Overall Study|Inability to comply with trial requirements|0|||
125173858|NCT03052127|450257329|FG004|Overall Study|Inability to comply with trial requirements|0|||
125173859|NCT03052127|450257330|FG005|Overall Study|Inability to comply with trial requirements|0|||
125173860|NCT03052127|450257331|FG006|Overall Study|Inability to comply with trial requirements|0|||
125173861|NCT03052127|450257332|FG007|Overall Study|Inability to comply with trial requirements|0|||
125173862|NCT03052127|450257333|FG008|Overall Study|Inability to comply with trial requirements|0|||
125173863|NCT03052127|450257334|FG009|Overall Study|Inability to comply with trial requirements|0|||
125173864|NCT03052127|450257335|FG010|Overall Study|Inability to comply with trial requirements|0|||
125173865|NCT03052127|450257336|FG011|Overall Study|Inability to comply with trial requirements|0|||
125173866|NCT03052127|450257325|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
125173867|NCT03052127|450257326|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
125173868|NCT03052127|450257327|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
125173869|NCT03052127|450257328|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
125173870|NCT03052127|450257329|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
125173871|NCT03052127|450257330|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
125173872|NCT03052127|450257331|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
125173873|NCT03052127|450257332|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
125230343|NCT00324155|450471582|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
125230344|NCT00324155|450471583|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
125230345|NCT00324155|450471582|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
125230346|NCT00324155|450471583|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
125230347|NCT00324155|450471582|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
125230348|NCT00324155|450471583|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
125230349|NCT00324155|450471582|FG000|Follow-up Phase|On-going participants still on drug|11|||
125230350|NCT00324155|450471583|FG001|Follow-up Phase|On-going participants still on drug|6|||
125230351|NCT03307174|450471584|FG000|Overall Study|Unplanned ICU Administrion|5|||
125230352|NCT03307174|450471585|FG001|Overall Study|Unplanned ICU Administrion|3|||
125230353|NCT03307174|450471584|FG000|Overall Study|Aborted Surgery|1|||
125230354|NCT03307174|450471585|FG001|Overall Study|Aborted Surgery|2|||
125230355|NCT03307174|450471584|FG000|Overall Study|Hypotension|6|||
125230356|NCT03307174|450471585|FG001|Overall Study|Hypotension|0|||
125230357|NCT03307174|450471584|FG000|Overall Study|Nonfunctional epidural|1|||
125230358|NCT03307174|450471585|FG001|Overall Study|Nonfunctional epidural|1|||
125230359|NCT03307174|450471584|FG000|Overall Study|Planned epidural removal|1|||
125173874|NCT03052127|450257333|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
125173875|NCT03052127|450257334|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
125173876|NCT03052127|450257335|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
125173877|NCT03052127|450257336|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
125173878|NCT03694327|450257339|FG000|Overall Study|Lost to Follow-up|13|||
125173879|NCT03694327|450257340|FG001|Overall Study|Lost to Follow-up|23|||
125173880|NCT01982812|450257343|FG000|Overall Study|Death|1|||
125173881|NCT01982812|450257344|FG001|Overall Study|Death|5|||
125173882|NCT01982812|450257343|FG000|Overall Study|Adverse Event|0|||
125173883|NCT01982812|450257344|FG001|Overall Study|Adverse Event|5|||
125230360|NCT03307174|450471585|FG001|Overall Study|Planned epidural removal|0|||
125230361|NCT03307174|450471584|FG000|Overall Study|Intrathecal catheter placement|0|||
125230362|NCT03307174|450471585|FG001|Overall Study|Intrathecal catheter placement|1|||
125173884|NCT04784533|450257345|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
125173885|NCT04784533|450257346|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
125173886|NCT04784533|450257347|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
125173887|NCT04784533|450257348|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
125173888|NCT04784533|450257349|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
125173889|NCT04784533|450257350|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
125173890|NCT04784533|450257351|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
125173891|NCT04784533|450257352|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
125173892|NCT04784533|450257353|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
125173893|NCT04784533|450257354|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
125173894|NCT04784533|450257345|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
125173895|NCT04784533|450257346|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
125173896|NCT04784533|450257347|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
125173897|NCT04784533|450257348|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
125173898|NCT04784533|450257349|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
125173899|NCT04784533|450257350|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
125173900|NCT04784533|450257351|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
125173901|NCT04784533|450257352|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
125173902|NCT04784533|450257353|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
125173903|NCT04784533|450257354|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
125173904|NCT04784533|450257345|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
125173905|NCT04784533|450257346|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
125173906|NCT04784533|450257347|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
125173907|NCT04784533|450257348|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
125173908|NCT04784533|450257349|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
125173909|NCT04784533|450257350|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
125173910|NCT04784533|450257351|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
125173911|NCT04784533|450257352|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
125173912|NCT04784533|450257353|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
125173913|NCT04784533|450257354|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
125173914|NCT04784533|450257345|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
125173915|NCT04784533|450257346|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
125173916|NCT04784533|450257347|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
125173917|NCT04784533|450257348|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
125173918|NCT04784533|450257349|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
125173919|NCT04784533|450257350|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
125173920|NCT04784533|450257351|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
125173921|NCT04784533|450257352|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
125173922|NCT04784533|450257353|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
125173923|NCT04784533|450257354|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
125173924|NCT04784533|450257345|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
125173925|NCT04784533|450257346|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
125173926|NCT04784533|450257347|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
125173927|NCT04784533|450257348|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
125173928|NCT04784533|450257349|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
125173929|NCT04784533|450257350|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
125173930|NCT04784533|450257351|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
125173931|NCT04784533|450257352|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
125173932|NCT04784533|450257353|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
125173933|NCT04784533|450257354|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
125173934|NCT04784533|450257345|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
125173935|NCT04784533|450257346|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
125173936|NCT04784533|450257347|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
125173937|NCT04784533|450257348|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
125173938|NCT04784533|450257349|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
125173939|NCT04784533|450257350|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
125173940|NCT04784533|450257351|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
125173941|NCT04784533|450257352|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
125173942|NCT04784533|450257353|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
125173943|NCT04784533|450257354|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
125173944|NCT04784533|450257345|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
125173945|NCT04784533|450257346|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
125173946|NCT04784533|450257347|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
125173947|NCT04784533|450257348|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
125173948|NCT04784533|450257349|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
125173949|NCT04784533|450257350|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
125173950|NCT04784533|450257351|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
125173951|NCT04784533|450257352|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
125173952|NCT04784533|450257353|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
125173953|NCT04784533|450257354|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
125173954|NCT04784533|450257345|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
125173955|NCT04784533|450257346|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
125173956|NCT04784533|450257347|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
125173957|NCT04784533|450257348|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
125173958|NCT04784533|450257349|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
125173959|NCT04784533|450257350|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
125173960|NCT04784533|450257351|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
125173961|NCT04784533|450257352|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
125173962|NCT04784533|450257353|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
125173963|NCT04784533|450257354|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
125173964|NCT04784533|450257345|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
125173965|NCT04784533|450257346|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
125173966|NCT04784533|450257347|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
125173967|NCT04784533|450257348|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
125173968|NCT04784533|450257349|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
125173969|NCT04784533|450257350|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
125173970|NCT04784533|450257351|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
125173971|NCT04784533|450257352|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
125173972|NCT04784533|450257353|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
125173973|NCT04784533|450257354|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
125173974|NCT00307437|450257355|FG000|Controlled Period|Adverse Event|7|||
125173975|NCT00307437|450257356|FG001|Controlled Period|Adverse Event|2|||
125173976|NCT00307437|450257357|FG002|Controlled Period|Adverse Event|5|||
125173977|NCT00307437|450257358|FG003|Controlled Period|Adverse Event|0|||
125173978|NCT00307437|450257359|FG004|Controlled Period|Adverse Event|0|||
125173979|NCT00307437|450257360|FG005|Controlled Period|Adverse Event|0|||
125173980|NCT00307437|450257361|FG006|Controlled Period|Adverse Event|0|||
125173981|NCT00307437|450257355|FG000|Controlled Period|Death|0|||
125173982|NCT00307437|450257356|FG001|Controlled Period|Death|0|||
125173983|NCT00307437|450257357|FG002|Controlled Period|Death|1|||
125173984|NCT00307437|450257358|FG003|Controlled Period|Death|0|||
125173985|NCT00307437|450257359|FG004|Controlled Period|Death|0|||
125173986|NCT00307437|450257360|FG005|Controlled Period|Death|0|||
125173987|NCT00307437|450257361|FG006|Controlled Period|Death|0|||
125173988|NCT00307437|450257355|FG000|Controlled Period|Lack of Efficacy|2|||
125173989|NCT00307437|450257356|FG001|Controlled Period|Lack of Efficacy|0|||
125173990|NCT00307437|450257357|FG002|Controlled Period|Lack of Efficacy|0|||
125173991|NCT00307437|450257358|FG003|Controlled Period|Lack of Efficacy|0|||
125173992|NCT00307437|450257359|FG004|Controlled Period|Lack of Efficacy|0|||
125173993|NCT00307437|450257360|FG005|Controlled Period|Lack of Efficacy|0|||
125173994|NCT00307437|450257361|FG006|Controlled Period|Lack of Efficacy|0|||
125173995|NCT00307437|450257355|FG000|Controlled Period|Lost to Follow-up|2|||
125173996|NCT00307437|450257356|FG001|Controlled Period|Lost to Follow-up|3|||
125173997|NCT00307437|450257357|FG002|Controlled Period|Lost to Follow-up|0|||
125173998|NCT00307437|450257358|FG003|Controlled Period|Lost to Follow-up|0|||
125173999|NCT00307437|450257359|FG004|Controlled Period|Lost to Follow-up|0|||
125174000|NCT00307437|450257360|FG005|Controlled Period|Lost to Follow-up|0|||
125174001|NCT00307437|450257361|FG006|Controlled Period|Lost to Follow-up|0|||
125174002|NCT00307437|450257355|FG000|Controlled Period|Other|5|||
125174003|NCT00307437|450257356|FG001|Controlled Period|Other|1|||
125174004|NCT00307437|450257357|FG002|Controlled Period|Other|3|||
125174005|NCT00307437|450257358|FG003|Controlled Period|Other|0|||
125174006|NCT00307437|450257359|FG004|Controlled Period|Other|0|||
125174007|NCT00307437|450257360|FG005|Controlled Period|Other|0|||
125174008|NCT00307437|450257361|FG006|Controlled Period|Other|0|||
125174009|NCT00307437|450257355|FG000|After Controlled Period|Adverse Event|0|||
125174010|NCT00307437|450257356|FG001|After Controlled Period|Adverse Event|0|||
125174011|NCT00307437|450257357|FG002|After Controlled Period|Adverse Event|0|||
125174012|NCT00307437|450257358|FG003|After Controlled Period|Adverse Event|18|||
125174013|NCT00307437|450257359|FG004|After Controlled Period|Adverse Event|16|||
125174014|NCT00307437|450257360|FG005|After Controlled Period|Adverse Event|31|||
125174015|NCT00307437|450257361|FG006|After Controlled Period|Adverse Event|40|||
125174016|NCT00307437|450257355|FG000|After Controlled Period|Death|0|||
125174017|NCT00307437|450257356|FG001|After Controlled Period|Death|0|||
125174018|NCT00307437|450257357|FG002|After Controlled Period|Death|0|||
125174019|NCT00307437|450257358|FG003|After Controlled Period|Death|3|||
125174020|NCT00307437|450257359|FG004|After Controlled Period|Death|1|||
125174021|NCT00307437|450257360|FG005|After Controlled Period|Death|1|||
125174022|NCT00307437|450257361|FG006|After Controlled Period|Death|3|||
125174023|NCT00307437|450257355|FG000|After Controlled Period|Lack of Efficacy|0|||
125174024|NCT00307437|450257356|FG001|After Controlled Period|Lack of Efficacy|0|||
125174025|NCT00307437|450257357|FG002|After Controlled Period|Lack of Efficacy|0|||
125174026|NCT00307437|450257358|FG003|After Controlled Period|Lack of Efficacy|15|||
125174027|NCT00307437|450257359|FG004|After Controlled Period|Lack of Efficacy|17|||
125174028|NCT00307437|450257360|FG005|After Controlled Period|Lack of Efficacy|37|||
125174029|NCT00307437|450257361|FG006|After Controlled Period|Lack of Efficacy|24|||
125174030|NCT00307437|450257355|FG000|After Controlled Period|Lost to Follow-up|0|||
125174031|NCT00307437|450257356|FG001|After Controlled Period|Lost to Follow-up|0|||
125174032|NCT00307437|450257357|FG002|After Controlled Period|Lost to Follow-up|0|||
125174033|NCT00307437|450257358|FG003|After Controlled Period|Lost to Follow-up|7|||
125174034|NCT00307437|450257359|FG004|After Controlled Period|Lost to Follow-up|12|||
125174035|NCT00307437|450257360|FG005|After Controlled Period|Lost to Follow-up|13|||
125174036|NCT00307437|450257361|FG006|After Controlled Period|Lost to Follow-up|18|||
125174037|NCT00307437|450257355|FG000|After Controlled Period|Other|0|||
125174038|NCT00307437|450257356|FG001|After Controlled Period|Other|0|||
125174039|NCT00307437|450257357|FG002|After Controlled Period|Other|0|||
125174040|NCT00307437|450257358|FG003|After Controlled Period|Other|15|||
125174041|NCT00307437|450257359|FG004|After Controlled Period|Other|9|||
125174042|NCT00307437|450257360|FG005|After Controlled Period|Other|40|||
125174043|NCT00307437|450257361|FG006|After Controlled Period|Other|28|||
125174044|NCT03316547|450257370|FG000|Overall Study|Death|3|||
125174045|NCT03316547|450257371|FG001|Overall Study|Death|1|||
125174046|NCT03316547|450257370|FG000|Overall Study|Lost to Follow-up|6|||
125174047|NCT03316547|450257371|FG001|Overall Study|Lost to Follow-up|6|||
125174048|NCT03316547|450257370|FG000|Overall Study|Withdrawal by Subject|3|||
125174049|NCT03316547|450257371|FG001|Overall Study|Withdrawal by Subject|2|||
125174050|NCT03316547|450257370|FG000|Overall Study|Transfer to another hospital|6|||
125174051|NCT03316547|450257371|FG001|Overall Study|Transfer to another hospital|4|||
125174052|NCT00721227|450257372|FG000|Overall Study|Lost to Follow-up|3|||
125174053|NCT00721227|450257373|FG001|Overall Study|Lost to Follow-up|0|||
125174054|NCT00721227|450257372|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
125174055|NCT00721227|450257373|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
125174056|NCT02759692|450257374|FG000|Period 1|Test article no longer available|1|||
125174057|NCT02759692|450257375|FG001|Period 1|Test article no longer available|1|||
125174058|NCT02759692|450257374|FG000|Period 1|No longer meets eligibility criteria.|1|||
125174059|NCT02759692|450257375|FG001|Period 1|No longer meets eligibility criteria.|0|||
125174060|NCT02759692|450257374|FG000|Period 1|Miss-Randomized|1|||
125174061|NCT02759692|450257375|FG001|Period 1|Miss-Randomized|1|||
125174062|NCT02759692|450257374|FG000|Period 2|Lost to Follow-up|1|||
125174063|NCT02759692|450257375|FG001|Period 2|Lost to Follow-up|0|||
125174064|NCT02759692|450257374|FG000|Period 2|Test article no longer available|0|||
125174065|NCT02759692|450257375|FG001|Period 2|Test article no longer available|1|||
125174066|NCT00451178|450257376|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
125174067|NCT00451178|450257377|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
125174068|NCT00451178|450257376|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
125174069|NCT00451178|450257377|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
125174070|NCT00451178|450257376|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
125174071|NCT00451178|450257377|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
125174072|NCT00451178|450257376|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
125174073|NCT00451178|450257377|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
125174074|NCT00451178|450257376|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
125230363|NCT00846053|450471586|FG000|Overall Study|Physician Decision|3|||
125230364|NCT00846053|450471587|FG001|Overall Study|Physician Decision|0|||
125230365|NCT00111761|450471588|FG000|Part 1|Physician Decision|0|||
125230366|NCT00111761|450471589|FG001|Part 1|Physician Decision|1|||
125174075|NCT00451178|450257377|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
125174076|NCT00451178|450257376|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
125174077|NCT00451178|450257377|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
125174078|NCT00451178|450257376|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
125174079|NCT00451178|450257377|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
125174080|NCT00451178|450257376|FG000|Prior to Maintenance Therapy|PD|2|||
125174081|NCT00451178|450257377|FG001|Prior to Maintenance Therapy|PD|0|||
125174082|NCT00451178|450257376|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
125174083|NCT00451178|450257377|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
125174084|NCT00451178|450257376|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
125230367|NCT00111761|450471588|FG000|Part 1|Death|0|||
125174085|NCT00451178|450257377|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
125174086|NCT00451178|450257376|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
125174087|NCT00451178|450257377|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
125174088|NCT00451178|450257376|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
125174089|NCT00451178|450257377|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
125174090|NCT00451178|450257376|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
125174091|NCT00451178|450257377|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
125174092|NCT00451178|450257376|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
125174093|NCT00451178|450257377|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
125174094|NCT00451178|450257376|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
125174095|NCT00451178|450257377|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
125174096|NCT01243775|450257378|FG000|Overall Study|Withdrawal by Subject|2|||
125174097|NCT02447744|450257379|FG000|Overall Study|Withdrawal by Subject|3|||
125174098|NCT02447744|450257380|FG001|Overall Study|Withdrawal by Subject|1|||
125174099|NCT02447744|450257379|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
125174100|NCT02447744|450257380|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
125174101|NCT03207867|450257381|FG000|Overall Study|Adverse Event|1|||
125174102|NCT03207867|450257382|FG001|Overall Study|Adverse Event|0|||
125174103|NCT03207867|450257383|FG002|Overall Study|Adverse Event|1|||
125174104|NCT03207867|450257384|FG003|Overall Study|Adverse Event|0|||
125174105|NCT03207867|450257385|FG004|Overall Study|Adverse Event|0|||
125174106|NCT03207867|450257386|FG005|Overall Study|Adverse Event|2|||
125174107|NCT03207867|450257387|FG006|Overall Study|Adverse Event|1|||
125174108|NCT03207867|450257388|FG007|Overall Study|Adverse Event|1|||
125174109|NCT03207867|450257389|FG008|Overall Study|Adverse Event|2|||
125174110|NCT03207867|450257390|FG009|Overall Study|Adverse Event|2|||
125174111|NCT03207867|450257391|FG010|Overall Study|Adverse Event|0|||
125174112|NCT03207867|450257392|FG011|Overall Study|Adverse Event|0|||
125174113|NCT03207867|450257393|FG012|Overall Study|Adverse Event|0|||
125174114|NCT03207867|450257394|FG013|Overall Study|Adverse Event|0|||
125174115|NCT03207867|450257395|FG014|Overall Study|Adverse Event|0|||
125174116|NCT03207867|450257396|FG015|Overall Study|Adverse Event|0|||
125174117|NCT03207867|450257397|FG016|Overall Study|Adverse Event|3|||
125174118|NCT03207867|450257398|FG017|Overall Study|Adverse Event|1|||
125174119|NCT03207867|450257399|FG018|Overall Study|Adverse Event|2|||
125174120|NCT03207867|450257400|FG019|Overall Study|Adverse Event|1|||
125174121|NCT03207867|450257401|FG020|Overall Study|Adverse Event|0|||
125174122|NCT03207867|450257402|FG021|Overall Study|Adverse Event|0|||
125174123|NCT03207867|450257403|FG022|Overall Study|Adverse Event|0|||
125174124|NCT03207867|450257404|FG023|Overall Study|Adverse Event|0|||
125174125|NCT03207867|450257381|FG000|Overall Study|Death|0|||
125174126|NCT03207867|450257382|FG001|Overall Study|Death|0|||
125174127|NCT03207867|450257383|FG002|Overall Study|Death|0|||
125174128|NCT03207867|450257384|FG003|Overall Study|Death|0|||
125174129|NCT03207867|450257385|FG004|Overall Study|Death|0|||
125174130|NCT03207867|450257386|FG005|Overall Study|Death|1|||
125174131|NCT03207867|450257387|FG006|Overall Study|Death|0|||
125174132|NCT03207867|450257388|FG007|Overall Study|Death|3|||
125174133|NCT03207867|450257389|FG008|Overall Study|Death|1|||
125174134|NCT03207867|450257390|FG009|Overall Study|Death|2|||
125174135|NCT03207867|450257391|FG010|Overall Study|Death|0|||
125174136|NCT03207867|450257392|FG011|Overall Study|Death|1|||
125174137|NCT03207867|450257393|FG012|Overall Study|Death|0|||
125174138|NCT03207867|450257394|FG013|Overall Study|Death|1|||
125174139|NCT03207867|450257395|FG014|Overall Study|Death|0|||
125174140|NCT03207867|450257396|FG015|Overall Study|Death|0|||
125174141|NCT03207867|450257397|FG016|Overall Study|Death|0|||
125174142|NCT03207867|450257398|FG017|Overall Study|Death|2|||
125174143|NCT03207867|450257399|FG018|Overall Study|Death|0|||
125174144|NCT03207867|450257400|FG019|Overall Study|Death|1|||
125174145|NCT03207867|450257401|FG020|Overall Study|Death|0|||
125174146|NCT03207867|450257402|FG021|Overall Study|Death|0|||
125174147|NCT03207867|450257403|FG022|Overall Study|Death|0|||
125174148|NCT03207867|450257404|FG023|Overall Study|Death|0|||
125174149|NCT03207867|450257381|FG000|Overall Study|Physician Decision|3|||
125174150|NCT03207867|450257382|FG001|Overall Study|Physician Decision|5|||
125174151|NCT03207867|450257383|FG002|Overall Study|Physician Decision|0|||
125174152|NCT03207867|450257384|FG003|Overall Study|Physician Decision|3|||
125174153|NCT03207867|450257385|FG004|Overall Study|Physician Decision|2|||
125174154|NCT03207867|450257386|FG005|Overall Study|Physician Decision|0|||
125174155|NCT03207867|450257387|FG006|Overall Study|Physician Decision|0|||
125174156|NCT03207867|450257388|FG007|Overall Study|Physician Decision|0|||
125174157|NCT03207867|450257389|FG008|Overall Study|Physician Decision|4|||
125174158|NCT03207867|450257390|FG009|Overall Study|Physician Decision|2|||
125174159|NCT03207867|450257391|FG010|Overall Study|Physician Decision|0|||
125174160|NCT03207867|450257392|FG011|Overall Study|Physician Decision|4|||
125174161|NCT03207867|450257393|FG012|Overall Study|Physician Decision|0|||
125174162|NCT03207867|450257394|FG013|Overall Study|Physician Decision|0|||
125174163|NCT03207867|450257395|FG014|Overall Study|Physician Decision|2|||
125174164|NCT03207867|450257396|FG015|Overall Study|Physician Decision|1|||
125174165|NCT03207867|450257397|FG016|Overall Study|Physician Decision|1|||
125174166|NCT03207867|450257398|FG017|Overall Study|Physician Decision|2|||
125174167|NCT03207867|450257399|FG018|Overall Study|Physician Decision|1|||
125174168|NCT03207867|450257400|FG019|Overall Study|Physician Decision|3|||
125174169|NCT03207867|450257401|FG020|Overall Study|Physician Decision|0|||
125174170|NCT03207867|450257402|FG021|Overall Study|Physician Decision|0|||
125174171|NCT03207867|450257403|FG022|Overall Study|Physician Decision|0|||
125174172|NCT03207867|450257404|FG023|Overall Study|Physician Decision|0|||
125174173|NCT03207867|450257381|FG000|Overall Study|Progressive Disease|7|||
125174174|NCT03207867|450257382|FG001|Overall Study|Progressive Disease|7|||
125174175|NCT03207867|450257383|FG002|Overall Study|Progressive Disease|9|||
125174176|NCT03207867|450257384|FG003|Overall Study|Progressive Disease|10|||
125174177|NCT03207867|450257385|FG004|Overall Study|Progressive Disease|11|||
125174178|NCT03207867|450257386|FG005|Overall Study|Progressive Disease|10|||
125174179|NCT03207867|450257387|FG006|Overall Study|Progressive Disease|9|||
125174180|NCT03207867|450257388|FG007|Overall Study|Progressive Disease|8|||
125174181|NCT03207867|450257389|FG008|Overall Study|Progressive Disease|19|||
125174182|NCT03207867|450257390|FG009|Overall Study|Progressive Disease|23|||
125174183|NCT03207867|450257391|FG010|Overall Study|Progressive Disease|2|||
125174184|NCT03207867|450257392|FG011|Overall Study|Progressive Disease|24|||
125174185|NCT03207867|450257393|FG012|Overall Study|Progressive Disease|3|||
125174186|NCT03207867|450257394|FG013|Overall Study|Progressive Disease|11|||
125174187|NCT03207867|450257395|FG014|Overall Study|Progressive Disease|9|||
125174188|NCT03207867|450257396|FG015|Overall Study|Progressive Disease|5|||
125174189|NCT03207867|450257397|FG016|Overall Study|Progressive Disease|10|||
125174190|NCT03207867|450257398|FG017|Overall Study|Progressive Disease|14|||
125174191|NCT03207867|450257399|FG018|Overall Study|Progressive Disease|13|||
125174192|NCT03207867|450257400|FG019|Overall Study|Progressive Disease|14|||
125174193|NCT03207867|450257401|FG020|Overall Study|Progressive Disease|6|||
125174194|NCT03207867|450257402|FG021|Overall Study|Progressive Disease|3|||
125174195|NCT03207867|450257403|FG022|Overall Study|Progressive Disease|3|||
125174196|NCT03207867|450257404|FG023|Overall Study|Progressive Disease|3|||
125174197|NCT03207867|450257381|FG000|Overall Study|Patient/guardian Decision|0|||
125174198|NCT03207867|450257382|FG001|Overall Study|Patient/guardian Decision|0|||
125174199|NCT03207867|450257383|FG002|Overall Study|Patient/guardian Decision|1|||
125174200|NCT03207867|450257384|FG003|Overall Study|Patient/guardian Decision|1|||
125174201|NCT03207867|450257385|FG004|Overall Study|Patient/guardian Decision|1|||
125174202|NCT03207867|450257386|FG005|Overall Study|Patient/guardian Decision|2|||
125174203|NCT03207867|450257387|FG006|Overall Study|Patient/guardian Decision|1|||
125174204|NCT03207867|450257388|FG007|Overall Study|Patient/guardian Decision|0|||
125174205|NCT03207867|450257389|FG008|Overall Study|Patient/guardian Decision|1|||
125174206|NCT03207867|450257390|FG009|Overall Study|Patient/guardian Decision|0|||
125174207|NCT03207867|450257391|FG010|Overall Study|Patient/guardian Decision|0|||
125174208|NCT03207867|450257392|FG011|Overall Study|Patient/guardian Decision|1|||
125174209|NCT03207867|450257393|FG012|Overall Study|Patient/guardian Decision|0|||
125174210|NCT03207867|450257394|FG013|Overall Study|Patient/guardian Decision|1|||
125174211|NCT03207867|450257395|FG014|Overall Study|Patient/guardian Decision|2|||
125174212|NCT03207867|450257396|FG015|Overall Study|Patient/guardian Decision|0|||
125174213|NCT03207867|450257397|FG016|Overall Study|Patient/guardian Decision|1|||
125174214|NCT03207867|450257398|FG017|Overall Study|Patient/guardian Decision|3|||
125174215|NCT03207867|450257399|FG018|Overall Study|Patient/guardian Decision|4|||
125174216|NCT03207867|450257400|FG019|Overall Study|Patient/guardian Decision|1|||
125174217|NCT03207867|450257401|FG020|Overall Study|Patient/guardian Decision|0|||
125174218|NCT03207867|450257402|FG021|Overall Study|Patient/guardian Decision|0|||
125174219|NCT03207867|450257403|FG022|Overall Study|Patient/guardian Decision|0|||
125174220|NCT03207867|450257404|FG023|Overall Study|Patient/guardian Decision|0|||
125174221|NCT05422625|450257405|FG000|Overall Study|Withdrawal by Subject|1|||
125174222|NCT05422625|450257406|FG001|Overall Study|Withdrawal by Subject|0|||
125174223|NCT01277601|450259246|FG000|Overall Study|Adverse Event|5|||
125174224|NCT01277601|450259247|FG001|Overall Study|Adverse Event|3|||
125174225|NCT01277601|450259248|FG002|Overall Study|Adverse Event|0|||
125174226|NCT01277601|450259249|FG003|Overall Study|Adverse Event|7|||
125174227|NCT01277601|450259246|FG000|Overall Study|Withdrawal by Subject|18|||
125174228|NCT01277601|450259247|FG001|Overall Study|Withdrawal by Subject|21|||
125174229|NCT01277601|450259248|FG002|Overall Study|Withdrawal by Subject|8|||
125174230|NCT01277601|450259249|FG003|Overall Study|Withdrawal by Subject|17|||
125174231|NCT01277601|450259246|FG000|Overall Study|Lost to Follow-up|7|||
125174232|NCT01277601|450259247|FG001|Overall Study|Lost to Follow-up|9|||
125174233|NCT01277601|450259248|FG002|Overall Study|Lost to Follow-up|4|||
125174234|NCT01277601|450259249|FG003|Overall Study|Lost to Follow-up|2|||
125174235|NCT01277601|450259246|FG000|Overall Study|Physician Decision|3|||
125174236|NCT01277601|450259247|FG001|Overall Study|Physician Decision|5|||
125174237|NCT01277601|450259248|FG002|Overall Study|Physician Decision|1|||
125174238|NCT01277601|450259249|FG003|Overall Study|Physician Decision|6|||
125174239|NCT01277601|450259246|FG000|Overall Study|Pregnancy|2|||
125174240|NCT01277601|450259247|FG001|Overall Study|Pregnancy|2|||
125174241|NCT01277601|450259248|FG002|Overall Study|Pregnancy|4|||
125174242|NCT01277601|450259249|FG003|Overall Study|Pregnancy|1|||
125174243|NCT01277601|450259246|FG000|Overall Study|Noncompliance with Study Drug|1|||
125174244|NCT01277601|450259247|FG001|Overall Study|Noncompliance with Study Drug|3|||
125174245|NCT01277601|450259248|FG002|Overall Study|Noncompliance with Study Drug|2|||
125174246|NCT01277601|450259249|FG003|Overall Study|Noncompliance with Study Drug|0|||
125174247|NCT01277601|450259246|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
125174248|NCT01277601|450259247|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
125174249|NCT01277601|450259248|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
125174250|NCT01277601|450259249|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
125174251|NCT01277601|450259246|FG000|Overall Study|Protocol Violation|0|||
125174252|NCT01277601|450259247|FG001|Overall Study|Protocol Violation|2|||
125174253|NCT01277601|450259248|FG002|Overall Study|Protocol Violation|5|||
125174254|NCT01277601|450259249|FG003|Overall Study|Protocol Violation|0|||
125174255|NCT01277601|450259246|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
125174256|NCT01277601|450259247|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
125174257|NCT01277601|450259248|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
125174258|NCT01277601|450259249|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
125174259|NCT00678210|450259251|FG000|Overall Study|Adverse Event|1|||
125174260|NCT00678210|450259252|FG001|Overall Study|Adverse Event|2|||
125174261|NCT00678210|450259253|FG002|Overall Study|Adverse Event|3|||
125174262|NCT00678210|450259254|FG003|Overall Study|Adverse Event|3|||
125174263|NCT00678210|450259251|FG000|Overall Study|Lack of Efficacy|2|||
125174264|NCT00678210|450259252|FG001|Overall Study|Lack of Efficacy|3|||
125174265|NCT00678210|450259253|FG002|Overall Study|Lack of Efficacy|1|||
125174266|NCT00678210|450259254|FG003|Overall Study|Lack of Efficacy|9|||
125174267|NCT00678210|450259251|FG000|Overall Study|Lost to Follow-up|4|||
125174268|NCT00678210|450259252|FG001|Overall Study|Lost to Follow-up|2|||
125174269|NCT00678210|450259253|FG002|Overall Study|Lost to Follow-up|0|||
125174270|NCT00678210|450259254|FG003|Overall Study|Lost to Follow-up|1|||
125174271|NCT00678210|450259251|FG000|Overall Study|Withdrawal by Subject|3|||
125174272|NCT00678210|450259252|FG001|Overall Study|Withdrawal by Subject|4|||
125174273|NCT00678210|450259253|FG002|Overall Study|Withdrawal by Subject|1|||
125174274|NCT00678210|450259254|FG003|Overall Study|Withdrawal by Subject|7|||
125174275|NCT00678210|450259251|FG000|Overall Study|Other|1|||
125174276|NCT00678210|450259252|FG001|Overall Study|Other|0|||
125174277|NCT00678210|450259253|FG002|Overall Study|Other|1|||
125174278|NCT00678210|450259254|FG003|Overall Study|Other|0|||
125174279|NCT04825912|450259255|FG000|Overall Study|Death|3|||
125174280|NCT04825912|450259255|FG000|Overall Study|Withdrawal by Subject|1|||
125174281|NCT02077140|450259256|FG000|Overall Study|Lost to Follow-up|4|||
125174282|NCT02077140|450259257|FG001|Overall Study|Lost to Follow-up|1|||
125174283|NCT02077140|450259258|FG002|Overall Study|Lost to Follow-up|2|||
125174284|NCT02077140|450259259|FG003|Overall Study|Lost to Follow-up|2|||
125174285|NCT02077140|450259260|FG004|Overall Study|Lost to Follow-up|3|||
125174286|NCT02077140|450259256|FG000|Overall Study|Withdrawal by Subject|0|||
125174287|NCT02077140|450259257|FG001|Overall Study|Withdrawal by Subject|1|||
125174288|NCT02077140|450259258|FG002|Overall Study|Withdrawal by Subject|0|||
125174289|NCT02077140|450259259|FG003|Overall Study|Withdrawal by Subject|2|||
125174290|NCT02077140|450259260|FG004|Overall Study|Withdrawal by Subject|2|||
125174291|NCT00974922|450259261|FG000|Overall Study|study terminated|24|||
125174292|NCT01009814|450259264|FG000|Overall Study|No longer met study criteria|1|||
125174293|NCT01009814|450259265|FG001|Overall Study|No longer met study criteria|1|||
125174294|NCT01009814|450259266|FG002|Overall Study|No longer met study criteria|0|||
125174295|NCT01009814|450259267|FG003|Overall Study|No longer met study criteria|0|||
125174296|NCT01009814|450259268|FG004|Overall Study|No longer met study criteria|0|||
125174297|NCT00618371|450259269|FG000|Overall Study|Withdrawal by Subject|2|||
125174298|NCT03022084|450259272|FG000|Overall Study|Lost to Follow-up|2|||
125174299|NCT03022084|450259273|FG001|Overall Study|Lost to Follow-up|3|||
125174300|NCT01207583|450259276|FG000|Overall Study|Withdrawal by Subject|0|||
125174301|NCT01207583|450259277|FG001|Overall Study|Withdrawal by Subject|3|||
125174302|NCT01207583|450259278|FG002|Overall Study|Withdrawal by Subject|1|||
125174303|NCT01207583|450259276|FG000|Overall Study|Participant failed to return|1|||
125174304|NCT01207583|450259277|FG001|Overall Study|Participant failed to return|0|||
125174305|NCT01207583|450259278|FG002|Overall Study|Participant failed to return|0|||
125174306|NCT01207583|450259276|FG000|Overall Study|Lost to Follow-up|0|||
125174307|NCT01207583|450259277|FG001|Overall Study|Lost to Follow-up|2|||
125174308|NCT01207583|450259278|FG002|Overall Study|Lost to Follow-up|0|||
125174309|NCT04974749|450259287|FG000|Overall Study|Withdrawal by Subject|2|||
125174310|NCT04974749|450259287|FG000|Overall Study|Gestation|1|||
125174311|NCT04414618|450259288|FG000|Overall Study|Death|3|||
125174312|NCT04414618|450259289|FG001|Overall Study|Death|3|||
125174313|NCT04414618|450259288|FG000|Overall Study|Withdrawal by Subject|2|||
125174314|NCT04414618|450259289|FG001|Overall Study|Withdrawal by Subject|1|||
125174315|NCT04414618|450259288|FG000|Overall Study|Lost to Follow-up|2|||
125174316|NCT04414618|450259289|FG001|Overall Study|Lost to Follow-up|3|||
125174317|NCT04414618|450259288|FG000|Overall Study|Physician Decision|1|||
125174318|NCT04414618|450259289|FG001|Overall Study|Physician Decision|0|||
125174319|NCT00362336|450259290|FG000|Overall Study|Serious Adverse Event|1|||
125174320|NCT00362336|450259291|FG001|Overall Study|Serious Adverse Event|0|||
125174321|NCT00362336|450259292|FG002|Overall Study|Serious Adverse Event|1|||
125174322|NCT00362336|450259290|FG000|Overall Study|Protocol Violation|0|||
125174323|NCT00362336|450259291|FG001|Overall Study|Protocol Violation|0|||
125174324|NCT00362336|450259292|FG002|Overall Study|Protocol Violation|1|||
125174325|NCT00362336|450259290|FG000|Overall Study|Lost to Follow-up|6|||
125174326|NCT00362336|450259291|FG001|Overall Study|Lost to Follow-up|4|||
125174327|NCT00362336|450259292|FG002|Overall Study|Lost to Follow-up|0|||
125230368|NCT00111761|450471589|FG001|Part 1|Death|2|||
125230369|NCT00111761|450471588|FG000|Part 1|Other|0|||
125230370|NCT00111761|450471589|FG001|Part 1|Other|1|||
125230371|NCT00111761|450471588|FG000|Part 1|Withdrawal by Subject|0|||
125174328|NCT00362336|450259290|FG000|Overall Study|Withdrawal by Subject|3|||
125174329|NCT00362336|450259291|FG001|Overall Study|Withdrawal by Subject|3|||
125174330|NCT00362336|450259292|FG002|Overall Study|Withdrawal by Subject|1|||
125174331|NCT00658879|450259293|FG000|Overall Study|Protocol Violation|1|||
125174332|NCT02661217|450259296|FG000|Overall Study|Physician Decision|12|||
125174333|NCT02661217|450259297|FG001|Overall Study|Physician Decision|15|||
125174334|NCT02661217|450259296|FG000|Overall Study|Lost to Follow-up|1|||
125174335|NCT02661217|450259297|FG001|Overall Study|Lost to Follow-up|4|||
125174336|NCT02661217|450259296|FG000|Overall Study|Protocol Deviation|0|||
125174337|NCT02661217|450259297|FG001|Overall Study|Protocol Deviation|4|||
125174338|NCT02661217|450259296|FG000|Overall Study|Non-compliance with study treatment|5|||
125174339|NCT02661217|450259297|FG001|Overall Study|Non-compliance with study treatment|5|||
125174340|NCT02661217|450259296|FG000|Overall Study|Death|21|||
125174341|NCT02661217|450259297|FG001|Overall Study|Death|15|||
125174342|NCT02661217|450259296|FG000|Overall Study|Adverse Event|10|||
125174343|NCT02661217|450259297|FG001|Overall Study|Adverse Event|8|||
125174344|NCT02661217|450259296|FG000|Overall Study|Withdrawal by Subject|15|||
125174345|NCT02661217|450259297|FG001|Overall Study|Withdrawal by Subject|19|||
125174346|NCT02661217|450259296|FG000|Overall Study|Did not enter follow-up epoch|7|||
125174347|NCT02661217|450259297|FG001|Overall Study|Did not enter follow-up epoch|10|||
125174348|NCT02661217|450259296|FG000|Overall Study|Death - no study drug received|1|||
125174349|NCT02661217|450259297|FG001|Overall Study|Death - no study drug received|2|||
125174350|NCT02661217|450259296|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
125174351|NCT02661217|450259297|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
125174352|NCT02075515|450259298|FG000|Overall Study|Serious Adverse Event|1|||
125174353|NCT02075515|450259299|FG001|Overall Study|Serious Adverse Event|1|||
125174354|NCT02075515|450259300|FG002|Overall Study|Serious Adverse Event|1|||
125174355|NCT02075515|450259298|FG000|Overall Study|Non-Serious Adverse Event|0|||
125174356|NCT02075515|450259299|FG001|Overall Study|Non-Serious Adverse Event|1|||
125174357|NCT02075515|450259300|FG002|Overall Study|Non-Serious Adverse Event|0|||
125174358|NCT02075515|450259298|FG000|Overall Study|Withdrawal by Subject|2|||
125174359|NCT02075515|450259299|FG001|Overall Study|Withdrawal by Subject|0|||
125174360|NCT02075515|450259300|FG002|Overall Study|Withdrawal by Subject|1|||
125174361|NCT02075515|450259298|FG000|Overall Study|Lost to Follow-up|1|||
125174362|NCT02075515|450259299|FG001|Overall Study|Lost to Follow-up|3|||
125174363|NCT02075515|450259300|FG002|Overall Study|Lost to Follow-up|6|||
125174364|NCT00378573|450259301|FG000|Treatment Period|Adverse Event|9|||
125174365|NCT00378573|450259301|FG000|Treatment Period|Physician Decision|1|||
125174366|NCT00378573|450259301|FG000|Treatment Period|Withdrawal by Subject|2|||
125174367|NCT00378573|450259301|FG000|Treatment Period|Disease Progression|4|||
125174368|NCT00378573|450259301|FG000|Treatment Period|Sponsor decision to close study|1|||
125174369|NCT00378573|450259301|FG000|Follow-up|Death|12|||
125174370|NCT00378573|450259301|FG000|Follow-up|Lost to Follow-up|1|||
125174371|NCT00378573|450259301|FG000|Follow-up|Withdrawal by Subject|1|||
125174372|NCT00196326|450259306|FG000|Overall Study|Did not meet protocol requirements|64|||
125174373|NCT00196326|450259306|FG000|Overall Study|Non-compliance with the protocol|81|||
125174374|NCT00196326|450259306|FG000|Overall Study|Physician Decision|3|||
125174375|NCT00196326|450259306|FG000|Overall Study|Withdrawal by Subject|225|||
125174376|NCT00196326|450259306|FG000|Overall Study|Adverse Event|253|||
125230372|NCT00111761|450471589|FG001|Part 1|Withdrawal by Subject|1|||
125230373|NCT00111761|450471588|FG000|Part 2|Adverse Event|1|||
125174377|NCT00196326|450259306|FG000|Overall Study|Pregnancy|34|||
125174378|NCT00196326|450259306|FG000|Overall Study|Lost to Follow-up|304|||
125174379|NCT00196326|450259306|FG000|Overall Study|Other|22|||
125174380|NCT01372748|450259307|FG000|Overall Study|Lost to Follow-up|16|||
125174381|NCT01372748|450259308|FG001|Overall Study|Lost to Follow-up|34|||
125174382|NCT01372748|450259307|FG000|Overall Study|Withdrawal by Subject|7|||
125174383|NCT01372748|450259308|FG001|Overall Study|Withdrawal by Subject|5|||
125174384|NCT00134901|450259309|FG000|Overall Study|Lost to Follow-up|5|||
125174385|NCT00134901|450259310|FG001|Overall Study|Lost to Follow-up|5|||
125174386|NCT00134901|450259309|FG000|Overall Study|discontinued intervention|12|||
125174387|NCT00134901|450259310|FG001|Overall Study|discontinued intervention|10|||
125174388|NCT04238650|450259313|FG000|Overall Study|Withdrawal by Subject|0|||
125174389|NCT04238650|450259314|FG001|Overall Study|Withdrawal by Subject|1|||
125230374|NCT00111761|450471589|FG001|Part 2|Adverse Event|0|||
125174390|NCT01807065|450259315|FG000|Overall Study|Receive no sip-T due to IV access|1|||
125230375|NCT00111761|450471588|FG000|Part 2|Physician Decision|1|||
125174391|NCT01807065|450259316|FG001|Overall Study|Receive no sip-T due to IV access|1|||
125174392|NCT02789137|450259317|FG000|Overall Study|Dropped out/Died|58|||
125174393|NCT00356525|450259318|FG000|Overall Study|Progressive Disease|8|||
125174394|NCT00356525|450259319|FG001|Overall Study|Progressive Disease|5|||
125174395|NCT00356525|450259320|FG002|Overall Study|Progressive Disease|4|||
125174396|NCT00356525|450259321|FG003|Overall Study|Progressive Disease|2|||
125230376|NCT00111761|450471589|FG001|Part 2|Physician Decision|0|||
125230377|NCT00111761|450471588|FG000|Part 2|Death|1|||
125230378|NCT00111761|450471589|FG001|Part 2|Death|0|||
125230379|NCT00111761|450471588|FG000|Part 2|Disease progression|3|||
125230380|NCT00111761|450471589|FG001|Part 2|Disease progression|0|||
125230381|NCT00111761|450471588|FG000|Part 2|Protocol-specified criteria|1|||
125230382|NCT00111761|450471589|FG001|Part 2|Protocol-specified criteria|0|||
125230383|NCT00111761|450471588|FG000|Part 2|Other|1|||
125230384|NCT00111761|450471589|FG001|Part 2|Other|0|||
125230385|NCT00746551|450471590|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
125230386|NCT00746551|450471591|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
125230387|NCT00746551|450471590|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
125230388|NCT00746551|450471591|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
125230389|NCT00746551|450471590|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
125230390|NCT00746551|450471591|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
125230391|NCT00171249|450471592|FG000|Overall Study|Withdrawal by Subject|2|||
125230392|NCT00171249|450471593|FG001|Overall Study|Withdrawal by Subject|0|||
125230393|NCT00171249|450471594|FG002|Overall Study|Withdrawal by Subject|0|||
125230394|NCT00171249|450471595|FG003|Overall Study|Withdrawal by Subject|6|||
125230395|NCT00171249|450471596|FG004|Overall Study|Withdrawal by Subject|0|||
125230396|NCT00171249|450471597|FG005|Overall Study|Withdrawal by Subject|0|||
125230397|NCT00171249|450471598|FG006|Overall Study|Withdrawal by Subject|0|||
125230398|NCT00171249|450471592|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
125230399|NCT00171249|450471593|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
125230400|NCT00171249|450471594|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
125230401|NCT00171249|450471595|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
125230402|NCT00171249|450471596|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
125230403|NCT00171249|450471597|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
125230404|NCT00171249|450471598|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
125230405|NCT00171249|450471592|FG000|Overall Study|Death|7|||
125230406|NCT00171249|450471593|FG001|Overall Study|Death|1|||
125230407|NCT00171249|450471594|FG002|Overall Study|Death|0|||
125230408|NCT00171249|450471595|FG003|Overall Study|Death|4|||
125230409|NCT00171249|450471596|FG004|Overall Study|Death|0|||
125230410|NCT00171249|450471597|FG005|Overall Study|Death|3|||
125230411|NCT00171249|450471598|FG006|Overall Study|Death|1|||
125230412|NCT00171249|450471592|FG000|Overall Study|Other|10|||
125230413|NCT00171249|450471593|FG001|Overall Study|Other|0|||
125230414|NCT00171249|450471594|FG002|Overall Study|Other|0|||
125230415|NCT00171249|450471595|FG003|Overall Study|Other|43|||
125230416|NCT00171249|450471596|FG004|Overall Study|Other|0|||
125230417|NCT00171249|450471597|FG005|Overall Study|Other|2|||
125230418|NCT00171249|450471598|FG006|Overall Study|Other|0|||
125230419|NCT00171249|450471592|FG000|Overall Study|No Longer Requires Study Drug|4|||
125230420|NCT00171249|450471593|FG001|Overall Study|No Longer Requires Study Drug|0|||
125230421|NCT00171249|450471594|FG002|Overall Study|No Longer Requires Study Drug|0|||
125230422|NCT00171249|450471595|FG003|Overall Study|No Longer Requires Study Drug|3|||
125230423|NCT00171249|450471596|FG004|Overall Study|No Longer Requires Study Drug|0|||
125230424|NCT00171249|450471597|FG005|Overall Study|No Longer Requires Study Drug|5|||
125230425|NCT00171249|450471598|FG006|Overall Study|No Longer Requires Study Drug|0|||
125230426|NCT00171249|450471592|FG000|Overall Study|Administrative Problems|1|||
125230427|NCT00171249|450471593|FG001|Overall Study|Administrative Problems|0|||
125230428|NCT00171249|450471594|FG002|Overall Study|Administrative Problems|0|||
125230429|NCT00171249|450471595|FG003|Overall Study|Administrative Problems|2|||
125230430|NCT00171249|450471596|FG004|Overall Study|Administrative Problems|0|||
125230431|NCT00171249|450471597|FG005|Overall Study|Administrative Problems|0|||
125230432|NCT00171249|450471598|FG006|Overall Study|Administrative Problems|0|||
125230433|NCT00171249|450471592|FG000|Overall Study|Adverse Event|3|||
125230434|NCT00171249|450471593|FG001|Overall Study|Adverse Event|1|||
125230435|NCT00171249|450471594|FG002|Overall Study|Adverse Event|0|||
125230436|NCT00171249|450471595|FG003|Overall Study|Adverse Event|15|||
125230437|NCT00171249|450471596|FG004|Overall Study|Adverse Event|0|||
125230438|NCT00171249|450471597|FG005|Overall Study|Adverse Event|2|||
125230439|NCT00171249|450471598|FG006|Overall Study|Adverse Event|0|||
125230440|NCT00171249|450471592|FG000|Overall Study|Lost to Follow-up|5|||
125230441|NCT00171249|450471593|FG001|Overall Study|Lost to Follow-up|0|||
125230442|NCT00171249|450471594|FG002|Overall Study|Lost to Follow-up|0|||
125230443|NCT00171249|450471595|FG003|Overall Study|Lost to Follow-up|9|||
125230444|NCT00171249|450471596|FG004|Overall Study|Lost to Follow-up|0|||
125230445|NCT00171249|450471597|FG005|Overall Study|Lost to Follow-up|0|||
125230446|NCT00171249|450471598|FG006|Overall Study|Lost to Follow-up|0|||
125230447|NCT03608826|450471600|FG000|Overall Study|Death|3|||
125230448|NCT03608826|450471600|FG000|Overall Study|Heart Transplant|3|||
125230449|NCT03608826|450471600|FG000|Overall Study|Physician Decision|4|||
125230450|NCT03122171|450471613|FG000|Overall Study|Withdrawal by Subject|1|||
125230451|NCT00720499|450471620|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
125230452|NCT00720499|450471621|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
125230453|NCT00720499|450471620|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
125174397|NCT00356525|450259318|FG000|Overall Study|Adverse Event|1|||
125174398|NCT00356525|450259319|FG001|Overall Study|Adverse Event|3|||
125174399|NCT00356525|450259320|FG002|Overall Study|Adverse Event|1|||
125174400|NCT00356525|450259321|FG003|Overall Study|Adverse Event|1|||
125174401|NCT00356525|450259318|FG000|Overall Study|Lost to Follow-up|1|||
125174402|NCT00356525|450259319|FG001|Overall Study|Lost to Follow-up|0|||
125174403|NCT00356525|450259320|FG002|Overall Study|Lost to Follow-up|0|||
125174404|NCT00356525|450259321|FG003|Overall Study|Lost to Follow-up|0|||
125174405|NCT00356525|450259318|FG000|Overall Study|Physician Decision|2|||
125174406|NCT00356525|450259319|FG001|Overall Study|Physician Decision|2|||
125174407|NCT00356525|450259320|FG002|Overall Study|Physician Decision|2|||
125174408|NCT00356525|450259321|FG003|Overall Study|Physician Decision|1|||
125174409|NCT00356525|450259318|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
125174410|NCT00356525|450259319|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
125174411|NCT00356525|450259320|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
125174412|NCT00356525|450259321|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
125174413|NCT00356525|450259318|FG000|Overall Study|Withdrawal by Subject|1|||
125174414|NCT00356525|450259319|FG001|Overall Study|Withdrawal by Subject|1|||
125174415|NCT00356525|450259320|FG002|Overall Study|Withdrawal by Subject|0|||
125174416|NCT00356525|450259321|FG003|Overall Study|Withdrawal by Subject|3|||
125174417|NCT00356525|450259318|FG000|Overall Study|Death|0|||
125174418|NCT00356525|450259319|FG001|Overall Study|Death|0|||
125174419|NCT00356525|450259320|FG002|Overall Study|Death|0|||
125174420|NCT00356525|450259321|FG003|Overall Study|Death|1|||
125174421|NCT00356525|450259318|FG000|Overall Study|Sponsor Decision|0|||
125174422|NCT00356525|450259319|FG001|Overall Study|Sponsor Decision|0|||
125174423|NCT00356525|450259320|FG002|Overall Study|Sponsor Decision|0|||
125174424|NCT00356525|450259321|FG003|Overall Study|Sponsor Decision|1|||
125174425|NCT01295320|450259322|FG000|Overall Study|Adverse Event|2|||
125174426|NCT01295320|450259322|FG000|Overall Study|Lost to Follow-up|4|||
125174427|NCT01295320|450259322|FG000|Overall Study|Withdrawal by Subject|2|||
125174428|NCT01295320|450259322|FG000|Overall Study|Subject was bedridden|1|||
125174429|NCT01295320|450259322|FG000|Overall Study|Unable to travel|1|||
125174430|NCT00462904|450259323|FG000|Overall Study|Lost to Follow-up|1|||
125174431|NCT01685840|450259327|FG000|Overall Study|Death|77|||
125174432|NCT01685840|450259328|FG001|Overall Study|Death|66|||
125174433|NCT01685840|450259327|FG000|Overall Study|Lost to Follow-up|27|||
125174434|NCT01685840|450259328|FG001|Overall Study|Lost to Follow-up|25|||
125174435|NCT01685840|450259327|FG000|Overall Study|Physician Decision|3|||
125174436|NCT01685840|450259328|FG001|Overall Study|Physician Decision|7|||
125174437|NCT01685840|450259327|FG000|Overall Study|Withdrawal by Subject|14|||
125174438|NCT01685840|450259328|FG001|Overall Study|Withdrawal by Subject|17|||
125174439|NCT01685840|450259327|FG000|Overall Study|Futility|197|||
125174440|NCT01685840|450259328|FG001|Overall Study|Futility|200|||
125174441|NCT01685840|450259327|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
125174442|NCT01685840|450259328|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
125174443|NCT04036110|450259332|FG000|Overall Study|Lost to Follow-up|3|||
125174444|NCT04036110|450259333|FG001|Overall Study|Lost to Follow-up|2|||
125174445|NCT04036110|450259334|FG002|Overall Study|Lost to Follow-up|1|||
125174446|NCT04036110|450259332|FG000|Overall Study|Study Suspended|4|||
125174447|NCT04036110|450259333|FG001|Overall Study|Study Suspended|5|||
125174448|NCT04036110|450259334|FG002|Overall Study|Study Suspended|1|||
125174449|NCT00246324|450259339|FG000|Overall Study|Withdrawal by Subject|1|||
125174450|NCT02006732|450259340|FG000|Overall Study|Adverse Event|10|||
125174451|NCT02006732|450259341|FG001|Overall Study|Adverse Event|7|||
125174452|NCT02006732|450259342|FG002|Overall Study|Adverse Event|4|||
125174453|NCT02006732|450259343|FG003|Overall Study|Adverse Event|2|||
125174454|NCT02006732|450259340|FG000|Overall Study|Lack of Efficacy|6|||
125174455|NCT02006732|450259341|FG001|Overall Study|Lack of Efficacy|3|||
125174456|NCT02006732|450259342|FG002|Overall Study|Lack of Efficacy|1|||
125174457|NCT02006732|450259343|FG003|Overall Study|Lack of Efficacy|1|||
125174458|NCT02006732|450259340|FG000|Overall Study|Protocol Violation|1|||
125174459|NCT02006732|450259341|FG001|Overall Study|Protocol Violation|1|||
125174460|NCT02006732|450259342|FG002|Overall Study|Protocol Violation|0|||
125174461|NCT02006732|450259343|FG003|Overall Study|Protocol Violation|0|||
125174462|NCT02006732|450259340|FG000|Overall Study|Lost to Follow-up|0|||
125174463|NCT02006732|450259341|FG001|Overall Study|Lost to Follow-up|1|||
125174464|NCT02006732|450259342|FG002|Overall Study|Lost to Follow-up|0|||
125174465|NCT02006732|450259343|FG003|Overall Study|Lost to Follow-up|0|||
125174466|NCT02006732|450259340|FG000|Overall Study|Withdrawal by Subject|3|||
125174467|NCT02006732|450259341|FG001|Overall Study|Withdrawal by Subject|0|||
125174468|NCT02006732|450259342|FG002|Overall Study|Withdrawal by Subject|4|||
125174469|NCT02006732|450259343|FG003|Overall Study|Withdrawal by Subject|1|||
125174470|NCT03516513|450259344|FG000|Overall Study|Withdrawal by Subject|2|||
125174471|NCT03516513|450259345|FG001|Overall Study|Withdrawal by Subject|2|||
125174472|NCT03516513|450259346|FG002|Overall Study|Withdrawal by Subject|0|||
125174473|NCT03516513|450259347|FG003|Overall Study|Withdrawal by Subject|0|||
125174474|NCT01098487|450259348|FG000|Overall Study|Adverse Event|22|||
125174475|NCT01098487|450259348|FG000|Overall Study|Lack of Efficacy|11|||
125230454|NCT00720499|450471621|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
125230455|NCT00720499|450471620|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
125230456|NCT00720499|450471621|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
125230457|NCT01326871|450471624|FG000|Overall Study|Major surgery|0|||
125230458|NCT01326871|450471625|FG001|Overall Study|Major surgery|1|||
125230459|NCT01326871|450471626|FG002|Overall Study|Major surgery|0|||
125230460|NCT01326871|450471624|FG000|Overall Study|SAE and death|0|||
125230461|NCT01326871|450471625|FG001|Overall Study|SAE and death|2|||
125230462|NCT01326871|450471626|FG002|Overall Study|SAE and death|0|||
125230463|NCT01326871|450471624|FG000|Overall Study|Physician decision and decreased performance status|0|||
125230464|NCT01326871|450471625|FG001|Overall Study|Physician decision and decreased performance status|1|||
125230465|NCT01326871|450471626|FG002|Overall Study|Physician decision and decreased performance status|0|||
125230466|NCT01326871|450471624|FG000|Overall Study|Disease progression|0|||
125230467|NCT01326871|450471625|FG001|Overall Study|Disease progression|11|||
125230468|NCT01326871|450471626|FG002|Overall Study|Disease progression|5|||
125230469|NCT01326871|450471624|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
125230470|NCT01326871|450471625|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
125230471|NCT01326871|450471626|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
125230472|NCT01326871|450471624|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
125230473|NCT01326871|450471625|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
125230474|NCT01326871|450471626|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
125230475|NCT01326871|450471624|FG000|Overall Study|Withdrawal by Subject|0|||
125230476|NCT01326871|450471625|FG001|Overall Study|Withdrawal by Subject|1|||
125230477|NCT01326871|450471626|FG002|Overall Study|Withdrawal by Subject|0|||
125230478|NCT01326871|450471624|FG000|Overall Study|DLT|0|||
125230479|NCT01326871|450471625|FG001|Overall Study|DLT|2|||
125230480|NCT01326871|450471626|FG002|Overall Study|DLT|0|||
125230481|NCT01326871|450471624|FG000|Overall Study|SAE, disease progression and subject decision|0|||
125230482|NCT01326871|450471625|FG001|Overall Study|SAE, disease progression and subject decision|1|||
125230483|NCT01326871|450471626|FG002|Overall Study|SAE, disease progression and subject decision|0|||
125230484|NCT01326871|450471624|FG000|Overall Study|Death|0|||
125230485|NCT01326871|450471625|FG001|Overall Study|Death|1|||
125230486|NCT01326871|450471626|FG002|Overall Study|Death|0|||
125230487|NCT01326871|450471624|FG000|Overall Study|Other|0|||
125230488|NCT01326871|450471625|FG001|Overall Study|Other|3|||
125230489|NCT01326871|450471626|FG002|Overall Study|Other|0|||
125230490|NCT01326871|450471624|FG000|Overall Study|SAE and disease progression|0|||
125230491|NCT01326871|450471625|FG001|Overall Study|SAE and disease progression|0|||
125230492|NCT01326871|450471626|FG002|Overall Study|SAE and disease progression|1|||
125230493|NCT01326871|450471624|FG000|Overall Study|SAE and physician decision|0|||
125230494|NCT01326871|450471625|FG001|Overall Study|SAE and physician decision|0|||
125230495|NCT01326871|450471626|FG002|Overall Study|SAE and physician decision|1|||
125230496|NCT01326871|450471624|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
125230497|NCT01326871|450471625|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
125230498|NCT01326871|450471626|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
125230499|NCT01326871|450471624|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
125230500|NCT01326871|450471625|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
125230501|NCT01326871|450471626|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
125230502|NCT01326871|450471624|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
125230503|NCT01326871|450471625|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
125230504|NCT01326871|450471626|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
125230505|NCT01326871|450471624|FG000|Overall Study|Physician Decision|0|||
125230506|NCT01326871|450471625|FG001|Overall Study|Physician Decision|0|||
125230507|NCT01326871|450471626|FG002|Overall Study|Physician Decision|1|||
125230508|NCT01326871|450471624|FG000|Overall Study|SAE|0|||
125230509|NCT01326871|450471625|FG001|Overall Study|SAE|0|||
125230510|NCT01326871|450471626|FG002|Overall Study|SAE|1|||
125230511|NCT01326871|450471624|FG000|Overall Study|Disease progression and death|0|||
125230512|NCT01326871|450471625|FG001|Overall Study|Disease progression and death|0|||
125230513|NCT01326871|450471626|FG002|Overall Study|Disease progression and death|1|||
125230514|NCT01326871|450471624|FG000|Overall Study|Subject decision|0|||
125230515|NCT01326871|450471625|FG001|Overall Study|Subject decision|0|||
125230516|NCT01326871|450471626|FG002|Overall Study|Subject decision|1|||
125230517|NCT01296412|450471632|FG000|Overall Study|Adverse Event|8|||
125230518|NCT01296412|450471633|FG001|Overall Study|Adverse Event|29|||
125230519|NCT01296412|450471632|FG000|Overall Study|Lack of Efficacy|1|||
125230520|NCT01296412|450471633|FG001|Overall Study|Lack of Efficacy|0|||
125230521|NCT01296412|450471632|FG000|Overall Study|Lost to Follow-up|10|||
125230522|NCT01296412|450471633|FG001|Overall Study|Lost to Follow-up|7|||
125230523|NCT01296412|450471632|FG000|Overall Study|Non-compliance with study drug|1|||
125230524|NCT01296412|450471633|FG001|Overall Study|Non-compliance with study drug|2|||
125230525|NCT01296412|450471632|FG000|Overall Study|Other reason not specified|20|||
125230526|NCT01296412|450471633|FG001|Overall Study|Other reason not specified|15|||
125230527|NCT01296412|450471632|FG000|Overall Study|Physician Decision|1|||
125230528|NCT01296412|450471633|FG001|Overall Study|Physician Decision|3|||
125230529|NCT01296412|450471632|FG000|Overall Study|Pregnancy|0|||
125230530|NCT01296412|450471633|FG001|Overall Study|Pregnancy|1|||
125230531|NCT01296412|450471632|FG000|Overall Study|Withdrawal by Subject|10|||
125230532|NCT01296412|450471633|FG001|Overall Study|Withdrawal by Subject|13|||
125230533|NCT02160626|450471635|FG000|Overall Study|Adverse Event|1|||
125230534|NCT02160626|450471636|FG001|Overall Study|Adverse Event|0|||
125230535|NCT02160626|450471637|FG002|Overall Study|Adverse Event|0|||
125174476|NCT01098487|450259348|FG000|Overall Study|Withdrawal by Subject|7|||
125174477|NCT01098487|450259348|FG000|Overall Study|Lost to Follow-up|3|||
125174478|NCT01098487|450259348|FG000|Overall Study|Physician Decision|1|||
125174479|NCT00345631|450259349|FG000|Overall Study|Withdrawal by Subject|1|||
125174480|NCT00345631|450259350|FG001|Overall Study|Withdrawal by Subject|0|||
125174481|NCT00345631|450259351|FG002|Overall Study|Withdrawal by Subject|1|||
125230536|NCT02160626|450471635|FG000|Overall Study|Schedule not conducive to study visits|0|||
125230537|NCT02160626|450471636|FG001|Overall Study|Schedule not conducive to study visits|0|||
125230538|NCT02160626|450471637|FG002|Overall Study|Schedule not conducive to study visits|1|||
125230539|NCT02160626|450471635|FG000|Overall Study|Withdrawal by Subject|0|||
125230540|NCT02160626|450471636|FG001|Overall Study|Withdrawal by Subject|1|||
125230541|NCT02160626|450471637|FG002|Overall Study|Withdrawal by Subject|0|||
125230542|NCT04239924|450471638|FG000|Overall Study|Lost to Follow-up|2|||
125230543|NCT00499122|450473743|FG000|Overall Study|Withdrawal by Subject|2|||
125230544|NCT00903968|450473744|FG000|Overall Study|Adverse Event|0|||
125230545|NCT00903968|450473745|FG001|Overall Study|Adverse Event|0|||
125230546|NCT00903968|450473746|FG002|Overall Study|Adverse Event|0|||
125230547|NCT00903968|450473747|FG003|Overall Study|Adverse Event|0|||
125230548|NCT00903968|450473748|FG004|Overall Study|Adverse Event|0|||
125230549|NCT00903968|450473749|FG005|Overall Study|Adverse Event|0|||
125230550|NCT00903968|450473750|FG006|Overall Study|Adverse Event|1|||
125230551|NCT00903968|450473751|FG007|Overall Study|Adverse Event|8|||
125230552|NCT00903968|450473744|FG000|Overall Study|DLT|0|||
125230553|NCT00903968|450473745|FG001|Overall Study|DLT|0|||
125230554|NCT00903968|450473746|FG002|Overall Study|DLT|0|||
125230555|NCT00903968|450473747|FG003|Overall Study|DLT|0|||
125174482|NCT00345631|450259349|FG000|Overall Study|Adverse Event|0|||
125174483|NCT00345631|450259350|FG001|Overall Study|Adverse Event|1|||
125174484|NCT00345631|450259351|FG002|Overall Study|Adverse Event|0|||
125174485|NCT00345631|450259349|FG000|Overall Study|Lost to Follow-up|3|||
125174486|NCT00345631|450259350|FG001|Overall Study|Lost to Follow-up|7|||
125174487|NCT00345631|450259351|FG002|Overall Study|Lost to Follow-up|4|||
125174488|NCT00345631|450259349|FG000|Overall Study|Other reasons|0|||
125174489|NCT00345631|450259350|FG001|Overall Study|Other reasons|0|||
125174490|NCT00345631|450259351|FG002|Overall Study|Other reasons|1|||
125174491|NCT00447993|450259352|FG000|Overall Study|Lost to Follow-up|0|||
125174492|NCT00447993|450259353|FG001|Overall Study|Lost to Follow-up|0|||
125174493|NCT00447993|450259354|FG002|Overall Study|Lost to Follow-up|2|||
125174494|NCT00447993|450259355|FG003|Overall Study|Lost to Follow-up|2|||
125174495|NCT00447993|450259352|FG000|Overall Study|Withdrawal by Subject|0|||
125174496|NCT00447993|450259353|FG001|Overall Study|Withdrawal by Subject|0|||
125174497|NCT00447993|450259354|FG002|Overall Study|Withdrawal by Subject|2|||
125174498|NCT00447993|450259355|FG003|Overall Study|Withdrawal by Subject|2|||
125174499|NCT01885195|450259356|FG000|Overall Study|Adverse Event|29|||
125174500|NCT01885195|450259356|FG000|Overall Study|Death|1|||
125174501|NCT01885195|450259356|FG000|Overall Study|Disease Progression|67|||
125174502|NCT01885195|450259356|FG000|Overall Study|Protocol Deviation|2|||
125174503|NCT01885195|450259356|FG000|Overall Study|Physician Decision|3|||
125230556|NCT00903968|450473748|FG004|Overall Study|DLT|0|||
125230557|NCT00903968|450473749|FG005|Overall Study|DLT|0|||
125230558|NCT00903968|450473750|FG006|Overall Study|DLT|2|||
125174504|NCT01885195|450259356|FG000|Overall Study|Patient/guardian decision|8|||
125230559|NCT00903968|450473751|FG007|Overall Study|DLT|0|||
125230560|NCT00903968|450473744|FG000|Overall Study|Withdrawal by Subject|1|||
125230561|NCT00903968|450473745|FG001|Overall Study|Withdrawal by Subject|0|||
125174505|NCT00548093|450259357|FG000|Overall Study|Death|33|||
125174506|NCT00548093|450259358|FG001|Overall Study|Death|13|||
125174507|NCT00548093|450259357|FG000|Overall Study|Lost to Follow-up|3|||
125174508|NCT00548093|450259358|FG001|Overall Study|Lost to Follow-up|1|||
125174509|NCT00548093|450259357|FG000|Overall Study|Objective progression or relapse|1|||
125174510|NCT00548093|450259358|FG001|Overall Study|Objective progression or relapse|1|||
125230562|NCT00903968|450473746|FG002|Overall Study|Withdrawal by Subject|1|||
125230563|NCT00903968|450473747|FG003|Overall Study|Withdrawal by Subject|0|||
125230564|NCT00903968|450473748|FG004|Overall Study|Withdrawal by Subject|1|||
125230565|NCT00903968|450473749|FG005|Overall Study|Withdrawal by Subject|1|||
125174511|NCT00548093|450259357|FG000|Overall Study|Other|11|||
125174512|NCT00548093|450259358|FG001|Overall Study|Other|1|||
125230566|NCT00903968|450473750|FG006|Overall Study|Withdrawal by Subject|0|||
125174513|NCT00548093|450259357|FG000|Overall Study|Withdrawal by Subject|1|||
125174514|NCT00548093|450259358|FG001|Overall Study|Withdrawal by Subject|0|||
125174515|NCT00548093|450259357|FG000|Overall Study|Completed post-treatment follow-up|1|||
125174516|NCT00548093|450259358|FG001|Overall Study|Completed post-treatment follow-up|0|||
125174517|NCT00509795|450259360|FG000|Overall Study|Adverse Event|4|||
125174518|NCT00509795|450259361|FG001|Overall Study|Adverse Event|3|||
125174519|NCT00509795|450259362|FG002|Overall Study|Adverse Event|5|||
125174520|NCT00509795|450259363|FG003|Overall Study|Adverse Event|4|||
125174521|NCT00509795|450259360|FG000|Overall Study|Death|3|||
125174522|NCT00509795|450259361|FG001|Overall Study|Death|1|||
125174523|NCT00509795|450259362|FG002|Overall Study|Death|2|||
125174524|NCT00509795|450259363|FG003|Overall Study|Death|7|||
125174525|NCT00509795|450259360|FG000|Overall Study|Lack of Efficacy|0|||
125174526|NCT00509795|450259361|FG001|Overall Study|Lack of Efficacy|0|||
125174527|NCT00509795|450259362|FG002|Overall Study|Lack of Efficacy|2|||
125174528|NCT00509795|450259363|FG003|Overall Study|Lack of Efficacy|2|||
125174529|NCT00509795|450259360|FG000|Overall Study|Lost to Follow-up|1|||
125174530|NCT00509795|450259361|FG001|Overall Study|Lost to Follow-up|2|||
125174531|NCT00509795|450259362|FG002|Overall Study|Lost to Follow-up|4|||
125174532|NCT00509795|450259363|FG003|Overall Study|Lost to Follow-up|4|||
125174533|NCT00509795|450259360|FG000|Overall Study|OTHER|1|||
125174534|NCT00509795|450259361|FG001|Overall Study|OTHER|0|||
125174535|NCT00509795|450259362|FG002|Overall Study|OTHER|4|||
125174536|NCT00509795|450259363|FG003|Overall Study|OTHER|1|||
125174537|NCT00509795|450259360|FG000|Overall Study|Protocol Violation|3|||
125174538|NCT00509795|450259361|FG001|Overall Study|Protocol Violation|0|||
125174539|NCT00509795|450259362|FG002|Overall Study|Protocol Violation|3|||
125174540|NCT00509795|450259363|FG003|Overall Study|Protocol Violation|1|||
125174541|NCT00509795|450259360|FG000|Overall Study|Withdrawal by Subject|10|||
125174542|NCT00509795|450259361|FG001|Overall Study|Withdrawal by Subject|5|||
125174543|NCT00509795|450259362|FG002|Overall Study|Withdrawal by Subject|7|||
125174544|NCT00509795|450259363|FG003|Overall Study|Withdrawal by Subject|8|||
125174545|NCT02296931|450259364|FG000|Overall Study|Protocol Violation|0|||
125174546|NCT02296931|450259365|FG001|Overall Study|Protocol Violation|2|||
125174547|NCT00912912|450259369|FG000|Overall Study|Withdrawal by Subject|1|||
125174548|NCT00912912|450259369|FG000|Overall Study|Disease Progression|3|||
125174549|NCT00306995|450259370|FG000|Study Part I|Withdrawal by Subject|0|||
125174550|NCT00306995|450259371|FG001|Study Part I|Withdrawal by Subject|0|||
125174551|NCT00306995|450259372|FG002|Study Part I|Withdrawal by Subject|0|||
125174552|NCT00306995|450259373|FG003|Study Part I|Withdrawal by Subject|0|||
125174553|NCT00306995|450259374|FG004|Study Part I|Withdrawal by Subject|0|||
125174554|NCT00306995|450259375|FG005|Study Part I|Withdrawal by Subject|0|||
125174555|NCT00306995|450259376|FG006|Study Part I|Withdrawal by Subject|1|||
125174556|NCT00306995|450259370|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
125174557|NCT00306995|450259371|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
125174558|NCT00306995|450259372|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
125174559|NCT00306995|450259373|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
125174560|NCT00306995|450259374|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
125174561|NCT00306995|450259375|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
125174562|NCT00306995|450259376|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
125174563|NCT04324073|450261614|FG000|Overall Study|withdrew consent|0|||
125174564|NCT04324073|450261615|FG001|Overall Study|withdrew consent|4|||
125174565|NCT04324073|450261616|FG002|Overall Study|withdrew consent|2|||
125174566|NCT04324073|450261617|FG003|Overall Study|withdrew consent|8|||
125174567|NCT05833139|450261618|FG000|Study Period 2|Adverse Event|1|||
125174568|NCT00371033|450261619|FG000|Overall Study|Lost to Follow-up|3|||
125174569|NCT00371033|450261620|FG001|Overall Study|Lost to Follow-up|2|||
125174570|NCT00371033|450261619|FG000|Overall Study|No longer interested|2|||
125174571|NCT00371033|450261620|FG001|Overall Study|No longer interested|0|||
125174572|NCT00371033|450261619|FG000|Overall Study|Uknown|3|||
125174573|NCT00371033|450261620|FG001|Overall Study|Uknown|1|||
125174574|NCT03922529|450261621|FG000|Overall Study|Withdrawal by Subject|13|||
125174575|NCT03922529|450261622|FG001|Overall Study|Withdrawal by Subject|12|||
125174576|NCT03922529|450261621|FG000|Overall Study|Death|7|||
125174577|NCT03922529|450261622|FG001|Overall Study|Death|12|||
125174578|NCT03922529|450261621|FG000|Overall Study|Lost to Follow-up|12|||
125174579|NCT03922529|450261622|FG001|Overall Study|Lost to Follow-up|19|||
125174580|NCT03922529|450261621|FG000|Overall Study|Adverse Event|1|||
125174581|NCT03922529|450261622|FG001|Overall Study|Adverse Event|0|||
125174582|NCT03922529|450261621|FG000|Overall Study|Death after withdrawal|1|||
125174583|NCT03922529|450261622|FG001|Overall Study|Death after withdrawal|0|||
125174584|NCT03922529|450261621|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
125174585|NCT03922529|450261622|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
125174586|NCT03922529|450261621|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
125174587|NCT03922529|450261622|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
125174588|NCT04158245|450261623|FG000|Overall Study|Lost to Follow-up|1|||
125174589|NCT03842228|450261626|FG000|Overall Study|Adverse Event|1|||
125230567|NCT00903968|450473751|FG007|Overall Study|Withdrawal by Subject|4|||
125230568|NCT00903968|450473744|FG000|Overall Study|Non-Compliance|0|||
125230569|NCT00903968|450473745|FG001|Overall Study|Non-Compliance|0|||
125230570|NCT00903968|450473746|FG002|Overall Study|Non-Compliance|0|||
125230571|NCT00903968|450473747|FG003|Overall Study|Non-Compliance|0|||
125230572|NCT00903968|450473748|FG004|Overall Study|Non-Compliance|0|||
125230573|NCT00903968|450473749|FG005|Overall Study|Non-Compliance|1|||
125230574|NCT00903968|450473750|FG006|Overall Study|Non-Compliance|0|||
125230575|NCT00903968|450473751|FG007|Overall Study|Non-Compliance|0|||
125230576|NCT00903968|450473744|FG000|Overall Study|Physician Decision|0|||
125230577|NCT00903968|450473745|FG001|Overall Study|Physician Decision|0|||
125230578|NCT00903968|450473746|FG002|Overall Study|Physician Decision|0|||
125230579|NCT00903968|450473747|FG003|Overall Study|Physician Decision|0|||
125230580|NCT00903968|450473748|FG004|Overall Study|Physician Decision|0|||
125230581|NCT00903968|450473749|FG005|Overall Study|Physician Decision|1|||
125230582|NCT00903968|450473750|FG006|Overall Study|Physician Decision|0|||
125230583|NCT00903968|450473751|FG007|Overall Study|Physician Decision|0|||
125230584|NCT00903968|450473744|FG000|Overall Study|Progressive Disease|2|||
125230585|NCT00903968|450473745|FG001|Overall Study|Progressive Disease|3|||
125230586|NCT00903968|450473746|FG002|Overall Study|Progressive Disease|2|||
125230587|NCT00903968|450473747|FG003|Overall Study|Progressive Disease|3|||
125230588|NCT00903968|450473748|FG004|Overall Study|Progressive Disease|3|||
125230589|NCT00903968|450473749|FG005|Overall Study|Progressive Disease|3|||
125230590|NCT00903968|450473750|FG006|Overall Study|Progressive Disease|0|||
125230591|NCT00903968|450473751|FG007|Overall Study|Progressive Disease|18|||
125230592|NCT00903968|450473744|FG000|Overall Study|Lack of Efficacy|0|||
125230593|NCT00903968|450473745|FG001|Overall Study|Lack of Efficacy|0|||
125230594|NCT00903968|450473746|FG002|Overall Study|Lack of Efficacy|0|||
125230595|NCT00903968|450473747|FG003|Overall Study|Lack of Efficacy|0|||
125230596|NCT00903968|450473748|FG004|Overall Study|Lack of Efficacy|0|||
125230597|NCT00903968|450473749|FG005|Overall Study|Lack of Efficacy|0|||
125230598|NCT00903968|450473750|FG006|Overall Study|Lack of Efficacy|0|||
125230599|NCT00903968|450473751|FG007|Overall Study|Lack of Efficacy|3|||
125230600|NCT01663623|450473752|FG000|Overall Study|Adverse Event|3|||
125230601|NCT01663623|450473753|FG001|Overall Study|Adverse Event|7|||
125230602|NCT01663623|450473752|FG000|Overall Study|Lack of Efficacy|5|||
125230603|NCT01663623|450473753|FG001|Overall Study|Lack of Efficacy|6|||
125230604|NCT01663623|450473752|FG000|Overall Study|Protocol Violation|0|||
125230605|NCT01663623|450473753|FG001|Overall Study|Protocol Violation|1|||
125230606|NCT01663623|450473752|FG000|Overall Study|Other-Study closed/terminated|1|||
125230607|NCT01663623|450473753|FG001|Overall Study|Other-Study closed/terminated|1|||
125230608|NCT01663623|450473752|FG000|Overall Study|Physician Decision|1|||
125230609|NCT01663623|450473753|FG001|Overall Study|Physician Decision|4|||
125230610|NCT01663623|450473752|FG000|Overall Study|Withdrawal by Subject|2|||
125230611|NCT01663623|450473753|FG001|Overall Study|Withdrawal by Subject|1|||
125230612|NCT02251275|450473754|FG000|Overall Study|Adverse Event|23|||
125230613|NCT02251275|450473755|FG001|Overall Study|Adverse Event|60|||
125230614|NCT02251275|450473756|FG002|Overall Study|Adverse Event|28|||
125230615|NCT02251275|450473757|FG003|Overall Study|Adverse Event|0|||
125230616|NCT02251275|450473758|FG004|Overall Study|Adverse Event|0|||
125230617|NCT02251275|450473754|FG000|Overall Study|Lost to Follow-up|5|||
125230618|NCT02251275|450473755|FG001|Overall Study|Lost to Follow-up|6|||
125230619|NCT02251275|450473756|FG002|Overall Study|Lost to Follow-up|4|||
125230620|NCT02251275|450473757|FG003|Overall Study|Lost to Follow-up|0|||
125230621|NCT02251275|450473758|FG004|Overall Study|Lost to Follow-up|0|||
125230622|NCT02251275|450473754|FG000|Overall Study|Physician Decision|19|||
125230623|NCT02251275|450473755|FG001|Overall Study|Physician Decision|30|||
125230624|NCT02251275|450473756|FG002|Overall Study|Physician Decision|26|||
125230625|NCT02251275|450473757|FG003|Overall Study|Physician Decision|0|||
125230626|NCT02251275|450473758|FG004|Overall Study|Physician Decision|1|||
125230627|NCT02251275|450473754|FG000|Overall Study|Protocol Deviation|0|||
125230628|NCT02251275|450473755|FG001|Overall Study|Protocol Deviation|0|||
125230629|NCT02251275|450473756|FG002|Overall Study|Protocol Deviation|1|||
125230630|NCT02251275|450473757|FG003|Overall Study|Protocol Deviation|0|||
125230631|NCT02251275|450473758|FG004|Overall Study|Protocol Deviation|0|||
125230632|NCT02251275|450473754|FG000|Overall Study|Withdrawal by Subject|25|||
125230633|NCT02251275|450473755|FG001|Overall Study|Withdrawal by Subject|51|||
125230634|NCT02251275|450473756|FG002|Overall Study|Withdrawal by Subject|35|||
125230635|NCT02251275|450473757|FG003|Overall Study|Withdrawal by Subject|1|||
125230636|NCT02251275|450473758|FG004|Overall Study|Withdrawal by Subject|0|||
125230637|NCT00856180|450473764|FG000|Overall Study|Adverse Event|4|||
125230638|NCT00856180|450473764|FG000|Overall Study|Progressive Disease|16|||
125230639|NCT02265510|450473765|FG000|Overall Study|Withdrawal by Subject|1|||
125230640|NCT02265510|450473766|FG001|Overall Study|Withdrawal by Subject|1|||
125230641|NCT02265510|450473767|FG002|Overall Study|Withdrawal by Subject|2|||
125230642|NCT02265510|450473768|FG003|Overall Study|Withdrawal by Subject|1|||
125230643|NCT02265510|450473769|FG004|Overall Study|Withdrawal by Subject|0|||
125230644|NCT02265510|450473770|FG005|Overall Study|Withdrawal by Subject|2|||
125230645|NCT02265510|450473771|FG006|Overall Study|Withdrawal by Subject|0|||
125230646|NCT02265510|450473772|FG007|Overall Study|Withdrawal by Subject|2|||
125174590|NCT03842228|450261627|FG001|Overall Study|Adverse Event|1|||
125174591|NCT03842228|450261628|FG002|Overall Study|Adverse Event|1|||
125174592|NCT03842228|450261629|FG003|Overall Study|Adverse Event|0|||
125174593|NCT03842228|450261630|FG004|Overall Study|Adverse Event|0|||
125174594|NCT03842228|450261631|FG005|Overall Study|Adverse Event|0|||
125174595|NCT03842228|450261632|FG006|Overall Study|Adverse Event|0|||
125174596|NCT03842228|450261626|FG000|Overall Study|Death|0|||
125174597|NCT03842228|450261627|FG001|Overall Study|Death|1|||
125174598|NCT03842228|450261628|FG002|Overall Study|Death|0|||
125174599|NCT03842228|450261629|FG003|Overall Study|Death|0|||
125174600|NCT03842228|450261630|FG004|Overall Study|Death|0|||
125174601|NCT03842228|450261631|FG005|Overall Study|Death|0|||
125174602|NCT03842228|450261632|FG006|Overall Study|Death|0|||
125174603|NCT03842228|450261626|FG000|Overall Study|Withdrawal by Subject|0|||
125174604|NCT03842228|450261627|FG001|Overall Study|Withdrawal by Subject|0|||
125174605|NCT03842228|450261628|FG002|Overall Study|Withdrawal by Subject|2|||
125174606|NCT03842228|450261629|FG003|Overall Study|Withdrawal by Subject|1|||
125174607|NCT03842228|450261630|FG004|Overall Study|Withdrawal by Subject|0|||
125174608|NCT03842228|450261631|FG005|Overall Study|Withdrawal by Subject|0|||
125174609|NCT03842228|450261632|FG006|Overall Study|Withdrawal by Subject|2|||
125174610|NCT03842228|450261626|FG000|Overall Study|Progression|8|||
125174611|NCT03842228|450261627|FG001|Overall Study|Progression|1|||
125174612|NCT03842228|450261628|FG002|Overall Study|Progression|7|||
125174613|NCT03842228|450261629|FG003|Overall Study|Progression|5|||
125174614|NCT03842228|450261630|FG004|Overall Study|Progression|4|||
125174615|NCT03842228|450261631|FG005|Overall Study|Progression|2|||
125174616|NCT03842228|450261632|FG006|Overall Study|Progression|3|||
125174617|NCT06390826|450261633|FG000|Overall Study|Never Start Protocol Therapy|1|||
125174618|NCT06390826|450261633|FG000|Overall Study|Adverse Event|1|||
125174619|NCT06390826|450261633|FG000|Overall Study|Disease Progression|8|||
125174620|NCT06390839|450261634|FG000|Overall Study|Ineligible|2|||
125174621|NCT06390839|450261634|FG000|Overall Study|Never start protocol therapy|3|||
125174622|NCT06390839|450261634|FG000|Overall Study|Adverse Event|1|||
125174623|NCT06390839|450261634|FG000|Overall Study|Alternative therapy|2|||
125174624|NCT06390839|450261634|FG000|Overall Study|Death|3|||
125174625|NCT06390839|450261634|FG000|Overall Study|Disease progression|28|||
125174626|NCT06390839|450261634|FG000|Overall Study|Withdrawal by Subject|2|||
125174627|NCT06390839|450261634|FG000|Overall Study|Complicating disease|1|||
125174628|NCT06390839|450261634|FG000|Overall Study|Noncompliance|1|||
125174629|NCT06351371|450261635|FG000|Overall Study|Mutation Status Not Confirmed|9|||
125174630|NCT06351371|450261635|FG000|Overall Study|Ineligible|1|||
125174631|NCT06351371|450261635|FG000|Overall Study|Adverse Event|4|||
125174632|NCT06351371|450261635|FG000|Overall Study|Death|1|||
125174633|NCT06351371|450261635|FG000|Overall Study|Disease progression|14|||
125174634|NCT06351371|450261635|FG000|Overall Study|Withdrawal by Subject|3|||
125174635|NCT06351371|450261635|FG000|Overall Study|Physician Decision|3|||
125174636|NCT01272037|450261637|FG000|Overall Study|Death|25|||
125174637|NCT01272037|450261638|FG001|Overall Study|Death|28|||
125174638|NCT01272037|450261637|FG000|Overall Study|Adverse Event|12|||
125174639|NCT01272037|450261638|FG001|Overall Study|Adverse Event|7|||
125174640|NCT01272037|450261637|FG000|Overall Study|Withdrawal by Subject|175|||
125174641|NCT01272037|450261638|FG001|Overall Study|Withdrawal by Subject|93|||
125174642|NCT01272037|450261637|FG000|Overall Study|Disease progression|70|||
125174643|NCT01272037|450261638|FG001|Overall Study|Disease progression|111|||
125174644|NCT01272037|450261637|FG000|Overall Study|Other reason|42|||
125174645|NCT01272037|450261638|FG001|Overall Study|Other reason|41|||
125174646|NCT01272037|450261637|FG000|Overall Study|Delinquent data|24|||
125174647|NCT01272037|450261638|FG001|Overall Study|Delinquent data|19|||
125174648|NCT01272037|450261637|FG000|Overall Study|Reason under review|33|||
125174649|NCT01272037|450261638|FG001|Overall Study|Reason under review|29|||
125174650|NCT01272037|450261637|FG000|Overall Study|On treatment|626|||
125174651|NCT01272037|450261638|FG001|Overall Study|On treatment|632|||
125174652|NCT01121562|450261639|FG000|Overall Study|Objective progression or relapse|8|||
125174653|NCT01121562|450261639|FG000|Overall Study|Withdrawal by Subject|1|||
125174654|NCT01121562|450261639|FG000|Overall Study|Adverse Event|1|||
125174655|NCT01121562|450261639|FG000|Overall Study|Sponsor Decision|1|||
125174656|NCT01121562|450261639|FG000|Overall Study|Met study discontinuation criteria|1|||
125174657|NCT04152863|450261640|FG000|Overall Study|Death|13|||
125174658|NCT04152863|450261641|FG001|Overall Study|Death|12|||
125174659|NCT04152863|450261642|FG002|Overall Study|Death|7|||
125174660|NCT04152863|450261640|FG000|Overall Study|Physician Decision|1|||
125174661|NCT04152863|450261641|FG001|Overall Study|Physician Decision|1|||
125174662|NCT04152863|450261642|FG002|Overall Study|Physician Decision|1|||
125174663|NCT04152863|450261640|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
125174664|NCT04152863|450261641|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
125174665|NCT04152863|450261642|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
125174666|NCT04152863|450261640|FG000|Overall Study|Withdrawal by Subject|2|||
125174667|NCT04152863|450261641|FG001|Overall Study|Withdrawal by Subject|1|||
125174668|NCT04152863|450261642|FG002|Overall Study|Withdrawal by Subject|3|||
125174669|NCT02540083|450261648|FG000|Overall Study|Withdrawal by Subject|16|||
125230647|NCT02265510|450473773|FG008|Overall Study|Withdrawal by Subject|0|||
125230648|NCT02265510|450473774|FG009|Overall Study|Withdrawal by Subject|0|||
125230649|NCT02265510|450473775|FG010|Overall Study|Withdrawal by Subject|0|||
125230650|NCT02265510|450473776|FG011|Overall Study|Withdrawal by Subject|0|||
125230651|NCT02265510|450473777|FG012|Overall Study|Withdrawal by Subject|1|||
125230652|NCT02265510|450473778|FG013|Overall Study|Withdrawal by Subject|0|||
125230653|NCT02265510|450473765|FG000|Overall Study|Disease Progression|0|||
125230654|NCT02265510|450473766|FG001|Overall Study|Disease Progression|1|||
125230655|NCT02265510|450473767|FG002|Overall Study|Disease Progression|2|||
125230656|NCT02265510|450473768|FG003|Overall Study|Disease Progression|1|||
125230657|NCT02265510|450473769|FG004|Overall Study|Disease Progression|1|||
125230658|NCT02265510|450473770|FG005|Overall Study|Disease Progression|0|||
125230659|NCT02265510|450473771|FG006|Overall Study|Disease Progression|0|||
125230660|NCT02265510|450473772|FG007|Overall Study|Disease Progression|0|||
125230661|NCT02265510|450473773|FG008|Overall Study|Disease Progression|0|||
125230662|NCT02265510|450473774|FG009|Overall Study|Disease Progression|0|||
125230663|NCT02265510|450473775|FG010|Overall Study|Disease Progression|0|||
125230664|NCT02265510|450473776|FG011|Overall Study|Disease Progression|0|||
125230665|NCT02265510|450473777|FG012|Overall Study|Disease Progression|0|||
125230666|NCT02265510|450473778|FG013|Overall Study|Disease Progression|0|||
125230667|NCT02265510|450473765|FG000|Overall Study|Death|2|||
125230668|NCT02265510|450473766|FG001|Overall Study|Death|0|||
125230669|NCT02265510|450473767|FG002|Overall Study|Death|2|||
125230670|NCT02265510|450473768|FG003|Overall Study|Death|2|||
125230671|NCT02265510|450473769|FG004|Overall Study|Death|1|||
125230672|NCT02265510|450473770|FG005|Overall Study|Death|3|||
125230673|NCT02265510|450473771|FG006|Overall Study|Death|2|||
125230674|NCT02265510|450473772|FG007|Overall Study|Death|1|||
125230675|NCT02265510|450473773|FG008|Overall Study|Death|3|||
125230676|NCT02265510|450473774|FG009|Overall Study|Death|3|||
125230677|NCT02265510|450473775|FG010|Overall Study|Death|4|||
125230678|NCT02265510|450473776|FG011|Overall Study|Death|12|||
125230679|NCT02265510|450473777|FG012|Overall Study|Death|7|||
125230680|NCT02265510|450473778|FG013|Overall Study|Death|6|||
125230681|NCT02265510|450473765|FG000|Overall Study|Lost to Follow-up|0|||
125230682|NCT02265510|450473766|FG001|Overall Study|Lost to Follow-up|0|||
125230683|NCT02265510|450473767|FG002|Overall Study|Lost to Follow-up|0|||
125230684|NCT02265510|450473768|FG003|Overall Study|Lost to Follow-up|0|||
125230685|NCT02265510|450473769|FG004|Overall Study|Lost to Follow-up|1|||
125230686|NCT02265510|450473770|FG005|Overall Study|Lost to Follow-up|0|||
125230687|NCT02265510|450473771|FG006|Overall Study|Lost to Follow-up|0|||
125230688|NCT02265510|450473772|FG007|Overall Study|Lost to Follow-up|0|||
125230689|NCT02265510|450473773|FG008|Overall Study|Lost to Follow-up|0|||
125230690|NCT02265510|450473774|FG009|Overall Study|Lost to Follow-up|2|||
125230691|NCT02265510|450473775|FG010|Overall Study|Lost to Follow-up|0|||
125230692|NCT02265510|450473776|FG011|Overall Study|Lost to Follow-up|0|||
125230693|NCT02265510|450473777|FG012|Overall Study|Lost to Follow-up|0|||
125230694|NCT02265510|450473778|FG013|Overall Study|Lost to Follow-up|2|||
125230695|NCT02265510|450473765|FG000|Overall Study|Other|0|||
125230696|NCT02265510|450473766|FG001|Overall Study|Other|1|||
125230697|NCT02265510|450473767|FG002|Overall Study|Other|0|||
125230698|NCT02265510|450473768|FG003|Overall Study|Other|0|||
125230699|NCT02265510|450473769|FG004|Overall Study|Other|0|||
125230700|NCT02265510|450473770|FG005|Overall Study|Other|0|||
125230701|NCT02265510|450473771|FG006|Overall Study|Other|0|||
125230702|NCT02265510|450473772|FG007|Overall Study|Other|0|||
125230703|NCT02265510|450473773|FG008|Overall Study|Other|0|||
125230704|NCT02265510|450473774|FG009|Overall Study|Other|0|||
125230705|NCT02265510|450473775|FG010|Overall Study|Other|0|||
125230706|NCT02265510|450473776|FG011|Overall Study|Other|0|||
125230707|NCT02265510|450473777|FG012|Overall Study|Other|0|||
125230708|NCT02265510|450473778|FG013|Overall Study|Other|0|||
125230709|NCT02265510|450473765|FG000|Overall Study|Study Terminated by Sponsor|0|||
125230710|NCT02265510|450473766|FG001|Overall Study|Study Terminated by Sponsor|0|||
125230711|NCT02265510|450473767|FG002|Overall Study|Study Terminated by Sponsor|0|||
125230712|NCT02265510|450473768|FG003|Overall Study|Study Terminated by Sponsor|0|||
125230713|NCT02265510|450473769|FG004|Overall Study|Study Terminated by Sponsor|0|||
125230714|NCT02265510|450473770|FG005|Overall Study|Study Terminated by Sponsor|1|||
125230715|NCT02265510|450473771|FG006|Overall Study|Study Terminated by Sponsor|1|||
125230716|NCT02265510|450473772|FG007|Overall Study|Study Terminated by Sponsor|1|||
125230717|NCT02265510|450473773|FG008|Overall Study|Study Terminated by Sponsor|1|||
125230718|NCT02265510|450473774|FG009|Overall Study|Study Terminated by Sponsor|2|||
125230719|NCT02265510|450473775|FG010|Overall Study|Study Terminated by Sponsor|1|||
125230720|NCT02265510|450473776|FG011|Overall Study|Study Terminated by Sponsor|4|||
125230721|NCT02265510|450473777|FG012|Overall Study|Study Terminated by Sponsor|1|||
125230722|NCT02265510|450473778|FG013|Overall Study|Study Terminated by Sponsor|2|||
125230723|NCT01004614|450473779|FG000|Washout|Withdrawal by Subject|0|||
125230724|NCT01004614|450473780|FG001|Washout|Withdrawal by Subject|1|||
125230725|NCT01004614|450473781|FG002|Washout|Withdrawal by Subject|0|||
125230726|NCT01004614|450473782|FG003|Washout|Withdrawal by Subject|0|||
125230727|NCT02111083|450473783|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
125230728|NCT02111083|450473784|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
125230729|NCT00368550|450473785|FG000|Overall Study|Adverse Event|7|||
125230730|NCT00368550|450473786|FG001|Overall Study|Adverse Event|4|||
125230731|NCT00368550|450473785|FG000|Overall Study|Lack of Efficacy|4|||
125230732|NCT00368550|450473786|FG001|Overall Study|Lack of Efficacy|9|||
125230733|NCT00368550|450473785|FG000|Overall Study|Withdrawal by Subject|17|||
125230734|NCT00368550|450473786|FG001|Overall Study|Withdrawal by Subject|10|||
125230735|NCT00486044|450473787|FG000|Overall Study|Withdrawal by Subject|2|||
125230736|NCT00486044|450473788|FG001|Overall Study|Withdrawal by Subject|1|||
125230737|NCT00486044|450473787|FG000|Overall Study|Adverse Event|0|||
125230738|NCT00486044|450473788|FG001|Overall Study|Adverse Event|1|||
125230739|NCT00486044|450473787|FG000|Overall Study|Lost to Follow-up|0|||
125230740|NCT00486044|450473788|FG001|Overall Study|Lost to Follow-up|1|||
125230741|NCT01670292|450473792|FG000|Overall Study|Lost to Follow-up|14|||
125230742|NCT03154086|450473797|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230743|NCT03154086|450473798|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230744|NCT03154086|450473799|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230745|NCT03154086|450473800|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
125230746|NCT03154086|450473801|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230747|NCT03154086|450473802|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230748|NCT03154086|450473803|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230749|NCT03154086|450473804|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230750|NCT03154086|450473805|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230751|NCT03154086|450473806|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230752|NCT03154086|450473807|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230753|NCT03154086|450473808|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230754|NCT03154086|450473809|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230755|NCT03154086|450473810|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230756|NCT03154086|450473811|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230757|NCT03154086|450473797|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230758|NCT03154086|450473798|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
125230759|NCT03154086|450473799|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230760|NCT03154086|450473800|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230761|NCT03154086|450473801|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230762|NCT03154086|450473802|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230763|NCT03154086|450473803|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230764|NCT03154086|450473804|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230765|NCT03154086|450473805|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230766|NCT03154086|450473806|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230767|NCT03154086|450473807|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230768|NCT03154086|450473808|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230769|NCT03154086|450473809|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230770|NCT03154086|450473810|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230771|NCT03154086|450473811|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230772|NCT03154086|450473797|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230773|NCT03154086|450473798|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230774|NCT03154086|450473799|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
125230775|NCT03154086|450473800|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230776|NCT03154086|450473801|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230777|NCT03154086|450473802|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230778|NCT03154086|450473803|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230779|NCT03154086|450473804|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230780|NCT03154086|450473805|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230781|NCT03154086|450473806|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230782|NCT03154086|450473807|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230783|NCT03154086|450473808|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230784|NCT03154086|450473809|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230785|NCT03154086|450473810|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230786|NCT03154086|450473811|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230787|NCT03154086|450473797|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
125230788|NCT03154086|450473798|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230789|NCT03154086|450473799|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230790|NCT03154086|450473800|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230791|NCT03154086|450473801|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230792|NCT03154086|450473802|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230793|NCT03154086|450473803|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230794|NCT03154086|450473804|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230795|NCT03154086|450473805|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230796|NCT03154086|450473806|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230797|NCT03154086|450473807|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230798|NCT03154086|450473808|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230799|NCT03154086|450473809|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230800|NCT03154086|450473810|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230801|NCT03154086|450473811|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230802|NCT03154086|450473797|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230803|NCT03154086|450473798|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230804|NCT03154086|450473799|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230805|NCT03154086|450473800|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230806|NCT03154086|450473801|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230807|NCT03154086|450473802|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230808|NCT03154086|450473803|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230809|NCT03154086|450473804|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230810|NCT03154086|450473805|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
125230811|NCT03154086|450473806|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230812|NCT03154086|450473807|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230813|NCT03154086|450473808|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230814|NCT03154086|450473809|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230815|NCT03154086|450473810|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230816|NCT03154086|450473811|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230817|NCT03154086|450473797|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230818|NCT03154086|450473798|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230819|NCT03154086|450473799|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230820|NCT03154086|450473800|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230821|NCT03154086|450473801|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230822|NCT03154086|450473802|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230823|NCT03154086|450473803|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230824|NCT03154086|450473804|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
125230825|NCT03154086|450473805|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230826|NCT03154086|450473806|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230827|NCT03154086|450473807|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230828|NCT03154086|450473808|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230829|NCT03154086|450473809|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230830|NCT03154086|450473810|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230831|NCT03154086|450473811|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230832|NCT03154086|450473797|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
125230833|NCT03154086|450473798|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
125230834|NCT03154086|450473799|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
125230835|NCT03154086|450473800|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
125230836|NCT03154086|450473801|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
125230837|NCT03154086|450473802|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
125230838|NCT03154086|450473803|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
125230839|NCT03154086|450473804|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
125230840|NCT03154086|450473805|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
125230841|NCT03154086|450473806|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
125230842|NCT03154086|450473807|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
125230843|NCT03154086|450473808|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
125230844|NCT03154086|450473809|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
125230845|NCT03154086|450473810|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
125230846|NCT03154086|450473811|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
125230847|NCT01603277|450473812|FG000|Overall Study|Adverse Event|1|||
125174670|NCT02797171|450261649|FG000|Overall Study|Lost to Follow-up|2|||
125174671|NCT02797171|450261650|FG001|Overall Study|Lost to Follow-up|0|||
125174672|NCT02797171|450261651|FG002|Overall Study|Lost to Follow-up|2|||
125174673|NCT02797171|450261652|FG003|Overall Study|Lost to Follow-up|1|||
125174674|NCT02797171|450261653|FG004|Overall Study|Lost to Follow-up|2|||
125174675|NCT02797171|450261654|FG005|Overall Study|Lost to Follow-up|0|||
125174676|NCT02797171|450261649|FG000|Overall Study|Withdrawal by Subject|1|||
125174677|NCT02797171|450261650|FG001|Overall Study|Withdrawal by Subject|1|||
125174678|NCT02797171|450261651|FG002|Overall Study|Withdrawal by Subject|0|||
125174679|NCT02797171|450261652|FG003|Overall Study|Withdrawal by Subject|0|||
125174680|NCT02797171|450261653|FG004|Overall Study|Withdrawal by Subject|0|||
125174681|NCT02797171|450261654|FG005|Overall Study|Withdrawal by Subject|0|||
125174682|NCT02797171|450261649|FG000|Overall Study|Protocol Violation|1|||
125174683|NCT02797171|450261650|FG001|Overall Study|Protocol Violation|0|||
125174684|NCT02797171|450261651|FG002|Overall Study|Protocol Violation|0|||
125174685|NCT02797171|450261652|FG003|Overall Study|Protocol Violation|0|||
125174686|NCT02797171|450261653|FG004|Overall Study|Protocol Violation|0|||
125230848|NCT01603277|450473813|FG001|Overall Study|Adverse Event|2|||
125230849|NCT01603277|450473812|FG000|Overall Study|Physician Decision|0|||
125230850|NCT01603277|450473813|FG001|Overall Study|Physician Decision|1|||
125230851|NCT01603277|450473812|FG000|Overall Study|Protocol Violation|6|||
125230852|NCT01603277|450473813|FG001|Overall Study|Protocol Violation|10|||
125174687|NCT02797171|450261654|FG005|Overall Study|Protocol Violation|0|||
125174688|NCT02797171|450261649|FG000|Overall Study|Participant unable to adhere|0|||
125174689|NCT02797171|450261650|FG001|Overall Study|Participant unable to adhere|1|||
125174690|NCT02797171|450261651|FG002|Overall Study|Participant unable to adhere|0|||
125174691|NCT02797171|450261652|FG003|Overall Study|Participant unable to adhere|0|||
125174692|NCT02797171|450261653|FG004|Overall Study|Participant unable to adhere|0|||
125174693|NCT02797171|450261654|FG005|Overall Study|Participant unable to adhere|0|||
125174694|NCT02797171|450261649|FG000|Overall Study|Not Randomized|0|||
125174695|NCT02797171|450261650|FG001|Overall Study|Not Randomized|0|||
125174696|NCT02797171|450261651|FG002|Overall Study|Not Randomized|0|||
125174697|NCT02797171|450261652|FG003|Overall Study|Not Randomized|0|||
125174698|NCT02797171|450261653|FG004|Overall Study|Not Randomized|0|||
125174699|NCT02797171|450261654|FG005|Overall Study|Not Randomized|1|||
125174700|NCT03993379|450261655|FG000|Overall Study|The study was terminated early due to business decision.|0|||
125174701|NCT03993379|450261656|FG001|Overall Study|The study was terminated early due to business decision.|2|||
125174702|NCT03993379|450261657|FG002|Overall Study|The study was terminated early due to business decision.|0|||
125174703|NCT03993379|450261658|FG003|Overall Study|The study was terminated early due to business decision.|0|||
125174704|NCT03993379|450261655|FG000|Overall Study|Withdrawal by Subject|0|||
125174705|NCT03993379|450261656|FG001|Overall Study|Withdrawal by Subject|1|||
125174706|NCT03993379|450261657|FG002|Overall Study|Withdrawal by Subject|0|||
125174707|NCT03993379|450261658|FG003|Overall Study|Withdrawal by Subject|0|||
125174708|NCT01427608|450261659|FG000|Overall Study|Death|1|||
125174709|NCT01427608|450261660|FG001|Overall Study|Death|0|||
125174710|NCT01427608|450261659|FG000|Overall Study|Withdrawal by Subject|7|||
125174711|NCT01427608|450261660|FG001|Overall Study|Withdrawal by Subject|3|||
125174712|NCT01427608|450261659|FG000|Overall Study|Relapsed-all cause|13|||
125174713|NCT01427608|450261660|FG001|Overall Study|Relapsed-all cause|34|||
125174714|NCT01427608|450261659|FG000|Overall Study|Events not attributed to study meds|0|||
125174715|NCT01427608|450261660|FG001|Overall Study|Events not attributed to study meds|1|||
125174716|NCT04289363|450261665|FG000|Overall Study|Lost to Follow-up|14|||
125174717|NCT04289363|450261666|FG001|Overall Study|Lost to Follow-up|0|||
125174718|NCT02585778|450261667|FG000|Overall Study|Adverse Event|17|||
125174719|NCT02585778|450261668|FG001|Overall Study|Adverse Event|4|||
125174720|NCT02585778|450261667|FG000|Overall Study|Participant did not wish to continue|9|||
125174721|NCT02585778|450261668|FG001|Overall Study|Participant did not wish to continue|4|||
125174722|NCT02585778|450261667|FG000|Overall Study|Poor compliance to study protocol|0|||
125174723|NCT02585778|450261668|FG001|Overall Study|Poor compliance to study protocol|2|||
125174724|NCT02585778|450261667|FG000|Overall Study|Death|0|||
125174725|NCT02585778|450261668|FG001|Overall Study|Death|1|||
125174726|NCT02585778|450261667|FG000|Overall Study|Randomized but not treated|1|||
125174727|NCT02585778|450261668|FG001|Overall Study|Randomized but not treated|2|||
125174728|NCT02585778|450261667|FG000|Overall Study|Other than specified above|6|||
125174729|NCT02585778|450261668|FG001|Overall Study|Other than specified above|2|||
125174730|NCT00445432|450261670|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
125174731|NCT00445432|450261671|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
125174732|NCT00445432|450261672|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
125174733|NCT00445432|450261673|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
125174734|NCT00445432|450261670|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
125174735|NCT00445432|450261671|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
125174736|NCT00445432|450261672|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
125174737|NCT00445432|450261673|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
125174738|NCT00445432|450261670|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
125174739|NCT00445432|450261671|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
125174740|NCT00445432|450261672|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
125174741|NCT00445432|450261673|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
125230853|NCT01603277|450473812|FG000|Overall Study|Withdrawal by Subject|5|||
125230854|NCT01603277|450473813|FG001|Overall Study|Withdrawal by Subject|4|||
125230855|NCT01603277|450473812|FG000|Overall Study|Non-Compliance|2|||
125174742|NCT00445432|450261670|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
125174743|NCT00445432|450261671|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
125174744|NCT00445432|450261672|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
125174745|NCT00445432|450261673|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
125174746|NCT00445432|450261670|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
125174747|NCT00445432|450261671|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
125174748|NCT00445432|450261672|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
125174749|NCT00445432|450261673|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
125230856|NCT01603277|450473813|FG001|Overall Study|Non-Compliance|1|||
125230857|NCT04494646|450473818|FG000|Overall Study|Adverse Event|0|||
125230858|NCT04494646|450473819|FG001|Overall Study|Adverse Event|1|||
125230859|NCT04494646|450473818|FG000|Overall Study|Withdrawal by Subject|0|||
125230860|NCT04494646|450473819|FG001|Overall Study|Withdrawal by Subject|1|||
125230861|NCT02785939|450473822|FG000|Overall Study|Progression|25|||
125230862|NCT02785939|450473823|FG001|Overall Study|Progression|8|||
125174750|NCT00445432|450261670|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
125174751|NCT00445432|450261671|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
125174752|NCT00445432|450261672|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
125174753|NCT00445432|450261673|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
125174754|NCT00445432|450261670|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
125174755|NCT00445432|450261671|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
125174756|NCT00445432|450261672|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
125174757|NCT00445432|450261673|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
125174758|NCT01482312|450261676|FG000|Period 1, 90 Minutes of Wear|Other|1|||
125174759|NCT01482312|450261677|FG001|Period 1, 90 Minutes of Wear|Other|0|||
125174760|NCT01482312|450261678|FG002|Period 1, 90 Minutes of Wear|Other|0|||
125174761|NCT01482312|450261676|FG000|Period 2, 90 Minutes of Wear|Other|1|||
125174762|NCT01482312|450261677|FG001|Period 2, 90 Minutes of Wear|Other|0|||
125174763|NCT01482312|450261678|FG002|Period 2, 90 Minutes of Wear|Other|0|||
125174764|NCT01699815|450261679|FG000|Overall Study|Protocol Violation|4|||
125174765|NCT01699815|450261680|FG001|Overall Study|Protocol Violation|7|||
125174766|NCT01699815|450261679|FG000|Overall Study|record could not be located|1|||
125174767|NCT01699815|450261680|FG001|Overall Study|record could not be located|0|||
125174768|NCT01699815|450261679|FG000|Overall Study|Adverse Event|0|||
125174769|NCT01699815|450261680|FG001|Overall Study|Adverse Event|1|||
125174770|NCT00799058|450261691|FG000|Overall Study|Withdrawal by Subject|2|||
125174771|NCT00799058|450261692|FG001|Overall Study|Withdrawal by Subject|2|||
125174772|NCT00799058|450261693|FG002|Overall Study|Withdrawal by Subject|2|||
125174773|NCT00799058|450261691|FG000|Overall Study|Lost to Follow-up|1|||
125174774|NCT00799058|450261692|FG001|Overall Study|Lost to Follow-up|2|||
125174775|NCT00799058|450261693|FG002|Overall Study|Lost to Follow-up|1|||
125174776|NCT00799058|450261691|FG000|Overall Study|Adverse Event|0|||
125174777|NCT00799058|450261692|FG001|Overall Study|Adverse Event|2|||
125174778|NCT00799058|450261693|FG002|Overall Study|Adverse Event|0|||
125174779|NCT00799058|450261691|FG000|Overall Study|Pregnancy|1|||
125174780|NCT00799058|450261692|FG001|Overall Study|Pregnancy|0|||
125174781|NCT00799058|450261693|FG002|Overall Study|Pregnancy|0|||
125174782|NCT00799058|450261691|FG000|Overall Study|Not adherent|3|||
125174783|NCT00799058|450261692|FG001|Overall Study|Not adherent|2|||
125174784|NCT00799058|450261693|FG002|Overall Study|Not adherent|1|||
125174785|NCT00799058|450261691|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
125174786|NCT00799058|450261692|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
125174787|NCT00799058|450261693|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
125174788|NCT00799058|450261691|FG000|Overall Study|IP dispensing error|1|||
125174789|NCT00799058|450261692|FG001|Overall Study|IP dispensing error|0|||
125174790|NCT00799058|450261693|FG002|Overall Study|IP dispensing error|0|||
125174791|NCT00799058|450261691|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
125174792|NCT00799058|450261692|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
125174793|NCT00799058|450261693|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
125174794|NCT00799058|450261691|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
125174795|NCT00799058|450261692|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
125174796|NCT00799058|450261693|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
125174797|NCT00799058|450261691|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
125174798|NCT00799058|450261692|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
125174799|NCT00799058|450261693|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
125174800|NCT00799058|450261691|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
125174801|NCT00799058|450261692|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
125174802|NCT00799058|450261693|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
125174803|NCT03639779|450261694|FG000|Overall Study|Lost to Follow-up|1|||
125174804|NCT02088697|450261695|FG000|Period I|Physician Decision|1|||
125230863|NCT02785939|450473822|FG000|Overall Study|Adverse Event|3|||
125230864|NCT02785939|450473823|FG001|Overall Study|Adverse Event|1|||
125230865|NCT02785939|450473822|FG000|Overall Study|Death|1|||
125174805|NCT02088697|450261696|FG001|Period I|Physician Decision|4|||
125174806|NCT02088697|450261695|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
125174807|NCT02088697|450261696|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
125174808|NCT00810511|450261697|FG000|Overall Study|Protocol Violation|0|||
125174809|NCT00810511|450261698|FG001|Overall Study|Protocol Violation|1|||
125230866|NCT02785939|450473823|FG001|Overall Study|Death|0|||
125230867|NCT02785939|450473822|FG000|Overall Study|Refusal|1|||
125174810|NCT00810511|450261697|FG000|Overall Study|Lack of Efficacy|9|||
125174811|NCT00810511|450261698|FG001|Overall Study|Lack of Efficacy|1|||
125230868|NCT02785939|450473823|FG001|Overall Study|Refusal|0|||
125230869|NCT02785939|450473822|FG000|Overall Study|Deteriorating health|1|||
125230870|NCT02785939|450473823|FG001|Overall Study|Deteriorating health|0|||
125230871|NCT02785939|450473822|FG000|Overall Study|Not protocol specified|0|||
125230872|NCT02785939|450473823|FG001|Overall Study|Not protocol specified|1|||
125230873|NCT04465422|450473824|FG000|Overall Study|Lost to Follow-up|0|||
125230874|NCT04465422|450473825|FG001|Overall Study|Lost to Follow-up|2|||
125230875|NCT00572832|450473829|FG000|Overall Study|Lost to Follow-up|0|||
125230876|NCT00572832|450473830|FG001|Overall Study|Lost to Follow-up|11|||
125230877|NCT00572832|450473829|FG000|Overall Study|Pregnancy|0|||
125230878|NCT00572832|450473830|FG001|Overall Study|Pregnancy|1|||
125230879|NCT03444584|450473836|FG000|Overall Study|Withdrawal by Subject|0|||
125230880|NCT03444584|450473837|FG001|Overall Study|Withdrawal by Subject|1|||
125230881|NCT03444584|450473836|FG000|Overall Study|Other|0|||
125230882|NCT03444584|450473837|FG001|Overall Study|Other|1|||
125230883|NCT01142336|450473838|FG000|Overall Study|Adverse Event|1|||
125230884|NCT01142336|450473839|FG001|Overall Study|Adverse Event|1|||
125230885|NCT01142336|450473838|FG000|Overall Study|Lost to Follow-up|0|||
125230886|NCT01142336|450473839|FG001|Overall Study|Lost to Follow-up|1|||
125230887|NCT01704261|450473840|FG000|Overall Study|Withdrawal by Subject|12|||
125230888|NCT01704261|450473841|FG001|Overall Study|Withdrawal by Subject|15|||
125230889|NCT01704261|450473840|FG000|Overall Study|Lost to Follow-up|1|||
125230890|NCT01704261|450473841|FG001|Overall Study|Lost to Follow-up|0|||
125230891|NCT02722967|450473842|FG000|Overall Study|Adverse Event|1|||
125230892|NCT02722967|450473843|FG001|Overall Study|Adverse Event|0|||
125230893|NCT02722967|450473844|FG002|Overall Study|Adverse Event|0|||
125230894|NCT02722967|450473842|FG000|Overall Study|Lost to Follow-up|0|||
125230895|NCT02722967|450473843|FG001|Overall Study|Lost to Follow-up|1|||
125230896|NCT02722967|450473844|FG002|Overall Study|Lost to Follow-up|0|||
125230897|NCT02722967|450473842|FG000|Overall Study|Non-compliance with patch wearing|2|||
125230898|NCT02722967|450473843|FG001|Overall Study|Non-compliance with patch wearing|1|||
125230899|NCT02722967|450473844|FG002|Overall Study|Non-compliance with patch wearing|1|||
125230900|NCT02722967|450473842|FG000|Overall Study|Withdrawal by Subject|1|||
125230901|NCT02722967|450473843|FG001|Overall Study|Withdrawal by Subject|0|||
125230902|NCT02722967|450473844|FG002|Overall Study|Withdrawal by Subject|1|||
125230903|NCT02722967|450473842|FG000|Overall Study|Physician Decision|1|||
125230904|NCT02722967|450473843|FG001|Overall Study|Physician Decision|0|||
125230905|NCT02722967|450473844|FG002|Overall Study|Physician Decision|0|||
125230906|NCT02722967|450473842|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
125230907|NCT02722967|450473843|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
125230908|NCT02722967|450473844|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
125230909|NCT02391337|450473845|FG000|6 Months Follow-up|Death|5|||
125230910|NCT02391337|450473846|FG001|6 Months Follow-up|Death|4|||
125230911|NCT02391337|450473845|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
125230912|NCT02391337|450473846|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
125230913|NCT02391337|450473845|FG000|12 Months Follow-up|Death|2|||
125230914|NCT02391337|450473846|FG001|12 Months Follow-up|Death|0|||
125230915|NCT02391337|450473845|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
125174812|NCT00810511|450261697|FG000|Overall Study|death in the family|0|||
125174813|NCT00810511|450261698|FG001|Overall Study|death in the family|1|||
125174814|NCT00810511|450261697|FG000|Overall Study|Lost to Follow-up|1|||
125174815|NCT00810511|450261698|FG001|Overall Study|Lost to Follow-up|0|||
125174816|NCT00810511|450261697|FG000|Overall Study|deposits on contact lens|0|||
125174817|NCT00810511|450261698|FG001|Overall Study|deposits on contact lens|1|||
125174818|NCT00911300|450261702|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
125174819|NCT00911300|450261703|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
125174820|NCT00911300|450261702|FG000|Overall Study|Death|1|||
125174821|NCT00911300|450261703|FG001|Overall Study|Death|0|||
125174822|NCT00911300|450261702|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
125174823|NCT00911300|450261703|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
125174824|NCT00911300|450261702|FG000|Overall Study|Adverse Event|14|||
125174825|NCT00911300|450261703|FG001|Overall Study|Adverse Event|6|||
125174826|NCT00911300|450261702|FG000|Overall Study|Protocol Violation|3|||
125174827|NCT00911300|450261703|FG001|Overall Study|Protocol Violation|2|||
125174828|NCT00911300|450261702|FG000|Overall Study|Consent Withdrawn|4|||
125174829|NCT00911300|450261703|FG001|Overall Study|Consent Withdrawn|12|||
125174830|NCT00911300|450261702|FG000|Overall Study|Coronary Angiography Performed|1|||
125174831|NCT00911300|450261703|FG001|Overall Study|Coronary Angiography Performed|0|||
125230916|NCT02391337|450473846|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
125230917|NCT02391337|450473845|FG000|12 Months Follow-up|Lost to Follow-up|0|||
125230918|NCT02391337|450473846|FG001|12 Months Follow-up|Lost to Follow-up|2|||
125174832|NCT00911300|450261702|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
125230919|NCT03704064|450473847|FG000|Overall Study|Lost to Follow-up|8|||
125230920|NCT03704064|450473848|FG001|Overall Study|Lost to Follow-up|4|||
125230921|NCT03704064|450473847|FG000|Overall Study|Withdrawal by Subject|1|||
125174833|NCT00911300|450261703|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
125174834|NCT00911300|450261702|FG000|Overall Study|Received Commercial Treatment|1|||
125230922|NCT03704064|450473848|FG001|Overall Study|Withdrawal by Subject|1|||
125174835|NCT00911300|450261703|FG001|Overall Study|Received Commercial Treatment|0|||
125174836|NCT00911300|450261702|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
125174837|NCT00911300|450261703|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
125174838|NCT00911300|450261702|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
125174839|NCT00911300|450261703|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
125174840|NCT00911300|450261702|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
125174841|NCT00911300|450261703|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
125174842|NCT00911300|450261702|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
125174843|NCT00911300|450261703|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
125174844|NCT00911300|450261702|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
125174845|NCT00911300|450261703|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
125174846|NCT00911300|450261702|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
125174847|NCT00911300|450261703|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
125174848|NCT00911300|450261702|FG000|Overall Study|International Normalized Ratio Too High|0|||
125174849|NCT00911300|450261703|FG001|Overall Study|International Normalized Ratio Too High|1|||
125174850|NCT00911300|450261702|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
125174851|NCT00911300|450261703|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
125174852|NCT00911300|450261702|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
125174853|NCT00911300|450261703|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
125174854|NCT00911300|450261702|FG000|Overall Study|Physician Decision|0|||
125174855|NCT00911300|450261703|FG001|Overall Study|Physician Decision|1|||
125174856|NCT00911300|450261702|FG000|Overall Study|Treatment Stopped by Mistake|0|||
125174857|NCT00911300|450261703|FG001|Overall Study|Treatment Stopped by Mistake|1|||
125174858|NCT00911300|450261702|FG000|Overall Study|Randomized; No Study Medication Received|0|||
125174859|NCT00911300|450261703|FG001|Overall Study|Randomized; No Study Medication Received|2|||
125174860|NCT01128543|450261705|FG000|Overall Study|Withdrawal by Subject|3|||
125174861|NCT01128543|450261705|FG000|Overall Study|Protocol Violation|1|||
125174862|NCT01941498|450261709|FG000|Overall Study|Relocated out of state|1|||
125174863|NCT00396565|450261710|FG000|Overall Study|Physician Decision|3|||
125174864|NCT00396565|450261711|FG001|Overall Study|Physician Decision|1|||
125174865|NCT00396565|450261712|FG002|Overall Study|Physician Decision|2|||
125174866|NCT00396565|450261710|FG000|Overall Study|Adverse Event|5|||
125174867|NCT00396565|450261711|FG001|Overall Study|Adverse Event|13|||
125174868|NCT00396565|450261712|FG002|Overall Study|Adverse Event|3|||
125174869|NCT00396565|450261710|FG000|Overall Study|Withdrawal by Subject|8|||
125174870|NCT00396565|450261711|FG001|Overall Study|Withdrawal by Subject|13|||
125174871|NCT00396565|450261712|FG002|Overall Study|Withdrawal by Subject|1|||
125174872|NCT00396565|450261710|FG000|Overall Study|Lack of Efficacy|32|||
125174873|NCT00396565|450261711|FG001|Overall Study|Lack of Efficacy|64|||
125174874|NCT00396565|450261712|FG002|Overall Study|Lack of Efficacy|11|||
125174875|NCT04324021|450261713|FG000|Overall Study|Adverse Event|1|||
125174876|NCT04324021|450261714|FG001|Overall Study|Adverse Event|0|||
125174877|NCT04324021|450261715|FG002|Overall Study|Adverse Event|0|||
125174878|NCT04324021|450261713|FG000|Overall Study|Lack of Efficacy|0|||
125174879|NCT04324021|450261714|FG001|Overall Study|Lack of Efficacy|0|||
125174880|NCT04324021|450261715|FG002|Overall Study|Lack of Efficacy|1|||
125174881|NCT04324021|450261713|FG000|Overall Study|Death|1|||
125174882|NCT04324021|450261714|FG001|Overall Study|Death|1|||
125174883|NCT04324021|450261715|FG002|Overall Study|Death|0|||
125174884|NCT03097991|450261716|FG000|Overall Study|Didn't meet study criteria|8|||
125174885|NCT03097991|450261717|FG001|Overall Study|Didn't meet study criteria|0|||
125174886|NCT03097991|450261716|FG000|Overall Study|Withdrawal by Subject|12|||
125174887|NCT03097991|450261717|FG001|Overall Study|Withdrawal by Subject|6|||
125174888|NCT03097991|450261716|FG000|Overall Study|Death of Baby|3|||
125174889|NCT03097991|450261717|FG001|Overall Study|Death of Baby|1|||
125174890|NCT03097991|450261716|FG000|Overall Study|Lost to Follow-up|24|||
125174891|NCT03097991|450261717|FG001|Overall Study|Lost to Follow-up|38|||
125174892|NCT03097991|450261716|FG000|Overall Study|Adverse Event|3|||
125174893|NCT03097991|450261717|FG001|Overall Study|Adverse Event|5|||
125174894|NCT00299130|450261718|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
125174895|NCT00299130|450261719|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
125174896|NCT00299130|450261720|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
125174897|NCT00299130|450261718|FG000|Treatment Period (up to 5 Years)|Death|1|||
125174898|NCT00299130|450261719|FG001|Treatment Period (up to 5 Years)|Death|3|||
125174899|NCT00299130|450261720|FG002|Treatment Period (up to 5 Years)|Death|1|||
125174900|NCT00299130|450261718|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
125174901|NCT00299130|450261719|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
125174902|NCT00299130|450261720|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
125174903|NCT00299130|450261718|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
125174904|NCT00299130|450261719|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
125174905|NCT00299130|450261720|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
125174906|NCT00299130|450261718|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
125174907|NCT00299130|450261719|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
125174908|NCT00299130|450261720|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
125174909|NCT00299130|450261718|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
125174910|NCT00299130|450261719|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
125174911|NCT00299130|450261720|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
125174912|NCT00299130|450261718|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
125174913|NCT00299130|450261719|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
125174914|NCT00299130|450261720|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
125174915|NCT00299130|450261718|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
125174916|NCT00299130|450261719|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
125174917|NCT00299130|450261720|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
125174918|NCT00299130|450261718|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
125174919|NCT00299130|450261719|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
125174920|NCT00299130|450261720|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
125174921|NCT00299130|450261718|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
125174922|NCT00299130|450261719|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
125174923|NCT00299130|450261720|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
125174924|NCT00299130|450261718|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
125174925|NCT00299130|450261719|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
125174926|NCT00299130|450261720|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
125174927|NCT00299130|450261718|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
125174928|NCT00299130|450261719|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
125174929|NCT00299130|450261720|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
125174930|NCT00299130|450261718|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
125174931|NCT00299130|450261719|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
125174932|NCT00299130|450261720|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
125174933|NCT00299130|450261718|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
125174934|NCT00299130|450261719|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
125174935|NCT00299130|450261720|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
125174936|NCT00299130|450261718|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
125174937|NCT00299130|450261719|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
125174938|NCT00299130|450261720|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
125174939|NCT00299130|450261718|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
125174940|NCT00299130|450261719|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
125174941|NCT00299130|450261720|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
125174942|NCT00299130|450261718|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
125174943|NCT00299130|450261719|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
125174944|NCT00299130|450261720|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
125174945|NCT02211417|450261721|FG000|Overall Study|Withdrawal by Subject|11|||
125174946|NCT02211417|450261722|FG001|Overall Study|Withdrawal by Subject|8|||
125174947|NCT02211417|450261721|FG000|Overall Study|Protocol Violation|1|||
125174948|NCT02211417|450261722|FG001|Overall Study|Protocol Violation|0|||
125174949|NCT02211417|450261721|FG000|Overall Study|Pregnancy|0|||
125174950|NCT02211417|450261722|FG001|Overall Study|Pregnancy|1|||
125174951|NCT02211417|450261721|FG000|Overall Study|Lost to Follow-up|2|||
125174952|NCT02211417|450261722|FG001|Overall Study|Lost to Follow-up|3|||
125174953|NCT02211417|450261721|FG000|Overall Study|Adverse Event|1|||
125174954|NCT02211417|450261722|FG001|Overall Study|Adverse Event|4|||
125174955|NCT01198132|450261723|FG000|Overall Study|Withdrawal by Subject|4|||
125174956|NCT01198132|450261724|FG001|Overall Study|Withdrawal by Subject|5|||
125174957|NCT01198132|450261723|FG000|Overall Study|Physician Decision|5|||
125174958|NCT01198132|450261724|FG001|Overall Study|Physician Decision|4|||
125174959|NCT01198132|450261723|FG000|Overall Study|Other Unspecified|3|||
125174960|NCT01198132|450261724|FG001|Overall Study|Other Unspecified|6|||
125174961|NCT01198132|450261723|FG000|Overall Study|Lack of Efficacy|2|||
125174962|NCT01198132|450261724|FG001|Overall Study|Lack of Efficacy|3|||
125174963|NCT01198132|450261723|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
125174964|NCT01198132|450261724|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
125174965|NCT01198132|450261723|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
125174966|NCT01198132|450261724|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
125174967|NCT01198132|450261723|FG000|Overall Study|Adverse Event|0|||
125174968|NCT01198132|450261724|FG001|Overall Study|Adverse Event|1|||
125174969|NCT01198132|450261723|FG000|Overall Study|Protocol Violation|1|||
125174970|NCT01198132|450261724|FG001|Overall Study|Protocol Violation|0|||
125174971|NCT01755091|450261725|FG000|Overall Study|Withdrawal by Subject|6|||
125174972|NCT01755091|450261726|FG001|Overall Study|Withdrawal by Subject|1|||
125174973|NCT01755091|450261727|FG002|Overall Study|Withdrawal by Subject|3|||
125174974|NCT01755091|450261725|FG000|Overall Study|Adverse Event|1|||
125174975|NCT01755091|450261726|FG001|Overall Study|Adverse Event|1|||
125174976|NCT01755091|450261727|FG002|Overall Study|Adverse Event|1|||
125174977|NCT01755091|450261725|FG000|Overall Study|Lost to Follow-up|1|||
125174978|NCT01755091|450261726|FG001|Overall Study|Lost to Follow-up|0|||
125174979|NCT01755091|450261727|FG002|Overall Study|Lost to Follow-up|1|||
125174980|NCT01755091|450261725|FG000|Overall Study|Physician Decision|1|||
125174981|NCT01755091|450261726|FG001|Overall Study|Physician Decision|1|||
125174982|NCT01755091|450261727|FG002|Overall Study|Physician Decision|2|||
125174983|NCT00490841|450261728|FG000|Overall Study|Death|5|||
125174984|NCT00490841|450261728|FG000|Overall Study|Withdrawal by Subject|4|||
125174985|NCT00490841|450261728|FG000|Overall Study|Lost to Follow-up|1|||
125174986|NCT00490841|450261728|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
125174987|NCT04700137|450261735|FG000|Overall Study|Lost to Follow-up|1|||
125174988|NCT04700137|450261736|FG001|Overall Study|Lost to Follow-up|6|||
125174989|NCT04700137|450261737|FG002|Overall Study|Lost to Follow-up|1|||
125174990|NCT04700137|450261738|FG003|Overall Study|Lost to Follow-up|1|||
125174991|NCT04700137|450261735|FG000|Overall Study|Withdrawal by Subject|0|||
125174992|NCT04700137|450261736|FG001|Overall Study|Withdrawal by Subject|0|||
125174993|NCT04700137|450261737|FG002|Overall Study|Withdrawal by Subject|1|||
125174994|NCT04700137|450261738|FG003|Overall Study|Withdrawal by Subject|0|||
125174995|NCT04700137|450261735|FG000|Overall Study|Death|0|||
125174996|NCT04700137|450261736|FG001|Overall Study|Death|0|||
125174997|NCT04700137|450261737|FG002|Overall Study|Death|1|||
125174998|NCT04700137|450261738|FG003|Overall Study|Death|0|||
125174999|NCT00174954|450261739|FG000|Overall Study|Adverse Event|2|||
125175000|NCT00174954|450261739|FG000|Overall Study|No tophi found in MRI|1|||
125175001|NCT00174954|450261739|FG000|Overall Study|Physician Decision|1|||
125175002|NCT00839254|450261740|FG000|Overall Study|Protocol Violation|0|||
125175003|NCT00839254|450261741|FG001|Overall Study|Protocol Violation|1|||
125175004|NCT00839254|450261742|FG002|Overall Study|Protocol Violation|1|||
125175005|NCT00839254|450261743|FG003|Overall Study|Protocol Violation|1|||
125175006|NCT00839254|450261744|FG004|Overall Study|Protocol Violation|0|||
125175007|NCT00839254|450261745|FG005|Overall Study|Protocol Violation|0|||
125175008|NCT00839254|450261746|FG006|Overall Study|Protocol Violation|1|||
125175009|NCT00839254|450261747|FG007|Overall Study|Protocol Violation|2|||
125175010|NCT00839254|450261740|FG000|Overall Study|Physician Decision|0|||
125175011|NCT00839254|450261741|FG001|Overall Study|Physician Decision|1|||
125175012|NCT00839254|450261742|FG002|Overall Study|Physician Decision|0|||
125175013|NCT00839254|450261743|FG003|Overall Study|Physician Decision|0|||
125175014|NCT00839254|450261744|FG004|Overall Study|Physician Decision|0|||
125175015|NCT00839254|450261745|FG005|Overall Study|Physician Decision|0|||
125175016|NCT00839254|450261746|FG006|Overall Study|Physician Decision|0|||
125175017|NCT00839254|450261747|FG007|Overall Study|Physician Decision|1|||
125175018|NCT00839254|450261740|FG000|Overall Study|Wrong treatment number allocation|0|||
125175019|NCT00839254|450261741|FG001|Overall Study|Wrong treatment number allocation|1|||
125175020|NCT00839254|450261742|FG002|Overall Study|Wrong treatment number allocation|0|||
125175021|NCT00839254|450261743|FG003|Overall Study|Wrong treatment number allocation|0|||
125175022|NCT00839254|450261744|FG004|Overall Study|Wrong treatment number allocation|0|||
125175023|NCT00839254|450261745|FG005|Overall Study|Wrong treatment number allocation|1|||
125175024|NCT00839254|450261746|FG006|Overall Study|Wrong treatment number allocation|0|||
125175025|NCT00839254|450261747|FG007|Overall Study|Wrong treatment number allocation|0|||
125175026|NCT00839254|450261740|FG000|Overall Study|Adverse Event|12|||
125175027|NCT00839254|450261741|FG001|Overall Study|Adverse Event|6|||
125175028|NCT00839254|450261742|FG002|Overall Study|Adverse Event|3|||
125175029|NCT00839254|450261743|FG003|Overall Study|Adverse Event|5|||
125175030|NCT00839254|450261744|FG004|Overall Study|Adverse Event|2|||
125175031|NCT00839254|450261745|FG005|Overall Study|Adverse Event|1|||
125175032|NCT00839254|450261746|FG006|Overall Study|Adverse Event|0|||
125175033|NCT00839254|450261747|FG007|Overall Study|Adverse Event|1|||
125175034|NCT00839254|450261740|FG000|Overall Study|Withdrawal by Subject|87|||
125175035|NCT00839254|450261741|FG001|Overall Study|Withdrawal by Subject|53|||
125175036|NCT00839254|450261742|FG002|Overall Study|Withdrawal by Subject|54|||
125175037|NCT00839254|450261743|FG003|Overall Study|Withdrawal by Subject|32|||
125175038|NCT00839254|450261744|FG004|Overall Study|Withdrawal by Subject|27|||
125175039|NCT00839254|450261745|FG005|Overall Study|Withdrawal by Subject|15|||
125175040|NCT00839254|450261746|FG006|Overall Study|Withdrawal by Subject|22|||
125175041|NCT00839254|450261747|FG007|Overall Study|Withdrawal by Subject|9|||
125175042|NCT00839254|450261740|FG000|Overall Study|Wrong group allocation|0|||
125175043|NCT00839254|450261741|FG001|Overall Study|Wrong group allocation|0|||
125175044|NCT00839254|450261742|FG002|Overall Study|Wrong group allocation|0|||
125175045|NCT00839254|450261743|FG003|Overall Study|Wrong group allocation|0|||
125175046|NCT00839254|450261744|FG004|Overall Study|Wrong group allocation|0|||
125175047|NCT00839254|450261745|FG005|Overall Study|Wrong group allocation|0|||
125175048|NCT00839254|450261746|FG006|Overall Study|Wrong group allocation|1|||
125175049|NCT00839254|450261747|FG007|Overall Study|Wrong group allocation|0|||
125175050|NCT00839254|450261740|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
125175051|NCT00839254|450261741|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
125175052|NCT00839254|450261742|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
125175053|NCT00839254|450261743|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
125175054|NCT00839254|450261744|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
125175055|NCT00839254|450261745|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
125175056|NCT00839254|450261746|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
125175057|NCT00839254|450261747|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
125175058|NCT00839254|450261740|FG000|Overall Study|Withdrawn due to non-compliance|2|||
125175059|NCT00839254|450261741|FG001|Overall Study|Withdrawn due to non-compliance|0|||
125175060|NCT00839254|450261742|FG002|Overall Study|Withdrawn due to non-compliance|0|||
125175061|NCT00839254|450261743|FG003|Overall Study|Withdrawn due to non-compliance|0|||
125175062|NCT00839254|450261744|FG004|Overall Study|Withdrawn due to non-compliance|0|||
125175063|NCT00839254|450261745|FG005|Overall Study|Withdrawn due to non-compliance|0|||
125175064|NCT00839254|450261746|FG006|Overall Study|Withdrawn due to non-compliance|0|||
125175065|NCT00839254|450261747|FG007|Overall Study|Withdrawn due to non-compliance|0|||
125175066|NCT00839254|450261740|FG000|Overall Study|Lost to Follow-up|51|||
125175067|NCT00839254|450261741|FG001|Overall Study|Lost to Follow-up|30|||
125175068|NCT00839254|450261742|FG002|Overall Study|Lost to Follow-up|32|||
125175069|NCT00839254|450261743|FG003|Overall Study|Lost to Follow-up|24|||
125175070|NCT00839254|450261744|FG004|Overall Study|Lost to Follow-up|8|||
125175071|NCT00839254|450261745|FG005|Overall Study|Lost to Follow-up|8|||
125175072|NCT00839254|450261746|FG006|Overall Study|Lost to Follow-up|4|||
125175073|NCT00839254|450261747|FG007|Overall Study|Lost to Follow-up|2|||
125175074|NCT01320150|450261749|FG000|Overall Study|Protocol Violation|15|||
125175075|NCT01320150|450261749|FG000|Overall Study|Withdrawal by Subject|5|||
125175076|NCT01320150|450261749|FG000|Overall Study|Death|2|||
125175077|NCT01320150|450261749|FG000|Overall Study|Lost to Follow-up|44|||
125175078|NCT00489827|450261761|FG000|Overall Study|Intraoperative exclusion criteria|1|||
125175079|NCT00489827|450261762|FG001|Overall Study|Intraoperative exclusion criteria|1|||
125175080|NCT00489827|450261761|FG000|Overall Study|Intraoperative exclusion criteria|1|||
125175081|NCT00489827|450261762|FG001|Overall Study|Intraoperative exclusion criteria|1|||
125175082|NCT01590277|450261763|FG000|Overall Study|Withdrawal by Subject|3|||
125175083|NCT01590277|450261763|FG000|Overall Study|Withdrawal by Subject|2|||
125175084|NCT01590277|450261763|FG000|Overall Study|Withdrawal by Subject|1|||
125175085|NCT01590277|450261763|FG000|Overall Study|Withdrawal by Subject|1|||
125175086|NCT04386616|450261764|FG000|Overall Study|Death|22|||
125175087|NCT04386616|450261765|FG001|Overall Study|Death|22|||
125175088|NCT04386616|450261766|FG002|Overall Study|Death|21|||
125175089|NCT04386616|450261764|FG000|Overall Study|Lost to Follow-up|5|||
125175090|NCT04386616|450261765|FG001|Overall Study|Lost to Follow-up|8|||
125175091|NCT04386616|450261766|FG002|Overall Study|Lost to Follow-up|6|||
125175092|NCT04386616|450261764|FG000|Overall Study|Withdrawal by Subject|2|||
125175093|NCT04386616|450261765|FG001|Overall Study|Withdrawal by Subject|4|||
125175094|NCT04386616|450261766|FG002|Overall Study|Withdrawal by Subject|1|||
125175095|NCT04386616|450261764|FG000|Overall Study|Adverse Event|1|||
125175096|NCT04386616|450261765|FG001|Overall Study|Adverse Event|1|||
125175097|NCT04386616|450261766|FG002|Overall Study|Adverse Event|0|||
125175098|NCT01377012|450261767|FG000|Core Study|Study terminated by Sponsor|47|||
125175099|NCT01377012|450261768|FG001|Core Study|Study terminated by Sponsor|54|||
125175100|NCT01377012|450261769|FG002|Core Study|Study terminated by Sponsor|46|||
125175101|NCT01377012|450261767|FG000|Core Study|Technical problems|1|||
125175102|NCT01377012|450261768|FG001|Core Study|Technical problems|0|||
125175103|NCT01377012|450261769|FG002|Core Study|Technical problems|0|||
125175104|NCT01377012|450261767|FG000|Core Study|Withdrawal by Subject|15|||
125175105|NCT01377012|450261768|FG001|Core Study|Withdrawal by Subject|23|||
125175106|NCT01377012|450261769|FG002|Core Study|Withdrawal by Subject|18|||
125175107|NCT01377012|450261767|FG000|Core Study|Protocol Violation|7|||
125175108|NCT01377012|450261768|FG001|Core Study|Protocol Violation|3|||
125175109|NCT01377012|450261769|FG002|Core Study|Protocol Violation|2|||
125175110|NCT01377012|450261767|FG000|Core Study|Pregnancy|0|||
125175111|NCT01377012|450261768|FG001|Core Study|Pregnancy|0|||
125175112|NCT01377012|450261769|FG002|Core Study|Pregnancy|1|||
125175113|NCT01377012|450261767|FG000|Core Study|Physician Decision|5|||
125175114|NCT01377012|450261768|FG001|Core Study|Physician Decision|4|||
125175115|NCT01377012|450261769|FG002|Core Study|Physician Decision|10|||
125175116|NCT01377012|450261767|FG000|Core Study|Non-Compliant with study treatment|0|||
125175117|NCT01377012|450261768|FG001|Core Study|Non-Compliant with study treatment|0|||
125175118|NCT01377012|450261769|FG002|Core Study|Non-Compliant with study treatment|1|||
125175119|NCT01377012|450261767|FG000|Core Study|No Longer require treatment|0|||
125175120|NCT01377012|450261768|FG001|Core Study|No Longer require treatment|0|||
125175121|NCT01377012|450261769|FG002|Core Study|No Longer require treatment|1|||
125175122|NCT01377012|450261767|FG000|Core Study|Lost to Follow-up|7|||
125175123|NCT01377012|450261768|FG001|Core Study|Lost to Follow-up|5|||
125175124|NCT01377012|450261769|FG002|Core Study|Lost to Follow-up|4|||
125175125|NCT01377012|450261767|FG000|Core Study|Lack of Efficacy|41|||
125175126|NCT01377012|450261768|FG001|Core Study|Lack of Efficacy|28|||
125175127|NCT01377012|450261769|FG002|Core Study|Lack of Efficacy|37|||
125175128|NCT01377012|450261767|FG000|Core Study|Death|1|||
125175129|NCT01377012|450261768|FG001|Core Study|Death|1|||
125175130|NCT01377012|450261769|FG002|Core Study|Death|1|||
125175131|NCT01377012|450261767|FG000|Core Study|Adverse Event|10|||
125175132|NCT01377012|450261768|FG001|Core Study|Adverse Event|14|||
125175133|NCT01377012|450261769|FG002|Core Study|Adverse Event|13|||
125175134|NCT01377012|450261767|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
125175135|NCT01377012|450261768|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
125175136|NCT01377012|450261769|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
125175137|NCT01377012|450261767|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
125175138|NCT01377012|450261768|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
125175139|NCT01377012|450261769|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
125175140|NCT01377012|450261767|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
125175141|NCT01377012|450261768|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
125175142|NCT01377012|450261769|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
125175143|NCT01377012|450261767|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
125175144|NCT01377012|450261768|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
125175145|NCT01377012|450261769|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
125175146|NCT01377012|450261767|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
125175147|NCT01377012|450261768|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
125175148|NCT01377012|450261769|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
125175149|NCT01377012|450261767|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
125175150|NCT01377012|450261768|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
125175151|NCT01377012|450261769|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
125175152|NCT00805961|450261772|FG000|Modality Therapy|Withdrawal by Subject|1|||
125175153|NCT00805961|450261772|FG000|Modality Therapy|Adverse Event|1|||
125175154|NCT00805961|450261772|FG000|Modality Therapy|Disease Progression|2|||
125175155|NCT00805961|450261772|FG000|Treatment-Free Interval|Adverse Event|3|||
125175156|NCT00805961|450261772|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
125175157|NCT00805961|450261772|FG000|Treatment-Free Interval|Physician Decision|1|||
125175158|NCT00805961|450261772|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
125175159|NCT00805961|450261772|FG000|Maintenance Treatment|Lack of Efficacy|13|||
125175160|NCT00805961|450261772|FG000|Maintenance Treatment|Intercurrent Illness|7|||
125175161|NCT00805961|450261772|FG000|Maintenance Treatment|Adverse Event|6|||
125175162|NCT00805961|450261772|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
125175163|NCT00805961|450261772|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
125175164|NCT00805961|450261772|FG000|Maintenance Treatment|Withdrawn Consent|1|||
125175165|NCT04380961|450261773|FG000|Overall Study|Lost to Follow-up|17|||
125175166|NCT04380961|450261774|FG001|Overall Study|Lost to Follow-up|11|||
125175167|NCT04380961|450261773|FG000|Overall Study|Withdrawal by Subject|3|||
125175168|NCT04380961|450261774|FG001|Overall Study|Withdrawal by Subject|0|||
125175169|NCT04380961|450261773|FG000|Overall Study|Death|22|||
125175170|NCT04380961|450261774|FG001|Overall Study|Death|16|||
125175171|NCT04380961|450261773|FG000|Overall Study|Other|1|||
125175172|NCT04380961|450261774|FG001|Overall Study|Other|0|||
125175173|NCT04380961|450261773|FG000|Overall Study|Randomized but Not Treated|1|||
125175174|NCT04380961|450261774|FG001|Overall Study|Randomized but Not Treated|2|||
125175175|NCT01862484|450261775|FG000|Overall Study|Lack of Efficacy|1|||
125175176|NCT01862484|450261776|FG001|Overall Study|Lack of Efficacy|1|||
125175177|NCT01862484|450261775|FG000|Overall Study|Lost to Follow-up|1|||
125175178|NCT01862484|450261776|FG001|Overall Study|Lost to Follow-up|2|||
125175179|NCT01862484|450261775|FG000|Overall Study|Protocol Violation|0|||
125175180|NCT01862484|450261776|FG001|Overall Study|Protocol Violation|2|||
125175181|NCT01862484|450261775|FG000|Overall Study|Withdrawal by Subject|0|||
125175182|NCT01862484|450261776|FG001|Overall Study|Withdrawal by Subject|3|||
125175183|NCT01632280|450261777|FG000|Overall Study|Withdrawal by Subject|1|||
125175184|NCT01632280|450261778|FG001|Overall Study|Withdrawal by Subject|0|||
125175185|NCT00993421|450261779|FG000|Overall Study|Adverse Event|2|||
125175186|NCT00993421|450261780|FG001|Overall Study|Adverse Event|7|||
125175187|NCT00993421|450261781|FG002|Overall Study|Adverse Event|6|||
125175188|NCT00993421|450261782|FG003|Overall Study|Adverse Event|9|||
125175189|NCT00993421|450261783|FG004|Overall Study|Adverse Event|5|||
125175190|NCT00993421|450261784|FG005|Overall Study|Adverse Event|7|||
125175191|NCT00993421|450261785|FG006|Overall Study|Adverse Event|1|||
125175192|NCT00993421|450261779|FG000|Overall Study|Sponsor Decision|36|||
125175193|NCT00993421|450261780|FG001|Overall Study|Sponsor Decision|31|||
125175194|NCT00993421|450261781|FG002|Overall Study|Sponsor Decision|28|||
125175195|NCT00993421|450261782|FG003|Overall Study|Sponsor Decision|30|||
125175196|NCT00993421|450261783|FG004|Overall Study|Sponsor Decision|38|||
125175197|NCT00993421|450261784|FG005|Overall Study|Sponsor Decision|30|||
125175198|NCT00993421|450261785|FG006|Overall Study|Sponsor Decision|29|||
125175199|NCT00993421|450261779|FG000|Overall Study|Lost to Follow-up|3|||
125175200|NCT00993421|450261780|FG001|Overall Study|Lost to Follow-up|5|||
125175201|NCT00993421|450261781|FG002|Overall Study|Lost to Follow-up|5|||
125175202|NCT00993421|450261782|FG003|Overall Study|Lost to Follow-up|0|||
125175203|NCT00993421|450261783|FG004|Overall Study|Lost to Follow-up|0|||
125175204|NCT00993421|450261784|FG005|Overall Study|Lost to Follow-up|0|||
125175205|NCT00993421|450261785|FG006|Overall Study|Lost to Follow-up|6|||
125175206|NCT00993421|450261779|FG000|Overall Study|Withdrawal by Subject|3|||
125175207|NCT00993421|450261780|FG001|Overall Study|Withdrawal by Subject|2|||
125175208|NCT00993421|450261781|FG002|Overall Study|Withdrawal by Subject|3|||
125175209|NCT00993421|450261782|FG003|Overall Study|Withdrawal by Subject|3|||
125175210|NCT00993421|450261783|FG004|Overall Study|Withdrawal by Subject|3|||
125175211|NCT00993421|450261784|FG005|Overall Study|Withdrawal by Subject|5|||
125175212|NCT00993421|450261785|FG006|Overall Study|Withdrawal by Subject|3|||
125175213|NCT00993421|450261779|FG000|Overall Study|Death|0|||
125175214|NCT00993421|450261780|FG001|Overall Study|Death|0|||
125175215|NCT00993421|450261781|FG002|Overall Study|Death|0|||
125175216|NCT00993421|450261782|FG003|Overall Study|Death|0|||
125175217|NCT00993421|450261783|FG004|Overall Study|Death|0|||
125175218|NCT00993421|450261784|FG005|Overall Study|Death|0|||
125175219|NCT00993421|450261785|FG006|Overall Study|Death|1|||
125175220|NCT00993421|450261779|FG000|Overall Study|Entry Criteria Exclusion|0|||
125175221|NCT00993421|450261780|FG001|Overall Study|Entry Criteria Exclusion|0|||
125175222|NCT00993421|450261781|FG002|Overall Study|Entry Criteria Exclusion|1|||
125175223|NCT00993421|450261782|FG003|Overall Study|Entry Criteria Exclusion|3|||
125175224|NCT00993421|450261783|FG004|Overall Study|Entry Criteria Exclusion|0|||
125175225|NCT00993421|450261784|FG005|Overall Study|Entry Criteria Exclusion|1|||
125175226|NCT00993421|450261785|FG006|Overall Study|Entry Criteria Exclusion|0|||
125175227|NCT00993421|450261779|FG000|Overall Study|Physician Decision|0|||
125175228|NCT00993421|450261780|FG001|Overall Study|Physician Decision|0|||
125175229|NCT00993421|450261781|FG002|Overall Study|Physician Decision|0|||
125175230|NCT00993421|450261782|FG003|Overall Study|Physician Decision|0|||
125175231|NCT00993421|450261783|FG004|Overall Study|Physician Decision|0|||
125175232|NCT00993421|450261784|FG005|Overall Study|Physician Decision|1|||
125175233|NCT00993421|450261785|FG006|Overall Study|Physician Decision|1|||
125175234|NCT00993421|450261779|FG000|Overall Study|Protocol Violation|0|||
125175235|NCT00993421|450261780|FG001|Overall Study|Protocol Violation|0|||
125175236|NCT00993421|450261781|FG002|Overall Study|Protocol Violation|0|||
125175237|NCT00993421|450261782|FG003|Overall Study|Protocol Violation|0|||
125175238|NCT00993421|450261783|FG004|Overall Study|Protocol Violation|0|||
125175239|NCT00993421|450261784|FG005|Overall Study|Protocol Violation|2|||
125175240|NCT00993421|450261785|FG006|Overall Study|Protocol Violation|1|||
125175241|NCT03736031|450261787|FG000|Overall Study|Death|2|||
125175242|NCT03736031|450261788|FG001|Overall Study|Death|4|||
125175243|NCT03736031|450261787|FG000|Overall Study|Lost to Follow-up|21|||
125175244|NCT03736031|450261788|FG001|Overall Study|Lost to Follow-up|2|||
125175245|NCT03736031|450261787|FG000|Overall Study|Withdrawal by Subject|9|||
125175246|NCT03736031|450261788|FG001|Overall Study|Withdrawal by Subject|0|||
125175247|NCT02215967|450261789|FG000|Overall Study|Patient became ineligible for treatment|0|||
125175248|NCT02215967|450261790|FG001|Overall Study|Patient became ineligible for treatment|0|||
125175249|NCT02215967|450261791|FG002|Overall Study|Patient became ineligible for treatment|0|||
125175250|NCT02215967|450261792|FG003|Overall Study|Patient became ineligible for treatment|3|||
125175251|NCT02215967|450261789|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
125175252|NCT02215967|450261790|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
125175253|NCT02215967|450261791|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
125175254|NCT02215967|450261792|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
125175255|NCT01954745|450261796|FG000|Overall Study|Radiological Progression|11|||
125175256|NCT01954745|450261796|FG000|Overall Study|Clinical Progression|5|||
125175257|NCT01954745|450261796|FG000|Overall Study|Adverse Event|2|||
125175258|NCT01954745|450261796|FG000|Overall Study|Death|1|||
125175259|NCT00352417|450261797|FG000|Overall Study|Adverse Event|1|||
125175260|NCT00352417|450261798|FG001|Overall Study|Adverse Event|0|||
125175261|NCT00352417|450261797|FG000|Overall Study|Protocol Violation|0|||
125175262|NCT00352417|450261798|FG001|Overall Study|Protocol Violation|2|||
125175263|NCT00352417|450261797|FG000|Overall Study|Withdrawal by Subject|1|||
125175264|NCT00352417|450261798|FG001|Overall Study|Withdrawal by Subject|2|||
125175265|NCT00352417|450261797|FG000|Overall Study|Lost to Follow-up|1|||
125175266|NCT00352417|450261798|FG001|Overall Study|Lost to Follow-up|0|||
125175267|NCT00352417|450261797|FG000|Overall Study|Schedule Change|2|||
125175268|NCT00352417|450261798|FG001|Overall Study|Schedule Change|1|||
125175269|NCT01496976|450263532|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
125175270|NCT05938621|450263533|FG000|Overall Study|Lost to Follow-up|1|||
125175271|NCT05938621|450263534|FG001|Overall Study|Lost to Follow-up|5|||
125175272|NCT05938621|450263535|FG002|Overall Study|Lost to Follow-up|2|||
125175273|NCT05938621|450263536|FG003|Overall Study|Lost to Follow-up|2|||
125175274|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
125175275|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
125175276|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
125175277|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
125230923|NCT03704064|450473847|FG000|Overall Study|No longer available for study visits|0|||
125175278|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
125175279|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
125175280|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
125175281|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
125175282|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
125175283|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
125175284|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
125175285|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
125175286|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
125175287|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
125175288|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
125175289|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
125175290|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
125175291|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
125175292|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
125175293|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
125175294|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
125175295|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
125175296|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
125175297|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
125175298|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
125175299|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
125175300|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
125175301|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
125175302|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
125175303|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
125175304|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
125175305|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
125175306|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
125175307|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
125175308|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
125175309|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
125175310|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
125175311|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
125175312|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
125175313|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
125175314|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
125175315|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
125175316|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
125175317|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
125175318|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
125175319|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
125175320|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
125175321|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
125175322|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
125175323|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
125175324|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
125175325|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
125175326|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
125175327|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
125175328|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175329|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
125175330|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175331|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175332|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175333|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175334|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175335|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175336|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175337|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
125175338|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
125175339|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
125175340|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
125175341|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
125175342|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
125175343|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
125175344|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
125175345|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
125175346|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
125175347|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
125230924|NCT03704064|450473848|FG001|Overall Study|No longer available for study visits|1|||
125230925|NCT03704064|450473847|FG000|Overall Study|Censoring event|1|||
125230926|NCT03704064|450473848|FG001|Overall Study|Censoring event|0|||
125230927|NCT00062166|450473858|FG000|Overall Study|Withdrawal by Subject|6|||
125230928|NCT02475369|450473859|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
125230929|NCT02475369|450473860|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
125230930|NCT01200329|450473878|FG000|Overall Study|Lack of financial coverage|2|||
125230931|NCT01200329|450473878|FG000|Overall Study|Progressive disease|1|||
125230932|NCT03641508|450473883|FG000|First Injection|Lost to Follow-up|2|||
125230933|NCT03641508|450473884|FG001|First Injection|Lost to Follow-up|0|||
125230934|NCT03642990|450473885|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
125230935|NCT03642990|450473885|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
125230936|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
125230937|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
125230938|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
125230939|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
125230940|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
125230941|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
125230942|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
125230943|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
125230944|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
125230945|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
125230946|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
125230947|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
125230948|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
125230949|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
125230950|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
125230951|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
125230952|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
125230953|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
125230954|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
125230955|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
125230956|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
125230957|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
125230958|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
125230959|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
125230960|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
125230961|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
125230962|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
125230963|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
125230964|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
125230965|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
125230966|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
125230967|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
125230968|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
125230969|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
125230970|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
125230971|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
125230972|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
125230973|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
125230974|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
125230975|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
125230976|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
125230977|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
125230978|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
125230979|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
125230980|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
125230981|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
125230982|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
125230983|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
125230984|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
125230985|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
125230986|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
125230987|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
125230988|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
125230989|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
125175348|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
125175349|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
125175350|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
125175351|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
125175352|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
125175353|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
125175354|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
125175355|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
125175356|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
125175357|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
125175358|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
125175359|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
125175360|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
125175361|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
125175362|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
125175363|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
125175364|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
125175365|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
125175366|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
125175367|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
125175368|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
125175369|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
125175370|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
125175371|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
125175372|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
125175373|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175374|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
125175375|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
125175376|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175377|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175378|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175379|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175380|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175381|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175382|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
125175383|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
125175384|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
125175385|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
125175386|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
125175387|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
125175388|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
125175389|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
125175390|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
125175391|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
125175392|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
125175393|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
125175394|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
125175395|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
125175396|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
125175397|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
125175398|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
125175399|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
125175400|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
125175401|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
125175402|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
125175403|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
125175404|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
125175405|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
125175406|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
125175407|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
125175408|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
125175409|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
125175410|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
125175411|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
125175412|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
125175413|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
125175414|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
125175415|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
125175416|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
125175417|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
125175418|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
125175419|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
125175420|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
125175421|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
125175422|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
125175423|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
125175424|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
125175425|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
125175426|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
125175427|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
125175428|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
125175429|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
125175430|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
125175431|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
125175432|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
125175433|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
125175434|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
125175435|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
125175436|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
125175437|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
125175438|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
125175439|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
125175440|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
125175441|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
125175442|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
125175443|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
125175444|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
125175445|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
125175446|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
125175447|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
125175448|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
125175449|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
125175450|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
125175451|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
125175452|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
125175453|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
125175454|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
125175455|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
125175456|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
125175457|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
125175458|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
125175459|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
125175460|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
125175461|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
125175462|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
125175463|NCT03598790|450263537|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
125175464|NCT03598790|450263538|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
125175465|NCT03598790|450263539|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
125175466|NCT03598790|450263540|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
125175467|NCT03598790|450263541|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
125175468|NCT03598790|450263542|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
125175469|NCT03598790|450263543|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
125175470|NCT03598790|450263544|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
125175471|NCT03598790|450263545|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
125175472|NCT03598790|450263537|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
125175473|NCT03598790|450263538|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
125175474|NCT03598790|450263539|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
125175475|NCT03598790|450263540|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
125175476|NCT03598790|450263541|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
125175477|NCT03598790|450263542|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
125175478|NCT03598790|450263543|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
125175479|NCT03598790|450263544|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
125175480|NCT03598790|450263545|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
125175481|NCT03598790|450263537|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125175482|NCT03598790|450263538|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125175483|NCT03598790|450263539|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125175484|NCT03598790|450263540|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
125175485|NCT03598790|450263541|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125175486|NCT03598790|450263542|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125175487|NCT03598790|450263543|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125175488|NCT03598790|450263544|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125175489|NCT03598790|450263545|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125175490|NCT03598790|450263537|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
125175491|NCT03598790|450263538|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
125175492|NCT03598790|450263539|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
125175493|NCT03598790|450263540|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
125175494|NCT03598790|450263541|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
125175495|NCT03598790|450263542|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
125175496|NCT03598790|450263543|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
125175497|NCT03598790|450263544|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
125175498|NCT03598790|450263545|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
125175499|NCT03598790|450263537|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
125175500|NCT03598790|450263538|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
125175501|NCT03598790|450263539|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
125175502|NCT03598790|450263540|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
125175503|NCT03598790|450263541|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
125175504|NCT03598790|450263542|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
125175505|NCT03598790|450263543|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
125175506|NCT03598790|450263544|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
125175507|NCT03598790|450263545|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
125175508|NCT05292183|450263556|FG000|Overall Study|Adverse Event|1|||
125175509|NCT02506153|450263559|FG000|Overall Study|Adverse Event|359|||
125175510|NCT02506153|450263560|FG001|Overall Study|Adverse Event|114|||
125175511|NCT02506153|450263559|FG000|Overall Study|Refused unrelated to adverse event|127|||
125175512|NCT02506153|450263560|FG001|Overall Study|Refused unrelated to adverse event|18|||
125175513|NCT02506153|450263559|FG000|Overall Study|Progression/relapse|91|||
125175514|NCT02506153|450263560|FG001|Overall Study|Progression/relapse|136|||
125175515|NCT02506153|450263559|FG000|Overall Study|Death|2|||
125175516|NCT02506153|450263560|FG001|Overall Study|Death|1|||
125175517|NCT02506153|450263559|FG000|Overall Study|Other - not protocol specified|23|||
125175518|NCT02506153|450263560|FG001|Overall Study|Other - not protocol specified|12|||
125175519|NCT06400238|450263565|FG000|Overall Study|Started Protocol Therapy|2|||
125175520|NCT06400238|450263565|FG000|Overall Study|Adverse Event|1|||
125175521|NCT06400238|450263565|FG000|Overall Study|Death|1|||
125175522|NCT06400238|450263565|FG000|Overall Study|Disease Progression|27|||
125175523|NCT06400238|450263565|FG000|Overall Study|Withdrawal by Subject|2|||
125175524|NCT06400238|450263565|FG000|Overall Study|Physician Decision|2|||
125175525|NCT06419907|450263566|FG000|Overall Study|Protocol Violation|0|||
125175526|NCT06419907|450263567|FG001|Overall Study|Protocol Violation|3|||
125175527|NCT06419907|450263568|FG002|Overall Study|Protocol Violation|0|||
125175528|NCT06419907|450263569|FG003|Overall Study|Protocol Violation|1|||
125230990|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
125303079|NCT03100058|450736667|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
125175529|NCT06419907|450263566|FG000|Overall Study|Lost to Follow-up|0|||
125175530|NCT06419907|450263567|FG001|Overall Study|Lost to Follow-up|0|||
125175531|NCT06419907|450263568|FG002|Overall Study|Lost to Follow-up|2|||
125175532|NCT06419907|450263569|FG003|Overall Study|Lost to Follow-up|1|||
125175533|NCT05929651|450263572|FG000|Overall Study|Protocol Deviation|1|||
125175534|NCT05929651|450263572|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
125175535|NCT02260570|450263573|FG000|Overall Study|Withdrawal by Subject|2|||
125175536|NCT02260570|450263574|FG001|Overall Study|Withdrawal by Subject|1|||
125175537|NCT02260570|450263573|FG000|Overall Study|Physician Decision|1|||
125175538|NCT02260570|450263574|FG001|Overall Study|Physician Decision|1|||
125175539|NCT05026177|450263575|FG000|Overall Study|Adverse Event|33|||
125175540|NCT05026177|450263576|FG001|Overall Study|Adverse Event|33|||
125175541|NCT05026177|450263577|FG002|Overall Study|Adverse Event|17|||
125175542|NCT05026177|450263575|FG000|Overall Study|Lost to Follow-up|7|||
125175543|NCT05026177|450263576|FG001|Overall Study|Lost to Follow-up|6|||
125175544|NCT05026177|450263577|FG002|Overall Study|Lost to Follow-up|8|||
125175545|NCT05026177|450263575|FG000|Overall Study|Noncompliance with study drug|6|||
125175546|NCT05026177|450263576|FG001|Overall Study|Noncompliance with study drug|2|||
125175547|NCT05026177|450263577|FG002|Overall Study|Noncompliance with study drug|1|||
125175548|NCT05026177|450263575|FG000|Overall Study|Physician Decision|4|||
125175549|NCT05026177|450263576|FG001|Overall Study|Physician Decision|1|||
125175550|NCT05026177|450263577|FG002|Overall Study|Physician Decision|0|||
125175551|NCT05026177|450263575|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
125175552|NCT05026177|450263576|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
125175553|NCT05026177|450263577|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
125175554|NCT05026177|450263575|FG000|Overall Study|Withdrawal by Subject|53|||
125175555|NCT05026177|450263576|FG001|Overall Study|Withdrawal by Subject|51|||
125175556|NCT05026177|450263577|FG002|Overall Study|Withdrawal by Subject|55|||
125175557|NCT05026177|450263575|FG000|Overall Study|Protocol Violation|0|||
125175558|NCT05026177|450263576|FG001|Overall Study|Protocol Violation|1|||
125175559|NCT05026177|450263577|FG002|Overall Study|Protocol Violation|0|||
125175560|NCT05026177|450263575|FG000|Overall Study|Study terminated by sponsor|70|||
125175561|NCT05026177|450263576|FG001|Overall Study|Study terminated by sponsor|74|||
125175562|NCT05026177|450263577|FG002|Overall Study|Study terminated by sponsor|67|||
125175563|NCT05026177|450263575|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
125175564|NCT05026177|450263576|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
125175565|NCT05026177|450263577|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
125175566|NCT05026177|450263575|FG000|Overall Study|Starting alternative treatment|0|||
125175567|NCT05026177|450263576|FG001|Overall Study|Starting alternative treatment|1|||
125175568|NCT05026177|450263577|FG002|Overall Study|Starting alternative treatment|1|||
125175569|NCT05026177|450263575|FG000|Overall Study|Noncompliance with study procedures|0|||
125175570|NCT05026177|450263576|FG001|Overall Study|Noncompliance with study procedures|1|||
125175571|NCT05026177|450263577|FG002|Overall Study|Noncompliance with study procedures|1|||
125175572|NCT05026177|450263575|FG000|Overall Study|Met stopping criteria|0|||
125175573|NCT05026177|450263576|FG001|Overall Study|Met stopping criteria|0|||
125175574|NCT05026177|450263577|FG002|Overall Study|Met stopping criteria|1|||
125175575|NCT05026177|450263575|FG000|Overall Study|Health issues preventing continuation|0|||
125175576|NCT05026177|450263576|FG001|Overall Study|Health issues preventing continuation|0|||
125175577|NCT05026177|450263577|FG002|Overall Study|Health issues preventing continuation|1|||
125175578|NCT05026177|450263575|FG000|Overall Study|Randomized in error, not treated|0|||
125175579|NCT05026177|450263576|FG001|Overall Study|Randomized in error, not treated|0|||
125175580|NCT05026177|450263577|FG002|Overall Study|Randomized in error, not treated|2|||
125175581|NCT04856917|450263578|FG000|Overall Study|Withdrawal by Subject|4|||
125175582|NCT04856917|450263579|FG001|Overall Study|Withdrawal by Subject|3|||
125175583|NCT04856917|450263580|FG002|Overall Study|Withdrawal by Subject|1|||
125175584|NCT04856917|450263578|FG000|Overall Study|Lost to Follow-up|3|||
125175585|NCT04856917|450263579|FG001|Overall Study|Lost to Follow-up|1|||
125175586|NCT04856917|450263580|FG002|Overall Study|Lost to Follow-up|1|||
125175587|NCT04856917|450263578|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
125175588|NCT04856917|450263579|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
125175589|NCT04856917|450263580|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
125175590|NCT04856917|450263578|FG000|Overall Study|Other|1|||
125175591|NCT04856917|450263579|FG001|Overall Study|Other|1|||
125175592|NCT04856917|450263580|FG002|Overall Study|Other|0|||
125175593|NCT01169337|450263581|FG000|Overall Study|Lack of Efficacy|5|||
125175594|NCT01169337|450263582|FG001|Overall Study|Lack of Efficacy|7|||
125175595|NCT01169337|450263583|FG002|Overall Study|Lack of Efficacy|0|||
125175596|NCT01169337|450263581|FG000|Overall Study|Adverse Event|12|||
125175597|NCT01169337|450263582|FG001|Overall Study|Adverse Event|18|||
125175598|NCT01169337|450263583|FG002|Overall Study|Adverse Event|0|||
125175599|NCT01169337|450263581|FG000|Overall Study|Death|2|||
125175600|NCT01169337|450263582|FG001|Overall Study|Death|0|||
125175601|NCT01169337|450263583|FG002|Overall Study|Death|0|||
125175602|NCT01169337|450263581|FG000|Overall Study|Withdrawal by Subject|11|||
125175603|NCT01169337|450263582|FG001|Overall Study|Withdrawal by Subject|11|||
125175604|NCT01169337|450263583|FG002|Overall Study|Withdrawal by Subject|6|||
125175605|NCT01169337|450263581|FG000|Overall Study|Noncompliance|2|||
125230991|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
125230992|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
125230993|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
125230994|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
125230995|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
125230996|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
125230997|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
125230998|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
125230999|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
125231000|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
125231001|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
125231002|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
125231003|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
125231004|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
125231005|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
125231006|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
125231007|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
125231008|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
125231009|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
125231010|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
125231011|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
125231012|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
125231013|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
125231014|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
125231015|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
125231016|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
125231017|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
125231018|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
125231019|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
125231020|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
125231021|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
125231022|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
125231023|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
125231024|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
125231025|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
125231026|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
125231027|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
125231028|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
125231029|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
125231030|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
125231031|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
125231032|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
125231033|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
125231034|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
125231035|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
125175606|NCT01169337|450263582|FG001|Overall Study|Noncompliance|0|||
125175607|NCT01169337|450263583|FG002|Overall Study|Noncompliance|0|||
125175608|NCT01169337|450263581|FG000|Overall Study|Other complicating disease|1|||
125175609|NCT01169337|450263582|FG001|Overall Study|Other complicating disease|1|||
125175610|NCT01169337|450263583|FG002|Overall Study|Other complicating disease|0|||
125175611|NCT01169337|450263581|FG000|Overall Study|Physician Decision|1|||
125175612|NCT01169337|450263582|FG001|Overall Study|Physician Decision|5|||
125175613|NCT01169337|450263583|FG002|Overall Study|Physician Decision|0|||
125175614|NCT01169337|450263581|FG000|Overall Study|Alternative therapy|0|||
125175615|NCT01169337|450263582|FG001|Overall Study|Alternative therapy|2|||
125175616|NCT01169337|450263583|FG002|Overall Study|Alternative therapy|0|||
125175617|NCT01169337|450263581|FG000|Overall Study|Changed hospital|0|||
125175618|NCT01169337|450263582|FG001|Overall Study|Changed hospital|1|||
125231036|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
125231037|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
125231038|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
125231039|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
125231040|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
125231041|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
125231042|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
125231043|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
125231044|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
125231045|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
125231046|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
125231047|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
125231048|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
125231049|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
125231050|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
125231051|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
125231052|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
125231053|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
125231054|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
125231055|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
125231056|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
125231057|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
125231058|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
125231059|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
125231060|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
125231061|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
125231062|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
125231063|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
125231064|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
125231065|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
125231066|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
125231067|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
125231068|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
125231069|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
125231070|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
125231071|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
125231072|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
125231073|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
125231074|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
125231075|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
125231076|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
125231077|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
125231078|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
125231079|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
125231080|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
125231081|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
125231082|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
125231083|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
125231084|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
125231085|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
125231086|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
125231087|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
125231088|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
125231089|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
125231090|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
125231091|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
125231092|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
125231093|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
125231094|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
125231095|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
125231096|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
125231097|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
125231098|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
125231099|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
125231100|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
125231101|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
125231102|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
125231103|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
125231104|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
125231105|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
125231106|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
125231107|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
125231108|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
125231109|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
125231110|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
125231111|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
125231112|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
125231113|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
125231114|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
125231115|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
125231116|NCT00855218|450473892|FG000|Overall Study|Adverse Event|43|||
125231117|NCT00855218|450473893|FG001|Overall Study|Adverse Event|27|||
125231118|NCT00855218|450473892|FG000|Overall Study|Withdrawal by Subject|10|||
125231119|NCT00855218|450473893|FG001|Overall Study|Withdrawal by Subject|6|||
125231120|NCT00855218|450473892|FG000|Overall Study|Physician Decision|18|||
125231121|NCT00855218|450473893|FG001|Overall Study|Physician Decision|11|||
125231122|NCT00855218|450473892|FG000|Overall Study|Lost to Follow-up|0|||
125231123|NCT00855218|450473893|FG001|Overall Study|Lost to Follow-up|1|||
125231124|NCT00855218|450473892|FG000|Overall Study|Protocol Violation|5|||
125231125|NCT00855218|450473893|FG001|Overall Study|Protocol Violation|9|||
125231126|NCT00855218|450473892|FG000|Overall Study|non-compliant with study drug|3|||
125231127|NCT00855218|450473893|FG001|Overall Study|non-compliant with study drug|1|||
125231128|NCT00855218|450473892|FG000|Overall Study|patient convenience|2|||
125231129|NCT00855218|450473893|FG001|Overall Study|patient convenience|0|||
125231130|NCT00855218|450473892|FG000|Overall Study|technical problems|2|||
125231131|NCT00855218|450473893|FG001|Overall Study|technical problems|1|||
125231132|NCT00855218|450473892|FG000|Overall Study|Still treated with study medication|0|||
125231133|NCT00855218|450473893|FG001|Overall Study|Still treated with study medication|1|||
125231134|NCT00855218|450473892|FG000|Overall Study|Untreatable disease progression|54|||
125231135|NCT00855218|450473893|FG001|Overall Study|Untreatable disease progression|67|||
125231136|NCT00855218|450473892|FG000|Overall Study|Second malignancy|0|||
125231137|NCT00855218|450473893|FG001|Overall Study|Second malignancy|1|||
125231138|NCT00855218|450473892|FG000|Overall Study|Progression measurement proven|7|||
125231139|NCT00855218|450473893|FG001|Overall Study|Progression measurement proven|15|||
125231140|NCT00855218|450473892|FG000|Overall Study|Clinical endpoint reached|10|||
125231141|NCT00855218|450473893|FG001|Overall Study|Clinical endpoint reached|13|||
125231142|NCT00764790|450473894|FG000|Overall Study|Protocol Violation|0|||
125231143|NCT00764790|450473895|FG001|Overall Study|Protocol Violation|0|||
125231144|NCT00764790|450473896|FG002|Overall Study|Protocol Violation|1|||
125231145|NCT00764790|450473894|FG000|Overall Study|Withdrawal by Subject|10|||
125231146|NCT00764790|450473895|FG001|Overall Study|Withdrawal by Subject|12|||
125231147|NCT00764790|450473896|FG002|Overall Study|Withdrawal by Subject|6|||
125231148|NCT00764790|450473894|FG000|Overall Study|Lost to Follow-up|28|||
125231149|NCT00764790|450473895|FG001|Overall Study|Lost to Follow-up|29|||
125231150|NCT00764790|450473896|FG002|Overall Study|Lost to Follow-up|23|||
125231151|NCT03191552|450473897|FG000|Overall Study|Lost to Follow-up|1|||
125231152|NCT03191552|450473898|FG001|Overall Study|Lost to Follow-up|0|||
125231153|NCT03191552|450473899|FG002|Overall Study|Lost to Follow-up|0|||
125231154|NCT03191552|450473897|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
125231155|NCT03191552|450473898|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
125231156|NCT03191552|450473899|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
125231157|NCT01265498|450473900|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
125231158|NCT01265498|450473901|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
125231159|NCT00617279|450473904|FG000|Overall Study|Study terminated by Sponsor|10|||
125231160|NCT00617279|450473905|FG001|Overall Study|Study terminated by Sponsor|15|||
125231161|NCT00617279|450473904|FG000|Overall Study|Graft abandonment|2|||
125231162|NCT00617279|450473905|FG001|Overall Study|Graft abandonment|0|||
125231163|NCT00617279|450473904|FG000|Overall Study|Lost to Follow-up|1|||
125231164|NCT00617279|450473905|FG001|Overall Study|Lost to Follow-up|0|||
125231165|NCT00617279|450473904|FG000|Overall Study|Death|1|||
125231166|NCT00617279|450473905|FG001|Overall Study|Death|2|||
125231167|NCT00921024|450473908|FG000|Overall Study|Lost to Follow-up|2|||
125231168|NCT00921024|450473909|FG001|Overall Study|Lost to Follow-up|0|||
125231169|NCT00921024|450473908|FG000|Overall Study|Received concomittant therapy|2|||
125231170|NCT00921024|450473909|FG001|Overall Study|Received concomittant therapy|0|||
125231171|NCT00921024|450473908|FG000|Overall Study|Withdrawal by Subject|0|||
125231172|NCT00921024|450473909|FG001|Overall Study|Withdrawal by Subject|3|||
125231173|NCT03225287|450473910|FG000|Overall Study|Adverse Event|0|||
125231174|NCT03225287|450473911|FG001|Overall Study|Adverse Event|0|||
125231175|NCT03225287|450473912|FG002|Overall Study|Adverse Event|1|||
125231176|NCT03225287|450473910|FG000|Overall Study|Protocol non-compliance|0|||
125231177|NCT03225287|450473911|FG001|Overall Study|Protocol non-compliance|0|||
125231178|NCT03225287|450473912|FG002|Overall Study|Protocol non-compliance|1|||
125231179|NCT03225287|450473910|FG000|Overall Study|Subject withdraws consent|3|||
125231180|NCT03225287|450473911|FG001|Overall Study|Subject withdraws consent|0|||
125231181|NCT03225287|450473912|FG002|Overall Study|Subject withdraws consent|0|||
125231182|NCT03225287|450473910|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
125231183|NCT03225287|450473911|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
125231184|NCT03225287|450473912|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
125231185|NCT03225287|450473910|FG000|Overall Study|Trial drug not effective|0|||
125231186|NCT03225287|450473911|FG001|Overall Study|Trial drug not effective|1|||
125231187|NCT03225287|450473912|FG002|Overall Study|Trial drug not effective|0|||
125231188|NCT03225287|450473910|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
125231189|NCT03225287|450473911|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
125231190|NCT03225287|450473912|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
125231191|NCT03225287|450473910|FG000|Overall Study|Stem cell transplantation|0|||
125231192|NCT03225287|450473911|FG001|Overall Study|Stem cell transplantation|1|||
125231193|NCT03225287|450473912|FG002|Overall Study|Stem cell transplantation|0|||
125231194|NCT01093846|450473915|FG000|Overall Study|Adverse Event|0|||
125231195|NCT01093846|450473916|FG001|Overall Study|Adverse Event|0|||
125231196|NCT01093846|450473917|FG002|Overall Study|Adverse Event|1|||
125231197|NCT01093846|450473915|FG000|Overall Study|Lack of Efficacy|0|||
125231198|NCT01093846|450473916|FG001|Overall Study|Lack of Efficacy|0|||
125231199|NCT01093846|450473917|FG002|Overall Study|Lack of Efficacy|4|||
125231200|NCT01093846|450473915|FG000|Overall Study|Condition no longer required study drug|1|||
125231201|NCT01093846|450473916|FG001|Overall Study|Condition no longer required study drug|1|||
125231202|NCT01093846|450473917|FG002|Overall Study|Condition no longer required study drug|1|||
125231203|NCT01093846|450473915|FG000|Overall Study|Administrative Problems|18|||
125231204|NCT01093846|450473916|FG001|Overall Study|Administrative Problems|17|||
125231205|NCT01093846|450473917|FG002|Overall Study|Administrative Problems|15|||
125231206|NCT01416571|450473918|FG000|Overall Study|Lost to Follow-up|2|||
125231207|NCT00296244|450476310|FG000|Overall Study|Underwent retransplant|0|||
125231208|NCT00296244|450476311|FG001|Overall Study|Underwent retransplant|1|||
125231209|NCT00427934|450476312|FG000|Overall Study|Adverse Event|1|||
125231210|NCT00427934|450476313|FG001|Overall Study|Adverse Event|0|||
125231211|NCT00427934|450476314|FG002|Overall Study|Adverse Event|5|||
125231212|NCT00427934|450476315|FG003|Overall Study|Adverse Event|4|||
125231213|NCT00427934|450476312|FG000|Overall Study|Lack of Efficacy|0|||
125231214|NCT00427934|450476313|FG001|Overall Study|Lack of Efficacy|0|||
125231215|NCT00427934|450476314|FG002|Overall Study|Lack of Efficacy|5|||
125231216|NCT00427934|450476315|FG003|Overall Study|Lack of Efficacy|2|||
125231217|NCT00427934|450476312|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
125231218|NCT00427934|450476313|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
125231219|NCT00427934|450476314|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
125231220|NCT00427934|450476315|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
125231221|NCT00427934|450476312|FG000|Overall Study|Other|0|||
125231222|NCT00427934|450476313|FG001|Overall Study|Other|0|||
125231223|NCT00427934|450476314|FG002|Overall Study|Other|11|||
125231224|NCT00427934|450476315|FG003|Overall Study|Other|5|||
125231225|NCT00427934|450476312|FG000|Overall Study|Withdrawal by Subject|0|||
125175619|NCT01169337|450263583|FG002|Overall Study|Changed hospital|0|||
125175620|NCT01169337|450263581|FG000|Overall Study|Never started treatment|0|||
125175621|NCT01169337|450263582|FG001|Overall Study|Never started treatment|2|||
125175622|NCT01169337|450263583|FG002|Overall Study|Never started treatment|0|||
125175623|NCT01169337|450263581|FG000|Overall Study|Reason not reported|1|||
125175624|NCT01169337|450263582|FG001|Overall Study|Reason not reported|0|||
125175625|NCT01169337|450263583|FG002|Overall Study|Reason not reported|0|||
125231226|NCT00427934|450476313|FG001|Overall Study|Withdrawal by Subject|0|||
125231227|NCT00427934|450476314|FG002|Overall Study|Withdrawal by Subject|1|||
125231228|NCT00427934|450476315|FG003|Overall Study|Withdrawal by Subject|3|||
125231229|NCT04539275|450476318|FG000|Overall Study|Death|2|||
125231230|NCT04539275|450476319|FG001|Overall Study|Death|4|||
125231231|NCT04539275|450476318|FG000|Overall Study|Lost to Follow-up|1|||
125231232|NCT04539275|450476319|FG001|Overall Study|Lost to Follow-up|1|||
125231233|NCT04539275|450476318|FG000|Overall Study|Withdrawal by Subject|3|||
125231234|NCT04539275|450476319|FG001|Overall Study|Withdrawal by Subject|0|||
125231235|NCT01373164|450476320|FG000|Overall Study|Lost to Follow-up|0|||
125231236|NCT01373164|450476321|FG001|Overall Study|Lost to Follow-up|0|||
125231237|NCT01373164|450476322|FG002|Overall Study|Lost to Follow-up|1|||
125231238|NCT01373164|450476323|FG003|Overall Study|Lost to Follow-up|2|||
125175626|NCT01169337|450263581|FG000|Overall Study|Continuing lenalidomide|9|||
125175627|NCT01169337|450263582|FG001|Overall Study|Continuing lenalidomide|43|||
125175628|NCT01169337|450263583|FG002|Overall Study|Continuing lenalidomide|0|||
125175629|NCT04008030|450263584|FG000|Pre-Treatment|Withdrawal by Subject|0|||
125175630|NCT04008030|450263585|FG001|Pre-Treatment|Withdrawal by Subject|0|||
125231239|NCT01373164|450476324|FG004|Overall Study|Lost to Follow-up|0|||
125231240|NCT01373164|450476320|FG000|Overall Study|Withdrawal by Subject|0|||
125231241|NCT01373164|450476321|FG001|Overall Study|Withdrawal by Subject|1|||
125175631|NCT04008030|450263586|FG002|Pre-Treatment|Withdrawal by Subject|9|||
125175632|NCT04008030|450263584|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
125175633|NCT04008030|450263585|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
125175634|NCT04008030|450263586|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
125175635|NCT04008030|450263584|FG000|Pre-Treatment|Other reasons|0|||
125175636|NCT04008030|450263585|FG001|Pre-Treatment|Other reasons|1|||
125175637|NCT04008030|450263586|FG002|Pre-Treatment|Other reasons|6|||
125175638|NCT04008030|450263584|FG000|Treatment|Withdrawal by Subject|1|||
125175639|NCT04008030|450263585|FG001|Treatment|Withdrawal by Subject|1|||
125175640|NCT04008030|450263586|FG002|Treatment|Withdrawal by Subject|1|||
125175641|NCT04008030|450263584|FG000|Treatment|Death|2|||
125175642|NCT04008030|450263585|FG001|Treatment|Death|4|||
125175643|NCT04008030|450263586|FG002|Treatment|Death|0|||
125175644|NCT04008030|450263584|FG000|Treatment|Pregnancy|0|||
125175645|NCT04008030|450263585|FG001|Treatment|Pregnancy|1|||
125175646|NCT04008030|450263586|FG002|Treatment|Pregnancy|0|||
125175647|NCT04008030|450263584|FG000|Treatment|Participant no longer meets study criteria|0|||
125175648|NCT04008030|450263585|FG001|Treatment|Participant no longer meets study criteria|1|||
125175649|NCT04008030|450263586|FG002|Treatment|Participant no longer meets study criteria|0|||
125175650|NCT04008030|450263584|FG000|Treatment|Other reasons|5|||
125175651|NCT04008030|450263585|FG001|Treatment|Other reasons|13|||
125175652|NCT04008030|450263586|FG002|Treatment|Other reasons|6|||
125175653|NCT04008030|450263584|FG000|Treatment|Disease Progression|137|||
125175654|NCT04008030|450263585|FG001|Treatment|Disease Progression|82|||
125175655|NCT04008030|450263586|FG002|Treatment|Disease Progression|85|||
125175656|NCT04008030|450263584|FG000|Treatment|Study drug toxicity|28|||
125175657|NCT04008030|450263585|FG001|Treatment|Study drug toxicity|48|||
125175658|NCT04008030|450263586|FG002|Treatment|Study drug toxicity|8|||
125175659|NCT04008030|450263584|FG000|Treatment|Adverse Event unrelated to study drug|28|||
125175660|NCT04008030|450263585|FG001|Treatment|Adverse Event unrelated to study drug|22|||
125175661|NCT04008030|450263586|FG002|Treatment|Adverse Event unrelated to study drug|6|||
125175662|NCT04008030|450263584|FG000|Treatment|Maximum Clinical Benefit|0|||
125175663|NCT04008030|450263585|FG001|Treatment|Maximum Clinical Benefit|1|||
125175664|NCT04008030|450263586|FG002|Treatment|Maximum Clinical Benefit|9|||
125175665|NCT04008030|450263584|FG000|Treatment|On-going treatment|13|||
125175666|NCT04008030|450263585|FG001|Treatment|On-going treatment|20|||
125175667|NCT04008030|450263586|FG002|Treatment|On-going treatment|0|||
125175668|NCT03560037|450263587|FG000|Overall Study|Protocol Violation|1|||
125175669|NCT03560037|450263588|FG001|Overall Study|Protocol Violation|0|||
125175670|NCT03560037|450263587|FG000|Overall Study|Physician Decision|0|||
125175671|NCT03560037|450263588|FG001|Overall Study|Physician Decision|1|||
125175672|NCT04034927|450263589|FG000|Overall Study|Adverse Event|4|||
125175673|NCT04034927|450263590|FG001|Overall Study|Adverse Event|9|||
125175674|NCT04034927|450263589|FG000|Overall Study|Death|0|||
125175675|NCT04034927|450263590|FG001|Overall Study|Death|1|||
125175676|NCT04034927|450263589|FG000|Overall Study|Withdrawal by Subject|0|||
125175677|NCT04034927|450263590|FG001|Overall Study|Withdrawal by Subject|3|||
125175678|NCT04034927|450263589|FG000|Overall Study|Still on Treatment|2|||
125175679|NCT04034927|450263590|FG001|Overall Study|Still on Treatment|1|||
125175680|NCT04034927|450263589|FG000|Overall Study|Other|1|||
125175681|NCT04034927|450263590|FG001|Overall Study|Other|1|||
125175682|NCT03996447|450263593|FG000|First MRI Examination|Adverse Event|2|||
125175683|NCT03996447|450263594|FG001|First MRI Examination|Adverse Event|0|||
125175684|NCT03996447|450263593|FG000|First MRI Examination|Withdrawal by Subject|1|||
125175685|NCT03996447|450263594|FG001|First MRI Examination|Withdrawal by Subject|2|||
125175686|NCT03996447|450263593|FG000|First MRI Examination|Protocol Violation|0|||
125175687|NCT03996447|450263594|FG001|First MRI Examination|Protocol Violation|1|||
125175688|NCT03996447|450263593|FG000|Washout|Adverse Event|2|||
125175689|NCT03996447|450263594|FG001|Washout|Adverse Event|0|||
125175690|NCT03996447|450263593|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
125175691|NCT03996447|450263594|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
125231242|NCT01373164|450476322|FG002|Overall Study|Withdrawal by Subject|0|||
125175692|NCT03996447|450263593|FG000|Washout|Withdrawal by Subject|0|||
125175693|NCT03996447|450263594|FG001|Washout|Withdrawal by Subject|1|||
125175694|NCT03996447|450263593|FG000|Washout|Other reason|1|||
125231243|NCT01373164|450476323|FG003|Overall Study|Withdrawal by Subject|10|||
125175695|NCT03996447|450263594|FG001|Washout|Other reason|1|||
125175696|NCT03816878|450263595|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
125175697|NCT03816878|450263596|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
125231244|NCT01373164|450476324|FG004|Overall Study|Withdrawal by Subject|2|||
125231245|NCT01799941|450476329|FG000|Overall Study|Adverse Event|34|||
125175698|NCT03816878|450263595|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
125175699|NCT03816878|450263596|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
125175700|NCT03355469|450263597|FG000|Overall Study|COVID-19|3|||
125175701|NCT03355469|450263598|FG001|Overall Study|COVID-19|2|||
125175702|NCT03355469|450263599|FG002|Overall Study|COVID-19|3|||
125175703|NCT03355469|450263600|FG003|Overall Study|COVID-19|3|||
125175704|NCT03355469|450263597|FG000|Overall Study|Lost to Follow-up|1|||
125175705|NCT03355469|450263598|FG001|Overall Study|Lost to Follow-up|0|||
125175706|NCT03355469|450263599|FG002|Overall Study|Lost to Follow-up|1|||
125175707|NCT03355469|450263600|FG003|Overall Study|Lost to Follow-up|0|||
125175708|NCT03355469|450263597|FG000|Overall Study|Withdrawal by Subject|2|||
125175709|NCT03355469|450263598|FG001|Overall Study|Withdrawal by Subject|1|||
125175710|NCT03355469|450263599|FG002|Overall Study|Withdrawal by Subject|0|||
125175711|NCT03355469|450263600|FG003|Overall Study|Withdrawal by Subject|3|||
125175712|NCT01708941|450263601|FG000|Overall Study|Adverse Event|4|||
125175713|NCT01708941|450263602|FG001|Overall Study|Adverse Event|6|||
125175714|NCT01708941|450263603|FG002|Overall Study|Adverse Event|1|||
125175715|NCT01708941|450263604|FG003|Overall Study|Adverse Event|0|||
125175716|NCT01708941|450263601|FG000|Overall Study|Death|1|||
125175717|NCT01708941|450263602|FG001|Overall Study|Death|1|||
125175718|NCT01708941|450263603|FG002|Overall Study|Death|2|||
125175719|NCT01708941|450263604|FG003|Overall Study|Death|14|||
125175720|NCT01708941|450263601|FG000|Overall Study|Withdrawal by Subject|1|||
125175721|NCT01708941|450263602|FG001|Overall Study|Withdrawal by Subject|0|||
125175722|NCT01708941|450263603|FG002|Overall Study|Withdrawal by Subject|3|||
125175723|NCT01708941|450263604|FG003|Overall Study|Withdrawal by Subject|4|||
125175724|NCT01708941|450263601|FG000|Overall Study|Disease progression|9|||
125175725|NCT01708941|450263602|FG001|Overall Study|Disease progression|10|||
125175726|NCT01708941|450263603|FG002|Overall Study|Disease progression|8|||
125175727|NCT01708941|450263604|FG003|Overall Study|Disease progression|0|||
125175728|NCT01708941|450263601|FG000|Overall Study|Alternative therapy|0|||
125175729|NCT01708941|450263602|FG001|Overall Study|Alternative therapy|0|||
125175730|NCT01708941|450263603|FG002|Overall Study|Alternative therapy|2|||
125175731|NCT01708941|450263604|FG003|Overall Study|Alternative therapy|0|||
125175732|NCT01708941|450263601|FG000|Overall Study|Ineligible and never started treatment|1|||
125175733|NCT01708941|450263602|FG001|Overall Study|Ineligible and never started treatment|0|||
125175734|NCT01708941|450263603|FG002|Overall Study|Ineligible and never started treatment|1|||
125175735|NCT01708941|450263604|FG003|Overall Study|Ineligible and never started treatment|0|||
125175736|NCT01708941|450263601|FG000|Overall Study|Never started treatment|2|||
125175737|NCT01708941|450263602|FG001|Overall Study|Never started treatment|1|||
125175738|NCT01708941|450263603|FG002|Overall Study|Never started treatment|0|||
125175739|NCT01708941|450263604|FG003|Overall Study|Never started treatment|0|||
125175740|NCT01708941|450263601|FG000|Overall Study|Ineligible|0|||
125175741|NCT01708941|450263602|FG001|Overall Study|Ineligible|0|||
125175742|NCT01708941|450263603|FG002|Overall Study|Ineligible|2|||
125175743|NCT01708941|450263604|FG003|Overall Study|Ineligible|0|||
125175744|NCT01575548|450263605|FG000|Overall Study|Adverse Event|15|||
125175745|NCT01575548|450263606|FG001|Overall Study|Adverse Event|2|||
125175746|NCT01575548|450263605|FG000|Overall Study|Disease progression|12|||
125175747|NCT01575548|450263606|FG001|Overall Study|Disease progression|25|||
125175748|NCT01575548|450263605|FG000|Overall Study|Death|1|||
125175749|NCT01575548|450263606|FG001|Overall Study|Death|0|||
125175750|NCT01575548|450263605|FG000|Overall Study|Other complicating disease|1|||
125175751|NCT01575548|450263606|FG001|Overall Study|Other complicating disease|0|||
125175752|NCT01575548|450263605|FG000|Overall Study|Withdrawal by Subject|7|||
125175753|NCT01575548|450263606|FG001|Overall Study|Withdrawal by Subject|3|||
125175754|NCT01575548|450263605|FG000|Overall Study|Noncompliance|1|||
125175755|NCT01575548|450263606|FG001|Overall Study|Noncompliance|0|||
125175756|NCT01575548|450263605|FG000|Overall Study|Anticipated surgery|0|||
125231246|NCT01799941|450476329|FG000|Overall Study|Withdrawal by Subject|21|||
125231247|NCT01799941|450476329|FG000|Overall Study|Death|2|||
125231248|NCT01799941|450476329|FG000|Overall Study|Investigator Decision|4|||
125231249|NCT01799941|450476329|FG000|Overall Study|Lack of Efficacy|3|||
125231250|NCT01799941|450476329|FG000|Overall Study|Lost to Follow-up|17|||
125231251|NCT01799941|450476329|FG000|Overall Study|Other|15|||
125175757|NCT01575548|450263606|FG001|Overall Study|Anticipated surgery|1|||
125175758|NCT01575548|450263605|FG000|Overall Study|Never started protocol therapy|3|||
125175759|NCT01575548|450263606|FG001|Overall Study|Never started protocol therapy|2|||
125175760|NCT04175912|450263607|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
125231252|NCT00420745|450476336|FG000|Overall Study|Adverse Event|2|||
125231253|NCT00420745|450476337|FG001|Overall Study|Adverse Event|2|||
125175761|NCT04175912|450263608|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
125175762|NCT04175912|450263607|FG000|Overall Study|Adverse Event|0|||
125175763|NCT04175912|450263608|FG001|Overall Study|Adverse Event|3|||
125175764|NCT04175912|450263607|FG000|Overall Study|Never started treatment|3|||
125175765|NCT04175912|450263608|FG001|Overall Study|Never started treatment|3|||
125175766|NCT04175912|450263607|FG000|Overall Study|Death|0|||
125231254|NCT00420745|450476336|FG000|Overall Study|Lost to Follow-up|10|||
125231255|NCT00420745|450476337|FG001|Overall Study|Lost to Follow-up|2|||
125231256|NCT00420745|450476336|FG000|Overall Study|Protocol Violation|1|||
125231257|NCT00420745|450476337|FG001|Overall Study|Protocol Violation|0|||
125231258|NCT00420745|450476336|FG000|Overall Study|Physician Decision|1|||
125231259|NCT00420745|450476337|FG001|Overall Study|Physician Decision|1|||
125231260|NCT00420745|450476336|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
125175767|NCT04175912|450263608|FG001|Overall Study|Death|1|||
125175768|NCT02048813|450263612|FG000|Overall Study|Still on treatment|279|||
125175769|NCT02048813|450263613|FG001|Overall Study|Still on treatment|0|||
125175770|NCT02048813|450263612|FG000|Overall Study|Adverse Event|40|||
125175771|NCT02048813|450263613|FG001|Overall Study|Adverse Event|38|||
125175772|NCT02048813|450263612|FG000|Overall Study|Disease progression|13|||
125175773|NCT02048813|450263613|FG001|Overall Study|Disease progression|3|||
125175774|NCT02048813|450263612|FG000|Overall Study|Withdrawal by Subject|7|||
125175775|NCT02048813|450263613|FG001|Overall Study|Withdrawal by Subject|8|||
125175776|NCT02048813|450263612|FG000|Overall Study|Death|2|||
125175777|NCT02048813|450263613|FG001|Overall Study|Death|1|||
125175778|NCT02048813|450263612|FG000|Overall Study|Complication|2|||
125175779|NCT02048813|450263613|FG001|Overall Study|Complication|2|||
125175780|NCT02048813|450263612|FG000|Overall Study|Non-protocol therapy|0|||
125175781|NCT02048813|450263613|FG001|Overall Study|Non-protocol therapy|1|||
125175782|NCT02048813|450263612|FG000|Overall Study|Second primary cancer|2|||
125175783|NCT02048813|450263613|FG001|Overall Study|Second primary cancer|0|||
125175784|NCT02048813|450263612|FG000|Overall Study|Insurance|2|||
125175785|NCT02048813|450263613|FG001|Overall Study|Insurance|0|||
125175786|NCT02048813|450263612|FG000|Overall Study|Wound infection/healing|2|||
125175787|NCT02048813|450263613|FG001|Overall Study|Wound infection/healing|0|||
125175788|NCT02048813|450263612|FG000|Overall Study|Missed appointment|3|||
125175789|NCT02048813|450263613|FG001|Overall Study|Missed appointment|0|||
125175790|NCT02048813|450263612|FG000|Overall Study|Never started treatment|2|||
125175791|NCT02048813|450263613|FG001|Overall Study|Never started treatment|17|||
125175792|NCT01708954|450263614|FG000|Step 1|Disease progression|26|||
125175793|NCT01708954|450263615|FG001|Step 1|Disease progression|17|||
125175794|NCT01708954|450263616|FG002|Step 1|Disease progression|14|||
125175795|NCT01708954|450263614|FG000|Step 1|Adverse Event|3|||
125175796|NCT01708954|450263615|FG001|Step 1|Adverse Event|11|||
125175797|NCT01708954|450263616|FG002|Step 1|Adverse Event|13|||
125175798|NCT01708954|450263614|FG000|Step 1|Death|3|||
125175799|NCT01708954|450263615|FG001|Step 1|Death|2|||
125175800|NCT01708954|450263616|FG002|Step 1|Death|3|||
125175801|NCT01708954|450263614|FG000|Step 1|Withdrawal by Subject|2|||
125175802|NCT01708954|450263615|FG001|Step 1|Withdrawal by Subject|5|||
125175803|NCT01708954|450263616|FG002|Step 1|Withdrawal by Subject|3|||
125175804|NCT01708954|450263614|FG000|Step 1|Other complicating disease|0|||
125175805|NCT01708954|450263615|FG001|Step 1|Other complicating disease|2|||
125175806|NCT01708954|450263616|FG002|Step 1|Other complicating disease|0|||
125175807|NCT01708954|450263614|FG000|Step 1|Crossed over to Step 2|2|||
125175808|NCT01708954|450263615|FG001|Step 1|Crossed over to Step 2|0|||
125175809|NCT01708954|450263616|FG002|Step 1|Crossed over to Step 2|0|||
125175810|NCT01708954|450263614|FG000|Step 1|Symptomatic deterioration|1|||
125175811|NCT01708954|450263615|FG001|Step 1|Symptomatic deterioration|0|||
125175812|NCT01708954|450263616|FG002|Step 1|Symptomatic deterioration|1|||
125175813|NCT01708954|450263614|FG000|Step 1|Off-treatment reason not submitted|1|||
125175814|NCT01708954|450263615|FG001|Step 1|Off-treatment reason not submitted|1|||
125175815|NCT01708954|450263616|FG002|Step 1|Off-treatment reason not submitted|1|||
125175816|NCT01708954|450263614|FG000|Step 1|Ineligible or never received treatment|4|||
125175817|NCT01708954|450263615|FG001|Step 1|Ineligible or never received treatment|2|||
125175818|NCT01708954|450263616|FG002|Step 1|Ineligible or never received treatment|8|||
125175819|NCT01708954|450263614|FG000|Step 2|Disease progression|9|||
125175820|NCT01708954|450263615|FG001|Step 2|Disease progression|4|||
125175821|NCT01708954|450263616|FG002|Step 2|Disease progression|0|||
125175822|NCT01708954|450263614|FG000|Step 2|Adverse Event|3|||
125231261|NCT00420745|450476337|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
125175823|NCT01708954|450263615|FG001|Step 2|Adverse Event|2|||
125175824|NCT01708954|450263616|FG002|Step 2|Adverse Event|0|||
125175825|NCT01708954|450263614|FG000|Step 2|Withdrawal by Subject|1|||
125175826|NCT01708954|450263615|FG001|Step 2|Withdrawal by Subject|1|||
125175827|NCT01708954|450263616|FG002|Step 2|Withdrawal by Subject|0|||
125175828|NCT06400251|450263617|FG000|Overall Study|Never Start Protocol Therapy|1|||
125175829|NCT06400251|450263617|FG000|Overall Study|Ineligible|2|||
125175830|NCT06400251|450263617|FG000|Overall Study|Mutation Status Not Confirmed|3|||
125175831|NCT06400251|450263617|FG000|Overall Study|Disease Progression|25|||
125175832|NCT06400251|450263617|FG000|Overall Study|Adverse Event|1|||
125175833|NCT06400251|450263617|FG000|Overall Study|Complicating Disease|1|||
125175834|NCT06400251|450263617|FG000|Overall Study|Physician Decision|2|||
125175835|NCT03631199|450263618|FG000|Overall Study|Progressive disease|9|||
125175836|NCT03631199|450263619|FG001|Overall Study|Progressive disease|5|||
125175837|NCT03631199|450263620|FG002|Overall Study|Progressive disease|5|||
125231262|NCT00420745|450476336|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
125231263|NCT00420745|450476337|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
125231264|NCT01125930|450476345|FG000|Overall Study|Adverse Event|0|||
125231265|NCT01125930|450476346|FG001|Overall Study|Adverse Event|1|||
125231266|NCT01125930|450476345|FG000|Overall Study|Withdrawal by Subject|1|||
125231267|NCT01125930|450476346|FG001|Overall Study|Withdrawal by Subject|6|||
125231268|NCT01125930|450476345|FG000|Overall Study|Protocol Violation|0|||
125231269|NCT01125930|450476346|FG001|Overall Study|Protocol Violation|1|||
125231270|NCT01125930|450476345|FG000|Overall Study|Lost to Follow-up|0|||
125231271|NCT01125930|450476346|FG001|Overall Study|Lost to Follow-up|2|||
125231272|NCT01715831|450476347|FG000|Overall Study|Adverse Event|1|||
125231273|NCT03098979|450476350|FG000|Overall Study|Adverse Event|1|||
125231274|NCT03098979|450476351|FG001|Overall Study|Adverse Event|0|||
125231275|NCT03098979|450476352|FG002|Overall Study|Adverse Event|1|||
125231276|NCT03098979|450476353|FG003|Overall Study|Adverse Event|4|||
125231277|NCT03098979|450476354|FG004|Overall Study|Adverse Event|6|||
125231278|NCT03098979|450476355|FG005|Overall Study|Adverse Event|1|||
125231279|NCT03098979|450476350|FG000|Overall Study|Withdrawal by Subject|2|||
125231280|NCT03098979|450476351|FG001|Overall Study|Withdrawal by Subject|1|||
125231281|NCT03098979|450476352|FG002|Overall Study|Withdrawal by Subject|1|||
125231282|NCT03098979|450476353|FG003|Overall Study|Withdrawal by Subject|1|||
125231283|NCT03098979|450476354|FG004|Overall Study|Withdrawal by Subject|2|||
125231284|NCT03098979|450476355|FG005|Overall Study|Withdrawal by Subject|1|||
125231285|NCT03098979|450476350|FG000|Overall Study|Death|1|||
125231286|NCT03098979|450476351|FG001|Overall Study|Death|0|||
125231287|NCT03098979|450476352|FG002|Overall Study|Death|2|||
125231288|NCT03098979|450476353|FG003|Overall Study|Death|0|||
125231289|NCT03098979|450476354|FG004|Overall Study|Death|1|||
125231290|NCT03098979|450476355|FG005|Overall Study|Death|0|||
125231291|NCT03098979|450476350|FG000|Overall Study|Physician Decision|2|||
125231292|NCT03098979|450476351|FG001|Overall Study|Physician Decision|1|||
125231293|NCT03098979|450476352|FG002|Overall Study|Physician Decision|0|||
125231294|NCT03098979|450476353|FG003|Overall Study|Physician Decision|0|||
125231295|NCT03098979|450476354|FG004|Overall Study|Physician Decision|0|||
125231296|NCT03098979|450476355|FG005|Overall Study|Physician Decision|0|||
125231297|NCT03098979|450476350|FG000|Overall Study|Non-compliance|0|||
125231298|NCT03098979|450476351|FG001|Overall Study|Non-compliance|0|||
125231299|NCT03098979|450476352|FG002|Overall Study|Non-compliance|0|||
125231300|NCT03098979|450476353|FG003|Overall Study|Non-compliance|0|||
125231301|NCT03098979|450476354|FG004|Overall Study|Non-compliance|0|||
125231302|NCT03098979|450476355|FG005|Overall Study|Non-compliance|1|||
125231303|NCT03098979|450476350|FG000|Overall Study|Protocol Violation|0|||
125231304|NCT03098979|450476351|FG001|Overall Study|Protocol Violation|0|||
125231305|NCT03098979|450476352|FG002|Overall Study|Protocol Violation|0|||
125231306|NCT03098979|450476353|FG003|Overall Study|Protocol Violation|0|||
125231307|NCT03098979|450476354|FG004|Overall Study|Protocol Violation|0|||
125231308|NCT03098979|450476355|FG005|Overall Study|Protocol Violation|1|||
125231309|NCT02426684|450476356|FG000|Overall Study|Physician Decision|1|||
125231310|NCT03736967|450476357|FG000|Overall Study|Withdrawal by Subject|26|||
125231311|NCT03736967|450476358|FG001|Overall Study|Withdrawal by Subject|25|||
125231312|NCT03736967|450476359|FG002|Overall Study|Withdrawal by Subject|23|||
125231313|NCT03736967|450476360|FG003|Overall Study|Withdrawal by Subject|26|||
125231314|NCT03736967|450476357|FG000|Overall Study|Lost to Follow-up|3|||
125231315|NCT03736967|450476358|FG001|Overall Study|Lost to Follow-up|2|||
125231316|NCT03736967|450476359|FG002|Overall Study|Lost to Follow-up|1|||
125231317|NCT03736967|450476360|FG003|Overall Study|Lost to Follow-up|1|||
125231318|NCT03736967|450476357|FG000|Overall Study|Physician Decision|1|||
125231319|NCT03736967|450476358|FG001|Overall Study|Physician Decision|0|||
125231320|NCT03736967|450476359|FG002|Overall Study|Physician Decision|0|||
125231321|NCT03736967|450476360|FG003|Overall Study|Physician Decision|1|||
125231322|NCT03736967|450476357|FG000|Overall Study|Adverse Event|0|||
125231323|NCT03736967|450476358|FG001|Overall Study|Adverse Event|1|||
125231324|NCT03736967|450476359|FG002|Overall Study|Adverse Event|0|||
125231325|NCT03736967|450476360|FG003|Overall Study|Adverse Event|1|||
125231326|NCT03736967|450476357|FG000|Overall Study|Death|0|||
125231327|NCT03736967|450476358|FG001|Overall Study|Death|0|||
125231328|NCT03736967|450476359|FG002|Overall Study|Death|0|||
125231329|NCT03736967|450476360|FG003|Overall Study|Death|1|||
125231330|NCT03736967|450476357|FG000|Overall Study|Randomized but never treated|1|||
125231331|NCT03736967|450476358|FG001|Overall Study|Randomized but never treated|0|||
125231332|NCT03736967|450476359|FG002|Overall Study|Randomized but never treated|0|||
125231333|NCT03736967|450476360|FG003|Overall Study|Randomized but never treated|0|||
125231334|NCT02369653|450476361|FG000|Overall Study|Lost to Follow-up|0|||
125231335|NCT02369653|450476362|FG001|Overall Study|Lost to Follow-up|1|||
125231336|NCT02369653|450476361|FG000|Overall Study|Administrative reason by sponsor|0|||
125231337|NCT02369653|450476362|FG001|Overall Study|Administrative reason by sponsor|1|||
125231338|NCT02369653|450476361|FG000|Overall Study|Death|1|||
125231339|NCT02369653|450476362|FG001|Overall Study|Death|2|||
125231340|NCT02369653|450476361|FG000|Overall Study|Participant withdrew consent|13|||
125231341|NCT02369653|450476362|FG001|Overall Study|Participant withdrew consent|3|||
125231342|NCT02419807|450476363|FG000|Overall Study|Withdrawal by Subject|4|||
125231343|NCT02419807|450476363|FG000|Overall Study|Physician Decision|1|||
125231344|NCT02419807|450476363|FG000|Overall Study|Protocol Violation|5|||
125231345|NCT01458587|450476364|FG000|Overall Study|Withdrawal by Subject|1|||
125231346|NCT01458587|450476365|FG001|Overall Study|Withdrawal by Subject|0|||
125231347|NCT01006629|450476366|FG000|Overall Study|Adverse Event|1|||
125231348|NCT01006629|450476366|FG000|Overall Study|Parent refused to continue participation|1|||
125231349|NCT01006629|450476366|FG000|Overall Study|Parent unable to perform site visit|4|||
125231350|NCT01118299|450476367|FG000|Overall Study|Death|7|||
125231351|NCT01118299|450476368|FG001|Overall Study|Death|5|||
125231352|NCT01118299|450476367|FG000|Overall Study|Withdrawal by Subject|8|||
125231353|NCT01118299|450476368|FG001|Overall Study|Withdrawal by Subject|8|||
125231354|NCT01118299|450476367|FG000|Overall Study|Lost to Follow-up|2|||
125231355|NCT01118299|450476368|FG001|Overall Study|Lost to Follow-up|1|||
125231356|NCT01118299|450476367|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
125231357|NCT01118299|450476368|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
125231358|NCT04459338|450476370|FG000|Overall Study|Loss of IV during study|1|||
125231359|NCT04459338|450476371|FG001|Overall Study|Loss of IV during study|0|||
125231360|NCT03157089|450476372|FG000|Overall Study|Treated only with pembrolizumab|1|||
125231361|NCT03157089|450476373|FG001|Overall Study|Treated only with pembrolizumab|0|||
125231362|NCT03157089|450476372|FG000|Overall Study|Adverse Event|5|||
125231363|NCT03157089|450476373|FG001|Overall Study|Adverse Event|4|||
125231364|NCT03157089|450476372|FG000|Overall Study|Progressive disease|6|||
125231365|NCT03157089|450476373|FG001|Overall Study|Progressive disease|8|||
125231366|NCT02932943|450476374|FG000|Overall Study|Lost to Follow-up|0|||
125231367|NCT02932943|450476375|FG001|Overall Study|Lost to Follow-up|2|||
125231368|NCT02932943|450476374|FG000|Overall Study|Adverse Event|2|||
125231369|NCT02932943|450476375|FG001|Overall Study|Adverse Event|2|||
125231370|NCT02932943|450476374|FG000|Overall Study|Withdrawal by Subject|3|||
125231371|NCT02932943|450476375|FG001|Overall Study|Withdrawal by Subject|3|||
125231372|NCT01454284|450476378|FG000|Overall Study|Adverse Event|20|||
125231373|NCT01454284|450476379|FG001|Overall Study|Adverse Event|7|||
125231374|NCT01454284|450476378|FG000|Overall Study|Death|0|||
125231375|NCT01454284|450476379|FG001|Overall Study|Death|3|||
125231376|NCT01454284|450476378|FG000|Overall Study|Lost to Follow-up|13|||
125231377|NCT01454284|450476379|FG001|Overall Study|Lost to Follow-up|8|||
125231378|NCT01454284|450476378|FG000|Overall Study|Protocol Violation|9|||
125231379|NCT01454284|450476379|FG001|Overall Study|Protocol Violation|6|||
125231380|NCT01454284|450476378|FG000|Overall Study|Withdrawal by Subject|58|||
125231381|NCT01454284|450476379|FG001|Overall Study|Withdrawal by Subject|36|||
125231382|NCT01454284|450476378|FG000|Overall Study|Physician Decision|16|||
125231383|NCT01454284|450476379|FG001|Overall Study|Physician Decision|11|||
125231384|NCT01454284|450476378|FG000|Overall Study|Sponsor Decision|0|||
125231385|NCT01454284|450476379|FG001|Overall Study|Sponsor Decision|2|||
125231386|NCT03248037|450476380|FG000|Overall Study|Withdrawal by Subject|6|||
125231387|NCT03248037|450476381|FG001|Overall Study|Withdrawal by Subject|9|||
125231388|NCT03248037|450476380|FG000|Overall Study|Adverse Event|15|||
125231389|NCT03248037|450476381|FG001|Overall Study|Adverse Event|0|||
125231390|NCT02300610|450476382|FG000|Overall Study|Withdrawal by Subject|1|||
125231391|NCT02300610|450476383|FG001|Overall Study|Withdrawal by Subject|0|||
125231392|NCT02300610|450476384|FG002|Overall Study|Withdrawal by Subject|1|||
125231393|NCT04018066|450476385|FG000|Overall Study|participants started taking medications during the study period|3|||
125231394|NCT04018066|450476385|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
125231395|NCT03817528|450476386|FG000|Overall Study|Withdrawal by Subject|1|||
125231396|NCT03817528|450476386|FG000|Overall Study|Adverse Event|2|||
125231397|NCT01259245|450476393|FG000|Overall Study|Withdrawal by Subject|27|||
125231398|NCT01259245|450476394|FG001|Overall Study|Withdrawal by Subject|24|||
125231399|NCT01259245|450476393|FG000|Overall Study|Death|1|||
125231400|NCT01259245|450476394|FG001|Overall Study|Death|2|||
125231401|NCT01462942|450476405|FG000|Overall Study|Adverse Event|7|||
125231402|NCT01462942|450476406|FG001|Overall Study|Adverse Event|12|||
125231403|NCT01462942|450476407|FG002|Overall Study|Adverse Event|10|||
125231404|NCT01462942|450476408|FG003|Overall Study|Adverse Event|11|||
125231405|NCT01462942|450476409|FG004|Overall Study|Adverse Event|11|||
125231406|NCT01462942|450476405|FG000|Overall Study|Other, including COPD exacerbation|3|||
125231407|NCT01462942|450476406|FG001|Overall Study|Other, including COPD exacerbation|5|||
125231408|NCT01462942|450476407|FG002|Overall Study|Other, including COPD exacerbation|2|||
125231409|NCT01462942|450476408|FG003|Overall Study|Other, including COPD exacerbation|8|||
125231410|NCT01462942|450476409|FG004|Overall Study|Other, including COPD exacerbation|5|||
125231411|NCT01462942|450476405|FG000|Overall Study|Withdrawal by Subject|14|||
125231412|NCT01462942|450476406|FG001|Overall Study|Withdrawal by Subject|10|||
125231413|NCT01462942|450476407|FG002|Overall Study|Withdrawal by Subject|14|||
125231414|NCT01462942|450476408|FG003|Overall Study|Withdrawal by Subject|16|||
125231415|NCT01462942|450476409|FG004|Overall Study|Withdrawal by Subject|19|||
125231416|NCT01462942|450476405|FG000|Overall Study|Lack of Efficacy|6|||
125231417|NCT01462942|450476406|FG001|Overall Study|Lack of Efficacy|0|||
125231418|NCT01462942|450476407|FG002|Overall Study|Lack of Efficacy|4|||
125175838|NCT03631199|450263621|FG003|Overall Study|Progressive disease|149|||
125175839|NCT03631199|450263622|FG004|Overall Study|Progressive disease|148|||
125175840|NCT03631199|450263618|FG000|Overall Study|Physician Decision|0|||
125175841|NCT03631199|450263619|FG001|Overall Study|Physician Decision|2|||
125175842|NCT03631199|450263620|FG002|Overall Study|Physician Decision|3|||
125175843|NCT03631199|450263621|FG003|Overall Study|Physician Decision|19|||
125175844|NCT03631199|450263622|FG004|Overall Study|Physician Decision|13|||
125175845|NCT03631199|450263618|FG000|Overall Study|Adverse Event|1|||
125175846|NCT03631199|450263619|FG001|Overall Study|Adverse Event|1|||
125175847|NCT03631199|450263620|FG002|Overall Study|Adverse Event|0|||
125175848|NCT03631199|450263621|FG003|Overall Study|Adverse Event|28|||
125175849|NCT03631199|450263622|FG004|Overall Study|Adverse Event|29|||
125175850|NCT03631199|450263618|FG000|Overall Study|Death|0|||
125175851|NCT03631199|450263619|FG001|Overall Study|Death|1|||
125175852|NCT03631199|450263620|FG002|Overall Study|Death|0|||
125175853|NCT03631199|450263621|FG003|Overall Study|Death|35|||
125175854|NCT03631199|450263622|FG004|Overall Study|Death|48|||
125175855|NCT03631199|450263618|FG000|Overall Study|Subject decision|0|||
125175856|NCT03631199|450263619|FG001|Overall Study|Subject decision|1|||
125175857|NCT03631199|450263620|FG002|Overall Study|Subject decision|0|||
125175858|NCT03631199|450263621|FG003|Overall Study|Subject decision|12|||
125175859|NCT03631199|450263622|FG004|Overall Study|Subject decision|12|||
125175860|NCT03631199|450263618|FG000|Overall Study|No treated|0|||
125175861|NCT03631199|450263619|FG001|Overall Study|No treated|0|||
125175862|NCT03631199|450263620|FG002|Overall Study|No treated|0|||
125175863|NCT03631199|450263621|FG003|Overall Study|No treated|0|||
125175864|NCT03631199|450263622|FG004|Overall Study|No treated|1|||
125175865|NCT03631199|450263618|FG000|Overall Study|Treatment ongoing|0|||
125175866|NCT03631199|450263619|FG001|Overall Study|Treatment ongoing|1|||
125175867|NCT03631199|450263620|FG002|Overall Study|Treatment ongoing|1|||
125175868|NCT03631199|450263621|FG003|Overall Study|Treatment ongoing|76|||
125175869|NCT03631199|450263622|FG004|Overall Study|Treatment ongoing|71|||
125175870|NCT03631199|450263618|FG000|Overall Study|Guardian decision|0|||
125175871|NCT03631199|450263619|FG001|Overall Study|Guardian decision|0|||
125175872|NCT03631199|450263620|FG002|Overall Study|Guardian decision|0|||
125175873|NCT03631199|450263621|FG003|Overall Study|Guardian decision|1|||
125175874|NCT03631199|450263622|FG004|Overall Study|Guardian decision|1|||
125175875|NCT02567435|450263623|FG000|Overall Study|Death|1|||
125175876|NCT02567435|450263624|FG001|Overall Study|Death|1|||
125175877|NCT02567435|450263625|FG002|Overall Study|Death|0|||
125175878|NCT02567435|450263626|FG003|Overall Study|Death|0|||
125175879|NCT02567435|450263623|FG000|Overall Study|Ineligible|1|||
125175880|NCT02567435|450263624|FG001|Overall Study|Ineligible|3|||
125175881|NCT02567435|450263625|FG002|Overall Study|Ineligible|0|||
125175882|NCT02567435|450263626|FG003|Overall Study|Ineligible|0|||
125175883|NCT02567435|450263623|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
125175884|NCT02567435|450263624|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
125175885|NCT02567435|450263625|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
125175886|NCT02567435|450263626|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
125175887|NCT04458922|450263628|FG000|Overall Study|Withdrawal by Subject|1|||
125175888|NCT04458922|450263629|FG001|Overall Study|Withdrawal by Subject|0|||
125175889|NCT04458922|450263630|FG002|Overall Study|Withdrawal by Subject|2|||
125175890|NCT04458922|450263628|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
125175891|NCT04458922|450263629|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
125175892|NCT04458922|450263630|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
125175893|NCT04458922|450263628|FG000|Overall Study|Adverse Event|1|||
125175894|NCT04458922|450263629|FG001|Overall Study|Adverse Event|0|||
125175895|NCT04458922|450263630|FG002|Overall Study|Adverse Event|0|||
125175896|NCT04458922|450263628|FG000|Overall Study|Started new study|0|||
125175897|NCT04458922|450263629|FG001|Overall Study|Started new study|0|||
125175898|NCT04458922|450263630|FG002|Overall Study|Started new study|1|||
125175899|NCT04458922|450263628|FG000|Overall Study|Progressive disease|6|||
125231419|NCT01462942|450476408|FG003|Overall Study|Lack of Efficacy|5|||
125175900|NCT04458922|450263629|FG001|Overall Study|Progressive disease|8|||
125175901|NCT04458922|450263630|FG002|Overall Study|Progressive disease|2|||
125175902|NCT04458922|450263628|FG000|Overall Study|Death|1|||
125175903|NCT04458922|450263629|FG001|Overall Study|Death|0|||
125175904|NCT04458922|450263630|FG002|Overall Study|Death|2|||
125175905|NCT04458922|450263628|FG000|Overall Study|Participant started chemotherapy|0|||
125231420|NCT01462942|450476409|FG004|Overall Study|Lack of Efficacy|3|||
125175906|NCT04458922|450263629|FG001|Overall Study|Participant started chemotherapy|1|||
125175907|NCT04458922|450263630|FG002|Overall Study|Participant started chemotherapy|0|||
125175908|NCT03651700|450263632|FG000|Overall Study|Withdrawal by Subject|1|||
125175909|NCT03651700|450263633|FG001|Overall Study|Withdrawal by Subject|0|||
125175910|NCT04856930|450263634|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
125175911|NCT04856930|450263635|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
125175912|NCT04856930|450263636|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
125175913|NCT04856930|450263634|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
125231421|NCT01462942|450476405|FG000|Overall Study|Lost to Follow-up|0|||
125231422|NCT01462942|450476406|FG001|Overall Study|Lost to Follow-up|1|||
125231423|NCT01462942|450476407|FG002|Overall Study|Lost to Follow-up|1|||
125231424|NCT01462942|450476408|FG003|Overall Study|Lost to Follow-up|1|||
125231425|NCT01462942|450476409|FG004|Overall Study|Lost to Follow-up|1|||
125231426|NCT01462942|450476405|FG000|Overall Study|Protocol Violation|4|||
125231427|NCT01462942|450476406|FG001|Overall Study|Protocol Violation|6|||
125231428|NCT01462942|450476407|FG002|Overall Study|Protocol Violation|9|||
125231429|NCT01462942|450476408|FG003|Overall Study|Protocol Violation|9|||
125231430|NCT01462942|450476409|FG004|Overall Study|Protocol Violation|6|||
125231431|NCT01027845|450476410|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
125231432|NCT01027845|450476411|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
125231433|NCT01027845|450476412|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
125231434|NCT01027845|450476413|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
125231435|NCT01027845|450476410|FG000|Primary Vaccination Phase|Adverse Event|1|||
125231436|NCT01027845|450476411|FG001|Primary Vaccination Phase|Adverse Event|0|||
125231437|NCT01027845|450476412|FG002|Primary Vaccination Phase|Adverse Event|0|||
125231438|NCT01027845|450476413|FG003|Primary Vaccination Phase|Adverse Event|0|||
125231439|NCT01027845|450476410|FG000|Primary Vaccination Phase|Protocol Violation|1|||
125231440|NCT01027845|450476411|FG001|Primary Vaccination Phase|Protocol Violation|0|||
125231441|NCT01027845|450476412|FG002|Primary Vaccination Phase|Protocol Violation|0|||
125231442|NCT01027845|450476413|FG003|Primary Vaccination Phase|Protocol Violation|0|||
125231443|NCT01027845|450476410|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
125231444|NCT01027845|450476411|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
125231445|NCT01027845|450476412|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
125231446|NCT01027845|450476413|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
125231447|NCT01027845|450476410|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
125231448|NCT01027845|450476411|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
125231449|NCT01027845|450476412|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
125231450|NCT01027845|450476413|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
125231451|NCT01027845|450476410|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
125231452|NCT01027845|450476411|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
125231453|NCT01027845|450476412|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
125231454|NCT01027845|450476413|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
125231455|NCT00087178|450476416|FG000|Overall Study|No follow up data|5|||
125231456|NCT00087178|450476417|FG001|Overall Study|No follow up data|15|||
125231457|NCT00087178|450476416|FG000|Overall Study|No clinical assessment|1|||
125231458|NCT00087178|450476417|FG001|Overall Study|No clinical assessment|2|||
125231459|NCT00087178|450476416|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
125231460|NCT00087178|450476417|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
125231461|NCT01692119|450476418|FG000|Overall Study|Protocol Violation|3|||
125231462|NCT01692119|450476419|FG001|Overall Study|Protocol Violation|1|||
125231463|NCT01692119|450476418|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
125231464|NCT01692119|450476419|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
125231465|NCT02147626|450476420|FG000|Overall Study|Lost to Follow-up|4|||
125231466|NCT02147626|450476421|FG001|Overall Study|Lost to Follow-up|4|||
125231467|NCT02147626|450476420|FG000|Overall Study|Pregnancy|1|||
125231468|NCT02147626|450476421|FG001|Overall Study|Pregnancy|2|||
125231469|NCT02147626|450476420|FG000|Overall Study|Withdrawal by Subject|0|||
125231470|NCT02147626|450476421|FG001|Overall Study|Withdrawal by Subject|1|||
125231471|NCT00997893|450476422|FG000|Overall Study|Adverse Event|1|||
125231472|NCT00997893|450476423|FG001|Overall Study|Adverse Event|0|||
125231473|NCT00997893|450476424|FG002|Overall Study|Adverse Event|0|||
125231474|NCT00997893|450476422|FG000|Overall Study|Unable to meet study timelines|1|||
125231475|NCT00997893|450476423|FG001|Overall Study|Unable to meet study timelines|0|||
125231476|NCT00997893|450476424|FG002|Overall Study|Unable to meet study timelines|0|||
125231477|NCT00997893|450476422|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
125231478|NCT00997893|450476423|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
125231479|NCT00997893|450476424|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
125231480|NCT00071981|450476425|FG000|Overall Study|Lack of Efficacy|37|||
125231481|NCT00071981|450476426|FG001|Overall Study|Lack of Efficacy|29|||
125231482|NCT00071981|450476427|FG002|Overall Study|Lack of Efficacy|30|||
125231483|NCT00071981|450476428|FG003|Overall Study|Lack of Efficacy|43|||
125231484|NCT00071981|450476425|FG000|Overall Study|Adverse Event|4|||
125231485|NCT00071981|450476426|FG001|Overall Study|Adverse Event|4|||
125231486|NCT00071981|450476427|FG002|Overall Study|Adverse Event|3|||
125231487|NCT00071981|450476428|FG003|Overall Study|Adverse Event|1|||
125231488|NCT00071981|450476425|FG000|Overall Study|Death|0|||
125231489|NCT00071981|450476426|FG001|Overall Study|Death|0|||
125231490|NCT00071981|450476427|FG002|Overall Study|Death|1|||
125231491|NCT00071981|450476428|FG003|Overall Study|Death|1|||
125231492|NCT00071981|450476425|FG000|Overall Study|Withdrawal by Subject|3|||
125231493|NCT00071981|450476426|FG001|Overall Study|Withdrawal by Subject|1|||
125231494|NCT00071981|450476427|FG002|Overall Study|Withdrawal by Subject|0|||
125231495|NCT00071981|450476428|FG003|Overall Study|Withdrawal by Subject|0|||
125231496|NCT00071981|450476425|FG000|Overall Study|No protocol therapy|2|||
125231497|NCT00071981|450476426|FG001|Overall Study|No protocol therapy|5|||
125231498|NCT00071981|450476427|FG002|Overall Study|No protocol therapy|1|||
125231499|NCT00071981|450476428|FG003|Overall Study|No protocol therapy|0|||
125231500|NCT00071981|450476425|FG000|Overall Study|others (not specified in the study)|0|||
125231501|NCT00071981|450476426|FG001|Overall Study|others (not specified in the study)|2|||
125231502|NCT00071981|450476427|FG002|Overall Study|others (not specified in the study)|2|||
125231503|NCT00071981|450476428|FG003|Overall Study|others (not specified in the study)|0|||
125231504|NCT00467519|450476429|FG000|Overall Study|Protocol Violation|8|||
125231505|NCT00467519|450476430|FG001|Overall Study|Protocol Violation|4|||
125231506|NCT00467519|450476429|FG000|Overall Study|Lost to Follow-up|2|||
125231507|NCT00467519|450476430|FG001|Overall Study|Lost to Follow-up|9|||
125231508|NCT00467519|450476429|FG000|Overall Study|Withdrawal by Subject|4|||
125231509|NCT00467519|450476430|FG001|Overall Study|Withdrawal by Subject|10|||
125231510|NCT01123655|450476431|FG000|Overall Study|Medication for RA had to be changed|1|||
125231511|NCT01123655|450476432|FG001|Overall Study|Medication for RA had to be changed|0|||
125231512|NCT01123655|450476433|FG002|Overall Study|Medication for RA had to be changed|0|||
125231513|NCT01123655|450476431|FG000|Overall Study|new illness|0|||
125231514|NCT01123655|450476432|FG001|Overall Study|new illness|1|||
125231515|NCT01123655|450476433|FG002|Overall Study|new illness|0|||
125231516|NCT01123655|450476431|FG000|Overall Study|began prohibitive drug|0|||
125231517|NCT01123655|450476432|FG001|Overall Study|began prohibitive drug|0|||
125231518|NCT01123655|450476433|FG002|Overall Study|began prohibitive drug|1|||
125231519|NCT00833755|450476434|FG000|Overall Study|Physician Decision|4|||
125231520|NCT00833755|450476435|FG001|Overall Study|Physician Decision|4|||
125231521|NCT00833755|450476436|FG002|Overall Study|Physician Decision|2|||
125231522|NCT00833755|450476437|FG003|Overall Study|Physician Decision|6|||
125231523|NCT00833755|450476434|FG000|Overall Study|Subject had scheduling issues|0|||
125231524|NCT00833755|450476435|FG001|Overall Study|Subject had scheduling issues|1|||
125231525|NCT00833755|450476436|FG002|Overall Study|Subject had scheduling issues|0|||
125231526|NCT00833755|450476437|FG003|Overall Study|Subject had scheduling issues|0|||
125231527|NCT01776554|450476441|FG000|Overall Study|Adverse Event|1|||
125231528|NCT01776554|450476442|FG001|Overall Study|Adverse Event|0|||
125231529|NCT01776554|450476441|FG000|Overall Study|Withdrawal by Subject|3|||
125231530|NCT01776554|450476442|FG001|Overall Study|Withdrawal by Subject|8|||
125231531|NCT01776554|450476441|FG000|Overall Study|Lost to Follow-up|6|||
125231532|NCT01776554|450476442|FG001|Overall Study|Lost to Follow-up|9|||
125231533|NCT01776554|450476441|FG000|Overall Study|Administrative Reason|2|||
125231534|NCT01776554|450476442|FG001|Overall Study|Administrative Reason|5|||
125231535|NCT01776554|450476441|FG000|Overall Study|Protocol Violation|1|||
125231536|NCT01776554|450476442|FG001|Overall Study|Protocol Violation|0|||
125231537|NCT01776554|450476441|FG000|Overall Study|Unclassified|4|||
125231538|NCT01776554|450476442|FG001|Overall Study|Unclassified|1|||
125231539|NCT02908347|450476446|FG000|Overall Study|Adverse Event|0|||
125231540|NCT02908347|450476447|FG001|Overall Study|Adverse Event|1|||
125231541|NCT02908347|450476446|FG000|Overall Study|Lost to Follow-up|1|||
125231542|NCT02908347|450476447|FG001|Overall Study|Lost to Follow-up|0|||
125231543|NCT03087058|450476453|FG000|Overall Study|Withdrawal by Subject|2|||
125231544|NCT03087058|450476454|FG001|Overall Study|Withdrawal by Subject|0|||
125231545|NCT03087058|450476455|FG002|Overall Study|Withdrawal by Subject|0|||
125231546|NCT02577029|450476456|FG000|Overall Study|Adverse Event|1|||
125231547|NCT02577029|450476457|FG001|Overall Study|Adverse Event|0|||
125231548|NCT02577029|450476458|FG002|Overall Study|Adverse Event|2|||
125231549|NCT02577029|450476459|FG003|Overall Study|Adverse Event|0|||
125231550|NCT02577029|450476460|FG004|Overall Study|Adverse Event|1|||
125231551|NCT02577029|450476461|FG005|Overall Study|Adverse Event|0|||
125231552|NCT02577029|450476462|FG006|Overall Study|Adverse Event|0|||
125231553|NCT02577029|450476463|FG007|Overall Study|Adverse Event|0|||
125231554|NCT02577029|450476456|FG000|Overall Study|Withdrawal by Subject|0|||
125231555|NCT02577029|450476457|FG001|Overall Study|Withdrawal by Subject|0|||
125231556|NCT02577029|450476458|FG002|Overall Study|Withdrawal by Subject|0|||
125231557|NCT02577029|450476459|FG003|Overall Study|Withdrawal by Subject|0|||
125231558|NCT02577029|450476460|FG004|Overall Study|Withdrawal by Subject|0|||
125231559|NCT02577029|450476461|FG005|Overall Study|Withdrawal by Subject|1|||
125231560|NCT02577029|450476462|FG006|Overall Study|Withdrawal by Subject|0|||
125231561|NCT02577029|450476463|FG007|Overall Study|Withdrawal by Subject|0|||
125231562|NCT02577029|450476456|FG000|Overall Study|Sponsor Termination of the Study|9|||
125231563|NCT02577029|450476457|FG001|Overall Study|Sponsor Termination of the Study|2|||
125231564|NCT02577029|450476458|FG002|Overall Study|Sponsor Termination of the Study|5|||
125231565|NCT02577029|450476459|FG003|Overall Study|Sponsor Termination of the Study|12|||
125231566|NCT02577029|450476460|FG004|Overall Study|Sponsor Termination of the Study|10|||
125231567|NCT02577029|450476461|FG005|Overall Study|Sponsor Termination of the Study|12|||
125231568|NCT02577029|450476462|FG006|Overall Study|Sponsor Termination of the Study|12|||
125231569|NCT02577029|450476463|FG007|Overall Study|Sponsor Termination of the Study|12|||
125231570|NCT02078817|450476464|FG000|Overall Study|Withdrawal by Subject|1|||
125231571|NCT01420536|450476465|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
125231572|NCT01420536|450476466|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
125231573|NCT03054428|450476467|FG000|Overall Study|Physician Decision|0|||
125231574|NCT03054428|450476468|FG001|Overall Study|Physician Decision|1|||
125231575|NCT03054428|450476469|FG002|Overall Study|Physician Decision|1|||
125231576|NCT03054428|450476467|FG000|Overall Study|Lack of Efficacy|3|||
125231577|NCT03054428|450476468|FG001|Overall Study|Lack of Efficacy|1|||
125231578|NCT03054428|450476469|FG002|Overall Study|Lack of Efficacy|0|||
125231579|NCT03054428|450476467|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
125231580|NCT03054428|450476468|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
125231581|NCT03054428|450476469|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
125231582|NCT03054428|450476467|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
125231583|NCT03054428|450476468|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
125231584|NCT03054428|450476469|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
125231585|NCT03054428|450476467|FG000|Overall Study|Transitioned to OLE study|76|||
125231586|NCT03054428|450476468|FG001|Overall Study|Transitioned to OLE study|76|||
125231587|NCT03054428|450476469|FG002|Overall Study|Transitioned to OLE study|73|||
125231588|NCT03054428|450476467|FG000|Overall Study|Withdrawal by Subject|3|||
125231589|NCT03054428|450476468|FG001|Overall Study|Withdrawal by Subject|2|||
125231590|NCT03054428|450476469|FG002|Overall Study|Withdrawal by Subject|3|||
125231591|NCT03054428|450476467|FG000|Overall Study|Lost to Follow-up|0|||
125231592|NCT03054428|450476468|FG001|Overall Study|Lost to Follow-up|0|||
125231593|NCT03054428|450476469|FG002|Overall Study|Lost to Follow-up|1|||
125231594|NCT01652690|450476471|FG000|Overall Study|Withdrawal by Subject|16|||
125231595|NCT01652690|450476472|FG001|Overall Study|Withdrawal by Subject|4|||
125231596|NCT01652690|450476471|FG000|Overall Study|Other|8|||
125231597|NCT01652690|450476472|FG001|Overall Study|Other|9|||
125231598|NCT01652690|450476471|FG000|Overall Study|Lost to Follow-up|6|||
125231599|NCT01652690|450476472|FG001|Overall Study|Lost to Follow-up|6|||
125231600|NCT01652690|450476471|FG000|Overall Study|Death|5|||
125231601|NCT01652690|450476472|FG001|Overall Study|Death|2|||
125231602|NCT03415178|450476473|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
125231603|NCT03415178|450476474|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
125231604|NCT03415178|450476473|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
125231605|NCT03415178|450476474|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
125231606|NCT01884597|450476475|FG000|Overall Study|Adverse Event|0|||
125231607|NCT01884597|450476476|FG001|Overall Study|Adverse Event|0|||
125231608|NCT01884597|450476477|FG002|Overall Study|Adverse Event|1|||
125231609|NCT01884597|450476475|FG000|Overall Study|Lack of Efficacy|1|||
125231610|NCT01884597|450476476|FG001|Overall Study|Lack of Efficacy|0|||
125231611|NCT01884597|450476477|FG002|Overall Study|Lack of Efficacy|0|||
125231612|NCT01884597|450476475|FG000|Overall Study|Death|0|||
125231613|NCT01884597|450476476|FG001|Overall Study|Death|1|||
125231614|NCT01884597|450476477|FG002|Overall Study|Death|0|||
125231615|NCT02097823|450476478|FG000|Overall Study|Withdrawal by Subject|1|||
125231616|NCT02097823|450476479|FG001|Overall Study|Withdrawal by Subject|1|||
125231617|NCT03082729|450476481|FG000|Overall Study|Lost to Follow-up|7|||
125231618|NCT03082729|450476481|FG000|Overall Study|Physician Decision|2|||
125231619|NCT03082729|450476481|FG000|Overall Study|Withdrawal by Subject|1|||
125231620|NCT03082729|450476481|FG000|Overall Study|Lack of Efficacy|9|||
125231621|NCT03082729|450476481|FG000|Overall Study|Adverse Event|4|||
125231622|NCT03082729|450476481|FG000|Overall Study|Protocol Violation|6|||
125231623|NCT03082729|450476481|FG000|Overall Study|Fear of study procedure|1|||
125231624|NCT03082729|450476481|FG000|Overall Study|Scheduling conflict|1|||
125231625|NCT00753519|450477987|FG000|Overall Study|Withdrawal by Subject|0|||
125231626|NCT00753519|450477988|FG001|Overall Study|Withdrawal by Subject|2|||
125231627|NCT00959751|450477989|FG000|Overall Study|Lost to Follow-up|2|||
125231628|NCT00959751|450477990|FG001|Overall Study|Lost to Follow-up|3|||
125231629|NCT00959751|450477989|FG000|Overall Study|Consent Withdrawn|0|||
125231630|NCT00959751|450477990|FG001|Overall Study|Consent Withdrawn|1|||
125231631|NCT00959751|450477989|FG000|Overall Study|Non-compliance to Study Procedures|0|||
125231632|NCT00959751|450477990|FG001|Overall Study|Non-compliance to Study Procedures|1|||
125231633|NCT00959751|450477989|FG000|Overall Study|No migraine headache without aura|7|||
125231634|NCT00959751|450477990|FG001|Overall Study|No migraine headache without aura|7|||
125231635|NCT00434252|450477991|FG000|Overall Study|Lack of Efficacy|50|||
125231636|NCT00434252|450477992|FG001|Overall Study|Lack of Efficacy|100|||
125231637|NCT00434252|450477991|FG000|Overall Study|Adverse Event|6|||
125231638|NCT00434252|450477992|FG001|Overall Study|Adverse Event|13|||
125231639|NCT00434252|450477991|FG000|Overall Study|Death|1|||
125231640|NCT00434252|450477992|FG001|Overall Study|Death|2|||
125231641|NCT00434252|450477991|FG000|Overall Study|Lost to Follow-up|0|||
125231642|NCT00434252|450477992|FG001|Overall Study|Lost to Follow-up|1|||
125231643|NCT00434252|450477991|FG000|Overall Study|Physician Decision|4|||
125231644|NCT00434252|450477992|FG001|Overall Study|Physician Decision|8|||
125231645|NCT00434252|450477991|FG000|Overall Study|Withdrawal by Subject|3|||
125231646|NCT00434252|450477992|FG001|Overall Study|Withdrawal by Subject|7|||
125231647|NCT02807259|450477993|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
125231648|NCT02807259|450477994|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
125231649|NCT02807259|450477993|FG000|Midline (3 Months)|migration, refusal, not available|30|||
125231650|NCT02807259|450477994|FG001|Midline (3 Months)|migration, refusal, not available|34|||
125231651|NCT02807259|450477993|FG000|Endline (3 Months)|migration, refusal, not available|35|||
125231652|NCT02807259|450477994|FG001|Endline (3 Months)|migration, refusal, not available|87|||
125231653|NCT03861039|450477995|FG000|Overall Study|Adverse Event|2|||
125231654|NCT03861039|450477996|FG001|Overall Study|Adverse Event|5|||
125231655|NCT03861039|450477997|FG002|Overall Study|Adverse Event|11|||
125231656|NCT03861039|450477995|FG000|Overall Study|Withdrawal by Subject|1|||
125231657|NCT03861039|450477996|FG001|Overall Study|Withdrawal by Subject|3|||
125231658|NCT03861039|450477997|FG002|Overall Study|Withdrawal by Subject|4|||
125231659|NCT01673386|450477998|FG000|Overall Study|Study terminated by sponsor|16|||
125231660|NCT01673386|450477999|FG001|Overall Study|Study terminated by sponsor|22|||
125231661|NCT01673386|450477998|FG000|Overall Study|Adverse Event|5|||
125231662|NCT01673386|450477999|FG001|Overall Study|Adverse Event|2|||
125231663|NCT01673386|450477998|FG000|Overall Study|Progressive disease|4|||
125231664|NCT01673386|450477999|FG001|Overall Study|Progressive disease|1|||
125231665|NCT01673386|450477998|FG000|Overall Study|Withdrawal by Subject|0|||
125231666|NCT01673386|450477999|FG001|Overall Study|Withdrawal by Subject|2|||
125231667|NCT02934178|450478000|FG000|Received Vaccination 2|Death|0|||
125231668|NCT02934178|450478001|FG001|Received Vaccination 2|Death|1|||
125231669|NCT02934178|450478000|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
125231670|NCT02934178|450478001|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
125231671|NCT01898078|450478005|FG000|Overall Study|Progressive Disease|1|||
125231672|NCT01898078|450478006|FG001|Overall Study|Progressive Disease|5|||
125231673|NCT01898078|450478005|FG000|Overall Study|Adverse Event|2|||
125231674|NCT01898078|450478006|FG001|Overall Study|Adverse Event|1|||
125231675|NCT01898078|450478005|FG000|Overall Study|Withdrawal by Subject|1|||
125231676|NCT01898078|450478006|FG001|Overall Study|Withdrawal by Subject|1|||
125231677|NCT01898078|450478005|FG000|Overall Study|Symptomatic Deterioration|2|||
125231678|NCT01898078|450478006|FG001|Overall Study|Symptomatic Deterioration|0|||
125231679|NCT01898078|450478005|FG000|Overall Study|Reason not Specified|0|||
125231680|NCT01898078|450478006|FG001|Overall Study|Reason not Specified|1|||
125231681|NCT01140906|450478007|FG000|Overall Study|Adverse Event|7|||
125231682|NCT01140906|450478008|FG001|Overall Study|Adverse Event|10|||
125231683|NCT01140906|450478009|FG002|Overall Study|Adverse Event|17|||
125231684|NCT01140906|450478010|FG003|Overall Study|Adverse Event|7|||
125231685|NCT01140906|450478007|FG000|Overall Study|Lack of Efficacy|6|||
125231686|NCT01140906|450478008|FG001|Overall Study|Lack of Efficacy|8|||
125231687|NCT01140906|450478009|FG002|Overall Study|Lack of Efficacy|2|||
125231688|NCT01140906|450478010|FG003|Overall Study|Lack of Efficacy|1|||
125231689|NCT01140906|450478007|FG000|Overall Study|Non-compliance|0|||
125231690|NCT01140906|450478008|FG001|Overall Study|Non-compliance|1|||
125231691|NCT01140906|450478009|FG002|Overall Study|Non-compliance|0|||
125231692|NCT01140906|450478010|FG003|Overall Study|Non-compliance|1|||
125231693|NCT01140906|450478007|FG000|Overall Study|Protocol Violation|5|||
125231694|NCT01140906|450478008|FG001|Overall Study|Protocol Violation|3|||
125231695|NCT01140906|450478009|FG002|Overall Study|Protocol Violation|2|||
125231696|NCT01140906|450478010|FG003|Overall Study|Protocol Violation|1|||
125231697|NCT01140906|450478007|FG000|Overall Study|Withdrawal of consent|6|||
125231698|NCT01140906|450478008|FG001|Overall Study|Withdrawal of consent|6|||
125231699|NCT01140906|450478009|FG002|Overall Study|Withdrawal of consent|2|||
125231700|NCT01140906|450478010|FG003|Overall Study|Withdrawal of consent|2|||
125231701|NCT01140906|450478007|FG000|Overall Study|Lost to Follow-up|1|||
125231702|NCT01140906|450478008|FG001|Overall Study|Lost to Follow-up|1|||
125231703|NCT01140906|450478009|FG002|Overall Study|Lost to Follow-up|0|||
125231704|NCT01140906|450478010|FG003|Overall Study|Lost to Follow-up|2|||
125231705|NCT01140906|450478007|FG000|Overall Study|Administrative or other reason|0|||
125231706|NCT01140906|450478008|FG001|Overall Study|Administrative or other reason|5|||
125231707|NCT01140906|450478009|FG002|Overall Study|Administrative or other reason|3|||
125231708|NCT01140906|450478010|FG003|Overall Study|Administrative or other reason|2|||
125231709|NCT00703534|450478011|FG000|Overall Study|Adverse Event|14|||
125231710|NCT00703534|450478012|FG001|Overall Study|Adverse Event|3|||
125231711|NCT00703534|450478011|FG000|Overall Study|Withdrawal by Subject|8|||
125231712|NCT00703534|450478012|FG001|Overall Study|Withdrawal by Subject|7|||
125231713|NCT00703534|450478011|FG000|Overall Study|Incorrect Enrollment|6|||
125231714|NCT00703534|450478012|FG001|Overall Study|Incorrect Enrollment|6|||
125231715|NCT00703534|450478011|FG000|Overall Study|Lost to Follow-up|1|||
125231716|NCT00703534|450478012|FG001|Overall Study|Lost to Follow-up|4|||
125231717|NCT00703534|450478011|FG000|Overall Study|Severe Non Compliance|1|||
125231718|NCT00703534|450478012|FG001|Overall Study|Severe Non Compliance|5|||
125231719|NCT00900562|450478013|FG000|Overall Study|Progressive disease|9|||
125231720|NCT00900562|450478014|FG001|Overall Study|Progressive disease|5|||
125231721|NCT00900562|450478013|FG000|Overall Study|Toxicity|1|||
125231722|NCT00900562|450478014|FG001|Overall Study|Toxicity|0|||
125231723|NCT00900562|450478013|FG000|Overall Study|Death|1|||
125231724|NCT00900562|450478014|FG001|Overall Study|Death|1|||
125231725|NCT00900562|450478013|FG000|Overall Study|Withdrawal by Subject|0|||
125231726|NCT00900562|450478014|FG001|Overall Study|Withdrawal by Subject|1|||
125175914|NCT04856930|450263635|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
125175915|NCT04856930|450263636|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
125175916|NCT04856930|450263634|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
125175917|NCT04856930|450263635|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
125175918|NCT04856930|450263636|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
125175919|NCT04856930|450263634|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
125175920|NCT04856930|450263635|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
125175921|NCT04856930|450263636|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
125175922|NCT04856930|450263634|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
125175923|NCT04856930|450263635|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
125175924|NCT04856930|450263636|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
125175925|NCT04856930|450263634|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
125175926|NCT04856930|450263635|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
125175927|NCT04856930|450263636|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
125175928|NCT04856930|450263634|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
125175929|NCT04856930|450263635|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
125175930|NCT04856930|450263636|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
125175931|NCT04856930|450263634|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
125175932|NCT04856930|450263635|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
125175933|NCT04856930|450263636|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
125175934|NCT04856930|450263634|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
125175935|NCT04856930|450263635|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
125175936|NCT04856930|450263636|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
125175937|NCT04856930|450263634|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
125175938|NCT04856930|450263635|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
125175939|NCT04856930|450263636|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
125175940|NCT04856930|450263634|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
125175941|NCT04856930|450263635|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
125175942|NCT04856930|450263636|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
125175943|NCT04856930|450263634|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
125175944|NCT04856930|450263635|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
125175945|NCT04856930|450263636|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
125175946|NCT04856930|450263634|FG000|Extension Period (16 Weeks)|Other than specified|0|||
125175947|NCT04856930|450263635|FG001|Extension Period (16 Weeks)|Other than specified|0|||
125175948|NCT04856930|450263636|FG002|Extension Period (16 Weeks)|Other than specified|1|||
125175949|NCT04856930|450263634|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
125175950|NCT04856930|450263635|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
125175951|NCT04856930|450263636|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
125175952|NCT04856930|450263634|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
125175953|NCT04856930|450263635|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
125175954|NCT04856930|450263636|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
125175955|NCT04856930|450263634|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
125175956|NCT04856930|450263635|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
125175957|NCT04856930|450263636|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
125175958|NCT04856930|450263634|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
125175959|NCT04856930|450263635|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
125175960|NCT04856930|450263636|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
125175961|NCT03965689|450263637|FG000|Overall Study|Too sick to get study intervention|2|||
125175962|NCT03104400|450263638|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
125175963|NCT03104400|450263639|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
125175964|NCT03104400|450263640|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
125175965|NCT03104400|450263641|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
125175966|NCT03104400|450263642|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
125175967|NCT03104400|450263643|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
125175968|NCT03104400|450263644|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
125175969|NCT03104400|450263645|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
125175970|NCT03104400|450263646|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
125175971|NCT03104400|450263647|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
125175972|NCT03104400|450263638|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
125175973|NCT03104400|450263639|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
125175974|NCT03104400|450263640|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
125175975|NCT03104400|450263641|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
125175976|NCT03104400|450263642|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
125175977|NCT03104400|450263643|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
125175978|NCT03104400|450263644|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
125175979|NCT03104400|450263645|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
125231727|NCT00900562|450478013|FG000|Overall Study|Unrelated adverse event|1|||
125231728|NCT00900562|450478014|FG001|Overall Study|Unrelated adverse event|0|||
125231729|NCT03587636|450478015|FG000|Overall Study|Lost to Follow-up|2|||
125231730|NCT03587636|450478016|FG001|Overall Study|Lost to Follow-up|5|||
125175980|NCT03104400|450263646|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
125175981|NCT03104400|450263647|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
125175982|NCT03104400|450263638|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
125175983|NCT03104400|450263639|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
125175984|NCT03104400|450263640|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
125175985|NCT03104400|450263641|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
125175986|NCT03104400|450263642|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
125175987|NCT03104400|450263643|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
125175988|NCT03104400|450263644|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
125175989|NCT03104400|450263645|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
125175990|NCT03104400|450263646|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
125175991|NCT03104400|450263647|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
125175992|NCT03104400|450263638|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
125175993|NCT03104400|450263639|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
125175994|NCT03104400|450263640|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
125175995|NCT03104400|450263641|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
125175996|NCT03104400|450263642|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
125175997|NCT03104400|450263643|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
125175998|NCT03104400|450263644|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
125175999|NCT03104400|450263645|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
125176000|NCT03104400|450263646|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
125176001|NCT03104400|450263647|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
125176002|NCT03104400|450263638|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
125176003|NCT03104400|450263639|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
125176004|NCT03104400|450263640|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
125176005|NCT03104400|450263641|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
125176006|NCT03104400|450263642|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
125176007|NCT03104400|450263643|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
125176008|NCT03104400|450263644|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
125176009|NCT03104400|450263645|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
125176010|NCT03104400|450263646|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
125176011|NCT03104400|450263647|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
125176012|NCT03104400|450263638|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
125176013|NCT03104400|450263639|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
125176014|NCT03104400|450263640|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
125176015|NCT03104400|450263641|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
125176016|NCT03104400|450263642|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
125176017|NCT03104400|450263643|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
125176018|NCT03104400|450263644|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
125176019|NCT03104400|450263645|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
125176020|NCT03104400|450263646|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
125176021|NCT03104400|450263647|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
125176022|NCT03104400|450263638|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
125176023|NCT03104400|450263639|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
125176024|NCT03104400|450263640|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
125176025|NCT03104400|450263641|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
125176026|NCT03104400|450263642|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
125176027|NCT03104400|450263643|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
125231731|NCT02665117|450478017|FG000|Overall Study|Physician Decision|1|||
125231732|NCT02665117|450478018|FG001|Overall Study|Physician Decision|0|||
125231733|NCT03743194|450478020|FG000|Overall Study|Protocol Violation|7|||
125231734|NCT03743194|450478021|FG001|Overall Study|Protocol Violation|7|||
125231735|NCT03743194|450478020|FG000|Overall Study|Physician Decision|0|||
125231736|NCT03743194|450478021|FG001|Overall Study|Physician Decision|2|||
125231737|NCT01829347|450478024|FG000|VTI-210|Death|5|||
125231738|NCT01829347|450478025|FG001|VTI-210|Death|3|||
125231739|NCT01829347|450478024|FG000|VTI-210|Withdrawal by Subject|1|||
125176028|NCT03104400|450263644|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
125231740|NCT01829347|450478025|FG001|VTI-210|Withdrawal by Subject|0|||
125231741|NCT01829347|450478024|FG000|VTI-210E|Death|2|||
125231742|NCT01829347|450478025|FG001|VTI-210E|Death|1|||
125231743|NCT01829347|450478024|FG000|VTI-210E|Study terminated prematurely|1|||
125176029|NCT03104400|450263645|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
125176030|NCT03104400|450263646|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
125176031|NCT03104400|450263647|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
125176032|NCT03104400|450263638|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
125176033|NCT03104400|450263639|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
125231744|NCT01829347|450478025|FG001|VTI-210E|Study terminated prematurely|5|||
125231745|NCT02152007|450478037|FG000|Overall Study|Withdrawal by Subject|1|||
125231746|NCT01302899|450478040|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
125176034|NCT03104400|450263640|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
125176035|NCT03104400|450263641|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
125176036|NCT03104400|450263642|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
125176037|NCT03104400|450263643|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
125176038|NCT03104400|450263644|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
125176039|NCT03104400|450263645|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
125176040|NCT03104400|450263646|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
125176041|NCT03104400|450263647|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
125176042|NCT03104400|450263638|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
125176043|NCT03104400|450263639|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
125176044|NCT03104400|450263640|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
125176045|NCT03104400|450263641|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
125176046|NCT03104400|450263642|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
125176047|NCT03104400|450263643|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
125176048|NCT03104400|450263644|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
125176049|NCT03104400|450263645|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
125176050|NCT03104400|450263646|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
125176051|NCT03104400|450263647|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
125176052|NCT03104400|450263638|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
125176053|NCT03104400|450263639|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
125176054|NCT03104400|450263640|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
125176055|NCT03104400|450263641|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
125176056|NCT03104400|450263642|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
125176057|NCT03104400|450263643|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
125176058|NCT03104400|450263644|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
125176059|NCT03104400|450263645|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
125176060|NCT03104400|450263646|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
125176061|NCT03104400|450263647|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
125176062|NCT03104400|450263638|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
125176063|NCT03104400|450263639|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
125176064|NCT03104400|450263640|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
125231747|NCT01302899|450478041|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
125231748|NCT01302899|450478040|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
125231749|NCT01302899|450478041|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
125231750|NCT02834975|450478042|FG000|Overall Study|Physician Decision|2|||
125231751|NCT02834975|450478042|FG000|Overall Study|Adverse Event|1|||
125231752|NCT02834975|450478042|FG000|Overall Study|Withdrawal by Subject|1|||
125231753|NCT02834975|450478042|FG000|Overall Study|Lack of Efficacy|1|||
125231754|NCT03558516|450478044|FG000|Overall Study|Protocol Violation|2|||
125231755|NCT03558516|450478045|FG001|Overall Study|Protocol Violation|2|||
125231756|NCT03363906|450478046|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
125231757|NCT03363906|450478047|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
125231758|NCT03363906|450478046|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
125231759|NCT03363906|450478047|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
125231760|NCT03363906|450478046|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
125231761|NCT03363906|450478047|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
125231762|NCT03363906|450478046|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
125231763|NCT03363906|450478047|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
125231764|NCT00676143|450478048|FG000|Overall Study|Adverse Event|34|||
125231765|NCT00676143|450478049|FG001|Overall Study|Adverse Event|60|||
125231766|NCT00676143|450478048|FG000|Overall Study|Death|4|||
125231767|NCT00676143|450478049|FG001|Overall Study|Death|4|||
125231768|NCT00676143|450478048|FG000|Overall Study|Lack of Efficacy|0|||
125231769|NCT00676143|450478049|FG001|Overall Study|Lack of Efficacy|6|||
125231770|NCT00676143|450478048|FG000|Overall Study|Lost to Follow-up|0|||
125231771|NCT00676143|450478049|FG001|Overall Study|Lost to Follow-up|13|||
125176065|NCT03104400|450263641|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
125176066|NCT03104400|450263642|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
125176067|NCT03104400|450263643|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
125176068|NCT03104400|450263644|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
125231772|NCT00676143|450478048|FG000|Overall Study|Physician Decision|5|||
125231773|NCT00676143|450478049|FG001|Overall Study|Physician Decision|8|||
125231774|NCT00676143|450478048|FG000|Overall Study|Protocol Violation|4|||
125176069|NCT03104400|450263645|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
125176070|NCT03104400|450263646|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
125231775|NCT00676143|450478049|FG001|Overall Study|Protocol Violation|8|||
125231776|NCT00676143|450478048|FG000|Overall Study|Withdrawal by Subject|24|||
125231777|NCT00676143|450478049|FG001|Overall Study|Withdrawal by Subject|42|||
125231778|NCT00676143|450478048|FG000|Overall Study|Discontinuation of study by sponsor|65|||
125231779|NCT00676143|450478049|FG001|Overall Study|Discontinuation of study by sponsor|88|||
125231780|NCT00676143|450478048|FG000|Overall Study|Failed to return|2|||
125231781|NCT00676143|450478049|FG001|Overall Study|Failed to return|1|||
125231782|NCT00676143|450478048|FG000|Overall Study|Loss of caregiver|5|||
125231783|NCT00676143|450478049|FG001|Overall Study|Loss of caregiver|3|||
125231784|NCT00676143|450478048|FG000|Overall Study|Other|11|||
125231785|NCT00676143|450478049|FG001|Overall Study|Other|20|||
125231786|NCT00676143|450478048|FG000|Overall Study|Participant participation unknown|1|||
125231787|NCT00676143|450478049|FG001|Overall Study|Participant participation unknown|4|||
125231788|NCT00676143|450478048|FG000|Overall Study|Vasogenic edema recurrence|1|||
125231789|NCT00676143|450478049|FG001|Overall Study|Vasogenic edema recurrence|3|||
125231790|NCT00929669|450478050|FG000|Overall Study|elevated glucose levels|1|||
125231791|NCT02714153|450478052|FG000|Overall Study|Death|1|||
125231792|NCT02065557|450478056|FG000|Induction Period|Withdrawal by Subject|2|||
125231793|NCT02065557|450478057|FG001|Induction Period|Withdrawal by Subject|1|||
125231794|NCT02065557|450478058|FG002|Induction Period|Withdrawal by Subject|0|||
125231795|NCT02065557|450478059|FG003|Induction Period|Withdrawal by Subject|0|||
125231796|NCT02065557|450478060|FG004|Induction Period|Withdrawal by Subject|0|||
125231797|NCT02065557|450478061|FG005|Induction Period|Withdrawal by Subject|0|||
125231798|NCT02065557|450478056|FG000|Induction Period|Lack of Efficacy|2|||
125231799|NCT02065557|450478057|FG001|Induction Period|Lack of Efficacy|1|||
125231800|NCT02065557|450478058|FG002|Induction Period|Lack of Efficacy|1|||
125231801|NCT02065557|450478059|FG003|Induction Period|Lack of Efficacy|0|||
125231802|NCT02065557|450478060|FG004|Induction Period|Lack of Efficacy|0|||
125231803|NCT02065557|450478061|FG005|Induction Period|Lack of Efficacy|0|||
125231804|NCT02065557|450478056|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
125231805|NCT02065557|450478057|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
125231806|NCT02065557|450478058|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
125231807|NCT02065557|450478059|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
125231808|NCT02065557|450478060|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
125231809|NCT02065557|450478061|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
125231810|NCT02065557|450478056|FG000|Induction Period|Non-Responder at Week 8|4|||
125231811|NCT02065557|450478057|FG001|Induction Period|Non-Responder at Week 8|4|||
125231812|NCT02065557|450478058|FG002|Induction Period|Non-Responder at Week 8|0|||
125231813|NCT02065557|450478059|FG003|Induction Period|Non-Responder at Week 8|0|||
125231814|NCT02065557|450478060|FG004|Induction Period|Non-Responder at Week 8|0|||
125231815|NCT02065557|450478061|FG005|Induction Period|Non-Responder at Week 8|0|||
125231816|NCT02065557|450478056|FG000|Induction Period|Adverse Event|1|||
125231817|NCT02065557|450478057|FG001|Induction Period|Adverse Event|1|||
125231818|NCT02065557|450478058|FG002|Induction Period|Adverse Event|0|||
125231819|NCT02065557|450478059|FG003|Induction Period|Adverse Event|0|||
125231820|NCT02065557|450478060|FG004|Induction Period|Adverse Event|0|||
125231821|NCT02065557|450478061|FG005|Induction Period|Adverse Event|0|||
125231822|NCT02065557|450478056|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
125231823|NCT02065557|450478057|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
125231824|NCT02065557|450478058|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
125231825|NCT02065557|450478059|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
125231826|NCT02065557|450478060|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
125231827|NCT02065557|450478061|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
125231828|NCT02065557|450478056|FG000|Maintenance Period|Withdrawal by Subject|0|||
125231829|NCT02065557|450478057|FG001|Maintenance Period|Withdrawal by Subject|0|||
125231830|NCT02065557|450478058|FG002|Maintenance Period|Withdrawal by Subject|0|||
125231831|NCT02065557|450478059|FG003|Maintenance Period|Withdrawal by Subject|0|||
125231832|NCT02065557|450478060|FG004|Maintenance Period|Withdrawal by Subject|2|||
125231833|NCT02065557|450478061|FG005|Maintenance Period|Withdrawal by Subject|1|||
125231834|NCT02065557|450478056|FG000|Maintenance Period|Lack of Efficacy|0|||
125231835|NCT02065557|450478057|FG001|Maintenance Period|Lack of Efficacy|0|||
125231836|NCT02065557|450478058|FG002|Maintenance Period|Lack of Efficacy|0|||
125231837|NCT02065557|450478059|FG003|Maintenance Period|Lack of Efficacy|0|||
125231838|NCT02065557|450478060|FG004|Maintenance Period|Lack of Efficacy|5|||
125231839|NCT02065557|450478061|FG005|Maintenance Period|Lack of Efficacy|2|||
125231840|NCT02065557|450478056|FG000|Maintenance Period|Subject Non-Compliance|0|||
125231841|NCT02065557|450478057|FG001|Maintenance Period|Subject Non-Compliance|0|||
125231842|NCT02065557|450478058|FG002|Maintenance Period|Subject Non-Compliance|0|||
125231843|NCT02065557|450478059|FG003|Maintenance Period|Subject Non-Compliance|0|||
125231844|NCT02065557|450478060|FG004|Maintenance Period|Subject Non-Compliance|0|||
125231845|NCT02065557|450478061|FG005|Maintenance Period|Subject Non-Compliance|1|||
125231846|NCT00250588|450478062|FG000|Overall Study|Withdrawal by Subject|3|||
125231847|NCT00250588|450478063|FG001|Overall Study|Withdrawal by Subject|6|||
125231848|NCT00250588|450478064|FG002|Overall Study|Withdrawal by Subject|0|||
125231849|NCT00250588|450478062|FG000|Overall Study|Lost to Follow-up|6|||
125231850|NCT00250588|450478063|FG001|Overall Study|Lost to Follow-up|13|||
125231851|NCT00250588|450478064|FG002|Overall Study|Lost to Follow-up|13|||
125231852|NCT00706797|450478065|FG000|Overall Study|Lack of Efficacy|3|||
125231853|NCT00706797|450478066|FG001|Overall Study|Lack of Efficacy|0|||
125231854|NCT00706797|450478065|FG000|Overall Study|Adverse Event|0|||
125231855|NCT00706797|450478066|FG001|Overall Study|Adverse Event|3|||
125231856|NCT00706797|450478065|FG000|Overall Study|Withdrawal by Subject|8|||
125231857|NCT00706797|450478066|FG001|Overall Study|Withdrawal by Subject|1|||
125231858|NCT00706797|450478065|FG000|Overall Study|Death|1|||
125231859|NCT00706797|450478066|FG001|Overall Study|Death|0|||
125231860|NCT00706797|450478065|FG000|Overall Study|Discontinuation of study by sponsor|52|||
125231861|NCT00706797|450478066|FG001|Overall Study|Discontinuation of study by sponsor|63|||
125231862|NCT00706797|450478065|FG000|Overall Study|Protocol Violation|3|||
125231863|NCT00706797|450478066|FG001|Overall Study|Protocol Violation|2|||
125231864|NCT00706797|450478065|FG000|Overall Study|Lost to Follow-up|1|||
125231865|NCT00706797|450478066|FG001|Overall Study|Lost to Follow-up|2|||
125231866|NCT00706797|450478065|FG000|Overall Study|Other|1|||
125231867|NCT00706797|450478066|FG001|Overall Study|Other|0|||
125231868|NCT00485303|450478069|FG000|Overall Study|Adverse Event|5|||
125231869|NCT00485303|450478069|FG000|Overall Study|Progressive Disease|44|||
125231870|NCT00485303|450478069|FG000|Overall Study|Other|3|||
125231871|NCT00485303|450478069|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
125231872|NCT00485303|450478069|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
125231873|NCT00112957|450478078|FG000|Overall Study|Progressive disease|18|||
125231874|NCT00112957|450478078|FG000|Overall Study|Physician Decision|1|||
125231875|NCT02309359|450478081|FG000|Overall Study|Adverse Event|4|||
125231876|NCT02309359|450478082|FG001|Overall Study|Adverse Event|5|||
125231877|NCT02309359|450478083|FG002|Overall Study|Adverse Event|5|||
125231878|NCT02309359|450478084|FG003|Overall Study|Adverse Event|4|||
125231879|NCT02309359|450478085|FG004|Overall Study|Adverse Event|4|||
125231880|NCT02309359|450478081|FG000|Overall Study|Death|1|||
125231881|NCT02309359|450478082|FG001|Overall Study|Death|0|||
125231882|NCT02309359|450478083|FG002|Overall Study|Death|0|||
125231883|NCT02309359|450478084|FG003|Overall Study|Death|0|||
125231884|NCT02309359|450478085|FG004|Overall Study|Death|0|||
125231885|NCT02309359|450478081|FG000|Overall Study|Withdrawal by Subject|2|||
125231886|NCT02309359|450478082|FG001|Overall Study|Withdrawal by Subject|2|||
125231887|NCT02309359|450478083|FG002|Overall Study|Withdrawal by Subject|4|||
125231888|NCT02309359|450478084|FG003|Overall Study|Withdrawal by Subject|4|||
125231889|NCT02309359|450478085|FG004|Overall Study|Withdrawal by Subject|0|||
125231890|NCT02309359|450478081|FG000|Overall Study|Lack of Efficacy|3|||
125231891|NCT02309359|450478082|FG001|Overall Study|Lack of Efficacy|1|||
125231892|NCT02309359|450478083|FG002|Overall Study|Lack of Efficacy|0|||
125231893|NCT02309359|450478084|FG003|Overall Study|Lack of Efficacy|0|||
125231894|NCT02309359|450478085|FG004|Overall Study|Lack of Efficacy|3|||
125231895|NCT02309359|450478081|FG000|Overall Study|Lost to Follow-up|0|||
125231896|NCT02309359|450478082|FG001|Overall Study|Lost to Follow-up|0|||
125231897|NCT02309359|450478083|FG002|Overall Study|Lost to Follow-up|0|||
125231898|NCT02309359|450478084|FG003|Overall Study|Lost to Follow-up|1|||
125231899|NCT02309359|450478085|FG004|Overall Study|Lost to Follow-up|0|||
125231900|NCT02309359|450478081|FG000|Overall Study|Other|2|||
125231901|NCT02309359|450478082|FG001|Overall Study|Other|0|||
125231902|NCT02309359|450478083|FG002|Overall Study|Other|2|||
125231903|NCT02309359|450478084|FG003|Overall Study|Other|3|||
125231904|NCT02309359|450478085|FG004|Overall Study|Other|2|||
125231905|NCT00701363|450478086|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
125231906|NCT00701363|450478087|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
125231907|NCT00701363|450478088|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
125231908|NCT00701363|450478089|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
125231909|NCT00701363|450478086|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
125231910|NCT00701363|450478087|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
125231911|NCT00701363|450478088|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
125231912|NCT00701363|450478089|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
125231913|NCT00701363|450478086|FG000|Treatment Phase 1|Adverse Event|7|||
125231914|NCT00701363|450478087|FG001|Treatment Phase 1|Adverse Event|0|||
125231915|NCT00701363|450478088|FG002|Treatment Phase 1|Adverse Event|0|||
125231916|NCT00701363|450478089|FG003|Treatment Phase 1|Adverse Event|0|||
125231917|NCT00701363|450478086|FG000|Treatment Phase 1|Protocol Violation|1|||
125231918|NCT00701363|450478087|FG001|Treatment Phase 1|Protocol Violation|0|||
125231919|NCT00701363|450478088|FG002|Treatment Phase 1|Protocol Violation|0|||
125231920|NCT00701363|450478089|FG003|Treatment Phase 1|Protocol Violation|0|||
125231921|NCT00701363|450478086|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
125231922|NCT00701363|450478087|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
125231923|NCT00701363|450478088|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
125231924|NCT00701363|450478089|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
125231925|NCT00701363|450478086|FG000|Treatment Phase 1|Lack of Efficacy|1|||
125231926|NCT00701363|450478087|FG001|Treatment Phase 1|Lack of Efficacy|0|||
125231927|NCT00701363|450478088|FG002|Treatment Phase 1|Lack of Efficacy|0|||
125231928|NCT00701363|450478089|FG003|Treatment Phase 1|Lack of Efficacy|0|||
125231929|NCT00701363|450478086|FG000|Treatment Phase 2|Adverse Event|0|||
125231930|NCT00701363|450478087|FG001|Treatment Phase 2|Adverse Event|0|||
125231931|NCT00701363|450478088|FG002|Treatment Phase 2|Adverse Event|1|||
125231932|NCT00701363|450478089|FG003|Treatment Phase 2|Adverse Event|0|||
125231933|NCT00701363|450478086|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
125231934|NCT00701363|450478087|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
125231935|NCT00701363|450478088|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
125231936|NCT00701363|450478089|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
125231937|NCT00863707|450478092|FG000|Overall Study|Randomized, but drug not received|4|||
125231938|NCT00863707|450478093|FG001|Overall Study|Randomized, but drug not received|3|||
125231939|NCT00289276|450478094|FG000|Second Part of FAST Study (Expansion)|Death|0|||
125231940|NCT00289276|450478095|FG001|Second Part of FAST Study (Expansion)|Death|2|||
125231941|NCT00289276|450478094|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
125231942|NCT00289276|450478095|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
125231943|NCT00869960|450478096|FG000|Overall Study|Lost to Follow-up|2|||
125231944|NCT02029417|450478097|FG000|Overall Study|Death|1|||
125231945|NCT02029417|450478097|FG000|Overall Study|Adverse Event|1|||
125231946|NCT02783911|450478098|FG000|Overall Study|Lost to Follow-up|3|||
125231947|NCT02783911|450478099|FG001|Overall Study|Lost to Follow-up|32|||
125231948|NCT01041859|450478102|FG000|Open-Label Titration|Adverse Event|69|||
125231949|NCT01041859|450478103|FG001|Open-Label Titration|Adverse Event|0|||
125231950|NCT01041859|450478104|FG002|Open-Label Titration|Adverse Event|0|||
125231951|NCT01041859|450478102|FG000|Open-Label Titration|Lack of Efficacy|3|||
125231952|NCT01041859|450478103|FG001|Open-Label Titration|Lack of Efficacy|0|||
125231953|NCT01041859|450478104|FG002|Open-Label Titration|Lack of Efficacy|0|||
125231954|NCT01041859|450478102|FG000|Open-Label Titration|Lost to Follow-up|1|||
125231955|NCT01041859|450478103|FG001|Open-Label Titration|Lost to Follow-up|0|||
125231956|NCT01041859|450478104|FG002|Open-Label Titration|Lost to Follow-up|0|||
125231957|NCT01041859|450478102|FG000|Open-Label Titration|Physician Decision|1|||
125231958|NCT01041859|450478103|FG001|Open-Label Titration|Physician Decision|0|||
125231959|NCT01041859|450478104|FG002|Open-Label Titration|Physician Decision|0|||
125231960|NCT01041859|450478102|FG000|Open-Label Titration|Protocol Violation|1|||
125231961|NCT01041859|450478103|FG001|Open-Label Titration|Protocol Violation|0|||
125231962|NCT01041859|450478104|FG002|Open-Label Titration|Protocol Violation|0|||
125231963|NCT01041859|450478102|FG000|Open-Label Titration|Other|7|||
125231964|NCT01041859|450478103|FG001|Open-Label Titration|Other|0|||
125231965|NCT01041859|450478104|FG002|Open-Label Titration|Other|0|||
125231966|NCT01041859|450478102|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
125231967|NCT01041859|450478103|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
125231968|NCT01041859|450478104|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
125231969|NCT01041859|450478102|FG000|Open-Label Titration|Withdrawal by Subject|11|||
125231970|NCT01041859|450478103|FG001|Open-Label Titration|Withdrawal by Subject|0|||
125231971|NCT01041859|450478104|FG002|Open-Label Titration|Withdrawal by Subject|0|||
125231972|NCT01041859|450478102|FG000|Double-Blind Maintenance|Adverse Event|0|||
125231973|NCT01041859|450478103|FG001|Double-Blind Maintenance|Adverse Event|23|||
125231974|NCT01041859|450478104|FG002|Double-Blind Maintenance|Adverse Event|13|||
125231975|NCT01041859|450478102|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
125231976|NCT01041859|450478103|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
125231977|NCT01041859|450478104|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
125231978|NCT01041859|450478102|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
125231979|NCT01041859|450478103|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
125231980|NCT01041859|450478104|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
125231981|NCT01041859|450478102|FG000|Double-Blind Maintenance|Physician Decision|0|||
125231982|NCT01041859|450478103|FG001|Double-Blind Maintenance|Physician Decision|2|||
125231983|NCT01041859|450478104|FG002|Double-Blind Maintenance|Physician Decision|1|||
125231984|NCT01041859|450478102|FG000|Double-Blind Maintenance|Protocol Violation|0|||
125231985|NCT01041859|450478103|FG001|Double-Blind Maintenance|Protocol Violation|1|||
125231986|NCT01041859|450478104|FG002|Double-Blind Maintenance|Protocol Violation|3|||
125231987|NCT01041859|450478102|FG000|Double-Blind Maintenance|Other|0|||
125231988|NCT01041859|450478103|FG001|Double-Blind Maintenance|Other|6|||
125231989|NCT01041859|450478104|FG002|Double-Blind Maintenance|Other|2|||
125231990|NCT01041859|450478102|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
125231991|NCT01041859|450478103|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
125231992|NCT01041859|450478104|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
125231993|NCT01041859|450478102|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
125231994|NCT01041859|450478103|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
125231995|NCT01041859|450478104|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
125231996|NCT00885118|450478107|FG000|Overall Study|Adverse Event|1|||
125231997|NCT00885118|450478108|FG001|Overall Study|Adverse Event|0|||
125231998|NCT00885118|450478109|FG002|Overall Study|Adverse Event|0|||
125231999|NCT00885118|450478110|FG003|Overall Study|Adverse Event|0|||
125232000|NCT00885118|450478111|FG004|Overall Study|Adverse Event|0|||
125232001|NCT00885118|450478107|FG000|Overall Study|Withdrawal by Subject|0|||
125232002|NCT00885118|450478108|FG001|Overall Study|Withdrawal by Subject|0|||
125232003|NCT00885118|450478109|FG002|Overall Study|Withdrawal by Subject|0|||
125232004|NCT00885118|450478110|FG003|Overall Study|Withdrawal by Subject|0|||
125232005|NCT00885118|450478111|FG004|Overall Study|Withdrawal by Subject|1|||
125232006|NCT00885118|450478107|FG000|Overall Study|Other reason not defined above|0|||
125176071|NCT03104400|450263647|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
125176072|NCT03104400|450263638|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
125176073|NCT03104400|450263639|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
125176074|NCT03104400|450263640|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
125176075|NCT03104400|450263641|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
125176076|NCT03104400|450263642|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
125176077|NCT03104400|450263643|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
125176078|NCT03104400|450263644|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
125176079|NCT03104400|450263645|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
125176080|NCT03104400|450263646|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
125176081|NCT03104400|450263647|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
125176082|NCT03104400|450263638|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
125176083|NCT03104400|450263639|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
125176084|NCT03104400|450263640|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
125176085|NCT03104400|450263641|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
125176086|NCT03104400|450263642|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
125176087|NCT03104400|450263643|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
125176088|NCT03104400|450263644|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
125176089|NCT03104400|450263645|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
125176090|NCT03104400|450263646|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
125176091|NCT03104400|450263647|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
125176092|NCT03104400|450263638|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
125176093|NCT03104400|450263639|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
125176094|NCT03104400|450263640|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
125176095|NCT03104400|450263641|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
125176096|NCT03104400|450263642|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
125176097|NCT03104400|450263643|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
125176098|NCT03104400|450263644|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
125176099|NCT03104400|450263645|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
125176100|NCT03104400|450263646|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
125176101|NCT03104400|450263647|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
125176102|NCT03104400|450263638|FG000|Period 2 Week 56 - 260)|Other|0|||
125176103|NCT03104400|450263639|FG001|Period 2 Week 56 - 260)|Other|0|||
125176104|NCT03104400|450263640|FG002|Period 2 Week 56 - 260)|Other|0|||
125176105|NCT03104400|450263641|FG003|Period 2 Week 56 - 260)|Other|0|||
125176106|NCT03104400|450263642|FG004|Period 2 Week 56 - 260)|Other|0|||
125176107|NCT03104400|450263643|FG005|Period 2 Week 56 - 260)|Other|0|||
125176108|NCT03104400|450263644|FG006|Period 2 Week 56 - 260)|Other|0|||
125176109|NCT03104400|450263645|FG007|Period 2 Week 56 - 260)|Other|0|||
125176110|NCT03104400|450263646|FG008|Period 2 Week 56 - 260)|Other|1|||
125176111|NCT03104400|450263647|FG009|Period 2 Week 56 - 260)|Other|1|||
125176112|NCT04948333|450263648|FG000|Overall Study|Adverse Event|6|||
125176113|NCT04948333|450263649|FG001|Overall Study|Adverse Event|4|||
125176114|NCT04948333|450263650|FG002|Overall Study|Adverse Event|0|||
125176115|NCT04948333|450263651|FG003|Overall Study|Adverse Event|2|||
125176116|NCT04948333|450263648|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
125176117|NCT04948333|450263649|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
125176118|NCT04948333|450263650|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
125176119|NCT04948333|450263651|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
125176120|NCT04948333|450263648|FG000|Overall Study|Progressive Disease|1|||
125176121|NCT04948333|450263649|FG001|Overall Study|Progressive Disease|5|||
125176122|NCT04948333|450263650|FG002|Overall Study|Progressive Disease|0|||
125176123|NCT04948333|450263651|FG003|Overall Study|Progressive Disease|0|||
125176124|NCT04948333|450263648|FG000|Overall Study|Physician Decision|2|||
125176125|NCT04948333|450263649|FG001|Overall Study|Physician Decision|2|||
125176126|NCT04948333|450263650|FG002|Overall Study|Physician Decision|0|||
125176127|NCT04948333|450263651|FG003|Overall Study|Physician Decision|0|||
125176128|NCT04948333|450263648|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
125176129|NCT04948333|450263649|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
125176130|NCT04948333|450263650|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
125176131|NCT04948333|450263651|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
125176132|NCT04948333|450263648|FG000|Overall Study|Withdrawal by Subject|2|||
125176133|NCT04948333|450263649|FG001|Overall Study|Withdrawal by Subject|0|||
125176134|NCT04948333|450263650|FG002|Overall Study|Withdrawal by Subject|0|||
125176135|NCT04948333|450263651|FG003|Overall Study|Withdrawal by Subject|1|||
125176136|NCT04948333|450263648|FG000|Overall Study|Protocol Violation|0|||
125176137|NCT04948333|450263649|FG001|Overall Study|Protocol Violation|1|||
125176138|NCT04948333|450263650|FG002|Overall Study|Protocol Violation|0|||
125176139|NCT04948333|450263651|FG003|Overall Study|Protocol Violation|0|||
125176140|NCT04948333|450263648|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
125232007|NCT00885118|450478108|FG001|Overall Study|Other reason not defined above|0|||
125176141|NCT04948333|450263649|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
125176142|NCT04948333|450263650|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
125176143|NCT04948333|450263651|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
125176144|NCT01625988|450263652|FG000|Overall Study|Lost to Follow-up|5|||
125176145|NCT01625988|450263653|FG001|Overall Study|Lost to Follow-up|6|||
125176146|NCT01625988|450263652|FG000|Overall Study|Withdrawal by Subject|8|||
125176147|NCT01625988|450263653|FG001|Overall Study|Withdrawal by Subject|3|||
125176148|NCT01625988|450263652|FG000|Overall Study|Adverse Event|0|||
125176149|NCT01625988|450263653|FG001|Overall Study|Adverse Event|1|||
125176150|NCT01625988|450263652|FG000|Overall Study|Lack of Efficacy|0|||
125176151|NCT01625988|450263653|FG001|Overall Study|Lack of Efficacy|1|||
125176152|NCT01625988|450263652|FG000|Overall Study|Randomized Inappropriately|1|||
125176153|NCT01625988|450263653|FG001|Overall Study|Randomized Inappropriately|0|||
125176154|NCT01625988|450263652|FG000|Overall Study|Protocol Violation|0|||
125176155|NCT01625988|450263653|FG001|Overall Study|Protocol Violation|2|||
125176156|NCT01495702|450263654|FG000|Randomized Phase|Randomized But Not Treated|1|||
125176157|NCT01495702|450263655|FG001|Randomized Phase|Randomized But Not Treated|4|||
125176158|NCT01495702|450263654|FG000|Randomized Phase|Adverse Event|2|||
125176159|NCT01495702|450263655|FG001|Randomized Phase|Adverse Event|2|||
125176160|NCT01495702|450263654|FG000|Randomized Phase|Death|1|||
125176161|NCT01495702|450263655|FG001|Randomized Phase|Death|0|||
125176162|NCT01495702|450263654|FG000|Randomized Phase|Lack of Efficacy|2|||
125176163|NCT01495702|450263655|FG001|Randomized Phase|Lack of Efficacy|0|||
125176164|NCT01495702|450263654|FG000|Randomized Phase|Investigators Discretion|2|||
125176165|NCT01495702|450263655|FG001|Randomized Phase|Investigators Discretion|0|||
125176166|NCT01495702|450263654|FG000|Randomized Phase|Withdrew Consent|10|||
125176167|NCT01495702|450263655|FG001|Randomized Phase|Withdrew Consent|18|||
125176168|NCT01495702|450263654|FG000|Randomized Phase|Lost to Follow-up|4|||
125176169|NCT01495702|450263655|FG001|Randomized Phase|Lost to Follow-up|3|||
125176170|NCT01495702|450263654|FG000|Randomized Phase|Participant Noncompliance|1|||
125176171|NCT01495702|450263655|FG001|Randomized Phase|Participant Noncompliance|0|||
125176172|NCT01495702|450263654|FG000|Randomized Phase|Protocol Violation|3|||
125176173|NCT01495702|450263655|FG001|Randomized Phase|Protocol Violation|1|||
125176174|NCT01644617|450263656|FG000|Overall Study|Withdrawal by Subject|3|||
125176175|NCT01644617|450263657|FG001|Overall Study|Withdrawal by Subject|4|||
125176176|NCT01644617|450263658|FG002|Overall Study|Withdrawal by Subject|1|||
125176177|NCT01644617|450263656|FG000|Overall Study|Lost to Follow-up|0|||
125176178|NCT01644617|450263657|FG001|Overall Study|Lost to Follow-up|1|||
125176179|NCT01644617|450263658|FG002|Overall Study|Lost to Follow-up|0|||
125176180|NCT01644617|450263656|FG000|Overall Study|Adverse Event|3|||
125176181|NCT01644617|450263657|FG001|Overall Study|Adverse Event|0|||
125176182|NCT01644617|450263658|FG002|Overall Study|Adverse Event|6|||
125176183|NCT05246670|450263659|FG000|Overall Study|Withdrawal by Subject|2|||
125176184|NCT05246670|450263660|FG001|Overall Study|Withdrawal by Subject|3|||
125176185|NCT05246670|450263661|FG002|Overall Study|Withdrawal by Subject|0|||
125176186|NCT05246670|450263662|FG003|Overall Study|Withdrawal by Subject|1|||
125176187|NCT05246670|450263659|FG000|Overall Study|Adverse Event|0|||
125176188|NCT05246670|450263660|FG001|Overall Study|Adverse Event|0|||
125176189|NCT05246670|450263661|FG002|Overall Study|Adverse Event|1|||
125176190|NCT05246670|450263662|FG003|Overall Study|Adverse Event|0|||
125176191|NCT05246670|450263659|FG000|Overall Study|Physician Decision|1|||
125176192|NCT05246670|450263660|FG001|Overall Study|Physician Decision|0|||
125176193|NCT05246670|450263661|FG002|Overall Study|Physician Decision|0|||
125176194|NCT05246670|450263662|FG003|Overall Study|Physician Decision|0|||
125176195|NCT05246670|450263659|FG000|Overall Study|Protocol Violation|1|||
125176196|NCT05246670|450263660|FG001|Overall Study|Protocol Violation|0|||
125176197|NCT05246670|450263661|FG002|Overall Study|Protocol Violation|0|||
125176198|NCT05246670|450263662|FG003|Overall Study|Protocol Violation|0|||
125176199|NCT04152291|450263665|FG000|Overall Study|Covid-19 restrictions|27|||
125176200|NCT04152291|450263665|FG000|Overall Study|Withdrawal by Subject|3|||
125176201|NCT05124691|450263666|FG000|Phase II|Eligibility criteria|0|||
125176202|NCT05124691|450263667|FG001|Phase II|Eligibility criteria|1|||
125176203|NCT05124691|450263668|FG002|Phase II|Eligibility criteria|0|||
125176204|NCT05124691|450263666|FG000|Phase II|Withdrawal by Subject|6|||
125176205|NCT05124691|450263667|FG001|Phase II|Withdrawal by Subject|2|||
125176206|NCT05124691|450263668|FG002|Phase II|Withdrawal by Subject|3|||
125176207|NCT05124691|450263666|FG000|Phase III|Withdrawal by Subject|6|||
125176208|NCT05124691|450263667|FG001|Phase III|Withdrawal by Subject|4|||
125176209|NCT05124691|450263668|FG002|Phase III|Withdrawal by Subject|4|||
125176210|NCT05124691|450263666|FG000|Phase III|Lost to Follow-up|1|||
125176211|NCT05124691|450263667|FG001|Phase III|Lost to Follow-up|0|||
125176212|NCT05124691|450263668|FG002|Phase III|Lost to Follow-up|0|||
125176213|NCT03509467|450263669|FG000|Overall Study|Withdrawal by Subject|5|||
125176214|NCT03509467|450263670|FG001|Overall Study|Withdrawal by Subject|1|||
125232008|NCT00885118|450478109|FG002|Overall Study|Other reason not defined above|1|||
125232009|NCT00885118|450478110|FG003|Overall Study|Other reason not defined above|0|||
125232010|NCT00885118|450478111|FG004|Overall Study|Other reason not defined above|0|||
125232011|NCT00666237|450478117|FG000|Overall Study|Death|5|||
125232012|NCT00666237|450478118|FG001|Overall Study|Death|5|||
125232013|NCT00666237|450478117|FG000|Overall Study|Lost to Follow-up|29|||
125232014|NCT00666237|450478118|FG001|Overall Study|Lost to Follow-up|25|||
125232015|NCT03321721|450478119|FG000|Overall Study|Lost to Follow-up|4|||
125232016|NCT03321721|450478120|FG001|Overall Study|Lost to Follow-up|8|||
125232017|NCT03321721|450478121|FG002|Overall Study|Lost to Follow-up|11|||
125232018|NCT01075048|450479678|FG000|Overall Study|Death|4|||
125232019|NCT01075048|450479679|FG001|Overall Study|Death|17|||
125232020|NCT01075048|450479680|FG002|Overall Study|Death|12|||
125232021|NCT01075048|450479678|FG000|Overall Study|Start of other or new therapy|4|||
125232022|NCT01075048|450479679|FG001|Overall Study|Start of other or new therapy|36|||
125232023|NCT01075048|450479680|FG002|Overall Study|Start of other or new therapy|46|||
125232024|NCT01075048|450479678|FG000|Overall Study|Withdrawal by Subject|1|||
125232025|NCT01075048|450479679|FG001|Overall Study|Withdrawal by Subject|6|||
125232026|NCT01075048|450479680|FG002|Overall Study|Withdrawal by Subject|3|||
125232027|NCT01075048|450479678|FG000|Overall Study|Lost to Follow-up|0|||
125232028|NCT01075048|450479679|FG001|Overall Study|Lost to Follow-up|1|||
125232029|NCT01075048|450479680|FG002|Overall Study|Lost to Follow-up|1|||
125232030|NCT01287936|450479684|FG000|Overall Study|Lost to Follow-up|0|||
125232031|NCT01287936|450479685|FG001|Overall Study|Lost to Follow-up|1|||
125232032|NCT01287936|450479686|FG002|Overall Study|Lost to Follow-up|1|||
125232033|NCT02791269|450479687|FG000|Overall Study|Lost to Follow-up|0|||
125232034|NCT02791269|450479688|FG001|Overall Study|Lost to Follow-up|1|||
125232035|NCT00336544|450479689|FG000|Overall Study|Lack of Efficacy|8|||
125232036|NCT00336544|450479690|FG001|Overall Study|Lack of Efficacy|5|||
125232037|NCT00336544|450479689|FG000|Overall Study|Adverse Event|4|||
125232038|NCT00336544|450479690|FG001|Overall Study|Adverse Event|9|||
125232039|NCT00336544|450479689|FG000|Overall Study|Withdrawal by Subject|4|||
125232040|NCT00336544|450479690|FG001|Overall Study|Withdrawal by Subject|3|||
125232041|NCT00336544|450479689|FG000|Overall Study|Other|3|||
125232042|NCT00336544|450479690|FG001|Overall Study|Other|5|||
125232043|NCT01649765|450479691|FG000|Overall Study|Adverse Event|5|||
125232044|NCT01649765|450479692|FG001|Overall Study|Adverse Event|3|||
125232045|NCT01649765|450479691|FG000|Overall Study|Lack of Efficacy|1|||
125232046|NCT01649765|450479692|FG001|Overall Study|Lack of Efficacy|1|||
125232047|NCT01649765|450479691|FG000|Overall Study|Physician Decision|0|||
125232048|NCT01649765|450479692|FG001|Overall Study|Physician Decision|3|||
125232049|NCT01649765|450479691|FG000|Overall Study|Protocol Violation|1|||
125232050|NCT01649765|450479692|FG001|Overall Study|Protocol Violation|0|||
125232051|NCT01649765|450479691|FG000|Overall Study|Withdrawal by Subject|2|||
125232052|NCT01649765|450479692|FG001|Overall Study|Withdrawal by Subject|1|||
125232053|NCT00715208|450479693|FG000|Overall Study|Withdrawal by Subject|1|||
125232054|NCT00715208|450479694|FG001|Overall Study|Withdrawal by Subject|1|||
125232055|NCT00715208|450479693|FG000|Overall Study|Adverse Event|0|||
125232056|NCT00715208|450479694|FG001|Overall Study|Adverse Event|6|||
125232057|NCT00715208|450479693|FG000|Overall Study|Lack of Efficacy|0|||
125232058|NCT00715208|450479694|FG001|Overall Study|Lack of Efficacy|2|||
125232059|NCT01648764|450479695|FG000|Overall Study|Progressive Disease|0|||
125232060|NCT01648764|450479696|FG001|Overall Study|Progressive Disease|1|||
125232061|NCT01648764|450479697|FG002|Overall Study|Progressive Disease|0|||
125232062|NCT01648764|450479698|FG003|Overall Study|Progressive Disease|0|||
125232063|NCT01648764|450479699|FG004|Overall Study|Progressive Disease|0|||
125232064|NCT01648764|450479700|FG005|Overall Study|Progressive Disease|1|||
125232065|NCT01648764|450479701|FG006|Overall Study|Progressive Disease|1|||
125232066|NCT01648764|450479702|FG007|Overall Study|Progressive Disease|0|||
125232067|NCT01648764|450479703|FG008|Overall Study|Progressive Disease|0|||
125232068|NCT01648764|450479704|FG009|Overall Study|Progressive Disease|2|||
125232069|NCT01648764|450479705|FG010|Overall Study|Progressive Disease|0|||
125232070|NCT01648764|450479706|FG011|Overall Study|Progressive Disease|1|||
125232071|NCT01648764|450479707|FG012|Overall Study|Progressive Disease|2|||
125232072|NCT01648764|450479708|FG013|Overall Study|Progressive Disease|1|||
125232073|NCT01648764|450479695|FG000|Overall Study|Adverse Event|0|||
125232074|NCT01648764|450479696|FG001|Overall Study|Adverse Event|0|||
125232075|NCT01648764|450479697|FG002|Overall Study|Adverse Event|0|||
125232076|NCT01648764|450479698|FG003|Overall Study|Adverse Event|0|||
125232077|NCT01648764|450479699|FG004|Overall Study|Adverse Event|0|||
125232078|NCT01648764|450479700|FG005|Overall Study|Adverse Event|1|||
125232079|NCT01648764|450479701|FG006|Overall Study|Adverse Event|0|||
125232080|NCT01648764|450479702|FG007|Overall Study|Adverse Event|0|||
125232081|NCT01648764|450479703|FG008|Overall Study|Adverse Event|0|||
125232082|NCT01648764|450479704|FG009|Overall Study|Adverse Event|1|||
125232083|NCT01648764|450479705|FG010|Overall Study|Adverse Event|0|||
125232084|NCT01648764|450479706|FG011|Overall Study|Adverse Event|3|||
125232085|NCT01648764|450479707|FG012|Overall Study|Adverse Event|1|||
125232086|NCT01648764|450479708|FG013|Overall Study|Adverse Event|1|||
125232087|NCT01648764|450479695|FG000|Overall Study|Death|0|||
125232088|NCT01648764|450479696|FG001|Overall Study|Death|0|||
125232089|NCT01648764|450479697|FG002|Overall Study|Death|0|||
125232090|NCT01648764|450479698|FG003|Overall Study|Death|0|||
125232091|NCT01648764|450479699|FG004|Overall Study|Death|0|||
125232092|NCT01648764|450479700|FG005|Overall Study|Death|0|||
125232093|NCT01648764|450479701|FG006|Overall Study|Death|1|||
125232094|NCT01648764|450479702|FG007|Overall Study|Death|0|||
125232095|NCT01648764|450479703|FG008|Overall Study|Death|0|||
125232096|NCT01648764|450479704|FG009|Overall Study|Death|0|||
125232097|NCT01648764|450479705|FG010|Overall Study|Death|0|||
125232098|NCT01648764|450479706|FG011|Overall Study|Death|0|||
125232099|NCT01648764|450479707|FG012|Overall Study|Death|0|||
125232100|NCT01648764|450479708|FG013|Overall Study|Death|1|||
125232101|NCT01648764|450479695|FG000|Overall Study|Withdrawal by Subject|0|||
125232102|NCT01648764|450479696|FG001|Overall Study|Withdrawal by Subject|0|||
125232103|NCT01648764|450479697|FG002|Overall Study|Withdrawal by Subject|0|||
125232104|NCT01648764|450479698|FG003|Overall Study|Withdrawal by Subject|0|||
125232105|NCT01648764|450479699|FG004|Overall Study|Withdrawal by Subject|0|||
125232106|NCT01648764|450479700|FG005|Overall Study|Withdrawal by Subject|0|||
125232107|NCT01648764|450479701|FG006|Overall Study|Withdrawal by Subject|2|||
125232108|NCT01648764|450479702|FG007|Overall Study|Withdrawal by Subject|0|||
125232109|NCT01648764|450479703|FG008|Overall Study|Withdrawal by Subject|0|||
125232110|NCT01648764|450479704|FG009|Overall Study|Withdrawal by Subject|0|||
125232111|NCT01648764|450479705|FG010|Overall Study|Withdrawal by Subject|0|||
125232112|NCT01648764|450479706|FG011|Overall Study|Withdrawal by Subject|0|||
125232113|NCT01648764|450479707|FG012|Overall Study|Withdrawal by Subject|1|||
125232114|NCT01648764|450479708|FG013|Overall Study|Withdrawal by Subject|0|||
125232115|NCT01648764|450479695|FG000|Overall Study|Investigator Decision|0|||
125232116|NCT01648764|450479696|FG001|Overall Study|Investigator Decision|0|||
125232117|NCT01648764|450479697|FG002|Overall Study|Investigator Decision|0|||
125232118|NCT01648764|450479698|FG003|Overall Study|Investigator Decision|0|||
125232119|NCT01648764|450479699|FG004|Overall Study|Investigator Decision|0|||
125232120|NCT01648764|450479700|FG005|Overall Study|Investigator Decision|0|||
125232121|NCT01648764|450479701|FG006|Overall Study|Investigator Decision|1|||
125232122|NCT01648764|450479702|FG007|Overall Study|Investigator Decision|0|||
125176215|NCT03509467|450263671|FG002|Overall Study|Withdrawal by Subject|6|||
125176216|NCT03509467|450263672|FG003|Overall Study|Withdrawal by Subject|7|||
125176217|NCT03509467|450263673|FG004|Overall Study|Withdrawal by Subject|10|||
125176218|NCT03509467|450263674|FG005|Overall Study|Withdrawal by Subject|10|||
125176219|NCT03509467|450263675|FG006|Overall Study|Withdrawal by Subject|10|||
125176220|NCT03509467|450263676|FG007|Overall Study|Withdrawal by Subject|10|||
125176221|NCT03509467|450263669|FG000|Overall Study|Death|0|||
125176222|NCT03509467|450263670|FG001|Overall Study|Death|0|||
125176223|NCT03509467|450263671|FG002|Overall Study|Death|2|||
125176224|NCT03509467|450263672|FG003|Overall Study|Death|2|||
125176225|NCT03509467|450263673|FG004|Overall Study|Death|1|||
125176226|NCT03509467|450263674|FG005|Overall Study|Death|0|||
125176227|NCT03509467|450263675|FG006|Overall Study|Death|1|||
125176228|NCT03509467|450263676|FG007|Overall Study|Death|0|||
125176229|NCT03509467|450263669|FG000|Overall Study|Proxy Withdrawal|0|||
125176230|NCT03509467|450263670|FG001|Overall Study|Proxy Withdrawal|0|||
125176231|NCT03509467|450263671|FG002|Overall Study|Proxy Withdrawal|0|||
125176232|NCT03509467|450263672|FG003|Overall Study|Proxy Withdrawal|0|||
125176233|NCT03509467|450263673|FG004|Overall Study|Proxy Withdrawal|0|||
125176234|NCT03509467|450263674|FG005|Overall Study|Proxy Withdrawal|0|||
125176235|NCT03509467|450263675|FG006|Overall Study|Proxy Withdrawal|0|||
125176236|NCT03509467|450263676|FG007|Overall Study|Proxy Withdrawal|1|||
125176237|NCT02829918|450263677|FG000|Overall Study|Death|2|||
125176238|NCT02829918|450263677|FG000|Overall Study|Withdrawal by Subject|4|||
125176239|NCT02829918|450263677|FG000|Overall Study|Adverse Event|1|||
125176240|NCT02829918|450263677|FG000|Overall Study|Progression|1|||
125176241|NCT04223752|450263683|FG000|Overall Study|Participant enrolled in error|0|||
125176242|NCT04223752|450263684|FG001|Overall Study|Participant enrolled in error|0|||
125176243|NCT04223752|450263685|FG002|Overall Study|Participant enrolled in error|0|||
125176244|NCT04223752|450263686|FG003|Overall Study|Participant enrolled in error|0|||
125176245|NCT04223752|450263687|FG004|Overall Study|Participant enrolled in error|1|||
125176246|NCT04223752|450263683|FG000|Overall Study|Death|0|||
125176247|NCT04223752|450263684|FG001|Overall Study|Death|0|||
125176248|NCT04223752|450263685|FG002|Overall Study|Death|0|||
125176249|NCT04223752|450263686|FG003|Overall Study|Death|2|||
125176250|NCT04223752|450263687|FG004|Overall Study|Death|1|||
125176251|NCT04759703|450263688|FG000|Overall Study|Withdrawal by Subject|4|||
125176252|NCT04759703|450263689|FG001|Overall Study|Withdrawal by Subject|9|||
125176253|NCT04759703|450263688|FG000|Overall Study|Adverse Event|1|||
125176254|NCT04759703|450263689|FG001|Overall Study|Adverse Event|0|||
125232123|NCT01648764|450479703|FG008|Overall Study|Investigator Decision|0|||
125232124|NCT01648764|450479704|FG009|Overall Study|Investigator Decision|0|||
125232125|NCT01648764|450479705|FG010|Overall Study|Investigator Decision|0|||
125232126|NCT01648764|450479706|FG011|Overall Study|Investigator Decision|1|||
125232127|NCT01648764|450479707|FG012|Overall Study|Investigator Decision|0|||
125232128|NCT01648764|450479708|FG013|Overall Study|Investigator Decision|0|||
125232129|NCT01316614|450479709|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
125232130|NCT01316614|450479709|FG000|Overall Study|Cytology slides not available for review|4|||
125232131|NCT01316614|450479709|FG000|Overall Study|Cystic lesion|5|||
125232132|NCT01316614|450479709|FG000|Overall Study|Inadequate number of passes|2|||
125232133|NCT01316614|450479709|FG000|Overall Study|Medically unstable|1|||
125232134|NCT03427411|450479710|FG000|Overall Study|Screen failure - platelets too low|0|||
125232135|NCT03427411|450479711|FG001|Overall Study|Screen failure - platelets too low|1|||
125232136|NCT00076570|450479712|FG000|Overall Study|Drug intolerance|8|||
125232137|NCT00076570|450479713|FG001|Overall Study|Drug intolerance|8|||
125232138|NCT04889040|450479714|FG000|Overall Study|Withdrawal by Subject|3|||
125232139|NCT04889040|450479715|FG001|Overall Study|Withdrawal by Subject|3|||
125232140|NCT04889040|450479714|FG000|Overall Study|Lost to Follow-up|0|||
125232141|NCT04889040|450479715|FG001|Overall Study|Lost to Follow-up|1|||
125232142|NCT04889040|450479714|FG000|Overall Study|Adverse Event|2|||
125232143|NCT04889040|450479715|FG001|Overall Study|Adverse Event|1|||
125232144|NCT02058095|450479716|FG000|Overall Study|Adverse Event|1|||
125232145|NCT02058095|450479717|FG001|Overall Study|Adverse Event|0|||
125232146|NCT00998946|450479718|FG000|Overall Study|Lost to Follow-up|1|||
125232147|NCT00998946|450479718|FG000|Overall Study|Withdrawal by Subject|1|||
125232148|NCT00998946|450479718|FG000|Overall Study|Death|2|||
125232149|NCT00998946|450479718|FG000|Overall Study|Reason Unspecified|3|||
125232150|NCT00998946|450479718|FG000|Overall Study|Enrolled but not Dosed|2|||
125232151|NCT00316004|450479721|FG000|Overall Study|Subject was not given study fluid.|14|||
125232152|NCT00316004|450479722|FG001|Overall Study|Subject was not given study fluid.|14|||
125232153|NCT00316004|450479723|FG002|Overall Study|Subject was not given study fluid.|21|||
125232154|NCT00977197|450479726|FG000|Overall Study|Withdrawal by Subject|3|||
125232155|NCT00977197|450479727|FG001|Overall Study|Withdrawal by Subject|4|||
125232156|NCT00977197|450479726|FG000|Overall Study|Adverse Event|3|||
125232157|NCT00977197|450479727|FG001|Overall Study|Adverse Event|1|||
125232158|NCT00977197|450479726|FG000|Overall Study|Lack of Efficacy|1|||
125232159|NCT00977197|450479727|FG001|Overall Study|Lack of Efficacy|0|||
125232160|NCT00977197|450479726|FG000|Overall Study|Lost to Follow-up|1|||
125232161|NCT00977197|450479727|FG001|Overall Study|Lost to Follow-up|3|||
125232162|NCT00977197|450479726|FG000|Overall Study|Nonadherence|1|||
125232163|NCT00977197|450479727|FG001|Overall Study|Nonadherence|1|||
125232164|NCT00784875|450479728|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
125232165|NCT00784875|450479729|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
125232166|NCT00784875|450479730|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
125232167|NCT00784875|450479731|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
125232168|NCT00784875|450479728|FG000|Period A - Baseline|Adverse Event|0|||
125232169|NCT00784875|450479729|FG001|Period A - Baseline|Adverse Event|0|||
125232170|NCT00784875|450479730|FG002|Period A - Baseline|Adverse Event|0|||
125232171|NCT00784875|450479731|FG003|Period A - Baseline|Adverse Event|8|||
125232172|NCT00784875|450479728|FG000|Period A - Baseline|Protocol Violation|0|||
125232173|NCT00784875|450479729|FG001|Period A - Baseline|Protocol Violation|0|||
125232174|NCT00784875|450479730|FG002|Period A - Baseline|Protocol Violation|0|||
125232175|NCT00784875|450479731|FG003|Period A - Baseline|Protocol Violation|25|||
125232176|NCT00784875|450479728|FG000|Period A - Baseline|Withdrawal by Subject|0|||
125232177|NCT00784875|450479729|FG001|Period A - Baseline|Withdrawal by Subject|0|||
125232178|NCT00784875|450479730|FG002|Period A - Baseline|Withdrawal by Subject|0|||
125232179|NCT00784875|450479731|FG003|Period A - Baseline|Withdrawal by Subject|27|||
125176255|NCT04759703|450263688|FG000|Overall Study|Lost to Follow-up|2|||
125176256|NCT04759703|450263689|FG001|Overall Study|Lost to Follow-up|0|||
125176257|NCT04487067|450263701|FG000|Overall Study|Adverse Event|3|||
125176258|NCT04487067|450263701|FG000|Overall Study|Death Other Than Progressive Disease|60|||
125176259|NCT04487067|450263701|FG000|Overall Study|Death Due To Progressive Disease|40|||
125176260|NCT04487067|450263701|FG000|Overall Study|Lost to Follow-up|3|||
125176261|NCT04487067|450263701|FG000|Overall Study|Progressive Disease|1|||
125176262|NCT04487067|450263701|FG000|Overall Study|Protocol Violation|3|||
125176263|NCT04487067|450263701|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
125176264|NCT04487067|450263701|FG000|Overall Study|Withdrawal by Subject|15|||
125176265|NCT04877457|450263702|FG000|Overall Study|Early termination of study due to low enrollment|2|||
125232180|NCT00784875|450479728|FG000|Period A - Baseline|Physician Decision|0|||
125232181|NCT00784875|450479729|FG001|Period A - Baseline|Physician Decision|0|||
125176266|NCT04877457|450263703|FG001|Overall Study|Early termination of study due to low enrollment|1|||
125232182|NCT00784875|450479730|FG002|Period A - Baseline|Physician Decision|0|||
125232183|NCT00784875|450479731|FG003|Period A - Baseline|Physician Decision|2|||
125232184|NCT00784875|450479728|FG000|Period A - Baseline|Sponsor Decision|0|||
125232185|NCT00784875|450479729|FG001|Period A - Baseline|Sponsor Decision|0|||
125232186|NCT00784875|450479730|FG002|Period A - Baseline|Sponsor Decision|0|||
125232187|NCT00784875|450479731|FG003|Period A - Baseline|Sponsor Decision|113|||
125232188|NCT00784875|450479728|FG000|Period A - Baseline|Lost to Follow-up|0|||
125232189|NCT00784875|450479729|FG001|Period A - Baseline|Lost to Follow-up|0|||
125176267|NCT06385483|450263704|FG000|Overall Study|Withdrawal by Subject|2|||
125176268|NCT06385483|450263704|FG000|Overall Study|Never start protocol therapy|2|||
125176269|NCT06385483|450263704|FG000|Overall Study|Disease progression|15|||
125176270|NCT02503787|450263705|FG000|Enrollment|Withdrawal by Subject|6|||
125176271|NCT02503787|450263705|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
125176272|NCT02503787|450263705|FG000|Enrollment|Physician Decision|2|||
125176273|NCT02503787|450263705|FG000|Enrollment|Insurance issue|2|||
125176274|NCT02503787|450263705|FG000|Enrollment|Lost to Follow-up|1|||
125176275|NCT02503787|450263705|FG000|Enrollment|Study closure|1|||
125176276|NCT02503787|450263705|FG000|Enrollment|Adverse Event|1|||
125176277|NCT02503787|450263705|FG000|Enrollment|Protocol Violation|1|||
125176278|NCT02503787|450263705|FG000|Enrollment|Inability to implant system|1|||
125176279|NCT02503787|450263705|FG000|Enrollment|Unable to be programmed|1|||
125176280|NCT02503787|450263705|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
125176281|NCT02503787|450263705|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
125176282|NCT02503787|450263705|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
125176283|NCT02503787|450263705|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
125176284|NCT02503787|450263705|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
125176285|NCT02503787|450263705|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
125176286|NCT04787627|450263706|FG000|Overall Study|Withdrawal by Subject|3|||
125176287|NCT04787627|450263707|FG001|Overall Study|Withdrawal by Subject|0|||
125176288|NCT04787627|450263706|FG000|Overall Study|Physician Decision|2|||
125176289|NCT04787627|450263707|FG001|Overall Study|Physician Decision|0|||
125176290|NCT04787627|450263706|FG000|Overall Study|Excluded|0|||
125176291|NCT04787627|450263707|FG001|Overall Study|Excluded|1|||
125176292|NCT00919854|450263709|FG000|Overall Study|Adverse Event|1|||
125176293|NCT00985491|450263710|FG000|Overall Study|Adverse Event|8|||
125176294|NCT00985491|450263710|FG000|Overall Study|device migration|7|||
125176295|NCT00985491|450263710|FG000|Overall Study|Withdrawal by Subject|1|||
125176296|NCT00985491|450263710|FG000|Overall Study|implant failure|3|||
125176297|NCT00588770|450264409|FG000|Overall Study|Disease progression|85|||
125176298|NCT00588770|450264410|FG001|Overall Study|Disease progression|68|||
125176299|NCT00588770|450264409|FG000|Overall Study|Adverse Event|29|||
125176300|NCT00588770|450264410|FG001|Overall Study|Adverse Event|58|||
125176301|NCT00588770|450264409|FG000|Overall Study|Death|13|||
125176302|NCT00588770|450264410|FG001|Overall Study|Death|22|||
125176303|NCT00588770|450264409|FG000|Overall Study|Withdrawal by Subject|15|||
125176304|NCT00588770|450264410|FG001|Overall Study|Withdrawal by Subject|25|||
125176305|NCT00588770|450264409|FG000|Overall Study|Alternative therapy|2|||
125176306|NCT00588770|450264410|FG001|Overall Study|Alternative therapy|4|||
125176307|NCT00588770|450264409|FG000|Overall Study|Other complicating disease|3|||
125176308|NCT00588770|450264410|FG001|Overall Study|Other complicating disease|2|||
125176309|NCT00588770|450264409|FG000|Overall Study|Not start protocol therapy|0|||
125176310|NCT00588770|450264410|FG001|Overall Study|Not start protocol therapy|9|||
125176311|NCT00588770|450264409|FG000|Overall Study|Lack of Efficacy|8|||
125176312|NCT00588770|450264410|FG001|Overall Study|Lack of Efficacy|10|||
125176313|NCT00588770|450264409|FG000|Overall Study|Physician discretion|2|||
125176314|NCT00588770|450264410|FG001|Overall Study|Physician discretion|0|||
125176315|NCT00588770|450264409|FG000|Overall Study|Patient non-compliance|2|||
125176316|NCT00588770|450264410|FG001|Overall Study|Patient non-compliance|2|||
125176317|NCT03698019|450264411|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
125176318|NCT03698019|450264412|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
125176319|NCT03698019|450264411|FG000|Step 1: Registration|Withdrawal by Subject|7|||
125176320|NCT03698019|450264412|FG001|Step 1: Registration|Withdrawal by Subject|2|||
125176321|NCT03698019|450264411|FG000|Step 1: Registration|Toxicity|0|||
125176322|NCT03698019|450264412|FG001|Step 1: Registration|Toxicity|1|||
125176323|NCT03698019|450264411|FG000|Step 1: Registration|Disease Progression|0|||
125176324|NCT03698019|450264412|FG001|Step 1: Registration|Disease Progression|12|||
125176325|NCT03698019|450264411|FG000|Step 1: Registration|Co-morbidities|0|||
125176326|NCT03698019|450264412|FG001|Step 1: Registration|Co-morbidities|1|||
125176327|NCT03698019|450264411|FG000|Step 1: Registration|Scheduling Issues|1|||
125176328|NCT03698019|450264412|FG001|Step 1: Registration|Scheduling Issues|0|||
125176329|NCT03698019|450264411|FG000|Step 1: Registration|Participant Refusal|0|||
125176330|NCT03698019|450264412|FG001|Step 1: Registration|Participant Refusal|1|||
125176331|NCT03698019|450264411|FG000|Step 2: Surgery|Participant Refusal|2|||
125176332|NCT03698019|450264412|FG001|Step 2: Surgery|Participant Refusal|1|||
125176333|NCT03698019|450264411|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
125176334|NCT03698019|450264412|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
125176335|NCT03698019|450264411|FG000|Step 2: Surgery|Metastatic Disease|16|||
125176336|NCT03698019|450264412|FG001|Step 2: Surgery|Metastatic Disease|9|||
125176337|NCT03698019|450264411|FG000|Step 2: Surgery|Residual Disease|2|||
125176338|NCT03698019|450264412|FG001|Step 2: Surgery|Residual Disease|1|||
125176339|NCT03698019|450264411|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
125176340|NCT03698019|450264412|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
125176341|NCT03698019|450264411|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
125176342|NCT03698019|450264412|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
125176343|NCT03698019|450264411|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
125176344|NCT03698019|450264412|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
125176345|NCT03698019|450264411|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
125176346|NCT03698019|450264412|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
125176347|NCT03698019|450264411|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
125176348|NCT03698019|450264412|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
125176349|NCT03698019|450264411|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
125176350|NCT03698019|450264412|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
125176351|NCT03698019|450264411|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
125176352|NCT03698019|450264412|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
125176353|NCT03698019|450264411|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
125176354|NCT03698019|450264412|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
125176355|NCT01856192|450264413|FG000|Overall Study|Adverse Event|12|||
125176356|NCT01856192|450264414|FG001|Overall Study|Adverse Event|4|||
125176357|NCT01856192|450264413|FG000|Overall Study|Alternative therapy|0|||
125176358|NCT01856192|450264414|FG001|Overall Study|Alternative therapy|3|||
125176359|NCT01856192|450264413|FG000|Overall Study|Death|3|||
125176360|NCT01856192|450264414|FG001|Overall Study|Death|5|||
125176361|NCT01856192|450264413|FG000|Overall Study|Lack of Efficacy|0|||
125176362|NCT01856192|450264414|FG001|Overall Study|Lack of Efficacy|5|||
125176363|NCT01856192|450264413|FG000|Overall Study|Withdrawal by Subject|1|||
125176364|NCT01856192|450264414|FG001|Overall Study|Withdrawal by Subject|1|||
125176365|NCT01856192|450264413|FG000|Overall Study|Other diseases|1|||
125176366|NCT01856192|450264414|FG001|Overall Study|Other diseases|0|||
125176367|NCT01856192|450264413|FG000|Overall Study|Never started treatment|7|||
125176368|NCT01856192|450264414|FG001|Overall Study|Never started treatment|5|||
125176369|NCT01856192|450264413|FG000|Overall Study|Path ineligible|20|||
125176370|NCT01856192|450264414|FG001|Overall Study|Path ineligible|34|||
125176371|NCT01856192|450264413|FG000|Overall Study|Non-path ineligible|2|||
125176372|NCT01856192|450264414|FG001|Overall Study|Non-path ineligible|2|||
125176373|NCT01856192|450264413|FG000|Overall Study|Physician Decision|1|||
125176374|NCT01856192|450264414|FG001|Overall Study|Physician Decision|1|||
125176375|NCT01856192|450264413|FG000|Overall Study|Suspicion of progressive disease|1|||
125176376|NCT01856192|450264414|FG001|Overall Study|Suspicion of progressive disease|0|||
125176377|NCT01856192|450264413|FG000|Overall Study|Non-compliance|1|||
125176378|NCT01856192|450264414|FG001|Overall Study|Non-compliance|0|||
125176379|NCT02642042|450264415|FG000|Overall Study|Adverse Event|22|||
125176380|NCT02642042|450264415|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
125176381|NCT02642042|450264415|FG000|Overall Study|Progression/Relapse|28|||
125176382|NCT02642042|450264415|FG000|Overall Study|Death|1|||
125176383|NCT02642042|450264415|FG000|Overall Study|Not Protocol Specified|2|||
125176384|NCT04976621|450264416|FG000|Overall Study|Lost to Follow-up|2|||
125176385|NCT04976621|450264417|FG001|Overall Study|Lost to Follow-up|1|||
125176386|NCT04976621|450264416|FG000|Overall Study|Withdrawal by Subject|1|||
125176387|NCT04976621|450264417|FG001|Overall Study|Withdrawal by Subject|0|||
125176388|NCT03348631|450264420|FG000|Overall Study|Not Eligible, No treatment|0|||
125176389|NCT03348631|450264421|FG001|Overall Study|Not Eligible, No treatment|1|||
125176390|NCT03348631|450264420|FG000|Overall Study|Not Eligible, Treated|2|||
125176391|NCT03348631|450264421|FG001|Overall Study|Not Eligible, Treated|0|||
125176392|NCT03348631|450264420|FG000|Overall Study|Eligible, No Treatment|1|||
125176393|NCT03348631|450264421|FG001|Overall Study|Eligible, No Treatment|0|||
125176394|NCT05223920|450264429|FG000|Overall Study|Adverse Event|6|||
125176395|NCT05223920|450264430|FG001|Overall Study|Adverse Event|3|||
125176396|NCT05223920|450264429|FG000|Overall Study|Death|2|||
125176397|NCT05223920|450264430|FG001|Overall Study|Death|0|||
125176398|NCT05223920|450264429|FG000|Overall Study|Disease Progression|1|||
125176399|NCT05223920|450264430|FG001|Overall Study|Disease Progression|2|||
125176400|NCT05223920|450264429|FG000|Overall Study|Physician Decision|1|||
125176401|NCT05223920|450264430|FG001|Overall Study|Physician Decision|2|||
125176402|NCT05223920|450264429|FG000|Overall Study|Sponsor decision|11|||
125176403|NCT05223920|450264430|FG001|Overall Study|Sponsor decision|9|||
125176404|NCT05223920|450264429|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
125176405|NCT05223920|450264430|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
125176406|NCT05223920|450264429|FG000|Overall Study|Subject decision|1|||
125176407|NCT05223920|450264430|FG001|Overall Study|Subject decision|0|||
125176408|NCT05223920|450264429|FG000|Overall Study|Withdrawal by Subject|1|||
125176409|NCT05223920|450264430|FG001|Overall Study|Withdrawal by Subject|6|||
125176410|NCT03790657|450264431|FG000|Overall Study|Adverse Event|1|||
125176411|NCT03790657|450264432|FG001|Overall Study|Adverse Event|1|||
125176412|NCT03790657|450264431|FG000|Overall Study|Withdrawal by Subject|1|||
125176413|NCT03790657|450264432|FG001|Overall Study|Withdrawal by Subject|1|||
125176414|NCT04186845|450264443|FG000|Overall Study|Death|2|||
125176415|NCT04186845|450264443|FG000|Overall Study|Lost to Follow-up|1|||
125176416|NCT04186845|450264443|FG000|Overall Study|Physician Decision|1|||
125176417|NCT04186845|450264443|FG000|Overall Study|Protocol Violation|1|||
125176418|NCT04186845|450264443|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
125176419|NCT04186845|450264443|FG000|Overall Study|Biopsy ordered but not done|1|||
125176420|NCT04186845|450264443|FG000|Overall Study|It was previously confirmed|1|||
125176421|NCT04186845|450264443|FG000|Overall Study|Patient cancelled scheduled scans|2|||
125176422|NCT04186845|450264443|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
125176423|NCT04186845|450264443|FG000|Overall Study|Subject refused confirmatory imaging|1|||
125176424|NCT04186845|450264443|FG000|Overall Study|Too small to biopsy|1|||
125176425|NCT05061420|450264446|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
125176426|NCT05061420|450264447|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
125176427|NCT05061420|450264448|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
125176428|NCT05061420|450264446|FG000|Overall Study|Progressive disease|11|||
125176429|NCT05061420|450264447|FG001|Overall Study|Progressive disease|15|||
125176430|NCT05061420|450264448|FG002|Overall Study|Progressive disease|14|||
125176431|NCT05061420|450264446|FG000|Overall Study|Withdrawal by Subject|2|||
125176432|NCT05061420|450264447|FG001|Overall Study|Withdrawal by Subject|0|||
125176433|NCT05061420|450264448|FG002|Overall Study|Withdrawal by Subject|1|||
125176434|NCT05061420|450264446|FG000|Overall Study|Not related to COVID-19|2|||
125176435|NCT05061420|450264447|FG001|Overall Study|Not related to COVID-19|0|||
125176436|NCT05061420|450264448|FG002|Overall Study|Not related to COVID-19|0|||
125176437|NCT02859142|450264449|FG000|Overall Study|Adverse Event|1|||
125176438|NCT02859142|450264450|FG001|Overall Study|Adverse Event|2|||
125176439|NCT02859142|450264449|FG000|Overall Study|Lost to Follow-up|1|||
125176440|NCT02859142|450264450|FG001|Overall Study|Lost to Follow-up|4|||
125176441|NCT02859142|450264449|FG000|Overall Study|Withdrawal by Subject|2|||
125176442|NCT02859142|450264450|FG001|Overall Study|Withdrawal by Subject|0|||
125176443|NCT02859142|450264449|FG000|Overall Study|Scheduling difficulties|0|||
125176444|NCT02859142|450264450|FG001|Overall Study|Scheduling difficulties|3|||
125176445|NCT03290079|450264451|FG000|Overall Study|Death|2|||
125176446|NCT02466685|450264452|FG000|Overall Study|Adverse Event|5|||
125176447|NCT02466685|450264453|FG001|Overall Study|Adverse Event|2|||
125176448|NCT02466685|450264452|FG000|Overall Study|Lost to Follow-up|1|||
125176449|NCT02466685|450264453|FG001|Overall Study|Lost to Follow-up|1|||
125176450|NCT02466685|450264452|FG000|Overall Study|Withdrawal by Subject|1|||
125176451|NCT02466685|450264453|FG001|Overall Study|Withdrawal by Subject|0|||
125176452|NCT02466685|450264452|FG000|Overall Study|Physician Decision|1|||
125176453|NCT02466685|450264453|FG001|Overall Study|Physician Decision|1|||
125176454|NCT04697069|450264454|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
125176455|NCT04697069|450264455|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
125176456|NCT04697069|450264454|FG000|Overall Study|Study termination|2|||
125176457|NCT04697069|450264455|FG001|Overall Study|Study termination|1|||
125176458|NCT05180227|450264456|FG000|Overall Study|Hypertension at screening|1|||
125176459|NCT05180227|450264456|FG000|Overall Study|Lost to Follow-up|1|||
125176460|NCT04739800|450264457|FG000|Overall Study|Adverse Event|2|||
125176461|NCT04739800|450264458|FG001|Overall Study|Adverse Event|1|||
125176462|NCT04739800|450264459|FG002|Overall Study|Adverse Event|4|||
125176463|NCT04739800|450264460|FG003|Overall Study|Adverse Event|5|||
125176464|NCT04739800|450264457|FG000|Overall Study|Never Treated|2|||
125176465|NCT04739800|450264458|FG001|Overall Study|Never Treated|0|||
125176466|NCT04739800|450264459|FG002|Overall Study|Never Treated|1|||
125176467|NCT04739800|450264460|FG003|Overall Study|Never Treated|1|||
125176468|NCT04739800|450264457|FG000|Overall Study|On Treatment|5|||
125176469|NCT04739800|450264458|FG001|Overall Study|On Treatment|9|||
125176470|NCT04739800|450264459|FG002|Overall Study|On Treatment|9|||
125176471|NCT04739800|450264460|FG003|Overall Study|On Treatment|9|||
125176472|NCT04739800|450264457|FG000|Overall Study|Symptomatic Deterioration|1|||
125176473|NCT04739800|450264458|FG001|Overall Study|Symptomatic Deterioration|1|||
125176474|NCT04739800|450264459|FG002|Overall Study|Symptomatic Deterioration|3|||
125176475|NCT04739800|450264460|FG003|Overall Study|Symptomatic Deterioration|0|||
125176476|NCT04739800|450264457|FG000|Overall Study|Withdrawal by Subject|1|||
125176477|NCT04739800|450264458|FG001|Overall Study|Withdrawal by Subject|2|||
125176478|NCT04739800|450264459|FG002|Overall Study|Withdrawal by Subject|1|||
125176479|NCT04739800|450264460|FG003|Overall Study|Withdrawal by Subject|3|||
125176480|NCT04739800|450264457|FG000|Overall Study|Other Reason|1|||
125176481|NCT04739800|450264458|FG001|Overall Study|Other Reason|3|||
125176482|NCT04739800|450264459|FG002|Overall Study|Other Reason|5|||
125176483|NCT04739800|450264460|FG003|Overall Study|Other Reason|4|||
125176484|NCT02779855|450264461|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
125176485|NCT02779855|450264462|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
125176486|NCT02779855|450264463|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
125176487|NCT01070953|450264467|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
125176488|NCT01070953|450264467|FG000|Participants for Safety Evaluation|Off-label use|283|||
125176489|NCT01070953|450264467|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
125176490|NCT01070953|450264467|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
125176491|NCT01070953|450264467|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
125232190|NCT00784875|450479730|FG002|Period A - Baseline|Lost to Follow-up|0|||
125232191|NCT00784875|450479731|FG003|Period A - Baseline|Lost to Follow-up|2|||
125232192|NCT00784875|450479728|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
125232193|NCT00784875|450479729|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
125232194|NCT00784875|450479730|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
125232195|NCT00784875|450479731|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
125232196|NCT00784875|450479728|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
125232197|NCT00784875|450479729|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
125232198|NCT00784875|450479730|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
125232199|NCT00784875|450479731|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
125232200|NCT00784875|450479728|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
125232201|NCT00784875|450479729|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
125232202|NCT00784875|450479730|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
125232203|NCT00784875|450479731|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
125232204|NCT00784875|450479728|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
125232205|NCT00784875|450479729|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
125232206|NCT00784875|450479730|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
125232207|NCT00784875|450479731|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
125232208|NCT00784875|450479728|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
125176492|NCT01070953|450264467|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
125176493|NCT01070953|450264467|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
125176494|NCT01070953|450264467|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
125176495|NCT01070953|450264467|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
125176496|NCT01070953|450264467|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
125176497|NCT03514017|450264468|FG000|Overall Study|Death|1|||
125176498|NCT03514017|450264468|FG000|Overall Study|Adverse Event|1|||
125176499|NCT05192889|450264471|FG000|Block 1: All Eligible Patients|Death|2|||
125176500|NCT05192889|450264472|FG001|Block 1: All Eligible Patients|Death|0|||
125176501|NCT05192889|450264473|FG002|Block 1: All Eligible Patients|Death|0|||
125176502|NCT05192889|450264471|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
125176503|NCT05192889|450264472|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
125176504|NCT05192889|450264473|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
125176505|NCT05192889|450264471|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
125176506|NCT05192889|450264472|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
125176507|NCT05192889|450264473|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
125176508|NCT01290302|450265968|FG000|Overall Study|Adverse Event|2|||
125176509|NCT01290302|450265969|FG001|Overall Study|Adverse Event|0|||
125176510|NCT01290302|450265968|FG000|Overall Study|Withdrawal by Subject|1|||
125176511|NCT01290302|450265969|FG001|Overall Study|Withdrawal by Subject|0|||
125176512|NCT01290302|450265968|FG000|Overall Study|Physician Decision|0|||
125176513|NCT01290302|450265969|FG001|Overall Study|Physician Decision|2|||
125176514|NCT01290302|450265968|FG000|Overall Study|Expiration of time for screening window|1|||
125176515|NCT01290302|450265969|FG001|Overall Study|Expiration of time for screening window|0|||
125176516|NCT01059786|450265970|FG000|Overall Study|Did not receive 6 cycles.|0|||
125176517|NCT01059786|450265971|FG001|Overall Study|Did not receive 6 cycles.|0|||
125176518|NCT01059786|450265972|FG002|Overall Study|Did not receive 6 cycles.|4|||
125176519|NCT01059786|450265973|FG003|Overall Study|Did not receive 6 cycles.|1|||
125176520|NCT01059786|450265974|FG004|Overall Study|Did not receive 6 cycles.|0|||
125176521|NCT02454608|450265977|FG000|Double-Blind Period|Lack of Efficacy|0|||
125176522|NCT02454608|450265978|FG001|Double-Blind Period|Lack of Efficacy|2|||
125176523|NCT02454608|450265979|FG002|Double-Blind Period|Lack of Efficacy|0|||
125176524|NCT02454608|450265977|FG000|Open Label Period|Lost to Follow-up|0|||
125176525|NCT02454608|450265978|FG001|Open Label Period|Lost to Follow-up|0|||
125176526|NCT02454608|450265979|FG002|Open Label Period|Lost to Follow-up|11|||
125176527|NCT02454608|450265977|FG000|Open Label Period|Withdrawal by Subject|0|||
125232209|NCT00784875|450479729|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
125232210|NCT00784875|450479730|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
125232211|NCT00784875|450479731|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
125232212|NCT00784875|450479728|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
125232213|NCT00784875|450479729|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
125232214|NCT00784875|450479730|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
125232215|NCT00784875|450479731|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
125232216|NCT00784875|450479728|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
125176528|NCT02454608|450265978|FG001|Open Label Period|Withdrawal by Subject|0|||
125176529|NCT02454608|450265979|FG002|Open Label Period|Withdrawal by Subject|8|||
125232217|NCT00784875|450479729|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
125232218|NCT00784875|450479730|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
125232219|NCT00784875|450479731|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
125232220|NCT00784875|450479728|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
125232221|NCT00784875|450479729|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
125176530|NCT01769456|450265980|FG000|Overall Study|Lost to Follow-up|19|||
125176531|NCT01769456|450265980|FG000|Overall Study|Withdrawal by Subject|3|||
125176532|NCT01769456|450265980|FG000|Overall Study|Did not receive PCC intervention|6|||
125176533|NCT01769456|450265980|FG000|Overall Study|Moved out of the area|3|||
125176534|NCT01769456|450265980|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
125176535|NCT01769456|450265980|FG000|Overall Study|Parental request to youth to withdraw|1|||
125176536|NCT05490771|450265986|FG000|Overall Study|Disease progression|18|||
125176537|NCT05490771|450265986|FG000|Overall Study|Adverse Event|3|||
125176538|NCT05490771|450265986|FG000|Overall Study|Other complicating disease|1|||
125176539|NCT05490771|450265986|FG000|Overall Study|Withdrawal by Subject|3|||
125176540|NCT05490771|450265986|FG000|Overall Study|Physician Decision|1|||
125176541|NCT05490771|450265986|FG000|Overall Study|Still on treatment|2|||
125176542|NCT05490771|450265986|FG000|Overall Study|Never start protocol therapy|5|||
125176543|NCT05490771|450265986|FG000|Overall Study|Ineligible|2|||
125176544|NCT00661193|450265990|FG000|Overall Study|Adverse Event|2|||
125176545|NCT00661193|450265991|FG001|Overall Study|Adverse Event|1|||
125176546|NCT00661193|450265990|FG000|Overall Study|Withdrawal by Subject|3|||
125176547|NCT00661193|450265991|FG001|Overall Study|Withdrawal by Subject|1|||
125176548|NCT00661193|450265990|FG000|Overall Study|Progression|27|||
125176549|NCT00661193|450265991|FG001|Overall Study|Progression|24|||
125176550|NCT00661193|450265990|FG000|Overall Study|Not protocol specified|1|||
125176551|NCT00661193|450265991|FG001|Overall Study|Not protocol specified|0|||
125176552|NCT02862730|450265994|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
125176553|NCT02862730|450265995|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
125176554|NCT02862730|450265996|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
125176555|NCT02862730|450265997|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
125176556|NCT02862730|450265998|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
125176557|NCT02862730|450265999|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
125176558|NCT02862730|450266000|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
125176559|NCT02862730|450265994|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
125176560|NCT02862730|450265995|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
125176561|NCT02862730|450265996|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
125176562|NCT02862730|450265997|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
125176563|NCT02862730|450265998|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
125176564|NCT02862730|450265999|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
125176565|NCT02862730|450266000|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
125176566|NCT02862730|450265994|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
125176567|NCT02862730|450265995|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
125176568|NCT02862730|450265996|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
125176569|NCT02862730|450265997|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
125176570|NCT02862730|450265998|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
125176571|NCT02862730|450265999|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
125176572|NCT02862730|450266000|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
125176573|NCT02862730|450265994|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
125176574|NCT02862730|450265995|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
125176575|NCT02862730|450265996|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
125176576|NCT02862730|450265997|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
125176577|NCT02862730|450265998|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
125176578|NCT02862730|450265999|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
125176579|NCT02862730|450266000|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
125176580|NCT03685344|450266001|FG000|Overall Study|Withdrawal by Subject|1|||
125176581|NCT03685344|450266002|FG001|Overall Study|Withdrawal by Subject|1|||
125176582|NCT03685344|450266003|FG002|Overall Study|Withdrawal by Subject|2|||
125176583|NCT03685344|450266004|FG003|Overall Study|Withdrawal by Subject|0|||
125176584|NCT03685344|450266001|FG000|Overall Study|Physician Decision|1|||
125176585|NCT03685344|450266002|FG001|Overall Study|Physician Decision|1|||
125176586|NCT03685344|450266003|FG002|Overall Study|Physician Decision|5|||
125176587|NCT03685344|450266004|FG003|Overall Study|Physician Decision|0|||
125176588|NCT03685344|450266001|FG000|Overall Study|Death|1|||
125176589|NCT03685344|450266002|FG001|Overall Study|Death|1|||
125176590|NCT03685344|450266003|FG002|Overall Study|Death|0|||
125176591|NCT03685344|450266004|FG003|Overall Study|Death|0|||
125176592|NCT03126435|450266006|FG000|Overall Study|Death|90|||
125176593|NCT03126435|450266007|FG001|Overall Study|Death|84|||
125176594|NCT03126435|450266006|FG000|Overall Study|Lost to Follow-up|4|||
125176595|NCT03126435|450266007|FG001|Overall Study|Lost to Follow-up|3|||
125176596|NCT03126435|450266006|FG000|Overall Study|Physician Decision|0|||
125176597|NCT03126435|450266007|FG001|Overall Study|Physician Decision|1|||
125176598|NCT03126435|450266006|FG000|Overall Study|Withdrawal by Subject|6|||
125176599|NCT03126435|450266007|FG001|Overall Study|Withdrawal by Subject|12|||
125176600|NCT03126435|450266006|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
125176601|NCT03126435|450266007|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
125176602|NCT03971474|450266010|FG000|Overall Study|Adverse Event|11|||
125176603|NCT03971474|450266011|FG001|Overall Study|Adverse Event|7|||
125176604|NCT03971474|450266010|FG000|Overall Study|Refusal unrelated to adverse event|5|||
125176605|NCT03971474|450266011|FG001|Overall Study|Refusal unrelated to adverse event|1|||
125176606|NCT03971474|450266010|FG000|Overall Study|Progression/relapse|40|||
125176607|NCT03971474|450266011|FG001|Overall Study|Progression/relapse|47|||
125176608|NCT03971474|450266010|FG000|Overall Study|Death|6|||
125176609|NCT03971474|450266011|FG001|Overall Study|Death|3|||
125176610|NCT03971474|450266010|FG000|Overall Study|Other - not protocol specified|5|||
125176611|NCT03971474|450266011|FG001|Overall Study|Other - not protocol specified|4|||
125176612|NCT03971474|450266010|FG000|Overall Study|On treatment|0|||
125176613|NCT03971474|450266011|FG001|Overall Study|On treatment|7|||
125176614|NCT00261950|450266012|FG000|Overall Study|Lost to Follow-up|2|||
125176615|NCT00261950|450266012|FG000|Overall Study|Death|6|||
125176616|NCT00261950|450266012|FG000|Overall Study|Withdrawal by Subject|5|||
125176617|NCT00261950|450266012|FG000|Overall Study|Other|1|||
125176618|NCT00261950|450266012|FG000|Overall Study|Physician Decision|1|||
125176619|NCT00261950|450266012|FG000|Overall Study|Protocol specified Criteria|11|||
125176620|NCT01937871|450266019|FG000|Overall Study|Adverse Event|6|||
125176621|NCT01937871|450266020|FG001|Overall Study|Adverse Event|6|||
125176622|NCT01937871|450266021|FG002|Overall Study|Adverse Event|2|||
125176623|NCT01937871|450266019|FG000|Overall Study|Lost to Follow-up|8|||
125176624|NCT01937871|450266020|FG001|Overall Study|Lost to Follow-up|2|||
125176625|NCT01937871|450266021|FG002|Overall Study|Lost to Follow-up|4|||
125176626|NCT01937871|450266019|FG000|Overall Study|Withdrawal by Subject|9|||
125176627|NCT01937871|450266020|FG001|Overall Study|Withdrawal by Subject|6|||
125176628|NCT01937871|450266021|FG002|Overall Study|Withdrawal by Subject|4|||
125176629|NCT01937871|450266019|FG000|Overall Study|Physician Decision|0|||
125176630|NCT01937871|450266020|FG001|Overall Study|Physician Decision|1|||
125176631|NCT01937871|450266021|FG002|Overall Study|Physician Decision|0|||
125176632|NCT01937871|450266019|FG000|Overall Study|Entry Criteria Not Met|1|||
125176633|NCT01937871|450266020|FG001|Overall Study|Entry Criteria Not Met|2|||
125176634|NCT01937871|450266021|FG002|Overall Study|Entry Criteria Not Met|1|||
125176635|NCT00577863|450266028|FG000|Overall Study|Adverse Event|4|||
125176636|NCT00577863|450266029|FG001|Overall Study|Adverse Event|2|||
125176637|NCT00577863|450266028|FG000|Overall Study|Death|1|||
125176638|NCT00577863|450266029|FG001|Overall Study|Death|0|||
125176639|NCT00577863|450266028|FG000|Overall Study|Lost to Follow-up|2|||
125176640|NCT00577863|450266029|FG001|Overall Study|Lost to Follow-up|2|||
125176641|NCT00577863|450266028|FG000|Overall Study|Entry Criteria Exclusion|1|||
125176642|NCT00577863|450266029|FG001|Overall Study|Entry Criteria Exclusion|0|||
125176643|NCT00577863|450266028|FG000|Overall Study|Withdrawal by Subject|0|||
125176644|NCT00577863|450266029|FG001|Overall Study|Withdrawal by Subject|2|||
125176645|NCT00577863|450266028|FG000|Overall Study|Sponsor Decision|2|||
125176646|NCT00577863|450266029|FG001|Overall Study|Sponsor Decision|7|||
125176647|NCT00577863|450266028|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
125176648|NCT00577863|450266029|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
125176649|NCT03154125|450266030|FG000|Overall Study|Lost to Follow-up|11|||
125176650|NCT03154125|450266031|FG001|Overall Study|Lost to Follow-up|11|||
125176651|NCT03154125|450266032|FG002|Overall Study|Lost to Follow-up|0|||
125176652|NCT03154125|450266030|FG000|Overall Study|Withdrawal by Subject|49|||
125176653|NCT03154125|450266031|FG001|Overall Study|Withdrawal by Subject|55|||
125176654|NCT03154125|450266032|FG002|Overall Study|Withdrawal by Subject|8|||
125176655|NCT03154125|450266030|FG000|Overall Study|Physician Decision|13|||
125176656|NCT03154125|450266031|FG001|Overall Study|Physician Decision|6|||
125176657|NCT03154125|450266032|FG002|Overall Study|Physician Decision|0|||
125176658|NCT03154125|450266030|FG000|Overall Study|Protocol Violation|3|||
125176659|NCT03154125|450266031|FG001|Overall Study|Protocol Violation|5|||
125176660|NCT03154125|450266032|FG002|Overall Study|Protocol Violation|0|||
125232222|NCT00784875|450479730|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
125232223|NCT00784875|450479731|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
125232224|NCT00784875|450479728|FG000|Period C|Adverse Event|1|||
125232225|NCT00784875|450479729|FG001|Period C|Adverse Event|0|||
125232226|NCT00784875|450479730|FG002|Period C|Adverse Event|4|||
125232227|NCT00784875|450479731|FG003|Period C|Adverse Event|2|||
125176661|NCT05219448|450266033|FG000|Overall Study|Lost to Follow-up|9|||
125176662|NCT05219448|450266034|FG001|Overall Study|Lost to Follow-up|0|||
125176663|NCT02287922|450266035|FG000|Overall Study|Adverse Event|1|||
125176664|NCT02287922|450266036|FG001|Overall Study|Adverse Event|1|||
125176665|NCT02287922|450266037|FG002|Overall Study|Adverse Event|3|||
125176666|NCT02287922|450266038|FG003|Overall Study|Adverse Event|4|||
125176667|NCT02287922|450266035|FG000|Overall Study|Withdrawal by Subject|1|||
125176668|NCT02287922|450266036|FG001|Overall Study|Withdrawal by Subject|1|||
125176669|NCT02287922|450266037|FG002|Overall Study|Withdrawal by Subject|1|||
125176670|NCT02287922|450266038|FG003|Overall Study|Withdrawal by Subject|2|||
125176671|NCT02287922|450266035|FG000|Overall Study|Lost to Follow-up|0|||
125176672|NCT02287922|450266036|FG001|Overall Study|Lost to Follow-up|0|||
125176673|NCT02287922|450266037|FG002|Overall Study|Lost to Follow-up|1|||
125176674|NCT02287922|450266038|FG003|Overall Study|Lost to Follow-up|0|||
125176675|NCT02287922|450266035|FG000|Overall Study|Sponsor's decision|0|||
125176676|NCT02287922|450266036|FG001|Overall Study|Sponsor's decision|0|||
125232228|NCT00784875|450479728|FG000|Period C|Protocol Violation|0|||
125176677|NCT02287922|450266037|FG002|Overall Study|Sponsor's decision|0|||
125176678|NCT02287922|450266038|FG003|Overall Study|Sponsor's decision|1|||
125176679|NCT02287922|450266035|FG000|Overall Study|Other|1|||
125176680|NCT02287922|450266036|FG001|Overall Study|Other|0|||
125176681|NCT02287922|450266037|FG002|Overall Study|Other|2|||
125176682|NCT02287922|450266038|FG003|Overall Study|Other|0|||
125176683|NCT00668317|450266039|FG000|Overall Study|Adverse Event|2|||
125176684|NCT01814553|450266048|FG000|Overall Study|PD per clinical progression|6|||
125176685|NCT01814553|450266049|FG001|Overall Study|PD per clinical progression|8|||
125176686|NCT01814553|450266048|FG000|Overall Study|Other Adverse Event|4|||
125176687|NCT01814553|450266049|FG001|Overall Study|Other Adverse Event|5|||
125176688|NCT01814553|450266048|FG000|Overall Study|Withdrawal by Subject|1|||
125176689|NCT01814553|450266049|FG001|Overall Study|Withdrawal by Subject|1|||
125176690|NCT01814553|450266048|FG000|Overall Study|Other than stated|7|||
125176691|NCT01814553|450266049|FG001|Overall Study|Other than stated|8|||
125176692|NCT04138823|450266050|FG000|Overall Study|Clinical disease progression|0|||
125176693|NCT04138823|450266051|FG001|Overall Study|Clinical disease progression|0|||
125176694|NCT04138823|450266052|FG002|Overall Study|Clinical disease progression|1|||
125176695|NCT04138823|450266050|FG000|Overall Study|Objective disease progression|3|||
125176696|NCT04138823|450266051|FG001|Overall Study|Objective disease progression|2|||
125176697|NCT04138823|450266052|FG002|Overall Study|Objective disease progression|5|||
125176698|NCT04868500|450266053|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
125176699|NCT04868500|450266054|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
125176700|NCT04868500|450266053|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
125176701|NCT04868500|450266054|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
125176702|NCT03340974|450266055|FG000|Completion of Study -Long Term Follow up|Death|8|||
125176703|NCT03340974|450266056|FG001|Completion of Study -Long Term Follow up|Death|5|||
125176704|NCT03340974|450266057|FG002|Completion of Study -Long Term Follow up|Death|5|||
125176705|NCT03340974|450266058|FG003|Completion of Study -Long Term Follow up|Death|7|||
125176706|NCT03340974|450266055|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
125176707|NCT03340974|450266056|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
125176708|NCT03340974|450266057|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
125176709|NCT03340974|450266058|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
125176710|NCT03340974|450266055|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
125176711|NCT03340974|450266056|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
125176712|NCT03340974|450266057|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
125176713|NCT03340974|450266058|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
125176714|NCT03340974|450266055|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
125176715|NCT03340974|450266056|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
125176716|NCT03340974|450266057|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
125176717|NCT03340974|450266058|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
125176718|NCT02676765|450266059|FG000|Overall Study|Lost to Follow-up|0|||
125176719|NCT02676765|450266060|FG001|Overall Study|Lost to Follow-up|1|||
125176720|NCT05299528|450266069|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
125176721|NCT05299528|450266070|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
125176722|NCT05299528|450266071|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
125176723|NCT05299528|450266072|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
125176724|NCT05299528|450266073|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
125176725|NCT05299528|450266074|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
125176726|NCT05299528|450266075|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
125176727|NCT05299528|450266069|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
125176728|NCT05299528|450266070|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
125176729|NCT05299528|450266071|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
125176730|NCT05299528|450266072|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
125176731|NCT05299528|450266073|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
125176732|NCT05299528|450266074|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
125176733|NCT05299528|450266075|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
125176734|NCT05299528|450266069|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
125176735|NCT05299528|450266070|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
125176736|NCT05299528|450266071|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
125176737|NCT05299528|450266072|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
125176738|NCT05299528|450266073|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
125176739|NCT05299528|450266074|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
125176740|NCT05299528|450266075|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
125176741|NCT02445963|450266080|FG000|Overall Study|Lost to Follow-up|1|||
125176742|NCT02445963|450266081|FG001|Overall Study|Lost to Follow-up|0|||
125176743|NCT02445963|450266082|FG002|Overall Study|Lost to Follow-up|0|||
125176744|NCT02445963|450266083|FG003|Overall Study|Lost to Follow-up|0|||
125176745|NCT02445963|450266080|FG000|Overall Study|Change in employment|1|||
125176746|NCT02445963|450266081|FG001|Overall Study|Change in employment|0|||
125176747|NCT02445963|450266082|FG002|Overall Study|Change in employment|0|||
125176748|NCT02445963|450266083|FG003|Overall Study|Change in employment|0|||
125176749|NCT02445963|450266080|FG000|Overall Study|Symptoms post-vaccination|0|||
125176750|NCT02445963|450266081|FG001|Overall Study|Symptoms post-vaccination|0|||
125176751|NCT02445963|450266082|FG002|Overall Study|Symptoms post-vaccination|1|||
125176752|NCT02445963|450266083|FG003|Overall Study|Symptoms post-vaccination|0|||
125176753|NCT01957176|450266084|FG000|Overall Study|Adverse Event|2|||
125176754|NCT01957176|450266085|FG001|Overall Study|Adverse Event|0|||
125176755|NCT01957176|450266084|FG000|Overall Study|Physician Decision|2|||
125176756|NCT01957176|450266085|FG001|Overall Study|Physician Decision|1|||
125176757|NCT01957176|450266084|FG000|Overall Study|Withdrawal by Subject|1|||
125176758|NCT01957176|450266085|FG001|Overall Study|Withdrawal by Subject|0|||
125176759|NCT02359994|450266088|FG000|Overall Population Study|Adverse Event|1|||
125176760|NCT02359994|450266089|FG001|Overall Population Study|Adverse Event|1|||
125176761|NCT02359994|450266088|FG000|Overall Population Study|Death|1|||
125176762|NCT02359994|450266089|FG001|Overall Population Study|Death|5|||
125176763|NCT02359994|450266088|FG000|Overall Population Study|Lost to Follow-up|1|||
125176764|NCT02359994|450266089|FG001|Overall Population Study|Lost to Follow-up|1|||
125176765|NCT02359994|450266088|FG000|Overall Population Study|Withdrawal by Subject|1|||
125176766|NCT02359994|450266089|FG001|Overall Population Study|Withdrawal by Subject|0|||
125176767|NCT02359994|450266088|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
125176768|NCT02359994|450266089|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
125176769|NCT02359994|450266088|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
125176770|NCT02359994|450266089|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
125176771|NCT02359994|450266088|FG000|Extended Oncology 24-Month Survival|Death|19|||
125176772|NCT02359994|450266089|FG001|Extended Oncology 24-Month Survival|Death|21|||
125176773|NCT02359994|450266088|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
125176774|NCT02359994|450266089|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
125176775|NCT04597632|450266090|FG000|Overall Study|Withdrawal by Subject|10|||
125176776|NCT04597632|450266090|FG000|Overall Study|Lost to Follow-up|1|||
125176777|NCT04597632|450266090|FG000|Overall Study|Death|1|||
125176778|NCT04597632|450266090|FG000|Overall Study|Adverse Event|5|||
125176779|NCT01823835|450266091|FG000|Overall Study|Adverse Event|0|||
125176780|NCT01823835|450266092|FG001|Overall Study|Adverse Event|0|||
125176781|NCT01823835|450266093|FG002|Overall Study|Adverse Event|0|||
125176782|NCT01823835|450266094|FG003|Overall Study|Adverse Event|0|||
125176783|NCT01823835|450266095|FG004|Overall Study|Adverse Event|1|||
125176784|NCT01823835|450266096|FG005|Overall Study|Adverse Event|0|||
125176785|NCT01823835|450266097|FG006|Overall Study|Adverse Event|1|||
125176786|NCT01823835|450266098|FG007|Overall Study|Adverse Event|0|||
125176787|NCT01823835|450266099|FG008|Overall Study|Adverse Event|0|||
125176788|NCT01823835|450266100|FG009|Overall Study|Adverse Event|0|||
125176789|NCT01823835|450266101|FG010|Overall Study|Adverse Event|1|||
125176790|NCT01823835|450266102|FG011|Overall Study|Adverse Event|2|||
125176791|NCT01823835|450266103|FG012|Overall Study|Adverse Event|0|||
125176792|NCT01823835|450266104|FG013|Overall Study|Adverse Event|0|||
125176793|NCT01823835|450266105|FG014|Overall Study|Adverse Event|0|||
125176794|NCT01823835|450266091|FG000|Overall Study|Physician Decision|0|||
125176795|NCT01823835|450266092|FG001|Overall Study|Physician Decision|0|||
125176796|NCT01823835|450266093|FG002|Overall Study|Physician Decision|0|||
125176797|NCT01823835|450266094|FG003|Overall Study|Physician Decision|0|||
125176798|NCT01823835|450266095|FG004|Overall Study|Physician Decision|0|||
125176799|NCT01823835|450266096|FG005|Overall Study|Physician Decision|0|||
125176800|NCT01823835|450266097|FG006|Overall Study|Physician Decision|0|||
125176801|NCT01823835|450266098|FG007|Overall Study|Physician Decision|0|||
125176802|NCT01823835|450266099|FG008|Overall Study|Physician Decision|0|||
125176803|NCT01823835|450266100|FG009|Overall Study|Physician Decision|0|||
125176804|NCT01823835|450266101|FG010|Overall Study|Physician Decision|0|||
125176805|NCT01823835|450266102|FG011|Overall Study|Physician Decision|2|||
125176806|NCT01823835|450266103|FG012|Overall Study|Physician Decision|0|||
125176807|NCT01823835|450266104|FG013|Overall Study|Physician Decision|0|||
125232229|NCT00784875|450479729|FG001|Period C|Protocol Violation|0|||
125232230|NCT00784875|450479730|FG002|Period C|Protocol Violation|1|||
125232231|NCT00784875|450479731|FG003|Period C|Protocol Violation|2|||
125232232|NCT00784875|450479728|FG000|Period C|Lack of Efficacy|0|||
125232233|NCT00784875|450479729|FG001|Period C|Lack of Efficacy|0|||
125232234|NCT00784875|450479730|FG002|Period C|Lack of Efficacy|1|||
125232235|NCT00784875|450479731|FG003|Period C|Lack of Efficacy|0|||
125232236|NCT00784875|450479728|FG000|Period C|Withdrawal by Subject|1|||
125232237|NCT00784875|450479729|FG001|Period C|Withdrawal by Subject|1|||
125232238|NCT00784875|450479730|FG002|Period C|Withdrawal by Subject|2|||
125232239|NCT00784875|450479731|FG003|Period C|Withdrawal by Subject|0|||
125232240|NCT00784875|450479728|FG000|Period C|Physician Decision|0|||
125232241|NCT00784875|450479729|FG001|Period C|Physician Decision|0|||
125232242|NCT00784875|450479730|FG002|Period C|Physician Decision|1|||
125232243|NCT00784875|450479731|FG003|Period C|Physician Decision|1|||
125232244|NCT00784875|450479728|FG000|Period C|Sponsor Decision|5|||
125232245|NCT00784875|450479729|FG001|Period C|Sponsor Decision|5|||
125232246|NCT00784875|450479730|FG002|Period C|Sponsor Decision|4|||
125232247|NCT00784875|450479731|FG003|Period C|Sponsor Decision|2|||
125232248|NCT00784875|450479728|FG000|Period D|Adverse Event|0|||
125232249|NCT00784875|450479729|FG001|Period D|Adverse Event|2|||
125232250|NCT00784875|450479730|FG002|Period D|Adverse Event|2|||
125232251|NCT00784875|450479731|FG003|Period D|Adverse Event|0|||
125232252|NCT00784875|450479728|FG000|Period D|Protocol Violation|1|||
125232253|NCT00784875|450479729|FG001|Period D|Protocol Violation|0|||
125232254|NCT00784875|450479730|FG002|Period D|Protocol Violation|0|||
125232255|NCT00784875|450479731|FG003|Period D|Protocol Violation|0|||
125232256|NCT00784875|450479728|FG000|Period D|Withdrawal by Subject|2|||
125232257|NCT00784875|450479729|FG001|Period D|Withdrawal by Subject|0|||
125232258|NCT00784875|450479730|FG002|Period D|Withdrawal by Subject|2|||
125232259|NCT00784875|450479731|FG003|Period D|Withdrawal by Subject|0|||
125232260|NCT00784875|450479728|FG000|Period D|Physician Decision|0|||
125232261|NCT00784875|450479729|FG001|Period D|Physician Decision|1|||
125232262|NCT00784875|450479730|FG002|Period D|Physician Decision|0|||
125232263|NCT00784875|450479731|FG003|Period D|Physician Decision|0|||
125232264|NCT00784875|450479728|FG000|Period D|Sponsor Decision|1|||
125232265|NCT00784875|450479729|FG001|Period D|Sponsor Decision|1|||
125232266|NCT00784875|450479730|FG002|Period D|Sponsor Decision|1|||
125232267|NCT00784875|450479731|FG003|Period D|Sponsor Decision|0|||
125232268|NCT00784875|450479728|FG000|Period D|Lost to Follow-up|1|||
125232269|NCT00784875|450479729|FG001|Period D|Lost to Follow-up|0|||
125232270|NCT00784875|450479730|FG002|Period D|Lost to Follow-up|1|||
125232271|NCT00784875|450479731|FG003|Period D|Lost to Follow-up|1|||
125176808|NCT01823835|450266105|FG014|Overall Study|Physician Decision|0|||
125176809|NCT01823835|450266091|FG000|Overall Study|Progressive Disease|3|||
125176810|NCT01823835|450266092|FG001|Overall Study|Progressive Disease|4|||
125176811|NCT01823835|450266093|FG002|Overall Study|Progressive Disease|3|||
125176812|NCT01823835|450266094|FG003|Overall Study|Progressive Disease|6|||
125176813|NCT01823835|450266095|FG004|Overall Study|Progressive Disease|4|||
125176814|NCT01823835|450266096|FG005|Overall Study|Progressive Disease|6|||
125176815|NCT01823835|450266097|FG006|Overall Study|Progressive Disease|5|||
125176816|NCT01823835|450266098|FG007|Overall Study|Progressive Disease|3|||
125176817|NCT01823835|450266099|FG008|Overall Study|Progressive Disease|3|||
125176818|NCT01823835|450266100|FG009|Overall Study|Progressive Disease|18|||
125176819|NCT01823835|450266101|FG010|Overall Study|Progressive Disease|8|||
125176820|NCT01823835|450266102|FG011|Overall Study|Progressive Disease|46|||
125176821|NCT01823835|450266103|FG012|Overall Study|Progressive Disease|18|||
125176822|NCT01823835|450266104|FG013|Overall Study|Progressive Disease|4|||
125176823|NCT01823835|450266105|FG014|Overall Study|Progressive Disease|6|||
125176824|NCT01823835|450266091|FG000|Overall Study|Study Termination|0|||
125176825|NCT01823835|450266092|FG001|Overall Study|Study Termination|0|||
125176826|NCT01823835|450266093|FG002|Overall Study|Study Termination|0|||
125176827|NCT01823835|450266094|FG003|Overall Study|Study Termination|0|||
125176828|NCT01823835|450266095|FG004|Overall Study|Study Termination|1|||
125232272|NCT02842866|450479732|FG000|Overall Study|Serious Adverse Event|0|||
125232273|NCT02842866|450479733|FG001|Overall Study|Serious Adverse Event|1|||
125232274|NCT02842866|450479732|FG000|Overall Study|Protocol Violation|4|||
125232275|NCT02842866|450479733|FG001|Overall Study|Protocol Violation|2|||
125232276|NCT02842866|450479732|FG000|Overall Study|Lost to Follow-up|2|||
125232277|NCT02842866|450479733|FG001|Overall Study|Lost to Follow-up|0|||
125232278|NCT02842866|450479732|FG000|Overall Study|Withdrawal by Subject|1|||
125232279|NCT02842866|450479733|FG001|Overall Study|Withdrawal by Subject|0|||
125232280|NCT02897349|450479738|FG000|Overall Study|Lost to Follow-up|2|||
125232281|NCT02897349|450479739|FG001|Overall Study|Lost to Follow-up|2|||
125232282|NCT02897349|450479738|FG000|Overall Study|Adverse Event|3|||
125232283|NCT02897349|450479739|FG001|Overall Study|Adverse Event|3|||
125176829|NCT01823835|450266096|FG005|Overall Study|Study Termination|0|||
125176830|NCT01823835|450266097|FG006|Overall Study|Study Termination|0|||
125176831|NCT01823835|450266098|FG007|Overall Study|Study Termination|0|||
125176832|NCT01823835|450266099|FG008|Overall Study|Study Termination|0|||
125176833|NCT01823835|450266100|FG009|Overall Study|Study Termination|0|||
125176834|NCT01823835|450266101|FG010|Overall Study|Study Termination|0|||
125176835|NCT01823835|450266102|FG011|Overall Study|Study Termination|1|||
125176836|NCT01823835|450266103|FG012|Overall Study|Study Termination|0|||
125176837|NCT01823835|450266104|FG013|Overall Study|Study Termination|0|||
125176838|NCT01823835|450266105|FG014|Overall Study|Study Termination|0|||
125176839|NCT01823835|450266091|FG000|Overall Study|Withdrawal by Subject|0|||
125176840|NCT01823835|450266092|FG001|Overall Study|Withdrawal by Subject|0|||
125176841|NCT01823835|450266093|FG002|Overall Study|Withdrawal by Subject|1|||
125176842|NCT01823835|450266094|FG003|Overall Study|Withdrawal by Subject|0|||
125176843|NCT01823835|450266095|FG004|Overall Study|Withdrawal by Subject|0|||
125176844|NCT01823835|450266096|FG005|Overall Study|Withdrawal by Subject|0|||
125176845|NCT01823835|450266097|FG006|Overall Study|Withdrawal by Subject|0|||
125176846|NCT01823835|450266098|FG007|Overall Study|Withdrawal by Subject|0|||
125176847|NCT01823835|450266099|FG008|Overall Study|Withdrawal by Subject|0|||
125176848|NCT01823835|450266100|FG009|Overall Study|Withdrawal by Subject|1|||
125176849|NCT01823835|450266101|FG010|Overall Study|Withdrawal by Subject|1|||
125176850|NCT01823835|450266102|FG011|Overall Study|Withdrawal by Subject|2|||
125176851|NCT01823835|450266103|FG012|Overall Study|Withdrawal by Subject|1|||
125176852|NCT01823835|450266104|FG013|Overall Study|Withdrawal by Subject|0|||
125176853|NCT01823835|450266105|FG014|Overall Study|Withdrawal by Subject|0|||
125176854|NCT03017612|450266106|FG000|Overall Study|Adverse Event|2|||
125176855|NCT04895982|450266107|FG000|Overall Study|Withdrawal by Subject|0|||
125176856|NCT04895982|450266108|FG001|Overall Study|Withdrawal by Subject|0|||
125176857|NCT04895982|450266109|FG002|Overall Study|Withdrawal by Subject|0|||
125176858|NCT04895982|450266110|FG003|Overall Study|Withdrawal by Subject|0|||
125176859|NCT04895982|450266111|FG004|Overall Study|Withdrawal by Subject|0|||
125176860|NCT04895982|450266112|FG005|Overall Study|Withdrawal by Subject|1|||
125176861|NCT04895982|450266113|FG006|Overall Study|Withdrawal by Subject|1|||
125176862|NCT04895982|450266114|FG007|Overall Study|Withdrawal by Subject|0|||
125176863|NCT04895982|450266115|FG008|Overall Study|Withdrawal by Subject|0|||
125176864|NCT04895982|450266116|FG009|Overall Study|Withdrawal by Subject|1|||
125176865|NCT04895982|450266117|FG010|Overall Study|Withdrawal by Subject|0|||
125176866|NCT04895982|450266118|FG011|Overall Study|Withdrawal by Subject|1|||
125176867|NCT04895982|450266107|FG000|Overall Study|Withdrawal by parent/guardian|2|||
125176868|NCT04895982|450266108|FG001|Overall Study|Withdrawal by parent/guardian|3|||
125176869|NCT04895982|450266109|FG002|Overall Study|Withdrawal by parent/guardian|3|||
125176870|NCT04895982|450266110|FG003|Overall Study|Withdrawal by parent/guardian|1|||
125176871|NCT04895982|450266111|FG004|Overall Study|Withdrawal by parent/guardian|3|||
125176872|NCT04895982|450266112|FG005|Overall Study|Withdrawal by parent/guardian|2|||
125176873|NCT04895982|450266113|FG006|Overall Study|Withdrawal by parent/guardian|1|||
125176874|NCT04895982|450266114|FG007|Overall Study|Withdrawal by parent/guardian|0|||
125176875|NCT04895982|450266115|FG008|Overall Study|Withdrawal by parent/guardian|3|||
125176876|NCT04895982|450266116|FG009|Overall Study|Withdrawal by parent/guardian|0|||
125176877|NCT04895982|450266117|FG010|Overall Study|Withdrawal by parent/guardian|0|||
125176878|NCT04895982|450266118|FG011|Overall Study|Withdrawal by parent/guardian|0|||
125176879|NCT04895982|450266107|FG000|Overall Study|Other|0|||
125176880|NCT04895982|450266108|FG001|Overall Study|Other|0|||
125176881|NCT04895982|450266109|FG002|Overall Study|Other|1|||
125176882|NCT04895982|450266110|FG003|Overall Study|Other|1|||
125176883|NCT04895982|450266111|FG004|Overall Study|Other|0|||
125176884|NCT04895982|450266112|FG005|Overall Study|Other|0|||
125176885|NCT04895982|450266113|FG006|Overall Study|Other|0|||
125176886|NCT04895982|450266114|FG007|Overall Study|Other|0|||
125176887|NCT04895982|450266115|FG008|Overall Study|Other|0|||
125176888|NCT04895982|450266116|FG009|Overall Study|Other|1|||
125176889|NCT04895982|450266117|FG010|Overall Study|Other|0|||
125176890|NCT04895982|450266118|FG011|Overall Study|Other|0|||
125176891|NCT04895982|450266107|FG000|Overall Study|Protocol Violation|0|||
125176892|NCT04895982|450266108|FG001|Overall Study|Protocol Violation|0|||
125176893|NCT04895982|450266109|FG002|Overall Study|Protocol Violation|1|||
125176894|NCT04895982|450266110|FG003|Overall Study|Protocol Violation|1|||
125176895|NCT04895982|450266111|FG004|Overall Study|Protocol Violation|1|||
125232284|NCT02897349|450479738|FG000|Overall Study|Other than listed above|0|||
125176896|NCT04895982|450266112|FG005|Overall Study|Protocol Violation|0|||
125176897|NCT04895982|450266113|FG006|Overall Study|Protocol Violation|0|||
125176898|NCT04895982|450266114|FG007|Overall Study|Protocol Violation|1|||
125176899|NCT04895982|450266115|FG008|Overall Study|Protocol Violation|0|||
125176900|NCT04895982|450266116|FG009|Overall Study|Protocol Violation|0|||
125176901|NCT04895982|450266117|FG010|Overall Study|Protocol Violation|0|||
125176902|NCT04895982|450266118|FG011|Overall Study|Protocol Violation|0|||
125176903|NCT04895982|450266107|FG000|Overall Study|Lost to Follow-up|0|||
125176904|NCT04895982|450266108|FG001|Overall Study|Lost to Follow-up|0|||
125176905|NCT04895982|450266109|FG002|Overall Study|Lost to Follow-up|1|||
125176906|NCT04895982|450266110|FG003|Overall Study|Lost to Follow-up|0|||
125176907|NCT04895982|450266111|FG004|Overall Study|Lost to Follow-up|0|||
125176908|NCT04895982|450266112|FG005|Overall Study|Lost to Follow-up|1|||
125176909|NCT04895982|450266113|FG006|Overall Study|Lost to Follow-up|0|||
125176910|NCT04895982|450266114|FG007|Overall Study|Lost to Follow-up|0|||
125176911|NCT04895982|450266115|FG008|Overall Study|Lost to Follow-up|1|||
125176912|NCT04895982|450266116|FG009|Overall Study|Lost to Follow-up|0|||
125176913|NCT04895982|450266117|FG010|Overall Study|Lost to Follow-up|0|||
125176914|NCT04895982|450266118|FG011|Overall Study|Lost to Follow-up|0|||
125176915|NCT04895982|450266107|FG000|Overall Study|Refused further study procedures|0|||
125176916|NCT04895982|450266108|FG001|Overall Study|Refused further study procedures|0|||
125176917|NCT04895982|450266109|FG002|Overall Study|Refused further study procedures|1|||
125176918|NCT04895982|450266110|FG003|Overall Study|Refused further study procedures|0|||
125176919|NCT04895982|450266111|FG004|Overall Study|Refused further study procedures|0|||
125176920|NCT04895982|450266112|FG005|Overall Study|Refused further study procedures|0|||
125176921|NCT04895982|450266113|FG006|Overall Study|Refused further study procedures|0|||
125176922|NCT04895982|450266114|FG007|Overall Study|Refused further study procedures|0|||
125176923|NCT04895982|450266115|FG008|Overall Study|Refused further study procedures|0|||
125176924|NCT04895982|450266116|FG009|Overall Study|Refused further study procedures|0|||
125176925|NCT04895982|450266117|FG010|Overall Study|Refused further study procedures|0|||
125176926|NCT04895982|450266118|FG011|Overall Study|Refused further study procedures|0|||
125176927|NCT01893346|450266119|FG000|Overall Study|Lost to Follow-up|0|||
125176928|NCT01893346|450266120|FG001|Overall Study|Lost to Follow-up|1|||
125176929|NCT01893346|450266121|FG002|Overall Study|Lost to Follow-up|0|||
125176930|NCT01893346|450266122|FG003|Overall Study|Lost to Follow-up|0|||
125176931|NCT01893346|450266119|FG000|Overall Study|Protocol Violation|1|||
125176932|NCT01893346|450266120|FG001|Overall Study|Protocol Violation|0|||
125176933|NCT01893346|450266121|FG002|Overall Study|Protocol Violation|0|||
125176934|NCT01893346|450266122|FG003|Overall Study|Protocol Violation|0|||
125176935|NCT01893346|450266119|FG000|Overall Study|Withdrawal by Subject|2|||
125176936|NCT01893346|450266120|FG001|Overall Study|Withdrawal by Subject|0|||
125176937|NCT01893346|450266121|FG002|Overall Study|Withdrawal by Subject|0|||
125176938|NCT01893346|450266122|FG003|Overall Study|Withdrawal by Subject|0|||
125176939|NCT01449812|450266125|FG000|Overall Study|Migrated/moved from study area|1|||
125176940|NCT01449812|450266126|FG001|Overall Study|Migrated/moved from study area|0|||
125176941|NCT01449812|450266127|FG002|Overall Study|Migrated/moved from study area|0|||
125176942|NCT01449812|450266125|FG000|Overall Study|Withdrawal by Subject|0|||
125176943|NCT01449812|450266126|FG001|Overall Study|Withdrawal by Subject|0|||
125176944|NCT01449812|450266127|FG002|Overall Study|Withdrawal by Subject|1|||
125176945|NCT01449812|450266125|FG000|Overall Study|Lost to Follow-up|1|||
125176946|NCT01449812|450266126|FG001|Overall Study|Lost to Follow-up|0|||
125176947|NCT01449812|450266127|FG002|Overall Study|Lost to Follow-up|0|||
125176948|NCT01866098|450266128|FG000|Overall Study|Lost to Follow-up|11|||
125176949|NCT01866098|450266129|FG001|Overall Study|Lost to Follow-up|18|||
125176950|NCT01866098|450266130|FG002|Overall Study|Lost to Follow-up|13|||
125176951|NCT01866098|450266128|FG000|Overall Study|Physician Decision|0|||
125176952|NCT01866098|450266129|FG001|Overall Study|Physician Decision|1|||
125176953|NCT01866098|450266130|FG002|Overall Study|Physician Decision|2|||
125176954|NCT01866098|450266128|FG000|Overall Study|Adverse Event|1|||
125176955|NCT01866098|450266129|FG001|Overall Study|Adverse Event|5|||
125176956|NCT01866098|450266130|FG002|Overall Study|Adverse Event|4|||
125176957|NCT01866098|450266128|FG000|Overall Study|Protocol Violation|1|||
125176958|NCT01866098|450266129|FG001|Overall Study|Protocol Violation|0|||
125176959|NCT01866098|450266130|FG002|Overall Study|Protocol Violation|0|||
125176960|NCT01866098|450266128|FG000|Overall Study|Withdrawal by Subject|1|||
125176961|NCT01866098|450266129|FG001|Overall Study|Withdrawal by Subject|2|||
125176962|NCT01866098|450266130|FG002|Overall Study|Withdrawal by Subject|0|||
125176963|NCT01866098|450266128|FG000|Overall Study|Unrelated Hospitalization|2|||
125176964|NCT01866098|450266129|FG001|Overall Study|Unrelated Hospitalization|0|||
125176965|NCT01866098|450266130|FG002|Overall Study|Unrelated Hospitalization|1|||
125176966|NCT01866098|450266128|FG000|Overall Study|Non-compliance|1|||
125176967|NCT01866098|450266129|FG001|Overall Study|Non-compliance|0|||
125176968|NCT01866098|450266130|FG002|Overall Study|Non-compliance|1|||
125176969|NCT01866098|450266128|FG000|Overall Study|Pregnancy|2|||
125176970|NCT01866098|450266129|FG001|Overall Study|Pregnancy|0|||
125176971|NCT01866098|450266130|FG002|Overall Study|Pregnancy|0|||
125176972|NCT01866098|450266128|FG000|Overall Study|Death|0|||
125176973|NCT01866098|450266129|FG001|Overall Study|Death|1|||
125176974|NCT01866098|450266130|FG002|Overall Study|Death|0|||
125176975|NCT04239027|450266131|FG000|Overall Study|Adverse Event|4|||
125176976|NCT04239027|450266131|FG000|Overall Study|Withdrawal by Subject|9|||
125176977|NCT04239027|450266131|FG000|Overall Study|Death|1|||
125176978|NCT04239027|450266131|FG000|Overall Study|Physician Decision|9|||
125176979|NCT04239027|450266131|FG000|Overall Study|Lost to Follow-up|2|||
125176980|NCT04239027|450266131|FG000|Overall Study|Lack of Efficacy|1|||
125176981|NCT03449446|450266132|FG000|Overall Study|Randomized but Never Treated|0|||
125176982|NCT03449446|450266133|FG001|Overall Study|Randomized but Never Treated|0|||
125176983|NCT03449446|450266134|FG002|Overall Study|Randomized but Never Treated|1|||
125232285|NCT02897349|450479739|FG001|Overall Study|Other than listed above|1|||
125232286|NCT01027949|450479745|FG000|Overall Study|Death|174|||
125232287|NCT01027949|450479745|FG000|Overall Study|Progressive Disease|163|||
125232288|NCT01027949|450479745|FG000|Overall Study|Adverse Event|172|||
125232289|NCT01027949|450479745|FG000|Overall Study|Withdrawal by Subject|113|||
125232290|NCT01027949|450479745|FG000|Overall Study|Lost to Follow-up|17|||
125232291|NCT01027949|450479745|FG000|Overall Study|Protocol Violation|13|||
125232292|NCT01027949|450479745|FG000|Overall Study|PI Decision|8|||
125232293|NCT01027949|450479745|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
125232294|NCT01027949|450479745|FG000|Overall Study|Non-compliance with Study Procedures|7|||
125232295|NCT01027949|450479745|FG000|Overall Study|Lung Transplant|5|||
125232296|NCT01027949|450479745|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
125232297|NCT01027949|450479745|FG000|Overall Study|Use of Excluded Medication|2|||
125232298|NCT01027949|450479745|FG000|Overall Study|Patient Self-discontinuation|1|||
125232299|NCT01027949|450479745|FG000|Overall Study|Pregnancy|1|||
125232300|NCT01027949|450479745|FG000|Overall Study|Surgery|1|||
125232301|NCT00671749|450479748|FG000|Overall Study|Adverse Event|2|||
125232302|NCT00671749|450479748|FG000|Overall Study|Withdrawal by Subject|4|||
125232303|NCT00671749|450479748|FG000|Overall Study|Protocol Violation|1|||
125232304|NCT00671749|450479748|FG000|Overall Study|Lost to Follow-up|1|||
125232305|NCT02515227|450479749|FG000|Overall Study|Adverse Event|0|||
125232306|NCT02515227|450479750|FG001|Overall Study|Adverse Event|2|||
125232307|NCT02515227|450479749|FG000|Overall Study|Progressive disease|2|||
125232308|NCT02515227|450479750|FG001|Overall Study|Progressive disease|9|||
125232309|NCT03451071|450479751|FG000|First Vaccine|Withdrawal by Subject|1|||
125232310|NCT03451071|450479751|FG000|Second Vaccine|Lost to Follow-up|19|||
125232311|NCT03451071|450479751|FG000|Third Vaccine|Lost to Follow-up|22|||
125232312|NCT03451071|450479751|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
125232313|NCT01901185|450479752|FG000|Overall Study|Withdrawal by Subject|2|||
125232314|NCT03502798|450479753|FG000|Overall Study|equipment failure|0|||
125232315|NCT03502798|450479754|FG001|Overall Study|equipment failure|7|||
125232316|NCT00296335|450479755|FG000|Overall Study|Recurrence|3|||
125232317|NCT00296335|450479756|FG001|Overall Study|Recurrence|51|||
125232318|NCT00296335|450479755|FG000|Overall Study|Adverse Event|17|||
125232319|NCT00296335|450479756|FG001|Overall Study|Adverse Event|27|||
125176984|NCT03449446|450266135|FG003|Overall Study|Randomized but Never Treated|1|||
125176985|NCT03449446|450266136|FG004|Overall Study|Randomized but Never Treated|1|||
125176986|NCT03449446|450266137|FG005|Overall Study|Randomized but Never Treated|0|||
125176987|NCT03449446|450266138|FG006|Overall Study|Randomized but Never Treated|0|||
125176988|NCT03449446|450266132|FG000|Overall Study|Unknown Reason|33|||
125176989|NCT03449446|450266133|FG001|Overall Study|Unknown Reason|1|||
125176990|NCT03449446|450266134|FG002|Overall Study|Unknown Reason|1|||
125176991|NCT03449446|450266135|FG003|Overall Study|Unknown Reason|1|||
125176992|NCT03449446|450266136|FG004|Overall Study|Unknown Reason|2|||
125176993|NCT03449446|450266137|FG005|Overall Study|Unknown Reason|2|||
125176994|NCT03449446|450266138|FG006|Overall Study|Unknown Reason|0|||
125176995|NCT03449446|450266132|FG000|Overall Study|Withdrew Consent|1|||
125176996|NCT03449446|450266133|FG001|Overall Study|Withdrew Consent|3|||
125176997|NCT03449446|450266134|FG002|Overall Study|Withdrew Consent|1|||
125176998|NCT03449446|450266135|FG003|Overall Study|Withdrew Consent|4|||
125176999|NCT03449446|450266136|FG004|Overall Study|Withdrew Consent|4|||
125177000|NCT03449446|450266137|FG005|Overall Study|Withdrew Consent|4|||
125177001|NCT03449446|450266138|FG006|Overall Study|Withdrew Consent|1|||
125177002|NCT03449446|450266132|FG000|Overall Study|Adverse Event|1|||
125177003|NCT03449446|450266133|FG001|Overall Study|Adverse Event|2|||
125177004|NCT03449446|450266134|FG002|Overall Study|Adverse Event|1|||
125177005|NCT03449446|450266135|FG003|Overall Study|Adverse Event|0|||
125177006|NCT03449446|450266136|FG004|Overall Study|Adverse Event|0|||
125177007|NCT03449446|450266137|FG005|Overall Study|Adverse Event|2|||
125177008|NCT03449446|450266138|FG006|Overall Study|Adverse Event|0|||
125177009|NCT03449446|450266132|FG000|Overall Study|Lost to Follow-up|0|||
125177010|NCT03449446|450266133|FG001|Overall Study|Lost to Follow-up|0|||
125177011|NCT03449446|450266134|FG002|Overall Study|Lost to Follow-up|2|||
125232320|NCT00296335|450479755|FG000|Overall Study|Lost to Follow-up|7|||
125232321|NCT00296335|450479756|FG001|Overall Study|Lost to Follow-up|33|||
125177012|NCT03449446|450266135|FG003|Overall Study|Lost to Follow-up|1|||
125177013|NCT03449446|450266136|FG004|Overall Study|Lost to Follow-up|3|||
125177014|NCT03449446|450266137|FG005|Overall Study|Lost to Follow-up|0|||
125232322|NCT00296335|450479755|FG000|Overall Study|Physician Decision|3|||
125177015|NCT03449446|450266138|FG006|Overall Study|Lost to Follow-up|0|||
125177016|NCT03449446|450266132|FG000|Overall Study|Investigator's Discretion|0|||
125177017|NCT03449446|450266133|FG001|Overall Study|Investigator's Discretion|1|||
125232323|NCT00296335|450479756|FG001|Overall Study|Physician Decision|11|||
125232324|NCT01401322|450479757|FG000|Overall Study|Withdrawal by Subject|1|||
125232325|NCT01401322|450479757|FG000|Overall Study|Physician Decision|1|||
125232326|NCT02737722|450479758|FG000|Overall Study|Physician Decision|0|||
125232327|NCT02737722|450479759|FG001|Overall Study|Physician Decision|0|||
125232328|NCT02737722|450479760|FG002|Overall Study|Physician Decision|1|||
125232329|NCT02737722|450479761|FG003|Overall Study|Physician Decision|0|||
125177018|NCT03449446|450266134|FG002|Overall Study|Investigator's Discretion|1|||
125177019|NCT03449446|450266135|FG003|Overall Study|Investigator's Discretion|2|||
125177020|NCT03449446|450266136|FG004|Overall Study|Investigator's Discretion|0|||
125177021|NCT03449446|450266137|FG005|Overall Study|Investigator's Discretion|0|||
125177022|NCT03449446|450266138|FG006|Overall Study|Investigator's Discretion|0|||
125177023|NCT03449446|450266132|FG000|Overall Study|Non Compliance with Study Drug|1|||
125177024|NCT03449446|450266133|FG001|Overall Study|Non Compliance with Study Drug|0|||
125177025|NCT03449446|450266134|FG002|Overall Study|Non Compliance with Study Drug|0|||
125177026|NCT03449446|450266135|FG003|Overall Study|Non Compliance with Study Drug|0|||
125177027|NCT03449446|450266136|FG004|Overall Study|Non Compliance with Study Drug|0|||
125177028|NCT03449446|450266137|FG005|Overall Study|Non Compliance with Study Drug|0|||
125177029|NCT03449446|450266138|FG006|Overall Study|Non Compliance with Study Drug|0|||
125177030|NCT03449446|450266132|FG000|Overall Study|Protocol Violation|0|||
125177031|NCT03449446|450266133|FG001|Overall Study|Protocol Violation|0|||
125177032|NCT03449446|450266134|FG002|Overall Study|Protocol Violation|0|||
125177033|NCT03449446|450266135|FG003|Overall Study|Protocol Violation|0|||
125177034|NCT03449446|450266136|FG004|Overall Study|Protocol Violation|1|||
125177035|NCT03449446|450266137|FG005|Overall Study|Protocol Violation|1|||
125177036|NCT03449446|450266138|FG006|Overall Study|Protocol Violation|0|||
125177037|NCT03449446|450266132|FG000|Overall Study|Death|0|||
125177038|NCT03449446|450266133|FG001|Overall Study|Death|0|||
125177039|NCT03449446|450266134|FG002|Overall Study|Death|0|||
125177040|NCT03449446|450266135|FG003|Overall Study|Death|0|||
125177041|NCT03449446|450266136|FG004|Overall Study|Death|1|||
125177042|NCT03449446|450266137|FG005|Overall Study|Death|0|||
125177043|NCT03449446|450266138|FG006|Overall Study|Death|0|||
125177044|NCT02839707|450266145|FG000|Phase I|Not eligible for analysis|9|||
125177045|NCT02839707|450266146|FG001|Phase I|Not eligible for analysis|0|||
125177046|NCT02839707|450266147|FG002|Phase I|Not eligible for analysis|0|||
125177047|NCT02839707|450266145|FG000|Phase II|Not treated according to protocol|4|||
125177048|NCT02839707|450266146|FG001|Phase II|Not treated according to protocol|0|||
125177049|NCT02839707|450266147|FG002|Phase II|Not treated according to protocol|2|||
125177050|NCT02839707|450266145|FG000|Phase III|Not treated according to protocol|0|||
125177051|NCT02839707|450266146|FG001|Phase III|Not treated according to protocol|0|||
125177052|NCT02839707|450266147|FG002|Phase III|Not treated according to protocol|4|||
125177053|NCT01950390|450266148|FG000|Overall Study|Never started treatment|3|||
125177054|NCT01950390|450266149|FG001|Overall Study|Never started treatment|2|||
125177055|NCT01950390|450266148|FG000|Overall Study|Disease progression|45|||
125177056|NCT01950390|450266149|FG001|Overall Study|Disease progression|52|||
125177057|NCT01950390|450266148|FG000|Overall Study|Adverse Event|22|||
125177058|NCT01950390|450266149|FG001|Overall Study|Adverse Event|16|||
125177059|NCT01950390|450266148|FG000|Overall Study|Death|5|||
125177060|NCT01950390|450266149|FG001|Overall Study|Death|3|||
125177061|NCT01950390|450266148|FG000|Overall Study|Withdrawal by Subject|5|||
125177062|NCT01950390|450266149|FG001|Overall Study|Withdrawal by Subject|1|||
125177063|NCT01950390|450266148|FG000|Overall Study|Alternative therapy|0|||
125177064|NCT01950390|450266149|FG001|Overall Study|Alternative therapy|3|||
125177065|NCT01950390|450266148|FG000|Overall Study|Complicating disease|1|||
125177066|NCT01950390|450266149|FG001|Overall Study|Complicating disease|0|||
125177067|NCT01950390|450266148|FG000|Overall Study|On treatment|1|||
125177068|NCT01950390|450266149|FG001|Overall Study|On treatment|0|||
125177069|NCT01950390|450266148|FG000|Overall Study|Symptomatic deterioration|2|||
125177070|NCT01950390|450266149|FG001|Overall Study|Symptomatic deterioration|1|||
125177071|NCT01950390|450266148|FG000|Overall Study|Physician Decision|0|||
125177072|NCT01950390|450266149|FG001|Overall Study|Physician Decision|4|||
125177073|NCT01950390|450266148|FG000|Overall Study|Lack of clinical benefit|0|||
125177074|NCT01950390|450266149|FG001|Overall Study|Lack of clinical benefit|1|||
125177075|NCT01950390|450266148|FG000|Overall Study|Maintained PR and moved to observation only|0|||
125177076|NCT01950390|450266149|FG001|Overall Study|Maintained PR and moved to observation only|1|||
125177077|NCT02586688|450267904|FG000|Overall Study|Lost to Follow-up|2|||
125177078|NCT02586688|450267905|FG001|Overall Study|Lost to Follow-up|1|||
125177079|NCT02586688|450267904|FG000|Overall Study|Withdrawal by Subject|1|||
125177080|NCT02586688|450267905|FG001|Overall Study|Withdrawal by Subject|1|||
125177081|NCT02586688|450267904|FG000|Overall Study|Adverse Event|3|||
125177082|NCT02586688|450267905|FG001|Overall Study|Adverse Event|1|||
125177083|NCT01433055|450267906|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
125177084|NCT01433055|450267907|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
125177085|NCT01433055|450267906|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
125177086|NCT01433055|450267907|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
125177087|NCT02717455|450267908|FG000|Overall Study|Adverse Event|1|||
125177088|NCT02717455|450267909|FG001|Overall Study|Adverse Event|0|||
125177089|NCT02717455|450267910|FG002|Overall Study|Adverse Event|0|||
125177090|NCT02717455|450267911|FG003|Overall Study|Adverse Event|2|||
125177091|NCT02717455|450267912|FG004|Overall Study|Adverse Event|2|||
125177092|NCT02717455|450267913|FG005|Overall Study|Adverse Event|2|||
125177093|NCT02717455|450267908|FG000|Overall Study|Withdrawal by Subject|1|||
125177094|NCT02717455|450267909|FG001|Overall Study|Withdrawal by Subject|1|||
125177095|NCT02717455|450267910|FG002|Overall Study|Withdrawal by Subject|0|||
125177096|NCT02717455|450267911|FG003|Overall Study|Withdrawal by Subject|2|||
125177097|NCT02717455|450267912|FG004|Overall Study|Withdrawal by Subject|2|||
125177098|NCT02717455|450267913|FG005|Overall Study|Withdrawal by Subject|1|||
125177099|NCT02717455|450267908|FG000|Overall Study|Death|1|||
125177100|NCT02717455|450267909|FG001|Overall Study|Death|0|||
125177101|NCT02717455|450267910|FG002|Overall Study|Death|0|||
125177102|NCT02717455|450267911|FG003|Overall Study|Death|0|||
125177103|NCT02717455|450267912|FG004|Overall Study|Death|1|||
125177104|NCT02717455|450267913|FG005|Overall Study|Death|0|||
125177105|NCT02717455|450267908|FG000|Overall Study|Did not receive study drug|0|||
125177106|NCT02717455|450267909|FG001|Overall Study|Did not receive study drug|0|||
125177107|NCT02717455|450267910|FG002|Overall Study|Did not receive study drug|0|||
125177108|NCT02717455|450267911|FG003|Overall Study|Did not receive study drug|1|||
125177109|NCT02717455|450267912|FG004|Overall Study|Did not receive study drug|0|||
125177110|NCT02717455|450267913|FG005|Overall Study|Did not receive study drug|1|||
125177111|NCT02717455|450267908|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
125177112|NCT02717455|450267909|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
125177113|NCT02717455|450267910|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
125177114|NCT02717455|450267911|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
125177115|NCT02717455|450267912|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
125177116|NCT02717455|450267913|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
125177117|NCT02717455|450267908|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
125177118|NCT02717455|450267909|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
125177119|NCT02717455|450267910|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
125177120|NCT02717455|450267911|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
125177121|NCT02717455|450267912|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
125177122|NCT02717455|450267913|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
125177123|NCT00233948|450267919|FG000|Overall Study|Adverse Event|1|||
125177124|NCT00233948|450267920|FG001|Overall Study|Adverse Event|0|||
125177125|NCT00233948|450267921|FG002|Overall Study|Adverse Event|0|||
125177126|NCT00233948|450267922|FG003|Overall Study|Adverse Event|0|||
125177127|NCT00233948|450267923|FG004|Overall Study|Adverse Event|0|||
125177128|NCT00233948|450267924|FG005|Overall Study|Adverse Event|0|||
125177129|NCT03573830|450267925|FG000|Overall Study|Dropped without completing treatment|0|||
125177130|NCT03573830|450267926|FG001|Overall Study|Dropped without completing treatment|7|||
125177131|NCT03573830|450267925|FG000|Overall Study|Lost to Follow-up|4|||
125177132|NCT03573830|450267926|FG001|Overall Study|Lost to Follow-up|0|||
125177133|NCT02465398|450267933|FG000|Overall Study|Death|7|||
125177134|NCT02465398|450267933|FG000|Overall Study|Revision|7|||
125177135|NCT02465398|450267933|FG000|Overall Study|did not receive study device|1|||
125177136|NCT02465398|450267933|FG000|Overall Study|Withdrawal by Subject|1|||
125177137|NCT02465398|450267933|FG000|Overall Study|Lost to Follow-up|14|||
125177138|NCT05244122|450267938|FG000|Overall Study|Withdrawal by Subject|318|||
125177139|NCT02969382|450267943|FG000|Overall Study|Adverse Event|8|||
125177140|NCT02969382|450267944|FG001|Overall Study|Adverse Event|10|||
125177141|NCT02969382|450267943|FG000|Overall Study|Lack of Efficacy|4|||
125177142|NCT02969382|450267944|FG001|Overall Study|Lack of Efficacy|5|||
125177143|NCT02969382|450267943|FG000|Overall Study|Death|0|||
125177144|NCT02969382|450267944|FG001|Overall Study|Death|1|||
125177145|NCT02969382|450267943|FG000|Overall Study|PROTOCOL DEVIATION|0|||
125177146|NCT02969382|450267944|FG001|Overall Study|PROTOCOL DEVIATION|1|||
125177147|NCT02969382|450267943|FG000|Overall Study|Withdrawal by Subject|14|||
125177148|NCT02969382|450267944|FG001|Overall Study|Withdrawal by Subject|9|||
125177149|NCT02847260|450267948|FG000|Overall Study|Adverse Event|3|||
125177150|NCT02847260|450267948|FG000|Overall Study|Withdrawal by Subject|2|||
125177151|NCT02847260|450267948|FG000|Overall Study|Clinical Deterioration|1|||
125177152|NCT02847260|450267948|FG000|Overall Study|Physician Decision|1|||
125177153|NCT00886015|450267951|FG000|Overall Study|Death|0|||
125177154|NCT00886015|450267952|FG001|Overall Study|Death|2|||
125177155|NCT01692626|450267953|FG000|Overall Study|Death|0|||
125177156|NCT01692626|450267954|FG001|Overall Study|Death|1|||
125177157|NCT01692626|450267953|FG000|Overall Study|Adverse Event|2|||
125177158|NCT01692626|450267954|FG001|Overall Study|Adverse Event|3|||
125177159|NCT01692626|450267953|FG000|Overall Study|Protocol Violation|1|||
125177160|NCT01692626|450267954|FG001|Overall Study|Protocol Violation|2|||
125177161|NCT01692626|450267953|FG000|Overall Study|Withdrawal by Subject|1|||
125177162|NCT01692626|450267954|FG001|Overall Study|Withdrawal by Subject|0|||
125177163|NCT00855894|450267955|FG000|Overall Study|Death|31|||
125177164|NCT00855894|450267955|FG000|Overall Study|Patient's decision|1|||
125177165|NCT00855894|450267955|FG000|Overall Study|Disease progression|1|||
125177166|NCT00444587|450267965|FG000|Overall Study|Death|2|||
125177167|NCT00444587|450267966|FG001|Overall Study|Death|1|||
125177168|NCT00444587|450267965|FG000|Overall Study|Progression of the disease|73|||
125177169|NCT00444587|450267966|FG001|Overall Study|Progression of the disease|8|||
125232330|NCT00284856|450479776|FG000|Overall Study|Adverse Event|3|||
125232331|NCT00284856|450479777|FG001|Overall Study|Adverse Event|3|||
125232332|NCT00284856|450479778|FG002|Overall Study|Adverse Event|3|||
125232333|NCT00284856|450479776|FG000|Overall Study|Lack of Efficacy|2|||
125232334|NCT00284856|450479777|FG001|Overall Study|Lack of Efficacy|1|||
125232335|NCT00284856|450479778|FG002|Overall Study|Lack of Efficacy|8|||
125232336|NCT00284856|450479776|FG000|Overall Study|Lost to Follow-up|25|||
125232337|NCT00284856|450479777|FG001|Overall Study|Lost to Follow-up|21|||
125232338|NCT00284856|450479778|FG002|Overall Study|Lost to Follow-up|22|||
125232339|NCT00284856|450479776|FG000|Overall Study|Protocol Violation|5|||
125232340|NCT00284856|450479777|FG001|Overall Study|Protocol Violation|4|||
125232341|NCT00284856|450479778|FG002|Overall Study|Protocol Violation|5|||
125232342|NCT00284856|450479776|FG000|Overall Study|Withdrawal by Subject|12|||
125232343|NCT00284856|450479777|FG001|Overall Study|Withdrawal by Subject|16|||
125232344|NCT00284856|450479778|FG002|Overall Study|Withdrawal by Subject|18|||
125232345|NCT00284856|450479776|FG000|Overall Study|Other|4|||
125232346|NCT00284856|450479777|FG001|Overall Study|Other|5|||
125232347|NCT00284856|450479778|FG002|Overall Study|Other|4|||
125232348|NCT01192815|450479780|FG000|Overall Study|Withdrawal by Subject|1|||
125232349|NCT01192815|450479780|FG000|Overall Study|Lack of Efficacy|1|||
125232350|NCT03451045|450479782|FG000|Overall Study|Lack of Efficacy|3|||
125232351|NCT03451045|450479783|FG001|Overall Study|Lack of Efficacy|2|||
125232352|NCT03451045|450479784|FG002|Overall Study|Lack of Efficacy|2|||
125232353|NCT03451045|450479782|FG000|Overall Study|Physician Decision|1|||
125232354|NCT03451045|450479783|FG001|Overall Study|Physician Decision|1|||
125232355|NCT03451045|450479784|FG002|Overall Study|Physician Decision|1|||
125232356|NCT03451045|450479782|FG000|Overall Study|Withdrawal by Subject|4|||
125232357|NCT03451045|450479783|FG001|Overall Study|Withdrawal by Subject|0|||
125232358|NCT03451045|450479784|FG002|Overall Study|Withdrawal by Subject|5|||
125232359|NCT03451045|450479782|FG000|Overall Study|Pregnancy|0|||
125232360|NCT03451045|450479783|FG001|Overall Study|Pregnancy|0|||
125232361|NCT03451045|450479784|FG002|Overall Study|Pregnancy|2|||
125232362|NCT03451045|450479782|FG000|Overall Study|Adverse Event|7|||
125232363|NCT03451045|450479783|FG001|Overall Study|Adverse Event|1|||
125232364|NCT03451045|450479784|FG002|Overall Study|Adverse Event|3|||
125232365|NCT03451045|450479782|FG000|Overall Study|Non-compliance with study|2|||
125232366|NCT03451045|450479783|FG001|Overall Study|Non-compliance with study|0|||
125232367|NCT03451045|450479784|FG002|Overall Study|Non-compliance with study|1|||
125232368|NCT03451045|450479782|FG000|Overall Study|any other reason|10|||
125232369|NCT03451045|450479783|FG001|Overall Study|any other reason|2|||
125232370|NCT03451045|450479784|FG002|Overall Study|any other reason|13|||
125232371|NCT04142242|450479787|FG000|Stage I|Non-compliance with the protocol|1|||
125232372|NCT04142242|450479788|FG001|Stage I|Non-compliance with the protocol|0|||
125232373|NCT04142242|450479789|FG002|Stage I|Non-compliance with the protocol|0|||
125232374|NCT04142242|450479790|FG003|Stage I|Non-compliance with the protocol|0|||
125232375|NCT04142242|450479791|FG004|Stage I|Non-compliance with the protocol|0|||
125232376|NCT04142242|450479792|FG005|Stage I|Non-compliance with the protocol|1|||
125232377|NCT04142242|450479787|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
125232378|NCT04142242|450479788|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
125232379|NCT04142242|450479789|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
125232380|NCT04142242|450479790|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
125232381|NCT04142242|450479791|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
125232382|NCT04142242|450479792|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
125232383|NCT04142242|450479787|FG000|Stage II|Non-compliance with the protocol|0|||
125232384|NCT04142242|450479788|FG001|Stage II|Non-compliance with the protocol|0|||
125232385|NCT04142242|450479789|FG002|Stage II|Non-compliance with the protocol|0|||
125232386|NCT04142242|450479790|FG003|Stage II|Non-compliance with the protocol|2|||
125232387|NCT04142242|450479791|FG004|Stage II|Non-compliance with the protocol|0|||
125232388|NCT04142242|450479792|FG005|Stage II|Non-compliance with the protocol|0|||
125232389|NCT04142242|450479787|FG000|Stage II|Lost to Follow-up|0|||
125232390|NCT04142242|450479788|FG001|Stage II|Lost to Follow-up|0|||
125232391|NCT04142242|450479789|FG002|Stage II|Lost to Follow-up|1|||
125232392|NCT04142242|450479790|FG003|Stage II|Lost to Follow-up|2|||
125232393|NCT04142242|450479791|FG004|Stage II|Lost to Follow-up|0|||
125232394|NCT04142242|450479792|FG005|Stage II|Lost to Follow-up|0|||
125232395|NCT04142242|450479787|FG000|Stage II|Withdrawal by Subject|0|||
125232396|NCT04142242|450479788|FG001|Stage II|Withdrawal by Subject|0|||
125232397|NCT04142242|450479789|FG002|Stage II|Withdrawal by Subject|5|||
125232398|NCT04142242|450479790|FG003|Stage II|Withdrawal by Subject|9|||
125232399|NCT04142242|450479791|FG004|Stage II|Withdrawal by Subject|0|||
125232400|NCT04142242|450479792|FG005|Stage II|Withdrawal by Subject|0|||
125232401|NCT03040726|450479793|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
125232402|NCT03040726|450479794|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
125232403|NCT03040726|450479793|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
125232404|NCT03040726|450479794|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
125232405|NCT03040726|450479793|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
125232406|NCT03040726|450479794|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
125232407|NCT03040726|450479793|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
125232408|NCT03040726|450479794|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
125232409|NCT03040726|450479793|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
125232410|NCT03040726|450479794|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
125232411|NCT00465179|450479796|FG000|Overall Study|Adverse Event|4|||
125232412|NCT00465179|450479796|FG000|Overall Study|Withdrawal by Subject|2|||
125232413|NCT00465179|450479796|FG000|Overall Study|Progression of Disease|47|||
125232414|NCT00262925|450479802|FG000|Overall Study|Lack of Efficacy|3|||
125232415|NCT00262925|450479802|FG000|Overall Study|Adverse Event|4|||
125232416|NCT00262925|450479802|FG000|Overall Study|Death|2|||
125232417|NCT00262925|450479802|FG000|Overall Study|alternative therapy|1|||
125232418|NCT00262925|450479802|FG000|Overall Study|Other|1|||
125232419|NCT04682301|450479804|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
125232420|NCT04682301|450479804|FG000|Overall Study|Death|2|||
125232421|NCT05219162|450479805|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
125232422|NCT05219162|450479805|FG000|Overall Study|Withdrawal by Subject|23|||
125232423|NCT01499810|450479821|FG000|Overall Study|Lost to Follow-up|10|||
125232424|NCT01499810|450479821|FG000|Overall Study|Protocol Violation|1|||
125232425|NCT01499810|450479821|FG000|Overall Study|Withdrawal by Subject|1|||
125232426|NCT02273167|450479827|FG000|Overall Study|Adverse Event|1|||
125232427|NCT02273167|450479828|FG001|Overall Study|Adverse Event|0|||
125232428|NCT02273167|450479829|FG002|Overall Study|Adverse Event|0|||
125232429|NCT02273167|450479827|FG000|Overall Study|Protocol Violation|3|||
125232430|NCT02273167|450479828|FG001|Overall Study|Protocol Violation|1|||
125232431|NCT02273167|450479829|FG002|Overall Study|Protocol Violation|1|||
125232432|NCT02273167|450479827|FG000|Overall Study|Lost to Follow-up|0|||
125232433|NCT02273167|450479828|FG001|Overall Study|Lost to Follow-up|1|||
125232434|NCT02273167|450479829|FG002|Overall Study|Lost to Follow-up|1|||
125232435|NCT02273167|450479827|FG000|Overall Study|Withdrawal by Subject|10|||
125232436|NCT02273167|450479828|FG001|Overall Study|Withdrawal by Subject|12|||
125232437|NCT02273167|450479829|FG002|Overall Study|Withdrawal by Subject|11|||
125232438|NCT02273167|450479827|FG000|Overall Study|Various|10|||
125232439|NCT02273167|450479828|FG001|Overall Study|Various|9|||
125232440|NCT02273167|450479829|FG002|Overall Study|Various|8|||
125232441|NCT02781324|450479834|FG000|Overall Study|Withdrawal by Subject|1|||
125232442|NCT02781324|450479835|FG001|Overall Study|Withdrawal by Subject|0|||
125232443|NCT02781324|450479834|FG000|Overall Study|Physician Decision|1|||
125232444|NCT02781324|450479835|FG001|Overall Study|Physician Decision|2|||
125232445|NCT00834041|450479836|FG000|Overall Study|Withdrawal by Subject|1|||
125232446|NCT00834041|450479837|FG001|Overall Study|Withdrawal by Subject|0|||
125232447|NCT00834041|450479836|FG000|Overall Study|Lost to Follow-up|0|||
125232448|NCT00834041|450479837|FG001|Overall Study|Lost to Follow-up|1|||
125232449|NCT03353220|450479838|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
125232450|NCT03353220|450479839|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
125232451|NCT02711137|450481674|FG000|Overall Study|Death|1|||
125232452|NCT02711137|450481675|FG001|Overall Study|Death|4|||
125232453|NCT02711137|450481676|FG002|Overall Study|Death|5|||
125232454|NCT02711137|450481677|FG003|Overall Study|Death|5|||
125232455|NCT02711137|450481678|FG004|Overall Study|Death|3|||
125232456|NCT02711137|450481679|FG005|Overall Study|Death|1|||
125232457|NCT02711137|450481680|FG006|Overall Study|Death|61|||
125232458|NCT02711137|450481681|FG007|Overall Study|Death|3|||
125232459|NCT02711137|450481682|FG008|Overall Study|Death|0|||
125232460|NCT02711137|450481683|FG009|Overall Study|Death|1|||
125232461|NCT02711137|450481684|FG010|Overall Study|Death|1|||
125232462|NCT02711137|450481685|FG011|Overall Study|Death|1|||
125232463|NCT02711137|450481686|FG012|Overall Study|Death|0|||
125232464|NCT02711137|450481687|FG013|Overall Study|Death|0|||
125232465|NCT02711137|450481688|FG014|Overall Study|Death|0|||
125232466|NCT02711137|450481674|FG000|Overall Study|Study Terminated by Sponsor|0|||
125232467|NCT02711137|450481675|FG001|Overall Study|Study Terminated by Sponsor|0|||
125232468|NCT02711137|450481676|FG002|Overall Study|Study Terminated by Sponsor|1|||
125232469|NCT02711137|450481677|FG003|Overall Study|Study Terminated by Sponsor|0|||
125232470|NCT02711137|450481678|FG004|Overall Study|Study Terminated by Sponsor|0|||
125232471|NCT02711137|450481679|FG005|Overall Study|Study Terminated by Sponsor|0|||
125232472|NCT02711137|450481680|FG006|Overall Study|Study Terminated by Sponsor|1|||
125232473|NCT02711137|450481681|FG007|Overall Study|Study Terminated by Sponsor|0|||
125232474|NCT02711137|450481682|FG008|Overall Study|Study Terminated by Sponsor|0|||
125232475|NCT02711137|450481683|FG009|Overall Study|Study Terminated by Sponsor|0|||
125232476|NCT02711137|450481684|FG010|Overall Study|Study Terminated by Sponsor|0|||
125232477|NCT02711137|450481685|FG011|Overall Study|Study Terminated by Sponsor|0|||
125232478|NCT02711137|450481686|FG012|Overall Study|Study Terminated by Sponsor|0|||
125232479|NCT02711137|450481687|FG013|Overall Study|Study Terminated by Sponsor|0|||
125232480|NCT02711137|450481688|FG014|Overall Study|Study Terminated by Sponsor|0|||
125232481|NCT02711137|450481674|FG000|Overall Study|Physician Decision|1|||
125232482|NCT02711137|450481675|FG001|Overall Study|Physician Decision|0|||
125232483|NCT02711137|450481676|FG002|Overall Study|Physician Decision|2|||
125232484|NCT02711137|450481677|FG003|Overall Study|Physician Decision|1|||
125232485|NCT02711137|450481678|FG004|Overall Study|Physician Decision|1|||
125232486|NCT02711137|450481679|FG005|Overall Study|Physician Decision|0|||
125232487|NCT02711137|450481680|FG006|Overall Study|Physician Decision|12|||
125232488|NCT02711137|450481681|FG007|Overall Study|Physician Decision|2|||
125232489|NCT02711137|450481682|FG008|Overall Study|Physician Decision|1|||
125232490|NCT02711137|450481683|FG009|Overall Study|Physician Decision|1|||
125232491|NCT02711137|450481684|FG010|Overall Study|Physician Decision|3|||
125232492|NCT02711137|450481685|FG011|Overall Study|Physician Decision|2|||
125232493|NCT02711137|450481686|FG012|Overall Study|Physician Decision|1|||
125232494|NCT02711137|450481687|FG013|Overall Study|Physician Decision|1|||
125232495|NCT02711137|450481688|FG014|Overall Study|Physician Decision|2|||
125232496|NCT02711137|450481674|FG000|Overall Study|Other|0|||
125232497|NCT02711137|450481675|FG001|Overall Study|Other|1|||
125232498|NCT02711137|450481676|FG002|Overall Study|Other|0|||
125232499|NCT02711137|450481677|FG003|Overall Study|Other|0|||
125232500|NCT02711137|450481678|FG004|Overall Study|Other|0|||
125232501|NCT02711137|450481679|FG005|Overall Study|Other|0|||
125232502|NCT02711137|450481680|FG006|Overall Study|Other|3|||
125232503|NCT02711137|450481681|FG007|Overall Study|Other|0|||
125232504|NCT02711137|450481682|FG008|Overall Study|Other|0|||
125232505|NCT02711137|450481683|FG009|Overall Study|Other|0|||
125232506|NCT02711137|450481684|FG010|Overall Study|Other|0|||
125232507|NCT02711137|450481685|FG011|Overall Study|Other|0|||
125232508|NCT02711137|450481686|FG012|Overall Study|Other|0|||
125232509|NCT02711137|450481687|FG013|Overall Study|Other|0|||
125232510|NCT02711137|450481688|FG014|Overall Study|Other|1|||
125232511|NCT02711137|450481674|FG000|Overall Study|Withdrawal by Subject|1|||
125232512|NCT02711137|450481675|FG001|Overall Study|Withdrawal by Subject|0|||
125232513|NCT02711137|450481676|FG002|Overall Study|Withdrawal by Subject|0|||
125232514|NCT02711137|450481677|FG003|Overall Study|Withdrawal by Subject|1|||
125232515|NCT02711137|450481678|FG004|Overall Study|Withdrawal by Subject|1|||
125232516|NCT02711137|450481679|FG005|Overall Study|Withdrawal by Subject|0|||
125232517|NCT02711137|450481680|FG006|Overall Study|Withdrawal by Subject|7|||
125232518|NCT02711137|450481681|FG007|Overall Study|Withdrawal by Subject|0|||
125232519|NCT02711137|450481682|FG008|Overall Study|Withdrawal by Subject|0|||
125232520|NCT02711137|450481683|FG009|Overall Study|Withdrawal by Subject|0|||
125232521|NCT02711137|450481684|FG010|Overall Study|Withdrawal by Subject|0|||
125177170|NCT00444587|450267965|FG000|Overall Study|Refused treatment/did not cooperate|4|||
125177171|NCT00444587|450267966|FG001|Overall Study|Refused treatment/did not cooperate|1|||
125177172|NCT00444587|450267965|FG000|Overall Study|Investigator decision|3|||
125177173|NCT00444587|450267966|FG001|Overall Study|Investigator decision|0|||
125177174|NCT00444587|450267965|FG000|Overall Study|Protocol Violation|1|||
125177175|NCT00444587|450267966|FG001|Overall Study|Protocol Violation|0|||
125177176|NCT00444587|450267965|FG000|Overall Study|Missing|0|||
125177177|NCT00444587|450267966|FG001|Overall Study|Missing|5|||
125177178|NCT01720225|450267975|FG000|Overall Study|Withdrawal by Subject|0|||
125177179|NCT01720225|450267976|FG001|Overall Study|Withdrawal by Subject|1|||
125177180|NCT01720225|450267975|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
125177181|NCT01720225|450267976|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
125177182|NCT01473407|450267977|FG000|Overall Study|Physician Decision|1|||
125177183|NCT01473407|450267978|FG001|Overall Study|Physician Decision|4|||
125177184|NCT01473407|450267977|FG000|Overall Study|Lost to Follow-up|10|||
125177185|NCT01473407|450267978|FG001|Overall Study|Lost to Follow-up|4|||
125177186|NCT01473407|450267977|FG000|Overall Study|Adverse Event|8|||
125177187|NCT01473407|450267978|FG001|Overall Study|Adverse Event|8|||
125177188|NCT01473407|450267977|FG000|Overall Study|Randomization Error|3|||
125177189|NCT01473407|450267978|FG001|Overall Study|Randomization Error|1|||
125177190|NCT01473407|450267977|FG000|Overall Study|Withdrawal by Subject|4|||
125177191|NCT01473407|450267978|FG001|Overall Study|Withdrawal by Subject|7|||
125177192|NCT01473407|450267977|FG000|Overall Study|Kidney Transplant|7|||
125177193|NCT01473407|450267978|FG001|Overall Study|Kidney Transplant|6|||
125177194|NCT01473407|450267977|FG000|Overall Study|Vacation/Travel|1|||
125177195|NCT01473407|450267978|FG001|Overall Study|Vacation/Travel|1|||
125177196|NCT01473407|450267977|FG000|Overall Study|Elevated Hemoglobin|1|||
125177197|NCT01473407|450267978|FG001|Overall Study|Elevated Hemoglobin|0|||
125177198|NCT01473407|450267977|FG000|Overall Study|Patient Received Aranesp|1|||
125177199|NCT01473407|450267978|FG001|Overall Study|Patient Received Aranesp|0|||
125177200|NCT01473407|450267977|FG000|Overall Study|Patient Lost Green Card Status|1|||
125177201|NCT01473407|450267978|FG001|Overall Study|Patient Lost Green Card Status|0|||
125177202|NCT01473407|450267977|FG000|Overall Study|Temperature Excursion|2|||
125177203|NCT01473407|450267978|FG001|Overall Study|Temperature Excursion|3|||
125232522|NCT02711137|450481685|FG011|Overall Study|Withdrawal by Subject|0|||
125232523|NCT02711137|450481686|FG012|Overall Study|Withdrawal by Subject|0|||
125232524|NCT02711137|450481687|FG013|Overall Study|Withdrawal by Subject|1|||
125232525|NCT02711137|450481688|FG014|Overall Study|Withdrawal by Subject|0|||
125232526|NCT02711137|450481674|FG000|Overall Study|Lost to Follow-up|1|||
125232527|NCT02711137|450481675|FG001|Overall Study|Lost to Follow-up|0|||
125232528|NCT02711137|450481676|FG002|Overall Study|Lost to Follow-up|0|||
125232529|NCT02711137|450481677|FG003|Overall Study|Lost to Follow-up|0|||
125232530|NCT02711137|450481678|FG004|Overall Study|Lost to Follow-up|0|||
125232531|NCT02711137|450481679|FG005|Overall Study|Lost to Follow-up|0|||
125232532|NCT02711137|450481680|FG006|Overall Study|Lost to Follow-up|2|||
125232533|NCT02711137|450481681|FG007|Overall Study|Lost to Follow-up|0|||
125232534|NCT02711137|450481682|FG008|Overall Study|Lost to Follow-up|0|||
125232535|NCT02711137|450481683|FG009|Overall Study|Lost to Follow-up|0|||
125232536|NCT02711137|450481684|FG010|Overall Study|Lost to Follow-up|0|||
125232537|NCT02711137|450481685|FG011|Overall Study|Lost to Follow-up|0|||
125232538|NCT02711137|450481686|FG012|Overall Study|Lost to Follow-up|0|||
125232539|NCT02711137|450481687|FG013|Overall Study|Lost to Follow-up|0|||
125232540|NCT02711137|450481688|FG014|Overall Study|Lost to Follow-up|0|||
125232541|NCT00750269|450481689|FG000|Overall Study|Protocol Violation|0|||
125232542|NCT00750269|450481690|FG001|Overall Study|Protocol Violation|1|||
125232543|NCT00750269|450481691|FG002|Overall Study|Protocol Violation|1|||
125232544|NCT00750269|450481692|FG003|Overall Study|Protocol Violation|2|||
125232545|NCT00750269|450481693|FG004|Overall Study|Protocol Violation|4|||
125232546|NCT00750269|450481689|FG000|Overall Study|Withdrawal by Subject|0|||
125232547|NCT00750269|450481690|FG001|Overall Study|Withdrawal by Subject|0|||
125232548|NCT00750269|450481691|FG002|Overall Study|Withdrawal by Subject|2|||
125232549|NCT00750269|450481692|FG003|Overall Study|Withdrawal by Subject|2|||
125232550|NCT00750269|450481693|FG004|Overall Study|Withdrawal by Subject|2|||
125232551|NCT00750269|450481689|FG000|Overall Study|Physician Decision|0|||
125232552|NCT00750269|450481690|FG001|Overall Study|Physician Decision|0|||
125232553|NCT00750269|450481691|FG002|Overall Study|Physician Decision|0|||
125232554|NCT00750269|450481692|FG003|Overall Study|Physician Decision|0|||
125232555|NCT00750269|450481693|FG004|Overall Study|Physician Decision|2|||
125232556|NCT00750269|450481689|FG000|Overall Study|Patient too large for positioning|0|||
125232557|NCT00750269|450481690|FG001|Overall Study|Patient too large for positioning|0|||
125232558|NCT00750269|450481691|FG002|Overall Study|Patient too large for positioning|1|||
125232559|NCT00750269|450481692|FG003|Overall Study|Patient too large for positioning|0|||
125232560|NCT00750269|450481693|FG004|Overall Study|Patient too large for positioning|0|||
125232561|NCT00750269|450481689|FG000|Overall Study|Site error|0|||
125232562|NCT00750269|450481690|FG001|Overall Study|Site error|0|||
125232563|NCT00750269|450481691|FG002|Overall Study|Site error|0|||
125232564|NCT00750269|450481692|FG003|Overall Study|Site error|1|||
125232565|NCT00750269|450481693|FG004|Overall Study|Site error|0|||
125232566|NCT00750269|450481689|FG000|Overall Study|SBRT plan could not be drawn|0|||
125232567|NCT00750269|450481690|FG001|Overall Study|SBRT plan could not be drawn|0|||
125232568|NCT00750269|450481691|FG002|Overall Study|SBRT plan could not be drawn|0|||
125232569|NCT00750269|450481692|FG003|Overall Study|SBRT plan could not be drawn|0|||
125232570|NCT00750269|450481693|FG004|Overall Study|SBRT plan could not be drawn|1|||
125232571|NCT00750269|450481689|FG000|Overall Study|Fiducials could not be placed|0|||
125232572|NCT00750269|450481690|FG001|Overall Study|Fiducials could not be placed|0|||
125232573|NCT00750269|450481691|FG002|Overall Study|Fiducials could not be placed|0|||
125232574|NCT00750269|450481692|FG003|Overall Study|Fiducials could not be placed|0|||
125232575|NCT00750269|450481693|FG004|Overall Study|Fiducials could not be placed|1|||
125232576|NCT01799889|450481694|FG000|Overall Study|Adverse Event|4|||
125232577|NCT01799889|450481695|FG001|Overall Study|Adverse Event|4|||
125232578|NCT01799889|450481696|FG002|Overall Study|Adverse Event|5|||
125232579|NCT01799889|450481697|FG003|Overall Study|Adverse Event|1|||
125232580|NCT01799889|450481698|FG004|Overall Study|Adverse Event|11|||
125232581|NCT01799889|450481699|FG005|Overall Study|Adverse Event|1|||
125232582|NCT01799889|450481700|FG006|Overall Study|Adverse Event|5|||
125232583|NCT01799889|450481701|FG007|Overall Study|Adverse Event|2|||
125232584|NCT01799889|450481702|FG008|Overall Study|Adverse Event|3|||
125232585|NCT01799889|450481703|FG009|Overall Study|Adverse Event|1|||
125232586|NCT01799889|450481704|FG010|Overall Study|Adverse Event|1|||
125232587|NCT01799889|450481705|FG011|Overall Study|Adverse Event|0|||
125232588|NCT01799889|450481694|FG000|Overall Study|Death|1|||
125232589|NCT01799889|450481695|FG001|Overall Study|Death|0|||
125232590|NCT01799889|450481696|FG002|Overall Study|Death|5|||
125232591|NCT01799889|450481697|FG003|Overall Study|Death|3|||
125232592|NCT01799889|450481698|FG004|Overall Study|Death|1|||
125232593|NCT01799889|450481699|FG005|Overall Study|Death|0|||
125232594|NCT01799889|450481700|FG006|Overall Study|Death|0|||
125232595|NCT01799889|450481701|FG007|Overall Study|Death|0|||
125232596|NCT01799889|450481702|FG008|Overall Study|Death|1|||
125232597|NCT01799889|450481703|FG009|Overall Study|Death|0|||
125232598|NCT01799889|450481704|FG010|Overall Study|Death|1|||
125232599|NCT01799889|450481705|FG011|Overall Study|Death|0|||
125232600|NCT01799889|450481694|FG000|Overall Study|Lack of Efficacy|1|||
125232601|NCT01799889|450481695|FG001|Overall Study|Lack of Efficacy|1|||
125232602|NCT01799889|450481696|FG002|Overall Study|Lack of Efficacy|0|||
125232603|NCT01799889|450481697|FG003|Overall Study|Lack of Efficacy|1|||
125232604|NCT01799889|450481698|FG004|Overall Study|Lack of Efficacy|2|||
125232605|NCT01799889|450481699|FG005|Overall Study|Lack of Efficacy|2|||
125232606|NCT01799889|450481700|FG006|Overall Study|Lack of Efficacy|0|||
125232607|NCT01799889|450481701|FG007|Overall Study|Lack of Efficacy|0|||
125232608|NCT01799889|450481702|FG008|Overall Study|Lack of Efficacy|2|||
125232609|NCT01799889|450481703|FG009|Overall Study|Lack of Efficacy|0|||
125232610|NCT01799889|450481704|FG010|Overall Study|Lack of Efficacy|1|||
125232611|NCT01799889|450481705|FG011|Overall Study|Lack of Efficacy|0|||
125232612|NCT01799889|450481694|FG000|Overall Study|Lost to Follow-up|0|||
125232613|NCT01799889|450481695|FG001|Overall Study|Lost to Follow-up|1|||
125232614|NCT01799889|450481696|FG002|Overall Study|Lost to Follow-up|0|||
125232615|NCT01799889|450481697|FG003|Overall Study|Lost to Follow-up|0|||
125232616|NCT01799889|450481698|FG004|Overall Study|Lost to Follow-up|0|||
125232617|NCT01799889|450481699|FG005|Overall Study|Lost to Follow-up|0|||
125232618|NCT01799889|450481700|FG006|Overall Study|Lost to Follow-up|0|||
125232619|NCT01799889|450481701|FG007|Overall Study|Lost to Follow-up|0|||
125232620|NCT01799889|450481702|FG008|Overall Study|Lost to Follow-up|0|||
125232621|NCT01799889|450481703|FG009|Overall Study|Lost to Follow-up|0|||
125232622|NCT01799889|450481704|FG010|Overall Study|Lost to Follow-up|0|||
125232623|NCT01799889|450481705|FG011|Overall Study|Lost to Follow-up|0|||
125232624|NCT01799889|450481694|FG000|Overall Study|Physician Decision|3|||
125232625|NCT01799889|450481695|FG001|Overall Study|Physician Decision|2|||
125232626|NCT01799889|450481696|FG002|Overall Study|Physician Decision|4|||
125232627|NCT01799889|450481697|FG003|Overall Study|Physician Decision|4|||
125232628|NCT01799889|450481698|FG004|Overall Study|Physician Decision|5|||
125232629|NCT01799889|450481699|FG005|Overall Study|Physician Decision|5|||
125232630|NCT01799889|450481700|FG006|Overall Study|Physician Decision|5|||
125232631|NCT01799889|450481701|FG007|Overall Study|Physician Decision|2|||
125232632|NCT01799889|450481702|FG008|Overall Study|Physician Decision|6|||
125232633|NCT01799889|450481703|FG009|Overall Study|Physician Decision|0|||
125232634|NCT01799889|450481704|FG010|Overall Study|Physician Decision|0|||
125232635|NCT01799889|450481705|FG011|Overall Study|Physician Decision|1|||
125232636|NCT01799889|450481694|FG000|Overall Study|Progressive Disease|30|||
125232637|NCT01799889|450481695|FG001|Overall Study|Progressive Disease|26|||
125232638|NCT01799889|450481696|FG002|Overall Study|Progressive Disease|25|||
125232639|NCT01799889|450481697|FG003|Overall Study|Progressive Disease|30|||
125232640|NCT01799889|450481698|FG004|Overall Study|Progressive Disease|23|||
125232641|NCT01799889|450481699|FG005|Overall Study|Progressive Disease|9|||
125232642|NCT01799889|450481700|FG006|Overall Study|Progressive Disease|8|||
125232643|NCT01799889|450481701|FG007|Overall Study|Progressive Disease|13|||
125232644|NCT01799889|450481702|FG008|Overall Study|Progressive Disease|18|||
125232645|NCT01799889|450481703|FG009|Overall Study|Progressive Disease|5|||
125232646|NCT01799889|450481704|FG010|Overall Study|Progressive Disease|3|||
125232647|NCT01799889|450481705|FG011|Overall Study|Progressive Disease|1|||
125232648|NCT01799889|450481694|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
125232649|NCT01799889|450481695|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
125232650|NCT01799889|450481696|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
125232651|NCT01799889|450481697|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
125232652|NCT01799889|450481698|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
125232653|NCT01799889|450481699|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
125232654|NCT01799889|450481700|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
125232655|NCT01799889|450481701|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
125232656|NCT01799889|450481702|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
125232657|NCT01799889|450481703|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
125232658|NCT01799889|450481704|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
125232659|NCT01799889|450481705|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
125177204|NCT01473407|450267977|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
125177205|NCT01473407|450267978|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
125177206|NCT01473407|450267977|FG000|Overall Study|Sponsor's Decision|10|||
125177207|NCT01473407|450267978|FG001|Overall Study|Sponsor's Decision|10|||
125177208|NCT01473407|450267977|FG000|Overall Study|Site Closure|1|||
125177209|NCT01473407|450267978|FG001|Overall Study|Site Closure|0|||
125177210|NCT04071405|450267979|FG000|Overall Study|Protocol Violation|3|||
125177211|NCT02422797|450267980|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
125177212|NCT02422797|450267981|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
125177213|NCT02422797|450267980|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
125177214|NCT02422797|450267981|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
125177215|NCT02422797|450267980|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
125177216|NCT02422797|450267981|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
125177217|NCT02422797|450267980|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
125177218|NCT02422797|450267981|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
125177219|NCT02422797|450267980|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
125177220|NCT02422797|450267981|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
125177221|NCT02422797|450267980|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
125177222|NCT02422797|450267981|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
125177223|NCT02422797|450267980|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
125232660|NCT01799889|450481694|FG000|Overall Study|Study Terminated By Sponsor|1|||
125232661|NCT01799889|450481695|FG001|Overall Study|Study Terminated By Sponsor|0|||
125232662|NCT01799889|450481696|FG002|Overall Study|Study Terminated By Sponsor|0|||
125232663|NCT01799889|450481697|FG003|Overall Study|Study Terminated By Sponsor|0|||
125177224|NCT02422797|450267981|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
125177225|NCT02422797|450267980|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
125177226|NCT02422797|450267981|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
125177227|NCT02422797|450267980|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
125177228|NCT02422797|450267981|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
125177229|NCT02422797|450267980|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
125177230|NCT02422797|450267981|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
125177231|NCT02422797|450267980|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
125177232|NCT02422797|450267981|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
125177233|NCT02422797|450267980|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
125177234|NCT02422797|450267981|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
125177235|NCT02422797|450267980|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
125177236|NCT02422797|450267981|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
125177237|NCT02422797|450267980|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
125177238|NCT02422797|450267981|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
125177239|NCT02422797|450267980|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
125177240|NCT02422797|450267981|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
125177241|NCT02422797|450267980|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
125177242|NCT02422797|450267981|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
125177243|NCT02422797|450267980|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
125177244|NCT02422797|450267981|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
125177245|NCT02422797|450267980|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
125177246|NCT02422797|450267981|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
125177247|NCT02422797|450267980|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
125177248|NCT02422797|450267981|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
125177249|NCT02422797|450267980|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
125177250|NCT02422797|450267981|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
125177251|NCT02422797|450267980|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
125177252|NCT02422797|450267981|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
125177253|NCT00369941|450267982|FG000|Overall Study|Never Treated|1|||
125177254|NCT00369941|450267983|FG001|Overall Study|Never Treated|2|||
125177255|NCT00369941|450267982|FG000|Overall Study|Adverse Event|14|||
125177256|NCT00369941|450267983|FG001|Overall Study|Adverse Event|28|||
125177257|NCT00369941|450267982|FG000|Overall Study|Lack of Efficacy|6|||
125177258|NCT00369941|450267983|FG001|Overall Study|Lack of Efficacy|10|||
125177259|NCT00369941|450267982|FG000|Overall Study|Lost to Follow-up|12|||
125177260|NCT00369941|450267983|FG001|Overall Study|Lost to Follow-up|22|||
125177261|NCT00369941|450267982|FG000|Overall Study|Protocol Violation|5|||
125177262|NCT00369941|450267983|FG001|Overall Study|Protocol Violation|3|||
125177263|NCT00369941|450267982|FG000|Overall Study|Withdrawal by Subject|5|||
125177264|NCT00369941|450267983|FG001|Overall Study|Withdrawal by Subject|18|||
125177265|NCT00369941|450267982|FG000|Overall Study|Pregnancy|4|||
125177266|NCT00369941|450267983|FG001|Overall Study|Pregnancy|2|||
125177267|NCT00369941|450267982|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
125177268|NCT00369941|450267983|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
125177269|NCT00369941|450267982|FG000|Overall Study|Moved|11|||
125177270|NCT00369941|450267983|FG001|Overall Study|Moved|5|||
125177271|NCT00369941|450267982|FG000|Overall Study|Treatment with Prohibited Medication|3|||
125177272|NCT00369941|450267983|FG001|Overall Study|Treatment with Prohibited Medication|1|||
125177273|NCT00369941|450267982|FG000|Overall Study|Employment Interfered with Study Visits|1|||
125177274|NCT00369941|450267983|FG001|Overall Study|Employment Interfered with Study Visits|0|||
125177275|NCT00369941|450267982|FG000|Overall Study|Study Site Terminated|2|||
125177276|NCT00369941|450267983|FG001|Overall Study|Study Site Terminated|0|||
125177277|NCT00369941|450267982|FG000|Overall Study|Miscellaneous|3|||
125177278|NCT00369941|450267983|FG001|Overall Study|Miscellaneous|3|||
125177279|NCT01027702|450267984|FG000|Overall Study|Received subsequent therapy|1|||
125177280|NCT01027702|450267985|FG001|Overall Study|Received subsequent therapy|2|||
125177281|NCT01027702|450267986|FG002|Overall Study|Received subsequent therapy|0|||
125177282|NCT01027702|450267987|FG003|Overall Study|Received subsequent therapy|4|||
125177283|NCT01027702|450267988|FG004|Overall Study|Received subsequent therapy|1|||
125177284|NCT01027702|450267989|FG005|Overall Study|Received subsequent therapy|0|||
125177285|NCT01027702|450267990|FG006|Overall Study|Received subsequent therapy|1|||
125177286|NCT01027702|450267984|FG000|Overall Study|Death|0|||
125177287|NCT01027702|450267985|FG001|Overall Study|Death|0|||
125177288|NCT01027702|450267986|FG002|Overall Study|Death|1|||
125177289|NCT01027702|450267987|FG003|Overall Study|Death|0|||
125177290|NCT01027702|450267988|FG004|Overall Study|Death|0|||
125177291|NCT01027702|450267989|FG005|Overall Study|Death|0|||
125177292|NCT01027702|450267990|FG006|Overall Study|Death|0|||
125177293|NCT00403585|450267991|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
125177294|NCT00403585|450267991|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
125232664|NCT01799889|450481698|FG004|Overall Study|Study Terminated By Sponsor|2|||
125232665|NCT01799889|450481699|FG005|Overall Study|Study Terminated By Sponsor|1|||
125232666|NCT01799889|450481700|FG006|Overall Study|Study Terminated By Sponsor|0|||
125232667|NCT01799889|450481701|FG007|Overall Study|Study Terminated By Sponsor|2|||
125232668|NCT01799889|450481702|FG008|Overall Study|Study Terminated By Sponsor|1|||
125232669|NCT01799889|450481703|FG009|Overall Study|Study Terminated By Sponsor|1|||
125232670|NCT01799889|450481704|FG010|Overall Study|Study Terminated By Sponsor|0|||
125232671|NCT01799889|450481705|FG011|Overall Study|Study Terminated By Sponsor|0|||
125232672|NCT01799889|450481694|FG000|Overall Study|Withdrawal by Subject|1|||
125232673|NCT01799889|450481695|FG001|Overall Study|Withdrawal by Subject|6|||
125232674|NCT01799889|450481696|FG002|Overall Study|Withdrawal by Subject|4|||
125232675|NCT01799889|450481697|FG003|Overall Study|Withdrawal by Subject|0|||
125232676|NCT01799889|450481698|FG004|Overall Study|Withdrawal by Subject|5|||
125232677|NCT01799889|450481699|FG005|Overall Study|Withdrawal by Subject|1|||
125232678|NCT01799889|450481700|FG006|Overall Study|Withdrawal by Subject|3|||
125232679|NCT01799889|450481701|FG007|Overall Study|Withdrawal by Subject|1|||
125232680|NCT01799889|450481702|FG008|Overall Study|Withdrawal by Subject|2|||
125232681|NCT01799889|450481703|FG009|Overall Study|Withdrawal by Subject|1|||
125232682|NCT01799889|450481704|FG010|Overall Study|Withdrawal by Subject|1|||
125232683|NCT01799889|450481705|FG011|Overall Study|Withdrawal by Subject|1|||
125232684|NCT01799889|450481694|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125232685|NCT01799889|450481695|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125232686|NCT01799889|450481696|FG002|Overall Study|Non-Compliance With Study Drug|0|||
125232687|NCT01799889|450481697|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125232688|NCT01799889|450481698|FG004|Overall Study|Non-Compliance With Study Drug|0|||
125232689|NCT01799889|450481699|FG005|Overall Study|Non-Compliance With Study Drug|1|||
125232690|NCT01799889|450481700|FG006|Overall Study|Non-Compliance With Study Drug|0|||
125232691|NCT01799889|450481701|FG007|Overall Study|Non-Compliance With Study Drug|0|||
125232692|NCT01799889|450481702|FG008|Overall Study|Non-Compliance With Study Drug|0|||
125232693|NCT01799889|450481703|FG009|Overall Study|Non-Compliance With Study Drug|0|||
125232694|NCT01799889|450481704|FG010|Overall Study|Non-Compliance With Study Drug|0|||
125232695|NCT01799889|450481705|FG011|Overall Study|Non-Compliance With Study Drug|0|||
125232696|NCT03944616|450481706|FG000|Overall Study|Lost to Follow-up|0|||
125232697|NCT03944616|450481707|FG001|Overall Study|Lost to Follow-up|2|||
125232698|NCT01721798|450481708|FG000|Overall Study|Death|0|||
125232699|NCT01721798|450481709|FG001|Overall Study|Death|0|||
125232700|NCT01721798|450481710|FG002|Overall Study|Death|1|||
125232701|NCT01721798|450481711|FG003|Overall Study|Death|1|||
125232702|NCT01721798|450481708|FG000|Overall Study|Lost to Follow-up|2|||
125232703|NCT01721798|450481709|FG001|Overall Study|Lost to Follow-up|2|||
125232704|NCT01721798|450481710|FG002|Overall Study|Lost to Follow-up|9|||
125232705|NCT01721798|450481711|FG003|Overall Study|Lost to Follow-up|9|||
125232706|NCT01721798|450481708|FG000|Overall Study|Pregnancy|0|||
125232707|NCT01721798|450481709|FG001|Overall Study|Pregnancy|0|||
125232708|NCT01721798|450481710|FG002|Overall Study|Pregnancy|1|||
125232709|NCT01721798|450481711|FG003|Overall Study|Pregnancy|1|||
125232710|NCT01721798|450481708|FG000|Overall Study|Withdrawal by Subject|1|||
125177295|NCT00403585|450267991|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
125177296|NCT02964312|450268000|FG000|Overall Study|Lost to Follow-up|28|||
125177297|NCT02964312|450268000|FG000|Overall Study|Withdrawal by Subject|11|||
125177298|NCT02964312|450268000|FG000|Overall Study|Lack of Efficacy|10|||
125177299|NCT02964312|450268000|FG000|Overall Study|Did not consent to long-term FU|14|||
125177300|NCT02964312|450268000|FG000|Overall Study|Death|1|||
125177301|NCT02276807|450268001|FG000|Overall Study|Withdrawal by Subject|8|||
125177302|NCT02276807|450268002|FG001|Overall Study|Withdrawal by Subject|7|||
125177303|NCT02276807|450268001|FG000|Overall Study|Lost to Follow-up|10|||
125177304|NCT02276807|450268002|FG001|Overall Study|Lost to Follow-up|10|||
125177305|NCT01023035|450268004|FG000|Treatment Period|Adverse Event|27|||
125177306|NCT01023035|450268005|FG001|Treatment Period|Adverse Event|32|||
125177307|NCT01023035|450268006|FG002|Treatment Period|Adverse Event|50|||
125177308|NCT01023035|450268004|FG000|Treatment Period|Non-Medical Reasons|19|||
125177309|NCT01023035|450268005|FG001|Treatment Period|Non-Medical Reasons|22|||
125177310|NCT01023035|450268006|FG002|Treatment Period|Non-Medical Reasons|44|||
125177311|NCT01023035|450268004|FG000|Treatment Period|Treatment Failure|26|||
125177312|NCT01023035|450268005|FG001|Treatment Period|Treatment Failure|31|||
125177313|NCT01023035|450268006|FG002|Treatment Period|Treatment Failure|24|||
125232711|NCT01721798|450481709|FG001|Overall Study|Withdrawal by Subject|0|||
125232712|NCT01721798|450481710|FG002|Overall Study|Withdrawal by Subject|2|||
125232713|NCT01721798|450481711|FG003|Overall Study|Withdrawal by Subject|1|||
125177314|NCT01023035|450268004|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
125177315|NCT01023035|450268005|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
125177316|NCT01023035|450268006|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
125232714|NCT01721798|450481708|FG000|Overall Study|Not eligible for 24 month visit|1|||
125232715|NCT01721798|450481709|FG001|Overall Study|Not eligible for 24 month visit|0|||
125232716|NCT01721798|450481710|FG002|Overall Study|Not eligible for 24 month visit|8|||
125232717|NCT01721798|450481711|FG003|Overall Study|Not eligible for 24 month visit|7|||
125232718|NCT01294046|450481712|FG000|Overall Study|Infection and surgical explant|1|||
125232719|NCT01294046|450481712|FG000|Overall Study|Eligibility criteria expanded|1|||
125232720|NCT01294046|450481712|FG000|Overall Study|Stimulation response inadqequate|1|||
125232721|NCT01286129|450481715|FG000|Overall Study|Withdrawal by Subject|4|||
125232722|NCT01286129|450481716|FG001|Overall Study|Withdrawal by Subject|1|||
125232723|NCT01286129|450481715|FG000|Overall Study|Could not comply with study requirements|4|||
125232724|NCT01286129|450481716|FG001|Overall Study|Could not comply with study requirements|4|||
125232725|NCT01394276|450481717|FG000|Overall Study|Related Adverse event (AEs)|15|||
125232726|NCT01394276|450481717|FG000|Overall Study|Not related AEs|9|||
125232727|NCT01394276|450481717|FG000|Overall Study|Remission of disease|2|||
125232728|NCT01394276|450481717|FG000|Overall Study|Insufficient therapeutic effect|17|||
125232729|NCT01394276|450481717|FG000|Overall Study|Insufficient compliance|9|||
125232730|NCT01394276|450481717|FG000|Overall Study|Lost to Follow-up|5|||
125232731|NCT01394276|450481717|FG000|Overall Study|Participant moved to another site|1|||
125232732|NCT01394276|450481717|FG000|Overall Study|Pregnancy|1|||
125232733|NCT01394276|450481717|FG000|Overall Study|unavailability of drug at the Hospital|2|||
125232734|NCT01394276|450481717|FG000|Overall Study|Symptoms of concurrent diseases|1|||
125232735|NCT02187783|450481718|FG000|Overall Study|Adverse Event|8|||
125232736|NCT02187783|450481718|FG000|Overall Study|Death|3|||
125232737|NCT02187783|450481718|FG000|Overall Study|Progressive disease|80|||
125232738|NCT02187783|450481718|FG000|Overall Study|Protocol Violation|3|||
125232739|NCT02187783|450481718|FG000|Overall Study|Physician Decision|2|||
125232740|NCT02187783|450481718|FG000|Overall Study|Withdrawal by Subject|9|||
125232741|NCT02187783|450481718|FG000|Overall Study|Study terminated by sponsor|1|||
125232742|NCT00471497|450481719|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
125232743|NCT00471497|450481720|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
125232744|NCT00471497|450481721|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
125232745|NCT00471497|450481719|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
125232746|NCT00471497|450481720|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
125232747|NCT00471497|450481721|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
125232748|NCT00471497|450481719|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
125232749|NCT00471497|450481720|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
125232750|NCT00471497|450481721|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
125232751|NCT00471497|450481719|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
125232752|NCT00471497|450481720|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
125232753|NCT00471497|450481721|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
125232754|NCT00471497|450481719|FG000|Core Treatment Phase|Lost to Follow-up|6|||
125232755|NCT00471497|450481720|FG001|Core Treatment Phase|Lost to Follow-up|6|||
125232756|NCT00471497|450481721|FG002|Core Treatment Phase|Lost to Follow-up|3|||
125232757|NCT00471497|450481719|FG000|Core Treatment Phase|Death|3|||
125232758|NCT00471497|450481720|FG001|Core Treatment Phase|Death|9|||
125232759|NCT00471497|450481721|FG002|Core Treatment Phase|Death|3|||
125232760|NCT00471497|450481719|FG000|Core Treatment Phase|Disease Progression|10|||
125232761|NCT00471497|450481720|FG001|Core Treatment Phase|Disease Progression|2|||
125232762|NCT00471497|450481721|FG002|Core Treatment Phase|Disease Progression|4|||
125232763|NCT00471497|450481719|FG000|Core Treatment Phase|Protocol Violation|6|||
125232764|NCT00471497|450481720|FG001|Core Treatment Phase|Protocol Violation|15|||
125232765|NCT00471497|450481721|FG002|Core Treatment Phase|Protocol Violation|11|||
125232766|NCT00471497|450481719|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
125232767|NCT00471497|450481720|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
125232768|NCT00471497|450481721|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
125232769|NCT00471497|450481719|FG000|Core Treatment Phase|Administrative problems|14|||
125232770|NCT00471497|450481720|FG001|Core Treatment Phase|Administrative problems|14|||
125232771|NCT00471497|450481721|FG002|Core Treatment Phase|Administrative problems|12|||
125232772|NCT00471497|450481719|FG000|Core Treatment Phase|Adverse Event|43|||
125232773|NCT00471497|450481720|FG001|Core Treatment Phase|Adverse Event|53|||
125232774|NCT00471497|450481721|FG002|Core Treatment Phase|Adverse Event|89|||
125232775|NCT00471497|450481719|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
125232776|NCT00471497|450481720|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
125232777|NCT00471497|450481721|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
125232778|NCT00471497|450481719|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
125232779|NCT00471497|450481720|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
125232780|NCT00471497|450481721|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
125232781|NCT00471497|450481719|FG000|Extension Phase|Adverse Event|9|||
125232782|NCT00471497|450481720|FG001|Extension Phase|Adverse Event|5|||
125232783|NCT00471497|450481721|FG002|Extension Phase|Adverse Event|1|||
125232784|NCT00471497|450481719|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
125232785|NCT00471497|450481720|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
125232786|NCT00471497|450481721|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
125232787|NCT00471497|450481719|FG000|Extension Phase|Withdrawal by Subject|3|||
125232788|NCT00471497|450481720|FG001|Extension Phase|Withdrawal by Subject|1|||
125232789|NCT00471497|450481721|FG002|Extension Phase|Withdrawal by Subject|0|||
125177317|NCT01023035|450268004|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
125177318|NCT01023035|450268005|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
125177319|NCT01023035|450268006|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
125177320|NCT00524420|450268007|FG000|Overall Study|Lack of Efficacy|1|||
125177321|NCT00524420|450268008|FG001|Overall Study|Lack of Efficacy|0|||
125177322|NCT01090414|450268009|FG000|Study 101-99|Progressive Disease|28|||
125177323|NCT01090414|450268010|FG001|Study 101-99|Progressive Disease|48|||
125177324|NCT01090414|450268011|FG002|Study 101-99|Progressive Disease|10|||
125177325|NCT01090414|450268012|FG003|Study 101-99|Progressive Disease|4|||
125177326|NCT01090414|450268009|FG000|Study 101-99|Adverse Event|10|||
125177327|NCT01090414|450268010|FG001|Study 101-99|Adverse Event|28|||
125177328|NCT01090414|450268011|FG002|Study 101-99|Adverse Event|18|||
125177329|NCT01090414|450268012|FG003|Study 101-99|Adverse Event|0|||
125177330|NCT01090414|450268009|FG000|Study 101-99|Investigator Request|1|||
125177331|NCT01090414|450268010|FG001|Study 101-99|Investigator Request|11|||
125177332|NCT01090414|450268011|FG002|Study 101-99|Investigator Request|4|||
125177333|NCT01090414|450268012|FG003|Study 101-99|Investigator Request|0|||
125177334|NCT01090414|450268009|FG000|Study 101-99|Death|3|||
125177335|NCT01090414|450268010|FG001|Study 101-99|Death|8|||
125177336|NCT01090414|450268011|FG002|Study 101-99|Death|1|||
125177337|NCT01090414|450268012|FG003|Study 101-99|Death|0|||
125177338|NCT01090414|450268009|FG000|Study 101-99|Sponsor Discontinued Study|0|||
125177339|NCT01090414|450268010|FG001|Study 101-99|Sponsor Discontinued Study|7|||
125177340|NCT01090414|450268011|FG002|Study 101-99|Sponsor Discontinued Study|5|||
125177341|NCT01090414|450268012|FG003|Study 101-99|Sponsor Discontinued Study|0|||
125177342|NCT01090414|450268009|FG000|Study 101-99|Other (Unknown Reasons)|3|||
125177343|NCT01090414|450268010|FG001|Study 101-99|Other (Unknown Reasons)|3|||
125177344|NCT01090414|450268011|FG002|Study 101-99|Other (Unknown Reasons)|0|||
125177345|NCT01090414|450268012|FG003|Study 101-99|Other (Unknown Reasons)|0|||
125177346|NCT01090414|450268009|FG000|Study 101-99|Withdrew Consent|0|||
125177347|NCT01090414|450268010|FG001|Study 101-99|Withdrew Consent|2|||
125177348|NCT01090414|450268011|FG002|Study 101-99|Withdrew Consent|3|||
125177349|NCT01090414|450268012|FG003|Study 101-99|Withdrew Consent|1|||
125177350|NCT01090414|450268009|FG000|Study 101-99|Participant Request|3|||
125177351|NCT01090414|450268010|FG001|Study 101-99|Participant Request|1|||
125177352|NCT01090414|450268011|FG002|Study 101-99|Participant Request|0|||
125177353|NCT01090414|450268012|FG003|Study 101-99|Participant Request|0|||
125177354|NCT02413229|450268022|FG000|Overall Study|Adverse Event|0|||
125177355|NCT02413229|450268023|FG001|Overall Study|Adverse Event|0|||
125177356|NCT02413229|450268024|FG002|Overall Study|Adverse Event|0|||
125177357|NCT02413229|450268025|FG003|Overall Study|Adverse Event|1|||
125177358|NCT02413229|450268026|FG004|Overall Study|Adverse Event|0|||
125177359|NCT02413229|450268027|FG005|Overall Study|Adverse Event|0|||
125177360|NCT02413229|450268028|FG006|Overall Study|Adverse Event|0|||
125177361|NCT02413229|450268029|FG007|Overall Study|Adverse Event|1|||
125177362|NCT02413229|450268022|FG000|Overall Study|Lost to Follow-up|0|||
125177363|NCT02413229|450268023|FG001|Overall Study|Lost to Follow-up|0|||
125177364|NCT02413229|450268024|FG002|Overall Study|Lost to Follow-up|1|||
125177365|NCT02413229|450268025|FG003|Overall Study|Lost to Follow-up|0|||
125177366|NCT02413229|450268026|FG004|Overall Study|Lost to Follow-up|2|||
125177367|NCT02413229|450268027|FG005|Overall Study|Lost to Follow-up|0|||
125177368|NCT02413229|450268028|FG006|Overall Study|Lost to Follow-up|0|||
125177369|NCT02413229|450268029|FG007|Overall Study|Lost to Follow-up|0|||
125177370|NCT02413229|450268022|FG000|Overall Study|Withdrawal by Subject|1|||
125177371|NCT02413229|450268023|FG001|Overall Study|Withdrawal by Subject|1|||
125177372|NCT02413229|450268024|FG002|Overall Study|Withdrawal by Subject|0|||
125177373|NCT02413229|450268025|FG003|Overall Study|Withdrawal by Subject|0|||
125177374|NCT02413229|450268026|FG004|Overall Study|Withdrawal by Subject|1|||
125177375|NCT02413229|450268027|FG005|Overall Study|Withdrawal by Subject|0|||
125177376|NCT02413229|450268028|FG006|Overall Study|Withdrawal by Subject|0|||
125177377|NCT02413229|450268029|FG007|Overall Study|Withdrawal by Subject|2|||
125177378|NCT02413229|450268022|FG000|Overall Study|Progressive Disease|0|||
125177379|NCT02413229|450268023|FG001|Overall Study|Progressive Disease|0|||
125177380|NCT02413229|450268024|FG002|Overall Study|Progressive Disease|0|||
125232790|NCT00471497|450481719|FG000|Extension Phase|Lost to Follow-up|2|||
125232791|NCT00471497|450481720|FG001|Extension Phase|Lost to Follow-up|0|||
125232792|NCT00471497|450481721|FG002|Extension Phase|Lost to Follow-up|0|||
125232793|NCT00471497|450481719|FG000|Extension Phase|Death|1|||
125232794|NCT00471497|450481720|FG001|Extension Phase|Death|0|||
125232795|NCT00471497|450481721|FG002|Extension Phase|Death|0|||
125232796|NCT00471497|450481719|FG000|Extension Phase|Disease progression|2|||
125232797|NCT00471497|450481720|FG001|Extension Phase|Disease progression|0|||
125232798|NCT00471497|450481721|FG002|Extension Phase|Disease progression|0|||
125232799|NCT00471497|450481719|FG000|Extension Phase|Protocol Violation|2|||
125232800|NCT00471497|450481720|FG001|Extension Phase|Protocol Violation|2|||
125232801|NCT00471497|450481721|FG002|Extension Phase|Protocol Violation|0|||
125232802|NCT01654276|450481722|FG000|Overall Study|Lack of Efficacy|1|||
125232803|NCT01654276|450481722|FG000|Overall Study|Lost to Follow-up|4|||
125232804|NCT01654276|450481722|FG000|Overall Study|Withdrawal by Subject|1|||
125232805|NCT01991795|450481723|FG000|Overall Study|Lost to Follow-up|6|||
125232806|NCT01991795|450481724|FG001|Overall Study|Lost to Follow-up|4|||
125232807|NCT01991795|450481723|FG000|Overall Study|Withdrawal by Subject|117|||
125232808|NCT01991795|450481724|FG001|Overall Study|Withdrawal by Subject|94|||
125232809|NCT01991795|450481723|FG000|Overall Study|Site prematurely closed by sponsor|26|||
125232810|NCT01991795|450481724|FG001|Overall Study|Site prematurely closed by sponsor|25|||
125232811|NCT03344757|450481725|FG000|Overall Study|Withdrawal by Subject|18|||
125232812|NCT03344757|450481726|FG001|Overall Study|Withdrawal by Subject|16|||
125232813|NCT03344757|450481725|FG000|Overall Study|Lost to Follow-up|0|||
125232814|NCT03344757|450481726|FG001|Overall Study|Lost to Follow-up|2|||
125232815|NCT02121210|450481727|FG000|Overall Study|Adverse Event|5|||
125232816|NCT02121210|450481728|FG001|Overall Study|Adverse Event|7|||
125232817|NCT02121210|450481727|FG000|Overall Study|Lack of Efficacy|2|||
125232818|NCT02121210|450481728|FG001|Overall Study|Lack of Efficacy|0|||
125232819|NCT02121210|450481727|FG000|Overall Study|Other than specified above|0|||
125232820|NCT02121210|450481728|FG001|Overall Study|Other than specified above|2|||
125232821|NCT04609514|450481729|FG000|Overall Study|Lost to Follow-up|5|||
125232822|NCT04609514|450481730|FG001|Overall Study|Lost to Follow-up|4|||
125232823|NCT04609514|450481729|FG000|Overall Study|Withdrawal by PI|0|||
125232824|NCT04609514|450481730|FG001|Overall Study|Withdrawal by PI|2|||
125232825|NCT00909870|450481731|FG000|Overall Study|Adverse Event|13|||
125232826|NCT00909870|450481732|FG001|Overall Study|Adverse Event|7|||
125232827|NCT00909870|450481731|FG000|Overall Study|Protocol Violation|1|||
125232828|NCT00909870|450481732|FG001|Overall Study|Protocol Violation|2|||
125232829|NCT00909870|450481731|FG000|Overall Study|Withdrawal by Subject|5|||
125232830|NCT00909870|450481732|FG001|Overall Study|Withdrawal by Subject|8|||
125232831|NCT00909870|450481731|FG000|Overall Study|Lost to Follow-up|3|||
125232832|NCT00909870|450481732|FG001|Overall Study|Lost to Follow-up|3|||
125232833|NCT00909870|450481731|FG000|Overall Study|Physician Decision|0|||
125232834|NCT00909870|450481732|FG001|Overall Study|Physician Decision|2|||
125232835|NCT00909870|450481731|FG000|Overall Study|Other|1|||
125177381|NCT02413229|450268025|FG003|Overall Study|Progressive Disease|0|||
125177382|NCT02413229|450268026|FG004|Overall Study|Progressive Disease|0|||
125177383|NCT02413229|450268027|FG005|Overall Study|Progressive Disease|0|||
125177384|NCT02413229|450268028|FG006|Overall Study|Progressive Disease|0|||
125177385|NCT02413229|450268029|FG007|Overall Study|Progressive Disease|1|||
125177386|NCT02932462|450268030|FG000|Overall Study|Adverse Event|1|||
125177387|NCT02932462|450268031|FG001|Overall Study|Adverse Event|2|||
125177388|NCT02932462|450268030|FG000|Overall Study|Lost to Follow-up|4|||
125177389|NCT02932462|450268031|FG001|Overall Study|Lost to Follow-up|1|||
125177390|NCT02932462|450268030|FG000|Overall Study|Protocol Violation|0|||
125177391|NCT02932462|450268031|FG001|Overall Study|Protocol Violation|5|||
125177392|NCT02932462|450268030|FG000|Overall Study|Withdrawal by Subject|1|||
125177393|NCT02932462|450268031|FG001|Overall Study|Withdrawal by Subject|4|||
125177394|NCT02932462|450268030|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125177395|NCT02932462|450268031|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125177396|NCT02932462|450268030|FG000|Overall Study|Progressive Disease|1|||
125177397|NCT02932462|450268031|FG001|Overall Study|Progressive Disease|0|||
125177398|NCT02652949|450268032|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
125177399|NCT02652949|450268032|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
125177400|NCT02652949|450268032|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
125177401|NCT02652949|450268032|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
125177402|NCT02652949|450268032|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
125177403|NCT02652949|450268032|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
125177404|NCT02652949|450268032|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
125177405|NCT02652949|450268032|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
125177406|NCT02652949|450268032|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
125232836|NCT00909870|450481732|FG001|Overall Study|Other|5|||
125232837|NCT01316575|450481733|FG000|Overall Study|Withdrawal by Subject|2|||
125232838|NCT01316575|450481734|FG001|Overall Study|Withdrawal by Subject|0|||
125232839|NCT01316575|450481733|FG000|Overall Study|Required alternate treatment|0|||
125232840|NCT01316575|450481734|FG001|Overall Study|Required alternate treatment|1|||
125232841|NCT01232283|450481737|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
125232842|NCT01232283|450481738|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
125232843|NCT01232283|450481739|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
125232844|NCT01232283|450481740|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
125232845|NCT01232283|450481741|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
125232846|NCT01232283|450481742|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
125232847|NCT01232283|450481743|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
125232848|NCT01232283|450481744|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
125232849|NCT01232283|450481745|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
125232850|NCT01232283|450481746|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
125232851|NCT01232283|450481737|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
125232852|NCT01232283|450481738|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
125232853|NCT01232283|450481739|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125232854|NCT01232283|450481740|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125232855|NCT01232283|450481741|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125232856|NCT01232283|450481742|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125232857|NCT01232283|450481743|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125232858|NCT01232283|450481744|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125232859|NCT01232283|450481745|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125232860|NCT01232283|450481746|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125232861|NCT01232283|450481737|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
125232862|NCT01232283|450481738|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
125232863|NCT01232283|450481739|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
125232864|NCT01232283|450481740|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
125232865|NCT01232283|450481741|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
125232866|NCT01232283|450481742|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
125232867|NCT01232283|450481743|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
125232868|NCT01232283|450481744|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
125232869|NCT01232283|450481745|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
125232870|NCT01232283|450481746|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
125232871|NCT01232283|450481737|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
125232872|NCT01232283|450481738|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
125232873|NCT01232283|450481739|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125232874|NCT01232283|450481740|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125232875|NCT01232283|450481741|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125232876|NCT01232283|450481742|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125232877|NCT01232283|450481743|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125232878|NCT01232283|450481744|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125232879|NCT01232283|450481745|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125232880|NCT01232283|450481746|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125232881|NCT01232283|450481737|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
125232882|NCT01232283|450481738|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
125232883|NCT01232283|450481739|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
125232884|NCT01232283|450481740|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
125232885|NCT01232283|450481741|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
125232886|NCT01232283|450481742|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
125232887|NCT01232283|450481743|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
125232888|NCT01232283|450481744|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
125232889|NCT01232283|450481745|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
125232890|NCT01232283|450481746|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
125232891|NCT01232283|450481737|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
125232892|NCT01232283|450481738|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
125232893|NCT01232283|450481739|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
125232894|NCT01232283|450481740|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
125232895|NCT01232283|450481741|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
125232896|NCT01232283|450481742|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
125232897|NCT01232283|450481743|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
125232898|NCT01232283|450481744|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
125232899|NCT01232283|450481745|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
125232900|NCT01232283|450481746|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
125232901|NCT01232283|450481737|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
125232902|NCT01232283|450481738|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
125232903|NCT01232283|450481739|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
125232904|NCT01232283|450481740|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
125232905|NCT01232283|450481741|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
125232906|NCT01232283|450481742|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
125232907|NCT01232283|450481743|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
125232908|NCT01232283|450481744|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
125232909|NCT01232283|450481745|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
125232910|NCT01232283|450481746|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
125232911|NCT01232283|450481737|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
125232912|NCT01232283|450481738|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
125232913|NCT01232283|450481739|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
125232914|NCT01232283|450481740|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
125232915|NCT01232283|450481741|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
125232916|NCT01232283|450481742|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
125232917|NCT01232283|450481743|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
125232918|NCT01232283|450481744|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
125232919|NCT01232283|450481745|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
125232920|NCT01232283|450481746|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
125232921|NCT01232283|450481737|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
125232922|NCT01232283|450481738|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
125232923|NCT01232283|450481739|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
125232924|NCT01232283|450481740|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
125232925|NCT01232283|450481741|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
125232926|NCT01232283|450481742|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
125232927|NCT01232283|450481743|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
125232928|NCT01232283|450481744|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
125232929|NCT01232283|450481745|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
125232930|NCT01232283|450481746|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
125232931|NCT01232283|450481737|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
125232932|NCT01232283|450481738|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
125232933|NCT01232283|450481739|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
125232934|NCT01232283|450481740|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
125232935|NCT01232283|450481741|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
125232936|NCT01232283|450481742|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
125232937|NCT01232283|450481743|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
125232938|NCT01232283|450481744|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
125232939|NCT01232283|450481745|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
125232940|NCT01232283|450481746|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
125232941|NCT01232283|450481737|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
125232942|NCT01232283|450481738|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
125232943|NCT01232283|450481739|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
125232944|NCT01232283|450481740|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
125232945|NCT01232283|450481741|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
125232946|NCT01232283|450481742|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
125232947|NCT01232283|450481743|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
125232948|NCT01232283|450481744|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
125232949|NCT01232283|450481745|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
125232950|NCT01232283|450481746|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
125232951|NCT01232283|450481737|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
125232952|NCT01232283|450481738|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
125232953|NCT01232283|450481739|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
125232954|NCT01232283|450481740|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
125232955|NCT01232283|450481741|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
125232956|NCT01232283|450481742|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
125232957|NCT01232283|450481743|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
125232958|NCT01232283|450481744|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
125232959|NCT01232283|450481745|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
125232960|NCT01232283|450481746|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
125232961|NCT01232283|450481737|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
125232962|NCT01232283|450481738|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
125232963|NCT01232283|450481739|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
125232964|NCT01232283|450481740|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
125232965|NCT01232283|450481741|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
125232966|NCT01232283|450481742|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
125232967|NCT01232283|450481743|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
125232968|NCT01232283|450481744|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
125232969|NCT01232283|450481745|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
125232970|NCT01232283|450481746|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
125232971|NCT01232283|450481737|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
125232972|NCT01232283|450481738|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
125232973|NCT01232283|450481739|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
125232974|NCT01232283|450481740|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
125232975|NCT01232283|450481741|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
125232976|NCT01232283|450481742|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
125232977|NCT01232283|450481743|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
125232978|NCT01232283|450481744|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
125232979|NCT01232283|450481745|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
125232980|NCT01232283|450481746|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
125232981|NCT01232283|450481737|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
125232982|NCT01232283|450481738|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
125232983|NCT01232283|450481739|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
125232984|NCT01232283|450481740|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
125232985|NCT01232283|450481741|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
125232986|NCT01232283|450481742|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
125232987|NCT01232283|450481743|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
125232988|NCT01232283|450481744|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
125232989|NCT01232283|450481745|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
125232990|NCT01232283|450481746|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
125232991|NCT01232283|450481737|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
125232992|NCT01232283|450481738|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
125232993|NCT01232283|450481739|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
125232994|NCT01232283|450481740|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
125232995|NCT01232283|450481741|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
125232996|NCT01232283|450481742|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
125232997|NCT01232283|450481743|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
125232998|NCT01232283|450481744|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
125232999|NCT01232283|450481745|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
125233000|NCT01232283|450481746|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
125233001|NCT01232283|450481737|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
125233002|NCT01232283|450481738|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
125233003|NCT01232283|450481739|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
125233004|NCT01232283|450481740|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
125233005|NCT01232283|450481741|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
125233006|NCT01232283|450481742|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
125233007|NCT01232283|450481743|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
125233008|NCT01232283|450481744|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
125233009|NCT01232283|450481745|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
125233010|NCT01232283|450481746|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
125233011|NCT01232283|450481737|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
125233012|NCT01232283|450481738|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
125233013|NCT01232283|450481739|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
125233014|NCT01232283|450481740|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
125233015|NCT01232283|450481741|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
125233016|NCT01232283|450481742|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
125233017|NCT01232283|450481743|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
125233018|NCT01232283|450481744|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
125233019|NCT01232283|450481745|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
125233020|NCT01232283|450481746|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
125233021|NCT01232283|450481737|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
125233022|NCT01232283|450481738|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
125233023|NCT01232283|450481739|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
125233024|NCT01232283|450481740|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
125233025|NCT01232283|450481741|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
125233026|NCT01232283|450481742|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
125233027|NCT01232283|450481743|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
125233028|NCT01232283|450481744|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
125233029|NCT01232283|450481745|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
125233030|NCT01232283|450481746|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
125233031|NCT01232283|450481737|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
125233032|NCT01232283|450481738|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
125233033|NCT01232283|450481739|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
125233034|NCT01232283|450481740|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
125233035|NCT01232283|450481741|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
125233036|NCT01232283|450481742|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
125233037|NCT01232283|450481743|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
125233038|NCT01232283|450481744|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
125233039|NCT01232283|450481745|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
125233040|NCT01232283|450481746|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
125233041|NCT01232283|450481737|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
125233042|NCT01232283|450481738|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
125233043|NCT01232283|450481739|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
125233044|NCT01232283|450481740|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
125233045|NCT01232283|450481741|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
125233046|NCT01232283|450481742|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
125233047|NCT01232283|450481743|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
125233048|NCT01232283|450481744|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
125233049|NCT01232283|450481745|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
125233050|NCT01232283|450481746|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
125233051|NCT01232283|450481737|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
125233052|NCT01232283|450481738|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
125233053|NCT01232283|450481739|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
125233054|NCT01232283|450481740|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
125233055|NCT01232283|450481741|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
125233056|NCT01232283|450481742|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
125233057|NCT01232283|450481743|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
125177407|NCT02652949|450268032|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
125177408|NCT02652949|450268032|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
125177409|NCT02652949|450268032|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
125177410|NCT02652949|450268032|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
125177411|NCT02652949|450268032|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
125177412|NCT02652949|450268032|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
125177413|NCT02652949|450268032|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
125177414|NCT02652949|450268032|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
125177415|NCT01487525|450268035|FG000|Overall Study|Withdrawal by Subject|0|||
125177416|NCT01487525|450268036|FG001|Overall Study|Withdrawal by Subject|1|||
125177417|NCT04650204|450268037|FG000|Overall Study|Study was Terminated|2|||
125177418|NCT04650204|450268038|FG001|Overall Study|Study was Terminated|1|||
125177419|NCT01330303|450268039|FG000|Period 1|Adverse Event|1|||
125177420|NCT01330303|450268040|FG001|Period 1|Adverse Event|0|||
125177421|NCT01330303|450268039|FG000|Period 1|Protocol Violation|0|||
125177422|NCT01330303|450268040|FG001|Period 1|Protocol Violation|1|||
125177423|NCT01330303|450268039|FG000|Period 1|Withdrawal by Subject|0|||
125177424|NCT01330303|450268040|FG001|Period 1|Withdrawal by Subject|1|||
125177425|NCT01107197|450268041|FG000|Overall Study|Death|12|||
125177426|NCT01107197|450268042|FG001|Overall Study|Death|10|||
125177427|NCT01107197|450268041|FG000|Overall Study|Lost to Follow-up|5|||
125177428|NCT01107197|450268042|FG001|Overall Study|Lost to Follow-up|8|||
125177429|NCT01107197|450268041|FG000|Overall Study|Withdrawal by Subject|3|||
125177430|NCT01107197|450268042|FG001|Overall Study|Withdrawal by Subject|5|||
125177431|NCT03548337|450268043|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
125177432|NCT03548337|450268044|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
125177433|NCT03548337|450268043|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
125177434|NCT03548337|450268044|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
125177435|NCT03548337|450268043|FG000|Infant Series|Lost to Follow-up|2|||
125177436|NCT03548337|450268044|FG001|Infant Series|Lost to Follow-up|1|||
125177437|NCT03548337|450268043|FG000|Infant Series|Adverse Event|0|||
125177438|NCT03548337|450268044|FG001|Infant Series|Adverse Event|2|||
125177439|NCT03548337|450268043|FG000|Infant Series|Randomized but Not Vaccinated|1|||
125177440|NCT03548337|450268044|FG001|Infant Series|Randomized but Not Vaccinated|0|||
125177441|NCT03548337|450268043|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
125177442|NCT03548337|450268044|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
125177443|NCT01911273|450268046|FG000|Overall Study|Progression of Disease|1|||
125177444|NCT01911273|450268047|FG001|Overall Study|Progression of Disease|0|||
125177445|NCT01911273|450268046|FG000|Overall Study|Withdrawal by Subject|0|||
125177446|NCT01911273|450268047|FG001|Overall Study|Withdrawal by Subject|2|||
125177447|NCT01855828|450268051|FG000|Overall Study|Adverse Event|1|||
125177448|NCT01855828|450268051|FG000|Overall Study|Withdrawal by Subject|1|||
125177449|NCT02517463|450268063|FG000|Overall Study|Lost to Follow-up|5|||
125233058|NCT01232283|450481744|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
125233059|NCT01232283|450481745|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
125177450|NCT02517463|450268064|FG001|Overall Study|Lost to Follow-up|2|||
125177451|NCT02890355|450268080|FG000|Overall Study|Adverse Event|5|||
125177452|NCT02890355|450268081|FG001|Overall Study|Adverse Event|5|||
125177453|NCT02890355|450268080|FG000|Overall Study|Refusal unrelated to adverse event|5|||
125177454|NCT02890355|450268081|FG001|Overall Study|Refusal unrelated to adverse event|10|||
125177455|NCT02890355|450268080|FG000|Overall Study|Progression/relapse|46|||
125177456|NCT02890355|450268081|FG001|Overall Study|Progression/relapse|39|||
125233060|NCT01232283|450481746|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
125177457|NCT02890355|450268080|FG000|Overall Study|Not protocol specified|3|||
125177458|NCT02890355|450268081|FG001|Overall Study|Not protocol specified|4|||
125177459|NCT01128179|450268082|FG000|Overall Study|Death|1|||
125177460|NCT01128179|450268083|FG001|Overall Study|Death|0|||
125177461|NCT01128179|450268082|FG000|Overall Study|Protocol Violation|1|||
125177462|NCT01128179|450268083|FG001|Overall Study|Protocol Violation|0|||
125177463|NCT00720382|450268084|FG000|Overall Study|Adverse Event|54|||
125177464|NCT00720382|450268085|FG001|Overall Study|Adverse Event|17|||
125177465|NCT00720382|450268084|FG000|Overall Study|Lack of Efficacy|18|||
125233061|NCT01232283|450481737|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
125233062|NCT01232283|450481738|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
125233063|NCT01232283|450481739|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
125233064|NCT01232283|450481740|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
125233065|NCT01232283|450481741|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
125233066|NCT01232283|450481742|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
125233067|NCT01232283|450481743|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
125233068|NCT01232283|450481744|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
125233069|NCT01232283|450481745|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
125233070|NCT01232283|450481746|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
125233071|NCT01232283|450481737|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
125233072|NCT01232283|450481738|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
125233073|NCT01232283|450481739|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
125233074|NCT01232283|450481740|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
125233075|NCT01232283|450481741|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
125233076|NCT01232283|450481742|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
125233077|NCT01232283|450481743|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
125233078|NCT01232283|450481744|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
125233079|NCT01232283|450481745|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
125233080|NCT01232283|450481746|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
125233081|NCT01232283|450481737|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
125233082|NCT01232283|450481738|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
125233083|NCT01232283|450481739|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
125233084|NCT01232283|450481740|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
125233085|NCT01232283|450481741|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
125233086|NCT01232283|450481742|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
125233087|NCT01232283|450481743|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
125233088|NCT01232283|450481744|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
125233089|NCT01232283|450481745|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
125233090|NCT01232283|450481746|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
125233091|NCT01232283|450481737|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
125233092|NCT01232283|450481738|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
125233093|NCT01232283|450481739|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
125233094|NCT01232283|450481740|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
125233095|NCT01232283|450481741|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
125233096|NCT01232283|450481742|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
125233097|NCT01232283|450481743|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
125233098|NCT01232283|450481744|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
125233099|NCT01232283|450481745|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
125233100|NCT01232283|450481746|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
125233101|NCT01232283|450481737|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
125233102|NCT01232283|450481738|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
125233103|NCT01232283|450481739|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
125233104|NCT01232283|450481740|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
125233105|NCT01232283|450481741|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
125233106|NCT01232283|450481742|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
125233107|NCT01232283|450481743|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
125233108|NCT01232283|450481744|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
125233109|NCT01232283|450481745|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
125177466|NCT00720382|450268085|FG001|Overall Study|Lack of Efficacy|7|||
125177467|NCT00720382|450268084|FG000|Overall Study|Non-Compliance|15|||
125177468|NCT00720382|450268085|FG001|Overall Study|Non-Compliance|5|||
125233110|NCT01232283|450481746|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
125177469|NCT00720382|450268084|FG000|Overall Study|Withdrawal by Subject|47|||
125177470|NCT00720382|450268085|FG001|Overall Study|Withdrawal by Subject|11|||
125177471|NCT00720382|450268084|FG000|Overall Study|Lost to Follow-up|28|||
125177472|NCT00720382|450268085|FG001|Overall Study|Lost to Follow-up|14|||
125177473|NCT00720382|450268084|FG000|Overall Study|administrative|14|||
125177474|NCT00720382|450268085|FG001|Overall Study|administrative|5|||
125177475|NCT04460885|450270470|FG000|Overall Study|Withdrawal by Subject|6|||
125177476|NCT04460885|450270471|FG001|Overall Study|Withdrawal by Subject|8|||
125177477|NCT04460885|450270470|FG000|Overall Study|Site closure|1|||
125177478|NCT04460885|450270471|FG001|Overall Study|Site closure|0|||
125177479|NCT04460885|450270470|FG000|Overall Study|Death|5|||
125177480|NCT04460885|450270471|FG001|Overall Study|Death|4|||
125177481|NCT04460885|450270470|FG000|Overall Study|Physician Decision|2|||
125177482|NCT04460885|450270471|FG001|Overall Study|Physician Decision|1|||
125177483|NCT04460885|450270470|FG000|Overall Study|Lost to Follow-up|4|||
125177484|NCT04460885|450270471|FG001|Overall Study|Lost to Follow-up|4|||
125177485|NCT04559347|450270472|FG000|Overall Study|Death|1|||
125177486|NCT04559347|450270473|FG001|Overall Study|Death|0|||
125177487|NCT04559347|450270472|FG000|Overall Study|Thoracotomy conversion|1|||
125177488|NCT04559347|450270473|FG001|Overall Study|Thoracotomy conversion|1|||
125177489|NCT04559347|450270472|FG000|Overall Study|Provider unavailable|2|||
125177490|NCT04559347|450270473|FG001|Overall Study|Provider unavailable|1|||
125177491|NCT04559347|450270472|FG000|Overall Study|Other|2|||
125177492|NCT04559347|450270473|FG001|Overall Study|Other|1|||
125177493|NCT03999996|450270478|FG000|Prior to Booster|Adverse Event|2|||
125177494|NCT03999996|450270479|FG001|Prior to Booster|Adverse Event|0|||
125177495|NCT03999996|450270480|FG002|Prior to Booster|Adverse Event|0|||
125177496|NCT03999996|450270481|FG003|Prior to Booster|Adverse Event|0|||
125177497|NCT03999996|450270478|FG000|Prior to Booster|Lost to Follow-up|17|||
125177498|NCT03999996|450270479|FG001|Prior to Booster|Lost to Follow-up|22|||
125177499|NCT03999996|450270480|FG002|Prior to Booster|Lost to Follow-up|0|||
125177500|NCT03999996|450270481|FG003|Prior to Booster|Lost to Follow-up|0|||
125177501|NCT03999996|450270478|FG000|Prior to Booster|Withdrawal of Consent|51|||
125177502|NCT03999996|450270479|FG001|Prior to Booster|Withdrawal of Consent|8|||
125177503|NCT03999996|450270480|FG002|Prior to Booster|Withdrawal of Consent|0|||
125177504|NCT03999996|450270481|FG003|Prior to Booster|Withdrawal of Consent|0|||
125177505|NCT03999996|450270478|FG000|Prior to Booster|Death|0|||
125177506|NCT03999996|450270479|FG001|Prior to Booster|Death|1|||
125177507|NCT03999996|450270480|FG002|Prior to Booster|Death|0|||
125177508|NCT03999996|450270481|FG003|Prior to Booster|Death|0|||
125177509|NCT03999996|450270478|FG000|Prior to Booster|Reason Not Specified|27|||
125177510|NCT03999996|450270479|FG001|Prior to Booster|Reason Not Specified|4|||
125177511|NCT03999996|450270480|FG002|Prior to Booster|Reason Not Specified|0|||
125177512|NCT03999996|450270481|FG003|Prior to Booster|Reason Not Specified|0|||
125177513|NCT03999996|450270478|FG000|Booster Phase|Lost to Follow-up|0|||
125177514|NCT03999996|450270479|FG001|Booster Phase|Lost to Follow-up|0|||
125177515|NCT03999996|450270480|FG002|Booster Phase|Lost to Follow-up|3|||
125177516|NCT03999996|450270481|FG003|Booster Phase|Lost to Follow-up|3|||
125177517|NCT03999996|450270478|FG000|Booster Phase|Withdrawal of Consent|0|||
125177518|NCT03999996|450270479|FG001|Booster Phase|Withdrawal of Consent|0|||
125177519|NCT03999996|450270480|FG002|Booster Phase|Withdrawal of Consent|0|||
125177520|NCT03999996|450270481|FG003|Booster Phase|Withdrawal of Consent|1|||
125177521|NCT03999996|450270478|FG000|Booster Phase|Reason Not Specified|0|||
125177522|NCT03999996|450270479|FG001|Booster Phase|Reason Not Specified|0|||
125177523|NCT03999996|450270480|FG002|Booster Phase|Reason Not Specified|0|||
125177524|NCT03999996|450270481|FG003|Booster Phase|Reason Not Specified|1|||
125177525|NCT00733005|450270482|FG000|Overall Study|Adverse Event|0|||
125177526|NCT00733005|450270483|FG001|Overall Study|Adverse Event|1|||
125177527|NCT00733005|450270482|FG000|Overall Study|Treatment Failure|0|||
125233111|NCT01232283|450481737|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
125233112|NCT01232283|450481738|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
125233113|NCT01232283|450481739|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
125233114|NCT01232283|450481740|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
125233115|NCT01232283|450481741|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
125177528|NCT00733005|450270483|FG001|Overall Study|Treatment Failure|1|||
125233116|NCT01232283|450481742|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
125233117|NCT01232283|450481743|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
125233118|NCT01232283|450481744|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
125177529|NCT00733005|450270482|FG000|Overall Study|Withdrawal by Subject|0|||
125177530|NCT00733005|450270483|FG001|Overall Study|Withdrawal by Subject|1|||
125177531|NCT00733005|450270482|FG000|Overall Study|Protocol Violation|2|||
125177532|NCT00733005|450270483|FG001|Overall Study|Protocol Violation|0|||
125177533|NCT03410056|450270484|FG000|Overall Study|Decision by Sponsor|0|||
125177534|NCT03410056|450270485|FG001|Overall Study|Decision by Sponsor|0|||
125177535|NCT03410056|450270486|FG002|Overall Study|Decision by Sponsor|3|||
125177536|NCT03410056|450270487|FG003|Overall Study|Decision by Sponsor|0|||
125177537|NCT03410056|450270488|FG004|Overall Study|Decision by Sponsor|0|||
125177538|NCT03410056|450270489|FG005|Overall Study|Decision by Sponsor|0|||
125177539|NCT03410056|450270490|FG006|Overall Study|Decision by Sponsor|0|||
125177540|NCT03410056|450270484|FG000|Overall Study|Withdrawal by Subject|0|||
125177541|NCT03410056|450270485|FG001|Overall Study|Withdrawal by Subject|2|||
125233119|NCT01232283|450481745|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
125233120|NCT01232283|450481746|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
125233121|NCT00402831|450481747|FG000|Overall Study|Lost to Follow-up|1|||
125233122|NCT00402831|450481748|FG001|Overall Study|Lost to Follow-up|2|||
125233123|NCT00402831|450481747|FG000|Overall Study|Non-compliance with protocol|0|||
125233124|NCT00402831|450481748|FG001|Overall Study|Non-compliance with protocol|1|||
125233125|NCT02792504|450481753|FG000|Overall Study|Lost to Follow-up|24|||
125233126|NCT02792504|450481753|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
125233127|NCT00848497|450481760|FG000|Overall Study|Screen failure|2|||
125233128|NCT00848497|450481761|FG001|Overall Study|Screen failure|0|||
125233129|NCT00848497|450481760|FG000|Overall Study|Withdrawal by Subject|0|||
125233130|NCT00848497|450481761|FG001|Overall Study|Withdrawal by Subject|1|||
125233131|NCT01114724|450481762|FG000|Overall Study|Death|8|||
125233132|NCT01114724|450481762|FG000|Overall Study|Lost to Follow-up|1|||
125233133|NCT01114724|450481762|FG000|Overall Study|Withdrawal by Subject|1|||
125233134|NCT02966834|450481763|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
125233135|NCT02966834|450481764|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
125233136|NCT02966834|450481765|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
125233137|NCT02966834|450481766|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
125233138|NCT02966834|450481767|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
125233139|NCT02966834|450481768|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
125233140|NCT02966834|450481763|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
125233141|NCT02966834|450481764|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125233142|NCT02966834|450481765|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125233143|NCT02966834|450481766|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125233144|NCT02966834|450481767|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125233145|NCT02966834|450481768|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125233146|NCT02966834|450481763|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
125233147|NCT02966834|450481764|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
125233148|NCT02966834|450481765|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
125233149|NCT02966834|450481766|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
125233150|NCT02966834|450481767|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
125233151|NCT02966834|450481768|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
125233152|NCT02966834|450481763|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
125233153|NCT02966834|450481764|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
125233154|NCT02966834|450481765|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
125233155|NCT02966834|450481766|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
125233156|NCT02966834|450481767|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
125233157|NCT02966834|450481768|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
125233158|NCT02966834|450481763|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
125233159|NCT02966834|450481764|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
125233160|NCT02966834|450481765|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
125233161|NCT02966834|450481766|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
125233162|NCT02966834|450481767|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
125233163|NCT02966834|450481768|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
125233164|NCT02966834|450481763|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
125233165|NCT02966834|450481764|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
125233166|NCT02966834|450481765|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
125233167|NCT02966834|450481766|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
125233168|NCT02966834|450481767|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
125233169|NCT02966834|450481768|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
125233170|NCT03883386|450481769|FG000|First Assignment|Lost to Follow-up|1|||
125233171|NCT03883386|450481770|FG001|First Assignment|Lost to Follow-up|0|||
125233172|NCT03883386|450481769|FG000|First Assignment|Withdrawal by Subject|1|||
125233173|NCT03883386|450481770|FG001|First Assignment|Withdrawal by Subject|1|||
125233174|NCT02814526|450481771|FG000|Overall Study|Adverse Event|4|||
125233175|NCT02814526|450481772|FG001|Overall Study|Adverse Event|3|||
125233176|NCT02814526|450481771|FG000|Overall Study|Death|1|||
125233177|NCT02814526|450481772|FG001|Overall Study|Death|1|||
125233178|NCT02814526|450481771|FG000|Overall Study|Lost to Follow-up|3|||
125233179|NCT02814526|450481772|FG001|Overall Study|Lost to Follow-up|4|||
125233180|NCT02814526|450481771|FG000|Overall Study|non site physician decision|1|||
125233181|NCT02814526|450481772|FG001|Overall Study|non site physician decision|0|||
125233182|NCT02814526|450481771|FG000|Overall Study|participant noncompliance|1|||
125233183|NCT02814526|450481772|FG001|Overall Study|participant noncompliance|1|||
125233184|NCT02814526|450481771|FG000|Overall Study|Withdrawal by Subject|20|||
125233185|NCT02814526|450481772|FG001|Overall Study|Withdrawal by Subject|14|||
125233186|NCT02814526|450481771|FG000|Overall Study|safety risk|2|||
125233187|NCT02814526|450481772|FG001|Overall Study|safety risk|1|||
125233188|NCT02814526|450481771|FG000|Overall Study|early termination-study terminated|1|||
125233189|NCT02814526|450481772|FG001|Overall Study|early termination-study terminated|2|||
125233190|NCT02814526|450481771|FG000|Overall Study|Other|0|||
125233191|NCT02814526|450481772|FG001|Overall Study|Other|4|||
125233192|NCT00251758|450481773|FG000|Overall Study|Adverse Event|7|||
125233193|NCT00251758|450481774|FG001|Overall Study|Adverse Event|9|||
125233194|NCT00251758|450481775|FG002|Overall Study|Adverse Event|11|||
125233195|NCT00251758|450481773|FG000|Overall Study|Lost to Follow-up|4|||
125233196|NCT00251758|450481774|FG001|Overall Study|Lost to Follow-up|2|||
125233197|NCT00251758|450481775|FG002|Overall Study|Lost to Follow-up|5|||
125233198|NCT00251758|450481773|FG000|Overall Study|Withdrawal by Subject|13|||
125233199|NCT00251758|450481774|FG001|Overall Study|Withdrawal by Subject|7|||
125233200|NCT00251758|450481775|FG002|Overall Study|Withdrawal by Subject|3|||
125233201|NCT00251758|450481773|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
125233202|NCT00251758|450481774|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
125233203|NCT00251758|450481775|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
125233204|NCT00251758|450481773|FG000|Overall Study|Lack of Efficacy|3|||
125233205|NCT00251758|450481774|FG001|Overall Study|Lack of Efficacy|0|||
125233206|NCT00251758|450481775|FG002|Overall Study|Lack of Efficacy|0|||
125233207|NCT00251758|450481773|FG000|Overall Study|Noncompliant|0|||
125233208|NCT00251758|450481774|FG001|Overall Study|Noncompliant|2|||
125233209|NCT00251758|450481775|FG002|Overall Study|Noncompliant|2|||
125233210|NCT00251758|450481773|FG000|Overall Study|Pregnancy|0|||
125233211|NCT00251758|450481774|FG001|Overall Study|Pregnancy|1|||
125177542|NCT03410056|450270486|FG002|Overall Study|Withdrawal by Subject|5|||
125177543|NCT03410056|450270487|FG003|Overall Study|Withdrawal by Subject|5|||
125177544|NCT03410056|450270488|FG004|Overall Study|Withdrawal by Subject|0|||
125177545|NCT03410056|450270489|FG005|Overall Study|Withdrawal by Subject|0|||
125177546|NCT03410056|450270490|FG006|Overall Study|Withdrawal by Subject|0|||
125177547|NCT00266630|450270491|FG000|Overall Study|Adverse Event|8|||
125177548|NCT00266630|450270492|FG001|Overall Study|Adverse Event|6|||
125177549|NCT00266630|450270491|FG000|Overall Study|Lack of Efficacy|1|||
125177550|NCT00266630|450270492|FG001|Overall Study|Lack of Efficacy|4|||
125177551|NCT00266630|450270491|FG000|Overall Study|Entry Criteria not met|1|||
125177552|NCT00266630|450270492|FG001|Overall Study|Entry Criteria not met|0|||
125177553|NCT00266630|450270491|FG000|Overall Study|Protocol Violation|1|||
125177554|NCT00266630|450270492|FG001|Overall Study|Protocol Violation|3|||
125177555|NCT00266630|450270491|FG000|Overall Study|Physician Decision|1|||
125177556|NCT00266630|450270492|FG001|Overall Study|Physician Decision|2|||
125177557|NCT00266630|450270491|FG000|Overall Study|Withdrawal by Subject|10|||
125177558|NCT00266630|450270492|FG001|Overall Study|Withdrawal by Subject|2|||
125177559|NCT00266630|450270491|FG000|Overall Study|Lost to Follow-up|1|||
125177560|NCT00266630|450270492|FG001|Overall Study|Lost to Follow-up|0|||
125177561|NCT00266630|450270491|FG000|Overall Study|Other|19|||
125177562|NCT00266630|450270492|FG001|Overall Study|Other|11|||
125177563|NCT03284723|450270493|FG000|Overall Study|Death|0|||
125177564|NCT03284723|450270494|FG001|Overall Study|Death|0|||
125177565|NCT03284723|450270495|FG002|Overall Study|Death|0|||
125177566|NCT03284723|450270496|FG003|Overall Study|Death|1|||
125177567|NCT03284723|450270497|FG004|Overall Study|Death|0|||
125177568|NCT03284723|450270498|FG005|Overall Study|Death|0|||
125177569|NCT03284723|450270499|FG006|Overall Study|Death|1|||
125177570|NCT03284723|450270500|FG007|Overall Study|Death|0|||
125177571|NCT03284723|450270501|FG008|Overall Study|Death|0|||
125177572|NCT03284723|450270502|FG009|Overall Study|Death|2|||
125177573|NCT03284723|450270503|FG010|Overall Study|Death|1|||
125177574|NCT03284723|450270504|FG011|Overall Study|Death|0|||
125177575|NCT03284723|450270493|FG000|Overall Study|Lost to Follow-up|0|||
125177576|NCT03284723|450270494|FG001|Overall Study|Lost to Follow-up|0|||
125177577|NCT03284723|450270495|FG002|Overall Study|Lost to Follow-up|0|||
125177578|NCT03284723|450270496|FG003|Overall Study|Lost to Follow-up|0|||
125177579|NCT03284723|450270497|FG004|Overall Study|Lost to Follow-up|0|||
125177580|NCT03284723|450270498|FG005|Overall Study|Lost to Follow-up|2|||
125177581|NCT03284723|450270499|FG006|Overall Study|Lost to Follow-up|1|||
125177582|NCT03284723|450270500|FG007|Overall Study|Lost to Follow-up|0|||
125177583|NCT03284723|450270501|FG008|Overall Study|Lost to Follow-up|0|||
125177584|NCT03284723|450270502|FG009|Overall Study|Lost to Follow-up|2|||
125177585|NCT03284723|450270503|FG010|Overall Study|Lost to Follow-up|0|||
125177586|NCT03284723|450270504|FG011|Overall Study|Lost to Follow-up|0|||
125177587|NCT03284723|450270493|FG000|Overall Study|Study Terminated By Sponsor|0|||
125233212|NCT00251758|450481775|FG002|Overall Study|Pregnancy|0|||
125233213|NCT00251758|450481773|FG000|Overall Study|Per Subject Request|0|||
125177588|NCT03284723|450270494|FG001|Overall Study|Study Terminated By Sponsor|0|||
125177589|NCT03284723|450270495|FG002|Overall Study|Study Terminated By Sponsor|0|||
125177590|NCT03284723|450270496|FG003|Overall Study|Study Terminated By Sponsor|0|||
125177591|NCT03284723|450270497|FG004|Overall Study|Study Terminated By Sponsor|1|||
125177592|NCT03284723|450270498|FG005|Overall Study|Study Terminated By Sponsor|0|||
125177593|NCT03284723|450270499|FG006|Overall Study|Study Terminated By Sponsor|0|||
125177594|NCT03284723|450270500|FG007|Overall Study|Study Terminated By Sponsor|0|||
125233214|NCT00251758|450481774|FG001|Overall Study|Per Subject Request|0|||
125177595|NCT03284723|450270501|FG008|Overall Study|Study Terminated By Sponsor|1|||
125177596|NCT03284723|450270502|FG009|Overall Study|Study Terminated By Sponsor|1|||
125177597|NCT03284723|450270503|FG010|Overall Study|Study Terminated By Sponsor|1|||
125177598|NCT03284723|450270504|FG011|Overall Study|Study Terminated By Sponsor|1|||
125177599|NCT03284723|450270493|FG000|Overall Study|Withdrawal by Subject|0|||
125177600|NCT03284723|450270494|FG001|Overall Study|Withdrawal by Subject|0|||
125177601|NCT03284723|450270495|FG002|Overall Study|Withdrawal by Subject|0|||
125177602|NCT03284723|450270496|FG003|Overall Study|Withdrawal by Subject|0|||
125177603|NCT03284723|450270497|FG004|Overall Study|Withdrawal by Subject|5|||
125177604|NCT03284723|450270498|FG005|Overall Study|Withdrawal by Subject|3|||
125177605|NCT03284723|450270499|FG006|Overall Study|Withdrawal by Subject|1|||
125177606|NCT03284723|450270500|FG007|Overall Study|Withdrawal by Subject|0|||
125177607|NCT03284723|450270501|FG008|Overall Study|Withdrawal by Subject|6|||
125177608|NCT03284723|450270502|FG009|Overall Study|Withdrawal by Subject|0|||
125177609|NCT03284723|450270503|FG010|Overall Study|Withdrawal by Subject|3|||
125177610|NCT03284723|450270504|FG011|Overall Study|Withdrawal by Subject|1|||
125177611|NCT03284723|450270493|FG000|Overall Study|Other|1|||
125177612|NCT03284723|450270494|FG001|Overall Study|Other|0|||
125177613|NCT03284723|450270495|FG002|Overall Study|Other|1|||
125177614|NCT03284723|450270496|FG003|Overall Study|Other|0|||
125177615|NCT03284723|450270497|FG004|Overall Study|Other|1|||
125177616|NCT03284723|450270498|FG005|Overall Study|Other|0|||
125177617|NCT03284723|450270499|FG006|Overall Study|Other|0|||
125177618|NCT03284723|450270500|FG007|Overall Study|Other|0|||
125177619|NCT03284723|450270501|FG008|Overall Study|Other|0|||
125177620|NCT03284723|450270502|FG009|Overall Study|Other|0|||
125177621|NCT03284723|450270503|FG010|Overall Study|Other|1|||
125177622|NCT03284723|450270504|FG011|Overall Study|Other|0|||
125177623|NCT03284723|450270493|FG000|Overall Study|Adverse Event|0|||
125177624|NCT03284723|450270494|FG001|Overall Study|Adverse Event|0|||
125177625|NCT03284723|450270495|FG002|Overall Study|Adverse Event|0|||
125177626|NCT03284723|450270496|FG003|Overall Study|Adverse Event|0|||
125177627|NCT03284723|450270497|FG004|Overall Study|Adverse Event|0|||
125177628|NCT03284723|450270498|FG005|Overall Study|Adverse Event|0|||
125177629|NCT03284723|450270499|FG006|Overall Study|Adverse Event|0|||
125177630|NCT03284723|450270500|FG007|Overall Study|Adverse Event|0|||
125177631|NCT03284723|450270501|FG008|Overall Study|Adverse Event|1|||
125177632|NCT03284723|450270502|FG009|Overall Study|Adverse Event|0|||
125177633|NCT03284723|450270503|FG010|Overall Study|Adverse Event|0|||
125177634|NCT03284723|450270504|FG011|Overall Study|Adverse Event|0|||
125177635|NCT00615199|450270505|FG000|Overall Study|Adverse Event|3|||
125177636|NCT00615199|450270506|FG001|Overall Study|Adverse Event|1|||
125177637|NCT00615199|450270507|FG002|Overall Study|Adverse Event|1|||
125177638|NCT00615199|450270508|FG003|Overall Study|Adverse Event|0|||
125177639|NCT00615199|450270505|FG000|Overall Study|Lack of Efficacy|2|||
125177640|NCT00615199|450270506|FG001|Overall Study|Lack of Efficacy|0|||
125177641|NCT00615199|450270507|FG002|Overall Study|Lack of Efficacy|0|||
125177642|NCT00615199|450270508|FG003|Overall Study|Lack of Efficacy|1|||
125177643|NCT00615199|450270505|FG000|Overall Study|Lost to Follow-up|1|||
125177644|NCT00615199|450270506|FG001|Overall Study|Lost to Follow-up|0|||
125177645|NCT00615199|450270507|FG002|Overall Study|Lost to Follow-up|0|||
125177646|NCT00615199|450270508|FG003|Overall Study|Lost to Follow-up|0|||
125177647|NCT00615199|450270505|FG000|Overall Study|Other|0|||
125177648|NCT00615199|450270506|FG001|Overall Study|Other|0|||
125177649|NCT00615199|450270507|FG002|Overall Study|Other|0|||
125177650|NCT00615199|450270508|FG003|Overall Study|Other|1|||
125177651|NCT00615199|450270505|FG000|Overall Study|Withdrawal by Subject|2|||
125177652|NCT00615199|450270506|FG001|Overall Study|Withdrawal by Subject|1|||
125177653|NCT00615199|450270507|FG002|Overall Study|Withdrawal by Subject|0|||
125177654|NCT00615199|450270508|FG003|Overall Study|Withdrawal by Subject|0|||
125177655|NCT00064987|450270513|FG000|Overall Study|Physician Decision|3|||
125177656|NCT00064987|450270514|FG001|Overall Study|Physician Decision|0|||
125177657|NCT01214655|450270515|FG000|Part A|Progressive Disease|7|||
125177658|NCT01214655|450270516|FG001|Part A|Progressive Disease|0|||
125177659|NCT01214655|450270517|FG002|Part A|Progressive Disease|0|||
125177660|NCT01214655|450270515|FG000|Part A|Physician Decision|1|||
125177661|NCT01214655|450270516|FG001|Part A|Physician Decision|0|||
125177662|NCT01214655|450270517|FG002|Part A|Physician Decision|0|||
125177663|NCT01214655|450270515|FG000|Part B|Progressive disease|0|||
125177664|NCT01214655|450270516|FG001|Part B|Progressive disease|10|||
125177665|NCT01214655|450270517|FG002|Part B|Progressive disease|0|||
125177666|NCT01214655|450270515|FG000|Part B|Death|0|||
125177667|NCT01214655|450270516|FG001|Part B|Death|1|||
125177668|NCT01214655|450270517|FG002|Part B|Death|0|||
125177669|NCT01214655|450270515|FG000|Part B|Withdrawal by Subject|0|||
125177670|NCT01214655|450270516|FG001|Part B|Withdrawal by Subject|2|||
125177671|NCT01214655|450270517|FG002|Part B|Withdrawal by Subject|0|||
125177672|NCT01214655|450270515|FG000|Part C|Progressive Disease|0|||
125177673|NCT01214655|450270516|FG001|Part C|Progressive Disease|0|||
125177674|NCT01214655|450270517|FG002|Part C|Progressive Disease|5|||
125177675|NCT01214655|450270515|FG000|Part C|Death|0|||
125177676|NCT01214655|450270516|FG001|Part C|Death|0|||
125177677|NCT01214655|450270517|FG002|Part C|Death|1|||
125177678|NCT01214655|450270515|FG000|Part C|Physician Decision|0|||
125233215|NCT00251758|450481775|FG002|Overall Study|Per Subject Request|1|||
125233216|NCT00251758|450481773|FG000|Overall Study|Per Investigator Request|1|||
125233217|NCT00251758|450481774|FG001|Overall Study|Per Investigator Request|0|||
125233218|NCT00251758|450481775|FG002|Overall Study|Per Investigator Request|0|||
125233219|NCT01387269|450481777|FG000|Overall Study|Death|38|||
125233220|NCT01387269|450481778|FG001|Overall Study|Death|20|||
125233221|NCT01387269|450481777|FG000|Overall Study|Other|8|||
125233222|NCT01387269|450481778|FG001|Overall Study|Other|7|||
125233223|NCT01387269|450481777|FG000|Overall Study|Unrelated AE|12|||
125233224|NCT01387269|450481778|FG001|Overall Study|Unrelated AE|3|||
125233225|NCT01387269|450481777|FG000|Overall Study|Withdrawal by patient|32|||
125233226|NCT01387269|450481778|FG001|Overall Study|Withdrawal by patient|10|||
125233227|NCT01387269|450481777|FG000|Overall Study|Study drug-related AE|1|||
125233228|NCT01387269|450481778|FG001|Overall Study|Study drug-related AE|0|||
125233229|NCT01387269|450481777|FG000|Overall Study|Lost to Follow-up|1|||
125233230|NCT01387269|450481778|FG001|Overall Study|Lost to Follow-up|0|||
125233231|NCT01981616|450481783|FG000|Overall Study|Adverse Event|0|||
125233232|NCT01981616|450481784|FG001|Overall Study|Adverse Event|1|||
125233233|NCT01981616|450481783|FG000|Overall Study|Protocol Violation|1|||
125233234|NCT01981616|450481784|FG001|Overall Study|Protocol Violation|0|||
125233235|NCT01020123|450481786|FG000|Main Period|Withdrawal by Subject|6|||
125233236|NCT01020123|450481787|FG001|Main Period|Withdrawal by Subject|5|||
125233237|NCT01020123|450481788|FG002|Main Period|Withdrawal by Subject|3|||
125233238|NCT01020123|450481789|FG003|Main Period|Withdrawal by Subject|1|||
125233239|NCT01020123|450481790|FG004|Main Period|Withdrawal by Subject|6|||
125233240|NCT01020123|450481791|FG005|Main Period|Withdrawal by Subject|3|||
125233241|NCT01020123|450481792|FG006|Main Period|Withdrawal by Subject|2|||
125233242|NCT01020123|450481786|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
125233243|NCT01020123|450481787|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
125233244|NCT01020123|450481788|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
125233245|NCT01020123|450481789|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
125233246|NCT01020123|450481790|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
125233247|NCT01020123|450481791|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
125233248|NCT01020123|450481792|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
125233249|NCT01020123|450481786|FG000|Main Period|Adverse Event|5|||
125233250|NCT01020123|450481787|FG001|Main Period|Adverse Event|2|||
125233251|NCT01020123|450481788|FG002|Main Period|Adverse Event|2|||
125233252|NCT01020123|450481789|FG003|Main Period|Adverse Event|1|||
125233253|NCT01020123|450481790|FG004|Main Period|Adverse Event|1|||
125233254|NCT01020123|450481791|FG005|Main Period|Adverse Event|2|||
125233255|NCT01020123|450481792|FG006|Main Period|Adverse Event|1|||
125233256|NCT01020123|450481786|FG000|Main Period|Protocol Violation|4|||
125233257|NCT01020123|450481787|FG001|Main Period|Protocol Violation|4|||
125233258|NCT01020123|450481788|FG002|Main Period|Protocol Violation|2|||
125233259|NCT01020123|450481789|FG003|Main Period|Protocol Violation|5|||
125233260|NCT01020123|450481790|FG004|Main Period|Protocol Violation|2|||
125233261|NCT01020123|450481791|FG005|Main Period|Protocol Violation|3|||
125233262|NCT01020123|450481792|FG006|Main Period|Protocol Violation|2|||
125233263|NCT01020123|450481786|FG000|Main Period|Lost to Follow-up|0|||
125233264|NCT01020123|450481787|FG001|Main Period|Lost to Follow-up|2|||
125233265|NCT01020123|450481788|FG002|Main Period|Lost to Follow-up|0|||
125233266|NCT01020123|450481789|FG003|Main Period|Lost to Follow-up|0|||
125233267|NCT01020123|450481790|FG004|Main Period|Lost to Follow-up|0|||
125233268|NCT01020123|450481791|FG005|Main Period|Lost to Follow-up|0|||
125233269|NCT01020123|450481792|FG006|Main Period|Lost to Follow-up|0|||
125233270|NCT01020123|450481786|FG000|Main Period|Unclasified|2|||
125233271|NCT01020123|450481787|FG001|Main Period|Unclasified|0|||
125233272|NCT01020123|450481788|FG002|Main Period|Unclasified|1|||
125233273|NCT01020123|450481789|FG003|Main Period|Unclasified|0|||
125233274|NCT01020123|450481790|FG004|Main Period|Unclasified|1|||
125233275|NCT01020123|450481791|FG005|Main Period|Unclasified|3|||
125233276|NCT01020123|450481792|FG006|Main Period|Unclasified|6|||
125233277|NCT01020123|450481786|FG000|Extention Period|Withdrawal by Subject|2|||
125233278|NCT01020123|450481787|FG001|Extention Period|Withdrawal by Subject|1|||
125233279|NCT01020123|450481788|FG002|Extention Period|Withdrawal by Subject|1|||
125233280|NCT01020123|450481789|FG003|Extention Period|Withdrawal by Subject|0|||
125233281|NCT01020123|450481790|FG004|Extention Period|Withdrawal by Subject|0|||
125233282|NCT01020123|450481791|FG005|Extention Period|Withdrawal by Subject|0|||
125233283|NCT01020123|450481792|FG006|Extention Period|Withdrawal by Subject|0|||
125233284|NCT01020123|450481786|FG000|Extention Period|Adverse Event|0|||
125233285|NCT01020123|450481787|FG001|Extention Period|Adverse Event|0|||
125233286|NCT01020123|450481788|FG002|Extention Period|Adverse Event|0|||
125233287|NCT01020123|450481789|FG003|Extention Period|Adverse Event|1|||
125233288|NCT01020123|450481790|FG004|Extention Period|Adverse Event|0|||
125233289|NCT01020123|450481791|FG005|Extention Period|Adverse Event|0|||
125233290|NCT01020123|450481792|FG006|Extention Period|Adverse Event|0|||
125233291|NCT01020123|450481786|FG000|Extention Period|Protocol Violation|1|||
125233292|NCT01020123|450481787|FG001|Extention Period|Protocol Violation|1|||
125233293|NCT01020123|450481788|FG002|Extention Period|Protocol Violation|1|||
125233294|NCT01020123|450481789|FG003|Extention Period|Protocol Violation|0|||
125177679|NCT01214655|450270516|FG001|Part C|Physician Decision|0|||
125177680|NCT01214655|450270517|FG002|Part C|Physician Decision|1|||
125177681|NCT00764881|450270518|FG000|Overall Study|Adverse Event|5|||
125177682|NCT00764881|450270519|FG001|Overall Study|Adverse Event|1|||
125177683|NCT00764881|450270518|FG000|Overall Study|Withdrawal by Subject|1|||
125177684|NCT00764881|450270519|FG001|Overall Study|Withdrawal by Subject|3|||
125177685|NCT00764881|450270518|FG000|Overall Study|Protocol Violation|2|||
125177686|NCT00764881|450270519|FG001|Overall Study|Protocol Violation|2|||
125177687|NCT00764881|450270518|FG000|Overall Study|Lost to Follow-up|2|||
125177688|NCT00764881|450270519|FG001|Overall Study|Lost to Follow-up|0|||
125177689|NCT00764881|450270518|FG000|Overall Study|Noncompliant|1|||
125177690|NCT00764881|450270519|FG001|Overall Study|Noncompliant|0|||
125177691|NCT00764881|450270518|FG000|Overall Study|Accidentally discontinued study drug|1|||
125177692|NCT00764881|450270519|FG001|Overall Study|Accidentally discontinued study drug|0|||
125177693|NCT00764881|450270518|FG000|Overall Study|Wished to become pregnant|1|||
125177694|NCT00764881|450270519|FG001|Overall Study|Wished to become pregnant|0|||
125177695|NCT00764881|450270518|FG000|Overall Study|Carcinoma detected|1|||
125177696|NCT00764881|450270519|FG001|Overall Study|Carcinoma detected|0|||
125177697|NCT00764881|450270518|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
125177698|NCT00764881|450270519|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
125177699|NCT00764881|450270518|FG000|Overall Study|no treatment or no observation|2|||
125177700|NCT00764881|450270519|FG001|Overall Study|no treatment or no observation|2|||
125177701|NCT05256134|450270520|FG000|Overall Study|Study Terminated by Sponsor|11|||
125177702|NCT05256134|450270521|FG001|Overall Study|Study Terminated by Sponsor|10|||
125177703|NCT05256134|450270520|FG000|Overall Study|Withdrawal by Subject|1|||
125177704|NCT05256134|450270521|FG001|Overall Study|Withdrawal by Subject|3|||
125177705|NCT01567462|450270528|FG000|Overall Study|Withdrawal by Subject|4|||
125177706|NCT01567462|450270529|FG001|Overall Study|Withdrawal by Subject|7|||
125177707|NCT01977417|450270530|FG000|Overall Study|Adverse Event|1|||
125177708|NCT01977417|450270531|FG001|Overall Study|Adverse Event|0|||
125177709|NCT01977417|450270530|FG000|Overall Study|Withdrawal by Subject|2|||
125177710|NCT01977417|450270531|FG001|Overall Study|Withdrawal by Subject|4|||
125177711|NCT01977417|450270530|FG000|Overall Study|Female enrollment goal met|0|||
125177712|NCT01977417|450270531|FG001|Overall Study|Female enrollment goal met|2|||
125177713|NCT02548156|450270537|FG000|Washout Period 1|Lost to Follow-up|0|||
125177714|NCT02548156|450270538|FG001|Washout Period 1|Lost to Follow-up|0|||
125177715|NCT02548156|450270539|FG002|Washout Period 1|Lost to Follow-up|0|||
125177716|NCT02548156|450270540|FG003|Washout Period 1|Lost to Follow-up|0|||
125177717|NCT02548156|450270541|FG004|Washout Period 1|Lost to Follow-up|1|||
125177718|NCT02548156|450270542|FG005|Washout Period 1|Lost to Follow-up|0|||
125177719|NCT01068262|450270543|FG000|Overall Study|Adverse Event|2|||
125177720|NCT01068262|450270544|FG001|Overall Study|Adverse Event|0|||
125177721|NCT01068262|450270545|FG002|Overall Study|Adverse Event|1|||
125177722|NCT01068262|450270546|FG003|Overall Study|Adverse Event|0|||
125177723|NCT01068262|450270543|FG000|Overall Study|Protocol Violation|1|||
125177724|NCT01068262|450270544|FG001|Overall Study|Protocol Violation|0|||
125177725|NCT01068262|450270545|FG002|Overall Study|Protocol Violation|0|||
125177726|NCT01068262|450270546|FG003|Overall Study|Protocol Violation|0|||
125177727|NCT01068262|450270543|FG000|Overall Study|Withdrawal by Subject|0|||
125177728|NCT01068262|450270544|FG001|Overall Study|Withdrawal by Subject|1|||
125177729|NCT01068262|450270545|FG002|Overall Study|Withdrawal by Subject|0|||
125177730|NCT01068262|450270546|FG003|Overall Study|Withdrawal by Subject|0|||
125177731|NCT01153425|450270548|FG000|Overall Study|Withdrawal by Subject|3|||
125177732|NCT01153425|450270549|FG001|Overall Study|Withdrawal by Subject|3|||
125177733|NCT01232452|450270550|FG000|Overall Study|Adverse Event|17|||
125177734|NCT01232452|450270551|FG001|Overall Study|Adverse Event|15|||
125177735|NCT01232452|450270550|FG000|Overall Study|Withdrawal by Subject|11|||
125177736|NCT01232452|450270551|FG001|Overall Study|Withdrawal by Subject|8|||
125177737|NCT01232452|450270550|FG000|Overall Study|Physician Decision|8|||
125177738|NCT01232452|450270551|FG001|Overall Study|Physician Decision|12|||
125177739|NCT01232452|450270550|FG000|Overall Study|Protocol entry criterion not met|0|||
125177740|NCT01232452|450270551|FG001|Overall Study|Protocol entry criterion not met|2|||
125177741|NCT01232452|450270550|FG000|Overall Study|Sponsor Decision|3|||
125177742|NCT01232452|450270551|FG001|Overall Study|Sponsor Decision|1|||
125177743|NCT01232452|450270550|FG000|Overall Study|Protocol Violation|0|||
125177744|NCT01232452|450270551|FG001|Overall Study|Protocol Violation|1|||
125177745|NCT05024747|450270552|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
125177746|NCT05024747|450270553|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
125177747|NCT05024747|450270552|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
125177748|NCT05024747|450270553|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
125177749|NCT05024747|450270552|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
125177750|NCT05024747|450270553|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
125177751|NCT03022370|450270554|FG000|Overall Study|Death|6|||
125177752|NCT03022370|450270555|FG001|Overall Study|Death|12|||
125177753|NCT03022370|450270554|FG000|Overall Study|Lost to Follow-up|174|||
125177754|NCT03022370|450270555|FG001|Overall Study|Lost to Follow-up|109|||
125177755|NCT00699816|450270556|FG000|Overall Study|Protocol Violation|1|||
125177756|NCT00699816|450270557|FG001|Overall Study|Protocol Violation|3|||
125177757|NCT02454933|450270560|FG000|Overall Study|Progressive disease|10|||
125177758|NCT02454933|450270561|FG001|Overall Study|Progressive disease|7|||
125177759|NCT02454933|450270560|FG000|Overall Study|Adverse Event|1|||
125177760|NCT02454933|450270561|FG001|Overall Study|Adverse Event|1|||
125177761|NCT02454933|450270560|FG000|Overall Study|Withdrawal by Subject|0|||
125177762|NCT02454933|450270561|FG001|Overall Study|Withdrawal by Subject|3|||
125177763|NCT02454933|450270560|FG000|Overall Study|Lost to Follow-up|1|||
125177764|NCT02454933|450270561|FG001|Overall Study|Lost to Follow-up|0|||
125177765|NCT01526655|450270564|FG000|Overall Study|Withdrawal by Subject|0|||
125177766|NCT01526655|450270565|FG001|Overall Study|Withdrawal by Subject|1|||
125177767|NCT04753216|450270566|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
125177768|NCT04753216|450270566|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
125177769|NCT04753216|450270566|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
125177770|NCT02001987|450270568|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
125177771|NCT02001987|450270568|FG000|Core Study Period (24 Weeks)|Death|1|||
125177772|NCT02001987|450270568|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
125177773|NCT02001987|450270568|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
125177774|NCT02001987|450270568|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
125177775|NCT02001987|450270568|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
125177776|NCT02001987|450270568|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
125177777|NCT02001987|450270568|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
125177778|NCT02001987|450270568|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
125177779|NCT02001987|450270568|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
125177780|NCT02001987|450270568|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
125177781|NCT02001987|450270568|FG000|LTE Period (52 Weeks)|Other|3|||
125177782|NCT02288325|450270575|FG000|Run-in Period|Adverse Event|48|||
125177783|NCT02288325|450270576|FG001|Run-in Period|Adverse Event|0|||
125177784|NCT02288325|450270577|FG002|Run-in Period|Adverse Event|0|||
125177785|NCT02288325|450270575|FG000|Run-in Period|Lack of Efficacy|16|||
125177786|NCT02288325|450270576|FG001|Run-in Period|Lack of Efficacy|0|||
125177787|NCT02288325|450270577|FG002|Run-in Period|Lack of Efficacy|0|||
125177788|NCT02288325|450270575|FG000|Run-in Period|Withdrawal of Consent|28|||
125177789|NCT02288325|450270576|FG001|Run-in Period|Withdrawal of Consent|0|||
125177790|NCT02288325|450270577|FG002|Run-in Period|Withdrawal of Consent|0|||
125177791|NCT02288325|450270575|FG000|Run-in Period|Lost to Follow-up|25|||
125177792|NCT02288325|450270576|FG001|Run-in Period|Lost to Follow-up|0|||
125177793|NCT02288325|450270577|FG002|Run-in Period|Lost to Follow-up|0|||
125177794|NCT02288325|450270575|FG000|Run-in Period|Protocol Violation|17|||
125177795|NCT02288325|450270576|FG001|Run-in Period|Protocol Violation|0|||
125177796|NCT02288325|450270577|FG002|Run-in Period|Protocol Violation|0|||
125177797|NCT02288325|450270575|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
125177798|NCT02288325|450270576|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
125177799|NCT02288325|450270577|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
125177800|NCT02288325|450270575|FG000|Run-in Period|Reason not Specified|8|||
125177801|NCT02288325|450270576|FG001|Run-in Period|Reason not Specified|0|||
125177802|NCT02288325|450270577|FG002|Run-in Period|Reason not Specified|0|||
125177803|NCT02288325|450270575|FG000|Stabilization Period|Adverse Event|13|||
125177804|NCT02288325|450270576|FG001|Stabilization Period|Adverse Event|0|||
125177805|NCT02288325|450270577|FG002|Stabilization Period|Adverse Event|0|||
125177806|NCT02288325|450270575|FG000|Stabilization Period|Lack of Efficacy|22|||
125177807|NCT02288325|450270576|FG001|Stabilization Period|Lack of Efficacy|0|||
125177808|NCT02288325|450270577|FG002|Stabilization Period|Lack of Efficacy|0|||
125177809|NCT02288325|450270575|FG000|Stabilization Period|Withdrawal of Consent|23|||
125177810|NCT02288325|450270576|FG001|Stabilization Period|Withdrawal of Consent|0|||
125177811|NCT02288325|450270577|FG002|Stabilization Period|Withdrawal of Consent|0|||
125177812|NCT02288325|450270575|FG000|Stabilization Period|Lost to Follow-up|12|||
125177813|NCT02288325|450270576|FG001|Stabilization Period|Lost to Follow-up|0|||
125177814|NCT02288325|450270577|FG002|Stabilization Period|Lost to Follow-up|0|||
125177815|NCT02288325|450270575|FG000|Stabilization Period|Protocol Violation|8|||
125177816|NCT02288325|450270576|FG001|Stabilization Period|Protocol Violation|0|||
125177817|NCT02288325|450270577|FG002|Stabilization Period|Protocol Violation|0|||
125177818|NCT02288325|450270575|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
125177819|NCT02288325|450270576|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
125177820|NCT02288325|450270577|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
125177821|NCT02288325|450270575|FG000|Stabilization Period|Reason not Specified|15|||
125177822|NCT02288325|450270576|FG001|Stabilization Period|Reason not Specified|0|||
125177823|NCT02288325|450270577|FG002|Stabilization Period|Reason not Specified|0|||
125177824|NCT02288325|450270575|FG000|Double-blind Treatment Period|Adverse Event|0|||
125177825|NCT02288325|450270576|FG001|Double-blind Treatment Period|Adverse Event|2|||
125177826|NCT02288325|450270577|FG002|Double-blind Treatment Period|Adverse Event|5|||
125177827|NCT02288325|450270575|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
125177828|NCT02288325|450270576|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
125233295|NCT01020123|450481790|FG004|Extention Period|Protocol Violation|0|||
125233296|NCT01020123|450481791|FG005|Extention Period|Protocol Violation|0|||
125233297|NCT01020123|450481792|FG006|Extention Period|Protocol Violation|1|||
125233298|NCT01020123|450481786|FG000|Extention Period|Lost to Follow-up|0|||
125233299|NCT01020123|450481787|FG001|Extention Period|Lost to Follow-up|0|||
125233300|NCT01020123|450481788|FG002|Extention Period|Lost to Follow-up|0|||
125233301|NCT01020123|450481789|FG003|Extention Period|Lost to Follow-up|0|||
125233302|NCT01020123|450481790|FG004|Extention Period|Lost to Follow-up|0|||
125233303|NCT01020123|450481791|FG005|Extention Period|Lost to Follow-up|2|||
125233304|NCT01020123|450481792|FG006|Extention Period|Lost to Follow-up|0|||
125233305|NCT04711005|450481797|FG000|Overall Study|Withdrawal by Subject|0|||
125233306|NCT04711005|450481798|FG001|Overall Study|Withdrawal by Subject|0|||
125233307|NCT04711005|450481799|FG002|Overall Study|Withdrawal by Subject|0|||
125233308|NCT04711005|450481800|FG003|Overall Study|Withdrawal by Subject|0|||
125233309|NCT04711005|450481801|FG004|Overall Study|Withdrawal by Subject|0|||
125233310|NCT04711005|450481802|FG005|Overall Study|Withdrawal by Subject|0|||
125233311|NCT04711005|450481803|FG006|Overall Study|Withdrawal by Subject|0|||
125233312|NCT04711005|450481804|FG007|Overall Study|Withdrawal by Subject|1|||
125233313|NCT04711005|450481805|FG008|Overall Study|Withdrawal by Subject|0|||
125233314|NCT04711005|450481806|FG009|Overall Study|Withdrawal by Subject|0|||
125233315|NCT04711005|450481797|FG000|Overall Study|Physician Decision|0|||
125233316|NCT04711005|450481798|FG001|Overall Study|Physician Decision|0|||
125233317|NCT04711005|450481799|FG002|Overall Study|Physician Decision|0|||
125233318|NCT04711005|450481800|FG003|Overall Study|Physician Decision|0|||
125233319|NCT04711005|450481801|FG004|Overall Study|Physician Decision|0|||
125233320|NCT04711005|450481802|FG005|Overall Study|Physician Decision|0|||
125233321|NCT04711005|450481803|FG006|Overall Study|Physician Decision|0|||
125233322|NCT04711005|450481804|FG007|Overall Study|Physician Decision|2|||
125233323|NCT04711005|450481805|FG008|Overall Study|Physician Decision|1|||
125233324|NCT04711005|450481806|FG009|Overall Study|Physician Decision|0|||
125233325|NCT03824561|450481814|FG000|Overall Study|Protocol Violation|19|||
125233326|NCT01773928|450481815|FG000|Overall Study|Adverse Event|0|||
125233327|NCT01773928|450481816|FG001|Overall Study|Adverse Event|0|||
125233328|NCT01773928|450481817|FG002|Overall Study|Adverse Event|0|||
125233329|NCT01773928|450481818|FG003|Overall Study|Adverse Event|0|||
125233330|NCT01773928|450481819|FG004|Overall Study|Adverse Event|0|||
125233331|NCT01773928|450481820|FG005|Overall Study|Adverse Event|0|||
125233332|NCT01773928|450481821|FG006|Overall Study|Adverse Event|0|||
125233333|NCT01773928|450481822|FG007|Overall Study|Adverse Event|1|||
125233334|NCT01773928|450481823|FG008|Overall Study|Adverse Event|0|||
125233335|NCT01773928|450481815|FG000|Overall Study|Physician Decision|0|||
125233336|NCT01773928|450481816|FG001|Overall Study|Physician Decision|0|||
125233337|NCT01773928|450481817|FG002|Overall Study|Physician Decision|0|||
125233338|NCT01773928|450481818|FG003|Overall Study|Physician Decision|1|||
125233339|NCT01773928|450481819|FG004|Overall Study|Physician Decision|0|||
125233340|NCT01773928|450481820|FG005|Overall Study|Physician Decision|0|||
125233341|NCT01773928|450481821|FG006|Overall Study|Physician Decision|0|||
125233342|NCT01773928|450481822|FG007|Overall Study|Physician Decision|0|||
125233343|NCT01773928|450481823|FG008|Overall Study|Physician Decision|0|||
125233344|NCT01773928|450481815|FG000|Overall Study|Withdrawal by Subject|5|||
125233345|NCT01773928|450481816|FG001|Overall Study|Withdrawal by Subject|4|||
125233346|NCT01773928|450481817|FG002|Overall Study|Withdrawal by Subject|4|||
125233347|NCT01773928|450481818|FG003|Overall Study|Withdrawal by Subject|4|||
125233348|NCT01773928|450481819|FG004|Overall Study|Withdrawal by Subject|7|||
125233349|NCT01773928|450481820|FG005|Overall Study|Withdrawal by Subject|1|||
125233350|NCT01773928|450481821|FG006|Overall Study|Withdrawal by Subject|0|||
125233351|NCT01773928|450481822|FG007|Overall Study|Withdrawal by Subject|0|||
125233352|NCT01773928|450481823|FG008|Overall Study|Withdrawal by Subject|1|||
125233353|NCT01773928|450481815|FG000|Overall Study|Lost to Follow-up|0|||
125233354|NCT01773928|450481816|FG001|Overall Study|Lost to Follow-up|0|||
125233355|NCT01773928|450481817|FG002|Overall Study|Lost to Follow-up|0|||
125233356|NCT01773928|450481818|FG003|Overall Study|Lost to Follow-up|0|||
125233357|NCT01773928|450481819|FG004|Overall Study|Lost to Follow-up|0|||
125233358|NCT01773928|450481820|FG005|Overall Study|Lost to Follow-up|1|||
125233359|NCT01773928|450481821|FG006|Overall Study|Lost to Follow-up|0|||
125233360|NCT01773928|450481822|FG007|Overall Study|Lost to Follow-up|0|||
125233361|NCT01773928|450481823|FG008|Overall Study|Lost to Follow-up|0|||
125233362|NCT01773928|450481815|FG000|Overall Study|Subject misrepresented age|0|||
125233363|NCT01773928|450481816|FG001|Overall Study|Subject misrepresented age|1|||
125233364|NCT01773928|450481817|FG002|Overall Study|Subject misrepresented age|0|||
125233365|NCT01773928|450481818|FG003|Overall Study|Subject misrepresented age|0|||
125233366|NCT01773928|450481819|FG004|Overall Study|Subject misrepresented age|0|||
125233367|NCT01773928|450481820|FG005|Overall Study|Subject misrepresented age|0|||
125233368|NCT01773928|450481821|FG006|Overall Study|Subject misrepresented age|0|||
125233369|NCT01773928|450481822|FG007|Overall Study|Subject misrepresented age|0|||
125233370|NCT01773928|450481823|FG008|Overall Study|Subject misrepresented age|0|||
125233371|NCT01773928|450481815|FG000|Overall Study|Subject met exclusion criteria|0|||
125233372|NCT01773928|450481816|FG001|Overall Study|Subject met exclusion criteria|0|||
125233373|NCT01773928|450481817|FG002|Overall Study|Subject met exclusion criteria|0|||
125233374|NCT01773928|450481818|FG003|Overall Study|Subject met exclusion criteria|0|||
125233375|NCT01773928|450481819|FG004|Overall Study|Subject met exclusion criteria|0|||
125233376|NCT01773928|450481820|FG005|Overall Study|Subject met exclusion criteria|0|||
125233377|NCT01773928|450481821|FG006|Overall Study|Subject met exclusion criteria|0|||
125233378|NCT01773928|450481822|FG007|Overall Study|Subject met exclusion criteria|0|||
125233379|NCT01773928|450481823|FG008|Overall Study|Subject met exclusion criteria|1|||
125233380|NCT01773928|450481815|FG000|Overall Study|Randomized, had to leave, never returned|0|||
125233381|NCT01773928|450481816|FG001|Overall Study|Randomized, had to leave, never returned|0|||
125233382|NCT01773928|450481817|FG002|Overall Study|Randomized, had to leave, never returned|0|||
125233383|NCT01773928|450481818|FG003|Overall Study|Randomized, had to leave, never returned|1|||
125233384|NCT01773928|450481819|FG004|Overall Study|Randomized, had to leave, never returned|0|||
125233385|NCT01773928|450481820|FG005|Overall Study|Randomized, had to leave, never returned|0|||
125233386|NCT01773928|450481821|FG006|Overall Study|Randomized, had to leave, never returned|0|||
125233387|NCT01773928|450481822|FG007|Overall Study|Randomized, had to leave, never returned|0|||
125233388|NCT01773928|450481823|FG008|Overall Study|Randomized, had to leave, never returned|0|||
125233389|NCT01773928|450481815|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
125233390|NCT01773928|450481816|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
125233391|NCT01773928|450481817|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
125233392|NCT01773928|450481818|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
125233393|NCT01773928|450481819|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
125233394|NCT01773928|450481820|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
125233395|NCT01773928|450481821|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
125233396|NCT01773928|450481822|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
125233397|NCT01773928|450481823|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
125233398|NCT03092752|450481824|FG000|Overall Study|Aged <40 years|14209|||
125233399|NCT03092752|450481824|FG000|Overall Study|At least one claim with T2DM|61299|||
125233400|NCT03092752|450481824|FG000|Overall Study|Having no claim of study drugs|29282|||
125233401|NCT03092752|450481824|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
125233402|NCT03092752|450481824|FG000|Overall Study|<6 month history|245900|||
125233403|NCT03573297|450481827|FG000|Open Label Treatment Period|Adverse Event|67|||
125233404|NCT03573297|450481828|FG001|Open Label Treatment Period|Adverse Event|0|||
125177829|NCT02288325|450270577|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
125177830|NCT02288325|450270575|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
125177831|NCT02288325|450270576|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
125177832|NCT02288325|450270577|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
125177833|NCT02288325|450270575|FG000|Double-blind Treatment Period|Protocol Violation|0|||
125177834|NCT02288325|450270576|FG001|Double-blind Treatment Period|Protocol Violation|1|||
125177835|NCT02288325|450270577|FG002|Double-blind Treatment Period|Protocol Violation|2|||
125177836|NCT02288325|450270575|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
125177837|NCT02288325|450270576|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
125177838|NCT02288325|450270577|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
125177839|NCT02288325|450270575|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
125177840|NCT02288325|450270576|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
125177841|NCT02288325|450270577|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
125177842|NCT05211726|450270583|FG000|Overall Study|Withdrawal by Subject|2|||
125177843|NCT05211726|450270584|FG001|Overall Study|Withdrawal by Subject|3|||
125177844|NCT05211726|450270583|FG000|Overall Study|Protocol Violation|0|||
125177845|NCT05211726|450270584|FG001|Overall Study|Protocol Violation|1|||
125177846|NCT00344448|450270592|FG000|Screening|Withdrawal by Subject|0|||
125177847|NCT00344448|450270593|FG001|Screening|Withdrawal by Subject|1|||
125177848|NCT00344448|450270592|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
125177849|NCT00344448|450270593|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
125177850|NCT00344448|450270592|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
125177851|NCT00344448|450270593|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
125177852|NCT00344448|450270592|FG000|Open Label|Withdrawal by Subject|1|||
125177853|NCT00344448|450270593|FG001|Open Label|Withdrawal by Subject|1|||
125177854|NCT00344448|450270592|FG000|Open Label|Study terminated|1|||
125177855|NCT00344448|450270593|FG001|Open Label|Study terminated|0|||
125233405|NCT03573297|450481829|FG002|Open Label Treatment Period|Adverse Event|0|||
125233406|NCT03573297|450481830|FG003|Open Label Treatment Period|Adverse Event|0|||
125233407|NCT03573297|450481827|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
125233408|NCT03573297|450481828|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
125233409|NCT03573297|450481829|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
125233410|NCT03573297|450481830|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
125233411|NCT03573297|450481827|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
125233412|NCT03573297|450481828|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
125233413|NCT03573297|450481829|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
125233414|NCT03573297|450481830|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
125233415|NCT03573297|450481827|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
125233416|NCT03573297|450481828|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
125233417|NCT03573297|450481829|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
125233418|NCT03573297|450481830|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
125233419|NCT03573297|450481827|FG000|Open Label Treatment Period|Pregnancy|1|||
125233420|NCT03573297|450481828|FG001|Open Label Treatment Period|Pregnancy|0|||
125233421|NCT03573297|450481829|FG002|Open Label Treatment Period|Pregnancy|0|||
125233422|NCT03573297|450481830|FG003|Open Label Treatment Period|Pregnancy|0|||
125233423|NCT03573297|450481827|FG000|Open Label Treatment Period|Protocol Violation|17|||
125233424|NCT03573297|450481828|FG001|Open Label Treatment Period|Protocol Violation|0|||
125233425|NCT03573297|450481829|FG002|Open Label Treatment Period|Protocol Violation|0|||
125233426|NCT03573297|450481830|FG003|Open Label Treatment Period|Protocol Violation|0|||
125233427|NCT03573297|450481827|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
125233428|NCT03573297|450481828|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
125233429|NCT03573297|450481829|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
125233430|NCT03573297|450481830|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
125233431|NCT03573297|450481827|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
125233432|NCT03573297|450481828|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
125233433|NCT03573297|450481829|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
125233434|NCT03573297|450481830|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
125233435|NCT03573297|450481827|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
125233436|NCT03573297|450481828|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
125233437|NCT03573297|450481829|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
125233438|NCT03573297|450481830|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
125233439|NCT03573297|450481827|FG000|Open Label Treatment Period|Other, Not Specified|7|||
125233440|NCT03573297|450481828|FG001|Open Label Treatment Period|Other, Not Specified|0|||
125233441|NCT03573297|450481829|FG002|Open Label Treatment Period|Other, Not Specified|0|||
125233442|NCT03573297|450481830|FG003|Open Label Treatment Period|Other, Not Specified|0|||
125233443|NCT03573297|450481827|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
125233444|NCT03573297|450481828|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
125233445|NCT03573297|450481829|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
125233446|NCT03573297|450481830|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
125233447|NCT03573297|450481827|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125233448|NCT03573297|450481828|FG001|Double-Blind Treatment Period|Adverse Event|1|||
125233449|NCT03573297|450481829|FG002|Double-Blind Treatment Period|Adverse Event|5|||
125233450|NCT03573297|450481830|FG003|Double-Blind Treatment Period|Adverse Event|1|||
125233451|NCT03573297|450481827|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
125233452|NCT03573297|450481828|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
125233453|NCT03573297|450481829|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
125233454|NCT03573297|450481830|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
125233455|NCT03573297|450481827|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125233456|NCT03573297|450481828|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
125233457|NCT03573297|450481829|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
125233458|NCT03573297|450481830|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
125233459|NCT03573297|450481827|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
125233460|NCT03573297|450481828|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
125233461|NCT03573297|450481829|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
125233462|NCT03573297|450481830|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
125233463|NCT03573297|450481827|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
125233464|NCT03573297|450481828|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
125233465|NCT03573297|450481829|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
125233466|NCT03573297|450481830|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
125233467|NCT03573297|450481827|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
125233468|NCT03573297|450481828|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
125233469|NCT03573297|450481829|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
125233470|NCT03573297|450481830|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
125233471|NCT03573297|450481827|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
125233472|NCT03573297|450481828|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
125233473|NCT03573297|450481829|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
125233474|NCT03573297|450481830|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
125233475|NCT06996301|450481831|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
125233476|NCT06996301|450481832|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
125233477|NCT06996301|450481831|FG000|Overall Study|Patients with discordant diagnostic results|107|||
125233478|NCT06996301|450481832|FG001|Overall Study|Patients with discordant diagnostic results|90|||
125233479|NCT06996301|450481831|FG000|Overall Study|Lost to Follow-up|31|||
125233480|NCT06996301|450481832|FG001|Overall Study|Lost to Follow-up|56|||
125233481|NCT06996301|450481831|FG000|Overall Study|Withdrawal by Subject|12|||
125233482|NCT06996301|450481832|FG001|Overall Study|Withdrawal by Subject|7|||
125233483|NCT00661388|450481836|FG000|Overall Study|Adverse Event|14|||
125233484|NCT00661388|450481836|FG000|Overall Study|Protocol Violation|7|||
125233485|NCT00661388|450481836|FG000|Overall Study|Renal transplantation|1|||
125233486|NCT00661388|450481836|FG000|Overall Study|Dialysis initiation|1|||
125233487|NCT00661388|450481836|FG000|Overall Study|Administrative reasons|1|||
125233488|NCT03370172|450483187|FG000|Overall Study|Withdrawal by Subject|0|||
125233489|NCT03370172|450483188|FG001|Overall Study|Withdrawal by Subject|1|||
125233490|NCT01171534|450483192|FG000|Overall Study|Lost to Follow-up|0|||
125233491|NCT01171534|450483193|FG001|Overall Study|Lost to Follow-up|2|||
125233492|NCT01171534|450483192|FG000|Overall Study|screen failure|0|||
125233493|NCT01171534|450483193|FG001|Overall Study|screen failure|1|||
125233494|NCT00849056|450483194|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
125233495|NCT00849056|450483195|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
125233496|NCT00849056|450483194|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
125233497|NCT00849056|450483195|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
125233498|NCT00849056|450483194|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
125233499|NCT00849056|450483195|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
125233500|NCT00849056|450483194|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
125233501|NCT00849056|450483195|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
125233502|NCT00849056|450483194|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
125233503|NCT00849056|450483195|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
125233504|NCT00849056|450483194|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
125233505|NCT00849056|450483195|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
125233506|NCT00849056|450483194|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
125233507|NCT00849056|450483195|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
125233508|NCT00849056|450483194|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
125233509|NCT00849056|450483195|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
125233510|NCT00849056|450483194|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
125233511|NCT00849056|450483195|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
125233512|NCT00849056|450483194|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
125233513|NCT00849056|450483195|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
125233514|NCT00849056|450483194|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
125233515|NCT00849056|450483195|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
125233516|NCT00849056|450483194|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
125233517|NCT00849056|450483195|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
125233518|NCT00849056|450483194|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
125233519|NCT00849056|450483195|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
125233520|NCT00849056|450483194|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
125233521|NCT00849056|450483195|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
125233522|NCT00849056|450483194|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
125233523|NCT00849056|450483195|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
125233524|NCT00849056|450483194|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
125233525|NCT00849056|450483195|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
125233526|NCT03427892|450483196|FG000|Overall Study|Lost to Follow-up|2|||
125233527|NCT00548327|450483197|FG000|Overall Study|Adverse Event|0|||
125233528|NCT00548327|450483198|FG001|Overall Study|Adverse Event|1|||
125233529|NCT00362232|450483199|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
125233530|NCT00362232|450483200|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
125233531|NCT00362232|450483199|FG000|Treatment (12 +/- 2 Days)|Death|1|||
125233532|NCT00362232|450483200|FG001|Treatment (12 +/- 2 Days)|Death|3|||
125233533|NCT00362232|450483199|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
125233534|NCT00362232|450483200|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
125233535|NCT00362232|450483199|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
125233536|NCT00362232|450483200|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
125233537|NCT00362232|450483199|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
125233538|NCT00362232|450483200|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
125233539|NCT00362232|450483199|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
125233540|NCT00362232|450483200|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
125233541|NCT00362232|450483199|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
125233542|NCT00362232|450483200|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
125233543|NCT00362232|450483199|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
125233544|NCT00362232|450483200|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
125233545|NCT00362232|450483199|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
125233546|NCT00362232|450483200|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
125233547|NCT00362232|450483199|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
125233548|NCT00362232|450483200|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
125233549|NCT00362232|450483199|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
125233550|NCT00362232|450483200|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
125233551|NCT00362232|450483199|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
125233552|NCT00362232|450483200|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
125233553|NCT00362232|450483199|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
125233554|NCT00362232|450483200|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
125233555|NCT00274456|450483201|FG000|Overall Study|Still on treatment|2|||
125233556|NCT00274456|450483202|FG001|Overall Study|Still on treatment|3|||
125233557|NCT00274456|450483203|FG002|Overall Study|Still on treatment|5|||
125233558|NCT00274456|450483204|FG003|Overall Study|Still on treatment|1|||
125233559|NCT00274456|450483201|FG000|Overall Study|Unacceptable toxicity|10|||
125233560|NCT00274456|450483202|FG001|Overall Study|Unacceptable toxicity|5|||
125233561|NCT00274456|450483203|FG002|Overall Study|Unacceptable toxicity|12|||
125233562|NCT00274456|450483204|FG003|Overall Study|Unacceptable toxicity|16|||
125233563|NCT00274456|450483201|FG000|Overall Study|Adverse Event|0|||
125233564|NCT00274456|450483202|FG001|Overall Study|Adverse Event|1|||
125233565|NCT00274456|450483203|FG002|Overall Study|Adverse Event|2|||
125233566|NCT00274456|450483204|FG003|Overall Study|Adverse Event|2|||
125233567|NCT00274456|450483201|FG000|Overall Study|Physician Decision|7|||
125233568|NCT00274456|450483202|FG001|Overall Study|Physician Decision|5|||
125233569|NCT00274456|450483203|FG002|Overall Study|Physician Decision|6|||
125233570|NCT00274456|450483204|FG003|Overall Study|Physician Decision|13|||
125233571|NCT00274456|450483201|FG000|Overall Study|Lost to Follow-up|0|||
125233572|NCT00274456|450483202|FG001|Overall Study|Lost to Follow-up|0|||
125233573|NCT00274456|450483203|FG002|Overall Study|Lost to Follow-up|1|||
125233574|NCT00274456|450483204|FG003|Overall Study|Lost to Follow-up|0|||
125233575|NCT00274456|450483201|FG000|Overall Study|Withdrawal by Subject|18|||
125233576|NCT00274456|450483202|FG001|Overall Study|Withdrawal by Subject|13|||
125233577|NCT00274456|450483203|FG002|Overall Study|Withdrawal by Subject|9|||
125233578|NCT00274456|450483204|FG003|Overall Study|Withdrawal by Subject|13|||
125233579|NCT03255187|450483208|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
125233580|NCT03255187|450483209|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
125233581|NCT03255187|450483208|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
125233582|NCT03255187|450483209|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
125233583|NCT00375752|450483210|FG000|Overall Study|Lack of Efficacy|4|||
125233584|NCT00375752|450483211|FG001|Overall Study|Lack of Efficacy|4|||
125233585|NCT00375752|450483210|FG000|Overall Study|Adverse Event|1|||
125233586|NCT00375752|450483211|FG001|Overall Study|Adverse Event|6|||
125233587|NCT00375752|450483210|FG000|Overall Study|Withdrawal by Subject|6|||
125233588|NCT00375752|450483211|FG001|Overall Study|Withdrawal by Subject|1|||
125233589|NCT00375752|450483210|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
125233590|NCT00375752|450483211|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
125233591|NCT00375752|450483210|FG000|Overall Study|Protocol Violation|0|||
125233592|NCT00375752|450483211|FG001|Overall Study|Protocol Violation|2|||
125233593|NCT00375752|450483210|FG000|Overall Study|Administrative Problems|0|||
125233594|NCT00375752|450483211|FG001|Overall Study|Administrative Problems|1|||
125233595|NCT02034006|450483212|FG000|Overall Study|Withdrawal by Subject|7|||
125233596|NCT02034006|450483212|FG000|Overall Study|Lost to Follow-up|5|||
125233597|NCT02034006|450483212|FG000|Overall Study|Death|1|||
125233598|NCT02034006|450483212|FG000|Overall Study|Pregnancy|1|||
125233599|NCT00109343|450483216|FG000|Overall Study|Adverse Event|1|||
125233600|NCT00109343|450483217|FG001|Overall Study|Adverse Event|0|||
125233601|NCT00109343|450483218|FG002|Overall Study|Adverse Event|2|||
125233602|NCT00109343|450483216|FG000|Overall Study|Lack of Efficacy|1|||
125233603|NCT00109343|450483217|FG001|Overall Study|Lack of Efficacy|0|||
125233604|NCT00109343|450483218|FG002|Overall Study|Lack of Efficacy|0|||
125233605|NCT00109343|450483216|FG000|Overall Study|Lost to Follow-up|35|||
125233606|NCT00109343|450483217|FG001|Overall Study|Lost to Follow-up|20|||
125233607|NCT00109343|450483218|FG002|Overall Study|Lost to Follow-up|14|||
125233608|NCT00109343|450483216|FG000|Overall Study|Protocol Violation|1|||
125233609|NCT00109343|450483217|FG001|Overall Study|Protocol Violation|2|||
125233610|NCT00109343|450483218|FG002|Overall Study|Protocol Violation|2|||
125233611|NCT00109343|450483216|FG000|Overall Study|Withdrawal by Subject|15|||
125233612|NCT00109343|450483217|FG001|Overall Study|Withdrawal by Subject|11|||
125233613|NCT00109343|450483218|FG002|Overall Study|Withdrawal by Subject|10|||
125233614|NCT00109343|450483216|FG000|Overall Study|Subject Moved|6|||
125233615|NCT00109343|450483217|FG001|Overall Study|Subject Moved|2|||
125233616|NCT00109343|450483218|FG002|Overall Study|Subject Moved|1|||
125233617|NCT00109343|450483216|FG000|Overall Study|Other|5|||
125233618|NCT00109343|450483217|FG001|Overall Study|Other|2|||
125233619|NCT00109343|450483218|FG002|Overall Study|Other|1|||
125233620|NCT01499511|450483219|FG000|Overall Study|Death|1|||
125233621|NCT01499511|450483220|FG001|Overall Study|Death|0|||
125233622|NCT00577408|450483221|FG000|Overall Study|Stopped attending study visits|9|||
125233623|NCT00577408|450483222|FG001|Overall Study|Stopped attending study visits|11|||
125233624|NCT00577408|450483221|FG000|Overall Study|Continued opioid use|3|||
125233625|NCT00577408|450483222|FG001|Overall Study|Continued opioid use|2|||
125233626|NCT00577408|450483221|FG000|Overall Study|Non-compliance with study meds|0|||
125233627|NCT00577408|450483222|FG001|Overall Study|Non-compliance with study meds|3|||
125233628|NCT00577408|450483221|FG000|Overall Study|Refused Oral Naltrexone|0|||
125177856|NCT02374346|450270595|FG000|Overall Study|operated or discharged during weekend|48|||
125177857|NCT02565511|450270596|FG000|Overall Study|Study terminated by Sponsor|35|||
125177858|NCT02565511|450270597|FG001|Overall Study|Study terminated by Sponsor|22|||
125177859|NCT02565511|450270598|FG002|Overall Study|Study terminated by Sponsor|235|||
125177860|NCT02565511|450270599|FG003|Overall Study|Study terminated by Sponsor|156|||
125177861|NCT02565511|450270596|FG000|Overall Study|Withdrawal by Subject|3|||
125177862|NCT02565511|450270597|FG001|Overall Study|Withdrawal by Subject|0|||
125177863|NCT02565511|450270598|FG002|Overall Study|Withdrawal by Subject|12|||
125177864|NCT02565511|450270599|FG003|Overall Study|Withdrawal by Subject|5|||
125177865|NCT02565511|450270596|FG000|Overall Study|Adverse Event|0|||
125177866|NCT02565511|450270597|FG001|Overall Study|Adverse Event|0|||
125177867|NCT02565511|450270598|FG002|Overall Study|Adverse Event|1|||
125177868|NCT02565511|450270599|FG003|Overall Study|Adverse Event|1|||
125177869|NCT02565511|450270596|FG000|Overall Study|Lost to Follow-up|4|||
125177870|NCT02565511|450270597|FG001|Overall Study|Lost to Follow-up|1|||
125177871|NCT02565511|450270598|FG002|Overall Study|Lost to Follow-up|0|||
125177872|NCT02565511|450270599|FG003|Overall Study|Lost to Follow-up|1|||
125177873|NCT02565511|450270596|FG000|Overall Study|Physician Decision|0|||
125177874|NCT02565511|450270597|FG001|Overall Study|Physician Decision|0|||
125177875|NCT02565511|450270598|FG002|Overall Study|Physician Decision|0|||
125177876|NCT02565511|450270599|FG003|Overall Study|Physician Decision|1|||
125177877|NCT02565511|450270596|FG000|Overall Study|Protocol deviation|0|||
125177878|NCT02565511|450270597|FG001|Overall Study|Protocol deviation|0|||
125177879|NCT02565511|450270598|FG002|Overall Study|Protocol deviation|3|||
125177880|NCT02565511|450270599|FG003|Overall Study|Protocol deviation|0|||
125177881|NCT04807400|450270602|FG000|Overall Study|Adverse Event|2|||
125177882|NCT04807400|450270603|FG001|Overall Study|Adverse Event|3|||
125177883|NCT04807400|450270604|FG002|Overall Study|Adverse Event|3|||
125177884|NCT04807400|450270602|FG000|Overall Study|Death|2|||
125177885|NCT04807400|450270603|FG001|Overall Study|Death|0|||
125177886|NCT04807400|450270604|FG002|Overall Study|Death|0|||
125177887|NCT04807400|450270602|FG000|Overall Study|Lost to Follow-up|8|||
125177888|NCT04807400|450270603|FG001|Overall Study|Lost to Follow-up|6|||
125177889|NCT04807400|450270604|FG002|Overall Study|Lost to Follow-up|6|||
125177890|NCT04807400|450270602|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125177891|NCT04807400|450270603|FG001|Overall Study|Non-Compliance With Study Drug|4|||
125177892|NCT04807400|450270604|FG002|Overall Study|Non-Compliance With Study Drug|1|||
125177893|NCT04807400|450270602|FG000|Overall Study|Participant Decision|20|||
125177894|NCT04807400|450270603|FG001|Overall Study|Participant Decision|19|||
125177895|NCT04807400|450270604|FG002|Overall Study|Participant Decision|26|||
125177896|NCT04807400|450270602|FG000|Overall Study|Physician Decision|0|||
125177897|NCT04807400|450270603|FG001|Overall Study|Physician Decision|1|||
125177898|NCT04807400|450270604|FG002|Overall Study|Physician Decision|0|||
125177899|NCT04807400|450270602|FG000|Overall Study|Protocol Violation|4|||
125177900|NCT04807400|450270603|FG001|Overall Study|Protocol Violation|3|||
125177901|NCT04807400|450270604|FG002|Overall Study|Protocol Violation|7|||
125177902|NCT04807400|450270602|FG000|Overall Study|Withdrawal by Subject|13|||
125177903|NCT04807400|450270603|FG001|Overall Study|Withdrawal by Subject|9|||
125177904|NCT04807400|450270604|FG002|Overall Study|Withdrawal by Subject|20|||
125177905|NCT04807400|450270602|FG000|Overall Study|Mis-randomized|1|||
125177906|NCT04807400|450270603|FG001|Overall Study|Mis-randomized|0|||
125177907|NCT04807400|450270604|FG002|Overall Study|Mis-randomized|0|||
125177908|NCT03656744|450270605|FG000|Overall Study|Adverse Event|1|||
125177909|NCT03656744|450270606|FG001|Overall Study|Adverse Event|4|||
125177910|NCT03656744|450270607|FG002|Overall Study|Adverse Event|1|||
125177911|NCT03656744|450270605|FG000|Overall Study|Protocol Violation|1|||
125177912|NCT03656744|450270606|FG001|Overall Study|Protocol Violation|0|||
125177913|NCT03656744|450270607|FG002|Overall Study|Protocol Violation|0|||
125177914|NCT03656744|450270605|FG000|Overall Study|Lost to Follow-up|2|||
125177915|NCT03656744|450270606|FG001|Overall Study|Lost to Follow-up|2|||
125177916|NCT03656744|450270607|FG002|Overall Study|Lost to Follow-up|0|||
125177917|NCT03656744|450270605|FG000|Overall Study|Withdrawal by Subject|0|||
125177918|NCT03656744|450270606|FG001|Overall Study|Withdrawal by Subject|1|||
125177919|NCT03656744|450270607|FG002|Overall Study|Withdrawal by Subject|0|||
125177920|NCT03656744|450270605|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
125177921|NCT03656744|450270606|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
125177922|NCT03656744|450270607|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
125177923|NCT03076775|450270610|FG000|Overall Study|Lost to Follow-up|1|||
125177924|NCT03076775|450270611|FG001|Overall Study|Lost to Follow-up|0|||
125233629|NCT00577408|450483222|FG001|Overall Study|Refused Oral Naltrexone|1|||
125177925|NCT01332292|450270614|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
125177926|NCT01332292|450270615|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
125177927|NCT01332292|450270614|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
125177928|NCT01332292|450270615|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
125177929|NCT01332292|450270614|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
125177930|NCT01332292|450270615|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
125233630|NCT00577408|450483221|FG000|Overall Study|Moved out of state|0|||
125233631|NCT00577408|450483222|FG001|Overall Study|Moved out of state|1|||
125233632|NCT00577408|450483221|FG000|Overall Study|Scheduling Issues|0|||
125233633|NCT00577408|450483222|FG001|Overall Study|Scheduling Issues|3|||
125233634|NCT00577408|450483221|FG000|Overall Study|Death|0|||
125233635|NCT00577408|450483222|FG001|Overall Study|Death|1|||
125233636|NCT00577408|450483221|FG000|Overall Study|Psychiatric hospitalization|0|||
125233637|NCT00577408|450483222|FG001|Overall Study|Psychiatric hospitalization|1|||
125233638|NCT00656617|450483223|FG000|Overall Study|Adverse Event|1|||
125233639|NCT00656617|450483223|FG000|Overall Study|Death|2|||
125233640|NCT00656617|450483223|FG000|Overall Study|Insurance Issues|2|||
125233641|NCT00656617|450483223|FG000|Overall Study|Move to different clinical trial|2|||
125233642|NCT02349386|450483233|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
125233643|NCT02349386|450483234|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
125233644|NCT02349386|450483235|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
125233645|NCT02349386|450483236|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
125233646|NCT02349386|450483233|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
125233647|NCT02349386|450483234|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
125233648|NCT02349386|450483235|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
125233649|NCT02349386|450483236|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
125233650|NCT02349386|450483233|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
125233651|NCT02349386|450483234|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
125233652|NCT02349386|450483235|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
125233653|NCT02349386|450483236|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
125233654|NCT02349386|450483233|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
125233655|NCT02349386|450483234|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
125233656|NCT02349386|450483235|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
125233657|NCT02349386|450483236|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
125233658|NCT02349386|450483233|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
125233659|NCT02349386|450483234|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
125233660|NCT02349386|450483235|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
125233661|NCT02349386|450483236|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
125233662|NCT02349386|450483233|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
125233663|NCT02349386|450483234|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
125233664|NCT02349386|450483235|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
125233665|NCT02349386|450483236|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
125233666|NCT01712178|450483237|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
125233667|NCT01712178|450483238|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
125233668|NCT01712178|450483237|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
125233669|NCT01712178|450483238|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
125233670|NCT01712178|450483237|FG000|Overall Study|Lost to Follow-up|0|||
125233671|NCT01712178|450483238|FG001|Overall Study|Lost to Follow-up|1|||
125233672|NCT00091819|450483239|FG000|Overall Study|Adverse Event|1|||
125233673|NCT00091819|450483240|FG001|Overall Study|Adverse Event|1|||
125233674|NCT00091819|450483239|FG000|Overall Study|Death|4|||
125233675|NCT00091819|450483240|FG001|Overall Study|Death|5|||
125233676|NCT00091819|450483239|FG000|Overall Study|Lost to Follow-up|26|||
125233677|NCT00091819|450483240|FG001|Overall Study|Lost to Follow-up|23|||
125233678|NCT00091819|450483239|FG000|Overall Study|Withdrawal by Subject|5|||
125233679|NCT00091819|450483240|FG001|Overall Study|Withdrawal by Subject|8|||
125233680|NCT00091819|450483239|FG000|Overall Study|Protocol Violation|1|||
125233681|NCT00091819|450483240|FG001|Overall Study|Protocol Violation|2|||
125233682|NCT00091819|450483239|FG000|Overall Study|Other|2|||
125233683|NCT00091819|450483240|FG001|Overall Study|Other|3|||
125233684|NCT00091819|450483239|FG000|Overall Study|Never received study treatment|3|||
125233685|NCT00091819|450483240|FG001|Overall Study|Never received study treatment|4|||
125233686|NCT00961415|450483241|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
125233687|NCT00961415|450483242|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
125233688|NCT00961415|450483243|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
125233689|NCT00961415|450483241|FG000|Induction Treatment Phase|Death|77|||
125233690|NCT00961415|450483242|FG001|Induction Treatment Phase|Death|0|||
125233691|NCT00961415|450483243|FG002|Induction Treatment Phase|Death|0|||
125233692|NCT00961415|450483241|FG000|Induction Treatment Phase|Protocol Violation|1|||
125233693|NCT00961415|450483242|FG001|Induction Treatment Phase|Protocol Violation|0|||
125233694|NCT00961415|450483243|FG002|Induction Treatment Phase|Protocol Violation|0|||
125233695|NCT00961415|450483241|FG000|Induction Treatment Phase|Physician Decision|2|||
125233696|NCT00961415|450483242|FG001|Induction Treatment Phase|Physician Decision|0|||
125233697|NCT00961415|450483243|FG002|Induction Treatment Phase|Physician Decision|0|||
125233698|NCT00961415|450483241|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
125233699|NCT00961415|450483242|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
125177931|NCT03910673|450270619|FG000|Overall Study|Adverse Event|0|||
125177932|NCT03910673|450270620|FG001|Overall Study|Adverse Event|0|||
125177933|NCT03910673|450270621|FG002|Overall Study|Adverse Event|0|||
125177934|NCT03910673|450270622|FG003|Overall Study|Adverse Event|2|||
125177935|NCT03910673|450270623|FG004|Overall Study|Adverse Event|0|||
125177936|NCT00098774|450270624|FG000|Overall Study|Adverse Event|2|||
125177937|NCT00098774|450270624|FG000|Overall Study|Disease Progression|9|||
125177938|NCT00098774|450270624|FG000|Overall Study|Withdrawal by Subject|1|||
125177939|NCT00098774|450270624|FG000|Overall Study|Failed (to respond) during induction|4|||
125177940|NCT00098774|450270624|FG000|Overall Study|Physician Decision|2|||
125177941|NCT02324582|450270625|FG000|Overall Study|Screen Failures|0|||
125177942|NCT02324582|450270626|FG001|Overall Study|Screen Failures|5|||
125177943|NCT03541317|450270627|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
125177944|NCT03541317|450270628|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
125177945|NCT03541317|450270629|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
125177946|NCT03541317|450270630|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
125177947|NCT03541317|450270631|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
125177948|NCT03541317|450270632|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
125177949|NCT02123446|450270633|FG000|Washout Period (1 Day)|Physician Decision|1|||
125177950|NCT02123446|450270634|FG001|Washout Period (1 Day)|Physician Decision|0|||
125177951|NCT04388553|450270635|FG000|Overall Study|Protocol Violation|1|||
125177952|NCT04388553|450270636|FG001|Overall Study|Protocol Violation|0|||
125177953|NCT04502212|450270639|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
125177954|NCT04502212|450270639|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
125177955|NCT04208750|450270655|FG000|Overall Study|Lost to Follow-up|16|||
125177956|NCT04208750|450270656|FG001|Overall Study|Lost to Follow-up|15|||
125177957|NCT05377749|450272635|FG000|3 Weeks|Lost to Follow-up|2|||
125177958|NCT05377749|450272636|FG001|3 Weeks|Lost to Follow-up|4|||
125177959|NCT05377749|450272635|FG000|3 Weeks|Withdrawal by Subject|1|||
125177960|NCT05377749|450272636|FG001|3 Weeks|Withdrawal by Subject|1|||
125177961|NCT02301390|450272639|FG000|Overall Study|Withdrawal by Subject|3|||
125177962|NCT02301390|450272640|FG001|Overall Study|Withdrawal by Subject|5|||
125177963|NCT02301390|450272639|FG000|Overall Study|Protocol Violation|1|||
125177964|NCT02301390|450272640|FG001|Overall Study|Protocol Violation|0|||
125177965|NCT02301390|450272639|FG000|Overall Study|Physician Decision|1|||
125177966|NCT02301390|450272640|FG001|Overall Study|Physician Decision|0|||
125177967|NCT02301390|450272639|FG000|Overall Study|Lost to Follow-up|0|||
125177968|NCT02301390|450272640|FG001|Overall Study|Lost to Follow-up|1|||
125177969|NCT02301390|450272639|FG000|Overall Study|Death|2|||
125177970|NCT02301390|450272640|FG001|Overall Study|Death|2|||
125177971|NCT02301390|450272639|FG000|Overall Study|Procedure not completed|0|||
125177972|NCT02301390|450272640|FG001|Overall Study|Procedure not completed|4|||
125177973|NCT02301390|450272639|FG000|Overall Study|Missed multiple visits|1|||
125177974|NCT02301390|450272640|FG001|Overall Study|Missed multiple visits|1|||
125177975|NCT02301390|450272639|FG000|Overall Study|study terminated|2|||
125177976|NCT02301390|450272640|FG001|Overall Study|study terminated|0|||
125177977|NCT02121652|450272641|FG000|Overall Study|Lost to Follow-up|2|||
125177978|NCT02121652|450272642|FG001|Overall Study|Lost to Follow-up|1|||
125177979|NCT02121652|450272641|FG000|Overall Study|Death|1|||
125177980|NCT02121652|450272642|FG001|Overall Study|Death|0|||
125177981|NCT02121652|450272641|FG000|Overall Study|Withdrawal by Subject|3|||
125177982|NCT02121652|450272642|FG001|Overall Study|Withdrawal by Subject|3|||
125177983|NCT04108299|450272649|FG000|Overall Study|Not interested in participating|2|||
125177984|NCT04108299|450272650|FG001|Overall Study|Not interested in participating|1|||
125177985|NCT04108299|450272651|FG002|Overall Study|Not interested in participating|2|||
125177986|NCT04108299|450272652|FG003|Overall Study|Not interested in participating|1|||
125177987|NCT00247676|450272653|FG000|Overall Study|Death|5|||
125177988|NCT00247676|450272653|FG000|Overall Study|Adverse Event|11|||
125177989|NCT00247676|450272653|FG000|Overall Study|Lack of Efficacy|15|||
125177990|NCT00247676|450272653|FG000|Overall Study|Other|3|||
125177991|NCT00247676|450272653|FG000|Overall Study|Withdrawal by Subject|2|||
125177992|NCT04123405|450272654|FG000|Overall Study|Adverse Event|1|||
125177993|NCT04123405|450272655|FG001|Overall Study|Adverse Event|2|||
125177994|NCT04123405|450272656|FG002|Overall Study|Adverse Event|3|||
125177995|NCT04123405|450272657|FG003|Overall Study|Adverse Event|3|||
125177996|NCT04123405|450272654|FG000|Overall Study|Exclusion criteria met|1|||
125177997|NCT04123405|450272655|FG001|Overall Study|Exclusion criteria met|2|||
125177998|NCT04123405|450272656|FG002|Overall Study|Exclusion criteria met|0|||
125177999|NCT04123405|450272657|FG003|Overall Study|Exclusion criteria met|2|||
125178000|NCT04123405|450272654|FG000|Overall Study|Withdrawal by Subject|1|||
125178001|NCT04123405|450272655|FG001|Overall Study|Withdrawal by Subject|3|||
125178002|NCT04123405|450272656|FG002|Overall Study|Withdrawal by Subject|0|||
125178003|NCT04123405|450272657|FG003|Overall Study|Withdrawal by Subject|2|||
125178004|NCT04123405|450272654|FG000|Overall Study|Contact to subject lost|0|||
125178005|NCT04123405|450272655|FG001|Overall Study|Contact to subject lost|0|||
125178006|NCT04123405|450272656|FG002|Overall Study|Contact to subject lost|0|||
125233700|NCT00961415|450483243|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
125233701|NCT00961415|450483241|FG000|Induction Treatment Phase|Other Reason|5|||
125233702|NCT00961415|450483242|FG001|Induction Treatment Phase|Other Reason|0|||
125233703|NCT00961415|450483243|FG002|Induction Treatment Phase|Other Reason|0|||
125233704|NCT00961415|450483241|FG000|Maintenance Treatment Phase|Death|0|||
125233705|NCT00961415|450483242|FG001|Maintenance Treatment Phase|Death|42|||
125233706|NCT00961415|450483243|FG002|Maintenance Treatment Phase|Death|34|||
125233707|NCT00961415|450483241|FG000|Maintenance Treatment Phase|Investigators decision|0|||
125233708|NCT00961415|450483242|FG001|Maintenance Treatment Phase|Investigators decision|2|||
125233709|NCT00961415|450483243|FG002|Maintenance Treatment Phase|Investigators decision|0|||
125233710|NCT00961415|450483241|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125233711|NCT00961415|450483242|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
125233712|NCT00961415|450483243|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
125233713|NCT00961415|450483241|FG000|Maintenance Treatment Phase|Other reason|0|||
125233714|NCT00961415|450483242|FG001|Maintenance Treatment Phase|Other reason|1|||
125233715|NCT00961415|450483243|FG002|Maintenance Treatment Phase|Other reason|3|||
125233716|NCT04759131|450483247|FG000|Overall Study|Investigator's discretion|1|||
125233717|NCT04759131|450483248|FG001|Overall Study|Investigator's discretion|0|||
125233718|NCT04759131|450483247|FG000|Overall Study|Subject withdrawal|1|||
125233719|NCT04759131|450483248|FG001|Overall Study|Subject withdrawal|0|||
125233720|NCT05144945|450483249|FG000|Overall Study|Withdrawal by Subject|1|||
125233721|NCT05144945|450483250|FG001|Overall Study|Withdrawal by Subject|0|||
125233722|NCT03692949|450483253|FG000|Overall Study|Lost to Follow-up|0|||
125233723|NCT03692949|450483254|FG001|Overall Study|Lost to Follow-up|0|||
125233724|NCT03692949|450483255|FG002|Overall Study|Lost to Follow-up|0|||
125233725|NCT03692949|450483256|FG003|Overall Study|Lost to Follow-up|0|||
125233726|NCT03692949|450483257|FG004|Overall Study|Lost to Follow-up|0|||
125233727|NCT03692949|450483258|FG005|Overall Study|Lost to Follow-up|0|||
125233728|NCT03692949|450483259|FG006|Overall Study|Lost to Follow-up|0|||
125233729|NCT03692949|450483260|FG007|Overall Study|Lost to Follow-up|1|||
125233730|NCT02592824|450483262|FG000|Overall Study|Protocol Violation|5|||
125233731|NCT02592824|450483263|FG001|Overall Study|Protocol Violation|3|||
125233732|NCT02592824|450483262|FG000|Overall Study|Lost to Follow-up|2|||
125233733|NCT02592824|450483263|FG001|Overall Study|Lost to Follow-up|1|||
125233734|NCT03426878|450483264|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
125233735|NCT03426878|450483264|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
125233736|NCT03426878|450483264|FG000|Overall Study|Declined to receive results|3|||
125233737|NCT03426878|450483264|FG000|Overall Study|Received negative results by mailed letter|65|||
125233738|NCT03426878|450483264|FG000|Overall Study|Lost to Follow-up|177|||
125233739|NCT00465517|450483265|FG000|Overall Study|Adverse Event|7|||
125233740|NCT00465517|450483266|FG001|Overall Study|Adverse Event|3|||
125233741|NCT00465517|450483265|FG000|Overall Study|Lost to Follow-up|1|||
125233742|NCT00465517|450483266|FG001|Overall Study|Lost to Follow-up|0|||
125233743|NCT00465517|450483265|FG000|Overall Study|Withdrawal by Subject|4|||
125233744|NCT00465517|450483266|FG001|Overall Study|Withdrawal by Subject|1|||
125233745|NCT05233761|450483273|FG000|Treatment Period A|Withdrawal by Subject|12|||
125233746|NCT05233761|450483274|FG001|Treatment Period A|Withdrawal by Subject|10|||
125233747|NCT05233761|450483273|FG000|Treatment Period A|Lost to Follow-up|6|||
125233748|NCT05233761|450483274|FG001|Treatment Period A|Lost to Follow-up|12|||
125233749|NCT05233761|450483273|FG000|Treatment Period A|Protocol Violation|8|||
125233750|NCT05233761|450483274|FG001|Treatment Period A|Protocol Violation|15|||
125233751|NCT01604785|450483275|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
125233752|NCT01604785|450483276|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
125233753|NCT05049122|450483279|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
125233754|NCT05049122|450483279|FG000|Overall Study|Participant moved|1|||
125233755|NCT05049122|450483279|FG000|Overall Study|At the direction of the doctor|1|||
125233756|NCT00560404|450483280|FG000|Overall Study|Adverse Event|2|||
125233757|NCT00560404|450483281|FG001|Overall Study|Adverse Event|3|||
125233758|NCT00560404|450483280|FG000|Overall Study|Death|3|||
125233759|NCT00560404|450483281|FG001|Overall Study|Death|3|||
125233760|NCT00560404|450483280|FG000|Overall Study|Protocol Violation|12|||
125233761|NCT00560404|450483281|FG001|Overall Study|Protocol Violation|7|||
125233762|NCT00560404|450483280|FG000|Overall Study|Administrative Reasons|1|||
125233763|NCT00560404|450483281|FG001|Overall Study|Administrative Reasons|1|||
125233764|NCT00560404|450483280|FG000|Overall Study|Withdrew Consent|4|||
125233765|NCT00560404|450483281|FG001|Overall Study|Withdrew Consent|0|||
125233766|NCT00560404|450483280|FG000|Overall Study|Failure to return|1|||
125233767|NCT00560404|450483281|FG001|Overall Study|Failure to return|2|||
125233768|NCT00560404|450483280|FG000|Overall Study|Other withdrawal reason|13|||
125233769|NCT00560404|450483281|FG001|Overall Study|Other withdrawal reason|5|||
125233770|NCT00392223|450483288|FG000|Overall Study|Adverse Event|5|||
125233771|NCT00392223|450483289|FG001|Overall Study|Adverse Event|4|||
125178007|NCT04123405|450272657|FG003|Overall Study|Contact to subject lost|1|||
125178008|NCT04123405|450272654|FG000|Overall Study|screening failure|1|||
125178009|NCT04123405|450272655|FG001|Overall Study|screening failure|0|||
125178010|NCT04123405|450272656|FG002|Overall Study|screening failure|0|||
125178011|NCT04123405|450272657|FG003|Overall Study|screening failure|0|||
125178012|NCT00662649|450272658|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
125178013|NCT00662649|450272659|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
125178014|NCT00662649|450272660|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
125178015|NCT00662649|450272661|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
125178016|NCT00662649|450272662|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
125178017|NCT00662649|450272658|FG000|Core Study (24 Months)|Adverse Event|22|||
125178018|NCT00662649|450272659|FG001|Core Study (24 Months)|Adverse Event|13|||
125178019|NCT00662649|450272660|FG002|Core Study (24 Months)|Adverse Event|18|||
125178020|NCT00662649|450272661|FG003|Core Study (24 Months)|Adverse Event|0|||
125178021|NCT00662649|450272662|FG004|Core Study (24 Months)|Adverse Event|0|||
125178022|NCT00662649|450272658|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
125178023|NCT00662649|450272659|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
125178024|NCT00662649|450272660|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
125178025|NCT00662649|450272661|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
125178026|NCT00662649|450272662|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
125178027|NCT00662649|450272658|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
125178028|NCT00662649|450272659|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
125178029|NCT00662649|450272660|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
125178030|NCT00662649|450272661|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
125178031|NCT00662649|450272662|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
125178032|NCT00662649|450272658|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
125178033|NCT00662649|450272659|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
125178034|NCT00662649|450272660|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
125178035|NCT00662649|450272661|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
125178036|NCT00662649|450272662|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
125178037|NCT00662649|450272658|FG000|Core Study (24 Months)|Protocol Violation|5|||
125178038|NCT00662649|450272659|FG001|Core Study (24 Months)|Protocol Violation|5|||
125178039|NCT00662649|450272660|FG002|Core Study (24 Months)|Protocol Violation|4|||
125178040|NCT00662649|450272661|FG003|Core Study (24 Months)|Protocol Violation|0|||
125178041|NCT00662649|450272662|FG004|Core Study (24 Months)|Protocol Violation|0|||
125178042|NCT00662649|450272658|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
125178043|NCT00662649|450272659|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
125178044|NCT00662649|450272660|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
125178045|NCT00662649|450272661|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
125178046|NCT00662649|450272662|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
125178047|NCT00662649|450272658|FG000|Core Study (24 Months)|Death|1|||
125178048|NCT00662649|450272659|FG001|Core Study (24 Months)|Death|0|||
125178049|NCT00662649|450272660|FG002|Core Study (24 Months)|Death|2|||
125178050|NCT00662649|450272661|FG003|Core Study (24 Months)|Death|0|||
125178051|NCT00662649|450272662|FG004|Core Study (24 Months)|Death|0|||
125178052|NCT00662649|450272658|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
125178053|NCT00662649|450272659|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
125178054|NCT00662649|450272660|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
125178055|NCT00662649|450272661|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
125178056|NCT00662649|450272662|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
125178057|NCT00662649|450272658|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
125178058|NCT00662649|450272659|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
125178059|NCT00662649|450272660|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
125178060|NCT00662649|450272661|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
125178061|NCT00662649|450272662|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
125178062|NCT00662649|450272658|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
125178063|NCT00662649|450272659|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
125178064|NCT00662649|450272660|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
125178065|NCT00662649|450272661|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
125178066|NCT00662649|450272662|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
125178067|NCT00662649|450272658|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
125178068|NCT00662649|450272659|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
125178069|NCT00662649|450272660|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
125178070|NCT00662649|450272661|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
125178071|NCT00662649|450272662|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
125178072|NCT00662649|450272658|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
125178073|NCT00662649|450272659|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
125233772|NCT00392223|450483288|FG000|Overall Study|Lost to Follow-up|1|||
125233773|NCT00392223|450483289|FG001|Overall Study|Lost to Follow-up|4|||
125233774|NCT00392223|450483288|FG000|Overall Study|Protocol Violation|0|||
125233775|NCT00392223|450483289|FG001|Overall Study|Protocol Violation|3|||
125233776|NCT00392223|450483288|FG000|Overall Study|Withdrawal by Subject|3|||
125233777|NCT00392223|450483289|FG001|Overall Study|Withdrawal by Subject|2|||
125233778|NCT03104374|450483293|FG000|Period 1|Adverse Event|7|||
125233779|NCT03104374|450483294|FG001|Period 1|Adverse Event|7|||
125233780|NCT03104374|450483295|FG002|Period 1|Adverse Event|12|||
125233781|NCT03104374|450483296|FG003|Period 1|Adverse Event|14|||
125233782|NCT03104374|450483293|FG000|Period 1|Withdrawal by Subject|18|||
125233783|NCT03104374|450483294|FG001|Period 1|Withdrawal by Subject|9|||
125233784|NCT03104374|450483295|FG002|Period 1|Withdrawal by Subject|10|||
125233785|NCT03104374|450483296|FG003|Period 1|Withdrawal by Subject|17|||
125233786|NCT03104374|450483293|FG000|Period 1|Lost to Follow-up|4|||
125233787|NCT03104374|450483294|FG001|Period 1|Lost to Follow-up|4|||
125233788|NCT03104374|450483295|FG002|Period 1|Lost to Follow-up|6|||
125233789|NCT03104374|450483296|FG003|Period 1|Lost to Follow-up|8|||
125233790|NCT03104374|450483293|FG000|Period 1|Lack of Efficacy|6|||
125233791|NCT03104374|450483294|FG001|Period 1|Lack of Efficacy|7|||
125233792|NCT03104374|450483295|FG002|Period 1|Lack of Efficacy|12|||
125233793|NCT03104374|450483296|FG003|Period 1|Lack of Efficacy|6|||
125233794|NCT03104374|450483293|FG000|Period 1|Other|2|||
125233795|NCT03104374|450483294|FG001|Period 1|Other|2|||
125233796|NCT03104374|450483295|FG002|Period 1|Other|4|||
125233797|NCT03104374|450483296|FG003|Period 1|Other|7|||
125233798|NCT03104374|450483293|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
125233799|NCT03104374|450483294|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
125233800|NCT03104374|450483295|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
125233801|NCT03104374|450483296|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
125233802|NCT03104374|450483293|FG000|Period 2|Adverse Event|4|||
125233803|NCT03104374|450483294|FG001|Period 2|Adverse Event|7|||
125233804|NCT03104374|450483295|FG002|Period 2|Adverse Event|10|||
125233805|NCT03104374|450483296|FG003|Period 2|Adverse Event|10|||
125233806|NCT03104374|450483293|FG000|Period 2|Withdrawal by Subject|3|||
125233807|NCT03104374|450483294|FG001|Period 2|Withdrawal by Subject|7|||
125178074|NCT00662649|450272660|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
125178075|NCT00662649|450272661|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
125178076|NCT00662649|450272662|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
125178077|NCT00662649|450272658|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
125178078|NCT00662649|450272659|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
125178079|NCT00662649|450272660|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
125178080|NCT00662649|450272661|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
125178081|NCT00662649|450272662|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
125178082|NCT00662649|450272658|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
125178083|NCT00662649|450272659|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
125178084|NCT00662649|450272660|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
125178085|NCT00662649|450272661|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
125178086|NCT00662649|450272662|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
125178087|NCT00662649|450272658|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
125178088|NCT00662649|450272659|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
125178089|NCT00662649|450272660|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
125178090|NCT00662649|450272661|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
125178091|NCT00662649|450272662|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
125178092|NCT00662649|450272658|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
125178093|NCT00662649|450272659|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
125178094|NCT00662649|450272660|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
125178095|NCT00662649|450272661|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
125178096|NCT00662649|450272662|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
125178097|NCT03594071|450272663|FG000|Overall Study|Re-operation|3|||
125178098|NCT03594071|450272663|FG000|Overall Study|Missed visit|2|||
125178099|NCT01026194|450272664|FG000|Period 1：Double Blind Period|Adverse Event|2|||
125178100|NCT01026194|450272665|FG001|Period 1：Double Blind Period|Adverse Event|1|||
125178101|NCT01026194|450272664|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
125178102|NCT01026194|450272665|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
125178103|NCT01026194|450272664|FG000|Period 1：Double Blind Period|Physician Decision|0|||
125178104|NCT01026194|450272665|FG001|Period 1：Double Blind Period|Physician Decision|4|||
125178105|NCT01026194|450272664|FG000|Period 2：Open-label Period|Adverse Event|4|||
125178106|NCT01026194|450272665|FG001|Period 2：Open-label Period|Adverse Event|5|||
125178107|NCT01026194|450272664|FG000|Period 2：Open-label Period|Physician Decision|3|||
125178108|NCT01026194|450272665|FG001|Period 2：Open-label Period|Physician Decision|1|||
125233808|NCT03104374|450483295|FG002|Period 2|Withdrawal by Subject|13|||
125233809|NCT03104374|450483296|FG003|Period 2|Withdrawal by Subject|16|||
125178109|NCT01026194|450272664|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
125178110|NCT01026194|450272665|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
125178111|NCT01750190|450272666|FG000|Overall Study|Adverse Event|47|||
125178112|NCT01750190|450272667|FG001|Overall Study|Adverse Event|19|||
125178113|NCT01750190|450272666|FG000|Overall Study|Death|38|||
125178114|NCT01750190|450272667|FG001|Overall Study|Death|11|||
125178115|NCT01750190|450272666|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
125178116|NCT01750190|450272667|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
125178117|NCT01750190|450272666|FG000|Overall Study|Lost to Follow-up|28|||
125178118|NCT01750190|450272667|FG001|Overall Study|Lost to Follow-up|7|||
125178119|NCT01750190|450272666|FG000|Overall Study|Physician Decision|16|||
125178120|NCT01750190|450272667|FG001|Overall Study|Physician Decision|17|||
125178121|NCT01750190|450272666|FG000|Overall Study|Protocol Violation|6|||
125178122|NCT01750190|450272667|FG001|Overall Study|Protocol Violation|5|||
125178123|NCT01750190|450272666|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
125178124|NCT01750190|450272667|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
125178125|NCT01750190|450272666|FG000|Overall Study|Withdrawal by Subject|83|||
125178126|NCT01750190|450272667|FG001|Overall Study|Withdrawal by Subject|89|||
125178127|NCT01750190|450272666|FG000|Overall Study|Kidney Transplant|8|||
125178128|NCT01750190|450272667|FG001|Overall Study|Kidney Transplant|4|||
125178129|NCT01750190|450272666|FG000|Overall Study|Dialysis|22|||
125178130|NCT01750190|450272667|FG001|Overall Study|Dialysis|8|||
125178131|NCT01750190|450272666|FG000|Overall Study|Other than Specified|13|||
125178132|NCT01750190|450272667|FG001|Overall Study|Other than Specified|4|||
125178133|NCT02009722|450272674|FG000|Overall Study|Protocol Violation|1|||
125178134|NCT02009722|450272675|FG001|Overall Study|Protocol Violation|2|||
125178135|NCT02009722|450272674|FG000|Overall Study|Did not receive intervention|0|||
125178136|NCT02009722|450272675|FG001|Overall Study|Did not receive intervention|1|||
125178137|NCT02955212|450272676|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
125178138|NCT02955212|450272677|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
125178139|NCT02955212|450272676|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
125178140|NCT02955212|450272677|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
125178141|NCT02955212|450272676|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
125178142|NCT02955212|450272677|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
125178143|NCT02955212|450272676|FG000|Period 1: Double-blind Treatment Period|Other|3|||
125178144|NCT02955212|450272677|FG001|Period 1: Double-blind Treatment Period|Other|2|||
125178145|NCT02955212|450272676|FG000|Period 2: Open-label Extension|Adverse Event|11|||
125178146|NCT02955212|450272677|FG001|Period 2: Open-label Extension|Adverse Event|7|||
125178147|NCT02955212|450272676|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
125178148|NCT02955212|450272677|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
125178149|NCT02955212|450272676|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
125178150|NCT02955212|450272677|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
125178151|NCT02955212|450272676|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
125178152|NCT02955212|450272677|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
125178153|NCT02955212|450272676|FG000|Period 2: Open-label Extension|Other|2|||
125178154|NCT02955212|450272677|FG001|Period 2: Open-label Extension|Other|4|||
125178155|NCT00545714|450272682|FG000|Induction Phase (6 Months)|Physician Decision|3|||
125178156|NCT00545714|450272682|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
125178157|NCT00545714|450272682|FG000|Induction Phase (6 Months)|Disease Progression|1|||
125178158|NCT00545714|450272682|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
125178159|NCT00545714|450272682|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
125178160|NCT00545714|450272682|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
125178161|NCT00545714|450272682|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
125178162|NCT00545714|450272682|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
125178163|NCT00545714|450272682|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
125178164|NCT00545714|450272682|FG000|Maintenance Phase (36 Months)|Death|2|||
125178165|NCT04428034|450272685|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
125178166|NCT00560391|450272686|FG000|Overall Study|Still on treatment|0|||
125178167|NCT00560391|450272687|FG001|Overall Study|Still on treatment|0|||
125178168|NCT00560391|450272688|FG002|Overall Study|Still on treatment|0|||
125178169|NCT00560391|450272689|FG003|Overall Study|Still on treatment|1|||
125178170|NCT00560391|450272690|FG004|Overall Study|Still on treatment|2|||
125178171|NCT02556801|450272691|FG000|Overall Study|Lost to Follow-up|1|||
125178172|NCT02556801|450272692|FG001|Overall Study|Lost to Follow-up|0|||
125178173|NCT02556801|450272693|FG002|Overall Study|Lost to Follow-up|2|||
125178174|NCT02556801|450272694|FG003|Overall Study|Lost to Follow-up|0|||
125178175|NCT02556801|450272691|FG000|Overall Study|Withdrawal by Subject|1|||
125178176|NCT02556801|450272692|FG001|Overall Study|Withdrawal by Subject|1|||
125178177|NCT02556801|450272693|FG002|Overall Study|Withdrawal by Subject|1|||
125178178|NCT02556801|450272694|FG003|Overall Study|Withdrawal by Subject|0|||
125178179|NCT02556801|450272691|FG000|Overall Study|Protocol Violation|0|||
125178180|NCT02556801|450272692|FG001|Overall Study|Protocol Violation|3|||
125178181|NCT02556801|450272693|FG002|Overall Study|Protocol Violation|1|||
125178182|NCT02556801|450272694|FG003|Overall Study|Protocol Violation|1|||
125178183|NCT02556801|450272691|FG000|Overall Study|Adverse Event|0|||
125178184|NCT02556801|450272692|FG001|Overall Study|Adverse Event|2|||
125178185|NCT02556801|450272693|FG002|Overall Study|Adverse Event|0|||
125178186|NCT02556801|450272694|FG003|Overall Study|Adverse Event|3|||
125178187|NCT02556801|450272691|FG000|Overall Study|Pregnancy|0|||
125178188|NCT02556801|450272692|FG001|Overall Study|Pregnancy|1|||
125178189|NCT02556801|450272693|FG002|Overall Study|Pregnancy|0|||
125178190|NCT02556801|450272694|FG003|Overall Study|Pregnancy|0|||
125178191|NCT02556801|450272691|FG000|Overall Study|Personal reasons patient|0|||
125178192|NCT02556801|450272692|FG001|Overall Study|Personal reasons patient|0|||
125178193|NCT02556801|450272693|FG002|Overall Study|Personal reasons patient|0|||
125178194|NCT02556801|450272694|FG003|Overall Study|Personal reasons patient|1|||
125178195|NCT03668808|450272695|FG000|First Intervention|Withdrawal by Subject|2|||
125178196|NCT03668808|450272696|FG001|First Intervention|Withdrawal by Subject|2|||
125178197|NCT01965860|450272706|FG000|Overall Study|Pregnancy|1|||
125178198|NCT01965860|450272707|FG001|Overall Study|Pregnancy|0|||
125178199|NCT01965860|450272708|FG002|Overall Study|Pregnancy|1|||
125178200|NCT01965860|450272706|FG000|Overall Study|Logistics|1|||
125178201|NCT01965860|450272707|FG001|Overall Study|Logistics|0|||
125178202|NCT01965860|450272708|FG002|Overall Study|Logistics|0|||
125178203|NCT03735121|450272712|FG000|Overall Study|Death|3|||
125178204|NCT03735121|450272713|FG001|Overall Study|Death|6|||
125178205|NCT03735121|450272714|FG002|Overall Study|Death|8|||
125178206|NCT03735121|450272715|FG003|Overall Study|Death|37|||
125178207|NCT03735121|450272716|FG004|Overall Study|Death|86|||
125178208|NCT03735121|450272712|FG000|Overall Study|Withdrawal by Subject|1|||
125178209|NCT03735121|450272713|FG001|Overall Study|Withdrawal by Subject|1|||
125178210|NCT03735121|450272714|FG002|Overall Study|Withdrawal by Subject|3|||
125178211|NCT03735121|450272715|FG003|Overall Study|Withdrawal by Subject|4|||
125178212|NCT03735121|450272716|FG004|Overall Study|Withdrawal by Subject|2|||
125178213|NCT03735121|450272712|FG000|Overall Study|Progressive Disease|0|||
125178214|NCT03735121|450272713|FG001|Overall Study|Progressive Disease|0|||
125178215|NCT03735121|450272714|FG002|Overall Study|Progressive Disease|1|||
125178216|NCT03735121|450272715|FG003|Overall Study|Progressive Disease|0|||
125178217|NCT03735121|450272716|FG004|Overall Study|Progressive Disease|0|||
125178218|NCT03735121|450272712|FG000|Overall Study|Lost to Follow-up|0|||
125178219|NCT03735121|450272713|FG001|Overall Study|Lost to Follow-up|0|||
125178220|NCT03735121|450272714|FG002|Overall Study|Lost to Follow-up|0|||
125178221|NCT03735121|450272715|FG003|Overall Study|Lost to Follow-up|0|||
125178222|NCT03735121|450272716|FG004|Overall Study|Lost to Follow-up|1|||
125178223|NCT03735121|450272712|FG000|Overall Study|Ongoing|3|||
125178224|NCT03735121|450272713|FG001|Overall Study|Ongoing|3|||
125178225|NCT03735121|450272714|FG002|Overall Study|Ongoing|26|||
125178226|NCT03735121|450272715|FG003|Overall Study|Ongoing|83|||
125178227|NCT03735121|450272716|FG004|Overall Study|Ongoing|158|||
125178228|NCT03138655|450272718|FG000|Overall Study|Adverse Event|2|||
125178229|NCT03138655|450272719|FG001|Overall Study|Adverse Event|1|||
125178230|NCT03138655|450272720|FG002|Overall Study|Adverse Event|2|||
125178231|NCT03138655|450272721|FG003|Overall Study|Adverse Event|1|||
125178232|NCT03138655|450272722|FG004|Overall Study|Adverse Event|1|||
125178233|NCT03138655|450272723|FG005|Overall Study|Adverse Event|4|||
125178234|NCT03138655|450272724|FG006|Overall Study|Adverse Event|2|||
125178235|NCT03138655|450272725|FG007|Overall Study|Adverse Event|2|||
125178236|NCT03138655|450272718|FG000|Overall Study|Withdrawal by Subject|0|||
125178237|NCT03138655|450272719|FG001|Overall Study|Withdrawal by Subject|1|||
125178238|NCT03138655|450272720|FG002|Overall Study|Withdrawal by Subject|0|||
125178239|NCT03138655|450272721|FG003|Overall Study|Withdrawal by Subject|0|||
125178240|NCT03138655|450272722|FG004|Overall Study|Withdrawal by Subject|0|||
125178241|NCT03138655|450272723|FG005|Overall Study|Withdrawal by Subject|0|||
125233810|NCT03104374|450483293|FG000|Period 2|Lost to Follow-up|2|||
125233811|NCT03104374|450483294|FG001|Period 2|Lost to Follow-up|2|||
125178242|NCT03138655|450272724|FG006|Overall Study|Withdrawal by Subject|1|||
125178243|NCT03138655|450272725|FG007|Overall Study|Withdrawal by Subject|0|||
125178244|NCT03138655|450272718|FG000|Overall Study|Reason not Specified|1|||
125178245|NCT03138655|450272719|FG001|Overall Study|Reason not Specified|0|||
125178246|NCT03138655|450272720|FG002|Overall Study|Reason not Specified|0|||
125178247|NCT03138655|450272721|FG003|Overall Study|Reason not Specified|2|||
125178248|NCT03138655|450272722|FG004|Overall Study|Reason not Specified|1|||
125178249|NCT03138655|450272723|FG005|Overall Study|Reason not Specified|1|||
125178250|NCT03138655|450272724|FG006|Overall Study|Reason not Specified|0|||
125178251|NCT03138655|450272725|FG007|Overall Study|Reason not Specified|0|||
125178252|NCT03151304|450272726|FG000|Overall Study|Termination of study by Sponsor|23|||
125233812|NCT03104374|450483295|FG002|Period 2|Lost to Follow-up|3|||
125178253|NCT03151304|450272726|FG000|Overall Study|missing|3|||
125178254|NCT03151304|450272726|FG000|Overall Study|Withdrawal by Subject|8|||
125178255|NCT03151304|450272726|FG000|Overall Study|multiple reasons|30|||
125178256|NCT03519087|450272727|FG000|Clinic Evaluation|Physician Decision|15|||
125178257|NCT03519087|450272728|FG001|Clinic Evaluation|Physician Decision|18|||
125233813|NCT03104374|450483296|FG003|Period 2|Lost to Follow-up|5|||
125233814|NCT03104374|450483293|FG000|Period 2|Lack of Efficacy|2|||
125233815|NCT03104374|450483294|FG001|Period 2|Lack of Efficacy|4|||
125233816|NCT03104374|450483295|FG002|Period 2|Lack of Efficacy|7|||
125233817|NCT03104374|450483296|FG003|Period 2|Lack of Efficacy|4|||
125233818|NCT03104374|450483293|FG000|Period 2|COVID-19 Infection|0|||
125233819|NCT03104374|450483294|FG001|Period 2|COVID-19 Infection|0|||
125233820|NCT03104374|450483295|FG002|Period 2|COVID-19 Infection|1|||
125233821|NCT03104374|450483296|FG003|Period 2|COVID-19 Infection|0|||
125233822|NCT03104374|450483293|FG000|Period 2|Other|3|||
125233823|NCT03104374|450483294|FG001|Period 2|Other|2|||
125233824|NCT03104374|450483295|FG002|Period 2|Other|2|||
125233825|NCT03104374|450483296|FG003|Period 2|Other|4|||
125233826|NCT00094445|450483299|FG000|Overall Study|Withdrawal by Subject|3|||
125233827|NCT00094445|450483299|FG000|Overall Study|Lost to Follow-up|1|||
125233828|NCT00094445|450483299|FG000|Overall Study|Progressive Disease|2|||
125233829|NCT00769561|450483300|FG000|Overall Study|Withdrawal by Subject|2|||
125233830|NCT00769561|450483301|FG001|Overall Study|Withdrawal by Subject|2|||
125233831|NCT00769561|450483300|FG000|Overall Study|Lost to Follow-up|1|||
125233832|NCT00769561|450483301|FG001|Overall Study|Lost to Follow-up|3|||
125233833|NCT04585893|450483302|FG000|Overall Study|Death|1|||
125233834|NCT04585893|450483303|FG001|Overall Study|Death|0|||
125233835|NCT03729362|450484986|FG000|Overall Study|Withdrawal by Subject|2|||
125233836|NCT03729362|450484987|FG001|Overall Study|Withdrawal by Subject|0|||
125233837|NCT03729362|450484986|FG000|Overall Study|Physician Decision|1|||
125233838|NCT03729362|450484987|FG001|Overall Study|Physician Decision|0|||
125233839|NCT03729362|450484986|FG000|Overall Study|COVID-19 Pandemic|1|||
125233840|NCT03729362|450484987|FG001|Overall Study|COVID-19 Pandemic|0|||
125233841|NCT03729362|450484986|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
125233842|NCT03729362|450484987|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
125233843|NCT03729362|450484986|FG000|Overall Study|Adverse Event|0|||
125233844|NCT03729362|450484987|FG001|Overall Study|Adverse Event|1|||
125233845|NCT03729362|450484986|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
125233846|NCT03729362|450484987|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
125233847|NCT01113749|450484988|FG000|Overall Study|Lost to Follow-up|1|||
125233848|NCT01113749|450484989|FG001|Overall Study|Lost to Follow-up|2|||
125233849|NCT00961064|450484992|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
125233850|NCT00961064|450484992|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
125233851|NCT00961064|450484992|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
125233852|NCT00961064|450484992|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
125233853|NCT00961064|450484992|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
125233854|NCT00961064|450484992|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
125233855|NCT00961064|450484992|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
125233856|NCT00961064|450484992|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
125233857|NCT00576758|450484993|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
125233858|NCT00576758|450484994|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
125233859|NCT00576758|450484993|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
125233860|NCT00576758|450484994|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
125233861|NCT00576758|450484993|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
125233862|NCT00576758|450484994|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
125233863|NCT00576758|450484993|FG000|Induction Treatment Period|Death|1|||
125233864|NCT00576758|450484994|FG001|Induction Treatment Period|Death|0|||
125233865|NCT00576758|450484993|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
125233866|NCT00576758|450484994|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
125233867|NCT00576758|450484993|FG000|Induction Treatment Period|Withdrew consent|1|||
125233868|NCT00576758|450484994|FG001|Induction Treatment Period|Withdrew consent|0|||
125233869|NCT00576758|450484993|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
125233870|NCT00576758|450484994|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
125233871|NCT00576758|450484993|FG000|Extension Treatment Period|Death|1|||
125233872|NCT00576758|450484994|FG001|Extension Treatment Period|Death|1|||
125233873|NCT00576758|450484993|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
125233874|NCT00576758|450484994|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
125233875|NCT00576758|450484993|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
125233876|NCT00576758|450484994|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
125233877|NCT00576758|450484993|FG000|Extension Treatment Period|Administrative/Other|3|||
125233878|NCT00576758|450484994|FG001|Extension Treatment Period|Administrative/Other|1|||
125233879|NCT00576758|450484993|FG000|Follow-up Period|Administrative/Other|6|||
125233880|NCT00576758|450484994|FG001|Follow-up Period|Administrative/Other|8|||
125233881|NCT00576758|450484993|FG000|Follow-up Period|Death|3|||
125233882|NCT00576758|450484994|FG001|Follow-up Period|Death|3|||
125233883|NCT00576758|450484993|FG000|Follow-up Period|Insufficient therapeutic response|16|||
125233884|NCT00576758|450484994|FG001|Follow-up Period|Insufficient therapeutic response|5|||
125233885|NCT00576758|450484993|FG000|Follow-up Period|Withdrew consent|2|||
125233886|NCT00576758|450484994|FG001|Follow-up Period|Withdrew consent|1|||
125178258|NCT03519087|450272729|FG002|Clinic Evaluation|Physician Decision|0|||
125178259|NCT03519087|450272730|FG003|Clinic Evaluation|Physician Decision|0|||
125178260|NCT03519087|450272731|FG004|Clinic Evaluation|Physician Decision|0|||
125178261|NCT03519087|450272727|FG000|Clinic Evaluation|Protocol Violation|1|||
125178262|NCT03519087|450272728|FG001|Clinic Evaluation|Protocol Violation|0|||
125178263|NCT03519087|450272729|FG002|Clinic Evaluation|Protocol Violation|0|||
125178264|NCT03519087|450272730|FG003|Clinic Evaluation|Protocol Violation|0|||
125178265|NCT03519087|450272731|FG004|Clinic Evaluation|Protocol Violation|0|||
125178266|NCT03519087|450272727|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
125178267|NCT03519087|450272728|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
125178268|NCT03519087|450272729|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
125178269|NCT03519087|450272730|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
125178270|NCT03519087|450272731|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
125178271|NCT03519087|450272727|FG000|Re-randomization for Treatment|Not appropriate|2|||
125178272|NCT03519087|450272728|FG001|Re-randomization for Treatment|Not appropriate|3|||
125178273|NCT03519087|450272729|FG002|Re-randomization for Treatment|Not appropriate|0|||
125178274|NCT03519087|450272730|FG003|Re-randomization for Treatment|Not appropriate|0|||
125178275|NCT03519087|450272731|FG004|Re-randomization for Treatment|Not appropriate|0|||
125178276|NCT03519087|450272727|FG000|Laboratory Testing|Lost to Follow-up|0|||
125178277|NCT03519087|450272728|FG001|Laboratory Testing|Lost to Follow-up|0|||
125178278|NCT03519087|450272729|FG002|Laboratory Testing|Lost to Follow-up|2|||
125178279|NCT03519087|450272730|FG003|Laboratory Testing|Lost to Follow-up|3|||
125178280|NCT03519087|450272731|FG004|Laboratory Testing|Lost to Follow-up|6|||
125178281|NCT03519087|450272727|FG000|Laboratory Testing|Protocol Violation|0|||
125178282|NCT03519087|450272728|FG001|Laboratory Testing|Protocol Violation|0|||
125178283|NCT03519087|450272729|FG002|Laboratory Testing|Protocol Violation|0|||
125178284|NCT03519087|450272730|FG003|Laboratory Testing|Protocol Violation|1|||
125178285|NCT03519087|450272731|FG004|Laboratory Testing|Protocol Violation|0|||
125178286|NCT01137071|450272732|FG000|Overall Study|Disease Progression|11|||
125178287|NCT01137071|450272732|FG000|Overall Study|Withdrawal by Subject|2|||
125178288|NCT01137071|450272732|FG000|Overall Study|Wrongly Included|1|||
125178289|NCT04194645|450272733|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178290|NCT04194645|450272734|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178291|NCT04194645|450272735|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178292|NCT04194645|450272736|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178293|NCT04194645|450272737|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178294|NCT04194645|450272738|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178295|NCT04194645|450272739|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178296|NCT04194645|450272740|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178297|NCT04194645|450272741|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178298|NCT04194645|450272742|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
125178299|NCT04194645|450272743|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178300|NCT04194645|450272744|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178301|NCT04194645|450272745|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178302|NCT04194645|450272746|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178303|NCT04194645|450272747|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178304|NCT01783886|450272748|FG000|Overall Study|Lost to Follow-up|0|||
125178305|NCT01783886|450272749|FG001|Overall Study|Lost to Follow-up|3|||
125178306|NCT01783886|450272750|FG002|Overall Study|Lost to Follow-up|0|||
125178307|NCT01783886|450272748|FG000|Overall Study|Protocol deviation|0|||
125178308|NCT01783886|450272749|FG001|Overall Study|Protocol deviation|0|||
125178309|NCT01783886|450272750|FG002|Overall Study|Protocol deviation|2|||
125178310|NCT01783886|450272748|FG000|Overall Study|Withdrawal of consent by participant|1|||
125178311|NCT01783886|450272749|FG001|Overall Study|Withdrawal of consent by participant|3|||
125178312|NCT01783886|450272750|FG002|Overall Study|Withdrawal of consent by participant|4|||
125178313|NCT01783886|450272748|FG000|Overall Study|Adverse Event|4|||
125178314|NCT01783886|450272749|FG001|Overall Study|Adverse Event|5|||
125178315|NCT01783886|450272750|FG002|Overall Study|Adverse Event|4|||
125178316|NCT04542057|450272751|FG000|Overall Study|Death|3|||
125178317|NCT04542057|450272752|FG001|Overall Study|Death|1|||
125178318|NCT04542057|450272751|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
125178319|NCT04542057|450272752|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
125178320|NCT04542057|450272751|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
125178321|NCT04542057|450272752|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
125178322|NCT04542057|450272751|FG000|Overall Study|Adverse Event|15|||
125178323|NCT04542057|450272752|FG001|Overall Study|Adverse Event|6|||
125178324|NCT04542057|450272751|FG000|Overall Study|COVID-19 adverse event|6|||
125178325|NCT04542057|450272752|FG001|Overall Study|COVID-19 adverse event|4|||
125178326|NCT04542057|450272751|FG000|Overall Study|Lack of Efficacy|2|||
125178327|NCT04542057|450272752|FG001|Overall Study|Lack of Efficacy|5|||
125178328|NCT04542057|450272751|FG000|Overall Study|Study terminated by sponsor|1|||
125178329|NCT04542057|450272752|FG001|Overall Study|Study terminated by sponsor|0|||
125178330|NCT04542057|450272751|FG000|Overall Study|Investigator discretion|2|||
125233887|NCT00761319|450484995|FG000|Overall Study|Protocol Violation|21|||
125178331|NCT04542057|450272752|FG001|Overall Study|Investigator discretion|1|||
125178332|NCT04542057|450272751|FG000|Overall Study|Withdrawal by Subject|52|||
125178333|NCT04542057|450272752|FG001|Overall Study|Withdrawal by Subject|30|||
125178334|NCT04542057|450272751|FG000|Overall Study|Lost to Follow-up|8|||
125178335|NCT04542057|450272752|FG001|Overall Study|Lost to Follow-up|11|||
125178336|NCT04542057|450272751|FG000|Overall Study|Other|2|||
125178337|NCT04542057|450272752|FG001|Overall Study|Other|2|||
125178338|NCT00104572|450272753|FG000|Overall Study|Withdrawal by Subject|3|||
125178339|NCT00104572|450272754|FG001|Overall Study|Withdrawal by Subject|3|||
125178340|NCT00104572|450272755|FG002|Overall Study|Withdrawal by Subject|0|||
125178341|NCT00940316|450272756|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
125178342|NCT00940316|450272757|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
125178343|NCT00940316|450272758|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
125178344|NCT00940316|450272756|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
125178345|NCT00940316|450272757|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
125178346|NCT00940316|450272758|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
125178347|NCT00940316|450272756|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
125178348|NCT00940316|450272757|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
125178349|NCT00940316|450272758|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
125178350|NCT00940316|450272756|FG000|Treated After Cycle 5|Adverse Event|0|||
125178351|NCT00940316|450272757|FG001|Treated After Cycle 5|Adverse Event|0|||
125178352|NCT00940316|450272758|FG002|Treated After Cycle 5|Adverse Event|1|||
125178353|NCT00940316|450272756|FG000|Treated After Cycle 5|Progressive disease|0|||
125178354|NCT00940316|450272757|FG001|Treated After Cycle 5|Progressive disease|1|||
125178355|NCT00940316|450272758|FG002|Treated After Cycle 5|Progressive disease|0|||
125178356|NCT00796757|450272760|FG000|Overall Study|Withdrawal by Subject|14|||
125178357|NCT00796757|450272760|FG000|Overall Study|Death|61|||
125178358|NCT00796757|450272760|FG000|Overall Study|Protocol Violation|1|||
125178359|NCT00796757|450272760|FG000|Overall Study|Participant noncompliance|1|||
125178360|NCT00796757|450272760|FG000|Overall Study|Investigator's decision|2|||
125178361|NCT00796757|450272760|FG000|Overall Study|Other|7|||
125178362|NCT02290405|450272763|FG000|Overall Study|Withdrawal by Subject|1|||
125178363|NCT02290405|450272764|FG001|Overall Study|Withdrawal by Subject|0|||
125178364|NCT02016183|450272765|FG000|Overall Study|Case Report Forms Uncollected|13|||
125178365|NCT02016183|450272765|FG000|Overall Study|Protocol Violation|52|||
125178366|NCT00996489|450272766|FG000|Overall Study|Device failure|45|||
125178367|NCT00996489|450272766|FG000|Overall Study|Discontinued|116|||
125178368|NCT03142191|450272767|FG000|Placebo Controlled Period|Death|0|||
125178369|NCT03142191|450272768|FG001|Placebo Controlled Period|Death|1|||
125178370|NCT03142191|450272769|FG002|Placebo Controlled Period|Death|1|||
125178371|NCT03142191|450272770|FG003|Placebo Controlled Period|Death|0|||
125178372|NCT03142191|450272771|FG004|Placebo Controlled Period|Death|0|||
125178373|NCT03142191|450272767|FG000|Placebo Controlled Period|Adverse Event|4|||
125178374|NCT03142191|450272768|FG001|Placebo Controlled Period|Adverse Event|5|||
125178375|NCT03142191|450272769|FG002|Placebo Controlled Period|Adverse Event|1|||
125178376|NCT03142191|450272770|FG003|Placebo Controlled Period|Adverse Event|0|||
125178377|NCT03142191|450272771|FG004|Placebo Controlled Period|Adverse Event|0|||
125178378|NCT03142191|450272767|FG000|Placebo Controlled Period|Progressive Disease|1|||
125178379|NCT03142191|450272768|FG001|Placebo Controlled Period|Progressive Disease|0|||
125178380|NCT03142191|450272769|FG002|Placebo Controlled Period|Progressive Disease|1|||
125178381|NCT03142191|450272770|FG003|Placebo Controlled Period|Progressive Disease|0|||
125178382|NCT03142191|450272771|FG004|Placebo Controlled Period|Progressive Disease|0|||
125178383|NCT03142191|450272767|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
125178384|NCT03142191|450272768|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
125178385|NCT03142191|450272769|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
125178386|NCT03142191|450272770|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
125178387|NCT03142191|450272771|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
125178388|NCT03142191|450272767|FG000|Placebo Controlled Period|Other Reasons|1|||
125178389|NCT03142191|450272768|FG001|Placebo Controlled Period|Other Reasons|0|||
125178390|NCT03142191|450272769|FG002|Placebo Controlled Period|Other Reasons|0|||
125178391|NCT03142191|450272770|FG003|Placebo Controlled Period|Other Reasons|0|||
125178392|NCT03142191|450272771|FG004|Placebo Controlled Period|Other Reasons|0|||
125178393|NCT03142191|450272767|FG000|Active Treatment Extension Period|Death|2|||
125178394|NCT03142191|450272768|FG001|Active Treatment Extension Period|Death|1|||
125178395|NCT03142191|450272769|FG002|Active Treatment Extension Period|Death|1|||
125178396|NCT03142191|450272770|FG003|Active Treatment Extension Period|Death|1|||
125178397|NCT03142191|450272771|FG004|Active Treatment Extension Period|Death|0|||
125178398|NCT03142191|450272767|FG000|Active Treatment Extension Period|Adverse Event|6|||
125178399|NCT03142191|450272768|FG001|Active Treatment Extension Period|Adverse Event|5|||
125178400|NCT03142191|450272769|FG002|Active Treatment Extension Period|Adverse Event|4|||
125178401|NCT03142191|450272770|FG003|Active Treatment Extension Period|Adverse Event|1|||
125178402|NCT03142191|450272771|FG004|Active Treatment Extension Period|Adverse Event|0|||
125178403|NCT03142191|450272767|FG000|Active Treatment Extension Period|Progressive Disease|10|||
125178404|NCT03142191|450272768|FG001|Active Treatment Extension Period|Progressive Disease|5|||
125233888|NCT00761319|450484996|FG001|Overall Study|Protocol Violation|14|||
125233889|NCT00761319|450484995|FG000|Overall Study|Adverse Event|11|||
125233890|NCT00761319|450484996|FG001|Overall Study|Adverse Event|7|||
125233891|NCT00761319|450484995|FG000|Overall Study|Withdrawal by Subject|8|||
125233892|NCT00761319|450484996|FG001|Overall Study|Withdrawal by Subject|7|||
125233893|NCT00761319|450484995|FG000|Overall Study|Noncompliance|4|||
125233894|NCT00761319|450484996|FG001|Overall Study|Noncompliance|3|||
125233895|NCT00761319|450484995|FG000|Overall Study|Lost to Follow-up|1|||
125233896|NCT00761319|450484996|FG001|Overall Study|Lost to Follow-up|1|||
125233897|NCT00761319|450484995|FG000|Overall Study|Nonspecified|2|||
125233898|NCT00761319|450484996|FG001|Overall Study|Nonspecified|2|||
125233899|NCT00761319|450484995|FG000|Overall Study|Missing|1|||
125233900|NCT00761319|450484996|FG001|Overall Study|Missing|0|||
125233901|NCT02472405|450484997|FG000|Overall Study|Lost to Follow-up|9|||
125233902|NCT02472405|450484997|FG000|Overall Study|Adverse Event|1|||
125233903|NCT01715298|450484998|FG000|Overall Study|Lost to Follow-up|0|||
125233904|NCT01715298|450484999|FG001|Overall Study|Lost to Follow-up|2|||
125233905|NCT01715298|450484998|FG000|Overall Study|Patient/guardian decision|7|||
125233906|NCT01715298|450484999|FG001|Overall Study|Patient/guardian decision|9|||
125233907|NCT00726453|450485001|FG000|Primary Enrollment Group|Death|18|||
125233908|NCT00726453|450485002|FG001|Primary Enrollment Group|Death|0|||
125233909|NCT00726453|450485001|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
125233910|NCT00726453|450485002|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
125233911|NCT00726453|450485001|FG000|38 mm Length Group|Death|0|||
125233912|NCT00726453|450485002|FG001|38 mm Length Group|Death|3|||
125233913|NCT01432951|450485005|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
125233914|NCT00853385|450485006|FG000|Overall Study|Death|0|||
125233915|NCT00853385|450485007|FG001|Overall Study|Death|0|||
125233916|NCT00853385|450485008|FG002|Overall Study|Death|0|||
125233917|NCT00853385|450485009|FG003|Overall Study|Death|0|||
125233918|NCT00853385|450485010|FG004|Overall Study|Death|1|||
125233919|NCT00853385|450485006|FG000|Overall Study|Adverse Event|24|||
125233920|NCT00853385|450485007|FG001|Overall Study|Adverse Event|24|||
125233921|NCT00853385|450485008|FG002|Overall Study|Adverse Event|2|||
125233922|NCT00853385|450485009|FG003|Overall Study|Adverse Event|5|||
125233923|NCT00853385|450485010|FG004|Overall Study|Adverse Event|22|||
125233924|NCT00853385|450485006|FG000|Overall Study|Lack of Efficacy|6|||
125233925|NCT00853385|450485007|FG001|Overall Study|Lack of Efficacy|7|||
125233926|NCT00853385|450485008|FG002|Overall Study|Lack of Efficacy|3|||
125233927|NCT00853385|450485009|FG003|Overall Study|Lack of Efficacy|3|||
125233928|NCT00853385|450485010|FG004|Overall Study|Lack of Efficacy|6|||
125233929|NCT00853385|450485006|FG000|Overall Study|Lost to Follow-up|2|||
125233930|NCT00853385|450485007|FG001|Overall Study|Lost to Follow-up|1|||
125233931|NCT00853385|450485008|FG002|Overall Study|Lost to Follow-up|0|||
125233932|NCT00853385|450485009|FG003|Overall Study|Lost to Follow-up|0|||
125233933|NCT00853385|450485010|FG004|Overall Study|Lost to Follow-up|0|||
125233934|NCT00853385|450485006|FG000|Overall Study|Withdrawal by Subject|4|||
125233935|NCT00853385|450485007|FG001|Overall Study|Withdrawal by Subject|2|||
125233936|NCT00853385|450485008|FG002|Overall Study|Withdrawal by Subject|0|||
125233937|NCT00853385|450485009|FG003|Overall Study|Withdrawal by Subject|1|||
125233938|NCT00853385|450485010|FG004|Overall Study|Withdrawal by Subject|1|||
125233939|NCT00853385|450485006|FG000|Overall Study|Other|18|||
125233940|NCT00853385|450485007|FG001|Overall Study|Other|9|||
125233941|NCT00853385|450485008|FG002|Overall Study|Other|4|||
125233942|NCT00853385|450485009|FG003|Overall Study|Other|4|||
125233943|NCT00853385|450485010|FG004|Overall Study|Other|12|||
125233944|NCT00915525|450485013|FG000|Overall Study|Protocol Violation|9|||
125233945|NCT00915525|450485014|FG001|Overall Study|Protocol Violation|4|||
125233946|NCT00915525|450485013|FG000|Overall Study|Withdrawal by Subject|59|||
125233947|NCT00915525|450485014|FG001|Overall Study|Withdrawal by Subject|21|||
125233948|NCT00915525|450485013|FG000|Overall Study|Lost to Follow-up|27|||
125233949|NCT00915525|450485014|FG001|Overall Study|Lost to Follow-up|16|||
125233950|NCT00915525|450485013|FG000|Overall Study|Pregnancy|2|||
125233951|NCT00915525|450485014|FG001|Overall Study|Pregnancy|0|||
125233952|NCT00915525|450485013|FG000|Overall Study|Lack of Efficacy|15|||
125233953|NCT00915525|450485014|FG001|Overall Study|Lack of Efficacy|32|||
125233954|NCT00915525|450485013|FG000|Overall Study|Adverse Event|29|||
125233955|NCT00915525|450485014|FG001|Overall Study|Adverse Event|13|||
125233956|NCT00915525|450485013|FG000|Overall Study|Missing|12|||
125233957|NCT00915525|450485014|FG001|Overall Study|Missing|1|||
125233958|NCT00915525|450485013|FG000|Overall Study|Other Reason|35|||
125233959|NCT00915525|450485014|FG001|Overall Study|Other Reason|12|||
125233960|NCT00915525|450485013|FG000|Overall Study|Site Closed|27|||
125233961|NCT00915525|450485014|FG001|Overall Study|Site Closed|9|||
125233962|NCT00915525|450485013|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
125233963|NCT00915525|450485014|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
125233964|NCT00915525|450485013|FG000|Overall Study|Study Burden|28|||
125233965|NCT00915525|450485014|FG001|Overall Study|Study Burden|12|||
125233966|NCT00915525|450485013|FG000|Overall Study|Non-Compliance|3|||
125233967|NCT00915525|450485014|FG001|Overall Study|Non-Compliance|1|||
125233968|NCT00915525|450485013|FG000|Overall Study|Patient Moved|15|||
125233969|NCT00915525|450485014|FG001|Overall Study|Patient Moved|9|||
125233970|NCT00941928|450485015|FG000|Overall Study|Withdrawal by Subject|1|||
125233971|NCT00941928|450485015|FG000|Overall Study|Disease Progression|1|||
125233972|NCT02765035|450485027|FG000|First Intervention (90 Days)|Adverse Event|1|||
125233973|NCT02765035|450485028|FG001|First Intervention (90 Days)|Adverse Event|1|||
125233974|NCT02765035|450485027|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
125233975|NCT02765035|450485028|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
125233976|NCT00984867|450485029|FG000|Overall Study|Adverse Event|3|||
125233977|NCT00984867|450485030|FG001|Overall Study|Adverse Event|7|||
125233978|NCT00984867|450485029|FG000|Overall Study|Death|1|||
125233979|NCT00984867|450485030|FG001|Overall Study|Death|0|||
125233980|NCT00984867|450485029|FG000|Overall Study|Withdrawal by Subject|13|||
125233981|NCT00984867|450485030|FG001|Overall Study|Withdrawal by Subject|4|||
125233982|NCT00984867|450485029|FG000|Overall Study|Lost to Follow-up|3|||
125233983|NCT00984867|450485030|FG001|Overall Study|Lost to Follow-up|4|||
125233984|NCT00984867|450485029|FG000|Overall Study|Poor/non-compliance|0|||
125233985|NCT00984867|450485030|FG001|Overall Study|Poor/non-compliance|1|||
125233986|NCT00984867|450485029|FG000|Overall Study|Subject no longer meets study criteria|1|||
125233987|NCT00984867|450485030|FG001|Overall Study|Subject no longer meets study criteria|1|||
125233988|NCT00984867|450485029|FG000|Overall Study|site closing|1|||
125233989|NCT00984867|450485030|FG001|Overall Study|site closing|0|||
125233990|NCT00984867|450485029|FG000|Overall Study|lack of efficacy and subject compliance|1|||
125233991|NCT00984867|450485030|FG001|Overall Study|lack of efficacy and subject compliance|0|||
125233992|NCT03482024|450485035|FG000|Overall Study|Physician Decision|1|||
125233993|NCT03482024|450485036|FG001|Overall Study|Physician Decision|0|||
125233994|NCT03482024|450485037|FG002|Overall Study|Physician Decision|0|||
125233995|NCT03482024|450485038|FG003|Overall Study|Physician Decision|0|||
125233996|NCT03482024|450485039|FG004|Overall Study|Physician Decision|0|||
125233997|NCT03937778|450485040|FG000|Overall Study|Withdrawal by Subject|1|||
125233998|NCT03937778|450485040|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
125233999|NCT00819039|450485041|FG000|Overall Study|Physician Decision|1|||
125234000|NCT00819039|450485042|FG001|Overall Study|Physician Decision|0|||
125234001|NCT00819039|450485043|FG002|Overall Study|Physician Decision|1|||
125234002|NCT00819039|450485041|FG000|Overall Study|Protocol Violation|1|||
125234003|NCT00819039|450485042|FG001|Overall Study|Protocol Violation|0|||
125234004|NCT00819039|450485043|FG002|Overall Study|Protocol Violation|0|||
125234005|NCT01240694|450485044|FG000|Overall Study|Adverse Event|9|||
125234006|NCT01240694|450485044|FG000|Overall Study|Lack of Efficacy|6|||
125234007|NCT01240694|450485044|FG000|Overall Study|Withdrawal by Subject|6|||
125234008|NCT01240694|450485044|FG000|Overall Study|Protocol Violation|2|||
125234009|NCT01240694|450485044|FG000|Overall Study|Lost to Follow-up|2|||
125234010|NCT01240694|450485044|FG000|Overall Study|Other than specified|3|||
125234011|NCT01240694|450485044|FG000|Overall Study|Withdrawn due to early study termination|107|||
125234012|NCT01881425|450485045|FG000|Overall Study|Death|5|||
125234013|NCT01881425|450485046|FG001|Overall Study|Death|1|||
125234014|NCT01881425|450485045|FG000|Overall Study|Withdrawal by Subject|8|||
125234015|NCT01881425|450485046|FG001|Overall Study|Withdrawal by Subject|3|||
125234016|NCT01881425|450485045|FG000|Overall Study|Physician Decision|2|||
125234017|NCT01881425|450485046|FG001|Overall Study|Physician Decision|1|||
125234018|NCT01881425|450485045|FG000|Overall Study|Adverse Event|3|||
125234019|NCT01881425|450485046|FG001|Overall Study|Adverse Event|0|||
125234020|NCT01881425|450485045|FG000|Overall Study|General Anesthesia panic attack|0|||
125234021|NCT01881425|450485046|FG001|Overall Study|General Anesthesia panic attack|1|||
125234022|NCT01881425|450485045|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
125234023|NCT01881425|450485046|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
125234024|NCT01881425|450485045|FG000|Overall Study|Lost to Follow-up|7|||
125234025|NCT01881425|450485046|FG001|Overall Study|Lost to Follow-up|2|||
125234026|NCT01200355|450485051|FG000|Overall Study|Death|7|||
125234027|NCT01200355|450485052|FG001|Overall Study|Death|2|||
125234028|NCT03185208|450485053|FG000|Overall Study|Did not start study medication|0|||
125234029|NCT03185208|450485054|FG001|Overall Study|Did not start study medication|3|||
125234030|NCT03834350|450485055|FG000|Overall Study|Withdrawal by Subject|1|||
125234031|NCT02410629|450485056|FG000|Overall Study|Family cannot commit to the study|2|||
125234032|NCT02410629|450485057|FG001|Overall Study|Family cannot commit to the study|1|||
125234033|NCT02410629|450485056|FG000|Overall Study|Subject returned to work|1|||
125234034|NCT02410629|450485057|FG001|Overall Study|Subject returned to work|0|||
125234035|NCT02410629|450485056|FG000|Overall Study|Subject moved back to home country|0|||
125234036|NCT02410629|450485057|FG001|Overall Study|Subject moved back to home country|1|||
125234037|NCT02410629|450485056|FG000|Overall Study|Subject underwent heart surgery|0|||
125234038|NCT02410629|450485057|FG001|Overall Study|Subject underwent heart surgery|1|||
125234039|NCT02765165|450485058|FG000|Treatment Period|Progressive disease|3|||
125234040|NCT02765165|450485059|FG001|Treatment Period|Progressive disease|2|||
125234041|NCT02765165|450485060|FG002|Treatment Period|Progressive disease|3|||
125234042|NCT02765165|450485061|FG003|Treatment Period|Progressive disease|3|||
125234043|NCT02765165|450485062|FG004|Treatment Period|Progressive disease|4|||
125234044|NCT02765165|450485063|FG005|Treatment Period|Progressive disease|2|||
125234045|NCT02765165|450485064|FG006|Treatment Period|Progressive disease|2|||
125234046|NCT02765165|450485058|FG000|Treatment Period|Physician Decision|0|||
125234047|NCT02765165|450485059|FG001|Treatment Period|Physician Decision|1|||
125234048|NCT02765165|450485060|FG002|Treatment Period|Physician Decision|0|||
125234049|NCT02765165|450485061|FG003|Treatment Period|Physician Decision|0|||
125234050|NCT02765165|450485062|FG004|Treatment Period|Physician Decision|0|||
125234051|NCT02765165|450485063|FG005|Treatment Period|Physician Decision|0|||
125234052|NCT02765165|450485064|FG006|Treatment Period|Physician Decision|0|||
125234053|NCT02765165|450485058|FG000|Treatment Period|Adverse Event|0|||
125234054|NCT02765165|450485059|FG001|Treatment Period|Adverse Event|1|||
125234055|NCT02765165|450485060|FG002|Treatment Period|Adverse Event|0|||
125234056|NCT02765165|450485061|FG003|Treatment Period|Adverse Event|0|||
125234057|NCT02765165|450485062|FG004|Treatment Period|Adverse Event|0|||
125234058|NCT02765165|450485063|FG005|Treatment Period|Adverse Event|0|||
125234059|NCT02765165|450485064|FG006|Treatment Period|Adverse Event|0|||
125234060|NCT02765165|450485058|FG000|Treatment Period|Withdrawal by Subject|0|||
125234061|NCT02765165|450485059|FG001|Treatment Period|Withdrawal by Subject|0|||
125234062|NCT02765165|450485060|FG002|Treatment Period|Withdrawal by Subject|0|||
125234063|NCT02765165|450485061|FG003|Treatment Period|Withdrawal by Subject|0|||
125234064|NCT02765165|450485062|FG004|Treatment Period|Withdrawal by Subject|2|||
125234065|NCT02765165|450485063|FG005|Treatment Period|Withdrawal by Subject|0|||
125234066|NCT02765165|450485064|FG006|Treatment Period|Withdrawal by Subject|0|||
125234067|NCT02765165|450485058|FG000|Treatment Period|Study terminated|0|||
125234068|NCT02765165|450485059|FG001|Treatment Period|Study terminated|0|||
125234069|NCT02765165|450485060|FG002|Treatment Period|Study terminated|0|||
125234070|NCT02765165|450485061|FG003|Treatment Period|Study terminated|0|||
125234071|NCT02765165|450485062|FG004|Treatment Period|Study terminated|0|||
125234072|NCT02765165|450485063|FG005|Treatment Period|Study terminated|1|||
125234073|NCT02765165|450485064|FG006|Treatment Period|Study terminated|2|||
125234074|NCT02765165|450485058|FG000|Post-treatment Follow-up|Death|1|||
125234075|NCT02765165|450485059|FG001|Post-treatment Follow-up|Death|2|||
125234076|NCT02765165|450485060|FG002|Post-treatment Follow-up|Death|1|||
125234077|NCT02765165|450485061|FG003|Post-treatment Follow-up|Death|1|||
125234078|NCT02765165|450485062|FG004|Post-treatment Follow-up|Death|1|||
125234079|NCT02765165|450485063|FG005|Post-treatment Follow-up|Death|1|||
125234080|NCT02765165|450485064|FG006|Post-treatment Follow-up|Death|0|||
125234081|NCT02765165|450485058|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
125234082|NCT02765165|450485059|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
125234083|NCT02765165|450485060|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
125234084|NCT02765165|450485061|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
125234085|NCT02765165|450485062|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
125234086|NCT02765165|450485063|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
125234087|NCT02765165|450485064|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
125234088|NCT02765165|450485058|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
125234089|NCT02765165|450485059|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
125234090|NCT02765165|450485060|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
125234091|NCT02765165|450485061|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
125234092|NCT02765165|450485062|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
125178405|NCT03142191|450272769|FG002|Active Treatment Extension Period|Progressive Disease|4|||
125178406|NCT03142191|450272770|FG003|Active Treatment Extension Period|Progressive Disease|1|||
125178407|NCT03142191|450272771|FG004|Active Treatment Extension Period|Progressive Disease|2|||
125178408|NCT03142191|450272767|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
125178409|NCT03142191|450272768|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
125178410|NCT03142191|450272769|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
125178411|NCT03142191|450272770|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
125178412|NCT03142191|450272771|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
125178413|NCT03142191|450272767|FG000|Active Treatment Extension Period|Physician Decision|2|||
125178414|NCT03142191|450272768|FG001|Active Treatment Extension Period|Physician Decision|0|||
125178415|NCT03142191|450272769|FG002|Active Treatment Extension Period|Physician Decision|0|||
125178416|NCT03142191|450272770|FG003|Active Treatment Extension Period|Physician Decision|0|||
125178417|NCT03142191|450272771|FG004|Active Treatment Extension Period|Physician Decision|0|||
125178418|NCT03142191|450272767|FG000|Active Treatment Extension Period|Other Reasons|3|||
125234093|NCT02765165|450485063|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
125234094|NCT02765165|450485064|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
125234095|NCT02765165|450485058|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
125234096|NCT02765165|450485059|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
125234097|NCT02765165|450485060|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
125234098|NCT02765165|450485061|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
125234099|NCT02765165|450485062|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
125178419|NCT03142191|450272768|FG001|Active Treatment Extension Period|Other Reasons|3|||
125178420|NCT03142191|450272769|FG002|Active Treatment Extension Period|Other Reasons|3|||
125178421|NCT03142191|450272770|FG003|Active Treatment Extension Period|Other Reasons|8|||
125178422|NCT03142191|450272771|FG004|Active Treatment Extension Period|Other Reasons|3|||
125178423|NCT03142191|450272767|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
125178424|NCT03142191|450272768|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
125178425|NCT03142191|450272769|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
125178426|NCT03142191|450272770|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
125178427|NCT03142191|450272771|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
125178428|NCT01277211|450272774|FG000|Overall Study|Adverse Event|60|||
125178429|NCT01277211|450272775|FG001|Overall Study|Adverse Event|22|||
125178430|NCT01277211|450272774|FG000|Overall Study|Pregnancy|9|||
125178431|NCT01277211|450272775|FG001|Overall Study|Pregnancy|4|||
125234100|NCT02765165|450485063|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
125234101|NCT02765165|450485064|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
125234102|NCT02765165|450485058|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
125234103|NCT02765165|450485059|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
125234104|NCT02765165|450485060|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
125234105|NCT02765165|450485061|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
125234106|NCT02765165|450485062|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
125234107|NCT02765165|450485063|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
125234108|NCT02765165|450485064|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
125234109|NCT02765165|450485058|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
125234110|NCT02765165|450485059|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
125234111|NCT02765165|450485060|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
125234112|NCT02765165|450485061|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
125234113|NCT02765165|450485062|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
125234114|NCT02765165|450485063|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
125234115|NCT02765165|450485064|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
125234116|NCT01206764|450485065|FG000|Overall Study|Adverse Event|20|||
125234117|NCT01206764|450485065|FG000|Overall Study|Abnormal laboratory value|2|||
125234118|NCT01206764|450485065|FG000|Overall Study|Abnormal test procedure result|1|||
125234119|NCT01206764|450485065|FG000|Overall Study|Patient withdrew consent|5|||
125234120|NCT01206764|450485065|FG000|Overall Study|Lost to Follow-up|6|||
125234121|NCT01206764|450485065|FG000|Overall Study|Death|11|||
125234122|NCT01206764|450485065|FG000|Overall Study|New cancer therapy|2|||
125234123|NCT01206764|450485065|FG000|Overall Study|Disease progression|88|||
125234124|NCT01206764|450485065|FG000|Overall Study|Protocol deviation|3|||
125234125|NCT01186770|450485066|FG000|Overall Study|Ineligibility|0|||
125234126|NCT01186770|450485067|FG001|Overall Study|Ineligibility|0|||
125234127|NCT01186770|450485068|FG002|Overall Study|Ineligibility|2|||
125234128|NCT01186770|450485069|FG003|Overall Study|Ineligibility|0|||
125234129|NCT01186770|450485066|FG000|Overall Study|Protocol Violation|7|||
125234130|NCT01186770|450485067|FG001|Overall Study|Protocol Violation|9|||
125234131|NCT01186770|450485068|FG002|Overall Study|Protocol Violation|12|||
125234132|NCT01186770|450485069|FG003|Overall Study|Protocol Violation|14|||
125234133|NCT01186770|450485066|FG000|Overall Study|Adverse Event|2|||
125234134|NCT01186770|450485067|FG001|Overall Study|Adverse Event|9|||
125234135|NCT01186770|450485068|FG002|Overall Study|Adverse Event|7|||
125234136|NCT01186770|450485069|FG003|Overall Study|Adverse Event|9|||
125234137|NCT01186770|450485066|FG000|Overall Study|Withdrawal by Subject|15|||
125234138|NCT01186770|450485067|FG001|Overall Study|Withdrawal by Subject|13|||
125234139|NCT01186770|450485068|FG002|Overall Study|Withdrawal by Subject|11|||
125234140|NCT01186770|450485069|FG003|Overall Study|Withdrawal by Subject|17|||
125234141|NCT01186770|450485066|FG000|Overall Study|Lost to Follow-up|10|||
125234142|NCT01186770|450485067|FG001|Overall Study|Lost to Follow-up|6|||
125234143|NCT01186770|450485068|FG002|Overall Study|Lost to Follow-up|14|||
125234144|NCT01186770|450485069|FG003|Overall Study|Lost to Follow-up|9|||
125234145|NCT01186770|450485066|FG000|Overall Study|Insufficient response to treatment|7|||
125234146|NCT01186770|450485067|FG001|Overall Study|Insufficient response to treatment|8|||
125234147|NCT01186770|450485068|FG002|Overall Study|Insufficient response to treatment|5|||
125234148|NCT01186770|450485069|FG003|Overall Study|Insufficient response to treatment|7|||
125234149|NCT01186770|450485066|FG000|Overall Study|Other than specified|0|||
125234150|NCT01186770|450485067|FG001|Overall Study|Other than specified|1|||
125178432|NCT01277211|450272774|FG000|Overall Study|Lost to Follow-up|14|||
125178433|NCT01277211|450272775|FG001|Overall Study|Lost to Follow-up|9|||
125178434|NCT01277211|450272774|FG000|Overall Study|Did not wish to continue|17|||
125178435|NCT01277211|450272775|FG001|Overall Study|Did not wish to continue|0|||
125178436|NCT01277211|450272774|FG000|Overall Study|Withdrew Consent|9|||
125234151|NCT01186770|450485068|FG002|Overall Study|Other than specified|1|||
125234152|NCT01186770|450485069|FG003|Overall Study|Other than specified|2|||
125234153|NCT02567188|450485070|FG000|Overall Study|Death|10|||
125234154|NCT02567188|450485070|FG000|Overall Study|Terminated Mircera Treatment|9|||
125234155|NCT02567188|450485070|FG000|Overall Study|Lost to Follow-up|5|||
125178437|NCT01277211|450272775|FG001|Overall Study|Withdrew Consent|9|||
125234156|NCT02567188|450485070|FG000|Overall Study|Adverse Event|1|||
125234157|NCT02567188|450485070|FG000|Overall Study|Withdrawal by Subject|1|||
125234158|NCT02567188|450485070|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
125234159|NCT02567188|450485070|FG000|Overall Study|Moved and Changed Clinic|1|||
125234160|NCT02567188|450485070|FG000|Overall Study|Started Hemodialysis|2|||
125234161|NCT02567188|450485070|FG000|Overall Study|Protocol Violation|5|||
125234162|NCT01033136|450485071|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
125234163|NCT01033136|450485072|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
125234164|NCT00321763|450485074|FG000|Overall Study|Adverse Event|1|||
125234165|NCT00321763|450485075|FG001|Overall Study|Adverse Event|1|||
125234166|NCT00321763|450485076|FG002|Overall Study|Adverse Event|0|||
125234167|NCT00321763|450485077|FG003|Overall Study|Adverse Event|1|||
125234168|NCT00321763|450485074|FG000|Overall Study|Withdrawal by Subject|2|||
125234169|NCT00321763|450485075|FG001|Overall Study|Withdrawal by Subject|0|||
125234170|NCT00321763|450485076|FG002|Overall Study|Withdrawal by Subject|1|||
125234171|NCT00321763|450485077|FG003|Overall Study|Withdrawal by Subject|0|||
125234172|NCT00321763|450485074|FG000|Overall Study|Lost to Follow-up|3|||
125234173|NCT00321763|450485075|FG001|Overall Study|Lost to Follow-up|1|||
125234174|NCT00321763|450485076|FG002|Overall Study|Lost to Follow-up|5|||
125234175|NCT00321763|450485077|FG003|Overall Study|Lost to Follow-up|4|||
125234176|NCT00410163|450485078|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
125234177|NCT00410163|450485079|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
125234178|NCT00410163|450485078|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
125234179|NCT00410163|450485079|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
125234180|NCT00410163|450485078|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
125234181|NCT00410163|450485079|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
125234182|NCT00410163|450485078|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
125234183|NCT00410163|450485079|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
125234184|NCT00410163|450485078|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
125234185|NCT00410163|450485079|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
125234186|NCT00410163|450485078|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
125234187|NCT00410163|450485079|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
125234188|NCT00410163|450485078|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
125234189|NCT00410163|450485079|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
125234190|NCT00410163|450485078|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
125234191|NCT00410163|450485079|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
125234192|NCT00410163|450485078|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
125234193|NCT00410163|450485079|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
125234194|NCT00410163|450485078|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
125234195|NCT00410163|450485079|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
125234196|NCT00410163|450485078|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
125234197|NCT00410163|450485079|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
125234198|NCT00410163|450485078|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
125234199|NCT00410163|450485079|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
125234200|NCT00410163|450485078|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
125234201|NCT00410163|450485079|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
125234202|NCT00410163|450485078|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
125234203|NCT00410163|450485079|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
125234204|NCT00797563|450485081|FG000|Overall Study|Adverse Event|1|||
125234205|NCT00688597|450485082|FG000|Overall Study|Adverse Event|2|||
125234206|NCT00688597|450485083|FG001|Overall Study|Adverse Event|0|||
125234207|NCT00688597|450485084|FG002|Overall Study|Adverse Event|0|||
125234208|NCT00688597|450485082|FG000|Overall Study|Physician Decision|1|||
125234209|NCT00688597|450485083|FG001|Overall Study|Physician Decision|0|||
125234210|NCT00688597|450485084|FG002|Overall Study|Physician Decision|0|||
125234211|NCT05853120|450485085|FG000|Overall Study|Lost to Follow-up|4|||
125234212|NCT05853120|450485086|FG001|Overall Study|Lost to Follow-up|4|||
125234213|NCT05853120|450485085|FG000|Overall Study|Physician Decision|3|||
125234214|NCT05853120|450485086|FG001|Overall Study|Physician Decision|0|||
125234215|NCT05853120|450485085|FG000|Overall Study|Withdrawal by Subject|5|||
125234216|NCT05853120|450485086|FG001|Overall Study|Withdrawal by Subject|2|||
125234217|NCT02763566|450485091|FG000|Overall Study|Lost to Follow-up|1|||
125234218|NCT02763566|450485092|FG001|Overall Study|Lost to Follow-up|4|||
125234219|NCT02763566|450485093|FG002|Overall Study|Lost to Follow-up|0|||
125234220|NCT02763566|450485094|FG003|Overall Study|Lost to Follow-up|1|||
125234221|NCT02763566|450485091|FG000|Overall Study|On study treatment at study conclusion|114|||
125234222|NCT02763566|450485092|FG001|Overall Study|On study treatment at study conclusion|34|||
125234223|NCT02763566|450485093|FG002|Overall Study|On study treatment at study conclusion|54|||
125234224|NCT02763566|450485094|FG003|Overall Study|On study treatment at study conclusion|13|||
125234225|NCT02763566|450485091|FG000|Overall Study|Withdrawal by Subject|3|||
125234226|NCT02763566|450485092|FG001|Overall Study|Withdrawal by Subject|1|||
125234227|NCT02763566|450485093|FG002|Overall Study|Withdrawal by Subject|0|||
125234228|NCT02763566|450485094|FG003|Overall Study|Withdrawal by Subject|0|||
125234229|NCT02855268|450485095|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
125234230|NCT02855268|450485096|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
125234231|NCT02855268|450485095|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
125234232|NCT02855268|450485096|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
125234233|NCT02855268|450485095|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
125234234|NCT02855268|450485096|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
125234235|NCT02855268|450485095|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
125234236|NCT02855268|450485096|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
125178438|NCT01277211|450272774|FG000|Overall Study|Non-compliance with protocol|13|||
125178439|NCT01277211|450272775|FG001|Overall Study|Non-compliance with protocol|4|||
125178440|NCT01277211|450272774|FG000|Overall Study|Did not meet protocol eligibility|1|||
125178441|NCT01277211|450272775|FG001|Overall Study|Did not meet protocol eligibility|0|||
125178442|NCT01277211|450272774|FG000|Overall Study|Administrative|3|||
125178443|NCT01277211|450272775|FG001|Overall Study|Administrative|0|||
125178444|NCT01277211|450272774|FG000|Overall Study|Pregnancy wish|0|||
125178445|NCT01277211|450272775|FG001|Overall Study|Pregnancy wish|2|||
125178446|NCT01277211|450272774|FG000|Overall Study|Discontinued prior to treatment|24|||
125178447|NCT01277211|450272775|FG001|Overall Study|Discontinued prior to treatment|13|||
125178448|NCT00770328|450272776|FG000|Overall Study|Adverse Event|11|||
125178449|NCT00770328|450272777|FG001|Overall Study|Adverse Event|2|||
125178450|NCT00770328|450272776|FG000|Overall Study|Lost to Follow-up|2|||
125178451|NCT00770328|450272777|FG001|Overall Study|Lost to Follow-up|2|||
125178452|NCT01130493|450272778|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
125178453|NCT01130493|450272779|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
125178454|NCT01130493|450272780|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
125178455|NCT01130493|450272778|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
125178456|NCT01130493|450272779|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
125178457|NCT01130493|450272780|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
125178458|NCT01130493|450272778|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
125178459|NCT01130493|450272779|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
125178460|NCT01130493|450272780|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
125178461|NCT01130493|450272778|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
125178462|NCT01130493|450272779|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
125178463|NCT01130493|450272780|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
125178464|NCT01130493|450272778|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
125178465|NCT01130493|450272779|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
125178466|NCT01130493|450272780|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
125178467|NCT01130493|450272778|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
125178468|NCT01130493|450272779|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
125178469|NCT01130493|450272780|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
125178470|NCT01130493|450272778|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
125178471|NCT01130493|450272779|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
125178472|NCT01130493|450272780|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
125178473|NCT01130493|450272778|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
125178474|NCT01130493|450272779|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
125178475|NCT01130493|450272780|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
125178476|NCT01130493|450272778|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
125178477|NCT01130493|450272779|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
125178478|NCT01130493|450272780|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
125178479|NCT01130493|450272778|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
125178480|NCT01130493|450272779|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
125178481|NCT01130493|450272780|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
125178482|NCT01130493|450272778|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
125178483|NCT01130493|450272779|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
125178484|NCT01130493|450272780|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
125178485|NCT01130493|450272778|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
125178486|NCT01130493|450272779|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
125178487|NCT01130493|450272780|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
125178488|NCT01130493|450272778|FG000|Part 2: OLE|Adverse Event|0|||
125234237|NCT02855268|450485095|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
125178489|NCT01130493|450272779|FG001|Part 2: OLE|Adverse Event|2|||
125178490|NCT01130493|450272780|FG002|Part 2: OLE|Adverse Event|1|||
125178491|NCT01130493|450272778|FG000|Part 2: OLE|Withdrawal by Subject|0|||
125178492|NCT01130493|450272779|FG001|Part 2: OLE|Withdrawal by Subject|1|||
125234238|NCT02855268|450485096|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
125234239|NCT02855268|450485095|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
125234240|NCT02855268|450485096|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
125234241|NCT00639509|450485099|FG000|Overall Study|Death|1|||
125234242|NCT04513366|450485108|FG000|Treatment Phase|Withdrawal by Subject|6|||
125234243|NCT04513366|450485109|FG001|Treatment Phase|Withdrawal by Subject|8|||
125234244|NCT04513366|450485110|FG002|Treatment Phase|Withdrawal by Subject|3|||
125234245|NCT04513366|450485108|FG000|Treatment Phase|Lost to Follow-up|1|||
125234246|NCT04513366|450485109|FG001|Treatment Phase|Lost to Follow-up|2|||
125234247|NCT04513366|450485110|FG002|Treatment Phase|Lost to Follow-up|5|||
125234248|NCT04513366|450485108|FG000|Treatment Phase|Other than Specified|1|||
125234249|NCT04513366|450485109|FG001|Treatment Phase|Other than Specified|0|||
125234250|NCT04513366|450485110|FG002|Treatment Phase|Other than Specified|2|||
125234251|NCT04513366|450485108|FG000|Treatment Phase|Physician Decision|2|||
125234252|NCT04513366|450485109|FG001|Treatment Phase|Physician Decision|0|||
125234253|NCT04513366|450485110|FG002|Treatment Phase|Physician Decision|0|||
125234254|NCT04513366|450485108|FG000|Treatment Phase|Adverse Event|0|||
125234255|NCT04513366|450485109|FG001|Treatment Phase|Adverse Event|1|||
125234256|NCT04513366|450485110|FG002|Treatment Phase|Adverse Event|1|||
125234257|NCT04513366|450485108|FG000|Extension Phase|Withdrawal by Subject|3|||
125234258|NCT04513366|450485109|FG001|Extension Phase|Withdrawal by Subject|1|||
125234259|NCT04513366|450485110|FG002|Extension Phase|Withdrawal by Subject|1|||
125234260|NCT04513366|450485108|FG000|Extension Phase|Other than Specified|4|||
125234261|NCT04513366|450485109|FG001|Extension Phase|Other than Specified|0|||
125234262|NCT04513366|450485110|FG002|Extension Phase|Other than Specified|1|||
125234263|NCT04513366|450485108|FG000|Extension Phase|Lost to Follow-up|1|||
125234264|NCT04513366|450485109|FG001|Extension Phase|Lost to Follow-up|1|||
125234265|NCT04513366|450485110|FG002|Extension Phase|Lost to Follow-up|1|||
125234266|NCT04513366|450485108|FG000|Extension Phase|Sponsor Decision|0|||
125234267|NCT04513366|450485109|FG001|Extension Phase|Sponsor Decision|1|||
125234268|NCT04513366|450485110|FG002|Extension Phase|Sponsor Decision|0|||
125234269|NCT04513366|450485108|FG000|Extension Phase|Death|0|||
125234270|NCT04513366|450485109|FG001|Extension Phase|Death|1|||
125234271|NCT04513366|450485110|FG002|Extension Phase|Death|0|||
125234272|NCT04513366|450485108|FG000|Extension Phase|Adverse Event|0|||
125234273|NCT04513366|450485109|FG001|Extension Phase|Adverse Event|0|||
125234274|NCT04513366|450485110|FG002|Extension Phase|Adverse Event|1|||
125234275|NCT02657551|450485113|FG000|Overall Study|Adverse Event|2|||
125234276|NCT02657551|450485113|FG000|Overall Study|Withdrawal by Subject|1|||
125234277|NCT02657551|450485113|FG000|Overall Study|Non-Compliance|1|||
125234278|NCT02657551|450485113|FG000|Overall Study|Progression / Relapse|4|||
125234279|NCT04478266|450485115|FG000|Overall Study|Adverse Event|20|||
125234280|NCT04478266|450485116|FG001|Overall Study|Adverse Event|21|||
125234281|NCT04478266|450485115|FG000|Overall Study|Progressive disease|146|||
125234282|NCT04478266|450485116|FG001|Overall Study|Progressive disease|168|||
125234283|NCT04478266|450485115|FG000|Overall Study|Poor compliance to protocol|1|||
125234284|NCT04478266|450485116|FG001|Overall Study|Poor compliance to protocol|0|||
125234285|NCT04478266|450485115|FG000|Overall Study|Withdrawal by Subject|19|||
125234286|NCT04478266|450485116|FG001|Overall Study|Withdrawal by Subject|16|||
125234287|NCT04478266|450485115|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
125234288|NCT04478266|450485116|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
125234289|NCT04478266|450485115|FG000|Overall Study|Study terminated by sponsor|33|||
125234290|NCT04478266|450485116|FG001|Overall Study|Study terminated by sponsor|35|||
125234291|NCT04478266|450485115|FG000|Overall Study|Other: unspecified|5|||
125234292|NCT04478266|450485116|FG001|Overall Study|Other: unspecified|7|||
125234293|NCT04478266|450485115|FG000|Overall Study|Randomized but not treated|1|||
125234294|NCT04478266|450485116|FG001|Overall Study|Randomized but not treated|1|||
125234295|NCT04798027|450485119|FG000|Overall Study|Protocol Violation|0|||
125234296|NCT04798027|450485120|FG001|Overall Study|Protocol Violation|0|||
125234297|NCT04798027|450485121|FG002|Overall Study|Protocol Violation|0|||
125234298|NCT04798027|450485122|FG003|Overall Study|Protocol Violation|0|||
125234299|NCT04798027|450485123|FG004|Overall Study|Protocol Violation|1|||
125234300|NCT04798027|450485124|FG005|Overall Study|Protocol Violation|0|||
125234301|NCT04798027|450485125|FG006|Overall Study|Protocol Violation|0|||
125234302|NCT04798027|450485126|FG007|Overall Study|Protocol Violation|1|||
125234303|NCT04798027|450485127|FG008|Overall Study|Protocol Violation|0|||
125234304|NCT04798027|450485119|FG000|Overall Study|Withdrawal by Subject|1|||
125234305|NCT04798027|450485120|FG001|Overall Study|Withdrawal by Subject|0|||
125234306|NCT04798027|450485121|FG002|Overall Study|Withdrawal by Subject|1|||
125234307|NCT04798027|450485122|FG003|Overall Study|Withdrawal by Subject|1|||
125234308|NCT04798027|450485123|FG004|Overall Study|Withdrawal by Subject|1|||
125234309|NCT04798027|450485124|FG005|Overall Study|Withdrawal by Subject|1|||
125234310|NCT04798027|450485125|FG006|Overall Study|Withdrawal by Subject|3|||
125234311|NCT04798027|450485126|FG007|Overall Study|Withdrawal by Subject|2|||
125234312|NCT04798027|450485127|FG008|Overall Study|Withdrawal by Subject|2|||
125234313|NCT04798027|450485119|FG000|Overall Study|Lost to Follow-up|1|||
125234314|NCT04798027|450485120|FG001|Overall Study|Lost to Follow-up|3|||
125234315|NCT04798027|450485121|FG002|Overall Study|Lost to Follow-up|0|||
125234316|NCT04798027|450485122|FG003|Overall Study|Lost to Follow-up|0|||
125234317|NCT04798027|450485123|FG004|Overall Study|Lost to Follow-up|0|||
125234318|NCT04798027|450485124|FG005|Overall Study|Lost to Follow-up|1|||
125234319|NCT04798027|450485125|FG006|Overall Study|Lost to Follow-up|0|||
125234320|NCT04798027|450485126|FG007|Overall Study|Lost to Follow-up|0|||
125234321|NCT04798027|450485127|FG008|Overall Study|Lost to Follow-up|1|||
125234322|NCT04798027|450485119|FG000|Overall Study|Withdrawal by Sponsor|8|||
125234323|NCT04798027|450485120|FG001|Overall Study|Withdrawal by Sponsor|22|||
125234324|NCT04798027|450485121|FG002|Overall Study|Withdrawal by Sponsor|9|||
125234325|NCT04798027|450485122|FG003|Overall Study|Withdrawal by Sponsor|26|||
125234326|NCT04798027|450485123|FG004|Overall Study|Withdrawal by Sponsor|24|||
125234327|NCT04798027|450485124|FG005|Overall Study|Withdrawal by Sponsor|11|||
125234328|NCT04798027|450485125|FG006|Overall Study|Withdrawal by Sponsor|25|||
125234329|NCT04798027|450485126|FG007|Overall Study|Withdrawal by Sponsor|26|||
125234330|NCT04798027|450485127|FG008|Overall Study|Withdrawal by Sponsor|11|||
125234331|NCT02659865|450486306|FG000|Period 1|Withdrawal by Subject|1|||
125234332|NCT02659865|450486307|FG001|Period 1|Withdrawal by Subject|0|||
125234333|NCT02659865|450486308|FG002|Period 1|Withdrawal by Subject|0|||
125234334|NCT02659865|450486309|FG003|Period 1|Withdrawal by Subject|0|||
125234335|NCT02659865|450486310|FG004|Period 1|Withdrawal by Subject|0|||
125234336|NCT02659865|450486306|FG000|Period 1|Adverse Event|0|||
125234337|NCT02659865|450486307|FG001|Period 1|Adverse Event|0|||
125234338|NCT02659865|450486308|FG002|Period 1|Adverse Event|0|||
125234339|NCT02659865|450486309|FG003|Period 1|Adverse Event|0|||
125234340|NCT02659865|450486310|FG004|Period 1|Adverse Event|1|||
125234341|NCT02100631|450486311|FG000|Overall Study|Withdrawal by Subject|1|||
125234342|NCT02100631|450486312|FG001|Overall Study|Withdrawal by Subject|0|||
125234343|NCT02100631|450486313|FG002|Overall Study|Withdrawal by Subject|0|||
125234344|NCT02100631|450486311|FG000|Overall Study|Lost to Follow-up|3|||
125234345|NCT02100631|450486312|FG001|Overall Study|Lost to Follow-up|4|||
125234346|NCT02100631|450486313|FG002|Overall Study|Lost to Follow-up|0|||
125234347|NCT02100631|450486311|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
125234348|NCT02100631|450486312|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
125234349|NCT02100631|450486313|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
125234350|NCT00300053|450486314|FG000|Overall Study|Patient/Caregiver Preference|2|||
125234351|NCT00300053|450486315|FG001|Overall Study|Patient/Caregiver Preference|2|||
125234352|NCT00300053|450486316|FG002|Overall Study|Patient/Caregiver Preference|3|||
125234353|NCT00300053|450486314|FG000|Overall Study|Death|0|||
125234354|NCT00300053|450486315|FG001|Overall Study|Death|0|||
125234355|NCT00300053|450486316|FG002|Overall Study|Death|3|||
125234356|NCT00300053|450486314|FG000|Overall Study|Lost to Follow-up|0|||
125234357|NCT00300053|450486315|FG001|Overall Study|Lost to Follow-up|1|||
125234358|NCT00300053|450486316|FG002|Overall Study|Lost to Follow-up|0|||
125234359|NCT03261401|450486319|FG000|Overall Study|Withdrawal by Subject|0|||
125234360|NCT03261401|450486320|FG001|Overall Study|Withdrawal by Subject|0|||
125234361|NCT03261401|450486321|FG002|Overall Study|Withdrawal by Subject|0|||
125234362|NCT03261401|450486322|FG003|Overall Study|Withdrawal by Subject|0|||
125234363|NCT03261401|450486323|FG004|Overall Study|Withdrawal by Subject|0|||
125234364|NCT03261401|450486324|FG005|Overall Study|Withdrawal by Subject|1|||
125234365|NCT03261401|450486325|FG006|Overall Study|Withdrawal by Subject|0|||
125234366|NCT03261401|450486326|FG007|Overall Study|Withdrawal by Subject|0|||
125234367|NCT03261401|450486327|FG008|Overall Study|Withdrawal by Subject|0|||
125234368|NCT03261401|450486328|FG009|Overall Study|Withdrawal by Subject|0|||
125234369|NCT03261401|450486329|FG010|Overall Study|Withdrawal by Subject|0|||
125234370|NCT03261401|450486330|FG011|Overall Study|Withdrawal by Subject|0|||
125234371|NCT03261401|450486331|FG012|Overall Study|Withdrawal by Subject|0|||
125234372|NCT03261401|450486319|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
125234373|NCT03261401|450486320|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
125234374|NCT03261401|450486321|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
125234375|NCT03261401|450486322|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
125234376|NCT03261401|450486323|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
125234377|NCT03261401|450486324|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
125234378|NCT03261401|450486325|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
125234379|NCT03261401|450486326|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
125234380|NCT03261401|450486327|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
125234381|NCT03261401|450486328|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
125234382|NCT03261401|450486329|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
125234383|NCT03261401|450486330|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
125234384|NCT03261401|450486331|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
125234385|NCT01983930|450486337|FG000|Overall Study|Withdrawal by Subject|9|||
125234386|NCT01983930|450486338|FG001|Overall Study|Withdrawal by Subject|8|||
125234387|NCT01983930|450486337|FG000|Overall Study|Adverse Event|0|||
125234388|NCT01983930|450486338|FG001|Overall Study|Adverse Event|1|||
125234389|NCT00634504|450486341|FG000|Overall Study|Protocol Violation|1|||
125234390|NCT00634504|450486342|FG001|Overall Study|Protocol Violation|0|||
125234391|NCT05001620|450486345|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
125234392|NCT05001620|450486346|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
125234393|NCT00481676|450486349|FG000|Overall Study|Adverse Event|0|||
125234394|NCT00481676|450486350|FG001|Overall Study|Adverse Event|1|||
125234395|NCT00481676|450486349|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125234396|NCT00481676|450486350|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
125234397|NCT00481676|450486349|FG000|Overall Study|Administrative problem|1|||
125234398|NCT00481676|450486350|FG001|Overall Study|Administrative problem|0|||
125234399|NCT01513590|450486351|FG000|Overall Study|Adverse Event|2|||
125234400|NCT01513590|450486352|FG001|Overall Study|Adverse Event|3|||
125234401|NCT01513590|450486351|FG000|Overall Study|Withdrawal Criteria|3|||
125234402|NCT01513590|450486352|FG001|Overall Study|Withdrawal Criteria|0|||
125234403|NCT01513590|450486351|FG000|Overall Study|Unclassified|5|||
125234404|NCT01513590|450486352|FG001|Overall Study|Unclassified|10|||
125234405|NCT01056276|450486353|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
125234406|NCT01056276|450486354|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
125234407|NCT01056276|450486353|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
125234408|NCT01056276|450486354|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
125234409|NCT01056276|450486353|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
125234410|NCT01056276|450486354|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
125234411|NCT01056276|450486353|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
125234412|NCT01056276|450486354|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
125234413|NCT01056276|450486353|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
125234414|NCT01056276|450486354|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
125234415|NCT01056276|450486353|FG000|Treatment Period-Cycles 1-8|Death|3|||
125234416|NCT01056276|450486354|FG001|Treatment Period-Cycles 1-8|Death|1|||
125234417|NCT01056276|450486353|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
125234418|NCT01056276|450486354|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
125234419|NCT01056276|450486353|FG000|Maintenance Therapy|Toxicity|0|||
125234420|NCT01056276|450486354|FG001|Maintenance Therapy|Toxicity|2|||
125234421|NCT01056276|450486353|FG000|Maintenance Therapy|Progressive Disease|0|||
125234422|NCT01056276|450486354|FG001|Maintenance Therapy|Progressive Disease|9|||
125234423|NCT01056276|450486353|FG000|Maintenance Therapy|Physician Decision|0|||
125234424|NCT01056276|450486354|FG001|Maintenance Therapy|Physician Decision|1|||
125234425|NCT01056276|450486353|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
125234426|NCT01056276|450486354|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
125234427|NCT01056276|450486353|FG000|Maintenance Therapy|Intercurrent Illness|0|||
125234428|NCT01056276|450486354|FG001|Maintenance Therapy|Intercurrent Illness|1|||
125234429|NCT01056276|450486353|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
125234430|NCT01056276|450486354|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
125234431|NCT04424901|450486357|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
125234432|NCT04424901|450486358|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
125234433|NCT00147238|450486359|FG000|Overall Study|Inevaluable|8|||
125234434|NCT00297167|450486360|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
125234435|NCT00297167|450486361|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
125234436|NCT00297167|450486362|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
125234437|NCT00297167|450486360|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
125234438|NCT00297167|450486361|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
125234439|NCT00297167|450486362|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
125234440|NCT02701634|450486366|FG000|Overall Study|Adverse Event|2|||
125234441|NCT02701634|450486367|FG001|Overall Study|Adverse Event|3|||
125234442|NCT02701634|450486366|FG000|Overall Study|Death|1|||
125234443|NCT02701634|450486367|FG001|Overall Study|Death|0|||
125234444|NCT02701634|450486366|FG000|Overall Study|Investigator's Discretion|7|||
125234445|NCT02701634|450486367|FG001|Overall Study|Investigator's Discretion|4|||
125234446|NCT02701634|450486366|FG000|Overall Study|Study terminated by Sponsor|15|||
125234447|NCT02701634|450486367|FG001|Overall Study|Study terminated by Sponsor|17|||
125234448|NCT02701634|450486366|FG000|Overall Study|Withdrew Consent|6|||
125234449|NCT02701634|450486367|FG001|Overall Study|Withdrew Consent|7|||
125234450|NCT02701634|450486366|FG000|Overall Study|Randomized but not treated|1|||
125234451|NCT02701634|450486367|FG001|Overall Study|Randomized but not treated|0|||
125234452|NCT04009837|450486374|FG000|Overall Study|Withdrawal by Subject|5|||
125234453|NCT04009837|450486375|FG001|Overall Study|Withdrawal by Subject|4|||
125234454|NCT04009837|450486374|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
125234455|NCT04009837|450486375|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
125234456|NCT01572792|450486378|FG000|Lead-in Study|Lost to Follow-up|5|||
125234457|NCT01572792|450486379|FG001|Lead-in Study|Lost to Follow-up|9|||
125234458|NCT01572792|450486380|FG002|Lead-in Study|Lost to Follow-up|4|||
125234459|NCT01572792|450486381|FG003|Lead-in Study|Lost to Follow-up|2|||
125234460|NCT01572792|450486382|FG004|Lead-in Study|Lost to Follow-up|4|||
125234461|NCT01572792|450486378|FG000|Lead-in Study|Withdrawal by Subject|22|||
125234462|NCT01572792|450486379|FG001|Lead-in Study|Withdrawal by Subject|11|||
125234463|NCT01572792|450486380|FG002|Lead-in Study|Withdrawal by Subject|12|||
125178493|NCT01130493|450272780|FG002|Part 2: OLE|Withdrawal by Subject|4|||
125178494|NCT03452943|450272781|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
125178495|NCT03452943|450272782|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
125178496|NCT03452943|450272781|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
125178497|NCT03452943|450272782|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
125178498|NCT03452943|450272781|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
125178499|NCT03452943|450272782|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
125178500|NCT03452943|450272781|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
125178501|NCT03452943|450272782|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
125178502|NCT03452943|450272781|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
125178503|NCT03452943|450272782|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
125178504|NCT03452943|450272781|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
125178505|NCT03452943|450272782|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
125178506|NCT00879086|450272785|FG000|Overall Study|Adverse Event|3|||
125178507|NCT00879086|450272786|FG001|Overall Study|Adverse Event|15|||
125178508|NCT00879086|450272785|FG000|Overall Study|Participant choice|2|||
125178509|NCT00879086|450272786|FG001|Overall Study|Participant choice|2|||
125178510|NCT00879086|450272785|FG000|Overall Study|Progression of disease|40|||
125178511|NCT00879086|450272786|FG001|Overall Study|Progression of disease|26|||
125178512|NCT00879086|450272785|FG000|Overall Study|Withdrawal of consent|2|||
125178513|NCT00879086|450272786|FG001|Overall Study|Withdrawal of consent|1|||
125178514|NCT00879086|450272785|FG000|Overall Study|Other|4|||
125178515|NCT00879086|450272786|FG001|Overall Study|Other|6|||
125178516|NCT00879086|450272785|FG000|Overall Study|Death|1|||
125178517|NCT00879086|450272786|FG001|Overall Study|Death|2|||
125178518|NCT02536846|450272787|FG000|Overall Study|Withdrawal by Subject|1|||
125178519|NCT02593110|450272788|FG000|Overall Study|Withdrawal by Subject|0|||
125178520|NCT02593110|450272789|FG001|Overall Study|Withdrawal by Subject|3|||
125178521|NCT02593110|450272790|FG002|Overall Study|Withdrawal by Subject|3|||
125178522|NCT02593110|450272791|FG003|Overall Study|Withdrawal by Subject|2|||
125178523|NCT02593110|450272788|FG000|Overall Study|Death|0|||
125178524|NCT02593110|450272789|FG001|Overall Study|Death|0|||
125178525|NCT02593110|450272790|FG002|Overall Study|Death|1|||
125178526|NCT02593110|450272791|FG003|Overall Study|Death|0|||
125178527|NCT04604795|450272792|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
125178528|NCT04604795|450272793|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
125178529|NCT04604795|450272794|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
125178530|NCT04604795|450272795|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
125178531|NCT04604795|450272796|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
125178532|NCT04604795|450272797|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
125178533|NCT04604795|450272798|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
125178534|NCT04604795|450272799|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
125178535|NCT04604795|450272800|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
125178536|NCT04604795|450272801|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
125178537|NCT04604795|450272792|FG000|Part B: Up to Day 14|Adverse Event|0|||
125178538|NCT04604795|450272793|FG001|Part B: Up to Day 14|Adverse Event|0|||
125178539|NCT04604795|450272794|FG002|Part B: Up to Day 14|Adverse Event|0|||
125178540|NCT04604795|450272795|FG003|Part B: Up to Day 14|Adverse Event|0|||
125178541|NCT04604795|450272796|FG004|Part B: Up to Day 14|Adverse Event|2|||
125178542|NCT04604795|450272797|FG005|Part B: Up to Day 14|Adverse Event|1|||
125178543|NCT04604795|450272798|FG006|Part B: Up to Day 14|Adverse Event|0|||
125178544|NCT04604795|450272799|FG007|Part B: Up to Day 14|Adverse Event|0|||
125178545|NCT04604795|450272800|FG008|Part B: Up to Day 14|Adverse Event|0|||
125178546|NCT04604795|450272801|FG009|Part B: Up to Day 14|Adverse Event|0|||
125178547|NCT04604795|450272792|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
125178548|NCT04604795|450272793|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
125178549|NCT04604795|450272794|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
125178550|NCT04604795|450272795|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
125178551|NCT04604795|450272796|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
125178552|NCT04604795|450272797|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
125178553|NCT04604795|450272798|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
125178554|NCT04604795|450272799|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
125178555|NCT04604795|450272800|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
125178556|NCT04604795|450272801|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
125178557|NCT04604795|450272792|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
125178558|NCT04604795|450272793|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
125178559|NCT04604795|450272794|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
125178560|NCT04604795|450272795|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
125178561|NCT04604795|450272796|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
125178562|NCT04604795|450272797|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
125178563|NCT04604795|450272798|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
125234464|NCT01572792|450486381|FG003|Lead-in Study|Withdrawal by Subject|24|||
125234465|NCT01572792|450486382|FG004|Lead-in Study|Withdrawal by Subject|11|||
125234466|NCT01572792|450486378|FG000|Lead-in Study|Protocol Violation|19|||
125234467|NCT01572792|450486379|FG001|Lead-in Study|Protocol Violation|10|||
125234468|NCT01572792|450486380|FG002|Lead-in Study|Protocol Violation|12|||
125234469|NCT01572792|450486381|FG003|Lead-in Study|Protocol Violation|13|||
125234470|NCT01572792|450486382|FG004|Lead-in Study|Protocol Violation|21|||
125234471|NCT01572792|450486378|FG000|Lead-in Study|Lack of Efficacy|20|||
125234472|NCT01572792|450486379|FG001|Lead-in Study|Lack of Efficacy|5|||
125234473|NCT01572792|450486380|FG002|Lead-in Study|Lack of Efficacy|4|||
125234474|NCT01572792|450486381|FG003|Lead-in Study|Lack of Efficacy|8|||
125234475|NCT01572792|450486382|FG004|Lead-in Study|Lack of Efficacy|10|||
125234476|NCT01572792|450486378|FG000|Lead-in Study|Adverse Event|21|||
125234477|NCT01572792|450486379|FG001|Lead-in Study|Adverse Event|21|||
125234478|NCT01572792|450486380|FG002|Lead-in Study|Adverse Event|22|||
125234479|NCT01572792|450486381|FG003|Lead-in Study|Adverse Event|16|||
125234480|NCT01572792|450486382|FG004|Lead-in Study|Adverse Event|14|||
125234481|NCT01572792|450486378|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
125234482|NCT01572792|450486379|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
125234483|NCT01572792|450486380|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
125234484|NCT01572792|450486381|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
125234485|NCT01572792|450486382|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
125234486|NCT01572792|450486378|FG000|Extension Study|Lost to Follow-up|6|||
125234487|NCT01572792|450486379|FG001|Extension Study|Lost to Follow-up|2|||
125234488|NCT01572792|450486380|FG002|Extension Study|Lost to Follow-up|0|||
125234489|NCT01572792|450486381|FG003|Extension Study|Lost to Follow-up|3|||
125234490|NCT01572792|450486382|FG004|Extension Study|Lost to Follow-up|3|||
125234491|NCT01572792|450486378|FG000|Extension Study|Withdrawal by Subject|7|||
125234492|NCT01572792|450486379|FG001|Extension Study|Withdrawal by Subject|6|||
125234493|NCT01572792|450486380|FG002|Extension Study|Withdrawal by Subject|11|||
125234494|NCT01572792|450486381|FG003|Extension Study|Withdrawal by Subject|8|||
125234495|NCT01572792|450486382|FG004|Extension Study|Withdrawal by Subject|14|||
125234496|NCT01572792|450486378|FG000|Extension Study|Protocol Violation|0|||
125234497|NCT01572792|450486379|FG001|Extension Study|Protocol Violation|4|||
125234498|NCT01572792|450486380|FG002|Extension Study|Protocol Violation|3|||
125234499|NCT01572792|450486381|FG003|Extension Study|Protocol Violation|4|||
125234500|NCT01572792|450486382|FG004|Extension Study|Protocol Violation|3|||
125234501|NCT01572792|450486378|FG000|Extension Study|Lack of Efficacy|2|||
125234502|NCT01572792|450486379|FG001|Extension Study|Lack of Efficacy|3|||
125234503|NCT01572792|450486380|FG002|Extension Study|Lack of Efficacy|3|||
125234504|NCT01572792|450486381|FG003|Extension Study|Lack of Efficacy|2|||
125234505|NCT01572792|450486382|FG004|Extension Study|Lack of Efficacy|2|||
125234506|NCT01572792|450486378|FG000|Extension Study|Adverse Event|7|||
125234507|NCT01572792|450486379|FG001|Extension Study|Adverse Event|6|||
125234508|NCT01572792|450486380|FG002|Extension Study|Adverse Event|5|||
125234509|NCT01572792|450486381|FG003|Extension Study|Adverse Event|6|||
125234510|NCT01572792|450486382|FG004|Extension Study|Adverse Event|4|||
125234511|NCT01572792|450486378|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
125234512|NCT01572792|450486379|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
125234513|NCT01572792|450486380|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
125234514|NCT01572792|450486381|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
125234515|NCT01572792|450486382|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
125234516|NCT03530696|450486383|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
125234517|NCT03530696|450486384|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
125234518|NCT02472353|450486385|FG000|Overall Study|Lost to Follow-up|1|||
125234519|NCT02472353|450486386|FG001|Overall Study|Lost to Follow-up|1|||
125234520|NCT02472353|450486385|FG000|Overall Study|Withdrawal by Subject|2|||
125234521|NCT02472353|450486386|FG001|Overall Study|Withdrawal by Subject|1|||
125234522|NCT02472353|450486385|FG000|Overall Study|Study Termination|1|||
125234523|NCT02472353|450486386|FG001|Overall Study|Study Termination|4|||
125234524|NCT01129128|450486387|FG000|Overall Study|Lost to Follow-up|2|||
125234525|NCT01129128|450486388|FG001|Overall Study|Lost to Follow-up|2|||
125234526|NCT01129128|450486389|FG002|Overall Study|Lost to Follow-up|1|||
125234527|NCT01129128|450486387|FG000|Overall Study|Protocol Violation|0|||
125234528|NCT01129128|450486388|FG001|Overall Study|Protocol Violation|1|||
125234529|NCT01129128|450486389|FG002|Overall Study|Protocol Violation|0|||
125234530|NCT01129128|450486387|FG000|Overall Study|Withdrawal by Subject|0|||
125234531|NCT01129128|450486388|FG001|Overall Study|Withdrawal by Subject|1|||
125234532|NCT01129128|450486389|FG002|Overall Study|Withdrawal by Subject|3|||
125234533|NCT01129128|450486387|FG000|Overall Study|Physician Decision|1|||
125234534|NCT01129128|450486388|FG001|Overall Study|Physician Decision|0|||
125234535|NCT01129128|450486389|FG002|Overall Study|Physician Decision|0|||
125234536|NCT05722015|450486398|FG000|Overall Study|Death|57|||
125234537|NCT05722015|450486399|FG001|Overall Study|Death|37|||
125234538|NCT05722015|450486398|FG000|Overall Study|Lost to Follow-up|1|||
125234539|NCT05722015|450486399|FG001|Overall Study|Lost to Follow-up|0|||
125234540|NCT05722015|450486398|FG000|Overall Study|Withdrawal by Subject|5|||
125178564|NCT04604795|450272799|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
125178565|NCT04604795|450272800|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
125178566|NCT04604795|450272801|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
125178567|NCT04604795|450272792|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
125178568|NCT04604795|450272793|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
125178569|NCT04604795|450272794|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
125178570|NCT04604795|450272795|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
125178571|NCT04604795|450272796|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
125178572|NCT04604795|450272797|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
125178573|NCT04604795|450272798|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
125178574|NCT04604795|450272799|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
125178575|NCT04604795|450272800|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
125178576|NCT04604795|450272801|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
125178577|NCT04604795|450272792|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
125178578|NCT04604795|450272793|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
125178579|NCT04604795|450272794|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
125178580|NCT04604795|450272795|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
125178581|NCT04604795|450272796|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
125178582|NCT04604795|450272797|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
125178583|NCT04604795|450272798|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
125178584|NCT04604795|450272799|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
125178585|NCT04604795|450272800|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
125178586|NCT04604795|450272801|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
125178587|NCT00111241|450272809|FG000|Overall Study|Lost to Follow-up|1|||
125178588|NCT00111241|450272810|FG001|Overall Study|Lost to Follow-up|0|||
125178589|NCT00111241|450272809|FG000|Overall Study|Withdrawal by Subject|4|||
125178590|NCT00111241|450272810|FG001|Overall Study|Withdrawal by Subject|0|||
125178591|NCT00111241|450272809|FG000|Overall Study|Protocol Violation|9|||
125178592|NCT00111241|450272810|FG001|Overall Study|Protocol Violation|8|||
125178593|NCT00111241|450272809|FG000|Overall Study|Adverse Event|1|||
125178594|NCT00111241|450272810|FG001|Overall Study|Adverse Event|0|||
125178595|NCT02096744|450272811|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
125178596|NCT02096744|450272812|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
125178597|NCT02096744|450272811|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
125178598|NCT02096744|450272812|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
125178599|NCT02096744|450272811|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
125178600|NCT02096744|450272812|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
125178601|NCT00952731|450272818|FG000|Overall Study|Drug supply expired|1|||
125178602|NCT00952731|450272819|FG001|Overall Study|Drug supply expired|0|||
125178603|NCT01450683|450272820|FG000|Overall Study|Adverse Event|2|||
125178604|NCT02108912|450272821|FG000|Overall Study|Lost to Follow-up|1|||
125178605|NCT02108912|450272822|FG001|Overall Study|Lost to Follow-up|1|||
125178606|NCT02108912|450272821|FG000|Overall Study|lack of transportation|1|||
125178607|NCT02108912|450272822|FG001|Overall Study|lack of transportation|0|||
125178608|NCT02108912|450272821|FG000|Overall Study|high blood pressure|1|||
125178609|NCT02108912|450272822|FG001|Overall Study|high blood pressure|0|||
125178610|NCT00625872|450272823|FG000|Overall Study|Withdrawal by Subject|1|||
125178611|NCT00625872|450272824|FG001|Overall Study|Withdrawal by Subject|0|||
125178612|NCT00625872|450272823|FG000|Overall Study|Does not meet inclusion criteria|1|||
125178613|NCT00625872|450272824|FG001|Overall Study|Does not meet inclusion criteria|0|||
125178614|NCT00625872|450272823|FG000|Overall Study|Terminated by sponsor|2|||
125178615|NCT00625872|450272824|FG001|Overall Study|Terminated by sponsor|5|||
125178616|NCT00625872|450272823|FG000|Overall Study|Randomized but not treated|0|||
125178617|NCT00625872|450272824|FG001|Overall Study|Randomized but not treated|1|||
125178618|NCT00852202|450272825|FG000|Overall Study|Adverse Event|2|||
125178619|NCT00852202|450272826|FG001|Overall Study|Adverse Event|3|||
125178620|NCT00852202|450272827|FG002|Overall Study|Adverse Event|7|||
125178621|NCT00852202|450272825|FG000|Overall Study|Lack of Efficacy|4|||
125178622|NCT00852202|450272826|FG001|Overall Study|Lack of Efficacy|1|||
125178623|NCT00852202|450272827|FG002|Overall Study|Lack of Efficacy|2|||
125178624|NCT00852202|450272825|FG000|Overall Study|Protocol Violation|2|||
125178625|NCT00852202|450272826|FG001|Overall Study|Protocol Violation|2|||
125178626|NCT00852202|450272827|FG002|Overall Study|Protocol Violation|7|||
125178627|NCT00852202|450272825|FG000|Overall Study|Withdrawal by Subject|3|||
125178628|NCT00852202|450272826|FG001|Overall Study|Withdrawal by Subject|1|||
125178629|NCT00852202|450272827|FG002|Overall Study|Withdrawal by Subject|2|||
125178630|NCT00852202|450272825|FG000|Overall Study|Lost to Follow-up|5|||
125178631|NCT00852202|450272826|FG001|Overall Study|Lost to Follow-up|5|||
125234541|NCT05722015|450486399|FG001|Overall Study|Withdrawal by Subject|1|||
125234542|NCT05722015|450486398|FG000|Overall Study|Participants Ongoing|188|||
125234543|NCT05722015|450486399|FG001|Overall Study|Participants Ongoing|88|||
125234544|NCT04058717|450486400|FG000|Randomization Period|Lost to Follow-up|2|||
125234545|NCT04058717|450486401|FG001|Randomization Period|Lost to Follow-up|3|||
125234546|NCT04058717|450486402|FG002|Randomization Period|Lost to Follow-up|4|||
125234547|NCT04058717|450486403|FG003|Randomization Period|Lost to Follow-up|4|||
125234548|NCT04058717|450486400|FG000|Randomization Period|Withdrawal by Subject|1|||
125234549|NCT04058717|450486401|FG001|Randomization Period|Withdrawal by Subject|3|||
125234550|NCT04058717|450486402|FG002|Randomization Period|Withdrawal by Subject|3|||
125234551|NCT04058717|450486403|FG003|Randomization Period|Withdrawal by Subject|3|||
125234552|NCT04058717|450486400|FG000|Randomization Period|PI decision|0|||
125234553|NCT04058717|450486401|FG001|Randomization Period|PI decision|1|||
125234554|NCT04058717|450486402|FG002|Randomization Period|PI decision|0|||
125234555|NCT04058717|450486403|FG003|Randomization Period|PI decision|0|||
125234556|NCT00671788|450486404|FG000|Overall Study|Adverse Event|8|||
125234557|NCT00671788|450486404|FG000|Overall Study|Refused further treatment|3|||
125234558|NCT00671788|450486404|FG000|Overall Study|Ineligible|1|||
125234559|NCT00671788|450486404|FG000|Overall Study|MD Decision|1|||
125234560|NCT00671788|450486404|FG000|Overall Study|Other|1|||
125234561|NCT01832766|450486405|FG000|Washout|Lost to Follow-up|0|||
125234562|NCT01832766|450486406|FG001|Washout|Lost to Follow-up|1|||
125234563|NCT01925417|450486409|FG000|Overall Study|Withdrawal by Subject|2|||
125234564|NCT01925417|450486409|FG000|Overall Study|Death|1|||
125234565|NCT03479905|450486410|FG000|Overall Study|Other airway method used|4|||
125234566|NCT03479905|450486411|FG001|Overall Study|Other airway method used|5|||
125234567|NCT03479905|450486412|FG002|Overall Study|Other airway method used|5|||
125234568|NCT00720759|450486413|FG000|Overall Study|Lost to Follow-up|0|||
125234569|NCT00720759|450486414|FG001|Overall Study|Lost to Follow-up|1|||
125234570|NCT00720759|450486415|FG002|Overall Study|Lost to Follow-up|1|||
125234571|NCT00720759|450486416|FG003|Overall Study|Lost to Follow-up|0|||
125234572|NCT01047319|450486417|FG000|Overall Study|Teva requested participant withdrawal|3|||
125234573|NCT01047319|450486418|FG001|Overall Study|Teva requested participant withdrawal|0|||
125234574|NCT01047319|450486419|FG002|Overall Study|Teva requested participant withdrawal|1|||
125234575|NCT01047319|450486417|FG000|Overall Study|Protocol Violation|3|||
125234576|NCT01047319|450486418|FG001|Overall Study|Protocol Violation|2|||
125234577|NCT01047319|450486419|FG002|Overall Study|Protocol Violation|4|||
125234578|NCT01047319|450486417|FG000|Overall Study|Lack of Efficacy|4|||
125234579|NCT01047319|450486418|FG001|Overall Study|Lack of Efficacy|3|||
125234580|NCT01047319|450486419|FG002|Overall Study|Lack of Efficacy|3|||
125234581|NCT01047319|450486417|FG000|Overall Study|Death|5|||
125234582|NCT01047319|450486418|FG001|Overall Study|Death|1|||
125234583|NCT01047319|450486419|FG002|Overall Study|Death|5|||
125234584|NCT01047319|450486417|FG000|Overall Study|Pregnancy|13|||
125234585|NCT01047319|450486418|FG001|Overall Study|Pregnancy|8|||
125234586|NCT01047319|450486419|FG002|Overall Study|Pregnancy|8|||
125234587|NCT01047319|450486417|FG000|Overall Study|Physician Decision|12|||
125234588|NCT01047319|450486418|FG001|Overall Study|Physician Decision|9|||
125234589|NCT01047319|450486419|FG002|Overall Study|Physician Decision|10|||
125234590|NCT01047319|450486417|FG000|Overall Study|Lost to Follow-up|14|||
125234591|NCT01047319|450486418|FG001|Overall Study|Lost to Follow-up|10|||
125234592|NCT01047319|450486419|FG002|Overall Study|Lost to Follow-up|10|||
125234593|NCT01047319|450486417|FG000|Overall Study|Adverse Event|16|||
125234594|NCT01047319|450486418|FG001|Overall Study|Adverse Event|27|||
125234595|NCT01047319|450486419|FG002|Overall Study|Adverse Event|21|||
125234596|NCT01047319|450486417|FG000|Overall Study|Withdrawal by Subject|77|||
125234597|NCT01047319|450486418|FG001|Overall Study|Withdrawal by Subject|75|||
125234598|NCT01047319|450486419|FG002|Overall Study|Withdrawal by Subject|87|||
125234599|NCT01047319|450486417|FG000|Overall Study|Study terminated by Sponsor|198|||
125234600|NCT01047319|450486418|FG001|Overall Study|Study terminated by Sponsor|215|||
125234601|NCT01047319|450486419|FG002|Overall Study|Study terminated by Sponsor|203|||
125234602|NCT02598661|450486422|FG000|Overall Study|Death|27|||
125234603|NCT02598661|450486423|FG001|Overall Study|Death|34|||
125234604|NCT02598661|450486424|FG002|Overall Study|Death|14|||
125234605|NCT02598661|450486425|FG003|Overall Study|Death|1|||
125234606|NCT02598661|450486426|FG004|Overall Study|Death|0|||
125234607|NCT02598661|450486422|FG000|Overall Study|Lost to Follow-up|2|||
125234608|NCT02598661|450486423|FG001|Overall Study|Lost to Follow-up|3|||
125234609|NCT02598661|450486424|FG002|Overall Study|Lost to Follow-up|2|||
125234610|NCT02598661|450486425|FG003|Overall Study|Lost to Follow-up|0|||
125234611|NCT02598661|450486426|FG004|Overall Study|Lost to Follow-up|0|||
125234612|NCT02598661|450486422|FG000|Overall Study|Withdrawal by Subject|13|||
125234613|NCT02598661|450486423|FG001|Overall Study|Withdrawal by Subject|24|||
125234614|NCT02598661|450486424|FG002|Overall Study|Withdrawal by Subject|14|||
125234615|NCT02598661|450486425|FG003|Overall Study|Withdrawal by Subject|1|||
125234616|NCT02598661|450486426|FG004|Overall Study|Withdrawal by Subject|1|||
125234617|NCT02598661|450486422|FG000|Overall Study|Adverse Event|0|||
125234618|NCT02598661|450486423|FG001|Overall Study|Adverse Event|0|||
125234619|NCT02598661|450486424|FG002|Overall Study|Adverse Event|1|||
125234620|NCT02598661|450486425|FG003|Overall Study|Adverse Event|0|||
125234621|NCT02598661|450486426|FG004|Overall Study|Adverse Event|0|||
125234622|NCT02598661|450486422|FG000|Overall Study|Randomized, Never Treated|0|||
125234623|NCT02598661|450486423|FG001|Overall Study|Randomized, Never Treated|0|||
125234624|NCT02598661|450486424|FG002|Overall Study|Randomized, Never Treated|0|||
125234625|NCT02598661|450486425|FG003|Overall Study|Randomized, Never Treated|0|||
125234626|NCT02598661|450486426|FG004|Overall Study|Randomized, Never Treated|1|||
125234627|NCT01366092|450486427|FG000|Overall Study|Progressive cGVHD|2|||
125234628|NCT01366092|450486427|FG000|Overall Study|Physician Decision|1|||
125234629|NCT01366092|450486427|FG000|Overall Study|Withdrawal by Subject|1|||
125234630|NCT03074500|450486428|FG000|Overall Study|Lost to Follow-up|1|||
125234631|NCT03074500|450486429|FG001|Overall Study|Lost to Follow-up|0|||
125234632|NCT03074500|450486430|FG002|Overall Study|Lost to Follow-up|0|||
125234633|NCT03074500|450486428|FG000|Overall Study|Lack of Efficacy|0|||
125234634|NCT03074500|450486429|FG001|Overall Study|Lack of Efficacy|1|||
125234635|NCT03074500|450486430|FG002|Overall Study|Lack of Efficacy|0|||
125234636|NCT03074500|450486428|FG000|Overall Study|Adverse Event|0|||
125234637|NCT03074500|450486429|FG001|Overall Study|Adverse Event|0|||
125234638|NCT03074500|450486430|FG002|Overall Study|Adverse Event|1|||
125234639|NCT03608163|450486431|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
125234640|NCT03608163|450486432|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
125234641|NCT03836053|450487701|FG000|Overall Study|Protocol-specified criteria|0|||
125234642|NCT03836053|450487702|FG001|Overall Study|Protocol-specified criteria|2|||
125234643|NCT03836053|450487703|FG002|Overall Study|Protocol-specified criteria|1|||
125234644|NCT03836053|450487701|FG000|Overall Study|Death|1|||
125234645|NCT03836053|450487702|FG001|Overall Study|Death|6|||
125234646|NCT03836053|450487703|FG002|Overall Study|Death|4|||
125234647|NCT03836053|450487701|FG000|Overall Study|Withdrawal of consent from study|0|||
125234648|NCT03836053|450487702|FG001|Overall Study|Withdrawal of consent from study|0|||
125234649|NCT03836053|450487703|FG002|Overall Study|Withdrawal of consent from study|1|||
125234650|NCT03836053|450487701|FG000|Overall Study|Decision by sponsor|0|||
125234651|NCT03836053|450487702|FG001|Overall Study|Decision by sponsor|2|||
125234652|NCT03836053|450487703|FG002|Overall Study|Decision by sponsor|4|||
125234653|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
125234654|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
125234655|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
125234656|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|Death|1|||
125234657|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|Death|1|||
125234658|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|Death|0|||
125234659|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
125234660|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
125234661|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
125234662|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
125234663|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
125234664|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
125234665|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
125234666|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
125234667|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
125234668|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
125234669|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
125234670|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
125234671|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
125234672|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
125234673|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
125234674|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
125234675|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
125234676|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
125234677|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
125234678|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
125234679|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
125234680|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
125234681|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
125234682|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
125234683|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|Other|10|||
125234684|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|Other|4|||
125234685|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|Other|0|||
125234686|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
125234687|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
125234688|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
125234689|NCT04006457|450487704|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
125234690|NCT04006457|450487705|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
125234691|NCT04006457|450487706|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
125234692|NCT04006457|450487704|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
125234693|NCT04006457|450487705|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
125178632|NCT00852202|450272827|FG002|Overall Study|Lost to Follow-up|6|||
125178633|NCT00852202|450272825|FG000|Overall Study|pregnancy,moving away and surgery|1|||
125234694|NCT04006457|450487706|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
125234695|NCT04006457|450487704|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
125234696|NCT04006457|450487705|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
125234697|NCT04006457|450487706|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
125234698|NCT04006457|450487704|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
125234699|NCT04006457|450487705|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
125234700|NCT04006457|450487706|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
125234701|NCT04006457|450487704|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
125234702|NCT04006457|450487705|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
125234703|NCT04006457|450487706|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
125234704|NCT04006457|450487704|FG000|Main Study: Treatment Period 2|Other|2|||
125234705|NCT04006457|450487705|FG001|Main Study: Treatment Period 2|Other|3|||
125234706|NCT04006457|450487706|FG002|Main Study: Treatment Period 2|Other|0|||
125234707|NCT04006457|450487704|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
125234708|NCT04006457|450487705|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
125234709|NCT04006457|450487706|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
125234710|NCT04006457|450487704|FG000|Main Study: Treatment Period 2|Ongoing|86|||
125234711|NCT04006457|450487705|FG001|Main Study: Treatment Period 2|Ongoing|96|||
125234712|NCT04006457|450487706|FG002|Main Study: Treatment Period 2|Ongoing|0|||
125234713|NCT04006457|450487704|FG000|Main Study Observation Period|Adverse Event|1|||
125234714|NCT04006457|450487705|FG001|Main Study Observation Period|Adverse Event|1|||
125234715|NCT04006457|450487706|FG002|Main Study Observation Period|Adverse Event|0|||
125234716|NCT04006457|450487704|FG000|Main Study Observation Period|Lost to Follow-up|0|||
125234717|NCT04006457|450487705|FG001|Main Study Observation Period|Lost to Follow-up|1|||
125234718|NCT04006457|450487706|FG002|Main Study Observation Period|Lost to Follow-up|0|||
125234719|NCT04006457|450487704|FG000|Main Study Observation Period|Pregnancy|1|||
125234720|NCT04006457|450487705|FG001|Main Study Observation Period|Pregnancy|0|||
125234721|NCT04006457|450487706|FG002|Main Study Observation Period|Pregnancy|0|||
125234722|NCT04006457|450487704|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
125234723|NCT04006457|450487705|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
125234724|NCT04006457|450487706|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
125234725|NCT04006457|450487704|FG000|Main Study Observation Period|Other|8|||
125234726|NCT04006457|450487705|FG001|Main Study Observation Period|Other|16|||
125234727|NCT04006457|450487706|FG002|Main Study Observation Period|Other|0|||
125234728|NCT04006457|450487704|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
125234729|NCT04006457|450487705|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
125234730|NCT04006457|450487706|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
125234731|NCT04006457|450487704|FG000|Main Study Observation Period|Ongoing|2|||
125234732|NCT04006457|450487705|FG001|Main Study Observation Period|Ongoing|1|||
125234733|NCT04006457|450487706|FG002|Main Study Observation Period|Ongoing|0|||
125234734|NCT04006457|450487704|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
125178634|NCT00852202|450272826|FG001|Overall Study|pregnancy,moving away and surgery|0|||
125178635|NCT00852202|450272827|FG002|Overall Study|pregnancy,moving away and surgery|2|||
125178636|NCT05022212|450272830|FG000|Overall Study|Lost to Follow-up|0|||
125178637|NCT05022212|450272831|FG001|Overall Study|Lost to Follow-up|2|||
125178638|NCT01682811|450272832|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
125178639|NCT01682811|450272833|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
125178640|NCT01682811|450272834|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
125178641|NCT01682811|450272835|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
125178642|NCT01682811|450272836|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
125178643|NCT01682811|450272837|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
125178644|NCT01682811|450272838|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
125178645|NCT01682811|450272832|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
125178646|NCT01682811|450272833|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
125178647|NCT01682811|450272834|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
125178648|NCT01682811|450272835|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
125234735|NCT04006457|450487705|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
125234736|NCT04006457|450487706|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
125234737|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
125178649|NCT01682811|450272836|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
125178650|NCT01682811|450272837|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
125178651|NCT01682811|450272838|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
125178652|NCT01682811|450272832|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
125178653|NCT01682811|450272833|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
125234738|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
125178654|NCT01682811|450272834|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
125234739|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
125234740|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
125234741|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
125234742|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
125234743|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
125234744|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
125234745|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
125234746|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
125234747|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
125234748|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
125234749|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
125234750|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
125234751|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
125234752|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
125234753|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
125234754|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
125234755|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
125234756|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
125234757|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
125234758|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
125234759|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
125234760|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
125234761|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
125234762|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
125234763|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
125234764|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
125234765|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
125234766|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
125234767|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
125234768|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
125234769|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
125234770|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
125234771|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
125234772|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
125234773|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
125234774|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
125234775|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
125234776|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
125234777|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
125234778|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
125234779|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
125234780|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
125234781|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
125234782|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
125234783|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
125234784|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
125234785|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
125234786|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
125234787|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
125234788|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
125234789|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
125234790|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
125234791|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
125234792|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
125234793|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
125234794|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
125234795|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
125234796|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
125234797|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
125234798|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
125234799|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
125234800|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
125234801|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
125234802|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
125234803|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
125234804|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
125234805|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
125234806|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
125234807|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
125234808|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
125234809|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
125234810|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
125234811|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
125234812|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
125234813|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
125234814|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
125234815|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
125234816|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
125234817|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
125234818|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
125234819|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
125234820|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
125234821|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
125234822|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
125234823|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
125234824|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
125234825|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
125234826|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
125234827|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
125234828|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
125234829|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
125234830|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
125234831|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
125234832|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
125234833|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
125234834|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
125234835|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
125234836|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
125234837|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
125234838|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
125234839|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
125234840|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
125234841|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
125234842|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
125234843|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
125234844|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
125234845|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
125234846|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
125234847|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
125234848|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
125234849|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
125234850|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
125234851|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
125234852|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
125234853|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
125234854|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
125234855|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
125234856|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
125234857|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
125234858|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
125234859|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
125234860|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
125234861|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
125234862|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
125234863|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
125234864|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
125234865|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
125234866|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
125234867|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
125234868|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
125234869|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
125234870|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
125234871|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
125234872|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
125234873|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
125234874|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
125234875|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
125234876|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
125234877|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
125234878|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Death|1|||
125234879|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Death|0|||
125234880|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Death|1|||
125234881|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
125234882|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
125234883|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
125234884|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
125234885|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
125234886|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
125234887|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
125234888|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
125234889|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
125234890|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
125234891|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
125234892|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
125234893|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
125234894|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
125234895|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
125234896|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
125234897|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
125234898|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
125234899|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
125234900|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
125234901|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
125234902|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Depression|0|||
125234903|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Depression|1|||
125234904|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Depression|0|||
125234905|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
125234906|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
125234907|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
125234908|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Jailed|0|||
125234909|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Jailed|1|||
125234910|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Jailed|0|||
125234911|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Other|0|||
125234912|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Other|1|||
125234913|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Other|0|||
125234914|NCT04476043|450487716|FG000|Overall Study|Withdrawal by Subject|1|||
125234915|NCT04476043|450487717|FG001|Overall Study|Withdrawal by Subject|3|||
125234916|NCT04476043|450487718|FG002|Overall Study|Withdrawal by Subject|4|||
125234917|NCT04476043|450487719|FG003|Overall Study|Withdrawal by Subject|1|||
125234918|NCT04476043|450487716|FG000|Overall Study|Lost to Follow-up|1|||
125234919|NCT04476043|450487717|FG001|Overall Study|Lost to Follow-up|1|||
125234920|NCT04476043|450487718|FG002|Overall Study|Lost to Follow-up|2|||
125234921|NCT04476043|450487719|FG003|Overall Study|Lost to Follow-up|1|||
125234922|NCT04476043|450487716|FG000|Overall Study|Adverse Event|2|||
125234923|NCT04476043|450487717|FG001|Overall Study|Adverse Event|0|||
125234924|NCT04476043|450487718|FG002|Overall Study|Adverse Event|1|||
125234925|NCT04476043|450487719|FG003|Overall Study|Adverse Event|0|||
125234926|NCT04476043|450487716|FG000|Overall Study|Protocol Violation|0|||
125234927|NCT04476043|450487717|FG001|Overall Study|Protocol Violation|1|||
125234928|NCT04476043|450487718|FG002|Overall Study|Protocol Violation|0|||
125234929|NCT04476043|450487719|FG003|Overall Study|Protocol Violation|0|||
125234930|NCT02194465|450487722|FG000|Overall Study|Adverse Event|6|||
125234931|NCT02194465|450487723|FG001|Overall Study|Adverse Event|1|||
125234932|NCT02194465|450487724|FG002|Overall Study|Adverse Event|4|||
125234933|NCT02194465|450487725|FG003|Overall Study|Adverse Event|4|||
125234934|NCT02194465|450487726|FG004|Overall Study|Adverse Event|4|||
125234935|NCT02194465|450487727|FG005|Overall Study|Adverse Event|2|||
125234936|NCT02194465|450487728|FG006|Overall Study|Adverse Event|0|||
125234937|NCT02194465|450487722|FG000|Overall Study|Lost to Follow-up|0|||
125234938|NCT02194465|450487723|FG001|Overall Study|Lost to Follow-up|0|||
125234939|NCT02194465|450487724|FG002|Overall Study|Lost to Follow-up|0|||
125234940|NCT02194465|450487725|FG003|Overall Study|Lost to Follow-up|1|||
125234941|NCT02194465|450487726|FG004|Overall Study|Lost to Follow-up|0|||
125234942|NCT02194465|450487727|FG005|Overall Study|Lost to Follow-up|1|||
125234943|NCT02194465|450487728|FG006|Overall Study|Lost to Follow-up|0|||
125234944|NCT02194465|450487722|FG000|Overall Study|Physician Decision|1|||
125234945|NCT02194465|450487723|FG001|Overall Study|Physician Decision|0|||
125234946|NCT02194465|450487724|FG002|Overall Study|Physician Decision|0|||
125234947|NCT02194465|450487725|FG003|Overall Study|Physician Decision|0|||
125234948|NCT02194465|450487726|FG004|Overall Study|Physician Decision|0|||
125234949|NCT02194465|450487727|FG005|Overall Study|Physician Decision|0|||
125234950|NCT02194465|450487728|FG006|Overall Study|Physician Decision|0|||
125234951|NCT02194465|450487722|FG000|Overall Study|Protocol Violation|1|||
125234952|NCT02194465|450487723|FG001|Overall Study|Protocol Violation|1|||
125234953|NCT02194465|450487724|FG002|Overall Study|Protocol Violation|2|||
125234954|NCT02194465|450487725|FG003|Overall Study|Protocol Violation|1|||
125234955|NCT02194465|450487726|FG004|Overall Study|Protocol Violation|1|||
125234956|NCT02194465|450487727|FG005|Overall Study|Protocol Violation|0|||
125234957|NCT02194465|450487728|FG006|Overall Study|Protocol Violation|0|||
125234958|NCT02194465|450487722|FG000|Overall Study|Withdrawal by Subject|1|||
125234959|NCT02194465|450487723|FG001|Overall Study|Withdrawal by Subject|3|||
125234960|NCT02194465|450487724|FG002|Overall Study|Withdrawal by Subject|1|||
125234961|NCT02194465|450487725|FG003|Overall Study|Withdrawal by Subject|2|||
125234962|NCT02194465|450487726|FG004|Overall Study|Withdrawal by Subject|2|||
125234963|NCT02194465|450487727|FG005|Overall Study|Withdrawal by Subject|1|||
125234964|NCT02194465|450487728|FG006|Overall Study|Withdrawal by Subject|2|||
125234965|NCT02194465|450487722|FG000|Overall Study|Discontinued follow-up period|0|||
125234966|NCT02194465|450487723|FG001|Overall Study|Discontinued follow-up period|2|||
125234967|NCT02194465|450487724|FG002|Overall Study|Discontinued follow-up period|1|||
125234968|NCT02194465|450487725|FG003|Overall Study|Discontinued follow-up period|0|||
125178655|NCT01682811|450272835|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
125178656|NCT01682811|450272836|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
125178657|NCT01682811|450272837|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
125178658|NCT01682811|450272838|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
125178659|NCT01682811|450272832|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
125178660|NCT01682811|450272833|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
125178661|NCT01682811|450272834|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
125178662|NCT01682811|450272835|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
125178663|NCT01682811|450272836|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
125178664|NCT01682811|450272837|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
125178665|NCT01682811|450272838|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
125178666|NCT02694328|450272839|FG000|Overall Study|Adverse Event|27|||
125178667|NCT02694328|450272840|FG001|Overall Study|Adverse Event|33|||
125178668|NCT02694328|450272839|FG000|Overall Study|Withdrawal by Subject|27|||
125178669|NCT02694328|450272840|FG001|Overall Study|Withdrawal by Subject|23|||
125178670|NCT02694328|450272839|FG000|Overall Study|Lost to Follow-up|26|||
125178671|NCT02694328|450272840|FG001|Overall Study|Lost to Follow-up|22|||
125178672|NCT02694328|450272839|FG000|Overall Study|Noncompliant with study drug|11|||
125178673|NCT02694328|450272840|FG001|Overall Study|Noncompliant with study drug|8|||
125178674|NCT02694328|450272839|FG000|Overall Study|Incarceration|1|||
125178675|NCT02694328|450272840|FG001|Overall Study|Incarceration|1|||
125178676|NCT02694328|450272839|FG000|Overall Study|Lack of Efficacy|1|||
125178677|NCT02694328|450272840|FG001|Overall Study|Lack of Efficacy|2|||
125178678|NCT02694328|450272839|FG000|Overall Study|Pregnancy|1|||
125178679|NCT02694328|450272840|FG001|Overall Study|Pregnancy|1|||
125178680|NCT02694328|450272839|FG000|Overall Study|Protocol Violation|6|||
125234969|NCT02194465|450487726|FG004|Overall Study|Discontinued follow-up period|2|||
125234970|NCT02194465|450487727|FG005|Overall Study|Discontinued follow-up period|0|||
125234971|NCT02194465|450487728|FG006|Overall Study|Discontinued follow-up period|0|||
125234972|NCT01408641|450487729|FG000|Overall Study|Physician Decision|1|||
125178681|NCT02694328|450272840|FG001|Overall Study|Protocol Violation|5|||
125178682|NCT02694328|450272839|FG000|Overall Study|Abnormal Laboratory Value|0|||
125234973|NCT01408641|450487730|FG001|Overall Study|Physician Decision|0|||
125234974|NCT03979313|450487731|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
125178683|NCT02694328|450272840|FG001|Overall Study|Abnormal Laboratory Value|3|||
125178684|NCT02514447|450274778|FG000|Overall Study|Withdrawal by Subject|3|||
125178685|NCT02514447|450274779|FG001|Overall Study|Withdrawal by Subject|1|||
125178686|NCT02514447|450274780|FG002|Overall Study|Withdrawal by Subject|1|||
125178687|NCT02514447|450274781|FG003|Overall Study|Withdrawal by Subject|0|||
125178688|NCT02514447|450274782|FG004|Overall Study|Withdrawal by Subject|0|||
125178689|NCT02514447|450274783|FG005|Overall Study|Withdrawal by Subject|0|||
125178690|NCT02514447|450274784|FG006|Overall Study|Withdrawal by Subject|0|||
125178691|NCT02514447|450274785|FG007|Overall Study|Withdrawal by Subject|1|||
125178692|NCT02514447|450274786|FG008|Overall Study|Withdrawal by Subject|1|||
125178693|NCT02514447|450274778|FG000|Overall Study|Death|24|||
125178694|NCT02514447|450274779|FG001|Overall Study|Death|28|||
125178695|NCT02514447|450274780|FG002|Overall Study|Death|29|||
125178696|NCT02514447|450274781|FG003|Overall Study|Death|0|||
125178697|NCT02514447|450274782|FG004|Overall Study|Death|3|||
125178698|NCT02514447|450274783|FG005|Overall Study|Death|4|||
125178699|NCT02514447|450274784|FG006|Overall Study|Death|8|||
125178700|NCT02514447|450274785|FG007|Overall Study|Death|6|||
125178701|NCT02514447|450274786|FG008|Overall Study|Death|5|||
125178702|NCT02514447|450274778|FG000|Overall Study|Lost to Follow-up|1|||
125178703|NCT02514447|450274779|FG001|Overall Study|Lost to Follow-up|0|||
125178704|NCT02514447|450274780|FG002|Overall Study|Lost to Follow-up|0|||
125178705|NCT02514447|450274781|FG003|Overall Study|Lost to Follow-up|0|||
125178706|NCT02514447|450274782|FG004|Overall Study|Lost to Follow-up|0|||
125178707|NCT02514447|450274783|FG005|Overall Study|Lost to Follow-up|0|||
125178708|NCT02514447|450274784|FG006|Overall Study|Lost to Follow-up|0|||
125178709|NCT02514447|450274785|FG007|Overall Study|Lost to Follow-up|0|||
125178710|NCT02514447|450274786|FG008|Overall Study|Lost to Follow-up|1|||
125178711|NCT02514447|450274778|FG000|Overall Study|Sponsor Termination of Study|0|||
125178712|NCT02514447|450274779|FG001|Overall Study|Sponsor Termination of Study|1|||
125178713|NCT02514447|450274780|FG002|Overall Study|Sponsor Termination of Study|1|||
125178714|NCT02514447|450274781|FG003|Overall Study|Sponsor Termination of Study|0|||
125178715|NCT02514447|450274782|FG004|Overall Study|Sponsor Termination of Study|0|||
125178716|NCT02514447|450274783|FG005|Overall Study|Sponsor Termination of Study|0|||
125178717|NCT02514447|450274784|FG006|Overall Study|Sponsor Termination of Study|0|||
125178718|NCT02514447|450274785|FG007|Overall Study|Sponsor Termination of Study|0|||
125178719|NCT02514447|450274786|FG008|Overall Study|Sponsor Termination of Study|0|||
125178720|NCT02514447|450274778|FG000|Overall Study|Study completion per Investigator|1|||
125178721|NCT02514447|450274779|FG001|Overall Study|Study completion per Investigator|0|||
125178722|NCT02514447|450274780|FG002|Overall Study|Study completion per Investigator|1|||
125178723|NCT02514447|450274781|FG003|Overall Study|Study completion per Investigator|2|||
125178724|NCT02514447|450274782|FG004|Overall Study|Study completion per Investigator|0|||
125178725|NCT02514447|450274783|FG005|Overall Study|Study completion per Investigator|0|||
125178726|NCT02514447|450274784|FG006|Overall Study|Study completion per Investigator|0|||
125178727|NCT02514447|450274785|FG007|Overall Study|Study completion per Investigator|0|||
125178728|NCT02514447|450274786|FG008|Overall Study|Study completion per Investigator|1|||
125178729|NCT02731638|450274791|FG000|Overall Study|Lost to Follow-up|6|||
125178730|NCT02731638|450274792|FG001|Overall Study|Lost to Follow-up|9|||
125178731|NCT05626231|450274793|FG000|Provider Enrollment|Worked part-time|4|||
125178732|NCT05626231|450274793|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
125178733|NCT05626231|450274793|FG000|Provider Enrollment|Non-clinical employee|1|||
125178734|NCT05626231|450274793|FG000|Provider Enrollment|Provider does not see clients|3|||
125178735|NCT05626231|450274793|FG000|Provider Enrollment|Other|5|||
125178736|NCT05878093|450274794|FG000|Overall Study|Withdrawal by Subject|3|||
125178737|NCT05878093|450274795|FG001|Overall Study|Withdrawal by Subject|1|||
125178738|NCT04995029|450274796|FG000|Induction Phase|Did not meet eligibility criteria|5|||
125178739|NCT04995029|450274797|FG001|Induction Phase|Did not meet eligibility criteria|2|||
125178740|NCT04995029|450274798|FG002|Induction Phase|Did not meet eligibility criteria|0|||
125178741|NCT04995029|450274799|FG003|Induction Phase|Did not meet eligibility criteria|0|||
125178742|NCT04995029|450274796|FG000|Induction Phase|Withdrawal by Subject|85|||
125178743|NCT04995029|450274797|FG001|Induction Phase|Withdrawal by Subject|42|||
125178744|NCT04995029|450274798|FG002|Induction Phase|Withdrawal by Subject|0|||
125178745|NCT04995029|450274799|FG003|Induction Phase|Withdrawal by Subject|0|||
125178746|NCT04995029|450274796|FG000|Induction Phase|Lost to Follow-up|103|||
125178747|NCT04995029|450274797|FG001|Induction Phase|Lost to Follow-up|67|||
125178748|NCT04995029|450274798|FG002|Induction Phase|Lost to Follow-up|0|||
125178749|NCT04995029|450274799|FG003|Induction Phase|Lost to Follow-up|0|||
125178750|NCT04995029|450274796|FG000|Induction Phase|Adverse Event|5|||
125178751|NCT04995029|450274797|FG001|Induction Phase|Adverse Event|3|||
125178752|NCT04995029|450274798|FG002|Induction Phase|Adverse Event|0|||
125178753|NCT04995029|450274799|FG003|Induction Phase|Adverse Event|0|||
125178754|NCT04995029|450274796|FG000|Induction Phase|Physician Decision|11|||
125178755|NCT04995029|450274797|FG001|Induction Phase|Physician Decision|8|||
125178756|NCT04995029|450274798|FG002|Induction Phase|Physician Decision|0|||
125178757|NCT04995029|450274799|FG003|Induction Phase|Physician Decision|0|||
125178758|NCT04995029|450274796|FG000|Induction Phase|Incarceration|6|||
125234975|NCT03979313|450487732|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
125234976|NCT03979313|450487731|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
125234977|NCT03979313|450487732|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
125234978|NCT03979313|450487731|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
125234979|NCT03979313|450487732|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
125234980|NCT03979313|450487731|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
125234981|NCT03979313|450487732|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
125234982|NCT03979313|450487731|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
125234983|NCT03979313|450487732|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
125234984|NCT03979313|450487731|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
125234985|NCT03979313|450487732|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
125234986|NCT03979313|450487731|FG000|All Subjects|Any Other Reason|16|||
125234987|NCT03979313|450487732|FG001|All Subjects|Any Other Reason|23|||
125234988|NCT03979313|450487731|FG000|All Subjects|Covid-19|1|||
125234989|NCT03979313|450487732|FG001|All Subjects|Covid-19|3|||
125234990|NCT03979313|450487731|FG000|All Subjects|Withdrawal by Subject|35|||
125234991|NCT03979313|450487732|FG001|All Subjects|Withdrawal by Subject|44|||
125234992|NCT03979313|450487731|FG000|All Subjects|Death|0|||
125234993|NCT03979313|450487732|FG001|All Subjects|Death|5|||
125234994|NCT03979313|450487731|FG000|All Subjects|Lost to Follow-up|28|||
125234995|NCT03979313|450487732|FG001|All Subjects|Lost to Follow-up|61|||
125234996|NCT00089648|450487733|FG000|Overall Study|Adverse Event|7|||
125234997|NCT00089648|450487733|FG000|Overall Study|Withdrawal by Subject|1|||
125234998|NCT00089648|450487733|FG000|Overall Study|Lack of Efficacy|33|||
125234999|NCT00423605|450487734|FG000|Overall Study|Adverse Event|129|||
125235000|NCT00423605|450487734|FG000|Overall Study|Withdrawal by Subject|36|||
125235001|NCT00423605|450487734|FG000|Overall Study|Lost to Follow-up|15|||
125235002|NCT00423605|450487734|FG000|Overall Study|Lack of Efficacy|38|||
125235003|NCT00423605|450487734|FG000|Overall Study|Sponsor Decision|3|||
125235004|NCT00423605|450487734|FG000|Overall Study|Physician Decision|8|||
125235005|NCT00423605|450487734|FG000|Overall Study|Protocol Violation|7|||
125235006|NCT00423605|450487734|FG000|Overall Study|Not one of the pre-specified options|5|||
125235007|NCT03183908|450487737|FG000|Overall Study|Missing Symptom Diary Data|0|||
125235008|NCT03183908|450487738|FG001|Overall Study|Missing Symptom Diary Data|2|||
125235009|NCT01240746|450487742|FG000|Overall Study|Adverse Event|2|||
125235010|NCT01240746|450487743|FG001|Overall Study|Adverse Event|0|||
125235011|NCT01240746|450487744|FG002|Overall Study|Adverse Event|10|||
125235012|NCT01240746|450487742|FG000|Overall Study|Lost to Follow-up|23|||
125235013|NCT01240746|450487743|FG001|Overall Study|Lost to Follow-up|20|||
125235014|NCT01240746|450487744|FG002|Overall Study|Lost to Follow-up|102|||
125235015|NCT01240746|450487742|FG000|Overall Study|Protocol Violation|24|||
125235016|NCT01240746|450487743|FG001|Overall Study|Protocol Violation|15|||
125235017|NCT01240746|450487744|FG002|Overall Study|Protocol Violation|72|||
125235018|NCT01240746|450487742|FG000|Overall Study|Withdrawal by Subject|10|||
125178759|NCT04995029|450274797|FG001|Induction Phase|Incarceration|3|||
125178760|NCT04995029|450274798|FG002|Induction Phase|Incarceration|0|||
125178761|NCT04995029|450274799|FG003|Induction Phase|Incarceration|0|||
125178762|NCT04995029|450274796|FG000|Induction Phase|Not otherwise described|5|||
125178763|NCT04995029|450274797|FG001|Induction Phase|Not otherwise described|5|||
125178764|NCT04995029|450274798|FG002|Induction Phase|Not otherwise described|0|||
125178765|NCT04995029|450274799|FG003|Induction Phase|Not otherwise described|0|||
125178766|NCT04995029|450274796|FG000|Maintenance Phase|Lost to Follow-up|0|||
125178767|NCT04995029|450274797|FG001|Maintenance Phase|Lost to Follow-up|0|||
125178768|NCT04995029|450274798|FG002|Maintenance Phase|Lost to Follow-up|51|||
125178769|NCT04995029|450274799|FG003|Maintenance Phase|Lost to Follow-up|44|||
125178770|NCT04995029|450274796|FG000|Maintenance Phase|Did not meet eligibility criteria|0|||
125178771|NCT04995029|450274797|FG001|Maintenance Phase|Did not meet eligibility criteria|0|||
125178772|NCT04995029|450274798|FG002|Maintenance Phase|Did not meet eligibility criteria|0|||
125178773|NCT04995029|450274799|FG003|Maintenance Phase|Did not meet eligibility criteria|1|||
125178774|NCT04995029|450274796|FG000|Maintenance Phase|Adverse Event|0|||
125178775|NCT04995029|450274797|FG001|Maintenance Phase|Adverse Event|0|||
125178776|NCT04995029|450274798|FG002|Maintenance Phase|Adverse Event|0|||
125178777|NCT04995029|450274799|FG003|Maintenance Phase|Adverse Event|1|||
125178778|NCT04995029|450274796|FG000|Maintenance Phase|Physician Decision|0|||
125178779|NCT04995029|450274797|FG001|Maintenance Phase|Physician Decision|0|||
125178780|NCT04995029|450274798|FG002|Maintenance Phase|Physician Decision|8|||
125178781|NCT04995029|450274799|FG003|Maintenance Phase|Physician Decision|4|||
125178782|NCT04995029|450274796|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125235019|NCT01240746|450487743|FG001|Overall Study|Withdrawal by Subject|13|||
125235020|NCT01240746|450487744|FG002|Overall Study|Withdrawal by Subject|59|||
125235021|NCT03738696|450487745|FG000|Overall Study|Withdrawal by Subject|0|||
125235022|NCT03738696|450487746|FG001|Overall Study|Withdrawal by Subject|1|||
125178783|NCT04995029|450274797|FG001|Maintenance Phase|Withdrawal by Subject|0|||
125178784|NCT04995029|450274798|FG002|Maintenance Phase|Withdrawal by Subject|17|||
125178785|NCT04995029|450274799|FG003|Maintenance Phase|Withdrawal by Subject|31|||
125178786|NCT04995029|450274796|FG000|Maintenance Phase|Incarceration|0|||
125178787|NCT04995029|450274797|FG001|Maintenance Phase|Incarceration|0|||
125178788|NCT04995029|450274798|FG002|Maintenance Phase|Incarceration|4|||
125178789|NCT04995029|450274799|FG003|Maintenance Phase|Incarceration|3|||
125178790|NCT04995029|450274796|FG000|Maintenance Phase|Not otherwise described|0|||
125178791|NCT04995029|450274797|FG001|Maintenance Phase|Not otherwise described|0|||
125178792|NCT04995029|450274798|FG002|Maintenance Phase|Not otherwise described|2|||
125178793|NCT04995029|450274799|FG003|Maintenance Phase|Not otherwise described|3|||
125178794|NCT04995029|450274796|FG000|Maintenance Phase|Pregnancy|0|||
125178795|NCT04995029|450274797|FG001|Maintenance Phase|Pregnancy|0|||
125178796|NCT04995029|450274798|FG002|Maintenance Phase|Pregnancy|2|||
125178797|NCT04995029|450274799|FG003|Maintenance Phase|Pregnancy|2|||
125178798|NCT03690388|450274802|FG000|Overall Study|Adverse Event|8|||
125178799|NCT03690388|450274803|FG001|Overall Study|Adverse Event|1|||
125178800|NCT03690388|450274802|FG000|Overall Study|Radiographic Progression|14|||
125178801|NCT03690388|450274803|FG001|Overall Study|Radiographic Progression|29|||
125178802|NCT03690388|450274802|FG000|Overall Study|Clinical deterioration|10|||
125178803|NCT03690388|450274803|FG001|Overall Study|Clinical deterioration|6|||
125178804|NCT03690388|450274802|FG000|Overall Study|Withdrawal by Subject|2|||
125178805|NCT03690388|450274803|FG001|Overall Study|Withdrawal by Subject|0|||
125178806|NCT03690388|450274802|FG000|Overall Study|Lack of Efficacy|1|||
125178807|NCT03690388|450274803|FG001|Overall Study|Lack of Efficacy|0|||
125178808|NCT03690388|450274802|FG000|Overall Study|Lost to Follow-up|1|||
125178809|NCT03690388|450274803|FG001|Overall Study|Lost to Follow-up|0|||
125178810|NCT04100018|450274805|FG000|Pre-Treatment Period|Not Reported|0|||
125178811|NCT04100018|450274806|FG001|Pre-Treatment Period|Not Reported|4|||
125178812|NCT04100018|450274805|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
125178813|NCT04100018|450274806|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
125178814|NCT04100018|450274805|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
125178815|NCT04100018|450274806|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
125178816|NCT04100018|450274805|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
125178817|NCT04100018|450274806|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
125178818|NCT04100018|450274805|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
125178819|NCT04100018|450274806|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
125178820|NCT04100018|450274805|FG000|Treatment Period|Ongoing Treatment|1|||
125178821|NCT04100018|450274806|FG001|Treatment Period|Ongoing Treatment|0|||
125178822|NCT04100018|450274805|FG000|Treatment Period|Other Reason|26|||
125178823|NCT04100018|450274806|FG001|Treatment Period|Other Reason|37|||
125178824|NCT04100018|450274805|FG000|Treatment Period|Completed treatment as per protocol|1|||
125178825|NCT04100018|450274806|FG001|Treatment Period|Completed treatment as per protocol|2|||
125178826|NCT04100018|450274805|FG000|Treatment Period|Maximum clinical benefit|3|||
125178827|NCT04100018|450274806|FG001|Treatment Period|Maximum clinical benefit|0|||
125178828|NCT04100018|450274805|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
125178829|NCT04100018|450274806|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
125178830|NCT04100018|450274805|FG000|Treatment Period|Study drug toxicity|67|||
125178831|NCT04100018|450274806|FG001|Treatment Period|Study drug toxicity|28|||
125178832|NCT04100018|450274805|FG000|Treatment Period|Disease Progression|284|||
125178833|NCT04100018|450274806|FG001|Treatment Period|Disease Progression|327|||
125178834|NCT04100018|450274805|FG000|Treatment Period|Administrative reasons by sponsor|16|||
125178835|NCT04100018|450274806|FG001|Treatment Period|Administrative reasons by sponsor|30|||
125178836|NCT04100018|450274805|FG000|Treatment Period|Poor/Non-Compliance|1|||
125178837|NCT04100018|450274806|FG001|Treatment Period|Poor/Non-Compliance|0|||
125178838|NCT04100018|450274805|FG000|Treatment Period|Lost to Follow-up|2|||
125178839|NCT04100018|450274806|FG001|Treatment Period|Lost to Follow-up|2|||
125178840|NCT04100018|450274805|FG000|Treatment Period|Death|16|||
125178841|NCT04100018|450274806|FG001|Treatment Period|Death|11|||
125178842|NCT04100018|450274805|FG000|Treatment Period|Participant withdrew consent|10|||
125178843|NCT04100018|450274806|FG001|Treatment Period|Participant withdrew consent|10|||
125178844|NCT04100018|450274805|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
125178845|NCT04100018|450274806|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
125178846|NCT04100018|450274805|FG000|Treatment Period|Adverse Event|14|||
125178847|NCT04100018|450274806|FG001|Treatment Period|Adverse Event|6|||
125178848|NCT04100018|450274805|FG000|Treatment Period|Lack of Efficacy|4|||
125235023|NCT03738696|450487745|FG000|Overall Study|Lost to Follow-up|8|||
125178849|NCT04100018|450274806|FG001|Treatment Period|Lack of Efficacy|2|||
125178850|NCT02653625|450274813|FG000|Overall Study|Adverse Event|1|||
125178851|NCT02653625|450274813|FG000|Overall Study|Non-compliance with Study Drug|1|||
125178852|NCT02653625|450274813|FG000|Overall Study|Protocol Violation|1|||
125235024|NCT03738696|450487746|FG001|Overall Study|Lost to Follow-up|14|||
125178853|NCT02653625|450274813|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
125235025|NCT02566005|450487747|FG000|Overall Study|vaginal bleeding|0|||
125235026|NCT02566005|450487748|FG001|Overall Study|vaginal bleeding|1|||
125235027|NCT02566005|450487747|FG000|Overall Study|received foley|8|||
125235028|NCT02566005|450487748|FG001|Overall Study|received foley|0|||
125235029|NCT02566005|450487747|FG000|Overall Study|did not receive foley|0|||
125235030|NCT02566005|450487748|FG001|Overall Study|did not receive foley|1|||
125235031|NCT02566005|450487747|FG000|Overall Study|labor after randomization|0|||
125235032|NCT02566005|450487748|FG001|Overall Study|labor after randomization|4|||
125235033|NCT03617588|450487749|FG000|Overall Study|Withdrawal by Subject|1|||
125235034|NCT03617588|450487750|FG001|Overall Study|Withdrawal by Subject|0|||
125235035|NCT01294514|450487751|FG000|Overall Study|Excluded due to Arrhythmia|1|||
125235036|NCT02690727|450487752|FG000|Overall Study|Adverse Event|2|||
125235037|NCT02690727|450487753|FG001|Overall Study|Adverse Event|2|||
125235038|NCT00141921|450487759|FG000|Overall Study|Remain on Study|28|||
125235039|NCT00141921|450487759|FG000|Overall Study|Withdrawal by Subject|42|||
125235040|NCT00141921|450487759|FG000|Overall Study|Lost to Follow-up|19|||
125235041|NCT00141921|450487759|FG000|Overall Study|Noncompliance|17|||
125235042|NCT00141921|450487759|FG000|Overall Study|Disease Progression|7|||
125235043|NCT00141921|450487759|FG000|Overall Study|Protocol Deviation|7|||
125235044|NCT00141921|450487759|FG000|Overall Study|Adverse Event|5|||
125235045|NCT00141921|450487759|FG000|Overall Study|Administrative Decision|2|||
125235046|NCT00141921|450487759|FG000|Overall Study|Pregnancy|4|||
125235047|NCT00141921|450487759|FG000|Overall Study|Ineligibility Determined|2|||
125235048|NCT00141921|450487759|FG000|Overall Study|Other|8|||
125235049|NCT02471339|450487760|FG000|Overall Study|Did not provide follow-up data|2|||
125235050|NCT02471339|450487761|FG001|Overall Study|Did not provide follow-up data|0|||
125235051|NCT00626639|450487763|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
125235052|NCT00626639|450487764|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
125235053|NCT01461551|450487765|FG000|Overall Study|Physician Decision|2|||
125235054|NCT01461551|450487766|FG001|Overall Study|Physician Decision|1|||
125235055|NCT01461551|450487767|FG002|Overall Study|Physician Decision|2|||
125235056|NCT01155141|450487768|FG000|Overall Study|Withdrawal by Subject|1|||
125235057|NCT01155141|450487768|FG000|Overall Study|Screen Failure|1|||
125235058|NCT00303186|450487769|FG000|Overall Study|Other|52|||
125235059|NCT03473197|450487770|FG000|Overall Study|Adverse Event|4|||
125235060|NCT03473197|450487770|FG000|Overall Study|Lost to Follow-up|1|||
125235061|NCT03473197|450487770|FG000|Overall Study|Withdrawal by Subject|5|||
125235062|NCT00785629|450487773|FG000|Overall Study|Adverse Event|2|||
125235063|NCT00785629|450487774|FG001|Overall Study|Adverse Event|1|||
125235064|NCT00785629|450487775|FG002|Overall Study|Adverse Event|1|||
125235065|NCT00785629|450487776|FG003|Overall Study|Adverse Event|5|||
125235066|NCT00785629|450487773|FG000|Overall Study|Protocol Violation|1|||
125235067|NCT00785629|450487774|FG001|Overall Study|Protocol Violation|2|||
125235068|NCT00785629|450487775|FG002|Overall Study|Protocol Violation|4|||
125235069|NCT00785629|450487776|FG003|Overall Study|Protocol Violation|5|||
125235070|NCT00785629|450487773|FG000|Overall Study|administrative decision|5|||
125235071|NCT00785629|450487774|FG001|Overall Study|administrative decision|1|||
125235072|NCT00785629|450487775|FG002|Overall Study|administrative decision|3|||
125235073|NCT00785629|450487776|FG003|Overall Study|administrative decision|4|||
125235074|NCT00785629|450487773|FG000|Overall Study|Withdrawal by Subject|0|||
125235075|NCT00785629|450487774|FG001|Overall Study|Withdrawal by Subject|1|||
125235076|NCT00785629|450487775|FG002|Overall Study|Withdrawal by Subject|2|||
125235077|NCT00785629|450487776|FG003|Overall Study|Withdrawal by Subject|2|||
125235078|NCT00851591|450487778|FG000|Overall Study|Withdrawal by Subject|2|||
125235079|NCT00851591|450487779|FG001|Overall Study|Withdrawal by Subject|0|||
125235080|NCT01933594|450487787|FG000|Overall Study|Lost to Follow-up|1|||
125235081|NCT01933594|450487788|FG001|Overall Study|Lost to Follow-up|0|||
125235082|NCT01933594|450487789|FG002|Overall Study|Lost to Follow-up|0|||
125235083|NCT01933594|450487790|FG003|Overall Study|Lost to Follow-up|0|||
125235084|NCT01933594|450487791|FG004|Overall Study|Lost to Follow-up|1|||
125235085|NCT01933594|450487792|FG005|Overall Study|Lost to Follow-up|0|||
125235086|NCT01933594|450487787|FG000|Overall Study|Ineligible for subsequent study step|0|||
125235087|NCT01933594|450487788|FG001|Overall Study|Ineligible for subsequent study step|0|||
125235088|NCT01933594|450487789|FG002|Overall Study|Ineligible for subsequent study step|0|||
125235089|NCT01933594|450487790|FG003|Overall Study|Ineligible for subsequent study step|0|||
125235090|NCT01933594|450487791|FG004|Overall Study|Ineligible for subsequent study step|1|||
125235091|NCT01933594|450487792|FG005|Overall Study|Ineligible for subsequent study step|0|||
125235092|NCT00315445|450487793|FG000|Overall Study|Adverse Event|7|||
125235093|NCT00315445|450487794|FG001|Overall Study|Adverse Event|12|||
125235094|NCT00315445|450487795|FG002|Overall Study|Adverse Event|15|||
125235095|NCT00315445|450487793|FG000|Overall Study|Lack of Efficacy|16|||
125235096|NCT00315445|450487794|FG001|Overall Study|Lack of Efficacy|1|||
125235097|NCT00315445|450487795|FG002|Overall Study|Lack of Efficacy|7|||
125235098|NCT00315445|450487793|FG000|Overall Study|Lost to Follow-up|1|||
125235099|NCT00315445|450487794|FG001|Overall Study|Lost to Follow-up|0|||
125235100|NCT00315445|450487795|FG002|Overall Study|Lost to Follow-up|1|||
125235101|NCT00315445|450487793|FG000|Overall Study|Protocol Violation|2|||
125178854|NCT02090725|450274814|FG000|Overall Study|Withdrawal by Subject|1|||
125178855|NCT02090725|450274814|FG000|Overall Study|participants moved from area|3|||
125178856|NCT01499095|450274815|FG000|Overall Study|Randomized But Not Treated|1|||
125178857|NCT01499095|450274816|FG001|Overall Study|Randomized But Not Treated|1|||
125178858|NCT01499095|450274815|FG000|Overall Study|Adverse Event|12|||
125178859|NCT01499095|450274816|FG001|Overall Study|Adverse Event|7|||
125178860|NCT01499095|450274815|FG000|Overall Study|Lack of Efficacy|2|||
125178861|NCT01499095|450274816|FG001|Overall Study|Lack of Efficacy|1|||
125178862|NCT01499095|450274815|FG000|Overall Study|Protocol Violation|6|||
125178863|NCT01499095|450274816|FG001|Overall Study|Protocol Violation|7|||
125178864|NCT01499095|450274815|FG000|Overall Study|Received Rescue Therapy|32|||
125178865|NCT01499095|450274816|FG001|Overall Study|Received Rescue Therapy|40|||
125178866|NCT01499095|450274815|FG000|Overall Study|Diverse Reasons|22|||
125178867|NCT01499095|450274816|FG001|Overall Study|Diverse Reasons|25|||
125178868|NCT01499095|450274815|FG000|Overall Study|Lost to Follow-up|6|||
125178869|NCT01499095|450274816|FG001|Overall Study|Lost to Follow-up|4|||
125178870|NCT01499095|450274815|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
125178871|NCT01499095|450274816|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
125178872|NCT01499095|450274815|FG000|Overall Study|Hypoglycemia|3|||
125178873|NCT01499095|450274816|FG001|Overall Study|Hypoglycemia|1|||
125178874|NCT01499095|450274815|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
125178875|NCT01499095|450274816|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
125178876|NCT01499095|450274815|FG000|Overall Study|Change in Injection Schedule|2|||
125178877|NCT01499095|450274816|FG001|Overall Study|Change in Injection Schedule|0|||
125178878|NCT01499095|450274815|FG000|Overall Study|Perceived Lack of Efficacy|1|||
125178879|NCT01499095|450274816|FG001|Overall Study|Perceived Lack of Efficacy|1|||
125178880|NCT04358081|450274818|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
125178881|NCT04358081|450274819|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
125178882|NCT04358081|450274820|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
125178883|NCT04358081|450274818|FG000|Treatment Phase of Study|Adverse Event|1|||
125178884|NCT04358081|450274819|FG001|Treatment Phase of Study|Adverse Event|0|||
125178885|NCT04358081|450274820|FG002|Treatment Phase of Study|Adverse Event|1|||
125178886|NCT04358081|450274818|FG000|Treatment Phase of Study|Physician Decision|2|||
125178887|NCT04358081|450274819|FG001|Treatment Phase of Study|Physician Decision|0|||
125178888|NCT04358081|450274820|FG002|Treatment Phase of Study|Physician Decision|1|||
125178889|NCT04358081|450274818|FG000|Treatment Phase of Study|Protocol Violation|1|||
125178890|NCT04358081|450274819|FG001|Treatment Phase of Study|Protocol Violation|0|||
125178891|NCT04358081|450274820|FG002|Treatment Phase of Study|Protocol Violation|0|||
125178892|NCT04358081|450274818|FG000|Study Completion Phase|Death|0|||
125178893|NCT04358081|450274819|FG001|Study Completion Phase|Death|0|||
125178894|NCT04358081|450274820|FG002|Study Completion Phase|Death|1|||
125178895|NCT04358081|450274818|FG000|Study Completion Phase|Lost to Follow-up|1|||
125178896|NCT04358081|450274819|FG001|Study Completion Phase|Lost to Follow-up|0|||
125178897|NCT04358081|450274820|FG002|Study Completion Phase|Lost to Follow-up|1|||
125178898|NCT01130532|450274823|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
125178899|NCT01130532|450274824|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
125178900|NCT01130532|450274825|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
125178901|NCT01130532|450274826|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
125178902|NCT01130532|450274823|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
125178903|NCT01130532|450274824|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
125178904|NCT01130532|450274825|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
125178905|NCT01130532|450274826|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
125178906|NCT01130532|450274823|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
125178907|NCT01130532|450274824|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
125178908|NCT01130532|450274825|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
125178909|NCT01130532|450274826|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
125178910|NCT01130532|450274823|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
125178911|NCT01130532|450274824|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
125178912|NCT01130532|450274825|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
125178913|NCT01130532|450274826|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
125178914|NCT01130532|450274823|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
125178915|NCT01130532|450274824|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
125178916|NCT01130532|450274825|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
125178917|NCT01130532|450274826|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
125178918|NCT01130532|450274823|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
125178919|NCT01130532|450274824|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
125178920|NCT01130532|450274825|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
125178921|NCT01130532|450274826|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
125178922|NCT01130532|450274823|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
125178923|NCT01130532|450274824|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
125178924|NCT01130532|450274825|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
125178925|NCT01130532|450274826|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
125178926|NCT01130532|450274823|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
125178927|NCT01130532|450274824|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
125178928|NCT01130532|450274825|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
125178929|NCT01130532|450274826|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
125178930|NCT01130532|450274823|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
125178931|NCT01130532|450274824|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
125178932|NCT01130532|450274825|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
125178933|NCT01130532|450274826|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
125178934|NCT01130532|450274823|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
125178935|NCT01130532|450274824|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
125178936|NCT01130532|450274825|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
125178937|NCT01130532|450274826|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
125178938|NCT01130532|450274823|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
125178939|NCT01130532|450274824|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
125178940|NCT01130532|450274825|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
125178941|NCT01130532|450274826|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
125178942|NCT02762929|450274827|FG000|Overall Study|Adverse Event|0|||
125178943|NCT02762929|450274828|FG001|Overall Study|Adverse Event|0|||
125178944|NCT02762929|450274829|FG002|Overall Study|Adverse Event|0|||
125178945|NCT02762929|450274830|FG003|Overall Study|Adverse Event|1|||
125178946|NCT02762929|450274831|FG004|Overall Study|Adverse Event|0|||
125178947|NCT02762929|450274832|FG005|Overall Study|Adverse Event|0|||
125178948|NCT02762929|450274827|FG000|Overall Study|Lost to Follow-up|1|||
125178949|NCT02762929|450274828|FG001|Overall Study|Lost to Follow-up|2|||
125178950|NCT02762929|450274829|FG002|Overall Study|Lost to Follow-up|0|||
125178951|NCT02762929|450274830|FG003|Overall Study|Lost to Follow-up|1|||
125178952|NCT02762929|450274831|FG004|Overall Study|Lost to Follow-up|0|||
125178953|NCT02762929|450274832|FG005|Overall Study|Lost to Follow-up|0|||
125178954|NCT02762929|450274827|FG000|Overall Study|Withdrawal by Subject|0|||
125178955|NCT02762929|450274828|FG001|Overall Study|Withdrawal by Subject|1|||
125178956|NCT02762929|450274829|FG002|Overall Study|Withdrawal by Subject|0|||
125178957|NCT02762929|450274830|FG003|Overall Study|Withdrawal by Subject|0|||
125178958|NCT02762929|450274831|FG004|Overall Study|Withdrawal by Subject|0|||
125178959|NCT02762929|450274832|FG005|Overall Study|Withdrawal by Subject|0|||
125178960|NCT02762929|450274827|FG000|Overall Study|exclusionary medication disclosed late|0|||
125178961|NCT02762929|450274828|FG001|Overall Study|exclusionary medication disclosed late|0|||
125178962|NCT02762929|450274829|FG002|Overall Study|exclusionary medication disclosed late|0|||
125178963|NCT02762929|450274830|FG003|Overall Study|exclusionary medication disclosed late|1|||
125178964|NCT02762929|450274831|FG004|Overall Study|exclusionary medication disclosed late|0|||
125178965|NCT02762929|450274832|FG005|Overall Study|exclusionary medication disclosed late|0|||
125178966|NCT02656303|450274833|FG000|Overall Study|Adverse Event|3|||
125178967|NCT02656303|450274834|FG001|Overall Study|Adverse Event|2|||
125178968|NCT02656303|450274835|FG002|Overall Study|Adverse Event|0|||
125178969|NCT02656303|450274833|FG000|Overall Study|Death|12|||
125178970|NCT02656303|450274834|FG001|Overall Study|Death|4|||
125178971|NCT02656303|450274835|FG002|Overall Study|Death|1|||
125178972|NCT02656303|450274833|FG000|Overall Study|Lack of Efficacy|1|||
125178973|NCT02656303|450274834|FG001|Overall Study|Lack of Efficacy|0|||
125178974|NCT02656303|450274835|FG002|Overall Study|Lack of Efficacy|0|||
125178975|NCT02656303|450274833|FG000|Overall Study|Non-Compliance with Study|1|||
125178976|NCT02656303|450274834|FG001|Overall Study|Non-Compliance with Study|1|||
125178977|NCT02656303|450274835|FG002|Overall Study|Non-Compliance with Study|0|||
125178978|NCT02656303|450274833|FG000|Overall Study|Investigator Decision|2|||
125178979|NCT02656303|450274834|FG001|Overall Study|Investigator Decision|1|||
125178980|NCT02656303|450274835|FG002|Overall Study|Investigator Decision|0|||
125178981|NCT02656303|450274833|FG000|Overall Study|Progressive Disease|25|||
125178982|NCT02656303|450274834|FG001|Overall Study|Progressive Disease|14|||
125178983|NCT02656303|450274835|FG002|Overall Study|Progressive Disease|10|||
125178984|NCT02656303|450274833|FG000|Overall Study|Study Terminated by Sponsor|20|||
125178985|NCT02656303|450274834|FG001|Overall Study|Study Terminated by Sponsor|7|||
125178986|NCT02656303|450274835|FG002|Overall Study|Study Terminated by Sponsor|5|||
125178987|NCT02656303|450274833|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
125178988|NCT02656303|450274834|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
125178989|NCT02656303|450274835|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
125178990|NCT02656303|450274833|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
125178991|NCT02656303|450274834|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
125178992|NCT02656303|450274835|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
125178993|NCT02656303|450274833|FG000|Overall Study|Reason not Specified|1|||
125178994|NCT02656303|450274834|FG001|Overall Study|Reason not Specified|1|||
125178995|NCT02656303|450274835|FG002|Overall Study|Reason not Specified|2|||
125178996|NCT01842438|450274838|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
125178997|NCT01842438|450274839|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
125178998|NCT01842438|450274838|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
125178999|NCT01842438|450274839|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
125179000|NCT01842438|450274838|FG000|T2: 6month Follow-up|Death|0|||
125179001|NCT01842438|450274839|FG001|T2: 6month Follow-up|Death|1|||
125235102|NCT00315445|450487794|FG001|Overall Study|Protocol Violation|0|||
125235103|NCT00315445|450487795|FG002|Overall Study|Protocol Violation|1|||
125235104|NCT00315445|450487793|FG000|Overall Study|Other|1|||
125235105|NCT00315445|450487794|FG001|Overall Study|Other|3|||
125235106|NCT00315445|450487795|FG002|Overall Study|Other|0|||
125235107|NCT01811238|450487796|FG000|Overall Study|Withdrawal by Subject|42|||
125235108|NCT01811238|450487796|FG000|Overall Study|Adverse Event|25|||
125235109|NCT01811238|450487796|FG000|Overall Study|Protocol Violation|4|||
125235110|NCT01811238|450487796|FG000|Overall Study|Lack of Efficacy|4|||
125235111|NCT01811238|450487796|FG000|Overall Study|subject refused study medication|6|||
125235112|NCT01035138|450487797|FG000|Overall Study|Adverse Event|4|||
125235113|NCT01035138|450487798|FG001|Overall Study|Adverse Event|0|||
125235114|NCT01035138|450487799|FG002|Overall Study|Adverse Event|2|||
125235115|NCT01035138|450487797|FG000|Overall Study|Caregiver Decision|2|||
125235116|NCT01035138|450487798|FG001|Overall Study|Caregiver Decision|0|||
125235117|NCT01035138|450487799|FG002|Overall Study|Caregiver Decision|1|||
125235118|NCT01035138|450487797|FG000|Overall Study|Withdrawal by Subject|1|||
125235119|NCT01035138|450487798|FG001|Overall Study|Withdrawal by Subject|0|||
125235120|NCT01035138|450487799|FG002|Overall Study|Withdrawal by Subject|0|||
125235121|NCT01035138|450487797|FG000|Overall Study|Physician Decision|0|||
125235122|NCT01035138|450487798|FG001|Overall Study|Physician Decision|0|||
125235123|NCT01035138|450487799|FG002|Overall Study|Physician Decision|1|||
125235124|NCT01035138|450487797|FG000|Overall Study|Sponsor Decision|66|||
125235125|NCT01035138|450487798|FG001|Overall Study|Sponsor Decision|60|||
125235126|NCT01035138|450487799|FG002|Overall Study|Sponsor Decision|42|||
125235127|NCT01035138|450487797|FG000|Overall Study|Lost to Follow-up|0|||
125235128|NCT01035138|450487798|FG001|Overall Study|Lost to Follow-up|0|||
125235129|NCT01035138|450487799|FG002|Overall Study|Lost to Follow-up|1|||
125235130|NCT02164916|450487802|FG000|Overall Study|Adverse Event|3|||
125235131|NCT02164916|450487803|FG001|Overall Study|Adverse Event|8|||
125235132|NCT02164916|450487802|FG000|Overall Study|Death|1|||
125235133|NCT02164916|450487803|FG001|Overall Study|Death|1|||
125235134|NCT02164916|450487802|FG000|Overall Study|Refusal unrelated to adverse event|3|||
125235135|NCT02164916|450487803|FG001|Overall Study|Refusal unrelated to adverse event|7|||
125235136|NCT02164916|450487802|FG000|Overall Study|Progression|37|||
125235137|NCT02164916|450487803|FG001|Overall Study|Progression|26|||
125235138|NCT02164916|450487802|FG000|Overall Study|Not protocol specified|5|||
125235139|NCT02164916|450487803|FG001|Overall Study|Not protocol specified|1|||
125235140|NCT02164916|450487802|FG000|Overall Study|Reason under review|1|||
125235141|NCT02164916|450487803|FG001|Overall Study|Reason under review|6|||
125235142|NCT02164916|450487802|FG000|Overall Study|Not eligible|2|||
125235143|NCT02164916|450487803|FG001|Overall Study|Not eligible|5|||
125235144|NCT02916927|450487806|FG000|Overall Study|Discharged prior to study drug receipt|0|||
125235145|NCT02916927|450487807|FG001|Overall Study|Discharged prior to study drug receipt|2|||
125235146|NCT02916927|450487806|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
125235147|NCT02916927|450487807|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
125235148|NCT02916927|450487806|FG000|Overall Study|Withdrawal before first time point|1|||
125235149|NCT02916927|450487807|FG001|Overall Study|Withdrawal before first time point|0|||
125235150|NCT00655889|450487812|FG000|Overall Study|Inadequate cell growth|1|||
125235151|NCT00655889|450487812|FG000|Overall Study|Protocol Violation|1|||
125235152|NCT02318940|450487813|FG000|Overall Study|lost the record|1|||
125235153|NCT02318940|450487814|FG001|Overall Study|lost the record|0|||
125235154|NCT03454555|450489792|FG000|Overall Study|Death|6|||
125235155|NCT03454555|450489793|FG001|Overall Study|Death|6|||
125235156|NCT03454555|450489792|FG000|Overall Study|Lost to Follow-up|31|||
125235157|NCT03454555|450489793|FG001|Overall Study|Lost to Follow-up|12|||
125235158|NCT03454555|450489792|FG000|Overall Study|Physician Decision|2|||
125235159|NCT03454555|450489793|FG001|Overall Study|Physician Decision|6|||
125235160|NCT03454555|450489792|FG000|Overall Study|Withdrawal by Subject|34|||
125235161|NCT03454555|450489793|FG001|Overall Study|Withdrawal by Subject|5|||
125235162|NCT03454555|450489792|FG000|Overall Study|Ineligible|1|||
125235163|NCT03454555|450489793|FG001|Overall Study|Ineligible|5|||
125235164|NCT05399680|450489794|FG000|Overall Study|Lost to Follow-up|1|||
125235165|NCT05399680|450489795|FG001|Overall Study|Lost to Follow-up|0|||
125235166|NCT05399680|450489794|FG000|Overall Study|Death|0|||
125235167|NCT05399680|450489795|FG001|Overall Study|Death|1|||
125235168|NCT04530630|450489796|FG000|Overall Study|Physician Decision|1|||
125235169|NCT03675308|450489799|FG000|Overall Study|Adverse Event|3|||
125235170|NCT03675308|450489800|FG001|Overall Study|Adverse Event|2|||
125235171|NCT03675308|450489799|FG000|Overall Study|Withdrawal by Subject|6|||
125235172|NCT03675308|450489800|FG001|Overall Study|Withdrawal by Subject|4|||
125235173|NCT03675308|450489799|FG000|Overall Study|Lost to Follow-up|3|||
125235174|NCT03675308|450489800|FG001|Overall Study|Lost to Follow-up|0|||
125235175|NCT03675308|450489799|FG000|Overall Study|Lack of Efficacy|1|||
125235176|NCT03675308|450489800|FG001|Overall Study|Lack of Efficacy|1|||
125235177|NCT03675308|450489799|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
125235178|NCT03675308|450489800|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
125235179|NCT03675308|450489799|FG000|Overall Study|Other|0|||
125235180|NCT03675308|450489800|FG001|Overall Study|Other|1|||
125179002|NCT00782626|450274843|FG000|Overall Study|Adverse Event|1|||
125179003|NCT00782626|450274843|FG000|Overall Study|Progressive Disease|5|||
125179004|NCT00782626|450274843|FG000|Overall Study|Other Complicating Disease|1|||
125179005|NCT04909853|450274844|FG000|Part 1|Assigned but not treated|0|||
125179006|NCT04909853|450274845|FG001|Part 1|Assigned but not treated|0|||
125179007|NCT04909853|450274846|FG002|Part 1|Assigned but not treated|1|||
125179008|NCT04909853|450274847|FG003|Part 1|Assigned but not treated|0|||
125179009|NCT04909853|450274844|FG000|Part 2|Adverse Event|0|||
125179010|NCT04909853|450274845|FG001|Part 2|Adverse Event|0|||
125179011|NCT04909853|450274846|FG002|Part 2|Adverse Event|0|||
125179012|NCT04909853|450274847|FG003|Part 2|Adverse Event|1|||
125179013|NCT04054765|450274848|FG000|Baseline|Withdrawal by Subject|5|||
125179014|NCT04054765|450274849|FG001|Baseline|Withdrawal by Subject|3|||
125179015|NCT04054765|450274848|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
125179016|NCT04054765|450274849|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
125179017|NCT04054765|450274848|FG000|3-month Follow up|Withdrawal by Subject|0|||
125179018|NCT04054765|450274849|FG001|3-month Follow up|Withdrawal by Subject|3|||
125179019|NCT04054765|450274848|FG000|6-month Follow up|Lost to Follow-up|32|||
125179020|NCT04054765|450274849|FG001|6-month Follow up|Lost to Follow-up|32|||
125179021|NCT00077207|450274851|FG000|Overall Study|Adverse Event|5|||
125179022|NCT00077207|450274851|FG000|Overall Study|Lack of Efficacy|12|||
125179023|NCT00077207|450274851|FG000|Overall Study|Physician Decision|6|||
125179024|NCT00077207|450274851|FG000|Overall Study|Withdrawal by Subject|6|||
125179025|NCT00077207|450274851|FG000|Overall Study|Ineligible|1|||
125179026|NCT04182490|450274854|FG000|Overall Study|Withdrawal by Subject|3|||
125179027|NCT04182490|450274855|FG001|Overall Study|Withdrawal by Subject|3|||
125179028|NCT04182490|450274854|FG000|Overall Study|Lost to Follow-up|0|||
125179029|NCT04182490|450274855|FG001|Overall Study|Lost to Follow-up|1|||
125179030|NCT04182490|450274854|FG000|Overall Study|Physician Decision|0|||
125179031|NCT04182490|450274855|FG001|Overall Study|Physician Decision|1|||
125179032|NCT00853099|450274856|FG000|Double-blind Period|Adverse Event|7|||
125179033|NCT00853099|450274857|FG001|Double-blind Period|Adverse Event|9|||
125179034|NCT00853099|450274858|FG002|Double-blind Period|Adverse Event|13|||
125179035|NCT00853099|450274859|FG003|Double-blind Period|Adverse Event|0|||
125179036|NCT00853099|450274856|FG000|Double-blind Period|Withdrawal by Subject|2|||
125179037|NCT00853099|450274857|FG001|Double-blind Period|Withdrawal by Subject|3|||
125179038|NCT00853099|450274858|FG002|Double-blind Period|Withdrawal by Subject|0|||
125179039|NCT00853099|450274859|FG003|Double-blind Period|Withdrawal by Subject|0|||
125179040|NCT00853099|450274856|FG000|Double-blind Period|Lack of Efficacy|14|||
125179041|NCT00853099|450274857|FG001|Double-blind Period|Lack of Efficacy|17|||
125179042|NCT00853099|450274858|FG002|Double-blind Period|Lack of Efficacy|16|||
125179043|NCT00853099|450274859|FG003|Double-blind Period|Lack of Efficacy|0|||
125179044|NCT00853099|450274856|FG000|Double-blind Period|Other|0|||
125179045|NCT00853099|450274857|FG001|Double-blind Period|Other|0|||
125179046|NCT00853099|450274858|FG002|Double-blind Period|Other|1|||
125179047|NCT00853099|450274859|FG003|Double-blind Period|Other|0|||
125179048|NCT00853099|450274856|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
125179049|NCT00853099|450274857|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
125179050|NCT00853099|450274858|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
125179051|NCT00853099|450274859|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
125179052|NCT00853099|450274856|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
125179053|NCT00853099|450274857|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
125179054|NCT00853099|450274858|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
125179055|NCT00853099|450274859|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
125179056|NCT00853099|450274856|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
125179057|NCT00853099|450274857|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
125179058|NCT00853099|450274858|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
125179059|NCT00853099|450274859|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
125179060|NCT00853099|450274856|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
125235181|NCT01288430|450489803|FG000|Part 1|Progressive disease|2|||
125235182|NCT01288430|450489804|FG001|Part 1|Progressive disease|1|||
125179061|NCT00853099|450274857|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
125235183|NCT01288430|450489805|FG002|Part 1|Progressive disease|1|||
125179062|NCT00853099|450274858|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
125179063|NCT00853099|450274859|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
125179064|NCT00853099|450274856|FG000|Double-blind + Open-label Periods|Other|0|||
125179065|NCT00853099|450274857|FG001|Double-blind + Open-label Periods|Other|0|||
125179066|NCT00853099|450274858|FG002|Double-blind + Open-label Periods|Other|0|||
125179067|NCT00853099|450274859|FG003|Double-blind + Open-label Periods|Other|6|||
125179068|NCT01811472|450274860|FG000|Overall Study|Adverse Event|1|||
125179069|NCT01811472|450274861|FG001|Overall Study|Adverse Event|0|||
125179070|NCT01811472|450274862|FG002|Overall Study|Adverse Event|4|||
125179071|NCT01811472|450274860|FG000|Overall Study|Lost to Follow-up|0|||
125179072|NCT01811472|450274861|FG001|Overall Study|Lost to Follow-up|0|||
125235184|NCT01288430|450489806|FG003|Part 1|Progressive disease|6|||
125179073|NCT01811472|450274862|FG002|Overall Study|Lost to Follow-up|1|||
125179074|NCT01811472|450274860|FG000|Overall Study|Subject/guardian decision|1|||
125179075|NCT01811472|450274861|FG001|Overall Study|Subject/guardian decision|0|||
125179076|NCT01811472|450274862|FG002|Overall Study|Subject/guardian decision|0|||
125179077|NCT03280264|450274863|FG000|Overall Study|Adverse Event|1|||
125179078|NCT03280264|450274863|FG000|Overall Study|Physician Decision|1|||
125179079|NCT03280264|450274863|FG000|Overall Study|Withdrawal by Subject|1|||
125179080|NCT02738138|450274865|FG000|Overall Study|Adverse Event|0|||
125179081|NCT02738138|450274866|FG001|Overall Study|Adverse Event|1|||
125179082|NCT02738138|450274865|FG000|Overall Study|Lost to Follow-up|2|||
125179083|NCT02738138|450274866|FG001|Overall Study|Lost to Follow-up|0|||
125179084|NCT02738138|450274865|FG000|Overall Study|Other - not further specified|1|||
125179085|NCT02738138|450274866|FG001|Overall Study|Other - not further specified|0|||
125179086|NCT01995513|450274869|FG000|Period 1: First Open Label Treatment|Other|34|||
125179087|NCT01995513|450274870|FG001|Period 1: First Open Label Treatment|Other|0|||
125179088|NCT01995513|450274871|FG002|Period 1: First Open Label Treatment|Other|0|||
125179089|NCT01995513|450274872|FG003|Period 1: First Open Label Treatment|Other|0|||
125179090|NCT01995513|450274869|FG000|Period 1: First Open Label Treatment|Death|14|||
125179091|NCT01995513|450274870|FG001|Period 1: First Open Label Treatment|Death|0|||
125179092|NCT01995513|450274871|FG002|Period 1: First Open Label Treatment|Death|0|||
125179093|NCT01995513|450274872|FG003|Period 1: First Open Label Treatment|Death|0|||
125179094|NCT01995513|450274869|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
125179095|NCT01995513|450274870|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
125179096|NCT01995513|450274871|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
125179097|NCT01995513|450274872|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
125179098|NCT01995513|450274869|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
125179099|NCT01995513|450274870|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
125179100|NCT01995513|450274871|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
125179101|NCT01995513|450274872|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
125179102|NCT01995513|450274869|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
125179103|NCT01995513|450274870|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
125179104|NCT01995513|450274871|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
125179105|NCT01995513|450274872|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
125179106|NCT01995513|450274869|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
125179107|NCT01995513|450274870|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
125179108|NCT01995513|450274871|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
125179109|NCT01995513|450274872|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
125179110|NCT01995513|450274869|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
125179111|NCT01995513|450274870|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
125179112|NCT01995513|450274871|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
125179113|NCT01995513|450274872|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
125179114|NCT01995513|450274869|FG000|Period 1: Second Open Label Treatment|Other|0|||
125179115|NCT01995513|450274870|FG001|Period 1: Second Open Label Treatment|Other|2|||
125179116|NCT01995513|450274871|FG002|Period 1: Second Open Label Treatment|Other|0|||
125179117|NCT01995513|450274872|FG003|Period 1: Second Open Label Treatment|Other|0|||
125179118|NCT01995513|450274869|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
125179119|NCT01995513|450274870|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
125235185|NCT01288430|450489807|FG004|Part 1|Progressive disease|2|||
125235186|NCT01288430|450489808|FG005|Part 1|Progressive disease|4|||
125235187|NCT01288430|450489809|FG006|Part 1|Progressive disease|2|||
125235188|NCT01288430|450489810|FG007|Part 1|Progressive disease|0|||
125235189|NCT01288430|450489811|FG008|Part 1|Progressive disease|0|||
125235190|NCT01288430|450489812|FG009|Part 1|Progressive disease|0|||
125235191|NCT01288430|450489803|FG000|Part 1|Clinical disease progression|0|||
125235192|NCT01288430|450489804|FG001|Part 1|Clinical disease progression|0|||
125235193|NCT01288430|450489805|FG002|Part 1|Clinical disease progression|1|||
125235194|NCT01288430|450489806|FG003|Part 1|Clinical disease progression|0|||
125235195|NCT01288430|450489807|FG004|Part 1|Clinical disease progression|0|||
125235196|NCT01288430|450489808|FG005|Part 1|Clinical disease progression|2|||
125235197|NCT01288430|450489809|FG006|Part 1|Clinical disease progression|2|||
125235198|NCT01288430|450489810|FG007|Part 1|Clinical disease progression|0|||
125235199|NCT01288430|450489811|FG008|Part 1|Clinical disease progression|0|||
125235200|NCT01288430|450489812|FG009|Part 1|Clinical disease progression|0|||
125235201|NCT01288430|450489803|FG000|Part 1|Death due to disease progression|0|||
125235202|NCT01288430|450489804|FG001|Part 1|Death due to disease progression|0|||
125235203|NCT01288430|450489805|FG002|Part 1|Death due to disease progression|0|||
125235204|NCT01288430|450489806|FG003|Part 1|Death due to disease progression|0|||
125235205|NCT01288430|450489807|FG004|Part 1|Death due to disease progression|1|||
125235206|NCT01288430|450489808|FG005|Part 1|Death due to disease progression|0|||
125235207|NCT01288430|450489809|FG006|Part 1|Death due to disease progression|0|||
125235208|NCT01288430|450489810|FG007|Part 1|Death due to disease progression|0|||
125235209|NCT01288430|450489811|FG008|Part 1|Death due to disease progression|0|||
125235210|NCT01288430|450489812|FG009|Part 1|Death due to disease progression|0|||
125235211|NCT01288430|450489803|FG000|Part 1|Adverse Event|0|||
125235212|NCT01288430|450489804|FG001|Part 1|Adverse Event|0|||
125235213|NCT01288430|450489805|FG002|Part 1|Adverse Event|3|||
125235214|NCT01288430|450489806|FG003|Part 1|Adverse Event|1|||
125235215|NCT01288430|450489807|FG004|Part 1|Adverse Event|0|||
125235216|NCT01288430|450489808|FG005|Part 1|Adverse Event|0|||
125235217|NCT01288430|450489809|FG006|Part 1|Adverse Event|2|||
125235218|NCT01288430|450489810|FG007|Part 1|Adverse Event|0|||
125235219|NCT01288430|450489811|FG008|Part 1|Adverse Event|0|||
125235220|NCT01288430|450489812|FG009|Part 1|Adverse Event|0|||
125235221|NCT01288430|450489803|FG000|Part 1|Other|0|||
125235222|NCT01288430|450489804|FG001|Part 1|Other|2|||
125235223|NCT01288430|450489805|FG002|Part 1|Other|0|||
125235224|NCT01288430|450489806|FG003|Part 1|Other|0|||
125235225|NCT01288430|450489807|FG004|Part 1|Other|0|||
125235226|NCT01288430|450489808|FG005|Part 1|Other|0|||
125235227|NCT01288430|450489809|FG006|Part 1|Other|1|||
125235228|NCT01288430|450489810|FG007|Part 1|Other|0|||
125235229|NCT01288430|450489811|FG008|Part 1|Other|0|||
125235230|NCT01288430|450489812|FG009|Part 1|Other|0|||
125235231|NCT01288430|450489803|FG000|Part 2|Progressive disease|0|||
125235232|NCT01288430|450489804|FG001|Part 2|Progressive disease|0|||
125235233|NCT01288430|450489805|FG002|Part 2|Progressive disease|0|||
125235234|NCT01288430|450489806|FG003|Part 2|Progressive disease|0|||
125235235|NCT01288430|450489807|FG004|Part 2|Progressive disease|0|||
125235236|NCT01288430|450489808|FG005|Part 2|Progressive disease|0|||
125235237|NCT01288430|450489809|FG006|Part 2|Progressive disease|0|||
125235238|NCT01288430|450489810|FG007|Part 2|Progressive disease|8|||
125235239|NCT01288430|450489811|FG008|Part 2|Progressive disease|7|||
125235240|NCT01288430|450489812|FG009|Part 2|Progressive disease|2|||
125235241|NCT01288430|450489803|FG000|Part 2|Clinical disease progression|0|||
125235242|NCT01288430|450489804|FG001|Part 2|Clinical disease progression|0|||
125235243|NCT01288430|450489805|FG002|Part 2|Clinical disease progression|0|||
125235244|NCT01288430|450489806|FG003|Part 2|Clinical disease progression|0|||
125235245|NCT01288430|450489807|FG004|Part 2|Clinical disease progression|0|||
125235246|NCT01288430|450489808|FG005|Part 2|Clinical disease progression|0|||
125235247|NCT01288430|450489809|FG006|Part 2|Clinical disease progression|0|||
125235248|NCT01288430|450489810|FG007|Part 2|Clinical disease progression|2|||
125235249|NCT01288430|450489811|FG008|Part 2|Clinical disease progression|0|||
125235250|NCT01288430|450489812|FG009|Part 2|Clinical disease progression|0|||
125235251|NCT01288430|450489803|FG000|Part 2|Withdrawal by Subject|0|||
125235252|NCT01288430|450489804|FG001|Part 2|Withdrawal by Subject|0|||
125235253|NCT01288430|450489805|FG002|Part 2|Withdrawal by Subject|0|||
125235254|NCT01288430|450489806|FG003|Part 2|Withdrawal by Subject|0|||
125235255|NCT01288430|450489807|FG004|Part 2|Withdrawal by Subject|0|||
125235256|NCT01288430|450489808|FG005|Part 2|Withdrawal by Subject|0|||
125235257|NCT01288430|450489809|FG006|Part 2|Withdrawal by Subject|0|||
125235258|NCT01288430|450489810|FG007|Part 2|Withdrawal by Subject|1|||
125235259|NCT01288430|450489811|FG008|Part 2|Withdrawal by Subject|4|||
125235260|NCT01288430|450489812|FG009|Part 2|Withdrawal by Subject|0|||
125235261|NCT01288430|450489803|FG000|Part 2|Adverse Event|0|||
125235262|NCT01288430|450489804|FG001|Part 2|Adverse Event|0|||
125235263|NCT01288430|450489805|FG002|Part 2|Adverse Event|0|||
125235264|NCT01288430|450489806|FG003|Part 2|Adverse Event|0|||
125235265|NCT01288430|450489807|FG004|Part 2|Adverse Event|0|||
125235266|NCT01288430|450489808|FG005|Part 2|Adverse Event|0|||
125179120|NCT01995513|450274871|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
125179121|NCT01995513|450274872|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
125179122|NCT01995513|450274869|FG000|Period 2: Double Blind Treatment|Death|0|||
125179123|NCT01995513|450274870|FG001|Period 2: Double Blind Treatment|Death|0|||
125179124|NCT01995513|450274871|FG002|Period 2: Double Blind Treatment|Death|0|||
125179125|NCT01995513|450274872|FG003|Period 2: Double Blind Treatment|Death|1|||
125179126|NCT01995513|450274869|FG000|Period 2: Double Blind Treatment|Other|0|||
125179127|NCT01995513|450274870|FG001|Period 2: Double Blind Treatment|Other|0|||
125179128|NCT01995513|450274871|FG002|Period 2: Double Blind Treatment|Other|3|||
125179129|NCT01995513|450274872|FG003|Period 2: Double Blind Treatment|Other|3|||
125179130|NCT01995513|450274869|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
125179131|NCT01995513|450274870|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
125179132|NCT01995513|450274871|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
125179133|NCT01995513|450274872|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
125179134|NCT01995513|450274869|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
125179135|NCT01995513|450274870|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
125179136|NCT01995513|450274871|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
125179137|NCT01995513|450274872|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
125179138|NCT01995513|450274869|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
125179139|NCT01995513|450274870|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
125179140|NCT01995513|450274871|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
125179141|NCT01995513|450274872|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
125179142|NCT01995513|450274869|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
125179143|NCT01995513|450274870|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
125179144|NCT01995513|450274871|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
125179145|NCT01995513|450274872|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
125179146|NCT02071225|450274880|FG000|Overall Study|Withdrawal of Consent|2|||
125179147|NCT02071225|450274880|FG000|Overall Study|Protocol Deviation|1|||
125179148|NCT02071225|450274880|FG000|Overall Study|Lost to Follow-up|2|||
125179149|NCT02071225|450274880|FG000|Overall Study|Death|25|||
125179150|NCT00280735|450274885|FG000|Overall Study|Adverse Event|5|||
125179151|NCT00280735|450274885|FG000|Overall Study|Lack of Efficacy|3|||
125179152|NCT00280735|450274885|FG000|Overall Study|Withdrawal by Subject|8|||
125179153|NCT00280735|450274885|FG000|Overall Study|Intercurrent Illness|2|||
125179154|NCT01895777|450274886|FG000|Overall Study|Adverse Event|1|||
125179155|NCT01895777|450274887|FG001|Overall Study|Adverse Event|2|||
125179156|NCT01895777|450274886|FG000|Overall Study|Lost to Follow-up|2|||
125179157|NCT01895777|450274887|FG001|Overall Study|Lost to Follow-up|0|||
125179158|NCT01895777|450274886|FG000|Overall Study|Not treated|1|||
125179159|NCT01895777|450274887|FG001|Overall Study|Not treated|0|||
125179160|NCT01895777|450274886|FG000|Overall Study|Other reasons|3|||
125179161|NCT01895777|450274887|FG001|Overall Study|Other reasons|2|||
125179162|NCT01895777|450274886|FG000|Overall Study|Non-compliance with the CTP|2|||
125179163|NCT01895777|450274887|FG001|Overall Study|Non-compliance with the CTP|1|||
125179164|NCT02064296|450274888|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
125179165|NCT02064296|450274889|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
125179166|NCT02064296|450274890|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
125179167|NCT02064296|450274888|FG000|Intervention|Withdrawal by Subject|0|||
125179168|NCT02064296|450274889|FG001|Intervention|Withdrawal by Subject|1|||
125179169|NCT02064296|450274890|FG002|Intervention|Withdrawal by Subject|2|||
125179170|NCT03885661|450274902|FG000|Overall Study|Withdrawal by Subject|0|||
125179171|NCT03885661|450274903|FG001|Overall Study|Withdrawal by Subject|1|||
125179172|NCT03885661|450274902|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
125179173|NCT03885661|450274903|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
125179174|NCT02286843|450274908|FG000|Overall Study|Not Treated|4|||
125179175|NCT02286843|450274908|FG000|Overall Study|Protocol Violation|1|||
125179176|NCT02286843|450274908|FG000|Overall Study|Withdrawal by Subject|1|||
125179177|NCT03172494|450274909|FG000|Overall Study|Adverse Event|5|||
125179178|NCT03172494|450274910|FG001|Overall Study|Adverse Event|1|||
125179179|NCT03172494|450274911|FG002|Overall Study|Adverse Event|15|||
125179180|NCT03172494|450274909|FG000|Overall Study|Protocol Violation|3|||
125179181|NCT03172494|450274910|FG001|Overall Study|Protocol Violation|2|||
125179182|NCT03172494|450274911|FG002|Overall Study|Protocol Violation|1|||
125179183|NCT03172494|450274909|FG000|Overall Study|Lack of Efficacy|0|||
125179184|NCT03172494|450274910|FG001|Overall Study|Lack of Efficacy|0|||
125179185|NCT03172494|450274911|FG002|Overall Study|Lack of Efficacy|4|||
125179186|NCT03172494|450274909|FG000|Overall Study|Pregnancy|0|||
125179187|NCT03172494|450274910|FG001|Overall Study|Pregnancy|1|||
125179188|NCT03172494|450274911|FG002|Overall Study|Pregnancy|0|||
125235267|NCT01288430|450489809|FG006|Part 2|Adverse Event|0|||
125235268|NCT01288430|450489810|FG007|Part 2|Adverse Event|1|||
125235269|NCT01288430|450489811|FG008|Part 2|Adverse Event|1|||
125235270|NCT01288430|450489812|FG009|Part 2|Adverse Event|0|||
125235271|NCT01288430|450489803|FG000|Part 2|Other|0|||
125235272|NCT01288430|450489804|FG001|Part 2|Other|0|||
125235273|NCT01288430|450489805|FG002|Part 2|Other|0|||
125235274|NCT01288430|450489806|FG003|Part 2|Other|0|||
125235275|NCT01288430|450489807|FG004|Part 2|Other|0|||
125235276|NCT01288430|450489808|FG005|Part 2|Other|0|||
125235277|NCT01288430|450489809|FG006|Part 2|Other|0|||
125235278|NCT01288430|450489810|FG007|Part 2|Other|0|||
125235279|NCT01288430|450489811|FG008|Part 2|Other|0|||
125235280|NCT01288430|450489812|FG009|Part 2|Other|1|||
125235281|NCT01386385|450489813|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
125235282|NCT01386385|450489814|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
125235283|NCT01386385|450489815|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
125235284|NCT01386385|450489816|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
125235285|NCT01386385|450489817|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
125235286|NCT01386385|450489818|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
125235287|NCT01386385|450489819|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
125235288|NCT01386385|450489820|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
125235289|NCT01386385|450489813|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
125235290|NCT01386385|450489814|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
125235291|NCT01386385|450489815|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
125235292|NCT01386385|450489816|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
125235293|NCT01386385|450489817|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
125235294|NCT01386385|450489818|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
125235295|NCT01386385|450489819|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
125235296|NCT01386385|450489820|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
125235297|NCT01386385|450489813|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
125235298|NCT01386385|450489814|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
125235299|NCT01386385|450489815|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
125235300|NCT01386385|450489816|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
125235301|NCT01386385|450489817|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
125235302|NCT01386385|450489818|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
125235303|NCT01386385|450489819|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
125235304|NCT01386385|450489820|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
125235305|NCT01386385|450489813|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
125235306|NCT01386385|450489814|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
125235307|NCT01386385|450489815|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
125235308|NCT01386385|450489816|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
125235309|NCT01386385|450489817|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
125235310|NCT01386385|450489818|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
125235311|NCT01386385|450489819|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
125235312|NCT01386385|450489820|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
125235313|NCT01386385|450489813|FG000|Phase II Concurrent CRT|Adverse Event|0|||
125235314|NCT01386385|450489814|FG001|Phase II Concurrent CRT|Adverse Event|0|||
125235315|NCT01386385|450489815|FG002|Phase II Concurrent CRT|Adverse Event|0|||
125235316|NCT01386385|450489816|FG003|Phase II Concurrent CRT|Adverse Event|0|||
125235317|NCT01386385|450489817|FG004|Phase II Concurrent CRT|Adverse Event|0|||
125235318|NCT01386385|450489818|FG005|Phase II Concurrent CRT|Adverse Event|0|||
125235319|NCT01386385|450489819|FG006|Phase II Concurrent CRT|Adverse Event|3|||
125235320|NCT01386385|450489820|FG007|Phase II Concurrent CRT|Adverse Event|3|||
125235321|NCT01386385|450489813|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
125235322|NCT01386385|450489814|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
125235323|NCT01386385|450489815|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
125235324|NCT01386385|450489816|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
125235325|NCT01386385|450489817|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
125235326|NCT01386385|450489818|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
125235327|NCT01386385|450489819|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
125235328|NCT01386385|450489820|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
125235329|NCT01386385|450489813|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
125235330|NCT01386385|450489814|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
125235331|NCT01386385|450489815|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
125235332|NCT01386385|450489816|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
125235333|NCT01386385|450489817|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
125235334|NCT01386385|450489818|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
125235335|NCT01386385|450489819|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
125235336|NCT01386385|450489820|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
125235337|NCT01386385|450489813|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
125235338|NCT01386385|450489814|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
125179189|NCT03172494|450274909|FG000|Overall Study|Withdrawal by Subject|10|||
125179190|NCT03172494|450274910|FG001|Overall Study|Withdrawal by Subject|8|||
125179191|NCT03172494|450274911|FG002|Overall Study|Withdrawal by Subject|8|||
125179192|NCT03172494|450274909|FG000|Overall Study|Severe hypoglycaemic episode|0|||
125179193|NCT03172494|450274910|FG001|Overall Study|Severe hypoglycaemic episode|0|||
125179194|NCT03172494|450274911|FG002|Overall Study|Severe hypoglycaemic episode|1|||
125179195|NCT03172494|450274909|FG000|Overall Study|Non-compliance towards treatment|2|||
125179196|NCT03172494|450274910|FG001|Overall Study|Non-compliance towards treatment|0|||
125179197|NCT03172494|450274911|FG002|Overall Study|Non-compliance towards treatment|0|||
125179198|NCT03086551|450274912|FG000|First Intervention|Failure to meet inclusion criterion|1|||
125179199|NCT03086551|450274913|FG001|First Intervention|Failure to meet inclusion criterion|0|||
125179200|NCT03086551|450274912|FG000|First Intervention|Lost to Follow-up|0|||
125179201|NCT03086551|450274913|FG001|First Intervention|Lost to Follow-up|1|||
125179202|NCT03086551|450274912|FG000|Washout|Lost to Follow-up|1|||
125179203|NCT03086551|450274913|FG001|Washout|Lost to Follow-up|2|||
125179204|NCT03086551|450274912|FG000|Washout|Withdrawal by Subject|2|||
125179205|NCT03086551|450274913|FG001|Washout|Withdrawal by Subject|1|||
125179206|NCT02764151|450274914|FG000|Overall Study|Subject refused further follow-up|0|||
125179207|NCT02764151|450274915|FG001|Overall Study|Subject refused further follow-up|0|||
125179208|NCT02764151|450274916|FG002|Overall Study|Subject refused further follow-up|0|||
125179209|NCT02764151|450274917|FG003|Overall Study|Subject refused further follow-up|1|||
125179210|NCT02764151|450274914|FG000|Overall Study|Other|0|||
125179211|NCT02764151|450274915|FG001|Overall Study|Other|0|||
125179212|NCT02764151|450274916|FG002|Overall Study|Other|0|||
125179213|NCT02764151|450274917|FG003|Overall Study|Other|2|||
125179214|NCT02201277|450274919|FG000|Overall Study|Death|3|||
125179215|NCT02201277|450274920|FG001|Overall Study|Death|4|||
125179216|NCT02201277|450274919|FG000|Overall Study|Lost to Follow-up|2|||
125179217|NCT02201277|450274920|FG001|Overall Study|Lost to Follow-up|1|||
125179218|NCT02201277|450274919|FG000|Overall Study|Failed retrieval|1|||
125179219|NCT02201277|450274920|FG001|Overall Study|Failed retrieval|0|||
125179220|NCT02201277|450274919|FG000|Overall Study|Physician Decision|1|||
125179221|NCT02201277|450274920|FG001|Overall Study|Physician Decision|0|||
125179222|NCT00489255|450274921|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
125179223|NCT00489255|450274922|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
125179224|NCT00489255|450274921|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
125179225|NCT00489255|450274922|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
125179226|NCT00489255|450274921|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
125179227|NCT00489255|450274922|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
125179228|NCT00489255|450274921|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
125179229|NCT00489255|450274922|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
125179230|NCT00489255|450274921|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
125179231|NCT00489255|450274922|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
125179232|NCT00489255|450274921|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
125179233|NCT00489255|450274922|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
125179234|NCT00489255|450274921|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
125179235|NCT00489255|450274922|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
125179236|NCT00489255|450274921|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
125179237|NCT00489255|450274922|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
125179238|NCT00489255|450274921|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
125179239|NCT00489255|450274922|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
125179240|NCT00489255|450274921|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
125179241|NCT00489255|450274922|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
125179242|NCT03485352|450274923|FG000|Overall Study|Lost to Follow-up|9|||
125179243|NCT01512160|450274924|FG000|Overall Study|Lost to Follow-up|1|||
125179244|NCT01512160|450274925|FG001|Overall Study|Lost to Follow-up|0|||
125179245|NCT01512160|450274926|FG002|Overall Study|Lost to Follow-up|0|||
125179246|NCT01512160|450274927|FG003|Overall Study|Lost to Follow-up|0|||
125179247|NCT01512160|450274924|FG000|Overall Study|Withdrawal by Subject|1|||
125179248|NCT01512160|450274925|FG001|Overall Study|Withdrawal by Subject|0|||
125179249|NCT01512160|450274926|FG002|Overall Study|Withdrawal by Subject|0|||
125179250|NCT01512160|450274927|FG003|Overall Study|Withdrawal by Subject|1|||
125179251|NCT01260701|450274929|FG000|Overall Study|Adverse Event|9|||
125179252|NCT01260701|450274929|FG000|Overall Study|Withdrawal by Subject|2|||
125179253|NCT01260701|450274929|FG000|Overall Study|Progression|53|||
125179254|NCT01260701|450274929|FG000|Overall Study|Death|2|||
125179255|NCT01260701|450274929|FG000|Overall Study|Not protocol specified|3|||
125179256|NCT01260701|450274929|FG000|Overall Study|Under review|1|||
125179257|NCT01260701|450274929|FG000|Overall Study|Ineligible|4|||
125179258|NCT01260701|450274929|FG000|Overall Study|Did not begin protocol therapy|1|||
125179259|NCT04205812|450276030|FG000|Randomized Treatment Period|Ongoing|28|||
125179260|NCT04205812|450276031|FG001|Randomized Treatment Period|Ongoing|138|||
125179261|NCT04205812|450276030|FG000|Randomized Treatment Period|Death|94|||
125179262|NCT04205812|450276031|FG001|Randomized Treatment Period|Death|226|||
125179263|NCT04205812|450276030|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
125179264|NCT04205812|450276031|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
125179265|NCT04205812|450276030|FG000|Randomized Treatment Period|Physician Decision|1|||
125179266|NCT04205812|450276031|FG001|Randomized Treatment Period|Physician Decision|4|||
125179267|NCT04205812|450276030|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
125179268|NCT04205812|450276031|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
125179269|NCT04205812|450276030|FG000|Randomized Treatment Period|Progressive Disease|0|||
125179270|NCT04205812|450276031|FG001|Randomized Treatment Period|Progressive Disease|1|||
125179271|NCT04205812|450276030|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
125179272|NCT04205812|450276031|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
125179273|NCT04205812|450276030|FG000|Monotherapy Treatment Period|Ongoing|17|||
125179274|NCT04205812|450276031|FG001|Monotherapy Treatment Period|Ongoing|0|||
125179275|NCT04205812|450276030|FG000|Monotherapy Treatment Period|Death|39|||
125179276|NCT04205812|450276031|FG001|Monotherapy Treatment Period|Death|0|||
125179277|NCT04205812|450276030|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
125179278|NCT04205812|450276031|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
125179279|NCT04205812|450276030|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
125179280|NCT04205812|450276031|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
125179281|NCT05221320|450276032|FG000|Overall Study|Lack of Efficacy|3|||
125179282|NCT05221320|450276033|FG001|Overall Study|Lack of Efficacy|7|||
125179283|NCT05221320|450276034|FG002|Overall Study|Lack of Efficacy|10|||
125179284|NCT05221320|450276035|FG003|Overall Study|Lack of Efficacy|1|||
125179285|NCT05221320|450276036|FG004|Overall Study|Lack of Efficacy|0|||
125179286|NCT05221320|450276037|FG005|Overall Study|Lack of Efficacy|0|||
125179287|NCT05221320|450276032|FG000|Overall Study|Physician Decision|1|||
125179288|NCT05221320|450276033|FG001|Overall Study|Physician Decision|0|||
125179289|NCT05221320|450276034|FG002|Overall Study|Physician Decision|3|||
125179290|NCT05221320|450276035|FG003|Overall Study|Physician Decision|1|||
125179291|NCT05221320|450276036|FG004|Overall Study|Physician Decision|0|||
125179292|NCT05221320|450276037|FG005|Overall Study|Physician Decision|0|||
125179293|NCT05221320|450276032|FG000|Overall Study|Withdrawal by Subject|0|||
125179294|NCT05221320|450276033|FG001|Overall Study|Withdrawal by Subject|3|||
125179295|NCT05221320|450276034|FG002|Overall Study|Withdrawal by Subject|1|||
125179296|NCT05221320|450276035|FG003|Overall Study|Withdrawal by Subject|0|||
125179297|NCT05221320|450276036|FG004|Overall Study|Withdrawal by Subject|0|||
125179298|NCT05221320|450276037|FG005|Overall Study|Withdrawal by Subject|0|||
125179299|NCT05221320|450276032|FG000|Overall Study|Death|0|||
125179300|NCT05221320|450276033|FG001|Overall Study|Death|5|||
125179301|NCT05221320|450276034|FG002|Overall Study|Death|6|||
125179302|NCT05221320|450276035|FG003|Overall Study|Death|0|||
125179303|NCT05221320|450276036|FG004|Overall Study|Death|1|||
125179304|NCT05221320|450276037|FG005|Overall Study|Death|0|||
125179305|NCT06473519|450276038|FG000|Overall Study|Lost to Follow-up|2|||
125179306|NCT06473519|450276039|FG001|Overall Study|Lost to Follow-up|5|||
125179307|NCT06473519|450276038|FG000|Overall Study|Withdrawal by Subject|1|||
125179308|NCT06473519|450276039|FG001|Overall Study|Withdrawal by Subject|4|||
125179309|NCT06473519|450276038|FG000|Overall Study|Randomized but not vaccinated|1|||
125179310|NCT06473519|450276039|FG001|Overall Study|Randomized but not vaccinated|2|||
125179311|NCT04903288|450276044|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
125179312|NCT04903288|450276044|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
125179313|NCT04903288|450276044|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
125179314|NCT04903288|450276044|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
125179315|NCT03713593|450276045|FG000|Overall Study|Sponsor Decision|73|||
125179316|NCT03713593|450276046|FG001|Overall Study|Sponsor Decision|41|||
125179317|NCT03713593|450276045|FG000|Overall Study|Lost to Follow-up|2|||
125179318|NCT03713593|450276046|FG001|Overall Study|Lost to Follow-up|1|||
125179319|NCT03713593|450276045|FG000|Overall Study|Death|314|||
125179320|NCT03713593|450276046|FG001|Overall Study|Death|349|||
125179321|NCT03713593|450276045|FG000|Overall Study|Withdrawal by Subject|6|||
125179322|NCT03713593|450276046|FG001|Overall Study|Withdrawal by Subject|8|||
125179323|NCT04776148|450276047|FG000|Overall Study|Death|249|||
125179324|NCT04776148|450276048|FG001|Overall Study|Death|260|||
125179325|NCT04776148|450276047|FG000|Overall Study|Lost to Follow-up|0|||
125179326|NCT04776148|450276048|FG001|Overall Study|Lost to Follow-up|1|||
125179327|NCT04776148|450276047|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125179328|NCT04776148|450276048|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
125179329|NCT04776148|450276047|FG000|Overall Study|Withdrawal by Subject|3|||
125179330|NCT04776148|450276048|FG001|Overall Study|Withdrawal by Subject|4|||
125179331|NCT04776148|450276047|FG000|Overall Study|Sponsor Decision|30|||
125179332|NCT04776148|450276048|FG001|Overall Study|Sponsor Decision|15|||
125179333|NCT03130777|450276049|FG000|Overall Study|Death|0|||
125179334|NCT03130777|450276050|FG001|Overall Study|Death|1|||
125179335|NCT03130777|450276049|FG000|Overall Study|Did not meet eligibility criteria|1|||
125179336|NCT03130777|450276050|FG001|Overall Study|Did not meet eligibility criteria|0|||
125179337|NCT02498613|450276051|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
125179338|NCT02498613|450276052|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
125179339|NCT02498613|450276053|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
125179340|NCT02498613|450276054|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
125179341|NCT02498613|450276051|FG000|Overall Study|Withdrawal by Subject|3|||
125179342|NCT02498613|450276052|FG001|Overall Study|Withdrawal by Subject|1|||
125179343|NCT02498613|450276053|FG002|Overall Study|Withdrawal by Subject|0|||
125179344|NCT02498613|450276054|FG003|Overall Study|Withdrawal by Subject|0|||
125179345|NCT05168202|450276055|FG000|Overall Study|Progressive Disease|4|||
125179346|NCT05168202|450276056|FG001|Overall Study|Progressive Disease|4|||
125179347|NCT05168202|450276057|FG002|Overall Study|Progressive Disease|2|||
125179348|NCT05168202|450276058|FG003|Overall Study|Progressive Disease|3|||
125179349|NCT05168202|450276059|FG004|Overall Study|Progressive Disease|2|||
125179350|NCT05168202|450276060|FG005|Overall Study|Progressive Disease|3|||
125179351|NCT05168202|450276061|FG006|Overall Study|Progressive Disease|2|||
125179352|NCT05168202|450276055|FG000|Overall Study|Adverse Event|2|||
125179353|NCT05168202|450276056|FG001|Overall Study|Adverse Event|1|||
125179354|NCT05168202|450276057|FG002|Overall Study|Adverse Event|4|||
125179355|NCT05168202|450276058|FG003|Overall Study|Adverse Event|4|||
125179356|NCT05168202|450276059|FG004|Overall Study|Adverse Event|3|||
125179357|NCT05168202|450276060|FG005|Overall Study|Adverse Event|2|||
125179358|NCT05168202|450276061|FG006|Overall Study|Adverse Event|0|||
125179359|NCT05168202|450276055|FG000|Overall Study|Lack of Efficacy|0|||
125179360|NCT05168202|450276056|FG001|Overall Study|Lack of Efficacy|1|||
125179361|NCT05168202|450276057|FG002|Overall Study|Lack of Efficacy|1|||
125179362|NCT05168202|450276058|FG003|Overall Study|Lack of Efficacy|0|||
125179363|NCT05168202|450276059|FG004|Overall Study|Lack of Efficacy|1|||
125179364|NCT05168202|450276060|FG005|Overall Study|Lack of Efficacy|2|||
125179365|NCT05168202|450276061|FG006|Overall Study|Lack of Efficacy|2|||
125179366|NCT05168202|450276055|FG000|Overall Study|Withdrawal by Subject|0|||
125179367|NCT05168202|450276056|FG001|Overall Study|Withdrawal by Subject|0|||
125179368|NCT05168202|450276057|FG002|Overall Study|Withdrawal by Subject|1|||
125179369|NCT05168202|450276058|FG003|Overall Study|Withdrawal by Subject|1|||
125179370|NCT05168202|450276059|FG004|Overall Study|Withdrawal by Subject|1|||
125179371|NCT05168202|450276060|FG005|Overall Study|Withdrawal by Subject|1|||
125179372|NCT05168202|450276061|FG006|Overall Study|Withdrawal by Subject|0|||
125179373|NCT05168202|450276055|FG000|Overall Study|Disease Relapse|0|||
125179374|NCT05168202|450276056|FG001|Overall Study|Disease Relapse|1|||
125179375|NCT05168202|450276057|FG002|Overall Study|Disease Relapse|0|||
125179376|NCT05168202|450276058|FG003|Overall Study|Disease Relapse|1|||
125179377|NCT05168202|450276059|FG004|Overall Study|Disease Relapse|1|||
125179378|NCT05168202|450276060|FG005|Overall Study|Disease Relapse|0|||
125179379|NCT05168202|450276061|FG006|Overall Study|Disease Relapse|0|||
125179380|NCT05168202|450276055|FG000|Overall Study|Other Reasons|0|||
125179381|NCT05168202|450276056|FG001|Overall Study|Other Reasons|0|||
125179382|NCT05168202|450276057|FG002|Overall Study|Other Reasons|0|||
125179383|NCT05168202|450276058|FG003|Overall Study|Other Reasons|0|||
125179384|NCT05168202|450276059|FG004|Overall Study|Other Reasons|0|||
125179385|NCT05168202|450276060|FG005|Overall Study|Other Reasons|2|||
125179386|NCT05168202|450276061|FG006|Overall Study|Other Reasons|1|||
125179387|NCT05168202|450276055|FG000|Overall Study|Physician Decision|0|||
125179388|NCT05168202|450276056|FG001|Overall Study|Physician Decision|1|||
125179389|NCT05168202|450276057|FG002|Overall Study|Physician Decision|1|||
125179390|NCT05168202|450276058|FG003|Overall Study|Physician Decision|0|||
125179391|NCT05168202|450276059|FG004|Overall Study|Physician Decision|0|||
125179392|NCT05168202|450276060|FG005|Overall Study|Physician Decision|0|||
125179393|NCT05168202|450276061|FG006|Overall Study|Physician Decision|0|||
125179394|NCT05168202|450276055|FG000|Overall Study|Study Terminated by Sponsor|0|||
125179395|NCT05168202|450276056|FG001|Overall Study|Study Terminated by Sponsor|0|||
125179396|NCT05168202|450276057|FG002|Overall Study|Study Terminated by Sponsor|0|||
125179397|NCT05168202|450276058|FG003|Overall Study|Study Terminated by Sponsor|1|||
125179398|NCT05168202|450276059|FG004|Overall Study|Study Terminated by Sponsor|0|||
125179399|NCT05168202|450276060|FG005|Overall Study|Study Terminated by Sponsor|0|||
125179400|NCT05168202|450276061|FG006|Overall Study|Study Terminated by Sponsor|0|||
125179401|NCT05109611|450276062|FG000|Overall Study|Adverse Event|13|||
125179402|NCT05109611|450276063|FG001|Overall Study|Adverse Event|10|||
125179403|NCT05109611|450276062|FG000|Overall Study|Withdrawal by Subject|1|||
125179404|NCT05109611|450276063|FG001|Overall Study|Withdrawal by Subject|0|||
125179405|NCT05109611|450276062|FG000|Overall Study|Lost to Follow-up|1|||
125179406|NCT05109611|450276063|FG001|Overall Study|Lost to Follow-up|2|||
125179407|NCT05109611|450276062|FG000|Overall Study|Protocol Violation|0|||
125179408|NCT05109611|450276063|FG001|Overall Study|Protocol Violation|4|||
125179409|NCT05109611|450276062|FG000|Overall Study|Information unavailable|1|||
125179410|NCT05109611|450276063|FG001|Overall Study|Information unavailable|1|||
125179411|NCT06195930|450276064|FG000|Overall Study|Adverse Event|4|||
125235339|NCT01386385|450489815|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
125235340|NCT01386385|450489816|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
125235341|NCT01386385|450489817|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
125235342|NCT01386385|450489818|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
125235343|NCT01386385|450489819|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
125235344|NCT01386385|450489820|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
125235345|NCT01386385|450489813|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
125235346|NCT01386385|450489814|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
125235347|NCT01386385|450489815|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
125235348|NCT01386385|450489816|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
125235349|NCT01386385|450489817|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
125235350|NCT01386385|450489818|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
125235351|NCT01386385|450489819|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
125235352|NCT01386385|450489820|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
125235353|NCT04486716|450489822|FG000|Core Phase|Subject decision|6|||
125235354|NCT04486716|450489822|FG000|Core Phase|Adverse Event|5|||
125235355|NCT04486716|450489822|FG000|Core Phase|Lost to Follow-up|1|||
125235356|NCT04486716|450489822|FG000|Core Phase|Physician Decision|1|||
125235357|NCT04486716|450489822|FG000|Core Phase|Enrolled subjects not treated|9|||
125235358|NCT03737994|450489823|FG000|Overall Study|Withdrawal by Subject|0|||
125235359|NCT03737994|450489824|FG001|Overall Study|Withdrawal by Subject|0|||
125235360|NCT03737994|450489825|FG002|Overall Study|Withdrawal by Subject|0|||
125235361|NCT03737994|450489826|FG003|Overall Study|Withdrawal by Subject|0|||
125235362|NCT03737994|450489827|FG004|Overall Study|Withdrawal by Subject|0|||
125235363|NCT03737994|450489828|FG005|Overall Study|Withdrawal by Subject|0|||
125235364|NCT03737994|450489829|FG006|Overall Study|Withdrawal by Subject|1|||
125235365|NCT02332707|450489830|FG000|Overall Study|Adverse Event|0|||
125235366|NCT02332707|450489831|FG001|Overall Study|Adverse Event|0|||
125235367|NCT02332707|450489832|FG002|Overall Study|Adverse Event|0|||
125235368|NCT02332707|450489833|FG003|Overall Study|Adverse Event|0|||
125235369|NCT02332707|450489834|FG004|Overall Study|Adverse Event|0|||
125235370|NCT02332707|450489835|FG005|Overall Study|Adverse Event|0|||
125235371|NCT02332707|450489836|FG006|Overall Study|Adverse Event|0|||
125235372|NCT02332707|450489837|FG007|Overall Study|Adverse Event|0|||
125235373|NCT02332707|450489838|FG008|Overall Study|Adverse Event|0|||
125235374|NCT02332707|450489839|FG009|Overall Study|Adverse Event|0|||
125235375|NCT02332707|450489840|FG010|Overall Study|Adverse Event|0|||
125235376|NCT02332707|450489841|FG011|Overall Study|Adverse Event|0|||
125235377|NCT02332707|450489842|FG012|Overall Study|Adverse Event|1|||
125235378|NCT02332707|450489843|FG013|Overall Study|Adverse Event|0|||
125235379|NCT02332707|450489844|FG014|Overall Study|Adverse Event|0|||
125235380|NCT02332707|450489845|FG015|Overall Study|Adverse Event|0|||
125235381|NCT02332707|450489846|FG016|Overall Study|Adverse Event|0|||
125235382|NCT02332707|450489847|FG017|Overall Study|Adverse Event|0|||
125235383|NCT02332707|450489830|FG000|Overall Study|Lost to Follow-up|0|||
125235384|NCT02332707|450489831|FG001|Overall Study|Lost to Follow-up|0|||
125235385|NCT02332707|450489832|FG002|Overall Study|Lost to Follow-up|0|||
125235386|NCT02332707|450489833|FG003|Overall Study|Lost to Follow-up|0|||
125235387|NCT02332707|450489834|FG004|Overall Study|Lost to Follow-up|0|||
125235388|NCT02332707|450489835|FG005|Overall Study|Lost to Follow-up|1|||
125235389|NCT02332707|450489836|FG006|Overall Study|Lost to Follow-up|0|||
125235390|NCT02332707|450489837|FG007|Overall Study|Lost to Follow-up|0|||
125235391|NCT02332707|450489838|FG008|Overall Study|Lost to Follow-up|0|||
125235392|NCT02332707|450489839|FG009|Overall Study|Lost to Follow-up|0|||
125235393|NCT02332707|450489840|FG010|Overall Study|Lost to Follow-up|2|||
125235394|NCT02332707|450489841|FG011|Overall Study|Lost to Follow-up|0|||
125235395|NCT02332707|450489842|FG012|Overall Study|Lost to Follow-up|3|||
125235396|NCT02332707|450489843|FG013|Overall Study|Lost to Follow-up|0|||
125235397|NCT02332707|450489844|FG014|Overall Study|Lost to Follow-up|0|||
125235398|NCT02332707|450489845|FG015|Overall Study|Lost to Follow-up|0|||
125235399|NCT02332707|450489846|FG016|Overall Study|Lost to Follow-up|0|||
125235400|NCT02332707|450489847|FG017|Overall Study|Lost to Follow-up|0|||
125235401|NCT02332707|450489830|FG000|Overall Study|Physician Decision|0|||
125235402|NCT02332707|450489831|FG001|Overall Study|Physician Decision|0|||
125235403|NCT02332707|450489832|FG002|Overall Study|Physician Decision|0|||
125179412|NCT03041311|450276071|FG000|Overall Study|Death|39|||
125179413|NCT03041311|450276072|FG001|Overall Study|Death|42|||
125179414|NCT03041311|450276071|FG000|Overall Study|Lost to Follow-up|0|||
125179415|NCT03041311|450276072|FG001|Overall Study|Lost to Follow-up|1|||
125179416|NCT03041311|450276071|FG000|Overall Study|Withdrawal by Subject|8|||
125179417|NCT03041311|450276072|FG001|Overall Study|Withdrawal by Subject|5|||
125179418|NCT03041311|450276071|FG000|Overall Study|Sponsor Terminated Study|2|||
125179419|NCT03041311|450276072|FG001|Overall Study|Sponsor Terminated Study|4|||
125179420|NCT03041311|450276071|FG000|Overall Study|Disease Progression|3|||
125179421|NCT03041311|450276072|FG001|Overall Study|Disease Progression|1|||
125179422|NCT03041311|450276071|FG000|Overall Study|Randomized in error, did not receive drug|2|||
125179423|NCT03041311|450276072|FG001|Overall Study|Randomized in error, did not receive drug|0|||
125179424|NCT03934541|450276078|FG000|Overall Study|Study Terminated by Sponsor|0|||
125179425|NCT03934541|450276079|FG001|Overall Study|Study Terminated by Sponsor|1|||
125179426|NCT03934541|450276080|FG002|Overall Study|Study Terminated by Sponsor|0|||
125179427|NCT03934541|450276081|FG003|Overall Study|Study Terminated by Sponsor|0|||
125179428|NCT02673775|450276082|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
125179429|NCT02673775|450276083|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
125179430|NCT02673775|450276082|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
125179431|NCT02673775|450276083|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
125179432|NCT02673775|450276082|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
125179433|NCT02673775|450276083|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
125179434|NCT02673775|450276082|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
125179435|NCT02673775|450276083|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
125179436|NCT02441686|450276084|FG000|Induction|Adverse Event|4|||
125179437|NCT02441686|450276084|FG000|Induction|Complicating disease|1|||
125179438|NCT02441686|450276084|FG000|Induction|Physician Decision|1|||
125179439|NCT02441686|450276084|FG000|Induction|Withdrawal by Subject|1|||
125179440|NCT02441686|450276084|FG000|Induction|Did not receive treatment|1|||
125179441|NCT02441686|450276084|FG000|Maintenance|Remaining on Treatment|23|||
125179442|NCT02441686|450276084|FG000|Maintenance|Physician Decision|1|||
125179443|NCT02441686|450276084|FG000|Maintenance|Adverse Event|3|||
125179444|NCT02441686|450276084|FG000|Maintenance|Progressive Disease|10|||
125179445|NCT02441686|450276084|FG000|Maintenance|Withdrawal by Subject|1|||
125179446|NCT03164616|450276085|FG000|Overall Study|Death|250|||
125179447|NCT03164616|450276086|FG001|Overall Study|Death|264|||
125179448|NCT03164616|450276087|FG002|Overall Study|Death|279|||
125179449|NCT03164616|450276085|FG000|Overall Study|Lost to Follow-up|2|||
125179450|NCT03164616|450276086|FG001|Overall Study|Lost to Follow-up|2|||
125179451|NCT03164616|450276087|FG002|Overall Study|Lost to Follow-up|2|||
125179452|NCT03164616|450276085|FG000|Overall Study|Withdrawal by Subject|6|||
125179453|NCT03164616|450276086|FG001|Overall Study|Withdrawal by Subject|7|||
125179454|NCT03164616|450276087|FG002|Overall Study|Withdrawal by Subject|16|||
125179455|NCT06018129|450276099|FG000|Overall Study|Death|1|||
125179456|NCT06018129|450276100|FG001|Overall Study|Death|1|||
125179457|NCT06018129|450276101|FG002|Overall Study|Death|2|||
125179458|NCT06018129|450276099|FG000|Overall Study|Sponsor Decision|2|||
125179459|NCT06018129|450276100|FG001|Overall Study|Sponsor Decision|2|||
125179460|NCT06018129|450276101|FG002|Overall Study|Sponsor Decision|1|||
125179461|NCT04917861|450276102|FG000|Main Study (196 Days)|Adverse Event|0|||
125179462|NCT04917861|450276103|FG001|Main Study (196 Days)|Adverse Event|1|||
125179463|NCT04917861|450276104|FG002|Main Study (196 Days)|Adverse Event|0|||
125179464|NCT04917861|450276105|FG003|Main Study (196 Days)|Adverse Event|0|||
125179465|NCT04917861|450276102|FG000|Main Study (196 Days)|Death|0|||
125179466|NCT04917861|450276103|FG001|Main Study (196 Days)|Death|0|||
125179467|NCT04917861|450276104|FG002|Main Study (196 Days)|Death|0|||
125179468|NCT04917861|450276105|FG003|Main Study (196 Days)|Death|1|||
125179469|NCT04917861|450276102|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
125179470|NCT04917861|450276103|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
125179471|NCT04917861|450276104|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
125179472|NCT04917861|450276105|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
125179473|NCT04917861|450276102|FG000|Main Study (196 Days)|Physician Decision|0|||
125179474|NCT04917861|450276103|FG001|Main Study (196 Days)|Physician Decision|0|||
125179475|NCT04917861|450276104|FG002|Main Study (196 Days)|Physician Decision|0|||
125179476|NCT04917861|450276105|FG003|Main Study (196 Days)|Physician Decision|1|||
125179477|NCT04917861|450276102|FG000|Main Study (196 Days)|Pregnancy|1|||
125179478|NCT04917861|450276103|FG001|Main Study (196 Days)|Pregnancy|1|||
125179479|NCT04917861|450276104|FG002|Main Study (196 Days)|Pregnancy|0|||
125179480|NCT04917861|450276105|FG003|Main Study (196 Days)|Pregnancy|0|||
125179481|NCT04917861|450276102|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
125179482|NCT04917861|450276103|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
125179483|NCT04917861|450276104|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
125179484|NCT04917861|450276105|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
125179485|NCT04917861|450276102|FG000|Main Study (196 Days)|Other Than Specified|1|||
125179486|NCT04917861|450276103|FG001|Main Study (196 Days)|Other Than Specified|0|||
125179487|NCT04917861|450276104|FG002|Main Study (196 Days)|Other Than Specified|1|||
125235404|NCT02332707|450489833|FG003|Overall Study|Physician Decision|1|||
125235405|NCT02332707|450489834|FG004|Overall Study|Physician Decision|0|||
125235406|NCT02332707|450489835|FG005|Overall Study|Physician Decision|0|||
125235407|NCT02332707|450489836|FG006|Overall Study|Physician Decision|0|||
125235408|NCT02332707|450489837|FG007|Overall Study|Physician Decision|0|||
125235409|NCT02332707|450489838|FG008|Overall Study|Physician Decision|0|||
125235410|NCT02332707|450489839|FG009|Overall Study|Physician Decision|0|||
125235411|NCT02332707|450489840|FG010|Overall Study|Physician Decision|0|||
125235412|NCT02332707|450489841|FG011|Overall Study|Physician Decision|0|||
125235413|NCT02332707|450489842|FG012|Overall Study|Physician Decision|1|||
125235414|NCT02332707|450489843|FG013|Overall Study|Physician Decision|0|||
125235415|NCT02332707|450489844|FG014|Overall Study|Physician Decision|0|||
125235416|NCT02332707|450489845|FG015|Overall Study|Physician Decision|0|||
125235417|NCT02332707|450489846|FG016|Overall Study|Physician Decision|0|||
125235418|NCT02332707|450489847|FG017|Overall Study|Physician Decision|0|||
125235419|NCT02332707|450489830|FG000|Overall Study|Withdrawal by Subject|0|||
125235420|NCT02332707|450489831|FG001|Overall Study|Withdrawal by Subject|0|||
125235421|NCT02332707|450489832|FG002|Overall Study|Withdrawal by Subject|1|||
125235422|NCT02332707|450489833|FG003|Overall Study|Withdrawal by Subject|0|||
125235423|NCT02332707|450489834|FG004|Overall Study|Withdrawal by Subject|0|||
125235424|NCT02332707|450489835|FG005|Overall Study|Withdrawal by Subject|0|||
125235425|NCT02332707|450489836|FG006|Overall Study|Withdrawal by Subject|0|||
125235426|NCT02332707|450489837|FG007|Overall Study|Withdrawal by Subject|0|||
125235427|NCT02332707|450489838|FG008|Overall Study|Withdrawal by Subject|0|||
125235428|NCT02332707|450489839|FG009|Overall Study|Withdrawal by Subject|3|||
125235429|NCT02332707|450489840|FG010|Overall Study|Withdrawal by Subject|0|||
125235430|NCT02332707|450489841|FG011|Overall Study|Withdrawal by Subject|0|||
125235431|NCT02332707|450489842|FG012|Overall Study|Withdrawal by Subject|0|||
125235432|NCT02332707|450489843|FG013|Overall Study|Withdrawal by Subject|0|||
125235433|NCT02332707|450489844|FG014|Overall Study|Withdrawal by Subject|0|||
125235434|NCT02332707|450489845|FG015|Overall Study|Withdrawal by Subject|0|||
125179488|NCT04917861|450276105|FG003|Main Study (196 Days)|Other Than Specified|2|||
125179489|NCT04917861|450276102|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
125179490|NCT04917861|450276103|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
125179491|NCT04917861|450276104|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
125179492|NCT04917861|450276105|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
125179493|NCT04917861|450276102|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
125179494|NCT04917861|450276103|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
125179495|NCT04917861|450276104|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
125179496|NCT04917861|450276105|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
125179497|NCT04917861|450276102|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
125179498|NCT04917861|450276103|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
125179499|NCT04917861|450276104|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
125179500|NCT04917861|450276105|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
125179501|NCT04917861|450276102|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
125179502|NCT04917861|450276103|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
125179503|NCT04917861|450276104|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
125179504|NCT04917861|450276105|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
125179505|NCT04917861|450276102|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
125179506|NCT04917861|450276103|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
125179507|NCT04917861|450276104|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
125235435|NCT02332707|450489846|FG016|Overall Study|Withdrawal by Subject|0|||
125235436|NCT02332707|450489847|FG017|Overall Study|Withdrawal by Subject|0|||
125235437|NCT01473134|450489848|FG000|Overall Study|Lost to Follow-up|21|||
125179508|NCT04917861|450276105|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
125179509|NCT04917861|450276102|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
125235438|NCT01473134|450489849|FG001|Overall Study|Lost to Follow-up|13|||
125235439|NCT01473134|450489848|FG000|Overall Study|Protocol Violation|32|||
125235440|NCT01473134|450489849|FG001|Overall Study|Protocol Violation|19|||
125235441|NCT01473134|450489848|FG000|Overall Study|Withdrawal by Subject|1|||
125235442|NCT01473134|450489849|FG001|Overall Study|Withdrawal by Subject|2|||
125235443|NCT01473134|450489848|FG000|Overall Study|Death|0|||
125235444|NCT01473134|450489849|FG001|Overall Study|Death|1|||
125235445|NCT01473134|450489848|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
125235446|NCT01473134|450489849|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
125235447|NCT04761822|450489850|FG000|Overall Study|Adverse Event|3|||
125235448|NCT04761822|450489851|FG001|Overall Study|Adverse Event|1|||
125235449|NCT04761822|450489852|FG002|Overall Study|Adverse Event|1|||
125235450|NCT04761822|450489853|FG003|Overall Study|Adverse Event|3|||
125235451|NCT04761822|450489850|FG000|Overall Study|Lost to Follow-up|1|||
125235452|NCT04761822|450489851|FG001|Overall Study|Lost to Follow-up|0|||
125235453|NCT04761822|450489852|FG002|Overall Study|Lost to Follow-up|2|||
125235454|NCT04761822|450489853|FG003|Overall Study|Lost to Follow-up|3|||
125235455|NCT04761822|450489850|FG000|Overall Study|Physician Decision|0|||
125235456|NCT04761822|450489851|FG001|Overall Study|Physician Decision|1|||
125235457|NCT04761822|450489852|FG002|Overall Study|Physician Decision|0|||
125235458|NCT04761822|450489853|FG003|Overall Study|Physician Decision|0|||
125235459|NCT04761822|450489850|FG000|Overall Study|Withdrawal by Subject|3|||
125235460|NCT04761822|450489851|FG001|Overall Study|Withdrawal by Subject|8|||
125235461|NCT04761822|450489852|FG002|Overall Study|Withdrawal by Subject|1|||
125179510|NCT04917861|450276103|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
125179511|NCT04917861|450276104|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
125179512|NCT04917861|450276105|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
125179513|NCT06389487|450276106|FG000|Overall Study|Lost to Follow-up|9|||
125179514|NCT06389487|450276107|FG001|Overall Study|Lost to Follow-up|5|||
125179515|NCT06389487|450276108|FG002|Overall Study|Lost to Follow-up|13|||
125179516|NCT06389487|450276106|FG000|Overall Study|Protocol Violation|0|||
125179517|NCT06389487|450276107|FG001|Overall Study|Protocol Violation|0|||
125179518|NCT06389487|450276108|FG002|Overall Study|Protocol Violation|2|||
125179519|NCT06389487|450276106|FG000|Overall Study|Withdrawal by Subject|2|||
125179520|NCT06389487|450276107|FG001|Overall Study|Withdrawal by Subject|2|||
125179521|NCT06389487|450276108|FG002|Overall Study|Withdrawal by Subject|1|||
125179522|NCT06389487|450276106|FG000|Overall Study|Other|1|||
125179523|NCT06389487|450276107|FG001|Overall Study|Other|0|||
125179524|NCT06389487|450276108|FG002|Overall Study|Other|1|||
125179525|NCT00001521|450277178|FG000|Overall Study|Withdrawal by Subject|3|||
125179526|NCT00001521|450277179|FG001|Overall Study|Withdrawal by Subject|3|||
125179527|NCT00001521|450277178|FG000|Overall Study|Physician Decision|1|||
125179528|NCT00001521|450277179|FG001|Overall Study|Physician Decision|1|||
125179529|NCT00001521|450277178|FG000|Overall Study|Noncompliant|6|||
125179530|NCT00001521|450277179|FG001|Overall Study|Noncompliant|3|||
125179531|NCT00970593|450277181|FG000|Overall Study|Adverse Event|1|||
125179532|NCT00970593|450277182|FG001|Overall Study|Adverse Event|1|||
125179533|NCT00970593|450277183|FG002|Overall Study|Adverse Event|0|||
125179534|NCT00970593|450277184|FG003|Overall Study|Adverse Event|0|||
125179535|NCT00970593|450277185|FG004|Overall Study|Adverse Event|0|||
125179536|NCT00970593|450277186|FG005|Overall Study|Adverse Event|0|||
125179537|NCT00970593|450277187|FG006|Overall Study|Adverse Event|0|||
125179538|NCT00970593|450277181|FG000|Overall Study|Discontinuation of study by sponsor|0|||
125179539|NCT00970593|450277182|FG001|Overall Study|Discontinuation of study by sponsor|0|||
125179540|NCT00970593|450277183|FG002|Overall Study|Discontinuation of study by sponsor|5|||
125179541|NCT00970593|450277184|FG003|Overall Study|Discontinuation of study by sponsor|0|||
125179542|NCT00970593|450277185|FG004|Overall Study|Discontinuation of study by sponsor|0|||
125179543|NCT00970593|450277186|FG005|Overall Study|Discontinuation of study by sponsor|0|||
125179544|NCT00970593|450277187|FG006|Overall Study|Discontinuation of study by sponsor|2|||
125179545|NCT00970593|450277181|FG000|Overall Study|Withdrawal by Subject|0|||
125179546|NCT00970593|450277182|FG001|Overall Study|Withdrawal by Subject|0|||
125179547|NCT00970593|450277183|FG002|Overall Study|Withdrawal by Subject|1|||
125179548|NCT00970593|450277184|FG003|Overall Study|Withdrawal by Subject|0|||
125179549|NCT00970593|450277185|FG004|Overall Study|Withdrawal by Subject|0|||
125179550|NCT00970593|450277186|FG005|Overall Study|Withdrawal by Subject|0|||
125179551|NCT00970593|450277187|FG006|Overall Study|Withdrawal by Subject|0|||
125179552|NCT04176250|450277188|FG000|Overall Study|Adverse Event|0|||
125179553|NCT04176250|450277189|FG001|Overall Study|Adverse Event|1|||
125179554|NCT04176250|450277190|FG002|Overall Study|Adverse Event|0|||
125179555|NCT04176250|450277191|FG003|Overall Study|Adverse Event|1|||
125179556|NCT04176250|450277192|FG004|Overall Study|Adverse Event|0|||
125179557|NCT04176250|450277193|FG005|Overall Study|Adverse Event|1|||
125179558|NCT04176250|450277188|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
125179559|NCT04176250|450277189|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
125179560|NCT04176250|450277190|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
125179561|NCT04176250|450277191|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
125179562|NCT04176250|450277192|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
125179563|NCT04176250|450277193|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
125179564|NCT04176250|450277188|FG000|Overall Study|Withdrawal by Subject|0|||
125179565|NCT04176250|450277189|FG001|Overall Study|Withdrawal by Subject|0|||
125179566|NCT04176250|450277190|FG002|Overall Study|Withdrawal by Subject|0|||
125179567|NCT04176250|450277191|FG003|Overall Study|Withdrawal by Subject|0|||
125179568|NCT04176250|450277192|FG004|Overall Study|Withdrawal by Subject|0|||
125179569|NCT04176250|450277193|FG005|Overall Study|Withdrawal by Subject|1|||
125179570|NCT04176250|450277188|FG000|Overall Study|Randomized in error|0|||
125179571|NCT04176250|450277189|FG001|Overall Study|Randomized in error|0|||
125179572|NCT04176250|450277190|FG002|Overall Study|Randomized in error|0|||
125179573|NCT04176250|450277191|FG003|Overall Study|Randomized in error|0|||
125179574|NCT04176250|450277192|FG004|Overall Study|Randomized in error|1|||
125179575|NCT04176250|450277193|FG005|Overall Study|Randomized in error|0|||
125179576|NCT01342081|450277196|FG000|Overall Study|Did not receive allocated intervention|0|||
125179577|NCT01342081|450277197|FG001|Overall Study|Did not receive allocated intervention|0|||
125179578|NCT01342081|450277198|FG002|Overall Study|Did not receive allocated intervention|1|||
125179579|NCT01342081|450277196|FG000|Overall Study|Adverse Event|1|||
125179580|NCT01342081|450277197|FG001|Overall Study|Adverse Event|0|||
125179581|NCT01342081|450277198|FG002|Overall Study|Adverse Event|0|||
125179582|NCT01342081|450277196|FG000|Overall Study|Physician Decision|0|||
125179583|NCT01342081|450277197|FG001|Overall Study|Physician Decision|1|||
125179584|NCT01342081|450277198|FG002|Overall Study|Physician Decision|0|||
125179585|NCT01342081|450277196|FG000|Overall Study|Withdrawal by Subject|1|||
125179586|NCT01342081|450277197|FG001|Overall Study|Withdrawal by Subject|1|||
125179587|NCT01342081|450277198|FG002|Overall Study|Withdrawal by Subject|0|||
125179588|NCT02790437|450277200|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
125179589|NCT02790437|450277201|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
125179590|NCT02790437|450277200|FG000|Overall Study|Adverse Event|1|||
125179591|NCT02790437|450277201|FG001|Overall Study|Adverse Event|0|||
125179592|NCT02790437|450277200|FG000|Overall Study|Withdrawal by Subject|1|||
125179593|NCT02790437|450277201|FG001|Overall Study|Withdrawal by Subject|0|||
125179594|NCT01202175|450277202|FG000|Overall Study|Lost to Follow-up|2|||
125179595|NCT01202175|450277202|FG000|Overall Study|Withdrawal by Subject|1|||
125179596|NCT01202175|450277202|FG000|Overall Study|Adverse Event|2|||
125179597|NCT04720053|450277206|FG000|Overall Study|Lost to Follow-up|12|||
125179598|NCT00666328|450277209|FG000|Overall Study|Death|2|||
125179599|NCT00666328|450277209|FG000|Overall Study|Lost to Follow-up|2|||
125179600|NCT00666328|450277209|FG000|Overall Study|No longer met eligibility criteria|1|||
125179601|NCT05064397|450277210|FG000|Overall Study|Adverse Event|4|||
125179602|NCT05064397|450277210|FG000|Overall Study|Lack of Efficacy|12|||
125179603|NCT05064397|450277210|FG000|Overall Study|Withdrawal by Subject|3|||
125179604|NCT05064397|450277210|FG000|Overall Study|Lost to Follow-up|1|||
125179605|NCT05064397|450277210|FG000|Overall Study|Other reasons|3|||
125179606|NCT02232984|450277211|FG000|Overall Study|Withdrawal by Subject|5|||
125179607|NCT02232984|450277211|FG000|Overall Study|Death|1|||
125179608|NCT02232984|450277211|FG000|Overall Study|Investigator withdrawal|10|||
125179609|NCT02232984|450277211|FG000|Overall Study|Device implant unsuccessful|53|||
125179610|NCT02232984|450277211|FG000|Overall Study|not disclosed by site|7|||
125179611|NCT02232984|450277211|FG000|Overall Study|Protocol Violation|1|||
125179612|NCT00535405|450277214|FG000|Overall Study|Adverse Event|6|||
125179613|NCT00535405|450277215|FG001|Overall Study|Adverse Event|8|||
125179614|NCT00535405|450277216|FG002|Overall Study|Adverse Event|3|||
125179615|NCT00535405|450277217|FG003|Overall Study|Adverse Event|8|||
125179616|NCT00535405|450277218|FG004|Overall Study|Adverse Event|6|||
125179617|NCT00535405|450277214|FG000|Overall Study|Lost to Follow-up|1|||
125179618|NCT00535405|450277215|FG001|Overall Study|Lost to Follow-up|3|||
125179619|NCT00535405|450277216|FG002|Overall Study|Lost to Follow-up|3|||
125179620|NCT00535405|450277217|FG003|Overall Study|Lost to Follow-up|2|||
125179621|NCT00535405|450277218|FG004|Overall Study|Lost to Follow-up|1|||
125179622|NCT00535405|450277214|FG000|Overall Study|Physician Decision|3|||
125179623|NCT00535405|450277215|FG001|Overall Study|Physician Decision|2|||
125179624|NCT00535405|450277216|FG002|Overall Study|Physician Decision|0|||
125179625|NCT00535405|450277217|FG003|Overall Study|Physician Decision|1|||
125179626|NCT00535405|450277218|FG004|Overall Study|Physician Decision|1|||
125179627|NCT00535405|450277214|FG000|Overall Study|Protocol Violation|2|||
125179628|NCT00535405|450277215|FG001|Overall Study|Protocol Violation|2|||
125179629|NCT00535405|450277216|FG002|Overall Study|Protocol Violation|2|||
125179630|NCT00535405|450277217|FG003|Overall Study|Protocol Violation|1|||
125179631|NCT00535405|450277218|FG004|Overall Study|Protocol Violation|0|||
125179632|NCT00535405|450277214|FG000|Overall Study|Withdrawal by Subject|5|||
125179633|NCT00535405|450277215|FG001|Overall Study|Withdrawal by Subject|11|||
125179634|NCT00535405|450277216|FG002|Overall Study|Withdrawal by Subject|10|||
125179635|NCT00535405|450277217|FG003|Overall Study|Withdrawal by Subject|10|||
125179636|NCT00535405|450277218|FG004|Overall Study|Withdrawal by Subject|8|||
125179637|NCT03404674|450277219|FG000|Overall Study|Inability to Attend Future Visits|0|||
125179638|NCT03404674|450277220|FG001|Overall Study|Inability to Attend Future Visits|1|||
125179639|NCT03404674|450277221|FG002|Overall Study|Inability to Attend Future Visits|1|||
125179640|NCT03404674|450277222|FG003|Overall Study|Inability to Attend Future Visits|0|||
125179641|NCT03404674|450277223|FG004|Overall Study|Inability to Attend Future Visits|0|||
125179642|NCT03404674|450277224|FG005|Overall Study|Inability to Attend Future Visits|0|||
125179643|NCT03404674|450277219|FG000|Overall Study|Behavioral Problems|0|||
125179644|NCT03404674|450277220|FG001|Overall Study|Behavioral Problems|0|||
125179645|NCT03404674|450277221|FG002|Overall Study|Behavioral Problems|1|||
125179646|NCT03404674|450277222|FG003|Overall Study|Behavioral Problems|0|||
125179647|NCT03404674|450277223|FG004|Overall Study|Behavioral Problems|0|||
125179648|NCT03404674|450277224|FG005|Overall Study|Behavioral Problems|0|||
125179649|NCT03404674|450277219|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
125179650|NCT03404674|450277220|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
125179651|NCT03404674|450277221|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
125179652|NCT03404674|450277222|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
125179653|NCT03404674|450277223|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
125179654|NCT03404674|450277224|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
125179655|NCT04728802|450277229|FG000|Overall Study|Withdrawal by Subject|4|||
125179656|NCT04728802|450277230|FG001|Overall Study|Withdrawal by Subject|20|||
125179657|NCT04728802|450277229|FG000|Overall Study|Physician Decision|7|||
125179658|NCT04728802|450277230|FG001|Overall Study|Physician Decision|7|||
125179659|NCT04728802|450277229|FG000|Overall Study|Protocol Violation|10|||
125179660|NCT04728802|450277230|FG001|Overall Study|Protocol Violation|4|||
125179661|NCT04728802|450277229|FG000|Overall Study|Transfer|1|||
125179662|NCT04728802|450277230|FG001|Overall Study|Transfer|0|||
125179663|NCT04728802|450277229|FG000|Overall Study|Death|4|||
125179664|NCT04728802|450277230|FG001|Overall Study|Death|5|||
125179665|NCT04728802|450277229|FG000|Overall Study|Other|3|||
125179666|NCT04728802|450277230|FG001|Overall Study|Other|0|||
125179667|NCT01176513|450277231|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
125179668|NCT01959295|450277236|FG000|Overall Study|Adverse Event|2|||
125179669|NCT01959295|450277237|FG001|Overall Study|Adverse Event|0|||
125179670|NCT01959295|450277236|FG000|Overall Study|Lost to Follow-up|0|||
125179671|NCT01959295|450277237|FG001|Overall Study|Lost to Follow-up|2|||
125179672|NCT01959295|450277236|FG000|Overall Study|Physician Decision|2|||
125179673|NCT01959295|450277237|FG001|Overall Study|Physician Decision|3|||
125179674|NCT01959295|450277236|FG000|Overall Study|Protocol Violation|16|||
125179675|NCT01959295|450277237|FG001|Overall Study|Protocol Violation|5|||
125179676|NCT01959295|450277236|FG000|Overall Study|Withdrawal by Subject|3|||
125179677|NCT01959295|450277237|FG001|Overall Study|Withdrawal by Subject|1|||
125179678|NCT01959295|450277236|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
125179679|NCT01959295|450277237|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
125179680|NCT04011722|450279095|FG000|30 Days|Death|5|||
125179681|NCT04011722|450279096|FG001|30 Days|Death|1|||
125179682|NCT04011722|450279095|FG000|1 Year|Death|13|||
125179683|NCT04011722|450279096|FG001|1 Year|Death|5|||
125179684|NCT04011722|450279095|FG000|1 Year|Withdrawal by Subject|8|||
125179685|NCT04011722|450279096|FG001|1 Year|Withdrawal by Subject|2|||
125179686|NCT04011722|450279095|FG000|1 Year|Missed Visit|6|||
125179687|NCT04011722|450279096|FG001|1 Year|Missed Visit|1|||
125179688|NCT04011722|450279095|FG000|1 Year|Pending Visit|0|||
125179689|NCT04011722|450279096|FG001|1 Year|Pending Visit|11|||
125179690|NCT04011722|450279095|FG000|1 Year|Not Yet Due|0|||
125179691|NCT04011722|450279096|FG001|1 Year|Not Yet Due|9|||
125179692|NCT04011722|450279095|FG000|2 Year|Death|16|||
125179693|NCT04011722|450279096|FG001|2 Year|Death|1|||
125179694|NCT04011722|450279095|FG000|2 Year|Withdrawal by Subject|10|||
125179695|NCT04011722|450279096|FG001|2 Year|Withdrawal by Subject|1|||
125179696|NCT04011722|450279095|FG000|2 Year|Missed Visit|9|||
125179697|NCT04011722|450279096|FG001|2 Year|Missed Visit|0|||
125179698|NCT04011722|450279095|FG000|2 Year|Visit Pending|1|||
125179699|NCT04011722|450279096|FG001|2 Year|Visit Pending|3|||
125179700|NCT04011722|450279095|FG000|2 Year|Not Yet Due|43|||
125179701|NCT04011722|450279096|FG001|2 Year|Not Yet Due|54|||
125179702|NCT04011722|450279095|FG000|3 Year|Death|10|||
125179703|NCT04011722|450279096|FG001|3 Year|Death|0|||
125179704|NCT04011722|450279095|FG000|3 Year|Withdrawal by Subject|2|||
125179705|NCT04011722|450279096|FG001|3 Year|Withdrawal by Subject|0|||
125179706|NCT04011722|450279095|FG000|3 Year|Missed Visit|2|||
125179707|NCT04011722|450279096|FG001|3 Year|Missed Visit|0|||
125179708|NCT04011722|450279095|FG000|3 Year|Pending Visit|34|||
125179709|NCT04011722|450279096|FG001|3 Year|Pending Visit|0|||
125179710|NCT04011722|450279095|FG000|3 Year|Not Yet Due|99|||
125179711|NCT04011722|450279096|FG001|3 Year|Not Yet Due|0|||
125179712|NCT05061134|450279097|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
125179713|NCT05061134|450279098|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
125179714|NCT05061134|450279099|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
125179715|NCT05061134|450279097|FG000|Overall Study|Subject not treated|0|||
125179716|NCT05061134|450279098|FG001|Overall Study|Subject not treated|0|||
125179717|NCT05061134|450279099|FG002|Overall Study|Subject not treated|2|||
125179718|NCT05061134|450279097|FG000|Overall Study|Other|0|||
125179719|NCT05061134|450279098|FG001|Overall Study|Other|0|||
125179720|NCT05061134|450279099|FG002|Overall Study|Other|9|||
125179721|NCT05061134|450279097|FG000|Overall Study|Withdrawal by Subject|9|||
125179722|NCT05061134|450279098|FG001|Overall Study|Withdrawal by Subject|8|||
125235462|NCT04761822|450489853|FG003|Overall Study|Withdrawal by Subject|11|||
125235463|NCT04761822|450489850|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
125235464|NCT04761822|450489851|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
125235465|NCT04761822|450489852|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
125235466|NCT04761822|450489853|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
125179723|NCT05061134|450279099|FG002|Overall Study|Withdrawal by Subject|5|||
125179724|NCT05061134|450279097|FG000|Overall Study|Study Terminated by Sponsor|22|||
125179725|NCT05061134|450279098|FG001|Overall Study|Study Terminated by Sponsor|14|||
125235467|NCT04761822|450489850|FG000|Overall Study|Participant requested unblinding|0|||
125235468|NCT04761822|450489851|FG001|Overall Study|Participant requested unblinding|0|||
125235469|NCT04761822|450489852|FG002|Overall Study|Participant requested unblinding|0|||
125235470|NCT04761822|450489853|FG003|Overall Study|Participant requested unblinding|1|||
125235471|NCT04734652|450489854|FG000|Overall Study|Withdrawal by Subject|2|||
125235472|NCT04734652|450489855|FG001|Overall Study|Withdrawal by Subject|0|||
125235473|NCT04734652|450489854|FG000|Overall Study|Death|0|||
125235474|NCT04734652|450489855|FG001|Overall Study|Death|1|||
125235475|NCT02233413|450489856|FG000|Overall Study|Lost to Follow-up|7|||
125235476|NCT02233413|450489857|FG001|Overall Study|Lost to Follow-up|9|||
125235477|NCT02233413|450489856|FG000|Overall Study|Withdrawal by Subject|4|||
125235478|NCT02233413|450489857|FG001|Overall Study|Withdrawal by Subject|5|||
125235479|NCT02471183|450489866|FG000|Main Treatment Period|Adverse Event|1|||
125235480|NCT02471183|450489866|FG000|Main Treatment Period|Withdrawal by Subject|1|||
125235481|NCT02471183|450489866|FG000|Extended Treatment Period|Lack of Efficacy|1|||
125235482|NCT00827567|450489868|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
125235483|NCT02326883|450489869|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
125235484|NCT02326883|450489870|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
125235485|NCT02326883|450489871|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
125235486|NCT02736617|450489872|FG000|Treatment|Adverse Event|1|||
125235487|NCT02736617|450489872|FG000|Treatment|Lack of Efficacy|1|||
125235488|NCT02736617|450489872|FG000|Treatment|Withdrawal by Subject|1|||
125235489|NCT02736617|450489872|FG000|Maintenance|Lack of Efficacy|4|||
125235490|NCT02736617|450489872|FG000|Maintenance|Physician Decision|1|||
125235491|NCT02911116|450489875|FG000|Overall Study|Insufficient Therapeutic Response|1|||
125235492|NCT02911116|450489876|FG001|Overall Study|Insufficient Therapeutic Response|0|||
125235493|NCT02911116|450489875|FG000|Overall Study|Lost to Follow-up|0|||
125235494|NCT02911116|450489876|FG001|Overall Study|Lost to Follow-up|1|||
125235495|NCT04796415|450489877|FG000|Overall Study|not interested|12|||
125235496|NCT04796415|450489877|FG000|Overall Study|health issue|8|||
125235497|NCT04796415|450489877|FG000|Overall Study|Other|4|||
125235498|NCT04796415|450489877|FG000|Overall Study|discharged from home health service|3|||
125235499|NCT04796415|450489877|FG000|Overall Study|re-hospitalization|2|||
125235500|NCT04796415|450489877|FG000|Overall Study|moving to nursing home|1|||
125235501|NCT04796415|450489877|FG000|Overall Study|lost contact|1|||
125235502|NCT02469857|450489878|FG000|Overall Study|Death|24|||
125235503|NCT02469857|450489879|FG001|Overall Study|Death|29|||
125235504|NCT02469857|450489878|FG000|Overall Study|Discontinuation|1|||
125235505|NCT02469857|450489879|FG001|Overall Study|Discontinuation|3|||
125235506|NCT02110693|450489880|FG000|Overall Study|Withdrawal by Subject|6|||
125235507|NCT02110693|450489881|FG001|Overall Study|Withdrawal by Subject|7|||
125235508|NCT02110693|450489880|FG000|Overall Study|skipped assessment|15|||
125235509|NCT02110693|450489881|FG001|Overall Study|skipped assessment|18|||
125235510|NCT02110693|450489880|FG000|Overall Study|technical difficulties|6|||
125235511|NCT02110693|450489881|FG001|Overall Study|technical difficulties|4|||
125235512|NCT02110693|450489880|FG000|Overall Study|Other|1|||
125179726|NCT05061134|450279099|FG002|Overall Study|Study Terminated by Sponsor|7|||
125179727|NCT05061134|450279097|FG000|Overall Study|Progressive Disease|1|||
125179728|NCT05061134|450279098|FG001|Overall Study|Progressive Disease|2|||
125179729|NCT05061134|450279099|FG002|Overall Study|Progressive Disease|0|||
125179730|NCT05061134|450279097|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
125179731|NCT05061134|450279098|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
125179732|NCT05061134|450279099|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
125179733|NCT05061134|450279097|FG000|Overall Study|Lost to Follow-up|1|||
125179734|NCT05061134|450279098|FG001|Overall Study|Lost to Follow-up|0|||
125179735|NCT05061134|450279099|FG002|Overall Study|Lost to Follow-up|0|||
125179736|NCT05061134|450279097|FG000|Overall Study|Physician Decision|1|||
125235513|NCT02110693|450489881|FG001|Overall Study|Other|0|||
125235514|NCT00937950|450489882|FG000|Overall Study|Withdrawal by Subject|23|||
125235515|NCT00937950|450489882|FG000|Overall Study|Migrated/moved from study area|27|||
125235516|NCT00937950|450489882|FG000|Overall Study|Lost to Follow-up|144|||
125235517|NCT00937950|450489882|FG000|Overall Study|Missing confirmed|4|||
125235518|NCT00937950|450489882|FG000|Overall Study|Other|18|||
125235519|NCT04810962|450489883|FG000|Overall Study|Adverse Event|0|||
125235520|NCT04810962|450489884|FG001|Overall Study|Adverse Event|1|||
125179737|NCT05061134|450279098|FG001|Overall Study|Physician Decision|1|||
125179738|NCT05061134|450279099|FG002|Overall Study|Physician Decision|0|||
125179739|NCT05061134|450279097|FG000|Overall Study|Disease progression|1|||
125179740|NCT05061134|450279098|FG001|Overall Study|Disease progression|0|||
125179741|NCT05061134|450279099|FG002|Overall Study|Disease progression|0|||
125179742|NCT05061134|450279097|FG000|Overall Study|Death|43|||
125179743|NCT05061134|450279098|FG001|Overall Study|Death|23|||
125179744|NCT05061134|450279099|FG002|Overall Study|Death|14|||
125179745|NCT05061134|450279097|FG000|Overall Study|Database lock|2|||
125179746|NCT05061134|450279098|FG001|Overall Study|Database lock|0|||
125179747|NCT05061134|450279099|FG002|Overall Study|Database lock|0|||
125179748|NCT04848480|450279103|FG000|Main Phase (26 Weeks)|Death|1|||
125179749|NCT04848480|450279104|FG001|Main Phase (26 Weeks)|Death|0|||
125179750|NCT04848480|450279103|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
125179751|NCT04848480|450279104|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
125179752|NCT04848480|450279103|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
125179753|NCT04848480|450279104|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
125179754|NCT04848480|450279103|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
125179755|NCT04848480|450279104|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
125179756|NCT04848480|450279103|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
125179757|NCT04848480|450279104|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
125179758|NCT04848480|450279103|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
125179759|NCT04848480|450279104|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
125179760|NCT01368497|450279105|FG000|Overall Study|Lost to Follow-up|2|||
125179761|NCT02366689|450279107|FG000|Overall Study|Withdrawal by Subject|1|||
125179762|NCT02366689|450279108|FG001|Overall Study|Withdrawal by Subject|0|||
125179763|NCT02366689|450279109|FG002|Overall Study|Withdrawal by Subject|1|||
125179764|NCT02366689|450279107|FG000|Overall Study|Lost to Follow-up|3|||
125179765|NCT02366689|450279108|FG001|Overall Study|Lost to Follow-up|2|||
125179766|NCT02366689|450279109|FG002|Overall Study|Lost to Follow-up|0|||
125179767|NCT02366689|450279107|FG000|Overall Study|Pregnancy|0|||
125179768|NCT02366689|450279108|FG001|Overall Study|Pregnancy|1|||
125179769|NCT02366689|450279109|FG002|Overall Study|Pregnancy|1|||
125179770|NCT03283566|450279110|FG000|Overall Study|Lost to Follow-up|1|||
125179771|NCT03283566|450279111|FG001|Overall Study|Lost to Follow-up|2|||
125179772|NCT03718832|450279112|FG000|Analysis Sample|Withdrawal by Subject|18|||
125179773|NCT03718832|450279113|FG001|Analysis Sample|Withdrawal by Subject|15|||
125179774|NCT03718832|450279112|FG000|Analysis Sample|Legal hold on data|1|||
125179775|NCT03718832|450279113|FG001|Analysis Sample|Legal hold on data|0|||
125179776|NCT03718832|450279112|FG000|Analysis Sample|Participant from treated household|0|||
125179777|NCT03718832|450279113|FG001|Analysis Sample|Participant from treated household|1|||
125179778|NCT03718832|450279112|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
125179779|NCT03718832|450279113|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
125179780|NCT03288714|450279118|FG000|Overall Study|Lost to Follow-up|2|||
125179781|NCT03288714|450279119|FG001|Overall Study|Lost to Follow-up|1|||
125179782|NCT03288714|450279118|FG000|Overall Study|Non-compliance with study schedule|2|||
125179783|NCT03288714|450279119|FG001|Overall Study|Non-compliance with study schedule|0|||
125179784|NCT03288714|450279118|FG000|Overall Study|Withdrawal by Subject|3|||
125179785|NCT03288714|450279119|FG001|Overall Study|Withdrawal by Subject|1|||
125179786|NCT03288714|450279118|FG000|Overall Study|Clinical Worsening|2|||
125179787|NCT03288714|450279119|FG001|Overall Study|Clinical Worsening|1|||
125179788|NCT03288714|450279118|FG000|Overall Study|Adverse Event|1|||
125179789|NCT03288714|450279119|FG001|Overall Study|Adverse Event|0|||
125179790|NCT04882241|450279120|FG000|Overall Study|Ongoing in study|46|||
125179791|NCT04882241|450279121|FG001|Overall Study|Ongoing in study|48|||
125179792|NCT04882241|450279122|FG002|Overall Study|Ongoing in study|0|||
125179793|NCT04882241|450279123|FG003|Overall Study|Ongoing in study|0|||
125179794|NCT04882241|450279120|FG000|Overall Study|Death|13|||
125179795|NCT04882241|450279121|FG001|Overall Study|Death|13|||
125179796|NCT04882241|450279122|FG002|Overall Study|Death|0|||
125179797|NCT04882241|450279123|FG003|Overall Study|Death|0|||
125179798|NCT02203357|450279133|FG000|Overall Study|Lost to Follow-up|58|||
125179799|NCT02203357|450279134|FG001|Overall Study|Lost to Follow-up|66|||
125179800|NCT02203357|450279135|FG002|Overall Study|Lost to Follow-up|70|||
125179801|NCT00470535|450279148|FG000|Overall Study|Disease Progression|13|||
125179802|NCT00470535|450279148|FG000|Overall Study|Withdrawal by Subject|1|||
125179803|NCT00470535|450279148|FG000|Overall Study|Adverse Event|1|||
125179804|NCT00470535|450279148|FG000|Overall Study|Death|1|||
125179805|NCT00470535|450279148|FG000|Overall Study|Other|2|||
125179806|NCT02070965|450279153|FG000|Overall Study|Lost to Follow-up|0|||
125179807|NCT02070965|450279154|FG001|Overall Study|Lost to Follow-up|1|||
125179808|NCT02070965|450279155|FG002|Overall Study|Lost to Follow-up|0|||
125179809|NCT02070965|450279153|FG000|Overall Study|Withdrawal by Subject|1|||
125179810|NCT02070965|450279154|FG001|Overall Study|Withdrawal by Subject|1|||
125179811|NCT02070965|450279155|FG002|Overall Study|Withdrawal by Subject|1|||
125179812|NCT02070965|450279153|FG000|Overall Study|Subject moved|1|||
125179813|NCT02070965|450279154|FG001|Overall Study|Subject moved|0|||
125179814|NCT02070965|450279155|FG002|Overall Study|Subject moved|0|||
125179815|NCT02515331|450279156|FG000|Overall Study|Withdrawal by Subject|0|||
125179816|NCT02515331|450279157|FG001|Overall Study|Withdrawal by Subject|0|||
125235521|NCT04810962|450489883|FG000|Overall Study|Lost to Follow-up|2|||
125179817|NCT02515331|450279158|FG002|Overall Study|Withdrawal by Subject|1|||
125179818|NCT02515331|450279156|FG000|Overall Study|Protocol deviation|0|||
125179819|NCT02515331|450279157|FG001|Overall Study|Protocol deviation|0|||
125179820|NCT02515331|450279158|FG002|Overall Study|Protocol deviation|3|||
125179821|NCT02515331|450279156|FG000|Overall Study|Adverse Event|2|||
125179822|NCT02515331|450279157|FG001|Overall Study|Adverse Event|0|||
125179823|NCT02515331|450279158|FG002|Overall Study|Adverse Event|0|||
125179824|NCT00124748|450279159|FG000|Overall Study|Adverse Event|8|||
125179825|NCT00124748|450279160|FG001|Overall Study|Adverse Event|39|||
125179826|NCT00124748|450279159|FG000|Overall Study|Abnormal laboratory Value|2|||
125179827|NCT00124748|450279160|FG001|Overall Study|Abnormal laboratory Value|2|||
125179828|NCT00124748|450279159|FG000|Overall Study|Abnormal Procedure|0|||
125179829|NCT00124748|450279160|FG001|Overall Study|Abnormal Procedure|1|||
125179830|NCT00124748|450279159|FG000|Overall Study|Lack of Efficacy|20|||
125179831|NCT00124748|450279160|FG001|Overall Study|Lack of Efficacy|41|||
125179832|NCT00124748|450279159|FG000|Overall Study|No longer requires study drug|1|||
125179833|NCT00124748|450279160|FG001|Overall Study|No longer requires study drug|1|||
125179834|NCT00124748|450279159|FG000|Overall Study|Protocol Violation|3|||
125179835|NCT00124748|450279160|FG001|Overall Study|Protocol Violation|1|||
125179836|NCT00124748|450279159|FG000|Overall Study|Withdrawal by Subject|5|||
125179837|NCT00124748|450279160|FG001|Overall Study|Withdrawal by Subject|15|||
125179838|NCT00124748|450279159|FG000|Overall Study|Lost to Follow-up|2|||
125179839|NCT00124748|450279160|FG001|Overall Study|Lost to Follow-up|7|||
125179840|NCT00124748|450279159|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
125179841|NCT00124748|450279160|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
125179842|NCT00124748|450279159|FG000|Overall Study|Death|1|||
125179843|NCT00124748|450279160|FG001|Overall Study|Death|3|||
125179844|NCT00322712|450279161|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
125179845|NCT03889886|450279163|FG000|Overall Study|Other|0|||
125179846|NCT03889886|450279164|FG001|Overall Study|Other|1|||
125179847|NCT03889886|450279165|FG002|Overall Study|Other|0|||
125179848|NCT03889886|450279166|FG003|Overall Study|Other|1|||
125179849|NCT03889886|450279163|FG000|Overall Study|Withdrawal by Subject|0|||
125179850|NCT03889886|450279164|FG001|Overall Study|Withdrawal by Subject|0|||
125179851|NCT03889886|450279165|FG002|Overall Study|Withdrawal by Subject|1|||
125179852|NCT03889886|450279166|FG003|Overall Study|Withdrawal by Subject|0|||
125179853|NCT03889886|450279163|FG000|Overall Study|Adverse Event|0|||
125179854|NCT03889886|450279164|FG001|Overall Study|Adverse Event|0|||
125179855|NCT03889886|450279165|FG002|Overall Study|Adverse Event|0|||
125179856|NCT03889886|450279166|FG003|Overall Study|Adverse Event|6|||
125179857|NCT00758524|450279167|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
125179858|NCT00758524|450279168|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
125179859|NCT00758524|450279169|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
125179860|NCT00758524|450279170|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179861|NCT00758524|450279171|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
125179862|NCT00758524|450279172|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
125179863|NCT00758524|450279173|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179864|NCT00758524|450279174|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179865|NCT00758524|450279175|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179866|NCT00758524|450279176|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179867|NCT00758524|450279177|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179868|NCT00758524|450279178|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179869|NCT00758524|450279179|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179870|NCT00758524|450279180|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179871|NCT00758524|450279181|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179872|NCT00758524|450279182|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179873|NCT00758524|450279183|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179874|NCT00758524|450279167|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
125179875|NCT00758524|450279168|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179876|NCT00758524|450279169|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
125179877|NCT00758524|450279170|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
125179878|NCT00758524|450279171|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
125179879|NCT00758524|450279172|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
125179880|NCT00758524|450279173|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179881|NCT00758524|450279174|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179882|NCT00758524|450279175|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179883|NCT00758524|450279176|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179884|NCT00758524|450279177|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179885|NCT00758524|450279178|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179886|NCT00758524|450279179|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179887|NCT00758524|450279180|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179888|NCT00758524|450279181|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179889|NCT00758524|450279182|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125235522|NCT04810962|450489884|FG001|Overall Study|Lost to Follow-up|1|||
125235523|NCT04810962|450489883|FG000|Overall Study|Physician Decision|1|||
125235524|NCT04810962|450489884|FG001|Overall Study|Physician Decision|0|||
125235525|NCT04810962|450489883|FG000|Overall Study|Withdrawal by Subject|1|||
125235526|NCT04810962|450489884|FG001|Overall Study|Withdrawal by Subject|3|||
125235527|NCT04810962|450489883|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
125179890|NCT00758524|450279183|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179891|NCT00758524|450279167|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
125179892|NCT00758524|450279168|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
125179893|NCT00758524|450279169|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
125179894|NCT00758524|450279170|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
125179895|NCT00758524|450279171|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
125179896|NCT00758524|450279172|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
125179897|NCT00758524|450279173|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179898|NCT00758524|450279174|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179899|NCT00758524|450279175|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179900|NCT00758524|450279176|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179901|NCT00758524|450279177|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179902|NCT00758524|450279178|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179903|NCT00758524|450279179|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179904|NCT00758524|450279180|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179905|NCT00758524|450279181|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179906|NCT00758524|450279182|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179907|NCT00758524|450279183|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179908|NCT00758524|450279167|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179909|NCT00758524|450279168|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
125179910|NCT00758524|450279169|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
125179911|NCT00758524|450279170|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179912|NCT00758524|450279171|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
125179913|NCT00758524|450279172|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
125179914|NCT00758524|450279173|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179915|NCT00758524|450279174|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179916|NCT00758524|450279175|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179917|NCT00758524|450279176|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179918|NCT00758524|450279177|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179919|NCT00758524|450279178|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179920|NCT00758524|450279179|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179921|NCT00758524|450279180|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179922|NCT00758524|450279181|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179923|NCT00758524|450279182|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179924|NCT00758524|450279183|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179925|NCT00758524|450279167|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179926|NCT00758524|450279168|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179927|NCT00758524|450279169|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
125179928|NCT00758524|450279170|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
125179929|NCT00758524|450279171|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179930|NCT00758524|450279172|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179931|NCT00758524|450279173|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179932|NCT00758524|450279174|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179933|NCT00758524|450279175|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179934|NCT00758524|450279176|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179935|NCT00758524|450279177|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179936|NCT00758524|450279178|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179937|NCT00758524|450279179|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179938|NCT00758524|450279180|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179939|NCT00758524|450279181|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179940|NCT00758524|450279182|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179941|NCT00758524|450279183|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179942|NCT00758524|450279167|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179943|NCT00758524|450279168|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179944|NCT00758524|450279169|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179945|NCT00758524|450279170|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179946|NCT00758524|450279171|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
125179947|NCT00758524|450279172|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179948|NCT00758524|450279173|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179949|NCT00758524|450279174|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179950|NCT00758524|450279175|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179951|NCT00758524|450279176|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179952|NCT00758524|450279177|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179953|NCT00758524|450279178|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179954|NCT00758524|450279179|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179955|NCT00758524|450279180|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179956|NCT00758524|450279181|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179957|NCT00758524|450279182|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179958|NCT00758524|450279183|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179959|NCT00758524|450279167|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179960|NCT00758524|450279168|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
125179961|NCT00758524|450279169|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179962|NCT00758524|450279170|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179963|NCT00758524|450279171|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179964|NCT00758524|450279172|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179965|NCT00758524|450279173|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179966|NCT00758524|450279174|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179967|NCT00758524|450279175|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179968|NCT00758524|450279176|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179969|NCT00758524|450279177|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179970|NCT00758524|450279178|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179971|NCT00758524|450279179|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179972|NCT00758524|450279180|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179973|NCT00758524|450279181|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179974|NCT00758524|450279182|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179975|NCT00758524|450279183|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179976|NCT00758524|450279167|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179977|NCT00758524|450279168|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
125179978|NCT00758524|450279169|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179979|NCT00758524|450279170|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179980|NCT00758524|450279171|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179981|NCT00758524|450279172|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179982|NCT00758524|450279173|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179983|NCT00758524|450279174|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179984|NCT00758524|450279175|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179985|NCT00758524|450279176|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179986|NCT00758524|450279177|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179987|NCT00758524|450279178|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179988|NCT00758524|450279179|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179989|NCT00758524|450279180|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179990|NCT00758524|450279181|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179991|NCT00758524|450279182|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179992|NCT00758524|450279183|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179993|NCT00758524|450279167|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125179994|NCT00758524|450279168|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125179995|NCT00758524|450279169|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125179996|NCT00758524|450279170|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125179997|NCT00758524|450279171|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125179998|NCT00758524|450279172|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125179999|NCT00758524|450279173|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125180000|NCT00758524|450279174|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125180001|NCT00758524|450279175|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
125180002|NCT00758524|450279176|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125180003|NCT00758524|450279177|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125180004|NCT00758524|450279178|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125180005|NCT00758524|450279179|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125180006|NCT00758524|450279180|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125180007|NCT00758524|450279181|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125180008|NCT00758524|450279182|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125180009|NCT00758524|450279183|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125180010|NCT00758524|450279167|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180011|NCT00758524|450279168|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180012|NCT00758524|450279169|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180013|NCT00758524|450279170|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180014|NCT00758524|450279171|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180015|NCT00758524|450279172|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180016|NCT00758524|450279173|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
125180017|NCT00758524|450279174|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180018|NCT00758524|450279175|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180019|NCT00758524|450279176|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180020|NCT00758524|450279177|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180021|NCT00758524|450279178|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180022|NCT00758524|450279179|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180023|NCT00758524|450279180|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180024|NCT00758524|450279181|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180025|NCT00758524|450279182|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180026|NCT00758524|450279183|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180027|NCT04747470|450279198|FG000|Overall Study|Death|0|||
125180028|NCT04747470|450279199|FG001|Overall Study|Death|3|||
125180029|NCT04747470|450279200|FG002|Overall Study|Death|2|||
125180030|NCT04747470|450279201|FG003|Overall Study|Death|2|||
125180031|NCT04747470|450279202|FG004|Overall Study|Death|2|||
125180032|NCT04747470|450279203|FG005|Overall Study|Death|0|||
125180033|NCT04747470|450279204|FG006|Overall Study|Death|0|||
125180034|NCT04747470|450279205|FG007|Overall Study|Death|0|||
125180035|NCT04747470|450279206|FG008|Overall Study|Death|0|||
125180036|NCT04747470|450279207|FG009|Overall Study|Death|0|||
125180037|NCT04747470|450279208|FG010|Overall Study|Death|0|||
125180038|NCT04747470|450279198|FG000|Overall Study|Withdrew Consent|0|||
125180039|NCT04747470|450279199|FG001|Overall Study|Withdrew Consent|0|||
125180040|NCT04747470|450279200|FG002|Overall Study|Withdrew Consent|0|||
125180041|NCT04747470|450279201|FG003|Overall Study|Withdrew Consent|1|||
125180042|NCT04747470|450279202|FG004|Overall Study|Withdrew Consent|0|||
125180043|NCT04747470|450279203|FG005|Overall Study|Withdrew Consent|0|||
125180044|NCT04747470|450279204|FG006|Overall Study|Withdrew Consent|0|||
125180045|NCT04747470|450279205|FG007|Overall Study|Withdrew Consent|0|||
125180046|NCT04747470|450279206|FG008|Overall Study|Withdrew Consent|0|||
125180047|NCT04747470|450279207|FG009|Overall Study|Withdrew Consent|0|||
125180048|NCT04747470|450279208|FG010|Overall Study|Withdrew Consent|0|||
125180049|NCT04747470|450279198|FG000|Overall Study|Study Terminated by Sponsor|0|||
125180050|NCT04747470|450279199|FG001|Overall Study|Study Terminated by Sponsor|0|||
125180051|NCT04747470|450279200|FG002|Overall Study|Study Terminated by Sponsor|1|||
125180052|NCT04747470|450279201|FG003|Overall Study|Study Terminated by Sponsor|0|||
125180053|NCT04747470|450279202|FG004|Overall Study|Study Terminated by Sponsor|2|||
125180054|NCT04747470|450279203|FG005|Overall Study|Study Terminated by Sponsor|0|||
125180055|NCT04747470|450279204|FG006|Overall Study|Study Terminated by Sponsor|0|||
125180056|NCT04747470|450279205|FG007|Overall Study|Study Terminated by Sponsor|0|||
125180057|NCT04747470|450279206|FG008|Overall Study|Study Terminated by Sponsor|0|||
125180058|NCT04747470|450279207|FG009|Overall Study|Study Terminated by Sponsor|0|||
125180059|NCT04747470|450279208|FG010|Overall Study|Study Terminated by Sponsor|0|||
125180060|NCT01942993|450279209|FG000|Overall Study|Lost to Follow-up|1|||
125180061|NCT01942993|450279209|FG000|Overall Study|Physician Decision|1|||
125180062|NCT01350271|450279213|FG000|Overall Study|Lost to Follow-up|21|||
125180063|NCT01350271|450279214|FG001|Overall Study|Lost to Follow-up|17|||
125180064|NCT01350271|450279215|FG002|Overall Study|Lost to Follow-up|26|||
125180065|NCT02906670|450279216|FG000|Cohort 1, QW|Radiological Progression|1|||
125180066|NCT02906670|450279217|FG001|Cohort 1, QW|Radiological Progression|0|||
125180067|NCT02906670|450279218|FG002|Cohort 1, QW|Radiological Progression|0|||
125180068|NCT02906670|450279219|FG003|Cohort 1, QW|Radiological Progression|0|||
125180069|NCT02906670|450279220|FG004|Cohort 1, QW|Radiological Progression|0|||
125180070|NCT02906670|450279221|FG005|Cohort 1, QW|Radiological Progression|0|||
125180071|NCT02906670|450279222|FG006|Cohort 1, QW|Radiological Progression|0|||
125180072|NCT02906670|450279223|FG007|Cohort 1, QW|Radiological Progression|0|||
125180073|NCT02906670|450279224|FG008|Cohort 1, QW|Radiological Progression|0|||
125180074|NCT02906670|450279225|FG009|Cohort 1, QW|Radiological Progression|0|||
125180075|NCT02906670|450279216|FG000|Cohort 2, QW|Radiological Progression|0|||
125180076|NCT02906670|450279217|FG001|Cohort 2, QW|Radiological Progression|1|||
125180077|NCT02906670|450279218|FG002|Cohort 2, QW|Radiological Progression|0|||
125180078|NCT02906670|450279219|FG003|Cohort 2, QW|Radiological Progression|0|||
125180079|NCT02906670|450279220|FG004|Cohort 2, QW|Radiological Progression|0|||
125180080|NCT02906670|450279221|FG005|Cohort 2, QW|Radiological Progression|0|||
125180081|NCT02906670|450279222|FG006|Cohort 2, QW|Radiological Progression|0|||
125180082|NCT02906670|450279223|FG007|Cohort 2, QW|Radiological Progression|0|||
125180083|NCT02906670|450279224|FG008|Cohort 2, QW|Radiological Progression|0|||
125180084|NCT02906670|450279225|FG009|Cohort 2, QW|Radiological Progression|0|||
125303080|NCT03100058|450736668|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
125180085|NCT02906670|450279216|FG000|Cohort 3, QW|Radiological Progression|0|||
125180086|NCT02906670|450279217|FG001|Cohort 3, QW|Radiological Progression|0|||
125180087|NCT02906670|450279218|FG002|Cohort 3, QW|Radiological Progression|2|||
125180088|NCT02906670|450279219|FG003|Cohort 3, QW|Radiological Progression|0|||
125180089|NCT02906670|450279220|FG004|Cohort 3, QW|Radiological Progression|0|||
125235528|NCT04810962|450489884|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
125235529|NCT02412657|450489888|FG000|Overall Study|Lost to Follow-up|1|||
125235530|NCT02412657|450489889|FG001|Overall Study|Lost to Follow-up|0|||
125235531|NCT02412657|450489890|FG002|Overall Study|Lost to Follow-up|0|||
125235532|NCT02412657|450489888|FG000|Overall Study|Protocol Violation|0|||
125235533|NCT02412657|450489889|FG001|Overall Study|Protocol Violation|2|||
125235534|NCT02412657|450489890|FG002|Overall Study|Protocol Violation|3|||
125235535|NCT00460798|450489891|FG000|Overall Study|Death|59|||
125180090|NCT02906670|450279221|FG005|Cohort 3, QW|Radiological Progression|0|||
125180091|NCT02906670|450279222|FG006|Cohort 3, QW|Radiological Progression|0|||
125180092|NCT02906670|450279223|FG007|Cohort 3, QW|Radiological Progression|0|||
125180093|NCT02906670|450279224|FG008|Cohort 3, QW|Radiological Progression|0|||
125180094|NCT02906670|450279225|FG009|Cohort 3, QW|Radiological Progression|0|||
125180095|NCT02906670|450279216|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
125180096|NCT02906670|450279217|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
125180097|NCT02906670|450279218|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
125180098|NCT02906670|450279219|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
125180099|NCT02906670|450279220|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
125180100|NCT02906670|450279221|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
125180101|NCT02906670|450279222|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
125180102|NCT02906670|450279223|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
125180103|NCT02906670|450279224|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
125180104|NCT02906670|450279225|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
125180105|NCT02906670|450279216|FG000|Cohort 4, Q2W|Radiological Progression|0|||
125180106|NCT02906670|450279217|FG001|Cohort 4, Q2W|Radiological Progression|0|||
125180107|NCT02906670|450279218|FG002|Cohort 4, Q2W|Radiological Progression|0|||
125180108|NCT02906670|450279219|FG003|Cohort 4, Q2W|Radiological Progression|0|||
125180109|NCT02906670|450279220|FG004|Cohort 4, Q2W|Radiological Progression|0|||
125180110|NCT02906670|450279221|FG005|Cohort 4, Q2W|Radiological Progression|1|||
125180111|NCT02906670|450279222|FG006|Cohort 4, Q2W|Radiological Progression|0|||
125180112|NCT02906670|450279223|FG007|Cohort 4, Q2W|Radiological Progression|0|||
125180113|NCT02906670|450279224|FG008|Cohort 4, Q2W|Radiological Progression|0|||
125180114|NCT02906670|450279225|FG009|Cohort 4, Q2W|Radiological Progression|0|||
125180115|NCT02906670|450279216|FG000|Cohort 4, Q2W|Clinical Progression|0|||
125180116|NCT02906670|450279217|FG001|Cohort 4, Q2W|Clinical Progression|0|||
125180117|NCT02906670|450279218|FG002|Cohort 4, Q2W|Clinical Progression|0|||
125180118|NCT02906670|450279219|FG003|Cohort 4, Q2W|Clinical Progression|0|||
125180119|NCT02906670|450279220|FG004|Cohort 4, Q2W|Clinical Progression|0|||
125180120|NCT02906670|450279221|FG005|Cohort 4, Q2W|Clinical Progression|2|||
125180121|NCT02906670|450279222|FG006|Cohort 4, Q2W|Clinical Progression|0|||
125180122|NCT02906670|450279223|FG007|Cohort 4, Q2W|Clinical Progression|0|||
125180123|NCT02906670|450279224|FG008|Cohort 4, Q2W|Clinical Progression|0|||
125180124|NCT02906670|450279225|FG009|Cohort 4, Q2W|Clinical Progression|0|||
125180125|NCT02906670|450279216|FG000|Cohort 5, Q2W|Radiological Progression|0|||
125180126|NCT02906670|450279217|FG001|Cohort 5, Q2W|Radiological Progression|0|||
125180127|NCT02906670|450279218|FG002|Cohort 5, Q2W|Radiological Progression|0|||
125180128|NCT02906670|450279219|FG003|Cohort 5, Q2W|Radiological Progression|0|||
125180129|NCT02906670|450279220|FG004|Cohort 5, Q2W|Radiological Progression|0|||
125180130|NCT02906670|450279221|FG005|Cohort 5, Q2W|Radiological Progression|0|||
125180131|NCT02906670|450279222|FG006|Cohort 5, Q2W|Radiological Progression|4|||
125180132|NCT02906670|450279223|FG007|Cohort 5, Q2W|Radiological Progression|0|||
125180133|NCT02906670|450279224|FG008|Cohort 5, Q2W|Radiological Progression|0|||
125180134|NCT02906670|450279225|FG009|Cohort 5, Q2W|Radiological Progression|0|||
125180135|NCT02906670|450279216|FG000|Cohort 5, Q2W|Clinical Progression|0|||
125180136|NCT02906670|450279217|FG001|Cohort 5, Q2W|Clinical Progression|0|||
125180137|NCT02906670|450279218|FG002|Cohort 5, Q2W|Clinical Progression|0|||
125180138|NCT02906670|450279219|FG003|Cohort 5, Q2W|Clinical Progression|0|||
125180139|NCT02906670|450279220|FG004|Cohort 5, Q2W|Clinical Progression|0|||
125180140|NCT02906670|450279221|FG005|Cohort 5, Q2W|Clinical Progression|0|||
125180141|NCT02906670|450279222|FG006|Cohort 5, Q2W|Clinical Progression|1|||
125180142|NCT02906670|450279223|FG007|Cohort 5, Q2W|Clinical Progression|0|||
125180143|NCT02906670|450279224|FG008|Cohort 5, Q2W|Clinical Progression|0|||
125180144|NCT02906670|450279225|FG009|Cohort 5, Q2W|Clinical Progression|0|||
125180145|NCT02906670|450279216|FG000|Cohort 5, Q2W|Adverse Event|0|||
125180146|NCT02906670|450279217|FG001|Cohort 5, Q2W|Adverse Event|0|||
125180147|NCT02906670|450279218|FG002|Cohort 5, Q2W|Adverse Event|0|||
125180148|NCT02906670|450279219|FG003|Cohort 5, Q2W|Adverse Event|0|||
125180149|NCT02906670|450279220|FG004|Cohort 5, Q2W|Adverse Event|0|||
125180150|NCT02906670|450279221|FG005|Cohort 5, Q2W|Adverse Event|0|||
125235536|NCT00460798|450489891|FG000|Overall Study|Adverse Event|27|||
125180151|NCT02906670|450279222|FG006|Cohort 5, Q2W|Adverse Event|1|||
125180152|NCT02906670|450279223|FG007|Cohort 5, Q2W|Adverse Event|0|||
125180153|NCT02906670|450279224|FG008|Cohort 5, Q2W|Adverse Event|0|||
125180154|NCT02906670|450279225|FG009|Cohort 5, Q2W|Adverse Event|0|||
125180155|NCT02906670|450279216|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
125180156|NCT02906670|450279217|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
125180157|NCT02906670|450279218|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
125180158|NCT02906670|450279219|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
125180159|NCT02906670|450279220|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
125180160|NCT02906670|450279221|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
125180161|NCT02906670|450279222|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
125180162|NCT02906670|450279223|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
125180163|NCT02906670|450279224|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
125180164|NCT02906670|450279225|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
125180165|NCT02906670|450279216|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
125180166|NCT02906670|450279217|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
125180167|NCT02906670|450279218|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
125180168|NCT02906670|450279219|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
125180169|NCT02906670|450279220|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
125180170|NCT02906670|450279221|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
125180171|NCT02906670|450279222|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
125180172|NCT02906670|450279223|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
125180173|NCT02906670|450279224|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
125180174|NCT02906670|450279225|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
125180175|NCT02906670|450279216|FG000|Cohort 5P, Q2W|Adverse Event|0|||
125180176|NCT02906670|450279217|FG001|Cohort 5P, Q2W|Adverse Event|0|||
125180177|NCT02906670|450279218|FG002|Cohort 5P, Q2W|Adverse Event|0|||
125180178|NCT02906670|450279219|FG003|Cohort 5P, Q2W|Adverse Event|0|||
125180179|NCT02906670|450279220|FG004|Cohort 5P, Q2W|Adverse Event|0|||
125180180|NCT02906670|450279221|FG005|Cohort 5P, Q2W|Adverse Event|0|||
125180181|NCT02906670|450279222|FG006|Cohort 5P, Q2W|Adverse Event|0|||
125180182|NCT02906670|450279223|FG007|Cohort 5P, Q2W|Adverse Event|1|||
125180183|NCT02906670|450279224|FG008|Cohort 5P, Q2W|Adverse Event|0|||
125180184|NCT02906670|450279225|FG009|Cohort 5P, Q2W|Adverse Event|0|||
125180185|NCT02906670|450279216|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
125180186|NCT02906670|450279217|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
125180187|NCT02906670|450279218|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
125180188|NCT02906670|450279219|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
125180189|NCT02906670|450279220|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
125180190|NCT02906670|450279221|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
125180191|NCT02906670|450279222|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
125180192|NCT02906670|450279223|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
125180193|NCT02906670|450279224|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
125180194|NCT02906670|450279225|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
125180195|NCT02906670|450279216|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
125180196|NCT02906670|450279217|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
125180197|NCT02906670|450279218|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
125180198|NCT02906670|450279219|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
125180199|NCT02906670|450279220|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
125180200|NCT02906670|450279221|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
125180201|NCT02906670|450279222|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
125180202|NCT02906670|450279223|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
125180203|NCT02906670|450279224|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
125180204|NCT02906670|450279225|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
125180205|NCT02906670|450279216|FG000|Cohort 4P, QW|Radiological Progression|0|||
125180206|NCT02906670|450279217|FG001|Cohort 4P, QW|Radiological Progression|0|||
125180207|NCT02906670|450279218|FG002|Cohort 4P, QW|Radiological Progression|0|||
125180208|NCT02906670|450279219|FG003|Cohort 4P, QW|Radiological Progression|3|||
125180209|NCT02906670|450279220|FG004|Cohort 4P, QW|Radiological Progression|0|||
125180210|NCT02906670|450279221|FG005|Cohort 4P, QW|Radiological Progression|0|||
125180211|NCT02906670|450279222|FG006|Cohort 4P, QW|Radiological Progression|0|||
125180212|NCT02906670|450279223|FG007|Cohort 4P, QW|Radiological Progression|0|||
125180213|NCT02906670|450279224|FG008|Cohort 4P, QW|Radiological Progression|0|||
125180214|NCT02906670|450279225|FG009|Cohort 4P, QW|Radiological Progression|0|||
125180215|NCT02906670|450279216|FG000|Cohort 7P, Q2W|Adverse Event|0|||
125180216|NCT02906670|450279217|FG001|Cohort 7P, Q2W|Adverse Event|0|||
125180217|NCT02906670|450279218|FG002|Cohort 7P, Q2W|Adverse Event|0|||
125180218|NCT02906670|450279219|FG003|Cohort 7P, Q2W|Adverse Event|0|||
125180219|NCT02906670|450279220|FG004|Cohort 7P, Q2W|Adverse Event|0|||
125180220|NCT02906670|450279221|FG005|Cohort 7P, Q2W|Adverse Event|0|||
125180221|NCT02906670|450279222|FG006|Cohort 7P, Q2W|Adverse Event|0|||
125180222|NCT02906670|450279223|FG007|Cohort 7P, Q2W|Adverse Event|0|||
125180223|NCT02906670|450279224|FG008|Cohort 7P, Q2W|Adverse Event|0|||
125180224|NCT02906670|450279225|FG009|Cohort 7P, Q2W|Adverse Event|1|||
125180225|NCT02906670|450279216|FG000|Cohort 7P, Q2W|Physician Decision|0|||
125180226|NCT02906670|450279217|FG001|Cohort 7P, Q2W|Physician Decision|0|||
125180227|NCT02906670|450279218|FG002|Cohort 7P, Q2W|Physician Decision|0|||
125180228|NCT02906670|450279219|FG003|Cohort 7P, Q2W|Physician Decision|0|||
125180229|NCT02906670|450279220|FG004|Cohort 7P, Q2W|Physician Decision|0|||
125180230|NCT02906670|450279221|FG005|Cohort 7P, Q2W|Physician Decision|0|||
125180231|NCT02906670|450279222|FG006|Cohort 7P, Q2W|Physician Decision|0|||
125180232|NCT02906670|450279223|FG007|Cohort 7P, Q2W|Physician Decision|0|||
125180233|NCT02906670|450279224|FG008|Cohort 7P, Q2W|Physician Decision|0|||
125180234|NCT02906670|450279225|FG009|Cohort 7P, Q2W|Physician Decision|1|||
125180235|NCT02906670|450279216|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
125180236|NCT02906670|450279217|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
125180237|NCT02906670|450279218|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
125180238|NCT02906670|450279219|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
125180239|NCT02906670|450279220|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
125180240|NCT02906670|450279221|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
125180241|NCT02906670|450279222|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
125180242|NCT02906670|450279223|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
125180243|NCT02906670|450279224|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
125180244|NCT02906670|450279225|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
125180245|NCT02906670|450279216|FG000|Cohort 5P, QW|Radiological Progression|0|||
125180246|NCT02906670|450279217|FG001|Cohort 5P, QW|Radiological Progression|0|||
125180247|NCT02906670|450279218|FG002|Cohort 5P, QW|Radiological Progression|0|||
125180248|NCT02906670|450279219|FG003|Cohort 5P, QW|Radiological Progression|0|||
125180249|NCT02906670|450279220|FG004|Cohort 5P, QW|Radiological Progression|3|||
125180250|NCT02906670|450279221|FG005|Cohort 5P, QW|Radiological Progression|0|||
125180251|NCT02906670|450279222|FG006|Cohort 5P, QW|Radiological Progression|0|||
125180252|NCT02906670|450279223|FG007|Cohort 5P, QW|Radiological Progression|0|||
125180253|NCT02906670|450279224|FG008|Cohort 5P, QW|Radiological Progression|0|||
125180254|NCT02906670|450279225|FG009|Cohort 5P, QW|Radiological Progression|0|||
125180255|NCT01349192|450279226|FG000|Overall Study|Protocol Violation|0|||
125180256|NCT01349192|450279227|FG001|Overall Study|Protocol Violation|1|||
125180257|NCT01349192|450279226|FG000|Overall Study|Withdrawal by Subject|0|||
125180258|NCT01349192|450279227|FG001|Overall Study|Withdrawal by Subject|2|||
125180259|NCT01349192|450279226|FG000|Overall Study|Lost to Follow-up|1|||
125180260|NCT01349192|450279227|FG001|Overall Study|Lost to Follow-up|3|||
125180261|NCT01349192|450279226|FG000|Overall Study|Failure to adhere to Protocol|2|||
125180262|NCT01349192|450279227|FG001|Overall Study|Failure to adhere to Protocol|0|||
125180263|NCT03749330|450279228|FG000|Overall Study|Clinicians left work in the CICU|0|||
125180264|NCT03749330|450279229|FG001|Overall Study|Clinicians left work in the CICU|2|||
125180265|NCT03749330|450279230|FG002|Overall Study|Clinicians left work in the CICU|0|||
125180266|NCT03749330|450279231|FG003|Overall Study|Clinicians left work in the CICU|0|||
125180267|NCT03749330|450279232|FG004|Overall Study|Clinicians left work in the CICU|0|||
125180268|NCT03749330|450279233|FG005|Overall Study|Clinicians left work in the CICU|0|||
125180269|NCT01973439|450279234|FG000|Overall Study|Lost samples from one PK Day|2|||
125180270|NCT01973439|450279234|FG000|Overall Study|Vomiting after commencing once daily|1|||
125180271|NCT01973439|450279234|FG000|Overall Study|PK curve incomplete|2|||
125180272|NCT02038010|450279239|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
125180273|NCT02038010|450279240|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
125180274|NCT02038010|450279241|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
125180275|NCT02038010|450279242|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
125180276|NCT02038010|450279239|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
125180277|NCT02038010|450279240|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
125180278|NCT02038010|450279241|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
125180279|NCT02038010|450279242|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
125180280|NCT02038010|450279239|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
125180281|NCT02038010|450279240|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
125180282|NCT02038010|450279241|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
125180283|NCT02038010|450279242|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
125180284|NCT02038010|450279239|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
125180285|NCT02038010|450279240|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
125180286|NCT02038010|450279241|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
125180287|NCT02038010|450279242|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
125180288|NCT02038010|450279239|FG000|Follow Up|Death|4|||
125180289|NCT02038010|450279240|FG001|Follow Up|Death|3|||
125180290|NCT02038010|450279241|FG002|Follow Up|Death|0|||
125180291|NCT02038010|450279242|FG003|Follow Up|Death|0|||
125180292|NCT02038010|450279239|FG000|Follow Up|Other|3|||
125180293|NCT02038010|450279240|FG001|Follow Up|Other|0|||
125180294|NCT02038010|450279241|FG002|Follow Up|Other|0|||
125180295|NCT02038010|450279242|FG003|Follow Up|Other|0|||
125180296|NCT03908125|450279244|FG000|Overall Study|Withdrawal by Subject|92|||
125180297|NCT03908125|450279244|FG000|Overall Study|Lost to Follow-up|8|||
125180298|NCT02262325|450279245|FG000|Overall Study|Death|16|||
125180299|NCT02262325|450279245|FG000|Overall Study|Lost to Follow-up|1|||
125180300|NCT02815995|450279246|FG000|Overall Study|Disease Progression|3|||
125180301|NCT02815995|450279247|FG001|Overall Study|Disease Progression|7|||
125235537|NCT00460798|450489891|FG000|Overall Study|Lost to Follow-up|19|||
125235538|NCT00460798|450489891|FG000|Overall Study|Progressive Disease|99|||
125235539|NCT00460798|450489891|FG000|Overall Study|Other|27|||
125235540|NCT00460798|450489891|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
125235541|NCT00460798|450489891|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
125235542|NCT01898130|450489892|FG000|Treatment|Withdrawal by Subject|2|||
125235543|NCT01898130|450489892|FG000|Treatment|Progressive Disease|4|||
125235544|NCT01898130|450489892|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
125235545|NCT00630292|450489893|FG000|Overall Study|Withdrawal by Subject|1|||
125180302|NCT02815995|450279248|FG002|Overall Study|Disease Progression|2|||
125180303|NCT02815995|450279249|FG003|Overall Study|Disease Progression|4|||
125180304|NCT02815995|450279250|FG004|Overall Study|Disease Progression|3|||
125180305|NCT02815995|450279251|FG005|Overall Study|Disease Progression|9|||
125180306|NCT02815995|450279252|FG006|Overall Study|Disease Progression|3|||
125180307|NCT02815995|450279253|FG007|Overall Study|Disease Progression|1|||
125180308|NCT02815995|450279246|FG000|Overall Study|Adverse Event|1|||
125180309|NCT02815995|450279247|FG001|Overall Study|Adverse Event|2|||
125180310|NCT02815995|450279248|FG002|Overall Study|Adverse Event|2|||
125180311|NCT02815995|450279249|FG003|Overall Study|Adverse Event|0|||
125180312|NCT02815995|450279250|FG004|Overall Study|Adverse Event|0|||
125180313|NCT02815995|450279251|FG005|Overall Study|Adverse Event|1|||
125180314|NCT02815995|450279252|FG006|Overall Study|Adverse Event|0|||
125180315|NCT02815995|450279253|FG007|Overall Study|Adverse Event|0|||
125180316|NCT02815995|450279246|FG000|Overall Study|Pregnancy|0|||
125180317|NCT02815995|450279247|FG001|Overall Study|Pregnancy|0|||
125180318|NCT02815995|450279248|FG002|Overall Study|Pregnancy|0|||
125180319|NCT02815995|450279249|FG003|Overall Study|Pregnancy|0|||
125180320|NCT02815995|450279250|FG004|Overall Study|Pregnancy|0|||
125180321|NCT02815995|450279251|FG005|Overall Study|Pregnancy|0|||
125180322|NCT02815995|450279252|FG006|Overall Study|Pregnancy|1|||
125180323|NCT02815995|450279253|FG007|Overall Study|Pregnancy|0|||
125180324|NCT01071915|450279254|FG000|Overall Study|Adverse Event|3|||
125180325|NCT01071915|450279254|FG000|Overall Study|Physician Decision|2|||
125180326|NCT01071915|450279254|FG000|Overall Study|Withdrawal by Subject|2|||
125180327|NCT01071915|450279254|FG000|Overall Study|Miscellaneous Reasons|2|||
125180328|NCT00114140|450279255|FG000|Overall Study|Protocol Violation|7|||
125180329|NCT00769379|450279258|FG000|Overall Study|No follow up data mapped to Other.|3|||
125180330|NCT00769379|450279259|FG001|Overall Study|No follow up data mapped to Other.|13|||
125180331|NCT01928472|450279260|FG000|Overall Study|Death|0|||
125180332|NCT01928472|450279261|FG001|Overall Study|Death|0|||
125180333|NCT01928472|450279262|FG002|Overall Study|Death|1|||
125180334|NCT01928472|450279263|FG003|Overall Study|Death|0|||
125180335|NCT01928472|450279260|FG000|Overall Study|Withdrawal by Subject|4|||
125180336|NCT01928472|450279261|FG001|Overall Study|Withdrawal by Subject|4|||
125180337|NCT01928472|450279262|FG002|Overall Study|Withdrawal by Subject|1|||
125180338|NCT01928472|450279263|FG003|Overall Study|Withdrawal by Subject|2|||
125180339|NCT01928472|450279260|FG000|Overall Study|Lost to Follow-up|2|||
125180340|NCT01928472|450279261|FG001|Overall Study|Lost to Follow-up|3|||
125180341|NCT01928472|450279262|FG002|Overall Study|Lost to Follow-up|4|||
125180342|NCT01928472|450279263|FG003|Overall Study|Lost to Follow-up|0|||
125180343|NCT01928472|450279260|FG000|Overall Study|Administrative Reason|2|||
125180344|NCT01928472|450279261|FG001|Overall Study|Administrative Reason|1|||
125180345|NCT01928472|450279262|FG002|Overall Study|Administrative Reason|0|||
125180346|NCT01928472|450279263|FG003|Overall Study|Administrative Reason|0|||
125180347|NCT01928472|450279260|FG000|Overall Study|Unclassified|0|||
125180348|NCT01928472|450279261|FG001|Overall Study|Unclassified|0|||
125180349|NCT01928472|450279262|FG002|Overall Study|Unclassified|1|||
125180350|NCT01928472|450279263|FG003|Overall Study|Unclassified|0|||
125180351|NCT01308424|450279264|FG000|Baseline Eligibility|Screen Failures|71|||
125180352|NCT01308424|450279265|FG001|Baseline Eligibility|Screen Failures|0|||
125180353|NCT01308424|450279266|FG002|Baseline Eligibility|Screen Failures|0|||
125180354|NCT01308424|450279264|FG000|Randomization|Adverse Event|0|||
125180355|NCT01308424|450279265|FG001|Randomization|Adverse Event|1|||
125180356|NCT01308424|450279266|FG002|Randomization|Adverse Event|1|||
125180357|NCT01308424|450279264|FG000|Randomization|Lost to Follow-up|0|||
125180358|NCT01308424|450279265|FG001|Randomization|Lost to Follow-up|1|||
125180359|NCT01308424|450279266|FG002|Randomization|Lost to Follow-up|0|||
125180360|NCT01308424|450279264|FG000|Randomization|Physician Decision|0|||
125235546|NCT00142415|450489894|FG000|Overall Study|Physician Decision|0|||
125180361|NCT01308424|450279265|FG001|Randomization|Physician Decision|1|||
125180362|NCT01308424|450279266|FG002|Randomization|Physician Decision|1|||
125180363|NCT00129545|450279270|FG000|Overall Study|Death|5|||
125180364|NCT00129545|450279271|FG001|Overall Study|Death|60|||
125180365|NCT00129545|450279272|FG002|Overall Study|Death|44|||
125180366|NCT00129545|450279270|FG000|Overall Study|Withdrawal by Subject|3|||
125180367|NCT00129545|450279271|FG001|Overall Study|Withdrawal by Subject|18|||
125180368|NCT00129545|450279272|FG002|Overall Study|Withdrawal by Subject|44|||
125180369|NCT00129545|450279270|FG000|Overall Study|Lost to Follow-up|2|||
125180370|NCT00129545|450279271|FG001|Overall Study|Lost to Follow-up|22|||
125235547|NCT00142415|450489895|FG001|Overall Study|Physician Decision|0|||
125235548|NCT00142415|450489896|FG002|Overall Study|Physician Decision|0|||
125235549|NCT00142415|450489897|FG003|Overall Study|Physician Decision|0|||
125235550|NCT00142415|450489898|FG004|Overall Study|Physician Decision|1|||
125235551|NCT00142415|450489899|FG005|Overall Study|Physician Decision|2|||
125235552|NCT01189266|450489900|FG000|Overall Study|Adverse Event|1|||
125235553|NCT01189266|450489901|FG001|Overall Study|Adverse Event|0|||
125235554|NCT01189266|450489902|FG002|Overall Study|Adverse Event|5|||
125235555|NCT01189266|450489900|FG000|Overall Study|Death|0|||
125235556|NCT01189266|450489901|FG001|Overall Study|Death|0|||
125235557|NCT01189266|450489902|FG002|Overall Study|Death|5|||
125235558|NCT01189266|450489900|FG000|Overall Study|Lack of Efficacy|4|||
125235559|NCT01189266|450489901|FG001|Overall Study|Lack of Efficacy|5|||
125235560|NCT01189266|450489902|FG002|Overall Study|Lack of Efficacy|44|||
125235561|NCT01189266|450489900|FG000|Overall Study|Physician Decision|0|||
125235562|NCT01189266|450489901|FG001|Overall Study|Physician Decision|0|||
125235563|NCT01189266|450489902|FG002|Overall Study|Physician Decision|1|||
125235564|NCT01189266|450489900|FG000|Overall Study|Protocol Violation|0|||
125235565|NCT01189266|450489901|FG001|Overall Study|Protocol Violation|1|||
125235566|NCT01189266|450489902|FG002|Overall Study|Protocol Violation|1|||
125235567|NCT01189266|450489900|FG000|Overall Study|Withdrawal by Subject|0|||
125235568|NCT01189266|450489901|FG001|Overall Study|Withdrawal by Subject|0|||
125235569|NCT01189266|450489902|FG002|Overall Study|Withdrawal by Subject|1|||
125235570|NCT01189266|450489900|FG000|Overall Study|Patient refuses further therapy|1|||
125235571|NCT01189266|450489901|FG001|Overall Study|Patient refuses further therapy|0|||
125235572|NCT01189266|450489902|FG002|Overall Study|Patient refuses further therapy|7|||
125235573|NCT01189266|450489900|FG000|Overall Study|No treatment|0|||
125235574|NCT01189266|450489901|FG001|Overall Study|No treatment|0|||
125235575|NCT01189266|450489902|FG002|Overall Study|No treatment|1|||
125235576|NCT00537277|450489903|FG000|Overall Study|Adverse Event|1|||
125235577|NCT00537277|450489903|FG000|Overall Study|Lack of Efficacy|2|||
125235578|NCT00537277|450489903|FG000|Overall Study|Lost to Follow-up|12|||
125235579|NCT00537277|450489903|FG000|Overall Study|Protocol Violation|11|||
125235580|NCT00537277|450489903|FG000|Overall Study|Unclassified|4|||
125235581|NCT00537277|450489903|FG000|Overall Study|Inability to tolerate trial medication|4|||
125235582|NCT00537277|450489903|FG000|Overall Study|Non-compliance with trial procedures|15|||
125235583|NCT03620162|450489904|FG000|Overall Study|Physician Decision|4|||
125235584|NCT03620162|450489905|FG001|Overall Study|Physician Decision|0|||
125235585|NCT03620162|450489906|FG002|Overall Study|Physician Decision|1|||
125235586|NCT03620162|450489907|FG003|Overall Study|Physician Decision|0|||
125235587|NCT03620162|450489908|FG004|Overall Study|Physician Decision|2|||
125235588|NCT03620162|450489904|FG000|Overall Study|Lost to Follow-up|2|||
125235589|NCT03620162|450489905|FG001|Overall Study|Lost to Follow-up|6|||
125235590|NCT03620162|450489906|FG002|Overall Study|Lost to Follow-up|7|||
125235591|NCT03620162|450489907|FG003|Overall Study|Lost to Follow-up|3|||
125235592|NCT03620162|450489908|FG004|Overall Study|Lost to Follow-up|2|||
125235593|NCT03620162|450489904|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
125235594|NCT03620162|450489905|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
125235595|NCT03620162|450489906|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
125235596|NCT03620162|450489907|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
125235597|NCT03620162|450489908|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
125235598|NCT01838876|450489911|FG000|Overall Study|Adverse Event|49|||
125235599|NCT01838876|450489911|FG000|Overall Study|Insufficient Therapeutic Response|10|||
125235600|NCT01838876|450489911|FG000|Overall Study|Protocol Violation|34|||
125235601|NCT01838876|450489911|FG000|Overall Study|Withdrawal of Consent|33|||
125235602|NCT01838876|450489911|FG000|Overall Study|Lost to Follow-up|21|||
125235603|NCT01838876|450489911|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
125235604|NCT01838876|450489911|FG000|Overall Study|Reason not Specified|7|||
125235605|NCT01838876|450489911|FG000|Overall Study|Did not meet eligibility criteria|78|||
125235606|NCT02101294|450489912|FG000|Overall Study|Withdrawal by Subject|5|||
125235607|NCT02101294|450489912|FG000|Overall Study|Lost to Follow-up|6|||
125235608|NCT03416179|450489913|FG000|Overall Study|Death|90|||
125235609|NCT03416179|450489914|FG001|Overall Study|Death|87|||
125235610|NCT03416179|450489915|FG002|Overall Study|Death|117|||
125235611|NCT03416179|450489916|FG003|Overall Study|Death|113|||
125235612|NCT03416179|450489913|FG000|Overall Study|Withdrawal by Subject|15|||
125235613|NCT03416179|450489914|FG001|Overall Study|Withdrawal by Subject|20|||
125235614|NCT03416179|450489915|FG002|Overall Study|Withdrawal by Subject|6|||
125235615|NCT03416179|450489916|FG003|Overall Study|Withdrawal by Subject|9|||
125235616|NCT03416179|450489913|FG000|Overall Study|Lost to Follow-up|1|||
125235617|NCT03416179|450489914|FG001|Overall Study|Lost to Follow-up|1|||
125235618|NCT03416179|450489915|FG002|Overall Study|Lost to Follow-up|0|||
125235619|NCT03416179|450489916|FG003|Overall Study|Lost to Follow-up|3|||
125235620|NCT03416179|450489913|FG000|Overall Study|Study participation terminated by Sponsor|93|||
125235621|NCT03416179|450489914|FG001|Overall Study|Study participation terminated by Sponsor|91|||
125235622|NCT03416179|450489915|FG002|Overall Study|Study participation terminated by Sponsor|26|||
125235623|NCT03416179|450489916|FG003|Overall Study|Study participation terminated by Sponsor|31|||
125235624|NCT03416179|450489913|FG000|Overall Study|Other|2|||
125235625|NCT03416179|450489914|FG001|Overall Study|Other|3|||
125235626|NCT03416179|450489915|FG002|Overall Study|Other|1|||
125235627|NCT03416179|450489916|FG003|Overall Study|Other|0|||
125235628|NCT01682031|450489919|FG000|Overall Study|Withdrawal by Subject|0|||
125235629|NCT01682031|450489920|FG001|Overall Study|Withdrawal by Subject|1|||
125235630|NCT01682031|450489919|FG000|Overall Study|Adverse Event|0|||
125235631|NCT01682031|450489920|FG001|Overall Study|Adverse Event|2|||
125235632|NCT01682031|450489919|FG000|Overall Study|MRI results indicate increased nodul|0|||
125235633|NCT01682031|450489920|FG001|Overall Study|MRI results indicate increased nodul|1|||
125235634|NCT01682031|450489919|FG000|Overall Study|Patient could not swallow tablets|1|||
125235635|NCT01682031|450489920|FG001|Overall Study|Patient could not swallow tablets|0|||
125235636|NCT01682031|450489919|FG000|Overall Study|Patient stopped selenium on his own|0|||
125235637|NCT01682031|450489920|FG001|Overall Study|Patient stopped selenium on his own|1|||
125235638|NCT01056536|450489926|FG000|Overall Study|Lost to Follow-up|202|||
125235639|NCT01056536|450489927|FG001|Overall Study|Lost to Follow-up|116|||
125235640|NCT01056536|450489928|FG002|Overall Study|Lost to Follow-up|248|||
125235641|NCT00924898|450489930|FG000|Overall Study|Withdrawal by Subject|2|||
125235642|NCT01285518|450489931|FG000|Overall Study|Lost to Follow-up|0|||
125235643|NCT01285518|450489932|FG001|Overall Study|Lost to Follow-up|0|||
125235644|NCT01285518|450489933|FG002|Overall Study|Lost to Follow-up|0|||
125235645|NCT01285518|450489934|FG003|Overall Study|Lost to Follow-up|0|||
125235646|NCT01285518|450489935|FG004|Overall Study|Lost to Follow-up|0|||
125235647|NCT01285518|450489936|FG005|Overall Study|Lost to Follow-up|1|||
125235648|NCT01285518|450489937|FG006|Overall Study|Lost to Follow-up|0|||
125235649|NCT01285518|450489938|FG007|Overall Study|Lost to Follow-up|0|||
125235650|NCT00294658|450489939|FG000|Overall Study|Death|0|||
125235651|NCT00294658|450489940|FG001|Overall Study|Death|1|||
125235652|NCT00294658|450489939|FG000|Overall Study|Lost to Follow-up|4|||
125235653|NCT00294658|450489940|FG001|Overall Study|Lost to Follow-up|0|||
125235654|NCT00294658|450489939|FG000|Overall Study|Physician Decision|1|||
125235655|NCT00294658|450489940|FG001|Overall Study|Physician Decision|2|||
125235656|NCT00294658|450489939|FG000|Overall Study|Pregnancy|0|||
125235657|NCT00294658|450489940|FG001|Overall Study|Pregnancy|1|||
125235658|NCT00294658|450489939|FG000|Overall Study|Withdrawal by Subject|0|||
125235659|NCT00294658|450489940|FG001|Overall Study|Withdrawal by Subject|4|||
125235660|NCT00294658|450489939|FG000|Overall Study|Found to have invasive thymoma|1|||
125235661|NCT00294658|450489940|FG001|Overall Study|Found to have invasive thymoma|0|||
125235662|NCT00294658|450489939|FG000|Overall Study|Patient and family were not satisfied|0|||
125235663|NCT00294658|450489940|FG001|Overall Study|Patient and family were not satisfied|1|||
125235664|NCT03805841|450489941|FG000|Overall Study|Clinical Progression|2|||
125235665|NCT03805841|450489942|FG001|Overall Study|Clinical Progression|0|||
125235666|NCT03805841|450489943|FG002|Overall Study|Clinical Progression|0|||
125235667|NCT03805841|450489941|FG000|Overall Study|Death|0|||
125235668|NCT03805841|450489942|FG001|Overall Study|Death|3|||
125235669|NCT03805841|450489943|FG002|Overall Study|Death|1|||
125235670|NCT03805841|450489941|FG000|Overall Study|Lost to Follow-up|0|||
125235671|NCT03805841|450489942|FG001|Overall Study|Lost to Follow-up|0|||
125235672|NCT03805841|450489943|FG002|Overall Study|Lost to Follow-up|1|||
125235673|NCT03805841|450489941|FG000|Overall Study|Withdrawal by Subject|2|||
125235674|NCT03805841|450489942|FG001|Overall Study|Withdrawal by Subject|3|||
125235675|NCT03805841|450489943|FG002|Overall Study|Withdrawal by Subject|0|||
125235676|NCT03805841|450489941|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
125235677|NCT03805841|450489942|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
125235678|NCT03805841|450489943|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
125235679|NCT00846365|450489946|FG000|Overall Study|Adverse Event|20|||
125235680|NCT00846365|450489947|FG001|Overall Study|Adverse Event|30|||
125235681|NCT00846365|450489948|FG002|Overall Study|Adverse Event|11|||
125235682|NCT00846365|450489946|FG000|Overall Study|Protocol Violation|5|||
125235683|NCT00846365|450489947|FG001|Overall Study|Protocol Violation|4|||
125235684|NCT00846365|450489948|FG002|Overall Study|Protocol Violation|0|||
125235685|NCT00846365|450489946|FG000|Overall Study|Lost to Follow-up|8|||
125235686|NCT00846365|450489947|FG001|Overall Study|Lost to Follow-up|2|||
125235687|NCT00846365|450489948|FG002|Overall Study|Lost to Follow-up|5|||
125235688|NCT00846365|450489946|FG000|Overall Study|Withdrawal by Subject|11|||
125235689|NCT00846365|450489947|FG001|Overall Study|Withdrawal by Subject|11|||
125235690|NCT00846365|450489948|FG002|Overall Study|Withdrawal by Subject|9|||
125235691|NCT00846365|450489946|FG000|Overall Study|Pregnancy|1|||
125235692|NCT00846365|450489947|FG001|Overall Study|Pregnancy|0|||
125235693|NCT00846365|450489948|FG002|Overall Study|Pregnancy|0|||
125235694|NCT00846365|450489946|FG000|Overall Study|Lack of Efficacy|1|||
125235695|NCT00846365|450489947|FG001|Overall Study|Lack of Efficacy|1|||
125235696|NCT00846365|450489948|FG002|Overall Study|Lack of Efficacy|2|||
125235697|NCT00846365|450489946|FG000|Overall Study|Other|9|||
125235698|NCT00846365|450489947|FG001|Overall Study|Other|1|||
125235699|NCT00846365|450489948|FG002|Overall Study|Other|6|||
125235700|NCT00862992|450489951|FG000|Overall Study|Adverse Event|2|||
125235701|NCT00862992|450489952|FG001|Overall Study|Adverse Event|1|||
125235702|NCT00862992|450489953|FG002|Overall Study|Adverse Event|1|||
125235703|NCT00862992|450489951|FG000|Overall Study|Physician Decision|1|||
125235704|NCT00862992|450489952|FG001|Overall Study|Physician Decision|0|||
125235705|NCT00862992|450489953|FG002|Overall Study|Physician Decision|0|||
125235706|NCT00862992|450489951|FG000|Overall Study|Withdrawal by Subject|0|||
125235707|NCT00862992|450489952|FG001|Overall Study|Withdrawal by Subject|0|||
125235708|NCT00862992|450489953|FG002|Overall Study|Withdrawal by Subject|2|||
125235709|NCT02696798|450489966|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
125235710|NCT02696798|450489967|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
125235711|NCT02696798|450489968|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
125235712|NCT02696798|450489966|FG000|Blinded Treatment Dosing Period|Death|0|||
125235713|NCT02696798|450489967|FG001|Blinded Treatment Dosing Period|Death|0|||
125235714|NCT02696798|450489968|FG002|Blinded Treatment Dosing Period|Death|1|||
125235715|NCT02696798|450489966|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
125235716|NCT02696798|450489967|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
125235717|NCT02696798|450489968|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
125235718|NCT02696798|450489966|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
125235719|NCT02696798|450489967|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
125235720|NCT02696798|450489968|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
125235721|NCT02696798|450489966|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
125235722|NCT02696798|450489967|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
125235723|NCT02696798|450489968|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
125235724|NCT02696798|450489966|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
125235725|NCT02696798|450489967|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
125235726|NCT02696798|450489968|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
125235727|NCT02696798|450489966|FG000|Extended Treatment Period|Adverse Event|1|||
125235728|NCT02696798|450489967|FG001|Extended Treatment Period|Adverse Event|4|||
125235729|NCT02696798|450489968|FG002|Extended Treatment Period|Adverse Event|5|||
125235730|NCT02696798|450489966|FG000|Extended Treatment Period|Lack of Efficacy|7|||
125235731|NCT02696798|450489967|FG001|Extended Treatment Period|Lack of Efficacy|2|||
125235732|NCT02696798|450489968|FG002|Extended Treatment Period|Lack of Efficacy|2|||
125235733|NCT02696798|450489966|FG000|Extended Treatment Period|Lost to Follow-up|1|||
125235734|NCT02696798|450489967|FG001|Extended Treatment Period|Lost to Follow-up|0|||
125235735|NCT02696798|450489968|FG002|Extended Treatment Period|Lost to Follow-up|0|||
125235736|NCT02696798|450489966|FG000|Extended Treatment Period|Physician Decision|0|||
125235737|NCT02696798|450489967|FG001|Extended Treatment Period|Physician Decision|1|||
125235738|NCT02696798|450489968|FG002|Extended Treatment Period|Physician Decision|0|||
125235739|NCT02696798|450489966|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
125235740|NCT02696798|450489967|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
125235741|NCT02696798|450489968|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
125235742|NCT02696798|450489966|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
125235743|NCT02696798|450489967|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
125235744|NCT02696798|450489968|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
125235745|NCT02696798|450489966|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
125235746|NCT02696798|450489967|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
125235747|NCT02696798|450489968|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
125235748|NCT02696798|450489966|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
125235749|NCT02696798|450489967|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
125235750|NCT02696798|450489968|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
125235751|NCT02696798|450489966|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
125235752|NCT02696798|450489967|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
125235753|NCT02696798|450489968|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
125235754|NCT02696798|450489966|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
125235755|NCT02696798|450489967|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
125235756|NCT02696798|450489968|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
125235757|NCT02696798|450489966|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
125235758|NCT02696798|450489967|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
125235759|NCT02696798|450489968|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
125235760|NCT01277861|450489969|FG000|Overall Study|Physician Decision|2|||
125235761|NCT01277861|450489970|FG001|Overall Study|Physician Decision|2|||
125235762|NCT00857389|450489971|FG000|Overall Study|Did not proceed to transplant|2|||
125235763|NCT01157845|450489972|FG000|Overall Study|Lost to Follow-up|5|||
125235764|NCT01157845|450489972|FG000|Overall Study|Withdrawal by Subject|12|||
125235765|NCT01157845|450489972|FG000|Overall Study|Physician Decision|3|||
125235766|NCT01157845|450489972|FG000|Overall Study|Protocol Violation|13|||
125235767|NCT01157845|450489972|FG000|Overall Study|Study was ended|1|||
125235768|NCT01157845|450489972|FG000|Overall Study|Device malfunction|1|||
125235769|NCT03311555|450489973|FG000|Overall Study|Adverse Event|1|||
125235770|NCT00788671|450491597|FG000|Overall Study|Death|2|||
125235771|NCT00788671|450491597|FG000|Overall Study|Unable to biopsy|1|||
125235772|NCT00788671|450491597|FG000|Overall Study|Withdrawal by Subject|4|||
125235773|NCT00788671|450491597|FG000|Overall Study|IUD expulsed|1|||
125180371|NCT00129545|450279272|FG002|Overall Study|Lost to Follow-up|13|||
125180372|NCT00129545|450279270|FG000|Overall Study|Physician Decision|0|||
125180373|NCT00129545|450279271|FG001|Overall Study|Physician Decision|3|||
125180374|NCT00129545|450279272|FG002|Overall Study|Physician Decision|10|||
125180375|NCT00129545|450279270|FG000|Overall Study|Device not implanted|16|||
125180376|NCT00129545|450279271|FG001|Overall Study|Device not implanted|61|||
125180377|NCT00129545|450279272|FG002|Overall Study|Device not implanted|0|||
125180378|NCT01841593|450279273|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
125180379|NCT01841593|450279274|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
125180380|NCT01841593|450279273|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
125180381|NCT01841593|450279274|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
125180382|NCT00307086|450279277|FG000|Overall Study|ineligible|5|||
125180383|NCT02969044|450279280|FG000|Overall Study|Withdrawal by Subject|2|||
125180384|NCT02969044|450279281|FG001|Overall Study|Withdrawal by Subject|6|||
125180385|NCT02969044|450279280|FG000|Overall Study|Adverse Event|3|||
125180386|NCT02969044|450279281|FG001|Overall Study|Adverse Event|0|||
125180387|NCT00312338|450279282|FG000|Overall Study|Adverse Event|7|||
125180388|NCT00312338|450279283|FG001|Overall Study|Adverse Event|2|||
125180389|NCT00312338|450279282|FG000|Overall Study|Lost to Follow-up|9|||
125180390|NCT00312338|450279283|FG001|Overall Study|Lost to Follow-up|1|||
125180391|NCT00312338|450279282|FG000|Overall Study|Withdrawal by Subject|4|||
125180392|NCT00312338|450279283|FG001|Overall Study|Withdrawal by Subject|0|||
125180393|NCT00312338|450279282|FG000|Overall Study|Subsequent infection|2|||
125180394|NCT00312338|450279283|FG001|Overall Study|Subsequent infection|0|||
125180395|NCT00262028|450279284|FG000|Overall Study|Withdrawal by Subject|6|||
125180396|NCT00262028|450279285|FG001|Overall Study|Withdrawal by Subject|3|||
125180397|NCT00262028|450279286|FG002|Overall Study|Withdrawal by Subject|6|||
125180398|NCT00262028|450279287|FG003|Overall Study|Withdrawal by Subject|5|||
125180399|NCT00262028|450279288|FG004|Overall Study|Withdrawal by Subject|2|||
125180400|NCT00262028|450279289|FG005|Overall Study|Withdrawal by Subject|3|||
125180401|NCT00262028|450279290|FG006|Overall Study|Withdrawal by Subject|5|||
125180402|NCT00262028|450279291|FG007|Overall Study|Withdrawal by Subject|7|||
125180403|NCT00262028|450279292|FG008|Overall Study|Withdrawal by Subject|2|||
125180404|NCT00262028|450279284|FG000|Overall Study|Lost to Follow-up|7|||
125180405|NCT00262028|450279285|FG001|Overall Study|Lost to Follow-up|7|||
125180406|NCT00262028|450279286|FG002|Overall Study|Lost to Follow-up|5|||
125180407|NCT00262028|450279287|FG003|Overall Study|Lost to Follow-up|5|||
125180408|NCT00262028|450279288|FG004|Overall Study|Lost to Follow-up|4|||
125180409|NCT00262028|450279289|FG005|Overall Study|Lost to Follow-up|3|||
125180410|NCT00262028|450279290|FG006|Overall Study|Lost to Follow-up|3|||
125180411|NCT00262028|450279291|FG007|Overall Study|Lost to Follow-up|5|||
125180412|NCT00262028|450279292|FG008|Overall Study|Lost to Follow-up|6|||
125180413|NCT00262028|450279284|FG000|Overall Study|Administrative Reason|11|||
125180414|NCT00262028|450279285|FG001|Overall Study|Administrative Reason|14|||
125180415|NCT00262028|450279286|FG002|Overall Study|Administrative Reason|9|||
125180416|NCT00262028|450279287|FG003|Overall Study|Administrative Reason|12|||
125180417|NCT00262028|450279288|FG004|Overall Study|Administrative Reason|6|||
125180418|NCT00262028|450279289|FG005|Overall Study|Administrative Reason|7|||
125180419|NCT00262028|450279290|FG006|Overall Study|Administrative Reason|4|||
125180420|NCT00262028|450279291|FG007|Overall Study|Administrative Reason|6|||
125180421|NCT00262028|450279292|FG008|Overall Study|Administrative Reason|10|||
125180422|NCT00262028|450279284|FG000|Overall Study|Protocol Violation|0|||
125180423|NCT00262028|450279285|FG001|Overall Study|Protocol Violation|0|||
125180424|NCT00262028|450279286|FG002|Overall Study|Protocol Violation|0|||
125180425|NCT00262028|450279287|FG003|Overall Study|Protocol Violation|1|||
125180426|NCT00262028|450279288|FG004|Overall Study|Protocol Violation|0|||
125180427|NCT00262028|450279289|FG005|Overall Study|Protocol Violation|0|||
125180428|NCT00262028|450279290|FG006|Overall Study|Protocol Violation|0|||
125180429|NCT00262028|450279291|FG007|Overall Study|Protocol Violation|0|||
125180430|NCT00262028|450279292|FG008|Overall Study|Protocol Violation|0|||
125180431|NCT00262028|450279284|FG000|Overall Study|Unable to classify|0|||
125180432|NCT00262028|450279285|FG001|Overall Study|Unable to classify|3|||
125180433|NCT00262028|450279286|FG002|Overall Study|Unable to classify|0|||
125180434|NCT00262028|450279287|FG003|Overall Study|Unable to classify|0|||
125180435|NCT00262028|450279288|FG004|Overall Study|Unable to classify|0|||
125180436|NCT00262028|450279289|FG005|Overall Study|Unable to classify|0|||
125180437|NCT00262028|450279290|FG006|Overall Study|Unable to classify|0|||
125180438|NCT00262028|450279291|FG007|Overall Study|Unable to classify|0|||
125180439|NCT00262028|450279292|FG008|Overall Study|Unable to classify|1|||
125180440|NCT02308124|450279293|FG000|Overall Study|Lost to Follow-up|6|||
125180441|NCT02308124|450279294|FG001|Overall Study|Lost to Follow-up|6|||
125180442|NCT02308124|450279295|FG002|Overall Study|Lost to Follow-up|6|||
125180443|NCT02308124|450279293|FG000|Overall Study|Adverse Event|0|||
125180444|NCT02308124|450279294|FG001|Overall Study|Adverse Event|2|||
125180445|NCT02308124|450279295|FG002|Overall Study|Adverse Event|2|||
125180446|NCT01329900|450279296|FG000|Overall Study|Elevated creatinine/renal function|1|||
125180447|NCT04233073|450279300|FG000|Overall Study|Death|5|||
125180448|NCT00143390|450279301|FG000|Overall Study|Death|2|||
125235774|NCT00788671|450491597|FG000|Overall Study|Lost to follow up|2|||
125235775|NCT03405870|450491598|FG000|Overall Study|Withdrawal|1|||
125235776|NCT03405870|450491599|FG001|Overall Study|Withdrawal|0|||
125235777|NCT03405870|450491600|FG002|Overall Study|Withdrawal|1|||
125235778|NCT03405870|450491601|FG003|Overall Study|Withdrawal|0|||
125235779|NCT03405870|450491602|FG004|Overall Study|Withdrawal|0|||
125235780|NCT03405870|450491603|FG005|Overall Study|Withdrawal|0|||
125235781|NCT03405870|450491604|FG006|Overall Study|Withdrawal|1|||
125235782|NCT03405870|450491605|FG007|Overall Study|Withdrawal|0|||
125235783|NCT05172609|450491606|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
125235784|NCT05172609|450491607|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
125235785|NCT05172609|450491606|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
125235786|NCT05172609|450491607|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
125235787|NCT05172609|450491606|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
125235788|NCT05172609|450491607|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
125235789|NCT00549055|450491608|FG000|Overall Study|Adverse Event|4|||
125235790|NCT00549055|450491608|FG000|Overall Study|Lack of Efficacy|18|||
125235791|NCT00549055|450491608|FG000|Overall Study|Stabilization|5|||
125235792|NCT00549055|450491608|FG000|Overall Study|Progression to fibrosis|2|||
125235793|NCT00549055|450491608|FG000|Overall Study|Decrease of size|1|||
125235794|NCT00549055|450491608|FG000|Overall Study|Active choroidal neovascula increased|1|||
125235795|NCT00549055|450491608|FG000|Overall Study|Vitreous hemorrhage|1|||
125235796|NCT00549055|450491608|FG000|Overall Study|Growth choroidal neovascularisation|1|||
125235797|NCT00549055|450491608|FG000|Overall Study|Choroidal neovascularization|1|||
125235798|NCT00549055|450491608|FG000|Overall Study|Very low visual acuity (VA)|1|||
125235799|NCT03846479|450491609|FG000|Overall Study|Death|8|||
125235800|NCT03846479|450491609|FG000|Overall Study|Lost to Follow-up|1|||
125235801|NCT05020015|450491610|FG000|Overall Study|Ongoing on study|1|||
125235802|NCT05020015|450491611|FG001|Overall Study|Ongoing on study|3|||
125235803|NCT05020015|450491612|FG002|Overall Study|Ongoing on study|4|||
125235804|NCT05020015|450491613|FG003|Overall Study|Ongoing on study|7|||
125235805|NCT05020015|450491610|FG000|Overall Study|Death|2|||
125235806|NCT05020015|450491611|FG001|Overall Study|Death|3|||
125235807|NCT05020015|450491612|FG002|Overall Study|Death|4|||
125235808|NCT05020015|450491613|FG003|Overall Study|Death|0|||
125235809|NCT05020015|450491610|FG000|Overall Study|Withdrawal by Subject|0|||
125235810|NCT05020015|450491611|FG001|Overall Study|Withdrawal by Subject|0|||
125235811|NCT05020015|450491612|FG002|Overall Study|Withdrawal by Subject|1|||
125235812|NCT05020015|450491613|FG003|Overall Study|Withdrawal by Subject|0|||
125235813|NCT05020015|450491610|FG000|Overall Study|Reason Not Specified|0|||
125235814|NCT05020015|450491611|FG001|Overall Study|Reason Not Specified|0|||
125235815|NCT05020015|450491612|FG002|Overall Study|Reason Not Specified|2|||
125235816|NCT05020015|450491613|FG003|Overall Study|Reason Not Specified|0|||
125235817|NCT06217380|450491616|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
125235818|NCT06217380|450491616|FG000|Overall Study|Physician Decision|1|||
125235819|NCT06217380|450491616|FG000|Overall Study|Withdrawal by Subject|2|||
125235820|NCT06633965|450491617|FG000|Overall Study|Withdrawal by Subject|0|||
125235821|NCT06633965|450491618|FG001|Overall Study|Withdrawal by Subject|1|||
125235822|NCT00947544|450491621|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
125235823|NCT00947544|450491622|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
125235824|NCT01963611|450491627|FG000|Overall Study|Adverse Event|1|||
125235825|NCT01963611|450491628|FG001|Overall Study|Adverse Event|1|||
125235826|NCT01963611|450491629|FG002|Overall Study|Adverse Event|3|||
125235827|NCT01963611|450491630|FG003|Overall Study|Adverse Event|4|||
125235828|NCT01963611|450491631|FG004|Overall Study|Adverse Event|3|||
125235829|NCT01963611|450491627|FG000|Overall Study|Protocol Violation|0|||
125235830|NCT01963611|450491628|FG001|Overall Study|Protocol Violation|0|||
125235831|NCT01963611|450491629|FG002|Overall Study|Protocol Violation|0|||
125235832|NCT01963611|450491630|FG003|Overall Study|Protocol Violation|1|||
125235833|NCT01963611|450491631|FG004|Overall Study|Protocol Violation|0|||
125235834|NCT01963611|450491627|FG000|Overall Study|Lack of Efficacy|0|||
125235835|NCT01963611|450491628|FG001|Overall Study|Lack of Efficacy|0|||
125235836|NCT01963611|450491629|FG002|Overall Study|Lack of Efficacy|0|||
125235837|NCT01963611|450491630|FG003|Overall Study|Lack of Efficacy|1|||
125235838|NCT01963611|450491631|FG004|Overall Study|Lack of Efficacy|0|||
125235839|NCT01963611|450491627|FG000|Overall Study|Withdrawal by Subject|3|||
125235840|NCT01963611|450491628|FG001|Overall Study|Withdrawal by Subject|2|||
125235841|NCT01963611|450491629|FG002|Overall Study|Withdrawal by Subject|1|||
125235842|NCT01963611|450491630|FG003|Overall Study|Withdrawal by Subject|1|||
125235843|NCT01963611|450491631|FG004|Overall Study|Withdrawal by Subject|3|||
125235844|NCT01963611|450491627|FG000|Overall Study|Other|47|||
125235845|NCT01963611|450491628|FG001|Overall Study|Other|46|||
125235846|NCT01963611|450491629|FG002|Overall Study|Other|48|||
125235847|NCT01963611|450491630|FG003|Overall Study|Other|45|||
125235848|NCT01963611|450491631|FG004|Overall Study|Other|45|||
125235849|NCT01126424|450491632|FG000|Overall Study|Adverse Event|0|||
125235850|NCT01126424|450491633|FG001|Overall Study|Adverse Event|0|||
125180449|NCT00143390|450279302|FG001|Overall Study|Death|0|||
125180450|NCT00143390|450279301|FG000|Overall Study|Not meeting entry criteria|2|||
125180451|NCT00143390|450279302|FG001|Overall Study|Not meeting entry criteria|5|||
125180452|NCT00143390|450279301|FG000|Overall Study|Withdrawal by Subject|4|||
125180453|NCT00143390|450279302|FG001|Overall Study|Withdrawal by Subject|4|||
125180454|NCT00143390|450279301|FG000|Overall Study|Progressive disease|119|||
125180455|NCT00143390|450279302|FG001|Overall Study|Progressive disease|115|||
125180456|NCT00143390|450279301|FG000|Overall Study|Protocol Violation|2|||
125180457|NCT00143390|450279302|FG001|Overall Study|Protocol Violation|0|||
125180458|NCT00143390|450279301|FG000|Overall Study|Study termination|10|||
125180459|NCT00143390|450279302|FG001|Overall Study|Study termination|15|||
125180460|NCT00143390|450279301|FG000|Overall Study|Adverse Event|9|||
125180461|NCT00143390|450279302|FG001|Overall Study|Adverse Event|8|||
125180462|NCT00143390|450279301|FG000|Overall Study|Other|1|||
125180463|NCT00143390|450279302|FG001|Overall Study|Other|2|||
125180464|NCT00041132|450279305|FG000|Overall Study|Adverse Event|19|||
125180465|NCT00041132|450279305|FG000|Overall Study|Death|1|||
125180466|NCT00041132|450279305|FG000|Overall Study|Not Eligible|7|||
125180467|NCT00041132|450279305|FG000|Overall Study|Withdrawal by Subject|1|||
125180468|NCT00041132|450279305|FG000|Overall Study|Physician Decision|2|||
125180469|NCT00995774|450279308|FG000|Training Period 2|Withdrawal by Subject|2|||
125180470|NCT00995774|450279309|FG001|Training Period 2|Withdrawal by Subject|0|||
125180471|NCT03953612|450279311|FG000|Overall Study|Randomized but did not start|1|||
125180472|NCT03953612|450279312|FG001|Overall Study|Randomized but did not start|1|||
125180473|NCT03953612|450279313|FG002|Overall Study|Randomized but did not start|1|||
125180474|NCT03953612|450279311|FG000|Overall Study|Withdrawal by Subject|2|||
125180475|NCT03953612|450279312|FG001|Overall Study|Withdrawal by Subject|1|||
125180476|NCT03953612|450279313|FG002|Overall Study|Withdrawal by Subject|0|||
125180477|NCT03200717|450279331|FG000|Overall Study|Progressive disease|24|||
125180478|NCT03200717|450279332|FG001|Overall Study|Progressive disease|5|||
125180479|NCT03200717|450279331|FG000|Overall Study|Adverse Event|11|||
125180480|NCT03200717|450279332|FG001|Overall Study|Adverse Event|8|||
125180481|NCT03200717|450279331|FG000|Overall Study|Physician Decision|3|||
125180482|NCT03200717|450279332|FG001|Overall Study|Physician Decision|2|||
125180483|NCT03200717|450279331|FG000|Overall Study|Death|2|||
125180484|NCT03200717|450279332|FG001|Overall Study|Death|0|||
125180485|NCT03200717|450279331|FG000|Overall Study|Subject/Guardian Decision|1|||
125180486|NCT03200717|450279332|FG001|Overall Study|Subject/Guardian Decision|0|||
125180487|NCT04211831|450279337|FG000|Overall Study|Withdrawal by Subject|4|||
125180488|NCT04211831|450279338|FG001|Overall Study|Withdrawal by Subject|1|||
125180489|NCT04211831|450279339|FG002|Overall Study|Withdrawal by Subject|1|||
125180490|NCT04211831|450279337|FG000|Overall Study|Protocol Violation|0|||
125180491|NCT04211831|450279338|FG001|Overall Study|Protocol Violation|0|||
125180492|NCT04211831|450279339|FG002|Overall Study|Protocol Violation|1|||
125180493|NCT04211831|450279337|FG000|Overall Study|Adverse Event|0|||
125180494|NCT04211831|450279338|FG001|Overall Study|Adverse Event|1|||
125180495|NCT04211831|450279339|FG002|Overall Study|Adverse Event|0|||
125180496|NCT04211831|450279337|FG000|Overall Study|Lack of Efficacy|0|||
125180497|NCT04211831|450279338|FG001|Overall Study|Lack of Efficacy|0|||
125180498|NCT04211831|450279339|FG002|Overall Study|Lack of Efficacy|1|||
125180499|NCT04211831|450279337|FG000|Overall Study|Lost to Follow-up|0|||
125180500|NCT04211831|450279338|FG001|Overall Study|Lost to Follow-up|0|||
125180501|NCT04211831|450279339|FG002|Overall Study|Lost to Follow-up|2|||
125180502|NCT04211831|450279337|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
125180503|NCT04211831|450279338|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
125180504|NCT04211831|450279339|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
125180505|NCT04211831|450279337|FG000|Overall Study|Other|0|||
125180506|NCT04211831|450279338|FG001|Overall Study|Other|1|||
125180507|NCT04211831|450279339|FG002|Overall Study|Other|0|||
125180508|NCT01256879|450279341|FG000|Overall Study|Withdrawal by Subject|1|||
125180509|NCT00397514|450279342|FG000|Overall Study|Withdrawal by Subject|1|||
125180510|NCT00397514|450279342|FG000|Overall Study|Pacing wire malfunction|1|||
125180511|NCT00397514|450279342|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
125180512|NCT00397514|450279342|FG000|Overall Study|early extubation|2|||
125180513|NCT00397514|450279342|FG000|Overall Study|poor echocardiographic windows|1|||
125180514|NCT03493685|450281365|FG000|Overall Study|Death|4|||
125180515|NCT03493685|450281366|FG001|Overall Study|Death|3|||
125180516|NCT03493685|450281365|FG000|Overall Study|Lost to Follow-up|3|||
125180517|NCT03493685|450281366|FG001|Overall Study|Lost to Follow-up|2|||
125180518|NCT03493685|450281365|FG000|Overall Study|Physician Decision|2|||
125180519|NCT03493685|450281366|FG001|Overall Study|Physician Decision|0|||
125180520|NCT03493685|450281365|FG000|Overall Study|Withdrawal by Subject|7|||
125180521|NCT03493685|450281366|FG001|Overall Study|Withdrawal by Subject|11|||
125180522|NCT03300817|450281367|FG000|Overall Study|Withdrawal by Subject|1|||
125180523|NCT03300817|450281367|FG000|Overall Study|Adverse Event|1|||
125180524|NCT03300817|450281367|FG000|Overall Study|Subject Found to be Ineligible|2|||
125235851|NCT01126424|450491634|FG002|Overall Study|Adverse Event|0|||
125235852|NCT01126424|450491635|FG003|Overall Study|Adverse Event|0|||
125235853|NCT01126424|450491636|FG004|Overall Study|Adverse Event|1|||
125235854|NCT01126424|450491637|FG005|Overall Study|Adverse Event|0|||
125235855|NCT01126424|450491632|FG000|Overall Study|Withdrawal by Subject|0|||
125235856|NCT01126424|450491633|FG001|Overall Study|Withdrawal by Subject|0|||
125235857|NCT01126424|450491634|FG002|Overall Study|Withdrawal by Subject|1|||
125235858|NCT01126424|450491635|FG003|Overall Study|Withdrawal by Subject|3|||
125235859|NCT01126424|450491636|FG004|Overall Study|Withdrawal by Subject|1|||
125235860|NCT01126424|450491637|FG005|Overall Study|Withdrawal by Subject|0|||
125235861|NCT03801252|450491638|FG000|Overall Study|Protocol Violation|1|||
125235862|NCT03801252|450491639|FG001|Overall Study|Protocol Violation|2|||
125235863|NCT01134042|450491640|FG000|Overall Study|Adverse Event|3|||
125235864|NCT01134042|450491641|FG001|Overall Study|Adverse Event|7|||
125235865|NCT01134042|450491642|FG002|Overall Study|Adverse Event|2|||
125235866|NCT01134042|450491640|FG000|Overall Study|Lack of Efficacy|21|||
125235867|NCT01134042|450491641|FG001|Overall Study|Lack of Efficacy|6|||
125235868|NCT01134042|450491642|FG002|Overall Study|Lack of Efficacy|18|||
125235869|NCT01134042|450491640|FG000|Overall Study|Protocol Violation|5|||
125235870|NCT01134042|450491641|FG001|Overall Study|Protocol Violation|3|||
125235871|NCT01134042|450491642|FG002|Overall Study|Protocol Violation|5|||
125235872|NCT01134042|450491640|FG000|Overall Study|Lost to Follow-up|2|||
125235873|NCT01134042|450491641|FG001|Overall Study|Lost to Follow-up|0|||
125235874|NCT01134042|450491642|FG002|Overall Study|Lost to Follow-up|1|||
125235875|NCT01134042|450491640|FG000|Overall Study|Physician Decision|4|||
125235876|NCT01134042|450491641|FG001|Overall Study|Physician Decision|8|||
125235877|NCT01134042|450491642|FG002|Overall Study|Physician Decision|1|||
125235878|NCT01134042|450491640|FG000|Overall Study|Withdrawal by Subject|13|||
125235879|NCT01134042|450491641|FG001|Overall Study|Withdrawal by Subject|4|||
125235880|NCT01134042|450491642|FG002|Overall Study|Withdrawal by Subject|7|||
125235881|NCT00393367|450491644|FG000|Overall Study|Protocol Violation|2|||
125235882|NCT00393367|450491645|FG001|Overall Study|Protocol Violation|5|||
125235883|NCT00393367|450491644|FG000|Overall Study|Withdrawal by Subject|0|||
125235884|NCT00393367|450491645|FG001|Overall Study|Withdrawal by Subject|2|||
125235885|NCT03286504|450491646|FG000|Overall Study|Lost to Follow-up|19|||
125235886|NCT03286504|450491647|FG001|Overall Study|Lost to Follow-up|16|||
125235887|NCT05350423|450491648|FG000|Overall Study|Lost to Follow-up|3|||
125235888|NCT05350423|450491649|FG001|Overall Study|Lost to Follow-up|3|||
125235889|NCT05350423|450491648|FG000|Overall Study|screen failure|5|||
125235890|NCT05350423|450491649|FG001|Overall Study|screen failure|6|||
125235891|NCT01432327|450491650|FG000|Posttest 3 Months|depression|3|||
125235892|NCT01432327|450491651|FG001|Posttest 3 Months|depression|0|||
125235893|NCT01432327|450491652|FG002|Posttest 3 Months|depression|0|||
125235894|NCT01432327|450491653|FG003|Posttest 3 Months|depression|0|||
125235895|NCT01432327|450491650|FG000|Posttest 3 Months|Lost to Follow-up|1|||
125235896|NCT01432327|450491651|FG001|Posttest 3 Months|Lost to Follow-up|0|||
125235897|NCT01432327|450491652|FG002|Posttest 3 Months|Lost to Follow-up|2|||
125235898|NCT01432327|450491653|FG003|Posttest 3 Months|Lost to Follow-up|1|||
125180525|NCT00265759|450281368|FG000|Overall Study|Withdrawal by Subject|0|||
125180526|NCT00265759|450281369|FG001|Overall Study|Withdrawal by Subject|1|||
125180527|NCT00265759|450281370|FG002|Overall Study|Withdrawal by Subject|2|||
125180528|NCT00265759|450281371|FG003|Overall Study|Withdrawal by Subject|2|||
125180529|NCT00265759|450281368|FG000|Overall Study|Cancel|0|||
125180530|NCT00265759|450281369|FG001|Overall Study|Cancel|0|||
125180531|NCT00265759|450281370|FG002|Overall Study|Cancel|0|||
125180532|NCT00265759|450281371|FG003|Overall Study|Cancel|3|||
125180533|NCT00265759|450281368|FG000|Overall Study|Ineligible|0|||
125180534|NCT00265759|450281369|FG001|Overall Study|Ineligible|0|||
125180535|NCT00265759|450281370|FG002|Overall Study|Ineligible|0|||
125180536|NCT00265759|450281371|FG003|Overall Study|Ineligible|1|||
125180537|NCT00265759|450281368|FG000|Overall Study|Bilateral disease|0|||
125180538|NCT00265759|450281369|FG001|Overall Study|Bilateral disease|0|||
125180539|NCT00265759|450281370|FG002|Overall Study|Bilateral disease|0|||
125180540|NCT00265759|450281371|FG003|Overall Study|Bilateral disease|2|||
125180541|NCT00265759|450281368|FG000|Overall Study|Discontinued due to intolerability|0|||
125180542|NCT00265759|450281369|FG001|Overall Study|Discontinued due to intolerability|0|||
125180543|NCT00265759|450281370|FG002|Overall Study|Discontinued due to intolerability|0|||
125180544|NCT00265759|450281371|FG003|Overall Study|Discontinued due to intolerability|1|||
125180545|NCT03729596|450281374|FG000|Overall Study|Death|3|||
125180546|NCT03729596|450281375|FG001|Overall Study|Death|5|||
125180547|NCT03729596|450281376|FG002|Overall Study|Death|4|||
125180548|NCT03729596|450281377|FG003|Overall Study|Death|1|||
125180549|NCT03729596|450281378|FG004|Overall Study|Death|0|||
125235899|NCT01432327|450491650|FG000|Posttest 3 Months|Allergic reaction|0|||
125180550|NCT03729596|450281379|FG005|Overall Study|Death|34|||
125180551|NCT03729596|450281380|FG006|Overall Study|Death|18|||
125180552|NCT03729596|450281381|FG007|Overall Study|Death|14|||
125180553|NCT03729596|450281382|FG008|Overall Study|Death|19|||
125180554|NCT03729596|450281383|FG009|Overall Study|Death|9|||
125235900|NCT01432327|450491651|FG001|Posttest 3 Months|Allergic reaction|2|||
125180555|NCT03729596|450281374|FG000|Overall Study|Lost to Follow-up|0|||
125180556|NCT03729596|450281375|FG001|Overall Study|Lost to Follow-up|0|||
125180557|NCT03729596|450281376|FG002|Overall Study|Lost to Follow-up|0|||
125180558|NCT03729596|450281377|FG003|Overall Study|Lost to Follow-up|0|||
125180559|NCT03729596|450281378|FG004|Overall Study|Lost to Follow-up|0|||
125180560|NCT03729596|450281379|FG005|Overall Study|Lost to Follow-up|0|||
125180561|NCT03729596|450281380|FG006|Overall Study|Lost to Follow-up|1|||
125180562|NCT03729596|450281381|FG007|Overall Study|Lost to Follow-up|0|||
125180563|NCT03729596|450281382|FG008|Overall Study|Lost to Follow-up|0|||
125180564|NCT03729596|450281383|FG009|Overall Study|Lost to Follow-up|1|||
125180565|NCT03729596|450281374|FG000|Overall Study|protocol amendment|0|||
125180566|NCT03729596|450281375|FG001|Overall Study|protocol amendment|1|||
125180567|NCT03729596|450281376|FG002|Overall Study|protocol amendment|3|||
125180568|NCT03729596|450281377|FG003|Overall Study|protocol amendment|6|||
125180569|NCT03729596|450281378|FG004|Overall Study|protocol amendment|5|||
125180570|NCT03729596|450281379|FG005|Overall Study|protocol amendment|0|||
125180571|NCT03729596|450281380|FG006|Overall Study|protocol amendment|0|||
125180572|NCT03729596|450281381|FG007|Overall Study|protocol amendment|0|||
125180573|NCT03729596|450281382|FG008|Overall Study|protocol amendment|0|||
125180574|NCT03729596|450281383|FG009|Overall Study|protocol amendment|0|||
125180575|NCT03729596|450281374|FG000|Overall Study|Withdrawal by Subject|0|||
125180576|NCT03729596|450281375|FG001|Overall Study|Withdrawal by Subject|0|||
125180577|NCT03729596|450281376|FG002|Overall Study|Withdrawal by Subject|0|||
125180578|NCT03729596|450281377|FG003|Overall Study|Withdrawal by Subject|0|||
125180579|NCT03729596|450281378|FG004|Overall Study|Withdrawal by Subject|0|||
125180580|NCT03729596|450281379|FG005|Overall Study|Withdrawal by Subject|4|||
125180581|NCT03729596|450281380|FG006|Overall Study|Withdrawal by Subject|2|||
125180582|NCT03729596|450281381|FG007|Overall Study|Withdrawal by Subject|3|||
125180583|NCT03729596|450281382|FG008|Overall Study|Withdrawal by Subject|2|||
125180584|NCT03729596|450281383|FG009|Overall Study|Withdrawal by Subject|3|||
125180585|NCT03729596|450281374|FG000|Overall Study|study terminated by sponsor|0|||
125180586|NCT03729596|450281375|FG001|Overall Study|study terminated by sponsor|0|||
125180587|NCT03729596|450281376|FG002|Overall Study|study terminated by sponsor|0|||
125180588|NCT03729596|450281377|FG003|Overall Study|study terminated by sponsor|0|||
125180589|NCT03729596|450281378|FG004|Overall Study|study terminated by sponsor|1|||
125180590|NCT03729596|450281379|FG005|Overall Study|study terminated by sponsor|3|||
125180591|NCT03729596|450281380|FG006|Overall Study|study terminated by sponsor|0|||
125180592|NCT03729596|450281381|FG007|Overall Study|study terminated by sponsor|1|||
125180593|NCT03729596|450281382|FG008|Overall Study|study terminated by sponsor|0|||
125180594|NCT03729596|450281383|FG009|Overall Study|study terminated by sponsor|0|||
125180595|NCT04467840|450281384|FG000|Overall Study|Death|35|||
125180596|NCT04467840|450281385|FG001|Overall Study|Death|39|||
125180597|NCT04467840|450281384|FG000|Overall Study|Withdrawal by Subject|8|||
125180598|NCT04467840|450281385|FG001|Overall Study|Withdrawal by Subject|4|||
125180599|NCT04467840|450281384|FG000|Overall Study|Adverse Event|2|||
125180600|NCT04467840|450281385|FG001|Overall Study|Adverse Event|0|||
125180601|NCT04467840|450281384|FG000|Overall Study|Lost to Follow-up|1|||
125180602|NCT04467840|450281385|FG001|Overall Study|Lost to Follow-up|3|||
125180603|NCT04467840|450281384|FG000|Overall Study|Physician Decision|1|||
125180604|NCT04467840|450281385|FG001|Overall Study|Physician Decision|0|||
125180605|NCT04467840|450281384|FG000|Overall Study|Other|1|||
125180606|NCT04467840|450281385|FG001|Overall Study|Other|5|||
125180607|NCT04467840|450281384|FG000|Overall Study|Missing study completion status|3|||
125180608|NCT04467840|450281385|FG001|Overall Study|Missing study completion status|1|||
125180609|NCT05126693|450281388|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
125180610|NCT05126693|450281389|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
125180611|NCT05126693|450281388|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
125180612|NCT05126693|450281389|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
125180613|NCT05126693|450281388|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
125180614|NCT05126693|450281389|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
125180615|NCT00443729|450281396|FG000|Overall Study|Never Treated|0|||
125180616|NCT00443729|450281397|FG001|Overall Study|Never Treated|1|||
125180617|NCT00443729|450281396|FG000|Overall Study|Lack of Efficacy|4|||
125180618|NCT00443729|450281397|FG001|Overall Study|Lack of Efficacy|2|||
125180619|NCT00443729|450281396|FG000|Overall Study|Lost to Follow-up|0|||
125180620|NCT00443729|450281397|FG001|Overall Study|Lost to Follow-up|1|||
125180621|NCT00443729|450281396|FG000|Overall Study|Physician Decision|2|||
125180622|NCT00443729|450281397|FG001|Overall Study|Physician Decision|1|||
125180623|NCT00443729|450281396|FG000|Overall Study|Protocol Violation|1|||
125180624|NCT00443729|450281397|FG001|Overall Study|Protocol Violation|1|||
125180625|NCT00443729|450281396|FG000|Overall Study|Withdrawal by Subject|3|||
125180626|NCT00443729|450281397|FG001|Overall Study|Withdrawal by Subject|1|||
125180627|NCT01269918|450281402|FG000|Overall Study|Did not receive study drug|0|||
125180628|NCT01269918|450281403|FG001|Overall Study|Did not receive study drug|3|||
125180629|NCT03571828|450281404|FG000|Overall Study|Withdrawal by Subject|1|||
125180630|NCT03571828|450281405|FG001|Overall Study|Withdrawal by Subject|0|||
125180631|NCT03571828|450281404|FG000|Overall Study|Decision by sponsor|5|||
125180632|NCT03571828|450281405|FG001|Overall Study|Decision by sponsor|1|||
125180633|NCT03571828|450281404|FG000|Overall Study|Death|2|||
125235901|NCT01432327|450491652|FG002|Posttest 3 Months|Allergic reaction|0|||
125235902|NCT01432327|450491653|FG003|Posttest 3 Months|Allergic reaction|0|||
125180634|NCT03571828|450281405|FG001|Overall Study|Death|0|||
125180635|NCT04471428|450281406|FG000|Overall Study|Withdrawal by Subject|29|||
125180636|NCT04471428|450281407|FG001|Overall Study|Withdrawal by Subject|1|||
125180637|NCT04471428|450281406|FG000|Overall Study|Physician Decision|0|||
125180638|NCT04471428|450281407|FG001|Overall Study|Physician Decision|1|||
125180639|NCT04471428|450281406|FG000|Overall Study|Reason Not Specified|0|||
125180640|NCT04471428|450281407|FG001|Overall Study|Reason Not Specified|2|||
125180641|NCT04471428|450281406|FG000|Overall Study|Death|106|||
125180642|NCT04471428|450281407|FG001|Overall Study|Death|114|||
125180643|NCT04471428|450281406|FG000|Overall Study|Ongoing in the study|45|||
125180644|NCT04471428|450281407|FG001|Overall Study|Ongoing in the study|68|||
125180645|NCT01870778|450281411|FG000|Overall Study|Withdrawal by Subject|8|||
125180646|NCT01870778|450281412|FG001|Overall Study|Withdrawal by Subject|7|||
125180647|NCT01870778|450281411|FG000|Overall Study|Lost to Follow-up|0|||
125180648|NCT01870778|450281412|FG001|Overall Study|Lost to Follow-up|2|||
125180649|NCT02553772|450281416|FG000|Overall Study|Adverse Event|2|||
125180650|NCT02553772|450281417|FG001|Overall Study|Adverse Event|3|||
125180651|NCT02553772|450281416|FG000|Overall Study|Lost to Follow-up|2|||
125180652|NCT02553772|450281417|FG001|Overall Study|Lost to Follow-up|1|||
125180653|NCT02553772|450281416|FG000|Overall Study|Withdrawal of Consent|1|||
125180654|NCT02553772|450281417|FG001|Overall Study|Withdrawal of Consent|1|||
125180655|NCT02553772|450281416|FG000|Overall Study|Lack of Efficacy|1|||
125180656|NCT02553772|450281417|FG001|Overall Study|Lack of Efficacy|0|||
125180657|NCT02553772|450281416|FG000|Overall Study|Other Miscellaneous Reasons|0|||
125180658|NCT02553772|450281417|FG001|Overall Study|Other Miscellaneous Reasons|1|||
125180659|NCT00786409|450281418|FG000|Overall Study|Withdrawal by Subject|2|||
125180660|NCT00786409|450281418|FG000|Overall Study|Adverse Event|2|||
125180661|NCT00786409|450281418|FG000|Overall Study|Pregnancy|2|||
125180662|NCT00786409|450281418|FG000|Overall Study|Lost to Follow-up|1|||
125180663|NCT00610129|450281419|FG000|Overall Study|Not treated since patients ineligible|3|||
125180664|NCT01184079|450281425|FG000|Overall Study|Lost to Follow-up|14|||
125180665|NCT01184079|450281426|FG001|Overall Study|Lost to Follow-up|2|||
125180666|NCT02198963|450281431|FG000|Overall Study|Adverse Event|1|||
125180667|NCT02198963|450281431|FG000|Overall Study|Withdrawal by Subject|6|||
125180668|NCT00281957|450281435|FG000|Overall Study|Adverse Event|7|||
125180669|NCT00281957|450281436|FG001|Overall Study|Adverse Event|2|||
125180670|NCT00281957|450281435|FG000|Overall Study|Death|1|||
125180671|NCT00281957|450281436|FG001|Overall Study|Death|0|||
125180672|NCT00281957|450281435|FG000|Overall Study|Progression/relapse|47|||
125180673|NCT00281957|450281436|FG001|Overall Study|Progression/relapse|35|||
125180674|NCT00281957|450281435|FG000|Overall Study|Not protocol specified|8|||
125180675|NCT00281957|450281436|FG001|Overall Study|Not protocol specified|1|||
125180676|NCT00281957|450281435|FG000|Overall Study|Not eligible|1|||
125180677|NCT00281957|450281436|FG001|Overall Study|Not eligible|2|||
125180678|NCT00281957|450281435|FG000|Overall Study|Did not start treatment|3|||
125180679|NCT00281957|450281436|FG001|Overall Study|Did not start treatment|1|||
125180680|NCT00281957|450281435|FG000|Overall Study|Refusal unrelated to adverse events|0|||
125180681|NCT00281957|450281436|FG001|Overall Study|Refusal unrelated to adverse events|1|||
125180682|NCT01876446|450281437|FG000|Overall Study|Death|0|||
125180683|NCT01876446|450281438|FG001|Overall Study|Death|1|||
125180684|NCT01876446|450281437|FG000|Overall Study|Withdrawal by Subject|1|||
125180685|NCT01876446|450281438|FG001|Overall Study|Withdrawal by Subject|2|||
125180686|NCT01876446|450281437|FG000|Overall Study|Physician Decision|1|||
125180687|NCT01876446|450281438|FG001|Overall Study|Physician Decision|3|||
125180688|NCT03180645|450281440|FG000|Overall Study|Adverse Event|0|||
125180689|NCT03180645|450281441|FG001|Overall Study|Adverse Event|1|||
125180690|NCT03180645|450281442|FG002|Overall Study|Adverse Event|2|||
125180691|NCT01808573|450281443|FG000|Overall Study|Death|212|||
125180692|NCT01808573|450281444|FG001|Overall Study|Death|240|||
125180693|NCT01808573|450281443|FG000|Overall Study|Withdrawal by Subject|12|||
125180694|NCT01808573|450281444|FG001|Overall Study|Withdrawal by Subject|10|||
125180695|NCT01808573|450281443|FG000|Overall Study|Lost to Follow-up|3|||
125180696|NCT01808573|450281444|FG001|Overall Study|Lost to Follow-up|0|||
125235903|NCT01432327|450491650|FG000|Posttest 6 Months|Lost to Follow-up|0|||
125180697|NCT01808573|450281443|FG000|Overall Study|Discontinuation of study by sponsor|79|||
125180698|NCT01808573|450281444|FG001|Overall Study|Discontinuation of study by sponsor|64|||
125180699|NCT01808573|450281443|FG000|Overall Study|Randomized in Error|1|||
125180700|NCT01808573|450281444|FG001|Overall Study|Randomized in Error|0|||
125180701|NCT02208089|450281445|FG000|Overall Study|Withdrawal by Subject|1|||
125180702|NCT02208089|450281446|FG001|Overall Study|Withdrawal by Subject|0|||
125180703|NCT02208089|450281445|FG000|Overall Study|Lost to Follow-up|6|||
125180704|NCT02208089|450281446|FG001|Overall Study|Lost to Follow-up|0|||
125235904|NCT01432327|450491651|FG001|Posttest 6 Months|Lost to Follow-up|0|||
125180705|NCT03629184|450281448|FG000|Overall Study|Withdrawal by Subject|2|||
125180706|NCT03629184|450281449|FG001|Overall Study|Withdrawal by Subject|1|||
125180707|NCT03629184|450281448|FG000|Overall Study|Physician Decision|1|||
125180708|NCT03629184|450281449|FG001|Overall Study|Physician Decision|0|||
125180709|NCT00972595|450281450|FG000|Period 1|Adverse Event|1|||
125180710|NCT00972595|450281451|FG001|Period 1|Adverse Event|0|||
125180711|NCT01461538|450281452|FG000|Overall Study|Death|15|||
125180712|NCT01461538|450281453|FG001|Overall Study|Death|6|||
125180713|NCT01461538|450281454|FG002|Overall Study|Death|2|||
125180714|NCT01461538|450281452|FG000|Overall Study|Study Stopped by Sponsor|2|||
125180715|NCT01461538|450281453|FG001|Overall Study|Study Stopped by Sponsor|1|||
125180716|NCT01461538|450281454|FG002|Overall Study|Study Stopped by Sponsor|0|||
125180717|NCT01461538|450281452|FG000|Overall Study|Withdrawal by Subject|1|||
125180718|NCT01461538|450281453|FG001|Overall Study|Withdrawal by Subject|1|||
125180719|NCT01461538|450281454|FG002|Overall Study|Withdrawal by Subject|0|||
125180720|NCT00141778|450281455|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
125180721|NCT00141778|450281456|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
125180722|NCT00141778|450281457|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
125180723|NCT00141778|450281455|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
125180724|NCT00141778|450281456|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
125180725|NCT00141778|450281457|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
125180726|NCT00141778|450281455|FG000|Started Study Medication|Withdrawal by Subject|0|||
125180727|NCT00141778|450281456|FG001|Started Study Medication|Withdrawal by Subject|2|||
125180728|NCT00141778|450281457|FG002|Started Study Medication|Withdrawal by Subject|0|||
125180729|NCT00141778|450281455|FG000|Started Study Medication|Difficulty Swallowing|0|||
125180730|NCT00141778|450281456|FG001|Started Study Medication|Difficulty Swallowing|1|||
125180731|NCT00141778|450281457|FG002|Started Study Medication|Difficulty Swallowing|0|||
125180732|NCT00141778|450281455|FG000|Started Study Medication|Chest Discomfort|0|||
125180733|NCT00141778|450281456|FG001|Started Study Medication|Chest Discomfort|0|||
125180734|NCT00141778|450281457|FG002|Started Study Medication|Chest Discomfort|1|||
125180735|NCT02729909|450281458|FG000|Overall Study|Lost to Follow-up|0|||
125180736|NCT02729909|450281459|FG001|Overall Study|Lost to Follow-up|1|||
125180737|NCT02729909|450281458|FG000|Overall Study|Lack of Efficacy|0|||
125180738|NCT02729909|450281459|FG001|Overall Study|Lack of Efficacy|2|||
125180739|NCT02729909|450281458|FG000|Overall Study|Significant Protocol Deviation|0|||
125180740|NCT02729909|450281459|FG001|Overall Study|Significant Protocol Deviation|2|||
125180741|NCT02729909|450281458|FG000|Overall Study|Voluntary Withdrawal|1|||
125180742|NCT02729909|450281459|FG001|Overall Study|Voluntary Withdrawal|0|||
125180743|NCT02046603|450281466|FG000|Overall Study|Other|11|||
125180744|NCT02046603|450281467|FG001|Overall Study|Other|66|||
125180745|NCT02046603|450281466|FG000|Overall Study|Protocol Violation|0|||
125180746|NCT02046603|450281467|FG001|Overall Study|Protocol Violation|1|||
125180747|NCT02046603|450281466|FG000|Overall Study|Participant/legal guardian decision|1|||
125180748|NCT02046603|450281467|FG001|Overall Study|Participant/legal guardian decision|3|||
125180749|NCT02046603|450281466|FG000|Overall Study|Physician Decision|2|||
125180750|NCT02046603|450281467|FG001|Overall Study|Physician Decision|1|||
125180751|NCT02046603|450281466|FG000|Overall Study|Lost to Follow-up|1|||
125180752|NCT02046603|450281467|FG001|Overall Study|Lost to Follow-up|2|||
125180753|NCT02046603|450281466|FG000|Overall Study|Death|0|||
125180754|NCT02046603|450281467|FG001|Overall Study|Death|1|||
125180755|NCT02046603|450281466|FG000|Overall Study|Adverse Event|0|||
125180756|NCT02046603|450281467|FG001|Overall Study|Adverse Event|1|||
125180757|NCT05101343|450281468|FG000|Overall Study|Withdrawal by Subject|2|||
125180758|NCT05101343|450281469|FG001|Overall Study|Withdrawal by Subject|1|||
125180759|NCT02461160|450281470|FG000|Overall Study|Lost to Follow-up|0|||
125180760|NCT02461160|450281471|FG001|Overall Study|Lost to Follow-up|0|||
125180761|NCT02461160|450281472|FG002|Overall Study|Lost to Follow-up|0|||
125180762|NCT02461160|450281473|FG003|Overall Study|Lost to Follow-up|0|||
125180763|NCT02461160|450281474|FG004|Overall Study|Lost to Follow-up|0|||
125180764|NCT02461160|450281475|FG005|Overall Study|Lost to Follow-up|0|||
125180765|NCT02461160|450281476|FG006|Overall Study|Lost to Follow-up|0|||
125180766|NCT02461160|450281477|FG007|Overall Study|Lost to Follow-up|1|||
125180767|NCT02461160|450281478|FG008|Overall Study|Lost to Follow-up|0|||
125180768|NCT02461160|450281479|FG009|Overall Study|Lost to Follow-up|0|||
125180769|NCT02461160|450281480|FG010|Overall Study|Lost to Follow-up|0|||
125180770|NCT02461160|450281481|FG011|Overall Study|Lost to Follow-up|0|||
125180771|NCT02461160|450281482|FG012|Overall Study|Lost to Follow-up|0|||
125180772|NCT00193050|450281483|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
125180773|NCT00193050|450281483|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
125180774|NCT00193050|450281483|FG000|Neoadjuvant Treatment|Physician Decision|2|||
125180775|NCT00193050|450281483|FG000|Neoadjuvant Treatment|Adverse Event|2|||
125180776|NCT00193050|450281483|FG000|Adjuvant|Physician Decision|5|||
125180777|NCT00193050|450281483|FG000|Adjuvant|Intercurrent Hospitalization|3|||
125180778|NCT00193050|450281483|FG000|Adjuvant|Lack of Efficacy|2|||
125180779|NCT00061932|450281484|FG000|Overall Study|Withdrawal by Subject|13|||
125180780|NCT00061932|450281485|FG001|Overall Study|Withdrawal by Subject|4|||
125180781|NCT02899962|450281486|FG000|Open-label Phase|Adverse Event|2|||
125180782|NCT02899962|450281487|FG001|Open-label Phase|Adverse Event|0|||
125180783|NCT02899962|450281488|FG002|Open-label Phase|Adverse Event|0|||
125235905|NCT01432327|450491652|FG002|Posttest 6 Months|Lost to Follow-up|3|||
125235906|NCT01432327|450491653|FG003|Posttest 6 Months|Lost to Follow-up|2|||
125235907|NCT01432327|450491650|FG000|Posttest 6 Months|Allergic reaction|0|||
125235908|NCT01432327|450491651|FG001|Posttest 6 Months|Allergic reaction|0|||
125235909|NCT01432327|450491652|FG002|Posttest 6 Months|Allergic reaction|1|||
125235910|NCT01432327|450491653|FG003|Posttest 6 Months|Allergic reaction|0|||
125235911|NCT01432327|450491650|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
125235912|NCT01432327|450491651|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
125235913|NCT01432327|450491652|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
125235914|NCT01432327|450491653|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
125235915|NCT01432327|450491650|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
125235916|NCT01432327|450491651|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
125235917|NCT01432327|450491652|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
125235918|NCT01432327|450491653|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
125235919|NCT01432327|450491650|FG000|Posttest 1 Year|Lost to Follow-up|0|||
125235920|NCT01432327|450491651|FG001|Posttest 1 Year|Lost to Follow-up|0|||
125235921|NCT01432327|450491652|FG002|Posttest 1 Year|Lost to Follow-up|4|||
125235922|NCT01432327|450491653|FG003|Posttest 1 Year|Lost to Follow-up|2|||
125235923|NCT01432327|450491650|FG000|Posttest 1 Year|Allergic reaction|0|||
125235924|NCT01432327|450491651|FG001|Posttest 1 Year|Allergic reaction|0|||
125235925|NCT01432327|450491652|FG002|Posttest 1 Year|Allergic reaction|1|||
125235926|NCT01432327|450491653|FG003|Posttest 1 Year|Allergic reaction|1|||
125235927|NCT03320369|450491656|FG000|Overall Study|Adverse Event|1|||
125235928|NCT03320369|450491656|FG000|Overall Study|Withdrawal by Subject|2|||
125235929|NCT01732692|450491657|FG000|Overall Study|Adverse Event|0|||
125235930|NCT01732692|450491658|FG001|Overall Study|Adverse Event|1|||
125235931|NCT02030600|450491661|FG000|Treatment Period 1|Adverse Event|5|||
125235932|NCT02030600|450491662|FG001|Treatment Period 1|Adverse Event|7|||
125235933|NCT02030600|450491661|FG000|Treatment Period 1|Lack of Efficacy|0|||
125235934|NCT02030600|450491662|FG001|Treatment Period 1|Lack of Efficacy|1|||
125235935|NCT02030600|450491661|FG000|Treatment Period 1|Lost to Follow-up|11|||
125235936|NCT02030600|450491662|FG001|Treatment Period 1|Lost to Follow-up|3|||
125235937|NCT02030600|450491661|FG000|Treatment Period 1|Protocol Violation|22|||
125235938|NCT02030600|450491662|FG001|Treatment Period 1|Protocol Violation|17|||
125235939|NCT02030600|450491661|FG000|Treatment Period 1|Withdrawal by Subject|13|||
125235940|NCT02030600|450491662|FG001|Treatment Period 1|Withdrawal by Subject|17|||
125235941|NCT02030600|450491661|FG000|Treatment Period 1|Casebook Unsigned|1|||
125235942|NCT02030600|450491662|FG001|Treatment Period 1|Casebook Unsigned|0|||
125235943|NCT02030600|450491661|FG000|Treatment Period 1|Unclassified|1|||
125235944|NCT02030600|450491662|FG001|Treatment Period 1|Unclassified|0|||
125235945|NCT02030600|450491661|FG000|Treatment Period 2|Adverse Event|4|||
125235946|NCT02030600|450491662|FG001|Treatment Period 2|Adverse Event|4|||
125235947|NCT02030600|450491661|FG000|Treatment Period 2|Lack of Efficacy|2|||
125235948|NCT02030600|450491662|FG001|Treatment Period 2|Lack of Efficacy|1|||
125235949|NCT02030600|450491661|FG000|Treatment Period 2|Lost to Follow-up|4|||
125235950|NCT02030600|450491662|FG001|Treatment Period 2|Lost to Follow-up|2|||
125235951|NCT02030600|450491661|FG000|Treatment Period 2|Protocol Violation|1|||
125235952|NCT02030600|450491662|FG001|Treatment Period 2|Protocol Violation|2|||
125180784|NCT02899962|450281486|FG000|Open-label Phase|Lost to Follow-up|9|||
125180785|NCT02899962|450281487|FG001|Open-label Phase|Lost to Follow-up|0|||
125180786|NCT02899962|450281488|FG002|Open-label Phase|Lost to Follow-up|0|||
125180787|NCT02899962|450281486|FG000|Open-label Phase|Other reasons|9|||
125180788|NCT02899962|450281487|FG001|Open-label Phase|Other reasons|0|||
125180789|NCT02899962|450281488|FG002|Open-label Phase|Other reasons|0|||
125180790|NCT02899962|450281486|FG000|Open-label Phase|Withdrawal by Subject|7|||
125180791|NCT02899962|450281487|FG001|Open-label Phase|Withdrawal by Subject|0|||
125235953|NCT02030600|450491661|FG000|Treatment Period 2|Withdrawal by Subject|13|||
125235954|NCT02030600|450491662|FG001|Treatment Period 2|Withdrawal by Subject|9|||
125235955|NCT02030600|450491661|FG000|Treatment Period 2|Unclassified|1|||
125235956|NCT02030600|450491662|FG001|Treatment Period 2|Unclassified|0|||
125235957|NCT01155323|450491663|FG000|First Intervention|exclusion criteria|1|||
125235958|NCT01155323|450491664|FG001|First Intervention|exclusion criteria|1|||
125235959|NCT01155323|450491663|FG000|Second Intervention|Lost to Follow-up|1|||
125235960|NCT01155323|450491664|FG001|Second Intervention|Lost to Follow-up|1|||
125235961|NCT04154956|450491674|FG000|Overall Study|Death|109|||
125235962|NCT04154956|450491675|FG001|Overall Study|Death|110|||
125235963|NCT04154956|450491674|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
125235964|NCT04154956|450491675|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
125235965|NCT04154956|450491674|FG000|Overall Study|Withdrawal by Subject|1|||
125235966|NCT04154956|450491675|FG001|Overall Study|Withdrawal by Subject|7|||
125180792|NCT02899962|450281488|FG002|Open-label Phase|Withdrawal by Subject|0|||
125180793|NCT02899962|450281486|FG000|Maintenance Phase|Adverse Event|0|||
125180794|NCT02899962|450281487|FG001|Maintenance Phase|Adverse Event|2|||
125180795|NCT02899962|450281488|FG002|Maintenance Phase|Adverse Event|1|||
125235967|NCT04154956|450491674|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
125180796|NCT02899962|450281486|FG000|Maintenance Phase|Death|0|||
125235968|NCT04154956|450491675|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
125235969|NCT00805532|450491676|FG000|Overall Study|invalid data|0|||
125235970|NCT00805532|450491677|FG001|Overall Study|invalid data|1|||
125235971|NCT01859741|450491678|FG000|Overall Study|Death|3|||
125235972|NCT01859741|450491679|FG001|Overall Study|Death|2|||
125235973|NCT01859741|450491680|FG002|Overall Study|Death|4|||
125235974|NCT01859741|450491681|FG003|Overall Study|Death|3|||
125235975|NCT01859741|450491682|FG004|Overall Study|Death|5|||
125235976|NCT01859741|450491683|FG005|Overall Study|Death|4|||
125235977|NCT01859741|450491684|FG006|Overall Study|Death|51|||
125235978|NCT01859741|450491685|FG007|Overall Study|Death|51|||
125235979|NCT01859741|450491678|FG000|Overall Study|Lost to Follow-up|0|||
125235980|NCT01859741|450491679|FG001|Overall Study|Lost to Follow-up|0|||
125235981|NCT01859741|450491680|FG002|Overall Study|Lost to Follow-up|0|||
125235982|NCT01859741|450491681|FG003|Overall Study|Lost to Follow-up|0|||
125235983|NCT01859741|450491682|FG004|Overall Study|Lost to Follow-up|0|||
125235984|NCT01859741|450491683|FG005|Overall Study|Lost to Follow-up|1|||
125235985|NCT01859741|450491684|FG006|Overall Study|Lost to Follow-up|0|||
125235986|NCT01859741|450491685|FG007|Overall Study|Lost to Follow-up|4|||
125235987|NCT01859741|450491678|FG000|Overall Study|Withdrawal by Subject|0|||
125235988|NCT01859741|450491679|FG001|Overall Study|Withdrawal by Subject|1|||
125235989|NCT01859741|450491680|FG002|Overall Study|Withdrawal by Subject|2|||
125235990|NCT01859741|450491681|FG003|Overall Study|Withdrawal by Subject|0|||
125235991|NCT01859741|450491682|FG004|Overall Study|Withdrawal by Subject|0|||
125235992|NCT01859741|450491683|FG005|Overall Study|Withdrawal by Subject|1|||
125235993|NCT01859741|450491684|FG006|Overall Study|Withdrawal by Subject|1|||
125235994|NCT01859741|450491685|FG007|Overall Study|Withdrawal by Subject|1|||
125235995|NCT01859741|450491678|FG000|Overall Study|Study Terminated by Sponsor|0|||
125235996|NCT01859741|450491679|FG001|Overall Study|Study Terminated by Sponsor|0|||
125235997|NCT01859741|450491680|FG002|Overall Study|Study Terminated by Sponsor|0|||
125235998|NCT01859741|450491681|FG003|Overall Study|Study Terminated by Sponsor|0|||
125235999|NCT01859741|450491682|FG004|Overall Study|Study Terminated by Sponsor|1|||
125236000|NCT01859741|450491683|FG005|Overall Study|Study Terminated by Sponsor|0|||
125236001|NCT01859741|450491684|FG006|Overall Study|Study Terminated by Sponsor|16|||
125236002|NCT01859741|450491685|FG007|Overall Study|Study Terminated by Sponsor|14|||
125236003|NCT01859741|450491678|FG000|Overall Study|Other|0|||
125236004|NCT01859741|450491679|FG001|Overall Study|Other|0|||
125236005|NCT01859741|450491680|FG002|Overall Study|Other|0|||
125236006|NCT01859741|450491681|FG003|Overall Study|Other|0|||
125236007|NCT01859741|450491682|FG004|Overall Study|Other|0|||
125236008|NCT01859741|450491683|FG005|Overall Study|Other|0|||
125236009|NCT01859741|450491684|FG006|Overall Study|Other|2|||
125236010|NCT01859741|450491685|FG007|Overall Study|Other|0|||
125236011|NCT01281306|450491693|FG000|Overall Study|Lack of Efficacy|0|||
125236012|NCT01281306|450491694|FG001|Overall Study|Lack of Efficacy|1|||
125236013|NCT01281306|450491695|FG002|Overall Study|Lack of Efficacy|3|||
125236014|NCT01281306|450491696|FG003|Overall Study|Lack of Efficacy|0|||
125236015|NCT01281306|450491697|FG004|Overall Study|Lack of Efficacy|2|||
125236016|NCT01281306|450491698|FG005|Overall Study|Lack of Efficacy|0|||
125236017|NCT01281306|450491699|FG006|Overall Study|Lack of Efficacy|1|||
125236018|NCT01281306|450491693|FG000|Overall Study|Withdrawal by Subject|1|||
125236019|NCT01281306|450491694|FG001|Overall Study|Withdrawal by Subject|0|||
125236020|NCT01281306|450491695|FG002|Overall Study|Withdrawal by Subject|2|||
125236021|NCT01281306|450491696|FG003|Overall Study|Withdrawal by Subject|4|||
125236022|NCT01281306|450491697|FG004|Overall Study|Withdrawal by Subject|1|||
125236023|NCT01281306|450491698|FG005|Overall Study|Withdrawal by Subject|3|||
125236024|NCT01281306|450491699|FG006|Overall Study|Withdrawal by Subject|1|||
125236025|NCT01281306|450491693|FG000|Overall Study|Protocol deviation|0|||
125236026|NCT01281306|450491694|FG001|Overall Study|Protocol deviation|1|||
125236027|NCT01281306|450491695|FG002|Overall Study|Protocol deviation|1|||
125236028|NCT01281306|450491696|FG003|Overall Study|Protocol deviation|1|||
125236029|NCT01281306|450491697|FG004|Overall Study|Protocol deviation|1|||
125236030|NCT01281306|450491698|FG005|Overall Study|Protocol deviation|0|||
125236031|NCT01281306|450491699|FG006|Overall Study|Protocol deviation|0|||
125236032|NCT01281306|450491693|FG000|Overall Study|Condition no longer requires study drug|1|||
125236033|NCT01281306|450491694|FG001|Overall Study|Condition no longer requires study drug|0|||
125236034|NCT01281306|450491695|FG002|Overall Study|Condition no longer requires study drug|0|||
125236035|NCT01281306|450491696|FG003|Overall Study|Condition no longer requires study drug|0|||
125236036|NCT01281306|450491697|FG004|Overall Study|Condition no longer requires study drug|0|||
125236037|NCT01281306|450491698|FG005|Overall Study|Condition no longer requires study drug|1|||
125236038|NCT01281306|450491699|FG006|Overall Study|Condition no longer requires study drug|1|||
125236039|NCT01281306|450491693|FG000|Overall Study|Lost to Follow-up|1|||
125236040|NCT01281306|450491694|FG001|Overall Study|Lost to Follow-up|0|||
125236041|NCT01281306|450491695|FG002|Overall Study|Lost to Follow-up|0|||
125236042|NCT01281306|450491696|FG003|Overall Study|Lost to Follow-up|2|||
125236043|NCT01281306|450491697|FG004|Overall Study|Lost to Follow-up|0|||
125180797|NCT02899962|450281487|FG001|Maintenance Phase|Death|0|||
125180798|NCT02899962|450281488|FG002|Maintenance Phase|Death|1|||
125180799|NCT02899962|450281486|FG000|Maintenance Phase|Lack of Efficacy|0|||
125180800|NCT02899962|450281487|FG001|Maintenance Phase|Lack of Efficacy|20|||
125180801|NCT02899962|450281488|FG002|Maintenance Phase|Lack of Efficacy|16|||
125180802|NCT02899962|450281486|FG000|Maintenance Phase|Lost to Follow-up|0|||
125180803|NCT02899962|450281487|FG001|Maintenance Phase|Lost to Follow-up|12|||
125180804|NCT02899962|450281488|FG002|Maintenance Phase|Lost to Follow-up|14|||
125180805|NCT02899962|450281486|FG000|Maintenance Phase|Other reasons|0|||
125180806|NCT02899962|450281487|FG001|Maintenance Phase|Other reasons|9|||
125180807|NCT02899962|450281488|FG002|Maintenance Phase|Other reasons|13|||
125180808|NCT02899962|450281486|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
125180809|NCT02899962|450281487|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
125180810|NCT02899962|450281488|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
125180811|NCT02899962|450281486|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
125180812|NCT02899962|450281487|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
125180813|NCT02899962|450281488|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
125180814|NCT02899962|450281486|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125180815|NCT02899962|450281487|FG001|Maintenance Phase|Withdrawal by Subject|30|||
125180816|NCT02899962|450281488|FG002|Maintenance Phase|Withdrawal by Subject|36|||
125180817|NCT01245283|450281489|FG000|Overall Study|Lost to Follow-up|14|||
125180818|NCT01245283|450281490|FG001|Overall Study|Lost to Follow-up|11|||
125180819|NCT01245283|450281491|FG002|Overall Study|Lost to Follow-up|11|||
125180820|NCT01610492|450281500|FG000|Overall Study|Adverse Event|1|||
125180821|NCT01610492|450281500|FG000|Overall Study|Lack of Efficacy|3|||
125180822|NCT01610492|450281500|FG000|Overall Study|Other: Reached stopping criteria|1|||
125180823|NCT01610492|450281500|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
125180824|NCT01982955|450281501|FG000|Overall Study|Randomized but not treated|0|||
125180825|NCT01982955|450281502|FG001|Overall Study|Randomized but not treated|0|||
125180826|NCT01982955|450281503|FG002|Overall Study|Randomized but not treated|0|||
125180827|NCT01982955|450281504|FG003|Overall Study|Randomized but not treated|1|||
125180828|NCT01982955|450281505|FG004|Overall Study|Randomized but not treated|0|||
125180829|NCT00866359|450281508|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
125180830|NCT00866359|450281509|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
125180831|NCT00866359|450281510|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
125180832|NCT00866359|450281511|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
125180833|NCT00866359|450281508|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
125180834|NCT00866359|450281509|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
125180835|NCT00866359|450281510|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
125180836|NCT00866359|450281511|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
125180837|NCT00866359|450281508|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
125180838|NCT00866359|450281509|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
125180839|NCT00866359|450281510|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
125180840|NCT00866359|450281511|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
125180841|NCT00866359|450281508|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
125180842|NCT00866359|450281509|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
125180843|NCT00866359|450281510|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
125180844|NCT00866359|450281511|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
125180845|NCT00866359|450281508|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
125180846|NCT00866359|450281509|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
125180847|NCT00866359|450281510|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
125180848|NCT00866359|450281511|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
125180849|NCT00866359|450281508|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
125180850|NCT00866359|450281509|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
125180851|NCT00866359|450281510|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
125180852|NCT00866359|450281511|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
125180853|NCT01625091|450281512|FG000|Intervention|Death|1|||
125180854|NCT01625091|450281513|FG001|Intervention|Death|1|||
125180855|NCT01625091|450281512|FG000|Intervention|Withdrawal by Subject|4|||
125180856|NCT01625091|450281513|FG001|Intervention|Withdrawal by Subject|1|||
125180857|NCT01625091|450281512|FG000|Intervention|Adverse Event|0|||
125180858|NCT01625091|450281513|FG001|Intervention|Adverse Event|2|||
125180859|NCT01625091|450281512|FG000|Intervention|Lost to Follow-up|4|||
125180860|NCT01625091|450281513|FG001|Intervention|Lost to Follow-up|4|||
125180861|NCT01625091|450281512|FG000|Intervention|Study termination|2|||
125180862|NCT01625091|450281513|FG001|Intervention|Study termination|3|||
125180863|NCT01625091|450281512|FG000|Post-intervention|Death|0|||
125180864|NCT01625091|450281513|FG001|Post-intervention|Death|1|||
125180865|NCT01625091|450281512|FG000|Post-intervention|Lost to Follow-up|2|||
125180866|NCT01625091|450281513|FG001|Post-intervention|Lost to Follow-up|0|||
125180867|NCT01625091|450281512|FG000|Post-intervention|Study termination|2|||
125180868|NCT01625091|450281513|FG001|Post-intervention|Study termination|1|||
125180869|NCT02163057|450281514|FG000|Overall Study|Participant Refusal to Continue|2|||
125236044|NCT01281306|450491698|FG005|Overall Study|Lost to Follow-up|0|||
125236045|NCT01281306|450491699|FG006|Overall Study|Lost to Follow-up|1|||
125236046|NCT01281306|450491693|FG000|Overall Study|Death|1|||
125236047|NCT01281306|450491694|FG001|Overall Study|Death|0|||
125236048|NCT01281306|450491695|FG002|Overall Study|Death|0|||
125236049|NCT01281306|450491696|FG003|Overall Study|Death|0|||
125236050|NCT01281306|450491697|FG004|Overall Study|Death|0|||
125236051|NCT01281306|450491698|FG005|Overall Study|Death|0|||
125236052|NCT01281306|450491699|FG006|Overall Study|Death|0|||
125236053|NCT01281306|450491693|FG000|Overall Study|Adverse Event|3|||
125236054|NCT01281306|450491694|FG001|Overall Study|Adverse Event|2|||
125236055|NCT01281306|450491695|FG002|Overall Study|Adverse Event|2|||
125236056|NCT01281306|450491696|FG003|Overall Study|Adverse Event|3|||
125236057|NCT01281306|450491697|FG004|Overall Study|Adverse Event|5|||
125236058|NCT01281306|450491698|FG005|Overall Study|Adverse Event|3|||
125236059|NCT01281306|450491699|FG006|Overall Study|Adverse Event|3|||
125236060|NCT01281306|450491693|FG000|Overall Study|Randomized in error|1|||
125236061|NCT01281306|450491694|FG001|Overall Study|Randomized in error|0|||
125236062|NCT01281306|450491695|FG002|Overall Study|Randomized in error|0|||
125236063|NCT01281306|450491696|FG003|Overall Study|Randomized in error|1|||
125236064|NCT01281306|450491697|FG004|Overall Study|Randomized in error|0|||
125236065|NCT01281306|450491698|FG005|Overall Study|Randomized in error|0|||
125236066|NCT01281306|450491699|FG006|Overall Study|Randomized in error|0|||
125236067|NCT04491994|450491700|FG000|Overall Study|Withdrawal by Subject|10|||
125236068|NCT04491994|450491701|FG001|Overall Study|Withdrawal by Subject|5|||
125236069|NCT04491994|450491700|FG000|Overall Study|developed fever > 3 days|4|||
125236070|NCT04491994|450491701|FG001|Overall Study|developed fever > 3 days|1|||
125236071|NCT04491994|450491700|FG000|Overall Study|Protocol Violation|11|||
125236072|NCT04491994|450491701|FG001|Overall Study|Protocol Violation|2|||
125236073|NCT04491994|450491700|FG000|Overall Study|Lost to Follow-up|4|||
125236074|NCT04491994|450491701|FG001|Overall Study|Lost to Follow-up|3|||
125236075|NCT02320396|450491707|FG000|Overall Study|Adverse Event|2|||
125236076|NCT02320396|450491708|FG001|Overall Study|Adverse Event|2|||
125236077|NCT02320396|450491707|FG000|Overall Study|Pregnancy|0|||
125236078|NCT02320396|450491708|FG001|Overall Study|Pregnancy|1|||
125236079|NCT02320396|450491707|FG000|Overall Study|Protocol Violation|0|||
125236080|NCT02320396|450491708|FG001|Overall Study|Protocol Violation|1|||
125236081|NCT02320396|450491707|FG000|Overall Study|Withdrawal by Subject|2|||
125236082|NCT02320396|450491708|FG001|Overall Study|Withdrawal by Subject|0|||
125236083|NCT03331562|450491709|FG000|Overall Study|Adverse Event|2|||
125236084|NCT03331562|450491710|FG001|Overall Study|Adverse Event|0|||
125236085|NCT03331562|450491709|FG000|Overall Study|Death|1|||
125236086|NCT03331562|450491710|FG001|Overall Study|Death|0|||
125236087|NCT03718000|450491711|FG000|Overall Study|Relocation|2|||
125236088|NCT03718000|450491712|FG001|Overall Study|Relocation|4|||
125236089|NCT03718000|450491711|FG000|Overall Study|Pregnancy|0|||
125236090|NCT03718000|450491712|FG001|Overall Study|Pregnancy|1|||
125236091|NCT02441283|450491713|FG000|Overall Study|Withdrew consent|15|||
125236092|NCT02441283|450491713|FG000|Overall Study|Lost to Follow-up|42|||
125236093|NCT02441283|450491713|FG000|Overall Study|Death|1|||
125236094|NCT02441283|450491713|FG000|Overall Study|Other, not specified|32|||
125180870|NCT02163057|450281515|FG001|Overall Study|Participant Refusal to Continue|2|||
125180871|NCT02163057|450281514|FG000|Overall Study|Participant Significant Noncompliance|0|||
125180872|NCT02163057|450281515|FG001|Overall Study|Participant Significant Noncompliance|1|||
125180873|NCT02163057|450281514|FG000|Overall Study|Progression of Disease|1|||
125180874|NCT02163057|450281515|FG001|Overall Study|Progression of Disease|2|||
125180875|NCT00768248|450281516|FG000|Overall Study|Research coordinator didn't collect data|1|||
125180876|NCT00768248|450281517|FG001|Overall Study|Research coordinator didn't collect data|1|||
125180877|NCT01547390|450281518|FG000|Overall Study|Withdrawal by Subject|10|||
125236095|NCT00226655|450491714|FG000|Overall Study|Death|13|||
125236096|NCT00226655|450491714|FG000|Overall Study|Withdrawal by Subject|15|||
125236097|NCT00226655|450491714|FG000|Overall Study|Adverse Event|35|||
125236098|NCT00226655|450491714|FG000|Overall Study|Physician Decision|6|||
125236099|NCT00226655|450491714|FG000|Overall Study|Clinical deterioration|10|||
125236100|NCT01910441|450491720|FG000|Overall Study|Sponsor decision|0|||
125236101|NCT01910441|450491721|FG001|Overall Study|Sponsor decision|2|||
125236102|NCT01910441|450491720|FG000|Overall Study|Lost to Follow-up|6|||
125236103|NCT01910441|450491721|FG001|Overall Study|Lost to Follow-up|5|||
125236104|NCT01910441|450491720|FG000|Overall Study|Withdrawal by Subject|0|||
125236105|NCT01910441|450491721|FG001|Overall Study|Withdrawal by Subject|1|||
125236106|NCT01910441|450491720|FG000|Overall Study|Non-compliance|0|||
125236107|NCT01910441|450491721|FG001|Overall Study|Non-compliance|1|||
125236108|NCT01910441|450491720|FG000|Overall Study|Adverse Event|1|||
125236109|NCT01910441|450491721|FG001|Overall Study|Adverse Event|0|||
125236110|NCT01910441|450491720|FG000|Overall Study|Physician Decision|0|||
125236111|NCT01910441|450491721|FG001|Overall Study|Physician Decision|1|||
125236112|NCT02340949|450491722|FG000|Overall Study|Adverse Event|4|||
125236113|NCT02340949|450491723|FG001|Overall Study|Adverse Event|2|||
125236114|NCT02340949|450491722|FG000|Overall Study|Withdrawal by Subject|2|||
125236115|NCT02340949|450491723|FG001|Overall Study|Withdrawal by Subject|0|||
125236116|NCT02340949|450491722|FG000|Overall Study|Progression disease|6|||
125236117|NCT02340949|450491723|FG001|Overall Study|Progression disease|2|||
125236118|NCT02340949|450491722|FG000|Overall Study|Death|3|||
125236119|NCT02340949|450491723|FG001|Overall Study|Death|0|||
125236120|NCT02340949|450491722|FG000|Overall Study|Physician Decision|1|||
125236121|NCT02340949|450491723|FG001|Overall Study|Physician Decision|0|||
125236122|NCT01192178|450491724|FG000|Overall Study|Withdrawal by Subject|6|||
125236123|NCT01192178|450491725|FG001|Overall Study|Withdrawal by Subject|10|||
125236124|NCT01192178|450491724|FG000|Overall Study|Protocol Violation|10|||
125236125|NCT01192178|450491725|FG001|Overall Study|Protocol Violation|3|||
125236126|NCT01192178|450491724|FG000|Overall Study|Physician Decision|2|||
125236127|NCT01192178|450491725|FG001|Overall Study|Physician Decision|4|||
125236128|NCT01192178|450491724|FG000|Overall Study|Lost to Follow-up|3|||
125236129|NCT01192178|450491725|FG001|Overall Study|Lost to Follow-up|3|||
125236130|NCT01192178|450491724|FG000|Overall Study|Adverse Event|2|||
125236131|NCT01192178|450491725|FG001|Overall Study|Adverse Event|1|||
125236132|NCT01192178|450491724|FG000|Overall Study|Lack of Efficacy|1|||
125236133|NCT01192178|450491725|FG001|Overall Study|Lack of Efficacy|2|||
125236134|NCT01977846|450491726|FG000|Total Study - Prospective|Death|0|||
125236135|NCT01977846|450491727|FG001|Total Study - Prospective|Death|1|||
125236136|NCT01977846|450491726|FG000|Total Study - Prospective|Lost to Follow-up|0|||
125236137|NCT01977846|450491727|FG001|Total Study - Prospective|Lost to Follow-up|8|||
125236138|NCT01977846|450491726|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
125236139|NCT01977846|450491727|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
125236140|NCT01977846|450491726|FG000|Total Study - Prospective|Not available at time of visit|0|||
125236141|NCT01977846|450491727|FG001|Total Study - Prospective|Not available at time of visit|5|||
125236142|NCT01977846|450491726|FG000|Total Study - Prospective|No show|0|||
125236143|NCT01977846|450491727|FG001|Total Study - Prospective|No show|1|||
125236144|NCT01977846|450491726|FG000|Total Study - Prospective|Protocol Violation|0|||
125236145|NCT01977846|450491727|FG001|Total Study - Prospective|Protocol Violation|1|||
125236146|NCT02460289|450491728|FG000|Overall Study|Adverse Event|1|||
125236147|NCT02460289|450491728|FG000|Overall Study|Withdrawal by Subject|8|||
125236148|NCT02460289|450491728|FG000|Overall Study|Lost to Follow-up|1|||
125236149|NCT01155570|450491729|FG000|Overall Study|Adverse Event|39|||
125236150|NCT01155570|450491729|FG000|Overall Study|Lack of Efficacy|46|||
125236151|NCT01155570|450491729|FG000|Overall Study|Participant's Economic Reasons|17|||
125236152|NCT01155570|450491729|FG000|Overall Study|No Hospital Visits|7|||
125236153|NCT01155570|450491729|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
125236154|NCT01155570|450491729|FG000|Overall Study|Adverse Event + Other Reasons|7|||
125236155|NCT01155570|450491729|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
125236156|NCT01155570|450491729|FG000|Overall Study|Other Reasons|23|||
125236157|NCT00296517|450491730|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
125236158|NCT00296517|450491731|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
125236159|NCT00296517|450491730|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
125236160|NCT00296517|450491731|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
125236161|NCT00296517|450491730|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
125236162|NCT00296517|450491731|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
125236163|NCT00296517|450491730|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
125236164|NCT00296517|450491731|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
125236165|NCT00296517|450491730|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
125236166|NCT00296517|450491731|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
125236167|NCT00296517|450491730|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
125236168|NCT00296517|450491731|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
125236169|NCT00296517|450491730|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
125236170|NCT00296517|450491731|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
125236171|NCT00296517|450491730|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
125236172|NCT00296517|450491731|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
125236173|NCT00296517|450491730|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
125236174|NCT00296517|450491731|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
125236175|NCT00964782|450491735|FG000|Overall Study|Lost to Follow-up|1|||
125236176|NCT00964782|450491736|FG001|Overall Study|Lost to Follow-up|0|||
125236177|NCT00596635|450491740|FG000|Overall Study|Lost to Follow-up|0|||
125236178|NCT00596635|450491741|FG001|Overall Study|Lost to Follow-up|2|||
125236179|NCT00596635|450491742|FG002|Overall Study|Lost to Follow-up|0|||
125236180|NCT00596635|450491740|FG000|Overall Study|Treatment for symptomatic UTI|4|||
125236181|NCT00596635|450491741|FG001|Overall Study|Treatment for symptomatic UTI|6|||
125236182|NCT00596635|450491742|FG002|Overall Study|Treatment for symptomatic UTI|3|||
125236183|NCT00596635|450491740|FG000|Overall Study|Hip fracture|2|||
125236184|NCT00596635|450491741|FG001|Overall Study|Hip fracture|3|||
125236185|NCT00596635|450491742|FG002|Overall Study|Hip fracture|3|||
125236186|NCT00596635|450491740|FG000|Overall Study|Could not provide urine specimen|1|||
125236187|NCT00596635|450491741|FG001|Overall Study|Could not provide urine specimen|2|||
125236188|NCT00596635|450491742|FG002|Overall Study|Could not provide urine specimen|2|||
125236189|NCT01143324|450491745|FG000|Overall Study|Lost to Follow-up|11|||
125236190|NCT01143324|450491745|FG000|Overall Study|Withdrawal by Subject|4|||
125236191|NCT01143324|450491745|FG000|Overall Study|Explant of the device|4|||
125236192|NCT01101178|450491749|FG000|Period 1|Withdrawal by Subject|1|||
125236193|NCT01101178|450491750|FG001|Period 1|Withdrawal by Subject|2|||
125236194|NCT01101178|450491749|FG000|Period 1|Positive drug screen|1|||
125236195|NCT01101178|450491750|FG001|Period 1|Positive drug screen|1|||
125236196|NCT01101178|450491749|FG000|Period 1|Adverse Event|2|||
125236197|NCT01101178|450491750|FG001|Period 1|Adverse Event|1|||
125236198|NCT01101178|450491749|FG000|Period 2|Withdrawal by Subject|0|||
125236199|NCT01101178|450491750|FG001|Period 2|Withdrawal by Subject|1|||
125236200|NCT01850641|450491751|FG000|Overall Study|Physician Decision|1|||
125236201|NCT01850641|450491751|FG000|Overall Study|Decrease in serum phosphorus|1|||
125180878|NCT01547390|450281519|FG001|Overall Study|Withdrawal by Subject|7|||
125236202|NCT01850641|450491751|FG000|Overall Study|Decrease in serum calcium|2|||
125236203|NCT01850641|450491751|FG000|Overall Study|Increase in serum ferritin|1|||
125236204|NCT00141817|450491752|FG000|Overall Study|Protocol Violation|0|||
125236205|NCT00141817|450491753|FG001|Overall Study|Protocol Violation|0|||
125236206|NCT00141817|450491754|FG002|Overall Study|Protocol Violation|1|||
125236207|NCT00141817|450491755|FG003|Overall Study|Protocol Violation|0|||
125236208|NCT00141817|450491752|FG000|Overall Study|Parent request|1|||
125236209|NCT00141817|450491753|FG001|Overall Study|Parent request|0|||
125236210|NCT00141817|450491754|FG002|Overall Study|Parent request|0|||
125236211|NCT00141817|450491755|FG003|Overall Study|Parent request|0|||
125236212|NCT00127803|450491756|FG000|Overall Study|Adverse Event|2|||
125180879|NCT01547390|450281518|FG000|Overall Study|termination of pregnancy|0|||
125180880|NCT01547390|450281519|FG001|Overall Study|termination of pregnancy|1|||
125180881|NCT01547390|450281518|FG000|Overall Study|Lost to Follow-up|0|||
125180882|NCT01547390|450281519|FG001|Overall Study|Lost to Follow-up|2|||
125180883|NCT01547390|450281518|FG000|Overall Study|Adverse Event|3|||
125180884|NCT01547390|450281519|FG001|Overall Study|Adverse Event|0|||
125180885|NCT01459783|450281520|FG000|Baseline to 6 Months|Death|1|||
125180886|NCT01459783|450281521|FG001|Baseline to 6 Months|Death|0|||
125180887|NCT01459783|450281520|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
125180888|NCT01459783|450281521|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
125180889|NCT01459783|450281520|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
125180890|NCT01459783|450281521|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
125180891|NCT01459783|450281520|FG000|6 Months to 12 Months|Death|0|||
125180892|NCT01459783|450281521|FG001|6 Months to 12 Months|Death|1|||
125180893|NCT01459783|450281520|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
125180894|NCT01459783|450281521|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
125180895|NCT01459783|450281520|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
125180896|NCT01459783|450281521|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
125180897|NCT01459783|450281520|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
125180898|NCT01459783|450281521|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
125180899|NCT00640315|450281522|FG000|Overall Study|Withdrawal by Subject|0|||
125180900|NCT00640315|450281523|FG001|Overall Study|Withdrawal by Subject|1|||
125180901|NCT04452669|450283456|FG000|Overall Study|Death|1|||
125180902|NCT04452669|450283457|FG001|Overall Study|Death|4|||
125180903|NCT05201794|450283458|FG000|Overall Study|Withdrawal by Subject|13|||
125180904|NCT05201794|450283459|FG001|Overall Study|Withdrawal by Subject|12|||
125180905|NCT05201794|450283460|FG002|Overall Study|Withdrawal by Subject|14|||
125180906|NCT05201794|450283461|FG003|Overall Study|Withdrawal by Subject|0|||
125180907|NCT05201794|450283458|FG000|Overall Study|Adverse Event|5|||
125236213|NCT00127803|450491757|FG001|Overall Study|Adverse Event|0|||
125236214|NCT00127803|450491758|FG002|Overall Study|Adverse Event|0|||
125236215|NCT00127803|450491759|FG003|Overall Study|Adverse Event|0|||
125236216|NCT00127803|450491756|FG000|Overall Study|Withdrawal by Subject|1|||
125236217|NCT00127803|450491757|FG001|Overall Study|Withdrawal by Subject|0|||
125236218|NCT00127803|450491758|FG002|Overall Study|Withdrawal by Subject|0|||
125180908|NCT05201794|450283459|FG001|Overall Study|Adverse Event|5|||
125180909|NCT05201794|450283460|FG002|Overall Study|Adverse Event|4|||
125180910|NCT05201794|450283461|FG003|Overall Study|Adverse Event|0|||
125180911|NCT05201794|450283458|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
125180912|NCT05201794|450283459|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
125236219|NCT00127803|450491759|FG003|Overall Study|Withdrawal by Subject|0|||
125236220|NCT00127803|450491756|FG000|Overall Study|Lost to Follow-up|0|||
125236221|NCT00127803|450491757|FG001|Overall Study|Lost to Follow-up|0|||
125236222|NCT00127803|450491758|FG002|Overall Study|Lost to Follow-up|0|||
125236223|NCT00127803|450491759|FG003|Overall Study|Lost to Follow-up|1|||
125180913|NCT05201794|450283460|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
125180914|NCT05201794|450283461|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125180915|NCT05201794|450283458|FG000|Overall Study|Non-Compliance With Study Drug|2|||
125180916|NCT05201794|450283459|FG001|Overall Study|Non-Compliance With Study Drug|3|||
125180917|NCT05201794|450283460|FG002|Overall Study|Non-Compliance With Study Drug|3|||
125180918|NCT05201794|450283461|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125180919|NCT05201794|450283458|FG000|Overall Study|Physician Decision|1|||
125180920|NCT05201794|450283459|FG001|Overall Study|Physician Decision|3|||
125180921|NCT05201794|450283460|FG002|Overall Study|Physician Decision|2|||
125180922|NCT05201794|450283461|FG003|Overall Study|Physician Decision|0|||
125180923|NCT05201794|450283458|FG000|Overall Study|Lost to Follow-up|2|||
125180924|NCT05201794|450283459|FG001|Overall Study|Lost to Follow-up|2|||
125180925|NCT05201794|450283460|FG002|Overall Study|Lost to Follow-up|0|||
125180926|NCT05201794|450283461|FG003|Overall Study|Lost to Follow-up|0|||
125180927|NCT05201794|450283458|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
125180928|NCT05201794|450283459|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
125180929|NCT05201794|450283460|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
125180930|NCT05201794|450283461|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
125180931|NCT05201794|450283458|FG000|Overall Study|Protocol Violation|2|||
125180932|NCT05201794|450283459|FG001|Overall Study|Protocol Violation|0|||
125180933|NCT05201794|450283460|FG002|Overall Study|Protocol Violation|1|||
125180934|NCT05201794|450283461|FG003|Overall Study|Protocol Violation|0|||
125180935|NCT05201794|450283458|FG000|Overall Study|Death|1|||
125180936|NCT05201794|450283459|FG001|Overall Study|Death|0|||
125180937|NCT05201794|450283460|FG002|Overall Study|Death|0|||
125180938|NCT05201794|450283461|FG003|Overall Study|Death|0|||
125180939|NCT05201794|450283458|FG000|Overall Study|Site Terminated By Sponsor|0|||
125180940|NCT05201794|450283459|FG001|Overall Study|Site Terminated By Sponsor|1|||
125180941|NCT05201794|450283460|FG002|Overall Study|Site Terminated By Sponsor|0|||
125180942|NCT05201794|450283461|FG003|Overall Study|Site Terminated By Sponsor|0|||
125180943|NCT05201794|450283458|FG000|Overall Study|Other|3|||
125180944|NCT05201794|450283459|FG001|Overall Study|Other|3|||
125180945|NCT05201794|450283460|FG002|Overall Study|Other|3|||
125180946|NCT05201794|450283461|FG003|Overall Study|Other|0|||
125180947|NCT05201794|450283458|FG000|Overall Study|Randomized But Not Treated|1|||
125180948|NCT05201794|450283459|FG001|Overall Study|Randomized But Not Treated|2|||
125180949|NCT05201794|450283460|FG002|Overall Study|Randomized But Not Treated|1|||
125180950|NCT05201794|450283461|FG003|Overall Study|Randomized But Not Treated|0|||
125180951|NCT04653454|450283466|FG000|Overall Study|Withdrawal by Subject|1|||
125180952|NCT04653454|450283466|FG000|Overall Study|Physician Decision|40|||
125180953|NCT03620708|450283467|FG000|Overall Study|Lost to Follow-up|1|||
125180954|NCT03620708|450283468|FG001|Overall Study|Lost to Follow-up|1|||
125180955|NCT03620708|450283469|FG002|Overall Study|Lost to Follow-up|2|||
125180956|NCT03620708|450283467|FG000|Overall Study|Withdrawal by Subject|0|||
125180957|NCT03620708|450283468|FG001|Overall Study|Withdrawal by Subject|0|||
125180958|NCT03620708|450283469|FG002|Overall Study|Withdrawal by Subject|1|||
125180959|NCT06082843|450283470|FG000|Overall Study|Withdrawal by Subject|0|||
125180960|NCT06082843|450283471|FG001|Overall Study|Withdrawal by Subject|2|||
125180961|NCT06082843|450283470|FG000|Overall Study|Study terminated by sponsor|12|||
125180962|NCT06082843|450283471|FG001|Overall Study|Study terminated by sponsor|8|||
125180963|NCT05525520|450283473|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
125180964|NCT05525520|450283474|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
125180965|NCT05525520|450283473|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
125180966|NCT05525520|450283474|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
125180967|NCT03176134|450283475|FG000|Overall Study|Lost to Follow-up|0|||
125180968|NCT03176134|450283476|FG001|Overall Study|Lost to Follow-up|2|||
125180969|NCT03176134|450283477|FG002|Overall Study|Lost to Follow-up|0|||
125180970|NCT03176134|450283478|FG003|Overall Study|Lost to Follow-up|0|||
125180971|NCT03176134|450283479|FG004|Overall Study|Lost to Follow-up|0|||
125180972|NCT03176134|450283480|FG005|Overall Study|Lost to Follow-up|0|||
125180973|NCT03176134|450283481|FG006|Overall Study|Lost to Follow-up|0|||
125180974|NCT03176134|450283482|FG007|Overall Study|Lost to Follow-up|0|||
125180975|NCT03176134|450283475|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
125180976|NCT03176134|450283476|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125180977|NCT03176134|450283477|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
125180978|NCT03176134|450283478|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
125180979|NCT03176134|450283479|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
125180980|NCT03176134|450283480|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
125180981|NCT03176134|450283481|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
125180982|NCT03176134|450283482|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
125180983|NCT03657797|450283483|FG000|Overall Study|Lost to Follow-up|0|||
125180984|NCT03657797|450283484|FG001|Overall Study|Lost to Follow-up|1|||
125180985|NCT03657797|450283485|FG002|Overall Study|Lost to Follow-up|1|||
125180986|NCT03657797|450283486|FG003|Overall Study|Lost to Follow-up|0|||
125180987|NCT03657797|450283483|FG000|Overall Study|Physician Decision|0|||
125180988|NCT03657797|450283484|FG001|Overall Study|Physician Decision|1|||
125180989|NCT03657797|450283485|FG002|Overall Study|Physician Decision|0|||
125236224|NCT02774889|450491769|FG000|Overall Study|Lost to Follow-up|2|||
125236225|NCT02774889|450491770|FG001|Overall Study|Lost to Follow-up|1|||
125236226|NCT00858988|450491771|FG000|Analysis|Lactulose unable to be detected in urine|2|||
125236227|NCT00858988|450491772|FG001|Analysis|Lactulose unable to be detected in urine|1|||
125236228|NCT00614393|450493814|FG000|Overall Study|Adverse Event|20|||
125236229|NCT00614393|450493815|FG001|Overall Study|Adverse Event|2|||
125236230|NCT00614393|450493816|FG002|Overall Study|Adverse Event|3|||
125236231|NCT00614393|450493817|FG003|Overall Study|Adverse Event|13|||
125236232|NCT00614393|450493818|FG004|Overall Study|Adverse Event|21|||
125236233|NCT00614393|450493814|FG000|Overall Study|Lost to Follow-up|0|||
125236234|NCT00614393|450493815|FG001|Overall Study|Lost to Follow-up|0|||
125236235|NCT00614393|450493816|FG002|Overall Study|Lost to Follow-up|0|||
125236236|NCT00614393|450493817|FG003|Overall Study|Lost to Follow-up|1|||
125236237|NCT00614393|450493818|FG004|Overall Study|Lost to Follow-up|2|||
125236238|NCT00614393|450493814|FG000|Overall Study|Physician Decision|17|||
125236239|NCT00614393|450493815|FG001|Overall Study|Physician Decision|0|||
125236240|NCT00614393|450493816|FG002|Overall Study|Physician Decision|1|||
125236241|NCT00614393|450493817|FG003|Overall Study|Physician Decision|8|||
125236242|NCT00614393|450493818|FG004|Overall Study|Physician Decision|9|||
125236243|NCT00614393|450493814|FG000|Overall Study|Progressive Disease|118|||
125236244|NCT00614393|450493815|FG001|Overall Study|Progressive Disease|5|||
125236245|NCT00614393|450493816|FG002|Overall Study|Progressive Disease|5|||
125236246|NCT00614393|450493817|FG003|Overall Study|Progressive Disease|138|||
125236247|NCT00614393|450493818|FG004|Overall Study|Progressive Disease|130|||
125236248|NCT00614393|450493814|FG000|Overall Study|Protocol Violation|1|||
125236249|NCT00614393|450493815|FG001|Overall Study|Protocol Violation|0|||
125236250|NCT00614393|450493816|FG002|Overall Study|Protocol Violation|0|||
125236251|NCT00614393|450493817|FG003|Overall Study|Protocol Violation|0|||
125236252|NCT00614393|450493818|FG004|Overall Study|Protocol Violation|0|||
125236253|NCT00614393|450493814|FG000|Overall Study|Terminated by Sponsor|0|||
125236254|NCT00614393|450493815|FG001|Overall Study|Terminated by Sponsor|0|||
125236255|NCT00614393|450493816|FG002|Overall Study|Terminated by Sponsor|0|||
125236256|NCT00614393|450493817|FG003|Overall Study|Terminated by Sponsor|0|||
125236257|NCT00614393|450493818|FG004|Overall Study|Terminated by Sponsor|1|||
125236258|NCT00614393|450493814|FG000|Overall Study|Withdrawal by Subject|20|||
125236259|NCT00614393|450493815|FG001|Overall Study|Withdrawal by Subject|1|||
125236260|NCT00614393|450493816|FG002|Overall Study|Withdrawal by Subject|1|||
125236261|NCT00614393|450493817|FG003|Overall Study|Withdrawal by Subject|16|||
125236262|NCT00614393|450493818|FG004|Overall Study|Withdrawal by Subject|13|||
125236263|NCT00614393|450493814|FG000|Overall Study|Other|4|||
125236264|NCT00614393|450493815|FG001|Overall Study|Other|0|||
125236265|NCT00614393|450493816|FG002|Overall Study|Other|0|||
125236266|NCT00614393|450493817|FG003|Overall Study|Other|4|||
125236267|NCT00614393|450493818|FG004|Overall Study|Other|2|||
125236268|NCT00614393|450493814|FG000|Overall Study|Not Treated|0|||
125236269|NCT00614393|450493815|FG001|Overall Study|Not Treated|0|||
125236270|NCT00614393|450493816|FG002|Overall Study|Not Treated|0|||
125236271|NCT00614393|450493817|FG003|Overall Study|Not Treated|0|||
125236272|NCT00614393|450493818|FG004|Overall Study|Not Treated|2|||
125236273|NCT02328105|450493819|FG000|Overall Study|Death|6|||
125236274|NCT02328105|450493819|FG000|Overall Study|Withdrawal by Subject|1|||
125236275|NCT02328105|450493819|FG000|Overall Study|Still On Study in Follow-Up|4|||
125236276|NCT00855582|450493820|FG000|Overall Study|Adverse Event|2|||
125236277|NCT00855582|450493821|FG001|Overall Study|Adverse Event|6|||
125236278|NCT00855582|450493822|FG002|Overall Study|Adverse Event|3|||
125236279|NCT00855582|450493820|FG000|Overall Study|Death|1|||
125236280|NCT00855582|450493821|FG001|Overall Study|Death|0|||
125236281|NCT00855582|450493822|FG002|Overall Study|Death|0|||
125236282|NCT00855582|450493820|FG000|Overall Study|Lack of Efficacy|1|||
125236283|NCT00855582|450493821|FG001|Overall Study|Lack of Efficacy|3|||
125236284|NCT00855582|450493822|FG002|Overall Study|Lack of Efficacy|8|||
125236285|NCT00855582|450493820|FG000|Overall Study|Lost to Follow-up|1|||
125236286|NCT00855582|450493821|FG001|Overall Study|Lost to Follow-up|3|||
125236287|NCT00855582|450493822|FG002|Overall Study|Lost to Follow-up|1|||
125236288|NCT00855582|450493820|FG000|Overall Study|Physician Decision|0|||
125236289|NCT00855582|450493821|FG001|Overall Study|Physician Decision|0|||
125236290|NCT00855582|450493822|FG002|Overall Study|Physician Decision|1|||
125236291|NCT00855582|450493820|FG000|Overall Study|Protocol Violation|6|||
125236292|NCT00855582|450493821|FG001|Overall Study|Protocol Violation|2|||
125236293|NCT00855582|450493822|FG002|Overall Study|Protocol Violation|6|||
125236294|NCT00855582|450493820|FG000|Overall Study|Entry Criteria Not Met|8|||
125236295|NCT00855582|450493821|FG001|Overall Study|Entry Criteria Not Met|6|||
125236296|NCT00855582|450493822|FG002|Overall Study|Entry Criteria Not Met|3|||
125236297|NCT00855582|450493820|FG000|Overall Study|Withdrawal by Subject|7|||
125236298|NCT00855582|450493821|FG001|Overall Study|Withdrawal by Subject|4|||
125236299|NCT00855582|450493822|FG002|Overall Study|Withdrawal by Subject|8|||
125236300|NCT01588509|450493826|FG000|Overall Study|Lost to Follow-up|1|||
125236301|NCT01588509|450493827|FG001|Overall Study|Lost to Follow-up|0|||
125236302|NCT03345004|450493828|FG000|Overall Study|Physician Decision|1|||
125236303|NCT03345004|450493829|FG001|Overall Study|Physician Decision|0|||
125236304|NCT03345004|450493828|FG000|Overall Study|Withdrawal by Subject|0|||
125236305|NCT03345004|450493829|FG001|Overall Study|Withdrawal by Subject|1|||
125236306|NCT01013753|450493830|FG000|Overall Study|Adverse Event|8|||
125236307|NCT01013753|450493830|FG000|Overall Study|Protocol Violation|3|||
125236308|NCT01013753|450493830|FG000|Overall Study|Lost to Follow-up|1|||
125236309|NCT01013753|450493830|FG000|Overall Study|Withdrawal by Subject|2|||
125236310|NCT01013753|450493830|FG000|Overall Study|Other|2|||
125236311|NCT04757636|450493831|FG000|Overall Study|Adverse Event|25|||
125236312|NCT04757636|450493832|FG001|Overall Study|Adverse Event|8|||
125236313|NCT04757636|450493833|FG002|Overall Study|Adverse Event|11|||
125236314|NCT04757636|450493831|FG000|Overall Study|Death|9|||
125236315|NCT04757636|450493832|FG001|Overall Study|Death|12|||
125236316|NCT04757636|450493833|FG002|Overall Study|Death|6|||
125236317|NCT04757636|450493831|FG000|Overall Study|Lack of Efficacy|2|||
125236318|NCT04757636|450493832|FG001|Overall Study|Lack of Efficacy|0|||
125236319|NCT04757636|450493833|FG002|Overall Study|Lack of Efficacy|0|||
125236320|NCT04757636|450493831|FG000|Overall Study|Lost to Follow-up|1|||
125236321|NCT04757636|450493832|FG001|Overall Study|Lost to Follow-up|6|||
125236322|NCT04757636|450493833|FG002|Overall Study|Lost to Follow-up|7|||
125236323|NCT04757636|450493831|FG000|Overall Study|Physician Decision|1|||
125236324|NCT04757636|450493832|FG001|Overall Study|Physician Decision|3|||
125236325|NCT04757636|450493833|FG002|Overall Study|Physician Decision|4|||
125236326|NCT04757636|450493831|FG000|Overall Study|Withdrawal by Subject|20|||
125236327|NCT04757636|450493832|FG001|Overall Study|Withdrawal by Subject|23|||
125236328|NCT04757636|450493833|FG002|Overall Study|Withdrawal by Subject|18|||
125236329|NCT04757636|450493831|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
125180990|NCT03657797|450283486|FG003|Overall Study|Physician Decision|0|||
125180991|NCT03657797|450283483|FG000|Overall Study|Withdrawal by Subject|0|||
125180992|NCT03657797|450283484|FG001|Overall Study|Withdrawal by Subject|1|||
125180993|NCT03657797|450283485|FG002|Overall Study|Withdrawal by Subject|2|||
125180994|NCT03657797|450283486|FG003|Overall Study|Withdrawal by Subject|0|||
125180995|NCT03657797|450283483|FG000|Overall Study|Adverse Event|0|||
125180996|NCT03657797|450283484|FG001|Overall Study|Adverse Event|0|||
125180997|NCT03657797|450283485|FG002|Overall Study|Adverse Event|2|||
125180998|NCT03657797|450283486|FG003|Overall Study|Adverse Event|0|||
125180999|NCT00118157|450283487|FG000|Overall Study|Adverse Event|2|||
125181000|NCT00118157|450283487|FG000|Overall Study|Death|8|||
125181001|NCT00118157|450283487|FG000|Overall Study|Withdrawal by Subject|2|||
125181002|NCT05989672|450283488|FG000|Overall Study|Adverse Event|3|||
125181003|NCT05989672|450283489|FG001|Overall Study|Adverse Event|0|||
125181004|NCT05989672|450283490|FG002|Overall Study|Adverse Event|0|||
125181005|NCT00696423|450283491|FG000|Overall Study|Lost to Follow-up|0|||
125181006|NCT00696423|450283492|FG001|Overall Study|Lost to Follow-up|5|||
125181007|NCT03989102|450283493|FG000|Year 1|Withdrawal by Subject|6|||
125181008|NCT03989102|450283494|FG001|Year 1|Withdrawal by Subject|2|||
125181009|NCT03989102|450283495|FG002|Year 1|Withdrawal by Subject|7|||
125181010|NCT03989102|450283493|FG000|Year 1|Lost to Follow-up|5|||
125181011|NCT03989102|450283494|FG001|Year 1|Lost to Follow-up|2|||
125181012|NCT03989102|450283495|FG002|Year 1|Lost to Follow-up|5|||
125181013|NCT03989102|450283493|FG000|Year 1|Subject met withdrawal criteria|1|||
125181014|NCT03989102|450283494|FG001|Year 1|Subject met withdrawal criteria|0|||
125181015|NCT03989102|450283495|FG002|Year 1|Subject met withdrawal criteria|1|||
125181016|NCT03989102|450283493|FG000|Year 2|Lost to Follow-up|7|||
125181017|NCT03989102|450283494|FG001|Year 2|Lost to Follow-up|3|||
125181018|NCT03989102|450283495|FG002|Year 2|Lost to Follow-up|4|||
125181019|NCT03989102|450283493|FG000|Year 2|Withdrawal by Subject|3|||
125236330|NCT04757636|450493832|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
125236331|NCT04757636|450493833|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
125236332|NCT04757636|450493831|FG000|Overall Study|Study Terminated by Sponsor|103|||
125236333|NCT04757636|450493832|FG001|Overall Study|Study Terminated by Sponsor|104|||
125236334|NCT04757636|450493833|FG002|Overall Study|Study Terminated by Sponsor|114|||
125236335|NCT04757636|450493831|FG000|Overall Study|Sponsor Decision|0|||
125236336|NCT04757636|450493832|FG001|Overall Study|Sponsor Decision|0|||
125236337|NCT04757636|450493833|FG002|Overall Study|Sponsor Decision|1|||
125236338|NCT04757636|450493831|FG000|Overall Study|Randomized in Error|0|||
125236339|NCT04757636|450493832|FG001|Overall Study|Randomized in Error|0|||
125236340|NCT04757636|450493833|FG002|Overall Study|Randomized in Error|2|||
125236341|NCT02097277|450493843|FG000|Overall Study|Subject no longer meets study criteria|0|||
125181020|NCT03989102|450283494|FG001|Year 2|Withdrawal by Subject|1|||
125181021|NCT03989102|450283495|FG002|Year 2|Withdrawal by Subject|2|||
125181022|NCT03989102|450283493|FG000|Year 2|Subject non-compliant|3|||
125181023|NCT03989102|450283494|FG001|Year 2|Subject non-compliant|2|||
125181024|NCT03989102|450283495|FG002|Year 2|Subject non-compliant|0|||
125181025|NCT03989102|450283493|FG000|Year 2|Travel|1|||
125181026|NCT03989102|450283494|FG001|Year 2|Travel|0|||
125181027|NCT03989102|450283495|FG002|Year 2|Travel|1|||
125181028|NCT03989102|450283493|FG000|Year 2|P16 missing|4|||
125181029|NCT03989102|450283494|FG001|Year 2|P16 missing|2|||
125181030|NCT03989102|450283495|FG002|Year 2|P16 missing|1|||
125181031|NCT03989102|450283493|FG000|Year 2|P11 missing|1|||
125181032|NCT03989102|450283494|FG001|Year 2|P11 missing|3|||
125181033|NCT03989102|450283495|FG002|Year 2|P11 missing|7|||
125181034|NCT03989102|450283493|FG000|Year 2|Definitive displacement outside the study site|0|||
125181035|NCT03989102|450283494|FG001|Year 2|Definitive displacement outside the study site|1|||
125181036|NCT03989102|450283495|FG002|Year 2|Definitive displacement outside the study site|0|||
125181037|NCT03989102|450283493|FG000|Year 2|Subject missed last study visit|0|||
125181038|NCT03989102|450283494|FG001|Year 2|Subject missed last study visit|1|||
125181039|NCT03989102|450283495|FG002|Year 2|Subject missed last study visit|0|||
125181040|NCT03989102|450283493|FG000|Year 2|Death|0|||
125181041|NCT03989102|450283494|FG001|Year 2|Death|1|||
125181042|NCT03989102|450283495|FG002|Year 2|Death|0|||
125181043|NCT03989102|450283493|FG000|Year 2|Subject not reachable|0|||
125181044|NCT03989102|450283494|FG001|Year 2|Subject not reachable|0|||
125181045|NCT03989102|450283495|FG002|Year 2|Subject not reachable|1|||
125181046|NCT03989102|450283493|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
125181047|NCT03989102|450283494|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
125181048|NCT03989102|450283495|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
125181049|NCT03989102|450283493|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
125181050|NCT03989102|450283494|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
125181051|NCT03989102|450283495|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
125181052|NCT03989102|450283493|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
125181053|NCT03989102|450283494|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
125181054|NCT03989102|450283495|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
125181055|NCT03989102|450283493|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
125181056|NCT03989102|450283494|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
125181057|NCT03989102|450283495|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
125181058|NCT03989102|450283493|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
125181059|NCT03989102|450283494|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
125181060|NCT03989102|450283495|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
125181061|NCT03989102|450283493|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
125181062|NCT03989102|450283494|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
125181063|NCT03989102|450283495|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
125181064|NCT03642262|450283496|FG000|Period 1|Withdrawal by Subject|1|||
125181065|NCT03642262|450283497|FG001|Period 1|Withdrawal by Subject|1|||
125181066|NCT03642262|450283496|FG000|Period 1|Adverse Event|0|||
125181067|NCT03642262|450283497|FG001|Period 1|Adverse Event|1|||
125181068|NCT02760004|450283503|FG000|Overall Study|Lost to Follow-up|13|||
125181069|NCT02760004|450283504|FG001|Overall Study|Lost to Follow-up|22|||
125181070|NCT01050530|450283505|FG000|Overall Study|Adverse Event|6|||
125181071|NCT01050530|450283506|FG001|Overall Study|Adverse Event|3|||
125181072|NCT01050530|450283505|FG000|Overall Study|Lack of Efficacy|1|||
125181073|NCT01050530|450283506|FG001|Overall Study|Lack of Efficacy|4|||
125181074|NCT01050530|450283505|FG000|Overall Study|Withdrawal by Subject|0|||
125181075|NCT01050530|450283506|FG001|Overall Study|Withdrawal by Subject|3|||
125181076|NCT01050530|450283505|FG000|Overall Study|Protocol Violation|1|||
125181077|NCT01050530|450283506|FG001|Overall Study|Protocol Violation|0|||
125181078|NCT02288312|450283507|FG000|Overall Study|Pregnancy|1|||
125181079|NCT02288312|450283508|FG001|Overall Study|Pregnancy|0|||
125181080|NCT02288312|450283509|FG002|Overall Study|Pregnancy|0|||
125181081|NCT01276041|450283510|FG000|Overall Study|Adverse Event|2|||
125181082|NCT01276041|450283510|FG000|Overall Study|Protocol Violation|1|||
125181083|NCT00485264|450283511|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
125181084|NCT00485264|450283512|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
125181085|NCT00485264|450283513|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
125181086|NCT00485264|450283514|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
125181087|NCT00485264|450283515|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
125181088|NCT00485264|450283516|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
125181089|NCT00485264|450283511|FG000|Overall Study|Death|1|||
125181090|NCT00485264|450283512|FG001|Overall Study|Death|0|||
125181091|NCT00485264|450283513|FG002|Overall Study|Death|0|||
125181092|NCT00485264|450283514|FG003|Overall Study|Death|0|||
125181093|NCT00485264|450283515|FG004|Overall Study|Death|1|||
125181094|NCT00485264|450283516|FG005|Overall Study|Death|0|||
125181095|NCT00485264|450283511|FG000|Overall Study|Adverse Event|1|||
125181096|NCT00485264|450283512|FG001|Overall Study|Adverse Event|0|||
125181097|NCT00485264|450283513|FG002|Overall Study|Adverse Event|2|||
125181098|NCT00485264|450283514|FG003|Overall Study|Adverse Event|3|||
125181099|NCT00485264|450283515|FG004|Overall Study|Adverse Event|1|||
125181100|NCT00485264|450283516|FG005|Overall Study|Adverse Event|3|||
125181101|NCT00485264|450283511|FG000|Overall Study|Pregnancy|4|||
125181102|NCT00485264|450283512|FG001|Overall Study|Pregnancy|0|||
125181103|NCT00485264|450283513|FG002|Overall Study|Pregnancy|0|||
125181104|NCT00485264|450283514|FG003|Overall Study|Pregnancy|0|||
125181105|NCT00485264|450283515|FG004|Overall Study|Pregnancy|0|||
125181106|NCT00485264|450283516|FG005|Overall Study|Pregnancy|0|||
125181107|NCT00485264|450283511|FG000|Overall Study|Disallowed Medication|0|||
125181108|NCT00485264|450283512|FG001|Overall Study|Disallowed Medication|0|||
125181109|NCT00485264|450283513|FG002|Overall Study|Disallowed Medication|0|||
125181110|NCT00485264|450283514|FG003|Overall Study|Disallowed Medication|0|||
125181111|NCT00485264|450283515|FG004|Overall Study|Disallowed Medication|0|||
125181112|NCT00485264|450283516|FG005|Overall Study|Disallowed Medication|1|||
125181113|NCT00485264|450283511|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
125181114|NCT00485264|450283512|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
125181115|NCT00485264|450283513|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
125181116|NCT00485264|450283514|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
125181117|NCT00485264|450283515|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
125181118|NCT00485264|450283516|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
125181119|NCT00485264|450283511|FG000|Overall Study|Lack of Efficacy|0|||
125181120|NCT00485264|450283512|FG001|Overall Study|Lack of Efficacy|1|||
125181121|NCT00485264|450283513|FG002|Overall Study|Lack of Efficacy|0|||
125181122|NCT00485264|450283514|FG003|Overall Study|Lack of Efficacy|0|||
125181123|NCT00485264|450283515|FG004|Overall Study|Lack of Efficacy|0|||
125181124|NCT00485264|450283516|FG005|Overall Study|Lack of Efficacy|0|||
125181125|NCT00485264|450283511|FG000|Overall Study|Guardian Consent Withdrawn|1|||
125181126|NCT00485264|450283512|FG001|Overall Study|Guardian Consent Withdrawn|0|||
125181127|NCT00485264|450283513|FG002|Overall Study|Guardian Consent Withdrawn|0|||
125181128|NCT00485264|450283514|FG003|Overall Study|Guardian Consent Withdrawn|0|||
125181129|NCT00485264|450283515|FG004|Overall Study|Guardian Consent Withdrawn|1|||
125181130|NCT00485264|450283516|FG005|Overall Study|Guardian Consent Withdrawn|0|||
125181131|NCT00485264|450283511|FG000|Overall Study|Physician Decision|0|||
125181132|NCT00485264|450283512|FG001|Overall Study|Physician Decision|2|||
125181133|NCT00485264|450283513|FG002|Overall Study|Physician Decision|0|||
125181134|NCT00485264|450283514|FG003|Overall Study|Physician Decision|0|||
125181135|NCT00485264|450283515|FG004|Overall Study|Physician Decision|0|||
125181136|NCT00485264|450283516|FG005|Overall Study|Physician Decision|0|||
125181137|NCT00485264|450283511|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
125181138|NCT00485264|450283512|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
125181139|NCT00485264|450283513|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
125181140|NCT00485264|450283514|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
125181141|NCT00485264|450283515|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
125181142|NCT00485264|450283516|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
125181143|NCT00485264|450283511|FG000|Overall Study|Not Able to Attend Clinic|5|||
125181144|NCT00485264|450283512|FG001|Overall Study|Not Able to Attend Clinic|0|||
125181145|NCT00485264|450283513|FG002|Overall Study|Not Able to Attend Clinic|0|||
125181146|NCT00485264|450283514|FG003|Overall Study|Not Able to Attend Clinic|1|||
125181147|NCT00485264|450283515|FG004|Overall Study|Not Able to Attend Clinic|1|||
125181148|NCT00485264|450283516|FG005|Overall Study|Not Able to Attend Clinic|2|||
125181149|NCT00485264|450283511|FG000|Overall Study|Non-Compliant|17|||
125181150|NCT00485264|450283512|FG001|Overall Study|Non-Compliant|2|||
125181151|NCT00485264|450283513|FG002|Overall Study|Non-Compliant|1|||
125181152|NCT00485264|450283514|FG003|Overall Study|Non-Compliant|0|||
125181153|NCT00485264|450283515|FG004|Overall Study|Non-Compliant|1|||
125181154|NCT00485264|450283516|FG005|Overall Study|Non-Compliant|0|||
125181155|NCT00485264|450283511|FG000|Overall Study|Lost to Follow-up|2|||
125181156|NCT00485264|450283512|FG001|Overall Study|Lost to Follow-up|1|||
125181157|NCT00485264|450283513|FG002|Overall Study|Lost to Follow-up|1|||
125181158|NCT00485264|450283514|FG003|Overall Study|Lost to Follow-up|0|||
125181159|NCT00485264|450283515|FG004|Overall Study|Lost to Follow-up|0|||
125181160|NCT00485264|450283516|FG005|Overall Study|Lost to Follow-up|1|||
125181161|NCT00485264|450283511|FG000|Overall Study|Other Reason|3|||
125181162|NCT00485264|450283512|FG001|Overall Study|Other Reason|0|||
125181163|NCT00485264|450283513|FG002|Overall Study|Other Reason|0|||
125181164|NCT00485264|450283514|FG003|Overall Study|Other Reason|0|||
125181165|NCT00485264|450283515|FG004|Overall Study|Other Reason|0|||
125181166|NCT00485264|450283516|FG005|Overall Study|Other Reason|0|||
125181167|NCT00276484|450283517|FG000|Overall Study|Adverse Event|4|||
125181168|NCT00276484|450283518|FG001|Overall Study|Adverse Event|7|||
125181169|NCT00276484|450283517|FG000|Overall Study|Lost to Follow-up|1|||
125181170|NCT00276484|450283518|FG001|Overall Study|Lost to Follow-up|1|||
125181171|NCT00276484|450283517|FG000|Overall Study|Protocol Violation|0|||
125181172|NCT00276484|450283518|FG001|Overall Study|Protocol Violation|1|||
125181173|NCT00276484|450283517|FG000|Overall Study|Withdrawal by Subject|4|||
125181174|NCT00276484|450283518|FG001|Overall Study|Withdrawal by Subject|3|||
125181175|NCT00276484|450283517|FG000|Overall Study|Could not take time off work|0|||
125181176|NCT00276484|450283518|FG001|Overall Study|Could not take time off work|1|||
125181177|NCT02440464|450283519|FG000|Overall Study|Withdrawal by Subject|3|||
125181178|NCT02440464|450283520|FG001|Overall Study|Withdrawal by Subject|2|||
125181179|NCT04688671|450283521|FG000|Overall Study|Adverse Event|3|||
125181180|NCT04688671|450283522|FG001|Overall Study|Adverse Event|1|||
125181181|NCT04688671|450283521|FG000|Overall Study|Withdrawal by Subject|3|||
125181182|NCT04688671|450283522|FG001|Overall Study|Withdrawal by Subject|1|||
125181183|NCT04688671|450283521|FG000|Overall Study|Lack of Efficacy|1|||
125181184|NCT04688671|450283522|FG001|Overall Study|Lack of Efficacy|1|||
125236342|NCT02097277|450493844|FG001|Overall Study|Subject no longer meets study criteria|1|||
125236343|NCT02097277|450493845|FG002|Overall Study|Subject no longer meets study criteria|0|||
125236344|NCT02097277|450493846|FG003|Overall Study|Subject no longer meets study criteria|1|||
125236345|NCT02097277|450493847|FG004|Overall Study|Subject no longer meets study criteria|0|||
125236346|NCT02097277|450493843|FG000|Overall Study|Subject request to discontinue treatment|0|||
125236347|NCT02097277|450493844|FG001|Overall Study|Subject request to discontinue treatment|0|||
125236348|NCT02097277|450493845|FG002|Overall Study|Subject request to discontinue treatment|0|||
125236349|NCT02097277|450493846|FG003|Overall Study|Subject request to discontinue treatment|0|||
125181185|NCT04688671|450283521|FG000|Overall Study|Protocol Violation|1|||
125181186|NCT04688671|450283522|FG001|Overall Study|Protocol Violation|0|||
125181187|NCT04688671|450283521|FG000|Overall Study|Lost to Follow-up|0|||
125181188|NCT04688671|450283522|FG001|Overall Study|Lost to Follow-up|1|||
125181189|NCT01626690|450283523|FG000|Overall Study|Protocol Violation|1|||
125181190|NCT01626690|450283524|FG001|Overall Study|Protocol Violation|0|||
125181191|NCT01626690|450283523|FG000|Overall Study|Adverse Event|1|||
125181192|NCT01626690|450283524|FG001|Overall Study|Adverse Event|0|||
125181193|NCT02414958|450283528|FG000|Overall Study|Adverse Event|6|||
125181194|NCT02414958|450283529|FG001|Overall Study|Adverse Event|6|||
125181195|NCT02414958|450283530|FG002|Overall Study|Adverse Event|3|||
125181196|NCT02414958|450283528|FG000|Overall Study|Protocol Violation|10|||
125181197|NCT02414958|450283529|FG001|Overall Study|Protocol Violation|3|||
125181198|NCT02414958|450283530|FG002|Overall Study|Protocol Violation|1|||
125181199|NCT02414958|450283528|FG000|Overall Study|Lost to Follow-up|7|||
125181200|NCT02414958|450283529|FG001|Overall Study|Lost to Follow-up|4|||
125181201|NCT02414958|450283530|FG002|Overall Study|Lost to Follow-up|0|||
125181202|NCT02414958|450283528|FG000|Overall Study|Withdrawal by Subject|5|||
125181203|NCT02414958|450283529|FG001|Overall Study|Withdrawal by Subject|3|||
125181204|NCT02414958|450283530|FG002|Overall Study|Withdrawal by Subject|5|||
125181205|NCT02414958|450283528|FG000|Overall Study|Other than specified|4|||
125181206|NCT02414958|450283529|FG001|Overall Study|Other than specified|4|||
125181207|NCT02414958|450283530|FG002|Overall Study|Other than specified|5|||
125181208|NCT05767905|450283533|FG000|Overall Study|Adverse Event|0|||
125181209|NCT05767905|450283534|FG001|Overall Study|Adverse Event|0|||
125181210|NCT05767905|450283535|FG002|Overall Study|Adverse Event|1|||
125181211|NCT03762239|450283536|FG000|Overall Study|Appointment to the doctor|1|||
125181212|NCT03762239|450283537|FG001|Overall Study|Appointment to the doctor|1|||
125181213|NCT03645863|450283538|FG000|Overall Study|Withdrawal by Subject|1|||
125181214|NCT03645863|450283539|FG001|Overall Study|Withdrawal by Subject|0|||
125181215|NCT03645863|450283540|FG002|Overall Study|Withdrawal by Subject|0|||
125181216|NCT03624192|450283550|FG000|Overall Study|Lost to Follow-up|1|||
125181217|NCT03624192|450283551|FG001|Overall Study|Lost to Follow-up|1|||
125181218|NCT04660331|450283556|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
125181219|NCT04660331|450283557|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
125181220|NCT04660331|450283558|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
125181221|NCT02635984|450283559|FG000|Overall Study|Lost to Follow-up|2|||
125181222|NCT02635984|450283560|FG001|Overall Study|Lost to Follow-up|4|||
125181223|NCT02635984|450283559|FG000|Overall Study|Study Arm Closed|1|||
125181224|NCT02635984|450283560|FG001|Overall Study|Study Arm Closed|0|||
125181225|NCT01640249|450283562|FG000|Period 1|Withdrawal by Subject|1|||
125181226|NCT01640249|450283563|FG001|Period 1|Withdrawal by Subject|0|||
125181227|NCT01640249|450283564|FG002|Period 1|Withdrawal by Subject|0|||
125181228|NCT01640249|450283565|FG003|Period 1|Withdrawal by Subject|0|||
125181229|NCT01640249|450283566|FG004|Period 1|Withdrawal by Subject|0|||
125181230|NCT01640249|450283567|FG005|Period 1|Withdrawal by Subject|1|||
125181231|NCT01640249|450283568|FG006|Period 1|Withdrawal by Subject|0|||
125181232|NCT01215136|450283571|FG000|Overall Study|Adverse Event|2|||
125181233|NCT01215136|450283572|FG001|Overall Study|Adverse Event|9|||
125181234|NCT01215136|450283571|FG000|Overall Study|Disease Progression|3|||
125236350|NCT02097277|450493847|FG004|Overall Study|Subject request to discontinue treatment|1|||
125181235|NCT01215136|450283572|FG001|Overall Study|Disease Progression|14|||
125181236|NCT01215136|450283571|FG000|Overall Study|Symptomatic Deterioration|1|||
125181237|NCT01215136|450283572|FG001|Overall Study|Symptomatic Deterioration|1|||
125181238|NCT01215136|450283571|FG000|Overall Study|Death|0|||
125181239|NCT01215136|450283572|FG001|Overall Study|Death|2|||
125181240|NCT01215136|450283571|FG000|Overall Study|Withdrawal by Subject|0|||
125181241|NCT01215136|450283572|FG001|Overall Study|Withdrawal by Subject|1|||
125181242|NCT00613171|450283577|FG000|Overall Study|Adverse Event|7|||
125181243|NCT00613171|450283577|FG000|Overall Study|Withdrawal by Subject|3|||
125236351|NCT02097277|450493843|FG000|Overall Study|Lost to Follow-up|0|||
125236352|NCT02097277|450493844|FG001|Overall Study|Lost to Follow-up|1|||
125181244|NCT00613171|450283577|FG000|Overall Study|Reason not Specified|4|||
125181245|NCT00951496|450283578|FG000|Overall Study|Did not initiate study treatment|10|||
125181246|NCT00951496|450283579|FG001|Overall Study|Did not initiate study treatment|8|||
125181247|NCT00951496|450283580|FG002|Overall Study|Did not initiate study treatment|13|||
125181248|NCT01042093|450283592|FG000|Overall Study|Protocol Violation|2|||
125181249|NCT01042093|450283593|FG001|Overall Study|Protocol Violation|2|||
125181250|NCT01042093|450283594|FG002|Overall Study|Protocol Violation|2|||
125181251|NCT01042093|450283595|FG003|Overall Study|Protocol Violation|3|||
125181252|NCT01042093|450283592|FG000|Overall Study|Withdrawal by Subject|0|||
125181253|NCT01042093|450283593|FG001|Overall Study|Withdrawal by Subject|0|||
125181254|NCT01042093|450283594|FG002|Overall Study|Withdrawal by Subject|0|||
125181255|NCT01042093|450283595|FG003|Overall Study|Withdrawal by Subject|1|||
125181256|NCT02273388|450283596|FG000|Overall Study|Adverse Event|0|||
125181257|NCT02273388|450283597|FG001|Overall Study|Adverse Event|0|||
125181258|NCT02273388|450283598|FG002|Overall Study|Adverse Event|0|||
125181259|NCT02273388|450283599|FG003|Overall Study|Adverse Event|0|||
125181260|NCT02273388|450283600|FG004|Overall Study|Adverse Event|0|||
125181261|NCT02273388|450283601|FG005|Overall Study|Adverse Event|0|||
125181262|NCT02273388|450283602|FG006|Overall Study|Adverse Event|1|||
125181263|NCT02273388|450283603|FG007|Overall Study|Adverse Event|2|||
125181264|NCT02273388|450283604|FG008|Overall Study|Adverse Event|0|||
125181265|NCT02273388|450283605|FG009|Overall Study|Adverse Event|0|||
125181266|NCT02273388|450283606|FG010|Overall Study|Adverse Event|0|||
125181267|NCT02273388|450283607|FG011|Overall Study|Adverse Event|0|||
125181268|NCT02273388|450283596|FG000|Overall Study|Adverse Event study disease worse|4|||
125181269|NCT02273388|450283597|FG001|Overall Study|Adverse Event study disease worse|3|||
125181270|NCT02273388|450283598|FG002|Overall Study|Adverse Event study disease worse|3|||
125181271|NCT02273388|450283599|FG003|Overall Study|Adverse Event study disease worse|2|||
125181272|NCT02273388|450283600|FG004|Overall Study|Adverse Event study disease worse|4|||
125181273|NCT02273388|450283601|FG005|Overall Study|Adverse Event study disease worse|3|||
125181274|NCT02273388|450283602|FG006|Overall Study|Adverse Event study disease worse|14|||
125181275|NCT02273388|450283603|FG007|Overall Study|Adverse Event study disease worse|6|||
125181276|NCT02273388|450283604|FG008|Overall Study|Adverse Event study disease worse|6|||
125181277|NCT02273388|450283605|FG009|Overall Study|Adverse Event study disease worse|5|||
125181278|NCT02273388|450283606|FG010|Overall Study|Adverse Event study disease worse|10|||
125181279|NCT02273388|450283607|FG011|Overall Study|Adverse Event study disease worse|1|||
125181280|NCT02273388|450283596|FG000|Overall Study|Sponsor decision|0|||
125181281|NCT02273388|450283597|FG001|Overall Study|Sponsor decision|0|||
125181282|NCT02273388|450283598|FG002|Overall Study|Sponsor decision|0|||
125181283|NCT02273388|450283599|FG003|Overall Study|Sponsor decision|0|||
125181284|NCT02273388|450283600|FG004|Overall Study|Sponsor decision|0|||
125181285|NCT02273388|450283601|FG005|Overall Study|Sponsor decision|0|||
125181286|NCT02273388|450283602|FG006|Overall Study|Sponsor decision|0|||
125181287|NCT02273388|450283603|FG007|Overall Study|Sponsor decision|0|||
125181288|NCT02273388|450283604|FG008|Overall Study|Sponsor decision|0|||
125181289|NCT02273388|450283605|FG009|Overall Study|Sponsor decision|0|||
125181290|NCT02273388|450283606|FG010|Overall Study|Sponsor decision|0|||
125181291|NCT02273388|450283607|FG011|Overall Study|Sponsor decision|1|||
125181292|NCT01523002|450283615|FG000|Period 1|Withdrawal by Subject|1|||
125181293|NCT01523002|450283616|FG001|Period 1|Withdrawal by Subject|3|||
125181294|NCT01523002|450283615|FG000|Period 1|Lost to Follow-up|1|||
125181295|NCT01523002|450283616|FG001|Period 1|Lost to Follow-up|0|||
125181296|NCT01523002|450283615|FG000|Period 1|Adverse Event|0|||
125181297|NCT01523002|450283616|FG001|Period 1|Adverse Event|8|||
125181298|NCT01523002|450283615|FG000|Period 2|Withdrawal by Subject|4|||
125181299|NCT01523002|450283616|FG001|Period 2|Withdrawal by Subject|1|||
125181300|NCT01523002|450283615|FG000|Period 2|Adverse Event|2|||
125181301|NCT01523002|450283616|FG001|Period 2|Adverse Event|5|||
125181302|NCT01523002|450283615|FG000|Period 3|Withdrawal by Subject|1|||
125181303|NCT01523002|450283616|FG001|Period 3|Withdrawal by Subject|0|||
125181304|NCT01523002|450283615|FG000|Period 3|Adverse Event|3|||
125181305|NCT01523002|450283616|FG001|Period 3|Adverse Event|0|||
125181306|NCT01256502|450283617|FG000|Overall Study|Had scaffold removed|4|||
125181307|NCT01256502|450283617|FG000|Overall Study|Personal reasons|5|||
125181308|NCT01256502|450283617|FG000|Overall Study|Protocol deviation|1|||
125181309|NCT03281876|450283618|FG000|Overall Study|Adverse Event|4|||
125181310|NCT03281876|450283619|FG001|Overall Study|Adverse Event|15|||
125181311|NCT03281876|450283618|FG000|Overall Study|Lost to Follow-up|1|||
125181312|NCT03281876|450283619|FG001|Overall Study|Lost to Follow-up|4|||
125181313|NCT03281876|450283618|FG000|Overall Study|Withdrawal by Subject|11|||
125181314|NCT03281876|450283619|FG001|Overall Study|Withdrawal by Subject|15|||
125181315|NCT03281876|450283618|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
125181316|NCT03281876|450283619|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125181317|NCT03281876|450283618|FG000|Overall Study|OTHER|5|||
125181318|NCT03281876|450283619|FG001|Overall Study|OTHER|5|||
125181319|NCT01478373|450283620|FG000|Treatment Phase|Protocol Violation|1|||
125236353|NCT02097277|450493845|FG002|Overall Study|Lost to Follow-up|1|||
125181320|NCT01478373|450283620|FG000|Survival Phase|Adverse Event|8|||
125181321|NCT01478373|450283620|FG000|Survival Phase|Protocol Violation|1|||
125181322|NCT01478373|450283620|FG000|Survival Phase|crossover to another study|2|||
125181323|NCT01478373|450283620|FG000|Survival Phase|Progressive Disease|27|||
125181324|NCT01074944|450283622|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
125181325|NCT01074944|450283623|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
125181326|NCT01074944|450283624|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
125181327|NCT01074944|450283625|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
125236354|NCT02097277|450493846|FG003|Overall Study|Lost to Follow-up|0|||
125236355|NCT02097277|450493847|FG004|Overall Study|Lost to Follow-up|0|||
125236356|NCT02097277|450493843|FG000|Overall Study|Withdrawal by Subject|2|||
125236357|NCT02097277|450493844|FG001|Overall Study|Withdrawal by Subject|1|||
125236358|NCT02097277|450493845|FG002|Overall Study|Withdrawal by Subject|0|||
125236359|NCT02097277|450493846|FG003|Overall Study|Withdrawal by Subject|1|||
125236360|NCT02097277|450493847|FG004|Overall Study|Withdrawal by Subject|0|||
125236361|NCT02097277|450493843|FG000|Overall Study|Adverse Event|0|||
125236362|NCT02097277|450493844|FG001|Overall Study|Adverse Event|0|||
125236363|NCT02097277|450493845|FG002|Overall Study|Adverse Event|1|||
125236364|NCT02097277|450493846|FG003|Overall Study|Adverse Event|2|||
125236365|NCT02097277|450493847|FG004|Overall Study|Adverse Event|0|||
125236366|NCT01091259|450493848|FG000|Overall Study|Adverse Event|3|||
125236367|NCT01091259|450493848|FG000|Overall Study|Lack of Efficacy|2|||
125236368|NCT03813654|450493849|FG000|Overall Study|Protocol Violation|0|||
125236369|NCT03813654|450493850|FG001|Overall Study|Protocol Violation|1|||
125236370|NCT03813654|450493851|FG002|Overall Study|Protocol Violation|2|||
125236371|NCT03813654|450493849|FG000|Overall Study|Withdrawal by Subject|1|||
125236372|NCT03813654|450493850|FG001|Overall Study|Withdrawal by Subject|0|||
125236373|NCT03813654|450493851|FG002|Overall Study|Withdrawal by Subject|0|||
125236374|NCT01208051|450493852|FG000|Total Enrollment|Withdrawal by Subject|0|||
125236375|NCT01208051|450493853|FG001|Total Enrollment|Withdrawal by Subject|1|||
125236376|NCT01208051|450493854|FG002|Total Enrollment|Withdrawal by Subject|0|||
125236377|NCT01208051|450493855|FG003|Total Enrollment|Withdrawal by Subject|0|||
125236378|NCT01208051|450493856|FG004|Total Enrollment|Withdrawal by Subject|2|||
125236379|NCT01208051|450493852|FG000|Total Enrollment|Brain metastases|0|||
125236380|NCT01208051|450493853|FG001|Total Enrollment|Brain metastases|0|||
125236381|NCT01208051|450493854|FG002|Total Enrollment|Brain metastases|1|||
125236382|NCT01208051|450493855|FG003|Total Enrollment|Brain metastases|0|||
125236383|NCT01208051|450493856|FG004|Total Enrollment|Brain metastases|0|||
125236384|NCT00973973|450493861|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
125236385|NCT00973973|450493862|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
125236386|NCT00973973|450493861|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
125236387|NCT00973973|450493862|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
125236388|NCT00973973|450493861|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
125236389|NCT00973973|450493862|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
125236390|NCT00973973|450493861|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
125236391|NCT00973973|450493862|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
125236392|NCT00973973|450493861|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
125236393|NCT00973973|450493862|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
125236394|NCT00973973|450493861|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
125236395|NCT00973973|450493862|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
125236396|NCT00973973|450493861|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
125236397|NCT00973973|450493862|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
125236398|NCT00973973|450493861|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
125236399|NCT00973973|450493862|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
125236400|NCT00973973|450493861|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
125236401|NCT00973973|450493862|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
125236402|NCT00973973|450493861|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
125236403|NCT00973973|450493862|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
125236404|NCT00973973|450493861|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
125236405|NCT00973973|450493862|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
125236406|NCT00973973|450493861|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
125236407|NCT00973973|450493862|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
125236408|NCT01541748|450493863|FG000|Overall Study|Lost to Follow-up|17|||
125236409|NCT01541748|450493863|FG000|Overall Study|Moved out of state|1|||
125236410|NCT01541748|450493863|FG000|Overall Study|Withdrawal by Subject|7|||
125236411|NCT01541748|450493863|FG000|Overall Study|Screen failure|5|||
125236412|NCT01541748|450493863|FG000|Overall Study|Did not receive study device|1|||
125236413|NCT06057064|450493864|FG000|Overall Study|Death|2|||
125236414|NCT06057064|450493865|FG001|Overall Study|Death|0|||
125236415|NCT06057064|450493864|FG000|Overall Study|Physician Decision|1|||
125236416|NCT06057064|450493865|FG001|Overall Study|Physician Decision|0|||
125236417|NCT06057064|450493864|FG000|Overall Study|Withdrawal by Subject|1|||
125236418|NCT06057064|450493865|FG001|Overall Study|Withdrawal by Subject|1|||
125236419|NCT02832037|450493866|FG000|Overall Study|Administrative reasons|0|||
125236420|NCT02832037|450493867|FG001|Overall Study|Administrative reasons|0|||
125236421|NCT02832037|450493868|FG002|Overall Study|Administrative reasons|1|||
125236422|NCT02832037|450493869|FG003|Overall Study|Administrative reasons|0|||
125236423|NCT02832037|450493870|FG004|Overall Study|Administrative reasons|0|||
125236424|NCT02832037|450493866|FG000|Overall Study|Protocol Violation|3|||
125236425|NCT02832037|450493867|FG001|Overall Study|Protocol Violation|0|||
125236426|NCT02832037|450493868|FG002|Overall Study|Protocol Violation|4|||
125181328|NCT01074944|450283626|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
125181329|NCT01074944|450283622|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
125236427|NCT02832037|450493869|FG003|Overall Study|Protocol Violation|1|||
125236428|NCT02832037|450493870|FG004|Overall Study|Protocol Violation|2|||
125236429|NCT02832037|450493866|FG000|Overall Study|Lost to Follow-up|2|||
125236430|NCT02832037|450493867|FG001|Overall Study|Lost to Follow-up|0|||
125236431|NCT02832037|450493868|FG002|Overall Study|Lost to Follow-up|3|||
125236432|NCT02832037|450493869|FG003|Overall Study|Lost to Follow-up|0|||
125236433|NCT02832037|450493870|FG004|Overall Study|Lost to Follow-up|5|||
125236434|NCT02832037|450493866|FG000|Overall Study|Withdrawal by Subject|9|||
125236435|NCT02832037|450493867|FG001|Overall Study|Withdrawal by Subject|8|||
125236436|NCT02832037|450493868|FG002|Overall Study|Withdrawal by Subject|0|||
125236437|NCT02832037|450493869|FG003|Overall Study|Withdrawal by Subject|4|||
125236438|NCT02832037|450493870|FG004|Overall Study|Withdrawal by Subject|8|||
125236439|NCT02832037|450493866|FG000|Overall Study|Adverse Event|5|||
125236440|NCT02832037|450493867|FG001|Overall Study|Adverse Event|4|||
125236441|NCT02832037|450493868|FG002|Overall Study|Adverse Event|0|||
125236442|NCT02832037|450493869|FG003|Overall Study|Adverse Event|2|||
125236443|NCT02832037|450493870|FG004|Overall Study|Adverse Event|4|||
125236444|NCT01137786|450493872|FG000|Overall Study|Lost to Follow-up|0|||
125236445|NCT01137786|450493873|FG001|Overall Study|Lost to Follow-up|2|||
125236446|NCT01137786|450493872|FG000|Overall Study|Withdrawal by Subject|1|||
125236447|NCT01137786|450493873|FG001|Overall Study|Withdrawal by Subject|1|||
125181330|NCT01074944|450283623|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
125181331|NCT01074944|450283624|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
125181332|NCT01074944|450283625|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
125181333|NCT01074944|450283626|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
125181334|NCT01074944|450283622|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
125181335|NCT01074944|450283623|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
125181336|NCT01074944|450283624|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
125181337|NCT01074944|450283625|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
125181338|NCT01074944|450283626|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
125181339|NCT01074944|450283622|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
125181340|NCT01074944|450283623|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
125181341|NCT01074944|450283624|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
125181342|NCT01074944|450283625|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
125181343|NCT01074944|450283626|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
125181344|NCT01074944|450283622|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
125181345|NCT01074944|450283623|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
125181346|NCT01074944|450283624|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
125181347|NCT01074944|450283625|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
125181348|NCT01074944|450283626|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
125181349|NCT01074944|450283622|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
125181350|NCT01074944|450283623|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
125181351|NCT01074944|450283624|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
125181352|NCT01074944|450283625|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
125181353|NCT01074944|450283626|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
125181354|NCT01074944|450283622|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
125181355|NCT01074944|450283623|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
125181356|NCT01074944|450283624|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
125181357|NCT01074944|450283625|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
125236448|NCT01531153|450493874|FG000|Overall Study|Withdrawal by Subject|10|||
125236449|NCT01531153|450493875|FG001|Overall Study|Withdrawal by Subject|9|||
125236450|NCT01531153|450493876|FG002|Overall Study|Withdrawal by Subject|15|||
125236451|NCT00770367|450493877|FG000|First Intervention|Withdrawal by Subject|0|||
125236452|NCT00770367|450493878|FG001|First Intervention|Withdrawal by Subject|2|||
125236453|NCT00770367|450493877|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
125181358|NCT01074944|450283626|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
125181359|NCT01074944|450283622|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
125181360|NCT01074944|450283623|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
125181361|NCT01074944|450283624|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
125181362|NCT01074944|450283625|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
125181363|NCT01074944|450283626|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
125181364|NCT01074944|450283622|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
125181365|NCT01074944|450283623|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
125236454|NCT00770367|450493878|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
125236455|NCT00770367|450493877|FG000|Second Intervention|Lost to Follow-up|2|||
125236456|NCT00770367|450493878|FG001|Second Intervention|Lost to Follow-up|0|||
125236457|NCT00435942|450493879|FG000|Overall Study|Death|17|||
125236458|NCT00435942|450493880|FG001|Overall Study|Death|10|||
125236459|NCT00435942|450493879|FG000|Overall Study|Withdrawal by Subject|2|||
125236460|NCT00435942|450493880|FG001|Overall Study|Withdrawal by Subject|0|||
125236461|NCT00435942|450493879|FG000|Overall Study|Lost to Follow-up|0|||
125236462|NCT00435942|450493880|FG001|Overall Study|Lost to Follow-up|16|||
125236463|NCT00435942|450493879|FG000|Overall Study|Conversion to Open Repair|1|||
125236464|NCT00435942|450493880|FG001|Overall Study|Conversion to Open Repair|0|||
125236465|NCT00435942|450493879|FG000|Overall Study|Technical Failure|3|||
125236466|NCT00435942|450493880|FG001|Overall Study|Technical Failure|0|||
125236467|NCT00435942|450493879|FG000|Overall Study|Other|0|||
125236468|NCT00435942|450493880|FG001|Overall Study|Other|1|||
125181366|NCT01074944|450283624|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
125181367|NCT01074944|450283625|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
125181368|NCT01074944|450283626|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
125181369|NCT01074944|450283622|FG000|Long Term Treatment|Adverse Event|0|||
125181370|NCT01074944|450283623|FG001|Long Term Treatment|Adverse Event|0|||
125181371|NCT01074944|450283624|FG002|Long Term Treatment|Adverse Event|0|||
125181372|NCT01074944|450283625|FG003|Long Term Treatment|Adverse Event|3|||
125181373|NCT01074944|450283626|FG004|Long Term Treatment|Adverse Event|0|||
125181374|NCT01074944|450283622|FG000|Long Term Treatment|Lost to Follow-up|0|||
125181375|NCT01074944|450283623|FG001|Long Term Treatment|Lost to Follow-up|0|||
125181376|NCT01074944|450283624|FG002|Long Term Treatment|Lost to Follow-up|0|||
125181377|NCT01074944|450283625|FG003|Long Term Treatment|Lost to Follow-up|2|||
125181378|NCT01074944|450283626|FG004|Long Term Treatment|Lost to Follow-up|0|||
125181379|NCT01074944|450283622|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
125181380|NCT01074944|450283623|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
125181381|NCT01074944|450283624|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
125181382|NCT01074944|450283625|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
125181383|NCT01074944|450283626|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
125181384|NCT01074944|450283622|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
125181385|NCT01074944|450283623|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
125181386|NCT01074944|450283624|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
125181387|NCT01074944|450283625|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
125181388|NCT01074944|450283626|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
125181389|NCT01074944|450283622|FG000|Long Term Treatment|Withdrawal by Subject|0|||
125181390|NCT01074944|450283623|FG001|Long Term Treatment|Withdrawal by Subject|0|||
125181391|NCT01074944|450283624|FG002|Long Term Treatment|Withdrawal by Subject|0|||
125181392|NCT01074944|450283625|FG003|Long Term Treatment|Withdrawal by Subject|2|||
125181393|NCT01074944|450283626|FG004|Long Term Treatment|Withdrawal by Subject|0|||
125181394|NCT01074944|450283622|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
125181395|NCT01074944|450283623|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
125181396|NCT01074944|450283624|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
125181397|NCT01074944|450283625|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
125181398|NCT01074944|450283626|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
125181399|NCT01074944|450283622|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
125181400|NCT01074944|450283623|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
125181401|NCT01074944|450283624|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
125181402|NCT01074944|450283625|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
125181403|NCT01074944|450283626|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
125181404|NCT02905032|450283628|FG000|Overall Study|Withdrawal by Subject|2|||
125181405|NCT02905032|450283629|FG001|Overall Study|Withdrawal by Subject|0|||
125181406|NCT02905032|450283630|FG002|Overall Study|Withdrawal by Subject|0|||
125181407|NCT02905032|450283628|FG000|Overall Study|Protocol Violation|6|||
125236469|NCT00920816|450493881|FG000|Overall Study|Death|116|||
125236470|NCT00920816|450493882|FG001|Overall Study|Death|63|||
125236471|NCT00920816|450493883|FG002|Overall Study|Death|8|||
125236472|NCT00920816|450493884|FG003|Overall Study|Death|3|||
125181408|NCT02905032|450283629|FG001|Overall Study|Protocol Violation|12|||
125181409|NCT02905032|450283630|FG002|Overall Study|Protocol Violation|0|||
125181410|NCT00550459|450283631|FG000|Overall Study|Adverse Event|0|||
125181411|NCT00550459|450283632|FG001|Overall Study|Adverse Event|2|||
125181412|NCT00550459|450283631|FG000|Overall Study|Withdrawal by Subject|1|||
125181413|NCT00550459|450283632|FG001|Overall Study|Withdrawal by Subject|1|||
125181414|NCT00625820|450283633|FG000|Overall Study|Withdrawal by Subject|1|||
125181415|NCT00445146|450283634|FG000|Overall Study|Withdrew Consent|29|||
125181416|NCT00445146|450283634|FG000|Overall Study|Lack of Efficacy|28|||
125181417|NCT00445146|450283634|FG000|Overall Study|Investigator's Discretion|22|||
125181418|NCT00445146|450283634|FG000|Overall Study|Adverse Event|13|||
125181419|NCT00445146|450283634|FG000|Overall Study|Lost to Follow-up|13|||
125181420|NCT00445146|450283634|FG000|Overall Study|Death|9|||
125236473|NCT00920816|450493881|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
125236474|NCT00920816|450493882|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
125236475|NCT00920816|450493883|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
125236476|NCT00920816|450493884|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
125236477|NCT00920816|450493881|FG000|Overall Study|Global deterioration of health status|2|||
125236478|NCT00920816|450493882|FG001|Overall Study|Global deterioration of health status|0|||
125236479|NCT00920816|450493883|FG002|Overall Study|Global deterioration of health status|0|||
125236480|NCT00920816|450493884|FG003|Overall Study|Global deterioration of health status|0|||
125236481|NCT00920816|450493881|FG000|Overall Study|Objective progression or relapse|6|||
125236482|NCT00920816|450493882|FG001|Overall Study|Objective progression or relapse|2|||
125236483|NCT00920816|450493883|FG002|Overall Study|Objective progression or relapse|0|||
125236484|NCT00920816|450493884|FG003|Overall Study|Objective progression or relapse|0|||
125236485|NCT00920816|450493881|FG000|Overall Study|Other|26|||
125236486|NCT00920816|450493882|FG001|Overall Study|Other|15|||
125236487|NCT00920816|450493883|FG002|Overall Study|Other|1|||
125236488|NCT00920816|450493884|FG003|Overall Study|Other|2|||
125236489|NCT00920816|450493881|FG000|Overall Study|Lost to Follow-up|11|||
125236490|NCT00920816|450493882|FG001|Overall Study|Lost to Follow-up|2|||
125236491|NCT00920816|450493883|FG002|Overall Study|Lost to Follow-up|0|||
125236492|NCT00920816|450493884|FG003|Overall Study|Lost to Follow-up|0|||
125236493|NCT00920816|450493881|FG000|Overall Study|Adverse Event|1|||
125236494|NCT00920816|450493882|FG001|Overall Study|Adverse Event|1|||
125236495|NCT00920816|450493883|FG002|Overall Study|Adverse Event|1|||
125236496|NCT00920816|450493884|FG003|Overall Study|Adverse Event|0|||
125236497|NCT00920816|450493881|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
125236498|NCT00920816|450493882|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
125236499|NCT00920816|450493883|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
125236500|NCT00920816|450493884|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
125236501|NCT00920816|450493881|FG000|Overall Study|Randomized but not treated|3|||
125236502|NCT00920816|450493882|FG001|Overall Study|Randomized but not treated|0|||
125236503|NCT00920816|450493883|FG002|Overall Study|Randomized but not treated|0|||
125236504|NCT00920816|450493884|FG003|Overall Study|Randomized but not treated|0|||
125236505|NCT01180777|450493885|FG000|Overall Study|Protocol Violation|6|||
125236506|NCT01180777|450493885|FG000|Overall Study|Poor lens fit|4|||
125236507|NCT01180777|450493885|FG000|Overall Study|Lost to Follow-up|1|||
125236508|NCT01180777|450493885|FG000|Overall Study|Adverse Event|1|||
125236509|NCT04167462|450493890|FG000|Overall Study|Other reasons|3|||
125236510|NCT04167462|450493891|FG001|Overall Study|Other reasons|2|||
125236511|NCT04167462|450493890|FG000|Overall Study|Withdrawal by Subject|6|||
125236512|NCT04167462|450493891|FG001|Overall Study|Withdrawal by Subject|7|||
125236513|NCT04167462|450493890|FG000|Overall Study|Adverse Event|4|||
125236514|NCT04167462|450493891|FG001|Overall Study|Adverse Event|0|||
125236515|NCT04167462|450493890|FG000|Overall Study|Pregnancy|1|||
125236516|NCT04167462|450493891|FG001|Overall Study|Pregnancy|0|||
125236517|NCT04167462|450493890|FG000|Overall Study|Lack of Efficacy|0|||
125236518|NCT04167462|450493891|FG001|Overall Study|Lack of Efficacy|1|||
125236519|NCT02606253|450493892|FG000|Overall Study|Adverse Event|2|||
125236520|NCT02606253|450493893|FG001|Overall Study|Adverse Event|0|||
125236521|NCT02606253|450493894|FG002|Overall Study|Adverse Event|0|||
125236522|NCT02606253|450493892|FG000|Overall Study|Protocol Violation|2|||
125236523|NCT02606253|450493893|FG001|Overall Study|Protocol Violation|1|||
125236524|NCT02606253|450493894|FG002|Overall Study|Protocol Violation|0|||
125236525|NCT02606253|450493892|FG000|Overall Study|Physician Decision|1|||
125236526|NCT02606253|450493893|FG001|Overall Study|Physician Decision|1|||
125236527|NCT02606253|450493894|FG002|Overall Study|Physician Decision|0|||
125236528|NCT05522751|450493899|FG000|Overall Study|Adverse Event|1|||
125236529|NCT02475213|450493900|FG000|Overall Study|Adverse Event|2|||
125236530|NCT02475213|450493901|FG001|Overall Study|Adverse Event|0|||
125236531|NCT02475213|450493902|FG002|Overall Study|Adverse Event|0|||
125236532|NCT02475213|450493903|FG003|Overall Study|Adverse Event|1|||
125236533|NCT02475213|450493904|FG004|Overall Study|Adverse Event|1|||
125236534|NCT02475213|450493905|FG005|Overall Study|Adverse Event|4|||
125236535|NCT02475213|450493906|FG006|Overall Study|Adverse Event|6|||
125236536|NCT02475213|450493907|FG007|Overall Study|Adverse Event|2|||
125236537|NCT02475213|450493900|FG000|Overall Study|Physician Decision|1|||
125236538|NCT02475213|450493901|FG001|Overall Study|Physician Decision|1|||
125236539|NCT02475213|450493902|FG002|Overall Study|Physician Decision|1|||
125236540|NCT02475213|450493903|FG003|Overall Study|Physician Decision|0|||
125236541|NCT02475213|450493904|FG004|Overall Study|Physician Decision|0|||
125236542|NCT02475213|450493905|FG005|Overall Study|Physician Decision|1|||
125236543|NCT02475213|450493906|FG006|Overall Study|Physician Decision|4|||
125236544|NCT02475213|450493907|FG007|Overall Study|Physician Decision|0|||
125236545|NCT02475213|450493900|FG000|Overall Study|Progressive Disease|3|||
125236546|NCT02475213|450493901|FG001|Overall Study|Progressive Disease|2|||
125236547|NCT02475213|450493902|FG002|Overall Study|Progressive Disease|2|||
125236548|NCT02475213|450493903|FG003|Overall Study|Progressive Disease|13|||
125236549|NCT02475213|450493904|FG004|Overall Study|Progressive Disease|15|||
125236550|NCT02475213|450493905|FG005|Overall Study|Progressive Disease|25|||
125236551|NCT02475213|450493906|FG006|Overall Study|Progressive Disease|30|||
125236552|NCT02475213|450493907|FG007|Overall Study|Progressive Disease|10|||
125236553|NCT02475213|450493900|FG000|Overall Study|Death|0|||
125236554|NCT02475213|450493901|FG001|Overall Study|Death|0|||
125236555|NCT02475213|450493902|FG002|Overall Study|Death|0|||
125236556|NCT02475213|450493903|FG003|Overall Study|Death|0|||
125236557|NCT02475213|450493904|FG004|Overall Study|Death|0|||
125236558|NCT02475213|450493905|FG005|Overall Study|Death|4|||
125236559|NCT02475213|450493906|FG006|Overall Study|Death|1|||
125236560|NCT02475213|450493907|FG007|Overall Study|Death|0|||
125236561|NCT02475213|450493900|FG000|Overall Study|Protocol Violation|0|||
125236562|NCT02475213|450493901|FG001|Overall Study|Protocol Violation|0|||
125236563|NCT02475213|450493902|FG002|Overall Study|Protocol Violation|0|||
125236564|NCT02475213|450493903|FG003|Overall Study|Protocol Violation|0|||
125236565|NCT02475213|450493904|FG004|Overall Study|Protocol Violation|1|||
125236566|NCT02475213|450493905|FG005|Overall Study|Protocol Violation|0|||
125236567|NCT02475213|450493906|FG006|Overall Study|Protocol Violation|0|||
125236568|NCT02475213|450493907|FG007|Overall Study|Protocol Violation|0|||
125236569|NCT02475213|450493900|FG000|Overall Study|Withdrawal by Subject|0|||
125236570|NCT02475213|450493901|FG001|Overall Study|Withdrawal by Subject|0|||
125236571|NCT02475213|450493902|FG002|Overall Study|Withdrawal by Subject|0|||
125236572|NCT02475213|450493903|FG003|Overall Study|Withdrawal by Subject|1|||
125236573|NCT02475213|450493904|FG004|Overall Study|Withdrawal by Subject|0|||
125236574|NCT02475213|450493905|FG005|Overall Study|Withdrawal by Subject|2|||
125236575|NCT02475213|450493906|FG006|Overall Study|Withdrawal by Subject|2|||
125236576|NCT02475213|450493907|FG007|Overall Study|Withdrawal by Subject|0|||
125236577|NCT02475213|450493900|FG000|Overall Study|Other|0|||
125236578|NCT02475213|450493901|FG001|Overall Study|Other|0|||
125236579|NCT02475213|450493902|FG002|Overall Study|Other|0|||
125236580|NCT02475213|450493903|FG003|Overall Study|Other|1|||
125181421|NCT00445146|450283634|FG000|Overall Study|Protocol Violation|4|||
125181422|NCT00445146|450283634|FG000|Overall Study|Pregnancy|1|||
125181423|NCT00967330|450283635|FG000|Overall Study|Protocol Violation|3|||
125181424|NCT00967330|450283636|FG001|Overall Study|Protocol Violation|4|||
125181425|NCT00967330|450283635|FG000|Overall Study|Regular|10|||
125181426|NCT00967330|450283636|FG001|Overall Study|Regular|3|||
125181427|NCT00967330|450283635|FG000|Overall Study|Withdrawal by Subject|6|||
125181428|NCT00967330|450283636|FG001|Overall Study|Withdrawal by Subject|0|||
125181429|NCT00967330|450283635|FG000|Overall Study|Lost to Follow-up|1|||
125181430|NCT00967330|450283636|FG001|Overall Study|Lost to Follow-up|1|||
125181431|NCT00967330|450283635|FG000|Overall Study|Death|102|||
125181432|NCT00967330|450283636|FG001|Overall Study|Death|51|||
125181433|NCT00967330|450283635|FG000|Overall Study|Severe protocol deviation|0|||
125181434|NCT00967330|450283636|FG001|Overall Study|Severe protocol deviation|1|||
125181435|NCT02623725|450283638|FG000|Overall Study|Non compliance with protocol|9|||
125181436|NCT02623725|450283639|FG001|Overall Study|Non compliance with protocol|3|||
125181437|NCT02623725|450283638|FG000|Overall Study|Serious adverse event|0|||
125181438|NCT02623725|450283639|FG001|Overall Study|Serious adverse event|2|||
125181439|NCT02623725|450283638|FG000|Overall Study|Withdrawal by Subject|7|||
125181440|NCT02623725|450283639|FG001|Overall Study|Withdrawal by Subject|1|||
125181441|NCT03759392|450283640|FG000|Overall Study|Adverse Event|12|||
125181442|NCT03759392|450283641|FG001|Overall Study|Adverse Event|4|||
125181443|NCT03759392|450283640|FG000|Overall Study|Death|2|||
125181444|NCT03759392|450283641|FG001|Overall Study|Death|1|||
125181445|NCT03759392|450283640|FG000|Overall Study|Withdrawal by Subject|2|||
125181446|NCT03759392|450283641|FG001|Overall Study|Withdrawal by Subject|0|||
125181447|NCT03759392|450283640|FG000|Overall Study|Protocol Violation|2|||
125181448|NCT03759392|450283641|FG001|Overall Study|Protocol Violation|0|||
125181449|NCT03759392|450283640|FG000|Overall Study|Physician Decision|0|||
125181450|NCT03759392|450283641|FG001|Overall Study|Physician Decision|1|||
125181451|NCT03759392|450283640|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
125181452|NCT03759392|450283641|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
125236581|NCT02475213|450493904|FG004|Overall Study|Other|3|||
125236582|NCT02475213|450493905|FG005|Overall Study|Other|1|||
125236583|NCT02475213|450493906|FG006|Overall Study|Other|0|||
125181453|NCT03759392|450283640|FG000|Overall Study|No longer able to take medicines|1|||
125181454|NCT03759392|450283641|FG001|Overall Study|No longer able to take medicines|0|||
125181455|NCT03759392|450283640|FG000|Overall Study|Stopped taking study drug|1|||
125181456|NCT03759392|450283641|FG001|Overall Study|Stopped taking study drug|0|||
125181457|NCT02548143|450283642|FG000|Overall Study|Adverse Event|1|||
125181458|NCT02548143|450283643|FG001|Overall Study|Adverse Event|0|||
125181459|NCT02548143|450283642|FG000|Overall Study|Withdrawal by Subject|0|||
125181460|NCT02548143|450283643|FG001|Overall Study|Withdrawal by Subject|1|||
125236584|NCT02475213|450493907|FG007|Overall Study|Other|0|||
125236585|NCT00505921|450493908|FG000|Overall Study|Ineligible|1|||
125181461|NCT05620082|450283646|FG000|Overall Study|Discharged before study end|1|||
125181462|NCT05620082|450283647|FG001|Overall Study|Discharged before study end|4|||
125236586|NCT00505921|450493908|FG000|Overall Study|Failed to Mobilize|8|||
125236587|NCT02382939|450493914|FG000|Overall Study|Adverse Event|1|||
125181463|NCT05620082|450283648|FG002|Overall Study|Discharged before study end|0|||
125181464|NCT05620082|450283646|FG000|Overall Study|Moved to a different ward|1|||
125181465|NCT05620082|450283647|FG001|Overall Study|Moved to a different ward|0|||
125181466|NCT05620082|450283648|FG002|Overall Study|Moved to a different ward|0|||
125181467|NCT05620082|450283646|FG000|Overall Study|Feeling too unwell|1|||
125181468|NCT05620082|450283647|FG001|Overall Study|Feeling too unwell|0|||
125181469|NCT05620082|450283648|FG002|Overall Study|Feeling too unwell|0|||
125181470|NCT02603146|450285646|FG000|Overall Study|Lost to Follow-up|5|||
125181471|NCT02603146|450285647|FG001|Overall Study|Lost to Follow-up|6|||
125181472|NCT02603146|450285646|FG000|Overall Study|Withdrawal by Subject|8|||
125181473|NCT02603146|450285647|FG001|Overall Study|Withdrawal by Subject|10|||
125181474|NCT02603146|450285646|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
125181475|NCT02603146|450285647|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
125181476|NCT02603146|450285646|FG000|Overall Study|Participant moved|2|||
125181477|NCT02603146|450285647|FG001|Overall Study|Participant moved|0|||
125181478|NCT02603146|450285646|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
125181479|NCT02603146|450285647|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
125181480|NCT00654095|450285654|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
125181481|NCT00654095|450285654|FG000|Overall Study|Elevated triglyceride level (2)|1|||
125181482|NCT00654095|450285654|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
125181483|NCT00654095|450285654|FG000|Overall Study|Adverse Event|11|||
125181484|NCT00654095|450285654|FG000|Overall Study|Withdrawal by Subject|5|||
125181485|NCT00654095|450285654|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
125181486|NCT00654095|450285654|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
125181487|NCT00654095|450285654|FG000|Overall Study|Did not meet inclusion criteria|1|||
125181488|NCT01431079|450285655|FG000|Overall Study|Lost to Follow-up|35|||
125181489|NCT01431079|450285656|FG001|Overall Study|Lost to Follow-up|39|||
125181490|NCT03565900|450285659|FG000|Overall Study|Disposition Unknown|4|||
125181491|NCT03565900|450285660|FG001|Overall Study|Disposition Unknown|1|||
125181492|NCT03565900|450285659|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
125181493|NCT03565900|450285660|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
125181494|NCT03565900|450285659|FG000|Overall Study|Withdrawal by Subject|4|||
125181495|NCT03565900|450285660|FG001|Overall Study|Withdrawal by Subject|5|||
125181496|NCT03565900|450285659|FG000|Overall Study|Randomized By Mistake|0|||
125181497|NCT03565900|450285660|FG001|Overall Study|Randomized By Mistake|2|||
125181498|NCT03565900|450285659|FG000|Overall Study|Physician Decision|7|||
125181499|NCT03565900|450285660|FG001|Overall Study|Physician Decision|11|||
125181500|NCT03565900|450285659|FG000|Overall Study|Death|9|||
125181501|NCT03565900|450285660|FG001|Overall Study|Death|7|||
125181502|NCT00245466|450285668|FG000|Overall Study|Adverse Event|2|||
125181503|NCT00245466|450285669|FG001|Overall Study|Adverse Event|8|||
125181504|NCT00245466|450285670|FG002|Overall Study|Adverse Event|4|||
125181505|NCT00245466|450285668|FG000|Overall Study|Low prostate specific antigen suppr|16|||
125181506|NCT00245466|450285669|FG001|Overall Study|Low prostate specific antigen suppr|14|||
125181507|NCT00245466|450285670|FG002|Overall Study|Low prostate specific antigen suppr|5|||
125181508|NCT00245466|450285668|FG000|Overall Study|Insufficient testosterone suppr|12|||
125181509|NCT00245466|450285669|FG001|Overall Study|Insufficient testosterone suppr|12|||
125181510|NCT00245466|450285670|FG002|Overall Study|Insufficient testosterone suppr|21|||
125181511|NCT00245466|450285668|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
125181512|NCT00245466|450285669|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
125181513|NCT00245466|450285670|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
125181514|NCT00245466|450285668|FG000|Overall Study|Withdrawal by Subject|2|||
125181515|NCT00245466|450285669|FG001|Overall Study|Withdrawal by Subject|2|||
125181516|NCT00245466|450285670|FG002|Overall Study|Withdrawal by Subject|1|||
125181517|NCT00245466|450285668|FG000|Overall Study|Lost to Follow-up|3|||
125181518|NCT00245466|450285669|FG001|Overall Study|Lost to Follow-up|0|||
125181519|NCT00245466|450285670|FG002|Overall Study|Lost to Follow-up|0|||
125181520|NCT00245466|450285668|FG000|Overall Study|Disease progression|0|||
125181521|NCT00245466|450285669|FG001|Overall Study|Disease progression|3|||
125181522|NCT00245466|450285670|FG002|Overall Study|Disease progression|1|||
125181523|NCT00245466|450285668|FG000|Overall Study|Protocol Violation|1|||
125181524|NCT00245466|450285669|FG001|Overall Study|Protocol Violation|2|||
125181525|NCT00245466|450285670|FG002|Overall Study|Protocol Violation|2|||
125181526|NCT00245466|450285668|FG000|Overall Study|Death|0|||
125181527|NCT00245466|450285669|FG001|Overall Study|Death|2|||
125181528|NCT00245466|450285670|FG002|Overall Study|Death|0|||
125181529|NCT00245466|450285668|FG000|Overall Study|Administrative reasons|0|||
125181530|NCT00245466|450285669|FG001|Overall Study|Administrative reasons|1|||
125181531|NCT00245466|450285670|FG002|Overall Study|Administrative reasons|0|||
125181532|NCT01958437|450285671|FG000|Overall Study|Incidental MRI findings|0|||
125181533|NCT01958437|450285672|FG001|Overall Study|Incidental MRI findings|0|||
125181534|NCT01958437|450285673|FG002|Overall Study|Incidental MRI findings|1|||
125181535|NCT01958437|450285674|FG003|Overall Study|Incidental MRI findings|1|||
125236588|NCT02382939|450493915|FG001|Overall Study|Adverse Event|1|||
125236589|NCT02382939|450493914|FG000|Overall Study|Withdrawal by Subject|2|||
125236590|NCT02382939|450493915|FG001|Overall Study|Withdrawal by Subject|2|||
125236591|NCT05383209|450493918|FG000|Overall Study|Adverse Event: Non-ocular|0|||
125236592|NCT05383209|450493919|FG001|Overall Study|Adverse Event: Non-ocular|1|||
125236593|NCT05383209|450493920|FG002|Overall Study|Adverse Event: Non-ocular|0|||
125236594|NCT05383209|450493918|FG000|Overall Study|Lost to Follow-up|2|||
125236595|NCT05383209|450493919|FG001|Overall Study|Lost to Follow-up|1|||
125236596|NCT05383209|450493920|FG002|Overall Study|Lost to Follow-up|4|||
125236597|NCT05383209|450493918|FG000|Overall Study|Withdrawal by Subject|2|||
125236598|NCT05383209|450493919|FG001|Overall Study|Withdrawal by Subject|0|||
125236599|NCT05383209|450493920|FG002|Overall Study|Withdrawal by Subject|1|||
125236600|NCT05383209|450493918|FG000|Overall Study|Death|1|||
125236601|NCT05383209|450493919|FG001|Overall Study|Death|0|||
125236602|NCT05383209|450493920|FG002|Overall Study|Death|0|||
125236603|NCT05383209|450493918|FG000|Overall Study|Other|0|||
125236604|NCT05383209|450493919|FG001|Overall Study|Other|1|||
125236605|NCT05383209|450493920|FG002|Overall Study|Other|0|||
125236606|NCT01582451|450493921|FG000|Overall Study|Adverse Event|1|||
125236607|NCT01582451|450493922|FG001|Overall Study|Adverse Event|3|||
125236608|NCT01582451|450493921|FG000|Overall Study|Death|3|||
125236609|NCT01582451|450493922|FG001|Overall Study|Death|3|||
125236610|NCT01582451|450493921|FG000|Overall Study|Lost to Follow-up|0|||
125236611|NCT01582451|450493922|FG001|Overall Study|Lost to Follow-up|2|||
125236612|NCT01582451|450493921|FG000|Overall Study|Protocol Violation|11|||
125236613|NCT01582451|450493922|FG001|Overall Study|Protocol Violation|3|||
125236614|NCT01582451|450493921|FG000|Overall Study|Withdrawal by Subject|13|||
125236615|NCT01582451|450493922|FG001|Overall Study|Withdrawal by Subject|9|||
125236616|NCT01582451|450493921|FG000|Overall Study|Physician Decision|3|||
125236617|NCT01582451|450493922|FG001|Overall Study|Physician Decision|0|||
125236618|NCT01582451|450493921|FG000|Overall Study|Sponsor Decision|1|||
125236619|NCT01582451|450493922|FG001|Overall Study|Sponsor Decision|0|||
125236620|NCT00717886|450493923|FG000|Overall Study|Withdrawal by Subject|3|||
125236621|NCT00717886|450493923|FG000|Overall Study|Treatment Failure|1|||
125236622|NCT00716417|450493924|FG000|Overall Study|Adverse Event|0|||
125236623|NCT00716417|450493925|FG001|Overall Study|Adverse Event|0|||
125236624|NCT00716417|450493926|FG002|Overall Study|Adverse Event|2|||
125236625|NCT00716417|450493927|FG003|Overall Study|Adverse Event|1|||
125236626|NCT00716417|450493928|FG004|Overall Study|Adverse Event|0|||
125236627|NCT00716417|450493929|FG005|Overall Study|Adverse Event|0|||
125236628|NCT00716417|450493930|FG006|Overall Study|Adverse Event|3|||
125236629|NCT00716417|450493931|FG007|Overall Study|Adverse Event|1|||
125236630|NCT00716417|450493932|FG008|Overall Study|Adverse Event|0|||
125236631|NCT00716417|450493933|FG009|Overall Study|Adverse Event|3|||
125236632|NCT00716417|450493924|FG000|Overall Study|Withdrawal by Subject|0|||
125236633|NCT00716417|450493925|FG001|Overall Study|Withdrawal by Subject|1|||
125236634|NCT00716417|450493926|FG002|Overall Study|Withdrawal by Subject|0|||
125236635|NCT00716417|450493927|FG003|Overall Study|Withdrawal by Subject|2|||
125236636|NCT00716417|450493928|FG004|Overall Study|Withdrawal by Subject|0|||
125236637|NCT00716417|450493929|FG005|Overall Study|Withdrawal by Subject|0|||
125236638|NCT00716417|450493930|FG006|Overall Study|Withdrawal by Subject|1|||
125236639|NCT00716417|450493931|FG007|Overall Study|Withdrawal by Subject|0|||
125236640|NCT00716417|450493932|FG008|Overall Study|Withdrawal by Subject|0|||
125236641|NCT00716417|450493933|FG009|Overall Study|Withdrawal by Subject|0|||
125236642|NCT00716417|450493924|FG000|Overall Study|Progressive disease|3|||
125236643|NCT00716417|450493925|FG001|Overall Study|Progressive disease|5|||
125236644|NCT00716417|450493926|FG002|Overall Study|Progressive disease|3|||
125236645|NCT00716417|450493927|FG003|Overall Study|Progressive disease|8|||
125236646|NCT00716417|450493928|FG004|Overall Study|Progressive disease|0|||
125236647|NCT00716417|450493929|FG005|Overall Study|Progressive disease|3|||
125236648|NCT00716417|450493930|FG006|Overall Study|Progressive disease|3|||
125236649|NCT00716417|450493931|FG007|Overall Study|Progressive disease|1|||
125236650|NCT00716417|450493932|FG008|Overall Study|Progressive disease|5|||
125236651|NCT00716417|450493933|FG009|Overall Study|Progressive disease|0|||
125236652|NCT00716417|450493924|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
125236653|NCT00716417|450493925|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
125236654|NCT00716417|450493926|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
125236655|NCT00716417|450493927|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
125236656|NCT00716417|450493928|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
125236657|NCT00716417|450493929|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
125236658|NCT00716417|450493930|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
125236659|NCT00716417|450493931|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
125236660|NCT00716417|450493932|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
125236661|NCT00716417|450493933|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
125236662|NCT00716417|450493924|FG000|Overall Study|On patient request due to toxicities|0|||
125236663|NCT00716417|450493925|FG001|Overall Study|On patient request due to toxicities|0|||
125236664|NCT00716417|450493926|FG002|Overall Study|On patient request due to toxicities|0|||
125236665|NCT00716417|450493927|FG003|Overall Study|On patient request due to toxicities|0|||
125181536|NCT04886596|450285677|FG000|Overall Study|Adverse Event|442|||
125181537|NCT04886596|450285678|FG001|Overall Study|Adverse Event|441|||
125181538|NCT04886596|450285677|FG000|Overall Study|Lost to Follow-up|448|||
125181539|NCT04886596|450285678|FG001|Overall Study|Lost to Follow-up|465|||
125181540|NCT04886596|450285677|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
125181541|NCT04886596|450285678|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
125181542|NCT04886596|450285677|FG000|Overall Study|Migrated/moved from the study area|201|||
125181543|NCT04886596|450285678|FG001|Overall Study|Migrated/moved from the study area|184|||
125181544|NCT04886596|450285677|FG000|Overall Study|Other|298|||
125181545|NCT04886596|450285678|FG001|Overall Study|Other|326|||
125181546|NCT00948155|450285680|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
125181547|NCT00948155|450285681|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
125181548|NCT00948155|450285680|FG000|Washout 14 Days|Lost to Follow-up|1|||
125181549|NCT00948155|450285681|FG001|Washout 14 Days|Lost to Follow-up|2|||
125181550|NCT04620746|450285682|FG000|Overall Study|Adverse Event|2|||
125181551|NCT04620746|450285683|FG001|Overall Study|Adverse Event|0|||
125181552|NCT04620746|450285682|FG000|Overall Study|Uniterpretable skin test|1|||
125181553|NCT04620746|450285683|FG001|Overall Study|Uniterpretable skin test|0|||
125181554|NCT04620746|450285682|FG000|Overall Study|Withdrawal by Subject|0|||
125181555|NCT04620746|450285683|FG001|Overall Study|Withdrawal by Subject|1|||
125181556|NCT03473925|450285684|FG000|Overall Study|Death|48|||
125181557|NCT03473925|450285685|FG001|Overall Study|Death|44|||
125181558|NCT03473925|450285684|FG000|Overall Study|Sponsor Decision|2|||
125181559|NCT03473925|450285685|FG001|Overall Study|Sponsor Decision|7|||
125181560|NCT03473925|450285684|FG000|Overall Study|Withdrawal by Subject|1|||
125181561|NCT03473925|450285685|FG001|Overall Study|Withdrawal by Subject|3|||
125181562|NCT03473925|450285684|FG000|Overall Study|Not Treated|1|||
125181563|NCT03473925|450285685|FG001|Overall Study|Not Treated|1|||
125181564|NCT03411863|450285686|FG000|Overall Study|Withdrawal by Subject|3|||
125181565|NCT03411863|450285687|FG001|Overall Study|Withdrawal by Subject|1|||
125181566|NCT03411863|450285686|FG000|Overall Study|Physician Decision|0|||
125181567|NCT03411863|450285687|FG001|Overall Study|Physician Decision|1|||
125181568|NCT04661150|450285692|FG000|Overall Study|Ongoing in study|19|||
125181569|NCT04661150|450285693|FG001|Overall Study|Ongoing in study|20|||
125181570|NCT04661150|450285692|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
125181571|NCT04661150|450285693|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
125181572|NCT04661150|450285692|FG000|Overall Study|Death|2|||
125181573|NCT04661150|450285693|FG001|Overall Study|Death|0|||
125181574|NCT00100828|450285694|FG000|Overall Study|Physician Decision|6|||
125181575|NCT01197911|450285695|FG000|Overall Study|Adverse Event|0|||
125181576|NCT01197911|450285696|FG001|Overall Study|Adverse Event|0|||
125181577|NCT01197911|450285697|FG002|Overall Study|Adverse Event|1|||
125181578|NCT01526057|450285699|FG000|Overall Study|Withdrawal by Subject|3|||
125181579|NCT01526057|450285700|FG001|Overall Study|Withdrawal by Subject|2|||
125181580|NCT01526057|450285701|FG002|Overall Study|Withdrawal by Subject|2|||
125181581|NCT01526057|450285699|FG000|Overall Study|Adverse Event|3|||
125181582|NCT01526057|450285700|FG001|Overall Study|Adverse Event|1|||
125181583|NCT01526057|450285701|FG002|Overall Study|Adverse Event|1|||
125181584|NCT01526057|450285699|FG000|Overall Study|Death|1|||
125181585|NCT01526057|450285700|FG001|Overall Study|Death|0|||
125181586|NCT01526057|450285701|FG002|Overall Study|Death|0|||
125181587|NCT01526057|450285699|FG000|Overall Study|Lost to Follow-up|1|||
125181588|NCT01526057|450285700|FG001|Overall Study|Lost to Follow-up|0|||
125181589|NCT01526057|450285701|FG002|Overall Study|Lost to Follow-up|1|||
125181590|NCT01526057|450285699|FG000|Overall Study|Other|1|||
125181591|NCT01526057|450285700|FG001|Overall Study|Other|0|||
125181592|NCT01526057|450285701|FG002|Overall Study|Other|1|||
125181593|NCT01526057|450285699|FG000|Overall Study|Protocol Violation|0|||
125181594|NCT01526057|450285700|FG001|Overall Study|Protocol Violation|0|||
125181595|NCT01526057|450285701|FG002|Overall Study|Protocol Violation|1|||
125181596|NCT02289729|450285704|FG000|Overall Study|Lack of Efficacy|3|||
125181597|NCT02289729|450285704|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
125181598|NCT02289729|450285704|FG000|Overall Study|Withdrawal by Subject|1|||
125181599|NCT02289729|450285704|FG000|Overall Study|Death|1|||
125181600|NCT04870710|450285710|FG000|Overall Study|Lost to Follow-up|3|||
125181601|NCT00476190|450285711|FG000|Overall Study|Ineligible|1|||
125181602|NCT00476190|450285712|FG001|Overall Study|Ineligible|1|||
125181603|NCT00476190|450285711|FG000|Overall Study|Induction Death|2|||
125181604|NCT00476190|450285712|FG001|Overall Study|Induction Death|0|||
125181605|NCT00476190|450285711|FG000|Overall Study|Induction Failure|2|||
125181606|NCT00476190|450285712|FG001|Overall Study|Induction Failure|4|||
125181607|NCT00476190|450285711|FG000|Overall Study|Lost to Follow-up|1|||
125181608|NCT00476190|450285712|FG001|Overall Study|Lost to Follow-up|0|||
125181609|NCT00476190|450285711|FG000|Overall Study|Relapse/Progression|5|||
125181610|NCT00476190|450285712|FG001|Overall Study|Relapse/Progression|2|||
125181611|NCT00476190|450285711|FG000|Overall Study|Remission Death|0|||
125181612|NCT00476190|450285712|FG001|Overall Study|Remission Death|1|||
125181613|NCT00476190|450285711|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
125181614|NCT00476190|450285712|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
125181615|NCT00476190|450285711|FG000|Overall Study|Withdrawal by Subject|6|||
125181616|NCT00476190|450285712|FG001|Overall Study|Withdrawal by Subject|2|||
125181617|NCT00476190|450285711|FG000|Overall Study|Other|9|||
125181618|NCT00476190|450285712|FG001|Overall Study|Other|10|||
125181619|NCT05724589|450285713|FG000|Overall Study|Lost to Follow-up|1|||
125181620|NCT04331808|450285717|FG000|Overall Study|Withdrew consent|1|||
125181621|NCT04331808|450285718|FG001|Overall Study|Withdrew consent|0|||
125181622|NCT04331808|450285719|FG002|Overall Study|Withdrew consent|2|||
125181623|NCT04331808|450285720|FG003|Overall Study|Withdrew consent|3|||
125181624|NCT02189837|450285721|FG000|Overall Study|Withdrawal by Subject|2|||
125181625|NCT02189837|450285722|FG001|Overall Study|Withdrawal by Subject|1|||
125181626|NCT02189837|450285723|FG002|Overall Study|Withdrawal by Subject|3|||
125181627|NCT02189837|450285724|FG003|Overall Study|Withdrawal by Subject|1|||
125181628|NCT02189837|450285721|FG000|Overall Study|Sponsor Decision|0|||
125181629|NCT02189837|450285722|FG001|Overall Study|Sponsor Decision|0|||
125181630|NCT02189837|450285723|FG002|Overall Study|Sponsor Decision|0|||
125181631|NCT02189837|450285724|FG003|Overall Study|Sponsor Decision|1|||
125181632|NCT00822692|450285730|FG000|Overall Study|Lost to Follow-up|17|||
125181633|NCT00822692|450285731|FG001|Overall Study|Lost to Follow-up|25|||
125181634|NCT02443740|450285732|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
125181635|NCT02443740|450285733|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
125181636|NCT02443740|450285734|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
125181637|NCT02443740|450285735|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
125181638|NCT02443740|450285736|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
125181639|NCT02443740|450285737|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
125181640|NCT02443740|450285738|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
125181641|NCT02443740|450285739|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
125181642|NCT02443740|450285740|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
125181643|NCT02443740|450285741|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
125181644|NCT02443740|450285742|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
125181645|NCT02443740|450285732|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
125181646|NCT02443740|450285733|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
125181647|NCT02443740|450285734|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
125181648|NCT02443740|450285735|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
125181649|NCT02443740|450285736|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
125181650|NCT02443740|450285737|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
125181651|NCT02443740|450285738|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
125181652|NCT02443740|450285739|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
125181653|NCT02443740|450285740|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
125181654|NCT02443740|450285741|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
125181655|NCT02443740|450285742|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
125181656|NCT02443740|450285732|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
125181657|NCT02443740|450285733|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
125181658|NCT02443740|450285734|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
125181659|NCT02443740|450285735|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
125181660|NCT02443740|450285736|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
125181661|NCT02443740|450285737|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
125181662|NCT02443740|450285738|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
125181663|NCT02443740|450285739|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
125181664|NCT02443740|450285740|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
125181665|NCT02443740|450285741|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
125181666|NCT02443740|450285742|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
125181667|NCT00456300|450285743|FG000|Overall Study|Adverse Event|1|||
125181668|NCT00456300|450285744|FG001|Overall Study|Adverse Event|0|||
125181669|NCT02348112|450285748|FG000|Overall Study|Withdrawal by Subject|32|||
125181670|NCT02348112|450285749|FG001|Overall Study|Withdrawal by Subject|29|||
125181671|NCT02348112|450285748|FG000|Overall Study|Lost to Follow-up|24|||
125181672|NCT02348112|450285749|FG001|Overall Study|Lost to Follow-up|20|||
125181673|NCT02348112|450285748|FG000|Overall Study|Physician Decision|17|||
125181674|NCT02348112|450285749|FG001|Overall Study|Physician Decision|15|||
125181675|NCT02348112|450285748|FG000|Overall Study|Site closed due to PI leaving|0|||
125181676|NCT02348112|450285749|FG001|Overall Study|Site closed due to PI leaving|30|||
125181677|NCT02348112|450285748|FG000|Overall Study|Sponsor withdrawal|0|||
125181678|NCT02348112|450285749|FG001|Overall Study|Sponsor withdrawal|7|||
125181679|NCT02348112|450285748|FG000|Overall Study|Death|0|||
125181680|NCT02348112|450285749|FG001|Overall Study|Death|1|||
125181681|NCT01998841|450285757|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
125181682|NCT01998841|450285758|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
125181683|NCT01998841|450285759|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
125181684|NCT01998841|450285760|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
125181685|NCT01998841|450285761|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
125181686|NCT01998841|450285757|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
125236666|NCT00716417|450493928|FG004|Overall Study|On patient request due to toxicities|0|||
125236667|NCT00716417|450493929|FG005|Overall Study|On patient request due to toxicities|0|||
125236668|NCT00716417|450493930|FG006|Overall Study|On patient request due to toxicities|0|||
125236669|NCT00716417|450493931|FG007|Overall Study|On patient request due to toxicities|1|||
125236670|NCT00716417|450493932|FG008|Overall Study|On patient request due to toxicities|0|||
125236671|NCT00716417|450493933|FG009|Overall Study|On patient request due to toxicities|0|||
125236672|NCT01553851|450493934|FG000|Overall Study|Adverse Event|2|||
125236673|NCT01553851|450493934|FG000|Overall Study|constipation|1|||
125236674|NCT01369433|450493935|FG000|Overall Study|Adverse Event|31|||
125236675|NCT01369433|450493936|FG001|Overall Study|Adverse Event|1|||
125181687|NCT01998841|450285758|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
125181688|NCT01998841|450285759|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
125181689|NCT01998841|450285760|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
125236676|NCT01369433|450493935|FG000|Overall Study|Required significant surgical procedure|1|||
125236677|NCT01369433|450493936|FG001|Overall Study|Required significant surgical procedure|0|||
125236678|NCT01369433|450493935|FG000|Overall Study|Non-compliance|1|||
125236679|NCT01369433|450493936|FG001|Overall Study|Non-compliance|0|||
125236680|NCT01369433|450493935|FG000|Overall Study|Withdrawal by Subject|5|||
125236681|NCT01369433|450493936|FG001|Overall Study|Withdrawal by Subject|2|||
125236682|NCT01369433|450493935|FG000|Overall Study|Study terminated by Sponsor|67|||
125236683|NCT01369433|450493936|FG001|Overall Study|Study terminated by Sponsor|0|||
125236684|NCT01369433|450493935|FG000|Overall Study|Lost to Follow-up|1|||
125236685|NCT01369433|450493936|FG001|Overall Study|Lost to Follow-up|0|||
125236686|NCT01369433|450493935|FG000|Overall Study|Death|5|||
125236687|NCT01369433|450493936|FG001|Overall Study|Death|0|||
125236688|NCT01369433|450493935|FG000|Overall Study|Investigator discretion|6|||
125236689|NCT01369433|450493936|FG001|Overall Study|Investigator discretion|1|||
125236690|NCT01369433|450493935|FG000|Overall Study|Progressive Disease|92|||
125236691|NCT01369433|450493936|FG001|Overall Study|Progressive Disease|12|||
125236692|NCT00487188|450493938|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
125236693|NCT00487188|450493939|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
125236694|NCT00487188|450493940|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
125236695|NCT00487188|450493938|FG000|Induction Phase|Adverse Event|5|||
125236696|NCT00487188|450493939|FG001|Induction Phase|Adverse Event|0|||
125236697|NCT00487188|450493940|FG002|Induction Phase|Adverse Event|0|||
125236698|NCT00487188|450493938|FG000|Induction Phase|Lack of Efficacy|0|||
125236699|NCT00487188|450493939|FG001|Induction Phase|Lack of Efficacy|1|||
125236700|NCT00487188|450493940|FG002|Induction Phase|Lack of Efficacy|0|||
125236701|NCT00487188|450493938|FG000|Induction Phase|Protocol Violation|1|||
125236702|NCT00487188|450493939|FG001|Induction Phase|Protocol Violation|0|||
125236703|NCT00487188|450493940|FG002|Induction Phase|Protocol Violation|0|||
125236704|NCT00487188|450493938|FG000|Induction Phase|Refused Treatment|1|||
125236705|NCT00487188|450493939|FG001|Induction Phase|Refused Treatment|2|||
125236706|NCT00487188|450493940|FG002|Induction Phase|Refused Treatment|0|||
125236707|NCT00487188|450493938|FG000|Induction Phase|Lost to Follow-up|2|||
125236708|NCT00487188|450493939|FG001|Induction Phase|Lost to Follow-up|2|||
125236709|NCT00487188|450493940|FG002|Induction Phase|Lost to Follow-up|0|||
125236710|NCT00487188|450493938|FG000|Induction Phase|Administrative|0|||
125236711|NCT00487188|450493939|FG001|Induction Phase|Administrative|1|||
125236712|NCT00487188|450493940|FG002|Induction Phase|Administrative|0|||
125236713|NCT00487188|450493938|FG000|Maintenance Phase|Adverse Event|1|||
125236714|NCT00487188|450493939|FG001|Maintenance Phase|Adverse Event|0|||
125236715|NCT00487188|450493940|FG002|Maintenance Phase|Adverse Event|0|||
125236716|NCT00487188|450493938|FG000|Maintenance Phase|Death|1|||
125236717|NCT00487188|450493939|FG001|Maintenance Phase|Death|0|||
125236718|NCT00487188|450493940|FG002|Maintenance Phase|Death|0|||
125236719|NCT00487188|450493938|FG000|Maintenance Phase|Lost to Follow-up|1|||
125236720|NCT00487188|450493939|FG001|Maintenance Phase|Lost to Follow-up|0|||
125236721|NCT00487188|450493940|FG002|Maintenance Phase|Lost to Follow-up|0|||
125236722|NCT00487188|450493938|FG000|Maintenance Phase|Administrative|0|||
125236723|NCT00487188|450493939|FG001|Maintenance Phase|Administrative|0|||
125181690|NCT01998841|450285761|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
125181691|NCT02552121|450285762|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
125181692|NCT02552121|450285763|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
125236724|NCT00487188|450493940|FG002|Maintenance Phase|Administrative|1|||
125236725|NCT03822416|450493951|FG000|Overall Study|Lost to Follow-up|1|||
125236726|NCT03822416|450493952|FG001|Overall Study|Lost to Follow-up|0|||
125236727|NCT03822416|450493951|FG000|Overall Study|Withdrawal by Subject|0|||
125236728|NCT03822416|450493952|FG001|Overall Study|Withdrawal by Subject|1|||
125236729|NCT04666298|450493955|FG000|Overall Study|Subject decision|1|||
125236730|NCT04666298|450493956|FG001|Overall Study|Subject decision|0|||
125236731|NCT04666298|450493957|FG002|Overall Study|Subject decision|0|||
125181693|NCT02552121|450285764|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
125181694|NCT02552121|450285765|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
125181695|NCT02552121|450285766|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
125181696|NCT02552121|450285767|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
125181697|NCT02552121|450285768|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
125181698|NCT02552121|450285769|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
125181699|NCT02552121|450285762|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
125181700|NCT02552121|450285763|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
125181701|NCT02552121|450285764|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
125181702|NCT02552121|450285765|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
125181703|NCT02552121|450285766|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
125181704|NCT02552121|450285767|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
125181705|NCT02552121|450285768|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
125181706|NCT02552121|450285769|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
125181707|NCT02552121|450285762|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
125181708|NCT02552121|450285763|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
125181709|NCT02552121|450285764|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
125181710|NCT02552121|450285765|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
125181711|NCT02552121|450285766|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
125181712|NCT02552121|450285767|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
125181713|NCT02552121|450285768|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
125181714|NCT02552121|450285769|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
125181715|NCT02552121|450285762|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
125181716|NCT02552121|450285763|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
125181717|NCT02552121|450285764|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
125181718|NCT02552121|450285765|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
125181719|NCT02552121|450285766|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
125181720|NCT02552121|450285767|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
125181721|NCT02552121|450285768|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
125181722|NCT02552121|450285769|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
125181723|NCT02552121|450285762|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
125181724|NCT02552121|450285763|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
125181725|NCT02552121|450285764|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
125181726|NCT02552121|450285765|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
125181727|NCT02552121|450285766|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
125181728|NCT02552121|450285767|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
125181729|NCT02552121|450285768|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
125181730|NCT02552121|450285769|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
125181731|NCT02552121|450285762|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
125181732|NCT02552121|450285763|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
125181733|NCT02552121|450285764|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
125181734|NCT02552121|450285765|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
125181735|NCT02552121|450285766|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
125181736|NCT02552121|450285767|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
125181737|NCT02552121|450285768|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
125181738|NCT02552121|450285769|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
125181739|NCT02552121|450285762|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
125181740|NCT02552121|450285763|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
125181741|NCT02552121|450285764|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
125181742|NCT02552121|450285765|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
125181743|NCT02552121|450285766|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
125181744|NCT02552121|450285767|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
125181745|NCT02552121|450285768|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
125181746|NCT02552121|450285769|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
125181747|NCT02552121|450285762|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
125236732|NCT04666298|450493958|FG003|Overall Study|Subject decision|2|||
125236733|NCT04666298|450493955|FG000|Overall Study|Death|1|||
125236734|NCT04666298|450493956|FG001|Overall Study|Death|0|||
125236735|NCT04666298|450493957|FG002|Overall Study|Death|0|||
125236736|NCT04666298|450493958|FG003|Overall Study|Death|0|||
125181748|NCT02552121|450285763|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
125181749|NCT02552121|450285764|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
125236737|NCT04666298|450493955|FG000|Overall Study|Lost to Follow-up|0|||
125236738|NCT04666298|450493956|FG001|Overall Study|Lost to Follow-up|0|||
125181750|NCT02552121|450285765|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
125181751|NCT02552121|450285766|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
125181752|NCT02552121|450285767|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
125181753|NCT02552121|450285768|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
125181754|NCT02552121|450285769|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
125236739|NCT04666298|450493957|FG002|Overall Study|Lost to Follow-up|0|||
125236740|NCT04666298|450493958|FG003|Overall Study|Lost to Follow-up|1|||
125236741|NCT04666298|450493955|FG000|Overall Study|Physician Decision|0|||
125236742|NCT04666298|450493956|FG001|Overall Study|Physician Decision|0|||
125236743|NCT04666298|450493957|FG002|Overall Study|Physician Decision|0|||
125236744|NCT04666298|450493958|FG003|Overall Study|Physician Decision|1|||
125236745|NCT04666298|450493955|FG000|Overall Study|Protocol deviation|0|||
125236746|NCT04666298|450493956|FG001|Overall Study|Protocol deviation|0|||
125236747|NCT04666298|450493957|FG002|Overall Study|Protocol deviation|1|||
125236748|NCT04666298|450493958|FG003|Overall Study|Protocol deviation|0|||
125236749|NCT00844519|450493959|FG000|Overall Study|Withdrawal by Subject|1|||
125236750|NCT00844519|450493960|FG001|Overall Study|Withdrawal by Subject|1|||
125236751|NCT00844519|450493959|FG000|Overall Study|Adverse Event|1|||
125236752|NCT00844519|450493960|FG001|Overall Study|Adverse Event|0|||
125236753|NCT06438601|450493961|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
125236754|NCT06438601|450493962|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
125236755|NCT06438601|450493961|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
125236756|NCT06438601|450493962|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
125236757|NCT01311661|450493965|FG000|Overall Study|Adverse Event|2|||
125236758|NCT01311661|450493965|FG000|Overall Study|Protocol Violation|3|||
125236759|NCT01311661|450493965|FG000|Overall Study|Withdrawal by Subject|2|||
125236760|NCT00207740|450493966|FG000|Overall Study|Adverse Event|4|||
125236761|NCT00207740|450493967|FG001|Overall Study|Adverse Event|14|||
125236762|NCT00207740|450493968|FG002|Overall Study|Adverse Event|14|||
125236763|NCT00207740|450493969|FG003|Overall Study|Adverse Event|11|||
125236764|NCT00207740|450493966|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125236765|NCT00207740|450493967|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125236766|NCT00207740|450493968|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
125236767|NCT00207740|450493969|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
125236768|NCT00207740|450493966|FG000|Overall Study|Lost to Follow-up|0|||
125236769|NCT00207740|450493967|FG001|Overall Study|Lost to Follow-up|2|||
125236770|NCT00207740|450493968|FG002|Overall Study|Lost to Follow-up|1|||
125236771|NCT00207740|450493969|FG003|Overall Study|Lost to Follow-up|1|||
125236772|NCT00207740|450493966|FG000|Overall Study|Death|0|||
125236773|NCT00207740|450493967|FG001|Overall Study|Death|0|||
125236774|NCT00207740|450493968|FG002|Overall Study|Death|0|||
125236775|NCT00207740|450493969|FG003|Overall Study|Death|1|||
125236776|NCT00207740|450493966|FG000|Overall Study|Sponsor Directive|22|||
125236777|NCT00207740|450493967|FG001|Overall Study|Sponsor Directive|15|||
125236778|NCT00207740|450493968|FG002|Overall Study|Sponsor Directive|16|||
125236779|NCT00207740|450493969|FG003|Overall Study|Sponsor Directive|21|||
125236780|NCT00207740|450493966|FG000|Overall Study|Other|2|||
125236781|NCT00207740|450493967|FG001|Overall Study|Other|10|||
125236782|NCT00207740|450493968|FG002|Overall Study|Other|7|||
125236783|NCT00207740|450493969|FG003|Overall Study|Other|5|||
125236784|NCT00390013|450493970|FG000|Phase 1|tired|0|||
125236785|NCT00390013|450493971|FG001|Phase 1|tired|0|||
125236786|NCT00390013|450493972|FG002|Phase 1|tired|0|||
125236787|NCT00390013|450493973|FG003|Phase 1|tired|1|||
125236788|NCT00390013|450493970|FG000|Phase 2 First Treatment|tired|1|||
125236789|NCT00390013|450493971|FG001|Phase 2 First Treatment|tired|0|||
125236790|NCT00390013|450493972|FG002|Phase 2 First Treatment|tired|0|||
125236791|NCT00390013|450493973|FG003|Phase 2 First Treatment|tired|0|||
125236792|NCT00390013|450493970|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
125236793|NCT00390013|450493971|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
125236794|NCT00390013|450493972|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
125236795|NCT00390013|450493973|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
125236796|NCT03188822|450493976|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
125236797|NCT03188822|450493976|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
125236798|NCT01349595|450493981|FG000|Overall Study|Lack of funding|2|||
125236799|NCT01349595|450493982|FG001|Overall Study|Lack of funding|2|||
125236800|NCT04584788|450493983|FG000|Overall Study|Physician Decision|8|||
125236801|NCT04584788|450493983|FG000|Overall Study|Withdrawal by Subject|1|||
125236802|NCT04584788|450493983|FG000|Overall Study|Adverse Event|3|||
125236803|NCT00770809|450495968|FG000|Overall Study|Adverse Event|9|||
125236804|NCT00770809|450495969|FG001|Overall Study|Adverse Event|1|||
125236805|NCT00770809|450495970|FG002|Overall Study|Adverse Event|12|||
125236806|NCT00770809|450495968|FG000|Overall Study|Death|1|||
125236807|NCT00770809|450495969|FG001|Overall Study|Death|0|||
125236808|NCT00770809|450495970|FG002|Overall Study|Death|0|||
125236809|NCT00770809|450495968|FG000|Overall Study|Withdrawal by Subject|3|||
125236810|NCT00770809|450495969|FG001|Overall Study|Withdrawal by Subject|3|||
125236811|NCT00770809|450495970|FG002|Overall Study|Withdrawal by Subject|7|||
125236812|NCT00770809|450495968|FG000|Overall Study|Progression|2|||
125236813|NCT00770809|450495969|FG001|Overall Study|Progression|2|||
125236814|NCT00770809|450495970|FG002|Overall Study|Progression|0|||
125236815|NCT00770809|450495968|FG000|Overall Study|Complicating illness|0|||
125236816|NCT00770809|450495969|FG001|Overall Study|Complicating illness|0|||
125236817|NCT00770809|450495970|FG002|Overall Study|Complicating illness|1|||
125236818|NCT00770809|450495968|FG000|Overall Study|Other Medical Reasons|2|||
125236819|NCT00770809|450495969|FG001|Overall Study|Other Medical Reasons|4|||
125236820|NCT00770809|450495970|FG002|Overall Study|Other Medical Reasons|3|||
125236821|NCT03329001|450495982|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
125236822|NCT03329001|450495983|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
125236823|NCT03329001|450495984|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
125236824|NCT03329001|450495985|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
125236825|NCT03329001|450495986|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
125236826|NCT03329001|450495987|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
125236827|NCT03329001|450495988|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
125236828|NCT03329001|450495989|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
125236829|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
125236830|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
125236831|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
125236832|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
125236833|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
125236834|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
125236835|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
125236836|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
125236837|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
125236838|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
125236839|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
125236840|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
125236841|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
125236842|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
125236843|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
125236844|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
125236845|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
125236846|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
125236847|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
125236848|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
125236849|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
125236850|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
125236851|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
125236852|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
125236853|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
125236854|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
125236855|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
125236856|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
125236857|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
125236858|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
125236859|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
125236860|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
125236861|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
125236862|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
125236863|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
125236864|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
125236865|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
125236866|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
125236867|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
125236868|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
125236869|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
125236870|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
125236871|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
125181755|NCT02552121|450285762|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
125181756|NCT02552121|450285763|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
125181757|NCT02552121|450285764|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
125181758|NCT02552121|450285765|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
125181759|NCT02552121|450285766|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
125181760|NCT02552121|450285767|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
125181761|NCT02552121|450285768|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
125181762|NCT02552121|450285769|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
125181763|NCT02552121|450285762|FG000|Part 2: Cohort Expansion|Death|0|||
125181764|NCT02552121|450285763|FG001|Part 2: Cohort Expansion|Death|0|||
125181765|NCT02552121|450285764|FG002|Part 2: Cohort Expansion|Death|1|||
125181766|NCT02552121|450285765|FG003|Part 2: Cohort Expansion|Death|0|||
125181767|NCT02552121|450285766|FG004|Part 2: Cohort Expansion|Death|0|||
125181768|NCT02552121|450285767|FG005|Part 2: Cohort Expansion|Death|0|||
125181769|NCT02552121|450285768|FG006|Part 2: Cohort Expansion|Death|0|||
125181770|NCT02552121|450285769|FG007|Part 2: Cohort Expansion|Death|0|||
125181771|NCT03447743|450285770|FG000|Overall Study|Withdrawal by Subject|2|||
125181772|NCT03447743|450285770|FG000|Overall Study|Lost to Follow-up|3|||
125181773|NCT03447743|450285770|FG000|Overall Study|Adverse Event|1|||
125181774|NCT03447743|450285770|FG000|Overall Study|Did not meet criteria to continue|1|||
125181775|NCT02854527|450285771|FG000|Overall Study|Adverse Event|0|||
125181776|NCT02854527|450285772|FG001|Overall Study|Adverse Event|0|||
125181777|NCT02854527|450285773|FG002|Overall Study|Adverse Event|0|||
125181778|NCT02854527|450285774|FG003|Overall Study|Adverse Event|0|||
125181779|NCT02854527|450285775|FG004|Overall Study|Adverse Event|1|||
125181780|NCT02854527|450285776|FG005|Overall Study|Adverse Event|0|||
125181781|NCT02854527|450285777|FG006|Overall Study|Adverse Event|0|||
125181782|NCT02854527|450285778|FG007|Overall Study|Adverse Event|0|||
125181783|NCT02854527|450285779|FG008|Overall Study|Adverse Event|0|||
125181784|NCT02854527|450285780|FG009|Overall Study|Adverse Event|0|||
125181785|NCT02854527|450285771|FG000|Overall Study|Lost to Follow-up|0|||
125181786|NCT02854527|450285772|FG001|Overall Study|Lost to Follow-up|0|||
125181787|NCT02854527|450285773|FG002|Overall Study|Lost to Follow-up|0|||
125181788|NCT02854527|450285774|FG003|Overall Study|Lost to Follow-up|1|||
125181789|NCT02854527|450285775|FG004|Overall Study|Lost to Follow-up|0|||
125181790|NCT02854527|450285776|FG005|Overall Study|Lost to Follow-up|0|||
125181791|NCT02854527|450285777|FG006|Overall Study|Lost to Follow-up|0|||
125181792|NCT02854527|450285778|FG007|Overall Study|Lost to Follow-up|0|||
125181793|NCT02854527|450285779|FG008|Overall Study|Lost to Follow-up|0|||
125181794|NCT02854527|450285780|FG009|Overall Study|Lost to Follow-up|0|||
125181795|NCT03567980|450285781|FG000|Overall Study|Adverse Event|1|||
125181796|NCT02575833|450285783|FG000|Overall Study|Withdrawal by Subject|0|||
125181797|NCT02575833|450285784|FG001|Overall Study|Withdrawal by Subject|1|||
125181798|NCT02575833|450285783|FG000|Overall Study|Lost to Follow-up|1|||
125181799|NCT02575833|450285784|FG001|Overall Study|Lost to Follow-up|0|||
125181800|NCT03093259|450285785|FG000|Overall Study|Adverse Event|1|||
125181801|NCT03093259|450285786|FG001|Overall Study|Adverse Event|0|||
125181802|NCT03093259|450285785|FG000|Overall Study|Withdrawal by Subject|1|||
125181803|NCT03093259|450285786|FG001|Overall Study|Withdrawal by Subject|0|||
125181804|NCT01821807|450285787|FG000|Overall Study|Lost to Follow-up|3|||
125181805|NCT01821807|450285788|FG001|Overall Study|Lost to Follow-up|1|||
125181806|NCT02633787|450285790|FG000|Overall Study|Withdrawal by Subject|1|||
125181807|NCT01742897|450285791|FG000|Overall Study|Adverse Event|3|||
125181808|NCT01742897|450285791|FG000|Overall Study|Withdrawal by Subject|1|||
125181809|NCT01742897|450285791|FG000|Overall Study|Other|1|||
125181810|NCT02404805|450285792|FG000|Overall Study|Withdrawal by Subject|1|||
125181811|NCT02404805|450285793|FG001|Overall Study|Withdrawal by Subject|0|||
125181812|NCT02404805|450285794|FG002|Overall Study|Withdrawal by Subject|0|||
125181813|NCT02404805|450285795|FG003|Overall Study|Withdrawal by Subject|0|||
125181814|NCT02404805|450285796|FG004|Overall Study|Withdrawal by Subject|0|||
125181815|NCT02404805|450285797|FG005|Overall Study|Withdrawal by Subject|0|||
125181816|NCT02601014|450285799|FG000|Overall Study|Adverse Event|3|||
125181817|NCT02601014|450285800|FG001|Overall Study|Adverse Event|3|||
125181818|NCT02601014|450285799|FG000|Overall Study|Death|3|||
125181819|NCT02601014|450285800|FG001|Overall Study|Death|1|||
125181820|NCT02601014|450285799|FG000|Overall Study|Disease progression|4|||
125181821|NCT02601014|450285800|FG001|Overall Study|Disease progression|8|||
125181822|NCT01168427|450285801|FG000|Overall Study|Patient exited prior to implant|1|||
125181823|NCT02456740|450285802|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
125181824|NCT02456740|450285803|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
125181825|NCT02456740|450285804|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
125181826|NCT02456740|450285805|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
125181827|NCT02456740|450285806|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
125181828|NCT02456740|450285807|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
125181829|NCT02456740|450285808|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
125181830|NCT02456740|450285809|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
125181831|NCT02456740|450285810|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
125236872|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
125236873|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
125236874|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
125236875|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
125236876|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
125236877|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
125236878|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
125236879|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
125236880|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
125236881|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
125236882|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
125236883|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
125236884|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
125236885|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
125236886|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
125236887|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
125236888|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
125236889|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
125236890|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
125236891|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
125236892|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
125236893|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
125236894|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
125236895|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
125236896|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
125236897|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
125236898|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
125236899|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
125236900|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
125236901|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
125236902|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
125236903|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
125236904|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
125236905|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
125236906|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
125236907|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
125236908|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
125236909|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
125236910|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
125236911|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
125236912|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
125236913|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
125236914|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
125236915|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
125236916|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
125236917|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
125236918|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
125236919|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
125236920|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
125236921|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
125236922|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
125236923|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
125236924|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
125236925|NCT03329001|450495982|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
125236926|NCT03329001|450495983|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
125236927|NCT03329001|450495984|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
125236928|NCT03329001|450495985|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
125236929|NCT03329001|450495986|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
125236930|NCT03329001|450495987|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
125236931|NCT03329001|450495988|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
125181832|NCT02456740|450285802|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
125181833|NCT02456740|450285803|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
125181834|NCT02456740|450285804|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
125181835|NCT02456740|450285805|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
125181836|NCT02456740|450285806|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
125181837|NCT02456740|450285807|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
125181838|NCT02456740|450285808|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
125181839|NCT02456740|450285809|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
125181840|NCT02456740|450285810|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
125181841|NCT02456740|450285802|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
125181842|NCT02456740|450285803|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
125181843|NCT02456740|450285804|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
125181844|NCT02456740|450285805|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
125181845|NCT02456740|450285806|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
125181846|NCT02456740|450285807|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
125181847|NCT02456740|450285808|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
125181848|NCT02456740|450285809|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
125181849|NCT02456740|450285810|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
125181850|NCT02456740|450285802|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
125181851|NCT02456740|450285803|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
125181852|NCT02456740|450285804|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
125181853|NCT02456740|450285805|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
125181854|NCT02456740|450285806|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
125181855|NCT02456740|450285807|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
125181856|NCT02456740|450285808|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
125181857|NCT02456740|450285809|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
125181858|NCT02456740|450285810|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
125181859|NCT02456740|450285802|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
125181860|NCT02456740|450285803|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
125181861|NCT02456740|450285804|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
125181862|NCT02456740|450285805|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
125181863|NCT02456740|450285806|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
125181864|NCT02456740|450285807|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
125181865|NCT02456740|450285808|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
125181866|NCT02456740|450285809|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
125181867|NCT02456740|450285810|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
125181868|NCT02456740|450285802|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
125181869|NCT02456740|450285803|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
125181870|NCT02456740|450285804|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
125181871|NCT02456740|450285805|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
125181872|NCT02456740|450285806|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
125181873|NCT02456740|450285807|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
125181874|NCT02456740|450285808|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
125181875|NCT02456740|450285809|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
125181876|NCT02456740|450285810|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
125181877|NCT02456740|450285802|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
125181878|NCT02456740|450285803|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
125181879|NCT02456740|450285804|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
125181880|NCT02456740|450285805|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
125181881|NCT02456740|450285806|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
125181882|NCT02456740|450285807|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
125181883|NCT02456740|450285808|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
125181884|NCT02456740|450285809|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
125181885|NCT02456740|450285810|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
125181886|NCT04871776|450285812|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
125181887|NCT04871776|450285813|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
125181888|NCT04871776|450285814|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
125181889|NCT04871776|450285812|FG000|Overall Study|Did not meet eligibility criteria|1|||
125181890|NCT04871776|450285813|FG001|Overall Study|Did not meet eligibility criteria|1|||
125181891|NCT04871776|450285814|FG002|Overall Study|Did not meet eligibility criteria|1|||
125181892|NCT04075487|450287683|FG000|Overall Study|Withdrawal by Subject|1|||
125236932|NCT03329001|450495989|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
125236933|NCT03329001|450495982|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
125236934|NCT03329001|450495983|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
125236935|NCT03329001|450495984|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
125236936|NCT03329001|450495985|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
125236937|NCT03329001|450495986|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
125236938|NCT03329001|450495987|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
125236939|NCT03329001|450495988|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
125236940|NCT03329001|450495989|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
125236941|NCT03329001|450495982|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
125236942|NCT03329001|450495983|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
125236943|NCT03329001|450495984|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
125236944|NCT03329001|450495985|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
125236945|NCT03329001|450495986|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
125236946|NCT03329001|450495987|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
125236947|NCT03329001|450495988|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
125236948|NCT03329001|450495989|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
125236949|NCT03329001|450495982|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
125236950|NCT03329001|450495983|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
125236951|NCT03329001|450495984|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
125236952|NCT03329001|450495985|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
125236953|NCT03329001|450495986|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
125236954|NCT03329001|450495987|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
125181893|NCT02848001|450287686|FG000|Overall Study|other reasons|0|||
125181894|NCT02848001|450287687|FG001|Overall Study|other reasons|0|||
125181895|NCT02848001|450287688|FG002|Overall Study|other reasons|1|||
125181896|NCT02848001|450287689|FG003|Overall Study|other reasons|0|||
125181897|NCT02848001|450287690|FG004|Overall Study|other reasons|4|||
125181898|NCT02848001|450287691|FG005|Overall Study|other reasons|1|||
125181899|NCT02848001|450287692|FG006|Overall Study|other reasons|0|||
125181900|NCT02848001|450287693|FG007|Overall Study|other reasons|2|||
125181901|NCT02848001|450287694|FG008|Overall Study|other reasons|2|||
125181902|NCT02848001|450287695|FG009|Overall Study|other reasons|3|||
125181903|NCT02848001|450287696|FG010|Overall Study|other reasons|0|||
125181904|NCT02848001|450287697|FG011|Overall Study|other reasons|1|||
125181905|NCT02848001|450287698|FG012|Overall Study|other reasons|1|||
125181906|NCT02848001|450287699|FG013|Overall Study|other reasons|0|||
125181907|NCT02848001|450287700|FG014|Overall Study|other reasons|0|||
125181908|NCT02848001|450287701|FG015|Overall Study|other reasons|2|||
125181909|NCT02848001|450287702|FG016|Overall Study|other reasons|1|||
125181910|NCT02848001|450287686|FG000|Overall Study|Lack of Efficacy|0|||
125181911|NCT02848001|450287687|FG001|Overall Study|Lack of Efficacy|1|||
125181912|NCT02848001|450287688|FG002|Overall Study|Lack of Efficacy|1|||
125181913|NCT02848001|450287689|FG003|Overall Study|Lack of Efficacy|2|||
125181914|NCT02848001|450287690|FG004|Overall Study|Lack of Efficacy|3|||
125181915|NCT02848001|450287691|FG005|Overall Study|Lack of Efficacy|0|||
125181916|NCT02848001|450287692|FG006|Overall Study|Lack of Efficacy|1|||
125181917|NCT02848001|450287693|FG007|Overall Study|Lack of Efficacy|0|||
125181918|NCT02848001|450287694|FG008|Overall Study|Lack of Efficacy|0|||
125181919|NCT02848001|450287695|FG009|Overall Study|Lack of Efficacy|1|||
125181920|NCT02848001|450287696|FG010|Overall Study|Lack of Efficacy|0|||
125181921|NCT02848001|450287697|FG011|Overall Study|Lack of Efficacy|2|||
125181922|NCT02848001|450287698|FG012|Overall Study|Lack of Efficacy|0|||
125181923|NCT02848001|450287699|FG013|Overall Study|Lack of Efficacy|2|||
125181924|NCT02848001|450287700|FG014|Overall Study|Lack of Efficacy|2|||
125181925|NCT02848001|450287701|FG015|Overall Study|Lack of Efficacy|0|||
125181926|NCT02848001|450287702|FG016|Overall Study|Lack of Efficacy|0|||
125181927|NCT02848001|450287686|FG000|Overall Study|Progressive Disease|2|||
125181928|NCT02848001|450287687|FG001|Overall Study|Progressive Disease|1|||
125181929|NCT02848001|450287688|FG002|Overall Study|Progressive Disease|0|||
125181930|NCT02848001|450287689|FG003|Overall Study|Progressive Disease|4|||
125181931|NCT02848001|450287690|FG004|Overall Study|Progressive Disease|3|||
125181932|NCT02848001|450287691|FG005|Overall Study|Progressive Disease|0|||
125181933|NCT02848001|450287692|FG006|Overall Study|Progressive Disease|4|||
125181934|NCT02848001|450287693|FG007|Overall Study|Progressive Disease|1|||
125181935|NCT02848001|450287694|FG008|Overall Study|Progressive Disease|0|||
125181936|NCT02848001|450287695|FG009|Overall Study|Progressive Disease|2|||
125181937|NCT02848001|450287696|FG010|Overall Study|Progressive Disease|3|||
125181938|NCT02848001|450287697|FG011|Overall Study|Progressive Disease|2|||
125181939|NCT02848001|450287698|FG012|Overall Study|Progressive Disease|1|||
125181940|NCT02848001|450287699|FG013|Overall Study|Progressive Disease|0|||
125181941|NCT02848001|450287700|FG014|Overall Study|Progressive Disease|2|||
125236955|NCT03329001|450495988|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
125236956|NCT03329001|450495989|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
125236957|NCT03329001|450495982|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
125236958|NCT03329001|450495983|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
125236959|NCT03329001|450495984|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
125236960|NCT03329001|450495985|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
125236961|NCT03329001|450495986|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
125236962|NCT03329001|450495987|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
125236963|NCT03329001|450495988|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
125236964|NCT03329001|450495989|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
125236965|NCT03329001|450495982|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
125236966|NCT03329001|450495983|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
125236967|NCT03329001|450495984|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
125236968|NCT03329001|450495985|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
125236969|NCT03329001|450495986|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
125236970|NCT03329001|450495987|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
125236971|NCT03329001|450495988|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
125236972|NCT03329001|450495989|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
125236973|NCT03329001|450495982|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
125236974|NCT03329001|450495983|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
125236975|NCT03329001|450495984|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
125236976|NCT03329001|450495985|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
125236977|NCT03329001|450495986|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
125236978|NCT03329001|450495987|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
125236979|NCT03329001|450495988|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
125236980|NCT03329001|450495989|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
125236981|NCT03329001|450495982|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
125236982|NCT03329001|450495983|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
125236983|NCT03329001|450495984|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
125236984|NCT03329001|450495985|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
125236985|NCT03329001|450495986|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
125236986|NCT03329001|450495987|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
125236987|NCT03329001|450495988|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
125236988|NCT03329001|450495989|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
125236989|NCT03329001|450495982|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
125236990|NCT03329001|450495983|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
125236991|NCT03329001|450495984|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
125236992|NCT03329001|450495985|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
125236993|NCT03329001|450495986|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
125236994|NCT03329001|450495987|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
125236995|NCT03329001|450495988|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
125236996|NCT03329001|450495989|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
125236997|NCT03329001|450495982|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
125236998|NCT03329001|450495983|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
125236999|NCT03329001|450495984|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
125237000|NCT03329001|450495985|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
125237001|NCT03329001|450495986|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
125237002|NCT03329001|450495987|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
125237003|NCT03329001|450495988|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
125237004|NCT03329001|450495989|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
125237005|NCT03329001|450495982|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
125237006|NCT03329001|450495983|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
125237007|NCT03329001|450495984|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
125237008|NCT03329001|450495985|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
125237009|NCT03329001|450495986|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
125237010|NCT03329001|450495987|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
125237011|NCT03329001|450495988|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
125237012|NCT03329001|450495989|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
125237013|NCT03329001|450495982|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
125237014|NCT03329001|450495983|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
125181942|NCT02848001|450287701|FG015|Overall Study|Progressive Disease|4|||
125181943|NCT02848001|450287702|FG016|Overall Study|Progressive Disease|0|||
125181944|NCT02848001|450287686|FG000|Overall Study|Adverse Event|0|||
125181945|NCT02848001|450287687|FG001|Overall Study|Adverse Event|0|||
125181946|NCT02848001|450287688|FG002|Overall Study|Adverse Event|0|||
125181947|NCT02848001|450287689|FG003|Overall Study|Adverse Event|0|||
125181948|NCT02848001|450287690|FG004|Overall Study|Adverse Event|2|||
125181949|NCT02848001|450287691|FG005|Overall Study|Adverse Event|0|||
125181950|NCT02848001|450287692|FG006|Overall Study|Adverse Event|0|||
125181951|NCT02848001|450287693|FG007|Overall Study|Adverse Event|0|||
125181952|NCT02848001|450287694|FG008|Overall Study|Adverse Event|0|||
125181953|NCT02848001|450287695|FG009|Overall Study|Adverse Event|1|||
125181954|NCT02848001|450287696|FG010|Overall Study|Adverse Event|0|||
125181955|NCT02848001|450287697|FG011|Overall Study|Adverse Event|1|||
125181956|NCT02848001|450287698|FG012|Overall Study|Adverse Event|1|||
125181957|NCT02848001|450287699|FG013|Overall Study|Adverse Event|0|||
125181958|NCT02848001|450287700|FG014|Overall Study|Adverse Event|2|||
125181959|NCT02848001|450287701|FG015|Overall Study|Adverse Event|0|||
125181960|NCT02848001|450287702|FG016|Overall Study|Adverse Event|0|||
125181961|NCT02848001|450287686|FG000|Overall Study|Death|0|||
125181962|NCT02848001|450287687|FG001|Overall Study|Death|0|||
125181963|NCT02848001|450287688|FG002|Overall Study|Death|0|||
125181964|NCT02848001|450287689|FG003|Overall Study|Death|1|||
125181965|NCT02848001|450287690|FG004|Overall Study|Death|3|||
125181966|NCT02848001|450287691|FG005|Overall Study|Death|1|||
125181967|NCT02848001|450287692|FG006|Overall Study|Death|2|||
125181968|NCT02848001|450287693|FG007|Overall Study|Death|3|||
125181969|NCT02848001|450287694|FG008|Overall Study|Death|4|||
125181970|NCT02848001|450287695|FG009|Overall Study|Death|1|||
125181971|NCT02848001|450287696|FG010|Overall Study|Death|0|||
125181972|NCT02848001|450287697|FG011|Overall Study|Death|1|||
125181973|NCT02848001|450287698|FG012|Overall Study|Death|3|||
125181974|NCT02848001|450287699|FG013|Overall Study|Death|0|||
125181975|NCT02848001|450287700|FG014|Overall Study|Death|2|||
125181976|NCT02848001|450287701|FG015|Overall Study|Death|3|||
125181977|NCT02848001|450287702|FG016|Overall Study|Death|0|||
125181978|NCT02848001|450287686|FG000|Overall Study|Physician Decision|0|||
125181979|NCT02848001|450287687|FG001|Overall Study|Physician Decision|0|||
125181980|NCT02848001|450287688|FG002|Overall Study|Physician Decision|0|||
125181981|NCT02848001|450287689|FG003|Overall Study|Physician Decision|0|||
125181982|NCT02848001|450287690|FG004|Overall Study|Physician Decision|0|||
125181983|NCT02848001|450287691|FG005|Overall Study|Physician Decision|0|||
125181984|NCT02848001|450287692|FG006|Overall Study|Physician Decision|0|||
125181985|NCT02848001|450287693|FG007|Overall Study|Physician Decision|0|||
125181986|NCT02848001|450287694|FG008|Overall Study|Physician Decision|1|||
125181987|NCT02848001|450287695|FG009|Overall Study|Physician Decision|1|||
125181988|NCT02848001|450287696|FG010|Overall Study|Physician Decision|0|||
125181989|NCT02848001|450287697|FG011|Overall Study|Physician Decision|0|||
125181990|NCT02848001|450287698|FG012|Overall Study|Physician Decision|2|||
125181991|NCT02848001|450287699|FG013|Overall Study|Physician Decision|0|||
125181992|NCT02848001|450287700|FG014|Overall Study|Physician Decision|0|||
125181993|NCT02848001|450287701|FG015|Overall Study|Physician Decision|0|||
125181994|NCT02848001|450287702|FG016|Overall Study|Physician Decision|0|||
125181995|NCT02848001|450287686|FG000|Overall Study|Withdrawal by Subject|0|||
125181996|NCT02848001|450287687|FG001|Overall Study|Withdrawal by Subject|0|||
125181997|NCT02848001|450287688|FG002|Overall Study|Withdrawal by Subject|0|||
125181998|NCT02848001|450287689|FG003|Overall Study|Withdrawal by Subject|0|||
125181999|NCT02848001|450287690|FG004|Overall Study|Withdrawal by Subject|0|||
125182000|NCT02848001|450287691|FG005|Overall Study|Withdrawal by Subject|1|||
125303081|NCT03100058|450736669|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
125182001|NCT02848001|450287692|FG006|Overall Study|Withdrawal by Subject|1|||
125182002|NCT02848001|450287693|FG007|Overall Study|Withdrawal by Subject|1|||
125182003|NCT02848001|450287694|FG008|Overall Study|Withdrawal by Subject|0|||
125182004|NCT02848001|450287695|FG009|Overall Study|Withdrawal by Subject|0|||
125182005|NCT02848001|450287696|FG010|Overall Study|Withdrawal by Subject|0|||
125182006|NCT02848001|450287697|FG011|Overall Study|Withdrawal by Subject|0|||
125182007|NCT02848001|450287698|FG012|Overall Study|Withdrawal by Subject|0|||
125182008|NCT02848001|450287699|FG013|Overall Study|Withdrawal by Subject|0|||
125182009|NCT02848001|450287700|FG014|Overall Study|Withdrawal by Subject|0|||
125182010|NCT02848001|450287701|FG015|Overall Study|Withdrawal by Subject|0|||
125182011|NCT02848001|450287702|FG016|Overall Study|Withdrawal by Subject|0|||
125182012|NCT00725283|450287705|FG000|Overall Study|Missing Code|3|||
125182013|NCT00725283|450287705|FG000|Overall Study|Death|5|||
125182014|NCT00725283|450287705|FG000|Overall Study|Other|6|||
125182015|NCT00725283|450287705|FG000|Overall Study|Withdrawal by Subject|10|||
125182016|NCT02115269|450287706|FG000|Overall Study|Lost to Follow-up|43|||
125182017|NCT02115269|450287706|FG000|Overall Study|Did not complete patient diary|3|||
125182018|NCT02115269|450287706|FG000|Overall Study|Moved to another city|7|||
125182019|NCT02115269|450287706|FG000|Overall Study|Withdrawal by Subject|2|||
125182020|NCT02115269|450287706|FG000|Overall Study|Didn't take study drug|2|||
125182021|NCT01402570|450287707|FG000|Overall Study|Adverse Event|1|||
125237015|NCT03329001|450495984|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
125237016|NCT03329001|450495985|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
125237017|NCT03329001|450495986|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
125237018|NCT03329001|450495987|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
125237019|NCT03329001|450495988|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
125237020|NCT03329001|450495989|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
125237021|NCT03329001|450495982|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
125237022|NCT03329001|450495983|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
125237023|NCT03329001|450495984|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
125237024|NCT03329001|450495985|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
125237025|NCT03329001|450495986|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
125237026|NCT03329001|450495987|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
125237027|NCT03329001|450495988|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
125237028|NCT03329001|450495989|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
125237029|NCT03329001|450495982|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
125237030|NCT03329001|450495983|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
125237031|NCT03329001|450495984|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
125237032|NCT03329001|450495985|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
125237033|NCT03329001|450495986|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
125237034|NCT03329001|450495987|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
125237035|NCT03329001|450495988|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
125237036|NCT03329001|450495989|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
125237037|NCT03329001|450495982|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
125237038|NCT03329001|450495983|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
125237039|NCT03329001|450495984|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
125237040|NCT03329001|450495985|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
125237041|NCT03329001|450495986|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
125237042|NCT03329001|450495987|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
125237043|NCT03329001|450495988|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
125237044|NCT03329001|450495989|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
125237045|NCT03329001|450495982|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
125237046|NCT03329001|450495983|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
125237047|NCT03329001|450495984|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
125237048|NCT03329001|450495985|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
125237049|NCT03329001|450495986|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
125237050|NCT03329001|450495987|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
125237051|NCT03329001|450495988|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
125237052|NCT03329001|450495989|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
125237053|NCT02178956|450495990|FG000|Overall Study|Lost to Follow-up|4|||
125237054|NCT02178956|450495991|FG001|Overall Study|Lost to Follow-up|4|||
125237055|NCT02178956|450495990|FG000|Overall Study|Sponsor terminated study|49|||
125237056|NCT02178956|450495991|FG001|Overall Study|Sponsor terminated study|58|||
125237057|NCT02178956|450495990|FG000|Overall Study|Withdrawal by Subject|15|||
125237058|NCT02178956|450495991|FG001|Overall Study|Withdrawal by Subject|11|||
125237059|NCT02178956|450495990|FG000|Overall Study|Various Reasons|3|||
125237060|NCT02178956|450495991|FG001|Overall Study|Various Reasons|5|||
125237061|NCT01138046|450495992|FG000|Overall Study|Withdrawal due to death|6|||
125237062|NCT02709369|450495994|FG000|Overall Study|Lost to Follow-up|15|||
125237063|NCT02709369|450495994|FG000|Overall Study|Withdrawal by Subject|10|||
125237064|NCT02709369|450495994|FG000|Overall Study|Did not received intervention|2|||
125237065|NCT01900314|450495995|FG000|Overall Study|Lost to Follow-up|1|||
125237066|NCT01900314|450495996|FG001|Overall Study|Lost to Follow-up|0|||
125237067|NCT01900314|450495995|FG000|Overall Study|Protocol Violation|0|||
125237068|NCT01900314|450495996|FG001|Overall Study|Protocol Violation|1|||
125237069|NCT01900314|450495995|FG000|Overall Study|Withdrawal by Subject|3|||
125237070|NCT01900314|450495996|FG001|Overall Study|Withdrawal by Subject|3|||
125237071|NCT01104766|450495998|FG000|Overall Study|Did not meet inc/exc criteria|1|||
125237072|NCT01104766|450495999|FG001|Overall Study|Did not meet inc/exc criteria|0|||
125237073|NCT01104766|450496000|FG002|Overall Study|Did not meet inc/exc criteria|0|||
125237074|NCT01104766|450496001|FG003|Overall Study|Did not meet inc/exc criteria|0|||
125237075|NCT01104766|450495998|FG000|Overall Study|Adverse Event|17|||
125237076|NCT01104766|450495999|FG001|Overall Study|Adverse Event|15|||
125237077|NCT01104766|450496000|FG002|Overall Study|Adverse Event|20|||
125237078|NCT01104766|450496001|FG003|Overall Study|Adverse Event|14|||
125237079|NCT01104766|450495998|FG000|Overall Study|Lack of Efficacy|20|||
125237080|NCT01104766|450495999|FG001|Overall Study|Lack of Efficacy|15|||
125237081|NCT01104766|450496000|FG002|Overall Study|Lack of Efficacy|14|||
125237082|NCT01104766|450496001|FG003|Overall Study|Lack of Efficacy|8|||
125237083|NCT01104766|450495998|FG000|Overall Study|Protocol Violation|2|||
125237084|NCT01104766|450495999|FG001|Overall Study|Protocol Violation|0|||
125237085|NCT01104766|450496000|FG002|Overall Study|Protocol Violation|0|||
125237086|NCT01104766|450496001|FG003|Overall Study|Protocol Violation|0|||
125237087|NCT01104766|450495998|FG000|Overall Study|Withdrawal by Subject|17|||
125237088|NCT01104766|450495999|FG001|Overall Study|Withdrawal by Subject|19|||
125237089|NCT01104766|450496000|FG002|Overall Study|Withdrawal by Subject|25|||
125237090|NCT01104766|450496001|FG003|Overall Study|Withdrawal by Subject|15|||
125237091|NCT01104766|450495998|FG000|Overall Study|Lost to Follow-up|1|||
125237092|NCT01104766|450495999|FG001|Overall Study|Lost to Follow-up|2|||
125237093|NCT01104766|450496000|FG002|Overall Study|Lost to Follow-up|1|||
125237094|NCT01104766|450496001|FG003|Overall Study|Lost to Follow-up|1|||
125237095|NCT01341470|450496002|FG000|Overall Study|Sponsor decision|0|||
125237096|NCT01341470|450496003|FG001|Overall Study|Sponsor decision|0|||
125237097|NCT01341470|450496004|FG002|Overall Study|Sponsor decision|1|||
125237098|NCT01341470|450496005|FG003|Overall Study|Sponsor decision|1|||
125237099|NCT01341470|450496006|FG004|Overall Study|Sponsor decision|0|||
125237100|NCT01341470|450496007|FG005|Overall Study|Sponsor decision|1|||
125237101|NCT04225832|450496009|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
125237102|NCT04225832|450496010|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
125237103|NCT04225832|450496009|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
125237104|NCT04225832|450496010|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
125237105|NCT00311168|450496011|FG000|First Intervention|Withdrawal by Subject|2|||
125237106|NCT00311168|450496012|FG001|First Intervention|Withdrawal by Subject|2|||
125237107|NCT00311168|450496011|FG000|First Intervention|Lost to Follow-up|1|||
125237108|NCT00311168|450496012|FG001|First Intervention|Lost to Follow-up|1|||
125237109|NCT00311168|450496011|FG000|First Intervention|Protocol Violation|1|||
125237110|NCT00311168|450496012|FG001|First Intervention|Protocol Violation|1|||
125237111|NCT00311168|450496011|FG000|First Intervention|Adverse Event|1|||
125237112|NCT00311168|450496012|FG001|First Intervention|Adverse Event|0|||
125237113|NCT00311168|450496011|FG000|First Intervention|Other|2|||
125237114|NCT00311168|450496012|FG001|First Intervention|Other|2|||
125237115|NCT00311168|450496011|FG000|Second Intervention|Lost to Follow-up|9|||
125237116|NCT00311168|450496012|FG001|Second Intervention|Lost to Follow-up|2|||
125237117|NCT00311168|450496011|FG000|Second Intervention|Withdrawal by Subject|0|||
125237118|NCT00311168|450496012|FG001|Second Intervention|Withdrawal by Subject|1|||
125237119|NCT00311168|450496011|FG000|Second Intervention|Other|1|||
125237120|NCT00311168|450496012|FG001|Second Intervention|Other|1|||
125237121|NCT03965923|450496015|FG000|Overall Study|Withdrawal by Subject|1|||
125237122|NCT03965923|450496016|FG001|Overall Study|Withdrawal by Subject|2|||
125237123|NCT03965923|450496017|FG002|Overall Study|Withdrawal by Subject|3|||
125237124|NCT03965923|450496018|FG003|Overall Study|Withdrawal by Subject|1|||
125237125|NCT03965923|450496019|FG004|Overall Study|Withdrawal by Subject|2|||
125237126|NCT03965923|450496020|FG005|Overall Study|Withdrawal by Subject|0|||
125237127|NCT03965923|450496021|FG006|Overall Study|Withdrawal by Subject|4|||
125237128|NCT03965923|450496022|FG007|Overall Study|Withdrawal by Subject|3|||
125237129|NCT03965923|450496023|FG008|Overall Study|Withdrawal by Subject|4|||
125237130|NCT03965923|450496024|FG009|Overall Study|Withdrawal by Subject|0|||
125237131|NCT03965923|450496025|FG010|Overall Study|Withdrawal by Subject|2|||
125237132|NCT03965923|450496026|FG011|Overall Study|Withdrawal by Subject|0|||
125237133|NCT03965923|450496015|FG000|Overall Study|Lost to Follow-up|2|||
125237134|NCT03965923|450496016|FG001|Overall Study|Lost to Follow-up|1|||
125237135|NCT03965923|450496017|FG002|Overall Study|Lost to Follow-up|1|||
125237136|NCT03965923|450496018|FG003|Overall Study|Lost to Follow-up|0|||
125237137|NCT03965923|450496019|FG004|Overall Study|Lost to Follow-up|2|||
125237138|NCT03965923|450496020|FG005|Overall Study|Lost to Follow-up|1|||
125237139|NCT03965923|450496021|FG006|Overall Study|Lost to Follow-up|2|||
125237140|NCT03965923|450496022|FG007|Overall Study|Lost to Follow-up|1|||
125237141|NCT03965923|450496023|FG008|Overall Study|Lost to Follow-up|0|||
125237142|NCT03965923|450496024|FG009|Overall Study|Lost to Follow-up|2|||
125237143|NCT03965923|450496025|FG010|Overall Study|Lost to Follow-up|0|||
125237144|NCT03965923|450496026|FG011|Overall Study|Lost to Follow-up|0|||
125237145|NCT03965923|450496015|FG000|Overall Study|Death|0|||
125237146|NCT03965923|450496016|FG001|Overall Study|Death|0|||
125237147|NCT03965923|450496017|FG002|Overall Study|Death|0|||
125237148|NCT03965923|450496018|FG003|Overall Study|Death|0|||
125237149|NCT03965923|450496019|FG004|Overall Study|Death|0|||
125237150|NCT03965923|450496020|FG005|Overall Study|Death|0|||
125237151|NCT03965923|450496021|FG006|Overall Study|Death|0|||
125237152|NCT03965923|450496022|FG007|Overall Study|Death|1|||
125237153|NCT03965923|450496023|FG008|Overall Study|Death|4|||
125237154|NCT03965923|450496024|FG009|Overall Study|Death|0|||
125237155|NCT03965923|450496025|FG010|Overall Study|Death|4|||
125237156|NCT03965923|450496026|FG011|Overall Study|Death|0|||
125237157|NCT03965923|450496015|FG000|Overall Study|Other reason|0|||
125237158|NCT03965923|450496016|FG001|Overall Study|Other reason|0|||
125237159|NCT03965923|450496017|FG002|Overall Study|Other reason|0|||
125237160|NCT03965923|450496018|FG003|Overall Study|Other reason|1|||
125182022|NCT04179838|450287714|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
125182023|NCT04179838|450287715|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
125182024|NCT04179838|450287714|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
125182025|NCT04179838|450287715|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
125182026|NCT01290068|450287720|FG000|Overall Study|Adverse Event|1|||
125182027|NCT01290068|450287721|FG001|Overall Study|Adverse Event|3|||
125182028|NCT01290068|450287720|FG000|Overall Study|Lost to Follow-up|3|||
125182029|NCT01290068|450287721|FG001|Overall Study|Lost to Follow-up|0|||
125182030|NCT01290068|450287720|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
125182031|NCT01290068|450287721|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
125182032|NCT01290068|450287720|FG000|Overall Study|Other|3|||
125182033|NCT01290068|450287721|FG001|Overall Study|Other|1|||
125182034|NCT00513695|450287722|FG000|Overall Study|Discontinued therapy|2|||
125182035|NCT00513695|450287722|FG000|Overall Study|Progression prior to surgery|3|||
125182036|NCT01417156|450287728|FG000|Overall Study|Adverse Event|12|||
125182037|NCT01417156|450287728|FG000|Overall Study|Protocol Violation|2|||
125182038|NCT00818766|450287729|FG000|Overall Study|Could not be Contacted on Day 28|11|||
125182039|NCT00818766|450287730|FG001|Overall Study|Could not be Contacted on Day 28|10|||
125182040|NCT00818766|450287729|FG000|Overall Study|Death|1|||
125182041|NCT00818766|450287730|FG001|Overall Study|Death|0|||
125182042|NCT00818766|450287729|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
125182043|NCT00818766|450287730|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
125182044|NCT01996241|450287731|FG000|Overall Study|Lost to Follow-up|252|||
125182045|NCT01996241|450287732|FG001|Overall Study|Lost to Follow-up|235|||
125182046|NCT00086684|450287733|FG000|Overall Study|Adverse Event|12|||
125182047|NCT00086684|450287734|FG001|Overall Study|Adverse Event|17|||
125182048|NCT00086684|450287735|FG002|Overall Study|Adverse Event|14|||
125182049|NCT00086684|450287733|FG000|Overall Study|Lack of Efficacy|6|||
125182050|NCT00086684|450287734|FG001|Overall Study|Lack of Efficacy|6|||
125182051|NCT00086684|450287735|FG002|Overall Study|Lack of Efficacy|5|||
125182052|NCT00086684|450287733|FG000|Overall Study|Lost to Follow-up|15|||
125182053|NCT00086684|450287734|FG001|Overall Study|Lost to Follow-up|8|||
125182054|NCT00086684|450287735|FG002|Overall Study|Lost to Follow-up|10|||
125182055|NCT00086684|450287733|FG000|Overall Study|Protocol Violation|8|||
125182056|NCT00086684|450287734|FG001|Overall Study|Protocol Violation|3|||
125182057|NCT00086684|450287735|FG002|Overall Study|Protocol Violation|0|||
125182058|NCT00086684|450287733|FG000|Overall Study|Withdrawal by Subject|0|||
125182059|NCT00086684|450287734|FG001|Overall Study|Withdrawal by Subject|4|||
125182060|NCT00086684|450287735|FG002|Overall Study|Withdrawal by Subject|10|||
125182061|NCT00086684|450287733|FG000|Overall Study|NONCOMPLIANCE|5|||
125182062|NCT00086684|450287734|FG001|Overall Study|NONCOMPLIANCE|7|||
125182063|NCT00086684|450287735|FG002|Overall Study|NONCOMPLIANCE|6|||
125182064|NCT00086684|450287733|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
125182065|NCT00086684|450287734|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
125182066|NCT00086684|450287735|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
125182067|NCT00086684|450287733|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
125182068|NCT00086684|450287734|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
125182069|NCT00086684|450287735|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
125182070|NCT00086684|450287733|FG000|Overall Study|Other|4|||
125182071|NCT00086684|450287734|FG001|Overall Study|Other|2|||
125182072|NCT00086684|450287735|FG002|Overall Study|Other|3|||
125182073|NCT04515147|450287737|FG000|Overall Study|Withdrawal by Subject|1|||
125182074|NCT04515147|450287738|FG001|Overall Study|Withdrawal by Subject|0|||
125182075|NCT04515147|450287739|FG002|Overall Study|Withdrawal by Subject|10|||
125182076|NCT04515147|450287740|FG003|Overall Study|Withdrawal by Subject|18|||
125182077|NCT04515147|450287741|FG004|Overall Study|Withdrawal by Subject|1|||
125182078|NCT04515147|450287742|FG005|Overall Study|Withdrawal by Subject|8|||
125182079|NCT04515147|450287737|FG000|Overall Study|Lost to Follow-up|0|||
125182080|NCT04515147|450287738|FG001|Overall Study|Lost to Follow-up|1|||
125182081|NCT04515147|450287739|FG002|Overall Study|Lost to Follow-up|5|||
125182082|NCT04515147|450287740|FG003|Overall Study|Lost to Follow-up|6|||
125182083|NCT04515147|450287741|FG004|Overall Study|Lost to Follow-up|2|||
125182084|NCT04515147|450287742|FG005|Overall Study|Lost to Follow-up|1|||
125182085|NCT04515147|450287737|FG000|Overall Study|Adverse Event|0|||
125182086|NCT04515147|450287738|FG001|Overall Study|Adverse Event|0|||
125182087|NCT04515147|450287739|FG002|Overall Study|Adverse Event|0|||
125237161|NCT03965923|450496019|FG004|Overall Study|Other reason|0|||
125182088|NCT04515147|450287740|FG003|Overall Study|Adverse Event|2|||
125182089|NCT04515147|450287741|FG004|Overall Study|Adverse Event|0|||
125182090|NCT04515147|450287742|FG005|Overall Study|Adverse Event|0|||
125182091|NCT04515147|450287737|FG000|Overall Study|Miscellaneous|0|||
125182092|NCT04515147|450287738|FG001|Overall Study|Miscellaneous|0|||
125182093|NCT04515147|450287739|FG002|Overall Study|Miscellaneous|0|||
125182094|NCT04515147|450287740|FG003|Overall Study|Miscellaneous|1|||
125182095|NCT04515147|450287741|FG004|Overall Study|Miscellaneous|0|||
125182096|NCT04515147|450287742|FG005|Overall Study|Miscellaneous|1|||
125182097|NCT02094300|450287743|FG000|Overall Study|Death|7|||
125182098|NCT02094300|450287743|FG000|Overall Study|Lost to Follow-up|10|||
125237162|NCT03965923|450496020|FG005|Overall Study|Other reason|0|||
125237163|NCT03965923|450496021|FG006|Overall Study|Other reason|0|||
125237164|NCT03965923|450496022|FG007|Overall Study|Other reason|0|||
125237165|NCT03965923|450496023|FG008|Overall Study|Other reason|0|||
125237166|NCT03965923|450496024|FG009|Overall Study|Other reason|0|||
125237167|NCT03965923|450496025|FG010|Overall Study|Other reason|2|||
125237168|NCT03965923|450496026|FG011|Overall Study|Other reason|0|||
125237169|NCT03282097|450496027|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
125237170|NCT03282097|450496028|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
125237171|NCT03282097|450496027|FG000|Intervention Visit Complete|Patient Death|13|||
125237172|NCT03282097|450496028|FG001|Intervention Visit Complete|Patient Death|15|||
125237173|NCT03282097|450496027|FG000|Intervention Visit Complete|Caregiver Death|0|||
125237174|NCT03282097|450496028|FG001|Intervention Visit Complete|Caregiver Death|3|||
125237175|NCT03282097|450496027|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
125237176|NCT03282097|450496028|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
125237177|NCT03282097|450496027|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
125237178|NCT03282097|450496028|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
125237179|NCT03282097|450496027|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
125237180|NCT03282097|450496028|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
125237181|NCT03282097|450496027|FG000|Primary Outcome Data Collection Complete|Missing|2|||
125237182|NCT03282097|450496028|FG001|Primary Outcome Data Collection Complete|Missing|3|||
125237183|NCT03282097|450496027|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
125237184|NCT03282097|450496028|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
125237185|NCT03282097|450496027|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
125237186|NCT03282097|450496028|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
125237187|NCT03282097|450496027|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
125237188|NCT03282097|450496028|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
125237189|NCT06001021|450496032|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
125237190|NCT06001021|450496033|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
125237191|NCT06001021|450496034|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
125237192|NCT06001021|450496035|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
125237193|NCT06001021|450496036|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
125237194|NCT06001021|450496037|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
125237195|NCT06001021|450496038|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
125237196|NCT06001021|450496032|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
125237197|NCT06001021|450496033|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
125237198|NCT06001021|450496034|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
125237199|NCT06001021|450496035|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
125237200|NCT06001021|450496036|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
125237201|NCT06001021|450496037|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
125237202|NCT06001021|450496038|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
125237203|NCT02755090|450496039|FG000|Overall Study|equipment malfunction|1|||
125237204|NCT02755090|450496040|FG001|Overall Study|equipment malfunction|0|||
125237205|NCT04797169|450496042|FG000|Overall Study|Lost to Follow-up|84|||
125237206|NCT04797169|450496043|FG001|Overall Study|Lost to Follow-up|67|||
125237207|NCT04797169|450496042|FG000|Overall Study|Pregnancy|1|||
125237208|NCT04797169|450496043|FG001|Overall Study|Pregnancy|3|||
125237209|NCT04797169|450496042|FG000|Overall Study|Withdrawal by Subject|27|||
125237210|NCT04797169|450496043|FG001|Overall Study|Withdrawal by Subject|35|||
125237211|NCT03839641|450496052|FG000|Overall Study|Withdrawal by Subject|1|||
125182099|NCT02094300|450287743|FG000|Overall Study|Still be eligible for follow-up|3|||
125182100|NCT00942357|450287763|FG000|Overall Study|Ineligible|37|||
125182101|NCT00942357|450287764|FG001|Overall Study|Ineligible|40|||
125182102|NCT01960257|450287767|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
125182103|NCT01960257|450287768|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
125182104|NCT01960257|450287769|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
125182105|NCT01960257|450287767|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
125182106|NCT01960257|450287768|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
125182107|NCT01960257|450287769|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
125237212|NCT03839641|450496053|FG001|Overall Study|Withdrawal by Subject|1|||
125237213|NCT04221490|450496054|FG000|At 30 Days Follow-up|Death|7|||
125237214|NCT04221490|450496054|FG000|At 30 Days Follow-up|Missed Visit|4|||
125237215|NCT04221490|450496054|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
125237216|NCT04221490|450496054|FG000|At 6 Months Follow-up|Death|9|||
125237217|NCT04221490|450496054|FG000|At 6 Months Follow-up|Physician Decision|1|||
125237218|NCT04221490|450496054|FG000|At 6 Months Follow-up|Missed Visit|8|||
125182108|NCT01960257|450287767|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
125182109|NCT01960257|450287768|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
125182110|NCT01960257|450287769|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
125182111|NCT02002221|450287772|FG000|Overall Study|Adverse Event|2|||
125237219|NCT04221490|450496054|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
125237220|NCT03034967|450496055|FG000|Overall Study|Withdrawal by Subject|9|||
125237221|NCT03034967|450496056|FG001|Overall Study|Withdrawal by Subject|2|||
125237222|NCT03034967|450496057|FG002|Overall Study|Withdrawal by Subject|6|||
125237223|NCT03034967|450496058|FG003|Overall Study|Withdrawal by Subject|6|||
125237224|NCT03034967|450496059|FG004|Overall Study|Withdrawal by Subject|9|||
125237225|NCT03034967|450496060|FG005|Overall Study|Withdrawal by Subject|2|||
125237226|NCT03034967|450496055|FG000|Overall Study|Physician Decision|1|||
125237227|NCT03034967|450496056|FG001|Overall Study|Physician Decision|0|||
125237228|NCT03034967|450496057|FG002|Overall Study|Physician Decision|1|||
125237229|NCT03034967|450496058|FG003|Overall Study|Physician Decision|1|||
125237230|NCT03034967|450496059|FG004|Overall Study|Physician Decision|1|||
125237231|NCT03034967|450496060|FG005|Overall Study|Physician Decision|0|||
125237232|NCT03034967|450496055|FG000|Overall Study|Lost to Follow-up|0|||
125237233|NCT03034967|450496056|FG001|Overall Study|Lost to Follow-up|0|||
125237234|NCT03034967|450496057|FG002|Overall Study|Lost to Follow-up|0|||
125237235|NCT03034967|450496058|FG003|Overall Study|Lost to Follow-up|1|||
125237236|NCT03034967|450496059|FG004|Overall Study|Lost to Follow-up|0|||
125237237|NCT03034967|450496060|FG005|Overall Study|Lost to Follow-up|2|||
125237238|NCT03034967|450496055|FG000|Overall Study|Liver function test abnormality|0|||
125237239|NCT03034967|450496056|FG001|Overall Study|Liver function test abnormality|0|||
125237240|NCT03034967|450496057|FG002|Overall Study|Liver function test abnormality|1|||
125237241|NCT03034967|450496058|FG003|Overall Study|Liver function test abnormality|0|||
125237242|NCT03034967|450496059|FG004|Overall Study|Liver function test abnormality|0|||
125237243|NCT03034967|450496060|FG005|Overall Study|Liver function test abnormality|0|||
125237244|NCT03034967|450496055|FG000|Overall Study|Protocol Violation|1|||
125237245|NCT03034967|450496056|FG001|Overall Study|Protocol Violation|0|||
125237246|NCT03034967|450496057|FG002|Overall Study|Protocol Violation|0|||
125182112|NCT02002221|450287773|FG001|Overall Study|Adverse Event|1|||
125182113|NCT02002221|450287772|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125182114|NCT02002221|450287773|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125182115|NCT02002221|450287772|FG000|Overall Study|Patient withdrew consent|0|||
125182116|NCT02002221|450287773|FG001|Overall Study|Patient withdrew consent|1|||
125182117|NCT03347110|450287774|FG000|Overall Study|Other (Participant is incarcerated)|1|||
125182118|NCT03347110|450287774|FG000|Overall Study|Withdrawal by Subject|9|||
125182119|NCT03347110|450287774|FG000|Overall Study|Lost to Follow-up|1|||
125182120|NCT03347110|450287774|FG000|Overall Study|Lack of Efficacy|2|||
125182121|NCT03347110|450287774|FG000|Overall Study|Adverse Event, non-fatal|9|||
125182122|NCT01518322|450287775|FG000|Overall Study|FeNO measurement was missing|13|||
125182123|NCT00110396|450287780|FG000|Overall Study|Adverse Event|15|||
125182124|NCT00110396|450287780|FG000|Overall Study|Lost to Follow-up|1|||
125182125|NCT00110396|450287780|FG000|Overall Study|Administration of plasmapheresis|1|||
125182126|NCT00110396|450287780|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
125182127|NCT00110396|450287780|FG000|Overall Study|Lack of Efficacy|1|||
125182128|NCT00110396|450287780|FG000|Overall Study|Decided not to continue treatment|1|||
125182129|NCT00110396|450287780|FG000|Overall Study|Patient non-compliance|1|||
125182130|NCT00110396|450287780|FG000|Overall Study|Patient refused to continue|1|||
125182131|NCT00110396|450287780|FG000|Overall Study|Patient refused to participate|1|||
125182132|NCT00110396|450287780|FG000|Overall Study|Patient will|1|||
125182133|NCT00110396|450287780|FG000|Overall Study|Patient's decision|1|||
125182134|NCT00110396|450287780|FG000|Overall Study|Participation in MS vaccine study|1|||
125182135|NCT00110396|450287780|FG000|Overall Study|Pregnancy|1|||
125182136|NCT00110396|450287780|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
125182137|NCT00110396|450287780|FG000|Overall Study|Protocol Violation|2|||
125182138|NCT00110396|450287780|FG000|Overall Study|Patient refused to come back|1|||
125182139|NCT00110396|450287780|FG000|Overall Study|The patient has refused|2|||
125182140|NCT00110396|450287780|FG000|Overall Study|The patient has refused to visit site|1|||
125182141|NCT00110396|450287780|FG000|Overall Study|Patient is to be administered copaxone|1|||
125182142|NCT00882518|450287781|FG000|Overall Study|Adverse Event|9|||
125237247|NCT03034967|450496058|FG003|Overall Study|Protocol Violation|0|||
125237248|NCT03034967|450496059|FG004|Overall Study|Protocol Violation|0|||
125182143|NCT00882518|450287782|FG001|Overall Study|Adverse Event|18|||
125182144|NCT00882518|450287781|FG000|Overall Study|Withdrawal by Subject|9|||
125237249|NCT03034967|450496060|FG005|Overall Study|Protocol Violation|2|||
125237250|NCT03034967|450496055|FG000|Overall Study|Lack of Efficacy|0|||
125237251|NCT03034967|450496056|FG001|Overall Study|Lack of Efficacy|1|||
125237252|NCT03034967|450496057|FG002|Overall Study|Lack of Efficacy|2|||
125237253|NCT03034967|450496058|FG003|Overall Study|Lack of Efficacy|1|||
125237254|NCT03034967|450496059|FG004|Overall Study|Lack of Efficacy|1|||
125237255|NCT03034967|450496060|FG005|Overall Study|Lack of Efficacy|0|||
125182145|NCT00882518|450287782|FG001|Overall Study|Withdrawal by Subject|13|||
125182146|NCT00882518|450287781|FG000|Overall Study|Lack of Efficacy|12|||
125182147|NCT00882518|450287782|FG001|Overall Study|Lack of Efficacy|9|||
125182148|NCT00882518|450287781|FG000|Overall Study|Severe non-compliance to protocol|3|||
125182149|NCT00882518|450287782|FG001|Overall Study|Severe non-compliance to protocol|1|||
125237256|NCT03034967|450496055|FG000|Overall Study|Adverse Event, non-fatal|3|||
125237257|NCT03034967|450496056|FG001|Overall Study|Adverse Event, non-fatal|1|||
125237258|NCT03034967|450496057|FG002|Overall Study|Adverse Event, non-fatal|2|||
125237259|NCT03034967|450496058|FG003|Overall Study|Adverse Event, non-fatal|0|||
125237260|NCT03034967|450496059|FG004|Overall Study|Adverse Event, non-fatal|2|||
125237261|NCT03034967|450496060|FG005|Overall Study|Adverse Event, non-fatal|8|||
125237262|NCT03034967|450496055|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
125237263|NCT03034967|450496056|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
125237264|NCT03034967|450496057|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
125237265|NCT03034967|450496058|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
125237266|NCT03034967|450496059|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
125237267|NCT03034967|450496060|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
125237268|NCT02550795|450496070|FG000|Overall Study|Physician Decision|0|||
125237269|NCT02550795|450496071|FG001|Overall Study|Physician Decision|1|||
125182150|NCT00882518|450287781|FG000|Overall Study|Incorrect enrolment|4|||
125182151|NCT00882518|450287782|FG001|Overall Study|Incorrect enrolment|2|||
125182152|NCT00882518|450287781|FG000|Overall Study|Central lab closure for National day|1|||
125182153|NCT00882518|450287782|FG001|Overall Study|Central lab closure for National day|0|||
125182154|NCT00882518|450287781|FG000|Overall Study|Allocating random number by mistake|0|||
125182155|NCT00882518|450287782|FG001|Overall Study|Allocating random number by mistake|1|||
125182156|NCT02137252|450287783|FG000|Overall Study|trial terminated early|2|||
125182157|NCT02137252|450287784|FG001|Overall Study|trial terminated early|1|||
125182158|NCT03535740|450287785|FG000|Overall Study|Death|44|||
125182159|NCT03535740|450287785|FG000|Overall Study|Lost to Follow-up|1|||
125182160|NCT03535740|450287785|FG000|Overall Study|Withdrawal by Subject|13|||
125182161|NCT03535740|450287785|FG000|Overall Study|Site terminated by Sponsor|45|||
125182162|NCT05198518|450287790|FG000|Screening Visit|Deemed unable to participate|58|||
125182163|NCT05198518|450287791|FG001|Screening Visit|Deemed unable to participate|0|||
125182164|NCT05198518|450287792|FG002|Screening Visit|Deemed unable to participate|0|||
125182165|NCT02756611|450287795|FG000|Overall Study|Death|70|||
125182166|NCT02756611|450287795|FG000|Overall Study|Withdrawal by Subject|2|||
125182167|NCT02756611|450287795|FG000|Overall Study|Lost to Follow-up|3|||
125182168|NCT02756611|450287795|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
125182169|NCT02756611|450287795|FG000|Overall Study|Other|10|||
125182170|NCT03125798|450287797|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
125182171|NCT03125798|450287798|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
125182172|NCT03125798|450287797|FG000|Overall Study|Conversion to thoracotomy|7|||
125182173|NCT03125798|450287798|FG001|Overall Study|Conversion to thoracotomy|7|||
125182174|NCT00065156|450287802|FG000|Overall Study|Adverse Event|37|||
125182175|NCT00065156|450287802|FG000|Overall Study|Lack of Efficacy|52|||
125182176|NCT00065156|450287802|FG000|Overall Study|Withdrawal by Subject|8|||
125182177|NCT00065156|450287802|FG000|Overall Study|Lost to Follow-up|1|||
125182178|NCT00065156|450287802|FG000|Overall Study|Death|11|||
125182179|NCT00065156|450287802|FG000|Overall Study|Study Closed by Sponsor|2|||
125182180|NCT00065156|450287802|FG000|Overall Study|Disease Progression|7|||
125182181|NCT00065156|450287802|FG000|Overall Study|Investigator Decision|2|||
125182182|NCT00065156|450287802|FG000|Overall Study|Non-Compliance|2|||
125182183|NCT00065156|450287802|FG000|Overall Study|Loss of Response|1|||
125182184|NCT00065156|450287802|FG000|Overall Study|Secondary Malign Disease|1|||
125182185|NCT04583735|450287803|FG000|Double-masked Treatment Period|Adverse Event|0|||
125182186|NCT04583735|450287804|FG001|Double-masked Treatment Period|Adverse Event|1|||
125182187|NCT04583735|450287803|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
125182188|NCT04583735|450287804|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
125182189|NCT04583735|450287803|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
125182190|NCT04583735|450287804|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
125182191|NCT04583735|450287803|FG000|Open-label Treatment Period|Adverse Event|1|||
125237270|NCT02550795|450496072|FG002|Overall Study|Physician Decision|0|||
125237271|NCT00879658|450496073|FG000|Overall Study|Abnormal laboratory value(s)|3|||
125182192|NCT04583735|450287804|FG001|Open-label Treatment Period|Adverse Event|1|||
125182193|NCT04583735|450287803|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
125182194|NCT04583735|450287804|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
125182195|NCT04583735|450287803|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
125182196|NCT04583735|450287804|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
125237272|NCT00879658|450496074|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125237273|NCT00879658|450496075|FG002|Overall Study|Abnormal laboratory value(s)|0|||
125182197|NCT00124917|450287805|FG000|Overall Study|Physician Decision|3|||
125182198|NCT03518008|450287806|FG000|Period 2, Second Week of Wear|Family emergency|0|||
125182199|NCT03518008|450287807|FG001|Period 2, Second Week of Wear|Family emergency|1|||
125182200|NCT01169350|450287808|FG000|Overall Study|Physician Decision|3|||
125182201|NCT01169350|450287808|FG000|Overall Study|Lost to Follow-up|2|||
125182202|NCT00931411|450287809|FG000|First Intervention - 42 Days|Adverse Event|2|||
125182203|NCT00931411|450287810|FG001|First Intervention - 42 Days|Adverse Event|3|||
125182204|NCT00931411|450287809|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
125182205|NCT00931411|450287810|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
125237274|NCT00879658|450496076|FG003|Overall Study|Abnormal laboratory value(s)|1|||
125237275|NCT00879658|450496077|FG004|Overall Study|Abnormal laboratory value(s)|0|||
125237276|NCT00879658|450496078|FG005|Overall Study|Abnormal laboratory value(s)|0|||
125237277|NCT00879658|450496079|FG006|Overall Study|Abnormal laboratory value(s)|0|||
125237278|NCT00879658|450496073|FG000|Overall Study|Administrative problems|2|||
125237279|NCT00879658|450496074|FG001|Overall Study|Administrative problems|1|||
125237280|NCT00879658|450496075|FG002|Overall Study|Administrative problems|0|||
125237281|NCT00879658|450496076|FG003|Overall Study|Administrative problems|1|||
125237282|NCT00879658|450496077|FG004|Overall Study|Administrative problems|0|||
125237283|NCT00879658|450496078|FG005|Overall Study|Administrative problems|0|||
125237284|NCT00879658|450496079|FG006|Overall Study|Administrative problems|0|||
125237285|NCT00879658|450496073|FG000|Overall Study|Adverse Event|6|||
125237286|NCT00879658|450496074|FG001|Overall Study|Adverse Event|4|||
125237287|NCT00879658|450496075|FG002|Overall Study|Adverse Event|3|||
125237288|NCT00879658|450496076|FG003|Overall Study|Adverse Event|1|||
125237289|NCT00879658|450496077|FG004|Overall Study|Adverse Event|2|||
125237290|NCT00879658|450496078|FG005|Overall Study|Adverse Event|0|||
125237291|NCT00879658|450496079|FG006|Overall Study|Adverse Event|0|||
125237292|NCT00879658|450496073|FG000|Overall Study|Protocol Violation|1|||
125237293|NCT00879658|450496074|FG001|Overall Study|Protocol Violation|0|||
125237294|NCT00879658|450496075|FG002|Overall Study|Protocol Violation|0|||
125237295|NCT00879658|450496076|FG003|Overall Study|Protocol Violation|0|||
125237296|NCT00879658|450496077|FG004|Overall Study|Protocol Violation|0|||
125237297|NCT00879658|450496078|FG005|Overall Study|Protocol Violation|0|||
125237298|NCT00879658|450496079|FG006|Overall Study|Protocol Violation|0|||
125237299|NCT00879658|450496073|FG000|Overall Study|Withdrawal by Subject|3|||
125237300|NCT00879658|450496074|FG001|Overall Study|Withdrawal by Subject|0|||
125237301|NCT00879658|450496075|FG002|Overall Study|Withdrawal by Subject|2|||
125237302|NCT00879658|450496076|FG003|Overall Study|Withdrawal by Subject|0|||
125237303|NCT00879658|450496077|FG004|Overall Study|Withdrawal by Subject|0|||
125237304|NCT00879658|450496078|FG005|Overall Study|Withdrawal by Subject|1|||
125237305|NCT00879658|450496079|FG006|Overall Study|Withdrawal by Subject|0|||
125237306|NCT00879658|450496073|FG000|Overall Study|Lack of Efficacy|0|||
125237307|NCT00879658|450496074|FG001|Overall Study|Lack of Efficacy|0|||
125237308|NCT00879658|450496075|FG002|Overall Study|Lack of Efficacy|2|||
125237309|NCT00879658|450496076|FG003|Overall Study|Lack of Efficacy|0|||
125237310|NCT00879658|450496077|FG004|Overall Study|Lack of Efficacy|0|||
125237311|NCT00879658|450496078|FG005|Overall Study|Lack of Efficacy|0|||
125237312|NCT00879658|450496079|FG006|Overall Study|Lack of Efficacy|0|||
125237313|NCT00879658|450496073|FG000|Overall Study|misrandomized (never received study med)|0|||
125237314|NCT00879658|450496074|FG001|Overall Study|misrandomized (never received study med)|0|||
125237315|NCT00879658|450496075|FG002|Overall Study|misrandomized (never received study med)|0|||
125237316|NCT00879658|450496076|FG003|Overall Study|misrandomized (never received study med)|1|||
125182206|NCT00931411|450287809|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
125182207|NCT00931411|450287810|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
125182208|NCT04338022|450287813|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
125182209|NCT04338022|450287814|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
125182210|NCT04338022|450287813|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
125182211|NCT04338022|450287814|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
125182212|NCT04338022|450287813|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
125182213|NCT04338022|450287814|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
125182214|NCT04338022|450287813|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
125182215|NCT04338022|450287814|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
125182216|NCT04338022|450287813|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
125182217|NCT04338022|450287814|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
125182218|NCT04338022|450287813|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
125237317|NCT00879658|450496077|FG004|Overall Study|misrandomized (never received study med)|0|||
125237318|NCT00879658|450496078|FG005|Overall Study|misrandomized (never received study med)|0|||
125237319|NCT00879658|450496079|FG006|Overall Study|misrandomized (never received study med)|0|||
125237320|NCT00314145|450496082|FG000|Overall Study|Withdrawal by Subject|8|||
125237321|NCT00314145|450496083|FG001|Overall Study|Withdrawal by Subject|10|||
125237322|NCT00314145|450496082|FG000|Overall Study|Lost to Follow-up|5|||
125237323|NCT00314145|450496083|FG001|Overall Study|Lost to Follow-up|12|||
125237324|NCT00314145|450496082|FG000|Overall Study|Physician Decision|3|||
125237325|NCT00314145|450496083|FG001|Overall Study|Physician Decision|4|||
125237326|NCT00314145|450496082|FG000|Overall Study|Adverse Event|0|||
125237327|NCT00314145|450496083|FG001|Overall Study|Adverse Event|3|||
125237328|NCT00314145|450496082|FG000|Overall Study|Protocol Violation|3|||
125237329|NCT00314145|450496083|FG001|Overall Study|Protocol Violation|0|||
125237330|NCT00314145|450496082|FG000|Overall Study|Sponsor Decision|2|||
125237331|NCT00314145|450496083|FG001|Overall Study|Sponsor Decision|0|||
125182219|NCT04338022|450287814|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
125237332|NCT00580840|450496084|FG000|Run-in|Adverse Event|17|||
125182220|NCT04338022|450287813|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
125182221|NCT04338022|450287814|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
125182222|NCT04338022|450287813|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
125182223|NCT04338022|450287814|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
125182224|NCT04338022|450287813|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
125182225|NCT04338022|450287814|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
125182226|NCT04338022|450287813|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
125182227|NCT04338022|450287814|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
125182228|NCT04338022|450287813|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
125182229|NCT04338022|450287814|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
125182230|NCT04338022|450287813|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
125182231|NCT04338022|450287814|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
125182232|NCT04338022|450287813|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
125182233|NCT04338022|450287814|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
125182234|NCT04338022|450287813|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
125182235|NCT04338022|450287814|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
125182236|NCT02860546|450287819|FG000|Overall Study|Clinical Progression|6|||
125182237|NCT02860546|450287819|FG000|Overall Study|Radiological Progression|12|||
125182238|NCT02466321|450287820|FG000|Overall Study|Death|26|||
125182239|NCT02466321|450287820|FG000|Overall Study|Revision|6|||
125182240|NCT02466321|450287820|FG000|Overall Study|Lost to Follow-up|60|||
125182241|NCT02466321|450287820|FG000|Overall Study|Did not receive study device|1|||
125182242|NCT06071754|450287821|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
125182243|NCT00683657|450287827|FG000|Overall Study|Adverse Event|0|||
125182244|NCT00683657|450287828|FG001|Overall Study|Adverse Event|1|||
125182245|NCT00683657|450287827|FG000|Overall Study|Subject Withdrew Consent|1|||
125182246|NCT00683657|450287828|FG001|Overall Study|Subject Withdrew Consent|0|||
125182247|NCT01408043|450287830|FG000|Overall Study|unable to collect cells|1|||
125182248|NCT00739063|450287831|FG000|Overall Study|Screen failures|8|||
125182249|NCT00931528|450289323|FG000|Overall Study|Protocol Violation|9|||
125182250|NCT00931528|450289324|FG001|Overall Study|Protocol Violation|12|||
125182251|NCT00931528|450289323|FG000|Overall Study|Withdrawal by Subject|4|||
125182252|NCT00931528|450289324|FG001|Overall Study|Withdrawal by Subject|12|||
125182253|NCT00931528|450289323|FG000|Overall Study|Lost to Follow-up|6|||
125182254|NCT00931528|450289324|FG001|Overall Study|Lost to Follow-up|13|||
125182255|NCT00931528|450289323|FG000|Overall Study|Assessment outside of Time Frame|22|||
125182256|NCT00931528|450289324|FG001|Overall Study|Assessment outside of Time Frame|23|||
125182257|NCT00711243|450289328|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
125182258|NCT00711243|450289329|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
125182259|NCT00711243|450289330|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
125182260|NCT00711243|450289331|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
125182261|NCT00711243|450289332|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
125182262|NCT00711243|450289333|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
125182263|NCT00711243|450289328|FG000|Reached First Response/4 Cycles|Death|0|||
125182264|NCT00711243|450289329|FG001|Reached First Response/4 Cycles|Death|0|||
125182265|NCT00711243|450289330|FG002|Reached First Response/4 Cycles|Death|0|||
125182266|NCT00711243|450289331|FG003|Reached First Response/4 Cycles|Death|0|||
125182267|NCT00711243|450289332|FG004|Reached First Response/4 Cycles|Death|0|||
125182268|NCT00711243|450289333|FG005|Reached First Response/4 Cycles|Death|2|||
125182269|NCT00711243|450289328|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
125182270|NCT00711243|450289329|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
125182271|NCT00711243|450289330|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
125182272|NCT00711243|450289331|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
125182273|NCT00711243|450289332|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
125182274|NCT00711243|450289333|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
125182275|NCT00711243|450289328|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
125182276|NCT00711243|450289329|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
125182277|NCT00711243|450289330|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
125182278|NCT00711243|450289331|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
125182279|NCT00711243|450289332|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
125182280|NCT00711243|450289333|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
125182281|NCT00711243|450289328|FG000|Treated Cycle 5 After First Response|Death|0|||
125182282|NCT00711243|450289329|FG001|Treated Cycle 5 After First Response|Death|0|||
125182283|NCT00711243|450289330|FG002|Treated Cycle 5 After First Response|Death|0|||
125182284|NCT00711243|450289331|FG003|Treated Cycle 5 After First Response|Death|0|||
125182285|NCT00711243|450289332|FG004|Treated Cycle 5 After First Response|Death|0|||
125182286|NCT00711243|450289333|FG005|Treated Cycle 5 After First Response|Death|2|||
125237333|NCT00580840|450496085|FG001|Run-in|Adverse Event|0|||
125182287|NCT00711243|450289328|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
125237334|NCT00580840|450496086|FG002|Run-in|Adverse Event|0|||
125182288|NCT00711243|450289329|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
125182289|NCT00711243|450289330|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
125182290|NCT00711243|450289331|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
125182291|NCT00711243|450289332|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
125182292|NCT00711243|450289333|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
125182293|NCT00711243|450289328|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
125182294|NCT00711243|450289329|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
125182295|NCT00711243|450289330|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
125182296|NCT00711243|450289331|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
125182297|NCT00711243|450289332|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
125182298|NCT00711243|450289333|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
125182299|NCT01557504|450289336|FG000|Overall Study|Physician Decision|1|||
125182300|NCT01557504|450289337|FG001|Overall Study|Physician Decision|0|||
125182301|NCT01962103|450289338|FG000|Phase 1|Adverse Event|4|||
125182302|NCT01962103|450289339|FG001|Phase 1|Adverse Event|0|||
125182303|NCT01962103|450289340|FG002|Phase 1|Adverse Event|2|||
125182304|NCT01962103|450289341|FG003|Phase 1|Adverse Event|1|||
125182305|NCT01962103|450289342|FG004|Phase 1|Adverse Event|2|||
125182306|NCT01962103|450289343|FG005|Phase 1|Adverse Event|2|||
125182307|NCT01962103|450289344|FG006|Phase 1|Adverse Event|0|||
125182308|NCT01962103|450289345|FG007|Phase 1|Adverse Event|0|||
125182309|NCT01962103|450289346|FG008|Phase 1|Adverse Event|0|||
125182310|NCT01962103|450289338|FG000|Phase 1|Progressive Disease|8|||
125182311|NCT01962103|450289339|FG001|Phase 1|Progressive Disease|6|||
125182312|NCT01962103|450289340|FG002|Phase 1|Progressive Disease|8|||
125182313|NCT01962103|450289341|FG003|Phase 1|Progressive Disease|4|||
125182314|NCT01962103|450289342|FG004|Phase 1|Progressive Disease|5|||
125182315|NCT01962103|450289343|FG005|Phase 1|Progressive Disease|4|||
125182316|NCT01962103|450289344|FG006|Phase 1|Progressive Disease|0|||
125182317|NCT01962103|450289345|FG007|Phase 1|Progressive Disease|0|||
125182318|NCT01962103|450289346|FG008|Phase 1|Progressive Disease|0|||
125182319|NCT01962103|450289338|FG000|Phase 1|Withdrawal by Subject|0|||
125182320|NCT01962103|450289339|FG001|Phase 1|Withdrawal by Subject|0|||
125182321|NCT01962103|450289340|FG002|Phase 1|Withdrawal by Subject|0|||
125182322|NCT01962103|450289341|FG003|Phase 1|Withdrawal by Subject|2|||
125182323|NCT01962103|450289342|FG004|Phase 1|Withdrawal by Subject|0|||
125182324|NCT01962103|450289343|FG005|Phase 1|Withdrawal by Subject|0|||
125182325|NCT01962103|450289344|FG006|Phase 1|Withdrawal by Subject|0|||
125237335|NCT00580840|450496087|FG003|Run-in|Adverse Event|0|||
125237336|NCT00580840|450496084|FG000|Run-in|Lack of Efficacy|93|||
125237337|NCT00580840|450496085|FG001|Run-in|Lack of Efficacy|0|||
125237338|NCT00580840|450496086|FG002|Run-in|Lack of Efficacy|0|||
125237339|NCT00580840|450496087|FG003|Run-in|Lack of Efficacy|0|||
125237340|NCT00580840|450496084|FG000|Run-in|Loss of Efficacy|1|||
125237341|NCT00580840|450496085|FG001|Run-in|Loss of Efficacy|0|||
125237342|NCT00580840|450496086|FG002|Run-in|Loss of Efficacy|0|||
125237343|NCT00580840|450496087|FG003|Run-in|Loss of Efficacy|0|||
125237344|NCT00580840|450496084|FG000|Run-in|Lost to Follow-up|4|||
125237345|NCT00580840|450496085|FG001|Run-in|Lost to Follow-up|0|||
125237346|NCT00580840|450496086|FG002|Run-in|Lost to Follow-up|0|||
125237347|NCT00580840|450496087|FG003|Run-in|Lost to Follow-up|0|||
125237348|NCT00580840|450496084|FG000|Run-in|Withdrawal by Subject|5|||
125237349|NCT00580840|450496085|FG001|Run-in|Withdrawal by Subject|0|||
125237350|NCT00580840|450496086|FG002|Run-in|Withdrawal by Subject|0|||
125237351|NCT00580840|450496087|FG003|Run-in|Withdrawal by Subject|0|||
125237352|NCT00580840|450496084|FG000|Run-in|Other: Per Sponsor Request|2|||
125237353|NCT00580840|450496085|FG001|Run-in|Other: Per Sponsor Request|0|||
125237354|NCT00580840|450496086|FG002|Run-in|Other: Per Sponsor Request|0|||
125237355|NCT00580840|450496087|FG003|Run-in|Other: Per Sponsor Request|0|||
125237356|NCT00580840|450496084|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
125237357|NCT00580840|450496085|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
125237358|NCT00580840|450496086|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
125182326|NCT01962103|450289345|FG007|Phase 1|Withdrawal by Subject|0|||
125182327|NCT01962103|450289346|FG008|Phase 1|Withdrawal by Subject|0|||
125182328|NCT01962103|450289338|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
125182329|NCT01962103|450289339|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
125182330|NCT01962103|450289340|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
125182331|NCT01962103|450289341|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
125182332|NCT01962103|450289342|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
125182333|NCT01962103|450289343|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
125182334|NCT01962103|450289344|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
125182335|NCT01962103|450289345|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
125182336|NCT01962103|450289346|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
125237359|NCT00580840|450496087|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
125182337|NCT01962103|450289338|FG000|Phase 1|Physician Decision|0|||
125237360|NCT00580840|450496084|FG000|Run-in|Other: Exclusionary Lab Value|1|||
125237361|NCT00580840|450496085|FG001|Run-in|Other: Exclusionary Lab Value|0|||
125237362|NCT00580840|450496086|FG002|Run-in|Other: Exclusionary Lab Value|0|||
125237363|NCT00580840|450496087|FG003|Run-in|Other: Exclusionary Lab Value|0|||
125237364|NCT00580840|450496084|FG000|Double-Blind|Adverse Event|0|||
125237365|NCT00580840|450496085|FG001|Double-Blind|Adverse Event|3|||
125237366|NCT00580840|450496086|FG002|Double-Blind|Adverse Event|4|||
125237367|NCT00580840|450496087|FG003|Double-Blind|Adverse Event|1|||
125237368|NCT00580840|450496084|FG000|Double-Blind|Loss of Efficacy|0|||
125237369|NCT00580840|450496085|FG001|Double-Blind|Loss of Efficacy|1|||
125237370|NCT00580840|450496086|FG002|Double-Blind|Loss of Efficacy|2|||
125237371|NCT00580840|450496087|FG003|Double-Blind|Loss of Efficacy|10|||
125237372|NCT00580840|450496084|FG000|Double-Blind|Lost to Follow-up|0|||
125237373|NCT00580840|450496085|FG001|Double-Blind|Lost to Follow-up|1|||
125237374|NCT00580840|450496086|FG002|Double-Blind|Lost to Follow-up|0|||
125237375|NCT00580840|450496087|FG003|Double-Blind|Lost to Follow-up|2|||
125237376|NCT00580840|450496084|FG000|Double-Blind|Withdrawal by Subject|0|||
125237377|NCT00580840|450496085|FG001|Double-Blind|Withdrawal by Subject|1|||
125237378|NCT00580840|450496086|FG002|Double-Blind|Withdrawal by Subject|2|||
125237379|NCT00580840|450496087|FG003|Double-Blind|Withdrawal by Subject|2|||
125237380|NCT00580840|450496084|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
125237381|NCT00580840|450496085|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
125237382|NCT00580840|450496086|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
125237383|NCT00580840|450496087|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
125237384|NCT00580840|450496084|FG000|Double-Blind|Other: Forbidden Medication|0|||
125237385|NCT00580840|450496085|FG001|Double-Blind|Other: Forbidden Medication|0|||
125237386|NCT00580840|450496086|FG002|Double-Blind|Other: Forbidden Medication|1|||
125237387|NCT00580840|450496087|FG003|Double-Blind|Other: Forbidden Medication|0|||
125237388|NCT01551173|450496088|FG000|Overall Study|Withdrawal by Subject|11|||
125237389|NCT01551173|450496089|FG001|Overall Study|Withdrawal by Subject|16|||
125237390|NCT01551173|450496088|FG000|Overall Study|Adverse Event|7|||
125237391|NCT01551173|450496089|FG001|Overall Study|Adverse Event|6|||
125237392|NCT01551173|450496088|FG000|Overall Study|Lost to Follow-up|5|||
125237393|NCT01551173|450496089|FG001|Overall Study|Lost to Follow-up|7|||
125237394|NCT01551173|450496088|FG000|Overall Study|Other|5|||
125237395|NCT01551173|450496089|FG001|Overall Study|Other|3|||
125237396|NCT04530344|450496090|FG000|Overall Study|Lost to Follow-up|3|||
125237397|NCT04530344|450496091|FG001|Overall Study|Lost to Follow-up|3|||
125237398|NCT04530344|450496092|FG002|Overall Study|Lost to Follow-up|3|||
125237399|NCT04530344|450496093|FG003|Overall Study|Lost to Follow-up|10|||
125237400|NCT04530344|450496090|FG000|Overall Study|Withdrawal by Subject|14|||
125237401|NCT04530344|450496091|FG001|Overall Study|Withdrawal by Subject|5|||
125237402|NCT04530344|450496092|FG002|Overall Study|Withdrawal by Subject|18|||
125237403|NCT04530344|450496093|FG003|Overall Study|Withdrawal by Subject|33|||
125237404|NCT04530344|450496090|FG000|Overall Study|Adverse Event|0|||
125237405|NCT04530344|450496091|FG001|Overall Study|Adverse Event|0|||
125237406|NCT04530344|450496092|FG002|Overall Study|Adverse Event|0|||
125237407|NCT04530344|450496093|FG003|Overall Study|Adverse Event|1|||
125237408|NCT04530344|450496090|FG000|Overall Study|Lack of Efficacy|0|||
125237409|NCT04530344|450496091|FG001|Overall Study|Lack of Efficacy|0|||
125237410|NCT04530344|450496092|FG002|Overall Study|Lack of Efficacy|0|||
125237411|NCT04530344|450496093|FG003|Overall Study|Lack of Efficacy|1|||
125237412|NCT04530344|450496090|FG000|Overall Study|Physician Decision|0|||
125237413|NCT04530344|450496091|FG001|Overall Study|Physician Decision|0|||
125237414|NCT04530344|450496092|FG002|Overall Study|Physician Decision|1|||
125237415|NCT04530344|450496093|FG003|Overall Study|Physician Decision|1|||
125237416|NCT04530344|450496090|FG000|Overall Study|Pregnancy|0|||
125237417|NCT04530344|450496091|FG001|Overall Study|Pregnancy|0|||
125237418|NCT04530344|450496092|FG002|Overall Study|Pregnancy|2|||
125237419|NCT04530344|450496093|FG003|Overall Study|Pregnancy|1|||
125237420|NCT04530344|450496090|FG000|Overall Study|Protocol Violation|0|||
125237421|NCT04530344|450496091|FG001|Overall Study|Protocol Violation|0|||
125237422|NCT04530344|450496092|FG002|Overall Study|Protocol Violation|0|||
125237423|NCT04530344|450496093|FG003|Overall Study|Protocol Violation|1|||
125237424|NCT04530344|450496090|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
125237425|NCT04530344|450496091|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
125237426|NCT04530344|450496092|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
125237427|NCT04530344|450496093|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
125237428|NCT04530344|450496090|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
125237429|NCT04530344|450496091|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
125237430|NCT04530344|450496092|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
125237431|NCT04530344|450496093|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
125237432|NCT04530344|450496090|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
125237433|NCT04530344|450496091|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
125237434|NCT04530344|450496092|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
125237435|NCT04530344|450496093|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
125237436|NCT04530344|450496090|FG000|Overall Study|Personal Reasons|0|||
125237437|NCT04530344|450496091|FG001|Overall Study|Personal Reasons|0|||
125237438|NCT04530344|450496092|FG002|Overall Study|Personal Reasons|0|||
125237439|NCT04530344|450496093|FG003|Overall Study|Personal Reasons|1|||
125237440|NCT04530344|450496090|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
125237441|NCT04530344|450496091|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
125237442|NCT04530344|450496092|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
125237443|NCT04530344|450496093|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
125237444|NCT01402700|450496094|FG000|Overall Study|Death|3|||
125237445|NCT01402700|450496094|FG000|Overall Study|Withdrawal by Subject|3|||
125237446|NCT01402700|450496094|FG000|Overall Study|Missed Visit|1|||
125237447|NCT05523297|450496100|FG000|Overall Study|Death|7|||
125237448|NCT05523297|450496101|FG001|Overall Study|Death|8|||
125237449|NCT05523297|450496100|FG000|Overall Study|Lost to Follow-up|2|||
125237450|NCT05523297|450496101|FG001|Overall Study|Lost to Follow-up|1|||
125237451|NCT03462680|450496102|FG000|Overall Study|Withdrawal by Subject|3|||
125237452|NCT03462680|450496103|FG001|Overall Study|Withdrawal by Subject|5|||
125237453|NCT02246777|450496104|FG000|Overall Study|Adverse Event|2|||
125237454|NCT02246777|450496104|FG000|Overall Study|Change of residence|1|||
125237455|NCT02401230|450496105|FG000|Overall Study|Adverse Event|3|||
125237456|NCT02401230|450496106|FG001|Overall Study|Adverse Event|2|||
125237457|NCT02401230|450496107|FG002|Overall Study|Adverse Event|0|||
125237458|NCT02401230|450496105|FG000|Overall Study|Withdrawal by Subject|2|||
125237459|NCT02401230|450496106|FG001|Overall Study|Withdrawal by Subject|1|||
125237460|NCT02401230|450496107|FG002|Overall Study|Withdrawal by Subject|1|||
125237461|NCT02401230|450496105|FG000|Overall Study|Lost to Follow-up|1|||
125237462|NCT02401230|450496106|FG001|Overall Study|Lost to Follow-up|3|||
125237463|NCT02401230|450496107|FG002|Overall Study|Lost to Follow-up|3|||
125237464|NCT04133909|450496108|FG000|Overall Study|Death|11|||
125237465|NCT04133909|450496109|FG001|Overall Study|Death|11|||
125237466|NCT04133909|450496108|FG000|Overall Study|Adverse Event|4|||
125237467|NCT04133909|450496109|FG001|Overall Study|Adverse Event|5|||
125237468|NCT04133909|450496108|FG000|Overall Study|Lost to Follow-up|3|||
125182338|NCT01962103|450289339|FG001|Phase 1|Physician Decision|0|||
125182339|NCT01962103|450289340|FG002|Phase 1|Physician Decision|0|||
125182340|NCT01962103|450289341|FG003|Phase 1|Physician Decision|1|||
125182341|NCT01962103|450289342|FG004|Phase 1|Physician Decision|0|||
125182342|NCT01962103|450289343|FG005|Phase 1|Physician Decision|0|||
125182343|NCT01962103|450289344|FG006|Phase 1|Physician Decision|0|||
125182344|NCT01962103|450289345|FG007|Phase 1|Physician Decision|0|||
125182345|NCT01962103|450289346|FG008|Phase 1|Physician Decision|0|||
125182346|NCT01962103|450289338|FG000|Phase 1|Symptomatic Deterioration|3|||
125182347|NCT01962103|450289339|FG001|Phase 1|Symptomatic Deterioration|2|||
125182348|NCT01962103|450289340|FG002|Phase 1|Symptomatic Deterioration|2|||
125237469|NCT04133909|450496109|FG001|Overall Study|Lost to Follow-up|5|||
125237470|NCT04133909|450496108|FG000|Overall Study|Physician Decision|4|||
125237471|NCT04133909|450496109|FG001|Overall Study|Physician Decision|7|||
125237472|NCT04133909|450496108|FG000|Overall Study|Withdrawal by Subject|40|||
125237473|NCT04133909|450496109|FG001|Overall Study|Withdrawal by Subject|35|||
125237474|NCT04133909|450496108|FG000|Overall Study|Lack of Efficacy|2|||
125237475|NCT04133909|450496109|FG001|Overall Study|Lack of Efficacy|7|||
125237476|NCT04133909|450496108|FG000|Overall Study|Randomized in error|1|||
125237477|NCT04133909|450496109|FG001|Overall Study|Randomized in error|1|||
125237478|NCT00830765|450496110|FG000|Overall Study|Protocol Violation|3|||
125237479|NCT00830765|450496111|FG001|Overall Study|Protocol Violation|2|||
125237480|NCT01299909|450496112|FG000|Overall Study|Lost to Follow-up|22|||
125237481|NCT01299909|450496113|FG001|Overall Study|Lost to Follow-up|18|||
125237482|NCT01299909|450496114|FG002|Overall Study|Lost to Follow-up|17|||
125237483|NCT03069989|450496118|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
125237484|NCT03069989|450496119|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
125237485|NCT05399485|450497590|FG000|DBT Phase|Other|6|||
125237486|NCT05399485|450497591|FG001|DBT Phase|Other|5|||
125237487|NCT05399485|450497590|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
125182349|NCT01962103|450289341|FG003|Phase 1|Symptomatic Deterioration|2|||
125182350|NCT01962103|450289342|FG004|Phase 1|Symptomatic Deterioration|1|||
125182351|NCT01962103|450289343|FG005|Phase 1|Symptomatic Deterioration|1|||
125182352|NCT01962103|450289344|FG006|Phase 1|Symptomatic Deterioration|0|||
125237488|NCT05399485|450497591|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
125237489|NCT05399485|450497590|FG000|DBT Phase|Withdrawal by Subject|3|||
125237490|NCT05399485|450497591|FG001|DBT Phase|Withdrawal by Subject|2|||
125237491|NCT05399485|450497590|FG000|DBT Phase|Protocol Violation|2|||
125237492|NCT05399485|450497591|FG001|DBT Phase|Protocol Violation|1|||
125237493|NCT05399485|450497590|FG000|DBT Phase|Physician Decision|0|||
125237494|NCT05399485|450497591|FG001|DBT Phase|Physician Decision|1|||
125182353|NCT01962103|450289345|FG007|Phase 1|Symptomatic Deterioration|0|||
125182354|NCT01962103|450289346|FG008|Phase 1|Symptomatic Deterioration|0|||
125182355|NCT01962103|450289338|FG000|Phase 1|Miscellaneous|1|||
125182356|NCT01962103|450289339|FG001|Phase 1|Miscellaneous|0|||
125182357|NCT01962103|450289340|FG002|Phase 1|Miscellaneous|0|||
125182358|NCT01962103|450289341|FG003|Phase 1|Miscellaneous|0|||
125237495|NCT05399485|450497590|FG000|DBT Phase|Adverse Event|2|||
125237496|NCT05399485|450497591|FG001|DBT Phase|Adverse Event|1|||
125237497|NCT05399485|450497590|FG000|OLE Phase|Not reported|0|||
125237498|NCT05399485|450497591|FG001|OLE Phase|Not reported|1|||
125237499|NCT05399485|450497590|FG000|OLE Phase|Other|3|||
125237500|NCT05399485|450497591|FG001|OLE Phase|Other|3|||
125237501|NCT05399485|450497590|FG000|OLE Phase|Withdrawal by Subject|8|||
125237502|NCT05399485|450497591|FG001|OLE Phase|Withdrawal by Subject|5|||
125237503|NCT05399485|450497590|FG000|OLE Phase|Pregnancy|0|||
125237504|NCT05399485|450497591|FG001|OLE Phase|Pregnancy|1|||
125237505|NCT05399485|450497590|FG000|OLE Phase|Physician Decision|2|||
125237506|NCT05399485|450497591|FG001|OLE Phase|Physician Decision|0|||
125237507|NCT05399485|450497590|FG000|OLE Phase|Adverse Event|0|||
125237508|NCT05399485|450497591|FG001|OLE Phase|Adverse Event|1|||
125237509|NCT05399485|450497590|FG000|OLE Phase|Ongoing in the OLE Phase|141|||
125237510|NCT05399485|450497591|FG001|OLE Phase|Ongoing in the OLE Phase|140|||
125237511|NCT06125964|450497592|FG000|Overall Study|Lost to Follow-up|0|||
125237512|NCT06125964|450497593|FG001|Overall Study|Lost to Follow-up|1|||
125182359|NCT01962103|450289342|FG004|Phase 1|Miscellaneous|0|||
125182360|NCT01962103|450289343|FG005|Phase 1|Miscellaneous|0|||
125182361|NCT01962103|450289344|FG006|Phase 1|Miscellaneous|0|||
125182362|NCT01962103|450289345|FG007|Phase 1|Miscellaneous|0|||
125182363|NCT01962103|450289346|FG008|Phase 1|Miscellaneous|0|||
125182364|NCT01962103|450289338|FG000|Phase 2|Adverse Event|0|||
125182365|NCT01962103|450289339|FG001|Phase 2|Adverse Event|0|||
125182366|NCT01962103|450289340|FG002|Phase 2|Adverse Event|0|||
125182367|NCT01962103|450289341|FG003|Phase 2|Adverse Event|0|||
125182368|NCT01962103|450289342|FG004|Phase 2|Adverse Event|0|||
125182369|NCT01962103|450289343|FG005|Phase 2|Adverse Event|0|||
125182370|NCT01962103|450289344|FG006|Phase 2|Adverse Event|1|||
125182371|NCT01962103|450289345|FG007|Phase 2|Adverse Event|0|||
125182372|NCT01962103|450289346|FG008|Phase 2|Adverse Event|3|||
125182373|NCT01962103|450289338|FG000|Phase 2|Progressive Disease|0|||
125182374|NCT01962103|450289339|FG001|Phase 2|Progressive Disease|0|||
125182375|NCT01962103|450289340|FG002|Phase 2|Progressive Disease|0|||
125182376|NCT01962103|450289341|FG003|Phase 2|Progressive Disease|0|||
125182377|NCT01962103|450289342|FG004|Phase 2|Progressive Disease|0|||
125182378|NCT01962103|450289343|FG005|Phase 2|Progressive Disease|0|||
125182379|NCT01962103|450289344|FG006|Phase 2|Progressive Disease|11|||
125182380|NCT01962103|450289345|FG007|Phase 2|Progressive Disease|12|||
125182381|NCT01962103|450289346|FG008|Phase 2|Progressive Disease|11|||
125182382|NCT01962103|450289338|FG000|Phase 2|Symptomatic Deterioration|0|||
125182383|NCT01962103|450289339|FG001|Phase 2|Symptomatic Deterioration|0|||
125182384|NCT01962103|450289340|FG002|Phase 2|Symptomatic Deterioration|0|||
125182385|NCT01962103|450289341|FG003|Phase 2|Symptomatic Deterioration|0|||
125182386|NCT01962103|450289342|FG004|Phase 2|Symptomatic Deterioration|0|||
125182387|NCT01962103|450289343|FG005|Phase 2|Symptomatic Deterioration|0|||
125182388|NCT01962103|450289344|FG006|Phase 2|Symptomatic Deterioration|2|||
125182389|NCT01962103|450289345|FG007|Phase 2|Symptomatic Deterioration|2|||
125182390|NCT01962103|450289346|FG008|Phase 2|Symptomatic Deterioration|0|||
125182391|NCT01321749|450289347|FG000|Overall Study|Lost to Follow-up|4|||
125182392|NCT01321749|450289348|FG001|Overall Study|Lost to Follow-up|11|||
125182393|NCT01321749|450289347|FG000|Overall Study|Protocol Violation|4|||
125182394|NCT01321749|450289348|FG001|Overall Study|Protocol Violation|7|||
125182395|NCT01321749|450289347|FG000|Overall Study|Withdrawal by Subject|5|||
125182396|NCT01321749|450289348|FG001|Overall Study|Withdrawal by Subject|4|||
125182397|NCT02750618|450289349|FG000|Overall Study|Withdrawal by Subject|1|||
125182398|NCT01067105|450289352|FG000|Overall Study|Adverse Event|14|||
125182399|NCT01067105|450289352|FG000|Overall Study|Protocol Violation|48|||
125182400|NCT01067105|450289352|FG000|Overall Study|Withdrawal by Subject|36|||
125182401|NCT01067105|450289352|FG000|Overall Study|Lost to Follow-up|6|||
125182402|NCT01067105|450289352|FG000|Overall Study|Physician Decision|6|||
125182403|NCT01067105|450289352|FG000|Overall Study|Other|31|||
125182404|NCT02302833|450289355|FG000|Overall Study|Lost to Follow-up|3|||
125182405|NCT04878432|450289356|FG000|Overall Study|Adverse Event|1|||
125182406|NCT04878432|450289356|FG000|Overall Study|Death|2|||
125182407|NCT04878432|450289356|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
125182408|NCT04878432|450289356|FG000|Overall Study|Withdrawal by Subject|6|||
125182409|NCT04878432|450289356|FG000|Overall Study|Progressive Disease|7|||
125182410|NCT04878432|450289356|FG000|Overall Study|New Therapy for Study Indication|7|||
125182411|NCT04878432|450289356|FG000|Overall Study|Physician Decision|11|||
125182412|NCT00725491|450289359|FG000|Overall Study|Adverse Event|3|||
125182413|NCT00725491|450289360|FG001|Overall Study|Adverse Event|2|||
125182414|NCT00725491|450289359|FG000|Overall Study|Pregnancy|0|||
125182415|NCT00725491|450289360|FG001|Overall Study|Pregnancy|3|||
125182416|NCT00725491|450289359|FG000|Overall Study|Risk for hyperstimulation|2|||
125182417|NCT00725491|450289360|FG001|Overall Study|Risk for hyperstimulation|9|||
125182418|NCT00725491|450289359|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
125182419|NCT00725491|450289360|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
125182420|NCT00725491|450289359|FG000|Overall Study|Fertilization failure|0|||
125182421|NCT00725491|450289360|FG001|Overall Study|Fertilization failure|1|||
125237513|NCT06125964|450497594|FG002|Overall Study|Lost to Follow-up|0|||
125182422|NCT00725491|450289359|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
125237514|NCT06125964|450497595|FG003|Overall Study|Lost to Follow-up|0|||
125237515|NCT02469233|450497596|FG000|Overall Study|Death|1|||
125237516|NCT02469233|450497597|FG001|Overall Study|Death|1|||
125237517|NCT02469233|450497596|FG000|Overall Study|Lost to post or 6 month follow up|7|||
125237518|NCT02469233|450497597|FG001|Overall Study|Lost to post or 6 month follow up|2|||
125237519|NCT03474107|450497598|FG000|Overall Study|Adverse Event|42|||
125237520|NCT03474107|450497599|FG001|Overall Study|Adverse Event|46|||
125237521|NCT03474107|450497598|FG000|Overall Study|Death|2|||
125237522|NCT03474107|450497599|FG001|Overall Study|Death|2|||
125237523|NCT03474107|450497598|FG000|Overall Study|Lost to Follow-up|0|||
125237524|NCT03474107|450497599|FG001|Overall Study|Lost to Follow-up|1|||
125237525|NCT03474107|450497598|FG000|Overall Study|Progressive Disease|177|||
125237526|NCT03474107|450497599|FG001|Overall Study|Progressive Disease|180|||
125237527|NCT03474107|450497598|FG000|Overall Study|Protocol Violation|1|||
125237528|NCT03474107|450497599|FG001|Overall Study|Protocol Violation|1|||
125237529|NCT03474107|450497598|FG000|Overall Study|Withdrawal by Subject|15|||
125237530|NCT03474107|450497599|FG001|Overall Study|Withdrawal by Subject|27|||
125237531|NCT03474107|450497598|FG000|Overall Study|Physician Decision|7|||
125237532|NCT03474107|450497599|FG001|Overall Study|Physician Decision|22|||
125237533|NCT03474107|450497598|FG000|Overall Study|Miscellaneous|1|||
125237534|NCT03474107|450497599|FG001|Overall Study|Miscellaneous|6|||
125237535|NCT01787838|450497600|FG000|Overall Study|refused|1413|||
125237536|NCT03095287|450497601|FG000|Overall Study|Treatment Failure|1|||
125237537|NCT03095287|450497601|FG000|Overall Study|Adverse Event|1|||
125237538|NCT01431976|450497602|FG000|Overall Study|Adverse Event|6|||
125237539|NCT01431976|450497602|FG000|Overall Study|Lack of Efficacy|2|||
125237540|NCT01431976|450497602|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
125237541|NCT01431976|450497602|FG000|Overall Study|Physician Decision|1|||
125237542|NCT01431976|450497602|FG000|Overall Study|Withdrawal by Subject|1|||
125237543|NCT02127671|450497610|FG000|Overall Study|Death|2|||
125237544|NCT02127671|450497611|FG001|Overall Study|Death|2|||
125237545|NCT02127671|450497610|FG000|Overall Study|Lost to Follow-up|4|||
125237546|NCT02127671|450497611|FG001|Overall Study|Lost to Follow-up|2|||
125237547|NCT02127671|450497610|FG000|Overall Study|Physician Decision|1|||
125237548|NCT02127671|450497611|FG001|Overall Study|Physician Decision|0|||
125237549|NCT02127671|450497610|FG000|Overall Study|incarceration|0|||
125237550|NCT02127671|450497611|FG001|Overall Study|incarceration|1|||
125237551|NCT02127671|450497610|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
125237552|NCT02127671|450497611|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
125237553|NCT01136954|450497612|FG000|Overall Study|Adverse Event|3|||
125237554|NCT01136954|450497613|FG001|Overall Study|Adverse Event|2|||
125237555|NCT01136954|450497612|FG000|Overall Study|Withdrawal by Subject|6|||
125237556|NCT01136954|450497613|FG001|Overall Study|Withdrawal by Subject|2|||
125237557|NCT01136954|450497612|FG000|Overall Study|Lack of Efficacy|14|||
125237558|NCT01136954|450497613|FG001|Overall Study|Lack of Efficacy|13|||
125237559|NCT01136954|450497612|FG000|Overall Study|Physician Decision|0|||
125237560|NCT01136954|450497613|FG001|Overall Study|Physician Decision|1|||
125237561|NCT01136954|450497612|FG000|Overall Study|Other|1|||
125237562|NCT01136954|450497613|FG001|Overall Study|Other|3|||
125237563|NCT02394275|450497614|FG000|Overall Study|Adverse Event|22|||
125237564|NCT02394275|450497614|FG000|Overall Study|Lost to Follow-up|7|||
125237565|NCT00782067|450497617|FG000|Overall Study|Adverse Event|35|||
125237566|NCT00782067|450497617|FG000|Overall Study|Subject withdrew consent|11|||
125237567|NCT00782067|450497617|FG000|Overall Study|Lost to Follow-up|2|||
125237568|NCT00782067|450497617|FG000|Overall Study|Administrative problems|14|||
125237569|NCT00782067|450497617|FG000|Overall Study|Death|9|||
125237570|NCT00782067|450497617|FG000|Overall Study|Disease progression|43|||
125237571|NCT00782067|450497617|FG000|Overall Study|Protocol deviation|2|||
125237572|NCT00764517|450497621|FG000|Overall Study|Adverse Event|9|||
125237573|NCT00764517|450497622|FG001|Overall Study|Adverse Event|3|||
125237574|NCT00764517|450497621|FG000|Overall Study|Death|3|||
125237575|NCT00764517|450497622|FG001|Overall Study|Death|11|||
125237576|NCT00764517|450497621|FG000|Overall Study|Physician Decision|3|||
125237577|NCT00764517|450497622|FG001|Overall Study|Physician Decision|0|||
125237578|NCT00671060|450497630|FG000|Overall Study|Protocol Violation|1|||
125237579|NCT00671060|450497631|FG001|Overall Study|Protocol Violation|0|||
125237580|NCT00671060|450497630|FG000|Overall Study|Physician Decision|0|||
125237581|NCT00671060|450497631|FG001|Overall Study|Physician Decision|1|||
125237582|NCT02020941|450497632|FG000|Overall Study|Adverse Event|1|||
125237583|NCT02020941|450497632|FG000|Overall Study|Physician Decision|2|||
125237584|NCT02020941|450497632|FG000|Overall Study|Withdrawal by Subject|1|||
125237585|NCT02020941|450497632|FG000|Overall Study|Disease Progression|4|||
125237586|NCT02107898|450497635|FG000|Overall Study|Adverse Event|4|||
125237587|NCT02107898|450497636|FG001|Overall Study|Adverse Event|7|||
125237588|NCT02107898|450497635|FG000|Overall Study|Poor compliance to protocol|0|||
125237589|NCT02107898|450497636|FG001|Overall Study|Poor compliance to protocol|1|||
125237590|NCT02107898|450497635|FG000|Overall Study|Participant moved|0|||
125237591|NCT02107898|450497636|FG001|Overall Study|Participant moved|2|||
125237592|NCT02107898|450497635|FG000|Overall Study|Consent withdrawn by participant|2|||
125237593|NCT02107898|450497636|FG001|Overall Study|Consent withdrawn by participant|1|||
125237594|NCT02107898|450497635|FG000|Overall Study|Randomized but not treated|0|||
125237595|NCT02107898|450497636|FG001|Overall Study|Randomized but not treated|1|||
125237596|NCT03329989|450497637|FG000|Overall Study|Withdrawal by Subject|9|||
125237597|NCT03329989|450497637|FG000|Overall Study|Lost to Follow-up|8|||
125237598|NCT03329989|450497637|FG000|Overall Study|Adverse Event|5|||
125237599|NCT03329989|450497637|FG000|Overall Study|Protocol Violation|1|||
125237600|NCT00620542|450497638|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
125237601|NCT00620542|450497639|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
125237602|NCT00620542|450497640|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
125237603|NCT00620542|450497641|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
125237604|NCT00620542|450497638|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
125237605|NCT00620542|450497639|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
125237606|NCT00620542|450497640|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
125237607|NCT00620542|450497641|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
125237608|NCT00620542|450497638|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
125237609|NCT00620542|450497639|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
125237610|NCT00620542|450497640|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
125237611|NCT00620542|450497641|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
125237612|NCT00620542|450497638|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
125237613|NCT00620542|450497639|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
125237614|NCT00620542|450497640|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
125237615|NCT00620542|450497641|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
125237616|NCT00620542|450497638|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
125237617|NCT00620542|450497639|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
125237618|NCT00620542|450497640|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
125237619|NCT00620542|450497641|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
125237620|NCT00620542|450497638|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
125237621|NCT00620542|450497639|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
125237622|NCT00620542|450497640|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
125237623|NCT00620542|450497641|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
125237624|NCT00620542|450497638|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
125237625|NCT00620542|450497639|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
125237626|NCT00620542|450497640|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
125237627|NCT00620542|450497641|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
125237628|NCT00620542|450497638|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
125237629|NCT00620542|450497639|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
125237630|NCT00620542|450497640|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
125182423|NCT00725491|450289360|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
125182424|NCT01495000|450289361|FG000|Overall Study|Lost to Follow-up|2|||
125182425|NCT01495000|450289362|FG001|Overall Study|Lost to Follow-up|2|||
125182426|NCT01495000|450289361|FG000|Overall Study|Protocol Violation|1|||
125182427|NCT01495000|450289362|FG001|Overall Study|Protocol Violation|0|||
125182428|NCT01495000|450289361|FG000|Overall Study|Withdrawal by Subject|10|||
125182429|NCT01495000|450289362|FG001|Overall Study|Withdrawal by Subject|10|||
125182430|NCT01514461|450289363|FG000|Overall Study|Adverse Event|2|||
125182431|NCT01514461|450289364|FG001|Overall Study|Adverse Event|1|||
125182432|NCT01514461|450289365|FG002|Overall Study|Adverse Event|3|||
125182433|NCT01514461|450289363|FG000|Overall Study|Physician Decision|1|||
125182434|NCT01514461|450289364|FG001|Overall Study|Physician Decision|1|||
125182435|NCT01514461|450289365|FG002|Overall Study|Physician Decision|0|||
125182436|NCT01514461|450289363|FG000|Overall Study|Patient/guardian decision|1|||
125182437|NCT01514461|450289364|FG001|Overall Study|Patient/guardian decision|1|||
125182438|NCT01514461|450289365|FG002|Overall Study|Patient/guardian decision|1|||
125182439|NCT01514461|450289363|FG000|Overall Study|Death|1|||
125182440|NCT01514461|450289364|FG001|Overall Study|Death|0|||
125182441|NCT01514461|450289365|FG002|Overall Study|Death|0|||
125182442|NCT03499067|450289366|FG000|First Intervention|Physician Decision|2|||
125182443|NCT03499067|450289367|FG001|First Intervention|Physician Decision|1|||
125182444|NCT03499067|450289366|FG000|First Intervention|Withdrawal by Subject|3|||
125182445|NCT03499067|450289367|FG001|First Intervention|Withdrawal by Subject|6|||
125182446|NCT02548832|450289368|FG000|Overall Study|Lost to Follow-up|2|||
125182447|NCT02548832|450289369|FG001|Overall Study|Lost to Follow-up|2|||
125182448|NCT02548832|450289370|FG002|Overall Study|Lost to Follow-up|2|||
125182449|NCT03345420|450289371|FG000|Overall Study|Withdrawal by Subject|1|||
125182450|NCT02058069|450289372|FG000|Overall Study|Exclusion due to implant size|5|||
125182451|NCT02058069|450289372|FG000|Overall Study|Withdrawal by Subject|6|||
125182452|NCT00711087|450289394|FG000|Overall Study|Lost to Follow-up|1|||
125182453|NCT00711087|450289395|FG001|Overall Study|Lost to Follow-up|0|||
125182454|NCT00856193|450289396|FG000|Period 2|Abnormal test procedure results|0|||
125182455|NCT00856193|450289397|FG001|Period 2|Abnormal test procedure results|1|||
125182456|NCT00856193|450289396|FG000|Period 2|Lost to Follow-up|0|||
125182457|NCT00856193|450289397|FG001|Period 2|Lost to Follow-up|1|||
125182458|NCT02569801|450289398|FG000|Overall Study|Withdrawal by Subject|9|||
125182459|NCT02569801|450289399|FG001|Overall Study|Withdrawal by Subject|9|||
125182460|NCT02569801|450289398|FG000|Overall Study|Sponsor Decision|13|||
125182461|NCT02569801|450289399|FG001|Overall Study|Sponsor Decision|14|||
125237631|NCT00620542|450497641|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
125182462|NCT02569801|450289398|FG000|Overall Study|Progressive Disease|2|||
125182463|NCT02569801|450289399|FG001|Overall Study|Progressive Disease|7|||
125182464|NCT02569801|450289398|FG000|Overall Study|Lost to Follow-up|0|||
125182465|NCT02569801|450289399|FG001|Overall Study|Lost to Follow-up|1|||
125182466|NCT02569801|450289398|FG000|Overall Study|Death|12|||
125182467|NCT02569801|450289399|FG001|Overall Study|Death|4|||
125182468|NCT00428246|450289400|FG000|Overall Study|Withdrawal by Subject|0|||
125182469|NCT00428246|450289401|FG001|Overall Study|Withdrawal by Subject|0|||
125182470|NCT00428246|450289402|FG002|Overall Study|Withdrawal by Subject|1|||
125182471|NCT00428246|450289400|FG000|Overall Study|Adverse Event|1|||
125182472|NCT00428246|450289401|FG001|Overall Study|Adverse Event|0|||
125182473|NCT00428246|450289402|FG002|Overall Study|Adverse Event|0|||
125182474|NCT01125917|450289404|FG000|Overall Study|Adverse Event|43|||
125182475|NCT01125917|450289404|FG000|Overall Study|Lost to Follow-up|23|||
125182476|NCT01125917|450289404|FG000|Overall Study|Withdrawal by Subject|31|||
125182477|NCT01125917|450289404|FG000|Overall Study|Administrative|223|||
125182478|NCT01125917|450289404|FG000|Overall Study|Lack of Efficacy|19|||
125182479|NCT00838526|450289413|FG000|Overall Study|Adverse Event|3|||
125182480|NCT00838526|450289414|FG001|Overall Study|Adverse Event|12|||
125182481|NCT00838526|450289413|FG000|Overall Study|Lost to Follow-up|4|||
125182482|NCT00838526|450289414|FG001|Overall Study|Lost to Follow-up|12|||
125182483|NCT00838526|450289413|FG000|Overall Study|Withdrawal by Subject|4|||
125182484|NCT00838526|450289414|FG001|Overall Study|Withdrawal by Subject|5|||
125182485|NCT00838526|450289413|FG000|Overall Study|Lack of Efficacy|2|||
125182486|NCT00838526|450289414|FG001|Overall Study|Lack of Efficacy|3|||
125182487|NCT00838526|450289413|FG000|Overall Study|Other|11|||
125182488|NCT00838526|450289414|FG001|Overall Study|Other|7|||
125182489|NCT01320293|450289415|FG000|Overall Study|Lack of Efficacy|1|||
125182490|NCT01320293|450289415|FG000|Overall Study|Adverse Event|1|||
125182491|NCT00470470|450289416|FG000|Overall Study|Adverse Event|2|||
125182492|NCT00470470|450289416|FG000|Overall Study|Death|2|||
125182493|NCT00470470|450289416|FG000|Overall Study|Not treated|1|||
125182494|NCT03483012|450289417|FG000|Overall Study|Lack of Efficacy|6|||
125182495|NCT04782076|450289423|FG000|Overall Study|Family Emergency|1|||
125182496|NCT01949662|450289428|FG000|Overall Study|Death|9|||
125182497|NCT01949662|450289429|FG001|Overall Study|Death|7|||
125182498|NCT01949662|450289428|FG000|Overall Study|Discharged before an agitation event|8|||
125182499|NCT01949662|450289429|FG001|Overall Study|Discharged before an agitation event|3|||
125182500|NCT01949662|450289428|FG000|Overall Study|Dropped out|1|||
125182501|NCT01949662|450289429|FG001|Overall Study|Dropped out|3|||
125182502|NCT01949662|450289428|FG000|Overall Study|Ineligible|0|||
125182503|NCT01949662|450289429|FG001|Overall Study|Ineligible|1|||
125182504|NCT00729937|450289432|FG000|Overall Study|Lost to Follow-up|49|||
125182505|NCT00729937|450289433|FG001|Overall Study|Lost to Follow-up|58|||
125182506|NCT00729937|450289434|FG002|Overall Study|Lost to Follow-up|18|||
125182507|NCT00729937|450289435|FG003|Overall Study|Lost to Follow-up|33|||
125182508|NCT00729937|450289436|FG004|Overall Study|Lost to Follow-up|18|||
125182509|NCT00729937|450289437|FG005|Overall Study|Lost to Follow-up|23|||
125182510|NCT00729937|450289432|FG000|Overall Study|Physician Decision|7|||
125182511|NCT00729937|450289433|FG001|Overall Study|Physician Decision|16|||
125182512|NCT00729937|450289434|FG002|Overall Study|Physician Decision|2|||
125182513|NCT00729937|450289435|FG003|Overall Study|Physician Decision|0|||
125182514|NCT00729937|450289436|FG004|Overall Study|Physician Decision|5|||
125182515|NCT00729937|450289437|FG005|Overall Study|Physician Decision|8|||
125182516|NCT00729937|450289432|FG000|Overall Study|Death|1|||
125182517|NCT00729937|450289433|FG001|Overall Study|Death|0|||
125182518|NCT00729937|450289434|FG002|Overall Study|Death|1|||
125182519|NCT00729937|450289435|FG003|Overall Study|Death|0|||
125182520|NCT00729937|450289436|FG004|Overall Study|Death|0|||
125182521|NCT00729937|450289437|FG005|Overall Study|Death|1|||
125182522|NCT00729937|450289432|FG000|Overall Study|Withdrawal by Subject|3|||
125182523|NCT00729937|450289433|FG001|Overall Study|Withdrawal by Subject|5|||
125182524|NCT00729937|450289434|FG002|Overall Study|Withdrawal by Subject|6|||
125182525|NCT00729937|450289435|FG003|Overall Study|Withdrawal by Subject|0|||
125182526|NCT00729937|450289436|FG004|Overall Study|Withdrawal by Subject|4|||
125182527|NCT00729937|450289437|FG005|Overall Study|Withdrawal by Subject|2|||
125182528|NCT00729937|450289432|FG000|Overall Study|Randomized but not treated|12|||
125182529|NCT00729937|450289433|FG001|Overall Study|Randomized but not treated|6|||
125182530|NCT00729937|450289434|FG002|Overall Study|Randomized but not treated|1|||
125182531|NCT00729937|450289435|FG003|Overall Study|Randomized but not treated|0|||
125182532|NCT00729937|450289436|FG004|Overall Study|Randomized but not treated|1|||
125182533|NCT00729937|450289437|FG005|Overall Study|Randomized but not treated|3|||
125182534|NCT00729937|450289432|FG000|Overall Study|Did not meet eligibility criteria|2|||
125182535|NCT00729937|450289433|FG001|Overall Study|Did not meet eligibility criteria|1|||
125182536|NCT00729937|450289434|FG002|Overall Study|Did not meet eligibility criteria|0|||
125182537|NCT00729937|450289435|FG003|Overall Study|Did not meet eligibility criteria|0|||
125182538|NCT00729937|450289436|FG004|Overall Study|Did not meet eligibility criteria|0|||
125182539|NCT00729937|450289437|FG005|Overall Study|Did not meet eligibility criteria|0|||
125182540|NCT00729937|450289432|FG000|Overall Study|Incarcerated|0|||
125182541|NCT00729937|450289433|FG001|Overall Study|Incarcerated|2|||
125182542|NCT00729937|450289434|FG002|Overall Study|Incarcerated|1|||
125182543|NCT00729937|450289435|FG003|Overall Study|Incarcerated|1|||
125182544|NCT00729937|450289436|FG004|Overall Study|Incarcerated|0|||
125182545|NCT00729937|450289437|FG005|Overall Study|Incarcerated|0|||
125182546|NCT00243412|450289439|FG000|Overall Study|Death|0|||
125182547|NCT00243412|450289440|FG001|Overall Study|Death|1|||
125182548|NCT00243412|450289439|FG000|Overall Study|Adverse Event|4|||
125182549|NCT00243412|450289440|FG001|Overall Study|Adverse Event|2|||
125182550|NCT00243412|450289439|FG000|Overall Study|Lost to Follow-up|0|||
125182551|NCT00243412|450289440|FG001|Overall Study|Lost to Follow-up|1|||
125182552|NCT00243412|450289439|FG000|Overall Study|Physician Decision|1|||
125182553|NCT00243412|450289440|FG001|Overall Study|Physician Decision|1|||
125182554|NCT00243412|450289439|FG000|Overall Study|Withdrawal by Subject|4|||
125182555|NCT00243412|450289440|FG001|Overall Study|Withdrawal by Subject|5|||
125182556|NCT00243412|450289439|FG000|Overall Study|Other|1|||
125182557|NCT00243412|450289440|FG001|Overall Study|Other|1|||
125182558|NCT02586155|450289449|FG000|Overall Study|Adverse Event|2|||
125182559|NCT02586155|450289450|FG001|Overall Study|Adverse Event|3|||
125182560|NCT02586155|450289449|FG000|Overall Study|Withdrawal by Subject|31|||
125182561|NCT02586155|450289450|FG001|Overall Study|Withdrawal by Subject|24|||
125182562|NCT02586155|450289449|FG000|Overall Study|Lost to Follow-up|7|||
125182563|NCT02586155|450289450|FG001|Overall Study|Lost to Follow-up|13|||
125182564|NCT02586155|450289449|FG000|Overall Study|Death|61|||
125182565|NCT02586155|450289450|FG001|Overall Study|Death|72|||
125182566|NCT02586155|450289449|FG000|Overall Study|Other reasons|26|||
125182567|NCT02586155|450289450|FG001|Overall Study|Other reasons|15|||
125182568|NCT04779879|450289451|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
125182569|NCT04779879|450289452|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
125182570|NCT04779879|450289453|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
125182571|NCT04779879|450289454|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
125182572|NCT04779879|450289455|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
125182573|NCT04779879|450289456|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
125182574|NCT04779879|450289451|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
125182575|NCT04779879|450289452|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
125182576|NCT04779879|450289453|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
125182577|NCT04779879|450289454|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
125182578|NCT04779879|450289455|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
125182579|NCT04779879|450289456|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
125182580|NCT04779879|450289451|FG000|Part C: Up to Week 36|Death|0|||
125182581|NCT04779879|450289452|FG001|Part C: Up to Week 36|Death|0|||
125182582|NCT04779879|450289453|FG002|Part C: Up to Week 36|Death|0|||
125182583|NCT04779879|450289454|FG003|Part C: Up to Week 36|Death|0|||
125182584|NCT04779879|450289455|FG004|Part C: Up to Week 36|Death|0|||
125182585|NCT04779879|450289456|FG005|Part C: Up to Week 36|Death|1|||
125182586|NCT04779879|450289451|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
125182587|NCT04779879|450289452|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
125182588|NCT04779879|450289453|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
125182589|NCT04779879|450289454|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
125182590|NCT04779879|450289455|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
125182591|NCT04779879|450289456|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
125182592|NCT02072980|450289457|FG000|Period 2, Second Wear|Adverse Event|0|||
125182593|NCT02072980|450289458|FG001|Period 2, Second Wear|Adverse Event|1|||
125182594|NCT00955617|450289464|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
125182595|NCT00955617|450289465|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
125182596|NCT00955617|450289464|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
125182597|NCT00955617|450289465|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
125182598|NCT00955617|450289464|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
125182599|NCT00955617|450289465|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
125182600|NCT00955617|450289464|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
125182601|NCT00955617|450289465|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
125182602|NCT00070564|450290909|FG000|Overall Study|Progression|2|||
125182603|NCT00070564|450290910|FG001|Overall Study|Progression|4|||
125182604|NCT00070564|450290911|FG002|Overall Study|Progression|7|||
125182605|NCT00070564|450290912|FG003|Overall Study|Progression|7|||
125182606|NCT00070564|450290913|FG004|Overall Study|Progression|1|||
125182607|NCT00070564|450290914|FG005|Overall Study|Progression|0|||
125182608|NCT00070564|450290909|FG000|Overall Study|Delinquent|1|||
125182609|NCT00070564|450290910|FG001|Overall Study|Delinquent|4|||
125182610|NCT00070564|450290911|FG002|Overall Study|Delinquent|2|||
125182611|NCT00070564|450290912|FG003|Overall Study|Delinquent|0|||
125182612|NCT00070564|450290913|FG004|Overall Study|Delinquent|0|||
125182613|NCT00070564|450290914|FG005|Overall Study|Delinquent|0|||
125182614|NCT00070564|450290909|FG000|Overall Study|Adverse Event|150|||
125182615|NCT00070564|450290910|FG001|Overall Study|Adverse Event|142|||
125182616|NCT00070564|450290911|FG002|Overall Study|Adverse Event|120|||
125182617|NCT00070564|450290912|FG003|Overall Study|Adverse Event|108|||
125182618|NCT00070564|450290913|FG004|Overall Study|Adverse Event|63|||
125182619|NCT00070564|450290914|FG005|Overall Study|Adverse Event|36|||
125182620|NCT00070564|450290909|FG000|Overall Study|Death|4|||
125182621|NCT00070564|450290910|FG001|Overall Study|Death|1|||
125182622|NCT00070564|450290911|FG002|Overall Study|Death|5|||
125182623|NCT00070564|450290912|FG003|Overall Study|Death|3|||
125182624|NCT00070564|450290913|FG004|Overall Study|Death|0|||
125182625|NCT00070564|450290914|FG005|Overall Study|Death|1|||
125182626|NCT00070564|450290909|FG000|Overall Study|Other, not protocol specified|17|||
125182627|NCT00070564|450290910|FG001|Overall Study|Other, not protocol specified|15|||
125182628|NCT00070564|450290911|FG002|Overall Study|Other, not protocol specified|14|||
125182629|NCT00070564|450290912|FG003|Overall Study|Other, not protocol specified|19|||
125182630|NCT00070564|450290913|FG004|Overall Study|Other, not protocol specified|6|||
125182631|NCT00070564|450290914|FG005|Overall Study|Other, not protocol specified|7|||
125182632|NCT00070564|450290909|FG000|Overall Study|Withdrawal by Subject|26|||
125182633|NCT00070564|450290910|FG001|Overall Study|Withdrawal by Subject|37|||
125182634|NCT00070564|450290911|FG002|Overall Study|Withdrawal by Subject|23|||
125182635|NCT00070564|450290912|FG003|Overall Study|Withdrawal by Subject|30|||
125182636|NCT00070564|450290913|FG004|Overall Study|Withdrawal by Subject|8|||
125182637|NCT00070564|450290914|FG005|Overall Study|Withdrawal by Subject|8|||
125182638|NCT00070564|450290909|FG000|Overall Study|Not reported|0|||
125182639|NCT00070564|450290910|FG001|Overall Study|Not reported|0|||
125182640|NCT00070564|450290911|FG002|Overall Study|Not reported|0|||
125182641|NCT00070564|450290912|FG003|Overall Study|Not reported|0|||
125182642|NCT00070564|450290913|FG004|Overall Study|Not reported|1|||
125182643|NCT00070564|450290914|FG005|Overall Study|Not reported|0|||
125182644|NCT04576507|450290918|FG000|Overall Study|Adverse Event|4|||
125182645|NCT04576507|450290918|FG000|Overall Study|Withdrawal by Subject|1|||
125182646|NCT01749826|450290923|FG000|Overall Study|Study Terminated|20|||
125182647|NCT01749826|450290924|FG001|Overall Study|Study Terminated|0|||
125182648|NCT02721732|450290925|FG000|Overall Study|Adverse Event|2|||
125182649|NCT02721732|450290926|FG001|Overall Study|Adverse Event|0|||
125182650|NCT02721732|450290927|FG002|Overall Study|Adverse Event|2|||
125182651|NCT02721732|450290928|FG003|Overall Study|Adverse Event|0|||
125182652|NCT02721732|450290929|FG004|Overall Study|Adverse Event|1|||
125182653|NCT02721732|450290930|FG005|Overall Study|Adverse Event|0|||
125182654|NCT02721732|450290931|FG006|Overall Study|Adverse Event|1|||
125182655|NCT02721732|450290932|FG007|Overall Study|Adverse Event|0|||
125182656|NCT02721732|450290933|FG008|Overall Study|Adverse Event|1|||
125182657|NCT02721732|450290934|FG009|Overall Study|Adverse Event|1|||
125182658|NCT02721732|450290925|FG000|Overall Study|Death|0|||
125182659|NCT02721732|450290926|FG001|Overall Study|Death|0|||
125182660|NCT02721732|450290927|FG002|Overall Study|Death|0|||
125182661|NCT02721732|450290928|FG003|Overall Study|Death|0|||
125182662|NCT02721732|450290929|FG004|Overall Study|Death|1|||
125182663|NCT02721732|450290930|FG005|Overall Study|Death|0|||
125182664|NCT02721732|450290931|FG006|Overall Study|Death|1|||
125182665|NCT02721732|450290932|FG007|Overall Study|Death|0|||
125182666|NCT02721732|450290933|FG008|Overall Study|Death|0|||
125182667|NCT02721732|450290934|FG009|Overall Study|Death|1|||
125182668|NCT02721732|450290925|FG000|Overall Study|Lack of Efficacy|12|||
125182669|NCT02721732|450290926|FG001|Overall Study|Lack of Efficacy|11|||
125182670|NCT02721732|450290927|FG002|Overall Study|Lack of Efficacy|18|||
125182671|NCT02721732|450290928|FG003|Overall Study|Lack of Efficacy|5|||
125182672|NCT02721732|450290929|FG004|Overall Study|Lack of Efficacy|21|||
125182673|NCT02721732|450290930|FG005|Overall Study|Lack of Efficacy|2|||
125182674|NCT02721732|450290931|FG006|Overall Study|Lack of Efficacy|8|||
125182675|NCT02721732|450290932|FG007|Overall Study|Lack of Efficacy|11|||
125182676|NCT02721732|450290933|FG008|Overall Study|Lack of Efficacy|10|||
125182677|NCT02721732|450290934|FG009|Overall Study|Lack of Efficacy|20|||
125182678|NCT02721732|450290925|FG000|Overall Study|Physician Decision|0|||
125182679|NCT02721732|450290926|FG001|Overall Study|Physician Decision|0|||
125182680|NCT02721732|450290927|FG002|Overall Study|Physician Decision|1|||
125182681|NCT02721732|450290928|FG003|Overall Study|Physician Decision|0|||
125182682|NCT02721732|450290929|FG004|Overall Study|Physician Decision|0|||
125182683|NCT02721732|450290930|FG005|Overall Study|Physician Decision|0|||
125182684|NCT02721732|450290931|FG006|Overall Study|Physician Decision|0|||
125182685|NCT02721732|450290932|FG007|Overall Study|Physician Decision|0|||
125182686|NCT02721732|450290933|FG008|Overall Study|Physician Decision|0|||
125182687|NCT02721732|450290934|FG009|Overall Study|Physician Decision|0|||
125182688|NCT02721732|450290925|FG000|Overall Study|Withdrawal by Subject|1|||
125182689|NCT02721732|450290926|FG001|Overall Study|Withdrawal by Subject|0|||
125182690|NCT02721732|450290927|FG002|Overall Study|Withdrawal by Subject|0|||
125182691|NCT02721732|450290928|FG003|Overall Study|Withdrawal by Subject|0|||
125182692|NCT02721732|450290929|FG004|Overall Study|Withdrawal by Subject|3|||
125182693|NCT02721732|450290930|FG005|Overall Study|Withdrawal by Subject|0|||
125182694|NCT02721732|450290931|FG006|Overall Study|Withdrawal by Subject|1|||
125182695|NCT02721732|450290932|FG007|Overall Study|Withdrawal by Subject|1|||
125182696|NCT02721732|450290933|FG008|Overall Study|Withdrawal by Subject|0|||
125182697|NCT02721732|450290934|FG009|Overall Study|Withdrawal by Subject|1|||
125182698|NCT02721732|450290925|FG000|Overall Study|Participant Choice|1|||
125182699|NCT02721732|450290926|FG001|Overall Study|Participant Choice|0|||
125182700|NCT02721732|450290927|FG002|Overall Study|Participant Choice|0|||
125182701|NCT02721732|450290928|FG003|Overall Study|Participant Choice|0|||
125182702|NCT02721732|450290929|FG004|Overall Study|Participant Choice|0|||
125182703|NCT02721732|450290930|FG005|Overall Study|Participant Choice|0|||
125182704|NCT02721732|450290931|FG006|Overall Study|Participant Choice|0|||
125182705|NCT02721732|450290932|FG007|Overall Study|Participant Choice|0|||
125182706|NCT02721732|450290933|FG008|Overall Study|Participant Choice|0|||
125182707|NCT02721732|450290934|FG009|Overall Study|Participant Choice|1|||
125182708|NCT02721732|450290925|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
125182709|NCT02721732|450290926|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
125182710|NCT02721732|450290927|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
125182711|NCT02721732|450290928|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
125182712|NCT02721732|450290929|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
125182713|NCT02721732|450290930|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
125182714|NCT02721732|450290931|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
125182715|NCT02721732|450290932|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
125182716|NCT02721732|450290933|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
125182717|NCT02721732|450290934|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
125182718|NCT02721732|450290925|FG000|Overall Study|Progression and withdrew consent|1|||
125182719|NCT02721732|450290926|FG001|Overall Study|Progression and withdrew consent|1|||
125182720|NCT02721732|450290927|FG002|Overall Study|Progression and withdrew consent|0|||
125182721|NCT02721732|450290928|FG003|Overall Study|Progression and withdrew consent|0|||
125182722|NCT02721732|450290929|FG004|Overall Study|Progression and withdrew consent|0|||
125182723|NCT02721732|450290930|FG005|Overall Study|Progression and withdrew consent|0|||
125182724|NCT02721732|450290931|FG006|Overall Study|Progression and withdrew consent|0|||
125182725|NCT02721732|450290932|FG007|Overall Study|Progression and withdrew consent|0|||
125182726|NCT02721732|450290933|FG008|Overall Study|Progression and withdrew consent|0|||
125182727|NCT02721732|450290934|FG009|Overall Study|Progression and withdrew consent|1|||
125182728|NCT02721732|450290925|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
125182729|NCT02721732|450290926|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
125182730|NCT02721732|450290927|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
125182731|NCT02721732|450290928|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
125182732|NCT02721732|450290929|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
125182733|NCT02721732|450290930|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
125182734|NCT02721732|450290931|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
125182735|NCT02721732|450290932|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
125182736|NCT02721732|450290933|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
125182737|NCT02721732|450290934|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
125182738|NCT02572570|450290941|FG000|Overall Study|Study Terminated|27|||
125182739|NCT02763046|450290942|FG000|Overall Study|Adverse Event|5|||
125182740|NCT02763046|450290943|FG001|Overall Study|Adverse Event|4|||
125182741|NCT02763046|450290944|FG002|Overall Study|Adverse Event|0|||
125182742|NCT02763046|450290942|FG000|Overall Study|Lack of Efficacy|1|||
125182743|NCT02763046|450290943|FG001|Overall Study|Lack of Efficacy|1|||
125182744|NCT02763046|450290944|FG002|Overall Study|Lack of Efficacy|3|||
125182745|NCT02763046|450290942|FG000|Overall Study|Physician Decision|1|||
125182746|NCT02763046|450290943|FG001|Overall Study|Physician Decision|0|||
125182747|NCT02763046|450290944|FG002|Overall Study|Physician Decision|1|||
125182748|NCT02763046|450290942|FG000|Overall Study|Subject/guardian decision|2|||
125182749|NCT02763046|450290943|FG001|Overall Study|Subject/guardian decision|0|||
125182750|NCT02763046|450290944|FG002|Overall Study|Subject/guardian decision|4|||
125182751|NCT03052751|450290948|FG000|Dosing Period 1|Adverse Event|0|||
125182752|NCT03052751|450290949|FG001|Dosing Period 1|Adverse Event|1|||
125182753|NCT03052751|450290950|FG002|Dosing Period 1|Adverse Event|0|||
125182754|NCT03052751|450290951|FG003|Dosing Period 1|Adverse Event|0|||
125182755|NCT03052751|450290952|FG004|Dosing Period 1|Adverse Event|0|||
125182756|NCT03052751|450290953|FG005|Dosing Period 1|Adverse Event|0|||
125182757|NCT03052751|450290948|FG000|Dosing Period 2|Adverse Event|0|||
125182758|NCT03052751|450290949|FG001|Dosing Period 2|Adverse Event|0|||
125182759|NCT03052751|450290950|FG002|Dosing Period 2|Adverse Event|3|||
125182760|NCT03052751|450290951|FG003|Dosing Period 2|Adverse Event|0|||
125182761|NCT03052751|450290952|FG004|Dosing Period 2|Adverse Event|0|||
125182762|NCT03052751|450290953|FG005|Dosing Period 2|Adverse Event|0|||
125182763|NCT03052751|450290948|FG000|Observation Period|Adverse Event|0|||
125182764|NCT03052751|450290949|FG001|Observation Period|Adverse Event|0|||
125182765|NCT03052751|450290950|FG002|Observation Period|Adverse Event|0|||
125182766|NCT03052751|450290951|FG003|Observation Period|Adverse Event|0|||
125182767|NCT03052751|450290952|FG004|Observation Period|Adverse Event|1|||
125182768|NCT03052751|450290953|FG005|Observation Period|Adverse Event|0|||
125182769|NCT05017246|450290954|FG000|Overall Study|Withdrawal by Subject|5|||
125182770|NCT05017246|450290955|FG001|Overall Study|Withdrawal by Subject|3|||
125182771|NCT05017246|450290954|FG000|Overall Study|Determined to be ineligible|0|||
125182772|NCT05017246|450290955|FG001|Overall Study|Determined to be ineligible|1|||
125182773|NCT05017246|450290954|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
125182774|NCT05017246|450290955|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
125182775|NCT05017246|450290954|FG000|Overall Study|Technical failure|1|||
125182776|NCT05017246|450290955|FG001|Overall Study|Technical failure|3|||
125182777|NCT02719184|450290956|FG000|Overall Study|Other than listed|1|||
125182778|NCT02719184|450290957|FG001|Overall Study|Other than listed|12|||
125182779|NCT02719184|450290958|FG002|Overall Study|Other than listed|13|||
125182780|NCT02719184|450290959|FG003|Overall Study|Other than listed|22|||
125182781|NCT02719184|450290960|FG004|Overall Study|Other than listed|9|||
125182782|NCT02719184|450290956|FG000|Overall Study|Withdrawal by Subject|5|||
125182783|NCT02719184|450290957|FG001|Overall Study|Withdrawal by Subject|3|||
125182784|NCT02719184|450290958|FG002|Overall Study|Withdrawal by Subject|6|||
125182785|NCT02719184|450290959|FG003|Overall Study|Withdrawal by Subject|6|||
125182786|NCT02719184|450290960|FG004|Overall Study|Withdrawal by Subject|0|||
125182787|NCT02719184|450290956|FG000|Overall Study|Lost to Follow-up|0|||
125182788|NCT02719184|450290957|FG001|Overall Study|Lost to Follow-up|4|||
125182789|NCT02719184|450290958|FG002|Overall Study|Lost to Follow-up|1|||
125182790|NCT02719184|450290959|FG003|Overall Study|Lost to Follow-up|3|||
125182791|NCT02719184|450290960|FG004|Overall Study|Lost to Follow-up|0|||
125182792|NCT02719184|450290956|FG000|Overall Study|Protocol Violation|0|||
125182793|NCT02719184|450290957|FG001|Overall Study|Protocol Violation|3|||
125182794|NCT02719184|450290958|FG002|Overall Study|Protocol Violation|0|||
125182795|NCT02719184|450290959|FG003|Overall Study|Protocol Violation|2|||
125182796|NCT02719184|450290960|FG004|Overall Study|Protocol Violation|0|||
125182797|NCT02719184|450290956|FG000|Overall Study|Adverse Event|0|||
125182798|NCT02719184|450290957|FG001|Overall Study|Adverse Event|0|||
125182799|NCT02719184|450290958|FG002|Overall Study|Adverse Event|0|||
125182800|NCT02719184|450290959|FG003|Overall Study|Adverse Event|3|||
125182801|NCT02719184|450290960|FG004|Overall Study|Adverse Event|0|||
125182802|NCT02439216|450290961|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
125182803|NCT02439216|450290962|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
125182804|NCT02439216|450290963|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
125182805|NCT02439216|450290964|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
125182806|NCT02439216|450290965|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
125182807|NCT02439216|450290966|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
125182808|NCT02439216|450290967|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
125182809|NCT02439216|450290968|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
125182810|NCT02439216|450290969|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
125182811|NCT02439216|450290961|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
125182812|NCT02439216|450290962|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
125182813|NCT02439216|450290963|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
125182814|NCT02439216|450290964|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
125182815|NCT02439216|450290965|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
125182816|NCT02439216|450290966|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
125182817|NCT02439216|450290967|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
125182818|NCT02439216|450290968|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
125182819|NCT02439216|450290969|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
125182820|NCT02439216|450290961|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
125182821|NCT02439216|450290962|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
125182822|NCT02439216|450290963|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
125182823|NCT02439216|450290964|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
125182824|NCT02439216|450290965|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
125182825|NCT02439216|450290966|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
125182826|NCT02439216|450290967|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
125182827|NCT02439216|450290968|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
125182828|NCT02439216|450290969|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
125182829|NCT02439216|450290961|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
125182830|NCT02439216|450290962|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
125182831|NCT02439216|450290963|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
125182832|NCT02439216|450290964|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
125182833|NCT02439216|450290965|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
125182834|NCT02439216|450290966|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
125182835|NCT02439216|450290967|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
125182836|NCT02439216|450290968|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
125182837|NCT02439216|450290969|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
125182838|NCT02439216|450290961|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
125182839|NCT02439216|450290962|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
125182840|NCT02439216|450290963|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
125182841|NCT02439216|450290964|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
125182842|NCT02439216|450290965|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
125182843|NCT02439216|450290966|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
125182844|NCT02439216|450290967|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
125182845|NCT02439216|450290968|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
125182846|NCT02439216|450290969|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
125182847|NCT03359850|450290971|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
125182848|NCT03359850|450290972|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
125182849|NCT03359850|450290971|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
125182850|NCT03359850|450290972|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
125182851|NCT03359850|450290971|FG000|Extension Phase (Up to 28 Months)|Death|2|||
125182852|NCT03359850|450290972|FG001|Extension Phase (Up to 28 Months)|Death|4|||
125182853|NCT03359850|450290971|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
125182854|NCT03359850|450290972|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
125182855|NCT03359850|450290971|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
125182856|NCT03359850|450290972|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
125182857|NCT03472014|450290975|FG000|Overall Study|Lost to Follow-up|4|||
125182858|NCT02792517|450290976|FG000|Overall Study|Withdrawal by Subject|10|||
125182859|NCT02792517|450290976|FG000|Overall Study|Decision by Sponsor|7|||
125182860|NCT02792517|450290976|FG000|Overall Study|Lost to Follow-up|3|||
125182861|NCT03743051|450290981|FG000|Overall Study|Adverse Event|5|||
125182862|NCT03743051|450290982|FG001|Overall Study|Adverse Event|9|||
125182863|NCT03743051|450290981|FG000|Overall Study|Death|27|||
125182864|NCT03743051|450290982|FG001|Overall Study|Death|26|||
125182865|NCT03743051|450290981|FG000|Overall Study|Lost to Follow-up|4|||
125182866|NCT03743051|450290982|FG001|Overall Study|Lost to Follow-up|8|||
125182867|NCT03743051|450290981|FG000|Overall Study|Withdrawal by Subject|32|||
125182868|NCT03743051|450290982|FG001|Overall Study|Withdrawal by Subject|19|||
125182869|NCT03743051|450290981|FG000|Overall Study|Physician Decision|10|||
125182870|NCT03743051|450290982|FG001|Overall Study|Physician Decision|15|||
125182871|NCT03743051|450290981|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
125182872|NCT03743051|450290982|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
125182873|NCT00811733|450290983|FG000|Overall Study|Investigator Discretion|10|||
125182874|NCT00811733|450290984|FG001|Overall Study|Investigator Discretion|8|||
125182875|NCT00811733|450290983|FG000|Overall Study|Withdrawal by Subject|1|||
125182876|NCT00811733|450290984|FG001|Overall Study|Withdrawal by Subject|2|||
125182877|NCT00793871|450290985|FG000|Overall Study|Death|50|||
125182878|NCT00793871|450290985|FG000|Overall Study|Lost to Follow-up|3|||
125182879|NCT00793871|450290985|FG000|Overall Study|Study terminated by the Sponsor|7|||
125182880|NCT02500589|450290987|FG000|Overall Study|Withdrawal by Subject|11|||
125182881|NCT02500589|450290988|FG001|Overall Study|Withdrawal by Subject|14|||
125182882|NCT02500589|450290987|FG000|Overall Study|Lost to Follow-up|10|||
125182883|NCT02500589|450290988|FG001|Overall Study|Lost to Follow-up|12|||
125182884|NCT02500589|450290987|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
125182885|NCT02500589|450290988|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
125182886|NCT02500589|450290987|FG000|Overall Study|Death|7|||
125182887|NCT02500589|450290988|FG001|Overall Study|Death|5|||
125182888|NCT03652051|450290989|FG000|Stage 1|Adverse Event|0|||
125182889|NCT03652051|450290990|FG001|Stage 1|Adverse Event|5|||
125182890|NCT03652051|450290991|FG002|Stage 1|Adverse Event|7|||
125182891|NCT03652051|450290992|FG003|Stage 1|Adverse Event|1|||
125182892|NCT03652051|450290989|FG000|Stage 1|Withdrawal by Subject|0|||
125182893|NCT03652051|450290990|FG001|Stage 1|Withdrawal by Subject|0|||
125182894|NCT03652051|450290991|FG002|Stage 1|Withdrawal by Subject|1|||
125182895|NCT03652051|450290992|FG003|Stage 1|Withdrawal by Subject|0|||
125182896|NCT03652051|450290989|FG000|Stage 2|Adverse Event|0|||
125182897|NCT03652051|450290990|FG001|Stage 2|Adverse Event|2|||
125182898|NCT03652051|450290991|FG002|Stage 2|Adverse Event|1|||
125182899|NCT03652051|450290992|FG003|Stage 2|Adverse Event|0|||
125182900|NCT03652051|450290989|FG000|Stage 2|Protocol Violation|0|||
125182901|NCT03652051|450290990|FG001|Stage 2|Protocol Violation|1|||
125182902|NCT03652051|450290991|FG002|Stage 2|Protocol Violation|6|||
125182903|NCT03652051|450290992|FG003|Stage 2|Protocol Violation|0|||
125182904|NCT03652051|450290989|FG000|Stage 2|Lost to Follow-up|0|||
125182905|NCT03652051|450290990|FG001|Stage 2|Lost to Follow-up|2|||
125182906|NCT03652051|450290991|FG002|Stage 2|Lost to Follow-up|0|||
125182907|NCT03652051|450290992|FG003|Stage 2|Lost to Follow-up|3|||
125182908|NCT03652051|450290989|FG000|Stage 2|Withdrawal by Subject|0|||
125182909|NCT03652051|450290990|FG001|Stage 2|Withdrawal by Subject|11|||
125182910|NCT03652051|450290991|FG002|Stage 2|Withdrawal by Subject|9|||
125182911|NCT03652051|450290992|FG003|Stage 2|Withdrawal by Subject|3|||
125182912|NCT03442751|450290996|FG000|Overall Study|Withdrawal by Subject|3|||
125182913|NCT03442751|450290997|FG001|Overall Study|Withdrawal by Subject|1|||
125182914|NCT03442751|450290996|FG000|Overall Study|Lost to Follow-up|3|||
125182915|NCT03442751|450290997|FG001|Overall Study|Lost to Follow-up|0|||
125182916|NCT02766335|450290999|FG000|Initial Registration|Adverse Event|6|||
125182917|NCT02766335|450291000|FG001|Initial Registration|Adverse Event|3|||
125182918|NCT02766335|450291001|FG002|Initial Registration|Adverse Event|0|||
125182919|NCT02766335|450290999|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
125182920|NCT02766335|450291000|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
125182921|NCT02766335|450291001|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
125182922|NCT02766335|450290999|FG000|Initial Registration|Progression/relapse|49|||
125182923|NCT02766335|450291000|FG001|Initial Registration|Progression/relapse|15|||
125182924|NCT02766335|450291001|FG002|Initial Registration|Progression/relapse|0|||
125182925|NCT02766335|450290999|FG000|Initial Registration|Death|1|||
125182926|NCT02766335|450291000|FG001|Initial Registration|Death|3|||
125182927|NCT02766335|450291001|FG002|Initial Registration|Death|0|||
125182928|NCT02766335|450290999|FG000|Initial Registration|not protocol specified|1|||
125182929|NCT02766335|450291000|FG001|Initial Registration|not protocol specified|9|||
125182930|NCT02766335|450291001|FG002|Initial Registration|not protocol specified|0|||
125182931|NCT02766335|450290999|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
125182932|NCT02766335|450291000|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
125182933|NCT02766335|450291001|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
125182934|NCT02766335|450290999|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
125182935|NCT02766335|450291000|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
125182936|NCT02766335|450291001|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
125182937|NCT01515423|450291008|FG000|Open Label Phase|Adverse Event|57|||
125182938|NCT01515423|450291009|FG001|Open Label Phase|Adverse Event|0|||
125182939|NCT01515423|450291010|FG002|Open Label Phase|Adverse Event|0|||
125182940|NCT01515423|450291008|FG000|Open Label Phase|Death|2|||
125182941|NCT01515423|450291009|FG001|Open Label Phase|Death|0|||
125182942|NCT01515423|450291010|FG002|Open Label Phase|Death|0|||
125182943|NCT01515423|450291008|FG000|Open Label Phase|Lack of Efficacy|117|||
125182944|NCT01515423|450291009|FG001|Open Label Phase|Lack of Efficacy|0|||
125182945|NCT01515423|450291010|FG002|Open Label Phase|Lack of Efficacy|0|||
125182946|NCT01515423|450291008|FG000|Open Label Phase|Lost to Follow-up|21|||
125182947|NCT01515423|450291009|FG001|Open Label Phase|Lost to Follow-up|0|||
125182948|NCT01515423|450291010|FG002|Open Label Phase|Lost to Follow-up|0|||
125182949|NCT01515423|450291008|FG000|Open Label Phase|Withdrawal by Subject|118|||
125182950|NCT01515423|450291009|FG001|Open Label Phase|Withdrawal by Subject|0|||
125182951|NCT01515423|450291010|FG002|Open Label Phase|Withdrawal by Subject|0|||
125182952|NCT01515423|450291008|FG000|Open Label Phase|excluded from DB Phase|70|||
125182953|NCT01515423|450291009|FG001|Open Label Phase|excluded from DB Phase|0|||
125182954|NCT01515423|450291010|FG002|Open Label Phase|excluded from DB Phase|0|||
125182955|NCT01515423|450291008|FG000|Open Label Phase|Other|28|||
125182956|NCT01515423|450291009|FG001|Open Label Phase|Other|0|||
125182957|NCT01515423|450291010|FG002|Open Label Phase|Other|0|||
125182958|NCT01515423|450291008|FG000|DOUBLE BLIND|Adverse Event|0|||
125182959|NCT01515423|450291009|FG001|DOUBLE BLIND|Adverse Event|15|||
125182960|NCT01515423|450291010|FG002|DOUBLE BLIND|Adverse Event|13|||
125182961|NCT01515423|450291008|FG000|DOUBLE BLIND|Death|0|||
125182962|NCT01515423|450291009|FG001|DOUBLE BLIND|Death|1|||
125182963|NCT01515423|450291010|FG002|DOUBLE BLIND|Death|2|||
125182964|NCT01515423|450291008|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
125182965|NCT01515423|450291009|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
125182966|NCT01515423|450291010|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
125182967|NCT01515423|450291008|FG000|DOUBLE BLIND|Pregnancy|0|||
125182968|NCT01515423|450291009|FG001|DOUBLE BLIND|Pregnancy|2|||
125182969|NCT01515423|450291010|FG002|DOUBLE BLIND|Pregnancy|0|||
125182970|NCT01515423|450291008|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
125182971|NCT01515423|450291009|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
125182972|NCT01515423|450291010|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
125182973|NCT01515423|450291008|FG000|DOUBLE BLIND|Other|0|||
125182974|NCT01515423|450291009|FG001|DOUBLE BLIND|Other|6|||
125182975|NCT01515423|450291010|FG002|DOUBLE BLIND|Other|12|||
125182976|NCT01515423|450291008|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
125182977|NCT01515423|450291009|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
125182978|NCT01515423|450291010|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
125182979|NCT04421131|450291013|FG000|Overall Study|Lost to Follow-up|1|||
125182980|NCT04421131|450291013|FG000|Overall Study|Protocol Violation|2|||
125182981|NCT04421131|450291013|FG000|Overall Study|App crashed|5|||
125182982|NCT02501928|450291014|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
125182983|NCT02501928|450291015|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
125182984|NCT02501928|450291016|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
125182985|NCT02501928|450291017|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
125182986|NCT02501928|450291018|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
125182987|NCT02501928|450291019|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
125182988|NCT02452476|450291023|FG000|Overall Study|Death|4|||
125182989|NCT02452476|450291024|FG001|Overall Study|Death|7|||
125182990|NCT02452476|450291023|FG000|Overall Study|Lost to Follow-up|1|||
125182991|NCT02452476|450291024|FG001|Overall Study|Lost to Follow-up|1|||
125182992|NCT02452476|450291023|FG000|Overall Study|Physician Decision|1|||
125182993|NCT02452476|450291024|FG001|Overall Study|Physician Decision|1|||
125182994|NCT02452476|450291023|FG000|Overall Study|Not treated|5|||
125182995|NCT02452476|450291024|FG001|Overall Study|Not treated|1|||
125182996|NCT02201784|450291025|FG000|Overall Study|Failure to achieve adequate block|2|||
125182997|NCT02201784|450291026|FG001|Overall Study|Failure to achieve adequate block|0|||
125182998|NCT01757275|450291027|FG000|Overall Study|Lost to Follow-up|1|||
125182999|NCT01757275|450291028|FG001|Overall Study|Lost to Follow-up|2|||
125183000|NCT01757275|450291027|FG000|Overall Study|Adverse Event|3|||
125183001|NCT01757275|450291028|FG001|Overall Study|Adverse Event|3|||
125183002|NCT01757275|450291027|FG000|Overall Study|Withdrawal by Subject|2|||
125183003|NCT01757275|450291028|FG001|Overall Study|Withdrawal by Subject|4|||
125183004|NCT01757275|450291027|FG000|Overall Study|Not treated|3|||
125183005|NCT01757275|450291028|FG001|Overall Study|Not treated|4|||
125183006|NCT01401452|450291031|FG000|Overall Study|Adverse reaction|9|||
125183007|NCT01401452|450291031|FG000|Overall Study|Lost to Follow-up|12|||
125183008|NCT01401452|450291031|FG000|Overall Study|Lack of Efficacy|30|||
125183009|NCT01401452|450291031|FG000|Overall Study|Participant developed breast cancer|1|||
125183010|NCT01401452|450291031|FG000|Overall Study|Tx stopped due to financial reasons|1|||
125183011|NCT01401452|450291031|FG000|Overall Study|Tx stopped by psychiatrist|1|||
125183012|NCT01401452|450291031|FG000|Overall Study|No more visits within the 36 wk followup|4|||
125183013|NCT01401452|450291031|FG000|Overall Study|Subject did not come to follow up visits|2|||
125183014|NCT01401452|450291031|FG000|Overall Study|Subject didn't return for routine visits|1|||
125183015|NCT01401452|450291031|FG000|Overall Study|Subject moved to another city|1|||
125183016|NCT01401452|450291031|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
125183017|NCT01401452|450291031|FG000|Overall Study|Psoriatic arthritis|1|||
125183018|NCT01401452|450291031|FG000|Overall Study|Participant stopped Tx|2|||
125183019|NCT01401452|450291031|FG000|Overall Study|Discontinuation for personal reasons|1|||
125183020|NCT01401452|450291031|FG000|Overall Study|Treatment failure|1|||
125183021|NCT01401452|450291031|FG000|Overall Study|Unsatisfactory output|1|||
125183022|NCT01401452|450291031|FG000|Overall Study|Subject withdrew because of Tx success|1|||
125183023|NCT01401452|450291031|FG000|Overall Study|Subject chose to discontinue treatment|1|||
125183024|NCT01401452|450291031|FG000|Overall Study|Participant withdrew consent|1|||
125183025|NCT02654054|450291033|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
125183026|NCT02654054|450291034|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
125183027|NCT02654054|450291035|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
125183028|NCT02654054|450291033|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
125183029|NCT02654054|450291034|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125183030|NCT02654054|450291035|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
125183031|NCT02654054|450291033|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
125183032|NCT02654054|450291034|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
125183033|NCT02654054|450291035|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
125183034|NCT02654054|450291033|FG000|Post-Treatment Follow-Up Period|Other|1|||
125183035|NCT02654054|450291034|FG001|Post-Treatment Follow-Up Period|Other|0|||
125183036|NCT02654054|450291035|FG002|Post-Treatment Follow-Up Period|Other|4|||
125183037|NCT02654054|450291033|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
125183038|NCT02654054|450291034|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
125183039|NCT02654054|450291035|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
125183040|NCT00420420|450291036|FG000|Overall Study|Adverse Event|5|||
125183041|NCT00420420|450291037|FG001|Overall Study|Adverse Event|3|||
125183042|NCT00420420|450291036|FG000|Overall Study|Protocol Violation|1|||
125183043|NCT00420420|450291037|FG001|Overall Study|Protocol Violation|1|||
125183044|NCT00420420|450291036|FG000|Overall Study|Withdrawal by Subject|1|||
125183045|NCT00420420|450291037|FG001|Overall Study|Withdrawal by Subject|0|||
125183046|NCT00420420|450291036|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
125183047|NCT00420420|450291037|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
125183048|NCT00273182|450291038|FG000|Overall Study|Death|450|||
125183049|NCT00273182|450291038|FG000|Overall Study|Lost to Follow-up|88|||
125183050|NCT00273182|450291038|FG000|Overall Study|Withdrawal by Subject|257|||
125183051|NCT00273182|450291038|FG000|Overall Study|Device/System Explant|154|||
125183052|NCT00273182|450291038|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
125183053|NCT00856492|450291039|FG000|Overall Study|Ineligible or withdrew consent|1|||
125183054|NCT00856492|450291040|FG001|Overall Study|Ineligible or withdrew consent|1|||
125183055|NCT00856492|450291041|FG002|Overall Study|Ineligible or withdrew consent|2|||
125183056|NCT05842967|450292973|FG000|Period 1: SSA|Adverse Event|1|||
125183057|NCT05842967|450292974|FG001|Period 1: SSA|Adverse Event|1|||
125183058|NCT05842967|450292975|FG002|Period 1: SSA|Adverse Event|0|||
125183059|NCT05842967|450292976|FG003|Period 1: SSA|Adverse Event|0|||
125183060|NCT05842967|450292973|FG000|Period 1: SSA|Death|1|||
125183061|NCT05842967|450292974|FG001|Period 1: SSA|Death|0|||
125183062|NCT05842967|450292975|FG002|Period 1: SSA|Death|0|||
125183063|NCT05842967|450292976|FG003|Period 1: SSA|Death|0|||
125183064|NCT05842967|450292973|FG000|Period 1: SSA|Lost to Follow-up|16|||
125183065|NCT05842967|450292974|FG001|Period 1: SSA|Lost to Follow-up|4|||
125183066|NCT05842967|450292975|FG002|Period 1: SSA|Lost to Follow-up|0|||
125183067|NCT05842967|450292976|FG003|Period 1: SSA|Lost to Follow-up|0|||
125183068|NCT05842967|450292973|FG000|Period 1: SSA|Physician Decision|1|||
125183069|NCT05842967|450292974|FG001|Period 1: SSA|Physician Decision|0|||
125183070|NCT05842967|450292975|FG002|Period 1: SSA|Physician Decision|0|||
125183071|NCT05842967|450292976|FG003|Period 1: SSA|Physician Decision|0|||
125183072|NCT05842967|450292973|FG000|Period 1: SSA|Withdrawal by Subject|2|||
125183073|NCT05842967|450292974|FG001|Period 1: SSA|Withdrawal by Subject|2|||
125183074|NCT05842967|450292975|FG002|Period 1: SSA|Withdrawal by Subject|0|||
125183075|NCT05842967|450292976|FG003|Period 1: SSA|Withdrawal by Subject|0|||
125183076|NCT05842967|450292973|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
125183077|NCT05842967|450292974|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
125183078|NCT05842967|450292975|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
125183079|NCT05842967|450292976|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
125183080|NCT05842967|450292973|FG000|Period 2: SSB|Adverse Event|0|||
125183081|NCT05842967|450292974|FG001|Period 2: SSB|Adverse Event|0|||
125183082|NCT05842967|450292975|FG002|Period 2: SSB|Adverse Event|2|||
125183083|NCT05842967|450292976|FG003|Period 2: SSB|Adverse Event|0|||
125183084|NCT05842967|450292973|FG000|Period 2: SSB|Lost to Follow-up|0|||
125183085|NCT05842967|450292974|FG001|Period 2: SSB|Lost to Follow-up|0|||
125183086|NCT05842967|450292975|FG002|Period 2: SSB|Lost to Follow-up|4|||
125183087|NCT05842967|450292976|FG003|Period 2: SSB|Lost to Follow-up|3|||
125183088|NCT05842967|450292973|FG000|Period 2: SSB|Withdrawal by Subject|0|||
125183089|NCT05842967|450292974|FG001|Period 2: SSB|Withdrawal by Subject|0|||
125183090|NCT05842967|450292975|FG002|Period 2: SSB|Withdrawal by Subject|1|||
125183091|NCT05842967|450292976|FG003|Period 2: SSB|Withdrawal by Subject|0|||
125183092|NCT05842967|450292973|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
125183093|NCT05842967|450292974|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
125183094|NCT05842967|450292975|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
125183095|NCT05842967|450292976|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
125183096|NCT05842967|450292973|FG000|Period 2: SSB|Protocol Violation|0|||
125183097|NCT05842967|450292974|FG001|Period 2: SSB|Protocol Violation|0|||
125183098|NCT05842967|450292975|FG002|Period 2: SSB|Protocol Violation|0|||
125183099|NCT05842967|450292976|FG003|Period 2: SSB|Protocol Violation|1|||
125183100|NCT01103180|450292977|FG000|Overall Study|Withdrawal by Subject|8|||
125183101|NCT01103180|450292978|FG001|Overall Study|Withdrawal by Subject|13|||
125183102|NCT01103180|450292977|FG000|Overall Study|Lost to Follow-up|13|||
125183103|NCT01103180|450292978|FG001|Overall Study|Lost to Follow-up|7|||
125183104|NCT01103180|450292977|FG000|Overall Study|Physician Decision|1|||
125183105|NCT01103180|450292978|FG001|Overall Study|Physician Decision|0|||
125183106|NCT01103180|450292977|FG000|Overall Study|Protocol Violation|0|||
125183107|NCT01103180|450292978|FG001|Overall Study|Protocol Violation|1|||
125183108|NCT01173523|450292979|FG000|Overall Study|Clinical Progression|1|||
125183109|NCT01173523|450292980|FG001|Overall Study|Clinical Progression|1|||
125183110|NCT01173523|450292979|FG000|Overall Study|Progressive Disease|10|||
125183111|NCT01173523|450292980|FG001|Overall Study|Progressive Disease|8|||
125183112|NCT01173523|450292979|FG000|Overall Study|Other|2|||
125183113|NCT01173523|450292980|FG001|Overall Study|Other|3|||
125183114|NCT01439802|450292985|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
125183115|NCT01439802|450292985|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
125183116|NCT01866826|450292986|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
125183117|NCT01866826|450292987|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
125183118|NCT01866826|450292986|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
125183119|NCT01866826|450292987|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
125183120|NCT01866826|450292986|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
125183121|NCT01866826|450292987|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
125183122|NCT02493660|450292988|FG000|Overall Study|Physician Decision|0|||
125183123|NCT02493660|450292989|FG001|Overall Study|Physician Decision|1|||
125183124|NCT02493660|450292988|FG000|Overall Study|Adverse Event|4|||
125183125|NCT02493660|450292989|FG001|Overall Study|Adverse Event|2|||
125183126|NCT02493660|450292988|FG000|Overall Study|Withdrawal by Subject|2|||
125183127|NCT02493660|450292989|FG001|Overall Study|Withdrawal by Subject|3|||
125183128|NCT02493660|450292988|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
125183129|NCT02493660|450292989|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
125183130|NCT02493660|450292988|FG000|Overall Study|Protocol Violation|0|||
125183131|NCT02493660|450292989|FG001|Overall Study|Protocol Violation|1|||
125183132|NCT02493660|450292988|FG000|Overall Study|Death|0|||
125183133|NCT02493660|450292989|FG001|Overall Study|Death|1|||
125183134|NCT02493660|450292988|FG000|Overall Study|Lost to Follow-up|2|||
125183135|NCT02493660|450292989|FG001|Overall Study|Lost to Follow-up|4|||
125183136|NCT02502149|450292993|FG000|Intermediate|Discontinued prematurely|1|||
125183137|NCT02502149|450292994|FG001|Intermediate|Discontinued prematurely|0|||
125183138|NCT02502149|450292995|FG002|Intermediate|Discontinued prematurely|0|||
125183139|NCT02502149|450292996|FG003|Intermediate|Discontinued prematurely|0|||
125183140|NCT02502149|450292997|FG004|Intermediate|Discontinued prematurely|0|||
125183141|NCT02968576|450292998|FG000|Overall Study|Pregnancy|0|||
125183142|NCT02968576|450292999|FG001|Overall Study|Pregnancy|1|||
125183143|NCT02222922|450293000|FG000|Overall Study|Death|0|||
125183144|NCT02222922|450293001|FG001|Overall Study|Death|0|||
125183145|NCT02222922|450293002|FG002|Overall Study|Death|0|||
125183146|NCT02222922|450293003|FG003|Overall Study|Death|0|||
125183147|NCT02222922|450293004|FG004|Overall Study|Death|13|||
125183148|NCT02222922|450293005|FG005|Overall Study|Death|0|||
125183149|NCT02222922|450293006|FG006|Overall Study|Death|0|||
125183150|NCT02222922|450293007|FG007|Overall Study|Death|0|||
125183151|NCT02222922|450293008|FG008|Overall Study|Death|2|||
125183152|NCT02222922|450293000|FG000|Overall Study|Lost to Follow-up|0|||
125183153|NCT02222922|450293001|FG001|Overall Study|Lost to Follow-up|0|||
125183154|NCT02222922|450293002|FG002|Overall Study|Lost to Follow-up|1|||
125183155|NCT02222922|450293003|FG003|Overall Study|Lost to Follow-up|0|||
125183156|NCT02222922|450293004|FG004|Overall Study|Lost to Follow-up|9|||
125183157|NCT02222922|450293005|FG005|Overall Study|Lost to Follow-up|1|||
125183158|NCT02222922|450293006|FG006|Overall Study|Lost to Follow-up|0|||
125183159|NCT02222922|450293007|FG007|Overall Study|Lost to Follow-up|0|||
125183160|NCT02222922|450293008|FG008|Overall Study|Lost to Follow-up|0|||
125183161|NCT02222922|450293000|FG000|Overall Study|Other|0|||
125183162|NCT02222922|450293001|FG001|Overall Study|Other|0|||
125183163|NCT02222922|450293002|FG002|Overall Study|Other|0|||
125183164|NCT02222922|450293003|FG003|Overall Study|Other|2|||
125183165|NCT02222922|450293004|FG004|Overall Study|Other|10|||
125183166|NCT02222922|450293005|FG005|Overall Study|Other|2|||
125183167|NCT02222922|450293006|FG006|Overall Study|Other|2|||
125183168|NCT02222922|450293007|FG007|Overall Study|Other|4|||
125183169|NCT02222922|450293008|FG008|Overall Study|Other|1|||
125183170|NCT02222922|450293000|FG000|Overall Study|Participant refused further follow-up|1|||
125183171|NCT02222922|450293001|FG001|Overall Study|Participant refused further follow-up|0|||
125183172|NCT02222922|450293002|FG002|Overall Study|Participant refused further follow-up|0|||
125183173|NCT02222922|450293003|FG003|Overall Study|Participant refused further follow-up|1|||
125183174|NCT02222922|450293004|FG004|Overall Study|Participant refused further follow-up|6|||
125183175|NCT02222922|450293005|FG005|Overall Study|Participant refused further follow-up|0|||
125183176|NCT02222922|450293006|FG006|Overall Study|Participant refused further follow-up|0|||
125183177|NCT02222922|450293007|FG007|Overall Study|Participant refused further follow-up|0|||
125183178|NCT02222922|450293008|FG008|Overall Study|Participant refused further follow-up|3|||
125183179|NCT00116779|450293012|FG000|Overall Study|Adverse Event|4|||
125183180|NCT00116779|450293013|FG001|Overall Study|Adverse Event|2|||
125183181|NCT00116779|450293012|FG000|Overall Study|Protocol Violation|1|||
125183182|NCT00116779|450293013|FG001|Overall Study|Protocol Violation|4|||
125183183|NCT00116779|450293012|FG000|Overall Study|Withdrawal by Subject|4|||
125183184|NCT00116779|450293013|FG001|Overall Study|Withdrawal by Subject|1|||
125183185|NCT00116779|450293012|FG000|Overall Study|Inadequate testosterone suppression|7|||
125183186|NCT00116779|450293013|FG001|Overall Study|Inadequate testosterone suppression|9|||
125183187|NCT00116779|450293012|FG000|Overall Study|Physician Decision|3|||
125183188|NCT00116779|450293013|FG001|Overall Study|Physician Decision|1|||
125183189|NCT00116779|450293012|FG000|Overall Study|Elevated PSA levels|2|||
125183190|NCT00116779|450293013|FG001|Overall Study|Elevated PSA levels|2|||
125183191|NCT02105467|450293014|FG000|Period 1|Lost to Follow-up|1|||
125183192|NCT02105467|450293015|FG001|Period 1|Lost to Follow-up|0|||
125183193|NCT02105467|450293014|FG000|Period 1|Death|1|||
125183194|NCT02105467|450293015|FG001|Period 1|Death|0|||
125183195|NCT02105467|450293014|FG000|Period 2|Lost to Follow-up|1|||
125183196|NCT02105467|450293015|FG001|Period 2|Lost to Follow-up|0|||
125183197|NCT02105467|450293014|FG000|Period 2|Death|1|||
125183198|NCT02105467|450293015|FG001|Period 2|Death|0|||
125183199|NCT02105467|450293014|FG000|Period 2|Withdrawal by Subject|0|||
125237632|NCT00620542|450497638|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
125183200|NCT02105467|450293015|FG001|Period 2|Withdrawal by Subject|2|||
125237633|NCT00620542|450497639|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
125183201|NCT02105467|450293014|FG000|Period 3|Lost to Follow-up|0|||
125183202|NCT02105467|450293015|FG001|Period 3|Lost to Follow-up|1|||
125183203|NCT01037218|450293016|FG000|Overall Study|Adverse Event|4|||
125183204|NCT01037218|450293017|FG001|Overall Study|Adverse Event|2|||
125183205|NCT01037218|450293018|FG002|Overall Study|Adverse Event|2|||
125183206|NCT01037218|450293019|FG003|Overall Study|Adverse Event|1|||
125183207|NCT01037218|450293016|FG000|Overall Study|Lack of Efficacy|0|||
125183208|NCT01037218|450293017|FG001|Overall Study|Lack of Efficacy|2|||
125183209|NCT01037218|450293018|FG002|Overall Study|Lack of Efficacy|1|||
125183210|NCT01037218|450293019|FG003|Overall Study|Lack of Efficacy|5|||
125183211|NCT01037218|450293016|FG000|Overall Study|Lost to Follow-up|3|||
125183212|NCT01037218|450293017|FG001|Overall Study|Lost to Follow-up|5|||
125183213|NCT01037218|450293018|FG002|Overall Study|Lost to Follow-up|4|||
125183214|NCT01037218|450293019|FG003|Overall Study|Lost to Follow-up|2|||
125183215|NCT01037218|450293016|FG000|Overall Study|Withdrawal by Subject|6|||
125183216|NCT01037218|450293017|FG001|Overall Study|Withdrawal by Subject|7|||
125183217|NCT01037218|450293018|FG002|Overall Study|Withdrawal by Subject|7|||
125183218|NCT01037218|450293019|FG003|Overall Study|Withdrawal by Subject|4|||
125183219|NCT01037218|450293016|FG000|Overall Study|Partner Withdrew Consent|0|||
125183220|NCT01037218|450293017|FG001|Overall Study|Partner Withdrew Consent|3|||
125183221|NCT01037218|450293018|FG002|Overall Study|Partner Withdrew Consent|2|||
125183222|NCT01037218|450293019|FG003|Overall Study|Partner Withdrew Consent|1|||
125183223|NCT01037218|450293016|FG000|Overall Study|Protocol Violation|0|||
125183224|NCT01037218|450293017|FG001|Overall Study|Protocol Violation|0|||
125183225|NCT01037218|450293018|FG002|Overall Study|Protocol Violation|2|||
125183226|NCT01037218|450293019|FG003|Overall Study|Protocol Violation|2|||
125183227|NCT01037218|450293016|FG000|Overall Study|Various|3|||
125183228|NCT01037218|450293017|FG001|Overall Study|Various|2|||
125183229|NCT01037218|450293018|FG002|Overall Study|Various|3|||
125183230|NCT01037218|450293019|FG003|Overall Study|Various|1|||
125183231|NCT02676882|450293020|FG000|Overall Study|Adverse Event|1|||
125183232|NCT02676882|450293021|FG001|Overall Study|Adverse Event|0|||
125183233|NCT02676882|450293020|FG000|Overall Study|Lost to Follow-up|1|||
125183234|NCT02676882|450293021|FG001|Overall Study|Lost to Follow-up|0|||
125183235|NCT02676882|450293020|FG000|Overall Study|Withdrawal by Subject|1|||
125183236|NCT02676882|450293021|FG001|Overall Study|Withdrawal by Subject|2|||
125183237|NCT02568072|450293022|FG000|Overall Study|Unavailable for appointment|23|||
125183238|NCT02568072|450293022|FG000|Overall Study|Unable to contact|3|||
125183239|NCT02568072|450293022|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
125183240|NCT02568072|450293022|FG000|Overall Study|Withdrawal by Subject|1|||
125183241|NCT02568072|450293022|FG000|Overall Study|Sustained injury, marathon not run|24|||
125183242|NCT01321879|450293026|FG000|Overall Study|Lack of Efficacy|5|||
125183243|NCT01321879|450293026|FG000|Overall Study|Adverse Event|5|||
125183244|NCT01321879|450293026|FG000|Overall Study|Death|3|||
125183245|NCT01321879|450293026|FG000|Overall Study|Withdrawal by Subject|1|||
125183246|NCT00897715|450293027|FG000|Overall Study|Lost to Follow-up|0|||
125183247|NCT00897715|450293028|FG001|Overall Study|Lost to Follow-up|1|||
125183248|NCT00897715|450293027|FG000|Overall Study|Physician Decision|1|||
125183249|NCT00897715|450293028|FG001|Overall Study|Physician Decision|0|||
125183250|NCT00897715|450293027|FG000|Overall Study|increased risk of infection|1|||
125183251|NCT00897715|450293028|FG001|Overall Study|increased risk of infection|0|||
125183252|NCT00958828|450293029|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
125183253|NCT00958828|450293030|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
125183254|NCT00958828|450293029|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
125183255|NCT00958828|450293030|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
125183256|NCT02687451|450293032|FG000|Overall Study|Withdrawal by Subject|1|||
125183257|NCT02687451|450293033|FG001|Overall Study|Withdrawal by Subject|0|||
125183258|NCT02687451|450293034|FG002|Overall Study|Withdrawal by Subject|0|||
125183259|NCT02687451|450293035|FG003|Overall Study|Withdrawal by Subject|0|||
125183260|NCT02687451|450293036|FG004|Overall Study|Withdrawal by Subject|0|||
125183261|NCT02687451|450293037|FG005|Overall Study|Withdrawal by Subject|1|||
125183262|NCT01125189|450293044|FG000|Treatment Period|Lack of Efficacy|15|||
125183263|NCT01125189|450293045|FG001|Treatment Period|Lack of Efficacy|18|||
125183264|NCT01125189|450293046|FG002|Treatment Period|Lack of Efficacy|25|||
125183265|NCT01125189|450293044|FG000|Treatment Period|Adverse Event|7|||
125183266|NCT01125189|450293045|FG001|Treatment Period|Adverse Event|8|||
125183267|NCT01125189|450293046|FG002|Treatment Period|Adverse Event|8|||
125183268|NCT01125189|450293044|FG000|Treatment Period|Withdrawal by Subject|3|||
125183269|NCT01125189|450293045|FG001|Treatment Period|Withdrawal by Subject|1|||
125183270|NCT01125189|450293046|FG002|Treatment Period|Withdrawal by Subject|1|||
125183271|NCT01125189|450293044|FG000|Treatment Period|Death|1|||
125183272|NCT01125189|450293045|FG001|Treatment Period|Death|0|||
125183273|NCT01125189|450293046|FG002|Treatment Period|Death|0|||
125183274|NCT01125189|450293044|FG000|Treatment Period|Lost to Follow-up|1|||
125183275|NCT01125189|450293045|FG001|Treatment Period|Lost to Follow-up|2|||
125183276|NCT01125189|450293046|FG002|Treatment Period|Lost to Follow-up|1|||
125183277|NCT01125189|450293044|FG000|Treatment Period|Poor compliance/noncompliance|0|||
125183278|NCT01125189|450293045|FG001|Treatment Period|Poor compliance/noncompliance|1|||
125183279|NCT01125189|450293046|FG002|Treatment Period|Poor compliance/noncompliance|0|||
125183280|NCT01125189|450293044|FG000|Treatment Period|Participants requested to discontinue|1|||
125183281|NCT01125189|450293045|FG001|Treatment Period|Participants requested to discontinue|3|||
125183282|NCT01125189|450293046|FG002|Treatment Period|Participants requested to discontinue|4|||
125183283|NCT01125189|450293044|FG000|Treatment Period|Other reasons|1|||
125183284|NCT01125189|450293045|FG001|Treatment Period|Other reasons|1|||
125183285|NCT01125189|450293046|FG002|Treatment Period|Other reasons|0|||
125183286|NCT01125189|450293044|FG000|Treatment Period|Completed 24 week treatment period only|2|||
125183287|NCT01125189|450293045|FG001|Treatment Period|Completed 24 week treatment period only|1|||
125183288|NCT01125189|450293046|FG002|Treatment Period|Completed 24 week treatment period only|2|||
125183289|NCT01125189|450293044|FG000|Follow up Period|Withdrawal by Subject|3|||
125183290|NCT01125189|450293045|FG001|Follow up Period|Withdrawal by Subject|2|||
125183291|NCT01125189|450293046|FG002|Follow up Period|Withdrawal by Subject|5|||
125183292|NCT01125189|450293044|FG000|Follow up Period|Death|1|||
125183293|NCT01125189|450293045|FG001|Follow up Period|Death|0|||
125183294|NCT01125189|450293046|FG002|Follow up Period|Death|0|||
125183295|NCT01125189|450293044|FG000|Follow up Period|Lost to Follow-up|12|||
125183296|NCT01125189|450293045|FG001|Follow up Period|Lost to Follow-up|9|||
125183297|NCT01125189|450293046|FG002|Follow up Period|Lost to Follow-up|6|||
125183298|NCT01125189|450293044|FG000|Follow up Period|Other reasons|4|||
125183299|NCT01125189|450293045|FG001|Follow up Period|Other reasons|4|||
125183300|NCT01125189|450293046|FG002|Follow up Period|Other reasons|5|||
125183301|NCT00927589|450293047|FG000|Overall Study|Death|1|||
125183302|NCT00927589|450293047|FG000|Overall Study|Physician Decision|1|||
125183303|NCT00927589|450293047|FG000|Overall Study|Withdrawal by Subject|3|||
125183304|NCT00927589|450293047|FG000|Overall Study|Adverse Event|2|||
125183305|NCT00927589|450293047|FG000|Overall Study|Disease Progression|8|||
125183306|NCT00927589|450293047|FG000|Overall Study|Non-compliance|1|||
125183307|NCT00707239|450293048|FG000|Overall Study|Adverse Event|5|||
125183308|NCT00707239|450293049|FG001|Overall Study|Adverse Event|3|||
125183309|NCT00707239|450293050|FG002|Overall Study|Adverse Event|2|||
125183310|NCT00707239|450293048|FG000|Overall Study|Death|3|||
125183311|NCT00707239|450293049|FG001|Overall Study|Death|1|||
125183312|NCT00707239|450293050|FG002|Overall Study|Death|3|||
125183313|NCT00707239|450293048|FG000|Overall Study|Physician Decision|1|||
125183314|NCT00707239|450293049|FG001|Overall Study|Physician Decision|1|||
125183315|NCT00707239|450293050|FG002|Overall Study|Physician Decision|2|||
125183316|NCT00707239|450293048|FG000|Overall Study|Protocol Violation|0|||
125183317|NCT00707239|450293049|FG001|Overall Study|Protocol Violation|0|||
125183318|NCT00707239|450293050|FG002|Overall Study|Protocol Violation|1|||
125183319|NCT00707239|450293048|FG000|Overall Study|Lack of Efficacy|1|||
125183320|NCT00707239|450293049|FG001|Overall Study|Lack of Efficacy|2|||
125183321|NCT00707239|450293050|FG002|Overall Study|Lack of Efficacy|0|||
125183322|NCT00707239|450293048|FG000|Overall Study|Randomized, but not treated|1|||
125183323|NCT00707239|450293049|FG001|Overall Study|Randomized, but not treated|1|||
125183324|NCT00707239|450293050|FG002|Overall Study|Randomized, but not treated|1|||
125183325|NCT00707239|450293048|FG000|Overall Study|Other|8|||
125183326|NCT00707239|450293049|FG001|Overall Study|Other|3|||
125183327|NCT00707239|450293050|FG002|Overall Study|Other|5|||
125183328|NCT01651117|450293053|FG000|Overall Study|Death|2|||
125183329|NCT01651117|450293054|FG001|Overall Study|Death|3|||
125183330|NCT01651117|450293055|FG002|Overall Study|Death|2|||
125183331|NCT01651117|450293056|FG003|Overall Study|Death|2|||
125183332|NCT02714218|450293059|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125183333|NCT02714218|450293060|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
125183334|NCT02714218|450293061|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125183335|NCT02714218|450293059|FG000|Pre-Treatment Period|Other reasons|0|||
125183336|NCT02714218|450293060|FG001|Pre-Treatment Period|Other reasons|1|||
125183337|NCT02714218|450293061|FG002|Pre-Treatment Period|Other reasons|0|||
125183338|NCT02714218|450293059|FG000|Treatment Period|Disease Progression|55|||
125183339|NCT02714218|450293060|FG001|Treatment Period|Disease Progression|52|||
125183340|NCT02714218|450293061|FG002|Treatment Period|Disease Progression|14|||
125183341|NCT02714218|450293059|FG000|Treatment Period|Study drug toxicity|46|||
125183342|NCT02714218|450293060|FG001|Treatment Period|Study drug toxicity|70|||
125183343|NCT02714218|450293061|FG002|Treatment Period|Study drug toxicity|6|||
125183344|NCT02714218|450293059|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
125183345|NCT02714218|450293060|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
125183346|NCT02714218|450293061|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
125183347|NCT02714218|450293059|FG000|Treatment Period|Request to discontinue treatment|1|||
125183348|NCT02714218|450293060|FG001|Treatment Period|Request to discontinue treatment|4|||
125183349|NCT02714218|450293061|FG002|Treatment Period|Request to discontinue treatment|1|||
125183350|NCT02714218|450293059|FG000|Treatment Period|Participant withdrew consent|2|||
125183351|NCT02714218|450293060|FG001|Treatment Period|Participant withdrew consent|2|||
125183352|NCT02714218|450293061|FG002|Treatment Period|Participant withdrew consent|0|||
125183353|NCT02714218|450293059|FG000|Treatment Period|Maximum clinical benefit|4|||
125183354|NCT02714218|450293060|FG001|Treatment Period|Maximum clinical benefit|2|||
125183355|NCT02714218|450293061|FG002|Treatment Period|Maximum clinical benefit|0|||
125183356|NCT02714218|450293059|FG000|Treatment Period|Administrative reason by sponsor|2|||
125183357|NCT02714218|450293060|FG001|Treatment Period|Administrative reason by sponsor|1|||
125183358|NCT02714218|450293061|FG002|Treatment Period|Administrative reason by sponsor|0|||
125183359|NCT02714218|450293059|FG000|Treatment Period|Other reasons|6|||
125183360|NCT02714218|450293060|FG001|Treatment Period|Other reasons|6|||
125183361|NCT02714218|450293061|FG002|Treatment Period|Other reasons|0|||
125183362|NCT02714218|450293059|FG000|Treatment Period|Completed treatment as per protocol|36|||
125183363|NCT02714218|450293060|FG001|Treatment Period|Completed treatment as per protocol|27|||
125183364|NCT02714218|450293061|FG002|Treatment Period|Completed treatment as per protocol|3|||
125183365|NCT02714218|450293059|FG000|Treatment Period|Not reported|9|||
125183366|NCT02714218|450293060|FG001|Treatment Period|Not reported|6|||
125183367|NCT02714218|450293061|FG002|Treatment Period|Not reported|0|||
125183368|NCT01113892|450293062|FG000|Overall Study|Lost to Follow-up|2|||
125183369|NCT01113892|450293063|FG001|Overall Study|Lost to Follow-up|2|||
125183370|NCT01113892|450293062|FG000|Overall Study|Withdrawal by Subject|1|||
125183371|NCT01113892|450293063|FG001|Overall Study|Withdrawal by Subject|1|||
125183372|NCT01113892|450293062|FG000|Overall Study|Death|2|||
125183373|NCT01113892|450293063|FG001|Overall Study|Death|4|||
125183374|NCT01113892|450293062|FG000|Overall Study|Graft no longer evaluable|9|||
125183375|NCT01113892|450293063|FG001|Overall Study|Graft no longer evaluable|9|||
125183376|NCT02603887|450293069|FG000|Stage 1|Adverse Event|4|||
125183377|NCT02603887|450293069|FG000|Stage 1|Disease progression|1|||
125183378|NCT02603887|450293069|FG000|Stage 2|FDA guidance|1|||
125183379|NCT00235755|450293078|FG000|4-Week Titration Phase|Adverse Event|6|||
125183380|NCT00235755|450293079|FG001|4-Week Titration Phase|Adverse Event|14|||
125183381|NCT00235755|450293080|FG002|4-Week Titration Phase|Adverse Event|20|||
125183382|NCT00235755|450293078|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
125183383|NCT00235755|450293079|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
125183384|NCT00235755|450293080|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
125183385|NCT00235755|450293078|FG000|4-Week Titration Phase|Protocol Violation|2|||
125183386|NCT00235755|450293079|FG001|4-Week Titration Phase|Protocol Violation|2|||
125183387|NCT00235755|450293080|FG002|4-Week Titration Phase|Protocol Violation|1|||
125183388|NCT00235755|450293078|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
125183389|NCT00235755|450293079|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
125183390|NCT00235755|450293080|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
125183391|NCT00235755|450293078|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
125183392|NCT00235755|450293079|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
125183393|NCT00235755|450293080|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
125183394|NCT00235755|450293078|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
125183395|NCT00235755|450293079|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
125183396|NCT00235755|450293080|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
125183397|NCT00235755|450293078|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
125183398|NCT00235755|450293079|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
125183399|NCT00235755|450293080|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
125183400|NCT00235755|450293078|FG000|12-Week Maintenance Phase|Adverse Event|8|||
125183401|NCT00235755|450293079|FG001|12-Week Maintenance Phase|Adverse Event|12|||
125183402|NCT00235755|450293080|FG002|12-Week Maintenance Phase|Adverse Event|26|||
125183403|NCT00235755|450293078|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
125183404|NCT00235755|450293079|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
125183405|NCT00235755|450293080|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
125183406|NCT00235755|450293078|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
125183407|NCT00235755|450293079|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
125183408|NCT00235755|450293080|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
125183409|NCT00235755|450293078|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
125183410|NCT00235755|450293079|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
125183411|NCT00235755|450293080|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
125183412|NCT00235755|450293078|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
125183413|NCT00235755|450293079|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
125183414|NCT00235755|450293080|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
125183415|NCT00235755|450293078|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
125183416|NCT00235755|450293079|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
125183417|NCT00235755|450293080|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
125183418|NCT03164551|450293081|FG000|Overall Study|Imaging discontinued prior completion|8|||
125183419|NCT03164551|450293082|FG001|Overall Study|Imaging discontinued prior completion|0|||
125183420|NCT03164551|450293081|FG000|Overall Study|Participant was non-compliant|1|||
125183421|NCT03164551|450293082|FG001|Overall Study|Participant was non-compliant|0|||
125183422|NCT03164551|450293081|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
125183423|NCT03164551|450293082|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
125183424|NCT03164551|450293081|FG000|Overall Study|Other|8|||
125183425|NCT03164551|450293082|FG001|Overall Study|Other|2|||
125183426|NCT02314026|450293085|FG000|Overall Study|Protocol Violation|28|||
125183427|NCT01406574|450293087|FG000|Overall Study|Adverse Event|0|||
125183428|NCT01406574|450293088|FG001|Overall Study|Adverse Event|0|||
125183429|NCT01406574|450293089|FG002|Overall Study|Adverse Event|1|||
125183430|NCT01406574|450293090|FG003|Overall Study|Adverse Event|3|||
125183431|NCT01406574|450293087|FG000|Overall Study|Physician Decision|0|||
125183432|NCT01406574|450293088|FG001|Overall Study|Physician Decision|0|||
125183433|NCT01406574|450293089|FG002|Overall Study|Physician Decision|0|||
125183434|NCT01406574|450293090|FG003|Overall Study|Physician Decision|1|||
125183435|NCT01406574|450293087|FG000|Overall Study|Withdrawal by Subject|0|||
125183436|NCT01406574|450293088|FG001|Overall Study|Withdrawal by Subject|1|||
125183437|NCT01406574|450293089|FG002|Overall Study|Withdrawal by Subject|0|||
125183438|NCT01406574|450293090|FG003|Overall Study|Withdrawal by Subject|0|||
125183439|NCT01406574|450293087|FG000|Overall Study|Definite progression of primary disease|1|||
125183440|NCT01406574|450293088|FG001|Overall Study|Definite progression of primary disease|0|||
125183441|NCT01406574|450293089|FG002|Overall Study|Definite progression of primary disease|0|||
125183442|NCT01406574|450293090|FG003|Overall Study|Definite progression of primary disease|0|||
125183443|NCT04052620|450293091|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
125183444|NCT04052620|450293092|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
125183445|NCT04052620|450293091|FG000|Overall Study|Withdrawal by Subject|1|||
125183446|NCT04052620|450293092|FG001|Overall Study|Withdrawal by Subject|0|||
125183447|NCT04052620|450293091|FG000|Overall Study|Lost to Follow-up|1|||
125183448|NCT04052620|450293092|FG001|Overall Study|Lost to Follow-up|1|||
125183449|NCT04052620|450293091|FG000|Overall Study|Adverse Event|1|||
125183450|NCT04052620|450293092|FG001|Overall Study|Adverse Event|0|||
125183451|NCT04052620|450293091|FG000|Overall Study|Subject did not meet study Criteria|0|||
125183452|NCT04052620|450293092|FG001|Overall Study|Subject did not meet study Criteria|1|||
125183453|NCT04052620|450293091|FG000|Overall Study|Screened failure, randomized by mistake|0|||
125183454|NCT04052620|450293092|FG001|Overall Study|Screened failure, randomized by mistake|1|||
125183455|NCT04052620|450293091|FG000|Overall Study|Personal reasons|2|||
125183456|NCT04052620|450293092|FG001|Overall Study|Personal reasons|4|||
125183457|NCT04052620|450293091|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
125183458|NCT04052620|450293092|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
125183459|NCT03552380|450293093|FG000|Study Treatment|Disease Progression|3|||
125183460|NCT03552380|450293094|FG001|Study Treatment|Disease Progression|4|||
125183461|NCT03552380|450293093|FG000|Study Treatment|Adverse Event|2|||
125183462|NCT03552380|450293094|FG001|Study Treatment|Adverse Event|2|||
125183463|NCT03552380|450293093|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
125183464|NCT03552380|450293094|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
125183465|NCT03552380|450293093|FG000|Follow up|Death|3|||
125183466|NCT03552380|450293094|FG001|Follow up|Death|4|||
125183467|NCT03552380|450293093|FG000|Follow up|Site IRB terminated|0|||
125183468|NCT03552380|450293094|FG001|Follow up|Site IRB terminated|1|||
125183469|NCT02431364|450293099|FG000|Overall Study|Adverse Event|0|||
125183470|NCT02431364|450293100|FG001|Overall Study|Adverse Event|1|||
125183471|NCT02431364|450293101|FG002|Overall Study|Adverse Event|0|||
125183472|NCT02431364|450293102|FG003|Overall Study|Adverse Event|0|||
125183473|NCT02431364|450293103|FG004|Overall Study|Adverse Event|0|||
125183474|NCT02431364|450293099|FG000|Overall Study|Randomized but never treated|0|||
125183475|NCT02431364|450293100|FG001|Overall Study|Randomized but never treated|0|||
125183476|NCT02431364|450293101|FG002|Overall Study|Randomized but never treated|0|||
125183477|NCT02431364|450293102|FG003|Overall Study|Randomized but never treated|1|||
125183478|NCT02431364|450293103|FG004|Overall Study|Randomized but never treated|0|||
125183479|NCT00916383|450293104|FG000|Overall Study|Adverse Event|1|||
125183480|NCT00916383|450293104|FG000|Overall Study|Death|1|||
125183481|NCT00916383|450293104|FG000|Overall Study|Protocol Violation|1|||
125183482|NCT00258960|450293105|FG000|Overall Study|Death|2|||
125183483|NCT00258960|450293105|FG000|Overall Study|Disease Progression|7|||
125183484|NCT00258960|450293105|FG000|Overall Study|Adverse Event|4|||
125183485|NCT00258960|450293105|FG000|Overall Study|Physician Decision|1|||
125183486|NCT00258960|450293105|FG000|Overall Study|Withdrawal by Subject|1|||
125183487|NCT00258960|450293105|FG000|Overall Study|Mistake|2|||
125183488|NCT00473590|450293106|FG000|Overall Study|Adverse Event|3|||
125183489|NCT00473590|450293107|FG001|Overall Study|Adverse Event|3|||
125183490|NCT00473590|450293106|FG000|Overall Study|Death|4|||
125183491|NCT00473590|450293107|FG001|Overall Study|Death|2|||
125183492|NCT00473590|450293106|FG000|Overall Study|Progression not resulting in death|24|||
125183493|NCT00473590|450293107|FG001|Overall Study|Progression not resulting in death|20|||
125183494|NCT00473590|450293106|FG000|Overall Study|Non-protocol-specified therapy|7|||
125183495|NCT00473590|450293107|FG001|Overall Study|Non-protocol-specified therapy|5|||
125183496|NCT00473590|450293106|FG000|Overall Study|Physician Decision|2|||
125183497|NCT00473590|450293107|FG001|Overall Study|Physician Decision|4|||
125183498|NCT00473590|450293106|FG000|Overall Study|Withdrawal by Subject|5|||
125183499|NCT00473590|450293107|FG001|Overall Study|Withdrawal by Subject|3|||
125183500|NCT00473590|450293106|FG000|Overall Study|Other|0|||
125183501|NCT00473590|450293107|FG001|Overall Study|Other|1|||
125183502|NCT01112059|450293108|FG000|Overall Study|Withdrawal by Subject|1|||
125183503|NCT01112059|450293109|FG001|Overall Study|Withdrawal by Subject|0|||
125183504|NCT03367819|450293114|FG000|Overall Study|Adverse Event|4|||
125237634|NCT00620542|450497640|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
125183505|NCT03367819|450293115|FG001|Overall Study|Adverse Event|4|||
125183506|NCT03367819|450293114|FG000|Overall Study|Progressive Disease|15|||
125183507|NCT03367819|450293115|FG001|Overall Study|Progressive Disease|13|||
125183508|NCT03367819|450293114|FG000|Overall Study|Withdrawal by Subject|1|||
125183509|NCT03367819|450293115|FG001|Overall Study|Withdrawal by Subject|0|||
125183510|NCT03367819|450293114|FG000|Overall Study|Other|4|||
125183511|NCT03367819|450293115|FG001|Overall Study|Other|2|||
125183512|NCT00584454|450293116|FG000|Overall Study|Adverse Event|1|||
125183513|NCT00584454|450293116|FG000|Overall Study|Relocation|1|||
125183514|NCT00584454|450293116|FG000|Overall Study|Clinical Hold|2|||
125183515|NCT00725920|450293117|FG000|Overall Study|Lack of Efficacy|3|||
125183516|NCT00725920|450293118|FG001|Overall Study|Lack of Efficacy|6|||
125183517|NCT03918629|450293119|FG000|Overall Study|Adverse Event|19|||
125183518|NCT03918629|450293120|FG001|Overall Study|Adverse Event|20|||
125183519|NCT03918629|450293119|FG000|Overall Study|Death|14|||
125183520|NCT03918629|450293120|FG001|Overall Study|Death|7|||
125183521|NCT03918629|450293119|FG000|Overall Study|Lost to Follow-up|36|||
125183522|NCT03918629|450293120|FG001|Overall Study|Lost to Follow-up|28|||
125183523|NCT03918629|450293119|FG000|Overall Study|Physician Decision|1|||
125183524|NCT03918629|450293120|FG001|Overall Study|Physician Decision|0|||
125183525|NCT03918629|450293119|FG000|Overall Study|Protocol Violation|7|||
125183526|NCT03918629|450293120|FG001|Overall Study|Protocol Violation|4|||
125183527|NCT03918629|450293119|FG000|Overall Study|Withdrawal by Subject|47|||
125183528|NCT03918629|450293120|FG001|Overall Study|Withdrawal by Subject|47|||
125183529|NCT03918629|450293119|FG000|Overall Study|Other|7|||
125183530|NCT03918629|450293120|FG001|Overall Study|Other|11|||
125183531|NCT03918629|450293119|FG000|Overall Study|Randomized but not vaccinated|2|||
125183532|NCT03918629|450293120|FG001|Overall Study|Randomized but not vaccinated|1|||
125183533|NCT01891864|450293121|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
125183534|NCT01891864|450293122|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
125183535|NCT01891864|450293123|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
125183536|NCT01891864|450293124|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
125183537|NCT01891864|450293125|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
125183538|NCT01891864|450293126|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
125183539|NCT01891864|450293121|FG000|Treatment Period 1|Physician Decision|0|||
125183540|NCT01891864|450293122|FG001|Treatment Period 1|Physician Decision|1|||
125183541|NCT01891864|450293123|FG002|Treatment Period 1|Physician Decision|0|||
125183542|NCT01891864|450293124|FG003|Treatment Period 1|Physician Decision|0|||
125183543|NCT01891864|450293125|FG004|Treatment Period 1|Physician Decision|0|||
125183544|NCT01891864|450293126|FG005|Treatment Period 1|Physician Decision|0|||
125183545|NCT01891864|450293121|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
125183546|NCT01891864|450293122|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
125183547|NCT01891864|450293123|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
125183548|NCT01891864|450293124|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
125183549|NCT01891864|450293125|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
125183550|NCT01891864|450293126|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
125183551|NCT01891864|450293121|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
125183552|NCT01891864|450293122|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
125183553|NCT01891864|450293123|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
125183554|NCT01891864|450293124|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
125183555|NCT01891864|450293125|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
125183556|NCT01891864|450293126|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
125183557|NCT01891864|450293121|FG000|Treatment Period 1|Withdrawal by Subject|2|||
125183558|NCT01891864|450293122|FG001|Treatment Period 1|Withdrawal by Subject|5|||
125183559|NCT01891864|450293123|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125183560|NCT01891864|450293124|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125183561|NCT01891864|450293125|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125183562|NCT01891864|450293126|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125183563|NCT01891864|450293121|FG000|Treatment Period 1|Lost to Follow-up|1|||
125183564|NCT01891864|450293122|FG001|Treatment Period 1|Lost to Follow-up|0|||
125183565|NCT01891864|450293123|FG002|Treatment Period 1|Lost to Follow-up|0|||
125183566|NCT01891864|450293124|FG003|Treatment Period 1|Lost to Follow-up|0|||
125183567|NCT01891864|450293125|FG004|Treatment Period 1|Lost to Follow-up|0|||
125183568|NCT01891864|450293126|FG005|Treatment Period 1|Lost to Follow-up|0|||
125183569|NCT01891864|450293121|FG000|Treatment Period 2|Protocol Violation|0|||
125183570|NCT01891864|450293122|FG001|Treatment Period 2|Protocol Violation|0|||
125183571|NCT01891864|450293123|FG002|Treatment Period 2|Protocol Violation|0|||
125183572|NCT01891864|450293124|FG003|Treatment Period 2|Protocol Violation|1|||
125183573|NCT01891864|450293125|FG004|Treatment Period 2|Protocol Violation|0|||
125183574|NCT01891864|450293126|FG005|Treatment Period 2|Protocol Violation|0|||
125183575|NCT01891864|450293121|FG000|Treatment Period 2|Physician Decision|0|||
125183576|NCT01891864|450293122|FG001|Treatment Period 2|Physician Decision|0|||
125183577|NCT01891864|450293123|FG002|Treatment Period 2|Physician Decision|1|||
125183578|NCT01891864|450293124|FG003|Treatment Period 2|Physician Decision|0|||
125183579|NCT01891864|450293125|FG004|Treatment Period 2|Physician Decision|0|||
125183580|NCT01891864|450293126|FG005|Treatment Period 2|Physician Decision|0|||
125183581|NCT01891864|450293121|FG000|Treatment Period 2|Site Termination|0|||
125183582|NCT01891864|450293122|FG001|Treatment Period 2|Site Termination|0|||
125183583|NCT01891864|450293123|FG002|Treatment Period 2|Site Termination|1|||
125183584|NCT01891864|450293124|FG003|Treatment Period 2|Site Termination|2|||
125183585|NCT01891864|450293125|FG004|Treatment Period 2|Site Termination|0|||
125183586|NCT01891864|450293126|FG005|Treatment Period 2|Site Termination|0|||
125183587|NCT01891864|450293121|FG000|Treatment Period 2|Lack of Efficacy|0|||
125183588|NCT01891864|450293122|FG001|Treatment Period 2|Lack of Efficacy|0|||
125183589|NCT01891864|450293123|FG002|Treatment Period 2|Lack of Efficacy|1|||
125183590|NCT01891864|450293124|FG003|Treatment Period 2|Lack of Efficacy|0|||
125183591|NCT01891864|450293125|FG004|Treatment Period 2|Lack of Efficacy|1|||
125183592|NCT01891864|450293126|FG005|Treatment Period 2|Lack of Efficacy|0|||
125183593|NCT01891864|450293121|FG000|Treatment Period 2|Adverse Event|0|||
125183594|NCT01891864|450293122|FG001|Treatment Period 2|Adverse Event|0|||
125183595|NCT01891864|450293123|FG002|Treatment Period 2|Adverse Event|1|||
125183596|NCT01891864|450293124|FG003|Treatment Period 2|Adverse Event|2|||
125183597|NCT01891864|450293125|FG004|Treatment Period 2|Adverse Event|0|||
125183598|NCT01891864|450293126|FG005|Treatment Period 2|Adverse Event|4|||
125183599|NCT01891864|450293121|FG000|Treatment Period 2|Termination of Site|0|||
125183600|NCT01891864|450293122|FG001|Treatment Period 2|Termination of Site|0|||
125183601|NCT01891864|450293123|FG002|Treatment Period 2|Termination of Site|0|||
125183602|NCT01891864|450293124|FG003|Treatment Period 2|Termination of Site|0|||
125183603|NCT01891864|450293125|FG004|Treatment Period 2|Termination of Site|2|||
125183604|NCT01891864|450293126|FG005|Treatment Period 2|Termination of Site|0|||
125183605|NCT01891864|450293121|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125183606|NCT01891864|450293122|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125183607|NCT01891864|450293123|FG002|Treatment Period 2|Withdrawal by Subject|3|||
125183608|NCT01891864|450293124|FG003|Treatment Period 2|Withdrawal by Subject|4|||
125183609|NCT01891864|450293125|FG004|Treatment Period 2|Withdrawal by Subject|1|||
125183610|NCT01891864|450293126|FG005|Treatment Period 2|Withdrawal by Subject|1|||
125183611|NCT01891864|450293121|FG000|Extension Period|Lack of Efficacy|0|||
125183612|NCT01891864|450293122|FG001|Extension Period|Lack of Efficacy|0|||
125183613|NCT01891864|450293123|FG002|Extension Period|Lack of Efficacy|0|||
125183614|NCT01891864|450293124|FG003|Extension Period|Lack of Efficacy|1|||
125183615|NCT01891864|450293125|FG004|Extension Period|Lack of Efficacy|1|||
125183616|NCT01891864|450293126|FG005|Extension Period|Lack of Efficacy|0|||
125183617|NCT01891864|450293121|FG000|Extension Period|Pregnancy|0|||
125183618|NCT01891864|450293122|FG001|Extension Period|Pregnancy|0|||
125183619|NCT01891864|450293123|FG002|Extension Period|Pregnancy|1|||
125183620|NCT01891864|450293124|FG003|Extension Period|Pregnancy|0|||
125183621|NCT01891864|450293125|FG004|Extension Period|Pregnancy|0|||
125183622|NCT01891864|450293126|FG005|Extension Period|Pregnancy|0|||
125183623|NCT01891864|450293121|FG000|Extension Period|Adverse Event|0|||
125183624|NCT01891864|450293122|FG001|Extension Period|Adverse Event|0|||
125183625|NCT01891864|450293123|FG002|Extension Period|Adverse Event|4|||
125183626|NCT01891864|450293124|FG003|Extension Period|Adverse Event|2|||
125183627|NCT01891864|450293125|FG004|Extension Period|Adverse Event|2|||
125183628|NCT01891864|450293126|FG005|Extension Period|Adverse Event|0|||
125183629|NCT01891864|450293121|FG000|Extension Period|Withdrawal by Subject|0|||
125183630|NCT01891864|450293122|FG001|Extension Period|Withdrawal by Subject|0|||
125183631|NCT01891864|450293123|FG002|Extension Period|Withdrawal by Subject|1|||
125183632|NCT01891864|450293124|FG003|Extension Period|Withdrawal by Subject|2|||
125183633|NCT01891864|450293125|FG004|Extension Period|Withdrawal by Subject|4|||
125183634|NCT01891864|450293126|FG005|Extension Period|Withdrawal by Subject|0|||
125183635|NCT01891864|450293121|FG000|Extension Period|Lost to Follow-up|0|||
125183636|NCT01891864|450293122|FG001|Extension Period|Lost to Follow-up|0|||
125183637|NCT01891864|450293123|FG002|Extension Period|Lost to Follow-up|2|||
125183638|NCT01891864|450293124|FG003|Extension Period|Lost to Follow-up|0|||
125183639|NCT01891864|450293125|FG004|Extension Period|Lost to Follow-up|0|||
125183640|NCT01891864|450293126|FG005|Extension Period|Lost to Follow-up|0|||
125183641|NCT04720105|450293129|FG000|Overall Study|Lack of Efficacy|1|||
125183642|NCT04720105|450293129|FG000|Overall Study|Lost to Follow-up|1|||
125183643|NCT04720105|450293129|FG000|Overall Study|Withdrawal by Subject|3|||
125183644|NCT01133067|450293130|FG000|Overall Study|Death|136|||
125183645|NCT01133067|450293130|FG000|Overall Study|Lost to Follow-up|3|||
125183646|NCT04135937|450293134|FG000|Overall Study|Lost to Follow-up|2|||
125183647|NCT04135937|450293134|FG000|Overall Study|Withdrawal by Subject|1|||
125183648|NCT00868530|450293138|FG000|Overall Study|Adverse Event|3|||
125183649|NCT00868530|450293138|FG000|Overall Study|Lost to Follow-up|1|||
125183650|NCT00858273|450293139|FG000|Overall Study|Protocol Violation|3|||
125183651|NCT00858273|450293140|FG001|Overall Study|Protocol Violation|5|||
125183652|NCT04199104|450294707|FG000|Overall Study|Death|148|||
125183653|NCT04199104|450294708|FG001|Overall Study|Death|134|||
125183654|NCT04199104|450294707|FG000|Overall Study|Lost to Follow-up|1|||
125183655|NCT04199104|450294708|FG001|Overall Study|Lost to Follow-up|1|||
125183656|NCT04199104|450294707|FG000|Overall Study|Withdrawal by Subject|4|||
125183657|NCT04199104|450294708|FG001|Overall Study|Withdrawal by Subject|4|||
125183658|NCT04199104|450294707|FG000|Overall Study|Participants Ongoing|103|||
125183659|NCT04199104|450294708|FG001|Overall Study|Participants Ongoing|116|||
125183660|NCT02325973|450294713|FG000|Overall Study|Death|5|||
125183661|NCT02325973|450294713|FG000|Overall Study|Withdrawal by subject or investigator|16|||
125183662|NCT05655546|450294714|FG000|Overall Study|Withdrawal by Subject|2|||
125183663|NCT05655546|450294715|FG001|Overall Study|Withdrawal by Subject|4|||
125183664|NCT04510090|450294716|FG000|FE-HS|Withdrawal by Subject|0|||
125183665|NCT04510090|450294717|FG001|FE-HS|Withdrawal by Subject|0|||
125183666|NCT04510090|450294718|FG002|FE-HS|Withdrawal by Subject|0|||
125183667|NCT04510090|450294719|FG003|FE-HS|Withdrawal by Subject|0|||
125183668|NCT04510090|450294720|FG004|FE-HS|Withdrawal by Subject|1|||
125183669|NCT04510090|450294721|FG005|FE-HS|Withdrawal by Subject|0|||
125183670|NCT04510090|450294722|FG006|FE-HS|Withdrawal by Subject|0|||
125183671|NCT04510090|450294723|FG007|FE-HS|Withdrawal by Subject|0|||
125183672|NCT05825404|450294724|FG000|First Intervention (Weeks 2-5)|Death|0|||
125183673|NCT05825404|450294725|FG001|First Intervention (Weeks 2-5)|Death|1|||
125183674|NCT05825404|450294724|FG000|Second Intervention (Weeks 8-11)|Death|0|||
125183675|NCT05825404|450294725|FG001|Second Intervention (Weeks 8-11)|Death|1|||
125183676|NCT01415518|450294726|FG000|Overall Study|Withdrawal by Subject|2|||
125183677|NCT01415518|450294727|FG001|Overall Study|Withdrawal by Subject|12|||
125183678|NCT01415518|450294726|FG000|Overall Study|Protocol Violation|6|||
125183679|NCT01415518|450294727|FG001|Overall Study|Protocol Violation|8|||
125183680|NCT01415518|450294726|FG000|Overall Study|Lost to Follow-up|3|||
125183681|NCT01415518|450294727|FG001|Overall Study|Lost to Follow-up|5|||
125183682|NCT01415518|450294726|FG000|Overall Study|Adverse Event|3|||
125183683|NCT01415518|450294727|FG001|Overall Study|Adverse Event|4|||
125183684|NCT01415518|450294726|FG000|Overall Study|Death|1|||
125183685|NCT01415518|450294727|FG001|Overall Study|Death|1|||
125183686|NCT01415518|450294726|FG000|Overall Study|Condition under Investigation Worsened|1|||
125183687|NCT01415518|450294727|FG001|Overall Study|Condition under Investigation Worsened|1|||
125183688|NCT00679211|450294728|FG000|Overall Study|Progressive disease|82|||
125183689|NCT00679211|450294728|FG000|Overall Study|Adverse Event|7|||
125183690|NCT00679211|450294728|FG000|Overall Study|Withdrawal by Subject|2|||
125183691|NCT00679211|450294728|FG000|Overall Study|Physician Decision|5|||
125183692|NCT00679211|450294728|FG000|Overall Study|Refused to undergo protocol procedures|1|||
125183693|NCT00679211|450294728|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
125183694|NCT00679211|450294728|FG000|Overall Study|Other|1|||
125183695|NCT01730053|450294729|FG000|Overall Study|Participant moved|0|||
125183696|NCT01730053|450294730|FG001|Overall Study|Participant moved|0|||
125183697|NCT01730053|450294731|FG002|Overall Study|Participant moved|1|||
125183698|NCT01730053|450294732|FG003|Overall Study|Participant moved|0|||
125183699|NCT01730053|450294733|FG004|Overall Study|Participant moved|0|||
125183700|NCT01730053|450294734|FG005|Overall Study|Participant moved|0|||
125183701|NCT01730053|450294729|FG000|Overall Study|Physician Decision|0|||
125183702|NCT01730053|450294730|FG001|Overall Study|Physician Decision|0|||
125183703|NCT01730053|450294731|FG002|Overall Study|Physician Decision|0|||
125183704|NCT01730053|450294732|FG003|Overall Study|Physician Decision|1|||
125183705|NCT01730053|450294733|FG004|Overall Study|Physician Decision|0|||
125183706|NCT01730053|450294734|FG005|Overall Study|Physician Decision|0|||
125183707|NCT01730053|450294729|FG000|Overall Study|Adverse Event|2|||
125183708|NCT01730053|450294730|FG001|Overall Study|Adverse Event|6|||
125183709|NCT01730053|450294731|FG002|Overall Study|Adverse Event|3|||
125183710|NCT01730053|450294732|FG003|Overall Study|Adverse Event|3|||
125183711|NCT01730053|450294733|FG004|Overall Study|Adverse Event|2|||
125183712|NCT01730053|450294734|FG005|Overall Study|Adverse Event|2|||
125183713|NCT01730053|450294729|FG000|Overall Study|Poor compliance to protocol|1|||
125183714|NCT01730053|450294730|FG001|Overall Study|Poor compliance to protocol|2|||
125183715|NCT01730053|450294731|FG002|Overall Study|Poor compliance to protocol|2|||
125183716|NCT01730053|450294732|FG003|Overall Study|Poor compliance to protocol|0|||
125183717|NCT01730053|450294733|FG004|Overall Study|Poor compliance to protocol|0|||
125183718|NCT01730053|450294734|FG005|Overall Study|Poor compliance to protocol|2|||
125183719|NCT01730053|450294729|FG000|Overall Study|Other than specified|2|||
125183720|NCT01730053|450294730|FG001|Overall Study|Other than specified|6|||
125183721|NCT01730053|450294731|FG002|Overall Study|Other than specified|5|||
125183722|NCT01730053|450294732|FG003|Overall Study|Other than specified|4|||
125183723|NCT01730053|450294733|FG004|Overall Study|Other than specified|7|||
125183724|NCT01730053|450294734|FG005|Overall Study|Other than specified|9|||
125183725|NCT01470248|450294735|FG000|Overall Study|Withdrawal by Subject|1|||
125183726|NCT05085834|450294736|FG000|Overall Study|Lost to Follow-up|9|||
125183727|NCT05085834|450294737|FG001|Overall Study|Lost to Follow-up|2|||
125183728|NCT05085834|450294736|FG000|Overall Study|Adverse Event|6|||
125183729|NCT05085834|450294737|FG001|Overall Study|Adverse Event|0|||
125183730|NCT05085834|450294736|FG000|Overall Study|Death|1|||
125183731|NCT05085834|450294737|FG001|Overall Study|Death|0|||
125183732|NCT05085834|450294736|FG000|Overall Study|Inability to swallow the pill|0|||
125183733|NCT05085834|450294737|FG001|Overall Study|Inability to swallow the pill|1|||
125183734|NCT02243605|450294738|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
125183735|NCT02243605|450294739|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
125183736|NCT02243605|450294738|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
125183737|NCT02243605|450294739|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
125183738|NCT02243605|450294738|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
125183739|NCT02243605|450294739|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
125183740|NCT02243605|450294738|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
125183741|NCT02243605|450294739|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
125183742|NCT02243605|450294738|FG000|Stage 2 - Final Analysis Population|Progression|0|||
125183743|NCT02243605|450294739|FG001|Stage 2 - Final Analysis Population|Progression|1|||
125183744|NCT04173507|450294740|FG000|Overall Study|On Treatment|3|||
125183745|NCT04173507|450294740|FG000|Overall Study|Adverse Event|3|||
125183746|NCT04173507|450294740|FG000|Overall Study|Progression/Relapse|34|||
125183747|NCT04173507|450294740|FG000|Overall Study|Death|2|||
125183748|NCT01823328|450294741|FG000|Overall Study|Withdrawal by Subject|8|||
125183749|NCT01823328|450294742|FG001|Overall Study|Withdrawal by Subject|6|||
125183750|NCT02157935|450294743|FG000|Overall Study|Withdrawal by Subject|25|||
125183751|NCT02157935|450294744|FG001|Overall Study|Withdrawal by Subject|39|||
125183752|NCT02157935|450294743|FG000|Overall Study|Screen failure|1|||
125183753|NCT02157935|450294744|FG001|Overall Study|Screen failure|2|||
125183754|NCT02157935|450294743|FG000|Overall Study|Protocol Violation|1|||
125183755|NCT02157935|450294744|FG001|Overall Study|Protocol Violation|0|||
125183756|NCT02157935|450294743|FG000|Overall Study|Progressive disease|0|||
125183757|NCT02157935|450294744|FG001|Overall Study|Progressive disease|2|||
125183758|NCT02157935|450294743|FG000|Overall Study|Other|5|||
125183759|NCT02157935|450294744|FG001|Overall Study|Other|12|||
125183760|NCT02157935|450294743|FG000|Overall Study|Lack of Efficacy|0|||
125183761|NCT02157935|450294744|FG001|Overall Study|Lack of Efficacy|1|||
125183762|NCT02157935|450294743|FG000|Overall Study|Death|4|||
125183763|NCT02157935|450294744|FG001|Overall Study|Death|4|||
125183764|NCT02157935|450294743|FG000|Overall Study|Adverse Event|3|||
125183765|NCT02157935|450294744|FG001|Overall Study|Adverse Event|5|||
125183766|NCT02764762|450294745|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
125183767|NCT02764762|450294745|FG000|Overall Study|Lost to Follow-up|4|||
125183768|NCT02764762|450294745|FG000|Overall Study|Voluntary Withdrawal|8|||
125183769|NCT02764762|450294745|FG000|Overall Study|Site Termination|1|||
125183770|NCT02764762|450294745|FG000|Overall Study|Lack of Efficacy|16|||
125183771|NCT02764762|450294745|FG000|Overall Study|Reason not Specified|1|||
125183772|NCT02717507|450294748|FG000|Overall Study|Lost to Follow-up|5|||
125183773|NCT02717507|450294749|FG001|Overall Study|Lost to Follow-up|8|||
125183774|NCT02717507|450294748|FG000|Overall Study|Pregnancy|1|||
125183775|NCT02717507|450294749|FG001|Overall Study|Pregnancy|1|||
125183776|NCT02717507|450294748|FG000|Overall Study|Protocol Violation|2|||
125183777|NCT02717507|450294749|FG001|Overall Study|Protocol Violation|2|||
125183778|NCT02717507|450294748|FG000|Overall Study|Withdrawal by Subject|20|||
125183779|NCT02717507|450294749|FG001|Overall Study|Withdrawal by Subject|20|||
125183780|NCT02717507|450294748|FG000|Overall Study|Relapse|1|||
125183781|NCT02717507|450294749|FG001|Overall Study|Relapse|1|||
125183782|NCT02717507|450294748|FG000|Overall Study|Cardiac Event|2|||
125183783|NCT02717507|450294749|FG001|Overall Study|Cardiac Event|6|||
125183784|NCT00742209|450294754|FG000|Overall Study|Adverse Event|11|||
125183785|NCT00742209|450294755|FG001|Overall Study|Adverse Event|4|||
125183786|NCT00742209|450294756|FG002|Overall Study|Adverse Event|17|||
125183787|NCT00742209|450294757|FG003|Overall Study|Adverse Event|16|||
125183788|NCT00742209|450294758|FG004|Overall Study|Adverse Event|13|||
125183789|NCT00742209|450294754|FG000|Overall Study|Participant Withdrew Consent|8|||
125183790|NCT00742209|450294755|FG001|Overall Study|Participant Withdrew Consent|4|||
125183791|NCT00742209|450294756|FG002|Overall Study|Participant Withdrew Consent|14|||
125183792|NCT00742209|450294757|FG003|Overall Study|Participant Withdrew Consent|7|||
125183793|NCT00742209|450294758|FG004|Overall Study|Participant Withdrew Consent|4|||
125183794|NCT00742209|450294754|FG000|Overall Study|Protocol Violation|6|||
125183795|NCT00742209|450294755|FG001|Overall Study|Protocol Violation|5|||
125183796|NCT00742209|450294756|FG002|Overall Study|Protocol Violation|4|||
125183797|NCT00742209|450294757|FG003|Overall Study|Protocol Violation|5|||
125183798|NCT00742209|450294758|FG004|Overall Study|Protocol Violation|3|||
125183799|NCT00742209|450294754|FG000|Overall Study|Lost to Follow-up|3|||
125183800|NCT00742209|450294755|FG001|Overall Study|Lost to Follow-up|4|||
125183801|NCT00742209|450294756|FG002|Overall Study|Lost to Follow-up|5|||
125183802|NCT00742209|450294757|FG003|Overall Study|Lost to Follow-up|5|||
125183803|NCT00742209|450294758|FG004|Overall Study|Lost to Follow-up|3|||
125183804|NCT00742209|450294754|FG000|Overall Study|Lack of Efficacy|6|||
125183805|NCT00742209|450294755|FG001|Overall Study|Lack of Efficacy|1|||
125183806|NCT00742209|450294756|FG002|Overall Study|Lack of Efficacy|1|||
125183807|NCT00742209|450294757|FG003|Overall Study|Lack of Efficacy|3|||
125183808|NCT00742209|450294758|FG004|Overall Study|Lack of Efficacy|1|||
125183809|NCT00742209|450294754|FG000|Overall Study|Investigator Discretion|0|||
125183810|NCT00742209|450294755|FG001|Overall Study|Investigator Discretion|0|||
125183811|NCT00742209|450294756|FG002|Overall Study|Investigator Discretion|5|||
125183812|NCT00742209|450294757|FG003|Overall Study|Investigator Discretion|1|||
125183813|NCT00742209|450294758|FG004|Overall Study|Investigator Discretion|1|||
125183814|NCT02003209|450294762|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
125183815|NCT02003209|450294763|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
125183816|NCT00638508|450294764|FG000|Overall Study|Physician Decision|5|||
125183817|NCT00638508|450294765|FG001|Overall Study|Physician Decision|2|||
125183818|NCT03500198|450294766|FG000|Overall Study|Lost to Follow-up|0|||
125183819|NCT03500198|450294767|FG001|Overall Study|Lost to Follow-up|1|||
125183820|NCT00595621|450294768|FG000|Open Label Run in|Adverse Event|1|||
125183821|NCT00595621|450294769|FG001|Open Label Run in|Adverse Event|0|||
125183822|NCT00595621|450294768|FG000|Open Label Run in|Physician Decision|1|||
125183823|NCT00595621|450294769|FG001|Open Label Run in|Physician Decision|0|||
125183824|NCT00595621|450294768|FG000|Open Label Run in|Withdrawal by Subject|1|||
125183825|NCT00595621|450294769|FG001|Open Label Run in|Withdrawal by Subject|0|||
125183826|NCT00595621|450294768|FG000|Randomization and Study|Adverse Event|2|||
125183827|NCT00595621|450294769|FG001|Randomization and Study|Adverse Event|0|||
125183828|NCT00595621|450294768|FG000|Randomization and Study|Withdrawal by Subject|0|||
125183829|NCT00595621|450294769|FG001|Randomization and Study|Withdrawal by Subject|1|||
125183830|NCT00324987|450294770|FG000|Overall Study|Adverse Event|2|||
125183831|NCT00324987|450294771|FG001|Overall Study|Adverse Event|1|||
125183832|NCT00324987|450294770|FG000|Overall Study|Withdrawal by Subject|1|||
125183833|NCT00324987|450294771|FG001|Overall Study|Withdrawal by Subject|1|||
125183834|NCT00324987|450294770|FG000|Overall Study|Progression|1|||
125183835|NCT00324987|450294771|FG001|Overall Study|Progression|1|||
125183836|NCT00324987|450294770|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
125183837|NCT00324987|450294771|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
125183838|NCT02392481|450294772|FG000|Overall Study|Adverse Event|0|||
125183839|NCT02392481|450294773|FG001|Overall Study|Adverse Event|0|||
125183840|NCT02392481|450294774|FG002|Overall Study|Adverse Event|1|||
125183841|NCT02392481|450294775|FG003|Overall Study|Adverse Event|2|||
125183842|NCT02392481|450294772|FG000|Overall Study|Withdrawal by Subject|0|||
125183843|NCT02392481|450294773|FG001|Overall Study|Withdrawal by Subject|0|||
125183844|NCT02392481|450294774|FG002|Overall Study|Withdrawal by Subject|1|||
125183845|NCT02392481|450294775|FG003|Overall Study|Withdrawal by Subject|0|||
125183846|NCT01254643|450294777|FG000|Overall Study|Withdrawal by Subject|1|||
125183847|NCT03817125|450294778|FG000|Overall Study|Adverse Event|1|||
125183848|NCT03817125|450294779|FG001|Overall Study|Adverse Event|0|||
125183849|NCT03817125|450294778|FG000|Overall Study|Physician Decision|0|||
125183850|NCT03817125|450294779|FG001|Overall Study|Physician Decision|1|||
125183851|NCT03817125|450294778|FG000|Overall Study|Lack of Efficacy|1|||
125183852|NCT03817125|450294779|FG001|Overall Study|Lack of Efficacy|5|||
125183853|NCT01998919|450294780|FG000|Overall Study|Death|2|||
125183854|NCT01998919|450294781|FG001|Overall Study|Death|2|||
125183855|NCT01998919|450294780|FG000|Overall Study|Adverse Event|0|||
125183856|NCT01998919|450294781|FG001|Overall Study|Adverse Event|5|||
125183857|NCT01998919|450294780|FG000|Overall Study|Disease progression|31|||
125183858|NCT01998919|450294781|FG001|Overall Study|Disease progression|22|||
125183859|NCT01998919|450294780|FG000|Overall Study|Withdrawal by Subject|2|||
125183860|NCT01998919|450294781|FG001|Overall Study|Withdrawal by Subject|4|||
125183861|NCT01998919|450294780|FG000|Overall Study|Lost to Follow-up|2|||
125183862|NCT01998919|450294781|FG001|Overall Study|Lost to Follow-up|0|||
125183863|NCT01998919|450294780|FG000|Overall Study|Other|5|||
125183864|NCT01998919|450294781|FG001|Overall Study|Other|2|||
125183865|NCT02088177|450294784|FG000|Overall Study|Lost to Follow-up|3|||
125183866|NCT01778530|450294786|FG000|Overall Study|Progression on study|1|||
125183867|NCT01778530|450294786|FG000|Overall Study|Adverse event/side effect|1|||
125183868|NCT01199939|450294787|FG000|Overall Study|Adverse Event|4|||
125183869|NCT01199939|450294787|FG000|Overall Study|Protocol Violation|3|||
125183870|NCT01199939|450294787|FG000|Overall Study|Lost to Follow-up|2|||
125183871|NCT01199939|450294787|FG000|Overall Study|Reached a virologic endpoint|4|||
125183872|NCT01894919|450294788|FG000|Overall Study|Withdrawal by Subject|1|||
125183873|NCT01894919|450294789|FG001|Overall Study|Withdrawal by Subject|0|||
125183874|NCT01894919|450294790|FG002|Overall Study|Withdrawal by Subject|0|||
125183875|NCT01894919|450294791|FG003|Overall Study|Withdrawal by Subject|0|||
125183876|NCT01894919|450294792|FG004|Overall Study|Withdrawal by Subject|1|||
125183877|NCT01894919|450294793|FG005|Overall Study|Withdrawal by Subject|0|||
125183878|NCT01894919|450294794|FG006|Overall Study|Withdrawal by Subject|0|||
125183879|NCT01894919|450294795|FG007|Overall Study|Withdrawal by Subject|0|||
125183880|NCT01894919|450294796|FG008|Overall Study|Withdrawal by Subject|0|||
125183881|NCT01894919|450294797|FG009|Overall Study|Withdrawal by Subject|1|||
125183882|NCT01894919|450294798|FG010|Overall Study|Withdrawal by Subject|1|||
125183883|NCT01894919|450294799|FG011|Overall Study|Withdrawal by Subject|0|||
125183884|NCT01894919|450294800|FG012|Overall Study|Withdrawal by Subject|0|||
125183885|NCT01894919|450294788|FG000|Overall Study|Adverse Event|0|||
125183886|NCT01894919|450294789|FG001|Overall Study|Adverse Event|0|||
125183887|NCT01894919|450294790|FG002|Overall Study|Adverse Event|0|||
125183888|NCT01894919|450294791|FG003|Overall Study|Adverse Event|0|||
125183889|NCT01894919|450294792|FG004|Overall Study|Adverse Event|0|||
125183890|NCT01894919|450294793|FG005|Overall Study|Adverse Event|0|||
125183891|NCT01894919|450294794|FG006|Overall Study|Adverse Event|0|||
125183892|NCT01894919|450294795|FG007|Overall Study|Adverse Event|0|||
125183893|NCT01894919|450294796|FG008|Overall Study|Adverse Event|0|||
125183894|NCT01894919|450294797|FG009|Overall Study|Adverse Event|0|||
125183895|NCT01894919|450294798|FG010|Overall Study|Adverse Event|1|||
125183896|NCT01894919|450294799|FG011|Overall Study|Adverse Event|0|||
125183897|NCT01894919|450294800|FG012|Overall Study|Adverse Event|0|||
125183898|NCT01894919|450294788|FG000|Overall Study|Other-Unspecified|1|||
125183899|NCT01894919|450294789|FG001|Overall Study|Other-Unspecified|0|||
125183900|NCT01894919|450294790|FG002|Overall Study|Other-Unspecified|0|||
125183901|NCT01894919|450294791|FG003|Overall Study|Other-Unspecified|0|||
125183902|NCT01894919|450294792|FG004|Overall Study|Other-Unspecified|0|||
125183903|NCT01894919|450294793|FG005|Overall Study|Other-Unspecified|0|||
125183904|NCT01894919|450294794|FG006|Overall Study|Other-Unspecified|0|||
125183905|NCT01894919|450294795|FG007|Overall Study|Other-Unspecified|0|||
125183906|NCT01894919|450294796|FG008|Overall Study|Other-Unspecified|0|||
125183907|NCT01894919|450294797|FG009|Overall Study|Other-Unspecified|0|||
125183908|NCT01894919|450294798|FG010|Overall Study|Other-Unspecified|0|||
125183909|NCT01894919|450294799|FG011|Overall Study|Other-Unspecified|0|||
125183910|NCT01894919|450294800|FG012|Overall Study|Other-Unspecified|0|||
125183911|NCT01894919|450294788|FG000|Overall Study|Lost to Follow-up|0|||
125183912|NCT01894919|450294789|FG001|Overall Study|Lost to Follow-up|0|||
125183913|NCT01894919|450294790|FG002|Overall Study|Lost to Follow-up|0|||
125183914|NCT01894919|450294791|FG003|Overall Study|Lost to Follow-up|0|||
125183915|NCT01894919|450294792|FG004|Overall Study|Lost to Follow-up|2|||
125183916|NCT01894919|450294793|FG005|Overall Study|Lost to Follow-up|0|||
125183917|NCT01894919|450294794|FG006|Overall Study|Lost to Follow-up|0|||
125183918|NCT01894919|450294795|FG007|Overall Study|Lost to Follow-up|0|||
125183919|NCT01894919|450294796|FG008|Overall Study|Lost to Follow-up|0|||
125183920|NCT01894919|450294797|FG009|Overall Study|Lost to Follow-up|0|||
125183921|NCT01894919|450294798|FG010|Overall Study|Lost to Follow-up|0|||
125183922|NCT01894919|450294799|FG011|Overall Study|Lost to Follow-up|0|||
125183923|NCT01894919|450294800|FG012|Overall Study|Lost to Follow-up|0|||
125183924|NCT01433471|450294801|FG000|Overall Study|Withdrawal by Subject|0|||
125183925|NCT01433471|450294802|FG001|Overall Study|Withdrawal by Subject|1|||
125183926|NCT03711188|450294805|FG000|Overall Study|Disease progression|11|||
125183927|NCT03711188|450294805|FG000|Overall Study|Adverse Event|1|||
125183928|NCT03238651|450294806|FG000|Overall Study|Other|0|||
125183929|NCT03238651|450294807|FG001|Overall Study|Other|0|||
125183930|NCT03238651|450294808|FG002|Overall Study|Other|0|||
125183931|NCT03238651|450294809|FG003|Overall Study|Other|0|||
125183932|NCT03238651|450294810|FG004|Overall Study|Other|1|||
125183933|NCT03238651|450294806|FG000|Overall Study|Progressive Disease|2|||
125183934|NCT03238651|450294807|FG001|Overall Study|Progressive Disease|2|||
125183935|NCT03238651|450294808|FG002|Overall Study|Progressive Disease|2|||
125183936|NCT03238651|450294809|FG003|Overall Study|Progressive Disease|2|||
125183937|NCT03238651|450294810|FG004|Overall Study|Progressive Disease|0|||
125183938|NCT03238651|450294806|FG000|Overall Study|Withdrawal by Subject|0|||
125183939|NCT03238651|450294807|FG001|Overall Study|Withdrawal by Subject|1|||
125183940|NCT03238651|450294808|FG002|Overall Study|Withdrawal by Subject|0|||
125183941|NCT03238651|450294809|FG003|Overall Study|Withdrawal by Subject|1|||
125183942|NCT03238651|450294810|FG004|Overall Study|Withdrawal by Subject|0|||
125183943|NCT03238651|450294806|FG000|Overall Study|Adverse Event|1|||
125183944|NCT03238651|450294807|FG001|Overall Study|Adverse Event|3|||
125183945|NCT03238651|450294808|FG002|Overall Study|Adverse Event|2|||
125183946|NCT03238651|450294809|FG003|Overall Study|Adverse Event|0|||
125183947|NCT03238651|450294810|FG004|Overall Study|Adverse Event|0|||
125183948|NCT03875508|450294811|FG000|Overall Study|Adverse Event|1|||
125183949|NCT03875508|450294811|FG000|Overall Study|Lost to Follow-up|8|||
125183950|NCT03875508|450294811|FG000|Overall Study|Lack of Efficacy|1|||
125183951|NCT03875508|450294811|FG000|Overall Study|Other, not specified|2|||
125183952|NCT01532934|450294821|FG000|Overall Study|Lost to Follow-up|11|||
125183953|NCT01532934|450294822|FG001|Overall Study|Lost to Follow-up|11|||
125183954|NCT01532934|450294821|FG000|Overall Study|In controlled environment|3|||
125183955|NCT01532934|450294822|FG001|Overall Study|In controlled environment|2|||
125183956|NCT01147068|450294823|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
125183957|NCT01147068|450294824|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
125183958|NCT01147068|450294825|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
125183959|NCT01147068|450294826|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
125183960|NCT01147068|450294827|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
125183961|NCT01147068|450294828|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
125183962|NCT01147068|450294829|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
125183963|NCT01147068|450294823|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
125183964|NCT01147068|450294824|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
125183965|NCT01147068|450294825|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
125183966|NCT01147068|450294826|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
125183967|NCT01147068|450294827|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
125183968|NCT01147068|450294828|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
125183969|NCT01147068|450294829|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
125183970|NCT01147068|450294823|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
125183971|NCT01147068|450294824|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
125183972|NCT01147068|450294825|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
125183973|NCT01147068|450294826|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
125183974|NCT01147068|450294827|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
125183975|NCT01147068|450294828|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
125183976|NCT01147068|450294829|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
125183977|NCT01147068|450294823|FG000|Subjects That Received 2nd Dose|Other|0|||
125183978|NCT01147068|450294824|FG001|Subjects That Received 2nd Dose|Other|3|||
125183979|NCT01147068|450294825|FG002|Subjects That Received 2nd Dose|Other|3|||
125183980|NCT01147068|450294826|FG003|Subjects That Received 2nd Dose|Other|0|||
125183981|NCT01147068|450294827|FG004|Subjects That Received 2nd Dose|Other|1|||
125183982|NCT01147068|450294828|FG005|Subjects That Received 2nd Dose|Other|0|||
125183983|NCT01147068|450294829|FG006|Subjects That Received 2nd Dose|Other|0|||
125183984|NCT01147068|450294823|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
125183985|NCT01147068|450294824|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
125183986|NCT01147068|450294825|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
125183987|NCT01147068|450294826|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
125183988|NCT01147068|450294827|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
125183989|NCT01147068|450294828|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
125183990|NCT01147068|450294829|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
125183991|NCT01147068|450294823|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
125183992|NCT01147068|450294824|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
125183993|NCT01147068|450294825|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
125183994|NCT01147068|450294826|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
125183995|NCT01147068|450294827|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
125183996|NCT01147068|450294828|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
125183997|NCT01147068|450294829|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
125183998|NCT01147068|450294823|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
125183999|NCT01147068|450294824|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
125184000|NCT01147068|450294825|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
125184001|NCT01147068|450294826|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
125184002|NCT01147068|450294827|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
125184003|NCT01147068|450294828|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
125184004|NCT01147068|450294829|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
125184005|NCT02291237|450294830|FG000|Overall Study|Study Terminated by Sponsor|72|||
125184006|NCT02291237|450294831|FG001|Overall Study|Study Terminated by Sponsor|67|||
125184007|NCT02291237|450294830|FG000|Overall Study|Adverse Event|1|||
125184008|NCT02291237|450294831|FG001|Overall Study|Adverse Event|3|||
125184009|NCT02291237|450294830|FG000|Overall Study|Investigator's Discretion|0|||
125184010|NCT02291237|450294831|FG001|Overall Study|Investigator's Discretion|3|||
125184011|NCT02291237|450294830|FG000|Overall Study|Withdrew Consent|11|||
125184012|NCT02291237|450294831|FG001|Overall Study|Withdrew Consent|11|||
125184013|NCT02291237|450294830|FG000|Overall Study|Lost to Follow-up|0|||
125184014|NCT02291237|450294831|FG001|Overall Study|Lost to Follow-up|2|||
125184015|NCT02291237|450294830|FG000|Overall Study|Subject Required Prohibited Medication|2|||
125184016|NCT02291237|450294831|FG001|Overall Study|Subject Required Prohibited Medication|0|||
125184017|NCT01149863|450294832|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
125184018|NCT01306305|450294833|FG000|Overall Study|Lost to Follow-up|1|||
125184019|NCT01306305|450294834|FG001|Overall Study|Lost to Follow-up|0|||
125184020|NCT01306305|450294833|FG000|Overall Study|Withdrew consent|1|||
125184021|NCT01306305|450294834|FG001|Overall Study|Withdrew consent|0|||
125184022|NCT03326193|450294835|FG000|Overall Study|Sponsor decision|35|||
125184023|NCT00699998|450294837|FG000|Overall Study|Withdrawal by Subject|194|||
125184024|NCT00699998|450294838|FG001|Overall Study|Withdrawal by Subject|83|||
125184025|NCT00699998|450294839|FG002|Overall Study|Withdrawal by Subject|202|||
125184026|NCT00699998|450294840|FG003|Overall Study|Withdrawal by Subject|80|||
125184027|NCT00699998|450294837|FG000|Overall Study|Physician Decision|3|||
125184028|NCT00699998|450294838|FG001|Overall Study|Physician Decision|2|||
125184029|NCT00699998|450294839|FG002|Overall Study|Physician Decision|1|||
125184030|NCT00699998|450294840|FG003|Overall Study|Physician Decision|1|||
125184031|NCT00699998|450294837|FG000|Overall Study|Lost to Follow-up|2|||
125184032|NCT00699998|450294838|FG001|Overall Study|Lost to Follow-up|1|||
125184033|NCT00699998|450294839|FG002|Overall Study|Lost to Follow-up|3|||
125184034|NCT00699998|450294840|FG003|Overall Study|Lost to Follow-up|1|||
125184035|NCT02698163|450294841|FG000|Overall Study|Lost to Follow-up|0|||
125184036|NCT02698163|450294842|FG001|Overall Study|Lost to Follow-up|1|||
125184037|NCT05373108|450294843|FG000|Overall Study|Withdrawal by Subject|2|||
125184038|NCT02892331|450294844|FG000|Overall Study|Withdrawal by Subject|0|||
125184039|NCT02892331|450294845|FG001|Overall Study|Withdrawal by Subject|1|||
125184040|NCT02892331|450294846|FG002|Overall Study|Withdrawal by Subject|1|||
125184041|NCT02892331|450294844|FG000|Overall Study|Sick family member|0|||
125184042|NCT02892331|450294845|FG001|Overall Study|Sick family member|0|||
125184043|NCT02892331|450294846|FG002|Overall Study|Sick family member|1|||
125184044|NCT02892331|450294844|FG000|Overall Study|Corona virus pandemic|1|||
125184045|NCT02892331|450294845|FG001|Overall Study|Corona virus pandemic|0|||
125184046|NCT02892331|450294846|FG002|Overall Study|Corona virus pandemic|1|||
125184047|NCT02892331|450294844|FG000|Overall Study|Lost to Follow-up|1|||
125184048|NCT02892331|450294845|FG001|Overall Study|Lost to Follow-up|0|||
125184049|NCT02892331|450294846|FG002|Overall Study|Lost to Follow-up|1|||
125184050|NCT02892331|450294844|FG000|Overall Study|Blood pressure was too elevated|0|||
125184051|NCT02892331|450294845|FG001|Overall Study|Blood pressure was too elevated|1|||
125184052|NCT02892331|450294846|FG002|Overall Study|Blood pressure was too elevated|0|||
125184053|NCT02892331|450294844|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
125184054|NCT02892331|450294845|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
125184055|NCT02892331|450294846|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
125184056|NCT00349973|450294850|FG000|Overall Study|Adverse Event|3|||
125184057|NCT00349973|450294851|FG001|Overall Study|Adverse Event|3|||
125184058|NCT00349973|450294850|FG000|Overall Study|Withdrawal by Subject|1|||
125184059|NCT00349973|450294851|FG001|Overall Study|Withdrawal by Subject|0|||
125184060|NCT04314037|450294852|FG000|Treatment Period 2|Adverse Event|1|||
125184061|NCT04314037|450294853|FG001|Treatment Period 2|Adverse Event|0|||
125184062|NCT04314037|450294852|FG000|Treatment Period 3|Protocol Violation|1|||
125184063|NCT04314037|450294853|FG001|Treatment Period 3|Protocol Violation|0|||
125184064|NCT04314037|450294852|FG000|Treatment Period 3|Adverse Event|0|||
125184065|NCT04314037|450294853|FG001|Treatment Period 3|Adverse Event|1|||
125184066|NCT02546986|450296441|FG000|Treatment Period|Progressive Disease|20|||
125184067|NCT02546986|450296442|FG001|Treatment Period|Progressive Disease|22|||
125184068|NCT02546986|450296441|FG000|Treatment Period|Adverse Event|14|||
125184069|NCT02546986|450296442|FG001|Treatment Period|Adverse Event|6|||
125184070|NCT02546986|450296441|FG000|Treatment Period|Symptomatic Deterioration|4|||
125184071|NCT02546986|450296442|FG001|Treatment Period|Symptomatic Deterioration|3|||
125184072|NCT02546986|450296441|FG000|Treatment Period|Death|3|||
125184073|NCT02546986|450296442|FG001|Treatment Period|Death|4|||
125184074|NCT02546986|450296441|FG000|Treatment Period|Physician Decision|1|||
125184075|NCT02546986|450296442|FG001|Treatment Period|Physician Decision|2|||
125184076|NCT02546986|450296441|FG000|Treatment Period|Protocol Violation|1|||
125184077|NCT02546986|450296442|FG001|Treatment Period|Protocol Violation|0|||
125184078|NCT02546986|450296441|FG000|Treatment Period|Withdrawal by Subject|1|||
125184079|NCT02546986|450296442|FG001|Treatment Period|Withdrawal by Subject|1|||
125184080|NCT02546986|450296441|FG000|Treatment Period|Non-compliance with Study Drug|0|||
125184081|NCT02546986|450296442|FG001|Treatment Period|Non-compliance with Study Drug|1|||
125184082|NCT02546986|450296441|FG000|Treatment Period|Study Terminated by Sponsor|0|||
125184083|NCT02546986|450296442|FG001|Treatment Period|Study Terminated by Sponsor|1|||
125184084|NCT02546986|450296441|FG000|Treatment Period|Miscellaneous|7|||
125184085|NCT02546986|450296442|FG001|Treatment Period|Miscellaneous|9|||
125184086|NCT02546986|450296441|FG000|Survival Follow-Up Phase|Missing Status|3|||
125184087|NCT02546986|450296442|FG001|Survival Follow-Up Phase|Missing Status|5|||
125184088|NCT02546986|450296441|FG000|Survival Follow-Up Phase|Death|18|||
125184089|NCT02546986|450296442|FG001|Survival Follow-Up Phase|Death|12|||
125184090|NCT02546986|450296441|FG000|Survival Follow-Up Phase|Alive|13|||
125184091|NCT02546986|450296442|FG001|Survival Follow-Up Phase|Alive|16|||
125184092|NCT02546986|450296441|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
125184093|NCT02546986|450296442|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
125184094|NCT01168232|450296443|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
125184095|NCT01168232|450296443|FG000|Overall Study|Ineligible- Wrong cell type|6|||
125184096|NCT01168232|450296443|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
125184097|NCT05012098|450296446|FG000|Overall Study|Disease progression|5|||
125184098|NCT05012098|450296447|FG001|Overall Study|Disease progression|2|||
125184099|NCT05012098|450296446|FG000|Overall Study|Adverse Event|1|||
125184100|NCT05012098|450296447|FG001|Overall Study|Adverse Event|0|||
125184101|NCT05012098|450296446|FG000|Overall Study|Withdrawal by Subject|1|||
125184102|NCT05012098|450296447|FG001|Overall Study|Withdrawal by Subject|0|||
125184103|NCT05012098|450296446|FG000|Overall Study|Discontinuation per protocol|1|||
125184104|NCT05012098|450296447|FG001|Overall Study|Discontinuation per protocol|0|||
125184105|NCT05258773|450296448|FG000|Overall Study|Screen Failure|1|||
125184106|NCT05258773|450296449|FG001|Overall Study|Screen Failure|1|||
125184107|NCT05258773|450296448|FG000|Overall Study|Adverse Event|1|||
125184108|NCT05258773|450296449|FG001|Overall Study|Adverse Event|0|||
125184109|NCT05258773|450296448|FG000|Overall Study|Withdrawal by Subject|0|||
125184110|NCT05258773|450296449|FG001|Overall Study|Withdrawal by Subject|1|||
125184111|NCT03018288|450296452|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
125184112|NCT03018288|450296453|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
125184113|NCT03018288|450296454|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
125184114|NCT03018288|450296455|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
125184115|NCT03018288|450296452|FG000|Overall Study|Participant withdrew consent.|0|||
125184116|NCT03018288|450296453|FG001|Overall Study|Participant withdrew consent.|0|||
125184117|NCT03018288|450296454|FG002|Overall Study|Participant withdrew consent.|1|||
125184118|NCT03018288|450296455|FG003|Overall Study|Participant withdrew consent.|0|||
125184119|NCT03018288|450296452|FG000|Overall Study|Switched to alternative treatment.|0|||
125184120|NCT03018288|450296453|FG001|Overall Study|Switched to alternative treatment.|0|||
125184121|NCT03018288|450296454|FG002|Overall Study|Switched to alternative treatment.|1|||
125184122|NCT03018288|450296455|FG003|Overall Study|Switched to alternative treatment.|0|||
125184123|NCT03018288|450296452|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
125184124|NCT03018288|450296453|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
125184125|NCT03018288|450296454|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
125184126|NCT03018288|450296455|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
125184127|NCT03018288|450296452|FG000|Overall Study|Screen failures|0|||
125184128|NCT03018288|450296453|FG001|Overall Study|Screen failures|0|||
125184129|NCT03018288|450296454|FG002|Overall Study|Screen failures|0|||
125184130|NCT03018288|450296455|FG003|Overall Study|Screen failures|51|||
125184131|NCT03018288|450296452|FG000|Overall Study|Chose treatment outside of UNC|0|||
125184132|NCT03018288|450296453|FG001|Overall Study|Chose treatment outside of UNC|0|||
125184133|NCT03018288|450296454|FG002|Overall Study|Chose treatment outside of UNC|0|||
125184134|NCT03018288|450296455|FG003|Overall Study|Chose treatment outside of UNC|1|||
125184135|NCT03018288|450296452|FG000|Overall Study|Unable to comply with protocol requirements|1|||
125184136|NCT03018288|450296453|FG001|Overall Study|Unable to comply with protocol requirements|1|||
125184137|NCT03018288|450296454|FG002|Overall Study|Unable to comply with protocol requirements|0|||
125184138|NCT03018288|450296455|FG003|Overall Study|Unable to comply with protocol requirements|1|||
125184139|NCT03018288|450296452|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
125184140|NCT03018288|450296453|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
125184141|NCT03018288|450296454|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
125184142|NCT03018288|450296455|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
125184143|NCT03018288|450296452|FG000|Overall Study|Physician Decision|0|||
125184144|NCT03018288|450296453|FG001|Overall Study|Physician Decision|0|||
125184145|NCT03018288|450296454|FG002|Overall Study|Physician Decision|0|||
125184146|NCT03018288|450296455|FG003|Overall Study|Physician Decision|1|||
125184147|NCT01490086|450296459|FG000|Overall Study|Consent withdrawn|4|||
125184148|NCT01490086|450296460|FG001|Overall Study|Consent withdrawn|4|||
125184149|NCT01490086|450296461|FG002|Overall Study|Consent withdrawn|3|||
125184150|NCT01490086|450296462|FG003|Overall Study|Consent withdrawn|0|||
125184151|NCT01490086|450296463|FG004|Overall Study|Consent withdrawn|1|||
125184152|NCT01490086|450296459|FG000|Overall Study|Non-compliance|0|||
125184153|NCT01490086|450296460|FG001|Overall Study|Non-compliance|1|||
125184154|NCT01490086|450296461|FG002|Overall Study|Non-compliance|0|||
125184155|NCT01490086|450296462|FG003|Overall Study|Non-compliance|0|||
125184156|NCT01490086|450296463|FG004|Overall Study|Non-compliance|0|||
125184157|NCT01490086|450296459|FG000|Overall Study|Abnormal laboratory findings|1|||
125184158|NCT01490086|450296460|FG001|Overall Study|Abnormal laboratory findings|0|||
125184159|NCT01490086|450296461|FG002|Overall Study|Abnormal laboratory findings|0|||
125184160|NCT01490086|450296462|FG003|Overall Study|Abnormal laboratory findings|0|||
125184161|NCT01490086|450296463|FG004|Overall Study|Abnormal laboratory findings|0|||
125184162|NCT01490086|450296459|FG000|Overall Study|Lost to Follow-up|0|||
125184163|NCT01490086|450296460|FG001|Overall Study|Lost to Follow-up|0|||
125184164|NCT01490086|450296461|FG002|Overall Study|Lost to Follow-up|0|||
125184165|NCT01490086|450296462|FG003|Overall Study|Lost to Follow-up|0|||
125184166|NCT01490086|450296463|FG004|Overall Study|Lost to Follow-up|1|||
125184167|NCT01490086|450296459|FG000|Overall Study|Physician Decision|3|||
125184168|NCT01490086|450296460|FG001|Overall Study|Physician Decision|4|||
125184169|NCT01490086|450296461|FG002|Overall Study|Physician Decision|2|||
125184170|NCT01490086|450296462|FG003|Overall Study|Physician Decision|3|||
125184171|NCT01490086|450296463|FG004|Overall Study|Physician Decision|1|||
125184172|NCT01490086|450296459|FG000|Overall Study|Adverse Event|0|||
125184173|NCT01490086|450296460|FG001|Overall Study|Adverse Event|0|||
125184174|NCT01490086|450296461|FG002|Overall Study|Adverse Event|1|||
125184175|NCT01490086|450296462|FG003|Overall Study|Adverse Event|2|||
125184176|NCT01490086|450296463|FG004|Overall Study|Adverse Event|0|||
125184177|NCT01490086|450296459|FG000|Overall Study|Lack of Efficacy|0|||
125184178|NCT01490086|450296460|FG001|Overall Study|Lack of Efficacy|3|||
125184179|NCT01490086|450296461|FG002|Overall Study|Lack of Efficacy|1|||
125184180|NCT01490086|450296462|FG003|Overall Study|Lack of Efficacy|0|||
125184181|NCT01490086|450296463|FG004|Overall Study|Lack of Efficacy|8|||
125184182|NCT01490086|450296459|FG000|Overall Study|Worsening of symptoms|0|||
125184183|NCT01490086|450296460|FG001|Overall Study|Worsening of symptoms|1|||
125184184|NCT01490086|450296461|FG002|Overall Study|Worsening of symptoms|0|||
125184185|NCT01490086|450296462|FG003|Overall Study|Worsening of symptoms|1|||
125184186|NCT01490086|450296463|FG004|Overall Study|Worsening of symptoms|0|||
125184187|NCT01490086|450296459|FG000|Overall Study|Subject uncontrollable and abusive|0|||
125184188|NCT01490086|450296460|FG001|Overall Study|Subject uncontrollable and abusive|1|||
125184189|NCT01490086|450296461|FG002|Overall Study|Subject uncontrollable and abusive|0|||
125184190|NCT01490086|450296462|FG003|Overall Study|Subject uncontrollable and abusive|0|||
125184191|NCT01490086|450296463|FG004|Overall Study|Subject uncontrollable and abusive|0|||
125184192|NCT01490086|450296459|FG000|Overall Study|Subject left hospital|0|||
125184193|NCT01490086|450296460|FG001|Overall Study|Subject left hospital|1|||
125184194|NCT01490086|450296461|FG002|Overall Study|Subject left hospital|0|||
125184195|NCT01490086|450296462|FG003|Overall Study|Subject left hospital|1|||
125184196|NCT01490086|450296463|FG004|Overall Study|Subject left hospital|0|||
125184197|NCT06025721|450296464|FG000|Overall Study|Physician Decision|1|||
125184198|NCT06025721|450296464|FG000|Overall Study|Protocol Violation|1|||
125184199|NCT06025721|450296464|FG000|Overall Study|Incarceration|1|||
125184200|NCT01127256|450296465|FG000|Overall Study|Adverse Event|13|||
125184201|NCT01127256|450296466|FG001|Overall Study|Adverse Event|13|||
125184202|NCT01127256|450296465|FG000|Overall Study|Lack of Efficacy|4|||
125184203|NCT01127256|450296466|FG001|Overall Study|Lack of Efficacy|0|||
125184204|NCT01127256|450296465|FG000|Overall Study|Lost to Follow-up|16|||
125184205|NCT01127256|450296466|FG001|Overall Study|Lost to Follow-up|17|||
125184206|NCT01127256|450296465|FG000|Overall Study|Withdrawal by Subject|5|||
125184207|NCT01127256|450296466|FG001|Overall Study|Withdrawal by Subject|9|||
125184208|NCT01127256|450296465|FG000|Overall Study|Protocol Violation|1|||
125184209|NCT01127256|450296466|FG001|Overall Study|Protocol Violation|0|||
125184210|NCT02068508|450296468|FG000|Overall Study|Case report forms uncollected|27|||
125184211|NCT02068508|450296468|FG000|Overall Study|Patient did not visit the study site|1|||
125184212|NCT02068508|450296468|FG000|Overall Study|Protocol Violation|4|||
125184213|NCT04429503|450296473|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
125184214|NCT04429503|450296474|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
125184215|NCT04429503|450296475|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
125184216|NCT04429503|450296476|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
125184217|NCT04429503|450296477|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
125184218|NCT04429503|450296478|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
125184219|NCT04429503|450296473|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
125184220|NCT04429503|450296474|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
125184221|NCT04429503|450296475|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
125184222|NCT04429503|450296476|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
125184223|NCT04429503|450296477|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
125184224|NCT04429503|450296478|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
125184225|NCT04429503|450296473|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
125184226|NCT04429503|450296474|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
125184227|NCT04429503|450296475|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
125184228|NCT04429503|450296476|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
125184229|NCT04429503|450296477|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
125184230|NCT04429503|450296478|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
125184231|NCT04429503|450296473|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
125184232|NCT04429503|450296474|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
125184233|NCT04429503|450296475|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
125184234|NCT04429503|450296476|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
125184235|NCT04429503|450296477|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
125184236|NCT04429503|450296478|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
125184237|NCT04429503|450296473|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
125184238|NCT04429503|450296474|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
125184239|NCT04429503|450296475|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
125184240|NCT04429503|450296476|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
125237635|NCT00620542|450497641|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
125184241|NCT04429503|450296477|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
125237636|NCT00620542|450497638|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
125237637|NCT00620542|450497639|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
125184242|NCT04429503|450296478|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
125184243|NCT04429503|450296473|FG000|Main Study (Up to Wk 96)|Death|9|||
125184244|NCT04429503|450296474|FG001|Main Study (Up to Wk 96)|Death|18|||
125184245|NCT04429503|450296475|FG002|Main Study (Up to Wk 96)|Death|5|||
125184246|NCT04429503|450296476|FG003|Main Study (Up to Wk 96)|Death|0|||
125184247|NCT04429503|450296477|FG004|Main Study (Up to Wk 96)|Death|0|||
125184248|NCT04429503|450296478|FG005|Main Study (Up to Wk 96)|Death|0|||
125184249|NCT04429503|450296473|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
125184250|NCT04429503|450296474|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
125184251|NCT04429503|450296475|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
125184252|NCT04429503|450296476|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
125184253|NCT04429503|450296477|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
125184254|NCT04429503|450296478|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
125184255|NCT04429503|450296473|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
125184256|NCT04429503|450296474|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
125184257|NCT04429503|450296475|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
125184258|NCT04429503|450296476|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
125184259|NCT04429503|450296477|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
125184260|NCT04429503|450296478|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
125184261|NCT04429503|450296473|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
125184262|NCT04429503|450296474|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
125184263|NCT04429503|450296475|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
125184264|NCT04429503|450296476|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
125184265|NCT04429503|450296477|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
125184266|NCT04429503|450296478|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
125184267|NCT04429503|450296473|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
125184268|NCT04429503|450296474|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
125184269|NCT04429503|450296475|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
125184270|NCT04429503|450296476|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
125184271|NCT04429503|450296477|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
125184272|NCT04429503|450296478|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
125184273|NCT04429503|450296473|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
125184274|NCT04429503|450296474|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
125184275|NCT04429503|450296475|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
125184276|NCT04429503|450296476|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
125184277|NCT04429503|450296477|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
125184278|NCT04429503|450296478|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
125184279|NCT04429503|450296473|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
125184280|NCT04429503|450296474|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
125184281|NCT04429503|450296475|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
125184282|NCT04429503|450296476|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
125184283|NCT04429503|450296477|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
125184284|NCT04429503|450296478|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
125184285|NCT05516108|450296479|FG000|Overall Study|Time Commitment|3|||
125184286|NCT05516108|450296480|FG001|Overall Study|Time Commitment|1|||
125184287|NCT05516108|450296479|FG000|Overall Study|Reason Unknown|2|||
125184288|NCT05516108|450296480|FG001|Overall Study|Reason Unknown|4|||
125184289|NCT00709995|450296481|FG000|Overall Study|Adverse Event|4|||
125184290|NCT00709995|450296482|FG001|Overall Study|Adverse Event|2|||
125184291|NCT00709995|450296481|FG000|Overall Study|Withdrawal by Subject|1|||
125184292|NCT00709995|450296482|FG001|Overall Study|Withdrawal by Subject|3|||
125184293|NCT04341363|450296483|FG000|Overall Study|Adverse Event|1|||
125184294|NCT04341363|450296483|FG000|Overall Study|Withdrawal by Subject|1|||
125184295|NCT00063934|450296484|FG000|Overall Study|Ineligible|1|||
125184296|NCT00840749|450296488|FG000|Overall Study|Death|1|||
125184297|NCT00840749|450296489|FG001|Overall Study|Death|2|||
125184298|NCT00840749|450296488|FG000|Overall Study|not treated on study arm|11|||
125184299|NCT00840749|450296489|FG001|Overall Study|not treated on study arm|11|||
125184300|NCT00840749|450296488|FG000|Overall Study|study closed|19|||
125184301|NCT00840749|450296489|FG001|Overall Study|study closed|14|||
125184302|NCT02550561|450296490|FG000|Overall Study|Lost to Follow-up|5|||
125184303|NCT02550561|450296490|FG000|Overall Study|Withdrawal by Subject|1|||
125184304|NCT00395629|450296491|FG000|Core Study|Adverse Event|0|||
125184305|NCT00395629|450296492|FG001|Core Study|Adverse Event|3|||
125184306|NCT00395629|450296493|FG002|Core Study|Adverse Event|4|||
125184307|NCT00395629|450296491|FG000|Core Study|Abnormal laboratory value(s)|0|||
125184308|NCT00395629|450296492|FG001|Core Study|Abnormal laboratory value(s)|0|||
125184309|NCT00395629|450296493|FG002|Core Study|Abnormal laboratory value(s)|1|||
125184310|NCT00395629|450296491|FG000|Core Study|Protocol Violation|1|||
125184311|NCT00395629|450296492|FG001|Core Study|Protocol Violation|0|||
125184312|NCT00395629|450296493|FG002|Core Study|Protocol Violation|0|||
125184313|NCT00395629|450296491|FG000|Core Study|Withdrawal by Subject|0|||
125184314|NCT00395629|450296492|FG001|Core Study|Withdrawal by Subject|1|||
125184315|NCT00395629|450296493|FG002|Core Study|Withdrawal by Subject|1|||
125184316|NCT00395629|450296491|FG000|Core Study|Lost to Follow-up|0|||
125184317|NCT00395629|450296492|FG001|Core Study|Lost to Follow-up|0|||
125184318|NCT00395629|450296493|FG002|Core Study|Lost to Follow-up|1|||
125184319|NCT00395629|450296491|FG000|Extension Study|Adverse Event|0|||
125184320|NCT00395629|450296492|FG001|Extension Study|Adverse Event|0|||
125184321|NCT00395629|450296493|FG002|Extension Study|Adverse Event|2|||
125184322|NCT00395629|450296491|FG000|Extension Study|Administrative problems|0|||
125184323|NCT00395629|450296492|FG001|Extension Study|Administrative problems|0|||
125184324|NCT00395629|450296493|FG002|Extension Study|Administrative problems|1|||
125184325|NCT03534687|450296494|FG000|Overall Study|Lost to Follow-up|7|||
125184326|NCT03534687|450296495|FG001|Overall Study|Lost to Follow-up|2|||
125184327|NCT01051960|450296496|FG000|Overall Study|Adverse Event|1|||
125184328|NCT02394600|450296497|FG000|Overall Study|Adverse Event|3|||
125184329|NCT02394600|450296498|FG001|Overall Study|Adverse Event|0|||
125184330|NCT02394600|450296497|FG000|Overall Study|Lost to Follow-up|0|||
125184331|NCT02394600|450296498|FG001|Overall Study|Lost to Follow-up|1|||
125184332|NCT02394600|450296497|FG000|Overall Study|Withdrawal by Subject|0|||
125184333|NCT02394600|450296498|FG001|Overall Study|Withdrawal by Subject|1|||
125184334|NCT02394600|450296497|FG000|Overall Study|Protocol Violation|1|||
125184335|NCT02394600|450296498|FG001|Overall Study|Protocol Violation|0|||
125184336|NCT01686373|450296499|FG000|Overall Study|Lost to Follow-up|3|||
125184337|NCT01686373|450296500|FG001|Overall Study|Lost to Follow-up|0|||
125184338|NCT01686373|450296499|FG000|Overall Study|Withdrawal by Subject|0|||
125184339|NCT01686373|450296500|FG001|Overall Study|Withdrawal by Subject|1|||
125184340|NCT01686373|450296499|FG000|Overall Study|Adverse Event|0|||
125184341|NCT01686373|450296500|FG001|Overall Study|Adverse Event|1|||
125184342|NCT01960413|450296511|FG000|Overall Study|Withdrawal by Subject|1|||
125184343|NCT01960413|450296512|FG001|Overall Study|Withdrawal by Subject|1|||
125184344|NCT01960413|450296511|FG000|Overall Study|Physician Decision|1|||
125184345|NCT01960413|450296512|FG001|Overall Study|Physician Decision|0|||
125184346|NCT01960413|450296511|FG000|Overall Study|Lost to Follow-up|2|||
125184347|NCT01960413|450296512|FG001|Overall Study|Lost to Follow-up|0|||
125184348|NCT00791778|450296516|FG000|Double-blind Treatment|Adverse Event|49|||
125184349|NCT00791778|450296517|FG001|Double-blind Treatment|Adverse Event|9|||
125184350|NCT00791778|450296516|FG000|Double-blind Treatment|Physician Decision|6|||
125184351|NCT00791778|450296517|FG001|Double-blind Treatment|Physician Decision|26|||
125184352|NCT00791778|450296516|FG000|Double-blind Treatment|Protocol Violation|0|||
125184353|NCT00791778|450296517|FG001|Double-blind Treatment|Protocol Violation|4|||
125184354|NCT00791778|450296516|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
125184355|NCT00791778|450296517|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
125184356|NCT00791778|450296516|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
125184357|NCT00791778|450296517|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
125184358|NCT00791778|450296516|FG000|Follow-up|Withdrawal by Subject|3|||
125184359|NCT00791778|450296517|FG001|Follow-up|Withdrawal by Subject|0|||
125184360|NCT00791778|450296516|FG000|Follow-up|Lost to Follow-up|2|||
125184361|NCT00791778|450296517|FG001|Follow-up|Lost to Follow-up|1|||
125184362|NCT01082328|450296518|FG000|Overall Study|Adverse Event|1|||
125184363|NCT02285361|450296519|FG000|Overall Study|Protocol Violation|43|||
125184364|NCT02285361|450296519|FG000|Overall Study|Lost to Follow-up|5|||
125184365|NCT02285361|450296519|FG000|Overall Study|Not taken GIOTRIF|2|||
125184366|NCT02285361|450296519|FG000|Overall Study|Consented prior to the contract date|1|||
125184367|NCT02059135|450296520|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
125184368|NCT02059135|450296521|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
125184369|NCT02059135|450296520|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
125184370|NCT02059135|450296521|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
125184371|NCT02059135|450296520|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
125184372|NCT02059135|450296521|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
125184373|NCT02059135|450296520|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
125184374|NCT02059135|450296521|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
125184375|NCT02059135|450296520|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
125184376|NCT02059135|450296521|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
125184377|NCT02059135|450296520|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
125184378|NCT02059135|450296521|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
125184379|NCT02059135|450296520|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
125184380|NCT02059135|450296521|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
125184381|NCT02059135|450296520|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
125184382|NCT02059135|450296521|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
125184383|NCT03335475|450296523|FG000|Overall Study|Did not wear accelerometer|4|||
125184384|NCT03335475|450296524|FG001|Overall Study|Did not wear accelerometer|0|||
125184385|NCT03335475|450296523|FG000|Overall Study|Withdrawal by Subject|0|||
125184386|NCT03335475|450296524|FG001|Overall Study|Withdrawal by Subject|1|||
125184387|NCT02755103|450296525|FG000|Overall Study|Lost to Follow-up|17|||
125184388|NCT02755103|450296526|FG001|Overall Study|Lost to Follow-up|15|||
125184389|NCT02755103|450296525|FG000|Overall Study|Death|0|||
125184390|NCT02755103|450296526|FG001|Overall Study|Death|1|||
125184391|NCT02755103|450296525|FG000|Overall Study|Physician Decision|0|||
125184392|NCT02755103|450296526|FG001|Overall Study|Physician Decision|1|||
125184393|NCT02755103|450296525|FG000|Overall Study|Pregnancy|0|||
125184394|NCT02755103|450296526|FG001|Overall Study|Pregnancy|1|||
125184395|NCT02755103|450296525|FG000|Overall Study|Withdrawal by Subject|3|||
125184396|NCT02755103|450296526|FG001|Overall Study|Withdrawal by Subject|0|||
125184397|NCT00658723|450296529|FG000|Overall Study|Lost to Follow-up|0|||
125184398|NCT00658723|450296530|FG001|Overall Study|Lost to Follow-up|2|||
125184399|NCT00658723|450296531|FG002|Overall Study|Lost to Follow-up|2|||
125184400|NCT00658723|450296529|FG000|Overall Study|Death|2|||
125184401|NCT00658723|450296530|FG001|Overall Study|Death|1|||
125184402|NCT00658723|450296531|FG002|Overall Study|Death|4|||
125184403|NCT00658723|450296529|FG000|Overall Study|Scheduling Issue|1|||
125184404|NCT00658723|450296530|FG001|Overall Study|Scheduling Issue|1|||
125184405|NCT00658723|450296531|FG002|Overall Study|Scheduling Issue|0|||
125184406|NCT00658723|450296529|FG000|Overall Study|Withdrawal by Subject|1|||
125184407|NCT00658723|450296530|FG001|Overall Study|Withdrawal by Subject|0|||
125184408|NCT00658723|450296531|FG002|Overall Study|Withdrawal by Subject|1|||
125184409|NCT02411656|450296532|FG000|Overall Study|Adverse Event|4|||
125184410|NCT02411656|450296532|FG000|Overall Study|Clinical Progression|33|||
125184411|NCT06481709|450296533|FG000|Overall Study|Withdrawal by Subject|0|||
125184412|NCT06481709|450296534|FG001|Overall Study|Withdrawal by Subject|0|||
125184413|NCT06481709|450296535|FG002|Overall Study|Withdrawal by Subject|2|||
125184414|NCT06481709|450296536|FG003|Overall Study|Withdrawal by Subject|0|||
125184415|NCT05366010|450296539|FG000|Overall Study|Withdrawal by Subject|1|||
125184416|NCT05366010|450296539|FG000|Overall Study|Protocol Violation|1|||
125184417|NCT05366010|450296539|FG000|Overall Study|Lost to Follow-up|2|||
125184418|NCT05366010|450296539|FG000|Overall Study|Screen Failure|2|||
125184419|NCT02224157|450296540|FG000|Overall Study|Severe non-compliance to protocol|2|||
125184420|NCT02224157|450296541|FG001|Overall Study|Severe non-compliance to protocol|2|||
125184421|NCT02224157|450296540|FG000|Overall Study|Other|13|||
125184422|NCT02224157|450296541|FG001|Overall Study|Other|10|||
125184423|NCT02224157|450296540|FG000|Overall Study|Subject decision|58|||
125184424|NCT02224157|450296541|FG001|Overall Study|Subject decision|50|||
125184425|NCT02224157|450296540|FG000|Overall Study|Prematurely closed site|4|||
125184426|NCT02224157|450296541|FG001|Overall Study|Prematurely closed site|2|||
125184427|NCT02224157|450296540|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
125184428|NCT02224157|450296541|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
125184429|NCT02224157|450296540|FG000|Overall Study|Lost to Follow-up|27|||
125184430|NCT02224157|450296541|FG001|Overall Study|Lost to Follow-up|35|||
125184431|NCT02224157|450296540|FG000|Overall Study|Death|1|||
125184432|NCT02224157|450296541|FG001|Overall Study|Death|1|||
125184433|NCT02224157|450296540|FG000|Overall Study|Adverse Event|1|||
125184434|NCT02224157|450296541|FG001|Overall Study|Adverse Event|3|||
125184435|NCT05906628|450296544|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
125184436|NCT05906628|450296545|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
125184437|NCT05906628|450296544|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
125184438|NCT05906628|450296545|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
125184439|NCT05906628|450296544|FG000|16-Week DBVC Period|Protocol Violation|4|||
125184440|NCT05906628|450296545|FG001|16-Week DBVC Period|Protocol Violation|2|||
125184441|NCT05906628|450296544|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
125184442|NCT05906628|450296545|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
125184443|NCT05906628|450296544|FG000|16-Week OLE Period|Death|1|||
125184444|NCT05906628|450296545|FG001|16-Week OLE Period|Death|0|||
125184445|NCT05906628|450296544|FG000|16-Week OLE Period|Lost to Follow-up|1|||
125184446|NCT05906628|450296545|FG001|16-Week OLE Period|Lost to Follow-up|1|||
125184447|NCT05906628|450296544|FG000|16-Week OLE Period|Protocol Violation|0|||
125184448|NCT05906628|450296545|FG001|16-Week OLE Period|Protocol Violation|1|||
125184449|NCT05906628|450296544|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
125184450|NCT05906628|450296545|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
125184451|NCT04578535|450296546|FG000|Overall Study|Lost to Follow-up|1|||
125184452|NCT04578535|450296547|FG001|Overall Study|Lost to Follow-up|0|||
125184453|NCT04578535|450296548|FG002|Overall Study|Lost to Follow-up|0|||
125184454|NCT04578535|450296549|FG003|Overall Study|Lost to Follow-up|1|||
125184455|NCT04578535|450296550|FG004|Overall Study|Lost to Follow-up|0|||
125184456|NCT04578535|450296551|FG005|Overall Study|Lost to Follow-up|2|||
125184457|NCT04578535|450296546|FG000|Overall Study|Pregnancy|1|||
125184458|NCT04578535|450296547|FG001|Overall Study|Pregnancy|0|||
125184459|NCT04578535|450296548|FG002|Overall Study|Pregnancy|0|||
125184460|NCT04578535|450296549|FG003|Overall Study|Pregnancy|0|||
125184461|NCT04578535|450296550|FG004|Overall Study|Pregnancy|0|||
125184462|NCT04578535|450296551|FG005|Overall Study|Pregnancy|0|||
125184463|NCT04578535|450296546|FG000|Overall Study|Withdrawal by Subject|0|||
125184464|NCT04578535|450296547|FG001|Overall Study|Withdrawal by Subject|0|||
125184465|NCT04578535|450296548|FG002|Overall Study|Withdrawal by Subject|0|||
125184466|NCT04578535|450296549|FG003|Overall Study|Withdrawal by Subject|1|||
125184467|NCT04578535|450296550|FG004|Overall Study|Withdrawal by Subject|1|||
125184468|NCT04578535|450296551|FG005|Overall Study|Withdrawal by Subject|5|||
125184469|NCT04578535|450296546|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
125184470|NCT04578535|450296547|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
125184471|NCT04578535|450296548|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
125184472|NCT04578535|450296549|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
125184473|NCT04578535|450296550|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
125184474|NCT04578535|450296551|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
125184475|NCT05317312|450296552|FG000|Overall Study|Withdrawal by Subject|0|||
125184476|NCT05317312|450296553|FG001|Overall Study|Withdrawal by Subject|1|||
125184477|NCT05317312|450296554|FG002|Overall Study|Withdrawal by Subject|0|||
125184478|NCT05317312|450296555|FG003|Overall Study|Withdrawal by Subject|0|||
125184479|NCT05317312|450296552|FG000|Overall Study|Lost to Follow-up|0|||
125184480|NCT05317312|450296553|FG001|Overall Study|Lost to Follow-up|0|||
125184481|NCT05317312|450296554|FG002|Overall Study|Lost to Follow-up|0|||
125184482|NCT05317312|450296555|FG003|Overall Study|Lost to Follow-up|1|||
125184483|NCT05317312|450296552|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
125184484|NCT05317312|450296553|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
125184485|NCT05317312|450296554|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
125184486|NCT05317312|450296555|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
125184487|NCT01060072|450296556|FG000|Overall Study|Adverse Event|1|||
125184488|NCT01060072|450296557|FG001|Overall Study|Adverse Event|1|||
125184489|NCT01060072|450296556|FG000|Overall Study|Physician Decision|0|||
125184490|NCT01060072|450296557|FG001|Overall Study|Physician Decision|2|||
125184491|NCT01060072|450296556|FG000|Overall Study|Protocol Violation|0|||
125184492|NCT01060072|450296557|FG001|Overall Study|Protocol Violation|1|||
125184493|NCT01060072|450296556|FG000|Overall Study|Acute cholecystitis|1|||
125184494|NCT01060072|450296557|FG001|Overall Study|Acute cholecystitis|0|||
125184495|NCT01060072|450296556|FG000|Overall Study|Excluded Medications|0|||
125184496|NCT01060072|450296557|FG001|Overall Study|Excluded Medications|1|||
125184497|NCT00837148|450296558|FG000|Overall Study|Adverse Event|1|||
125184498|NCT00837148|450296558|FG000|Overall Study|Death|1|||
125184499|NCT00380874|450296559|FG000|Overall Study|Adverse Event|7|||
125184500|NCT00380874|450296560|FG001|Overall Study|Adverse Event|7|||
125184501|NCT00380874|450296559|FG000|Overall Study|Death|1|||
125184502|NCT00380874|450296560|FG001|Overall Study|Death|0|||
125184503|NCT00380874|450296559|FG000|Overall Study|Withdrawal by Subject|2|||
125184504|NCT00380874|450296560|FG001|Overall Study|Withdrawal by Subject|1|||
125184505|NCT00380874|450296559|FG000|Overall Study|Not related to study drug|3|||
125184506|NCT00380874|450296560|FG001|Overall Study|Not related to study drug|2|||
125184507|NCT03839628|450296561|FG000|Overall Study|Withdrawal by Subject|1|||
125184508|NCT01707290|450296562|FG000|Overall Study|Adverse event (AE)|1|||
125184509|NCT01707290|450296563|FG001|Overall Study|Adverse event (AE)|0|||
125184510|NCT01707290|450296562|FG000|Overall Study|Physician Decision|1|||
125184511|NCT01707290|450296563|FG001|Overall Study|Physician Decision|0|||
125184512|NCT01707290|450296562|FG000|Overall Study|Lost to Follow-up|3|||
125184513|NCT01707290|450296563|FG001|Overall Study|Lost to Follow-up|0|||
125184514|NCT01707290|450296562|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
125184515|NCT01707290|450296563|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
125184516|NCT01707290|450296562|FG000|Overall Study|Commercial drug available|60|||
125184517|NCT01707290|450296563|FG001|Overall Study|Commercial drug available|1|||
125184518|NCT01707290|450296562|FG000|Overall Study|Other unspecified|17|||
125184519|NCT01707290|450296563|FG001|Overall Study|Other unspecified|0|||
125184520|NCT01964976|450296564|FG000|Overall Study|Protocol Violation|31|||
125184521|NCT01565889|450296568|FG000|Part A|Withdrawal by Subject|1|||
125184522|NCT01565889|450296569|FG001|Part A|Withdrawal by Subject|0|||
125184523|NCT01565889|450296570|FG002|Part A|Withdrawal by Subject|0|||
125184524|NCT01565889|450296571|FG003|Part A|Withdrawal by Subject|0|||
125184525|NCT01565889|450296572|FG004|Part A|Withdrawal by Subject|0|||
125184526|NCT01565889|450296573|FG005|Part A|Withdrawal by Subject|0|||
125184527|NCT01565889|450296568|FG000|Part B|Withdrawal by Subject|0|||
125184528|NCT01565889|450296569|FG001|Part B|Withdrawal by Subject|0|||
125184529|NCT01565889|450296570|FG002|Part B|Withdrawal by Subject|0|||
125184530|NCT01565889|450296571|FG003|Part B|Withdrawal by Subject|0|||
125184531|NCT01565889|450296572|FG004|Part B|Withdrawal by Subject|0|||
125184532|NCT01565889|450296573|FG005|Part B|Withdrawal by Subject|1|||
125237638|NCT00620542|450497640|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
125184533|NCT01565889|450296568|FG000|Part B|Lack of Efficacy|0|||
125184534|NCT01565889|450296569|FG001|Part B|Lack of Efficacy|0|||
125184535|NCT01565889|450296570|FG002|Part B|Lack of Efficacy|0|||
125184536|NCT01565889|450296571|FG003|Part B|Lack of Efficacy|0|||
125184537|NCT01565889|450296572|FG004|Part B|Lack of Efficacy|0|||
125184538|NCT01565889|450296573|FG005|Part B|Lack of Efficacy|2|||
125184539|NCT01565889|450296568|FG000|Part B|Lost to Follow-up|0|||
125184540|NCT01565889|450296569|FG001|Part B|Lost to Follow-up|0|||
125184541|NCT01565889|450296570|FG002|Part B|Lost to Follow-up|0|||
125184542|NCT01565889|450296571|FG003|Part B|Lost to Follow-up|0|||
125184543|NCT01565889|450296572|FG004|Part B|Lost to Follow-up|0|||
125184544|NCT01565889|450296573|FG005|Part B|Lost to Follow-up|1|||
125184545|NCT01326845|450296576|FG000|Overall Study|Administrative Problems|5|||
125184546|NCT01326845|450296577|FG001|Overall Study|Administrative Problems|2|||
125184547|NCT01326845|450296576|FG000|Overall Study|Adverse Event|1|||
125184548|NCT01326845|450296577|FG001|Overall Study|Adverse Event|0|||
125184549|NCT01326845|450296576|FG000|Overall Study|Misisng|1|||
125184550|NCT01326845|450296577|FG001|Overall Study|Misisng|3|||
125184551|NCT00982657|450296578|FG000|Overall Study|Death|1|||
125184552|NCT00982657|450296579|FG001|Overall Study|Death|0|||
125184553|NCT00982657|450296580|FG002|Overall Study|Death|1|||
125184554|NCT00982657|450296581|FG003|Overall Study|Death|1|||
125184555|NCT00982657|450296578|FG000|Overall Study|Withdrawal by Subject|0|||
125184556|NCT00982657|450296579|FG001|Overall Study|Withdrawal by Subject|0|||
125184557|NCT00982657|450296580|FG002|Overall Study|Withdrawal by Subject|1|||
125184558|NCT00982657|450296581|FG003|Overall Study|Withdrawal by Subject|3|||
125184559|NCT00982657|450296578|FG000|Overall Study|Other|0|||
125184560|NCT00982657|450296579|FG001|Overall Study|Other|0|||
125184561|NCT00982657|450296580|FG002|Overall Study|Other|0|||
125184562|NCT00982657|450296581|FG003|Overall Study|Other|4|||
125184563|NCT00982657|450296578|FG000|Overall Study|On going at date of cut-off|0|||
125184564|NCT00982657|450296579|FG001|Overall Study|On going at date of cut-off|0|||
125184565|NCT00982657|450296580|FG002|Overall Study|On going at date of cut-off|0|||
125184566|NCT00982657|450296581|FG003|Overall Study|On going at date of cut-off|1|||
125184567|NCT00752128|450296584|FG000|Overall Study|Withdrawal by Subject|4|||
125184568|NCT02286713|450296585|FG000|One Week Follow-Up|Death|1|||
125184569|NCT02286713|450296586|FG001|One Week Follow-Up|Death|0|||
125184570|NCT02286713|450296585|FG000|One Week Follow-Up|Lost to Follow-up|17|||
125184571|NCT02286713|450296586|FG001|One Week Follow-Up|Lost to Follow-up|21|||
125184572|NCT02286713|450296585|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
125184573|NCT02286713|450296586|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
125184574|NCT02286713|450296585|FG000|Three Month Follow-Up|Death|1|||
125184575|NCT02286713|450296586|FG001|Three Month Follow-Up|Death|1|||
125184576|NCT02286713|450296585|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
125184577|NCT02286713|450296586|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
125184578|NCT02286713|450296585|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
125184579|NCT02286713|450296586|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
125184580|NCT02286713|450296585|FG000|Six Month Follow-Up|Death|2|||
125184581|NCT02286713|450296586|FG001|Six Month Follow-Up|Death|0|||
125184582|NCT02286713|450296585|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
125184583|NCT02286713|450296586|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
125184584|NCT03323398|450296587|FG000|Overall Study|Other than Specified|0|||
125184585|NCT03323398|450296588|FG001|Overall Study|Other than Specified|1|||
125184586|NCT03323398|450296589|FG002|Overall Study|Other than Specified|2|||
125184587|NCT03323398|450296590|FG003|Overall Study|Other than Specified|0|||
125184588|NCT03323398|450296591|FG004|Overall Study|Other than Specified|0|||
125184589|NCT03323398|450296592|FG005|Overall Study|Other than Specified|0|||
125184590|NCT03323398|450296593|FG006|Overall Study|Other than Specified|1|||
125184591|NCT03323398|450296594|FG007|Overall Study|Other than Specified|0|||
125184592|NCT03323398|450296595|FG008|Overall Study|Other than Specified|2|||
125184593|NCT03323398|450296587|FG000|Overall Study|Lost to Follow-up|1|||
125184594|NCT03323398|450296588|FG001|Overall Study|Lost to Follow-up|2|||
125184595|NCT03323398|450296589|FG002|Overall Study|Lost to Follow-up|1|||
125184596|NCT03323398|450296590|FG003|Overall Study|Lost to Follow-up|0|||
125184597|NCT03323398|450296591|FG004|Overall Study|Lost to Follow-up|0|||
125184598|NCT03323398|450296592|FG005|Overall Study|Lost to Follow-up|0|||
125184599|NCT03323398|450296593|FG006|Overall Study|Lost to Follow-up|0|||
125184600|NCT03323398|450296594|FG007|Overall Study|Lost to Follow-up|0|||
125184601|NCT03323398|450296595|FG008|Overall Study|Lost to Follow-up|0|||
125184602|NCT03323398|450296587|FG000|Overall Study|Death|4|||
125184603|NCT03323398|450296588|FG001|Overall Study|Death|6|||
125184604|NCT03323398|450296589|FG002|Overall Study|Death|2|||
125184605|NCT03323398|450296590|FG003|Overall Study|Death|2|||
125184606|NCT03323398|450296591|FG004|Overall Study|Death|1|||
125237639|NCT00620542|450497641|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
125184607|NCT03323398|450296592|FG005|Overall Study|Death|2|||
125184608|NCT03323398|450296593|FG006|Overall Study|Death|0|||
125184609|NCT03323398|450296594|FG007|Overall Study|Death|0|||
125184610|NCT03323398|450296595|FG008|Overall Study|Death|6|||
125184611|NCT03323398|450296587|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
125184612|NCT03323398|450296588|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
125184613|NCT03323398|450296589|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
125184614|NCT03323398|450296590|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
125184615|NCT03323398|450296591|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
125184616|NCT03323398|450296592|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
125184617|NCT03323398|450296593|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
125184618|NCT03323398|450296594|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
125184619|NCT03323398|450296595|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
125184620|NCT03323398|450296587|FG000|Overall Study|Withdrawal by Subject|2|||
125184621|NCT03323398|450296588|FG001|Overall Study|Withdrawal by Subject|1|||
125184622|NCT03323398|450296589|FG002|Overall Study|Withdrawal by Subject|3|||
125184623|NCT03323398|450296590|FG003|Overall Study|Withdrawal by Subject|0|||
125184624|NCT03323398|450296591|FG004|Overall Study|Withdrawal by Subject|0|||
125184625|NCT03323398|450296592|FG005|Overall Study|Withdrawal by Subject|1|||
125184626|NCT03323398|450296593|FG006|Overall Study|Withdrawal by Subject|0|||
125184627|NCT03323398|450296594|FG007|Overall Study|Withdrawal by Subject|0|||
125184628|NCT03323398|450296595|FG008|Overall Study|Withdrawal by Subject|0|||
125184629|NCT03323398|450296587|FG000|Overall Study|Participant was Put on Hospice|0|||
125184630|NCT03323398|450296588|FG001|Overall Study|Participant was Put on Hospice|0|||
125184631|NCT03323398|450296589|FG002|Overall Study|Participant was Put on Hospice|0|||
125184632|NCT03323398|450296590|FG003|Overall Study|Participant was Put on Hospice|0|||
125184633|NCT03323398|450296591|FG004|Overall Study|Participant was Put on Hospice|0|||
125184634|NCT03323398|450296592|FG005|Overall Study|Participant was Put on Hospice|0|||
125184635|NCT03323398|450296593|FG006|Overall Study|Participant was Put on Hospice|1|||
125184636|NCT03323398|450296594|FG007|Overall Study|Participant was Put on Hospice|0|||
125184637|NCT03323398|450296595|FG008|Overall Study|Participant was Put on Hospice|0|||
125184638|NCT03323398|450296587|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
125184639|NCT03323398|450296588|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
125184640|NCT03323398|450296589|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
125184641|NCT03323398|450296590|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
125184642|NCT03323398|450296591|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
125184643|NCT03323398|450296592|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
125184644|NCT03323398|450296593|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
125184645|NCT03323398|450296594|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
125184646|NCT03323398|450296595|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
125184647|NCT02235454|450296596|FG000|Overall Study|Withdrawal by Subject|2|||
125184648|NCT03641469|450296597|FG000|Overall Study|Ineligible|2|||
125184649|NCT03641469|450296597|FG000|Overall Study|Withdrawal by Subject|5|||
125184650|NCT03641469|450296597|FG000|Overall Study|Physician Decision|1|||
125184651|NCT03641469|450296597|FG000|Overall Study|Protocol Violation|1|||
125184652|NCT03641469|450296597|FG000|Overall Study|Lost to Follow-up|2|||
125184653|NCT05479435|450296598|FG000|Overall Study|Withdrawal by Subject|1|||
125184654|NCT05479435|450296599|FG001|Overall Study|Withdrawal by Subject|0|||
125184655|NCT05479435|450296600|FG002|Overall Study|Withdrawal by Subject|0|||
125184656|NCT05479435|450296598|FG000|Overall Study|Covid 19|0|||
125184657|NCT05479435|450296599|FG001|Overall Study|Covid 19|0|||
125184658|NCT05479435|450296600|FG002|Overall Study|Covid 19|2|||
125184659|NCT02562235|450298765|FG000|Overall Study|Adverse Event|3|||
125184660|NCT05016960|450298766|FG000|Overall Study|Withdrawal by Subject|1|||
125184661|NCT05016960|450298767|FG001|Overall Study|Withdrawal by Subject|9|||
125184662|NCT04796961|450298768|FG000|Overall Study|Lost to Follow-up|10|||
125184663|NCT04796961|450298768|FG000|Overall Study|Withdrawal by Subject|3|||
125184664|NCT04796961|450298768|FG000|Overall Study|Left Organization|10|||
125184665|NCT02513160|450298772|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
125184666|NCT02513160|450298773|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
125184667|NCT02513160|450298774|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
125184668|NCT02513160|450298775|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
125184669|NCT02513160|450298772|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
125184670|NCT02513160|450298773|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
125184671|NCT02513160|450298774|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
125184672|NCT02513160|450298775|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
125184673|NCT02513160|450298772|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
125184674|NCT02513160|450298773|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
125184675|NCT02513160|450298774|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
125184676|NCT02513160|450298775|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
125184677|NCT02513160|450298772|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
125184678|NCT02513160|450298773|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
125184679|NCT02513160|450298774|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
125184680|NCT02513160|450298775|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
125184681|NCT02513160|450298772|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
125184682|NCT02513160|450298773|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
125184683|NCT02513160|450298774|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
125184684|NCT02513160|450298775|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
125184685|NCT02513160|450298772|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
125184686|NCT02513160|450298773|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
125184687|NCT02513160|450298774|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
125184688|NCT02513160|450298775|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
125184689|NCT02513160|450298772|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
125184690|NCT02513160|450298773|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
125184691|NCT02513160|450298774|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
125184692|NCT02513160|450298775|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
125184693|NCT02513160|450298772|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
125184694|NCT02513160|450298773|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
125184695|NCT02513160|450298774|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
125184696|NCT02513160|450298775|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
125184697|NCT02513160|450298772|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
125184698|NCT02513160|450298773|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
125184699|NCT02513160|450298774|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
125184700|NCT02513160|450298775|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
125184701|NCT02513160|450298772|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
125184702|NCT02513160|450298773|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
125184703|NCT02513160|450298774|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
125184704|NCT02513160|450298775|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
125184705|NCT02513160|450298772|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
125184706|NCT02513160|450298773|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
125184707|NCT02513160|450298774|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
125184708|NCT02513160|450298775|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
125184709|NCT02513160|450298772|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
125184710|NCT02513160|450298773|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
125184711|NCT02513160|450298774|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
125184712|NCT02513160|450298775|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
125184713|NCT02844543|450298776|FG000|Overall Study|Withdrawal by Subject|4|||
125184714|NCT02844543|450298776|FG000|Overall Study|Did not meet eligibility criteria|1|||
125184715|NCT04710576|450298782|FG000|Overall Study|Participants still in the study|73|||
125184716|NCT04710576|450298783|FG001|Overall Study|Participants still in the study|70|||
125184717|NCT04710576|450298784|FG002|Overall Study|Participants still in the study|60|||
125184718|NCT04710576|450298782|FG000|Overall Study|Death|2|||
125184719|NCT04710576|450298783|FG001|Overall Study|Death|7|||
125184720|NCT04710576|450298784|FG002|Overall Study|Death|12|||
125184721|NCT04710576|450298782|FG000|Overall Study|Withdrawal by Subject|4|||
125184722|NCT04710576|450298783|FG001|Overall Study|Withdrawal by Subject|3|||
125184723|NCT04710576|450298784|FG002|Overall Study|Withdrawal by Subject|7|||
125184724|NCT04710576|450298782|FG000|Overall Study|Sponsor decision|1|||
125184725|NCT04710576|450298783|FG001|Overall Study|Sponsor decision|0|||
125184726|NCT04710576|450298784|FG002|Overall Study|Sponsor decision|0|||
125184727|NCT03428958|450298785|FG000|Overall Study|Adverse Event|0|||
125184728|NCT03428958|450298786|FG001|Overall Study|Adverse Event|0|||
125184729|NCT03428958|450298787|FG002|Overall Study|Adverse Event|0|||
125184730|NCT03428958|450298788|FG003|Overall Study|Adverse Event|1|||
125184731|NCT03428958|450298789|FG004|Overall Study|Adverse Event|0|||
125184732|NCT03428958|450298790|FG005|Overall Study|Adverse Event|2|||
125184733|NCT03428958|450298791|FG006|Overall Study|Adverse Event|1|||
125184734|NCT03428958|450298792|FG007|Overall Study|Adverse Event|0|||
125184735|NCT03428958|450298793|FG008|Overall Study|Adverse Event|0|||
125184736|NCT03428958|450298794|FG009|Overall Study|Adverse Event|0|||
125184737|NCT03428958|450298795|FG010|Overall Study|Adverse Event|0|||
125184738|NCT03428958|450298796|FG011|Overall Study|Adverse Event|0|||
125184739|NCT03428958|450298797|FG012|Overall Study|Adverse Event|0|||
125184740|NCT03428958|450298798|FG013|Overall Study|Adverse Event|0|||
125184741|NCT03428958|450298799|FG014|Overall Study|Adverse Event|0|||
125184742|NCT03428958|450298800|FG015|Overall Study|Adverse Event|0|||
125184743|NCT03428958|450298801|FG016|Overall Study|Adverse Event|0|||
125184744|NCT03428958|450298785|FG000|Overall Study|Clinical Progression|2|||
125184745|NCT03428958|450298786|FG001|Overall Study|Clinical Progression|3|||
125184746|NCT03428958|450298787|FG002|Overall Study|Clinical Progression|2|||
125184747|NCT03428958|450298788|FG003|Overall Study|Clinical Progression|1|||
125184748|NCT03428958|450298789|FG004|Overall Study|Clinical Progression|0|||
125184749|NCT03428958|450298790|FG005|Overall Study|Clinical Progression|2|||
125184750|NCT03428958|450298791|FG006|Overall Study|Clinical Progression|0|||
125184751|NCT03428958|450298792|FG007|Overall Study|Clinical Progression|0|||
125184752|NCT03428958|450298793|FG008|Overall Study|Clinical Progression|0|||
125184753|NCT03428958|450298794|FG009|Overall Study|Clinical Progression|0|||
125184754|NCT03428958|450298795|FG010|Overall Study|Clinical Progression|0|||
125184755|NCT03428958|450298796|FG011|Overall Study|Clinical Progression|0|||
125184756|NCT03428958|450298797|FG012|Overall Study|Clinical Progression|0|||
125184757|NCT03428958|450298798|FG013|Overall Study|Clinical Progression|0|||
125184758|NCT03428958|450298799|FG014|Overall Study|Clinical Progression|0|||
125184759|NCT03428958|450298800|FG015|Overall Study|Clinical Progression|0|||
125184760|NCT03428958|450298801|FG016|Overall Study|Clinical Progression|0|||
125184761|NCT03428958|450298785|FG000|Overall Study|Progression per RECIST|6|||
125184762|NCT03428958|450298786|FG001|Overall Study|Progression per RECIST|6|||
125184763|NCT03428958|450298787|FG002|Overall Study|Progression per RECIST|7|||
125184764|NCT03428958|450298788|FG003|Overall Study|Progression per RECIST|4|||
125184765|NCT03428958|450298789|FG004|Overall Study|Progression per RECIST|0|||
125184766|NCT03428958|450298790|FG005|Overall Study|Progression per RECIST|7|||
125184767|NCT03428958|450298791|FG006|Overall Study|Progression per RECIST|8|||
125184768|NCT03428958|450298792|FG007|Overall Study|Progression per RECIST|0|||
125184769|NCT03428958|450298793|FG008|Overall Study|Progression per RECIST|0|||
125184770|NCT03428958|450298794|FG009|Overall Study|Progression per RECIST|0|||
125184771|NCT03428958|450298795|FG010|Overall Study|Progression per RECIST|0|||
125184772|NCT03428958|450298796|FG011|Overall Study|Progression per RECIST|0|||
125184773|NCT03428958|450298797|FG012|Overall Study|Progression per RECIST|1|||
125184774|NCT03428958|450298798|FG013|Overall Study|Progression per RECIST|0|||
125184775|NCT03428958|450298799|FG014|Overall Study|Progression per RECIST|0|||
125184776|NCT03428958|450298800|FG015|Overall Study|Progression per RECIST|0|||
125184777|NCT03428958|450298801|FG016|Overall Study|Progression per RECIST|0|||
125184778|NCT03428958|450298785|FG000|Overall Study|Death|2|||
125184779|NCT03428958|450298786|FG001|Overall Study|Death|2|||
125184780|NCT03428958|450298787|FG002|Overall Study|Death|0|||
125184781|NCT03428958|450298788|FG003|Overall Study|Death|0|||
125184782|NCT03428958|450298789|FG004|Overall Study|Death|0|||
125184783|NCT03428958|450298790|FG005|Overall Study|Death|7|||
125184784|NCT03428958|450298791|FG006|Overall Study|Death|9|||
125184785|NCT03428958|450298792|FG007|Overall Study|Death|6|||
125184786|NCT03428958|450298793|FG008|Overall Study|Death|0|||
125184787|NCT03428958|450298794|FG009|Overall Study|Death|0|||
125184788|NCT03428958|450298795|FG010|Overall Study|Death|3|||
125184789|NCT03428958|450298796|FG011|Overall Study|Death|0|||
125184790|NCT03428958|450298797|FG012|Overall Study|Death|4|||
125184791|NCT03428958|450298798|FG013|Overall Study|Death|0|||
125184792|NCT03428958|450298799|FG014|Overall Study|Death|0|||
125184793|NCT03428958|450298800|FG015|Overall Study|Death|0|||
125184794|NCT03428958|450298801|FG016|Overall Study|Death|0|||
125184795|NCT03428958|450298785|FG000|Overall Study|Lost to Follow-up|0|||
125184796|NCT03428958|450298786|FG001|Overall Study|Lost to Follow-up|0|||
125184797|NCT03428958|450298787|FG002|Overall Study|Lost to Follow-up|0|||
125184798|NCT03428958|450298788|FG003|Overall Study|Lost to Follow-up|0|||
125184799|NCT03428958|450298789|FG004|Overall Study|Lost to Follow-up|0|||
125184800|NCT03428958|450298790|FG005|Overall Study|Lost to Follow-up|1|||
125184801|NCT03428958|450298791|FG006|Overall Study|Lost to Follow-up|1|||
125184802|NCT03428958|450298792|FG007|Overall Study|Lost to Follow-up|0|||
125184803|NCT03428958|450298793|FG008|Overall Study|Lost to Follow-up|0|||
125184804|NCT03428958|450298794|FG009|Overall Study|Lost to Follow-up|0|||
125184805|NCT03428958|450298795|FG010|Overall Study|Lost to Follow-up|0|||
125184806|NCT03428958|450298796|FG011|Overall Study|Lost to Follow-up|0|||
125184807|NCT03428958|450298797|FG012|Overall Study|Lost to Follow-up|0|||
125184808|NCT03428958|450298798|FG013|Overall Study|Lost to Follow-up|0|||
125184809|NCT03428958|450298799|FG014|Overall Study|Lost to Follow-up|0|||
125184810|NCT03428958|450298800|FG015|Overall Study|Lost to Follow-up|0|||
125184811|NCT03428958|450298801|FG016|Overall Study|Lost to Follow-up|0|||
125184812|NCT03428958|450298785|FG000|Overall Study|Physician/Sponsor Decision|1|||
125237640|NCT00620542|450497638|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
125184813|NCT03428958|450298786|FG001|Overall Study|Physician/Sponsor Decision|0|||
125184814|NCT03428958|450298787|FG002|Overall Study|Physician/Sponsor Decision|1|||
125184815|NCT03428958|450298788|FG003|Overall Study|Physician/Sponsor Decision|0|||
125184816|NCT03428958|450298789|FG004|Overall Study|Physician/Sponsor Decision|0|||
125184817|NCT03428958|450298790|FG005|Overall Study|Physician/Sponsor Decision|2|||
125184818|NCT03428958|450298791|FG006|Overall Study|Physician/Sponsor Decision|2|||
125184819|NCT03428958|450298792|FG007|Overall Study|Physician/Sponsor Decision|2|||
125184820|NCT03428958|450298793|FG008|Overall Study|Physician/Sponsor Decision|0|||
125184821|NCT03428958|450298794|FG009|Overall Study|Physician/Sponsor Decision|0|||
125184822|NCT03428958|450298795|FG010|Overall Study|Physician/Sponsor Decision|2|||
125184823|NCT03428958|450298796|FG011|Overall Study|Physician/Sponsor Decision|0|||
125184824|NCT03428958|450298797|FG012|Overall Study|Physician/Sponsor Decision|4|||
125184825|NCT03428958|450298798|FG013|Overall Study|Physician/Sponsor Decision|0|||
125184826|NCT03428958|450298799|FG014|Overall Study|Physician/Sponsor Decision|0|||
125184827|NCT03428958|450298800|FG015|Overall Study|Physician/Sponsor Decision|0|||
125184828|NCT03428958|450298801|FG016|Overall Study|Physician/Sponsor Decision|0|||
125184829|NCT03428958|450298785|FG000|Overall Study|Withdrawal by Subject|0|||
125184830|NCT03428958|450298786|FG001|Overall Study|Withdrawal by Subject|0|||
125184831|NCT03428958|450298787|FG002|Overall Study|Withdrawal by Subject|2|||
125184832|NCT03428958|450298788|FG003|Overall Study|Withdrawal by Subject|0|||
125184833|NCT03428958|450298789|FG004|Overall Study|Withdrawal by Subject|0|||
125184834|NCT03428958|450298790|FG005|Overall Study|Withdrawal by Subject|2|||
125184835|NCT03428958|450298791|FG006|Overall Study|Withdrawal by Subject|4|||
125184836|NCT03428958|450298792|FG007|Overall Study|Withdrawal by Subject|1|||
125184837|NCT03428958|450298793|FG008|Overall Study|Withdrawal by Subject|0|||
125184838|NCT03428958|450298794|FG009|Overall Study|Withdrawal by Subject|0|||
125184839|NCT03428958|450298795|FG010|Overall Study|Withdrawal by Subject|0|||
125184840|NCT03428958|450298796|FG011|Overall Study|Withdrawal by Subject|0|||
125184841|NCT03428958|450298797|FG012|Overall Study|Withdrawal by Subject|0|||
125184842|NCT03428958|450298798|FG013|Overall Study|Withdrawal by Subject|0|||
125184843|NCT03428958|450298799|FG014|Overall Study|Withdrawal by Subject|0|||
125184844|NCT03428958|450298800|FG015|Overall Study|Withdrawal by Subject|0|||
125184845|NCT03428958|450298801|FG016|Overall Study|Withdrawal by Subject|0|||
125184846|NCT01922037|450298802|FG000|Overall Study|Withdrawal by Subject|2|||
125184847|NCT01922037|450298803|FG001|Overall Study|Withdrawal by Subject|44|||
125184848|NCT01922037|450298802|FG000|Overall Study|Adverse Event|1|||
125184849|NCT01922037|450298803|FG001|Overall Study|Adverse Event|7|||
125184850|NCT01922037|450298802|FG000|Overall Study|Death|0|||
125184851|NCT01922037|450298803|FG001|Overall Study|Death|5|||
125184852|NCT01922037|450298802|FG000|Overall Study|Pregnancy|0|||
125184853|NCT01922037|450298803|FG001|Overall Study|Pregnancy|2|||
125184854|NCT01922037|450298802|FG000|Overall Study|Participant non-compliance|4|||
125184855|NCT01922037|450298803|FG001|Overall Study|Participant non-compliance|46|||
125184856|NCT01922037|450298802|FG000|Overall Study|Investigator/Sponsor decision|1|||
125184857|NCT01922037|450298803|FG001|Overall Study|Investigator/Sponsor decision|4|||
125184858|NCT01922037|450298802|FG000|Overall Study|Other unspecified|2|||
125184859|NCT01922037|450298803|FG001|Overall Study|Other unspecified|66|||
125184860|NCT00413699|450298807|FG000|Initial Period|Death|25|||
125184861|NCT00413699|450298808|FG001|Initial Period|Death|30|||
125184862|NCT00413699|450298809|FG002|Initial Period|Death|0|||
125184863|NCT00413699|450298807|FG000|Initial Period|Lack of Efficacy|59|||
125184864|NCT00413699|450298808|FG001|Initial Period|Lack of Efficacy|115|||
125184865|NCT00413699|450298809|FG002|Initial Period|Lack of Efficacy|0|||
125184866|NCT00413699|450298807|FG000|Initial Period|Lost to Follow-up|31|||
125184867|NCT00413699|450298808|FG001|Initial Period|Lost to Follow-up|101|||
125184868|NCT00413699|450298809|FG002|Initial Period|Lost to Follow-up|0|||
125184869|NCT00413699|450298807|FG000|Initial Period|Protocol Violation|38|||
125237641|NCT00620542|450497639|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
125184870|NCT00413699|450298808|FG001|Initial Period|Protocol Violation|89|||
125184871|NCT00413699|450298809|FG002|Initial Period|Protocol Violation|0|||
125184872|NCT00413699|450298807|FG000|Initial Period|Pregnancy|10|||
125184873|NCT00413699|450298808|FG001|Initial Period|Pregnancy|8|||
125184874|NCT00413699|450298809|FG002|Initial Period|Pregnancy|0|||
125184875|NCT00413699|450298807|FG000|Initial Period|Did not meet entrance criteria|2|||
125237642|NCT00620542|450497640|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
125237643|NCT00620542|450497641|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
125237644|NCT00620542|450497638|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
125237645|NCT00620542|450497639|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
125237646|NCT00620542|450497640|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
125237647|NCT00620542|450497641|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
125184876|NCT00413699|450298808|FG001|Initial Period|Did not meet entrance criteria|2|||
125184877|NCT00413699|450298809|FG002|Initial Period|Did not meet entrance criteria|0|||
125184878|NCT00413699|450298807|FG000|Initial Period|Medication error without adverse event|0|||
125184879|NCT00413699|450298808|FG001|Initial Period|Medication error without adverse event|1|||
125184880|NCT00413699|450298809|FG002|Initial Period|Medication error without adverse event|0|||
125184881|NCT00413699|450298807|FG000|Initial Period|Study terminated by Sponsor|0|||
125184882|NCT00413699|450298808|FG001|Initial Period|Study terminated by Sponsor|1|||
125184883|NCT00413699|450298809|FG002|Initial Period|Study terminated by Sponsor|0|||
125184884|NCT00413699|450298807|FG000|Initial Period|Other|67|||
125184885|NCT00413699|450298808|FG001|Initial Period|Other|211|||
125184886|NCT00413699|450298809|FG002|Initial Period|Other|0|||
125184887|NCT00413699|450298807|FG000|Initial Period|Adverse event related to study drug|178|||
125184888|NCT00413699|450298808|FG001|Initial Period|Adverse event related to study drug|527|||
125184889|NCT00413699|450298809|FG002|Initial Period|Adverse event related to study drug|0|||
125237648|NCT00620542|450497638|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
125237649|NCT00620542|450497639|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
125237650|NCT00620542|450497640|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
125237651|NCT00620542|450497641|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
125237652|NCT00620542|450497638|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
125237653|NCT00620542|450497639|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
125237654|NCT00620542|450497640|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
125237655|NCT00620542|450497641|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
125237656|NCT00620542|450497638|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
125237657|NCT00620542|450497639|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
125237658|NCT00620542|450497640|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
125237659|NCT00620542|450497641|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
125237660|NCT01283386|450497648|FG000|Overall Study|Death|2|||
125237661|NCT01283386|450497649|FG001|Overall Study|Death|0|||
125237662|NCT01283386|450497648|FG000|Overall Study|Withdrawal by Subject|2|||
125237663|NCT01283386|450497649|FG001|Overall Study|Withdrawal by Subject|1|||
125237664|NCT01283386|450497648|FG000|Overall Study|Relapse of underlying disease|1|||
125237665|NCT01283386|450497649|FG001|Overall Study|Relapse of underlying disease|3|||
125237666|NCT01283386|450497648|FG000|Overall Study|Progression of underlying disease|2|||
125237667|NCT01283386|450497649|FG001|Overall Study|Progression of underlying disease|7|||
125237668|NCT01283386|450497648|FG000|Overall Study|Reason not specified|1|||
125237669|NCT01283386|450497649|FG001|Overall Study|Reason not specified|0|||
125237670|NCT01283386|450497648|FG000|Overall Study|Protocol Violation|0|||
125237671|NCT01283386|450497649|FG001|Overall Study|Protocol Violation|1|||
125237672|NCT03483103|450497652|FG000|Pre-Treatment Phase|Other reasons|1|||
125237673|NCT03483103|450497652|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
125237674|NCT03483103|450497652|FG000|Pre-Treatment Phase|Disease-related complications|1|||
125237675|NCT03483103|450497652|FG000|Pre-Treatment Phase|Death|5|||
125237676|NCT03483103|450497652|FG000|Treatment Phase|Withdrawal by Subject|7|||
125237677|NCT03483103|450497652|FG000|Treatment Phase|Other reasons|1|||
125237678|NCT03483103|450497652|FG000|Treatment Phase|Death|23|||
125237679|NCT03483103|450497652|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
125237680|NCT03483103|450497652|FG000|Treatment Phase|Received nonconforming product|1|||
125237681|NCT02239328|450497653|FG000|Overall Study|Benign disease noted at time of surgery|6|||
125237682|NCT02239328|450497653|FG000|Overall Study|Equipment or website malfunction|2|||
125237683|NCT04115059|450497655|FG000|Overall Study|Withdrawal by Subject|1|||
125237684|NCT04115059|450497655|FG000|Overall Study|Lack of Efficacy|2|||
125237685|NCT06420232|450497656|FG000|Overall Study|Withdrawal by Subject|3|||
125237686|NCT03881371|450497657|FG000|Overall Study|Adverse Event|8|||
125237687|NCT03881371|450497658|FG001|Overall Study|Adverse Event|9|||
125237688|NCT03881371|450497657|FG000|Overall Study|Death|1|||
125237689|NCT03881371|450497658|FG001|Overall Study|Death|0|||
125237690|NCT03881371|450497657|FG000|Overall Study|Lost to Follow-up|1|||
125237691|NCT03881371|450497658|FG001|Overall Study|Lost to Follow-up|0|||
125237692|NCT03881371|450497657|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125237693|NCT03881371|450497658|FG001|Overall Study|Non-Compliance with Study Drug|2|||
125237694|NCT03881371|450497657|FG000|Overall Study|Physician Decision|3|||
125237695|NCT03881371|450497658|FG001|Overall Study|Physician Decision|3|||
125237696|NCT03881371|450497657|FG000|Overall Study|Withdrawal by Subject|2|||
125237697|NCT03881371|450497658|FG001|Overall Study|Withdrawal by Subject|10|||
125237698|NCT03881371|450497657|FG000|Overall Study|Discontinuation from Study|1|||
125237699|NCT03881371|450497658|FG001|Overall Study|Discontinuation from Study|0|||
125237700|NCT00933933|450497659|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
125237701|NCT00933933|450497660|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
125237702|NCT00933933|450497661|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
125237703|NCT00933933|450497659|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
125237704|NCT00933933|450497660|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
125237705|NCT00933933|450497661|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
125237706|NCT00963235|450497662|FG000|Overall Study|Withdrawal by Subject|22|||
125237707|NCT00963235|450497662|FG000|Overall Study|Lost to Follow-up|14|||
125237708|NCT00963235|450497662|FG000|Overall Study|Failed to return|9|||
125237709|NCT00963235|450497662|FG000|Overall Study|Protocol Violation|7|||
125237710|NCT00963235|450497662|FG000|Overall Study|Adverse Event|5|||
125237711|NCT00963235|450497662|FG000|Overall Study|Physician Decision|2|||
125237712|NCT00963235|450497662|FG000|Overall Study|Other|1|||
125237713|NCT01136915|450497663|FG000|Overall Study|Lost to Follow-up|2|||
125237714|NCT01136915|450497664|FG001|Overall Study|Lost to Follow-up|0|||
125237715|NCT01136915|450497663|FG000|Overall Study|Exclusion criterion met|0|||
125237716|NCT01136915|450497664|FG001|Overall Study|Exclusion criterion met|1|||
125237717|NCT01756235|450497665|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
125237718|NCT02337829|450497666|FG000|Overall Study|Death|0|||
125237719|NCT02337829|450497667|FG001|Overall Study|Death|1|||
125237720|NCT02337829|450497668|FG002|Overall Study|Death|0|||
125237721|NCT02337829|450497669|FG003|Overall Study|Death|0|||
125237722|NCT02337829|450497666|FG000|Overall Study|Study terminated by sponsor|12|||
125237723|NCT02337829|450497667|FG001|Overall Study|Study terminated by sponsor|10|||
125237724|NCT02337829|450497668|FG002|Overall Study|Study terminated by sponsor|5|||
125237725|NCT02337829|450497669|FG003|Overall Study|Study terminated by sponsor|6|||
125237726|NCT02337829|450497666|FG000|Overall Study|discontinued for other reasons|6|||
125237727|NCT02337829|450497667|FG001|Overall Study|discontinued for other reasons|3|||
125237728|NCT02337829|450497668|FG002|Overall Study|discontinued for other reasons|1|||
125237729|NCT02337829|450497669|FG003|Overall Study|discontinued for other reasons|4|||
125237730|NCT02802228|450497682|FG000|Overall Study|Withdrawal by Subject|2|||
125237731|NCT02802228|450497683|FG001|Overall Study|Withdrawal by Subject|0|||
125237732|NCT02802228|450497682|FG000|Overall Study|Lost to Follow-up|1|||
125237733|NCT02802228|450497683|FG001|Overall Study|Lost to Follow-up|0|||
125237734|NCT02802228|450497682|FG000|Overall Study|Adverse Event|1|||
125237735|NCT02802228|450497683|FG001|Overall Study|Adverse Event|0|||
125237736|NCT02802228|450497682|FG000|Overall Study|Physician Decision|1|||
125237737|NCT02802228|450497683|FG001|Overall Study|Physician Decision|0|||
125237738|NCT00695019|450497684|FG000|Overall Study|Withdrawal by Subject|8|||
125237739|NCT00695019|450497685|FG001|Overall Study|Withdrawal by Subject|6|||
125237740|NCT00695019|450497686|FG002|Overall Study|Withdrawal by Subject|4|||
125237741|NCT00695019|450497684|FG000|Overall Study|Protocol Violation|1|||
125237742|NCT00695019|450497685|FG001|Overall Study|Protocol Violation|3|||
125237743|NCT00695019|450497686|FG002|Overall Study|Protocol Violation|1|||
125237744|NCT00695019|450497684|FG000|Overall Study|Lack of Efficacy|0|||
125237745|NCT00695019|450497685|FG001|Overall Study|Lack of Efficacy|0|||
125237746|NCT00695019|450497686|FG002|Overall Study|Lack of Efficacy|1|||
125237747|NCT00695019|450497684|FG000|Overall Study|Various|4|||
125237748|NCT00695019|450497685|FG001|Overall Study|Various|5|||
125237749|NCT00695019|450497686|FG002|Overall Study|Various|4|||
125237750|NCT03197129|450497693|FG000|Overall Study|did not answer the VPT: shyness|4|||
125237751|NCT03197129|450497694|FG001|Overall Study|did not answer the VPT: shyness|5|||
125237752|NCT02879695|450497697|FG000|Overall Study|Did not start study treatment|2|||
125237753|NCT02879695|450497698|FG001|Overall Study|Did not start study treatment|0|||
125237754|NCT02879695|450497699|FG002|Overall Study|Did not start study treatment|3|||
125237755|NCT02879695|450497700|FG003|Overall Study|Did not start study treatment|0|||
125237756|NCT02442349|450497701|FG000|Overall Study|Death|95|||
125237757|NCT02442349|450497701|FG000|Overall Study|Withdrawal by Subject|27|||
125237758|NCT02442349|450497701|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
125237759|NCT02442349|450497701|FG000|Overall Study|Lost to Follow-up|1|||
125237760|NCT03507790|450497702|FG000|Overall Study|Adverse Event|0|||
125237761|NCT03507790|450497703|FG001|Overall Study|Adverse Event|11|||
125237762|NCT03507790|450497704|FG002|Overall Study|Adverse Event|3|||
125237763|NCT03507790|450497702|FG000|Overall Study|Withdrawal by Subject|2|||
125237764|NCT03507790|450497703|FG001|Overall Study|Withdrawal by Subject|0|||
125237765|NCT03507790|450497704|FG002|Overall Study|Withdrawal by Subject|0|||
125237766|NCT03507790|450497702|FG000|Overall Study|Subject moved to another location|1|||
125237767|NCT03507790|450497703|FG001|Overall Study|Subject moved to another location|2|||
125237768|NCT03507790|450497704|FG002|Overall Study|Subject moved to another location|0|||
125237769|NCT03507790|450497702|FG000|Overall Study|Non-compliance with study drug|0|||
125237770|NCT03507790|450497703|FG001|Overall Study|Non-compliance with study drug|0|||
125237771|NCT03507790|450497704|FG002|Overall Study|Non-compliance with study drug|1|||
125237772|NCT03507790|450497702|FG000|Overall Study|COVID 19 Pandemic|0|||
125237773|NCT03507790|450497703|FG001|Overall Study|COVID 19 Pandemic|1|||
125237774|NCT03507790|450497704|FG002|Overall Study|COVID 19 Pandemic|0|||
125237775|NCT03507790|450497702|FG000|Overall Study|Lost to Follow-up|0|||
125237776|NCT03507790|450497703|FG001|Overall Study|Lost to Follow-up|1|||
125237777|NCT03507790|450497704|FG002|Overall Study|Lost to Follow-up|0|||
125237778|NCT03507790|450497702|FG000|Overall Study|Discontinuation of the trial at the site|1|||
125237779|NCT03507790|450497703|FG001|Overall Study|Discontinuation of the trial at the site|1|||
125237780|NCT03507790|450497704|FG002|Overall Study|Discontinuation of the trial at the site|0|||
125237781|NCT03507790|450497702|FG000|Overall Study|Randomized in error|0|||
125237782|NCT03507790|450497703|FG001|Overall Study|Randomized in error|0|||
125237783|NCT03507790|450497704|FG002|Overall Study|Randomized in error|1|||
125237784|NCT01160614|450497707|FG000|Overall Study|Withdrawal by Subject|0|||
125237785|NCT01160614|450497708|FG001|Overall Study|Withdrawal by Subject|2|||
125237786|NCT05845619|450497709|FG000|Overall Study|duplicate enrollment|2|||
125237787|NCT05845619|450497710|FG001|Overall Study|duplicate enrollment|2|||
125237788|NCT05845619|450497711|FG002|Overall Study|duplicate enrollment|1|||
125237789|NCT03636477|450497712|FG000|Overall Study|Adverse Event|0|||
125237790|NCT03636477|450497713|FG001|Overall Study|Adverse Event|0|||
125237791|NCT03636477|450497714|FG002|Overall Study|Adverse Event|1|||
125237792|NCT03621592|450497715|FG000|Overall Study|Lost to Follow-up|1|||
125237793|NCT03621592|450497716|FG001|Overall Study|Lost to Follow-up|0|||
125237794|NCT03621592|450497715|FG000|Overall Study|Lack of Improvement|1|||
125237795|NCT03621592|450497716|FG001|Overall Study|Lack of Improvement|0|||
125237796|NCT03621592|450497715|FG000|Overall Study|Preference to receive wound care closer to home|1|||
125237797|NCT03621592|450497716|FG001|Overall Study|Preference to receive wound care closer to home|0|||
125237798|NCT03621592|450497715|FG000|Overall Study|Lack of healing|0|||
125237799|NCT03621592|450497716|FG001|Overall Study|Lack of healing|2|||
125237800|NCT02382380|450497717|FG000|Overall Study|Withdrawal by Subject|2|||
125237801|NCT02382380|450497718|FG001|Overall Study|Withdrawal by Subject|2|||
125237802|NCT02382380|450497717|FG000|Overall Study|Lost to Follow-up|0|||
125237803|NCT02382380|450497718|FG001|Overall Study|Lost to Follow-up|1|||
125237804|NCT04153864|450497726|FG000|Overall Study|Withdrawal by Subject|21|||
125237805|NCT04153864|450497727|FG001|Overall Study|Withdrawal by Subject|7|||
125237806|NCT04153864|450497728|FG002|Overall Study|Withdrawal by Subject|23|||
125237807|NCT04153864|450497729|FG003|Overall Study|Withdrawal by Subject|2|||
125237808|NCT04153864|450497726|FG000|Overall Study|Lost to Follow-up|4|||
125237809|NCT04153864|450497727|FG001|Overall Study|Lost to Follow-up|0|||
125237810|NCT04153864|450497728|FG002|Overall Study|Lost to Follow-up|3|||
125237811|NCT04153864|450497729|FG003|Overall Study|Lost to Follow-up|0|||
125237812|NCT04153864|450497726|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
125237813|NCT04153864|450497727|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
125237814|NCT04153864|450497728|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
125237815|NCT04153864|450497729|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
125237816|NCT00724945|450497730|FG000|Period 1|non-compliance|1|||
125237817|NCT00724945|450497731|FG001|Period 1|non-compliance|0|||
125237818|NCT00724945|450497730|FG000|Period 1|Adverse Event|1|||
125237819|NCT00724945|450497731|FG001|Period 1|Adverse Event|1|||
125237820|NCT00724945|450497730|FG000|Period 1|Lost to Follow-up|1|||
125237821|NCT00724945|450497731|FG001|Period 1|Lost to Follow-up|0|||
125237822|NCT00724945|450497730|FG000|Period 2|lens comfort issue|3|||
125237823|NCT00724945|450497731|FG001|Period 2|lens comfort issue|0|||
125237824|NCT00724945|450497730|FG000|Period 2|lens physiology issue|1|||
125237825|NCT00724945|450497731|FG001|Period 2|lens physiology issue|0|||
125237826|NCT04817410|450500298|FG000|Overall Study|Withdrawal by Subject|5|||
125237827|NCT04817410|450500298|FG000|Overall Study|Physician Decision|3|||
125237828|NCT03595748|450500300|FG000|Overall Study|Death|11|||
125237829|NCT03595748|450500301|FG001|Overall Study|Death|12|||
125237830|NCT03595748|450500300|FG000|Overall Study|Withdrawal by Subject|28|||
125237831|NCT03595748|450500301|FG001|Overall Study|Withdrawal by Subject|29|||
125237832|NCT03595748|450500300|FG000|Overall Study|Protocol Violation|0|||
125237833|NCT03595748|450500301|FG001|Overall Study|Protocol Violation|1|||
125237834|NCT04809974|450500303|FG000|Lead-in Phase|Withdrawal by Subject|3|||
125237835|NCT04809974|450500304|FG001|Lead-in Phase|Withdrawal by Subject|0|||
125237836|NCT04809974|450500305|FG002|Lead-in Phase|Withdrawal by Subject|0|||
125237837|NCT04809974|450500303|FG000|Lead-in Phase|No longer eligible|11|||
125237838|NCT04809974|450500304|FG001|Lead-in Phase|No longer eligible|0|||
125237839|NCT04809974|450500305|FG002|Lead-in Phase|No longer eligible|0|||
125237840|NCT04809974|450500303|FG000|Randomized Phase|Lost to Follow-up|0|||
125237841|NCT04809974|450500304|FG001|Randomized Phase|Lost to Follow-up|1|||
125237842|NCT04809974|450500305|FG002|Randomized Phase|Lost to Follow-up|5|||
125237843|NCT04809974|450500303|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
125237844|NCT04809974|450500304|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
125237845|NCT04809974|450500305|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
125237846|NCT04809974|450500303|FG000|Randomized Phase|Adverse Event|0|||
125237847|NCT04809974|450500304|FG001|Randomized Phase|Adverse Event|1|||
125237848|NCT04809974|450500305|FG002|Randomized Phase|Adverse Event|4|||
125237849|NCT04809974|450500303|FG000|Randomized Phase|Withdrawal by Subject|0|||
125237850|NCT04809974|450500304|FG001|Randomized Phase|Withdrawal by Subject|0|||
125237851|NCT04809974|450500305|FG002|Randomized Phase|Withdrawal by Subject|5|||
125237852|NCT05493111|450500306|FG000|Overall Study|Adverse Event|3|||
125237853|NCT05493111|450500307|FG001|Overall Study|Adverse Event|4|||
125237854|NCT05493111|450500306|FG000|Overall Study|Withdrawal of Consent|19|||
125237855|NCT05493111|450500307|FG001|Overall Study|Withdrawal of Consent|10|||
125237856|NCT05493111|450500306|FG000|Overall Study|Non-compliance|1|||
125237857|NCT05493111|450500307|FG001|Overall Study|Non-compliance|1|||
125237858|NCT05493111|450500306|FG000|Overall Study|Lost to Follow-up|8|||
125237859|NCT05493111|450500307|FG001|Overall Study|Lost to Follow-up|1|||
125237860|NCT05493111|450500306|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
125237861|NCT05493111|450500307|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
125237862|NCT05493111|450500306|FG000|Overall Study|Withdrawal by Subject|1|||
125237863|NCT05493111|450500307|FG001|Overall Study|Withdrawal by Subject|1|||
125237864|NCT01970371|450500308|FG000|Overall Study|Death|8|||
125237865|NCT01970371|450500309|FG001|Overall Study|Death|13|||
125237866|NCT01970371|450500310|FG002|Overall Study|Death|12|||
125237867|NCT01970371|450500308|FG000|Overall Study|Lost to Follow-up|0|||
125237868|NCT01970371|450500309|FG001|Overall Study|Lost to Follow-up|0|||
125237869|NCT01970371|450500310|FG002|Overall Study|Lost to Follow-up|1|||
125237870|NCT01348269|450500311|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
125237871|NCT01348269|450500312|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
125184890|NCT00413699|450298807|FG000|Initial Period|Adverse event not related to study drug|113|||
125184891|NCT00413699|450298808|FG001|Initial Period|Adverse event not related to study drug|248|||
125184892|NCT00413699|450298809|FG002|Initial Period|Adverse event not related to study drug|0|||
125184893|NCT00413699|450298807|FG000|Initial Period|Missing end of study page|0|||
125184894|NCT00413699|450298808|FG001|Initial Period|Missing end of study page|4|||
125184895|NCT00413699|450298809|FG002|Initial Period|Missing end of study page|0|||
125184896|NCT00413699|450298807|FG000|Initial Period|No longer willing to participate|116|||
125184897|NCT00413699|450298808|FG001|Initial Period|No longer willing to participate|368|||
125184898|NCT00413699|450298809|FG002|Initial Period|No longer willing to participate|0|||
125184899|NCT00413699|450298807|FG000|Extension Period|No Longer Willing to Participate|0|||
125184900|NCT00413699|450298808|FG001|Extension Period|No Longer Willing to Participate|0|||
125184901|NCT00413699|450298809|FG002|Extension Period|No Longer Willing to Participate|2|||
125184902|NCT00413699|450298807|FG000|Extension Period|Protocol Violation|0|||
125184903|NCT00413699|450298808|FG001|Extension Period|Protocol Violation|0|||
125184904|NCT00413699|450298809|FG002|Extension Period|Protocol Violation|1|||
125184905|NCT00413699|450298807|FG000|Extension Period|Adverse Event|0|||
125184906|NCT00413699|450298808|FG001|Extension Period|Adverse Event|0|||
125184907|NCT00413699|450298809|FG002|Extension Period|Adverse Event|2|||
125184908|NCT03511105|450298810|FG000|Overall Study|Adverse Event|1|||
125184909|NCT03511105|450298811|FG001|Overall Study|Adverse Event|0|||
125184910|NCT03511105|450298810|FG000|Overall Study|Withdrew consent|1|||
125184911|NCT03511105|450298811|FG001|Overall Study|Withdrew consent|0|||
125184912|NCT02810457|450298812|FG000|Overall Study|Randomised but no treatment received|2|||
125184913|NCT02810457|450298813|FG001|Overall Study|Randomised but no treatment received|1|||
125184914|NCT02810457|450298812|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
125184915|NCT02810457|450298813|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
125184916|NCT02810457|450298812|FG000|Overall Study|Adverse Event|37|||
125184917|NCT02810457|450298813|FG001|Overall Study|Adverse Event|43|||
125184918|NCT02810457|450298812|FG000|Overall Study|Patient decision|31|||
125184919|NCT02810457|450298813|FG001|Overall Study|Patient decision|35|||
125184920|NCT02810457|450298812|FG000|Overall Study|Patient lost to follow-up|2|||
125184921|NCT02810457|450298813|FG001|Overall Study|Patient lost to follow-up|2|||
125184922|NCT02810457|450298812|FG000|Overall Study|Death|39|||
125184923|NCT02810457|450298813|FG001|Overall Study|Death|28|||
125184924|NCT02810457|450298812|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
125184925|NCT02810457|450298813|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
125184926|NCT02810457|450298812|FG000|Overall Study|Clinical progression|15|||
125184927|NCT02810457|450298813|FG001|Overall Study|Clinical progression|16|||
125184928|NCT02810457|450298812|FG000|Overall Study|Investigator decision|3|||
125184929|NCT02810457|450298813|FG001|Overall Study|Investigator decision|2|||
125184930|NCT02810457|450298812|FG000|Overall Study|Patient ineligibility|3|||
125184931|NCT02810457|450298813|FG001|Overall Study|Patient ineligibility|0|||
125184932|NCT02810457|450298812|FG000|Overall Study|Miscalculated PD|1|||
125184933|NCT02810457|450298813|FG001|Overall Study|Miscalculated PD|0|||
125184934|NCT02810457|450298812|FG000|Overall Study|Physician Decision|0|||
125184935|NCT02810457|450298813|FG001|Overall Study|Physician Decision|1|||
125184936|NCT02832687|450298814|FG000|Overall Study|Adverse Event|0|||
125184937|NCT02832687|450298815|FG001|Overall Study|Adverse Event|2|||
125184938|NCT04231825|450298816|FG000|Overall Study|Protocol Violation|3|||
125184939|NCT04231825|450298817|FG001|Overall Study|Protocol Violation|3|||
125184940|NCT04231825|450298816|FG000|Overall Study|Lost to Follow-up|0|||
125184941|NCT04231825|450298817|FG001|Overall Study|Lost to Follow-up|1|||
125184942|NCT02019472|450298818|FG000|Overall Study|Adverse Event|14|||
125184943|NCT02019472|450298819|FG001|Overall Study|Adverse Event|23|||
125184944|NCT02019472|450298820|FG002|Overall Study|Adverse Event|17|||
125184945|NCT02019472|450298818|FG000|Overall Study|Death|0|||
125184946|NCT02019472|450298819|FG001|Overall Study|Death|1|||
125184947|NCT02019472|450298820|FG002|Overall Study|Death|1|||
125184948|NCT02019472|450298818|FG000|Overall Study|Lack of Efficacy|7|||
125184949|NCT02019472|450298819|FG001|Overall Study|Lack of Efficacy|4|||
125184950|NCT02019472|450298820|FG002|Overall Study|Lack of Efficacy|4|||
125184951|NCT02019472|450298818|FG000|Overall Study|Lost to Follow-up|0|||
125184952|NCT02019472|450298819|FG001|Overall Study|Lost to Follow-up|2|||
125184953|NCT02019472|450298820|FG002|Overall Study|Lost to Follow-up|1|||
125184954|NCT02019472|450298818|FG000|Overall Study|Physician Decision|1|||
125184955|NCT02019472|450298819|FG001|Overall Study|Physician Decision|2|||
125184956|NCT02019472|450298820|FG002|Overall Study|Physician Decision|0|||
125184957|NCT02019472|450298818|FG000|Overall Study|Pregnancy|1|||
125237872|NCT01348269|450500311|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
125184958|NCT02019472|450298819|FG001|Overall Study|Pregnancy|2|||
125184959|NCT02019472|450298820|FG002|Overall Study|Pregnancy|2|||
125184960|NCT02019472|450298818|FG000|Overall Study|Withdrawal by Subject|11|||
125184961|NCT02019472|450298819|FG001|Overall Study|Withdrawal by Subject|10|||
125184962|NCT02019472|450298820|FG002|Overall Study|Withdrawal by Subject|11|||
125184963|NCT02019472|450298818|FG000|Overall Study|Other|3|||
125184964|NCT02019472|450298819|FG001|Overall Study|Other|8|||
125184965|NCT02019472|450298820|FG002|Overall Study|Other|6|||
125184966|NCT01217112|450298823|FG000|Overall Study|Adverse Event|0|||
125184967|NCT01217112|450298824|FG001|Overall Study|Adverse Event|2|||
125184968|NCT01217112|450298825|FG002|Overall Study|Adverse Event|0|||
125184969|NCT01217112|450298826|FG003|Overall Study|Adverse Event|2|||
125184970|NCT01217112|450298827|FG004|Overall Study|Adverse Event|0|||
125184971|NCT01217112|450298823|FG000|Overall Study|Withdrawal by Subject|0|||
125184972|NCT01217112|450298824|FG001|Overall Study|Withdrawal by Subject|0|||
125184973|NCT01217112|450298825|FG002|Overall Study|Withdrawal by Subject|1|||
125184974|NCT01217112|450298826|FG003|Overall Study|Withdrawal by Subject|0|||
125184975|NCT01217112|450298827|FG004|Overall Study|Withdrawal by Subject|0|||
125184976|NCT01217112|450298823|FG000|Overall Study|Physician Decision|0|||
125184977|NCT01217112|450298824|FG001|Overall Study|Physician Decision|0|||
125184978|NCT01217112|450298825|FG002|Overall Study|Physician Decision|0|||
125184979|NCT01217112|450298826|FG003|Overall Study|Physician Decision|0|||
125184980|NCT01217112|450298827|FG004|Overall Study|Physician Decision|1|||
125184981|NCT03192488|450298828|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
125184982|NCT03192488|450298829|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
125184983|NCT03192488|450298830|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
125184984|NCT03192488|450298831|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
125184985|NCT03192488|450298832|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
125184986|NCT03192488|450298833|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
125184987|NCT03192488|450298828|FG000|Third Intervention (d1)|Adverse Event|0|||
125184988|NCT03192488|450298829|FG001|Third Intervention (d1)|Adverse Event|0|||
125184989|NCT03192488|450298830|FG002|Third Intervention (d1)|Adverse Event|0|||
125184990|NCT03192488|450298831|FG003|Third Intervention (d1)|Adverse Event|0|||
125184991|NCT03192488|450298832|FG004|Third Intervention (d1)|Adverse Event|1|||
125184992|NCT03192488|450298833|FG005|Third Intervention (d1)|Adverse Event|0|||
125184993|NCT01401361|450298834|FG000|Overall Study|Withdrawal by Subject|16|||
125184994|NCT01401361|450298834|FG000|Overall Study|Lack of Efficacy|6|||
125184995|NCT01401361|450298834|FG000|Overall Study|Physician Decision|1|||
125184996|NCT01401361|450298834|FG000|Overall Study|Lost to Follow-up|3|||
125184997|NCT01401361|450298834|FG000|Overall Study|Subject/family decision post procedure|2|||
125184998|NCT02512302|450298836|FG000|Period 1|Adverse Event|0|||
125184999|NCT02512302|450298837|FG001|Period 1|Adverse Event|1|||
125185000|NCT02512302|450298838|FG002|Period 1|Adverse Event|0|||
125185001|NCT02512302|450298839|FG003|Period 1|Adverse Event|0|||
125185002|NCT02512302|450298840|FG004|Period 1|Adverse Event|0|||
125185003|NCT02512302|450298841|FG005|Period 1|Adverse Event|0|||
125185004|NCT02512302|450298842|FG006|Period 1|Adverse Event|0|||
125185005|NCT02512302|450298843|FG007|Period 1|Adverse Event|0|||
125185006|NCT02512302|450298844|FG008|Period 1|Adverse Event|0|||
125185007|NCT02512302|450298845|FG009|Period 1|Adverse Event|0|||
125185008|NCT02512302|450298836|FG000|Period 2|Adverse Event|0|||
125185009|NCT02512302|450298837|FG001|Period 2|Adverse Event|0|||
125185010|NCT02512302|450298838|FG002|Period 2|Adverse Event|0|||
125185011|NCT02512302|450298839|FG003|Period 2|Adverse Event|0|||
125185012|NCT02512302|450298840|FG004|Period 2|Adverse Event|0|||
125185013|NCT02512302|450298841|FG005|Period 2|Adverse Event|0|||
125185014|NCT02512302|450298842|FG006|Period 2|Adverse Event|0|||
125185015|NCT02512302|450298843|FG007|Period 2|Adverse Event|0|||
125185016|NCT02512302|450298844|FG008|Period 2|Adverse Event|0|||
125185017|NCT02512302|450298845|FG009|Period 2|Adverse Event|1|||
125185018|NCT02512302|450298836|FG000|Period 3|Lost to Follow-up|0|||
125185019|NCT02512302|450298837|FG001|Period 3|Lost to Follow-up|0|||
125185020|NCT02512302|450298838|FG002|Period 3|Lost to Follow-up|1|||
125185021|NCT02512302|450298839|FG003|Period 3|Lost to Follow-up|0|||
125185022|NCT02512302|450298840|FG004|Period 3|Lost to Follow-up|0|||
125185023|NCT02512302|450298841|FG005|Period 3|Lost to Follow-up|0|||
125185024|NCT02512302|450298842|FG006|Period 3|Lost to Follow-up|0|||
125185025|NCT02512302|450298843|FG007|Period 3|Lost to Follow-up|0|||
125185026|NCT02512302|450298844|FG008|Period 3|Lost to Follow-up|0|||
125185027|NCT02512302|450298845|FG009|Period 3|Lost to Follow-up|0|||
125185028|NCT02512302|450298836|FG000|Period 4|Adverse Event|0|||
125185029|NCT02512302|450298837|FG001|Period 4|Adverse Event|0|||
125185030|NCT02512302|450298838|FG002|Period 4|Adverse Event|0|||
125185031|NCT02512302|450298839|FG003|Period 4|Adverse Event|0|||
125185032|NCT02512302|450298840|FG004|Period 4|Adverse Event|0|||
125185033|NCT02512302|450298841|FG005|Period 4|Adverse Event|0|||
125185034|NCT02512302|450298842|FG006|Period 4|Adverse Event|1|||
125185035|NCT02512302|450298843|FG007|Period 4|Adverse Event|0|||
125185036|NCT02512302|450298844|FG008|Period 4|Adverse Event|0|||
125185037|NCT02512302|450298845|FG009|Period 4|Adverse Event|0|||
125185038|NCT01002989|450298849|FG000|Overall Study|exclusion criteria, no consent|5|||
125185039|NCT02547428|450298856|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
125237873|NCT01348269|450500312|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
125237874|NCT01348269|450500311|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
125237875|NCT01348269|450500312|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
125237876|NCT04727749|450500313|FG000|Overall Study|Lost to Follow-up|10|||
125237877|NCT04727749|450500314|FG001|Overall Study|Lost to Follow-up|3|||
125237878|NCT01481779|450500315|FG000|Overall Study|Adverse Event|23|||
125185040|NCT02547428|450298857|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
125185041|NCT02547428|450298856|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
125185042|NCT02547428|450298857|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
125185043|NCT02547428|450298856|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
125185044|NCT02547428|450298857|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
125185045|NCT02547428|450298856|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
125185046|NCT02547428|450298857|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
125185047|NCT02547428|450298856|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
125185048|NCT02547428|450298857|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
125185049|NCT02547428|450298856|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
125185050|NCT02547428|450298857|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
125185051|NCT02547428|450298856|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
125185052|NCT02547428|450298857|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
125185053|NCT02547428|450298856|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
125185054|NCT02547428|450298857|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
125185055|NCT01479465|450298858|FG000|Overall Study|Disease Progression|9|||
125185056|NCT01479465|450298859|FG001|Overall Study|Disease Progression|61|||
125185057|NCT01479465|450298860|FG002|Overall Study|Disease Progression|65|||
125185058|NCT01479465|450298861|FG003|Overall Study|Disease Progression|70|||
125185059|NCT01479465|450298858|FG000|Overall Study|Study Discontinued by Sponsor|0|||
125185060|NCT01479465|450298859|FG001|Overall Study|Study Discontinued by Sponsor|7|||
125185061|NCT01479465|450298860|FG002|Overall Study|Study Discontinued by Sponsor|5|||
125185062|NCT01479465|450298861|FG003|Overall Study|Study Discontinued by Sponsor|3|||
125185063|NCT01479465|450298858|FG000|Overall Study|Adverse Event|0|||
125185064|NCT01479465|450298859|FG001|Overall Study|Adverse Event|3|||
125185065|NCT01479465|450298860|FG002|Overall Study|Adverse Event|6|||
125185066|NCT01479465|450298861|FG003|Overall Study|Adverse Event|4|||
125185067|NCT01479465|450298858|FG000|Overall Study|Investigator Discretion|1|||
125185068|NCT01479465|450298859|FG001|Overall Study|Investigator Discretion|4|||
125185069|NCT01479465|450298860|FG002|Overall Study|Investigator Discretion|2|||
125185070|NCT01479465|450298861|FG003|Overall Study|Investigator Discretion|4|||
125185071|NCT01479465|450298858|FG000|Overall Study|Subject Request|1|||
125185072|NCT01479465|450298859|FG001|Overall Study|Subject Request|3|||
125185073|NCT01479465|450298860|FG002|Overall Study|Subject Request|4|||
125185074|NCT01479465|450298861|FG003|Overall Study|Subject Request|2|||
125185075|NCT01479465|450298858|FG000|Overall Study|Subject Withdrew Consent|0|||
125185076|NCT01479465|450298859|FG001|Overall Study|Subject Withdrew Consent|5|||
125185077|NCT01479465|450298860|FG002|Overall Study|Subject Withdrew Consent|2|||
125185078|NCT01479465|450298861|FG003|Overall Study|Subject Withdrew Consent|1|||
125185079|NCT01479465|450298858|FG000|Overall Study|Protocol Violation|0|||
125185080|NCT01479465|450298859|FG001|Overall Study|Protocol Violation|1|||
125185081|NCT01479465|450298860|FG002|Overall Study|Protocol Violation|1|||
125185082|NCT01479465|450298861|FG003|Overall Study|Protocol Violation|0|||
125185083|NCT01479465|450298858|FG000|Overall Study|Death|0|||
125185084|NCT01479465|450298859|FG001|Overall Study|Death|0|||
125185085|NCT01479465|450298860|FG002|Overall Study|Death|0|||
125185086|NCT01479465|450298861|FG003|Overall Study|Death|1|||
125185087|NCT01479465|450298858|FG000|Overall Study|Lost to Follow-up|0|||
125185088|NCT01479465|450298859|FG001|Overall Study|Lost to Follow-up|0|||
125185089|NCT01479465|450298860|FG002|Overall Study|Lost to Follow-up|1|||
125185090|NCT01479465|450298861|FG003|Overall Study|Lost to Follow-up|0|||
125185091|NCT00370552|450298862|FG000|Overall Study|Adverse Event|2|||
125185092|NCT00370552|450298863|FG001|Overall Study|Adverse Event|2|||
125185093|NCT00370552|450298864|FG002|Overall Study|Adverse Event|2|||
125185094|NCT00370552|450298862|FG000|Overall Study|Disease progression|23|||
125185095|NCT00370552|450298863|FG001|Overall Study|Disease progression|23|||
125185096|NCT00370552|450298864|FG002|Overall Study|Disease progression|15|||
125185097|NCT00370552|450298862|FG000|Overall Study|Maximum clinical benefit|3|||
125185098|NCT00370552|450298863|FG001|Overall Study|Maximum clinical benefit|5|||
125185099|NCT00370552|450298864|FG002|Overall Study|Maximum clinical benefit|5|||
125185100|NCT00370552|450298862|FG000|Overall Study|Poor or noncompliance|0|||
125185101|NCT00370552|450298863|FG001|Overall Study|Poor or noncompliance|0|||
125185102|NCT00370552|450298864|FG002|Overall Study|Poor or noncompliance|1|||
125185103|NCT00370552|450298862|FG000|Overall Study|Study drug toxicity|11|||
125185104|NCT00370552|450298863|FG001|Overall Study|Study drug toxicity|8|||
125237879|NCT01481779|450500316|FG001|Overall Study|Adverse Event|5|||
125237880|NCT01481779|450500315|FG000|Overall Study|Lost to Follow-up|3|||
125237881|NCT01481779|450500316|FG001|Overall Study|Lost to Follow-up|2|||
125237882|NCT01481779|450500315|FG000|Overall Study|Protocol Violation|2|||
125185105|NCT00370552|450298864|FG002|Overall Study|Study drug toxicity|6|||
125185106|NCT00370552|450298862|FG000|Overall Study|Withdrawal by Subject|2|||
125185107|NCT00370552|450298863|FG001|Overall Study|Withdrawal by Subject|0|||
125185108|NCT00370552|450298864|FG002|Overall Study|Withdrawal by Subject|1|||
125185109|NCT00370552|450298862|FG000|Overall Study|Still on treatment|1|||
125185110|NCT00370552|450298863|FG001|Overall Study|Still on treatment|3|||
125185111|NCT00370552|450298864|FG002|Overall Study|Still on treatment|2|||
125185112|NCT00370552|450298862|FG000|Overall Study|Never treated|1|||
125185113|NCT00370552|450298863|FG001|Overall Study|Never treated|0|||
125185114|NCT00370552|450298864|FG002|Overall Study|Never treated|0|||
125185115|NCT00370552|450298862|FG000|Overall Study|Physician Decision|1|||
125185116|NCT00370552|450298863|FG001|Overall Study|Physician Decision|1|||
125185117|NCT00370552|450298864|FG002|Overall Study|Physician Decision|0|||
125185118|NCT00370552|450298862|FG000|Overall Study|Investigator decision|2|||
125185119|NCT00370552|450298863|FG001|Overall Study|Investigator decision|1|||
125185120|NCT00370552|450298864|FG002|Overall Study|Investigator decision|0|||
125185121|NCT00370552|450298862|FG000|Overall Study|High risk of allergic reaction|0|||
125185122|NCT00370552|450298863|FG001|Overall Study|High risk of allergic reaction|1|||
125185123|NCT00370552|450298864|FG002|Overall Study|High risk of allergic reaction|0|||
125185124|NCT00370552|450298862|FG000|Overall Study|Planned radiation for palliation|0|||
125185125|NCT00370552|450298863|FG001|Overall Study|Planned radiation for palliation|1|||
125185126|NCT00370552|450298864|FG002|Overall Study|Planned radiation for palliation|0|||
125185127|NCT00942084|450298876|FG000|Overall Study|Death|2|||
125185128|NCT01641640|450298878|FG000|Overall Study|Enrolled but not treated|1|||
125185129|NCT01641640|450298878|FG000|Overall Study|Efficacy failure|29|||
125185130|NCT01641640|450298878|FG000|Overall Study|Lost to Follow-up|3|||
125185131|NCT01641640|450298878|FG000|Overall Study|Withdrawal by Subject|2|||
125185132|NCT01641640|450298878|FG000|Overall Study|Adverse Event|1|||
125185133|NCT01234350|450298879|FG000|Overall Study|Adverse Event|277|||
125185134|NCT01234350|450298880|FG001|Overall Study|Adverse Event|92|||
125185135|NCT01234350|450298879|FG000|Overall Study|Withdrawal by Subject|61|||
125185136|NCT01234350|450298880|FG001|Overall Study|Withdrawal by Subject|36|||
125185137|NCT01234350|450298879|FG000|Overall Study|Lost to Follow-up|115|||
125185138|NCT01234350|450298880|FG001|Overall Study|Lost to Follow-up|47|||
125185139|NCT01234350|450298879|FG000|Overall Study|Covers a diverse set of reasons|234|||
125185140|NCT01234350|450298880|FG001|Overall Study|Covers a diverse set of reasons|92|||
125185141|NCT01836471|450298883|FG000|Overall Study|Pregnancy|1|||
125237883|NCT01481779|450500316|FG001|Overall Study|Protocol Violation|3|||
125237884|NCT01481779|450500315|FG000|Overall Study|Withdrawal by Subject|26|||
125237885|NCT01481779|450500316|FG001|Overall Study|Withdrawal by Subject|13|||
125237886|NCT01481779|450500315|FG000|Overall Study|Physician Decision|13|||
125237887|NCT01481779|450500316|FG001|Overall Study|Physician Decision|4|||
125237888|NCT01481779|450500315|FG000|Overall Study|Sponsor Decision|3|||
125237889|NCT01481779|450500316|FG001|Overall Study|Sponsor Decision|1|||
125237890|NCT02378181|450500317|FG000|Overall Study|Lost to Follow-up|2|||
125237891|NCT02378181|450500318|FG001|Overall Study|Lost to Follow-up|5|||
125237892|NCT02378181|450500317|FG000|Overall Study|Withdrawal by Subject|1|||
125237893|NCT02378181|450500318|FG001|Overall Study|Withdrawal by Subject|1|||
125237894|NCT02378181|450500317|FG000|Overall Study|Incarcerated|0|||
125237895|NCT02378181|450500318|FG001|Overall Study|Incarcerated|1|||
125237896|NCT03517137|450500329|FG000|Overall Study|Lack of Efficacy|1|||
125237897|NCT03517137|450500329|FG000|Overall Study|Adverse Event|2|||
125237898|NCT03517137|450500329|FG000|Overall Study|Withdrawal by Subject|2|||
125237899|NCT03517137|450500329|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
125237900|NCT02313155|450500331|FG000|Overall Study|Lost to Follow-up|0|||
125237901|NCT02313155|450500332|FG001|Overall Study|Lost to Follow-up|1|||
125237902|NCT00689936|450500333|FG000|Active Treatment Phase|Adverse Event|68|||
125237903|NCT00689936|450500334|FG001|Active Treatment Phase|Adverse Event|71|||
125185142|NCT01836471|450298884|FG001|Overall Study|Pregnancy|0|||
125185143|NCT01836471|450298885|FG002|Overall Study|Pregnancy|0|||
125185144|NCT01836471|450298886|FG003|Overall Study|Pregnancy|0|||
125185145|NCT01836471|450298887|FG004|Overall Study|Pregnancy|0|||
125185146|NCT01836471|450298883|FG000|Overall Study|Withdrawal by Subject|3|||
125237904|NCT00689936|450500335|FG002|Active Treatment Phase|Adverse Event|76|||
125237905|NCT00689936|450500333|FG000|Active Treatment Phase|Disease Progression|273|||
125185147|NCT01836471|450298884|FG001|Overall Study|Withdrawal by Subject|4|||
125185148|NCT01836471|450298885|FG002|Overall Study|Withdrawal by Subject|1|||
125237906|NCT00689936|450500334|FG001|Active Treatment Phase|Disease Progression|362|||
125237907|NCT00689936|450500335|FG002|Active Treatment Phase|Disease Progression|339|||
125237908|NCT00689936|450500333|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
125237909|NCT00689936|450500334|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
125237910|NCT00689936|450500335|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
125237911|NCT00689936|450500333|FG000|Active Treatment Phase|Death|60|||
125237912|NCT00689936|450500334|FG001|Active Treatment Phase|Death|28|||
125237913|NCT00689936|450500335|FG002|Active Treatment Phase|Death|37|||
125237914|NCT00689936|450500333|FG000|Active Treatment Phase|Lost to Follow-up|0|||
125237915|NCT00689936|450500334|FG001|Active Treatment Phase|Lost to Follow-up|2|||
125237916|NCT00689936|450500335|FG002|Active Treatment Phase|Lost to Follow-up|2|||
125237917|NCT00689936|450500333|FG000|Active Treatment Phase|Protocol Violation|2|||
125237918|NCT00689936|450500334|FG001|Active Treatment Phase|Protocol Violation|2|||
125237919|NCT00689936|450500335|FG002|Active Treatment Phase|Protocol Violation|4|||
125237920|NCT00689936|450500333|FG000|Active Treatment Phase|Study Close Out|64|||
125237921|NCT00689936|450500334|FG001|Active Treatment Phase|Study Close Out|26|||
125237922|NCT00689936|450500335|FG002|Active Treatment Phase|Study Close Out|21|||
125237923|NCT00689936|450500333|FG000|Active Treatment Phase|Miscellaneous|52|||
125237924|NCT00689936|450500334|FG001|Active Treatment Phase|Miscellaneous|34|||
125237925|NCT00689936|450500335|FG002|Active Treatment Phase|Miscellaneous|47|||
125237926|NCT00689936|450500333|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
125237927|NCT00689936|450500334|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
125237928|NCT00689936|450500335|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
125237929|NCT01303419|450500338|FG000|Overall Study|Discontinuation of study|60|||
125237930|NCT01303419|450500338|FG000|Overall Study|Did not complete both imaging methods|5|||
125237931|NCT01303419|450500338|FG000|Overall Study|Did not meet all I/E after screening|31|||
125237932|NCT01995201|450500339|FG000|From Baseline Until Week 24|Adverse Event|4|||
125237933|NCT01995201|450500340|FG001|From Baseline Until Week 24|Adverse Event|15|||
125237934|NCT01995201|450500341|FG002|From Baseline Until Week 24|Adverse Event|0|||
125237935|NCT01995201|450500342|FG003|From Baseline Until Week 24|Adverse Event|0|||
125237936|NCT01995201|450500343|FG004|From Baseline Until Week 24|Adverse Event|0|||
125237937|NCT01995201|450500344|FG005|From Baseline Until Week 24|Adverse Event|0|||
125237938|NCT01995201|450500345|FG006|From Baseline Until Week 24|Adverse Event|0|||
125237939|NCT01995201|450500339|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
125237940|NCT01995201|450500340|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
125237941|NCT01995201|450500341|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
125237942|NCT01995201|450500342|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
125237943|NCT01995201|450500343|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
125237944|NCT01995201|450500344|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
125237945|NCT01995201|450500345|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
125237946|NCT01995201|450500339|FG000|From Baseline Until Week 24|Death|0|||
125237947|NCT01995201|450500340|FG001|From Baseline Until Week 24|Death|1|||
125237948|NCT01995201|450500341|FG002|From Baseline Until Week 24|Death|0|||
125237949|NCT01995201|450500342|FG003|From Baseline Until Week 24|Death|0|||
125237950|NCT01995201|450500343|FG004|From Baseline Until Week 24|Death|0|||
125237951|NCT01995201|450500344|FG005|From Baseline Until Week 24|Death|0|||
125237952|NCT01995201|450500345|FG006|From Baseline Until Week 24|Death|0|||
125237953|NCT01995201|450500339|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
125237954|NCT01995201|450500340|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
125237955|NCT01995201|450500341|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
125237956|NCT01995201|450500342|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
125237957|NCT01995201|450500343|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
125237958|NCT01995201|450500344|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
125237959|NCT01995201|450500345|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
125237960|NCT01995201|450500339|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
125237961|NCT01995201|450500340|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
125237962|NCT01995201|450500341|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
125237963|NCT01995201|450500342|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
125237964|NCT01995201|450500343|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
125237965|NCT01995201|450500344|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
125237966|NCT01995201|450500345|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
125237967|NCT01995201|450500339|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
125237968|NCT01995201|450500340|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
125237969|NCT01995201|450500341|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
125237970|NCT01995201|450500342|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
125237971|NCT01995201|450500343|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
125237972|NCT01995201|450500344|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
125237973|NCT01995201|450500345|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
125237974|NCT01995201|450500339|FG000|From Baseline Until Week 24|Physician Decision|0|||
125237975|NCT01995201|450500340|FG001|From Baseline Until Week 24|Physician Decision|2|||
125237976|NCT01995201|450500341|FG002|From Baseline Until Week 24|Physician Decision|0|||
125237977|NCT01995201|450500342|FG003|From Baseline Until Week 24|Physician Decision|0|||
125185149|NCT01836471|450298886|FG003|Overall Study|Withdrawal by Subject|0|||
125185150|NCT01836471|450298887|FG004|Overall Study|Withdrawal by Subject|2|||
125185151|NCT01836471|450298883|FG000|Overall Study|Physician Decision|0|||
125185152|NCT01836471|450298884|FG001|Overall Study|Physician Decision|1|||
125185153|NCT01836471|450298885|FG002|Overall Study|Physician Decision|0|||
125185154|NCT01836471|450298886|FG003|Overall Study|Physician Decision|0|||
125185155|NCT01836471|450298887|FG004|Overall Study|Physician Decision|0|||
125185156|NCT01836471|450298883|FG000|Overall Study|Lost to Follow-up|0|||
125185157|NCT01836471|450298884|FG001|Overall Study|Lost to Follow-up|0|||
125185158|NCT01836471|450298885|FG002|Overall Study|Lost to Follow-up|0|||
125185159|NCT01836471|450298886|FG003|Overall Study|Lost to Follow-up|1|||
125185160|NCT01836471|450298887|FG004|Overall Study|Lost to Follow-up|1|||
125185161|NCT01836471|450298883|FG000|Overall Study|Adverse Event|6|||
125185162|NCT01836471|450298884|FG001|Overall Study|Adverse Event|3|||
125185163|NCT01836471|450298885|FG002|Overall Study|Adverse Event|1|||
125185164|NCT01836471|450298886|FG003|Overall Study|Adverse Event|1|||
125185165|NCT01836471|450298887|FG004|Overall Study|Adverse Event|2|||
125185166|NCT01836471|450298883|FG000|Overall Study|Non compliance with tx|1|||
125185167|NCT01836471|450298884|FG001|Overall Study|Non compliance with tx|1|||
125185168|NCT01836471|450298885|FG002|Overall Study|Non compliance with tx|0|||
125185169|NCT01836471|450298886|FG003|Overall Study|Non compliance with tx|0|||
125185170|NCT01836471|450298887|FG004|Overall Study|Non compliance with tx|0|||
125185171|NCT05506046|450298888|FG000|Overall Study|Lost to Follow-up|89|||
125185172|NCT05506046|450298889|FG001|Overall Study|Lost to Follow-up|101|||
125185173|NCT05506046|450298890|FG002|Overall Study|Lost to Follow-up|102|||
125185174|NCT05506046|450298891|FG003|Overall Study|Lost to Follow-up|99|||
125185175|NCT03051100|450298895|FG000|Overall Study|Withdrawal by Subject|1|||
125185176|NCT03051100|450298896|FG001|Overall Study|Withdrawal by Subject|0|||
125185177|NCT03776357|450298897|FG000|Overall Study|Lost to Follow-up|3|||
125185178|NCT05921903|450298898|FG000|Overall Study|Unsolicited non-SAE|0|||
125185179|NCT05921903|450298899|FG001|Overall Study|Unsolicited non-SAE|1|||
125185180|NCT05921903|450298900|FG002|Overall Study|Unsolicited non-SAE|0|||
125185181|NCT05921903|450298898|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
125185182|NCT05921903|450298899|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
125185183|NCT05921903|450298900|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
125185184|NCT05921903|450298898|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
125185185|NCT05921903|450298899|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
125185186|NCT05921903|450298900|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
125185187|NCT03305848|450298901|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
125185188|NCT03305848|450298901|FG000|Overall Study|Physician Decision|2|||
125185189|NCT00789854|450298904|FG000|Overall Study|Adverse Event|28|||
125185190|NCT00789854|450298905|FG001|Overall Study|Adverse Event|23|||
125185191|NCT00789854|450298906|FG002|Overall Study|Adverse Event|18|||
125185192|NCT00789854|450298904|FG000|Overall Study|Lost to Follow-up|1|||
125185193|NCT00789854|450298905|FG001|Overall Study|Lost to Follow-up|1|||
125185194|NCT00789854|450298906|FG002|Overall Study|Lost to Follow-up|4|||
125185195|NCT00789854|450298904|FG000|Overall Study|Withdrawal by Subject|9|||
125185196|NCT00789854|450298905|FG001|Overall Study|Withdrawal by Subject|6|||
125185197|NCT00789854|450298906|FG002|Overall Study|Withdrawal by Subject|17|||
125185198|NCT00789854|450298904|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
125185199|NCT00789854|450298905|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
125185200|NCT00789854|450298906|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
125185201|NCT00789854|450298904|FG000|Overall Study|Severe non-compliance to the protocol|3|||
125185202|NCT00789854|450298905|FG001|Overall Study|Severe non-compliance to the protocol|0|||
125185203|NCT00789854|450298906|FG002|Overall Study|Severe non-compliance to the protocol|0|||
125185204|NCT00789854|450298904|FG000|Overall Study|Safety reasons|0|||
125185205|NCT00789854|450298905|FG001|Overall Study|Safety reasons|0|||
125185206|NCT00789854|450298906|FG002|Overall Study|Safety reasons|2|||
125185207|NCT00789854|450298904|FG000|Overall Study|Other|6|||
125185208|NCT00789854|450298905|FG001|Overall Study|Other|0|||
125185209|NCT00789854|450298906|FG002|Overall Study|Other|5|||
125185210|NCT03181633|450298907|FG000|Overall Study|Withdrawal by Subject|1|||
125185211|NCT03181633|450298907|FG000|Overall Study|Missing follow-up visit|1|||
125185212|NCT05303194|450298908|FG000|Overall Study|Lost to Follow-up|1|||
125185213|NCT05303194|450298909|FG001|Overall Study|Lost to Follow-up|1|||
125185214|NCT05303194|450298908|FG000|Overall Study|Withdrawal by Subject|0|||
125185215|NCT05303194|450298909|FG001|Overall Study|Withdrawal by Subject|1|||
125237978|NCT01995201|450500343|FG004|From Baseline Until Week 24|Physician Decision|0|||
125237979|NCT01995201|450500344|FG005|From Baseline Until Week 24|Physician Decision|0|||
125185216|NCT04837196|450298919|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
125185217|NCT04837196|450298920|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
125237980|NCT01995201|450500345|FG006|From Baseline Until Week 24|Physician Decision|0|||
125237981|NCT01995201|450500339|FG000|From Baseline Until Week 24|Protocol Violation|0|||
125237982|NCT01995201|450500340|FG001|From Baseline Until Week 24|Protocol Violation|9|||
125237983|NCT01995201|450500341|FG002|From Baseline Until Week 24|Protocol Violation|0|||
125237984|NCT01995201|450500342|FG003|From Baseline Until Week 24|Protocol Violation|0|||
125237985|NCT01995201|450500343|FG004|From Baseline Until Week 24|Protocol Violation|0|||
125237986|NCT01995201|450500344|FG005|From Baseline Until Week 24|Protocol Violation|0|||
125237987|NCT01995201|450500345|FG006|From Baseline Until Week 24|Protocol Violation|0|||
125237988|NCT01995201|450500339|FG000|From Week 24 Until Week 48|Adverse Event|0|||
125237989|NCT01995201|450500340|FG001|From Week 24 Until Week 48|Adverse Event|0|||
125237990|NCT01995201|450500341|FG002|From Week 24 Until Week 48|Adverse Event|2|||
125237991|NCT01995201|450500342|FG003|From Week 24 Until Week 48|Adverse Event|1|||
125237992|NCT01995201|450500343|FG004|From Week 24 Until Week 48|Adverse Event|1|||
125237993|NCT01995201|450500344|FG005|From Week 24 Until Week 48|Adverse Event|3|||
125237994|NCT01995201|450500345|FG006|From Week 24 Until Week 48|Adverse Event|1|||
125237995|NCT01995201|450500339|FG000|From Week 24 Until Week 48|Death|0|||
125237996|NCT01995201|450500340|FG001|From Week 24 Until Week 48|Death|0|||
125237997|NCT01995201|450500341|FG002|From Week 24 Until Week 48|Death|0|||
125237998|NCT01995201|450500342|FG003|From Week 24 Until Week 48|Death|0|||
125237999|NCT01995201|450500343|FG004|From Week 24 Until Week 48|Death|0|||
125238000|NCT01995201|450500344|FG005|From Week 24 Until Week 48|Death|2|||
125238001|NCT01995201|450500345|FG006|From Week 24 Until Week 48|Death|0|||
125238002|NCT01995201|450500339|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
125238003|NCT01995201|450500340|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
125238004|NCT01995201|450500341|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
125238005|NCT01995201|450500342|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
125238006|NCT01995201|450500343|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
125238007|NCT01995201|450500344|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
125238008|NCT01995201|450500345|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
125238009|NCT01995201|450500339|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
125238010|NCT01995201|450500340|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
125238011|NCT01995201|450500341|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
125238012|NCT01995201|450500342|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
125238013|NCT01995201|450500343|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
125238014|NCT01995201|450500344|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
125238015|NCT01995201|450500345|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
125238016|NCT01995201|450500339|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
125238017|NCT01995201|450500340|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
125238018|NCT01995201|450500341|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
125238019|NCT01995201|450500342|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
125238020|NCT01995201|450500343|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
125238021|NCT01995201|450500344|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
125238022|NCT01995201|450500345|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
125238023|NCT01995201|450500339|FG000|From Week 24 Until Week 48|Physician Decision|0|||
125238024|NCT01995201|450500340|FG001|From Week 24 Until Week 48|Physician Decision|0|||
125238025|NCT01995201|450500341|FG002|From Week 24 Until Week 48|Physician Decision|0|||
125238026|NCT01995201|450500342|FG003|From Week 24 Until Week 48|Physician Decision|0|||
125238027|NCT01995201|450500343|FG004|From Week 24 Until Week 48|Physician Decision|1|||
125238028|NCT01995201|450500344|FG005|From Week 24 Until Week 48|Physician Decision|0|||
125238029|NCT01995201|450500345|FG006|From Week 24 Until Week 48|Physician Decision|0|||
125238030|NCT01995201|450500339|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
125238031|NCT01995201|450500340|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
125238032|NCT01995201|450500341|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
125238033|NCT01995201|450500342|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
125238034|NCT01995201|450500343|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
125238035|NCT01995201|450500344|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
125238036|NCT01995201|450500345|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
125238037|NCT05376358|450500349|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
125238038|NCT05376358|450500350|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
125238039|NCT05376358|450500349|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
125238040|NCT05376358|450500350|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
125238041|NCT05376358|450500349|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
125238042|NCT05376358|450500350|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
125238043|NCT05376358|450500349|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
125238044|NCT05376358|450500350|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
125238045|NCT05376358|450500349|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
125238046|NCT05376358|450500350|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
125238047|NCT05376358|450500349|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
125238048|NCT05376358|450500350|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
125238049|NCT02213926|450500353|FG000|Overall Study|Death|59|||
125238050|NCT02213926|450500353|FG000|Overall Study|Withdrawal by Subject|10|||
125238051|NCT02213926|450500353|FG000|Overall Study|study terminated by sponsor|51|||
125238052|NCT02213926|450500353|FG000|Overall Study|Lost to Follow-up|3|||
125238053|NCT02213926|450500353|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
125238054|NCT01697579|450500356|FG000|Base Study-Cycle 1|Adverse Event|1|||
125238055|NCT01697579|450500357|FG001|Base Study-Cycle 1|Adverse Event|0|||
125238056|NCT01697579|450500358|FG002|Base Study-Cycle 1|Adverse Event|0|||
125238057|NCT01697579|450500359|FG003|Base Study-Cycle 1|Adverse Event|0|||
125238058|NCT01697579|450500360|FG004|Base Study-Cycle 1|Adverse Event|0|||
125238059|NCT01697579|450500361|FG005|Base Study-Cycle 1|Adverse Event|0|||
125238060|NCT01697579|450500362|FG006|Base Study-Cycle 1|Adverse Event|0|||
125238061|NCT01697579|450500356|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
125238062|NCT01697579|450500357|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
125238063|NCT01697579|450500358|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
125238064|NCT01697579|450500359|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
125238065|NCT01697579|450500360|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
125238066|NCT01697579|450500361|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
125238067|NCT01697579|450500362|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
125238068|NCT01697579|450500356|FG000|Base Study-Cycle 1|Protocol Violation|0|||
125238069|NCT01697579|450500357|FG001|Base Study-Cycle 1|Protocol Violation|0|||
125238070|NCT01697579|450500358|FG002|Base Study-Cycle 1|Protocol Violation|0|||
125238071|NCT01697579|450500359|FG003|Base Study-Cycle 1|Protocol Violation|0|||
125238072|NCT01697579|450500360|FG004|Base Study-Cycle 1|Protocol Violation|3|||
125238073|NCT01697579|450500361|FG005|Base Study-Cycle 1|Protocol Violation|0|||
125238074|NCT01697579|450500362|FG006|Base Study-Cycle 1|Protocol Violation|0|||
125238075|NCT01697579|450500356|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
125238076|NCT01697579|450500357|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
125238077|NCT01697579|450500358|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
125238078|NCT01697579|450500359|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
125238079|NCT01697579|450500360|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
125238080|NCT01697579|450500361|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
125238081|NCT01697579|450500362|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
125238082|NCT01697579|450500356|FG000|Base Study-Cycle 1|Technical Problems|0|||
125238083|NCT01697579|450500357|FG001|Base Study-Cycle 1|Technical Problems|0|||
125238084|NCT01697579|450500358|FG002|Base Study-Cycle 1|Technical Problems|1|||
125238085|NCT01697579|450500359|FG003|Base Study-Cycle 1|Technical Problems|1|||
125238086|NCT01697579|450500360|FG004|Base Study-Cycle 1|Technical Problems|0|||
125238087|NCT01697579|450500361|FG005|Base Study-Cycle 1|Technical Problems|0|||
125238088|NCT01697579|450500362|FG006|Base Study-Cycle 1|Technical Problems|0|||
125238089|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Death|0|||
125238090|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Death|0|||
125238091|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Death|0|||
125238092|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Death|0|||
125238093|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Death|0|||
125238094|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Death|0|||
125238095|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Death|2|||
125238096|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
125238097|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
125238098|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
125238099|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
125238100|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
125238101|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
125238102|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
125238103|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
125238104|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
125238105|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
125238106|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
125238107|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
125238108|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
125238109|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
125238110|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
125238111|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
125238112|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
125238113|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
125238114|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
125185218|NCT04837196|450298921|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
125185219|NCT04837196|450298922|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
125185220|NCT04837196|450298923|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
125185221|NCT04837196|450298919|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
125185222|NCT04837196|450298920|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
125185223|NCT04837196|450298921|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
125185224|NCT04837196|450298922|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
125185225|NCT04837196|450298923|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
125185226|NCT04837196|450298919|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
125185227|NCT04837196|450298920|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
125185228|NCT04837196|450298921|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
125185229|NCT04837196|450298922|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
125185230|NCT04837196|450298923|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
125185231|NCT04837196|450298919|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
125185232|NCT04837196|450298920|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
125185233|NCT04837196|450298921|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
125185234|NCT04837196|450298922|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
125185235|NCT04837196|450298923|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
125185236|NCT04837196|450298919|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
125185237|NCT04837196|450298920|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
125185238|NCT04837196|450298921|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
125185239|NCT04837196|450298922|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
125185240|NCT04837196|450298923|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
125185241|NCT05271175|450298924|FG000|One Week Follow up|Lost to Follow-up|10|||
125185242|NCT05271175|450298925|FG001|One Week Follow up|Lost to Follow-up|7|||
125185243|NCT05271175|450298926|FG002|One Week Follow up|Lost to Follow-up|5|||
125185244|NCT05271175|450298924|FG000|One Month Follow up|Lost to Follow-up|12|||
125185245|NCT05271175|450298925|FG001|One Month Follow up|Lost to Follow-up|7|||
125185246|NCT05271175|450298926|FG002|One Month Follow up|Lost to Follow-up|9|||
125185247|NCT05271175|450298924|FG000|Six Months Follow up|Lost to Follow-up|8|||
125185248|NCT05271175|450298925|FG001|Six Months Follow up|Lost to Follow-up|2|||
125185249|NCT05271175|450298926|FG002|Six Months Follow up|Lost to Follow-up|2|||
125185250|NCT00991887|450298927|FG000|Overall Study|Lost to Follow-up|2|||
125185251|NCT00991887|450298928|FG001|Overall Study|Lost to Follow-up|1|||
125185252|NCT01522456|450298929|FG000|Overall Study|Adverse Event|2|||
125185253|NCT01522456|450298929|FG000|Overall Study|Lost to Follow-up|2|||
125185254|NCT01522456|450298929|FG000|Overall Study|Withdrawal by Subject|2|||
125185255|NCT01522456|450298929|FG000|Overall Study|Pregnancy|1|||
125185256|NCT01522456|450298929|FG000|Overall Study|Tolerability Assessment|1|||
125185257|NCT04581824|450300747|FG000|Overall Study|Lost to Follow-up|1|||
125185258|NCT04581824|450300748|FG001|Overall Study|Lost to Follow-up|0|||
125185259|NCT04581824|450300747|FG000|Overall Study|Withdrawal by Subject|2|||
125185260|NCT04581824|450300748|FG001|Overall Study|Withdrawal by Subject|7|||
125185261|NCT04581824|450300747|FG000|Overall Study|Study terminated by sponsor|37|||
125185262|NCT04581824|450300748|FG001|Overall Study|Study terminated by sponsor|23|||
125185263|NCT04796909|450300749|FG000|Overall Study|Withdrawal by Subject|1|||
125185264|NCT04796909|450300750|FG001|Overall Study|Withdrawal by Subject|1|||
125185265|NCT03879135|450300751|FG000|Overall Study|Physician Decision|0|||
125185266|NCT03879135|450300752|FG001|Overall Study|Physician Decision|0|||
125185267|NCT03879135|450300753|FG002|Overall Study|Physician Decision|0|||
125185268|NCT03879135|450300754|FG003|Overall Study|Physician Decision|1|||
125185269|NCT03879135|450300755|FG004|Overall Study|Physician Decision|0|||
125185270|NCT03879135|450300756|FG005|Overall Study|Physician Decision|0|||
125185271|NCT03879135|450300751|FG000|Overall Study|Withdrawal by Subject|0|||
125185272|NCT03879135|450300752|FG001|Overall Study|Withdrawal by Subject|0|||
125185273|NCT03879135|450300753|FG002|Overall Study|Withdrawal by Subject|0|||
125185274|NCT03879135|450300754|FG003|Overall Study|Withdrawal by Subject|0|||
125185275|NCT03879135|450300755|FG004|Overall Study|Withdrawal by Subject|0|||
125185276|NCT03879135|450300756|FG005|Overall Study|Withdrawal by Subject|1|||
125185277|NCT03879135|450300751|FG000|Overall Study|Site Closed by Sponsor|0|||
125185278|NCT03879135|450300752|FG001|Overall Study|Site Closed by Sponsor|0|||
125185279|NCT03879135|450300753|FG002|Overall Study|Site Closed by Sponsor|0|||
125185280|NCT03879135|450300754|FG003|Overall Study|Site Closed by Sponsor|1|||
125185281|NCT03879135|450300755|FG004|Overall Study|Site Closed by Sponsor|1|||
125185282|NCT03879135|450300756|FG005|Overall Study|Site Closed by Sponsor|0|||
125185283|NCT04162847|450300757|FG000|Overall Study|Withdrawal by Subject|7|||
125185284|NCT04162847|450300758|FG001|Overall Study|Withdrawal by Subject|1|||
125238115|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
125185285|NCT03874117|450300759|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
125185286|NCT03874117|450300760|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
125185287|NCT03874117|450300759|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
125238116|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
125238117|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
125238118|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
125238119|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
125238120|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
125238121|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
125238122|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
125238123|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
125238124|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
125238125|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
125238126|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
125238127|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
125238128|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
125238129|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
125238130|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
125238131|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
125238132|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
125238133|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
125238134|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
125238135|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
125238136|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
125238137|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
125238138|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
125238139|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
125238140|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
125238141|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
125238142|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
125238143|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
125238144|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
125238145|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
125238146|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
125238147|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
125238148|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
125238149|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
125238150|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
125238151|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
125238152|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
125238153|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
125238154|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
125238155|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
125238156|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
125238157|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
125238158|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
125238159|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
125238160|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
125238161|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
125238162|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
125238163|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
125238164|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
125238165|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
125238166|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
125238167|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
125238168|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
125238169|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
125238170|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
125238171|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
125238172|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
125238173|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
125238174|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
125238175|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
125238176|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
125238177|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
125238178|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
125238179|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
125238180|NCT01044498|450500365|FG000|Overall Study|Withdrew consent|1|||
125238181|NCT01044498|450500366|FG001|Overall Study|Withdrew consent|1|||
125238182|NCT01044498|450500365|FG000|Overall Study|Adverse Event|1|||
125238183|NCT01044498|450500366|FG001|Overall Study|Adverse Event|1|||
125238184|NCT01044498|450500365|FG000|Overall Study|Other|1|||
125238185|NCT01044498|450500366|FG001|Overall Study|Other|0|||
125238186|NCT02327078|450500371|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
125238187|NCT02327078|450500372|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
125238188|NCT02327078|450500373|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
125238189|NCT02327078|450500374|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
125238190|NCT02327078|450500375|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
125238191|NCT02327078|450500376|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
125238192|NCT02327078|450500377|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
125238193|NCT02327078|450500378|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
125238194|NCT02327078|450500379|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
125238195|NCT02327078|450500371|FG000|Overall Study|Death|2|||
125238196|NCT02327078|450500372|FG001|Overall Study|Death|4|||
125238197|NCT02327078|450500373|FG002|Overall Study|Death|10|||
125238198|NCT02327078|450500374|FG003|Overall Study|Death|6|||
125238199|NCT02327078|450500375|FG004|Overall Study|Death|4|||
125238200|NCT02327078|450500376|FG005|Overall Study|Death|3|||
125238201|NCT02327078|450500377|FG006|Overall Study|Death|2|||
125238202|NCT02327078|450500378|FG007|Overall Study|Death|51|||
125238203|NCT02327078|450500379|FG008|Overall Study|Death|97|||
125238204|NCT02327078|450500371|FG000|Overall Study|Lost to Follow-up|0|||
125238205|NCT02327078|450500372|FG001|Overall Study|Lost to Follow-up|1|||
125238206|NCT02327078|450500373|FG002|Overall Study|Lost to Follow-up|1|||
125238207|NCT02327078|450500374|FG003|Overall Study|Lost to Follow-up|0|||
125238208|NCT02327078|450500375|FG004|Overall Study|Lost to Follow-up|0|||
125238209|NCT02327078|450500376|FG005|Overall Study|Lost to Follow-up|0|||
125238210|NCT02327078|450500377|FG006|Overall Study|Lost to Follow-up|0|||
125238211|NCT02327078|450500378|FG007|Overall Study|Lost to Follow-up|2|||
125238212|NCT02327078|450500379|FG008|Overall Study|Lost to Follow-up|5|||
125238213|NCT02327078|450500371|FG000|Overall Study|Site Terminated by Sponsor|1|||
125238214|NCT02327078|450500372|FG001|Overall Study|Site Terminated by Sponsor|0|||
125238215|NCT02327078|450500373|FG002|Overall Study|Site Terminated by Sponsor|1|||
125238216|NCT02327078|450500374|FG003|Overall Study|Site Terminated by Sponsor|4|||
125238217|NCT02327078|450500375|FG004|Overall Study|Site Terminated by Sponsor|0|||
125238218|NCT02327078|450500376|FG005|Overall Study|Site Terminated by Sponsor|0|||
125238219|NCT02327078|450500377|FG006|Overall Study|Site Terminated by Sponsor|0|||
125238220|NCT02327078|450500378|FG007|Overall Study|Site Terminated by Sponsor|11|||
125238221|NCT02327078|450500379|FG008|Overall Study|Site Terminated by Sponsor|25|||
125238222|NCT02327078|450500371|FG000|Overall Study|Physician Decision|0|||
125238223|NCT02327078|450500372|FG001|Overall Study|Physician Decision|0|||
125238224|NCT02327078|450500373|FG002|Overall Study|Physician Decision|0|||
125238225|NCT02327078|450500374|FG003|Overall Study|Physician Decision|1|||
125238226|NCT02327078|450500375|FG004|Overall Study|Physician Decision|0|||
125238227|NCT02327078|450500376|FG005|Overall Study|Physician Decision|0|||
125238228|NCT02327078|450500377|FG006|Overall Study|Physician Decision|0|||
125238229|NCT02327078|450500378|FG007|Overall Study|Physician Decision|0|||
125238230|NCT02327078|450500379|FG008|Overall Study|Physician Decision|1|||
125238231|NCT02327078|450500371|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
125238232|NCT02327078|450500372|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
125238233|NCT02327078|450500373|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
125238234|NCT02327078|450500374|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
125238235|NCT02327078|450500375|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
125238236|NCT02327078|450500376|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
125238237|NCT02327078|450500377|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
125238238|NCT02327078|450500378|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
125238239|NCT02327078|450500379|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
125238240|NCT02327078|450500371|FG000|Overall Study|Reason not Specified|0|||
125238241|NCT02327078|450500372|FG001|Overall Study|Reason not Specified|0|||
125238242|NCT02327078|450500373|FG002|Overall Study|Reason not Specified|0|||
125238243|NCT02327078|450500374|FG003|Overall Study|Reason not Specified|0|||
125238244|NCT02327078|450500375|FG004|Overall Study|Reason not Specified|0|||
125238245|NCT02327078|450500376|FG005|Overall Study|Reason not Specified|0|||
125238246|NCT02327078|450500377|FG006|Overall Study|Reason not Specified|0|||
125238247|NCT02327078|450500378|FG007|Overall Study|Reason not Specified|5|||
125238248|NCT02327078|450500379|FG008|Overall Study|Reason not Specified|12|||
125238249|NCT05513950|450500380|FG000|Overall Study|Not treated due to technical reasons|0|||
125238250|NCT05513950|450500381|FG001|Overall Study|Not treated due to technical reasons|0|||
125238251|NCT05513950|450500382|FG002|Overall Study|Not treated due to technical reasons|1|||
125238252|NCT05513950|450500383|FG003|Overall Study|Not treated due to technical reasons|0|||
125185288|NCT03874117|450300760|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
125185289|NCT03874117|450300759|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
125185290|NCT03874117|450300760|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
125185291|NCT03874117|450300759|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
125185292|NCT03874117|450300760|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
125238253|NCT06001866|450500384|FG000|Overall Study|Withdrawal by Subject|0|||
125238254|NCT06001866|450500385|FG001|Overall Study|Withdrawal by Subject|2|||
125185293|NCT03874117|450300759|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
125185294|NCT03874117|450300760|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
125185295|NCT00813150|450300765|FG000|Treatment Period|Adverse Event|16|||
125185296|NCT00813150|450300766|FG001|Treatment Period|Adverse Event|15|||
125185297|NCT00813150|450300765|FG000|Treatment Period|Death|2|||
125185298|NCT00813150|450300766|FG001|Treatment Period|Death|0|||
125185299|NCT00813150|450300765|FG000|Treatment Period|Progressive disease|1|||
125185300|NCT00813150|450300766|FG001|Treatment Period|Progressive disease|0|||
125185301|NCT00813150|450300765|FG000|Treatment Period|Complete response|0|||
125185302|NCT00813150|450300766|FG001|Treatment Period|Complete response|1|||
125185303|NCT00813150|450300765|FG000|Treatment Period|Stable disease|1|||
125185304|NCT00813150|450300766|FG001|Treatment Period|Stable disease|2|||
125185305|NCT00813150|450300765|FG000|Treatment Period|Protocol Violation|3|||
125238255|NCT06001866|450500384|FG000|Overall Study|Protocol Violation|0|||
125238256|NCT06001866|450500385|FG001|Overall Study|Protocol Violation|2|||
125238257|NCT02903914|450500386|FG000|Overall Study|Adverse Event|0|||
125238258|NCT02903914|450500387|FG001|Overall Study|Adverse Event|0|||
125238259|NCT02903914|450500388|FG002|Overall Study|Adverse Event|1|||
125238260|NCT02903914|450500389|FG003|Overall Study|Adverse Event|0|||
125238261|NCT02903914|450500390|FG004|Overall Study|Adverse Event|0|||
125238262|NCT02903914|450500391|FG005|Overall Study|Adverse Event|0|||
125238263|NCT02903914|450500392|FG006|Overall Study|Adverse Event|2|||
125238264|NCT02903914|450500393|FG007|Overall Study|Adverse Event|0|||
125238265|NCT02903914|450500386|FG000|Overall Study|Withdrawal by Subject|3|||
125238266|NCT02903914|450500387|FG001|Overall Study|Withdrawal by Subject|1|||
125238267|NCT02903914|450500388|FG002|Overall Study|Withdrawal by Subject|28|||
125238268|NCT02903914|450500389|FG003|Overall Study|Withdrawal by Subject|0|||
125238269|NCT02903914|450500390|FG004|Overall Study|Withdrawal by Subject|1|||
125238270|NCT02903914|450500391|FG005|Overall Study|Withdrawal by Subject|2|||
125238271|NCT02903914|450500392|FG006|Overall Study|Withdrawal by Subject|12|||
125238272|NCT02903914|450500393|FG007|Overall Study|Withdrawal by Subject|0|||
125238273|NCT02903914|450500386|FG000|Overall Study|Progressive Disease|1|||
125238274|NCT02903914|450500387|FG001|Overall Study|Progressive Disease|0|||
125185306|NCT00813150|450300766|FG001|Treatment Period|Protocol Violation|4|||
125185307|NCT00813150|450300765|FG000|Treatment Period|Withdrawal by Subject|5|||
125185308|NCT00813150|450300766|FG001|Treatment Period|Withdrawal by Subject|3|||
125185309|NCT00813150|450300765|FG000|Treatment Period|Non compliance|0|||
125185310|NCT00813150|450300766|FG001|Treatment Period|Non compliance|1|||
125185311|NCT00813150|450300765|FG000|Treatment Period|Reason not specified|3|||
125185312|NCT00813150|450300766|FG001|Treatment Period|Reason not specified|4|||
125185313|NCT00813150|450300765|FG000|Treatment Period|Data not available|1|||
125185314|NCT00813150|450300766|FG001|Treatment Period|Data not available|2|||
125185315|NCT00813150|450300765|FG000|Long Term Follow-up|Death|0|||
125185316|NCT00813150|450300766|FG001|Long Term Follow-up|Death|4|||
125185317|NCT00813150|450300765|FG000|Long Term Follow-up|Other|0|||
125185318|NCT00813150|450300766|FG001|Long Term Follow-up|Other|3|||
125185319|NCT00813150|450300765|FG000|Long Term Follow-up|Lost to Follow-up|2|||
125238275|NCT02903914|450500388|FG002|Overall Study|Progressive Disease|4|||
125185320|NCT00813150|450300766|FG001|Long Term Follow-up|Lost to Follow-up|0|||
125238276|NCT02903914|450500389|FG003|Overall Study|Progressive Disease|0|||
125238277|NCT02903914|450500390|FG004|Overall Study|Progressive Disease|0|||
125238278|NCT02903914|450500391|FG005|Overall Study|Progressive Disease|0|||
125238279|NCT02903914|450500392|FG006|Overall Study|Progressive Disease|2|||
125185321|NCT00813150|450300765|FG000|Long Term Follow-up|Progression/Relapse|22|||
125185322|NCT00813150|450300766|FG001|Long Term Follow-up|Progression/Relapse|24|||
125185323|NCT03593525|450300780|FG000|Overall Study|Withdrawal by Subject|1|||
125185324|NCT03593525|450300781|FG001|Overall Study|Withdrawal by Subject|0|||
125185325|NCT03593525|450300780|FG000|Overall Study|Lost to Follow-up|7|||
125185326|NCT03593525|450300781|FG001|Overall Study|Lost to Follow-up|5|||
125185327|NCT03103087|450300782|FG000|Overall Study|Did not receive any study drug|1|||
125185328|NCT03103087|450300783|FG001|Overall Study|Did not receive any study drug|0|||
125185329|NCT03103087|450300784|FG002|Overall Study|Did not receive any study drug|0|||
125185330|NCT03103087|450300782|FG000|Overall Study|Protocol Violation|1|||
125185331|NCT03103087|450300783|FG001|Overall Study|Protocol Violation|2|||
125185332|NCT03103087|450300784|FG002|Overall Study|Protocol Violation|1|||
125185333|NCT03103087|450300782|FG000|Overall Study|Lack of Efficacy|2|||
125185334|NCT03103087|450300783|FG001|Overall Study|Lack of Efficacy|1|||
125185335|NCT03103087|450300784|FG002|Overall Study|Lack of Efficacy|1|||
125185336|NCT03103087|450300782|FG000|Overall Study|Pregnancy|0|||
125185337|NCT03103087|450300783|FG001|Overall Study|Pregnancy|0|||
125185338|NCT03103087|450300784|FG002|Overall Study|Pregnancy|1|||
125185339|NCT03103087|450300782|FG000|Overall Study|Adverse Event|2|||
125185340|NCT03103087|450300783|FG001|Overall Study|Adverse Event|15|||
125185341|NCT03103087|450300784|FG002|Overall Study|Adverse Event|6|||
125185342|NCT03103087|450300782|FG000|Overall Study|Withdrawal by Subject|13|||
125185343|NCT03103087|450300783|FG001|Overall Study|Withdrawal by Subject|6|||
125185344|NCT03103087|450300784|FG002|Overall Study|Withdrawal by Subject|6|||
125185345|NCT03103087|450300782|FG000|Overall Study|Lost to Follow-up|4|||
125185346|NCT03103087|450300783|FG001|Overall Study|Lost to Follow-up|2|||
125185347|NCT03103087|450300784|FG002|Overall Study|Lost to Follow-up|7|||
125185348|NCT03103087|450300782|FG000|Overall Study|Other reason not reported|1|||
125185349|NCT03103087|450300783|FG001|Overall Study|Other reason not reported|3|||
125185350|NCT03103087|450300784|FG002|Overall Study|Other reason not reported|5|||
125185351|NCT00075816|450300785|FG000|Overall Study|Did not undergo transplantation|14|||
125185352|NCT00075816|450300786|FG001|Overall Study|Did not undergo transplantation|11|||
125185353|NCT01892501|450300787|FG000|Overall Study|Protocol Violation|2|||
125185354|NCT01892501|450300787|FG000|Overall Study|Puncture not carried out|9|||
125185355|NCT01892501|450300787|FG000|Overall Study|Radiological monitoring not carried out|5|||
125185356|NCT01892501|450300787|FG000|Overall Study|Non-contributory histological result|12|||
125185357|NCT02549859|450300788|FG000|Long-term 60 Hz DBS|Study Closed|1|||
125185358|NCT03664232|450300790|FG000|Overall Study|Withdrawal by Subject|0|||
125185359|NCT03664232|450300791|FG001|Overall Study|Withdrawal by Subject|1|||
125185360|NCT03664232|450300792|FG002|Overall Study|Withdrawal by Subject|0|||
125185361|NCT03664232|450300793|FG003|Overall Study|Withdrawal by Subject|1|||
125185362|NCT03664232|450300790|FG000|Overall Study|Adverse Event|0|||
125185363|NCT03664232|450300791|FG001|Overall Study|Adverse Event|0|||
125185364|NCT03664232|450300792|FG002|Overall Study|Adverse Event|1|||
125185365|NCT03664232|450300793|FG003|Overall Study|Adverse Event|0|||
125185366|NCT03664232|450300790|FG000|Overall Study|Other-Non-compliance with study drug|0|||
125185367|NCT03664232|450300791|FG001|Overall Study|Other-Non-compliance with study drug|1|||
125185368|NCT03664232|450300792|FG002|Overall Study|Other-Non-compliance with study drug|0|||
125185369|NCT03664232|450300793|FG003|Overall Study|Other-Non-compliance with study drug|2|||
125185370|NCT03664232|450300790|FG000|Overall Study|Other-Unspecified|0|||
125185371|NCT03664232|450300791|FG001|Overall Study|Other-Unspecified|3|||
125185372|NCT03664232|450300792|FG002|Overall Study|Other-Unspecified|0|||
125185373|NCT03664232|450300793|FG003|Overall Study|Other-Unspecified|1|||
125185374|NCT03664232|450300790|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
125185375|NCT03664232|450300791|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
125185376|NCT03664232|450300792|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
125185377|NCT03664232|450300793|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
125185378|NCT03334435|450300794|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
125185379|NCT03334435|450300795|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
125185380|NCT03334435|450300796|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
125185381|NCT03334435|450300797|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
125185382|NCT03334435|450300798|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
125185383|NCT03334435|450300799|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
125185384|NCT03334435|450300800|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
125185385|NCT03334435|450300801|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
125185386|NCT03334435|450300802|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
125185387|NCT03334435|450300803|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
125185388|NCT03334435|450300804|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
125185389|NCT03334435|450300805|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
125238280|NCT02903914|450500393|FG007|Overall Study|Progressive Disease|0|||
125238281|NCT02903914|450500386|FG000|Overall Study|Death|0|||
125238282|NCT02903914|450500387|FG001|Overall Study|Death|0|||
125238283|NCT02903914|450500388|FG002|Overall Study|Death|9|||
125238284|NCT02903914|450500389|FG003|Overall Study|Death|0|||
125238285|NCT02903914|450500390|FG004|Overall Study|Death|1|||
125238286|NCT02903914|450500391|FG005|Overall Study|Death|3|||
125238287|NCT02903914|450500392|FG006|Overall Study|Death|24|||
125238288|NCT02903914|450500393|FG007|Overall Study|Death|2|||
125238289|NCT02903914|450500386|FG000|Overall Study|Lost to Follow-up|0|||
125238290|NCT02903914|450500387|FG001|Overall Study|Lost to Follow-up|1|||
125238291|NCT02903914|450500388|FG002|Overall Study|Lost to Follow-up|0|||
125238292|NCT02903914|450500389|FG003|Overall Study|Lost to Follow-up|0|||
125238293|NCT02903914|450500390|FG004|Overall Study|Lost to Follow-up|2|||
125238294|NCT02903914|450500391|FG005|Overall Study|Lost to Follow-up|0|||
125238295|NCT02903914|450500392|FG006|Overall Study|Lost to Follow-up|1|||
125238296|NCT02903914|450500393|FG007|Overall Study|Lost to Follow-up|0|||
125238297|NCT02903914|450500386|FG000|Overall Study|Physician Decision|0|||
125238298|NCT02903914|450500387|FG001|Overall Study|Physician Decision|0|||
125238299|NCT02903914|450500388|FG002|Overall Study|Physician Decision|1|||
125238300|NCT02903914|450500389|FG003|Overall Study|Physician Decision|0|||
125238301|NCT02903914|450500390|FG004|Overall Study|Physician Decision|0|||
125238302|NCT02903914|450500391|FG005|Overall Study|Physician Decision|0|||
125238303|NCT02903914|450500392|FG006|Overall Study|Physician Decision|1|||
125238304|NCT02903914|450500393|FG007|Overall Study|Physician Decision|0|||
125238305|NCT02903914|450500386|FG000|Overall Study|Symptomatic Deterioration|0|||
125238306|NCT02903914|450500387|FG001|Overall Study|Symptomatic Deterioration|0|||
125238307|NCT02903914|450500388|FG002|Overall Study|Symptomatic Deterioration|1|||
125238308|NCT02903914|450500389|FG003|Overall Study|Symptomatic Deterioration|0|||
125238309|NCT02903914|450500390|FG004|Overall Study|Symptomatic Deterioration|0|||
125238310|NCT02903914|450500391|FG005|Overall Study|Symptomatic Deterioration|0|||
125238311|NCT02903914|450500392|FG006|Overall Study|Symptomatic Deterioration|0|||
125238312|NCT02903914|450500393|FG007|Overall Study|Symptomatic Deterioration|0|||
125238313|NCT02903914|450500386|FG000|Overall Study|New Cancer Therapy|2|||
125238314|NCT02903914|450500387|FG001|Overall Study|New Cancer Therapy|2|||
125238315|NCT02903914|450500388|FG002|Overall Study|New Cancer Therapy|21|||
125238316|NCT02903914|450500389|FG003|Overall Study|New Cancer Therapy|4|||
125238317|NCT02903914|450500390|FG004|Overall Study|New Cancer Therapy|3|||
125238318|NCT02903914|450500391|FG005|Overall Study|New Cancer Therapy|6|||
125238319|NCT02903914|450500392|FG006|Overall Study|New Cancer Therapy|56|||
125238320|NCT02903914|450500393|FG007|Overall Study|New Cancer Therapy|3|||
125238321|NCT02903914|450500386|FG000|Overall Study|Didn't Return to Site|1|||
125238322|NCT02903914|450500387|FG001|Overall Study|Didn't Return to Site|0|||
125238323|NCT02903914|450500388|FG002|Overall Study|Didn't Return to Site|1|||
125238324|NCT02903914|450500389|FG003|Overall Study|Didn't Return to Site|1|||
125238325|NCT02903914|450500390|FG004|Overall Study|Didn't Return to Site|0|||
125238326|NCT02903914|450500391|FG005|Overall Study|Didn't Return to Site|0|||
125238327|NCT02903914|450500392|FG006|Overall Study|Didn't Return to Site|2|||
125238328|NCT02903914|450500393|FG007|Overall Study|Didn't Return to Site|0|||
125238329|NCT02903914|450500386|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
125238330|NCT02903914|450500387|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
125238331|NCT02903914|450500388|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
125238332|NCT02903914|450500389|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
125238333|NCT02903914|450500390|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
125238334|NCT02903914|450500391|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
125238335|NCT02903914|450500392|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
125238336|NCT02903914|450500393|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
125238337|NCT02903914|450500386|FG000|Overall Study|Follow-up Did Not Occur|0|||
125238338|NCT02903914|450500387|FG001|Overall Study|Follow-up Did Not Occur|1|||
125238339|NCT02903914|450500388|FG002|Overall Study|Follow-up Did Not Occur|1|||
125238340|NCT02903914|450500389|FG003|Overall Study|Follow-up Did Not Occur|0|||
125238341|NCT02903914|450500390|FG004|Overall Study|Follow-up Did Not Occur|2|||
125238342|NCT02903914|450500391|FG005|Overall Study|Follow-up Did Not Occur|0|||
125238343|NCT02903914|450500392|FG006|Overall Study|Follow-up Did Not Occur|8|||
125238344|NCT02903914|450500393|FG007|Overall Study|Follow-up Did Not Occur|0|||
125238345|NCT02903914|450500386|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
125238346|NCT02903914|450500387|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
125238347|NCT02903914|450500388|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
125238348|NCT02903914|450500389|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
125238349|NCT02903914|450500390|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
125238350|NCT02903914|450500391|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
125238351|NCT02903914|450500392|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
125238352|NCT02903914|450500393|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
125238353|NCT02903914|450500386|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
125238354|NCT02903914|450500387|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
125238355|NCT02903914|450500388|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
125238356|NCT02903914|450500389|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
125238357|NCT02903914|450500390|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
125238358|NCT02903914|450500391|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
125238359|NCT02903914|450500392|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
125238360|NCT02903914|450500393|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
125238361|NCT02903914|450500386|FG000|Overall Study|Clinical Disease Progression|0|||
125238362|NCT02903914|450500387|FG001|Overall Study|Clinical Disease Progression|0|||
125238363|NCT02903914|450500388|FG002|Overall Study|Clinical Disease Progression|2|||
125238364|NCT02903914|450500389|FG003|Overall Study|Clinical Disease Progression|0|||
125238365|NCT02903914|450500390|FG004|Overall Study|Clinical Disease Progression|0|||
125238366|NCT02903914|450500391|FG005|Overall Study|Clinical Disease Progression|0|||
125238367|NCT02903914|450500392|FG006|Overall Study|Clinical Disease Progression|0|||
125238368|NCT02903914|450500393|FG007|Overall Study|Clinical Disease Progression|0|||
125238369|NCT02903914|450500386|FG000|Overall Study|Completed Follow-up Period|0|||
125238370|NCT02903914|450500387|FG001|Overall Study|Completed Follow-up Period|0|||
125238371|NCT02903914|450500388|FG002|Overall Study|Completed Follow-up Period|6|||
125238372|NCT02903914|450500389|FG003|Overall Study|Completed Follow-up Period|2|||
125238373|NCT02903914|450500390|FG004|Overall Study|Completed Follow-up Period|1|||
125238374|NCT02903914|450500391|FG005|Overall Study|Completed Follow-up Period|0|||
125238375|NCT02903914|450500392|FG006|Overall Study|Completed Follow-up Period|9|||
125238376|NCT02903914|450500393|FG007|Overall Study|Completed Follow-up Period|1|||
125238377|NCT02903914|450500386|FG000|Overall Study|Taken off Treatment per Protocol|0|||
125238378|NCT02903914|450500387|FG001|Overall Study|Taken off Treatment per Protocol|0|||
125238379|NCT02903914|450500388|FG002|Overall Study|Taken off Treatment per Protocol|0|||
125238380|NCT02903914|450500389|FG003|Overall Study|Taken off Treatment per Protocol|0|||
125238381|NCT02903914|450500390|FG004|Overall Study|Taken off Treatment per Protocol|0|||
125238382|NCT02903914|450500391|FG005|Overall Study|Taken off Treatment per Protocol|1|||
125238383|NCT02903914|450500392|FG006|Overall Study|Taken off Treatment per Protocol|0|||
125238384|NCT02903914|450500393|FG007|Overall Study|Taken off Treatment per Protocol|0|||
125238385|NCT02903914|450500386|FG000|Overall Study|Refused Further Treatment/Contact|0|||
125238386|NCT02903914|450500387|FG001|Overall Study|Refused Further Treatment/Contact|0|||
125238387|NCT02903914|450500388|FG002|Overall Study|Refused Further Treatment/Contact|0|||
125238388|NCT02903914|450500389|FG003|Overall Study|Refused Further Treatment/Contact|0|||
125238389|NCT02903914|450500390|FG004|Overall Study|Refused Further Treatment/Contact|0|||
125238390|NCT02903914|450500391|FG005|Overall Study|Refused Further Treatment/Contact|0|||
125238391|NCT02903914|450500392|FG006|Overall Study|Refused Further Treatment/Contact|1|||
125238392|NCT02903914|450500393|FG007|Overall Study|Refused Further Treatment/Contact|0|||
125238393|NCT02903914|450500386|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
125238394|NCT02903914|450500387|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
125238395|NCT02903914|450500388|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
125238396|NCT02903914|450500389|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
125238397|NCT02903914|450500390|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
125238398|NCT02903914|450500391|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
125238399|NCT02903914|450500392|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
125238400|NCT02903914|450500393|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
125238401|NCT04725188|450500396|FG000|Overall Study|Death|72|||
125238402|NCT04725188|450500397|FG001|Overall Study|Death|69|||
125238403|NCT04725188|450500398|FG002|Overall Study|Death|76|||
125238404|NCT04725188|450500396|FG000|Overall Study|Lost to Follow-up|1|||
125238405|NCT04725188|450500397|FG001|Overall Study|Lost to Follow-up|0|||
125238406|NCT04725188|450500398|FG002|Overall Study|Lost to Follow-up|1|||
125238407|NCT04725188|450500396|FG000|Overall Study|Withdrawal by Subject|2|||
125238408|NCT04725188|450500397|FG001|Overall Study|Withdrawal by Subject|2|||
125185390|NCT03334435|450300806|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
125185391|NCT03334435|450300807|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
125185392|NCT03334435|450300808|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
125185393|NCT03334435|450300794|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
125238409|NCT04725188|450500398|FG002|Overall Study|Withdrawal by Subject|1|||
125238410|NCT04725188|450500396|FG000|Overall Study|Sponsor Decision|12|||
125238411|NCT04725188|450500397|FG001|Overall Study|Sponsor Decision|12|||
125238412|NCT04725188|450500398|FG002|Overall Study|Sponsor Decision|7|||
125238413|NCT03765073|450500399|FG000|Stage 1|Lost to Follow-up|1|||
125238414|NCT03765073|450500400|FG001|Stage 1|Lost to Follow-up|0|||
125238415|NCT03765073|450500401|FG002|Stage 1|Lost to Follow-up|0|||
125238416|NCT03765073|450500402|FG003|Stage 1|Lost to Follow-up|0|||
125238417|NCT03765073|450500403|FG004|Stage 1|Lost to Follow-up|0|||
125238418|NCT03765073|450500404|FG005|Stage 1|Lost to Follow-up|0|||
125238419|NCT03765073|450500405|FG006|Stage 1|Lost to Follow-up|0|||
125238420|NCT03765073|450500406|FG007|Stage 1|Lost to Follow-up|0|||
125238421|NCT03765073|450500407|FG008|Stage 1|Lost to Follow-up|0|||
125238422|NCT03765073|450500408|FG009|Stage 1|Lost to Follow-up|0|||
125238423|NCT03765073|450500409|FG010|Stage 1|Lost to Follow-up|0|||
125238424|NCT03765073|450500410|FG011|Stage 1|Lost to Follow-up|0|||
125238425|NCT03765073|450500411|FG012|Stage 1|Lost to Follow-up|0|||
125185394|NCT03334435|450300795|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
125185395|NCT03334435|450300796|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
125185396|NCT03334435|450300797|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
125185397|NCT03334435|450300798|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
125185398|NCT03334435|450300799|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
125185399|NCT03334435|450300800|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
125185400|NCT03334435|450300801|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
125185401|NCT03334435|450300802|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
125185402|NCT03334435|450300803|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
125185403|NCT03334435|450300804|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
125185404|NCT03334435|450300805|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
125185405|NCT03334435|450300806|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
125185406|NCT03334435|450300807|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
125185407|NCT03334435|450300808|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
125185408|NCT03334435|450300794|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
125185409|NCT03334435|450300795|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
125185410|NCT03334435|450300796|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
125185411|NCT03334435|450300797|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
125185412|NCT03334435|450300798|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
125185413|NCT03334435|450300799|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
125185414|NCT03334435|450300800|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
125185415|NCT03334435|450300801|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
125185416|NCT03334435|450300802|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
125185417|NCT03334435|450300803|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
125185418|NCT03334435|450300804|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
125185419|NCT03334435|450300805|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
125185420|NCT03334435|450300806|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
125185421|NCT03334435|450300807|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
125185422|NCT03334435|450300808|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
125185423|NCT03334435|450300794|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
125185424|NCT03334435|450300795|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
125185425|NCT03334435|450300796|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
125185426|NCT03334435|450300797|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
125185427|NCT03334435|450300798|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
125185428|NCT03334435|450300799|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
125185429|NCT03334435|450300800|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
125185430|NCT03334435|450300801|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
125185431|NCT03334435|450300802|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
125185432|NCT03334435|450300803|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
125185433|NCT03334435|450300804|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
125185434|NCT03334435|450300805|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
125185435|NCT03334435|450300806|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
125185436|NCT03334435|450300807|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
125185437|NCT03334435|450300808|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
125185438|NCT03334435|450300794|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
125185439|NCT03334435|450300795|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125185440|NCT03334435|450300796|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
125185441|NCT03334435|450300797|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
125185442|NCT03334435|450300798|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
125185443|NCT03334435|450300799|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125185444|NCT03334435|450300800|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125185445|NCT03334435|450300801|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125185446|NCT03334435|450300802|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125185447|NCT03334435|450300803|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125185448|NCT03334435|450300804|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125185449|NCT03334435|450300805|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125238426|NCT03765073|450500412|FG013|Stage 1|Lost to Follow-up|0|||
125238427|NCT03765073|450500413|FG014|Stage 1|Lost to Follow-up|0|||
125238428|NCT03765073|450500414|FG015|Stage 1|Lost to Follow-up|0|||
125238429|NCT03765073|450500415|FG016|Stage 1|Lost to Follow-up|0|||
125238430|NCT03765073|450500416|FG017|Stage 1|Lost to Follow-up|0|||
125238431|NCT03765073|450500417|FG018|Stage 1|Lost to Follow-up|0|||
125185450|NCT03334435|450300806|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125185451|NCT03334435|450300807|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125185452|NCT03334435|450300808|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125185453|NCT03334435|450300794|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185454|NCT03334435|450300795|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185455|NCT03334435|450300796|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185456|NCT03334435|450300797|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
125185457|NCT03334435|450300798|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185458|NCT03334435|450300799|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185459|NCT03334435|450300800|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185460|NCT03334435|450300801|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185461|NCT03334435|450300802|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185462|NCT03334435|450300803|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185463|NCT03334435|450300804|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185464|NCT03334435|450300805|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185465|NCT03334435|450300806|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185466|NCT03334435|450300807|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185467|NCT03334435|450300808|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185468|NCT03334435|450300794|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185469|NCT03334435|450300795|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
125185470|NCT03334435|450300796|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
125185471|NCT03334435|450300797|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
125185472|NCT03334435|450300798|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
125185473|NCT03334435|450300799|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185474|NCT03334435|450300800|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185475|NCT03334435|450300801|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185476|NCT03334435|450300802|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185477|NCT03334435|450300803|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185478|NCT03334435|450300804|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185479|NCT03334435|450300805|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185480|NCT03334435|450300806|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185481|NCT03334435|450300807|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185482|NCT03334435|450300808|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185483|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
125185484|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
125185485|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
125185486|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
125185487|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
125185488|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
125185489|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
125185490|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
125185491|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
125185492|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
125185493|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
125185494|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
125185495|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
125185496|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
125185497|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
125185498|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
125185499|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
125185500|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
125185501|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
125185502|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
125185503|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
125185504|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
125185505|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
125185506|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
125185507|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
125185508|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
125185509|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
125185510|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
125185511|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
125185512|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
125185513|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
125185514|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
125238432|NCT03765073|450500418|FG019|Stage 1|Lost to Follow-up|0|||
125238433|NCT03765073|450500419|FG020|Stage 1|Lost to Follow-up|0|||
125238434|NCT03765073|450500399|FG000|Stage 1|Withdrawal by participant|0|||
125238435|NCT03765073|450500400|FG001|Stage 1|Withdrawal by participant|1|||
125238436|NCT03765073|450500401|FG002|Stage 1|Withdrawal by participant|0|||
125238437|NCT03765073|450500402|FG003|Stage 1|Withdrawal by participant|0|||
125238438|NCT03765073|450500403|FG004|Stage 1|Withdrawal by participant|0|||
125238439|NCT03765073|450500404|FG005|Stage 1|Withdrawal by participant|0|||
125238440|NCT03765073|450500405|FG006|Stage 1|Withdrawal by participant|0|||
125238441|NCT03765073|450500406|FG007|Stage 1|Withdrawal by participant|0|||
125238442|NCT03765073|450500407|FG008|Stage 1|Withdrawal by participant|0|||
125238443|NCT03765073|450500408|FG009|Stage 1|Withdrawal by participant|0|||
125238444|NCT03765073|450500409|FG010|Stage 1|Withdrawal by participant|0|||
125238445|NCT03765073|450500410|FG011|Stage 1|Withdrawal by participant|0|||
125238446|NCT03765073|450500411|FG012|Stage 1|Withdrawal by participant|0|||
125238447|NCT03765073|450500412|FG013|Stage 1|Withdrawal by participant|0|||
125238448|NCT03765073|450500413|FG014|Stage 1|Withdrawal by participant|0|||
125238449|NCT03765073|450500414|FG015|Stage 1|Withdrawal by participant|0|||
125238450|NCT03765073|450500415|FG016|Stage 1|Withdrawal by participant|0|||
125238451|NCT03765073|450500416|FG017|Stage 1|Withdrawal by participant|0|||
125238452|NCT03765073|450500417|FG018|Stage 1|Withdrawal by participant|0|||
125238453|NCT03765073|450500418|FG019|Stage 1|Withdrawal by participant|0|||
125238454|NCT03765073|450500419|FG020|Stage 1|Withdrawal by participant|0|||
125238455|NCT03765073|450500399|FG000|Stage 2|Death|0|||
125238456|NCT03765073|450500400|FG001|Stage 2|Death|0|||
125238457|NCT03765073|450500401|FG002|Stage 2|Death|0|||
125238458|NCT03765073|450500402|FG003|Stage 2|Death|0|||
125238459|NCT03765073|450500403|FG004|Stage 2|Death|0|||
125238460|NCT03765073|450500404|FG005|Stage 2|Death|0|||
125238461|NCT03765073|450500405|FG006|Stage 2|Death|0|||
125238462|NCT03765073|450500406|FG007|Stage 2|Death|0|||
125238463|NCT03765073|450500407|FG008|Stage 2|Death|0|||
125238464|NCT03765073|450500408|FG009|Stage 2|Death|1|||
125238465|NCT03765073|450500409|FG010|Stage 2|Death|0|||
125238466|NCT03765073|450500410|FG011|Stage 2|Death|1|||
125238467|NCT03765073|450500411|FG012|Stage 2|Death|0|||
125238468|NCT03765073|450500412|FG013|Stage 2|Death|0|||
125238469|NCT03765073|450500413|FG014|Stage 2|Death|0|||
125238470|NCT03765073|450500414|FG015|Stage 2|Death|0|||
125238471|NCT03765073|450500415|FG016|Stage 2|Death|2|||
125238472|NCT03765073|450500416|FG017|Stage 2|Death|0|||
125238473|NCT03765073|450500417|FG018|Stage 2|Death|0|||
125238474|NCT03765073|450500418|FG019|Stage 2|Death|0|||
125238475|NCT03765073|450500419|FG020|Stage 2|Death|0|||
125238476|NCT03765073|450500399|FG000|Stage 2|Lost to Follow-up|0|||
125238477|NCT03765073|450500400|FG001|Stage 2|Lost to Follow-up|0|||
125238478|NCT03765073|450500401|FG002|Stage 2|Lost to Follow-up|0|||
125238479|NCT03765073|450500402|FG003|Stage 2|Lost to Follow-up|5|||
125238480|NCT03765073|450500403|FG004|Stage 2|Lost to Follow-up|1|||
125238481|NCT03765073|450500404|FG005|Stage 2|Lost to Follow-up|0|||
125238482|NCT03765073|450500405|FG006|Stage 2|Lost to Follow-up|3|||
125238483|NCT03765073|450500406|FG007|Stage 2|Lost to Follow-up|3|||
125238484|NCT03765073|450500407|FG008|Stage 2|Lost to Follow-up|1|||
125238485|NCT03765073|450500408|FG009|Stage 2|Lost to Follow-up|6|||
125238486|NCT03765073|450500409|FG010|Stage 2|Lost to Follow-up|5|||
125238487|NCT03765073|450500410|FG011|Stage 2|Lost to Follow-up|1|||
125238488|NCT03765073|450500411|FG012|Stage 2|Lost to Follow-up|1|||
125238489|NCT03765073|450500412|FG013|Stage 2|Lost to Follow-up|3|||
125238490|NCT03765073|450500413|FG014|Stage 2|Lost to Follow-up|3|||
125238491|NCT03765073|450500414|FG015|Stage 2|Lost to Follow-up|1|||
125238492|NCT03765073|450500415|FG016|Stage 2|Lost to Follow-up|6|||
125238493|NCT03765073|450500416|FG017|Stage 2|Lost to Follow-up|0|||
125238494|NCT03765073|450500417|FG018|Stage 2|Lost to Follow-up|0|||
125238495|NCT03765073|450500418|FG019|Stage 2|Lost to Follow-up|0|||
125238496|NCT03765073|450500419|FG020|Stage 2|Lost to Follow-up|0|||
125238497|NCT03765073|450500399|FG000|Stage 2|Other|0|||
125238498|NCT03765073|450500400|FG001|Stage 2|Other|0|||
125238499|NCT03765073|450500401|FG002|Stage 2|Other|0|||
125238500|NCT03765073|450500402|FG003|Stage 2|Other|0|||
125238501|NCT03765073|450500403|FG004|Stage 2|Other|0|||
125238502|NCT03765073|450500404|FG005|Stage 2|Other|0|||
125238503|NCT03765073|450500405|FG006|Stage 2|Other|0|||
125238504|NCT03765073|450500406|FG007|Stage 2|Other|1|||
125238505|NCT03765073|450500407|FG008|Stage 2|Other|1|||
125238506|NCT03765073|450500408|FG009|Stage 2|Other|3|||
125238507|NCT03765073|450500409|FG010|Stage 2|Other|0|||
125238508|NCT03765073|450500410|FG011|Stage 2|Other|0|||
125238509|NCT03765073|450500411|FG012|Stage 2|Other|0|||
125238510|NCT03765073|450500412|FG013|Stage 2|Other|0|||
125238511|NCT03765073|450500413|FG014|Stage 2|Other|0|||
125238512|NCT03765073|450500414|FG015|Stage 2|Other|1|||
125238513|NCT03765073|450500415|FG016|Stage 2|Other|2|||
125238514|NCT03765073|450500416|FG017|Stage 2|Other|0|||
125238515|NCT03765073|450500417|FG018|Stage 2|Other|0|||
125238516|NCT03765073|450500418|FG019|Stage 2|Other|0|||
125238517|NCT03765073|450500419|FG020|Stage 2|Other|0|||
125238518|NCT03765073|450500399|FG000|Stage 2|Withdrawal by parent/guardian|0|||
125238519|NCT03765073|450500400|FG001|Stage 2|Withdrawal by parent/guardian|0|||
125238520|NCT03765073|450500401|FG002|Stage 2|Withdrawal by parent/guardian|0|||
125185515|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
125185516|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
125185517|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
125185518|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
125185519|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
125185520|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
125185521|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
125185522|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
125185523|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
125185524|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
125185525|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
125185526|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
125185527|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
125185528|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
125185529|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
125185530|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
125185531|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
125185532|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
125185533|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
125185534|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
125185535|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
125185536|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
125185537|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
125185538|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
125185539|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
125185540|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
125185541|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
125185542|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
125185543|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
125185544|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
125185545|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
125185546|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
125185547|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
125185548|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
125185549|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
125185550|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
125185551|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
125185552|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
125185553|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
125185554|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
125185555|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
125185556|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
125185557|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
125185558|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185559|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185560|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185561|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185562|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185563|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185564|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185565|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185566|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185567|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185568|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185569|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
125185570|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185571|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
125185572|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185573|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
125185574|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
125185575|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
125185576|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
125238521|NCT03765073|450500402|FG003|Stage 2|Withdrawal by parent/guardian|0|||
125238522|NCT03765073|450500403|FG004|Stage 2|Withdrawal by parent/guardian|0|||
125238523|NCT03765073|450500404|FG005|Stage 2|Withdrawal by parent/guardian|0|||
125238524|NCT03765073|450500405|FG006|Stage 2|Withdrawal by parent/guardian|0|||
125238525|NCT03765073|450500406|FG007|Stage 2|Withdrawal by parent/guardian|0|||
125238526|NCT03765073|450500407|FG008|Stage 2|Withdrawal by parent/guardian|0|||
125238527|NCT03765073|450500408|FG009|Stage 2|Withdrawal by parent/guardian|0|||
125238528|NCT03765073|450500409|FG010|Stage 2|Withdrawal by parent/guardian|3|||
125238529|NCT03765073|450500410|FG011|Stage 2|Withdrawal by parent/guardian|3|||
125238530|NCT03765073|450500411|FG012|Stage 2|Withdrawal by parent/guardian|3|||
125238531|NCT03765073|450500412|FG013|Stage 2|Withdrawal by parent/guardian|1|||
125238532|NCT03765073|450500413|FG014|Stage 2|Withdrawal by parent/guardian|1|||
125238533|NCT03765073|450500414|FG015|Stage 2|Withdrawal by parent/guardian|0|||
125238534|NCT03765073|450500415|FG016|Stage 2|Withdrawal by parent/guardian|3|||
125238535|NCT03765073|450500416|FG017|Stage 2|Withdrawal by parent/guardian|0|||
125238536|NCT03765073|450500417|FG018|Stage 2|Withdrawal by parent/guardian|0|||
125238537|NCT03765073|450500418|FG019|Stage 2|Withdrawal by parent/guardian|0|||
125238538|NCT03765073|450500419|FG020|Stage 2|Withdrawal by parent/guardian|0|||
125238539|NCT03765073|450500399|FG000|Stage 2|Withdrawal by Subject|0|||
125238540|NCT03765073|450500400|FG001|Stage 2|Withdrawal by Subject|0|||
125238541|NCT03765073|450500401|FG002|Stage 2|Withdrawal by Subject|0|||
125238542|NCT03765073|450500402|FG003|Stage 2|Withdrawal by Subject|3|||
125238543|NCT03765073|450500403|FG004|Stage 2|Withdrawal by Subject|3|||
125238544|NCT03765073|450500404|FG005|Stage 2|Withdrawal by Subject|3|||
125238545|NCT03765073|450500405|FG006|Stage 2|Withdrawal by Subject|0|||
125238546|NCT03765073|450500406|FG007|Stage 2|Withdrawal by Subject|1|||
125238547|NCT03765073|450500407|FG008|Stage 2|Withdrawal by Subject|0|||
125238548|NCT03765073|450500408|FG009|Stage 2|Withdrawal by Subject|5|||
125238549|NCT03765073|450500409|FG010|Stage 2|Withdrawal by Subject|0|||
125238550|NCT03765073|450500410|FG011|Stage 2|Withdrawal by Subject|0|||
125238551|NCT03765073|450500411|FG012|Stage 2|Withdrawal by Subject|0|||
125238552|NCT03765073|450500412|FG013|Stage 2|Withdrawal by Subject|0|||
125238553|NCT03765073|450500413|FG014|Stage 2|Withdrawal by Subject|0|||
125238554|NCT03765073|450500414|FG015|Stage 2|Withdrawal by Subject|0|||
125238555|NCT03765073|450500415|FG016|Stage 2|Withdrawal by Subject|0|||
125238556|NCT03765073|450500416|FG017|Stage 2|Withdrawal by Subject|0|||
125238557|NCT03765073|450500417|FG018|Stage 2|Withdrawal by Subject|0|||
125238558|NCT03765073|450500418|FG019|Stage 2|Withdrawal by Subject|0|||
125238559|NCT03765073|450500419|FG020|Stage 2|Withdrawal by Subject|0|||
125238560|NCT03765073|450500399|FG000|Stage 3|Adverse Event|0|||
125238561|NCT03765073|450500400|FG001|Stage 3|Adverse Event|0|||
125238562|NCT03765073|450500401|FG002|Stage 3|Adverse Event|0|||
125238563|NCT03765073|450500402|FG003|Stage 3|Adverse Event|0|||
125238564|NCT03765073|450500403|FG004|Stage 3|Adverse Event|0|||
125238565|NCT03765073|450500404|FG005|Stage 3|Adverse Event|0|||
125238566|NCT03765073|450500405|FG006|Stage 3|Adverse Event|0|||
125238567|NCT03765073|450500406|FG007|Stage 3|Adverse Event|0|||
125238568|NCT03765073|450500407|FG008|Stage 3|Adverse Event|0|||
125238569|NCT03765073|450500408|FG009|Stage 3|Adverse Event|0|||
125238570|NCT03765073|450500409|FG010|Stage 3|Adverse Event|0|||
125238571|NCT03765073|450500410|FG011|Stage 3|Adverse Event|0|||
125238572|NCT03765073|450500411|FG012|Stage 3|Adverse Event|0|||
125238573|NCT03765073|450500412|FG013|Stage 3|Adverse Event|0|||
125238574|NCT03765073|450500413|FG014|Stage 3|Adverse Event|0|||
125238575|NCT03765073|450500414|FG015|Stage 3|Adverse Event|0|||
125238576|NCT03765073|450500415|FG016|Stage 3|Adverse Event|0|||
125238577|NCT03765073|450500416|FG017|Stage 3|Adverse Event|0|||
125238578|NCT03765073|450500417|FG018|Stage 3|Adverse Event|1|||
125238579|NCT03765073|450500418|FG019|Stage 3|Adverse Event|0|||
125238580|NCT03765073|450500419|FG020|Stage 3|Adverse Event|0|||
125238581|NCT03765073|450500399|FG000|Stage 3|Death|0|||
125238582|NCT03765073|450500400|FG001|Stage 3|Death|0|||
125238583|NCT03765073|450500401|FG002|Stage 3|Death|0|||
125238584|NCT03765073|450500402|FG003|Stage 3|Death|0|||
125238585|NCT03765073|450500403|FG004|Stage 3|Death|0|||
125238586|NCT03765073|450500404|FG005|Stage 3|Death|0|||
125238587|NCT03765073|450500405|FG006|Stage 3|Death|0|||
125238588|NCT03765073|450500406|FG007|Stage 3|Death|0|||
125238589|NCT03765073|450500407|FG008|Stage 3|Death|0|||
125238590|NCT03765073|450500408|FG009|Stage 3|Death|0|||
125238591|NCT03765073|450500409|FG010|Stage 3|Death|0|||
125238592|NCT03765073|450500410|FG011|Stage 3|Death|0|||
125238593|NCT03765073|450500411|FG012|Stage 3|Death|0|||
125238594|NCT03765073|450500412|FG013|Stage 3|Death|0|||
125238595|NCT03765073|450500413|FG014|Stage 3|Death|0|||
125238596|NCT03765073|450500414|FG015|Stage 3|Death|0|||
125238597|NCT03765073|450500415|FG016|Stage 3|Death|0|||
125238598|NCT03765073|450500416|FG017|Stage 3|Death|0|||
125238599|NCT03765073|450500417|FG018|Stage 3|Death|0|||
125238600|NCT03765073|450500418|FG019|Stage 3|Death|3|||
125238601|NCT03765073|450500419|FG020|Stage 3|Death|2|||
125238602|NCT03765073|450500399|FG000|Stage 3|Lost to Follow-up|0|||
125238603|NCT03765073|450500400|FG001|Stage 3|Lost to Follow-up|0|||
125238604|NCT03765073|450500401|FG002|Stage 3|Lost to Follow-up|0|||
125238605|NCT03765073|450500402|FG003|Stage 3|Lost to Follow-up|0|||
125238606|NCT03765073|450500403|FG004|Stage 3|Lost to Follow-up|0|||
125238607|NCT03765073|450500404|FG005|Stage 3|Lost to Follow-up|0|||
125238608|NCT03765073|450500405|FG006|Stage 3|Lost to Follow-up|0|||
125238609|NCT03765073|450500406|FG007|Stage 3|Lost to Follow-up|0|||
125238610|NCT03765073|450500407|FG008|Stage 3|Lost to Follow-up|0|||
125238611|NCT03765073|450500408|FG009|Stage 3|Lost to Follow-up|0|||
125238612|NCT03765073|450500409|FG010|Stage 3|Lost to Follow-up|0|||
125238613|NCT03765073|450500410|FG011|Stage 3|Lost to Follow-up|0|||
125238614|NCT03765073|450500411|FG012|Stage 3|Lost to Follow-up|0|||
125238615|NCT03765073|450500412|FG013|Stage 3|Lost to Follow-up|0|||
125238616|NCT03765073|450500413|FG014|Stage 3|Lost to Follow-up|0|||
125238617|NCT03765073|450500414|FG015|Stage 3|Lost to Follow-up|0|||
125238618|NCT03765073|450500415|FG016|Stage 3|Lost to Follow-up|0|||
125238619|NCT03765073|450500416|FG017|Stage 3|Lost to Follow-up|8|||
125238620|NCT03765073|450500417|FG018|Stage 3|Lost to Follow-up|5|||
125238621|NCT03765073|450500418|FG019|Stage 3|Lost to Follow-up|7|||
125238622|NCT03765073|450500419|FG020|Stage 3|Lost to Follow-up|4|||
125238623|NCT03765073|450500399|FG000|Stage 3|No longer meets eligibility criteria|0|||
125238624|NCT03765073|450500400|FG001|Stage 3|No longer meets eligibility criteria|0|||
125238625|NCT03765073|450500401|FG002|Stage 3|No longer meets eligibility criteria|0|||
125238626|NCT03765073|450500402|FG003|Stage 3|No longer meets eligibility criteria|0|||
125238627|NCT03765073|450500403|FG004|Stage 3|No longer meets eligibility criteria|0|||
125238628|NCT03765073|450500404|FG005|Stage 3|No longer meets eligibility criteria|0|||
125238629|NCT03765073|450500405|FG006|Stage 3|No longer meets eligibility criteria|0|||
125238630|NCT03765073|450500406|FG007|Stage 3|No longer meets eligibility criteria|0|||
125238631|NCT03765073|450500407|FG008|Stage 3|No longer meets eligibility criteria|0|||
125238632|NCT03765073|450500408|FG009|Stage 3|No longer meets eligibility criteria|0|||
125238633|NCT03765073|450500409|FG010|Stage 3|No longer meets eligibility criteria|0|||
125238634|NCT03765073|450500410|FG011|Stage 3|No longer meets eligibility criteria|0|||
125238635|NCT03765073|450500411|FG012|Stage 3|No longer meets eligibility criteria|0|||
125238636|NCT03765073|450500412|FG013|Stage 3|No longer meets eligibility criteria|0|||
125238637|NCT03765073|450500413|FG014|Stage 3|No longer meets eligibility criteria|0|||
125238638|NCT03765073|450500414|FG015|Stage 3|No longer meets eligibility criteria|0|||
125238639|NCT03765073|450500415|FG016|Stage 3|No longer meets eligibility criteria|0|||
125238640|NCT03765073|450500416|FG017|Stage 3|No longer meets eligibility criteria|0|||
125238641|NCT03765073|450500417|FG018|Stage 3|No longer meets eligibility criteria|1|||
125238642|NCT03765073|450500418|FG019|Stage 3|No longer meets eligibility criteria|0|||
125238643|NCT03765073|450500419|FG020|Stage 3|No longer meets eligibility criteria|1|||
125238644|NCT03765073|450500399|FG000|Stage 3|Other|0|||
125238645|NCT03765073|450500400|FG001|Stage 3|Other|0|||
125238646|NCT03765073|450500401|FG002|Stage 3|Other|0|||
125238647|NCT03765073|450500402|FG003|Stage 3|Other|0|||
125238648|NCT03765073|450500403|FG004|Stage 3|Other|0|||
125238649|NCT03765073|450500404|FG005|Stage 3|Other|0|||
125238650|NCT03765073|450500405|FG006|Stage 3|Other|0|||
125238651|NCT03765073|450500406|FG007|Stage 3|Other|0|||
125238652|NCT03765073|450500407|FG008|Stage 3|Other|0|||
125238653|NCT03765073|450500408|FG009|Stage 3|Other|0|||
125238654|NCT03765073|450500409|FG010|Stage 3|Other|0|||
125238655|NCT03765073|450500410|FG011|Stage 3|Other|0|||
125238656|NCT03765073|450500411|FG012|Stage 3|Other|0|||
125238657|NCT03765073|450500412|FG013|Stage 3|Other|0|||
125238658|NCT03765073|450500413|FG014|Stage 3|Other|0|||
125238659|NCT03765073|450500414|FG015|Stage 3|Other|0|||
125238660|NCT03765073|450500415|FG016|Stage 3|Other|0|||
125238661|NCT03765073|450500416|FG017|Stage 3|Other|1|||
125238662|NCT03765073|450500417|FG018|Stage 3|Other|2|||
125238663|NCT03765073|450500418|FG019|Stage 3|Other|2|||
125238664|NCT03765073|450500419|FG020|Stage 3|Other|2|||
125238665|NCT03765073|450500399|FG000|Stage 3|Withdrawal by parent/guardian|0|||
125238666|NCT03765073|450500400|FG001|Stage 3|Withdrawal by parent/guardian|0|||
125238667|NCT03765073|450500401|FG002|Stage 3|Withdrawal by parent/guardian|0|||
125238668|NCT03765073|450500402|FG003|Stage 3|Withdrawal by parent/guardian|0|||
125238669|NCT03765073|450500403|FG004|Stage 3|Withdrawal by parent/guardian|0|||
125238670|NCT03765073|450500404|FG005|Stage 3|Withdrawal by parent/guardian|0|||
125238671|NCT03765073|450500405|FG006|Stage 3|Withdrawal by parent/guardian|0|||
125238672|NCT03765073|450500406|FG007|Stage 3|Withdrawal by parent/guardian|0|||
125238673|NCT03765073|450500407|FG008|Stage 3|Withdrawal by parent/guardian|0|||
125238674|NCT03765073|450500408|FG009|Stage 3|Withdrawal by parent/guardian|0|||
125238675|NCT03765073|450500409|FG010|Stage 3|Withdrawal by parent/guardian|0|||
125238676|NCT03765073|450500410|FG011|Stage 3|Withdrawal by parent/guardian|0|||
125238677|NCT03765073|450500411|FG012|Stage 3|Withdrawal by parent/guardian|0|||
125238678|NCT03765073|450500412|FG013|Stage 3|Withdrawal by parent/guardian|0|||
125238679|NCT03765073|450500413|FG014|Stage 3|Withdrawal by parent/guardian|0|||
125238680|NCT03765073|450500414|FG015|Stage 3|Withdrawal by parent/guardian|0|||
125238681|NCT03765073|450500415|FG016|Stage 3|Withdrawal by parent/guardian|0|||
125238682|NCT03765073|450500416|FG017|Stage 3|Withdrawal by parent/guardian|0|||
125238683|NCT03765073|450500417|FG018|Stage 3|Withdrawal by parent/guardian|0|||
125238684|NCT03765073|450500418|FG019|Stage 3|Withdrawal by parent/guardian|6|||
125238685|NCT03765073|450500419|FG020|Stage 3|Withdrawal by parent/guardian|9|||
125238686|NCT03765073|450500399|FG000|Stage 3|Withdrawal by Subject|0|||
125238687|NCT03765073|450500400|FG001|Stage 3|Withdrawal by Subject|0|||
125238688|NCT03765073|450500401|FG002|Stage 3|Withdrawal by Subject|0|||
125238689|NCT03765073|450500402|FG003|Stage 3|Withdrawal by Subject|0|||
125238690|NCT03765073|450500403|FG004|Stage 3|Withdrawal by Subject|0|||
125238691|NCT03765073|450500404|FG005|Stage 3|Withdrawal by Subject|0|||
125238692|NCT03765073|450500405|FG006|Stage 3|Withdrawal by Subject|0|||
125238693|NCT03765073|450500406|FG007|Stage 3|Withdrawal by Subject|0|||
125238694|NCT03765073|450500407|FG008|Stage 3|Withdrawal by Subject|0|||
125238695|NCT03765073|450500408|FG009|Stage 3|Withdrawal by Subject|0|||
125238696|NCT03765073|450500409|FG010|Stage 3|Withdrawal by Subject|0|||
125238697|NCT03765073|450500410|FG011|Stage 3|Withdrawal by Subject|0|||
125238698|NCT03765073|450500411|FG012|Stage 3|Withdrawal by Subject|0|||
125238699|NCT03765073|450500412|FG013|Stage 3|Withdrawal by Subject|0|||
125238700|NCT03765073|450500413|FG014|Stage 3|Withdrawal by Subject|0|||
125238701|NCT03765073|450500414|FG015|Stage 3|Withdrawal by Subject|0|||
125238702|NCT03765073|450500415|FG016|Stage 3|Withdrawal by Subject|0|||
125238703|NCT03765073|450500416|FG017|Stage 3|Withdrawal by Subject|8|||
125238704|NCT03765073|450500417|FG018|Stage 3|Withdrawal by Subject|11|||
125238705|NCT03765073|450500418|FG019|Stage 3|Withdrawal by Subject|0|||
125238706|NCT03765073|450500419|FG020|Stage 3|Withdrawal by Subject|0|||
125238707|NCT04225039|450500422|FG000|Overall Study|Withdrawal by Subject|1|||
125238708|NCT04225039|450500423|FG001|Overall Study|Withdrawal by Subject|0|||
125238709|NCT04225039|450500424|FG002|Overall Study|Withdrawal by Subject|0|||
125238710|NCT04225039|450500425|FG003|Overall Study|Withdrawal by Subject|1|||
125238711|NCT04225039|450500422|FG000|Overall Study|Currently active on study treatment|0|||
125238712|NCT04225039|450500423|FG001|Overall Study|Currently active on study treatment|1|||
125238713|NCT04225039|450500424|FG002|Overall Study|Currently active on study treatment|0|||
125238714|NCT04225039|450500425|FG003|Overall Study|Currently active on study treatment|0|||
125238715|NCT04225039|450500422|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
125238716|NCT04225039|450500423|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
125238717|NCT04225039|450500424|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
125238718|NCT04225039|450500425|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
125238719|NCT04225039|450500422|FG000|Overall Study|Ineligible for treatment|0|||
125238720|NCT04225039|450500423|FG001|Overall Study|Ineligible for treatment|0|||
125238721|NCT04225039|450500424|FG002|Overall Study|Ineligible for treatment|0|||
125238722|NCT04225039|450500425|FG003|Overall Study|Ineligible for treatment|4|||
125238723|NCT02225587|450500434|FG000|Overall Study|Adverse Event|5|||
125238724|NCT02225587|450500435|FG001|Overall Study|Adverse Event|5|||
125238725|NCT02225587|450500434|FG000|Overall Study|Lost to Follow-up|5|||
125238726|NCT02225587|450500435|FG001|Overall Study|Lost to Follow-up|5|||
125238727|NCT02225587|450500434|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125238728|NCT02225587|450500435|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125238729|NCT02225587|450500434|FG000|Overall Study|Physician Decision|2|||
125238730|NCT02225587|450500435|FG001|Overall Study|Physician Decision|0|||
125238731|NCT02225587|450500434|FG000|Overall Study|Protocol Violation|1|||
125238732|NCT02225587|450500435|FG001|Overall Study|Protocol Violation|0|||
125238733|NCT02225587|450500434|FG000|Overall Study|Participant Moved|1|||
125238734|NCT02225587|450500435|FG001|Overall Study|Participant Moved|0|||
125238735|NCT02225587|450500434|FG000|Overall Study|Withdrawal by Subject|13|||
125238736|NCT02225587|450500435|FG001|Overall Study|Withdrawal by Subject|28|||
125185577|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
125185578|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
125185579|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
125185580|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
125185581|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
125185582|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
125238737|NCT01933932|450500438|FG000|Overall Study|Death|173|||
125238738|NCT01933932|450500439|FG001|Overall Study|Death|163|||
125238739|NCT01933932|450500438|FG000|Overall Study|Withdrawal by Subject|11|||
125238740|NCT01933932|450500439|FG001|Overall Study|Withdrawal by Subject|14|||
125238741|NCT01933932|450500438|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125238742|NCT01933932|450500439|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
125238743|NCT01564407|450500442|FG000|Overall Study|Lost to Follow-up|0|||
125238744|NCT01564407|450500443|FG001|Overall Study|Lost to Follow-up|1|||
125238745|NCT01564407|450500444|FG002|Overall Study|Lost to Follow-up|0|||
125238746|NCT01564407|450500445|FG003|Overall Study|Lost to Follow-up|0|||
125238747|NCT01564407|450500446|FG004|Overall Study|Lost to Follow-up|0|||
125238748|NCT01564407|450500442|FG000|Overall Study|Withdrawal by Subject|0|||
125238749|NCT01564407|450500443|FG001|Overall Study|Withdrawal by Subject|1|||
125238750|NCT01564407|450500444|FG002|Overall Study|Withdrawal by Subject|0|||
125238751|NCT01564407|450500445|FG003|Overall Study|Withdrawal by Subject|0|||
125238752|NCT01564407|450500446|FG004|Overall Study|Withdrawal by Subject|0|||
125238753|NCT01564407|450500442|FG000|Overall Study|funding lost, study ended|0|||
125238754|NCT01564407|450500443|FG001|Overall Study|funding lost, study ended|0|||
125185583|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
125238755|NCT01564407|450500444|FG002|Overall Study|funding lost, study ended|0|||
125238756|NCT01564407|450500445|FG003|Overall Study|funding lost, study ended|1|||
125238757|NCT01564407|450500446|FG004|Overall Study|funding lost, study ended|0|||
125238758|NCT03126110|450500447|FG000|Phase 1|Death|2|||
125238759|NCT03126110|450500448|FG001|Phase 1|Death|2|||
125238760|NCT03126110|450500449|FG002|Phase 1|Death|4|||
125238761|NCT03126110|450500450|FG003|Phase 1|Death|3|||
125238762|NCT03126110|450500451|FG004|Phase 1|Death|4|||
125238763|NCT03126110|450500452|FG005|Phase 1|Death|4|||
125238764|NCT03126110|450500453|FG006|Phase 1|Death|3|||
125238765|NCT03126110|450500454|FG007|Phase 1|Death|4|||
125238766|NCT03126110|450500455|FG008|Phase 1|Death|5|||
125238767|NCT03126110|450500456|FG009|Phase 1|Death|2|||
125238768|NCT03126110|450500457|FG010|Phase 1|Death|6|||
125238769|NCT03126110|450500458|FG011|Phase 1|Death|0|||
125238770|NCT03126110|450500459|FG012|Phase 1|Death|0|||
125185584|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
125185585|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
125185586|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
125185587|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
125185588|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
125185589|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
125185590|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
125185591|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
125185592|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
125185593|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
125185594|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
125185595|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
125185596|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
125185597|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
125185598|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
125185599|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
125185600|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
125185601|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
125185602|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
125185603|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
125185604|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
125185605|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
125185606|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
125185607|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
125185608|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
125185609|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
125185610|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
125185611|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
125185612|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
125185613|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
125185614|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
125185615|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
125185616|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
125185617|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
125185618|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185619|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185620|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185621|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185622|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185623|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
125185624|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185625|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185626|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185627|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185628|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
125185629|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185630|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185631|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125238771|NCT03126110|450500460|FG013|Phase 1|Death|0|||
125238772|NCT03126110|450500461|FG014|Phase 1|Death|0|||
125238773|NCT03126110|450500462|FG015|Phase 1|Death|0|||
125238774|NCT03126110|450500463|FG016|Phase 1|Death|0|||
125238775|NCT03126110|450500447|FG000|Phase 1|Lost to Follow-up|0|||
125185632|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
125185633|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
125185634|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
125185635|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
125185636|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
125185637|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
125185638|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
125185639|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
125185640|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
125185641|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
125185642|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
125185643|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
125185644|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
125185645|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
125185646|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
125185647|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
125185648|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185649|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185650|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185651|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185652|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185653|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185654|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185655|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185656|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185657|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185658|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185659|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
125185660|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185661|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
125185662|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
125185663|NCT03922321|450300809|FG000|Overall Study|Participant Moved|1|||
125185664|NCT03922321|450300809|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
125185665|NCT04067050|450300817|FG000|One Month|Lost to Follow-up|4|||
125185666|NCT04067050|450300818|FG001|One Month|Lost to Follow-up|0|||
125185667|NCT04067050|450300817|FG000|Two Month|Lost to Follow-up|1|||
125185668|NCT04067050|450300818|FG001|Two Month|Lost to Follow-up|0|||
125185669|NCT04067050|450300817|FG000|Two Month|Adverse Event|1|||
125185670|NCT04067050|450300818|FG001|Two Month|Adverse Event|0|||
125185671|NCT02342678|450300823|FG000|Overall Study|Lost to Follow-up|0|||
125185672|NCT02342678|450300824|FG001|Overall Study|Lost to Follow-up|1|||
125185673|NCT02342678|450300823|FG000|Overall Study|Too busy to complete study|0|||
125185674|NCT02342678|450300824|FG001|Overall Study|Too busy to complete study|2|||
125185675|NCT02342678|450300823|FG000|Overall Study|Family illness/emergency|0|||
125185676|NCT02342678|450300824|FG001|Overall Study|Family illness/emergency|1|||
125185677|NCT02342678|450300823|FG000|Overall Study|Illness/medical reason|1|||
125185678|NCT02342678|450300824|FG001|Overall Study|Illness/medical reason|1|||
125185679|NCT02383017|450300825|FG000|Overall Study|Injury Sustained Outside Study|1|||
125185680|NCT02383017|450300826|FG001|Overall Study|Injury Sustained Outside Study|0|||
125185681|NCT02383017|450300825|FG000|Overall Study|Compliance|3|||
125185682|NCT02383017|450300826|FG001|Overall Study|Compliance|2|||
125185683|NCT02383017|450300825|FG000|Overall Study|Found to be Hypogonadal|1|||
125185684|NCT02383017|450300826|FG001|Overall Study|Found to be Hypogonadal|0|||
125185685|NCT01068860|450300827|FG000|Overall Study|Withdrawal by Subject|0|||
125185686|NCT01068860|450300828|FG001|Overall Study|Withdrawal by Subject|0|||
125185687|NCT01068860|450300829|FG002|Overall Study|Withdrawal by Subject|0|||
125185688|NCT01068860|450300830|FG003|Overall Study|Withdrawal by Subject|0|||
125185689|NCT01068860|450300831|FG004|Overall Study|Withdrawal by Subject|0|||
125185690|NCT01068860|450300832|FG005|Overall Study|Withdrawal by Subject|2|||
125185691|NCT01068860|450300833|FG006|Overall Study|Withdrawal by Subject|0|||
125185692|NCT01068860|450300834|FG007|Overall Study|Withdrawal by Subject|0|||
125185693|NCT01068860|450300835|FG008|Overall Study|Withdrawal by Subject|0|||
125185694|NCT01068860|450300836|FG009|Overall Study|Withdrawal by Subject|3|||
125185695|NCT01068860|450300827|FG000|Overall Study|Administrative problems; misrandomized|0|||
125185696|NCT01068860|450300828|FG001|Overall Study|Administrative problems; misrandomized|0|||
125185697|NCT01068860|450300829|FG002|Overall Study|Administrative problems; misrandomized|0|||
125185698|NCT01068860|450300830|FG003|Overall Study|Administrative problems; misrandomized|1|||
125238776|NCT03126110|450500448|FG001|Phase 1|Lost to Follow-up|1|||
125185699|NCT01068860|450300831|FG004|Overall Study|Administrative problems; misrandomized|0|||
125185700|NCT01068860|450300832|FG005|Overall Study|Administrative problems; misrandomized|0|||
125185701|NCT01068860|450300833|FG006|Overall Study|Administrative problems; misrandomized|0|||
125238777|NCT03126110|450500449|FG002|Phase 1|Lost to Follow-up|0|||
125238778|NCT03126110|450500450|FG003|Phase 1|Lost to Follow-up|0|||
125238779|NCT03126110|450500451|FG004|Phase 1|Lost to Follow-up|0|||
125238780|NCT03126110|450500452|FG005|Phase 1|Lost to Follow-up|0|||
125238781|NCT03126110|450500453|FG006|Phase 1|Lost to Follow-up|0|||
125238782|NCT03126110|450500454|FG007|Phase 1|Lost to Follow-up|0|||
125238783|NCT03126110|450500455|FG008|Phase 1|Lost to Follow-up|1|||
125238784|NCT03126110|450500456|FG009|Phase 1|Lost to Follow-up|0|||
125238785|NCT03126110|450500457|FG010|Phase 1|Lost to Follow-up|0|||
125238786|NCT03126110|450500458|FG011|Phase 1|Lost to Follow-up|0|||
125238787|NCT03126110|450500459|FG012|Phase 1|Lost to Follow-up|0|||
125238788|NCT03126110|450500460|FG013|Phase 1|Lost to Follow-up|0|||
125238789|NCT03126110|450500461|FG014|Phase 1|Lost to Follow-up|0|||
125238790|NCT03126110|450500462|FG015|Phase 1|Lost to Follow-up|0|||
125238791|NCT03126110|450500463|FG016|Phase 1|Lost to Follow-up|0|||
125238792|NCT03126110|450500447|FG000|Phase 1|Withdrawal by Subject|1|||
125238793|NCT03126110|450500448|FG001|Phase 1|Withdrawal by Subject|0|||
125238794|NCT03126110|450500449|FG002|Phase 1|Withdrawal by Subject|0|||
125238795|NCT03126110|450500450|FG003|Phase 1|Withdrawal by Subject|1|||
125238796|NCT03126110|450500451|FG004|Phase 1|Withdrawal by Subject|1|||
125238797|NCT03126110|450500452|FG005|Phase 1|Withdrawal by Subject|0|||
125238798|NCT03126110|450500453|FG006|Phase 1|Withdrawal by Subject|0|||
125238799|NCT03126110|450500454|FG007|Phase 1|Withdrawal by Subject|0|||
125238800|NCT03126110|450500455|FG008|Phase 1|Withdrawal by Subject|2|||
125238801|NCT03126110|450500456|FG009|Phase 1|Withdrawal by Subject|1|||
125238802|NCT03126110|450500457|FG010|Phase 1|Withdrawal by Subject|0|||
125238803|NCT03126110|450500458|FG011|Phase 1|Withdrawal by Subject|0|||
125238804|NCT03126110|450500459|FG012|Phase 1|Withdrawal by Subject|0|||
125238805|NCT03126110|450500460|FG013|Phase 1|Withdrawal by Subject|0|||
125238806|NCT03126110|450500461|FG014|Phase 1|Withdrawal by Subject|0|||
125238807|NCT03126110|450500462|FG015|Phase 1|Withdrawal by Subject|0|||
125238808|NCT03126110|450500463|FG016|Phase 1|Withdrawal by Subject|0|||
125238809|NCT03126110|450500447|FG000|Phase 1|Safety follow-up no longer necessary|1|||
125238810|NCT03126110|450500448|FG001|Phase 1|Safety follow-up no longer necessary|0|||
125238811|NCT03126110|450500449|FG002|Phase 1|Safety follow-up no longer necessary|0|||
125238812|NCT03126110|450500450|FG003|Phase 1|Safety follow-up no longer necessary|0|||
125238813|NCT03126110|450500451|FG004|Phase 1|Safety follow-up no longer necessary|0|||
125238814|NCT03126110|450500452|FG005|Phase 1|Safety follow-up no longer necessary|0|||
125238815|NCT03126110|450500453|FG006|Phase 1|Safety follow-up no longer necessary|0|||
125238816|NCT03126110|450500454|FG007|Phase 1|Safety follow-up no longer necessary|0|||
125238817|NCT03126110|450500455|FG008|Phase 1|Safety follow-up no longer necessary|0|||
125238818|NCT03126110|450500456|FG009|Phase 1|Safety follow-up no longer necessary|0|||
125238819|NCT03126110|450500457|FG010|Phase 1|Safety follow-up no longer necessary|0|||
125238820|NCT03126110|450500458|FG011|Phase 1|Safety follow-up no longer necessary|0|||
125238821|NCT03126110|450500459|FG012|Phase 1|Safety follow-up no longer necessary|0|||
125238822|NCT03126110|450500460|FG013|Phase 1|Safety follow-up no longer necessary|0|||
125238823|NCT03126110|450500461|FG014|Phase 1|Safety follow-up no longer necessary|0|||
125238824|NCT03126110|450500462|FG015|Phase 1|Safety follow-up no longer necessary|0|||
125238825|NCT03126110|450500463|FG016|Phase 1|Safety follow-up no longer necessary|0|||
125238826|NCT03126110|450500447|FG000|Phase 1|Survival follow-up no longer necessary|0|||
125238827|NCT03126110|450500448|FG001|Phase 1|Survival follow-up no longer necessary|0|||
125238828|NCT03126110|450500449|FG002|Phase 1|Survival follow-up no longer necessary|1|||
125238829|NCT03126110|450500450|FG003|Phase 1|Survival follow-up no longer necessary|0|||
125238830|NCT03126110|450500451|FG004|Phase 1|Survival follow-up no longer necessary|0|||
125238831|NCT03126110|450500452|FG005|Phase 1|Survival follow-up no longer necessary|0|||
125238832|NCT03126110|450500453|FG006|Phase 1|Survival follow-up no longer necessary|0|||
125238833|NCT03126110|450500454|FG007|Phase 1|Survival follow-up no longer necessary|0|||
125238834|NCT03126110|450500455|FG008|Phase 1|Survival follow-up no longer necessary|0|||
125238835|NCT03126110|450500456|FG009|Phase 1|Survival follow-up no longer necessary|0|||
125238836|NCT03126110|450500457|FG010|Phase 1|Survival follow-up no longer necessary|0|||
125238837|NCT03126110|450500458|FG011|Phase 1|Survival follow-up no longer necessary|0|||
125238838|NCT03126110|450500459|FG012|Phase 1|Survival follow-up no longer necessary|0|||
125238839|NCT03126110|450500460|FG013|Phase 1|Survival follow-up no longer necessary|0|||
125238840|NCT03126110|450500461|FG014|Phase 1|Survival follow-up no longer necessary|0|||
125238841|NCT03126110|450500462|FG015|Phase 1|Survival follow-up no longer necessary|0|||
125238842|NCT03126110|450500463|FG016|Phase 1|Survival follow-up no longer necessary|0|||
125238843|NCT03126110|450500447|FG000|Phase 2|Study terminated by the sponsor|0|||
125238844|NCT03126110|450500448|FG001|Phase 2|Study terminated by the sponsor|0|||
125238845|NCT03126110|450500449|FG002|Phase 2|Study terminated by the sponsor|0|||
125238846|NCT03126110|450500450|FG003|Phase 2|Study terminated by the sponsor|0|||
125238847|NCT03126110|450500451|FG004|Phase 2|Study terminated by the sponsor|0|||
125238848|NCT03126110|450500452|FG005|Phase 2|Study terminated by the sponsor|0|||
125238849|NCT03126110|450500453|FG006|Phase 2|Study terminated by the sponsor|0|||
125238850|NCT03126110|450500454|FG007|Phase 2|Study terminated by the sponsor|0|||
125238851|NCT03126110|450500455|FG008|Phase 2|Study terminated by the sponsor|0|||
125238852|NCT03126110|450500456|FG009|Phase 2|Study terminated by the sponsor|0|||
125238853|NCT03126110|450500457|FG010|Phase 2|Study terminated by the sponsor|0|||
125238854|NCT03126110|450500458|FG011|Phase 2|Study terminated by the sponsor|0|||
125238855|NCT03126110|450500459|FG012|Phase 2|Study terminated by the sponsor|0|||
125238856|NCT03126110|450500460|FG013|Phase 2|Study terminated by the sponsor|4|||
125238857|NCT03126110|450500461|FG014|Phase 2|Study terminated by the sponsor|0|||
125238858|NCT03126110|450500462|FG015|Phase 2|Study terminated by the sponsor|0|||
125238859|NCT03126110|450500463|FG016|Phase 2|Study terminated by the sponsor|0|||
125238860|NCT03126110|450500447|FG000|Phase 2|Withdrawal by Subject|0|||
125238861|NCT03126110|450500448|FG001|Phase 2|Withdrawal by Subject|0|||
125238862|NCT03126110|450500449|FG002|Phase 2|Withdrawal by Subject|0|||
125238863|NCT03126110|450500450|FG003|Phase 2|Withdrawal by Subject|0|||
125238864|NCT03126110|450500451|FG004|Phase 2|Withdrawal by Subject|0|||
125238865|NCT03126110|450500452|FG005|Phase 2|Withdrawal by Subject|0|||
125238866|NCT03126110|450500453|FG006|Phase 2|Withdrawal by Subject|0|||
125238867|NCT03126110|450500454|FG007|Phase 2|Withdrawal by Subject|0|||
125238868|NCT03126110|450500455|FG008|Phase 2|Withdrawal by Subject|0|||
125238869|NCT03126110|450500456|FG009|Phase 2|Withdrawal by Subject|0|||
125238870|NCT03126110|450500457|FG010|Phase 2|Withdrawal by Subject|0|||
125238871|NCT03126110|450500458|FG011|Phase 2|Withdrawal by Subject|1|||
125238872|NCT03126110|450500459|FG012|Phase 2|Withdrawal by Subject|3|||
125238873|NCT03126110|450500460|FG013|Phase 2|Withdrawal by Subject|3|||
125238874|NCT03126110|450500461|FG014|Phase 2|Withdrawal by Subject|2|||
125238875|NCT03126110|450500462|FG015|Phase 2|Withdrawal by Subject|1|||
125238876|NCT03126110|450500463|FG016|Phase 2|Withdrawal by Subject|0|||
125238877|NCT03126110|450500447|FG000|Phase 2|Lost to Follow-up|0|||
125238878|NCT03126110|450500448|FG001|Phase 2|Lost to Follow-up|0|||
125238879|NCT03126110|450500449|FG002|Phase 2|Lost to Follow-up|0|||
125238880|NCT03126110|450500450|FG003|Phase 2|Lost to Follow-up|0|||
125238881|NCT03126110|450500451|FG004|Phase 2|Lost to Follow-up|0|||
125238882|NCT03126110|450500452|FG005|Phase 2|Lost to Follow-up|0|||
125238883|NCT03126110|450500453|FG006|Phase 2|Lost to Follow-up|0|||
125238884|NCT03126110|450500454|FG007|Phase 2|Lost to Follow-up|0|||
125238885|NCT03126110|450500455|FG008|Phase 2|Lost to Follow-up|0|||
125185702|NCT01068860|450300834|FG007|Overall Study|Administrative problems; misrandomized|0|||
125185703|NCT01068860|450300835|FG008|Overall Study|Administrative problems; misrandomized|0|||
125185704|NCT01068860|450300836|FG009|Overall Study|Administrative problems; misrandomized|1|||
125185705|NCT01068860|450300827|FG000|Overall Study|Lost to Follow-up|0|||
125185706|NCT01068860|450300828|FG001|Overall Study|Lost to Follow-up|1|||
125185707|NCT01068860|450300829|FG002|Overall Study|Lost to Follow-up|0|||
125185708|NCT01068860|450300830|FG003|Overall Study|Lost to Follow-up|0|||
125185709|NCT01068860|450300831|FG004|Overall Study|Lost to Follow-up|0|||
125185710|NCT01068860|450300832|FG005|Overall Study|Lost to Follow-up|0|||
125185711|NCT01068860|450300833|FG006|Overall Study|Lost to Follow-up|0|||
125185712|NCT01068860|450300834|FG007|Overall Study|Lost to Follow-up|0|||
125185713|NCT01068860|450300835|FG008|Overall Study|Lost to Follow-up|0|||
125185714|NCT01068860|450300836|FG009|Overall Study|Lost to Follow-up|0|||
125185715|NCT00460603|450300837|FG000|Phase 1|Death|1|||
125185716|NCT00460603|450300838|FG001|Phase 1|Death|0|||
125185717|NCT00460603|450300839|FG002|Phase 1|Death|0|||
125185718|NCT00460603|450300840|FG003|Phase 1|Death|2|||
125185719|NCT00460603|450300841|FG004|Phase 1|Death|0|||
125185720|NCT00460603|450300842|FG005|Phase 1|Death|0|||
125185721|NCT00460603|450300843|FG006|Phase 1|Death|0|||
125185722|NCT00460603|450300844|FG007|Phase 1|Death|0|||
125185723|NCT00460603|450300845|FG008|Phase 1|Death|1|||
125185724|NCT00460603|450300846|FG009|Phase 1|Death|0|||
125185725|NCT00460603|450300847|FG010|Phase 1|Death|0|||
125185726|NCT00460603|450300848|FG011|Phase 1|Death|0|||
125185727|NCT00460603|450300837|FG000|Phase 1|Adverse Event|3|||
125185728|NCT00460603|450300838|FG001|Phase 1|Adverse Event|1|||
125185729|NCT00460603|450300839|FG002|Phase 1|Adverse Event|1|||
125185730|NCT00460603|450300840|FG003|Phase 1|Adverse Event|2|||
125185731|NCT00460603|450300841|FG004|Phase 1|Adverse Event|0|||
125185732|NCT00460603|450300842|FG005|Phase 1|Adverse Event|0|||
125185733|NCT00460603|450300843|FG006|Phase 1|Adverse Event|3|||
125185734|NCT00460603|450300844|FG007|Phase 1|Adverse Event|0|||
125185735|NCT00460603|450300845|FG008|Phase 1|Adverse Event|4|||
125185736|NCT00460603|450300846|FG009|Phase 1|Adverse Event|0|||
125238886|NCT03126110|450500456|FG009|Phase 2|Lost to Follow-up|0|||
125238887|NCT03126110|450500457|FG010|Phase 2|Lost to Follow-up|0|||
125238888|NCT03126110|450500458|FG011|Phase 2|Lost to Follow-up|1|||
125238889|NCT03126110|450500459|FG012|Phase 2|Lost to Follow-up|1|||
125185737|NCT00460603|450300847|FG010|Phase 1|Adverse Event|0|||
125185738|NCT00460603|450300848|FG011|Phase 1|Adverse Event|0|||
125185739|NCT00460603|450300837|FG000|Phase 1|Lack of Efficacy|1|||
125185740|NCT00460603|450300838|FG001|Phase 1|Lack of Efficacy|0|||
125238890|NCT03126110|450500460|FG013|Phase 2|Lost to Follow-up|1|||
125238891|NCT03126110|450500461|FG014|Phase 2|Lost to Follow-up|2|||
125238892|NCT03126110|450500462|FG015|Phase 2|Lost to Follow-up|0|||
125238893|NCT03126110|450500463|FG016|Phase 2|Lost to Follow-up|0|||
125238894|NCT03126110|450500447|FG000|Phase 2|Death|0|||
125238895|NCT03126110|450500448|FG001|Phase 2|Death|0|||
125238896|NCT03126110|450500449|FG002|Phase 2|Death|0|||
125238897|NCT03126110|450500450|FG003|Phase 2|Death|0|||
125238898|NCT03126110|450500451|FG004|Phase 2|Death|0|||
125238899|NCT03126110|450500452|FG005|Phase 2|Death|0|||
125238900|NCT03126110|450500453|FG006|Phase 2|Death|0|||
125238901|NCT03126110|450500454|FG007|Phase 2|Death|0|||
125238902|NCT03126110|450500455|FG008|Phase 2|Death|0|||
125238903|NCT03126110|450500456|FG009|Phase 2|Death|0|||
125238904|NCT03126110|450500457|FG010|Phase 2|Death|0|||
125238905|NCT03126110|450500458|FG011|Phase 2|Death|6|||
125238906|NCT03126110|450500459|FG012|Phase 2|Death|12|||
125238907|NCT03126110|450500460|FG013|Phase 2|Death|25|||
125238908|NCT03126110|450500461|FG014|Phase 2|Death|11|||
125238909|NCT03126110|450500462|FG015|Phase 2|Death|3|||
125238910|NCT03126110|450500463|FG016|Phase 2|Death|2|||
125238911|NCT03126110|450500447|FG000|Phase 2|Progressive Disease|0|||
125238912|NCT03126110|450500448|FG001|Phase 2|Progressive Disease|0|||
125238913|NCT03126110|450500449|FG002|Phase 2|Progressive Disease|0|||
125238914|NCT03126110|450500450|FG003|Phase 2|Progressive Disease|0|||
125238915|NCT03126110|450500451|FG004|Phase 2|Progressive Disease|0|||
125238916|NCT03126110|450500452|FG005|Phase 2|Progressive Disease|0|||
125238917|NCT03126110|450500453|FG006|Phase 2|Progressive Disease|0|||
125238918|NCT03126110|450500454|FG007|Phase 2|Progressive Disease|0|||
125238919|NCT03126110|450500455|FG008|Phase 2|Progressive Disease|0|||
125238920|NCT03126110|450500456|FG009|Phase 2|Progressive Disease|0|||
125238921|NCT03126110|450500457|FG010|Phase 2|Progressive Disease|0|||
125238922|NCT03126110|450500458|FG011|Phase 2|Progressive Disease|0|||
125238923|NCT03126110|450500459|FG012|Phase 2|Progressive Disease|0|||
125238924|NCT03126110|450500460|FG013|Phase 2|Progressive Disease|1|||
125238925|NCT03126110|450500461|FG014|Phase 2|Progressive Disease|0|||
125238926|NCT03126110|450500462|FG015|Phase 2|Progressive Disease|0|||
125238927|NCT03126110|450500463|FG016|Phase 2|Progressive Disease|0|||
125238928|NCT03126110|450500447|FG000|Phase 2|Started new treatment|0|||
125238929|NCT03126110|450500448|FG001|Phase 2|Started new treatment|0|||
125238930|NCT03126110|450500449|FG002|Phase 2|Started new treatment|0|||
125238931|NCT03126110|450500450|FG003|Phase 2|Started new treatment|0|||
125238932|NCT03126110|450500451|FG004|Phase 2|Started new treatment|0|||
125238933|NCT03126110|450500452|FG005|Phase 2|Started new treatment|0|||
125238934|NCT03126110|450500453|FG006|Phase 2|Started new treatment|0|||
125238935|NCT03126110|450500454|FG007|Phase 2|Started new treatment|0|||
125238936|NCT03126110|450500455|FG008|Phase 2|Started new treatment|0|||
125238937|NCT03126110|450500456|FG009|Phase 2|Started new treatment|0|||
125238938|NCT03126110|450500457|FG010|Phase 2|Started new treatment|0|||
125238939|NCT03126110|450500458|FG011|Phase 2|Started new treatment|0|||
125238940|NCT03126110|450500459|FG012|Phase 2|Started new treatment|0|||
125238941|NCT03126110|450500460|FG013|Phase 2|Started new treatment|0|||
125238942|NCT03126110|450500461|FG014|Phase 2|Started new treatment|1|||
125238943|NCT03126110|450500462|FG015|Phase 2|Started new treatment|0|||
125238944|NCT03126110|450500463|FG016|Phase 2|Started new treatment|0|||
125238945|NCT04235374|450500464|FG000|Overall Study|Death|91|||
125238946|NCT04235374|450500465|FG001|Overall Study|Death|91|||
125238947|NCT04235374|450500464|FG000|Overall Study|Refused|2|||
125238948|NCT04235374|450500465|FG001|Overall Study|Refused|2|||
125238949|NCT04235374|450500464|FG000|Overall Study|Unavailable|12|||
125238950|NCT04235374|450500465|FG001|Overall Study|Unavailable|3|||
125238951|NCT04235374|450500464|FG000|Overall Study|Withdrawal by Subject|0|||
125238952|NCT04235374|450500465|FG001|Overall Study|Withdrawal by Subject|1|||
125238953|NCT04235374|450500464|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
125238954|NCT04235374|450500465|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
125238955|NCT00976027|450500468|FG000|Overall Study|Serious Adverse Event|36|||
125238956|NCT00976027|450500469|FG001|Overall Study|Serious Adverse Event|17|||
125238957|NCT00976027|450500468|FG000|Overall Study|Adverse Event|0|||
125238958|NCT00976027|450500469|FG001|Overall Study|Adverse Event|2|||
125238959|NCT00976027|450500468|FG000|Overall Study|Protocol Violation|60|||
125238960|NCT00976027|450500469|FG001|Overall Study|Protocol Violation|27|||
125238961|NCT00976027|450500468|FG000|Overall Study|Lost to Follow-up|208|||
125238962|NCT00976027|450500469|FG001|Overall Study|Lost to Follow-up|103|||
125238963|NCT00976027|450500468|FG000|Overall Study|Withdrawal by Subject|107|||
125238964|NCT00976027|450500469|FG001|Overall Study|Withdrawal by Subject|66|||
125238965|NCT01771107|450500472|FG000|Overall Study|Adverse Event|1|||
125238966|NCT01771107|450500473|FG001|Overall Study|Adverse Event|3|||
125238967|NCT01771107|450500472|FG000|Overall Study|Withdrawal by Subject|0|||
125238968|NCT01771107|450500473|FG001|Overall Study|Withdrawal by Subject|2|||
125238969|NCT01771107|450500472|FG000|Overall Study|Lost to Follow-up|0|||
125238970|NCT01771107|450500473|FG001|Overall Study|Lost to Follow-up|1|||
125238971|NCT01771107|450500472|FG000|Overall Study|participant moved|0|||
125238972|NCT01771107|450500473|FG001|Overall Study|participant moved|1|||
125238973|NCT01771107|450500472|FG000|Overall Study|Other|0|||
125238974|NCT01771107|450500473|FG001|Overall Study|Other|1|||
125238975|NCT02296125|450500478|FG000|Overall Study|Withdrawal by Subject|18|||
125238976|NCT02296125|450500479|FG001|Overall Study|Withdrawal by Subject|8|||
125238977|NCT02296125|450500480|FG002|Overall Study|Withdrawal by Subject|6|||
125238978|NCT02296125|450500481|FG003|Overall Study|Withdrawal by Subject|2|||
125238979|NCT02296125|450500478|FG000|Overall Study|Adverse Event|41|||
125238980|NCT02296125|450500479|FG001|Overall Study|Adverse Event|52|||
125238981|NCT02296125|450500480|FG002|Overall Study|Adverse Event|9|||
125238982|NCT02296125|450500481|FG003|Overall Study|Adverse Event|4|||
125238983|NCT02296125|450500478|FG000|Overall Study|Severe non-compliance to protocol|0|||
125238984|NCT02296125|450500479|FG001|Overall Study|Severe non-compliance to protocol|1|||
125238985|NCT02296125|450500480|FG002|Overall Study|Severe non-compliance to protocol|0|||
125238986|NCT02296125|450500481|FG003|Overall Study|Severe non-compliance to protocol|0|||
125238987|NCT02296125|450500478|FG000|Overall Study|Condition under investigation worsened|153|||
125238988|NCT02296125|450500479|FG001|Overall Study|Condition under investigation worsened|199|||
125238989|NCT02296125|450500480|FG002|Overall Study|Condition under investigation worsened|39|||
125238990|NCT02296125|450500481|FG003|Overall Study|Condition under investigation worsened|56|||
125238991|NCT02296125|450500478|FG000|Overall Study|Any reason not specifically recorded|6|||
125238992|NCT02296125|450500479|FG001|Overall Study|Any reason not specifically recorded|4|||
125238993|NCT02296125|450500480|FG002|Overall Study|Any reason not specifically recorded|2|||
125238994|NCT02296125|450500481|FG003|Overall Study|Any reason not specifically recorded|0|||
125238995|NCT00157755|450500482|FG000|Overall Study|Death|2|||
125238996|NCT00157755|450500483|FG001|Overall Study|Death|3|||
125238997|NCT00157755|450500484|FG002|Overall Study|Death|3|||
125238998|NCT00157755|450500485|FG003|Overall Study|Death|2|||
125238999|NCT00157755|450500486|FG004|Overall Study|Death|0|||
125239000|NCT00157755|450500487|FG005|Overall Study|Death|0|||
125239001|NCT00157755|450500482|FG000|Overall Study|Lost to Follow-up|0|||
125239002|NCT00157755|450500483|FG001|Overall Study|Lost to Follow-up|0|||
125239003|NCT00157755|450500484|FG002|Overall Study|Lost to Follow-up|1|||
125239004|NCT00157755|450500485|FG003|Overall Study|Lost to Follow-up|0|||
125239005|NCT00157755|450500486|FG004|Overall Study|Lost to Follow-up|0|||
125239006|NCT00157755|450500487|FG005|Overall Study|Lost to Follow-up|0|||
125239007|NCT00157755|450500482|FG000|Overall Study|Withdrawal by Subject|0|||
125239008|NCT00157755|450500483|FG001|Overall Study|Withdrawal by Subject|0|||
125239009|NCT00157755|450500484|FG002|Overall Study|Withdrawal by Subject|1|||
125239010|NCT00157755|450500485|FG003|Overall Study|Withdrawal by Subject|1|||
125239011|NCT00157755|450500486|FG004|Overall Study|Withdrawal by Subject|1|||
125239012|NCT00157755|450500487|FG005|Overall Study|Withdrawal by Subject|2|||
125239013|NCT00157755|450500482|FG000|Overall Study|Explant due to infection|0|||
125239014|NCT00157755|450500483|FG001|Overall Study|Explant due to infection|0|||
125239015|NCT00157755|450500484|FG002|Overall Study|Explant due to infection|1|||
125239016|NCT00157755|450500485|FG003|Overall Study|Explant due to infection|0|||
125239017|NCT00157755|450500486|FG004|Overall Study|Explant due to infection|0|||
125239018|NCT00157755|450500487|FG005|Overall Study|Explant due to infection|0|||
125239019|NCT00157755|450500482|FG000|Overall Study|Medical reason|0|||
125239020|NCT00157755|450500483|FG001|Overall Study|Medical reason|0|||
125239021|NCT00157755|450500484|FG002|Overall Study|Medical reason|1|||
125239022|NCT00157755|450500485|FG003|Overall Study|Medical reason|1|||
125239023|NCT00157755|450500486|FG004|Overall Study|Medical reason|0|||
125239024|NCT00157755|450500487|FG005|Overall Study|Medical reason|0|||
125239025|NCT00157755|450500482|FG000|Overall Study|Study site closure|0|||
125239026|NCT00157755|450500483|FG001|Overall Study|Study site closure|1|||
125239027|NCT00157755|450500484|FG002|Overall Study|Study site closure|0|||
125239028|NCT00157755|450500485|FG003|Overall Study|Study site closure|0|||
125239029|NCT00157755|450500486|FG004|Overall Study|Study site closure|0|||
125239030|NCT00157755|450500487|FG005|Overall Study|Study site closure|0|||
125239031|NCT00157755|450500482|FG000|Overall Study|Subject non-compliance|0|||
125239032|NCT00157755|450500483|FG001|Overall Study|Subject non-compliance|0|||
125239033|NCT00157755|450500484|FG002|Overall Study|Subject non-compliance|0|||
125239034|NCT00157755|450500485|FG003|Overall Study|Subject non-compliance|0|||
125239035|NCT00157755|450500486|FG004|Overall Study|Subject non-compliance|0|||
125239036|NCT00157755|450500487|FG005|Overall Study|Subject non-compliance|1|||
125239037|NCT00157755|450500482|FG000|Overall Study|Study completion|0|||
125239038|NCT00157755|450500483|FG001|Overall Study|Study completion|0|||
125239039|NCT00157755|450500484|FG002|Overall Study|Study completion|0|||
125239040|NCT00157755|450500485|FG003|Overall Study|Study completion|0|||
125239041|NCT00157755|450500486|FG004|Overall Study|Study completion|1|||
125239042|NCT00157755|450500487|FG005|Overall Study|Study completion|2|||
125239043|NCT03314935|450500490|FG000|Phase 1|Death|4|||
125239044|NCT03314935|450500491|FG001|Phase 1|Death|2|||
125239045|NCT03314935|450500492|FG002|Phase 1|Death|5|||
125239046|NCT03314935|450500493|FG003|Phase 1|Death|4|||
125239047|NCT03314935|450500494|FG004|Phase 1|Death|3|||
125239048|NCT03314935|450500495|FG005|Phase 1|Death|4|||
125239049|NCT03314935|450500496|FG006|Phase 1|Death|5|||
125239050|NCT03314935|450500497|FG007|Phase 1|Death|4|||
125239051|NCT03314935|450500498|FG008|Phase 1|Death|3|||
125239052|NCT03314935|450500499|FG009|Phase 1|Death|0|||
125239053|NCT03314935|450500500|FG010|Phase 1|Death|0|||
125239054|NCT03314935|450500501|FG011|Phase 1|Death|0|||
125239055|NCT03314935|450500502|FG012|Phase 1|Death|0|||
125239056|NCT03314935|450500503|FG013|Phase 1|Death|0|||
125239057|NCT03314935|450500504|FG014|Phase 1|Death|0|||
125239058|NCT03314935|450500490|FG000|Phase 1|Withdrawal by Subject|2|||
125239059|NCT03314935|450500491|FG001|Phase 1|Withdrawal by Subject|1|||
125239060|NCT03314935|450500492|FG002|Phase 1|Withdrawal by Subject|1|||
125239061|NCT03314935|450500493|FG003|Phase 1|Withdrawal by Subject|2|||
125239062|NCT03314935|450500494|FG004|Phase 1|Withdrawal by Subject|1|||
125239063|NCT03314935|450500495|FG005|Phase 1|Withdrawal by Subject|0|||
125239064|NCT03314935|450500496|FG006|Phase 1|Withdrawal by Subject|1|||
125239065|NCT03314935|450500497|FG007|Phase 1|Withdrawal by Subject|0|||
125239066|NCT03314935|450500498|FG008|Phase 1|Withdrawal by Subject|1|||
125239067|NCT03314935|450500499|FG009|Phase 1|Withdrawal by Subject|0|||
125239068|NCT03314935|450500500|FG010|Phase 1|Withdrawal by Subject|0|||
125239069|NCT03314935|450500501|FG011|Phase 1|Withdrawal by Subject|0|||
125239070|NCT03314935|450500502|FG012|Phase 1|Withdrawal by Subject|0|||
125239071|NCT03314935|450500503|FG013|Phase 1|Withdrawal by Subject|0|||
125239072|NCT03314935|450500504|FG014|Phase 1|Withdrawal by Subject|0|||
125239073|NCT03314935|450500490|FG000|Phase 1|Progressive Disease|2|||
125239074|NCT03314935|450500491|FG001|Phase 1|Progressive Disease|0|||
125239075|NCT03314935|450500492|FG002|Phase 1|Progressive Disease|0|||
125239076|NCT03314935|450500493|FG003|Phase 1|Progressive Disease|1|||
125239077|NCT03314935|450500494|FG004|Phase 1|Progressive Disease|0|||
125239078|NCT03314935|450500495|FG005|Phase 1|Progressive Disease|0|||
125239079|NCT03314935|450500496|FG006|Phase 1|Progressive Disease|0|||
125239080|NCT03314935|450500497|FG007|Phase 1|Progressive Disease|0|||
125239081|NCT03314935|450500498|FG008|Phase 1|Progressive Disease|0|||
125239082|NCT03314935|450500499|FG009|Phase 1|Progressive Disease|0|||
125239083|NCT03314935|450500500|FG010|Phase 1|Progressive Disease|0|||
125239084|NCT03314935|450500501|FG011|Phase 1|Progressive Disease|0|||
125239085|NCT03314935|450500502|FG012|Phase 1|Progressive Disease|0|||
125239086|NCT03314935|450500503|FG013|Phase 1|Progressive Disease|0|||
125239087|NCT03314935|450500504|FG014|Phase 1|Progressive Disease|0|||
125239088|NCT03314935|450500490|FG000|Phase 1|Study Terminated by Sponsor|0|||
125239089|NCT03314935|450500491|FG001|Phase 1|Study Terminated by Sponsor|1|||
125239090|NCT03314935|450500492|FG002|Phase 1|Study Terminated by Sponsor|0|||
125239091|NCT03314935|450500493|FG003|Phase 1|Study Terminated by Sponsor|0|||
125239092|NCT03314935|450500494|FG004|Phase 1|Study Terminated by Sponsor|0|||
125239093|NCT03314935|450500495|FG005|Phase 1|Study Terminated by Sponsor|0|||
125239094|NCT03314935|450500496|FG006|Phase 1|Study Terminated by Sponsor|0|||
125239095|NCT03314935|450500497|FG007|Phase 1|Study Terminated by Sponsor|0|||
125239096|NCT03314935|450500498|FG008|Phase 1|Study Terminated by Sponsor|1|||
125239097|NCT03314935|450500499|FG009|Phase 1|Study Terminated by Sponsor|0|||
125239098|NCT03314935|450500500|FG010|Phase 1|Study Terminated by Sponsor|0|||
125239099|NCT03314935|450500501|FG011|Phase 1|Study Terminated by Sponsor|0|||
125239100|NCT03314935|450500502|FG012|Phase 1|Study Terminated by Sponsor|0|||
125239101|NCT03314935|450500503|FG013|Phase 1|Study Terminated by Sponsor|0|||
125239102|NCT03314935|450500504|FG014|Phase 1|Study Terminated by Sponsor|0|||
125239103|NCT03314935|450500490|FG000|Phase 1|"Captured as Other in Database"|0|||
125239104|NCT03314935|450500491|FG001|Phase 1|"Captured as Other in Database"|2|||
125239105|NCT03314935|450500492|FG002|Phase 1|"Captured as Other in Database"|0|||
125239106|NCT03314935|450500493|FG003|Phase 1|"Captured as Other in Database"|0|||
125185741|NCT00460603|450300839|FG002|Phase 1|Lack of Efficacy|1|||
125185742|NCT00460603|450300840|FG003|Phase 1|Lack of Efficacy|2|||
125185743|NCT00460603|450300841|FG004|Phase 1|Lack of Efficacy|2|||
125185744|NCT00460603|450300842|FG005|Phase 1|Lack of Efficacy|2|||
125185745|NCT00460603|450300843|FG006|Phase 1|Lack of Efficacy|2|||
125185746|NCT00460603|450300844|FG007|Phase 1|Lack of Efficacy|2|||
125185747|NCT00460603|450300845|FG008|Phase 1|Lack of Efficacy|11|||
125185748|NCT00460603|450300846|FG009|Phase 1|Lack of Efficacy|0|||
125185749|NCT00460603|450300847|FG010|Phase 1|Lack of Efficacy|0|||
125185750|NCT00460603|450300848|FG011|Phase 1|Lack of Efficacy|0|||
125185751|NCT00460603|450300837|FG000|Phase 1|Withdrawal by Subject|1|||
125185752|NCT00460603|450300838|FG001|Phase 1|Withdrawal by Subject|2|||
125185753|NCT00460603|450300839|FG002|Phase 1|Withdrawal by Subject|1|||
125185754|NCT00460603|450300840|FG003|Phase 1|Withdrawal by Subject|1|||
125185755|NCT00460603|450300841|FG004|Phase 1|Withdrawal by Subject|3|||
125185756|NCT00460603|450300842|FG005|Phase 1|Withdrawal by Subject|0|||
125185757|NCT00460603|450300843|FG006|Phase 1|Withdrawal by Subject|1|||
125239107|NCT03314935|450500494|FG004|Phase 1|"Captured as Other in Database"|0|||
125239108|NCT03314935|450500495|FG005|Phase 1|"Captured as Other in Database"|0|||
125239109|NCT03314935|450500496|FG006|Phase 1|"Captured as Other in Database"|1|||
125239110|NCT03314935|450500497|FG007|Phase 1|"Captured as Other in Database"|1|||
125239111|NCT03314935|450500498|FG008|Phase 1|"Captured as Other in Database"|1|||
125239112|NCT03314935|450500499|FG009|Phase 1|"Captured as Other in Database"|0|||
125239113|NCT03314935|450500500|FG010|Phase 1|"Captured as Other in Database"|0|||
125185758|NCT00460603|450300844|FG007|Phase 1|Withdrawal by Subject|0|||
125185759|NCT00460603|450300845|FG008|Phase 1|Withdrawal by Subject|2|||
125239114|NCT03314935|450500501|FG011|Phase 1|"Captured as Other in Database"|0|||
125239115|NCT03314935|450500502|FG012|Phase 1|"Captured as Other in Database"|0|||
125185760|NCT00460603|450300846|FG009|Phase 1|Withdrawal by Subject|0|||
125185761|NCT00460603|450300847|FG010|Phase 1|Withdrawal by Subject|0|||
125185762|NCT00460603|450300848|FG011|Phase 1|Withdrawal by Subject|0|||
125239116|NCT03314935|450500503|FG013|Phase 1|"Captured as Other in Database"|0|||
125239117|NCT03314935|450500504|FG014|Phase 1|"Captured as Other in Database"|0|||
125239118|NCT03314935|450500490|FG000|Phase 1|Lost to Follow-up|0|||
125239119|NCT03314935|450500491|FG001|Phase 1|Lost to Follow-up|0|||
125239120|NCT03314935|450500492|FG002|Phase 1|Lost to Follow-up|0|||
125239121|NCT03314935|450500493|FG003|Phase 1|Lost to Follow-up|0|||
125239122|NCT03314935|450500494|FG004|Phase 1|Lost to Follow-up|0|||
125239123|NCT03314935|450500495|FG005|Phase 1|Lost to Follow-up|0|||
125239124|NCT03314935|450500496|FG006|Phase 1|Lost to Follow-up|0|||
125239125|NCT03314935|450500497|FG007|Phase 1|Lost to Follow-up|0|||
125239126|NCT03314935|450500498|FG008|Phase 1|Lost to Follow-up|1|||
125239127|NCT03314935|450500499|FG009|Phase 1|Lost to Follow-up|0|||
125239128|NCT03314935|450500500|FG010|Phase 1|Lost to Follow-up|0|||
125239129|NCT03314935|450500501|FG011|Phase 1|Lost to Follow-up|0|||
125239130|NCT03314935|450500502|FG012|Phase 1|Lost to Follow-up|0|||
125239131|NCT03314935|450500503|FG013|Phase 1|Lost to Follow-up|0|||
125239132|NCT03314935|450500504|FG014|Phase 1|Lost to Follow-up|0|||
125239133|NCT03314935|450500490|FG000|Phase 2|Death|0|||
125239134|NCT03314935|450500491|FG001|Phase 2|Death|0|||
125239135|NCT03314935|450500492|FG002|Phase 2|Death|0|||
125239136|NCT03314935|450500493|FG003|Phase 2|Death|0|||
125239137|NCT03314935|450500494|FG004|Phase 2|Death|0|||
125239138|NCT03314935|450500495|FG005|Phase 2|Death|0|||
125239139|NCT03314935|450500496|FG006|Phase 2|Death|0|||
125239140|NCT03314935|450500497|FG007|Phase 2|Death|0|||
125239141|NCT03314935|450500498|FG008|Phase 2|Death|0|||
125239142|NCT03314935|450500499|FG009|Phase 2|Death|5|||
125239143|NCT03314935|450500500|FG010|Phase 2|Death|20|||
125239144|NCT03314935|450500501|FG011|Phase 2|Death|6|||
125239145|NCT03314935|450500502|FG012|Phase 2|Death|7|||
125239146|NCT03314935|450500503|FG013|Phase 2|Death|6|||
125239147|NCT03314935|450500504|FG014|Phase 2|Death|17|||
125239148|NCT03314935|450500490|FG000|Phase 2|Withdrawal by Subject|0|||
125239149|NCT03314935|450500491|FG001|Phase 2|Withdrawal by Subject|0|||
125239150|NCT03314935|450500492|FG002|Phase 2|Withdrawal by Subject|0|||
125185763|NCT00460603|450300837|FG000|Phase 1|Other|0|||
125185764|NCT00460603|450300838|FG001|Phase 1|Other|3|||
125185765|NCT00460603|450300839|FG002|Phase 1|Other|1|||
125185766|NCT00460603|450300840|FG003|Phase 1|Other|1|||
125185767|NCT00460603|450300841|FG004|Phase 1|Other|1|||
125185768|NCT00460603|450300842|FG005|Phase 1|Other|2|||
125185769|NCT00460603|450300843|FG006|Phase 1|Other|0|||
125185770|NCT00460603|450300844|FG007|Phase 1|Other|1|||
125185771|NCT00460603|450300845|FG008|Phase 1|Other|0|||
125185772|NCT00460603|450300846|FG009|Phase 1|Other|0|||
125185773|NCT00460603|450300847|FG010|Phase 1|Other|0|||
125185774|NCT00460603|450300848|FG011|Phase 1|Other|0|||
125185775|NCT00460603|450300837|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125185776|NCT00460603|450300838|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125185777|NCT00460603|450300839|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125185778|NCT00460603|450300840|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125185779|NCT00460603|450300841|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125185780|NCT00460603|450300842|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125185781|NCT00460603|450300843|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125185782|NCT00460603|450300844|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125185783|NCT00460603|450300845|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125185784|NCT00460603|450300846|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
125185785|NCT00460603|450300847|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125185786|NCT00460603|450300848|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125239151|NCT03314935|450500493|FG003|Phase 2|Withdrawal by Subject|0|||
125239152|NCT03314935|450500494|FG004|Phase 2|Withdrawal by Subject|0|||
125239153|NCT03314935|450500495|FG005|Phase 2|Withdrawal by Subject|0|||
125239154|NCT03314935|450500496|FG006|Phase 2|Withdrawal by Subject|0|||
125239155|NCT03314935|450500497|FG007|Phase 2|Withdrawal by Subject|0|||
125239156|NCT03314935|450500498|FG008|Phase 2|Withdrawal by Subject|0|||
125185787|NCT00460603|450300837|FG000|Phase 2|Adverse Event|0|||
125185788|NCT00460603|450300838|FG001|Phase 2|Adverse Event|0|||
125185789|NCT00460603|450300839|FG002|Phase 2|Adverse Event|0|||
125185790|NCT00460603|450300840|FG003|Phase 2|Adverse Event|0|||
125185791|NCT00460603|450300841|FG004|Phase 2|Adverse Event|0|||
125185792|NCT00460603|450300842|FG005|Phase 2|Adverse Event|0|||
125185793|NCT00460603|450300843|FG006|Phase 2|Adverse Event|0|||
125185794|NCT00460603|450300844|FG007|Phase 2|Adverse Event|0|||
125185795|NCT00460603|450300845|FG008|Phase 2|Adverse Event|0|||
125239157|NCT03314935|450500499|FG009|Phase 2|Withdrawal by Subject|1|||
125239158|NCT03314935|450500500|FG010|Phase 2|Withdrawal by Subject|4|||
125239159|NCT03314935|450500501|FG011|Phase 2|Withdrawal by Subject|0|||
125239160|NCT03314935|450500502|FG012|Phase 2|Withdrawal by Subject|1|||
125239161|NCT03314935|450500503|FG013|Phase 2|Withdrawal by Subject|0|||
125185796|NCT00460603|450300846|FG009|Phase 2|Adverse Event|12|||
125185797|NCT00460603|450300847|FG010|Phase 2|Adverse Event|9|||
125185798|NCT00460603|450300848|FG011|Phase 2|Adverse Event|10|||
125185799|NCT00460603|450300837|FG000|Phase 2|Death|0|||
125185800|NCT00460603|450300838|FG001|Phase 2|Death|0|||
125185801|NCT00460603|450300839|FG002|Phase 2|Death|0|||
125185802|NCT00460603|450300840|FG003|Phase 2|Death|0|||
125185803|NCT00460603|450300841|FG004|Phase 2|Death|0|||
125185804|NCT00460603|450300842|FG005|Phase 2|Death|0|||
125185805|NCT00460603|450300843|FG006|Phase 2|Death|0|||
125185806|NCT00460603|450300844|FG007|Phase 2|Death|0|||
125185807|NCT00460603|450300845|FG008|Phase 2|Death|0|||
125185808|NCT00460603|450300846|FG009|Phase 2|Death|4|||
125185809|NCT00460603|450300847|FG010|Phase 2|Death|2|||
125185810|NCT00460603|450300848|FG011|Phase 2|Death|2|||
125185811|NCT00460603|450300837|FG000|Phase 2|Protocol Violation|0|||
125185812|NCT00460603|450300838|FG001|Phase 2|Protocol Violation|0|||
125185813|NCT00460603|450300839|FG002|Phase 2|Protocol Violation|0|||
125185814|NCT00460603|450300840|FG003|Phase 2|Protocol Violation|0|||
125185815|NCT00460603|450300841|FG004|Phase 2|Protocol Violation|0|||
125185816|NCT00460603|450300842|FG005|Phase 2|Protocol Violation|0|||
125185817|NCT00460603|450300843|FG006|Phase 2|Protocol Violation|0|||
125185818|NCT00460603|450300844|FG007|Phase 2|Protocol Violation|0|||
125185819|NCT00460603|450300845|FG008|Phase 2|Protocol Violation|0|||
125185820|NCT00460603|450300846|FG009|Phase 2|Protocol Violation|1|||
125185821|NCT00460603|450300847|FG010|Phase 2|Protocol Violation|1|||
125185822|NCT00460603|450300848|FG011|Phase 2|Protocol Violation|0|||
125185823|NCT00460603|450300837|FG000|Phase 2|Lost to Follow-up|0|||
125185824|NCT00460603|450300838|FG001|Phase 2|Lost to Follow-up|0|||
125185825|NCT00460603|450300839|FG002|Phase 2|Lost to Follow-up|0|||
125185826|NCT00460603|450300840|FG003|Phase 2|Lost to Follow-up|0|||
125185827|NCT00460603|450300841|FG004|Phase 2|Lost to Follow-up|0|||
125185828|NCT00460603|450300842|FG005|Phase 2|Lost to Follow-up|0|||
125185829|NCT00460603|450300843|FG006|Phase 2|Lost to Follow-up|0|||
125185830|NCT00460603|450300844|FG007|Phase 2|Lost to Follow-up|0|||
125185831|NCT00460603|450300845|FG008|Phase 2|Lost to Follow-up|0|||
125185832|NCT00460603|450300846|FG009|Phase 2|Lost to Follow-up|1|||
125185833|NCT00460603|450300847|FG010|Phase 2|Lost to Follow-up|0|||
125185834|NCT00460603|450300848|FG011|Phase 2|Lost to Follow-up|0|||
125185835|NCT00460603|450300837|FG000|Phase 2|Other|0|||
125185836|NCT00460603|450300838|FG001|Phase 2|Other|0|||
125185837|NCT00460603|450300839|FG002|Phase 2|Other|0|||
125185838|NCT00460603|450300840|FG003|Phase 2|Other|0|||
125185839|NCT00460603|450300841|FG004|Phase 2|Other|0|||
125185840|NCT00460603|450300842|FG005|Phase 2|Other|0|||
125185841|NCT00460603|450300843|FG006|Phase 2|Other|0|||
125185842|NCT00460603|450300844|FG007|Phase 2|Other|0|||
125185843|NCT00460603|450300845|FG008|Phase 2|Other|0|||
125185844|NCT00460603|450300846|FG009|Phase 2|Other|6|||
125185845|NCT00460603|450300847|FG010|Phase 2|Other|16|||
125185846|NCT00460603|450300848|FG011|Phase 2|Other|7|||
125185847|NCT00460603|450300837|FG000|Phase 2|Objective Progression or Relapse|0|||
125185848|NCT00460603|450300838|FG001|Phase 2|Objective Progression or Relapse|0|||
125185849|NCT00460603|450300839|FG002|Phase 2|Objective Progression or Relapse|0|||
125185850|NCT00460603|450300840|FG003|Phase 2|Objective Progression or Relapse|0|||
125185851|NCT00460603|450300841|FG004|Phase 2|Objective Progression or Relapse|0|||
125185852|NCT00460603|450300842|FG005|Phase 2|Objective Progression or Relapse|0|||
125185853|NCT00460603|450300843|FG006|Phase 2|Objective Progression or Relapse|0|||
125185854|NCT00460603|450300844|FG007|Phase 2|Objective Progression or Relapse|0|||
125185855|NCT00460603|450300845|FG008|Phase 2|Objective Progression or Relapse|0|||
125185856|NCT00460603|450300846|FG009|Phase 2|Objective Progression or Relapse|9|||
125185857|NCT00460603|450300847|FG010|Phase 2|Objective Progression or Relapse|10|||
125185858|NCT00460603|450300848|FG011|Phase 2|Objective Progression or Relapse|17|||
125185859|NCT00460603|450300837|FG000|Phase 2|Global Deterioration of Health Status|0|||
125185860|NCT00460603|450300838|FG001|Phase 2|Global Deterioration of Health Status|0|||
125185861|NCT00460603|450300839|FG002|Phase 2|Global Deterioration of Health Status|0|||
125185862|NCT00460603|450300840|FG003|Phase 2|Global Deterioration of Health Status|0|||
125185863|NCT00460603|450300841|FG004|Phase 2|Global Deterioration of Health Status|0|||
125185864|NCT00460603|450300842|FG005|Phase 2|Global Deterioration of Health Status|0|||
125185865|NCT00460603|450300843|FG006|Phase 2|Global Deterioration of Health Status|0|||
125185866|NCT00460603|450300844|FG007|Phase 2|Global Deterioration of Health Status|0|||
125185867|NCT00460603|450300845|FG008|Phase 2|Global Deterioration of Health Status|0|||
125185868|NCT00460603|450300846|FG009|Phase 2|Global Deterioration of Health Status|0|||
125185869|NCT00460603|450300847|FG010|Phase 2|Global Deterioration of Health Status|1|||
125185870|NCT00460603|450300848|FG011|Phase 2|Global Deterioration of Health Status|0|||
125185871|NCT00460603|450300837|FG000|Phase 2|Withdrawal by Subject|0|||
125185872|NCT00460603|450300838|FG001|Phase 2|Withdrawal by Subject|0|||
125185873|NCT00460603|450300839|FG002|Phase 2|Withdrawal by Subject|0|||
125185874|NCT00460603|450300840|FG003|Phase 2|Withdrawal by Subject|0|||
125185875|NCT00460603|450300841|FG004|Phase 2|Withdrawal by Subject|0|||
125185876|NCT00460603|450300842|FG005|Phase 2|Withdrawal by Subject|0|||
125185877|NCT00460603|450300843|FG006|Phase 2|Withdrawal by Subject|0|||
125185878|NCT00460603|450300844|FG007|Phase 2|Withdrawal by Subject|0|||
125239162|NCT03314935|450500504|FG014|Phase 2|Withdrawal by Subject|1|||
125239163|NCT03314935|450500490|FG000|Phase 2|Progressive Disease|0|||
125239164|NCT03314935|450500491|FG001|Phase 2|Progressive Disease|0|||
125239165|NCT03314935|450500492|FG002|Phase 2|Progressive Disease|0|||
125239166|NCT03314935|450500493|FG003|Phase 2|Progressive Disease|0|||
125239167|NCT03314935|450500494|FG004|Phase 2|Progressive Disease|0|||
125239168|NCT03314935|450500495|FG005|Phase 2|Progressive Disease|0|||
125239169|NCT03314935|450500496|FG006|Phase 2|Progressive Disease|0|||
125239170|NCT03314935|450500497|FG007|Phase 2|Progressive Disease|0|||
125239171|NCT03314935|450500498|FG008|Phase 2|Progressive Disease|0|||
125239172|NCT03314935|450500499|FG009|Phase 2|Progressive Disease|1|||
125239173|NCT03314935|450500500|FG010|Phase 2|Progressive Disease|1|||
125239174|NCT03314935|450500501|FG011|Phase 2|Progressive Disease|1|||
125239175|NCT03314935|450500502|FG012|Phase 2|Progressive Disease|2|||
125239176|NCT03314935|450500503|FG013|Phase 2|Progressive Disease|0|||
125239177|NCT03314935|450500504|FG014|Phase 2|Progressive Disease|1|||
125239178|NCT03314935|450500490|FG000|Phase 2|Study Terminated by Sponsor|0|||
125239179|NCT03314935|450500491|FG001|Phase 2|Study Terminated by Sponsor|0|||
125239180|NCT03314935|450500492|FG002|Phase 2|Study Terminated by Sponsor|0|||
125239181|NCT03314935|450500493|FG003|Phase 2|Study Terminated by Sponsor|0|||
125239182|NCT03314935|450500494|FG004|Phase 2|Study Terminated by Sponsor|0|||
125239183|NCT03314935|450500495|FG005|Phase 2|Study Terminated by Sponsor|0|||
125239184|NCT03314935|450500496|FG006|Phase 2|Study Terminated by Sponsor|0|||
125239185|NCT03314935|450500497|FG007|Phase 2|Study Terminated by Sponsor|0|||
125239186|NCT03314935|450500498|FG008|Phase 2|Study Terminated by Sponsor|0|||
125239187|NCT03314935|450500499|FG009|Phase 2|Study Terminated by Sponsor|0|||
125239188|NCT03314935|450500500|FG010|Phase 2|Study Terminated by Sponsor|7|||
125239189|NCT03314935|450500501|FG011|Phase 2|Study Terminated by Sponsor|2|||
125239190|NCT03314935|450500502|FG012|Phase 2|Study Terminated by Sponsor|1|||
125239191|NCT03314935|450500503|FG013|Phase 2|Study Terminated by Sponsor|4|||
125239192|NCT03314935|450500504|FG014|Phase 2|Study Terminated by Sponsor|4|||
125239193|NCT03314935|450500490|FG000|Phase 2|Lost to Follow-up|0|||
125239194|NCT03314935|450500491|FG001|Phase 2|Lost to Follow-up|0|||
125239195|NCT03314935|450500492|FG002|Phase 2|Lost to Follow-up|0|||
125239196|NCT03314935|450500493|FG003|Phase 2|Lost to Follow-up|0|||
125239197|NCT03314935|450500494|FG004|Phase 2|Lost to Follow-up|0|||
125239198|NCT03314935|450500495|FG005|Phase 2|Lost to Follow-up|0|||
125239199|NCT03314935|450500496|FG006|Phase 2|Lost to Follow-up|0|||
125239200|NCT03314935|450500497|FG007|Phase 2|Lost to Follow-up|0|||
125239201|NCT03314935|450500498|FG008|Phase 2|Lost to Follow-up|0|||
125239202|NCT03314935|450500499|FG009|Phase 2|Lost to Follow-up|1|||
125239203|NCT03314935|450500500|FG010|Phase 2|Lost to Follow-up|0|||
125239204|NCT03314935|450500501|FG011|Phase 2|Lost to Follow-up|0|||
125239205|NCT03314935|450500502|FG012|Phase 2|Lost to Follow-up|0|||
125239206|NCT03314935|450500503|FG013|Phase 2|Lost to Follow-up|0|||
125239207|NCT03314935|450500504|FG014|Phase 2|Lost to Follow-up|1|||
125239208|NCT03314935|450500490|FG000|Phase 2|Physician Decision|0|||
125239209|NCT03314935|450500491|FG001|Phase 2|Physician Decision|0|||
125239210|NCT03314935|450500492|FG002|Phase 2|Physician Decision|0|||
125239211|NCT03314935|450500493|FG003|Phase 2|Physician Decision|0|||
125239212|NCT03314935|450500494|FG004|Phase 2|Physician Decision|0|||
125239213|NCT03314935|450500495|FG005|Phase 2|Physician Decision|0|||
125239214|NCT03314935|450500496|FG006|Phase 2|Physician Decision|0|||
125239215|NCT03314935|450500497|FG007|Phase 2|Physician Decision|0|||
125239216|NCT03314935|450500498|FG008|Phase 2|Physician Decision|0|||
125239217|NCT03314935|450500499|FG009|Phase 2|Physician Decision|0|||
125239218|NCT03314935|450500500|FG010|Phase 2|Physician Decision|1|||
125239219|NCT03314935|450500501|FG011|Phase 2|Physician Decision|0|||
125239220|NCT03314935|450500502|FG012|Phase 2|Physician Decision|0|||
125239221|NCT03314935|450500503|FG013|Phase 2|Physician Decision|0|||
125239222|NCT03314935|450500504|FG014|Phase 2|Physician Decision|0|||
125239223|NCT03785366|450500509|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
125239224|NCT03785366|450500510|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
125239225|NCT03785366|450500509|FG000|Overall Study|Lost to Follow-up|1|||
125239226|NCT03785366|450500510|FG001|Overall Study|Lost to Follow-up|0|||
125239227|NCT03785366|450500509|FG000|Overall Study|Partial IUD Expulsion|0|||
125239228|NCT03785366|450500510|FG001|Overall Study|Partial IUD Expulsion|2|||
125239229|NCT03785366|450500509|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
125239230|NCT03785366|450500510|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
125239231|NCT00569127|450500511|FG000|Overall Study|Adverse Event|57|||
125239232|NCT00569127|450500512|FG001|Overall Study|Adverse Event|47|||
125239233|NCT00569127|450500511|FG000|Overall Study|Withdrawal by Subject|13|||
125239234|NCT00569127|450500512|FG001|Overall Study|Withdrawal by Subject|27|||
125239235|NCT00569127|450500511|FG000|Overall Study|Progression|99|||
125239236|NCT00569127|450500512|FG001|Overall Study|Progression|100|||
125239237|NCT00569127|450500511|FG000|Overall Study|Death|4|||
125239238|NCT00569127|450500512|FG001|Overall Study|Death|3|||
125239239|NCT00569127|450500511|FG000|Overall Study|Other|20|||
125239240|NCT00569127|450500512|FG001|Overall Study|Other|19|||
125239241|NCT00569127|450500511|FG000|Overall Study|Lost to Follow-up|0|||
125239242|NCT00569127|450500512|FG001|Overall Study|Lost to Follow-up|3|||
125239243|NCT00569127|450500511|FG000|Overall Study|Not Eligible|14|||
125239244|NCT00569127|450500512|FG001|Overall Study|Not Eligible|11|||
125239245|NCT00569127|450500511|FG000|Overall Study|Still on Treatment|7|||
125239246|NCT00569127|450500512|FG001|Overall Study|Still on Treatment|3|||
125239247|NCT04279522|450500514|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
125239248|NCT04279522|450500515|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
125239249|NCT04279522|450500514|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
125239250|NCT04279522|450500515|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
125239251|NCT04279522|450500514|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
125239252|NCT04279522|450500515|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
125239253|NCT04279522|450500514|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
125239254|NCT04279522|450500515|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
125239255|NCT04279522|450500514|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
125239256|NCT04279522|450500515|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
125239257|NCT04279522|450500514|FG000|Period 2: Open Label Phase|Physician Decision|0|||
125239258|NCT04279522|450500515|FG001|Period 2: Open Label Phase|Physician Decision|3|||
125239259|NCT04279522|450500514|FG000|Period 2: Open Label Phase|Adverse Event|0|||
125239260|NCT04279522|450500515|FG001|Period 2: Open Label Phase|Adverse Event|1|||
125239261|NCT04279522|450500514|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
125239262|NCT04279522|450500515|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
125239263|NCT02452190|450501923|FG000|Overall Study|Withdrawal by Sponsor|1|||
125239264|NCT02452190|450501924|FG001|Overall Study|Withdrawal by Sponsor|3|||
125239265|NCT02452190|450501923|FG000|Overall Study|Pregnancy|1|||
125239266|NCT02452190|450501924|FG001|Overall Study|Pregnancy|0|||
125239267|NCT02452190|450501923|FG000|Overall Study|Investigator's Decision|2|||
125239268|NCT02452190|450501924|FG001|Overall Study|Investigator's Decision|0|||
125239269|NCT02452190|450501923|FG000|Overall Study|Lack of Efficacy|3|||
125239270|NCT02452190|450501924|FG001|Overall Study|Lack of Efficacy|1|||
125239271|NCT02452190|450501923|FG000|Overall Study|Lost to Follow-up|4|||
125239272|NCT02452190|450501924|FG001|Overall Study|Lost to Follow-up|3|||
125239273|NCT02452190|450501923|FG000|Overall Study|Adverse Event|2|||
125239274|NCT02452190|450501924|FG001|Overall Study|Adverse Event|5|||
125239275|NCT02452190|450501923|FG000|Overall Study|Withdrawal by Subject|20|||
125239276|NCT02452190|450501924|FG001|Overall Study|Withdrawal by Subject|11|||
125239277|NCT02452190|450501923|FG000|Overall Study|Noncompliance with study drug|1|||
125239278|NCT02452190|450501924|FG001|Overall Study|Noncompliance with study drug|0|||
125239279|NCT02452190|450501923|FG000|Overall Study|Participant traveled abroad|1|||
125239280|NCT02452190|450501924|FG001|Overall Study|Participant traveled abroad|0|||
125239281|NCT02452190|450501923|FG000|Overall Study|Death|0|||
125239282|NCT02452190|450501924|FG001|Overall Study|Death|1|||
125239283|NCT03112603|450501926|FG000|End of Randomization Period|Lost to Follow-up|3|||
125239284|NCT03112603|450501927|FG001|End of Randomization Period|Lost to Follow-up|0|||
125239285|NCT03112603|450501928|FG002|End of Randomization Period|Lost to Follow-up|0|||
125239286|NCT03112603|450501926|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
125239287|NCT03112603|450501927|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
125239288|NCT03112603|450501928|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
125239289|NCT03112603|450501926|FG000|End of Randomization Period|Physician Decision|43|||
125239290|NCT03112603|450501927|FG001|End of Randomization Period|Physician Decision|18|||
125239291|NCT03112603|450501928|FG002|End of Randomization Period|Physician Decision|0|||
125239292|NCT03112603|450501926|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
125239293|NCT03112603|450501927|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
125239294|NCT03112603|450501928|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
125239295|NCT03112603|450501926|FG000|End of Randomization Period|Death|10|||
125239296|NCT03112603|450501927|FG001|End of Randomization Period|Death|7|||
125239297|NCT03112603|450501928|FG002|End of Randomization Period|Death|0|||
125239298|NCT03112603|450501926|FG000|End of Randomization Period|Disease Relapse|12|||
125239299|NCT03112603|450501927|FG001|End of Randomization Period|Disease Relapse|7|||
125239300|NCT03112603|450501928|FG002|End of Randomization Period|Disease Relapse|0|||
125239301|NCT03112603|450501926|FG000|End of Randomization Period|Lack of Efficacy|25|||
125239302|NCT03112603|450501927|FG001|End of Randomization Period|Lack of Efficacy|77|||
125239303|NCT03112603|450501928|FG002|End of Randomization Period|Lack of Efficacy|0|||
125239304|NCT03112603|450501926|FG000|End of Randomization Period|Adverse Event|32|||
125239305|NCT03112603|450501927|FG001|End of Randomization Period|Adverse Event|12|||
125239306|NCT03112603|450501928|FG002|End of Randomization Period|Adverse Event|0|||
125239307|NCT03112603|450501926|FG000|End of Cross Over Period|Death|0|||
125239308|NCT03112603|450501927|FG001|End of Cross Over Period|Death|0|||
125239309|NCT03112603|450501928|FG002|End of Cross Over Period|Death|2|||
125239310|NCT03112603|450501926|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
125239311|NCT03112603|450501927|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
125239312|NCT03112603|450501928|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
125239313|NCT03112603|450501926|FG000|End of Cross Over Period|Physician Decision|0|||
125239314|NCT03112603|450501927|FG001|End of Cross Over Period|Physician Decision|0|||
125185879|NCT00460603|450300845|FG008|Phase 2|Withdrawal by Subject|0|||
125185880|NCT00460603|450300846|FG009|Phase 2|Withdrawal by Subject|5|||
125185881|NCT00460603|450300847|FG010|Phase 2|Withdrawal by Subject|4|||
125185882|NCT00460603|450300848|FG011|Phase 2|Withdrawal by Subject|5|||
125185883|NCT00460603|450300837|FG000|Phase 2|Randomized, but not treated|0|||
125185884|NCT00460603|450300838|FG001|Phase 2|Randomized, but not treated|0|||
125185885|NCT00460603|450300839|FG002|Phase 2|Randomized, but not treated|0|||
125185886|NCT00460603|450300840|FG003|Phase 2|Randomized, but not treated|0|||
125185887|NCT00460603|450300841|FG004|Phase 2|Randomized, but not treated|0|||
125185888|NCT00460603|450300842|FG005|Phase 2|Randomized, but not treated|0|||
125185889|NCT00460603|450300843|FG006|Phase 2|Randomized, but not treated|0|||
125185890|NCT00460603|450300844|FG007|Phase 2|Randomized, but not treated|0|||
125185891|NCT00460603|450300845|FG008|Phase 2|Randomized, but not treated|0|||
125185892|NCT00460603|450300846|FG009|Phase 2|Randomized, but not treated|3|||
125185893|NCT00460603|450300847|FG010|Phase 2|Randomized, but not treated|0|||
125185894|NCT00460603|450300848|FG011|Phase 2|Randomized, but not treated|0|||
125185895|NCT00513240|450300849|FG000|Overall Study|Did not have intended surgery|3|||
125185896|NCT00513240|450300850|FG001|Overall Study|Did not have intended surgery|0|||
125185897|NCT00513240|450300849|FG000|Overall Study|Death|3|||
125185898|NCT00513240|450300850|FG001|Overall Study|Death|3|||
125185899|NCT00513240|450300849|FG000|Overall Study|Withdrawal by Subject|7|||
125185900|NCT00513240|450300850|FG001|Overall Study|Withdrawal by Subject|4|||
125185901|NCT05263908|450300851|FG000|Overall Study|No informed consent for publication of study results|397|||
125185902|NCT05263908|450300851|FG000|Overall Study|CRF not collected|1|||
125185903|NCT00289848|450300852|FG000|Overall Study|Adverse Event|6|||
125185904|NCT00289848|450300853|FG001|Overall Study|Adverse Event|4|||
125185905|NCT00289848|450300852|FG000|Overall Study|Death|1|||
125185906|NCT00289848|450300853|FG001|Overall Study|Death|0|||
125185907|NCT00289848|450300852|FG000|Overall Study|Lack of Efficacy|20|||
125185908|NCT00289848|450300853|FG001|Overall Study|Lack of Efficacy|24|||
125185909|NCT00289848|450300852|FG000|Overall Study|Lost to Follow-up|3|||
125185910|NCT00289848|450300853|FG001|Overall Study|Lost to Follow-up|1|||
125185911|NCT00289848|450300852|FG000|Overall Study|Protocol Violation|5|||
125185912|NCT00289848|450300853|FG001|Overall Study|Protocol Violation|2|||
125185913|NCT00289848|450300852|FG000|Overall Study|Withdrawal by Subject|5|||
125185914|NCT00289848|450300853|FG001|Overall Study|Withdrawal by Subject|11|||
125185915|NCT00289848|450300852|FG000|Overall Study|Patient Moved|6|||
125185916|NCT00289848|450300853|FG001|Overall Study|Patient Moved|2|||
125185917|NCT00289848|450300852|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
125185918|NCT00289848|450300853|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
125185919|NCT03871543|450300857|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
125185920|NCT03871543|450300857|FG000|Period 1|Investigator Error|1|||
125185921|NCT03871543|450300857|FG000|Period 1|Protocol Violation|2|||
125185922|NCT03871543|450300857|FG000|Period 1|COVID-19 Related|1|||
125185923|NCT03871543|450300857|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
125185924|NCT03871543|450300857|FG000|Period 1|Withdrawal by Subject|10|||
125185925|NCT03871543|450300857|FG000|Period 2|Adverse Event|1|||
125185926|NCT03871543|450300857|FG000|Period 2|Withdrawal by Subject|1|||
125185927|NCT01930162|450300859|FG000|Overall Study|Abnormal test procedure result(s)|4|||
125185928|NCT01930162|450300859|FG000|Overall Study|Death|1|||
125185929|NCT00031590|450300861|FG000|Overall Study|Adverse Event|1|||
125185930|NCT00031590|450300861|FG000|Overall Study|Withdrawal by parents|2|||
125185931|NCT00923013|450300867|FG000|Overall Study|Refused further treatment|0|||
125185932|NCT00923013|450300868|FG001|Overall Study|Refused further treatment|1|||
125185933|NCT00923013|450300869|FG002|Overall Study|Refused further treatment|2|||
125185934|NCT00923013|450300870|FG003|Overall Study|Refused further treatment|0|||
125185935|NCT00923013|450300871|FG004|Overall Study|Refused further treatment|0|||
125185936|NCT00923013|450300872|FG005|Overall Study|Refused further treatment|0|||
125185937|NCT00923013|450300867|FG000|Overall Study|Switched to alternative treatment|0|||
125185938|NCT00923013|450300868|FG001|Overall Study|Switched to alternative treatment|1|||
125185939|NCT00923013|450300869|FG002|Overall Study|Switched to alternative treatment|0|||
125185940|NCT00923013|450300870|FG003|Overall Study|Switched to alternative treatment|0|||
125185941|NCT00923013|450300871|FG004|Overall Study|Switched to alternative treatment|0|||
125185942|NCT00923013|450300872|FG005|Overall Study|Switched to alternative treatment|0|||
125185943|NCT00923013|450300867|FG000|Overall Study|Death on study|2|||
125185944|NCT00923013|450300868|FG001|Overall Study|Death on study|2|||
125185945|NCT00923013|450300869|FG002|Overall Study|Death on study|0|||
125185946|NCT00923013|450300870|FG003|Overall Study|Death on study|1|||
125185947|NCT00923013|450300871|FG004|Overall Study|Death on study|0|||
125185948|NCT00923013|450300872|FG005|Overall Study|Death on study|0|||
125185949|NCT02301169|450300875|FG000|Overall Study|Adverse Event|1|||
125185950|NCT02301169|450300876|FG001|Overall Study|Adverse Event|0|||
125185951|NCT01198470|450300881|FG000|Overall Study|Adverse Event|2|||
125185952|NCT02949973|450300882|FG000|Overall Study|Physician Decision|1|||
125185953|NCT01422213|450300883|FG000|Overall Study|Adverse Event|8|||
125185954|NCT01422213|450300884|FG001|Overall Study|Adverse Event|7|||
125185955|NCT01422213|450300885|FG002|Overall Study|Adverse Event|11|||
125185956|NCT01422213|450300883|FG000|Overall Study|Lack of Efficacy|10|||
125185957|NCT01422213|450300884|FG001|Overall Study|Lack of Efficacy|2|||
125185958|NCT01422213|450300885|FG002|Overall Study|Lack of Efficacy|2|||
125185959|NCT01422213|450300883|FG000|Overall Study|Non-compliance with study drug|0|||
125185960|NCT01422213|450300884|FG001|Overall Study|Non-compliance with study drug|1|||
125185961|NCT01422213|450300885|FG002|Overall Study|Non-compliance with study drug|0|||
125185962|NCT01422213|450300883|FG000|Overall Study|Protocol Violation|0|||
125185963|NCT01422213|450300884|FG001|Overall Study|Protocol Violation|2|||
125185964|NCT01422213|450300885|FG002|Overall Study|Protocol Violation|4|||
125185965|NCT01422213|450300883|FG000|Overall Study|Withdrawal of Consent|7|||
125185966|NCT01422213|450300884|FG001|Overall Study|Withdrawal of Consent|3|||
125185967|NCT01422213|450300885|FG002|Overall Study|Withdrawal of Consent|5|||
125185968|NCT01422213|450300883|FG000|Overall Study|Lost to Follow-up|3|||
125185969|NCT01422213|450300884|FG001|Overall Study|Lost to Follow-up|3|||
125185970|NCT01422213|450300885|FG002|Overall Study|Lost to Follow-up|5|||
125185971|NCT01422213|450300883|FG000|Overall Study|Administrative or Other Reason(s)|5|||
125185972|NCT01422213|450300884|FG001|Overall Study|Administrative or Other Reason(s)|4|||
125185973|NCT01422213|450300885|FG002|Overall Study|Administrative or Other Reason(s)|2|||
125185974|NCT04129125|450300892|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
125185975|NCT04129125|450300892|FG000|Overall Study|Study device was not used|3|||
125185976|NCT04484142|450300893|FG000|Overall Study|Adverse Event|13|||
125185977|NCT04484142|450300893|FG000|Overall Study|Progressive Disease|87|||
125185978|NCT04484142|450300893|FG000|Overall Study|Clinical Progression|10|||
125185979|NCT04484142|450300893|FG000|Overall Study|Withdrawal by Subject|6|||
125185980|NCT04484142|450300893|FG000|Overall Study|Physician Decision|1|||
125185981|NCT02723344|450300894|FG000|Overall Study|Lost to Follow-up|0|||
125185982|NCT02723344|450300895|FG001|Overall Study|Lost to Follow-up|4|||
125185983|NCT02964247|450300898|FG000|Overall Study|Lost to Follow-up|2|||
125185984|NCT02964247|450300899|FG001|Overall Study|Lost to Follow-up|0|||
125185985|NCT02964247|450300898|FG000|Overall Study|Withdrawal by Subject|1|||
125185986|NCT02964247|450300899|FG001|Overall Study|Withdrawal by Subject|2|||
125185987|NCT00740636|450300902|FG000|Overall Study|Adverse Event|0|||
125185988|NCT00740636|450300903|FG001|Overall Study|Adverse Event|2|||
125185989|NCT00740636|450300902|FG000|Overall Study|Patient Ineligible|0|||
125185990|NCT00740636|450300903|FG001|Overall Study|Patient Ineligible|1|||
125185991|NCT00740636|450300902|FG000|Overall Study|Patient Not Treated|0|||
125185992|NCT00740636|450300903|FG001|Overall Study|Patient Not Treated|1|||
125185993|NCT00740636|450300902|FG000|Overall Study|Progressive Disease|1|||
125185994|NCT00740636|450300903|FG001|Overall Study|Progressive Disease|0|||
125185995|NCT00740636|450300902|FG000|Overall Study|Death|1|||
125185996|NCT00740636|450300903|FG001|Overall Study|Death|0|||
125185997|NCT03832686|450300904|FG000|Overall Study|Lost to Follow-up|6|||
125185998|NCT03832686|450300905|FG001|Overall Study|Lost to Follow-up|9|||
125185999|NCT03832686|450300904|FG000|Overall Study|Discontinued Intervention|5|||
125186000|NCT03832686|450300905|FG001|Overall Study|Discontinued Intervention|4|||
125186001|NCT01609790|450300906|FG000|Overall Study|Protocol Violation|1|||
125186002|NCT01609790|450300907|FG001|Overall Study|Protocol Violation|7|||
125186003|NCT01609790|450300908|FG002|Overall Study|Protocol Violation|8|||
125186004|NCT00739882|450302359|FG000|Double-blind Period|Adverse Event|1|||
125186005|NCT00739882|450302360|FG001|Double-blind Period|Adverse Event|2|||
125186006|NCT00739882|450302359|FG000|Double-blind Period|Protocol Violation|1|||
125186007|NCT00739882|450302360|FG001|Double-blind Period|Protocol Violation|0|||
125186008|NCT00739882|450302359|FG000|Double-blind Period|Lack of Efficacy|1|||
125186009|NCT00739882|450302360|FG001|Double-blind Period|Lack of Efficacy|1|||
125186010|NCT00739882|450302359|FG000|Double-blind Period|Other|16|||
125186011|NCT00739882|450302360|FG001|Double-blind Period|Other|8|||
125186012|NCT00739882|450302359|FG000|Open-label Period|Adverse Event|1|||
125186013|NCT00739882|450302360|FG001|Open-label Period|Adverse Event|0|||
125186014|NCT00739882|450302359|FG000|Open-label Period|Other|9|||
125186015|NCT00739882|450302360|FG001|Open-label Period|Other|5|||
125186016|NCT01662635|450302361|FG000|Overall Study|scarce samples for evaluation|30|||
125186017|NCT02445248|450302362|FG000|Overall Study|Death|45|||
125186018|NCT02445248|450302363|FG001|Overall Study|Death|12|||
125186019|NCT02445248|450302362|FG000|Overall Study|Progressive disease|13|||
125186020|NCT02445248|450302363|FG001|Overall Study|Progressive disease|1|||
125186021|NCT02445248|450302362|FG000|Overall Study|Subject decision|8|||
125186022|NCT02445248|450302363|FG001|Overall Study|Subject decision|0|||
125186023|NCT02445248|450302362|FG000|Overall Study|Physician Decision|5|||
125186024|NCT02445248|450302363|FG001|Overall Study|Physician Decision|0|||
125239315|NCT03112603|450501928|FG002|End of Cross Over Period|Physician Decision|29|||
125239316|NCT03112603|450501926|FG000|End of Cross Over Period|Lack of Efficacy|0|||
125239317|NCT03112603|450501927|FG001|End of Cross Over Period|Lack of Efficacy|0|||
125239318|NCT03112603|450501928|FG002|End of Cross Over Period|Lack of Efficacy|8|||
125239319|NCT03112603|450501926|FG000|End of Cross Over Period|Adverse Event|0|||
125239320|NCT03112603|450501927|FG001|End of Cross Over Period|Adverse Event|0|||
125239321|NCT03112603|450501928|FG002|End of Cross Over Period|Adverse Event|6|||
125239322|NCT03112603|450501926|FG000|End of Cross Over Period|Disease Relapse|0|||
125239323|NCT03112603|450501927|FG001|End of Cross Over Period|Disease Relapse|0|||
125239324|NCT03112603|450501928|FG002|End of Cross Over Period|Disease Relapse|2|||
125239325|NCT03916926|450501932|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
125239326|NCT03916926|450501933|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
125239327|NCT03916926|450501932|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
125239328|NCT03916926|450501933|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
125239329|NCT03916926|450501932|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
125239330|NCT03916926|450501933|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
125239331|NCT03916926|450501932|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
125239332|NCT03916926|450501933|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
125239333|NCT03330197|450501934|FG000|Overall Study|Adverse Event|0|||
125239334|NCT03330197|450501935|FG001|Overall Study|Adverse Event|1|||
125239335|NCT03330197|450501934|FG000|Overall Study|Withdrawal by Subject|0|||
125239336|NCT03330197|450501935|FG001|Overall Study|Withdrawal by Subject|1|||
125239337|NCT04537299|450501936|FG000|Overall Study|Withdrawal by Subject|2|||
125239338|NCT04537299|450501937|FG001|Overall Study|Withdrawal by Subject|0|||
125239339|NCT04537299|450501936|FG000|Overall Study|Protocol Violation|1|||
125239340|NCT04537299|450501937|FG001|Overall Study|Protocol Violation|1|||
125239341|NCT03806296|450501938|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
125239342|NCT03806296|450501939|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
125239343|NCT03806296|450501940|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
125239344|NCT03806296|450501938|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
125239345|NCT03806296|450501939|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
125239346|NCT03806296|450501940|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
125239347|NCT03806296|450501938|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
125239348|NCT03806296|450501939|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
125239349|NCT03806296|450501940|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
125239350|NCT00876343|450501941|FG000|Overall Study|Adverse Event|7|||
125239351|NCT00876343|450501942|FG001|Overall Study|Adverse Event|8|||
125239352|NCT00876343|450501943|FG002|Overall Study|Adverse Event|2|||
125239353|NCT00876343|450501941|FG000|Overall Study|Withdrawal by Subject|4|||
125239354|NCT00876343|450501942|FG001|Overall Study|Withdrawal by Subject|4|||
125239355|NCT00876343|450501943|FG002|Overall Study|Withdrawal by Subject|3|||
125239356|NCT00876343|450501941|FG000|Overall Study|Lack of Efficacy|0|||
125239357|NCT00876343|450501942|FG001|Overall Study|Lack of Efficacy|0|||
125239358|NCT00876343|450501943|FG002|Overall Study|Lack of Efficacy|1|||
125239359|NCT00876343|450501941|FG000|Overall Study|Protocol Violation|4|||
125239360|NCT00876343|450501942|FG001|Overall Study|Protocol Violation|1|||
125239361|NCT00876343|450501943|FG002|Overall Study|Protocol Violation|1|||
125239362|NCT00876343|450501941|FG000|Overall Study|Physician Decision|0|||
125239363|NCT00876343|450501942|FG001|Overall Study|Physician Decision|1|||
125239364|NCT00876343|450501943|FG002|Overall Study|Physician Decision|1|||
125239365|NCT00876343|450501941|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
125239366|NCT00876343|450501942|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
125239367|NCT00876343|450501943|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
125239368|NCT00876343|450501941|FG000|Overall Study|Change of residence or other commitments|2|||
125239369|NCT00876343|450501942|FG001|Overall Study|Change of residence or other commitments|2|||
125239370|NCT00876343|450501943|FG002|Overall Study|Change of residence or other commitments|3|||
125239371|NCT04896385|450501944|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
125239372|NCT04896385|450501945|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
125239373|NCT04896385|450501946|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
125239374|NCT04896385|450501947|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
125239375|NCT04896385|450501944|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
125239376|NCT04896385|450501945|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
125239377|NCT04896385|450501946|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
125239378|NCT04896385|450501947|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
125239379|NCT04896385|450501944|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
125239380|NCT04896385|450501945|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
125239381|NCT04896385|450501946|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
125239382|NCT04896385|450501947|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
125239383|NCT04896385|450501944|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
125239384|NCT04896385|450501945|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
125239385|NCT04896385|450501946|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
125239386|NCT04896385|450501947|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
125239387|NCT04896385|450501944|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
125239388|NCT04896385|450501945|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
125239389|NCT04896385|450501946|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
125239390|NCT04896385|450501947|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
125239391|NCT04896385|450501944|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
125239392|NCT04896385|450501945|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
125239393|NCT04896385|450501946|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
125239394|NCT04896385|450501947|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
125239395|NCT01931098|450501951|FG000|Overall Study|Withdrawal by Subject|0|||
125239396|NCT01931098|450501952|FG001|Overall Study|Withdrawal by Subject|1|||
125239397|NCT01931098|450501951|FG000|Overall Study|Enrolled in different protocol|0|||
125239398|NCT01931098|450501952|FG001|Overall Study|Enrolled in different protocol|1|||
125239399|NCT01931098|450501951|FG000|Overall Study|Unable to begin trmt:active infection|0|||
125239400|NCT01931098|450501952|FG001|Overall Study|Unable to begin trmt:active infection|1|||
125239401|NCT01931098|450501951|FG000|Overall Study|Refused further treatment|0|||
125239402|NCT01931098|450501952|FG001|Overall Study|Refused further treatment|1|||
125239403|NCT01925794|450501959|FG000|180 Days|Death|2|||
125239404|NCT01925794|450501959|FG000|180 Days|Withdrawal by Subject|2|||
125239405|NCT01925794|450501959|FG000|270 Days|Death|2|||
125239406|NCT01925794|450501959|FG000|270 Days|Protocol Violation|3|||
125239407|NCT00790036|450501960|FG000|Overall Study|Abnormal lab values|3|||
125186025|NCT02445248|450302362|FG000|Overall Study|Adverse Event|1|||
125239408|NCT00790036|450501961|FG001|Overall Study|Abnormal lab values|2|||
125239409|NCT00790036|450501960|FG000|Overall Study|Administrative problems|5|||
125239410|NCT00790036|450501961|FG001|Overall Study|Administrative problems|9|||
125239411|NCT00790036|450501960|FG000|Overall Study|Adverse Event|113|||
125239412|NCT00790036|450501961|FG001|Overall Study|Adverse Event|44|||
125239413|NCT00790036|450501960|FG000|Overall Study|Death|1|||
125186026|NCT02445248|450302363|FG001|Overall Study|Adverse Event|0|||
125186027|NCT02445248|450302362|FG000|Overall Study|Lost to Follow-up|1|||
125186028|NCT02445248|450302363|FG001|Overall Study|Lost to Follow-up|0|||
125186029|NCT00351468|450302364|FG000|Overall Study|Adverse Event|42|||
125186030|NCT00351468|450302364|FG000|Overall Study|Withdrawal by Subject|39|||
125186031|NCT00351468|450302364|FG000|Overall Study|Various -follow up w clinical team|39|||
125186032|NCT00351468|450302364|FG000|Overall Study|Lack of Efficacy|32|||
125186033|NCT00351468|450302364|FG000|Overall Study|Non-compliance|8|||
125186034|NCT00351468|450302364|FG000|Overall Study|Lost to Follow-up|4|||
125186035|NCT00351468|450302364|FG000|Overall Study|Protocol Violation|3|||
125186036|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
125186037|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
125186038|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
125186039|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
125186040|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
125186041|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
125186042|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
125186043|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
125186044|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
125186045|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
125186046|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
125186047|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
125186048|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
125186049|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
125186050|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
125186051|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
125186052|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
125186053|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
125186054|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
125186055|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
125186056|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
125186057|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
125186058|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
125186059|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
125186060|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
125186061|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
125186062|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
125186063|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
125186064|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
125186065|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
125186066|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
125186067|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
125186068|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
125186069|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
125186070|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
125186071|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
125186072|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
125186073|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
125186074|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
125186075|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
125186076|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
125186077|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
125186078|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
125186079|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
125186080|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
125186081|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
125186082|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
125186083|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
125186084|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
125186085|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
125186086|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
125186087|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
125186088|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Site closed|0|||
125186089|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Site closed|0|||
125186090|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Site closed|1|||
125186091|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Site closed|0|||
125186092|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
125186093|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
125186094|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
125186095|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
125186096|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
125186097|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
125186098|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
125186099|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
125186100|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
125186101|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
125186102|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
125186103|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
125186104|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
125186105|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
125186106|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
125186107|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
125186108|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
125186109|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
125186110|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
125186111|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
125186112|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
125186113|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
125186114|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
125186115|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
125186116|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
125186117|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
125186118|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
125186119|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
125186120|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
125186121|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
125186122|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
125186123|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
125186124|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
125186125|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
125186126|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
125186127|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
125186128|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
125186129|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
125186130|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
125186131|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
125239414|NCT00790036|450501961|FG001|Overall Study|Death|0|||
125239415|NCT00790036|450501960|FG000|Overall Study|Disease progression|24|||
125186132|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
125186133|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
125186134|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
125186135|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
125186136|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
125186137|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
125186138|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
125186139|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
125186140|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
125186141|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
125186142|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
125186143|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
125186144|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|Missing|1|||
125186145|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|Missing|2|||
125186146|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|Missing|1|||
125186147|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|Missing|1|||
125186148|NCT04565145|450302369|FG000|Overall Study|Withdrawal by Subject|1|||
125186149|NCT04565145|450302370|FG001|Overall Study|Withdrawal by Subject|1|||
125186150|NCT03096314|450302371|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
125186151|NCT03096314|450302372|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
125186152|NCT00471822|450302373|FG000|Overall Study|Protocol Violation|2|||
125186153|NCT00683618|450302374|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
125186154|NCT00683618|450302375|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
125186155|NCT00683618|450302376|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
125186156|NCT00683618|450302374|FG000|Randomised Treatment Period|Protocol Violation|0|||
125186157|NCT00683618|450302375|FG001|Randomised Treatment Period|Protocol Violation|1|||
125186158|NCT00683618|450302376|FG002|Randomised Treatment Period|Protocol Violation|0|||
125186159|NCT00683618|450302374|FG000|Randomised Treatment Period|Adverse Event|2|||
125186160|NCT00683618|450302375|FG001|Randomised Treatment Period|Adverse Event|0|||
125186161|NCT00683618|450302376|FG002|Randomised Treatment Period|Adverse Event|2|||
125186162|NCT00683618|450302374|FG000|Randomised Treatment Period|Reason not provided|0|||
125186163|NCT00683618|450302375|FG001|Randomised Treatment Period|Reason not provided|0|||
125186164|NCT00683618|450302376|FG002|Randomised Treatment Period|Reason not provided|2|||
125186165|NCT00683618|450302374|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
125186166|NCT00683618|450302375|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
125186167|NCT00683618|450302376|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
125186168|NCT00683618|450302374|FG000|Extension Treatment Period|Adverse Event|1|||
125186169|NCT00683618|450302375|FG001|Extension Treatment Period|Adverse Event|0|||
125186170|NCT00683618|450302376|FG002|Extension Treatment Period|Adverse Event|0|||
125186171|NCT00683618|450302374|FG000|Extension Treatment Period|Protocol Violation|1|||
125186172|NCT00683618|450302375|FG001|Extension Treatment Period|Protocol Violation|0|||
125186173|NCT00683618|450302376|FG002|Extension Treatment Period|Protocol Violation|0|||
125186174|NCT04570670|450302377|FG000|Overall Study|Withdrawal by Subject|1|||
125186175|NCT04570670|450302378|FG001|Overall Study|Withdrawal by Subject|0|||
125186176|NCT01062425|450302379|FG000|Overall Study|Protocol Violation|3|||
125186177|NCT01062425|450302380|FG001|Overall Study|Protocol Violation|6|||
125186178|NCT03003962|450302381|FG000|Overall Study|Withdrawal by Subject|5|||
125186179|NCT03003962|450302382|FG001|Overall Study|Withdrawal by Subject|17|||
125186180|NCT03003962|450302381|FG000|Overall Study|Death|274|||
125186181|NCT03003962|450302382|FG001|Overall Study|Death|277|||
125186182|NCT03003962|450302381|FG000|Overall Study|Participants ongoing at DCO|55|||
125186183|NCT03003962|450302382|FG001|Overall Study|Participants ongoing at DCO|40|||
125186184|NCT02069015|450302384|FG000|Overall Study|Lost to Follow-up|39|||
125186185|NCT02069015|450302385|FG001|Overall Study|Lost to Follow-up|32|||
125186186|NCT02069015|450302384|FG000|Overall Study|Withdrawal by Subject|1|||
125186187|NCT02069015|450302385|FG001|Overall Study|Withdrawal by Subject|1|||
125186188|NCT01108718|450302388|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
125186189|NCT01108718|450302389|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
125186190|NCT00586703|450302392|FG000|Overall Study|Death|12|||
125186191|NCT03762265|450302397|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
125186192|NCT03762265|450302398|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
125186193|NCT03762265|450302397|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
125186194|NCT03762265|450302398|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
125186195|NCT03762265|450302397|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
125186196|NCT03762265|450302398|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
125186197|NCT03762265|450302397|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
125186198|NCT03762265|450302398|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
125186199|NCT03762265|450302397|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
125186200|NCT03762265|450302398|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
125186201|NCT03762265|450302397|FG000|BT Period: Weeks 1 to 37|Other|0|||
125186202|NCT03762265|450302398|FG001|BT Period: Weeks 1 to 37|Other|1|||
125186203|NCT03762265|450302397|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
125239416|NCT00790036|450501961|FG001|Overall Study|Disease progression|48|||
125239417|NCT00790036|450501960|FG000|Overall Study|Lost to Follow-up|1|||
125239418|NCT00790036|450501961|FG001|Overall Study|Lost to Follow-up|2|||
125239419|NCT00790036|450501960|FG000|Overall Study|Protocol Violation|10|||
125239420|NCT00790036|450501961|FG001|Overall Study|Protocol Violation|2|||
125239421|NCT00790036|450501960|FG000|Overall Study|Withdrawal by Subject|18|||
125239422|NCT00790036|450501961|FG001|Overall Study|Withdrawal by Subject|7|||
125239423|NCT00790036|450501960|FG000|Overall Study|Subject/guardian decision|20|||
125239424|NCT00790036|450501961|FG001|Overall Study|Subject/guardian decision|7|||
125239425|NCT02572167|450501962|FG000|Overall Study|Withdrawal by Subject|0|||
125239426|NCT02572167|450501963|FG001|Overall Study|Withdrawal by Subject|3|||
125239427|NCT02572167|450501964|FG002|Overall Study|Withdrawal by Subject|0|||
125239428|NCT02572167|450501962|FG000|Overall Study|Lost to Follow-up|2|||
125239429|NCT02572167|450501963|FG001|Overall Study|Lost to Follow-up|5|||
125239430|NCT02572167|450501964|FG002|Overall Study|Lost to Follow-up|3|||
125239431|NCT02572167|450501962|FG000|Overall Study|Death|0|||
125239432|NCT02572167|450501963|FG001|Overall Study|Death|8|||
125239433|NCT02572167|450501964|FG002|Overall Study|Death|3|||
125239434|NCT02572167|450501962|FG000|Overall Study|Did not meet inclusion criteria|0|||
125239435|NCT02572167|450501963|FG001|Overall Study|Did not meet inclusion criteria|0|||
125239436|NCT02572167|450501964|FG002|Overall Study|Did not meet inclusion criteria|1|||
125239437|NCT02572167|450501962|FG000|Overall Study|Study closure by Sponsor|4|||
125239438|NCT02572167|450501963|FG001|Overall Study|Study closure by Sponsor|40|||
125239439|NCT02572167|450501964|FG002|Overall Study|Study closure by Sponsor|24|||
125239440|NCT00005047|450501965|FG000|Overall Study|Withdrawal by Subject|12|||
125239441|NCT00005047|450501966|FG001|Overall Study|Withdrawal by Subject|0|||
125239442|NCT00005047|450501967|FG002|Overall Study|Withdrawal by Subject|0|||
125239443|NCT00005047|450501968|FG003|Overall Study|Withdrawal by Subject|0|||
125239444|NCT00005047|450501965|FG000|Overall Study|Adverse Event|5|||
125239445|NCT00005047|450501966|FG001|Overall Study|Adverse Event|0|||
125239446|NCT00005047|450501967|FG002|Overall Study|Adverse Event|0|||
125239447|NCT00005047|450501968|FG003|Overall Study|Adverse Event|0|||
125239448|NCT00005047|450501965|FG000|Overall Study|Lost to Follow-up|1|||
125239449|NCT00005047|450501966|FG001|Overall Study|Lost to Follow-up|0|||
125239450|NCT00005047|450501967|FG002|Overall Study|Lost to Follow-up|0|||
125239451|NCT00005047|450501968|FG003|Overall Study|Lost to Follow-up|0|||
125239452|NCT00005047|450501965|FG000|Overall Study|Lack of Efficacy|1|||
125239453|NCT00005047|450501966|FG001|Overall Study|Lack of Efficacy|0|||
125239454|NCT00005047|450501967|FG002|Overall Study|Lack of Efficacy|0|||
125239455|NCT00005047|450501968|FG003|Overall Study|Lack of Efficacy|0|||
125239456|NCT00088153|450501969|FG000|Overall Study|Physician Decision|3|||
125239457|NCT00088153|450501970|FG001|Overall Study|Physician Decision|3|||
125239458|NCT00088153|450501969|FG000|Overall Study|Withdrawal by Subject|10|||
125239459|NCT00088153|450501970|FG001|Overall Study|Withdrawal by Subject|10|||
125239460|NCT00088153|450501969|FG000|Overall Study|Lost to Follow-up|11|||
125239461|NCT00088153|450501970|FG001|Overall Study|Lost to Follow-up|12|||
125239462|NCT05248386|450501977|FG000|Overall Study|Technical problems|0|||
125239463|NCT05248386|450501978|FG001|Overall Study|Technical problems|1|||
125239464|NCT05248386|450501977|FG000|Overall Study|Withdrawal by Subject|15|||
125239465|NCT05248386|450501978|FG001|Overall Study|Withdrawal by Subject|10|||
125239466|NCT05248386|450501977|FG000|Overall Study|Physician Decision|0|||
125239467|NCT05248386|450501978|FG001|Overall Study|Physician Decision|1|||
125239468|NCT05248386|450501977|FG000|Overall Study|Adverse Event|2|||
125239469|NCT05248386|450501978|FG001|Overall Study|Adverse Event|4|||
125239470|NCT05248386|450501977|FG000|Overall Study|Other|1|||
125239471|NCT05248386|450501978|FG001|Overall Study|Other|0|||
125239472|NCT05248386|450501977|FG000|Overall Study|Lack of Efficacy|14|||
125239473|NCT05248386|450501978|FG001|Overall Study|Lack of Efficacy|12|||
125239474|NCT04967222|450501980|FG000|Randomized|Lost to Follow-up|0|||
125239475|NCT04967222|450501981|FG001|Randomized|Lost to Follow-up|1|||
125239476|NCT04967222|450501982|FG002|Randomized|Lost to Follow-up|1|||
125239477|NCT04967222|450501980|FG000|Randomized|Physician Decision|0|||
125239478|NCT04967222|450501981|FG001|Randomized|Physician Decision|0|||
125239479|NCT04967222|450501982|FG002|Randomized|Physician Decision|1|||
125239480|NCT04967222|450501980|FG000|Randomized|Withdrawal by Subject|0|||
125239481|NCT04967222|450501981|FG001|Randomized|Withdrawal by Subject|0|||
125239482|NCT04967222|450501982|FG002|Randomized|Withdrawal by Subject|2|||
125239483|NCT04967222|450501980|FG000|Randomized|abnormal finding in MRI|0|||
125239484|NCT04967222|450501981|FG001|Randomized|abnormal finding in MRI|2|||
125239485|NCT04967222|450501982|FG002|Randomized|abnormal finding in MRI|0|||
125239486|NCT01295944|450501983|FG000|Overall Study|Switched to alternative treatment|1|||
125239487|NCT01295944|450501983|FG000|Overall Study|Ineligible|9|||
125239488|NCT01295944|450501983|FG000|Overall Study|Withdrawal by Subject|1|||
125239489|NCT01295944|450501983|FG000|Overall Study|Participant chose to be treated in Peru|1|||
125239490|NCT01295944|450501983|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
125239491|NCT01295944|450501983|FG000|Overall Study|Physician Decision|1|||
125239492|NCT01295944|450501983|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
125239493|NCT01295944|450501983|FG000|Overall Study|Disease progression|4|||
125239494|NCT01295944|450501983|FG000|Overall Study|Transferred care before starting new treatment|1|||
125239495|NCT05168800|450501984|FG000|Time 1 Survey|Did not start T1 survey|182|||
125239496|NCT05168800|450501985|FG001|Time 1 Survey|Did not start T1 survey|150|||
125239497|NCT05168800|450501986|FG002|Time 1 Survey|Did not start T1 survey|140|||
125239498|NCT05168800|450501984|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
125239499|NCT05168800|450501985|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
125239500|NCT05168800|450501986|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
125239501|NCT05168800|450501984|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
125239502|NCT05168800|450501985|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
125239503|NCT05168800|450501986|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
125239504|NCT05168800|450501984|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
125239505|NCT05168800|450501985|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
125239506|NCT05168800|450501986|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
125239507|NCT05168800|450501984|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
125239508|NCT05168800|450501985|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
125239509|NCT05168800|450501986|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
125239510|NCT05168800|450501984|FG000|Time 1 Survey|Withdrawal by Subject|6|||
125239511|NCT05168800|450501985|FG001|Time 1 Survey|Withdrawal by Subject|3|||
125239512|NCT05168800|450501986|FG002|Time 1 Survey|Withdrawal by Subject|2|||
125239513|NCT05168800|450501984|FG000|Time 2 Survey|Already excluded at Time 1|228|||
125239514|NCT05168800|450501985|FG001|Time 2 Survey|Already excluded at Time 1|202|||
125239515|NCT05168800|450501986|FG002|Time 2 Survey|Already excluded at Time 1|173|||
125239516|NCT05168800|450501984|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
125239517|NCT05168800|450501985|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
125239518|NCT05168800|450501986|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
125239519|NCT05168800|450501984|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
125239520|NCT05168800|450501985|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
125239521|NCT05168800|450501986|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
125239522|NCT05168800|450501984|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
125239523|NCT05168800|450501985|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
125239524|NCT05168800|450501986|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
125239525|NCT05168800|450501984|FG000|Time 2 Survey|Withdrawal by Subject|1|||
125239526|NCT05168800|450501985|FG001|Time 2 Survey|Withdrawal by Subject|0|||
125239527|NCT05168800|450501986|FG002|Time 2 Survey|Withdrawal by Subject|1|||
125239528|NCT05168800|450501984|FG000|Time 3 Survey|Already excluded at Time 1|228|||
125239529|NCT05168800|450501985|FG001|Time 3 Survey|Already excluded at Time 1|200|||
125239530|NCT05168800|450501986|FG002|Time 3 Survey|Already excluded at Time 1|173|||
125239531|NCT05168800|450501984|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
125239532|NCT05168800|450501985|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
125239533|NCT05168800|450501986|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
125239534|NCT05168800|450501984|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
125239535|NCT05168800|450501985|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
125239536|NCT05168800|450501986|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
125239537|NCT05168800|450501984|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
125239538|NCT05168800|450501985|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
125239539|NCT05168800|450501986|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
125239540|NCT03240874|450501987|FG000|Overall Study|Lost to Follow-up|0|||
125239541|NCT03240874|450501988|FG001|Overall Study|Lost to Follow-up|2|||
125239542|NCT03240874|450501989|FG002|Overall Study|Lost to Follow-up|4|||
125239543|NCT03240874|450501990|FG003|Overall Study|Lost to Follow-up|1|||
125239544|NCT04958707|450501991|FG000|Post Intervention|Withdrawal by Subject|1|||
125239545|NCT04958707|450501992|FG001|Post Intervention|Withdrawal by Subject|0|||
125239546|NCT04958707|450501993|FG002|Post Intervention|Withdrawal by Subject|0|||
125239547|NCT04958707|450501991|FG000|3 Months Follow- up|Lost to Follow-up|0|||
125239548|NCT04958707|450501992|FG001|3 Months Follow- up|Lost to Follow-up|3|||
125239549|NCT04958707|450501993|FG002|3 Months Follow- up|Lost to Follow-up|0|||
125239550|NCT04958707|450501991|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
125239551|NCT04958707|450501992|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
125239552|NCT04958707|450501993|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
125239553|NCT02629159|450501996|FG000|Overall Study|Adverse Event|17|||
125239554|NCT02629159|450501997|FG001|Overall Study|Adverse Event|20|||
125239555|NCT02629159|450501998|FG002|Overall Study|Adverse Event|22|||
125239556|NCT02629159|450501996|FG000|Overall Study|Withdrawal by Subject|22|||
125239557|NCT02629159|450501997|FG001|Overall Study|Withdrawal by Subject|11|||
125239558|NCT02629159|450501998|FG002|Overall Study|Withdrawal by Subject|15|||
125239559|NCT02629159|450501996|FG000|Overall Study|Lost to Follow-up|7|||
125239560|NCT02629159|450501997|FG001|Overall Study|Lost to Follow-up|4|||
125239561|NCT02629159|450501998|FG002|Overall Study|Lost to Follow-up|5|||
125239562|NCT02629159|450501996|FG000|Overall Study|Lack of Efficacy|4|||
125239563|NCT02629159|450501997|FG001|Overall Study|Lack of Efficacy|0|||
125239564|NCT02629159|450501998|FG002|Overall Study|Lack of Efficacy|1|||
125239565|NCT02629159|450501996|FG000|Overall Study|Other|6|||
125239566|NCT02629159|450501997|FG001|Overall Study|Other|4|||
125239567|NCT02629159|450501998|FG002|Overall Study|Other|8|||
125239568|NCT03036254|450502003|FG000|Overall Study|Adverse Event|6|||
125239569|NCT03036254|450502004|FG001|Overall Study|Adverse Event|4|||
125239570|NCT03036254|450502003|FG000|Overall Study|Death|3|||
125239571|NCT03036254|450502004|FG001|Overall Study|Death|1|||
125239572|NCT03036254|450502003|FG000|Overall Study|Lack of Efficacy|5|||
125239573|NCT03036254|450502004|FG001|Overall Study|Lack of Efficacy|1|||
125239574|NCT03036254|450502003|FG000|Overall Study|Withdrawal by Subject|3|||
125239575|NCT03036254|450502004|FG001|Overall Study|Withdrawal by Subject|5|||
125239576|NCT04717557|450502013|FG000|Overall Study|Withdrawal by Subject|2|||
125239577|NCT04717557|450502014|FG001|Overall Study|Withdrawal by Subject|0|||
125239578|NCT04717557|450502013|FG000|Overall Study|Death|1|||
125239579|NCT04717557|450502014|FG001|Overall Study|Death|0|||
125239580|NCT05352399|450502016|FG000|Overall Study|Discontinued intervention|6|||
125239581|NCT01802281|450502019|FG000|Overall Study|Death|1|||
125239582|NCT01802281|450502020|FG001|Overall Study|Death|2|||
125239583|NCT01802281|450502019|FG000|Overall Study|Withdrawal by Subject|2|||
125239584|NCT01802281|450502020|FG001|Overall Study|Withdrawal by Subject|1|||
125239585|NCT01802281|450502019|FG000|Overall Study|Ineligible|5|||
125239586|NCT01802281|450502020|FG001|Overall Study|Ineligible|3|||
125239587|NCT02685735|450502021|FG000|Overall Study|Surgery Cancelled|4|||
125239588|NCT02685735|450502022|FG001|Overall Study|Surgery Cancelled|9|||
125239589|NCT02685735|450502021|FG000|Overall Study|Adverse Event|10|||
125239590|NCT02685735|450502022|FG001|Overall Study|Adverse Event|3|||
125239591|NCT02685735|450502021|FG000|Overall Study|Preop testing found to be incomplete|2|||
125239592|NCT02685735|450502022|FG001|Overall Study|Preop testing found to be incomplete|2|||
125239593|NCT02685735|450502021|FG000|Overall Study|Withdrawal by Subject|1|||
125239594|NCT02685735|450502022|FG001|Overall Study|Withdrawal by Subject|2|||
125239595|NCT02685735|450502021|FG000|Overall Study|Death|1|||
125239596|NCT02685735|450502022|FG001|Overall Study|Death|0|||
125239597|NCT00927472|450502032|FG000|Overall Study|Withdrawal by Subject|10|||
125239598|NCT00927472|450502033|FG001|Overall Study|Withdrawal by Subject|11|||
125239599|NCT00927472|450502032|FG000|Overall Study|Lost to Follow-up|1|||
125239600|NCT00927472|450502033|FG001|Overall Study|Lost to Follow-up|6|||
125239601|NCT00927472|450502032|FG000|Overall Study|Protocol Violation|0|||
125239602|NCT00927472|450502033|FG001|Overall Study|Protocol Violation|1|||
125239603|NCT00927472|450502032|FG000|Overall Study|Post treatment Assessment out of window|0|||
125239604|NCT00927472|450502033|FG001|Overall Study|Post treatment Assessment out of window|4|||
125239605|NCT04556097|450502034|FG000|Overall Study|Death|0|||
125239606|NCT04556097|450502035|FG001|Overall Study|Death|5|||
125239607|NCT04556097|450502036|FG002|Overall Study|Death|0|||
125239608|NCT04556097|450502037|FG003|Overall Study|Death|0|||
125239609|NCT04556097|450502034|FG000|Overall Study|No caregiver|43|||
125239610|NCT04556097|450502035|FG001|Overall Study|No caregiver|53|||
125239611|NCT04556097|450502036|FG002|Overall Study|No caregiver|0|||
125239612|NCT04556097|450502037|FG003|Overall Study|No caregiver|0|||
125239613|NCT04556097|450502034|FG000|Overall Study|Ineligible, SNF|2|||
125239614|NCT04556097|450502035|FG001|Overall Study|Ineligible, SNF|2|||
125239615|NCT04556097|450502036|FG002|Overall Study|Ineligible, SNF|0|||
125239616|NCT04556097|450502037|FG003|Overall Study|Ineligible, SNF|0|||
125239617|NCT04556097|450502034|FG000|Overall Study|Ineligible, health|3|||
125239618|NCT04556097|450502035|FG001|Overall Study|Ineligible, health|4|||
125239619|NCT04556097|450502036|FG002|Overall Study|Ineligible, health|0|||
125239620|NCT04556097|450502037|FG003|Overall Study|Ineligible, health|0|||
125239621|NCT04556097|450502034|FG000|Overall Study|Ineligible, language|0|||
125239622|NCT04556097|450502035|FG001|Overall Study|Ineligible, language|1|||
125239623|NCT04556097|450502036|FG002|Overall Study|Ineligible, language|0|||
125239624|NCT04556097|450502037|FG003|Overall Study|Ineligible, language|0|||
125239625|NCT04556097|450502034|FG000|Overall Study|Ineligible, no longer in care management|0|||
125239626|NCT04556097|450502035|FG001|Overall Study|Ineligible, no longer in care management|2|||
125239627|NCT04556097|450502036|FG002|Overall Study|Ineligible, no longer in care management|1|||
125239628|NCT04556097|450502037|FG003|Overall Study|Ineligible, no longer in care management|0|||
125239629|NCT04556097|450502034|FG000|Overall Study|No dementia|13|||
125239630|NCT04556097|450502035|FG001|Overall Study|No dementia|3|||
125239631|NCT04556097|450502036|FG002|Overall Study|No dementia|0|||
125239632|NCT04556097|450502037|FG003|Overall Study|No dementia|0|||
125239633|NCT04556097|450502034|FG000|Overall Study|Missing identifier|2|||
125239634|NCT04556097|450502035|FG001|Overall Study|Missing identifier|4|||
125239635|NCT04556097|450502036|FG002|Overall Study|Missing identifier|0|||
125239636|NCT04556097|450502037|FG003|Overall Study|Missing identifier|0|||
125239637|NCT04556097|450502034|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
125239638|NCT04556097|450502035|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
125239639|NCT04556097|450502036|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
125239640|NCT04556097|450502037|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
125239641|NCT02516241|450502043|FG000|Overall Study|Death|255|||
125239642|NCT02516241|450502044|FG001|Overall Study|Death|262|||
125239643|NCT02516241|450502045|FG002|Overall Study|Death|270|||
125239644|NCT02516241|450502043|FG000|Overall Study|Lost to Follow-up|1|||
125239645|NCT02516241|450502044|FG001|Overall Study|Lost to Follow-up|1|||
125239646|NCT02516241|450502045|FG002|Overall Study|Lost to Follow-up|3|||
125239647|NCT02516241|450502043|FG000|Overall Study|Withdrawal by Subject|2|||
125239648|NCT02516241|450502044|FG001|Overall Study|Withdrawal by Subject|7|||
125239649|NCT02516241|450502045|FG002|Overall Study|Withdrawal by Subject|12|||
125239650|NCT02516241|450502043|FG000|Overall Study|participants ongoing at data cut-off|84|||
125239651|NCT02516241|450502044|FG001|Overall Study|participants ongoing at data cut-off|76|||
125239652|NCT02516241|450502045|FG002|Overall Study|participants ongoing at data cut-off|59|||
125239653|NCT03228537|450502046|FG000|Neoadjuvant|Adverse Event|2|||
125239654|NCT03228537|450502046|FG000|Neoadjuvant|Progression/Relapse|4|||
125239655|NCT03228537|450502046|FG000|Neoadjuvant|Death|1|||
125239656|NCT03228537|450502046|FG000|Surgery|Death|1|||
125239657|NCT03228537|450502046|FG000|Surgery|Other - Not Protocol Specified|2|||
125239658|NCT03228537|450502046|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
125239659|NCT03228537|450502046|FG000|Maintenance|Progression/Relapse|10|||
125239660|NCT05977868|450503216|FG000|Overall Study|Withdrawal by Subject|1|||
125239661|NCT05977868|450503217|FG001|Overall Study|Withdrawal by Subject|2|||
125239662|NCT05977868|450503216|FG000|Overall Study|Transitioned to comfort care|1|||
125239663|NCT05977868|450503217|FG001|Overall Study|Transitioned to comfort care|0|||
125239664|NCT03575364|450503224|FG000|Overall Study|Death|45|||
125239665|NCT03575364|450503224|FG000|Overall Study|Lost to Follow-up|114|||
125239666|NCT03575364|450503224|FG000|Overall Study|Withdrawal by Subject|21|||
125239667|NCT03575364|450503224|FG000|Overall Study|Physician Decision|11|||
125239668|NCT03575364|450503224|FG000|Overall Study|Subject Refused Follow-up|13|||
125239669|NCT03575364|450503224|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
125239670|NCT03575364|450503224|FG000|Overall Study|Patient moved out of the state|1|||
125239671|NCT03575364|450503224|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
125239672|NCT03575364|450503224|FG000|Overall Study|Patient is lost to follow up|1|||
125239673|NCT03575364|450503224|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
125239674|NCT04092777|450503228|FG000|Overall Study|Lost to Follow-up|28|||
125239675|NCT04092777|450503229|FG001|Overall Study|Lost to Follow-up|46|||
125239676|NCT04092777|450503228|FG000|Overall Study|Withdrawal by Subject|8|||
125239677|NCT04092777|450503229|FG001|Overall Study|Withdrawal by Subject|5|||
125239678|NCT02306161|450503230|FG000|Overall Study|Death|1|||
125239679|NCT02306161|450503231|FG001|Overall Study|Death|3|||
125239680|NCT02306161|450503230|FG000|Overall Study|Lack of Efficacy|20|||
125239681|NCT02306161|450503231|FG001|Overall Study|Lack of Efficacy|43|||
125239682|NCT02306161|450503230|FG000|Overall Study|Physician Decision|30|||
125239683|NCT02306161|450503231|FG001|Overall Study|Physician Decision|18|||
125239684|NCT02306161|450503230|FG000|Overall Study|Withdrawal by Subject|4|||
125239685|NCT02306161|450503231|FG001|Overall Study|Withdrawal by Subject|0|||
125239686|NCT02306161|450503230|FG000|Overall Study|Ineligible|9|||
125239687|NCT02306161|450503231|FG001|Overall Study|Ineligible|5|||
125239688|NCT01081951|450503232|FG000|Overall Study|Death|54|||
125239689|NCT01081951|450503233|FG001|Overall Study|Death|47|||
125239690|NCT01081951|450503232|FG000|Overall Study|Withdrawal by Subject|2|||
125239691|NCT01081951|450503233|FG001|Overall Study|Withdrawal by Subject|6|||
125239692|NCT01081951|450503232|FG000|Overall Study|Allocated treatment but did not take it|0|||
125239693|NCT01081951|450503233|FG001|Overall Study|Allocated treatment but did not take it|1|||
125239694|NCT01081951|450503232|FG000|Overall Study|Lost to Follow-up|0|||
125239695|NCT01081951|450503233|FG001|Overall Study|Lost to Follow-up|1|||
125239696|NCT00975923|450503239|FG000|Overall Study|Withdrawal by Subject|0|||
125239697|NCT00975923|450503240|FG001|Overall Study|Withdrawal by Subject|1|||
125239698|NCT05291689|450503243|FG000|Overall Study|Adverse Event|3|||
125239699|NCT05291689|450503243|FG000|Overall Study|Lack of Efficacy|10|||
125239700|NCT05291689|450503243|FG000|Overall Study|Withdrawal by Subject|4|||
125239701|NCT01901562|450503244|FG000|Overall Study|Protocol Violation|5|||
125239702|NCT01901562|450503244|FG000|Overall Study|Excluded intraoperatively|4|||
125239703|NCT02612155|450503245|FG000|Overall Study|Death|1|||
125239704|NCT02612155|450503246|FG001|Overall Study|Death|1|||
125239705|NCT02612155|450503245|FG000|Overall Study|Lost to Follow-up|2|||
125239706|NCT02612155|450503246|FG001|Overall Study|Lost to Follow-up|2|||
125239707|NCT04435626|450503247|FG000|Overall Study|Lost to Follow-up|1|||
125239708|NCT04435626|450503248|FG001|Overall Study|Lost to Follow-up|5|||
125239709|NCT04435626|450503247|FG000|Overall Study|Withdrawal by Subject|6|||
125239710|NCT04435626|450503248|FG001|Overall Study|Withdrawal by Subject|7|||
125239711|NCT04435626|450503247|FG000|Overall Study|major GCP violations|8|||
125239712|NCT04435626|450503248|FG001|Overall Study|major GCP violations|7|||
125239713|NCT02864992|450503251|FG000|Overall Study|still on treatment|15|||
125239714|NCT02864992|450503252|FG001|Overall Study|still on treatment|1|||
125239715|NCT02864992|450503253|FG002|Overall Study|still on treatment|33|||
125239716|NCT05252702|450503254|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
125239717|NCT05252702|450503254|FG000|Overall Study|Death|16|||
125239718|NCT05252702|450503254|FG000|Overall Study|System explant|5|||
125239719|NCT05252702|450503254|FG000|Overall Study|Lost to Follow-up|1|||
125239720|NCT05252702|450503254|FG000|Overall Study|Withdrawn by investigator|1|||
125239721|NCT05252702|450503254|FG000|Overall Study|Visit not due|306|||
125239722|NCT05252702|450503254|FG000|Overall Study|Visit within window but not completed|92|||
125239723|NCT05252702|450503254|FG000|Overall Study|Unsuccessful implant|1|||
125239724|NCT02783274|450503256|FG000|Overall Study|Withdrawal by Subject|16|||
125239725|NCT02783274|450503256|FG000|Overall Study|Physician Decision|6|||
125239726|NCT02783274|450503256|FG000|Overall Study|Death|9|||
125239727|NCT02783274|450503256|FG000|Overall Study|Lost to Follow-up|22|||
125239728|NCT02783274|450503256|FG000|Overall Study|Other|22|||
125239729|NCT00098475|450503264|FG000|Step 1|Progressive disease|33|||
125239730|NCT00098475|450503265|FG001|Step 1|Progressive disease|35|||
125239731|NCT00098475|450503266|FG002|Step 1|Progressive disease|2|||
125239732|NCT00098475|450503267|FG003|Step 1|Progressive disease|1|||
125239733|NCT00098475|450503264|FG000|Step 1|Adverse Event|56|||
125239734|NCT00098475|450503265|FG001|Step 1|Adverse Event|37|||
125239735|NCT00098475|450503266|FG002|Step 1|Adverse Event|0|||
125239736|NCT00098475|450503267|FG003|Step 1|Adverse Event|1|||
125239737|NCT00098475|450503264|FG000|Step 1|Death|8|||
125239738|NCT00098475|450503265|FG001|Step 1|Death|5|||
125239739|NCT00098475|450503266|FG002|Step 1|Death|0|||
125239740|NCT00098475|450503267|FG003|Step 1|Death|1|||
125239741|NCT00098475|450503264|FG000|Step 1|Withdrawal by Subject|14|||
125239742|NCT00098475|450503265|FG001|Step 1|Withdrawal by Subject|11|||
125239743|NCT00098475|450503266|FG002|Step 1|Withdrawal by Subject|0|||
125239744|NCT00098475|450503267|FG003|Step 1|Withdrawal by Subject|0|||
125239745|NCT00098475|450503264|FG000|Step 1|Physician Decision|5|||
125239746|NCT00098475|450503265|FG001|Step 1|Physician Decision|2|||
125239747|NCT00098475|450503266|FG002|Step 1|Physician Decision|0|||
125239748|NCT00098475|450503267|FG003|Step 1|Physician Decision|0|||
125239749|NCT00098475|450503264|FG000|Step 1|Alternative therapy|31|||
125239750|NCT00098475|450503265|FG001|Step 1|Alternative therapy|43|||
125239751|NCT00098475|450503266|FG002|Step 1|Alternative therapy|1|||
125239752|NCT00098475|450503267|FG003|Step 1|Alternative therapy|0|||
125239753|NCT00098475|450503264|FG000|Step 1|Other disease|2|||
125239754|NCT00098475|450503265|FG001|Step 1|Other disease|1|||
125239755|NCT00098475|450503266|FG002|Step 1|Other disease|1|||
125239756|NCT00098475|450503267|FG003|Step 1|Other disease|0|||
125239757|NCT00098475|450503264|FG000|Step 1|Never started treatment|0|||
125239758|NCT00098475|450503265|FG001|Step 1|Never started treatment|2|||
125239759|NCT00098475|450503266|FG002|Step 1|Never started treatment|0|||
125239760|NCT00098475|450503267|FG003|Step 1|Never started treatment|0|||
125239761|NCT00098475|450503264|FG000|Step 1|Still on treatment as of this analysis|14|||
125239762|NCT00098475|450503265|FG001|Step 1|Still on treatment as of this analysis|27|||
125239763|NCT00098475|450503266|FG002|Step 1|Still on treatment as of this analysis|0|||
125239764|NCT00098475|450503267|FG003|Step 1|Still on treatment as of this analysis|0|||
125239765|NCT00098475|450503264|FG000|Step 1|Knee surgery|1|||
125239766|NCT00098475|450503265|FG001|Step 1|Knee surgery|0|||
125239767|NCT00098475|450503266|FG002|Step 1|Knee surgery|0|||
125239768|NCT00098475|450503267|FG003|Step 1|Knee surgery|0|||
125239769|NCT00098475|450503264|FG000|Step 1|Complications|1|||
125239770|NCT00098475|450503265|FG001|Step 1|Complications|0|||
125239771|NCT00098475|450503266|FG002|Step 1|Complications|0|||
125239772|NCT00098475|450503267|FG003|Step 1|Complications|0|||
125239773|NCT00098475|450503264|FG000|Step 1|Cannot comply due to other tx|0|||
125239774|NCT00098475|450503265|FG001|Step 1|Cannot comply due to other tx|1|||
125239775|NCT00098475|450503266|FG002|Step 1|Cannot comply due to other tx|0|||
125239776|NCT00098475|450503267|FG003|Step 1|Cannot comply due to other tx|0|||
125239777|NCT00098475|450503264|FG000|Step 1|Both patient and physician's decision|2|||
125186204|NCT03762265|450302398|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
125186205|NCT03762265|450302397|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
125186206|NCT03762265|450302398|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
125186207|NCT03762265|450302397|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
125186208|NCT03762265|450302398|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
125186209|NCT03762265|450302397|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
125186210|NCT03762265|450302398|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
125186211|NCT03762265|450302397|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
125186212|NCT03762265|450302398|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
125186213|NCT03762265|450302397|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
125186214|NCT03762265|450302398|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
125186215|NCT03762265|450302397|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
125186216|NCT03762265|450302398|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
125186217|NCT03762265|450302397|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
125186218|NCT03762265|450302398|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
125186219|NCT03762265|450302397|FG000|LTE Period: Weeks 61 to 109|Other|1|||
125186220|NCT03762265|450302398|FG001|LTE Period: Weeks 61 to 109|Other|0|||
125186221|NCT00806403|450302399|FG000|Overall Study|Death|4|||
125186222|NCT00806403|450302400|FG001|Overall Study|Death|3|||
125186223|NCT01882985|450302401|FG000|Overall Study|Lost to Follow-up|1|||
125186224|NCT01882985|450302401|FG000|Overall Study|Withdrawal by Subject|1|||
125186225|NCT00765102|450302402|FG000|Overall Study|Progressive disease|18|||
125186226|NCT00765102|450302402|FG000|Overall Study|Adverse Event|6|||
125186227|NCT00765102|450302402|FG000|Overall Study|Physician Decision|4|||
125186228|NCT00765102|450302402|FG000|Overall Study|Withdrawal by Subject|2|||
125186229|NCT00765102|450302402|FG000|Overall Study|Protocol Violation|1|||
125186230|NCT02857816|450302403|FG000|Overall Study|Screen Failure|33|||
125186231|NCT02857816|450302403|FG000|Overall Study|Withdrawal by Subject|4|||
125186232|NCT02857816|450302403|FG000|Overall Study|Lost to Follow-up|1|||
125186233|NCT01787292|450302406|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
125186234|NCT01787292|450302407|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
125186235|NCT01787292|450302406|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
125186236|NCT01787292|450302407|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
125186237|NCT01827111|450302408|FG000|Overall Study|Disease Progression|1|||
125186238|NCT02962648|450302410|FG000|Overall Study|Withdrawal by Subject|3|||
125186239|NCT02962648|450302410|FG000|Overall Study|Lost to Follow-up|3|||
125186240|NCT02962648|450302410|FG000|Overall Study|Physician Decision|1|||
125186241|NCT02962648|450302410|FG000|Overall Study|Subject had problems with transportation|2|||
125186242|NCT01597778|450302411|FG000|Overall Study|Death|7|||
125186243|NCT01597778|450302412|FG001|Overall Study|Death|10|||
125186244|NCT01597778|450302411|FG000|Overall Study|Withdrawal by Subject|3|||
125186245|NCT01597778|450302412|FG001|Overall Study|Withdrawal by Subject|4|||
125186246|NCT01597778|450302411|FG000|Overall Study|Adverse Event|1|||
125186247|NCT01597778|450302412|FG001|Overall Study|Adverse Event|1|||
125186248|NCT01597778|450302411|FG000|Overall Study|Protocol Violation|1|||
125186249|NCT01597778|450302412|FG001|Overall Study|Protocol Violation|11|||
125186250|NCT01597778|450302411|FG000|Overall Study|Transplanted off protocol|2|||
125186251|NCT01597778|450302412|FG001|Overall Study|Transplanted off protocol|3|||
125186252|NCT04383327|450302414|FG000|Overall Study|Lost to Follow-up|112|||
125186253|NCT04383327|450302415|FG001|Overall Study|Lost to Follow-up|14|||
125186254|NCT04383327|450302416|FG002|Overall Study|Lost to Follow-up|78|||
125186255|NCT04383327|450302417|FG003|Overall Study|Lost to Follow-up|13|||
125186256|NCT04383327|450302418|FG004|Overall Study|Lost to Follow-up|110|||
125186257|NCT04383327|450302419|FG005|Overall Study|Lost to Follow-up|13|||
125186258|NCT04383327|450302420|FG006|Overall Study|Lost to Follow-up|74|||
125186259|NCT04383327|450302421|FG007|Overall Study|Lost to Follow-up|13|||
125186260|NCT04383327|450302422|FG008|Overall Study|Lost to Follow-up|78|||
125186261|NCT04383327|450302423|FG009|Overall Study|Lost to Follow-up|10|||
125186262|NCT04383327|450302424|FG010|Overall Study|Lost to Follow-up|160|||
125186263|NCT04383327|450302425|FG011|Overall Study|Lost to Follow-up|13|||
125186264|NCT01289678|450302426|FG000|Overall Study|Physician Decision|6|||
125186265|NCT00468819|450302427|FG000|Overall Study|Withdrawal by Subject|4|||
125186266|NCT00468819|450302428|FG001|Overall Study|Withdrawal by Subject|0|||
125186267|NCT00468819|450302429|FG002|Overall Study|Withdrawal by Subject|1|||
125186268|NCT00468819|450302427|FG000|Overall Study|Lost to Follow-up|0|||
125186269|NCT00468819|450302428|FG001|Overall Study|Lost to Follow-up|0|||
125186270|NCT00468819|450302429|FG002|Overall Study|Lost to Follow-up|1|||
125186271|NCT00468819|450302427|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
125186272|NCT00468819|450302428|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
125186273|NCT00468819|450302429|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
125186274|NCT04030299|450302430|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
125186275|NCT04030299|450302430|FG000|Overall Study|Withdrawal by Subject|3|||
125239778|NCT00098475|450503265|FG001|Step 1|Both patient and physician's decision|1|||
125239779|NCT00098475|450503266|FG002|Step 1|Both patient and physician's decision|0|||
125239780|NCT00098475|450503267|FG003|Step 1|Both patient and physician's decision|0|||
125239781|NCT00098475|450503264|FG000|Step 1|Incorrect disease assessment|2|||
125239782|NCT00098475|450503265|FG001|Step 1|Incorrect disease assessment|0|||
125239783|NCT00098475|450503266|FG002|Step 1|Incorrect disease assessment|0|||
125239784|NCT00098475|450503267|FG003|Step 1|Incorrect disease assessment|0|||
125239785|NCT00098475|450503264|FG000|Step 1|Off treatment for > specified timeframe|1|||
125239786|NCT00098475|450503265|FG001|Step 1|Off treatment for > specified timeframe|1|||
125239787|NCT00098475|450503266|FG002|Step 1|Off treatment for > specified timeframe|0|||
125239788|NCT00098475|450503267|FG003|Step 1|Off treatment for > specified timeframe|0|||
125239789|NCT00098475|450503264|FG000|Step 1|Declining performance status|0|||
125239790|NCT00098475|450503265|FG001|Step 1|Declining performance status|1|||
125239791|NCT00098475|450503266|FG002|Step 1|Declining performance status|0|||
125239792|NCT00098475|450503267|FG003|Step 1|Declining performance status|0|||
125239793|NCT00098475|450503264|FG000|Step 1|Insurance issue|0|||
125239794|NCT00098475|450503265|FG001|Step 1|Insurance issue|1|||
125239795|NCT00098475|450503266|FG002|Step 1|Insurance issue|0|||
125239796|NCT00098475|450503267|FG003|Step 1|Insurance issue|0|||
125239797|NCT00098475|450503264|FG000|Step 1|Rising paraprotein|0|||
125239798|NCT00098475|450503265|FG001|Step 1|Rising paraprotein|1|||
125239799|NCT00098475|450503266|FG002|Step 1|Rising paraprotein|0|||
125239800|NCT00098475|450503267|FG003|Step 1|Rising paraprotein|0|||
125239801|NCT00098475|450503264|FG000|Step 1|Referred to other physicians|0|||
125239802|NCT00098475|450503265|FG001|Step 1|Referred to other physicians|1|||
125239803|NCT00098475|450503266|FG002|Step 1|Referred to other physicians|0|||
125239804|NCT00098475|450503267|FG003|Step 1|Referred to other physicians|0|||
125239805|NCT00098475|450503264|FG000|Step 1|Criteria to continue treatment not met|0|||
125239806|NCT00098475|450503265|FG001|Step 1|Criteria to continue treatment not met|1|||
125239807|NCT00098475|450503266|FG002|Step 1|Criteria to continue treatment not met|0|||
125239808|NCT00098475|450503267|FG003|Step 1|Criteria to continue treatment not met|0|||
125239809|NCT00098475|450503264|FG000|Step 1|Misinterpretation of lab data|0|||
125239810|NCT00098475|450503265|FG001|Step 1|Misinterpretation of lab data|1|||
125239811|NCT00098475|450503266|FG002|Step 1|Misinterpretation of lab data|0|||
125239812|NCT00098475|450503267|FG003|Step 1|Misinterpretation of lab data|0|||
125239813|NCT00098475|450503264|FG000|Step 1|Patient fell with fracture|1|||
125239814|NCT00098475|450503265|FG001|Step 1|Patient fell with fracture|0|||
125239815|NCT00098475|450503266|FG002|Step 1|Patient fell with fracture|0|||
125239816|NCT00098475|450503267|FG003|Step 1|Patient fell with fracture|0|||
125186276|NCT04740918|450302431|FG000|Overall Study|Study Terminated by Sponsor|41|||
125186277|NCT04740918|450302432|FG001|Overall Study|Study Terminated by Sponsor|32|||
125186278|NCT04740918|450302431|FG000|Overall Study|Death|3|||
125186279|NCT04740918|450302432|FG001|Overall Study|Death|6|||
125186280|NCT04740918|450302431|FG000|Overall Study|Withdrawal by Subject|5|||
125186281|NCT04740918|450302432|FG001|Overall Study|Withdrawal by Subject|4|||
125186282|NCT04740918|450302431|FG000|Overall Study|Lost to Follow-up|1|||
125186283|NCT04740918|450302432|FG001|Overall Study|Lost to Follow-up|3|||
125186284|NCT04740918|450302431|FG000|Overall Study|Progressive disease|0|||
125186285|NCT04740918|450302432|FG001|Overall Study|Progressive disease|1|||
125186286|NCT02524847|450302433|FG000|Overall Study|Adverse Event|4|||
125186287|NCT02524847|450302433|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
125186288|NCT02524847|450302433|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
125186289|NCT02524847|450302433|FG000|Overall Study|Death|1|||
125186290|NCT02524847|450302433|FG000|Overall Study|Reason not Specified|1|||
125186291|NCT04352101|450302434|FG000|Overall Study|Physician Decision|2|||
125186292|NCT04352101|450302435|FG001|Overall Study|Physician Decision|1|||
125186293|NCT01709500|450302436|FG000|Overall Study|Randomized but not treated|0|||
125186294|NCT01709500|450302437|FG001|Overall Study|Randomized but not treated|1|||
125186295|NCT01709500|450302436|FG000|Overall Study|Adverse Event|5|||
125186296|NCT01709500|450302437|FG001|Overall Study|Adverse Event|1|||
125186297|NCT01709500|450302436|FG000|Overall Study|Poor compliance to protocol|2|||
125186298|NCT01709500|450302437|FG001|Overall Study|Poor compliance to protocol|1|||
125186299|NCT01709500|450302436|FG000|Overall Study|Other|3|||
125239817|NCT00098475|450503264|FG000|Step 1|Not documented|0|||
125239818|NCT00098475|450503265|FG001|Step 1|Not documented|1|||
125239819|NCT00098475|450503266|FG002|Step 1|Not documented|0|||
125186300|NCT01709500|450302437|FG001|Overall Study|Other|1|||
125186301|NCT01709500|450302436|FG000|Overall Study|Related to IMP administration|1|||
125239820|NCT00098475|450503267|FG003|Step 1|Not documented|0|||
125239821|NCT00098475|450503264|FG000|Step 2|Disease progression|1|||
125239822|NCT00098475|450503265|FG001|Step 2|Disease progression|4|||
125186302|NCT01709500|450302437|FG001|Overall Study|Related to IMP administration|0|||
125186303|NCT01709500|450302436|FG000|Overall Study|Treatment ongoing|156|||
125186304|NCT01709500|450302437|FG001|Overall Study|Treatment ongoing|78|||
125186305|NCT02387840|450302438|FG000|Overall Study|Death|0|||
125186306|NCT02387840|450302439|FG001|Overall Study|Death|0|||
125186307|NCT02387840|450302440|FG002|Overall Study|Death|0|||
125186308|NCT02387840|450302441|FG003|Overall Study|Death|0|||
125186309|NCT02387840|450302442|FG004|Overall Study|Death|0|||
125186310|NCT02387840|450302443|FG005|Overall Study|Death|1|||
125186311|NCT00908544|450302444|FG000|Overall Study|Withdrawal by Subject|2|||
125186312|NCT00908544|450302445|FG001|Overall Study|Withdrawal by Subject|4|||
125186313|NCT00908544|450302444|FG000|Overall Study|Lack of Efficacy|0|||
125186314|NCT00908544|450302445|FG001|Overall Study|Lack of Efficacy|1|||
125186315|NCT00908544|450302444|FG000|Overall Study|Pregnancy|1|||
125186316|NCT00908544|450302445|FG001|Overall Study|Pregnancy|0|||
125186317|NCT00908544|450302444|FG000|Overall Study|Relocation abroad|1|||
125186318|NCT00908544|450302445|FG001|Overall Study|Relocation abroad|1|||
125186319|NCT00908544|450302444|FG000|Overall Study|Unable to visit sutdy center|1|||
125186320|NCT00908544|450302445|FG001|Overall Study|Unable to visit sutdy center|0|||
125186321|NCT03170544|450302446|FG000|Part 1|Lost to Follow-up|1|||
125186322|NCT03170544|450302447|FG001|Part 1|Lost to Follow-up|0|||
125186323|NCT03170544|450302448|FG002|Part 1|Lost to Follow-up|0|||
125186324|NCT03170544|450302449|FG003|Part 1|Lost to Follow-up|0|||
125186325|NCT03170544|450302450|FG004|Part 1|Lost to Follow-up|0|||
125186326|NCT03170544|450302451|FG005|Part 1|Lost to Follow-up|0|||
125186327|NCT03170544|450302452|FG006|Part 1|Lost to Follow-up|0|||
125186328|NCT03170544|450302453|FG007|Part 1|Lost to Follow-up|0|||
125186329|NCT03170544|450302454|FG008|Part 1|Lost to Follow-up|0|||
125186330|NCT03170544|450302455|FG009|Part 1|Lost to Follow-up|0|||
125186331|NCT03170544|450302456|FG010|Part 1|Lost to Follow-up|0|||
125186332|NCT03170544|450302457|FG011|Part 1|Lost to Follow-up|0|||
125186333|NCT03170544|450302446|FG000|Part 1|Not treated|0|||
125186334|NCT03170544|450302447|FG001|Part 1|Not treated|0|||
125186335|NCT03170544|450302448|FG002|Part 1|Not treated|0|||
125186336|NCT03170544|450302449|FG003|Part 1|Not treated|1|||
125186337|NCT03170544|450302450|FG004|Part 1|Not treated|0|||
125186338|NCT03170544|450302451|FG005|Part 1|Not treated|0|||
125186339|NCT03170544|450302452|FG006|Part 1|Not treated|0|||
125186340|NCT03170544|450302453|FG007|Part 1|Not treated|0|||
125186341|NCT03170544|450302454|FG008|Part 1|Not treated|0|||
125186342|NCT03170544|450302455|FG009|Part 1|Not treated|0|||
125186343|NCT03170544|450302456|FG010|Part 1|Not treated|0|||
125186344|NCT03170544|450302457|FG011|Part 1|Not treated|0|||
125186345|NCT03539302|450302463|FG000|Overall Study|Spontaneous cardio version|0|||
125186346|NCT03539302|450302464|FG001|Overall Study|Spontaneous cardio version|0|||
125186347|NCT03539302|450302465|FG002|Overall Study|Spontaneous cardio version|0|||
125186348|NCT03539302|450302466|FG003|Overall Study|Spontaneous cardio version|0|||
125186349|NCT03539302|450302467|FG004|Overall Study|Spontaneous cardio version|0|||
125186350|NCT03539302|450302468|FG005|Overall Study|Spontaneous cardio version|1|||
125186351|NCT03539302|450302469|FG006|Overall Study|Spontaneous cardio version|1|||
125186352|NCT02174627|450302472|FG000|Overall Study|Missing|0|||
125186353|NCT02174627|450302473|FG001|Overall Study|Missing|1|||
125186354|NCT02174627|450302472|FG000|Overall Study|Incorrect enrolment before randomization|0|||
125186355|NCT02174627|450302473|FG001|Overall Study|Incorrect enrolment before randomization|1|||
125186356|NCT02174627|450302472|FG000|Overall Study|Participant decision|84|||
125186357|NCT02174627|450302473|FG001|Overall Study|Participant decision|128|||
125186358|NCT00071110|450302474|FG000|Overall Study|Protocol Violation|0|||
125186359|NCT00071110|450302475|FG001|Overall Study|Protocol Violation|4|||
125186360|NCT02389829|450302478|FG000|Overall Study|Lost to Follow-up|0|||
125186361|NCT02389829|450302479|FG001|Overall Study|Lost to Follow-up|1|||
125186362|NCT02362360|450302480|FG000|Period 1|Lack of Efficacy|1|||
125186363|NCT02362360|450302481|FG001|Period 1|Lack of Efficacy|0|||
125186364|NCT02362360|450302480|FG000|Period 1|Withdrawal by Subject|2|||
125186365|NCT02362360|450302481|FG001|Period 1|Withdrawal by Subject|1|||
125186366|NCT03578367|450302482|FG000|Overall Study|Adverse Event|0|||
125239823|NCT00098475|450503266|FG002|Step 2|Disease progression|0|||
125186367|NCT03578367|450302483|FG001|Overall Study|Adverse Event|3|||
125186368|NCT03578367|450302484|FG002|Overall Study|Adverse Event|0|||
125186369|NCT03578367|450302485|FG003|Overall Study|Adverse Event|5|||
125186370|NCT03578367|450302482|FG000|Overall Study|Withdrawal by Subject|2|||
125186371|NCT03578367|450302483|FG001|Overall Study|Withdrawal by Subject|2|||
125186372|NCT03578367|450302484|FG002|Overall Study|Withdrawal by Subject|1|||
125186373|NCT03578367|450302485|FG003|Overall Study|Withdrawal by Subject|3|||
125186374|NCT03578367|450302482|FG000|Overall Study|Physician Decision|0|||
125186375|NCT03578367|450302483|FG001|Overall Study|Physician Decision|0|||
125186376|NCT03578367|450302484|FG002|Overall Study|Physician Decision|14|||
125186377|NCT03578367|450302485|FG003|Overall Study|Physician Decision|0|||
125186378|NCT03578367|450302482|FG000|Overall Study|Death|1|||
125186379|NCT03578367|450302483|FG001|Overall Study|Death|0|||
125186380|NCT03578367|450302484|FG002|Overall Study|Death|0|||
125186381|NCT03578367|450302485|FG003|Overall Study|Death|0|||
125186382|NCT03578367|450302482|FG000|Overall Study|Not treated|0|||
125186383|NCT03578367|450302483|FG001|Overall Study|Not treated|0|||
125239824|NCT00098475|450503267|FG003|Step 2|Disease progression|0|||
125239825|NCT00098475|450503264|FG000|Step 2|Adverse Event|2|||
125239826|NCT00098475|450503265|FG001|Step 2|Adverse Event|0|||
125239827|NCT00098475|450503266|FG002|Step 2|Adverse Event|0|||
125239828|NCT00098475|450503267|FG003|Step 2|Adverse Event|0|||
125239829|NCT00098475|450503264|FG000|Step 2|Withdrawal by Subject|0|||
125239830|NCT00098475|450503265|FG001|Step 2|Withdrawal by Subject|2|||
125239831|NCT00098475|450503266|FG002|Step 2|Withdrawal by Subject|0|||
125239832|NCT00098475|450503267|FG003|Step 2|Withdrawal by Subject|0|||
125239833|NCT00098475|450503264|FG000|Step 2|Physician Decision|0|||
125239834|NCT00098475|450503265|FG001|Step 2|Physician Decision|1|||
125239835|NCT00098475|450503266|FG002|Step 2|Physician Decision|0|||
125239836|NCT00098475|450503267|FG003|Step 2|Physician Decision|0|||
125239837|NCT00098475|450503264|FG000|Step 2|Alternative therapy|1|||
125239838|NCT00098475|450503265|FG001|Step 2|Alternative therapy|2|||
125239839|NCT00098475|450503266|FG002|Step 2|Alternative therapy|0|||
125239840|NCT00098475|450503267|FG003|Step 2|Alternative therapy|0|||
125239841|NCT00098475|450503264|FG000|Step 2|Never started treatment|1|||
125186384|NCT03578367|450302484|FG002|Overall Study|Not treated|1|||
125186385|NCT03578367|450302485|FG003|Overall Study|Not treated|0|||
125186386|NCT02729025|450302489|FG000|Overall Study|Sponsor Decision|0|||
125186387|NCT02729025|450302490|FG001|Overall Study|Sponsor Decision|1|||
125186388|NCT05207865|450303633|FG000|Open-Label Treatment Phase|Adverse Event|7|||
125186389|NCT05207865|450303633|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
125186390|NCT05207865|450303633|FG000|Open-Label Treatment Phase|Non-compliance|3|||
125186391|NCT05207865|450303633|FG000|Open-Label Treatment Phase|Other|17|||
125186392|NCT05207865|450303633|FG000|Open-Label Treatment Phase|Physician Decision|2|||
125186393|NCT05207865|450303633|FG000|Open-Label Treatment Phase|Pregnancy|1|||
125186394|NCT05207865|450303633|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
125186395|NCT05207865|450303633|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
125186396|NCT05207865|450303633|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
125186397|NCT05207865|450303633|FG000|Follow-up Phase|Lost to Follow-up|1|||
125186398|NCT05207865|450303633|FG000|Follow-up Phase|Non-compliance|1|||
125186399|NCT05207865|450303633|FG000|Follow-up Phase|Not reported|2|||
125186400|NCT05207865|450303633|FG000|Follow-up Phase|Not collected|11|||
125186401|NCT05423093|450303634|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
125186402|NCT05423093|450303634|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
125186403|NCT05423093|450303634|FG000|Attended Intervention Session|Lost to Follow-up|3|||
125186404|NCT05423093|450303634|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
125186405|NCT05423093|450303634|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
125186406|NCT05364931|450303635|FG000|Overall Study|Adverse Event|0|||
125186407|NCT05364931|450303636|FG001|Overall Study|Adverse Event|2|||
125186408|NCT05364931|450303637|FG002|Overall Study|Adverse Event|1|||
125186409|NCT05364931|450303638|FG003|Overall Study|Adverse Event|0|||
125186410|NCT05364931|450303635|FG000|Overall Study|Lost to Follow-up|1|||
125186411|NCT05364931|450303636|FG001|Overall Study|Lost to Follow-up|0|||
125186412|NCT05364931|450303637|FG002|Overall Study|Lost to Follow-up|0|||
125186413|NCT05364931|450303638|FG003|Overall Study|Lost to Follow-up|0|||
125186414|NCT05364931|450303635|FG000|Overall Study|Withdrawal by Subject|1|||
125186415|NCT05364931|450303636|FG001|Overall Study|Withdrawal by Subject|1|||
125186416|NCT05364931|450303637|FG002|Overall Study|Withdrawal by Subject|3|||
125239842|NCT00098475|450503265|FG001|Step 2|Never started treatment|1|||
125239843|NCT00098475|450503266|FG002|Step 2|Never started treatment|0|||
125186417|NCT05364931|450303638|FG003|Overall Study|Withdrawal by Subject|2|||
125186418|NCT05364931|450303635|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
125186419|NCT05364931|450303636|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
125186420|NCT05364931|450303637|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
125186421|NCT05364931|450303638|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
125186422|NCT05364931|450303635|FG000|Overall Study|Discontinued|1|||
125186423|NCT05364931|450303636|FG001|Overall Study|Discontinued|0|||
125186424|NCT05364931|450303637|FG002|Overall Study|Discontinued|0|||
125186425|NCT05364931|450303638|FG003|Overall Study|Discontinued|0|||
125239844|NCT00098475|450503267|FG003|Step 2|Never started treatment|0|||
125239845|NCT03370276|450503268|FG000|Overall Study|Death|0|||
125239846|NCT03370276|450503269|FG001|Overall Study|Death|2|||
125239847|NCT03370276|450503270|FG002|Overall Study|Death|5|||
125239848|NCT00831844|450503273|FG000|Overall Study|Adverse Event|2|||
125239849|NCT00831844|450503274|FG001|Overall Study|Adverse Event|0|||
125239850|NCT00831844|450503275|FG002|Overall Study|Adverse Event|0|||
125239851|NCT00831844|450503276|FG003|Overall Study|Adverse Event|0|||
125239852|NCT00831844|450503277|FG004|Overall Study|Adverse Event|1|||
125239853|NCT00831844|450503278|FG005|Overall Study|Adverse Event|1|||
125239854|NCT00831844|450503279|FG006|Overall Study|Adverse Event|2|||
125239855|NCT00831844|450503280|FG007|Overall Study|Adverse Event|0|||
125239856|NCT00831844|450503281|FG008|Overall Study|Adverse Event|0|||
125239857|NCT00831844|450503282|FG009|Overall Study|Adverse Event|0|||
125239858|NCT00831844|450503273|FG000|Overall Study|Death|0|||
125239859|NCT00831844|450503274|FG001|Overall Study|Death|0|||
125239860|NCT00831844|450503275|FG002|Overall Study|Death|0|||
125239861|NCT00831844|450503276|FG003|Overall Study|Death|1|||
125239862|NCT00831844|450503277|FG004|Overall Study|Death|0|||
125239863|NCT00831844|450503278|FG005|Overall Study|Death|0|||
125239864|NCT00831844|450503279|FG006|Overall Study|Death|0|||
125239865|NCT00831844|450503280|FG007|Overall Study|Death|0|||
125239866|NCT00831844|450503281|FG008|Overall Study|Death|0|||
125239867|NCT00831844|450503282|FG009|Overall Study|Death|0|||
125239868|NCT00831844|450503273|FG000|Overall Study|Lack of Efficacy|8|||
125239869|NCT00831844|450503274|FG001|Overall Study|Lack of Efficacy|10|||
125239870|NCT00831844|450503275|FG002|Overall Study|Lack of Efficacy|15|||
125239871|NCT00831844|450503276|FG003|Overall Study|Lack of Efficacy|8|||
125239872|NCT00831844|450503277|FG004|Overall Study|Lack of Efficacy|11|||
125239873|NCT00831844|450503278|FG005|Overall Study|Lack of Efficacy|17|||
125239874|NCT00831844|450503279|FG006|Overall Study|Lack of Efficacy|8|||
125239875|NCT00831844|450503280|FG007|Overall Study|Lack of Efficacy|9|||
125239876|NCT00831844|450503281|FG008|Overall Study|Lack of Efficacy|7|||
125239877|NCT00831844|450503282|FG009|Overall Study|Lack of Efficacy|0|||
125239878|NCT00831844|450503273|FG000|Overall Study|Physician Decision|0|||
125239879|NCT00831844|450503274|FG001|Overall Study|Physician Decision|1|||
125239880|NCT00831844|450503275|FG002|Overall Study|Physician Decision|3|||
125239881|NCT00831844|450503276|FG003|Overall Study|Physician Decision|1|||
125239882|NCT00831844|450503277|FG004|Overall Study|Physician Decision|1|||
125239883|NCT00831844|450503278|FG005|Overall Study|Physician Decision|1|||
125239884|NCT00831844|450503279|FG006|Overall Study|Physician Decision|0|||
125239885|NCT00831844|450503280|FG007|Overall Study|Physician Decision|0|||
125239886|NCT00831844|450503281|FG008|Overall Study|Physician Decision|1|||
125239887|NCT00831844|450503282|FG009|Overall Study|Physician Decision|0|||
125239888|NCT00831844|450503273|FG000|Overall Study|Withdrawal by Subject|0|||
125239889|NCT00831844|450503274|FG001|Overall Study|Withdrawal by Subject|0|||
125239890|NCT00831844|450503275|FG002|Overall Study|Withdrawal by Subject|1|||
125239891|NCT00831844|450503276|FG003|Overall Study|Withdrawal by Subject|0|||
125239892|NCT00831844|450503277|FG004|Overall Study|Withdrawal by Subject|0|||
125239893|NCT00831844|450503278|FG005|Overall Study|Withdrawal by Subject|0|||
125239894|NCT00831844|450503279|FG006|Overall Study|Withdrawal by Subject|0|||
125186426|NCT03504397|450303641|FG000|Overall Study|Progressive Disease|151|||
125186427|NCT03504397|450303642|FG001|Overall Study|Progressive Disease|199|||
125186428|NCT03504397|450303641|FG000|Overall Study|Withdrawal by Subject|29|||
125186429|NCT03504397|450303642|FG001|Overall Study|Withdrawal by Subject|17|||
125186430|NCT03504397|450303641|FG000|Overall Study|Lost to Follow-up|1|||
125186431|NCT03504397|450303642|FG001|Overall Study|Lost to Follow-up|0|||
125186432|NCT03504397|450303641|FG000|Overall Study|Death|14|||
125186433|NCT03504397|450303642|FG001|Overall Study|Death|16|||
125186434|NCT03504397|450303641|FG000|Overall Study|Adverse Event|40|||
125186435|NCT03504397|450303642|FG001|Overall Study|Adverse Event|14|||
125186436|NCT03504397|450303641|FG000|Overall Study|miscellaneous|17|||
125239895|NCT00831844|450503280|FG007|Overall Study|Withdrawal by Subject|1|||
125239896|NCT00831844|450503281|FG008|Overall Study|Withdrawal by Subject|1|||
125239897|NCT00831844|450503282|FG009|Overall Study|Withdrawal by Subject|0|||
125239898|NCT00831844|450503273|FG000|Overall Study|Ineligible|0|||
125239899|NCT00831844|450503274|FG001|Overall Study|Ineligible|1|||
125186437|NCT03504397|450303642|FG001|Overall Study|miscellaneous|15|||
125186438|NCT03504397|450303641|FG000|Overall Study|Protocol deviation|1|||
125239900|NCT00831844|450503275|FG002|Overall Study|Ineligible|1|||
125239901|NCT00831844|450503276|FG003|Overall Study|Ineligible|0|||
125239902|NCT00831844|450503277|FG004|Overall Study|Ineligible|1|||
125239903|NCT00831844|450503278|FG005|Overall Study|Ineligible|0|||
125239904|NCT00831844|450503279|FG006|Overall Study|Ineligible|0|||
125186439|NCT03504397|450303642|FG001|Overall Study|Protocol deviation|0|||
125186440|NCT03504397|450303641|FG000|Overall Study|Participants who did not take the study drug|4|||
125186441|NCT03504397|450303642|FG001|Overall Study|Participants who did not take the study drug|4|||
125239905|NCT00831844|450503280|FG007|Overall Study|Ineligible|0|||
125239906|NCT00831844|450503281|FG008|Overall Study|Ineligible|0|||
125239907|NCT00831844|450503282|FG009|Overall Study|Ineligible|0|||
125239908|NCT04057365|450503285|FG000|Overall Study|Withdrawal by Subject|2|||
125239909|NCT04057365|450503286|FG001|Overall Study|Withdrawal by Subject|0|||
125239910|NCT03976375|450503287|FG000|Overall Study|Death|158|||
125239911|NCT03976375|450503288|FG001|Overall Study|Death|160|||
125239912|NCT03976375|450503289|FG002|Overall Study|Death|42|||
125239913|NCT03976375|450503287|FG000|Overall Study|Lost to Follow-up|2|||
125239914|NCT03976375|450503288|FG001|Overall Study|Lost to Follow-up|1|||
125239915|NCT03976375|450503289|FG002|Overall Study|Lost to Follow-up|1|||
125239916|NCT03976375|450503287|FG000|Overall Study|Withdrawal by Subject|5|||
125239917|NCT03976375|450503288|FG001|Overall Study|Withdrawal by Subject|9|||
125239918|NCT03976375|450503289|FG002|Overall Study|Withdrawal by Subject|4|||
125239919|NCT03976375|450503287|FG000|Overall Study|Sponsor decision|20|||
125239920|NCT03976375|450503288|FG001|Overall Study|Sponsor decision|19|||
125239921|NCT03976375|450503289|FG002|Overall Study|Sponsor decision|1|||
125239922|NCT04635423|450503290|FG000|Overall Study|Ongoing|493|||
125239923|NCT04635423|450503291|FG001|Overall Study|Ongoing|501|||
125239924|NCT04635423|450503290|FG000|Overall Study|Withdrawal by Subject|36|||
125239925|NCT04635423|450503291|FG001|Overall Study|Withdrawal by Subject|29|||
125239926|NCT05119569|450503302|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
125239927|NCT05119569|450503303|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
125239928|NCT05119569|450503304|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
125239929|NCT05119569|450503305|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
125239930|NCT05119569|450503302|FG000|Double Blind Treatment Phase|Adverse Event|6|||
125239931|NCT05119569|450503303|FG001|Double Blind Treatment Phase|Adverse Event|0|||
125239932|NCT05119569|450503304|FG002|Double Blind Treatment Phase|Adverse Event|0|||
125239933|NCT05119569|450503305|FG003|Double Blind Treatment Phase|Adverse Event|0|||
125239934|NCT05119569|450503302|FG000|Open Label Extension Phase|Ongoing in the study|0|||
125239935|NCT05119569|450503303|FG001|Open Label Extension Phase|Ongoing in the study|0|||
125239936|NCT05119569|450503304|FG002|Open Label Extension Phase|Ongoing in the study|65|||
125239937|NCT05119569|450503305|FG003|Open Label Extension Phase|Ongoing in the study|34|||
125239938|NCT03683030|450503306|FG000|Overall Study|Enrolled but screen failures|12|||
125239939|NCT03683030|450503307|FG001|Overall Study|Enrolled but screen failures|7|||
125239940|NCT03683030|450503306|FG000|Overall Study|Enrolled but no catheter inserted|11|||
125239941|NCT03683030|450503307|FG001|Overall Study|Enrolled but no catheter inserted|13|||
125239942|NCT03683030|450503306|FG000|Overall Study|Withdrawal by Subject|0|||
125239943|NCT03683030|450503307|FG001|Overall Study|Withdrawal by Subject|2|||
125239944|NCT03683030|450503306|FG000|Overall Study|Early termination by subject|1|||
125239945|NCT03683030|450503307|FG001|Overall Study|Early termination by subject|0|||
125239946|NCT03683030|450503306|FG000|Overall Study|Lost to Follow-up|0|||
125239947|NCT03683030|450503307|FG001|Overall Study|Lost to Follow-up|6|||
125239948|NCT03683030|450503306|FG000|Overall Study|Death|0|||
125239949|NCT03683030|450503307|FG001|Overall Study|Death|2|||
125239950|NCT03683030|450503306|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
125239951|NCT03683030|450503307|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
125239952|NCT03980223|450503308|FG000|Overall Study|Lost to Follow-up|3|||
125239953|NCT03980223|450503309|FG001|Overall Study|Lost to Follow-up|7|||
125239954|NCT03980223|450503310|FG002|Overall Study|Lost to Follow-up|10|||
125239955|NCT03980223|450503311|FG003|Overall Study|Lost to Follow-up|8|||
125239956|NCT03980223|450503308|FG000|Overall Study|Withdrawal by Subject|0|||
125239957|NCT03980223|450503309|FG001|Overall Study|Withdrawal by Subject|0|||
125239958|NCT03980223|450503310|FG002|Overall Study|Withdrawal by Subject|1|||
125239959|NCT03980223|450503311|FG003|Overall Study|Withdrawal by Subject|2|||
125239960|NCT03980223|450503308|FG000|Overall Study|Physician Decision|0|||
125239961|NCT03980223|450503309|FG001|Overall Study|Physician Decision|0|||
125239962|NCT03980223|450503310|FG002|Overall Study|Physician Decision|1|||
125239963|NCT03980223|450503311|FG003|Overall Study|Physician Decision|0|||
125239964|NCT03980223|450503308|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
125239965|NCT03980223|450503309|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
125239966|NCT03980223|450503310|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
125239967|NCT03980223|450503311|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
125239968|NCT06239610|450503312|FG000|Overall Study|no usable migration data for minimum of one day|11|||
125239969|NCT01922934|450503316|FG000|Eligible Patients|Death|0|||
125239970|NCT01922934|450503317|FG001|Eligible Patients|Death|7|||
125239971|NCT01922934|450503316|FG000|Eligible Patients|Physician Decision|17|||
125239972|NCT01922934|450503317|FG001|Eligible Patients|Physician Decision|0|||
125239973|NCT01922934|450503316|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
125239974|NCT01922934|450503317|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
125239975|NCT01922934|450503316|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
125239976|NCT01922934|450503317|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
125239977|NCT01922934|450503316|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
125239978|NCT01922934|450503317|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
125239979|NCT01922934|450503316|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
125239980|NCT01922934|450503317|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
125239981|NCT01069939|450503322|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
125239982|NCT01069939|450503323|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
125239983|NCT01069939|450503322|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
125239984|NCT01069939|450503323|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
125239985|NCT01069939|450503322|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
125239986|NCT01069939|450503323|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
125239987|NCT01069939|450503322|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
125239988|NCT01069939|450503323|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
125239989|NCT01069939|450503322|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
125239990|NCT01069939|450503323|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
125239991|NCT01069939|450503322|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
125239992|NCT01069939|450503323|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
125239993|NCT01069939|450503322|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
125239994|NCT01069939|450503323|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
125239995|NCT01069939|450503322|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
125239996|NCT01069939|450503323|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
125239997|NCT01069939|450503322|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
125239998|NCT01069939|450503323|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
125239999|NCT01069939|450503322|FG000|Randomised and Included in the Analyses|Removal|1|||
125240000|NCT01069939|450503323|FG001|Randomised and Included in the Analyses|Removal|0|||
125240001|NCT05166876|450503324|FG000|Overall Study|Withdrawal by Subject|1|||
125240002|NCT05166876|450503325|FG001|Overall Study|Withdrawal by Subject|0|||
125240003|NCT05166876|450503326|FG002|Overall Study|Withdrawal by Subject|0|||
125240004|NCT00385840|450503328|FG000|Overall Study|Adverse Event|1|||
125240005|NCT00385840|450503329|FG001|Overall Study|Adverse Event|1|||
125240006|NCT00385840|450503328|FG000|Overall Study|Lost to Follow-up|3|||
125240007|NCT00385840|450503329|FG001|Overall Study|Lost to Follow-up|13|||
125240008|NCT00832975|450503331|FG000|Overall Study|Lost to Follow-up|7|||
125240009|NCT00832975|450503331|FG000|Overall Study|Protocol Violation|6|||
125240010|NCT00832975|450503331|FG000|Overall Study|Death|5|||
125240011|NCT00832975|450503331|FG000|Overall Study|Physician Decision|4|||
125240012|NCT00832975|450503331|FG000|Overall Study|Withdrawal by Subject|3|||
125240013|NCT00832975|450503331|FG000|Overall Study|Other reasons|14|||
125240014|NCT02101853|450503335|FG000|Block 1 Induction|Adverse Event|11|||
125240015|NCT02101853|450503336|FG001|Block 1 Induction|Adverse Event|0|||
125240016|NCT02101853|450503337|FG002|Block 1 Induction|Adverse Event|0|||
125240017|NCT02101853|450503338|FG003|Block 1 Induction|Adverse Event|0|||
125240018|NCT02101853|450503339|FG004|Block 1 Induction|Adverse Event|0|||
125240019|NCT02101853|450503340|FG005|Block 1 Induction|Adverse Event|0|||
125240020|NCT02101853|450503335|FG000|Block 1 Induction|Death|20|||
125240021|NCT02101853|450503336|FG001|Block 1 Induction|Death|0|||
125240022|NCT02101853|450503337|FG002|Block 1 Induction|Death|0|||
125240023|NCT02101853|450503338|FG003|Block 1 Induction|Death|0|||
125240024|NCT02101853|450503339|FG004|Block 1 Induction|Death|0|||
125240025|NCT02101853|450503340|FG005|Block 1 Induction|Death|0|||
125240026|NCT02101853|450503335|FG000|Block 1 Induction|Lack of Efficacy|6|||
125240027|NCT02101853|450503336|FG001|Block 1 Induction|Lack of Efficacy|0|||
125240028|NCT02101853|450503337|FG002|Block 1 Induction|Lack of Efficacy|0|||
125240029|NCT02101853|450503338|FG003|Block 1 Induction|Lack of Efficacy|0|||
125240030|NCT02101853|450503339|FG004|Block 1 Induction|Lack of Efficacy|0|||
125240031|NCT02101853|450503340|FG005|Block 1 Induction|Lack of Efficacy|0|||
125240032|NCT02101853|450503335|FG000|Block 1 Induction|Physician Decision|61|||
125240033|NCT02101853|450503336|FG001|Block 1 Induction|Physician Decision|0|||
125240034|NCT02101853|450503337|FG002|Block 1 Induction|Physician Decision|0|||
125240035|NCT02101853|450503338|FG003|Block 1 Induction|Physician Decision|0|||
125240036|NCT02101853|450503339|FG004|Block 1 Induction|Physician Decision|0|||
125240037|NCT02101853|450503340|FG005|Block 1 Induction|Physician Decision|0|||
125240038|NCT02101853|450503335|FG000|Block 1 Induction|Protocol Violation|2|||
125240039|NCT02101853|450503336|FG001|Block 1 Induction|Protocol Violation|0|||
125240040|NCT02101853|450503337|FG002|Block 1 Induction|Protocol Violation|0|||
125240041|NCT02101853|450503338|FG003|Block 1 Induction|Protocol Violation|0|||
125240042|NCT02101853|450503339|FG004|Block 1 Induction|Protocol Violation|0|||
125240043|NCT02101853|450503340|FG005|Block 1 Induction|Protocol Violation|0|||
125240044|NCT02101853|450503335|FG000|Block 1 Induction|Withdrawal by Subject|65|||
125240045|NCT02101853|450503336|FG001|Block 1 Induction|Withdrawal by Subject|0|||
125240046|NCT02101853|450503337|FG002|Block 1 Induction|Withdrawal by Subject|0|||
125240047|NCT02101853|450503338|FG003|Block 1 Induction|Withdrawal by Subject|0|||
125240048|NCT02101853|450503339|FG004|Block 1 Induction|Withdrawal by Subject|0|||
125240049|NCT02101853|450503340|FG005|Block 1 Induction|Withdrawal by Subject|0|||
125240050|NCT02101853|450503335|FG000|Block 1 Induction|Ineligible|8|||
125240051|NCT02101853|450503336|FG001|Block 1 Induction|Ineligible|0|||
125240052|NCT02101853|450503337|FG002|Block 1 Induction|Ineligible|0|||
125240053|NCT02101853|450503338|FG003|Block 1 Induction|Ineligible|0|||
125240054|NCT02101853|450503339|FG004|Block 1 Induction|Ineligible|0|||
125240055|NCT02101853|450503340|FG005|Block 1 Induction|Ineligible|0|||
125240056|NCT02101853|450503335|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
125240057|NCT02101853|450503336|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
125240058|NCT02101853|450503337|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
125240059|NCT02101853|450503338|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
125240060|NCT02101853|450503339|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
125240061|NCT02101853|450503340|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
125240062|NCT02101853|450503335|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
125240063|NCT02101853|450503336|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
125240064|NCT02101853|450503337|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
125240065|NCT02101853|450503338|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
125240066|NCT02101853|450503339|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
125240067|NCT02101853|450503340|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
125240068|NCT02101853|450503335|FG000|Post Induction Randomization|Adverse Event|0|||
125240069|NCT02101853|450503336|FG001|Post Induction Randomization|Adverse Event|3|||
125240070|NCT02101853|450503337|FG002|Post Induction Randomization|Adverse Event|8|||
125240071|NCT02101853|450503338|FG003|Post Induction Randomization|Adverse Event|4|||
125240072|NCT02101853|450503339|FG004|Post Induction Randomization|Adverse Event|4|||
125240073|NCT02101853|450503340|FG005|Post Induction Randomization|Adverse Event|0|||
125240074|NCT02101853|450503335|FG000|Post Induction Randomization|Death|0|||
125240075|NCT02101853|450503336|FG001|Post Induction Randomization|Death|9|||
125240076|NCT02101853|450503337|FG002|Post Induction Randomization|Death|2|||
125240077|NCT02101853|450503338|FG003|Post Induction Randomization|Death|2|||
125240078|NCT02101853|450503339|FG004|Post Induction Randomization|Death|0|||
125240079|NCT02101853|450503340|FG005|Post Induction Randomization|Death|0|||
125240080|NCT02101853|450503335|FG000|Post Induction Randomization|Lack of Efficacy|0|||
125240081|NCT02101853|450503336|FG001|Post Induction Randomization|Lack of Efficacy|14|||
125240082|NCT02101853|450503337|FG002|Post Induction Randomization|Lack of Efficacy|23|||
125240083|NCT02101853|450503338|FG003|Post Induction Randomization|Lack of Efficacy|18|||
125240084|NCT02101853|450503339|FG004|Post Induction Randomization|Lack of Efficacy|21|||
125240085|NCT02101853|450503340|FG005|Post Induction Randomization|Lack of Efficacy|0|||
125240086|NCT02101853|450503335|FG000|Post Induction Randomization|Physician Decision|0|||
125240087|NCT02101853|450503336|FG001|Post Induction Randomization|Physician Decision|43|||
125240088|NCT02101853|450503337|FG002|Post Induction Randomization|Physician Decision|23|||
125240089|NCT02101853|450503338|FG003|Post Induction Randomization|Physician Decision|14|||
125240090|NCT02101853|450503339|FG004|Post Induction Randomization|Physician Decision|14|||
125240091|NCT02101853|450503340|FG005|Post Induction Randomization|Physician Decision|0|||
125240092|NCT02101853|450503335|FG000|Post Induction Randomization|Protocol Violation|0|||
125240093|NCT02101853|450503336|FG001|Post Induction Randomization|Protocol Violation|3|||
125240094|NCT02101853|450503337|FG002|Post Induction Randomization|Protocol Violation|0|||
125240095|NCT02101853|450503338|FG003|Post Induction Randomization|Protocol Violation|0|||
125240096|NCT02101853|450503339|FG004|Post Induction Randomization|Protocol Violation|0|||
125240097|NCT02101853|450503340|FG005|Post Induction Randomization|Protocol Violation|0|||
125240098|NCT02101853|450503335|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
125240099|NCT02101853|450503336|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
125240100|NCT02101853|450503337|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
125240101|NCT02101853|450503338|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
125240102|NCT02101853|450503339|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
125240103|NCT02101853|450503340|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
125240104|NCT02101853|450503335|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
125240105|NCT02101853|450503336|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
125240106|NCT02101853|450503337|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
125240107|NCT02101853|450503338|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
125240108|NCT02101853|450503339|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
125240109|NCT02101853|450503340|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
125240110|NCT02101853|450503335|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
125240111|NCT02101853|450503336|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
125240112|NCT02101853|450503337|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
125240113|NCT02101853|450503338|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
125240114|NCT02101853|450503339|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
125240115|NCT02101853|450503340|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
125240116|NCT02101853|450503335|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
125240117|NCT02101853|450503336|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
125240118|NCT02101853|450503337|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
125240119|NCT02101853|450503338|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
125240120|NCT02101853|450503339|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
125240121|NCT02101853|450503340|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
125240122|NCT02101853|450503335|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
125240123|NCT02101853|450503336|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
125240124|NCT02101853|450503337|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
125240125|NCT02101853|450503338|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
125240126|NCT02101853|450503339|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
125240127|NCT02101853|450503340|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
125240128|NCT02101853|450503335|FG000|Blinatumomab Salvage Therapy|Death|0|||
125240129|NCT02101853|450503336|FG001|Blinatumomab Salvage Therapy|Death|0|||
125240130|NCT02101853|450503337|FG002|Blinatumomab Salvage Therapy|Death|0|||
125240131|NCT02101853|450503338|FG003|Blinatumomab Salvage Therapy|Death|0|||
125240132|NCT02101853|450503339|FG004|Blinatumomab Salvage Therapy|Death|0|||
125240133|NCT02101853|450503340|FG005|Blinatumomab Salvage Therapy|Death|2|||
125240134|NCT02101853|450503335|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
125240135|NCT02101853|450503336|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
125240136|NCT02101853|450503337|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
125240137|NCT02101853|450503338|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
125240138|NCT02101853|450503339|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
125240139|NCT02101853|450503340|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
125240140|NCT02101853|450503335|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
125240141|NCT02101853|450503336|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
125240142|NCT02101853|450503337|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
125240143|NCT02101853|450503338|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
125240144|NCT02101853|450503339|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
125240145|NCT02101853|450503340|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
125240146|NCT02101853|450503335|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
125240147|NCT02101853|450503336|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
125240148|NCT02101853|450503337|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
125240149|NCT02101853|450503338|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
125240150|NCT02101853|450503339|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
125240151|NCT02101853|450503340|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
125240152|NCT02112916|450503341|FG000|Overall Study|Adverse Event|6|||
125240153|NCT02112916|450503342|FG001|Overall Study|Adverse Event|9|||
125240154|NCT02112916|450503343|FG002|Overall Study|Adverse Event|3|||
125240155|NCT02112916|450503344|FG003|Overall Study|Adverse Event|2|||
125240156|NCT02112916|450503341|FG000|Overall Study|Death|9|||
125240157|NCT02112916|450503342|FG001|Overall Study|Death|9|||
125240158|NCT02112916|450503343|FG002|Overall Study|Death|3|||
125240159|NCT02112916|450503344|FG003|Overall Study|Death|4|||
125240160|NCT02112916|450503341|FG000|Overall Study|Lost to Follow-up|1|||
125240161|NCT02112916|450503342|FG001|Overall Study|Lost to Follow-up|0|||
125240162|NCT02112916|450503343|FG002|Overall Study|Lost to Follow-up|0|||
125240163|NCT02112916|450503344|FG003|Overall Study|Lost to Follow-up|0|||
125240164|NCT02112916|450503341|FG000|Overall Study|Physician Decision|94|||
125240165|NCT02112916|450503342|FG001|Overall Study|Physician Decision|72|||
125240166|NCT02112916|450503343|FG002|Overall Study|Physician Decision|24|||
125240167|NCT02112916|450503344|FG003|Overall Study|Physician Decision|15|||
125240168|NCT02112916|450503341|FG000|Overall Study|Withdrawal by Subject|5|||
125240169|NCT02112916|450503342|FG001|Overall Study|Withdrawal by Subject|3|||
125240170|NCT02112916|450503343|FG002|Overall Study|Withdrawal by Subject|1|||
125240171|NCT02112916|450503344|FG003|Overall Study|Withdrawal by Subject|1|||
125240172|NCT02112916|450503341|FG000|Overall Study|Ineligible|4|||
125240173|NCT02112916|450503342|FG001|Overall Study|Ineligible|8|||
125240174|NCT02112916|450503343|FG002|Overall Study|Ineligible|3|||
125240175|NCT02112916|450503344|FG003|Overall Study|Ineligible|8|||
125240176|NCT02112916|450503341|FG000|Overall Study|Inevaluable|6|||
125240177|NCT02112916|450503342|FG001|Overall Study|Inevaluable|4|||
125240178|NCT02112916|450503343|FG002|Overall Study|Inevaluable|5|||
125240179|NCT02112916|450503344|FG003|Overall Study|Inevaluable|5|||
125240180|NCT02112916|450503341|FG000|Overall Study|Refusal of further protocol therapy|19|||
125240181|NCT02112916|450503342|FG001|Overall Study|Refusal of further protocol therapy|16|||
125240182|NCT02112916|450503343|FG002|Overall Study|Refusal of further protocol therapy|1|||
125240183|NCT02112916|450503344|FG003|Overall Study|Refusal of further protocol therapy|7|||
125240184|NCT02112916|450503341|FG000|Overall Study|Development of SMN|1|||
125240185|NCT02112916|450503342|FG001|Overall Study|Development of SMN|0|||
125240186|NCT02112916|450503343|FG002|Overall Study|Development of SMN|0|||
125240187|NCT02112916|450503344|FG003|Overall Study|Development of SMN|1|||
125240188|NCT02112916|450503341|FG000|Overall Study|Relapse/Progression|10|||
125240189|NCT02112916|450503342|FG001|Overall Study|Relapse/Progression|18|||
125240190|NCT02112916|450503343|FG002|Overall Study|Relapse/Progression|15|||
125240191|NCT02112916|450503344|FG003|Overall Study|Relapse/Progression|2|||
125240192|NCT02112916|450503341|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
125240193|NCT02112916|450503342|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
125240194|NCT02112916|450503343|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
125240195|NCT02112916|450503344|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
125240196|NCT02112916|450503341|FG000|Overall Study|Still on Therapy|44|||
125240197|NCT02112916|450503342|FG001|Overall Study|Still on Therapy|47|||
125240198|NCT02112916|450503343|FG002|Overall Study|Still on Therapy|3|||
125240199|NCT02112916|450503344|FG003|Overall Study|Still on Therapy|2|||
125240200|NCT02112916|450503341|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
125240201|NCT02112916|450503342|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
125240202|NCT02112916|450503343|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
125240203|NCT02112916|450503344|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
125240204|NCT02112916|450503341|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
125240205|NCT02112916|450503342|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
125240206|NCT02112916|450503343|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
125240207|NCT02112916|450503344|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
125240208|NCT04409002|450503345|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
125240209|NCT04835441|450503346|FG000|Overall Study|Physician Decision|4|||
125240210|NCT04835441|450503347|FG001|Overall Study|Physician Decision|4|||
125240211|NCT04835441|450503346|FG000|Overall Study|Other|1|||
125240212|NCT04835441|450503347|FG001|Overall Study|Other|1|||
125240213|NCT04835441|450503346|FG000|Overall Study|Lost to Follow-up|0|||
125240214|NCT04835441|450503347|FG001|Overall Study|Lost to Follow-up|1|||
125240215|NCT05032196|450503348|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
125240216|NCT05032196|450503349|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
125240217|NCT05032196|450503350|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
125240218|NCT05032196|450503351|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
125240219|NCT05032196|450503352|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
125240220|NCT05032196|450503353|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
125240221|NCT05032196|450503348|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
125240222|NCT05032196|450503349|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
125240223|NCT05032196|450503350|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
125240224|NCT05032196|450503351|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
125240225|NCT05032196|450503352|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
125240226|NCT05032196|450503353|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
125240227|NCT05032196|450503348|FG000|Period 2 (Multidose)|Physician Decision|0|||
125240228|NCT05032196|450503349|FG001|Period 2 (Multidose)|Physician Decision|0|||
125240229|NCT05032196|450503350|FG002|Period 2 (Multidose)|Physician Decision|0|||
125240230|NCT05032196|450503351|FG003|Period 2 (Multidose)|Physician Decision|0|||
125240231|NCT05032196|450503352|FG004|Period 2 (Multidose)|Physician Decision|1|||
125240232|NCT05032196|450503353|FG005|Period 2 (Multidose)|Physician Decision|0|||
125240233|NCT05260008|450503354|FG000|Overall Study|Physician Decision|0|||
125240234|NCT05260008|450503355|FG001|Overall Study|Physician Decision|1|||
125240235|NCT05260008|450503356|FG002|Overall Study|Physician Decision|0|||
125240236|NCT05260008|450503357|FG003|Overall Study|Physician Decision|0|||
125240237|NCT05696847|450504376|FG000|Overall Study|Withdrawal by Subject|1|||
125240238|NCT05696847|450504377|FG001|Overall Study|Withdrawal by Subject|0|||
125240239|NCT05696847|450504378|FG002|Overall Study|Withdrawal by Subject|0|||
125240240|NCT05696847|450504379|FG003|Overall Study|Withdrawal by Subject|0|||
125240241|NCT05696847|450504380|FG004|Overall Study|Withdrawal by Subject|0|||
125240242|NCT05696847|450504381|FG005|Overall Study|Withdrawal by Subject|0|||
125240243|NCT05696847|450504376|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125240244|NCT05696847|450504377|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
125240245|NCT05696847|450504378|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
125240246|NCT05696847|450504379|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
125240247|NCT05696847|450504380|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
125240248|NCT05696847|450504381|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
125240249|NCT05696847|450504376|FG000|Overall Study|Adverse Event|0|||
125240250|NCT05696847|450504377|FG001|Overall Study|Adverse Event|0|||
125240251|NCT05696847|450504378|FG002|Overall Study|Adverse Event|0|||
125240252|NCT05696847|450504379|FG003|Overall Study|Adverse Event|0|||
125240253|NCT05696847|450504380|FG004|Overall Study|Adverse Event|0|||
125240254|NCT05696847|450504381|FG005|Overall Study|Adverse Event|1|||
125240255|NCT05696847|450504376|FG000|Overall Study|Sponsor Decision|0|||
125240256|NCT05696847|450504377|FG001|Overall Study|Sponsor Decision|0|||
125240257|NCT05696847|450504378|FG002|Overall Study|Sponsor Decision|0|||
125240258|NCT05696847|450504379|FG003|Overall Study|Sponsor Decision|1|||
125240259|NCT05696847|450504380|FG004|Overall Study|Sponsor Decision|0|||
125240260|NCT05696847|450504381|FG005|Overall Study|Sponsor Decision|0|||
125240261|NCT03323502|450504382|FG000|Overall Study|Resident could not be linked to CMS data|594|||
125240262|NCT03323502|450504383|FG001|Overall Study|Resident could not be linked to CMS data|435|||
125240263|NCT03323502|450504382|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
125240264|NCT03323502|450504383|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
125240265|NCT03323502|450504382|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
125240266|NCT03323502|450504383|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
125240267|NCT03323502|450504382|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
125240268|NCT03323502|450504383|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
125240269|NCT03323502|450504382|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
125240270|NCT03323502|450504383|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
125240271|NCT02278354|450504384|FG000|Overall Study|Lost to Follow-up|2|||
125240272|NCT02278354|450504385|FG001|Overall Study|Lost to Follow-up|2|||
125240273|NCT02278354|450504384|FG000|Overall Study|Withdrawal by Subject|0|||
125240274|NCT02278354|450504385|FG001|Overall Study|Withdrawal by Subject|1|||
125240275|NCT02278354|450504384|FG000|Overall Study|<10 professional fights|2|||
125240276|NCT02278354|450504385|FG001|Overall Study|<10 professional fights|0|||
125240277|NCT06354257|450504392|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125240278|NCT06354257|450504392|FG000|Treatment Period 2|Adverse Event|1|||
125240279|NCT03168672|450504393|FG000|Overall Study|Withdrawal by Subject|13|||
125240280|NCT03168672|450504393|FG000|Overall Study|Death|3|||
125240281|NCT03168672|450504393|FG000|Overall Study|Investigator's Decision|137|||
125240282|NCT03168672|450504393|FG000|Overall Study|Adverse Event|1|||
125240283|NCT03168672|450504393|FG000|Overall Study|Other|2|||
125240284|NCT03168672|450504393|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
125240285|NCT00433537|450504394|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
125240286|NCT00433537|450504395|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
125240287|NCT00433537|450504396|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
125240288|NCT00433537|450504394|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
125240289|NCT00433537|450504395|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
125240290|NCT00433537|450504396|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
125240291|NCT00433537|450504394|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
125240292|NCT00433537|450504395|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
125240293|NCT00433537|450504396|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
125240294|NCT00433537|450504394|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
125240295|NCT00433537|450504395|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
125240296|NCT00433537|450504396|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
125186442|NCT02596971|450303645|FG000|Overall Study|Death|5|||
125186443|NCT02596971|450303646|FG001|Overall Study|Death|1|||
125186444|NCT02596971|450303647|FG002|Overall Study|Death|5|||
125186445|NCT02596971|450303645|FG000|Overall Study|Withdrawal by Subject|5|||
125186446|NCT02596971|450303646|FG001|Overall Study|Withdrawal by Subject|1|||
125186447|NCT02596971|450303647|FG002|Overall Study|Withdrawal by Subject|4|||
125186448|NCT00595920|450303648|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
125186449|NCT03588910|450303649|FG000|Overall Study|Withdrawal by Subject|1|||
125186450|NCT03588910|450303650|FG001|Overall Study|Withdrawal by Subject|0|||
125186451|NCT03588910|450303649|FG000|Overall Study|Allergy|2|||
125186452|NCT03588910|450303650|FG001|Overall Study|Allergy|0|||
125186453|NCT03588910|450303649|FG000|Overall Study|Protocol Violation|0|||
125186454|NCT03588910|450303650|FG001|Overall Study|Protocol Violation|3|||
125186455|NCT03588910|450303649|FG000|Overall Study|Did not complete Day 1 Survey|5|||
125186456|NCT03588910|450303650|FG001|Overall Study|Did not complete Day 1 Survey|10|||
125186457|NCT03588910|450303649|FG000|Overall Study|Did not complete Day 7 Survey|5|||
125186458|NCT03588910|450303650|FG001|Overall Study|Did not complete Day 7 Survey|2|||
125186459|NCT00611923|450303651|FG000|Overall Study|Withdrawal by Subject|2|||
125186460|NCT00611923|450303652|FG001|Overall Study|Withdrawal by Subject|2|||
125186461|NCT03802825|450303660|FG000|Overall Study|Lost to follow-up for intervention|12|||
125186462|NCT03802825|450303661|FG001|Overall Study|Lost to follow-up for intervention|3|||
125186463|NCT03802825|450303660|FG000|Overall Study|Received only 1 component of intervention|0|||
125186464|NCT03802825|450303661|FG001|Overall Study|Received only 1 component of intervention|13|||
125186465|NCT03428152|450303663|FG000|Overall Study|Physician Decision|4|||
125186466|NCT03428152|450303664|FG001|Overall Study|Physician Decision|2|||
125186467|NCT03428152|450303663|FG000|Overall Study|Protocol Violation|3|||
125186468|NCT03428152|450303664|FG001|Overall Study|Protocol Violation|5|||
125186469|NCT03428152|450303663|FG000|Overall Study|Lack of Efficacy|0|||
125186470|NCT03428152|450303664|FG001|Overall Study|Lack of Efficacy|4|||
125186471|NCT04426006|450303665|FG000|Inclusion|Protocol Violation|1|||
125186472|NCT04426006|450303665|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
125186473|NCT04426006|450303665|FG000|Inclusion|Blood sample at inclusion not done|1|||
125186474|NCT04426006|450303665|FG000|3 Months|Lost to Follow-up|17|||
125186475|NCT04426006|450303665|FG000|12 Months|Lost to Follow-up|38|||
125186476|NCT03380429|450303668|FG000|Overall Study|Physician Decision|0|||
125186477|NCT03380429|450303669|FG001|Overall Study|Physician Decision|1|||
125186478|NCT03380429|450303670|FG002|Overall Study|Physician Decision|0|||
125186479|NCT03380429|450303671|FG003|Overall Study|Physician Decision|1|||
125186480|NCT03380429|450303672|FG004|Overall Study|Physician Decision|1|||
125186481|NCT03380429|450303668|FG000|Overall Study|Withdrawal by Subject|3|||
125186482|NCT03380429|450303669|FG001|Overall Study|Withdrawal by Subject|3|||
125186483|NCT03380429|450303670|FG002|Overall Study|Withdrawal by Subject|5|||
125186484|NCT03380429|450303671|FG003|Overall Study|Withdrawal by Subject|2|||
125186485|NCT03380429|450303672|FG004|Overall Study|Withdrawal by Subject|1|||
125186486|NCT03380429|450303668|FG000|Overall Study|Lost to Follow-up|0|||
125186487|NCT03380429|450303669|FG001|Overall Study|Lost to Follow-up|2|||
125186488|NCT03380429|450303670|FG002|Overall Study|Lost to Follow-up|4|||
125186489|NCT03380429|450303671|FG003|Overall Study|Lost to Follow-up|3|||
125186490|NCT03380429|450303672|FG004|Overall Study|Lost to Follow-up|1|||
125186491|NCT03380429|450303668|FG000|Overall Study|Protocol Violation|1|||
125186492|NCT03380429|450303669|FG001|Overall Study|Protocol Violation|0|||
125186493|NCT03380429|450303670|FG002|Overall Study|Protocol Violation|1|||
125186494|NCT03380429|450303671|FG003|Overall Study|Protocol Violation|0|||
125186495|NCT03380429|450303672|FG004|Overall Study|Protocol Violation|1|||
125186496|NCT03380429|450303668|FG000|Overall Study|Lack of Efficacy|0|||
125186497|NCT03380429|450303669|FG001|Overall Study|Lack of Efficacy|0|||
125186498|NCT03380429|450303670|FG002|Overall Study|Lack of Efficacy|0|||
125186499|NCT03380429|450303671|FG003|Overall Study|Lack of Efficacy|2|||
125186500|NCT03380429|450303672|FG004|Overall Study|Lack of Efficacy|1|||
125186501|NCT03380429|450303668|FG000|Overall Study|Adverse Event|1|||
125186502|NCT03380429|450303669|FG001|Overall Study|Adverse Event|1|||
125186503|NCT03380429|450303670|FG002|Overall Study|Adverse Event|1|||
125186504|NCT03380429|450303671|FG003|Overall Study|Adverse Event|2|||
125186505|NCT03380429|450303672|FG004|Overall Study|Adverse Event|0|||
125186506|NCT01924689|450303674|FG000|Overall Study|Death|0|||
125186507|NCT01924689|450303675|FG001|Overall Study|Death|1|||
125186508|NCT01924689|450303676|FG002|Overall Study|Death|0|||
125186509|NCT01924689|450303677|FG003|Overall Study|Death|1|||
125186510|NCT01924689|450303678|FG004|Overall Study|Death|0|||
125186511|NCT01924689|450303679|FG005|Overall Study|Death|0|||
125186512|NCT01924689|450303674|FG000|Overall Study|Disease progression|0|||
125186513|NCT01924689|450303675|FG001|Overall Study|Disease progression|0|||
125186514|NCT01924689|450303676|FG002|Overall Study|Disease progression|2|||
125186515|NCT01924689|450303677|FG003|Overall Study|Disease progression|0|||
125186516|NCT01924689|450303678|FG004|Overall Study|Disease progression|3|||
125186517|NCT01924689|450303679|FG005|Overall Study|Disease progression|2|||
125186518|NCT01924689|450303674|FG000|Overall Study|New therapy or study|3|||
125186519|NCT01924689|450303675|FG001|Overall Study|New therapy or study|2|||
125186520|NCT01924689|450303676|FG002|Overall Study|New therapy or study|1|||
125240297|NCT00433537|450504394|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
125240298|NCT00433537|450504395|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
125240299|NCT00433537|450504396|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
125240300|NCT00433537|450504394|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
125240301|NCT00433537|450504395|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
125240302|NCT00433537|450504396|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
125240303|NCT00433537|450504394|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
125240304|NCT00433537|450504395|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
125240305|NCT00433537|450504396|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
125240306|NCT00433537|450504394|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
125240307|NCT00433537|450504395|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
125240308|NCT00433537|450504396|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
125240309|NCT00433537|450504394|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
125240310|NCT00433537|450504395|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
125240311|NCT00433537|450504396|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
125240312|NCT01757847|450504397|FG000|Overall Study|Withdrawal by Subject|3|||
125240313|NCT01757847|450504398|FG001|Overall Study|Withdrawal by Subject|4|||
125240314|NCT05436613|450504399|FG000|Overall Study|Lost to Follow-up|9|||
125240315|NCT05436613|450504399|FG000|Overall Study|Withdrawal by Subject|3|||
125240316|NCT04738487|450504400|FG000|Overall Study|Participant Ongoing in Study|298|||
125240317|NCT04738487|450504401|FG001|Overall Study|Participant Ongoing in Study|297|||
125240318|NCT04738487|450504400|FG000|Overall Study|Withdrawal by Subject|7|||
125240319|NCT04738487|450504401|FG001|Overall Study|Withdrawal by Subject|9|||
125240320|NCT04738487|450504400|FG000|Overall Study|Lost to Follow-up|2|||
125240321|NCT04738487|450504401|FG001|Overall Study|Lost to Follow-up|0|||
125240322|NCT04738487|450504400|FG000|Overall Study|Death|287|||
125240323|NCT04738487|450504401|FG001|Overall Study|Death|306|||
125240324|NCT05350202|450504402|FG000|Visit 1 - Baseline|Not-treated|18|||
125240325|NCT05350202|450504403|FG001|Visit 1 - Baseline|Not-treated|0|||
125240326|NCT05350202|450504402|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
125240327|NCT05350202|450504403|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
125240328|NCT05350202|450504402|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
125240329|NCT05350202|450504403|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
125240330|NCT05350202|450504402|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
125240331|NCT05350202|450504403|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
125240332|NCT05350202|450504402|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
125240333|NCT05350202|450504403|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
125240334|NCT05350202|450504402|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
125240335|NCT05350202|450504403|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
125240336|NCT05350202|450504402|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
125240337|NCT05350202|450504403|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
125240338|NCT05556057|450504404|FG000|Overall Study|Lost to Follow-up|5|||
125240339|NCT05556057|450504405|FG001|Overall Study|Lost to Follow-up|4|||
125240340|NCT05556057|450504404|FG000|Overall Study|Withdrawal by Subject|0|||
125240341|NCT05556057|450504405|FG001|Overall Study|Withdrawal by Subject|2|||
125240342|NCT02390284|450504412|FG000|Overall Study|Physician Decision|0|||
125240343|NCT02390284|450504413|FG001|Overall Study|Physician Decision|0|||
125240344|NCT02390284|450504414|FG002|Overall Study|Physician Decision|9|||
125240345|NCT00658528|450504417|FG000|Overall Study|Adverse Event|5|||
125240346|NCT00658528|450504418|FG001|Overall Study|Adverse Event|7|||
125240347|NCT00658528|450504417|FG000|Overall Study|Lost to Follow-up|14|||
125240348|NCT00658528|450504418|FG001|Overall Study|Lost to Follow-up|22|||
125240349|NCT00658528|450504417|FG000|Overall Study|Withdrawal by Subject|8|||
125240350|NCT00658528|450504418|FG001|Overall Study|Withdrawal by Subject|6|||
125240351|NCT00658528|450504417|FG000|Overall Study|Withdrawal of consent|5|||
125240352|NCT00658528|450504418|FG001|Overall Study|Withdrawal of consent|6|||
125240353|NCT00658528|450504417|FG000|Overall Study|Other|8|||
125240354|NCT00658528|450504418|FG001|Overall Study|Other|4|||
125240355|NCT01937299|450504419|FG000|Overall Study|Adverse Event|13|||
125240356|NCT01937299|450504420|FG001|Overall Study|Adverse Event|0|||
125240357|NCT01937299|450504419|FG000|Overall Study|Lack of Efficacy|0|||
125240358|NCT01937299|450504420|FG001|Overall Study|Lack of Efficacy|4|||
125240359|NCT01937299|450504419|FG000|Overall Study|Withdrawal by Subject|1|||
125240360|NCT01937299|450504420|FG001|Overall Study|Withdrawal by Subject|0|||
125240361|NCT04017962|450504421|FG000|Overall Study|Death|2|||
125240362|NCT04017962|450504422|FG001|Overall Study|Death|0|||
125240363|NCT04017962|450504421|FG000|Overall Study|Lost to Follow-up|2|||
125240364|NCT04017962|450504422|FG001|Overall Study|Lost to Follow-up|0|||
125240365|NCT04017962|450504421|FG000|Overall Study|Physician Decision|1|||
125240366|NCT04017962|450504422|FG001|Overall Study|Physician Decision|0|||
125240367|NCT04017962|450504421|FG000|Overall Study|Discontinued LTV|5|||
125240368|NCT04017962|450504422|FG001|Overall Study|Discontinued LTV|0|||
125240369|NCT01260948|450504430|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
125240370|NCT01260948|450504431|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
125240371|NCT01260948|450504430|FG000|Second Intervention|Emesis|0|||
125240372|NCT01260948|450504431|FG001|Second Intervention|Emesis|1|||
125240373|NCT00462462|450504432|FG000|Overall Study|Physician Decision|0|||
125240374|NCT00462462|450504433|FG001|Overall Study|Physician Decision|1|||
125240375|NCT01163617|450504434|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
125240376|NCT01163617|450504435|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
125240377|NCT01163617|450504436|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
125240378|NCT01163617|450504437|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
125240379|NCT01163617|450504438|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
125240380|NCT01163617|450504439|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
125240381|NCT01163617|450504440|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
125240382|NCT01163617|450504441|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
125240383|NCT01163617|450504434|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
125240384|NCT01163617|450504435|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
125240385|NCT01163617|450504436|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
125240386|NCT01163617|450504437|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
125240387|NCT01163617|450504438|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
125240388|NCT01163617|450504439|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
125240389|NCT01163617|450504440|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
125240390|NCT01163617|450504441|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
125240391|NCT01163617|450504434|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
125240392|NCT01163617|450504435|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
125240393|NCT01163617|450504436|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
125240394|NCT01163617|450504437|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
125240395|NCT01163617|450504438|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
125240396|NCT01163617|450504439|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
125240397|NCT01163617|450504440|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
125240398|NCT01163617|450504441|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
125240399|NCT02394756|450504442|FG000|Period 1|Lens Discomfort|0|||
125240400|NCT02394756|450504443|FG001|Period 1|Lens Discomfort|0|||
125240401|NCT02394756|450504444|FG002|Period 1|Lens Discomfort|0|||
125240402|NCT02394756|450504445|FG003|Period 1|Lens Discomfort|0|||
125240403|NCT02394756|450504446|FG004|Period 1|Lens Discomfort|0|||
125240404|NCT02394756|450504447|FG005|Period 1|Lens Discomfort|1|||
125240405|NCT02394756|450504442|FG000|Period 1|Withdrawal by Subject|0|||
125240406|NCT02394756|450504443|FG001|Period 1|Withdrawal by Subject|1|||
125240407|NCT02394756|450504444|FG002|Period 1|Withdrawal by Subject|1|||
125240408|NCT02394756|450504445|FG003|Period 1|Withdrawal by Subject|1|||
125240409|NCT02394756|450504446|FG004|Period 1|Withdrawal by Subject|0|||
125240410|NCT02394756|450504447|FG005|Period 1|Withdrawal by Subject|0|||
125240411|NCT02394756|450504442|FG000|Period 2|Unsatisfactory Visual Response|0|||
125240412|NCT02394756|450504443|FG001|Period 2|Unsatisfactory Visual Response|0|||
125240413|NCT02394756|450504444|FG002|Period 2|Unsatisfactory Visual Response|0|||
125240414|NCT02394756|450504445|FG003|Period 2|Unsatisfactory Visual Response|0|||
125240415|NCT02394756|450504446|FG004|Period 2|Unsatisfactory Visual Response|1|||
125240416|NCT02394756|450504447|FG005|Period 2|Unsatisfactory Visual Response|0|||
125240417|NCT02335944|450504448|FG000|Treatment Phase|Progressive Disease|2|||
125240418|NCT02335944|450504449|FG001|Treatment Phase|Progressive Disease|5|||
125240419|NCT02335944|450504450|FG002|Treatment Phase|Progressive Disease|2|||
125240420|NCT02335944|450504451|FG003|Treatment Phase|Progressive Disease|11|||
125240421|NCT02335944|450504452|FG004|Treatment Phase|Progressive Disease|4|||
125240422|NCT02335944|450504453|FG005|Treatment Phase|Progressive Disease|25|||
125240423|NCT02335944|450504454|FG006|Treatment Phase|Progressive Disease|2|||
125240424|NCT02335944|450504455|FG007|Treatment Phase|Progressive Disease|30|||
125240425|NCT02335944|450504456|FG008|Treatment Phase|Progressive Disease|27|||
125240426|NCT02335944|450504457|FG009|Treatment Phase|Progressive Disease|0|||
125240427|NCT02335944|450504448|FG000|Treatment Phase|Adverse Event|2|||
125240428|NCT02335944|450504449|FG001|Treatment Phase|Adverse Event|0|||
125186521|NCT01924689|450303677|FG003|Overall Study|New therapy or study|4|||
125186522|NCT01924689|450303678|FG004|Overall Study|New therapy or study|2|||
125186523|NCT01924689|450303679|FG005|Overall Study|New therapy or study|0|||
125186524|NCT01924689|450303674|FG000|Overall Study|Withdrawal of consent|0|||
125186525|NCT01924689|450303675|FG001|Overall Study|Withdrawal of consent|0|||
125186526|NCT01924689|450303676|FG002|Overall Study|Withdrawal of consent|1|||
125186527|NCT01924689|450303677|FG003|Overall Study|Withdrawal of consent|1|||
125186528|NCT01924689|450303678|FG004|Overall Study|Withdrawal of consent|0|||
125186529|NCT01924689|450303679|FG005|Overall Study|Withdrawal of consent|0|||
125186530|NCT01924689|450303674|FG000|Overall Study|Other|0|||
125186531|NCT01924689|450303675|FG001|Overall Study|Other|0|||
125186532|NCT01924689|450303676|FG002|Overall Study|Other|0|||
125186533|NCT01924689|450303677|FG003|Overall Study|Other|0|||
125186534|NCT01924689|450303678|FG004|Overall Study|Other|1|||
125186535|NCT01924689|450303679|FG005|Overall Study|Other|0|||
125186536|NCT03267212|450303680|FG000|First Intervention|Lost to Follow-up|0|||
125186537|NCT03267212|450303681|FG001|First Intervention|Lost to Follow-up|2|||
125186538|NCT03267212|450303680|FG000|First Intervention|Withdrawal by Subject|1|||
125186539|NCT03267212|450303681|FG001|First Intervention|Withdrawal by Subject|1|||
125186540|NCT03267212|450303680|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
125186541|NCT03267212|450303681|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
125186542|NCT05691712|450303684|FG000|Overall Study|Adverse Event|0|||
125186543|NCT05691712|450303685|FG001|Overall Study|Adverse Event|1|||
125186544|NCT05691712|450303686|FG002|Overall Study|Adverse Event|2|||
125186545|NCT05691712|450303687|FG003|Overall Study|Adverse Event|1|||
125186546|NCT05691712|450303684|FG000|Overall Study|Withdrawal by Subject|2|||
125186547|NCT05691712|450303685|FG001|Overall Study|Withdrawal by Subject|3|||
125186548|NCT05691712|450303686|FG002|Overall Study|Withdrawal by Subject|3|||
125186549|NCT05691712|450303687|FG003|Overall Study|Withdrawal by Subject|1|||
125186550|NCT05691712|450303684|FG000|Overall Study|Death|1|||
125186551|NCT05691712|450303685|FG001|Overall Study|Death|0|||
125186552|NCT05691712|450303686|FG002|Overall Study|Death|0|||
125186553|NCT05691712|450303687|FG003|Overall Study|Death|0|||
125186554|NCT05691712|450303684|FG000|Overall Study|Pregnancy|0|||
125186555|NCT05691712|450303685|FG001|Overall Study|Pregnancy|1|||
125186556|NCT05691712|450303686|FG002|Overall Study|Pregnancy|0|||
125186557|NCT05691712|450303687|FG003|Overall Study|Pregnancy|0|||
125186558|NCT05691712|450303684|FG000|Overall Study|Assigned Treatment by Mistake|1|||
125186559|NCT05691712|450303685|FG001|Overall Study|Assigned Treatment by Mistake|0|||
125186560|NCT05691712|450303686|FG002|Overall Study|Assigned Treatment by Mistake|0|||
125186561|NCT05691712|450303687|FG003|Overall Study|Assigned Treatment by Mistake|1|||
125186562|NCT00226499|450303688|FG000|Overall Study|Adverse Event|10|||
125186563|NCT00226499|450303689|FG001|Overall Study|Adverse Event|6|||
125186564|NCT00226499|450303690|FG002|Overall Study|Adverse Event|3|||
125186565|NCT00226499|450303688|FG000|Overall Study|Others|1064|||
125186566|NCT00226499|450303689|FG001|Overall Study|Others|1066|||
125186567|NCT00226499|450303690|FG002|Overall Study|Others|356|||
125186568|NCT00946920|450303691|FG000|Overall Study|Withdrawal by Subject|28|||
125186569|NCT00946920|450303692|FG001|Overall Study|Withdrawal by Subject|15|||
125186570|NCT00946920|450303691|FG000|Overall Study|Lost to Follow-up|2|||
125186571|NCT00946920|450303692|FG001|Overall Study|Lost to Follow-up|2|||
125186572|NCT00946920|450303691|FG000|Overall Study|Physician Decision|5|||
125186573|NCT00946920|450303692|FG001|Overall Study|Physician Decision|2|||
125186574|NCT00946920|450303691|FG000|Overall Study|Adverse Event|41|||
125186575|NCT00946920|450303692|FG001|Overall Study|Adverse Event|14|||
125186576|NCT00946920|450303691|FG000|Overall Study|Protocol Violation|16|||
125240429|NCT02335944|450504450|FG002|Treatment Phase|Adverse Event|0|||
125240430|NCT02335944|450504451|FG003|Treatment Phase|Adverse Event|2|||
125186577|NCT00946920|450303692|FG001|Overall Study|Protocol Violation|8|||
125186578|NCT00946920|450303691|FG000|Overall Study|Miscellaneous reasons|18|||
125186579|NCT00946920|450303692|FG001|Overall Study|Miscellaneous reasons|3|||
125186580|NCT01288079|450303702|FG000|Overall Study|Withdrawal by Subject|2|||
125186581|NCT01288079|450303703|FG001|Overall Study|Withdrawal by Subject|4|||
125240431|NCT02335944|450504452|FG004|Treatment Phase|Adverse Event|1|||
125240432|NCT02335944|450504453|FG005|Treatment Phase|Adverse Event|15|||
125240433|NCT02335944|450504454|FG006|Treatment Phase|Adverse Event|0|||
125240434|NCT02335944|450504455|FG007|Treatment Phase|Adverse Event|5|||
125240435|NCT02335944|450504456|FG008|Treatment Phase|Adverse Event|7|||
125240436|NCT02335944|450504457|FG009|Treatment Phase|Adverse Event|0|||
125240437|NCT02335944|450504448|FG000|Treatment Phase|Physician Decision|0|||
125240438|NCT02335944|450504449|FG001|Treatment Phase|Physician Decision|0|||
125240439|NCT02335944|450504450|FG002|Treatment Phase|Physician Decision|0|||
125240440|NCT02335944|450504451|FG003|Treatment Phase|Physician Decision|1|||
125240441|NCT02335944|450504452|FG004|Treatment Phase|Physician Decision|0|||
125240442|NCT02335944|450504453|FG005|Treatment Phase|Physician Decision|6|||
125240443|NCT02335944|450504454|FG006|Treatment Phase|Physician Decision|1|||
125240444|NCT02335944|450504455|FG007|Treatment Phase|Physician Decision|2|||
125240445|NCT02335944|450504456|FG008|Treatment Phase|Physician Decision|1|||
125240446|NCT02335944|450504457|FG009|Treatment Phase|Physician Decision|0|||
125240447|NCT02335944|450504448|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
125240448|NCT02335944|450504449|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
125240449|NCT02335944|450504450|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
125240450|NCT02335944|450504451|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
125240451|NCT02335944|450504452|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
125240452|NCT02335944|450504453|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
125240453|NCT02335944|450504454|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
125240454|NCT02335944|450504455|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
125240455|NCT02335944|450504456|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
125240456|NCT02335944|450504457|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
125240457|NCT02335944|450504448|FG000|Treatment Phase|Subject/Guardian Decision|0|||
125240458|NCT02335944|450504449|FG001|Treatment Phase|Subject/Guardian Decision|0|||
125240459|NCT02335944|450504450|FG002|Treatment Phase|Subject/Guardian Decision|1|||
125240460|NCT02335944|450504451|FG003|Treatment Phase|Subject/Guardian Decision|0|||
125240461|NCT02335944|450504452|FG004|Treatment Phase|Subject/Guardian Decision|0|||
125240462|NCT02335944|450504453|FG005|Treatment Phase|Subject/Guardian Decision|1|||
125240463|NCT02335944|450504454|FG006|Treatment Phase|Subject/Guardian Decision|0|||
125240464|NCT02335944|450504455|FG007|Treatment Phase|Subject/Guardian Decision|4|||
125240465|NCT02335944|450504456|FG008|Treatment Phase|Subject/Guardian Decision|0|||
125240466|NCT02335944|450504457|FG009|Treatment Phase|Subject/Guardian Decision|0|||
125240467|NCT02335944|450504448|FG000|Post-treatment Follow-up|Progressive Disease|0|||
125240468|NCT02335944|450504449|FG001|Post-treatment Follow-up|Progressive Disease|0|||
125240469|NCT02335944|450504450|FG002|Post-treatment Follow-up|Progressive Disease|0|||
125240470|NCT02335944|450504451|FG003|Post-treatment Follow-up|Progressive Disease|1|||
125240471|NCT02335944|450504452|FG004|Post-treatment Follow-up|Progressive Disease|0|||
125240472|NCT02335944|450504453|FG005|Post-treatment Follow-up|Progressive Disease|9|||
125240473|NCT02335944|450504454|FG006|Post-treatment Follow-up|Progressive Disease|0|||
125240474|NCT02335944|450504455|FG007|Post-treatment Follow-up|Progressive Disease|2|||
125240475|NCT02335944|450504456|FG008|Post-treatment Follow-up|Progressive Disease|3|||
125240476|NCT02335944|450504457|FG009|Post-treatment Follow-up|Progressive Disease|0|||
125240477|NCT02335944|450504448|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
125240478|NCT02335944|450504449|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
125240479|NCT02335944|450504450|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
125240480|NCT02335944|450504451|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
125240481|NCT02335944|450504452|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
125240482|NCT02335944|450504453|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
125240483|NCT02335944|450504454|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
125240484|NCT02335944|450504455|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
125240485|NCT02335944|450504456|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
125240486|NCT02335944|450504457|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
125240487|NCT02335944|450504448|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
125240488|NCT02335944|450504449|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
125240489|NCT02335944|450504450|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
125240490|NCT02335944|450504451|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
125240491|NCT02335944|450504452|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
125240492|NCT02335944|450504453|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
125240493|NCT02335944|450504454|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
125240494|NCT02335944|450504455|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
125240495|NCT02335944|450504456|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
125240496|NCT02335944|450504457|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
125240497|NCT02335944|450504448|FG000|Post-treatment Follow-up|Adverse Event|0|||
125240498|NCT02335944|450504449|FG001|Post-treatment Follow-up|Adverse Event|0|||
125240499|NCT02335944|450504450|FG002|Post-treatment Follow-up|Adverse Event|0|||
125240500|NCT02335944|450504451|FG003|Post-treatment Follow-up|Adverse Event|0|||
125240501|NCT02335944|450504452|FG004|Post-treatment Follow-up|Adverse Event|0|||
125240502|NCT02335944|450504453|FG005|Post-treatment Follow-up|Adverse Event|1|||
125240503|NCT02335944|450504454|FG006|Post-treatment Follow-up|Adverse Event|0|||
125240504|NCT02335944|450504455|FG007|Post-treatment Follow-up|Adverse Event|0|||
125240505|NCT02335944|450504456|FG008|Post-treatment Follow-up|Adverse Event|0|||
125240506|NCT02335944|450504457|FG009|Post-treatment Follow-up|Adverse Event|0|||
125240507|NCT02335944|450504448|FG000|Post-treatment Follow-up|Death|0|||
125240508|NCT02335944|450504449|FG001|Post-treatment Follow-up|Death|0|||
125240509|NCT02335944|450504450|FG002|Post-treatment Follow-up|Death|0|||
125240510|NCT02335944|450504451|FG003|Post-treatment Follow-up|Death|1|||
125240511|NCT02335944|450504452|FG004|Post-treatment Follow-up|Death|0|||
125240512|NCT02335944|450504453|FG005|Post-treatment Follow-up|Death|1|||
125240513|NCT02335944|450504454|FG006|Post-treatment Follow-up|Death|0|||
125240514|NCT02335944|450504455|FG007|Post-treatment Follow-up|Death|0|||
125240515|NCT02335944|450504456|FG008|Post-treatment Follow-up|Death|0|||
125240516|NCT02335944|450504457|FG009|Post-treatment Follow-up|Death|0|||
125240517|NCT02335944|450504448|FG000|Post-treatment Follow-up|Physician Decision|1|||
125240518|NCT02335944|450504449|FG001|Post-treatment Follow-up|Physician Decision|0|||
125240519|NCT02335944|450504450|FG002|Post-treatment Follow-up|Physician Decision|0|||
125240520|NCT02335944|450504451|FG003|Post-treatment Follow-up|Physician Decision|0|||
125240521|NCT02335944|450504452|FG004|Post-treatment Follow-up|Physician Decision|0|||
125240522|NCT02335944|450504453|FG005|Post-treatment Follow-up|Physician Decision|0|||
125240523|NCT02335944|450504454|FG006|Post-treatment Follow-up|Physician Decision|0|||
125240524|NCT02335944|450504455|FG007|Post-treatment Follow-up|Physician Decision|1|||
125240525|NCT02335944|450504456|FG008|Post-treatment Follow-up|Physician Decision|0|||
125240526|NCT02335944|450504457|FG009|Post-treatment Follow-up|Physician Decision|0|||
125240527|NCT01706328|450504463|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
125240528|NCT01706328|450504464|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
125240529|NCT01706328|450504465|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
125240530|NCT01706328|450504463|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
125240531|NCT01706328|450504464|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
125240532|NCT01706328|450504465|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
125240533|NCT01706328|450504463|FG000|2-week Run-in Period|Physician Decision|4|||
125240534|NCT01706328|450504464|FG001|2-week Run-in Period|Physician Decision|0|||
125240535|NCT01706328|450504465|FG002|2-week Run-in Period|Physician Decision|0|||
125240536|NCT01706328|450504463|FG000|2-week Run-in Period|Adverse Event|4|||
125240537|NCT01706328|450504464|FG001|2-week Run-in Period|Adverse Event|0|||
125240538|NCT01706328|450504465|FG002|2-week Run-in Period|Adverse Event|0|||
125240539|NCT01706328|450504463|FG000|2-week Run-in Period|Lost to Follow-up|2|||
125240540|NCT01706328|450504464|FG001|2-week Run-in Period|Lost to Follow-up|0|||
125240541|NCT01706328|450504465|FG002|2-week Run-in Period|Lost to Follow-up|0|||
125240542|NCT01706328|450504463|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
125240543|NCT01706328|450504464|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
125240544|NCT01706328|450504465|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
125240545|NCT01706328|450504463|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
125240546|NCT01706328|450504464|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
125240547|NCT01706328|450504465|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
125240548|NCT01706328|450504463|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
125240549|NCT01706328|450504464|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
125240550|NCT01706328|450504465|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
125240551|NCT01706328|450504463|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
125240552|NCT01706328|450504464|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
125240553|NCT01706328|450504465|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
125240554|NCT01706328|450504463|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
125240555|NCT01706328|450504464|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
125240556|NCT01706328|450504465|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
125240557|NCT01706328|450504463|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
125240558|NCT01706328|450504464|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
125240559|NCT01706328|450504465|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
125240560|NCT01706328|450504463|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
125240561|NCT01706328|450504464|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
125240562|NCT01706328|450504465|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
125240563|NCT03018938|450504468|FG000|Overall Study|Death|0|||
125240564|NCT03018938|450504469|FG001|Overall Study|Death|1|||
125240565|NCT03018938|450504468|FG000|Overall Study|Lost to Follow-up|21|||
125240566|NCT03018938|450504469|FG001|Overall Study|Lost to Follow-up|32|||
125240567|NCT03018938|450504468|FG000|Overall Study|Withdrawal by Subject|38|||
125240568|NCT03018938|450504469|FG001|Overall Study|Withdrawal by Subject|45|||
125240569|NCT03018938|450504468|FG000|Overall Study|Physician Decision|3|||
125240570|NCT03018938|450504469|FG001|Overall Study|Physician Decision|2|||
125240571|NCT03018938|450504468|FG000|Overall Study|Sponsor Decision|0|||
125240572|NCT03018938|450504469|FG001|Overall Study|Sponsor Decision|1|||
125240573|NCT03018938|450504468|FG000|Overall Study|Screen failure-After randomization|4|||
125240574|NCT03018938|450504469|FG001|Overall Study|Screen failure-After randomization|2|||
125240575|NCT03018938|450504468|FG000|Overall Study|Not recorded|0|||
125240576|NCT03018938|450504469|FG001|Overall Study|Not recorded|2|||
125240577|NCT00191100|450504470|FG000|Overall Study|Adverse Event|18|||
125240578|NCT00191100|450504471|FG001|Overall Study|Adverse Event|1|||
125240579|NCT00191100|450504470|FG000|Overall Study|Lost to Follow-up|2|||
125240580|NCT00191100|450504471|FG001|Overall Study|Lost to Follow-up|0|||
125240581|NCT00191100|450504470|FG000|Overall Study|Patient Moved|0|||
125240582|NCT00191100|450504471|FG001|Overall Study|Patient Moved|1|||
125240583|NCT00191100|450504470|FG000|Overall Study|Withdrawal by Subject|9|||
125240584|NCT00191100|450504471|FG001|Overall Study|Withdrawal by Subject|3|||
125240585|NCT00191100|450504470|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
125240586|NCT00191100|450504471|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
125240587|NCT00191100|450504470|FG000|Overall Study|Clinical Relapse|2|||
125240588|NCT00191100|450504471|FG001|Overall Study|Clinical Relapse|1|||
125240589|NCT00191100|450504470|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
125240590|NCT00191100|450504471|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
125240591|NCT00191100|450504470|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
125240592|NCT00191100|450504471|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
125240593|NCT00191100|450504470|FG000|Overall Study|Physician Decision|3|||
125240594|NCT00191100|450504471|FG001|Overall Study|Physician Decision|1|||
125240595|NCT00191100|450504470|FG000|Overall Study|Death from Study Drug Toxicity|2|||
125240596|NCT00191100|450504471|FG001|Overall Study|Death from Study Drug Toxicity|0|||
125240597|NCT00191100|450504470|FG000|Overall Study|Protocol Violation|1|||
125240598|NCT00191100|450504471|FG001|Overall Study|Protocol Violation|1|||
125240599|NCT00191100|450504470|FG000|Overall Study|Death from Other Cause|1|||
125240600|NCT00191100|450504471|FG001|Overall Study|Death from Other Cause|0|||
125240601|NCT00191100|450504470|FG000|Overall Study|Reason Not Specified|0|||
125240602|NCT00191100|450504471|FG001|Overall Study|Reason Not Specified|1|||
125240603|NCT02811159|450504474|FG000|Treatment Course 1|Lost to Follow-up|1|||
125240604|NCT02916771|450504475|FG000|Overall Study|Withdrawal by Subject|9|||
125240605|NCT02916771|450504475|FG000|Overall Study|Physician Decision|1|||
125240606|NCT02916771|450504475|FG000|Overall Study|Began treatment for another active malignancy|1|||
125240607|NCT01525589|450504476|FG000|Overall Study|Non-treatment-related AE|1|||
125240608|NCT01525589|450504477|FG001|Overall Study|Non-treatment-related AE|0|||
125240609|NCT01525589|450504478|FG002|Overall Study|Non-treatment-related AE|0|||
125240610|NCT01525589|450504476|FG000|Overall Study|Progressive disease|48|||
125240611|NCT01525589|450504477|FG001|Overall Study|Progressive disease|15|||
125240612|NCT01525589|450504478|FG002|Overall Study|Progressive disease|29|||
125240613|NCT01525589|450504476|FG000|Overall Study|Never treated|2|||
125240614|NCT01525589|450504477|FG001|Overall Study|Never treated|0|||
125240615|NCT01525589|450504478|FG002|Overall Study|Never treated|0|||
125240616|NCT01525589|450504476|FG000|Overall Study|Physician Decision|4|||
125240617|NCT01525589|450504477|FG001|Overall Study|Physician Decision|2|||
125240618|NCT01525589|450504478|FG002|Overall Study|Physician Decision|2|||
125240619|NCT01525589|450504476|FG000|Overall Study|Death|0|||
125240620|NCT01525589|450504477|FG001|Overall Study|Death|0|||
125240621|NCT01525589|450504478|FG002|Overall Study|Death|2|||
125240622|NCT01525589|450504476|FG000|Overall Study|Treatment-related AE|1|||
125240623|NCT01525589|450504477|FG001|Overall Study|Treatment-related AE|1|||
125240624|NCT01525589|450504478|FG002|Overall Study|Treatment-related AE|2|||
125240625|NCT01525589|450504476|FG000|Overall Study|Other reasons|0|||
125240626|NCT01525589|450504477|FG001|Overall Study|Other reasons|1|||
125240627|NCT01525589|450504478|FG002|Overall Study|Other reasons|0|||
125240628|NCT01525589|450504476|FG000|Overall Study|Withdrawal by Subject|0|||
125240629|NCT01525589|450504477|FG001|Overall Study|Withdrawal by Subject|1|||
125240630|NCT01525589|450504478|FG002|Overall Study|Withdrawal by Subject|0|||
125240631|NCT02924376|450504479|FG000|Overall Study|Progressive Disease|4|||
125240632|NCT02924376|450504480|FG001|Overall Study|Progressive Disease|0|||
125240633|NCT02924376|450504481|FG002|Overall Study|Progressive Disease|1|||
125240634|NCT02924376|450504482|FG003|Overall Study|Progressive Disease|0|||
125240635|NCT02924376|450504479|FG000|Overall Study|Death|73|||
125240636|NCT02924376|450504480|FG001|Overall Study|Death|18|||
125240637|NCT02924376|450504481|FG002|Overall Study|Death|15|||
125240638|NCT02924376|450504482|FG003|Overall Study|Death|2|||
125240639|NCT02924376|450504479|FG000|Overall Study|Lost to Follow-up|3|||
125240640|NCT02924376|450504480|FG001|Overall Study|Lost to Follow-up|0|||
125240641|NCT02924376|450504481|FG002|Overall Study|Lost to Follow-up|0|||
125240642|NCT02924376|450504482|FG003|Overall Study|Lost to Follow-up|0|||
125240643|NCT02924376|450504479|FG000|Overall Study|Study Terminated by Sponsor|19|||
125240644|NCT02924376|450504480|FG001|Overall Study|Study Terminated by Sponsor|0|||
125240645|NCT02924376|450504481|FG002|Overall Study|Study Terminated by Sponsor|0|||
125240646|NCT02924376|450504482|FG003|Overall Study|Study Terminated by Sponsor|0|||
125240647|NCT02924376|450504479|FG000|Overall Study|Physician Decision|1|||
125240648|NCT02924376|450504480|FG001|Overall Study|Physician Decision|0|||
125240649|NCT02924376|450504481|FG002|Overall Study|Physician Decision|0|||
125240650|NCT02924376|450504482|FG003|Overall Study|Physician Decision|0|||
125240651|NCT02924376|450504479|FG000|Overall Study|Withdrawal by Subject|7|||
125240652|NCT02924376|450504480|FG001|Overall Study|Withdrawal by Subject|2|||
125240653|NCT02924376|450504481|FG002|Overall Study|Withdrawal by Subject|1|||
125240654|NCT02924376|450504482|FG003|Overall Study|Withdrawal by Subject|0|||
125240655|NCT02924376|450504479|FG000|Overall Study|Rolled Over to Another Study|1|||
125240656|NCT02924376|450504480|FG001|Overall Study|Rolled Over to Another Study|0|||
125240657|NCT02924376|450504481|FG002|Overall Study|Rolled Over to Another Study|0|||
125240658|NCT02924376|450504482|FG003|Overall Study|Rolled Over to Another Study|0|||
125240659|NCT05763875|450504488|FG000|Overall Study|Subject decision|5|||
125240660|NCT05763875|450504489|FG001|Overall Study|Subject decision|2|||
125240661|NCT05763875|450504490|FG002|Overall Study|Subject decision|1|||
125240662|NCT05763875|450504488|FG000|Overall Study|Lost to Follow-up|4|||
125240663|NCT05763875|450504489|FG001|Overall Study|Lost to Follow-up|1|||
125240664|NCT05763875|450504490|FG002|Overall Study|Lost to Follow-up|2|||
125240665|NCT05763875|450504488|FG000|Overall Study|Adverse Event|1|||
125240666|NCT05763875|450504489|FG001|Overall Study|Adverse Event|0|||
125240667|NCT05763875|450504490|FG002|Overall Study|Adverse Event|0|||
125240668|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
125240669|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
125240670|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
125240671|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
125240672|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
125240673|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
125240674|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
125240675|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
125240676|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
125240677|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
125240678|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
125240679|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
125240680|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
125240681|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
125240682|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
125240683|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
125240684|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
125240685|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
125240686|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
125240687|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
125240688|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
125240689|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
125240690|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
125240691|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
125240692|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
125240693|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
125240694|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
125240695|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
125240696|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
125240697|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
125240698|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
125240699|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
125240700|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
125240701|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
125240702|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
125240703|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
125240704|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
125240705|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
125240706|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
125240707|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
125240708|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
125240709|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
125240710|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
125240711|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
125240712|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
125240713|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
125240714|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
125240715|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
125240716|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
125240717|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
125240718|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
125240719|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
125240720|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
125240721|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
125240722|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
125240723|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
125240724|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
125240725|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
125240726|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
125240727|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
125240728|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
125240729|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
125240730|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
125240731|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
125240732|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
125240733|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
125240734|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
125240735|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
125240736|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
125240737|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
125240738|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
125240739|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
125240740|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
125240741|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
125240742|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
125240743|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
125240744|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Study suspension|0|||
125240745|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Study suspension|45|||
125240746|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Study suspension|0|||
125240747|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Study suspension|0|||
125240748|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
125240749|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
125240750|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
125240751|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
125240752|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Death|2|||
125240753|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Death|3|||
125240754|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Death|0|||
125240755|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Death|0|||
125240756|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
125240757|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
125240758|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
125240759|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
125240760|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
125240761|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
125240762|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
125240763|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
125240764|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
125240765|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
125240766|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
125240767|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
125240768|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
125240769|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
125240770|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
125240771|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
125240772|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
125240773|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
125240774|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
125240775|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
125240776|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
125240777|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
125240778|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
125240779|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
125240780|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
125240781|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
125240782|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
125240783|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
125240784|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Other|1|||
125240785|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Other|2|||
125240786|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Other|0|||
125240787|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Other|0|||
125240788|NCT04132050|450505066|FG000|Period I (Double-blind Period)|Adverse Event|3|||
125240789|NCT04132050|450505067|FG001|Period I (Double-blind Period)|Adverse Event|0|||
125240790|NCT04132050|450505066|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
125240791|NCT04132050|450505067|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
125240792|NCT04132050|450505066|FG000|R788 Treatment Period|Adverse Event|5|||
125240793|NCT04132050|450505067|FG001|R788 Treatment Period|Adverse Event|0|||
125240794|NCT04132050|450505066|FG000|R788 Treatment Period|Lack of Efficacy|5|||
125240795|NCT04132050|450505067|FG001|R788 Treatment Period|Lack of Efficacy|0|||
125240796|NCT04132050|450505066|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
125240797|NCT04132050|450505067|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
125240798|NCT03506477|450505068|FG000|Overall Study|Withdrawal by Subject|1|||
125240799|NCT03506477|450505069|FG001|Overall Study|Withdrawal by Subject|0|||
125240800|NCT00843882|450505070|FG000|Step 1|Lack of Efficacy|14|||
125240801|NCT00843882|450505071|FG001|Step 1|Lack of Efficacy|10|||
125240802|NCT00843882|450505072|FG002|Step 1|Lack of Efficacy|21|||
125240803|NCT00843882|450505070|FG000|Step 1|Adverse Event|8|||
125240804|NCT00843882|450505071|FG001|Step 1|Adverse Event|17|||
125240805|NCT00843882|450505072|FG002|Step 1|Adverse Event|20|||
125240806|NCT00843882|450505070|FG000|Step 1|Death|1|||
125240807|NCT00843882|450505071|FG001|Step 1|Death|2|||
125240808|NCT00843882|450505072|FG002|Step 1|Death|4|||
125240809|NCT00843882|450505070|FG000|Step 1|Withdrawal by Subject|6|||
125240810|NCT00843882|450505071|FG001|Step 1|Withdrawal by Subject|12|||
125240811|NCT00843882|450505072|FG002|Step 1|Withdrawal by Subject|9|||
125240812|NCT00843882|450505070|FG000|Step 1|Physician Decision|0|||
125240813|NCT00843882|450505071|FG001|Step 1|Physician Decision|5|||
125240814|NCT00843882|450505072|FG002|Step 1|Physician Decision|1|||
125240815|NCT00843882|450505070|FG000|Step 1|Patient and physician's decision|0|||
125240816|NCT00843882|450505071|FG001|Step 1|Patient and physician's decision|0|||
125240817|NCT00843882|450505072|FG002|Step 1|Patient and physician's decision|1|||
125240818|NCT00843882|450505070|FG000|Step 1|Other complicating disease|1|||
125240819|NCT00843882|450505071|FG001|Step 1|Other complicating disease|3|||
125240820|NCT00843882|450505072|FG002|Step 1|Other complicating disease|4|||
125240821|NCT00843882|450505070|FG000|Step 1|Alternative therapy|0|||
125240822|NCT00843882|450505071|FG001|Step 1|Alternative therapy|1|||
125240823|NCT00843882|450505072|FG002|Step 1|Alternative therapy|1|||
125240824|NCT00843882|450505070|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
125240825|NCT00843882|450505071|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
125240826|NCT00843882|450505072|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
125240827|NCT00843882|450505070|FG000|Step 1|Off treatment reason unknown|0|||
125240828|NCT00843882|450505071|FG001|Step 1|Off treatment reason unknown|1|||
125240829|NCT00843882|450505072|FG002|Step 1|Off treatment reason unknown|4|||
125240830|NCT00843882|450505070|FG000|Step 1|Never started treatment|2|||
125240831|NCT00843882|450505071|FG001|Step 1|Never started treatment|0|||
125240832|NCT00843882|450505072|FG002|Step 1|Never started treatment|0|||
125240833|NCT00843882|450505070|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
125240834|NCT00843882|450505071|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
125240835|NCT00843882|450505072|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
125240836|NCT00843882|450505070|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
125240837|NCT00843882|450505071|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
125240838|NCT00843882|450505072|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
125240839|NCT00843882|450505070|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
125240840|NCT00843882|450505071|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
125240841|NCT00843882|450505072|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
125240842|NCT00843882|450505070|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
125240843|NCT00843882|450505071|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
125240844|NCT00843882|450505072|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
125240845|NCT00843882|450505070|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
125240846|NCT00843882|450505071|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
125240847|NCT00843882|450505072|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
125240848|NCT00843882|450505070|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
125240849|NCT00843882|450505071|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
125240850|NCT00843882|450505072|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
125240851|NCT00843882|450505070|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
125240852|NCT00843882|450505071|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
125240853|NCT00843882|450505072|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
125240854|NCT05317546|450505073|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
125240855|NCT05317546|450505074|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
125240856|NCT03331250|450505075|FG000|Overall Study|Withdrawal by Subject|1|||
125240857|NCT04590963|450505076|FG000|Overall Study|Death|118|||
125240858|NCT04590963|450505077|FG001|Overall Study|Death|59|||
125240859|NCT04590963|450505076|FG000|Overall Study|Lost to Follow-up|1|||
125240860|NCT04590963|450505077|FG001|Overall Study|Lost to Follow-up|1|||
125240861|NCT04590963|450505076|FG000|Overall Study|Progressive disease|0|||
125240862|NCT04590963|450505077|FG001|Overall Study|Progressive disease|1|||
125240863|NCT04590963|450505076|FG000|Overall Study|Study terminated by sponsor|103|||
125240864|NCT04590963|450505077|FG001|Overall Study|Study terminated by sponsor|50|||
125240865|NCT04590963|450505076|FG000|Overall Study|Withdrawal by Subject|15|||
125240866|NCT04590963|450505077|FG001|Overall Study|Withdrawal by Subject|8|||
125240867|NCT04590963|450505076|FG000|Overall Study|Ongoing at data cut-off|9|||
125240868|NCT04590963|450505077|FG001|Overall Study|Ongoing at data cut-off|4|||
125240869|NCT04590963|450505076|FG000|Overall Study|Screen failure|1|||
125240870|NCT04590963|450505077|FG001|Overall Study|Screen failure|0|||
125240871|NCT01063114|450505078|FG000|Overall Study|Lost to Follow-up|1|||
125240872|NCT02717611|450505091|FG000|Overall Study|Death|13|||
125240873|NCT02717611|450505091|FG000|Overall Study|Withdrawal by Subject|6|||
125240874|NCT02717611|450505091|FG000|Overall Study|Active, not recruiting|40|||
125240875|NCT02717611|450505091|FG000|Overall Study|Complicating disease|1|||
125240876|NCT02466971|450505095|FG000|Overall Study|eligible and never treated|14|||
125240877|NCT02466971|450505096|FG001|Overall Study|eligible and never treated|20|||
125240878|NCT02466971|450505095|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
125240879|NCT02466971|450505096|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
125240880|NCT02466971|450505095|FG000|Overall Study|ineligible and treated|1|||
125240881|NCT02466971|450505096|FG001|Overall Study|ineligible and treated|0|||
125240882|NCT02466971|450505095|FG000|Overall Study|ineligible and never treated|0|||
125240883|NCT02466971|450505096|FG001|Overall Study|ineligible and never treated|1|||
125240884|NCT04818112|450505101|FG000|Overall Study|Withdrawal by Subject|54|||
125240885|NCT04818112|450505102|FG001|Overall Study|Withdrawal by Subject|12|||
125240886|NCT04818112|450505101|FG000|Overall Study|Lost to Follow-up|38|||
125240887|NCT04818112|450505102|FG001|Overall Study|Lost to Follow-up|10|||
125240888|NCT02406612|450505103|FG000|Overall Study|Screening Failure|3|||
125240889|NCT02406612|450505104|FG001|Overall Study|Screening Failure|0|||
125240890|NCT02406612|450505103|FG000|Overall Study|Intra-procedural Exclusion|1|||
125240891|NCT02406612|450505104|FG001|Overall Study|Intra-procedural Exclusion|3|||
125240892|NCT02406612|450505103|FG000|Overall Study|Guidewire Failure|0|||
125240893|NCT02406612|450505104|FG001|Overall Study|Guidewire Failure|1|||
125240894|NCT05759338|450505109|FG000|Overall Study|Withdrawal by Subject|3|||
125240895|NCT06481579|450505110|FG000|Overall Study|Death|1|||
125240896|NCT06481579|450505111|FG001|Overall Study|Death|0|||
125240897|NCT06481579|450505110|FG000|Overall Study|Withdrawal by Subject|3|||
125240898|NCT06481579|450505111|FG001|Overall Study|Withdrawal by Subject|0|||
125240899|NCT06481579|450505110|FG000|Overall Study|Other|1|||
125240900|NCT06481579|450505111|FG001|Overall Study|Other|1|||
125240901|NCT06170827|450505112|FG000|Overall Study|Withdrawal by Subject|1|||
125240902|NCT06170827|450505113|FG001|Overall Study|Withdrawal by Subject|1|||
125240903|NCT05253807|450505114|FG000|Overall Study|Death|1|||
125240904|NCT05253807|450505115|FG001|Overall Study|Death|4|||
125240905|NCT05253807|450505114|FG000|Overall Study|Withdrawal by Subject|1|||
125240906|NCT05253807|450505115|FG001|Overall Study|Withdrawal by Subject|0|||
125240907|NCT05253807|450505114|FG000|Overall Study|Study Terminated by Sponsor|1|||
125240908|NCT05253807|450505115|FG001|Overall Study|Study Terminated by Sponsor|1|||
125240909|NCT04611126|450505116|FG000|Overall Study|TIL expansion unsuccessful|1|||
125240910|NCT04611126|450505117|FG001|Overall Study|TIL expansion unsuccessful|0|||
125240911|NCT03459846|450505122|FG000|Overall Study|Death|52|||
125240912|NCT03459846|450505123|FG001|Overall Study|Death|46|||
125186582|NCT01288079|450303704|FG002|Overall Study|Withdrawal by Subject|1|||
125186583|NCT01288079|450303705|FG003|Overall Study|Withdrawal by Subject|0|||
125186584|NCT01288079|450303702|FG000|Overall Study|Adverse Event|2|||
125186585|NCT01288079|450303703|FG001|Overall Study|Adverse Event|1|||
125186586|NCT01288079|450303704|FG002|Overall Study|Adverse Event|2|||
125186587|NCT01288079|450303705|FG003|Overall Study|Adverse Event|3|||
125186588|NCT01288079|450303702|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
125186589|NCT01288079|450303703|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
125186590|NCT01288079|450303704|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
125186591|NCT01288079|450303705|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
125186592|NCT01288079|450303702|FG000|Overall Study|Condition under Investigation Worsened|0|||
125186593|NCT01288079|450303703|FG001|Overall Study|Condition under Investigation Worsened|0|||
125186594|NCT01288079|450303704|FG002|Overall Study|Condition under Investigation Worsened|0|||
125186595|NCT01288079|450303705|FG003|Overall Study|Condition under Investigation Worsened|1|||
125186596|NCT01288079|450303702|FG000|Overall Study|Lack of Efficacy|2|||
125186597|NCT01288079|450303703|FG001|Overall Study|Lack of Efficacy|2|||
125186598|NCT01288079|450303704|FG002|Overall Study|Lack of Efficacy|0|||
125186599|NCT01288079|450303705|FG003|Overall Study|Lack of Efficacy|2|||
125186600|NCT01288079|450303702|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
125186601|NCT01288079|450303703|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
125186602|NCT01288079|450303704|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
125186603|NCT01288079|450303705|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
125186604|NCT01288079|450303702|FG000|Overall Study|Lost to Follow-up|1|||
125186605|NCT01288079|450303703|FG001|Overall Study|Lost to Follow-up|1|||
125186606|NCT01288079|450303704|FG002|Overall Study|Lost to Follow-up|1|||
125186607|NCT01288079|450303705|FG003|Overall Study|Lost to Follow-up|0|||
125186608|NCT01288079|450303702|FG000|Overall Study|Other or Study Termination|11|||
125186609|NCT01288079|450303703|FG001|Overall Study|Other or Study Termination|15|||
125186610|NCT01288079|450303704|FG002|Overall Study|Other or Study Termination|14|||
125186611|NCT01288079|450303705|FG003|Overall Study|Other or Study Termination|8|||
125186612|NCT01530464|450303706|FG000|Washout (24h)|Withdrawal by Subject|1|||
125186613|NCT01530464|450303707|FG001|Washout (24h)|Withdrawal by Subject|0|||
125186614|NCT01530464|450303706|FG000|Washout (24h)|Withdrawal by Subject|0|||
125186615|NCT01530464|450303707|FG001|Washout (24h)|Withdrawal by Subject|1|||
125186616|NCT04564092|450303713|FG000|Overall Study|Withdrawal by Subject|1|||
125186617|NCT00503698|450303717|FG000|Overall Study|Protocol Violation|5|||
125186618|NCT00503698|450303718|FG001|Overall Study|Protocol Violation|6|||
125186619|NCT00503698|450303717|FG000|Overall Study|Adverse Event|52|||
125186620|NCT00503698|450303718|FG001|Overall Study|Adverse Event|41|||
125186621|NCT00503698|450303717|FG000|Overall Study|Death|1|||
125186622|NCT00503698|450303718|FG001|Overall Study|Death|0|||
125186623|NCT00503698|450303717|FG000|Overall Study|Lack of Efficacy|3|||
125186624|NCT00503698|450303718|FG001|Overall Study|Lack of Efficacy|4|||
125186625|NCT00503698|450303717|FG000|Overall Study|Trial terminated|216|||
125186626|NCT00503698|450303718|FG001|Overall Study|Trial terminated|253|||
125186627|NCT00503698|450303717|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
125186628|NCT00503698|450303718|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
125186629|NCT00503698|450303717|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
125186630|NCT00503698|450303718|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
125186631|NCT00503698|450303717|FG000|Overall Study|Any condition in exclusion criteria|4|||
125186632|NCT00503698|450303718|FG001|Overall Study|Any condition in exclusion criteria|6|||
125186633|NCT00503698|450303717|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
125186634|NCT00503698|450303718|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
125186635|NCT00503698|450303717|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
125186636|NCT00503698|450303718|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
125186637|NCT00503698|450303717|FG000|Overall Study|Critically ill|2|||
125186638|NCT00503698|450303718|FG001|Overall Study|Critically ill|0|||
125186639|NCT00503698|450303717|FG000|Overall Study|Unclassified|48|||
125186640|NCT00503698|450303718|FG001|Overall Study|Unclassified|32|||
125186641|NCT00503698|450303717|FG000|Overall Study|Not exposed to trial drug|11|||
125186642|NCT00503698|450303718|FG001|Overall Study|Not exposed to trial drug|6|||
125186643|NCT02107131|450303721|FG000|Overall Study|Lost to Follow-up|4|||
125186644|NCT02107131|450303722|FG001|Overall Study|Lost to Follow-up|4|||
125186645|NCT02107131|450303721|FG000|Overall Study|Physician Decision|1|||
125186646|NCT02107131|450303722|FG001|Overall Study|Physician Decision|0|||
125186647|NCT02107131|450303721|FG000|Overall Study|Withdrawal by Subject|2|||
125186648|NCT02107131|450303722|FG001|Overall Study|Withdrawal by Subject|0|||
125186649|NCT02107131|450303721|FG000|Overall Study|mental instability|1|||
125186650|NCT02107131|450303722|FG001|Overall Study|mental instability|0|||
125186651|NCT02107131|450303721|FG000|Overall Study|Death|0|||
125186652|NCT02107131|450303722|FG001|Overall Study|Death|1|||
125186653|NCT02107131|450303721|FG000|Overall Study|Protocol Violation|0|||
125186654|NCT02107131|450303722|FG001|Overall Study|Protocol Violation|4|||
125186655|NCT02259010|450303723|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
125186656|NCT03830333|450303724|FG000|Overall Study|Death|0|||
125186657|NCT03830333|450303725|FG001|Overall Study|Death|1|||
125240913|NCT03459846|450505122|FG000|Overall Study|Study terminated by sponsor|24|||
125240914|NCT03459846|450505123|FG001|Overall Study|Study terminated by sponsor|28|||
125240915|NCT03459846|450505122|FG000|Overall Study|Withdrawal by Subject|2|||
125240916|NCT03459846|450505123|FG001|Overall Study|Withdrawal by Subject|2|||
125240917|NCT06455111|450505129|FG000|Overall Study|Withdrawal by Subject|11|||
125240918|NCT06455111|450505130|FG001|Overall Study|Withdrawal by Subject|4|||
125240919|NCT05578872|450505138|FG000|Overall Study|Withdrawal by Subject|2|||
125240920|NCT05578872|450505139|FG001|Overall Study|Withdrawal by Subject|1|||
125240921|NCT05578872|450505138|FG000|Overall Study|Adverse Event|1|||
125240922|NCT05578872|450505139|FG001|Overall Study|Adverse Event|1|||
125240923|NCT05578872|450505138|FG000|Overall Study|Physician Decision|1|||
125240924|NCT05578872|450505139|FG001|Overall Study|Physician Decision|2|||
125240925|NCT05578872|450505138|FG000|Overall Study|Progressive disease|10|||
125240926|NCT05578872|450505139|FG001|Overall Study|Progressive disease|9|||
125240927|NCT05578872|450505138|FG000|Overall Study|Sponsor decision|0|||
125240928|NCT05578872|450505139|FG001|Overall Study|Sponsor decision|1|||
125240929|NCT05578872|450505138|FG000|Overall Study|Toxicity and Patient's decision|0|||
125240930|NCT05578872|450505139|FG001|Overall Study|Toxicity and Patient's decision|1|||
125240931|NCT04598828|450505862|FG000|Overall Study|Physician Decision|1|||
125240932|NCT04598828|450505863|FG001|Overall Study|Physician Decision|0|||
125240933|NCT04598828|450505862|FG000|Overall Study|Withdrawal by Subject|0|||
125240934|NCT04598828|450505863|FG001|Overall Study|Withdrawal by Subject|1|||
125240935|NCT04598828|450505862|FG000|Overall Study|Withdrawal by Subject|0|||
125240936|NCT04598828|450505863|FG001|Overall Study|Withdrawal by Subject|1|||
125240937|NCT06187909|450505864|FG000|Overall Study|Withdrawal by Subject|2|||
125240938|NCT06187909|450505865|FG001|Overall Study|Withdrawal by Subject|2|||
125240939|NCT02676973|450505866|FG000|Overall Study|Withdrawal by Subject|9|||
125240940|NCT02676973|450505867|FG001|Overall Study|Withdrawal by Subject|8|||
125240941|NCT02676973|450505868|FG002|Overall Study|Withdrawal by Subject|11|||
125240942|NCT02676973|450505866|FG000|Overall Study|Lost to Follow-up|8|||
125240943|NCT02676973|450505867|FG001|Overall Study|Lost to Follow-up|12|||
125240944|NCT02676973|450505868|FG002|Overall Study|Lost to Follow-up|8|||
125240945|NCT02676973|450505866|FG000|Overall Study|Death|2|||
125240946|NCT02676973|450505867|FG001|Overall Study|Death|1|||
125240947|NCT02676973|450505868|FG002|Overall Study|Death|5|||
125240948|NCT05020743|450505870|FG000|Overall Study|Enrollment in Interventional Study|2|||
125240949|NCT05020743|450505871|FG001|Overall Study|Enrollment in Interventional Study|9|||
125240950|NCT05020743|450505872|FG002|Overall Study|Enrollment in Interventional Study|0|||
125240951|NCT05020743|450505870|FG000|Overall Study|Withdrawal by Subject|0|||
125240952|NCT05020743|450505871|FG001|Overall Study|Withdrawal by Subject|3|||
125240953|NCT05020743|450505872|FG002|Overall Study|Withdrawal by Subject|1|||
125240954|NCT05020743|450505870|FG000|Overall Study|Lost to Follow-up|1|||
125240955|NCT05020743|450505871|FG001|Overall Study|Lost to Follow-up|0|||
125240956|NCT05020743|450505872|FG002|Overall Study|Lost to Follow-up|0|||
125240957|NCT05020743|450505870|FG000|Overall Study|Study Termination by Sponsor|10|||
125240958|NCT05020743|450505871|FG001|Overall Study|Study Termination by Sponsor|11|||
125240959|NCT05020743|450505872|FG002|Overall Study|Study Termination by Sponsor|10|||
125240960|NCT03488524|450505873|FG000|Overall Study|Withdrawal by Subject|51|||
125240961|NCT03488524|450505873|FG000|Overall Study|Death|19|||
125240962|NCT03488524|450505873|FG000|Overall Study|Study Sponsor|11|||
125240963|NCT03488524|450505873|FG000|Overall Study|Physician Decision|4|||
125240964|NCT03488524|450505873|FG000|Overall Study|Lost to Follow-up|3|||
125240965|NCT01078662|450505874|FG000|Overall Study|Death|41|||
125240966|NCT01078662|450505875|FG001|Overall Study|Death|103|||
125240967|NCT01078662|450505876|FG002|Overall Study|Death|18|||
125240968|NCT01078662|450505877|FG003|Overall Study|Death|5|||
125240969|NCT01078662|450505878|FG004|Overall Study|Death|8|||
125240970|NCT01078662|450505874|FG000|Overall Study|Patients reached data cut-off|12|||
125240971|NCT01078662|450505875|FG001|Overall Study|Patients reached data cut-off|53|||
125240972|NCT01078662|450505876|FG002|Overall Study|Patients reached data cut-off|2|||
125240973|NCT01078662|450505877|FG003|Overall Study|Patients reached data cut-off|2|||
125240974|NCT01078662|450505878|FG004|Overall Study|Patients reached data cut-off|3|||
125240975|NCT01078662|450505874|FG000|Overall Study|Withdrawal by Subject|4|||
125240976|NCT01078662|450505875|FG001|Overall Study|Withdrawal by Subject|11|||
125240977|NCT01078662|450505876|FG002|Overall Study|Withdrawal by Subject|1|||
125240978|NCT01078662|450505877|FG003|Overall Study|Withdrawal by Subject|0|||
125240979|NCT01078662|450505878|FG004|Overall Study|Withdrawal by Subject|0|||
125240980|NCT01078662|450505874|FG000|Overall Study|Protocol Violation|0|||
125240981|NCT01078662|450505875|FG001|Overall Study|Protocol Violation|1|||
125240982|NCT01078662|450505876|FG002|Overall Study|Protocol Violation|0|||
125240983|NCT01078662|450505877|FG003|Overall Study|Protocol Violation|0|||
125240984|NCT01078662|450505878|FG004|Overall Study|Protocol Violation|0|||
125240985|NCT01078662|450505874|FG000|Overall Study|Lost to Follow-up|1|||
125240986|NCT01078662|450505875|FG001|Overall Study|Lost to Follow-up|0|||
125240987|NCT01078662|450505876|FG002|Overall Study|Lost to Follow-up|0|||
125240988|NCT01078662|450505877|FG003|Overall Study|Lost to Follow-up|0|||
125240989|NCT01078662|450505878|FG004|Overall Study|Lost to Follow-up|0|||
125240990|NCT00325416|450505879|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
125240991|NCT00325416|450505880|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
125240992|NCT00325416|450505879|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
125240993|NCT00325416|450505880|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
125240994|NCT00325416|450505879|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
125240995|NCT00325416|450505880|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
125240996|NCT00325416|450505879|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
125240997|NCT00325416|450505880|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
125240998|NCT00325416|450505879|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
125240999|NCT00325416|450505880|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
125241000|NCT00325416|450505879|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
125241001|NCT00325416|450505880|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
125241002|NCT04589650|450505881|FG000|Overall Study|Subject decision|6|||
125241003|NCT04589650|450505882|FG001|Overall Study|Subject decision|2|||
125241004|NCT04589650|450505883|FG002|Overall Study|Subject decision|2|||
125241005|NCT04589650|450505884|FG003|Overall Study|Subject decision|0|||
125241006|NCT04589650|450505885|FG004|Overall Study|Subject decision|0|||
125241007|NCT04589650|450505886|FG005|Overall Study|Subject decision|0|||
125241008|NCT04589650|450505881|FG000|Overall Study|Adverse Event|3|||
125241009|NCT04589650|450505882|FG001|Overall Study|Adverse Event|1|||
125241010|NCT04589650|450505883|FG002|Overall Study|Adverse Event|1|||
125241011|NCT04589650|450505884|FG003|Overall Study|Adverse Event|1|||
125241012|NCT04589650|450505885|FG004|Overall Study|Adverse Event|0|||
125241013|NCT04589650|450505886|FG005|Overall Study|Adverse Event|1|||
125186658|NCT03830333|450303724|FG000|Overall Study|Withdrawal by Subject|5|||
125186659|NCT03830333|450303725|FG001|Overall Study|Withdrawal by Subject|1|||
125186660|NCT03830333|450303724|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
125186661|NCT03830333|450303725|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
125186662|NCT01546025|450303733|FG000|Overall Study|Lost to Follow-up|0|||
125186663|NCT01546025|450303734|FG001|Overall Study|Lost to Follow-up|1|||
125186664|NCT05966584|450303742|FG000|Overall Study|Lost to Follow-up|1|||
125186665|NCT04242446|450305066|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
125186666|NCT04242446|450305067|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
125186667|NCT04242446|450305068|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
125186668|NCT04242446|450305069|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
125186669|NCT04242446|450305070|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
125186670|NCT04242446|450305071|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
125186671|NCT04242446|450305072|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
125186672|NCT04242446|450305066|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
125186673|NCT04242446|450305067|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
125186674|NCT04242446|450305068|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
125186675|NCT04242446|450305069|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
125186676|NCT04242446|450305070|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
125186677|NCT04242446|450305071|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
125186678|NCT04242446|450305072|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
125186679|NCT04242446|450305066|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
125186680|NCT04242446|450305067|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
125241014|NCT04589650|450505881|FG000|Overall Study|Physician Decision|1|||
125241015|NCT04589650|450505882|FG001|Overall Study|Physician Decision|1|||
125241016|NCT04589650|450505883|FG002|Overall Study|Physician Decision|0|||
125241017|NCT04589650|450505884|FG003|Overall Study|Physician Decision|0|||
125241018|NCT04589650|450505885|FG004|Overall Study|Physician Decision|0|||
125241019|NCT04589650|450505886|FG005|Overall Study|Physician Decision|0|||
125241020|NCT04589650|450505881|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125241021|NCT04589650|450505882|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125241022|NCT04589650|450505883|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
125241023|NCT04589650|450505884|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
125241024|NCT04589650|450505885|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
125241025|NCT04589650|450505886|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
125186681|NCT04242446|450305068|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
125186682|NCT04242446|450305069|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
125241026|NCT04589650|450505881|FG000|Overall Study|Death|0|||
125241027|NCT04589650|450505882|FG001|Overall Study|Death|0|||
125241028|NCT04589650|450505883|FG002|Overall Study|Death|0|||
125241029|NCT04589650|450505884|FG003|Overall Study|Death|1|||
125241030|NCT04589650|450505885|FG004|Overall Study|Death|0|||
125241031|NCT04589650|450505886|FG005|Overall Study|Death|0|||
125241032|NCT04589650|450505881|FG000|Overall Study|Guardian Decision|0|||
125241033|NCT04589650|450505882|FG001|Overall Study|Guardian Decision|0|||
125241034|NCT04589650|450505883|FG002|Overall Study|Guardian Decision|0|||
125241035|NCT04589650|450505884|FG003|Overall Study|Guardian Decision|1|||
125241036|NCT04589650|450505885|FG004|Overall Study|Guardian Decision|0|||
125241037|NCT04589650|450505886|FG005|Overall Study|Guardian Decision|0|||
125241038|NCT02324153|450505887|FG000|Overall Study|Withdrawal by Subject|4|||
125241039|NCT02324153|450505888|FG001|Overall Study|Withdrawal by Subject|1|||
125241040|NCT02324153|450505887|FG000|Overall Study|Surgery postponed after randomization|3|||
125241041|NCT02324153|450505888|FG001|Overall Study|Surgery postponed after randomization|0|||
125241042|NCT02324153|450505887|FG000|Overall Study|Developed delirium preoperatively|1|||
125241043|NCT02324153|450505888|FG001|Overall Study|Developed delirium preoperatively|0|||
125241044|NCT03122106|450505891|FG000|Overall Study|Not enough tissue|1|||
125241045|NCT03122106|450505891|FG000|Overall Study|Disease progression during screening|2|||
125241046|NCT03122106|450505891|FG000|Overall Study|Poor RNA quality for vaccine|1|||
125241047|NCT01913353|450505893|FG000|Overall Study|Adverse Event|2|||
125241048|NCT01913353|450505894|FG001|Overall Study|Adverse Event|0|||
125241049|NCT01913353|450505893|FG000|Overall Study|Physician Decision|0|||
125241050|NCT01913353|450505894|FG001|Overall Study|Physician Decision|2|||
125241051|NCT01913353|450505893|FG000|Overall Study|Withdrawal by Subject|20|||
125241052|NCT01913353|450505894|FG001|Overall Study|Withdrawal by Subject|6|||
125241053|NCT01913353|450505893|FG000|Overall Study|multiple reasons|10|||
125241054|NCT01913353|450505894|FG001|Overall Study|multiple reasons|7|||
125241055|NCT01147458|450505896|FG000|First Intervention|Study terminated by sponsor|8|||
125241056|NCT01147458|450505897|FG001|First Intervention|Study terminated by sponsor|8|||
125241057|NCT01147458|450505898|FG002|First Intervention|Study terminated by sponsor|7|||
125241058|NCT01147458|450505899|FG003|First Intervention|Study terminated by sponsor|8|||
125241059|NCT01147458|450505896|FG000|First Intervention|Protocol Violation|2|||
125241060|NCT01147458|450505897|FG001|First Intervention|Protocol Violation|3|||
125241061|NCT01147458|450505898|FG002|First Intervention|Protocol Violation|2|||
125241062|NCT01147458|450505899|FG003|First Intervention|Protocol Violation|3|||
125241063|NCT01147458|450505896|FG000|First Intervention|Withdrawal by Subject|3|||
125241064|NCT01147458|450505897|FG001|First Intervention|Withdrawal by Subject|0|||
125241065|NCT01147458|450505898|FG002|First Intervention|Withdrawal by Subject|1|||
125241066|NCT01147458|450505899|FG003|First Intervention|Withdrawal by Subject|0|||
125241067|NCT01147458|450505896|FG000|First Intervention|Adverse Event|0|||
125241068|NCT01147458|450505897|FG001|First Intervention|Adverse Event|3|||
125241069|NCT01147458|450505898|FG002|First Intervention|Adverse Event|2|||
125241070|NCT01147458|450505899|FG003|First Intervention|Adverse Event|3|||
125241071|NCT01147458|450505896|FG000|First Intervention|Other|1|||
125241072|NCT01147458|450505897|FG001|First Intervention|Other|2|||
125241073|NCT01147458|450505898|FG002|First Intervention|Other|0|||
125241074|NCT01147458|450505899|FG003|First Intervention|Other|0|||
125241075|NCT01147458|450505896|FG000|Second Intervention|Study terminated by sponsor|7|||
125241076|NCT01147458|450505897|FG001|Second Intervention|Study terminated by sponsor|5|||
125241077|NCT01147458|450505898|FG002|Second Intervention|Study terminated by sponsor|5|||
125241078|NCT01147458|450505899|FG003|Second Intervention|Study terminated by sponsor|3|||
125241079|NCT01147458|450505896|FG000|Second Intervention|Protocol Violation|0|||
125241080|NCT01147458|450505897|FG001|Second Intervention|Protocol Violation|1|||
125241081|NCT01147458|450505898|FG002|Second Intervention|Protocol Violation|1|||
125241082|NCT01147458|450505899|FG003|Second Intervention|Protocol Violation|0|||
125241083|NCT01147458|450505896|FG000|Second Intervention|Withdrawal by Subject|0|||
125241084|NCT01147458|450505897|FG001|Second Intervention|Withdrawal by Subject|1|||
125241085|NCT01147458|450505898|FG002|Second Intervention|Withdrawal by Subject|0|||
125241086|NCT01147458|450505899|FG003|Second Intervention|Withdrawal by Subject|0|||
125241087|NCT01147458|450505896|FG000|Second Intervention|Adverse Event|2|||
125241088|NCT01147458|450505897|FG001|Second Intervention|Adverse Event|0|||
125241089|NCT01147458|450505898|FG002|Second Intervention|Adverse Event|1|||
125241090|NCT01147458|450505899|FG003|Second Intervention|Adverse Event|1|||
125241091|NCT01147458|450505896|FG000|Second Intervention|Other|0|||
125241092|NCT01147458|450505897|FG001|Second Intervention|Other|0|||
125241093|NCT01147458|450505898|FG002|Second Intervention|Other|1|||
125241094|NCT01147458|450505899|FG003|Second Intervention|Other|0|||
125241095|NCT03550209|450505900|FG000|Overall Study|Lost to Follow-up|1|||
125241096|NCT03550209|450505901|FG001|Overall Study|Lost to Follow-up|0|||
125241097|NCT03550209|450505902|FG002|Overall Study|Lost to Follow-up|1|||
125241098|NCT03550209|450505903|FG003|Overall Study|Lost to Follow-up|0|||
125241099|NCT03550209|450505900|FG000|Overall Study|Withdrawal by Subject|0|||
125241100|NCT03550209|450505901|FG001|Overall Study|Withdrawal by Subject|3|||
125241101|NCT03550209|450505902|FG002|Overall Study|Withdrawal by Subject|1|||
125241102|NCT03550209|450505903|FG003|Overall Study|Withdrawal by Subject|2|||
125241103|NCT03550209|450505900|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
125241104|NCT03550209|450505901|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
125241105|NCT03550209|450505902|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
125241106|NCT03550209|450505903|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
125241107|NCT02555878|450505904|FG000|Overall Study|Lost to Follow-up|2|||
125241108|NCT02555878|450505905|FG001|Overall Study|Lost to Follow-up|3|||
125241109|NCT02555878|450505904|FG000|Overall Study|Withdrawal by Subject|48|||
125241110|NCT02555878|450505905|FG001|Overall Study|Withdrawal by Subject|48|||
125241111|NCT02555878|450505904|FG000|Overall Study|Adverse Event|12|||
125241112|NCT02555878|450505905|FG001|Overall Study|Adverse Event|8|||
125241113|NCT02555878|450505904|FG000|Overall Study|Death|74|||
125241114|NCT02555878|450505905|FG001|Overall Study|Death|59|||
125241115|NCT02555878|450505904|FG000|Overall Study|Protocol Violation|1|||
125241116|NCT02555878|450505905|FG001|Overall Study|Protocol Violation|2|||
125241117|NCT02555878|450505904|FG000|Overall Study|Physician Decision|12|||
125241118|NCT02555878|450505905|FG001|Overall Study|Physician Decision|13|||
125241119|NCT02555878|450505904|FG000|Overall Study|Other|17|||
125241120|NCT02555878|450505905|FG001|Overall Study|Other|17|||
125241121|NCT00765076|450505906|FG000|Overall Study|Adverse Event|1|||
125241122|NCT00765076|450505907|FG001|Overall Study|Adverse Event|0|||
125241123|NCT00765076|450505908|FG002|Overall Study|Adverse Event|0|||
125241124|NCT00765076|450505906|FG000|Overall Study|Withdrawal by Subject|0|||
125241125|NCT00765076|450505907|FG001|Overall Study|Withdrawal by Subject|0|||
125241126|NCT00765076|450505908|FG002|Overall Study|Withdrawal by Subject|1|||
125241127|NCT02875080|450505909|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
125241128|NCT02875080|450505910|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
125241129|NCT02875080|450505911|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
125241130|NCT00768053|450505912|FG000|Overall Study|Adverse Event|10|||
125241131|NCT00768053|450505912|FG000|Overall Study|Lost to Follow-up|1|||
125241132|NCT01164475|450505913|FG000|Overall Study|Lack of Efficacy|1|||
125241133|NCT01164475|450505914|FG001|Overall Study|Lack of Efficacy|0|||
125241134|NCT01164475|450505913|FG000|Overall Study|Other|0|||
125241135|NCT01164475|450505914|FG001|Overall Study|Other|1|||
125241136|NCT01164475|450505913|FG000|Overall Study|Progressive disease|0|||
125241137|NCT01164475|450505914|FG001|Overall Study|Progressive disease|1|||
125241138|NCT01164475|450505913|FG000|Overall Study|Protocol Violation|1|||
125241139|NCT01164475|450505914|FG001|Overall Study|Protocol Violation|0|||
125241140|NCT04603066|450505916|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
125241141|NCT04603066|450505917|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
125241142|NCT04937387|450505918|FG000|Overall Study|Adverse Event|1|||
125241143|NCT04937387|450505919|FG001|Overall Study|Adverse Event|0|||
125241144|NCT04937387|450505920|FG002|Overall Study|Adverse Event|2|||
125241145|NCT04937387|450505921|FG003|Overall Study|Adverse Event|0|||
125241146|NCT04937387|450505918|FG000|Overall Study|Lack of Efficacy|1|||
125241147|NCT04937387|450505919|FG001|Overall Study|Lack of Efficacy|0|||
125241148|NCT04937387|450505920|FG002|Overall Study|Lack of Efficacy|0|||
125241149|NCT04937387|450505921|FG003|Overall Study|Lack of Efficacy|1|||
125241150|NCT04937387|450505918|FG000|Overall Study|Withdrawal by Subject|1|||
125241151|NCT04937387|450505919|FG001|Overall Study|Withdrawal by Subject|0|||
125241152|NCT04937387|450505920|FG002|Overall Study|Withdrawal by Subject|1|||
125241153|NCT04937387|450505921|FG003|Overall Study|Withdrawal by Subject|1|||
125241154|NCT04937387|450505918|FG000|Overall Study|Randomized in error|0|||
125241155|NCT04937387|450505919|FG001|Overall Study|Randomized in error|0|||
125241156|NCT04937387|450505920|FG002|Overall Study|Randomized in error|0|||
125241157|NCT04937387|450505921|FG003|Overall Study|Randomized in error|1|||
125241158|NCT04134845|450505922|FG000|Overall Study|withdrawl by PI|12|||
125241159|NCT04134845|450505923|FG001|Overall Study|withdrawl by PI|5|||
125241160|NCT01371981|450505924|FG000|Overall Study|Adverse Event|12|||
125241161|NCT01371981|450505925|FG001|Overall Study|Adverse Event|17|||
125241162|NCT01371981|450505926|FG002|Overall Study|Adverse Event|0|||
125241163|NCT01371981|450505927|FG003|Overall Study|Adverse Event|4|||
125241164|NCT01371981|450505928|FG004|Overall Study|Adverse Event|1|||
125241165|NCT01371981|450505929|FG005|Overall Study|Adverse Event|0|||
125241166|NCT01371981|450505924|FG000|Overall Study|Death|22|||
125241167|NCT01371981|450505925|FG001|Overall Study|Death|16|||
125241168|NCT01371981|450505926|FG002|Overall Study|Death|0|||
125241169|NCT01371981|450505927|FG003|Overall Study|Death|0|||
125241170|NCT01371981|450505928|FG004|Overall Study|Death|2|||
125241171|NCT01371981|450505929|FG005|Overall Study|Death|2|||
125241172|NCT01371981|450505924|FG000|Overall Study|Lack of Efficacy|69|||
125241173|NCT01371981|450505925|FG001|Overall Study|Lack of Efficacy|61|||
125241174|NCT01371981|450505926|FG002|Overall Study|Lack of Efficacy|4|||
125241175|NCT01371981|450505927|FG003|Overall Study|Lack of Efficacy|8|||
125241176|NCT01371981|450505928|FG004|Overall Study|Lack of Efficacy|5|||
125241177|NCT01371981|450505929|FG005|Overall Study|Lack of Efficacy|0|||
125241178|NCT01371981|450505924|FG000|Overall Study|Physician Decision|48|||
125241179|NCT01371981|450505925|FG001|Overall Study|Physician Decision|63|||
125241180|NCT01371981|450505926|FG002|Overall Study|Physician Decision|1|||
125241181|NCT01371981|450505927|FG003|Overall Study|Physician Decision|7|||
125241182|NCT01371981|450505928|FG004|Overall Study|Physician Decision|14|||
125241183|NCT01371981|450505929|FG005|Overall Study|Physician Decision|3|||
125186683|NCT04242446|450305070|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
125186684|NCT04242446|450305071|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
125186685|NCT04242446|450305072|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
125186686|NCT04242446|450305066|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
125186687|NCT04242446|450305067|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
125186688|NCT04242446|450305068|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
125186689|NCT04242446|450305069|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
125186690|NCT04242446|450305070|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
125186691|NCT04242446|450305071|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
125186692|NCT04242446|450305072|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
125186693|NCT04242446|450305066|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
125186694|NCT04242446|450305067|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
125186695|NCT04242446|450305068|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
125186696|NCT04242446|450305069|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
125186697|NCT04242446|450305070|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
125186698|NCT04242446|450305071|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
125186699|NCT04242446|450305072|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
125186700|NCT04242446|450305066|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
125186701|NCT04242446|450305067|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
125186702|NCT04242446|450305068|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
125186703|NCT04242446|450305069|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
125186704|NCT04242446|450305070|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
125186705|NCT04242446|450305071|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
125186706|NCT04242446|450305072|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
125186707|NCT04242446|450305066|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
125186708|NCT04242446|450305067|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
125186709|NCT04242446|450305068|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
125186710|NCT04242446|450305069|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
125186711|NCT04242446|450305070|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
125186712|NCT04242446|450305071|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
125186713|NCT04242446|450305072|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
125241184|NCT01371981|450505924|FG000|Overall Study|Withdrawal by Subject|12|||
125186714|NCT04242446|450305066|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
125186715|NCT04242446|450305067|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
125186716|NCT04242446|450305068|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
125186717|NCT04242446|450305069|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
125186718|NCT04242446|450305070|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
125186719|NCT04242446|450305071|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
125186720|NCT04242446|450305072|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
125186721|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
125186722|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
125186723|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
125186724|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
125186725|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
125186726|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
125186727|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
125186728|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
125186729|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
125186730|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
125186731|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
125186732|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
125186733|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
125186734|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
125186735|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
125186736|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
125186737|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
125186738|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
125186739|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
125186740|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
125186741|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
125186742|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
125186743|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
125186744|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
125186745|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
125186746|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
125186747|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
125186748|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
125186749|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
125186750|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
125186751|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
125186752|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
125186753|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
125186754|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
125186755|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
125186756|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
125186757|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
125186758|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
125186759|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
125186760|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
125186761|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
125186762|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
125186763|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
125186764|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
125186765|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
125186766|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
125186767|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
125186768|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
125186769|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
125186770|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
125186771|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
125186772|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
125186773|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
125186774|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
125186775|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
125186776|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
125186777|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
125186778|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
125186779|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
125186780|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
125186781|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
125186782|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
125186783|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
125186784|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
125186785|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
125186786|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
125186787|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
125186788|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
125186789|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
125186790|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
125186791|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
125186792|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
125186793|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
125186794|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
125186795|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
125186796|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
125186797|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
125186798|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
125186799|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
125186800|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
125186801|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
125186802|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
125186803|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
125186804|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
125186805|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
125186806|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
125186807|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
125186808|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
125186809|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
125186810|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
125186811|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
125186812|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
125186813|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
125186814|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
125186815|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
125186816|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
125186817|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
125186818|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
125186819|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
125186820|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
125186821|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
125186822|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
125186823|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
125186824|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
125186825|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
125186826|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
125241185|NCT01371981|450505925|FG001|Overall Study|Withdrawal by Subject|19|||
125186827|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
125186828|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
125186829|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
125186830|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
125186831|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
125186832|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
125186833|NCT04563754|450305076|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
125186834|NCT04563754|450305077|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
125186835|NCT04563754|450305078|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
125186836|NCT04563754|450305076|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
125186837|NCT04563754|450305077|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
125186838|NCT04563754|450305078|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
125186839|NCT04563754|450305076|FG000|Follow up|Lost to Follow-up|61|||
125186840|NCT04563754|450305077|FG001|Follow up|Lost to Follow-up|23|||
125186841|NCT04563754|450305078|FG002|Follow up|Lost to Follow-up|5|||
125186842|NCT04563754|450305076|FG000|Follow up|Death|0|||
125186843|NCT04563754|450305077|FG001|Follow up|Death|2|||
125186844|NCT04563754|450305078|FG002|Follow up|Death|0|||
125186845|NCT04563754|450305076|FG000|Follow up|Ongoing|0|||
125186846|NCT04563754|450305077|FG001|Follow up|Ongoing|28|||
125186847|NCT04563754|450305078|FG002|Follow up|Ongoing|0|||
125186848|NCT04023396|450305079|FG000|Overall Study|Adverse Event|16|||
125186849|NCT04023396|450305079|FG000|Overall Study|Death|1|||
125186850|NCT04023396|450305079|FG000|Overall Study|Lost to Follow-up|1|||
125186851|NCT04023396|450305079|FG000|Overall Study|Withdrawal by Subject|14|||
125186852|NCT04023396|450305079|FG000|Overall Study|Pregnancy|4|||
125186853|NCT04023396|450305079|FG000|Overall Study|Lack of Efficacy|3|||
125186854|NCT04023396|450305079|FG000|Overall Study|Physician Decision|4|||
125186855|NCT04023396|450305079|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
125186856|NCT04075825|450305080|FG000|Overall Study|Withdrawal by Subject|6|||
125186857|NCT04075825|450305081|FG001|Overall Study|Withdrawal by Subject|8|||
125186858|NCT04075825|450305080|FG000|Overall Study|Physician Decision|3|||
125186859|NCT04075825|450305081|FG001|Overall Study|Physician Decision|1|||
125186860|NCT04075825|450305080|FG000|Overall Study|Lost to Follow-up|5|||
125186861|NCT04075825|450305081|FG001|Overall Study|Lost to Follow-up|1|||
125186862|NCT04075825|450305080|FG000|Overall Study|Participation in New Clinical Trial|1|||
125186863|NCT04075825|450305081|FG001|Overall Study|Participation in New Clinical Trial|1|||
125186864|NCT04075825|450305080|FG000|Overall Study|Reason Not Specified|2|||
125186865|NCT04075825|450305081|FG001|Overall Study|Reason Not Specified|2|||
125186866|NCT04021914|450305082|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
125186867|NCT03349060|450305083|FG000|Overall Study|Adverse Event|9|||
125186868|NCT03349060|450305084|FG001|Overall Study|Adverse Event|9|||
125186869|NCT03349060|450305085|FG002|Overall Study|Adverse Event|7|||
125186870|NCT03349060|450305083|FG000|Overall Study|Lack of Efficacy|1|||
125186871|NCT03349060|450305084|FG001|Overall Study|Lack of Efficacy|0|||
125186872|NCT03349060|450305085|FG002|Overall Study|Lack of Efficacy|2|||
125186873|NCT03349060|450305083|FG000|Overall Study|Lost to Follow-up|2|||
125186874|NCT03349060|450305084|FG001|Overall Study|Lost to Follow-up|1|||
125186875|NCT03349060|450305085|FG002|Overall Study|Lost to Follow-up|1|||
125186876|NCT03349060|450305083|FG000|Overall Study|Protocol Violation|2|||
125186877|NCT03349060|450305084|FG001|Overall Study|Protocol Violation|2|||
125186878|NCT03349060|450305085|FG002|Overall Study|Protocol Violation|1|||
125186879|NCT03349060|450305083|FG000|Overall Study|Withdrawal by Subject|5|||
125186880|NCT03349060|450305084|FG001|Overall Study|Withdrawal by Subject|3|||
125186881|NCT03349060|450305085|FG002|Overall Study|Withdrawal by Subject|4|||
125186882|NCT03349060|450305083|FG000|Overall Study|Medication error,no linked adverse event|0|||
125186883|NCT03349060|450305084|FG001|Overall Study|Medication error,no linked adverse event|0|||
125186884|NCT03349060|450305085|FG002|Overall Study|Medication error,no linked adverse event|1|||
125186885|NCT03349060|450305083|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
125186886|NCT03349060|450305084|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
125186887|NCT03349060|450305085|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
125186888|NCT03349060|450305083|FG000|Overall Study|Other|2|||
125186889|NCT03349060|450305084|FG001|Overall Study|Other|1|||
125186890|NCT03349060|450305085|FG002|Overall Study|Other|0|||
125186891|NCT02861586|450305086|FG000|Overall Study|Withdrawal by Subject|1|||
125186892|NCT02861586|450305087|FG001|Overall Study|Withdrawal by Subject|2|||
125186893|NCT02861586|450305088|FG002|Overall Study|Withdrawal by Subject|0|||
125186894|NCT02861586|450305089|FG003|Overall Study|Withdrawal by Subject|0|||
125186895|NCT02861586|450305090|FG004|Overall Study|Withdrawal by Subject|0|||
125186896|NCT02861586|450305091|FG005|Overall Study|Withdrawal by Subject|1|||
125186897|NCT02861586|450305092|FG006|Overall Study|Withdrawal by Subject|1|||
125186898|NCT02861586|450305093|FG007|Overall Study|Withdrawal by Subject|0|||
125186899|NCT02861586|450305086|FG000|Overall Study|Lost to Follow-up|3|||
125186900|NCT02861586|450305087|FG001|Overall Study|Lost to Follow-up|1|||
125186901|NCT02861586|450305088|FG002|Overall Study|Lost to Follow-up|1|||
125186902|NCT02861586|450305089|FG003|Overall Study|Lost to Follow-up|0|||
125186903|NCT02861586|450305090|FG004|Overall Study|Lost to Follow-up|0|||
125186904|NCT02861586|450305091|FG005|Overall Study|Lost to Follow-up|3|||
125186905|NCT02861586|450305092|FG006|Overall Study|Lost to Follow-up|0|||
125186906|NCT02861586|450305093|FG007|Overall Study|Lost to Follow-up|0|||
125186907|NCT02861586|450305086|FG000|Overall Study|Adverse Event|0|||
125186908|NCT02861586|450305087|FG001|Overall Study|Adverse Event|0|||
125186909|NCT02861586|450305088|FG002|Overall Study|Adverse Event|0|||
125186910|NCT02861586|450305089|FG003|Overall Study|Adverse Event|0|||
125186911|NCT02861586|450305090|FG004|Overall Study|Adverse Event|0|||
125186912|NCT02861586|450305091|FG005|Overall Study|Adverse Event|1|||
125186913|NCT02861586|450305092|FG006|Overall Study|Adverse Event|0|||
125186914|NCT02861586|450305093|FG007|Overall Study|Adverse Event|0|||
125186915|NCT00955409|450305094|FG000|Overall Study|Lack of Efficacy|1|||
125186916|NCT00955409|450305095|FG001|Overall Study|Lack of Efficacy|0|||
125186917|NCT00955409|450305096|FG002|Overall Study|Lack of Efficacy|0|||
125186918|NCT00955409|450305097|FG003|Overall Study|Lack of Efficacy|0|||
125186919|NCT00955409|450305098|FG004|Overall Study|Lack of Efficacy|0|||
125186920|NCT00955409|450305099|FG005|Overall Study|Lack of Efficacy|0|||
125186921|NCT00955409|450305100|FG006|Overall Study|Lack of Efficacy|0|||
125186922|NCT00955409|450305101|FG007|Overall Study|Lack of Efficacy|0|||
125186923|NCT00955409|450305102|FG008|Overall Study|Lack of Efficacy|0|||
125186924|NCT00955409|450305103|FG009|Overall Study|Lack of Efficacy|0|||
125186925|NCT00955409|450305094|FG000|Overall Study|Withdrawal by Subject|1|||
125186926|NCT00955409|450305095|FG001|Overall Study|Withdrawal by Subject|0|||
125186927|NCT00955409|450305096|FG002|Overall Study|Withdrawal by Subject|5|||
125186928|NCT00955409|450305097|FG003|Overall Study|Withdrawal by Subject|2|||
125186929|NCT00955409|450305098|FG004|Overall Study|Withdrawal by Subject|0|||
125186930|NCT00955409|450305099|FG005|Overall Study|Withdrawal by Subject|0|||
125186931|NCT00955409|450305100|FG006|Overall Study|Withdrawal by Subject|2|||
125186932|NCT00955409|450305101|FG007|Overall Study|Withdrawal by Subject|0|||
125186933|NCT00955409|450305102|FG008|Overall Study|Withdrawal by Subject|1|||
125186934|NCT00955409|450305103|FG009|Overall Study|Withdrawal by Subject|0|||
125186935|NCT00955409|450305094|FG000|Overall Study|Caregiver Request|2|||
125186936|NCT00955409|450305095|FG001|Overall Study|Caregiver Request|0|||
125186937|NCT00955409|450305096|FG002|Overall Study|Caregiver Request|6|||
125186938|NCT00955409|450305097|FG003|Overall Study|Caregiver Request|5|||
125186939|NCT00955409|450305098|FG004|Overall Study|Caregiver Request|0|||
125186940|NCT00955409|450305099|FG005|Overall Study|Caregiver Request|2|||
125186941|NCT00955409|450305100|FG006|Overall Study|Caregiver Request|3|||
125186942|NCT00955409|450305101|FG007|Overall Study|Caregiver Request|1|||
125186943|NCT00955409|450305102|FG008|Overall Study|Caregiver Request|3|||
125186944|NCT00955409|450305103|FG009|Overall Study|Caregiver Request|0|||
125186945|NCT00955409|450305094|FG000|Overall Study|Investigator Request|0|||
125186946|NCT00955409|450305095|FG001|Overall Study|Investigator Request|0|||
125186947|NCT00955409|450305096|FG002|Overall Study|Investigator Request|1|||
125186948|NCT00955409|450305097|FG003|Overall Study|Investigator Request|0|||
125186949|NCT00955409|450305098|FG004|Overall Study|Investigator Request|0|||
125186950|NCT00955409|450305099|FG005|Overall Study|Investigator Request|0|||
125186951|NCT00955409|450305100|FG006|Overall Study|Investigator Request|0|||
125186952|NCT00955409|450305101|FG007|Overall Study|Investigator Request|0|||
125186953|NCT00955409|450305102|FG008|Overall Study|Investigator Request|0|||
125186954|NCT00955409|450305103|FG009|Overall Study|Investigator Request|0|||
125186955|NCT00955409|450305094|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
125186956|NCT00955409|450305095|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
125186957|NCT00955409|450305096|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
125186958|NCT00955409|450305097|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
125186959|NCT00955409|450305098|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
125186960|NCT00955409|450305099|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
125186961|NCT00955409|450305100|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
125186962|NCT00955409|450305101|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
125186963|NCT00955409|450305102|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
125186964|NCT00955409|450305103|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
125186965|NCT00955409|450305094|FG000|Overall Study|Lost to Follow-up|0|||
125186966|NCT00955409|450305095|FG001|Overall Study|Lost to Follow-up|0|||
125186967|NCT00955409|450305096|FG002|Overall Study|Lost to Follow-up|1|||
125186968|NCT00955409|450305097|FG003|Overall Study|Lost to Follow-up|0|||
125186969|NCT00955409|450305098|FG004|Overall Study|Lost to Follow-up|0|||
125186970|NCT00955409|450305099|FG005|Overall Study|Lost to Follow-up|0|||
125186971|NCT00955409|450305100|FG006|Overall Study|Lost to Follow-up|1|||
125186972|NCT00955409|450305101|FG007|Overall Study|Lost to Follow-up|0|||
125186973|NCT00955409|450305102|FG008|Overall Study|Lost to Follow-up|0|||
125186974|NCT00955409|450305103|FG009|Overall Study|Lost to Follow-up|0|||
125186975|NCT00955409|450305094|FG000|Overall Study|Failed to Return|2|||
125186976|NCT00955409|450305095|FG001|Overall Study|Failed to Return|0|||
125186977|NCT00955409|450305096|FG002|Overall Study|Failed to Return|0|||
125186978|NCT00955409|450305097|FG003|Overall Study|Failed to Return|0|||
125186979|NCT00955409|450305098|FG004|Overall Study|Failed to Return|0|||
125186980|NCT00955409|450305099|FG005|Overall Study|Failed to Return|0|||
125186981|NCT00955409|450305100|FG006|Overall Study|Failed to Return|0|||
125186982|NCT00955409|450305101|FG007|Overall Study|Failed to Return|2|||
125186983|NCT00955409|450305102|FG008|Overall Study|Failed to Return|0|||
125186984|NCT00955409|450305103|FG009|Overall Study|Failed to Return|0|||
125186985|NCT00955409|450305094|FG000|Overall Study|Adverse Event (AE)|2|||
125186986|NCT00955409|450305095|FG001|Overall Study|Adverse Event (AE)|0|||
125186987|NCT00955409|450305096|FG002|Overall Study|Adverse Event (AE)|0|||
125186988|NCT00955409|450305097|FG003|Overall Study|Adverse Event (AE)|0|||
125186989|NCT00955409|450305098|FG004|Overall Study|Adverse Event (AE)|0|||
125186990|NCT00955409|450305099|FG005|Overall Study|Adverse Event (AE)|1|||
125186991|NCT00955409|450305100|FG006|Overall Study|Adverse Event (AE)|2|||
125186992|NCT00955409|450305101|FG007|Overall Study|Adverse Event (AE)|0|||
125186993|NCT00955409|450305102|FG008|Overall Study|Adverse Event (AE)|2|||
125186994|NCT00955409|450305103|FG009|Overall Study|Adverse Event (AE)|0|||
125186995|NCT00955409|450305094|FG000|Overall Study|Reason not Specified|2|||
125186996|NCT00955409|450305095|FG001|Overall Study|Reason not Specified|1|||
125186997|NCT00955409|450305096|FG002|Overall Study|Reason not Specified|13|||
125186998|NCT00955409|450305097|FG003|Overall Study|Reason not Specified|1|||
125186999|NCT00955409|450305098|FG004|Overall Study|Reason not Specified|2|||
125187000|NCT00955409|450305099|FG005|Overall Study|Reason not Specified|0|||
125187001|NCT00955409|450305100|FG006|Overall Study|Reason not Specified|16|||
125187002|NCT00955409|450305101|FG007|Overall Study|Reason not Specified|0|||
125187003|NCT00955409|450305102|FG008|Overall Study|Reason not Specified|8|||
125187004|NCT00955409|450305103|FG009|Overall Study|Reason not Specified|1|||
125187005|NCT00485732|450305104|FG000|Overall Study|Protocol Violation|1|||
125187006|NCT00485732|450305105|FG001|Overall Study|Protocol Violation|3|||
125187007|NCT00485732|450305104|FG000|Overall Study|Withdrawal by Subject|5|||
125187008|NCT00485732|450305105|FG001|Overall Study|Withdrawal by Subject|4|||
125187009|NCT00485732|450305104|FG000|Overall Study|Lost to Follow-up|2|||
125187010|NCT00485732|450305105|FG001|Overall Study|Lost to Follow-up|2|||
125187011|NCT00803790|450305106|FG000|Period 1|Adverse Event|0|||
125187012|NCT00803790|450305107|FG001|Period 1|Adverse Event|1|||
125187013|NCT00803790|450305108|FG002|Period 1|Adverse Event|0|||
125187014|NCT00803790|450305109|FG003|Period 1|Adverse Event|0|||
125187015|NCT00803790|450305106|FG000|Period 1|Lost to Follow-up|1|||
125187016|NCT00803790|450305107|FG001|Period 1|Lost to Follow-up|2|||
125187017|NCT00803790|450305108|FG002|Period 1|Lost to Follow-up|0|||
125187018|NCT00803790|450305109|FG003|Period 1|Lost to Follow-up|0|||
125187019|NCT00803790|450305106|FG000|Period 1|Withdrawal by Subject|8|||
125187020|NCT00803790|450305107|FG001|Period 1|Withdrawal by Subject|6|||
125187021|NCT00803790|450305108|FG002|Period 1|Withdrawal by Subject|0|||
125187022|NCT00803790|450305109|FG003|Period 1|Withdrawal by Subject|0|||
125187023|NCT00803790|450305106|FG000|Period 1|positive drug screen or personal reasons|0|||
125187024|NCT00803790|450305107|FG001|Period 1|positive drug screen or personal reasons|3|||
125187025|NCT00803790|450305108|FG002|Period 1|positive drug screen or personal reasons|0|||
125187026|NCT00803790|450305109|FG003|Period 1|positive drug screen or personal reasons|4|||
125241186|NCT01371981|450505926|FG002|Overall Study|Withdrawal by Subject|1|||
125241187|NCT01371981|450505927|FG003|Overall Study|Withdrawal by Subject|2|||
125241188|NCT01371981|450505928|FG004|Overall Study|Withdrawal by Subject|10|||
125241189|NCT01371981|450505929|FG005|Overall Study|Withdrawal by Subject|3|||
125241190|NCT01371981|450505924|FG000|Overall Study|Ineligible|19|||
125241191|NCT01371981|450505925|FG001|Overall Study|Ineligible|13|||
125241192|NCT01371981|450505926|FG002|Overall Study|Ineligible|0|||
125241193|NCT01371981|450505927|FG003|Overall Study|Ineligible|0|||
125241194|NCT01371981|450505928|FG004|Overall Study|Ineligible|0|||
125241195|NCT01371981|450505929|FG005|Overall Study|Ineligible|4|||
125187027|NCT00803790|450305106|FG000|Period 1|Protocol Violation|0|||
125187028|NCT00803790|450305107|FG001|Period 1|Protocol Violation|0|||
125241196|NCT01371981|450505924|FG000|Overall Study|Did not start treatment|2|||
125241197|NCT01371981|450505925|FG001|Overall Study|Did not start treatment|3|||
125187029|NCT00803790|450305108|FG002|Period 1|Protocol Violation|1|||
125187030|NCT00803790|450305109|FG003|Period 1|Protocol Violation|0|||
125187031|NCT00803790|450305106|FG000|Period 2|Adverse Event|0|||
125187032|NCT00803790|450305107|FG001|Period 2|Adverse Event|0|||
125187033|NCT00803790|450305108|FG002|Period 2|Adverse Event|1|||
125187034|NCT00803790|450305109|FG003|Period 2|Adverse Event|1|||
125187035|NCT00803790|450305106|FG000|Period 2|Withdrawal by Subject|1|||
125187036|NCT00803790|450305107|FG001|Period 2|Withdrawal by Subject|0|||
125187037|NCT00803790|450305108|FG002|Period 2|Withdrawal by Subject|0|||
125187038|NCT00803790|450305109|FG003|Period 2|Withdrawal by Subject|0|||
125187039|NCT00803790|450305106|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
125187040|NCT00803790|450305107|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
125187041|NCT00803790|450305108|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
125187042|NCT00803790|450305109|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
125187043|NCT01880554|450305110|FG000|Overall Study|Protocol Violation|14|||
125187044|NCT01880554|450305110|FG000|Overall Study|Simon's design requirements|2|||
125187045|NCT05161481|450305111|FG000|Overall Study|Withdrawal of consent|0|||
125187046|NCT05161481|450305112|FG001|Overall Study|Withdrawal of consent|1|||
125187047|NCT05161481|450305113|FG002|Overall Study|Withdrawal of consent|1|||
125187048|NCT05161481|450305111|FG000|Overall Study|Study terminated by sponsor|3|||
125187049|NCT05161481|450305112|FG001|Overall Study|Study terminated by sponsor|3|||
125187050|NCT05161481|450305113|FG002|Overall Study|Study terminated by sponsor|2|||
125187051|NCT05161481|450305111|FG000|Overall Study|Adverse Event|3|||
125187052|NCT05161481|450305112|FG001|Overall Study|Adverse Event|0|||
125187053|NCT05161481|450305113|FG002|Overall Study|Adverse Event|6|||
125187054|NCT05161481|450305111|FG000|Overall Study|Randomised in error and was not treated|1|||
125187055|NCT05161481|450305112|FG001|Overall Study|Randomised in error and was not treated|0|||
125187056|NCT05161481|450305113|FG002|Overall Study|Randomised in error and was not treated|0|||
125187057|NCT05161481|450305111|FG000|Overall Study|Subject decision|0|||
125187058|NCT05161481|450305112|FG001|Overall Study|Subject decision|0|||
125187059|NCT05161481|450305113|FG002|Overall Study|Subject decision|1|||
125187060|NCT03985800|450305114|FG000|Overall Study|Death|1|||
125187061|NCT03985800|450305115|FG001|Overall Study|Death|2|||
125187062|NCT03985800|450305114|FG000|Overall Study|Withdrawal by Subject|3|||
125187063|NCT03985800|450305115|FG001|Overall Study|Withdrawal by Subject|6|||
125187064|NCT03985800|450305114|FG000|Overall Study|Protocol Violation|2|||
125187065|NCT03985800|450305115|FG001|Overall Study|Protocol Violation|0|||
125187066|NCT04815083|450305116|FG000|Overall Study|Physician Decision|1|||
125187067|NCT04815083|450305116|FG000|Overall Study|Study pause|2|||
125187068|NCT04815083|450305116|FG000|Overall Study|Screening failure|4|||
125187069|NCT02570308|450305130|FG000|Overall Study|Death|1|||
125187070|NCT02570308|450305131|FG001|Overall Study|Death|5|||
125187071|NCT02570308|450305132|FG002|Overall Study|Death|4|||
125187072|NCT02570308|450305133|FG003|Overall Study|Death|4|||
125187073|NCT02570308|450305134|FG004|Overall Study|Death|69|||
125187074|NCT02570308|450305130|FG000|Overall Study|Lost to Follow-up|0|||
125187075|NCT02570308|450305131|FG001|Overall Study|Lost to Follow-up|0|||
125187076|NCT02570308|450305132|FG002|Overall Study|Lost to Follow-up|0|||
125187077|NCT02570308|450305133|FG003|Overall Study|Lost to Follow-up|0|||
125187078|NCT02570308|450305134|FG004|Overall Study|Lost to Follow-up|2|||
125187079|NCT02570308|450305130|FG000|Overall Study|Withdrawal by Subject|0|||
125187080|NCT02570308|450305131|FG001|Overall Study|Withdrawal by Subject|0|||
125187081|NCT02570308|450305132|FG002|Overall Study|Withdrawal by Subject|0|||
125187082|NCT02570308|450305133|FG003|Overall Study|Withdrawal by Subject|0|||
125187083|NCT02570308|450305134|FG004|Overall Study|Withdrawal by Subject|1|||
125187084|NCT02570308|450305130|FG000|Overall Study|Other|0|||
125187085|NCT02570308|450305131|FG001|Overall Study|Other|0|||
125187086|NCT02570308|450305132|FG002|Overall Study|Other|0|||
125187087|NCT02570308|450305133|FG003|Overall Study|Other|0|||
125187088|NCT02570308|450305134|FG004|Overall Study|Other|2|||
125187089|NCT00957801|450305135|FG000|Overall Study|Withdrawal by Subject|0|||
125187090|NCT00957801|450305136|FG001|Overall Study|Withdrawal by Subject|0|||
125187091|NCT00957801|450305137|FG002|Overall Study|Withdrawal by Subject|0|||
125187092|NCT00957801|450305138|FG003|Overall Study|Withdrawal by Subject|1|||
125187093|NCT01283464|450305139|FG000|Overall Study|Lost to Follow-up|0|||
125187094|NCT01283464|450305140|FG001|Overall Study|Lost to Follow-up|1|||
125187095|NCT01283464|450305139|FG000|Overall Study|Withdrawal by Subject|1|||
125187096|NCT01283464|450305140|FG001|Overall Study|Withdrawal by Subject|0|||
125187097|NCT01283464|450305139|FG000|Overall Study|Physician Decision|1|||
125187098|NCT01283464|450305140|FG001|Overall Study|Physician Decision|0|||
125187099|NCT01778855|450305141|FG000|Overall Study|Death|0|||
125187100|NCT01778855|450305142|FG001|Overall Study|Death|1|||
125187101|NCT01286467|450305145|FG000|Overall Study|Death|1|||
125187102|NCT01286467|450305146|FG001|Overall Study|Death|1|||
125187103|NCT01286467|450305147|FG002|Overall Study|Death|1|||
125187104|NCT01286467|450305148|FG003|Overall Study|Death|0|||
125187105|NCT01286467|450305145|FG000|Overall Study|Lost to Follow-up|0|||
125187106|NCT01286467|450305146|FG001|Overall Study|Lost to Follow-up|0|||
125187107|NCT01286467|450305147|FG002|Overall Study|Lost to Follow-up|0|||
125187108|NCT01286467|450305148|FG003|Overall Study|Lost to Follow-up|1|||
125187109|NCT01286467|450305145|FG000|Overall Study|Withdrawal by Subject|0|||
125187110|NCT01286467|450305146|FG001|Overall Study|Withdrawal by Subject|0|||
125241198|NCT01371981|450505926|FG002|Overall Study|Did not start treatment|0|||
125241199|NCT01371981|450505927|FG003|Overall Study|Did not start treatment|0|||
125241200|NCT01371981|450505928|FG004|Overall Study|Did not start treatment|0|||
125241201|NCT01371981|450505929|FG005|Overall Study|Did not start treatment|2|||
125187111|NCT01286467|450305147|FG002|Overall Study|Withdrawal by Subject|1|||
125187112|NCT01286467|450305148|FG003|Overall Study|Withdrawal by Subject|0|||
125187113|NCT01286467|450305145|FG000|Overall Study|Physician Decision|0|||
125187114|NCT01286467|450305146|FG001|Overall Study|Physician Decision|0|||
125187115|NCT01286467|450305147|FG002|Overall Study|Physician Decision|0|||
125187116|NCT01286467|450305148|FG003|Overall Study|Physician Decision|1|||
125187117|NCT01286467|450305145|FG000|Overall Study|Disease progression|3|||
125187118|NCT01286467|450305146|FG001|Overall Study|Disease progression|2|||
125187119|NCT01286467|450305147|FG002|Overall Study|Disease progression|2|||
125187120|NCT01286467|450305148|FG003|Overall Study|Disease progression|3|||
125187121|NCT01286467|450305145|FG000|Overall Study|Adverse Event|0|||
125187122|NCT01286467|450305146|FG001|Overall Study|Adverse Event|1|||
125187123|NCT01286467|450305147|FG002|Overall Study|Adverse Event|2|||
125187124|NCT01286467|450305148|FG003|Overall Study|Adverse Event|3|||
125187125|NCT01286467|450305145|FG000|Overall Study|Study drug stop longer than 14 days|0|||
125187126|NCT01286467|450305146|FG001|Overall Study|Study drug stop longer than 14 days|0|||
125187127|NCT01286467|450305147|FG002|Overall Study|Study drug stop longer than 14 days|1|||
125187128|NCT01286467|450305148|FG003|Overall Study|Study drug stop longer than 14 days|0|||
125187129|NCT01058642|450305149|FG000|Treatment Period 1|Adverse Event|0|||
125187130|NCT01058642|450305150|FG001|Treatment Period 1|Adverse Event|1|||
125187131|NCT01058642|450305151|FG002|Treatment Period 1|Adverse Event|1|||
125187132|NCT01058642|450305152|FG003|Treatment Period 1|Adverse Event|0|||
125187133|NCT01058642|450305149|FG000|Treatment Period 1|Physician Decision|0|||
125187134|NCT01058642|450305150|FG001|Treatment Period 1|Physician Decision|0|||
125187135|NCT01058642|450305151|FG002|Treatment Period 1|Physician Decision|1|||
125187136|NCT01058642|450305152|FG003|Treatment Period 1|Physician Decision|0|||
125187137|NCT01058642|450305149|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125187138|NCT01058642|450305150|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125187139|NCT01058642|450305151|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125187140|NCT01058642|450305152|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125187141|NCT01058642|450305149|FG000|Treatment Period 1|Lack of Efficacy|0|||
125187142|NCT01058642|450305150|FG001|Treatment Period 1|Lack of Efficacy|0|||
125187143|NCT01058642|450305151|FG002|Treatment Period 1|Lack of Efficacy|0|||
125187144|NCT01058642|450305152|FG003|Treatment Period 1|Lack of Efficacy|1|||
125187145|NCT01058642|450305149|FG000|Treatment Period 1|Protocol Violation|0|||
125187146|NCT01058642|450305150|FG001|Treatment Period 1|Protocol Violation|0|||
125187147|NCT01058642|450305151|FG002|Treatment Period 1|Protocol Violation|0|||
125187148|NCT01058642|450305152|FG003|Treatment Period 1|Protocol Violation|1|||
125187149|NCT01058642|450305149|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
125187150|NCT01058642|450305150|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
125187151|NCT01058642|450305151|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
125187152|NCT01058642|450305152|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
125187153|NCT01256450|450305153|FG000|Open-label Titration|Adverse Event|39|||
125187154|NCT01256450|450305154|FG001|Open-label Titration|Adverse Event|0|||
125187155|NCT01256450|450305155|FG002|Open-label Titration|Adverse Event|0|||
125187156|NCT01256450|450305153|FG000|Open-label Titration|Lost to Follow-up|7|||
125187157|NCT01256450|450305154|FG001|Open-label Titration|Lost to Follow-up|0|||
125187158|NCT01256450|450305155|FG002|Open-label Titration|Lost to Follow-up|0|||
125187159|NCT01256450|450305153|FG000|Open-label Titration|Lack of analgesic effect|30|||
125187160|NCT01256450|450305154|FG001|Open-label Titration|Lack of analgesic effect|0|||
125187161|NCT01256450|450305155|FG002|Open-label Titration|Lack of analgesic effect|0|||
125187162|NCT01256450|450305153|FG000|Open-label Titration|Non-compliance|9|||
125187163|NCT01256450|450305154|FG001|Open-label Titration|Non-compliance|0|||
125187164|NCT01256450|450305155|FG002|Open-label Titration|Non-compliance|0|||
125187165|NCT01256450|450305153|FG000|Open-label Titration|Screen failure|1|||
125187166|NCT01256450|450305154|FG001|Open-label Titration|Screen failure|0|||
125187167|NCT01256450|450305155|FG002|Open-label Titration|Screen failure|0|||
125187168|NCT01256450|450305153|FG000|Open-label Titration|Other|13|||
125187169|NCT01256450|450305154|FG001|Open-label Titration|Other|0|||
125187170|NCT01256450|450305155|FG002|Open-label Titration|Other|0|||
125187171|NCT01256450|450305153|FG000|Double-blind Treatment|Adverse Event|0|||
125187172|NCT01256450|450305154|FG001|Double-blind Treatment|Adverse Event|8|||
125187173|NCT01256450|450305155|FG002|Double-blind Treatment|Adverse Event|6|||
125187174|NCT01256450|450305153|FG000|Double-blind Treatment|Lost to Follow-up|0|||
125187175|NCT01256450|450305154|FG001|Double-blind Treatment|Lost to Follow-up|1|||
125187176|NCT01256450|450305155|FG002|Double-blind Treatment|Lost to Follow-up|7|||
125187177|NCT01256450|450305153|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
125187178|NCT01256450|450305154|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
125187179|NCT01256450|450305155|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
125241202|NCT03244189|450505930|FG000|Overall Study|Death|0|||
125241203|NCT03244189|450505931|FG001|Overall Study|Death|2|||
125241204|NCT03244189|450505930|FG000|Overall Study|Lost to Follow-up|92|||
125241205|NCT03244189|450505931|FG001|Overall Study|Lost to Follow-up|107|||
125241206|NCT03244189|450505930|FG000|Overall Study|Physician Decision|4|||
125241207|NCT03244189|450505931|FG001|Overall Study|Physician Decision|2|||
125241208|NCT03244189|450505930|FG000|Overall Study|Pregnancy|7|||
125241209|NCT03244189|450505931|FG001|Overall Study|Pregnancy|5|||
125241210|NCT03244189|450505930|FG000|Overall Study|Protocol Violation|0|||
125241211|NCT03244189|450505931|FG001|Overall Study|Protocol Violation|2|||
125241212|NCT03244189|450505930|FG000|Overall Study|Withdrawal by Subject|45|||
125241213|NCT03244189|450505931|FG001|Overall Study|Withdrawal by Subject|23|||
125241214|NCT03244189|450505930|FG000|Overall Study|Technical Problems|2|||
125241215|NCT03244189|450505931|FG001|Overall Study|Technical Problems|0|||
125241216|NCT02145390|450505934|FG000|Overall Study|Withdrawal by Subject|1|||
125241217|NCT01732783|450506747|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
125241218|NCT01732783|450506748|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
125241219|NCT01732783|450506749|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
125241220|NCT01732783|450506747|FG000|Overall Study|Death|13|||
125241221|NCT01732783|450506748|FG001|Overall Study|Death|4|||
125241222|NCT01732783|450506749|FG002|Overall Study|Death|1|||
125241223|NCT01732783|450506747|FG000|Overall Study|Lost to Follow-up|7|||
125241224|NCT01732783|450506748|FG001|Overall Study|Lost to Follow-up|1|||
125241225|NCT01732783|450506749|FG002|Overall Study|Lost to Follow-up|1|||
125241226|NCT01732783|450506747|FG000|Overall Study|Administrative Decision|8|||
125241227|NCT01732783|450506748|FG001|Overall Study|Administrative Decision|2|||
125241228|NCT01732783|450506749|FG002|Overall Study|Administrative Decision|1|||
125241229|NCT01732783|450506747|FG000|Overall Study|Withdrawal by Subject|1|||
125241230|NCT01732783|450506748|FG001|Overall Study|Withdrawal by Subject|0|||
125241231|NCT01732783|450506749|FG002|Overall Study|Withdrawal by Subject|0|||
125241232|NCT04615507|450506750|FG000|Period 1|Covid-19 exposure|2|||
125241233|NCT04615507|450506751|FG001|Period 1|Covid-19 exposure|1|||
125241234|NCT04615507|450506750|FG000|Period 2|Covid-19 exposure|0|||
125241235|NCT04615507|450506751|FG001|Period 2|Covid-19 exposure|1|||
125241236|NCT04615507|450506750|FG000|Period 2|Protocol Violation|1|||
125241237|NCT04615507|450506751|FG001|Period 2|Protocol Violation|0|||
125241238|NCT04615507|450506750|FG000|Period 2|Withdrawal by Subject|1|||
125241239|NCT04615507|450506751|FG001|Period 2|Withdrawal by Subject|0|||
125241240|NCT04615507|450506750|FG000|Period 2|Adverse Event|0|||
125241241|NCT04615507|450506751|FG001|Period 2|Adverse Event|1|||
125241242|NCT04615507|450506750|FG000|Period 3|Covid-19 exposure|0|||
125241243|NCT04615507|450506751|FG001|Period 3|Covid-19 exposure|1|||
125241244|NCT03421808|450506756|FG000|Overall Study|COVID related problems|2|||
125241245|NCT03421808|450506757|FG001|Overall Study|COVID related problems|0|||
125241246|NCT03421808|450506756|FG000|Overall Study|Withdrawal by Subject|1|||
125241247|NCT03421808|450506757|FG001|Overall Study|Withdrawal by Subject|0|||
125241248|NCT03421808|450506756|FG000|Overall Study|Protocol Violation|0|||
125241249|NCT03421808|450506757|FG001|Overall Study|Protocol Violation|1|||
125241250|NCT00632359|450506758|FG000|Overall Study|Withdrawal by Subject|2|||
125241251|NCT02872714|450506759|FG000|Overall Study|Progressive Disease|1|||
125241252|NCT02872714|450506760|FG001|Overall Study|Progressive Disease|2|||
125241253|NCT02872714|450506761|FG002|Overall Study|Progressive Disease|0|||
125241254|NCT02872714|450506762|FG003|Overall Study|Progressive Disease|0|||
125241255|NCT02872714|450506763|FG004|Overall Study|Progressive Disease|0|||
125241256|NCT02872714|450506759|FG000|Overall Study|Death|87|||
125241257|NCT02872714|450506760|FG001|Overall Study|Death|36|||
125241258|NCT02872714|450506761|FG002|Overall Study|Death|8|||
125241259|NCT02872714|450506762|FG003|Overall Study|Death|81|||
125241260|NCT02872714|450506763|FG004|Overall Study|Death|2|||
125241261|NCT02872714|450506759|FG000|Overall Study|Lost to Follow-up|2|||
125241262|NCT02872714|450506760|FG001|Overall Study|Lost to Follow-up|1|||
125241263|NCT02872714|450506761|FG002|Overall Study|Lost to Follow-up|0|||
125241264|NCT02872714|450506762|FG003|Overall Study|Lost to Follow-up|3|||
125241265|NCT02872714|450506763|FG004|Overall Study|Lost to Follow-up|0|||
125241266|NCT02872714|450506759|FG000|Overall Study|Physician Decision|0|||
125241267|NCT02872714|450506760|FG001|Overall Study|Physician Decision|0|||
125241268|NCT02872714|450506761|FG002|Overall Study|Physician Decision|0|||
125241269|NCT02872714|450506762|FG003|Overall Study|Physician Decision|1|||
125241270|NCT02872714|450506763|FG004|Overall Study|Physician Decision|0|||
125241271|NCT02872714|450506759|FG000|Overall Study|Withdrawal by Subject|1|||
125241272|NCT02872714|450506760|FG001|Overall Study|Withdrawal by Subject|3|||
125241273|NCT02872714|450506761|FG002|Overall Study|Withdrawal by Subject|0|||
125241274|NCT02872714|450506762|FG003|Overall Study|Withdrawal by Subject|2|||
125241275|NCT02872714|450506763|FG004|Overall Study|Withdrawal by Subject|0|||
125241276|NCT02872714|450506759|FG000|Overall Study|Captured as Other|2|||
125241277|NCT02872714|450506760|FG001|Overall Study|Captured as Other|0|||
125241278|NCT02872714|450506761|FG002|Overall Study|Captured as Other|0|||
125241279|NCT02872714|450506762|FG003|Overall Study|Captured as Other|1|||
125241280|NCT02872714|450506763|FG004|Overall Study|Captured as Other|0|||
125241281|NCT06717399|450506764|FG000|Overall Study|Death|1|||
125241282|NCT02180867|450506767|FG000|Overall Study|Adverse Event|3|||
125241283|NCT02180867|450506768|FG001|Overall Study|Adverse Event|4|||
125187180|NCT01256450|450305153|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
125187181|NCT01256450|450305154|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
125187182|NCT01256450|450305155|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
125187183|NCT01256450|450305153|FG000|Double-blind Treatment|Non-compliance|0|||
125241284|NCT02180867|450506769|FG002|Overall Study|Adverse Event|1|||
125241285|NCT02180867|450506770|FG003|Overall Study|Adverse Event|5|||
125241286|NCT02180867|450506771|FG004|Overall Study|Adverse Event|0|||
125241287|NCT02180867|450506772|FG005|Overall Study|Adverse Event|0|||
125241288|NCT02180867|450506773|FG006|Overall Study|Adverse Event|0|||
125241289|NCT02180867|450506767|FG000|Overall Study|Death|0|||
125241290|NCT02180867|450506768|FG001|Overall Study|Death|0|||
125241291|NCT02180867|450506769|FG002|Overall Study|Death|0|||
125241292|NCT02180867|450506770|FG003|Overall Study|Death|0|||
125241293|NCT02180867|450506771|FG004|Overall Study|Death|1|||
125241294|NCT02180867|450506772|FG005|Overall Study|Death|0|||
125241295|NCT02180867|450506773|FG006|Overall Study|Death|0|||
125241296|NCT02180867|450506767|FG000|Overall Study|Lack of Efficacy|0|||
125241297|NCT02180867|450506768|FG001|Overall Study|Lack of Efficacy|2|||
125241298|NCT02180867|450506769|FG002|Overall Study|Lack of Efficacy|0|||
125241299|NCT02180867|450506770|FG003|Overall Study|Lack of Efficacy|1|||
125241300|NCT02180867|450506771|FG004|Overall Study|Lack of Efficacy|6|||
125241301|NCT02180867|450506772|FG005|Overall Study|Lack of Efficacy|0|||
125241302|NCT02180867|450506773|FG006|Overall Study|Lack of Efficacy|1|||
125241303|NCT02180867|450506767|FG000|Overall Study|Physician Decision|1|||
125241304|NCT02180867|450506768|FG001|Overall Study|Physician Decision|3|||
125241305|NCT02180867|450506769|FG002|Overall Study|Physician Decision|1|||
125241306|NCT02180867|450506770|FG003|Overall Study|Physician Decision|10|||
125241307|NCT02180867|450506771|FG004|Overall Study|Physician Decision|9|||
125241308|NCT02180867|450506772|FG005|Overall Study|Physician Decision|3|||
125241309|NCT02180867|450506773|FG006|Overall Study|Physician Decision|4|||
125241310|NCT02180867|450506767|FG000|Overall Study|Withdrawal by Subject|0|||
125241311|NCT02180867|450506768|FG001|Overall Study|Withdrawal by Subject|0|||
125241312|NCT02180867|450506769|FG002|Overall Study|Withdrawal by Subject|0|||
125241313|NCT02180867|450506770|FG003|Overall Study|Withdrawal by Subject|1|||
125241314|NCT02180867|450506771|FG004|Overall Study|Withdrawal by Subject|1|||
125241315|NCT02180867|450506772|FG005|Overall Study|Withdrawal by Subject|0|||
125241316|NCT02180867|450506773|FG006|Overall Study|Withdrawal by Subject|0|||
125241317|NCT02180867|450506767|FG000|Overall Study|Ineligible|1|||
125241318|NCT02180867|450506768|FG001|Overall Study|Ineligible|2|||
125241319|NCT02180867|450506769|FG002|Overall Study|Ineligible|0|||
125241320|NCT02180867|450506770|FG003|Overall Study|Ineligible|3|||
125241321|NCT02180867|450506771|FG004|Overall Study|Ineligible|5|||
125241322|NCT02180867|450506772|FG005|Overall Study|Ineligible|0|||
125241323|NCT02180867|450506773|FG006|Overall Study|Ineligible|0|||
125241324|NCT02180867|450506767|FG000|Overall Study|Repeat Eligibility Studies|0|||
125241325|NCT02180867|450506768|FG001|Overall Study|Repeat Eligibility Studies|0|||
125241326|NCT02180867|450506769|FG002|Overall Study|Repeat Eligibility Studies|0|||
125241327|NCT02180867|450506770|FG003|Overall Study|Repeat Eligibility Studies|0|||
125241328|NCT02180867|450506771|FG004|Overall Study|Repeat Eligibility Studies|1|||
125241329|NCT02180867|450506772|FG005|Overall Study|Repeat Eligibility Studies|0|||
125241330|NCT02180867|450506773|FG006|Overall Study|Repeat Eligibility Studies|0|||
125241331|NCT02180867|450506767|FG000|Overall Study|Refusal of further protocol therapy|1|||
125241332|NCT02180867|450506768|FG001|Overall Study|Refusal of further protocol therapy|0|||
125241333|NCT02180867|450506769|FG002|Overall Study|Refusal of further protocol therapy|2|||
125241334|NCT02180867|450506770|FG003|Overall Study|Refusal of further protocol therapy|6|||
125241335|NCT02180867|450506771|FG004|Overall Study|Refusal of further protocol therapy|4|||
125241336|NCT02180867|450506772|FG005|Overall Study|Refusal of further protocol therapy|0|||
125241337|NCT02180867|450506773|FG006|Overall Study|Refusal of further protocol therapy|0|||
125241338|NCT02337686|450506774|FG000|Overall Study|Adverse Event|1|||
125241339|NCT00177671|450507584|FG000|Overall Study|Withdrawal by Subject|5|||
125241340|NCT00177671|450507585|FG001|Overall Study|Withdrawal by Subject|6|||
125241341|NCT00177671|450507584|FG000|Overall Study|medical complications|2|||
125241342|NCT00177671|450507585|FG001|Overall Study|medical complications|0|||
125241343|NCT00177671|450507584|FG000|Overall Study|Adverse Event|6|||
125241344|NCT00177671|450507585|FG001|Overall Study|Adverse Event|0|||
125241345|NCT00177671|450507584|FG000|Overall Study|Physician Decision|12|||
125241346|NCT00177671|450507585|FG001|Overall Study|Physician Decision|8|||
125241347|NCT02293499|450507586|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
125241348|NCT02293499|450507587|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
125241349|NCT02293499|450507588|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
125241350|NCT02293499|450507586|FG000|Intervention - Camp|Withdrawal by Subject|3|||
125241351|NCT02293499|450507587|FG001|Intervention - Camp|Withdrawal by Subject|6|||
125241352|NCT02293499|450507588|FG002|Intervention - Camp|Withdrawal by Subject|2|||
125241353|NCT02293499|450507586|FG000|Intervention - Camp|these are those not showing up at camp|24|||
125241354|NCT02293499|450507587|FG001|Intervention - Camp|these are those not showing up at camp|28|||
125241355|NCT02293499|450507588|FG002|Intervention - Camp|these are those not showing up at camp|4|||
125241356|NCT02293499|450507586|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
125241357|NCT02293499|450507587|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
125241358|NCT02293499|450507588|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
125241359|NCT02293499|450507586|FG000|3 Month Follow Up|Lost to Follow-up|14|||
125187184|NCT01256450|450305154|FG001|Double-blind Treatment|Non-compliance|5|||
125187185|NCT01256450|450305155|FG002|Double-blind Treatment|Non-compliance|4|||
125187186|NCT01256450|450305153|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
125187187|NCT01256450|450305154|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
125187188|NCT01256450|450305155|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
125187189|NCT01256450|450305153|FG000|Double-blind Treatment|Other|0|||
125187190|NCT01256450|450305154|FG001|Double-blind Treatment|Other|9|||
125187191|NCT01256450|450305155|FG002|Double-blind Treatment|Other|12|||
125187192|NCT03866512|450305156|FG000|Overall Study|Lost to Follow-up|1|||
125187193|NCT03866512|450305157|FG001|Overall Study|Lost to Follow-up|2|||
125187194|NCT03866512|450305158|FG002|Overall Study|Lost to Follow-up|1|||
125187195|NCT03866512|450305156|FG000|Overall Study|Cannulation issues|0|||
125187196|NCT03866512|450305157|FG001|Overall Study|Cannulation issues|1|||
125187197|NCT03866512|450305158|FG002|Overall Study|Cannulation issues|2|||
125187198|NCT00777296|450305166|FG000|Overall Study|Adverse Event|0|||
125187199|NCT00777296|450305167|FG001|Overall Study|Adverse Event|1|||
125187200|NCT00777296|450305168|FG002|Overall Study|Adverse Event|0|||
125187201|NCT00777296|450305169|FG003|Overall Study|Adverse Event|1|||
125187202|NCT00777296|450305166|FG000|Overall Study|Withdrawal by Subject|1|||
125187203|NCT00777296|450305167|FG001|Overall Study|Withdrawal by Subject|0|||
125187204|NCT00777296|450305168|FG002|Overall Study|Withdrawal by Subject|0|||
125187205|NCT00777296|450305169|FG003|Overall Study|Withdrawal by Subject|0|||
125187206|NCT00777296|450305166|FG000|Overall Study|CRF form not completed|0|||
125187207|NCT00777296|450305167|FG001|Overall Study|CRF form not completed|0|||
125187208|NCT00777296|450305168|FG002|Overall Study|CRF form not completed|2|||
125187209|NCT00777296|450305169|FG003|Overall Study|CRF form not completed|0|||
125187210|NCT01139125|450305171|FG000|Overall Study|Withdrawal by Subject|1|||
125187211|NCT04242498|450305177|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
125187212|NCT04242498|450305178|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
125187213|NCT04242498|450305179|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
125187214|NCT04242498|450305180|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
125187215|NCT04242498|450305181|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
125187216|NCT04242498|450305182|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
125187217|NCT04242498|450305183|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
125187218|NCT04242498|450305177|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
125187219|NCT04242498|450305178|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
125187220|NCT04242498|450305179|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
125187221|NCT04242498|450305180|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
125187222|NCT04242498|450305181|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
125187223|NCT04242498|450305182|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
125187224|NCT04242498|450305183|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
125187225|NCT04242498|450305177|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
125187226|NCT04242498|450305178|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
125187227|NCT04242498|450305179|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
125187228|NCT04242498|450305180|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
125187229|NCT04242498|450305181|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
125187230|NCT04242498|450305182|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
125187231|NCT04242498|450305183|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
125187232|NCT04242498|450305177|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
125187233|NCT04242498|450305178|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
125187234|NCT04242498|450305179|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
125187235|NCT04242498|450305180|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
125187236|NCT04242498|450305181|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
125187237|NCT04242498|450305182|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
125187238|NCT04242498|450305183|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
125187239|NCT04242498|450305177|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
125187240|NCT04242498|450305178|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
125187241|NCT04242498|450305179|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
125241360|NCT02293499|450507587|FG001|3 Month Follow Up|Lost to Follow-up|15|||
125241361|NCT02293499|450507588|FG002|3 Month Follow Up|Lost to Follow-up|6|||
125241362|NCT02293499|450507586|FG000|6 Month Follow Up|Lost to Follow-up|17|||
125241363|NCT02293499|450507587|FG001|6 Month Follow Up|Lost to Follow-up|27|||
125241364|NCT02293499|450507588|FG002|6 Month Follow Up|Lost to Follow-up|6|||
125241365|NCT02293499|450507586|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
125241366|NCT02293499|450507587|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
125241367|NCT02293499|450507588|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
125241368|NCT02293499|450507586|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
125241369|NCT02293499|450507587|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
125241370|NCT02293499|450507588|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
125241371|NCT02293499|450507586|FG000|9 Month Follow Up|Lost to Follow-up|24|||
125241372|NCT02293499|450507587|FG001|9 Month Follow Up|Lost to Follow-up|28|||
125241373|NCT02293499|450507588|FG002|9 Month Follow Up|Lost to Follow-up|4|||
125241374|NCT02293499|450507586|FG000|12 Month Follow Up|Lost to Follow-up|26|||
125241375|NCT02293499|450507587|FG001|12 Month Follow Up|Lost to Follow-up|25|||
125241376|NCT02293499|450507588|FG002|12 Month Follow Up|Lost to Follow-up|6|||
125241377|NCT02293499|450507586|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
125241378|NCT02293499|450507587|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
125241379|NCT02293499|450507588|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
125241380|NCT02293499|450507586|FG000|15 Month Follow Up|Lost to Follow-up|22|||
125241381|NCT02293499|450507587|FG001|15 Month Follow Up|Lost to Follow-up|22|||
125241382|NCT02293499|450507588|FG002|15 Month Follow Up|Lost to Follow-up|7|||
125241383|NCT00690898|450507589|FG000|SCREENING|Screen failure|18|||
125241384|NCT00690898|450507589|FG000|TREATMENT|Adverse Event|3|||
125241385|NCT00690898|450507589|FG000|TREATMENT|Lack of Efficacy|18|||
125241386|NCT00690898|450507589|FG000|TREATMENT|Withdrawal by Subject|4|||
125241387|NCT00690898|450507589|FG000|TREATMENT|Other (not otherwise specified)|1|||
125241388|NCT01847209|450507592|FG000|Overall Study|Withdrawal by Subject|1|||
125241389|NCT01847209|450507592|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
125241390|NCT02008370|450507610|FG000|Overall Study|Lost to Follow-up|7|||
125241391|NCT03317496|450507614|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
125241392|NCT03317496|450507615|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
125241393|NCT03317496|450507616|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
125241394|NCT03317496|450507617|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
125241395|NCT03317496|450507618|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
125241396|NCT03317496|450507614|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
125241397|NCT03317496|450507615|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
125241398|NCT03317496|450507616|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
125241399|NCT03317496|450507617|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
125241400|NCT03317496|450507618|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
125241401|NCT03317496|450507614|FG000|Phase 1b Lead-in: Treatment|Death|0|||
125241402|NCT03317496|450507615|FG001|Phase 1b Lead-in: Treatment|Death|0|||
125241403|NCT03317496|450507616|FG002|Phase 1b Lead-in: Treatment|Death|1|||
125241404|NCT03317496|450507617|FG003|Phase 1b Lead-in: Treatment|Death|0|||
125241405|NCT03317496|450507618|FG004|Phase 1b Lead-in: Treatment|Death|0|||
125241406|NCT03317496|450507614|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
125241407|NCT03317496|450507615|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
125241408|NCT03317496|450507616|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
125241409|NCT03317496|450507617|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
125241410|NCT03317496|450507618|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
125241411|NCT03317496|450507614|FG000|Phase 1b Lead-in: Treatment|Other|2|||
125241412|NCT03317496|450507615|FG001|Phase 1b Lead-in: Treatment|Other|1|||
125241413|NCT03317496|450507616|FG002|Phase 1b Lead-in: Treatment|Other|0|||
125241414|NCT03317496|450507617|FG003|Phase 1b Lead-in: Treatment|Other|0|||
125241415|NCT03317496|450507618|FG004|Phase 1b Lead-in: Treatment|Other|0|||
125241416|NCT03317496|450507614|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
125241417|NCT03317496|450507615|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
125241418|NCT03317496|450507616|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
125241419|NCT03317496|450507617|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
125241420|NCT03317496|450507618|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
125241421|NCT03317496|450507614|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
125241422|NCT03317496|450507615|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
125241423|NCT03317496|450507616|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
125241424|NCT03317496|450507617|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
125241425|NCT03317496|450507618|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
125241426|NCT03317496|450507614|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
125241427|NCT03317496|450507615|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
125241428|NCT03317496|450507616|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
125241429|NCT03317496|450507617|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
125241430|NCT03317496|450507618|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
125241431|NCT03317496|450507614|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
125187242|NCT04242498|450305180|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
125187243|NCT04242498|450305181|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
125241432|NCT03317496|450507615|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
125241433|NCT03317496|450507616|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
125241434|NCT03317496|450507617|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
125241435|NCT03317496|450507618|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
125241436|NCT03317496|450507614|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
125241437|NCT03317496|450507615|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
125241438|NCT03317496|450507616|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
125241439|NCT03317496|450507617|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
125241440|NCT03317496|450507618|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
125241441|NCT03317496|450507614|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
125241442|NCT03317496|450507615|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
125241443|NCT03317496|450507616|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
125241444|NCT03317496|450507617|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
125241445|NCT03317496|450507618|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
125241446|NCT03317496|450507614|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
125241447|NCT03317496|450507615|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
125241448|NCT03317496|450507616|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
125241449|NCT03317496|450507617|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
125241450|NCT03317496|450507618|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
125241451|NCT03317496|450507614|FG000|Phase 2: Treatment|Adverse Event|0|||
125241452|NCT03317496|450507615|FG001|Phase 2: Treatment|Adverse Event|0|||
125241453|NCT03317496|450507616|FG002|Phase 2: Treatment|Adverse Event|0|||
125241454|NCT03317496|450507617|FG003|Phase 2: Treatment|Adverse Event|0|||
125241455|NCT03317496|450507618|FG004|Phase 2: Treatment|Adverse Event|6|||
125241456|NCT03317496|450507614|FG000|Phase 2: Treatment|Progressive disease|0|||
125241457|NCT03317496|450507615|FG001|Phase 2: Treatment|Progressive disease|0|||
125241458|NCT03317496|450507616|FG002|Phase 2: Treatment|Progressive disease|0|||
125241459|NCT03317496|450507617|FG003|Phase 2: Treatment|Progressive disease|0|||
125241460|NCT03317496|450507618|FG004|Phase 2: Treatment|Progressive disease|22|||
125241461|NCT03317496|450507614|FG000|Phase 2: Treatment|Other|0|||
125241462|NCT03317496|450507615|FG001|Phase 2: Treatment|Other|0|||
125241463|NCT03317496|450507616|FG002|Phase 2: Treatment|Other|0|||
125241464|NCT03317496|450507617|FG003|Phase 2: Treatment|Other|0|||
125241465|NCT03317496|450507618|FG004|Phase 2: Treatment|Other|4|||
125241466|NCT03317496|450507614|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
125241467|NCT03317496|450507615|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
125241468|NCT03317496|450507616|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
125241469|NCT03317496|450507617|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
125241470|NCT03317496|450507618|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
125241471|NCT03317496|450507614|FG000|Phase 2: Treatment|Physician Decision|0|||
125241472|NCT03317496|450507615|FG001|Phase 2: Treatment|Physician Decision|0|||
125241473|NCT03317496|450507616|FG002|Phase 2: Treatment|Physician Decision|0|||
125241474|NCT03317496|450507617|FG003|Phase 2: Treatment|Physician Decision|0|||
125241475|NCT03317496|450507618|FG004|Phase 2: Treatment|Physician Decision|1|||
125241476|NCT03317496|450507614|FG000|Phase 2: Treatment|Death|0|||
125241477|NCT03317496|450507615|FG001|Phase 2: Treatment|Death|0|||
125241478|NCT03317496|450507616|FG002|Phase 2: Treatment|Death|0|||
125241479|NCT03317496|450507617|FG003|Phase 2: Treatment|Death|0|||
125241480|NCT03317496|450507618|FG004|Phase 2: Treatment|Death|1|||
125241481|NCT03317496|450507614|FG000|Phase 2: Follow-up|Death|0|||
125241482|NCT03317496|450507615|FG001|Phase 2: Follow-up|Death|0|||
125241483|NCT03317496|450507616|FG002|Phase 2: Follow-up|Death|0|||
125241484|NCT03317496|450507617|FG003|Phase 2: Follow-up|Death|0|||
125241485|NCT03317496|450507618|FG004|Phase 2: Follow-up|Death|24|||
125241486|NCT03317496|450507614|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
125241487|NCT03317496|450507615|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
125241488|NCT03317496|450507616|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
125241489|NCT03317496|450507617|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
125241490|NCT03317496|450507618|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
125241491|NCT03317496|450507614|FG000|Phase 2: Follow-up|Other|0|||
125241492|NCT03317496|450507615|FG001|Phase 2: Follow-up|Other|0|||
125241493|NCT03317496|450507616|FG002|Phase 2: Follow-up|Other|0|||
125241494|NCT03317496|450507617|FG003|Phase 2: Follow-up|Other|0|||
125241495|NCT03317496|450507618|FG004|Phase 2: Follow-up|Other|1|||
125241496|NCT03317496|450507614|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
125241497|NCT03317496|450507615|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
125241498|NCT03317496|450507616|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
125241499|NCT03317496|450507617|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
125241500|NCT03317496|450507618|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
125241501|NCT02737618|450507619|FG000|Overall Study|Withdrawal by Subject|9|||
125241502|NCT00817063|450507622|FG000|Overall Study|Adverse Event|32|||
125241503|NCT00817063|450507623|FG001|Overall Study|Adverse Event|13|||
125241504|NCT00817063|450507622|FG000|Overall Study|Death|1|||
125241505|NCT00817063|450507623|FG001|Overall Study|Death|1|||
125241506|NCT00817063|450507622|FG000|Overall Study|Lack of Efficacy|33|||
125241507|NCT00817063|450507623|FG001|Overall Study|Lack of Efficacy|86|||
125241508|NCT00817063|450507622|FG000|Overall Study|Failure to Return|13|||
125241509|NCT00817063|450507623|FG001|Overall Study|Failure to Return|12|||
125241510|NCT00817063|450507622|FG000|Overall Study|Violation of Selection at Entry|7|||
125241511|NCT00817063|450507623|FG001|Overall Study|Violation of Selection at Entry|4|||
125241512|NCT00817063|450507622|FG000|Overall Study|Protocol Violation|3|||
125241513|NCT00817063|450507623|FG001|Overall Study|Protocol Violation|8|||
125241514|NCT00817063|450507622|FG000|Overall Study|Withdrawal by Subject|17|||
125241515|NCT00817063|450507623|FG001|Overall Study|Withdrawal by Subject|37|||
125241516|NCT00817063|450507622|FG000|Overall Study|Early Improvement|19|||
125241517|NCT00817063|450507623|FG001|Overall Study|Early Improvement|4|||
125241518|NCT00817063|450507622|FG000|Overall Study|Administrative|10|||
125241519|NCT00817063|450507623|FG001|Overall Study|Administrative|4|||
125241520|NCT00817063|450507622|FG000|Overall Study|Abnormality of Laboratory Test|2|||
125241521|NCT00817063|450507623|FG001|Overall Study|Abnormality of Laboratory Test|1|||
125241522|NCT02362451|450507625|FG000|Overall Study|Withdrawal by Subject|0|||
125241523|NCT02362451|450507626|FG001|Overall Study|Withdrawal by Subject|1|||
125241524|NCT02362451|450507625|FG000|Overall Study|Lack of Efficacy|2|||
125241525|NCT02362451|450507626|FG001|Overall Study|Lack of Efficacy|0|||
125241526|NCT02362451|450507625|FG000|Overall Study|Progression|1|||
125241527|NCT02362451|450507626|FG001|Overall Study|Progression|0|||
125241528|NCT02362451|450507625|FG000|Overall Study|Participant chose other therapy.|1|||
125241529|NCT02362451|450507626|FG001|Overall Study|Participant chose other therapy.|0|||
125241530|NCT01879852|450507627|FG000|Overall Study|Withdrawal by Subject|2|||
125241531|NCT01879852|450507628|FG001|Overall Study|Withdrawal by Subject|0|||
125241532|NCT02696616|450507630|FG000|Overall Study|Adverse Event|0|||
125241533|NCT02696616|450507631|FG001|Overall Study|Adverse Event|1|||
125241534|NCT02696616|450507632|FG002|Overall Study|Adverse Event|0|||
125241535|NCT02696616|450507633|FG003|Overall Study|Adverse Event|0|||
125241536|NCT02696616|450507634|FG004|Overall Study|Adverse Event|0|||
125241537|NCT02696616|450507635|FG005|Overall Study|Adverse Event|0|||
125241538|NCT02696616|450507636|FG006|Overall Study|Adverse Event|0|||
125241539|NCT01500083|450507637|FG000|Overall Study|Adverse Event|4|||
125241540|NCT01500083|450507638|FG001|Overall Study|Adverse Event|17|||
125241541|NCT01500083|450507637|FG000|Overall Study|Death|0|||
125241542|NCT01500083|450507638|FG001|Overall Study|Death|2|||
125241543|NCT01500083|450507637|FG000|Overall Study|Lost to Follow-up|1|||
125241544|NCT01500083|450507638|FG001|Overall Study|Lost to Follow-up|0|||
125241545|NCT01500083|450507637|FG000|Overall Study|Withdrawal of Consent|0|||
125241546|NCT01500083|450507638|FG001|Overall Study|Withdrawal of Consent|1|||
125241547|NCT01500083|450507637|FG000|Overall Study|Disease Progression|2|||
125241548|NCT01500083|450507638|FG001|Overall Study|Disease Progression|10|||
125241549|NCT01500083|450507637|FG000|Overall Study|Investigator Discretion|3|||
125241550|NCT01500083|450507638|FG001|Overall Study|Investigator Discretion|8|||
125241551|NCT01500083|450507637|FG000|Overall Study|Other Reasons|2|||
125241552|NCT01500083|450507638|FG001|Overall Study|Other Reasons|5|||
125241553|NCT01555931|450507639|FG000|Overall Study|Lost to Follow-up|2|||
125241554|NCT01555931|450507640|FG001|Overall Study|Lost to Follow-up|5|||
125241555|NCT01922011|450507641|FG000|Overall Study|Protocol Violation|0|||
125241556|NCT01922011|450507642|FG001|Overall Study|Protocol Violation|1|||
125241557|NCT01922011|450507641|FG000|Overall Study|Physician Decision|0|||
125241558|NCT01922011|450507642|FG001|Overall Study|Physician Decision|1|||
125241559|NCT01922011|450507641|FG000|Overall Study|Parent/Guardian Decision|3|||
125241560|NCT01922011|450507642|FG001|Overall Study|Parent/Guardian Decision|0|||
125241561|NCT01922011|450507641|FG000|Overall Study|Lost to Follow-up|0|||
125241562|NCT01922011|450507642|FG001|Overall Study|Lost to Follow-up|1|||
125241563|NCT01922011|450507641|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
125241564|NCT01922011|450507642|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
125241565|NCT01922011|450507641|FG000|Overall Study|Not Treated|1|||
125241566|NCT01922011|450507642|FG001|Overall Study|Not Treated|0|||
125241567|NCT01922011|450507641|FG000|Overall Study|Lack of willing home health agency|1|||
125241568|NCT01922011|450507642|FG001|Overall Study|Lack of willing home health agency|0|||
125241569|NCT01922011|450507641|FG000|Overall Study|Randomized in error|1|||
125241570|NCT01922011|450507642|FG001|Overall Study|Randomized in error|0|||
125241571|NCT02299167|450507645|FG000|Overall Study|patients were excluded from the study|11|||
125241572|NCT00700635|450507646|FG000|Overall Study|Adverse Event|1|||
125241573|NCT00700635|450507647|FG001|Overall Study|Adverse Event|0|||
125241574|NCT00700635|450507648|FG002|Overall Study|Adverse Event|0|||
125241575|NCT00700635|450507646|FG000|Overall Study|Lost to Follow-up|1|||
125241576|NCT00700635|450507647|FG001|Overall Study|Lost to Follow-up|3|||
125241577|NCT00700635|450507648|FG002|Overall Study|Lost to Follow-up|0|||
125241578|NCT00700635|450507646|FG000|Overall Study|Protocol Violation|2|||
125241579|NCT00700635|450507647|FG001|Overall Study|Protocol Violation|2|||
125241580|NCT00700635|450507648|FG002|Overall Study|Protocol Violation|0|||
125241581|NCT00700635|450507646|FG000|Overall Study|Withdrawal by Subject|7|||
125241582|NCT00700635|450507647|FG001|Overall Study|Withdrawal by Subject|3|||
125241583|NCT00700635|450507648|FG002|Overall Study|Withdrawal by Subject|1|||
125241584|NCT05172570|450507649|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
125241585|NCT05172570|450507650|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
125241586|NCT05172570|450507651|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
125241587|NCT05172570|450507649|FG000|Overall Study|PI Decision due to equipment shortages|0|||
125241588|NCT05172570|450507650|FG001|Overall Study|PI Decision due to equipment shortages|0|||
125241589|NCT05172570|450507651|FG002|Overall Study|PI Decision due to equipment shortages|1|||
125241590|NCT02207608|450507657|FG000|Overall Study|Adverse Event|1|||
125241591|NCT02207608|450507658|FG001|Overall Study|Adverse Event|0|||
125241592|NCT00980460|450507659|FG000|Overall Study|Death|0|||
125241593|NCT00980460|450507660|FG001|Overall Study|Death|0|||
125241594|NCT00980460|450507661|FG002|Overall Study|Death|1|||
125241595|NCT00980460|450507662|FG003|Overall Study|Death|2|||
125241596|NCT00980460|450507663|FG004|Overall Study|Death|1|||
125241597|NCT00980460|450507659|FG000|Overall Study|Lack of Efficacy|0|||
125241598|NCT00980460|450507660|FG001|Overall Study|Lack of Efficacy|0|||
125241599|NCT00980460|450507661|FG002|Overall Study|Lack of Efficacy|10|||
125241600|NCT00980460|450507662|FG003|Overall Study|Lack of Efficacy|6|||
125241601|NCT00980460|450507663|FG004|Overall Study|Lack of Efficacy|8|||
125241602|NCT00980460|450507659|FG000|Overall Study|Lost to Follow-up|0|||
125241603|NCT00980460|450507660|FG001|Overall Study|Lost to Follow-up|0|||
125241604|NCT00980460|450507661|FG002|Overall Study|Lost to Follow-up|0|||
125241605|NCT00980460|450507662|FG003|Overall Study|Lost to Follow-up|1|||
125241606|NCT00980460|450507663|FG004|Overall Study|Lost to Follow-up|0|||
125241607|NCT00980460|450507659|FG000|Overall Study|Physician Decision|0|||
125241608|NCT00980460|450507660|FG001|Overall Study|Physician Decision|0|||
125241609|NCT00980460|450507661|FG002|Overall Study|Physician Decision|11|||
125241610|NCT00980460|450507662|FG003|Overall Study|Physician Decision|5|||
125241611|NCT00980460|450507663|FG004|Overall Study|Physician Decision|3|||
125241612|NCT00980460|450507659|FG000|Overall Study|Withdrawal by Subject|0|||
125241613|NCT00980460|450507660|FG001|Overall Study|Withdrawal by Subject|0|||
125241614|NCT00980460|450507661|FG002|Overall Study|Withdrawal by Subject|1|||
125241615|NCT00980460|450507662|FG003|Overall Study|Withdrawal by Subject|0|||
125241616|NCT00980460|450507663|FG004|Overall Study|Withdrawal by Subject|0|||
125241617|NCT00980460|450507659|FG000|Overall Study|Ineligible|0|||
125241618|NCT00980460|450507660|FG001|Overall Study|Ineligible|2|||
125241619|NCT00980460|450507661|FG002|Overall Study|Ineligible|3|||
125241620|NCT00980460|450507662|FG003|Overall Study|Ineligible|1|||
125241621|NCT00980460|450507663|FG004|Overall Study|Ineligible|4|||
125241622|NCT00980460|450507659|FG000|Overall Study|Refusal of further therapy|0|||
125241623|NCT00980460|450507660|FG001|Overall Study|Refusal of further therapy|2|||
125241624|NCT00980460|450507661|FG002|Overall Study|Refusal of further therapy|3|||
125241625|NCT00980460|450507662|FG003|Overall Study|Refusal of further therapy|2|||
125241626|NCT00980460|450507663|FG004|Overall Study|Refusal of further therapy|0|||
125241627|NCT00980460|450507659|FG000|Overall Study|No therapy within 42 days of resection|0|||
125241628|NCT00980460|450507660|FG001|Overall Study|No therapy within 42 days of resection|0|||
125241629|NCT00980460|450507661|FG002|Overall Study|No therapy within 42 days of resection|3|||
125241630|NCT00980460|450507662|FG003|Overall Study|No therapy within 42 days of resection|1|||
125187244|NCT04242498|450305182|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
125187245|NCT04242498|450305183|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
125187246|NCT04242498|450305177|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
125187247|NCT04242498|450305178|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
125187248|NCT04242498|450305179|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
125187249|NCT04242498|450305180|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
125187250|NCT04242498|450305181|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
125187251|NCT04242498|450305182|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
125187252|NCT04242498|450305183|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
125187253|NCT04242498|450305177|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
125187254|NCT04242498|450305178|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
125187255|NCT04242498|450305179|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
125187256|NCT04242498|450305180|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
125187257|NCT04242498|450305181|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
125187258|NCT04242498|450305182|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
125187259|NCT04242498|450305183|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
125187260|NCT04242498|450305177|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
125187261|NCT04242498|450305178|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
125241631|NCT00980460|450507663|FG004|Overall Study|No therapy within 42 days of resection|0|||
125241632|NCT00980460|450507659|FG000|Overall Study|No transplant by protocol timepoints|0|||
125241633|NCT00980460|450507660|FG001|Overall Study|No transplant by protocol timepoints|0|||
125241634|NCT00980460|450507661|FG002|Overall Study|No transplant by protocol timepoints|3|||
125241635|NCT00980460|450507662|FG003|Overall Study|No transplant by protocol timepoints|0|||
125241636|NCT00980460|450507663|FG004|Overall Study|No transplant by protocol timepoints|0|||
125241637|NCT01001104|450508350|FG000|Overall Study|Adverse Event|2|||
125241638|NCT01001104|450508351|FG001|Overall Study|Adverse Event|1|||
125187262|NCT04242498|450305179|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
125187263|NCT04242498|450305180|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
125187264|NCT04242498|450305181|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
125187265|NCT04242498|450305182|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
125187266|NCT04242498|450305183|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
125187267|NCT04242498|450305177|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
125187268|NCT04242498|450305178|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
125187269|NCT04242498|450305179|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
125187270|NCT04242498|450305180|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
125187271|NCT04242498|450305181|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
125187272|NCT04242498|450305182|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
125187273|NCT04242498|450305183|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
125187274|NCT04242498|450305177|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
125187275|NCT04242498|450305178|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
125187276|NCT04242498|450305179|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
125187277|NCT04242498|450305180|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
125187278|NCT04242498|450305181|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
125187279|NCT04242498|450305182|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
125187280|NCT04242498|450305183|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
125187281|NCT04242498|450305177|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
125187282|NCT04242498|450305178|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
125187283|NCT04242498|450305179|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
125187284|NCT04242498|450305180|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
125187285|NCT04242498|450305181|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
125187286|NCT04242498|450305182|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
125187287|NCT04242498|450305183|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
125187288|NCT04242498|450305177|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
125187289|NCT04242498|450305178|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
125187290|NCT04242498|450305179|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
125187291|NCT04242498|450305180|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
125187292|NCT04242498|450305181|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
125187293|NCT04242498|450305182|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
125187294|NCT04242498|450305183|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
125187295|NCT04242498|450305177|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
125187296|NCT04242498|450305178|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
125187297|NCT04242498|450305179|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
125187298|NCT04242498|450305180|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
125187299|NCT04242498|450305181|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
125187300|NCT04242498|450305182|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
125187301|NCT04242498|450305183|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
125187302|NCT04242498|450305177|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
125187303|NCT04242498|450305178|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
125187304|NCT04242498|450305179|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
125187305|NCT04242498|450305180|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
125187306|NCT04242498|450305181|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
125187307|NCT04242498|450305182|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
125187308|NCT04242498|450305183|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
125187309|NCT04242498|450305177|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
125187310|NCT04242498|450305178|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
125187311|NCT04242498|450305179|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
125187312|NCT04242498|450305180|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
125187313|NCT04242498|450305181|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
125187314|NCT04242498|450305182|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
125187315|NCT04242498|450305183|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
125187316|NCT04242498|450305177|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
125187317|NCT04242498|450305178|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
125187318|NCT04242498|450305179|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
125187319|NCT04242498|450305180|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
125241639|NCT01001104|450508352|FG002|Overall Study|Adverse Event|0|||
125241640|NCT01001104|450508353|FG003|Overall Study|Adverse Event|0|||
125241641|NCT01001104|450508350|FG000|Overall Study|Lost to Follow-up|0|||
125241642|NCT01001104|450508351|FG001|Overall Study|Lost to Follow-up|0|||
125241643|NCT01001104|450508352|FG002|Overall Study|Lost to Follow-up|1|||
125241644|NCT01001104|450508353|FG003|Overall Study|Lost to Follow-up|0|||
125241645|NCT01001104|450508350|FG000|Overall Study|Entry Criteria Not Met|0|||
125241646|NCT01001104|450508351|FG001|Overall Study|Entry Criteria Not Met|0|||
125241647|NCT01001104|450508352|FG002|Overall Study|Entry Criteria Not Met|0|||
125241648|NCT01001104|450508353|FG003|Overall Study|Entry Criteria Not Met|1|||
125241649|NCT01001104|450508350|FG000|Overall Study|Withdrawal by Subject|0|||
125241650|NCT01001104|450508351|FG001|Overall Study|Withdrawal by Subject|0|||
125241651|NCT01001104|450508352|FG002|Overall Study|Withdrawal by Subject|0|||
125241652|NCT01001104|450508353|FG003|Overall Study|Withdrawal by Subject|2|||
125241653|NCT02397837|450508355|FG000|Overall Study|Withdrawal by Subject|6|||
125241654|NCT02397837|450508356|FG001|Overall Study|Withdrawal by Subject|5|||
125241655|NCT02397837|450508355|FG000|Overall Study|Physician Decision|1|||
125241656|NCT02397837|450508356|FG001|Overall Study|Physician Decision|1|||
125241657|NCT00599313|450508357|FG000|Overall Study|Adverse Event|19|||
125241658|NCT00599313|450508357|FG000|Overall Study|Disease Progression|12|||
125241659|NCT00599313|450508357|FG000|Overall Study|Patient Request|4|||
125241660|NCT00599313|450508357|FG000|Overall Study|Ineligible|1|||
125241661|NCT02536794|450508358|FG000|Reached 1st Response Assessment|Adverse Event|2|||
125241662|NCT02536794|450508358|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
125241663|NCT02536794|450508358|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
125241664|NCT02536794|450508358|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
125241665|NCT02536794|450508358|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
125241666|NCT02536794|450508358|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
125241667|NCT01496456|450508365|FG000|Overall Study|Protocol Violation|1|||
125241668|NCT01496456|450508365|FG000|Overall Study|Lost to Follow-up|7|||
125241669|NCT01695746|450508368|FG000|Overall Study|Adverse Event|1|||
125241670|NCT01695746|450508368|FG000|Overall Study|Non-compliance by the participant|3|||
125241671|NCT01695746|450508368|FG000|Overall Study|Protocol Violation|5|||
125241672|NCT01695746|450508368|FG000|Overall Study|Participant not willing to participate|3|||
125241673|NCT03010501|450508370|FG000|Study Week 1|Withdrawal by Subject|2|||
125241674|NCT03010501|450508371|FG001|Study Week 1|Withdrawal by Subject|1|||
125241675|NCT03010501|450508372|FG002|Study Week 1|Withdrawal by Subject|0|||
125241676|NCT03010501|450508373|FG003|Study Week 1|Withdrawal by Subject|2|||
125241677|NCT03010501|450508374|FG004|Study Week 1|Withdrawal by Subject|0|||
125241678|NCT03010501|450508375|FG005|Study Week 1|Withdrawal by Subject|0|||
125241679|NCT03010501|450508370|FG000|Study Week 3|Withdrawal by Subject|0|||
125241680|NCT03010501|450508371|FG001|Study Week 3|Withdrawal by Subject|0|||
125241681|NCT03010501|450508372|FG002|Study Week 3|Withdrawal by Subject|0|||
125241682|NCT03010501|450508373|FG003|Study Week 3|Withdrawal by Subject|1|||
125241683|NCT03010501|450508374|FG004|Study Week 3|Withdrawal by Subject|0|||
125241684|NCT03010501|450508375|FG005|Study Week 3|Withdrawal by Subject|0|||
125241685|NCT00640289|450508376|FG000|Overall Study|Death|3|||
125241686|NCT00640289|450508376|FG000|Overall Study|Withdrawal by Subject|1|||
125241687|NCT00640289|450508376|FG000|Overall Study|Lost to Follow-up|1|||
125241688|NCT00640289|450508376|FG000|Overall Study|Data collected under different amendment|2|||
125241689|NCT00640289|450508376|FG000|Overall Study|Transferred to another center|1|||
125241690|NCT00640289|450508376|FG000|Overall Study|Missing status|5|||
125241691|NCT01202591|450508377|FG000|Overall Study|Adverse Event|2|||
125241692|NCT01202591|450508378|FG001|Overall Study|Adverse Event|1|||
125241693|NCT01202591|450508379|FG002|Overall Study|Adverse Event|4|||
125241694|NCT01202591|450508380|FG003|Overall Study|Adverse Event|4|||
125241695|NCT01202591|450508381|FG004|Overall Study|Adverse Event|0|||
125241696|NCT01202591|450508382|FG005|Overall Study|Adverse Event|0|||
125187320|NCT04242498|450305181|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
125187321|NCT04242498|450305182|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
125187322|NCT04242498|450305183|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
125187323|NCT04760626|450305184|FG000|Overall Study|Withdrawal by Subject|24|||
125187324|NCT04760626|450305185|FG001|Overall Study|Withdrawal by Subject|20|||
125187325|NCT04760626|450305184|FG000|Overall Study|Lost to Follow-up|14|||
125187326|NCT04760626|450305185|FG001|Overall Study|Lost to Follow-up|19|||
125187327|NCT04760626|450305184|FG000|Overall Study|Physician Decision|3|||
125187328|NCT04760626|450305185|FG001|Overall Study|Physician Decision|5|||
125187329|NCT04760626|450305184|FG000|Overall Study|Death|3|||
125187330|NCT04760626|450305185|FG001|Overall Study|Death|6|||
125187331|NCT04760626|450305184|FG000|Overall Study|Site closure|1|||
125187332|NCT04760626|450305185|FG001|Overall Study|Site closure|0|||
125187333|NCT01753310|450305186|FG000|Overall Study|Entered into open label extension study|25|||
125187334|NCT01753310|450305187|FG001|Overall Study|Entered into open label extension study|22|||
125187335|NCT01753310|450305186|FG000|Overall Study|Adverse Event|1|||
125187336|NCT01753310|450305187|FG001|Overall Study|Adverse Event|0|||
125187337|NCT01753310|450305186|FG000|Overall Study|Lost to Follow-up|2|||
125187338|NCT01753310|450305187|FG001|Overall Study|Lost to Follow-up|0|||
125187339|NCT01753310|450305186|FG000|Overall Study|Subject decision|2|||
125187340|NCT01753310|450305187|FG001|Overall Study|Subject decision|2|||
125187341|NCT01753310|450305186|FG000|Overall Study|Sponsor decision|1|||
125187342|NCT01753310|450305187|FG001|Overall Study|Sponsor decision|0|||
125187343|NCT01753310|450305186|FG000|Overall Study|Withdrawal by Subject|1|||
125187344|NCT01753310|450305187|FG001|Overall Study|Withdrawal by Subject|0|||
125187345|NCT02946463|450305188|FG000|Primary Evaluation Period|Physician Decision|0|||
125187346|NCT02946463|450305189|FG001|Primary Evaluation Period|Physician Decision|1|||
125187347|NCT02946463|450305190|FG002|Primary Evaluation Period|Physician Decision|0|||
125187348|NCT02946463|450305191|FG003|Primary Evaluation Period|Physician Decision|0|||
125187349|NCT02946463|450305188|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
125187350|NCT02946463|450305189|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
125187351|NCT02946463|450305190|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
125187352|NCT02946463|450305191|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
125187353|NCT02946463|450305188|FG000|Extension Period|Death|4|||
125187354|NCT02946463|450305189|FG001|Extension Period|Death|4|||
125187355|NCT02946463|450305190|FG002|Extension Period|Death|0|||
125187356|NCT02946463|450305191|FG003|Extension Period|Death|0|||
125187357|NCT02946463|450305188|FG000|Extension Period|Withdrawal by Subject|4|||
125187358|NCT02946463|450305189|FG001|Extension Period|Withdrawal by Subject|3|||
125187359|NCT02946463|450305190|FG002|Extension Period|Withdrawal by Subject|0|||
125187360|NCT02946463|450305191|FG003|Extension Period|Withdrawal by Subject|0|||
125187361|NCT02946463|450305188|FG000|Extension Period|Other than specified|2|||
125187362|NCT02946463|450305189|FG001|Extension Period|Other than specified|3|||
125187363|NCT02946463|450305190|FG002|Extension Period|Other than specified|2|||
125187364|NCT02946463|450305191|FG003|Extension Period|Other than specified|0|||
125187365|NCT02946463|450305188|FG000|Extension Period|Physician Decision|1|||
125187366|NCT02946463|450305189|FG001|Extension Period|Physician Decision|4|||
125187367|NCT02946463|450305190|FG002|Extension Period|Physician Decision|0|||
125187368|NCT02946463|450305191|FG003|Extension Period|Physician Decision|0|||
125187369|NCT02946463|450305188|FG000|Extension Period|Pregnancy|3|||
125187370|NCT02946463|450305189|FG001|Extension Period|Pregnancy|1|||
125187371|NCT02946463|450305190|FG002|Extension Period|Pregnancy|0|||
125187372|NCT02946463|450305191|FG003|Extension Period|Pregnancy|0|||
125187373|NCT02946463|450305188|FG000|Extension Period|Adverse Event|1|||
125187374|NCT02946463|450305189|FG001|Extension Period|Adverse Event|2|||
125187375|NCT02946463|450305190|FG002|Extension Period|Adverse Event|0|||
125187376|NCT02946463|450305191|FG003|Extension Period|Adverse Event|0|||
125187377|NCT02946463|450305188|FG000|Extension Period|Lost to Follow-up|1|||
125187378|NCT02946463|450305189|FG001|Extension Period|Lost to Follow-up|0|||
125187379|NCT02946463|450305190|FG002|Extension Period|Lost to Follow-up|0|||
125187380|NCT02946463|450305191|FG003|Extension Period|Lost to Follow-up|0|||
125187381|NCT01383174|450305192|FG000|3 Month Assessment|Death|0|||
125187382|NCT01383174|450305193|FG001|3 Month Assessment|Death|1|||
125187383|NCT01383174|450305192|FG000|3 Month Assessment|Lost to Follow-up|2|||
125187384|NCT01383174|450305193|FG001|3 Month Assessment|Lost to Follow-up|0|||
125187385|NCT01383174|450305192|FG000|3 Month Assessment|Refused to complete|4|||
125187386|NCT01383174|450305193|FG001|3 Month Assessment|Refused to complete|0|||
125187387|NCT01383174|450305192|FG000|6 Month Assessment|Lost to Follow-up|1|||
125187388|NCT01383174|450305193|FG001|6 Month Assessment|Lost to Follow-up|1|||
125187389|NCT01383174|450305192|FG000|6 Month Assessment|Refused to complete|4|||
125187390|NCT01383174|450305193|FG001|6 Month Assessment|Refused to complete|0|||
125187391|NCT02169271|450305194|FG000|Overall Study|Protocol Violation|1|||
125187392|NCT02169271|450305195|FG001|Overall Study|Protocol Violation|2|||
125187393|NCT04616612|450305196|FG000|Overall Study|Lost to Follow-up|6|||
125241697|NCT01202591|450508377|FG000|Overall Study|Other reason as per investigator|3|||
125241698|NCT01202591|450508378|FG001|Overall Study|Other reason as per investigator|4|||
125241699|NCT01202591|450508379|FG002|Overall Study|Other reason as per investigator|7|||
125241700|NCT01202591|450508380|FG003|Overall Study|Other reason as per investigator|3|||
125241701|NCT01202591|450508381|FG004|Overall Study|Other reason as per investigator|1|||
125241702|NCT01202591|450508382|FG005|Overall Study|Other reason as per investigator|3|||
125241703|NCT01202591|450508377|FG000|Overall Study|Withdrawal by Subject|0|||
125241704|NCT01202591|450508378|FG001|Overall Study|Withdrawal by Subject|0|||
125241705|NCT01202591|450508379|FG002|Overall Study|Withdrawal by Subject|0|||
125241706|NCT01202591|450508380|FG003|Overall Study|Withdrawal by Subject|0|||
125241707|NCT01202591|450508381|FG004|Overall Study|Withdrawal by Subject|2|||
125241708|NCT01202591|450508382|FG005|Overall Study|Withdrawal by Subject|1|||
125241709|NCT01202591|450508377|FG000|Overall Study|Objective Disease Progression|0|||
125241710|NCT01202591|450508378|FG001|Overall Study|Objective Disease Progression|0|||
125241711|NCT01202591|450508379|FG002|Overall Study|Objective Disease Progression|0|||
125241712|NCT01202591|450508380|FG003|Overall Study|Objective Disease Progression|0|||
125241713|NCT01202591|450508381|FG004|Overall Study|Objective Disease Progression|2|||
125241714|NCT01202591|450508382|FG005|Overall Study|Objective Disease Progression|0|||
125241715|NCT02830087|450508387|FG000|Overall Study|No study staff to follow-up patients|4|||
125241716|NCT02830087|450508388|FG001|Overall Study|No study staff to follow-up patients|4|||
125241717|NCT02830087|450508389|FG002|Overall Study|No study staff to follow-up patients|4|||
125241718|NCT02830087|450508390|FG003|Overall Study|No study staff to follow-up patients|3|||
125241719|NCT02830087|450508391|FG004|Overall Study|No study staff to follow-up patients|3|||
125241720|NCT02830087|450508392|FG005|Overall Study|No study staff to follow-up patients|3|||
125241721|NCT02583269|450508393|FG000|Overall Study|Patient hospitalized prior to start|1|||
125241722|NCT02583269|450508394|FG001|Overall Study|Patient hospitalized prior to start|0|||
125241723|NCT02583269|450508395|FG002|Overall Study|Patient hospitalized prior to start|0|||
125241724|NCT02583269|450508396|FG003|Overall Study|Patient hospitalized prior to start|0|||
125241725|NCT02583269|450508397|FG004|Overall Study|Patient hospitalized prior to start|0|||
125241726|NCT03611946|450508401|FG000|Overall Study|Withdrawal by Subject|0|||
125241727|NCT03611946|450508402|FG001|Overall Study|Withdrawal by Subject|0|||
125241728|NCT03611946|450508403|FG002|Overall Study|Withdrawal by Subject|1|||
125241729|NCT03611946|450508404|FG003|Overall Study|Withdrawal by Subject|0|||
125241730|NCT03580928|450508410|FG000|Overall Study|Death|0|||
125241731|NCT03580928|450508411|FG001|Overall Study|Death|3|||
125241732|NCT03580928|450508410|FG000|Overall Study|Withdrawal by Subject|2|||
125241733|NCT03580928|450508411|FG001|Overall Study|Withdrawal by Subject|1|||
125241734|NCT03580928|450508410|FG000|Overall Study|Lost to Follow-up|2|||
125187394|NCT04616612|450305197|FG001|Overall Study|Lost to Follow-up|3|||
125187395|NCT01597973|450305198|FG000|Overall Study|Found ineligible before study medication started|4|||
125187396|NCT01597973|450305199|FG001|Overall Study|Found ineligible before study medication started|2|||
125187397|NCT01597973|450305198|FG000|Overall Study|Eligible pathogen not confirmed|14|||
125187398|NCT01597973|450305199|FG001|Overall Study|Eligible pathogen not confirmed|15|||
125187399|NCT01597973|450305198|FG000|Overall Study|LAR not authorized to consent|0|||
125187400|NCT01597973|450305199|FG001|Overall Study|LAR not authorized to consent|1|||
125187401|NCT01597973|450305198|FG000|Overall Study|Ineligible due to early seizures|1|||
125187402|NCT01597973|450305199|FG001|Overall Study|Ineligible due to early seizures|0|||
125187403|NCT01597973|450305198|FG000|Overall Study|Ineligible due to non-target infection|1|||
125187404|NCT01597973|450305199|FG001|Overall Study|Ineligible due to non-target infection|1|||
125187405|NCT02208362|450305200|FG000|Overall Study|Participant did not complete treatment|0|||
125187406|NCT02208362|450305201|FG001|Overall Study|Participant did not complete treatment|1|||
125187407|NCT02208362|450305202|FG002|Overall Study|Participant did not complete treatment|0|||
125187408|NCT02208362|450305203|FG003|Overall Study|Participant did not complete treatment|0|||
125187409|NCT02208362|450305204|FG004|Overall Study|Participant did not complete treatment|0|||
125187410|NCT02208362|450305205|FG005|Overall Study|Participant did not complete treatment|0|||
125187411|NCT02208362|450305206|FG006|Overall Study|Participant did not complete treatment|1|||
125187412|NCT02208362|450305207|FG007|Overall Study|Participant did not complete treatment|1|||
125187413|NCT02208362|450305208|FG008|Overall Study|Participant did not complete treatment|2|||
125187414|NCT02208362|450305209|FG009|Overall Study|Participant did not complete treatment|0|||
125187415|NCT02208362|450305210|FG010|Overall Study|Participant did not complete treatment|1|||
125187416|NCT02208362|450305211|FG011|Overall Study|Participant did not complete treatment|0|||
125187417|NCT02208362|450305200|FG000|Overall Study|Participant received disallowed treatment|0|||
125187418|NCT02208362|450305201|FG001|Overall Study|Participant received disallowed treatment|0|||
125187419|NCT02208362|450305202|FG002|Overall Study|Participant received disallowed treatment|0|||
125187420|NCT02208362|450305203|FG003|Overall Study|Participant received disallowed treatment|0|||
125187421|NCT02208362|450305204|FG004|Overall Study|Participant received disallowed treatment|0|||
125187422|NCT02208362|450305205|FG005|Overall Study|Participant received disallowed treatment|0|||
125187423|NCT02208362|450305206|FG006|Overall Study|Participant received disallowed treatment|0|||
125187424|NCT02208362|450305207|FG007|Overall Study|Participant received disallowed treatment|0|||
125187425|NCT02208362|450305208|FG008|Overall Study|Participant received disallowed treatment|1|||
125187426|NCT02208362|450305209|FG009|Overall Study|Participant received disallowed treatment|0|||
125187427|NCT02208362|450305210|FG010|Overall Study|Participant received disallowed treatment|0|||
125187428|NCT02208362|450305211|FG011|Overall Study|Participant received disallowed treatment|0|||
125187429|NCT04281485|450306558|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
125187430|NCT04281485|450306559|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
125187431|NCT04281485|450306558|FG000|Overall Study|Ongoing (Safety data collection)|10|||
125187432|NCT04281485|450306559|FG001|Overall Study|Ongoing (Safety data collection)|5|||
125187433|NCT02393950|450306563|FG000|Overall Study|Adverse Event|1|||
125187434|NCT02393950|450306564|FG001|Overall Study|Adverse Event|0|||
125187435|NCT02393950|450306563|FG000|Overall Study|Withdrawal by Subject|0|||
125187436|NCT02393950|450306564|FG001|Overall Study|Withdrawal by Subject|1|||
125187437|NCT04335123|450306565|FG000|Overall Study|Withdrawal by Subject|2|||
125187438|NCT04335123|450306566|FG001|Overall Study|Withdrawal by Subject|0|||
125187439|NCT04335123|450306565|FG000|Overall Study|Physician Decision|2|||
125187440|NCT04335123|450306566|FG001|Overall Study|Physician Decision|0|||
125187441|NCT01293695|450306569|FG000|Overall Study|Withdrawal by Subject|7|||
125187442|NCT01293695|450306570|FG001|Overall Study|Withdrawal by Subject|1|||
125187443|NCT01293695|450306569|FG000|Overall Study|Lost to Follow-up|8|||
125187444|NCT01293695|450306570|FG001|Overall Study|Lost to Follow-up|6|||
125187445|NCT02626026|450306571|FG000|Overall Study|Randomized but Never Treated|0|||
125187446|NCT02626026|450306572|FG001|Overall Study|Randomized but Never Treated|0|||
125187447|NCT02626026|450306573|FG002|Overall Study|Randomized but Never Treated|0|||
125187448|NCT02626026|450306574|FG003|Overall Study|Randomized but Never Treated|0|||
125187449|NCT02626026|450306575|FG004|Overall Study|Randomized but Never Treated|1|||
125187450|NCT02626026|450306576|FG005|Overall Study|Randomized but Never Treated|0|||
125187451|NCT00191477|450306578|FG000|Overall Study|Tumor Recurrence|49|||
125187452|NCT00191477|450306579|FG001|Overall Study|Tumor Recurrence|48|||
125187453|NCT00191477|450306578|FG000|Overall Study|Death, Study Disease|1|||
125241735|NCT03580928|450508411|FG001|Overall Study|Lost to Follow-up|0|||
125241736|NCT03580928|450508410|FG000|Overall Study|Progressive Disease|0|||
125241737|NCT03580928|450508411|FG001|Overall Study|Progressive Disease|1|||
125241738|NCT05800145|450508412|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
125241739|NCT05800145|450508413|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
125241740|NCT05800145|450508414|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
125241741|NCT05800145|450508415|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
125241742|NCT05800145|450508416|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
125241743|NCT05800145|450508417|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
125241744|NCT05800145|450508412|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
125241745|NCT05800145|450508413|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
125241746|NCT05800145|450508414|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
125241747|NCT05800145|450508415|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
125241748|NCT05800145|450508416|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
125241749|NCT05800145|450508417|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
125241750|NCT05800145|450508412|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
125241751|NCT05800145|450508413|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
125241752|NCT05800145|450508414|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
125241753|NCT05800145|450508415|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
125241754|NCT05800145|450508416|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
125241755|NCT05800145|450508417|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
125241756|NCT02850406|450508418|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
125241757|NCT02850406|450508419|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
125241758|NCT02850406|450508420|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
125241759|NCT02850406|450508421|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
125241760|NCT02850406|450508422|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
125241761|NCT02850406|450508423|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
125241762|NCT02850406|450508424|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
125241763|NCT02850406|450508425|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
125241764|NCT02850406|450508418|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
125241765|NCT02850406|450508419|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
125241766|NCT02850406|450508420|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
125241767|NCT02850406|450508421|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
125241768|NCT02850406|450508422|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
125241769|NCT02850406|450508423|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
125241770|NCT02850406|450508424|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
125241771|NCT02850406|450508425|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
125241772|NCT02850406|450508418|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
125241773|NCT02850406|450508419|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
125241774|NCT02850406|450508420|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
125241775|NCT02850406|450508421|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
125241776|NCT02850406|450508422|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
125241777|NCT02850406|450508423|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
125241778|NCT02850406|450508424|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
125241779|NCT02850406|450508425|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
125241780|NCT02850406|450508418|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
125241781|NCT02850406|450508419|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
125241782|NCT02850406|450508420|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
125241783|NCT02850406|450508421|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
125241784|NCT02850406|450508422|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
125241785|NCT02850406|450508423|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
125241786|NCT02850406|450508424|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
125241787|NCT02850406|450508425|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
125241788|NCT02850406|450508418|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
125241789|NCT02850406|450508419|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
125241790|NCT02850406|450508420|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
125241791|NCT02850406|450508421|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
125241792|NCT02850406|450508422|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
125241793|NCT02850406|450508423|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
125241794|NCT02850406|450508424|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
125241795|NCT02850406|450508425|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
125241796|NCT02850406|450508418|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241797|NCT02850406|450508419|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241798|NCT02850406|450508420|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241799|NCT02850406|450508421|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241800|NCT02850406|450508422|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
125241801|NCT02850406|450508423|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
125241802|NCT02850406|450508424|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241803|NCT02850406|450508425|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241804|NCT02850406|450508418|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
125241805|NCT02850406|450508419|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
125241806|NCT02850406|450508420|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
125241807|NCT02850406|450508421|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
125241808|NCT02850406|450508422|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
125241809|NCT02850406|450508423|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
125241810|NCT02850406|450508424|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
125241811|NCT02850406|450508425|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
125241812|NCT02850406|450508418|FG000|Part C (Up to 52 Weeks)|Other|0|||
125241813|NCT02850406|450508419|FG001|Part C (Up to 52 Weeks)|Other|0|||
125241814|NCT02850406|450508420|FG002|Part C (Up to 52 Weeks)|Other|0|||
125241815|NCT02850406|450508421|FG003|Part C (Up to 52 Weeks)|Other|0|||
125241816|NCT02850406|450508422|FG004|Part C (Up to 52 Weeks)|Other|1|||
125241817|NCT02850406|450508423|FG005|Part C (Up to 52 Weeks)|Other|3|||
125241818|NCT02850406|450508424|FG006|Part C (Up to 52 Weeks)|Other|0|||
125241819|NCT02850406|450508425|FG007|Part C (Up to 52 Weeks)|Other|0|||
125241820|NCT02850406|450508418|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
125241821|NCT02850406|450508419|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
125241822|NCT02850406|450508420|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
125241823|NCT02850406|450508421|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
125241824|NCT02850406|450508422|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
125241825|NCT02850406|450508423|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
125241826|NCT02850406|450508424|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
125241827|NCT02850406|450508425|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
125241828|NCT02850406|450508418|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241829|NCT02850406|450508419|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241830|NCT02850406|450508420|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241831|NCT02850406|450508421|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241832|NCT02850406|450508422|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241833|NCT02850406|450508423|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241834|NCT02850406|450508424|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241835|NCT02850406|450508425|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
125241836|NCT02850406|450508418|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
125241837|NCT02850406|450508419|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
125241838|NCT02850406|450508420|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
125241839|NCT02850406|450508421|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
125241840|NCT02850406|450508422|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
125241841|NCT02850406|450508423|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
125241842|NCT02850406|450508424|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
125241843|NCT02850406|450508425|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
125241844|NCT02850406|450508418|FG000|Part D (Up to 52 Weeks)|Other|0|||
125241845|NCT02850406|450508419|FG001|Part D (Up to 52 Weeks)|Other|0|||
125241846|NCT02850406|450508420|FG002|Part D (Up to 52 Weeks)|Other|0|||
125241847|NCT02850406|450508421|FG003|Part D (Up to 52 Weeks)|Other|0|||
125241848|NCT02850406|450508422|FG004|Part D (Up to 52 Weeks)|Other|0|||
125241849|NCT02850406|450508423|FG005|Part D (Up to 52 Weeks)|Other|0|||
125241850|NCT02850406|450508424|FG006|Part D (Up to 52 Weeks)|Other|0|||
125241851|NCT02850406|450508425|FG007|Part D (Up to 52 Weeks)|Other|1|||
125241852|NCT04167670|450509580|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
125241853|NCT04167670|450509581|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
125241854|NCT04167670|450509582|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
125241855|NCT04167670|450509580|FG000|Overall Study|Significant protocol deviation|3|||
125241856|NCT04167670|450509581|FG001|Overall Study|Significant protocol deviation|1|||
125241857|NCT04167670|450509582|FG002|Overall Study|Significant protocol deviation|0|||
125241858|NCT04167670|450509580|FG000|Overall Study|Lost to Follow-up|0|||
125241859|NCT04167670|450509581|FG001|Overall Study|Lost to Follow-up|3|||
125241860|NCT04167670|450509582|FG002|Overall Study|Lost to Follow-up|3|||
125241861|NCT04167670|450509580|FG000|Overall Study|Voluntary Withdrawal|0|||
125241862|NCT04167670|450509581|FG001|Overall Study|Voluntary Withdrawal|1|||
125241863|NCT04167670|450509582|FG002|Overall Study|Voluntary Withdrawal|1|||
125241864|NCT04167670|450509580|FG000|Overall Study|Withdrawal of Consent|4|||
125241865|NCT04167670|450509581|FG001|Overall Study|Withdrawal of Consent|1|||
125241866|NCT04167670|450509582|FG002|Overall Study|Withdrawal of Consent|3|||
125241867|NCT04167670|450509580|FG000|Overall Study|Miscellaneous|7|||
125241868|NCT04167670|450509581|FG001|Overall Study|Miscellaneous|5|||
125241869|NCT04167670|450509582|FG002|Overall Study|Miscellaneous|3|||
125241870|NCT00587457|450509587|FG000|Overall Study|Adverse Event|1|||
125241871|NCT00587457|450509588|FG001|Overall Study|Adverse Event|2|||
125241872|NCT00587457|450509589|FG002|Overall Study|Adverse Event|1|||
125241873|NCT00587457|450509587|FG000|Overall Study|Disease progression|2|||
125241874|NCT00587457|450509588|FG001|Overall Study|Disease progression|0|||
125241875|NCT00587457|450509589|FG002|Overall Study|Disease progression|2|||
125241876|NCT00587457|450509587|FG000|Overall Study|Initiation of alternative therapy|0|||
125241877|NCT00587457|450509588|FG001|Overall Study|Initiation of alternative therapy|1|||
125241878|NCT00587457|450509589|FG002|Overall Study|Initiation of alternative therapy|0|||
125241879|NCT00587457|450509587|FG000|Overall Study|Undefined|0|||
125241880|NCT00587457|450509588|FG001|Overall Study|Undefined|0|||
125241881|NCT00587457|450509589|FG002|Overall Study|Undefined|1|||
125241882|NCT00587457|450509587|FG000|Overall Study|Development of neutralizing Abs|0|||
125241883|NCT00587457|450509588|FG001|Overall Study|Development of neutralizing Abs|0|||
125241884|NCT00587457|450509589|FG002|Overall Study|Development of neutralizing Abs|1|||
125241885|NCT00876395|450509590|FG000|Overall Study|Untreated|8|||
125241886|NCT00876395|450509591|FG001|Overall Study|Untreated|1|||
125241887|NCT00876395|450509590|FG000|Overall Study|Adverse Event|63|||
125241888|NCT00876395|450509591|FG001|Overall Study|Adverse Event|11|||
125241889|NCT00876395|450509590|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125241890|NCT00876395|450509591|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125241891|NCT00876395|450509590|FG000|Overall Study|Disease progression|259|||
125241892|NCT00876395|450509591|FG001|Overall Study|Disease progression|162|||
125241893|NCT00876395|450509590|FG000|Overall Study|New cancer therapy|25|||
125241894|NCT00876395|450509591|FG001|Overall Study|New cancer therapy|7|||
125241895|NCT00876395|450509590|FG000|Overall Study|Protocol Violation|5|||
125241896|NCT00876395|450509591|FG001|Overall Study|Protocol Violation|2|||
125241897|NCT00876395|450509590|FG000|Overall Study|Withdrawal by Subject|66|||
125241898|NCT00876395|450509591|FG001|Overall Study|Withdrawal by Subject|33|||
125241899|NCT00876395|450509590|FG000|Overall Study|Lost to Follow-up|2|||
125241900|NCT00876395|450509591|FG001|Overall Study|Lost to Follow-up|0|||
125241901|NCT00876395|450509590|FG000|Overall Study|Administrative problems|39|||
125241902|NCT00876395|450509591|FG001|Overall Study|Administrative problems|23|||
125241903|NCT00876395|450509590|FG000|Overall Study|Death|12|||
125241904|NCT00876395|450509591|FG001|Overall Study|Death|0|||
125241905|NCT03807843|450509592|FG000|Overall Study|Lost to Follow-up|1|||
125241906|NCT03807843|450509593|FG001|Overall Study|Lost to Follow-up|0|||
125241907|NCT01312129|450509594|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
125241908|NCT01312129|450509595|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
125241909|NCT00924651|450509598|FG000|Overall Study|Chemo started too soon|2|||
125241910|NCT00924651|450509599|FG001|Overall Study|Chemo started too soon|3|||
125241911|NCT00924651|450509598|FG000|Overall Study|No Reason|3|||
125241912|NCT00924651|450509599|FG001|Overall Study|No Reason|7|||
125241913|NCT00924651|450509598|FG000|Overall Study|Overwhelmed|6|||
125241914|NCT00924651|450509599|FG001|Overall Study|Overwhelmed|6|||
125241915|NCT00924651|450509598|FG000|Overall Study|Noncompliant|1|||
125241916|NCT00924651|450509599|FG001|Overall Study|Noncompliant|4|||
125241917|NCT00924651|450509598|FG000|Overall Study|Medical|1|||
125241918|NCT00924651|450509599|FG001|Overall Study|Medical|3|||
125241919|NCT00924651|450509598|FG000|Overall Study|Changed Mind|10|||
125241920|NCT00924651|450509599|FG001|Overall Study|Changed Mind|1|||
125241921|NCT00924651|450509598|FG000|Overall Study|Incomplete Form|2|||
125241922|NCT00924651|450509599|FG001|Overall Study|Incomplete Form|1|||
125241923|NCT00729586|450509600|FG000|Overall Study|Ineligible|0|||
125241924|NCT00729586|450509601|FG001|Overall Study|Ineligible|1|||
125241925|NCT00729586|450509600|FG000|Overall Study|never treated|1|||
125241926|NCT00729586|450509601|FG001|Overall Study|never treated|0|||
125241927|NCT00662259|450509602|FG000|Overall Study|Adverse Event|2|||
125241928|NCT00662259|450509603|FG001|Overall Study|Adverse Event|0|||
125241929|NCT01750346|450509604|FG000|Overall Study|Adverse Event|1|||
125241930|NCT01750346|450509605|FG001|Overall Study|Adverse Event|0|||
125241931|NCT01750346|450509606|FG002|Overall Study|Adverse Event|0|||
125241932|NCT02034591|450509607|FG000|Overall Study|Withdrawal by Subject|0|||
125241933|NCT02034591|450509608|FG001|Overall Study|Withdrawal by Subject|0|||
125241934|NCT02034591|450509609|FG002|Overall Study|Withdrawal by Subject|0|||
125241935|NCT02034591|450509610|FG003|Overall Study|Withdrawal by Subject|0|||
125241936|NCT02034591|450509611|FG004|Overall Study|Withdrawal by Subject|1|||
125241937|NCT02034591|450509612|FG005|Overall Study|Withdrawal by Subject|0|||
125241938|NCT04307394|450509615|FG000|Overall Study|Lost to Follow-up|3|||
125241939|NCT04307394|450509615|FG000|Overall Study|Withdrawal by Subject|2|||
125241940|NCT01121926|450509616|FG000|First Intervention Period|Adverse Event|1|||
125241941|NCT01121926|450509617|FG001|First Intervention Period|Adverse Event|0|||
125241942|NCT01121926|450509616|FG000|Washout Period|Adverse Event|0|||
125241943|NCT01121926|450509617|FG001|Washout Period|Adverse Event|1|||
125241944|NCT01121926|450509616|FG000|Washout Period|Positive pregnancy test|0|||
125241945|NCT01121926|450509617|FG001|Washout Period|Positive pregnancy test|1|||
125241946|NCT00416949|450509618|FG000|Overall Study|Patients refused to participate|5|||
125241947|NCT02782468|450509619|FG000|Overall Study|Progressive Disease|2|||
125241948|NCT02782468|450509620|FG001|Overall Study|Progressive Disease|5|||
125241949|NCT02782468|450509621|FG002|Overall Study|Progressive Disease|0|||
125241950|NCT02782468|450509622|FG003|Overall Study|Progressive Disease|4|||
125241951|NCT02782468|450509619|FG000|Overall Study|Adverse Event|0|||
125241952|NCT02782468|450509620|FG001|Overall Study|Adverse Event|2|||
125241953|NCT02782468|450509621|FG002|Overall Study|Adverse Event|2|||
125241954|NCT02782468|450509622|FG003|Overall Study|Adverse Event|3|||
125241955|NCT02782468|450509619|FG000|Overall Study|Other|0|||
125241956|NCT02782468|450509620|FG001|Overall Study|Other|0|||
125241957|NCT02782468|450509621|FG002|Overall Study|Other|1|||
125241958|NCT02782468|450509622|FG003|Overall Study|Other|1|||
125241959|NCT02782468|450509619|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
125241960|NCT02782468|450509620|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
125241961|NCT02782468|450509621|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
125241962|NCT02782468|450509622|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
125241963|NCT02782468|450509619|FG000|Overall Study|Symptomatic Deterioration|0|||
125241964|NCT02782468|450509620|FG001|Overall Study|Symptomatic Deterioration|0|||
125241965|NCT02782468|450509621|FG002|Overall Study|Symptomatic Deterioration|0|||
125241966|NCT02782468|450509622|FG003|Overall Study|Symptomatic Deterioration|1|||
125241967|NCT02782468|450509619|FG000|Overall Study|Withdrawal by Subject|1|||
125241968|NCT02782468|450509620|FG001|Overall Study|Withdrawal by Subject|0|||
125241969|NCT02782468|450509621|FG002|Overall Study|Withdrawal by Subject|0|||
125241970|NCT02782468|450509622|FG003|Overall Study|Withdrawal by Subject|0|||
125241971|NCT01410604|450509624|FG000|Overall Study|Adverse Event|2|||
125241972|NCT01410604|450509625|FG001|Overall Study|Adverse Event|1|||
125241973|NCT01410604|450509624|FG000|Overall Study|Lost to Follow-up|1|||
125241974|NCT01410604|450509625|FG001|Overall Study|Lost to Follow-up|0|||
125241975|NCT01410604|450509624|FG000|Overall Study|Physician Decision|0|||
125241976|NCT01410604|450509625|FG001|Overall Study|Physician Decision|1|||
125241977|NCT00356590|450509626|FG000|Overall Study|Adverse Event|54|||
125241978|NCT00356590|450509626|FG000|Overall Study|Death|10|||
125241979|NCT00356590|450509626|FG000|Overall Study|Lost to Follow-up|35|||
125241980|NCT00356590|450509626|FG000|Overall Study|Physician Decision|46|||
125241981|NCT00356590|450509626|FG000|Overall Study|Withdrawal by Subject|41|||
125241982|NCT00356590|450509626|FG000|Overall Study|Completed month 12 only|2|||
125241983|NCT00356590|450509626|FG000|Overall Study|Protocol issues|6|||
125241984|NCT00356590|450509626|FG000|Overall Study|Response status|28|||
125241985|NCT00356590|450509626|FG000|Overall Study|Other|52|||
125241986|NCT00898807|450509634|FG000|Overall Study|Withdrawal by Subject|5|||
125241987|NCT00898807|450509635|FG001|Overall Study|Withdrawal by Subject|3|||
125241988|NCT00898807|450509634|FG000|Overall Study|Family pressure to discontinue|2|||
125241989|NCT00898807|450509635|FG001|Overall Study|Family pressure to discontinue|2|||
125241990|NCT00898807|450509634|FG000|Overall Study|Lost to Follow-up|1|||
125241991|NCT00898807|450509635|FG001|Overall Study|Lost to Follow-up|3|||
125241992|NCT00898807|450509634|FG000|Overall Study|Death|0|||
125241993|NCT00898807|450509635|FG001|Overall Study|Death|1|||
125241994|NCT04919161|450509636|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
125241995|NCT04919161|450509637|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
125241996|NCT04919161|450509636|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
125241997|NCT04919161|450509637|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
125241998|NCT04919161|450509636|FG000|Overall Study|Acute ankle sprain after session 1|0|||
125241999|NCT04919161|450509637|FG001|Overall Study|Acute ankle sprain after session 1|1|||
125242000|NCT00712920|450509638|FG000|Overall Study|Adverse Event|3|||
125242001|NCT00712920|450509639|FG001|Overall Study|Adverse Event|4|||
125242002|NCT00712920|450509640|FG002|Overall Study|Adverse Event|7|||
125242003|NCT00712920|450509638|FG000|Overall Study|Withdrawal by Subject|4|||
125242004|NCT00712920|450509639|FG001|Overall Study|Withdrawal by Subject|2|||
125242005|NCT00712920|450509640|FG002|Overall Study|Withdrawal by Subject|1|||
125242006|NCT00712920|450509638|FG000|Overall Study|Lost to Follow-up|1|||
125242007|NCT00712920|450509639|FG001|Overall Study|Lost to Follow-up|4|||
125242008|NCT00712920|450509640|FG002|Overall Study|Lost to Follow-up|0|||
125242009|NCT00712920|450509638|FG000|Overall Study|Lack of Efficacy|1|||
125242010|NCT00712920|450509639|FG001|Overall Study|Lack of Efficacy|0|||
125242011|NCT00712920|450509640|FG002|Overall Study|Lack of Efficacy|1|||
125242012|NCT00712920|450509638|FG000|Overall Study|Other|5|||
125242013|NCT00712920|450509639|FG001|Overall Study|Other|7|||
125242014|NCT00712920|450509640|FG002|Overall Study|Other|3|||
125242015|NCT00712920|450509638|FG000|Overall Study|Non-compliance|3|||
125242016|NCT00712920|450509639|FG001|Overall Study|Non-compliance|0|||
125242017|NCT00712920|450509640|FG002|Overall Study|Non-compliance|0|||
125242018|NCT02489773|450509641|FG000|Overall Study|Lost to Follow-up|4|||
125242019|NCT02489773|450509642|FG001|Overall Study|Lost to Follow-up|1|||
125242020|NCT02489773|450509641|FG000|Overall Study|Physician Decision|1|||
125242021|NCT02489773|450509642|FG001|Overall Study|Physician Decision|0|||
125242022|NCT02489773|450509641|FG000|Overall Study|Withdrawal by Subject|1|||
125242023|NCT02489773|450509642|FG001|Overall Study|Withdrawal by Subject|0|||
125242024|NCT02489773|450509641|FG000|Overall Study|Leave the country or the state|1|||
125187454|NCT00191477|450306579|FG001|Overall Study|Death, Study Disease|1|||
125187455|NCT00191477|450306578|FG000|Overall Study|Death, Other Cause|3|||
125187456|NCT00191477|450306579|FG001|Overall Study|Death, Other Cause|6|||
125187457|NCT00191477|450306578|FG000|Overall Study|Lost to Follow-up|23|||
125187458|NCT00191477|450306579|FG001|Overall Study|Lost to Follow-up|21|||
125187459|NCT00191477|450306578|FG000|Overall Study|Protocol Violation|1|||
125187460|NCT00191477|450306579|FG001|Overall Study|Protocol Violation|1|||
125187461|NCT00191477|450306578|FG000|Overall Study|Treatment Change|2|||
125187462|NCT00191477|450306579|FG001|Overall Study|Treatment Change|0|||
125187463|NCT00191477|450306578|FG000|Overall Study|Withdrawal by Subject|2|||
125187464|NCT00191477|450306579|FG001|Overall Study|Withdrawal by Subject|0|||
125187465|NCT00191477|450306578|FG000|Overall Study|Other|2|||
125187466|NCT00191477|450306579|FG001|Overall Study|Other|0|||
125187467|NCT00191477|450306578|FG000|Overall Study|Not Eligible|41|||
125187468|NCT00191477|450306579|FG001|Overall Study|Not Eligible|38|||
125187469|NCT00191477|450306578|FG000|Overall Study|Pathological Specimen Lost|1|||
125187470|NCT00191477|450306579|FG001|Overall Study|Pathological Specimen Lost|0|||
125187471|NCT00191477|450306578|FG000|Overall Study|Discontinued Prior to Instillation|13|||
125187472|NCT00191477|450306579|FG001|Overall Study|Discontinued Prior to Instillation|14|||
125187473|NCT03922308|450306584|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
125187474|NCT03922308|450306585|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
125187475|NCT03922308|450306586|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
125187476|NCT03922308|450306584|FG000|Overall Study|Lost to Follow-up|1|||
125187477|NCT03922308|450306585|FG001|Overall Study|Lost to Follow-up|0|||
125187478|NCT03922308|450306586|FG002|Overall Study|Lost to Follow-up|0|||
125187479|NCT03922308|450306584|FG000|Overall Study|Reason not Specified|0|||
125187480|NCT03922308|450306585|FG001|Overall Study|Reason not Specified|2|||
125187481|NCT03922308|450306586|FG002|Overall Study|Reason not Specified|1|||
125187482|NCT01697748|450306587|FG000|Overall Study|ineligible skin incision|1|||
125187483|NCT01697748|450306588|FG001|Overall Study|ineligible skin incision|2|||
125187484|NCT01697748|450306587|FG000|Overall Study|ineligible uterine incision|4|||
125187485|NCT01697748|450306588|FG001|Overall Study|ineligible uterine incision|1|||
125187486|NCT01697748|450306587|FG000|Overall Study|Lost to Follow-up|53|||
125187487|NCT01697748|450306588|FG001|Overall Study|Lost to Follow-up|65|||
125187488|NCT03376789|450306591|FG000|Overall Study|Withdrawal by Subject|3|||
125187489|NCT03376789|450306592|FG001|Overall Study|Withdrawal by Subject|5|||
125187490|NCT03376789|450306591|FG000|Overall Study|Protocol Violation|0|||
125187491|NCT03376789|450306592|FG001|Overall Study|Protocol Violation|1|||
125187492|NCT03376789|450306591|FG000|Overall Study|Adverse Event|0|||
125187493|NCT03376789|450306592|FG001|Overall Study|Adverse Event|1|||
125187494|NCT03376789|450306591|FG000|Overall Study|Lost to Follow-up|1|||
125187495|NCT03376789|450306592|FG001|Overall Study|Lost to Follow-up|1|||
125187496|NCT03376789|450306591|FG000|Overall Study|Per sponsor due to noncompliance|1|||
125187497|NCT03376789|450306592|FG001|Overall Study|Per sponsor due to noncompliance|0|||
125187498|NCT03376789|450306591|FG000|Overall Study|Subject off study medication|0|||
125187499|NCT03376789|450306592|FG001|Overall Study|Subject off study medication|1|||
125187500|NCT04177095|450306593|FG000|Overall Study|Withdrawal by Subject|3|||
125187501|NCT04177095|450306593|FG000|Overall Study|Screen Failure|3|||
125187502|NCT04177095|450306593|FG000|Overall Study|Problems with the Trugraf assay|1|||
125187503|NCT03876743|450306596|FG000|Overall Study|Lost to Follow-up|6|||
125187504|NCT03876743|450306597|FG001|Overall Study|Lost to Follow-up|4|||
125187505|NCT03876743|450306598|FG002|Overall Study|Lost to Follow-up|4|||
125187506|NCT03876743|450306599|FG003|Overall Study|Lost to Follow-up|7|||
125187507|NCT03889418|450306600|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
125187508|NCT03889418|450306601|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
125187509|NCT03889418|450306602|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
125187510|NCT03889418|450306603|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
125187511|NCT03889418|450306604|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
125187512|NCT03889418|450306605|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
125187513|NCT03889418|450306606|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
125187514|NCT03889418|450306607|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
125187515|NCT03889418|450306608|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
125187516|NCT03889418|450306609|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
125242025|NCT02489773|450509642|FG001|Overall Study|Leave the country or the state|1|||
125242026|NCT02115386|450509645|FG000|Overall Study|Protocol Violation|1|||
125187517|NCT03889418|450306600|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
125187518|NCT03889418|450306601|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
125187519|NCT03889418|450306602|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
125187520|NCT03889418|450306603|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
125187521|NCT03889418|450306604|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
125187522|NCT03889418|450306605|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
125187523|NCT03889418|450306606|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
125187524|NCT03889418|450306607|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
125187525|NCT03889418|450306608|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
125242027|NCT02115386|450509645|FG000|Overall Study|Administrative - trial was terminated|6|||
125242028|NCT02493855|450509646|FG000|Overall Study|Non-compliance|1|||
125242029|NCT02493855|450509647|FG001|Overall Study|Non-compliance|0|||
125242030|NCT02493855|450509648|FG002|Overall Study|Non-compliance|0|||
125242031|NCT02493855|450509646|FG000|Overall Study|Adverse Event|0|||
125242032|NCT02493855|450509647|FG001|Overall Study|Adverse Event|1|||
125242033|NCT02493855|450509648|FG002|Overall Study|Adverse Event|0|||
125242034|NCT02493855|450509646|FG000|Overall Study|Withdrawal by Subject|1|||
125242035|NCT02493855|450509647|FG001|Overall Study|Withdrawal by Subject|0|||
125242036|NCT02493855|450509648|FG002|Overall Study|Withdrawal by Subject|0|||
125242037|NCT02453048|450509649|FG000|Overall Study|Only part of initial 6 mo. study|0|||
125242038|NCT02453048|450509650|FG001|Overall Study|Only part of initial 6 mo. study|0|||
125242039|NCT02453048|450509651|FG002|Overall Study|Only part of initial 6 mo. study|0|||
125242040|NCT02453048|450509652|FG003|Overall Study|Only part of initial 6 mo. study|0|||
125242041|NCT02453048|450509653|FG004|Overall Study|Only part of initial 6 mo. study|6|||
125242042|NCT02453048|450509649|FG000|Overall Study|Lost to Follow-up|0|||
125242043|NCT02453048|450509650|FG001|Overall Study|Lost to Follow-up|1|||
125242044|NCT02453048|450509651|FG002|Overall Study|Lost to Follow-up|2|||
125242045|NCT02453048|450509652|FG003|Overall Study|Lost to Follow-up|0|||
125242046|NCT02453048|450509653|FG004|Overall Study|Lost to Follow-up|0|||
125242047|NCT01482221|450509654|FG000|Overall Study|Lack of Efficacy|1|||
125242048|NCT01482221|450509655|FG001|Overall Study|Lack of Efficacy|0|||
125242049|NCT01482221|450509656|FG002|Overall Study|Lack of Efficacy|1|||
125242050|NCT01482221|450509654|FG000|Overall Study|Lost to Follow-up|3|||
125242051|NCT01482221|450509655|FG001|Overall Study|Lost to Follow-up|2|||
125242052|NCT01482221|450509656|FG002|Overall Study|Lost to Follow-up|1|||
125242053|NCT01482221|450509654|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
125242054|NCT01482221|450509655|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
125242055|NCT01482221|450509656|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
125242056|NCT01482221|450509654|FG000|Overall Study|Condition under Investigation Worsened|3|||
125242057|NCT01482221|450509655|FG001|Overall Study|Condition under Investigation Worsened|2|||
125242058|NCT01482221|450509656|FG002|Overall Study|Condition under Investigation Worsened|4|||
125242059|NCT01482221|450509654|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
125242060|NCT01482221|450509655|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
125242061|NCT01482221|450509656|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
125242062|NCT01482221|450509654|FG000|Overall Study|Adverse Event|1|||
125242063|NCT01482221|450509655|FG001|Overall Study|Adverse Event|7|||
125242064|NCT01482221|450509656|FG002|Overall Study|Adverse Event|3|||
125242065|NCT01482221|450509654|FG000|Overall Study|Withdrawal by Subject|10|||
125242066|NCT01482221|450509655|FG001|Overall Study|Withdrawal by Subject|7|||
125242067|NCT01482221|450509656|FG002|Overall Study|Withdrawal by Subject|12|||
125242068|NCT01482221|450509654|FG000|Overall Study|Incorrect randomization|0|||
125242069|NCT01482221|450509655|FG001|Overall Study|Incorrect randomization|1|||
125242070|NCT01482221|450509656|FG002|Overall Study|Incorrect randomization|0|||
125242071|NCT01482221|450509654|FG000|Overall Study|Physician Decision|0|||
125242072|NCT01482221|450509655|FG001|Overall Study|Physician Decision|1|||
125242073|NCT01482221|450509656|FG002|Overall Study|Physician Decision|0|||
125242074|NCT03086343|450509657|FG000|Period 1|Adverse Event|7|||
125242075|NCT03086343|450509658|FG001|Period 1|Adverse Event|7|||
125242076|NCT03086343|450509659|FG002|Period 1|Adverse Event|0|||
125242077|NCT03086343|450509660|FG003|Period 1|Adverse Event|1|||
125242078|NCT03086343|450509657|FG000|Period 1|Withdrawal by Subject|6|||
125242079|NCT03086343|450509658|FG001|Period 1|Withdrawal by Subject|10|||
125242080|NCT03086343|450509659|FG002|Period 1|Withdrawal by Subject|0|||
125242081|NCT03086343|450509660|FG003|Period 1|Withdrawal by Subject|0|||
125242082|NCT03086343|450509657|FG000|Period 1|Lost to Follow-up|1|||
125242083|NCT03086343|450509658|FG001|Period 1|Lost to Follow-up|3|||
125242084|NCT03086343|450509659|FG002|Period 1|Lost to Follow-up|1|||
125242085|NCT03086343|450509660|FG003|Period 1|Lost to Follow-up|0|||
125242086|NCT03086343|450509657|FG000|Period 1|Other, Not Specified|10|||
125242087|NCT03086343|450509658|FG001|Period 1|Other, Not Specified|12|||
125242088|NCT03086343|450509659|FG002|Period 1|Other, Not Specified|2|||
125242089|NCT03086343|450509660|FG003|Period 1|Other, Not Specified|1|||
125242090|NCT03086343|450509657|FG000|Period 1|Missing|1|||
125242091|NCT03086343|450509658|FG001|Period 1|Missing|0|||
125242092|NCT03086343|450509659|FG002|Period 1|Missing|0|||
125242093|NCT03086343|450509660|FG003|Period 1|Missing|0|||
125242094|NCT03086343|450509657|FG000|Period 2|Adverse Event|20|||
125242095|NCT03086343|450509658|FG001|Period 2|Adverse Event|11|||
125242096|NCT03086343|450509659|FG002|Period 2|Adverse Event|1|||
125242097|NCT03086343|450509660|FG003|Period 2|Adverse Event|2|||
125242098|NCT03086343|450509657|FG000|Period 2|Withdrawal by Subject|15|||
125242099|NCT03086343|450509658|FG001|Period 2|Withdrawal by Subject|25|||
125242100|NCT03086343|450509659|FG002|Period 2|Withdrawal by Subject|2|||
125242101|NCT03086343|450509660|FG003|Period 2|Withdrawal by Subject|2|||
125242102|NCT03086343|450509657|FG000|Period 2|Lost to Follow-up|6|||
125242103|NCT03086343|450509658|FG001|Period 2|Lost to Follow-up|11|||
125242104|NCT03086343|450509659|FG002|Period 2|Lost to Follow-up|1|||
125242105|NCT03086343|450509660|FG003|Period 2|Lost to Follow-up|0|||
125187526|NCT03889418|450306609|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
125187527|NCT03889418|450306600|FG000|October-December 2019 (Month 7-9)|Death|0|||
125187528|NCT03889418|450306601|FG001|October-December 2019 (Month 7-9)|Death|0|||
125187529|NCT03889418|450306602|FG002|October-December 2019 (Month 7-9)|Death|0|||
125187530|NCT03889418|450306603|FG003|October-December 2019 (Month 7-9)|Death|0|||
125187531|NCT03889418|450306604|FG004|October-December 2019 (Month 7-9)|Death|0|||
125187532|NCT03889418|450306605|FG005|October-December 2019 (Month 7-9)|Death|0|||
125187533|NCT03889418|450306606|FG006|October-December 2019 (Month 7-9)|Death|0|||
125187534|NCT03889418|450306607|FG007|October-December 2019 (Month 7-9)|Death|0|||
125187535|NCT03889418|450306608|FG008|October-December 2019 (Month 7-9)|Death|1|||
125187536|NCT03889418|450306609|FG009|October-December 2019 (Month 7-9)|Death|0|||
125187537|NCT03889418|450306600|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
125187538|NCT03889418|450306601|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
125187539|NCT03889418|450306602|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
125187540|NCT03889418|450306603|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
125187541|NCT03889418|450306604|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
125187542|NCT03889418|450306605|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
125187543|NCT03889418|450306606|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
125187544|NCT03889418|450306607|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
125187545|NCT03889418|450306608|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
125187546|NCT03889418|450306609|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
125187547|NCT03889418|450306600|FG000|April - June 2020 (Month 13-15)|Death|0|||
125187548|NCT03889418|450306601|FG001|April - June 2020 (Month 13-15)|Death|1|||
125187549|NCT03889418|450306602|FG002|April - June 2020 (Month 13-15)|Death|0|||
125187550|NCT03889418|450306603|FG003|April - June 2020 (Month 13-15)|Death|0|||
125187551|NCT03889418|450306604|FG004|April - June 2020 (Month 13-15)|Death|0|||
125187552|NCT03889418|450306605|FG005|April - June 2020 (Month 13-15)|Death|0|||
125187553|NCT03889418|450306606|FG006|April - June 2020 (Month 13-15)|Death|0|||
125187554|NCT03889418|450306607|FG007|April - June 2020 (Month 13-15)|Death|0|||
125187555|NCT03889418|450306608|FG008|April - June 2020 (Month 13-15)|Death|0|||
125187556|NCT03889418|450306609|FG009|April - June 2020 (Month 13-15)|Death|0|||
125187557|NCT03889418|450306600|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
125187558|NCT03889418|450306601|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
125187559|NCT03889418|450306602|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
125187560|NCT03889418|450306603|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
125187561|NCT03889418|450306604|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
125187562|NCT03889418|450306605|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
125187563|NCT03889418|450306606|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
125187564|NCT03889418|450306607|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
125187565|NCT03889418|450306608|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
125187566|NCT03889418|450306609|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
125187567|NCT03889418|450306600|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
125187568|NCT03889418|450306601|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
125187569|NCT03889418|450306602|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
125187570|NCT03889418|450306603|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
125187571|NCT03889418|450306604|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
125187572|NCT03889418|450306605|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
125187573|NCT03889418|450306606|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
125187574|NCT03889418|450306607|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
125187575|NCT03889418|450306608|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
125187576|NCT03889418|450306609|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
125187577|NCT03889418|450306600|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
125187578|NCT03889418|450306601|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
125187579|NCT03889418|450306602|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
125187580|NCT03889418|450306603|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
125187581|NCT03889418|450306604|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
125187582|NCT03889418|450306605|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
125187583|NCT03889418|450306606|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
125187584|NCT03889418|450306607|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
125187585|NCT03889418|450306608|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
125187586|NCT03889418|450306609|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
125187587|NCT00092118|450306610|FG000|Overall Study|Adverse Event|35|||
125187588|NCT00092118|450306611|FG001|Overall Study|Adverse Event|32|||
125187589|NCT00092118|450306610|FG000|Overall Study|Lack of Efficacy|12|||
125187590|NCT00092118|450306611|FG001|Overall Study|Lack of Efficacy|14|||
125187591|NCT00092118|450306610|FG000|Overall Study|Lost to Follow-up|4|||
125187592|NCT00092118|450306611|FG001|Overall Study|Lost to Follow-up|3|||
125187593|NCT00092118|450306610|FG000|Overall Study|Protocol Violation|23|||
125187594|NCT00092118|450306611|FG001|Overall Study|Protocol Violation|25|||
125187595|NCT00092118|450306610|FG000|Overall Study|Withdrawal by Subject|4|||
125187596|NCT00092118|450306611|FG001|Overall Study|Withdrawal by Subject|10|||
125187597|NCT00092118|450306610|FG000|Overall Study|Other|6|||
125187598|NCT00092118|450306611|FG001|Overall Study|Other|5|||
125187599|NCT03751098|450306612|FG000|Overall Study|Withdrawal by Subject|0|||
125187600|NCT03751098|450306613|FG001|Overall Study|Withdrawal by Subject|1|||
125187601|NCT02022202|450306615|FG000|Overall Study|Withdrawal by Subject|2|||
125187602|NCT02022202|450306615|FG000|Overall Study|Disease Progression|3|||
125187603|NCT02022202|450306615|FG000|Overall Study|Desire go to immediately to surgery|3|||
125187604|NCT05581641|450306616|FG000|Overall Study|Withdrawal by Subject|0|||
125187605|NCT05581641|450306617|FG001|Overall Study|Withdrawal by Subject|1|||
125187606|NCT05581641|450306618|FG002|Overall Study|Withdrawal by Subject|3|||
125187607|NCT05581641|450306619|FG003|Overall Study|Withdrawal by Subject|1|||
125187608|NCT05581641|450306616|FG000|Overall Study|Lost to Follow-up|0|||
125187609|NCT05581641|450306617|FG001|Overall Study|Lost to Follow-up|1|||
125187610|NCT05581641|450306618|FG002|Overall Study|Lost to Follow-up|0|||
125187611|NCT05581641|450306619|FG003|Overall Study|Lost to Follow-up|1|||
125187612|NCT05581641|450306616|FG000|Overall Study|Protocol Violation|1|||
125187613|NCT05581641|450306617|FG001|Overall Study|Protocol Violation|0|||
125187614|NCT05581641|450306618|FG002|Overall Study|Protocol Violation|0|||
125187615|NCT05581641|450306619|FG003|Overall Study|Protocol Violation|0|||
125187616|NCT05581641|450306616|FG000|Overall Study|Other|1|||
125187617|NCT05581641|450306617|FG001|Overall Study|Other|0|||
125187618|NCT05581641|450306618|FG002|Overall Study|Other|2|||
125187619|NCT05581641|450306619|FG003|Overall Study|Other|1|||
125187620|NCT02166333|450306622|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
125187621|NCT02166333|450306623|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
125187622|NCT02166333|450306624|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
125187623|NCT02166333|450306625|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
125187624|NCT02166333|450306626|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
125187625|NCT02166333|450306627|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
125187626|NCT02166333|450306622|FG000|Stage 1|Death|4|||
125187627|NCT02166333|450306623|FG001|Stage 1|Death|0|||
125187628|NCT02166333|450306624|FG002|Stage 1|Death|2|||
125187629|NCT02166333|450306625|FG003|Stage 1|Death|0|||
125187630|NCT02166333|450306626|FG004|Stage 1|Death|3|||
125187631|NCT02166333|450306627|FG005|Stage 1|Death|2|||
125187632|NCT02166333|450306622|FG000|Stage 1|Lost to Follow-up|12|||
125187633|NCT02166333|450306623|FG001|Stage 1|Lost to Follow-up|0|||
125187634|NCT02166333|450306624|FG002|Stage 1|Lost to Follow-up|6|||
125187635|NCT02166333|450306625|FG003|Stage 1|Lost to Follow-up|0|||
125187636|NCT02166333|450306626|FG004|Stage 1|Lost to Follow-up|3|||
125187637|NCT02166333|450306627|FG005|Stage 1|Lost to Follow-up|3|||
125187638|NCT02166333|450306622|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
125187639|NCT02166333|450306623|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
125187640|NCT02166333|450306624|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
125187641|NCT02166333|450306625|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
125187642|NCT02166333|450306626|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
125187643|NCT02166333|450306627|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
125187644|NCT02166333|450306622|FG000|Stage 2|Death|4|||
125187645|NCT02166333|450306623|FG001|Stage 2|Death|2|||
125187646|NCT02166333|450306624|FG002|Stage 2|Death|1|||
125187647|NCT02166333|450306625|FG003|Stage 2|Death|0|||
125187648|NCT02166333|450306626|FG004|Stage 2|Death|0|||
125187649|NCT02166333|450306627|FG005|Stage 2|Death|1|||
125187650|NCT02166333|450306622|FG000|Stage 2|Lost to Follow-up|23|||
125187651|NCT02166333|450306623|FG001|Stage 2|Lost to Follow-up|4|||
125187652|NCT02166333|450306624|FG002|Stage 2|Lost to Follow-up|11|||
125187653|NCT02166333|450306625|FG003|Stage 2|Lost to Follow-up|9|||
125187654|NCT02166333|450306626|FG004|Stage 2|Lost to Follow-up|3|||
125242106|NCT03086343|450509657|FG000|Period 2|COVID-19 Infection|5|||
125242107|NCT03086343|450509658|FG001|Period 2|COVID-19 Infection|0|||
125242108|NCT03086343|450509659|FG002|Period 2|COVID-19 Infection|0|||
125242109|NCT03086343|450509660|FG003|Period 2|COVID-19 Infection|0|||
125242110|NCT03086343|450509657|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
125242111|NCT03086343|450509658|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
125242112|NCT03086343|450509659|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
125242113|NCT03086343|450509660|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
125242114|NCT03086343|450509657|FG000|Period 2|Other, Not Specified|23|||
125242115|NCT03086343|450509658|FG001|Period 2|Other, Not Specified|22|||
125242116|NCT03086343|450509659|FG002|Period 2|Other, Not Specified|2|||
125242117|NCT03086343|450509660|FG003|Period 2|Other, Not Specified|4|||
125242118|NCT01047501|450509661|FG000|Overall Study|Adverse Event|7|||
125242119|NCT01047501|450509662|FG001|Overall Study|Adverse Event|8|||
125242120|NCT01047501|450509663|FG002|Overall Study|Adverse Event|5|||
125242121|NCT01047501|450509661|FG000|Overall Study|Withdrew Consent|6|||
125242122|NCT01047501|450509662|FG001|Overall Study|Withdrew Consent|2|||
125242123|NCT01047501|450509663|FG002|Overall Study|Withdrew Consent|4|||
125242124|NCT01047501|450509661|FG000|Overall Study|Lost to Follow-up|0|||
125242125|NCT01047501|450509662|FG001|Overall Study|Lost to Follow-up|1|||
125242126|NCT01047501|450509663|FG002|Overall Study|Lost to Follow-up|1|||
125242127|NCT01047501|450509661|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
125242128|NCT01047501|450509662|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
125242129|NCT01047501|450509663|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
125242130|NCT01047501|450509661|FG000|Overall Study|Death|1|||
125242131|NCT01047501|450509662|FG001|Overall Study|Death|0|||
125242132|NCT01047501|450509663|FG002|Overall Study|Death|0|||
125242133|NCT01047501|450509661|FG000|Overall Study|Other discontinuation|1|||
125242134|NCT01047501|450509662|FG001|Overall Study|Other discontinuation|0|||
125242135|NCT01047501|450509663|FG002|Overall Study|Other discontinuation|1|||
125242136|NCT01047501|450509661|FG000|Overall Study|Investigator judgement|0|||
125242137|NCT01047501|450509662|FG001|Overall Study|Investigator judgement|0|||
125242138|NCT01047501|450509663|FG002|Overall Study|Investigator judgement|1|||
125242139|NCT00741611|450509664|FG000|Overall Study|Death|0|||
125242140|NCT00741611|450509665|FG001|Overall Study|Death|0|||
125242141|NCT00741611|450509666|FG002|Overall Study|Death|1|||
125242142|NCT00741611|450509664|FG000|Overall Study|Withdrawal by Subject|0|||
125242143|NCT00741611|450509665|FG001|Overall Study|Withdrawal by Subject|2|||
125242144|NCT00741611|450509666|FG002|Overall Study|Withdrawal by Subject|2|||
125242145|NCT00429299|450509671|FG000|Overall Study|Disease Progression|1|||
125242146|NCT00429299|450509672|FG001|Overall Study|Disease Progression|1|||
125242147|NCT00429299|450509673|FG002|Overall Study|Disease Progression|0|||
125242148|NCT00429299|450509671|FG000|Overall Study|Adverse Event|2|||
125242149|NCT00429299|450509672|FG001|Overall Study|Adverse Event|5|||
125242150|NCT00429299|450509673|FG002|Overall Study|Adverse Event|1|||
125242151|NCT00429299|450509671|FG000|Overall Study|Protocol Violation|1|||
125242152|NCT00429299|450509672|FG001|Overall Study|Protocol Violation|0|||
125242153|NCT00429299|450509673|FG002|Overall Study|Protocol Violation|0|||
125242154|NCT00429299|450509671|FG000|Overall Study|Withdrawal by Subject|0|||
125242155|NCT00429299|450509672|FG001|Overall Study|Withdrawal by Subject|1|||
125242156|NCT00429299|450509673|FG002|Overall Study|Withdrawal by Subject|3|||
125242157|NCT01510756|450509674|FG000|Overall Study|Death|1|||
125242158|NCT01510756|450509674|FG000|Overall Study|Lack of Efficacy|2|||
125242159|NCT01510756|450509674|FG000|Overall Study|Physician Decision|1|||
125242160|NCT04871113|450509675|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
125242161|NCT04871113|450509676|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
125242162|NCT04871113|450509677|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
125242163|NCT04871113|450509678|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
125242164|NCT04871113|450509679|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
125242165|NCT04871113|450509680|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
125242166|NCT04871113|450509681|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
125242167|NCT04871113|450509682|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
125242168|NCT04871113|450509683|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
125242169|NCT04871113|450509684|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
125242170|NCT04871113|450509675|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
125242171|NCT04871113|450509676|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
125242172|NCT04871113|450509677|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
125242173|NCT04871113|450509678|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
125242174|NCT04871113|450509679|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
125242175|NCT04871113|450509680|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
125242176|NCT04871113|450509681|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
125242177|NCT04871113|450509682|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
125242178|NCT04871113|450509683|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
125242179|NCT04871113|450509684|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
125242180|NCT01257542|450509687|FG000|Overall Study|Protocol Violation|3|||
125187655|NCT02166333|450306627|FG005|Stage 2|Lost to Follow-up|6|||
125187656|NCT00682786|450306632|FG000|Overall Study|Withdrawal by Subject|2|||
125187657|NCT00682786|450306633|FG001|Overall Study|Withdrawal by Subject|2|||
125187658|NCT00682786|450306632|FG000|Overall Study|Did not receive irinotecan|0|||
125187659|NCT00682786|450306633|FG001|Overall Study|Did not receive irinotecan|1|||
125187660|NCT00359424|450306634|FG000|Overall Study|Death|99|||
125187661|NCT00359424|450306635|FG001|Overall Study|Death|58|||
125187662|NCT00359424|450306634|FG000|Overall Study|Lost to Follow-up|19|||
125187663|NCT00359424|450306635|FG001|Overall Study|Lost to Follow-up|7|||
125187664|NCT00359424|450306634|FG000|Overall Study|Withdrawal by Subject|10|||
125187665|NCT00359424|450306635|FG001|Overall Study|Withdrawal by Subject|2|||
125187666|NCT00359424|450306634|FG000|Overall Study|follow up not conducted|2|||
125187667|NCT00359424|450306635|FG001|Overall Study|follow up not conducted|0|||
125187668|NCT02462603|450306638|FG000|Overall Study|Investigator Decision|1|||
125187669|NCT02462603|450306638|FG000|Overall Study|Non-Compliance|1|||
125187670|NCT02462603|450306638|FG000|Overall Study|Withdrawal by Subject|2|||
125187671|NCT01591096|450306640|FG000|Overall Study|Adverse Event|1|||
125187672|NCT01831635|450306641|FG000|Overall Study|Withdrawal by Subject|0|||
125187673|NCT01831635|450306642|FG001|Overall Study|Withdrawal by Subject|2|||
125187674|NCT01831635|450306643|FG002|Overall Study|Withdrawal by Subject|0|||
125187675|NCT03655405|450306646|FG000|Overall Study|Death after initial data collection|4|||
125187676|NCT03655405|450306647|FG001|Overall Study|Death after initial data collection|2|||
125187677|NCT03655405|450306646|FG000|Overall Study|Died before initial data collection|1|||
125187678|NCT03655405|450306647|FG001|Overall Study|Died before initial data collection|2|||
125187679|NCT03655405|450306646|FG000|Overall Study|Protocol Violation|0|||
125187680|NCT03655405|450306647|FG001|Overall Study|Protocol Violation|1|||
125187681|NCT01991743|450306649|FG000|Overall Study|external cephalic version not performed|0|||
125187682|NCT01991743|450306650|FG001|Overall Study|external cephalic version not performed|0|||
125187683|NCT01991743|450306651|FG002|Overall Study|external cephalic version not performed|1|||
125187684|NCT01991743|450306652|FG003|Overall Study|external cephalic version not performed|0|||
125187685|NCT02859337|450306654|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
125187686|NCT02859337|450306655|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
125187687|NCT02859337|450306656|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
125187688|NCT02859337|450306654|FG000|Overall Study|Withdrawal by Subject|3|||
125187689|NCT02859337|450306655|FG001|Overall Study|Withdrawal by Subject|1|||
125187690|NCT02859337|450306656|FG002|Overall Study|Withdrawal by Subject|0|||
125187691|NCT02859337|450306654|FG000|Overall Study|Lost to Follow-up|1|||
125187692|NCT02859337|450306655|FG001|Overall Study|Lost to Follow-up|0|||
125187693|NCT02859337|450306656|FG002|Overall Study|Lost to Follow-up|0|||
125187694|NCT01445730|450306657|FG000|Overall Study|Adverse Event|1|||
125187695|NCT01445730|450306657|FG000|Overall Study|For the advice of a dentist|1|||
125187696|NCT01445730|450306657|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
125187697|NCT01167140|450306658|FG000|Overall Study|Withdrawal by Subject|1|||
125187698|NCT03805412|450306659|FG000|Overall Study|Lost to Follow-up|0|||
125187699|NCT03805412|450306660|FG001|Overall Study|Lost to Follow-up|1|||
125187700|NCT04390113|450306665|FG000|Overall Study|Not Treated|0|||
125187701|NCT04390113|450306666|FG001|Overall Study|Not Treated|1|||
125187702|NCT04390113|450306665|FG000|Overall Study|Adverse Event|1|||
125187703|NCT04390113|450306666|FG001|Overall Study|Adverse Event|0|||
125187704|NCT04390113|450306665|FG000|Overall Study|Death|2|||
125187705|NCT04390113|450306666|FG001|Overall Study|Death|1|||
125187706|NCT04390113|450306665|FG000|Overall Study|Physician Decision|1|||
125187707|NCT04390113|450306666|FG001|Overall Study|Physician Decision|3|||
125187708|NCT04390113|450306665|FG000|Overall Study|Study Terminated by Sponsor|5|||
125187709|NCT04390113|450306666|FG001|Overall Study|Study Terminated by Sponsor|3|||
125187710|NCT04390113|450306665|FG000|Overall Study|Withdrawal by Subject|10|||
125187711|NCT04390113|450306666|FG001|Overall Study|Withdrawal by Subject|5|||
125187712|NCT04390113|450306665|FG000|Overall Study|Other|1|||
125187713|NCT04390113|450306666|FG001|Overall Study|Other|0|||
125187714|NCT04390113|450306665|FG000|Overall Study|Missing|0|||
125187715|NCT04390113|450306666|FG001|Overall Study|Missing|1|||
125187716|NCT00030901|450306674|FG000|Initial Registration|Ineligible|167|||
125187717|NCT00030901|450306675|FG001|Initial Registration|Ineligible|0|||
125187718|NCT00030901|450306676|FG002|Initial Registration|Ineligible|0|||
125187719|NCT00030901|450306674|FG000|Randomization|Adverse Event|0|||
125187720|NCT00030901|450306675|FG001|Randomization|Adverse Event|11|||
125187721|NCT00030901|450306676|FG002|Randomization|Adverse Event|7|||
125187722|NCT00030901|450306674|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
125187723|NCT00030901|450306675|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
125187724|NCT00030901|450306676|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
125187725|NCT00030901|450306674|FG000|Randomization|Progression/Relapse|0|||
125187726|NCT00030901|450306675|FG001|Randomization|Progression/Relapse|22|||
125187727|NCT00030901|450306676|FG002|Randomization|Progression/Relapse|21|||
125187728|NCT00030901|450306674|FG000|Randomization|Death|0|||
125187729|NCT00030901|450306675|FG001|Randomization|Death|1|||
125187730|NCT00030901|450306676|FG002|Randomization|Death|3|||
125187731|NCT00030901|450306674|FG000|Randomization|Other|0|||
125242181|NCT01257542|450509688|FG001|Overall Study|Protocol Violation|5|||
125242182|NCT01257542|450509687|FG000|Overall Study|Withdrawal by Subject|0|||
125242183|NCT01257542|450509688|FG001|Overall Study|Withdrawal by Subject|2|||
125242184|NCT03600428|450509694|FG000|Overall Study|Not eligible|0|||
125242185|NCT03600428|450509695|FG001|Overall Study|Not eligible|1|||
125242186|NCT03600428|450509694|FG000|Overall Study|Lost to Follow-up|5|||
125242187|NCT03600428|450509695|FG001|Overall Study|Lost to Follow-up|4|||
125242188|NCT04398134|450509696|FG000|Overall Study|Adverse Event|0|||
125242189|NCT04398134|450509697|FG001|Overall Study|Adverse Event|0|||
125242190|NCT04398134|450509698|FG002|Overall Study|Adverse Event|1|||
125242191|NCT04398134|450509699|FG003|Overall Study|Adverse Event|0|||
125242192|NCT04398134|450509696|FG000|Overall Study|Withdrawal by Subject|2|||
125242193|NCT04398134|450509697|FG001|Overall Study|Withdrawal by Subject|0|||
125242194|NCT04398134|450509698|FG002|Overall Study|Withdrawal by Subject|0|||
125242195|NCT04398134|450509699|FG003|Overall Study|Withdrawal by Subject|1|||
125242196|NCT04398134|450509696|FG000|Overall Study|Study Terminated by Sponsor|30|||
125242197|NCT04398134|450509697|FG001|Overall Study|Study Terminated by Sponsor|11|||
125242198|NCT04398134|450509698|FG002|Overall Study|Study Terminated by Sponsor|32|||
125242199|NCT04398134|450509699|FG003|Overall Study|Study Terminated by Sponsor|11|||
125242200|NCT00153920|450509701|FG000|Overall Study|Adverse Event|9|||
125242201|NCT00153920|450509701|FG000|Overall Study|Progressive Disease|9|||
125242202|NCT00153920|450509701|FG000|Overall Study|Physician Decision|3|||
125242203|NCT00153920|450509701|FG000|Overall Study|Lack of Response|3|||
125242204|NCT00153920|450509701|FG000|Overall Study|Death|2|||
125242205|NCT00153920|450509701|FG000|Overall Study|Withdrawal by Subject|1|||
125242206|NCT00153920|450509701|FG000|Overall Study|Non-Protocol Therapy|1|||
125242207|NCT00153920|450509701|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
125242208|NCT00153920|450509701|FG000|Overall Study|Progressive Disease before Trt|1|||
125242209|NCT01666652|450509707|FG000|Overall Study|Serious Adverse Event|0|||
125242210|NCT01666652|450509708|FG001|Overall Study|Serious Adverse Event|0|||
125242211|NCT01666652|450509709|FG002|Overall Study|Serious Adverse Event|0|||
125242212|NCT01666652|450509710|FG003|Overall Study|Serious Adverse Event|1|||
125242213|NCT01666652|450509711|FG004|Overall Study|Serious Adverse Event|0|||
125242214|NCT01666652|450509707|FG000|Overall Study|Withdrawal by Subject|0|||
125242215|NCT01666652|450509708|FG001|Overall Study|Withdrawal by Subject|0|||
125242216|NCT01666652|450509709|FG002|Overall Study|Withdrawal by Subject|0|||
125242217|NCT01666652|450509710|FG003|Overall Study|Withdrawal by Subject|0|||
125242218|NCT01666652|450509711|FG004|Overall Study|Withdrawal by Subject|1|||
125242219|NCT01666652|450509707|FG000|Overall Study|Moved from study area|1|||
125242220|NCT01666652|450509708|FG001|Overall Study|Moved from study area|0|||
125242221|NCT01666652|450509709|FG002|Overall Study|Moved from study area|0|||
125242222|NCT01666652|450509710|FG003|Overall Study|Moved from study area|2|||
125242223|NCT01666652|450509711|FG004|Overall Study|Moved from study area|0|||
125242224|NCT01666652|450509707|FG000|Overall Study|Lost to Follow-up|1|||
125242225|NCT01666652|450509708|FG001|Overall Study|Lost to Follow-up|1|||
125242226|NCT01666652|450509709|FG002|Overall Study|Lost to Follow-up|1|||
125242227|NCT01666652|450509710|FG003|Overall Study|Lost to Follow-up|1|||
125242228|NCT01666652|450509711|FG004|Overall Study|Lost to Follow-up|0|||
125242229|NCT01018979|450509712|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
125242230|NCT01018979|450509713|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
125242231|NCT01018979|450509712|FG000|Overall Study|Not received at least one dose|0|||
125242232|NCT01018979|450509713|FG001|Overall Study|Not received at least one dose|1|||
125242233|NCT00544882|450509716|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
125242234|NCT00544882|450509717|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
125242235|NCT00544882|450509718|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
125242236|NCT00544882|450509716|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
125242237|NCT00544882|450509717|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
125242238|NCT00544882|450509718|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
125242239|NCT00544882|450509716|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
125242240|NCT00544882|450509717|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
125242241|NCT00544882|450509718|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
125242242|NCT00544882|450509716|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
125242243|NCT00544882|450509717|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
125242244|NCT00544882|450509718|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
125242245|NCT00544882|450509716|FG000|Cycle 3: Follow-up|Noncompliance|0|||
125242246|NCT00544882|450509717|FG001|Cycle 3: Follow-up|Noncompliance|1|||
125242247|NCT00544882|450509718|FG002|Cycle 3: Follow-up|Noncompliance|0|||
125242248|NCT00544882|450509716|FG000|Cycle 3: Follow-up|Pregnancy|0|||
125242249|NCT00544882|450509717|FG001|Cycle 3: Follow-up|Pregnancy|1|||
125242250|NCT00544882|450509718|FG002|Cycle 3: Follow-up|Pregnancy|0|||
125242251|NCT03043573|450509719|FG000|Overall Study|Lost to Follow-up|3|||
125242252|NCT03043573|450509720|FG001|Overall Study|Lost to Follow-up|3|||
125242253|NCT03043573|450509719|FG000|Overall Study|Physician Decision|0|||
125242254|NCT03043573|450509720|FG001|Overall Study|Physician Decision|5|||
125242255|NCT03043573|450509719|FG000|Overall Study|Withdrawal by Subject|0|||
125242256|NCT03043573|450509720|FG001|Overall Study|Withdrawal by Subject|4|||
125242257|NCT01251861|450509723|FG000|Overall Study|Disease progression|6|||
125242258|NCT01251861|450509724|FG001|Overall Study|Disease progression|6|||
125242259|NCT01251861|450509723|FG000|Overall Study|Adverse Event|2|||
125242260|NCT01251861|450509724|FG001|Overall Study|Adverse Event|17|||
125242261|NCT01251861|450509723|FG000|Overall Study|Withdrawal by Subject|2|||
125242262|NCT01251861|450509724|FG001|Overall Study|Withdrawal by Subject|2|||
125242263|NCT01251861|450509723|FG000|Overall Study|Alternative therapy|1|||
125242264|NCT01251861|450509724|FG001|Overall Study|Alternative therapy|0|||
125242265|NCT01251861|450509723|FG000|Overall Study|Other complicating disease|0|||
125242266|NCT01251861|450509724|FG001|Overall Study|Other complicating disease|1|||
125187732|NCT00030901|450306675|FG001|Randomization|Other|36|||
125242267|NCT01251861|450509723|FG000|Overall Study|Physician Decision|1|||
125242268|NCT01251861|450509724|FG001|Overall Study|Physician Decision|0|||
125242269|NCT01251861|450509723|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
125242270|NCT01251861|450509724|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
125242271|NCT01251861|450509723|FG000|Overall Study|Other|1|||
125242272|NCT01251861|450509724|FG001|Overall Study|Other|0|||
125242273|NCT01251861|450509723|FG000|Overall Study|Never started therapy|4|||
125242274|NCT01251861|450509724|FG001|Overall Study|Never started therapy|1|||
125242275|NCT01251861|450509723|FG000|Overall Study|Potential interaction of drugs|0|||
125242276|NCT01251861|450509724|FG001|Overall Study|Potential interaction of drugs|1|||
125187733|NCT00030901|450306676|FG002|Randomization|Other|33|||
125187734|NCT00030901|450306674|FG000|Randomization|Ineligible|0|||
125187735|NCT00030901|450306675|FG001|Randomization|Ineligible|15|||
125187736|NCT00030901|450306676|FG002|Randomization|Ineligible|14|||
125187737|NCT01806051|450306677|FG000|Overall Study|Withdrawal by Subject|6|||
125187738|NCT02576847|450306678|FG000|Overall Study|Adverse Event|27|||
125187739|NCT02576847|450306678|FG000|Overall Study|Lost to Follow-up|22|||
125187740|NCT02576847|450306678|FG000|Overall Study|Physician Decision|1|||
125187741|NCT02576847|450306678|FG000|Overall Study|Pregnancy|1|||
125187742|NCT02576847|450306678|FG000|Overall Study|Protocol Violation|3|||
125187743|NCT02576847|450306678|FG000|Overall Study|Withdrawal by Subject|78|||
125187744|NCT02576847|450306678|FG000|Overall Study|Other|5|||
125187745|NCT03817190|450306679|FG000|Overall Study|Early Termination|13|||
125187746|NCT03817190|450306680|FG001|Overall Study|Early Termination|20|||
125187747|NCT03817190|450306679|FG000|Overall Study|Adverse Event|10|||
125187748|NCT03817190|450306680|FG001|Overall Study|Adverse Event|17|||
125187749|NCT03817190|450306679|FG000|Overall Study|Withdrawal by Subject|12|||
125187750|NCT03817190|450306680|FG001|Overall Study|Withdrawal by Subject|8|||
125187751|NCT03817190|450306679|FG000|Overall Study|Lost to Follow-up|11|||
125187752|NCT03817190|450306680|FG001|Overall Study|Lost to Follow-up|7|||
125187753|NCT03817190|450306679|FG000|Overall Study|Lack of Efficacy|7|||
125187754|NCT03817190|450306680|FG001|Overall Study|Lack of Efficacy|5|||
125187755|NCT03817190|450306679|FG000|Overall Study|Investigator Decision|5|||
125187756|NCT03817190|450306680|FG001|Overall Study|Investigator Decision|1|||
125187757|NCT03817190|450306679|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
125187758|NCT03817190|450306680|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
125187759|NCT03817190|450306679|FG000|Overall Study|Lack of Contact|1|||
125187760|NCT03817190|450306680|FG001|Overall Study|Lack of Contact|0|||
125187761|NCT03817190|450306679|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
125187762|NCT03817190|450306680|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
125187763|NCT03525678|450306681|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
125187764|NCT03525678|450306682|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
125187765|NCT03525678|450306683|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
125187766|NCT03525678|450306684|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
125187767|NCT03525678|450306685|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
125187768|NCT03525678|450306681|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
125242277|NCT00479232|450510923|FG000|Overall Study|Adverse Event|0|||
125242278|NCT00479232|450510924|FG001|Overall Study|Adverse Event|0|||
125242279|NCT00479232|450510925|FG002|Overall Study|Adverse Event|5|||
125242280|NCT00479232|450510926|FG003|Overall Study|Adverse Event|0|||
125242281|NCT00479232|450510927|FG004|Overall Study|Adverse Event|0|||
125242282|NCT00479232|450510928|FG005|Overall Study|Adverse Event|10|||
125242283|NCT00479232|450510923|FG000|Overall Study|Deviation from Protocol|0|||
125187769|NCT03525678|450306682|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
125187770|NCT03525678|450306683|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
125187771|NCT03525678|450306684|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
125242284|NCT00479232|450510924|FG001|Overall Study|Deviation from Protocol|0|||
125242285|NCT00479232|450510925|FG002|Overall Study|Deviation from Protocol|1|||
125242286|NCT00479232|450510926|FG003|Overall Study|Deviation from Protocol|0|||
125242287|NCT00479232|450510927|FG004|Overall Study|Deviation from Protocol|0|||
125242288|NCT00479232|450510928|FG005|Overall Study|Deviation from Protocol|0|||
125242289|NCT00479232|450510923|FG000|Overall Study|Lack of Efficacy|0|||
125242290|NCT00479232|450510924|FG001|Overall Study|Lack of Efficacy|0|||
125242291|NCT00479232|450510925|FG002|Overall Study|Lack of Efficacy|2|||
125242292|NCT00479232|450510926|FG003|Overall Study|Lack of Efficacy|0|||
125242293|NCT00479232|450510927|FG004|Overall Study|Lack of Efficacy|0|||
125242294|NCT00479232|450510928|FG005|Overall Study|Lack of Efficacy|4|||
125242295|NCT00479232|450510923|FG000|Overall Study|Physician Decision|0|||
125242296|NCT00479232|450510924|FG001|Overall Study|Physician Decision|0|||
125242297|NCT00479232|450510925|FG002|Overall Study|Physician Decision|2|||
125242298|NCT00479232|450510926|FG003|Overall Study|Physician Decision|0|||
125242299|NCT00479232|450510927|FG004|Overall Study|Physician Decision|0|||
125242300|NCT00479232|450510928|FG005|Overall Study|Physician Decision|1|||
125242301|NCT00479232|450510923|FG000|Overall Study|Progressive Disease|3|||
125242302|NCT00479232|450510924|FG001|Overall Study|Progressive Disease|1|||
125242303|NCT00479232|450510925|FG002|Overall Study|Progressive Disease|12|||
125242304|NCT00479232|450510926|FG003|Overall Study|Progressive Disease|3|||
125242305|NCT00479232|450510927|FG004|Overall Study|Progressive Disease|3|||
125242306|NCT00479232|450510928|FG005|Overall Study|Progressive Disease|12|||
125242307|NCT00479232|450510923|FG000|Overall Study|Withdrew Consent|0|||
125242308|NCT00479232|450510924|FG001|Overall Study|Withdrew Consent|2|||
125242309|NCT00479232|450510925|FG002|Overall Study|Withdrew Consent|6|||
125242310|NCT00479232|450510926|FG003|Overall Study|Withdrew Consent|0|||
125242311|NCT00479232|450510927|FG004|Overall Study|Withdrew Consent|1|||
125242312|NCT00479232|450510928|FG005|Overall Study|Withdrew Consent|3|||
125242313|NCT01373229|450510929|FG000|Overall Study|Death|3|||
125242314|NCT01373229|450510929|FG000|Overall Study|Physician Decision|3|||
125242315|NCT01991314|450510930|FG000|Overall Study|Adverse Event|5|||
125242316|NCT01991314|450510931|FG001|Overall Study|Adverse Event|1|||
125242317|NCT01991314|450510930|FG000|Overall Study|Lost to Follow-up|6|||
125242318|NCT01991314|450510931|FG001|Overall Study|Lost to Follow-up|10|||
125242319|NCT00970944|450510933|FG000|Overall Study|Death|1|||
125242320|NCT00970944|450510934|FG001|Overall Study|Death|0|||
125242321|NCT00970944|450510933|FG000|Overall Study|Physician Decision|0|||
125242322|NCT00970944|450510934|FG001|Overall Study|Physician Decision|2|||
125242323|NCT00972738|450510935|FG000|Overall Study|Adverse Event|7|||
125242324|NCT00972738|450510936|FG001|Overall Study|Adverse Event|1|||
125242325|NCT00972738|450510937|FG002|Overall Study|Adverse Event|8|||
125242326|NCT00972738|450510935|FG000|Overall Study|Protocol Violation|2|||
125242327|NCT00972738|450510936|FG001|Overall Study|Protocol Violation|1|||
125242328|NCT00972738|450510937|FG002|Overall Study|Protocol Violation|3|||
125242329|NCT00972738|450510935|FG000|Overall Study|Lost to Follow-up|1|||
125242330|NCT00972738|450510936|FG001|Overall Study|Lost to Follow-up|0|||
125242331|NCT00972738|450510937|FG002|Overall Study|Lost to Follow-up|1|||
125242332|NCT00972738|450510935|FG000|Overall Study|Lack of Efficacy|5|||
125242333|NCT00972738|450510936|FG001|Overall Study|Lack of Efficacy|1|||
125242334|NCT00972738|450510937|FG002|Overall Study|Lack of Efficacy|11|||
125242335|NCT00972738|450510935|FG000|Overall Study|Withdrawal by Subject|5|||
125242336|NCT00972738|450510936|FG001|Overall Study|Withdrawal by Subject|1|||
125242337|NCT00972738|450510937|FG002|Overall Study|Withdrawal by Subject|4|||
125242338|NCT00972738|450510935|FG000|Overall Study|Moved|0|||
125242339|NCT00972738|450510936|FG001|Overall Study|Moved|0|||
125242340|NCT00972738|450510937|FG002|Overall Study|Moved|1|||
125242341|NCT00972738|450510935|FG000|Overall Study|Other|1|||
125242342|NCT00972738|450510936|FG001|Overall Study|Other|2|||
125242343|NCT00972738|450510937|FG002|Overall Study|Other|1|||
125242344|NCT03915067|450510938|FG000|Overall Study|Adverse Event|0|||
125242345|NCT03915067|450510939|FG001|Overall Study|Adverse Event|0|||
125242346|NCT03915067|450510940|FG002|Overall Study|Adverse Event|1|||
125242347|NCT03915067|450510938|FG000|Overall Study|Withdrawal by Subject|4|||
125242348|NCT03915067|450510939|FG001|Overall Study|Withdrawal by Subject|3|||
125242349|NCT03915067|450510940|FG002|Overall Study|Withdrawal by Subject|0|||
125242350|NCT03915067|450510938|FG000|Overall Study|Lost to Follow-up|3|||
125242351|NCT03915067|450510939|FG001|Overall Study|Lost to Follow-up|2|||
125242352|NCT03915067|450510940|FG002|Overall Study|Lost to Follow-up|0|||
125242353|NCT03915067|450510938|FG000|Overall Study|Protocol Deviation|0|||
125242354|NCT03915067|450510939|FG001|Overall Study|Protocol Deviation|0|||
125242355|NCT03915067|450510940|FG002|Overall Study|Protocol Deviation|1|||
125242356|NCT03915067|450510938|FG000|Overall Study|Covid-19 Related Issues|2|||
125242357|NCT03915067|450510939|FG001|Overall Study|Covid-19 Related Issues|4|||
125242358|NCT03915067|450510940|FG002|Overall Study|Covid-19 Related Issues|4|||
125242359|NCT03915067|450510938|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
125242360|NCT03915067|450510939|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
125242361|NCT03915067|450510940|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
125242362|NCT01033942|450510941|FG000|Overall Study|Withdrawal by Subject|1|||
125242363|NCT01033942|450510942|FG001|Overall Study|Withdrawal by Subject|1|||
125187772|NCT03525678|450306685|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
125187773|NCT03525678|450306681|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
125187774|NCT03525678|450306682|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
125187775|NCT03525678|450306683|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
125187776|NCT03525678|450306684|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
125187777|NCT03525678|450306685|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
125187778|NCT03525678|450306681|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
125187779|NCT03525678|450306682|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
125187780|NCT03525678|450306683|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
125187781|NCT03525678|450306684|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
125187782|NCT03525678|450306685|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
125187783|NCT03525678|450306681|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
125187784|NCT03525678|450306682|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
125187785|NCT03525678|450306683|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
125187786|NCT03525678|450306684|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
125187787|NCT03525678|450306685|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
125187788|NCT03525678|450306681|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
125187789|NCT03525678|450306682|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
125187790|NCT03525678|450306683|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
125187791|NCT03525678|450306684|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
125187792|NCT03525678|450306685|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
125187793|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
125187794|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
125187795|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
125187796|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
125187797|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
125187798|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
125187799|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
125187800|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
125187801|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
125187802|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
125187803|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
125187804|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
125187805|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
125187806|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
125187807|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
125187808|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
125187809|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
125187810|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
125187811|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
125187812|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
125187813|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
125187814|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
125187815|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
125187816|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
125187817|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
125187818|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
125187819|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
125187820|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
125187821|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
125187822|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
125187823|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
125187824|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
125187825|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187826|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187827|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
125187828|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187829|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187830|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187831|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
125242364|NCT01033942|450510943|FG002|Overall Study|Withdrawal by Subject|1|||
125242365|NCT01033942|450510941|FG000|Overall Study|Lost to Follow-up|1|||
125187832|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187833|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
125187834|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
125187835|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
125187836|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
125187837|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
125187838|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
125187839|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
125187840|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
125187841|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
125187842|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
125187843|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
125187844|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
125187845|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
125187846|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
125187847|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
125187848|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
125187849|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
125187850|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
125187851|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
125187852|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
125187853|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
125187854|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
125187855|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
125187856|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
125187857|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
125187858|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
125187859|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
125187860|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
125187861|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
125187862|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
125187863|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
125187864|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
125187865|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187866|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187867|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187868|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187869|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187870|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
125187871|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187872|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187873|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
125187874|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
125187875|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
125187876|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
125187877|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
125242366|NCT01033942|450510942|FG001|Overall Study|Lost to Follow-up|0|||
125242367|NCT01033942|450510943|FG002|Overall Study|Lost to Follow-up|0|||
125242368|NCT01033942|450510941|FG000|Overall Study|Enrolled in Extension Study|0|||
125242369|NCT01033942|450510942|FG001|Overall Study|Enrolled in Extension Study|3|||
125242370|NCT01033942|450510943|FG002|Overall Study|Enrolled in Extension Study|0|||
125242371|NCT02693418|450510944|FG000|Overall Study|Lost to Follow-up|1|||
125242372|NCT02693418|450510945|FG001|Overall Study|Lost to Follow-up|2|||
125242373|NCT02693418|450510946|FG002|Overall Study|Lost to Follow-up|0|||
125242374|NCT02693418|450510947|FG003|Overall Study|Lost to Follow-up|0|||
125242375|NCT02693418|450510948|FG004|Overall Study|Lost to Follow-up|0|||
125242376|NCT02693418|450510944|FG000|Overall Study|Menses during study period|0|||
125242377|NCT02693418|450510945|FG001|Overall Study|Menses during study period|0|||
125242378|NCT02693418|450510946|FG002|Overall Study|Menses during study period|2|||
125242379|NCT02693418|450510947|FG003|Overall Study|Menses during study period|0|||
125242380|NCT02693418|450510948|FG004|Overall Study|Menses during study period|0|||
125242381|NCT02260986|450510954|FG000|Overall Study|Adverse Event|24|||
125242382|NCT02260986|450510955|FG001|Overall Study|Adverse Event|0|||
125242383|NCT02260986|450510956|FG002|Overall Study|Adverse Event|11|||
125242384|NCT02260986|450510954|FG000|Overall Study|Lack of Efficacy|27|||
125242385|NCT02260986|450510955|FG001|Overall Study|Lack of Efficacy|3|||
125242386|NCT02260986|450510956|FG002|Overall Study|Lack of Efficacy|0|||
125242387|NCT02260986|450510954|FG000|Overall Study|Protocol Violation|14|||
125242388|NCT02260986|450510955|FG001|Overall Study|Protocol Violation|5|||
125242389|NCT02260986|450510956|FG002|Overall Study|Protocol Violation|16|||
125242390|NCT02260986|450510954|FG000|Overall Study|Car accident|0|||
125242391|NCT02260986|450510955|FG001|Overall Study|Car accident|0|||
125242392|NCT02260986|450510956|FG002|Overall Study|Car accident|1|||
125242393|NCT02260986|450510954|FG000|Overall Study|Withdrawal by Subject|17|||
125242394|NCT02260986|450510955|FG001|Overall Study|Withdrawal by Subject|4|||
125242395|NCT02260986|450510956|FG002|Overall Study|Withdrawal by Subject|9|||
125242396|NCT02260986|450510954|FG000|Overall Study|Incorrect randomization|0|||
125242397|NCT02260986|450510955|FG001|Overall Study|Incorrect randomization|1|||
125242398|NCT02260986|450510956|FG002|Overall Study|Incorrect randomization|0|||
125242399|NCT02260986|450510954|FG000|Overall Study|Lack of investigation product supply|2|||
125242400|NCT02260986|450510955|FG001|Overall Study|Lack of investigation product supply|0|||
125242401|NCT02260986|450510956|FG002|Overall Study|Lack of investigation product supply|1|||
125242402|NCT02260986|450510954|FG000|Overall Study|Lost to Follow-up|4|||
125242403|NCT02260986|450510955|FG001|Overall Study|Lost to Follow-up|0|||
125242404|NCT02260986|450510956|FG002|Overall Study|Lost to Follow-up|3|||
125242405|NCT02260986|450510954|FG000|Overall Study|Pregnancy|2|||
125242406|NCT02260986|450510955|FG001|Overall Study|Pregnancy|0|||
125242407|NCT02260986|450510956|FG002|Overall Study|Pregnancy|0|||
125242408|NCT01793935|450510959|FG000|Overall Study|Pregnancy|1|||
125242409|NCT01793935|450510960|FG001|Overall Study|Pregnancy|0|||
125242410|NCT01793935|450510959|FG000|Overall Study|Protocol Violation|2|||
125242411|NCT01793935|450510960|FG001|Overall Study|Protocol Violation|1|||
125242412|NCT01793935|450510959|FG000|Overall Study|Adverse Event|2|||
125242413|NCT01793935|450510960|FG001|Overall Study|Adverse Event|0|||
125242414|NCT01793935|450510959|FG000|Overall Study|Patient did not take study medication|1|||
125242415|NCT01793935|450510960|FG001|Overall Study|Patient did not take study medication|1|||
125242416|NCT01793935|450510959|FG000|Overall Study|Lost to Follow-up|0|||
125242417|NCT01793935|450510960|FG001|Overall Study|Lost to Follow-up|1|||
125242418|NCT01771913|450510962|FG000|Overall Study|Withdrawal by Subject|1|||
125242419|NCT01771913|450510963|FG001|Overall Study|Withdrawal by Subject|0|||
125242420|NCT00313170|450510965|FG000|Overall Study|Death|2|||
125242421|NCT00313170|450510966|FG001|Overall Study|Death|4|||
125242422|NCT00313170|450510967|FG002|Overall Study|Death|2|||
125242423|NCT00313170|450510965|FG000|Overall Study|Adverse Event|1|||
125242424|NCT00313170|450510966|FG001|Overall Study|Adverse Event|2|||
125242425|NCT00313170|450510967|FG002|Overall Study|Adverse Event|0|||
125242426|NCT00313170|450510965|FG000|Overall Study|Disease progression|31|||
125242427|NCT00313170|450510966|FG001|Overall Study|Disease progression|26|||
125242428|NCT00313170|450510967|FG002|Overall Study|Disease progression|27|||
125242429|NCT00313170|450510965|FG000|Overall Study|Withdrawal by Subject|1|||
125242430|NCT00313170|450510966|FG001|Overall Study|Withdrawal by Subject|0|||
125242431|NCT00313170|450510967|FG002|Overall Study|Withdrawal by Subject|1|||
125242432|NCT00313170|450510965|FG000|Overall Study|Incorrect enrollment|0|||
125242433|NCT00313170|450510966|FG001|Overall Study|Incorrect enrollment|2|||
125242434|NCT00313170|450510967|FG002|Overall Study|Incorrect enrollment|1|||
125242435|NCT00313170|450510965|FG000|Overall Study|Lost to Follow-up|0|||
125242436|NCT00313170|450510966|FG001|Overall Study|Lost to Follow-up|0|||
125242437|NCT00313170|450510967|FG002|Overall Study|Lost to Follow-up|1|||
125242438|NCT00313170|450510965|FG000|Overall Study|Progression (investigators opinion)|1|||
125242439|NCT00313170|450510966|FG001|Overall Study|Progression (investigators opinion)|0|||
125242440|NCT00313170|450510967|FG002|Overall Study|Progression (investigators opinion)|0|||
125242441|NCT04900272|450510968|FG000|Overall Study|Lost to Follow-up|2|||
125242442|NCT04900272|450510968|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
125242443|NCT04900272|450510968|FG000|Overall Study|Withdrawal by Subject|1|||
125242444|NCT05059080|450510970|FG000|Overall Study|Withdrawal by Subject|3|||
125242445|NCT05059080|450510970|FG000|Overall Study|Study Terminated by Sponsor|64|||
125187878|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
125187879|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
125187880|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
125187881|NCT00210210|450308153|FG000|Overall Study|Withdrawal by Subject|3|||
125187882|NCT00210210|450308154|FG001|Overall Study|Withdrawal by Subject|2|||
125187883|NCT00210210|450308153|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
125187884|NCT00210210|450308154|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
125187885|NCT04225715|450308156|FG000|Overall Study|Reason not Specified|1|||
125187886|NCT04225715|450308157|FG001|Overall Study|Reason not Specified|0|||
125187887|NCT04225715|450308158|FG002|Overall Study|Reason not Specified|0|||
125187888|NCT04225715|450308159|FG003|Overall Study|Reason not Specified|0|||
125187889|NCT04225715|450308160|FG004|Overall Study|Reason not Specified|0|||
125242446|NCT05607043|450510971|FG000|Overall Study|Lost to Follow-up|2|||
125242447|NCT00800540|450510975|FG000|Period One: 6 Weeks|Noncompliance|1|||
125242448|NCT00800540|450510976|FG001|Period One: 6 Weeks|Noncompliance|0|||
125242449|NCT00800540|450510975|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
125242450|NCT00800540|450510976|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
125242451|NCT00800540|450510975|FG000|Period 2: 6 Weeks|Adverse Event|0|||
125242452|NCT00800540|450510976|FG001|Period 2: 6 Weeks|Adverse Event|1|||
125242453|NCT02447029|450510979|FG000|Overall Study|Withdrawal by Subject|3|||
125242454|NCT02447029|450510980|FG001|Overall Study|Withdrawal by Subject|2|||
125242455|NCT00549328|450510981|FG000|Overall Study|Adverse Event|2|||
125242456|NCT00549328|450510981|FG000|Overall Study|Disease Progression|10|||
125242457|NCT00549328|450510981|FG000|Overall Study|Death|1|||
125242458|NCT00549328|450510981|FG000|Overall Study|Use of Prohibited Medication|1|||
125242459|NCT00770484|450510982|FG000|Overall Study|Withdrawal by Subject|1|||
125242460|NCT00770484|450510983|FG001|Overall Study|Withdrawal by Subject|0|||
125242461|NCT03097315|450510988|FG000|Overall Study|Withdrawal by Subject|1|||
125242462|NCT01946802|450510989|FG000|Overall Study|Death|1|||
125242463|NCT01946802|450510989|FG000|Overall Study|Withdrawal by Subject|2|||
125242464|NCT01946802|450510989|FG000|Overall Study|Combined septic shock|1|||
125242465|NCT01946802|450510989|FG000|Overall Study|Protocol Violation|1|||
125242466|NCT04327271|450510990|FG000|Overall Study|Death|1|||
125242467|NCT04327271|450510991|FG001|Overall Study|Death|0|||
125242468|NCT04327271|450510990|FG000|Overall Study|Withdrawal by Subject|1|||
125242469|NCT04327271|450510991|FG001|Overall Study|Withdrawal by Subject|0|||
125242470|NCT04327271|450510990|FG000|Overall Study|randomization error (data capture)|4|||
125242471|NCT04327271|450510991|FG001|Overall Study|randomization error (data capture)|3|||
125242472|NCT03637374|450510992|FG000|Overall Study|Death|2|||
125242473|NCT03637374|450510993|FG001|Overall Study|Death|0|||
125242474|NCT01479530|450510995|FG000|Overall Study|Adverse Event|5|||
125242475|NCT01479530|450510996|FG001|Overall Study|Adverse Event|6|||
125242476|NCT01479530|450510995|FG000|Overall Study|Lack of Efficacy|0|||
125242477|NCT01479530|450510996|FG001|Overall Study|Lack of Efficacy|1|||
125242478|NCT01479530|450510995|FG000|Overall Study|Protocol Violation|2|||
125242479|NCT01479530|450510996|FG001|Overall Study|Protocol Violation|3|||
125242480|NCT01479530|450510995|FG000|Overall Study|Withdrawal of Consent|3|||
125242481|NCT01479530|450510996|FG001|Overall Study|Withdrawal of Consent|2|||
125242482|NCT00303628|450510997|FG000|Overall Study|Disease progression|0|||
125242483|NCT00303628|450510998|FG001|Overall Study|Disease progression|1|||
125242484|NCT00303628|450510997|FG000|Overall Study|Adverse Event|26|||
125242485|NCT00303628|450510998|FG001|Overall Study|Adverse Event|36|||
125242486|NCT00303628|450510997|FG000|Overall Study|Death|0|||
125242487|NCT00303628|450510998|FG001|Overall Study|Death|1|||
125242488|NCT00303628|450510997|FG000|Overall Study|Withdrawal by Subject|11|||
125242489|NCT00303628|450510998|FG001|Overall Study|Withdrawal by Subject|20|||
125242490|NCT00303628|450510997|FG000|Overall Study|Alternative therapy|2|||
125242491|NCT00303628|450510998|FG001|Overall Study|Alternative therapy|0|||
125242492|NCT00303628|450510997|FG000|Overall Study|Other complicating disease|0|||
125242493|NCT00303628|450510998|FG001|Overall Study|Other complicating disease|1|||
125242494|NCT00303628|450510997|FG000|Overall Study|Not start protocol therapy|3|||
125242495|NCT00303628|450510998|FG001|Overall Study|Not start protocol therapy|5|||
125242496|NCT00303628|450510997|FG000|Overall Study|Other|8|||
125242497|NCT00303628|450510998|FG001|Overall Study|Other|9|||
125242498|NCT00376506|450510999|FG000|Overall Study|Death|0|||
125242499|NCT00376506|450511000|FG001|Overall Study|Death|2|||
125242500|NCT00776997|450511002|FG000|Overall Study|Adverse Event|2|||
125242501|NCT02948400|450511003|FG000|Overall Study|Withdrawal by Subject|17|||
125242502|NCT02948400|450511004|FG001|Overall Study|Withdrawal by Subject|10|||
125242503|NCT02948400|450511003|FG000|Overall Study|failed to attend appointments|47|||
125242504|NCT02948400|450511004|FG001|Overall Study|failed to attend appointments|34|||
125242505|NCT02948400|450511003|FG000|Overall Study|COVID-related closure|6|||
125242506|NCT02948400|450511004|FG001|Overall Study|COVID-related closure|2|||
125242507|NCT02948400|450511003|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
125242508|NCT02948400|450511004|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
125242509|NCT02948400|450511003|FG000|Overall Study|motion sickness in virtual reality|2|||
125242510|NCT02948400|450511004|FG001|Overall Study|motion sickness in virtual reality|0|||
125242511|NCT02403271|450511005|FG000|Period 1|Other varied reasons|1|||
125242512|NCT02403271|450511006|FG001|Period 1|Other varied reasons|0|||
125242513|NCT02403271|450511005|FG000|Period 2|Withdrawal by Subject|0|||
125242514|NCT02403271|450511006|FG001|Period 2|Withdrawal by Subject|14|||
125242515|NCT02403271|450511005|FG000|Period 2|Death|0|||
125242516|NCT02403271|450511006|FG001|Period 2|Death|84|||
125242517|NCT02403271|450511005|FG000|Period 2|Lost to Follow-up|0|||
125242518|NCT02403271|450511006|FG001|Period 2|Lost to Follow-up|2|||
125242519|NCT02403271|450511005|FG000|Period 2|Study Terminated by Sponsor|0|||
125242520|NCT02403271|450511006|FG001|Period 2|Study Terminated by Sponsor|14|||
125242521|NCT02403271|450511005|FG000|Period 2|Other varied reasons|0|||
125242522|NCT02403271|450511006|FG001|Period 2|Other varied reasons|10|||
125242523|NCT03487445|450511007|FG000|Randomization|Not treated for administrative reasons|1|||
125242524|NCT03487445|450511008|FG001|Randomization|Not treated for administrative reasons|0|||
125242525|NCT00221104|450511009|FG000|Overall Study|Adverse Event|1|||
125242526|NCT00221104|450511010|FG001|Overall Study|Adverse Event|0|||
125242527|NCT00221104|450511009|FG000|Overall Study|Physician Decision|1|||
125242528|NCT00221104|450511010|FG001|Overall Study|Physician Decision|0|||
125242529|NCT00221104|450511009|FG000|Overall Study|Protocol Violation|2|||
125242530|NCT00221104|450511010|FG001|Overall Study|Protocol Violation|0|||
125242531|NCT00221104|450511009|FG000|Overall Study|Withdrawal by Subject|42|||
125242532|NCT00221104|450511010|FG001|Overall Study|Withdrawal by Subject|29|||
125242533|NCT00221104|450511009|FG000|Overall Study|Others|37|||
125242534|NCT00221104|450511010|FG001|Overall Study|Others|47|||
125242535|NCT03301714|450511011|FG000|Overall Study|Lost to Follow-up|10|||
125242536|NCT03301714|450511012|FG001|Overall Study|Lost to Follow-up|4|||
125242537|NCT03301714|450511013|FG002|Overall Study|Lost to Follow-up|4|||
125242538|NCT03301714|450511011|FG000|Overall Study|Did not receive allocated intervention|0|||
125242539|NCT03301714|450511012|FG001|Overall Study|Did not receive allocated intervention|2|||
125242540|NCT03301714|450511013|FG002|Overall Study|Did not receive allocated intervention|3|||
125242541|NCT05324371|450511022|FG000|Overall Study|Withdrawal by Subject|1|||
125242542|NCT05324371|450511022|FG000|Overall Study|Death|1|||
125242543|NCT03599713|450511026|FG000|Overall Study|Death|38|||
125242544|NCT03599713|450511027|FG001|Overall Study|Death|3|||
125242545|NCT03599713|450511026|FG000|Overall Study|Withdrawal by Subject|17|||
125242546|NCT03599713|450511027|FG001|Overall Study|Withdrawal by Subject|0|||
125242547|NCT03599713|450511026|FG000|Overall Study|Lost to Follow-up|4|||
125242548|NCT03599713|450511027|FG001|Overall Study|Lost to Follow-up|0|||
125242549|NCT03599713|450511026|FG000|Overall Study|Discontinued Due to End of Study|42|||
125242550|NCT03599713|450511027|FG001|Overall Study|Discontinued Due to End of Study|3|||
125242551|NCT01127061|450512200|FG000|Overall Study|Lost to Follow-up|7|||
125242552|NCT01127061|450512201|FG001|Overall Study|Lost to Follow-up|10|||
125242553|NCT01127061|450512200|FG000|Overall Study|Physician Decision|3|||
125242554|NCT01127061|450512201|FG001|Overall Study|Physician Decision|3|||
125242555|NCT04827446|450512202|FG000|Overall Study|Lost to Follow-up|1|||
125242556|NCT04827446|450512203|FG001|Overall Study|Lost to Follow-up|1|||
125242557|NCT04827446|450512202|FG000|Overall Study|Death|2|||
125242558|NCT04827446|450512203|FG001|Overall Study|Death|0|||
125242559|NCT04827446|450512202|FG000|Overall Study|Withdrawal by Subject|2|||
125242560|NCT04827446|450512203|FG001|Overall Study|Withdrawal by Subject|2|||
125242561|NCT00003456|450512206|FG000|Overall Study|Not evaluable|8|||
125242562|NCT05399771|450512207|FG000|Overall Study|Physician Decision|3|||
125242563|NCT05399771|450512207|FG000|Overall Study|Adverse Event|1|||
125242564|NCT00143507|450512210|FG000|Overall Study|Death|572|||
125242565|NCT00143507|450512211|FG001|Overall Study|Death|547|||
125242566|NCT00143507|450512210|FG000|Overall Study|Withdrawal by Subject|114|||
125242567|NCT00143507|450512211|FG001|Overall Study|Withdrawal by Subject|102|||
125242568|NCT00143507|450512210|FG000|Overall Study|Lost to Follow-up|1|||
125242569|NCT00143507|450512211|FG001|Overall Study|Lost to Follow-up|0|||
125242570|NCT00143507|450512210|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
125242571|NCT00143507|450512211|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
125242572|NCT00484159|450512212|FG000|Overall Study|Lost to Follow-up|1|||
125242573|NCT00484159|450512213|FG001|Overall Study|Lost to Follow-up|1|||
125242574|NCT00484159|450512214|FG002|Overall Study|Lost to Follow-up|0|||
125242575|NCT03234881|450512215|FG000|Overall Study|Lost to Follow-up|9|||
125242576|NCT03234881|450512216|FG001|Overall Study|Lost to Follow-up|3|||
125242577|NCT02513199|450512219|FG000|Treatment|Death|1|||
125242578|NCT02513199|450512219|FG000|Treatment|Lost to Follow-up|1|||
125242579|NCT02513199|450512219|FG000|Follow-Up|Death|11|||
125242580|NCT00407511|450512231|FG000|Overall Study|Adverse Event|9|||
125242581|NCT00407511|450512231|FG000|Overall Study|Lost to Follow-up|4|||
125242582|NCT00407511|450512231|FG000|Overall Study|Other|5|||
125242583|NCT00407511|450512231|FG000|Overall Study|Withdrawal by Subject|4|||
125242584|NCT00529035|450512232|FG000|Overall Study|Withdrawal by Subject|1|||
125242585|NCT03439514|450512233|FG000|Double-Blind Treatment Period|Other|4|||
125242586|NCT03439514|450512234|FG001|Double-Blind Treatment Period|Other|1|||
125242587|NCT03439514|450512233|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
125242588|NCT03439514|450512234|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
125242589|NCT03439514|450512233|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
125242590|NCT03439514|450512234|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
125242591|NCT03439514|450512233|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
125242592|NCT03439514|450512234|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
125242593|NCT03439514|450512233|FG000|Double-Blind Treatment Period|Death|1|||
125242594|NCT03439514|450512234|FG001|Double-Blind Treatment Period|Death|2|||
125242595|NCT01521364|450512235|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
125242596|NCT01521364|450512235|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
125242597|NCT02175758|450512236|FG000|Treatment Phase|Lost to Follow-up|0|||
125242598|NCT02175758|450512237|FG001|Treatment Phase|Lost to Follow-up|1|||
125242599|NCT02175758|450512238|FG002|Treatment Phase|Lost to Follow-up|0|||
125242600|NCT02175758|450512239|FG003|Treatment Phase|Lost to Follow-up|0|||
125242601|NCT02175758|450512240|FG004|Treatment Phase|Lost to Follow-up|0|||
125242602|NCT02175758|450512241|FG005|Treatment Phase|Lost to Follow-up|0|||
125242603|NCT02175758|450512236|FG000|Treatment Phase|Adverse Event|0|||
125242604|NCT02175758|450512237|FG001|Treatment Phase|Adverse Event|0|||
125242605|NCT02175758|450512238|FG002|Treatment Phase|Adverse Event|0|||
125242606|NCT02175758|450512239|FG003|Treatment Phase|Adverse Event|0|||
125242607|NCT02175758|450512240|FG004|Treatment Phase|Adverse Event|1|||
125242608|NCT02175758|450512241|FG005|Treatment Phase|Adverse Event|0|||
125242609|NCT02636283|450512242|FG000|Overall Study|Adverse Event|2|||
125242610|NCT02636283|450512243|FG001|Overall Study|Adverse Event|0|||
125242611|NCT02636283|450512242|FG000|Overall Study|Trial Terminated Prematurely|0|||
125242612|NCT02636283|450512243|FG001|Overall Study|Trial Terminated Prematurely|3|||
125242613|NCT03927157|450512246|FG000|Overall Study|Adverse Event|1|||
125242614|NCT03927157|450512247|FG001|Overall Study|Adverse Event|3|||
125242615|NCT03927157|450512246|FG000|Overall Study|Protocol Violation|1|||
125242616|NCT03927157|450512247|FG001|Overall Study|Protocol Violation|2|||
125242617|NCT03927157|450512246|FG000|Overall Study|Withdrawal by Subject|8|||
125242618|NCT03927157|450512247|FG001|Overall Study|Withdrawal by Subject|21|||
125242619|NCT03927157|450512246|FG000|Overall Study|Due to COVID-19 pandemic|5|||
125242620|NCT03927157|450512247|FG001|Overall Study|Due to COVID-19 pandemic|2|||
125242621|NCT03927157|450512246|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
125187890|NCT04225715|450308161|FG005|Overall Study|Reason not Specified|0|||
125187891|NCT04225715|450308162|FG006|Overall Study|Reason not Specified|0|||
125187892|NCT04225715|450308163|FG007|Overall Study|Reason not Specified|0|||
125187893|NCT04225715|450308164|FG008|Overall Study|Reason not Specified|0|||
125187894|NCT04225715|450308156|FG000|Overall Study|Protocol Violation|1|||
125187895|NCT04225715|450308157|FG001|Overall Study|Protocol Violation|0|||
125187896|NCT04225715|450308158|FG002|Overall Study|Protocol Violation|0|||
125187897|NCT04225715|450308159|FG003|Overall Study|Protocol Violation|0|||
125187898|NCT04225715|450308160|FG004|Overall Study|Protocol Violation|0|||
125187899|NCT04225715|450308161|FG005|Overall Study|Protocol Violation|9|||
125187900|NCT04225715|450308162|FG006|Overall Study|Protocol Violation|0|||
125187901|NCT04225715|450308163|FG007|Overall Study|Protocol Violation|0|||
125187902|NCT04225715|450308164|FG008|Overall Study|Protocol Violation|0|||
125187903|NCT04225715|450308156|FG000|Overall Study|Withdrawal by Subject|4|||
125187904|NCT04225715|450308157|FG001|Overall Study|Withdrawal by Subject|1|||
125187905|NCT04225715|450308158|FG002|Overall Study|Withdrawal by Subject|1|||
125187906|NCT04225715|450308159|FG003|Overall Study|Withdrawal by Subject|0|||
125187907|NCT04225715|450308160|FG004|Overall Study|Withdrawal by Subject|3|||
125187908|NCT04225715|450308161|FG005|Overall Study|Withdrawal by Subject|1|||
125187909|NCT04225715|450308162|FG006|Overall Study|Withdrawal by Subject|1|||
125187910|NCT04225715|450308163|FG007|Overall Study|Withdrawal by Subject|1|||
125187911|NCT04225715|450308164|FG008|Overall Study|Withdrawal by Subject|0|||
125187912|NCT04225715|450308156|FG000|Overall Study|Adverse Event|0|||
125187913|NCT04225715|450308157|FG001|Overall Study|Adverse Event|0|||
125187914|NCT04225715|450308158|FG002|Overall Study|Adverse Event|0|||
125187915|NCT04225715|450308159|FG003|Overall Study|Adverse Event|0|||
125187916|NCT04225715|450308160|FG004|Overall Study|Adverse Event|0|||
125187917|NCT04225715|450308161|FG005|Overall Study|Adverse Event|0|||
125187918|NCT04225715|450308162|FG006|Overall Study|Adverse Event|0|||
125187919|NCT04225715|450308163|FG007|Overall Study|Adverse Event|0|||
125187920|NCT04225715|450308164|FG008|Overall Study|Adverse Event|1|||
125187921|NCT04225715|450308156|FG000|Overall Study|Arm Terminated By Sponsor|0|||
125187922|NCT04225715|450308157|FG001|Overall Study|Arm Terminated By Sponsor|0|||
125187923|NCT04225715|450308158|FG002|Overall Study|Arm Terminated By Sponsor|0|||
125187924|NCT04225715|450308159|FG003|Overall Study|Arm Terminated By Sponsor|0|||
125187925|NCT04225715|450308160|FG004|Overall Study|Arm Terminated By Sponsor|0|||
125187926|NCT04225715|450308161|FG005|Overall Study|Arm Terminated By Sponsor|0|||
125187927|NCT04225715|450308162|FG006|Overall Study|Arm Terminated By Sponsor|0|||
125187928|NCT04225715|450308163|FG007|Overall Study|Arm Terminated By Sponsor|17|||
125187929|NCT04225715|450308164|FG008|Overall Study|Arm Terminated By Sponsor|18|||
125187930|NCT03318861|450308172|FG000|Overall Study|Death|2|||
125187931|NCT03318861|450308173|FG001|Overall Study|Death|3|||
125187932|NCT03318861|450308174|FG002|Overall Study|Death|3|||
125187933|NCT03318861|450308175|FG003|Overall Study|Death|2|||
125187934|NCT03318861|450308176|FG004|Overall Study|Death|2|||
125187935|NCT03318861|450308172|FG000|Overall Study|Enrolled But Never Treated|0|||
125187936|NCT03318861|450308173|FG001|Overall Study|Enrolled But Never Treated|1|||
125187937|NCT03318861|450308174|FG002|Overall Study|Enrolled But Never Treated|0|||
125187938|NCT03318861|450308175|FG003|Overall Study|Enrolled But Never Treated|1|||
125187939|NCT03318861|450308176|FG004|Overall Study|Enrolled But Never Treated|1|||
125187940|NCT03318861|450308172|FG000|Overall Study|Informed Consent Withdraw|0|||
125187941|NCT03318861|450308173|FG001|Overall Study|Informed Consent Withdraw|0|||
125187942|NCT03318861|450308174|FG002|Overall Study|Informed Consent Withdraw|0|||
125187943|NCT03318861|450308175|FG003|Overall Study|Informed Consent Withdraw|1|||
125187944|NCT03318861|450308176|FG004|Overall Study|Informed Consent Withdraw|0|||
125187945|NCT03318861|450308172|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
125187946|NCT03318861|450308173|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
125187947|NCT03318861|450308174|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
125187948|NCT03318861|450308175|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
125187949|NCT03318861|450308176|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
125187950|NCT00917852|450308177|FG000|Overall Study|Death|6|||
125187951|NCT00471081|450308178|FG000|Active Phase|Protocol Violation|1|||
125187952|NCT00471081|450308179|FG001|Active Phase|Protocol Violation|1|||
125187953|NCT00471081|450308178|FG000|Active Phase|Withdrawal by Subject|0|||
125187954|NCT00471081|450308179|FG001|Active Phase|Withdrawal by Subject|3|||
125187955|NCT00471081|450308178|FG000|Active Phase|Lost to Follow-up|0|||
125187956|NCT00471081|450308179|FG001|Active Phase|Lost to Follow-up|1|||
125187957|NCT00471081|450308178|FG000|Active Phase|Lost health plan/insurance|1|||
125187958|NCT00471081|450308179|FG001|Active Phase|Lost health plan/insurance|8|||
125187959|NCT00471081|450308178|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
125187960|NCT00471081|450308179|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
125187961|NCT00471081|450308178|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
125187962|NCT00471081|450308179|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
125187963|NCT00471081|450308178|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
125187964|NCT00471081|450308179|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
125187965|NCT02844933|450308180|FG000|Overall Study|Discontinued due to premature termination of study|3|||
125242622|NCT03927157|450512247|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
125242623|NCT03927157|450512246|FG000|Overall Study|Other than above|0|||
125242624|NCT03927157|450512247|FG001|Overall Study|Other than above|1|||
125242625|NCT00726557|450512248|FG000|Overall Study|Screening failure|4|||
125242626|NCT00726557|450512248|FG000|Overall Study|No end of treatment documentation|37|||
125242627|NCT00726557|450512248|FG000|Overall Study|No follow-up documentation available|55|||
125242628|NCT00726557|450512248|FG000|Overall Study|Treatment less than 3 months|17|||
125242629|NCT00726557|450512248|FG000|Overall Study|Inclusion criteria not met|15|||
125242630|NCT01239745|450512249|FG000|Overall Study|Study terminated by sponsor|45|||
125242631|NCT01239745|450512249|FG000|Overall Study|Adverse Event|1|||
125242632|NCT00081458|450512250|FG000|Overall Study|Adverse Event|1|||
125242633|NCT00081458|450512251|FG001|Overall Study|Adverse Event|5|||
125242634|NCT00081458|450512252|FG002|Overall Study|Adverse Event|2|||
125242635|NCT00081458|450512250|FG000|Overall Study|Withdrawal by Subject|0|||
125242636|NCT00081458|450512251|FG001|Overall Study|Withdrawal by Subject|3|||
125242637|NCT00081458|450512252|FG002|Overall Study|Withdrawal by Subject|1|||
125242638|NCT00081458|450512250|FG000|Overall Study|Randomized but not dosed|0|||
125242639|NCT00081458|450512251|FG001|Overall Study|Randomized but not dosed|0|||
125242640|NCT00081458|450512252|FG002|Overall Study|Randomized but not dosed|1|||
125242641|NCT03384966|450512253|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
125242642|NCT03384966|450512254|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
125242643|NCT03384966|450512255|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
125242644|NCT03384966|450512253|FG000|Follow-up Period|Adverse Event|1|||
125242645|NCT03384966|450512254|FG001|Follow-up Period|Adverse Event|0|||
125242646|NCT03384966|450512255|FG002|Follow-up Period|Adverse Event|0|||
125242647|NCT02202616|450512256|FG000|Overall Study|Screen failed|24|||
125242648|NCT02202616|450512256|FG000|Overall Study|Adverse Event|32|||
125242649|NCT02202616|450512256|FG000|Overall Study|Protocol deviation|18|||
125242650|NCT02202616|450512256|FG000|Overall Study|Patient withdrew consent|12|||
125242651|NCT02202616|450512256|FG000|Overall Study|Lost to Follow-up|6|||
125242652|NCT02202616|450512256|FG000|Overall Study|Administrative problems|6|||
125242653|NCT02202616|450512256|FG000|Overall Study|Abnormal test procedure result|1|||
125242654|NCT02202616|450512256|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125242655|NCT01334515|450512257|FG000|Overall Study|Adverse Event|1|||
125242656|NCT01334515|450512258|FG001|Overall Study|Adverse Event|6|||
125242657|NCT01334515|450512257|FG000|Overall Study|Death|1|||
125242658|NCT01334515|450512258|FG001|Overall Study|Death|0|||
125242659|NCT01334515|450512257|FG000|Overall Study|Lack of Efficacy|8|||
125242660|NCT01334515|450512258|FG001|Overall Study|Lack of Efficacy|21|||
125242661|NCT01334515|450512257|FG000|Overall Study|Physician Decision|1|||
125242662|NCT01334515|450512258|FG001|Overall Study|Physician Decision|1|||
125242663|NCT01334515|450512257|FG000|Overall Study|Withdrawal by Subject|1|||
125242664|NCT01334515|450512258|FG001|Overall Study|Withdrawal by Subject|1|||
125242665|NCT02836769|450512262|FG000|Overall Study|Lost to Follow-up|10|||
125242666|NCT02836769|450512262|FG000|Overall Study|Medical withdrawal|2|||
125242667|NCT02836769|450512262|FG000|Overall Study|Withdrawal by Subject|3|||
125242668|NCT02989389|450512272|FG000|Period 1|Lost to Follow-up|0|||
125242669|NCT02989389|450512273|FG001|Period 1|Lost to Follow-up|1|||
125242670|NCT02989389|450512274|FG002|Period 1|Lost to Follow-up|0|||
125242671|NCT02989389|450512275|FG003|Period 1|Lost to Follow-up|0|||
125242672|NCT02989389|450512276|FG004|Period 1|Lost to Follow-up|0|||
125242673|NCT02989389|450512277|FG005|Period 1|Lost to Follow-up|0|||
125242674|NCT02989389|450512278|FG006|Period 1|Lost to Follow-up|0|||
125242675|NCT02989389|450512279|FG007|Period 1|Lost to Follow-up|0|||
125242676|NCT02989389|450512280|FG008|Period 1|Lost to Follow-up|0|||
125242677|NCT02989389|450512281|FG009|Period 1|Lost to Follow-up|0|||
125242678|NCT02989389|450512272|FG000|Period 1|Physician Decision|0|||
125242679|NCT02989389|450512273|FG001|Period 1|Physician Decision|0|||
125242680|NCT02989389|450512274|FG002|Period 1|Physician Decision|0|||
125242681|NCT02989389|450512275|FG003|Period 1|Physician Decision|0|||
125242682|NCT02989389|450512276|FG004|Period 1|Physician Decision|0|||
125242683|NCT02989389|450512277|FG005|Period 1|Physician Decision|0|||
125242684|NCT02989389|450512278|FG006|Period 1|Physician Decision|0|||
125242685|NCT02989389|450512279|FG007|Period 1|Physician Decision|0|||
125242686|NCT02989389|450512280|FG008|Period 1|Physician Decision|1|||
125242687|NCT02989389|450512281|FG009|Period 1|Physician Decision|0|||
125242688|NCT00374868|450512282|FG000|Overall Study|Adverse Event|12|||
125187966|NCT02844933|450308181|FG001|Overall Study|Discontinued due to premature termination of study|2|||
125187967|NCT04537078|450308182|FG000|Overall Study|Protocol Violation|3|||
125187968|NCT04537078|450308183|FG001|Overall Study|Protocol Violation|2|||
125187969|NCT04537078|450308182|FG000|Overall Study|Lost to Follow-up|1|||
125187970|NCT04537078|450308183|FG001|Overall Study|Lost to Follow-up|0|||
125187971|NCT04537078|450308182|FG000|Overall Study|Withdrawal by Subject|0|||
125187972|NCT04537078|450308183|FG001|Overall Study|Withdrawal by Subject|1|||
125187973|NCT01568892|450308184|FG000|Open-label Phase|Adverse Event|2|||
125187974|NCT01568892|450308185|FG001|Open-label Phase|Adverse Event|0|||
125187975|NCT01568892|450308184|FG000|Open-label Phase|Lack of Efficacy|4|||
125187976|NCT01568892|450308185|FG001|Open-label Phase|Lack of Efficacy|2|||
125187977|NCT01568892|450308184|FG000|Open-label Phase|Lost to Follow-up|0|||
125187978|NCT01568892|450308185|FG001|Open-label Phase|Lost to Follow-up|1|||
125187979|NCT01704495|450308193|FG000|Subjects Randomized|Other Reason|3|||
125187980|NCT01704495|450308194|FG001|Subjects Randomized|Other Reason|2|||
125187981|NCT01704495|450308195|FG002|Subjects Randomized|Other Reason|3|||
125187982|NCT01704495|450308196|FG003|Subjects Randomized|Other Reason|2|||
125187983|NCT01704495|450308193|FG000|Subjects Randomized|Discontinuation criteria met|4|||
125187984|NCT01704495|450308194|FG001|Subjects Randomized|Discontinuation criteria met|2|||
125187985|NCT01704495|450308195|FG002|Subjects Randomized|Discontinuation criteria met|2|||
125187986|NCT01704495|450308196|FG003|Subjects Randomized|Discontinuation criteria met|0|||
125187987|NCT01704495|450308193|FG000|Subjects Randomized|Adverse Event|8|||
125187988|NCT01704495|450308194|FG001|Subjects Randomized|Adverse Event|2|||
125187989|NCT01704495|450308195|FG002|Subjects Randomized|Adverse Event|0|||
125187990|NCT01704495|450308196|FG003|Subjects Randomized|Adverse Event|7|||
125187991|NCT01704495|450308193|FG000|Subjects Randomized|Withdrawal by Subject|5|||
125187992|NCT01704495|450308194|FG001|Subjects Randomized|Withdrawal by Subject|5|||
125187993|NCT01704495|450308195|FG002|Subjects Randomized|Withdrawal by Subject|5|||
125187994|NCT01704495|450308196|FG003|Subjects Randomized|Withdrawal by Subject|5|||
125187995|NCT01704495|450308193|FG000|Subjects Randomized|Protocol Violation|1|||
125242689|NCT00374868|450512282|FG000|Overall Study|Progressive Disease|7|||
125187996|NCT01704495|450308194|FG001|Subjects Randomized|Protocol Violation|1|||
125187997|NCT01704495|450308195|FG002|Subjects Randomized|Protocol Violation|2|||
125187998|NCT01704495|450308196|FG003|Subjects Randomized|Protocol Violation|0|||
125187999|NCT01704495|450308193|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
125188000|NCT01704495|450308194|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
125188001|NCT01704495|450308195|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
125188002|NCT01704495|450308196|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
125188003|NCT01704495|450308193|FG000|Optional Safety Extension|Adverse Event|0|||
125188004|NCT01704495|450308194|FG001|Optional Safety Extension|Adverse Event|4|||
125188005|NCT01704495|450308195|FG002|Optional Safety Extension|Adverse Event|0|||
125188006|NCT01704495|450308196|FG003|Optional Safety Extension|Adverse Event|1|||
125188007|NCT01704495|450308193|FG000|Optional Safety Extension|Other reason|27|||
125188008|NCT01704495|450308194|FG001|Optional Safety Extension|Other reason|29|||
125188009|NCT01704495|450308195|FG002|Optional Safety Extension|Other reason|30|||
125188010|NCT01704495|450308196|FG003|Optional Safety Extension|Other reason|28|||
125188011|NCT01704495|450308193|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
125188012|NCT01704495|450308194|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
125188013|NCT01704495|450308195|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
125188014|NCT01704495|450308196|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
125188015|NCT00997373|450308201|FG000|Overall Study|Withdrawal by Subject|5|||
125188016|NCT00997373|450308202|FG001|Overall Study|Withdrawal by Subject|0|||
125188017|NCT00997373|450308201|FG000|Overall Study|wrong tumor type|4|||
125188018|NCT00997373|450308202|FG001|Overall Study|wrong tumor type|0|||
125188019|NCT00997373|450308201|FG000|Overall Study|could not have hysterectomy|6|||
125188020|NCT00997373|450308202|FG001|Overall Study|could not have hysterectomy|0|||
125188021|NCT01592786|450308204|FG000|Overall Study|Adverse Event|60|||
125188022|NCT01592786|450308204|FG000|Overall Study|Lack of Efficacy|19|||
125188023|NCT01592786|450308204|FG000|Overall Study|Protocol Violation|14|||
125188024|NCT01592786|450308204|FG000|Overall Study|Withdrawal by Subject|23|||
125188025|NCT01592786|450308204|FG000|Overall Study|Lost to Follow-up|19|||
125188026|NCT01592786|450308204|FG000|Overall Study|Other|3|||
125188027|NCT02172664|450308207|FG000|Overall Study|Lost to Follow-up|4|||
125188028|NCT02172664|450308208|FG001|Overall Study|Lost to Follow-up|4|||
125188029|NCT02172664|450308207|FG000|Overall Study|Death|1|||
125188030|NCT02172664|450308208|FG001|Overall Study|Death|1|||
125188031|NCT02172664|450308207|FG000|Overall Study|Moved out of area|1|||
125188032|NCT02172664|450308208|FG001|Overall Study|Moved out of area|1|||
125188033|NCT03810092|450308209|FG000|Overall Study|no ground support|17|||
125188034|NCT03810092|450308209|FG000|Overall Study|ADL not done at J0|16|||
125188035|NCT03810092|450308209|FG000|Overall Study|No hemoglobin measure at J5|27|||
125188036|NCT02492867|450308214|FG000|Overall Study|Alternate therapy|1|||
125188037|NCT02492867|450308214|FG000|Overall Study|Withdrawal by Subject|2|||
125188038|NCT02492867|450308214|FG000|Overall Study|Disease progression after treatment started|1|||
125188039|NCT02492867|450308214|FG000|Overall Study|Death|1|||
125188040|NCT03296527|450308215|FG000|Overall Study|Adverse Event|15|||
125188041|NCT03296527|450308216|FG001|Overall Study|Adverse Event|33|||
125188042|NCT03296527|450308215|FG000|Overall Study|Protocol Deviation|4|||
125188043|NCT03296527|450308216|FG001|Overall Study|Protocol Deviation|0|||
125188044|NCT03296527|450308215|FG000|Overall Study|Participant withdrew consent|3|||
125188045|NCT03296527|450308216|FG001|Overall Study|Participant withdrew consent|1|||
125188046|NCT03296527|450308215|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
125188047|NCT03296527|450308216|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
125188048|NCT03296527|450308215|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
125188049|NCT03296527|450308216|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
125188050|NCT03296527|450308215|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
125188051|NCT03296527|450308216|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
125188052|NCT03296527|450308215|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
125188053|NCT03296527|450308216|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
125188054|NCT03296527|450308215|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
125188055|NCT03296527|450308216|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
125188056|NCT00122382|450308217|FG000|Double-Blind Study|Adverse Event|9|||
125188057|NCT00122382|450308218|FG001|Double-Blind Study|Adverse Event|11|||
125188058|NCT00122382|450308219|FG002|Double-Blind Study|Adverse Event|0|||
125188059|NCT00122382|450308217|FG000|Double-Blind Study|Death|2|||
125188060|NCT00122382|450308218|FG001|Double-Blind Study|Death|2|||
125188061|NCT00122382|450308219|FG002|Double-Blind Study|Death|0|||
125188062|NCT00122382|450308217|FG000|Double-Blind Study|Lack of Efficacy|0|||
125188063|NCT00122382|450308218|FG001|Double-Blind Study|Lack of Efficacy|8|||
125188064|NCT00122382|450308219|FG002|Double-Blind Study|Lack of Efficacy|0|||
125188065|NCT00122382|450308217|FG000|Double-Blind Study|Lost to Follow-up|2|||
125188066|NCT00122382|450308218|FG001|Double-Blind Study|Lost to Follow-up|1|||
125188067|NCT00122382|450308219|FG002|Double-Blind Study|Lost to Follow-up|0|||
125188068|NCT00122382|450308217|FG000|Double-Blind Study|Pregnancy|2|||
125188069|NCT00122382|450308218|FG001|Double-Blind Study|Pregnancy|0|||
125188070|NCT00122382|450308219|FG002|Double-Blind Study|Pregnancy|0|||
125188071|NCT00122382|450308217|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
125188072|NCT00122382|450308218|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
125188073|NCT00122382|450308219|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
125188074|NCT00122382|450308217|FG000|Double-Blind Study|Withdrawal of Consent|7|||
125188075|NCT00122382|450308218|FG001|Double-Blind Study|Withdrawal of Consent|3|||
125188076|NCT00122382|450308219|FG002|Double-Blind Study|Withdrawal of Consent|0|||
125188077|NCT00122382|450308217|FG000|Double-Blind Study|Protocol Violation|1|||
125188078|NCT00122382|450308218|FG001|Double-Blind Study|Protocol Violation|0|||
125188079|NCT00122382|450308219|FG002|Double-Blind Study|Protocol Violation|0|||
125188080|NCT00122382|450308217|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
125188081|NCT00122382|450308218|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
125188082|NCT00122382|450308219|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
125188083|NCT00122382|450308217|FG000|Double-Blind Study|Randomized but not treated|0|||
125188084|NCT00122382|450308218|FG001|Double-Blind Study|Randomized but not treated|2|||
125188085|NCT00122382|450308219|FG002|Double-Blind Study|Randomized but not treated|0|||
125188086|NCT00122382|450308217|FG000|Open-Label Study|Adverse Event|0|||
125188087|NCT00122382|450308218|FG001|Open-Label Study|Adverse Event|0|||
125188088|NCT00122382|450308219|FG002|Open-Label Study|Adverse Event|11|||
125188089|NCT00122382|450308217|FG000|Open-Label Study|Death|0|||
125188090|NCT00122382|450308218|FG001|Open-Label Study|Death|0|||
125188091|NCT00122382|450308219|FG002|Open-Label Study|Death|2|||
125188092|NCT00122382|450308217|FG000|Open-Label Study|Lack of Efficacy|0|||
125188093|NCT00122382|450308218|FG001|Open-Label Study|Lack of Efficacy|0|||
125188094|NCT00122382|450308219|FG002|Open-Label Study|Lack of Efficacy|3|||
125188095|NCT00122382|450308217|FG000|Open-Label Study|Lost to Follow-up|0|||
125188096|NCT00122382|450308218|FG001|Open-Label Study|Lost to Follow-up|0|||
125188097|NCT00122382|450308219|FG002|Open-Label Study|Lost to Follow-up|3|||
125188098|NCT00122382|450308217|FG000|Open-Label Study|Pregnancy|0|||
125188099|NCT00122382|450308218|FG001|Open-Label Study|Pregnancy|0|||
125188100|NCT00122382|450308219|FG002|Open-Label Study|Pregnancy|2|||
125188101|NCT00122382|450308217|FG000|Open-Label Study|Poor/Non-Compliance|0|||
125188102|NCT00122382|450308218|FG001|Open-Label Study|Poor/Non-Compliance|0|||
125188103|NCT00122382|450308219|FG002|Open-Label Study|Poor/Non-Compliance|1|||
125188104|NCT00122382|450308217|FG000|Open-Label Study|Withdrawal of Consent|0|||
125188105|NCT00122382|450308218|FG001|Open-Label Study|Withdrawal of Consent|0|||
125188106|NCT00122382|450308219|FG002|Open-Label Study|Withdrawal of Consent|4|||
125188107|NCT02040805|450308220|FG000|Overall Study|Lost to Follow-up|14|||
125188108|NCT02040805|450308221|FG001|Overall Study|Lost to Follow-up|9|||
125188109|NCT02040805|450308220|FG000|Overall Study|Withdrawal by Subject|28|||
125188110|NCT02040805|450308221|FG001|Overall Study|Withdrawal by Subject|41|||
125188111|NCT01213966|450308223|FG000|Overall Study|Protocol Violation|1|||
125188112|NCT01213966|450308224|FG001|Overall Study|Protocol Violation|0|||
125188113|NCT01213966|450308225|FG002|Overall Study|Protocol Violation|3|||
125188114|NCT01213966|450308226|FG003|Overall Study|Protocol Violation|1|||
125188115|NCT03591874|450308227|FG000|Overall Study|Adverse Event|4|||
125188116|NCT03591874|450308228|FG001|Overall Study|Adverse Event|0|||
125188117|NCT03591874|450308227|FG000|Overall Study|Withdrawal by Subject|2|||
125188118|NCT03591874|450308228|FG001|Overall Study|Withdrawal by Subject|1|||
125188119|NCT03591874|450308227|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
125188120|NCT03591874|450308228|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
125188121|NCT03591874|450308227|FG000|Overall Study|On Study at Time of Study Termination|12|||
125188122|NCT03591874|450308228|FG001|Overall Study|On Study at Time of Study Termination|6|||
125188123|NCT03644342|450308231|FG000|Overall Study|Adverse Event|2|||
125188124|NCT03644342|450308232|FG001|Overall Study|Adverse Event|0|||
125188125|NCT03644342|450308231|FG000|Overall Study|Protocol Violation|0|||
125188126|NCT03644342|450308232|FG001|Overall Study|Protocol Violation|1|||
125188127|NCT04762160|450308235|FG000|Overall Study|Study terminated early due to business reasons|5|||
125188128|NCT01205776|450308238|FG000|Overall Study|Lost to Follow-up|53|||
125188129|NCT01205776|450308239|FG001|Overall Study|Lost to Follow-up|61|||
125188130|NCT01205776|450308238|FG000|Overall Study|Withdrawal by Subject|11|||
125188131|NCT01205776|450308239|FG001|Overall Study|Withdrawal by Subject|34|||
125188132|NCT00734994|450308240|FG000|Overall Study|Withdrawal by Subject|1|||
125188133|NCT01622673|450308243|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125188134|NCT01622673|450308244|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125188135|NCT01622673|450308245|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125188136|NCT01622673|450308246|FG003|Treatment Period 1|Withdrawal by Subject|1|||
125188137|NCT01622673|450308247|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125188138|NCT01622673|450308248|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125188139|NCT01622673|450308243|FG000|Treatment Period 1|Protocol Violation|0|||
125188140|NCT01622673|450308244|FG001|Treatment Period 1|Protocol Violation|1|||
125188141|NCT01622673|450308245|FG002|Treatment Period 1|Protocol Violation|0|||
125188142|NCT01622673|450308246|FG003|Treatment Period 1|Protocol Violation|0|||
125188143|NCT01622673|450308247|FG004|Treatment Period 1|Protocol Violation|0|||
125188144|NCT01622673|450308248|FG005|Treatment Period 1|Protocol Violation|0|||
125188145|NCT01622673|450308243|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125188146|NCT01622673|450308244|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125188147|NCT01622673|450308245|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125188148|NCT01622673|450308246|FG003|Treatment Period 2|Withdrawal by Subject|1|||
125188149|NCT01622673|450308247|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125188150|NCT01622673|450308248|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125188151|NCT01622673|450308243|FG000|Treatment Period 3|Protocol Violation|0|||
125188152|NCT01622673|450308244|FG001|Treatment Period 3|Protocol Violation|1|||
125188153|NCT01622673|450308245|FG002|Treatment Period 3|Protocol Violation|0|||
125188154|NCT01622673|450308246|FG003|Treatment Period 3|Protocol Violation|0|||
125188155|NCT01622673|450308247|FG004|Treatment Period 3|Protocol Violation|0|||
125188156|NCT01622673|450308248|FG005|Treatment Period 3|Protocol Violation|0|||
125188157|NCT04146012|450308249|FG000|Overall Study|Study Terminated|30|||
125188158|NCT04146012|450308250|FG001|Overall Study|Study Terminated|15|||
125188159|NCT05514873|450308251|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
125188160|NCT05514873|450308251|FG000|Main Treatment Period|Adverse Event|2|||
125188161|NCT05514873|450308251|FG000|Extension Treatment Period|Lost to Follow-up|3|||
125188162|NCT02747108|450308254|FG000|Overall Study|Death|2|||
125188163|NCT02747108|450308255|FG001|Overall Study|Death|2|||
125188164|NCT02747108|450308254|FG000|Overall Study|Withdrawal by Subject|1|||
125188165|NCT02747108|450308255|FG001|Overall Study|Withdrawal by Subject|0|||
125188166|NCT02747108|450308254|FG000|Overall Study|Protocol Violation|2|||
125188167|NCT02747108|450308255|FG001|Overall Study|Protocol Violation|0|||
125188168|NCT00437021|450309110|FG000|Overall Study|Adverse Event|0|||
125188169|NCT00437021|450309111|FG001|Overall Study|Adverse Event|0|||
125188170|NCT00437021|450309112|FG002|Overall Study|Adverse Event|0|||
125188171|NCT00437021|450309113|FG003|Overall Study|Adverse Event|0|||
125188172|NCT00437021|450309114|FG004|Overall Study|Adverse Event|0|||
125188173|NCT00437021|450309115|FG005|Overall Study|Adverse Event|0|||
125188174|NCT00437021|450309116|FG006|Overall Study|Adverse Event|1|||
125188175|NCT00437021|450309117|FG007|Overall Study|Adverse Event|0|||
125188176|NCT00437021|450309118|FG008|Overall Study|Adverse Event|0|||
125188177|NCT00437021|450309119|FG009|Overall Study|Adverse Event|0|||
125188178|NCT00437021|450309120|FG010|Overall Study|Adverse Event|0|||
125188179|NCT00437021|450309121|FG011|Overall Study|Adverse Event|0|||
125188180|NCT00437021|450309110|FG000|Overall Study|Lost to Follow-up|0|||
125188181|NCT00437021|450309111|FG001|Overall Study|Lost to Follow-up|3|||
125188182|NCT00437021|450309112|FG002|Overall Study|Lost to Follow-up|0|||
125188183|NCT00437021|450309113|FG003|Overall Study|Lost to Follow-up|0|||
125188184|NCT00437021|450309114|FG004|Overall Study|Lost to Follow-up|0|||
125188185|NCT00437021|450309115|FG005|Overall Study|Lost to Follow-up|2|||
125188186|NCT00437021|450309116|FG006|Overall Study|Lost to Follow-up|0|||
125188187|NCT00437021|450309117|FG007|Overall Study|Lost to Follow-up|1|||
125188188|NCT00437021|450309118|FG008|Overall Study|Lost to Follow-up|0|||
125188189|NCT00437021|450309119|FG009|Overall Study|Lost to Follow-up|0|||
125188190|NCT00437021|450309120|FG010|Overall Study|Lost to Follow-up|0|||
125188191|NCT00437021|450309121|FG011|Overall Study|Lost to Follow-up|0|||
125188192|NCT00437021|450309110|FG000|Overall Study|Withdrawal by Subject|2|||
125188193|NCT00437021|450309111|FG001|Overall Study|Withdrawal by Subject|1|||
125188194|NCT00437021|450309112|FG002|Overall Study|Withdrawal by Subject|0|||
125188195|NCT00437021|450309113|FG003|Overall Study|Withdrawal by Subject|0|||
125188196|NCT00437021|450309114|FG004|Overall Study|Withdrawal by Subject|0|||
125188197|NCT00437021|450309115|FG005|Overall Study|Withdrawal by Subject|0|||
125188198|NCT00437021|450309116|FG006|Overall Study|Withdrawal by Subject|0|||
125188199|NCT00437021|450309117|FG007|Overall Study|Withdrawal by Subject|0|||
125188200|NCT00437021|450309118|FG008|Overall Study|Withdrawal by Subject|0|||
125188201|NCT00437021|450309119|FG009|Overall Study|Withdrawal by Subject|0|||
125188202|NCT00437021|450309120|FG010|Overall Study|Withdrawal by Subject|0|||
125188203|NCT00437021|450309121|FG011|Overall Study|Withdrawal by Subject|0|||
125188204|NCT05573464|450309122|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
125188205|NCT05573464|450309123|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
125188206|NCT05573464|450309122|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
125188207|NCT05573464|450309123|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
125188208|NCT05573464|450309122|FG000|12-week Treatment Period|Protocol Violation|3|||
125188209|NCT05573464|450309123|FG001|12-week Treatment Period|Protocol Violation|1|||
125188210|NCT05573464|450309122|FG000|12-week Treatment Period|Physician Decision|1|||
125188211|NCT05573464|450309123|FG001|12-week Treatment Period|Physician Decision|2|||
125188212|NCT05573464|450309122|FG000|12-week Treatment Period|Lost to Follow-up|2|||
125188213|NCT05573464|450309123|FG001|12-week Treatment Period|Lost to Follow-up|0|||
125188214|NCT05573464|450309122|FG000|12-week Treatment Period|Adverse Event|20|||
125188215|NCT05573464|450309123|FG001|12-week Treatment Period|Adverse Event|9|||
125188216|NCT05573464|450309122|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
125188217|NCT05573464|450309123|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
125188218|NCT05573464|450309122|FG000|12-week Treatment Period|Randomised, not treated|0|||
125188219|NCT05573464|450309123|FG001|12-week Treatment Period|Randomised, not treated|1|||
125188220|NCT05573464|450309122|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
125188221|NCT05573464|450309123|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
125188222|NCT05573464|450309122|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
125188223|NCT05573464|450309123|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
125188224|NCT05573464|450309122|FG000|52-week Treatment Period|Protocol Violation|1|||
125242690|NCT00374868|450512282|FG000|Overall Study|Physician Decision|13|||
125242691|NCT00374868|450512282|FG000|Overall Study|Lost to Follow-up|1|||
125242692|NCT00374868|450512282|FG000|Overall Study|Death|2|||
125188225|NCT05573464|450309123|FG001|52-week Treatment Period|Protocol Violation|1|||
125188226|NCT05573464|450309122|FG000|52-week Treatment Period|Physician Decision|2|||
125188227|NCT05573464|450309123|FG001|52-week Treatment Period|Physician Decision|2|||
125242693|NCT00374868|450512282|FG000|Overall Study|Other - Not Specified|1|||
125242694|NCT04470427|450512283|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
125242695|NCT04470427|450512284|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
125242696|NCT04470427|450512285|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
125188228|NCT05573464|450309122|FG000|52-week Treatment Period|Lost to Follow-up|1|||
125188229|NCT05573464|450309123|FG001|52-week Treatment Period|Lost to Follow-up|1|||
125188230|NCT05573464|450309122|FG000|52-week Treatment Period|Adverse Event|11|||
125188231|NCT05573464|450309123|FG001|52-week Treatment Period|Adverse Event|8|||
125188232|NCT05573464|450309122|FG000|52-week Treatment Period|Death|1|||
125188233|NCT05573464|450309123|FG001|52-week Treatment Period|Death|1|||
125188234|NCT05734157|450309124|FG000|Overall Study|Death|3|||
125188235|NCT05734157|450309124|FG000|Overall Study|Withdrawal by Subject|2|||
125188236|NCT05734157|450309124|FG000|Overall Study|Lost to Follow-up|1|||
125188237|NCT05734157|450309124|FG000|Overall Study|Telephone call|3|||
125188238|NCT02275546|450309135|FG000|Treatment Period 2|Withdrawal by Subject|2|||
125188239|NCT02275546|450309136|FG001|Treatment Period 2|Withdrawal by Subject|1|||
125188240|NCT02275546|450309135|FG000|Treatment Period 2|Protocol Violation|0|||
125188241|NCT02275546|450309136|FG001|Treatment Period 2|Protocol Violation|1|||
125188242|NCT02955355|450309137|FG000|Overall Study|Adverse Event|4|||
125188243|NCT02955355|450309137|FG000|Overall Study|Death|1|||
125188244|NCT02955355|450309137|FG000|Overall Study|Physician Decision|21|||
125188245|NCT02955355|450309137|FG000|Overall Study|Site Terminated by Sponsor|35|||
125188246|NCT02955355|450309137|FG000|Overall Study|Withdrawal by Subject|19|||
125188247|NCT02955355|450309137|FG000|Overall Study|Reason Not Specified|5|||
125188248|NCT02612623|450309138|FG000|Overall Study|Withdrawal by Subject|0|||
125188249|NCT02612623|450309139|FG001|Overall Study|Withdrawal by Subject|1|||
125188250|NCT02612623|450309140|FG002|Overall Study|Withdrawal by Subject|0|||
125188251|NCT02612623|450309141|FG003|Overall Study|Withdrawal by Subject|0|||
125188252|NCT02612623|450309138|FG000|Overall Study|Adverse Event|1|||
125188253|NCT02612623|450309139|FG001|Overall Study|Adverse Event|0|||
125188254|NCT02612623|450309140|FG002|Overall Study|Adverse Event|1|||
125188255|NCT02612623|450309141|FG003|Overall Study|Adverse Event|0|||
125188256|NCT05177484|450309142|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
125188257|NCT05177484|450309143|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
125188258|NCT05177484|450309142|FG000|Overall Study|Inadvertently withdrawn|3|||
125188259|NCT05177484|450309143|FG001|Overall Study|Inadvertently withdrawn|1|||
125188260|NCT05177484|450309142|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
125188261|NCT05177484|450309143|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
125188262|NCT05486091|450309148|FG000|Overall Study|Withdrawal by Subject|1|||
125188263|NCT05486091|450309148|FG000|Overall Study|Lost to Follow-up|2|||
125188264|NCT03971071|450309149|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
125188265|NCT03971071|450309150|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
125188266|NCT03971071|450309151|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
125188267|NCT03971071|450309152|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
125188268|NCT03971071|450309153|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
125188269|NCT03971071|450309149|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
125188270|NCT03971071|450309150|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
125188271|NCT03971071|450309151|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
125188272|NCT03971071|450309152|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
125188273|NCT03971071|450309153|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
125188274|NCT03971071|450309149|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
125188275|NCT03971071|450309150|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
125188276|NCT03971071|450309151|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
125188277|NCT03971071|450309152|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
125188278|NCT03971071|450309153|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
125188279|NCT03971071|450309149|FG000|Open-label Treatment Period|Sponsor decision|0|||
125188280|NCT03971071|450309150|FG001|Open-label Treatment Period|Sponsor decision|0|||
125242697|NCT04470427|450512286|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
125242698|NCT04470427|450512287|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
125188281|NCT03971071|450309151|FG002|Open-label Treatment Period|Sponsor decision|0|||
125188282|NCT03971071|450309152|FG003|Open-label Treatment Period|Sponsor decision|0|||
125188283|NCT03971071|450309153|FG004|Open-label Treatment Period|Sponsor decision|1|||
125242699|NCT04470427|450512288|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
125242700|NCT04470427|450512283|FG000|Part B :Open-label|Other than specified|0|||
125242701|NCT04470427|450512284|FG001|Part B :Open-label|Other than specified|0|||
125242702|NCT04470427|450512285|FG002|Part B :Open-label|Other than specified|788|||
125242703|NCT04470427|450512286|FG003|Part B :Open-label|Other than specified|0|||
125242704|NCT04470427|450512287|FG004|Part B :Open-label|Other than specified|523|||
125242705|NCT04470427|450512288|FG005|Part B :Open-label|Other than specified|0|||
125242706|NCT04470427|450512283|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
125242707|NCT04470427|450512284|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
125242708|NCT04470427|450512285|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
125242709|NCT04470427|450512286|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
125242710|NCT04470427|450512287|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
125242711|NCT04470427|450512288|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
125242712|NCT04470427|450512283|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
125242713|NCT04470427|450512284|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
125242714|NCT04470427|450512285|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
125242715|NCT04470427|450512286|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
125242716|NCT04470427|450512287|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
125242717|NCT04470427|450512288|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
125242718|NCT01179516|450512289|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
125242719|NCT01179516|450512290|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
125242720|NCT01179516|450512291|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
125242721|NCT01179516|450512289|FG000|Overall Study|Lack of Efficacy|4|||
125242722|NCT01179516|450512290|FG001|Overall Study|Lack of Efficacy|2|||
125242723|NCT01179516|450512291|FG002|Overall Study|Lack of Efficacy|0|||
125242724|NCT01179516|450512289|FG000|Overall Study|Noncompliance with Study Drug|2|||
125242725|NCT01179516|450512290|FG001|Overall Study|Noncompliance with Study Drug|0|||
125242726|NCT01179516|450512291|FG002|Overall Study|Noncompliance with Study Drug|1|||
125242727|NCT01179516|450512289|FG000|Overall Study|Protocol Deviations|4|||
125242728|NCT01179516|450512290|FG001|Overall Study|Protocol Deviations|3|||
125242729|NCT01179516|450512291|FG002|Overall Study|Protocol Deviations|3|||
125242730|NCT01179516|450512289|FG000|Overall Study|Withdrawal of Consent|2|||
125242731|NCT01179516|450512290|FG001|Overall Study|Withdrawal of Consent|6|||
125242732|NCT01179516|450512291|FG002|Overall Study|Withdrawal of Consent|10|||
125242733|NCT01179516|450512289|FG000|Overall Study|Lost to Follow-up|7|||
125242734|NCT01179516|450512290|FG001|Overall Study|Lost to Follow-up|7|||
125242735|NCT01179516|450512291|FG002|Overall Study|Lost to Follow-up|3|||
125242736|NCT01179516|450512289|FG000|Overall Study|Other|2|||
125242737|NCT01179516|450512290|FG001|Overall Study|Other|0|||
125242738|NCT01179516|450512291|FG002|Overall Study|Other|2|||
125242739|NCT03349515|450512293|FG000|Overall Study|Lack of Efficacy|2|||
125242740|NCT03349515|450512294|FG001|Overall Study|Lack of Efficacy|0|||
125242741|NCT03349515|450512293|FG000|Overall Study|Physician Decision|3|||
125242742|NCT03349515|450512294|FG001|Overall Study|Physician Decision|1|||
125242743|NCT03412890|450512295|FG000|Overall Study|Adverse Event|5|||
125242744|NCT03412890|450512296|FG001|Overall Study|Adverse Event|5|||
125242745|NCT03412890|450512297|FG002|Overall Study|Adverse Event|9|||
125242746|NCT03412890|450512295|FG000|Overall Study|Protocol deviation|2|||
125242747|NCT03412890|450512296|FG001|Overall Study|Protocol deviation|1|||
125242748|NCT03412890|450512297|FG002|Overall Study|Protocol deviation|2|||
125242749|NCT03412890|450512295|FG000|Overall Study|Lost to Follow-up|7|||
125242750|NCT03412890|450512296|FG001|Overall Study|Lost to Follow-up|10|||
125242751|NCT03412890|450512297|FG002|Overall Study|Lost to Follow-up|10|||
125242752|NCT03412890|450512295|FG000|Overall Study|Withdrawal by Subject|9|||
125242753|NCT03412890|450512296|FG001|Overall Study|Withdrawal by Subject|12|||
125242754|NCT03412890|450512297|FG002|Overall Study|Withdrawal by Subject|11|||
125242755|NCT03412890|450512295|FG000|Overall Study|Lack of Efficacy|2|||
125242756|NCT03412890|450512296|FG001|Overall Study|Lack of Efficacy|7|||
125242757|NCT03412890|450512297|FG002|Overall Study|Lack of Efficacy|5|||
125242758|NCT03412890|450512295|FG000|Overall Study|Other|5|||
125242759|NCT03412890|450512296|FG001|Overall Study|Other|6|||
125242760|NCT03412890|450512297|FG002|Overall Study|Other|5|||
125242761|NCT03412890|450512295|FG000|Overall Study|Participants who did not receive any study drug|0|||
125242762|NCT03412890|450512296|FG001|Overall Study|Participants who did not receive any study drug|1|||
125242763|NCT03412890|450512297|FG002|Overall Study|Participants who did not receive any study drug|0|||
125242764|NCT02315625|450512298|FG000|First Intervention|Disease Progression|1|||
125242765|NCT02315625|450512299|FG001|First Intervention|Disease Progression|0|||
125242766|NCT02315625|450512298|FG000|Second Intervention|Physician Decision|2|||
125242767|NCT02315625|450512299|FG001|Second Intervention|Physician Decision|1|||
125242768|NCT02315625|450512298|FG000|Second Intervention|Study closure|1|||
125242769|NCT02315625|450512299|FG001|Second Intervention|Study closure|0|||
125242770|NCT02315625|450512298|FG000|Second Intervention|Disease Progression|1|||
125242771|NCT02315625|450512299|FG001|Second Intervention|Disease Progression|0|||
125242772|NCT00021255|450512300|FG000|Overall Study|Death|1|||
125242773|NCT00021255|450512301|FG001|Overall Study|Death|0|||
125242774|NCT00021255|450512302|FG002|Overall Study|Death|2|||
125188284|NCT03971071|450309149|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
125188285|NCT03971071|450309150|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
125188286|NCT03971071|450309151|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
125188287|NCT03971071|450309152|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
125188288|NCT03971071|450309153|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
125188289|NCT03971071|450309149|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
125188290|NCT03971071|450309150|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
125188291|NCT03971071|450309151|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
125188292|NCT03971071|450309152|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
125188293|NCT03971071|450309153|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
125188294|NCT03210714|450309156|FG000|Overall Study|Adverse Event|6|||
125188295|NCT03210714|450309156|FG000|Overall Study|Physician Decision|1|||
125188296|NCT03210714|450309156|FG000|Overall Study|Progressive disease|11|||
125188297|NCT03210714|450309156|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
125188298|NCT01909934|450309157|FG000|Overall Study|Withdrawal by Subject|3|||
125188299|NCT01909934|450309157|FG000|Overall Study|Lost to Follow-up|1|||
125188300|NCT01909934|450309157|FG000|Overall Study|Death|25|||
125188301|NCT01909934|450309157|FG000|Overall Study|Withdrawal of Informed Consent|1|||
125188302|NCT01909934|450309157|FG000|Overall Study|Reason Not Specified|1|||
125188303|NCT01139775|450309160|FG000|Overall Study|Adverse Event|0|||
125188304|NCT01139775|450309161|FG001|Overall Study|Adverse Event|6|||
125188305|NCT01139775|450309162|FG002|Overall Study|Adverse Event|2|||
125188306|NCT01139775|450309160|FG000|Overall Study|Protocol Violation|0|||
125188307|NCT01139775|450309161|FG001|Overall Study|Protocol Violation|5|||
125188308|NCT01139775|450309162|FG002|Overall Study|Protocol Violation|0|||
125188309|NCT01139775|450309160|FG000|Overall Study|Withdrawal by Subject|1|||
125188310|NCT01139775|450309161|FG001|Overall Study|Withdrawal by Subject|0|||
125188311|NCT01139775|450309162|FG002|Overall Study|Withdrawal by Subject|2|||
125188312|NCT01139775|450309160|FG000|Overall Study|Physician Decision|0|||
125188313|NCT01139775|450309161|FG001|Overall Study|Physician Decision|2|||
125188314|NCT01139775|450309162|FG002|Overall Study|Physician Decision|2|||
125188315|NCT03193853|450309165|FG000|Overall Study|Death|6|||
125188316|NCT01956773|450309173|FG000|Overall Study|Lost to Follow-up|628|||
125188317|NCT01956773|450309174|FG001|Overall Study|Lost to Follow-up|1|||
125188318|NCT00450437|450309175|FG000|Overall Study|Withdrawal by Subject|10|||
125188319|NCT00450437|450309176|FG001|Overall Study|Withdrawal by Subject|2|||
125188320|NCT00450437|450309177|FG002|Overall Study|Withdrawal by Subject|0|||
125188321|NCT00450437|450309178|FG003|Overall Study|Withdrawal by Subject|1|||
125188322|NCT00450437|450309175|FG000|Overall Study|Lost to Follow-up|31|||
125188323|NCT00450437|450309176|FG001|Overall Study|Lost to Follow-up|12|||
125188324|NCT00450437|450309177|FG002|Overall Study|Lost to Follow-up|19|||
125188325|NCT00450437|450309178|FG003|Overall Study|Lost to Follow-up|9|||
125188326|NCT00450437|450309175|FG000|Overall Study|Protocol Violation|0|||
125188327|NCT00450437|450309176|FG001|Overall Study|Protocol Violation|1|||
125188328|NCT00450437|450309177|FG002|Overall Study|Protocol Violation|0|||
125188329|NCT00450437|450309178|FG003|Overall Study|Protocol Violation|1|||
125188330|NCT00450437|450309175|FG000|Overall Study|Inappropriate enrollment|4|||
125188331|NCT00450437|450309176|FG001|Overall Study|Inappropriate enrollment|1|||
125188332|NCT00450437|450309177|FG002|Overall Study|Inappropriate enrollment|3|||
125188333|NCT00450437|450309178|FG003|Overall Study|Inappropriate enrollment|0|||
125188334|NCT00450437|450309175|FG000|Overall Study|Administrative reason|0|||
125188335|NCT00450437|450309176|FG001|Overall Study|Administrative reason|0|||
125188336|NCT00450437|450309177|FG002|Overall Study|Administrative reason|1|||
125188337|NCT00450437|450309178|FG003|Overall Study|Administrative reason|0|||
125188338|NCT00450437|450309175|FG000|Overall Study|Unable to Classify|1|||
125188339|NCT00450437|450309176|FG001|Overall Study|Unable to Classify|0|||
125188340|NCT00450437|450309177|FG002|Overall Study|Unable to Classify|1|||
125188341|NCT00450437|450309178|FG003|Overall Study|Unable to Classify|0|||
125188342|NCT03907488|450309179|FG000|Overall Study|Adverse Event|20|||
125188343|NCT03907488|450309180|FG001|Overall Study|Adverse Event|20|||
125188344|NCT03907488|450309179|FG000|Overall Study|Withdrawal by Subject|9|||
125188345|NCT03907488|450309180|FG001|Overall Study|Withdrawal by Subject|13|||
125188346|NCT03907488|450309179|FG000|Overall Study|Lack of Efficacy|0|||
125188347|NCT03907488|450309180|FG001|Overall Study|Lack of Efficacy|9|||
125188348|NCT03907488|450309179|FG000|Overall Study|Death|3|||
125188349|NCT03907488|450309180|FG001|Overall Study|Death|8|||
125188350|NCT03907488|450309179|FG000|Overall Study|not protocol specified|5|||
125188351|NCT03907488|450309180|FG001|Overall Study|not protocol specified|8|||
125188352|NCT03907488|450309179|FG000|Overall Study|Ineligible|9|||
125188353|NCT03907488|450309180|FG001|Overall Study|Ineligible|15|||
125188354|NCT02269098|450309181|FG000|Overall Study|Lost to Follow-up|14|||
125188355|NCT02269098|450309182|FG001|Overall Study|Lost to Follow-up|9|||
125188356|NCT03194542|450309185|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
125188357|NCT03194542|450309186|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
125188358|NCT03194542|450309187|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
125188359|NCT03194542|450309188|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
125242775|NCT00021255|450512300|FG000|Overall Study|Breast cancer relapse|5|||
125242776|NCT00021255|450512301|FG001|Overall Study|Breast cancer relapse|18|||
125242777|NCT00021255|450512302|FG002|Overall Study|Breast cancer relapse|11|||
125242778|NCT00021255|450512300|FG000|Overall Study|Second primary malignancy|0|||
125242779|NCT00021255|450512301|FG001|Overall Study|Second primary malignancy|4|||
125242780|NCT00021255|450512302|FG002|Overall Study|Second primary malignancy|1|||
125242781|NCT00021255|450512300|FG000|Overall Study|Withdrawal by Subject|41|||
125242782|NCT00021255|450512301|FG001|Overall Study|Withdrawal by Subject|64|||
125242783|NCT00021255|450512302|FG002|Overall Study|Withdrawal by Subject|26|||
125242784|NCT00021255|450512300|FG000|Overall Study|Lost to Follow-up|0|||
125242785|NCT00021255|450512301|FG001|Overall Study|Lost to Follow-up|2|||
125242786|NCT00021255|450512302|FG002|Overall Study|Lost to Follow-up|3|||
125242787|NCT00021255|450512300|FG000|Overall Study|Cardiac toxicity|0|||
125242788|NCT00021255|450512301|FG001|Overall Study|Cardiac toxicity|61|||
125242789|NCT00021255|450512302|FG002|Overall Study|Cardiac toxicity|32|||
125242790|NCT00021255|450512300|FG000|Overall Study|Herceptin toxicity|0|||
125242791|NCT00021255|450512301|FG001|Overall Study|Herceptin toxicity|22|||
125242792|NCT00021255|450512302|FG002|Overall Study|Herceptin toxicity|6|||
125242793|NCT00021255|450512300|FG000|Overall Study|Adverse Event|46|||
125242794|NCT00021255|450512301|FG001|Overall Study|Adverse Event|30|||
125242795|NCT00021255|450512302|FG002|Overall Study|Adverse Event|18|||
125242796|NCT00021255|450512300|FG000|Overall Study|Protocol Violation|0|||
125242797|NCT00021255|450512301|FG001|Overall Study|Protocol Violation|2|||
125242798|NCT00021255|450512302|FG002|Overall Study|Protocol Violation|0|||
125242799|NCT00021255|450512300|FG000|Overall Study|Other than specified above|0|||
125242800|NCT00021255|450512301|FG001|Overall Study|Other than specified above|38|||
125242801|NCT00021255|450512302|FG002|Overall Study|Other than specified above|19|||
125242802|NCT00021255|450512300|FG000|Overall Study|Missing|0|||
125242803|NCT00021255|450512301|FG001|Overall Study|Missing|27|||
125242804|NCT00021255|450512302|FG002|Overall Study|Missing|13|||
125242805|NCT00021255|450512300|FG000|Overall Study|Randomized but not treated|28|||
125242806|NCT00021255|450512301|FG001|Overall Study|Randomized but not treated|2|||
125242807|NCT00021255|450512302|FG002|Overall Study|Randomized but not treated|18|||
125242808|NCT02337946|450512305|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
125242809|NCT02337946|450512306|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
125242810|NCT02337946|450512307|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
125242811|NCT02337946|450512305|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
125242812|NCT02337946|450512306|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
125242813|NCT02337946|450512307|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
125242814|NCT02337946|450512305|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
125242815|NCT02337946|450512306|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
125242816|NCT02337946|450512307|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
125242817|NCT02337946|450512305|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
125242818|NCT02337946|450512306|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
125242819|NCT02337946|450512307|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
125242820|NCT02337946|450512305|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
125242821|NCT02337946|450512306|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
125242822|NCT02337946|450512307|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
125242823|NCT02337946|450512305|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
125242824|NCT02337946|450512306|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
125242825|NCT02337946|450512307|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
125242826|NCT02337946|450512305|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
125242827|NCT02337946|450512306|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
125242828|NCT02337946|450512307|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
125242829|NCT02337946|450512305|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
125242830|NCT02337946|450512306|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
125242831|NCT02337946|450512307|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
125242832|NCT02337946|450512305|FG000|In-between Period|Without Informed Consent|1|||
125242833|NCT02337946|450512306|FG001|In-between Period|Without Informed Consent|0|||
125242834|NCT02337946|450512307|FG002|In-between Period|Without Informed Consent|0|||
125242835|NCT02337946|450512305|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
125242836|NCT02337946|450512306|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
125242837|NCT02337946|450512307|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
125242838|NCT02337946|450512305|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
125242839|NCT02337946|450512306|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
125242840|NCT02337946|450512307|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
125242841|NCT02337946|450512305|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
125242842|NCT02337946|450512306|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
125242843|NCT02337946|450512307|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
125188360|NCT03194542|450309185|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
125188361|NCT03194542|450309186|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
125188362|NCT03194542|450309187|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
125188363|NCT03194542|450309188|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
125188364|NCT03194542|450309185|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
125188365|NCT03194542|450309186|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
125188366|NCT03194542|450309187|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
125188367|NCT03194542|450309188|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
125188368|NCT03194542|450309185|FG000|Overall Study|Loss of Response|4|||
125188369|NCT03194542|450309186|FG001|Overall Study|Loss of Response|2|||
125188370|NCT03194542|450309187|FG002|Overall Study|Loss of Response|3|||
125188371|NCT03194542|450309188|FG003|Overall Study|Loss of Response|4|||
125188372|NCT03194542|450309185|FG000|Overall Study|Physician Decision|0|||
125188373|NCT03194542|450309186|FG001|Overall Study|Physician Decision|1|||
125188374|NCT03194542|450309187|FG002|Overall Study|Physician Decision|0|||
125188375|NCT03194542|450309188|FG003|Overall Study|Physician Decision|0|||
125188376|NCT03194542|450309185|FG000|Overall Study|Lack of Efficacy|2|||
125188377|NCT03194542|450309186|FG001|Overall Study|Lack of Efficacy|2|||
125188378|NCT03194542|450309187|FG002|Overall Study|Lack of Efficacy|2|||
125188379|NCT03194542|450309188|FG003|Overall Study|Lack of Efficacy|6|||
125188380|NCT03194542|450309185|FG000|Overall Study|Withdrawal by Subject|2|||
125188381|NCT03194542|450309186|FG001|Overall Study|Withdrawal by Subject|1|||
125188382|NCT03194542|450309187|FG002|Overall Study|Withdrawal by Subject|5|||
125188383|NCT03194542|450309188|FG003|Overall Study|Withdrawal by Subject|4|||
125188384|NCT03194542|450309185|FG000|Overall Study|Progressive Disease|1|||
125188385|NCT03194542|450309186|FG001|Overall Study|Progressive Disease|0|||
125188386|NCT03194542|450309187|FG002|Overall Study|Progressive Disease|1|||
125188387|NCT03194542|450309188|FG003|Overall Study|Progressive Disease|1|||
125188388|NCT03194542|450309185|FG000|Overall Study|Adverse Event|1|||
125188389|NCT03194542|450309186|FG001|Overall Study|Adverse Event|2|||
125188390|NCT03194542|450309187|FG002|Overall Study|Adverse Event|0|||
125188391|NCT03194542|450309188|FG003|Overall Study|Adverse Event|5|||
125188392|NCT03194542|450309185|FG000|Overall Study|Death|1|||
125188393|NCT03194542|450309186|FG001|Overall Study|Death|2|||
125188394|NCT03194542|450309187|FG002|Overall Study|Death|0|||
125188395|NCT03194542|450309188|FG003|Overall Study|Death|5|||
125188396|NCT03194542|450309185|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
125188397|NCT03194542|450309186|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
125188398|NCT03194542|450309187|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
125188399|NCT03194542|450309188|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
125188400|NCT01611883|450309191|FG000|Overall Study|Adverse Event|1|||
125188401|NCT01611883|450309192|FG001|Overall Study|Adverse Event|1|||
125188402|NCT05142722|450309793|FG000|Overall Study|Lost to Follow-up|16|||
125188403|NCT05142722|450309794|FG001|Overall Study|Lost to Follow-up|38|||
125188404|NCT05142722|450309793|FG000|Overall Study|Withdrawal by Subject|20|||
125188405|NCT05142722|450309794|FG001|Overall Study|Withdrawal by Subject|27|||
125188406|NCT05142722|450309793|FG000|Overall Study|Death|11|||
125188407|NCT05142722|450309794|FG001|Overall Study|Death|17|||
125188408|NCT05142722|450309793|FG000|Overall Study|Physician Decision|0|||
125188409|NCT05142722|450309794|FG001|Overall Study|Physician Decision|1|||
125188410|NCT05142722|450309793|FG000|Overall Study|Participant Moved Away|0|||
125188411|NCT05142722|450309794|FG001|Overall Study|Participant Moved Away|2|||
125188412|NCT05142722|450309793|FG000|Overall Study|Adverse Event|2|||
125188413|NCT05142722|450309794|FG001|Overall Study|Adverse Event|1|||
125188414|NCT05731700|450309795|FG000|Overall Study|Death|1|||
125188415|NCT05468164|450309812|FG000|Treatment Period 4|Adverse Event|0|||
125188416|NCT05468164|450309813|FG001|Treatment Period 4|Adverse Event|0|||
125188417|NCT05468164|450309814|FG002|Treatment Period 4|Adverse Event|0|||
125188418|NCT05468164|450309815|FG003|Treatment Period 4|Adverse Event|1|||
125242844|NCT02337946|450512305|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
125242845|NCT02337946|450512306|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
125242846|NCT02337946|450512307|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
125242847|NCT02337946|450512305|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
125242848|NCT02337946|450512306|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
125242849|NCT02337946|450512307|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
125242850|NCT02337946|450512305|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
125242851|NCT02337946|450512306|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
125242852|NCT02337946|450512307|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
125242853|NCT02949934|450512312|FG000|Natural Drinking Period|Adverse Event|1|||
125242854|NCT02949934|450512313|FG001|Natural Drinking Period|Adverse Event|0|||
125242855|NCT02949934|450512314|FG002|Natural Drinking Period|Adverse Event|0|||
125242856|NCT02949934|450512315|FG003|Natural Drinking Period|Adverse Event|1|||
125242857|NCT02949934|450512316|FG004|Natural Drinking Period|Adverse Event|0|||
125242858|NCT02949934|450512317|FG005|Natural Drinking Period|Adverse Event|0|||
125242859|NCT02949934|450512312|FG000|Natural Drinking Period|Lost to Follow-up|0|||
125242860|NCT02949934|450512313|FG001|Natural Drinking Period|Lost to Follow-up|0|||
125242861|NCT02949934|450512314|FG002|Natural Drinking Period|Lost to Follow-up|0|||
125242862|NCT02949934|450512315|FG003|Natural Drinking Period|Lost to Follow-up|0|||
125242863|NCT02949934|450512316|FG004|Natural Drinking Period|Lost to Follow-up|1|||
125242864|NCT02949934|450512317|FG005|Natural Drinking Period|Lost to Follow-up|0|||
125242865|NCT02949934|450512312|FG000|Neuroimaging|Protocol Violation|2|||
125242866|NCT02949934|450512313|FG001|Neuroimaging|Protocol Violation|0|||
125242867|NCT02949934|450512314|FG002|Neuroimaging|Protocol Violation|0|||
125242868|NCT02949934|450512315|FG003|Neuroimaging|Protocol Violation|0|||
125242869|NCT02949934|450512316|FG004|Neuroimaging|Protocol Violation|1|||
125242870|NCT02949934|450512317|FG005|Neuroimaging|Protocol Violation|0|||
125242871|NCT02949934|450512312|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
125242872|NCT02949934|450512313|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
125242873|NCT02949934|450512314|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
125242874|NCT02949934|450512315|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
125242875|NCT02949934|450512316|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
125242876|NCT02949934|450512317|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
125242877|NCT02949934|450512312|FG000|Neuroimaging|Not scanned|0|||
125242878|NCT02949934|450512313|FG001|Neuroimaging|Not scanned|0|||
125242879|NCT02949934|450512314|FG002|Neuroimaging|Not scanned|1|||
125242880|NCT02949934|450512315|FG003|Neuroimaging|Not scanned|0|||
125242881|NCT02949934|450512316|FG004|Neuroimaging|Not scanned|0|||
125242882|NCT02949934|450512317|FG005|Neuroimaging|Not scanned|2|||
125242883|NCT02949934|450512312|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
125242884|NCT02949934|450512313|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
125242885|NCT02949934|450512314|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
125242886|NCT02949934|450512315|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
125242887|NCT02949934|450512316|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
125242888|NCT02949934|450512317|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
125242889|NCT02949934|450512312|FG000|Bar Laboratory|Adverse Event|1|||
125242890|NCT02949934|450512313|FG001|Bar Laboratory|Adverse Event|0|||
125242891|NCT02949934|450512314|FG002|Bar Laboratory|Adverse Event|2|||
125242892|NCT02949934|450512315|FG003|Bar Laboratory|Adverse Event|0|||
125242893|NCT02949934|450512316|FG004|Bar Laboratory|Adverse Event|1|||
125242894|NCT02949934|450512317|FG005|Bar Laboratory|Adverse Event|0|||
125242895|NCT02949934|450512312|FG000|Bar Laboratory|Protocol Violation|0|||
125242896|NCT02949934|450512313|FG001|Bar Laboratory|Protocol Violation|0|||
125242897|NCT02949934|450512314|FG002|Bar Laboratory|Protocol Violation|0|||
125242898|NCT02949934|450512315|FG003|Bar Laboratory|Protocol Violation|1|||
125242899|NCT02949934|450512316|FG004|Bar Laboratory|Protocol Violation|0|||
125242900|NCT02949934|450512317|FG005|Bar Laboratory|Protocol Violation|0|||
125242901|NCT00118287|450512320|FG000|Overall Study|Intracranial haemorrhage|1|||
125242902|NCT00118287|450512320|FG000|Overall Study|Muscle pain|1|||
125242903|NCT03442569|450512323|FG000|Overall Study|Subject was ineligible after enrollment|1|||
125242904|NCT01214720|450512326|FG000|Overall Study|Alive and still on treatment|34|||
125242905|NCT01214720|450512327|FG001|Overall Study|Alive and still on treatment|18|||
125242906|NCT01214720|450512326|FG000|Overall Study|Alive and in follow-up|45|||
125242907|NCT01214720|450512327|FG001|Overall Study|Alive and in follow-up|48|||
125242908|NCT01214720|450512326|FG000|Overall Study|Lost to Follow-up|6|||
125242909|NCT01214720|450512327|FG001|Overall Study|Lost to Follow-up|2|||
125242910|NCT02347787|450512328|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
125242911|NCT02347787|450512329|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
125242912|NCT02347787|450512328|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
125242913|NCT02347787|450512329|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
125242914|NCT02347787|450512328|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
125242915|NCT02347787|450512329|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
125242916|NCT02347787|450512328|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
125242917|NCT02347787|450512329|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
125188419|NCT04846569|450309816|FG000|Overall Study|Withdrawal by Subject|3|||
125188420|NCT04846569|450309817|FG001|Overall Study|Withdrawal by Subject|1|||
125188421|NCT01467713|450309818|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
125188422|NCT01467713|450309819|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
125188423|NCT01467713|450309820|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
125188424|NCT01467713|450309821|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
125188425|NCT01467713|450309818|FG000|Overall Study|Major Protocol Deviation|2|||
125188426|NCT01467713|450309819|FG001|Overall Study|Major Protocol Deviation|4|||
125188427|NCT01467713|450309820|FG002|Overall Study|Major Protocol Deviation|4|||
125188428|NCT01467713|450309821|FG003|Overall Study|Major Protocol Deviation|1|||
125188429|NCT01467713|450309818|FG000|Overall Study|Lost to Follow-up|9|||
125188430|NCT01467713|450309819|FG001|Overall Study|Lost to Follow-up|12|||
125188431|NCT01467713|450309820|FG002|Overall Study|Lost to Follow-up|6|||
125188432|NCT01467713|450309821|FG003|Overall Study|Lost to Follow-up|9|||
125188433|NCT01467713|450309818|FG000|Overall Study|Voluntary Withdrawal|18|||
125188434|NCT01467713|450309819|FG001|Overall Study|Voluntary Withdrawal|14|||
125188435|NCT01467713|450309820|FG002|Overall Study|Voluntary Withdrawal|21|||
125188436|NCT01467713|450309821|FG003|Overall Study|Voluntary Withdrawal|20|||
125188437|NCT01467713|450309818|FG000|Overall Study|Study Termination|23|||
125188438|NCT01467713|450309819|FG001|Overall Study|Study Termination|33|||
125188439|NCT01467713|450309820|FG002|Overall Study|Study Termination|28|||
125188440|NCT01467713|450309821|FG003|Overall Study|Study Termination|29|||
125188441|NCT01467713|450309818|FG000|Overall Study|Pregnancy|0|||
125188442|NCT01467713|450309819|FG001|Overall Study|Pregnancy|1|||
125188443|NCT01467713|450309820|FG002|Overall Study|Pregnancy|1|||
125188444|NCT01467713|450309821|FG003|Overall Study|Pregnancy|3|||
125188445|NCT01467713|450309818|FG000|Overall Study|Relapse|35|||
125188446|NCT01467713|450309819|FG001|Overall Study|Relapse|25|||
125188447|NCT01467713|450309820|FG002|Overall Study|Relapse|28|||
125188448|NCT01467713|450309821|FG003|Overall Study|Relapse|35|||
125188449|NCT01467713|450309818|FG000|Overall Study|Reason not Specified|6|||
125188450|NCT01467713|450309819|FG001|Overall Study|Reason not Specified|11|||
125188451|NCT01467713|450309820|FG002|Overall Study|Reason not Specified|8|||
125188452|NCT01467713|450309821|FG003|Overall Study|Reason not Specified|7|||
125188453|NCT00536939|450309822|FG000|Overall Study|Withdrawal by Subject|1|||
125188454|NCT00536939|450309823|FG001|Overall Study|Withdrawal by Subject|0|||
125188455|NCT00536939|450309822|FG000|Overall Study|Other Complicating Disease|1|||
125188456|NCT00536939|450309823|FG001|Overall Study|Other Complicating Disease|0|||
125188457|NCT01611935|450309826|FG000|Overall Study|Family Declined Participation|1|||
125188458|NCT01611935|450309827|FG001|Overall Study|Family Declined Participation|0|||
125188459|NCT03817853|450309831|FG000|Induction Phase|Adverse Event|5|||
125188460|NCT03817853|450309832|FG001|Induction Phase|Adverse Event|0|||
125188461|NCT03817853|450309833|FG002|Induction Phase|Adverse Event|0|||
125188462|NCT03817853|450309831|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
125188463|NCT03817853|450309832|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
125188464|NCT03817853|450309833|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
125188465|NCT03817853|450309831|FG000|Induction Phase|Physician Decision|2|||
125188466|NCT03817853|450309832|FG001|Induction Phase|Physician Decision|0|||
125188467|NCT03817853|450309833|FG002|Induction Phase|Physician Decision|0|||
125188468|NCT03817853|450309831|FG000|Induction Phase|Progressive Disease|6|||
125188469|NCT03817853|450309832|FG001|Induction Phase|Progressive Disease|0|||
125188470|NCT03817853|450309833|FG002|Induction Phase|Progressive Disease|0|||
125188471|NCT03817853|450309831|FG000|Induction Phase|Withdrawal by Subject|4|||
125188472|NCT03817853|450309832|FG001|Induction Phase|Withdrawal by Subject|0|||
125188473|NCT03817853|450309833|FG002|Induction Phase|Withdrawal by Subject|0|||
125188474|NCT03817853|450309831|FG000|Maintenance Phase|Adverse Event|0|||
125188475|NCT03817853|450309832|FG001|Maintenance Phase|Adverse Event|8|||
125188476|NCT03817853|450309833|FG002|Maintenance Phase|Adverse Event|0|||
125188477|NCT03817853|450309831|FG000|Maintenance Phase|Death|0|||
125188478|NCT03817853|450309832|FG001|Maintenance Phase|Death|5|||
125188479|NCT03817853|450309833|FG002|Maintenance Phase|Death|0|||
125188480|NCT03817853|450309831|FG000|Maintenance Phase|Progressive Disease|0|||
125188481|NCT03817853|450309832|FG001|Maintenance Phase|Progressive Disease|7|||
125188482|NCT03817853|450309833|FG002|Maintenance Phase|Progressive Disease|0|||
125188483|NCT03817853|450309831|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125188484|NCT03817853|450309832|FG001|Maintenance Phase|Withdrawal by Subject|2|||
125188485|NCT03817853|450309833|FG002|Maintenance Phase|Withdrawal by Subject|0|||
125188486|NCT03817853|450309831|FG000|Maintenance Phase|Physician Decision|0|||
125188487|NCT03817853|450309832|FG001|Maintenance Phase|Physician Decision|1|||
125188488|NCT03817853|450309833|FG002|Maintenance Phase|Physician Decision|0|||
125188489|NCT03817853|450309831|FG000|Maintenance Phase|Various reasons|0|||
125188490|NCT03817853|450309832|FG001|Maintenance Phase|Various reasons|4|||
125188491|NCT03817853|450309833|FG002|Maintenance Phase|Various reasons|0|||
125188492|NCT03817853|450309831|FG000|Maintenance Phase|Protocol Deviation|0|||
125188493|NCT03817853|450309832|FG001|Maintenance Phase|Protocol Deviation|1|||
125242918|NCT03720847|450513359|FG000|Washout|Physician Decision|1|||
125242919|NCT03720847|450513360|FG001|Washout|Physician Decision|2|||
125242920|NCT01239680|450513361|FG000|Overall Study|Withdrawal by Subject|2|||
125242921|NCT01239680|450513362|FG001|Overall Study|Withdrawal by Subject|0|||
125242922|NCT03033901|450513363|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
125242923|NCT03033901|450513363|FG000|Overall Study|Refused PSG|23|||
125242924|NCT03033901|450513363|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
125242925|NCT03033901|450513363|FG000|Overall Study|Missing Oximetry Data|3|||
125242926|NCT05177094|450513370|FG000|Overall Study|Adverse Event|5|||
125242927|NCT05177094|450513371|FG001|Overall Study|Adverse Event|5|||
125242928|NCT05177094|450513370|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
125242929|NCT05177094|450513371|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
125242930|NCT05177094|450513370|FG000|Overall Study|Protocol Deviation|3|||
125242931|NCT05177094|450513371|FG001|Overall Study|Protocol Deviation|0|||
125242932|NCT05177094|450513370|FG000|Overall Study|Withdrawal by Subject|6|||
125242933|NCT05177094|450513371|FG001|Overall Study|Withdrawal by Subject|3|||
125242934|NCT05177094|450513370|FG000|Overall Study|Participant could not tolerate long study visits|1|||
125242935|NCT05177094|450513371|FG001|Overall Study|Participant could not tolerate long study visits|0|||
125242936|NCT00875667|450513377|FG000|Overall Study|Adverse Event|29|||
125242937|NCT00875667|450513378|FG001|Overall Study|Adverse Event|10|||
125242938|NCT00875667|450513377|FG000|Overall Study|Withdrawal by Subject|17|||
125242939|NCT00875667|450513378|FG001|Overall Study|Withdrawal by Subject|5|||
125242940|NCT00875667|450513377|FG000|Overall Study|Death|7|||
125242941|NCT00875667|450513378|FG001|Overall Study|Death|2|||
125242942|NCT00875667|450513377|FG000|Overall Study|Protocol Violation|2|||
125242943|NCT00875667|450513378|FG001|Overall Study|Protocol Violation|0|||
125242944|NCT00875667|450513377|FG000|Overall Study|Disease Progression|100|||
125242945|NCT00875667|450513378|FG001|Overall Study|Disease Progression|49|||
125242946|NCT00875667|450513377|FG000|Overall Study|Miscellaneous|12|||
125242947|NCT00875667|450513378|FG001|Overall Study|Miscellaneous|6|||
125242948|NCT00875667|450513377|FG000|Overall Study|Randomized but no Study Drug Given|3|||
125242949|NCT00875667|450513378|FG001|Overall Study|Randomized but no Study Drug Given|1|||
125242950|NCT00894647|450513379|FG000|Overall Study|Adverse Event|5|||
125242951|NCT00894647|450513380|FG001|Overall Study|Adverse Event|4|||
125242952|NCT00894647|450513379|FG000|Overall Study|Withdrawal by Subject|4|||
125242953|NCT00894647|450513380|FG001|Overall Study|Withdrawal by Subject|4|||
125242954|NCT00894647|450513379|FG000|Overall Study|Lost to Follow-up|0|||
125242955|NCT00894647|450513380|FG001|Overall Study|Lost to Follow-up|2|||
125242956|NCT00894647|450513379|FG000|Overall Study|Non-compliance with study procedures|0|||
125242957|NCT00894647|450513380|FG001|Overall Study|Non-compliance with study procedures|2|||
125242958|NCT00894647|450513379|FG000|Overall Study|Other, not due to AE|1|||
125242959|NCT00894647|450513380|FG001|Overall Study|Other, not due to AE|2|||
125242960|NCT00195429|450513386|FG000|Overall Study|Adverse Event|2|||
125242961|NCT00195429|450513387|FG001|Overall Study|Adverse Event|4|||
125242962|NCT00195429|450513386|FG000|Overall Study|Lack of Efficacy|2|||
125242963|NCT00195429|450513387|FG001|Overall Study|Lack of Efficacy|1|||
125242964|NCT00195429|450513386|FG000|Overall Study|Lost to Follow-up|1|||
125242965|NCT00195429|450513387|FG001|Overall Study|Lost to Follow-up|0|||
125242966|NCT02541903|450513388|FG000|Overall Study|Death|1|||
125242967|NCT04795323|450513389|FG000|Overall Study|Did not interact with TARA|1|||
125242968|NCT04795323|450513390|FG001|Overall Study|Did not interact with TARA|0|||
125242969|NCT02691663|450513392|FG000|Overall Study|Screen failure after baseline|2|||
125242970|NCT02691663|450513393|FG001|Overall Study|Screen failure after baseline|2|||
125242971|NCT02691663|450513392|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
125242972|NCT02691663|450513393|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
125242973|NCT02691663|450513392|FG000|Overall Study|Withdrawn after Follow up 2|1|||
125242974|NCT02691663|450513393|FG001|Overall Study|Withdrawn after Follow up 2|1|||
125242975|NCT02691663|450513392|FG000|Overall Study|Lost to Follow-up|3|||
125242976|NCT02691663|450513393|FG001|Overall Study|Lost to Follow-up|2|||
125242977|NCT03142750|450513394|FG000|Overall Study|Lost to Follow-up|4|||
125242978|NCT03142750|450513395|FG001|Overall Study|Lost to Follow-up|1|||
125242979|NCT04925934|450513396|FG000|Overall Study|Adverse Event|1|||
125242980|NCT04925934|450513397|FG001|Overall Study|Adverse Event|0|||
125242981|NCT04925934|450513398|FG002|Overall Study|Adverse Event|0|||
125242982|NCT04925934|450513396|FG000|Overall Study|Lost to Follow-up|2|||
125242983|NCT04925934|450513397|FG001|Overall Study|Lost to Follow-up|0|||
125242984|NCT04925934|450513398|FG002|Overall Study|Lost to Follow-up|1|||
125242985|NCT04925934|450513396|FG000|Overall Study|Death|0|||
125242986|NCT04925934|450513397|FG001|Overall Study|Death|1|||
125242987|NCT04925934|450513398|FG002|Overall Study|Death|0|||
125242988|NCT04925934|450513396|FG000|Overall Study|Withdrawal by Subject|8|||
125242989|NCT04925934|450513397|FG001|Overall Study|Withdrawal by Subject|5|||
125188494|NCT03817853|450309833|FG002|Maintenance Phase|Protocol Deviation|0|||
125188495|NCT03817853|450309831|FG000|Follow-up Phase|Adverse Event|0|||
125188496|NCT03817853|450309832|FG001|Follow-up Phase|Adverse Event|0|||
125242990|NCT04925934|450513398|FG002|Overall Study|Withdrawal by Subject|9|||
125242991|NCT04925934|450513396|FG000|Overall Study|Other|2|||
125242992|NCT04925934|450513397|FG001|Overall Study|Other|2|||
125242993|NCT04925934|450513398|FG002|Overall Study|Other|2|||
125242994|NCT04925934|450513396|FG000|Overall Study|Eastern European Conflict|7|||
125242995|NCT04925934|450513397|FG001|Overall Study|Eastern European Conflict|3|||
125242996|NCT04925934|450513398|FG002|Overall Study|Eastern European Conflict|2|||
125242997|NCT03158688|450513399|FG000|Overall Study|Withdrawal by Subject|14|||
125242998|NCT03158688|450513400|FG001|Overall Study|Withdrawal by Subject|28|||
125242999|NCT03158688|450513399|FG000|Overall Study|Decision by sponsor|13|||
125243000|NCT03158688|450513400|FG001|Overall Study|Decision by sponsor|37|||
125243001|NCT03158688|450513399|FG000|Overall Study|Lost to Follow-up|4|||
125243002|NCT03158688|450513400|FG001|Overall Study|Lost to Follow-up|3|||
125243003|NCT03158688|450513399|FG000|Overall Study|Death|74|||
125243004|NCT03158688|450513400|FG001|Overall Study|Death|142|||
125243005|NCT01944774|450513408|FG000|Overall Study|Withdrawal by Subject|2|||
125243006|NCT01944774|450513409|FG001|Overall Study|Withdrawal by Subject|3|||
125243007|NCT01944774|450513410|FG002|Overall Study|Withdrawal by Subject|3|||
125243008|NCT01944774|450513408|FG000|Overall Study|Adverse Event|3|||
125243009|NCT01944774|450513409|FG001|Overall Study|Adverse Event|2|||
125243010|NCT01944774|450513410|FG002|Overall Study|Adverse Event|3|||
125243011|NCT01944774|450513408|FG000|Overall Study|Lack of Efficacy|1|||
125243012|NCT01944774|450513409|FG001|Overall Study|Lack of Efficacy|2|||
125243013|NCT01944774|450513410|FG002|Overall Study|Lack of Efficacy|2|||
125243014|NCT01944774|450513408|FG000|Overall Study|Lost to Follow-up|0|||
125243015|NCT01944774|450513409|FG001|Overall Study|Lost to Follow-up|1|||
125243016|NCT01944774|450513410|FG002|Overall Study|Lost to Follow-up|0|||
125243017|NCT03188185|450513411|FG000|Stage 1|Adverse Event|4|||
125243018|NCT03188185|450513412|FG001|Stage 1|Adverse Event|12|||
125243019|NCT03188185|450513413|FG002|Stage 1|Adverse Event|0|||
125243020|NCT03188185|450513414|FG003|Stage 1|Adverse Event|0|||
125243021|NCT03188185|450513411|FG000|Stage 1|Lack of Efficacy|0|||
125243022|NCT03188185|450513412|FG001|Stage 1|Lack of Efficacy|2|||
125243023|NCT03188185|450513413|FG002|Stage 1|Lack of Efficacy|0|||
125243024|NCT03188185|450513414|FG003|Stage 1|Lack of Efficacy|0|||
125243025|NCT03188185|450513411|FG000|Stage 1|Lost to Follow-up|6|||
125243026|NCT03188185|450513412|FG001|Stage 1|Lost to Follow-up|1|||
125243027|NCT03188185|450513413|FG002|Stage 1|Lost to Follow-up|0|||
125243028|NCT03188185|450513414|FG003|Stage 1|Lost to Follow-up|0|||
125243029|NCT03188185|450513411|FG000|Stage 1|Withdrawal by Subject|9|||
125243030|NCT03188185|450513412|FG001|Stage 1|Withdrawal by Subject|0|||
125243031|NCT03188185|450513413|FG002|Stage 1|Withdrawal by Subject|0|||
125243032|NCT03188185|450513414|FG003|Stage 1|Withdrawal by Subject|0|||
125243033|NCT03188185|450513411|FG000|Stage 1|Identified as a professional patient|0|||
125243034|NCT03188185|450513412|FG001|Stage 1|Identified as a professional patient|1|||
125243035|NCT03188185|450513413|FG002|Stage 1|Identified as a professional patient|0|||
125243036|NCT03188185|450513414|FG003|Stage 1|Identified as a professional patient|0|||
125243037|NCT03188185|450513411|FG000|Stage 2|Adverse Event|0|||
125243038|NCT03188185|450513412|FG001|Stage 2|Adverse Event|0|||
125243039|NCT03188185|450513413|FG002|Stage 2|Adverse Event|2|||
125243040|NCT03188185|450513414|FG003|Stage 2|Adverse Event|4|||
125243041|NCT03188185|450513411|FG000|Stage 2|Lack of Efficacy|0|||
125243042|NCT03188185|450513412|FG001|Stage 2|Lack of Efficacy|0|||
125243043|NCT03188185|450513413|FG002|Stage 2|Lack of Efficacy|3|||
125243044|NCT03188185|450513414|FG003|Stage 2|Lack of Efficacy|0|||
125243045|NCT03188185|450513411|FG000|Stage 2|Lost to Follow-up|0|||
125188497|NCT03817853|450309833|FG002|Follow-up Phase|Adverse Event|2|||
125188498|NCT03817853|450309831|FG000|Follow-up Phase|Death|0|||
125188499|NCT03817853|450309832|FG001|Follow-up Phase|Death|0|||
125188500|NCT03817853|450309833|FG002|Follow-up Phase|Death|1|||
125188501|NCT03817853|450309831|FG000|Follow-up Phase|Progressive Disease|0|||
125188502|NCT03817853|450309832|FG001|Follow-up Phase|Progressive Disease|0|||
125243046|NCT03188185|450513412|FG001|Stage 2|Lost to Follow-up|0|||
125188503|NCT03817853|450309833|FG002|Follow-up Phase|Progressive Disease|3|||
125188504|NCT03817853|450309831|FG000|Follow-up Phase|Withdrawal by Subject|0|||
125243047|NCT03188185|450513413|FG002|Stage 2|Lost to Follow-up|1|||
125243048|NCT03188185|450513414|FG003|Stage 2|Lost to Follow-up|0|||
125243049|NCT03188185|450513411|FG000|Stage 2|Physician Decision|0|||
125243050|NCT03188185|450513412|FG001|Stage 2|Physician Decision|0|||
125243051|NCT03188185|450513413|FG002|Stage 2|Physician Decision|0|||
125243052|NCT03188185|450513414|FG003|Stage 2|Physician Decision|1|||
125243053|NCT03188185|450513411|FG000|Stage 2|Withdrawal by Subject|0|||
125243054|NCT03188185|450513412|FG001|Stage 2|Withdrawal by Subject|0|||
125243055|NCT03188185|450513413|FG002|Stage 2|Withdrawal by Subject|3|||
125243056|NCT03188185|450513414|FG003|Stage 2|Withdrawal by Subject|1|||
125243057|NCT03325439|450513415|FG000|Overall Study|Ineligibility|3|||
125243058|NCT00774748|450513420|FG000|Overall Study|Lost to Follow-up|3|||
125243059|NCT02503865|450513421|FG000|Overall Study|Moved out of area|1|||
125243060|NCT02503865|450513422|FG001|Overall Study|Moved out of area|8|||
125188505|NCT03817853|450309832|FG001|Follow-up Phase|Withdrawal by Subject|0|||
125188506|NCT03817853|450309833|FG002|Follow-up Phase|Withdrawal by Subject|1|||
125188507|NCT00314340|450309834|FG000|Overall Study|lost interest|1|||
125188508|NCT01620138|450309837|FG000|Overall Study|Withdrawal by Subject|3|||
125188509|NCT01620138|450309838|FG001|Overall Study|Withdrawal by Subject|0|||
125188510|NCT01620138|450309837|FG000|Overall Study|Lack of Efficacy|1|||
125188511|NCT01620138|450309838|FG001|Overall Study|Lack of Efficacy|0|||
125188512|NCT01620138|450309837|FG000|Overall Study|Adverse Event|2|||
125188513|NCT01620138|450309838|FG001|Overall Study|Adverse Event|0|||
125188514|NCT03252535|450309839|FG000|Overall Study|Withdrawal by Subject|1|||
125188515|NCT03252535|450309840|FG001|Overall Study|Withdrawal by Subject|0|||
125188516|NCT03252535|450309841|FG002|Overall Study|Withdrawal by Subject|0|||
125188517|NCT03252535|450309839|FG000|Overall Study|Physician Decision|0|||
125188518|NCT03252535|450309840|FG001|Overall Study|Physician Decision|1|||
125188519|NCT03252535|450309841|FG002|Overall Study|Physician Decision|0|||
125188520|NCT03252535|450309839|FG000|Overall Study|Met discontinuation criteria|0|||
125188521|NCT03252535|450309840|FG001|Overall Study|Met discontinuation criteria|1|||
125188522|NCT03252535|450309841|FG002|Overall Study|Met discontinuation criteria|0|||
125188523|NCT05600283|450309842|FG000|Overall Study|Withdrawal by Subject|3|||
125188524|NCT05600283|450309843|FG001|Overall Study|Withdrawal by Subject|8|||
125188525|NCT05600283|450309842|FG000|Overall Study|invalid individual swab|1|||
125188526|NCT05600283|450309843|FG001|Overall Study|invalid individual swab|0|||
125188527|NCT05600283|450309842|FG000|Overall Study|missing clinician collection|3|||
125188528|NCT05600283|450309843|FG001|Overall Study|missing clinician collection|0|||
125188529|NCT05600283|450309842|FG000|Overall Study|screening failure|0|||
125188530|NCT05600283|450309843|FG001|Overall Study|screening failure|2|||
125188531|NCT01662492|450309852|FG000|Overall Study|Other miscellaneous reasons.|1|||
125188532|NCT01662492|450309853|FG001|Overall Study|Other miscellaneous reasons.|0|||
125188533|NCT01662492|450309854|FG002|Overall Study|Other miscellaneous reasons.|1|||
125188534|NCT01662492|450309852|FG000|Overall Study|Withdrawal by Subject|0|||
125188535|NCT01662492|450309853|FG001|Overall Study|Withdrawal by Subject|0|||
125188536|NCT01662492|450309854|FG002|Overall Study|Withdrawal by Subject|1|||
125188537|NCT01662492|450309852|FG000|Overall Study|Protocol Violation|1|||
125188538|NCT01662492|450309853|FG001|Overall Study|Protocol Violation|0|||
125188539|NCT01662492|450309854|FG002|Overall Study|Protocol Violation|0|||
125188540|NCT01662492|450309852|FG000|Overall Study|Lost to Follow-up|0|||
125188541|NCT01662492|450309853|FG001|Overall Study|Lost to Follow-up|0|||
125188542|NCT01662492|450309854|FG002|Overall Study|Lost to Follow-up|2|||
125188543|NCT01662492|450309852|FG000|Overall Study|Lack of Efficacy|1|||
125188544|NCT01662492|450309853|FG001|Overall Study|Lack of Efficacy|1|||
125188545|NCT01662492|450309854|FG002|Overall Study|Lack of Efficacy|2|||
125188546|NCT01100086|450310963|FG000|Period 1|Withdrawal by Subject|1|||
125188547|NCT01100086|450310964|FG001|Period 1|Withdrawal by Subject|0|||
125188548|NCT02954601|450310969|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
125188549|NCT02954601|450310970|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
125188550|NCT02954601|450310971|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
125188551|NCT02954601|450310972|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
125188552|NCT00333983|450310973|FG000|Overall Study|Lost to Follow-up|2|||
125188553|NCT00333983|450310974|FG001|Overall Study|Lost to Follow-up|1|||
125188554|NCT00333983|450310975|FG002|Overall Study|Lost to Follow-up|0|||
125188555|NCT00333983|450310973|FG000|Overall Study|Adverse Event|1|||
125188556|NCT00333983|450310974|FG001|Overall Study|Adverse Event|1|||
125188557|NCT00333983|450310975|FG002|Overall Study|Adverse Event|1|||
125188558|NCT00333983|450310973|FG000|Overall Study|Withdrawal by Subject|0|||
125188559|NCT00333983|450310974|FG001|Overall Study|Withdrawal by Subject|3|||
125188560|NCT00333983|450310975|FG002|Overall Study|Withdrawal by Subject|1|||
125188561|NCT00833105|450310976|FG000|Overall Study|Withdrawal by Subject|1|||
125188562|NCT00833105|450310976|FG000|Overall Study|Adverse Event|2|||
125188563|NCT02075203|450310984|FG000|Overall Study|Withdrawal by Subject|1|||
125188564|NCT02075203|450310985|FG001|Overall Study|Withdrawal by Subject|0|||
125188565|NCT02075203|450310986|FG002|Overall Study|Withdrawal by Subject|1|||
125188566|NCT02075203|450310984|FG000|Overall Study|Adverse Event|1|||
125188567|NCT02075203|450310985|FG001|Overall Study|Adverse Event|0|||
125188568|NCT02075203|450310986|FG002|Overall Study|Adverse Event|0|||
125188569|NCT02075203|450310984|FG000|Overall Study|participant refused to use contraception|1|||
125188570|NCT02075203|450310985|FG001|Overall Study|participant refused to use contraception|0|||
125188571|NCT02075203|450310986|FG002|Overall Study|participant refused to use contraception|0|||
125188572|NCT03214224|450310987|FG000|Overall Study|Protocol Violation|1|||
125188573|NCT03214224|450310987|FG000|Overall Study|Withdrawal by Subject|2|||
125188574|NCT03214224|450310987|FG000|Overall Study|Practice controls or therapists|6|||
125188575|NCT02712320|450310988|FG000|Overall Study|Lost to Follow-up|1|||
125188576|NCT02712320|450310988|FG000|Overall Study|Withdrawal by Subject|1|||
125188577|NCT02712320|450310988|FG000|Overall Study|Transferred to another facility|1|||
125188578|NCT02712320|450310988|FG000|Overall Study|Treating with the prohibited medications|2|||
125243061|NCT02503865|450513423|FG002|Overall Study|Moved out of area|0|||
125188579|NCT00568451|450310991|FG000|Overall Study|Disease Progression|0|||
125188580|NCT00568451|450310992|FG001|Overall Study|Disease Progression|0|||
125188581|NCT00568451|450310993|FG002|Overall Study|Disease Progression|2|||
125188582|NCT00568451|450310994|FG003|Overall Study|Disease Progression|7|||
125188583|NCT05266053|450310995|FG000|Overall Study|Withdrawal by Subject|8|||
125188584|NCT05266053|450310996|FG001|Overall Study|Withdrawal by Subject|4|||
125188585|NCT05344560|450310997|FG000|Period 1|Subject out of visit window|1|||
125188586|NCT05344560|450310998|FG001|Period 1|Subject out of visit window|1|||
125188587|NCT05344560|450310997|FG000|Period 2|Covid-19 Related|1|||
125188588|NCT05344560|450310998|FG001|Period 2|Covid-19 Related|0|||
125188589|NCT05344560|450310997|FG000|Period 2|Adverse Event|1|||
125188590|NCT05344560|450310998|FG001|Period 2|Adverse Event|0|||
125188591|NCT05344560|450310997|FG000|Period 2|Subject out of visit window|1|||
125188592|NCT05344560|450310998|FG001|Period 2|Subject out of visit window|1|||
125188593|NCT05344560|450310997|FG000|Period 3|Subject out of visit window|1|||
125188594|NCT05344560|450310998|FG001|Period 3|Subject out of visit window|0|||
125243062|NCT02503865|450513421|FG000|Overall Study|Refused treatment|4|||
125243063|NCT02503865|450513422|FG001|Overall Study|Refused treatment|39|||
125243064|NCT02503865|450513423|FG002|Overall Study|Refused treatment|2|||
125243065|NCT00303953|450513424|FG000|Overall Study|Ineligible|1|||
125243066|NCT00303953|450513424|FG000|Overall Study|Death|1|||
125243067|NCT00303953|450513424|FG000|Overall Study|Adverse Event|4|||
125243068|NCT00303953|450513424|FG000|Overall Study|Lack of Efficacy|12|||
125243069|NCT00303953|450513424|FG000|Overall Study|Physician Decision|1|||
125243070|NCT01132755|450513427|FG000|Overall Study|Procedure not done due to medical reason|23|||
125243071|NCT01132755|450513427|FG000|Overall Study|Protocol Violation|15|||
125188595|NCT01343043|450311001|FG000|Overall Study|Disease progression before treatment|1|||
125188596|NCT01343043|450311002|FG001|Overall Study|Disease progression before treatment|0|||
125188597|NCT01343043|450311003|FG002|Overall Study|Disease progression before treatment|0|||
125188598|NCT01343043|450311004|FG003|Overall Study|Disease progression before treatment|0|||
125188599|NCT01343043|450311001|FG000|Overall Study|Withdrawal by Subject|1|||
125188600|NCT01343043|450311002|FG001|Overall Study|Withdrawal by Subject|0|||
125188601|NCT01343043|450311003|FG002|Overall Study|Withdrawal by Subject|0|||
125188602|NCT01343043|450311004|FG003|Overall Study|Withdrawal by Subject|0|||
125188603|NCT01343043|450311001|FG000|Overall Study|Death|1|||
125188604|NCT01343043|450311002|FG001|Overall Study|Death|1|||
125188605|NCT01343043|450311003|FG002|Overall Study|Death|0|||
125188606|NCT01343043|450311004|FG003|Overall Study|Death|1|||
125188607|NCT00360282|450311005|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
125188608|NCT00360282|450311006|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
125188609|NCT00360282|450311007|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
125188610|NCT00360282|450311008|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
125188611|NCT00360282|450311005|FG000|Second Intervention|Adverse Event|0|||
125188612|NCT00360282|450311006|FG001|Second Intervention|Adverse Event|1|||
125188613|NCT00360282|450311007|FG002|Second Intervention|Adverse Event|0|||
125188614|NCT00360282|450311008|FG003|Second Intervention|Adverse Event|0|||
125188615|NCT00925704|450311009|FG000|First Intervention|Withdrew consent|0|||
125188616|NCT00925704|450311010|FG001|First Intervention|Withdrew consent|0|||
125188617|NCT00925704|450311011|FG002|First Intervention|Withdrew consent|0|||
125188618|NCT00925704|450311012|FG003|First Intervention|Withdrew consent|1|||
125188619|NCT00925704|450311013|FG004|First Intervention|Withdrew consent|1|||
125188620|NCT00925704|450311014|FG005|First Intervention|Withdrew consent|0|||
125188621|NCT00925704|450311009|FG000|Second Intervention|Withdrawal by Subject|1|||
125188622|NCT00925704|450311010|FG001|Second Intervention|Withdrawal by Subject|0|||
125188623|NCT00925704|450311011|FG002|Second Intervention|Withdrawal by Subject|0|||
125188624|NCT00925704|450311012|FG003|Second Intervention|Withdrawal by Subject|0|||
125188625|NCT00925704|450311013|FG004|Second Intervention|Withdrawal by Subject|1|||
125188626|NCT00925704|450311014|FG005|Second Intervention|Withdrawal by Subject|0|||
125188627|NCT00925704|450311009|FG000|Third Intervention|Withdrew consent|0|||
125188628|NCT00925704|450311010|FG001|Third Intervention|Withdrew consent|0|||
125188629|NCT00925704|450311011|FG002|Third Intervention|Withdrew consent|0|||
125188630|NCT00925704|450311012|FG003|Third Intervention|Withdrew consent|0|||
125188631|NCT00925704|450311013|FG004|Third Intervention|Withdrew consent|0|||
125188632|NCT00925704|450311014|FG005|Third Intervention|Withdrew consent|1|||
125243072|NCT01132755|450513427|FG000|Overall Study|Withdrawal by Subject|4|||
125243073|NCT02232698|450513428|FG000|Overall Study|Pregnancy|1|||
125243074|NCT02232698|450513429|FG001|Overall Study|Pregnancy|1|||
125188633|NCT02996968|450311015|FG000|Overall Study|Withdrawal by Subject|1|||
125188634|NCT02996968|450311016|FG001|Overall Study|Withdrawal by Subject|0|||
125188635|NCT02044302|450311020|FG000|Overall Study|study terminated|2|||
125243075|NCT02232698|450513428|FG000|Overall Study|Met exclusion criteria|1|||
125243076|NCT02232698|450513429|FG001|Overall Study|Met exclusion criteria|1|||
125243077|NCT02232698|450513428|FG000|Overall Study|Had device-associated symptoms|7|||
125188636|NCT02044302|450311021|FG001|Overall Study|study terminated|0|||
125188637|NCT00449865|450311026|FG000|Overall Study|Withdrawal by Subject|110|||
125188638|NCT00449865|450311027|FG001|Overall Study|Withdrawal by Subject|110|||
125243078|NCT02232698|450513429|FG001|Overall Study|Had device-associated symptoms|0|||
125243079|NCT02232698|450513428|FG000|Overall Study|Non-compliance with study device|1|||
125188639|NCT00449865|450311026|FG000|Overall Study|Lost to Follow-up|36|||
125188640|NCT00449865|450311027|FG001|Overall Study|Lost to Follow-up|37|||
125188641|NCT00449865|450311026|FG000|Overall Study|Physician Decision|13|||
125188642|NCT00449865|450311027|FG001|Overall Study|Physician Decision|12|||
125188643|NCT00449865|450311026|FG000|Overall Study|Death|31|||
125188644|NCT00449865|450311027|FG001|Overall Study|Death|40|||
125188645|NCT00449865|450311026|FG000|Overall Study|Protocol Violation|8|||
125188646|NCT00449865|450311027|FG001|Overall Study|Protocol Violation|7|||
125188647|NCT00449865|450311026|FG000|Overall Study|Study was stopped|324|||
125188648|NCT00449865|450311027|FG001|Overall Study|Study was stopped|328|||
125188649|NCT00444535|450311028|FG000|Overall Study|Withdrawal by Subject|5|||
125188650|NCT00444535|450311028|FG000|Overall Study|Physician Decision|5|||
125188651|NCT00444535|450311028|FG000|Overall Study|progressive disease|1|||
125188652|NCT00444535|450311028|FG000|Overall Study|Adverse Event|2|||
125188653|NCT02556775|450311029|FG000|Overall Study|Withdrawal by Subject|1|||
125188654|NCT02556775|450311030|FG001|Overall Study|Withdrawal by Subject|0|||
125188655|NCT02556775|450311031|FG002|Overall Study|Withdrawal by Subject|1|||
125188656|NCT02556775|450311032|FG003|Overall Study|Withdrawal by Subject|0|||
125188657|NCT02556775|450311029|FG000|Overall Study|Lost to Follow-up|1|||
125188658|NCT02556775|450311030|FG001|Overall Study|Lost to Follow-up|0|||
125188659|NCT02556775|450311031|FG002|Overall Study|Lost to Follow-up|0|||
125188660|NCT02556775|450311032|FG003|Overall Study|Lost to Follow-up|0|||
125188661|NCT00558467|450311038|FG000|Overall Study|Adverse Event|1|||
125188662|NCT00558467|450311039|FG001|Overall Study|Adverse Event|2|||
125188663|NCT00558467|450311038|FG000|Overall Study|Lack of Efficacy|0|||
125188664|NCT00558467|450311039|FG001|Overall Study|Lack of Efficacy|1|||
125188665|NCT00558467|450311038|FG000|Overall Study|Patient moving out of state|0|||
125188666|NCT00558467|450311039|FG001|Overall Study|Patient moving out of state|1|||
125188667|NCT02025725|450311048|FG000|Overall Study|Adverse Event|5|||
125188668|NCT02025725|450311049|FG001|Overall Study|Adverse Event|0|||
125188669|NCT02025725|450311048|FG000|Overall Study|Lost to Follow-up|2|||
125188670|NCT02025725|450311049|FG001|Overall Study|Lost to Follow-up|0|||
125188671|NCT02025725|450311048|FG000|Overall Study|Protocol Violation|1|||
125188672|NCT02025725|450311049|FG001|Overall Study|Protocol Violation|1|||
125188673|NCT02025725|450311048|FG000|Overall Study|Withdrawal by Subject|3|||
125188674|NCT02025725|450311049|FG001|Overall Study|Withdrawal by Subject|2|||
125188675|NCT02025725|450311048|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
125188676|NCT02025725|450311049|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
125188677|NCT06509438|450311050|FG000|Overall Study|Adverse Event|1|||
125188678|NCT06509438|450311050|FG000|Overall Study|Lost to Follow-up|3|||
125188679|NCT03331796|450311051|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
125188680|NCT03331796|450311052|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
125188681|NCT03331796|450311053|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
125188682|NCT03331796|450311051|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
125188683|NCT03331796|450311052|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
125188684|NCT03331796|450311053|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
125188685|NCT03331796|450311051|FG000|Extended Follow-up|Adverse Event|1|||
125188686|NCT03331796|450311052|FG001|Extended Follow-up|Adverse Event|0|||
125188687|NCT03331796|450311053|FG002|Extended Follow-up|Adverse Event|1|||
125188688|NCT03331796|450311051|FG000|Extended Follow-up|Lost to Follow-up|0|||
125188689|NCT03331796|450311052|FG001|Extended Follow-up|Lost to Follow-up|0|||
125188690|NCT03331796|450311053|FG002|Extended Follow-up|Lost to Follow-up|1|||
125188691|NCT03331796|450311051|FG000|Extended Follow-up|Withdrawal by Subject|1|||
125188692|NCT03331796|450311052|FG001|Extended Follow-up|Withdrawal by Subject|0|||
125188693|NCT03331796|450311053|FG002|Extended Follow-up|Withdrawal by Subject|0|||
125188694|NCT03331796|450311051|FG000|Extended Follow-up|Termination of Funding|0|||
125188695|NCT03331796|450311052|FG001|Extended Follow-up|Termination of Funding|1|||
125188696|NCT03331796|450311053|FG002|Extended Follow-up|Termination of Funding|0|||
125188697|NCT02867592|450311054|FG000|Overall Study|Adverse Event|3|||
125188698|NCT02867592|450311055|FG001|Overall Study|Adverse Event|0|||
125188699|NCT02867592|450311056|FG002|Overall Study|Adverse Event|2|||
125188700|NCT02867592|450311057|FG003|Overall Study|Adverse Event|1|||
125188701|NCT02867592|450311058|FG004|Overall Study|Adverse Event|1|||
125188702|NCT02867592|450311059|FG005|Overall Study|Adverse Event|5|||
125188703|NCT02867592|450311054|FG000|Overall Study|Death|0|||
125188704|NCT02867592|450311055|FG001|Overall Study|Death|0|||
125188705|NCT02867592|450311056|FG002|Overall Study|Death|0|||
125188706|NCT02867592|450311057|FG003|Overall Study|Death|1|||
125188707|NCT02867592|450311058|FG004|Overall Study|Death|0|||
125188708|NCT02867592|450311059|FG005|Overall Study|Death|1|||
125188709|NCT02867592|450311054|FG000|Overall Study|Lack of Efficacy|8|||
125188710|NCT02867592|450311055|FG001|Overall Study|Lack of Efficacy|10|||
125188711|NCT02867592|450311056|FG002|Overall Study|Lack of Efficacy|8|||
125188712|NCT02867592|450311057|FG003|Overall Study|Lack of Efficacy|8|||
125188713|NCT02867592|450311058|FG004|Overall Study|Lack of Efficacy|12|||
125188714|NCT02867592|450311059|FG005|Overall Study|Lack of Efficacy|17|||
125188715|NCT02867592|450311054|FG000|Overall Study|Physician Decision|1|||
125188716|NCT02867592|450311055|FG001|Overall Study|Physician Decision|2|||
125188717|NCT02867592|450311056|FG002|Overall Study|Physician Decision|2|||
125243080|NCT02232698|450513429|FG001|Overall Study|Non-compliance with study device|4|||
125243081|NCT02232698|450513428|FG000|Overall Study|Allocated to control group|0|||
125243082|NCT02232698|450513429|FG001|Overall Study|Allocated to control group|3|||
125243083|NCT02232698|450513428|FG000|Overall Study|Withdrawal by Subject|0|||
125243084|NCT02232698|450513429|FG001|Overall Study|Withdrawal by Subject|11|||
125243085|NCT00387127|450513430|FG000|Overall Study|Lost to Follow-up|0|||
125243086|NCT00387127|450513431|FG001|Overall Study|Lost to Follow-up|4|||
125243087|NCT00387127|450513430|FG000|Overall Study|Death|16|||
125243088|NCT00387127|450513431|FG001|Overall Study|Death|16|||
125243089|NCT00387127|450513430|FG000|Overall Study|Physician Decision|0|||
125243090|NCT00387127|450513431|FG001|Overall Study|Physician Decision|1|||
125243091|NCT00387127|450513430|FG000|Overall Study|Withdrawal by Subject|3|||
125243092|NCT00387127|450513431|FG001|Overall Study|Withdrawal by Subject|2|||
125243093|NCT00387127|450513430|FG000|Overall Study|Required by Protocol Amendment #4|12|||
125243094|NCT00387127|450513431|FG001|Overall Study|Required by Protocol Amendment #4|10|||
125243095|NCT00387127|450513430|FG000|Overall Study|Serious Adverse Event|1|||
125243096|NCT00387127|450513431|FG001|Overall Study|Serious Adverse Event|1|||
125243097|NCT00387127|450513430|FG000|Overall Study|Sponsor Unblinded|1|||
125243098|NCT00387127|450513431|FG001|Overall Study|Sponsor Unblinded|0|||
125243099|NCT02393755|450513432|FG000|Overall Study|Withdrawal by Subject|0|||
125243100|NCT02393755|450513433|FG001|Overall Study|Withdrawal by Subject|3|||
125243101|NCT02393755|450513432|FG000|Overall Study|Adverse Event|0|||
125243102|NCT02393755|450513433|FG001|Overall Study|Adverse Event|2|||
125243103|NCT02393755|450513432|FG000|Overall Study|Physician Decision|0|||
125243104|NCT02393755|450513433|FG001|Overall Study|Physician Decision|2|||
125243105|NCT01786109|450513434|FG000|Overall Study|fail manometry barostat tube placement|1|||
125243106|NCT01786109|450513435|FG001|Overall Study|fail manometry barostat tube placement|0|||
125243107|NCT01786109|450513436|FG002|Overall Study|fail manometry barostat tube placement|0|||
125243108|NCT01786109|450513434|FG000|Overall Study|unrelated illness|0|||
125243109|NCT01786109|450513435|FG001|Overall Study|unrelated illness|0|||
125243110|NCT01786109|450513436|FG002|Overall Study|unrelated illness|1|||
125243111|NCT01786109|450513434|FG000|Overall Study|adverse effects colon preparation|0|||
125243112|NCT01786109|450513435|FG001|Overall Study|adverse effects colon preparation|0|||
125243113|NCT01786109|450513436|FG002|Overall Study|adverse effects colon preparation|1|||
125243114|NCT04069520|450513442|FG000|Overall Study|Lost to Follow-up|0|||
125243115|NCT04069520|450513443|FG001|Overall Study|Lost to Follow-up|2|||
125243116|NCT04069520|450513442|FG000|Overall Study|Withdrawal by Subject|0|||
125243117|NCT04069520|450513443|FG001|Overall Study|Withdrawal by Subject|1|||
125243118|NCT04069520|450513442|FG000|Overall Study|Prior Injury|1|||
125243119|NCT04069520|450513443|FG001|Overall Study|Prior Injury|0|||
125243120|NCT04069520|450513442|FG000|Overall Study|Orthodontia|1|||
125243121|NCT04069520|450513443|FG001|Overall Study|Orthodontia|0|||
125243122|NCT04069520|450513442|FG000|Overall Study|Cut from team|0|||
125243123|NCT04069520|450513443|FG001|Overall Study|Cut from team|2|||
125243124|NCT01068912|450513444|FG000|Overall Study|Adverse Event|2|||
125243125|NCT01068912|450513445|FG001|Overall Study|Adverse Event|3|||
125243126|NCT01068912|450513446|FG002|Overall Study|Adverse Event|2|||
125243127|NCT01068912|450513444|FG000|Overall Study|Withdrawal by Subject|5|||
125243128|NCT01068912|450513445|FG001|Overall Study|Withdrawal by Subject|6|||
125243129|NCT01068912|450513446|FG002|Overall Study|Withdrawal by Subject|6|||
125243130|NCT01068912|450513444|FG000|Overall Study|Lost to Follow-up|3|||
125243131|NCT01068912|450513445|FG001|Overall Study|Lost to Follow-up|7|||
125243132|NCT01068912|450513446|FG002|Overall Study|Lost to Follow-up|3|||
125243133|NCT01068912|450513444|FG000|Overall Study|Protocol Violation|0|||
125243134|NCT01068912|450513445|FG001|Overall Study|Protocol Violation|2|||
125243135|NCT01068912|450513446|FG002|Overall Study|Protocol Violation|0|||
125243136|NCT01068912|450513444|FG000|Overall Study|aggravation influenza|1|||
125243137|NCT01068912|450513445|FG001|Overall Study|aggravation influenza|1|||
125243138|NCT01068912|450513446|FG002|Overall Study|aggravation influenza|1|||
125243139|NCT01068912|450513444|FG000|Overall Study|other underlying illness|0|||
125243140|NCT01068912|450513445|FG001|Overall Study|other underlying illness|3|||
125243141|NCT01068912|450513446|FG002|Overall Study|other underlying illness|3|||
125188718|NCT02867592|450311057|FG003|Overall Study|Physician Decision|0|||
125188719|NCT02867592|450311058|FG004|Overall Study|Physician Decision|5|||
125188720|NCT02867592|450311059|FG005|Overall Study|Physician Decision|1|||
125188721|NCT02867592|450311054|FG000|Overall Study|Protocol Violation|0|||
125188722|NCT02867592|450311055|FG001|Overall Study|Protocol Violation|0|||
125188723|NCT02867592|450311056|FG002|Overall Study|Protocol Violation|0|||
125188724|NCT02867592|450311057|FG003|Overall Study|Protocol Violation|0|||
125243142|NCT04822194|450513447|FG000|Overall Study|Withdrawal by Subject|5|||
125188725|NCT02867592|450311058|FG004|Overall Study|Protocol Violation|1|||
125188726|NCT02867592|450311059|FG005|Overall Study|Protocol Violation|1|||
125243143|NCT04822194|450513448|FG001|Overall Study|Withdrawal by Subject|4|||
125243144|NCT04822194|450513447|FG000|Overall Study|Technical issues with MR scanner|1|||
125243145|NCT04822194|450513448|FG001|Overall Study|Technical issues with MR scanner|0|||
125243146|NCT04822194|450513447|FG000|Overall Study|Lost to Follow-up|5|||
125243147|NCT04822194|450513448|FG001|Overall Study|Lost to Follow-up|7|||
125243148|NCT01947933|450513450|FG000|Overall Study|Withdrawal by Subject|0|||
125243149|NCT01947933|450513451|FG001|Overall Study|Withdrawal by Subject|0|||
125243150|NCT01947933|450513452|FG002|Overall Study|Withdrawal by Subject|1|||
125243151|NCT01947933|450513453|FG003|Overall Study|Withdrawal by Subject|0|||
125243152|NCT01947933|450513454|FG004|Overall Study|Withdrawal by Subject|0|||
125243153|NCT01947933|450513455|FG005|Overall Study|Withdrawal by Subject|0|||
125243154|NCT01947933|450513456|FG006|Overall Study|Withdrawal by Subject|0|||
125243155|NCT01947933|450513457|FG007|Overall Study|Withdrawal by Subject|0|||
125243156|NCT01947933|450513458|FG008|Overall Study|Withdrawal by Subject|0|||
125243157|NCT01947933|450513450|FG000|Overall Study|Lost to Follow-up|0|||
125243158|NCT01947933|450513451|FG001|Overall Study|Lost to Follow-up|0|||
125243159|NCT01947933|450513452|FG002|Overall Study|Lost to Follow-up|0|||
125243160|NCT01947933|450513453|FG003|Overall Study|Lost to Follow-up|0|||
125243161|NCT01947933|450513454|FG004|Overall Study|Lost to Follow-up|0|||
125243162|NCT01947933|450513455|FG005|Overall Study|Lost to Follow-up|0|||
125243163|NCT01947933|450513456|FG006|Overall Study|Lost to Follow-up|0|||
125243164|NCT01947933|450513457|FG007|Overall Study|Lost to Follow-up|0|||
125243165|NCT01947933|450513458|FG008|Overall Study|Lost to Follow-up|1|||
125243166|NCT00294398|450513461|FG000|Overall Study|Lost to Follow-up|21|||
125243167|NCT00294398|450513462|FG001|Overall Study|Lost to Follow-up|26|||
125243168|NCT02965833|450513463|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
125243169|NCT02965833|450513464|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
125243170|NCT02965833|450513463|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
125243171|NCT02965833|450513464|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
125243172|NCT02965833|450513463|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
125243173|NCT02965833|450513464|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
125243174|NCT02965833|450513463|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
125243175|NCT02965833|450513464|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
125243176|NCT02965833|450513463|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
125243177|NCT02965833|450513464|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
125243178|NCT03407482|450513468|FG000|Overall Study|Adverse Event|12|||
125243179|NCT03407482|450513468|FG000|Overall Study|Disease Relapse|1|||
125243180|NCT03407482|450513468|FG000|Overall Study|Lost to Follow-up|1|||
125243181|NCT03407482|450513468|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125243182|NCT03407482|450513468|FG000|Overall Study|Pregnancy|2|||
125243183|NCT03407482|450513468|FG000|Overall Study|Protocol Violation|1|||
125243184|NCT03407482|450513468|FG000|Overall Study|Study Terminated By Sponsor|106|||
125243185|NCT03407482|450513468|FG000|Overall Study|Withdrawal by Subject|6|||
125243186|NCT03407482|450513468|FG000|Overall Study|Data Entry Error|1|||
125243187|NCT05643794|450514626|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
125243188|NCT05643794|450514627|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
125243189|NCT05643794|450514628|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
125243190|NCT05643794|450514626|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
125243191|NCT05643794|450514627|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125243192|NCT05643794|450514628|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125243193|NCT05643794|450514626|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
125243194|NCT05643794|450514627|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
125243195|NCT05643794|450514628|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
125243196|NCT05643794|450514626|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
125243197|NCT05643794|450514627|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
125243198|NCT05643794|450514628|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
125243199|NCT05643794|450514626|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
125243200|NCT05643794|450514627|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
125243201|NCT05643794|450514628|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
125243202|NCT05643794|450514626|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
125243203|NCT05643794|450514627|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
125243204|NCT05643794|450514628|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
125243205|NCT01363076|450514633|FG000|Overall Study|Withdrawal by Subject|0|||
125243206|NCT01363076|450514634|FG001|Overall Study|Withdrawal by Subject|1|||
125243207|NCT04706403|450514635|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
125243208|NCT04706403|450514636|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
125243209|NCT04706403|450514637|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
125243210|NCT04706403|450514638|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
125188727|NCT02867592|450311054|FG000|Overall Study|Withdrawal by Subject|0|||
125188728|NCT02867592|450311055|FG001|Overall Study|Withdrawal by Subject|1|||
125188729|NCT02867592|450311056|FG002|Overall Study|Withdrawal by Subject|0|||
125188730|NCT02867592|450311057|FG003|Overall Study|Withdrawal by Subject|1|||
125188731|NCT02867592|450311058|FG004|Overall Study|Withdrawal by Subject|3|||
125188732|NCT02867592|450311059|FG005|Overall Study|Withdrawal by Subject|3|||
125188733|NCT02867592|450311054|FG000|Overall Study|Ineligible|1|||
125188734|NCT02867592|450311055|FG001|Overall Study|Ineligible|1|||
125188735|NCT02867592|450311056|FG002|Overall Study|Ineligible|0|||
125188736|NCT02867592|450311057|FG003|Overall Study|Ineligible|0|||
125188737|NCT02867592|450311058|FG004|Overall Study|Ineligible|2|||
125188738|NCT02867592|450311059|FG005|Overall Study|Ineligible|0|||
125188739|NCT02867592|450311054|FG000|Overall Study|No Treatment|1|||
125188740|NCT02867592|450311055|FG001|Overall Study|No Treatment|0|||
125188741|NCT02867592|450311056|FG002|Overall Study|No Treatment|0|||
125188742|NCT02867592|450311057|FG003|Overall Study|No Treatment|0|||
125188743|NCT02867592|450311058|FG004|Overall Study|No Treatment|0|||
125188744|NCT02867592|450311059|FG005|Overall Study|No Treatment|0|||
125188745|NCT02867592|450311054|FG000|Overall Study|Still on Therapy|0|||
125188746|NCT02867592|450311055|FG001|Overall Study|Still on Therapy|0|||
125188747|NCT02867592|450311056|FG002|Overall Study|Still on Therapy|0|||
125188748|NCT02867592|450311057|FG003|Overall Study|Still on Therapy|0|||
125188749|NCT02867592|450311058|FG004|Overall Study|Still on Therapy|1|||
125188750|NCT02867592|450311059|FG005|Overall Study|Still on Therapy|0|||
125188751|NCT02867592|450311054|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
125188752|NCT02867592|450311055|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
125188753|NCT02867592|450311056|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
125188754|NCT02867592|450311057|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
125188755|NCT02867592|450311058|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
125188756|NCT02867592|450311059|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
125188757|NCT02867592|450311054|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
125188758|NCT02867592|450311055|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
125188759|NCT02867592|450311056|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
125188760|NCT02867592|450311057|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
125188761|NCT02867592|450311058|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
125188762|NCT02867592|450311059|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
125188763|NCT00594165|450311060|FG000|Overall Study|Major protocol violation|1|||
125188764|NCT00594165|450311060|FG000|Overall Study|Lack of Efficacy|12|||
125188765|NCT00594165|450311060|FG000|Overall Study|Adverse Event|52|||
125188766|NCT00594165|450311060|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
125188767|NCT00594165|450311060|FG000|Overall Study|Subject withdrew consent|27|||
125188768|NCT00594165|450311060|FG000|Overall Study|Study ended per sponsor|102|||
125188769|NCT00594165|450311060|FG000|Overall Study|Lost to Follow-up|4|||
125188770|NCT00594165|450311060|FG000|Overall Study|Other: PI discretion|5|||
125188771|NCT00594165|450311060|FG000|Overall Study|Other: Subject moving|3|||
125188772|NCT00594165|450311060|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
125188773|NCT00594165|450311060|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
125188774|NCT00594165|450311060|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
125188775|NCT00594165|450311060|FG000|Overall Study|Other: Site terminated participation|2|||
125188776|NCT00571727|450311063|FG000|Overall Study|Did not enter in this study|1|||
125188777|NCT00571727|450311063|FG000|Overall Study|Non-compliance|4|||
125188778|NCT00571727|450311063|FG000|Overall Study|Lost to Follow-up|30|||
125188779|NCT00571727|450311063|FG000|Overall Study|Poor growth|1|||
125188780|NCT00571727|450311063|FG000|Overall Study|Parent/patient decision|2|||
125188781|NCT00571727|450311063|FG000|Overall Study|Participant transferred to commercial drug|14|||
125188782|NCT00571727|450311063|FG000|Overall Study|Unable to provide study drug|6|||
125188783|NCT00571727|450311063|FG000|Overall Study|On-treatment at end of study|8|||
125188784|NCT03581292|450311064|FG000|Overall Study|Physician Decision|9|||
125188785|NCT03581292|450311065|FG001|Overall Study|Physician Decision|5|||
125188786|NCT03581292|450311064|FG000|Overall Study|Withdrawal by Subject|3|||
125188787|NCT03581292|450311065|FG001|Overall Study|Withdrawal by Subject|0|||
125188788|NCT03581292|450311064|FG000|Overall Study|Withdrawal before Therapy Start|1|||
125188789|NCT03581292|450311065|FG001|Overall Study|Withdrawal before Therapy Start|0|||
125188790|NCT01735916|450312935|FG000|Overall Study|Subject not eligible to be randomized|11|||
125188791|NCT01735916|450312936|FG001|Overall Study|Subject not eligible to be randomized|0|||
125188792|NCT01735916|450312937|FG002|Overall Study|Subject not eligible to be randomized|0|||
125188793|NCT01735916|450312935|FG000|Overall Study|Early termination of study by sponsor|4|||
125188794|NCT01735916|450312936|FG001|Overall Study|Early termination of study by sponsor|19|||
125188795|NCT01735916|450312937|FG002|Overall Study|Early termination of study by sponsor|7|||
125188796|NCT01735916|450312935|FG000|Overall Study|Withdrawal by Subject|3|||
125188797|NCT01735916|450312936|FG001|Overall Study|Withdrawal by Subject|0|||
125188798|NCT01735916|450312937|FG002|Overall Study|Withdrawal by Subject|0|||
125188799|NCT04227197|450312941|FG000|Randomization|Protocol Violation|1|||
125188800|NCT04227197|450312942|FG001|Randomization|Protocol Violation|0|||
125188801|NCT04227197|450312941|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
125188802|NCT04227197|450312942|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
125188803|NCT04227197|450312941|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
125188804|NCT04227197|450312942|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
125188805|NCT04227197|450312941|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
125188806|NCT04227197|450312942|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
125188807|NCT04227197|450312941|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
125188808|NCT04227197|450312942|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
125188809|NCT04227197|450312941|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
125188810|NCT04227197|450312942|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
125188811|NCT04227197|450312941|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
125188812|NCT04227197|450312942|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
125188813|NCT00570141|450312943|FG000|Overall Study|Adverse Event|1|||
125188814|NCT00570141|450312943|FG000|Overall Study|Missed visits|1|||
125188815|NCT00570141|450312943|FG000|Overall Study|Lost to Follow-up|1|||
125188816|NCT01209949|450312955|FG000|Overall Study|Lost to Follow-up|3|||
125188817|NCT00729612|450312960|FG000|Overall Study|Non evaluable for response|10|||
125188818|NCT03207815|450312966|FG000|Overall Study|Protocol Violation|3|||
125188819|NCT03207815|450312967|FG001|Overall Study|Protocol Violation|1|||
125188820|NCT03207815|450312966|FG000|Overall Study|Adverse Event|1|||
125188821|NCT03207815|450312967|FG001|Overall Study|Adverse Event|2|||
125188822|NCT03207815|450312966|FG000|Overall Study|Lost to Follow-up|1|||
125188823|NCT03207815|450312967|FG001|Overall Study|Lost to Follow-up|2|||
125188824|NCT03207815|450312966|FG000|Overall Study|Investigator's Discretion|1|||
125188825|NCT03207815|450312967|FG001|Overall Study|Investigator's Discretion|1|||
125188826|NCT03207815|450312966|FG000|Overall Study|Lack of Efficacy|0|||
125188827|NCT03207815|450312967|FG001|Overall Study|Lack of Efficacy|1|||
125188828|NCT03207815|450312966|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
125188829|NCT03207815|450312967|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
125188830|NCT03207815|450312966|FG000|Overall Study|Withdrew Consent|1|||
125188831|NCT03207815|450312967|FG001|Overall Study|Withdrew Consent|0|||
125188832|NCT01671007|450312968|FG000|Overall Study|Other reasons than listed|166|||
125188833|NCT01671007|450312969|FG001|Overall Study|Other reasons than listed|373|||
125188834|NCT01671007|450312970|FG002|Overall Study|Other reasons than listed|197|||
125188835|NCT01671007|450312971|FG003|Overall Study|Other reasons than listed|228|||
125188836|NCT01671007|450312972|FG004|Overall Study|Other reasons than listed|14|||
125188837|NCT01671007|450312973|FG005|Overall Study|Other reasons than listed|71|||
125188838|NCT01671007|450312974|FG006|Overall Study|Other reasons than listed|17|||
125188839|NCT01671007|450312975|FG007|Overall Study|Other reasons than listed|66|||
125188840|NCT01671007|450312976|FG008|Overall Study|Other reasons than listed|0|||
125188841|NCT01671007|450312968|FG000|Overall Study|Withdrawal by Subject|36|||
125188842|NCT01671007|450312969|FG001|Overall Study|Withdrawal by Subject|59|||
125188843|NCT01671007|450312970|FG002|Overall Study|Withdrawal by Subject|53|||
125188844|NCT01671007|450312971|FG003|Overall Study|Withdrawal by Subject|58|||
125188845|NCT01671007|450312972|FG004|Overall Study|Withdrawal by Subject|4|||
125188846|NCT01671007|450312973|FG005|Overall Study|Withdrawal by Subject|15|||
125188847|NCT01671007|450312974|FG006|Overall Study|Withdrawal by Subject|1|||
125188848|NCT01671007|450312975|FG007|Overall Study|Withdrawal by Subject|19|||
125188849|NCT01671007|450312976|FG008|Overall Study|Withdrawal by Subject|0|||
125188850|NCT01671007|450312968|FG000|Overall Study|Lost to Follow-up|93|||
125188851|NCT01671007|450312969|FG001|Overall Study|Lost to Follow-up|142|||
125188852|NCT01671007|450312970|FG002|Overall Study|Lost to Follow-up|91|||
125188853|NCT01671007|450312971|FG003|Overall Study|Lost to Follow-up|63|||
125188854|NCT01671007|450312972|FG004|Overall Study|Lost to Follow-up|7|||
125188855|NCT01671007|450312973|FG005|Overall Study|Lost to Follow-up|20|||
125188856|NCT01671007|450312974|FG006|Overall Study|Lost to Follow-up|2|||
125188857|NCT01671007|450312975|FG007|Overall Study|Lost to Follow-up|28|||
125188858|NCT01671007|450312976|FG008|Overall Study|Lost to Follow-up|0|||
125188859|NCT01671007|450312968|FG000|Overall Study|No end of study case report form|3|||
125188860|NCT01671007|450312969|FG001|Overall Study|No end of study case report form|1|||
125188861|NCT01671007|450312970|FG002|Overall Study|No end of study case report form|0|||
125188862|NCT01671007|450312971|FG003|Overall Study|No end of study case report form|2|||
125188863|NCT01671007|450312972|FG004|Overall Study|No end of study case report form|0|||
125188864|NCT01671007|450312973|FG005|Overall Study|No end of study case report form|0|||
125188865|NCT01671007|450312974|FG006|Overall Study|No end of study case report form|0|||
125188866|NCT01671007|450312975|FG007|Overall Study|No end of study case report form|0|||
125188867|NCT01671007|450312976|FG008|Overall Study|No end of study case report form|0|||
125188868|NCT01671007|450312968|FG000|Overall Study|Not eligible|23|||
125188869|NCT01671007|450312969|FG001|Overall Study|Not eligible|76|||
125188870|NCT01671007|450312970|FG002|Overall Study|Not eligible|25|||
125188871|NCT01671007|450312971|FG003|Overall Study|Not eligible|17|||
125188872|NCT01671007|450312972|FG004|Overall Study|Not eligible|0|||
125188873|NCT01671007|450312973|FG005|Overall Study|Not eligible|6|||
125188874|NCT01671007|450312974|FG006|Overall Study|Not eligible|1|||
125188875|NCT01671007|450312975|FG007|Overall Study|Not eligible|19|||
125188876|NCT01671007|450312976|FG008|Overall Study|Not eligible|0|||
125188877|NCT00391768|450312977|FG000|Overall Study|Withdrawal by Subject|0|||
125188878|NCT00391768|450312978|FG001|Overall Study|Withdrawal by Subject|0|||
125188879|NCT00391768|450312979|FG002|Overall Study|Withdrawal by Subject|1|||
125188880|NCT00391768|450312980|FG003|Overall Study|Withdrawal by Subject|0|||
125188881|NCT00391768|450312981|FG004|Overall Study|Withdrawal by Subject|0|||
125188882|NCT00391768|450312982|FG005|Overall Study|Withdrawal by Subject|1|||
125188883|NCT00391768|450312983|FG006|Overall Study|Withdrawal by Subject|1|||
125188884|NCT00391768|450312977|FG000|Overall Study|Lost to Follow-up|0|||
125188885|NCT00391768|450312978|FG001|Overall Study|Lost to Follow-up|0|||
125188886|NCT00391768|450312979|FG002|Overall Study|Lost to Follow-up|0|||
125188887|NCT00391768|450312980|FG003|Overall Study|Lost to Follow-up|1|||
125188888|NCT00391768|450312981|FG004|Overall Study|Lost to Follow-up|2|||
125188889|NCT00391768|450312982|FG005|Overall Study|Lost to Follow-up|2|||
125188890|NCT00391768|450312983|FG006|Overall Study|Lost to Follow-up|3|||
125188891|NCT00406367|450312984|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
125188892|NCT00406367|450312985|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
125188893|NCT00406367|450312984|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
125188894|NCT00406367|450312985|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
125188895|NCT00406367|450312984|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
125188896|NCT00406367|450312985|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
125188897|NCT00406367|450312984|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
125188898|NCT00406367|450312985|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
125188899|NCT00406367|450312984|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
125188900|NCT00406367|450312985|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
125188901|NCT00406367|450312984|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
125188902|NCT00406367|450312985|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
125188903|NCT00406367|450312984|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
125188904|NCT00406367|450312985|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
125188905|NCT00406367|450312984|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
125188906|NCT00406367|450312985|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
125188907|NCT00406367|450312984|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
125188908|NCT00406367|450312985|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
125188909|NCT00406367|450312984|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
125188910|NCT00406367|450312985|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
125188911|NCT00406367|450312984|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
125188912|NCT00406367|450312985|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
125188913|NCT00406367|450312984|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
125188914|NCT00406367|450312985|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
125188915|NCT00171210|450312986|FG000|Overall Study|Adverse Event|16|||
125188916|NCT00171210|450312987|FG001|Overall Study|Adverse Event|27|||
125188917|NCT00171210|450312986|FG000|Overall Study|Abnormal laboratory value(s)|6|||
125188918|NCT00171210|450312987|FG001|Overall Study|Abnormal laboratory value(s)|3|||
125188919|NCT00171210|450312986|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125188920|NCT00171210|450312987|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125188921|NCT00171210|450312986|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
125188922|NCT00171210|450312987|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
125188923|NCT00171210|450312986|FG000|Overall Study|Protocol Violation|0|||
125188924|NCT00171210|450312987|FG001|Overall Study|Protocol Violation|2|||
125188925|NCT00171210|450312986|FG000|Overall Study|Withdrawal by Subject|32|||
125188926|NCT00171210|450312987|FG001|Overall Study|Withdrawal by Subject|30|||
125188927|NCT00171210|450312986|FG000|Overall Study|Lost to Follow-up|1|||
125188928|NCT00171210|450312987|FG001|Overall Study|Lost to Follow-up|0|||
125188929|NCT00171210|450312986|FG000|Overall Study|Administrative problems|1|||
125188930|NCT00171210|450312987|FG001|Overall Study|Administrative problems|1|||
125188931|NCT00171210|450312986|FG000|Overall Study|Death|2|||
125188932|NCT00171210|450312987|FG001|Overall Study|Death|3|||
125188933|NCT00171210|450312986|FG000|Overall Study|Stopped at end of core|0|||
125188934|NCT00171210|450312987|FG001|Overall Study|Stopped at end of core|32|||
125188935|NCT00171210|450312986|FG000|Overall Study|Stopped at end of extension 1|0|||
125188936|NCT00171210|450312987|FG001|Overall Study|Stopped at end of extension 1|1|||
125188937|NCT03187301|450312990|FG000|Titration Period|Adverse Event|0|||
125188938|NCT03187301|450312991|FG001|Titration Period|Adverse Event|0|||
125188939|NCT03187301|450312992|FG002|Titration Period|Adverse Event|0|||
125188940|NCT03187301|450312993|FG003|Titration Period|Adverse Event|0|||
125188941|NCT03187301|450312994|FG004|Titration Period|Adverse Event|0|||
125188942|NCT03187301|450312995|FG005|Titration Period|Adverse Event|0|||
125188943|NCT03187301|450312996|FG006|Titration Period|Adverse Event|5|||
125188944|NCT03187301|450312990|FG000|Titration Period|Withdrawal by Subject|0|||
125188945|NCT03187301|450312991|FG001|Titration Period|Withdrawal by Subject|0|||
125188946|NCT03187301|450312992|FG002|Titration Period|Withdrawal by Subject|0|||
125188947|NCT03187301|450312993|FG003|Titration Period|Withdrawal by Subject|0|||
125188948|NCT03187301|450312994|FG004|Titration Period|Withdrawal by Subject|0|||
125188949|NCT03187301|450312995|FG005|Titration Period|Withdrawal by Subject|0|||
125188950|NCT03187301|450312996|FG006|Titration Period|Withdrawal by Subject|1|||
125188951|NCT03187301|450312990|FG000|Titration Period|Exclusion Criteria Met|0|||
125188952|NCT03187301|450312991|FG001|Titration Period|Exclusion Criteria Met|0|||
125188953|NCT03187301|450312992|FG002|Titration Period|Exclusion Criteria Met|0|||
125188954|NCT03187301|450312993|FG003|Titration Period|Exclusion Criteria Met|0|||
125188955|NCT03187301|450312994|FG004|Titration Period|Exclusion Criteria Met|0|||
125188956|NCT03187301|450312995|FG005|Titration Period|Exclusion Criteria Met|0|||
125188957|NCT03187301|450312996|FG006|Titration Period|Exclusion Criteria Met|1|||
125188958|NCT03187301|450312990|FG000|Pre-Intervention|Withdrawal by Subject|1|||
125188959|NCT03187301|450312991|FG001|Pre-Intervention|Withdrawal by Subject|0|||
125188960|NCT03187301|450312992|FG002|Pre-Intervention|Withdrawal by Subject|0|||
125188961|NCT03187301|450312993|FG003|Pre-Intervention|Withdrawal by Subject|0|||
125188962|NCT03187301|450312994|FG004|Pre-Intervention|Withdrawal by Subject|0|||
125188963|NCT03187301|450312995|FG005|Pre-Intervention|Withdrawal by Subject|0|||
125188964|NCT03187301|450312996|FG006|Pre-Intervention|Withdrawal by Subject|0|||
125188965|NCT05005507|450313002|FG000|Overall Study|Premature termination of study|1|||
125188966|NCT04630002|450313007|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
125188967|NCT04630002|450313008|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
125188968|NCT04630002|450313009|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
125188969|NCT04630002|450313007|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
125188970|NCT04630002|450313008|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
125188971|NCT04630002|450313009|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
125188972|NCT04630002|450313007|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
125188973|NCT04630002|450313008|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
125188974|NCT04630002|450313009|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
125188975|NCT04630002|450313007|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
125188976|NCT04630002|450313008|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
125188977|NCT04630002|450313009|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
125188978|NCT04630002|450313007|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
125188979|NCT04630002|450313008|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
125188980|NCT04630002|450313009|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
125188981|NCT04630002|450313007|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
125188982|NCT04630002|450313008|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
125188983|NCT04630002|450313009|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
125188984|NCT04630002|450313007|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
125188985|NCT04630002|450313008|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
125188986|NCT04630002|450313009|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
125188987|NCT04630002|450313007|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
125188988|NCT04630002|450313008|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
125188989|NCT04630002|450313009|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
125188990|NCT00442897|450313011|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
125188991|NCT00442897|450313012|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
125188992|NCT00442897|450313011|FG000|Base Study (12 Week Follow-up)|Death|0|||
125188993|NCT00442897|450313012|FG001|Base Study (12 Week Follow-up)|Death|1|||
125188994|NCT00442897|450313011|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
125188995|NCT00442897|450313012|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
125188996|NCT00442897|450313011|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
125188997|NCT00442897|450313012|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
125188998|NCT00442897|450313011|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
125188999|NCT00442897|450313012|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
125189000|NCT00442897|450313011|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
125189001|NCT00442897|450313012|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
125189002|NCT00442897|450313011|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
125189003|NCT00442897|450313012|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
125189004|NCT00442897|450313011|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
125189005|NCT00442897|450313012|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
125189006|NCT04498182|450313013|FG000|Overall Study|Adverse Event|2|||
125243211|NCT04706403|450514639|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
125243212|NCT00182637|450514640|FG000|Overall Study|Adverse Event|2|||
125243213|NCT00182637|450514640|FG000|Overall Study|Disease Progression|1|||
125243214|NCT04766333|450514642|FG000|Overall Study|Lost to Follow-up|40|||
125243215|NCT04766333|450514643|FG001|Overall Study|Lost to Follow-up|826|||
125243216|NCT00639379|450514647|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
125243217|NCT00639379|450514648|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
125243218|NCT00639379|450514647|FG000|Period 1 - 2 Weeks|lens issue|3|||
125243219|NCT00639379|450514648|FG001|Period 1 - 2 Weeks|lens issue|0|||
125243220|NCT00723944|450514649|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
125243221|NCT00723944|450514650|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
125243222|NCT00723944|450514649|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
125243223|NCT00723944|450514650|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
125243224|NCT00723944|450514649|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
125243225|NCT00723944|450514650|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
125243226|NCT02400736|450514651|FG000|Overall Study|Lost to Follow-up|6|||
125243227|NCT02400736|450514652|FG001|Overall Study|Lost to Follow-up|6|||
125243228|NCT02400736|450514651|FG000|Overall Study|Withdrawal by Subject|2|||
125243229|NCT02400736|450514652|FG001|Overall Study|Withdrawal by Subject|1|||
125243230|NCT02400736|450514651|FG000|Overall Study|Moved from the area|3|||
125243231|NCT02400736|450514652|FG001|Overall Study|Moved from the area|1|||
125243232|NCT02383173|450514655|FG000|Overall Study|Palliative Care Team withdrew|0|||
125243233|NCT02383173|450514656|FG001|Overall Study|Palliative Care Team withdrew|2|||
125243234|NCT01297244|450514657|FG000|Overall Study|Progressive disease|22|||
125243235|NCT01297244|450514658|FG001|Overall Study|Progressive disease|3|||
125243236|NCT01297244|450514657|FG000|Overall Study|Adverse Event|9|||
125243237|NCT01297244|450514658|FG001|Overall Study|Adverse Event|1|||
125243238|NCT01297244|450514657|FG000|Overall Study|Death|1|||
125243239|NCT01297244|450514658|FG001|Overall Study|Death|1|||
125243240|NCT01297244|450514657|FG000|Overall Study|Clinical progression|1|||
125243241|NCT01297244|450514658|FG001|Overall Study|Clinical progression|1|||
125243242|NCT01297244|450514657|FG000|Overall Study|Withdrawal by Subject|2|||
125243243|NCT01297244|450514658|FG001|Overall Study|Withdrawal by Subject|0|||
125243244|NCT03677401|450514659|FG000|Overall Study|Adverse Event|4|||
125243245|NCT03677401|450514660|FG001|Overall Study|Adverse Event|14|||
125243246|NCT03677401|450514659|FG000|Overall Study|Lack of Efficacy|3|||
125243247|NCT03677401|450514660|FG001|Overall Study|Lack of Efficacy|1|||
125243248|NCT03677401|450514659|FG000|Overall Study|Withdrawal by Subject|2|||
125243249|NCT03677401|450514660|FG001|Overall Study|Withdrawal by Subject|2|||
125243250|NCT03677401|450514659|FG000|Overall Study|Sponsor decision|0|||
125243251|NCT03677401|450514660|FG001|Overall Study|Sponsor decision|1|||
125243252|NCT03677401|450514659|FG000|Overall Study|Reason Unspecified|1|||
125243253|NCT03677401|450514660|FG001|Overall Study|Reason Unspecified|0|||
125243254|NCT01177410|450514663|FG000|Overall Study|Adverse Event|0|||
125243255|NCT01177410|450514664|FG001|Overall Study|Adverse Event|2|||
125243256|NCT01177410|450514665|FG002|Overall Study|Adverse Event|2|||
125243257|NCT01177410|450514663|FG000|Overall Study|Withdrawal by Subject|1|||
125243258|NCT01177410|450514664|FG001|Overall Study|Withdrawal by Subject|4|||
125243259|NCT01177410|450514665|FG002|Overall Study|Withdrawal by Subject|3|||
125243260|NCT01177410|450514663|FG000|Overall Study|Lost to Follow-up|0|||
125243261|NCT01177410|450514664|FG001|Overall Study|Lost to Follow-up|1|||
125243262|NCT01177410|450514665|FG002|Overall Study|Lost to Follow-up|0|||
125243263|NCT02143778|450514667|FG000|Overall Study|Withdrawal by Subject|2|||
125243264|NCT02143778|450514667|FG000|Overall Study|Device malfunction|1|||
125243265|NCT00625378|450514669|FG000|Overall Study|Adverse Event|22|||
125243266|NCT00625378|450514670|FG001|Overall Study|Adverse Event|0|||
125243267|NCT00625378|450514669|FG000|Overall Study|Withdrawal by Subject|16|||
125243268|NCT00625378|450514670|FG001|Overall Study|Withdrawal by Subject|0|||
125243269|NCT00625378|450514669|FG000|Overall Study|Death|38|||
125243270|NCT00625378|450514670|FG001|Overall Study|Death|0|||
125243271|NCT00625378|450514669|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
125243272|NCT00625378|450514670|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
125243273|NCT00625378|450514669|FG000|Overall Study|Lost to Follow-up|17|||
125243274|NCT00625378|450514670|FG001|Overall Study|Lost to Follow-up|0|||
125243275|NCT00625378|450514669|FG000|Overall Study|Non-compliant with study medication|3|||
125243276|NCT00625378|450514670|FG001|Overall Study|Non-compliant with study medication|0|||
125243277|NCT00625378|450514669|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
125243278|NCT00625378|450514670|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
125243279|NCT00625378|450514669|FG000|Overall Study|Medical decision|1|||
125243280|NCT00625378|450514670|FG001|Overall Study|Medical decision|0|||
125243281|NCT00625378|450514669|FG000|Overall Study|Multiple toxicities|1|||
125243282|NCT00625378|450514670|FG001|Overall Study|Multiple toxicities|0|||
125243283|NCT00625378|450514669|FG000|Overall Study|New cancer|1|||
125243284|NCT00625378|450514670|FG001|Overall Study|New cancer|0|||
125243285|NCT00625378|450514669|FG000|Overall Study|PTA program|2|||
125243286|NCT00625378|450514670|FG001|Overall Study|PTA program|0|||
125243287|NCT00625378|450514669|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
125243288|NCT00625378|450514670|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
125243289|NCT00625378|450514669|FG000|Overall Study|Sponsor decision|1|||
125243290|NCT00625378|450514670|FG001|Overall Study|Sponsor decision|0|||
125243291|NCT00625378|450514669|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
125243292|NCT00625378|450514670|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
125243293|NCT00625378|450514669|FG000|Overall Study|Switch to commercial drug|6|||
125243294|NCT00625378|450514670|FG001|Overall Study|Switch to commercial drug|1|||
125243295|NCT00625378|450514669|FG000|Overall Study|Missing|2|||
125243296|NCT00625378|450514670|FG001|Overall Study|Missing|0|||
125243297|NCT00625378|450514669|FG000|Overall Study|End of treatment not available|2|||
125243298|NCT00625378|450514670|FG001|Overall Study|End of treatment not available|0|||
125243299|NCT00625378|450514669|FG000|Overall Study|Never treated|2|||
125243300|NCT00625378|450514670|FG001|Overall Study|Never treated|0|||
125243301|NCT02639559|450514672|FG000|Overall Study|Mobilization failure|0|||
125243302|NCT02639559|450514673|FG001|Overall Study|Mobilization failure|3|||
125189007|NCT04498182|450313014|FG001|Overall Study|Adverse Event|3|||
125189008|NCT04498182|450313015|FG002|Overall Study|Adverse Event|2|||
125189009|NCT04498182|450313013|FG000|Overall Study|Withdrawal of Consent|3|||
125189010|NCT04498182|450313014|FG001|Overall Study|Withdrawal of Consent|4|||
125189011|NCT04498182|450313015|FG002|Overall Study|Withdrawal of Consent|3|||
125189012|NCT04498182|450313013|FG000|Overall Study|Non-Compliant|1|||
125189013|NCT04498182|450313014|FG001|Overall Study|Non-Compliant|0|||
125189014|NCT04498182|450313015|FG002|Overall Study|Non-Compliant|1|||
125189015|NCT04498182|450313013|FG000|Overall Study|Lost to Follow-up|0|||
125189016|NCT04498182|450313014|FG001|Overall Study|Lost to Follow-up|0|||
125189017|NCT04498182|450313015|FG002|Overall Study|Lost to Follow-up|1|||
125189018|NCT04498182|450313013|FG000|Overall Study|Investigator Decision|0|||
125189019|NCT04498182|450313014|FG001|Overall Study|Investigator Decision|0|||
125189020|NCT04498182|450313015|FG002|Overall Study|Investigator Decision|1|||
125189021|NCT04498182|450313013|FG000|Overall Study|Protocol Violation|1|||
125189022|NCT04498182|450313014|FG001|Overall Study|Protocol Violation|0|||
125189023|NCT04498182|450313015|FG002|Overall Study|Protocol Violation|2|||
125189024|NCT02182843|450313017|FG000|Overall Study|Withdrawal by Subject|7|||
125189025|NCT02182843|450313017|FG000|Overall Study|Lost to Follow-up|2|||
125189026|NCT02182843|450313017|FG000|Overall Study|Adverse Event|1|||
125189027|NCT02375971|450313018|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
125189028|NCT02375971|450313019|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
125189029|NCT02375971|450313020|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
125243303|NCT02639559|450514672|FG000|Overall Study|Issues with vascular acess|1|||
125243304|NCT02639559|450514673|FG001|Overall Study|Issues with vascular acess|0|||
125243305|NCT03880565|450514674|FG000|Overall Study|Withdrawal by Subject|1|||
125243306|NCT03880565|450514675|FG001|Overall Study|Withdrawal by Subject|0|||
125243307|NCT02969018|450514680|FG000|Overall Study|Adverse Event|2|||
125243308|NCT02969018|450514681|FG001|Overall Study|Adverse Event|4|||
125243309|NCT02969018|450514682|FG002|Overall Study|Adverse Event|1|||
125243310|NCT02969018|450514683|FG003|Overall Study|Adverse Event|2|||
125243311|NCT02969018|450514684|FG004|Overall Study|Adverse Event|0|||
125189030|NCT02375971|450313018|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
125189031|NCT02375971|450313019|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
125189032|NCT02375971|450313020|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
125189033|NCT02375971|450313018|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
125243312|NCT02969018|450514685|FG005|Overall Study|Adverse Event|1|||
125243313|NCT02969018|450514686|FG006|Overall Study|Adverse Event|2|||
125243314|NCT02969018|450514687|FG007|Overall Study|Adverse Event|0|||
125243315|NCT02969018|450514680|FG000|Overall Study|Lack of Efficacy|0|||
125243316|NCT02969018|450514681|FG001|Overall Study|Lack of Efficacy|1|||
125243317|NCT02969018|450514682|FG002|Overall Study|Lack of Efficacy|0|||
125243318|NCT02969018|450514683|FG003|Overall Study|Lack of Efficacy|0|||
125243319|NCT02969018|450514684|FG004|Overall Study|Lack of Efficacy|1|||
125243320|NCT02969018|450514685|FG005|Overall Study|Lack of Efficacy|1|||
125243321|NCT02969018|450514686|FG006|Overall Study|Lack of Efficacy|1|||
125243322|NCT02969018|450514687|FG007|Overall Study|Lack of Efficacy|1|||
125189034|NCT02375971|450313019|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
125189035|NCT02375971|450313020|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
125189036|NCT02375971|450313018|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
125189037|NCT02375971|450313019|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
125189038|NCT02375971|450313020|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
125189039|NCT02375971|450313018|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
125189040|NCT02375971|450313019|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
125189041|NCT02375971|450313020|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
125189042|NCT02375971|450313018|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
125189043|NCT02375971|450313019|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
125189044|NCT02375971|450313020|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
125189045|NCT02375971|450313018|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
125189046|NCT02375971|450313019|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
125189047|NCT02375971|450313020|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
125189048|NCT02375971|450313018|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
125189049|NCT02375971|450313019|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
125189050|NCT02375971|450313020|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
125189051|NCT00832455|450313022|FG000|Overall Study|Adverse Event|13|||
125189052|NCT00832455|450313022|FG000|Overall Study|Lost to Follow-up|26|||
125189053|NCT00832455|450313022|FG000|Overall Study|Protocol Violation|4|||
125189054|NCT00832455|450313022|FG000|Overall Study|Withdrawal by Subject|17|||
125189055|NCT00832455|450313022|FG000|Overall Study|Screening Failure|2|||
125189056|NCT00832455|450313022|FG000|Overall Study|Stopped Medication|4|||
125189057|NCT00832455|450313022|FG000|Overall Study|Parent misunderstood study|1|||
125189058|NCT00832455|450313022|FG000|Overall Study|Parent dissatisfied|1|||
125189059|NCT00832455|450313022|FG000|Overall Study|No improvement|3|||
125189060|NCT00832455|450313022|FG000|Overall Study|Patient moved|1|||
125189061|NCT02275819|450313023|FG000|Overall Study|Adverse Event|0|||
125189062|NCT02275819|450313024|FG001|Overall Study|Adverse Event|1|||
125189063|NCT01346059|450313025|FG000|Overall Study|Withdrawal by Subject|1|||
125189064|NCT01346059|450313026|FG001|Overall Study|Withdrawal by Subject|0|||
125189065|NCT05047211|450313028|FG000|Overall Study|Lost to Follow-up|8|||
125189066|NCT05047211|450313029|FG001|Overall Study|Lost to Follow-up|5|||
125189067|NCT00561392|450313030|FG000|Overall Study|Adverse Event|38|||
125189068|NCT00561392|450313030|FG000|Overall Study|Lack of Efficacy|2|||
125189069|NCT00561392|450313030|FG000|Overall Study|Protocol Violation|1|||
125189070|NCT00561392|450313030|FG000|Overall Study|Withdrawal by Subject|8|||
125189071|NCT00561392|450313030|FG000|Overall Study|Administrative problems|4|||
125189072|NCT01575834|450313031|FG000|Overall Study|Withdrawal by Subject|352|||
125189073|NCT01575834|450313032|FG001|Overall Study|Withdrawal by Subject|390|||
125189074|NCT01575834|450313031|FG000|Overall Study|Death|81|||
125189075|NCT01575834|450313032|FG001|Overall Study|Death|74|||
125189076|NCT01575834|450313031|FG000|Overall Study|Other|70|||
125189077|NCT01575834|450313032|FG001|Overall Study|Other|70|||
125189078|NCT01575834|450313031|FG000|Overall Study|Adverse Event|63|||
125189079|NCT01575834|450313032|FG001|Overall Study|Adverse Event|61|||
125189080|NCT01575834|450313031|FG000|Overall Study|Lost to Follow-up|55|||
125189081|NCT01575834|450313032|FG001|Overall Study|Lost to Follow-up|68|||
125189082|NCT01575834|450313031|FG000|Overall Study|Noncompliance|52|||
125189083|NCT01575834|450313032|FG001|Overall Study|Noncompliance|27|||
125189084|NCT01575834|450313031|FG000|Overall Study|Administrative decision|15|||
125189085|NCT01575834|450313032|FG001|Overall Study|Administrative decision|33|||
125189086|NCT01575834|450313031|FG000|Overall Study|Ineligibility Determined|5|||
125189087|NCT01575834|450313032|FG001|Overall Study|Ineligibility Determined|8|||
125189088|NCT01575834|450313031|FG000|Overall Study|Protocol Deviation|4|||
125189089|NCT01575834|450313032|FG001|Overall Study|Protocol Deviation|3|||
125189090|NCT01575834|450313031|FG000|Overall Study|Requirement for Alternative Therapy|2|||
125189091|NCT01575834|450313032|FG001|Overall Study|Requirement for Alternative Therapy|4|||
125189092|NCT01000155|450313039|FG000|Overall Study|Withdrawal by Subject|1|||
125189093|NCT01000155|450313039|FG000|Overall Study|Adverse Event|1|||
125189094|NCT00720213|450313042|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
125189095|NCT00720213|450313043|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
125189096|NCT00720213|450313044|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
125189097|NCT01808066|450313049|FG000|Overall Study|Withdrawal by Subject|15|||
125243323|NCT02969018|450514680|FG000|Overall Study|Lost to Follow-up|1|||
125243324|NCT02969018|450514681|FG001|Overall Study|Lost to Follow-up|2|||
125243325|NCT02969018|450514682|FG002|Overall Study|Lost to Follow-up|2|||
125243326|NCT02969018|450514683|FG003|Overall Study|Lost to Follow-up|0|||
125243327|NCT02969018|450514684|FG004|Overall Study|Lost to Follow-up|1|||
125243328|NCT02969018|450514685|FG005|Overall Study|Lost to Follow-up|1|||
125243329|NCT02969018|450514686|FG006|Overall Study|Lost to Follow-up|0|||
125243330|NCT02969018|450514687|FG007|Overall Study|Lost to Follow-up|1|||
125243331|NCT02969018|450514680|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
125243332|NCT02969018|450514681|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
125243333|NCT02969018|450514682|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
125243334|NCT02969018|450514683|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
125243335|NCT02969018|450514684|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
125243336|NCT02969018|450514685|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
125243337|NCT02969018|450514686|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
125243338|NCT02969018|450514687|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
125243339|NCT02969018|450514680|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125243340|NCT02969018|450514681|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125243341|NCT02969018|450514682|FG002|Overall Study|Non-Compliance With Study Drug|0|||
125243342|NCT02969018|450514683|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125243343|NCT02969018|450514684|FG004|Overall Study|Non-Compliance With Study Drug|0|||
125243344|NCT02969018|450514685|FG005|Overall Study|Non-Compliance With Study Drug|0|||
125243345|NCT02969018|450514686|FG006|Overall Study|Non-Compliance With Study Drug|0|||
125243346|NCT02969018|450514687|FG007|Overall Study|Non-Compliance With Study Drug|0|||
125243347|NCT02969018|450514680|FG000|Overall Study|Other|0|||
125243348|NCT02969018|450514681|FG001|Overall Study|Other|0|||
125243349|NCT02969018|450514682|FG002|Overall Study|Other|0|||
125243350|NCT02969018|450514683|FG003|Overall Study|Other|1|||
125243351|NCT02969018|450514684|FG004|Overall Study|Other|0|||
125243352|NCT02969018|450514685|FG005|Overall Study|Other|0|||
125243353|NCT02969018|450514686|FG006|Overall Study|Other|0|||
125243354|NCT02969018|450514687|FG007|Overall Study|Other|2|||
125243355|NCT02969018|450514680|FG000|Overall Study|Pregnancy|0|||
125243356|NCT02969018|450514681|FG001|Overall Study|Pregnancy|0|||
125243357|NCT02969018|450514682|FG002|Overall Study|Pregnancy|0|||
125243358|NCT02969018|450514683|FG003|Overall Study|Pregnancy|0|||
125243359|NCT02969018|450514684|FG004|Overall Study|Pregnancy|0|||
125243360|NCT02969018|450514685|FG005|Overall Study|Pregnancy|1|||
125243361|NCT02969018|450514686|FG006|Overall Study|Pregnancy|0|||
125243362|NCT02969018|450514687|FG007|Overall Study|Pregnancy|0|||
125243363|NCT02969018|450514680|FG000|Overall Study|Protocol Violation|0|||
125243364|NCT02969018|450514681|FG001|Overall Study|Protocol Violation|0|||
125243365|NCT02969018|450514682|FG002|Overall Study|Protocol Violation|1|||
125243366|NCT02969018|450514683|FG003|Overall Study|Protocol Violation|1|||
125243367|NCT02969018|450514684|FG004|Overall Study|Protocol Violation|0|||
125243368|NCT02969018|450514685|FG005|Overall Study|Protocol Violation|0|||
125243369|NCT02969018|450514686|FG006|Overall Study|Protocol Violation|0|||
125243370|NCT02969018|450514687|FG007|Overall Study|Protocol Violation|0|||
125243371|NCT02969018|450514680|FG000|Overall Study|Withdrawal by Subject|0|||
125243372|NCT02969018|450514681|FG001|Overall Study|Withdrawal by Subject|1|||
125243373|NCT02969018|450514682|FG002|Overall Study|Withdrawal by Subject|2|||
125243374|NCT02969018|450514683|FG003|Overall Study|Withdrawal by Subject|1|||
125243375|NCT02969018|450514684|FG004|Overall Study|Withdrawal by Subject|0|||
125243376|NCT02969018|450514685|FG005|Overall Study|Withdrawal by Subject|4|||
125243377|NCT02969018|450514686|FG006|Overall Study|Withdrawal by Subject|4|||
125243378|NCT02969018|450514687|FG007|Overall Study|Withdrawal by Subject|3|||
125243379|NCT00367458|450514688|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
125243380|NCT00367458|450514689|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
125243381|NCT05762679|450514695|FG000|Overall Study|Withdrawal by Subject|1|||
125243382|NCT05762679|450514695|FG000|Overall Study|No analyzable imaging data|1|||
125243383|NCT03670628|450514696|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
125243384|NCT03670628|450514697|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
125243385|NCT03670628|450514696|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
125243386|NCT03670628|450514697|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
125243387|NCT02942407|450514698|FG000|Overall Study|Lost to Follow-up|3|||
125243388|NCT02942407|450514699|FG001|Overall Study|Lost to Follow-up|2|||
125243389|NCT02942407|450514698|FG000|Overall Study|Withdrawal by Subject|7|||
125243390|NCT02942407|450514699|FG001|Overall Study|Withdrawal by Subject|9|||
125243391|NCT02942407|450514698|FG000|Overall Study|Death|16|||
125243392|NCT02942407|450514699|FG001|Overall Study|Death|13|||
125243393|NCT01716156|450514701|FG000|Overall Study|Protocol Violation|1|||
125243394|NCT01716156|450514702|FG001|Overall Study|Protocol Violation|0|||
125243395|NCT01716156|450514703|FG002|Overall Study|Protocol Violation|0|||
125243396|NCT01716156|450514701|FG000|Overall Study|Withdrawal by Subject|0|||
125243397|NCT01716156|450514702|FG001|Overall Study|Withdrawal by Subject|1|||
125243398|NCT01716156|450514703|FG002|Overall Study|Withdrawal by Subject|2|||
125243399|NCT01716156|450514701|FG000|Overall Study|Lost to Follow-up|1|||
125243400|NCT01716156|450514702|FG001|Overall Study|Lost to Follow-up|0|||
125243401|NCT01716156|450514703|FG002|Overall Study|Lost to Follow-up|0|||
125243402|NCT03925220|450514704|FG000|Overall Study|Withdrawal by Subject|4|||
125243403|NCT03925220|450514705|FG001|Overall Study|Withdrawal by Subject|4|||
125243404|NCT03925220|450514706|FG002|Overall Study|Withdrawal by Subject|4|||
125243405|NCT03925220|450514707|FG003|Overall Study|Withdrawal by Subject|4|||
125243406|NCT03925220|450514704|FG000|Overall Study|Lost to Follow-up|40|||
125243407|NCT03925220|450514705|FG001|Overall Study|Lost to Follow-up|46|||
125243408|NCT03925220|450514706|FG002|Overall Study|Lost to Follow-up|37|||
125243409|NCT03925220|450514707|FG003|Overall Study|Lost to Follow-up|38|||
125243410|NCT05221866|450514708|FG000|Overall Study|Withdrawal by Subject|5|||
125243411|NCT05221866|450514709|FG001|Overall Study|Withdrawal by Subject|7|||
125243412|NCT05221866|450514710|FG002|Overall Study|Withdrawal by Subject|6|||
125243413|NCT05221866|450514711|FG003|Overall Study|Withdrawal by Subject|4|||
125243414|NCT05221866|450514708|FG000|Overall Study|Physician Decision|3|||
125243415|NCT05221866|450514709|FG001|Overall Study|Physician Decision|2|||
125243416|NCT05221866|450514710|FG002|Overall Study|Physician Decision|1|||
125243417|NCT05221866|450514711|FG003|Overall Study|Physician Decision|4|||
125243418|NCT05221866|450514708|FG000|Overall Study|Lost to Follow-up|12|||
125243419|NCT05221866|450514709|FG001|Overall Study|Lost to Follow-up|17|||
125243420|NCT05221866|450514710|FG002|Overall Study|Lost to Follow-up|14|||
125243421|NCT05221866|450514711|FG003|Overall Study|Lost to Follow-up|14|||
125303082|NCT03100058|450736670|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
125189098|NCT01252095|450313050|FG000|Overall Study|Disease progression|1|||
125189099|NCT01252095|450313051|FG001|Overall Study|Disease progression|0|||
125189100|NCT00365794|450313052|FG000|Overall Study|Withdrawal by Subject|2|||
125189101|NCT00745901|450313053|FG000|Overall Study|Adverse Event|3|||
125189102|NCT00745901|450313054|FG001|Overall Study|Adverse Event|4|||
125189103|NCT00745901|450313053|FG000|Overall Study|Protocol Violation|0|||
125189104|NCT00745901|450313054|FG001|Overall Study|Protocol Violation|1|||
125189105|NCT00745901|450313053|FG000|Overall Study|Withdrawal by Subject|1|||
125189106|NCT00745901|450313054|FG001|Overall Study|Withdrawal by Subject|0|||
125189107|NCT00745901|450313053|FG000|Overall Study|Lost to Follow-up|7|||
125189108|NCT00745901|450313054|FG001|Overall Study|Lost to Follow-up|4|||
125189109|NCT00745901|450313053|FG000|Overall Study|Pregnancy|2|||
125189110|NCT00745901|450313054|FG001|Overall Study|Pregnancy|4|||
125189111|NCT00745901|450313053|FG000|Overall Study|Lack of compliance|2|||
125189112|NCT00745901|450313054|FG001|Overall Study|Lack of compliance|2|||
125189113|NCT00745901|450313053|FG000|Overall Study|Patient's next menses did not start with|1|||
125189114|NCT00745901|450313054|FG001|Overall Study|Patient's next menses did not start with|0|||
125189115|NCT00745901|450313053|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
125189116|NCT00745901|450313054|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
125189117|NCT00745901|450313053|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
125189118|NCT00745901|450313054|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
125189119|NCT00745901|450313053|FG000|Overall Study|Patient didn't take any study medication|7|||
125189120|NCT00745901|450313054|FG001|Overall Study|Patient didn't take any study medication|3|||
125189121|NCT00884117|450313055|FG000|Overall Study|Adverse Event|2|||
125189122|NCT00884117|450313055|FG000|Overall Study|Withdrawal by Subject|89|||
125189123|NCT00884117|450313055|FG000|Overall Study|Death|3|||
125189124|NCT00884117|450313055|FG000|Overall Study|Lost to Follow-up|143|||
125189125|NCT00884117|450313055|FG000|Overall Study|Other|12|||
125243422|NCT05221866|450514708|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
125243423|NCT05221866|450514709|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
125243424|NCT05221866|450514710|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
125243425|NCT05221866|450514711|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
125243426|NCT05561140|450514712|FG000|Randomized Treatment Period|Adverse Event|1|||
125243427|NCT05561140|450514713|FG001|Randomized Treatment Period|Adverse Event|0|||
125243428|NCT05561140|450514712|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
125243429|NCT05561140|450514713|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
125243430|NCT05561140|450514712|FG000|Open Label Treatment Period|Adverse Event|6|||
125243431|NCT05561140|450514713|FG001|Open Label Treatment Period|Adverse Event|4|||
125243432|NCT05561140|450514712|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
125243433|NCT05561140|450514713|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
125243434|NCT05561140|450514712|FG000|Open Label Treatment Period|Physician Decision|0|||
125243435|NCT05561140|450514713|FG001|Open Label Treatment Period|Physician Decision|1|||
125243436|NCT05561140|450514712|FG000|Open Label Treatment Period|Pregnancy|1|||
125243437|NCT05561140|450514713|FG001|Open Label Treatment Period|Pregnancy|0|||
125243438|NCT05561140|450514712|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
125243439|NCT05561140|450514713|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
125243440|NCT05561140|450514712|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
125243441|NCT05561140|450514713|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
125243442|NCT05561140|450514712|FG000|Open Label Treatment Period|Other|1|||
125243443|NCT05561140|450514713|FG001|Open Label Treatment Period|Other|0|||
125243444|NCT06377488|450514714|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
125243445|NCT06377488|450514714|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
125243446|NCT06377488|450514714|FG000|Overall Study|Protocol Violation|1|||
125243447|NCT06377488|450514714|FG000|Overall Study|Lost to Follow-up|1|||
125243448|NCT06377488|450514714|FG000|Overall Study|Incorrect Lens Dispensed|2|||
125243449|NCT00866320|450514715|FG000|Overall Study|Withdrawal by Subject|4|||
125243450|NCT00866320|450514715|FG000|Overall Study|Death|2|||
125243451|NCT05073315|450514716|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
125243452|NCT05073315|450514717|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
125243453|NCT05073315|450514718|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
125243454|NCT05073315|450514716|FG000|Period 1 (Lead-in Period)|Death|1|||
125243455|NCT05073315|450514717|FG001|Period 1 (Lead-in Period)|Death|0|||
125243456|NCT05073315|450514718|FG002|Period 1 (Lead-in Period)|Death|0|||
125243457|NCT05073315|450514716|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
125243458|NCT05073315|450514717|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
125243459|NCT05073315|450514718|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
125243460|NCT05073315|450514716|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
125243461|NCT05073315|450514717|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
125243462|NCT05073315|450514718|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
125243463|NCT05073315|450514716|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
125243464|NCT05073315|450514717|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
125243465|NCT05073315|450514718|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
125243466|NCT05073315|450514716|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
125243467|NCT05073315|450514717|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
125243468|NCT05073315|450514718|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
125243469|NCT05073315|450514716|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
125243470|NCT05073315|450514717|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
125243471|NCT05073315|450514718|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
125243472|NCT05073315|450514716|FG000|Period 2|Adverse Event|0|||
125243473|NCT05073315|450514717|FG001|Period 2|Adverse Event|3|||
125243474|NCT05073315|450514718|FG002|Period 2|Adverse Event|6|||
125243475|NCT05073315|450514716|FG000|Period 2|Lost to Follow-up|0|||
125243476|NCT05073315|450514717|FG001|Period 2|Lost to Follow-up|5|||
125243477|NCT05073315|450514718|FG002|Period 2|Lost to Follow-up|5|||
125243478|NCT05073315|450514716|FG000|Period 2|Withdrawal by Subject|0|||
125243479|NCT05073315|450514717|FG001|Period 2|Withdrawal by Subject|4|||
125243480|NCT05073315|450514718|FG002|Period 2|Withdrawal by Subject|9|||
125243481|NCT05073315|450514716|FG000|Period 2|Protocol Violation|0|||
125243482|NCT05073315|450514717|FG001|Period 2|Protocol Violation|0|||
125243483|NCT05073315|450514718|FG002|Period 2|Protocol Violation|1|||
125243484|NCT05089357|450514721|FG000|Overall Study|Withdrawal by Subject|23|||
125243485|NCT05089357|450514721|FG000|Overall Study|Lost to Follow-up|6|||
125243486|NCT05089357|450514721|FG000|Overall Study|Medical reason|1|||
125243487|NCT05089357|450514721|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
125243488|NCT05089357|450514721|FG000|Overall Study|Pregnancy|2|||
125243489|NCT05537571|450514722|FG000|Overall Study|Withdrawal by Subject|1|||
125243490|NCT05537571|450514723|FG001|Overall Study|Withdrawal by Subject|1|||
125243491|NCT05537571|450514724|FG002|Overall Study|Withdrawal by Subject|0|||
125243492|NCT05537571|450514725|FG003|Overall Study|Withdrawal by Subject|0|||
125243493|NCT05537571|450514726|FG004|Overall Study|Withdrawal by Subject|0|||
125243494|NCT05537571|450514722|FG000|Overall Study|Adverse Event|2|||
125189126|NCT00153179|450313056|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
125189127|NCT00153179|450313057|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
125189128|NCT00153179|450313058|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
125189129|NCT00153179|450313059|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
125189130|NCT04495829|450313060|FG000|Overall Study|Lost to Follow-up|2|||
125189131|NCT04495829|450313060|FG000|Overall Study|Inclusion criterion not met|3|||
125189132|NCT02712554|450313061|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
125189133|NCT02712554|450313062|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
125189134|NCT02712554|450313061|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
125189135|NCT02712554|450313062|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
125189136|NCT02712554|450313061|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
125189137|NCT02712554|450313062|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
125189138|NCT02712554|450313061|FG000|Part B: Qualification Phase|Adverse Event|0|||
125189139|NCT02712554|450313062|FG001|Part B: Qualification Phase|Adverse Event|1|||
125189140|NCT02712554|450313061|FG000|Part B: Treatment Phase|Adverse Event|0|||
125189141|NCT02712554|450313062|FG001|Part B: Treatment Phase|Adverse Event|1|||
125189142|NCT02712554|450313061|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
125189143|NCT02712554|450313062|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
125189144|NCT02712554|450313061|FG000|Part B: Treatment Phase|Other|0|||
125189145|NCT02712554|450313062|FG001|Part B: Treatment Phase|Other|1|||
125189146|NCT03859427|450313063|FG000|Overall Study|Withdrawal by Subject|4|||
125189147|NCT03859427|450313064|FG001|Overall Study|Withdrawal by Subject|7|||
125189148|NCT03859427|450313063|FG000|Overall Study|Decision by sponsor|0|||
125189149|NCT03859427|450313064|FG001|Overall Study|Decision by sponsor|3|||
125189150|NCT03859427|450313063|FG000|Overall Study|Lost to Follow-up|3|||
125189151|NCT03859427|450313064|FG001|Overall Study|Lost to Follow-up|2|||
125189152|NCT03859427|450313063|FG000|Overall Study|Death|22|||
125189153|NCT03859427|450313064|FG001|Overall Study|Death|25|||
125189154|NCT02503540|450313065|FG000|Overall Study|Death|2|||
125189155|NCT02503540|450313065|FG000|Overall Study|Withdrawal by Subject|1|||
125189156|NCT01804946|450313066|FG000|Overall Study|Protocol Violation|1|||
125189157|NCT01804946|450313067|FG001|Overall Study|Protocol Violation|0|||
125189158|NCT01804946|450313066|FG000|Overall Study|Adverse Event|0|||
125189159|NCT01804946|450313067|FG001|Overall Study|Adverse Event|1|||
125189160|NCT01804946|450313066|FG000|Overall Study|Insufficient data available|0|||
125189161|NCT01804946|450313067|FG001|Overall Study|Insufficient data available|1|||
125189162|NCT01804946|450313066|FG000|Overall Study|Do not meet inclusion criteria|1|||
125189163|NCT01804946|450313067|FG001|Overall Study|Do not meet inclusion criteria|2|||
125189164|NCT00722137|450313068|FG000|Overall Study|Overt Disease Progression|5|||
125189165|NCT00722137|450313069|FG001|Overall Study|Overt Disease Progression|4|||
125189166|NCT00722137|450313068|FG000|Overall Study|Adverse Event|17|||
125189167|NCT00722137|450313069|FG001|Overall Study|Adverse Event|21|||
125189168|NCT00722137|450313068|FG000|Overall Study|Death|12|||
125189169|NCT00722137|450313069|FG001|Overall Study|Death|7|||
125189170|NCT00722137|450313068|FG000|Overall Study|Withdrawal by Subject|6|||
125189171|NCT00722137|450313069|FG001|Overall Study|Withdrawal by Subject|9|||
125189172|NCT00722137|450313068|FG000|Overall Study|Other Reason Unknown|3|||
125189173|NCT00722137|450313069|FG001|Overall Study|Other Reason Unknown|4|||
125189174|NCT00722137|450313068|FG000|Overall Study|Randomized But Not Treated|2|||
125189175|NCT00722137|450313069|FG001|Overall Study|Randomized But Not Treated|3|||
125189176|NCT01129557|450313070|FG000|Overall Study|Adverse Event|1|||
125189177|NCT01129557|450313071|FG001|Overall Study|Adverse Event|2|||
125189178|NCT01129557|450313072|FG002|Overall Study|Adverse Event|2|||
125189179|NCT01129557|450313070|FG000|Overall Study|Novartis terminated study early|3|||
125189180|NCT01129557|450313071|FG001|Overall Study|Novartis terminated study early|3|||
125189181|NCT01129557|450313072|FG002|Overall Study|Novartis terminated study early|2|||
125189182|NCT00669669|450313073|FG000|Overall Study|To late to start treatment|1|||
125189183|NCT00848718|450313074|FG000|Overall Study|Adverse Event|2|||
125189184|NCT00848718|450313075|FG001|Overall Study|Adverse Event|2|||
125189185|NCT00848718|450313076|FG002|Overall Study|Adverse Event|1|||
125189186|NCT00848718|450313077|FG003|Overall Study|Adverse Event|1|||
125189187|NCT00848718|450313078|FG004|Overall Study|Adverse Event|1|||
125189188|NCT00848718|450313079|FG005|Overall Study|Adverse Event|0|||
125189189|NCT00848718|450313080|FG006|Overall Study|Adverse Event|0|||
125189190|NCT00848718|450313081|FG007|Overall Study|Adverse Event|1|||
125189191|NCT00848718|450313082|FG008|Overall Study|Adverse Event|1|||
125189192|NCT00848718|450313083|FG009|Overall Study|Adverse Event|0|||
125189193|NCT00848718|450313084|FG010|Overall Study|Adverse Event|0|||
125189194|NCT00848718|450313085|FG011|Overall Study|Adverse Event|0|||
125189195|NCT00848718|450313086|FG012|Overall Study|Adverse Event|2|||
125189196|NCT00848718|450313074|FG000|Overall Study|Lack of Efficacy|0|||
125189197|NCT00848718|450313075|FG001|Overall Study|Lack of Efficacy|0|||
125243495|NCT05537571|450514723|FG001|Overall Study|Adverse Event|0|||
125243496|NCT05537571|450514724|FG002|Overall Study|Adverse Event|0|||
125243497|NCT05537571|450514725|FG003|Overall Study|Adverse Event|0|||
125243498|NCT05537571|450514726|FG004|Overall Study|Adverse Event|0|||
125243499|NCT05537571|450514722|FG000|Overall Study|Hepatitis A screening result|2|||
125243500|NCT05537571|450514723|FG001|Overall Study|Hepatitis A screening result|0|||
125243501|NCT05537571|450514724|FG002|Overall Study|Hepatitis A screening result|0|||
125243502|NCT05537571|450514725|FG003|Overall Study|Hepatitis A screening result|0|||
125243503|NCT05537571|450514726|FG004|Overall Study|Hepatitis A screening result|0|||
125243504|NCT05537571|450514722|FG000|Overall Study|Lost to Follow-up|0|||
125243505|NCT05537571|450514723|FG001|Overall Study|Lost to Follow-up|0|||
125243506|NCT05537571|450514724|FG002|Overall Study|Lost to Follow-up|1|||
125243507|NCT05537571|450514725|FG003|Overall Study|Lost to Follow-up|0|||
125243508|NCT05537571|450514726|FG004|Overall Study|Lost to Follow-up|1|||
125243509|NCT05752487|450514731|FG000|Overall Study|Enrolled, not treated|9|||
125243510|NCT05752487|450514731|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
125243511|NCT05752487|450514731|FG000|Overall Study|Withdrawal by Subject|2|||
125243512|NCT03091439|450514732|FG000|Overall Study|Study Terminated by the Sponsor|1|||
125243513|NCT03091439|450514733|FG001|Overall Study|Study Terminated by the Sponsor|0|||
125243514|NCT01860989|450514734|FG000|Overall Study|Unsatisfactory therapeutic|5|||
125243515|NCT01685437|450514737|FG000|Overall Study|Withdrawal by Subject|22|||
125243516|NCT01685437|450514737|FG000|Overall Study|Lost to Follow-up|3|||
125243517|NCT01685437|450514737|FG000|Overall Study|Adverse Event|1|||
125243518|NCT01685437|450514737|FG000|Overall Study|Protocol Violation|4|||
125243519|NCT01685437|450514737|FG000|Overall Study|Unable to make visits due to work|1|||
125243520|NCT03770455|450514744|FG000|Overall Study|Screen failures|3|||
125243521|NCT01039675|450514747|FG000|Overall Study|Adverse Event|0|||
125243522|NCT01039675|450514748|FG001|Overall Study|Adverse Event|2|||
125243523|NCT01039675|450514747|FG000|Overall Study|Lack of Efficacy|0|||
125243524|NCT01039675|450514748|FG001|Overall Study|Lack of Efficacy|2|||
125243525|NCT01039675|450514747|FG000|Overall Study|Withdrawal by Subject|0|||
125243526|NCT01039675|450514748|FG001|Overall Study|Withdrawal by Subject|1|||
125243527|NCT01039675|450514747|FG000|Overall Study|Lost to Follow-up|0|||
125243528|NCT01039675|450514748|FG001|Overall Study|Lost to Follow-up|1|||
125243529|NCT01039675|450514747|FG000|Overall Study|Physician Decision|0|||
125243530|NCT01039675|450514748|FG001|Overall Study|Physician Decision|1|||
125243531|NCT00134719|450516531|FG000|Primary Vaccination Phase|Adverse Event|4|||
125243532|NCT00134719|450516532|FG001|Primary Vaccination Phase|Adverse Event|0|||
125243533|NCT00134719|450516533|FG002|Primary Vaccination Phase|Adverse Event|0|||
125243534|NCT00134719|450516531|FG000|Primary Vaccination Phase|Protocol Violation|1|||
125243535|NCT00134719|450516532|FG001|Primary Vaccination Phase|Protocol Violation|0|||
125243536|NCT00134719|450516533|FG002|Primary Vaccination Phase|Protocol Violation|0|||
125243537|NCT00134719|450516531|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
125243538|NCT00134719|450516532|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
125243539|NCT00134719|450516533|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
125243540|NCT00134719|450516531|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
125243541|NCT00134719|450516532|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
125243542|NCT00134719|450516533|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
125243543|NCT00134719|450516531|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
125243544|NCT00134719|450516532|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
125243545|NCT00134719|450516533|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
125243546|NCT00134719|450516531|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
125243547|NCT00134719|450516532|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
125243548|NCT00134719|450516533|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
125243549|NCT03439839|450516534|FG000|Overall Study|Death|3|||
125243550|NCT03439839|450516535|FG001|Overall Study|Death|0|||
125243551|NCT02582632|450516543|FG000|Overall Study|Other|1|||
125243552|NCT03298061|450516544|FG000|Overall Study|Adverse Event|3|||
125243553|NCT03298061|450516544|FG000|Overall Study|Lack of Efficacy|6|||
125243554|NCT03298061|450516544|FG000|Overall Study|Protocol Violation|1|||
125243555|NCT03298061|450516544|FG000|Overall Study|Physician Decision|7|||
125243556|NCT03298061|450516544|FG000|Overall Study|Withdrawal by Subject|10|||
125243557|NCT00992836|450516547|FG000|Overall Study|Lost to Follow-up|1|||
125243558|NCT00992836|450516547|FG000|Overall Study|Withdrawal by Subject|2|||
125243559|NCT00992836|450516547|FG000|Overall Study|Protocol Violation|2|||
125243560|NCT01617967|450516551|FG000|Overall Study|Protocol Violation|0|||
125243561|NCT01617967|450516552|FG001|Overall Study|Protocol Violation|0|||
125243562|NCT01617967|450516553|FG002|Overall Study|Protocol Violation|0|||
125243563|NCT01617967|450516554|FG003|Overall Study|Protocol Violation|1|||
125243564|NCT01617967|450516555|FG004|Overall Study|Protocol Violation|0|||
125243565|NCT01617967|450516556|FG005|Overall Study|Protocol Violation|0|||
125243566|NCT01617967|450516551|FG000|Overall Study|Withdrawal by Subject|0|||
125243567|NCT01617967|450516552|FG001|Overall Study|Withdrawal by Subject|0|||
125243568|NCT01617967|450516553|FG002|Overall Study|Withdrawal by Subject|0|||
125243569|NCT01617967|450516554|FG003|Overall Study|Withdrawal by Subject|0|||
125243570|NCT01617967|450516555|FG004|Overall Study|Withdrawal by Subject|0|||
125189198|NCT00848718|450313076|FG002|Overall Study|Lack of Efficacy|1|||
125189199|NCT00848718|450313077|FG003|Overall Study|Lack of Efficacy|0|||
125189200|NCT00848718|450313078|FG004|Overall Study|Lack of Efficacy|0|||
125189201|NCT00848718|450313079|FG005|Overall Study|Lack of Efficacy|0|||
125189202|NCT00848718|450313080|FG006|Overall Study|Lack of Efficacy|1|||
125189203|NCT00848718|450313081|FG007|Overall Study|Lack of Efficacy|0|||
125189204|NCT00848718|450313082|FG008|Overall Study|Lack of Efficacy|0|||
125189205|NCT00848718|450313083|FG009|Overall Study|Lack of Efficacy|0|||
125189206|NCT00848718|450313084|FG010|Overall Study|Lack of Efficacy|0|||
125189207|NCT00848718|450313085|FG011|Overall Study|Lack of Efficacy|0|||
125189208|NCT00848718|450313086|FG012|Overall Study|Lack of Efficacy|0|||
125189209|NCT00848718|450313074|FG000|Overall Study|Physician Decision|0|||
125189210|NCT00848718|450313075|FG001|Overall Study|Physician Decision|1|||
125189211|NCT00848718|450313076|FG002|Overall Study|Physician Decision|0|||
125189212|NCT00848718|450313077|FG003|Overall Study|Physician Decision|0|||
125189213|NCT00848718|450313078|FG004|Overall Study|Physician Decision|1|||
125189214|NCT00848718|450313079|FG005|Overall Study|Physician Decision|1|||
125189215|NCT00848718|450313080|FG006|Overall Study|Physician Decision|0|||
125189216|NCT00848718|450313081|FG007|Overall Study|Physician Decision|0|||
125189217|NCT00848718|450313082|FG008|Overall Study|Physician Decision|1|||
125189218|NCT00848718|450313083|FG009|Overall Study|Physician Decision|2|||
125189219|NCT00848718|450313084|FG010|Overall Study|Physician Decision|0|||
125189220|NCT00848718|450313085|FG011|Overall Study|Physician Decision|0|||
125189221|NCT00848718|450313086|FG012|Overall Study|Physician Decision|1|||
125189222|NCT00848718|450313074|FG000|Overall Study|Progressive disease before treatment|1|||
125189223|NCT00848718|450313075|FG001|Overall Study|Progressive disease before treatment|5|||
125189224|NCT00848718|450313076|FG002|Overall Study|Progressive disease before treatment|1|||
125189225|NCT00848718|450313077|FG003|Overall Study|Progressive disease before treatment|3|||
125189226|NCT00848718|450313078|FG004|Overall Study|Progressive disease before treatment|4|||
125189227|NCT00848718|450313079|FG005|Overall Study|Progressive disease before treatment|4|||
125189228|NCT00848718|450313080|FG006|Overall Study|Progressive disease before treatment|2|||
125189229|NCT00848718|450313081|FG007|Overall Study|Progressive disease before treatment|1|||
125189230|NCT00848718|450313082|FG008|Overall Study|Progressive disease before treatment|2|||
125189231|NCT00848718|450313083|FG009|Overall Study|Progressive disease before treatment|7|||
125189232|NCT00848718|450313084|FG010|Overall Study|Progressive disease before treatment|3|||
125189233|NCT00848718|450313085|FG011|Overall Study|Progressive disease before treatment|6|||
125189234|NCT00848718|450313086|FG012|Overall Study|Progressive disease before treatment|2|||
125189235|NCT00848718|450313074|FG000|Overall Study|Protocol Violation|0|||
125189236|NCT00848718|450313075|FG001|Overall Study|Protocol Violation|1|||
125189237|NCT00848718|450313076|FG002|Overall Study|Protocol Violation|0|||
125189238|NCT00848718|450313077|FG003|Overall Study|Protocol Violation|0|||
125189239|NCT00848718|450313078|FG004|Overall Study|Protocol Violation|0|||
125189240|NCT00848718|450313079|FG005|Overall Study|Protocol Violation|0|||
125189241|NCT00848718|450313080|FG006|Overall Study|Protocol Violation|0|||
125189242|NCT00848718|450313081|FG007|Overall Study|Protocol Violation|1|||
125189243|NCT00848718|450313082|FG008|Overall Study|Protocol Violation|0|||
125189244|NCT00848718|450313083|FG009|Overall Study|Protocol Violation|0|||
125189245|NCT00848718|450313084|FG010|Overall Study|Protocol Violation|0|||
125189246|NCT00848718|450313085|FG011|Overall Study|Protocol Violation|0|||
125189247|NCT00848718|450313086|FG012|Overall Study|Protocol Violation|1|||
125189248|NCT00848718|450313074|FG000|Overall Study|Withdrawal by Subject|1|||
125189249|NCT00848718|450313075|FG001|Overall Study|Withdrawal by Subject|0|||
125189250|NCT00848718|450313076|FG002|Overall Study|Withdrawal by Subject|0|||
125189251|NCT00848718|450313077|FG003|Overall Study|Withdrawal by Subject|1|||
125189252|NCT00848718|450313078|FG004|Overall Study|Withdrawal by Subject|0|||
125189253|NCT00848718|450313079|FG005|Overall Study|Withdrawal by Subject|0|||
125189254|NCT00848718|450313080|FG006|Overall Study|Withdrawal by Subject|0|||
125189255|NCT00848718|450313081|FG007|Overall Study|Withdrawal by Subject|0|||
125189256|NCT00848718|450313082|FG008|Overall Study|Withdrawal by Subject|0|||
125189257|NCT00848718|450313083|FG009|Overall Study|Withdrawal by Subject|0|||
125189258|NCT00848718|450313084|FG010|Overall Study|Withdrawal by Subject|1|||
125189259|NCT00848718|450313085|FG011|Overall Study|Withdrawal by Subject|0|||
125189260|NCT00848718|450313086|FG012|Overall Study|Withdrawal by Subject|0|||
125189261|NCT00848718|450313074|FG000|Overall Study|Progressive disease during treatment|3|||
125189262|NCT00848718|450313075|FG001|Overall Study|Progressive disease during treatment|0|||
125189263|NCT00848718|450313076|FG002|Overall Study|Progressive disease during treatment|3|||
125189264|NCT00848718|450313077|FG003|Overall Study|Progressive disease during treatment|0|||
125189265|NCT00848718|450313078|FG004|Overall Study|Progressive disease during treatment|0|||
125189266|NCT00848718|450313079|FG005|Overall Study|Progressive disease during treatment|0|||
125189267|NCT00848718|450313080|FG006|Overall Study|Progressive disease during treatment|0|||
125189268|NCT00848718|450313081|FG007|Overall Study|Progressive disease during treatment|2|||
125189269|NCT00848718|450313082|FG008|Overall Study|Progressive disease during treatment|0|||
125189270|NCT00848718|450313083|FG009|Overall Study|Progressive disease during treatment|0|||
125189271|NCT00848718|450313084|FG010|Overall Study|Progressive disease during treatment|0|||
125243571|NCT01617967|450516556|FG005|Overall Study|Withdrawal by Subject|1|||
125189272|NCT00848718|450313085|FG011|Overall Study|Progressive disease during treatment|0|||
125189273|NCT00848718|450313086|FG012|Overall Study|Progressive disease during treatment|2|||
125189274|NCT02418182|450313088|FG000|Overall Study|Unable to re-consent|18|||
125189275|NCT02418182|450313089|FG001|Overall Study|Unable to re-consent|15|||
125189276|NCT02418182|450313088|FG000|Overall Study|Lost to Follow-up|0|||
125189277|NCT02418182|450313089|FG001|Overall Study|Lost to Follow-up|2|||
125189278|NCT02431676|450313092|FG000|Overall Study|no lab obtained|0|||
125243572|NCT01617967|450516551|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
125243573|NCT01617967|450516552|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
125243574|NCT01617967|450516553|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
125243575|NCT01617967|450516554|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
125189279|NCT02431676|450313093|FG001|Overall Study|no lab obtained|1|||
125189280|NCT02431676|450313094|FG002|Overall Study|no lab obtained|2|||
125189281|NCT01120184|450315023|FG000|Overall Study|Adverse Event|0|||
125189282|NCT01120184|450315024|FG001|Overall Study|Adverse Event|1|||
125189283|NCT01120184|450315025|FG002|Overall Study|Adverse Event|0|||
125189284|NCT01120184|450315023|FG000|Overall Study|Lost to Follow-up|13|||
125189285|NCT01120184|450315024|FG001|Overall Study|Lost to Follow-up|13|||
125189286|NCT01120184|450315025|FG002|Overall Study|Lost to Follow-up|11|||
125189287|NCT01120184|450315023|FG000|Overall Study|Physician Decision|9|||
125189288|NCT01120184|450315024|FG001|Overall Study|Physician Decision|1|||
125189289|NCT01120184|450315025|FG002|Overall Study|Physician Decision|3|||
125189290|NCT01120184|450315023|FG000|Overall Study|Reason not Specified|8|||
125189291|NCT01120184|450315024|FG001|Overall Study|Reason not Specified|3|||
125189292|NCT01120184|450315025|FG002|Overall Study|Reason not Specified|12|||
125189293|NCT01120184|450315023|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
125189294|NCT01120184|450315024|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
125189295|NCT01120184|450315025|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
125189296|NCT01120184|450315023|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
125189297|NCT01120184|450315024|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
125189298|NCT01120184|450315025|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
125189299|NCT01120184|450315023|FG000|Overall Study|Death|170|||
125189300|NCT01120184|450315024|FG001|Overall Study|Death|176|||
125189301|NCT01120184|450315025|FG002|Overall Study|Death|169|||
125189302|NCT04003636|450315026|FG000|Overall Study|Death|409|||
125189303|NCT04003636|450315027|FG001|Overall Study|Death|443|||
125189304|NCT04003636|450315026|FG000|Overall Study|Lost to Follow-up|0|||
125189305|NCT04003636|450315027|FG001|Overall Study|Lost to Follow-up|1|||
125189306|NCT04003636|450315026|FG000|Overall Study|Withdrawal by Subject|5|||
125189307|NCT04003636|450315027|FG001|Overall Study|Withdrawal by Subject|2|||
125189308|NCT04003636|450315026|FG000|Overall Study|Participant On-going|119|||
125189309|NCT04003636|450315027|FG001|Overall Study|Participant On-going|90|||
125189310|NCT03656068|450315028|FG000|Overall Study|Withdrawal by Subject|4|||
125189311|NCT03656068|450315028|FG000|Overall Study|Adverse Event|1|||
125189312|NCT03270657|450315030|FG000|Overall Study|Withdrawal by Subject|1|||
125189313|NCT00162981|450315031|FG000|Overall Study|Adverse Event|2|||
125189314|NCT00162981|450315032|FG001|Overall Study|Adverse Event|5|||
125189315|NCT00162981|450315031|FG000|Overall Study|Withdrawal by Subject|1|||
125189316|NCT00162981|450315032|FG001|Overall Study|Withdrawal by Subject|1|||
125189317|NCT00162981|450315031|FG000|Overall Study|Physician Decision|1|||
125189318|NCT00162981|450315032|FG001|Overall Study|Physician Decision|0|||
125189319|NCT00455403|450315039|FG000|Overall Study|Lost to Follow-up|2|||
125189320|NCT00455403|450315040|FG001|Overall Study|Lost to Follow-up|1|||
125189321|NCT00455403|450315039|FG000|Overall Study|Withdrawal by Subject|1|||
125189322|NCT00455403|450315040|FG001|Overall Study|Withdrawal by Subject|3|||
125189323|NCT00455403|450315039|FG000|Overall Study|Protocol Violation|0|||
125243576|NCT01617967|450516555|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
125243577|NCT01617967|450516556|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
125243578|NCT05276804|450516561|FG000|Overall Study|screen failure|23|||
125243579|NCT05276804|450516562|FG001|Overall Study|screen failure|0|||
125243580|NCT02827708|450516563|FG000|Overall Study|Lost to Follow-up|3|||
125243581|NCT02827708|450516564|FG001|Overall Study|Lost to Follow-up|1|||
125243582|NCT02827708|450516563|FG000|Overall Study|Withdrawal by Subject|1|||
125243583|NCT02827708|450516564|FG001|Overall Study|Withdrawal by Subject|2|||
125243584|NCT02827708|450516563|FG000|Overall Study|Death|1|||
125189324|NCT00455403|450315040|FG001|Overall Study|Protocol Violation|2|||
125189325|NCT00350207|450315041|FG000|Overall Study|Adverse Event|5|||
125189326|NCT00350207|450315042|FG001|Overall Study|Adverse Event|2|||
125189327|NCT00350207|450315043|FG002|Overall Study|Adverse Event|2|||
125189328|NCT00350207|450315041|FG000|Overall Study|Lack of Efficacy|1|||
125189329|NCT00350207|450315042|FG001|Overall Study|Lack of Efficacy|0|||
125189330|NCT00350207|450315043|FG002|Overall Study|Lack of Efficacy|2|||
125189331|NCT00350207|450315041|FG000|Overall Study|Lost to Follow-up|1|||
125189332|NCT00350207|450315042|FG001|Overall Study|Lost to Follow-up|0|||
125189333|NCT00350207|450315043|FG002|Overall Study|Lost to Follow-up|1|||
125189334|NCT00350207|450315041|FG000|Overall Study|Withdrawal by Subject|0|||
125243585|NCT02827708|450516564|FG001|Overall Study|Death|2|||
125189335|NCT00350207|450315042|FG001|Overall Study|Withdrawal by Subject|1|||
125189336|NCT00350207|450315043|FG002|Overall Study|Withdrawal by Subject|1|||
125189337|NCT00350207|450315041|FG000|Overall Study|Other|1|||
125189338|NCT00350207|450315042|FG001|Overall Study|Other|3|||
125189339|NCT00350207|450315043|FG002|Overall Study|Other|1|||
125189340|NCT00495391|450315044|FG000|Overall Study|Lack of Efficacy|34|||
125189341|NCT00495391|450315045|FG001|Overall Study|Lack of Efficacy|18|||
125189342|NCT00495391|450315044|FG000|Overall Study|Withdrawal by Subject|2|||
125189343|NCT00495391|450315045|FG001|Overall Study|Withdrawal by Subject|3|||
125189344|NCT04509076|450315054|FG000|Overall Study|Withdrawal by Subject|1|||
125189345|NCT04509076|450315055|FG001|Overall Study|Withdrawal by Subject|2|||
125189346|NCT04509076|450315054|FG000|Overall Study|Lost to Follow-up|1|||
125189347|NCT04509076|450315055|FG001|Overall Study|Lost to Follow-up|2|||
125189348|NCT00502242|450315060|FG000|Overall Study|Lack of Efficacy|1|||
125189349|NCT00502242|450315061|FG001|Overall Study|Lack of Efficacy|11|||
125189350|NCT00502242|450315060|FG000|Overall Study|Adverse Event|31|||
125189351|NCT00502242|450315061|FG001|Overall Study|Adverse Event|20|||
125189352|NCT00502242|450315060|FG000|Overall Study|Physician Decision|2|||
125189353|NCT00502242|450315061|FG001|Overall Study|Physician Decision|3|||
125189354|NCT00502242|450315060|FG000|Overall Study|Other - Unspecified|8|||
125189355|NCT00502242|450315061|FG001|Overall Study|Other - Unspecified|14|||
125189356|NCT00502242|450315060|FG000|Overall Study|Protocol Violation|3|||
125189357|NCT00502242|450315061|FG001|Overall Study|Protocol Violation|1|||
125243586|NCT01137812|450516565|FG000|Overall Study|Adverse Event|21|||
125243587|NCT01137812|450516566|FG001|Overall Study|Adverse Event|14|||
125243588|NCT01137812|450516565|FG000|Overall Study|Lost to Follow-up|6|||
125243589|NCT01137812|450516566|FG001|Overall Study|Lost to Follow-up|8|||
125243590|NCT01137812|450516565|FG000|Overall Study|Physician Decision|25|||
125189358|NCT00502242|450315060|FG000|Overall Study|Withdrawal by Subject|6|||
125189359|NCT00502242|450315061|FG001|Overall Study|Withdrawal by Subject|7|||
125243591|NCT01137812|450516566|FG001|Overall Study|Physician Decision|17|||
125243592|NCT01137812|450516565|FG000|Overall Study|Protocol Violation|5|||
125243593|NCT01137812|450516566|FG001|Overall Study|Protocol Violation|4|||
125243594|NCT01137812|450516565|FG000|Overall Study|Withdrawal by Subject|5|||
125243595|NCT01137812|450516566|FG001|Overall Study|Withdrawal by Subject|13|||
125243596|NCT01137812|450516565|FG000|Overall Study|Death|2|||
125243597|NCT01137812|450516566|FG001|Overall Study|Death|0|||
125243598|NCT01137812|450516565|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
125243599|NCT01137812|450516566|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
125243600|NCT01137812|450516565|FG000|Overall Study|Other|19|||
125243601|NCT01137812|450516566|FG001|Overall Study|Other|27|||
125243602|NCT04621760|450516570|FG000|Overall Study|Lost to Follow-up|2|||
125243603|NCT04621760|450516571|FG001|Overall Study|Lost to Follow-up|4|||
125243604|NCT04621760|450516570|FG000|Overall Study|Withdrawal by Subject|1|||
125243605|NCT04621760|450516571|FG001|Overall Study|Withdrawal by Subject|0|||
125243606|NCT04602000|450516572|FG000|Overall Study|Withdrawal by Subject|3|||
125243607|NCT04602000|450516573|FG001|Overall Study|Withdrawal by Subject|6|||
125243608|NCT04602000|450516574|FG002|Overall Study|Withdrawal by Subject|3|||
125243609|NCT04602000|450516575|FG003|Overall Study|Withdrawal by Subject|27|||
125243610|NCT04602000|450516576|FG004|Overall Study|Withdrawal by Subject|39|||
125243611|NCT04602000|450516572|FG000|Overall Study|Physician Decision|1|||
125243612|NCT04602000|450516573|FG001|Overall Study|Physician Decision|0|||
125189360|NCT01812109|450315062|FG000|Overall Study|research personnel delay|16|||
125189361|NCT01812109|450315062|FG000|Overall Study|NIRS Unattainable|17|||
125189362|NCT03313180|450315063|FG000|Overall Study|Adverse Event|120|||
125189363|NCT03313180|450315063|FG000|Overall Study|Lost to Follow-up|3|||
125189364|NCT03313180|450315063|FG000|Overall Study|Withdrawal by Subject|39|||
125189365|NCT03313180|450315063|FG000|Overall Study|Other than listed above|15|||
125189366|NCT03313180|450315063|FG000|Overall Study|Covid-19 related|2|||
125189367|NCT00461630|450315064|FG000|Overall Study|Death|798|||
125189368|NCT00461630|450315065|FG001|Overall Study|Death|732|||
125189369|NCT00461630|450315064|FG000|Overall Study|Lost to Follow-up|108|||
125189370|NCT00461630|450315065|FG001|Overall Study|Lost to Follow-up|95|||
125189371|NCT00891020|450315068|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
125189372|NCT00891020|450315069|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
125189373|NCT00891020|450315070|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
125189374|NCT00891020|450315068|FG000|24 Week Treatment Period|Death|0|||
125189375|NCT00891020|450315069|FG001|24 Week Treatment Period|Death|2|||
125189376|NCT00891020|450315070|FG002|24 Week Treatment Period|Death|0|||
125189377|NCT00891020|450315068|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
125189378|NCT00891020|450315069|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
125189379|NCT00891020|450315070|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
125189380|NCT00891020|450315068|FG000|24 Week Treatment Period|Failure to return|4|||
125189381|NCT00891020|450315069|FG001|24 Week Treatment Period|Failure to return|5|||
125189382|NCT00891020|450315070|FG002|24 Week Treatment Period|Failure to return|5|||
125189383|NCT00891020|450315068|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
125189384|NCT00891020|450315069|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
125189385|NCT00891020|450315070|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
125189386|NCT00891020|450315068|FG000|24 Week Treatment Period|Other protocol violation|1|||
125189387|NCT00891020|450315069|FG001|24 Week Treatment Period|Other protocol violation|1|||
125189388|NCT00891020|450315070|FG002|24 Week Treatment Period|Other protocol violation|2|||
125189389|NCT00891020|450315068|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
125189390|NCT00891020|450315069|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
125189391|NCT00891020|450315070|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
125189392|NCT00891020|450315068|FG000|24 Week Treatment Period|Withdrew consent|6|||
125189393|NCT00891020|450315069|FG001|24 Week Treatment Period|Withdrew consent|3|||
125189394|NCT00891020|450315070|FG002|24 Week Treatment Period|Withdrew consent|15|||
125243613|NCT04602000|450516574|FG002|Overall Study|Physician Decision|0|||
125243614|NCT04602000|450516575|FG003|Overall Study|Physician Decision|2|||
125243615|NCT04602000|450516576|FG004|Overall Study|Physician Decision|2|||
125243616|NCT04602000|450516572|FG000|Overall Study|Death|0|||
125189395|NCT00891020|450315068|FG000|24 Week Treatment Period|Administrative/Other|5|||
125189396|NCT00891020|450315069|FG001|24 Week Treatment Period|Administrative/Other|6|||
125189397|NCT00891020|450315070|FG002|24 Week Treatment Period|Administrative/Other|1|||
125189398|NCT00891020|450315068|FG000|Long-term Extension Period|Adverse Event|1|||
125189399|NCT00891020|450315069|FG001|Long-term Extension Period|Adverse Event|11|||
125243617|NCT04602000|450516573|FG001|Overall Study|Death|1|||
125243618|NCT04602000|450516574|FG002|Overall Study|Death|0|||
125243619|NCT04602000|450516575|FG003|Overall Study|Death|1|||
125189400|NCT00891020|450315070|FG002|Long-term Extension Period|Adverse Event|10|||
125189401|NCT00891020|450315068|FG000|Long-term Extension Period|Death|0|||
125189402|NCT00891020|450315069|FG001|Long-term Extension Period|Death|0|||
125189403|NCT00891020|450315070|FG002|Long-term Extension Period|Death|1|||
125189404|NCT00891020|450315068|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
125189405|NCT00891020|450315069|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
125189406|NCT00891020|450315070|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
125189407|NCT00891020|450315068|FG000|Long-term Extension Period|Protocol Violation|0|||
125189408|NCT00891020|450315069|FG001|Long-term Extension Period|Protocol Violation|1|||
125189409|NCT00891020|450315070|FG002|Long-term Extension Period|Protocol Violation|1|||
125189410|NCT00891020|450315068|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
125189411|NCT00891020|450315069|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
125189412|NCT00891020|450315070|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
125189413|NCT00891020|450315068|FG000|Long-term Extension Period|Failure to return|0|||
125189414|NCT00891020|450315069|FG001|Long-term Extension Period|Failure to return|2|||
125189415|NCT00891020|450315070|FG002|Long-term Extension Period|Failure to return|3|||
125189416|NCT00891020|450315068|FG000|Long-term Extension Period|Administrative|1|||
125189417|NCT00891020|450315069|FG001|Long-term Extension Period|Administrative|2|||
125189418|NCT00891020|450315070|FG002|Long-term Extension Period|Administrative|2|||
125189419|NCT00320710|450315078|FG000|Overall Study|Disease progression|24|||
125189420|NCT00320710|450315079|FG001|Overall Study|Disease progression|19|||
125189421|NCT00320710|450315080|FG002|Overall Study|Disease progression|2|||
125189422|NCT00320710|450315078|FG000|Overall Study|Death|10|||
125189423|NCT00320710|450315079|FG001|Overall Study|Death|7|||
125189424|NCT00320710|450315080|FG002|Overall Study|Death|1|||
125189425|NCT00320710|450315078|FG000|Overall Study|Administrative problems|1|||
125189426|NCT00320710|450315079|FG001|Overall Study|Administrative problems|2|||
125189427|NCT00320710|450315080|FG002|Overall Study|Administrative problems|0|||
125189428|NCT00320710|450315078|FG000|Overall Study|Withdrawal by Subject|20|||
125189429|NCT00320710|450315079|FG001|Overall Study|Withdrawal by Subject|26|||
125189430|NCT00320710|450315080|FG002|Overall Study|Withdrawal by Subject|1|||
125189431|NCT00320710|450315078|FG000|Overall Study|Protocol Violation|6|||
125189432|NCT00320710|450315079|FG001|Overall Study|Protocol Violation|5|||
125189433|NCT00320710|450315080|FG002|Overall Study|Protocol Violation|0|||
125189434|NCT00320710|450315078|FG000|Overall Study|Abnormal test procedure result(s)|2|||
125189435|NCT00320710|450315079|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125189436|NCT00320710|450315080|FG002|Overall Study|Abnormal test procedure result(s)|0|||
125189437|NCT00320710|450315078|FG000|Overall Study|Abnormal laboratory value(s)|12|||
125189438|NCT00320710|450315079|FG001|Overall Study|Abnormal laboratory value(s)|3|||
125189439|NCT00320710|450315080|FG002|Overall Study|Abnormal laboratory value(s)|0|||
125189440|NCT00320710|450315078|FG000|Overall Study|Adverse Event|18|||
125189441|NCT00320710|450315079|FG001|Overall Study|Adverse Event|14|||
125189442|NCT00320710|450315080|FG002|Overall Study|Adverse Event|1|||
125189443|NCT00320710|450315078|FG000|Overall Study|Lost to Follow-up|1|||
125189444|NCT00320710|450315079|FG001|Overall Study|Lost to Follow-up|0|||
125189445|NCT00320710|450315080|FG002|Overall Study|Lost to Follow-up|0|||
125189446|NCT03448419|450315081|FG000|Overall Study|Adverse Event|10|||
125189447|NCT03448419|450315082|FG001|Overall Study|Adverse Event|9|||
125189448|NCT03448419|450315081|FG000|Overall Study|Lost to Follow-up|0|||
125189449|NCT03448419|450315082|FG001|Overall Study|Lost to Follow-up|2|||
125189450|NCT03448419|450315081|FG000|Overall Study|Withdrawal by Subject|3|||
125189451|NCT03448419|450315082|FG001|Overall Study|Withdrawal by Subject|1|||
125189452|NCT03448419|450315081|FG000|Overall Study|Not treated|0|||
125189453|NCT03448419|450315082|FG001|Overall Study|Not treated|1|||
125189454|NCT03448419|450315081|FG000|Overall Study|Patient did not attend all visits|0|||
125189455|NCT03448419|450315082|FG001|Overall Study|Patient did not attend all visits|2|||
125189456|NCT03448419|450315081|FG000|Overall Study|Withdrawn by Sponsor|0|||
125189457|NCT03448419|450315082|FG001|Overall Study|Withdrawn by Sponsor|1|||
125189458|NCT04548193|450315086|FG000|Overall Study|Lost to Follow-up|0|||
125189459|NCT04548193|450315087|FG001|Overall Study|Lost to Follow-up|1|||
125189460|NCT04548193|450315086|FG000|Overall Study|Death|0|||
125189461|NCT04548193|450315087|FG001|Overall Study|Death|1|||
125189462|NCT04548193|450315086|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
125189463|NCT04548193|450315087|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
125189464|NCT04548193|450315086|FG000|Overall Study|Withdrawal by Subject|2|||
125189465|NCT04548193|450315087|FG001|Overall Study|Withdrawal by Subject|2|||
125189466|NCT00630825|450315088|FG000|Overall Study|Adverse Event|4|||
125189467|NCT00630825|450315089|FG001|Overall Study|Adverse Event|4|||
125243620|NCT04602000|450516576|FG004|Overall Study|Death|2|||
125243621|NCT04602000|450516572|FG000|Overall Study|Lost to Follow-up|0|||
125189468|NCT00630825|450315090|FG002|Overall Study|Adverse Event|3|||
125189469|NCT00630825|450315091|FG003|Overall Study|Adverse Event|1|||
125189470|NCT00630825|450315088|FG000|Overall Study|Entry Criteria Not Met|1|||
125189471|NCT00630825|450315089|FG001|Overall Study|Entry Criteria Not Met|0|||
125189472|NCT00630825|450315090|FG002|Overall Study|Entry Criteria Not Met|2|||
125189473|NCT00630825|450315091|FG003|Overall Study|Entry Criteria Not Met|1|||
125189474|NCT00630825|450315088|FG000|Overall Study|Lost to Follow-up|1|||
125189475|NCT00630825|450315089|FG001|Overall Study|Lost to Follow-up|1|||
125189476|NCT00630825|450315090|FG002|Overall Study|Lost to Follow-up|1|||
125189477|NCT00630825|450315091|FG003|Overall Study|Lost to Follow-up|1|||
125189478|NCT00630825|450315088|FG000|Overall Study|Physician Decision|1|||
125189479|NCT00630825|450315089|FG001|Overall Study|Physician Decision|0|||
125189480|NCT00630825|450315090|FG002|Overall Study|Physician Decision|0|||
125189481|NCT00630825|450315091|FG003|Overall Study|Physician Decision|0|||
125189482|NCT00630825|450315088|FG000|Overall Study|Withdrawal by Subject|2|||
125189483|NCT00630825|450315089|FG001|Overall Study|Withdrawal by Subject|2|||
125189484|NCT00630825|450315090|FG002|Overall Study|Withdrawal by Subject|2|||
125189485|NCT00630825|450315091|FG003|Overall Study|Withdrawal by Subject|3|||
125189486|NCT02211209|450315093|FG000|Overall Study|Investigator judgment|0|||
125189487|NCT02211209|450315094|FG001|Overall Study|Investigator judgment|1|||
125189488|NCT02211209|450315093|FG000|Overall Study|Voluntary withdrawal|1|||
125189489|NCT02211209|450315094|FG001|Overall Study|Voluntary withdrawal|4|||
125189490|NCT02211209|450315093|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
125189491|NCT02211209|450315094|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
125189492|NCT02211209|450315093|FG000|Overall Study|Reason Not Specified|1|||
125189493|NCT02211209|450315094|FG001|Overall Study|Reason Not Specified|0|||
125189494|NCT02792062|450315095|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
125189495|NCT02792062|450315096|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
125189496|NCT02792062|450315097|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
125189497|NCT02792062|450315098|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
125189498|NCT02792062|450315099|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
125189499|NCT02792062|450315100|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
125189500|NCT00931255|450315101|FG000|Overall Study|Follow up biopsy not done|2|||
125189501|NCT00931255|450315102|FG001|Overall Study|Follow up biopsy not done|3|||
125189502|NCT01372995|450315103|FG000|Overall Study|Spouse withdrew participant from study|0|||
125189503|NCT01372995|450315104|FG001|Overall Study|Spouse withdrew participant from study|1|||
125189504|NCT01372995|450315105|FG002|Overall Study|Spouse withdrew participant from study|0|||
125189505|NCT01372995|450315103|FG000|Overall Study|Physician Decision|0|||
125189506|NCT01372995|450315104|FG001|Overall Study|Physician Decision|0|||
125189507|NCT01372995|450315105|FG002|Overall Study|Physician Decision|1|||
125189508|NCT01297517|450315111|FG000|Overall Study|Adverse Event|21|||
125189509|NCT01297517|450315112|FG001|Overall Study|Adverse Event|7|||
125189510|NCT01297517|450315113|FG002|Overall Study|Adverse Event|16|||
125189511|NCT01297517|450315111|FG000|Overall Study|Lost to Follow-up|1|||
125189512|NCT01297517|450315112|FG001|Overall Study|Lost to Follow-up|0|||
125189513|NCT01297517|450315113|FG002|Overall Study|Lost to Follow-up|1|||
125189514|NCT01297517|450315111|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
125189515|NCT01297517|450315112|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
125189516|NCT01297517|450315113|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
125189517|NCT01297517|450315111|FG000|Overall Study|Noncompliance|1|||
125189518|NCT01297517|450315112|FG001|Overall Study|Noncompliance|0|||
125189519|NCT01297517|450315113|FG002|Overall Study|Noncompliance|0|||
125189520|NCT01297517|450315111|FG000|Overall Study|Protocol Violation|1|||
125189521|NCT01297517|450315112|FG001|Overall Study|Protocol Violation|1|||
125189522|NCT01297517|450315113|FG002|Overall Study|Protocol Violation|1|||
125189523|NCT01297517|450315111|FG000|Overall Study|Inadequate Control of IOP|1|||
125189524|NCT01297517|450315112|FG001|Overall Study|Inadequate Control of IOP|1|||
125189525|NCT01297517|450315113|FG002|Overall Study|Inadequate Control of IOP|2|||
125189526|NCT01741688|450315115|FG000|Overall Study|Lack of insurance coverage|2|||
125189527|NCT01741688|450315115|FG000|Overall Study|Withdrawal by Subject|1|||
125189528|NCT02282813|450315116|FG000|Overall Study|Withdrawal by Subject|4|||
125189529|NCT02282813|450315117|FG001|Overall Study|Withdrawal by Subject|5|||
125189530|NCT02282813|450315118|FG002|Overall Study|Withdrawal by Subject|0|||
125189531|NCT02282813|450315116|FG000|Overall Study|Adverse Event|3|||
125189532|NCT02282813|450315117|FG001|Overall Study|Adverse Event|10|||
125189533|NCT02282813|450315118|FG002|Overall Study|Adverse Event|1|||
125189534|NCT02282813|450315116|FG000|Overall Study|Subject non-compliance|1|||
125189535|NCT02282813|450315117|FG001|Overall Study|Subject non-compliance|4|||
125189536|NCT02282813|450315118|FG002|Overall Study|Subject non-compliance|0|||
125189537|NCT02282813|450315116|FG000|Overall Study|Physician Decision|0|||
125189538|NCT02282813|450315117|FG001|Overall Study|Physician Decision|3|||
125189539|NCT02282813|450315118|FG002|Overall Study|Physician Decision|1|||
125189540|NCT02282813|450315116|FG000|Overall Study|Lost to Follow-up|2|||
125189541|NCT02282813|450315117|FG001|Overall Study|Lost to Follow-up|0|||
125189542|NCT02282813|450315118|FG002|Overall Study|Lost to Follow-up|1|||
125189543|NCT02282813|450315116|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
125189544|NCT02282813|450315117|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
125189545|NCT02282813|450315118|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
125189546|NCT02282813|450315116|FG000|Overall Study|Lack of Efficacy|1|||
125189547|NCT02282813|450315117|FG001|Overall Study|Lack of Efficacy|0|||
125189548|NCT02282813|450315118|FG002|Overall Study|Lack of Efficacy|0|||
125189549|NCT02282813|450315116|FG000|Overall Study|Administrative reasons|0|||
125189550|NCT02282813|450315117|FG001|Overall Study|Administrative reasons|1|||
125189551|NCT02282813|450315118|FG002|Overall Study|Administrative reasons|0|||
125189552|NCT02220764|450315120|FG000|Overall Study|Lost to Follow-up|3|||
125189553|NCT02220764|450315121|FG001|Overall Study|Lost to Follow-up|1|||
125189554|NCT02220764|450315120|FG000|Overall Study|Death|1|||
125189555|NCT02220764|450315121|FG001|Overall Study|Death|0|||
125189556|NCT05000164|450315122|FG000|Overall Study|Adverse Event|1|||
125189557|NCT05000164|450315122|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
125189558|NCT05000164|450315122|FG000|Overall Study|Lens Discomfort|3|||
125189559|NCT05000164|450315122|FG000|Overall Study|Withdrew Consent during Study|2|||
125189560|NCT05000164|450315122|FG000|Overall Study|Subject Withdrawn by PI|2|||
125189561|NCT05000164|450315122|FG000|Overall Study|Other Fractured Test Article|1|||
125189562|NCT03493854|450315123|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
125189563|NCT03493854|450315124|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
125189564|NCT03493854|450315123|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
125189565|NCT03493854|450315124|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
125189566|NCT03493854|450315123|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
125189567|NCT03493854|450315124|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
125189568|NCT03493854|450315123|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
125189569|NCT03493854|450315124|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
125189570|NCT03493854|450315123|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
125189571|NCT03493854|450315124|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
125189572|NCT03493854|450315123|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
125189573|NCT03493854|450315124|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
125189574|NCT03493854|450315123|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
125189575|NCT03493854|450315124|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
125189576|NCT03493854|450315123|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
125189577|NCT03493854|450315124|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
125189578|NCT03493854|450315123|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
125189579|NCT03493854|450315124|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
125189580|NCT03493854|450315123|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
125189581|NCT03493854|450315124|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
125189582|NCT03493854|450315123|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
125189583|NCT03493854|450315124|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
125189584|NCT03493854|450315123|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
125189585|NCT03493854|450315124|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
125189586|NCT03493854|450315123|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
125189587|NCT03493854|450315124|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
125189588|NCT03493854|450315123|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
125189589|NCT03493854|450315124|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
125189590|NCT03493854|450315123|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
125189591|NCT03493854|450315124|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
125189592|NCT03493854|450315123|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
125189593|NCT03493854|450315124|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
125189594|NCT03493854|450315123|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
125189595|NCT03493854|450315124|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
125189596|NCT03493854|450315123|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
125189597|NCT03493854|450315124|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
125189598|NCT00739661|450315127|FG000|Overall Study|Adverse Event|2|||
125189599|NCT00739661|450315128|FG001|Overall Study|Adverse Event|0|||
125189600|NCT00739661|450315127|FG000|Overall Study|Physician decision to withdraw patient|1|||
125189601|NCT00739661|450315128|FG001|Overall Study|Physician decision to withdraw patient|0|||
125189602|NCT00739661|450315127|FG000|Overall Study|Patient decision to withdraw|9|||
125189603|NCT00739661|450315128|FG001|Overall Study|Patient decision to withdraw|4|||
125189604|NCT00739661|450315127|FG000|Overall Study|Disease progression, radiographic|33|||
125189605|NCT00739661|450315128|FG001|Overall Study|Disease progression, radiographic|37|||
125189606|NCT00739661|450315127|FG000|Overall Study|Reason for discontinuation not available|1|||
125189607|NCT00739661|450315128|FG001|Overall Study|Reason for discontinuation not available|1|||
125189608|NCT02198664|450315129|FG000|Overall Study|Adverse Event|2|||
125189609|NCT02198664|450315130|FG001|Overall Study|Adverse Event|0|||
125189610|NCT02198664|450315129|FG000|Overall Study|Withdrawal by Subject|11|||
125189611|NCT02198664|450315130|FG001|Overall Study|Withdrawal by Subject|8|||
125189612|NCT02198664|450315129|FG000|Overall Study|Failure to tolerate|2|||
125243622|NCT04602000|450516573|FG001|Overall Study|Lost to Follow-up|0|||
125243623|NCT04602000|450516574|FG002|Overall Study|Lost to Follow-up|0|||
125243624|NCT04602000|450516575|FG003|Overall Study|Lost to Follow-up|3|||
125243625|NCT04602000|450516576|FG004|Overall Study|Lost to Follow-up|4|||
125243626|NCT04602000|450516572|FG000|Overall Study|Other|4|||
125243627|NCT04602000|450516573|FG001|Overall Study|Other|1|||
125243628|NCT04602000|450516574|FG002|Overall Study|Other|2|||
125243629|NCT04602000|450516575|FG003|Overall Study|Other|5|||
125189613|NCT02198664|450315130|FG001|Overall Study|Failure to tolerate|0|||
125189614|NCT02198664|450315129|FG000|Overall Study|Not stated|1|||
125189615|NCT02198664|450315130|FG001|Overall Study|Not stated|0|||
125189616|NCT05343364|450315134|FG000|Overall Study|Miscellaneous|0|||
125189617|NCT05343364|450315135|FG001|Overall Study|Miscellaneous|1|||
125189618|NCT02105987|450315137|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
125189619|NCT02105987|450315138|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
125189620|NCT02105987|450315139|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
125189621|NCT02105987|450315140|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
125189622|NCT02105987|450315141|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
125189623|NCT02105987|450315142|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
125189624|NCT02105987|450315137|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
125189625|NCT02105987|450315138|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
125189626|NCT02105987|450315139|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
125189627|NCT02105987|450315140|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
125189628|NCT02105987|450315141|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
125189629|NCT02105987|450315142|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
125189630|NCT02105987|450315137|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
125189631|NCT02105987|450315138|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
125189632|NCT02105987|450315139|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
125189633|NCT02105987|450315140|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
125189634|NCT02105987|450315141|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
125189635|NCT02105987|450315142|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
125189636|NCT02105987|450315137|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
125189637|NCT02105987|450315138|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
125189638|NCT02105987|450315139|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
125189639|NCT02105987|450315140|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
125189640|NCT02105987|450315141|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
125189641|NCT02105987|450315142|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
125189642|NCT02105987|450315137|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
125189643|NCT02105987|450315138|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
125189644|NCT02105987|450315139|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
125189645|NCT02105987|450315140|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
125189646|NCT02105987|450315141|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
125189647|NCT02105987|450315142|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
125189648|NCT02105987|450315137|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
125189649|NCT02105987|450315138|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
125189650|NCT02105987|450315139|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
125189651|NCT02105987|450315140|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
125189652|NCT02105987|450315141|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
125189653|NCT02105987|450315142|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
125243630|NCT04602000|450516576|FG004|Overall Study|Other|4|||
125189654|NCT02105987|450315137|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
125189655|NCT02105987|450315138|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
125189656|NCT02105987|450315139|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
125189657|NCT02105987|450315140|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
125189658|NCT02105987|450315141|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
125243631|NCT04602000|450516572|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
125243632|NCT04602000|450516573|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
125243633|NCT04602000|450516574|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
125243634|NCT04602000|450516575|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
125189659|NCT02105987|450315142|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
125243635|NCT04602000|450516576|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
125189660|NCT02105987|450315137|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
125189661|NCT02105987|450315138|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
125189662|NCT02105987|450315139|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
125189663|NCT02105987|450315140|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
125189664|NCT02105987|450315141|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
125189665|NCT02105987|450315142|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
125189666|NCT02105987|450315137|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
125189667|NCT02105987|450315138|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
125189668|NCT02105987|450315139|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
125189669|NCT02105987|450315140|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
125189670|NCT02105987|450315141|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
125189671|NCT02105987|450315142|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
125189672|NCT02105987|450315137|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
125189673|NCT02105987|450315138|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
125189674|NCT02105987|450315139|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
125189675|NCT02105987|450315140|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
125189676|NCT02105987|450315141|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
125189677|NCT02105987|450315142|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
125189678|NCT02105987|450315137|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
125189679|NCT02105987|450315138|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
125189680|NCT02105987|450315139|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
125189681|NCT02105987|450315140|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
125189682|NCT02105987|450315141|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
125189683|NCT02105987|450315142|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
125189684|NCT02105987|450315137|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
125189685|NCT02105987|450315138|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
125189686|NCT02105987|450315139|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
125189687|NCT02105987|450315140|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
125189688|NCT02105987|450315141|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
125189689|NCT02105987|450315142|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
125189690|NCT02105987|450315137|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
125189691|NCT02105987|450315138|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
125189692|NCT02105987|450315139|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
125189693|NCT02105987|450315140|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
125189694|NCT02105987|450315141|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
125189695|NCT02105987|450315142|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
125189696|NCT02105987|450315137|FG000|Continuation Phase|Protocol Violation|0|||
125189697|NCT02105987|450315138|FG001|Continuation Phase|Protocol Violation|0|||
125189698|NCT02105987|450315139|FG002|Continuation Phase|Protocol Violation|0|||
125189699|NCT02105987|450315140|FG003|Continuation Phase|Protocol Violation|0|||
125189700|NCT02105987|450315141|FG004|Continuation Phase|Protocol Violation|1|||
125189701|NCT02105987|450315142|FG005|Continuation Phase|Protocol Violation|0|||
125189702|NCT01262872|450315143|FG000|Step 2|Death|0|||
125189703|NCT01262872|450315144|FG001|Step 2|Death|0|||
125189704|NCT01262872|450315145|FG002|Step 2|Death|0|||
125189705|NCT01262872|450315146|FG003|Step 2|Death|1|||
125189706|NCT01262872|450315147|FG004|Step 2|Death|0|||
125189707|NCT01262872|450315148|FG005|Step 2|Death|2|||
125189708|NCT01262872|450315149|FG006|Step 2|Death|2|||
125189709|NCT01262872|450315150|FG007|Step 2|Death|1|||
125189710|NCT01262872|450315143|FG000|Step 2|Protocol Violation|0|||
125189711|NCT01262872|450315144|FG001|Step 2|Protocol Violation|0|||
125189712|NCT01262872|450315145|FG002|Step 2|Protocol Violation|1|||
125189713|NCT01262872|450315146|FG003|Step 2|Protocol Violation|0|||
125189714|NCT01262872|450315147|FG004|Step 2|Protocol Violation|0|||
125189715|NCT01262872|450315148|FG005|Step 2|Protocol Violation|0|||
125189716|NCT01262872|450315149|FG006|Step 2|Protocol Violation|3|||
125189717|NCT01262872|450315150|FG007|Step 2|Protocol Violation|1|||
125189718|NCT01262872|450315143|FG000|Step 2|Withdrawal by Subject|0|||
125243636|NCT00471354|450516578|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
125243637|NCT00471354|450516578|FG000|Overall Study|Adverse Event|13|||
125189719|NCT01262872|450315144|FG001|Step 2|Withdrawal by Subject|0|||
125189720|NCT01262872|450315145|FG002|Step 2|Withdrawal by Subject|4|||
125189721|NCT01262872|450315146|FG003|Step 2|Withdrawal by Subject|6|||
125189722|NCT01262872|450315147|FG004|Step 2|Withdrawal by Subject|3|||
125189723|NCT01262872|450315148|FG005|Step 2|Withdrawal by Subject|1|||
125189724|NCT01262872|450315149|FG006|Step 2|Withdrawal by Subject|2|||
125189725|NCT01262872|450315150|FG007|Step 2|Withdrawal by Subject|1|||
125189726|NCT01262872|450315143|FG000|Step 2|Migrated/moved from study area|0|||
125189727|NCT01262872|450315144|FG001|Step 2|Migrated/moved from study area|0|||
125189728|NCT01262872|450315145|FG002|Step 2|Migrated/moved from study area|4|||
125189729|NCT01262872|450315146|FG003|Step 2|Migrated/moved from study area|3|||
125189730|NCT01262872|450315147|FG004|Step 2|Migrated/moved from study area|2|||
125189731|NCT01262872|450315148|FG005|Step 2|Migrated/moved from study area|6|||
125189732|NCT01262872|450315149|FG006|Step 2|Migrated/moved from study area|2|||
125189733|NCT01262872|450315150|FG007|Step 2|Migrated/moved from study area|3|||
125189734|NCT01753570|450315151|FG000|Overall Study|Adverse Event|1|||
125189735|NCT01753570|450315152|FG001|Overall Study|Adverse Event|0|||
125189736|NCT01753570|450315153|FG002|Overall Study|Adverse Event|1|||
125189737|NCT01753570|450315151|FG000|Overall Study|Physician Decision|0|||
125189738|NCT01753570|450315152|FG001|Overall Study|Physician Decision|1|||
125189739|NCT01753570|450315153|FG002|Overall Study|Physician Decision|0|||
125189740|NCT01753570|450315151|FG000|Overall Study|Withdrawal by Subject|1|||
125189741|NCT01753570|450315152|FG001|Overall Study|Withdrawal by Subject|4|||
125189742|NCT01753570|450315153|FG002|Overall Study|Withdrawal by Subject|0|||
125189743|NCT01420068|450315157|FG000|Overall Study|Administrative problems|1|||
125189744|NCT01420068|450315158|FG001|Overall Study|Administrative problems|3|||
125189745|NCT01420068|450315157|FG000|Overall Study|Withdrawal by Subject|1|||
125189746|NCT01420068|450315158|FG001|Overall Study|Withdrawal by Subject|2|||
125189747|NCT01153815|450315165|FG000|Overall Study|Adverse Event|3|||
125189748|NCT01153815|450315166|FG001|Overall Study|Adverse Event|1|||
125189749|NCT01153815|450315165|FG000|Overall Study|Withdrawal by Subject|6|||
125189750|NCT01153815|450315166|FG001|Overall Study|Withdrawal by Subject|4|||
125189751|NCT01786993|450315167|FG000|Overall Study|Death|6|||
125189752|NCT01786993|450315168|FG001|Overall Study|Death|7|||
125189753|NCT01786993|450315167|FG000|Overall Study|Withdrawal by Subject|3|||
125189754|NCT01786993|450315168|FG001|Overall Study|Withdrawal by Subject|2|||
125189755|NCT01786993|450315167|FG000|Overall Study|Lost to Follow-up|0|||
125189756|NCT01786993|450315168|FG001|Overall Study|Lost to Follow-up|1|||
125189757|NCT01786993|450315167|FG000|Overall Study|Subject Non-Compliance|1|||
125189758|NCT01786993|450315168|FG001|Overall Study|Subject Non-Compliance|0|||
125189759|NCT01786993|450315167|FG000|Overall Study|System Explant|1|||
125189760|NCT01786993|450315168|FG001|Overall Study|System Explant|0|||
125189761|NCT01786993|450315167|FG000|Overall Study|Hospice Admission|1|||
125189762|NCT01786993|450315168|FG001|Overall Study|Hospice Admission|0|||
125189763|NCT01890122|450315169|FG000|Overall Study|Adverse Event|1|||
125189764|NCT01890122|450315170|FG001|Overall Study|Adverse Event|1|||
125189765|NCT01890122|450315171|FG002|Overall Study|Adverse Event|1|||
125189766|NCT01890122|450315172|FG003|Overall Study|Adverse Event|2|||
125189767|NCT01890122|450315169|FG000|Overall Study|Major Protocol Deviation|3|||
125189768|NCT01890122|450315170|FG001|Overall Study|Major Protocol Deviation|1|||
125243638|NCT00471354|450516578|FG000|Overall Study|Protocol Violation|12|||
125243639|NCT00471354|450516578|FG000|Overall Study|Withdrawal by Subject|1|||
125243640|NCT00471354|450516578|FG000|Overall Study|Physician Decision|4|||
125243641|NCT00471354|450516578|FG000|Overall Study|Sponsor Decision|1|||
125243642|NCT00471354|450516578|FG000|Overall Study|Lost to Follow-up|3|||
125243643|NCT00471354|450516578|FG000|Overall Study|Lack of Efficacy|5|||
125243644|NCT00471354|450516578|FG000|Overall Study|Patient/Caregiver Decision|12|||
125243645|NCT01875237|450516579|FG000|Overall Study|GVDH before DLI|1|||
125243646|NCT01875237|450516580|FG001|Overall Study|GVDH before DLI|0|||
125243647|NCT01875237|450516579|FG000|Overall Study|DLI cells could not be produced|1|||
125243648|NCT01875237|450516580|FG001|Overall Study|DLI cells could not be produced|0|||
125243649|NCT01913470|450516584|FG000|Overall Study|Lost to Follow-up|0|||
125243650|NCT01913470|450516585|FG001|Overall Study|Lost to Follow-up|1|||
125243651|NCT01913470|450516584|FG000|Overall Study|Physician Decision|0|||
125243652|NCT01913470|450516585|FG001|Overall Study|Physician Decision|1|||
125243653|NCT01913470|450516584|FG000|Overall Study|Withdrawal by Subject|0|||
125243654|NCT01913470|450516585|FG001|Overall Study|Withdrawal by Subject|1|||
125243655|NCT02573467|450516586|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
125189769|NCT01890122|450315171|FG002|Overall Study|Major Protocol Deviation|0|||
125189770|NCT01890122|450315172|FG003|Overall Study|Major Protocol Deviation|1|||
125189771|NCT01890122|450315169|FG000|Overall Study|Lost to Follow-up|0|||
125189772|NCT01890122|450315170|FG001|Overall Study|Lost to Follow-up|1|||
125189773|NCT01890122|450315171|FG002|Overall Study|Lost to Follow-up|2|||
125189774|NCT01890122|450315172|FG003|Overall Study|Lost to Follow-up|2|||
125189775|NCT01890122|450315169|FG000|Overall Study|Voluntary Withdrawal|8|||
125189776|NCT01890122|450315170|FG001|Overall Study|Voluntary Withdrawal|8|||
125189777|NCT01890122|450315171|FG002|Overall Study|Voluntary Withdrawal|2|||
125189778|NCT01890122|450315172|FG003|Overall Study|Voluntary Withdrawal|11|||
125189779|NCT01890122|450315169|FG000|Overall Study|Lack of Efficacy|14|||
125189780|NCT01890122|450315170|FG001|Overall Study|Lack of Efficacy|24|||
125189781|NCT01890122|450315171|FG002|Overall Study|Lack of Efficacy|7|||
125189782|NCT01890122|450315172|FG003|Overall Study|Lack of Efficacy|41|||
125189783|NCT01890122|450315169|FG000|Overall Study|Reason not Specified|0|||
125189784|NCT01890122|450315170|FG001|Overall Study|Reason not Specified|1|||
125189785|NCT01890122|450315171|FG002|Overall Study|Reason not Specified|1|||
125243656|NCT02573467|450516587|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
125243657|NCT02573467|450516588|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
125243658|NCT02573467|450516589|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
125243659|NCT02573467|450516586|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
125243660|NCT02573467|450516587|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
125243661|NCT02573467|450516588|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
125243662|NCT02573467|450516589|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
125243663|NCT02573467|450516586|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
125243664|NCT02573467|450516587|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
125243665|NCT02573467|450516588|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
125243666|NCT02573467|450516589|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
125243667|NCT02573467|450516586|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
125243668|NCT02573467|450516587|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
125243669|NCT02573467|450516588|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
125243670|NCT02573467|450516589|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
125243671|NCT02573467|450516586|FG000|Post-treatment Follow up Epoch|Death|1|||
125243672|NCT02573467|450516587|FG001|Post-treatment Follow up Epoch|Death|1|||
125243673|NCT02573467|450516588|FG002|Post-treatment Follow up Epoch|Death|0|||
125243674|NCT02573467|450516589|FG003|Post-treatment Follow up Epoch|Death|1|||
125243675|NCT02573467|450516586|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
125243676|NCT02573467|450516587|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
125243677|NCT02573467|450516588|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
125243678|NCT02573467|450516589|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
125243679|NCT02573467|450516586|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
125243680|NCT02573467|450516587|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
125243681|NCT02573467|450516588|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
125243682|NCT02573467|450516589|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
125243683|NCT00923702|450516590|FG000|Overall Study|Ongoing enrollment|0|||
125243684|NCT00923702|450516591|FG001|Overall Study|Ongoing enrollment|0|||
125243685|NCT00923702|450516592|FG002|Overall Study|Ongoing enrollment|0|||
125243686|NCT00923702|450516593|FG003|Overall Study|Ongoing enrollment|0|||
125243687|NCT00923702|450516594|FG004|Overall Study|Ongoing enrollment|354|||
125243688|NCT02153827|450516595|FG000|Overall Study|Lost to Follow-up|3|||
125243689|NCT02153827|450516596|FG001|Overall Study|Lost to Follow-up|9|||
125243690|NCT04790201|450516597|FG000|Overall Study|Lost to Follow-up|0|||
125243691|NCT04790201|450516598|FG001|Overall Study|Lost to Follow-up|0|||
125243692|NCT04790201|450516599|FG002|Overall Study|Lost to Follow-up|2|||
125243693|NCT04790201|450516597|FG000|Overall Study|Death|0|||
125243694|NCT04790201|450516598|FG001|Overall Study|Death|1|||
125243695|NCT04790201|450516599|FG002|Overall Study|Death|0|||
125243696|NCT04790201|450516597|FG000|Overall Study|Protocol Violation|1|||
125243697|NCT04790201|450516598|FG001|Overall Study|Protocol Violation|0|||
125243698|NCT04790201|450516599|FG002|Overall Study|Protocol Violation|1|||
125243699|NCT04339972|450516603|FG000|Overall Study|Scheduling Issues|3|||
125243700|NCT04339972|450516604|FG001|Overall Study|Scheduling Issues|3|||
125243701|NCT04339972|450516603|FG000|Overall Study|dropout|1|||
125243702|NCT04339972|450516604|FG001|Overall Study|dropout|1|||
125243703|NCT04339972|450516603|FG000|Overall Study|Technical issues|1|||
125243704|NCT04339972|450516604|FG001|Overall Study|Technical issues|0|||
125243705|NCT04339972|450516603|FG000|Overall Study|Claustraphobia|0|||
125243706|NCT04339972|450516604|FG001|Overall Study|Claustraphobia|1|||
125243707|NCT01529268|450516607|FG000|Overall Study|Lost to Follow-up|9|||
125243708|NCT01529268|450516608|FG001|Overall Study|Lost to Follow-up|3|||
125243709|NCT01529268|450516607|FG000|Overall Study|Moved|3|||
125243710|NCT01529268|450516608|FG001|Overall Study|Moved|0|||
125243711|NCT02691572|450516613|FG000|Overall Study|Withdrawal by Subject|1|||
125243712|NCT02691572|450516614|FG001|Overall Study|Withdrawal by Subject|0|||
125243713|NCT02691572|450516613|FG000|Overall Study|Protocol Violation|0|||
125243714|NCT02691572|450516614|FG001|Overall Study|Protocol Violation|1|||
125243715|NCT00699751|450516615|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
125243716|NCT00699751|450516616|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
125243717|NCT00699751|450516615|FG000|Period 1: Without/Before Drug Switch|Death|28|||
125243718|NCT00699751|450516616|FG001|Period 1: Without/Before Drug Switch|Death|29|||
125243719|NCT00699751|450516615|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
125243720|NCT00699751|450516616|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
125243721|NCT00699751|450516615|FG000|Period 1: Without/Before Drug Switch|Other|30|||
125243722|NCT00699751|450516616|FG001|Period 1: Without/Before Drug Switch|Other|20|||
125243723|NCT00699751|450516615|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
125243724|NCT00699751|450516616|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
125243725|NCT00699751|450516615|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
125243726|NCT00699751|450516616|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
125243727|NCT00699751|450516615|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
125243728|NCT00699751|450516616|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
125243729|NCT00699751|450516615|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
125243730|NCT00699751|450516616|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
125243731|NCT03370302|450516620|FG000|Dose Escalation Phase|Other|0|||
125243732|NCT03370302|450516621|FG001|Dose Escalation Phase|Other|1|||
125243733|NCT03370302|450516622|FG002|Dose Escalation Phase|Other|1|||
125243734|NCT03370302|450516623|FG003|Dose Escalation Phase|Other|0|||
125243735|NCT03370302|450516624|FG004|Dose Escalation Phase|Other|0|||
125243736|NCT03370302|450516625|FG005|Dose Escalation Phase|Other|0|||
125243737|NCT03370302|450516620|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
125243738|NCT03370302|450516621|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
125243739|NCT03370302|450516622|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
125243740|NCT03370302|450516623|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
125243741|NCT03370302|450516624|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
125243742|NCT03370302|450516625|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
125243743|NCT03370302|450516620|FG000|Dose Escalation Phase|Adverse Event|1|||
125243744|NCT03370302|450516621|FG001|Dose Escalation Phase|Adverse Event|0|||
125243745|NCT03370302|450516622|FG002|Dose Escalation Phase|Adverse Event|2|||
125243746|NCT03370302|450516623|FG003|Dose Escalation Phase|Adverse Event|0|||
125243747|NCT03370302|450516624|FG004|Dose Escalation Phase|Adverse Event|0|||
125243748|NCT03370302|450516625|FG005|Dose Escalation Phase|Adverse Event|0|||
125243749|NCT03370302|450516620|FG000|Dose Escalation Phase|Progressive Disease|2|||
125243750|NCT03370302|450516621|FG001|Dose Escalation Phase|Progressive Disease|4|||
125243751|NCT03370302|450516622|FG002|Dose Escalation Phase|Progressive Disease|2|||
125243752|NCT03370302|450516623|FG003|Dose Escalation Phase|Progressive Disease|0|||
125243753|NCT03370302|450516624|FG004|Dose Escalation Phase|Progressive Disease|3|||
125243754|NCT03370302|450516625|FG005|Dose Escalation Phase|Progressive Disease|1|||
125243755|NCT03370302|450516620|FG000|Dose Expansion Phase|Progressive Disease|0|||
125243756|NCT03370302|450516621|FG001|Dose Expansion Phase|Progressive Disease|0|||
125243757|NCT03370302|450516622|FG002|Dose Expansion Phase|Progressive Disease|0|||
125243758|NCT03370302|450516623|FG003|Dose Expansion Phase|Progressive Disease|6|||
125243759|NCT03370302|450516624|FG004|Dose Expansion Phase|Progressive Disease|0|||
125243760|NCT03370302|450516625|FG005|Dose Expansion Phase|Progressive Disease|0|||
125243761|NCT00985790|450516626|FG000|Overall Study|Withdrawal by Subject|1|||
125243762|NCT00985790|450516627|FG001|Overall Study|Withdrawal by Subject|1|||
125243763|NCT00985790|450516626|FG000|Overall Study|Lost to Follow-up|6|||
125243764|NCT00985790|450516627|FG001|Overall Study|Lost to Follow-up|7|||
125243765|NCT04180696|450516629|FG000|Overall Study|Death|5|||
125243766|NCT04180696|450516630|FG001|Overall Study|Death|6|||
125243767|NCT04180696|450516629|FG000|Overall Study|Lost to Follow-up|1|||
125243768|NCT04180696|450516630|FG001|Overall Study|Lost to Follow-up|0|||
125243769|NCT04180696|450516629|FG000|Overall Study|Withdrawal by Subject|0|||
125243770|NCT04180696|450516630|FG001|Overall Study|Withdrawal by Subject|1|||
125243771|NCT02593864|450516633|FG000|Overall Study|Withdrawal by Subject|3|||
125243772|NCT02593864|450516633|FG000|Overall Study|Lost to Follow-up|3|||
125243773|NCT04739709|450516634|FG000|Overall Study|Physician Decision|1|||
125243774|NCT04739709|450516635|FG001|Overall Study|Physician Decision|0|||
125243775|NCT04124965|450516636|FG000|Overall Study|Adverse event, non-fatal|3|||
125243776|NCT04124965|450516637|FG001|Overall Study|Adverse event, non-fatal|1|||
125243777|NCT04124965|450516636|FG000|Overall Study|Withdrawal by Subject|1|||
125243778|NCT04124965|450516637|FG001|Overall Study|Withdrawal by Subject|1|||
125243779|NCT04124965|450516636|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
125243780|NCT04124965|450516637|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
125243781|NCT04124965|450516636|FG000|Overall Study|Pregnancy|1|||
125243782|NCT04124965|450516637|FG001|Overall Study|Pregnancy|0|||
125243783|NCT04124965|450516636|FG000|Overall Study|Sponsor and participant decision|0|||
125243784|NCT04124965|450516637|FG001|Overall Study|Sponsor and participant decision|1|||
125243785|NCT04124965|450516636|FG000|Overall Study|Personal surgery|0|||
125243786|NCT04124965|450516637|FG001|Overall Study|Personal surgery|1|||
125243787|NCT04124965|450516636|FG000|Overall Study|Physician Decision|0|||
125243788|NCT04124965|450516637|FG001|Overall Study|Physician Decision|1|||
125243789|NCT02184156|450516638|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
125243790|NCT02184156|450516639|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
125243791|NCT02184156|450516638|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
125243792|NCT02184156|450516639|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
125243793|NCT00002874|450516640|FG000|Overall Study|Withdrawal by Subject|1|||
125189786|NCT01890122|450315172|FG003|Overall Study|Reason not Specified|2|||
125189787|NCT01890122|450315169|FG000|Overall Study|Randomized but not Treated|1|||
125189788|NCT01890122|450315170|FG001|Overall Study|Randomized but not Treated|1|||
125189789|NCT01890122|450315171|FG002|Overall Study|Randomized but not Treated|0|||
125189790|NCT01890122|450315172|FG003|Overall Study|Randomized but not Treated|0|||
125189791|NCT02062450|450315173|FG000|Overall Study|No follow-up visit|124|||
125189792|NCT02907177|450315176|FG000|Overall Study|Death|0|||
125189793|NCT02907177|450315177|FG001|Overall Study|Death|1|||
125189794|NCT02907177|450315176|FG000|Overall Study|Physician Decision|3|||
125189795|NCT02907177|450315177|FG001|Overall Study|Physician Decision|3|||
125189796|NCT02907177|450315176|FG000|Overall Study|Withdrawal by Subject|15|||
125189797|NCT02907177|450315177|FG001|Overall Study|Withdrawal by Subject|7|||
125189798|NCT02907177|450315176|FG000|Overall Study|Sponsor's Decision|50|||
125189799|NCT02907177|450315177|FG001|Overall Study|Sponsor's Decision|57|||
125189800|NCT02505217|450315178|FG000|Overall Study|Withdrawal by Subject|1|||
125189801|NCT02505217|450315179|FG001|Overall Study|Withdrawal by Subject|2|||
125189802|NCT00570687|450316755|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189803|NCT00570687|450316756|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189804|NCT00570687|450316757|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189805|NCT00570687|450316758|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189806|NCT00570687|450316759|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
125189807|NCT00570687|450316760|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
125189808|NCT00570687|450316761|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
125189809|NCT00570687|450316762|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
125189810|NCT00570687|450316763|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
125189811|NCT00570687|450316764|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
125189812|NCT00570687|450316755|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189813|NCT00570687|450316756|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189814|NCT00570687|450316757|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189815|NCT00570687|450316758|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189816|NCT00570687|450316759|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189817|NCT00570687|450316760|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189818|NCT00570687|450316761|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189819|NCT00570687|450316762|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189820|NCT00570687|450316763|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
125189821|NCT00570687|450316764|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189822|NCT00570687|450316755|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189823|NCT00570687|450316756|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189824|NCT00570687|450316757|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189825|NCT00570687|450316758|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189826|NCT00570687|450316759|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189827|NCT00570687|450316760|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189828|NCT00570687|450316761|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
125189829|NCT00570687|450316762|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189830|NCT00570687|450316763|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189831|NCT00570687|450316764|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189832|NCT01102257|450316770|FG000|Overall Study|Adverse Event|1|||
125189833|NCT01102257|450316771|FG001|Overall Study|Adverse Event|0|||
125189834|NCT01102257|450316770|FG000|Overall Study|Adverse Event|1|||
125189835|NCT01102257|450316771|FG001|Overall Study|Adverse Event|0|||
125189836|NCT03048747|450316772|FG000|Overall Study|Adverse Event|2|||
125189837|NCT03048747|450316772|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
125189838|NCT03048747|450316772|FG000|Overall Study|Physician Decision|1|||
125189839|NCT00824772|450316773|FG000|Overall Study|Withdrawal by Subject|8|||
125189840|NCT00866281|450316774|FG000|Overall Study|Adverse Event|1|||
125189841|NCT00866281|450316775|FG001|Overall Study|Adverse Event|0|||
125189842|NCT00866281|450316774|FG000|Overall Study|Withdrawal by participants|3|||
125189843|NCT00866281|450316775|FG001|Overall Study|Withdrawal by participants|0|||
125189844|NCT00866281|450316774|FG000|Overall Study|Disease progression|3|||
125189845|NCT00866281|450316775|FG001|Overall Study|Disease progression|11|||
125189846|NCT00866281|450316774|FG000|Overall Study|New cancer therapy|0|||
125189847|NCT00866281|450316775|FG001|Overall Study|New cancer therapy|4|||
125189848|NCT00529087|450316777|FG000|Overall Study|Adverse Event|10|||
125189849|NCT00529087|450316778|FG001|Overall Study|Adverse Event|13|||
125189850|NCT00529087|450316779|FG002|Overall Study|Adverse Event|4|||
125189851|NCT00529087|450316777|FG000|Overall Study|Lost to Follow-up|6|||
125189852|NCT00529087|450316778|FG001|Overall Study|Lost to Follow-up|4|||
125189853|NCT00529087|450316779|FG002|Overall Study|Lost to Follow-up|1|||
125189854|NCT00529087|450316777|FG000|Overall Study|Protocol Violation|8|||
125189855|NCT00529087|450316778|FG001|Overall Study|Protocol Violation|7|||
125189856|NCT00529087|450316779|FG002|Overall Study|Protocol Violation|6|||
125189857|NCT00529087|450316777|FG000|Overall Study|Withdrawal by Subject|3|||
125189858|NCT00529087|450316778|FG001|Overall Study|Withdrawal by Subject|3|||
125189859|NCT00529087|450316779|FG002|Overall Study|Withdrawal by Subject|3|||
125189860|NCT00529087|450316777|FG000|Overall Study|Protocol deviation|1|||
125189861|NCT00529087|450316778|FG001|Overall Study|Protocol deviation|1|||
125189862|NCT00529087|450316779|FG002|Overall Study|Protocol deviation|2|||
125189863|NCT00318474|450316780|FG000|Overall Study|Adverse Event|1|||
125189864|NCT00318474|450316781|FG001|Overall Study|Adverse Event|1|||
125189865|NCT00318474|450316780|FG000|Overall Study|Lost to Follow-up|0|||
125189866|NCT00318474|450316781|FG001|Overall Study|Lost to Follow-up|1|||
125189867|NCT00318474|450316780|FG000|Overall Study|Pregnancy|0|||
125189868|NCT00318474|450316781|FG001|Overall Study|Pregnancy|2|||
125189869|NCT00318474|450316780|FG000|Overall Study|Protocol Violation|1|||
125189870|NCT00318474|450316781|FG001|Overall Study|Protocol Violation|0|||
125189871|NCT00318474|450316780|FG000|Overall Study|Withdrawal by Subject|3|||
125189872|NCT00318474|450316781|FG001|Overall Study|Withdrawal by Subject|2|||
125189873|NCT00318474|450316780|FG000|Overall Study|Fall in GFR|3|||
125189874|NCT00318474|450316781|FG001|Overall Study|Fall in GFR|3|||
125189875|NCT00318474|450316780|FG000|Overall Study|Post-therapy hyperflycemia|0|||
125189876|NCT00318474|450316781|FG001|Overall Study|Post-therapy hyperflycemia|1|||
125189877|NCT00318474|450316780|FG000|Overall Study|Trial terminated|10|||
125189878|NCT00318474|450316781|FG001|Overall Study|Trial terminated|7|||
125189879|NCT00457002|450316786|FG000|Overall Study|Death|40|||
125189880|NCT00457002|450316787|FG001|Overall Study|Death|47|||
125189881|NCT00457002|450316786|FG000|Overall Study|Adverse Event|284|||
125189882|NCT00457002|450316787|FG001|Overall Study|Adverse Event|260|||
125189883|NCT00457002|450316786|FG000|Overall Study|Withdrawal by Subject|299|||
125189884|NCT00457002|450316787|FG001|Overall Study|Withdrawal by Subject|271|||
125189885|NCT00457002|450316786|FG000|Overall Study|Lost to Follow-up|72|||
125189886|NCT00457002|450316787|FG001|Overall Study|Lost to Follow-up|71|||
125189887|NCT00457002|450316786|FG000|Overall Study|Poor/Non-compliance|46|||
125189888|NCT00457002|450316787|FG001|Overall Study|Poor/Non-compliance|33|||
125189889|NCT00457002|450316786|FG000|Overall Study|No longer met criteria|41|||
125189890|NCT00457002|450316787|FG001|Overall Study|No longer met criteria|37|||
125189891|NCT00457002|450316786|FG000|Overall Study|Administrative reason by Sponsor|1|||
125189892|NCT00457002|450316787|FG001|Overall Study|Administrative reason by Sponsor|0|||
125189893|NCT00457002|450316786|FG000|Overall Study|non-specified|29|||
125189894|NCT00457002|450316787|FG001|Overall Study|non-specified|38|||
125189895|NCT00457002|450316786|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
125189896|NCT00457002|450316787|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
125189897|NCT02283268|450316793|FG000|Overall Study|Withdrawal by Subject|1|||
125189898|NCT01017874|450316794|FG000|Overall Study|Withdrawal by Subject|23|||
125189899|NCT01017874|450316795|FG001|Overall Study|Withdrawal by Subject|20|||
125189900|NCT01017874|450316794|FG000|Overall Study|Sponsor decision|3|||
125189901|NCT01017874|450316795|FG001|Overall Study|Sponsor decision|1|||
125189902|NCT01017874|450316794|FG000|Overall Study|Lost to Follow-up|3|||
125189903|NCT01017874|450316795|FG001|Overall Study|Lost to Follow-up|2|||
125189904|NCT01017874|450316794|FG000|Overall Study|Physician Decision|1|||
125189905|NCT01017874|450316795|FG001|Overall Study|Physician Decision|3|||
125189906|NCT01966120|450316796|FG000|Overall Study|Withdrawal by Subject|0|||
125189907|NCT01966120|450316797|FG001|Overall Study|Withdrawal by Subject|5|||
125189908|NCT01966120|450316796|FG000|Overall Study|Lost to Follow-up|1|||
125189909|NCT01966120|450316797|FG001|Overall Study|Lost to Follow-up|1|||
125189910|NCT02588612|450316800|FG000|Overall Study|Physician Decision|1|||
125189911|NCT02588612|450316800|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
125189912|NCT02588612|450316800|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
125189913|NCT02588612|450316800|FG000|Overall Study|Death prior to T-cell infusion|1|||
125189914|NCT02841995|450316801|FG000|Overall Study|Disease progression|5|||
125189915|NCT02841995|450316802|FG001|Overall Study|Disease progression|11|||
125189916|NCT02841995|450316803|FG002|Overall Study|Disease progression|8|||
125189917|NCT02841995|450316801|FG000|Overall Study|Withdrawal by Subject|2|||
125189918|NCT02841995|450316802|FG001|Overall Study|Withdrawal by Subject|4|||
125189919|NCT02841995|450316803|FG002|Overall Study|Withdrawal by Subject|4|||
125189920|NCT02841995|450316801|FG000|Overall Study|Adverse Event|2|||
125189921|NCT02841995|450316802|FG001|Overall Study|Adverse Event|0|||
125189922|NCT02841995|450316803|FG002|Overall Study|Adverse Event|1|||
125189923|NCT02841995|450316801|FG000|Overall Study|Investigator decision|2|||
125189924|NCT02841995|450316802|FG001|Overall Study|Investigator decision|0|||
125189925|NCT02841995|450316803|FG002|Overall Study|Investigator decision|1|||
125189926|NCT02841995|450316801|FG000|Overall Study|Death|0|||
125189927|NCT02841995|450316802|FG001|Overall Study|Death|0|||
125189928|NCT02841995|450316803|FG002|Overall Study|Death|2|||
125189929|NCT02841995|450316801|FG000|Overall Study|Noncompliance to protocol|1|||
125189930|NCT02841995|450316802|FG001|Overall Study|Noncompliance to protocol|0|||
125189931|NCT02841995|450316803|FG002|Overall Study|Noncompliance to protocol|0|||
125189932|NCT02841995|450316801|FG000|Overall Study|Sponsor decision|1|||
125189933|NCT02841995|450316802|FG001|Overall Study|Sponsor decision|0|||
125189934|NCT02841995|450316803|FG002|Overall Study|Sponsor decision|0|||
125189935|NCT02841995|450316801|FG000|Overall Study|Other|4|||
125189936|NCT02841995|450316802|FG001|Overall Study|Other|1|||
125189937|NCT02841995|450316803|FG002|Overall Study|Other|5|||
125189938|NCT03809663|450316810|FG000|Overall Study|Decision by sponsor|24|||
125189939|NCT03809663|450316811|FG001|Overall Study|Decision by sponsor|18|||
125189940|NCT03809663|450316812|FG002|Overall Study|Decision by sponsor|20|||
125189941|NCT03809663|450316813|FG003|Overall Study|Decision by sponsor|20|||
125189942|NCT03809663|450316814|FG004|Overall Study|Decision by sponsor|0|||
125189943|NCT03809663|450316815|FG005|Overall Study|Decision by sponsor|0|||
125189944|NCT03809663|450316810|FG000|Overall Study|Withdrawal by Subject|26|||
125189945|NCT03809663|450316811|FG001|Overall Study|Withdrawal by Subject|22|||
125189946|NCT03809663|450316812|FG002|Overall Study|Withdrawal by Subject|27|||
125189947|NCT03809663|450316813|FG003|Overall Study|Withdrawal by Subject|26|||
125189948|NCT03809663|450316814|FG004|Overall Study|Withdrawal by Subject|0|||
125189949|NCT03809663|450316815|FG005|Overall Study|Withdrawal by Subject|0|||
125189950|NCT03809663|450316810|FG000|Overall Study|Lost to Follow-up|1|||
125189951|NCT03809663|450316811|FG001|Overall Study|Lost to Follow-up|4|||
125189952|NCT03809663|450316812|FG002|Overall Study|Lost to Follow-up|1|||
125189953|NCT03809663|450316813|FG003|Overall Study|Lost to Follow-up|1|||
125189954|NCT03809663|450316814|FG004|Overall Study|Lost to Follow-up|0|||
125189955|NCT03809663|450316815|FG005|Overall Study|Lost to Follow-up|0|||
125189956|NCT01703260|450316817|FG000|Overall Study|Adverse Event|1|||
125189957|NCT01703260|450316818|FG001|Overall Study|Adverse Event|2|||
125189958|NCT01703260|450316819|FG002|Overall Study|Adverse Event|2|||
125189959|NCT01703260|450316817|FG000|Overall Study|Lost to Follow-up|1|||
125189960|NCT01703260|450316818|FG001|Overall Study|Lost to Follow-up|0|||
125189961|NCT01703260|450316819|FG002|Overall Study|Lost to Follow-up|0|||
125189962|NCT01703260|450316817|FG000|Overall Study|Withdrawal by Subject|0|||
125189963|NCT01703260|450316818|FG001|Overall Study|Withdrawal by Subject|0|||
125189964|NCT01703260|450316819|FG002|Overall Study|Withdrawal by Subject|1|||
125189965|NCT01703260|450316817|FG000|Overall Study|Study Termination|1|||
125189966|NCT01703260|450316818|FG001|Overall Study|Study Termination|2|||
125189967|NCT01703260|450316819|FG002|Overall Study|Study Termination|0|||
125189968|NCT02042014|450316821|FG000|Overall Study|Adverse Event|1|||
125189969|NCT02042014|450316821|FG000|Overall Study|Physician Decision|7|||
125189970|NCT03309943|450316826|FG000|Overall Study|Withdrawal by Subject|0|||
125189971|NCT03309943|450316827|FG001|Overall Study|Withdrawal by Subject|1|||
125189972|NCT03309943|450316826|FG000|Overall Study|Inappropriate behavior towards staff|0|||
125189973|NCT03309943|450316827|FG001|Overall Study|Inappropriate behavior towards staff|1|||
125189974|NCT03123393|450316828|FG000|Overall Study|Study Terminated by Sponsor|6|||
125189975|NCT03123393|450316829|FG001|Overall Study|Study Terminated by Sponsor|9|||
125189976|NCT03123393|450316828|FG000|Overall Study|Withdrawal by Subject|2|||
125189977|NCT03123393|450316829|FG001|Overall Study|Withdrawal by Subject|1|||
125189978|NCT03123393|450316828|FG000|Overall Study|Reason not Specified|13|||
125189979|NCT03123393|450316829|FG001|Overall Study|Reason not Specified|13|||
125189980|NCT00558701|450316834|FG000|Overall Study|Protocol Deviations|1|||
125189981|NCT00558701|450316835|FG001|Overall Study|Protocol Deviations|4|||
125189982|NCT00427648|450316836|FG000|Overall Study|Protocol Violation|1|||
125189983|NCT00427648|450316837|FG001|Overall Study|Protocol Violation|2|||
125189984|NCT00427648|450316836|FG000|Overall Study|Adverse Event|0|||
125189985|NCT00427648|450316837|FG001|Overall Study|Adverse Event|1|||
125189986|NCT00628212|450316842|FG000|Overall Study|Adverse Event|2|||
125189987|NCT00628212|450316843|FG001|Overall Study|Adverse Event|0|||
125189988|NCT00628212|450316844|FG002|Overall Study|Adverse Event|1|||
125189989|NCT00628212|450316845|FG003|Overall Study|Adverse Event|2|||
125189990|NCT00628212|450316842|FG000|Overall Study|Physician Decision|1|||
125189991|NCT00628212|450316843|FG001|Overall Study|Physician Decision|1|||
125189992|NCT00628212|450316844|FG002|Overall Study|Physician Decision|2|||
125189993|NCT00628212|450316845|FG003|Overall Study|Physician Decision|3|||
125189994|NCT01681212|450316846|FG000|Overall Study|No longer met study criteria|5|||
125189995|NCT01681212|450316846|FG000|Overall Study|Administrative reason by sponsor|1|||
125189996|NCT01464424|450316849|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
125189997|NCT01464424|450316850|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
125189998|NCT01464333|450316852|FG000|Overall Study|Adverse Event|34|||
125189999|NCT01464333|450316852|FG000|Overall Study|Lack of Efficacy|72|||
125190000|NCT01464333|450316852|FG000|Overall Study|Withdrawal by Subject|11|||
125190001|NCT01464333|450316852|FG000|Overall Study|Other|4|||
125190002|NCT01464333|450316852|FG000|Overall Study|No Hospital Visit|42|||
125190003|NCT00789373|450316853|FG000|Induction|Adverse Event|64|||
125190004|NCT00789373|450316854|FG001|Induction|Adverse Event|0|||
125190005|NCT00789373|450316855|FG002|Induction|Adverse Event|0|||
125190006|NCT00789373|450316853|FG000|Induction|Death Due to study disease|24|||
125190007|NCT00789373|450316854|FG001|Induction|Death Due to study disease|0|||
125190008|NCT00789373|450316855|FG002|Induction|Death Due to study disease|0|||
125190009|NCT00789373|450316853|FG000|Induction|Death due to adverse event|19|||
125190010|NCT00789373|450316854|FG001|Induction|Death due to adverse event|0|||
125190011|NCT00789373|450316855|FG002|Induction|Death due to adverse event|0|||
125190012|NCT00789373|450316853|FG000|Induction|Death due to toxicity|11|||
125190013|NCT00789373|450316854|FG001|Induction|Death due to toxicity|0|||
125190014|NCT00789373|450316855|FG002|Induction|Death due to toxicity|0|||
125190015|NCT00789373|450316853|FG000|Induction|Death due to procedure|1|||
125190016|NCT00789373|450316854|FG001|Induction|Death due to procedure|0|||
125190017|NCT00789373|450316855|FG002|Induction|Death due to procedure|0|||
125190018|NCT00789373|450316853|FG000|Induction|Investigator decision|7|||
125190019|NCT00789373|450316854|FG001|Induction|Investigator decision|0|||
125190020|NCT00789373|450316855|FG002|Induction|Investigator decision|0|||
125190021|NCT00789373|450316853|FG000|Induction|Protocol entry criteria not met|9|||
125190022|NCT00789373|450316854|FG001|Induction|Protocol entry criteria not met|0|||
125190023|NCT00789373|450316855|FG002|Induction|Protocol entry criteria not met|0|||
125190024|NCT00789373|450316853|FG000|Induction|Lost to Follow-up|6|||
125190025|NCT00789373|450316854|FG001|Induction|Lost to Follow-up|0|||
125190026|NCT00789373|450316855|FG002|Induction|Lost to Follow-up|0|||
125190027|NCT00789373|450316853|FG000|Induction|Protocol Violation|1|||
125190028|NCT00789373|450316854|FG001|Induction|Protocol Violation|0|||
125190029|NCT00789373|450316855|FG002|Induction|Protocol Violation|0|||
125190030|NCT00789373|450316853|FG000|Induction|Progressive Disease|220|||
125190031|NCT00789373|450316854|FG001|Induction|Progressive Disease|0|||
125190032|NCT00789373|450316855|FG002|Induction|Progressive Disease|0|||
125190033|NCT00789373|450316853|FG000|Induction|Withdrawal by Subject|37|||
125190034|NCT00789373|450316854|FG001|Induction|Withdrawal by Subject|0|||
125190035|NCT00789373|450316855|FG002|Induction|Withdrawal by Subject|0|||
125190036|NCT00789373|450316853|FG000|Maintenance|Adverse Event|0|||
125190037|NCT00789373|450316854|FG001|Maintenance|Adverse Event|65|||
125190038|NCT00789373|450316855|FG002|Maintenance|Adverse Event|12|||
125190039|NCT00789373|450316853|FG000|Maintenance|Death due to study disease|0|||
125190040|NCT00789373|450316854|FG001|Maintenance|Death due to study disease|3|||
125190041|NCT00789373|450316855|FG002|Maintenance|Death due to study disease|1|||
125190042|NCT00789373|450316853|FG000|Maintenance|Death due to adverse event|0|||
125190043|NCT00789373|450316854|FG001|Maintenance|Death due to adverse event|4|||
125190044|NCT00789373|450316855|FG002|Maintenance|Death due to adverse event|1|||
125190045|NCT00789373|450316853|FG000|Maintenance|Death due to toxicity|0|||
125190046|NCT00789373|450316854|FG001|Maintenance|Death due to toxicity|1|||
125190047|NCT00789373|450316855|FG002|Maintenance|Death due to toxicity|2|||
125190048|NCT00789373|450316853|FG000|Maintenance|Investigator Decision|0|||
125190049|NCT00789373|450316854|FG001|Maintenance|Investigator Decision|4|||
125190050|NCT00789373|450316855|FG002|Maintenance|Investigator Decision|2|||
125190051|NCT00789373|450316853|FG000|Maintenance|Protocol entry criteria not met|0|||
125190052|NCT00789373|450316854|FG001|Maintenance|Protocol entry criteria not met|2|||
125190053|NCT00789373|450316855|FG002|Maintenance|Protocol entry criteria not met|0|||
125190054|NCT00789373|450316853|FG000|Maintenance|Lost to Follow-up|0|||
125190055|NCT00789373|450316854|FG001|Maintenance|Lost to Follow-up|2|||
125190056|NCT00789373|450316855|FG002|Maintenance|Lost to Follow-up|0|||
125190057|NCT00789373|450316853|FG000|Maintenance|Progressive Disease|0|||
125190058|NCT00789373|450316854|FG001|Maintenance|Progressive Disease|253|||
125190059|NCT00789373|450316855|FG002|Maintenance|Progressive Disease|152|||
125190060|NCT00789373|450316853|FG000|Maintenance|Withdrawal by Subject|0|||
125190061|NCT00789373|450316854|FG001|Maintenance|Withdrawal by Subject|21|||
125190062|NCT00789373|450316855|FG002|Maintenance|Withdrawal by Subject|8|||
125190063|NCT00789373|450316853|FG000|Maintenance|Sponsor Decision|0|||
125190064|NCT00789373|450316854|FG001|Maintenance|Sponsor Decision|0|||
125190065|NCT00789373|450316855|FG002|Maintenance|Sponsor Decision|2|||
125190066|NCT00789373|450316853|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
125190067|NCT00789373|450316854|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
125190068|NCT00789373|450316855|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
125190069|NCT03321968|450316856|FG000|Overall Study|Withdrawal by Subject|1|||
125190070|NCT03321968|450316857|FG001|Overall Study|Withdrawal by Subject|2|||
125190071|NCT03321968|450316858|FG002|Overall Study|Withdrawal by Subject|1|||
125190072|NCT03321968|450316856|FG000|Overall Study|Lost to Follow-up|2|||
125190073|NCT03321968|450316857|FG001|Overall Study|Lost to Follow-up|0|||
125190074|NCT03321968|450316858|FG002|Overall Study|Lost to Follow-up|1|||
125190075|NCT03321968|450316856|FG000|Overall Study|Other than specified|0|||
125190076|NCT03321968|450316857|FG001|Overall Study|Other than specified|0|||
125190077|NCT03321968|450316858|FG002|Overall Study|Other than specified|1|||
125190078|NCT04830969|450316859|FG000|Overall Study|Withdrawal by Subject|6|||
125190079|NCT04830969|450316860|FG001|Overall Study|Withdrawal by Subject|2|||
125190080|NCT04830969|450316859|FG000|Overall Study|Protocol Violation|3|||
125190081|NCT04830969|450316860|FG001|Overall Study|Protocol Violation|9|||
125190082|NCT04830969|450316859|FG000|Overall Study|Lost to Follow-up|4|||
125190083|NCT04830969|450316860|FG001|Overall Study|Lost to Follow-up|4|||
125190084|NCT01537042|450316874|FG000|Overall Study|Adverse Event|0|||
125190085|NCT01537042|450316875|FG001|Overall Study|Adverse Event|2|||
125190086|NCT01537042|450316874|FG000|Overall Study|Lack of Efficacy|0|||
125190087|NCT01537042|450316875|FG001|Overall Study|Lack of Efficacy|1|||
125190088|NCT01537042|450316874|FG000|Overall Study|Protocol Violation|0|||
125190089|NCT01537042|450316875|FG001|Overall Study|Protocol Violation|1|||
125190090|NCT01537042|450316874|FG000|Overall Study|Other|0|||
125190091|NCT01537042|450316875|FG001|Overall Study|Other|1|||
125190092|NCT00979654|450316876|FG000|Overall Study|Lost to Follow-up|1|||
125190093|NCT00979654|450316876|FG000|Overall Study|Withdrawal by Subject|22|||
125190094|NCT00979654|450316876|FG000|Overall Study|Death|1|||
125190095|NCT00979654|450316876|FG000|Overall Study|Lack of Efficacy|6|||
125190096|NCT00979654|450316876|FG000|Overall Study|Adverse Event|1|||
125190097|NCT00979654|450316876|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
125190098|NCT00979654|450316876|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
125190099|NCT00979654|450316876|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
125190100|NCT00979654|450316876|FG000|Overall Study|Serious Adverse Event|1|||
125190101|NCT00979654|450316876|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
125190102|NCT01779440|450316877|FG000|Overall Study|Withdrawal by Subject|3|||
125190103|NCT01779440|450316878|FG001|Overall Study|Withdrawal by Subject|5|||
125190104|NCT01205269|450316879|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
125190105|NCT01205269|450316880|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
125190106|NCT01205269|450316881|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
125190107|NCT01205269|450316882|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
125190108|NCT01205269|450316883|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
125190109|NCT01205269|450316884|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
125243794|NCT00002874|450516641|FG001|Overall Study|Withdrawal by Subject|1|||
125243795|NCT00002874|450516640|FG000|Overall Study|Protocol Violation|44|||
125243796|NCT00002874|450516641|FG001|Overall Study|Protocol Violation|34|||
125243797|NCT01397747|450516646|FG000|Overall Study|Multitarget DNA test excluded|689|||
125243798|NCT01397747|450516646|FG000|Overall Study|Colonoscopy excluded|304|||
125243799|NCT01397747|450516646|FG000|Overall Study|FIT excluded|34|||
125243800|NCT03828383|450516647|FG000|Overall Study|Lost to Follow-up|3|||
125243801|NCT03828383|450516648|FG001|Overall Study|Lost to Follow-up|2|||
125243802|NCT03828383|450516647|FG000|Overall Study|Withdrawal by Subject|4|||
125243803|NCT03828383|450516648|FG001|Overall Study|Withdrawal by Subject|5|||
125243804|NCT00504309|450516649|FG000|Overall Study|Death|0|||
125243805|NCT00504309|450516650|FG001|Overall Study|Death|0|||
125243806|NCT00504309|450516651|FG002|Overall Study|Death|0|||
125243807|NCT00504309|450516652|FG003|Overall Study|Death|0|||
125243808|NCT00504309|450516653|FG004|Overall Study|Death|1|||
125243809|NCT00504309|450516654|FG005|Overall Study|Death|0|||
125243810|NCT00504309|450516649|FG000|Overall Study|Withdrawal by Subject|0|||
125243811|NCT00504309|450516650|FG001|Overall Study|Withdrawal by Subject|0|||
125243812|NCT00504309|450516651|FG002|Overall Study|Withdrawal by Subject|1|||
125243813|NCT00504309|450516652|FG003|Overall Study|Withdrawal by Subject|0|||
125243814|NCT00504309|450516653|FG004|Overall Study|Withdrawal by Subject|0|||
125243815|NCT00504309|450516654|FG005|Overall Study|Withdrawal by Subject|0|||
125243816|NCT03158311|450516657|FG000|Overall Study|Subject/Guardian Decision|10|||
125243817|NCT03158311|450516658|FG001|Overall Study|Subject/Guardian Decision|6|||
125243818|NCT03158311|450516659|FG002|Overall Study|Subject/Guardian Decision|11|||
125243819|NCT03158311|450516657|FG000|Overall Study|Adverse Event|5|||
125243820|NCT03158311|450516658|FG001|Overall Study|Adverse Event|3|||
125243821|NCT03158311|450516659|FG002|Overall Study|Adverse Event|3|||
125243822|NCT03158311|450516657|FG000|Overall Study|Techinical Problems|3|||
125243823|NCT03158311|450516658|FG001|Overall Study|Techinical Problems|1|||
125243824|NCT03158311|450516659|FG002|Overall Study|Techinical Problems|5|||
125243825|NCT03158311|450516657|FG000|Overall Study|Physician Decision|2|||
125243826|NCT03158311|450516658|FG001|Overall Study|Physician Decision|3|||
125243827|NCT03158311|450516659|FG002|Overall Study|Physician Decision|7|||
125243828|NCT03158311|450516657|FG000|Overall Study|Lost to Follow-up|1|||
125243829|NCT03158311|450516658|FG001|Overall Study|Lost to Follow-up|1|||
125190110|NCT01408303|450316885|FG000|Overall Study|Adverse Event|3|||
125190111|NCT01408303|450316886|FG001|Overall Study|Adverse Event|7|||
125190112|NCT01408303|450316887|FG002|Overall Study|Adverse Event|2|||
125190113|NCT01408303|450316885|FG000|Overall Study|Lost to Follow-up|0|||
125190114|NCT01408303|450316886|FG001|Overall Study|Lost to Follow-up|1|||
125190115|NCT01408303|450316887|FG002|Overall Study|Lost to Follow-up|2|||
125243830|NCT03158311|450516659|FG002|Overall Study|Lost to Follow-up|1|||
125243831|NCT03158311|450516657|FG000|Overall Study|Sponsor decision|1|||
125243832|NCT03158311|450516658|FG001|Overall Study|Sponsor decision|0|||
125243833|NCT03158311|450516659|FG002|Overall Study|Sponsor decision|0|||
125243834|NCT03158311|450516657|FG000|Overall Study|Pregnancy|0|||
125243835|NCT03158311|450516658|FG001|Overall Study|Pregnancy|2|||
125243836|NCT03158311|450516659|FG002|Overall Study|Pregnancy|0|||
125243837|NCT03158311|450516657|FG000|Overall Study|Randomized in error|0|||
125243838|NCT03158311|450516658|FG001|Overall Study|Randomized in error|0|||
125243839|NCT03158311|450516659|FG002|Overall Study|Randomized in error|1|||
125243840|NCT01018953|450516660|FG000|Overall Study|Adverse Event|2|||
125243841|NCT01018953|450516660|FG000|Overall Study|Withdrawal by Subject|1|||
125243842|NCT01018953|450516660|FG000|Overall Study|Study termination by sponsor|5|||
125243843|NCT01928771|450516667|FG000|Overall Study|Adverse Event|6|||
125243844|NCT01928771|450516668|FG001|Overall Study|Adverse Event|5|||
125190116|NCT01408303|450316885|FG000|Overall Study|Withdrawal by Subject|2|||
125243845|NCT01928771|450516669|FG002|Overall Study|Adverse Event|1|||
125243846|NCT01928771|450516667|FG000|Overall Study|Death|2|||
125243847|NCT01928771|450516668|FG001|Overall Study|Death|2|||
125243848|NCT01928771|450516669|FG002|Overall Study|Death|2|||
125243849|NCT01928771|450516667|FG000|Overall Study|Lost to Follow-up|5|||
125243850|NCT01928771|450516668|FG001|Overall Study|Lost to Follow-up|6|||
125243851|NCT01928771|450516669|FG002|Overall Study|Lost to Follow-up|3|||
125243852|NCT01928771|450516667|FG000|Overall Study|Withdrawal by Subject|20|||
125243853|NCT01928771|450516668|FG001|Overall Study|Withdrawal by Subject|15|||
125243854|NCT01928771|450516669|FG002|Overall Study|Withdrawal by Subject|17|||
125243855|NCT01928771|450516667|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
125243856|NCT01928771|450516668|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
125243857|NCT01928771|450516669|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
125243858|NCT01928771|450516667|FG000|Overall Study|Other Reasons|9|||
125243859|NCT01928771|450516668|FG001|Overall Study|Other Reasons|9|||
125243860|NCT01928771|450516669|FG002|Overall Study|Other Reasons|14|||
125243861|NCT01928771|450516667|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
125243862|NCT01928771|450516668|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
125243863|NCT01928771|450516669|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
125243864|NCT03932331|450516670|FG000|Overall Study|Death|0|||
125243865|NCT03932331|450516671|FG001|Overall Study|Death|7|||
125243866|NCT03932331|450516672|FG002|Overall Study|Death|2|||
125243867|NCT03932331|450516670|FG000|Overall Study|Withdrawal by Subject|0|||
125243868|NCT03932331|450516671|FG001|Overall Study|Withdrawal by Subject|3|||
125243869|NCT03932331|450516672|FG002|Overall Study|Withdrawal by Subject|0|||
125243870|NCT03932331|450516670|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
125243871|NCT03932331|450516671|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
125243872|NCT03932331|450516672|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
125243873|NCT03932331|450516670|FG000|Overall Study|Progressive disease|3|||
125243874|NCT03932331|450516671|FG001|Overall Study|Progressive disease|0|||
125243875|NCT03932331|450516672|FG002|Overall Study|Progressive disease|0|||
125243876|NCT03932331|450516670|FG000|Overall Study|Lung infection|1|||
125243877|NCT03932331|450516671|FG001|Overall Study|Lung infection|0|||
125243878|NCT03932331|450516672|FG002|Overall Study|Lung infection|0|||
125243879|NCT03932331|450516670|FG000|Overall Study|Other|0|||
125243880|NCT03932331|450516671|FG001|Overall Study|Other|0|||
125243881|NCT03932331|450516672|FG002|Overall Study|Other|58|||
125243882|NCT01407367|450516675|FG000|Overall Study|Death|24|||
125243883|NCT01407367|450516676|FG001|Overall Study|Death|32|||
125243884|NCT01407367|450516675|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
125243885|NCT01407367|450516676|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
125243886|NCT01407367|450516675|FG000|Overall Study|Withdrawal by Subject|4|||
125243887|NCT01407367|450516676|FG001|Overall Study|Withdrawal by Subject|15|||
125243888|NCT01407367|450516675|FG000|Overall Study|Lost to Follow-up|0|||
125243889|NCT01407367|450516676|FG001|Overall Study|Lost to Follow-up|2|||
125243890|NCT01452347|450516679|FG000|Overall Study|Adverse Event|2|||
125243891|NCT01452347|450516680|FG001|Overall Study|Adverse Event|1|||
125243892|NCT01452347|450516679|FG000|Overall Study|Non compliance protocol|2|||
125243893|NCT01452347|450516680|FG001|Overall Study|Non compliance protocol|0|||
125243894|NCT01452347|450516679|FG000|Overall Study|Lost to Follow-up|2|||
125243895|NCT01452347|450516680|FG001|Overall Study|Lost to Follow-up|0|||
125243896|NCT01452347|450516679|FG000|Overall Study|Withdrawal by Subject|3|||
125243897|NCT01452347|450516680|FG001|Overall Study|Withdrawal by Subject|3|||
125243898|NCT01452347|450516679|FG000|Overall Study|Not treated|6|||
125243899|NCT01452347|450516680|FG001|Overall Study|Not treated|3|||
125243900|NCT01452347|450516679|FG000|Overall Study|Other reason not defined above|2|||
125243901|NCT01452347|450516680|FG001|Overall Study|Other reason not defined above|0|||
125243902|NCT02642679|450518399|FG000|Overall Study|Withdrawal by Subject|1|||
125243903|NCT02642679|450518399|FG000|Overall Study|Physician Decision|1|||
125243904|NCT02642679|450518399|FG000|Overall Study|Physician Decision|1|||
125243905|NCT01112267|450518401|FG000|Overall Study|Adverse Event|24|||
125243906|NCT01112267|450518402|FG001|Overall Study|Adverse Event|6|||
125243907|NCT01112267|450518401|FG000|Overall Study|Withdrawal by Subject|3|||
125243908|NCT01112267|450518402|FG001|Overall Study|Withdrawal by Subject|5|||
125243909|NCT01112267|450518401|FG000|Overall Study|Protocol Violation|5|||
125243910|NCT01112267|450518402|FG001|Overall Study|Protocol Violation|3|||
125243911|NCT01112267|450518401|FG000|Overall Study|Participants not compliant|1|||
125243912|NCT01112267|450518402|FG001|Overall Study|Participants not compliant|2|||
125243913|NCT01112267|450518401|FG000|Overall Study|Participants not receive any study drug|1|||
125243914|NCT01112267|450518402|FG001|Overall Study|Participants not receive any study drug|2|||
125243915|NCT05638737|450518405|FG000|Overall Study|Withdrawal by Subject|4|||
125243916|NCT05638737|450518406|FG001|Overall Study|Withdrawal by Subject|7|||
125243917|NCT04633447|450518409|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
125243918|NCT04633447|450518410|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
125243919|NCT04633447|450518409|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
125243920|NCT04633447|450518410|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
125243921|NCT04633447|450518409|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
125243922|NCT04633447|450518410|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
125190117|NCT01408303|450316886|FG001|Overall Study|Withdrawal by Subject|3|||
125190118|NCT01408303|450316887|FG002|Overall Study|Withdrawal by Subject|1|||
125190119|NCT01408303|450316885|FG000|Overall Study|Protocol Violation|0|||
125190120|NCT01408303|450316886|FG001|Overall Study|Protocol Violation|1|||
125190121|NCT01408303|450316887|FG002|Overall Study|Protocol Violation|0|||
125190122|NCT01408303|450316885|FG000|Overall Study|Noncompliance|1|||
125190123|NCT01408303|450316886|FG001|Overall Study|Noncompliance|0|||
125190124|NCT01408303|450316887|FG002|Overall Study|Noncompliance|1|||
125190125|NCT01207687|450316888|FG000|Overall Study|Adverse Event|1|||
125190126|NCT01207687|450316888|FG000|Overall Study|Withdrawal by Subject|1|||
125190127|NCT01486446|450316889|FG000|Overall Study|Adverse Event|1|||
125190128|NCT01486446|450316890|FG001|Overall Study|Adverse Event|0|||
125190129|NCT01801865|450316891|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
125190130|NCT01801865|450316891|FG000|Overall Study|Physician Decision|7|||
125190131|NCT00523848|450316892|FG000|Overall Study|Adverse Event|11|||
125190132|NCT00523848|450316892|FG000|Overall Study|Withdrawal by Subject|2|||
125190133|NCT00523848|450316892|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
125190134|NCT00523848|450316892|FG000|Overall Study|Disease Progression|5|||
125190135|NCT00523848|450316892|FG000|Overall Study|Other, unspecified|4|||
125190136|NCT01367886|450316893|FG000|Overall Study|Lost to Follow-up|4|||
125190137|NCT01367886|450316893|FG000|Overall Study|Lack of Efficacy|2|||
125190138|NCT01367886|450316893|FG000|Overall Study|Death|1|||
125190139|NCT00985504|450316896|FG000|Acute Treatment Period|Adverse Event|3|||
125190140|NCT00985504|450316897|FG001|Acute Treatment Period|Adverse Event|4|||
125190141|NCT00985504|450316896|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
125190142|NCT00985504|450316897|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
125190143|NCT00985504|450316896|FG000|Acute Treatment Period|Protocol Violation|2|||
125190144|NCT00985504|450316897|FG001|Acute Treatment Period|Protocol Violation|0|||
125190145|NCT00985504|450316896|FG000|Acute Treatment Period|Sponsor Decision|0|||
125190146|NCT00985504|450316897|FG001|Acute Treatment Period|Sponsor Decision|1|||
125190147|NCT00985504|450316896|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
125190148|NCT00985504|450316897|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
125190149|NCT00985504|450316896|FG000|Optimization Period|Adverse Event|7|||
125190150|NCT00985504|450316897|FG001|Optimization Period|Adverse Event|9|||
125190151|NCT00985504|450316896|FG000|Optimization Period|Death|0|||
125190152|NCT00985504|450316897|FG001|Optimization Period|Death|1|||
125190153|NCT00985504|450316896|FG000|Optimization Period|Lack of Efficacy|5|||
125190154|NCT00985504|450316897|FG001|Optimization Period|Lack of Efficacy|3|||
125190155|NCT00985504|450316896|FG000|Optimization Period|Lost to Follow-up|0|||
125190156|NCT00985504|450316897|FG001|Optimization Period|Lost to Follow-up|1|||
125190157|NCT00985504|450316896|FG000|Optimization Period|Physician Decision|1|||
125190158|NCT00985504|450316897|FG001|Optimization Period|Physician Decision|0|||
125190159|NCT00985504|450316896|FG000|Optimization Period|Protocol Violation|3|||
125190160|NCT00985504|450316897|FG001|Optimization Period|Protocol Violation|1|||
125190161|NCT00985504|450316896|FG000|Optimization Period|Withdrawal by Subject|10|||
125190162|NCT00985504|450316897|FG001|Optimization Period|Withdrawal by Subject|8|||
125190163|NCT03711786|450316902|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
125190164|NCT03711786|450316903|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
125190165|NCT03711786|450316902|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
125190166|NCT03711786|450316903|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
125190167|NCT03711786|450316902|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
125190168|NCT03711786|450316903|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
125190169|NCT03711786|450316902|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
125190170|NCT03711786|450316903|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
125190171|NCT03711786|450316902|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
125190172|NCT03711786|450316903|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
125190173|NCT03711786|450316902|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
125190174|NCT03711786|450316903|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
125190175|NCT03379727|450316907|FG000|Overall Study|Lack of Efficacy|73|||
125190176|NCT03379727|450316907|FG000|Overall Study|Adverse Event|32|||
125190177|NCT03379727|450316907|FG000|Overall Study|Death|18|||
125190178|NCT03379727|450316907|FG000|Overall Study|Patient/guardian decision|17|||
125190179|NCT03379727|450316907|FG000|Overall Study|Physician Decision|104|||
125190180|NCT03379727|450316907|FG000|Overall Study|Protocol Violation|4|||
125190181|NCT03379727|450316907|FG000|Overall Study|Lost to Follow-up|1|||
125190182|NCT04031846|450316908|FG000|Overall Study|Lost to Follow-up|4|||
125190183|NCT04031846|450316909|FG001|Overall Study|Lost to Follow-up|4|||
125190184|NCT04031846|450316908|FG000|Overall Study|Physician Decision|0|||
125190185|NCT04031846|450316909|FG001|Overall Study|Physician Decision|1|||
125190186|NCT04031846|450316908|FG000|Overall Study|Protocol Violation|1|||
125190187|NCT04031846|450316909|FG001|Overall Study|Protocol Violation|1|||
125190188|NCT04031846|450316908|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
125190189|NCT04031846|450316909|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
125190190|NCT06868654|450316910|FG000|Overall Study|Death|4|||
125190191|NCT06868654|450316911|FG001|Overall Study|Death|14|||
125190192|NCT06868654|450316910|FG000|Overall Study|Lost to Follow-up|0|||
125190193|NCT06868654|450316911|FG001|Overall Study|Lost to Follow-up|1|||
125190194|NCT06868654|450316910|FG000|Overall Study|Withdrawal by Subject|5|||
125190195|NCT06868654|450316911|FG001|Overall Study|Withdrawal by Subject|3|||
125190196|NCT06868654|450316910|FG000|Overall Study|Physician Decision|0|||
125190197|NCT06868654|450316911|FG001|Overall Study|Physician Decision|1|||
125190198|NCT06868654|450316910|FG000|Overall Study|Ongoing|23|||
125190199|NCT06868654|450316911|FG001|Overall Study|Ongoing|21|||
125190200|NCT00764660|450316916|FG000|Overall Study|Adverse Event|6|||
125190201|NCT00764660|450316917|FG001|Overall Study|Adverse Event|3|||
125190202|NCT00764660|450316916|FG000|Overall Study|Lost to Follow-up|3|||
125190203|NCT00764660|450316917|FG001|Overall Study|Lost to Follow-up|4|||
125190204|NCT00764660|450316916|FG000|Overall Study|Withdrawal by Subject|7|||
125190205|NCT00764660|450316917|FG001|Overall Study|Withdrawal by Subject|3|||
125190206|NCT00764660|450316916|FG000|Overall Study|Noncompliance With Protocol|5|||
125190207|NCT00764660|450316917|FG001|Overall Study|Noncompliance With Protocol|1|||
125190208|NCT00764660|450316916|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
125190209|NCT00764660|450316917|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
125190210|NCT01131455|450316918|FG000|Overall Study|Death of PI|6|||
125190211|NCT01131455|450316919|FG001|Overall Study|Death of PI|4|||
125190212|NCT01131455|450316920|FG002|Overall Study|Death of PI|0|||
125190213|NCT03103152|450316921|FG000|Overall Study|Physician Decision|5|||
125190214|NCT03103152|450316922|FG001|Overall Study|Physician Decision|2|||
125190215|NCT03103152|450316923|FG002|Overall Study|Physician Decision|6|||
125190216|NCT03103152|450316924|FG003|Overall Study|Physician Decision|3|||
125190217|NCT03103152|450316925|FG004|Overall Study|Physician Decision|3|||
125190218|NCT03103152|450316926|FG005|Overall Study|Physician Decision|1|||
125190219|NCT03103152|450316921|FG000|Overall Study|Protocol Violation|2|||
125190220|NCT03103152|450316922|FG001|Overall Study|Protocol Violation|2|||
125190221|NCT03103152|450316923|FG002|Overall Study|Protocol Violation|1|||
125190222|NCT03103152|450316924|FG003|Overall Study|Protocol Violation|2|||
125190223|NCT03103152|450316925|FG004|Overall Study|Protocol Violation|1|||
125190224|NCT03103152|450316926|FG005|Overall Study|Protocol Violation|1|||
125190225|NCT03103152|450316921|FG000|Overall Study|Inter-current illness|0|||
125190226|NCT03103152|450316922|FG001|Overall Study|Inter-current illness|0|||
125190227|NCT03103152|450316923|FG002|Overall Study|Inter-current illness|1|||
125190228|NCT03103152|450316924|FG003|Overall Study|Inter-current illness|0|||
125190229|NCT03103152|450316925|FG004|Overall Study|Inter-current illness|0|||
125190230|NCT03103152|450316926|FG005|Overall Study|Inter-current illness|0|||
125190231|NCT03103152|450316921|FG000|Overall Study|Death|0|||
125190232|NCT03103152|450316922|FG001|Overall Study|Death|1|||
125190233|NCT03103152|450316923|FG002|Overall Study|Death|0|||
125190234|NCT03103152|450316924|FG003|Overall Study|Death|0|||
125190235|NCT03103152|450316925|FG004|Overall Study|Death|0|||
125190236|NCT03103152|450316926|FG005|Overall Study|Death|0|||
125190237|NCT03103152|450316921|FG000|Overall Study|Adverse Event|0|||
125190238|NCT03103152|450316922|FG001|Overall Study|Adverse Event|0|||
125190239|NCT03103152|450316923|FG002|Overall Study|Adverse Event|1|||
125190240|NCT03103152|450316924|FG003|Overall Study|Adverse Event|0|||
125190241|NCT03103152|450316925|FG004|Overall Study|Adverse Event|0|||
125190242|NCT03103152|450316926|FG005|Overall Study|Adverse Event|1|||
125190243|NCT03103152|450316921|FG000|Overall Study|Withdrawal by Subject|1|||
125190244|NCT03103152|450316922|FG001|Overall Study|Withdrawal by Subject|0|||
125190245|NCT03103152|450316923|FG002|Overall Study|Withdrawal by Subject|1|||
125190246|NCT03103152|450316924|FG003|Overall Study|Withdrawal by Subject|1|||
125190247|NCT03103152|450316925|FG004|Overall Study|Withdrawal by Subject|1|||
125190248|NCT03103152|450316926|FG005|Overall Study|Withdrawal by Subject|1|||
125190249|NCT03103152|450316921|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
125190250|NCT03103152|450316922|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
125190251|NCT03103152|450316923|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
125190252|NCT03103152|450316924|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
125190253|NCT03103152|450316925|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
125190254|NCT03103152|450316926|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
125190255|NCT03103152|450316921|FG000|Overall Study|Unacceptable side effects|0|||
125190256|NCT03103152|450316922|FG001|Overall Study|Unacceptable side effects|0|||
125190257|NCT03103152|450316923|FG002|Overall Study|Unacceptable side effects|0|||
125190258|NCT03103152|450316924|FG003|Overall Study|Unacceptable side effects|0|||
125190259|NCT03103152|450316925|FG004|Overall Study|Unacceptable side effects|0|||
125190260|NCT03103152|450316926|FG005|Overall Study|Unacceptable side effects|1|||
125190261|NCT03103152|450316921|FG000|Overall Study|Lost to Follow-up|0|||
125190262|NCT03103152|450316922|FG001|Overall Study|Lost to Follow-up|1|||
125190263|NCT03103152|450316923|FG002|Overall Study|Lost to Follow-up|0|||
125190264|NCT03103152|450316924|FG003|Overall Study|Lost to Follow-up|1|||
125190265|NCT03103152|450316925|FG004|Overall Study|Lost to Follow-up|0|||
125190266|NCT03103152|450316926|FG005|Overall Study|Lost to Follow-up|1|||
125190267|NCT03103152|450316921|FG000|Overall Study|Testicular pain|0|||
125190268|NCT03103152|450316922|FG001|Overall Study|Testicular pain|0|||
125190269|NCT03103152|450316923|FG002|Overall Study|Testicular pain|0|||
125190270|NCT03103152|450316924|FG003|Overall Study|Testicular pain|1|||
125190271|NCT03103152|450316925|FG004|Overall Study|Testicular pain|0|||
125190272|NCT03103152|450316926|FG005|Overall Study|Testicular pain|0|||
125190273|NCT01540487|450318680|FG000|Overall Study|Protocol Violation|1|||
125190274|NCT01540487|450318681|FG001|Overall Study|Protocol Violation|0|||
125190275|NCT02525783|450318684|FG000|Overall Study|Lost to Follow-up|10|||
125190276|NCT01894841|450318685|FG000|Overall Study|Withdrawal by Subject|9|||
125190277|NCT01894841|450318686|FG001|Overall Study|Withdrawal by Subject|4|||
125190278|NCT01894841|450318685|FG000|Overall Study|Withdrawn by investigator|2|||
125190279|NCT01894841|450318686|FG001|Overall Study|Withdrawn by investigator|2|||
125190280|NCT01894841|450318685|FG000|Overall Study|Lost to Follow-up|7|||
125190281|NCT01894841|450318686|FG001|Overall Study|Lost to Follow-up|3|||
125190282|NCT00454246|450318689|FG000|Overall Study|Adverse Event|2|||
125190283|NCT00454246|450318690|FG001|Overall Study|Adverse Event|2|||
125190284|NCT00454246|450318691|FG002|Overall Study|Adverse Event|0|||
125190285|NCT00454246|450318689|FG000|Overall Study|Violation of selection criteria at entry|6|||
125190286|NCT00454246|450318690|FG001|Overall Study|Violation of selection criteria at entry|0|||
125190287|NCT00454246|450318691|FG002|Overall Study|Violation of selection criteria at entry|0|||
125190288|NCT00454246|450318689|FG000|Overall Study|Protocol Violation|1|||
125190289|NCT00454246|450318690|FG001|Overall Study|Protocol Violation|0|||
125190290|NCT00454246|450318691|FG002|Overall Study|Protocol Violation|0|||
125190291|NCT00454246|450318689|FG000|Overall Study|Refused Treatment|1|||
125190292|NCT00454246|450318690|FG001|Overall Study|Refused Treatment|1|||
125190293|NCT00454246|450318691|FG002|Overall Study|Refused Treatment|0|||
125190294|NCT00454246|450318689|FG000|Overall Study|Failure to return|1|||
125190295|NCT00454246|450318690|FG001|Overall Study|Failure to return|0|||
125190296|NCT00454246|450318691|FG002|Overall Study|Failure to return|0|||
125190297|NCT00454246|450318689|FG000|Overall Study|Early termination of study|62|||
125190298|NCT00454246|450318690|FG001|Overall Study|Early termination of study|26|||
125190299|NCT00454246|450318691|FG002|Overall Study|Early termination of study|9|||
125190300|NCT05326529|450318692|FG000|Overall Study|Lack of Efficacy|0|||
125190301|NCT05326529|450318693|FG001|Overall Study|Lack of Efficacy|1|||
125190302|NCT05326529|450318694|FG002|Overall Study|Lack of Efficacy|0|||
125190303|NCT05326529|450318692|FG000|Overall Study|Physician Decision|0|||
125190304|NCT05326529|450318693|FG001|Overall Study|Physician Decision|0|||
125190305|NCT05326529|450318694|FG002|Overall Study|Physician Decision|2|||
125190306|NCT01379768|450318695|FG000|Overall Study|Adverse Event|1|||
125190307|NCT01379768|450318696|FG001|Overall Study|Adverse Event|1|||
125190308|NCT01379768|450318697|FG002|Overall Study|Adverse Event|0|||
125190309|NCT01379768|450318695|FG000|Overall Study|Lost to Follow-up|2|||
125190310|NCT01379768|450318696|FG001|Overall Study|Lost to Follow-up|0|||
125190311|NCT01379768|450318697|FG002|Overall Study|Lost to Follow-up|0|||
125190312|NCT01295671|450318701|FG000|Overall Study|Lost to Follow-up|4|||
125190313|NCT01295671|450318702|FG001|Overall Study|Lost to Follow-up|6|||
125190314|NCT01295671|450318703|FG002|Overall Study|Lost to Follow-up|3|||
125190315|NCT01295671|450318701|FG000|Overall Study|Withdrawal by Subject|3|||
125190316|NCT01295671|450318702|FG001|Overall Study|Withdrawal by Subject|1|||
125190317|NCT01295671|450318703|FG002|Overall Study|Withdrawal by Subject|0|||
125190318|NCT00708552|450318706|FG000|Overall Study|Adverse Event|10|||
125190319|NCT00708552|450318707|FG001|Overall Study|Adverse Event|3|||
125190320|NCT00708552|450318708|FG002|Overall Study|Adverse Event|4|||
125190321|NCT00708552|450318709|FG003|Overall Study|Adverse Event|6|||
125190322|NCT00708552|450318706|FG000|Overall Study|Lack of Efficacy|0|||
125190323|NCT00708552|450318707|FG001|Overall Study|Lack of Efficacy|4|||
125190324|NCT00708552|450318708|FG002|Overall Study|Lack of Efficacy|1|||
125190325|NCT00708552|450318709|FG003|Overall Study|Lack of Efficacy|0|||
125190326|NCT00708552|450318706|FG000|Overall Study|Protocol Violation|0|||
125190327|NCT00708552|450318707|FG001|Overall Study|Protocol Violation|0|||
125190328|NCT00708552|450318708|FG002|Overall Study|Protocol Violation|2|||
125190329|NCT00708552|450318709|FG003|Overall Study|Protocol Violation|4|||
125190330|NCT00708552|450318706|FG000|Overall Study|Lost to Follow-up|4|||
125190331|NCT00708552|450318707|FG001|Overall Study|Lost to Follow-up|2|||
125190332|NCT00708552|450318708|FG002|Overall Study|Lost to Follow-up|0|||
125190333|NCT00708552|450318709|FG003|Overall Study|Lost to Follow-up|1|||
125190334|NCT00708552|450318706|FG000|Overall Study|Physician Decision|1|||
125190335|NCT00708552|450318707|FG001|Overall Study|Physician Decision|2|||
125190336|NCT00708552|450318708|FG002|Overall Study|Physician Decision|0|||
125190337|NCT00708552|450318709|FG003|Overall Study|Physician Decision|0|||
125190338|NCT00708552|450318706|FG000|Overall Study|Withdrawal by Subject|12|||
125190339|NCT00708552|450318707|FG001|Overall Study|Withdrawal by Subject|7|||
125190340|NCT00708552|450318708|FG002|Overall Study|Withdrawal by Subject|8|||
125190341|NCT00708552|450318709|FG003|Overall Study|Withdrawal by Subject|10|||
125190342|NCT03168711|450318713|FG000|Overall Study|Adverse Event|2|||
125190343|NCT03168711|450318714|FG001|Overall Study|Adverse Event|0|||
125190344|NCT03168711|450318713|FG000|Overall Study|Withdrawal by Subject|0|||
125190345|NCT03168711|450318714|FG001|Overall Study|Withdrawal by Subject|1|||
125190346|NCT03168711|450318713|FG000|Overall Study|Death|0|||
125190347|NCT03168711|450318714|FG001|Overall Study|Death|1|||
125190348|NCT01609010|450318715|FG000|Overall Study|Stable disease (SD)|22|||
125190349|NCT01609010|450318716|FG001|Overall Study|Stable disease (SD)|16|||
125243923|NCT04633447|450518409|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
125243924|NCT04633447|450518410|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
125243925|NCT04633447|450518409|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
125243926|NCT04633447|450518410|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
125243927|NCT04633447|450518409|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
125243928|NCT04633447|450518410|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
125243929|NCT03641924|450518411|FG000|Overall Study|Withdrawal by Subject|26|||
125243930|NCT03641924|450518411|FG000|Overall Study|Lost to Follow-up|16|||
125243931|NCT03641924|450518411|FG000|Overall Study|Protocol Violation|10|||
125243932|NCT04333498|450518412|FG000|Overall Study|Lost to Follow-up|1|||
125243933|NCT04333498|450518413|FG001|Overall Study|Lost to Follow-up|0|||
125243934|NCT04333498|450518412|FG000|Overall Study|Lost to Follow-up|0|||
125243935|NCT04333498|450518413|FG001|Overall Study|Lost to Follow-up|1|||
125243936|NCT01565694|450518414|FG000|Dose-Titration Period|Adverse Event|4|||
125243937|NCT01565694|450518414|FG000|Dose-Titration Period|Protocol Violation|10|||
125243938|NCT01565694|450518414|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
125243939|NCT05417113|450518418|FG000|Overall Study|Lost to Follow-up|2|||
125243940|NCT05417113|450518419|FG001|Overall Study|Lost to Follow-up|2|||
125243941|NCT01022580|450518420|FG000|Overall Study|Death|18|||
125243942|NCT01022580|450518421|FG001|Overall Study|Death|22|||
125243943|NCT00541229|450518422|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
125243944|NCT00541229|450518423|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
125243945|NCT00541229|450518424|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
125243946|NCT00541229|450518425|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
125243947|NCT00541229|450518426|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
125243948|NCT00541229|450518427|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
125243949|NCT00541229|450518422|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
125243950|NCT00541229|450518423|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
125243951|NCT00541229|450518424|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
125243952|NCT00541229|450518425|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
125243953|NCT00541229|450518426|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
125243954|NCT00541229|450518427|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
125243955|NCT00541229|450518422|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
125243956|NCT00541229|450518423|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
125243957|NCT00541229|450518424|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
125243958|NCT00541229|450518425|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
125243959|NCT00541229|450518426|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
125243960|NCT00541229|450518427|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
125243961|NCT00541229|450518422|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
125243962|NCT00541229|450518423|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
125243963|NCT00541229|450518424|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
125243964|NCT00541229|450518425|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
125243965|NCT00541229|450518426|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
125243966|NCT00541229|450518427|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
125243967|NCT00541229|450518422|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
125243968|NCT00541229|450518423|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
125243969|NCT00541229|450518424|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
125243970|NCT00541229|450518425|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
125243971|NCT00541229|450518426|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
125243972|NCT00541229|450518427|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
125243973|NCT00541229|450518422|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
125243974|NCT00541229|450518423|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
125243975|NCT00541229|450518424|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
125243976|NCT00541229|450518425|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
125243977|NCT00541229|450518426|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
125243978|NCT00541229|450518427|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
125243979|NCT00541229|450518422|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
125243980|NCT00541229|450518423|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
125243981|NCT00541229|450518424|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
125243982|NCT00541229|450518425|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
125243983|NCT00541229|450518426|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
125243984|NCT00541229|450518427|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
125243985|NCT00541229|450518422|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
125243986|NCT00541229|450518423|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
125243987|NCT00541229|450518424|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
125243988|NCT00541229|450518425|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
125243989|NCT00541229|450518426|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
125243990|NCT00541229|450518427|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
125243991|NCT00541229|450518422|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
125243992|NCT00541229|450518423|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
125243993|NCT00541229|450518424|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
125243994|NCT00541229|450518425|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
125243995|NCT00541229|450518426|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
125243996|NCT00541229|450518427|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
125243997|NCT00541229|450518422|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
125243998|NCT00541229|450518423|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
125243999|NCT00541229|450518424|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
125244000|NCT00541229|450518425|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
125244001|NCT00541229|450518426|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
125244002|NCT00541229|450518427|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
125244003|NCT00541229|450518422|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
125244004|NCT00541229|450518423|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
125244005|NCT00541229|450518424|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
125244006|NCT00541229|450518425|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
125244007|NCT00541229|450518426|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
125244008|NCT00541229|450518427|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
125244009|NCT00541229|450518422|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
125244010|NCT00541229|450518423|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
125244011|NCT00541229|450518424|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
125244012|NCT00541229|450518425|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
125244013|NCT00541229|450518426|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
125190350|NCT01609010|450318715|FG000|Overall Study|Progressive disease (PD)|8|||
125190351|NCT01609010|450318716|FG001|Overall Study|Progressive disease (PD)|10|||
125190352|NCT01609010|450318715|FG000|Overall Study|Adverse Event|3|||
125190353|NCT01609010|450318716|FG001|Overall Study|Adverse Event|6|||
125190354|NCT01609010|450318715|FG000|Overall Study|Withdrawal by Subject|2|||
125190355|NCT01609010|450318716|FG001|Overall Study|Withdrawal by Subject|2|||
125190356|NCT01609010|450318715|FG000|Overall Study|Other|2|||
125190357|NCT01609010|450318716|FG001|Overall Study|Other|0|||
125190358|NCT01609010|450318715|FG000|Overall Study|Other malignancy|1|||
125190359|NCT01609010|450318716|FG001|Overall Study|Other malignancy|0|||
125190360|NCT01609010|450318715|FG000|Overall Study|Pathology review|2|||
125190361|NCT01609010|450318716|FG001|Overall Study|Pathology review|1|||
125190362|NCT01609010|450318715|FG000|Overall Study|Protocol Violation|1|||
125190363|NCT01609010|450318716|FG001|Overall Study|Protocol Violation|1|||
125190364|NCT01609010|450318715|FG000|Overall Study|New cancer|1|||
125190365|NCT01609010|450318716|FG001|Overall Study|New cancer|0|||
125190366|NCT01609010|450318715|FG000|Overall Study|Lost to Follow-up|1|||
125190367|NCT01609010|450318716|FG001|Overall Study|Lost to Follow-up|1|||
125190368|NCT00808210|450318721|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
125190369|NCT00808210|450318722|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
125190370|NCT00808210|450318721|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
125190371|NCT00808210|450318722|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
125190372|NCT00808210|450318721|FG000|Double-Blind TX Period|Adverse Event|0|||
125190373|NCT00808210|450318722|FG001|Double-Blind TX Period|Adverse Event|1|||
125190374|NCT00808210|450318721|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
125190375|NCT00808210|450318722|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
125190376|NCT00808210|450318721|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
125190377|NCT00808210|450318722|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
125190378|NCT00808210|450318721|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
125190379|NCT00808210|450318722|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
125190380|NCT02356588|450318723|FG000|Overall Study|Lack of Efficacy|4|||
125190381|NCT02356588|450318724|FG001|Overall Study|Lack of Efficacy|10|||
125190382|NCT02356588|450318723|FG000|Overall Study|Adverse Event|0|||
125190383|NCT02356588|450318724|FG001|Overall Study|Adverse Event|2|||
125190384|NCT02356588|450318723|FG000|Overall Study|Withdrawal by Subject|1|||
125190385|NCT02356588|450318724|FG001|Overall Study|Withdrawal by Subject|0|||
125190386|NCT02356588|450318723|FG000|Overall Study|Protocol Violation|0|||
125190387|NCT02356588|450318724|FG001|Overall Study|Protocol Violation|1|||
125190388|NCT03150719|450318727|FG000|Overall Study|Adverse Event|0|||
125190389|NCT03150719|450318728|FG001|Overall Study|Adverse Event|1|||
125190390|NCT03150719|450318727|FG000|Overall Study|Death|0|||
125190391|NCT03150719|450318728|FG001|Overall Study|Death|1|||
125190392|NCT03150719|450318727|FG000|Overall Study|Other|1|||
125190393|NCT03150719|450318728|FG001|Overall Study|Other|0|||
125190394|NCT01790984|450318729|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
125190395|NCT01790984|450318730|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
125190396|NCT01790984|450318731|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
125190397|NCT01790984|450318732|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
125190398|NCT01346696|450318734|FG000|Overall Study|Death|1|||
125190399|NCT00105079|450318736|FG000|Overall Study|Adverse Event|5|||
125190400|NCT00105079|450318737|FG001|Overall Study|Adverse Event|12|||
125190401|NCT00105079|450318736|FG000|Overall Study|Death|3|||
125190402|NCT00105079|450318737|FG001|Overall Study|Death|1|||
125190403|NCT00105079|450318736|FG000|Overall Study|Lost to Follow-up|12|||
125190404|NCT00105079|450318737|FG001|Overall Study|Lost to Follow-up|12|||
125190405|NCT00105079|450318736|FG000|Overall Study|Lack of Efficacy|9|||
125190406|NCT00105079|450318737|FG001|Overall Study|Lack of Efficacy|3|||
125190407|NCT00105079|450318736|FG000|Overall Study|Refused treatment|6|||
125190408|NCT00105079|450318737|FG001|Overall Study|Refused treatment|4|||
125190409|NCT00105079|450318736|FG000|Overall Study|Violation of selection criteria at entry|0|||
125190410|NCT00105079|450318737|FG001|Overall Study|Violation of selection criteria at entry|2|||
125190411|NCT00105079|450318736|FG000|Overall Study|Protocol Violation|1|||
125190412|NCT00105079|450318737|FG001|Overall Study|Protocol Violation|0|||
125190413|NCT00105079|450318736|FG000|Overall Study|Other|3|||
125190414|NCT00105079|450318737|FG001|Overall Study|Other|1|||
125190415|NCT01609296|450318743|FG000|Overall Study|Death|253|||
125190416|NCT01609296|450318743|FG000|Overall Study|Withdrawal by Subject|151|||
125190417|NCT01609296|450318743|FG000|Overall Study|Lost to Follow-up|21|||
125190418|NCT01609296|450318743|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
125190419|NCT01609296|450318743|FG000|Overall Study|missed visit but known to be alive|28|||
125190420|NCT00386360|450318744|FG000|Overall Study|Adverse Event|4|||
125190421|NCT00386360|450318745|FG001|Overall Study|Adverse Event|2|||
125190422|NCT00386360|450318744|FG000|Overall Study|Physician Decision|2|||
125190423|NCT00386360|450318745|FG001|Overall Study|Physician Decision|2|||
125244014|NCT00541229|450518427|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
125244015|NCT00541229|450518422|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
125244016|NCT00541229|450518423|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
125244017|NCT00541229|450518424|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
125244018|NCT00541229|450518425|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
125244019|NCT00541229|450518426|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
125244020|NCT00541229|450518427|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
125244021|NCT00541229|450518422|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
125244022|NCT00541229|450518423|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
125244023|NCT00541229|450518424|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
125244024|NCT00541229|450518425|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
125244025|NCT00541229|450518426|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
125244026|NCT00541229|450518427|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
125244027|NCT00541229|450518422|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
125244028|NCT00541229|450518423|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
125244029|NCT00541229|450518424|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
125244030|NCT00541229|450518425|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
125244031|NCT00541229|450518426|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
125244032|NCT00541229|450518427|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
125244033|NCT00541229|450518422|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
125244034|NCT00541229|450518423|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
125244035|NCT00541229|450518424|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
125244036|NCT00541229|450518425|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
125244037|NCT00541229|450518426|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
125244038|NCT00541229|450518427|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
125244039|NCT01807520|450518428|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
125244040|NCT01807520|450518429|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
125244041|NCT01807520|450518430|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
125244042|NCT01807520|450518431|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
125244043|NCT01807520|450518432|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
125244044|NCT01807520|450518433|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
125244045|NCT01807520|450518434|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
125244046|NCT01807520|450518428|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
125244047|NCT01807520|450518429|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
125244048|NCT01807520|450518430|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
125244049|NCT01807520|450518431|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
125244050|NCT01807520|450518432|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
125244051|NCT01807520|450518433|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
125244052|NCT01807520|450518434|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
125244053|NCT01807520|450518428|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
125244054|NCT01807520|450518429|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
125244055|NCT01807520|450518430|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
125244056|NCT01807520|450518431|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
125244057|NCT01807520|450518432|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
125244058|NCT01807520|450518433|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
125244059|NCT01807520|450518434|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
125244060|NCT01807520|450518428|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
125244061|NCT01807520|450518429|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
125244062|NCT01807520|450518430|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
125244063|NCT01807520|450518431|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
125244064|NCT01807520|450518432|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
125244065|NCT01807520|450518433|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
125244066|NCT01807520|450518434|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
125244067|NCT01807520|450518428|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
125244068|NCT01807520|450518429|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
125244069|NCT01807520|450518430|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
125244070|NCT01807520|450518431|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
125244071|NCT01807520|450518432|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
125244072|NCT01807520|450518433|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
125244073|NCT01807520|450518434|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
125244074|NCT01807520|450518428|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
125244075|NCT01807520|450518429|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
125244076|NCT01807520|450518430|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
125244077|NCT01807520|450518431|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
125244078|NCT01807520|450518432|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
125244079|NCT01807520|450518433|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
125190424|NCT00386360|450318744|FG000|Overall Study|Lost to Follow-up|0|||
125190425|NCT00386360|450318745|FG001|Overall Study|Lost to Follow-up|2|||
125190426|NCT00386360|450318744|FG000|Overall Study|Protocol Violation|0|||
125190427|NCT00386360|450318745|FG001|Overall Study|Protocol Violation|3|||
125190428|NCT00386360|450318744|FG000|Overall Study|Withdrawal by Subject|3|||
125190429|NCT00386360|450318745|FG001|Overall Study|Withdrawal by Subject|6|||
125190430|NCT00386360|450318744|FG000|Overall Study|Did not take any study medication|0|||
125190431|NCT00386360|450318745|FG001|Overall Study|Did not take any study medication|2|||
125190432|NCT02230904|450318746|FG000|Overall Study|Safety follow up could not take place|0|||
125190433|NCT02230904|450318747|FG001|Overall Study|Safety follow up could not take place|1|||
125190434|NCT01532518|450318748|FG000|Overall Study|Withdrawal by Subject|0|||
125190435|NCT01532518|450318749|FG001|Overall Study|Withdrawal by Subject|0|||
125190436|NCT01532518|450318750|FG002|Overall Study|Withdrawal by Subject|1|||
125190437|NCT02155283|450318754|FG000|Overall Study|Lost to Follow-up|3|||
125190438|NCT02155283|450318754|FG000|Overall Study|Withdrawal by Subject|1|||
125190439|NCT02155283|450318754|FG000|Overall Study|Protocol Violation|3|||
125190440|NCT00463047|450318758|FG000|Titration Period 1|Adverse Event|10|||
125190441|NCT00463047|450318759|FG001|Titration Period 1|Adverse Event|8|||
125190442|NCT00463047|450318758|FG000|Titration Period 1|Lack of Efficacy|10|||
125190443|NCT00463047|450318759|FG001|Titration Period 1|Lack of Efficacy|4|||
125190444|NCT00463047|450318758|FG000|Titration Period 1|Lost to Follow-up|2|||
125190445|NCT00463047|450318759|FG001|Titration Period 1|Lost to Follow-up|0|||
125190446|NCT00463047|450318758|FG000|Titration Period 1|Non-compliance with study medication|3|||
125190447|NCT00463047|450318759|FG001|Titration Period 1|Non-compliance with study medication|5|||
125190448|NCT00463047|450318758|FG000|Titration Period 1|Protocol Violation|5|||
125190449|NCT00463047|450318759|FG001|Titration Period 1|Protocol Violation|5|||
125190450|NCT00463047|450318758|FG000|Titration Period 1|Withdrawal by Subject|3|||
125190451|NCT00463047|450318759|FG001|Titration Period 1|Withdrawal by Subject|5|||
125190452|NCT00463047|450318758|FG000|Titration Period 1|Non-compliance procedures|4|||
125190453|NCT00463047|450318759|FG001|Titration Period 1|Non-compliance procedures|10|||
125190454|NCT00463047|450318758|FG000|Titration Period 1|Other|0|||
125190455|NCT00463047|450318759|FG001|Titration Period 1|Other|2|||
125190456|NCT00463047|450318758|FG000|Titration Period 2|Adverse Event|9|||
125190457|NCT00463047|450318759|FG001|Titration Period 2|Adverse Event|9|||
125190458|NCT00463047|450318758|FG000|Titration Period 2|Lack of Efficacy|6|||
125190459|NCT00463047|450318759|FG001|Titration Period 2|Lack of Efficacy|4|||
125190460|NCT00463047|450318758|FG000|Titration Period 2|Withdrawal by Subject|1|||
125190461|NCT00463047|450318759|FG001|Titration Period 2|Withdrawal by Subject|0|||
125190462|NCT00463047|450318758|FG000|Titration Period 2|Protocol Violation|2|||
125190463|NCT00463047|450318759|FG001|Titration Period 2|Protocol Violation|3|||
125190464|NCT00463047|450318758|FG000|Titration Period 2|Lost to Follow-up|1|||
125190465|NCT00463047|450318759|FG001|Titration Period 2|Lost to Follow-up|2|||
125190466|NCT00463047|450318758|FG000|Titration Period 2|Non-compliance study medication|4|||
125190467|NCT00463047|450318759|FG001|Titration Period 2|Non-compliance study medication|2|||
125190468|NCT00463047|450318758|FG000|Titration Period 2|Non-compliance procedures|4|||
125190469|NCT00463047|450318759|FG001|Titration Period 2|Non-compliance procedures|1|||
125190470|NCT00463047|450318758|FG000|Titration Period 2|Other|3|||
125190471|NCT00463047|450318759|FG001|Titration Period 2|Other|2|||
125190472|NCT00463047|450318758|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
125190473|NCT00463047|450318759|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
125190474|NCT00463047|450318758|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
125190475|NCT00463047|450318759|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
125190476|NCT00463047|450318758|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
125190477|NCT00463047|450318759|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
125190478|NCT00463047|450318758|FG000|Double-Blind Treatment Period 1|Other|1|||
125190479|NCT00463047|450318759|FG001|Double-Blind Treatment Period 1|Other|0|||
125190480|NCT00463047|450318758|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
125190481|NCT00463047|450318759|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
125190482|NCT00463047|450318758|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
125190483|NCT00463047|450318759|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
125190484|NCT00463047|450318758|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
125190485|NCT00463047|450318759|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
125190486|NCT03020992|450318765|FG000|Overall Study|Adverse Event|5|||
125190487|NCT03020992|450318765|FG000|Overall Study|Withdrawal by Subject|1|||
125190488|NCT01006122|450318766|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
125190489|NCT01006122|450318767|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
125190490|NCT01006122|450318766|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
125190491|NCT01006122|450318767|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
125190492|NCT01006122|450318766|FG000|First Double-blind Intervention Period|Pregnancy|0|||
125190493|NCT01006122|450318767|FG001|First Double-blind Intervention Period|Pregnancy|1|||
125190494|NCT01006122|450318766|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
125190495|NCT01006122|450318767|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
125244080|NCT01807520|450518434|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
125244081|NCT01807520|450518428|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
125244082|NCT01807520|450518429|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
125244083|NCT01807520|450518430|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
125244084|NCT01807520|450518431|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
125244085|NCT01807520|450518432|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
125244086|NCT01807520|450518433|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
125244087|NCT01807520|450518434|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
125244088|NCT01807520|450518428|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
125244089|NCT01807520|450518429|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
125244090|NCT01807520|450518430|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
125244091|NCT01807520|450518431|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
125244092|NCT01807520|450518432|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
125244093|NCT01807520|450518433|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
125244094|NCT01807520|450518434|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
125244095|NCT01807520|450518428|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
125244096|NCT01807520|450518429|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
125244097|NCT01807520|450518430|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
125244098|NCT01807520|450518431|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
125244099|NCT01807520|450518432|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
125244100|NCT01807520|450518433|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
125244101|NCT01807520|450518434|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
125244102|NCT01807520|450518428|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
125190496|NCT01006122|450318766|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
125190497|NCT01006122|450318767|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
125190498|NCT01006122|450318766|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
125190499|NCT01006122|450318767|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
125190500|NCT01006122|450318766|FG000|First Double-blind Intervention Period|Other|3|||
125190501|NCT01006122|450318767|FG001|First Double-blind Intervention Period|Other|0|||
125190502|NCT01006122|450318766|FG000|First Double-blind Intervention Period|Adverse Event|0|||
125190503|NCT01006122|450318767|FG001|First Double-blind Intervention Period|Adverse Event|4|||
125190504|NCT01006122|450318766|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
125190505|NCT01006122|450318767|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
125190506|NCT01006122|450318766|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
125190507|NCT01006122|450318767|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
125190508|NCT01006122|450318766|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
125190509|NCT01006122|450318767|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
125190510|NCT01006122|450318766|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
125190511|NCT01006122|450318767|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
125190512|NCT01006122|450318766|FG000|Second Double-blind Intervention Period|Death|0|||
125190513|NCT01006122|450318767|FG001|Second Double-blind Intervention Period|Death|1|||
125190514|NCT00529308|450318772|FG000|Overall Study|Withdrawal by Subject|1|||
125190515|NCT00529308|450318773|FG001|Overall Study|Withdrawal by Subject|1|||
125190516|NCT03926117|450318784|FG000|Overall Study|Unclassified|1|||
125190517|NCT03926117|450318785|FG001|Overall Study|Unclassified|4|||
125190518|NCT03926117|450318786|FG002|Overall Study|Unclassified|1|||
125190519|NCT03926117|450318787|FG003|Overall Study|Unclassified|4|||
125190520|NCT03926117|450318784|FG000|Overall Study|Withdrawal by Subject|3|||
125190521|NCT03926117|450318785|FG001|Overall Study|Withdrawal by Subject|0|||
125190522|NCT03926117|450318786|FG002|Overall Study|Withdrawal by Subject|1|||
125190523|NCT03926117|450318787|FG003|Overall Study|Withdrawal by Subject|1|||
125190524|NCT03926117|450318784|FG000|Overall Study|Lost to Follow-up|0|||
125190525|NCT03926117|450318785|FG001|Overall Study|Lost to Follow-up|2|||
125190526|NCT03926117|450318786|FG002|Overall Study|Lost to Follow-up|1|||
125190527|NCT03926117|450318787|FG003|Overall Study|Lost to Follow-up|0|||
125190528|NCT03926117|450318784|FG000|Overall Study|Adverse Event|1|||
125190529|NCT03926117|450318785|FG001|Overall Study|Adverse Event|2|||
125190530|NCT03926117|450318786|FG002|Overall Study|Adverse Event|3|||
125190531|NCT03926117|450318787|FG003|Overall Study|Adverse Event|1|||
125190532|NCT03926117|450318784|FG000|Overall Study|Randomized but not treated|1|||
125190533|NCT03926117|450318785|FG001|Overall Study|Randomized but not treated|1|||
125244103|NCT01807520|450518429|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
125244104|NCT01807520|450518430|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
125244105|NCT01807520|450518431|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
125190534|NCT03926117|450318786|FG002|Overall Study|Randomized but not treated|0|||
125190535|NCT03926117|450318787|FG003|Overall Study|Randomized but not treated|1|||
125190536|NCT02554682|450318788|FG000|Overall Study|Lost to Follow-up|11|||
125244106|NCT01807520|450518432|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
125244107|NCT01807520|450518433|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
125190537|NCT02554682|450318789|FG001|Overall Study|Lost to Follow-up|9|||
125190538|NCT02554682|450318790|FG002|Overall Study|Lost to Follow-up|4|||
125190539|NCT02554682|450318791|FG003|Overall Study|Lost to Follow-up|3|||
125190540|NCT02554682|450318792|FG004|Overall Study|Lost to Follow-up|2|||
125190541|NCT02554682|450318793|FG005|Overall Study|Lost to Follow-up|1|||
125190542|NCT02554682|450318794|FG006|Overall Study|Lost to Follow-up|6|||
125190543|NCT02554682|450318795|FG007|Overall Study|Lost to Follow-up|6|||
125190544|NCT02554682|450318796|FG008|Overall Study|Lost to Follow-up|2|||
125190545|NCT02554682|450318797|FG009|Overall Study|Lost to Follow-up|2|||
125190546|NCT02554682|450318788|FG000|Overall Study|Withdrawal by Subject|2|||
125190547|NCT02554682|450318789|FG001|Overall Study|Withdrawal by Subject|1|||
125190548|NCT02554682|450318790|FG002|Overall Study|Withdrawal by Subject|0|||
125190549|NCT02554682|450318791|FG003|Overall Study|Withdrawal by Subject|0|||
125190550|NCT02554682|450318792|FG004|Overall Study|Withdrawal by Subject|0|||
125190551|NCT02554682|450318793|FG005|Overall Study|Withdrawal by Subject|0|||
125190552|NCT02554682|450318794|FG006|Overall Study|Withdrawal by Subject|0|||
125190553|NCT02554682|450318795|FG007|Overall Study|Withdrawal by Subject|0|||
125190554|NCT02554682|450318796|FG008|Overall Study|Withdrawal by Subject|0|||
125190555|NCT02554682|450318797|FG009|Overall Study|Withdrawal by Subject|0|||
125190556|NCT02554682|450318788|FG000|Overall Study|Physician Decision|2|||
125190557|NCT02554682|450318789|FG001|Overall Study|Physician Decision|2|||
125190558|NCT02554682|450318790|FG002|Overall Study|Physician Decision|0|||
125190559|NCT02554682|450318791|FG003|Overall Study|Physician Decision|0|||
125190560|NCT02554682|450318792|FG004|Overall Study|Physician Decision|0|||
125190561|NCT02554682|450318793|FG005|Overall Study|Physician Decision|0|||
125190562|NCT02554682|450318794|FG006|Overall Study|Physician Decision|0|||
125190563|NCT02554682|450318795|FG007|Overall Study|Physician Decision|0|||
125190564|NCT02554682|450318796|FG008|Overall Study|Physician Decision|0|||
125190565|NCT02554682|450318797|FG009|Overall Study|Physician Decision|0|||
125190566|NCT04526288|450318800|FG000|Overall Study|Disease Progression|1|||
125190567|NCT04526288|450318801|FG001|Overall Study|Disease Progression|0|||
125190568|NCT00996125|450318804|FG000|Overall Study|Adverse Event|0|||
125190569|NCT00996125|450318805|FG001|Overall Study|Adverse Event|2|||
125190570|NCT00996125|450318804|FG000|Overall Study|Lost to Follow-up|1|||
125190571|NCT00996125|450318805|FG001|Overall Study|Lost to Follow-up|6|||
125190572|NCT00996125|450318804|FG000|Overall Study|Withdrawal by Subject|4|||
125190573|NCT00996125|450318805|FG001|Overall Study|Withdrawal by Subject|3|||
125190574|NCT00952068|450318806|FG000|Overall Study|Adverse Event|3|||
125190575|NCT00952068|450318806|FG000|Overall Study|Withdrawal by Subject|4|||
125190576|NCT00708461|450318813|FG000|Overall Study|Lost to Follow-up|18|||
125190577|NCT00708461|450318814|FG001|Overall Study|Lost to Follow-up|11|||
125190578|NCT00708461|450318813|FG000|Overall Study|Withdrawal by Subject|8|||
125190579|NCT00708461|450318814|FG001|Overall Study|Withdrawal by Subject|9|||
125190580|NCT00708461|450318813|FG000|Overall Study|left workforce|115|||
125190581|NCT00708461|450318814|FG001|Overall Study|left workforce|180|||
125190582|NCT02630251|450318817|FG000|Overall Study|Physician Decision|0|||
125190583|NCT02630251|450318818|FG001|Overall Study|Physician Decision|0|||
125190584|NCT02630251|450318819|FG002|Overall Study|Physician Decision|1|||
125190585|NCT02630251|450318820|FG003|Overall Study|Physician Decision|0|||
125190586|NCT01796392|450318823|FG000|Overall Study|Withdrawal by Subject|2|||
125190587|NCT01796392|450318824|FG001|Overall Study|Withdrawal by Subject|0|||
125190588|NCT01796392|450318823|FG000|Overall Study|Death|5|||
125190589|NCT01796392|450318824|FG001|Overall Study|Death|1|||
125190590|NCT01796392|450318823|FG000|Overall Study|Excluded for medical reasons|1|||
125190591|NCT01796392|450318824|FG001|Overall Study|Excluded for medical reasons|2|||
125190592|NCT01796392|450318823|FG000|Overall Study|Lost to Follow-up|1|||
125190593|NCT01796392|450318824|FG001|Overall Study|Lost to Follow-up|0|||
125190594|NCT03517540|450318831|FG000|Overall Study|Protocol Violation|2|||
125190595|NCT03517540|450318832|FG001|Overall Study|Protocol Violation|0|||
125190596|NCT03517540|450318833|FG002|Overall Study|Protocol Violation|0|||
125190597|NCT03517540|450318834|FG003|Overall Study|Protocol Violation|1|||
125190598|NCT03517540|450318831|FG000|Overall Study|Adverse Event|9|||
125190599|NCT03517540|450318832|FG001|Overall Study|Adverse Event|3|||
125190600|NCT03517540|450318833|FG002|Overall Study|Adverse Event|8|||
125190601|NCT03517540|450318834|FG003|Overall Study|Adverse Event|1|||
125190602|NCT03517540|450318831|FG000|Overall Study|Withdrawal by Subject|3|||
125190603|NCT03517540|450318832|FG001|Overall Study|Withdrawal by Subject|4|||
125190604|NCT03517540|450318833|FG002|Overall Study|Withdrawal by Subject|1|||
125190605|NCT03517540|450318834|FG003|Overall Study|Withdrawal by Subject|3|||
125190606|NCT03668119|450320607|FG000|Pre-treatment|Disease Progression|1|||
125190607|NCT03668119|450320608|FG001|Pre-treatment|Disease Progression|0|||
125190608|NCT03668119|450320607|FG000|Treatment|Disease Progression|76|||
125190609|NCT03668119|450320608|FG001|Treatment|Disease Progression|57|||
125190610|NCT03668119|450320607|FG000|Treatment|Study drug toxicity|19|||
125190611|NCT03668119|450320608|FG001|Treatment|Study drug toxicity|1|||
125190612|NCT03668119|450320607|FG000|Treatment|Death|3|||
125190613|NCT03668119|450320608|FG001|Treatment|Death|0|||
125190614|NCT03668119|450320607|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
125190615|NCT03668119|450320608|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
125244108|NCT01807520|450518434|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
125244109|NCT01807520|450518428|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
125244110|NCT01807520|450518429|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
125244111|NCT01807520|450518430|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
125244112|NCT01807520|450518431|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
125244113|NCT01807520|450518432|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
125244114|NCT01807520|450518433|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
125244115|NCT01807520|450518434|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
125244116|NCT01807520|450518428|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
125244117|NCT01807520|450518429|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
125244118|NCT01807520|450518430|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
125244119|NCT01807520|450518431|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
125244120|NCT01807520|450518432|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
125244121|NCT01807520|450518433|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
125244122|NCT01807520|450518434|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
125244123|NCT01807520|450518428|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
125244124|NCT01807520|450518429|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
125244125|NCT01807520|450518430|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
125244126|NCT01807520|450518431|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
125244127|NCT01807520|450518432|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
125244128|NCT01807520|450518433|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
125244129|NCT01807520|450518434|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
125244130|NCT01807520|450518428|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
125244131|NCT01807520|450518429|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
125244132|NCT01807520|450518430|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
125244133|NCT01807520|450518431|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
125244134|NCT01807520|450518432|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
125244135|NCT01807520|450518433|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
125244136|NCT01807520|450518434|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
125190616|NCT03668119|450320607|FG000|Treatment|Withdrawal by Subject|1|||
125190617|NCT03668119|450320608|FG001|Treatment|Withdrawal by Subject|1|||
125190618|NCT03668119|450320607|FG000|Treatment|Participant request to discontinue study treatment|3|||
125190619|NCT03668119|450320608|FG001|Treatment|Participant request to discontinue study treatment|1|||
125190620|NCT03668119|450320607|FG000|Treatment|Maximum Clinical Benefit|0|||
125190621|NCT03668119|450320608|FG001|Treatment|Maximum Clinical Benefit|1|||
125190622|NCT03668119|450320607|FG000|Treatment|Participants completed treatment|27|||
125190623|NCT03668119|450320608|FG001|Treatment|Participants completed treatment|11|||
125190624|NCT03668119|450320607|FG000|Treatment|Other reasons|2|||
125190625|NCT03668119|450320608|FG001|Treatment|Other reasons|1|||
125190626|NCT05336227|450320609|FG000|Overall Study|Adverse Event|1|||
125190627|NCT05336227|450320610|FG001|Overall Study|Adverse Event|0|||
125190628|NCT05336227|450320609|FG000|Overall Study|Lost to Follow-up|2|||
125190629|NCT05336227|450320610|FG001|Overall Study|Lost to Follow-up|0|||
125190630|NCT05336227|450320609|FG000|Overall Study|Withdrawal by Subject|1|||
125190631|NCT05336227|450320610|FG001|Overall Study|Withdrawal by Subject|0|||
125244137|NCT01807520|450518428|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
125244138|NCT01807520|450518429|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
125244139|NCT01807520|450518430|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
125244140|NCT01807520|450518431|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
125244141|NCT01807520|450518432|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
125244142|NCT01807520|450518433|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
125244143|NCT01807520|450518434|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
125244144|NCT01807520|450518428|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
125244145|NCT01807520|450518429|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
125244146|NCT01807520|450518430|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
125244147|NCT01807520|450518431|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
125244148|NCT01807520|450518432|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
125244149|NCT01807520|450518433|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
125244150|NCT01807520|450518434|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
125244151|NCT01807520|450518428|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
125244152|NCT01807520|450518429|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
125244153|NCT01807520|450518430|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
125244154|NCT01807520|450518431|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
125244155|NCT01807520|450518432|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
125244156|NCT01807520|450518433|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
125244157|NCT01807520|450518434|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
125190632|NCT01068678|450320613|FG000|Overall Study|Lack of Efficacy|3|||
125190633|NCT01068678|450320614|FG001|Overall Study|Lack of Efficacy|2|||
125190634|NCT01068678|450320613|FG000|Overall Study|Protocol Violation|5|||
125190635|NCT01068678|450320614|FG001|Overall Study|Protocol Violation|1|||
125190636|NCT01068678|450320613|FG000|Overall Study|Withdrawal criteria|12|||
125190637|NCT01068678|450320614|FG001|Overall Study|Withdrawal criteria|6|||
125244158|NCT01500096|450518435|FG000|Overall Study|Lost to Follow-up|1|||
125244159|NCT01500096|450518436|FG001|Overall Study|Lost to Follow-up|0|||
125244160|NCT01500096|450518437|FG002|Overall Study|Lost to Follow-up|0|||
125244161|NCT01500096|450518438|FG003|Overall Study|Lost to Follow-up|2|||
125244162|NCT01797185|450518439|FG000|Overall Study|Adverse Event|5|||
125190638|NCT01068678|450320613|FG000|Overall Study|Unclassified|18|||
125190639|NCT01068678|450320614|FG001|Overall Study|Unclassified|15|||
125190640|NCT00347958|450320615|FG000|Overall Study|Adverse Event|1|||
125244163|NCT01797185|450518440|FG001|Overall Study|Adverse Event|15|||
125244164|NCT01797185|450518441|FG002|Overall Study|Adverse Event|6|||
125244165|NCT01797185|450518439|FG000|Overall Study|Withdrawal by Subject|6|||
125244166|NCT01797185|450518440|FG001|Overall Study|Withdrawal by Subject|9|||
125190641|NCT00347958|450320615|FG000|Overall Study|Protocol Violation|2|||
125190642|NCT00347958|450320615|FG000|Overall Study|Withdrawal by Subject|1|||
125190643|NCT00754234|450320616|FG000|Overall Study|Withdrawal by Subject|3|||
125190644|NCT03055338|450320617|FG000|Overall Study|Lost to Follow-up|9|||
125190645|NCT03055338|450320618|FG001|Overall Study|Lost to Follow-up|2|||
125190646|NCT03055338|450320619|FG002|Overall Study|Lost to Follow-up|3|||
125190647|NCT03055338|450320617|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
125190648|NCT03055338|450320618|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
125190649|NCT03055338|450320619|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
125190650|NCT03055338|450320617|FG000|Overall Study|Physician Decision|0|||
125190651|NCT03055338|450320618|FG001|Overall Study|Physician Decision|0|||
125190652|NCT03055338|450320619|FG002|Overall Study|Physician Decision|2|||
125190653|NCT03055338|450320617|FG000|Overall Study|Withdrawal by Subject|9|||
125190654|NCT03055338|450320618|FG001|Overall Study|Withdrawal by Subject|8|||
125190655|NCT03055338|450320619|FG002|Overall Study|Withdrawal by Subject|7|||
125190656|NCT00975611|450320620|FG000|Overall Study|Screen Fail|16|||
125190657|NCT00975611|450320620|FG000|Overall Study|Physician Decision|1|||
125190658|NCT03058705|450320621|FG000|Overall Study|Withdrawal by Subject|2|||
125190659|NCT03058705|450320621|FG000|Overall Study|Physician Decision|2|||
125190660|NCT01682226|450320622|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
125190661|NCT01682226|450320622|FG000|Overall Study|Participants did not receive treatment|2|||
125190662|NCT01682226|450320622|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
125190663|NCT02151851|450320623|FG000|Overall Study|Lack of Efficacy|67|||
125190664|NCT02151851|450320624|FG001|Overall Study|Lack of Efficacy|94|||
125190665|NCT02151851|450320623|FG000|Overall Study|Protocol Violation|0|||
125190666|NCT02151851|450320624|FG001|Overall Study|Protocol Violation|1|||
125190667|NCT02151851|450320623|FG000|Overall Study|Withdrawal by Subject|2|||
125190668|NCT02151851|450320624|FG001|Overall Study|Withdrawal by Subject|5|||
125190669|NCT02151851|450320623|FG000|Overall Study|Medical impairment|1|||
125190670|NCT02151851|450320624|FG001|Overall Study|Medical impairment|0|||
125190671|NCT02151851|450320623|FG000|Overall Study|Low compliance to study visits|0|||
125190672|NCT02151851|450320624|FG001|Overall Study|Low compliance to study visits|1|||
125190673|NCT02151851|450320623|FG000|Overall Study|Subject entered into study in error|0|||
125190674|NCT02151851|450320624|FG001|Overall Study|Subject entered into study in error|1|||
125190675|NCT02151851|450320623|FG000|Overall Study|Adverse Event|6|||
125190676|NCT02151851|450320624|FG001|Overall Study|Adverse Event|28|||
125190677|NCT02159053|450320625|FG000|Overall Study|Death|2|||
125190678|NCT02159053|450320626|FG001|Overall Study|Death|0|||
125190679|NCT02159053|450320627|FG002|Overall Study|Death|1|||
125190680|NCT02159053|450320625|FG000|Overall Study|Physician Decision|0|||
125190681|NCT02159053|450320626|FG001|Overall Study|Physician Decision|1|||
125190682|NCT02159053|450320627|FG002|Overall Study|Physician Decision|1|||
125190683|NCT02159053|450320625|FG000|Overall Study|Lack of Efficacy|3|||
125190684|NCT02159053|450320626|FG001|Overall Study|Lack of Efficacy|4|||
125190685|NCT02159053|450320627|FG002|Overall Study|Lack of Efficacy|7|||
125190686|NCT02159053|450320625|FG000|Overall Study|Adverse Event|7|||
125190687|NCT02159053|450320626|FG001|Overall Study|Adverse Event|6|||
125190688|NCT02159053|450320627|FG002|Overall Study|Adverse Event|5|||
125190689|NCT02159053|450320625|FG000|Overall Study|Participants/guardian decision|8|||
125190690|NCT02159053|450320626|FG001|Overall Study|Participants/guardian decision|10|||
125190691|NCT02159053|450320627|FG002|Overall Study|Participants/guardian decision|6|||
125190692|NCT03503370|450320634|FG000|Overall Study|Death|3|||
125190693|NCT03503370|450320635|FG001|Overall Study|Death|1|||
125190694|NCT00298272|450320640|FG000|Double-blind Phase|Adverse Event|2|||
125190695|NCT00298272|450320641|FG001|Double-blind Phase|Adverse Event|0|||
125190696|NCT00298272|450320640|FG000|Double-blind Phase|Failure to Return|2|||
125190697|NCT00298272|450320641|FG001|Double-blind Phase|Failure to Return|0|||
125190698|NCT00298272|450320640|FG000|Double-blind Phase|Protocol Violation|2|||
125190699|NCT00298272|450320641|FG001|Double-blind Phase|Protocol Violation|0|||
125190700|NCT00298272|450320640|FG000|Double-blind Phase|Withdrawal by Subject|2|||
125190701|NCT00298272|450320641|FG001|Double-blind Phase|Withdrawal by Subject|0|||
125190702|NCT00298272|450320640|FG000|Open Label Retreatment Phase|Adverse Event|1|||
125190703|NCT00298272|450320641|FG001|Open Label Retreatment Phase|Adverse Event|2|||
125190704|NCT00298272|450320640|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
125190705|NCT00298272|450320641|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
125190706|NCT00298272|450320640|FG000|Open Label Retreatment Phase|Failure to Return|1|||
125190707|NCT00298272|450320641|FG001|Open Label Retreatment Phase|Failure to Return|0|||
125190708|NCT00298272|450320640|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
125190709|NCT00298272|450320641|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
125190710|NCT00298272|450320640|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
125190711|NCT00298272|450320641|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
125190712|NCT00298272|450320640|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
125190713|NCT00298272|450320641|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
125190714|NCT00298272|450320640|FG000|Safety Follow-up Phase|Failure to Return|1|||
125190715|NCT00298272|450320641|FG001|Safety Follow-up Phase|Failure to Return|1|||
125190716|NCT00298272|450320640|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
125190717|NCT00298272|450320641|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
125190718|NCT00298272|450320640|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
125190719|NCT00298272|450320641|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
125190720|NCT04168112|450320642|FG000|Overall Study|Lost to Follow-up|1|||
125190721|NCT04168112|450320643|FG001|Overall Study|Lost to Follow-up|0|||
125190722|NCT04168112|450320642|FG000|Overall Study|Withdrawal by Subject|1|||
125190723|NCT04168112|450320643|FG001|Overall Study|Withdrawal by Subject|0|||
125190724|NCT01344824|450320646|FG000|Overall Study|Adverse Event|15|||
125190725|NCT01344824|450320646|FG000|Overall Study|Withdrawal by Subject|6|||
125190726|NCT01344824|450320646|FG000|Overall Study|Other complicating disease|1|||
125190727|NCT01344824|450320646|FG000|Overall Study|Progression|15|||
125190728|NCT01436370|450320655|FG000|Overall Study|Lost to Follow-up|0|||
125190729|NCT01436370|450320656|FG001|Overall Study|Lost to Follow-up|0|||
125190730|NCT01436370|450320657|FG002|Overall Study|Lost to Follow-up|0|||
125190731|NCT01436370|450320658|FG003|Overall Study|Lost to Follow-up|0|||
125190732|NCT01436370|450320659|FG004|Overall Study|Lost to Follow-up|1|||
125190733|NCT01436370|450320660|FG005|Overall Study|Lost to Follow-up|0|||
125190734|NCT01436370|450320661|FG006|Overall Study|Lost to Follow-up|0|||
125190735|NCT01436370|450320662|FG007|Overall Study|Lost to Follow-up|0|||
125190736|NCT02395848|450320663|FG000|Overall Study|Lost to Follow-up|2|||
125190737|NCT01754129|450320664|FG000|Overall Study|Death|13|||
125190738|NCT01754129|450320664|FG000|Overall Study|Duodopa discontinuation|9|||
125190739|NCT01754129|450320664|FG000|Overall Study|Lost to Follow-up|7|||
125190740|NCT01754129|450320664|FG000|Overall Study|Withdrew consent|1|||
125190741|NCT01754129|450320664|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
125190742|NCT02058537|450320665|FG000|Overall Study|Withdrawal by Subject|1|||
125190743|NCT02126579|450320666|FG000|Overall Study|disease progression|0|||
125190744|NCT02126579|450320667|FG001|Overall Study|disease progression|0|||
125190745|NCT02126579|450320668|FG002|Overall Study|disease progression|0|||
125190746|NCT02126579|450320669|FG003|Overall Study|disease progression|1|||
125190747|NCT02126579|450320670|FG004|Overall Study|disease progression|0|||
125190748|NCT02126579|450320671|FG005|Overall Study|disease progression|0|||
125190749|NCT02126579|450320672|FG006|Overall Study|disease progression|1|||
125190750|NCT05483686|450320676|FG000|Overall Study|Lost to Follow-up|5|||
125190751|NCT05483686|450320677|FG001|Overall Study|Lost to Follow-up|7|||
125190752|NCT03351608|450320686|FG000|Overall Study|Lost to Follow-up|0|||
125190753|NCT03351608|450320687|FG001|Overall Study|Lost to Follow-up|1|||
125190754|NCT03351608|450320688|FG002|Overall Study|Lost to Follow-up|1|||
125190755|NCT03351608|450320689|FG003|Overall Study|Lost to Follow-up|1|||
125190756|NCT03351608|450320690|FG004|Overall Study|Lost to Follow-up|1|||
125190757|NCT03351608|450320686|FG000|Overall Study|Physician Decision|1|||
125190758|NCT03351608|450320687|FG001|Overall Study|Physician Decision|0|||
125190759|NCT03351608|450320688|FG002|Overall Study|Physician Decision|0|||
125190760|NCT03351608|450320689|FG003|Overall Study|Physician Decision|2|||
125190761|NCT03351608|450320690|FG004|Overall Study|Physician Decision|1|||
125190762|NCT03351608|450320686|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
125244167|NCT01797185|450518441|FG002|Overall Study|Withdrawal by Subject|5|||
125244168|NCT01797185|450518439|FG000|Overall Study|Site terminated|8|||
125244169|NCT01797185|450518440|FG001|Overall Study|Site terminated|4|||
125244170|NCT01797185|450518441|FG002|Overall Study|Site terminated|0|||
125244171|NCT01797185|450518439|FG000|Overall Study|Lost to Follow-up|2|||
125244172|NCT01797185|450518440|FG001|Overall Study|Lost to Follow-up|6|||
125244173|NCT01797185|450518441|FG002|Overall Study|Lost to Follow-up|1|||
125244174|NCT01797185|450518439|FG000|Overall Study|Withdrawn per sponsor|5|||
125244175|NCT01797185|450518440|FG001|Overall Study|Withdrawn per sponsor|0|||
125244176|NCT01797185|450518441|FG002|Overall Study|Withdrawn per sponsor|0|||
125244177|NCT01797185|450518439|FG000|Overall Study|Physician Decision|1|||
125244178|NCT01797185|450518440|FG001|Overall Study|Physician Decision|3|||
125244179|NCT01797185|450518441|FG002|Overall Study|Physician Decision|0|||
125244180|NCT01797185|450518439|FG000|Overall Study|Protocol Violation|1|||
125244181|NCT01797185|450518440|FG001|Overall Study|Protocol Violation|1|||
125244182|NCT01797185|450518441|FG002|Overall Study|Protocol Violation|0|||
125244183|NCT03520569|450518442|FG000|Overall Study|Withdrawal by Subject|1|||
125190763|NCT03351608|450320687|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
125190764|NCT03351608|450320688|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
125190765|NCT03351608|450320689|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
125190766|NCT03351608|450320690|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
125190767|NCT03351608|450320686|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125190768|NCT03351608|450320687|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125190769|NCT03351608|450320688|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125190770|NCT03351608|450320689|FG003|Overall Study|Withdrawal by parent/guardian|1|||
125190771|NCT03351608|450320690|FG004|Overall Study|Withdrawal by parent/guardian|0|||
125190772|NCT03351608|450320686|FG000|Overall Study|Other|0|||
125190773|NCT03351608|450320687|FG001|Overall Study|Other|1|||
125190774|NCT03351608|450320688|FG002|Overall Study|Other|1|||
125190775|NCT03351608|450320689|FG003|Overall Study|Other|3|||
125190776|NCT03351608|450320690|FG004|Overall Study|Other|0|||
125190777|NCT02877004|450320691|FG000|Overall Study|Pregnancy|0|||
125190778|NCT02877004|450320692|FG001|Overall Study|Pregnancy|0|||
125190779|NCT02877004|450320693|FG002|Overall Study|Pregnancy|1|||
125190780|NCT02727478|450320694|FG000|Overall Study|Withdrawal by Subject|8|||
125190781|NCT02727478|450320695|FG001|Overall Study|Withdrawal by Subject|10|||
125190782|NCT02633293|450320696|FG000|Overall Study|Death|56|||
125190783|NCT02633293|450320696|FG000|Overall Study|Progressive Disease|12|||
125190784|NCT02633293|450320696|FG000|Overall Study|Adverse Event|29|||
125190785|NCT02633293|450320696|FG000|Overall Study|Withdrawal by Subject|41|||
125190786|NCT02633293|450320696|FG000|Overall Study|Protocol Violation|1|||
125190787|NCT02633293|450320696|FG000|Overall Study|Lost to Follow-up|1|||
125190788|NCT02633293|450320696|FG000|Overall Study|Study Terminated by Sponsor|24|||
125190789|NCT02633293|450320696|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
125190790|NCT02633293|450320696|FG000|Overall Study|Lung Transplant|5|||
125190791|NCT02633293|450320696|FG000|Overall Study|Lack of Efficacy|2|||
125190792|NCT02633293|450320696|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
125190793|NCT03877068|450320697|FG000|Overall Study|Physician Decision|9|||
125190794|NCT03877068|450320698|FG001|Overall Study|Physician Decision|3|||
125190795|NCT00778817|450320699|FG000|Overall Study|Adverse Event|2|||
125190796|NCT00778817|450320699|FG000|Overall Study|Withdrawal by Subject|2|||
125190797|NCT01418378|450320700|FG000|Overall Study|Death|1|||
125190798|NCT01418378|450320701|FG001|Overall Study|Death|2|||
125190799|NCT01418378|450320700|FG000|Overall Study|Physician Decision|0|||
125190800|NCT01418378|450320701|FG001|Overall Study|Physician Decision|1|||
125190801|NCT01418378|450320700|FG000|Overall Study|ligament imbalance|0|||
125190802|NCT01418378|450320701|FG001|Overall Study|ligament imbalance|1|||
125190803|NCT01418378|450320700|FG000|Overall Study|developed chronic myopathy|0|||
125190804|NCT01418378|450320701|FG001|Overall Study|developed chronic myopathy|1|||
125190805|NCT01051791|450320707|FG000|Overall Study|Failed screening|3|||
125244184|NCT03418675|450518445|FG000|Overall Study|Lost to Follow-up|13|||
125244185|NCT03418675|450518446|FG001|Overall Study|Lost to Follow-up|10|||
125190806|NCT01051791|450320707|FG000|Overall Study|Withdrawal by Subject|1|||
125244186|NCT03418675|450518445|FG000|Overall Study|Adverse Event|2|||
125244187|NCT03418675|450518446|FG001|Overall Study|Adverse Event|0|||
125190807|NCT00288626|450320712|FG000|Overall Study|Death|3|||
125190808|NCT00288626|450320712|FG000|Overall Study|Withdrawal by Subject|4|||
125190809|NCT00506415|450320722|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
125190810|NCT00506415|450320723|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
125190811|NCT00506415|450320724|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
125190812|NCT00506415|450320725|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
125244188|NCT03422718|450518447|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
125244189|NCT03422718|450518448|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
125244190|NCT03422718|450518449|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
125244191|NCT03422718|450518450|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
125244192|NCT03422718|450518451|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
125244193|NCT03422718|450518452|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
125244194|NCT03422718|450518453|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
125244195|NCT03422718|450518454|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
125244196|NCT03422718|450518447|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
125244197|NCT03422718|450518448|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
125244198|NCT03422718|450518449|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
125244199|NCT03422718|450518450|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
125244200|NCT03422718|450518451|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
125244201|NCT03422718|450518452|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
125244202|NCT03422718|450518453|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
125244203|NCT03422718|450518454|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
125244204|NCT03422718|450518447|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
125244205|NCT03422718|450518448|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
125244206|NCT03422718|450518449|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
125244207|NCT03422718|450518450|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
125244208|NCT03422718|450518451|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
125244209|NCT03422718|450518452|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
125244210|NCT03422718|450518453|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
125244211|NCT03422718|450518454|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
125244212|NCT03422718|450518447|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
125244213|NCT03422718|450518448|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
125244214|NCT03422718|450518449|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
125244215|NCT03422718|450518450|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
125244216|NCT03422718|450518451|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
125244217|NCT03422718|450518452|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
125244218|NCT03422718|450518453|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
125244219|NCT03422718|450518454|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
125244220|NCT03422718|450518447|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
125244221|NCT03422718|450518448|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
125244222|NCT03422718|450518449|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
125244223|NCT03422718|450518450|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
125244224|NCT03422718|450518451|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
125244225|NCT03422718|450518452|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
125244226|NCT03422718|450518453|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
125244227|NCT03422718|450518454|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
125244228|NCT03422718|450518447|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
125244229|NCT03422718|450518448|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
125244230|NCT03422718|450518449|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
125244231|NCT03422718|450518450|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
125244232|NCT03422718|450518451|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
125244233|NCT03422718|450518452|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
125244234|NCT03422718|450518453|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
125244235|NCT03422718|450518454|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
125244236|NCT01178411|450518455|FG000|Overall Study|Adverse Event|5|||
125244237|NCT01178411|450518455|FG000|Overall Study|Withdrawal by Subject|4|||
125244238|NCT01178411|450518455|FG000|Overall Study|Protocol Violation|1|||
125244239|NCT01178411|450518455|FG000|Overall Study|Progressive disease per RECIST|32|||
125244240|NCT01178411|450518455|FG000|Overall Study|Progressive disease per clinician|9|||
125244241|NCT01178411|450518455|FG000|Overall Study|Physician Decision|6|||
125244242|NCT01178411|450518455|FG000|Overall Study|Death|1|||
125244243|NCT01178411|450518455|FG000|Overall Study|No reason provided|1|||
125244244|NCT01178411|450518455|FG000|Overall Study|Drug manufacturing ended|1|||
125244245|NCT00421733|450518463|FG000|Overall Study|Adverse Event|4|||
125244246|NCT00421733|450518464|FG001|Overall Study|Adverse Event|9|||
125244247|NCT00421733|450518465|FG002|Overall Study|Adverse Event|2|||
125244248|NCT00421733|450518463|FG000|Overall Study|Lost to Follow-up|1|||
125244249|NCT00421733|450518464|FG001|Overall Study|Lost to Follow-up|2|||
125244250|NCT00421733|450518465|FG002|Overall Study|Lost to Follow-up|4|||
125244251|NCT00421733|450518463|FG000|Overall Study|Withdrawal by Subject|1|||
125244252|NCT00421733|450518464|FG001|Overall Study|Withdrawal by Subject|2|||
125244253|NCT00421733|450518465|FG002|Overall Study|Withdrawal by Subject|7|||
125244254|NCT00421733|450518463|FG000|Overall Study|Death|0|||
125190813|NCT00506415|450320722|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
125190814|NCT00506415|450320723|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
125190815|NCT00506415|450320724|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
125190816|NCT00506415|450320725|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
125190817|NCT00506415|450320722|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
125190818|NCT00506415|450320723|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
125190819|NCT00506415|450320724|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
125190820|NCT00506415|450320725|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
125190821|NCT00506415|450320722|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
125190822|NCT00506415|450320723|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
125190823|NCT00506415|450320724|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
125190824|NCT00506415|450320725|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
125190825|NCT00506415|450320722|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
125190826|NCT00506415|450320723|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
125190827|NCT00506415|450320724|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
125190828|NCT00506415|450320725|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
125190829|NCT00506415|450320722|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
125190830|NCT00506415|450320723|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
125190831|NCT00506415|450320724|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
125190832|NCT00506415|450320725|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
125190833|NCT00506415|450320722|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
125190834|NCT00506415|450320723|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
125190835|NCT00506415|450320724|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
125190836|NCT00506415|450320725|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
125190837|NCT00506415|450320722|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
125190838|NCT00506415|450320723|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
125190839|NCT00506415|450320724|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
125190840|NCT00506415|450320725|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
125190841|NCT00506415|450320722|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
125190842|NCT00506415|450320723|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
125190843|NCT00506415|450320724|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
125190844|NCT00506415|450320725|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
125190845|NCT00506415|450320722|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
125190846|NCT00506415|450320723|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
125190847|NCT00506415|450320724|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
125190848|NCT00506415|450320725|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
125190849|NCT00506415|450320722|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
125190850|NCT00506415|450320723|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
125190851|NCT00506415|450320724|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
125190852|NCT00506415|450320725|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
125190853|NCT00506415|450320722|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
125190854|NCT00506415|450320723|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
125190855|NCT00506415|450320724|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
125190856|NCT00506415|450320725|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
125190857|NCT00506415|450320722|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
125190858|NCT00506415|450320723|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
125190859|NCT00506415|450320724|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
125190860|NCT00506415|450320725|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
125190861|NCT00506415|450320722|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
125190862|NCT00506415|450320723|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
125190863|NCT00506415|450320724|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
125190864|NCT00506415|450320725|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
125190865|NCT00506415|450320722|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
125190866|NCT00506415|450320723|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
125190867|NCT00506415|450320724|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
125190868|NCT00506415|450320725|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
125190869|NCT00506415|450320722|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
125190870|NCT00506415|450320723|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
125190871|NCT00506415|450320724|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
125190872|NCT00506415|450320725|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
125190873|NCT00506415|450320722|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
125190874|NCT00506415|450320723|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
125190875|NCT00506415|450320724|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
125190876|NCT00506415|450320725|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
125190877|NCT00506415|450320722|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
125190878|NCT00506415|450320723|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
125190879|NCT00506415|450320724|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
125190880|NCT00506415|450320725|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
125190881|NCT00506415|450320722|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
125190882|NCT00506415|450320723|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
125190883|NCT00506415|450320724|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
125190884|NCT00506415|450320725|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
125190885|NCT00506415|450320722|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
125190886|NCT00506415|450320723|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
125190887|NCT00506415|450320724|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
125190888|NCT00506415|450320725|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
125190889|NCT00506415|450320722|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
125190890|NCT00506415|450320723|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
125190891|NCT00506415|450320724|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
125190892|NCT00506415|450320725|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
125190893|NCT00506415|450320722|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
125190894|NCT00506415|450320723|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
125190895|NCT00506415|450320724|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
125190896|NCT00506415|450320725|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
125190897|NCT00506415|450320722|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
125190898|NCT00506415|450320723|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
125190899|NCT00506415|450320724|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
125190900|NCT00506415|450320725|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
125190901|NCT00506415|450320722|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
125190902|NCT00506415|450320723|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
125190903|NCT00506415|450320724|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
125190904|NCT00506415|450320725|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
125190905|NCT04578457|450320726|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
125190906|NCT04578457|450320726|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
125190907|NCT04578457|450320726|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
125190908|NCT04578457|450320726|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
125190909|NCT02019264|450320729|FG000|Overall Study|Not treated|6|||
125190910|NCT02019264|450320730|FG001|Overall Study|Not treated|4|||
125190911|NCT02019264|450320729|FG000|Overall Study|Lost to Follow-up|50|||
125190912|NCT02019264|450320730|FG001|Overall Study|Lost to Follow-up|47|||
125190913|NCT02019264|450320729|FG000|Overall Study|Withdrawal by Subject|142|||
125190914|NCT02019264|450320730|FG001|Overall Study|Withdrawal by Subject|117|||
125190915|NCT02019264|450320729|FG000|Overall Study|Administrative reason|36|||
125190916|NCT02019264|450320730|FG001|Overall Study|Administrative reason|28|||
125190917|NCT02019264|450320729|FG000|Overall Study|Missing|14|||
125190918|NCT02019264|450320730|FG001|Overall Study|Missing|11|||
125190919|NCT02187198|450320733|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
125190920|NCT02187198|450320734|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
125190921|NCT02187198|450320733|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
125190922|NCT02187198|450320734|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
125190923|NCT00546377|450320735|FG000|Overall Study|Deemed ineligible|1|||
125190924|NCT00546377|450320735|FG000|Overall Study|Adverse Event|6|||
125190925|NCT01964222|450320736|FG000|Overall Study|Lost to Follow-up|7|||
125190926|NCT01964222|450320737|FG001|Overall Study|Lost to Follow-up|5|||
125190927|NCT01964222|450320736|FG000|Overall Study|Withdrawal by Subject|6|||
125190928|NCT01964222|450320737|FG001|Overall Study|Withdrawal by Subject|6|||
125190929|NCT01964222|450320736|FG000|Overall Study|Screening Failure|2|||
125190930|NCT01964222|450320737|FG001|Overall Study|Screening Failure|0|||
125190931|NCT01737710|450320740|FG000|Overall Study|Lost to Follow-up|0|||
125190932|NCT01737710|450320741|FG001|Overall Study|Lost to Follow-up|2|||
125190933|NCT01737710|450320742|FG002|Overall Study|Lost to Follow-up|2|||
125190934|NCT01737710|450320743|FG003|Overall Study|Lost to Follow-up|0|||
125190935|NCT01737710|450320744|FG004|Overall Study|Lost to Follow-up|0|||
125190936|NCT01737710|450320740|FG000|Overall Study|Withdrawal by Subject|1|||
125190937|NCT01737710|450320741|FG001|Overall Study|Withdrawal by Subject|1|||
125190938|NCT01737710|450320742|FG002|Overall Study|Withdrawal by Subject|1|||
125244255|NCT00421733|450518464|FG001|Overall Study|Death|3|||
125190939|NCT01737710|450320743|FG003|Overall Study|Withdrawal by Subject|0|||
125190940|NCT01737710|450320744|FG004|Overall Study|Withdrawal by Subject|0|||
125190941|NCT01737710|450320740|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
125190942|NCT01737710|450320741|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
125190943|NCT01737710|450320742|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
125190944|NCT01737710|450320743|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
125244256|NCT00421733|450518465|FG002|Overall Study|Death|0|||
125190945|NCT01737710|450320744|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
125190946|NCT02677922|450320751|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
125190947|NCT02677922|450320752|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
125190948|NCT02677922|450320753|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
125190949|NCT02677922|450320754|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
125190950|NCT02677922|450320755|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
125190951|NCT02677922|450320756|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
125190952|NCT02677922|450320751|FG000|Treatment Period|Adverse Event|0|||
125190953|NCT02677922|450320752|FG001|Treatment Period|Adverse Event|0|||
125190954|NCT02677922|450320753|FG002|Treatment Period|Adverse Event|1|||
125190955|NCT02677922|450320754|FG003|Treatment Period|Adverse Event|3|||
125190956|NCT02677922|450320755|FG004|Treatment Period|Adverse Event|5|||
125190957|NCT02677922|450320756|FG005|Treatment Period|Adverse Event|2|||
125190958|NCT02677922|450320751|FG000|Treatment Period|Progressive Disease|1|||
125190959|NCT02677922|450320752|FG001|Treatment Period|Progressive Disease|1|||
125190960|NCT02677922|450320753|FG002|Treatment Period|Progressive Disease|0|||
125190961|NCT02677922|450320754|FG003|Treatment Period|Progressive Disease|0|||
125190962|NCT02677922|450320755|FG004|Treatment Period|Progressive Disease|8|||
125190963|NCT02677922|450320756|FG005|Treatment Period|Progressive Disease|7|||
125190964|NCT02677922|450320751|FG000|Treatment Period|Lack of Efficacy|0|||
125190965|NCT02677922|450320752|FG001|Treatment Period|Lack of Efficacy|0|||
125190966|NCT02677922|450320753|FG002|Treatment Period|Lack of Efficacy|0|||
125190967|NCT02677922|450320754|FG003|Treatment Period|Lack of Efficacy|1|||
125190968|NCT02677922|450320755|FG004|Treatment Period|Lack of Efficacy|1|||
125190969|NCT02677922|450320756|FG005|Treatment Period|Lack of Efficacy|6|||
125190970|NCT02677922|450320751|FG000|Treatment Period|Withdrawal by Subject|0|||
125190971|NCT02677922|450320752|FG001|Treatment Period|Withdrawal by Subject|0|||
125190972|NCT02677922|450320753|FG002|Treatment Period|Withdrawal by Subject|1|||
125190973|NCT02677922|450320754|FG003|Treatment Period|Withdrawal by Subject|3|||
125190974|NCT02677922|450320755|FG004|Treatment Period|Withdrawal by Subject|5|||
125190975|NCT02677922|450320756|FG005|Treatment Period|Withdrawal by Subject|5|||
125190976|NCT02677922|450320751|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
125190977|NCT02677922|450320752|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
125190978|NCT02677922|450320753|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
125190979|NCT02677922|450320754|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
125190980|NCT02677922|450320755|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
125190981|NCT02677922|450320756|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
125244257|NCT00421733|450518463|FG000|Overall Study|Required dialysis|1|||
125244258|NCT00421733|450518464|FG001|Overall Study|Required dialysis|0|||
125244259|NCT00421733|450518465|FG002|Overall Study|Required dialysis|0|||
125244260|NCT00421733|450518463|FG000|Overall Study|Administrative|2|||
125244261|NCT00421733|450518464|FG001|Overall Study|Administrative|0|||
125244262|NCT00421733|450518465|FG002|Overall Study|Administrative|0|||
125244263|NCT00421733|450518463|FG000|Overall Study|Did not satisfy entry criteria|1|||
125244264|NCT00421733|450518464|FG001|Overall Study|Did not satisfy entry criteria|3|||
125244265|NCT00421733|450518465|FG002|Overall Study|Did not satisfy entry criteria|2|||
125244266|NCT00421733|450518463|FG000|Overall Study|Sponsor request|1|||
125244267|NCT00421733|450518464|FG001|Overall Study|Sponsor request|0|||
125244268|NCT00421733|450518465|FG002|Overall Study|Sponsor request|3|||
125244269|NCT00421733|450518463|FG000|Overall Study|Protocol deviation|4|||
125244270|NCT00421733|450518464|FG001|Overall Study|Protocol deviation|7|||
125244271|NCT00421733|450518465|FG002|Overall Study|Protocol deviation|2|||
125244272|NCT02265744|450518466|FG000|Overall Study|Poor/Non-compliance|1|||
125244273|NCT02265744|450518467|FG001|Overall Study|Poor/Non-compliance|1|||
125244274|NCT02265744|450518468|FG002|Overall Study|Poor/Non-compliance|0|||
125244275|NCT02265744|450518469|FG003|Overall Study|Poor/Non-compliance|0|||
125244276|NCT02265744|450518470|FG004|Overall Study|Poor/Non-compliance|2|||
125244277|NCT02265744|450518466|FG000|Overall Study|Lost to Follow-up|0|||
125244278|NCT02265744|450518467|FG001|Overall Study|Lost to Follow-up|0|||
125244279|NCT02265744|450518468|FG002|Overall Study|Lost to Follow-up|0|||
125244280|NCT02265744|450518469|FG003|Overall Study|Lost to Follow-up|1|||
125244281|NCT02265744|450518470|FG004|Overall Study|Lost to Follow-up|0|||
125244282|NCT02265744|450518466|FG000|Overall Study|Death|0|||
125244283|NCT02265744|450518467|FG001|Overall Study|Death|0|||
125244284|NCT02265744|450518468|FG002|Overall Study|Death|0|||
125244285|NCT02265744|450518469|FG003|Overall Study|Death|2|||
125244286|NCT02265744|450518470|FG004|Overall Study|Death|0|||
125244287|NCT02265744|450518466|FG000|Overall Study|Withdrawal by Subject|2|||
125244288|NCT02265744|450518467|FG001|Overall Study|Withdrawal by Subject|0|||
125244289|NCT02265744|450518468|FG002|Overall Study|Withdrawal by Subject|0|||
125244290|NCT02265744|450518469|FG003|Overall Study|Withdrawal by Subject|2|||
125244291|NCT02265744|450518470|FG004|Overall Study|Withdrawal by Subject|0|||
125244292|NCT02265744|450518466|FG000|Overall Study|Participant request to discontinue|2|||
125244293|NCT02265744|450518467|FG001|Overall Study|Participant request to discontinue|2|||
125244294|NCT02265744|450518468|FG002|Overall Study|Participant request to discontinue|2|||
125244295|NCT02265744|450518469|FG003|Overall Study|Participant request to discontinue|0|||
125244296|NCT02265744|450518470|FG004|Overall Study|Participant request to discontinue|0|||
125244297|NCT02265744|450518466|FG000|Overall Study|Adverse Event|8|||
125244298|NCT02265744|450518467|FG001|Overall Study|Adverse Event|4|||
125244299|NCT02265744|450518468|FG002|Overall Study|Adverse Event|9|||
125244300|NCT02265744|450518469|FG003|Overall Study|Adverse Event|8|||
125244301|NCT02265744|450518470|FG004|Overall Study|Adverse Event|2|||
125244302|NCT02265744|450518466|FG000|Overall Study|Lack of Efficacy|2|||
125244303|NCT02265744|450518467|FG001|Overall Study|Lack of Efficacy|4|||
125244304|NCT02265744|450518468|FG002|Overall Study|Lack of Efficacy|3|||
125244305|NCT02265744|450518469|FG003|Overall Study|Lack of Efficacy|4|||
125244306|NCT02265744|450518470|FG004|Overall Study|Lack of Efficacy|5|||
125244307|NCT02265744|450518466|FG000|Overall Study|Reason not provided by Investigator|1|||
125244308|NCT02265744|450518467|FG001|Overall Study|Reason not provided by Investigator|0|||
125244309|NCT02265744|450518468|FG002|Overall Study|Reason not provided by Investigator|0|||
125244310|NCT02265744|450518469|FG003|Overall Study|Reason not provided by Investigator|2|||
125244311|NCT02265744|450518470|FG004|Overall Study|Reason not provided by Investigator|0|||
125244312|NCT02265744|450518466|FG000|Overall Study|Administrative reason by sponsor|3|||
125244313|NCT02265744|450518467|FG001|Overall Study|Administrative reason by sponsor|2|||
125244314|NCT02265744|450518468|FG002|Overall Study|Administrative reason by sponsor|2|||
125244315|NCT02265744|450518469|FG003|Overall Study|Administrative reason by sponsor|3|||
125244316|NCT02265744|450518470|FG004|Overall Study|Administrative reason by sponsor|3|||
125244317|NCT02265744|450518466|FG000|Overall Study|Subject no longer meets study criteria|0|||
125244318|NCT02265744|450518467|FG001|Overall Study|Subject no longer meets study criteria|0|||
125244319|NCT02265744|450518468|FG002|Overall Study|Subject no longer meets study criteria|0|||
125244320|NCT02265744|450518469|FG003|Overall Study|Subject no longer meets study criteria|0|||
125244321|NCT02265744|450518470|FG004|Overall Study|Subject no longer meets study criteria|1|||
125244322|NCT02265744|450518466|FG000|Overall Study|Pregnancy|1|||
125244323|NCT02265744|450518467|FG001|Overall Study|Pregnancy|2|||
125244324|NCT02265744|450518468|FG002|Overall Study|Pregnancy|1|||
125244325|NCT02265744|450518469|FG003|Overall Study|Pregnancy|1|||
125244326|NCT02265744|450518470|FG004|Overall Study|Pregnancy|0|||
125244327|NCT05161936|450518473|FG000|Overall Study|Study terminated by Sponsor|1|||
125244328|NCT05161936|450518474|FG001|Overall Study|Study terminated by Sponsor|0|||
125244329|NCT05161936|450518475|FG002|Overall Study|Study terminated by Sponsor|0|||
125244330|NCT05161936|450518473|FG000|Overall Study|Withdrawal by Subject|0|||
125244331|NCT05161936|450518474|FG001|Overall Study|Withdrawal by Subject|0|||
125244332|NCT05161936|450518475|FG002|Overall Study|Withdrawal by Subject|1|||
125244333|NCT04999020|450518483|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
125190982|NCT02677922|450320751|FG000|Treatment Period|Disease Relapse|0|||
125190983|NCT02677922|450320752|FG001|Treatment Period|Disease Relapse|0|||
125190984|NCT02677922|450320753|FG002|Treatment Period|Disease Relapse|0|||
125190985|NCT02677922|450320754|FG003|Treatment Period|Disease Relapse|3|||
125190986|NCT02677922|450320755|FG004|Treatment Period|Disease Relapse|6|||
125190987|NCT02677922|450320756|FG005|Treatment Period|Disease Relapse|1|||
125190988|NCT02677922|450320751|FG000|Treatment Period|Allogeneic HSCT|1|||
125190989|NCT02677922|450320752|FG001|Treatment Period|Allogeneic HSCT|0|||
125190990|NCT02677922|450320753|FG002|Treatment Period|Allogeneic HSCT|0|||
125190991|NCT02677922|450320754|FG003|Treatment Period|Allogeneic HSCT|1|||
125190992|NCT02677922|450320755|FG004|Treatment Period|Allogeneic HSCT|4|||
125190993|NCT02677922|450320756|FG005|Treatment Period|Allogeneic HSCT|1|||
125190994|NCT02677922|450320751|FG000|Treatment Period|Other Reasons|0|||
125190995|NCT02677922|450320752|FG001|Treatment Period|Other Reasons|0|||
125190996|NCT02677922|450320753|FG002|Treatment Period|Other Reasons|0|||
125190997|NCT02677922|450320754|FG003|Treatment Period|Other Reasons|1|||
125190998|NCT02677922|450320755|FG004|Treatment Period|Other Reasons|3|||
125190999|NCT02677922|450320756|FG005|Treatment Period|Other Reasons|5|||
125191000|NCT02677922|450320751|FG000|Treatment Period|Death|0|||
125191001|NCT02677922|450320752|FG001|Treatment Period|Death|0|||
125191002|NCT02677922|450320753|FG002|Treatment Period|Death|0|||
125191003|NCT02677922|450320754|FG003|Treatment Period|Death|0|||
125191004|NCT02677922|450320755|FG004|Treatment Period|Death|12|||
125191005|NCT02677922|450320756|FG005|Treatment Period|Death|1|||
125191006|NCT02677922|450320751|FG000|Treatment Period|Non-compliance with Study Drug|0|||
125191007|NCT02677922|450320752|FG001|Treatment Period|Non-compliance with Study Drug|0|||
125191008|NCT02677922|450320753|FG002|Treatment Period|Non-compliance with Study Drug|0|||
125191009|NCT02677922|450320754|FG003|Treatment Period|Non-compliance with Study Drug|0|||
125191010|NCT02677922|450320755|FG004|Treatment Period|Non-compliance with Study Drug|1|||
125191011|NCT02677922|450320756|FG005|Treatment Period|Non-compliance with Study Drug|0|||
125191012|NCT02677922|450320751|FG000|Treatment Period|Physician Decision|0|||
125191013|NCT02677922|450320752|FG001|Treatment Period|Physician Decision|0|||
125191014|NCT02677922|450320753|FG002|Treatment Period|Physician Decision|0|||
125191015|NCT02677922|450320754|FG003|Treatment Period|Physician Decision|0|||
125191016|NCT02677922|450320755|FG004|Treatment Period|Physician Decision|0|||
125191017|NCT02677922|450320756|FG005|Treatment Period|Physician Decision|1|||
125191018|NCT02677922|450320751|FG000|Treatment Period|Symptomatic Deterioration|0|||
125191019|NCT02677922|450320752|FG001|Treatment Period|Symptomatic Deterioration|0|||
125191020|NCT02677922|450320753|FG002|Treatment Period|Symptomatic Deterioration|0|||
125191021|NCT02677922|450320754|FG003|Treatment Period|Symptomatic Deterioration|0|||
125191022|NCT02677922|450320755|FG004|Treatment Period|Symptomatic Deterioration|1|||
125191023|NCT02677922|450320756|FG005|Treatment Period|Symptomatic Deterioration|0|||
125191024|NCT01791894|450320759|FG000|Overall Study|Adverse Event|1|||
125191025|NCT02268916|450320766|FG000|Overall Study|Lost to Follow-up|1|||
125191026|NCT02268916|450320767|FG001|Overall Study|Lost to Follow-up|1|||
125191027|NCT02268916|450320766|FG000|Overall Study|Withdrawal by Subject|6|||
125191028|NCT02268916|450320767|FG001|Overall Study|Withdrawal by Subject|5|||
125191029|NCT02268916|450320766|FG000|Overall Study|Participant did not have diabetes|1|||
125191030|NCT02268916|450320767|FG001|Overall Study|Participant did not have diabetes|0|||
125191031|NCT02268916|450320766|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
125191032|NCT02268916|450320767|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
125191033|NCT02418949|450320768|FG000|Overall Study|Withdrawal by Subject|1|||
125191034|NCT02418949|450320769|FG001|Overall Study|Withdrawal by Subject|0|||
125191035|NCT02418949|450320770|FG002|Overall Study|Withdrawal by Subject|1|||
125191036|NCT02418949|450320771|FG003|Overall Study|Withdrawal by Subject|1|||
125191037|NCT02418949|450320768|FG000|Overall Study|Lost to Follow-up|1|||
125191038|NCT02418949|450320769|FG001|Overall Study|Lost to Follow-up|0|||
125191039|NCT02418949|450320770|FG002|Overall Study|Lost to Follow-up|1|||
125191040|NCT02418949|450320771|FG003|Overall Study|Lost to Follow-up|0|||
125191041|NCT02418949|450320768|FG000|Overall Study|Physician Decision|1|||
125191042|NCT02418949|450320769|FG001|Overall Study|Physician Decision|1|||
125191043|NCT02418949|450320770|FG002|Overall Study|Physician Decision|1|||
125191044|NCT02418949|450320771|FG003|Overall Study|Physician Decision|0|||
125191045|NCT02684097|450320773|FG000|Overall Study|Lack of Efficacy|13|||
125191046|NCT02684097|450320774|FG001|Overall Study|Lack of Efficacy|6|||
125191047|NCT00460811|450320775|FG000|Overall Study|Adverse Event|4|||
125191048|NCT00460811|450320776|FG001|Overall Study|Adverse Event|6|||
125191049|NCT00460811|450320777|FG002|Overall Study|Adverse Event|3|||
125191050|NCT00460811|450320778|FG003|Overall Study|Adverse Event|10|||
125191051|NCT00460811|450320779|FG004|Overall Study|Adverse Event|2|||
125191052|NCT00460811|450320775|FG000|Overall Study|Noncompliance|1|||
125191053|NCT00460811|450320776|FG001|Overall Study|Noncompliance|0|||
125191054|NCT00460811|450320777|FG002|Overall Study|Noncompliance|0|||
125191055|NCT00460811|450320778|FG003|Overall Study|Noncompliance|2|||
125191056|NCT00460811|450320779|FG004|Overall Study|Noncompliance|1|||
125191057|NCT00460811|450320775|FG000|Overall Study|Withdrawal by Subject|7|||
125191058|NCT00460811|450320776|FG001|Overall Study|Withdrawal by Subject|7|||
125191059|NCT00460811|450320777|FG002|Overall Study|Withdrawal by Subject|6|||
125191060|NCT00460811|450320778|FG003|Overall Study|Withdrawal by Subject|3|||
125191061|NCT00460811|450320779|FG004|Overall Study|Withdrawal by Subject|11|||
125191062|NCT00460811|450320775|FG000|Overall Study|Physician Decision|1|||
125191063|NCT00460811|450320776|FG001|Overall Study|Physician Decision|0|||
125191064|NCT00460811|450320777|FG002|Overall Study|Physician Decision|0|||
125191065|NCT00460811|450320778|FG003|Overall Study|Physician Decision|0|||
125191066|NCT00460811|450320779|FG004|Overall Study|Physician Decision|0|||
125191067|NCT00460811|450320775|FG000|Overall Study|Lost to Follow-up|3|||
125191068|NCT00460811|450320776|FG001|Overall Study|Lost to Follow-up|2|||
125191069|NCT00460811|450320777|FG002|Overall Study|Lost to Follow-up|5|||
125191070|NCT00460811|450320778|FG003|Overall Study|Lost to Follow-up|3|||
125191071|NCT00460811|450320779|FG004|Overall Study|Lost to Follow-up|6|||
125191072|NCT02748356|450320780|FG000|Overall Study|Withdrawal by Subject|1|||
125191073|NCT03515811|450320782|FG000|Overall Study|Lost to Follow-up|2|||
125191074|NCT03515811|450320783|FG001|Overall Study|Lost to Follow-up|1|||
125191075|NCT03515811|450320782|FG000|Overall Study|Protocol Violation|1|||
125191076|NCT03515811|450320783|FG001|Overall Study|Protocol Violation|1|||
125191077|NCT03515811|450320782|FG000|Overall Study|Death|1|||
125191078|NCT03515811|450320783|FG001|Overall Study|Death|1|||
125191079|NCT03515811|450320782|FG000|Overall Study|Withdrawal by Subject|0|||
125191080|NCT03515811|450320783|FG001|Overall Study|Withdrawal by Subject|2|||
125191081|NCT03515811|450320782|FG000|Overall Study|Technical Problems|1|||
125191082|NCT03515811|450320783|FG001|Overall Study|Technical Problems|0|||
125191083|NCT03515811|450320782|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
125191084|NCT03515811|450320783|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
125191085|NCT03515811|450320782|FG000|Overall Study|COVID-19|0|||
125191086|NCT03515811|450320783|FG001|Overall Study|COVID-19|1|||
125191087|NCT00237458|450320784|FG000|Overall Study|Lack of Efficacy|1|||
125191088|NCT00237458|450320784|FG000|Overall Study|Adverse Event|1|||
125191089|NCT00237458|450320784|FG000|Overall Study|Withdrawal by Subject|1|||
125191090|NCT04331067|450320785|FG000|Overall Study|Adverse Event|1|||
125191091|NCT04331067|450320786|FG001|Overall Study|Adverse Event|3|||
125191092|NCT04331067|450320787|FG002|Overall Study|Adverse Event|1|||
125191093|NCT04331067|450320785|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
125191094|NCT04331067|450320786|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
125191095|NCT04331067|450320787|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
125191096|NCT04339062|450320788|FG000|Overall Study|Death|0|||
125191097|NCT04339062|450320789|FG001|Overall Study|Death|1|||
125191098|NCT05870371|450320790|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
125191099|NCT05870371|450320791|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
125191100|NCT01777282|450320792|FG000|Overall Study|Persistent Hyperglycemia|0|||
125191101|NCT01777282|450320793|FG001|Overall Study|Persistent Hyperglycemia|0|||
125191102|NCT01777282|450320794|FG002|Overall Study|Persistent Hyperglycemia|1|||
125191103|NCT01777282|450320795|FG003|Overall Study|Persistent Hyperglycemia|0|||
125191104|NCT01777282|450320796|FG004|Overall Study|Persistent Hyperglycemia|0|||
125244334|NCT04999020|450518484|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
125244335|NCT04999020|450518485|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
125244336|NCT04999020|450518486|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
125244337|NCT04999020|450518483|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
125244338|NCT04999020|450518484|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
125244339|NCT04999020|450518485|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
125244340|NCT04999020|450518486|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
125244341|NCT04999020|450518483|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
125244342|NCT04999020|450518484|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
125191105|NCT01777282|450320792|FG000|Overall Study|New Antidiabetic Medication|0|||
125191106|NCT01777282|450320793|FG001|Overall Study|New Antidiabetic Medication|0|||
125191107|NCT01777282|450320794|FG002|Overall Study|New Antidiabetic Medication|1|||
125191108|NCT01777282|450320795|FG003|Overall Study|New Antidiabetic Medication|0|||
125191109|NCT01777282|450320796|FG004|Overall Study|New Antidiabetic Medication|0|||
125191110|NCT01777282|450320792|FG000|Overall Study|Adverse Event|4|||
125191111|NCT01777282|450320793|FG001|Overall Study|Adverse Event|4|||
125191112|NCT01777282|450320794|FG002|Overall Study|Adverse Event|2|||
125191113|NCT01777282|450320795|FG003|Overall Study|Adverse Event|1|||
125191114|NCT01777282|450320796|FG004|Overall Study|Adverse Event|3|||
125244343|NCT04999020|450518485|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
125244344|NCT04999020|450518486|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
125191115|NCT01777282|450320792|FG000|Overall Study|Withdrawal by Subject|4|||
125191116|NCT01777282|450320793|FG001|Overall Study|Withdrawal by Subject|0|||
125191117|NCT01777282|450320794|FG002|Overall Study|Withdrawal by Subject|0|||
125191118|NCT01777282|450320795|FG003|Overall Study|Withdrawal by Subject|1|||
125244345|NCT04999020|450518483|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
125191119|NCT01777282|450320796|FG004|Overall Study|Withdrawal by Subject|2|||
125191120|NCT01777282|450320792|FG000|Overall Study|Protocol Violation|2|||
125191121|NCT01777282|450320793|FG001|Overall Study|Protocol Violation|0|||
125191122|NCT01777282|450320794|FG002|Overall Study|Protocol Violation|1|||
125191123|NCT01777282|450320795|FG003|Overall Study|Protocol Violation|0|||
125191124|NCT01777282|450320796|FG004|Overall Study|Protocol Violation|2|||
125191125|NCT01777282|450320792|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
125191126|NCT01777282|450320793|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
125191127|NCT01777282|450320794|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
125191128|NCT01777282|450320795|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
125191129|NCT01777282|450320796|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
125191130|NCT01780038|450322389|FG000|Overall Study|Lost to Follow-up|4|||
125191131|NCT01780038|450322390|FG001|Overall Study|Lost to Follow-up|1|||
125191132|NCT01085630|450322391|FG000|Overall Study|Insufficient data|1|||
125191133|NCT01085630|450322392|FG001|Overall Study|Insufficient data|0|||
125191134|NCT01085630|450322391|FG000|Overall Study|Ineligible|3|||
125191135|NCT01085630|450322392|FG001|Overall Study|Ineligible|0|||
125191136|NCT02609607|450322398|FG000|Overall Study|Lost to Follow-up|0|||
125191137|NCT02609607|450322399|FG001|Overall Study|Lost to Follow-up|1|||
125244346|NCT04999020|450518484|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
125244347|NCT04999020|450518485|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
125244348|NCT04999020|450518486|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
125244349|NCT04999020|450518483|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
125244350|NCT04999020|450518484|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
125244351|NCT04999020|450518485|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
125244352|NCT04999020|450518486|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
125244353|NCT04999020|450518483|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
125244354|NCT04999020|450518484|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
125244355|NCT04999020|450518485|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
125244356|NCT04999020|450518486|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
125244357|NCT04999020|450518483|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
125244358|NCT04999020|450518484|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
125244359|NCT04999020|450518485|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
125244360|NCT04999020|450518486|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
125244361|NCT04999020|450518483|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
125244362|NCT04999020|450518484|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
125244363|NCT04999020|450518485|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
125244364|NCT04999020|450518486|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
125244365|NCT02448043|450518487|FG000|Overall Study|Withdrawal by Subject|2|||
125244366|NCT02448043|450518488|FG001|Overall Study|Withdrawal by Subject|2|||
125244367|NCT02448043|450518487|FG000|Overall Study|Protocol Violation|1|||
125244368|NCT02448043|450518488|FG001|Overall Study|Protocol Violation|2|||
125244369|NCT00933166|450518493|FG000|Overall Study|Lost to Follow-up|4|||
125244370|NCT00933166|450518493|FG000|Overall Study|Lack of Efficacy|9|||
125244371|NCT00933166|450518493|FG000|Overall Study|Unavailable|4|||
125244372|NCT00933166|450518493|FG000|Overall Study|Withdrawal by Subject|1|||
125244373|NCT02112552|450518502|FG000|Overall Study|Withdrawal by Subject|1|||
125244374|NCT02112552|450518502|FG000|Overall Study|Adverse Event|1|||
125244375|NCT04465955|450518504|FG000|Overall Study|Withdrew consent|6|||
125244376|NCT04465955|450518505|FG001|Overall Study|Withdrew consent|10|||
125244377|NCT04465955|450518506|FG002|Overall Study|Withdrew consent|7|||
125244378|NCT04465955|450518504|FG000|Overall Study|Adverse Event|6|||
125244379|NCT04465955|450518505|FG001|Overall Study|Adverse Event|5|||
125244380|NCT04465955|450518506|FG002|Overall Study|Adverse Event|1|||
125244381|NCT04465955|450518504|FG000|Overall Study|Lost to Follow-up|2|||
125244382|NCT04465955|450518505|FG001|Overall Study|Lost to Follow-up|0|||
125244383|NCT04465955|450518506|FG002|Overall Study|Lost to Follow-up|3|||
125244384|NCT04465955|450518504|FG000|Overall Study|Other|1|||
125244385|NCT04465955|450518505|FG001|Overall Study|Other|1|||
125244386|NCT04465955|450518506|FG002|Overall Study|Other|3|||
125191138|NCT00651261|450322400|FG000|Overall Study|Adverse Event|32|||
125191139|NCT00651261|450322401|FG001|Overall Study|Adverse Event|22|||
125191140|NCT00651261|450322400|FG000|Overall Study|Death|18|||
125191141|NCT00651261|450322401|FG001|Overall Study|Death|18|||
125191142|NCT00651261|450322400|FG000|Overall Study|Withdrawal by Subject|22|||
125191143|NCT00651261|450322401|FG001|Overall Study|Withdrawal by Subject|40|||
125191144|NCT00651261|450322400|FG000|Overall Study|Induction failure|24|||
125191145|NCT00651261|450322401|FG001|Overall Study|Induction failure|35|||
125191146|NCT00651261|450322400|FG000|Overall Study|Disease progression|58|||
125191147|NCT00651261|450322401|FG001|Overall Study|Disease progression|58|||
125191148|NCT00651261|450322400|FG000|Overall Study|Alternative therapy|109|||
125191149|NCT00651261|450322401|FG001|Overall Study|Alternative therapy|107|||
125191150|NCT00651261|450322400|FG000|Overall Study|Other disease or participant decisions|23|||
125191151|NCT00651261|450322401|FG001|Overall Study|Other disease or participant decisions|23|||
125191152|NCT00651261|450322400|FG000|Overall Study|Never treated|5|||
125191153|NCT00651261|450322401|FG001|Overall Study|Never treated|3|||
125191154|NCT01134107|450322402|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
125191155|NCT01134107|450322403|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
125191156|NCT01134107|450322402|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
125191157|NCT01134107|450322403|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
125191158|NCT01134107|450322402|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
125191159|NCT01134107|450322403|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
125191160|NCT01134107|450322402|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
125191161|NCT01134107|450322403|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
125244387|NCT03501277|450518509|FG000|Intervention Period 1 (4 Days)|Other|0|||
125244388|NCT03501277|450518510|FG001|Intervention Period 1 (4 Days)|Other|0|||
125244389|NCT03501277|450518511|FG002|Intervention Period 1 (4 Days)|Other|1|||
125244390|NCT03501277|450518512|FG003|Intervention Period 1 (4 Days)|Other|0|||
125191162|NCT01134107|450322402|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
125191163|NCT01134107|450322403|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
125191164|NCT01134107|450322402|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
125191165|NCT01134107|450322403|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
125191166|NCT01134107|450322402|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
125191167|NCT01134107|450322403|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
125191168|NCT00687271|450322404|FG000|Overall Study|Adverse Event|1|||
125191169|NCT00687271|450322405|FG001|Overall Study|Adverse Event|3|||
125191170|NCT00687271|450322406|FG002|Overall Study|Adverse Event|1|||
125191171|NCT00687271|450322407|FG003|Overall Study|Adverse Event|0|||
125191172|NCT00687271|450322404|FG000|Overall Study|Lost to Follow-up|0|||
125191173|NCT00687271|450322405|FG001|Overall Study|Lost to Follow-up|1|||
125191174|NCT00687271|450322406|FG002|Overall Study|Lost to Follow-up|0|||
125191175|NCT00687271|450322407|FG003|Overall Study|Lost to Follow-up|0|||
125191176|NCT00687271|450322404|FG000|Overall Study|Protocol Violation|2|||
125191177|NCT00687271|450322405|FG001|Overall Study|Protocol Violation|1|||
125191178|NCT00687271|450322406|FG002|Overall Study|Protocol Violation|1|||
125191179|NCT00687271|450322407|FG003|Overall Study|Protocol Violation|0|||
125191180|NCT00687271|450322404|FG000|Overall Study|Withdrawal by Subject|0|||
125191181|NCT00687271|450322405|FG001|Overall Study|Withdrawal by Subject|1|||
125191182|NCT00687271|450322406|FG002|Overall Study|Withdrawal by Subject|3|||
125191183|NCT00687271|450322407|FG003|Overall Study|Withdrawal by Subject|0|||
125191184|NCT03656692|450322408|FG000|Overall Study|Worsening of disease activity|2|||
125191185|NCT03656692|450322408|FG000|Overall Study|Physician Decision|1|||
125191186|NCT02801617|450322416|FG000|Overall Study|Protocol Violation|2|||
125191187|NCT02801617|450322417|FG001|Overall Study|Protocol Violation|6|||
125191188|NCT01372618|450322418|FG000|Overall Study|PI Died. Study Terminated|9|||
125191189|NCT01954056|450322419|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
125191190|NCT01954056|450322420|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
125191191|NCT01081769|450322421|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
125191192|NCT01081769|450322422|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
125191193|NCT01081769|450322421|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
125191194|NCT01081769|450322422|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
125191195|NCT01081769|450322421|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
125191196|NCT01081769|450322422|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
125191197|NCT01081769|450322421|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
125191198|NCT01081769|450322422|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
125191199|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Adverse Event|14|||
125191200|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Adverse Event|11|||
125191201|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Death|1|||
125191202|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Death|1|||
125191203|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
125191204|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
125191205|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
125191206|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
125191207|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Pregnancy|1|||
125191208|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Pregnancy|0|||
125191209|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
125191210|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
125191211|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
125191212|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
125191213|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Other|0|||
125191214|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Other|1|||
125191215|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Ineligibility|3|||
125191216|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Ineligibility|4|||
125191217|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
125191218|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
125191219|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Patient Moved|2|||
125191220|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Patient Moved|2|||
125191221|NCT00507455|450322423|FG000|Overall Study|Adverse Event|3|||
125191222|NCT00507455|450322424|FG001|Overall Study|Adverse Event|3|||
125191223|NCT00507455|450322425|FG002|Overall Study|Adverse Event|6|||
125191224|NCT00507455|450322423|FG000|Overall Study|Withdrawal by Subject|2|||
125191225|NCT00507455|450322424|FG001|Overall Study|Withdrawal by Subject|1|||
125191226|NCT00507455|450322425|FG002|Overall Study|Withdrawal by Subject|2|||
125191227|NCT00507455|450322423|FG000|Overall Study|Protocol Violation|4|||
125191228|NCT00507455|450322424|FG001|Overall Study|Protocol Violation|1|||
125191229|NCT00507455|450322425|FG002|Overall Study|Protocol Violation|1|||
125191230|NCT00507455|450322423|FG000|Overall Study|Lost to Follow-up|2|||
125191231|NCT00507455|450322424|FG001|Overall Study|Lost to Follow-up|0|||
125191232|NCT00507455|450322425|FG002|Overall Study|Lost to Follow-up|2|||
125191233|NCT00507455|450322423|FG000|Overall Study|Lack of Efficacy|0|||
125191234|NCT00507455|450322424|FG001|Overall Study|Lack of Efficacy|1|||
125191235|NCT00507455|450322425|FG002|Overall Study|Lack of Efficacy|0|||
125244391|NCT03501277|450518509|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
125244392|NCT03501277|450518510|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
125244393|NCT03501277|450518511|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
125244394|NCT03501277|450518512|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
125244395|NCT03501277|450518509|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
125244396|NCT03501277|450518510|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
125244397|NCT03501277|450518511|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
125244398|NCT03501277|450518512|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
125244399|NCT03501277|450518509|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
125244400|NCT03501277|450518510|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
125244401|NCT03501277|450518511|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
125244402|NCT03501277|450518512|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
125244403|NCT01327703|450518513|FG000|Second Treatment Period|Adverse Event|1|||
125244404|NCT01327703|450518514|FG001|Second Treatment Period|Adverse Event|1|||
125244405|NCT01327703|450518513|FG000|Second Treatment Period|Protocol Violation|0|||
125244406|NCT01327703|450518514|FG001|Second Treatment Period|Protocol Violation|1|||
125244407|NCT01131585|450518515|FG000|Overall Study|Adverse Event|0|||
125244408|NCT01131585|450518516|FG001|Overall Study|Adverse Event|2|||
125244409|NCT01131585|450518515|FG000|Overall Study|Abnormal laboratory value|1|||
125244410|NCT01131585|450518516|FG001|Overall Study|Abnormal laboratory value|0|||
125244411|NCT01131585|450518515|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125244412|NCT01131585|450518516|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
125244413|NCT01131585|450518515|FG000|Overall Study|Protocol Violation|2|||
125244414|NCT01131585|450518516|FG001|Overall Study|Protocol Violation|1|||
125244415|NCT01131585|450518515|FG000|Overall Study|Withdrawal by Subject|3|||
125244416|NCT01131585|450518516|FG001|Overall Study|Withdrawal by Subject|3|||
125244417|NCT01131585|450518515|FG000|Overall Study|Lost to Follow-up|0|||
125244418|NCT01131585|450518516|FG001|Overall Study|Lost to Follow-up|1|||
125244419|NCT01131585|450518515|FG000|Overall Study|Administrative problems|1|||
125244420|NCT01131585|450518516|FG001|Overall Study|Administrative problems|1|||
125244421|NCT01131585|450518515|FG000|Overall Study|Study termination|78|||
125244422|NCT01131585|450518516|FG001|Overall Study|Study termination|32|||
125244423|NCT00812097|450518517|FG000|Overall Study|Death|3|||
125244424|NCT00812097|450518518|FG001|Overall Study|Death|10|||
125191236|NCT00507455|450322423|FG000|Overall Study|Other - miscellaneous reason|1|||
125191237|NCT00507455|450322424|FG001|Overall Study|Other - miscellaneous reason|0|||
125191238|NCT00507455|450322425|FG002|Overall Study|Other - miscellaneous reason|1|||
125191239|NCT03363776|450322431|FG000|Overall Study|Progressive disease|2|||
125191240|NCT03363776|450322432|FG001|Overall Study|Progressive disease|3|||
125191241|NCT03363776|450322433|FG002|Overall Study|Progressive disease|1|||
125191242|NCT03363776|450322431|FG000|Overall Study|Study drug toxicity|0|||
125191243|NCT03363776|450322432|FG001|Overall Study|Study drug toxicity|0|||
125191244|NCT03363776|450322433|FG002|Overall Study|Study drug toxicity|1|||
125191245|NCT03363776|450322431|FG000|Overall Study|Death|1|||
125191246|NCT03363776|450322432|FG001|Overall Study|Death|0|||
125191247|NCT03363776|450322433|FG002|Overall Study|Death|0|||
125191248|NCT02097238|450322438|FG000|Overall Study|Death|1|||
125191249|NCT02097238|450322438|FG000|Overall Study|Physician Decision|1|||
125191250|NCT02097238|450322438|FG000|Overall Study|Progressive Disease|17|||
125191251|NCT01106911|450322439|FG000|Overall Study|Physician Decision|2|||
125191252|NCT01106911|450322439|FG000|Overall Study|deemed ineligible after screening|3|||
125191253|NCT01814696|450322441|FG000|Overall Study|Withdrawal by Subject|1|||
125191254|NCT01814696|450322442|FG001|Overall Study|Withdrawal by Subject|0|||
125191255|NCT01814696|450322441|FG000|Overall Study|Randomized to wrong group|1|||
125191256|NCT01814696|450322442|FG001|Overall Study|Randomized to wrong group|0|||
125191257|NCT02861807|450322443|FG000|Overall Study|Lost to Follow-up|7|||
125191258|NCT02861807|450322444|FG001|Overall Study|Lost to Follow-up|6|||
125191259|NCT02861807|450322443|FG000|Overall Study|Withdrawal by Subject|5|||
125191260|NCT02861807|450322444|FG001|Overall Study|Withdrawal by Subject|8|||
125191261|NCT00410813|450322445|FG000|Overall Study|Adverse Event|6|||
125191262|NCT00410813|450322446|FG001|Overall Study|Adverse Event|11|||
125191263|NCT00410813|450322445|FG000|Overall Study|Progression|32|||
125191264|NCT00410813|450322446|FG001|Overall Study|Progression|21|||
125191265|NCT00410813|450322445|FG000|Overall Study|Not protocol specified|3|||
125191266|NCT00410813|450322446|FG001|Overall Study|Not protocol specified|4|||
125191267|NCT00410813|450322445|FG000|Overall Study|Ineligible|2|||
125191268|NCT00410813|450322446|FG001|Overall Study|Ineligible|4|||
125191269|NCT00410813|450322445|FG000|Overall Study|Death|0|||
125191270|NCT00410813|450322446|FG001|Overall Study|Death|2|||
125191271|NCT00954941|450322447|FG000|Overall Study|Received treatment at home|1|||
125244425|NCT00812097|450518519|FG002|Overall Study|Death|3|||
125244426|NCT00812097|450518520|FG003|Overall Study|Death|3|||
125244427|NCT00812097|450518517|FG000|Overall Study|Withdrawal by Subject|14|||
125244428|NCT00812097|450518518|FG001|Overall Study|Withdrawal by Subject|12|||
125244429|NCT00812097|450518519|FG002|Overall Study|Withdrawal by Subject|8|||
125244430|NCT00812097|450518520|FG003|Overall Study|Withdrawal by Subject|2|||
125244431|NCT00812097|450518517|FG000|Overall Study|Lost to Follow-up|90|||
125244432|NCT00812097|450518518|FG001|Overall Study|Lost to Follow-up|14|||
125244433|NCT00812097|450518519|FG002|Overall Study|Lost to Follow-up|17|||
125244434|NCT00812097|450518520|FG003|Overall Study|Lost to Follow-up|5|||
125244435|NCT00812097|450518517|FG000|Overall Study|Explantation of study device(s)|27|||
125244436|NCT00812097|450518518|FG001|Overall Study|Explantation of study device(s)|29|||
125244437|NCT00812097|450518519|FG002|Overall Study|Explantation of study device(s)|14|||
125244438|NCT00812097|450518520|FG003|Overall Study|Explantation of study device(s)|20|||
125244439|NCT00812097|450518517|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
125244440|NCT00812097|450518518|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
125244441|NCT00812097|450518519|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
125244442|NCT00812097|450518520|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
125244443|NCT00927082|450518521|FG000|Overall Study|Lost to Follow-up|9|||
125244444|NCT00927082|450518522|FG001|Overall Study|Lost to Follow-up|8|||
125244445|NCT00927082|450518523|FG002|Overall Study|Lost to Follow-up|12|||
125244446|NCT00927082|450518524|FG003|Overall Study|Lost to Follow-up|16|||
125244447|NCT00927082|450518521|FG000|Overall Study|Withdrawal by Subject|3|||
125244448|NCT00927082|450518522|FG001|Overall Study|Withdrawal by Subject|2|||
125244449|NCT00927082|450518523|FG002|Overall Study|Withdrawal by Subject|7|||
125244450|NCT00927082|450518524|FG003|Overall Study|Withdrawal by Subject|2|||
125244451|NCT00927082|450518521|FG000|Overall Study|Death|0|||
125244452|NCT00927082|450518522|FG001|Overall Study|Death|0|||
125244453|NCT00927082|450518523|FG002|Overall Study|Death|1|||
125244454|NCT00927082|450518524|FG003|Overall Study|Death|0|||
125244455|NCT00927082|450518521|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
125244456|NCT00927082|450518522|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
125244457|NCT00927082|450518523|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
125244458|NCT00927082|450518524|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
125244459|NCT00317369|450518525|FG000|Overall Study|Adverse Event|2|||
125244460|NCT00317369|450518526|FG001|Overall Study|Adverse Event|1|||
125244461|NCT00317369|450518527|FG002|Overall Study|Adverse Event|0|||
125244462|NCT00317369|450518525|FG000|Overall Study|Lack of Efficacy|0|||
125244463|NCT00317369|450518526|FG001|Overall Study|Lack of Efficacy|1|||
125244464|NCT00317369|450518527|FG002|Overall Study|Lack of Efficacy|1|||
125244465|NCT00317369|450518525|FG000|Overall Study|Withdrawal by Subject|0|||
125244466|NCT00317369|450518526|FG001|Overall Study|Withdrawal by Subject|0|||
125244467|NCT00317369|450518527|FG002|Overall Study|Withdrawal by Subject|1|||
125244468|NCT00849472|450518528|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
125244469|NCT00849472|450518528|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
125244470|NCT00849472|450518528|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
125244471|NCT00849472|450518528|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
125244472|NCT00849472|450518528|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
125244473|NCT00849472|450518528|FG000|Weekly Paclitaxel|Disease Progression|1|||
125244474|NCT00849472|450518528|FG000|Weekly Paclitaxel|Adverse Event|11|||
125244475|NCT00849472|450518528|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
125191272|NCT00954941|450322448|FG001|Overall Study|Received treatment at home|0|||
125191273|NCT00954941|450322447|FG000|Overall Study|Withdrawal by Subject|1|||
125191274|NCT00954941|450322448|FG001|Overall Study|Withdrawal by Subject|0|||
125191275|NCT00954941|450322447|FG000|Overall Study|Insurance Denial|2|||
125191276|NCT00954941|450322448|FG001|Overall Study|Insurance Denial|2|||
125191277|NCT00954941|450322447|FG000|Overall Study|Physician Decision|2|||
125191278|NCT00954941|450322448|FG001|Overall Study|Physician Decision|2|||
125191279|NCT00954941|450322447|FG000|Overall Study|Ineligible|2|||
125191280|NCT00954941|450322448|FG001|Overall Study|Ineligible|2|||
125191281|NCT00954941|450322447|FG000|Overall Study|Adverse Event|0|||
125191282|NCT00954941|450322448|FG001|Overall Study|Adverse Event|1|||
125191283|NCT05027451|450322449|FG000|Overall Study|Lost to Follow-up|1|||
125191284|NCT05027451|450322450|FG001|Overall Study|Lost to Follow-up|1|||
125191285|NCT00812981|450322451|FG000|Overall Study|Other|0|||
125191286|NCT00812981|450322452|FG001|Overall Study|Other|1|||
125191287|NCT02199795|450322453|FG000|Overall Study|no longer met inclusion criteria|1|||
125191288|NCT02199795|450322454|FG001|Overall Study|no longer met inclusion criteria|0|||
125191289|NCT02199795|450322453|FG000|Overall Study|withdrew due to shoulder pain|1|||
125191290|NCT02199795|450322454|FG001|Overall Study|withdrew due to shoulder pain|0|||
125191291|NCT05310071|450322455|FG000|Overall Study|Death|0|||
125244476|NCT00849472|450518528|FG000|Weekly Paclitaxel|Physician Decision|3|||
125244477|NCT00849472|450518528|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
125244478|NCT00849472|450518528|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
125244479|NCT00849472|450518528|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
125244480|NCT00849472|450518528|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
125244481|NCT00849472|450518528|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
125191292|NCT05310071|450322456|FG001|Overall Study|Death|3|||
125191293|NCT05310071|450322455|FG000|Overall Study|Adverse Event|4|||
125191294|NCT05310071|450322456|FG001|Overall Study|Adverse Event|31|||
125191295|NCT05310071|450322455|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
125191296|NCT05310071|450322456|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
125191297|NCT05310071|450322455|FG000|Overall Study|Protocol Deviation|2|||
125191298|NCT05310071|450322456|FG001|Overall Study|Protocol Deviation|0|||
125191299|NCT05310071|450322455|FG000|Overall Study|Randomized by Mistake|0|||
125191300|NCT05310071|450322456|FG001|Overall Study|Randomized by Mistake|1|||
125191301|NCT05310071|450322455|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
125191302|NCT05310071|450322456|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
125191303|NCT05310071|450322455|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
125191304|NCT05310071|450322456|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
125191305|NCT05310071|450322455|FG000|Overall Study|Site Terminated by Sponsor|0|||
125191306|NCT05310071|450322456|FG001|Overall Study|Site Terminated by Sponsor|2|||
125191307|NCT05310071|450322455|FG000|Overall Study|Study Terminated by Sponsor|282|||
125191308|NCT05310071|450322456|FG001|Overall Study|Study Terminated by Sponsor|559|||
125191309|NCT05310071|450322455|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
125191310|NCT05310071|450322456|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
125191311|NCT05310071|450322455|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
125191312|NCT05310071|450322456|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
125191313|NCT05310071|450322455|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
125191314|NCT05310071|450322456|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
125191315|NCT05310071|450322455|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
125191316|NCT05310071|450322456|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
125191317|NCT05310071|450322455|FG000|Overall Study|Withdrawal by Participant - Other|25|||
125191318|NCT05310071|450322456|FG001|Overall Study|Withdrawal by Participant - Other|30|||
125191319|NCT05310071|450322455|FG000|Overall Study|Lost to Follow-up|2|||
125191320|NCT05310071|450322456|FG001|Overall Study|Lost to Follow-up|4|||
125191321|NCT05310071|450322455|FG000|Overall Study|Reason Not Specified|1|||
125191322|NCT05310071|450322456|FG001|Overall Study|Reason Not Specified|3|||
125191323|NCT02097745|450322463|FG000|Overall Study|Adverse Event|25|||
125191324|NCT02097745|450322463|FG000|Overall Study|Death|16|||
125191325|NCT02097745|450322463|FG000|Overall Study|Failure to Return|14|||
125191326|NCT02097745|450322463|FG000|Overall Study|Administrative/Other|27|||
125191327|NCT02097745|450322463|FG000|Overall Study|Reason Not Specified|96|||
125191328|NCT00425750|450322464|FG000|Overall Study|Death|1|||
125191329|NCT00425750|450322464|FG000|Overall Study|Withdrawal by Subject|3|||
125191330|NCT00425750|450322464|FG000|Overall Study|Adverse Event|3|||
125191331|NCT00425750|450322464|FG000|Overall Study|Progression of disease|18|||
125191332|NCT01757184|450322465|FG000|Double-blind Period|Adverse Event|1|||
125191333|NCT01757184|450322466|FG001|Double-blind Period|Adverse Event|0|||
125191334|NCT01757184|450322467|FG002|Double-blind Period|Adverse Event|0|||
125191335|NCT01757184|450322468|FG003|Double-blind Period|Adverse Event|0|||
125191336|NCT01757184|450322465|FG000|Open-label Period|Lost to Follow-up|0|||
125191337|NCT01757184|450322466|FG001|Open-label Period|Lost to Follow-up|0|||
125191338|NCT01757184|450322467|FG002|Open-label Period|Lost to Follow-up|2|||
125191339|NCT01757184|450322468|FG003|Open-label Period|Lost to Follow-up|0|||
125191340|NCT01757184|450322465|FG000|Open-label Period|Withdrawal by Subject|0|||
125191341|NCT01757184|450322466|FG001|Open-label Period|Withdrawal by Subject|0|||
125191342|NCT01757184|450322467|FG002|Open-label Period|Withdrawal by Subject|1|||
125191343|NCT01757184|450322468|FG003|Open-label Period|Withdrawal by Subject|1|||
125191344|NCT01757184|450322465|FG000|Open-label Period|Discontinued by Sponsor|0|||
125191345|NCT01757184|450322466|FG001|Open-label Period|Discontinued by Sponsor|0|||
125191346|NCT01757184|450322467|FG002|Open-label Period|Discontinued by Sponsor|1|||
125191347|NCT01757184|450322468|FG003|Open-label Period|Discontinued by Sponsor|2|||
125191348|NCT01276756|450322478|FG000|Overall Study|Lost to Follow-up|2|||
125191349|NCT01276756|450322479|FG001|Overall Study|Lost to Follow-up|0|||
125191350|NCT01276756|450322478|FG000|Overall Study|Adverse Event|3|||
125191351|NCT01276756|450322479|FG001|Overall Study|Adverse Event|2|||
125191352|NCT02589639|450322480|FG000|Overall Study|Lost to Follow-up|1|||
125191353|NCT02589639|450322481|FG001|Overall Study|Lost to Follow-up|0|||
125191354|NCT02589639|450322482|FG002|Overall Study|Lost to Follow-up|0|||
125191355|NCT02589639|450322480|FG000|Overall Study|Protocol Violation|1|||
125191356|NCT02589639|450322481|FG001|Overall Study|Protocol Violation|0|||
125191357|NCT02589639|450322482|FG002|Overall Study|Protocol Violation|0|||
125191358|NCT02589639|450322480|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
125191359|NCT02589639|450322481|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
125191360|NCT02589639|450322482|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
125191361|NCT02589639|450322480|FG000|Overall Study|Adverse Event|4|||
125191362|NCT02589639|450322481|FG001|Overall Study|Adverse Event|5|||
125191363|NCT02589639|450322482|FG002|Overall Study|Adverse Event|3|||
125191364|NCT02589639|450322480|FG000|Overall Study|Other reason than specified above|1|||
125244482|NCT00849472|450518528|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
125244483|NCT00849472|450518528|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
125244484|NCT00849472|450518528|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
125244485|NCT00825175|450518529|FG000|Overall Study|Withdrawal by Subject|0|||
125244486|NCT00825175|450518530|FG001|Overall Study|Withdrawal by Subject|5|||
125244487|NCT01428128|450518532|FG000|Overall Study|Withdrawal by Subject|4|||
125244488|NCT01428128|450518532|FG000|Overall Study|Screen failure by p53|10|||
125244489|NCT01428128|450518532|FG000|Overall Study|Received Neulasta in one cycle|2|||
125244490|NCT01428128|450518532|FG000|Overall Study|Adverse Event|1|||
125244491|NCT00424008|450518533|FG000|Overall Study|Adverse Event|8|||
125244492|NCT00424008|450518534|FG001|Overall Study|Adverse Event|6|||
125244493|NCT00424008|450518533|FG000|Overall Study|Lack of Efficacy|40|||
125244494|NCT00424008|450518534|FG001|Overall Study|Lack of Efficacy|34|||
125244495|NCT00424008|450518533|FG000|Overall Study|Lost to Follow-up|1|||
125244496|NCT00424008|450518534|FG001|Overall Study|Lost to Follow-up|2|||
125244497|NCT00424008|450518533|FG000|Overall Study|Withdrawal by Subject|5|||
125244498|NCT00424008|450518534|FG001|Overall Study|Withdrawal by Subject|8|||
125244499|NCT00424008|450518533|FG000|Overall Study|Noncompliance with protocol|13|||
125244500|NCT00424008|450518534|FG001|Overall Study|Noncompliance with protocol|7|||
125244501|NCT00424008|450518533|FG000|Overall Study|Did not meet protocol eligibility|16|||
125244502|NCT00424008|450518534|FG001|Overall Study|Did not meet protocol eligibility|21|||
125244503|NCT00424008|450518533|FG000|Overall Study|Administrative|266|||
125244504|NCT00424008|450518534|FG001|Overall Study|Administrative|257|||
125244505|NCT02530242|450518551|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
125244506|NCT02530242|450518552|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
125244507|NCT00283959|450518553|FG000|Extension Period|Low Compliance|1|||
125244508|NCT05591755|450518554|FG000|Overall Study|Screen Failure|1|||
125244509|NCT05591755|450518555|FG001|Overall Study|Screen Failure|0|||
125244510|NCT05591755|450518556|FG002|Overall Study|Screen Failure|0|||
125244511|NCT05591755|450518557|FG003|Overall Study|Screen Failure|0|||
125244512|NCT05591755|450518554|FG000|Overall Study|Protocol Violation|0|||
125244513|NCT05591755|450518555|FG001|Overall Study|Protocol Violation|0|||
125244514|NCT05591755|450518556|FG002|Overall Study|Protocol Violation|2|||
125244515|NCT05591755|450518557|FG003|Overall Study|Protocol Violation|0|||
125244516|NCT05591755|450518554|FG000|Overall Study|Withdrawal by Subject|0|||
125244517|NCT05591755|450518555|FG001|Overall Study|Withdrawal by Subject|1|||
125244518|NCT05591755|450518556|FG002|Overall Study|Withdrawal by Subject|0|||
125244519|NCT05591755|450518557|FG003|Overall Study|Withdrawal by Subject|0|||
125244520|NCT00433290|450518558|FG000|Overall Study|Adverse Event|24|||
125244521|NCT00433290|450518559|FG001|Overall Study|Adverse Event|7|||
125244522|NCT00433290|450518558|FG000|Overall Study|Lack of Efficacy|1|||
125244523|NCT00433290|450518559|FG001|Overall Study|Lack of Efficacy|5|||
125244524|NCT00433290|450518558|FG000|Overall Study|Withdrawal by Subject|4|||
125244525|NCT00433290|450518559|FG001|Overall Study|Withdrawal by Subject|2|||
125244526|NCT00433290|450518558|FG000|Overall Study|Protocol Violation|3|||
125244527|NCT00433290|450518559|FG001|Overall Study|Protocol Violation|2|||
125244528|NCT00433290|450518558|FG000|Overall Study|Physician Decision|2|||
125244529|NCT00433290|450518559|FG001|Overall Study|Physician Decision|0|||
125244530|NCT00433290|450518558|FG000|Overall Study|Entry Criteria Not Met|0|||
125244531|NCT00433290|450518559|FG001|Overall Study|Entry Criteria Not Met|1|||
125244532|NCT00433290|450518558|FG000|Overall Study|Lost to Follow-up|1|||
125244533|NCT00433290|450518559|FG001|Overall Study|Lost to Follow-up|0|||
125244534|NCT01483651|450518560|FG000|Overall Study|Withdrawal by Subject|0|||
125244535|NCT01483651|450518561|FG001|Overall Study|Withdrawal by Subject|1|||
125244536|NCT01483651|450518562|FG002|Overall Study|Withdrawal by Subject|1|||
125244537|NCT01483651|450518563|FG003|Overall Study|Withdrawal by Subject|0|||
125244538|NCT01483651|450518564|FG004|Overall Study|Withdrawal by Subject|0|||
125244539|NCT01483651|450518565|FG005|Overall Study|Withdrawal by Subject|1|||
125244540|NCT00308685|450518572|FG000|Overall Study|Lost to Follow-up|1|||
125244541|NCT00308685|450518573|FG001|Overall Study|Lost to Follow-up|0|||
125244542|NCT00308685|450518572|FG000|Overall Study|Need to administer prohibited medication|1|||
125244543|NCT00308685|450518573|FG001|Overall Study|Need to administer prohibited medication|2|||
125244544|NCT00308685|450518572|FG000|Overall Study|Other than specified|1|||
125244545|NCT00308685|450518573|FG001|Overall Study|Other than specified|3|||
125244546|NCT03345095|450518574|FG000|Overall Study|Lack of Efficacy|184|||
125244547|NCT03345095|450518575|FG001|Overall Study|Lack of Efficacy|156|||
125191365|NCT02589639|450322481|FG001|Overall Study|Other reason than specified above|2|||
125191366|NCT02589639|450322482|FG002|Overall Study|Other reason than specified above|1|||
125191367|NCT02589639|450322480|FG000|Overall Study|Not Treated|0|||
125191368|NCT02589639|450322481|FG001|Overall Study|Not Treated|3|||
125191369|NCT02589639|450322482|FG002|Overall Study|Not Treated|0|||
125191370|NCT02203721|450322483|FG000|Overall Study|Lost to Follow-up|1|||
125191371|NCT02203721|450322484|FG001|Overall Study|Lost to Follow-up|0|||
125191372|NCT02203721|450322483|FG000|Overall Study|Death|0|||
125191373|NCT02203721|450322484|FG001|Overall Study|Death|2|||
125191374|NCT02203721|450322483|FG000|Overall Study|Illness|0|||
125191375|NCT02203721|450322484|FG001|Overall Study|Illness|1|||
125191376|NCT02593097|450322492|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
125191377|NCT02593097|450322493|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
125191378|NCT02593097|450322492|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
125191379|NCT02593097|450322493|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
125191380|NCT02593097|450322492|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
125191381|NCT02593097|450322493|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
125191382|NCT02593097|450322492|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
125191383|NCT02593097|450322493|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
125191384|NCT02593097|450322492|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
125191385|NCT02593097|450322493|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
125191386|NCT00703157|450322494|FG000|Overall Study|Lost to Follow-up|0|||
125191387|NCT00703157|450322495|FG001|Overall Study|Lost to Follow-up|1|||
125191388|NCT00703157|450322494|FG000|Overall Study|source data permanently lost/ other|4|||
125191389|NCT00703157|450322495|FG001|Overall Study|source data permanently lost/ other|1|||
125191390|NCT02968173|450322496|FG000|Overall Study|Withdrawal by Subject|1|||
125191391|NCT02670525|450322497|FG000|Overall Study|Death|94|||
125191392|NCT02670525|450322498|FG001|Overall Study|Death|14|||
125191393|NCT02670525|450322497|FG000|Overall Study|Lost to Follow-up|4|||
125191394|NCT02670525|450322498|FG001|Overall Study|Lost to Follow-up|1|||
125191395|NCT02670525|450322497|FG000|Overall Study|Subject withdrew consent|1|||
125191396|NCT02670525|450322498|FG001|Overall Study|Subject withdrew consent|0|||
125191397|NCT02670525|450322497|FG000|Overall Study|Unknown, data entry delayed|123|||
125191398|NCT02670525|450322498|FG001|Overall Study|Unknown, data entry delayed|78|||
125191399|NCT01554527|450322499|FG000|Overall Study|Withdrawal by Subject|1|||
125191400|NCT01554527|450322500|FG001|Overall Study|Withdrawal by Subject|0|||
125191401|NCT01554527|450322501|FG002|Overall Study|Withdrawal by Subject|3|||
125191402|NCT01554527|450322499|FG000|Overall Study|Lost to Follow-up|0|||
125191403|NCT01554527|450322500|FG001|Overall Study|Lost to Follow-up|0|||
125191404|NCT01554527|450322501|FG002|Overall Study|Lost to Follow-up|4|||
125191405|NCT01554527|450322499|FG000|Overall Study|Physician Decision|0|||
125191406|NCT01554527|450322500|FG001|Overall Study|Physician Decision|0|||
125191407|NCT01554527|450322501|FG002|Overall Study|Physician Decision|1|||
125191408|NCT01052480|450322502|FG000|Overall Study|Lost to Follow-up|3|||
125191409|NCT01052480|450322503|FG001|Overall Study|Lost to Follow-up|3|||
125191410|NCT01052480|450322502|FG000|Overall Study|Protocol Violation|1|||
125191411|NCT01052480|450322503|FG001|Overall Study|Protocol Violation|0|||
125191412|NCT01052480|450322502|FG000|Overall Study|Withdrawal by Subject|3|||
125191413|NCT01052480|450322503|FG001|Overall Study|Withdrawal by Subject|7|||
125191414|NCT01052480|450322502|FG000|Overall Study|Physician Decision|0|||
125191415|NCT01052480|450322503|FG001|Overall Study|Physician Decision|2|||
125191416|NCT01052480|450322502|FG000|Overall Study|Death|1|||
125191417|NCT01052480|450322503|FG001|Overall Study|Death|5|||
125191418|NCT00529373|450322504|FG000|Base Study|Adverse Event|525|||
125191419|NCT00529373|450322505|FG001|Base Study|Adverse Event|470|||
125191420|NCT00529373|450322504|FG000|Base Study|Lack of Efficacy|16|||
125191421|NCT00529373|450322505|FG001|Base Study|Lack of Efficacy|75|||
125191422|NCT00529373|450322504|FG000|Base Study|Lost to Follow-up|221|||
125191423|NCT00529373|450322505|FG001|Base Study|Lost to Follow-up|208|||
125191424|NCT00529373|450322504|FG000|Base Study|Other Protocol Specified Criteria|19|||
125191425|NCT00529373|450322505|FG001|Base Study|Other Protocol Specified Criteria|20|||
125191426|NCT00529373|450322504|FG000|Base Study|Physician Decision|60|||
125191427|NCT00529373|450322505|FG001|Base Study|Physician Decision|52|||
125191428|NCT00529373|450322504|FG000|Base Study|Protocol Violation|48|||
125191429|NCT00529373|450322505|FG001|Base Study|Protocol Violation|38|||
125191430|NCT00529373|450322504|FG000|Base Study|Withdrawal by Subject|1062|||
125191431|NCT00529373|450322505|FG001|Base Study|Withdrawal by Subject|967|||
125191432|NCT00529373|450322504|FG000|Base Study|Did not continue into Extension|1795|||
125191433|NCT00529373|450322505|FG001|Base Study|Did not continue into Extension|2238|||
125191434|NCT00529373|450322504|FG000|First Extension Study|Adverse Event|162|||
125191435|NCT00529373|450322505|FG001|First Extension Study|Adverse Event|142|||
125191436|NCT00529373|450322504|FG000|First Extension Study|Lack of Efficacy|65|||
125191437|NCT00529373|450322505|FG001|First Extension Study|Lack of Efficacy|427|||
125191438|NCT00529373|450322504|FG000|First Extension Study|Lost to Follow-up|41|||
125191439|NCT00529373|450322505|FG001|First Extension Study|Lost to Follow-up|37|||
125191440|NCT00529373|450322504|FG000|First Extension Study|Other|27|||
125191441|NCT00529373|450322505|FG001|First Extension Study|Other|47|||
125191442|NCT00529373|450322504|FG000|First Extension Study|Physician Decision|50|||
125244548|NCT03345095|450518574|FG000|Overall Study|Adverse Event|36|||
125244549|NCT03345095|450518575|FG001|Overall Study|Adverse Event|118|||
125244550|NCT03345095|450518574|FG000|Overall Study|Withdrawal by Subject|22|||
125244551|NCT03345095|450518575|FG001|Overall Study|Withdrawal by Subject|59|||
125244552|NCT03345095|450518574|FG000|Overall Study|Physician Decision|3|||
125244553|NCT03345095|450518575|FG001|Overall Study|Physician Decision|18|||
125244554|NCT03345095|450518574|FG000|Overall Study|Death|2|||
125244555|NCT03345095|450518575|FG001|Overall Study|Death|4|||
125244556|NCT03345095|450518574|FG000|Overall Study|Other reasons|2|||
125244557|NCT03345095|450518575|FG001|Overall Study|Other reasons|11|||
125244558|NCT03345095|450518574|FG000|Overall Study|Protocol Violation|0|||
125244559|NCT03345095|450518575|FG001|Overall Study|Protocol Violation|1|||
125244560|NCT01121575|450518576|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
125244561|NCT01121575|450518577|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
125244562|NCT01121575|450518578|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
125244563|NCT01121575|450518579|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
125244564|NCT01121575|450518580|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
125244565|NCT01121575|450518581|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
125244566|NCT01121575|450518576|FG000|Overall Study|Unspecified Reasons|8|||
125244567|NCT01121575|450518577|FG001|Overall Study|Unspecified Reasons|6|||
125244568|NCT01121575|450518578|FG002|Overall Study|Unspecified Reasons|7|||
125244569|NCT01121575|450518579|FG003|Overall Study|Unspecified Reasons|5|||
125244570|NCT01121575|450518580|FG004|Overall Study|Unspecified Reasons|13|||
125244571|NCT01121575|450518581|FG005|Overall Study|Unspecified Reasons|10|||
125244572|NCT01121575|450518576|FG000|Overall Study|Death|6|||
125244573|NCT01121575|450518577|FG001|Overall Study|Death|0|||
125244574|NCT01121575|450518578|FG002|Overall Study|Death|0|||
125244575|NCT01121575|450518579|FG003|Overall Study|Death|1|||
125244576|NCT01121575|450518580|FG004|Overall Study|Death|7|||
125244577|NCT01121575|450518581|FG005|Overall Study|Death|1|||
125244578|NCT02665455|450518583|FG000|Overall Study|Withdrawal by Subject|6|||
125244579|NCT02665455|450518583|FG000|Overall Study|Lost to Follow-up|1|||
125244580|NCT02665455|450518583|FG000|Overall Study|Adverse Event|1|||
125244581|NCT02665455|450518583|FG000|Overall Study|Protocol Violation|1|||
125244582|NCT00724503|450518584|FG000|Overall Study|Lost to Follow-up|4|||
125244583|NCT00724503|450518585|FG001|Overall Study|Lost to Follow-up|8|||
125244584|NCT00724503|450518584|FG000|Overall Study|Withdrawal by Subject|11|||
125244585|NCT00724503|450518585|FG001|Overall Study|Withdrawal by Subject|23|||
125244586|NCT00724503|450518584|FG000|Overall Study|Death|190|||
125244587|NCT00724503|450518585|FG001|Overall Study|Death|182|||
125244588|NCT00724503|450518584|FG000|Overall Study|Adverse Event|1|||
125244589|NCT00724503|450518585|FG001|Overall Study|Adverse Event|0|||
125244590|NCT00724503|450518584|FG000|Overall Study|Not otherwise specified|4|||
125244591|NCT00724503|450518585|FG001|Overall Study|Not otherwise specified|7|||
125244592|NCT01186419|450518586|FG000|Overall Study|Withdrawal by Subject|5|||
125191443|NCT00529373|450322505|FG001|First Extension Study|Physician Decision|45|||
125191444|NCT00529373|450322504|FG000|First Extension Study|Protocol Violation|16|||
125191445|NCT00529373|450322505|FG001|First Extension Study|Protocol Violation|13|||
125191446|NCT00529373|450322504|FG000|First Extension Study|Withdrawal by Subject|296|||
125191447|NCT00529373|450322505|FG001|First Extension Study|Withdrawal by Subject|287|||
125191448|NCT00529373|450322504|FG000|First Extension Study|Disposition record non-existing|0|||
125191449|NCT00529373|450322505|FG001|First Extension Study|Disposition record non-existing|1|||
125191450|NCT00529373|450322504|FG000|First Extension Study|Discontinued after 5 years completion|208|||
125191451|NCT00529373|450322505|FG001|First Extension Study|Discontinued after 5 years completion|346|||
125191452|NCT00529373|450322504|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
125191453|NCT00529373|450322505|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
125191454|NCT00529373|450322504|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
125191455|NCT00529373|450322505|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
125191456|NCT00529373|450322504|FG000|Second Extension Study|Adverse Event|101|||
125191457|NCT00529373|450322505|FG001|Second Extension Study|Adverse Event|51|||
125191458|NCT00529373|450322504|FG000|Second Extension Study|Lack of Efficacy|7|||
125191459|NCT00529373|450322505|FG001|Second Extension Study|Lack of Efficacy|15|||
125191460|NCT00529373|450322504|FG000|Second Extension Study|Lost to Follow-up|18|||
125191461|NCT00529373|450322505|FG001|Second Extension Study|Lost to Follow-up|12|||
125191462|NCT00529373|450322504|FG000|Second Extension Study|Other|7|||
125191463|NCT00529373|450322505|FG001|Second Extension Study|Other|12|||
125191464|NCT00529373|450322504|FG000|Second Extension Study|Physician Decision|63|||
125191465|NCT00529373|450322505|FG001|Second Extension Study|Physician Decision|26|||
125191466|NCT00529373|450322504|FG000|Second Extension Study|Protocol Violation|2|||
125191467|NCT00529373|450322505|FG001|Second Extension Study|Protocol Violation|1|||
125191468|NCT00529373|450322504|FG000|Second Extension Study|Withdrawal by Subject|97|||
125191469|NCT00529373|450322505|FG001|Second Extension Study|Withdrawal by Subject|75|||
125191470|NCT00529373|450322504|FG000|Second Extension Study|Status Missing|5|||
125191471|NCT00529373|450322505|FG001|Second Extension Study|Status Missing|5|||
125191472|NCT01863667|450322512|FG000|Overall Study|Adverse Event|1|||
125191473|NCT01863667|450322513|FG001|Overall Study|Adverse Event|0|||
125191474|NCT01863667|450322512|FG000|Overall Study|Study terminated by Sponsor|30|||
125191475|NCT01863667|450322513|FG001|Overall Study|Study terminated by Sponsor|30|||
125191476|NCT01863667|450322512|FG000|Overall Study|Withdrawal by Subject|2|||
125191477|NCT01863667|450322513|FG001|Overall Study|Withdrawal by Subject|2|||
125191478|NCT03627546|450322514|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
125191479|NCT03627546|450322515|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
125191480|NCT03627546|450322516|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
125191481|NCT03627546|450322514|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
125191482|NCT03627546|450322515|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
125191483|NCT03627546|450322516|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
125191484|NCT02965573|450322519|FG000|Overall Study|Lack of Efficacy|1|||
125191485|NCT02965573|450322520|FG001|Overall Study|Lack of Efficacy|0|||
125191486|NCT00315458|450322521|FG000|Overall Study|Administrative|0|||
125191487|NCT00315458|450322522|FG001|Overall Study|Administrative|3|||
125191488|NCT00315458|450322523|FG002|Overall Study|Administrative|8|||
125191489|NCT00315458|450322524|FG003|Overall Study|Administrative|21|||
125191490|NCT00315458|450322521|FG000|Overall Study|Adverse Event|2|||
125191491|NCT00315458|450322522|FG001|Overall Study|Adverse Event|4|||
125191492|NCT00315458|450322523|FG002|Overall Study|Adverse Event|23|||
125191493|NCT00315458|450322524|FG003|Overall Study|Adverse Event|3|||
125191494|NCT00315458|450322521|FG000|Overall Study|Lost to Follow-up|1|||
125191495|NCT00315458|450322522|FG001|Overall Study|Lost to Follow-up|2|||
125191496|NCT00315458|450322523|FG002|Overall Study|Lost to Follow-up|0|||
125191497|NCT00315458|450322524|FG003|Overall Study|Lost to Follow-up|2|||
125191498|NCT00315458|450322521|FG000|Overall Study|Withdrawal by Subject|0|||
125191499|NCT00315458|450322522|FG001|Overall Study|Withdrawal by Subject|3|||
125191500|NCT00315458|450322523|FG002|Overall Study|Withdrawal by Subject|0|||
125191501|NCT00315458|450322524|FG003|Overall Study|Withdrawal by Subject|2|||
125191502|NCT00315458|450322521|FG000|Overall Study|Lack of Efficacy|0|||
125191503|NCT00315458|450322522|FG001|Overall Study|Lack of Efficacy|0|||
125191504|NCT00315458|450322523|FG002|Overall Study|Lack of Efficacy|20|||
125191505|NCT00315458|450322524|FG003|Overall Study|Lack of Efficacy|1|||
125191506|NCT00315458|450322521|FG000|Overall Study|Did not qualify|0|||
125191507|NCT00315458|450322522|FG001|Overall Study|Did not qualify|0|||
125191508|NCT00315458|450322523|FG002|Overall Study|Did not qualify|1|||
125191509|NCT00315458|450322524|FG003|Overall Study|Did not qualify|0|||
125191510|NCT00987337|450322525|FG000|Overall Study|Adverse Event|10|||
125191511|NCT00987337|450322526|FG001|Overall Study|Adverse Event|9|||
125191512|NCT00987337|450322527|FG002|Overall Study|Adverse Event|8|||
125191513|NCT00987337|450322525|FG000|Overall Study|Insufficient Virologic Response|10|||
125191514|NCT00987337|450322526|FG001|Overall Study|Insufficient Virologic Response|7|||
125191515|NCT00987337|450322527|FG002|Overall Study|Insufficient Virologic Response|12|||
125191516|NCT00987337|450322525|FG000|Overall Study|Virologic Breakthrough|2|||
125191517|NCT00987337|450322526|FG001|Overall Study|Virologic Breakthrough|2|||
125191518|NCT00987337|450322527|FG002|Overall Study|Virologic Breakthrough|8|||
125191519|NCT00987337|450322525|FG000|Overall Study|Lost to Follow-up|10|||
125191520|NCT00987337|450322526|FG001|Overall Study|Lost to Follow-up|6|||
125191521|NCT00987337|450322527|FG002|Overall Study|Lost to Follow-up|2|||
125191522|NCT00987337|450322525|FG000|Overall Study|Withdrawal by Subject|6|||
125191523|NCT00987337|450322526|FG001|Overall Study|Withdrawal by Subject|9|||
125191524|NCT00987337|450322527|FG002|Overall Study|Withdrawal by Subject|9|||
125191525|NCT00987337|450322525|FG000|Overall Study|Other|0|||
125191526|NCT00987337|450322526|FG001|Overall Study|Other|2|||
125191527|NCT00987337|450322527|FG002|Overall Study|Other|5|||
125191528|NCT00987337|450322525|FG000|Overall Study|Protocol Violation|1|||
125191529|NCT00987337|450322526|FG001|Overall Study|Protocol Violation|0|||
125191530|NCT00987337|450322527|FG002|Overall Study|Protocol Violation|2|||
125191531|NCT00987337|450322525|FG000|Overall Study|Participant Relapsed|18|||
125191532|NCT00987337|450322526|FG001|Overall Study|Participant Relapsed|20|||
125191533|NCT00987337|450322527|FG002|Overall Study|Participant Relapsed|5|||
125191534|NCT00086619|450322529|FG000|Overall Study|Withdrawal by Subject|6|||
125191535|NCT00086619|450322530|FG001|Overall Study|Withdrawal by Subject|6|||
125191536|NCT00086619|450322529|FG000|Overall Study|Adverse Event|8|||
125191537|NCT00086619|450322530|FG001|Overall Study|Adverse Event|10|||
125191538|NCT00086619|450322529|FG000|Overall Study|Protocol Violation|1|||
125244593|NCT01186419|450518587|FG001|Overall Study|Withdrawal by Subject|3|||
125191539|NCT00086619|450322530|FG001|Overall Study|Protocol Violation|1|||
125244594|NCT01186419|450518586|FG000|Overall Study|Adverse Event|1|||
125244595|NCT01186419|450518587|FG001|Overall Study|Adverse Event|2|||
125244596|NCT01186419|450518586|FG000|Overall Study|Physician Decision|0|||
125244597|NCT01186419|450518587|FG001|Overall Study|Physician Decision|3|||
125244598|NCT01186419|450518586|FG000|Overall Study|Other|1|||
125244599|NCT01186419|450518587|FG001|Overall Study|Other|1|||
125244600|NCT01937117|450518588|FG000|Overall Study|Disease Progression|7|||
125244601|NCT01937117|450518588|FG000|Overall Study|Physician Decision|4|||
125244602|NCT01937117|450518588|FG000|Overall Study|Adverse Event|2|||
125244603|NCT01179399|450518589|FG000|Overall Study|Adverse Event|1|||
125244604|NCT01179399|450518589|FG000|Overall Study|Lack of Efficacy|30|||
125244605|NCT01179399|450518589|FG000|Overall Study|Withdrawal by Subject|1|||
125244606|NCT03921541|450520075|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
125244607|NCT03921541|450520076|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
125244608|NCT01653262|450520077|FG000|Overall Study|Lack of Efficacy|1|||
125244609|NCT01653262|450520077|FG000|Overall Study|SAE, non-fatal|1|||
125244610|NCT01653262|450520077|FG000|Overall Study|AE, non-serious non-fatal|1|||
125244611|NCT00420407|450520079|FG000|Overall Study|Lost to Follow-up|0|||
125244612|NCT00420407|450520080|FG001|Overall Study|Lost to Follow-up|3|||
125244613|NCT00420407|450520079|FG000|Overall Study|Physician Decision|2|||
125244614|NCT00420407|450520080|FG001|Overall Study|Physician Decision|1|||
125244615|NCT00420407|450520079|FG000|Overall Study|subject identified as detainee|1|||
125244616|NCT00420407|450520080|FG001|Overall Study|subject identified as detainee|0|||
125244617|NCT00420407|450520079|FG000|Overall Study|subject identified as Jehovah's witness|1|||
125244618|NCT00420407|450520080|FG001|Overall Study|subject identified as Jehovah's witness|0|||
125244619|NCT00420407|450520079|FG000|Overall Study|Withdrawal by Subject|0|||
125244620|NCT00420407|450520080|FG001|Overall Study|Withdrawal by Subject|2|||
125244621|NCT02724644|450520082|FG000|Overall Study|Adverse Event|7|||
125244622|NCT02724644|450520083|FG001|Overall Study|Adverse Event|1|||
125244623|NCT02724644|450520082|FG000|Overall Study|Lost to Follow-up|6|||
125244624|NCT02724644|450520083|FG001|Overall Study|Lost to Follow-up|2|||
125244625|NCT02724644|450520082|FG000|Overall Study|Withdrawal by Subject|7|||
125244626|NCT02724644|450520083|FG001|Overall Study|Withdrawal by Subject|1|||
125244627|NCT02724644|450520082|FG000|Overall Study|Administrative|1|||
125244628|NCT02724644|450520083|FG001|Overall Study|Administrative|0|||
125244629|NCT01734928|450520084|FG000|Randomization|Physician Decision|0|||
125244630|NCT01734928|450520085|FG001|Randomization|Physician Decision|1|||
125244631|NCT01734928|450520084|FG000|Randomization|clinical progression|0|||
125244632|NCT01734928|450520085|FG001|Randomization|clinical progression|1|||
125244633|NCT01734928|450520084|FG000|Randomization|progressive disease|0|||
125244634|NCT01734928|450520085|FG001|Randomization|progressive disease|2|||
125244635|NCT01734928|450520084|FG000|Randomization|Withdrew informed consent|0|||
125244636|NCT01734928|450520085|FG001|Randomization|Withdrew informed consent|4|||
125244637|NCT01734928|450520084|FG000|Randomization|Death|1|||
125244638|NCT01734928|450520085|FG001|Randomization|Death|0|||
125244639|NCT01734928|450520084|FG000|Randomization|Randomization error|1|||
125244640|NCT01734928|450520085|FG001|Randomization|Randomization error|0|||
125244641|NCT01734928|450520084|FG000|Randomization|Lost to Follow-up|1|||
125244642|NCT01734928|450520085|FG001|Randomization|Lost to Follow-up|0|||
125244643|NCT01734928|450520084|FG000|Treatment Period|Lost to Follow-up|0|||
125244644|NCT01734928|450520085|FG001|Treatment Period|Lost to Follow-up|2|||
125244645|NCT01734928|450520084|FG000|Treatment Period|Progressive Disease|167|||
125244646|NCT01734928|450520085|FG001|Treatment Period|Progressive Disease|165|||
125244647|NCT01734928|450520084|FG000|Treatment Period|Adverse Event|39|||
125244648|NCT01734928|450520085|FG001|Treatment Period|Adverse Event|52|||
125244649|NCT01734928|450520084|FG000|Treatment Period|Withdrawal of Consent|25|||
125244650|NCT01734928|450520085|FG001|Treatment Period|Withdrawal of Consent|22|||
125244651|NCT01734928|450520084|FG000|Treatment Period|Death|20|||
125244652|NCT01734928|450520085|FG001|Treatment Period|Death|9|||
125244653|NCT01734928|450520084|FG000|Treatment Period|Other Reasons|27|||
125244654|NCT01734928|450520085|FG001|Treatment Period|Other Reasons|19|||
125244655|NCT01734928|450520084|FG000|Treatment Period|Pregnancy|0|||
125244656|NCT01734928|450520085|FG001|Treatment Period|Pregnancy|1|||
125191540|NCT00489918|450322531|FG000|Overall Study|Withdrawal by Subject|2|||
125191541|NCT00489918|450322532|FG001|Overall Study|Withdrawal by Subject|1|||
125191542|NCT00489918|450322533|FG002|Overall Study|Withdrawal by Subject|1|||
125191543|NCT00489918|450322534|FG003|Overall Study|Withdrawal by Subject|0|||
125191544|NCT00489918|450322535|FG004|Overall Study|Withdrawal by Subject|1|||
125191545|NCT00489918|450322531|FG000|Overall Study|Adverse Event|0|||
125191546|NCT00489918|450322532|FG001|Overall Study|Adverse Event|1|||
125191547|NCT00489918|450322533|FG002|Overall Study|Adverse Event|1|||
125191548|NCT00489918|450322534|FG003|Overall Study|Adverse Event|0|||
125191549|NCT00489918|450322535|FG004|Overall Study|Adverse Event|0|||
125191550|NCT00489918|450322531|FG000|Overall Study|Lost to Follow-up|0|||
125191551|NCT00489918|450322532|FG001|Overall Study|Lost to Follow-up|0|||
125191552|NCT00489918|450322533|FG002|Overall Study|Lost to Follow-up|1|||
125191553|NCT00489918|450322534|FG003|Overall Study|Lost to Follow-up|1|||
125191554|NCT00489918|450322535|FG004|Overall Study|Lost to Follow-up|0|||
125191555|NCT00489918|450322531|FG000|Overall Study|Physician Decision|0|||
125191556|NCT00489918|450322532|FG001|Overall Study|Physician Decision|0|||
125191557|NCT00489918|450322533|FG002|Overall Study|Physician Decision|1|||
125191558|NCT00489918|450322534|FG003|Overall Study|Physician Decision|0|||
125191559|NCT00489918|450322535|FG004|Overall Study|Physician Decision|0|||
125191560|NCT01209520|450322536|FG000|Overall Study|Withdrawal by Subject|3|||
125191561|NCT00961350|450322537|FG000|Overall Study|Adverse Event|18|||
125191562|NCT00961350|450322538|FG001|Overall Study|Adverse Event|33|||
125191563|NCT00961350|450322537|FG000|Overall Study|Withdrawal by Subject|10|||
125191564|NCT00961350|450322538|FG001|Overall Study|Withdrawal by Subject|10|||
125191565|NCT00961350|450322537|FG000|Overall Study|Lost to Follow-up|3|||
125191566|NCT00961350|450322538|FG001|Overall Study|Lost to Follow-up|3|||
125191567|NCT00961350|450322537|FG000|Overall Study|Misc|16|||
125191568|NCT00961350|450322538|FG001|Overall Study|Misc|21|||
125191569|NCT02134015|450322539|FG000|Overall Study|Protocol Violation|0|||
125191570|NCT02134015|450322540|FG001|Overall Study|Protocol Violation|1|||
125191571|NCT02134015|450322539|FG000|Overall Study|Death|2|||
125191572|NCT02134015|450322540|FG001|Overall Study|Death|1|||
125191573|NCT02134015|450322539|FG000|Overall Study|Reason not provided|1|||
125191574|NCT02134015|450322540|FG001|Overall Study|Reason not provided|2|||
125191575|NCT02134015|450322539|FG000|Overall Study|Clinical progression|14|||
125191576|NCT02134015|450322540|FG001|Overall Study|Clinical progression|7|||
125191577|NCT02134015|450322539|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
125191578|NCT02134015|450322540|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
125191579|NCT02134015|450322539|FG000|Overall Study|Study terminated by sponsor|2|||
125191580|NCT02134015|450322540|FG001|Overall Study|Study terminated by sponsor|3|||
125191581|NCT02134015|450322539|FG000|Overall Study|Adverse Event|9|||
125191582|NCT02134015|450322540|FG001|Overall Study|Adverse Event|10|||
125191583|NCT02134015|450322539|FG000|Overall Study|Withdrawal by Subject|3|||
125191584|NCT02134015|450322540|FG001|Overall Study|Withdrawal by Subject|7|||
125191585|NCT00326716|450324232|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
125191586|NCT00326716|450324233|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
125191587|NCT00326716|450324234|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
125191588|NCT00326716|450324235|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
125191589|NCT00684411|450324236|FG000|Overall Study|New Primary Cancer|1|||
125191590|NCT00684411|450324236|FG000|Overall Study|Disease Progression|10|||
125191591|NCT00684411|450324236|FG000|Overall Study|Adverse Event|1|||
125191592|NCT05253573|450324237|FG000|Overall Study|Death|1|||
125191593|NCT05253573|450324238|FG001|Overall Study|Death|0|||
125191594|NCT06098339|450324239|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
125191595|NCT06098339|450324240|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
125191596|NCT06098339|450324239|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
125191597|NCT06098339|450324240|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
125191598|NCT04134767|450324241|FG000|Overall Study|Death|0|||
125191599|NCT04134767|450324242|FG001|Overall Study|Death|1|||
125191600|NCT04134767|450324241|FG000|Overall Study|Removed for harassing staff|0|||
125191601|NCT04134767|450324242|FG001|Overall Study|Removed for harassing staff|1|||
125191602|NCT04134767|450324241|FG000|Overall Study|Lost to Follow-up|44|||
125191603|NCT04134767|450324242|FG001|Overall Study|Lost to Follow-up|40|||
125191604|NCT02276560|450324243|FG000|Overall Study|Adverse Event|1|||
125191605|NCT02276560|450324244|FG001|Overall Study|Adverse Event|0|||
125191606|NCT02276560|450324245|FG002|Overall Study|Adverse Event|0|||
125191607|NCT00300885|450324246|FG000|Treatment|Adverse Event|134|||
125191608|NCT00300885|450324247|FG001|Treatment|Adverse Event|82|||
125191609|NCT00300885|450324246|FG000|Treatment|Death|20|||
125191610|NCT00300885|450324247|FG001|Treatment|Death|7|||
125191611|NCT00300885|450324246|FG000|Treatment|Lack of Efficacy|1|||
125191612|NCT00300885|450324247|FG001|Treatment|Lack of Efficacy|1|||
125191613|NCT00300885|450324246|FG000|Treatment|Lost to Follow-up|3|||
125191614|NCT00300885|450324247|FG001|Treatment|Lost to Follow-up|2|||
125191615|NCT00300885|450324246|FG000|Treatment|Physician Decision|4|||
125191616|NCT00300885|450324247|FG001|Treatment|Physician Decision|5|||
125191617|NCT00300885|450324246|FG000|Treatment|Protocol Violation|11|||
125191618|NCT00300885|450324247|FG001|Treatment|Protocol Violation|11|||
125191619|NCT00300885|450324246|FG000|Treatment|Withdrawal by Subject|26|||
125191620|NCT00300885|450324247|FG001|Treatment|Withdrawal by Subject|23|||
125191621|NCT00300885|450324246|FG000|Treatment|Disease progression|171|||
125191622|NCT00300885|450324247|FG001|Treatment|Disease progression|238|||
125191623|NCT00300885|450324246|FG000|Treatment|Random code broken (subject died)|0|||
125191624|NCT00300885|450324247|FG001|Treatment|Random code broken (subject died)|1|||
125191625|NCT00300885|450324246|FG000|Treatment|Non-compliant with study medication|3|||
125191626|NCT00300885|450324247|FG001|Treatment|Non-compliant with study medication|4|||
125191627|NCT00300885|450324246|FG000|Follow-up|Death|141|||
125191628|NCT00300885|450324247|FG001|Follow-up|Death|163|||
125191629|NCT00300885|450324246|FG000|Follow-up|Lost to Follow-up|11|||
125191630|NCT00300885|450324247|FG001|Follow-up|Lost to Follow-up|7|||
125191631|NCT00300885|450324246|FG000|Follow-up|Withdrawal by Subject|26|||
125191632|NCT00300885|450324247|FG001|Follow-up|Withdrawal by Subject|25|||
125191633|NCT02582242|450324248|FG000|Overall Study|Adverse Event|4|||
125191634|NCT02582242|450324249|FG001|Overall Study|Adverse Event|3|||
125191635|NCT02582242|450324248|FG000|Overall Study|Protocol Violation|3|||
125191636|NCT02582242|450324249|FG001|Overall Study|Protocol Violation|1|||
125191637|NCT02582242|450324248|FG000|Overall Study|Lost to Follow-up|0|||
125191638|NCT02582242|450324249|FG001|Overall Study|Lost to Follow-up|1|||
125191639|NCT02582242|450324248|FG000|Overall Study|Withdrawal by Subject|11|||
125191640|NCT02582242|450324249|FG001|Overall Study|Withdrawal by Subject|11|||
125191641|NCT02582242|450324248|FG000|Overall Study|Unclassified|2|||
125191642|NCT02582242|450324249|FG001|Overall Study|Unclassified|1|||
125191643|NCT00459290|450324253|FG000|Overall Study|Adverse Event|3|||
125191644|NCT00459290|450324253|FG000|Overall Study|Ineligible|2|||
125244657|NCT01778985|450520086|FG000|Overall Study|Lost to Follow-up|1|||
125244658|NCT01778985|450520087|FG001|Overall Study|Lost to Follow-up|0|||
125244659|NCT01778985|450520086|FG000|Overall Study|Physician Decision|2|||
125244660|NCT01778985|450520087|FG001|Overall Study|Physician Decision|2|||
125244661|NCT01778985|450520086|FG000|Overall Study|Protocol Violation|4|||
125244662|NCT01778985|450520087|FG001|Overall Study|Protocol Violation|1|||
125244663|NCT01631188|450520093|FG000|Overall Study|Physician Decision|75|||
125244664|NCT03600350|450520094|FG000|Overall Study|Death|1|||
125244665|NCT03600350|450520094|FG000|Overall Study|On Follow Up|18|||
125244666|NCT03684057|450520095|FG000|Overall Study|Withdrawal by Subject|4|||
125244667|NCT03684057|450520096|FG001|Overall Study|Withdrawal by Subject|5|||
125244668|NCT01105130|450520097|FG000|Overall Study|Withdrawal by Subject|4|||
125244669|NCT01105130|450520098|FG001|Overall Study|Withdrawal by Subject|6|||
125244670|NCT01105130|450520099|FG002|Overall Study|Withdrawal by Subject|2|||
125244671|NCT01105130|450520097|FG000|Overall Study|Never Started|2|||
125244672|NCT01105130|450520098|FG001|Overall Study|Never Started|2|||
125244673|NCT01105130|450520099|FG002|Overall Study|Never Started|4|||
125244674|NCT01105130|450520097|FG000|Overall Study|Toxicity|1|||
125244675|NCT01105130|450520098|FG001|Overall Study|Toxicity|3|||
125244676|NCT01105130|450520099|FG002|Overall Study|Toxicity|2|||
125244677|NCT01105130|450520097|FG000|Overall Study|Multiple Reasons|3|||
125244678|NCT01105130|450520098|FG001|Overall Study|Multiple Reasons|0|||
125244679|NCT01105130|450520099|FG002|Overall Study|Multiple Reasons|2|||
125244680|NCT01363440|450520102|FG000|Overall Study|Adverse Event|5|||
125244681|NCT01363440|450520103|FG001|Overall Study|Adverse Event|4|||
125244682|NCT01363440|450520104|FG002|Overall Study|Adverse Event|4|||
125244683|NCT01363440|450520102|FG000|Overall Study|Death|3|||
125244684|NCT01363440|450520103|FG001|Overall Study|Death|7|||
125244685|NCT01363440|450520104|FG002|Overall Study|Death|5|||
125244686|NCT01363440|450520102|FG000|Overall Study|Withdrawal by Subject|9|||
125244687|NCT01363440|450520103|FG001|Overall Study|Withdrawal by Subject|11|||
125244688|NCT01363440|450520104|FG002|Overall Study|Withdrawal by Subject|11|||
125244689|NCT01363440|450520102|FG000|Overall Study|Lost to Follow-up|2|||
125244690|NCT01363440|450520103|FG001|Overall Study|Lost to Follow-up|4|||
125244691|NCT01363440|450520104|FG002|Overall Study|Lost to Follow-up|5|||
125244692|NCT01363440|450520102|FG000|Overall Study|Other|4|||
125244693|NCT01363440|450520103|FG001|Overall Study|Other|5|||
125244694|NCT01363440|450520104|FG002|Overall Study|Other|2|||
125244695|NCT02323334|450520105|FG000|Period 3|Lost to Follow-up|0|||
125244696|NCT02323334|450520106|FG001|Period 3|Lost to Follow-up|0|||
125244697|NCT02323334|450520107|FG002|Period 3|Lost to Follow-up|1|||
125244698|NCT02323334|450520108|FG003|Period 3|Lost to Follow-up|0|||
125244699|NCT02323334|450520109|FG004|Period 3|Lost to Follow-up|0|||
125244700|NCT02323334|450520110|FG005|Period 3|Lost to Follow-up|0|||
125244701|NCT02323334|450520111|FG006|Period 3|Lost to Follow-up|0|||
125244702|NCT02323334|450520112|FG007|Period 3|Lost to Follow-up|0|||
125244703|NCT02323334|450520113|FG008|Period 3|Lost to Follow-up|0|||
125244704|NCT02323334|450520114|FG009|Period 3|Lost to Follow-up|0|||
125244705|NCT02323334|450520115|FG010|Period 3|Lost to Follow-up|0|||
125244706|NCT02323334|450520116|FG011|Period 3|Lost to Follow-up|0|||
125244707|NCT02323334|450520117|FG012|Period 3|Lost to Follow-up|0|||
125244708|NCT02323334|450520118|FG013|Period 3|Lost to Follow-up|0|||
125244709|NCT02323334|450520119|FG014|Period 3|Lost to Follow-up|0|||
125244710|NCT02323334|450520120|FG015|Period 3|Lost to Follow-up|0|||
125244711|NCT02323334|450520121|FG016|Period 3|Lost to Follow-up|0|||
125244712|NCT02323334|450520105|FG000|Period 3|Withdrawal by Subject|1|||
125244713|NCT02323334|450520106|FG001|Period 3|Withdrawal by Subject|0|||
125244714|NCT02323334|450520107|FG002|Period 3|Withdrawal by Subject|0|||
125244715|NCT02323334|450520108|FG003|Period 3|Withdrawal by Subject|0|||
125244716|NCT02323334|450520109|FG004|Period 3|Withdrawal by Subject|0|||
125244717|NCT02323334|450520110|FG005|Period 3|Withdrawal by Subject|0|||
125244718|NCT02323334|450520111|FG006|Period 3|Withdrawal by Subject|0|||
125244719|NCT02323334|450520112|FG007|Period 3|Withdrawal by Subject|0|||
125244720|NCT02323334|450520113|FG008|Period 3|Withdrawal by Subject|0|||
125244721|NCT02323334|450520114|FG009|Period 3|Withdrawal by Subject|0|||
125244722|NCT02323334|450520115|FG010|Period 3|Withdrawal by Subject|0|||
125244723|NCT02323334|450520116|FG011|Period 3|Withdrawal by Subject|0|||
125244724|NCT02323334|450520117|FG012|Period 3|Withdrawal by Subject|0|||
125244725|NCT02323334|450520118|FG013|Period 3|Withdrawal by Subject|0|||
125244726|NCT02323334|450520119|FG014|Period 3|Withdrawal by Subject|0|||
125244727|NCT02323334|450520120|FG015|Period 3|Withdrawal by Subject|0|||
125244728|NCT02323334|450520121|FG016|Period 3|Withdrawal by Subject|0|||
125244729|NCT01129284|450520123|FG000|Overall Study|Adverse Event|2|||
125244730|NCT01129284|450520124|FG001|Overall Study|Adverse Event|0|||
125244731|NCT01129284|450520125|FG002|Overall Study|Adverse Event|1|||
125244732|NCT01625182|450520126|FG000|Overall Study|Administrative problems|1|||
125244733|NCT01625182|450520127|FG001|Overall Study|Administrative problems|0|||
125244734|NCT01625182|450520126|FG000|Overall Study|Protocol deviation|0|||
125244735|NCT01625182|450520127|FG001|Overall Study|Protocol deviation|2|||
125244736|NCT01625182|450520126|FG000|Overall Study|Adverse Event|2|||
125244737|NCT01625182|450520127|FG001|Overall Study|Adverse Event|0|||
125244738|NCT01625182|450520126|FG000|Overall Study|Withdrawal by Subject|5|||
125244739|NCT01625182|450520127|FG001|Overall Study|Withdrawal by Subject|1|||
125244740|NCT01625182|450520126|FG000|Overall Study|Lack of Efficacy|12|||
125244741|NCT01625182|450520127|FG001|Overall Study|Lack of Efficacy|8|||
125244742|NCT00447278|450520130|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
125244743|NCT00447278|450520131|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
125244744|NCT00447278|450520130|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
125244745|NCT00447278|450520131|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
125244746|NCT00447278|450520130|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
125244747|NCT00447278|450520131|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
125244748|NCT00447278|450520130|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
125244749|NCT00447278|450520131|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
125244750|NCT00447278|450520130|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
125244751|NCT00447278|450520131|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
125244752|NCT00447278|450520130|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
125244753|NCT00447278|450520131|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
125244754|NCT00447278|450520130|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
125244755|NCT00447278|450520131|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
125244756|NCT00447278|450520130|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
125191645|NCT02366637|450324254|FG000|First Intervention Period|Adverse Event|0|||
125191646|NCT02366637|450324255|FG001|First Intervention Period|Adverse Event|1|||
125191647|NCT02366637|450324254|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
125191648|NCT02366637|450324255|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
125191649|NCT02366637|450324254|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
125191650|NCT02366637|450324255|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
125191651|NCT02309411|450324256|FG000|Overall Study|Physician Decision|1|||
125191652|NCT02309411|450324257|FG001|Overall Study|Physician Decision|0|||
125191653|NCT02309411|450324258|FG002|Overall Study|Physician Decision|0|||
125191654|NCT02309411|450324256|FG000|Overall Study|Withdrawal by Subject|1|||
125191655|NCT02309411|450324257|FG001|Overall Study|Withdrawal by Subject|1|||
125191656|NCT02309411|450324258|FG002|Overall Study|Withdrawal by Subject|0|||
125191657|NCT00839800|450324261|FG000|Overall Study|Adverse Event|8|||
125191658|NCT00839800|450324262|FG001|Overall Study|Adverse Event|12|||
125191659|NCT00839800|450324261|FG000|Overall Study|Lost to Follow-up|31|||
125191660|NCT00839800|450324262|FG001|Overall Study|Lost to Follow-up|26|||
125191661|NCT00839800|450324261|FG000|Overall Study|Withdrawal by Subject|28|||
125191662|NCT00839800|450324262|FG001|Overall Study|Withdrawal by Subject|34|||
125191663|NCT00839800|450324261|FG000|Overall Study|Incorrect Enrolment|3|||
125191664|NCT00839800|450324262|FG001|Overall Study|Incorrect Enrolment|3|||
125191665|NCT00839800|450324261|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
125191666|NCT00839800|450324262|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
125191667|NCT00839800|450324261|FG000|Overall Study|Safety Reasons|2|||
125191668|NCT00839800|450324262|FG001|Overall Study|Safety Reasons|1|||
125191669|NCT00839800|450324261|FG000|Overall Study|Other|8|||
125191670|NCT00839800|450324262|FG001|Overall Study|Other|14|||
125191671|NCT00839800|450324261|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
125191672|NCT00839800|450324262|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
125191673|NCT02510664|450324265|FG000|Overall Study|Transferred Care|9|||
125191674|NCT02510664|450324266|FG001|Overall Study|Transferred Care|9|||
125191675|NCT02510664|450324267|FG002|Overall Study|Transferred Care|0|||
125191676|NCT02510664|450324265|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
125191677|NCT02510664|450324266|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
125191678|NCT02510664|450324267|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
125191679|NCT02510664|450324265|FG000|Overall Study|Time Constraints|1|||
125191680|NCT02510664|450324266|FG001|Overall Study|Time Constraints|1|||
125191681|NCT02510664|450324267|FG002|Overall Study|Time Constraints|0|||
125191682|NCT06110494|450324270|FG000|Overall Study|Protocol Violation|2|||
125191683|NCT06110494|450324271|FG001|Overall Study|Protocol Violation|0|||
125191684|NCT06110494|450324272|FG002|Overall Study|Protocol Violation|1|||
125191685|NCT06110494|450324270|FG000|Overall Study|Dixon's test for outlier analysis|1|||
125191686|NCT06110494|450324271|FG001|Overall Study|Dixon's test for outlier analysis|1|||
125191687|NCT06110494|450324272|FG002|Overall Study|Dixon's test for outlier analysis|0|||
125191688|NCT02914613|450324277|FG000|Overall Study|Withdrawal by Subject|1|||
125191689|NCT02914613|450324278|FG001|Overall Study|Withdrawal by Subject|2|||
125191690|NCT02914613|450324277|FG000|Overall Study|Adverse Event|1|||
125244757|NCT00447278|450520131|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
125244758|NCT00447278|450520130|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
125244759|NCT00447278|450520131|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
125191691|NCT02914613|450324278|FG001|Overall Study|Adverse Event|0|||
125191692|NCT03850496|450324289|FG000|Overall Study|Withdrawal by Subject|1|||
125244760|NCT00447278|450520130|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
125244761|NCT00447278|450520131|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
125244762|NCT00447278|450520130|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
125244763|NCT00447278|450520131|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
125244764|NCT00447278|450520130|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
125244765|NCT00447278|450520131|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
125244766|NCT00447278|450520130|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
125244767|NCT00447278|450520131|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
125244768|NCT00447278|450520130|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
125244769|NCT00447278|450520131|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
125244770|NCT05427916|450520135|FG000|Overall Study|Adverse Event|3|||
125244771|NCT05427916|450520136|FG001|Overall Study|Adverse Event|0|||
125244772|NCT05427916|450520135|FG000|Overall Study|Lack of Efficacy|6|||
125244773|NCT05427916|450520136|FG001|Overall Study|Lack of Efficacy|0|||
125244774|NCT05427916|450520135|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
125244775|NCT05427916|450520136|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
125244776|NCT03558672|450520137|FG000|Overall Study|Study Early Termination|10|||
125244777|NCT01158404|450520145|FG000|Overall Study|Withdrawal by Subject|0|||
125244778|NCT01158404|450520146|FG001|Overall Study|Withdrawal by Subject|1|||
125244779|NCT01158404|450520147|FG002|Overall Study|Withdrawal by Subject|0|||
125244780|NCT01158404|450520148|FG003|Overall Study|Withdrawal by Subject|0|||
125244781|NCT01158404|450520149|FG004|Overall Study|Withdrawal by Subject|3|||
125244782|NCT01158404|450520150|FG005|Overall Study|Withdrawal by Subject|1|||
125244783|NCT01158404|450520151|FG006|Overall Study|Withdrawal by Subject|0|||
125244784|NCT01158404|450520152|FG007|Overall Study|Withdrawal by Subject|1|||
125244785|NCT01158404|450520145|FG000|Overall Study|Physician Decision|0|||
125244786|NCT01158404|450520146|FG001|Overall Study|Physician Decision|0|||
125244787|NCT01158404|450520147|FG002|Overall Study|Physician Decision|0|||
125244788|NCT01158404|450520148|FG003|Overall Study|Physician Decision|0|||
125244789|NCT01158404|450520149|FG004|Overall Study|Physician Decision|0|||
125244790|NCT01158404|450520150|FG005|Overall Study|Physician Decision|0|||
125244791|NCT01158404|450520151|FG006|Overall Study|Physician Decision|0|||
125244792|NCT01158404|450520152|FG007|Overall Study|Physician Decision|1|||
125244793|NCT01158404|450520145|FG000|Overall Study|Progressive Disease|0|||
125244794|NCT01158404|450520146|FG001|Overall Study|Progressive Disease|0|||
125244795|NCT01158404|450520147|FG002|Overall Study|Progressive Disease|0|||
125244796|NCT01158404|450520148|FG003|Overall Study|Progressive Disease|0|||
125244797|NCT01158404|450520149|FG004|Overall Study|Progressive Disease|0|||
125244798|NCT01158404|450520150|FG005|Overall Study|Progressive Disease|0|||
125244799|NCT01158404|450520151|FG006|Overall Study|Progressive Disease|1|||
125244800|NCT01158404|450520152|FG007|Overall Study|Progressive Disease|0|||
125244801|NCT02384460|450520154|FG000|Overall Study|Protocol Violation|0|||
125244802|NCT02384460|450520155|FG001|Overall Study|Protocol Violation|1|||
125244803|NCT02384460|450520154|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
125244804|NCT02384460|450520155|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
125244805|NCT02384460|450520154|FG000|Overall Study|Adverse Event|5|||
125244806|NCT02384460|450520155|FG001|Overall Study|Adverse Event|2|||
125244807|NCT02384460|450520154|FG000|Overall Study|Withdrawal by Subject|0|||
125244808|NCT02384460|450520155|FG001|Overall Study|Withdrawal by Subject|3|||
125244809|NCT02384460|450520154|FG000|Overall Study|Elective medical treatment|1|||
125244810|NCT02384460|450520155|FG001|Overall Study|Elective medical treatment|0|||
125244811|NCT02384460|450520154|FG000|Overall Study|Non-compliance|1|||
125191693|NCT03850496|450324290|FG001|Overall Study|Withdrawal by Subject|0|||
125191694|NCT03850496|450324291|FG002|Overall Study|Withdrawal by Subject|0|||
125191695|NCT03850496|450324289|FG000|Overall Study|Lost to Follow-up|0|||
125191696|NCT03850496|450324290|FG001|Overall Study|Lost to Follow-up|1|||
125191697|NCT03850496|450324291|FG002|Overall Study|Lost to Follow-up|4|||
125191698|NCT03777436|450324292|FG000|Placebo-controlled Phase|Adverse Event|8|||
125191699|NCT03777436|450324293|FG001|Placebo-controlled Phase|Adverse Event|10|||
125191700|NCT03777436|450324294|FG002|Placebo-controlled Phase|Adverse Event|0|||
125191701|NCT03777436|450324292|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
125244812|NCT02384460|450520155|FG001|Overall Study|Non-compliance|0|||
125244813|NCT01060111|450520156|FG000|Overall Study|Adverse Event|9|||
125244814|NCT01060111|450520157|FG001|Overall Study|Adverse Event|5|||
125244815|NCT01060111|450520158|FG002|Overall Study|Adverse Event|18|||
125244816|NCT01060111|450520156|FG000|Overall Study|Lack of Efficacy|2|||
125244817|NCT01060111|450520157|FG001|Overall Study|Lack of Efficacy|1|||
125244818|NCT01060111|450520158|FG002|Overall Study|Lack of Efficacy|0|||
125244819|NCT01060111|450520156|FG000|Overall Study|Inappropriate participant|5|||
125244820|NCT01060111|450520157|FG001|Overall Study|Inappropriate participant|4|||
125244821|NCT01060111|450520158|FG002|Overall Study|Inappropriate participant|5|||
125244822|NCT01060111|450520156|FG000|Overall Study|Participants' evasion for hospital visit|0|||
125244823|NCT01060111|450520157|FG001|Overall Study|Participants' evasion for hospital visit|3|||
125244824|NCT01060111|450520158|FG002|Overall Study|Participants' evasion for hospital visit|2|||
125244825|NCT01060111|450520156|FG000|Overall Study|Participants' non-cooperation|8|||
125244826|NCT01060111|450520157|FG001|Overall Study|Participants' non-cooperation|6|||
125244827|NCT01060111|450520158|FG002|Overall Study|Participants' non-cooperation|6|||
125244828|NCT01060111|450520156|FG000|Overall Study|Adverse event and insufficient effect|0|||
125244829|NCT01060111|450520157|FG001|Overall Study|Adverse event and insufficient effect|1|||
125244830|NCT01060111|450520158|FG002|Overall Study|Adverse event and insufficient effect|0|||
125244831|NCT01060111|450520156|FG000|Overall Study|Participants' non-cooperation|1|||
125244832|NCT01060111|450520157|FG001|Overall Study|Participants' non-cooperation|0|||
125244833|NCT01060111|450520158|FG002|Overall Study|Participants' non-cooperation|0|||
125244834|NCT01060111|450520156|FG000|Overall Study|Other|2|||
125244835|NCT01060111|450520157|FG001|Overall Study|Other|3|||
125244836|NCT01060111|450520158|FG002|Overall Study|Other|4|||
125244837|NCT00997126|450520161|FG000|Overall Study|Physician Decision|7|||
125244838|NCT00997126|450520162|FG001|Overall Study|Physician Decision|11|||
125244839|NCT00896233|450520169|FG000|Overall Study|Claustrophobia during MRI|1|||
125244840|NCT04280562|450520170|FG000|Study|Adverse Event|2|||
125244841|NCT04280562|450520171|FG001|Study|Adverse Event|0|||
125244842|NCT04280562|450520170|FG000|Study|Lost to Follow-up|3|||
125244843|NCT04280562|450520171|FG001|Study|Lost to Follow-up|3|||
125244844|NCT02965456|450520172|FG000|Overall Study|Lost to Follow-up|40|||
125244845|NCT02965456|450520173|FG001|Overall Study|Lost to Follow-up|18|||
125244846|NCT02965456|450520172|FG000|Overall Study|Subject Request|22|||
125244847|NCT02965456|450520173|FG001|Overall Study|Subject Request|13|||
125244848|NCT02965456|450520172|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
125244849|NCT02965456|450520173|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
125244850|NCT02965456|450520172|FG000|Overall Study|Adverse Event|3|||
125244851|NCT02965456|450520173|FG001|Overall Study|Adverse Event|0|||
125244852|NCT02965456|450520172|FG000|Overall Study|Noncompliance with Study Drug|1|||
125244853|NCT02965456|450520173|FG001|Overall Study|Noncompliance with Study Drug|1|||
125244854|NCT02965456|450520172|FG000|Overall Study|Worsening Condition|0|||
125244855|NCT02965456|450520173|FG001|Overall Study|Worsening Condition|2|||
125244856|NCT02965456|450520172|FG000|Overall Study|Lack of Efficacy|1|||
125244857|NCT02965456|450520173|FG001|Overall Study|Lack of Efficacy|0|||
125244858|NCT02965456|450520172|FG000|Overall Study|Physician Decision|0|||
125244859|NCT02965456|450520173|FG001|Overall Study|Physician Decision|1|||
125244860|NCT02965456|450520172|FG000|Overall Study|Pregnancy|1|||
125244861|NCT02965456|450520173|FG001|Overall Study|Pregnancy|0|||
125244862|NCT02965456|450520172|FG000|Overall Study|Protocol Violation|0|||
125244863|NCT02965456|450520173|FG001|Overall Study|Protocol Violation|1|||
125244864|NCT02965456|450520172|FG000|Overall Study|Participant ran out of study drug|0|||
125244865|NCT02965456|450520173|FG001|Overall Study|Participant ran out of study drug|1|||
125244866|NCT02583477|450520174|FG000|Overall Study|Adverse Event|0|||
125244867|NCT02583477|450520175|FG001|Overall Study|Adverse Event|2|||
125244868|NCT02583477|450520174|FG000|Overall Study|Death|1|||
125244869|NCT02583477|450520175|FG001|Overall Study|Death|16|||
125244870|NCT02583477|450520174|FG000|Overall Study|Study terminated|2|||
125244871|NCT02583477|450520175|FG001|Overall Study|Study terminated|2|||
125244872|NCT01860404|450520180|FG000|Overall Study|Lost to Follow-up|3|||
125244873|NCT01860404|450520181|FG001|Overall Study|Lost to Follow-up|4|||
125244874|NCT01860404|450520182|FG002|Overall Study|Lost to Follow-up|1|||
125244875|NCT01860404|450520183|FG003|Overall Study|Lost to Follow-up|6|||
125244876|NCT01860404|450520184|FG004|Overall Study|Lost to Follow-up|4|||
125244877|NCT01860404|450520180|FG000|Overall Study|Withdrawal by Subject|0|||
125244878|NCT01860404|450520181|FG001|Overall Study|Withdrawal by Subject|0|||
125244879|NCT01860404|450520182|FG002|Overall Study|Withdrawal by Subject|4|||
125244880|NCT01860404|450520183|FG003|Overall Study|Withdrawal by Subject|0|||
125244881|NCT01860404|450520184|FG004|Overall Study|Withdrawal by Subject|0|||
125244882|NCT02762604|450520185|FG000|Overall Study|Lost to Follow-up|2|||
125244883|NCT02762604|450520186|FG001|Overall Study|Lost to Follow-up|7|||
125244884|NCT02762604|450520185|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
125244885|NCT02762604|450520186|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
125244886|NCT06038643|450520187|FG000|Overall Study|Withdrawal by Subject|9|||
125244887|NCT06038643|450520188|FG001|Overall Study|Withdrawal by Subject|4|||
125244888|NCT06038643|450520187|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
125244889|NCT06038643|450520188|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
125244890|NCT05259033|450520198|FG000|Overall Study|Withdrawal by Subject|10|||
125244891|NCT05259033|450520199|FG001|Overall Study|Withdrawal by Subject|5|||
125244892|NCT05259033|450520198|FG000|Overall Study|Lost to Follow-up|1|||
125244893|NCT05259033|450520199|FG001|Overall Study|Lost to Follow-up|0|||
125244894|NCT05259033|450520198|FG000|Overall Study|Death|2|||
125244895|NCT05259033|450520199|FG001|Overall Study|Death|0|||
125244896|NCT04210375|450520200|FG000|Overall Study|Death|0|||
125244897|NCT04210375|450520201|FG001|Overall Study|Death|1|||
125244898|NCT04210375|450520202|FG002|Overall Study|Death|0|||
125244899|NCT04210375|450520203|FG003|Overall Study|Death|0|||
125244900|NCT01405911|450520204|FG000|Overall Study|Pre-treatment lab AE|0|||
125191702|NCT03777436|450324293|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
125191703|NCT03777436|450324294|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
125191704|NCT03777436|450324292|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
125191705|NCT03777436|450324293|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
125191706|NCT03777436|450324294|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
125191707|NCT03777436|450324292|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
125191708|NCT03777436|450324293|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
125191709|NCT03777436|450324294|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
125191710|NCT03777436|450324292|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
125191711|NCT03777436|450324293|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
125191712|NCT03777436|450324294|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
125191713|NCT03777436|450324292|FG000|Placebo-controlled Phase|Physician Decision|0|||
125191714|NCT03777436|450324293|FG001|Placebo-controlled Phase|Physician Decision|1|||
125191715|NCT03777436|450324294|FG002|Placebo-controlled Phase|Physician Decision|0|||
125191716|NCT03777436|450324292|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
125191717|NCT03777436|450324293|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
125191718|NCT03777436|450324294|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
125191719|NCT03777436|450324292|FG000|Apremilast Extension Phase|Adverse Event|0|||
125191720|NCT03777436|450324293|FG001|Apremilast Extension Phase|Adverse Event|0|||
125191721|NCT03777436|450324294|FG002|Apremilast Extension Phase|Adverse Event|6|||
125191722|NCT03777436|450324292|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
125191723|NCT03777436|450324293|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
125191724|NCT03777436|450324294|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
125191725|NCT03777436|450324292|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
125191726|NCT03777436|450324293|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
125191727|NCT03777436|450324294|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
125191728|NCT03777436|450324292|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
125191729|NCT03777436|450324293|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
125191730|NCT03777436|450324294|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
125191731|NCT03777436|450324292|FG000|Apremilast Extension Phase|Miscellaneous|0|||
125191732|NCT03777436|450324293|FG001|Apremilast Extension Phase|Miscellaneous|0|||
125191733|NCT03777436|450324294|FG002|Apremilast Extension Phase|Miscellaneous|1|||
125191734|NCT00869999|450324297|FG000|Overall Study|Withdrawal by Subject|1|||
125191735|NCT00869999|450324297|FG000|Overall Study|removed prior to starting therapy|1|||
125191736|NCT04478695|450324298|FG000|Overall Study|Death|1|||
125191737|NCT04478695|450324299|FG001|Overall Study|Death|0|||
125191738|NCT00644917|450324300|FG000|Overall Study|Withdrawal by Subject|2|||
125191739|NCT00758485|450324301|FG000|Overall Study|Lost to Follow-up|0|||
125191740|NCT00758485|450324302|FG001|Overall Study|Lost to Follow-up|1|||
125191741|NCT00758485|450324301|FG000|Overall Study|Not Treated|1|||
125191742|NCT00758485|450324302|FG001|Overall Study|Not Treated|2|||
125191743|NCT02347774|450324303|FG000|Study Participation|Lost to Follow-up|3|||
125191744|NCT02347774|450324304|FG001|Study Participation|Lost to Follow-up|6|||
125191745|NCT02347774|450324305|FG002|Study Participation|Lost to Follow-up|2|||
125191746|NCT02347774|450324303|FG000|Study Participation|Withdrawal by Subject|8|||
125191747|NCT02347774|450324304|FG001|Study Participation|Withdrawal by Subject|9|||
125191748|NCT02347774|450324305|FG002|Study Participation|Withdrawal by Subject|15|||
125191749|NCT02347774|450324303|FG000|Study Participation|Adverse Event|1|||
125191750|NCT02347774|450324304|FG001|Study Participation|Adverse Event|4|||
125191751|NCT02347774|450324305|FG002|Study Participation|Adverse Event|6|||
125191752|NCT02347774|450324303|FG000|Study Participation|withdrew consent|1|||
125191753|NCT02347774|450324304|FG001|Study Participation|withdrew consent|1|||
125191754|NCT02347774|450324305|FG002|Study Participation|withdrew consent|1|||
125191755|NCT02347774|450324303|FG000|Study Participation|Met Prolonged QT criteria|1|||
125191756|NCT02347774|450324304|FG001|Study Participation|Met Prolonged QT criteria|0|||
125191757|NCT02347774|450324305|FG002|Study Participation|Met Prolonged QT criteria|0|||
125191758|NCT02347774|450324303|FG000|Study Participation|non-compliance with study drug|0|||
125191759|NCT02347774|450324304|FG001|Study Participation|non-compliance with study drug|1|||
125191760|NCT02347774|450324305|FG002|Study Participation|non-compliance with study drug|0|||
125191761|NCT02347774|450324303|FG000|Study Participation|incarceration|1|||
125244901|NCT01405911|450520205|FG001|Overall Study|Pre-treatment lab AE|1|||
125244902|NCT01405911|450520206|FG002|Overall Study|Pre-treatment lab AE|0|||
125244903|NCT01405911|450520204|FG000|Overall Study|Lost to Follow-up|0|||
125244904|NCT01405911|450520205|FG001|Overall Study|Lost to Follow-up|1|||
125244905|NCT01405911|450520206|FG002|Overall Study|Lost to Follow-up|0|||
125244906|NCT01405911|450520204|FG000|Overall Study|Protocol Violation|1|||
125244907|NCT01405911|450520205|FG001|Overall Study|Protocol Violation|0|||
125244908|NCT01405911|450520206|FG002|Overall Study|Protocol Violation|0|||
125244909|NCT01405911|450520204|FG000|Overall Study|Withdrawal by Subject|3|||
125244910|NCT01405911|450520205|FG001|Overall Study|Withdrawal by Subject|1|||
125244911|NCT01405911|450520206|FG002|Overall Study|Withdrawal by Subject|1|||
125244912|NCT01980888|450520209|FG000|Overall Study|Study Terminated by Sponsor|116|||
125244913|NCT01980888|450520210|FG001|Overall Study|Study Terminated by Sponsor|122|||
125244914|NCT01980888|450520209|FG000|Overall Study|Withdrew Consent|17|||
125244915|NCT01980888|450520210|FG001|Overall Study|Withdrew Consent|6|||
125244916|NCT01980888|450520209|FG000|Overall Study|Investigator's Discretion|8|||
125244917|NCT01980888|450520210|FG001|Overall Study|Investigator's Discretion|3|||
125244918|NCT01980888|450520209|FG000|Overall Study|Non-Compliance with Study Drug|3|||
125244919|NCT01980888|450520210|FG001|Overall Study|Non-Compliance with Study Drug|2|||
125244920|NCT05762744|450520212|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
125244921|NCT05762744|450520213|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
125244922|NCT05762744|450520212|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
125244923|NCT05762744|450520213|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
125244924|NCT01671059|450520214|FG000|Overall Study|Adverse Event|4|||
125244925|NCT01671059|450520214|FG000|Overall Study|Lack of Efficacy|1|||
125244926|NCT01560416|450520215|FG000|Randomized Phase|Crossover Participants|7|||
125244927|NCT01560416|450520216|FG001|Randomized Phase|Crossover Participants|0|||
125244928|NCT03334175|450520217|FG000|Overall Study|Lost to Follow-up|0|||
125244929|NCT03334175|450520218|FG001|Overall Study|Lost to Follow-up|1|||
125244930|NCT03738215|450520219|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
125244931|NCT03738215|450520220|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
125244932|NCT03738215|450520221|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
125244933|NCT03738215|450520219|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
125244934|NCT03738215|450520220|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
125244935|NCT03738215|450520221|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
125244936|NCT03738215|450520219|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
125244937|NCT03738215|450520220|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
125244938|NCT03738215|450520221|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
125244939|NCT03738215|450520219|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
125244940|NCT03738215|450520220|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
125244941|NCT03738215|450520221|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
125244942|NCT03738215|450520219|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
125244943|NCT03738215|450520220|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
125244944|NCT03738215|450520221|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
125244945|NCT03738215|450520219|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
125244946|NCT03738215|450520220|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
125244947|NCT03738215|450520221|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
125244948|NCT03738215|450520219|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
125244949|NCT03738215|450520220|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
125244950|NCT03738215|450520221|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
125244951|NCT03738215|450520219|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
125244952|NCT03738215|450520220|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
125244953|NCT03738215|450520221|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
125244954|NCT03738215|450520219|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
125244955|NCT03738215|450520220|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
125244956|NCT03738215|450520221|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
125244957|NCT03738215|450520219|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
125244958|NCT03738215|450520220|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
125244959|NCT03738215|450520221|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
125244960|NCT01695772|450520222|FG000|Overall Study|Withdrawal by Subject|18|||
125244961|NCT01695772|450520222|FG000|Overall Study|Progressive Disease|8|||
125244962|NCT01695772|450520222|FG000|Overall Study|Investigator Decision|5|||
125244963|NCT01695772|450520222|FG000|Overall Study|Lost to Follow-up|4|||
125244964|NCT01695772|450520222|FG000|Overall Study|Protocol Violation|2|||
125244965|NCT01695772|450520222|FG000|Overall Study|Unspecified Reason|1|||
125244966|NCT04073407|450520226|FG000|Part 1|Withdrawal by Subject|1|||
125244967|NCT04073407|450520227|FG001|Part 1|Withdrawal by Subject|0|||
125303083|NCT03100058|450736671|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
125191762|NCT02347774|450324304|FG001|Study Participation|incarceration|0|||
125191763|NCT02347774|450324305|FG002|Study Participation|incarceration|0|||
125191764|NCT02347774|450324303|FG000|Study Participation|randomized in error|0|||
125191765|NCT02347774|450324304|FG001|Study Participation|randomized in error|0|||
125191766|NCT02347774|450324305|FG002|Study Participation|randomized in error|1|||
125191767|NCT02347774|450324303|FG000|On Study Treatment|Adverse Event|9|||
125191768|NCT02347774|450324304|FG001|On Study Treatment|Adverse Event|15|||
125191769|NCT02347774|450324305|FG002|On Study Treatment|Adverse Event|19|||
125191770|NCT02347774|450324303|FG000|On Study Treatment|Lack of Efficacy|3|||
125191771|NCT02347774|450324304|FG001|On Study Treatment|Lack of Efficacy|0|||
125191772|NCT02347774|450324305|FG002|On Study Treatment|Lack of Efficacy|2|||
125191773|NCT02347774|450324303|FG000|On Study Treatment|non-complicance with study medication|0|||
125191774|NCT02347774|450324304|FG001|On Study Treatment|non-complicance with study medication|2|||
125191775|NCT02347774|450324305|FG002|On Study Treatment|non-complicance with study medication|0|||
125191776|NCT02347774|450324303|FG000|On Study Treatment|Protocol Violation|0|||
125191777|NCT02347774|450324304|FG001|On Study Treatment|Protocol Violation|0|||
125191778|NCT02347774|450324305|FG002|On Study Treatment|Protocol Violation|1|||
125191779|NCT02347774|450324303|FG000|On Study Treatment|withdrew consent|9|||
125191780|NCT02347774|450324304|FG001|On Study Treatment|withdrew consent|8|||
125191781|NCT02347774|450324305|FG002|On Study Treatment|withdrew consent|12|||
125191782|NCT02347774|450324303|FG000|On Study Treatment|Lost to Follow-up|2|||
125191783|NCT02347774|450324304|FG001|On Study Treatment|Lost to Follow-up|6|||
125191784|NCT02347774|450324305|FG002|On Study Treatment|Lost to Follow-up|1|||
125191785|NCT02347774|450324303|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
125191786|NCT02347774|450324304|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
125191787|NCT02347774|450324305|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
125191788|NCT02347774|450324303|FG000|On Study Treatment|ranomized in error|0|||
125191789|NCT02347774|450324304|FG001|On Study Treatment|ranomized in error|0|||
125191790|NCT02347774|450324305|FG002|On Study Treatment|ranomized in error|1|||
125191791|NCT00656292|450324306|FG000|Overall Study|Withdrawal by Subject|2|||
125191792|NCT00656292|450324307|FG001|Overall Study|Withdrawal by Subject|3|||
125191793|NCT00656292|450324306|FG000|Overall Study|Screen failure|1|||
125191794|NCT00656292|450324307|FG001|Overall Study|Screen failure|2|||
125191795|NCT00921557|450324308|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
125191796|NCT00921557|450324309|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
125191797|NCT00921557|450324310|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
125191798|NCT00921557|450324308|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
125191799|NCT00921557|450324309|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
125191800|NCT00921557|450324310|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
125191801|NCT00921557|450324308|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
125191802|NCT00921557|450324309|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
125191803|NCT00921557|450324310|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
125191804|NCT00921557|450324308|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
125191805|NCT00921557|450324309|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
125191806|NCT00921557|450324310|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
125191807|NCT00921557|450324308|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
125191808|NCT00921557|450324309|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
125191809|NCT00921557|450324310|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
125191810|NCT01431716|450324318|FG000|Overall Study|Withdrawal of consent|1|||
125191811|NCT01303172|450324329|FG000|Overall Study|Physician Decision|9|||
125191812|NCT01303172|450324330|FG001|Overall Study|Physician Decision|6|||
125191813|NCT01303172|450324329|FG000|Overall Study|Adverse Event|5|||
125191814|NCT01303172|450324330|FG001|Overall Study|Adverse Event|2|||
125191815|NCT01303172|450324329|FG000|Overall Study|Withdrawal by Subject|4|||
125191816|NCT01303172|450324330|FG001|Overall Study|Withdrawal by Subject|2|||
125191817|NCT01303172|450324329|FG000|Overall Study|Death|20|||
125191818|NCT01303172|450324330|FG001|Overall Study|Death|7|||
125191819|NCT01303172|450324329|FG000|Overall Study|Lack of Efficacy|25|||
125191820|NCT01303172|450324330|FG001|Overall Study|Lack of Efficacy|17|||
125191821|NCT00462709|450324335|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
125191822|NCT00462709|450324335|FG000|Overall Study|Lost to Follow-up|10|||
125191823|NCT00462709|450324335|FG000|Overall Study|Withdrawal by Subject|8|||
125191824|NCT00462709|450324335|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
125191825|NCT00462709|450324335|FG000|Overall Study|Death|2|||
125191826|NCT00462709|450324335|FG000|Overall Study|Logistical reasons|2|||
125244968|NCT04073407|450520226|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
125191827|NCT00462709|450324335|FG000|Overall Study|Physician Decision|1|||
125191828|NCT00462709|450324335|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
125191829|NCT04468347|450324340|FG000|Overall Study|Withdrawal by Subject|0|||
125191830|NCT04468347|450324341|FG001|Overall Study|Withdrawal by Subject|1|||
125191831|NCT04468347|450324342|FG002|Overall Study|Withdrawal by Subject|3|||
125191832|NCT04468347|450324343|FG003|Overall Study|Withdrawal by Subject|3|||
125191833|NCT04468347|450324340|FG000|Overall Study|Lost to Follow-up|0|||
125191834|NCT04468347|450324341|FG001|Overall Study|Lost to Follow-up|0|||
125191835|NCT04468347|450324342|FG002|Overall Study|Lost to Follow-up|1|||
125191836|NCT04468347|450324343|FG003|Overall Study|Lost to Follow-up|1|||
125191837|NCT04468347|450324340|FG000|Overall Study|Physician Decision|1|||
125191838|NCT04468347|450324341|FG001|Overall Study|Physician Decision|0|||
125191839|NCT04468347|450324342|FG002|Overall Study|Physician Decision|2|||
125191840|NCT04468347|450324343|FG003|Overall Study|Physician Decision|0|||
125191841|NCT04468347|450324340|FG000|Overall Study|Protocol Violation|1|||
125191842|NCT04468347|450324341|FG001|Overall Study|Protocol Violation|0|||
125191843|NCT04468347|450324342|FG002|Overall Study|Protocol Violation|0|||
125191844|NCT04468347|450324343|FG003|Overall Study|Protocol Violation|0|||
125191845|NCT00554515|450324344|FG000|Overall Study|Withdrawal by Subject|3|||
125191846|NCT00554515|450324344|FG000|Overall Study|Disease progression|52|||
125191847|NCT00554515|450324344|FG000|Overall Study|Physician Decision|18|||
125191848|NCT00554515|450324344|FG000|Overall Study|Withdrawal by Subject|11|||
125191849|NCT00554515|450324344|FG000|Overall Study|Adverse Event|9|||
125191850|NCT00554515|450324344|FG000|Overall Study|Death|2|||
125191851|NCT00554515|450324344|FG000|Overall Study|Achieved Stable Disease|7|||
125191852|NCT00554515|450324344|FG000|Overall Study|Other|1|||
125191853|NCT00554515|450324344|FG000|Overall Study|Misc|15|||
125191854|NCT00488644|450324345|FG000|Overall Study|Not Eligible|1|||
125191855|NCT00488644|450324345|FG000|Overall Study|Not Evaluable|1|||
125191856|NCT02977572|450324346|FG000|Overall Study|Exclusion criterion|2|||
125191857|NCT02977572|450324347|FG001|Overall Study|Exclusion criterion|2|||
125191858|NCT05107492|450324348|FG000|Overall Study|Lost to Follow-up|1|||
125191859|NCT05107492|450324349|FG001|Overall Study|Lost to Follow-up|0|||
125191860|NCT01197534|450324351|FG000|Overall Study|Not reported|16|||
125191861|NCT01197534|450324352|FG001|Overall Study|Not reported|10|||
125191862|NCT01197534|450324353|FG002|Overall Study|Not reported|16|||
125191863|NCT01197534|450324351|FG000|Overall Study|Enrolment in long term extension|57|||
125191864|NCT01197534|450324352|FG001|Overall Study|Enrolment in long term extension|66|||
125191865|NCT01197534|450324353|FG002|Overall Study|Enrolment in long term extension|119|||
125191866|NCT01197534|450324351|FG000|Overall Study|Severe non-compliance to protocol|3|||
125191867|NCT01197534|450324352|FG001|Overall Study|Severe non-compliance to protocol|4|||
125191868|NCT01197534|450324353|FG002|Overall Study|Severe non-compliance to protocol|1|||
125191869|NCT01197534|450324351|FG000|Overall Study|Lack of therapeutic response|9|||
125191870|NCT01197534|450324352|FG001|Overall Study|Lack of therapeutic response|4|||
125191871|NCT01197534|450324353|FG002|Overall Study|Lack of therapeutic response|9|||
125191872|NCT01197534|450324351|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
125191873|NCT01197534|450324352|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
125191874|NCT01197534|450324353|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
125191875|NCT01197534|450324351|FG000|Overall Study|Lost to Follow-up|1|||
125191876|NCT01197534|450324352|FG001|Overall Study|Lost to Follow-up|4|||
125191877|NCT01197534|450324353|FG002|Overall Study|Lost to Follow-up|2|||
125191878|NCT01197534|450324351|FG000|Overall Study|Adverse Event|35|||
125191879|NCT01197534|450324352|FG001|Overall Study|Adverse Event|36|||
125191880|NCT01197534|450324353|FG002|Overall Study|Adverse Event|24|||
125191881|NCT02522884|450324357|FG000|Overall Study|Withdrawal by Subject|6|||
125191882|NCT02522884|450324357|FG000|Overall Study|Death|3|||
125191883|NCT02522884|450324357|FG000|Overall Study|Missed 12-month Follow-up|9|||
125191884|NCT00591565|450324358|FG000|Overall Study|lost follow up, withdrawn|5|||
125191885|NCT03564119|450324362|FG000|Overall Study|Adverse Event|4|||
125191886|NCT03564119|450324363|FG001|Overall Study|Adverse Event|0|||
125191887|NCT03564119|450324362|FG000|Overall Study|Lost to Follow-up|1|||
125191888|NCT03564119|450324363|FG001|Overall Study|Lost to Follow-up|4|||
125191889|NCT03564119|450324362|FG000|Overall Study|Protocol Violation|1|||
125191890|NCT03564119|450324363|FG001|Overall Study|Protocol Violation|0|||
125191891|NCT03564119|450324362|FG000|Overall Study|Withdrawal by Subject|9|||
125191892|NCT03564119|450324363|FG001|Overall Study|Withdrawal by Subject|4|||
125191893|NCT03564119|450324362|FG000|Overall Study|Other Than Specified|0|||
125191894|NCT03564119|450324363|FG001|Overall Study|Other Than Specified|1|||
125191895|NCT00634036|450324364|FG000|Overall Study|Lost to Follow-up|1|||
125191896|NCT00634036|450324365|FG001|Overall Study|Lost to Follow-up|1|||
125191897|NCT00634036|450324364|FG000|Overall Study|Withdrawal by Subject|1|||
125191898|NCT00634036|450324365|FG001|Overall Study|Withdrawal by Subject|1|||
125191899|NCT03896022|450324371|FG000|Overall Study|Withdrawal by Subject|1|||
125191900|NCT03896022|450324372|FG001|Overall Study|Withdrawal by Subject|0|||
125191901|NCT03896022|450324373|FG002|Overall Study|Withdrawal by Subject|0|||
125191902|NCT03896022|450324371|FG000|Overall Study|Did not have procedure|3|||
125191903|NCT03896022|450324372|FG001|Overall Study|Did not have procedure|0|||
125191904|NCT03896022|450324373|FG002|Overall Study|Did not have procedure|0|||
125191905|NCT00615550|450324378|FG000|Overall Study|Lost to Follow-up|6|||
125191906|NCT00615550|450324379|FG001|Overall Study|Lost to Follow-up|1|||
125191907|NCT00564850|450324380|FG000|Overall Study|Protocol Violation|2|||
125191908|NCT02640664|450324381|FG000|Epoch 1|Withdrawal of informed consent|1|||
125191909|NCT02640664|450324382|FG001|Epoch 1|Withdrawal of informed consent|0|||
125191910|NCT02640664|450324383|FG002|Epoch 1|Withdrawal of informed consent|0|||
125244969|NCT04073407|450520227|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
125244970|NCT04073407|450520226|FG000|Part 2|Withdrawal by Subject|0|||
125244971|NCT04073407|450520227|FG001|Part 2|Withdrawal by Subject|1|||
125244972|NCT03022630|450521971|FG000|Overall Study|Death|9|||
125244973|NCT03022630|450521972|FG001|Overall Study|Death|7|||
125244974|NCT03022630|450521971|FG000|Overall Study|Withdrawal by Subject|0|||
125244975|NCT03022630|450521972|FG001|Overall Study|Withdrawal by Subject|5|||
125244976|NCT00088881|450521973|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
125244977|NCT00088881|450521973|FG000|Step 1 - R-CHOP|Adverse Event|1|||
125244978|NCT00088881|450521973|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
125244979|NCT00088881|450521973|FG000|Step 1 - R-CHOP|Physician Decision|1|||
125244980|NCT00088881|450521973|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
125244981|NCT00088881|450521973|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
125244982|NCT00088881|450521973|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
125244983|NCT00835978|450521974|FG000|Overall Study|Death|33|||
125244984|NCT00835978|450521975|FG001|Overall Study|Death|40|||
125244985|NCT00835978|450521976|FG002|Overall Study|Death|49|||
125244986|NCT00835978|450521977|FG003|Overall Study|Death|4|||
125244987|NCT00835978|450521974|FG000|Overall Study|Lost to Follow-up|3|||
125244988|NCT00835978|450521975|FG001|Overall Study|Lost to Follow-up|4|||
125244989|NCT00835978|450521976|FG002|Overall Study|Lost to Follow-up|2|||
125244990|NCT00835978|450521977|FG003|Overall Study|Lost to Follow-up|1|||
125244991|NCT00835978|450521974|FG000|Overall Study|Other|5|||
125244992|NCT00835978|450521975|FG001|Overall Study|Other|1|||
125244993|NCT00835978|450521976|FG002|Overall Study|Other|8|||
125244994|NCT00835978|450521977|FG003|Overall Study|Other|0|||
125244995|NCT00835978|450521974|FG000|Overall Study|Objective progression or relapse|2|||
125244996|NCT00835978|450521975|FG001|Overall Study|Objective progression or relapse|0|||
125244997|NCT00835978|450521976|FG002|Overall Study|Objective progression or relapse|1|||
125244998|NCT00835978|450521977|FG003|Overall Study|Objective progression or relapse|0|||
125244999|NCT00835978|450521974|FG000|Overall Study|Adverse Event|1|||
125245000|NCT00835978|450521975|FG001|Overall Study|Adverse Event|0|||
125245001|NCT00835978|450521976|FG002|Overall Study|Adverse Event|1|||
125245002|NCT00835978|450521977|FG003|Overall Study|Adverse Event|0|||
125245003|NCT00835978|450521974|FG000|Overall Study|Withdrawal by Subject|0|||
125245004|NCT00835978|450521975|FG001|Overall Study|Withdrawal by Subject|3|||
125245005|NCT00835978|450521976|FG002|Overall Study|Withdrawal by Subject|0|||
125245006|NCT00835978|450521977|FG003|Overall Study|Withdrawal by Subject|5|||
125245007|NCT00835978|450521974|FG000|Overall Study|Study terminated by sponsor|12|||
125245008|NCT00835978|450521975|FG001|Overall Study|Study terminated by sponsor|8|||
125245009|NCT00835978|450521976|FG002|Overall Study|Study terminated by sponsor|30|||
125245010|NCT00835978|450521977|FG003|Overall Study|Study terminated by sponsor|0|||
125245011|NCT02927145|450521978|FG000|Initial Recruitment|Withdrawal by Subject|0|||
125245012|NCT02927145|450521979|FG001|Initial Recruitment|Withdrawal by Subject|1|||
125245013|NCT02927145|450521980|FG002|Initial Recruitment|Withdrawal by Subject|1|||
125245014|NCT02927145|450521981|FG003|Initial Recruitment|Withdrawal by Subject|4|||
125245015|NCT02927145|450521982|FG004|Initial Recruitment|Withdrawal by Subject|1|||
125245016|NCT02927145|450521983|FG005|Initial Recruitment|Withdrawal by Subject|1|||
125245017|NCT02927145|450521984|FG006|Initial Recruitment|Withdrawal by Subject|0|||
125245018|NCT02927145|450521985|FG007|Initial Recruitment|Withdrawal by Subject|0|||
125245019|NCT02927145|450521986|FG008|Initial Recruitment|Withdrawal by Subject|2|||
125245020|NCT02927145|450521978|FG000|Initial Recruitment|Adverse Event|0|||
125245021|NCT02927145|450521979|FG001|Initial Recruitment|Adverse Event|0|||
125245022|NCT02927145|450521980|FG002|Initial Recruitment|Adverse Event|0|||
125245023|NCT02927145|450521981|FG003|Initial Recruitment|Adverse Event|0|||
125245024|NCT02927145|450521982|FG004|Initial Recruitment|Adverse Event|2|||
125245025|NCT02927145|450521983|FG005|Initial Recruitment|Adverse Event|0|||
125245026|NCT02927145|450521984|FG006|Initial Recruitment|Adverse Event|0|||
125245027|NCT02927145|450521985|FG007|Initial Recruitment|Adverse Event|0|||
125245028|NCT02927145|450521986|FG008|Initial Recruitment|Adverse Event|0|||
125245029|NCT02927145|450521978|FG000|Invitation for Additional Challenge|Pregnancy|0|||
125245030|NCT02927145|450521979|FG001|Invitation for Additional Challenge|Pregnancy|0|||
125245031|NCT02927145|450521980|FG002|Invitation for Additional Challenge|Pregnancy|0|||
125245032|NCT02927145|450521981|FG003|Invitation for Additional Challenge|Pregnancy|0|||
125245033|NCT02927145|450521982|FG004|Invitation for Additional Challenge|Pregnancy|0|||
125245034|NCT02927145|450521983|FG005|Invitation for Additional Challenge|Pregnancy|0|||
125245035|NCT02927145|450521984|FG006|Invitation for Additional Challenge|Pregnancy|1|||
125245036|NCT02927145|450521985|FG007|Invitation for Additional Challenge|Pregnancy|0|||
125245037|NCT02927145|450521986|FG008|Invitation for Additional Challenge|Pregnancy|0|||
125245038|NCT00327171|450521987|FG000|Overall Study|Did not receive study medication|3|||
125245039|NCT00327171|450521988|FG001|Overall Study|Did not receive study medication|0|||
125245040|NCT00327171|450521987|FG000|Overall Study|Adverse Event|23|||
125245041|NCT00327171|450521988|FG001|Overall Study|Adverse Event|23|||
125245042|NCT00327171|450521987|FG000|Overall Study|Disease progression/lack of efficacy|68|||
125245043|NCT00327171|450521988|FG001|Overall Study|Disease progression/lack of efficacy|69|||
125191911|NCT02640664|450324381|FG000|Epoch 1|Death|0|||
125191912|NCT02640664|450324382|FG001|Epoch 1|Death|0|||
125191913|NCT02640664|450324383|FG002|Epoch 1|Death|1|||
125191914|NCT02640664|450324381|FG000|Epoch 2|Withdrawal of informed consent|3|||
125191915|NCT02640664|450324382|FG001|Epoch 2|Withdrawal of informed consent|4|||
125191916|NCT02640664|450324383|FG002|Epoch 2|Withdrawal of informed consent|2|||
125191917|NCT02640664|450324381|FG000|Epoch 2|Subject/guardian decision|0|||
125191918|NCT02640664|450324382|FG001|Epoch 2|Subject/guardian decision|2|||
125191919|NCT02640664|450324383|FG002|Epoch 2|Subject/guardian decision|2|||
125191920|NCT02640664|450324381|FG000|Epoch 2|Lost to Follow-up|3|||
125191921|NCT02640664|450324382|FG001|Epoch 2|Lost to Follow-up|4|||
125191922|NCT02640664|450324383|FG002|Epoch 2|Lost to Follow-up|1|||
125191923|NCT02640664|450324381|FG000|Epoch 2|Death|0|||
125191924|NCT02640664|450324382|FG001|Epoch 2|Death|0|||
125191925|NCT02640664|450324383|FG002|Epoch 2|Death|1|||
125191926|NCT00314327|450324384|FG000|Overall Study|Withdrawal by Subject|1|||
125191927|NCT02741076|450324387|FG000|Overall Study|Adverse Event|0|||
125191928|NCT02741076|450324388|FG001|Overall Study|Adverse Event|1|||
125191929|NCT02741076|450324389|FG002|Overall Study|Adverse Event|1|||
125191930|NCT02741076|450324390|FG003|Overall Study|Adverse Event|0|||
125191931|NCT02741076|450324387|FG000|Overall Study|Lack of Efficacy|1|||
125191932|NCT02741076|450324388|FG001|Overall Study|Lack of Efficacy|0|||
125191933|NCT02741076|450324389|FG002|Overall Study|Lack of Efficacy|0|||
125191934|NCT02741076|450324390|FG003|Overall Study|Lack of Efficacy|0|||
125191935|NCT02741076|450324387|FG000|Overall Study|Withdrawal by Subject|0|||
125191936|NCT02741076|450324388|FG001|Overall Study|Withdrawal by Subject|1|||
125191937|NCT02741076|450324389|FG002|Overall Study|Withdrawal by Subject|0|||
125191938|NCT02741076|450324390|FG003|Overall Study|Withdrawal by Subject|0|||
125191939|NCT02741076|450324387|FG000|Overall Study|Sponsor Request|2|||
125191940|NCT02741076|450324388|FG001|Overall Study|Sponsor Request|3|||
125191941|NCT02741076|450324389|FG002|Overall Study|Sponsor Request|0|||
125191942|NCT02741076|450324390|FG003|Overall Study|Sponsor Request|1|||
125191943|NCT02741076|450324387|FG000|Overall Study|No additional information available|0|||
125191944|NCT02741076|450324388|FG001|Overall Study|No additional information available|0|||
125191945|NCT02741076|450324389|FG002|Overall Study|No additional information available|1|||
125191946|NCT02741076|450324390|FG003|Overall Study|No additional information available|1|||
125191947|NCT02748213|450324393|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
125191948|NCT02748213|450324394|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
125191949|NCT02748213|450324393|FG000|Overall Study|Abnormal Laboratory Test|1|||
125191950|NCT02748213|450324394|FG001|Overall Study|Abnormal Laboratory Test|0|||
125191951|NCT02748213|450324393|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
125191952|NCT02748213|450324394|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
125191953|NCT02748213|450324393|FG000|Overall Study|Death|5|||
125191954|NCT02748213|450324394|FG001|Overall Study|Death|3|||
125191955|NCT02748213|450324393|FG000|Overall Study|Insufficient Therapeutic Response|56|||
125191956|NCT02748213|450324394|FG001|Overall Study|Insufficient Therapeutic Response|57|||
125191957|NCT02748213|450324393|FG000|Overall Study|Violation of Selection Criteria|2|||
125191958|NCT02748213|450324394|FG001|Overall Study|Violation of Selection Criteria|0|||
125191959|NCT02748213|450324393|FG000|Overall Study|Protocol Violation|6|||
125191960|NCT02748213|450324394|FG001|Overall Study|Protocol Violation|4|||
125191961|NCT02748213|450324393|FG000|Overall Study|Refused Treatment*|6|||
125191962|NCT02748213|450324394|FG001|Overall Study|Refused Treatment*|6|||
125191963|NCT02748213|450324393|FG000|Overall Study|Failure to Return|1|||
125191964|NCT02748213|450324394|FG001|Overall Study|Failure to Return|0|||
125191965|NCT02748213|450324393|FG000|Overall Study|Other|30|||
125191966|NCT02748213|450324394|FG001|Overall Study|Other|29|||
125191967|NCT04200651|450324395|FG000|Overall Study|Moved to another country during follow-up|2|||
125191968|NCT04200651|450324396|FG001|Overall Study|Moved to another country during follow-up|2|||
125191969|NCT04200651|450324395|FG000|Overall Study|Lost to Follow-up|1|||
125191970|NCT04200651|450324396|FG001|Overall Study|Lost to Follow-up|3|||
125191971|NCT03225105|450324398|FG000|Overall Study|Withdrawal by Subject|1|||
125191972|NCT03225105|450324399|FG001|Overall Study|Withdrawal by Subject|0|||
125191973|NCT03225105|450324400|FG002|Overall Study|Withdrawal by Subject|0|||
125191974|NCT03225105|450324401|FG003|Overall Study|Withdrawal by Subject|0|||
125191975|NCT03225105|450324398|FG000|Overall Study|Death|0|||
125191976|NCT03225105|450324399|FG001|Overall Study|Death|4|||
125191977|NCT03225105|450324400|FG002|Overall Study|Death|2|||
125191978|NCT03225105|450324401|FG003|Overall Study|Death|0|||
125191979|NCT03225105|450324398|FG000|Overall Study|Study termination per Sponsor Decision|2|||
125191980|NCT03225105|450324399|FG001|Overall Study|Study termination per Sponsor Decision|0|||
125191981|NCT03225105|450324400|FG002|Overall Study|Study termination per Sponsor Decision|3|||
125191982|NCT03225105|450324401|FG003|Overall Study|Study termination per Sponsor Decision|3|||
125191983|NCT01500382|450324402|FG000|Washout Period|Study site went out of business|0|||
125191984|NCT01500382|450324403|FG001|Washout Period|Study site went out of business|0|||
125191985|NCT01500382|450324404|FG002|Washout Period|Study site went out of business|1|||
125191986|NCT01500382|450324405|FG003|Washout Period|Study site went out of business|0|||
125191987|NCT00617890|450326043|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
125245044|NCT00327171|450521987|FG000|Overall Study|Investigator/participant request|1|||
125245045|NCT00327171|450521988|FG001|Overall Study|Investigator/participant request|8|||
125245046|NCT00327171|450521987|FG000|Overall Study|Clinical progression|12|||
125245047|NCT00327171|450521988|FG001|Overall Study|Clinical progression|8|||
125245048|NCT00327171|450521987|FG000|Overall Study|Undisclosed history of ischemia|0|||
125245049|NCT00327171|450521988|FG001|Overall Study|Undisclosed history of ischemia|1|||
125245050|NCT00327171|450521987|FG000|Overall Study|Other|1|||
125245051|NCT00327171|450521988|FG001|Overall Study|Other|0|||
125245052|NCT02506036|450521991|FG000|First Intervention (4-6 Weeks)|Death|1|||
125245053|NCT02506036|450521992|FG001|First Intervention (4-6 Weeks)|Death|0|||
125245054|NCT02506036|450521991|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
125245055|NCT02506036|450521992|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
125245056|NCT02506036|450521991|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
125245057|NCT02506036|450521992|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
125245058|NCT00530075|450521993|FG000|Overall Study|Adverse Event|1|||
125245059|NCT00530075|450521993|FG000|Overall Study|Death|1|||
125245060|NCT00530075|450521993|FG000|Overall Study|Lack of Efficacy|3|||
125191988|NCT00617890|450326044|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
125191989|NCT00617890|450326045|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
125191990|NCT00617890|450326046|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
125191991|NCT00617890|450326043|FG000|Overall Study|Lack of Efficacy|23|||
125191992|NCT00617890|450326044|FG001|Overall Study|Lack of Efficacy|26|||
125191993|NCT00617890|450326045|FG002|Overall Study|Lack of Efficacy|30|||
125191994|NCT00617890|450326046|FG003|Overall Study|Lack of Efficacy|97|||
125191995|NCT00617890|450326043|FG000|Overall Study|Lost to Follow-up|0|||
125191996|NCT00617890|450326044|FG001|Overall Study|Lost to Follow-up|0|||
125191997|NCT00617890|450326045|FG002|Overall Study|Lost to Follow-up|1|||
125191998|NCT00617890|450326046|FG003|Overall Study|Lost to Follow-up|2|||
125191999|NCT00617890|450326043|FG000|Overall Study|Withdrawal by Subject|4|||
125192000|NCT00617890|450326044|FG001|Overall Study|Withdrawal by Subject|1|||
125192001|NCT00617890|450326045|FG002|Overall Study|Withdrawal by Subject|0|||
125192002|NCT00617890|450326046|FG003|Overall Study|Withdrawal by Subject|2|||
125192003|NCT00617890|450326043|FG000|Overall Study|Protocol Violation|2|||
125192004|NCT00617890|450326044|FG001|Overall Study|Protocol Violation|1|||
125192005|NCT00617890|450326045|FG002|Overall Study|Protocol Violation|0|||
125192006|NCT00617890|450326046|FG003|Overall Study|Protocol Violation|0|||
125192007|NCT00617890|450326043|FG000|Overall Study|Adverse Event|1|||
125192008|NCT00617890|450326044|FG001|Overall Study|Adverse Event|0|||
125192009|NCT00617890|450326045|FG002|Overall Study|Adverse Event|3|||
125192010|NCT00617890|450326046|FG003|Overall Study|Adverse Event|8|||
125192011|NCT00617890|450326043|FG000|Overall Study|Not treated|1|||
125192012|NCT00617890|450326044|FG001|Overall Study|Not treated|0|||
125192013|NCT00617890|450326045|FG002|Overall Study|Not treated|1|||
125192014|NCT00617890|450326046|FG003|Overall Study|Not treated|1|||
125192015|NCT02640950|450326048|FG000|Overall Study|Adverse Event|1|||
125192016|NCT02640950|450326048|FG000|Overall Study|Withdrawal by Subject|1|||
125192017|NCT00915018|450326049|FG000|Overall Study|Death|75|||
125192018|NCT00915018|450326050|FG001|Overall Study|Death|70|||
125192019|NCT00915018|450326049|FG000|Overall Study|Lost to Follow-up|10|||
125192020|NCT00915018|450326050|FG001|Overall Study|Lost to Follow-up|5|||
125192021|NCT00915018|450326049|FG000|Overall Study|Withdrawal by Subject|38|||
125192022|NCT00915018|450326050|FG001|Overall Study|Withdrawal by Subject|27|||
125192023|NCT00915018|450326049|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
125192024|NCT00915018|450326050|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
125192025|NCT00154284|450326051|FG000|Overall Study|Adverse Event|6|||
125192026|NCT00154284|450326052|FG001|Overall Study|Adverse Event|9|||
125245061|NCT00530075|450521993|FG000|Overall Study|Protocol Violation|1|||
125245062|NCT00530075|450521993|FG000|Overall Study|Withdrawal by Subject|1|||
125245063|NCT00758043|450521994|FG000|Overall Study|Adverse Event|1|||
125245064|NCT00758043|450521995|FG001|Overall Study|Adverse Event|20|||
125245065|NCT00758043|450521996|FG002|Overall Study|Adverse Event|12|||
125192027|NCT00154284|450326051|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125192028|NCT00154284|450326052|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125192029|NCT00154284|450326051|FG000|Overall Study|Lack of Efficacy|1|||
125192030|NCT00154284|450326052|FG001|Overall Study|Lack of Efficacy|2|||
125192031|NCT00154284|450326051|FG000|Overall Study|Protocol Violation|0|||
125192032|NCT00154284|450326052|FG001|Overall Study|Protocol Violation|1|||
125192033|NCT00566020|450326053|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
125192034|NCT00566020|450326054|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
125192035|NCT00566020|450326053|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
125192036|NCT00566020|450326054|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
125192037|NCT00566020|450326053|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
125192038|NCT00566020|450326054|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
125192039|NCT00566020|450326053|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
125192040|NCT00566020|450326054|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
125245066|NCT00758043|450521997|FG003|Overall Study|Adverse Event|62|||
125245067|NCT00758043|450521994|FG000|Overall Study|Lack of Efficacy|0|||
125192041|NCT00566020|450326053|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
125192042|NCT00566020|450326054|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
125192043|NCT00566020|450326053|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
125192044|NCT00566020|450326054|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
125192045|NCT02101736|450326055|FG000|Overall Study|Protocol Violation|3|||
125192046|NCT02101736|450326056|FG001|Overall Study|Protocol Violation|0|||
125245068|NCT00758043|450521995|FG001|Overall Study|Lack of Efficacy|6|||
125245069|NCT00758043|450521996|FG002|Overall Study|Lack of Efficacy|18|||
125245070|NCT00758043|450521997|FG003|Overall Study|Lack of Efficacy|12|||
125245071|NCT00758043|450521994|FG000|Overall Study|Refused Further Treatment|0|||
125245072|NCT00758043|450521995|FG001|Overall Study|Refused Further Treatment|11|||
125245073|NCT00758043|450521996|FG002|Overall Study|Refused Further Treatment|5|||
125245074|NCT00758043|450521997|FG003|Overall Study|Refused Further Treatment|8|||
125245075|NCT00758043|450521994|FG000|Overall Study|Lost to Follow-up|0|||
125245076|NCT00758043|450521995|FG001|Overall Study|Lost to Follow-up|2|||
125245077|NCT00758043|450521996|FG002|Overall Study|Lost to Follow-up|2|||
125245078|NCT00758043|450521997|FG003|Overall Study|Lost to Follow-up|5|||
125245079|NCT00758043|450521994|FG000|Overall Study|Withdrawal by Subject|0|||
125245080|NCT00758043|450521995|FG001|Overall Study|Withdrawal by Subject|1|||
125245081|NCT00758043|450521996|FG002|Overall Study|Withdrawal by Subject|1|||
125245082|NCT00758043|450521997|FG003|Overall Study|Withdrawal by Subject|4|||
125245083|NCT00758043|450521994|FG000|Overall Study|Required Prohibited Medication|0|||
125245084|NCT00758043|450521995|FG001|Overall Study|Required Prohibited Medication|0|||
125245085|NCT00758043|450521996|FG002|Overall Study|Required Prohibited Medication|1|||
125245086|NCT00758043|450521997|FG003|Overall Study|Required Prohibited Medication|3|||
125245087|NCT00758043|450521994|FG000|Overall Study|Non-Compliant With study Drug|0|||
125245088|NCT00758043|450521995|FG001|Overall Study|Non-Compliant With study Drug|0|||
125245089|NCT00758043|450521996|FG002|Overall Study|Non-Compliant With study Drug|0|||
125245090|NCT00758043|450521997|FG003|Overall Study|Non-Compliant With study Drug|1|||
125245091|NCT00758043|450521994|FG000|Overall Study|Other Reasons|0|||
125245092|NCT00758043|450521995|FG001|Overall Study|Other Reasons|1|||
125245093|NCT00758043|450521996|FG002|Overall Study|Other Reasons|0|||
125245094|NCT00758043|450521997|FG003|Overall Study|Other Reasons|5|||
125192047|NCT02101736|450326055|FG000|Overall Study|Withdrawal by Subject|1|||
125245095|NCT00552058|450522003|FG000|Overall Study|Adverse Event|8|||
125245096|NCT00552058|450522004|FG001|Overall Study|Adverse Event|7|||
125245097|NCT00552058|450522003|FG000|Overall Study|Lack of Efficacy|1|||
125245098|NCT00552058|450522004|FG001|Overall Study|Lack of Efficacy|5|||
125245099|NCT00552058|450522003|FG000|Overall Study|Lost to Follow-up|1|||
125245100|NCT00552058|450522004|FG001|Overall Study|Lost to Follow-up|0|||
125245101|NCT00552058|450522003|FG000|Overall Study|Withdrawal by Subject|4|||
125245102|NCT00552058|450522004|FG001|Overall Study|Withdrawal by Subject|4|||
125245103|NCT00552058|450522003|FG000|Overall Study|Other: Protocol Violation|0|||
125245104|NCT00552058|450522004|FG001|Overall Study|Other: Protocol Violation|1|||
125245105|NCT00552058|450522003|FG000|Overall Study|Other: Non Compliance|1|||
125245106|NCT00552058|450522004|FG001|Overall Study|Other: Non Compliance|2|||
125245107|NCT00552058|450522003|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
125245108|NCT00552058|450522004|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
125245109|NCT00552058|450522003|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
125245110|NCT00552058|450522004|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
125245111|NCT00552058|450522003|FG000|Overall Study|Other: Positive Stool Result|0|||
125245112|NCT00552058|450522004|FG001|Overall Study|Other: Positive Stool Result|1|||
125245113|NCT00552058|450522003|FG000|Overall Study|Other: Randomized in error|0|||
125245114|NCT00552058|450522004|FG001|Overall Study|Other: Randomized in error|1|||
125245115|NCT00552058|450522003|FG000|Overall Study|Other: Sponsors Decision|0|||
125192048|NCT02101736|450326056|FG001|Overall Study|Withdrawal by Subject|1|||
125245116|NCT00552058|450522004|FG001|Overall Study|Other: Sponsors Decision|1|||
125245117|NCT00552058|450522003|FG000|Overall Study|Other: Early Roll Over|1|||
125245118|NCT00552058|450522004|FG001|Overall Study|Other: Early Roll Over|0|||
125245119|NCT00845182|450522005|FG000|Overall Study|Lost to Follow-up|3|||
125245120|NCT00845182|450522006|FG001|Overall Study|Lost to Follow-up|3|||
125245121|NCT00845182|450522007|FG002|Overall Study|Lost to Follow-up|4|||
125245122|NCT00845182|450522005|FG000|Overall Study|Adverse Event|0|||
125245123|NCT00845182|450522006|FG001|Overall Study|Adverse Event|1|||
125245124|NCT00845182|450522007|FG002|Overall Study|Adverse Event|1|||
125245125|NCT00845182|450522005|FG000|Overall Study|Physician Decision|0|||
125245126|NCT00845182|450522006|FG001|Overall Study|Physician Decision|0|||
125245127|NCT00845182|450522007|FG002|Overall Study|Physician Decision|1|||
125245128|NCT01348698|450522008|FG000|Overall Study|Does not meet lesion size criteria|1|||
125245129|NCT01348698|450522008|FG000|Overall Study|Death|3|||
125245130|NCT01348698|450522008|FG000|Overall Study|PI decision to close study|68|||
125245131|NCT02595749|450522009|FG000|Overall Study|Withdrawal by Subject|12|||
125245132|NCT02595749|450522010|FG001|Overall Study|Withdrawal by Subject|7|||
125245133|NCT00263562|450522011|FG000|Overall Study|Protocol Violation|3|||
125245134|NCT00263562|450522012|FG001|Overall Study|Protocol Violation|0|||
125245135|NCT00986232|450522015|FG000|Overall Study|Adverse Event|1|||
125245136|NCT00986232|450522016|FG001|Overall Study|Adverse Event|2|||
125245137|NCT00986232|450522017|FG002|Overall Study|Adverse Event|3|||
125245138|NCT00986232|450522018|FG003|Overall Study|Adverse Event|0|||
125245139|NCT00986232|450522015|FG000|Overall Study|Lost to Follow-up|19|||
125245140|NCT00986232|450522016|FG001|Overall Study|Lost to Follow-up|12|||
125245141|NCT00986232|450522017|FG002|Overall Study|Lost to Follow-up|12|||
125245142|NCT00986232|450522018|FG003|Overall Study|Lost to Follow-up|7|||
125245143|NCT00986232|450522015|FG000|Overall Study|Protocol Violation|2|||
125245144|NCT00986232|450522016|FG001|Overall Study|Protocol Violation|3|||
125245145|NCT00986232|450522017|FG002|Overall Study|Protocol Violation|0|||
125245146|NCT00986232|450522018|FG003|Overall Study|Protocol Violation|1|||
125245147|NCT00986232|450522015|FG000|Overall Study|Withdrawal by Subject|13|||
125245148|NCT00986232|450522016|FG001|Overall Study|Withdrawal by Subject|16|||
125245149|NCT00986232|450522017|FG002|Overall Study|Withdrawal by Subject|12|||
125245150|NCT00986232|450522018|FG003|Overall Study|Withdrawal by Subject|3|||
125245151|NCT00986232|450522015|FG000|Overall Study|Missed one or more bleeds|13|||
125245152|NCT00986232|450522016|FG001|Overall Study|Missed one or more bleeds|10|||
125245153|NCT00986232|450522017|FG002|Overall Study|Missed one or more bleeds|6|||
125245154|NCT00986232|450522018|FG003|Overall Study|Missed one or more bleeds|7|||
125245155|NCT00986232|450522015|FG000|Overall Study|Incomplete safety follow-up|3|||
125245156|NCT00986232|450522016|FG001|Overall Study|Incomplete safety follow-up|7|||
125245157|NCT00986232|450522017|FG002|Overall Study|Incomplete safety follow-up|2|||
125245158|NCT00986232|450522018|FG003|Overall Study|Incomplete safety follow-up|2|||
125245159|NCT05558410|450522019|FG000|Overall Study|Adverse Event|1|||
125245160|NCT05558410|450522020|FG001|Overall Study|Adverse Event|2|||
125245161|NCT05558410|450522021|FG002|Overall Study|Adverse Event|0|||
125245162|NCT05558410|450522019|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
125245163|NCT05558410|450522020|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
125245164|NCT05558410|450522021|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
125245165|NCT05558410|450522019|FG000|Overall Study|Lost to Follow-up|10|||
125245166|NCT05558410|450522020|FG001|Overall Study|Lost to Follow-up|17|||
125245167|NCT05558410|450522021|FG002|Overall Study|Lost to Follow-up|19|||
125245168|NCT05558410|450522019|FG000|Overall Study|Death|1|||
125245169|NCT05558410|450522020|FG001|Overall Study|Death|0|||
125245170|NCT05558410|450522021|FG002|Overall Study|Death|0|||
125245171|NCT05558410|450522019|FG000|Overall Study|Other non-compliance|0|||
125245172|NCT05558410|450522020|FG001|Overall Study|Other non-compliance|1|||
125245173|NCT05558410|450522021|FG002|Overall Study|Other non-compliance|2|||
125245174|NCT05558410|450522019|FG000|Overall Study|Sponsor Decision|1|||
125245175|NCT05558410|450522020|FG001|Overall Study|Sponsor Decision|0|||
125245176|NCT05558410|450522021|FG002|Overall Study|Sponsor Decision|0|||
125245177|NCT05558410|450522019|FG000|Overall Study|Other|1|||
125245178|NCT05558410|450522020|FG001|Overall Study|Other|0|||
125245179|NCT05558410|450522021|FG002|Overall Study|Other|1|||
125245180|NCT02400580|450522022|FG000|Overall Study|Withdrawal by Subject|1|||
125245181|NCT02400580|450522023|FG001|Overall Study|Withdrawal by Subject|1|||
125245182|NCT02400580|450522022|FG000|Overall Study|Adverse Event|1|||
125245183|NCT02400580|450522023|FG001|Overall Study|Adverse Event|0|||
125245184|NCT00965094|450522024|FG000|Overall Study|Adverse Event|5|||
125245185|NCT00965094|450522025|FG001|Overall Study|Adverse Event|0|||
125245186|NCT00965094|450522024|FG000|Overall Study|Lost to Follow-up|0|||
125245187|NCT00965094|450522025|FG001|Overall Study|Lost to Follow-up|1|||
125245188|NCT01336972|450522026|FG000|Overall Study|Adverse Event|1|||
125245189|NCT01336972|450522027|FG001|Overall Study|Adverse Event|1|||
125245190|NCT01336972|450522028|FG002|Overall Study|Adverse Event|0|||
125245191|NCT03446573|450522032|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
125245192|NCT03446573|450522033|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
125245193|NCT03446573|450522032|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
125245194|NCT03446573|450522033|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
125245195|NCT03446573|450522032|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
125245196|NCT03446573|450522033|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
125245197|NCT03446573|450522032|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
125245198|NCT03446573|450522033|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
125245199|NCT03446573|450522032|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
125245200|NCT03446573|450522033|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
125245201|NCT03446573|450522032|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
125245202|NCT03446573|450522033|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
125245203|NCT03446573|450522032|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
125245204|NCT03446573|450522033|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
125245205|NCT03446573|450522032|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
125245206|NCT03446573|450522033|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
125245207|NCT03446573|450522032|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
125245208|NCT03446573|450522033|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
125245209|NCT03446573|450522032|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
125245210|NCT03446573|450522033|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
125245211|NCT03446573|450522032|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
125245212|NCT03446573|450522033|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
125245213|NCT03446573|450522032|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
125245214|NCT03446573|450522033|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
125245215|NCT03446573|450522032|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
125245216|NCT03446573|450522033|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
125245217|NCT05987540|450522036|FG000|Overall Study|Withdrawal by Subject|2|||
125245218|NCT05987540|450522036|FG000|Overall Study|Death|1|||
125245219|NCT05987540|450522036|FG000|Overall Study|Study Termination|1|||
125245220|NCT05987540|450522036|FG000|Overall Study|Adverse Event|2|||
125245221|NCT00471107|450522037|FG000|Overall Study|Technical problems/data loss|3|||
125245222|NCT00471107|450522038|FG001|Overall Study|Technical problems/data loss|1|||
125245223|NCT00471107|450522039|FG002|Overall Study|Technical problems/data loss|3|||
125245224|NCT04996264|450522040|FG000|Overall Study|Lost to Follow-up|0|||
125245225|NCT04996264|450522041|FG001|Overall Study|Lost to Follow-up|1|||
125245226|NCT04996264|450522040|FG000|Overall Study|Withdrawal by Subject|4|||
125245227|NCT04996264|450522041|FG001|Overall Study|Withdrawal by Subject|3|||
125245228|NCT04996264|450522040|FG000|Overall Study|1 left AMA|0|||
125245229|NCT04996264|450522041|FG001|Overall Study|1 left AMA|1|||
125245230|NCT04996264|450522040|FG000|Overall Study|Subject changed hospitals|0|||
125245231|NCT04996264|450522041|FG001|Overall Study|Subject changed hospitals|1|||
125245232|NCT04996264|450522040|FG000|Overall Study|unable to complete due to work|0|||
125245233|NCT04996264|450522041|FG001|Overall Study|unable to complete due to work|1|||
125245234|NCT04433975|450522042|FG000|1-month Follow Up|Withdrawal by Subject|1|||
125245235|NCT04433975|450522043|FG001|1-month Follow Up|Withdrawal by Subject|1|||
125245236|NCT04433975|450522042|FG000|1-month Follow Up|Lost to Follow-up|21|||
125245237|NCT04433975|450522043|FG001|1-month Follow Up|Lost to Follow-up|25|||
125245238|NCT04433975|450522042|FG000|3-month Follow Up|Lost to Follow-up|20|||
125245239|NCT04433975|450522043|FG001|3-month Follow Up|Lost to Follow-up|24|||
125245240|NCT04433975|450522042|FG000|3-month Follow Up|Death|1|||
125245241|NCT04433975|450522043|FG001|3-month Follow Up|Death|0|||
125245242|NCT04433975|450522042|FG000|3-month Follow Up|Withdrawal by Subject|2|||
125245243|NCT04433975|450522043|FG001|3-month Follow Up|Withdrawal by Subject|0|||
125245244|NCT04433975|450522042|FG000|6-month Follow Up|Lost to Follow-up|23|||
125245245|NCT04433975|450522043|FG001|6-month Follow Up|Lost to Follow-up|28|||
125245246|NCT04433975|450522042|FG000|6-month Follow Up|Withdrawal by Subject|1|||
125245247|NCT04433975|450522043|FG001|6-month Follow Up|Withdrawal by Subject|1|||
125245248|NCT04433975|450522042|FG000|9-month Follow Up|Lost to Follow-up|27|||
125245249|NCT04433975|450522043|FG001|9-month Follow Up|Lost to Follow-up|36|||
125245250|NCT04433975|450522042|FG000|9-month Follow Up|Death|0|||
125245251|NCT04433975|450522043|FG001|9-month Follow Up|Death|1|||
125245252|NCT04433975|450522042|FG000|12-month Follow Up|Lost to Follow-up|27|||
125245253|NCT04433975|450522043|FG001|12-month Follow Up|Lost to Follow-up|31|||
125245254|NCT04606771|450522044|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
125245255|NCT04606771|450522045|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
125245256|NCT04606771|450522044|FG000|Overall Study|Death|5|||
125245257|NCT04606771|450522045|FG001|Overall Study|Death|6|||
125192049|NCT02498444|450326062|FG000|Overall Study|Withdrawal by Subject|3|||
125192050|NCT02498444|450326063|FG001|Overall Study|Withdrawal by Subject|0|||
125192051|NCT02498444|450326062|FG000|Overall Study|Physician Decision|1|||
125192052|NCT02498444|450326063|FG001|Overall Study|Physician Decision|0|||
125192053|NCT02027545|450326064|FG000|Overall Study|Failed to sign HIPAA|0|||
125192054|NCT02027545|450326065|FG001|Overall Study|Failed to sign HIPAA|2|||
125192055|NCT02027545|450326064|FG000|Overall Study|Failed to attend study visit|2|||
125192056|NCT02027545|450326065|FG001|Overall Study|Failed to attend study visit|0|||
125192057|NCT02027545|450326064|FG000|Overall Study|Protocol Violation|1|||
125192058|NCT02027545|450326065|FG001|Overall Study|Protocol Violation|0|||
125192059|NCT02453334|450326066|FG000|Overall Study|Death|15|||
125192060|NCT02453334|450326067|FG001|Overall Study|Death|13|||
125192061|NCT02453334|450326066|FG000|Overall Study|Adverse Event|2|||
125192062|NCT02453334|450326067|FG001|Overall Study|Adverse Event|1|||
125192063|NCT02453334|450326066|FG000|Overall Study|Lost to Follow-up|5|||
125192064|NCT02453334|450326067|FG001|Overall Study|Lost to Follow-up|9|||
125192065|NCT02453334|450326066|FG000|Overall Study|Physician Decision|1|||
125192066|NCT02453334|450326067|FG001|Overall Study|Physician Decision|0|||
125192067|NCT02453334|450326066|FG000|Overall Study|Withdrawal by Subject|17|||
125192068|NCT02453334|450326067|FG001|Overall Study|Withdrawal by Subject|13|||
125192069|NCT02453334|450326066|FG000|Overall Study|Other reason|1|||
125192070|NCT02453334|450326067|FG001|Overall Study|Other reason|4|||
125192071|NCT02693106|450326070|FG000|Overall Study|No time|3|||
125192072|NCT02509507|450326071|FG000|Overall Study|Death|21|||
125192073|NCT02509507|450326072|FG001|Overall Study|Death|3|||
125192074|NCT02509507|450326073|FG002|Overall Study|Death|22|||
125192075|NCT02509507|450326074|FG003|Overall Study|Death|14|||
125192076|NCT02509507|450326075|FG004|Overall Study|Death|8|||
125192077|NCT02509507|450326076|FG005|Overall Study|Death|12|||
125192078|NCT02509507|450326077|FG006|Overall Study|Death|5|||
125192079|NCT02509507|450326078|FG007|Overall Study|Death|4|||
125192080|NCT02509507|450326079|FG008|Overall Study|Death|8|||
125192081|NCT02509507|450326071|FG000|Overall Study|Lost to Follow-up|0|||
125192082|NCT02509507|450326072|FG001|Overall Study|Lost to Follow-up|1|||
125192083|NCT02509507|450326073|FG002|Overall Study|Lost to Follow-up|0|||
125192084|NCT02509507|450326074|FG003|Overall Study|Lost to Follow-up|0|||
125192085|NCT02509507|450326075|FG004|Overall Study|Lost to Follow-up|0|||
125192086|NCT02509507|450326076|FG005|Overall Study|Lost to Follow-up|2|||
125192087|NCT02509507|450326077|FG006|Overall Study|Lost to Follow-up|0|||
125192088|NCT02509507|450326078|FG007|Overall Study|Lost to Follow-up|0|||
125192089|NCT02509507|450326079|FG008|Overall Study|Lost to Follow-up|0|||
125192090|NCT02509507|450326071|FG000|Overall Study|Withdrawal by Subject|2|||
125192091|NCT02509507|450326072|FG001|Overall Study|Withdrawal by Subject|0|||
125192092|NCT02509507|450326073|FG002|Overall Study|Withdrawal by Subject|1|||
125192093|NCT02509507|450326074|FG003|Overall Study|Withdrawal by Subject|4|||
125192094|NCT02509507|450326075|FG004|Overall Study|Withdrawal by Subject|1|||
125192095|NCT02509507|450326076|FG005|Overall Study|Withdrawal by Subject|3|||
125192096|NCT02509507|450326077|FG006|Overall Study|Withdrawal by Subject|4|||
125192097|NCT02509507|450326078|FG007|Overall Study|Withdrawal by Subject|0|||
125192098|NCT02509507|450326079|FG008|Overall Study|Withdrawal by Subject|1|||
125192099|NCT03337113|450326085|FG000|Overall Study|Adverse Event|1|||
125192100|NCT03337113|450326086|FG001|Overall Study|Adverse Event|1|||
125192101|NCT03337113|450326087|FG002|Overall Study|Adverse Event|0|||
125192102|NCT03337113|450326088|FG003|Overall Study|Adverse Event|1|||
125192103|NCT03337113|450326085|FG000|Overall Study|Physician Decision|0|||
125192104|NCT03337113|450326086|FG001|Overall Study|Physician Decision|2|||
125192105|NCT03337113|450326087|FG002|Overall Study|Physician Decision|0|||
125192106|NCT03337113|450326088|FG003|Overall Study|Physician Decision|1|||
125192107|NCT03337113|450326085|FG000|Overall Study|Withdrawal by Subject|0|||
125192108|NCT03337113|450326086|FG001|Overall Study|Withdrawal by Subject|0|||
125192109|NCT03337113|450326087|FG002|Overall Study|Withdrawal by Subject|1|||
125192110|NCT03337113|450326088|FG003|Overall Study|Withdrawal by Subject|0|||
125192111|NCT02176655|450326092|FG000|Overall Study|Subjects did not treat|6|||
125192112|NCT04938180|450326097|FG000|Overall Study|Adverse Event|1|||
125192113|NCT04747886|450326098|FG000|Overall Study|Withdrawal by Subject|1|||
125192114|NCT04747886|450326099|FG001|Overall Study|Withdrawal by Subject|4|||
125192115|NCT00402688|450326105|FG000|Overall Study|Adverse Event|12|||
125192116|NCT00402688|450326106|FG001|Overall Study|Adverse Event|9|||
125192117|NCT00402688|450326107|FG002|Overall Study|Adverse Event|3|||
125192118|NCT00402688|450326105|FG000|Overall Study|Withdrawal by Subject|3|||
125192119|NCT00402688|450326106|FG001|Overall Study|Withdrawal by Subject|1|||
125192120|NCT00402688|450326107|FG002|Overall Study|Withdrawal by Subject|1|||
125245258|NCT04606771|450522044|FG000|Overall Study|Wrong randomisation|0|||
125192121|NCT00402688|450326105|FG000|Overall Study|Physician Decision|0|||
125192122|NCT00402688|450326106|FG001|Overall Study|Physician Decision|0|||
125192123|NCT00402688|450326107|FG002|Overall Study|Physician Decision|1|||
125192124|NCT00402688|450326105|FG000|Overall Study|Lack of Efficacy|4|||
125192125|NCT00402688|450326106|FG001|Overall Study|Lack of Efficacy|4|||
125192126|NCT00402688|450326107|FG002|Overall Study|Lack of Efficacy|5|||
125192127|NCT00402688|450326105|FG000|Overall Study|Protocol Violation|1|||
125245259|NCT04606771|450522045|FG001|Overall Study|Wrong randomisation|1|||
125245260|NCT04392635|450522048|FG000|Overall Study|Lost to Follow-up|0|||
125245261|NCT04392635|450522049|FG001|Overall Study|Lost to Follow-up|1|||
125245262|NCT02030418|450522050|FG000|Overall Study|Death|78|||
125245263|NCT02030418|450522050|FG000|Overall Study|Missed 12-Month Visit|9|||
125245264|NCT02030418|450522050|FG000|Overall Study|Withdrawn|57|||
125245265|NCT00888849|450522051|FG000|Overall Study|Death|4|||
125245266|NCT00888849|450522052|FG001|Overall Study|Death|7|||
125245267|NCT00888849|450522051|FG000|Overall Study|Lost to Follow-up|1|||
125245268|NCT00888849|450522052|FG001|Overall Study|Lost to Follow-up|2|||
125245269|NCT04149353|450522058|FG000|Overall Study|Study terminated|1|||
125245270|NCT00356421|450522060|FG000|Overall Study|Lack of Efficacy|3|||
125245271|NCT00356421|450522061|FG001|Overall Study|Lack of Efficacy|0|||
125245272|NCT00356421|450522060|FG000|Overall Study|Withdrawal by Subject|9|||
125245273|NCT00356421|450522061|FG001|Overall Study|Withdrawal by Subject|2|||
125245274|NCT00356421|450522060|FG000|Overall Study|Related to study drug|15|||
125245275|NCT00356421|450522061|FG001|Overall Study|Related to study drug|12|||
125245276|NCT00356421|450522060|FG000|Overall Study|Not related to study drug|5|||
125245277|NCT00356421|450522061|FG001|Overall Study|Not related to study drug|3|||
125245278|NCT00887588|450522062|FG000|Core Period|Death|1|||
125245279|NCT00887588|450522063|FG001|Core Period|Death|1|||
125245280|NCT00887588|450522062|FG000|Core Period|Lost to Follow-up|3|||
125245281|NCT00887588|450522063|FG001|Core Period|Lost to Follow-up|1|||
125245282|NCT00887588|450522062|FG000|Core Period|Withdrawal by Subject|6|||
125245283|NCT00887588|450522063|FG001|Core Period|Withdrawal by Subject|8|||
125245284|NCT00887588|450522062|FG000|Core Period|Adverse Event|9|||
125245285|NCT00887588|450522063|FG001|Core Period|Adverse Event|11|||
125245286|NCT00887588|450522062|FG000|Extension Period|Adverse Event|4|||
125245287|NCT00887588|450522063|FG001|Extension Period|Adverse Event|4|||
125245288|NCT00887588|450522062|FG000|Extension Period|Death|0|||
125245289|NCT00887588|450522063|FG001|Extension Period|Death|1|||
125245290|NCT00887588|450522062|FG000|Extension Period|Protocol deviation|1|||
125245291|NCT00887588|450522063|FG001|Extension Period|Protocol deviation|0|||
125245292|NCT00887588|450522062|FG000|Extension Period|Lost to Follow-up|1|||
125245293|NCT00887588|450522063|FG001|Extension Period|Lost to Follow-up|0|||
125245294|NCT03753542|450522066|FG000|Overall Study|Lost to Follow-up|9|||
125245295|NCT03753542|450522067|FG001|Overall Study|Lost to Follow-up|14|||
125245296|NCT06100250|450522068|FG000|Overall Study|Lost to Follow-up|5|||
125245297|NCT02021318|450522069|FG000|Overall Study|Adverse Event|2|||
125245298|NCT02021318|450522070|FG001|Overall Study|Adverse Event|1|||
125245299|NCT02021318|450522069|FG000|Overall Study|Death|33|||
125245300|NCT02021318|450522070|FG001|Overall Study|Death|34|||
125245301|NCT02021318|450522069|FG000|Overall Study|Lost to Follow-up|3|||
125245302|NCT02021318|450522070|FG001|Overall Study|Lost to Follow-up|3|||
125245303|NCT02021318|450522069|FG000|Overall Study|Progressive Disease|0|||
125245304|NCT02021318|450522070|FG001|Overall Study|Progressive Disease|1|||
125245305|NCT02021318|450522069|FG000|Overall Study|Withdrawal by Subject|30|||
125245306|NCT02021318|450522070|FG001|Overall Study|Withdrawal by Subject|18|||
125245307|NCT02021318|450522069|FG000|Overall Study|Physician Decision|3|||
125245308|NCT02021318|450522070|FG001|Overall Study|Physician Decision|3|||
125245309|NCT02021318|450522069|FG000|Overall Study|Miscellaneous|2|||
125245310|NCT02021318|450522070|FG001|Overall Study|Miscellaneous|3|||
125245311|NCT00421993|450522072|FG000|Overall Study|Withdrawal by Subject|22|||
125245312|NCT00421993|450522073|FG001|Overall Study|Withdrawal by Subject|23|||
125245313|NCT00421993|450522074|FG002|Overall Study|Withdrawal by Subject|23|||
125245314|NCT00421993|450522075|FG003|Overall Study|Withdrawal by Subject|24|||
125245315|NCT00421993|450522072|FG000|Overall Study|Lost to Follow-up|18|||
125245316|NCT00421993|450522073|FG001|Overall Study|Lost to Follow-up|19|||
125245317|NCT00421993|450522074|FG002|Overall Study|Lost to Follow-up|22|||
125245318|NCT00421993|450522075|FG003|Overall Study|Lost to Follow-up|20|||
125245319|NCT00421993|450522072|FG000|Overall Study|Adverse Event|11|||
125245320|NCT00421993|450522073|FG001|Overall Study|Adverse Event|1|||
125245321|NCT00421993|450522074|FG002|Overall Study|Adverse Event|6|||
125245322|NCT00421993|450522075|FG003|Overall Study|Adverse Event|4|||
125245323|NCT00421993|450522072|FG000|Overall Study|Protocol Violation|2|||
125245324|NCT00421993|450522073|FG001|Overall Study|Protocol Violation|2|||
125245325|NCT00421993|450522074|FG002|Overall Study|Protocol Violation|0|||
125245326|NCT00421993|450522075|FG003|Overall Study|Protocol Violation|1|||
125245327|NCT00421993|450522072|FG000|Overall Study|Lack of Efficacy|0|||
125245328|NCT00421993|450522073|FG001|Overall Study|Lack of Efficacy|3|||
125245329|NCT00421993|450522074|FG002|Overall Study|Lack of Efficacy|0|||
125245330|NCT00421993|450522075|FG003|Overall Study|Lack of Efficacy|5|||
125245331|NCT00421993|450522072|FG000|Overall Study|Pregnancy|0|||
125245332|NCT00421993|450522073|FG001|Overall Study|Pregnancy|1|||
125245333|NCT00421993|450522074|FG002|Overall Study|Pregnancy|1|||
125245334|NCT00421993|450522075|FG003|Overall Study|Pregnancy|2|||
125245335|NCT00421993|450522072|FG000|Overall Study|Subject transportation issues|0|||
125245336|NCT00421993|450522073|FG001|Overall Study|Subject transportation issues|0|||
125245337|NCT00421993|450522074|FG002|Overall Study|Subject transportation issues|0|||
125245338|NCT00421993|450522075|FG003|Overall Study|Subject transportation issues|1|||
125245339|NCT02015104|450522080|FG000|Overall Study|Withdrew consent after first dose drug|1|||
125245340|NCT02015104|450522081|FG001|Overall Study|Withdrew consent after first dose drug|0|||
125245341|NCT02015104|450522080|FG000|Overall Study|Withdrew consent prior to treatment|0|||
125245342|NCT02015104|450522081|FG001|Overall Study|Withdrew consent prior to treatment|1|||
125245343|NCT01030900|450522088|FG000|Overall Study|Not treated due to congestive heart failure|1|||
125245344|NCT01030900|450522088|FG000|Overall Study|Not treated due to rapid disease|1|||
125245345|NCT00441896|450522089|FG000|Overall Study|Withdrawal by Subject|0|||
125245346|NCT00441896|450522090|FG001|Overall Study|Withdrawal by Subject|0|||
125245347|NCT00441896|450522091|FG002|Overall Study|Withdrawal by Subject|0|||
125245348|NCT00441896|450522092|FG003|Overall Study|Withdrawal by Subject|1|||
125245349|NCT00441896|450522093|FG004|Overall Study|Withdrawal by Subject|0|||
125245350|NCT00441896|450522094|FG005|Overall Study|Withdrawal by Subject|0|||
125245351|NCT00441896|450522095|FG006|Overall Study|Withdrawal by Subject|0|||
125245352|NCT00441896|450522096|FG007|Overall Study|Withdrawal by Subject|0|||
125245353|NCT00441896|450522097|FG008|Overall Study|Withdrawal by Subject|0|||
125245354|NCT00441896|450522098|FG009|Overall Study|Withdrawal by Subject|0|||
125245355|NCT00441896|450522089|FG000|Overall Study|Other|0|||
125245356|NCT00441896|450522090|FG001|Overall Study|Other|0|||
125245357|NCT00441896|450522091|FG002|Overall Study|Other|0|||
125245358|NCT00441896|450522092|FG003|Overall Study|Other|0|||
125245359|NCT00441896|450522093|FG004|Overall Study|Other|1|||
125245360|NCT00441896|450522094|FG005|Overall Study|Other|0|||
125245361|NCT00441896|450522095|FG006|Overall Study|Other|0|||
125245362|NCT00441896|450522096|FG007|Overall Study|Other|0|||
125245363|NCT00441896|450522097|FG008|Overall Study|Other|0|||
125245364|NCT00441896|450522098|FG009|Overall Study|Other|0|||
125245365|NCT01301092|450522099|FG000|Overall Study|Lost to Follow-up|0|||
125245366|NCT01301092|450522100|FG001|Overall Study|Lost to Follow-up|0|||
125245367|NCT01301092|450522101|FG002|Overall Study|Lost to Follow-up|1|||
125245368|NCT01350973|450522105|FG000|Overall Study|Adverse Event|4|||
125245369|NCT01350973|450522106|FG001|Overall Study|Adverse Event|7|||
125245370|NCT01350973|450522107|FG002|Overall Study|Adverse Event|7|||
125245371|NCT01350973|450522105|FG000|Overall Study|Voluntary Withdrawal|2|||
125245372|NCT01350973|450522106|FG001|Overall Study|Voluntary Withdrawal|1|||
125245373|NCT01350973|450522107|FG002|Overall Study|Voluntary Withdrawal|1|||
125245374|NCT02638493|450522108|FG000|Overall Study|Inability to provide semen samples|2|||
125245375|NCT02638493|450522109|FG001|Overall Study|Inability to provide semen samples|0|||
125245376|NCT02638493|450522110|FG002|Overall Study|Inability to provide semen samples|0|||
125245377|NCT01033071|450522111|FG000|Overall Study|Adverse Event|28|||
125245378|NCT01033071|450522112|FG001|Overall Study|Adverse Event|51|||
125245379|NCT01033071|450522113|FG002|Overall Study|Adverse Event|26|||
125245380|NCT01033071|450522111|FG000|Overall Study|Protocol Violation|0|||
125245381|NCT01033071|450522112|FG001|Overall Study|Protocol Violation|2|||
125245382|NCT01033071|450522113|FG002|Overall Study|Protocol Violation|1|||
125245383|NCT01033071|450522111|FG000|Overall Study|Lost to Follow-up|4|||
125245384|NCT01033071|450522112|FG001|Overall Study|Lost to Follow-up|5|||
125245385|NCT01033071|450522113|FG002|Overall Study|Lost to Follow-up|5|||
125245386|NCT01033071|450522111|FG000|Overall Study|Withdrawal by Subject|17|||
125245387|NCT01033071|450522112|FG001|Overall Study|Withdrawal by Subject|14|||
125245388|NCT01033071|450522113|FG002|Overall Study|Withdrawal by Subject|11|||
125245389|NCT01033071|450522111|FG000|Overall Study|Lack of Efficacy|0|||
125245390|NCT01033071|450522112|FG001|Overall Study|Lack of Efficacy|1|||
125245391|NCT01033071|450522113|FG002|Overall Study|Lack of Efficacy|1|||
125245392|NCT01033071|450522111|FG000|Overall Study|Other|6|||
125245393|NCT01033071|450522112|FG001|Overall Study|Other|4|||
125245394|NCT01033071|450522113|FG002|Overall Study|Other|3|||
125245395|NCT00004859|450522116|FG000|Overall Study|Lack of Efficacy|43|||
125245396|NCT00004859|450522117|FG001|Overall Study|Lack of Efficacy|113|||
125245397|NCT00004859|450522116|FG000|Overall Study|Adverse Event|31|||
125245398|NCT00004859|450522117|FG001|Overall Study|Adverse Event|93|||
125245399|NCT00004859|450522116|FG000|Overall Study|Death|5|||
125245400|NCT00004859|450522117|FG001|Overall Study|Death|5|||
125245401|NCT00004859|450522116|FG000|Overall Study|Withdrawal by Subject|7|||
125245402|NCT00004859|450522117|FG001|Overall Study|Withdrawal by Subject|33|||
125245403|NCT00004859|450522116|FG000|Overall Study|Protocol Violation|2|||
125245404|NCT00004859|450522117|FG001|Overall Study|Protocol Violation|2|||
125245405|NCT00004859|450522116|FG000|Overall Study|other disease|0|||
125245406|NCT00004859|450522117|FG001|Overall Study|other disease|3|||
125245407|NCT00004859|450522116|FG000|Overall Study|error|3|||
125245408|NCT00004859|450522117|FG001|Overall Study|error|1|||
125245409|NCT00004859|450522116|FG000|Overall Study|missing data|14|||
125245410|NCT00004859|450522117|FG001|Overall Study|missing data|11|||
125245411|NCT00004859|450522116|FG000|Overall Study|Other|13|||
125245412|NCT00004859|450522117|FG001|Overall Study|Other|21|||
125245413|NCT04941898|450524478|FG000|Overall Study|Protocol Violation|1|||
125245414|NCT00884949|450524479|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
125245415|NCT00884949|450524479|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
125245416|NCT01567085|450524482|FG000|Overall Study|Death|6|||
125245417|NCT01567085|450524482|FG000|Overall Study|Adverse Event|6|||
125245418|NCT01567085|450524482|FG000|Overall Study|Lost to Follow-up|3|||
125245419|NCT01567085|450524482|FG000|Overall Study|Graft loss|2|||
125245420|NCT01567085|450524482|FG000|Overall Study|Renal transplantectomy|1|||
125245421|NCT01567085|450524482|FG000|Overall Study|Returned to chronic dialysis|1|||
125245422|NCT01567085|450524482|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
125245423|NCT00504231|450524486|FG000|Overall Study|Discrepant chart documentation re route|0|||
125245424|NCT00504231|450524487|FG001|Overall Study|Discrepant chart documentation re route|0|||
125245425|NCT00504231|450524488|FG002|Overall Study|Discrepant chart documentation re route|1|||
125245426|NCT00504231|450524489|FG003|Overall Study|Discrepant chart documentation re route|0|||
125245427|NCT03928704|450524491|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
125245428|NCT03928704|450524492|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
125245429|NCT03928704|450524493|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
125245430|NCT03928704|450524494|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
125245431|NCT03928704|450524495|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
125245432|NCT03928704|450524496|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
125245433|NCT03928704|450524491|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
125245434|NCT03928704|450524492|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
125245435|NCT03928704|450524493|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
125245436|NCT03928704|450524494|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
125245437|NCT03928704|450524495|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
125245438|NCT03928704|450524496|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
125245439|NCT03928704|450524491|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
125245440|NCT03928704|450524492|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
125245441|NCT03928704|450524493|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
125245442|NCT03928704|450524494|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
125245443|NCT03928704|450524495|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
125245444|NCT03928704|450524496|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
125245445|NCT03928704|450524491|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
125245446|NCT03928704|450524492|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
125245447|NCT03928704|450524493|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
125245448|NCT03928704|450524494|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
125245449|NCT03928704|450524495|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
125245450|NCT03928704|450524496|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
125245451|NCT03928704|450524491|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
125245452|NCT03928704|450524492|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
125245453|NCT03928704|450524493|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
125245454|NCT03928704|450524494|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
125245455|NCT03928704|450524495|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
125245456|NCT03928704|450524496|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
125245457|NCT03928704|450524491|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
125245458|NCT03928704|450524492|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
125245459|NCT03928704|450524493|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
125245460|NCT03928704|450524494|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
125245461|NCT03928704|450524495|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
125245462|NCT03928704|450524496|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
125245463|NCT03928704|450524491|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
125245464|NCT03928704|450524492|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
125245465|NCT03928704|450524493|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
125245466|NCT03928704|450524494|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
125245467|NCT03928704|450524495|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
125245468|NCT03928704|450524496|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
125245469|NCT03928704|450524491|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
125245470|NCT03928704|450524492|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
125245471|NCT03928704|450524493|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
125245472|NCT03928704|450524494|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
125245473|NCT03928704|450524495|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
125245474|NCT03928704|450524496|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
125245475|NCT03928704|450524491|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
125245476|NCT03928704|450524492|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
125245477|NCT03928704|450524493|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
125245478|NCT03928704|450524494|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
125303084|NCT03100058|450736672|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
125245479|NCT03928704|450524495|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
125245480|NCT03928704|450524496|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
125245481|NCT03928704|450524491|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
125245482|NCT03928704|450524492|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
125245483|NCT03928704|450524493|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
125245484|NCT03928704|450524494|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
125245485|NCT03928704|450524495|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
125245486|NCT03928704|450524496|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
125245487|NCT04575324|450524499|FG000|Overall Study|Lost to Follow-up|29|||
125245488|NCT04575324|450524500|FG001|Overall Study|Lost to Follow-up|25|||
125245489|NCT04575324|450524499|FG000|Overall Study|Death|1|||
125245490|NCT04575324|450524500|FG001|Overall Study|Death|2|||
125245491|NCT04575324|450524499|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
125245492|NCT04575324|450524500|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
125245493|NCT01002105|450524503|FG000|Overall Study|Lost to Follow-up|10|||
125245494|NCT01002105|450524504|FG001|Overall Study|Lost to Follow-up|16|||
125245495|NCT01002105|450524503|FG000|Overall Study|non compliance|5|||
125245496|NCT01002105|450524504|FG001|Overall Study|non compliance|3|||
125245497|NCT01002105|450524503|FG000|Overall Study|condition worsened|4|||
125245498|NCT01002105|450524504|FG001|Overall Study|condition worsened|2|||
125245499|NCT00456612|450524508|FG000|Overall Study|Withdrawal by Subject|3|||
125245500|NCT00266812|450524509|FG000|Overall Study|Disease Progression|9|||
125245501|NCT00266812|450524510|FG001|Overall Study|Disease Progression|3|||
125245502|NCT00266812|450524509|FG000|Overall Study|Death|5|||
125245503|NCT00266812|450524510|FG001|Overall Study|Death|4|||
125245504|NCT00266812|450524509|FG000|Overall Study|Adverse Event|3|||
125245505|NCT00266812|450524510|FG001|Overall Study|Adverse Event|1|||
125245506|NCT00266812|450524509|FG000|Overall Study|Protocol Violation|0|||
125245507|NCT00266812|450524510|FG001|Overall Study|Protocol Violation|1|||
125245508|NCT00266812|450524509|FG000|Overall Study|Withdrawal by Subject|0|||
125245509|NCT00266812|450524510|FG001|Overall Study|Withdrawal by Subject|2|||
125245510|NCT00266812|450524509|FG000|Overall Study|Discontinued before starting study drug|4|||
125245511|NCT00266812|450524510|FG001|Overall Study|Discontinued before starting study drug|0|||
125245512|NCT03695094|450524511|FG000|Overall Study|Adverse Event|1|||
125245513|NCT03695094|450524512|FG001|Overall Study|Adverse Event|1|||
125245514|NCT03695094|450524511|FG000|Overall Study|Withdrawal by Subject|1|||
125245515|NCT03695094|450524512|FG001|Overall Study|Withdrawal by Subject|0|||
125245516|NCT02316613|450524515|FG000|Overall Study|Death|63|||
125245517|NCT02316613|450524515|FG000|Overall Study|Lost to Follow-up|9|||
125245518|NCT02316613|450524515|FG000|Overall Study|Lymphoma transformation|2|||
125192128|NCT00402688|450326106|FG001|Overall Study|Protocol Violation|1|||
125192129|NCT00402688|450326107|FG002|Overall Study|Protocol Violation|1|||
125192130|NCT00402688|450326105|FG000|Overall Study|Lost to Follow-up|1|||
125192131|NCT00402688|450326106|FG001|Overall Study|Lost to Follow-up|0|||
125192132|NCT00402688|450326107|FG002|Overall Study|Lost to Follow-up|2|||
125192133|NCT00402688|450326105|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
125192134|NCT00402688|450326106|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
125192135|NCT00402688|450326107|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
125192136|NCT00402688|450326105|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
125192137|NCT00402688|450326106|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
125192138|NCT00402688|450326107|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
125192139|NCT00402688|450326105|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
125192140|NCT00402688|450326106|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
125192141|NCT00402688|450326107|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
125192142|NCT03259425|450326109|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
125192143|NCT04157296|450326110|FG000|Overall Study|Withdrawal by Subject|0|||
125192144|NCT04157296|450326111|FG001|Overall Study|Withdrawal by Subject|1|||
125245519|NCT02316613|450524515|FG000|Overall Study|Participant moved/changed medical team|11|||
125245520|NCT02316613|450524515|FG000|Overall Study|No data and duplicate cases|5|||
125245521|NCT02316613|450524515|FG000|Overall Study|Did not met selection criteria|14|||
125245522|NCT01166945|450524516|FG000|Randomized|diagnosed with Group A strep|4|||
125245523|NCT01166945|450524517|FG001|Randomized|diagnosed with Group A strep|4|||
125192145|NCT04157296|450326110|FG000|Overall Study|Did not obtain second fMRI.|0|||
125245524|NCT01166945|450524516|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
125245525|NCT01166945|450524517|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
125245526|NCT01166945|450524516|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
125245527|NCT01166945|450524517|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
125245528|NCT01166945|450524516|FG000|Day 30|Lost to Follow-up|4|||
125245529|NCT01166945|450524517|FG001|Day 30|Lost to Follow-up|3|||
125192146|NCT04157296|450326111|FG001|Overall Study|Did not obtain second fMRI.|1|||
125192147|NCT04157296|450326110|FG000|Overall Study|MRI failed/no second fMRI|0|||
125192148|NCT04157296|450326111|FG001|Overall Study|MRI failed/no second fMRI|1|||
125245530|NCT03309605|450524520|FG000|Overall Study|Adverse Event|0|||
125192149|NCT02237196|450326112|FG000|Overall Study|Adverse Event|0|||
125192150|NCT02237196|450326113|FG001|Overall Study|Adverse Event|1|||
125192151|NCT02237196|450326114|FG002|Overall Study|Adverse Event|1|||
125192152|NCT02237196|450326115|FG003|Overall Study|Adverse Event|0|||
125192153|NCT02237196|450326112|FG000|Overall Study|Lost to Follow-up|4|||
125192154|NCT02237196|450326113|FG001|Overall Study|Lost to Follow-up|2|||
125192155|NCT02237196|450326114|FG002|Overall Study|Lost to Follow-up|4|||
125192156|NCT02237196|450326115|FG003|Overall Study|Lost to Follow-up|6|||
125192157|NCT02237196|450326112|FG000|Overall Study|Physician Decision|2|||
125192158|NCT02237196|450326113|FG001|Overall Study|Physician Decision|0|||
125192159|NCT02237196|450326114|FG002|Overall Study|Physician Decision|0|||
125192160|NCT02237196|450326115|FG003|Overall Study|Physician Decision|1|||
125192161|NCT02237196|450326112|FG000|Overall Study|Pregnancy|0|||
125192162|NCT02237196|450326113|FG001|Overall Study|Pregnancy|0|||
125192163|NCT02237196|450326114|FG002|Overall Study|Pregnancy|1|||
125192164|NCT02237196|450326115|FG003|Overall Study|Pregnancy|1|||
125192165|NCT02237196|450326112|FG000|Overall Study|Withdrawal by Subject|1|||
125192166|NCT02237196|450326113|FG001|Overall Study|Withdrawal by Subject|1|||
125192167|NCT02237196|450326114|FG002|Overall Study|Withdrawal by Subject|4|||
125192168|NCT02237196|450326115|FG003|Overall Study|Withdrawal by Subject|1|||
125192169|NCT02237196|450326112|FG000|Overall Study|Site Error|1|||
125192170|NCT02237196|450326113|FG001|Overall Study|Site Error|2|||
125192171|NCT02237196|450326114|FG002|Overall Study|Site Error|0|||
125192172|NCT02237196|450326115|FG003|Overall Study|Site Error|2|||
125192173|NCT01421225|450326128|FG000|Overall Study|Withdrawal by Subject|0|||
125192174|NCT01421225|450326129|FG001|Overall Study|Withdrawal by Subject|1|||
125192175|NCT01322490|450326130|FG000|Treatment Period|Adverse Event|12|||
125192176|NCT01322490|450326131|FG001|Treatment Period|Adverse Event|18|||
125192177|NCT01322490|450326132|FG002|Treatment Period|Adverse Event|15|||
125192178|NCT01322490|450326130|FG000|Treatment Period|Death|5|||
125192179|NCT01322490|450326131|FG001|Treatment Period|Death|7|||
125192180|NCT01322490|450326132|FG002|Treatment Period|Death|3|||
125192181|NCT01322490|450326130|FG000|Treatment Period|Lack of Efficacy|89|||
125192182|NCT01322490|450326131|FG001|Treatment Period|Lack of Efficacy|100|||
125192183|NCT01322490|450326132|FG002|Treatment Period|Lack of Efficacy|112|||
125192184|NCT01322490|450326130|FG000|Treatment Period|Physician Decision|0|||
125192185|NCT01322490|450326131|FG001|Treatment Period|Physician Decision|2|||
125192186|NCT01322490|450326132|FG002|Treatment Period|Physician Decision|1|||
125192187|NCT01322490|450326130|FG000|Treatment Period|Protocol Violation|7|||
125192188|NCT01322490|450326131|FG001|Treatment Period|Protocol Violation|5|||
125192189|NCT01322490|450326132|FG002|Treatment Period|Protocol Violation|4|||
125192190|NCT01322490|450326130|FG000|Treatment Period|Withdrawal by Subject|14|||
125192191|NCT01322490|450326131|FG001|Treatment Period|Withdrawal by Subject|16|||
125192192|NCT01322490|450326132|FG002|Treatment Period|Withdrawal by Subject|11|||
125192193|NCT01322490|450326130|FG000|Treatment Period|Non-compliance with study drug|0|||
125192194|NCT01322490|450326131|FG001|Treatment Period|Non-compliance with study drug|0|||
125192195|NCT01322490|450326132|FG002|Treatment Period|Non-compliance with study drug|1|||
125192196|NCT01322490|450326130|FG000|Treatment Period|Other per report|2|||
125192197|NCT01322490|450326131|FG001|Treatment Period|Other per report|2|||
125192198|NCT01322490|450326132|FG002|Treatment Period|Other per report|1|||
125192199|NCT01322490|450326130|FG000|Treatment Period|Randomized but Not Treated|3|||
125192200|NCT01322490|450326131|FG001|Treatment Period|Randomized but Not Treated|3|||
125192201|NCT01322490|450326132|FG002|Treatment Period|Randomized but Not Treated|5|||
125192202|NCT01322490|450326130|FG000|Long Term Follow-up Period|Death|235|||
125192203|NCT01322490|450326131|FG001|Long Term Follow-up Period|Death|239|||
125192204|NCT01322490|450326132|FG002|Long Term Follow-up Period|Death|236|||
125192205|NCT01322490|450326130|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
125192206|NCT01322490|450326131|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
125192207|NCT01322490|450326132|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
125192208|NCT01322490|450326130|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
125192209|NCT01322490|450326131|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
125192210|NCT01322490|450326132|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
125192211|NCT01322490|450326130|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
125192212|NCT01322490|450326131|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
125192213|NCT01322490|450326132|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
125192214|NCT01322490|450326130|FG000|Long Term Follow-up Period|Other per report|3|||
125192215|NCT01322490|450326131|FG001|Long Term Follow-up Period|Other per report|2|||
125192216|NCT01322490|450326132|FG002|Long Term Follow-up Period|Other per report|2|||
125192217|NCT01322490|450326130|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
125192218|NCT01322490|450326131|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
125192219|NCT01322490|450326132|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
125192220|NCT00356148|450326133|FG000|Overall Study|Reoperation within 30 days|2|||
125192221|NCT00356148|450326134|FG001|Overall Study|Reoperation within 30 days|1|||
125192222|NCT02693002|450326135|FG000|Overall Study|Withdrawal by Subject|1|||
125192223|NCT02693002|450326136|FG001|Overall Study|Withdrawal by Subject|0|||
125192224|NCT00014495|450326137|FG000|Overall Study|Death|0|||
125192225|NCT00014495|450326138|FG001|Overall Study|Death|0|||
125192226|NCT00014495|450326139|FG002|Overall Study|Death|1|||
125192227|NCT00014495|450326140|FG003|Overall Study|Death|0|||
125192228|NCT00014495|450326137|FG000|Overall Study|Clinical deterioration|0|||
125192229|NCT00014495|450326138|FG001|Overall Study|Clinical deterioration|0|||
125192230|NCT00014495|450326139|FG002|Overall Study|Clinical deterioration|0|||
125192231|NCT00014495|450326140|FG003|Overall Study|Clinical deterioration|1|||
125192232|NCT00984542|450326141|FG000|Overall Study|disease progression|19|||
125192233|NCT00984542|450326141|FG000|Overall Study|toxicity|7|||
125192234|NCT00984542|450326141|FG000|Overall Study|Death|7|||
125192235|NCT00984542|450326141|FG000|Overall Study|complicating disease|3|||
125192236|NCT00984542|450326141|FG000|Overall Study|Withdrawal by Subject|3|||
125192237|NCT00984542|450326141|FG000|Overall Study|clinical deterioration|2|||
125192238|NCT02929589|450326176|FG000|Overall Study|Withdrawal by Subject|1|||
125192239|NCT02929589|450326177|FG001|Overall Study|Withdrawal by Subject|0|||
125192240|NCT02929589|450326178|FG002|Overall Study|Withdrawal by Subject|0|||
125192241|NCT02929589|450326179|FG003|Overall Study|Withdrawal by Subject|0|||
125192242|NCT02929589|450326176|FG000|Overall Study|Physician Decision|2|||
125192243|NCT02929589|450326177|FG001|Overall Study|Physician Decision|0|||
125192244|NCT02929589|450326178|FG002|Overall Study|Physician Decision|0|||
125192245|NCT02929589|450326179|FG003|Overall Study|Physician Decision|0|||
125192246|NCT01422889|450326180|FG000|Overall Study|No Data Entered for Study Stent|9|||
125192247|NCT02091089|450326181|FG000|Overall Study|Lost to Follow-up|2|||
125192248|NCT02343939|450326182|FG000|Overall Study|Death|0|||
125192249|NCT02343939|450326183|FG001|Overall Study|Death|15|||
125192250|NCT02343939|450326184|FG002|Overall Study|Death|4|||
125192251|NCT02343939|450326185|FG003|Overall Study|Death|2|||
125192252|NCT02343939|450326186|FG004|Overall Study|Death|5|||
125192253|NCT02343939|450326187|FG005|Overall Study|Death|11|||
125192254|NCT02343939|450326188|FG006|Overall Study|Death|8|||
125192255|NCT02343939|450326189|FG007|Overall Study|Death|22|||
125192256|NCT02343939|450326190|FG008|Overall Study|Death|1|||
125192257|NCT02343939|450326182|FG000|Overall Study|Study terminated by sponsor|0|||
125192258|NCT02343939|450326183|FG001|Overall Study|Study terminated by sponsor|27|||
125192259|NCT02343939|450326184|FG002|Overall Study|Study terminated by sponsor|0|||
125192260|NCT02343939|450326185|FG003|Overall Study|Study terminated by sponsor|1|||
125192261|NCT02343939|450326186|FG004|Overall Study|Study terminated by sponsor|1|||
125192262|NCT02343939|450326187|FG005|Overall Study|Study terminated by sponsor|5|||
125192263|NCT02343939|450326188|FG006|Overall Study|Study terminated by sponsor|3|||
125192264|NCT02343939|450326189|FG007|Overall Study|Study terminated by sponsor|4|||
125192265|NCT02343939|450326190|FG008|Overall Study|Study terminated by sponsor|0|||
125192266|NCT02343939|450326182|FG000|Overall Study|Withdrew consent|3|||
125192267|NCT02343939|450326183|FG001|Overall Study|Withdrew consent|6|||
125192268|NCT02343939|450326184|FG002|Overall Study|Withdrew consent|1|||
125192269|NCT02343939|450326185|FG003|Overall Study|Withdrew consent|2|||
125192270|NCT02343939|450326186|FG004|Overall Study|Withdrew consent|2|||
125192271|NCT02343939|450326187|FG005|Overall Study|Withdrew consent|0|||
125192272|NCT02343939|450326188|FG006|Overall Study|Withdrew consent|0|||
125192273|NCT02343939|450326189|FG007|Overall Study|Withdrew consent|8|||
125245531|NCT03309605|450524521|FG001|Overall Study|Adverse Event|0|||
125192274|NCT02343939|450326190|FG008|Overall Study|Withdrew consent|6|||
125192275|NCT02343939|450326182|FG000|Overall Study|Treatment failure|0|||
125192276|NCT02343939|450326183|FG001|Overall Study|Treatment failure|0|||
125192277|NCT02343939|450326184|FG002|Overall Study|Treatment failure|0|||
125192278|NCT02343939|450326185|FG003|Overall Study|Treatment failure|0|||
125192279|NCT02343939|450326186|FG004|Overall Study|Treatment failure|0|||
125192280|NCT02343939|450326187|FG005|Overall Study|Treatment failure|0|||
125192281|NCT02343939|450326188|FG006|Overall Study|Treatment failure|2|||
125192282|NCT02343939|450326189|FG007|Overall Study|Treatment failure|1|||
125192283|NCT02343939|450326190|FG008|Overall Study|Treatment failure|0|||
125192284|NCT02343939|450326182|FG000|Overall Study|Investigator's discretion|0|||
125192285|NCT02343939|450326183|FG001|Overall Study|Investigator's discretion|0|||
125192286|NCT02343939|450326184|FG002|Overall Study|Investigator's discretion|0|||
125192287|NCT02343939|450326185|FG003|Overall Study|Investigator's discretion|1|||
125192288|NCT02343939|450326186|FG004|Overall Study|Investigator's discretion|0|||
125192289|NCT02343939|450326187|FG005|Overall Study|Investigator's discretion|0|||
125192290|NCT02343939|450326188|FG006|Overall Study|Investigator's discretion|1|||
125192291|NCT02343939|450326189|FG007|Overall Study|Investigator's discretion|0|||
125192292|NCT02343939|450326190|FG008|Overall Study|Investigator's discretion|0|||
125192293|NCT02343939|450326182|FG000|Overall Study|Adverse Event|0|||
125192294|NCT02343939|450326183|FG001|Overall Study|Adverse Event|0|||
125192295|NCT02343939|450326184|FG002|Overall Study|Adverse Event|0|||
125192296|NCT02343939|450326185|FG003|Overall Study|Adverse Event|0|||
125192297|NCT02343939|450326186|FG004|Overall Study|Adverse Event|0|||
125192298|NCT02343939|450326187|FG005|Overall Study|Adverse Event|1|||
125192299|NCT02343939|450326188|FG006|Overall Study|Adverse Event|0|||
125192300|NCT02343939|450326189|FG007|Overall Study|Adverse Event|0|||
125192301|NCT02343939|450326190|FG008|Overall Study|Adverse Event|0|||
125192302|NCT02343939|450326182|FG000|Overall Study|Never Treated With ENTO|0|||
125192303|NCT02343939|450326183|FG001|Overall Study|Never Treated With ENTO|0|||
125192304|NCT02343939|450326184|FG002|Overall Study|Never Treated With ENTO|0|||
125192305|NCT02343939|450326185|FG003|Overall Study|Never Treated With ENTO|0|||
125192306|NCT02343939|450326186|FG004|Overall Study|Never Treated With ENTO|0|||
125192307|NCT02343939|450326187|FG005|Overall Study|Never Treated With ENTO|0|||
125192308|NCT02343939|450326188|FG006|Overall Study|Never Treated With ENTO|1|||
125192309|NCT02343939|450326189|FG007|Overall Study|Never Treated With ENTO|2|||
125192310|NCT02343939|450326190|FG008|Overall Study|Never Treated With ENTO|0|||
125192311|NCT01580670|450326195|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
125192312|NCT01580670|450326195|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
125192313|NCT00665431|450326198|FG000|Overall Study|Adverse Event|16|||
125192314|NCT00665431|450326199|FG001|Overall Study|Adverse Event|22|||
125192315|NCT00665431|450326200|FG002|Overall Study|Adverse Event|6|||
125192316|NCT00665431|450326198|FG000|Overall Study|Withdrawal by Subject|17|||
125192317|NCT00665431|450326199|FG001|Overall Study|Withdrawal by Subject|25|||
125192318|NCT00665431|450326200|FG002|Overall Study|Withdrawal by Subject|15|||
125192319|NCT00665431|450326198|FG000|Overall Study|Lost to Follow-up|3|||
125192320|NCT00665431|450326199|FG001|Overall Study|Lost to Follow-up|3|||
125192321|NCT00665431|450326200|FG002|Overall Study|Lost to Follow-up|1|||
125192322|NCT00665431|450326198|FG000|Overall Study|Other|4|||
125192323|NCT00665431|450326199|FG001|Overall Study|Other|7|||
125192324|NCT00665431|450326200|FG002|Overall Study|Other|2|||
125192325|NCT00757042|450326208|FG000|Overall Study|Lost to Follow-up|0|||
125192326|NCT00757042|450326209|FG001|Overall Study|Lost to Follow-up|0|||
125192327|NCT00757042|450326210|FG002|Overall Study|Lost to Follow-up|0|||
125192328|NCT00757042|450326211|FG003|Overall Study|Lost to Follow-up|0|||
125192329|NCT00757042|450326212|FG004|Overall Study|Lost to Follow-up|0|||
125192330|NCT00757042|450326213|FG005|Overall Study|Lost to Follow-up|0|||
125192331|NCT00757042|450326214|FG006|Overall Study|Lost to Follow-up|0|||
125192332|NCT00757042|450326215|FG007|Overall Study|Lost to Follow-up|0|||
125192333|NCT00757042|450326216|FG008|Overall Study|Lost to Follow-up|1|||
125192334|NCT00757042|450326217|FG009|Overall Study|Lost to Follow-up|0|||
125192335|NCT00757042|450326218|FG010|Overall Study|Lost to Follow-up|0|||
125192336|NCT00757042|450326208|FG000|Overall Study|Ineligibility Determined|0|||
125192337|NCT00757042|450326209|FG001|Overall Study|Ineligibility Determined|0|||
125192338|NCT00757042|450326210|FG002|Overall Study|Ineligibility Determined|0|||
125192339|NCT00757042|450326211|FG003|Overall Study|Ineligibility Determined|0|||
125192340|NCT00757042|450326212|FG004|Overall Study|Ineligibility Determined|0|||
125192341|NCT00757042|450326213|FG005|Overall Study|Ineligibility Determined|0|||
125192342|NCT00757042|450326214|FG006|Overall Study|Ineligibility Determined|0|||
125192343|NCT00757042|450326215|FG007|Overall Study|Ineligibility Determined|0|||
125192344|NCT00757042|450326216|FG008|Overall Study|Ineligibility Determined|0|||
125192345|NCT00757042|450326217|FG009|Overall Study|Ineligibility Determined|0|||
125192346|NCT00757042|450326218|FG010|Overall Study|Ineligibility Determined|1|||
125192347|NCT00757042|450326208|FG000|Overall Study|Withdrawal by Subject|0|||
125192348|NCT00757042|450326209|FG001|Overall Study|Withdrawal by Subject|0|||
125192349|NCT00757042|450326210|FG002|Overall Study|Withdrawal by Subject|0|||
125192350|NCT00757042|450326211|FG003|Overall Study|Withdrawal by Subject|0|||
125192351|NCT00757042|450326212|FG004|Overall Study|Withdrawal by Subject|0|||
125192352|NCT00757042|450326213|FG005|Overall Study|Withdrawal by Subject|0|||
125192353|NCT00757042|450326214|FG006|Overall Study|Withdrawal by Subject|0|||
125192354|NCT00757042|450326215|FG007|Overall Study|Withdrawal by Subject|0|||
125192355|NCT00757042|450326216|FG008|Overall Study|Withdrawal by Subject|0|||
125192356|NCT00757042|450326217|FG009|Overall Study|Withdrawal by Subject|1|||
125192357|NCT00757042|450326218|FG010|Overall Study|Withdrawal by Subject|0|||
125192358|NCT01870973|450326222|FG000|Overall Study|Lost to Follow-up|10|||
125192359|NCT01870973|450326223|FG001|Overall Study|Lost to Follow-up|3|||
125192360|NCT01266291|450326225|FG000|Overall Study|Adverse Event|1|||
125192361|NCT03291431|450326226|FG000|Overall Study|Protocol Violation|2|||
125192362|NCT03291431|450326227|FG001|Overall Study|Protocol Violation|1|||
125192363|NCT03291431|450326226|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
125192364|NCT03291431|450326227|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
125192365|NCT03291431|450326226|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
125192366|NCT03291431|450326227|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
125192367|NCT00550745|450326230|FG000|Overall Study|Death|20|||
125192368|NCT00550745|450326231|FG001|Overall Study|Death|16|||
125192369|NCT00550745|450326230|FG000|Overall Study|Lost to Follow-up|45|||
125192370|NCT00550745|450326231|FG001|Overall Study|Lost to Follow-up|30|||
125192371|NCT00550745|450326230|FG000|Overall Study|Physician Decision|0|||
125192372|NCT00550745|450326231|FG001|Overall Study|Physician Decision|2|||
125192373|NCT00550745|450326230|FG000|Overall Study|Protocol Violation|4|||
125192374|NCT00550745|450326231|FG001|Overall Study|Protocol Violation|2|||
125192375|NCT00550745|450326230|FG000|Overall Study|Withdrawal by Subject|17|||
125192376|NCT00550745|450326231|FG001|Overall Study|Withdrawal by Subject|10|||
125192377|NCT00550745|450326230|FG000|Overall Study|Screen failure|1|||
125192378|NCT00550745|450326231|FG001|Overall Study|Screen failure|0|||
125192379|NCT03850483|450326234|FG000|Treatment for Stage 1|Adverse Event|1|||
125192380|NCT03850483|450326235|FG001|Treatment for Stage 1|Adverse Event|1|||
125192381|NCT03850483|450326236|FG002|Treatment for Stage 1|Adverse Event|3|||
125192382|NCT03850483|450326237|FG003|Treatment for Stage 1|Adverse Event|0|||
125192383|NCT03850483|450326238|FG004|Treatment for Stage 1|Adverse Event|2|||
125192384|NCT03850483|450326239|FG005|Treatment for Stage 1|Adverse Event|0|||
125192385|NCT03850483|450326240|FG006|Treatment for Stage 1|Adverse Event|2|||
125192386|NCT03850483|450326241|FG007|Treatment for Stage 1|Adverse Event|2|||
125192387|NCT03850483|450326242|FG008|Treatment for Stage 1|Adverse Event|0|||
125192388|NCT03850483|450326243|FG009|Treatment for Stage 1|Adverse Event|0|||
125192389|NCT03850483|450326234|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
125192390|NCT03850483|450326235|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
125192391|NCT03850483|450326236|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
125192392|NCT03850483|450326237|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
125192393|NCT03850483|450326238|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
125192394|NCT03850483|450326239|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
125192395|NCT03850483|450326240|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
125192396|NCT03850483|450326241|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
125192397|NCT03850483|450326242|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
125192398|NCT03850483|450326243|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
125192399|NCT03850483|450326234|FG000|Treatment for Stage 1|Protocol Violation|1|||
125192400|NCT03850483|450326235|FG001|Treatment for Stage 1|Protocol Violation|0|||
125192401|NCT03850483|450326236|FG002|Treatment for Stage 1|Protocol Violation|0|||
125192402|NCT03850483|450326237|FG003|Treatment for Stage 1|Protocol Violation|0|||
125192403|NCT03850483|450326238|FG004|Treatment for Stage 1|Protocol Violation|0|||
125192404|NCT03850483|450326239|FG005|Treatment for Stage 1|Protocol Violation|0|||
125192405|NCT03850483|450326240|FG006|Treatment for Stage 1|Protocol Violation|1|||
125192406|NCT03850483|450326241|FG007|Treatment for Stage 1|Protocol Violation|0|||
125192407|NCT03850483|450326242|FG008|Treatment for Stage 1|Protocol Violation|0|||
125192408|NCT03850483|450326243|FG009|Treatment for Stage 1|Protocol Violation|0|||
125192409|NCT03850483|450326234|FG000|Treatment for Stage 1|Physician Decision|0|||
125192410|NCT03850483|450326235|FG001|Treatment for Stage 1|Physician Decision|0|||
125192411|NCT03850483|450326236|FG002|Treatment for Stage 1|Physician Decision|0|||
125192412|NCT03850483|450326237|FG003|Treatment for Stage 1|Physician Decision|0|||
125192413|NCT03850483|450326238|FG004|Treatment for Stage 1|Physician Decision|0|||
125192414|NCT03850483|450326239|FG005|Treatment for Stage 1|Physician Decision|1|||
125192415|NCT03850483|450326240|FG006|Treatment for Stage 1|Physician Decision|0|||
125192416|NCT03850483|450326241|FG007|Treatment for Stage 1|Physician Decision|0|||
125192417|NCT03850483|450326242|FG008|Treatment for Stage 1|Physician Decision|0|||
125192418|NCT03850483|450326243|FG009|Treatment for Stage 1|Physician Decision|0|||
125192419|NCT03850483|450326234|FG000|Treatment for Stage 1|Other|0|||
125192420|NCT03850483|450326235|FG001|Treatment for Stage 1|Other|0|||
125192421|NCT03850483|450326236|FG002|Treatment for Stage 1|Other|0|||
125192422|NCT03850483|450326237|FG003|Treatment for Stage 1|Other|0|||
125192423|NCT03850483|450326238|FG004|Treatment for Stage 1|Other|2|||
125192424|NCT03850483|450326239|FG005|Treatment for Stage 1|Other|1|||
125192425|NCT03850483|450326240|FG006|Treatment for Stage 1|Other|0|||
125192426|NCT03850483|450326241|FG007|Treatment for Stage 1|Other|0|||
125192427|NCT03850483|450326242|FG008|Treatment for Stage 1|Other|0|||
125192428|NCT03850483|450326243|FG009|Treatment for Stage 1|Other|0|||
125192429|NCT03850483|450326234|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
125192430|NCT03850483|450326235|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
125192431|NCT03850483|450326236|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
125192432|NCT03850483|450326237|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
125192433|NCT03850483|450326238|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
125192434|NCT03850483|450326239|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
125192435|NCT03850483|450326240|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
125192436|NCT03850483|450326241|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
125192437|NCT03850483|450326242|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
125192438|NCT03850483|450326243|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
125192439|NCT03850483|450326234|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
125192440|NCT03850483|450326235|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
125192441|NCT03850483|450326236|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
125192442|NCT03850483|450326237|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
125192443|NCT03850483|450326238|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
125192444|NCT03850483|450326239|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
125192445|NCT03850483|450326240|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
125192446|NCT03850483|450326241|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
125245532|NCT03309605|450524522|FG002|Overall Study|Adverse Event|0|||
125192447|NCT03850483|450326242|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
125192448|NCT03850483|450326243|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
125192449|NCT03850483|450326234|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
125192450|NCT03850483|450326235|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
125192451|NCT03850483|450326236|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
125192452|NCT03850483|450326237|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
125192453|NCT03850483|450326238|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
125192454|NCT03850483|450326239|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
125192455|NCT03850483|450326240|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
125192456|NCT03850483|450326241|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
125192457|NCT03850483|450326242|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
125192458|NCT03850483|450326243|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
125192459|NCT03850483|450326234|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
125192460|NCT03850483|450326235|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
125192461|NCT03850483|450326236|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
125192462|NCT03850483|450326237|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
125192463|NCT03850483|450326238|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
125192464|NCT03850483|450326239|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
125192465|NCT03850483|450326240|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
125192466|NCT03850483|450326241|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
125192467|NCT03850483|450326242|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
125192468|NCT03850483|450326243|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
125192469|NCT03850483|450326234|FG000|Treatment for Stage 1|Death|0|||
125192470|NCT03850483|450326235|FG001|Treatment for Stage 1|Death|0|||
125192471|NCT03850483|450326236|FG002|Treatment for Stage 1|Death|0|||
125192472|NCT03850483|450326237|FG003|Treatment for Stage 1|Death|0|||
125192473|NCT03850483|450326238|FG004|Treatment for Stage 1|Death|0|||
125192474|NCT03850483|450326239|FG005|Treatment for Stage 1|Death|1|||
125192475|NCT03850483|450326240|FG006|Treatment for Stage 1|Death|0|||
125192476|NCT03850483|450326241|FG007|Treatment for Stage 1|Death|0|||
125192477|NCT03850483|450326242|FG008|Treatment for Stage 1|Death|0|||
125192478|NCT03850483|450326243|FG009|Treatment for Stage 1|Death|0|||
125192479|NCT03850483|450326234|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
125192480|NCT03850483|450326235|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
125192481|NCT03850483|450326236|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
125192482|NCT03850483|450326237|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
125192483|NCT03850483|450326238|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
125192484|NCT03850483|450326239|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
125192485|NCT03850483|450326240|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
125192486|NCT03850483|450326241|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
125192487|NCT03850483|450326242|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
125192488|NCT03850483|450326243|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
125192489|NCT03850483|450326234|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
125192490|NCT03850483|450326235|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
125192491|NCT03850483|450326236|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
125192492|NCT03850483|450326237|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
125192493|NCT03850483|450326238|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
125192494|NCT03850483|450326239|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
125192495|NCT03850483|450326240|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
125192496|NCT03850483|450326241|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
125192497|NCT03850483|450326242|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
125192498|NCT03850483|450326243|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
125192499|NCT03850483|450326234|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
125192500|NCT03850483|450326235|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
125192501|NCT03850483|450326236|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
125192502|NCT03850483|450326237|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
125192503|NCT03850483|450326238|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
125192504|NCT03850483|450326239|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
125192505|NCT03850483|450326240|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
125192506|NCT03850483|450326241|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
125245533|NCT03309605|450524523|FG003|Overall Study|Adverse Event|1|||
125245534|NCT03309605|450524524|FG004|Overall Study|Adverse Event|0|||
125245535|NCT03309605|450524525|FG005|Overall Study|Adverse Event|0|||
125245536|NCT03309605|450524526|FG006|Overall Study|Adverse Event|2|||
125245537|NCT03309605|450524527|FG007|Overall Study|Adverse Event|1|||
125245538|NCT03309605|450524520|FG000|Overall Study|Withdrawal by Subject|0|||
125245539|NCT03309605|450524521|FG001|Overall Study|Withdrawal by Subject|0|||
125245540|NCT03309605|450524522|FG002|Overall Study|Withdrawal by Subject|0|||
125245541|NCT03309605|450524523|FG003|Overall Study|Withdrawal by Subject|0|||
125245542|NCT03309605|450524524|FG004|Overall Study|Withdrawal by Subject|1|||
125245543|NCT03309605|450524525|FG005|Overall Study|Withdrawal by Subject|0|||
125245544|NCT03309605|450524526|FG006|Overall Study|Withdrawal by Subject|1|||
125245545|NCT03309605|450524527|FG007|Overall Study|Withdrawal by Subject|1|||
125245546|NCT00784927|450524528|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
125245547|NCT00784927|450524528|FG000|Overall Study|Protocol Violation|1|||
125245548|NCT00784927|450524528|FG000|Overall Study|Ineligible|1|||
125245549|NCT01795937|450524535|FG000|Overall Study|Withdrawal by Subject|1|||
125245550|NCT01795937|450524536|FG001|Overall Study|Withdrawal by Subject|0|||
125245551|NCT01795937|450524537|FG002|Overall Study|Withdrawal by Subject|0|||
125245552|NCT01795937|450524535|FG000|Overall Study|Physician Decision|0|||
125245553|NCT01795937|450524536|FG001|Overall Study|Physician Decision|1|||
125245554|NCT01795937|450524537|FG002|Overall Study|Physician Decision|0|||
125245555|NCT01028053|450524538|FG000|Overall Study|Screen Failure|113|||
125245556|NCT01028053|450524538|FG000|Overall Study|Patient Request|11|||
125245557|NCT01028053|450524538|FG000|Overall Study|Protocol Violation|1|||
125192507|NCT03850483|450326242|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
125192508|NCT03850483|450326243|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
125192509|NCT03850483|450326234|FG000|Follow-up for Stage 1|Physician Decision|0|||
125192510|NCT03850483|450326235|FG001|Follow-up for Stage 1|Physician Decision|0|||
125192511|NCT03850483|450326236|FG002|Follow-up for Stage 1|Physician Decision|0|||
125192512|NCT03850483|450326237|FG003|Follow-up for Stage 1|Physician Decision|0|||
125192513|NCT03850483|450326238|FG004|Follow-up for Stage 1|Physician Decision|1|||
125192514|NCT03850483|450326239|FG005|Follow-up for Stage 1|Physician Decision|0|||
125192515|NCT03850483|450326240|FG006|Follow-up for Stage 1|Physician Decision|1|||
125192516|NCT03850483|450326241|FG007|Follow-up for Stage 1|Physician Decision|0|||
125192517|NCT03850483|450326242|FG008|Follow-up for Stage 1|Physician Decision|0|||
125192518|NCT03850483|450326243|FG009|Follow-up for Stage 1|Physician Decision|0|||
125192519|NCT03850483|450326234|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
125192520|NCT03850483|450326235|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
125192521|NCT03850483|450326236|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
125192522|NCT03850483|450326237|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
125192523|NCT03850483|450326238|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
125192524|NCT03850483|450326239|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
125192525|NCT03850483|450326240|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
125192526|NCT03850483|450326241|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
125192527|NCT03850483|450326242|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
125192528|NCT03850483|450326243|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
125192529|NCT03850483|450326234|FG000|Follow-up for Stage 1|Adverse Event|0|||
125192530|NCT03850483|450326235|FG001|Follow-up for Stage 1|Adverse Event|0|||
125192531|NCT03850483|450326236|FG002|Follow-up for Stage 1|Adverse Event|1|||
125192532|NCT03850483|450326237|FG003|Follow-up for Stage 1|Adverse Event|0|||
125192533|NCT03850483|450326238|FG004|Follow-up for Stage 1|Adverse Event|0|||
125192534|NCT03850483|450326239|FG005|Follow-up for Stage 1|Adverse Event|1|||
125192535|NCT03850483|450326240|FG006|Follow-up for Stage 1|Adverse Event|0|||
125192536|NCT03850483|450326241|FG007|Follow-up for Stage 1|Adverse Event|0|||
125192537|NCT03850483|450326242|FG008|Follow-up for Stage 1|Adverse Event|0|||
125192538|NCT03850483|450326243|FG009|Follow-up for Stage 1|Adverse Event|0|||
125192539|NCT03850483|450326234|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
125192540|NCT03850483|450326235|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
125192541|NCT03850483|450326236|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
125245558|NCT01028053|450524538|FG000|Overall Study|Physician Decision|2|||
125192542|NCT03850483|450326237|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
125192543|NCT03850483|450326238|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
125192544|NCT03850483|450326239|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
125192545|NCT03850483|450326240|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
125192546|NCT03850483|450326241|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
125192547|NCT03850483|450326242|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
125245559|NCT01028053|450524538|FG000|Overall Study|Technical Problem|1|||
125245560|NCT01028053|450524538|FG000|Overall Study|Terminated by Sponsor|1|||
125245561|NCT01028053|450524538|FG000|Overall Study|Various reasons|4|||
125245562|NCT04027946|450524539|FG000|Overall Study|Screen failures|3|||
125245563|NCT00983957|450524540|FG000|Overall Study|Adverse Event|1|||
125192548|NCT03850483|450326243|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
125192549|NCT03850483|450326234|FG000|Follow-up for Stage 1|Other|0|||
125192550|NCT03850483|450326235|FG001|Follow-up for Stage 1|Other|2|||
125192551|NCT03850483|450326236|FG002|Follow-up for Stage 1|Other|0|||
125192552|NCT03850483|450326237|FG003|Follow-up for Stage 1|Other|2|||
125192553|NCT03850483|450326238|FG004|Follow-up for Stage 1|Other|0|||
125192554|NCT03850483|450326239|FG005|Follow-up for Stage 1|Other|1|||
125192555|NCT03850483|450326240|FG006|Follow-up for Stage 1|Other|0|||
125192556|NCT03850483|450326241|FG007|Follow-up for Stage 1|Other|0|||
125192557|NCT03850483|450326242|FG008|Follow-up for Stage 1|Other|0|||
125192558|NCT03850483|450326243|FG009|Follow-up for Stage 1|Other|0|||
125192559|NCT03850483|450326234|FG000|Treatment for Stage 2|Adverse Event|0|||
125192560|NCT03850483|450326235|FG001|Treatment for Stage 2|Adverse Event|0|||
125192561|NCT03850483|450326236|FG002|Treatment for Stage 2|Adverse Event|0|||
125192562|NCT03850483|450326237|FG003|Treatment for Stage 2|Adverse Event|0|||
125192563|NCT03850483|450326238|FG004|Treatment for Stage 2|Adverse Event|0|||
125192564|NCT03850483|450326239|FG005|Treatment for Stage 2|Adverse Event|0|||
125192565|NCT03850483|450326240|FG006|Treatment for Stage 2|Adverse Event|0|||
125192566|NCT03850483|450326241|FG007|Treatment for Stage 2|Adverse Event|0|||
125192567|NCT03850483|450326242|FG008|Treatment for Stage 2|Adverse Event|0|||
125192568|NCT03850483|450326243|FG009|Treatment for Stage 2|Adverse Event|1|||
125192569|NCT03850483|450326234|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
125192570|NCT03850483|450326235|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
125192571|NCT03850483|450326236|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
125192572|NCT03850483|450326237|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
125192573|NCT03850483|450326238|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
125192574|NCT03850483|450326239|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
125192575|NCT03850483|450326240|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
125192576|NCT03850483|450326241|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
125192577|NCT03850483|450326242|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
125192578|NCT03850483|450326243|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
125192579|NCT03850483|450326234|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
125192580|NCT03850483|450326235|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
125192581|NCT03850483|450326236|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
125192582|NCT03850483|450326237|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
125192583|NCT03850483|450326238|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
125192584|NCT03850483|450326239|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
125192585|NCT03850483|450326240|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
125192586|NCT03850483|450326241|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
125192587|NCT03850483|450326242|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
125192588|NCT03850483|450326243|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
125192589|NCT03850483|450326234|FG000|Treatment for Stage 2|Physician Decision|0|||
125192590|NCT03850483|450326235|FG001|Treatment for Stage 2|Physician Decision|0|||
125192591|NCT03850483|450326236|FG002|Treatment for Stage 2|Physician Decision|0|||
125192592|NCT03850483|450326237|FG003|Treatment for Stage 2|Physician Decision|0|||
125192593|NCT03850483|450326238|FG004|Treatment for Stage 2|Physician Decision|0|||
125192594|NCT03850483|450326239|FG005|Treatment for Stage 2|Physician Decision|0|||
125192595|NCT03850483|450326240|FG006|Treatment for Stage 2|Physician Decision|0|||
125192596|NCT03850483|450326241|FG007|Treatment for Stage 2|Physician Decision|0|||
125192597|NCT03850483|450326242|FG008|Treatment for Stage 2|Physician Decision|0|||
125192598|NCT03850483|450326243|FG009|Treatment for Stage 2|Physician Decision|1|||
125192599|NCT03850483|450326234|FG000|Treatment for Stage 2|Protocol Violation|0|||
125192600|NCT03850483|450326235|FG001|Treatment for Stage 2|Protocol Violation|0|||
125192601|NCT03850483|450326236|FG002|Treatment for Stage 2|Protocol Violation|0|||
125192602|NCT03850483|450326237|FG003|Treatment for Stage 2|Protocol Violation|0|||
125192603|NCT03850483|450326238|FG004|Treatment for Stage 2|Protocol Violation|0|||
125192604|NCT03850483|450326239|FG005|Treatment for Stage 2|Protocol Violation|0|||
125192605|NCT03850483|450326240|FG006|Treatment for Stage 2|Protocol Violation|0|||
125192606|NCT03850483|450326241|FG007|Treatment for Stage 2|Protocol Violation|0|||
125192607|NCT03850483|450326242|FG008|Treatment for Stage 2|Protocol Violation|1|||
125192608|NCT03850483|450326243|FG009|Treatment for Stage 2|Protocol Violation|0|||
125192609|NCT03850483|450326234|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
125192610|NCT03850483|450326235|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
125192611|NCT03850483|450326236|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
125192612|NCT03850483|450326237|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
125192613|NCT03850483|450326238|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
125192614|NCT03850483|450326239|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
125192615|NCT03850483|450326240|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
125192616|NCT03850483|450326241|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
125192617|NCT03850483|450326242|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
125192618|NCT03850483|450326243|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
125192619|NCT03850483|450326234|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
125192620|NCT03850483|450326235|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
125192621|NCT03850483|450326236|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
125192622|NCT03850483|450326237|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
125192623|NCT03850483|450326238|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
125192624|NCT03850483|450326239|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
125192625|NCT03850483|450326240|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
125192626|NCT03850483|450326241|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
125192627|NCT03850483|450326242|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
125192628|NCT03850483|450326243|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
125192629|NCT03850483|450326234|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
125192630|NCT03850483|450326235|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
125192631|NCT03850483|450326236|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
125192632|NCT03850483|450326237|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
125192633|NCT03850483|450326238|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
125192634|NCT03850483|450326239|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
125192635|NCT03850483|450326240|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
125192636|NCT03850483|450326241|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
125192637|NCT03850483|450326242|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
125192638|NCT03850483|450326243|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
125192639|NCT03850483|450326234|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
125192640|NCT03850483|450326235|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
125192641|NCT03850483|450326236|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
125192642|NCT03850483|450326237|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
125192643|NCT03850483|450326238|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
125192644|NCT03850483|450326239|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
125192645|NCT03850483|450326240|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
125192646|NCT03850483|450326241|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
125192647|NCT03850483|450326242|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
125245564|NCT00983957|450524540|FG000|Overall Study|Personal Reasons|1|||
125245565|NCT00790933|450524541|FG000|Overall Study|Adverse Event|94|||
125245566|NCT00790933|450524542|FG001|Overall Study|Adverse Event|119|||
125245567|NCT00790933|450524543|FG002|Overall Study|Adverse Event|65|||
125245568|NCT00790933|450524544|FG003|Overall Study|Adverse Event|5|||
125245569|NCT00790933|450524545|FG004|Overall Study|Adverse Event|69|||
125245570|NCT00790933|450524541|FG000|Overall Study|Protocol Violation(s)|8|||
125245571|NCT00790933|450524542|FG001|Overall Study|Protocol Violation(s)|18|||
125245572|NCT00790933|450524543|FG002|Overall Study|Protocol Violation(s)|7|||
125245573|NCT00790933|450524544|FG003|Overall Study|Protocol Violation(s)|0|||
125245574|NCT00790933|450524545|FG004|Overall Study|Protocol Violation(s)|12|||
125192648|NCT03850483|450326243|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
125192649|NCT03850483|450326234|FG000|Follow-up For Stage 2|Other|0|||
125192650|NCT03850483|450326235|FG001|Follow-up For Stage 2|Other|0|||
125192651|NCT03850483|450326236|FG002|Follow-up For Stage 2|Other|0|||
125192652|NCT03850483|450326237|FG003|Follow-up For Stage 2|Other|0|||
125192653|NCT03850483|450326238|FG004|Follow-up For Stage 2|Other|0|||
125192654|NCT03850483|450326239|FG005|Follow-up For Stage 2|Other|0|||
125192655|NCT03850483|450326240|FG006|Follow-up For Stage 2|Other|0|||
125192656|NCT03850483|450326241|FG007|Follow-up For Stage 2|Other|0|||
125192657|NCT03850483|450326242|FG008|Follow-up For Stage 2|Other|0|||
125192658|NCT03850483|450326243|FG009|Follow-up For Stage 2|Other|1|||
125192659|NCT01464593|450328049|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
125192660|NCT00302328|450328050|FG000|Overall Study|Physician Decision|0|||
125192661|NCT00302328|450328051|FG001|Overall Study|Physician Decision|1|||
125192662|NCT00302328|450328052|FG002|Overall Study|Physician Decision|0|||
125245575|NCT00790933|450524541|FG000|Overall Study|Lack of Efficacy|192|||
125245576|NCT00790933|450524542|FG001|Overall Study|Lack of Efficacy|176|||
125245577|NCT00790933|450524543|FG002|Overall Study|Lack of Efficacy|130|||
125192663|NCT01288937|450328055|FG000|Overall Study|Adverse Event|1|||
125192664|NCT01288937|450328056|FG001|Overall Study|Adverse Event|0|||
125192665|NCT02490371|450328057|FG000|Overall Study|Lost to Follow-up|1|||
125192666|NCT02490371|450328058|FG001|Overall Study|Lost to Follow-up|1|||
125245578|NCT00790933|450524544|FG003|Overall Study|Lack of Efficacy|1|||
125245579|NCT00790933|450524545|FG004|Overall Study|Lack of Efficacy|121|||
125245580|NCT00790933|450524541|FG000|Overall Study|Study Terminated by Sponsor|0|||
125192667|NCT02476578|450328061|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
125192668|NCT02476578|450328062|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
125192669|NCT02476578|450328061|FG000|Overall Study|Lost to Follow-up|6|||
125192670|NCT02476578|450328062|FG001|Overall Study|Lost to Follow-up|13|||
125192671|NCT03018080|450328063|FG000|Overall Study|Death|12|||
125192672|NCT03018080|450328064|FG001|Overall Study|Death|19|||
125192673|NCT01019694|450328067|FG000|Overall Study|Adverse Event|12|||
125192674|NCT01019694|450328068|FG001|Overall Study|Adverse Event|16|||
125192675|NCT01019694|450328069|FG002|Overall Study|Adverse Event|19|||
125192676|NCT01019694|450328067|FG000|Overall Study|Protocol Violation|2|||
125192677|NCT01019694|450328068|FG001|Overall Study|Protocol Violation|6|||
125192678|NCT01019694|450328069|FG002|Overall Study|Protocol Violation|4|||
125192679|NCT01019694|450328067|FG000|Overall Study|Lost to Follow-up|5|||
125192680|NCT01019694|450328068|FG001|Overall Study|Lost to Follow-up|3|||
125192681|NCT01019694|450328069|FG002|Overall Study|Lost to Follow-up|3|||
125192682|NCT01019694|450328067|FG000|Overall Study|Withdrawal by Subject|4|||
125192683|NCT01019694|450328068|FG001|Overall Study|Withdrawal by Subject|6|||
125245581|NCT00790933|450524542|FG001|Overall Study|Study Terminated by Sponsor|0|||
125245582|NCT00790933|450524543|FG002|Overall Study|Study Terminated by Sponsor|1|||
125245583|NCT00790933|450524544|FG003|Overall Study|Study Terminated by Sponsor|0|||
125245584|NCT00790933|450524545|FG004|Overall Study|Study Terminated by Sponsor|0|||
125192684|NCT01019694|450328069|FG002|Overall Study|Withdrawal by Subject|12|||
125192685|NCT01019694|450328067|FG000|Overall Study|Not treated|0|||
125192686|NCT01019694|450328068|FG001|Overall Study|Not treated|2|||
125192687|NCT01019694|450328069|FG002|Overall Study|Not treated|3|||
125192688|NCT01019694|450328067|FG000|Overall Study|Other reason (not specified)|1|||
125192689|NCT01019694|450328068|FG001|Overall Study|Other reason (not specified)|5|||
125192690|NCT01019694|450328069|FG002|Overall Study|Other reason (not specified)|6|||
125192691|NCT00026494|450328072|FG000|Overall Study|Withdrawal by Subject|1|||
125192692|NCT00026494|450328073|FG001|Overall Study|Withdrawal by Subject|0|||
125192693|NCT00026494|450328074|FG002|Overall Study|Withdrawal by Subject|1|||
125192694|NCT00026494|450328075|FG003|Overall Study|Withdrawal by Subject|0|||
125192695|NCT00026494|450328072|FG000|Overall Study|Patient non-compliance|1|||
125192696|NCT00026494|450328073|FG001|Overall Study|Patient non-compliance|0|||
125192697|NCT00026494|450328074|FG002|Overall Study|Patient non-compliance|0|||
125192698|NCT00026494|450328075|FG003|Overall Study|Patient non-compliance|0|||
125192699|NCT00026494|450328072|FG000|Overall Study|Patient not treated|0|||
125192700|NCT00026494|450328073|FG001|Overall Study|Patient not treated|0|||
125192701|NCT00026494|450328074|FG002|Overall Study|Patient not treated|2|||
125192702|NCT00026494|450328075|FG003|Overall Study|Patient not treated|0|||
125192703|NCT00026494|450328072|FG000|Overall Study|Clinical progression|0|||
125192704|NCT00026494|450328073|FG001|Overall Study|Clinical progression|0|||
125192705|NCT00026494|450328074|FG002|Overall Study|Clinical progression|3|||
125245585|NCT00790933|450524541|FG000|Overall Study|Withdrawal by Subject|123|||
125245586|NCT00790933|450524542|FG001|Overall Study|Withdrawal by Subject|120|||
125245587|NCT00790933|450524543|FG002|Overall Study|Withdrawal by Subject|52|||
125245588|NCT00790933|450524544|FG003|Overall Study|Withdrawal by Subject|6|||
125245589|NCT00790933|450524545|FG004|Overall Study|Withdrawal by Subject|50|||
125245590|NCT00790933|450524541|FG000|Overall Study|Lost to Follow-up|13|||
125245591|NCT00790933|450524542|FG001|Overall Study|Lost to Follow-up|31|||
125245592|NCT00790933|450524543|FG002|Overall Study|Lost to Follow-up|10|||
125245593|NCT00790933|450524544|FG003|Overall Study|Lost to Follow-up|1|||
125245594|NCT00790933|450524545|FG004|Overall Study|Lost to Follow-up|15|||
125245595|NCT00790933|450524541|FG000|Overall Study|Reason Not Specified|8|||
125245596|NCT00790933|450524542|FG001|Overall Study|Reason Not Specified|16|||
125245597|NCT00790933|450524543|FG002|Overall Study|Reason Not Specified|4|||
125245598|NCT00790933|450524544|FG003|Overall Study|Reason Not Specified|1|||
125245599|NCT00790933|450524545|FG004|Overall Study|Reason Not Specified|9|||
125245600|NCT00245570|450524548|FG000|Washout Between Periods III and IV|Adverse Event|0|||
125245601|NCT00245570|450524549|FG001|Washout Between Periods III and IV|Adverse Event|1|||
125245602|NCT00245570|450524550|FG002|Washout Between Periods III and IV|Adverse Event|0|||
125245603|NCT00245570|450524551|FG003|Washout Between Periods III and IV|Adverse Event|0|||
125245604|NCT00245570|450524552|FG004|Washout Between Periods III and IV|Adverse Event|0|||
125245605|NCT00245570|450524553|FG005|Washout Between Periods III and IV|Adverse Event|0|||
125245606|NCT01829165|450524554|FG000|Overall Study|Did not complete intervention|2|||
125245607|NCT01829165|450524555|FG001|Overall Study|Did not complete intervention|0|||
125245608|NCT04233580|450524576|FG000|Overall Study|Adverse Event|3|||
125245609|NCT04233580|450524577|FG001|Overall Study|Adverse Event|3|||
125245610|NCT04233580|450524576|FG000|Overall Study|Withdrawal by Subject|2|||
125245611|NCT04233580|450524577|FG001|Overall Study|Withdrawal by Subject|1|||
125245612|NCT02441114|450524578|FG000|Washout2|Withdrawal by Subject|4|||
125245613|NCT01371565|450524580|FG000|Overall Study|Withdrawal by Subject|1|||
125245614|NCT01371565|450524580|FG000|Overall Study|Death|1|||
125245615|NCT01371565|450524580|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
125245616|NCT02070991|450524581|FG000|Overall Study|Death|2|||
125245617|NCT02070991|450524582|FG001|Overall Study|Death|0|||
125245618|NCT02070991|450524581|FG000|Overall Study|Withdrawal by Subject|1|||
125245619|NCT02070991|450524582|FG001|Overall Study|Withdrawal by Subject|0|||
125245620|NCT00827242|450524583|FG000|Overall Study|Withdrawal by Subject|2|||
125192706|NCT00026494|450328075|FG003|Overall Study|Clinical progression|0|||
125192707|NCT01684423|450328076|FG000|Overall Study|Withdrawal by Subject|0|||
125192708|NCT01684423|450328077|FG001|Overall Study|Withdrawal by Subject|0|||
125192709|NCT01684423|450328078|FG002|Overall Study|Withdrawal by Subject|1|||
125192710|NCT01684423|450328079|FG003|Overall Study|Withdrawal by Subject|0|||
125245621|NCT00827242|450524584|FG001|Overall Study|Withdrawal by Subject|4|||
125245622|NCT00827242|450524583|FG000|Overall Study|Protocol Violation|1|||
125245623|NCT00827242|450524584|FG001|Overall Study|Protocol Violation|3|||
125245624|NCT00827242|450524583|FG000|Overall Study|Lost to Follow-up|0|||
125192711|NCT01684423|450328080|FG004|Overall Study|Withdrawal by Subject|0|||
125245625|NCT00827242|450524584|FG001|Overall Study|Lost to Follow-up|3|||
125245626|NCT00827242|450524583|FG000|Overall Study|Adverse Event Excluding Death|2|||
125245627|NCT00827242|450524584|FG001|Overall Study|Adverse Event Excluding Death|1|||
125192712|NCT00441129|450328081|FG000|Overall Study|Withdrawal by Subject|6|||
125192713|NCT00441129|450328082|FG001|Overall Study|Withdrawal by Subject|14|||
125192714|NCT01455597|450328083|FG000|Overall Study|Adverse Event|7|||
125192715|NCT01455597|450328084|FG001|Overall Study|Adverse Event|0|||
125192716|NCT01455597|450328085|FG002|Overall Study|Adverse Event|5|||
125192717|NCT01455597|450328086|FG003|Overall Study|Adverse Event|1|||
125192718|NCT01455597|450328083|FG000|Overall Study|Lack of Efficacy|0|||
125192719|NCT01455597|450328084|FG001|Overall Study|Lack of Efficacy|1|||
125192720|NCT01455597|450328085|FG002|Overall Study|Lack of Efficacy|2|||
125192721|NCT01455597|450328086|FG003|Overall Study|Lack of Efficacy|0|||
125192722|NCT01455597|450328083|FG000|Overall Study|Lost to Follow-up|3|||
125192723|NCT01455597|450328084|FG001|Overall Study|Lost to Follow-up|0|||
125192724|NCT01455597|450328085|FG002|Overall Study|Lost to Follow-up|2|||
125192725|NCT01455597|450328086|FG003|Overall Study|Lost to Follow-up|1|||
125192726|NCT01455597|450328083|FG000|Overall Study|Withdrew Consent|6|||
125192727|NCT01455597|450328084|FG001|Overall Study|Withdrew Consent|5|||
125192728|NCT01455597|450328085|FG002|Overall Study|Withdrew Consent|8|||
125192729|NCT01455597|450328086|FG003|Overall Study|Withdrew Consent|5|||
125192730|NCT01455597|450328083|FG000|Overall Study|Reason not Specified|1|||
125192731|NCT01455597|450328084|FG001|Overall Study|Reason not Specified|2|||
125192732|NCT01455597|450328085|FG002|Overall Study|Reason not Specified|3|||
125192733|NCT01455597|450328086|FG003|Overall Study|Reason not Specified|3|||
125192734|NCT03412734|450328089|FG000|Overall Study|Incorrect labeling of samples|2|||
125192735|NCT03412734|450328090|FG001|Overall Study|Incorrect labeling of samples|0|||
125192736|NCT03412734|450328089|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
125192737|NCT03412734|450328090|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
125192738|NCT00423332|450328091|FG000|Overall Study|Adverse Event|6|||
125192739|NCT00423332|450328092|FG001|Overall Study|Adverse Event|2|||
125192740|NCT00423332|450328091|FG000|Overall Study|Withdrawal by Subject|1|||
125192741|NCT00423332|450328092|FG001|Overall Study|Withdrawal by Subject|0|||
125192742|NCT00423332|450328091|FG000|Overall Study|Condition under investigation worsened|1|||
125192743|NCT00423332|450328092|FG001|Overall Study|Condition under investigation worsened|1|||
125192744|NCT00423332|450328091|FG000|Overall Study|Progressive at Week 6|0|||
125192745|NCT00423332|450328092|FG001|Overall Study|Progressive at Week 6|1|||
125192746|NCT00423332|450328091|FG000|Overall Study|Unblinded before 12 weeks|1|||
125192747|NCT00423332|450328092|FG001|Overall Study|Unblinded before 12 weeks|3|||
125192748|NCT01136356|450328093|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
125192749|NCT01136356|450328094|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
125192750|NCT01136356|450328093|FG000|First 18-day Withdrawal|Physician Decision|1|||
125192751|NCT01136356|450328094|FG001|First 18-day Withdrawal|Physician Decision|0|||
125192752|NCT01136356|450328093|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
125192753|NCT01136356|450328094|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
125192754|NCT00927862|450328095|FG000|Overall Study|Missing data needed for endpt analyses|27|||
125192755|NCT00927862|450328096|FG001|Overall Study|Missing data needed for endpt analyses|45|||
125192756|NCT00820248|450328097|FG000|Overall Study|No treated|4|||
125192757|NCT00820248|450328098|FG001|Overall Study|No treated|1|||
125192758|NCT04112043|450328099|FG000|Overall Study|Withdrawal by Subject|1|||
125192759|NCT04112043|450328100|FG001|Overall Study|Withdrawal by Subject|1|||
125192760|NCT04112043|450328101|FG002|Overall Study|Withdrawal by Subject|1|||
125192761|NCT04112043|450328099|FG000|Overall Study|Taking NR supplement|1|||
125192762|NCT04112043|450328100|FG001|Overall Study|Taking NR supplement|0|||
125192763|NCT04112043|450328101|FG002|Overall Study|Taking NR supplement|0|||
125192764|NCT04112043|450328099|FG000|Overall Study|Adverse Event|0|||
125192765|NCT04112043|450328100|FG001|Overall Study|Adverse Event|1|||
125192766|NCT04112043|450328101|FG002|Overall Study|Adverse Event|0|||
125192767|NCT01750697|450328102|FG000|Overall Study|Transferred Back to Local Hospital|1|||
125192768|NCT01750697|450328102|FG000|Overall Study|Physician and Family Decision|1|||
125192769|NCT01750697|450328102|FG000|Overall Study|Transferred to Adult Services|5|||
125192770|NCT01750697|450328102|FG000|Overall Study|Physician Decision|1|||
125192771|NCT01750697|450328102|FG000|Overall Study|Withdrawal by Subject|1|||
125192772|NCT03674112|450328106|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
125192773|NCT03674112|450328107|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
125192774|NCT03674112|450328106|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
125192775|NCT03674112|450328107|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
125192776|NCT03674112|450328106|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
125192777|NCT03674112|450328107|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
125192778|NCT03674112|450328106|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
125192779|NCT03674112|450328107|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
125192780|NCT03674112|450328106|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
125192781|NCT03674112|450328107|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
125192782|NCT03674112|450328106|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
125192783|NCT03674112|450328107|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
125192784|NCT03674112|450328106|FG000|Follow-Up Period (≥3 Years)|Death|2|||
125192785|NCT03674112|450328107|FG001|Follow-Up Period (≥3 Years)|Death|0|||
125192786|NCT03674112|450328106|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
125192787|NCT03674112|450328107|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
125192788|NCT00862823|450328110|FG000|First Intervention|Withdrawal by Subject|1|||
125192789|NCT00862823|450328111|FG001|First Intervention|Withdrawal by Subject|1|||
125192790|NCT02049814|450328112|FG000|Overall Study|Reason not Specified|4|||
125192791|NCT02049814|450328113|FG001|Overall Study|Reason not Specified|3|||
125192792|NCT02049814|450328112|FG000|Overall Study|Pregnancy|1|||
125192793|NCT02049814|450328113|FG001|Overall Study|Pregnancy|0|||
125192794|NCT02049814|450328112|FG000|Overall Study|Lost to Follow-up|2|||
125192795|NCT02049814|450328113|FG001|Overall Study|Lost to Follow-up|3|||
125192796|NCT02049814|450328112|FG000|Overall Study|Serious Protocol Violation|5|||
125192797|NCT02049814|450328113|FG001|Overall Study|Serious Protocol Violation|7|||
125192798|NCT02049814|450328112|FG000|Overall Study|Study Termination|0|||
125192799|NCT02049814|450328113|FG001|Overall Study|Study Termination|1|||
125192800|NCT02049814|450328112|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
125192801|NCT02049814|450328113|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
125192802|NCT02049814|450328112|FG000|Overall Study|Voluntary withdrawal|9|||
125192803|NCT02049814|450328113|FG001|Overall Study|Voluntary withdrawal|8|||
125192804|NCT01282372|450328115|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
125192805|NCT01282372|450328115|FG000|Overall Study|Lost to Follow-up|23|||
125192806|NCT01282372|450328115|FG000|Overall Study|Withdrawal by Subject|11|||
125192807|NCT01282372|450328115|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
125192808|NCT01282372|450328115|FG000|Overall Study|Death|1|||
125192809|NCT01282372|450328115|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
125192810|NCT01282372|450328115|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
125192811|NCT01282372|450328115|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
125192812|NCT01282372|450328115|FG000|Overall Study|Adverse Event|12|||
125192813|NCT02993250|450328117|FG000|Overall Study|Lost to Follow-up|0|||
125192814|NCT02993250|450328118|FG001|Overall Study|Lost to Follow-up|1|||
125192815|NCT02527434|450328119|FG000|Overall Study|Lost to Follow-up|2|||
125192816|NCT02527434|450328120|FG001|Overall Study|Lost to Follow-up|2|||
125192817|NCT02527434|450328121|FG002|Overall Study|Lost to Follow-up|0|||
125192818|NCT02527434|450328119|FG000|Overall Study|Death|19|||
125192819|NCT02527434|450328120|FG001|Overall Study|Death|6|||
125192820|NCT02527434|450328121|FG002|Overall Study|Death|17|||
125192821|NCT02527434|450328119|FG000|Overall Study|Withdrawal by Subject|5|||
125192822|NCT02527434|450328120|FG001|Overall Study|Withdrawal by Subject|3|||
125192823|NCT02527434|450328121|FG002|Overall Study|Withdrawal by Subject|3|||
125192824|NCT02527434|450328119|FG000|Overall Study|Reason Not Specified|1|||
125192825|NCT02527434|450328120|FG001|Overall Study|Reason Not Specified|0|||
125192826|NCT02527434|450328121|FG002|Overall Study|Reason Not Specified|0|||
125192827|NCT02527434|450328119|FG000|Overall Study|Site closure|1|||
125192828|NCT02527434|450328120|FG001|Overall Study|Site closure|0|||
125192829|NCT02527434|450328121|FG002|Overall Study|Site closure|0|||
125192830|NCT00568061|450328122|FG000|Overall Study|Inclusion / exclusion criteria|5|||
125192831|NCT00568061|450328123|FG001|Overall Study|Inclusion / exclusion criteria|1|||
125192832|NCT00568061|450328122|FG000|Overall Study|Adverse Event|0|||
125192833|NCT00568061|450328123|FG001|Overall Study|Adverse Event|1|||
125192834|NCT01896128|450328124|FG000|Overall Study|Withdrawal by Subject|3|||
125192835|NCT01896128|450328125|FG001|Overall Study|Withdrawal by Subject|3|||
125192836|NCT02484456|450328128|FG000|Washout Period|Withdrawal by Subject|0|||
125192837|NCT02484456|450328129|FG001|Washout Period|Withdrawal by Subject|1|||
125192838|NCT02484456|450328128|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
125192839|NCT02484456|450328129|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
125192840|NCT02484456|450328128|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
125192841|NCT02484456|450328129|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
125192842|NCT02484456|450328128|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
125192843|NCT02484456|450328129|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
125192844|NCT01996254|450328132|FG000|Overall Study|Change in Eligibility|0|||
125192845|NCT01996254|450328133|FG001|Overall Study|Change in Eligibility|2|||
125192846|NCT01996254|450328134|FG002|Overall Study|Change in Eligibility|0|||
125192847|NCT01996254|450328132|FG000|Overall Study|Withdrawal by Subject|0|||
125192848|NCT01996254|450328133|FG001|Overall Study|Withdrawal by Subject|3|||
125192849|NCT01996254|450328134|FG002|Overall Study|Withdrawal by Subject|4|||
125192850|NCT01996254|450328132|FG000|Overall Study|Lost to Follow-up|1|||
125192851|NCT01996254|450328133|FG001|Overall Study|Lost to Follow-up|0|||
125192852|NCT01996254|450328134|FG002|Overall Study|Lost to Follow-up|4|||
125192853|NCT03348930|450328135|FG000|Washout (1 Week)|Lost to Follow-up|1|||
125192854|NCT03348930|450328136|FG001|Washout (1 Week)|Lost to Follow-up|1|||
125192855|NCT00708214|450328139|FG000|Overall Study|Other Adverse Event|3|||
125192856|NCT00708214|450328140|FG001|Overall Study|Other Adverse Event|6|||
125192857|NCT00708214|450328141|FG002|Overall Study|Other Adverse Event|2|||
125192858|NCT00708214|450328139|FG000|Overall Study|Other|0|||
125192859|NCT00708214|450328140|FG001|Overall Study|Other|1|||
125192860|NCT00708214|450328141|FG002|Overall Study|Other|1|||
125192861|NCT00708214|450328139|FG000|Overall Study|Progressive Disease|4|||
125192862|NCT00708214|450328140|FG001|Overall Study|Progressive Disease|6|||
125192863|NCT00708214|450328141|FG002|Overall Study|Progressive Disease|5|||
125192864|NCT02411396|450328142|FG000|Overall Study|Lost to Follow-up|31|||
125192865|NCT02411396|450328142|FG000|Overall Study|Death|10|||
125192866|NCT02865499|450328143|FG000|Baseline|Adverse Event|1|||
125192867|NCT02865499|450328143|FG000|Baseline|Withdrawal by Subject|1|||
125192868|NCT01931995|450328144|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
125192869|NCT01931995|450328145|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
125192870|NCT01931995|450328144|FG000|First Intervention (1 Day)|Physician Decision|1|||
125192871|NCT01931995|450328145|FG001|First Intervention (1 Day)|Physician Decision|1|||
125192872|NCT01931995|450328144|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
125192873|NCT01931995|450328145|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
125192874|NCT02064816|450328148|FG000|Overall Study|Adverse Event|3|||
125192875|NCT02064816|450328149|FG001|Overall Study|Adverse Event|2|||
125192876|NCT02064816|450328148|FG000|Overall Study|Withdrawal by Subject|2|||
125192877|NCT02064816|450328149|FG001|Overall Study|Withdrawal by Subject|1|||
125192878|NCT02064816|450328148|FG000|Overall Study|Lost to Follow-up|2|||
125192879|NCT02064816|450328149|FG001|Overall Study|Lost to Follow-up|1|||
125192880|NCT02064816|450328148|FG000|Overall Study|Therapeutic failure|0|||
125192881|NCT02064816|450328149|FG001|Overall Study|Therapeutic failure|1|||
125192882|NCT02064816|450328148|FG000|Overall Study|Other|1|||
125192883|NCT02064816|450328149|FG001|Overall Study|Other|3|||
125192884|NCT01732458|450328150|FG000|Overall Study|Lost to Follow-up|0|||
125192885|NCT01732458|450328151|FG001|Overall Study|Lost to Follow-up|2|||
125192886|NCT01732458|450328152|FG002|Overall Study|Lost to Follow-up|0|||
125192887|NCT01732458|450328153|FG003|Overall Study|Lost to Follow-up|0|||
125192888|NCT01732458|450328150|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125192889|NCT01732458|450328151|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125192890|NCT01732458|450328152|FG002|Overall Study|Non-Compliance With Study Drug|1|||
125192891|NCT01732458|450328153|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125192892|NCT01732458|450328150|FG000|Overall Study|Physician Decision|1|||
125192893|NCT01732458|450328151|FG001|Overall Study|Physician Decision|2|||
125192894|NCT01732458|450328152|FG002|Overall Study|Physician Decision|2|||
125192895|NCT01732458|450328153|FG003|Overall Study|Physician Decision|0|||
125192896|NCT01732458|450328150|FG000|Overall Study|Protocol Violation|2|||
125192897|NCT01732458|450328151|FG001|Overall Study|Protocol Violation|0|||
125192898|NCT01732458|450328152|FG002|Overall Study|Protocol Violation|0|||
125192899|NCT01732458|450328153|FG003|Overall Study|Protocol Violation|2|||
125192900|NCT01732458|450328150|FG000|Overall Study|Screen Failure|0|||
125192901|NCT01732458|450328151|FG001|Overall Study|Screen Failure|1|||
125192902|NCT01732458|450328152|FG002|Overall Study|Screen Failure|0|||
125192903|NCT01732458|450328153|FG003|Overall Study|Screen Failure|0|||
125192904|NCT03759587|450328154|FG000|Overall Study|Adverse Event|5|||
125192905|NCT03759587|450328154|FG000|Overall Study|Progressive Disease|10|||
125192906|NCT03759587|450328154|FG000|Overall Study|Site Terminated by Sponsor|3|||
125192907|NCT03759587|450328154|FG000|Overall Study|Withdrawal by Subject|1|||
125192908|NCT04615403|450328155|FG000|Overall Study|Death|1|||
125192909|NCT03340454|450328158|FG000|Overall Study|Lost to Follow-up|0|||
125192910|NCT03340454|450328159|FG001|Overall Study|Lost to Follow-up|4|||
125192911|NCT01464164|450328160|FG000|Overall Study|Screen failure|0|||
125192912|NCT01464164|450328161|FG001|Overall Study|Screen failure|1|||
125192913|NCT01464164|450328162|FG002|Overall Study|Screen failure|2|||
125192914|NCT01464164|450328163|FG003|Overall Study|Screen failure|0|||
125192915|NCT01464164|450328164|FG004|Overall Study|Screen failure|0|||
125192916|NCT01464164|450328165|FG005|Overall Study|Screen failure|0|||
125192917|NCT01464164|450328166|FG006|Overall Study|Screen failure|0|||
125192918|NCT01464164|450328160|FG000|Overall Study|Physician Decision|0|||
125192919|NCT01464164|450328161|FG001|Overall Study|Physician Decision|1|||
125192920|NCT01464164|450328162|FG002|Overall Study|Physician Decision|0|||
125192921|NCT01464164|450328163|FG003|Overall Study|Physician Decision|0|||
125192922|NCT01464164|450328164|FG004|Overall Study|Physician Decision|0|||
125192923|NCT01464164|450328165|FG005|Overall Study|Physician Decision|0|||
125192924|NCT01464164|450328166|FG006|Overall Study|Physician Decision|2|||
125192925|NCT00570063|450328167|FG000|Overall Study|Adverse Event|4|||
125192926|NCT00570063|450328168|FG001|Overall Study|Adverse Event|1|||
125192927|NCT00570063|450328167|FG000|Overall Study|Lack of Efficacy|0|||
125192928|NCT00570063|450328168|FG001|Overall Study|Lack of Efficacy|1|||
125192929|NCT00570063|450328167|FG000|Overall Study|Withdrawal by Subject|4|||
125192930|NCT00570063|450328168|FG001|Overall Study|Withdrawal by Subject|3|||
125192931|NCT00570063|450328167|FG000|Overall Study|Sponsor's Decision|7|||
125192932|NCT00570063|450328168|FG001|Overall Study|Sponsor's Decision|3|||
125192933|NCT00697463|450328169|FG000|Overall Study|Withdrawal by Subject|1|||
125192934|NCT03307252|450328170|FG000|Part 2, Period 1|Treatment not received|0|||
125192935|NCT03307252|450328171|FG001|Part 2, Period 1|Treatment not received|0|||
125192936|NCT03307252|450328172|FG002|Part 2, Period 1|Treatment not received|0|||
125192937|NCT03307252|450328173|FG003|Part 2, Period 1|Treatment not received|0|||
125192938|NCT03307252|450328174|FG004|Part 2, Period 1|Treatment not received|0|||
125192939|NCT03307252|450328175|FG005|Part 2, Period 1|Treatment not received|1|||
125192940|NCT03307252|450328176|FG006|Part 2, Period 1|Treatment not received|0|||
125192941|NCT03307252|450328177|FG007|Part 2, Period 1|Treatment not received|0|||
125192942|NCT03307252|450328178|FG008|Part 2, Period 1|Treatment not received|0|||
125192943|NCT03307252|450328179|FG009|Part 2, Period 1|Treatment not received|0|||
125192944|NCT03307252|450328180|FG010|Part 2, Period 1|Treatment not received|0|||
125192945|NCT03307252|450328170|FG000|Part 2, Period 3|Other than listed|0|||
125192946|NCT03307252|450328171|FG001|Part 2, Period 3|Other than listed|0|||
125192947|NCT03307252|450328172|FG002|Part 2, Period 3|Other than listed|0|||
125192948|NCT03307252|450328173|FG003|Part 2, Period 3|Other than listed|0|||
125192949|NCT03307252|450328174|FG004|Part 2, Period 3|Other than listed|1|||
125192950|NCT03307252|450328175|FG005|Part 2, Period 3|Other than listed|0|||
125192951|NCT03307252|450328176|FG006|Part 2, Period 3|Other than listed|0|||
125192952|NCT03307252|450328177|FG007|Part 2, Period 3|Other than listed|0|||
125192953|NCT03307252|450328178|FG008|Part 2, Period 3|Other than listed|0|||
125192954|NCT03307252|450328179|FG009|Part 2, Period 3|Other than listed|0|||
125192955|NCT03307252|450328180|FG010|Part 2, Period 3|Other than listed|0|||
125192956|NCT03307252|450328170|FG000|Part 2, Period 4|Other than listed|0|||
125192957|NCT03307252|450328171|FG001|Part 2, Period 4|Other than listed|0|||
125192958|NCT03307252|450328172|FG002|Part 2, Period 4|Other than listed|0|||
125192959|NCT03307252|450328173|FG003|Part 2, Period 4|Other than listed|0|||
125192960|NCT03307252|450328174|FG004|Part 2, Period 4|Other than listed|0|||
125192961|NCT03307252|450328175|FG005|Part 2, Period 4|Other than listed|0|||
125192962|NCT03307252|450328176|FG006|Part 2, Period 4|Other than listed|1|||
125192963|NCT03307252|450328177|FG007|Part 2, Period 4|Other than listed|0|||
125192964|NCT03307252|450328178|FG008|Part 2, Period 4|Other than listed|0|||
125192965|NCT03307252|450328179|FG009|Part 2, Period 4|Other than listed|0|||
125192966|NCT03307252|450328180|FG010|Part 2, Period 4|Other than listed|0|||
125192967|NCT03307252|450328170|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
125192968|NCT03307252|450328171|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
125192969|NCT03307252|450328172|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
125192970|NCT03307252|450328173|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
125192971|NCT03307252|450328174|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
125192972|NCT03307252|450328175|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
125192973|NCT03307252|450328176|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
125192974|NCT03307252|450328177|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
125192975|NCT03307252|450328178|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
125192976|NCT03307252|450328179|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
125192977|NCT03307252|450328180|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
125192978|NCT02568189|450328181|FG000|Overall Study|Protocol Violation|0|||
125192979|NCT02568189|450328182|FG001|Overall Study|Protocol Violation|0|||
125192980|NCT02568189|450328183|FG002|Overall Study|Protocol Violation|19|||
125192981|NCT02568189|450328184|FG003|Overall Study|Protocol Violation|18|||
125192982|NCT02157376|450328185|FG000|Overall Study|Death|10|||
125192983|NCT02157376|450328186|FG001|Overall Study|Death|4|||
125192984|NCT02157376|450328185|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125192985|NCT02157376|450328186|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
125192986|NCT02157376|450328185|FG000|Overall Study|Withdrawal by Subject|3|||
125192987|NCT02157376|450328186|FG001|Overall Study|Withdrawal by Subject|8|||
125192988|NCT02157376|450328185|FG000|Overall Study|Not treated|8|||
125192989|NCT02157376|450328186|FG001|Overall Study|Not treated|3|||
125192990|NCT02157376|450328185|FG000|Overall Study|Investigator's misjudgement|1|||
125192991|NCT02157376|450328186|FG001|Overall Study|Investigator's misjudgement|2|||
125192992|NCT01074268|450328187|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
125192993|NCT01074268|450328188|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
125192994|NCT01074268|450328187|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
125192995|NCT01074268|450328188|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
125192996|NCT01074268|450328187|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
125192997|NCT01074268|450328188|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
125192998|NCT01074268|450328187|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
125192999|NCT01074268|450328188|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
125193000|NCT01074268|450328187|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
125193001|NCT01074268|450328188|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
125193002|NCT01074268|450328187|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
125193003|NCT01074268|450328188|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
125193004|NCT01074268|450328187|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
125193005|NCT01074268|450328188|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
125193006|NCT01074268|450328187|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
125193007|NCT01074268|450328188|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
125193008|NCT01074268|450328187|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
125193009|NCT01074268|450328188|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
125193010|NCT01578239|450328191|FG000|Treatment Period|Progressive Disease|19|||
125193011|NCT01578239|450328192|FG001|Treatment Period|Progressive Disease|64|||
125193012|NCT01578239|450328191|FG000|Treatment Period|Physician Decision|17|||
125193013|NCT01578239|450328192|FG001|Treatment Period|Physician Decision|17|||
125193014|NCT01578239|450328191|FG000|Treatment Period|Adverse Event|13|||
125193015|NCT01578239|450328192|FG001|Treatment Period|Adverse Event|10|||
125193016|NCT01578239|450328191|FG000|Treatment Period|Non-compliance|2|||
125193017|NCT01578239|450328192|FG001|Treatment Period|Non-compliance|0|||
125193018|NCT01578239|450328191|FG000|Treatment Period|Withdrawal by Subject|10|||
125193019|NCT01578239|450328192|FG001|Treatment Period|Withdrawal by Subject|9|||
125193020|NCT01578239|450328191|FG000|Treatment Period|Other|6|||
125193021|NCT01578239|450328192|FG001|Treatment Period|Other|1|||
125193022|NCT01578239|450328191|FG000|Long-term Follow-Up Period|Death|69|||
125193023|NCT01578239|450328192|FG001|Long-term Follow-Up Period|Death|64|||
125193024|NCT01578239|450328191|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
125193025|NCT01578239|450328192|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
125193026|NCT01578239|450328191|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
125193027|NCT01578239|450328192|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
125193028|NCT01578239|450328191|FG000|Long-term Follow-Up Period|Other|2|||
125193029|NCT01578239|450328192|FG001|Long-term Follow-Up Period|Other|2|||
125193030|NCT01031680|450328198|FG000|Overall Study|Adverse Event|8|||
125193031|NCT01031680|450328199|FG001|Overall Study|Adverse Event|3|||
125193032|NCT01031680|450328198|FG000|Overall Study|Lost to Follow-up|2|||
125193033|NCT01031680|450328199|FG001|Overall Study|Lost to Follow-up|10|||
125193034|NCT01031680|450328198|FG000|Overall Study|Withdrawal by Subject|12|||
125193035|NCT01031680|450328199|FG001|Overall Study|Withdrawal by Subject|16|||
125193036|NCT01031680|450328198|FG000|Overall Study|Death|2|||
125193037|NCT01031680|450328199|FG001|Overall Study|Death|1|||
125193038|NCT01031680|450328198|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
125193039|NCT01031680|450328199|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
125193040|NCT01031680|450328198|FG000|Overall Study|Poor/Non-compliance|5|||
125193041|NCT01031680|450328199|FG001|Overall Study|Poor/Non-compliance|6|||
125193042|NCT01031680|450328198|FG000|Overall Study|Safety|1|||
125193043|NCT01031680|450328199|FG001|Overall Study|Safety|0|||
125193044|NCT01031680|450328198|FG000|Overall Study|Incorrect Enrolment|1|||
125193045|NCT01031680|450328199|FG001|Overall Study|Incorrect Enrolment|2|||
125193046|NCT01031680|450328198|FG000|Overall Study|Administrative Reason by Sponsor|0|||
125193047|NCT01031680|450328199|FG001|Overall Study|Administrative Reason by Sponsor|1|||
125193048|NCT01031680|450328198|FG000|Overall Study|Various|0|||
125193049|NCT01031680|450328199|FG001|Overall Study|Various|2|||
125193050|NCT02654977|450328204|FG000|Overall Study|Death|1|||
125193051|NCT02654977|450328204|FG000|Overall Study|Lost to Follow-up|1|||
125193052|NCT02654977|450328204|FG000|Overall Study|Adverse Event|1|||
125193053|NCT02654977|450328204|FG000|Overall Study|Withdrawal by Subject|1|||
125193054|NCT02654977|450328204|FG000|Overall Study|Lack of Efficacy|3|||
125193055|NCT01921101|450328205|FG000|Overall Study|Death|16|||
125193056|NCT01921101|450328206|FG001|Overall Study|Death|6|||
125193057|NCT01483027|450328207|FG000|Overall Study|Administrative Reasons|2|||
125193058|NCT01483027|450328208|FG001|Overall Study|Administrative Reasons|1|||
125193059|NCT01483027|450328207|FG000|Overall Study|Withdrawal by Subject|21|||
125193060|NCT01483027|450328208|FG001|Overall Study|Withdrawal by Subject|32|||
125193061|NCT01483027|450328207|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
125193062|NCT01483027|450328208|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
125193063|NCT01483027|450328207|FG000|Overall Study|Lost to Follow-up|1|||
125193064|NCT01483027|450328208|FG001|Overall Study|Lost to Follow-up|1|||
125193065|NCT01483027|450328207|FG000|Overall Study|Adverse Event|0|||
125193066|NCT01483027|450328208|FG001|Overall Study|Adverse Event|1|||
125193067|NCT01483027|450328207|FG000|Overall Study|Withdrawal by Subject|0|||
125193068|NCT01483027|450328208|FG001|Overall Study|Withdrawal by Subject|1|||
125193069|NCT04432831|450330141|FG000|Overall Study|Withdrawal by Subject|24|||
125193070|NCT04432831|450330142|FG001|Overall Study|Withdrawal by Subject|28|||
125193071|NCT04432831|450330143|FG002|Overall Study|Withdrawal by Subject|21|||
125193072|NCT04432831|450330141|FG000|Overall Study|Death|23|||
125193073|NCT04432831|450330142|FG001|Overall Study|Death|23|||
125245628|NCT00827242|450524583|FG000|Overall Study|Entry Criteria Not Met|4|||
125245629|NCT00827242|450524584|FG001|Overall Study|Entry Criteria Not Met|1|||
125245630|NCT00827242|450524583|FG000|Overall Study|Physician Decision|2|||
125193074|NCT04432831|450330143|FG002|Overall Study|Death|17|||
125193075|NCT04432831|450330141|FG000|Overall Study|Lost to Follow-up|15|||
125193076|NCT04432831|450330142|FG001|Overall Study|Lost to Follow-up|15|||
125193077|NCT04432831|450330143|FG002|Overall Study|Lost to Follow-up|12|||
125193078|NCT04432831|450330141|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
125193079|NCT04432831|450330142|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
125193080|NCT04432831|450330143|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
125245631|NCT00827242|450524584|FG001|Overall Study|Physician Decision|0|||
125193081|NCT04432831|450330141|FG000|Overall Study|Reason Not Specified|7|||
125193082|NCT04432831|450330142|FG001|Overall Study|Reason Not Specified|11|||
125193083|NCT04432831|450330143|FG002|Overall Study|Reason Not Specified|9|||
125193084|NCT04432831|450330141|FG000|Overall Study|Adverse Event|7|||
125245632|NCT00827242|450524583|FG000|Overall Study|Death|1|||
125245633|NCT00827242|450524584|FG001|Overall Study|Death|0|||
125245634|NCT00827242|450524583|FG000|Overall Study|Lack of Efficacy|1|||
125245635|NCT00827242|450524584|FG001|Overall Study|Lack of Efficacy|0|||
125245636|NCT00899847|450524585|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
125245637|NCT01769443|450524586|FG000|Overall Study|Study closure|1|||
125245638|NCT01769443|450524587|FG001|Overall Study|Study closure|0|||
125245639|NCT01279200|450524588|FG000|Overall Study|Withdrawal by Subject|1|||
125245640|NCT01279200|450524589|FG001|Overall Study|Withdrawal by Subject|3|||
125245641|NCT01279200|450524588|FG000|Overall Study|Patient withdrawal due to high cost|0|||
125245642|NCT01279200|450524589|FG001|Overall Study|Patient withdrawal due to high cost|1|||
125245643|NCT01279200|450524588|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
125245644|NCT01279200|450524589|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
125245645|NCT01279200|450524588|FG000|Overall Study|ultrasound screening failure|0|||
125245646|NCT01279200|450524589|FG001|Overall Study|ultrasound screening failure|1|||
125245647|NCT01279200|450524588|FG000|Overall Study|Lost to Follow-up|0|||
125245648|NCT01279200|450524589|FG001|Overall Study|Lost to Follow-up|1|||
125245649|NCT01279200|450524588|FG000|Overall Study|Adverse Event|1|||
125245650|NCT01279200|450524589|FG001|Overall Study|Adverse Event|0|||
125245651|NCT01149538|450524592|FG000|Overall Study|Lost to Follow-up|0|||
125245652|NCT01149538|450524593|FG001|Overall Study|Lost to Follow-up|1|||
125245653|NCT01149538|450524592|FG000|Overall Study|Withdrawal by Subject|5|||
125245654|NCT01149538|450524593|FG001|Overall Study|Withdrawal by Subject|3|||
125245655|NCT05507450|450524599|FG000|Overall Study|Death|0|||
125245656|NCT05507450|450524600|FG001|Overall Study|Death|0|||
125245657|NCT05507450|450524601|FG002|Overall Study|Death|1|||
125245658|NCT05507450|450524602|FG003|Overall Study|Death|0|||
125245659|NCT05507450|450524599|FG000|Overall Study|Lost to Follow-up|22|||
125245660|NCT05507450|450524600|FG001|Overall Study|Lost to Follow-up|20|||
125245661|NCT05507450|450524601|FG002|Overall Study|Lost to Follow-up|20|||
125245662|NCT05507450|450524602|FG003|Overall Study|Lost to Follow-up|7|||
125245663|NCT05507450|450524599|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125245664|NCT05507450|450524600|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
125245665|NCT05507450|450524601|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
125245666|NCT05507450|450524602|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125245667|NCT05507450|450524599|FG000|Overall Study|Withdrawal by Subject|4|||
125245668|NCT05507450|450524600|FG001|Overall Study|Withdrawal by Subject|11|||
125245669|NCT05507450|450524601|FG002|Overall Study|Withdrawal by Subject|7|||
125245670|NCT05507450|450524602|FG003|Overall Study|Withdrawal by Subject|3|||
125245671|NCT05507450|450524599|FG000|Overall Study|Participant left the country|0|||
125245672|NCT05507450|450524600|FG001|Overall Study|Participant left the country|0|||
125245673|NCT05507450|450524601|FG002|Overall Study|Participant left the country|1|||
125245674|NCT05507450|450524602|FG003|Overall Study|Participant left the country|0|||
125245675|NCT00514917|450524606|FG000|Overall Study|Death|4|||
125245676|NCT00514917|450524607|FG001|Overall Study|Death|10|||
125245677|NCT00514917|450524606|FG000|Overall Study|Protocol Violation|1|||
125245678|NCT00514917|450524607|FG001|Overall Study|Protocol Violation|0|||
125245679|NCT00514917|450524606|FG000|Overall Study|Lost to Follow-up|4|||
125245680|NCT00514917|450524607|FG001|Overall Study|Lost to Follow-up|3|||
125245681|NCT00514917|450524606|FG000|Overall Study|Withdrawal by Subject|18|||
125245682|NCT00514917|450524607|FG001|Overall Study|Withdrawal by Subject|16|||
125245683|NCT00514917|450524606|FG000|Overall Study|Discontinued due to study closure|88|||
125245684|NCT00514917|450524607|FG001|Overall Study|Discontinued due to study closure|81|||
125245685|NCT00514917|450524606|FG000|Overall Study|Undefined|11|||
125245686|NCT00514917|450524607|FG001|Overall Study|Undefined|5|||
125245687|NCT02697422|450524608|FG000|Overall Study|Declined exit survey|9|||
125245688|NCT02697422|450524609|FG001|Overall Study|Declined exit survey|2|||
125245689|NCT02697422|450524608|FG000|Overall Study|Lost to Follow-up|13|||
125245690|NCT02697422|450524609|FG001|Overall Study|Lost to Follow-up|8|||
125245691|NCT02697422|450524608|FG000|Overall Study|Death|2|||
125245692|NCT02697422|450524609|FG001|Overall Study|Death|1|||
125245693|NCT02697422|450524608|FG000|Overall Study|Withdrawal by Subject|0|||
125245694|NCT02697422|450524609|FG001|Overall Study|Withdrawal by Subject|1|||
125245695|NCT02697422|450524608|FG000|Overall Study|Physician Decision|1|||
125245696|NCT02697422|450524609|FG001|Overall Study|Physician Decision|1|||
125245697|NCT02697422|450524608|FG000|Overall Study|Exit survey data lost|1|||
125245698|NCT02697422|450524609|FG001|Overall Study|Exit survey data lost|0|||
125245699|NCT01873833|450524613|FG000|Overall Study|Withdrawal by Subject|1|||
125245700|NCT03983109|450524616|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
125245701|NCT03983109|450524617|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
125245702|NCT02068599|450524618|FG000|Overall Study|Adverse Event|4|||
125245703|NCT02068599|450524619|FG001|Overall Study|Adverse Event|1|||
125245704|NCT02068599|450524620|FG002|Overall Study|Adverse Event|1|||
125245705|NCT02068599|450524618|FG000|Overall Study|Withdrawal by Subject|2|||
125245706|NCT02068599|450524619|FG001|Overall Study|Withdrawal by Subject|7|||
125245707|NCT02068599|450524620|FG002|Overall Study|Withdrawal by Subject|5|||
125245708|NCT02068599|450524618|FG000|Overall Study|Protocol Violation|4|||
125245709|NCT02068599|450524619|FG001|Overall Study|Protocol Violation|2|||
125245710|NCT02068599|450524620|FG002|Overall Study|Protocol Violation|3|||
125245711|NCT02068599|450524618|FG000|Overall Study|Lost to Follow-up|1|||
125245712|NCT02068599|450524619|FG001|Overall Study|Lost to Follow-up|0|||
125245713|NCT02068599|450524620|FG002|Overall Study|Lost to Follow-up|0|||
125245714|NCT02068599|450524618|FG000|Overall Study|Lack of Efficacy|0|||
125245715|NCT02068599|450524619|FG001|Overall Study|Lack of Efficacy|0|||
125245716|NCT02068599|450524620|FG002|Overall Study|Lack of Efficacy|3|||
125245717|NCT02068599|450524618|FG000|Overall Study|Noncompliance|0|||
125245718|NCT02068599|450524619|FG001|Overall Study|Noncompliance|0|||
125245719|NCT02068599|450524620|FG002|Overall Study|Noncompliance|1|||
125245720|NCT01871727|450524623|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
125245721|NCT01871727|450524624|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
125245722|NCT01871727|450524625|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
125245723|NCT01871727|450524626|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
125245724|NCT01871727|450524627|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
125245725|NCT01871727|450524623|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
125245726|NCT01871727|450524624|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
125245727|NCT01871727|450524625|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
125245728|NCT01871727|450524626|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
125245729|NCT01871727|450524627|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
125245730|NCT01871727|450524623|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
125245731|NCT01871727|450524624|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
125245732|NCT01871727|450524625|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
125245733|NCT01871727|450524626|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
125245734|NCT01871727|450524627|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
125245735|NCT01871727|450524623|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
125245736|NCT01871727|450524624|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
125245737|NCT01871727|450524625|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
125245738|NCT01871727|450524626|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
125245739|NCT01871727|450524627|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
125245740|NCT01871727|450524623|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
125245741|NCT01871727|450524624|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
125245742|NCT01871727|450524625|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
125245743|NCT01871727|450524626|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
125245744|NCT01871727|450524627|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
125245745|NCT01871727|450524623|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
125245746|NCT01871727|450524624|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
125245747|NCT01871727|450524625|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
125245748|NCT01871727|450524626|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
125245749|NCT01871727|450524627|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
125245750|NCT01871727|450524623|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
125245751|NCT01871727|450524624|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
125245752|NCT01871727|450524625|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
125245753|NCT01871727|450524626|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
125245754|NCT01871727|450524627|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
125245755|NCT01263028|450524628|FG000|Overall Study|Withdrawal by Subject|1|||
125245756|NCT01263028|450524628|FG000|Overall Study|Adverse Event|1|||
125245757|NCT01263028|450524628|FG000|Overall Study|Study terminated due to low enrollment.|4|||
125245758|NCT00309244|450524629|FG000|Overall Study|Adverse Event|29|||
125245759|NCT00309244|450524630|FG001|Overall Study|Adverse Event|12|||
125245760|NCT00309244|450524629|FG000|Overall Study|Lost to Follow-up|6|||
125245761|NCT00309244|450524630|FG001|Overall Study|Lost to Follow-up|22|||
125245762|NCT00309244|450524629|FG000|Overall Study|Physician Decision|5|||
125245763|NCT00309244|450524630|FG001|Overall Study|Physician Decision|8|||
125245764|NCT00309244|450524629|FG000|Overall Study|Protocol Violation|6|||
125245765|NCT00309244|450524630|FG001|Overall Study|Protocol Violation|3|||
125245766|NCT00309244|450524629|FG000|Overall Study|Withdrawal by Subject|50|||
125245767|NCT00309244|450524630|FG001|Overall Study|Withdrawal by Subject|32|||
125245768|NCT00309244|450524629|FG000|Overall Study|Various|7|||
125245769|NCT00309244|450524630|FG001|Overall Study|Various|7|||
125245770|NCT00309244|450524629|FG000|Overall Study|Randomized but not dosed|11|||
125245771|NCT00309244|450524630|FG001|Overall Study|Randomized but not dosed|12|||
125245772|NCT00309244|450524629|FG000|Overall Study|Death|4|||
125245773|NCT00309244|450524630|FG001|Overall Study|Death|1|||
125245774|NCT03019588|450524631|FG000|Overall Study|Death|44|||
125245775|NCT03019588|450524632|FG001|Overall Study|Death|46|||
125245776|NCT03019588|450524631|FG000|Overall Study|Study terminated by Sponsor|3|||
125245777|NCT03019588|450524632|FG001|Overall Study|Study terminated by Sponsor|1|||
125245778|NCT00501085|450524633|FG000|Overall Study|Lost to Follow-up|195|||
125245779|NCT00501085|450524633|FG000|Overall Study|Withdrawal by Subject|34|||
125245780|NCT00501085|450524633|FG000|Overall Study|Subject Decision|1|||
125245781|NCT00501085|450524633|FG000|Overall Study|Revision Surgery|7|||
125193085|NCT04432831|450330142|FG001|Overall Study|Adverse Event|7|||
125193086|NCT04432831|450330143|FG002|Overall Study|Adverse Event|7|||
125193087|NCT04432831|450330141|FG000|Overall Study|Physician Decision|1|||
125193088|NCT04432831|450330142|FG001|Overall Study|Physician Decision|3|||
125193089|NCT04432831|450330143|FG002|Overall Study|Physician Decision|6|||
125193090|NCT04432831|450330141|FG000|Overall Study|Protocol Violation|1|||
125193091|NCT04432831|450330142|FG001|Overall Study|Protocol Violation|0|||
125193092|NCT04432831|450330143|FG002|Overall Study|Protocol Violation|2|||
125193093|NCT04432831|450330141|FG000|Overall Study|Pregnancy|0|||
125193094|NCT04432831|450330142|FG001|Overall Study|Pregnancy|1|||
125193095|NCT04432831|450330143|FG002|Overall Study|Pregnancy|0|||
125193096|NCT04432831|450330141|FG000|Overall Study|Lack of Efficacy|0|||
125245782|NCT00501085|450524633|FG000|Overall Study|Explantation Surgery|26|||
125245783|NCT00501085|450524633|FG000|Overall Study|Adverse Event|4|||
125245784|NCT00501085|450524633|FG000|Overall Study|Non-Compliance|24|||
125245785|NCT00501085|450524633|FG000|Overall Study|Study closed by sponsor|109|||
125245786|NCT00501085|450524633|FG000|Overall Study|Other loss to follow-up|32|||
125245787|NCT00366535|450524634|FG000|First Phase: 12 Weeks|Adverse Event|1|||
125245788|NCT00366535|450524635|FG001|First Phase: 12 Weeks|Adverse Event|3|||
125245789|NCT00366535|450524634|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
125245790|NCT00366535|450524635|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
125245791|NCT00366535|450524634|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
125245792|NCT00366535|450524635|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
125245793|NCT00366535|450524634|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
125193097|NCT04432831|450330142|FG001|Overall Study|Lack of Efficacy|0|||
125193098|NCT04432831|450330143|FG002|Overall Study|Lack of Efficacy|2|||
125193099|NCT00652626|450330146|FG000|Initial Treatment Phase|Adverse Event|0|||
125193100|NCT00652626|450330147|FG001|Initial Treatment Phase|Adverse Event|0|||
125193101|NCT00652626|450330148|FG002|Initial Treatment Phase|Adverse Event|0|||
125193102|NCT00652626|450330149|FG003|Initial Treatment Phase|Adverse Event|0|||
125193103|NCT00652626|450330150|FG004|Initial Treatment Phase|Adverse Event|1|||
125193104|NCT00652626|450330151|FG005|Initial Treatment Phase|Adverse Event|0|||
125193105|NCT00652626|450330152|FG006|Initial Treatment Phase|Adverse Event|0|||
125193106|NCT00652626|450330146|FG000|Initial Treatment Phase|Protocol Violation|0|||
125193107|NCT00652626|450330147|FG001|Initial Treatment Phase|Protocol Violation|0|||
125193108|NCT00652626|450330148|FG002|Initial Treatment Phase|Protocol Violation|0|||
125193109|NCT00652626|450330149|FG003|Initial Treatment Phase|Protocol Violation|1|||
125193110|NCT00652626|450330150|FG004|Initial Treatment Phase|Protocol Violation|0|||
125245794|NCT00366535|450524635|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
125245795|NCT02958527|450524640|FG000|Overall Study|Not collected CRFs|12|||
125245796|NCT00250718|450524643|FG000|Overall Study|Death|1|||
125245797|NCT00250718|450524643|FG000|Overall Study|Adverse Event|1|||
125245798|NCT00250718|450524643|FG000|Overall Study|Withdrawal by Subject|1|||
125245799|NCT01666314|450524644|FG000|Overall Study|Adverse Event|3|||
125245800|NCT01666314|450524645|FG001|Overall Study|Adverse Event|13|||
125245801|NCT01666314|450524646|FG002|Overall Study|Adverse Event|7|||
125245802|NCT01666314|450524647|FG003|Overall Study|Adverse Event|7|||
125245803|NCT01666314|450524644|FG000|Overall Study|Progressive Disease|11|||
125245804|NCT01666314|450524645|FG001|Overall Study|Progressive Disease|9|||
125245805|NCT01666314|450524646|FG002|Overall Study|Progressive Disease|19|||
125245806|NCT01666314|450524647|FG003|Overall Study|Progressive Disease|20|||
125245807|NCT01666314|450524644|FG000|Overall Study|Symptomatic Deterioration|1|||
125245808|NCT01666314|450524645|FG001|Overall Study|Symptomatic Deterioration|0|||
125245809|NCT01666314|450524646|FG002|Overall Study|Symptomatic Deterioration|2|||
125245810|NCT01666314|450524647|FG003|Overall Study|Symptomatic Deterioration|0|||
125245811|NCT01666314|450524644|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
125245812|NCT01666314|450524645|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
125245813|NCT01666314|450524646|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
125245814|NCT01666314|450524647|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
125245815|NCT01666314|450524644|FG000|Overall Study|Withdrawal by Subject|1|||
125245816|NCT01666314|450524645|FG001|Overall Study|Withdrawal by Subject|1|||
125193111|NCT00652626|450330151|FG005|Initial Treatment Phase|Protocol Violation|0|||
125193112|NCT00652626|450330152|FG006|Initial Treatment Phase|Protocol Violation|0|||
125193113|NCT00652626|450330146|FG000|Initial Treatment Phase|Physician Decision|0|||
125245817|NCT01666314|450524646|FG002|Overall Study|Withdrawal by Subject|2|||
125245818|NCT01666314|450524647|FG003|Overall Study|Withdrawal by Subject|3|||
125245819|NCT01666314|450524644|FG000|Overall Study|Reason not Specified|10|||
125245820|NCT01666314|450524645|FG001|Overall Study|Reason not Specified|7|||
125193114|NCT00652626|450330147|FG001|Initial Treatment Phase|Physician Decision|0|||
125193115|NCT00652626|450330148|FG002|Initial Treatment Phase|Physician Decision|0|||
125193116|NCT00652626|450330149|FG003|Initial Treatment Phase|Physician Decision|0|||
125245821|NCT01666314|450524646|FG002|Overall Study|Reason not Specified|5|||
125245822|NCT01666314|450524647|FG003|Overall Study|Reason not Specified|5|||
125245823|NCT00422461|450526613|FG000|Overall Study|Adverse Event|1|||
125245824|NCT00422461|450526614|FG001|Overall Study|Adverse Event|2|||
125245825|NCT00422461|450526615|FG002|Overall Study|Adverse Event|1|||
125245826|NCT00422461|450526616|FG003|Overall Study|Adverse Event|1|||
125245827|NCT00422461|450526613|FG000|Overall Study|Other|0|||
125245828|NCT00422461|450526614|FG001|Overall Study|Other|0|||
125245829|NCT00422461|450526615|FG002|Overall Study|Other|0|||
125245830|NCT00422461|450526616|FG003|Overall Study|Other|2|||
125245831|NCT00422461|450526613|FG000|Overall Study|Participants no longer willing to participate in study|1|||
125245832|NCT00422461|450526614|FG001|Overall Study|Participants no longer willing to participate in study|0|||
125245833|NCT00422461|450526615|FG002|Overall Study|Participants no longer willing to participate in study|0|||
125245834|NCT00422461|450526616|FG003|Overall Study|Participants no longer willing to participate in study|0|||
125245835|NCT00422461|450526613|FG000|Overall Study|Randomized but not treated|1|||
125245836|NCT00422461|450526614|FG001|Overall Study|Randomized but not treated|1|||
125245837|NCT00422461|450526615|FG002|Overall Study|Randomized but not treated|0|||
125245838|NCT00422461|450526616|FG003|Overall Study|Randomized but not treated|0|||
125245839|NCT01471574|450526617|FG000|Treatment Period|Lack of Efficacy|12|||
125245840|NCT01471574|450526618|FG001|Treatment Period|Lack of Efficacy|4|||
125245841|NCT01471574|450526619|FG002|Treatment Period|Lack of Efficacy|14|||
125245842|NCT01471574|450526620|FG003|Treatment Period|Lack of Efficacy|1|||
125245843|NCT01471574|450526617|FG000|Treatment Period|Adverse Event|7|||
125245844|NCT01471574|450526618|FG001|Treatment Period|Adverse Event|3|||
125245845|NCT01471574|450526619|FG002|Treatment Period|Adverse Event|6|||
125245846|NCT01471574|450526620|FG003|Treatment Period|Adverse Event|1|||
125245847|NCT01471574|450526617|FG000|Treatment Period|Withdrawal by Subject|5|||
125245848|NCT01471574|450526618|FG001|Treatment Period|Withdrawal by Subject|1|||
125245849|NCT01471574|450526619|FG002|Treatment Period|Withdrawal by Subject|1|||
125245850|NCT01471574|450526620|FG003|Treatment Period|Withdrawal by Subject|0|||
125245851|NCT01471574|450526617|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
125245852|NCT01471574|450526618|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
125245853|NCT01471574|450526619|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
125245854|NCT01471574|450526620|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
125245855|NCT01471574|450526617|FG000|Treatment Period|Lost to Follow-up|1|||
125245856|NCT01471574|450526618|FG001|Treatment Period|Lost to Follow-up|2|||
125245857|NCT01471574|450526619|FG002|Treatment Period|Lost to Follow-up|2|||
125245858|NCT01471574|450526620|FG003|Treatment Period|Lost to Follow-up|0|||
125245859|NCT01471574|450526617|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
125245860|NCT01471574|450526618|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
125245861|NCT01471574|450526619|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
125245862|NCT01471574|450526620|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
125245863|NCT01471574|450526617|FG000|Treatment Period|Other|1|||
125245864|NCT01471574|450526618|FG001|Treatment Period|Other|0|||
125245865|NCT01471574|450526619|FG002|Treatment Period|Other|0|||
125245866|NCT01471574|450526620|FG003|Treatment Period|Other|0|||
125245867|NCT01471574|450526617|FG000|Follow-up Period|Withdrawal by Subject|3|||
125245868|NCT01471574|450526618|FG001|Follow-up Period|Withdrawal by Subject|0|||
125245869|NCT01471574|450526619|FG002|Follow-up Period|Withdrawal by Subject|3|||
125245870|NCT01471574|450526620|FG003|Follow-up Period|Withdrawal by Subject|1|||
125245871|NCT01471574|450526617|FG000|Follow-up Period|Lost to Follow-up|4|||
125245872|NCT01471574|450526618|FG001|Follow-up Period|Lost to Follow-up|1|||
125245873|NCT01471574|450526619|FG002|Follow-up Period|Lost to Follow-up|3|||
125245874|NCT01471574|450526620|FG003|Follow-up Period|Lost to Follow-up|2|||
125245875|NCT01471574|450526617|FG000|Follow-up Period|Death|0|||
125245876|NCT01471574|450526618|FG001|Follow-up Period|Death|0|||
125245877|NCT01471574|450526619|FG002|Follow-up Period|Death|1|||
125245878|NCT01471574|450526620|FG003|Follow-up Period|Death|0|||
125245879|NCT01471574|450526617|FG000|Follow-up Period|Follow-up no longer required|0|||
125245880|NCT01471574|450526618|FG001|Follow-up Period|Follow-up no longer required|1|||
125245881|NCT01471574|450526619|FG002|Follow-up Period|Follow-up no longer required|0|||
125245882|NCT01471574|450526620|FG003|Follow-up Period|Follow-up no longer required|0|||
125245883|NCT00864513|450526626|FG000|Overall Study|Withdrawal by Subject|3|||
125245884|NCT00574951|450526627|FG000|Overall Study|Ineligible - improper prior treatment|1|||
125245885|NCT01160744|450526640|FG000|Overall Study|Withdrawal by Subject|11|||
125245886|NCT01160744|450526641|FG001|Overall Study|Withdrawal by Subject|5|||
125245887|NCT01160744|450526642|FG002|Overall Study|Withdrawal by Subject|6|||
125245888|NCT01160744|450526643|FG003|Overall Study|Withdrawal by Subject|4|||
125245889|NCT01160744|450526640|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
125245890|NCT01160744|450526641|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
125245891|NCT01160744|450526642|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
125245892|NCT01160744|450526643|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
125245893|NCT02056288|450526644|FG000|In-Hospital Data|Surgery cancelled|1|||
125245894|NCT02056288|450526645|FG001|In-Hospital Data|Surgery cancelled|0|||
125245895|NCT02056288|450526644|FG000|In-Hospital Data|Protocol Violation|3|||
125245896|NCT02056288|450526645|FG001|In-Hospital Data|Protocol Violation|0|||
125245897|NCT02056288|450526644|FG000|In-Hospital Data|Physician Decision|1|||
125245898|NCT02056288|450526645|FG001|In-Hospital Data|Physician Decision|0|||
125245899|NCT02056288|450526644|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
125245900|NCT02056288|450526645|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
125245901|NCT02301429|450526646|FG000|Overall Study|not acceptable vascular anatomy|3|||
125245902|NCT00500110|450526647|FG000|Overall Study|Withdrawal by Subject|3|||
125245903|NCT01502072|450526648|FG000|Overall Study|Withdrawal by Subject|1|||
125245904|NCT01502072|450526649|FG001|Overall Study|Withdrawal by Subject|0|||
125245905|NCT01502072|450526650|FG002|Overall Study|Withdrawal by Subject|0|||
125245906|NCT01502072|450526648|FG000|Overall Study|Death|0|||
125245907|NCT01502072|450526649|FG001|Overall Study|Death|1|||
125245908|NCT01502072|450526650|FG002|Overall Study|Death|0|||
125245909|NCT03954938|450526651|FG000|Overall Study|Withdrawal by Subject|2|||
125245910|NCT03954938|450526651|FG000|Overall Study|Adverse Event|1|||
125245911|NCT04676646|450526652|FG000|Open-label Run-in Phase|Adverse Event|3|||
125245912|NCT04676646|450526653|FG001|Open-label Run-in Phase|Adverse Event|0|||
125245913|NCT04676646|450526654|FG002|Open-label Run-in Phase|Adverse Event|0|||
125245914|NCT04676646|450526652|FG000|Open-label Run-in Phase|Death|3|||
125245915|NCT04676646|450526653|FG001|Open-label Run-in Phase|Death|0|||
125245916|NCT04676646|450526654|FG002|Open-label Run-in Phase|Death|0|||
125245917|NCT04676646|450526652|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
125245918|NCT04676646|450526653|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
125245919|NCT04676646|450526654|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
125245920|NCT04676646|450526652|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
125245921|NCT04676646|450526653|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
125245922|NCT04676646|450526654|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
125245923|NCT04676646|450526652|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
125245924|NCT04676646|450526653|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
125245925|NCT04676646|450526654|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
125245926|NCT04676646|450526652|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
125245927|NCT04676646|450526653|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
125245928|NCT04676646|450526654|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
125245929|NCT04676646|450526652|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
125245930|NCT04676646|450526653|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
125245931|NCT04676646|450526654|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
125245932|NCT04676646|450526652|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
125245933|NCT04676646|450526653|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
125245934|NCT04676646|450526654|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
125245935|NCT04676646|450526652|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
125245936|NCT04676646|450526653|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
125245937|NCT04676646|450526654|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
125193117|NCT00652626|450330150|FG004|Initial Treatment Phase|Physician Decision|1|||
125193118|NCT00652626|450330151|FG005|Initial Treatment Phase|Physician Decision|0|||
125193119|NCT00652626|450330152|FG006|Initial Treatment Phase|Physician Decision|0|||
125193120|NCT00652626|450330146|FG000|Initial Treatment Phase|Sponsor Request|0|||
125193121|NCT00652626|450330147|FG001|Initial Treatment Phase|Sponsor Request|0|||
125193122|NCT00652626|450330148|FG002|Initial Treatment Phase|Sponsor Request|1|||
125193123|NCT00652626|450330149|FG003|Initial Treatment Phase|Sponsor Request|0|||
125193124|NCT00652626|450330150|FG004|Initial Treatment Phase|Sponsor Request|0|||
125193125|NCT00652626|450330151|FG005|Initial Treatment Phase|Sponsor Request|0|||
125193126|NCT00652626|450330152|FG006|Initial Treatment Phase|Sponsor Request|0|||
125193127|NCT00652626|450330146|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
125193128|NCT00652626|450330147|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
125193129|NCT00652626|450330148|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
125193130|NCT00652626|450330149|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
125193131|NCT00652626|450330150|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
125193132|NCT00652626|450330151|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
125193133|NCT00652626|450330152|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
125193134|NCT00652626|450330146|FG000|Extension Phase|Withdrawal by Subject|0|||
125245938|NCT04676646|450526652|FG000|Randomised-withdrawal Phase|Death|0|||
125245939|NCT04676646|450526653|FG001|Randomised-withdrawal Phase|Death|1|||
125245940|NCT04676646|450526654|FG002|Randomised-withdrawal Phase|Death|2|||
125245941|NCT04676646|450526652|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
125245942|NCT04676646|450526653|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
125245943|NCT04676646|450526654|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
125193135|NCT00652626|450330147|FG001|Extension Phase|Withdrawal by Subject|0|||
125193136|NCT00652626|450330148|FG002|Extension Phase|Withdrawal by Subject|0|||
125193137|NCT00652626|450330149|FG003|Extension Phase|Withdrawal by Subject|0|||
125193138|NCT00652626|450330150|FG004|Extension Phase|Withdrawal by Subject|0|||
125245944|NCT04676646|450526652|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
125245945|NCT04676646|450526653|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
125245946|NCT04676646|450526654|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
125245947|NCT04676646|450526652|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
125245948|NCT04676646|450526653|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
125245949|NCT04676646|450526654|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
125245950|NCT04676646|450526652|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
125245951|NCT04676646|450526653|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
125245952|NCT04676646|450526654|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
125245953|NCT04676646|450526652|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
125245954|NCT04676646|450526653|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
125245955|NCT04676646|450526654|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
125245956|NCT04676646|450526652|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
125245957|NCT04676646|450526653|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
125245958|NCT04676646|450526654|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
125245959|NCT04676646|450526652|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
125245960|NCT04676646|450526653|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
125245961|NCT04676646|450526654|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
125245962|NCT02217982|450526655|FG000|Overall Study|Trial discontinued|1|||
125245963|NCT02217982|450526656|FG001|Overall Study|Trial discontinued|0|||
125245964|NCT02217982|450526655|FG000|Overall Study|Adverse Event|0|||
125245965|NCT02217982|450526656|FG001|Overall Study|Adverse Event|1|||
125245966|NCT04270760|450526657|FG000|Overall Study|Withdrawal by Subject|0|||
125245967|NCT04270760|450526658|FG001|Overall Study|Withdrawal by Subject|1|||
125245968|NCT04270760|450526659|FG002|Overall Study|Withdrawal by Subject|3|||
125245969|NCT04270760|450526660|FG003|Overall Study|Withdrawal by Subject|0|||
125245970|NCT04270760|450526661|FG004|Overall Study|Withdrawal by Subject|0|||
125245971|NCT04270760|450526657|FG000|Overall Study|Lost to Follow-up|1|||
125245972|NCT04270760|450526658|FG001|Overall Study|Lost to Follow-up|2|||
125245973|NCT04270760|450526659|FG002|Overall Study|Lost to Follow-up|1|||
125245974|NCT04270760|450526660|FG003|Overall Study|Lost to Follow-up|0|||
125245975|NCT04270760|450526661|FG004|Overall Study|Lost to Follow-up|0|||
125245976|NCT04270760|450526657|FG000|Overall Study|Death|0|||
125245977|NCT04270760|450526658|FG001|Overall Study|Death|0|||
125245978|NCT04270760|450526659|FG002|Overall Study|Death|0|||
125245979|NCT04270760|450526660|FG003|Overall Study|Death|0|||
125245980|NCT04270760|450526661|FG004|Overall Study|Death|1|||
125245981|NCT02421510|450526662|FG000|Overall Study|Other|4|||
125245982|NCT02421510|450526663|FG001|Overall Study|Other|2|||
125245983|NCT02421510|450526664|FG002|Overall Study|Other|3|||
125245984|NCT02421510|450526662|FG000|Overall Study|Protocol Violation|1|||
125245985|NCT02421510|450526663|FG001|Overall Study|Protocol Violation|2|||
125245986|NCT02421510|450526664|FG002|Overall Study|Protocol Violation|0|||
125245987|NCT02421510|450526662|FG000|Overall Study|Death|1|||
125245988|NCT02421510|450526663|FG001|Overall Study|Death|0|||
125245989|NCT02421510|450526664|FG002|Overall Study|Death|0|||
125245990|NCT02421510|450526662|FG000|Overall Study|Noncompliance with study drug|1|||
125245991|NCT02421510|450526663|FG001|Overall Study|Noncompliance with study drug|0|||
125245992|NCT02421510|450526664|FG002|Overall Study|Noncompliance with study drug|0|||
125245993|NCT02421510|450526662|FG000|Overall Study|Physician Decision|1|||
125245994|NCT02421510|450526663|FG001|Overall Study|Physician Decision|1|||
125245995|NCT02421510|450526664|FG002|Overall Study|Physician Decision|3|||
125245996|NCT02421510|450526662|FG000|Overall Study|Adverse Event|9|||
125245997|NCT02421510|450526663|FG001|Overall Study|Adverse Event|10|||
125245998|NCT02421510|450526664|FG002|Overall Study|Adverse Event|18|||
125245999|NCT02421510|450526662|FG000|Overall Study|Pregnancy|1|||
125246000|NCT02421510|450526663|FG001|Overall Study|Pregnancy|1|||
125246001|NCT02421510|450526664|FG002|Overall Study|Pregnancy|0|||
125246002|NCT02421510|450526662|FG000|Overall Study|Withdrawal by Subject|14|||
125246003|NCT02421510|450526663|FG001|Overall Study|Withdrawal by Subject|18|||
125246004|NCT02421510|450526664|FG002|Overall Study|Withdrawal by Subject|12|||
125246005|NCT02421510|450526662|FG000|Overall Study|Lost to Follow-up|1|||
125246006|NCT02421510|450526663|FG001|Overall Study|Lost to Follow-up|1|||
125246007|NCT02421510|450526664|FG002|Overall Study|Lost to Follow-up|0|||
125246008|NCT02609633|450526669|FG000|Overall Study|Consent Withdrawn|0|||
125246009|NCT02609633|450526670|FG001|Overall Study|Consent Withdrawn|1|||
125246010|NCT02609633|450526669|FG000|Overall Study|Protocol Deviation|1|||
125246011|NCT02609633|450526670|FG001|Overall Study|Protocol Deviation|0|||
125246012|NCT02609633|450526669|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
125193139|NCT00652626|450330151|FG005|Extension Phase|Withdrawal by Subject|2|||
125193140|NCT00652626|450330152|FG006|Extension Phase|Withdrawal by Subject|0|||
125193141|NCT00652626|450330146|FG000|Extension Phase|Adverse Event|0|||
125193142|NCT00652626|450330147|FG001|Extension Phase|Adverse Event|0|||
125193143|NCT00652626|450330148|FG002|Extension Phase|Adverse Event|0|||
125193144|NCT00652626|450330149|FG003|Extension Phase|Adverse Event|0|||
125193145|NCT00652626|450330150|FG004|Extension Phase|Adverse Event|0|||
125193146|NCT00652626|450330151|FG005|Extension Phase|Adverse Event|2|||
125193147|NCT00652626|450330152|FG006|Extension Phase|Adverse Event|1|||
125193148|NCT00652626|450330146|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
125193149|NCT00652626|450330147|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
125193150|NCT00652626|450330148|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
125193151|NCT00652626|450330149|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
125193152|NCT00652626|450330150|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
125193153|NCT00652626|450330151|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
125193154|NCT00652626|450330152|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
125193155|NCT00652626|450330146|FG000|Extension Phase|Physician Decision|0|||
125193156|NCT00652626|450330147|FG001|Extension Phase|Physician Decision|0|||
125193157|NCT00652626|450330148|FG002|Extension Phase|Physician Decision|0|||
125193158|NCT00652626|450330149|FG003|Extension Phase|Physician Decision|0|||
125193159|NCT00652626|450330150|FG004|Extension Phase|Physician Decision|0|||
125193160|NCT00652626|450330151|FG005|Extension Phase|Physician Decision|1|||
125193161|NCT00652626|450330152|FG006|Extension Phase|Physician Decision|1|||
125193162|NCT00652626|450330146|FG000|Extension Phase|Death|0|||
125193163|NCT00652626|450330147|FG001|Extension Phase|Death|0|||
125193164|NCT00652626|450330148|FG002|Extension Phase|Death|0|||
125193165|NCT00652626|450330149|FG003|Extension Phase|Death|0|||
125193166|NCT00652626|450330150|FG004|Extension Phase|Death|0|||
125193167|NCT00652626|450330151|FG005|Extension Phase|Death|1|||
125193168|NCT00652626|450330152|FG006|Extension Phase|Death|1|||
125193169|NCT01623310|450330153|FG000|Overall Study|Adverse Event|21|||
125193170|NCT01623310|450330153|FG000|Overall Study|Lost to Follow-up|18|||
125193171|NCT01623310|450330153|FG000|Overall Study|Lack of Efficacy|6|||
125193172|NCT01623310|450330153|FG000|Overall Study|Protocol Violation|6|||
125193173|NCT01623310|450330153|FG000|Overall Study|Withdrawal by Subject|25|||
125193174|NCT01623310|450330153|FG000|Overall Study|Became potentially child-bearing|1|||
125193175|NCT01623310|450330153|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
125193176|NCT01623310|450330153|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
125193177|NCT02898597|450330154|FG000|Overall Study|Protocol Violation|4|||
125193178|NCT02898597|450330155|FG001|Overall Study|Protocol Violation|2|||
125193179|NCT02898597|450330154|FG000|Overall Study|Lost to Follow-up|0|||
125193180|NCT02898597|450330155|FG001|Overall Study|Lost to Follow-up|9|||
125193181|NCT02898597|450330154|FG000|Overall Study|Death|0|||
125193182|NCT02898597|450330155|FG001|Overall Study|Death|1|||
125193183|NCT02530125|450330156|FG000|Completed Treatment|Early termination of study|1|||
125193184|NCT02530125|450330156|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
125193185|NCT00356603|450330157|FG000|Overall Study|Other|6|||
125193186|NCT00356603|450330158|FG001|Overall Study|Other|3|||
125193187|NCT00728468|450330160|FG000|Overall Study|Enrolled but not treated|1|||
125193188|NCT00728468|450330160|FG000|Overall Study|Death|1|||
125193189|NCT00728468|450330160|FG000|Overall Study|Protocol Violation|4|||
125193190|NCT00728468|450330160|FG000|Overall Study|Objective progression or relapse|9|||
125193191|NCT00728468|450330160|FG000|Overall Study|Study terminated by sponsor|1|||
125193192|NCT01568034|450330161|FG000|Overall Study|Withdrawal by Subject|1|||
125193193|NCT01568034|450330162|FG001|Overall Study|Withdrawal by Subject|0|||
125193194|NCT01568034|450330163|FG002|Overall Study|Withdrawal by Subject|0|||
125193195|NCT01568034|450330164|FG003|Overall Study|Withdrawal by Subject|0|||
125193196|NCT01262287|450330165|FG000|Overall Study|Lost to Follow-up|2|||
125193197|NCT01262287|450330166|FG001|Overall Study|Lost to Follow-up|1|||
125193198|NCT00932373|450330167|FG000|Overall Study|Progressive disease|3|||
125193199|NCT00932373|450330168|FG001|Overall Study|Progressive disease|1|||
125193200|NCT00932373|450330169|FG002|Overall Study|Progressive disease|0|||
125193201|NCT00932373|450330170|FG003|Overall Study|Progressive disease|0|||
125193202|NCT00932373|450330171|FG004|Overall Study|Progressive disease|10|||
125193203|NCT00932373|450330172|FG005|Overall Study|Progressive disease|1|||
125193204|NCT00932373|450330173|FG006|Overall Study|Progressive disease|0|||
125193205|NCT00932373|450330174|FG007|Overall Study|Progressive disease|2|||
125193206|NCT00932373|450330175|FG008|Overall Study|Progressive disease|1|||
125193207|NCT00932373|450330176|FG009|Overall Study|Progressive disease|9|||
125193208|NCT00932373|450330177|FG010|Overall Study|Progressive disease|2|||
125193209|NCT00932373|450330167|FG000|Overall Study|Adverse Event|0|||
125193210|NCT00932373|450330168|FG001|Overall Study|Adverse Event|0|||
125193211|NCT00932373|450330169|FG002|Overall Study|Adverse Event|0|||
125193212|NCT00932373|450330170|FG003|Overall Study|Adverse Event|0|||
125193213|NCT00932373|450330171|FG004|Overall Study|Adverse Event|2|||
125193214|NCT00932373|450330172|FG005|Overall Study|Adverse Event|1|||
125193215|NCT00932373|450330173|FG006|Overall Study|Adverse Event|0|||
125193216|NCT00932373|450330174|FG007|Overall Study|Adverse Event|1|||
125193217|NCT00932373|450330175|FG008|Overall Study|Adverse Event|0|||
125193218|NCT00932373|450330176|FG009|Overall Study|Adverse Event|2|||
125193219|NCT00932373|450330177|FG010|Overall Study|Adverse Event|1|||
125193220|NCT00932373|450330167|FG000|Overall Study|Physician Decision|0|||
125193221|NCT00932373|450330168|FG001|Overall Study|Physician Decision|0|||
125193222|NCT00932373|450330169|FG002|Overall Study|Physician Decision|1|||
125193223|NCT00932373|450330170|FG003|Overall Study|Physician Decision|0|||
125193224|NCT00932373|450330171|FG004|Overall Study|Physician Decision|2|||
125193225|NCT00932373|450330172|FG005|Overall Study|Physician Decision|0|||
125193226|NCT00932373|450330173|FG006|Overall Study|Physician Decision|0|||
125193227|NCT00932373|450330174|FG007|Overall Study|Physician Decision|0|||
125193228|NCT00932373|450330175|FG008|Overall Study|Physician Decision|0|||
125193229|NCT00932373|450330176|FG009|Overall Study|Physician Decision|1|||
125193230|NCT00932373|450330177|FG010|Overall Study|Physician Decision|0|||
125193231|NCT00932373|450330167|FG000|Overall Study|Dose limiting toxicity|0|||
125193232|NCT00932373|450330168|FG001|Overall Study|Dose limiting toxicity|0|||
125193233|NCT00932373|450330169|FG002|Overall Study|Dose limiting toxicity|0|||
125193234|NCT00932373|450330170|FG003|Overall Study|Dose limiting toxicity|0|||
125193235|NCT00932373|450330171|FG004|Overall Study|Dose limiting toxicity|0|||
125193236|NCT00932373|450330172|FG005|Overall Study|Dose limiting toxicity|1|||
125193237|NCT00932373|450330173|FG006|Overall Study|Dose limiting toxicity|0|||
125193238|NCT00932373|450330174|FG007|Overall Study|Dose limiting toxicity|0|||
125193239|NCT00932373|450330175|FG008|Overall Study|Dose limiting toxicity|0|||
125193240|NCT00932373|450330176|FG009|Overall Study|Dose limiting toxicity|0|||
125193241|NCT00932373|450330177|FG010|Overall Study|Dose limiting toxicity|0|||
125193242|NCT00932373|450330167|FG000|Overall Study|Withdrawal by Subject|0|||
125193243|NCT00932373|450330168|FG001|Overall Study|Withdrawal by Subject|0|||
125193244|NCT00932373|450330169|FG002|Overall Study|Withdrawal by Subject|0|||
125193245|NCT00932373|450330170|FG003|Overall Study|Withdrawal by Subject|0|||
125193246|NCT00932373|450330171|FG004|Overall Study|Withdrawal by Subject|0|||
125193247|NCT00932373|450330172|FG005|Overall Study|Withdrawal by Subject|0|||
125193248|NCT00932373|450330173|FG006|Overall Study|Withdrawal by Subject|0|||
125193249|NCT00932373|450330174|FG007|Overall Study|Withdrawal by Subject|0|||
125193250|NCT00932373|450330175|FG008|Overall Study|Withdrawal by Subject|1|||
125193251|NCT00932373|450330176|FG009|Overall Study|Withdrawal by Subject|0|||
125193252|NCT00932373|450330177|FG010|Overall Study|Withdrawal by Subject|0|||
125193253|NCT00932373|450330167|FG000|Overall Study|Clinical progression|0|||
125193254|NCT00932373|450330168|FG001|Overall Study|Clinical progression|0|||
125193255|NCT00932373|450330169|FG002|Overall Study|Clinical progression|0|||
125193256|NCT00932373|450330170|FG003|Overall Study|Clinical progression|0|||
125193257|NCT00932373|450330171|FG004|Overall Study|Clinical progression|0|||
125193258|NCT00932373|450330172|FG005|Overall Study|Clinical progression|0|||
125193259|NCT00932373|450330173|FG006|Overall Study|Clinical progression|1|||
125193260|NCT00932373|450330174|FG007|Overall Study|Clinical progression|0|||
125193261|NCT00932373|450330175|FG008|Overall Study|Clinical progression|0|||
125193262|NCT00932373|450330176|FG009|Overall Study|Clinical progression|0|||
125193263|NCT00932373|450330177|FG010|Overall Study|Clinical progression|0|||
125193264|NCT00932373|450330167|FG000|Overall Study|Lack of Efficacy|0|||
125193265|NCT00932373|450330168|FG001|Overall Study|Lack of Efficacy|0|||
125193266|NCT00932373|450330169|FG002|Overall Study|Lack of Efficacy|0|||
125193267|NCT00932373|450330170|FG003|Overall Study|Lack of Efficacy|0|||
125193268|NCT00932373|450330171|FG004|Overall Study|Lack of Efficacy|0|||
125193269|NCT00932373|450330172|FG005|Overall Study|Lack of Efficacy|0|||
125193270|NCT00932373|450330173|FG006|Overall Study|Lack of Efficacy|0|||
125193271|NCT00932373|450330174|FG007|Overall Study|Lack of Efficacy|0|||
125193272|NCT00932373|450330175|FG008|Overall Study|Lack of Efficacy|0|||
125193273|NCT00932373|450330176|FG009|Overall Study|Lack of Efficacy|1|||
125193274|NCT00932373|450330177|FG010|Overall Study|Lack of Efficacy|0|||
125193275|NCT01637922|450330178|FG000|Overall Study|Adverse Event|0|||
125193276|NCT01637922|450330179|FG001|Overall Study|Adverse Event|1|||
125193277|NCT01637922|450330178|FG000|Overall Study|Protocol Violation|0|||
125193278|NCT01637922|450330179|FG001|Overall Study|Protocol Violation|1|||
125193279|NCT01637922|450330178|FG000|Overall Study|Withdrawal by Subject|0|||
125193280|NCT01637922|450330179|FG001|Overall Study|Withdrawal by Subject|3|||
125193281|NCT01637922|450330178|FG000|Overall Study|Lost to Follow-up|2|||
125193282|NCT01637922|450330179|FG001|Overall Study|Lost to Follow-up|0|||
125193283|NCT00638404|450330180|FG000|Overall Study|Physician Decision|8|||
125193284|NCT00638404|450330181|FG001|Overall Study|Physician Decision|0|||
125193285|NCT02492984|450330182|FG000|Overall Study|Adverse Event|1|||
125193286|NCT02492984|450330183|FG001|Overall Study|Adverse Event|0|||
125193287|NCT02492984|450330182|FG000|Overall Study|Protocol Violation|1|||
125193288|NCT02492984|450330183|FG001|Overall Study|Protocol Violation|0|||
125193289|NCT02492984|450330182|FG000|Overall Study|Withdrawal by Subject|1|||
125193290|NCT02492984|450330183|FG001|Overall Study|Withdrawal by Subject|0|||
125193291|NCT04090060|450330189|FG000|Overall Study|Lost to Follow-up|76|||
125193292|NCT04090060|450330190|FG001|Overall Study|Lost to Follow-up|77|||
125193293|NCT01164579|450330197|FG000|Overall Study|Lack of Efficacy|0|||
125193294|NCT01164579|450330198|FG001|Overall Study|Lack of Efficacy|0|||
125193295|NCT01164579|450330199|FG002|Overall Study|Lack of Efficacy|6|||
125193296|NCT01164579|450330197|FG000|Overall Study|Lost to Follow-up|1|||
125193297|NCT01164579|450330198|FG001|Overall Study|Lost to Follow-up|1|||
125193298|NCT01164579|450330199|FG002|Overall Study|Lost to Follow-up|0|||
125193299|NCT01164579|450330197|FG000|Overall Study|Withdrawal by Subject|2|||
125193300|NCT01164579|450330198|FG001|Overall Study|Withdrawal by Subject|5|||
125193301|NCT01164579|450330199|FG002|Overall Study|Withdrawal by Subject|3|||
125193302|NCT01164579|450330197|FG000|Overall Study|Protocol Violation|0|||
125193303|NCT01164579|450330198|FG001|Overall Study|Protocol Violation|1|||
125193304|NCT01164579|450330199|FG002|Overall Study|Protocol Violation|2|||
125193305|NCT01164579|450330197|FG000|Overall Study|Adverse Event|4|||
125193306|NCT01164579|450330198|FG001|Overall Study|Adverse Event|2|||
125193307|NCT01164579|450330199|FG002|Overall Study|Adverse Event|5|||
125193308|NCT01164579|450330197|FG000|Overall Study|Reason not specified|1|||
125193309|NCT01164579|450330198|FG001|Overall Study|Reason not specified|0|||
125193310|NCT01164579|450330199|FG002|Overall Study|Reason not specified|0|||
125193311|NCT03491462|450330202|FG000|Overall Study|Lost to Follow-up|2|||
125193312|NCT03491462|450330203|FG001|Overall Study|Lost to Follow-up|0|||
125193313|NCT03491462|450330202|FG000|Overall Study|Adverse Event|11|||
125193314|NCT03491462|450330203|FG001|Overall Study|Adverse Event|1|||
125193315|NCT03491462|450330202|FG000|Overall Study|Physician Decision|3|||
125193316|NCT03491462|450330203|FG001|Overall Study|Physician Decision|0|||
125193317|NCT03491462|450330202|FG000|Overall Study|Withdrawal by Subject|22|||
125193318|NCT03491462|450330203|FG001|Overall Study|Withdrawal by Subject|15|||
125193319|NCT00740792|450330204|FG000|Overall Study|Adverse Event|3|||
125193320|NCT00740792|450330205|FG001|Overall Study|Adverse Event|1|||
125193321|NCT00740792|450330206|FG002|Overall Study|Adverse Event|1|||
125193322|NCT00740792|450330207|FG003|Overall Study|Adverse Event|3|||
125193323|NCT00740792|450330204|FG000|Overall Study|Lack of Efficacy|1|||
125193324|NCT00740792|450330205|FG001|Overall Study|Lack of Efficacy|1|||
125193325|NCT00740792|450330206|FG002|Overall Study|Lack of Efficacy|0|||
125193326|NCT00740792|450330207|FG003|Overall Study|Lack of Efficacy|3|||
125193327|NCT00740792|450330204|FG000|Overall Study|Lost to Follow-up|2|||
125193328|NCT00740792|450330205|FG001|Overall Study|Lost to Follow-up|1|||
125193329|NCT00740792|450330206|FG002|Overall Study|Lost to Follow-up|0|||
125193330|NCT00740792|450330207|FG003|Overall Study|Lost to Follow-up|0|||
125193331|NCT00740792|450330204|FG000|Overall Study|Protocol Violation|0|||
125193332|NCT00740792|450330205|FG001|Overall Study|Protocol Violation|1|||
125193333|NCT00740792|450330206|FG002|Overall Study|Protocol Violation|0|||
125193334|NCT00740792|450330207|FG003|Overall Study|Protocol Violation|2|||
125193335|NCT00740792|450330204|FG000|Overall Study|Withdrawal by Subject|1|||
125193336|NCT00740792|450330205|FG001|Overall Study|Withdrawal by Subject|1|||
125193337|NCT00740792|450330206|FG002|Overall Study|Withdrawal by Subject|0|||
125193338|NCT00740792|450330207|FG003|Overall Study|Withdrawal by Subject|0|||
125193339|NCT00740792|450330204|FG000|Overall Study|administrative|3|||
125193340|NCT00740792|450330205|FG001|Overall Study|administrative|3|||
125246013|NCT02609633|450526670|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
125246014|NCT02609633|450526669|FG000|Overall Study|Reason not Specified|2|||
125246015|NCT02609633|450526670|FG001|Overall Study|Reason not Specified|1|||
125246016|NCT02287025|450526673|FG000|Overall Study|Not treated|2|||
125246017|NCT02287025|450526674|FG001|Overall Study|Not treated|0|||
125246018|NCT02287025|450526673|FG000|Overall Study|Progression of disease|3|||
125246019|NCT02287025|450526674|FG001|Overall Study|Progression of disease|2|||
125246020|NCT02287025|450526673|FG000|Overall Study|Adverse Event|2|||
125246021|NCT02287025|450526674|FG001|Overall Study|Adverse Event|4|||
125246022|NCT02287025|450526673|FG000|Overall Study|Withdrawal by Subject|2|||
125246023|NCT02287025|450526674|FG001|Overall Study|Withdrawal by Subject|2|||
125246024|NCT02287025|450526673|FG000|Overall Study|Screening failed|1|||
125246025|NCT02287025|450526674|FG001|Overall Study|Screening failed|1|||
125246026|NCT01096186|450526675|FG000|Overall Study|Adverse Event|16|||
125246027|NCT01096186|450526675|FG000|Overall Study|Death|4|||
125246028|NCT01096186|450526675|FG000|Overall Study|Lack of Efficacy|4|||
125246029|NCT01096186|450526675|FG000|Overall Study|Lost to Follow-up|2|||
125246030|NCT01096186|450526675|FG000|Overall Study|Withdrawal by Subject|22|||
125246031|NCT01096186|450526675|FG000|Overall Study|Physician Decision|1|||
125246032|NCT01096186|450526675|FG000|Overall Study|Noncompliance with study drug|1|||
125246033|NCT04053452|450526676|FG000|Overall Study|Withdrawal by Subject|1|||
125246034|NCT04053452|450526677|FG001|Overall Study|Withdrawal by Subject|0|||
125246035|NCT04053452|450526676|FG000|Overall Study|Time restraint due to inpatient needs|1|||
125246036|NCT04053452|450526677|FG001|Overall Study|Time restraint due to inpatient needs|2|||
125193341|NCT00740792|450330206|FG002|Overall Study|administrative|8|||
125193342|NCT00740792|450330207|FG003|Overall Study|administrative|2|||
125193343|NCT00912743|450330212|FG000|Overall Study|Adverse Event|3|||
125193344|NCT00912743|450330213|FG001|Overall Study|Adverse Event|1|||
125193345|NCT00912743|450330212|FG000|Overall Study|Lack of Efficacy|9|||
125193346|NCT00912743|450330213|FG001|Overall Study|Lack of Efficacy|18|||
125193347|NCT00912743|450330212|FG000|Overall Study|Toxicity|0|||
125193348|NCT00912743|450330213|FG001|Overall Study|Toxicity|1|||
125193349|NCT00912743|450330212|FG000|Overall Study|End of treatment form was not collected|1|||
125193350|NCT00912743|450330213|FG001|Overall Study|End of treatment form was not collected|0|||
125193351|NCT00179660|450330223|FG000|Overall Study|Adverse Event|7|||
125193352|NCT00179660|450330223|FG000|Overall Study|Lack of therapeutic effect|28|||
125193353|NCT00179660|450330223|FG000|Overall Study|Withdrawal by Subject|2|||
125193354|NCT00179660|450330223|FG000|Overall Study|Lost to Follow-up|1|||
125193355|NCT00179660|450330223|FG000|Overall Study|Death|3|||
125193356|NCT00179660|450330223|FG000|Overall Study|Other - Unspecified|9|||
125193357|NCT00685399|450330228|FG000|Treatment Period 1|Withdrawal by Subject|2|||
125193358|NCT00685399|450330229|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125193359|NCT00685399|450330230|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125193360|NCT00685399|450330231|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125193361|NCT00685399|450330232|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125193362|NCT00685399|450330233|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125193363|NCT00685399|450330234|FG006|Treatment Period 1|Withdrawal by Subject|0|||
125193364|NCT00685399|450330235|FG007|Treatment Period 1|Withdrawal by Subject|0|||
125193365|NCT00685399|450330228|FG000|Treatment Period 1|Protocol Violation|1|||
125193366|NCT00685399|450330229|FG001|Treatment Period 1|Protocol Violation|0|||
125193367|NCT00685399|450330230|FG002|Treatment Period 1|Protocol Violation|0|||
125193368|NCT00685399|450330231|FG003|Treatment Period 1|Protocol Violation|0|||
125193369|NCT00685399|450330232|FG004|Treatment Period 1|Protocol Violation|0|||
125193370|NCT00685399|450330233|FG005|Treatment Period 1|Protocol Violation|0|||
125193371|NCT00685399|450330234|FG006|Treatment Period 1|Protocol Violation|0|||
125193372|NCT00685399|450330235|FG007|Treatment Period 1|Protocol Violation|0|||
125193373|NCT00685399|450330228|FG000|Treatment Period 1|Administrative|2|||
125193374|NCT00685399|450330229|FG001|Treatment Period 1|Administrative|0|||
125193375|NCT00685399|450330230|FG002|Treatment Period 1|Administrative|0|||
125193376|NCT00685399|450330231|FG003|Treatment Period 1|Administrative|0|||
125193377|NCT00685399|450330232|FG004|Treatment Period 1|Administrative|0|||
125193378|NCT00685399|450330233|FG005|Treatment Period 1|Administrative|0|||
125193379|NCT00685399|450330234|FG006|Treatment Period 1|Administrative|0|||
125193380|NCT00685399|450330235|FG007|Treatment Period 1|Administrative|0|||
125246037|NCT00122187|450526682|FG000|Overall Study|Withdrew because of resource limitations|2|||
125246038|NCT00122187|450526683|FG001|Overall Study|Withdrew because of resource limitations|2|||
125246039|NCT02061592|450526684|FG000|Period 1|Withdrawal by Subject|1|||
125246040|NCT02061592|450526685|FG001|Period 1|Withdrawal by Subject|0|||
125246041|NCT02061592|450526684|FG000|Period 1|Protocol Violation|1|||
125246042|NCT02061592|450526685|FG001|Period 1|Protocol Violation|0|||
125246043|NCT02061592|450526684|FG000|Period 2|Lost to Follow-up|0|||
125246044|NCT02061592|450526685|FG001|Period 2|Lost to Follow-up|1|||
125246045|NCT03338023|450526686|FG000|Overall Study|Withdrawal by Subject|3|||
125246046|NCT03338023|450526687|FG001|Overall Study|Withdrawal by Subject|4|||
125246047|NCT03338023|450526686|FG000|Overall Study|Protocol Violation|3|||
125246048|NCT03338023|450526687|FG001|Overall Study|Protocol Violation|3|||
125246049|NCT03338023|450526686|FG000|Overall Study|Lost to Follow-up|2|||
125246050|NCT03338023|450526687|FG001|Overall Study|Lost to Follow-up|1|||
125246051|NCT03338023|450526686|FG000|Overall Study|Physician Decision|1|||
125246052|NCT03338023|450526687|FG001|Overall Study|Physician Decision|2|||
125246053|NCT00799864|450526688|FG000|Overall Study|Participant reached a virologic endpoint|9|||
125246054|NCT00799864|450526689|FG001|Overall Study|Participant reached a virologic endpoint|2|||
125246055|NCT00799864|450526690|FG002|Overall Study|Participant reached a virologic endpoint|2|||
125246056|NCT00799864|450526691|FG003|Overall Study|Participant reached a virologic endpoint|0|||
125246057|NCT00799864|450526692|FG004|Overall Study|Participant reached a virologic endpoint|0|||
125246058|NCT00799864|450526688|FG000|Overall Study|Other|2|||
125246059|NCT00799864|450526689|FG001|Overall Study|Other|1|||
125246060|NCT00799864|450526690|FG002|Overall Study|Other|0|||
125246061|NCT00799864|450526691|FG003|Overall Study|Other|0|||
125246062|NCT00799864|450526692|FG004|Overall Study|Other|0|||
125246063|NCT00685698|450526695|FG000|Overall Study|Withdrawal by Subject|1|||
125246064|NCT00685698|450526695|FG000|Overall Study|Protocol Violation|6|||
125246065|NCT00685698|450526695|FG000|Overall Study|Adverse Event|3|||
125246066|NCT00685698|450526695|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
125246067|NCT00685698|450526695|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
125246068|NCT00685698|450526695|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
125246069|NCT05061706|450526697|FG000|Overall Study|Adverse Event|29|||
125246070|NCT05061706|450526698|FG001|Overall Study|Adverse Event|1|||
125246071|NCT05061706|450526697|FG000|Overall Study|Lack of Efficacy|0|||
125246072|NCT05061706|450526698|FG001|Overall Study|Lack of Efficacy|1|||
125246073|NCT05061706|450526697|FG000|Overall Study|Lost to Follow-up|2|||
125246074|NCT05061706|450526698|FG001|Overall Study|Lost to Follow-up|2|||
125246075|NCT05061706|450526697|FG000|Overall Study|Protocol Violation|3|||
125246076|NCT05061706|450526698|FG001|Overall Study|Protocol Violation|1|||
125246077|NCT05061706|450526697|FG000|Overall Study|Withdrawal by Subject|3|||
125246078|NCT05061706|450526698|FG001|Overall Study|Withdrawal by Subject|9|||
125246079|NCT00724893|450526699|FG000|Overall Study|Adverse Event|76|||
125246080|NCT00724893|450526700|FG001|Overall Study|Adverse Event|142|||
125246081|NCT00724893|450526699|FG000|Overall Study|Withdrawal by Subject|0|||
125246082|NCT00724893|450526700|FG001|Overall Study|Withdrawal by Subject|1|||
125246083|NCT00724893|450526699|FG000|Overall Study|Lack of virologic response|94|||
125246084|NCT00724893|450526700|FG001|Overall Study|Lack of virologic response|202|||
125246085|NCT00724893|450526699|FG000|Overall Study|Reason not specified|193|||
125246086|NCT00724893|450526700|FG001|Overall Study|Reason not specified|7|||
125246087|NCT00724893|450526699|FG000|Overall Study|Patient choice|0|||
125246088|NCT00724893|450526700|FG001|Overall Study|Patient choice|26|||
125246089|NCT00724893|450526699|FG000|Overall Study|Geographic reasons|0|||
125246090|NCT00724893|450526700|FG001|Overall Study|Geographic reasons|11|||
125246091|NCT00724893|450526699|FG000|Overall Study|Incarceration|0|||
125246092|NCT00724893|450526700|FG001|Overall Study|Incarceration|9|||
125246093|NCT00724893|450526699|FG000|Overall Study|Substance abuse|0|||
125246094|NCT00724893|450526700|FG001|Overall Study|Substance abuse|3|||
125246095|NCT00724893|450526699|FG000|Overall Study|Financial reasons|0|||
125246096|NCT00724893|450526700|FG001|Overall Study|Financial reasons|2|||
125246097|NCT00724893|450526699|FG000|Overall Study|Assigned shorter treatment|0|||
125246098|NCT00724893|450526700|FG001|Overall Study|Assigned shorter treatment|2|||
125246099|NCT00724893|450526699|FG000|Overall Study|Lost to Follow-up|0|||
125246100|NCT00724893|450526700|FG001|Overall Study|Lost to Follow-up|52|||
125246101|NCT00724893|450526699|FG000|Overall Study|Unknown, missing data|1|||
125246102|NCT00724893|450526700|FG001|Overall Study|Unknown, missing data|1|||
125246103|NCT01078545|450526703|FG000|Overall Study|Lost to Follow-up|13|||
125246104|NCT01078545|450526703|FG000|Overall Study|Physician Decision|6|||
125246105|NCT01078545|450526703|FG000|Overall Study|Withdrawal by Subject|3|||
125246106|NCT01078545|450526703|FG000|Overall Study|Death|3|||
125246107|NCT01078545|450526703|FG000|Overall Study|Participant moved to another physician|1|||
125246108|NCT01774370|450526706|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
125246109|NCT01774370|450526706|FG000|Overall Study|Administered prior to the contract date|4|||
125246110|NCT01774370|450526706|FG000|Overall Study|Subjects of contraindications|34|||
125246111|NCT01774370|450526706|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
125246112|NCT01774370|450526706|FG000|Overall Study|Follow-up failure|34|||
125246113|NCT05436288|450526707|FG000|Overall Study|Lost to Follow-up|1|||
125246114|NCT05436288|450526707|FG000|Overall Study|Adverse Event|1|||
125246115|NCT01436500|450526711|FG000|Overall Study|Death|1|||
125246116|NCT01436500|450526712|FG001|Overall Study|Death|0|||
125246117|NCT01436500|450526713|FG002|Overall Study|Death|0|||
125246118|NCT01436500|450526714|FG003|Overall Study|Death|0|||
125193381|NCT00685399|450330228|FG000|Treatment Period 1|Lack of Efficacy|1|||
125246119|NCT01436500|450526715|FG004|Overall Study|Death|0|||
125246120|NCT01436500|450526711|FG000|Overall Study|Adverse Event|0|||
125246121|NCT01436500|450526712|FG001|Overall Study|Adverse Event|2|||
125193382|NCT00685399|450330229|FG001|Treatment Period 1|Lack of Efficacy|0|||
125193383|NCT00685399|450330230|FG002|Treatment Period 1|Lack of Efficacy|0|||
125193384|NCT00685399|450330231|FG003|Treatment Period 1|Lack of Efficacy|0|||
125193385|NCT00685399|450330232|FG004|Treatment Period 1|Lack of Efficacy|0|||
125193386|NCT00685399|450330233|FG005|Treatment Period 1|Lack of Efficacy|0|||
125193387|NCT00685399|450330234|FG006|Treatment Period 1|Lack of Efficacy|0|||
125193388|NCT00685399|450330235|FG007|Treatment Period 1|Lack of Efficacy|0|||
125193389|NCT00685399|450330228|FG000|Treatment Period 2|Administrative Problems|0|||
125193390|NCT00685399|450330229|FG001|Treatment Period 2|Administrative Problems|2|||
125246122|NCT01436500|450526713|FG002|Overall Study|Adverse Event|2|||
125246123|NCT01436500|450526714|FG003|Overall Study|Adverse Event|0|||
125246124|NCT01436500|450526715|FG004|Overall Study|Adverse Event|1|||
125246125|NCT01436500|450526711|FG000|Overall Study|Withdrawal by Subject|0|||
125246126|NCT01436500|450526712|FG001|Overall Study|Withdrawal by Subject|0|||
125246127|NCT01436500|450526713|FG002|Overall Study|Withdrawal by Subject|2|||
125246128|NCT01436500|450526714|FG003|Overall Study|Withdrawal by Subject|0|||
125246129|NCT01436500|450526715|FG004|Overall Study|Withdrawal by Subject|2|||
125246130|NCT01436500|450526711|FG000|Overall Study|Physician Decision|0|||
125246131|NCT01436500|450526712|FG001|Overall Study|Physician Decision|0|||
125246132|NCT01436500|450526713|FG002|Overall Study|Physician Decision|1|||
125246133|NCT01436500|450526714|FG003|Overall Study|Physician Decision|0|||
125246134|NCT01436500|450526715|FG004|Overall Study|Physician Decision|0|||
125246135|NCT01436500|450526711|FG000|Overall Study|liver transplant|1|||
125246136|NCT01436500|450526712|FG001|Overall Study|liver transplant|0|||
125246137|NCT01436500|450526713|FG002|Overall Study|liver transplant|0|||
125246138|NCT01436500|450526714|FG003|Overall Study|liver transplant|0|||
125246139|NCT01436500|450526715|FG004|Overall Study|liver transplant|0|||
125246140|NCT01436500|450526711|FG000|Overall Study|initiation of dialysis|0|||
125246141|NCT01436500|450526712|FG001|Overall Study|initiation of dialysis|0|||
125246142|NCT01436500|450526713|FG002|Overall Study|initiation of dialysis|0|||
125246143|NCT01436500|450526714|FG003|Overall Study|initiation of dialysis|0|||
125246144|NCT01436500|450526715|FG004|Overall Study|initiation of dialysis|1|||
125246145|NCT01436500|450526711|FG000|Overall Study|discontinued study drug|1|||
125246146|NCT01436500|450526712|FG001|Overall Study|discontinued study drug|0|||
125246147|NCT01436500|450526713|FG002|Overall Study|discontinued study drug|0|||
125246148|NCT01436500|450526714|FG003|Overall Study|discontinued study drug|0|||
125246149|NCT01436500|450526715|FG004|Overall Study|discontinued study drug|0|||
125246150|NCT01436500|450526711|FG000|Overall Study|Other|0|||
125246151|NCT01436500|450526712|FG001|Overall Study|Other|1|||
125246152|NCT01436500|450526713|FG002|Overall Study|Other|0|||
125246153|NCT01436500|450526714|FG003|Overall Study|Other|1|||
125246154|NCT01436500|450526715|FG004|Overall Study|Other|0|||
125246155|NCT01487161|450526719|FG000|Overall Study|Adverse Event|1|||
125246156|NCT01487161|450526720|FG001|Overall Study|Adverse Event|0|||
125246157|NCT01487161|450526721|FG002|Overall Study|Adverse Event|0|||
125246158|NCT01487161|450526722|FG003|Overall Study|Adverse Event|0|||
125246159|NCT01487161|450526719|FG000|Overall Study|Withdrawal by Subject|1|||
125246160|NCT01487161|450526720|FG001|Overall Study|Withdrawal by Subject|1|||
125246161|NCT01487161|450526721|FG002|Overall Study|Withdrawal by Subject|1|||
125246162|NCT01487161|450526722|FG003|Overall Study|Withdrawal by Subject|2|||
125246163|NCT01487161|450526719|FG000|Overall Study|missing data|0|||
125193391|NCT00685399|450330230|FG002|Treatment Period 2|Administrative Problems|1|||
125193392|NCT00685399|450330231|FG003|Treatment Period 2|Administrative Problems|0|||
125193393|NCT00685399|450330232|FG004|Treatment Period 2|Administrative Problems|0|||
125193394|NCT00685399|450330233|FG005|Treatment Period 2|Administrative Problems|0|||
125193395|NCT00685399|450330234|FG006|Treatment Period 2|Administrative Problems|0|||
125193396|NCT00685399|450330235|FG007|Treatment Period 2|Administrative Problems|0|||
125193397|NCT00685399|450330228|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125193398|NCT00685399|450330229|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125246164|NCT01487161|450526720|FG001|Overall Study|missing data|1|||
125246165|NCT01487161|450526721|FG002|Overall Study|missing data|0|||
125246166|NCT01487161|450526722|FG003|Overall Study|missing data|0|||
125246167|NCT02945046|450526723|FG000|Overall Study|Adverse Event|1|||
125246168|NCT02945046|450526724|FG001|Overall Study|Adverse Event|0|||
125246169|NCT02945046|450526725|FG002|Overall Study|Adverse Event|2|||
125246170|NCT02945046|450526723|FG000|Overall Study|Withdrawal by Subject|3|||
125246171|NCT02945046|450526724|FG001|Overall Study|Withdrawal by Subject|3|||
125246172|NCT02945046|450526725|FG002|Overall Study|Withdrawal by Subject|3|||
125246173|NCT02945046|450526723|FG000|Overall Study|Protocol Violation|2|||
125246174|NCT02945046|450526724|FG001|Overall Study|Protocol Violation|3|||
125246175|NCT02945046|450526725|FG002|Overall Study|Protocol Violation|2|||
125246176|NCT02945046|450526723|FG000|Overall Study|Lost to Follow-up|1|||
125246177|NCT02945046|450526724|FG001|Overall Study|Lost to Follow-up|1|||
125246178|NCT02945046|450526725|FG002|Overall Study|Lost to Follow-up|0|||
125246179|NCT02945046|450526723|FG000|Overall Study|Lack of Efficacy|1|||
125246180|NCT02945046|450526724|FG001|Overall Study|Lack of Efficacy|2|||
125246181|NCT02945046|450526725|FG002|Overall Study|Lack of Efficacy|1|||
125246182|NCT02945046|450526723|FG000|Overall Study|Other than specified|5|||
125246183|NCT02945046|450526724|FG001|Overall Study|Other than specified|4|||
125246184|NCT02945046|450526725|FG002|Overall Study|Other than specified|7|||
125246185|NCT03113136|450526726|FG000|Overall Study|Lost to Follow-up|22|||
125246186|NCT03113136|450526727|FG001|Overall Study|Lost to Follow-up|47|||
125246187|NCT03113136|450526728|FG002|Overall Study|Lost to Follow-up|54|||
125246188|NCT03113136|450526726|FG000|Overall Study|Withdrawal by Subject|4|||
125246189|NCT03113136|450526727|FG001|Overall Study|Withdrawal by Subject|13|||
125246190|NCT03113136|450526728|FG002|Overall Study|Withdrawal by Subject|14|||
125246191|NCT03113136|450526726|FG000|Overall Study|Ineligible|0|||
125246192|NCT03113136|450526727|FG001|Overall Study|Ineligible|2|||
125246193|NCT03113136|450526728|FG002|Overall Study|Ineligible|1|||
125246194|NCT03113136|450526726|FG000|Overall Study|Study Team Decision|1|||
125246195|NCT03113136|450526727|FG001|Overall Study|Study Team Decision|4|||
125246196|NCT03113136|450526728|FG002|Overall Study|Study Team Decision|0|||
125246197|NCT02675452|450526729|FG000|Overall Study|Sponsor decision|0|||
125246198|NCT02675452|450526730|FG001|Overall Study|Sponsor decision|0|||
125246199|NCT02675452|450526731|FG002|Overall Study|Sponsor decision|0|||
125246200|NCT02675452|450526732|FG003|Overall Study|Sponsor decision|0|||
125246201|NCT02675452|450526733|FG004|Overall Study|Sponsor decision|0|||
125246202|NCT02675452|450526734|FG005|Overall Study|Sponsor decision|0|||
125246203|NCT02675452|450526735|FG006|Overall Study|Sponsor decision|0|||
125246204|NCT02675452|450526736|FG007|Overall Study|Sponsor decision|0|||
125246205|NCT02675452|450526737|FG008|Overall Study|Sponsor decision|0|||
125246206|NCT02675452|450526738|FG009|Overall Study|Sponsor decision|1|||
125246207|NCT02675452|450526739|FG010|Overall Study|Sponsor decision|0|||
125246208|NCT02675452|450526740|FG011|Overall Study|Sponsor decision|0|||
125246209|NCT02675452|450526741|FG012|Overall Study|Sponsor decision|0|||
125246210|NCT02675452|450526742|FG013|Overall Study|Sponsor decision|2|||
125246211|NCT02675452|450526743|FG014|Overall Study|Sponsor decision|1|||
125246212|NCT02675452|450526744|FG015|Overall Study|Sponsor decision|0|||
125246213|NCT02675452|450526745|FG016|Overall Study|Sponsor decision|1|||
125246214|NCT02675452|450526746|FG017|Overall Study|Sponsor decision|0|||
125246215|NCT02675452|450526747|FG018|Overall Study|Sponsor decision|0|||
125246216|NCT02675452|450526748|FG019|Overall Study|Sponsor decision|0|||
125246217|NCT02675452|450526749|FG020|Overall Study|Sponsor decision|0|||
125246218|NCT02675452|450526750|FG021|Overall Study|Sponsor decision|0|||
125246219|NCT02675452|450526751|FG022|Overall Study|Sponsor decision|0|||
125246220|NCT02675452|450526752|FG023|Overall Study|Sponsor decision|0|||
125246221|NCT02675452|450526753|FG024|Overall Study|Sponsor decision|0|||
125246222|NCT02675452|450526754|FG025|Overall Study|Sponsor decision|0|||
125246223|NCT02675452|450526755|FG026|Overall Study|Sponsor decision|2|||
125246224|NCT02675452|450526756|FG027|Overall Study|Sponsor decision|0|||
125246225|NCT02675452|450526757|FG028|Overall Study|Sponsor decision|0|||
125246226|NCT02675452|450526729|FG000|Overall Study|Withdrawal by Subject|0|||
125246227|NCT02675452|450526730|FG001|Overall Study|Withdrawal by Subject|0|||
125246228|NCT02675452|450526731|FG002|Overall Study|Withdrawal by Subject|0|||
125246229|NCT02675452|450526732|FG003|Overall Study|Withdrawal by Subject|0|||
125246230|NCT02675452|450526733|FG004|Overall Study|Withdrawal by Subject|0|||
125246231|NCT02675452|450526734|FG005|Overall Study|Withdrawal by Subject|0|||
125246232|NCT02675452|450526735|FG006|Overall Study|Withdrawal by Subject|0|||
125246233|NCT02675452|450526736|FG007|Overall Study|Withdrawal by Subject|0|||
125246234|NCT02675452|450526737|FG008|Overall Study|Withdrawal by Subject|0|||
125246235|NCT02675452|450526738|FG009|Overall Study|Withdrawal by Subject|1|||
125246236|NCT02675452|450526739|FG010|Overall Study|Withdrawal by Subject|0|||
125246237|NCT02675452|450526740|FG011|Overall Study|Withdrawal by Subject|1|||
125246238|NCT02675452|450526741|FG012|Overall Study|Withdrawal by Subject|0|||
125246239|NCT02675452|450526742|FG013|Overall Study|Withdrawal by Subject|1|||
125246240|NCT02675452|450526743|FG014|Overall Study|Withdrawal by Subject|1|||
125246241|NCT02675452|450526744|FG015|Overall Study|Withdrawal by Subject|0|||
125246242|NCT02675452|450526745|FG016|Overall Study|Withdrawal by Subject|2|||
125246243|NCT02675452|450526746|FG017|Overall Study|Withdrawal by Subject|0|||
125246244|NCT02675452|450526747|FG018|Overall Study|Withdrawal by Subject|0|||
125246245|NCT02675452|450526748|FG019|Overall Study|Withdrawal by Subject|0|||
125246246|NCT02675452|450526749|FG020|Overall Study|Withdrawal by Subject|0|||
125246247|NCT02675452|450526750|FG021|Overall Study|Withdrawal by Subject|0|||
125246248|NCT02675452|450526751|FG022|Overall Study|Withdrawal by Subject|3|||
125246249|NCT02675452|450526752|FG023|Overall Study|Withdrawal by Subject|0|||
125246250|NCT02675452|450526753|FG024|Overall Study|Withdrawal by Subject|1|||
125246251|NCT02675452|450526754|FG025|Overall Study|Withdrawal by Subject|0|||
125246252|NCT02675452|450526755|FG026|Overall Study|Withdrawal by Subject|1|||
125246253|NCT02675452|450526756|FG027|Overall Study|Withdrawal by Subject|3|||
125246254|NCT02675452|450526757|FG028|Overall Study|Withdrawal by Subject|4|||
125246255|NCT02675452|450526729|FG000|Overall Study|Death|0|||
125193399|NCT00685399|450330230|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125193400|NCT00685399|450330231|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125193401|NCT00685399|450330232|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125193402|NCT00685399|450330233|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125193403|NCT00685399|450330234|FG006|Treatment Period 2|Withdrawal by Subject|0|||
125193404|NCT00685399|450330235|FG007|Treatment Period 2|Withdrawal by Subject|2|||
125193405|NCT00685399|450330228|FG000|Treatment Period 2|Adverse Event|0|||
125193406|NCT00685399|450330229|FG001|Treatment Period 2|Adverse Event|0|||
125193407|NCT00685399|450330230|FG002|Treatment Period 2|Adverse Event|0|||
125193408|NCT00685399|450330231|FG003|Treatment Period 2|Adverse Event|0|||
125193409|NCT00685399|450330232|FG004|Treatment Period 2|Adverse Event|0|||
125193410|NCT00685399|450330233|FG005|Treatment Period 2|Adverse Event|1|||
125193411|NCT00685399|450330234|FG006|Treatment Period 2|Adverse Event|0|||
125193412|NCT00685399|450330235|FG007|Treatment Period 2|Adverse Event|0|||
125193413|NCT00685399|450330228|FG000|Treatment Period 2|Lack of Efficacy|0|||
125193414|NCT00685399|450330229|FG001|Treatment Period 2|Lack of Efficacy|10|||
125193415|NCT00685399|450330230|FG002|Treatment Period 2|Lack of Efficacy|2|||
125193416|NCT00685399|450330231|FG003|Treatment Period 2|Lack of Efficacy|0|||
125193417|NCT00685399|450330232|FG004|Treatment Period 2|Lack of Efficacy|0|||
125193418|NCT00685399|450330233|FG005|Treatment Period 2|Lack of Efficacy|1|||
125193419|NCT00685399|450330234|FG006|Treatment Period 2|Lack of Efficacy|0|||
125193420|NCT00685399|450330235|FG007|Treatment Period 2|Lack of Efficacy|0|||
125193421|NCT00685399|450330228|FG000|Extension|Administrative Issues|0|||
125193422|NCT00685399|450330229|FG001|Extension|Administrative Issues|0|||
125193423|NCT00685399|450330230|FG002|Extension|Administrative Issues|0|||
125193424|NCT00685399|450330231|FG003|Extension|Administrative Issues|1|||
125193425|NCT00685399|450330232|FG004|Extension|Administrative Issues|0|||
125193426|NCT00685399|450330233|FG005|Extension|Administrative Issues|0|||
125193427|NCT00685399|450330234|FG006|Extension|Administrative Issues|0|||
125193428|NCT00685399|450330235|FG007|Extension|Administrative Issues|0|||
125193429|NCT00685399|450330228|FG000|Extension|Withdrawal by Subject|0|||
125193430|NCT00685399|450330229|FG001|Extension|Withdrawal by Subject|0|||
125193431|NCT00685399|450330230|FG002|Extension|Withdrawal by Subject|0|||
125193432|NCT00685399|450330231|FG003|Extension|Withdrawal by Subject|1|||
125193433|NCT00685399|450330232|FG004|Extension|Withdrawal by Subject|0|||
125193434|NCT00685399|450330233|FG005|Extension|Withdrawal by Subject|0|||
125193435|NCT00685399|450330234|FG006|Extension|Withdrawal by Subject|0|||
125193436|NCT00685399|450330235|FG007|Extension|Withdrawal by Subject|0|||
125193437|NCT00685399|450330228|FG000|Extension|Protocol Violation|0|||
125193438|NCT00685399|450330229|FG001|Extension|Protocol Violation|0|||
125193439|NCT00685399|450330230|FG002|Extension|Protocol Violation|0|||
125193440|NCT00685399|450330231|FG003|Extension|Protocol Violation|1|||
125193441|NCT00685399|450330232|FG004|Extension|Protocol Violation|0|||
125193442|NCT00685399|450330233|FG005|Extension|Protocol Violation|0|||
125193443|NCT00685399|450330234|FG006|Extension|Protocol Violation|0|||
125193444|NCT00685399|450330235|FG007|Extension|Protocol Violation|0|||
125193445|NCT00685399|450330228|FG000|Extension|Lack of Efficacy|0|||
125193446|NCT00685399|450330229|FG001|Extension|Lack of Efficacy|0|||
125193447|NCT00685399|450330230|FG002|Extension|Lack of Efficacy|0|||
125193448|NCT00685399|450330231|FG003|Extension|Lack of Efficacy|2|||
125193449|NCT00685399|450330232|FG004|Extension|Lack of Efficacy|0|||
125193450|NCT00685399|450330233|FG005|Extension|Lack of Efficacy|0|||
125193451|NCT00685399|450330234|FG006|Extension|Lack of Efficacy|0|||
125193452|NCT00685399|450330235|FG007|Extension|Lack of Efficacy|0|||
125193453|NCT00685399|450330228|FG000|Extension|Adverse Event|0|||
125193454|NCT00685399|450330229|FG001|Extension|Adverse Event|0|||
125193455|NCT00685399|450330230|FG002|Extension|Adverse Event|0|||
125193456|NCT00685399|450330231|FG003|Extension|Adverse Event|2|||
125193457|NCT00685399|450330232|FG004|Extension|Adverse Event|0|||
125193458|NCT00685399|450330233|FG005|Extension|Adverse Event|0|||
125193459|NCT00685399|450330234|FG006|Extension|Adverse Event|0|||
125193460|NCT00685399|450330235|FG007|Extension|Adverse Event|0|||
125193461|NCT00178685|450330237|FG000|Overall Study|Death|3|||
125193462|NCT00178685|450330238|FG001|Overall Study|Death|3|||
125193463|NCT00178685|450330239|FG002|Overall Study|Death|6|||
125193464|NCT00178685|450330237|FG000|Overall Study|Lost to Follow-up|100|||
125193465|NCT00178685|450330238|FG001|Overall Study|Lost to Follow-up|187|||
125193466|NCT00178685|450330239|FG002|Overall Study|Lost to Follow-up|183|||
125193467|NCT00178685|450330237|FG000|Overall Study|Withdrawal by Subject|8|||
125193468|NCT00178685|450330238|FG001|Overall Study|Withdrawal by Subject|14|||
125193469|NCT00178685|450330239|FG002|Overall Study|Withdrawal by Subject|7|||
125193470|NCT01562782|450330242|FG000|Overall Study|Withdrawal by Subject|3|||
125193471|NCT01562782|450330243|FG001|Overall Study|Withdrawal by Subject|3|||
125193472|NCT01562782|450330242|FG000|Overall Study|screen failure|1|||
125193473|NCT01562782|450330243|FG001|Overall Study|screen failure|2|||
125193474|NCT00090493|450330250|FG000|Overall Study|Physician Decision|2|||
125193475|NCT02071706|450330251|FG000|Overall Study|Adverse Event|1|||
125193476|NCT02071706|450330251|FG000|Overall Study|Withdrawal by Subject|2|||
125193477|NCT01908829|450330257|FG000|Overall Study|Adverse Event|13|||
125193478|NCT01908829|450330258|FG001|Overall Study|Adverse Event|11|||
125193479|NCT01908829|450330259|FG002|Overall Study|Adverse Event|13|||
125193480|NCT01908829|450330257|FG000|Overall Study|Lost to Follow-up|4|||
125193481|NCT01908829|450330258|FG001|Overall Study|Lost to Follow-up|2|||
125193482|NCT01908829|450330259|FG002|Overall Study|Lost to Follow-up|1|||
125193483|NCT01908829|450330257|FG000|Overall Study|Randomized no double-blind drug received|1|||
125193484|NCT01908829|450330258|FG001|Overall Study|Randomized no double-blind drug received|0|||
125193485|NCT01908829|450330259|FG002|Overall Study|Randomized no double-blind drug received|1|||
125193486|NCT01908829|450330257|FG000|Overall Study|Discontinued (no EoT page)|2|||
125193487|NCT01908829|450330258|FG001|Overall Study|Discontinued (no EoT page)|0|||
125193488|NCT01908829|450330259|FG002|Overall Study|Discontinued (no EoT page)|0|||
125193489|NCT01908829|450330257|FG000|Overall Study|Miscellaneous|0|||
125193490|NCT01908829|450330258|FG001|Overall Study|Miscellaneous|2|||
125193491|NCT01908829|450330259|FG002|Overall Study|Miscellaneous|0|||
125193492|NCT01908829|450330257|FG000|Overall Study|Protocol Violation|2|||
125193493|NCT01908829|450330258|FG001|Overall Study|Protocol Violation|2|||
125193494|NCT01908829|450330259|FG002|Overall Study|Protocol Violation|0|||
125193495|NCT01908829|450330257|FG000|Overall Study|Lack of Efficacy|1|||
125193496|NCT01908829|450330258|FG001|Overall Study|Lack of Efficacy|3|||
125193497|NCT01908829|450330259|FG002|Overall Study|Lack of Efficacy|2|||
125193498|NCT01908829|450330257|FG000|Overall Study|Withdrawal by Subject|26|||
125193499|NCT01908829|450330258|FG001|Overall Study|Withdrawal by Subject|29|||
125193500|NCT01908829|450330259|FG002|Overall Study|Withdrawal by Subject|22|||
125193501|NCT02792192|450330260|FG000|Overall Study|Death|1|||
125193502|NCT02792192|450330261|FG001|Overall Study|Death|0|||
125193503|NCT02792192|450330262|FG002|Overall Study|Death|0|||
125193504|NCT02792192|450330263|FG003|Overall Study|Death|0|||
125193505|NCT02792192|450330260|FG000|Overall Study|Informed Consent Withdrawn|4|||
125193506|NCT02792192|450330261|FG001|Overall Study|Informed Consent Withdrawn|0|||
125193507|NCT02792192|450330262|FG002|Overall Study|Informed Consent Withdrawn|0|||
125193508|NCT02792192|450330263|FG003|Overall Study|Informed Consent Withdrawn|0|||
125193509|NCT02792192|450330260|FG000|Overall Study|Physician Decision|1|||
125193510|NCT02792192|450330261|FG001|Overall Study|Physician Decision|0|||
125193511|NCT02792192|450330262|FG002|Overall Study|Physician Decision|0|||
125193512|NCT02792192|450330263|FG003|Overall Study|Physician Decision|0|||
125193513|NCT02792192|450330260|FG000|Overall Study|Progressive Disease|0|||
125193514|NCT02792192|450330261|FG001|Overall Study|Progressive Disease|1|||
125193515|NCT02792192|450330262|FG002|Overall Study|Progressive Disease|0|||
125193516|NCT02792192|450330263|FG003|Overall Study|Progressive Disease|0|||
125193517|NCT02792192|450330260|FG000|Overall Study|Study Terminated By Sponsor|6|||
125193518|NCT02792192|450330261|FG001|Overall Study|Study Terminated By Sponsor|10|||
125193519|NCT02792192|450330262|FG002|Overall Study|Study Terminated By Sponsor|0|||
125193520|NCT02792192|450330263|FG003|Overall Study|Study Terminated By Sponsor|0|||
125193521|NCT02320058|450330264|FG000|Overall Study|Death|25|||
125193522|NCT02320058|450330265|FG001|Overall Study|Death|10|||
125193523|NCT02320058|450330264|FG000|Overall Study|Lost to Follow-up|4|||
125193524|NCT02320058|450330265|FG001|Overall Study|Lost to Follow-up|0|||
125193525|NCT02320058|450330264|FG000|Overall Study|Other reasons|4|||
125193526|NCT02320058|450330265|FG001|Overall Study|Other reasons|1|||
125193527|NCT02320058|450330264|FG000|Overall Study|Withdrawal by Subject|8|||
125193528|NCT02320058|450330265|FG001|Overall Study|Withdrawal by Subject|2|||
125193529|NCT02320058|450330264|FG000|Overall Study|Not reported|1|||
125246256|NCT02675452|450526730|FG001|Overall Study|Death|0|||
125246257|NCT02675452|450526731|FG002|Overall Study|Death|1|||
125246258|NCT02675452|450526732|FG003|Overall Study|Death|0|||
125246259|NCT02675452|450526733|FG004|Overall Study|Death|0|||
125246260|NCT02675452|450526734|FG005|Overall Study|Death|1|||
125246261|NCT02675452|450526735|FG006|Overall Study|Death|0|||
125246262|NCT02675452|450526736|FG007|Overall Study|Death|0|||
125246263|NCT02675452|450526737|FG008|Overall Study|Death|1|||
125246264|NCT02675452|450526738|FG009|Overall Study|Death|0|||
125246265|NCT02675452|450526739|FG010|Overall Study|Death|0|||
125246266|NCT02675452|450526740|FG011|Overall Study|Death|0|||
125246267|NCT02675452|450526741|FG012|Overall Study|Death|1|||
125246268|NCT02675452|450526742|FG013|Overall Study|Death|0|||
125246269|NCT02675452|450526743|FG014|Overall Study|Death|0|||
125246270|NCT02675452|450526744|FG015|Overall Study|Death|2|||
125246271|NCT02675452|450526745|FG016|Overall Study|Death|0|||
125246272|NCT02675452|450526746|FG017|Overall Study|Death|0|||
125246273|NCT02675452|450526747|FG018|Overall Study|Death|4|||
125246274|NCT02675452|450526748|FG019|Overall Study|Death|3|||
125246275|NCT02675452|450526749|FG020|Overall Study|Death|3|||
125246276|NCT02675452|450526750|FG021|Overall Study|Death|3|||
125246277|NCT02675452|450526751|FG022|Overall Study|Death|7|||
125246278|NCT02675452|450526752|FG023|Overall Study|Death|5|||
125246279|NCT02675452|450526753|FG024|Overall Study|Death|3|||
125246280|NCT02675452|450526754|FG025|Overall Study|Death|4|||
125246281|NCT02675452|450526755|FG026|Overall Study|Death|7|||
125246282|NCT02675452|450526756|FG027|Overall Study|Death|6|||
125246283|NCT02675452|450526757|FG028|Overall Study|Death|9|||
125246284|NCT02675452|450526729|FG000|Overall Study|Lost to Follow-up|0|||
125246285|NCT02675452|450526730|FG001|Overall Study|Lost to Follow-up|1|||
125246286|NCT02675452|450526731|FG002|Overall Study|Lost to Follow-up|0|||
125246287|NCT02675452|450526732|FG003|Overall Study|Lost to Follow-up|0|||
125246288|NCT02675452|450526733|FG004|Overall Study|Lost to Follow-up|0|||
125246289|NCT02675452|450526734|FG005|Overall Study|Lost to Follow-up|0|||
125246290|NCT02675452|450526735|FG006|Overall Study|Lost to Follow-up|0|||
125246291|NCT02675452|450526736|FG007|Overall Study|Lost to Follow-up|0|||
125246292|NCT02675452|450526737|FG008|Overall Study|Lost to Follow-up|0|||
125246293|NCT02675452|450526738|FG009|Overall Study|Lost to Follow-up|0|||
125246294|NCT02675452|450526739|FG010|Overall Study|Lost to Follow-up|0|||
125246295|NCT02675452|450526740|FG011|Overall Study|Lost to Follow-up|0|||
125193530|NCT02320058|450330265|FG001|Overall Study|Not reported|0|||
125193531|NCT01339923|450330266|FG000|Overall Study|Adverse Event|1|||
125193532|NCT01339923|450330267|FG001|Overall Study|Adverse Event|1|||
125193533|NCT01339923|450330268|FG002|Overall Study|Adverse Event|1|||
125193534|NCT01339923|450330269|FG003|Overall Study|Adverse Event|0|||
125193535|NCT01339923|450330270|FG004|Overall Study|Adverse Event|0|||
125193536|NCT01339923|450330271|FG005|Overall Study|Adverse Event|0|||
125193537|NCT01339923|450330272|FG006|Overall Study|Adverse Event|1|||
125193538|NCT01339923|450330266|FG000|Overall Study|Inappropriate Enrollment|1|||
125193539|NCT01339923|450330267|FG001|Overall Study|Inappropriate Enrollment|0|||
125193540|NCT01339923|450330268|FG002|Overall Study|Inappropriate Enrollment|0|||
125193541|NCT01339923|450330269|FG003|Overall Study|Inappropriate Enrollment|0|||
125193542|NCT01339923|450330270|FG004|Overall Study|Inappropriate Enrollment|0|||
125193543|NCT01339923|450330271|FG005|Overall Study|Inappropriate Enrollment|1|||
125193544|NCT01339923|450330272|FG006|Overall Study|Inappropriate Enrollment|0|||
125193545|NCT01339923|450330266|FG000|Overall Study|Lost to Follow-up|4|||
125193546|NCT01339923|450330267|FG001|Overall Study|Lost to Follow-up|4|||
125193547|NCT01339923|450330268|FG002|Overall Study|Lost to Follow-up|0|||
125193548|NCT01339923|450330269|FG003|Overall Study|Lost to Follow-up|3|||
125193549|NCT01339923|450330270|FG004|Overall Study|Lost to Follow-up|1|||
125193550|NCT01339923|450330271|FG005|Overall Study|Lost to Follow-up|1|||
125193551|NCT01339923|450330272|FG006|Overall Study|Lost to Follow-up|5|||
125193552|NCT01339923|450330266|FG000|Overall Study|Protocol Violation|0|||
125193553|NCT01339923|450330267|FG001|Overall Study|Protocol Violation|0|||
125193554|NCT01339923|450330268|FG002|Overall Study|Protocol Violation|0|||
125193555|NCT01339923|450330269|FG003|Overall Study|Protocol Violation|0|||
125193556|NCT01339923|450330270|FG004|Overall Study|Protocol Violation|0|||
125193557|NCT01339923|450330271|FG005|Overall Study|Protocol Violation|3|||
125193558|NCT01339923|450330272|FG006|Overall Study|Protocol Violation|1|||
125193559|NCT01339923|450330266|FG000|Overall Study|Unable to Classify|1|||
125193560|NCT01339923|450330267|FG001|Overall Study|Unable to Classify|0|||
125193561|NCT01339923|450330268|FG002|Overall Study|Unable to Classify|1|||
125193562|NCT01339923|450330269|FG003|Overall Study|Unable to Classify|0|||
125193563|NCT01339923|450330270|FG004|Overall Study|Unable to Classify|0|||
125193564|NCT01339923|450330271|FG005|Overall Study|Unable to Classify|1|||
125193565|NCT01339923|450330272|FG006|Overall Study|Unable to Classify|5|||
125193566|NCT01339923|450330266|FG000|Overall Study|Withdrawal by Subject|7|||
125193567|NCT01339923|450330267|FG001|Overall Study|Withdrawal by Subject|11|||
125246296|NCT02675452|450526741|FG012|Overall Study|Lost to Follow-up|1|||
125246297|NCT02675452|450526742|FG013|Overall Study|Lost to Follow-up|0|||
125246298|NCT02675452|450526743|FG014|Overall Study|Lost to Follow-up|0|||
125246299|NCT02675452|450526744|FG015|Overall Study|Lost to Follow-up|0|||
125246300|NCT02675452|450526745|FG016|Overall Study|Lost to Follow-up|0|||
125246301|NCT02675452|450526746|FG017|Overall Study|Lost to Follow-up|0|||
125246302|NCT02675452|450526747|FG018|Overall Study|Lost to Follow-up|0|||
125246303|NCT02675452|450526748|FG019|Overall Study|Lost to Follow-up|0|||
125246304|NCT02675452|450526749|FG020|Overall Study|Lost to Follow-up|0|||
125246305|NCT02675452|450526750|FG021|Overall Study|Lost to Follow-up|0|||
125246306|NCT02675452|450526751|FG022|Overall Study|Lost to Follow-up|0|||
125246307|NCT02675452|450526752|FG023|Overall Study|Lost to Follow-up|0|||
125246308|NCT02675452|450526753|FG024|Overall Study|Lost to Follow-up|0|||
125246309|NCT02675452|450526754|FG025|Overall Study|Lost to Follow-up|0|||
125246310|NCT02675452|450526755|FG026|Overall Study|Lost to Follow-up|1|||
125246311|NCT02675452|450526756|FG027|Overall Study|Lost to Follow-up|0|||
125246312|NCT02675452|450526757|FG028|Overall Study|Lost to Follow-up|0|||
125246313|NCT02675452|450526729|FG000|Overall Study|Other|0|||
125246314|NCT02675452|450526730|FG001|Overall Study|Other|0|||
125246315|NCT02675452|450526731|FG002|Overall Study|Other|0|||
125246316|NCT02675452|450526732|FG003|Overall Study|Other|0|||
125246317|NCT02675452|450526733|FG004|Overall Study|Other|0|||
125246318|NCT02675452|450526734|FG005|Overall Study|Other|0|||
125246319|NCT02675452|450526735|FG006|Overall Study|Other|0|||
125246320|NCT02675452|450526736|FG007|Overall Study|Other|0|||
125246321|NCT02675452|450526737|FG008|Overall Study|Other|0|||
125246322|NCT02675452|450526738|FG009|Overall Study|Other|0|||
125246323|NCT02675452|450526739|FG010|Overall Study|Other|0|||
125246324|NCT02675452|450526740|FG011|Overall Study|Other|0|||
125246325|NCT02675452|450526741|FG012|Overall Study|Other|0|||
125246326|NCT02675452|450526742|FG013|Overall Study|Other|0|||
125246327|NCT02675452|450526743|FG014|Overall Study|Other|0|||
125246328|NCT02675452|450526744|FG015|Overall Study|Other|0|||
125246329|NCT02675452|450526745|FG016|Overall Study|Other|0|||
125246330|NCT02675452|450526746|FG017|Overall Study|Other|0|||
125246331|NCT02675452|450526747|FG018|Overall Study|Other|0|||
125246332|NCT02675452|450526748|FG019|Overall Study|Other|0|||
125246333|NCT02675452|450526749|FG020|Overall Study|Other|0|||
125246334|NCT02675452|450526750|FG021|Overall Study|Other|0|||
125246335|NCT02675452|450526751|FG022|Overall Study|Other|0|||
125246336|NCT02675452|450526752|FG023|Overall Study|Other|0|||
125246337|NCT02675452|450526753|FG024|Overall Study|Other|0|||
125246338|NCT02675452|450526754|FG025|Overall Study|Other|0|||
125246339|NCT02675452|450526755|FG026|Overall Study|Other|1|||
125246340|NCT02675452|450526756|FG027|Overall Study|Other|0|||
125246341|NCT02675452|450526757|FG028|Overall Study|Other|0|||
125246342|NCT02939781|450526758|FG000|Overall Study|Protocol Violation|8|||
125246343|NCT02939781|450526758|FG000|Overall Study|Withdrawal by Subject|1|||
125246344|NCT02569242|450526760|FG000|Overall Study|Death|1|||
125246345|NCT02569242|450526761|FG001|Overall Study|Death|0|||
125246346|NCT02569242|450526760|FG000|Overall Study|Withdrawal by Subject|0|||
125246347|NCT02569242|450526761|FG001|Overall Study|Withdrawal by Subject|1|||
125246348|NCT00689052|450526762|FG000|Overall Study|Adverse Event|4|||
125246349|NCT00689052|450526763|FG001|Overall Study|Adverse Event|6|||
125246350|NCT00689052|450526762|FG000|Overall Study|Protocol Violation|1|||
125246351|NCT00689052|450526763|FG001|Overall Study|Protocol Violation|0|||
125246352|NCT00689052|450526762|FG000|Overall Study|Lost to Follow-up|2|||
125246353|NCT00689052|450526763|FG001|Overall Study|Lost to Follow-up|0|||
125246354|NCT00689052|450526762|FG000|Overall Study|Withdrawal by Subject|2|||
125246355|NCT00689052|450526763|FG001|Overall Study|Withdrawal by Subject|0|||
125246356|NCT00689052|450526762|FG000|Overall Study|Early termination of the trial|22|||
125246357|NCT00689052|450526763|FG001|Overall Study|Early termination of the trial|24|||
125246358|NCT03003468|450526764|FG000|Overall Study|Withdrawal by Subject|0|||
125246359|NCT03003468|450526765|FG001|Overall Study|Withdrawal by Subject|0|||
125246360|NCT03003468|450526766|FG002|Overall Study|Withdrawal by Subject|1|||
125246361|NCT03003468|450526764|FG000|Overall Study|No measurable lesions|0|||
125246362|NCT03003468|450526765|FG001|Overall Study|No measurable lesions|0|||
125246363|NCT03003468|450526766|FG002|Overall Study|No measurable lesions|1|||
125246364|NCT02114684|450526767|FG000|Overall Study|Death|6|||
125246365|NCT02114684|450526768|FG001|Overall Study|Death|4|||
125246366|NCT02114684|450526767|FG000|Overall Study|Lost to Follow-up|1|||
125246367|NCT02114684|450526768|FG001|Overall Study|Lost to Follow-up|2|||
125246368|NCT02114684|450526767|FG000|Overall Study|Withdrawal by Subject|1|||
125246369|NCT02114684|450526768|FG001|Overall Study|Withdrawal by Subject|2|||
125246370|NCT02114684|450526767|FG000|Overall Study|Relocation|3|||
125246371|NCT02114684|450526768|FG001|Overall Study|Relocation|1|||
125246372|NCT02114684|450526767|FG000|Overall Study|Rifampicin resistant on culture|0|||
125246373|NCT02114684|450526768|FG001|Overall Study|Rifampicin resistant on culture|1|||
125246374|NCT02114684|450526767|FG000|Overall Study|Patient Incarcerated|1|||
125246375|NCT02114684|450526768|FG001|Overall Study|Patient Incarcerated|0|||
125246376|NCT04625972|450526771|FG000|Overall Study|Death|3|||
125246377|NCT04625972|450526772|FG001|Overall Study|Death|2|||
125246378|NCT04625972|450526771|FG000|Overall Study|Lost to Follow-up|82|||
125246379|NCT04625972|450526772|FG001|Overall Study|Lost to Follow-up|38|||
125246380|NCT04625972|450526771|FG000|Overall Study|Physician Decision|2|||
125246381|NCT04625972|450526772|FG001|Overall Study|Physician Decision|0|||
125246382|NCT04625972|450526771|FG000|Overall Study|Protocol Violation|0|||
125246383|NCT04625972|450526772|FG001|Overall Study|Protocol Violation|1|||
125246384|NCT04625972|450526771|FG000|Overall Study|Withdrawal by Subject|37|||
125246385|NCT04625972|450526772|FG001|Overall Study|Withdrawal by Subject|24|||
125246386|NCT04625972|450526771|FG000|Overall Study|Not specified elsewhere|8|||
125246387|NCT04625972|450526772|FG001|Overall Study|Not specified elsewhere|6|||
125246388|NCT03259308|450526780|FG000|Overall Study|Adverse Event|5|||
125193568|NCT01339923|450330268|FG002|Overall Study|Withdrawal by Subject|6|||
125193569|NCT01339923|450330269|FG003|Overall Study|Withdrawal by Subject|1|||
125193570|NCT01339923|450330270|FG004|Overall Study|Withdrawal by Subject|4|||
125193571|NCT01339923|450330271|FG005|Overall Study|Withdrawal by Subject|3|||
125193572|NCT01339923|450330272|FG006|Overall Study|Withdrawal by Subject|2|||
125193573|NCT01430403|450330273|FG000|Overall Study|Lost to Follow-up|5|||
125193574|NCT01430403|450330274|FG001|Overall Study|Lost to Follow-up|5|||
125193575|NCT01430403|450330275|FG002|Overall Study|Lost to Follow-up|3|||
125193576|NCT01430403|450330273|FG000|Overall Study|Physician Decision|1|||
125193577|NCT01430403|450330274|FG001|Overall Study|Physician Decision|0|||
125193578|NCT01430403|450330275|FG002|Overall Study|Physician Decision|0|||
125193579|NCT01430403|450330273|FG000|Overall Study|Protocol Violation|2|||
125193580|NCT01430403|450330274|FG001|Overall Study|Protocol Violation|3|||
125193581|NCT01430403|450330275|FG002|Overall Study|Protocol Violation|2|||
125193582|NCT01430403|450330273|FG000|Overall Study|Withdrawal by Subject|9|||
125193583|NCT01430403|450330274|FG001|Overall Study|Withdrawal by Subject|1|||
125193584|NCT01430403|450330275|FG002|Overall Study|Withdrawal by Subject|3|||
125193585|NCT00403481|450330276|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
125193586|NCT00403481|450330276|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
125193587|NCT00403481|450330276|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
125193588|NCT00403481|450330276|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
125193589|NCT00403481|450330276|FG000|Olm 40 mg|Adverse Event|2|||
125193590|NCT00403481|450330276|FG000|Olm 40 mg|Protocol Violation|1|||
125193591|NCT00403481|450330276|FG000|Olm 40 mg|Withdrawal by Subject|1|||
125193592|NCT00403481|450330276|FG000|Olm 40 mg|Other|1|||
125193593|NCT00403481|450330276|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
125193594|NCT00403481|450330276|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
125193595|NCT00403481|450330276|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
125193596|NCT00403481|450330276|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
125193597|NCT00403481|450330276|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
125193598|NCT00403481|450330276|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
125193599|NCT02099110|450330279|FG000|Overall Study|Protocol Violation|2|||
125193600|NCT02099110|450330280|FG001|Overall Study|Protocol Violation|1|||
125193601|NCT02099110|450330281|FG002|Overall Study|Protocol Violation|0|||
125193602|NCT02099110|450330282|FG003|Overall Study|Protocol Violation|3|||
125193603|NCT02099110|450330283|FG004|Overall Study|Protocol Violation|1|||
125193604|NCT02099110|450330279|FG000|Overall Study|Participant moved|1|||
125193605|NCT02099110|450330280|FG001|Overall Study|Participant moved|1|||
125193606|NCT02099110|450330281|FG002|Overall Study|Participant moved|1|||
125193607|NCT02099110|450330282|FG003|Overall Study|Participant moved|0|||
125193608|NCT02099110|450330283|FG004|Overall Study|Participant moved|2|||
125193609|NCT02099110|450330279|FG000|Overall Study|Withdrawal by Subject|7|||
125193610|NCT02099110|450330280|FG001|Overall Study|Withdrawal by Subject|11|||
125193611|NCT02099110|450330281|FG002|Overall Study|Withdrawal by Subject|13|||
125246389|NCT03259308|450526781|FG001|Overall Study|Adverse Event|4|||
125193612|NCT02099110|450330282|FG003|Overall Study|Withdrawal by Subject|9|||
125193613|NCT02099110|450330283|FG004|Overall Study|Withdrawal by Subject|13|||
125193614|NCT02099110|450330279|FG000|Overall Study|Adverse Event|3|||
125193615|NCT02099110|450330280|FG001|Overall Study|Adverse Event|5|||
125193616|NCT02099110|450330281|FG002|Overall Study|Adverse Event|2|||
125193617|NCT02099110|450330282|FG003|Overall Study|Adverse Event|3|||
125193618|NCT02099110|450330283|FG004|Overall Study|Adverse Event|2|||
125193619|NCT02099110|450330279|FG000|Overall Study|Lost to Follow-up|6|||
125246390|NCT03259308|450526782|FG002|Overall Study|Adverse Event|1|||
125246391|NCT03259308|450526780|FG000|Overall Study|Withdrawal by Subject|2|||
125193620|NCT02099110|450330280|FG001|Overall Study|Lost to Follow-up|12|||
125193621|NCT02099110|450330281|FG002|Overall Study|Lost to Follow-up|11|||
125193622|NCT02099110|450330282|FG003|Overall Study|Lost to Follow-up|5|||
125193623|NCT02099110|450330283|FG004|Overall Study|Lost to Follow-up|6|||
125193624|NCT02099110|450330279|FG000|Overall Study|Death|0|||
125193625|NCT02099110|450330280|FG001|Overall Study|Death|1|||
125193626|NCT02099110|450330281|FG002|Overall Study|Death|0|||
125193627|NCT02099110|450330282|FG003|Overall Study|Death|0|||
125193628|NCT02099110|450330283|FG004|Overall Study|Death|0|||
125193629|NCT02099110|450330279|FG000|Overall Study|Screen failure|0|||
125193630|NCT02099110|450330280|FG001|Overall Study|Screen failure|0|||
125193631|NCT02099110|450330281|FG002|Overall Study|Screen failure|0|||
125193632|NCT02099110|450330282|FG003|Overall Study|Screen failure|0|||
125193633|NCT02099110|450330283|FG004|Overall Study|Screen failure|1|||
125193634|NCT02099110|450330279|FG000|Overall Study|Non-compliance with study drug|2|||
125193635|NCT02099110|450330280|FG001|Overall Study|Non-compliance with study drug|0|||
125193636|NCT02099110|450330281|FG002|Overall Study|Non-compliance with study drug|0|||
125193637|NCT02099110|450330282|FG003|Overall Study|Non-compliance with study drug|0|||
125193638|NCT02099110|450330283|FG004|Overall Study|Non-compliance with study drug|1|||
125193639|NCT02099110|450330279|FG000|Overall Study|Physician Decision|3|||
125193640|NCT02099110|450330280|FG001|Overall Study|Physician Decision|0|||
125193641|NCT02099110|450330281|FG002|Overall Study|Physician Decision|1|||
125193642|NCT02099110|450330282|FG003|Overall Study|Physician Decision|2|||
125193643|NCT02099110|450330283|FG004|Overall Study|Physician Decision|1|||
125193644|NCT02887248|450330287|FG000|Overall Study|Withdrawal by Subject|1|||
125193645|NCT02887248|450330287|FG000|Overall Study|Adverse Event|1|||
125193646|NCT02887248|450330287|FG000|Overall Study|Progressive Disease|1|||
125193647|NCT01166438|450330288|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
125193648|NCT01166438|450330289|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
125193649|NCT01166438|450330288|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
125193650|NCT01166438|450330289|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
125193651|NCT01166438|450330288|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
125193652|NCT01166438|450330289|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
125193653|NCT01166438|450330288|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
125193654|NCT01166438|450330289|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
125193655|NCT01166438|450330288|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
125193656|NCT01166438|450330289|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
125193657|NCT01166438|450330288|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
125193658|NCT01166438|450330289|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
125193659|NCT01377922|450330294|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
125193660|NCT01377922|450330295|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
125193661|NCT03170362|450330296|FG000|Overall Study|Death|2|||
125193662|NCT03170362|450330297|FG001|Overall Study|Death|2|||
125193663|NCT03170362|450330296|FG000|Overall Study|Withdrawal by Subject|23|||
125193664|NCT03170362|450330297|FG001|Overall Study|Withdrawal by Subject|22|||
125193665|NCT03170362|450330296|FG000|Overall Study|Lost to Follow-up|187|||
125193666|NCT03170362|450330297|FG001|Overall Study|Lost to Follow-up|167|||
125193667|NCT03682848|450330298|FG000|Overall Study|Withdrawal by Subject|2|||
125193668|NCT03682848|450330298|FG000|Overall Study|Site closed|5|||
125193669|NCT03682848|450330298|FG000|Overall Study|Protocol Deviation|1|||
125193670|NCT03682848|450330298|FG000|Overall Study|Adverse Event|1|||
125193671|NCT00454363|450330299|FG000|Overall Study|Adverse Event|1|||
125193672|NCT00454363|450330300|FG001|Overall Study|Adverse Event|2|||
125193673|NCT00454363|450330299|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
125193674|NCT00454363|450330300|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
125193675|NCT03482453|450330301|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125193676|NCT03482453|450330302|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125193677|NCT03482453|450330303|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125193678|NCT03482453|450330304|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125193679|NCT03482453|450330305|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125193680|NCT03482453|450330306|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125193681|NCT03482453|450330307|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125193682|NCT03482453|450330308|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125193683|NCT03482453|450330309|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125193684|NCT03482453|450330310|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125193685|NCT03482453|450330311|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
125193686|NCT03482453|450330312|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125193687|NCT02547220|450330318|FG000|Overall Study|Withdrawal by Subject|1|||
125193688|NCT02547220|450330319|FG001|Overall Study|Withdrawal by Subject|0|||
125193689|NCT02547220|450330318|FG000|Overall Study|Study terminated by sponsor|18|||
125193690|NCT02547220|450330319|FG001|Overall Study|Study terminated by sponsor|20|||
125193691|NCT00550043|450330320|FG000|Overall Study|Adverse Event|0|||
125193692|NCT00550043|450330321|FG001|Overall Study|Adverse Event|0|||
125193693|NCT00550043|450330322|FG002|Overall Study|Adverse Event|0|||
125193694|NCT00550043|450330323|FG003|Overall Study|Adverse Event|1|||
125193695|NCT00550043|450330324|FG004|Overall Study|Adverse Event|1|||
125193696|NCT00550043|450330320|FG000|Overall Study|Subject Withdrew Consent|0|||
125193697|NCT00550043|450330321|FG001|Overall Study|Subject Withdrew Consent|2|||
125193698|NCT00550043|450330322|FG002|Overall Study|Subject Withdrew Consent|1|||
125193699|NCT00550043|450330323|FG003|Overall Study|Subject Withdrew Consent|0|||
125193700|NCT00550043|450330324|FG004|Overall Study|Subject Withdrew Consent|0|||
125193701|NCT00550043|450330320|FG000|Overall Study|Other Reasons- Unspecified|0|||
125193702|NCT00550043|450330321|FG001|Overall Study|Other Reasons- Unspecified|1|||
125193703|NCT00550043|450330322|FG002|Overall Study|Other Reasons- Unspecified|0|||
125193704|NCT00550043|450330323|FG003|Overall Study|Other Reasons- Unspecified|1|||
125193705|NCT00550043|450330324|FG004|Overall Study|Other Reasons- Unspecified|0|||
125193706|NCT02887183|450330326|FG000|Overall Study|Adverse Event|44|||
125193707|NCT02887183|450330326|FG000|Overall Study|Death|30|||
125193708|NCT02887183|450330326|FG000|Overall Study|Pregnancy|1|||
125193709|NCT02887183|450330326|FG000|Overall Study|Protocol Violation|6|||
125193710|NCT02887183|450330326|FG000|Overall Study|Technical Problems|2|||
125193711|NCT02887183|450330326|FG000|Overall Study|Lost to Follow-up|13|||
125193712|NCT02887183|450330326|FG000|Overall Study|Physician Decision|10|||
125193713|NCT02887183|450330326|FG000|Overall Study|Withdrawal by Subject|35|||
125193714|NCT03300505|450332035|FG000|Overall Study|Death|0|||
125193715|NCT03300505|450332036|FG001|Overall Study|Death|1|||
125193716|NCT03300505|450332037|FG002|Overall Study|Death|0|||
125193717|NCT03300505|450332035|FG000|Overall Study|Withdrawal by Subject|0|||
125193718|NCT03300505|450332036|FG001|Overall Study|Withdrawal by Subject|1|||
125193719|NCT03300505|450332037|FG002|Overall Study|Withdrawal by Subject|1|||
125193720|NCT03300505|450332035|FG000|Overall Study|Sponsor Termination|0|||
125193721|NCT03300505|450332036|FG001|Overall Study|Sponsor Termination|1|||
125193722|NCT03300505|450332037|FG002|Overall Study|Sponsor Termination|0|||
125193723|NCT03300505|450332035|FG000|Overall Study|Adverse Event|0|||
125193724|NCT03300505|450332036|FG001|Overall Study|Adverse Event|0|||
125193725|NCT03300505|450332037|FG002|Overall Study|Adverse Event|2|||
125193726|NCT05119595|450332038|FG000|Overall Study|Death|1|||
125193727|NCT05119595|450332038|FG000|Overall Study|Lost to Follow-up|7|||
125193728|NCT00679029|450332039|FG000|Overall Study|Adverse Event|3|||
125193729|NCT00679029|450332039|FG000|Overall Study|Withdrawal by Subject|1|||
125193730|NCT00679029|450332039|FG000|Overall Study|Lost to Follow-up|1|||
125193731|NCT03483961|450332040|FG000|Overall Study|Lost to Follow-up|7|||
125193732|NCT03483961|450332041|FG001|Overall Study|Lost to Follow-up|6|||
125193733|NCT03483961|450332042|FG002|Overall Study|Lost to Follow-up|6|||
125193734|NCT03483961|450332043|FG003|Overall Study|Lost to Follow-up|6|||
125193735|NCT03483961|450332044|FG004|Overall Study|Lost to Follow-up|6|||
125193736|NCT03483961|450332045|FG005|Overall Study|Lost to Follow-up|4|||
125193737|NCT03483961|450332046|FG006|Overall Study|Lost to Follow-up|4|||
125193738|NCT03483961|450332047|FG007|Overall Study|Lost to Follow-up|11|||
125193739|NCT03483961|450332048|FG008|Overall Study|Lost to Follow-up|1|||
125193740|NCT03483961|450332049|FG009|Overall Study|Lost to Follow-up|0|||
125193741|NCT03483961|450332040|FG000|Overall Study|Withdrawal by Subject|3|||
125193742|NCT03483961|450332041|FG001|Overall Study|Withdrawal by Subject|4|||
125193743|NCT03483961|450332042|FG002|Overall Study|Withdrawal by Subject|5|||
125193744|NCT03483961|450332043|FG003|Overall Study|Withdrawal by Subject|3|||
125193745|NCT03483961|450332044|FG004|Overall Study|Withdrawal by Subject|4|||
125193746|NCT03483961|450332045|FG005|Overall Study|Withdrawal by Subject|2|||
125193747|NCT03483961|450332046|FG006|Overall Study|Withdrawal by Subject|1|||
125193748|NCT03483961|450332047|FG007|Overall Study|Withdrawal by Subject|2|||
125193749|NCT03483961|450332048|FG008|Overall Study|Withdrawal by Subject|1|||
125193750|NCT03483961|450332049|FG009|Overall Study|Withdrawal by Subject|0|||
125193751|NCT03483961|450332040|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
125193752|NCT03483961|450332041|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
125193753|NCT03483961|450332042|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
125193754|NCT03483961|450332043|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
125193755|NCT03483961|450332044|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
125193756|NCT03483961|450332045|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
125193757|NCT03483961|450332046|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
125193758|NCT03483961|450332047|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
125193759|NCT03483961|450332048|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
125193760|NCT03483961|450332049|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
125193761|NCT03483961|450332040|FG000|Overall Study|Adverse Event|0|||
125193762|NCT03483961|450332041|FG001|Overall Study|Adverse Event|0|||
125246392|NCT03259308|450526781|FG001|Overall Study|Withdrawal by Subject|1|||
125246393|NCT03259308|450526782|FG002|Overall Study|Withdrawal by Subject|3|||
125246394|NCT03259308|450526780|FG000|Overall Study|Lost to Follow-up|0|||
125246395|NCT03259308|450526781|FG001|Overall Study|Lost to Follow-up|0|||
125246396|NCT03259308|450526782|FG002|Overall Study|Lost to Follow-up|1|||
125246397|NCT03259308|450526780|FG000|Overall Study|Pregnancy|0|||
125246398|NCT03259308|450526781|FG001|Overall Study|Pregnancy|0|||
125246399|NCT03259308|450526782|FG002|Overall Study|Pregnancy|1|||
125246400|NCT03259308|450526780|FG000|Overall Study|Protocol Deviation|0|||
125246401|NCT03259308|450526781|FG001|Overall Study|Protocol Deviation|3|||
125246402|NCT03259308|450526782|FG002|Overall Study|Protocol Deviation|0|||
125246403|NCT03259308|450526780|FG000|Overall Study|Lack of Efficacy|0|||
125246404|NCT03259308|450526781|FG001|Overall Study|Lack of Efficacy|0|||
125246405|NCT03259308|450526782|FG002|Overall Study|Lack of Efficacy|1|||
125246406|NCT00694122|450526783|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
125246407|NCT00694122|450526784|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
125246408|NCT00694122|450526783|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
125246409|NCT00694122|450526784|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
125246410|NCT00694122|450526783|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
125246411|NCT00694122|450526784|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
125246412|NCT01727154|450526787|FG000|Overall Study|Death|17|||
125246413|NCT01727154|450526787|FG000|Overall Study|Withdrawal by Subject|14|||
125246414|NCT01727154|450526787|FG000|Overall Study|Subject Withdrew Consent|18|||
125246415|NCT01727154|450526787|FG000|Overall Study|Study Terminated|6|||
125246416|NCT01727154|450526787|FG000|Overall Study|No Discontinuation Documentation|4|||
125246417|NCT00003474|450526788|FG000|Overall Study|Not Evaluable|14|||
125246418|NCT03020888|450526791|FG000|Overall Study|Physician Decision|4|||
125246419|NCT03020888|450526791|FG000|Overall Study|Withdrawal by Subject|6|||
125246420|NCT03020888|450526791|FG000|Overall Study|Insurance coverage|2|||
125246421|NCT03020888|450526791|FG000|Overall Study|Lost to Follow-up|1|||
125246422|NCT01198548|450526798|FG000|Overall Study|Disease Progression|9|||
125246423|NCT01198548|450526798|FG000|Overall Study|Administrative Decision|1|||
125246424|NCT01245062|450526800|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
125246425|NCT01245062|450526801|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
125246426|NCT01245062|450526802|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
125246427|NCT01245062|450526800|FG000|Randomization and Crossover Phase|Physician Decision|2|||
125246428|NCT01245062|450526801|FG001|Randomization and Crossover Phase|Physician Decision|4|||
125246429|NCT01245062|450526802|FG002|Randomization and Crossover Phase|Physician Decision|0|||
125246430|NCT01245062|450526800|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
125246431|NCT01245062|450526801|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
125246432|NCT01245062|450526802|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
125246433|NCT01245062|450526800|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
125246434|NCT01245062|450526801|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
125246435|NCT01245062|450526802|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
125246436|NCT01245062|450526800|FG000|Cross-over Phase|Lost to Follow-up|0|||
125246437|NCT01245062|450526801|FG001|Cross-over Phase|Lost to Follow-up|0|||
125246438|NCT01245062|450526802|FG002|Cross-over Phase|Lost to Follow-up|1|||
125246439|NCT01245062|450526800|FG000|Cross-over Phase|Physician Decision|0|||
125246440|NCT01245062|450526801|FG001|Cross-over Phase|Physician Decision|0|||
125246441|NCT01245062|450526802|FG002|Cross-over Phase|Physician Decision|1|||
125246442|NCT01245062|450526800|FG000|Cross-over Phase|Withdrew Consent|0|||
125246443|NCT01245062|450526801|FG001|Cross-over Phase|Withdrew Consent|0|||
125246444|NCT01245062|450526802|FG002|Cross-over Phase|Withdrew Consent|4|||
125246445|NCT01245062|450526800|FG000|Cross-over Phase|Study closed/ terminated|0|||
125246446|NCT01245062|450526801|FG001|Cross-over Phase|Study closed/ terminated|0|||
125246447|NCT01245062|450526802|FG002|Cross-over Phase|Study closed/ terminated|11|||
125246448|NCT06025695|450526803|FG000|Overall Study|Adverse Event|5|||
125246449|NCT06025695|450526804|FG001|Overall Study|Adverse Event|6|||
125246450|NCT06025695|450526803|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
125246451|NCT06025695|450526804|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
125246452|NCT06025695|450526803|FG000|Overall Study|Other|23|||
125246453|NCT06025695|450526804|FG001|Overall Study|Other|19|||
125246454|NCT06025695|450526803|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
125246455|NCT06025695|450526804|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
125246456|NCT03834883|450526805|FG000|Second Treatment|Withdrawal by Subject|1|||
125193763|NCT03483961|450332042|FG002|Overall Study|Adverse Event|1|||
125193764|NCT03483961|450332043|FG003|Overall Study|Adverse Event|0|||
125193765|NCT03483961|450332044|FG004|Overall Study|Adverse Event|0|||
125193766|NCT03483961|450332045|FG005|Overall Study|Adverse Event|0|||
125193767|NCT03483961|450332046|FG006|Overall Study|Adverse Event|0|||
125193768|NCT03483961|450332047|FG007|Overall Study|Adverse Event|0|||
125193769|NCT03483961|450332048|FG008|Overall Study|Adverse Event|0|||
125193770|NCT03483961|450332049|FG009|Overall Study|Adverse Event|0|||
125193771|NCT01108341|450332052|FG000|Overall Study|Death|2|||
125193772|NCT01108341|450332052|FG000|Overall Study|Withdrawal by Subject|1|||
125193773|NCT01108341|450332052|FG000|Overall Study|Lost to Follow-up|1|||
125193774|NCT01108341|450332052|FG000|Overall Study|Other|1|||
125193775|NCT00267969|450332053|FG000|Controlled Period|Adverse Event|6|||
125193776|NCT00267969|450332054|FG001|Controlled Period|Adverse Event|0|||
125193777|NCT00267969|450332055|FG002|Controlled Period|Adverse Event|2|||
125193778|NCT00267969|450332056|FG003|Controlled Period|Adverse Event|0|||
125193779|NCT00267969|450332057|FG004|Controlled Period|Adverse Event|0|||
125193780|NCT00267969|450332058|FG005|Controlled Period|Adverse Event|0|||
125193781|NCT00267969|450332059|FG006|Controlled Period|Adverse Event|0|||
125193782|NCT00267969|450332053|FG000|Controlled Period|Lack of Efficacy|3|||
125193783|NCT00267969|450332054|FG001|Controlled Period|Lack of Efficacy|0|||
125193784|NCT00267969|450332055|FG002|Controlled Period|Lack of Efficacy|1|||
125193785|NCT00267969|450332056|FG003|Controlled Period|Lack of Efficacy|0|||
125193786|NCT00267969|450332057|FG004|Controlled Period|Lack of Efficacy|0|||
125193787|NCT00267969|450332058|FG005|Controlled Period|Lack of Efficacy|0|||
125193788|NCT00267969|450332059|FG006|Controlled Period|Lack of Efficacy|0|||
125193789|NCT00267969|450332053|FG000|Controlled Period|Lost to Follow-up|1|||
125193790|NCT00267969|450332054|FG001|Controlled Period|Lost to Follow-up|0|||
125193791|NCT00267969|450332055|FG002|Controlled Period|Lost to Follow-up|1|||
125193792|NCT00267969|450332056|FG003|Controlled Period|Lost to Follow-up|0|||
125193793|NCT00267969|450332057|FG004|Controlled Period|Lost to Follow-up|0|||
125193794|NCT00267969|450332058|FG005|Controlled Period|Lost to Follow-up|0|||
125193795|NCT00267969|450332059|FG006|Controlled Period|Lost to Follow-up|0|||
125193796|NCT00267969|450332053|FG000|Controlled Period|Randomized but not treated|0|||
125193797|NCT00267969|450332054|FG001|Controlled Period|Randomized but not treated|0|||
125193798|NCT00267969|450332055|FG002|Controlled Period|Randomized but not treated|1|||
125193799|NCT00267969|450332056|FG003|Controlled Period|Randomized but not treated|0|||
125193800|NCT00267969|450332057|FG004|Controlled Period|Randomized but not treated|0|||
125193801|NCT00267969|450332058|FG005|Controlled Period|Randomized but not treated|0|||
125193802|NCT00267969|450332059|FG006|Controlled Period|Randomized but not treated|0|||
125193803|NCT00267969|450332053|FG000|Controlled Period|Other|2|||
125193804|NCT00267969|450332054|FG001|Controlled Period|Other|1|||
125193805|NCT00267969|450332055|FG002|Controlled Period|Other|6|||
125193806|NCT00267969|450332056|FG003|Controlled Period|Other|0|||
125193807|NCT00267969|450332057|FG004|Controlled Period|Other|0|||
125193808|NCT00267969|450332058|FG005|Controlled Period|Other|0|||
125193809|NCT00267969|450332059|FG006|Controlled Period|Other|0|||
125193810|NCT00267969|450332053|FG000|After Controlled Period|Adverse Event|0|||
125193811|NCT00267969|450332054|FG001|After Controlled Period|Adverse Event|0|||
125193812|NCT00267969|450332055|FG002|After Controlled Period|Adverse Event|0|||
125193813|NCT00267969|450332056|FG003|After Controlled Period|Adverse Event|7|||
125193814|NCT00267969|450332057|FG004|After Controlled Period|Adverse Event|8|||
125193815|NCT00267969|450332058|FG005|After Controlled Period|Adverse Event|23|||
125193816|NCT00267969|450332059|FG006|After Controlled Period|Adverse Event|21|||
125193817|NCT00267969|450332053|FG000|After Controlled Period|Death|0|||
125193818|NCT00267969|450332054|FG001|After Controlled Period|Death|0|||
125193819|NCT00267969|450332055|FG002|After Controlled Period|Death|0|||
125193820|NCT00267969|450332056|FG003|After Controlled Period|Death|1|||
125193821|NCT00267969|450332057|FG004|After Controlled Period|Death|2|||
125193822|NCT00267969|450332058|FG005|After Controlled Period|Death|0|||
125193823|NCT00267969|450332059|FG006|After Controlled Period|Death|1|||
125193824|NCT00267969|450332053|FG000|After Controlled Period|Lack of Efficacy|0|||
125193825|NCT00267969|450332054|FG001|After Controlled Period|Lack of Efficacy|0|||
125193826|NCT00267969|450332055|FG002|After Controlled Period|Lack of Efficacy|0|||
125193827|NCT00267969|450332056|FG003|After Controlled Period|Lack of Efficacy|10|||
125193828|NCT00267969|450332057|FG004|After Controlled Period|Lack of Efficacy|6|||
125193829|NCT00267969|450332058|FG005|After Controlled Period|Lack of Efficacy|28|||
125193830|NCT00267969|450332059|FG006|After Controlled Period|Lack of Efficacy|15|||
125193831|NCT00267969|450332053|FG000|After Controlled Period|Lost to Follow-up|0|||
125193832|NCT00267969|450332054|FG001|After Controlled Period|Lost to Follow-up|0|||
125193833|NCT00267969|450332055|FG002|After Controlled Period|Lost to Follow-up|0|||
125193834|NCT00267969|450332056|FG003|After Controlled Period|Lost to Follow-up|5|||
125193835|NCT00267969|450332057|FG004|After Controlled Period|Lost to Follow-up|8|||
125246457|NCT03834883|450526806|FG001|Second Treatment|Withdrawal by Subject|0|||
125246458|NCT03834883|450526807|FG002|Second Treatment|Withdrawal by Subject|0|||
125246459|NCT03834883|450526808|FG003|Second Treatment|Withdrawal by Subject|0|||
125246460|NCT03834883|450526805|FG000|Second Treatment|COVID-19 pandemic|1|||
125246461|NCT03834883|450526806|FG001|Second Treatment|COVID-19 pandemic|0|||
125246462|NCT03834883|450526807|FG002|Second Treatment|COVID-19 pandemic|1|||
125246463|NCT03834883|450526808|FG003|Second Treatment|COVID-19 pandemic|1|||
125246464|NCT02487199|450526811|FG000|Overall Study|Withdrew Consent|0|||
125246465|NCT02487199|450526812|FG001|Overall Study|Withdrew Consent|1|||
125246466|NCT00853047|450526813|FG000|Core Phase|Participant Request|0|||
125246467|NCT00853047|450526814|FG001|Core Phase|Participant Request|0|||
125246468|NCT00853047|450526815|FG002|Core Phase|Participant Request|0|||
125246469|NCT00853047|450526816|FG003|Core Phase|Participant Request|1|||
125246470|NCT00853047|450526817|FG004|Core Phase|Participant Request|0|||
125246471|NCT00853047|450526818|FG005|Core Phase|Participant Request|0|||
125246472|NCT00853047|450526813|FG000|Open-Label Extension Phase|Participant Request|0|||
125246473|NCT00853047|450526814|FG001|Open-Label Extension Phase|Participant Request|0|||
125246474|NCT00853047|450526815|FG002|Open-Label Extension Phase|Participant Request|0|||
125246475|NCT00853047|450526816|FG003|Open-Label Extension Phase|Participant Request|0|||
125246476|NCT00853047|450526817|FG004|Open-Label Extension Phase|Participant Request|0|||
125246477|NCT00853047|450526818|FG005|Open-Label Extension Phase|Participant Request|7|||
125246478|NCT00853047|450526813|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
125246479|NCT00853047|450526814|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
125246480|NCT00853047|450526815|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
125246481|NCT00853047|450526816|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
125246482|NCT00853047|450526817|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
125246483|NCT00853047|450526818|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
125246484|NCT00853047|450526813|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
125246485|NCT00853047|450526814|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
125246486|NCT00853047|450526815|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
125246487|NCT00853047|450526816|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
125246488|NCT00853047|450526817|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
125246489|NCT00853047|450526818|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
125246490|NCT00853047|450526813|FG000|Open-Label Extension Phase|Investigator Decision|0|||
125246491|NCT00853047|450526814|FG001|Open-Label Extension Phase|Investigator Decision|0|||
125246492|NCT00853047|450526815|FG002|Open-Label Extension Phase|Investigator Decision|0|||
125246493|NCT00853047|450526816|FG003|Open-Label Extension Phase|Investigator Decision|0|||
125246494|NCT00853047|450526817|FG004|Open-Label Extension Phase|Investigator Decision|0|||
125246495|NCT00853047|450526818|FG005|Open-Label Extension Phase|Investigator Decision|1|||
125246496|NCT00853047|450526813|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
125246497|NCT00853047|450526814|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
125246498|NCT00853047|450526815|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
125246499|NCT00853047|450526816|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
125246500|NCT00853047|450526817|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
125246501|NCT00853047|450526818|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
125246502|NCT00160615|450528433|FG000|Overall Study|Adverse Event|5|||
125246503|NCT00160615|450528434|FG001|Overall Study|Adverse Event|12|||
125246504|NCT00160615|450528433|FG000|Overall Study|Withdrawal by Subject|0|||
125246505|NCT00160615|450528434|FG001|Overall Study|Withdrawal by Subject|2|||
125193836|NCT00267969|450332058|FG005|After Controlled Period|Lost to Follow-up|9|||
125193837|NCT00267969|450332059|FG006|After Controlled Period|Lost to Follow-up|10|||
125193838|NCT00267969|450332053|FG000|After Controlled Period|Other|0|||
125193839|NCT00267969|450332054|FG001|After Controlled Period|Other|0|||
125193840|NCT00267969|450332055|FG002|After Controlled Period|Other|0|||
125193841|NCT00267969|450332056|FG003|After Controlled Period|Other|13|||
125193842|NCT00267969|450332057|FG004|After Controlled Period|Other|11|||
125193843|NCT00267969|450332058|FG005|After Controlled Period|Other|22|||
125193844|NCT00267969|450332059|FG006|After Controlled Period|Other|25|||
125193845|NCT02308540|450332064|FG000|Overall Study|Lost to Follow-up|0|||
125193846|NCT02308540|450332065|FG001|Overall Study|Lost to Follow-up|0|||
125193847|NCT02308540|450332066|FG002|Overall Study|Lost to Follow-up|0|||
125193848|NCT02308540|450332067|FG003|Overall Study|Lost to Follow-up|0|||
125193849|NCT02308540|450332068|FG004|Overall Study|Lost to Follow-up|0|||
125193850|NCT02308540|450332069|FG005|Overall Study|Lost to Follow-up|1|||
125193851|NCT02285166|450332070|FG000|Overall Study|Case Report Forms Uncollected|564|||
125193852|NCT02285166|450332070|FG000|Overall Study|Protocol Deviation|402|||
125193853|NCT00384839|450332073|FG000|Overall Study|Adverse Event|4|||
125193854|NCT00384839|450332073|FG000|Overall Study|Investigator Request|1|||
125246506|NCT00160615|450528433|FG000|Overall Study|Lack of Efficacy|11|||
125246507|NCT00160615|450528434|FG001|Overall Study|Lack of Efficacy|23|||
125246508|NCT00160615|450528433|FG000|Overall Study|Patient decision|1|||
125246509|NCT00160615|450528434|FG001|Overall Study|Patient decision|2|||
125246510|NCT00160615|450528433|FG000|Overall Study|Investigator decision|1|||
125246511|NCT00160615|450528434|FG001|Overall Study|Investigator decision|1|||
125246512|NCT00160615|450528433|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
125246513|NCT00160615|450528434|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
125246514|NCT00160615|450528433|FG000|Overall Study|Switch to surgical treatment|0|||
125246515|NCT00160615|450528434|FG001|Overall Study|Switch to surgical treatment|2|||
125246516|NCT00160615|450528433|FG000|Overall Study|Non-compliance was suspected|0|||
125246517|NCT00160615|450528434|FG001|Overall Study|Non-compliance was suspected|1|||
125246518|NCT00160615|450528433|FG000|Overall Study|Poor compliance|0|||
125246519|NCT00160615|450528434|FG001|Overall Study|Poor compliance|1|||
125246520|NCT03166631|450528435|FG000|Overall Study|Progressive disease|2|||
125246521|NCT03166631|450528436|FG001|Overall Study|Progressive disease|1|||
125246522|NCT03166631|450528437|FG002|Overall Study|Progressive disease|3|||
125246523|NCT03166631|450528438|FG003|Overall Study|Progressive disease|4|||
125246524|NCT03166631|450528439|FG004|Overall Study|Progressive disease|2|||
125246525|NCT03166631|450528440|FG005|Overall Study|Progressive disease|2|||
125246526|NCT03166631|450528441|FG006|Overall Study|Progressive disease|5|||
125246527|NCT03166631|450528442|FG007|Overall Study|Progressive disease|6|||
125246528|NCT03166631|450528443|FG008|Overall Study|Progressive disease|11|||
125246529|NCT03166631|450528444|FG009|Overall Study|Progressive disease|5|||
125246530|NCT03166631|450528445|FG010|Overall Study|Progressive disease|7|||
125246531|NCT03166631|450528435|FG000|Overall Study|Physician Decision|0|||
125246532|NCT03166631|450528436|FG001|Overall Study|Physician Decision|0|||
125246533|NCT03166631|450528437|FG002|Overall Study|Physician Decision|0|||
125246534|NCT03166631|450528438|FG003|Overall Study|Physician Decision|0|||
125246535|NCT03166631|450528439|FG004|Overall Study|Physician Decision|0|||
125246536|NCT03166631|450528440|FG005|Overall Study|Physician Decision|0|||
125246537|NCT03166631|450528441|FG006|Overall Study|Physician Decision|1|||
125246538|NCT03166631|450528442|FG007|Overall Study|Physician Decision|0|||
125246539|NCT03166631|450528443|FG008|Overall Study|Physician Decision|1|||
125246540|NCT03166631|450528444|FG009|Overall Study|Physician Decision|0|||
125246541|NCT03166631|450528445|FG010|Overall Study|Physician Decision|1|||
125246542|NCT03166631|450528435|FG000|Overall Study|Death|0|||
125246543|NCT03166631|450528436|FG001|Overall Study|Death|0|||
125246544|NCT03166631|450528437|FG002|Overall Study|Death|0|||
125246545|NCT03166631|450528438|FG003|Overall Study|Death|0|||
125246546|NCT03166631|450528439|FG004|Overall Study|Death|1|||
125246547|NCT03166631|450528440|FG005|Overall Study|Death|0|||
125246548|NCT03166631|450528441|FG006|Overall Study|Death|1|||
125246549|NCT03166631|450528442|FG007|Overall Study|Death|0|||
125246550|NCT03166631|450528443|FG008|Overall Study|Death|0|||
125246551|NCT03166631|450528444|FG009|Overall Study|Death|0|||
125246552|NCT03166631|450528445|FG010|Overall Study|Death|0|||
125246553|NCT03166631|450528435|FG000|Overall Study|Adverse Event|1|||
125246554|NCT03166631|450528436|FG001|Overall Study|Adverse Event|0|||
125246555|NCT03166631|450528437|FG002|Overall Study|Adverse Event|0|||
125246556|NCT03166631|450528438|FG003|Overall Study|Adverse Event|0|||
125246557|NCT03166631|450528439|FG004|Overall Study|Adverse Event|0|||
125246558|NCT03166631|450528440|FG005|Overall Study|Adverse Event|1|||
125246559|NCT03166631|450528441|FG006|Overall Study|Adverse Event|1|||
125246560|NCT03166631|450528442|FG007|Overall Study|Adverse Event|0|||
125246561|NCT03166631|450528443|FG008|Overall Study|Adverse Event|1|||
125246562|NCT03166631|450528444|FG009|Overall Study|Adverse Event|2|||
125246563|NCT03166631|450528445|FG010|Overall Study|Adverse Event|1|||
125246564|NCT03166631|450528435|FG000|Overall Study|Withdrawal by Subject|0|||
125246565|NCT03166631|450528436|FG001|Overall Study|Withdrawal by Subject|0|||
125246566|NCT03166631|450528437|FG002|Overall Study|Withdrawal by Subject|0|||
125246567|NCT03166631|450528438|FG003|Overall Study|Withdrawal by Subject|0|||
125246568|NCT03166631|450528439|FG004|Overall Study|Withdrawal by Subject|0|||
125246569|NCT03166631|450528440|FG005|Overall Study|Withdrawal by Subject|0|||
125246570|NCT03166631|450528441|FG006|Overall Study|Withdrawal by Subject|0|||
125193855|NCT00384839|450332073|FG000|Overall Study|Patient Request|1|||
125193856|NCT00384839|450332073|FG000|Overall Study|Ineligible|2|||
125193857|NCT00443079|450332074|FG000|Overall Study|Lost to Follow-up|0|||
125193858|NCT00443079|450332075|FG001|Overall Study|Lost to Follow-up|1|||
125193859|NCT02649439|450332076|FG000|Overall Study|Switched to alternative treatment|6|||
125193860|NCT02649439|450332077|FG001|Overall Study|Switched to alternative treatment|4|||
125193861|NCT02649439|450332076|FG000|Overall Study|Patient decision|1|||
125193862|NCT02649439|450332077|FG001|Overall Study|Patient decision|0|||
125193863|NCT02649439|450332076|FG000|Overall Study|Patient going out of country|1|||
125193864|NCT02649439|450332077|FG001|Overall Study|Patient going out of country|0|||
125193865|NCT02649439|450332076|FG000|Overall Study|To start finasteride|1|||
125193866|NCT02649439|450332077|FG001|Overall Study|To start finasteride|0|||
125193867|NCT02649439|450332076|FG000|Overall Study|Physician Decision|1|||
125193868|NCT02649439|450332077|FG001|Overall Study|Physician Decision|0|||
125193869|NCT02649439|450332076|FG000|Overall Study|Disease progression on study|12|||
125193870|NCT02649439|450332077|FG001|Overall Study|Disease progression on study|13|||
125193871|NCT02649439|450332076|FG000|Overall Study|Refused further treatment|1|||
125193872|NCT02649439|450332077|FG001|Overall Study|Refused further treatment|0|||
125193873|NCT02649439|450332076|FG000|Overall Study|Refused further follow up|2|||
125193874|NCT02649439|450332077|FG001|Overall Study|Refused further follow up|7|||
125193875|NCT02649439|450332076|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
125193876|NCT02649439|450332077|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
125193877|NCT02649439|450332076|FG000|Overall Study|No treatment, per protocol|1|||
125193878|NCT02649439|450332077|FG001|Overall Study|No treatment, per protocol|0|||
125193879|NCT02649439|450332076|FG000|Overall Study|PSA DT makes ineligible|0|||
125193880|NCT02649439|450332077|FG001|Overall Study|PSA DT makes ineligible|1|||
125193881|NCT02649439|450332076|FG000|Overall Study|Rising PSA No Mets|0|||
125193882|NCT02649439|450332077|FG001|Overall Study|Rising PSA No Mets|1|||
125193883|NCT02649439|450332076|FG000|Overall Study|Rising PSA|0|||
125193884|NCT02649439|450332077|FG001|Overall Study|Rising PSA|1|||
125193885|NCT02649439|450332076|FG000|Overall Study|Signed follow up protocol|0|||
125193886|NCT02649439|450332077|FG001|Overall Study|Signed follow up protocol|1|||
125193887|NCT02714595|450332079|FG000|Overall Study|Lost to Follow-up|1|||
125193888|NCT02714595|450332080|FG001|Overall Study|Lost to Follow-up|0|||
125193889|NCT02714595|450332079|FG000|Overall Study|Withdrawal by Subject|1|||
125193890|NCT02714595|450332080|FG001|Overall Study|Withdrawal by Subject|2|||
125193891|NCT02714595|450332079|FG000|Overall Study|Lack of Efficacy|0|||
125193892|NCT02714595|450332080|FG001|Overall Study|Lack of Efficacy|1|||
125193893|NCT02714595|450332079|FG000|Overall Study|Death|30|||
125193894|NCT02714595|450332080|FG001|Overall Study|Death|9|||
125193895|NCT02714595|450332079|FG000|Overall Study|Other-Miscellaneous|0|||
125193896|NCT02714595|450332080|FG001|Overall Study|Other-Miscellaneous|1|||
125193897|NCT00713258|450332081|FG000|Overall Study|Adverse Event|2|||
125193898|NCT00713258|450332082|FG001|Overall Study|Adverse Event|4|||
125193899|NCT00713258|450332081|FG000|Overall Study|Non-Compliance|2|||
125193900|NCT00713258|450332082|FG001|Overall Study|Non-Compliance|1|||
125193901|NCT00713258|450332081|FG000|Overall Study|Other|1|||
125193902|NCT00713258|450332082|FG001|Overall Study|Other|1|||
125193903|NCT01053663|450332083|FG000|Overall Study|Death|2|||
125193904|NCT01053663|450332083|FG000|Overall Study|Lost to Follow-up|1|||
125193905|NCT01053663|450332083|FG000|Overall Study|Poor IV Access|1|||
125193906|NCT01053663|450332083|FG000|Overall Study|Transferred to Another Hospital|1|||
125193907|NCT01053663|450332083|FG000|Overall Study|Negative Influenza Diagnosis|1|||
125193908|NCT03533114|450332084|FG000|Overall|Adverse Event|16|||
125193909|NCT03533114|450332085|FG001|Overall|Adverse Event|11|||
125193910|NCT03533114|450332084|FG000|Overall|Consent Withdrawal by Participant|7|||
125193911|NCT03533114|450332085|FG001|Overall|Consent Withdrawal by Participant|6|||
125193912|NCT03533114|450332084|FG000|Overall|Lack of Efficacy|5|||
125193913|NCT03533114|450332085|FG001|Overall|Lack of Efficacy|3|||
125193914|NCT03533114|450332084|FG000|Overall|Lost to Follow-up|1|||
125193915|NCT03533114|450332085|FG001|Overall|Lost to Follow-up|1|||
125193916|NCT03533114|450332084|FG000|Overall|Physician Decision|0|||
125193917|NCT03533114|450332085|FG001|Overall|Physician Decision|2|||
125193918|NCT03533114|450332084|FG000|Overall|Protocol deviation|1|||
125193919|NCT03533114|450332085|FG001|Overall|Protocol deviation|1|||
125193920|NCT03533114|450332084|FG000|Overall|Failure to meet randomization criteria|1|||
125193921|NCT03533114|450332085|FG001|Overall|Failure to meet randomization criteria|2|||
125193922|NCT03533114|450332084|FG000|Overall|Non-Compliance with study drug|0|||
125193923|NCT03533114|450332085|FG001|Overall|Non-Compliance with study drug|1|||
125193924|NCT03533114|450332084|FG000|Overall|Other|0|||
125193925|NCT03533114|450332085|FG001|Overall|Other|1|||
125193926|NCT03533114|450332084|FG000|Open Label Titration and Optimization|Adverse Event|11|||
125193927|NCT03533114|450332085|FG001|Open Label Titration and Optimization|Adverse Event|8|||
125193928|NCT03533114|450332084|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
125193929|NCT03533114|450332085|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
125193930|NCT03533114|450332084|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
125193931|NCT03533114|450332085|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
125193932|NCT03533114|450332084|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
125193933|NCT03533114|450332085|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
125193934|NCT03533114|450332084|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
125193935|NCT03533114|450332085|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
125193936|NCT03533114|450332084|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
125193937|NCT03533114|450332085|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
125193938|NCT03533114|450332084|FG000|Stable Dose|Adverse Event|0|||
125193939|NCT03533114|450332085|FG001|Stable Dose|Adverse Event|2|||
125193940|NCT03533114|450332084|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
125193941|NCT03533114|450332085|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
125193942|NCT03533114|450332084|FG000|Stable Dose|Lack of Efficacy|1|||
125193943|NCT03533114|450332085|FG001|Stable Dose|Lack of Efficacy|0|||
125193944|NCT03533114|450332084|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
125193945|NCT03533114|450332085|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
125193946|NCT03533114|450332084|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
125193947|NCT03533114|450332085|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
125193948|NCT03533114|450332084|FG000|Open-Label Safety Extension|Adverse Event|3|||
125193949|NCT03533114|450332085|FG001|Open-Label Safety Extension|Adverse Event|0|||
125246571|NCT03166631|450528442|FG007|Overall Study|Withdrawal by Subject|0|||
125246572|NCT03166631|450528443|FG008|Overall Study|Withdrawal by Subject|1|||
125246573|NCT03166631|450528444|FG009|Overall Study|Withdrawal by Subject|1|||
125246574|NCT03166631|450528445|FG010|Overall Study|Withdrawal by Subject|0|||
125246575|NCT00567580|450528448|FG000|Overall Study|Protocol Violation|28|||
125246576|NCT00567580|450528449|FG001|Overall Study|Protocol Violation|24|||
125246577|NCT00567580|450528450|FG002|Overall Study|Protocol Violation|24|||
125246578|NCT03197935|450528453|FG000|Overall Study|Death due to any cause|26|||
125246579|NCT03197935|450528454|FG001|Overall Study|Death due to any cause|15|||
125246580|NCT03197935|450528453|FG000|Overall Study|Lost to Follow-up|3|||
125246581|NCT03197935|450528454|FG001|Overall Study|Lost to Follow-up|5|||
125246582|NCT03197935|450528453|FG000|Overall Study|Physician Decision|2|||
125246583|NCT03197935|450528454|FG001|Overall Study|Physician Decision|1|||
125246584|NCT03197935|450528453|FG000|Overall Study|Withdrawal by Subject|16|||
125246585|NCT03197935|450528454|FG001|Overall Study|Withdrawal by Subject|8|||
125246586|NCT00762788|450528455|FG000|Overall Study|Lost to Follow-up|26|||
125246587|NCT00762788|450528456|FG001|Overall Study|Lost to Follow-up|37|||
125246588|NCT00762788|450528457|FG002|Overall Study|Lost to Follow-up|21|||
125246589|NCT00762788|450528458|FG003|Overall Study|Lost to Follow-up|26|||
125246590|NCT00762788|450528459|FG004|Overall Study|Lost to Follow-up|13|||
125246591|NCT00762788|450528460|FG005|Overall Study|Lost to Follow-up|21|||
125246592|NCT03073109|450528461|FG000|Overall Study|Adverse Event|0|||
125246593|NCT03073109|450528462|FG001|Overall Study|Adverse Event|1|||
125246594|NCT03073109|450528461|FG000|Overall Study|Other|2|||
125246595|NCT03073109|450528462|FG001|Overall Study|Other|0|||
125246596|NCT03073109|450528461|FG000|Overall Study|Lost to Follow-up|8|||
125246597|NCT03073109|450528462|FG001|Overall Study|Lost to Follow-up|1|||
125246598|NCT05938010|450528463|FG000|Overall Study|Lost to Follow-up|2|||
125246599|NCT01562444|450528467|FG000|Overall Study|Did not meet entry criteria|2|||
125246600|NCT01562444|450528468|FG001|Overall Study|Did not meet entry criteria|0|||
125246601|NCT01562444|450528469|FG002|Overall Study|Did not meet entry criteria|3|||
125246602|NCT01562444|450528467|FG000|Overall Study|Did not comply with blood draw schedule|1|||
125246603|NCT01562444|450528468|FG001|Overall Study|Did not comply with blood draw schedule|0|||
125246604|NCT01562444|450528469|FG002|Overall Study|Did not comply with blood draw schedule|1|||
125193950|NCT03533114|450332084|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
125193951|NCT03533114|450332085|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
125246605|NCT01562444|450528467|FG000|Overall Study|Unavailable serological results|0|||
125246606|NCT01562444|450528468|FG001|Overall Study|Unavailable serological results|2|||
125246607|NCT01562444|450528469|FG002|Overall Study|Unavailable serological results|2|||
125246608|NCT01562444|450528467|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
125246609|NCT01562444|450528468|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
125193952|NCT03533114|450332084|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
125193953|NCT03533114|450332085|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
125193954|NCT03533114|450332084|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
125193955|NCT03533114|450332085|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
125193956|NCT03533114|450332084|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
125193957|NCT03533114|450332085|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
125193958|NCT01862250|450332086|FG000|Overall Study|Adverse Event|4|||
125193959|NCT01028014|450332090|FG000|Overall Study|Lost to Follow-up|1|||
125193960|NCT01028014|450332091|FG001|Overall Study|Lost to Follow-up|2|||
125193961|NCT01028014|450332092|FG002|Overall Study|Lost to Follow-up|0|||
125193962|NCT01028014|450332093|FG003|Overall Study|Lost to Follow-up|1|||
125193963|NCT01028014|450332094|FG004|Overall Study|Lost to Follow-up|1|||
125193964|NCT01028014|450332095|FG005|Overall Study|Lost to Follow-up|2|||
125193965|NCT02423343|450332096|FG000|Overall Study|Withdrawal by Subject|0|||
125193966|NCT02423343|450332097|FG001|Overall Study|Withdrawal by Subject|1|||
125193967|NCT02423343|450332098|FG002|Overall Study|Withdrawal by Subject|0|||
125193968|NCT02423343|450332099|FG003|Overall Study|Withdrawal by Subject|0|||
125193969|NCT02423343|450332100|FG004|Overall Study|Withdrawal by Subject|0|||
125193970|NCT02423343|450332101|FG005|Overall Study|Withdrawal by Subject|0|||
125193971|NCT02423343|450332096|FG000|Overall Study|Progressive Disease|0|||
125193972|NCT02423343|450332097|FG001|Overall Study|Progressive Disease|0|||
125193973|NCT02423343|450332098|FG002|Overall Study|Progressive Disease|0|||
125193974|NCT02423343|450332099|FG003|Overall Study|Progressive Disease|0|||
125193975|NCT02423343|450332100|FG004|Overall Study|Progressive Disease|2|||
125193976|NCT02423343|450332101|FG005|Overall Study|Progressive Disease|0|||
125193977|NCT02423343|450332096|FG000|Overall Study|Adverse Event|0|||
125193978|NCT02423343|450332097|FG001|Overall Study|Adverse Event|0|||
125193979|NCT02423343|450332098|FG002|Overall Study|Adverse Event|0|||
125193980|NCT02423343|450332099|FG003|Overall Study|Adverse Event|0|||
125193981|NCT02423343|450332100|FG004|Overall Study|Adverse Event|2|||
125193982|NCT02423343|450332101|FG005|Overall Study|Adverse Event|0|||
125193983|NCT02423343|450332096|FG000|Overall Study|Death|0|||
125193984|NCT02423343|450332097|FG001|Overall Study|Death|0|||
125193985|NCT02423343|450332098|FG002|Overall Study|Death|0|||
125193986|NCT02423343|450332099|FG003|Overall Study|Death|0|||
125193987|NCT02423343|450332100|FG004|Overall Study|Death|1|||
125193988|NCT02423343|450332101|FG005|Overall Study|Death|0|||
125193989|NCT02016105|450332102|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
125193990|NCT02016105|450332103|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
125193991|NCT02016105|450332104|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
125193992|NCT02016105|450332105|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
125193993|NCT02016105|450332106|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
125193994|NCT02016105|450332107|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
125193995|NCT02016105|450332102|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
125193996|NCT02016105|450332103|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
125193997|NCT02016105|450332104|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
125193998|NCT02016105|450332105|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
125193999|NCT02016105|450332106|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
125194000|NCT02016105|450332107|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
125194001|NCT02016105|450332102|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
125194002|NCT02016105|450332103|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
125194003|NCT02016105|450332104|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
125194004|NCT02016105|450332105|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
125194005|NCT02016105|450332106|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
125194006|NCT02016105|450332107|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
125194007|NCT02016105|450332102|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
125194008|NCT02016105|450332103|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
125246610|NCT01562444|450528469|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
125246611|NCT01562444|450528467|FG000|Overall Study|Protocol forbidden medication|1|||
125246612|NCT01562444|450528468|FG001|Overall Study|Protocol forbidden medication|0|||
125246613|NCT01562444|450528469|FG002|Overall Study|Protocol forbidden medication|0|||
125246614|NCT02568423|450528480|FG000|Overall Study|Lost to Follow-up|0|||
125246615|NCT02568423|450528481|FG001|Overall Study|Lost to Follow-up|2|||
125246616|NCT02568423|450528482|FG002|Overall Study|Lost to Follow-up|0|||
125246617|NCT02568423|450528483|FG003|Overall Study|Lost to Follow-up|0|||
125246618|NCT02568423|450528484|FG004|Overall Study|Lost to Follow-up|0|||
125246619|NCT02568423|450528485|FG005|Overall Study|Lost to Follow-up|0|||
125246620|NCT02568423|450528486|FG006|Overall Study|Lost to Follow-up|0|||
125246621|NCT02568423|450528487|FG007|Overall Study|Lost to Follow-up|0|||
125246622|NCT02568423|450528480|FG000|Overall Study|Physician Decision|0|||
125246623|NCT02568423|450528481|FG001|Overall Study|Physician Decision|0|||
125246624|NCT02568423|450528482|FG002|Overall Study|Physician Decision|0|||
125246625|NCT02568423|450528483|FG003|Overall Study|Physician Decision|0|||
125246626|NCT02568423|450528484|FG004|Overall Study|Physician Decision|0|||
125246627|NCT02568423|450528485|FG005|Overall Study|Physician Decision|1|||
125246628|NCT02568423|450528486|FG006|Overall Study|Physician Decision|0|||
125246629|NCT02568423|450528487|FG007|Overall Study|Physician Decision|0|||
125246630|NCT01027416|450528489|FG000|Overall Study|Withdrawal by Subject|0|||
125246631|NCT01027416|450528490|FG001|Overall Study|Withdrawal by Subject|1|||
125246632|NCT01027416|450528489|FG000|Overall Study|Physician Decision|1|||
125246633|NCT01027416|450528490|FG001|Overall Study|Physician Decision|4|||
125246634|NCT00676052|450528492|FG000|Overall Study|Adverse Event|0|||
125246635|NCT00676052|450528493|FG001|Overall Study|Adverse Event|1|||
125246636|NCT00676052|450528494|FG002|Overall Study|Adverse Event|1|||
125246637|NCT00676052|450528495|FG003|Overall Study|Adverse Event|2|||
125246638|NCT00676052|450528496|FG004|Overall Study|Adverse Event|2|||
125246639|NCT00676052|450528497|FG005|Overall Study|Adverse Event|2|||
125246640|NCT00676052|450528492|FG000|Overall Study|Lack of Efficacy|2|||
125246641|NCT00676052|450528493|FG001|Overall Study|Lack of Efficacy|2|||
125246642|NCT00676052|450528494|FG002|Overall Study|Lack of Efficacy|1|||
125246643|NCT00676052|450528495|FG003|Overall Study|Lack of Efficacy|1|||
125246644|NCT00676052|450528496|FG004|Overall Study|Lack of Efficacy|2|||
125246645|NCT00676052|450528497|FG005|Overall Study|Lack of Efficacy|1|||
125246646|NCT00676052|450528492|FG000|Overall Study|Protocol Violation|5|||
125246647|NCT00676052|450528493|FG001|Overall Study|Protocol Violation|3|||
125246648|NCT00676052|450528494|FG002|Overall Study|Protocol Violation|2|||
125246649|NCT00676052|450528495|FG003|Overall Study|Protocol Violation|2|||
125246650|NCT00676052|450528496|FG004|Overall Study|Protocol Violation|1|||
125246651|NCT00676052|450528497|FG005|Overall Study|Protocol Violation|2|||
125194009|NCT02016105|450332104|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
125194010|NCT02016105|450332105|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
125194011|NCT02016105|450332106|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
125194012|NCT02016105|450332107|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
125194013|NCT02016105|450332102|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
125194014|NCT02016105|450332103|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
125194015|NCT02016105|450332104|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
125194016|NCT02016105|450332105|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
125194017|NCT02016105|450332106|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
125194018|NCT02016105|450332107|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
125194019|NCT02016105|450332102|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
125194020|NCT02016105|450332103|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
125194021|NCT02016105|450332104|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
125194022|NCT02016105|450332105|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
125194023|NCT02016105|450332106|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
125194024|NCT02016105|450332107|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
125194025|NCT02016105|450332102|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
125194026|NCT02016105|450332103|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
125194027|NCT02016105|450332104|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
125194028|NCT02016105|450332105|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
125194029|NCT02016105|450332106|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
125194030|NCT02016105|450332107|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
125194031|NCT02016105|450332102|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
125194032|NCT02016105|450332103|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
125194033|NCT02016105|450332104|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
125194034|NCT02016105|450332105|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
125194035|NCT02016105|450332106|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
125194036|NCT02016105|450332107|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
125194037|NCT02016105|450332102|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
125194038|NCT02016105|450332103|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
125194039|NCT02016105|450332104|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
125194040|NCT02016105|450332105|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
125194041|NCT02016105|450332106|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
125194042|NCT02016105|450332107|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
125194043|NCT02016105|450332102|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
125194044|NCT02016105|450332103|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
125194045|NCT02016105|450332104|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
125194046|NCT02016105|450332105|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
125194047|NCT02016105|450332106|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
125194048|NCT02016105|450332107|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
125194049|NCT02016105|450332102|FG000|TREATMENT PERIOD 2|Death|0|||
125194050|NCT02016105|450332103|FG001|TREATMENT PERIOD 2|Death|0|||
125194051|NCT02016105|450332104|FG002|TREATMENT PERIOD 2|Death|0|||
125194052|NCT02016105|450332105|FG003|TREATMENT PERIOD 2|Death|0|||
125194053|NCT02016105|450332106|FG004|TREATMENT PERIOD 2|Death|0|||
125194054|NCT02016105|450332107|FG005|TREATMENT PERIOD 2|Death|1|||
125194055|NCT02016105|450332102|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
125194056|NCT02016105|450332103|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
125194057|NCT02016105|450332104|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
125194058|NCT02016105|450332105|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
125194059|NCT02016105|450332106|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
125194060|NCT02016105|450332107|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
125194061|NCT02016105|450332102|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
125194062|NCT02016105|450332103|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
125194063|NCT02016105|450332104|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
125194064|NCT02016105|450332105|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
125194065|NCT02016105|450332106|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
125194066|NCT02016105|450332107|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
125194067|NCT02016105|450332102|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
125194068|NCT02016105|450332103|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
125246652|NCT00676052|450528492|FG000|Overall Study|Lost to Follow-up|0|||
125246653|NCT00676052|450528493|FG001|Overall Study|Lost to Follow-up|0|||
125246654|NCT00676052|450528494|FG002|Overall Study|Lost to Follow-up|0|||
125246655|NCT00676052|450528495|FG003|Overall Study|Lost to Follow-up|0|||
125246656|NCT00676052|450528496|FG004|Overall Study|Lost to Follow-up|1|||
125246657|NCT00676052|450528497|FG005|Overall Study|Lost to Follow-up|0|||
125246658|NCT00676052|450528492|FG000|Overall Study|Physician Decision|1|||
125246659|NCT00676052|450528493|FG001|Overall Study|Physician Decision|1|||
125246660|NCT00676052|450528494|FG002|Overall Study|Physician Decision|1|||
125246661|NCT00676052|450528495|FG003|Overall Study|Physician Decision|0|||
125246662|NCT00676052|450528496|FG004|Overall Study|Physician Decision|0|||
125246663|NCT00676052|450528497|FG005|Overall Study|Physician Decision|1|||
125246664|NCT00676052|450528492|FG000|Overall Study|Withdrawal by Subject|1|||
125246665|NCT00676052|450528493|FG001|Overall Study|Withdrawal by Subject|0|||
125246666|NCT00676052|450528494|FG002|Overall Study|Withdrawal by Subject|1|||
125246667|NCT00676052|450528495|FG003|Overall Study|Withdrawal by Subject|0|||
125246668|NCT00676052|450528496|FG004|Overall Study|Withdrawal by Subject|0|||
125246669|NCT00676052|450528497|FG005|Overall Study|Withdrawal by Subject|0|||
125246670|NCT02930941|450528498|FG000|Overall Study|Lost to Follow-up|1|||
125246671|NCT02930941|450528499|FG001|Overall Study|Lost to Follow-up|2|||
125246672|NCT00289978|450528502|FG000|Overall Study|Withdrawal by Subject|31|||
125246673|NCT00289978|450528503|FG001|Overall Study|Withdrawal by Subject|17|||
125246674|NCT00289978|450528504|FG002|Overall Study|Withdrawal by Subject|28|||
125246675|NCT00289978|450528502|FG000|Overall Study|Adverse Event|22|||
125246676|NCT00289978|450528503|FG001|Overall Study|Adverse Event|13|||
125246677|NCT00289978|450528504|FG002|Overall Study|Adverse Event|18|||
125246678|NCT00289978|450528502|FG000|Overall Study|Lack of Efficacy|13|||
125246679|NCT00289978|450528503|FG001|Overall Study|Lack of Efficacy|6|||
125246680|NCT00289978|450528504|FG002|Overall Study|Lack of Efficacy|25|||
125246681|NCT00289978|450528502|FG000|Overall Study|Abnormal laboratory value(s)|20|||
125246682|NCT00289978|450528503|FG001|Overall Study|Abnormal laboratory value(s)|9|||
125246683|NCT00289978|450528504|FG002|Overall Study|Abnormal laboratory value(s)|1|||
125246684|NCT00289978|450528502|FG000|Overall Study|Lost to Follow-up|3|||
125246685|NCT00289978|450528503|FG001|Overall Study|Lost to Follow-up|5|||
125246686|NCT00289978|450528504|FG002|Overall Study|Lost to Follow-up|7|||
125246687|NCT00289978|450528502|FG000|Overall Study|Protocol Violation|5|||
125246688|NCT00289978|450528503|FG001|Overall Study|Protocol Violation|5|||
125246689|NCT00289978|450528504|FG002|Overall Study|Protocol Violation|4|||
125246690|NCT00289978|450528502|FG000|Overall Study|Abnormal test procedure result(s)|2|||
125246691|NCT00289978|450528503|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125246692|NCT00289978|450528504|FG002|Overall Study|Abnormal test procedure result(s)|1|||
125246693|NCT00289978|450528502|FG000|Overall Study|Death|1|||
125246694|NCT00289978|450528503|FG001|Overall Study|Death|0|||
125246695|NCT00289978|450528504|FG002|Overall Study|Death|2|||
125246696|NCT01967277|450528506|FG000|Overall Study|Lost to Follow-up|1|||
125246697|NCT01967277|450528507|FG001|Overall Study|Lost to Follow-up|2|||
125246698|NCT01967277|450528506|FG000|Overall Study|Unrelated illness|0|||
125246699|NCT01967277|450528507|FG001|Overall Study|Unrelated illness|1|||
125246700|NCT00103506|450528514|FG000|Overall Study|Study closed by sponsor|34|||
125246701|NCT00103506|450528515|FG001|Overall Study|Study closed by sponsor|37|||
125246702|NCT00103506|450528514|FG000|Overall Study|Death|257|||
125246703|NCT00103506|450528515|FG001|Overall Study|Death|253|||
125246704|NCT00103506|450528514|FG000|Overall Study|Lost to Follow-up|13|||
125246705|NCT00103506|450528515|FG001|Overall Study|Lost to Follow-up|13|||
125246706|NCT00103506|450528514|FG000|Overall Study|Withdrawal by Subject|18|||
125246707|NCT00103506|450528515|FG001|Overall Study|Withdrawal by Subject|21|||
125246708|NCT00585585|450528516|FG000|Overall Study|Adverse Event|1|||
125246709|NCT00585169|450528517|FG000|Overall Study|Withdrawal by Subject|1|||
125246710|NCT00710970|450528518|FG000|Overall Study|Never took drug|3|||
125246711|NCT01028560|450528519|FG000|Overall Study|Lack of Efficacy|3|||
125246712|NCT01028560|450528520|FG001|Overall Study|Lack of Efficacy|6|||
125246713|NCT01028560|450528519|FG000|Overall Study|Withdrawal by Subject|7|||
125246714|NCT01028560|450528520|FG001|Overall Study|Withdrawal by Subject|12|||
125246715|NCT03055221|450528521|FG000|Overall Study|Adverse Event|2|||
125246716|NCT03055221|450528521|FG000|Overall Study|Withdrawal by Subject|4|||
125246717|NCT03055221|450528521|FG000|Overall Study|Death|6|||
125246718|NCT03055221|450528521|FG000|Overall Study|Physician Decision|1|||
125246719|NCT03055221|450528521|FG000|Overall Study|Study terminated by Sponsor|3|||
125246720|NCT03055221|450528521|FG000|Overall Study|Lost to Follow-up|4|||
125246721|NCT01243424|450528522|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
125246722|NCT01243424|450528523|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
125246723|NCT01243424|450528522|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
125246724|NCT01243424|450528523|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
125246725|NCT01243424|450528522|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
125246726|NCT01243424|450528523|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
125194069|NCT02016105|450332104|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
125194070|NCT02016105|450332105|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
125194071|NCT02016105|450332106|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
125194072|NCT02016105|450332107|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
125194073|NCT02016105|450332102|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
125194074|NCT02016105|450332103|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
125194075|NCT02016105|450332104|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
125194076|NCT02016105|450332105|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
125194077|NCT02016105|450332106|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
125194078|NCT02016105|450332107|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
125194079|NCT02016105|450332102|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
125194080|NCT02016105|450332103|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
125194081|NCT02016105|450332104|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
125194082|NCT02016105|450332105|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
125194083|NCT02016105|450332106|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
125194084|NCT02016105|450332107|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
125194085|NCT02016105|450332102|FG000|EXTENSION PERIOD|Adverse Event|0|||
125194086|NCT02016105|450332103|FG001|EXTENSION PERIOD|Adverse Event|0|||
125194087|NCT02016105|450332104|FG002|EXTENSION PERIOD|Adverse Event|2|||
125194088|NCT02016105|450332105|FG003|EXTENSION PERIOD|Adverse Event|0|||
125194089|NCT02016105|450332106|FG004|EXTENSION PERIOD|Adverse Event|1|||
125194090|NCT02016105|450332107|FG005|EXTENSION PERIOD|Adverse Event|0|||
125194091|NCT02016105|450332102|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
125194092|NCT02016105|450332103|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
125194093|NCT02016105|450332104|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
125194094|NCT02016105|450332105|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
125194095|NCT02016105|450332106|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
125194096|NCT02016105|450332107|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
125194097|NCT02016105|450332102|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
125194098|NCT02016105|450332103|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
125194099|NCT02016105|450332104|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
125194100|NCT02016105|450332105|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
125194101|NCT02016105|450332106|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
125194102|NCT02016105|450332107|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
125194103|NCT02016105|450332102|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
125194104|NCT02016105|450332103|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
125194105|NCT02016105|450332104|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
125194106|NCT02016105|450332105|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
125194107|NCT02016105|450332106|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
125194108|NCT02016105|450332107|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
125194109|NCT02247440|450332108|FG000|Overall Study|Withdrawal by Subject|1|||
125194110|NCT02247440|450332108|FG000|Overall Study|Lack of Efficacy|3|||
125194111|NCT02751450|450332112|FG000|Overall Study|Adverse Event|1|||
125194112|NCT02751450|450332113|FG001|Overall Study|Adverse Event|0|||
125194113|NCT01290679|450332114|FG000|Overall Study|Adverse Event|2|||
125194114|NCT01290679|450332115|FG001|Overall Study|Adverse Event|0|||
125194115|NCT01290679|450332114|FG000|Overall Study|Lost to Follow-up|8|||
125194116|NCT01290679|450332115|FG001|Overall Study|Lost to Follow-up|10|||
125194117|NCT01290679|450332114|FG000|Overall Study|Protocol Violation|0|||
125194118|NCT01290679|450332115|FG001|Overall Study|Protocol Violation|1|||
125194119|NCT01290679|450332114|FG000|Overall Study|Withdrawal by Subject|6|||
125194120|NCT01290679|450332115|FG001|Overall Study|Withdrawal by Subject|5|||
125246727|NCT01243424|450528522|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
125246728|NCT01243424|450528523|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
125246729|NCT01243424|450528522|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
125246730|NCT01243424|450528523|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
125246731|NCT01243424|450528522|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
125246732|NCT01243424|450528523|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
125246733|NCT01243424|450528522|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
125246734|NCT01243424|450528523|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
125246735|NCT01243424|450528522|FG000|Discontinuation From Treatment|Not treated|5|||
125246736|NCT01243424|450528523|FG001|Discontinuation From Treatment|Not treated|4|||
125246737|NCT01243424|450528522|FG000|Discontinuation From Treatment|Adverse Event|457|||
125246738|NCT01243424|450528523|FG001|Discontinuation From Treatment|Adverse Event|523|||
125246739|NCT01243424|450528522|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
125246740|NCT01243424|450528523|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
125246741|NCT01243424|450528522|FG000|Discontinuation From Treatment|Protocol Violation|46|||
125246742|NCT01243424|450528523|FG001|Discontinuation From Treatment|Protocol Violation|47|||
125246743|NCT01243424|450528522|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
125246744|NCT01243424|450528523|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
125246745|NCT01243424|450528522|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
125246746|NCT01243424|450528523|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
125246747|NCT01243424|450528522|FG000|Discontinuation From Treatment|Other than listed above|230|||
125246748|NCT01243424|450528523|FG001|Discontinuation From Treatment|Other than listed above|211|||
125246749|NCT00397930|450528526|FG000|Overall Study|Personal reasons|14|||
125246750|NCT00397930|450528527|FG001|Overall Study|Personal reasons|8|||
125246751|NCT00397930|450528526|FG000|Overall Study|Other medical|9|||
125246752|NCT00397930|450528527|FG001|Overall Study|Other medical|4|||
125246753|NCT00397930|450528526|FG000|Overall Study|Unknown reasons|9|||
125246754|NCT00397930|450528527|FG001|Overall Study|Unknown reasons|14|||
125246755|NCT00397930|450528526|FG000|Overall Study|Noncompliant|3|||
125246756|NCT00397930|450528527|FG001|Overall Study|Noncompliant|2|||
125246757|NCT00397930|450528526|FG000|Overall Study|Too time-consuming|2|||
125194121|NCT01290679|450332114|FG000|Overall Study|Subject Entered Another Trial|0|||
125194122|NCT01290679|450332115|FG001|Overall Study|Subject Entered Another Trial|5|||
125194123|NCT00562302|450332116|FG000|Overall Study|Lost to Follow-up|3|||
125194124|NCT00562302|450332117|FG001|Overall Study|Lost to Follow-up|3|||
125246758|NCT00397930|450528527|FG001|Overall Study|Too time-consuming|9|||
125246759|NCT00397930|450528526|FG000|Overall Study|Started own yoga program|1|||
125246760|NCT00397930|450528527|FG001|Overall Study|Started own yoga program|1|||
125246761|NCT00397930|450528526|FG000|Overall Study|Did not want to be in control group|0|||
125246762|NCT00397930|450528527|FG001|Overall Study|Did not want to be in control group|1|||
125246763|NCT00397930|450528526|FG000|Overall Study|Withdrawal by Subject|0|||
125194125|NCT00562302|450332116|FG000|Overall Study|Adverse Event|0|||
125194126|NCT00562302|450332117|FG001|Overall Study|Adverse Event|6|||
125194127|NCT00562302|450332116|FG000|Overall Study|Non-compliance|1|||
125194128|NCT00562302|450332117|FG001|Overall Study|Non-compliance|2|||
125194129|NCT00562302|450332116|FG000|Overall Study|Withdrawal by Subject|7|||
125246764|NCT00397930|450528527|FG001|Overall Study|Withdrawal by Subject|8|||
125246765|NCT00397930|450528526|FG000|Overall Study|Missing data|0|||
125246766|NCT00397930|450528527|FG001|Overall Study|Missing data|4|||
125246767|NCT01960842|450528528|FG000|Overall Study|Adverse Event|1|||
125246768|NCT01960842|450528528|FG000|Overall Study|Withdrawal by Subject|2|||
125246769|NCT02391584|450528529|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
125194130|NCT00562302|450332117|FG001|Overall Study|Withdrawal by Subject|8|||
125194131|NCT00562302|450332116|FG000|Overall Study|Death|1|||
125194132|NCT00562302|450332117|FG001|Overall Study|Death|2|||
125194133|NCT00562302|450332116|FG000|Overall Study|Lung resection prior to study completion|7|||
125194134|NCT00562302|450332117|FG001|Overall Study|Lung resection prior to study completion|7|||
125194135|NCT00562302|450332116|FG000|Overall Study|Not stated|1|||
125194136|NCT00562302|450332117|FG001|Overall Study|Not stated|4|||
125194137|NCT03124407|450332123|FG000|Overall Study|Lost to Follow-up|1|||
125194138|NCT03124407|450332124|FG001|Overall Study|Lost to Follow-up|0|||
125194139|NCT03124407|450332125|FG002|Overall Study|Lost to Follow-up|0|||
125194140|NCT03124407|450332126|FG003|Overall Study|Lost to Follow-up|0|||
125194141|NCT03124407|450332123|FG000|Overall Study|Adverse Event|0|||
125194142|NCT03124407|450332124|FG001|Overall Study|Adverse Event|0|||
125194143|NCT03124407|450332125|FG002|Overall Study|Adverse Event|1|||
125194144|NCT03124407|450332126|FG003|Overall Study|Adverse Event|0|||
125194145|NCT01860040|450332129|FG000|Overall Study|Withdrawal by Subject|1|||
125194146|NCT01860040|450332130|FG001|Overall Study|Withdrawal by Subject|0|||
125194147|NCT02821754|450332131|FG000|Overall Study|Procedure not required prior to amendment change|13|||
125194148|NCT02821754|450332132|FG001|Overall Study|Procedure not required prior to amendment change|11|||
125194149|NCT02821754|450332133|FG002|Overall Study|Procedure not required prior to amendment change|0|||
125194150|NCT02821754|450332131|FG000|Overall Study|Participant's Clinical status|2|||
125194151|NCT02821754|450332132|FG001|Overall Study|Participant's Clinical status|0|||
125194152|NCT02821754|450332133|FG002|Overall Study|Participant's Clinical status|0|||
125194153|NCT02821754|450332131|FG000|Overall Study|Participant removed for noncompliance|1|||
125194154|NCT02821754|450332132|FG001|Overall Study|Participant removed for noncompliance|0|||
125194155|NCT02821754|450332133|FG002|Overall Study|Participant removed for noncompliance|0|||
125194156|NCT02821754|450332131|FG000|Overall Study|Drug not available.|0|||
125194157|NCT02821754|450332132|FG001|Overall Study|Drug not available.|0|||
125194158|NCT02821754|450332133|FG002|Overall Study|Drug not available.|1|||
125194159|NCT02821754|450332131|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
125194160|NCT02821754|450332132|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
125194161|NCT02821754|450332133|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
125194162|NCT00994461|450332143|FG000|Overall Study|Adverse Event|2|||
125194163|NCT00994461|450332144|FG001|Overall Study|Adverse Event|1|||
125194164|NCT00994461|450332145|FG002|Overall Study|Adverse Event|0|||
125194165|NCT02347813|450332147|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
125194166|NCT02347813|450332148|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
125194167|NCT02347813|450332147|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
125194168|NCT02347813|450332148|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
125194169|NCT02837731|450332151|FG000|Allocation|Admitted to General Floor|3|||
125194170|NCT02837731|450332152|FG001|Allocation|Admitted to General Floor|4|||
125194171|NCT02837731|450332151|FG000|Allocation|Immediate surgery/withdrew|2|||
125194172|NCT02837731|450332152|FG001|Allocation|Immediate surgery/withdrew|0|||
125194173|NCT02837731|450332151|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
125194174|NCT02837731|450332152|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
125194175|NCT02837731|450332151|FG000|Allocation|Withdrawal by Subject|2|||
125246770|NCT02391584|450528530|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
125246771|NCT02391584|450528529|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
125246772|NCT02391584|450528530|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
125246773|NCT02391584|450528529|FG000|3 Month|Lost to Follow-up|1|||
125246774|NCT02391584|450528530|FG001|3 Month|Lost to Follow-up|0|||
125246775|NCT02391584|450528529|FG000|6 Month|Withdrawal by Subject|1|||
125246776|NCT02391584|450528530|FG001|6 Month|Withdrawal by Subject|0|||
125246777|NCT02391584|450528529|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
125246778|NCT02391584|450528530|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
125246779|NCT00617903|450528544|FG000|Overall Study|Withdrawal by Subject|2|||
125246780|NCT00617903|450528545|FG001|Overall Study|Withdrawal by Subject|3|||
125246781|NCT00617903|450528544|FG000|Overall Study|Lost to Follow-up|1|||
125246782|NCT00617903|450528545|FG001|Overall Study|Lost to Follow-up|1|||
125246783|NCT00617903|450528544|FG000|Overall Study|Lack of Efficacy|0|||
125246784|NCT00617903|450528545|FG001|Overall Study|Lack of Efficacy|1|||
125246785|NCT00617903|450528544|FG000|Overall Study|Adverse Event|0|||
125246786|NCT00617903|450528545|FG001|Overall Study|Adverse Event|1|||
125246787|NCT00617903|450528544|FG000|Overall Study|noncompliance|0|||
125246788|NCT00617903|450528545|FG001|Overall Study|noncompliance|1|||
125194176|NCT02837731|450332152|FG001|Allocation|Withdrawal by Subject|0|||
125194177|NCT02837731|450332151|FG000|Allocation|Device not available|1|||
125194178|NCT02837731|450332152|FG001|Allocation|Device not available|0|||
125194179|NCT02837731|450332151|FG000|Allocation|Protocol not implemented|7|||
125194180|NCT02837731|450332152|FG001|Allocation|Protocol not implemented|0|||
125194181|NCT02837731|450332151|FG000|Allocation|Moribund/Do not resuscitate|2|||
125194182|NCT02837731|450332152|FG001|Allocation|Moribund/Do not resuscitate|0|||
125194183|NCT02837731|450332151|FG000|Allocation|Did not meet sepsis criteria|1|||
125194184|NCT02837731|450332152|FG001|Allocation|Did not meet sepsis criteria|2|||
125194185|NCT02837731|450332151|FG000|Allocation|Known aortic abnormalities|0|||
125246789|NCT05156125|450528546|FG000|Overall Study|Lack of Efficacy|1|||
125194186|NCT02837731|450332152|FG001|Allocation|Known aortic abnormalities|1|||
125194187|NCT01119859|450332153|FG000|Overall Study|Adverse Event|9|||
125194188|NCT01119859|450332154|FG001|Overall Study|Adverse Event|10|||
125194189|NCT01119859|450332153|FG000|Overall Study|Death|2|||
125194190|NCT01119859|450332154|FG001|Overall Study|Death|0|||
125194191|NCT01119859|450332153|FG000|Overall Study|Insufficient therapeutic response|7|||
125194192|NCT01119859|450332154|FG001|Overall Study|Insufficient therapeutic response|14|||
125194193|NCT01119859|450332153|FG000|Overall Study|Refused treatment|3|||
125194194|NCT01119859|450332154|FG001|Overall Study|Refused treatment|6|||
125194195|NCT01119859|450332153|FG000|Overall Study|Failure to return|3|||
125194196|NCT01119859|450332154|FG001|Overall Study|Failure to return|0|||
125194197|NCT00603473|450332155|FG000|Overall Study|Adverse Event|4|||
125194198|NCT00603473|450332155|FG000|Overall Study|Lack of Efficacy|4|||
125194199|NCT00603473|450332155|FG000|Overall Study|Protocol Violation|1|||
125194200|NCT02644668|450332156|FG000|Overall Study|Adverse Event|2|||
125194201|NCT02644668|450332157|FG001|Overall Study|Adverse Event|0|||
125194202|NCT02644668|450332158|FG002|Overall Study|Adverse Event|1|||
125194203|NCT02644668|450332156|FG000|Overall Study|Protocol Violation|0|||
125194204|NCT02644668|450332157|FG001|Overall Study|Protocol Violation|0|||
125194205|NCT02644668|450332158|FG002|Overall Study|Protocol Violation|1|||
125194206|NCT02644668|450332156|FG000|Overall Study|Withdrawal by Subject|0|||
125194207|NCT02644668|450332157|FG001|Overall Study|Withdrawal by Subject|0|||
125194208|NCT02644668|450332158|FG002|Overall Study|Withdrawal by Subject|1|||
125194209|NCT01134939|450332162|FG000|Overall Study|Adverse Event|9|||
125194210|NCT01134939|450332163|FG001|Overall Study|Adverse Event|3|||
125194211|NCT01134939|450332164|FG002|Overall Study|Adverse Event|4|||
125194212|NCT01134939|450332165|FG003|Overall Study|Adverse Event|5|||
125194213|NCT01134939|450332166|FG004|Overall Study|Adverse Event|5|||
125194214|NCT01134939|450332167|FG005|Overall Study|Adverse Event|5|||
125194215|NCT01134939|450332168|FG006|Overall Study|Adverse Event|1|||
125194216|NCT01134939|450332169|FG007|Overall Study|Adverse Event|0|||
125194217|NCT01134939|450332162|FG000|Overall Study|Lack of Efficacy|2|||
125246790|NCT05156125|450528547|FG001|Overall Study|Lack of Efficacy|1|||
125246791|NCT05156125|450528548|FG002|Overall Study|Lack of Efficacy|1|||
125246792|NCT05156125|450528546|FG000|Overall Study|Physician Decision|0|||
125246793|NCT05156125|450528547|FG001|Overall Study|Physician Decision|0|||
125246794|NCT05156125|450528548|FG002|Overall Study|Physician Decision|1|||
125246795|NCT05156125|450528546|FG000|Overall Study|Non-compliance|0|||
125246796|NCT05156125|450528547|FG001|Overall Study|Non-compliance|1|||
125246797|NCT05156125|450528548|FG002|Overall Study|Non-compliance|1|||
125246798|NCT05156125|450528546|FG000|Overall Study|Withdrawal by Subject|0|||
125246799|NCT05156125|450528547|FG001|Overall Study|Withdrawal by Subject|0|||
125246800|NCT05156125|450528548|FG002|Overall Study|Withdrawal by Subject|1|||
125194218|NCT01134939|450332163|FG001|Overall Study|Lack of Efficacy|5|||
125194219|NCT01134939|450332164|FG002|Overall Study|Lack of Efficacy|1|||
125194220|NCT01134939|450332165|FG003|Overall Study|Lack of Efficacy|0|||
125194221|NCT01134939|450332166|FG004|Overall Study|Lack of Efficacy|3|||
125194222|NCT01134939|450332167|FG005|Overall Study|Lack of Efficacy|0|||
125194223|NCT01134939|450332168|FG006|Overall Study|Lack of Efficacy|1|||
125194224|NCT01134939|450332169|FG007|Overall Study|Lack of Efficacy|0|||
125246801|NCT05156125|450528546|FG000|Overall Study|Adverse Event|2|||
125246802|NCT05156125|450528547|FG001|Overall Study|Adverse Event|1|||
125246803|NCT05156125|450528548|FG002|Overall Study|Adverse Event|0|||
125246804|NCT03123588|450528554|FG000|Overall Study|Study Terminated by Sponsor|2|||
125246805|NCT03123588|450528555|FG001|Overall Study|Study Terminated by Sponsor|5|||
125246806|NCT03123588|450528554|FG000|Overall Study|Withdrawal by Subject|1|||
125246807|NCT03123588|450528555|FG001|Overall Study|Withdrawal by Subject|0|||
125246808|NCT03123588|450528554|FG000|Overall Study|Adverse Event|1|||
125246809|NCT03123588|450528555|FG001|Overall Study|Adverse Event|0|||
125246810|NCT03123588|450528554|FG000|Overall Study|Physician Decision|2|||
125246811|NCT03123588|450528555|FG001|Overall Study|Physician Decision|1|||
125246812|NCT01698008|450528558|FG000|Overall Study|Withdrawal by Subject|1|||
125246813|NCT01698008|450528559|FG001|Overall Study|Withdrawal by Subject|2|||
125246814|NCT01755637|450528562|FG000|Period 1|Adverse Event|0|||
125246815|NCT01755637|450528563|FG001|Period 1|Adverse Event|1|||
125246816|NCT01814332|450528565|FG000|Overall Study|Adverse Event|8|||
125246817|NCT01814332|450528566|FG001|Overall Study|Adverse Event|3|||
125246818|NCT01814332|450528565|FG000|Overall Study|Withdrawal by Subject|3|||
125246819|NCT01814332|450528566|FG001|Overall Study|Withdrawal by Subject|8|||
125246820|NCT01814332|450528565|FG000|Overall Study|Protocol Violation|0|||
125194225|NCT01134939|450332162|FG000|Overall Study|Lost to Follow-up|2|||
125194226|NCT01134939|450332163|FG001|Overall Study|Lost to Follow-up|3|||
125194227|NCT01134939|450332164|FG002|Overall Study|Lost to Follow-up|0|||
125246821|NCT01814332|450528566|FG001|Overall Study|Protocol Violation|4|||
125246822|NCT01814332|450528565|FG000|Overall Study|Lost to Follow-up|5|||
125246823|NCT01814332|450528566|FG001|Overall Study|Lost to Follow-up|1|||
125246824|NCT02959892|450528567|FG000|Overall Study|PET tracer synthesis failure|1|||
125246825|NCT02959892|450528568|FG001|Overall Study|PET tracer synthesis failure|0|||
125246826|NCT02959892|450528567|FG000|Overall Study|Study termination|0|||
125194228|NCT01134939|450332165|FG003|Overall Study|Lost to Follow-up|1|||
125194229|NCT01134939|450332166|FG004|Overall Study|Lost to Follow-up|2|||
125194230|NCT01134939|450332167|FG005|Overall Study|Lost to Follow-up|1|||
125194231|NCT01134939|450332168|FG006|Overall Study|Lost to Follow-up|0|||
125194232|NCT01134939|450332169|FG007|Overall Study|Lost to Follow-up|0|||
125194233|NCT01134939|450332162|FG000|Overall Study|Death|0|||
125194234|NCT01134939|450332163|FG001|Overall Study|Death|1|||
125194235|NCT01134939|450332164|FG002|Overall Study|Death|0|||
125194236|NCT01134939|450332165|FG003|Overall Study|Death|0|||
125194237|NCT01134939|450332166|FG004|Overall Study|Death|0|||
125194238|NCT01134939|450332167|FG005|Overall Study|Death|0|||
125194239|NCT01134939|450332168|FG006|Overall Study|Death|0|||
125194240|NCT01134939|450332169|FG007|Overall Study|Death|0|||
125194241|NCT01134939|450332162|FG000|Overall Study|Termination page not available|4|||
125194242|NCT01134939|450332163|FG001|Overall Study|Termination page not available|6|||
125194243|NCT01134939|450332164|FG002|Overall Study|Termination page not available|5|||
125194244|NCT01134939|450332165|FG003|Overall Study|Termination page not available|8|||
125194245|NCT01134939|450332166|FG004|Overall Study|Termination page not available|0|||
125194246|NCT01134939|450332167|FG005|Overall Study|Termination page not available|3|||
125194247|NCT01134939|450332168|FG006|Overall Study|Termination page not available|7|||
125194248|NCT01134939|450332169|FG007|Overall Study|Termination page not available|0|||
125194249|NCT00733421|450332170|FG000|Overall Study|Withdrawal by Subject|1|||
125194250|NCT00733421|450332171|FG001|Overall Study|Withdrawal by Subject|1|||
125194251|NCT03478644|450332175|FG000|Phase 2|Withdrawal by Subject|2|||
125194252|NCT03478644|450332176|FG001|Phase 2|Withdrawal by Subject|1|||
125194253|NCT03478644|450332175|FG000|Phase 2|Lost to Follow-up|1|||
125194254|NCT03478644|450332176|FG001|Phase 2|Lost to Follow-up|0|||
125246827|NCT02959892|450528568|FG001|Overall Study|Study termination|1|||
125246828|NCT02346370|450528571|FG000|Overall Study|Not treated|1|||
125246829|NCT02346370|450528572|FG001|Overall Study|Not treated|0|||
125246830|NCT02346370|450528573|FG002|Overall Study|Not treated|0|||
125246831|NCT02346370|450528571|FG000|Overall Study|Withdrawal of consent|1|||
125246832|NCT02346370|450528572|FG001|Overall Study|Withdrawal of consent|0|||
125194255|NCT00789698|450332177|FG000|Overall Study|Lack of Efficacy|10|||
125194256|NCT00789698|450332178|FG001|Overall Study|Lack of Efficacy|4|||
125194257|NCT00789698|450332179|FG002|Overall Study|Lack of Efficacy|5|||
125194258|NCT00789698|450332180|FG003|Overall Study|Lack of Efficacy|18|||
125246833|NCT02346370|450528573|FG002|Overall Study|Withdrawal of consent|0|||
125194259|NCT00789698|450332177|FG000|Overall Study|Adverse Event|5|||
125194260|NCT00789698|450332178|FG001|Overall Study|Adverse Event|5|||
125194261|NCT00789698|450332179|FG002|Overall Study|Adverse Event|3|||
125194262|NCT00789698|450332180|FG003|Overall Study|Adverse Event|4|||
125194263|NCT00789698|450332177|FG000|Overall Study|Lost to Follow-up|5|||
125194264|NCT00789698|450332178|FG001|Overall Study|Lost to Follow-up|5|||
125194265|NCT00789698|450332179|FG002|Overall Study|Lost to Follow-up|2|||
125194266|NCT00789698|450332180|FG003|Overall Study|Lost to Follow-up|9|||
125194267|NCT00789698|450332177|FG000|Overall Study|Protocol Violation|6|||
125194268|NCT00789698|450332178|FG001|Overall Study|Protocol Violation|1|||
125194269|NCT00789698|450332179|FG002|Overall Study|Protocol Violation|2|||
125194270|NCT00789698|450332180|FG003|Overall Study|Protocol Violation|1|||
125194271|NCT00789698|450332177|FG000|Overall Study|Withdrawal by Subject|14|||
125194272|NCT00789698|450332178|FG001|Overall Study|Withdrawal by Subject|15|||
125194273|NCT00789698|450332179|FG002|Overall Study|Withdrawal by Subject|12|||
125194274|NCT00789698|450332180|FG003|Overall Study|Withdrawal by Subject|19|||
125194275|NCT00789698|450332177|FG000|Overall Study|Administrative|0|||
125194276|NCT00789698|450332178|FG001|Overall Study|Administrative|3|||
125194277|NCT00789698|450332179|FG002|Overall Study|Administrative|3|||
125194278|NCT00789698|450332180|FG003|Overall Study|Administrative|1|||
125194279|NCT00596817|450332181|FG000|Open-label Period|Adverse Event|0|||
125246834|NCT02346370|450528571|FG000|Overall Study|Death|1|||
125246835|NCT02346370|450528572|FG001|Overall Study|Death|3|||
125246836|NCT02346370|450528573|FG002|Overall Study|Death|1|||
125246837|NCT02346370|450528571|FG000|Overall Study|Sponsor discontinued study|5|||
125246838|NCT02346370|450528572|FG001|Overall Study|Sponsor discontinued study|0|||
125246839|NCT02346370|450528573|FG002|Overall Study|Sponsor discontinued study|2|||
125246840|NCT02346370|450528571|FG000|Overall Study|Radiologic progression|0|||
125246841|NCT02346370|450528572|FG001|Overall Study|Radiologic progression|0|||
125246842|NCT02346370|450528573|FG002|Overall Study|Radiologic progression|1|||
125246843|NCT02346370|450528571|FG000|Overall Study|Physician Decision|0|||
125246844|NCT02346370|450528572|FG001|Overall Study|Physician Decision|1|||
125246845|NCT02346370|450528573|FG002|Overall Study|Physician Decision|0|||
125246846|NCT03528577|450528574|FG000|Sequence 1|Failed Spirometry|1|||
125246847|NCT03528577|450528574|FG000|Sequence 1|Restricted medication|1|||
125194280|NCT00596817|450332182|FG001|Open-label Period|Adverse Event|49|||
125194281|NCT00596817|450332181|FG000|Open-label Period|Lack of Efficacy|0|||
125194282|NCT00596817|450332182|FG001|Open-label Period|Lack of Efficacy|33|||
125194283|NCT00596817|450332181|FG000|Open-label Period|Other Reasons|0|||
125246848|NCT03528577|450528574|FG000|Sequence 2|Adverse Event|1|||
125246849|NCT03528577|450528574|FG000|Sequence 2|Withdrawal by Subject|1|||
125246850|NCT03528577|450528574|FG000|Sequence 2|Failed Spirometry|1|||
125194284|NCT00596817|450332182|FG001|Open-label Period|Other Reasons|65|||
125194285|NCT00596817|450332181|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
125194286|NCT00596817|450332182|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
125194287|NCT00596817|450332181|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
125194288|NCT00596817|450332182|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
125194289|NCT00596817|450332181|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
125194290|NCT00596817|450332182|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
125194291|NCT00596817|450332181|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
125194292|NCT00596817|450332182|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
125194293|NCT00596817|450332181|FG000|Double-blind Period|Adverse Event|5|||
125194294|NCT00596817|450332182|FG001|Double-blind Period|Adverse Event|16|||
125194295|NCT00596817|450332181|FG000|Double-blind Period|Lack of Efficacy|52|||
125194296|NCT00596817|450332182|FG001|Double-blind Period|Lack of Efficacy|28|||
125194297|NCT00596817|450332181|FG000|Double-blind Period|Non-compliance With Study Product|3|||
125194298|NCT00596817|450332182|FG001|Double-blind Period|Non-compliance With Study Product|4|||
125194299|NCT00596817|450332181|FG000|Double-blind Period|Protocol Violation|11|||
125194300|NCT00596817|450332182|FG001|Double-blind Period|Protocol Violation|8|||
125194301|NCT00596817|450332181|FG000|Double-blind Period|Withdrawal of Consent|7|||
125246851|NCT03528577|450528574|FG000|Sequence 3|Failed Spirometry|1|||
125246852|NCT03528577|450528574|FG000|Sequence 4|Failed Spirometry|2|||
125246853|NCT03528577|450528574|FG000|Sequence 4|Adverse Event|1|||
125246854|NCT04882215|450528575|FG000|Overall Study|Withdrawal by Subject|5|||
125246855|NCT04882215|450528576|FG001|Overall Study|Withdrawal by Subject|0|||
125246856|NCT04098302|450528577|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
125246857|NCT04098302|450528578|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
125246858|NCT04098302|450528579|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
125246859|NCT04098302|450528580|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
125246860|NCT04098302|450528577|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
125246861|NCT04098302|450528578|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
125246862|NCT04098302|450528579|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
125246863|NCT04098302|450528580|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
125194302|NCT00596817|450332182|FG001|Double-blind Period|Withdrawal of Consent|3|||
125194303|NCT00596817|450332181|FG000|Double-blind Period|Lost to Follow-up|0|||
125194304|NCT00596817|450332182|FG001|Double-blind Period|Lost to Follow-up|2|||
125194305|NCT00596817|450332181|FG000|Double-blind Period|Other Reasons|10|||
125194306|NCT00596817|450332182|FG001|Double-blind Period|Other Reasons|18|||
125194307|NCT04402138|450333395|FG000|Overall Study|Progressive Disease|2|||
125194308|NCT04402138|450333395|FG000|Overall Study|Adverse Event|1|||
125194309|NCT03056638|450333398|FG000|Overall Study|Death|1|||
125194310|NCT03056638|450333399|FG001|Overall Study|Death|0|||
125194311|NCT03508726|450333400|FG000|Overall Study|Withdrawal by Subject|0|||
125194312|NCT03508726|450333401|FG001|Overall Study|Withdrawal by Subject|1|||
125194313|NCT04411810|450333405|FG000|Overall Study|Screen failure|1|||
125194314|NCT04411810|450333405|FG000|Overall Study|Withdrawal by Subject|1|||
125194315|NCT03981926|450333406|FG000|Overall Study|Lost to Follow-up|5|||
125194316|NCT03981926|450333407|FG001|Overall Study|Lost to Follow-up|9|||
125194317|NCT01920958|450333408|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
125194318|NCT00610155|450333409|FG000|Period 1|Withdrawal by Subject|0|||
125194319|NCT00610155|450333410|FG001|Period 1|Withdrawal by Subject|0|||
125194320|NCT00610155|450333411|FG002|Period 1|Withdrawal by Subject|1|||
125194321|NCT00610155|450333412|FG003|Period 1|Withdrawal by Subject|0|||
125194322|NCT00610155|450333413|FG004|Period 1|Withdrawal by Subject|0|||
125194323|NCT00610155|450333414|FG005|Period 1|Withdrawal by Subject|0|||
125194324|NCT00610155|450333409|FG000|Period 3|Adverse Event|1|||
125194325|NCT00610155|450333410|FG001|Period 3|Adverse Event|0|||
125194326|NCT00610155|450333411|FG002|Period 3|Adverse Event|0|||
125194327|NCT00610155|450333412|FG003|Period 3|Adverse Event|0|||
125194328|NCT00610155|450333413|FG004|Period 3|Adverse Event|0|||
125194329|NCT00610155|450333414|FG005|Period 3|Adverse Event|0|||
125194330|NCT01560234|450333415|FG000|Overall Study|Lost to Follow-up|3|||
125194331|NCT01560234|450333416|FG001|Overall Study|Lost to Follow-up|0|||
125194332|NCT01560234|450333417|FG002|Overall Study|Lost to Follow-up|1|||
125194333|NCT01560234|450333418|FG003|Overall Study|Lost to Follow-up|0|||
125194334|NCT01560234|450333419|FG004|Overall Study|Lost to Follow-up|0|||
125194335|NCT01560234|450333420|FG005|Overall Study|Lost to Follow-up|2|||
125194336|NCT01560234|450333421|FG006|Overall Study|Lost to Follow-up|0|||
125194337|NCT01560234|450333422|FG007|Overall Study|Lost to Follow-up|2|||
125194338|NCT01718535|450333423|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
125194339|NCT01718535|450333424|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
125194340|NCT01718535|450333425|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
125194341|NCT01718535|450333426|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
125194342|NCT01718535|450333427|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
125194343|NCT01718535|450333428|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
125194344|NCT01718535|450333429|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
125194345|NCT01718535|450333430|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
125194346|NCT01718535|450333431|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
125194347|NCT01718535|450333432|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
125194348|NCT01073605|450333436|FG000|Overall Study|Ongoing at Cutoff Date|1|||
125194349|NCT01073605|450333437|FG001|Overall Study|Ongoing at Cutoff Date|1|||
125194350|NCT01073605|450333438|FG002|Overall Study|Ongoing at Cutoff Date|0|||
125194351|NCT01073605|450333436|FG000|Overall Study|Adverse Event|2|||
125194352|NCT01073605|450333437|FG001|Overall Study|Adverse Event|1|||
125194353|NCT01073605|450333438|FG002|Overall Study|Adverse Event|0|||
125194354|NCT01073605|450333436|FG000|Overall Study|Lost to Follow-up|3|||
125194355|NCT01073605|450333437|FG001|Overall Study|Lost to Follow-up|4|||
125194356|NCT01073605|450333438|FG002|Overall Study|Lost to Follow-up|9|||
125194357|NCT01073605|450333436|FG000|Overall Study|Other|25|||
125194358|NCT01073605|450333437|FG001|Overall Study|Other|21|||
125194359|NCT01073605|450333438|FG002|Overall Study|Other|29|||
125194360|NCT01073605|450333436|FG000|Overall Study|Withdrawal by Subject|31|||
125194361|NCT01073605|450333437|FG001|Overall Study|Withdrawal by Subject|39|||
125194362|NCT01073605|450333438|FG002|Overall Study|Withdrawal by Subject|22|||
125194363|NCT01073605|450333436|FG000|Overall Study|Randomized But Not Treated|0|||
125194364|NCT01073605|450333437|FG001|Overall Study|Randomized But Not Treated|1|||
125194365|NCT01073605|450333438|FG002|Overall Study|Randomized But Not Treated|1|||
125194366|NCT01284348|450333439|FG000|Overall Study|Death|1|||
125194367|NCT01284348|450333440|FG001|Overall Study|Death|1|||
125194368|NCT01284348|450333439|FG000|Overall Study|Withdrew consent|0|||
125246864|NCT04098302|450528577|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
125194369|NCT01284348|450333440|FG001|Overall Study|Withdrew consent|1|||
125194370|NCT01284348|450333439|FG000|Overall Study|Status not recorded|9|||
125194371|NCT01284348|450333440|FG001|Overall Study|Status not recorded|10|||
125246865|NCT04098302|450528578|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
125194372|NCT02035202|450333444|FG000|Overall Study|Lost to Follow-up|8|||
125194373|NCT02035202|450333445|FG001|Overall Study|Lost to Follow-up|16|||
125194374|NCT02035202|450333446|FG002|Overall Study|Lost to Follow-up|2|||
125194375|NCT00083759|450333447|FG000|Overall Study|Adverse Event|5|||
125246866|NCT04098302|450528579|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
125246867|NCT04098302|450528580|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
125246868|NCT04098302|450528577|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
125246869|NCT04098302|450528578|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
125246870|NCT04098302|450528579|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
125246871|NCT04098302|450528580|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
125246872|NCT04098302|450528577|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
125246873|NCT04098302|450528578|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
125246874|NCT04098302|450528579|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
125246875|NCT04098302|450528580|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
125246876|NCT04098302|450528577|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
125246877|NCT04098302|450528578|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
125246878|NCT04098302|450528579|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
125246879|NCT04098302|450528580|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
125246880|NCT04098302|450528577|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
125246881|NCT04098302|450528578|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
125246882|NCT04098302|450528579|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
125246883|NCT04098302|450528580|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
125246884|NCT04098302|450528577|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
125246885|NCT04098302|450528578|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
125246886|NCT04098302|450528579|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
125246887|NCT04098302|450528580|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
125246888|NCT01290731|450528584|FG000|Overall Study|Withdrawal by Subject|1|||
125246889|NCT01399099|450528585|FG000|Overall Study|Lost to Follow-up|14|||
125246890|NCT01399099|450528585|FG000|Overall Study|Physician Decision|1|||
125246891|NCT01399099|450528585|FG000|Overall Study|Protocol Violation|1|||
125246892|NCT01399099|450528585|FG000|Overall Study|Skin Irritation|13|||
125246893|NCT01399099|450528585|FG000|Overall Study|Infection|1|||
125246894|NCT01399099|450528585|FG000|Overall Study|Miscellaneous|4|||
125246895|NCT01668537|450528586|FG000|Overall Study|Request to Discontinue Prematurely|1|||
125246896|NCT01668537|450528587|FG001|Overall Study|Request to Discontinue Prematurely|1|||
125246897|NCT01668537|450528586|FG000|Overall Study|Subject unwilling/unable to comply|5|||
125246898|NCT01668537|450528587|FG001|Overall Study|Subject unwilling/unable to comply|0|||
125246899|NCT01668537|450528586|FG000|Overall Study|Reason Precludes Participation|1|||
125246900|NCT01668537|450528587|FG001|Overall Study|Reason Precludes Participation|0|||
125246901|NCT01668537|450528586|FG000|Overall Study|Lost to Follow-up|13|||
125246902|NCT01668537|450528587|FG001|Overall Study|Lost to Follow-up|6|||
125246903|NCT01668537|450528586|FG000|Overall Study|Other|2|||
125246904|NCT01668537|450528587|FG001|Overall Study|Other|3|||
125246905|NCT05064800|450528588|FG000|Period 3|Withdrawal by Subject|0|||
125246906|NCT05064800|450528589|FG001|Period 3|Withdrawal by Subject|0|||
125246907|NCT05064800|450528590|FG002|Period 3|Withdrawal by Subject|0|||
125246908|NCT05064800|450528591|FG003|Period 3|Withdrawal by Subject|0|||
125246909|NCT05064800|450528592|FG004|Period 3|Withdrawal by Subject|1|||
125246910|NCT05064800|450528593|FG005|Period 3|Withdrawal by Subject|0|||
125246911|NCT04477486|450528594|FG000|Overall Study|Death|2|||
125246912|NCT04477486|450528594|FG000|Overall Study|Ongoing at Time of Analysis|11|||
125246913|NCT02497755|450528595|FG000|Overall Study|Protocol Violation|1|||
125246914|NCT02497755|450528596|FG001|Overall Study|Protocol Violation|0|||
125246915|NCT02547935|450528605|FG000|Overall Study|Other|0|||
125246916|NCT02547935|450528606|FG001|Overall Study|Other|1|||
125246917|NCT02547935|450528607|FG002|Overall Study|Other|0|||
125246918|NCT02547935|450528605|FG000|Overall Study|Withdrawal by Subject|2|||
125246919|NCT02547935|450528606|FG001|Overall Study|Withdrawal by Subject|3|||
125246920|NCT02547935|450528607|FG002|Overall Study|Withdrawal by Subject|4|||
125246921|NCT02547935|450528605|FG000|Overall Study|Screen Failure|2|||
125246922|NCT02547935|450528606|FG001|Overall Study|Screen Failure|0|||
125246923|NCT02547935|450528607|FG002|Overall Study|Screen Failure|0|||
125246924|NCT02547935|450528605|FG000|Overall Study|Physician Decision|0|||
125246925|NCT02547935|450528606|FG001|Overall Study|Physician Decision|1|||
125246926|NCT02547935|450528607|FG002|Overall Study|Physician Decision|0|||
125246927|NCT02547935|450528605|FG000|Overall Study|Lost to Follow-up|0|||
125246928|NCT02547935|450528606|FG001|Overall Study|Lost to Follow-up|2|||
125246929|NCT02547935|450528607|FG002|Overall Study|Lost to Follow-up|1|||
125246930|NCT02547935|450528605|FG000|Overall Study|Death|1|||
125246931|NCT02547935|450528606|FG001|Overall Study|Death|1|||
125246932|NCT02547935|450528607|FG002|Overall Study|Death|0|||
125246933|NCT03554473|450530896|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
125246934|NCT03554473|450530897|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
125246935|NCT03554473|450530898|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
125246936|NCT03554473|450530896|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
125246937|NCT03554473|450530897|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
125246938|NCT03554473|450530898|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
125246939|NCT03554473|450530896|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
125246940|NCT03554473|450530897|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
125246941|NCT03554473|450530898|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
125246942|NCT04971837|450530902|FG000|Overall Study|Long Term Illness|1|||
125246943|NCT04971837|450530902|FG000|Overall Study|BMI too low|9|||
125246944|NCT04971837|450530902|FG000|Overall Study|geographic location|1|||
125246945|NCT04971837|450530902|FG000|Overall Study|Discontinued scheduling conflict|1|||
125246946|NCT00382070|450530903|FG000|Overall Study|No follow up data mapped to Other|17|||
125246947|NCT00382070|450530904|FG001|Overall Study|No follow up data mapped to Other|19|||
125246948|NCT00382070|450530903|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
125246949|NCT00382070|450530904|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
125246950|NCT00382070|450530903|FG000|Overall Study|No clinical assessment|9|||
125246951|NCT00382070|450530904|FG001|Overall Study|No clinical assessment|11|||
125246952|NCT00284934|450530910|FG000|Overall Study|Adverse Event|1|||
125246953|NCT00284934|450530911|FG001|Overall Study|Adverse Event|2|||
125246954|NCT00284934|450530910|FG000|Overall Study|Other reasons|3|||
125246955|NCT00284934|450530911|FG001|Overall Study|Other reasons|1|||
125246956|NCT01245751|450530912|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
125246957|NCT01245751|450530913|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
125246958|NCT01245751|450530914|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
125246959|NCT01245751|450530915|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
125246960|NCT01245751|450530912|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
125246961|NCT01245751|450530913|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
125246962|NCT01245751|450530914|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
125246963|NCT01245751|450530915|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
125246964|NCT01245751|450530912|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
125246965|NCT01245751|450530913|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
125246966|NCT01245751|450530914|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
125246967|NCT01245751|450530915|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
125246968|NCT05788328|450530916|FG000|Treatment Period 4 (5 Days)|Other|1|||
125246969|NCT05788328|450530916|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
125246970|NCT02082483|450530917|FG000|Overall Study|Lost to Follow-up|1|||
125246971|NCT02082483|450530918|FG001|Overall Study|Lost to Follow-up|1|||
125246972|NCT02082483|450530917|FG000|Overall Study|Withdrawal by Subject|2|||
125246973|NCT02082483|450530918|FG001|Overall Study|Withdrawal by Subject|1|||
125246974|NCT02082483|450530917|FG000|Overall Study|Physician Decision|1|||
125246975|NCT02082483|450530918|FG001|Overall Study|Physician Decision|1|||
125246976|NCT02082483|450530917|FG000|Overall Study|Death|2|||
125246977|NCT02082483|450530918|FG001|Overall Study|Death|3|||
125246978|NCT00145327|450530920|FG000|Overall Study|Withdrawal by Subject|77|||
125246979|NCT00145327|450530921|FG001|Overall Study|Withdrawal by Subject|72|||
125246980|NCT00145327|450530922|FG002|Overall Study|Withdrawal by Subject|164|||
125246981|NCT00145327|450530920|FG000|Overall Study|Death|26|||
125246982|NCT00145327|450530921|FG001|Overall Study|Death|18|||
125246983|NCT00145327|450530922|FG002|Overall Study|Death|30|||
125246984|NCT00145327|450530920|FG000|Overall Study|Adverse Event|14|||
125246985|NCT00145327|450530921|FG001|Overall Study|Adverse Event|11|||
125246986|NCT00145327|450530922|FG002|Overall Study|Adverse Event|22|||
125246987|NCT00145327|450530920|FG000|Overall Study|Lost to Follow-up|9|||
125246988|NCT00145327|450530921|FG001|Overall Study|Lost to Follow-up|14|||
125246989|NCT00145327|450530922|FG002|Overall Study|Lost to Follow-up|14|||
125246990|NCT00145327|450530920|FG000|Overall Study|Administrative problems|12|||
125246991|NCT00145327|450530921|FG001|Overall Study|Administrative problems|9|||
125246992|NCT00145327|450530922|FG002|Overall Study|Administrative problems|13|||
125246993|NCT00145327|450530920|FG000|Overall Study|Protocol Violation|2|||
125246994|NCT00145327|450530921|FG001|Overall Study|Protocol Violation|0|||
125246995|NCT00145327|450530922|FG002|Overall Study|Protocol Violation|2|||
125246996|NCT00145327|450530920|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125246997|NCT00145327|450530921|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125246998|NCT00145327|450530922|FG002|Overall Study|Abnormal laboratory value(s)|2|||
125246999|NCT00145327|450530920|FG000|Overall Study|Missing - not stated|1|||
125247000|NCT00145327|450530921|FG001|Overall Study|Missing - not stated|0|||
125247001|NCT00145327|450530922|FG002|Overall Study|Missing - not stated|1|||
125247002|NCT02802865|450530923|FG000|Overall Study|Pregnancy|1|||
125247003|NCT02802865|450530924|FG001|Overall Study|Pregnancy|1|||
125247004|NCT02802865|450530923|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
125247005|NCT02802865|450530924|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
125247006|NCT00985192|450530926|FG000|Overall Study|Withdrawal by Subject|1|||
125247007|NCT00985192|450530926|FG000|Overall Study|Disease Progression|1|||
125247008|NCT00985192|450530926|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
125247009|NCT01454063|450530927|FG000|Randomized|Adverse Event|1|||
125247010|NCT01454063|450530928|FG001|Randomized|Adverse Event|1|||
125247011|NCT01454063|450530927|FG000|Randomized|Protocol Violation|0|||
125247012|NCT01454063|450530928|FG001|Randomized|Protocol Violation|1|||
125247013|NCT00509600|450530932|FG000|Overall Study|Adverse Event|1|||
125247014|NCT03055195|450530933|FG000|Overall Study|Lack of Efficacy|1|||
125247015|NCT03055195|450530934|FG001|Overall Study|Lack of Efficacy|0|||
125247016|NCT03055195|450530933|FG000|Overall Study|Withdrawal by Subject|6|||
125247017|NCT03055195|450530934|FG001|Overall Study|Withdrawal by Subject|7|||
125247018|NCT03055195|450530933|FG000|Overall Study|Study Terminated by Sponsor|2|||
125247019|NCT03055195|450530934|FG001|Overall Study|Study Terminated by Sponsor|6|||
125247020|NCT03055195|450530933|FG000|Overall Study|Protocol Violation|2|||
125247021|NCT03055195|450530934|FG001|Overall Study|Protocol Violation|1|||
125247022|NCT03055195|450530933|FG000|Overall Study|Physician Decision|1|||
125247023|NCT03055195|450530934|FG001|Overall Study|Physician Decision|0|||
125247024|NCT00720083|450530935|FG000|Overall Study|Ineligible|1|||
125247025|NCT00720083|450530936|FG001|Overall Study|Ineligible|2|||
125247026|NCT01441414|450530944|FG000|Overall Study|Participant died|9|||
125247027|NCT01441414|450530944|FG000|Overall Study|Other reasons|3|||
125247028|NCT01441414|450530944|FG000|Overall Study|Study terminated by sponsor|2|||
125247029|NCT01441414|450530944|FG000|Overall Study|Subject refused further follow-up|1|||
125247030|NCT01773889|450530945|FG000|Overall Study|lack of funding|2|||
125247031|NCT00976391|450530946|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
125247032|NCT00976391|450530947|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
125247033|NCT00976391|450530946|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
125247034|NCT00976391|450530947|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
125247035|NCT00976391|450530946|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
125247036|NCT00976391|450530947|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
125247037|NCT00976391|450530946|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
125247038|NCT00976391|450530947|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
125247039|NCT00976391|450530946|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
125247040|NCT00976391|450530947|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
125247041|NCT00976391|450530946|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
125247042|NCT00976391|450530947|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
125247043|NCT00976391|450530946|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
125247044|NCT00976391|450530947|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
125247045|NCT00976391|450530946|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
125247046|NCT00976391|450530947|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
125247047|NCT00976391|450530946|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
125247048|NCT00976391|450530947|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
125247049|NCT00976391|450530946|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
125247050|NCT00976391|450530947|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
125247051|NCT00976391|450530946|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
125247052|NCT00976391|450530947|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
125247053|NCT00976391|450530946|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
125247054|NCT00976391|450530947|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
125247055|NCT00976391|450530946|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
125247056|NCT00976391|450530947|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
125247057|NCT00976391|450530946|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
125247058|NCT00976391|450530947|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
125247059|NCT02018887|450530948|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
125247060|NCT02018887|450530949|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
125247061|NCT02018887|450530950|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
125247062|NCT02018887|450530951|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
125247063|NCT02018887|450530952|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
125247064|NCT02018887|450530953|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
125247065|NCT02018887|450530954|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
125247066|NCT02018887|450530955|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
125247067|NCT02018887|450530956|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
125247068|NCT02018887|450530957|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
125247069|NCT02018887|450530958|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
125247070|NCT02018887|450530948|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
125247071|NCT02018887|450530949|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
125247072|NCT02018887|450530950|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
125247073|NCT02018887|450530951|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
125247074|NCT02018887|450530952|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
125247075|NCT02018887|450530953|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
125247076|NCT02018887|450530954|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
125247077|NCT02018887|450530955|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
125247078|NCT02018887|450530956|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
125247079|NCT02018887|450530957|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
125247080|NCT02018887|450530958|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
125247081|NCT02018887|450530948|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
125247082|NCT02018887|450530949|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
125247083|NCT02018887|450530950|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
125247084|NCT02018887|450530951|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
125247085|NCT02018887|450530952|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
125247086|NCT02018887|450530953|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
125247087|NCT02018887|450530954|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
125247088|NCT02018887|450530955|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
125247089|NCT02018887|450530956|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
125247090|NCT02018887|450530957|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
125194376|NCT00083759|450333448|FG001|Overall Study|Adverse Event|3|||
125194377|NCT00083759|450333447|FG000|Overall Study|Lost to Follow-up|1|||
125194378|NCT00083759|450333448|FG001|Overall Study|Lost to Follow-up|0|||
125194379|NCT00083759|450333447|FG000|Overall Study|Death|1|||
125194380|NCT00083759|450333448|FG001|Overall Study|Death|1|||
125194381|NCT00083759|450333447|FG000|Overall Study|Inadequate Therapeutic Response|32|||
125194382|NCT00083759|450333448|FG001|Overall Study|Inadequate Therapeutic Response|35|||
125194383|NCT00083759|450333447|FG000|Overall Study|Subject Withdrew Consent|2|||
125194384|NCT00083759|450333448|FG001|Overall Study|Subject Withdrew Consent|2|||
125194385|NCT00083759|450333447|FG000|Overall Study|Non-Compliance|1|||
125247091|NCT02018887|450530958|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
125194386|NCT00083759|450333448|FG001|Overall Study|Non-Compliance|0|||
125194387|NCT00083759|450333447|FG000|Overall Study|Sponsor's Discretion|28|||
125247092|NCT02018887|450530948|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
125247093|NCT02018887|450530949|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
125247094|NCT02018887|450530950|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
125247095|NCT02018887|450530951|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
125194388|NCT00083759|450333448|FG001|Overall Study|Sponsor's Discretion|29|||
125194389|NCT00083759|450333447|FG000|Overall Study|Other|14|||
125194390|NCT00083759|450333448|FG001|Overall Study|Other|13|||
125194391|NCT02875613|450333452|FG000|Overall Study|Withdrawal by Subject|1|||
125194392|NCT02875613|450333452|FG000|Overall Study|Screen Failure|1|||
125194393|NCT03645395|450333462|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
125194394|NCT03645395|450333463|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
125194395|NCT03645395|450333464|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
125194396|NCT03645395|450333465|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
125194397|NCT03645395|450333462|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
125194398|NCT03645395|450333463|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
125194399|NCT03645395|450333464|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
125194400|NCT03645395|450333465|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
125194401|NCT03645395|450333462|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
125194402|NCT03645395|450333463|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
125194403|NCT03645395|450333464|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
125194404|NCT03645395|450333465|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
125194405|NCT03645395|450333462|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
125194406|NCT03645395|450333463|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
125194407|NCT03645395|450333464|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
125194408|NCT03645395|450333465|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
125194409|NCT01057810|450333466|FG000|Overall Study|Disease progression|156|||
125194410|NCT01057810|450333467|FG001|Overall Study|Disease progression|197|||
125194411|NCT01057810|450333466|FG000|Overall Study|Study drug toxicity|5|||
125194412|NCT01057810|450333467|FG001|Overall Study|Study drug toxicity|114|||
125194413|NCT01057810|450333466|FG000|Overall Study|Adverse event unrelated to study drug|13|||
125194414|NCT01057810|450333467|FG001|Overall Study|Adverse event unrelated to study drug|29|||
125194415|NCT01057810|450333466|FG000|Overall Study|Withdrawal by Subject|10|||
125194416|NCT01057810|450333467|FG001|Overall Study|Withdrawal by Subject|25|||
125194417|NCT01057810|450333466|FG000|Overall Study|Death|2|||
125194418|NCT01057810|450333467|FG001|Overall Study|Death|12|||
125194419|NCT01057810|450333466|FG000|Overall Study|Maximum clinical benefit|5|||
125194420|NCT01057810|450333467|FG001|Overall Study|Maximum clinical benefit|5|||
125194421|NCT01057810|450333466|FG000|Overall Study|Poor/non-compliance|0|||
125194422|NCT01057810|450333467|FG001|Overall Study|Poor/non-compliance|1|||
125194423|NCT01057810|450333466|FG000|Overall Study|No longer met study criteria|0|||
125194424|NCT01057810|450333467|FG001|Overall Study|No longer met study criteria|1|||
125194425|NCT01057810|450333466|FG000|Overall Study|Other|7|||
125194426|NCT01057810|450333467|FG001|Overall Study|Other|14|||
125194427|NCT02088905|450333468|FG000|Overall Study|Withdrawal by Subject|5|||
125194428|NCT02088905|450333469|FG001|Overall Study|Withdrawal by Subject|1|||
125194429|NCT04606394|450333471|FG000|Overall Study|Withdrawal by Subject|3|||
125194430|NCT04606394|450333471|FG000|Overall Study|Exclusion criteria screen failure|12|||
125194431|NCT04481789|450333474|FG000|Period 1|Withdrawal by Subject|1|||
125194432|NCT04481789|450333475|FG001|Period 1|Withdrawal by Subject|0|||
125194433|NCT04481789|450333476|FG002|Period 1|Withdrawal by Subject|0|||
125194434|NCT04481789|450333477|FG003|Period 1|Withdrawal by Subject|0|||
125194435|NCT04481789|450333478|FG004|Period 1|Withdrawal by Subject|0|||
125194436|NCT04481789|450333479|FG005|Period 1|Withdrawal by Subject|0|||
125194437|NCT04657198|450333488|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
125194438|NCT04657198|450333489|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
125194439|NCT04657198|450333490|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
125194440|NCT03793842|450333491|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
125194441|NCT03793842|450333492|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
125194442|NCT03793842|450333491|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
125194443|NCT03793842|450333492|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
125194444|NCT00427921|450333498|FG000|Overall Study|Adverse Event|26|||
125194445|NCT00427921|450333498|FG000|Overall Study|Withdrawal by Subject|4|||
125194446|NCT00427921|450333498|FG000|Overall Study|Lost to Follow-up|2|||
125194447|NCT00427921|450333498|FG000|Overall Study|Other reason not specified|10|||
125194448|NCT00427921|450333498|FG000|Overall Study|Adverse Event + Hospitalization|1|||
125194449|NCT00427921|450333498|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
125194450|NCT00427921|450333498|FG000|Overall Study|Adverse Event + No Response|1|||
125194451|NCT00427921|450333498|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
125194452|NCT00427921|450333498|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
125194453|NCT00427921|450333498|FG000|Overall Study|Adverse Event + Lost Response|1|||
125194454|NCT00427921|450333498|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
125194455|NCT00427921|450333498|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
125194456|NCT00900159|450333499|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
125194457|NCT00900159|450333500|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
125194458|NCT01075256|450333501|FG000|Overall Study|Withdrawal by Subject|1|||
125194459|NCT01075256|450333502|FG001|Overall Study|Withdrawal by Subject|0|||
125194460|NCT01075256|450333503|FG002|Overall Study|Withdrawal by Subject|0|||
125194461|NCT02858583|450333506|FG000|Overall Study|Declined consent|1|||
125194462|NCT02858583|450333507|FG001|Overall Study|Declined consent|1|||
125194463|NCT00347009|450333508|FG000|Overall Study|Death|1|||
125194464|NCT00347009|450333508|FG000|Overall Study|Adverse Event|6|||
125194465|NCT00347009|450333508|FG000|Overall Study|Withdrawal by Subject|3|||
125194466|NCT00347009|450333508|FG000|Overall Study|Physician Decision|5|||
125194467|NCT00347009|450333508|FG000|Overall Study|Lost to Follow-up|4|||
125194468|NCT00347009|450333508|FG000|Overall Study|Protocol Violation|2|||
125194469|NCT00347009|450333508|FG000|Overall Study|Adverse Laboratory Experience|1|||
125194470|NCT00347009|450333508|FG000|Overall Study|Insufficient Viral Suppression|3|||
125194471|NCT00347009|450333508|FG000|Overall Study|Increased ALT/HBV DNA|1|||
125194472|NCT00347009|450333508|FG000|Overall Study|Serious Adverse Event|1|||
125194473|NCT01029782|450333510|FG000|Overall Study|Lost to Follow-up|2|||
125194474|NCT01029782|450333511|FG001|Overall Study|Lost to Follow-up|2|||
125194475|NCT01029782|450333510|FG000|Overall Study|Diagnosis changed|1|||
125194476|NCT01029782|450333511|FG001|Overall Study|Diagnosis changed|1|||
125194477|NCT01029782|450333510|FG000|Overall Study|Adverse Event|0|||
125194478|NCT01029782|450333511|FG001|Overall Study|Adverse Event|1|||
125194479|NCT01029782|450333510|FG000|Overall Study|Physician Decision|0|||
125194480|NCT01029782|450333511|FG001|Overall Study|Physician Decision|1|||
125194481|NCT01029782|450333510|FG000|Overall Study|Protocol Violation|0|||
125194482|NCT01029782|450333511|FG001|Overall Study|Protocol Violation|2|||
125194483|NCT01029782|450333510|FG000|Overall Study|Withdrawal by Subject|0|||
125194484|NCT01029782|450333511|FG001|Overall Study|Withdrawal by Subject|1|||
125194485|NCT02195869|450333513|FG000|Overall Study|cGVHD Progression|5|||
125194486|NCT02195869|450333513|FG000|Overall Study|Malignancy Progression/relapse|2|||
125194487|NCT02195869|450333513|FG000|Overall Study|Adverse Event|15|||
125194488|NCT02195869|450333513|FG000|Overall Study|Withdrawal by Subject|7|||
125194489|NCT02195869|450333513|FG000|Overall Study|Physician Decision|4|||
125194490|NCT02195869|450333513|FG000|Overall Study|Study Terminated by Sponsor|7|||
125194491|NCT02195869|450333513|FG000|Overall Study|Noncompliance with study drug|2|||
125194492|NCT01515865|450334894|FG000|Part A (Open-label)|Other|3|||
125194493|NCT01515865|450334895|FG001|Part A (Open-label)|Other|0|||
125194494|NCT01515865|450334896|FG002|Part A (Open-label)|Other|0|||
125194495|NCT01515865|450334894|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
125194496|NCT01515865|450334895|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
125194497|NCT01515865|450334896|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
125194498|NCT01515865|450334894|FG000|Part B (Open-label)|Other|1|||
125194499|NCT01515865|450334895|FG001|Part B (Open-label)|Other|0|||
125194500|NCT01515865|450334896|FG002|Part B (Open-label)|Other|0|||
125194501|NCT03691207|450334897|FG000|Overall Study|Death|41|||
125194502|NCT03691207|450334898|FG001|Overall Study|Death|26|||
125194503|NCT03691207|450334897|FG000|Overall Study|Lost to Follow-up|1|||
125194504|NCT03691207|450334898|FG001|Overall Study|Lost to Follow-up|1|||
125194505|NCT03691207|450334897|FG000|Overall Study|Withdrawal by Subject|2|||
125194506|NCT03691207|450334898|FG001|Overall Study|Withdrawal by Subject|8|||
125194507|NCT03691207|450334897|FG000|Overall Study|Sponsor decision|1|||
125194508|NCT03691207|450334898|FG001|Overall Study|Sponsor decision|7|||
125194509|NCT01736397|450334900|FG000|Overall Study|Lack of Efficacy|1|||
125194510|NCT01736397|450334901|FG001|Overall Study|Lack of Efficacy|11|||
125194511|NCT01736397|450334900|FG000|Overall Study|Withdrawal by Subject|6|||
125194512|NCT01736397|450334901|FG001|Overall Study|Withdrawal by Subject|5|||
125194513|NCT01736397|450334900|FG000|Overall Study|Lost to Follow-up|0|||
125194514|NCT01736397|450334901|FG001|Overall Study|Lost to Follow-up|1|||
125194515|NCT01736397|450334900|FG000|Overall Study|Adverse Event|6|||
125194516|NCT01736397|450334901|FG001|Overall Study|Adverse Event|3|||
125194517|NCT01736397|450334900|FG000|Overall Study|Not stated|1|||
125194518|NCT01736397|450334901|FG001|Overall Study|Not stated|4|||
125194519|NCT02448537|450334904|FG000|Overall Study|Withdrawal by Subject|1|||
125194520|NCT02448537|450334905|FG001|Overall Study|Withdrawal by Subject|1|||
125194521|NCT02448537|450334906|FG002|Overall Study|Withdrawal by Subject|1|||
125194522|NCT04696055|450334909|FG000|Overall Study|Adverse Event|10|||
125247096|NCT02018887|450530952|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
125247097|NCT02018887|450530953|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
125247098|NCT02018887|450530954|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
125247099|NCT02018887|450530955|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
125247100|NCT02018887|450530956|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
125247101|NCT02018887|450530957|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
125247102|NCT02018887|450530958|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
125247103|NCT01058005|450530959|FG000|Overall Study|Adverse Event|0|||
125247104|NCT01058005|450530960|FG001|Overall Study|Adverse Event|2|||
125247105|NCT01058005|450530961|FG002|Overall Study|Adverse Event|1|||
125247106|NCT01058005|450530959|FG000|Overall Study|Physician Decision|2|||
125247107|NCT01058005|450530960|FG001|Overall Study|Physician Decision|2|||
125247108|NCT01058005|450530961|FG002|Overall Study|Physician Decision|0|||
125247109|NCT01058005|450530959|FG000|Overall Study|Withdrawal by Subject|4|||
125247110|NCT01058005|450530960|FG001|Overall Study|Withdrawal by Subject|5|||
125247111|NCT01058005|450530961|FG002|Overall Study|Withdrawal by Subject|11|||
125247112|NCT01058005|450530959|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
125247113|NCT01058005|450530960|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
125247114|NCT01058005|450530961|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
125247115|NCT01058005|450530959|FG000|Overall Study|Reason Missing|5|||
125247116|NCT01058005|450530960|FG001|Overall Study|Reason Missing|3|||
125247117|NCT01058005|450530961|FG002|Overall Study|Reason Missing|1|||
125247118|NCT00927186|450530962|FG000|12 Months Primary Study|Adverse Event|5|||
125247119|NCT00927186|450530963|FG001|12 Months Primary Study|Adverse Event|2|||
125247120|NCT00927186|450530962|FG000|12 Months Primary Study|Lost to Follow-up|1|||
125247121|NCT00927186|450530963|FG001|12 Months Primary Study|Lost to Follow-up|0|||
125247122|NCT00927186|450530962|FG000|12 Months Primary Study|Protocol Violation|0|||
125247123|NCT00927186|450530963|FG001|12 Months Primary Study|Protocol Violation|1|||
125247124|NCT00927186|450530962|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
125247125|NCT00927186|450530963|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
125247126|NCT01145222|450530964|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
125247127|NCT01145222|450530965|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
125247128|NCT01145222|450530966|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
125247129|NCT01145222|450530967|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
125247130|NCT01145222|450530964|FG000|Overall Study|Poor bowel preparation|0|||
125247131|NCT01145222|450530965|FG001|Overall Study|Poor bowel preparation|0|||
125247132|NCT01145222|450530966|FG002|Overall Study|Poor bowel preparation|0|||
125247133|NCT01145222|450530967|FG003|Overall Study|Poor bowel preparation|1|||
125247134|NCT01421134|450530968|FG000|Overall Study|Adverse Event|3|||
125247135|NCT01421134|450530969|FG001|Overall Study|Adverse Event|5|||
125247136|NCT01421134|450530968|FG000|Overall Study|Lack of Efficacy|2|||
125247137|NCT01421134|450530969|FG001|Overall Study|Lack of Efficacy|4|||
125247138|NCT01421134|450530968|FG000|Overall Study|Protocol Violation|0|||
125247139|NCT01421134|450530969|FG001|Overall Study|Protocol Violation|3|||
125247140|NCT01421134|450530968|FG000|Overall Study|Withdrawal by Subject|1|||
125247141|NCT01421134|450530969|FG001|Overall Study|Withdrawal by Subject|1|||
125247142|NCT01421134|450530968|FG000|Overall Study|Administrative|0|||
125247143|NCT01421134|450530969|FG001|Overall Study|Administrative|1|||
125247144|NCT01421134|450530968|FG000|Overall Study|Lost to Follow-up|1|||
125247145|NCT01421134|450530969|FG001|Overall Study|Lost to Follow-up|1|||
125247146|NCT04263532|450530971|FG000|Overall Study|Withdrawal by Subject|2|||
125247147|NCT04263532|450530972|FG001|Overall Study|Withdrawal by Subject|0|||
125247148|NCT01851369|450530977|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247149|NCT01851369|450530978|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247150|NCT01851369|450530979|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247151|NCT01851369|450530980|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247152|NCT01851369|450530981|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247153|NCT01851369|450530982|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
125247154|NCT01851369|450530983|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247155|NCT01851369|450530984|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247156|NCT01851369|450530985|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247157|NCT01851369|450530986|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247158|NCT01851369|450530987|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247159|NCT01851369|450530988|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247160|NCT01851369|450530989|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247161|NCT02453191|450530990|FG000|Overall Study|Withdrawal by Subject|1|||
125247162|NCT03364686|450530991|FG000|Overall Study|Physician Decision|2|||
125194523|NCT04696055|450334910|FG001|Overall Study|Adverse Event|2|||
125194524|NCT04696055|450334909|FG000|Overall Study|Death|4|||
125194525|NCT04696055|450334910|FG001|Overall Study|Death|0|||
125194526|NCT04696055|450334909|FG000|Overall Study|Other|7|||
125194527|NCT04696055|450334910|FG001|Overall Study|Other|2|||
125194528|NCT04696055|450334909|FG000|Overall Study|Physician Decision|3|||
125194529|NCT04696055|450334910|FG001|Overall Study|Physician Decision|0|||
125194530|NCT04696055|450334909|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
125194531|NCT04696055|450334910|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
125194532|NCT04696055|450334909|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
125194533|NCT04696055|450334910|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
125194534|NCT04696055|450334909|FG000|Overall Study|Subject Decision|1|||
125194535|NCT04696055|450334910|FG001|Overall Study|Subject Decision|2|||
125194536|NCT00379080|450334915|FG000|Overall Study|Withdrawal by Subject|0|||
125194537|NCT00379080|450334916|FG001|Overall Study|Withdrawal by Subject|4|||
125194538|NCT00379080|450334917|FG002|Overall Study|Withdrawal by Subject|0|||
125194539|NCT00857896|450334922|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
125194540|NCT01091662|450334924|FG000|Overall Study|Adverse Event|1|||
125194541|NCT01091662|450334925|FG001|Overall Study|Adverse Event|9|||
125194542|NCT01091662|450334924|FG000|Overall Study|Physician Decision|1|||
125194543|NCT01091662|450334925|FG001|Overall Study|Physician Decision|1|||
125194544|NCT01091662|450334924|FG000|Overall Study|Withdrawal by Subject|7|||
125247163|NCT02336503|450530994|FG000|Overall Study|Lost to Follow-up|0|||
125247164|NCT02336503|450530995|FG001|Overall Study|Lost to Follow-up|3|||
125247165|NCT02336503|450530996|FG002|Overall Study|Lost to Follow-up|0|||
125247166|NCT02336503|450530997|FG003|Overall Study|Lost to Follow-up|2|||
125247167|NCT02336503|450530994|FG000|Overall Study|Withdrawal by Subject|2|||
125247168|NCT02336503|450530995|FG001|Overall Study|Withdrawal by Subject|0|||
125247169|NCT02336503|450530996|FG002|Overall Study|Withdrawal by Subject|0|||
125247170|NCT02336503|450530997|FG003|Overall Study|Withdrawal by Subject|4|||
125247171|NCT02336503|450530994|FG000|Overall Study|Adverse Event|0|||
125247172|NCT02336503|450530995|FG001|Overall Study|Adverse Event|0|||
125247173|NCT02336503|450530996|FG002|Overall Study|Adverse Event|1|||
125247174|NCT02336503|450530997|FG003|Overall Study|Adverse Event|0|||
125247175|NCT01543503|450530998|FG000|Overall Study|Lost to Follow-up|32|||
125247176|NCT01543503|450530999|FG001|Overall Study|Lost to Follow-up|36|||
125247177|NCT01543503|450530998|FG000|Overall Study|Adverse Event|9|||
125247178|NCT01543503|450530999|FG001|Overall Study|Adverse Event|13|||
125247179|NCT01543503|450530998|FG000|Overall Study|Lack of Efficacy|4|||
125247180|NCT01543503|450530999|FG001|Overall Study|Lack of Efficacy|16|||
125247181|NCT01543503|450530998|FG000|Overall Study|Participant withdrew informed consent|8|||
125247182|NCT01543503|450530999|FG001|Overall Study|Participant withdrew informed consent|10|||
125247183|NCT01543503|450530998|FG000|Overall Study|Change of jobs|0|||
125247184|NCT01543503|450530999|FG001|Overall Study|Change of jobs|1|||
125247185|NCT01543503|450530998|FG000|Overall Study|Intolerance to the biologic treatment|0|||
125247186|NCT01543503|450530999|FG001|Overall Study|Intolerance to the biologic treatment|1|||
125247187|NCT01543503|450530998|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
125247188|NCT01543503|450530999|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
125247189|NCT01543503|450530998|FG000|Overall Study|Participant did not complete last visit|0|||
125247190|NCT01543503|450530999|FG001|Overall Study|Participant did not complete last visit|2|||
125247191|NCT01543503|450530998|FG000|Overall Study|Refused to continue treatment|7|||
125247192|NCT01543503|450530999|FG001|Overall Study|Refused to continue treatment|0|||
125194545|NCT01091662|450334925|FG001|Overall Study|Withdrawal by Subject|6|||
125194546|NCT01091662|450334924|FG000|Overall Study|met exit criteria|7|||
125194547|NCT01091662|450334925|FG001|Overall Study|met exit criteria|13|||
125194548|NCT01091662|450334924|FG000|Overall Study|met exclusion criteria|1|||
125194549|NCT01091662|450334925|FG001|Overall Study|met exclusion criteria|0|||
125194550|NCT01091662|450334924|FG000|Overall Study|Lost to Follow-up|0|||
125194551|NCT01091662|450334925|FG001|Overall Study|Lost to Follow-up|1|||
125194552|NCT01091662|450334924|FG000|Overall Study|Pregnancy|0|||
125247193|NCT01543503|450530998|FG000|Overall Study|Incorrect medication received|1|||
125247194|NCT01543503|450530999|FG001|Overall Study|Incorrect medication received|0|||
125247195|NCT01543503|450530998|FG000|Overall Study|Participant moved to another city|2|||
125247196|NCT01543503|450530999|FG001|Overall Study|Participant moved to another city|0|||
125247197|NCT01543503|450530998|FG000|Overall Study|Participant will not return for visits|0|||
125247198|NCT01543503|450530999|FG001|Overall Study|Participant will not return for visits|2|||
125247199|NCT01543503|450530998|FG000|Overall Study|Participant transferred to another city|1|||
125247200|NCT01543503|450530999|FG001|Overall Study|Participant transferred to another city|0|||
125247201|NCT01543503|450530998|FG000|Overall Study|Participant moved to Scotland|1|||
125247202|NCT01543503|450530999|FG001|Overall Study|Participant moved to Scotland|0|||
125247203|NCT01543503|450530998|FG000|Overall Study|Participant decision to stop treatment|1|||
125247204|NCT01543503|450530999|FG001|Overall Study|Participant decision to stop treatment|0|||
125247205|NCT01543503|450530998|FG000|Overall Study|Investigator did not wish to participate|1|||
125247206|NCT01543503|450530999|FG001|Overall Study|Investigator did not wish to participate|1|||
125247207|NCT01543503|450530998|FG000|Overall Study|Participant recruited after closing date|0|||
125247208|NCT01543503|450530999|FG001|Overall Study|Participant recruited after closing date|1|||
125247209|NCT01543503|450530998|FG000|Overall Study|Site stopped participation|5|||
125247210|NCT01543503|450530999|FG001|Overall Study|Site stopped participation|1|||
125247211|NCT01543503|450530998|FG000|Overall Study|Participant did not attend a visit|1|||
125247212|NCT01543503|450530999|FG001|Overall Study|Participant did not attend a visit|0|||
125247213|NCT01543503|450530998|FG000|Overall Study|Moved to other rheumatologic site|0|||
125247214|NCT01543503|450530999|FG001|Overall Study|Moved to other rheumatologic site|1|||
125247215|NCT01543503|450530998|FG000|Overall Study|Participant consented to another study|0|||
125247216|NCT01543503|450530999|FG001|Overall Study|Participant consented to another study|2|||
125247217|NCT01543503|450530998|FG000|Overall Study|Participant went to United States|1|||
125247218|NCT01543503|450530999|FG001|Overall Study|Participant went to United States|0|||
125247219|NCT01543503|450530998|FG000|Overall Study|Screen failure|1|||
125247220|NCT01543503|450530999|FG001|Overall Study|Screen failure|0|||
125247221|NCT01936974|450531002|FG000|Overall Study|Physician Decision|2|||
125247222|NCT01936974|450531003|FG001|Overall Study|Physician Decision|5|||
125247223|NCT04584554|450531006|FG000|Overall Study|Withdrawal by Subject|2|||
125247224|NCT04584554|450531007|FG001|Overall Study|Withdrawal by Subject|2|||
125247225|NCT00063999|450531008|FG000|Overall Study|Withdrawal by Subject|1|||
125247226|NCT00063999|450531009|FG001|Overall Study|Withdrawal by Subject|0|||
125247227|NCT00063999|450531008|FG000|Overall Study|Ineligible|44|||
125247228|NCT00063999|450531009|FG001|Overall Study|Ineligible|24|||
125247229|NCT03767894|450531010|FG000|Overall Study|Withdrawal by Subject|1|||
125247230|NCT04243837|450531011|FG000|Overall Study|Adverse Event|2|||
125247231|NCT04243837|450531012|FG001|Overall Study|Adverse Event|1|||
125247232|NCT04243837|450531011|FG000|Overall Study|Withdrawal by Subject|4|||
125247233|NCT04243837|450531012|FG001|Overall Study|Withdrawal by Subject|2|||
125247234|NCT04243837|450531011|FG000|Overall Study|Covid-19 lock down|1|||
125247235|NCT04243837|450531012|FG001|Overall Study|Covid-19 lock down|0|||
125247236|NCT04243837|450531011|FG000|Overall Study|Study Terminated by Sponsor|11|||
125247237|NCT04243837|450531012|FG001|Overall Study|Study Terminated by Sponsor|12|||
125247238|NCT02280499|450531013|FG000|Overall Study|Death|14|||
125247239|NCT02280499|450531013|FG000|Overall Study|Lost to Follow-up|42|||
125247240|NCT02280499|450531013|FG000|Overall Study|Adverse Event|5|||
125247241|NCT00977561|450531021|FG000|Overall Study|Death|3|||
125247242|NCT00977561|450531022|FG001|Overall Study|Death|2|||
125247243|NCT00977561|450531021|FG000|Overall Study|Study terminated|0|||
125247244|NCT00977561|450531022|FG001|Overall Study|Study terminated|2|||
125247245|NCT00977561|450531021|FG000|Overall Study|Other|2|||
125247246|NCT00977561|450531022|FG001|Overall Study|Other|0|||
125247247|NCT01968785|450531025|FG000|Overall Study|Withdrawal by Subject|1|||
125247248|NCT01968785|450531026|FG001|Overall Study|Withdrawal by Subject|0|||
125247249|NCT04000724|450531033|FG000|Overall Study|Withdrawal by Subject|5|||
125247250|NCT04000724|450531034|FG001|Overall Study|Withdrawal by Subject|3|||
125247251|NCT04000724|450531035|FG002|Overall Study|Withdrawal by Subject|4|||
125247252|NCT04000724|450531033|FG000|Overall Study|Lost to Follow-up|11|||
125247253|NCT04000724|450531034|FG001|Overall Study|Lost to Follow-up|7|||
125247254|NCT04000724|450531035|FG002|Overall Study|Lost to Follow-up|13|||
125247255|NCT00455455|450531036|FG000|Washout|Withdrawal by Subject|0|||
125247256|NCT00455455|450531037|FG001|Washout|Withdrawal by Subject|1|||
125247257|NCT00455455|450531036|FG000|Washout|Withdrawal by Subject|1|||
125247258|NCT00455455|450531037|FG001|Washout|Withdrawal by Subject|0|||
125247259|NCT01827943|450531038|FG000|Overall Study|Protocol Violation|8|||
125247260|NCT01827943|450531038|FG000|Overall Study|Never treated because of an rapid progression|1|||
125247261|NCT04689009|450531039|FG000|Overall Study|Adverse Event|1|||
125247262|NCT04689009|450531040|FG001|Overall Study|Adverse Event|0|||
125247263|NCT04689009|450531039|FG000|Overall Study|Lost to Follow-up|1|||
125247264|NCT04689009|450531040|FG001|Overall Study|Lost to Follow-up|2|||
125247265|NCT04689009|450531039|FG000|Overall Study|Withdrawal by Subject|4|||
125247266|NCT04689009|450531040|FG001|Overall Study|Withdrawal by Subject|3|||
125247267|NCT04689009|450531039|FG000|Overall Study|Protocol Violation|1|||
125194553|NCT01091662|450334925|FG001|Overall Study|Pregnancy|1|||
125194554|NCT01091662|450334924|FG000|Overall Study|Protocol Violation|0|||
125194555|NCT01091662|450334925|FG001|Overall Study|Protocol Violation|2|||
125194556|NCT01091662|450334924|FG000|Overall Study|unable to swallow capsule|0|||
125194557|NCT01091662|450334925|FG001|Overall Study|unable to swallow capsule|1|||
125194558|NCT04109391|450334926|FG000|Overall Study|Adverse Event|2|||
125194559|NCT04109391|450334927|FG001|Overall Study|Adverse Event|2|||
125194560|NCT04109391|450334928|FG002|Overall Study|Adverse Event|0|||
125194561|NCT04109391|450334926|FG000|Overall Study|Withdrawal by Subject|2|||
125194562|NCT04109391|450334927|FG001|Overall Study|Withdrawal by Subject|0|||
125194563|NCT04109391|450334928|FG002|Overall Study|Withdrawal by Subject|0|||
125194564|NCT04109391|450334926|FG000|Overall Study|Pregnancy|1|||
125194565|NCT04109391|450334927|FG001|Overall Study|Pregnancy|0|||
125194566|NCT04109391|450334928|FG002|Overall Study|Pregnancy|0|||
125194567|NCT04109391|450334926|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
125194568|NCT04109391|450334927|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
125194569|NCT04109391|450334928|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
125194570|NCT04109391|450334926|FG000|Overall Study|Lost to Follow-up|0|||
125194571|NCT04109391|450334927|FG001|Overall Study|Lost to Follow-up|0|||
125194572|NCT04109391|450334928|FG002|Overall Study|Lost to Follow-up|1|||
125194573|NCT04109391|450334926|FG000|Overall Study|Lack of Efficacy|2|||
125194574|NCT04109391|450334927|FG001|Overall Study|Lack of Efficacy|2|||
125194575|NCT04109391|450334928|FG002|Overall Study|Lack of Efficacy|3|||
125194576|NCT01222520|450334929|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
125194577|NCT01222520|450334930|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
125194578|NCT01222520|450334929|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
125194579|NCT01222520|450334930|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
125194580|NCT01222520|450334929|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
125194581|NCT01222520|450334930|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
125194582|NCT01222520|450334929|FG000|Double-blind Period|Adverse Event|0|||
125194583|NCT01222520|450334930|FG001|Double-blind Period|Adverse Event|1|||
125194584|NCT01222520|450334929|FG000|Double-blind Period|Lack of Efficacy|0|||
125194585|NCT01222520|450334930|FG001|Double-blind Period|Lack of Efficacy|1|||
125194586|NCT01222520|450334929|FG000|Double-blind Period|Study medication stolen|1|||
125194587|NCT01222520|450334930|FG001|Double-blind Period|Study medication stolen|0|||
125194588|NCT01089608|450334933|FG000|Overall Study|Adverse Event|0|||
125194589|NCT01089608|450334934|FG001|Overall Study|Adverse Event|4|||
125194590|NCT01089608|450334933|FG000|Overall Study|Lost to Follow-up|0|||
125194591|NCT01089608|450334934|FG001|Overall Study|Lost to Follow-up|2|||
125194592|NCT00955955|450334935|FG000|Overall Study|Lost to Follow-up|2|||
125194593|NCT00955955|450334936|FG001|Overall Study|Lost to Follow-up|0|||
125194594|NCT00955955|450334937|FG002|Overall Study|Lost to Follow-up|0|||
125194595|NCT03423173|450334938|FG000|Overall Study|Randomized but not vaccinated|1|||
125194596|NCT03423173|450334939|FG001|Overall Study|Randomized but not vaccinated|0|||
125194597|NCT03423173|450334940|FG002|Overall Study|Randomized but not vaccinated|2|||
125194598|NCT03423173|450334941|FG003|Overall Study|Randomized but not vaccinated|1|||
125194599|NCT03423173|450334938|FG000|Overall Study|Adverse Event|1|||
125194600|NCT03423173|450334939|FG001|Overall Study|Adverse Event|1|||
125194601|NCT03423173|450334940|FG002|Overall Study|Adverse Event|1|||
125194602|NCT03423173|450334941|FG003|Overall Study|Adverse Event|1|||
125194603|NCT03423173|450334938|FG000|Overall Study|Lost to Follow-up|10|||
125194604|NCT03423173|450334939|FG001|Overall Study|Lost to Follow-up|19|||
125194605|NCT03423173|450334940|FG002|Overall Study|Lost to Follow-up|17|||
125194606|NCT03423173|450334941|FG003|Overall Study|Lost to Follow-up|22|||
125194607|NCT03423173|450334938|FG000|Overall Study|Withdrawal of consent|4|||
125194608|NCT03423173|450334939|FG001|Overall Study|Withdrawal of consent|10|||
125194609|NCT03423173|450334940|FG002|Overall Study|Withdrawal of consent|4|||
125194610|NCT03423173|450334941|FG003|Overall Study|Withdrawal of consent|5|||
125194611|NCT03423173|450334938|FG000|Overall Study|Death|1|||
125194612|NCT03423173|450334939|FG001|Overall Study|Death|0|||
125194613|NCT03423173|450334940|FG002|Overall Study|Death|0|||
125194614|NCT03423173|450334941|FG003|Overall Study|Death|0|||
125194615|NCT03423173|450334938|FG000|Overall Study|Reason not Specified|2|||
125194616|NCT03423173|450334939|FG001|Overall Study|Reason not Specified|5|||
125194617|NCT03423173|450334940|FG002|Overall Study|Reason not Specified|3|||
125194618|NCT03423173|450334941|FG003|Overall Study|Reason not Specified|1|||
125194619|NCT02920008|450334942|FG000|Overall Study|Death|117|||
125194620|NCT02920008|450334943|FG001|Overall Study|Death|127|||
125194621|NCT02920008|450334942|FG000|Overall Study|Withdrawal by Subject|3|||
125194622|NCT02920008|450334943|FG001|Overall Study|Withdrawal by Subject|6|||
125194623|NCT02920008|450334942|FG000|Overall Study|Lost to Follow-up|0|||
125194624|NCT02920008|450334943|FG001|Overall Study|Lost to Follow-up|1|||
125194625|NCT02737930|450334944|FG000|Overall Study|Withdrawal by Subject|0|||
125194626|NCT02737930|450334945|FG001|Overall Study|Withdrawal by Subject|1|||
125194627|NCT03169881|450334946|FG000|Overall Study|Incomplete Follow-up|10|||
125194628|NCT03169881|450334947|FG001|Overall Study|Incomplete Follow-up|15|||
125194629|NCT03169881|450334946|FG000|Overall Study|Lost to Follow-up|18|||
125194630|NCT03169881|450334947|FG001|Overall Study|Lost to Follow-up|20|||
125194631|NCT03169881|450334946|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
125194632|NCT03169881|450334947|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
125194633|NCT03852264|450334948|FG000|Third Research Visit|Lost to Follow-up|1|||
125194634|NCT03852264|450334949|FG001|Third Research Visit|Lost to Follow-up|0|||
125194635|NCT00729157|450334956|FG000|Overall Study|Withdrawal by Subject|1|||
125194636|NCT02217410|450334957|FG000|Overall Study|Graft Loss|0|||
125194637|NCT02217410|450334958|FG001|Overall Study|Graft Loss|0|||
125194638|NCT02217410|450334959|FG002|Overall Study|Graft Loss|2|||
125194639|NCT02217410|450334957|FG000|Overall Study|Withdrawal by Subject|0|||
125194640|NCT02217410|450334958|FG001|Overall Study|Withdrawal by Subject|0|||
125194641|NCT02217410|450334959|FG002|Overall Study|Withdrawal by Subject|2|||
125194642|NCT02217410|450334957|FG000|Overall Study|Lost to Follow-up|0|||
125194643|NCT02217410|450334958|FG001|Overall Study|Lost to Follow-up|0|||
125194644|NCT02217410|450334959|FG002|Overall Study|Lost to Follow-up|1|||
125194645|NCT02217410|450334957|FG000|Overall Study|Lack of Efficacy|0|||
125194646|NCT02217410|450334958|FG001|Overall Study|Lack of Efficacy|1|||
125194647|NCT02217410|450334959|FG002|Overall Study|Lack of Efficacy|0|||
125194648|NCT02217410|450334957|FG000|Overall Study|Physician Decision|1|||
125194649|NCT02217410|450334958|FG001|Overall Study|Physician Decision|3|||
125194650|NCT02217410|450334959|FG002|Overall Study|Physician Decision|0|||
125194651|NCT00661609|450334961|FG000|Overall Study|Adverse Event|4|||
125194652|NCT00661609|450334961|FG000|Overall Study|Death|20|||
125194653|NCT00661609|450334961|FG000|Overall Study|Withdrawal by Subject|2|||
125194654|NCT00661609|450334961|FG000|Overall Study|PI Decision|1|||
125194655|NCT00661609|450334961|FG000|Overall Study|Survival follow up stage discontinued|11|||
125194656|NCT00661609|450334961|FG000|Overall Study|Disease progression|3|||
125194657|NCT00637000|450334962|FG000|Overall Study|Withdrawal by Subject|4|||
125194658|NCT00637000|450334963|FG001|Overall Study|Withdrawal by Subject|3|||
125194659|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
125194660|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
125194661|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
125194662|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
125194663|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
125194664|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
125194665|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
125194666|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
125194667|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
125194668|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
125194669|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
125194670|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
125194671|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
125194672|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
125194673|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
125194674|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
125194675|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
125194676|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
125194677|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
125194678|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
125194679|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
125194680|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
125194681|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
125194682|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
125194683|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
125194684|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
125194685|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
125194686|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
125194687|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
125194688|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
125194689|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
125194690|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
125194691|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
125194692|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
125194693|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
125194694|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
125194695|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
125194696|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
125194697|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
125247268|NCT04689009|450531040|FG001|Overall Study|Protocol Violation|0|||
125247269|NCT00545948|450531042|FG000|Overall Study|Not Treated|1|||
125247270|NCT00545948|450531043|FG001|Overall Study|Not Treated|1|||
125247271|NCT00545948|450531044|FG002|Overall Study|Not Treated|7|||
125247272|NCT03467945|450531045|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125247273|NCT03467945|450531046|FG001|Treatment Period 2|Withdrawal by Subject|1|||
125247274|NCT03467945|450531047|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125247275|NCT03467945|450531048|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125247276|NCT03467945|450531045|FG000|Treatment Period 3|Withdrawal by Subject|1|||
125247277|NCT03467945|450531046|FG001|Treatment Period 3|Withdrawal by Subject|0|||
125247278|NCT03467945|450531047|FG002|Treatment Period 3|Withdrawal by Subject|2|||
125247279|NCT03467945|450531048|FG003|Treatment Period 3|Withdrawal by Subject|1|||
125247280|NCT02187055|450531051|FG000|Overall Study|Lack of Efficacy|10|||
125247281|NCT02187055|450531052|FG001|Overall Study|Lack of Efficacy|3|||
125247282|NCT02187055|450531053|FG002|Overall Study|Lack of Efficacy|7|||
125247283|NCT02187055|450531051|FG000|Overall Study|Lost to Follow-up|2|||
125247284|NCT02187055|450531052|FG001|Overall Study|Lost to Follow-up|7|||
125247285|NCT02187055|450531053|FG002|Overall Study|Lost to Follow-up|3|||
125247286|NCT02187055|450531051|FG000|Overall Study|No longer meets eligibility criteria|0|||
125247287|NCT02187055|450531052|FG001|Overall Study|No longer meets eligibility criteria|2|||
125247288|NCT02187055|450531053|FG002|Overall Study|No longer meets eligibility criteria|0|||
125247289|NCT02187055|450531051|FG000|Overall Study|No longer willing to participate|6|||
125247290|NCT02187055|450531052|FG001|Overall Study|No longer willing to participate|8|||
125247291|NCT02187055|450531053|FG002|Overall Study|No longer willing to participate|10|||
125247292|NCT02187055|450531051|FG000|Overall Study|Other|5|||
125247293|NCT02187055|450531052|FG001|Overall Study|Other|6|||
125247294|NCT02187055|450531053|FG002|Overall Study|Other|3|||
125247295|NCT02187055|450531051|FG000|Overall Study|Protocol Violation|9|||
125247296|NCT02187055|450531052|FG001|Overall Study|Protocol Violation|9|||
125247297|NCT02187055|450531053|FG002|Overall Study|Protocol Violation|4|||
125247298|NCT02187055|450531051|FG000|Overall Study|Pregnancy|3|||
125247299|NCT02187055|450531052|FG001|Overall Study|Pregnancy|1|||
125247300|NCT02187055|450531053|FG002|Overall Study|Pregnancy|0|||
125247301|NCT02187055|450531051|FG000|Overall Study|Withdrawal by Subject|11|||
125247302|NCT02187055|450531052|FG001|Overall Study|Withdrawal by Subject|11|||
125247303|NCT02187055|450531053|FG002|Overall Study|Withdrawal by Subject|11|||
125247304|NCT02187055|450531051|FG000|Overall Study|Adverse Event|21|||
125247305|NCT02187055|450531052|FG001|Overall Study|Adverse Event|26|||
125247306|NCT02187055|450531053|FG002|Overall Study|Adverse Event|36|||
125247307|NCT02187055|450531051|FG000|Overall Study|Death|2|||
125247308|NCT02187055|450531052|FG001|Overall Study|Death|0|||
125247309|NCT02187055|450531053|FG002|Overall Study|Death|0|||
125247310|NCT03520387|450531056|FG000|Pre-Randomization|Withdrawal by Subject|1|||
125247311|NCT03520387|450531057|FG001|Pre-Randomization|Withdrawal by Subject|0|||
125247312|NCT03520387|450531058|FG002|Pre-Randomization|Withdrawal by Subject|0|||
125247313|NCT03520387|450531059|FG003|Pre-Randomization|Withdrawal by Subject|0|||
125247314|NCT03520387|450531060|FG004|Pre-Randomization|Withdrawal by Subject|0|||
125247315|NCT03520387|450531056|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
125247316|NCT03520387|450531057|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
125247317|NCT03520387|450531058|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
125247318|NCT03520387|450531059|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
125247319|NCT03520387|450531060|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
125247320|NCT03336866|450531061|FG000|Overall Study|Lost to Follow-up|2|||
125247321|NCT03336866|450531062|FG001|Overall Study|Lost to Follow-up|0|||
125247322|NCT03336866|450531063|FG002|Overall Study|Lost to Follow-up|3|||
125247323|NCT03336866|450531061|FG000|Overall Study|Withdrawal by Subject|1|||
125247324|NCT03336866|450531062|FG001|Overall Study|Withdrawal by Subject|1|||
125247325|NCT03336866|450531063|FG002|Overall Study|Withdrawal by Subject|0|||
125247326|NCT03336866|450531061|FG000|Overall Study|Noncompliance with clinic house rules|0|||
125247327|NCT03336866|450531062|FG001|Overall Study|Noncompliance with clinic house rules|0|||
125247328|NCT03336866|450531063|FG002|Overall Study|Noncompliance with clinic house rules|1|||
125247329|NCT00541775|450531064|FG000|Overall Study|Adverse Event|3|||
125247330|NCT00541775|450531065|FG001|Overall Study|Adverse Event|2|||
125247331|NCT00541775|450531066|FG002|Overall Study|Adverse Event|1|||
125247332|NCT00541775|450531064|FG000|Overall Study|Lack of Efficacy|0|||
125247333|NCT00541775|450531065|FG001|Overall Study|Lack of Efficacy|0|||
125247334|NCT00541775|450531066|FG002|Overall Study|Lack of Efficacy|3|||
125247335|NCT00541775|450531064|FG000|Overall Study|Lost to Follow-up|0|||
125247336|NCT00541775|450531065|FG001|Overall Study|Lost to Follow-up|0|||
125247337|NCT00541775|450531066|FG002|Overall Study|Lost to Follow-up|2|||
125247338|NCT00541775|450531064|FG000|Overall Study|Protocol Violation|1|||
125247339|NCT00541775|450531065|FG001|Overall Study|Protocol Violation|0|||
125247340|NCT00541775|450531066|FG002|Overall Study|Protocol Violation|0|||
125247341|NCT00541775|450531064|FG000|Overall Study|Withdrawal by Subject and Other|5|||
125247342|NCT00541775|450531065|FG001|Overall Study|Withdrawal by Subject and Other|0|||
125247343|NCT00541775|450531066|FG002|Overall Study|Withdrawal by Subject and Other|2|||
125247344|NCT00032487|450531067|FG000|Overall Study|Withdrawal by Subject|67|||
125247345|NCT00032487|450531068|FG001|Overall Study|Withdrawal by Subject|43|||
125247346|NCT00032487|450531067|FG000|Overall Study|Adverse Event|3|||
125247347|NCT00032487|450531068|FG001|Overall Study|Adverse Event|7|||
125247348|NCT00032487|450531067|FG000|Overall Study|Lost to Follow-up|57|||
125247349|NCT00032487|450531068|FG001|Overall Study|Lost to Follow-up|58|||
125247350|NCT00032487|450531067|FG000|Overall Study|Had other reason|12|||
125247351|NCT00032487|450531068|FG001|Overall Study|Had other reason|12|||
125247352|NCT02975700|450531069|FG000|Overall Study|Adverse Event|1|||
125247353|NCT02975700|450531069|FG000|Overall Study|Progressive disease|3|||
125247354|NCT02975700|450531069|FG000|Overall Study|Failed screening criteria|2|||
125247355|NCT01541254|450531071|FG000|Overall Study|Withdrawal by Subject|1|||
125247356|NCT01541254|450531071|FG000|Overall Study|excluded - metal allergy|1|||
125247357|NCT01541254|450531071|FG000|Overall Study|enrolled after study closed|1|||
125247358|NCT01541254|450531071|FG000|Overall Study|GI bleed prior to procedure|1|||
125247359|NCT01541254|450531071|FG000|Overall Study|stent not required|1|||
125247360|NCT01541254|450531071|FG000|Overall Study|alternate stent used|1|||
125247361|NCT05660538|450531072|FG000|Overall Study|Adverse Event|0|||
125247362|NCT05660538|450531073|FG001|Overall Study|Adverse Event|0|||
125194698|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
125194699|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
125194700|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
125194701|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
125194702|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
125194703|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
125194704|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
125194705|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
125194706|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
125194707|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
125194708|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
125194709|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
125194710|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
125194711|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
125194712|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
125194713|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
125194714|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
125194715|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
125194716|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
125194717|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
125194718|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
125194719|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
125194720|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
125194721|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
125194722|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
125194723|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
125194724|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
125194725|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
125194726|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
125194727|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
125194728|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
125194729|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
125194730|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
125194731|NCT01855243|450334969|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
125194732|NCT01855243|450334970|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
125194733|NCT01855243|450334971|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
125194734|NCT01704651|450334976|FG000|Overall Study|Pre-op withdrawal by subject|1|||
125194735|NCT01704651|450334977|FG001|Overall Study|Pre-op withdrawal by subject|1|||
125194736|NCT01704651|450334976|FG000|Overall Study|Pre-op change in treatment plan|1|||
125194737|NCT01704651|450334977|FG001|Overall Study|Pre-op change in treatment plan|4|||
125194738|NCT01704651|450334976|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
125194739|NCT01704651|450334977|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
125194740|NCT01704651|450334976|FG000|Overall Study|Post-op did not have laparotomy|2|||
125194741|NCT01704651|450334977|FG001|Overall Study|Post-op did not have laparotomy|1|||
125194742|NCT03315286|450334978|FG000|Overall Study|Lost to Follow-up|0|||
125194743|NCT03315286|450334979|FG001|Overall Study|Lost to Follow-up|3|||
125194744|NCT03315286|450334978|FG000|Overall Study|Withdrawal by Subject|1|||
125194745|NCT03315286|450334979|FG001|Overall Study|Withdrawal by Subject|0|||
125194746|NCT03315286|450334978|FG000|Overall Study|Protocol Violation|0|||
125194747|NCT03315286|450334979|FG001|Overall Study|Protocol Violation|1|||
125194748|NCT03075891|450334980|FG000|Overall Study|Withdrawal by Subject|3|||
125194749|NCT03075891|450334981|FG001|Overall Study|Withdrawal by Subject|6|||
125194750|NCT03075891|450334980|FG000|Overall Study|Lost to Follow-up|1|||
125194751|NCT03075891|450334981|FG001|Overall Study|Lost to Follow-up|0|||
125194752|NCT03075891|450334980|FG000|Overall Study|Pregnancy|3|||
125194753|NCT03075891|450334981|FG001|Overall Study|Pregnancy|1|||
125194754|NCT03075891|450334980|FG000|Overall Study|visits not performed (no time)|1|||
125194755|NCT03075891|450334981|FG001|Overall Study|visits not performed (no time)|0|||
125194756|NCT03075891|450334980|FG000|Overall Study|Drug abuse relapse issue|0|||
125194757|NCT03075891|450334981|FG001|Overall Study|Drug abuse relapse issue|1|||
125247363|NCT05660538|450531074|FG002|Overall Study|Adverse Event|1|||
125247364|NCT05660538|450531075|FG003|Overall Study|Adverse Event|0|||
125247365|NCT05660538|450531072|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
125247366|NCT05660538|450531073|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
125247367|NCT05660538|450531074|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
125247368|NCT05660538|450531075|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
125247369|NCT05660538|450531072|FG000|Overall Study|Lost to Follow-up|0|||
125247370|NCT05660538|450531073|FG001|Overall Study|Lost to Follow-up|0|||
125247371|NCT05660538|450531074|FG002|Overall Study|Lost to Follow-up|1|||
125247372|NCT05660538|450531075|FG003|Overall Study|Lost to Follow-up|1|||
125247373|NCT05660538|450531072|FG000|Overall Study|Death|0|||
125247374|NCT05660538|450531073|FG001|Overall Study|Death|0|||
125247375|NCT05660538|450531074|FG002|Overall Study|Death|1|||
125247376|NCT05660538|450531075|FG003|Overall Study|Death|0|||
125247377|NCT05660538|450531072|FG000|Overall Study|Physician Decision|0|||
125247378|NCT05660538|450531073|FG001|Overall Study|Physician Decision|0|||
125247379|NCT05660538|450531074|FG002|Overall Study|Physician Decision|0|||
125247380|NCT05660538|450531075|FG003|Overall Study|Physician Decision|1|||
125247381|NCT05660538|450531072|FG000|Overall Study|Sponsor Decision|1|||
125247382|NCT05660538|450531073|FG001|Overall Study|Sponsor Decision|0|||
125247383|NCT05660538|450531074|FG002|Overall Study|Sponsor Decision|0|||
125247384|NCT05660538|450531075|FG003|Overall Study|Sponsor Decision|0|||
125247385|NCT05660538|450531072|FG000|Overall Study|Other|1|||
125247386|NCT05660538|450531073|FG001|Overall Study|Other|0|||
125247387|NCT05660538|450531074|FG002|Overall Study|Other|0|||
125247388|NCT05660538|450531075|FG003|Overall Study|Other|1|||
125247389|NCT05660538|450531072|FG000|Overall Study|Randomized but did not receive study drug|1|||
125247390|NCT05660538|450531073|FG001|Overall Study|Randomized but did not receive study drug|0|||
125247391|NCT05660538|450531074|FG002|Overall Study|Randomized but did not receive study drug|0|||
125247392|NCT05660538|450531075|FG003|Overall Study|Randomized but did not receive study drug|1|||
125247393|NCT05660538|450531072|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
125247394|NCT05660538|450531073|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
125247395|NCT05660538|450531074|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
125247396|NCT05660538|450531075|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
125247397|NCT04518410|450531077|FG000|Overall Study|Lost to Follow-up|1|||
125247398|NCT04518410|450531078|FG001|Overall Study|Lost to Follow-up|1|||
125247399|NCT04518410|450531079|FG002|Overall Study|Lost to Follow-up|8|||
125247400|NCT04518410|450531080|FG003|Overall Study|Lost to Follow-up|5|||
125247401|NCT04518410|450531081|FG004|Overall Study|Lost to Follow-up|92|||
125247402|NCT04518410|450531082|FG005|Overall Study|Lost to Follow-up|25|||
125247403|NCT04518410|450531083|FG006|Overall Study|Lost to Follow-up|25|||
125247404|NCT04518410|450531084|FG007|Overall Study|Lost to Follow-up|3|||
125247405|NCT04518410|450531085|FG008|Overall Study|Lost to Follow-up|2|||
125247406|NCT04518410|450531086|FG009|Overall Study|Lost to Follow-up|13|||
125247407|NCT04518410|450531087|FG010|Overall Study|Lost to Follow-up|9|||
125247408|NCT04518410|450531088|FG011|Overall Study|Lost to Follow-up|13|||
125194758|NCT03075891|450334980|FG000|Overall Study|Participant requiring study withdrawal|0|||
125194759|NCT03075891|450334981|FG001|Overall Study|Participant requiring study withdrawal|1|||
125194760|NCT03075891|450334980|FG000|Overall Study|Adverse event, non-fatal|1|||
125194761|NCT03075891|450334981|FG001|Overall Study|Adverse event, non-fatal|4|||
125194762|NCT00828568|450334985|FG000|Randomized|Withdrawal by Subject|1|||
125194763|NCT00828568|450334986|FG001|Randomized|Withdrawal by Subject|0|||
125194764|NCT00828568|450334987|FG002|Randomized|Withdrawal by Subject|2|||
125194765|NCT00828568|450334985|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
125194766|NCT00828568|450334986|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
125194767|NCT00828568|450334987|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
125194768|NCT00828568|450334985|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
125194769|NCT00828568|450334986|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
125194770|NCT00828568|450334987|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
125194771|NCT00828568|450334985|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
125194772|NCT00828568|450334986|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
125194773|NCT00828568|450334987|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
125194774|NCT00828568|450334985|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
125194775|NCT00828568|450334986|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
125194776|NCT00828568|450334987|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
125194777|NCT00634803|450334988|FG000|Overall Study|Lost to Follow-up|6|||
125194778|NCT00634803|450334989|FG001|Overall Study|Lost to Follow-up|7|||
125194779|NCT00634803|450334990|FG002|Overall Study|Lost to Follow-up|7|||
125194780|NCT00396656|450334991|FG000|First Treatment Period|Withdrawal by Subject|0|||
125194781|NCT00396656|450334992|FG001|First Treatment Period|Withdrawal by Subject|2|||
125194782|NCT00396656|450334991|FG000|Second Treatment Period|Adverse Event|0|||
125194783|NCT00396656|450334992|FG001|Second Treatment Period|Adverse Event|1|||
125194784|NCT00364923|450334993|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
125194785|NCT00364923|450334993|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
125194786|NCT03474731|450334994|FG000|Overall Study|Withdrawal by Subject|36|||
125194787|NCT03474731|450334995|FG001|Overall Study|Withdrawal by Subject|29|||
125194788|NCT03474731|450334996|FG002|Overall Study|Withdrawal by Subject|11|||
125194789|NCT03474731|450334997|FG003|Overall Study|Withdrawal by Subject|27|||
125194790|NCT03474731|450334994|FG000|Overall Study|COVID|0|||
125194791|NCT03474731|450334995|FG001|Overall Study|COVID|23|||
125194792|NCT03474731|450334996|FG002|Overall Study|COVID|0|||
125194793|NCT03474731|450334997|FG003|Overall Study|COVID|0|||
125194794|NCT03474731|450334994|FG000|Overall Study|Participant moved from area|1|||
125194795|NCT03474731|450334995|FG001|Overall Study|Participant moved from area|0|||
125194796|NCT03474731|450334996|FG002|Overall Study|Participant moved from area|0|||
125194797|NCT03474731|450334997|FG003|Overall Study|Participant moved from area|0|||
125194798|NCT03474731|450334994|FG000|Overall Study|Lost to Follow-up|11|||
125194799|NCT03474731|450334995|FG001|Overall Study|Lost to Follow-up|3|||
125194800|NCT03474731|450334996|FG002|Overall Study|Lost to Follow-up|18|||
125194801|NCT03474731|450334997|FG003|Overall Study|Lost to Follow-up|17|||
125194802|NCT03474731|450334994|FG000|Overall Study|Death|0|||
125194803|NCT03474731|450334995|FG001|Overall Study|Death|1|||
125194804|NCT03474731|450334996|FG002|Overall Study|Death|0|||
125194805|NCT03474731|450334997|FG003|Overall Study|Death|0|||
125194806|NCT03474731|450334994|FG000|Overall Study|Participant Removed|0|||
125194807|NCT03474731|450334995|FG001|Overall Study|Participant Removed|0|||
125194808|NCT03474731|450334996|FG002|Overall Study|Participant Removed|0|||
125247409|NCT04518410|450531089|FG012|Overall Study|Lost to Follow-up|9|||
125247410|NCT04518410|450531090|FG013|Overall Study|Lost to Follow-up|13|||
125247411|NCT04518410|450531091|FG014|Overall Study|Lost to Follow-up|8|||
125247412|NCT04518410|450531092|FG015|Overall Study|Lost to Follow-up|10|||
125247413|NCT04518410|450531093|FG016|Overall Study|Lost to Follow-up|6|||
125247414|NCT04518410|450531094|FG017|Overall Study|Lost to Follow-up|13|||
125247415|NCT04518410|450531095|FG018|Overall Study|Lost to Follow-up|21|||
125247416|NCT04518410|450531096|FG019|Overall Study|Lost to Follow-up|6|||
125247417|NCT04518410|450531097|FG020|Overall Study|Lost to Follow-up|7|||
125194809|NCT03474731|450334997|FG003|Overall Study|Participant Removed|1|||
125194810|NCT00766636|450334998|FG000|Overall Study|Withdrawal by Subject|1|||
125194811|NCT00766636|450334999|FG001|Overall Study|Withdrawal by Subject|1|||
125194812|NCT00766636|450334998|FG000|Overall Study|Incomplete Treatment|0|||
125194813|NCT00766636|450334999|FG001|Overall Study|Incomplete Treatment|1|||
125194814|NCT00766636|450334998|FG000|Overall Study|Adverse Event|1|||
125194815|NCT00766636|450334999|FG001|Overall Study|Adverse Event|0|||
125247418|NCT04518410|450531098|FG021|Overall Study|Lost to Follow-up|21|||
125247419|NCT04518410|450531099|FG022|Overall Study|Lost to Follow-up|1|||
125247420|NCT04518410|450531100|FG023|Overall Study|Lost to Follow-up|7|||
125194816|NCT00766636|450334998|FG000|Overall Study|Disease Progression|1|||
125194817|NCT00766636|450334999|FG001|Overall Study|Disease Progression|0|||
125194818|NCT02477332|450335000|FG000|Overall Study|Adverse Event|0|||
125194819|NCT02477332|450335001|FG001|Overall Study|Adverse Event|1|||
125247421|NCT04518410|450531101|FG024|Overall Study|Lost to Follow-up|6|||
125247422|NCT04518410|450531077|FG000|Overall Study|Withdrawal by Subject|1|||
125247423|NCT04518410|450531078|FG001|Overall Study|Withdrawal by Subject|2|||
125247424|NCT04518410|450531079|FG002|Overall Study|Withdrawal by Subject|2|||
125247425|NCT04518410|450531080|FG003|Overall Study|Withdrawal by Subject|3|||
125247426|NCT04518410|450531081|FG004|Overall Study|Withdrawal by Subject|20|||
125247427|NCT04518410|450531082|FG005|Overall Study|Withdrawal by Subject|20|||
125247428|NCT04518410|450531083|FG006|Overall Study|Withdrawal by Subject|25|||
125247429|NCT04518410|450531084|FG007|Overall Study|Withdrawal by Subject|6|||
125247430|NCT04518410|450531085|FG008|Overall Study|Withdrawal by Subject|1|||
125247431|NCT04518410|450531086|FG009|Overall Study|Withdrawal by Subject|12|||
125247432|NCT04518410|450531087|FG010|Overall Study|Withdrawal by Subject|5|||
125247433|NCT04518410|450531088|FG011|Overall Study|Withdrawal by Subject|7|||
125247434|NCT04518410|450531089|FG012|Overall Study|Withdrawal by Subject|2|||
125247435|NCT04518410|450531090|FG013|Overall Study|Withdrawal by Subject|13|||
125247436|NCT04518410|450531091|FG014|Overall Study|Withdrawal by Subject|4|||
125247437|NCT04518410|450531092|FG015|Overall Study|Withdrawal by Subject|9|||
125247438|NCT04518410|450531093|FG016|Overall Study|Withdrawal by Subject|0|||
125247439|NCT04518410|450531094|FG017|Overall Study|Withdrawal by Subject|15|||
125247440|NCT04518410|450531095|FG018|Overall Study|Withdrawal by Subject|12|||
125247441|NCT04518410|450531096|FG019|Overall Study|Withdrawal by Subject|9|||
125247442|NCT04518410|450531097|FG020|Overall Study|Withdrawal by Subject|14|||
125247443|NCT04518410|450531098|FG021|Overall Study|Withdrawal by Subject|3|||
125194820|NCT02477332|450335002|FG002|Overall Study|Adverse Event|1|||
125194821|NCT02477332|450335003|FG003|Overall Study|Adverse Event|2|||
125194822|NCT02477332|450335004|FG004|Overall Study|Adverse Event|1|||
125194823|NCT02477332|450335005|FG005|Overall Study|Adverse Event|2|||
125194824|NCT02477332|450335000|FG000|Overall Study|Lack of Efficacy|1|||
125194825|NCT02477332|450335001|FG001|Overall Study|Lack of Efficacy|2|||
125194826|NCT02477332|450335002|FG002|Overall Study|Lack of Efficacy|1|||
125194827|NCT02477332|450335003|FG003|Overall Study|Lack of Efficacy|2|||
125194828|NCT02477332|450335004|FG004|Overall Study|Lack of Efficacy|1|||
125194829|NCT02477332|450335005|FG005|Overall Study|Lack of Efficacy|1|||
125194830|NCT02477332|450335000|FG000|Overall Study|Non-compliance with study treatment|0|||
125194831|NCT02477332|450335001|FG001|Overall Study|Non-compliance with study treatment|1|||
125194832|NCT02477332|450335002|FG002|Overall Study|Non-compliance with study treatment|2|||
125194833|NCT02477332|450335003|FG003|Overall Study|Non-compliance with study treatment|0|||
125194834|NCT02477332|450335004|FG004|Overall Study|Non-compliance with study treatment|0|||
125194835|NCT02477332|450335005|FG005|Overall Study|Non-compliance with study treatment|0|||
125194836|NCT02477332|450335000|FG000|Overall Study|Pregnancy|0|||
125194837|NCT02477332|450335001|FG001|Overall Study|Pregnancy|0|||
125194838|NCT02477332|450335002|FG002|Overall Study|Pregnancy|0|||
125194839|NCT02477332|450335003|FG003|Overall Study|Pregnancy|1|||
125194840|NCT02477332|450335004|FG004|Overall Study|Pregnancy|0|||
125194841|NCT02477332|450335005|FG005|Overall Study|Pregnancy|0|||
125194842|NCT02477332|450335000|FG000|Overall Study|Protocol Violation|2|||
125194843|NCT02477332|450335001|FG001|Overall Study|Protocol Violation|0|||
125194844|NCT02477332|450335002|FG002|Overall Study|Protocol Violation|3|||
125194845|NCT02477332|450335003|FG003|Overall Study|Protocol Violation|3|||
125194846|NCT02477332|450335004|FG004|Overall Study|Protocol Violation|1|||
125194847|NCT02477332|450335005|FG005|Overall Study|Protocol Violation|1|||
125194848|NCT02477332|450335000|FG000|Overall Study|Technical problems|0|||
125194849|NCT02477332|450335001|FG001|Overall Study|Technical problems|0|||
125194850|NCT02477332|450335002|FG002|Overall Study|Technical problems|1|||
125194851|NCT02477332|450335003|FG003|Overall Study|Technical problems|0|||
125194852|NCT02477332|450335004|FG004|Overall Study|Technical problems|0|||
125194853|NCT02477332|450335005|FG005|Overall Study|Technical problems|0|||
125194854|NCT02477332|450335000|FG000|Overall Study|Lost to Follow-up|0|||
125194855|NCT02477332|450335001|FG001|Overall Study|Lost to Follow-up|0|||
125194856|NCT02477332|450335002|FG002|Overall Study|Lost to Follow-up|2|||
125194857|NCT02477332|450335003|FG003|Overall Study|Lost to Follow-up|0|||
125194858|NCT02477332|450335004|FG004|Overall Study|Lost to Follow-up|0|||
125194859|NCT02477332|450335005|FG005|Overall Study|Lost to Follow-up|0|||
125194860|NCT02477332|450335000|FG000|Overall Study|Physician Decision|0|||
125194861|NCT02477332|450335001|FG001|Overall Study|Physician Decision|0|||
125194862|NCT02477332|450335002|FG002|Overall Study|Physician Decision|1|||
125247444|NCT04518410|450531099|FG022|Overall Study|Withdrawal by Subject|2|||
125247445|NCT04518410|450531100|FG023|Overall Study|Withdrawal by Subject|9|||
125194863|NCT02477332|450335003|FG003|Overall Study|Physician Decision|3|||
125194864|NCT02477332|450335004|FG004|Overall Study|Physician Decision|0|||
125194865|NCT02477332|450335005|FG005|Overall Study|Physician Decision|1|||
125194866|NCT02477332|450335000|FG000|Overall Study|Withdrawal by Subject|0|||
125194867|NCT02477332|450335001|FG001|Overall Study|Withdrawal by Subject|3|||
125194868|NCT02477332|450335002|FG002|Overall Study|Withdrawal by Subject|1|||
125194869|NCT02477332|450335003|FG003|Overall Study|Withdrawal by Subject|2|||
125247446|NCT04518410|450531101|FG024|Overall Study|Withdrawal by Subject|8|||
125194870|NCT02477332|450335004|FG004|Overall Study|Withdrawal by Subject|1|||
125194871|NCT02477332|450335005|FG005|Overall Study|Withdrawal by Subject|0|||
125194872|NCT02549287|450335006|FG000|Overall Study|Lost to Follow-up|65|||
125194873|NCT02549287|450335007|FG001|Overall Study|Lost to Follow-up|26|||
125194874|NCT02549287|450335006|FG000|Overall Study|Withdrawal by Subject|15|||
125194875|NCT02549287|450335007|FG001|Overall Study|Withdrawal by Subject|6|||
125194876|NCT00765336|450335008|FG000|Overall Study|Protocol Violation|4|||
125194877|NCT00765336|450335009|FG001|Overall Study|Protocol Violation|2|||
125194878|NCT00765336|450335008|FG000|Overall Study|Withdrawal by Subject|6|||
125194879|NCT00765336|450335009|FG001|Overall Study|Withdrawal by Subject|4|||
125194880|NCT00765336|450335008|FG000|Overall Study|Lost to Follow-up|7|||
125194881|NCT00765336|450335009|FG001|Overall Study|Lost to Follow-up|9|||
125194882|NCT00765336|450335008|FG000|Overall Study|Adverse Event|2|||
125194883|NCT00765336|450335009|FG001|Overall Study|Adverse Event|1|||
125194884|NCT01972438|450335010|FG000|Baseline-Month 3 Crossover Period|Death|1|||
125194885|NCT01972438|450335011|FG001|Baseline-Month 3 Crossover Period|Death|0|||
125194886|NCT01972438|450335010|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
125194887|NCT01972438|450335011|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
125194888|NCT01972438|450335010|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
125194889|NCT01972438|450335011|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
125194890|NCT01972438|450335010|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
125194891|NCT01972438|450335011|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
125194892|NCT01972438|450335010|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
125194893|NCT01972438|450335011|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
125194894|NCT01972438|450335010|FG000|Months 6-12 Study Period|Death|1|||
125194895|NCT01972438|450335011|FG001|Months 6-12 Study Period|Death|0|||
125194896|NCT01972438|450335010|FG000|Months 6-12 Study Period|Early Study Closure|2|||
125194897|NCT01972438|450335011|FG001|Months 6-12 Study Period|Early Study Closure|2|||
125194898|NCT01972438|450335010|FG000|Post Month 12 Study Period|Early Study Closure|3|||
125194899|NCT01972438|450335011|FG001|Post Month 12 Study Period|Early Study Closure|4|||
125194900|NCT01186692|450335016|FG000|Overall Study|Not Catheterized|11|||
125194901|NCT01186692|450335016|FG000|Overall Study|Futher testing contraindicated implant|19|||
125194902|NCT01186692|450335016|FG000|Overall Study|Adverse Event|2|||
125194903|NCT04463251|450335017|FG000|Overall Study|Death|1|||
125194904|NCT04463251|450335018|FG001|Overall Study|Death|0|||
125194905|NCT04463251|450335019|FG002|Overall Study|Death|1|||
125194906|NCT04463251|450335017|FG000|Overall Study|Adverse Event|0|||
125194907|NCT04463251|450335018|FG001|Overall Study|Adverse Event|1|||
125194908|NCT04463251|450335019|FG002|Overall Study|Adverse Event|0|||
125194909|NCT04463251|450335017|FG000|Overall Study|Lost to Follow-up|0|||
125194910|NCT04463251|450335018|FG001|Overall Study|Lost to Follow-up|1|||
125194911|NCT04463251|450335019|FG002|Overall Study|Lost to Follow-up|0|||
125194912|NCT04463251|450335017|FG000|Overall Study|Withdrawal by Subject|0|||
125194913|NCT04463251|450335018|FG001|Overall Study|Withdrawal by Subject|2|||
125194914|NCT04463251|450335019|FG002|Overall Study|Withdrawal by Subject|2|||
125194915|NCT04520997|450335025|FG000|Overall Study|Lost to Follow-up|1|||
125194916|NCT04520997|450335026|FG001|Overall Study|Lost to Follow-up|1|||
125194917|NCT04520997|450335025|FG000|Overall Study|Withdrawal by Subject|1|||
125194918|NCT04520997|450335026|FG001|Overall Study|Withdrawal by Subject|0|||
125194919|NCT04520997|450335025|FG000|Overall Study|Not Treated|0|||
125194920|NCT04520997|450335026|FG001|Overall Study|Not Treated|1|||
125194921|NCT02981082|450335027|FG000|Overall Study|Withdrawal by Subject|2|||
125194922|NCT02981082|450335028|FG001|Overall Study|Withdrawal by Subject|0|||
125194923|NCT02981082|450335027|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
125194924|NCT02981082|450335028|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
125194925|NCT02981082|450335027|FG000|Overall Study|Adverse Event|0|||
125194926|NCT02981082|450335028|FG001|Overall Study|Adverse Event|1|||
125194927|NCT05367973|450335029|FG000|Overall Study|Adverse Event|0|||
125194928|NCT05367973|450335030|FG001|Overall Study|Adverse Event|2|||
125194929|NCT01314872|450335034|FG000|Treatment Period 1|Protocol Violation|2|||
125194930|NCT01314872|450335035|FG001|Treatment Period 1|Protocol Violation|1|||
125194931|NCT01314872|450335036|FG002|Treatment Period 1|Protocol Violation|1|||
125194932|NCT01314872|450335037|FG003|Treatment Period 1|Protocol Violation|0|||
125194933|NCT01314872|450335038|FG004|Treatment Period 1|Protocol Violation|1|||
125194934|NCT01314872|450335039|FG005|Treatment Period 1|Protocol Violation|0|||
125194935|NCT01314872|450335040|FG006|Treatment Period 1|Protocol Violation|0|||
125194936|NCT01314872|450335041|FG007|Treatment Period 1|Protocol Violation|0|||
125194937|NCT01314872|450335042|FG008|Treatment Period 1|Protocol Violation|0|||
125194938|NCT01314872|450335043|FG009|Treatment Period 1|Protocol Violation|1|||
125194939|NCT01314872|450335044|FG010|Treatment Period 1|Protocol Violation|1|||
125194940|NCT01314872|450335045|FG011|Treatment Period 1|Protocol Violation|0|||
125194941|NCT01314872|450335046|FG012|Treatment Period 1|Protocol Violation|0|||
125194942|NCT01314872|450335047|FG013|Treatment Period 1|Protocol Violation|0|||
125194943|NCT01314872|450335048|FG014|Treatment Period 1|Protocol Violation|0|||
125194944|NCT01314872|450335034|FG000|Treatment Period 1|Physician Decision|0|||
125194945|NCT01314872|450335035|FG001|Treatment Period 1|Physician Decision|1|||
125194946|NCT01314872|450335036|FG002|Treatment Period 1|Physician Decision|0|||
125194947|NCT01314872|450335037|FG003|Treatment Period 1|Physician Decision|1|||
125194948|NCT01314872|450335038|FG004|Treatment Period 1|Physician Decision|0|||
125194949|NCT01314872|450335039|FG005|Treatment Period 1|Physician Decision|0|||
125194950|NCT01314872|450335040|FG006|Treatment Period 1|Physician Decision|0|||
125194951|NCT01314872|450335041|FG007|Treatment Period 1|Physician Decision|0|||
125194952|NCT01314872|450335042|FG008|Treatment Period 1|Physician Decision|0|||
125247447|NCT04518410|450531077|FG000|Overall Study|Other|1|||
125247448|NCT04518410|450531078|FG001|Overall Study|Other|0|||
125247449|NCT04518410|450531079|FG002|Overall Study|Other|0|||
125247450|NCT04518410|450531080|FG003|Overall Study|Other|1|||
125247451|NCT04518410|450531081|FG004|Overall Study|Other|6|||
125247452|NCT04518410|450531082|FG005|Overall Study|Other|6|||
125247453|NCT04518410|450531083|FG006|Overall Study|Other|5|||
125247454|NCT04518410|450531084|FG007|Overall Study|Other|2|||
125247455|NCT04518410|450531085|FG008|Overall Study|Other|0|||
125247456|NCT04518410|450531086|FG009|Overall Study|Other|1|||
125247457|NCT04518410|450531087|FG010|Overall Study|Other|0|||
125247458|NCT04518410|450531088|FG011|Overall Study|Other|2|||
125247459|NCT04518410|450531089|FG012|Overall Study|Other|0|||
125247460|NCT04518410|450531090|FG013|Overall Study|Other|0|||
125247461|NCT04518410|450531091|FG014|Overall Study|Other|0|||
125247462|NCT04518410|450531092|FG015|Overall Study|Other|3|||
125247463|NCT04518410|450531093|FG016|Overall Study|Other|1|||
125247464|NCT04518410|450531094|FG017|Overall Study|Other|1|||
125247465|NCT04518410|450531095|FG018|Overall Study|Other|1|||
125247466|NCT04518410|450531096|FG019|Overall Study|Other|0|||
125247467|NCT04518410|450531097|FG020|Overall Study|Other|1|||
125247468|NCT04518410|450531098|FG021|Overall Study|Other|0|||
125247469|NCT04518410|450531099|FG022|Overall Study|Other|1|||
125247470|NCT04518410|450531100|FG023|Overall Study|Other|2|||
125247471|NCT04518410|450531101|FG024|Overall Study|Other|2|||
125247472|NCT04518410|450531077|FG000|Overall Study|Protocol Violation|0|||
125247473|NCT04518410|450531078|FG001|Overall Study|Protocol Violation|0|||
125194953|NCT01314872|450335043|FG009|Treatment Period 1|Physician Decision|1|||
125194954|NCT01314872|450335044|FG010|Treatment Period 1|Physician Decision|0|||
125194955|NCT01314872|450335045|FG011|Treatment Period 1|Physician Decision|0|||
125194956|NCT01314872|450335046|FG012|Treatment Period 1|Physician Decision|0|||
125247474|NCT04518410|450531079|FG002|Overall Study|Protocol Violation|0|||
125194957|NCT01314872|450335047|FG013|Treatment Period 1|Physician Decision|0|||
125247475|NCT04518410|450531080|FG003|Overall Study|Protocol Violation|2|||
125247476|NCT04518410|450531081|FG004|Overall Study|Protocol Violation|17|||
125247477|NCT04518410|450531082|FG005|Overall Study|Protocol Violation|1|||
125194958|NCT01314872|450335048|FG014|Treatment Period 1|Physician Decision|0|||
125247478|NCT04518410|450531083|FG006|Overall Study|Protocol Violation|2|||
125247479|NCT04518410|450531084|FG007|Overall Study|Protocol Violation|1|||
125247480|NCT04518410|450531085|FG008|Overall Study|Protocol Violation|0|||
125247481|NCT04518410|450531086|FG009|Overall Study|Protocol Violation|0|||
125247482|NCT04518410|450531087|FG010|Overall Study|Protocol Violation|0|||
125194959|NCT01314872|450335034|FG000|Treatment Period 1|Lack of Efficacy|1|||
125194960|NCT01314872|450335035|FG001|Treatment Period 1|Lack of Efficacy|0|||
125194961|NCT01314872|450335036|FG002|Treatment Period 1|Lack of Efficacy|0|||
125194962|NCT01314872|450335037|FG003|Treatment Period 1|Lack of Efficacy|0|||
125194963|NCT01314872|450335038|FG004|Treatment Period 1|Lack of Efficacy|0|||
125194964|NCT01314872|450335039|FG005|Treatment Period 1|Lack of Efficacy|1|||
125194965|NCT01314872|450335040|FG006|Treatment Period 1|Lack of Efficacy|0|||
125194966|NCT01314872|450335041|FG007|Treatment Period 1|Lack of Efficacy|2|||
125194967|NCT01314872|450335042|FG008|Treatment Period 1|Lack of Efficacy|0|||
125194968|NCT01314872|450335043|FG009|Treatment Period 1|Lack of Efficacy|0|||
125194969|NCT01314872|450335044|FG010|Treatment Period 1|Lack of Efficacy|0|||
125194970|NCT01314872|450335045|FG011|Treatment Period 1|Lack of Efficacy|0|||
125194971|NCT01314872|450335046|FG012|Treatment Period 1|Lack of Efficacy|0|||
125247483|NCT04518410|450531088|FG011|Overall Study|Protocol Violation|0|||
125247484|NCT04518410|450531089|FG012|Overall Study|Protocol Violation|0|||
125247485|NCT04518410|450531090|FG013|Overall Study|Protocol Violation|0|||
125247486|NCT04518410|450531091|FG014|Overall Study|Protocol Violation|0|||
125194972|NCT01314872|450335047|FG013|Treatment Period 1|Lack of Efficacy|0|||
125247487|NCT04518410|450531092|FG015|Overall Study|Protocol Violation|0|||
125247488|NCT04518410|450531093|FG016|Overall Study|Protocol Violation|1|||
125247489|NCT04518410|450531094|FG017|Overall Study|Protocol Violation|1|||
125247490|NCT04518410|450531095|FG018|Overall Study|Protocol Violation|0|||
125247491|NCT04518410|450531096|FG019|Overall Study|Protocol Violation|0|||
125247492|NCT04518410|450531097|FG020|Overall Study|Protocol Violation|1|||
125247493|NCT04518410|450531098|FG021|Overall Study|Protocol Violation|2|||
125247494|NCT04518410|450531099|FG022|Overall Study|Protocol Violation|0|||
125247495|NCT04518410|450531100|FG023|Overall Study|Protocol Violation|3|||
125247496|NCT04518410|450531101|FG024|Overall Study|Protocol Violation|0|||
125247497|NCT04518410|450531077|FG000|Overall Study|Death|0|||
125247498|NCT04518410|450531078|FG001|Overall Study|Death|0|||
125247499|NCT04518410|450531079|FG002|Overall Study|Death|0|||
125194973|NCT01314872|450335048|FG014|Treatment Period 1|Lack of Efficacy|0|||
125194974|NCT01314872|450335034|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
125194975|NCT01314872|450335035|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
125194976|NCT01314872|450335036|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
125194977|NCT01314872|450335037|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
125194978|NCT01314872|450335038|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
125194979|NCT01314872|450335039|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
125194980|NCT01314872|450335040|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
125194981|NCT01314872|450335041|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
125194982|NCT01314872|450335042|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
125194983|NCT01314872|450335043|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
125194984|NCT01314872|450335044|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
125194985|NCT01314872|450335045|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
125194986|NCT01314872|450335046|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
125194987|NCT01314872|450335047|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
125194988|NCT01314872|450335048|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
125194989|NCT01314872|450335034|FG000|Treatment Period 1|Withdrawal by Subject|3|||
125194990|NCT01314872|450335035|FG001|Treatment Period 1|Withdrawal by Subject|1|||
125194991|NCT01314872|450335036|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125194992|NCT01314872|450335037|FG003|Treatment Period 1|Withdrawal by Subject|2|||
125194993|NCT01314872|450335038|FG004|Treatment Period 1|Withdrawal by Subject|3|||
125194994|NCT01314872|450335039|FG005|Treatment Period 1|Withdrawal by Subject|1|||
125194995|NCT01314872|450335040|FG006|Treatment Period 1|Withdrawal by Subject|3|||
125194996|NCT01314872|450335041|FG007|Treatment Period 1|Withdrawal by Subject|2|||
125194997|NCT01314872|450335042|FG008|Treatment Period 1|Withdrawal by Subject|2|||
125194998|NCT01314872|450335043|FG009|Treatment Period 1|Withdrawal by Subject|2|||
125194999|NCT01314872|450335044|FG010|Treatment Period 1|Withdrawal by Subject|1|||
125195000|NCT01314872|450335045|FG011|Treatment Period 1|Withdrawal by Subject|0|||
125195001|NCT01314872|450335046|FG012|Treatment Period 1|Withdrawal by Subject|0|||
125247500|NCT04518410|450531080|FG003|Overall Study|Death|0|||
125247501|NCT04518410|450531081|FG004|Overall Study|Death|12|||
125247502|NCT04518410|450531082|FG005|Overall Study|Death|2|||
125247503|NCT04518410|450531083|FG006|Overall Study|Death|11|||
125247504|NCT04518410|450531084|FG007|Overall Study|Death|0|||
125247505|NCT04518410|450531085|FG008|Overall Study|Death|1|||
125247506|NCT04518410|450531086|FG009|Overall Study|Death|0|||
125247507|NCT04518410|450531087|FG010|Overall Study|Death|0|||
125247508|NCT04518410|450531088|FG011|Overall Study|Death|0|||
125247509|NCT04518410|450531089|FG012|Overall Study|Death|0|||
125247510|NCT04518410|450531090|FG013|Overall Study|Death|1|||
125247511|NCT04518410|450531091|FG014|Overall Study|Death|1|||
125247512|NCT04518410|450531092|FG015|Overall Study|Death|0|||
125247513|NCT04518410|450531093|FG016|Overall Study|Death|0|||
125195002|NCT01314872|450335047|FG013|Treatment Period 1|Withdrawal by Subject|0|||
125195003|NCT01314872|450335048|FG014|Treatment Period 1|Withdrawal by Subject|0|||
125195004|NCT01314872|450335034|FG000|Treatment Period 1|Lost to Follow-up|0|||
125195005|NCT01314872|450335035|FG001|Treatment Period 1|Lost to Follow-up|1|||
125247514|NCT04518410|450531094|FG017|Overall Study|Death|1|||
125247515|NCT04518410|450531095|FG018|Overall Study|Death|4|||
125247516|NCT04518410|450531096|FG019|Overall Study|Death|4|||
125247517|NCT04518410|450531097|FG020|Overall Study|Death|1|||
125247518|NCT04518410|450531098|FG021|Overall Study|Death|0|||
125247519|NCT04518410|450531099|FG022|Overall Study|Death|0|||
125247520|NCT04518410|450531100|FG023|Overall Study|Death|0|||
125247521|NCT04518410|450531101|FG024|Overall Study|Death|0|||
125247522|NCT04518410|450531077|FG000|Overall Study|Requirement to start alternative therapy|0|||
125247523|NCT04518410|450531078|FG001|Overall Study|Requirement to start alternative therapy|0|||
125247524|NCT04518410|450531079|FG002|Overall Study|Requirement to start alternative therapy|1|||
125247525|NCT04518410|450531080|FG003|Overall Study|Requirement to start alternative therapy|0|||
125195006|NCT01314872|450335036|FG002|Treatment Period 1|Lost to Follow-up|2|||
125195007|NCT01314872|450335037|FG003|Treatment Period 1|Lost to Follow-up|2|||
125195008|NCT01314872|450335038|FG004|Treatment Period 1|Lost to Follow-up|1|||
125195009|NCT01314872|450335039|FG005|Treatment Period 1|Lost to Follow-up|1|||
125247526|NCT04518410|450531081|FG004|Overall Study|Requirement to start alternative therapy|0|||
125247527|NCT04518410|450531082|FG005|Overall Study|Requirement to start alternative therapy|0|||
125247528|NCT04518410|450531083|FG006|Overall Study|Requirement to start alternative therapy|0|||
125247529|NCT04518410|450531084|FG007|Overall Study|Requirement to start alternative therapy|0|||
125247530|NCT04518410|450531085|FG008|Overall Study|Requirement to start alternative therapy|0|||
125247531|NCT04518410|450531086|FG009|Overall Study|Requirement to start alternative therapy|0|||
125247532|NCT04518410|450531087|FG010|Overall Study|Requirement to start alternative therapy|0|||
125247533|NCT04518410|450531088|FG011|Overall Study|Requirement to start alternative therapy|0|||
125247534|NCT04518410|450531089|FG012|Overall Study|Requirement to start alternative therapy|0|||
125247535|NCT04518410|450531090|FG013|Overall Study|Requirement to start alternative therapy|0|||
125247536|NCT04518410|450531091|FG014|Overall Study|Requirement to start alternative therapy|0|||
125247537|NCT04518410|450531092|FG015|Overall Study|Requirement to start alternative therapy|0|||
125247538|NCT04518410|450531093|FG016|Overall Study|Requirement to start alternative therapy|0|||
125247539|NCT04518410|450531094|FG017|Overall Study|Requirement to start alternative therapy|0|||
125247540|NCT04518410|450531095|FG018|Overall Study|Requirement to start alternative therapy|0|||
125247541|NCT04518410|450531096|FG019|Overall Study|Requirement to start alternative therapy|0|||
125247542|NCT04518410|450531097|FG020|Overall Study|Requirement to start alternative therapy|0|||
125247543|NCT04518410|450531098|FG021|Overall Study|Requirement to start alternative therapy|0|||
125247544|NCT04518410|450531099|FG022|Overall Study|Requirement to start alternative therapy|0|||
125247545|NCT04518410|450531100|FG023|Overall Study|Requirement to start alternative therapy|0|||
125247546|NCT04518410|450531101|FG024|Overall Study|Requirement to start alternative therapy|0|||
125247547|NCT04518410|450531077|FG000|Overall Study|Randomized but not treated|0|||
125195010|NCT01314872|450335040|FG006|Treatment Period 1|Lost to Follow-up|1|||
125247548|NCT04518410|450531078|FG001|Overall Study|Randomized but not treated|0|||
125247549|NCT04518410|450531079|FG002|Overall Study|Randomized but not treated|0|||
125247550|NCT04518410|450531080|FG003|Overall Study|Randomized but not treated|2|||
125247551|NCT04518410|450531081|FG004|Overall Study|Randomized but not treated|6|||
125247552|NCT04518410|450531082|FG005|Overall Study|Randomized but not treated|4|||
125247553|NCT04518410|450531083|FG006|Overall Study|Randomized but not treated|3|||
125247554|NCT04518410|450531084|FG007|Overall Study|Randomized but not treated|3|||
125247555|NCT04518410|450531085|FG008|Overall Study|Randomized but not treated|0|||
125195011|NCT01314872|450335041|FG007|Treatment Period 1|Lost to Follow-up|1|||
125195012|NCT01314872|450335042|FG008|Treatment Period 1|Lost to Follow-up|1|||
125195013|NCT01314872|450335043|FG009|Treatment Period 1|Lost to Follow-up|0|||
125195014|NCT01314872|450335044|FG010|Treatment Period 1|Lost to Follow-up|0|||
125195015|NCT01314872|450335045|FG011|Treatment Period 1|Lost to Follow-up|0|||
125195016|NCT01314872|450335046|FG012|Treatment Period 1|Lost to Follow-up|0|||
125195017|NCT01314872|450335047|FG013|Treatment Period 1|Lost to Follow-up|0|||
125195018|NCT01314872|450335048|FG014|Treatment Period 1|Lost to Follow-up|0|||
125195019|NCT01314872|450335034|FG000|Period 2|Protocol Violation|0|||
125195020|NCT01314872|450335035|FG001|Period 2|Protocol Violation|0|||
125195021|NCT01314872|450335036|FG002|Period 2|Protocol Violation|0|||
125195022|NCT01314872|450335037|FG003|Period 2|Protocol Violation|0|||
125247556|NCT04518410|450531086|FG009|Overall Study|Randomized but not treated|4|||
125247557|NCT04518410|450531087|FG010|Overall Study|Randomized but not treated|0|||
125247558|NCT04518410|450531088|FG011|Overall Study|Randomized but not treated|0|||
125247559|NCT04518410|450531089|FG012|Overall Study|Randomized but not treated|1|||
125247560|NCT04518410|450531090|FG013|Overall Study|Randomized but not treated|3|||
125247561|NCT04518410|450531091|FG014|Overall Study|Randomized but not treated|3|||
125247562|NCT04518410|450531092|FG015|Overall Study|Randomized but not treated|3|||
125247563|NCT04518410|450531093|FG016|Overall Study|Randomized but not treated|4|||
125247564|NCT04518410|450531094|FG017|Overall Study|Randomized but not treated|5|||
125247565|NCT04518410|450531095|FG018|Overall Study|Randomized but not treated|4|||
125247566|NCT04518410|450531096|FG019|Overall Study|Randomized but not treated|0|||
125195023|NCT01314872|450335038|FG004|Period 2|Protocol Violation|0|||
125247567|NCT04518410|450531097|FG020|Overall Study|Randomized but not treated|0|||
125247568|NCT04518410|450531098|FG021|Overall Study|Randomized but not treated|5|||
125195024|NCT01314872|450335039|FG005|Period 2|Protocol Violation|0|||
125247569|NCT04518410|450531099|FG022|Overall Study|Randomized but not treated|0|||
125247570|NCT04518410|450531100|FG023|Overall Study|Randomized but not treated|3|||
125247571|NCT04518410|450531101|FG024|Overall Study|Randomized but not treated|1|||
125247572|NCT04518410|450531077|FG000|Overall Study|Screen Fail but Randomized|0|||
125247573|NCT04518410|450531078|FG001|Overall Study|Screen Fail but Randomized|0|||
125247574|NCT04518410|450531079|FG002|Overall Study|Screen Fail but Randomized|0|||
125247575|NCT04518410|450531080|FG003|Overall Study|Screen Fail but Randomized|0|||
125247576|NCT04518410|450531081|FG004|Overall Study|Screen Fail but Randomized|2|||
125195025|NCT01314872|450335040|FG006|Period 2|Protocol Violation|0|||
125195026|NCT01314872|450335041|FG007|Period 2|Protocol Violation|0|||
125195027|NCT01314872|450335042|FG008|Period 2|Protocol Violation|0|||
125195028|NCT01314872|450335043|FG009|Period 2|Protocol Violation|0|||
125195029|NCT01314872|450335044|FG010|Period 2|Protocol Violation|0|||
125195030|NCT01314872|450335045|FG011|Period 2|Protocol Violation|3|||
125195031|NCT01314872|450335046|FG012|Period 2|Protocol Violation|3|||
125195032|NCT01314872|450335047|FG013|Period 2|Protocol Violation|2|||
125195033|NCT01314872|450335048|FG014|Period 2|Protocol Violation|0|||
125195034|NCT01314872|450335034|FG000|Period 2|Non-compliance with study drug|0|||
125195035|NCT01314872|450335035|FG001|Period 2|Non-compliance with study drug|0|||
125195036|NCT01314872|450335036|FG002|Period 2|Non-compliance with study drug|0|||
125195037|NCT01314872|450335037|FG003|Period 2|Non-compliance with study drug|0|||
125195038|NCT01314872|450335038|FG004|Period 2|Non-compliance with study drug|0|||
125195039|NCT01314872|450335039|FG005|Period 2|Non-compliance with study drug|0|||
125195040|NCT01314872|450335040|FG006|Period 2|Non-compliance with study drug|0|||
125195041|NCT01314872|450335041|FG007|Period 2|Non-compliance with study drug|0|||
125195042|NCT01314872|450335042|FG008|Period 2|Non-compliance with study drug|0|||
125195043|NCT01314872|450335043|FG009|Period 2|Non-compliance with study drug|0|||
125195044|NCT01314872|450335044|FG010|Period 2|Non-compliance with study drug|0|||
125195045|NCT01314872|450335045|FG011|Period 2|Non-compliance with study drug|3|||
125195046|NCT01314872|450335046|FG012|Period 2|Non-compliance with study drug|3|||
125195047|NCT01314872|450335047|FG013|Period 2|Non-compliance with study drug|1|||
125195048|NCT01314872|450335048|FG014|Period 2|Non-compliance with study drug|2|||
125195049|NCT01314872|450335034|FG000|Period 2|Lack of Efficacy|0|||
125195050|NCT01314872|450335035|FG001|Period 2|Lack of Efficacy|0|||
125195051|NCT01314872|450335036|FG002|Period 2|Lack of Efficacy|0|||
125195052|NCT01314872|450335037|FG003|Period 2|Lack of Efficacy|0|||
125195053|NCT01314872|450335038|FG004|Period 2|Lack of Efficacy|0|||
125195054|NCT01314872|450335039|FG005|Period 2|Lack of Efficacy|0|||
125195055|NCT01314872|450335040|FG006|Period 2|Lack of Efficacy|0|||
125195056|NCT01314872|450335041|FG007|Period 2|Lack of Efficacy|0|||
125195057|NCT01314872|450335042|FG008|Period 2|Lack of Efficacy|0|||
125195058|NCT01314872|450335043|FG009|Period 2|Lack of Efficacy|0|||
125195059|NCT01314872|450335044|FG010|Period 2|Lack of Efficacy|0|||
125195060|NCT01314872|450335045|FG011|Period 2|Lack of Efficacy|7|||
125195061|NCT01314872|450335046|FG012|Period 2|Lack of Efficacy|12|||
125195062|NCT01314872|450335047|FG013|Period 2|Lack of Efficacy|9|||
125195063|NCT01314872|450335048|FG014|Period 2|Lack of Efficacy|2|||
125195064|NCT01314872|450335034|FG000|Period 2|Pregnancy|0|||
125195065|NCT01314872|450335035|FG001|Period 2|Pregnancy|0|||
125195066|NCT01314872|450335036|FG002|Period 2|Pregnancy|0|||
125195067|NCT01314872|450335037|FG003|Period 2|Pregnancy|0|||
125195068|NCT01314872|450335038|FG004|Period 2|Pregnancy|0|||
125195069|NCT01314872|450335039|FG005|Period 2|Pregnancy|0|||
125195070|NCT01314872|450335040|FG006|Period 2|Pregnancy|0|||
125195071|NCT01314872|450335041|FG007|Period 2|Pregnancy|0|||
125195072|NCT01314872|450335042|FG008|Period 2|Pregnancy|0|||
125195073|NCT01314872|450335043|FG009|Period 2|Pregnancy|0|||
125195074|NCT01314872|450335044|FG010|Period 2|Pregnancy|0|||
125195075|NCT01314872|450335045|FG011|Period 2|Pregnancy|0|||
125195076|NCT01314872|450335046|FG012|Period 2|Pregnancy|0|||
125195077|NCT01314872|450335047|FG013|Period 2|Pregnancy|0|||
125195078|NCT01314872|450335048|FG014|Period 2|Pregnancy|1|||
125195079|NCT01314872|450335034|FG000|Period 2|Study terminated by Sponsor|0|||
125195080|NCT01314872|450335035|FG001|Period 2|Study terminated by Sponsor|0|||
125195081|NCT01314872|450335036|FG002|Period 2|Study terminated by Sponsor|0|||
125195082|NCT01314872|450335037|FG003|Period 2|Study terminated by Sponsor|0|||
125195083|NCT01314872|450335038|FG004|Period 2|Study terminated by Sponsor|0|||
125195084|NCT01314872|450335039|FG005|Period 2|Study terminated by Sponsor|0|||
125195085|NCT01314872|450335040|FG006|Period 2|Study terminated by Sponsor|0|||
125195086|NCT01314872|450335041|FG007|Period 2|Study terminated by Sponsor|0|||
125195087|NCT01314872|450335042|FG008|Period 2|Study terminated by Sponsor|0|||
125195088|NCT01314872|450335043|FG009|Period 2|Study terminated by Sponsor|0|||
125195089|NCT01314872|450335044|FG010|Period 2|Study terminated by Sponsor|0|||
125195090|NCT01314872|450335045|FG011|Period 2|Study terminated by Sponsor|2|||
125195091|NCT01314872|450335046|FG012|Period 2|Study terminated by Sponsor|2|||
125195092|NCT01314872|450335047|FG013|Period 2|Study terminated by Sponsor|3|||
125195093|NCT01314872|450335048|FG014|Period 2|Study terminated by Sponsor|0|||
125195094|NCT01314872|450335034|FG000|Period 2|Adverse event, non-fatal|0|||
125195095|NCT01314872|450335035|FG001|Period 2|Adverse event, non-fatal|0|||
125195096|NCT01314872|450335036|FG002|Period 2|Adverse event, non-fatal|0|||
125195097|NCT01314872|450335037|FG003|Period 2|Adverse event, non-fatal|0|||
125195098|NCT01314872|450335038|FG004|Period 2|Adverse event, non-fatal|0|||
125195099|NCT01314872|450335039|FG005|Period 2|Adverse event, non-fatal|0|||
125247577|NCT04518410|450531082|FG005|Overall Study|Screen Fail but Randomized|0|||
125247578|NCT04518410|450531083|FG006|Overall Study|Screen Fail but Randomized|0|||
125247579|NCT04518410|450531084|FG007|Overall Study|Screen Fail but Randomized|0|||
125247580|NCT04518410|450531085|FG008|Overall Study|Screen Fail but Randomized|0|||
125247581|NCT04518410|450531086|FG009|Overall Study|Screen Fail but Randomized|0|||
125247582|NCT04518410|450531087|FG010|Overall Study|Screen Fail but Randomized|0|||
125247583|NCT04518410|450531088|FG011|Overall Study|Screen Fail but Randomized|0|||
125247584|NCT04518410|450531089|FG012|Overall Study|Screen Fail but Randomized|0|||
125247585|NCT04518410|450531090|FG013|Overall Study|Screen Fail but Randomized|0|||
125247586|NCT04518410|450531091|FG014|Overall Study|Screen Fail but Randomized|0|||
125247587|NCT04518410|450531092|FG015|Overall Study|Screen Fail but Randomized|0|||
125247588|NCT04518410|450531093|FG016|Overall Study|Screen Fail but Randomized|0|||
125247589|NCT04518410|450531094|FG017|Overall Study|Screen Fail but Randomized|0|||
125247590|NCT04518410|450531095|FG018|Overall Study|Screen Fail but Randomized|0|||
125247591|NCT04518410|450531096|FG019|Overall Study|Screen Fail but Randomized|0|||
125247592|NCT04518410|450531097|FG020|Overall Study|Screen Fail but Randomized|0|||
125247593|NCT04518410|450531098|FG021|Overall Study|Screen Fail but Randomized|0|||
125247594|NCT04518410|450531099|FG022|Overall Study|Screen Fail but Randomized|0|||
125247595|NCT04518410|450531100|FG023|Overall Study|Screen Fail but Randomized|0|||
125247596|NCT04518410|450531101|FG024|Overall Study|Screen Fail but Randomized|0|||
125247597|NCT04518410|450531077|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
125247598|NCT04518410|450531078|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
125247599|NCT04518410|450531079|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
125247600|NCT04518410|450531080|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
125247601|NCT04518410|450531081|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
125247602|NCT04518410|450531082|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
125247603|NCT04518410|450531083|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
125247604|NCT04518410|450531084|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
125247605|NCT04518410|450531085|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
125195100|NCT01314872|450335040|FG006|Period 2|Adverse event, non-fatal|0|||
125195101|NCT01314872|450335041|FG007|Period 2|Adverse event, non-fatal|0|||
125195102|NCT01314872|450335042|FG008|Period 2|Adverse event, non-fatal|0|||
125195103|NCT01314872|450335043|FG009|Period 2|Adverse event, non-fatal|0|||
125195104|NCT01314872|450335044|FG010|Period 2|Adverse event, non-fatal|0|||
125195105|NCT01314872|450335045|FG011|Period 2|Adverse event, non-fatal|13|||
125195106|NCT01314872|450335046|FG012|Period 2|Adverse event, non-fatal|16|||
125195107|NCT01314872|450335047|FG013|Period 2|Adverse event, non-fatal|24|||
125195108|NCT01314872|450335048|FG014|Period 2|Adverse event, non-fatal|9|||
125195109|NCT01314872|450335034|FG000|Period 2|Withdrawal by Subject|0|||
125195110|NCT01314872|450335035|FG001|Period 2|Withdrawal by Subject|0|||
125195111|NCT01314872|450335036|FG002|Period 2|Withdrawal by Subject|0|||
125195112|NCT01314872|450335037|FG003|Period 2|Withdrawal by Subject|0|||
125195113|NCT01314872|450335038|FG004|Period 2|Withdrawal by Subject|0|||
125195114|NCT01314872|450335039|FG005|Period 2|Withdrawal by Subject|0|||
125195115|NCT01314872|450335040|FG006|Period 2|Withdrawal by Subject|0|||
125195116|NCT01314872|450335041|FG007|Period 2|Withdrawal by Subject|0|||
125195117|NCT01314872|450335042|FG008|Period 2|Withdrawal by Subject|0|||
125195118|NCT01314872|450335043|FG009|Period 2|Withdrawal by Subject|0|||
125195119|NCT01314872|450335044|FG010|Period 2|Withdrawal by Subject|0|||
125195120|NCT01314872|450335045|FG011|Period 2|Withdrawal by Subject|14|||
125195121|NCT01314872|450335046|FG012|Period 2|Withdrawal by Subject|17|||
125195122|NCT01314872|450335047|FG013|Period 2|Withdrawal by Subject|12|||
125195123|NCT01314872|450335048|FG014|Period 2|Withdrawal by Subject|4|||
125195124|NCT01314872|450335034|FG000|Period 2|Lost to Follow-up|0|||
125195125|NCT01314872|450335035|FG001|Period 2|Lost to Follow-up|0|||
125195126|NCT01314872|450335036|FG002|Period 2|Lost to Follow-up|0|||
125195127|NCT01314872|450335037|FG003|Period 2|Lost to Follow-up|0|||
125195128|NCT01314872|450335038|FG004|Period 2|Lost to Follow-up|0|||
125195129|NCT01314872|450335039|FG005|Period 2|Lost to Follow-up|0|||
125195130|NCT01314872|450335040|FG006|Period 2|Lost to Follow-up|0|||
125195131|NCT01314872|450335041|FG007|Period 2|Lost to Follow-up|0|||
125195132|NCT01314872|450335042|FG008|Period 2|Lost to Follow-up|0|||
125195133|NCT01314872|450335043|FG009|Period 2|Lost to Follow-up|0|||
125195134|NCT01314872|450335044|FG010|Period 2|Lost to Follow-up|0|||
125195135|NCT01314872|450335045|FG011|Period 2|Lost to Follow-up|6|||
125195136|NCT01314872|450335046|FG012|Period 2|Lost to Follow-up|7|||
125195137|NCT01314872|450335047|FG013|Period 2|Lost to Follow-up|2|||
125195138|NCT01314872|450335048|FG014|Period 2|Lost to Follow-up|6|||
125195139|NCT03232931|450336620|FG000|Overall Study|Physician Decision|1|||
125195140|NCT03232931|450336621|FG001|Overall Study|Physician Decision|1|||
125195141|NCT03232931|450336620|FG000|Overall Study|Withdrawal by Subject|6|||
125195142|NCT03232931|450336621|FG001|Overall Study|Withdrawal by Subject|0|||
125195143|NCT03232931|450336620|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
125195144|NCT03232931|450336621|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
125195145|NCT03232931|450336620|FG000|Overall Study|Parent did not record voice|1|||
125195146|NCT03232931|450336621|FG001|Overall Study|Parent did not record voice|2|||
125195147|NCT03232931|450336620|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
125195148|NCT03232931|450336621|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
125195149|NCT04925557|450336622|FG000|Overall Study|Study closed|5|||
125195150|NCT04925557|450336623|FG001|Overall Study|Study closed|3|||
125195151|NCT05488470|450336624|FG000|Overall Study|Physician Decision|2|||
125195152|NCT05488470|450336624|FG000|Overall Study|Withdrawal by Subject|1|||
125195153|NCT05488470|450336624|FG000|Overall Study|Death|1|||
125195154|NCT00068393|450336625|FG000|Overall Study|Adverse Event|2|||
125195155|NCT00068393|450336625|FG000|Overall Study|Death|3|||
125195156|NCT00068393|450336625|FG000|Overall Study|Withdrawal by Subject|3|||
125195157|NCT00068393|450336625|FG000|Overall Study|Alternative treatment|1|||
125195158|NCT00068393|450336625|FG000|Overall Study|Quality of life worsening|1|||
125195159|NCT04981470|450336634|FG000|Overall Study|Device failure in all 4 patients|4|||
125195160|NCT04390503|450336636|FG000|Overall Study|Physician Decision|2|||
125195161|NCT04390503|450336637|FG001|Overall Study|Physician Decision|1|||
125195162|NCT04390503|450336636|FG000|Overall Study|Adverse Event|1|||
125195163|NCT04390503|450336637|FG001|Overall Study|Adverse Event|0|||
125195164|NCT00468481|450336638|FG000|Overall Study|Adverse Event|13|||
125195165|NCT00468481|450336639|FG001|Overall Study|Adverse Event|3|||
125195166|NCT00468481|450336638|FG000|Overall Study|Lost to Follow-up|25|||
125195167|NCT00468481|450336639|FG001|Overall Study|Lost to Follow-up|8|||
125195168|NCT00468481|450336638|FG000|Overall Study|Pregnancy|2|||
125195169|NCT00468481|450336639|FG001|Overall Study|Pregnancy|0|||
125247606|NCT04518410|450531086|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
125247607|NCT04518410|450531087|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
125247608|NCT04518410|450531088|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
125247609|NCT04518410|450531089|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
125247610|NCT04518410|450531090|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
125247611|NCT04518410|450531091|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
125247612|NCT04518410|450531092|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
125247613|NCT04518410|450531093|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
125247614|NCT04518410|450531094|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
125247615|NCT04518410|450531095|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
125247616|NCT04518410|450531096|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
125247617|NCT04518410|450531097|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
125247618|NCT04518410|450531098|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
125195170|NCT00468481|450336638|FG000|Overall Study|Protocol Violation|18|||
125195171|NCT00468481|450336639|FG001|Overall Study|Protocol Violation|8|||
125195172|NCT00468481|450336638|FG000|Overall Study|Withdrawal by Subject|12|||
125195173|NCT00468481|450336639|FG001|Overall Study|Withdrawal by Subject|3|||
125195174|NCT00468481|450336638|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
125195175|NCT00468481|450336639|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
125195176|NCT00468481|450336638|FG000|Overall Study|Prohibited Medication|1|||
125195177|NCT00468481|450336639|FG001|Overall Study|Prohibited Medication|1|||
125195178|NCT00468481|450336638|FG000|Overall Study|Egg Donor|1|||
125195179|NCT00468481|450336639|FG001|Overall Study|Egg Donor|0|||
125195180|NCT00468481|450336638|FG000|Overall Study|Moved out of area|4|||
125195181|NCT00468481|450336639|FG001|Overall Study|Moved out of area|1|||
125195182|NCT00468481|450336638|FG000|Overall Study|Non-Compliance|5|||
125195183|NCT00468481|450336639|FG001|Overall Study|Non-Compliance|0|||
125195184|NCT00468481|450336638|FG000|Overall Study|Other|6|||
125195185|NCT00468481|450336639|FG001|Overall Study|Other|0|||
125195186|NCT00593684|450336641|FG000|Overall Study|Death|2|||
125195187|NCT00593684|450336642|FG001|Overall Study|Death|1|||
125195188|NCT00734162|450336643|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
125195189|NCT00734162|450336644|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
125195190|NCT00734162|450336645|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
125195191|NCT00734162|450336646|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
125195192|NCT00734162|450336643|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
125195193|NCT00734162|450336644|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
125195194|NCT00734162|450336645|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
125195195|NCT00734162|450336646|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
125195196|NCT00734162|450336643|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
125195197|NCT00734162|450336644|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
125195198|NCT00734162|450336645|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
125195199|NCT00734162|450336646|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
125195200|NCT00734162|450336643|FG000|Open-Label Phase|Withdrew Consent|1|||
125195201|NCT00734162|450336644|FG001|Open-Label Phase|Withdrew Consent|0|||
125195202|NCT00734162|450336645|FG002|Open-Label Phase|Withdrew Consent|1|||
125195203|NCT00734162|450336646|FG003|Open-Label Phase|Withdrew Consent|1|||
125195204|NCT00734162|450336643|FG000|Open-Label Phase|Lost to Follow-up|1|||
125195205|NCT00734162|450336644|FG001|Open-Label Phase|Lost to Follow-up|2|||
125195206|NCT00734162|450336645|FG002|Open-Label Phase|Lost to Follow-up|0|||
125195207|NCT00734162|450336646|FG003|Open-Label Phase|Lost to Follow-up|1|||
125195208|NCT00734162|450336643|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
125195209|NCT00734162|450336644|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
125195210|NCT00734162|450336645|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
125195211|NCT00734162|450336646|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
125195212|NCT00596687|450336647|FG000|Overall Study|< 24 hours of insulin treatment|8|||
125195213|NCT00596687|450336648|FG001|Overall Study|< 24 hours of insulin treatment|6|||
125195214|NCT00596687|450336647|FG000|Overall Study|continuous insulin infusion during TPN|2|||
125195215|NCT00596687|450336648|FG001|Overall Study|continuous insulin infusion during TPN|1|||
125195216|NCT00596687|450336647|FG000|Overall Study|Withdrawal by Subject|3|||
125195217|NCT00596687|450336648|FG001|Overall Study|Withdrawal by Subject|1|||
125195218|NCT00596687|450336647|FG000|Overall Study|cancelled surgery|1|||
125195219|NCT00596687|450336648|FG001|Overall Study|cancelled surgery|1|||
125247619|NCT04518410|450531099|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
125247620|NCT04518410|450531100|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
125247621|NCT04518410|450531101|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
125247622|NCT04518410|450531077|FG000|Overall Study|Dual Enrolled Subject|0|||
125247623|NCT04518410|450531078|FG001|Overall Study|Dual Enrolled Subject|0|||
125247624|NCT04518410|450531079|FG002|Overall Study|Dual Enrolled Subject|0|||
125247625|NCT04518410|450531080|FG003|Overall Study|Dual Enrolled Subject|0|||
125247626|NCT04518410|450531081|FG004|Overall Study|Dual Enrolled Subject|0|||
125247627|NCT04518410|450531082|FG005|Overall Study|Dual Enrolled Subject|0|||
125247628|NCT04518410|450531083|FG006|Overall Study|Dual Enrolled Subject|0|||
125247629|NCT04518410|450531084|FG007|Overall Study|Dual Enrolled Subject|0|||
125247630|NCT04518410|450531085|FG008|Overall Study|Dual Enrolled Subject|0|||
125247631|NCT04518410|450531086|FG009|Overall Study|Dual Enrolled Subject|0|||
125247632|NCT04518410|450531087|FG010|Overall Study|Dual Enrolled Subject|0|||
125247633|NCT04518410|450531088|FG011|Overall Study|Dual Enrolled Subject|0|||
125247634|NCT04518410|450531089|FG012|Overall Study|Dual Enrolled Subject|0|||
125247635|NCT04518410|450531090|FG013|Overall Study|Dual Enrolled Subject|0|||
125247636|NCT04518410|450531091|FG014|Overall Study|Dual Enrolled Subject|0|||
125247637|NCT04518410|450531092|FG015|Overall Study|Dual Enrolled Subject|0|||
125247638|NCT04518410|450531093|FG016|Overall Study|Dual Enrolled Subject|0|||
125247639|NCT04518410|450531094|FG017|Overall Study|Dual Enrolled Subject|1|||
125247640|NCT04518410|450531095|FG018|Overall Study|Dual Enrolled Subject|0|||
125247641|NCT04518410|450531096|FG019|Overall Study|Dual Enrolled Subject|0|||
125247642|NCT04518410|450531097|FG020|Overall Study|Dual Enrolled Subject|0|||
125247643|NCT04518410|450531098|FG021|Overall Study|Dual Enrolled Subject|0|||
125247644|NCT04518410|450531099|FG022|Overall Study|Dual Enrolled Subject|0|||
125247645|NCT04518410|450531100|FG023|Overall Study|Dual Enrolled Subject|0|||
125247646|NCT04518410|450531101|FG024|Overall Study|Dual Enrolled Subject|0|||
125247647|NCT05737745|450531102|FG000|Overall Study|Withdrawal by Subject|0|||
125247648|NCT05737745|450531103|FG001|Overall Study|Withdrawal by Subject|6|||
125247649|NCT05737745|450531104|FG002|Overall Study|Withdrawal by Subject|1|||
125247650|NCT04289298|450532665|FG000|Overall Study|Lost to Follow-up|5|||
125247651|NCT04289298|450532666|FG001|Overall Study|Lost to Follow-up|0|||
125247652|NCT04289298|450532665|FG000|Overall Study|Withdrawal by Subject|2|||
125247653|NCT04289298|450532666|FG001|Overall Study|Withdrawal by Subject|0|||
125247654|NCT01108796|450532668|FG000|Overall Study|Adverse Event|0|||
125247655|NCT01108796|450532669|FG001|Overall Study|Adverse Event|1|||
125247656|NCT01108796|450532668|FG000|Overall Study|Lost to Follow-up|7|||
125247657|NCT01108796|450532669|FG001|Overall Study|Lost to Follow-up|6|||
125247658|NCT00454142|450532670|FG000|Overall Study|Withdrawal by Subject|1|||
125247659|NCT02545127|450532677|FG000|Overall Study|Lost to Follow-up|1|||
125247660|NCT02545127|450532678|FG001|Overall Study|Lost to Follow-up|0|||
125247661|NCT00520572|450532679|FG000|Overall Study|Adverse Event|9|||
125247662|NCT00520572|450532680|FG001|Overall Study|Adverse Event|3|||
125247663|NCT00520572|450532681|FG002|Overall Study|Adverse Event|6|||
125247664|NCT00520572|450532682|FG003|Overall Study|Adverse Event|9|||
125247665|NCT00520572|450532683|FG004|Overall Study|Adverse Event|7|||
125247666|NCT00520572|450532684|FG005|Overall Study|Adverse Event|2|||
125247667|NCT00520572|450532679|FG000|Overall Study|Withdrawal by Subject|0|||
125247668|NCT00520572|450532680|FG001|Overall Study|Withdrawal by Subject|9|||
125247669|NCT00520572|450532681|FG002|Overall Study|Withdrawal by Subject|5|||
125247670|NCT00520572|450532682|FG003|Overall Study|Withdrawal by Subject|2|||
125247671|NCT00520572|450532683|FG004|Overall Study|Withdrawal by Subject|2|||
125247672|NCT00520572|450532684|FG005|Overall Study|Withdrawal by Subject|0|||
125247673|NCT00520572|450532679|FG000|Overall Study|Protocol Violation|0|||
125247674|NCT00520572|450532680|FG001|Overall Study|Protocol Violation|0|||
125247675|NCT00520572|450532681|FG002|Overall Study|Protocol Violation|1|||
125247676|NCT00520572|450532682|FG003|Overall Study|Protocol Violation|0|||
125247677|NCT00520572|450532683|FG004|Overall Study|Protocol Violation|0|||
125247678|NCT00520572|450532684|FG005|Overall Study|Protocol Violation|0|||
125247679|NCT00520572|450532679|FG000|Overall Study|Lack of Efficacy|1|||
125247680|NCT00520572|450532680|FG001|Overall Study|Lack of Efficacy|1|||
125247681|NCT00520572|450532681|FG002|Overall Study|Lack of Efficacy|1|||
125247682|NCT00520572|450532682|FG003|Overall Study|Lack of Efficacy|2|||
125247683|NCT00520572|450532683|FG004|Overall Study|Lack of Efficacy|1|||
125247684|NCT00520572|450532684|FG005|Overall Study|Lack of Efficacy|0|||
125247685|NCT00520572|450532679|FG000|Overall Study|Lost to Follow-up|0|||
125247686|NCT00520572|450532680|FG001|Overall Study|Lost to Follow-up|0|||
125247687|NCT00520572|450532681|FG002|Overall Study|Lost to Follow-up|0|||
125247688|NCT00520572|450532682|FG003|Overall Study|Lost to Follow-up|0|||
125247689|NCT00520572|450532683|FG004|Overall Study|Lost to Follow-up|1|||
125247690|NCT00520572|450532684|FG005|Overall Study|Lost to Follow-up|0|||
125247691|NCT00520572|450532679|FG000|Overall Study|Incorrect enrollment|1|||
125247692|NCT00520572|450532680|FG001|Overall Study|Incorrect enrollment|0|||
125247693|NCT00520572|450532681|FG002|Overall Study|Incorrect enrollment|1|||
125247694|NCT00520572|450532682|FG003|Overall Study|Incorrect enrollment|0|||
125195220|NCT03831113|450336651|FG000|Overall Study|Withdrawal by Subject|0|||
125195221|NCT03831113|450336652|FG001|Overall Study|Withdrawal by Subject|2|||
125195222|NCT03831113|450336651|FG000|Overall Study|Protocol Violation|0|||
125195223|NCT03831113|450336652|FG001|Overall Study|Protocol Violation|9|||
125195224|NCT01068730|450336653|FG000|Period 3|Personal reason|1|||
125195225|NCT01068730|450336654|FG001|Period 3|Personal reason|0|||
125195226|NCT01068730|450336655|FG002|Period 3|Personal reason|0|||
125195227|NCT01068730|450336656|FG003|Period 3|Personal reason|0|||
125195228|NCT01068730|450336653|FG000|Period 4|Family emergency|0|||
125195229|NCT01068730|450336654|FG001|Period 4|Family emergency|1|||
125195230|NCT01068730|450336655|FG002|Period 4|Family emergency|0|||
125195231|NCT01068730|450336656|FG003|Period 4|Family emergency|0|||
125195232|NCT01270464|450336659|FG000|Overall Study|Protocol Violation|4|||
125195233|NCT01270464|450336660|FG001|Overall Study|Protocol Violation|3|||
125195234|NCT01270464|450336661|FG002|Overall Study|Protocol Violation|2|||
125195235|NCT01270464|450336659|FG000|Overall Study|Lack of Efficacy|2|||
125195236|NCT01270464|450336660|FG001|Overall Study|Lack of Efficacy|3|||
125195237|NCT01270464|450336661|FG002|Overall Study|Lack of Efficacy|1|||
125195238|NCT01270464|450336659|FG000|Overall Study|Adverse Event|9|||
125195239|NCT01270464|450336660|FG001|Overall Study|Adverse Event|1|||
125195240|NCT01270464|450336661|FG002|Overall Study|Adverse Event|7|||
125195241|NCT01270464|450336659|FG000|Overall Study|Withdrawal by Subject|2|||
125195242|NCT01270464|450336660|FG001|Overall Study|Withdrawal by Subject|1|||
125195243|NCT01270464|450336661|FG002|Overall Study|Withdrawal by Subject|4|||
125195244|NCT01270464|450336659|FG000|Overall Study|Lost to Follow-up|2|||
125195245|NCT01270464|450336660|FG001|Overall Study|Lost to Follow-up|3|||
125195246|NCT01270464|450336661|FG002|Overall Study|Lost to Follow-up|1|||
125195247|NCT01270464|450336659|FG000|Overall Study|Other|1|||
125195248|NCT01270464|450336660|FG001|Overall Study|Other|1|||
125195249|NCT01270464|450336661|FG002|Overall Study|Other|3|||
125195250|NCT04725812|450336663|FG000|Overall Study|Withdrawal by Subject|1|||
125195251|NCT03969901|450336666|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125195252|NCT03969901|450336667|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125195253|NCT03969901|450336668|FG002|Overall Study|Withdrawal by parent/guardian|0|||
125195254|NCT03969901|450336669|FG003|Overall Study|Withdrawal by parent/guardian|0|||
125195255|NCT03969901|450336670|FG004|Overall Study|Withdrawal by parent/guardian|1|||
125195256|NCT03969901|450336671|FG005|Overall Study|Withdrawal by parent/guardian|0|||
125195257|NCT03969901|450336672|FG006|Overall Study|Withdrawal by parent/guardian|0|||
125195258|NCT03969901|450336673|FG007|Overall Study|Withdrawal by parent/guardian|1|||
125195259|NCT03969901|450336674|FG008|Overall Study|Withdrawal by parent/guardian|1|||
125195260|NCT03969901|450336675|FG009|Overall Study|Withdrawal by parent/guardian|0|||
125195261|NCT02589626|450336682|FG000|Overall Study|Other than the reason specified|1|||
125195262|NCT02589626|450336683|FG001|Overall Study|Other than the reason specified|0|||
125195263|NCT02589626|450336682|FG000|Overall Study|Withdrawal by Subject|1|||
125195264|NCT02589626|450336683|FG001|Overall Study|Withdrawal by Subject|1|||
125195265|NCT02589626|450336682|FG000|Overall Study|Adverse Event|1|||
125195266|NCT02589626|450336683|FG001|Overall Study|Adverse Event|1|||
125195267|NCT02564900|450336684|FG000|Dose Escalation|Progressive disease per RECIST|2|||
125195268|NCT02564900|450336685|FG001|Dose Escalation|Progressive disease per RECIST|3|||
125195269|NCT02564900|450336686|FG002|Dose Escalation|Progressive disease per RECIST|3|||
125195270|NCT02564900|450336687|FG003|Dose Escalation|Progressive disease per RECIST|3|||
125195271|NCT02564900|450336688|FG004|Dose Escalation|Progressive disease per RECIST|3|||
125195272|NCT02564900|450336689|FG005|Dose Escalation|Progressive disease per RECIST|1|||
125195273|NCT02564900|450336690|FG006|Dose Escalation|Progressive disease per RECIST|0|||
125195274|NCT02564900|450336691|FG007|Dose Escalation|Progressive disease per RECIST|0|||
125195275|NCT02564900|450336692|FG008|Dose Escalation|Progressive disease per RECIST|0|||
125195276|NCT02564900|450336693|FG009|Dose Escalation|Progressive disease per RECIST|0|||
125195277|NCT02564900|450336694|FG010|Dose Escalation|Progressive disease per RECIST|0|||
125195278|NCT02564900|450336695|FG011|Dose Escalation|Progressive disease per RECIST|0|||
125195279|NCT02564900|450336696|FG012|Dose Escalation|Progressive disease per RECIST|0|||
125195280|NCT02564900|450336697|FG013|Dose Escalation|Progressive disease per RECIST|0|||
125195281|NCT02564900|450336698|FG014|Dose Escalation|Progressive disease per RECIST|0|||
125195282|NCT02564900|450336684|FG000|Dose Escalation|Ongoing|1|||
125195283|NCT02564900|450336685|FG001|Dose Escalation|Ongoing|0|||
125195284|NCT02564900|450336686|FG002|Dose Escalation|Ongoing|0|||
125195285|NCT02564900|450336687|FG003|Dose Escalation|Ongoing|2|||
125195286|NCT02564900|450336688|FG004|Dose Escalation|Ongoing|2|||
125195287|NCT02564900|450336689|FG005|Dose Escalation|Ongoing|2|||
125195288|NCT02564900|450336690|FG006|Dose Escalation|Ongoing|0|||
125195289|NCT02564900|450336691|FG007|Dose Escalation|Ongoing|0|||
125195290|NCT02564900|450336692|FG008|Dose Escalation|Ongoing|0|||
125195291|NCT02564900|450336693|FG009|Dose Escalation|Ongoing|0|||
125195292|NCT02564900|450336694|FG010|Dose Escalation|Ongoing|0|||
125195293|NCT02564900|450336695|FG011|Dose Escalation|Ongoing|0|||
125195294|NCT02564900|450336696|FG012|Dose Escalation|Ongoing|0|||
125195295|NCT02564900|450336697|FG013|Dose Escalation|Ongoing|0|||
125195296|NCT02564900|450336698|FG014|Dose Escalation|Ongoing|0|||
125195297|NCT02564900|450336684|FG000|Dose Escalation|Adverse Event|0|||
125247695|NCT00520572|450532683|FG004|Overall Study|Incorrect enrollment|1|||
125247696|NCT00520572|450532684|FG005|Overall Study|Incorrect enrollment|0|||
125247697|NCT00520572|450532679|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
125247698|NCT00520572|450532680|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
125247699|NCT00520572|450532681|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
125195298|NCT02564900|450336685|FG001|Dose Escalation|Adverse Event|0|||
125195299|NCT02564900|450336686|FG002|Dose Escalation|Adverse Event|0|||
125195300|NCT02564900|450336687|FG003|Dose Escalation|Adverse Event|1|||
125195301|NCT02564900|450336688|FG004|Dose Escalation|Adverse Event|1|||
125195302|NCT02564900|450336689|FG005|Dose Escalation|Adverse Event|3|||
125195303|NCT02564900|450336690|FG006|Dose Escalation|Adverse Event|0|||
125195304|NCT02564900|450336691|FG007|Dose Escalation|Adverse Event|0|||
125195305|NCT02564900|450336692|FG008|Dose Escalation|Adverse Event|0|||
125195306|NCT02564900|450336693|FG009|Dose Escalation|Adverse Event|0|||
125195307|NCT02564900|450336694|FG010|Dose Escalation|Adverse Event|0|||
125195308|NCT02564900|450336695|FG011|Dose Escalation|Adverse Event|0|||
125195309|NCT02564900|450336696|FG012|Dose Escalation|Adverse Event|0|||
125195310|NCT02564900|450336697|FG013|Dose Escalation|Adverse Event|0|||
125195311|NCT02564900|450336698|FG014|Dose Escalation|Adverse Event|0|||
125195312|NCT02564900|450336684|FG000|Dose Expansion|Progressive disease per RECIST|0|||
125195313|NCT02564900|450336685|FG001|Dose Expansion|Progressive disease per RECIST|0|||
125195314|NCT02564900|450336686|FG002|Dose Expansion|Progressive disease per RECIST|0|||
125195315|NCT02564900|450336687|FG003|Dose Expansion|Progressive disease per RECIST|0|||
125195316|NCT02564900|450336688|FG004|Dose Expansion|Progressive disease per RECIST|0|||
125195317|NCT02564900|450336689|FG005|Dose Expansion|Progressive disease per RECIST|0|||
125195318|NCT02564900|450336690|FG006|Dose Expansion|Progressive disease per RECIST|19|||
125195319|NCT02564900|450336691|FG007|Dose Expansion|Progressive disease per RECIST|17|||
125195320|NCT02564900|450336692|FG008|Dose Expansion|Progressive disease per RECIST|8|||
125195321|NCT02564900|450336693|FG009|Dose Expansion|Progressive disease per RECIST|16|||
125195322|NCT02564900|450336694|FG010|Dose Expansion|Progressive disease per RECIST|13|||
125195323|NCT02564900|450336695|FG011|Dose Expansion|Progressive disease per RECIST|19|||
125195324|NCT02564900|450336696|FG012|Dose Expansion|Progressive disease per RECIST|10|||
125195325|NCT02564900|450336697|FG013|Dose Expansion|Progressive disease per RECIST|13|||
125195326|NCT02564900|450336698|FG014|Dose Expansion|Progressive disease per RECIST|11|||
125195327|NCT02564900|450336684|FG000|Dose Expansion|Clinical progression|0|||
125195328|NCT02564900|450336685|FG001|Dose Expansion|Clinical progression|0|||
125195329|NCT02564900|450336686|FG002|Dose Expansion|Clinical progression|0|||
125195330|NCT02564900|450336687|FG003|Dose Expansion|Clinical progression|0|||
125195331|NCT02564900|450336688|FG004|Dose Expansion|Clinical progression|0|||
125195332|NCT02564900|450336689|FG005|Dose Expansion|Clinical progression|0|||
125195333|NCT02564900|450336690|FG006|Dose Expansion|Clinical progression|5|||
125195334|NCT02564900|450336691|FG007|Dose Expansion|Clinical progression|12|||
125195335|NCT02564900|450336692|FG008|Dose Expansion|Clinical progression|0|||
125195336|NCT02564900|450336693|FG009|Dose Expansion|Clinical progression|3|||
125195337|NCT02564900|450336694|FG010|Dose Expansion|Clinical progression|2|||
125195338|NCT02564900|450336695|FG011|Dose Expansion|Clinical progression|0|||
125195339|NCT02564900|450336696|FG012|Dose Expansion|Clinical progression|1|||
125195340|NCT02564900|450336697|FG013|Dose Expansion|Clinical progression|3|||
125195341|NCT02564900|450336698|FG014|Dose Expansion|Clinical progression|1|||
125195342|NCT02564900|450336684|FG000|Dose Expansion|Adverse Event|0|||
125195343|NCT02564900|450336685|FG001|Dose Expansion|Adverse Event|0|||
125195344|NCT02564900|450336686|FG002|Dose Expansion|Adverse Event|0|||
125195345|NCT02564900|450336687|FG003|Dose Expansion|Adverse Event|0|||
125195346|NCT02564900|450336688|FG004|Dose Expansion|Adverse Event|0|||
125195347|NCT02564900|450336689|FG005|Dose Expansion|Adverse Event|0|||
125195348|NCT02564900|450336690|FG006|Dose Expansion|Adverse Event|9|||
125195349|NCT02564900|450336691|FG007|Dose Expansion|Adverse Event|22|||
125195350|NCT02564900|450336692|FG008|Dose Expansion|Adverse Event|0|||
125195351|NCT02564900|450336693|FG009|Dose Expansion|Adverse Event|11|||
125195352|NCT02564900|450336694|FG010|Dose Expansion|Adverse Event|0|||
125195353|NCT02564900|450336695|FG011|Dose Expansion|Adverse Event|5|||
125195354|NCT02564900|450336696|FG012|Dose Expansion|Adverse Event|2|||
125195355|NCT02564900|450336697|FG013|Dose Expansion|Adverse Event|2|||
125195356|NCT02564900|450336698|FG014|Dose Expansion|Adverse Event|1|||
125195357|NCT02564900|450336684|FG000|Dose Expansion|Ongoing|0|||
125195358|NCT02564900|450336685|FG001|Dose Expansion|Ongoing|0|||
125195359|NCT02564900|450336686|FG002|Dose Expansion|Ongoing|0|||
125195360|NCT02564900|450336687|FG003|Dose Expansion|Ongoing|0|||
125195361|NCT02564900|450336688|FG004|Dose Expansion|Ongoing|0|||
125195362|NCT02564900|450336689|FG005|Dose Expansion|Ongoing|0|||
125195363|NCT02564900|450336690|FG006|Dose Expansion|Ongoing|9|||
125195364|NCT02564900|450336691|FG007|Dose Expansion|Ongoing|10|||
125247700|NCT00520572|450532682|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
125247701|NCT00520572|450532683|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
125247702|NCT00520572|450532684|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
125247703|NCT00520572|450532679|FG000|Overall Study|Long break in taking Medication|0|||
125247704|NCT00520572|450532680|FG001|Overall Study|Long break in taking Medication|0|||
125247705|NCT00520572|450532681|FG002|Overall Study|Long break in taking Medication|0|||
125247706|NCT00520572|450532682|FG003|Overall Study|Long break in taking Medication|1|||
125247707|NCT00520572|450532683|FG004|Overall Study|Long break in taking Medication|0|||
125247708|NCT00520572|450532684|FG005|Overall Study|Long break in taking Medication|0|||
125247709|NCT00520572|450532679|FG000|Overall Study|Did not receive Treatment|1|||
125247710|NCT00520572|450532680|FG001|Overall Study|Did not receive Treatment|0|||
125247711|NCT00520572|450532681|FG002|Overall Study|Did not receive Treatment|1|||
125247712|NCT00520572|450532682|FG003|Overall Study|Did not receive Treatment|0|||
125247713|NCT00520572|450532683|FG004|Overall Study|Did not receive Treatment|0|||
125247714|NCT00520572|450532684|FG005|Overall Study|Did not receive Treatment|0|||
125247715|NCT03315689|450532685|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
125247716|NCT03315689|450532686|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
125247717|NCT03315689|450532685|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
125247718|NCT03315689|450532686|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
125247719|NCT03315689|450532685|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
125247720|NCT03315689|450532686|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
125247721|NCT01783015|450532687|FG000|Blinded Treatment|Adverse Event|0|||
125247722|NCT01783015|450532688|FG001|Blinded Treatment|Adverse Event|1|||
125247723|NCT01783015|450532689|FG002|Blinded Treatment|Adverse Event|0|||
125247724|NCT01783015|450532687|FG000|Blinded Treatment|Protocol Violation|0|||
125247725|NCT01783015|450532688|FG001|Blinded Treatment|Protocol Violation|1|||
125247726|NCT01783015|450532689|FG002|Blinded Treatment|Protocol Violation|0|||
125247727|NCT01783015|450532687|FG000|Blinded Treatment|Withdrawal by Subject|0|||
125247728|NCT01783015|450532688|FG001|Blinded Treatment|Withdrawal by Subject|1|||
125247729|NCT01783015|450532689|FG002|Blinded Treatment|Withdrawal by Subject|0|||
125247730|NCT01783015|450532687|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
125247731|NCT01783015|450532688|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
125247732|NCT01783015|450532689|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
125247733|NCT01783015|450532687|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
125247734|NCT01783015|450532688|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
125247735|NCT01783015|450532689|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
125247736|NCT00669331|450532690|FG000|Randomisation to First Dose|Adverse Event|1|||
125247737|NCT00669331|450532691|FG001|Randomisation to First Dose|Adverse Event|0|||
125247738|NCT00669331|450532690|FG000|Randomisation to First Dose|Protocol Violation|1|||
125247739|NCT00669331|450532691|FG001|Randomisation to First Dose|Protocol Violation|0|||
125247740|NCT00669331|450532690|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
125247741|NCT00669331|450532691|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
125247742|NCT00669331|450532690|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
125247743|NCT00669331|450532691|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
125247744|NCT00669331|450532690|FG000|Randomisation to First Dose|Death|1|||
125247745|NCT00669331|450532691|FG001|Randomisation to First Dose|Death|0|||
125247746|NCT00669331|450532690|FG000|Randomisation to First Dose|Sponsor decision|0|||
125247747|NCT00669331|450532691|FG001|Randomisation to First Dose|Sponsor decision|1|||
125247748|NCT00669331|450532690|FG000|Randomisation to First Dose|Randomised in error|3|||
125247749|NCT00669331|450532691|FG001|Randomisation to First Dose|Randomised in error|10|||
125247750|NCT00669331|450532690|FG000|Blinded Treatment Period|Adverse Event|16|||
125247751|NCT00669331|450532691|FG001|Blinded Treatment Period|Adverse Event|10|||
125247752|NCT00669331|450532690|FG000|Blinded Treatment Period|Protocol Violation|1|||
125247753|NCT00669331|450532691|FG001|Blinded Treatment Period|Protocol Violation|1|||
125247754|NCT00669331|450532690|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
125247755|NCT00669331|450532691|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
125247756|NCT00669331|450532690|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
125247757|NCT00669331|450532691|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
125247758|NCT00669331|450532690|FG000|Blinded Treatment Period|Death|0|||
125247759|NCT00669331|450532691|FG001|Blinded Treatment Period|Death|2|||
125247760|NCT00669331|450532690|FG000|Blinded Treatment Period|Physician Decision|3|||
125247761|NCT00669331|450532691|FG001|Blinded Treatment Period|Physician Decision|3|||
125247762|NCT00669331|450532690|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
125247763|NCT00669331|450532691|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
125247764|NCT03794544|450532692|FG000|Overall Study|Withdrawal by Subject|1|||
125247765|NCT03794544|450532693|FG001|Overall Study|Withdrawal by Subject|1|||
125247766|NCT03794544|450532694|FG002|Overall Study|Withdrawal by Subject|0|||
125247767|NCT03794544|450532695|FG003|Overall Study|Withdrawal by Subject|0|||
125247768|NCT03794544|450532692|FG000|Overall Study|Death|0|||
125247769|NCT03794544|450532693|FG001|Overall Study|Death|0|||
125247770|NCT03794544|450532694|FG002|Overall Study|Death|0|||
125247771|NCT03794544|450532695|FG003|Overall Study|Death|1|||
125247772|NCT03794544|450532692|FG000|Overall Study|Lost to Follow-up|0|||
125247773|NCT03794544|450532693|FG001|Overall Study|Lost to Follow-up|1|||
125247774|NCT03794544|450532694|FG002|Overall Study|Lost to Follow-up|1|||
125247775|NCT03794544|450532695|FG003|Overall Study|Lost to Follow-up|0|||
125247776|NCT03794544|450532692|FG000|Overall Study|Other|0|||
125247777|NCT03794544|450532693|FG001|Overall Study|Other|1|||
125247778|NCT03794544|450532694|FG002|Overall Study|Other|0|||
125247779|NCT03794544|450532695|FG003|Overall Study|Other|0|||
125247780|NCT00120250|450532699|FG000|Overall Study|Lost to Follow-up|1|||
125247781|NCT00120250|450532700|FG001|Overall Study|Lost to Follow-up|1|||
125247782|NCT00120250|450532699|FG000|Overall Study|Protocol Violation|0|||
125247783|NCT00120250|450532700|FG001|Overall Study|Protocol Violation|1|||
125247784|NCT01964560|450532707|FG000|Overall Study|Adverse Event|23|||
125247785|NCT01964560|450532707|FG000|Overall Study|Lack of Efficacy|46|||
125247786|NCT01964560|450532707|FG000|Overall Study|Protocol deviation|2|||
125247787|NCT01964560|450532707|FG000|Overall Study|Lost to Follow-up|4|||
125247788|NCT01964560|450532707|FG000|Overall Study|Withdrawal by Subject|64|||
125247789|NCT01964560|450532707|FG000|Overall Study|Surgery-hemispherotomy|1|||
125247790|NCT01964560|450532707|FG000|Overall Study|Surgery|1|||
125247791|NCT01964560|450532707|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
125247792|NCT01964560|450532707|FG000|Overall Study|Patient and Investigator choice|1|||
125247793|NCT01964560|450532707|FG000|Overall Study|Patient was prescribed CBD|1|||
125247794|NCT01964560|450532707|FG000|Overall Study|Participant moved to another country|1|||
125247795|NCT00710554|450532708|FG000|Overall Study|Adverse Event|24|||
125247796|NCT00710554|450532709|FG001|Overall Study|Adverse Event|7|||
125247797|NCT00710554|450532708|FG000|Overall Study|Withdrawal by Subject|7|||
125247798|NCT00710554|450532709|FG001|Overall Study|Withdrawal by Subject|3|||
125247799|NCT00710554|450532708|FG000|Overall Study|Lost to Follow-up|7|||
125247800|NCT00710554|450532709|FG001|Overall Study|Lost to Follow-up|1|||
125247801|NCT00710554|450532708|FG000|Overall Study|Lack of Efficacy|11|||
125247802|NCT00710554|450532709|FG001|Overall Study|Lack of Efficacy|12|||
125247803|NCT00710554|450532708|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
125247804|NCT00710554|450532709|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
125247805|NCT01433978|450532710|FG000|Core Study|Adverse Event, Non-Fatal|0|||
125247806|NCT01433978|450532711|FG001|Core Study|Adverse Event, Non-Fatal|1|||
125247807|NCT01433978|450532712|FG002|Core Study|Adverse Event, Non-Fatal|0|||
125247808|NCT01433978|450532710|FG000|Core Study|Lack of Efficacy|5|||
125247809|NCT01433978|450532711|FG001|Core Study|Lack of Efficacy|1|||
125247810|NCT01433978|450532712|FG002|Core Study|Lack of Efficacy|0|||
125247811|NCT01433978|450532710|FG000|Core Study|Study Terminated by Sponsor|6|||
125247812|NCT01433978|450532711|FG001|Core Study|Study Terminated by Sponsor|9|||
125247813|NCT01433978|450532712|FG002|Core Study|Study Terminated by Sponsor|0|||
125247814|NCT01433978|450532710|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
125247815|NCT01433978|450532711|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
125247816|NCT01433978|450532712|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
125247817|NCT01433978|450532710|FG000|Extension Phase|Lack of Efficacy|0|||
125247818|NCT01433978|450532711|FG001|Extension Phase|Lack of Efficacy|0|||
125247819|NCT01433978|450532712|FG002|Extension Phase|Lack of Efficacy|1|||
125247820|NCT01433978|450532710|FG000|Extension Phase|Study Terminated by Sponsor|0|||
125247821|NCT01433978|450532711|FG001|Extension Phase|Study Terminated by Sponsor|0|||
125247822|NCT01433978|450532712|FG002|Extension Phase|Study Terminated by Sponsor|4|||
125247823|NCT00378560|450532713|FG000|Overall Study|Adverse Event|1|||
125195365|NCT02564900|450336692|FG008|Dose Expansion|Ongoing|11|||
125195366|NCT02564900|450336693|FG009|Dose Expansion|Ongoing|3|||
125195367|NCT02564900|450336694|FG010|Dose Expansion|Ongoing|0|||
125195368|NCT02564900|450336695|FG011|Dose Expansion|Ongoing|0|||
125195369|NCT02564900|450336696|FG012|Dose Expansion|Ongoing|4|||
125195370|NCT02564900|450336697|FG013|Dose Expansion|Ongoing|0|||
125195371|NCT02564900|450336698|FG014|Dose Expansion|Ongoing|6|||
125195372|NCT02564900|450336684|FG000|Dose Expansion|Death|0|||
125195373|NCT02564900|450336685|FG001|Dose Expansion|Death|0|||
125195374|NCT02564900|450336686|FG002|Dose Expansion|Death|0|||
125195375|NCT02564900|450336687|FG003|Dose Expansion|Death|0|||
125195376|NCT02564900|450336688|FG004|Dose Expansion|Death|0|||
125195377|NCT02564900|450336689|FG005|Dose Expansion|Death|0|||
125195378|NCT02564900|450336690|FG006|Dose Expansion|Death|1|||
125195379|NCT02564900|450336691|FG007|Dose Expansion|Death|0|||
125195380|NCT02564900|450336692|FG008|Dose Expansion|Death|0|||
125195381|NCT02564900|450336693|FG009|Dose Expansion|Death|0|||
125247824|NCT00378560|450532714|FG001|Overall Study|Adverse Event|0|||
125247825|NCT00378560|450532713|FG000|Overall Study|Lost to Follow-up|24|||
125247826|NCT00378560|450532714|FG001|Overall Study|Lost to Follow-up|29|||
125247827|NCT00378560|450532713|FG000|Overall Study|Protocol Violation|2|||
125247828|NCT00378560|450532714|FG001|Overall Study|Protocol Violation|0|||
125247829|NCT00378560|450532713|FG000|Overall Study|Withdrawal by Subject|17|||
125247830|NCT00378560|450532714|FG001|Overall Study|Withdrawal by Subject|21|||
125195382|NCT02564900|450336694|FG010|Dose Expansion|Death|1|||
125195383|NCT02564900|450336695|FG011|Dose Expansion|Death|0|||
125195384|NCT02564900|450336696|FG012|Dose Expansion|Death|1|||
125195385|NCT02564900|450336697|FG013|Dose Expansion|Death|1|||
125195386|NCT02564900|450336698|FG014|Dose Expansion|Death|0|||
125195387|NCT02564900|450336684|FG000|Dose Expansion|Withdrawal by Subject|0|||
125195388|NCT02564900|450336685|FG001|Dose Expansion|Withdrawal by Subject|0|||
125195389|NCT02564900|450336686|FG002|Dose Expansion|Withdrawal by Subject|0|||
125195390|NCT02564900|450336687|FG003|Dose Expansion|Withdrawal by Subject|0|||
125195391|NCT02564900|450336688|FG004|Dose Expansion|Withdrawal by Subject|0|||
125195392|NCT02564900|450336689|FG005|Dose Expansion|Withdrawal by Subject|0|||
125195393|NCT02564900|450336690|FG006|Dose Expansion|Withdrawal by Subject|4|||
125195394|NCT02564900|450336691|FG007|Dose Expansion|Withdrawal by Subject|0|||
125195395|NCT02564900|450336692|FG008|Dose Expansion|Withdrawal by Subject|0|||
125195396|NCT02564900|450336693|FG009|Dose Expansion|Withdrawal by Subject|0|||
125195397|NCT02564900|450336694|FG010|Dose Expansion|Withdrawal by Subject|1|||
125195398|NCT02564900|450336695|FG011|Dose Expansion|Withdrawal by Subject|0|||
125195399|NCT02564900|450336696|FG012|Dose Expansion|Withdrawal by Subject|0|||
125195400|NCT02564900|450336697|FG013|Dose Expansion|Withdrawal by Subject|1|||
125195401|NCT02564900|450336698|FG014|Dose Expansion|Withdrawal by Subject|1|||
125195402|NCT02564900|450336684|FG000|Dose Expansion|Other|0|||
125195403|NCT02564900|450336685|FG001|Dose Expansion|Other|0|||
125195404|NCT02564900|450336686|FG002|Dose Expansion|Other|0|||
125247831|NCT00378560|450532713|FG000|Overall Study|Moved|4|||
125247832|NCT00378560|450532714|FG001|Overall Study|Moved|3|||
125247833|NCT00378560|450532713|FG000|Overall Study|Pregnancy|7|||
125247834|NCT00378560|450532714|FG001|Overall Study|Pregnancy|5|||
125247835|NCT00378560|450532713|FG000|Overall Study|Laboratory test values abnormal|1|||
125247836|NCT00378560|450532714|FG001|Overall Study|Laboratory test values abnormal|0|||
125247837|NCT02852434|450532715|FG000|Overall Study|Withdrawal by Subject|0|||
125247838|NCT02852434|450532716|FG001|Overall Study|Withdrawal by Subject|1|||
125247839|NCT02852434|450532715|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
125247840|NCT02852434|450532716|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
125247841|NCT01011283|450532720|FG000|Overall Study|Adverse Event|4|||
125247842|NCT01011283|450532721|FG001|Overall Study|Adverse Event|2|||
125247843|NCT01011283|450532720|FG000|Overall Study|Progressive Disease|0|||
125247844|NCT01011283|450532721|FG001|Overall Study|Progressive Disease|2|||
125247845|NCT01011283|450532720|FG000|Overall Study|Terminated by Sponsor|5|||
125247846|NCT01011283|450532721|FG001|Overall Study|Terminated by Sponsor|5|||
125247847|NCT01011283|450532720|FG000|Overall Study|Other|2|||
125247848|NCT01011283|450532721|FG001|Overall Study|Other|2|||
125247849|NCT04865978|450532725|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
125247850|NCT04865978|450532726|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
125247851|NCT03835117|450532727|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
125247852|NCT03835117|450532728|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
125247853|NCT00609973|450532730|FG000|Overall Study|Adverse Event|2|||
125247854|NCT00609973|450532731|FG001|Overall Study|Adverse Event|1|||
125247855|NCT00609973|450532730|FG000|Overall Study|Protocol Violation|4|||
125247856|NCT00609973|450532731|FG001|Overall Study|Protocol Violation|3|||
125247857|NCT00609973|450532730|FG000|Overall Study|Lost to Follow-up|2|||
125247858|NCT00609973|450532731|FG001|Overall Study|Lost to Follow-up|1|||
125247859|NCT00609973|450532730|FG000|Overall Study|Withdrawal by Subject|0|||
125247860|NCT00609973|450532731|FG001|Overall Study|Withdrawal by Subject|1|||
125247861|NCT00191152|450532733|FG000|Initial Treatment|Adverse Event|43|||
125247862|NCT00191152|450532734|FG001|Initial Treatment|Adverse Event|67|||
125247863|NCT00191152|450532733|FG000|Initial Treatment|Physician Decision|40|||
125247864|NCT00191152|450532734|FG001|Initial Treatment|Physician Decision|31|||
125247865|NCT00191152|450532733|FG000|Initial Treatment|Withdrawal by Subject|40|||
125247866|NCT00191152|450532734|FG001|Initial Treatment|Withdrawal by Subject|28|||
125247867|NCT00191152|450532733|FG000|Initial Treatment|Lost to Follow-up|0|||
125247868|NCT00191152|450532734|FG001|Initial Treatment|Lost to Follow-up|6|||
125247869|NCT00191152|450532733|FG000|Initial Treatment|Other|18|||
125247870|NCT00191152|450532734|FG001|Initial Treatment|Other|21|||
125247871|NCT00191152|450532733|FG000|Crossover Treatment|Adverse Event|8|||
125247872|NCT00191152|450532734|FG001|Crossover Treatment|Adverse Event|8|||
125247873|NCT00191152|450532733|FG000|Crossover Treatment|Physician Decision|7|||
125247874|NCT00191152|450532734|FG001|Crossover Treatment|Physician Decision|7|||
125247875|NCT00191152|450532733|FG000|Crossover Treatment|Withdrawal by Subject|6|||
125247876|NCT00191152|450532734|FG001|Crossover Treatment|Withdrawal by Subject|9|||
125247877|NCT00191152|450532733|FG000|Crossover Treatment|Lost to Follow-up|2|||
125247878|NCT00191152|450532734|FG001|Crossover Treatment|Lost to Follow-up|1|||
125195405|NCT02564900|450336687|FG003|Dose Expansion|Other|0|||
125195406|NCT02564900|450336688|FG004|Dose Expansion|Other|0|||
125195407|NCT02564900|450336689|FG005|Dose Expansion|Other|0|||
125195408|NCT02564900|450336690|FG006|Dose Expansion|Other|1|||
125195409|NCT02564900|450336691|FG007|Dose Expansion|Other|0|||
125195410|NCT02564900|450336692|FG008|Dose Expansion|Other|1|||
125247879|NCT00191152|450532733|FG000|Crossover Treatment|Other|4|||
125195411|NCT02564900|450336693|FG009|Dose Expansion|Other|0|||
125195412|NCT02564900|450336694|FG010|Dose Expansion|Other|0|||
125247880|NCT00191152|450532734|FG001|Crossover Treatment|Other|3|||
125247881|NCT00114777|450532738|FG000|Randomization to Month 36|Death|10|||
125195413|NCT02564900|450336695|FG011|Dose Expansion|Other|0|||
125195414|NCT02564900|450336696|FG012|Dose Expansion|Other|0|||
125195415|NCT02564900|450336697|FG013|Dose Expansion|Other|0|||
125195416|NCT02564900|450336698|FG014|Dose Expansion|Other|1|||
125195417|NCT02564900|450336684|FG000|Dose Expansion|Did not receive treatment|0|||
125195418|NCT02564900|450336685|FG001|Dose Expansion|Did not receive treatment|0|||
125195419|NCT02564900|450336686|FG002|Dose Expansion|Did not receive treatment|0|||
125195420|NCT02564900|450336687|FG003|Dose Expansion|Did not receive treatment|0|||
125195421|NCT02564900|450336688|FG004|Dose Expansion|Did not receive treatment|0|||
125195422|NCT02564900|450336689|FG005|Dose Expansion|Did not receive treatment|0|||
125195423|NCT02564900|450336690|FG006|Dose Expansion|Did not receive treatment|1|||
125195424|NCT02564900|450336691|FG007|Dose Expansion|Did not receive treatment|1|||
125195425|NCT02564900|450336692|FG008|Dose Expansion|Did not receive treatment|0|||
125195426|NCT02564900|450336693|FG009|Dose Expansion|Did not receive treatment|0|||
125195427|NCT02564900|450336694|FG010|Dose Expansion|Did not receive treatment|0|||
125195428|NCT02564900|450336695|FG011|Dose Expansion|Did not receive treatment|0|||
125195429|NCT02564900|450336696|FG012|Dose Expansion|Did not receive treatment|0|||
125195430|NCT02564900|450336697|FG013|Dose Expansion|Did not receive treatment|0|||
125195431|NCT02564900|450336698|FG014|Dose Expansion|Did not receive treatment|1|||
125195432|NCT00892151|450336699|FG000|Overall Study|Protocol Violation|1|||
125195433|NCT04075682|450336702|FG000|Overall Study|Lost to Follow-up|5|||
125195434|NCT04075682|450336703|FG001|Overall Study|Lost to Follow-up|5|||
125195435|NCT04075682|450336704|FG002|Overall Study|Lost to Follow-up|2|||
125195436|NCT04075682|450336705|FG003|Overall Study|Lost to Follow-up|2|||
125195437|NCT04075682|450336702|FG000|Overall Study|Withdrawal by Subject|1|||
125195438|NCT04075682|450336703|FG001|Overall Study|Withdrawal by Subject|0|||
125195439|NCT04075682|450336704|FG002|Overall Study|Withdrawal by Subject|1|||
125195440|NCT04075682|450336705|FG003|Overall Study|Withdrawal by Subject|0|||
125195441|NCT04075682|450336702|FG000|Overall Study|Protocol Violation|0|||
125195442|NCT04075682|450336703|FG001|Overall Study|Protocol Violation|1|||
125195443|NCT04075682|450336704|FG002|Overall Study|Protocol Violation|1|||
125195444|NCT04075682|450336705|FG003|Overall Study|Protocol Violation|0|||
125195445|NCT04075682|450336702|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
125195446|NCT04075682|450336703|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
125195447|NCT04075682|450336704|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
125195448|NCT04075682|450336705|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
125195449|NCT04075682|450336702|FG000|Overall Study|Lost study phone the first day of study participation|0|||
125195450|NCT04075682|450336703|FG001|Overall Study|Lost study phone the first day of study participation|1|||
125195451|NCT04075682|450336704|FG002|Overall Study|Lost study phone the first day of study participation|0|||
125195452|NCT04075682|450336705|FG003|Overall Study|Lost study phone the first day of study participation|0|||
125195453|NCT00887315|450336706|FG000|Overall Study|Study termination|7|||
125195454|NCT00887315|450336707|FG001|Overall Study|Study termination|4|||
125195455|NCT00619892|450336708|FG000|Overall Study|Adverse Event|3|||
125195456|NCT00619892|450336709|FG001|Overall Study|Adverse Event|0|||
125195457|NCT00619892|450336708|FG000|Overall Study|Lost to Follow-up|0|||
125195458|NCT00619892|450336709|FG001|Overall Study|Lost to Follow-up|1|||
125195459|NCT00619892|450336708|FG000|Overall Study|Intercurrent illness|0|||
125195460|NCT00619892|450336709|FG001|Overall Study|Intercurrent illness|1|||
125195461|NCT00280397|450336711|FG000|Overall Study|Adverse Event|1|||
125195462|NCT02257489|450336714|FG000|Overall Study|Withdrawal by Subject|0|||
125195463|NCT02257489|450336715|FG001|Overall Study|Withdrawal by Subject|0|||
125195464|NCT02257489|450336716|FG002|Overall Study|Withdrawal by Subject|0|||
125195465|NCT02257489|450336717|FG003|Overall Study|Withdrawal by Subject|1|||
125195466|NCT02257489|450336718|FG004|Overall Study|Withdrawal by Subject|0|||
125195467|NCT02257489|450336719|FG005|Overall Study|Withdrawal by Subject|0|||
125195468|NCT02257489|450336720|FG006|Overall Study|Withdrawal by Subject|0|||
125195469|NCT02257489|450336721|FG007|Overall Study|Withdrawal by Subject|0|||
125247882|NCT00114777|450532739|FG001|Randomization to Month 36|Death|4|||
125247883|NCT00114777|450532740|FG002|Randomization to Month 36|Death|3|||
125247884|NCT00114777|450532738|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
125247885|NCT00114777|450532739|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
125247886|NCT00114777|450532740|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
125247887|NCT00114777|450532738|FG000|Randomization to Month 36|Lack of Efficacy|19|||
125247888|NCT00114777|450532739|FG001|Randomization to Month 36|Lack of Efficacy|15|||
125247889|NCT00114777|450532740|FG002|Randomization to Month 36|Lack of Efficacy|17|||
125247890|NCT00114777|450532738|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
125247891|NCT00114777|450532739|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
125247892|NCT00114777|450532740|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
125247893|NCT00114777|450532738|FG000|Randomization to Month 36|Adverse Event|34|||
125247894|NCT00114777|450532739|FG001|Randomization to Month 36|Adverse Event|35|||
125247895|NCT00114777|450532740|FG002|Randomization to Month 36|Adverse Event|44|||
125247896|NCT00114777|450532738|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
125247897|NCT00114777|450532739|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
125247898|NCT00114777|450532740|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
125247899|NCT00114777|450532738|FG000|Randomization to Month 36|Other|9|||
125247900|NCT00114777|450532739|FG001|Randomization to Month 36|Other|3|||
125247901|NCT00114777|450532740|FG002|Randomization to Month 36|Other|12|||
125247902|NCT00114777|450532738|FG000|Long-Term Extension to Month 84|Death|8|||
125247903|NCT00114777|450532739|FG001|Long-Term Extension to Month 84|Death|13|||
125247904|NCT00114777|450532740|FG002|Long-Term Extension to Month 84|Death|7|||
125247905|NCT00114777|450532738|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
125247906|NCT00114777|450532739|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
125247907|NCT00114777|450532740|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
125247908|NCT00114777|450532738|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
125247909|NCT00114777|450532739|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
125247910|NCT00114777|450532740|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
125195470|NCT02257489|450336722|FG008|Overall Study|Withdrawal by Subject|0|||
125195471|NCT03200704|450336724|FG000|Overall Study|Withdrawal by Subject|1|||
125195472|NCT03706430|450336726|FG000|Overall Study|No A-Line placed|5|||
125195473|NCT03706430|450336726|FG000|Overall Study|Subject had gel nail polish|1|||
125195474|NCT03706430|450336726|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
125195475|NCT03706430|450336726|FG000|Overall Study|Cancelled Case|6|||
125195476|NCT03706430|450336726|FG000|Overall Study|Physician Decision|2|||
125195477|NCT00478777|450336727|FG000|Overall Study|Adverse Event|29|||
125195478|NCT00478777|450336727|FG000|Overall Study|Lack of Efficacy|23|||
125195479|NCT00478777|450336727|FG000|Overall Study|Withdrawal by Subject|4|||
125195480|NCT00478777|450336727|FG000|Overall Study|Death|3|||
125195481|NCT00478777|450336727|FG000|Overall Study|Protocol Violation|3|||
125195482|NCT00478777|450336727|FG000|Overall Study|Lost to Follow-up|3|||
125195483|NCT00478777|450336727|FG000|Overall Study|Physician Decision|1|||
125195484|NCT00478777|450336727|FG000|Overall Study|Intolerance of therapy|1|||
125195485|NCT00478777|450336727|FG000|Overall Study|Lack of compliance|1|||
125195486|NCT00478777|450336727|FG000|Overall Study|Lymphocytes infusion|1|||
125195487|NCT00478777|450336727|FG000|Overall Study|End of therapy|2|||
125195488|NCT00478777|450336727|FG000|Overall Study|Not treated with lenalidomide|6|||
125195489|NCT01218087|450336728|FG000|Overall Study|Death|2|||
125195490|NCT01218087|450336729|FG001|Overall Study|Death|1|||
125195491|NCT01218087|450336728|FG000|Overall Study|Withdrawal by Subject|5|||
125195492|NCT01218087|450336729|FG001|Overall Study|Withdrawal by Subject|0|||
125195493|NCT01218087|450336728|FG000|Overall Study|Transferred|8|||
125195494|NCT01218087|450336729|FG001|Overall Study|Transferred|5|||
125195495|NCT00552396|450336730|FG000|Overall Study|protocol withdrawal criteria|3|||
125195496|NCT00552396|450336731|FG001|Overall Study|protocol withdrawal criteria|3|||
125195497|NCT00552396|450336732|FG002|Overall Study|protocol withdrawal criteria|3|||
125195498|NCT00552396|450336733|FG003|Overall Study|protocol withdrawal criteria|6|||
125195499|NCT00552396|450336734|FG004|Overall Study|protocol withdrawal criteria|3|||
125195500|NCT00552396|450336735|FG005|Overall Study|protocol withdrawal criteria|3|||
125195501|NCT00552396|450336736|FG006|Overall Study|protocol withdrawal criteria|9|||
125195502|NCT01323387|450336737|FG000|Overall Study|Withdrawal by Subject|41|||
125195503|NCT01323387|450336737|FG000|Overall Study|Radiographic Data Unavailable|1|||
125195504|NCT01323387|450336737|FG000|Overall Study|Revision|14|||
125195505|NCT01323387|450336737|FG000|Overall Study|Protocol Violation|12|||
125195506|NCT01323387|450336737|FG000|Overall Study|Randomized but Never Treated|16|||
125195507|NCT04185220|450336738|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
125195508|NCT04185220|450336739|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
125247911|NCT00114777|450532738|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
125247912|NCT00114777|450532739|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
125247913|NCT00114777|450532740|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
125195509|NCT04185220|450336738|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
125247914|NCT00114777|450532738|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
125247915|NCT00114777|450532739|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
125247916|NCT00114777|450532740|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
125247917|NCT00114777|450532738|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
125247918|NCT00114777|450532739|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
125247919|NCT00114777|450532740|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
125247920|NCT00114777|450532738|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
125247921|NCT00114777|450532739|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
125247922|NCT00114777|450532740|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
125247923|NCT00114777|450532738|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
125247924|NCT00114777|450532739|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
125247925|NCT00114777|450532740|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
125247926|NCT00114777|450532738|FG000|Long-Term Extension to Month 84|Other|2|||
125247927|NCT00114777|450532739|FG001|Long-Term Extension to Month 84|Other|0|||
125247928|NCT00114777|450532740|FG002|Long-Term Extension to Month 84|Other|2|||
125247929|NCT00629239|450532741|FG000|Overall Study|Adverse Event|7|||
125247930|NCT00629239|450532742|FG001|Overall Study|Adverse Event|4|||
125247931|NCT00629239|450532741|FG000|Overall Study|Physician Decision|1|||
125247932|NCT00629239|450532742|FG001|Overall Study|Physician Decision|0|||
125247933|NCT02460380|450532743|FG000|Overall Study|Withdrawal by Subject|10|||
125247934|NCT02460380|450532744|FG001|Overall Study|Withdrawal by Subject|5|||
125247935|NCT03566550|450532750|FG000|Overall Study|Withdrawal by Subject|0|||
125247936|NCT03566550|450532751|FG001|Overall Study|Withdrawal by Subject|1|||
125247937|NCT00052715|450532758|FG000|Overall Study|wrong histology|1|||
125247938|NCT01210443|450532759|FG000|Overall Study|Study terminated by sponsor|2|||
125247939|NCT02807181|450532760|FG000|Overall Study|Death|28|||
125247940|NCT02807181|450532761|FG001|Overall Study|Death|24|||
125247941|NCT02807181|450532760|FG000|Overall Study|Withdrawal by Subject|1|||
125247942|NCT02807181|450532761|FG001|Overall Study|Withdrawal by Subject|1|||
125247943|NCT02807181|450532760|FG000|Overall Study|Lost to Follow-up|0|||
125247944|NCT02807181|450532761|FG001|Overall Study|Lost to Follow-up|2|||
125247945|NCT02807181|450532760|FG000|Overall Study|Subject decision|1|||
125247946|NCT02807181|450532761|FG001|Overall Study|Subject decision|0|||
125247947|NCT02807181|450532760|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
125247948|NCT02807181|450532761|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
125247949|NCT02807181|450532760|FG000|Overall Study|In Study|3|||
125247950|NCT02807181|450532761|FG001|Overall Study|In Study|3|||
125247951|NCT02807181|450532760|FG000|Overall Study|Post Progression|3|||
125247952|NCT02807181|450532761|FG001|Overall Study|Post Progression|2|||
125247953|NCT01063881|450532762|FG000|Overall Study|Adverse Event|12|||
125247954|NCT01063881|450532763|FG001|Overall Study|Adverse Event|2|||
125247955|NCT01063881|450532764|FG002|Overall Study|Adverse Event|0|||
125247956|NCT01063881|450532762|FG000|Overall Study|Lost to Follow-up|13|||
125247957|NCT01063881|450532763|FG001|Overall Study|Lost to Follow-up|7|||
125247958|NCT01063881|450532764|FG002|Overall Study|Lost to Follow-up|1|||
125247959|NCT01063881|450532762|FG000|Overall Study|Withdrawal by Subject|25|||
125247960|NCT01063881|450532763|FG001|Overall Study|Withdrawal by Subject|1|||
125247961|NCT01063881|450532764|FG002|Overall Study|Withdrawal by Subject|0|||
125247962|NCT01063881|450532762|FG000|Overall Study|Reason for not completed not specified|5|||
125247963|NCT01063881|450532763|FG001|Overall Study|Reason for not completed not specified|1|||
125247964|NCT01063881|450532764|FG002|Overall Study|Reason for not completed not specified|0|||
125247965|NCT01309100|450532765|FG000|Overall Study|Protocol Violation|1|||
125247966|NCT01309100|450532765|FG000|Overall Study|Positive Slit lamp finding|1|||
125247967|NCT04146909|450532773|FG000|Overall Study|Withdrawal by Subject|3|||
125247968|NCT04146909|450532773|FG000|Overall Study|Did not qualify after consented|1|||
125247969|NCT03808909|450532774|FG000|Overall Study|Lost to Follow-up|3|||
125247970|NCT03808909|450532775|FG001|Overall Study|Lost to Follow-up|0|||
125247971|NCT03335566|450532776|FG000|Overall Study|Adverse Event|0|||
125247972|NCT03335566|450532777|FG001|Overall Study|Adverse Event|1|||
125247973|NCT03335566|450532776|FG000|Overall Study|Lost to Follow-up|1|||
125247974|NCT03335566|450532777|FG001|Overall Study|Lost to Follow-up|0|||
125247975|NCT03335566|450532776|FG000|Overall Study|Technical Problems|1|||
125247976|NCT03335566|450532777|FG001|Overall Study|Technical Problems|0|||
125247977|NCT03335566|450532776|FG000|Overall Study|Protocol Violation|1|||
125247978|NCT03335566|450532777|FG001|Overall Study|Protocol Violation|0|||
125247979|NCT03335566|450532776|FG000|Overall Study|Other than specified above|1|||
125247980|NCT03335566|450532777|FG001|Overall Study|Other than specified above|2|||
125247981|NCT01084135|450532778|FG000|20 Week|Physician Decision|0|||
125247982|NCT01084135|450532779|FG001|20 Week|Physician Decision|1|||
125247983|NCT00663351|450532780|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
125247984|NCT00663351|450532781|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
125247985|NCT00663351|450532780|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
125195510|NCT04185220|450336739|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
125195511|NCT00767455|450336745|FG000|Overall Study|Investigator error|19|||
125195512|NCT00022698|450336749|FG000|Overall Study|Adverse Event|5|||
125195513|NCT00022698|450336750|FG001|Overall Study|Adverse Event|9|||
125195514|NCT00022698|450336749|FG000|Overall Study|Death|0|||
125195515|NCT00022698|450336750|FG001|Overall Study|Death|2|||
125195516|NCT00022698|450336749|FG000|Overall Study|Failure to return|0|||
125195517|NCT00022698|450336750|FG001|Overall Study|Failure to return|1|||
125195518|NCT00022698|450336749|FG000|Overall Study|Refused treatment|0|||
125195519|NCT00022698|450336750|FG001|Overall Study|Refused treatment|2|||
125195520|NCT00022698|450336749|FG000|Overall Study|Insufficient therapeutic response|2|||
125247986|NCT00663351|450532781|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
125247987|NCT00663351|450532780|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
125247988|NCT00663351|450532781|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
125247989|NCT00663351|450532780|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
125247990|NCT00663351|450532781|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
125247991|NCT00663351|450532780|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
125247992|NCT00663351|450532781|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
125247993|NCT00663351|450532780|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
125247994|NCT00663351|450532781|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
125247995|NCT02362412|450532782|FG000|Treatment Period III|Lost to Follow-up|0|||
125247996|NCT02362412|450532783|FG001|Treatment Period III|Lost to Follow-up|1|||
125247997|NCT03462563|450532784|FG000|Overall Study|Death|1|||
125247998|NCT03462563|450532785|FG001|Overall Study|Death|1|||
125247999|NCT03462563|450532784|FG000|Overall Study|Termination of study|2|||
125248000|NCT03462563|450532785|FG001|Overall Study|Termination of study|1|||
125248001|NCT03462563|450532784|FG000|Overall Study|Adverse Event|1|||
125248002|NCT03462563|450532785|FG001|Overall Study|Adverse Event|3|||
125248003|NCT03462563|450532784|FG000|Overall Study|Unspecified reason|10|||
125248004|NCT03462563|450532785|FG001|Overall Study|Unspecified reason|12|||
125248005|NCT03462563|450532784|FG000|Overall Study|Physician Decision|1|||
125248006|NCT03462563|450532785|FG001|Overall Study|Physician Decision|0|||
125248007|NCT05103332|450532786|FG000|Overall Study|Lost to Follow-up|0|||
125248008|NCT05103332|450532787|FG001|Overall Study|Lost to Follow-up|2|||
125248009|NCT05103332|450532788|FG002|Overall Study|Lost to Follow-up|1|||
125248010|NCT05103332|450532789|FG003|Overall Study|Lost to Follow-up|0|||
125248011|NCT05103332|450532790|FG004|Overall Study|Lost to Follow-up|0|||
125248012|NCT05103332|450532791|FG005|Overall Study|Lost to Follow-up|2|||
125248013|NCT05103332|450532786|FG000|Overall Study|Physician Decision|0|||
125248014|NCT05103332|450532787|FG001|Overall Study|Physician Decision|1|||
125248015|NCT05103332|450532788|FG002|Overall Study|Physician Decision|0|||
125248016|NCT05103332|450532789|FG003|Overall Study|Physician Decision|1|||
125248017|NCT05103332|450532790|FG004|Overall Study|Physician Decision|0|||
125248018|NCT05103332|450532791|FG005|Overall Study|Physician Decision|0|||
125248019|NCT05103332|450532786|FG000|Overall Study|Participant Stopped Participation in the Study|2|||
125248020|NCT05103332|450532787|FG001|Overall Study|Participant Stopped Participation in the Study|3|||
125248021|NCT05103332|450532788|FG002|Overall Study|Participant Stopped Participation in the Study|5|||
125248022|NCT05103332|450532789|FG003|Overall Study|Participant Stopped Participation in the Study|3|||
125248023|NCT05103332|450532790|FG004|Overall Study|Participant Stopped Participation in the Study|3|||
125248024|NCT05103332|450532791|FG005|Overall Study|Participant Stopped Participation in the Study|7|||
125248025|NCT05103332|450532786|FG000|Overall Study|Unspeccified|0|||
125248026|NCT05103332|450532787|FG001|Overall Study|Unspeccified|0|||
125248027|NCT05103332|450532788|FG002|Overall Study|Unspeccified|0|||
125248028|NCT05103332|450532789|FG003|Overall Study|Unspeccified|1|||
125248029|NCT05103332|450532790|FG004|Overall Study|Unspeccified|0|||
125248030|NCT05103332|450532791|FG005|Overall Study|Unspeccified|0|||
125248031|NCT02218268|450532792|FG000|24 Hour Washout|Physician Decision|11|||
125248032|NCT02218268|450532793|FG001|24 Hour Washout|Physician Decision|9|||
125248033|NCT03651336|450532794|FG000|Overall Study|Withdrawal by Subject|4|||
125248034|NCT01740427|450532795|FG000|Overall Study|Objective Progression or Relapse|286|||
125195521|NCT00022698|450336750|FG001|Overall Study|Insufficient therapeutic response|14|||
125248035|NCT01740427|450532796|FG001|Overall Study|Objective Progression or Relapse|172|||
125248036|NCT01740427|450532795|FG000|Overall Study|Adverse Event|32|||
125248037|NCT01740427|450532796|FG001|Overall Study|Adverse Event|9|||
125248038|NCT01740427|450532795|FG000|Overall Study|Global Deterioration of Health Status|28|||
125248039|NCT01740427|450532796|FG001|Overall Study|Global Deterioration of Health Status|12|||
125248040|NCT01740427|450532795|FG000|Overall Study|Participant Refused Continued Treatment|27|||
125248041|NCT01740427|450532796|FG001|Overall Study|Participant Refused Continued Treatment|15|||
125248042|NCT01740427|450532795|FG000|Overall Study|Unspecified reasons|52|||
125248043|NCT01740427|450532796|FG001|Overall Study|Unspecified reasons|8|||
125248044|NCT01740427|450532795|FG000|Overall Study|Death|10|||
125195522|NCT00022698|450336749|FG000|Overall Study|Administrative /other|1|||
125248045|NCT01740427|450532796|FG001|Overall Study|Death|3|||
125248046|NCT01740427|450532795|FG000|Overall Study|Protocol Violation|5|||
125248047|NCT01740427|450532796|FG001|Overall Study|Protocol Violation|3|||
125248048|NCT01740427|450532795|FG000|Overall Study|Lost to Follow-up|3|||
125248049|NCT01740427|450532796|FG001|Overall Study|Lost to Follow-up|0|||
125248050|NCT01740427|450532795|FG000|Overall Study|Site Terminated by Sponsor|1|||
125248051|NCT01740427|450532796|FG001|Overall Study|Site Terminated by Sponsor|0|||
125248052|NCT04796207|450532799|FG000|Overall Study|Lost to Follow-up|7|||
125248053|NCT04796207|450532800|FG001|Overall Study|Lost to Follow-up|2|||
125248054|NCT00362609|450532801|FG000|Overall Study|Withdrawal by Subject|0|||
125248055|NCT00362609|450532802|FG001|Overall Study|Withdrawal by Subject|1|||
125248056|NCT00362609|450532801|FG000|Overall Study|Protocol Violation|0|||
125248057|NCT00362609|450532802|FG001|Overall Study|Protocol Violation|1|||
125248058|NCT01800058|450532811|FG000|Overall Study|Lost to Follow-up|1|||
125248059|NCT02186171|450532812|FG000|Overall Study|Withdrawal by Subject|1|||
125248060|NCT02186171|450532813|FG001|Overall Study|Withdrawal by Subject|9|||
125248061|NCT02186171|450532812|FG000|Overall Study|Lost to Follow-up|2|||
125248062|NCT02186171|450532813|FG001|Overall Study|Lost to Follow-up|2|||
125248063|NCT02186171|450532812|FG000|Overall Study|Death|1|||
125248064|NCT02186171|450532813|FG001|Overall Study|Death|2|||
125248065|NCT02186171|450532812|FG000|Overall Study|Protocol-specified Criteria|0|||
125248066|NCT02186171|450532813|FG001|Overall Study|Protocol-specified Criteria|2|||
125248067|NCT05206604|450534097|FG000|Overall Study|Non-compliance with study drug|0|||
125248068|NCT05206604|450534098|FG001|Overall Study|Non-compliance with study drug|0|||
125248069|NCT05206604|450534099|FG002|Overall Study|Non-compliance with study drug|0|||
125248070|NCT05206604|450534100|FG003|Overall Study|Non-compliance with study drug|0|||
125248071|NCT05206604|450534101|FG004|Overall Study|Non-compliance with study drug|0|||
125248072|NCT05206604|450534102|FG005|Overall Study|Non-compliance with study drug|1|||
125248073|NCT05206604|450534103|FG006|Overall Study|Non-compliance with study drug|0|||
125248074|NCT05206604|450534104|FG007|Overall Study|Non-compliance with study drug|0|||
125248075|NCT03735498|450534105|FG000|Overall Study|Withdrawal by Subject|3|||
125248076|NCT03735498|450534105|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
125248077|NCT03787212|450534107|FG000|Period 1|Study Termination|2|||
125248078|NCT03787212|450534108|FG001|Period 1|Study Termination|2|||
125248079|NCT02014103|450534109|FG000|Overall Study|Protocol Violation|7|||
125248080|NCT02014103|450534110|FG001|Overall Study|Protocol Violation|7|||
125248081|NCT02014103|450534109|FG000|Overall Study|Adverse Event|1|||
125248082|NCT02014103|450534110|FG001|Overall Study|Adverse Event|0|||
125248083|NCT02014103|450534109|FG000|Overall Study|Lost venous access|1|||
125248084|NCT02014103|450534110|FG001|Overall Study|Lost venous access|0|||
125248085|NCT02014103|450534109|FG000|Overall Study|Withdrawal by Subject|0|||
125248086|NCT02014103|450534110|FG001|Overall Study|Withdrawal by Subject|2|||
125248087|NCT00620035|450534111|FG000|Overall Study|Adverse Event|106|||
125248088|NCT00620035|450534111|FG000|Overall Study|Withdrawal of Informed Consent|1|||
125248089|NCT00620035|450534111|FG000|Overall Study|Other Reason|38|||
125248090|NCT04193176|450534113|FG000|Overall Study|Withdrawal by Subject|6|||
125248091|NCT04193176|450534114|FG001|Overall Study|Withdrawal by Subject|10|||
125248092|NCT01629563|450534115|FG000|Overall Study|Adverse Event|16|||
125248093|NCT01629563|450534116|FG001|Overall Study|Adverse Event|16|||
125248094|NCT01629563|450534115|FG000|Overall Study|Death|2|||
125248095|NCT01629563|450534116|FG001|Overall Study|Death|0|||
125248096|NCT01629563|450534115|FG000|Overall Study|Lack of Efficacy|2|||
125248097|NCT01629563|450534116|FG001|Overall Study|Lack of Efficacy|3|||
125248098|NCT01629563|450534115|FG000|Overall Study|Lost to Follow-up|1|||
125248099|NCT01629563|450534116|FG001|Overall Study|Lost to Follow-up|0|||
125248100|NCT01629563|450534115|FG000|Overall Study|Pregnancy|1|||
125248101|NCT01629563|450534116|FG001|Overall Study|Pregnancy|2|||
125248102|NCT01629563|450534115|FG000|Overall Study|Protocol Violation|0|||
125248103|NCT01629563|450534116|FG001|Overall Study|Protocol Violation|1|||
125248104|NCT01629563|450534115|FG000|Overall Study|Withdrawal by Subject|27|||
125248105|NCT01629563|450534116|FG001|Overall Study|Withdrawal by Subject|20|||
125248106|NCT01629563|450534115|FG000|Overall Study|surgery|0|||
125248107|NCT01629563|450534116|FG001|Overall Study|surgery|3|||
125248108|NCT01629563|450534115|FG000|Overall Study|Lack of return of menses|12|||
125248109|NCT01629563|450534116|FG001|Overall Study|Lack of return of menses|7|||
125248110|NCT01629563|450534115|FG000|Overall Study|Protocol Violation|0|||
125248111|NCT01629563|450534116|FG001|Overall Study|Protocol Violation|1|||
125248112|NCT02370394|450534117|FG000|Overall Study|Lost to Follow-up|2|||
125248113|NCT02370394|450534118|FG001|Overall Study|Lost to Follow-up|1|||
125248114|NCT02370394|450534117|FG000|Overall Study|Withdrawal by Subject|0|||
125248115|NCT02370394|450534118|FG001|Overall Study|Withdrawal by Subject|1|||
125248116|NCT01902303|450534120|FG000|Overall Study|Adverse Event|0|||
125248117|NCT01902303|450534121|FG001|Overall Study|Adverse Event|1|||
125248118|NCT01902303|450534120|FG000|Overall Study|Lost to Follow-up|0|||
125248119|NCT01902303|450534121|FG001|Overall Study|Lost to Follow-up|1|||
125248120|NCT01902303|450534120|FG000|Overall Study|Protocol Violation|2|||
125248121|NCT01902303|450534121|FG001|Overall Study|Protocol Violation|2|||
125248122|NCT01902303|450534120|FG000|Overall Study|subject lost investigational product|0|||
125248123|NCT01902303|450534121|FG001|Overall Study|subject lost investigational product|1|||
125248124|NCT01902303|450534120|FG000|Overall Study|Did not develop a cold sore|21|||
125248125|NCT01902303|450534121|FG001|Overall Study|Did not develop a cold sore|19|||
125248126|NCT02821000|450534122|FG000|Overall Study|Death|89|||
125248127|NCT02821000|450534122|FG000|Overall Study|Sponsor Decision|12|||
125248128|NCT02821000|450534122|FG000|Overall Study|Withdrawal by Subject|2|||
125248129|NCT00394472|450534130|FG000|Overall Study|Protocol Violation|1|||
125248130|NCT00394472|450534131|FG001|Overall Study|Protocol Violation|3|||
125248131|NCT00394472|450534130|FG000|Overall Study|incorrect enrolment|4|||
125248132|NCT00394472|450534131|FG001|Overall Study|incorrect enrolment|2|||
125248133|NCT00394472|450534130|FG000|Overall Study|Adverse Event|4|||
125248134|NCT00394472|450534131|FG001|Overall Study|Adverse Event|2|||
125248135|NCT00394472|450534130|FG000|Overall Study|Withdrawal by Subject|0|||
125248136|NCT00394472|450534131|FG001|Overall Study|Withdrawal by Subject|2|||
125248137|NCT00394472|450534130|FG000|Overall Study|Physician Decision|0|||
125248138|NCT00394472|450534131|FG001|Overall Study|Physician Decision|1|||
125248139|NCT00394472|450534130|FG000|Overall Study|Lost to Follow-up|0|||
125248140|NCT00394472|450534131|FG001|Overall Study|Lost to Follow-up|1|||
125248141|NCT02181621|450534132|FG000|Overall Study|Adverse Event|1|||
125248142|NCT02181621|450534133|FG001|Overall Study|Adverse Event|0|||
125248143|NCT02181621|450534132|FG000|Overall Study|Previously Enrolled|0|||
125248144|NCT02181621|450534133|FG001|Overall Study|Previously Enrolled|1|||
125248145|NCT02181621|450534132|FG000|Overall Study|Enrollment Hold|1|||
125248146|NCT02181621|450534133|FG001|Overall Study|Enrollment Hold|1|||
125248147|NCT00960856|450534134|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
125248148|NCT00960856|450534135|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
125248149|NCT00960856|450534136|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
125248150|NCT00960856|450534137|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
125248151|NCT00960856|450534134|FG000|Washout Period of 7 Days|Adverse Event|0|||
125248152|NCT00960856|450534135|FG001|Washout Period of 7 Days|Adverse Event|0|||
125248153|NCT00960856|450534136|FG002|Washout Period of 7 Days|Adverse Event|1|||
125248154|NCT00960856|450534137|FG003|Washout Period of 7 Days|Adverse Event|0|||
125248155|NCT03387046|450534139|FG000|Overall Study|Adverse Event|1|||
125248156|NCT03387046|450534140|FG001|Overall Study|Adverse Event|1|||
125248157|NCT01301001|450534152|FG000|First Intervention|Lost to Follow-up|4|||
125248158|NCT01301001|450534153|FG001|First Intervention|Lost to Follow-up|4|||
125248159|NCT01301001|450534152|FG000|First Intervention|Withdrawal by Subject|1|||
125248160|NCT01301001|450534153|FG001|First Intervention|Withdrawal by Subject|4|||
125248161|NCT01301001|450534152|FG000|First Intervention|Adverse Event|5|||
125248162|NCT01301001|450534153|FG001|First Intervention|Adverse Event|0|||
125248163|NCT01301001|450534152|FG000|First Intervention|Protocol Violation|0|||
125248164|NCT01301001|450534153|FG001|First Intervention|Protocol Violation|1|||
125248165|NCT01301001|450534152|FG000|Second Intervention|Adverse Event|2|||
125248166|NCT01301001|450534153|FG001|Second Intervention|Adverse Event|0|||
125248167|NCT01301001|450534152|FG000|Second Intervention|Withdrawal by Subject|2|||
125248168|NCT01301001|450534153|FG001|Second Intervention|Withdrawal by Subject|0|||
125248169|NCT01560988|450534154|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
125248170|NCT01560988|450534155|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
125248171|NCT01560988|450534154|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
125248172|NCT01560988|450534155|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
125248173|NCT01560988|450534154|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
125248174|NCT01560988|450534155|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
125248175|NCT01346709|450534156|FG000|Overall Study|Protocol Violation|35|||
125248176|NCT01346709|450534156|FG000|Overall Study|Lost to Follow-up|31|||
125248177|NCT01346709|450534156|FG000|Overall Study|Missing data in candidate risk factor|285|||
125248178|NCT00458705|450534161|FG000|Overall Study|Adverse Event|4|||
125248179|NCT00458705|450534161|FG000|Overall Study|Not Treated|1|||
125248180|NCT02565186|450534162|FG000|Overall Study|Adverse Event|113|||
125248181|NCT02565186|450534163|FG001|Overall Study|Adverse Event|148|||
125248182|NCT02565186|450534162|FG000|Overall Study|Lost to Follow-up|102|||
125248183|NCT02565186|450534163|FG001|Overall Study|Lost to Follow-up|93|||
125248184|NCT02565186|450534162|FG000|Overall Study|Non-Compliance|57|||
125248185|NCT02565186|450534163|FG001|Overall Study|Non-Compliance|55|||
125248186|NCT02565186|450534162|FG000|Overall Study|Withdrawal by Subject|229|||
125248187|NCT02565186|450534163|FG001|Overall Study|Withdrawal by Subject|214|||
125248188|NCT02565186|450534162|FG000|Overall Study|Physician Decision|18|||
125248189|NCT02565186|450534163|FG001|Overall Study|Physician Decision|16|||
125248190|NCT02565186|450534162|FG000|Overall Study|Sponsor Request|5|||
125248191|NCT02565186|450534163|FG001|Overall Study|Sponsor Request|9|||
125248192|NCT02565186|450534162|FG000|Overall Study|Missing|1|||
125248193|NCT02565186|450534163|FG001|Overall Study|Missing|0|||
125195523|NCT00022698|450336750|FG001|Overall Study|Administrative /other|7|||
125195524|NCT03425396|450336751|FG000|Overall Study|Lost to Follow-up|2|||
125195525|NCT03425396|450336752|FG001|Overall Study|Lost to Follow-up|5|||
125195526|NCT03425396|450336753|FG002|Overall Study|Lost to Follow-up|2|||
125195527|NCT03425396|450336754|FG003|Overall Study|Lost to Follow-up|0|||
125195528|NCT03425396|450336755|FG004|Overall Study|Lost to Follow-up|0|||
125195529|NCT03425396|450336751|FG000|Overall Study|Withdrawal by Subject|0|||
125195530|NCT03425396|450336752|FG001|Overall Study|Withdrawal by Subject|1|||
125195531|NCT03425396|450336753|FG002|Overall Study|Withdrawal by Subject|0|||
125195532|NCT03425396|450336754|FG003|Overall Study|Withdrawal by Subject|1|||
125195533|NCT03425396|450336755|FG004|Overall Study|Withdrawal by Subject|0|||
125195534|NCT03425396|450336751|FG000|Overall Study|Other|0|||
125195535|NCT03425396|450336752|FG001|Overall Study|Other|1|||
125195536|NCT03425396|450336753|FG002|Overall Study|Other|1|||
125195537|NCT03425396|450336754|FG003|Overall Study|Other|0|||
125195538|NCT03425396|450336755|FG004|Overall Study|Other|1|||
125195539|NCT03689374|450336757|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
125195540|NCT03689374|450336758|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
125195541|NCT03689374|450336759|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
125195542|NCT03689374|450336757|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
125195543|NCT03689374|450336758|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
125195544|NCT03689374|450336759|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
125195545|NCT03689374|450336757|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
125195546|NCT03689374|450336758|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
125195547|NCT03689374|450336759|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
125195548|NCT03689374|450336757|FG000|Treatment Period (Week 0 to 52)|Death|0|||
125195549|NCT03689374|450336758|FG001|Treatment Period (Week 0 to 52)|Death|11|||
125195550|NCT03689374|450336759|FG002|Treatment Period (Week 0 to 52)|Death|1|||
125195551|NCT05088603|450337881|FG000|Overall Study|Protocol Violation|6|||
125195552|NCT05088603|450337882|FG001|Overall Study|Protocol Violation|1|||
125195553|NCT00594100|450337885|FG000|Procedure|Technical Failure|9|||
125195554|NCT00594100|450337885|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
125195555|NCT00594100|450337885|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
125195556|NCT00594100|450337885|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
125195557|NCT03981900|450337886|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
125195558|NCT03981900|450337886|FG000|Overall Study|Adverse Event|5|||
125195559|NCT03981900|450337886|FG000|Overall Study|Protocol Violation|1|||
125195560|NCT03981900|450337886|FG000|Overall Study|Withdrawal by Subject|7|||
125195561|NCT03981900|450337886|FG000|Overall Study|Lost to Follow-up|46|||
125195562|NCT03981900|450337886|FG000|Overall Study|Decision of the researcher|3|||
125195563|NCT03981900|450337886|FG000|Overall Study|Death|3|||
125195564|NCT03981900|450337886|FG000|Overall Study|Other|5|||
125195565|NCT02162719|450337887|FG000|Overall Study|Death|41|||
125195566|NCT02162719|450337888|FG001|Overall Study|Death|46|||
125195567|NCT02162719|450337887|FG000|Overall Study|Lost to Follow-up|1|||
125195568|NCT02162719|450337888|FG001|Overall Study|Lost to Follow-up|3|||
125195569|NCT02162719|450337887|FG000|Overall Study|Disease Progression|2|||
125195570|NCT02162719|450337888|FG001|Overall Study|Disease Progression|1|||
125195571|NCT02162719|450337887|FG000|Overall Study|Withdrawal by Subject|8|||
125195572|NCT02162719|450337888|FG001|Overall Study|Withdrawal by Subject|2|||
125195573|NCT02162719|450337887|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
125195574|NCT02162719|450337888|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
125195575|NCT01931475|450337891|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
125195576|NCT01931475|450337892|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
125195577|NCT01931475|450337891|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
125195578|NCT01931475|450337892|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
125195579|NCT01931475|450337891|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
125195580|NCT01931475|450337892|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
125195581|NCT01931475|450337891|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
125195582|NCT01931475|450337892|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
125195583|NCT01931475|450337891|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
125195584|NCT01931475|450337892|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
125195585|NCT01931475|450337891|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
125195586|NCT01931475|450337892|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
125195587|NCT01931475|450337891|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
125195588|NCT01931475|450337892|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
125195589|NCT01931475|450337891|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
125195590|NCT01931475|450337892|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
125195591|NCT01931475|450337891|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
125195592|NCT01931475|450337892|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
125195593|NCT01931475|450337891|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
125195594|NCT01931475|450337892|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
125195595|NCT01931475|450337891|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
125195596|NCT01931475|450337892|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
125195597|NCT04292912|450337895|FG000|Overall Study|Physician Decision|1|||
125195598|NCT04292912|450337895|FG000|Overall Study|Protocol Violation|6|||
125195599|NCT05338502|450337905|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
125195600|NCT05338502|450337906|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
125195601|NCT05338502|450337907|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
125195602|NCT05338502|450337905|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
125195603|NCT05338502|450337906|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
125195604|NCT05338502|450337907|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
125195605|NCT03575793|450337914|FG000|Overall Study|Withdrawal by Subject|0|||
125195606|NCT03575793|450337915|FG001|Overall Study|Withdrawal by Subject|1|||
125195607|NCT03575793|450337914|FG000|Overall Study|Never Treated|0|||
125195608|NCT03575793|450337915|FG001|Overall Study|Never Treated|2|||
125195609|NCT01250873|450337916|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
125195610|NCT01250873|450337916|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
125195611|NCT02278939|450337917|FG000|Overall Study|lack of time|1|||
125195612|NCT02278939|450337918|FG001|Overall Study|lack of time|0|||
125195613|NCT02278939|450337917|FG000|Overall Study|Lost to Follow-up|1|||
125195614|NCT02278939|450337918|FG001|Overall Study|Lost to Follow-up|1|||
125195615|NCT02278939|450337917|FG000|Overall Study|death in family|1|||
125195616|NCT02278939|450337918|FG001|Overall Study|death in family|0|||
125195617|NCT02278939|450337917|FG000|Overall Study|family emergency unable to commit|2|||
125195618|NCT02278939|450337918|FG001|Overall Study|family emergency unable to commit|0|||
125195619|NCT01127451|450337923|FG000|Overall Study|Other|2|||
125195620|NCT01127451|450337924|FG001|Overall Study|Other|1|||
125195621|NCT01127451|450337923|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
125195622|NCT01127451|450337924|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
125195623|NCT01127451|450337923|FG000|Overall Study|Death|22|||
125195624|NCT01127451|450337924|FG001|Overall Study|Death|17|||
125195625|NCT01127451|450337923|FG000|Overall Study|Lost to Follow-up|3|||
125195626|NCT01127451|450337924|FG001|Overall Study|Lost to Follow-up|0|||
125195627|NCT01127451|450337923|FG000|Overall Study|Administrative Reason by Sponsor|2|||
125195628|NCT01127451|450337924|FG001|Overall Study|Administrative Reason by Sponsor|2|||
125195629|NCT00930774|450337925|FG000|Overall Study|Withdrawal by Subject|1|||
125195630|NCT00930774|450337926|FG001|Overall Study|Withdrawal by Subject|9|||
125195631|NCT00930774|450337927|FG002|Overall Study|Withdrawal by Subject|2|||
125195632|NCT00930774|450337928|FG003|Overall Study|Withdrawal by Subject|0|||
125195633|NCT01680861|450337929|FG000|Early Post-transplant Period|Protocol Violation|1|||
125195634|NCT01680861|450337930|FG001|Early Post-transplant Period|Protocol Violation|1|||
125195635|NCT01940887|450337933|FG000|Year 1|Protocol Violation|0|||
125195636|NCT01940887|450337934|FG001|Year 1|Protocol Violation|1|||
125195637|NCT01940887|450337933|FG000|Year 1|Physician Decision|7|||
125195638|NCT01940887|450337934|FG001|Year 1|Physician Decision|3|||
125195639|NCT01940887|450337933|FG000|Year 1|Death|5|||
125195640|NCT01940887|450337934|FG001|Year 1|Death|3|||
125195641|NCT01940887|450337933|FG000|Year 1|Adverse Event|7|||
125195642|NCT01940887|450337934|FG001|Year 1|Adverse Event|6|||
125195643|NCT01940887|450337933|FG000|Year 1|Withdrawal by Subject|18|||
125195644|NCT01940887|450337934|FG001|Year 1|Withdrawal by Subject|9|||
125195645|NCT01940887|450337933|FG000|Year 1|Lost to Follow-up|2|||
125195646|NCT01940887|450337934|FG001|Year 1|Lost to Follow-up|1|||
125195647|NCT01940887|450337933|FG000|Year 2|Physician Decision|8|||
125195648|NCT01940887|450337934|FG001|Year 2|Physician Decision|1|||
125195649|NCT01940887|450337933|FG000|Year 2|Death|0|||
125195650|NCT01940887|450337934|FG001|Year 2|Death|2|||
125195651|NCT01940887|450337933|FG000|Year 2|Sponsor Decision, early termination|192|||
125195652|NCT01940887|450337934|FG001|Year 2|Sponsor Decision, early termination|203|||
125195653|NCT01940887|450337933|FG000|Year 2|Adverse Event|8|||
125195654|NCT01940887|450337934|FG001|Year 2|Adverse Event|2|||
125195655|NCT01940887|450337933|FG000|Year 2|Withdrawal by Subject|8|||
125195656|NCT01940887|450337934|FG001|Year 2|Withdrawal by Subject|8|||
125195657|NCT01940887|450337933|FG000|Year 2|Lost to Follow-up|1|||
125195658|NCT01940887|450337934|FG001|Year 2|Lost to Follow-up|6|||
125195659|NCT02475265|450337937|FG000|Overall Study|Physician Decision|1|||
125195660|NCT02475265|450337937|FG000|Overall Study|Withdrawal by Subject|2|||
125195661|NCT01598090|450337938|FG000|Treatment Period|Poor/non-compliance|0|||
125195662|NCT01598090|450337939|FG001|Treatment Period|Poor/non-compliance|2|||
125195663|NCT01598090|450337940|FG002|Treatment Period|Poor/non-compliance|0|||
125195664|NCT01598090|450337938|FG000|Treatment Period|No longer meet study criteria|0|||
125195665|NCT01598090|450337939|FG001|Treatment Period|No longer meet study criteria|1|||
125248194|NCT02565186|450534162|FG000|Overall Study|Did Not Receive Study Drug|55|||
125248195|NCT02565186|450534163|FG001|Overall Study|Did Not Receive Study Drug|86|||
125248196|NCT00337194|450534164|FG000|Overall Study|Adverse Event|5|||
125248197|NCT00337194|450534165|FG001|Overall Study|Adverse Event|1|||
125248198|NCT00337194|450534164|FG000|Overall Study|Death|2|||
125248199|NCT00337194|450534165|FG001|Overall Study|Death|0|||
125248200|NCT00337194|450534164|FG000|Overall Study|Withdrawal by Subject|1|||
125248201|NCT00337194|450534165|FG001|Overall Study|Withdrawal by Subject|0|||
125248202|NCT00337194|450534164|FG000|Overall Study|Disease progression|1|||
125248203|NCT00337194|450534165|FG001|Overall Study|Disease progression|2|||
125248204|NCT00337194|450534164|FG000|Overall Study|Subsequent non-protocol therapy|3|||
125248205|NCT00337194|450534165|FG001|Overall Study|Subsequent non-protocol therapy|1|||
125248206|NCT03188705|450534166|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
125248207|NCT03188705|450534166|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
125248208|NCT01174459|450534167|FG000|Overall Study|case report form (CRF) not collected|5|||
125248209|NCT01623752|450534168|FG000|Phase 1 (78 Weeks)|No Data|249|||
125248210|NCT01623752|450534169|FG001|Phase 1 (78 Weeks)|No Data|66|||
125248211|NCT01623752|450534170|FG002|Phase 1 (78 Weeks)|No Data|2|||
125248212|NCT01623752|450534168|FG000|Phase 1 (78 Weeks)|Other|33|||
125248213|NCT01623752|450534169|FG001|Phase 1 (78 Weeks)|Other|20|||
125248214|NCT01623752|450534170|FG002|Phase 1 (78 Weeks)|Other|0|||
125248215|NCT01623752|450534168|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
125248216|NCT01623752|450534169|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
125248217|NCT01623752|450534170|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
125248218|NCT01623752|450534168|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
125248219|NCT01623752|450534169|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
125248220|NCT01623752|450534170|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
125248221|NCT01623752|450534168|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
125248222|NCT01623752|450534169|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
125248223|NCT01623752|450534170|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
125248224|NCT01623752|450534168|FG000|Phase 2 (78 Weeks)|Other|5|||
125248225|NCT01623752|450534169|FG001|Phase 2 (78 Weeks)|Other|1|||
125248226|NCT01623752|450534170|FG002|Phase 2 (78 Weeks)|Other|0|||
125248227|NCT01623752|450534168|FG000|Phase 2 (78 Weeks)|No Data|43|||
125248228|NCT01623752|450534169|FG001|Phase 2 (78 Weeks)|No Data|11|||
125248229|NCT01623752|450534170|FG002|Phase 2 (78 Weeks)|No Data|0|||
125248230|NCT01623752|450534168|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
125248231|NCT01623752|450534169|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
125248232|NCT01623752|450534170|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
125248233|NCT03994120|450534171|FG000|Overall Study|Lost to Follow-up|3|||
125248234|NCT03994120|450534172|FG001|Overall Study|Lost to Follow-up|1|||
125248235|NCT03511066|450534173|FG000|Overall Study|Withdrawal by Subject|1|||
125248236|NCT03511066|450534174|FG001|Overall Study|Withdrawal by Subject|2|||
125248237|NCT03511066|450534175|FG002|Overall Study|Withdrawal by Subject|3|||
125248238|NCT03511066|450534173|FG000|Overall Study|Lost to Follow-up|2|||
125248239|NCT03511066|450534174|FG001|Overall Study|Lost to Follow-up|3|||
125248240|NCT03511066|450534175|FG002|Overall Study|Lost to Follow-up|0|||
125248241|NCT00165698|450534178|FG000|Overall Study|Adverse Event|2|||
125248242|NCT00165698|450534179|FG001|Overall Study|Adverse Event|10|||
125248243|NCT00165698|450534178|FG000|Overall Study|Lost to Follow-up|2|||
125248244|NCT00165698|450534179|FG001|Overall Study|Lost to Follow-up|2|||
125248245|NCT00165698|450534178|FG000|Overall Study|Withdrawal by Subject|2|||
125248246|NCT00165698|450534179|FG001|Overall Study|Withdrawal by Subject|1|||
125248247|NCT00165698|450534178|FG000|Overall Study|Protocol Violation|1|||
125248248|NCT00165698|450534179|FG001|Overall Study|Protocol Violation|0|||
125248249|NCT00165698|450534178|FG000|Overall Study|Not Taken/Lost the medicine|1|||
125248250|NCT00165698|450534179|FG001|Overall Study|Not Taken/Lost the medicine|2|||
125248251|NCT03679884|450534180|FG000|Overall Study|Other|12|||
125248252|NCT03679884|450534181|FG001|Overall Study|Other|12|||
125248253|NCT03679884|450534182|FG002|Overall Study|Other|12|||
125248254|NCT03679884|450534183|FG003|Overall Study|Other|7|||
125248255|NCT03679884|450534184|FG004|Overall Study|Other|8|||
125248256|NCT03679884|450534180|FG000|Overall Study|Lack of Efficacy|15|||
125248257|NCT03679884|450534181|FG001|Overall Study|Lack of Efficacy|29|||
125248258|NCT03679884|450534182|FG002|Overall Study|Lack of Efficacy|13|||
125248259|NCT03679884|450534183|FG003|Overall Study|Lack of Efficacy|29|||
125248260|NCT03679884|450534184|FG004|Overall Study|Lack of Efficacy|10|||
125248261|NCT03679884|450534180|FG000|Overall Study|Death|1|||
125248262|NCT03679884|450534181|FG001|Overall Study|Death|0|||
125248263|NCT03679884|450534182|FG002|Overall Study|Death|0|||
125248264|NCT03679884|450534183|FG003|Overall Study|Death|0|||
125248265|NCT03679884|450534184|FG004|Overall Study|Death|0|||
125248266|NCT03679884|450534180|FG000|Overall Study|Adverse Event|2|||
125248267|NCT03679884|450534181|FG001|Overall Study|Adverse Event|10|||
125248268|NCT03679884|450534182|FG002|Overall Study|Adverse Event|9|||
125248269|NCT03679884|450534183|FG003|Overall Study|Adverse Event|6|||
125248270|NCT03679884|450534184|FG004|Overall Study|Adverse Event|6|||
125248271|NCT03679884|450534180|FG000|Overall Study|Withdrawal by Subject|12|||
125248272|NCT03679884|450534181|FG001|Overall Study|Withdrawal by Subject|23|||
125248273|NCT03679884|450534182|FG002|Overall Study|Withdrawal by Subject|8|||
125248274|NCT03679884|450534183|FG003|Overall Study|Withdrawal by Subject|8|||
125248275|NCT03679884|450534184|FG004|Overall Study|Withdrawal by Subject|9|||
125248276|NCT03679884|450534180|FG000|Overall Study|Lost to Follow-up|1|||
125248277|NCT03679884|450534181|FG001|Overall Study|Lost to Follow-up|4|||
125248278|NCT03679884|450534182|FG002|Overall Study|Lost to Follow-up|2|||
125248279|NCT03679884|450534183|FG003|Overall Study|Lost to Follow-up|0|||
125248280|NCT03679884|450534184|FG004|Overall Study|Lost to Follow-up|3|||
125248281|NCT01107457|450534185|FG000|Part A|Adverse Event|1|||
125248282|NCT01107457|450534186|FG001|Part A|Adverse Event|2|||
125248283|NCT01107457|450534187|FG002|Part A|Adverse Event|1|||
125248284|NCT01107457|450534188|FG003|Part A|Adverse Event|0|||
125248285|NCT01107457|450534189|FG004|Part A|Adverse Event|0|||
125248286|NCT01107457|450534190|FG005|Part A|Adverse Event|0|||
125248287|NCT01107457|450534185|FG000|Part A|Withdrawal by Subject|3|||
125248288|NCT01107457|450534186|FG001|Part A|Withdrawal by Subject|3|||
125248289|NCT01107457|450534187|FG002|Part A|Withdrawal by Subject|0|||
125248290|NCT01107457|450534188|FG003|Part A|Withdrawal by Subject|3|||
125248291|NCT01107457|450534189|FG004|Part A|Withdrawal by Subject|1|||
125248292|NCT01107457|450534190|FG005|Part A|Withdrawal by Subject|0|||
125248293|NCT01107457|450534185|FG000|Part A|Lost to Follow-up|0|||
125248294|NCT01107457|450534186|FG001|Part A|Lost to Follow-up|1|||
125248295|NCT01107457|450534187|FG002|Part A|Lost to Follow-up|0|||
125248296|NCT01107457|450534188|FG003|Part A|Lost to Follow-up|0|||
125248297|NCT01107457|450534189|FG004|Part A|Lost to Follow-up|0|||
125248298|NCT01107457|450534190|FG005|Part A|Lost to Follow-up|0|||
125248299|NCT01107457|450534185|FG000|Part A|Lack of Efficacy|1|||
125248300|NCT01107457|450534186|FG001|Part A|Lack of Efficacy|0|||
125248301|NCT01107457|450534187|FG002|Part A|Lack of Efficacy|0|||
125248302|NCT01107457|450534188|FG003|Part A|Lack of Efficacy|0|||
125248303|NCT01107457|450534189|FG004|Part A|Lack of Efficacy|0|||
125248304|NCT01107457|450534190|FG005|Part A|Lack of Efficacy|0|||
125248305|NCT01107457|450534185|FG000|Part A|Protocol Violation|0|||
125248306|NCT01107457|450534186|FG001|Part A|Protocol Violation|1|||
125248307|NCT01107457|450534187|FG002|Part A|Protocol Violation|0|||
125248308|NCT01107457|450534188|FG003|Part A|Protocol Violation|0|||
125195666|NCT01598090|450337940|FG002|Treatment Period|No longer meet study criteria|0|||
125195667|NCT01598090|450337938|FG000|Treatment Period|Lack of Efficacy|5|||
125195668|NCT01598090|450337939|FG001|Treatment Period|Lack of Efficacy|14|||
125195669|NCT01598090|450337940|FG002|Treatment Period|Lack of Efficacy|6|||
125195670|NCT01598090|450337938|FG000|Treatment Period|Adverse Event|2|||
125195671|NCT01598090|450337939|FG001|Treatment Period|Adverse Event|33|||
125195672|NCT01598090|450337940|FG002|Treatment Period|Adverse Event|17|||
125195673|NCT01598090|450337938|FG000|Treatment Period|Other reasons|0|||
125195674|NCT01598090|450337939|FG001|Treatment Period|Other reasons|4|||
125195675|NCT01598090|450337940|FG002|Treatment Period|Other reasons|1|||
125195676|NCT01598090|450337938|FG000|Treatment Period|Withdrawal by Subject|3|||
125195677|NCT01598090|450337939|FG001|Treatment Period|Withdrawal by Subject|13|||
125195678|NCT01598090|450337940|FG002|Treatment Period|Withdrawal by Subject|10|||
125195679|NCT01598090|450337938|FG000|Treatment Period|Lost to Follow-up|1|||
125195680|NCT01598090|450337939|FG001|Treatment Period|Lost to Follow-up|5|||
125195681|NCT01598090|450337940|FG002|Treatment Period|Lost to Follow-up|1|||
125195682|NCT01598090|450337938|FG000|Follow-up Period|Death|0|||
125195683|NCT01598090|450337939|FG001|Follow-up Period|Death|1|||
125195684|NCT01598090|450337940|FG002|Follow-up Period|Death|0|||
125195685|NCT01598090|450337938|FG000|Follow-up Period|No longer required per protocol|1|||
125195686|NCT01598090|450337939|FG001|Follow-up Period|No longer required per protocol|3|||
125195687|NCT01598090|450337940|FG002|Follow-up Period|No longer required per protocol|2|||
125195688|NCT01598090|450337938|FG000|Follow-up Period|Not reported|0|||
125195689|NCT01598090|450337939|FG001|Follow-up Period|Not reported|10|||
125195690|NCT01598090|450337940|FG002|Follow-up Period|Not reported|4|||
125195691|NCT01598090|450337938|FG000|Follow-up Period|Withdrawal by Subject|0|||
125195692|NCT01598090|450337939|FG001|Follow-up Period|Withdrawal by Subject|3|||
125195693|NCT01598090|450337940|FG002|Follow-up Period|Withdrawal by Subject|2|||
125195694|NCT01598090|450337938|FG000|Follow-up Period|Other reasons|2|||
125195695|NCT01598090|450337939|FG001|Follow-up Period|Other reasons|8|||
125195696|NCT01598090|450337940|FG002|Follow-up Period|Other reasons|8|||
125195697|NCT01598090|450337938|FG000|Follow-up Period|Lost to Follow-up|2|||
125195698|NCT01598090|450337939|FG001|Follow-up Period|Lost to Follow-up|10|||
125195699|NCT01598090|450337940|FG002|Follow-up Period|Lost to Follow-up|12|||
125195700|NCT04087720|450337950|FG000|Overall Study|Withdrawal by Subject|2|||
125195701|NCT04087720|450337950|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
125195702|NCT00520533|450337953|FG000|Overall Study|Death|1|||
125195703|NCT00520533|450337953|FG000|Overall Study|Suspension of the study for safety reasons|1|||
125195704|NCT00520533|450337953|FG000|Overall Study|Withdrawal by Subject|1|||
125195705|NCT00520533|450337953|FG000|Overall Study|Physician Decision|1|||
125195706|NCT02438826|450337954|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
125195707|NCT02438826|450337955|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
125248309|NCT01107457|450534189|FG004|Part A|Protocol Violation|0|||
125248310|NCT01107457|450534190|FG005|Part A|Protocol Violation|0|||
125248311|NCT01107457|450534185|FG000|Part B and C|Adverse Event|0|||
125248312|NCT01107457|450534186|FG001|Part B and C|Adverse Event|0|||
125248313|NCT01107457|450534187|FG002|Part B and C|Adverse Event|0|||
125248314|NCT01107457|450534188|FG003|Part B and C|Adverse Event|0|||
125248315|NCT01107457|450534189|FG004|Part B and C|Adverse Event|0|||
125248316|NCT01107457|450534190|FG005|Part B and C|Adverse Event|12|||
125248317|NCT01107457|450534185|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
125248318|NCT01107457|450534186|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
125248319|NCT01107457|450534187|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
125248320|NCT01107457|450534188|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
125248321|NCT01107457|450534189|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
125248322|NCT01107457|450534190|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
125248323|NCT01107457|450534185|FG000|Part B and C|Physician Decision|0|||
125248324|NCT01107457|450534186|FG001|Part B and C|Physician Decision|0|||
125248325|NCT01107457|450534187|FG002|Part B and C|Physician Decision|0|||
125248326|NCT01107457|450534188|FG003|Part B and C|Physician Decision|0|||
125248327|NCT01107457|450534189|FG004|Part B and C|Physician Decision|0|||
125248328|NCT01107457|450534190|FG005|Part B and C|Physician Decision|3|||
125195708|NCT02438826|450337956|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
125195709|NCT02438826|450337957|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
125195710|NCT02438826|450337954|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
125195711|NCT02438826|450337955|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
125195712|NCT02438826|450337956|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
125195713|NCT02438826|450337957|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
125195714|NCT02438826|450337954|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
125195715|NCT02438826|450337955|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
125195716|NCT02438826|450337956|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
125248329|NCT01107457|450534185|FG000|Part B and C|Lack of Efficacy|0|||
125248330|NCT01107457|450534186|FG001|Part B and C|Lack of Efficacy|0|||
125248331|NCT01107457|450534187|FG002|Part B and C|Lack of Efficacy|0|||
125248332|NCT01107457|450534188|FG003|Part B and C|Lack of Efficacy|0|||
125248333|NCT01107457|450534189|FG004|Part B and C|Lack of Efficacy|0|||
125248334|NCT01107457|450534190|FG005|Part B and C|Lack of Efficacy|7|||
125248335|NCT01107457|450534185|FG000|Part B and C|Lost to Follow-up|0|||
125248336|NCT01107457|450534186|FG001|Part B and C|Lost to Follow-up|0|||
125248337|NCT01107457|450534187|FG002|Part B and C|Lost to Follow-up|0|||
125248338|NCT01107457|450534188|FG003|Part B and C|Lost to Follow-up|0|||
125248339|NCT01107457|450534189|FG004|Part B and C|Lost to Follow-up|0|||
125248340|NCT01107457|450534190|FG005|Part B and C|Lost to Follow-up|10|||
125248341|NCT01107457|450534185|FG000|Part B and C|Protocol Violation|0|||
125248342|NCT01107457|450534186|FG001|Part B and C|Protocol Violation|0|||
125248343|NCT01107457|450534187|FG002|Part B and C|Protocol Violation|0|||
125248344|NCT01107457|450534188|FG003|Part B and C|Protocol Violation|0|||
125248345|NCT01107457|450534189|FG004|Part B and C|Protocol Violation|0|||
125248346|NCT01107457|450534190|FG005|Part B and C|Protocol Violation|1|||
125248347|NCT01107457|450534185|FG000|Part B and C|Sponsor Decision|0|||
125248348|NCT01107457|450534186|FG001|Part B and C|Sponsor Decision|0|||
125248349|NCT01107457|450534187|FG002|Part B and C|Sponsor Decision|0|||
125248350|NCT01107457|450534188|FG003|Part B and C|Sponsor Decision|0|||
125248351|NCT01107457|450534189|FG004|Part B and C|Sponsor Decision|0|||
125248352|NCT01107457|450534190|FG005|Part B and C|Sponsor Decision|66|||
125248353|NCT01107457|450534185|FG000|Part B and C|Withdrawal by Subject|0|||
125248354|NCT01107457|450534186|FG001|Part B and C|Withdrawal by Subject|0|||
125248355|NCT01107457|450534187|FG002|Part B and C|Withdrawal by Subject|0|||
125248356|NCT01107457|450534188|FG003|Part B and C|Withdrawal by Subject|0|||
125248357|NCT01107457|450534189|FG004|Part B and C|Withdrawal by Subject|0|||
125248358|NCT01107457|450534190|FG005|Part B and C|Withdrawal by Subject|16|||
125248359|NCT01107457|450534185|FG000|Part B and C|Clinical Relapse|0|||
125248360|NCT01107457|450534186|FG001|Part B and C|Clinical Relapse|0|||
125248361|NCT01107457|450534187|FG002|Part B and C|Clinical Relapse|0|||
125248362|NCT01107457|450534188|FG003|Part B and C|Clinical Relapse|0|||
125248363|NCT01107457|450534189|FG004|Part B and C|Clinical Relapse|0|||
125248364|NCT01107457|450534190|FG005|Part B and C|Clinical Relapse|4|||
125248365|NCT01026038|450534191|FG000|Overall Study|Lost to Follow-up|1|||
125248366|NCT01026038|450534192|FG001|Overall Study|Lost to Follow-up|1|||
125248367|NCT01026038|450534193|FG002|Overall Study|Lost to Follow-up|0|||
125248368|NCT03601052|450534194|FG000|Overall Study|Lost to Follow-up|2|||
125248369|NCT00837330|450534195|FG000|Overall Study|Lost to Follow-up|1|||
125248370|NCT00837330|450534196|FG001|Overall Study|Lost to Follow-up|3|||
125248371|NCT01227395|450534197|FG000|Overall Study|Protocol Violation|0|||
125248372|NCT01227395|450534198|FG001|Overall Study|Protocol Violation|1|||
125248373|NCT00105508|450534203|FG000|Overall Study|Prephase Dropout|1|||
125248374|NCT00105508|450534204|FG001|Overall Study|Prephase Dropout|0|||
125248375|NCT00105508|450534203|FG000|Overall Study|Adverse Event|16|||
125248376|NCT00105508|450534204|FG001|Overall Study|Adverse Event|19|||
125248377|NCT00105508|450534203|FG000|Overall Study|Insufficient Efficacy|1|||
125248378|NCT00105508|450534204|FG001|Overall Study|Insufficient Efficacy|0|||
125248379|NCT00105508|450534203|FG000|Overall Study|Withdrawal by Subject|10|||
125248380|NCT00105508|450534204|FG001|Overall Study|Withdrawal by Subject|6|||
125248381|NCT00105508|450534203|FG000|Overall Study|Lost to Follow-up|3|||
125248382|NCT00105508|450534204|FG001|Overall Study|Lost to Follow-up|0|||
125248383|NCT00105508|450534203|FG000|Overall Study|Protocol Violation|1|||
125248384|NCT00105508|450534204|FG001|Overall Study|Protocol Violation|2|||
125248385|NCT00105508|450534203|FG000|Overall Study|Other|8|||
125248386|NCT00105508|450534204|FG001|Overall Study|Other|9|||
125248387|NCT00086307|450534205|FG000|Overall Study|Lack of Efficacy|1|||
125248388|NCT00086307|450534206|FG001|Overall Study|Lack of Efficacy|1|||
125248389|NCT00086307|450534207|FG002|Overall Study|Lack of Efficacy|2|||
125248390|NCT00086307|450534205|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
125248391|NCT00086307|450534206|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
125248392|NCT00086307|450534207|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
125248393|NCT00086307|450534205|FG000|Overall Study|Nausea and headaches|0|||
125248394|NCT00086307|450534206|FG001|Overall Study|Nausea and headaches|0|||
125248395|NCT00086307|450534207|FG002|Overall Study|Nausea and headaches|1|||
125248396|NCT00086307|450534205|FG000|Overall Study|Constipation and sleepiness|0|||
125248397|NCT00086307|450534206|FG001|Overall Study|Constipation and sleepiness|0|||
125248398|NCT00086307|450534207|FG002|Overall Study|Constipation and sleepiness|1|||
125248399|NCT00086307|450534205|FG000|Overall Study|Suicidal ideation|0|||
125248400|NCT00086307|450534206|FG001|Overall Study|Suicidal ideation|0|||
125248401|NCT00086307|450534207|FG002|Overall Study|Suicidal ideation|1|||
125248402|NCT00086307|450534205|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
125248403|NCT00086307|450534206|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
125248404|NCT00086307|450534207|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
125248405|NCT00086307|450534205|FG000|Overall Study|Withdrawal by Subject|0|||
125248406|NCT00086307|450534206|FG001|Overall Study|Withdrawal by Subject|0|||
125248407|NCT00086307|450534207|FG002|Overall Study|Withdrawal by Subject|2|||
125248408|NCT00683384|450534208|FG000|Overall Study|Death|1|||
125195717|NCT02438826|450337957|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
125195718|NCT02438826|450337954|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
125195719|NCT02438826|450337955|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
125195720|NCT02438826|450337956|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
125195721|NCT02438826|450337957|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
125195722|NCT02438826|450337954|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
125195723|NCT02438826|450337955|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
125195724|NCT02438826|450337956|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
125195725|NCT02438826|450337957|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
125195726|NCT02438826|450337954|FG000|Open-Label Treatment Phase|Adverse Event|11|||
125195727|NCT02438826|450337955|FG001|Open-Label Treatment Phase|Adverse Event|6|||
125195728|NCT02438826|450337956|FG002|Open-Label Treatment Phase|Adverse Event|0|||
125195729|NCT02438826|450337957|FG003|Open-Label Treatment Phase|Adverse Event|0|||
125248409|NCT00683384|450534208|FG000|Overall Study|Adverse Event|1|||
125248410|NCT00120874|450534210|FG000|Overall Study|Death|0|||
125248411|NCT00120874|450534211|FG001|Overall Study|Death|1|||
125248412|NCT00300495|450534218|FG000|Overall Study|Protocol Violation|4|||
125248413|NCT00300495|450534219|FG001|Overall Study|Protocol Violation|1|||
125248414|NCT03632720|450534220|FG000|Overall Study|Adverse Event|2|||
125248415|NCT03632720|450534221|FG001|Overall Study|Adverse Event|0|||
125248416|NCT03632720|450534222|FG002|Overall Study|Adverse Event|0|||
125248417|NCT03632720|450534220|FG000|Overall Study|Lost to Follow-up|0|||
125248418|NCT03632720|450534221|FG001|Overall Study|Lost to Follow-up|1|||
125248419|NCT03632720|450534222|FG002|Overall Study|Lost to Follow-up|0|||
125248420|NCT03632720|450534220|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
125248421|NCT03632720|450534221|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
125248422|NCT03632720|450534222|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
125248423|NCT03632720|450534220|FG000|Overall Study|Screen failure|0|||
125248424|NCT03632720|450534221|FG001|Overall Study|Screen failure|1|||
125248425|NCT03632720|450534222|FG002|Overall Study|Screen failure|0|||
125248426|NCT00682435|450534223|FG000|Overall Study|Insufficient data|5|||
125248427|NCT00682435|450534223|FG000|Overall Study|Erroneously enrolled twice|2|||
125248428|NCT00290238|450534224|FG000|Overall Study|Study terminated|27|||
125248429|NCT00290238|450534225|FG001|Overall Study|Study terminated|27|||
125248430|NCT00290238|450534224|FG000|Overall Study|Lost to Follow-up|0|||
125248431|NCT00290238|450534225|FG001|Overall Study|Lost to Follow-up|1|||
125248432|NCT00290238|450534224|FG000|Overall Study|Withdrawal by Subject|15|||
125248433|NCT00290238|450534225|FG001|Overall Study|Withdrawal by Subject|13|||
125248434|NCT06868667|450534226|FG000|Overall Study|Death|0|||
125248435|NCT06868667|450534227|FG001|Overall Study|Death|4|||
125248436|NCT06868667|450534226|FG000|Overall Study|Lost to Follow-up|0|||
125248437|NCT06868667|450534227|FG001|Overall Study|Lost to Follow-up|1|||
125248438|NCT06868667|450534226|FG000|Overall Study|Withdrawal by Subject|1|||
125248439|NCT06868667|450534227|FG001|Overall Study|Withdrawal by Subject|0|||
125248440|NCT06868667|450534226|FG000|Overall Study|Ongoing|9|||
125248441|NCT06868667|450534227|FG001|Overall Study|Ongoing|9|||
125248442|NCT05330429|450534228|FG000|Overall Study|Study Terminated by Sponsor|4|||
125248443|NCT05330429|450534229|FG001|Overall Study|Study Terminated by Sponsor|33|||
125248444|NCT05330429|450534230|FG002|Overall Study|Study Terminated by Sponsor|12|||
125248445|NCT05330429|450534228|FG000|Overall Study|Death|5|||
125248446|NCT05330429|450534229|FG001|Overall Study|Death|2|||
125248447|NCT05330429|450534230|FG002|Overall Study|Death|4|||
125248448|NCT05330429|450534228|FG000|Overall Study|Withdrew Consent|0|||
125248449|NCT05330429|450534229|FG001|Overall Study|Withdrew Consent|5|||
125248450|NCT05330429|450534230|FG002|Overall Study|Withdrew Consent|4|||
125195730|NCT02438826|450337954|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
125195731|NCT02438826|450337955|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
125195732|NCT02438826|450337956|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
125195733|NCT02438826|450337957|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
125195734|NCT02438826|450337954|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
125195735|NCT02438826|450337955|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
125248451|NCT05330429|450534228|FG000|Overall Study|Investigator's Discretion|0|||
125248452|NCT05330429|450534229|FG001|Overall Study|Investigator's Discretion|1|||
125248453|NCT05330429|450534230|FG002|Overall Study|Investigator's Discretion|3|||
125248454|NCT05330429|450534228|FG000|Overall Study|Subject Decision|1|||
125248455|NCT05330429|450534229|FG001|Overall Study|Subject Decision|2|||
125248456|NCT05330429|450534230|FG002|Overall Study|Subject Decision|0|||
125248457|NCT05330429|450534228|FG000|Overall Study|Lost to Follow-up|0|||
125248458|NCT05330429|450534229|FG001|Overall Study|Lost to Follow-up|1|||
125248459|NCT05330429|450534230|FG002|Overall Study|Lost to Follow-up|0|||
125248460|NCT06097273|450534231|FG000|Overall Study|Death|2|||
125248461|NCT06097273|450534232|FG001|Overall Study|Death|1|||
125248462|NCT06097273|450534233|FG002|Overall Study|Death|2|||
125248463|NCT06097273|450534234|FG003|Overall Study|Death|2|||
125248464|NCT06097273|450534231|FG000|Overall Study|Lost to Follow-up|27|||
125248465|NCT06097273|450534232|FG001|Overall Study|Lost to Follow-up|18|||
125248466|NCT06097273|450534233|FG002|Overall Study|Lost to Follow-up|36|||
125195736|NCT02438826|450337956|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
125195737|NCT02438826|450337957|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
125195738|NCT02438826|450337954|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
125195739|NCT02438826|450337955|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
125195740|NCT02438826|450337956|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
125195741|NCT02438826|450337957|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
125195742|NCT02438826|450337954|FG000|Post-Treatment Phase|Adverse Event|3|||
125195743|NCT02438826|450337955|FG001|Post-Treatment Phase|Adverse Event|0|||
125195744|NCT02438826|450337956|FG002|Post-Treatment Phase|Adverse Event|0|||
125248467|NCT06097273|450534234|FG003|Overall Study|Lost to Follow-up|31|||
125248468|NCT06097273|450534231|FG000|Overall Study|Physician Decision|0|||
125248469|NCT06097273|450534232|FG001|Overall Study|Physician Decision|1|||
125248470|NCT06097273|450534233|FG002|Overall Study|Physician Decision|0|||
125248471|NCT06097273|450534234|FG003|Overall Study|Physician Decision|3|||
125248472|NCT06097273|450534231|FG000|Overall Study|Protocol Violation|1|||
125248473|NCT06097273|450534232|FG001|Overall Study|Protocol Violation|1|||
125248474|NCT06097273|450534233|FG002|Overall Study|Protocol Violation|2|||
125248475|NCT06097273|450534234|FG003|Overall Study|Protocol Violation|1|||
125248476|NCT06097273|450534231|FG000|Overall Study|Withdrawal by Subject|14|||
125248477|NCT06097273|450534232|FG001|Overall Study|Withdrawal by Subject|11|||
125248478|NCT06097273|450534233|FG002|Overall Study|Withdrawal by Subject|14|||
125248479|NCT06097273|450534234|FG003|Overall Study|Withdrawal by Subject|15|||
125248480|NCT06097273|450534231|FG000|Overall Study|Other Than Specified|7|||
125248481|NCT06097273|450534232|FG001|Overall Study|Other Than Specified|3|||
125248482|NCT06097273|450534233|FG002|Overall Study|Other Than Specified|11|||
125248483|NCT06097273|450534234|FG003|Overall Study|Other Than Specified|6|||
125248484|NCT03882801|450535937|FG000|Period 1|Adverse Event|0|||
125248485|NCT03882801|450535938|FG001|Period 1|Adverse Event|1|||
125248486|NCT03882801|450535937|FG000|Period 1|Non-compliance with study drug|1|||
125248487|NCT03882801|450535938|FG001|Period 1|Non-compliance with study drug|1|||
125248488|NCT03882801|450535937|FG000|Period 1|Never treated with study drug|1|||
125248489|NCT03882801|450535938|FG001|Period 1|Never treated with study drug|0|||
125248490|NCT03882801|450535937|FG000|Washout Period|Physician Decision|0|||
125248491|NCT03882801|450535938|FG001|Washout Period|Physician Decision|1|||
125248492|NCT03882801|450535937|FG000|Period 2|Non-compliance with study drug|0|||
125248493|NCT03882801|450535938|FG001|Period 2|Non-compliance with study drug|1|||
125248494|NCT03548415|450535942|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
125248495|NCT03548415|450535943|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
125248496|NCT03548415|450535944|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
125248497|NCT03548415|450535945|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
125248498|NCT03548415|450535946|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
125248499|NCT01803737|450535947|FG000|Overall Study|Lack of Time|1|||
125248500|NCT01803737|450535948|FG001|Overall Study|Lack of Time|0|||
125248501|NCT01803737|450535947|FG000|Overall Study|Medical Reason|0|||
125248502|NCT01803737|450535948|FG001|Overall Study|Medical Reason|1|||
125248503|NCT01803737|450535947|FG000|Overall Study|Lost to Follow-up|0|||
125248504|NCT01803737|450535948|FG001|Overall Study|Lost to Follow-up|2|||
125248505|NCT01748552|450535951|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
125248506|NCT01748552|450535952|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
125248507|NCT01748552|450535953|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
125248508|NCT01748552|450535954|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
125248509|NCT01748552|450535955|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
125248510|NCT01748552|450535956|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
125248511|NCT01748552|450535957|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
125248512|NCT01748552|450535958|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
125248513|NCT01748552|450535959|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
125248514|NCT01748552|450535960|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
125248515|NCT01748552|450535961|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
125248516|NCT01748552|450535962|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
125248517|NCT01748552|450535951|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
125248518|NCT01748552|450535952|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
125248519|NCT01748552|450535953|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
125248520|NCT01748552|450535954|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
125248521|NCT01748552|450535955|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
125248522|NCT01748552|450535956|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
125195745|NCT02438826|450337957|FG003|Post-Treatment Phase|Adverse Event|0|||
125195746|NCT02438826|450337954|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
125248523|NCT01748552|450535957|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
125248524|NCT01748552|450535958|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
125248525|NCT01748552|450535959|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
125248526|NCT01748552|450535960|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
125195747|NCT02438826|450337955|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
125195748|NCT02438826|450337956|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
125195749|NCT02438826|450337957|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
125195750|NCT02438826|450337954|FG000|Post-Treatment Phase|Physician Decision|1|||
125195751|NCT02438826|450337955|FG001|Post-Treatment Phase|Physician Decision|0|||
125195752|NCT02438826|450337956|FG002|Post-Treatment Phase|Physician Decision|0|||
125195753|NCT02438826|450337957|FG003|Post-Treatment Phase|Physician Decision|0|||
125195754|NCT02438826|450337954|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
125195755|NCT02438826|450337955|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
125195756|NCT02438826|450337956|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
125195757|NCT02438826|450337957|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
125195758|NCT02553499|450337960|FG000|Overall Study|Adverse Event|0|||
125195759|NCT02553499|450337961|FG001|Overall Study|Adverse Event|0|||
125195760|NCT02553499|450337962|FG002|Overall Study|Adverse Event|0|||
125195761|NCT02553499|450337963|FG003|Overall Study|Adverse Event|0|||
125195762|NCT02553499|450337964|FG004|Overall Study|Adverse Event|0|||
125195763|NCT02553499|450337965|FG005|Overall Study|Adverse Event|0|||
125195764|NCT02553499|450337966|FG006|Overall Study|Adverse Event|1|||
125195765|NCT02553499|450337967|FG007|Overall Study|Adverse Event|1|||
125195766|NCT02553499|450337968|FG008|Overall Study|Adverse Event|0|||
125195767|NCT02553499|450337969|FG009|Overall Study|Adverse Event|0|||
125195768|NCT02553499|450337970|FG010|Overall Study|Adverse Event|0|||
125195769|NCT02553499|450337971|FG011|Overall Study|Adverse Event|0|||
125195770|NCT02553499|450337972|FG012|Overall Study|Adverse Event|0|||
125195771|NCT02553499|450337973|FG013|Overall Study|Adverse Event|1|||
125195772|NCT02553499|450337960|FG000|Overall Study|Death|0|||
125195773|NCT02553499|450337961|FG001|Overall Study|Death|1|||
125195774|NCT02553499|450337962|FG002|Overall Study|Death|1|||
125195775|NCT02553499|450337963|FG003|Overall Study|Death|0|||
125195776|NCT02553499|450337964|FG004|Overall Study|Death|1|||
125195777|NCT02553499|450337965|FG005|Overall Study|Death|2|||
125195778|NCT02553499|450337966|FG006|Overall Study|Death|0|||
125195779|NCT02553499|450337967|FG007|Overall Study|Death|0|||
125195780|NCT02553499|450337968|FG008|Overall Study|Death|0|||
125195781|NCT02553499|450337969|FG009|Overall Study|Death|0|||
125195782|NCT02553499|450337970|FG010|Overall Study|Death|1|||
125195783|NCT02553499|450337971|FG011|Overall Study|Death|0|||
125195784|NCT02553499|450337972|FG012|Overall Study|Death|0|||
125195785|NCT02553499|450337973|FG013|Overall Study|Death|0|||
125195786|NCT02553499|450337960|FG000|Overall Study|Lost to Follow-up|0|||
125195787|NCT02553499|450337961|FG001|Overall Study|Lost to Follow-up|0|||
125195788|NCT02553499|450337962|FG002|Overall Study|Lost to Follow-up|0|||
125195789|NCT02553499|450337963|FG003|Overall Study|Lost to Follow-up|0|||
125195790|NCT02553499|450337964|FG004|Overall Study|Lost to Follow-up|0|||
125195791|NCT02553499|450337965|FG005|Overall Study|Lost to Follow-up|0|||
125195792|NCT02553499|450337966|FG006|Overall Study|Lost to Follow-up|1|||
125195793|NCT02553499|450337967|FG007|Overall Study|Lost to Follow-up|0|||
125195794|NCT02553499|450337968|FG008|Overall Study|Lost to Follow-up|0|||
125195795|NCT02553499|450337969|FG009|Overall Study|Lost to Follow-up|0|||
125195796|NCT02553499|450337970|FG010|Overall Study|Lost to Follow-up|0|||
125195797|NCT02553499|450337971|FG011|Overall Study|Lost to Follow-up|0|||
125195798|NCT02553499|450337972|FG012|Overall Study|Lost to Follow-up|0|||
125195799|NCT02553499|450337973|FG013|Overall Study|Lost to Follow-up|0|||
125195800|NCT02553499|450337960|FG000|Overall Study|Physician Decision|0|||
125195801|NCT02553499|450337961|FG001|Overall Study|Physician Decision|1|||
125195802|NCT02553499|450337962|FG002|Overall Study|Physician Decision|1|||
125195803|NCT02553499|450337963|FG003|Overall Study|Physician Decision|0|||
125195804|NCT02553499|450337964|FG004|Overall Study|Physician Decision|1|||
125195805|NCT02553499|450337965|FG005|Overall Study|Physician Decision|0|||
125195806|NCT02553499|450337966|FG006|Overall Study|Physician Decision|0|||
125195807|NCT02553499|450337967|FG007|Overall Study|Physician Decision|1|||
125195808|NCT02553499|450337968|FG008|Overall Study|Physician Decision|1|||
125195809|NCT02553499|450337969|FG009|Overall Study|Physician Decision|2|||
125195810|NCT02553499|450337970|FG010|Overall Study|Physician Decision|1|||
125195811|NCT02553499|450337971|FG011|Overall Study|Physician Decision|3|||
125195812|NCT02553499|450337972|FG012|Overall Study|Physician Decision|1|||
125195813|NCT02553499|450337973|FG013|Overall Study|Physician Decision|0|||
125195814|NCT02553499|450337960|FG000|Overall Study|Progressive Disease|0|||
125195815|NCT02553499|450337961|FG001|Overall Study|Progressive Disease|0|||
125195816|NCT02553499|450337962|FG002|Overall Study|Progressive Disease|0|||
125195817|NCT02553499|450337963|FG003|Overall Study|Progressive Disease|2|||
125195818|NCT02553499|450337964|FG004|Overall Study|Progressive Disease|1|||
125195819|NCT02553499|450337965|FG005|Overall Study|Progressive Disease|1|||
125195820|NCT02553499|450337966|FG006|Overall Study|Progressive Disease|1|||
125195821|NCT02553499|450337967|FG007|Overall Study|Progressive Disease|0|||
125195822|NCT02553499|450337968|FG008|Overall Study|Progressive Disease|0|||
125195823|NCT02553499|450337969|FG009|Overall Study|Progressive Disease|1|||
125195824|NCT02553499|450337970|FG010|Overall Study|Progressive Disease|0|||
125195825|NCT02553499|450337971|FG011|Overall Study|Progressive Disease|0|||
125195826|NCT02553499|450337972|FG012|Overall Study|Progressive Disease|2|||
125195827|NCT02553499|450337973|FG013|Overall Study|Progressive Disease|1|||
125248527|NCT01748552|450535961|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
125248528|NCT01748552|450535962|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
125248529|NCT00004228|450535965|FG000|Overall Study|Adverse Event|0|||
125248530|NCT00004228|450535966|FG001|Overall Study|Adverse Event|1|||
125248531|NCT00004228|450535967|FG002|Overall Study|Adverse Event|0|||
125248532|NCT00004228|450535968|FG003|Overall Study|Adverse Event|0|||
125248533|NCT00004228|450535969|FG004|Overall Study|Adverse Event|1|||
125248534|NCT00004228|450535970|FG005|Overall Study|Adverse Event|0|||
125248535|NCT00004228|450535971|FG006|Overall Study|Adverse Event|0|||
125248536|NCT00004228|450535965|FG000|Overall Study|Death|0|||
125248537|NCT00004228|450535966|FG001|Overall Study|Death|1|||
125248538|NCT00004228|450535967|FG002|Overall Study|Death|2|||
125248539|NCT00004228|450535968|FG003|Overall Study|Death|0|||
125248540|NCT00004228|450535969|FG004|Overall Study|Death|1|||
125248541|NCT00004228|450535970|FG005|Overall Study|Death|0|||
125248542|NCT00004228|450535971|FG006|Overall Study|Death|0|||
125248543|NCT00004228|450535965|FG000|Overall Study|Lack of Efficacy|1|||
125248544|NCT00004228|450535966|FG001|Overall Study|Lack of Efficacy|6|||
125248545|NCT00004228|450535967|FG002|Overall Study|Lack of Efficacy|5|||
125248546|NCT00004228|450535968|FG003|Overall Study|Lack of Efficacy|3|||
125248547|NCT00004228|450535969|FG004|Overall Study|Lack of Efficacy|9|||
125248548|NCT00004228|450535970|FG005|Overall Study|Lack of Efficacy|8|||
125248549|NCT00004228|450535971|FG006|Overall Study|Lack of Efficacy|4|||
125248550|NCT00004228|450535965|FG000|Overall Study|Lost to Follow-up|0|||
125248551|NCT00004228|450535966|FG001|Overall Study|Lost to Follow-up|0|||
125248552|NCT00004228|450535967|FG002|Overall Study|Lost to Follow-up|1|||
125248553|NCT00004228|450535968|FG003|Overall Study|Lost to Follow-up|0|||
125248554|NCT00004228|450535969|FG004|Overall Study|Lost to Follow-up|0|||
125248555|NCT00004228|450535970|FG005|Overall Study|Lost to Follow-up|0|||
125248556|NCT00004228|450535971|FG006|Overall Study|Lost to Follow-up|0|||
125248557|NCT00004228|450535965|FG000|Overall Study|Physician Decision|1|||
125248558|NCT00004228|450535966|FG001|Overall Study|Physician Decision|0|||
125248559|NCT00004228|450535967|FG002|Overall Study|Physician Decision|3|||
125248560|NCT00004228|450535968|FG003|Overall Study|Physician Decision|2|||
125248561|NCT00004228|450535969|FG004|Overall Study|Physician Decision|1|||
125248562|NCT00004228|450535970|FG005|Overall Study|Physician Decision|1|||
125248563|NCT00004228|450535971|FG006|Overall Study|Physician Decision|1|||
125248564|NCT00004228|450535965|FG000|Overall Study|Protocol Violation|0|||
125248565|NCT00004228|450535966|FG001|Overall Study|Protocol Violation|5|||
125248566|NCT00004228|450535967|FG002|Overall Study|Protocol Violation|2|||
125248567|NCT00004228|450535968|FG003|Overall Study|Protocol Violation|1|||
125248568|NCT00004228|450535969|FG004|Overall Study|Protocol Violation|1|||
125248569|NCT00004228|450535970|FG005|Overall Study|Protocol Violation|2|||
125248570|NCT00004228|450535971|FG006|Overall Study|Protocol Violation|0|||
125248571|NCT00004228|450535965|FG000|Overall Study|Withdrawal by Subject|3|||
125248572|NCT00004228|450535966|FG001|Overall Study|Withdrawal by Subject|0|||
125248573|NCT00004228|450535967|FG002|Overall Study|Withdrawal by Subject|1|||
125248574|NCT00004228|450535968|FG003|Overall Study|Withdrawal by Subject|0|||
125248575|NCT00004228|450535969|FG004|Overall Study|Withdrawal by Subject|2|||
125248576|NCT00004228|450535970|FG005|Overall Study|Withdrawal by Subject|1|||
125248577|NCT00004228|450535971|FG006|Overall Study|Withdrawal by Subject|2|||
125248578|NCT00004228|450535965|FG000|Overall Study|Other|0|||
125248579|NCT00004228|450535966|FG001|Overall Study|Other|0|||
125248580|NCT00004228|450535967|FG002|Overall Study|Other|1|||
125248581|NCT00004228|450535968|FG003|Overall Study|Other|0|||
125248582|NCT00004228|450535969|FG004|Overall Study|Other|0|||
125248583|NCT00004228|450535970|FG005|Overall Study|Other|0|||
125248584|NCT00004228|450535971|FG006|Overall Study|Other|0|||
125248585|NCT00004228|450535965|FG000|Overall Study|ineligible|4|||
125248586|NCT00004228|450535966|FG001|Overall Study|ineligible|2|||
125248587|NCT00004228|450535967|FG002|Overall Study|ineligible|4|||
125248588|NCT00004228|450535968|FG003|Overall Study|ineligible|1|||
125248589|NCT00004228|450535969|FG004|Overall Study|ineligible|1|||
125248590|NCT00004228|450535970|FG005|Overall Study|ineligible|2|||
125248591|NCT00004228|450535971|FG006|Overall Study|ineligible|5|||
125248592|NCT02533674|450535972|FG000|Dose Level I|Progressive disease|1|||
125248593|NCT02533674|450535973|FG001|Dose Level I|Progressive disease|0|||
125248594|NCT02533674|450535974|FG002|Dose Level I|Progressive disease|0|||
125248595|NCT02533674|450535975|FG003|Dose Level I|Progressive disease|0|||
125248596|NCT02533674|450535976|FG004|Dose Level I|Progressive disease|0|||
125248597|NCT02533674|450535977|FG005|Dose Level I|Progressive disease|0|||
125248598|NCT02533674|450535978|FG006|Dose Level I|Progressive disease|0|||
125248599|NCT02533674|450535979|FG007|Dose Level I|Progressive disease|0|||
125248600|NCT02533674|450535972|FG000|Dose Level I|Withdrawal by Subject|1|||
125248601|NCT02533674|450535973|FG001|Dose Level I|Withdrawal by Subject|0|||
125248602|NCT02533674|450535974|FG002|Dose Level I|Withdrawal by Subject|0|||
125248603|NCT02533674|450535975|FG003|Dose Level I|Withdrawal by Subject|0|||
125248604|NCT02533674|450535976|FG004|Dose Level I|Withdrawal by Subject|0|||
125248605|NCT02533674|450535977|FG005|Dose Level I|Withdrawal by Subject|0|||
125248606|NCT02533674|450535978|FG006|Dose Level I|Withdrawal by Subject|0|||
125248607|NCT02533674|450535979|FG007|Dose Level I|Withdrawal by Subject|0|||
125248608|NCT02533674|450535972|FG000|Dose Level I|Physician Decision|1|||
125248609|NCT02533674|450535973|FG001|Dose Level I|Physician Decision|0|||
125248610|NCT02533674|450535974|FG002|Dose Level I|Physician Decision|0|||
125248611|NCT02533674|450535975|FG003|Dose Level I|Physician Decision|0|||
125248612|NCT02533674|450535976|FG004|Dose Level I|Physician Decision|0|||
125248613|NCT02533674|450535977|FG005|Dose Level I|Physician Decision|0|||
125248614|NCT02533674|450535978|FG006|Dose Level I|Physician Decision|0|||
125248615|NCT02533674|450535979|FG007|Dose Level I|Physician Decision|0|||
125248616|NCT02533674|450535972|FG000|Dose Level I|Death|1|||
125248617|NCT02533674|450535973|FG001|Dose Level I|Death|0|||
125248618|NCT02533674|450535974|FG002|Dose Level I|Death|0|||
125248619|NCT02533674|450535975|FG003|Dose Level I|Death|0|||
125248620|NCT02533674|450535976|FG004|Dose Level I|Death|0|||
125248621|NCT02533674|450535977|FG005|Dose Level I|Death|0|||
125248622|NCT02533674|450535978|FG006|Dose Level I|Death|0|||
125248623|NCT02533674|450535979|FG007|Dose Level I|Death|0|||
125248624|NCT02533674|450535972|FG000|Dose Level I|Never Treated|1|||
125248625|NCT02533674|450535973|FG001|Dose Level I|Never Treated|0|||
125248626|NCT02533674|450535974|FG002|Dose Level I|Never Treated|0|||
125248627|NCT02533674|450535975|FG003|Dose Level I|Never Treated|0|||
125248628|NCT02533674|450535976|FG004|Dose Level I|Never Treated|0|||
125248629|NCT02533674|450535977|FG005|Dose Level I|Never Treated|0|||
125248630|NCT02533674|450535978|FG006|Dose Level I|Never Treated|0|||
125248631|NCT02533674|450535979|FG007|Dose Level I|Never Treated|0|||
125248632|NCT02533674|450535972|FG000|Dose Level II|Progressive disease|0|||
125248633|NCT02533674|450535973|FG001|Dose Level II|Progressive disease|3|||
125248634|NCT02533674|450535974|FG002|Dose Level II|Progressive disease|0|||
125248635|NCT02533674|450535975|FG003|Dose Level II|Progressive disease|0|||
125248636|NCT02533674|450535976|FG004|Dose Level II|Progressive disease|0|||
125248637|NCT02533674|450535977|FG005|Dose Level II|Progressive disease|0|||
125248638|NCT02533674|450535978|FG006|Dose Level II|Progressive disease|0|||
125248639|NCT02533674|450535979|FG007|Dose Level II|Progressive disease|0|||
125248640|NCT02533674|450535972|FG000|Dose Level II|Withdrawal by Subject|0|||
125248641|NCT02533674|450535973|FG001|Dose Level II|Withdrawal by Subject|1|||
125248642|NCT02533674|450535974|FG002|Dose Level II|Withdrawal by Subject|0|||
125248643|NCT02533674|450535975|FG003|Dose Level II|Withdrawal by Subject|0|||
125248644|NCT02533674|450535976|FG004|Dose Level II|Withdrawal by Subject|0|||
125248645|NCT02533674|450535977|FG005|Dose Level II|Withdrawal by Subject|0|||
125248646|NCT02533674|450535978|FG006|Dose Level II|Withdrawal by Subject|0|||
125248647|NCT02533674|450535979|FG007|Dose Level II|Withdrawal by Subject|0|||
125248648|NCT02533674|450535972|FG000|Dose Level II|Treatment-related AE|0|||
125248649|NCT02533674|450535973|FG001|Dose Level II|Treatment-related AE|1|||
125248650|NCT02533674|450535974|FG002|Dose Level II|Treatment-related AE|0|||
125248651|NCT02533674|450535975|FG003|Dose Level II|Treatment-related AE|0|||
125248652|NCT02533674|450535976|FG004|Dose Level II|Treatment-related AE|0|||
125248653|NCT02533674|450535977|FG005|Dose Level II|Treatment-related AE|0|||
125248654|NCT02533674|450535978|FG006|Dose Level II|Treatment-related AE|0|||
125248655|NCT02533674|450535979|FG007|Dose Level II|Treatment-related AE|0|||
125248656|NCT02533674|450535972|FG000|Dose Level II|Physician Decision|0|||
125248657|NCT02533674|450535973|FG001|Dose Level II|Physician Decision|1|||
125248658|NCT02533674|450535974|FG002|Dose Level II|Physician Decision|0|||
125248659|NCT02533674|450535975|FG003|Dose Level II|Physician Decision|0|||
125248660|NCT02533674|450535976|FG004|Dose Level II|Physician Decision|0|||
125248661|NCT02533674|450535977|FG005|Dose Level II|Physician Decision|0|||
125248662|NCT02533674|450535978|FG006|Dose Level II|Physician Decision|0|||
125248663|NCT02533674|450535979|FG007|Dose Level II|Physician Decision|0|||
125248664|NCT02533674|450535972|FG000|Dose Level II|Non-treatment-related AE|0|||
125248665|NCT02533674|450535973|FG001|Dose Level II|Non-treatment-related AE|1|||
125248666|NCT02533674|450535974|FG002|Dose Level II|Non-treatment-related AE|0|||
125248667|NCT02533674|450535975|FG003|Dose Level II|Non-treatment-related AE|0|||
125248668|NCT02533674|450535976|FG004|Dose Level II|Non-treatment-related AE|0|||
125248669|NCT02533674|450535977|FG005|Dose Level II|Non-treatment-related AE|0|||
125248670|NCT02533674|450535978|FG006|Dose Level II|Non-treatment-related AE|0|||
125248671|NCT02533674|450535979|FG007|Dose Level II|Non-treatment-related AE|0|||
125248672|NCT02533674|450535972|FG000|Dose Level III|Progressive disease|0|||
125248673|NCT02533674|450535973|FG001|Dose Level III|Progressive disease|0|||
125248674|NCT02533674|450535974|FG002|Dose Level III|Progressive disease|2|||
125248675|NCT02533674|450535975|FG003|Dose Level III|Progressive disease|0|||
125248676|NCT02533674|450535976|FG004|Dose Level III|Progressive disease|0|||
125248677|NCT02533674|450535977|FG005|Dose Level III|Progressive disease|0|||
125248678|NCT02533674|450535978|FG006|Dose Level III|Progressive disease|0|||
125248679|NCT02533674|450535979|FG007|Dose Level III|Progressive disease|0|||
125248680|NCT02533674|450535972|FG000|Dose Level III|Withdrawal by Subject|0|||
125248681|NCT02533674|450535973|FG001|Dose Level III|Withdrawal by Subject|0|||
125248682|NCT02533674|450535974|FG002|Dose Level III|Withdrawal by Subject|1|||
125248683|NCT02533674|450535975|FG003|Dose Level III|Withdrawal by Subject|0|||
125248684|NCT02533674|450535976|FG004|Dose Level III|Withdrawal by Subject|0|||
125248685|NCT02533674|450535977|FG005|Dose Level III|Withdrawal by Subject|0|||
125248686|NCT02533674|450535978|FG006|Dose Level III|Withdrawal by Subject|0|||
125248687|NCT02533674|450535979|FG007|Dose Level III|Withdrawal by Subject|0|||
125248688|NCT02533674|450535972|FG000|Dose Level III|Treatment-related AE|0|||
125248689|NCT02533674|450535973|FG001|Dose Level III|Treatment-related AE|0|||
125248690|NCT02533674|450535974|FG002|Dose Level III|Treatment-related AE|1|||
125248691|NCT02533674|450535975|FG003|Dose Level III|Treatment-related AE|0|||
125248692|NCT02533674|450535976|FG004|Dose Level III|Treatment-related AE|0|||
125248693|NCT02533674|450535977|FG005|Dose Level III|Treatment-related AE|0|||
125248694|NCT02533674|450535978|FG006|Dose Level III|Treatment-related AE|0|||
125248695|NCT02533674|450535979|FG007|Dose Level III|Treatment-related AE|0|||
125248696|NCT02533674|450535972|FG000|Dose Level IV|Progressive disease|0|||
125248697|NCT02533674|450535973|FG001|Dose Level IV|Progressive disease|0|||
125248698|NCT02533674|450535974|FG002|Dose Level IV|Progressive disease|0|||
125248699|NCT02533674|450535975|FG003|Dose Level IV|Progressive disease|3|||
125248700|NCT02533674|450535976|FG004|Dose Level IV|Progressive disease|0|||
125248701|NCT02533674|450535977|FG005|Dose Level IV|Progressive disease|0|||
125248702|NCT02533674|450535978|FG006|Dose Level IV|Progressive disease|0|||
125248703|NCT02533674|450535979|FG007|Dose Level IV|Progressive disease|0|||
125248704|NCT02533674|450535972|FG000|Dose Level IV|Withdrawal by Subject|0|||
125248705|NCT02533674|450535973|FG001|Dose Level IV|Withdrawal by Subject|0|||
125248706|NCT02533674|450535974|FG002|Dose Level IV|Withdrawal by Subject|0|||
125248707|NCT02533674|450535975|FG003|Dose Level IV|Withdrawal by Subject|1|||
125248708|NCT02533674|450535976|FG004|Dose Level IV|Withdrawal by Subject|0|||
125248709|NCT02533674|450535977|FG005|Dose Level IV|Withdrawal by Subject|0|||
125248710|NCT02533674|450535978|FG006|Dose Level IV|Withdrawal by Subject|0|||
125248711|NCT02533674|450535979|FG007|Dose Level IV|Withdrawal by Subject|0|||
125248712|NCT02533674|450535972|FG000|Dose Level IV|Physician Decision|0|||
125248713|NCT02533674|450535973|FG001|Dose Level IV|Physician Decision|0|||
125248714|NCT02533674|450535974|FG002|Dose Level IV|Physician Decision|0|||
125248715|NCT02533674|450535975|FG003|Dose Level IV|Physician Decision|1|||
125248716|NCT02533674|450535976|FG004|Dose Level IV|Physician Decision|0|||
125248717|NCT02533674|450535977|FG005|Dose Level IV|Physician Decision|0|||
125248718|NCT02533674|450535978|FG006|Dose Level IV|Physician Decision|0|||
125248719|NCT02533674|450535979|FG007|Dose Level IV|Physician Decision|0|||
125248720|NCT02533674|450535972|FG000|Dose Level V|Progressive disease|0|||
125248721|NCT02533674|450535973|FG001|Dose Level V|Progressive disease|0|||
125248722|NCT02533674|450535974|FG002|Dose Level V|Progressive disease|0|||
125248723|NCT02533674|450535975|FG003|Dose Level V|Progressive disease|0|||
125248724|NCT02533674|450535976|FG004|Dose Level V|Progressive disease|3|||
125248725|NCT02533674|450535977|FG005|Dose Level V|Progressive disease|0|||
125248726|NCT02533674|450535978|FG006|Dose Level V|Progressive disease|0|||
125248727|NCT02533674|450535979|FG007|Dose Level V|Progressive disease|0|||
125248728|NCT02533674|450535972|FG000|Dose Level V|Withdrawal by Subject|0|||
125248729|NCT02533674|450535973|FG001|Dose Level V|Withdrawal by Subject|0|||
125248730|NCT02533674|450535974|FG002|Dose Level V|Withdrawal by Subject|0|||
125248731|NCT02533674|450535975|FG003|Dose Level V|Withdrawal by Subject|0|||
125248732|NCT02533674|450535976|FG004|Dose Level V|Withdrawal by Subject|1|||
125248733|NCT02533674|450535977|FG005|Dose Level V|Withdrawal by Subject|0|||
125248734|NCT02533674|450535978|FG006|Dose Level V|Withdrawal by Subject|0|||
125248735|NCT02533674|450535979|FG007|Dose Level V|Withdrawal by Subject|0|||
125248736|NCT02533674|450535972|FG000|Dose Level V|Physician Decision|0|||
125248737|NCT02533674|450535973|FG001|Dose Level V|Physician Decision|0|||
125248738|NCT02533674|450535974|FG002|Dose Level V|Physician Decision|0|||
125248739|NCT02533674|450535975|FG003|Dose Level V|Physician Decision|0|||
125248740|NCT02533674|450535976|FG004|Dose Level V|Physician Decision|1|||
125248741|NCT02533674|450535977|FG005|Dose Level V|Physician Decision|0|||
125248742|NCT02533674|450535978|FG006|Dose Level V|Physician Decision|0|||
125248743|NCT02533674|450535979|FG007|Dose Level V|Physician Decision|0|||
125248744|NCT02533674|450535972|FG000|Dose Level VI|Progressive disease|0|||
125248745|NCT02533674|450535973|FG001|Dose Level VI|Progressive disease|0|||
125248746|NCT02533674|450535974|FG002|Dose Level VI|Progressive disease|0|||
125248747|NCT02533674|450535975|FG003|Dose Level VI|Progressive disease|0|||
125248748|NCT02533674|450535976|FG004|Dose Level VI|Progressive disease|0|||
125248749|NCT02533674|450535977|FG005|Dose Level VI|Progressive disease|7|||
125248750|NCT02533674|450535978|FG006|Dose Level VI|Progressive disease|0|||
125248751|NCT02533674|450535979|FG007|Dose Level VI|Progressive disease|0|||
125248752|NCT02533674|450535972|FG000|Dose Level VI|Withdrawal by Subject|0|||
125248753|NCT02533674|450535973|FG001|Dose Level VI|Withdrawal by Subject|0|||
125248754|NCT02533674|450535974|FG002|Dose Level VI|Withdrawal by Subject|0|||
125248755|NCT02533674|450535975|FG003|Dose Level VI|Withdrawal by Subject|0|||
125248756|NCT02533674|450535976|FG004|Dose Level VI|Withdrawal by Subject|0|||
125248757|NCT02533674|450535977|FG005|Dose Level VI|Withdrawal by Subject|1|||
125248758|NCT02533674|450535978|FG006|Dose Level VI|Withdrawal by Subject|0|||
125248759|NCT02533674|450535979|FG007|Dose Level VI|Withdrawal by Subject|0|||
125248760|NCT02533674|450535972|FG000|Dose Level VI|Treatment-related AE|0|||
125248761|NCT02533674|450535973|FG001|Dose Level VI|Treatment-related AE|0|||
125248762|NCT02533674|450535974|FG002|Dose Level VI|Treatment-related AE|0|||
125248763|NCT02533674|450535975|FG003|Dose Level VI|Treatment-related AE|0|||
125248764|NCT02533674|450535976|FG004|Dose Level VI|Treatment-related AE|0|||
125248765|NCT02533674|450535977|FG005|Dose Level VI|Treatment-related AE|1|||
125248766|NCT02533674|450535978|FG006|Dose Level VI|Treatment-related AE|0|||
125248767|NCT02533674|450535979|FG007|Dose Level VI|Treatment-related AE|0|||
125248768|NCT02533674|450535972|FG000|Dose Level VII|Progressive disease|0|||
125248769|NCT02533674|450535973|FG001|Dose Level VII|Progressive disease|0|||
125248770|NCT02533674|450535974|FG002|Dose Level VII|Progressive disease|0|||
125248771|NCT02533674|450535975|FG003|Dose Level VII|Progressive disease|0|||
125248772|NCT02533674|450535976|FG004|Dose Level VII|Progressive disease|0|||
125248773|NCT02533674|450535977|FG005|Dose Level VII|Progressive disease|0|||
125248774|NCT02533674|450535978|FG006|Dose Level VII|Progressive disease|10|||
125248775|NCT02533674|450535979|FG007|Dose Level VII|Progressive disease|0|||
125248776|NCT02533674|450535972|FG000|Dose Level VII|Withdrawal by Subject|0|||
125248777|NCT02533674|450535973|FG001|Dose Level VII|Withdrawal by Subject|0|||
125248778|NCT02533674|450535974|FG002|Dose Level VII|Withdrawal by Subject|0|||
125248779|NCT02533674|450535975|FG003|Dose Level VII|Withdrawal by Subject|0|||
125248780|NCT02533674|450535976|FG004|Dose Level VII|Withdrawal by Subject|0|||
125248781|NCT02533674|450535977|FG005|Dose Level VII|Withdrawal by Subject|0|||
125248782|NCT02533674|450535978|FG006|Dose Level VII|Withdrawal by Subject|3|||
125248783|NCT02533674|450535979|FG007|Dose Level VII|Withdrawal by Subject|0|||
125248784|NCT02533674|450535972|FG000|Dose Level VII|Treatment-related AE|0|||
125248785|NCT02533674|450535973|FG001|Dose Level VII|Treatment-related AE|0|||
125248786|NCT02533674|450535974|FG002|Dose Level VII|Treatment-related AE|0|||
125248787|NCT02533674|450535975|FG003|Dose Level VII|Treatment-related AE|0|||
125248788|NCT02533674|450535976|FG004|Dose Level VII|Treatment-related AE|0|||
125248789|NCT02533674|450535977|FG005|Dose Level VII|Treatment-related AE|0|||
125248790|NCT02533674|450535978|FG006|Dose Level VII|Treatment-related AE|1|||
125248791|NCT02533674|450535979|FG007|Dose Level VII|Treatment-related AE|0|||
125248792|NCT02533674|450535972|FG000|Dose Level VII|Death|0|||
125248793|NCT02533674|450535973|FG001|Dose Level VII|Death|0|||
125248794|NCT02533674|450535974|FG002|Dose Level VII|Death|0|||
125248795|NCT02533674|450535975|FG003|Dose Level VII|Death|0|||
125248796|NCT02533674|450535976|FG004|Dose Level VII|Death|0|||
125248797|NCT02533674|450535977|FG005|Dose Level VII|Death|0|||
125248798|NCT02533674|450535978|FG006|Dose Level VII|Death|2|||
125248799|NCT02533674|450535979|FG007|Dose Level VII|Death|0|||
125248800|NCT02533674|450535972|FG000|Dose Level VIII|Progressive disease|0|||
125248801|NCT02533674|450535973|FG001|Dose Level VIII|Progressive disease|0|||
125248802|NCT02533674|450535974|FG002|Dose Level VIII|Progressive disease|0|||
125248803|NCT02533674|450535975|FG003|Dose Level VIII|Progressive disease|0|||
125248804|NCT02533674|450535976|FG004|Dose Level VIII|Progressive disease|0|||
125248805|NCT02533674|450535977|FG005|Dose Level VIII|Progressive disease|0|||
125248806|NCT02533674|450535978|FG006|Dose Level VIII|Progressive disease|0|||
125248807|NCT02533674|450535979|FG007|Dose Level VIII|Progressive disease|3|||
125248808|NCT02533674|450535972|FG000|Dose Level VIII|Withdrawal by Subject|0|||
125248809|NCT02533674|450535973|FG001|Dose Level VIII|Withdrawal by Subject|0|||
125248810|NCT02533674|450535974|FG002|Dose Level VIII|Withdrawal by Subject|0|||
125248811|NCT02533674|450535975|FG003|Dose Level VIII|Withdrawal by Subject|0|||
125248812|NCT02533674|450535976|FG004|Dose Level VIII|Withdrawal by Subject|0|||
125248813|NCT02533674|450535977|FG005|Dose Level VIII|Withdrawal by Subject|0|||
125248814|NCT02533674|450535978|FG006|Dose Level VIII|Withdrawal by Subject|0|||
125248815|NCT02533674|450535979|FG007|Dose Level VIII|Withdrawal by Subject|1|||
125248816|NCT02533674|450535972|FG000|Dose Level VIII|Treatment-related AE|0|||
125248817|NCT02533674|450535973|FG001|Dose Level VIII|Treatment-related AE|0|||
125248818|NCT02533674|450535974|FG002|Dose Level VIII|Treatment-related AE|0|||
125248819|NCT02533674|450535975|FG003|Dose Level VIII|Treatment-related AE|0|||
125248820|NCT02533674|450535976|FG004|Dose Level VIII|Treatment-related AE|0|||
125248821|NCT02533674|450535977|FG005|Dose Level VIII|Treatment-related AE|0|||
125248822|NCT02533674|450535978|FG006|Dose Level VIII|Treatment-related AE|0|||
125248823|NCT02533674|450535979|FG007|Dose Level VIII|Treatment-related AE|1|||
125248824|NCT02533674|450535972|FG000|Dose Level VIII|Never treated|0|||
125248825|NCT02533674|450535973|FG001|Dose Level VIII|Never treated|0|||
125248826|NCT02533674|450535974|FG002|Dose Level VIII|Never treated|0|||
125248827|NCT02533674|450535975|FG003|Dose Level VIII|Never treated|0|||
125248828|NCT02533674|450535976|FG004|Dose Level VIII|Never treated|0|||
125248829|NCT02533674|450535977|FG005|Dose Level VIII|Never treated|0|||
125248830|NCT02533674|450535978|FG006|Dose Level VIII|Never treated|0|||
125248831|NCT02533674|450535979|FG007|Dose Level VIII|Never treated|1|||
125248832|NCT01292473|450535983|FG000|Overall Study|Adverse Event|1|||
125248833|NCT01292473|450535984|FG001|Overall Study|Adverse Event|0|||
125248834|NCT01292473|450535985|FG002|Overall Study|Adverse Event|1|||
125248835|NCT01292473|450535986|FG003|Overall Study|Adverse Event|1|||
125248836|NCT01292473|450535983|FG000|Overall Study|Lost to Follow-up|1|||
125248837|NCT01292473|450535984|FG001|Overall Study|Lost to Follow-up|1|||
125248838|NCT01292473|450535985|FG002|Overall Study|Lost to Follow-up|2|||
125248839|NCT01292473|450535986|FG003|Overall Study|Lost to Follow-up|2|||
125248840|NCT01292473|450535983|FG000|Overall Study|Withdrawal by Subject|3|||
125248841|NCT01292473|450535984|FG001|Overall Study|Withdrawal by Subject|4|||
125248842|NCT01292473|450535985|FG002|Overall Study|Withdrawal by Subject|3|||
125248843|NCT01292473|450535986|FG003|Overall Study|Withdrawal by Subject|3|||
125248844|NCT01292473|450535983|FG000|Overall Study|Physician Decision|0|||
125248845|NCT01292473|450535984|FG001|Overall Study|Physician Decision|1|||
125248846|NCT01292473|450535985|FG002|Overall Study|Physician Decision|0|||
125248847|NCT01292473|450535986|FG003|Overall Study|Physician Decision|0|||
125248848|NCT01292473|450535983|FG000|Overall Study|Disease Progression|0|||
125248849|NCT01292473|450535984|FG001|Overall Study|Disease Progression|1|||
125248850|NCT01292473|450535985|FG002|Overall Study|Disease Progression|3|||
125248851|NCT01292473|450535986|FG003|Overall Study|Disease Progression|6|||
125248852|NCT01717859|450535990|FG000|Overall Study|Adverse Event|5|||
125248853|NCT01717859|450535990|FG000|Overall Study|Moved out of state|1|||
125248854|NCT01717859|450535990|FG000|Overall Study|Patient concerned about mental health|1|||
125248855|NCT01717859|450535990|FG000|Overall Study|Lost to Follow-up|1|||
125248856|NCT01717859|450535990|FG000|Overall Study|Withdrawal by Subject|2|||
125248857|NCT04389671|450535991|FG000|Overall Study|Death|7|||
125248858|NCT01111292|450535992|FG000|Treatment|Physician Decision|1|||
125248859|NCT01111292|450535993|FG001|Treatment|Physician Decision|1|||
125248860|NCT05463705|450535997|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
125248861|NCT05463705|450535998|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
125248862|NCT05463705|450535999|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
125248863|NCT05463705|450536000|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
125248864|NCT05463705|450536001|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
125248865|NCT05463705|450536002|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
125248866|NCT01530997|450536008|FG000|Overall Study|Physician Decision|1|||
125248867|NCT01530997|450536008|FG000|Overall Study|Withdrawal by Subject|1|||
125248868|NCT02181738|450536011|FG000|Overall Study|Participant Withdrew Consent|2|||
125248869|NCT02181738|450536012|FG001|Overall Study|Participant Withdrew Consent|1|||
125248870|NCT02181738|450536013|FG002|Overall Study|Participant Withdrew Consent|1|||
125248871|NCT02181738|450536014|FG003|Overall Study|Participant Withdrew Consent|1|||
125248872|NCT02181738|450536011|FG000|Overall Study|Lost to Follow-up|1|||
125248873|NCT02181738|450536012|FG001|Overall Study|Lost to Follow-up|2|||
125248874|NCT02181738|450536013|FG002|Overall Study|Lost to Follow-up|1|||
125248875|NCT02181738|450536014|FG003|Overall Study|Lost to Follow-up|1|||
125248876|NCT02181738|450536011|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
125248877|NCT02181738|450536012|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
125248878|NCT02181738|450536013|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
125248879|NCT02181738|450536014|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
125248880|NCT02181738|450536011|FG000|Overall Study|Poor/Non-Compliance|1|||
125248881|NCT02181738|450536012|FG001|Overall Study|Poor/Non-Compliance|0|||
125195828|NCT02553499|450337960|FG000|Overall Study|Study Terminated by Sponsor|0|||
125195829|NCT02553499|450337961|FG001|Overall Study|Study Terminated by Sponsor|0|||
125195830|NCT02553499|450337962|FG002|Overall Study|Study Terminated by Sponsor|0|||
125195831|NCT02553499|450337963|FG003|Overall Study|Study Terminated by Sponsor|0|||
125195832|NCT02553499|450337964|FG004|Overall Study|Study Terminated by Sponsor|0|||
125195833|NCT02553499|450337965|FG005|Overall Study|Study Terminated by Sponsor|0|||
125195834|NCT02553499|450337966|FG006|Overall Study|Study Terminated by Sponsor|0|||
125195835|NCT02553499|450337967|FG007|Overall Study|Study Terminated by Sponsor|0|||
125195836|NCT02553499|450337968|FG008|Overall Study|Study Terminated by Sponsor|1|||
125195837|NCT02553499|450337969|FG009|Overall Study|Study Terminated by Sponsor|0|||
125195838|NCT02553499|450337970|FG010|Overall Study|Study Terminated by Sponsor|0|||
125195839|NCT02553499|450337971|FG011|Overall Study|Study Terminated by Sponsor|0|||
125195840|NCT02553499|450337972|FG012|Overall Study|Study Terminated by Sponsor|0|||
125195841|NCT02553499|450337973|FG013|Overall Study|Study Terminated by Sponsor|0|||
125195842|NCT02553499|450337960|FG000|Overall Study|Withdrawal by Subject|2|||
125195843|NCT02553499|450337961|FG001|Overall Study|Withdrawal by Subject|0|||
125195844|NCT02553499|450337962|FG002|Overall Study|Withdrawal by Subject|0|||
125195845|NCT02553499|450337963|FG003|Overall Study|Withdrawal by Subject|0|||
125195846|NCT02553499|450337964|FG004|Overall Study|Withdrawal by Subject|0|||
125195847|NCT02553499|450337965|FG005|Overall Study|Withdrawal by Subject|0|||
125195848|NCT02553499|450337966|FG006|Overall Study|Withdrawal by Subject|0|||
125195849|NCT02553499|450337967|FG007|Overall Study|Withdrawal by Subject|1|||
125195850|NCT02553499|450337968|FG008|Overall Study|Withdrawal by Subject|1|||
125195851|NCT02553499|450337969|FG009|Overall Study|Withdrawal by Subject|0|||
125248882|NCT02181738|450536013|FG002|Overall Study|Poor/Non-Compliance|2|||
125248883|NCT02181738|450536014|FG003|Overall Study|Poor/Non-Compliance|1|||
125248884|NCT02181738|450536011|FG000|Overall Study|Disease Progression|28|||
125248885|NCT02181738|450536012|FG001|Overall Study|Disease Progression|35|||
125248886|NCT02181738|450536013|FG002|Overall Study|Disease Progression|40|||
125248887|NCT02181738|450536014|FG003|Overall Study|Disease Progression|0|||
125248888|NCT02181738|450536011|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
125248889|NCT02181738|450536012|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
125248890|NCT02181738|450536013|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
125248891|NCT02181738|450536014|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
125248892|NCT02181738|450536011|FG000|Overall Study|Study Drug Toxicity|6|||
125248893|NCT02181738|450536012|FG001|Overall Study|Study Drug Toxicity|11|||
125248894|NCT02181738|450536013|FG002|Overall Study|Study Drug Toxicity|8|||
125248895|NCT02181738|450536014|FG003|Overall Study|Study Drug Toxicity|1|||
125248896|NCT02181738|450536011|FG000|Overall Study|Other Reasons|14|||
125248897|NCT02181738|450536012|FG001|Overall Study|Other Reasons|16|||
125248898|NCT02181738|450536013|FG002|Overall Study|Other Reasons|28|||
125248899|NCT02181738|450536014|FG003|Overall Study|Other Reasons|0|||
125248900|NCT02181738|450536011|FG000|Overall Study|Maximum Clinical Benefit|3|||
125248901|NCT02181738|450536012|FG001|Overall Study|Maximum Clinical Benefit|0|||
125248902|NCT02181738|450536013|FG002|Overall Study|Maximum Clinical Benefit|1|||
125248903|NCT02181738|450536014|FG003|Overall Study|Maximum Clinical Benefit|0|||
125248904|NCT02181738|450536011|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
125248905|NCT02181738|450536012|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
125248906|NCT02181738|450536013|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
125248907|NCT02181738|450536014|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
125195852|NCT02553499|450337970|FG010|Overall Study|Withdrawal by Subject|1|||
125248908|NCT01691482|450536018|FG000|Treatment Period 2|Adverse Event|0|||
125248909|NCT01691482|450536019|FG001|Treatment Period 2|Adverse Event|1|||
125248910|NCT01691482|450536018|FG000|Treatment Period 2|Protocol Violation|1|||
125248911|NCT01691482|450536019|FG001|Treatment Period 2|Protocol Violation|1|||
125195853|NCT02553499|450337971|FG011|Overall Study|Withdrawal by Subject|0|||
125195854|NCT02553499|450337972|FG012|Overall Study|Withdrawal by Subject|0|||
125195855|NCT02553499|450337973|FG013|Overall Study|Withdrawal by Subject|0|||
125248912|NCT00183391|450536020|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
125248913|NCT00183391|450536021|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
125248914|NCT00183391|450536020|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
125248915|NCT00183391|450536021|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
125248916|NCT01986751|450536022|FG000|Overall Study|improperly consented|10|||
125248917|NCT01986751|450536023|FG001|Overall Study|improperly consented|2|||
125248918|NCT01478087|450536024|FG000|Overall Study|due to sponsor closing study|1|||
125248919|NCT04576949|450536025|FG000|Overall Study|Adverse Event|1|||
125248920|NCT04576949|450536026|FG001|Overall Study|Adverse Event|3|||
125248921|NCT04576949|450536027|FG002|Overall Study|Adverse Event|2|||
125248922|NCT04576949|450536025|FG000|Overall Study|Withdrawal by Subject|41|||
125248923|NCT04576949|450536026|FG001|Overall Study|Withdrawal by Subject|26|||
125248924|NCT04576949|450536027|FG002|Overall Study|Withdrawal by Subject|18|||
125248925|NCT04576949|450536025|FG000|Overall Study|Physician Decision|3|||
125248926|NCT04576949|450536026|FG001|Overall Study|Physician Decision|0|||
125248927|NCT04576949|450536027|FG002|Overall Study|Physician Decision|0|||
125248928|NCT04576949|450536025|FG000|Overall Study|Death|0|||
125248929|NCT04576949|450536026|FG001|Overall Study|Death|1|||
125248930|NCT04576949|450536027|FG002|Overall Study|Death|0|||
125248931|NCT04576949|450536025|FG000|Overall Study|Lost to Follow-up|29|||
125248932|NCT04576949|450536026|FG001|Overall Study|Lost to Follow-up|37|||
125248933|NCT04576949|450536027|FG002|Overall Study|Lost to Follow-up|24|||
125248934|NCT04576949|450536025|FG000|Overall Study|Other, Not Specified|2|||
125248935|NCT04576949|450536026|FG001|Overall Study|Other, Not Specified|3|||
125248936|NCT04576949|450536027|FG002|Overall Study|Other, Not Specified|1|||
125248937|NCT04576949|450536025|FG000|Overall Study|Other|1|||
125248938|NCT04576949|450536026|FG001|Overall Study|Other|0|||
125248939|NCT04576949|450536027|FG002|Overall Study|Other|0|||
125248940|NCT00407030|450536028|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
125248941|NCT00407030|450536029|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
125248942|NCT00407030|450536030|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
125248943|NCT00407030|450536028|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
125248944|NCT00407030|450536029|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
125248945|NCT00407030|450536030|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
125248946|NCT00407030|450536028|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
125248947|NCT00407030|450536029|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
125248948|NCT00407030|450536030|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
125248949|NCT00407030|450536028|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
125248950|NCT00407030|450536029|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
125248951|NCT00407030|450536030|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
125248952|NCT00407030|450536028|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
125248953|NCT00407030|450536029|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
125248954|NCT00407030|450536030|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
125248955|NCT00407030|450536028|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
125195856|NCT01726270|450337976|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
125195857|NCT01726270|450337976|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
125195858|NCT01726270|450337976|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
125195859|NCT01726270|450337976|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
125195860|NCT01726270|450337976|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
125195861|NCT01726270|450337976|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
125195862|NCT02073929|450337989|FG000|Overall Study|Lost to Follow-up|2|||
125195863|NCT02073929|450337990|FG001|Overall Study|Lost to Follow-up|1|||
125195864|NCT02073929|450337989|FG000|Overall Study|Adverse Event|2|||
125195865|NCT02073929|450337990|FG001|Overall Study|Adverse Event|1|||
125195866|NCT02073929|450337989|FG000|Overall Study|Withdrawal by Subject|0|||
125195867|NCT02073929|450337990|FG001|Overall Study|Withdrawal by Subject|1|||
125195868|NCT03319732|450337994|FG000|Overall Study|Adverse Event|40|||
125195869|NCT03319732|450337994|FG000|Overall Study|Withdrawal by Subject|50|||
125195870|NCT03319732|450337994|FG000|Overall Study|MS relapse|10|||
125195871|NCT03319732|450337994|FG000|Overall Study|reason not specified|5|||
125195872|NCT03887442|450337995|FG000|Overall Study|Adverse Event|1|||
125195873|NCT03887442|450337996|FG001|Overall Study|Adverse Event|0|||
125195874|NCT00430573|450337997|FG000|Overall Study|Withdrawal by Subject|5|||
125195875|NCT00072280|450337998|FG000|Treatment|Found ineligible|1|||
125195876|NCT00072280|450337999|FG001|Treatment|Found ineligible|2|||
125195877|NCT00072280|450337998|FG000|Follow-up|Early termination of study|2|||
125195878|NCT00072280|450337999|FG001|Follow-up|Early termination of study|2|||
125195879|NCT05020665|450338000|FG000|Overall Study|Study terminated by Sponsor|5|||
125195880|NCT05020665|450338001|FG001|Overall Study|Study terminated by Sponsor|4|||
125195881|NCT05020665|450338000|FG000|Overall Study|Death|2|||
125195882|NCT05020665|450338001|FG001|Overall Study|Death|1|||
125248956|NCT00407030|450536029|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
125248957|NCT00407030|450536030|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
125248958|NCT00407030|450536028|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
125248959|NCT00407030|450536029|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
125248960|NCT00407030|450536030|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
125248961|NCT00407030|450536028|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
125248962|NCT00407030|450536029|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
125248963|NCT00407030|450536030|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
125248964|NCT00407030|450536028|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
125248965|NCT00407030|450536029|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
125248966|NCT00407030|450536030|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
125248967|NCT00407030|450536028|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
125248968|NCT00407030|450536029|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
125195883|NCT05020665|450338000|FG000|Overall Study|Physician Decision|0|||
125248969|NCT00407030|450536030|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
125248970|NCT00407030|450536028|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
125248971|NCT00407030|450536029|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
125248972|NCT00407030|450536030|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
125248973|NCT00407030|450536028|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
125248974|NCT00407030|450536029|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
125248975|NCT00407030|450536030|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
125248976|NCT00407030|450536028|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
125248977|NCT00407030|450536029|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
125248978|NCT00407030|450536030|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
125248979|NCT01489358|450536031|FG000|Overall Study|Lost to Follow-up|0|||
125248980|NCT01489358|450536032|FG001|Overall Study|Lost to Follow-up|0|||
125248981|NCT01489358|450536033|FG002|Overall Study|Lost to Follow-up|2|||
125248982|NCT00736476|450536034|FG000|Overall Study|Adverse Event|1|||
125248983|NCT00736476|450536035|FG001|Overall Study|Adverse Event|0|||
125248984|NCT03518203|450536041|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
125248985|NCT03518203|450536041|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
125248986|NCT02829957|450536042|FG000|Overall Study|Lost to Follow-up|2|||
125248987|NCT02829957|450536043|FG001|Overall Study|Lost to Follow-up|1|||
125248988|NCT04560309|450536045|FG000|Overall Study|Meet drop out criteria|1|||
125248989|NCT04560309|450536046|FG001|Overall Study|Meet drop out criteria|1|||
125248990|NCT05085405|450536047|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
125248991|NCT05085405|450536048|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
125248992|NCT05085405|450536049|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
125248993|NCT05085405|450536050|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
125195884|NCT05020665|450338001|FG001|Overall Study|Physician Decision|1|||
125195885|NCT05020665|450338000|FG000|Overall Study|Withdrawal by Subject|0|||
125195886|NCT05020665|450338001|FG001|Overall Study|Withdrawal by Subject|1|||
125195887|NCT05020665|450338000|FG000|Overall Study|Reason not specified|1|||
125195888|NCT05020665|450338001|FG001|Overall Study|Reason not specified|0|||
125195889|NCT02504827|450338002|FG000|Overall Study|Could not produce sputum|1|||
125195890|NCT00877487|450338010|FG000|Open-label Treatment Phase|Adverse Event|1|||
125195891|NCT00877487|450338011|FG001|Open-label Treatment Phase|Adverse Event|0|||
125195892|NCT00877487|450338010|FG000|Open-label Treatment Phase|Protocol Violation|3|||
125195893|NCT00877487|450338011|FG001|Open-label Treatment Phase|Protocol Violation|0|||
125195894|NCT00877487|450338010|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
125195895|NCT00877487|450338011|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
125195896|NCT00877487|450338010|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
125195897|NCT00877487|450338011|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
125195898|NCT00877487|450338010|FG000|Open-label Treatment Phase|Out of country for business|1|||
125195899|NCT00877487|450338011|FG001|Open-label Treatment Phase|Out of country for business|0|||
125195900|NCT00877487|450338010|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
125195901|NCT00877487|450338011|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
125195902|NCT00877487|450338010|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
125195903|NCT00877487|450338011|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
125195904|NCT00877487|450338010|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
125195905|NCT00877487|450338011|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
125195906|NCT00877487|450338010|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
125195907|NCT00877487|450338011|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
125195908|NCT03070002|450338012|FG000|Follow up for 2 Years|Death|1|||
125195909|NCT04740827|450338017|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
125195910|NCT04740827|450338018|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
125195911|NCT04740827|450338017|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
125248994|NCT05085405|450536051|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
125248995|NCT05085405|450536052|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
125195912|NCT04740827|450338018|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
125195913|NCT04740827|450338017|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
125195914|NCT04740827|450338018|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
125195915|NCT04740827|450338017|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
125195916|NCT04740827|450338018|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
125248996|NCT05085405|450536047|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
125248997|NCT05085405|450536048|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
125248998|NCT05085405|450536049|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
125248999|NCT05085405|450536050|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
125249000|NCT05085405|450536051|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
125249001|NCT05085405|450536052|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
125249002|NCT01370538|450536055|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
125249003|NCT01370538|450536056|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
125249004|NCT01370538|450536055|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125249005|NCT01370538|450536056|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
125249006|NCT01370538|450536055|FG000|Overall Study|Adverse Event|1|||
125249007|NCT01370538|450536056|FG001|Overall Study|Adverse Event|0|||
125249008|NCT01370538|450536055|FG000|Overall Study|Protocol Violation|8|||
125249009|NCT01370538|450536056|FG001|Overall Study|Protocol Violation|5|||
125249010|NCT01370538|450536055|FG000|Overall Study|Development of study specific withdrawal|1|||
125249011|NCT01370538|450536056|FG001|Overall Study|Development of study specific withdrawal|1|||
125249012|NCT01370538|450536055|FG000|Overall Study|Lost to follow up|6|||
125249013|NCT01370538|450536056|FG001|Overall Study|Lost to follow up|10|||
125249014|NCT04193527|450536057|FG000|Overall Study|Other|1|||
125249015|NCT04193527|450536058|FG001|Overall Study|Other|1|||
125249016|NCT04193527|450536059|FG002|Overall Study|Other|0|||
125249017|NCT02366130|450536060|FG000|Overall Study|Withdrawal by Subject|3|||
125249018|NCT02366130|450536060|FG000|Overall Study|Ineligible|6|||
125249019|NCT00567112|450536061|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
125249020|NCT00567112|450536062|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
125249021|NCT00567112|450536063|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
125249022|NCT00567112|450536061|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
125249023|NCT00567112|450536062|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
125249024|NCT00567112|450536063|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
125249025|NCT00567112|450536061|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
125195917|NCT04740827|450338017|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
125195918|NCT04740827|450338018|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
125195919|NCT04740827|450338017|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
125195920|NCT04740827|450338018|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
125195921|NCT01435018|450339869|FG000|Overall Study|Death|37|||
125195922|NCT01435018|450339870|FG001|Overall Study|Death|18|||
125195923|NCT01435018|450339871|FG002|Overall Study|Death|25|||
125195924|NCT01435018|450339869|FG000|Overall Study|Site is closing|4|||
125195925|NCT01435018|450339870|FG001|Overall Study|Site is closing|9|||
125195926|NCT01435018|450339871|FG002|Overall Study|Site is closing|7|||
125195927|NCT01435018|450339869|FG000|Overall Study|Withdrew consent|0|||
125195928|NCT01435018|450339870|FG001|Overall Study|Withdrew consent|3|||
125195929|NCT01435018|450339871|FG002|Overall Study|Withdrew consent|1|||
125195930|NCT01435018|450339869|FG000|Overall Study|Not willing to adhere to requirements|0|||
125195931|NCT01435018|450339870|FG001|Overall Study|Not willing to adhere to requirements|2|||
125195932|NCT01435018|450339871|FG002|Overall Study|Not willing to adhere to requirements|3|||
125195933|NCT01435018|450339869|FG000|Overall Study|Not able to get to clinic|2|||
125249026|NCT00567112|450536062|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
125249027|NCT00567112|450536063|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
125249028|NCT04595370|450536074|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
125249029|NCT04595370|450536075|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
125249030|NCT04595370|450536076|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
125195934|NCT01435018|450339870|FG001|Overall Study|Not able to get to clinic|0|||
125195935|NCT01435018|450339871|FG002|Overall Study|Not able to get to clinic|2|||
125195936|NCT01435018|450339869|FG000|Overall Study|Severe debilitation, unable to continue|0|||
125195937|NCT01435018|450339870|FG001|Overall Study|Severe debilitation, unable to continue|0|||
125195938|NCT01435018|450339871|FG002|Overall Study|Severe debilitation, unable to continue|1|||
125195939|NCT01435018|450339869|FG000|Overall Study|Unable to contact participant/parent|1|||
125195940|NCT01435018|450339870|FG001|Overall Study|Unable to contact participant/parent|1|||
125195941|NCT01435018|450339871|FG002|Overall Study|Unable to contact participant/parent|1|||
125195942|NCT01435018|450339869|FG000|Overall Study|Enrollment Violation|0|||
125195943|NCT01435018|450339870|FG001|Overall Study|Enrollment Violation|1|||
125195944|NCT01435018|450339871|FG002|Overall Study|Enrollment Violation|0|||
125195945|NCT01435018|450339869|FG000|Overall Study|Never started chemotherapy|3|||
125195946|NCT01435018|450339870|FG001|Overall Study|Never started chemotherapy|0|||
125195947|NCT01435018|450339871|FG002|Overall Study|Never started chemotherapy|1|||
125195950|NCT03806933|450339874|FG000|Main Period|Physician Decision|0|||
125195951|NCT03806933|450339875|FG001|Main Period|Physician Decision|0|||
125195952|NCT03806933|450339876|FG002|Main Period|Physician Decision|0|||
125195953|NCT03806933|450339877|FG003|Main Period|Physician Decision|1|||
125195954|NCT03806933|450339874|FG000|Main Period|Pregnancy|0|||
125195955|NCT03806933|450339875|FG001|Main Period|Pregnancy|0|||
125195956|NCT03806933|450339876|FG002|Main Period|Pregnancy|1|||
125195957|NCT03806933|450339877|FG003|Main Period|Pregnancy|0|||
125195958|NCT03806933|450339874|FG000|Main Period|Withdrawal by Subject|2|||
125195959|NCT03806933|450339875|FG001|Main Period|Withdrawal by Subject|1|||
125195960|NCT03806933|450339876|FG002|Main Period|Withdrawal by Subject|1|||
125195961|NCT03806933|450339877|FG003|Main Period|Withdrawal by Subject|2|||
125195962|NCT03806933|450339874|FG000|Main Period|Lost to Follow-up|2|||
125195963|NCT03806933|450339875|FG001|Main Period|Lost to Follow-up|2|||
125195964|NCT03806933|450339876|FG002|Main Period|Lost to Follow-up|0|||
125195965|NCT03806933|450339877|FG003|Main Period|Lost to Follow-up|0|||
125195966|NCT03806933|450339874|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
125195967|NCT03806933|450339875|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
125195968|NCT03806933|450339876|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
125195969|NCT03806933|450339877|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
125195970|NCT00078767|450339878|FG000|Overall Study|Withdrawal by Subject|1|||
125195971|NCT00078767|450339879|FG001|Overall Study|Withdrawal by Subject|1|||
125195972|NCT02282631|450339880|FG000|Overall Study|Lost to Follow-up|2|||
125195973|NCT02282631|450339881|FG001|Overall Study|Lost to Follow-up|0|||
125195974|NCT00831311|450339884|FG000|Overall Study|Definitive Contraindication|3|||
125195975|NCT00831311|450339885|FG001|Overall Study|Definitive Contraindication|3|||
125195976|NCT00831311|450339884|FG000|Overall Study|Lost to Follow-up|3|||
125195977|NCT00831311|450339885|FG001|Overall Study|Lost to Follow-up|0|||
125195978|NCT00831311|450339884|FG000|Overall Study|Physician Decision|0|||
125195979|NCT00831311|450339885|FG001|Overall Study|Physician Decision|1|||
125195980|NCT00831311|450339884|FG000|Overall Study|Withdrawal by Subject|6|||
125195981|NCT00831311|450339885|FG001|Overall Study|Withdrawal by Subject|4|||
125195982|NCT01841762|450339887|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
125195983|NCT01841762|450339887|FG000|Treatment Period|Adverse Event|16|||
125195984|NCT01841762|450339887|FG000|Treatment Period|Death|1|||
125195985|NCT01841762|450339887|FG000|Treatment Period|Withdrawal by Subject|7|||
125195986|NCT01841762|450339887|FG000|Treatment Period|Lost to Follow-up|1|||
125195987|NCT01841762|450339887|FG000|Treatment Period|Physician Decision|2|||
125195988|NCT01841762|450339887|FG000|Treatment Period|Other, including non-compliance|5|||
125195989|NCT01841762|450339887|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
125195990|NCT01841762|450339887|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
125195991|NCT01841762|450339887|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
125195992|NCT01841762|450339887|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
125195993|NCT01868438|450339888|FG000|First Intervention|Withdrawal by Subject|5|||
125195994|NCT01868438|450339889|FG001|First Intervention|Withdrawal by Subject|1|||
125195995|NCT01868438|450339888|FG000|First Intervention|Lost to Follow-up|2|||
125195996|NCT01868438|450339889|FG001|First Intervention|Lost to Follow-up|3|||
125195997|NCT01868438|450339888|FG000|First Intervention|Meeting the non-redosing criteria|0|||
125195998|NCT01868438|450339889|FG001|First Intervention|Meeting the non-redosing criteria|1|||
125195999|NCT01868438|450339888|FG000|Second Intervention|Adverse Event|3|||
125196000|NCT01868438|450339889|FG001|Second Intervention|Adverse Event|3|||
125196001|NCT03260244|450339890|FG000|Overall Study|Death|19|||
125196002|NCT03260244|450339890|FG000|Overall Study|Lost to Follow-up|60|||
125196003|NCT03260244|450339890|FG000|Overall Study|Withdrawal by Subject|48|||
125196004|NCT03260244|450339890|FG000|Overall Study|Procedure Not Performed|21|||
125196005|NCT03260244|450339890|FG000|Overall Study|Enrollment Criteria Not Met|31|||
125196006|NCT03260244|450339890|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
125196007|NCT03260244|450339890|FG000|Overall Study|Subject Noncompliance|6|||
125196008|NCT03260244|450339890|FG000|Overall Study|No inducible Arrhythmia|2|||
125196009|NCT03260244|450339890|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
125196010|NCT03260244|450339890|FG000|Overall Study|Screen Failure|2|||
125196011|NCT03260244|450339890|FG000|Overall Study|Treated Off Label|69|||
125249031|NCT04595370|450536077|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
125249032|NCT04595370|450536078|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
125249033|NCT04595370|450536079|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
125249034|NCT04595370|450536074|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
125249035|NCT04595370|450536075|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
125249036|NCT04595370|450536076|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
125249037|NCT04595370|450536077|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
125249038|NCT04595370|450536078|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
125249039|NCT04595370|450536079|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
125249040|NCT04595370|450536074|FG000|Overall Study|Adverse Event|0|||
125249041|NCT04595370|450536075|FG001|Overall Study|Adverse Event|4|||
125249042|NCT04595370|450536076|FG002|Overall Study|Adverse Event|3|||
125249043|NCT04595370|450536077|FG003|Overall Study|Adverse Event|1|||
125249044|NCT04595370|450536078|FG004|Overall Study|Adverse Event|1|||
125249045|NCT04595370|450536079|FG005|Overall Study|Adverse Event|1|||
125249046|NCT04595370|450536074|FG000|Overall Study|Withdrawal of Consent|1|||
125249047|NCT04595370|450536075|FG001|Overall Study|Withdrawal of Consent|1|||
125249048|NCT04595370|450536076|FG002|Overall Study|Withdrawal of Consent|1|||
125249049|NCT04595370|450536077|FG003|Overall Study|Withdrawal of Consent|0|||
125249050|NCT04595370|450536078|FG004|Overall Study|Withdrawal of Consent|0|||
125249051|NCT04595370|450536079|FG005|Overall Study|Withdrawal of Consent|0|||
125249052|NCT04595370|450536074|FG000|Overall Study|Death|0|||
125249053|NCT04595370|450536075|FG001|Overall Study|Death|1|||
125249054|NCT04595370|450536076|FG002|Overall Study|Death|0|||
125249055|NCT04595370|450536077|FG003|Overall Study|Death|0|||
125249056|NCT04595370|450536078|FG004|Overall Study|Death|1|||
125249057|NCT04595370|450536079|FG005|Overall Study|Death|0|||
125249058|NCT04595370|450536074|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125249059|NCT04595370|450536075|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125249060|NCT04595370|450536076|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
125249061|NCT04595370|450536077|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125249062|NCT04595370|450536078|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125249063|NCT04595370|450536079|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125249064|NCT04595370|450536074|FG000|Overall Study|Withdrawal by Subject|0|||
125249065|NCT04595370|450536075|FG001|Overall Study|Withdrawal by Subject|0|||
125249066|NCT04595370|450536076|FG002|Overall Study|Withdrawal by Subject|1|||
125249067|NCT04595370|450536077|FG003|Overall Study|Withdrawal by Subject|0|||
125196012|NCT03260244|450339890|FG000|Overall Study|No Radiofrequency Ablation|14|||
125196013|NCT03528369|450339893|FG000|Overall Study|Withdrawal by Subject|2|||
125196014|NCT03528369|450339894|FG001|Overall Study|Withdrawal by Subject|0|||
125196015|NCT03528369|450339895|FG002|Overall Study|Withdrawal by Subject|0|||
125196016|NCT03528369|450339893|FG000|Overall Study|Lost to Follow-up|1|||
125196017|NCT03528369|450339894|FG001|Overall Study|Lost to Follow-up|0|||
125196018|NCT03528369|450339895|FG002|Overall Study|Lost to Follow-up|0|||
125196019|NCT03528369|450339893|FG000|Overall Study|Adverse Event|0|||
125196020|NCT03528369|450339894|FG001|Overall Study|Adverse Event|1|||
125196021|NCT03528369|450339895|FG002|Overall Study|Adverse Event|0|||
125196022|NCT00160706|450339896|FG000|Overall Study|Adverse Event|53|||
125196023|NCT00160706|450339896|FG000|Overall Study|Adverse Event and Other Reason|105|||
125196024|NCT00160706|450339896|FG000|Overall Study|Protocol Violation|3|||
125196025|NCT00160706|450339896|FG000|Overall Study|Withdrawal by Subject|41|||
125196026|NCT00160706|450339896|FG000|Overall Study|Withdrawal by Subject and Other|12|||
125196027|NCT00160706|450339896|FG000|Overall Study|Physician Decision|10|||
125196028|NCT00160706|450339896|FG000|Overall Study|Physician Decision and Other|3|||
125196029|NCT00160706|450339896|FG000|Overall Study|Lost to Follow-up|4|||
125196030|NCT00160706|450339896|FG000|Overall Study|Lost to Follow-up and Other|1|||
125196031|NCT00160706|450339896|FG000|Overall Study|Lack of Efficacy|42|||
125196032|NCT00160706|450339896|FG000|Overall Study|Lack of Efficacy and Other|1|||
125196033|NCT00160706|450339896|FG000|Overall Study|Other Reason|11|||
125196034|NCT03214380|450339897|FG000|Lead-in|Adverse Event|3|||
125196035|NCT03214380|450339898|FG001|Lead-in|Adverse Event|0|||
125196036|NCT03214380|450339899|FG002|Lead-in|Adverse Event|0|||
125196037|NCT03214380|450339900|FG003|Lead-in|Adverse Event|1|||
125196038|NCT03214380|450339901|FG004|Lead-in|Adverse Event|0|||
125196039|NCT03214380|450339902|FG005|Lead-in|Adverse Event|0|||
125196040|NCT03214380|450339897|FG000|Lead-in|Lost to Follow-up|4|||
125196041|NCT03214380|450339898|FG001|Lead-in|Lost to Follow-up|0|||
125196042|NCT03214380|450339899|FG002|Lead-in|Lost to Follow-up|0|||
125196043|NCT03214380|450339900|FG003|Lead-in|Lost to Follow-up|1|||
125196044|NCT03214380|450339901|FG004|Lead-in|Lost to Follow-up|0|||
125196045|NCT03214380|450339902|FG005|Lead-in|Lost to Follow-up|0|||
125196046|NCT03214380|450339897|FG000|Lead-in|Eligibility Criteria|3|||
125196047|NCT03214380|450339898|FG001|Lead-in|Eligibility Criteria|0|||
125196048|NCT03214380|450339899|FG002|Lead-in|Eligibility Criteria|0|||
125196049|NCT03214380|450339900|FG003|Lead-in|Eligibility Criteria|0|||
125196050|NCT03214380|450339901|FG004|Lead-in|Eligibility Criteria|0|||
125196051|NCT03214380|450339902|FG005|Lead-in|Eligibility Criteria|0|||
125196052|NCT03214380|450339897|FG000|Lead-in|Physician Decision|6|||
125196053|NCT03214380|450339898|FG001|Lead-in|Physician Decision|0|||
125196054|NCT03214380|450339899|FG002|Lead-in|Physician Decision|0|||
125196055|NCT03214380|450339900|FG003|Lead-in|Physician Decision|0|||
125196056|NCT03214380|450339901|FG004|Lead-in|Physician Decision|0|||
125196057|NCT03214380|450339902|FG005|Lead-in|Physician Decision|0|||
125196058|NCT03214380|450339897|FG000|Lead-in|Protocol Deviation|7|||
125196059|NCT03214380|450339898|FG001|Lead-in|Protocol Deviation|0|||
125196060|NCT03214380|450339899|FG002|Lead-in|Protocol Deviation|0|||
125196061|NCT03214380|450339900|FG003|Lead-in|Protocol Deviation|3|||
125196062|NCT03214380|450339901|FG004|Lead-in|Protocol Deviation|0|||
125196063|NCT03214380|450339902|FG005|Lead-in|Protocol Deviation|0|||
125196064|NCT03214380|450339897|FG000|Lead-in|Withdrawal by Subject|41|||
125196065|NCT03214380|450339898|FG001|Lead-in|Withdrawal by Subject|0|||
125196066|NCT03214380|450339899|FG002|Lead-in|Withdrawal by Subject|0|||
125196067|NCT03214380|450339900|FG003|Lead-in|Withdrawal by Subject|14|||
125196068|NCT03214380|450339901|FG004|Lead-in|Withdrawal by Subject|0|||
125196069|NCT03214380|450339902|FG005|Lead-in|Withdrawal by Subject|0|||
125196070|NCT03214380|450339897|FG000|Lead-in|Family Emergency|1|||
125196071|NCT03214380|450339898|FG001|Lead-in|Family Emergency|0|||
125196072|NCT03214380|450339899|FG002|Lead-in|Family Emergency|0|||
125196073|NCT03214380|450339900|FG003|Lead-in|Family Emergency|0|||
125196074|NCT03214380|450339901|FG004|Lead-in|Family Emergency|0|||
125196075|NCT03214380|450339902|FG005|Lead-in|Family Emergency|0|||
125196076|NCT03214380|450339897|FG000|Lead-in|Natural Disaster|9|||
125196077|NCT03214380|450339898|FG001|Lead-in|Natural Disaster|0|||
125196078|NCT03214380|450339899|FG002|Lead-in|Natural Disaster|0|||
125196079|NCT03214380|450339900|FG003|Lead-in|Natural Disaster|0|||
125196080|NCT03214380|450339901|FG004|Lead-in|Natural Disaster|0|||
125196081|NCT03214380|450339902|FG005|Lead-in|Natural Disaster|0|||
125196082|NCT03214380|450339897|FG000|Lead-in|Non Compliance|1|||
125196083|NCT03214380|450339898|FG001|Lead-in|Non Compliance|0|||
125196084|NCT03214380|450339899|FG002|Lead-in|Non Compliance|0|||
125196085|NCT03214380|450339900|FG003|Lead-in|Non Compliance|0|||
125196086|NCT03214380|450339901|FG004|Lead-in|Non Compliance|0|||
125196087|NCT03214380|450339902|FG005|Lead-in|Non Compliance|0|||
125196088|NCT03214380|450339897|FG000|Lead-in|Participant Schedule|2|||
125196089|NCT03214380|450339898|FG001|Lead-in|Participant Schedule|0|||
125196090|NCT03214380|450339899|FG002|Lead-in|Participant Schedule|0|||
125196091|NCT03214380|450339900|FG003|Lead-in|Participant Schedule|0|||
125196092|NCT03214380|450339901|FG004|Lead-in|Participant Schedule|0|||
125196093|NCT03214380|450339902|FG005|Lead-in|Participant Schedule|0|||
125196094|NCT03214380|450339897|FG000|Treatment Period|Adverse Event|0|||
125249068|NCT04595370|450536078|FG004|Overall Study|Withdrawal by Subject|2|||
125249069|NCT04595370|450536079|FG005|Overall Study|Withdrawal by Subject|0|||
125249070|NCT04595370|450536074|FG000|Overall Study|Lost to Follow-up|0|||
125249071|NCT04595370|450536075|FG001|Overall Study|Lost to Follow-up|0|||
125249072|NCT04595370|450536076|FG002|Overall Study|Lost to Follow-up|0|||
125249073|NCT04595370|450536077|FG003|Overall Study|Lost to Follow-up|0|||
125249074|NCT04595370|450536078|FG004|Overall Study|Lost to Follow-up|1|||
125249075|NCT04595370|450536079|FG005|Overall Study|Lost to Follow-up|0|||
125249076|NCT04595370|450536074|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
125249077|NCT04595370|450536075|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
125249078|NCT04595370|450536076|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
125249079|NCT04595370|450536077|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
125249080|NCT04595370|450536078|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
125249081|NCT04595370|450536079|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
125249082|NCT01945242|450536080|FG000|Overall Study|Physician Decision|3|||
125249083|NCT01945242|450536081|FG001|Overall Study|Physician Decision|3|||
125249084|NCT05661734|450536084|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
125249085|NCT05661734|450536084|FG000|Overall Study|Lost to Follow-up|13|||
125249086|NCT05661734|450536084|FG000|Overall Study|Enrolled but not dosed|2|||
125249087|NCT01125748|450536085|FG000|Overall Study|Adverse Event|0|||
125249088|NCT01125748|450536086|FG001|Overall Study|Adverse Event|2|||
125249089|NCT01125748|450536085|FG000|Overall Study|Lost to Follow-up|0|||
125249090|NCT01125748|450536086|FG001|Overall Study|Lost to Follow-up|1|||
125249091|NCT01125748|450536085|FG000|Overall Study|Physician Decision|8|||
125249092|NCT01125748|450536086|FG001|Overall Study|Physician Decision|7|||
125249093|NCT01125748|450536085|FG000|Overall Study|Patient Decision to Withdraw|2|||
125249094|NCT01125748|450536086|FG001|Overall Study|Patient Decision to Withdraw|4|||
125249095|NCT02405962|450536087|FG000|Overall Study|Lost to Follow-up|1|||
125249096|NCT02405962|450536088|FG001|Overall Study|Lost to Follow-up|4|||
125249097|NCT02405962|450536087|FG000|Overall Study|A participant has moved to another place|0|||
125249098|NCT02405962|450536088|FG001|Overall Study|A participant has moved to another place|1|||
125249099|NCT01028391|450536089|FG000|Overall Study|Adverse Event|4|||
125249100|NCT01028391|450536090|FG001|Overall Study|Adverse Event|0|||
125249101|NCT01028391|450536089|FG000|Overall Study|Lack of Efficacy|0|||
125249102|NCT01028391|450536090|FG001|Overall Study|Lack of Efficacy|2|||
125249103|NCT01028391|450536089|FG000|Overall Study|Lost to Follow-up|3|||
125249104|NCT01028391|450536090|FG001|Overall Study|Lost to Follow-up|4|||
125249105|NCT01028391|450536089|FG000|Overall Study|Physician Decision|0|||
125249106|NCT01028391|450536090|FG001|Overall Study|Physician Decision|1|||
125249107|NCT01028391|450536089|FG000|Overall Study|Withdrawal by Subject|6|||
125249108|NCT01028391|450536090|FG001|Overall Study|Withdrawal by Subject|3|||
125249109|NCT01028391|450536089|FG000|Overall Study|Needed excluded medication|1|||
125249110|NCT01028391|450536090|FG001|Overall Study|Needed excluded medication|1|||
125249111|NCT01184118|450536091|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
125249112|NCT01184118|450536091|FG000|Overall Study|No physiologic confirmation of asthma|8|||
125249113|NCT01184118|450536091|FG000|Overall Study|FEV1 <60% predicted|2|||
125249114|NCT01184118|450536091|FG000|Overall Study|Exclusionary medical condition|2|||
125249115|NCT01184118|450536091|FG000|Overall Study|Withdrawal by Subject|5|||
125249116|NCT01049828|450536099|FG000|Overall Study|Claustrophibia and Frustration|2|||
125249117|NCT02946996|450536103|FG000|Overall Study|non-evaluable|3|||
125249118|NCT02946996|450536104|FG001|Overall Study|non-evaluable|6|||
125249119|NCT02946996|450536105|FG002|Overall Study|non-evaluable|5|||
125249120|NCT03572218|450536108|FG000|Overall Study|Lost to Follow-up|3|||
125249121|NCT03572218|450536109|FG001|Overall Study|Lost to Follow-up|2|||
125249122|NCT03572218|450536108|FG000|Overall Study|No longer available for study visits|2|||
125249123|NCT03572218|450536109|FG001|Overall Study|No longer available for study visits|1|||
125249124|NCT03572218|450536108|FG000|Overall Study|No longer interested|1|||
125249125|NCT03572218|450536109|FG001|Overall Study|No longer interested|2|||
125249126|NCT00286455|450536110|FG000|Overall Study|Hyperglycemia rescue|19|||
125249127|NCT00286455|450536111|FG001|Overall Study|Hyperglycemia rescue|13|||
125249128|NCT00286455|450536112|FG002|Overall Study|Hyperglycemia rescue|10|||
125249129|NCT00286455|450536110|FG000|Overall Study|Adverse Event|1|||
125249130|NCT00286455|450536111|FG001|Overall Study|Adverse Event|3|||
125249131|NCT00286455|450536112|FG002|Overall Study|Adverse Event|2|||
125249132|NCT00286455|450536110|FG000|Overall Study|Lost to Follow-up|0|||
125249133|NCT00286455|450536111|FG001|Overall Study|Lost to Follow-up|3|||
125249134|NCT00286455|450536112|FG002|Overall Study|Lost to Follow-up|3|||
125249135|NCT00286455|450536110|FG000|Overall Study|Physician Decision|3|||
125249136|NCT00286455|450536111|FG001|Overall Study|Physician Decision|0|||
125249137|NCT00286455|450536112|FG002|Overall Study|Physician Decision|2|||
125249138|NCT00286455|450536110|FG000|Overall Study|Protocol Violation|1|||
125249139|NCT00286455|450536111|FG001|Overall Study|Protocol Violation|1|||
125249140|NCT00286455|450536112|FG002|Overall Study|Protocol Violation|0|||
125249141|NCT00286455|450536110|FG000|Overall Study|Participant Non-compliance|1|||
125249142|NCT00286455|450536111|FG001|Overall Study|Participant Non-compliance|0|||
125196095|NCT03214380|450339898|FG001|Treatment Period|Adverse Event|1|||
125196096|NCT03214380|450339899|FG002|Treatment Period|Adverse Event|1|||
125196097|NCT03214380|450339900|FG003|Treatment Period|Adverse Event|0|||
125196098|NCT03214380|450339901|FG004|Treatment Period|Adverse Event|1|||
125196099|NCT03214380|450339902|FG005|Treatment Period|Adverse Event|0|||
125196100|NCT03214380|450339897|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
125196101|NCT03214380|450339898|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
125196102|NCT03214380|450339899|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
125196103|NCT03214380|450339900|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
125196104|NCT03214380|450339901|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
125196105|NCT03214380|450339902|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
125196106|NCT03214380|450339897|FG000|Treatment Period|Withdrawal by Subject|0|||
125196107|NCT03214380|450339898|FG001|Treatment Period|Withdrawal by Subject|10|||
125196108|NCT03214380|450339899|FG002|Treatment Period|Withdrawal by Subject|8|||
125196109|NCT03214380|450339900|FG003|Treatment Period|Withdrawal by Subject|0|||
125196110|NCT03214380|450339901|FG004|Treatment Period|Withdrawal by Subject|7|||
125196111|NCT03214380|450339902|FG005|Treatment Period|Withdrawal by Subject|11|||
125196112|NCT03214380|450339897|FG000|Treatment Period|Death|0|||
125196113|NCT03214380|450339898|FG001|Treatment Period|Death|1|||
125196114|NCT03214380|450339899|FG002|Treatment Period|Death|2|||
125196115|NCT03214380|450339900|FG003|Treatment Period|Death|0|||
125196116|NCT03214380|450339901|FG004|Treatment Period|Death|0|||
125196117|NCT03214380|450339902|FG005|Treatment Period|Death|0|||
125196118|NCT03214380|450339897|FG000|Treatment Period|Lost to Follow-up|0|||
125196119|NCT03214380|450339898|FG001|Treatment Period|Lost to Follow-up|6|||
125196120|NCT03214380|450339899|FG002|Treatment Period|Lost to Follow-up|3|||
125196121|NCT03214380|450339900|FG003|Treatment Period|Lost to Follow-up|0|||
125196122|NCT03214380|450339901|FG004|Treatment Period|Lost to Follow-up|0|||
125196123|NCT03214380|450339902|FG005|Treatment Period|Lost to Follow-up|0|||
125196124|NCT03214380|450339897|FG000|Treatment Period|Participant schedule|0|||
125196125|NCT03214380|450339898|FG001|Treatment Period|Participant schedule|0|||
125196126|NCT03214380|450339899|FG002|Treatment Period|Participant schedule|1|||
125196127|NCT03214380|450339900|FG003|Treatment Period|Participant schedule|0|||
125196128|NCT03214380|450339901|FG004|Treatment Period|Participant schedule|0|||
125196129|NCT03214380|450339902|FG005|Treatment Period|Participant schedule|0|||
125196130|NCT03214380|450339897|FG000|Treatment Period|Treatment Interruption|0|||
125196131|NCT03214380|450339898|FG001|Treatment Period|Treatment Interruption|0|||
125196132|NCT03214380|450339899|FG002|Treatment Period|Treatment Interruption|1|||
125196133|NCT03214380|450339900|FG003|Treatment Period|Treatment Interruption|0|||
125196134|NCT03214380|450339901|FG004|Treatment Period|Treatment Interruption|0|||
125196135|NCT03214380|450339902|FG005|Treatment Period|Treatment Interruption|0|||
125196136|NCT03555565|450339903|FG000|Overall Study|Case Report Forms Uncollected|2|||
125196137|NCT03555565|450339903|FG000|Overall Study|Protocol Deviation|13|||
125196138|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
125196139|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
125196140|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
125196141|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
125196142|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
125196143|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
125196144|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
125196145|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
125196146|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Death|0|||
125196147|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Death|1|||
125196148|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
125196149|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
125196150|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
125196151|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
125196152|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
125196153|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
125196154|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
125196155|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
125196156|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
125196157|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
125196158|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Non compliance|0|||
125196159|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Non compliance|1|||
125249143|NCT00286455|450536112|FG002|Overall Study|Participant Non-compliance|0|||
125196160|NCT00394836|450339904|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
125196161|NCT00394836|450339905|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
125196162|NCT00394836|450339904|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
125196163|NCT00394836|450339905|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
125196164|NCT00394836|450339904|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
125196165|NCT00394836|450339905|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
125196166|NCT00394836|450339904|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
125196167|NCT00394836|450339905|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
125196168|NCT01163851|450339911|FG000|Overall Study|Site Closure|0|||
125196169|NCT01163851|450339912|FG001|Overall Study|Site Closure|1|||
125196170|NCT01163851|450339911|FG000|Overall Study|Enrolled but not treated|1|||
125196171|NCT01163851|450339912|FG001|Overall Study|Enrolled but not treated|0|||
125196172|NCT03192306|450339915|FG000|Overall Study|Did not treat cold sore during study|149|||
125196173|NCT03192306|450339916|FG001|Overall Study|Did not treat cold sore during study|143|||
125196174|NCT03192306|450339915|FG000|Overall Study|Withdrawal by Subject|1|||
125196175|NCT03192306|450339916|FG001|Overall Study|Withdrawal by Subject|1|||
125196176|NCT03192306|450339915|FG000|Overall Study|Lost to Follow-up|1|||
125196177|NCT03192306|450339916|FG001|Overall Study|Lost to Follow-up|0|||
125196178|NCT03192306|450339915|FG000|Overall Study|Protocol Violation|1|||
125196179|NCT03192306|450339916|FG001|Overall Study|Protocol Violation|1|||
125196180|NCT01289639|450339924|FG000|Overall Study|Lost to Follow-up|1|||
125196181|NCT01289639|450339925|FG001|Overall Study|Lost to Follow-up|0|||
125196182|NCT01289639|450339926|FG002|Overall Study|Lost to Follow-up|0|||
125196183|NCT02780713|450339927|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
125196184|NCT02780713|450339928|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
125196185|NCT02780713|450339929|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
125196186|NCT02780713|450339930|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
125196187|NCT02780713|450339931|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
125196188|NCT02111577|450339932|FG000|Overall Study|Protocol Violation|2|||
125196189|NCT02111577|450339933|FG001|Overall Study|Protocol Violation|0|||
125196190|NCT02111577|450339932|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
125196191|NCT02111577|450339933|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
125196192|NCT02111577|450339932|FG000|Overall Study|Failure to produce study treatment|6|||
125196193|NCT02111577|450339933|FG001|Overall Study|Failure to produce study treatment|0|||
125196194|NCT02111577|450339932|FG000|Overall Study|Death|518|||
125196195|NCT02111577|450339933|FG001|Overall Study|Death|254|||
125196196|NCT02111577|450339932|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
125196197|NCT02111577|450339933|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
125196198|NCT02111577|450339932|FG000|Overall Study|Adverse Event|1|||
125196199|NCT02111577|450339933|FG001|Overall Study|Adverse Event|1|||
125196200|NCT02111577|450339932|FG000|Overall Study|Withdrawal by Subject|51|||
125196201|NCT02111577|450339933|FG001|Overall Study|Withdrawal by Subject|23|||
125196202|NCT02111577|450339932|FG000|Overall Study|Disease progression|0|||
125196203|NCT02111577|450339933|FG001|Overall Study|Disease progression|1|||
125196204|NCT02111577|450339932|FG000|Overall Study|Lost to Follow-up|19|||
125196205|NCT02111577|450339933|FG001|Overall Study|Lost to Follow-up|10|||
125196206|NCT02042950|450339934|FG000|Overall Study|Progressive Disease|4|||
125196207|NCT02429778|450339937|FG000|Overall Study|Lost to Follow-up|2|||
125196208|NCT02429778|450339938|FG001|Overall Study|Lost to Follow-up|0|||
125196209|NCT02429778|450339937|FG000|Overall Study|Withdrawal by Subject|5|||
125196210|NCT02429778|450339938|FG001|Overall Study|Withdrawal by Subject|0|||
125196211|NCT01981954|450339945|FG000|Titration Period|Protocol Deviation|1|||
125196212|NCT01981954|450339945|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
125196213|NCT03655470|450339946|FG000|Overall Study|Lost to Follow-up|6|||
125196214|NCT03655470|450339947|FG001|Overall Study|Lost to Follow-up|7|||
125196215|NCT03063086|450339951|FG000|Overall Study|technical problems|1|||
125196216|NCT03063086|450339952|FG001|Overall Study|technical problems|0|||
125196217|NCT03063086|450339953|FG002|Overall Study|technical problems|0|||
125196218|NCT03063086|450339954|FG003|Overall Study|technical problems|0|||
125196219|NCT03063086|450339955|FG004|Overall Study|technical problems|0|||
125196220|NCT03063086|450339956|FG005|Overall Study|technical problems|0|||
125196221|NCT03063086|450339951|FG000|Overall Study|Adverse Event|1|||
125196222|NCT03063086|450339952|FG001|Overall Study|Adverse Event|1|||
125196223|NCT03063086|450339953|FG002|Overall Study|Adverse Event|1|||
125196224|NCT03063086|450339954|FG003|Overall Study|Adverse Event|1|||
125196225|NCT03063086|450339955|FG004|Overall Study|Adverse Event|0|||
125196226|NCT03063086|450339956|FG005|Overall Study|Adverse Event|0|||
125196227|NCT03063086|450339951|FG000|Overall Study|subject/guardian decision|1|||
125249144|NCT00286455|450536110|FG000|Overall Study|Withdrawal by Subject|0|||
125249145|NCT00286455|450536111|FG001|Overall Study|Withdrawal by Subject|8|||
125196228|NCT03063086|450339952|FG001|Overall Study|subject/guardian decision|0|||
125196229|NCT03063086|450339953|FG002|Overall Study|subject/guardian decision|0|||
125196230|NCT03063086|450339954|FG003|Overall Study|subject/guardian decision|0|||
125196231|NCT03063086|450339955|FG004|Overall Study|subject/guardian decision|0|||
125196232|NCT03063086|450339956|FG005|Overall Study|subject/guardian decision|0|||
125196233|NCT03063086|450339951|FG000|Overall Study|Non-compliance with study treatment|0|||
125196234|NCT03063086|450339952|FG001|Overall Study|Non-compliance with study treatment|0|||
125196235|NCT03063086|450339953|FG002|Overall Study|Non-compliance with study treatment|0|||
125196236|NCT03063086|450339954|FG003|Overall Study|Non-compliance with study treatment|1|||
125196237|NCT03063086|450339955|FG004|Overall Study|Non-compliance with study treatment|0|||
125196238|NCT03063086|450339956|FG005|Overall Study|Non-compliance with study treatment|1|||
125196239|NCT03063086|450339951|FG000|Overall Study|Physician Decision|0|||
125196240|NCT03063086|450339952|FG001|Overall Study|Physician Decision|0|||
125196241|NCT03063086|450339953|FG002|Overall Study|Physician Decision|0|||
125196242|NCT03063086|450339954|FG003|Overall Study|Physician Decision|1|||
125196243|NCT03063086|450339955|FG004|Overall Study|Physician Decision|0|||
125196244|NCT03063086|450339956|FG005|Overall Study|Physician Decision|0|||
125196245|NCT04590586|450339957|FG000|Overall Study|Death|7|||
125196246|NCT04590586|450339958|FG001|Overall Study|Death|1|||
125196247|NCT04590586|450339959|FG002|Overall Study|Death|37|||
125196248|NCT04590586|450339960|FG003|Overall Study|Death|34|||
125196249|NCT04590586|450339961|FG004|Overall Study|Death|19|||
125196250|NCT04590586|450339962|FG005|Overall Study|Death|3|||
125196251|NCT04590586|450339957|FG000|Overall Study|Lost to Follow-up|3|||
125196252|NCT04590586|450339958|FG001|Overall Study|Lost to Follow-up|0|||
125196253|NCT04590586|450339959|FG002|Overall Study|Lost to Follow-up|11|||
125196254|NCT04590586|450339960|FG003|Overall Study|Lost to Follow-up|11|||
125196255|NCT04590586|450339961|FG004|Overall Study|Lost to Follow-up|6|||
125196256|NCT04590586|450339962|FG005|Overall Study|Lost to Follow-up|0|||
125196257|NCT04590586|450339957|FG000|Overall Study|Withdrawal by Subject|0|||
125196258|NCT04590586|450339958|FG001|Overall Study|Withdrawal by Subject|0|||
125196259|NCT04590586|450339959|FG002|Overall Study|Withdrawal by Subject|6|||
125196260|NCT04590586|450339960|FG003|Overall Study|Withdrawal by Subject|0|||
125196261|NCT04590586|450339961|FG004|Overall Study|Withdrawal by Subject|3|||
125196262|NCT04590586|450339962|FG005|Overall Study|Withdrawal by Subject|0|||
125196263|NCT04590586|450339957|FG000|Overall Study|Other|3|||
125196264|NCT04590586|450339958|FG001|Overall Study|Other|0|||
125196265|NCT04590586|450339959|FG002|Overall Study|Other|1|||
125196266|NCT04590586|450339960|FG003|Overall Study|Other|1|||
125196267|NCT04590586|450339961|FG004|Overall Study|Other|2|||
125196268|NCT04590586|450339962|FG005|Overall Study|Other|1|||
125196269|NCT02218736|450339963|FG000|Overall Study|Withdrawal by Subject|10|||
125196270|NCT02218736|450339964|FG001|Overall Study|Withdrawal by Subject|9|||
125196271|NCT02218736|450339963|FG000|Overall Study|Protocol Violation|2|||
125196272|NCT02218736|450339964|FG001|Overall Study|Protocol Violation|0|||
125249146|NCT00286455|450536112|FG002|Overall Study|Withdrawal by Subject|7|||
125249147|NCT04359680|450538134|FG000|Overall Study|Withdrawal by Subject|29|||
125249148|NCT04359680|450538135|FG001|Overall Study|Withdrawal by Subject|24|||
125249149|NCT04359680|450538134|FG000|Overall Study|Adverse Event|6|||
125249150|NCT04359680|450538135|FG001|Overall Study|Adverse Event|2|||
125249151|NCT04359680|450538134|FG000|Overall Study|Lost to Follow-up|56|||
125249152|NCT04359680|450538135|FG001|Overall Study|Lost to Follow-up|59|||
125249153|NCT04359680|450538134|FG000|Overall Study|Protocol Violation|3|||
125249154|NCT04359680|450538135|FG001|Overall Study|Protocol Violation|5|||
125249155|NCT04359680|450538134|FG000|Overall Study|Physician Decision|1|||
125249156|NCT04359680|450538135|FG001|Overall Study|Physician Decision|1|||
125249157|NCT04359680|450538134|FG000|Overall Study|Sponsor Decision|0|||
125249158|NCT04359680|450538135|FG001|Overall Study|Sponsor Decision|1|||
125249159|NCT03931785|450538136|FG000|Overall Study|Lost to Follow-up|4|||
125249160|NCT03931785|450538137|FG001|Overall Study|Lost to Follow-up|1|||
125249161|NCT03931785|450538138|FG002|Overall Study|Lost to Follow-up|4|||
125249162|NCT03931785|450538139|FG003|Overall Study|Lost to Follow-up|3|||
125249163|NCT03931785|450538136|FG000|Overall Study|Adverse Event|1|||
125249164|NCT03931785|450538137|FG001|Overall Study|Adverse Event|0|||
125249165|NCT03931785|450538138|FG002|Overall Study|Adverse Event|3|||
125249166|NCT03931785|450538139|FG003|Overall Study|Adverse Event|4|||
125249167|NCT03931785|450538136|FG000|Overall Study|Protocol Violation|0|||
125249168|NCT03931785|450538137|FG001|Overall Study|Protocol Violation|1|||
125249169|NCT03931785|450538138|FG002|Overall Study|Protocol Violation|0|||
125249170|NCT03931785|450538139|FG003|Overall Study|Protocol Violation|0|||
125249171|NCT03931785|450538136|FG000|Overall Study|Noncompliance With Study drug|0|||
125249172|NCT03931785|450538137|FG001|Overall Study|Noncompliance With Study drug|1|||
125249173|NCT03931785|450538138|FG002|Overall Study|Noncompliance With Study drug|0|||
125249174|NCT03931785|450538139|FG003|Overall Study|Noncompliance With Study drug|0|||
125249175|NCT03931785|450538136|FG000|Overall Study|Other Not specified|0|||
125249176|NCT03931785|450538137|FG001|Overall Study|Other Not specified|2|||
125249177|NCT03931785|450538138|FG002|Overall Study|Other Not specified|2|||
125249178|NCT03931785|450538139|FG003|Overall Study|Other Not specified|2|||
125249179|NCT03931785|450538136|FG000|Overall Study|Withdrawal by Subject|0|||
125249180|NCT03931785|450538137|FG001|Overall Study|Withdrawal by Subject|2|||
125249181|NCT03931785|450538138|FG002|Overall Study|Withdrawal by Subject|4|||
125249182|NCT03931785|450538139|FG003|Overall Study|Withdrawal by Subject|1|||
125249183|NCT03931785|450538136|FG000|Overall Study|Pregnancy|0|||
125249184|NCT03931785|450538137|FG001|Overall Study|Pregnancy|0|||
125249185|NCT03931785|450538138|FG002|Overall Study|Pregnancy|0|||
125249186|NCT03931785|450538139|FG003|Overall Study|Pregnancy|1|||
125249187|NCT04605588|450538143|FG000|Overall Study|Withdrawal by Subject|1|||
125249188|NCT04605588|450538144|FG001|Overall Study|Withdrawal by Subject|0|||
125249189|NCT01230814|450538145|FG000|Overall Study|Lost to Follow-up|11|||
125249190|NCT01230814|450538146|FG001|Overall Study|Lost to Follow-up|3|||
125249191|NCT01230814|450538145|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
125249192|NCT01230814|450538146|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
125249193|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
125249194|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
125249195|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
125249196|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
125249197|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
125249198|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
125249199|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
125249200|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
125249201|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
125249202|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
125249203|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
125249204|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
125249205|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
125249206|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
125249207|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
125249208|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
125249209|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
125249210|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
125249211|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
125249212|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
125249213|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
125249214|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
125249215|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
125249216|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
125249217|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
125249218|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
125249219|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
125249220|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
125249221|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
125249222|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
125249223|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
125249224|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
125249225|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
125249226|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
125249227|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
125249228|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
125249229|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
125249230|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
125249231|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
125249232|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
125249233|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
125249234|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
125249235|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
125249236|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
125249237|NCT01529112|450538155|FG000|Overall Study|Adverse Event|2|||
125249238|NCT01529112|450538156|FG001|Overall Study|Adverse Event|0|||
125249239|NCT01529112|450538155|FG000|Overall Study|Death|59|||
125249240|NCT01529112|450538156|FG001|Overall Study|Death|38|||
125249241|NCT01529112|450538155|FG000|Overall Study|Protocol Violation|1|||
125249242|NCT01529112|450538156|FG001|Overall Study|Protocol Violation|0|||
125249243|NCT01529112|450538155|FG000|Overall Study|Withdrawal by Subject|7|||
125249244|NCT01529112|450538156|FG001|Overall Study|Withdrawal by Subject|3|||
125249245|NCT02255279|450538157|FG000|Overall Study|Lost to Follow-up|2|||
125249246|NCT02255279|450538158|FG001|Overall Study|Lost to Follow-up|2|||
125249247|NCT02255279|450538157|FG000|Overall Study|Protocol Violation|0|||
125249248|NCT02255279|450538158|FG001|Overall Study|Protocol Violation|1|||
125249249|NCT02255279|450538157|FG000|Overall Study|Withdrawal by Subject|3|||
125249250|NCT02255279|450538158|FG001|Overall Study|Withdrawal by Subject|6|||
125249251|NCT03607695|450538159|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
125249252|NCT03607695|450538159|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
125249253|NCT02741193|450538160|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
125249254|NCT02741193|450538160|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
125249255|NCT02502383|450538161|FG000|Overall Study|Lost to Follow-up|130|||
125249256|NCT02502383|450538162|FG001|Overall Study|Lost to Follow-up|131|||
125249257|NCT02502383|450538161|FG000|Overall Study|Withdrawal by Subject|31|||
125249258|NCT02502383|450538162|FG001|Overall Study|Withdrawal by Subject|24|||
125249259|NCT00363467|450538163|FG000|Overall Study|Physician Decision|1|||
125249260|NCT00903344|450538164|FG000|Overall Study|Pregnancy|2|||
125249261|NCT00903344|450538165|FG001|Overall Study|Pregnancy|3|||
125196273|NCT05481125|450339965|FG000|Overall Study|Adverse Event|1|||
125196274|NCT05481125|450339966|FG001|Overall Study|Adverse Event|0|||
125196275|NCT05481125|450339965|FG000|Overall Study|Lost to Follow-up|0|||
125196276|NCT05481125|450339966|FG001|Overall Study|Lost to Follow-up|1|||
125196277|NCT05481125|450339965|FG000|Overall Study|Withdrawal by Subject|0|||
125196278|NCT05481125|450339966|FG001|Overall Study|Withdrawal by Subject|1|||
125196279|NCT02244463|450339969|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
125196280|NCT02244463|450339970|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
125196281|NCT02244463|450339971|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
125196282|NCT02244463|450339972|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
125196283|NCT02244463|450339973|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
125196284|NCT02244463|450339974|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
125249262|NCT00903344|450538164|FG000|Overall Study|Lost to Follow-up|3|||
125249263|NCT00903344|450538165|FG001|Overall Study|Lost to Follow-up|0|||
125249264|NCT01524705|450538166|FG000|Overall Study|Adverse Event|2|||
125249265|NCT01524705|450538167|FG001|Overall Study|Adverse Event|0|||
125249266|NCT01524705|450538166|FG000|Overall Study|Death|1|||
125249267|NCT01524705|450538167|FG001|Overall Study|Death|0|||
125249268|NCT01524705|450538166|FG000|Overall Study|Lost to Follow-up|0|||
125249269|NCT01524705|450538167|FG001|Overall Study|Lost to Follow-up|1|||
125249270|NCT01524705|450538166|FG000|Overall Study|Withdrawal by Subject|0|||
125249271|NCT01524705|450538167|FG001|Overall Study|Withdrawal by Subject|1|||
125249272|NCT01524705|450538166|FG000|Overall Study|Pancreatic Cancer|0|||
125249273|NCT01524705|450538167|FG001|Overall Study|Pancreatic Cancer|1|||
125249274|NCT01530256|450538170|FG000|Overall Study|Death|2|||
125249275|NCT00527748|450538171|FG000|Overall Study|Other|3|||
125249276|NCT01093885|450538175|FG000|Overall Study|Adverse Event|4|||
125249277|NCT01093885|450538175|FG000|Overall Study|Lost to Follow-up|1|||
125249278|NCT04621786|450538176|FG000|Overall Study|Lost to Follow-up|9|||
125249279|NCT04621786|450538176|FG000|Overall Study|Protocol Violation|3|||
125249280|NCT02123511|450538177|FG000|Overall Study|Cancelled treatment|1|||
125249281|NCT02123511|450538178|FG001|Overall Study|Cancelled treatment|0|||
125249282|NCT02123511|450538177|FG000|Overall Study|Incomplete data|1|||
125249283|NCT02123511|450538178|FG001|Overall Study|Incomplete data|3|||
125249284|NCT02123511|450538177|FG000|Overall Study|Ineligible|0|||
125249285|NCT02123511|450538178|FG001|Overall Study|Ineligible|1|||
125249286|NCT01975285|450538181|FG000|Overall Study|Failed Block and follow up|2|||
125249287|NCT01975285|450538182|FG001|Overall Study|Failed Block and follow up|2|||
125249288|NCT00604383|450538187|FG000|Overall Study|Withdrawal by Subject|33|||
125249289|NCT00604383|450538188|FG001|Overall Study|Withdrawal by Subject|31|||
125249290|NCT00604383|450538187|FG000|Overall Study|Lost to Follow-up|24|||
125249291|NCT00604383|450538188|FG001|Overall Study|Lost to Follow-up|19|||
125249292|NCT00604383|450538187|FG000|Overall Study|Death|14|||
125249293|NCT00604383|450538188|FG001|Overall Study|Death|22|||
125249294|NCT00604383|450538187|FG000|Overall Study|Adverse Event|16|||
125249295|NCT00604383|450538188|FG001|Overall Study|Adverse Event|9|||
125249296|NCT00604383|450538187|FG000|Overall Study|Physician Decision|0|||
125249297|NCT00604383|450538188|FG001|Overall Study|Physician Decision|3|||
125249298|NCT00474968|450538191|FG000|Overall Study|Withdrawal by Subject|8|||
125249299|NCT00474968|450538192|FG001|Overall Study|Withdrawal by Subject|7|||
125249300|NCT00474968|450538191|FG000|Overall Study|Protocol Violation|9|||
125249301|NCT00474968|450538192|FG001|Overall Study|Protocol Violation|8|||
125249302|NCT00474968|450538191|FG000|Overall Study|Sample not collected|1|||
125249303|NCT00474968|450538192|FG001|Overall Study|Sample not collected|1|||
125249304|NCT01750281|450538193|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
125249305|NCT01750281|450538194|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
125249306|NCT01750281|450538195|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
125249307|NCT01750281|450538193|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
125249308|NCT01750281|450538194|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
125249309|NCT01750281|450538195|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
125249310|NCT01750281|450538193|FG000|Overall Study|Did not receive treatment|0|||
125249311|NCT01750281|450538194|FG001|Overall Study|Did not receive treatment|1|||
125249312|NCT01750281|450538195|FG002|Overall Study|Did not receive treatment|0|||
125249313|NCT00281580|450538197|FG000|Overall Study|Adverse Event|2|||
125249314|NCT00281580|450538198|FG001|Overall Study|Adverse Event|0|||
125249315|NCT00281580|450538199|FG002|Overall Study|Adverse Event|2|||
125249316|NCT00281580|450538200|FG003|Overall Study|Adverse Event|4|||
125249317|NCT00281580|450538201|FG004|Overall Study|Adverse Event|1|||
125249318|NCT00281580|450538202|FG005|Overall Study|Adverse Event|0|||
125249319|NCT00281580|450538203|FG006|Overall Study|Adverse Event|1|||
125196285|NCT02244463|450339969|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
125196286|NCT02244463|450339970|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
125196287|NCT02244463|450339971|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
125196288|NCT02244463|450339972|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
125196289|NCT02244463|450339973|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
125196290|NCT02244463|450339974|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
125196291|NCT02244463|450339969|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
125196292|NCT02244463|450339970|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
125196293|NCT02244463|450339971|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
125196294|NCT02244463|450339972|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
125249320|NCT00281580|450538204|FG007|Overall Study|Adverse Event|0|||
125249321|NCT00281580|450538205|FG008|Overall Study|Adverse Event|1|||
125249322|NCT00281580|450538206|FG009|Overall Study|Adverse Event|6|||
125249323|NCT00281580|450538207|FG010|Overall Study|Adverse Event|0|||
125249324|NCT00281580|450538208|FG011|Overall Study|Adverse Event|5|||
125249325|NCT00281580|450538209|FG012|Overall Study|Adverse Event|8|||
125249326|NCT00281580|450538210|FG013|Overall Study|Adverse Event|2|||
125249327|NCT00281580|450538211|FG014|Overall Study|Adverse Event|3|||
125249328|NCT00281580|450538212|FG015|Overall Study|Adverse Event|3|||
125249329|NCT00281580|450538197|FG000|Overall Study|Protocol Violation|0|||
125249330|NCT00281580|450538198|FG001|Overall Study|Protocol Violation|0|||
125249331|NCT00281580|450538199|FG002|Overall Study|Protocol Violation|1|||
125249332|NCT00281580|450538200|FG003|Overall Study|Protocol Violation|1|||
125249333|NCT00281580|450538201|FG004|Overall Study|Protocol Violation|0|||
125249334|NCT00281580|450538202|FG005|Overall Study|Protocol Violation|0|||
125249335|NCT00281580|450538203|FG006|Overall Study|Protocol Violation|1|||
125196295|NCT02244463|450339973|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
125249336|NCT00281580|450538204|FG007|Overall Study|Protocol Violation|0|||
125249337|NCT00281580|450538205|FG008|Overall Study|Protocol Violation|2|||
125249338|NCT00281580|450538206|FG009|Overall Study|Protocol Violation|0|||
125249339|NCT00281580|450538207|FG010|Overall Study|Protocol Violation|1|||
125249340|NCT00281580|450538208|FG011|Overall Study|Protocol Violation|2|||
125249341|NCT00281580|450538209|FG012|Overall Study|Protocol Violation|0|||
125249342|NCT00281580|450538210|FG013|Overall Study|Protocol Violation|1|||
125249343|NCT00281580|450538211|FG014|Overall Study|Protocol Violation|1|||
125196296|NCT02244463|450339974|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
125196297|NCT02244463|450339969|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
125196298|NCT02244463|450339970|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
125196299|NCT02244463|450339971|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
125196300|NCT02244463|450339972|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
125196301|NCT02244463|450339973|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
125196302|NCT02244463|450339974|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
125196303|NCT02244463|450339969|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
125196304|NCT02244463|450339970|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
125196305|NCT02244463|450339971|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
125196306|NCT02244463|450339972|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
125196307|NCT02244463|450339973|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
125196308|NCT02244463|450339974|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
125196309|NCT02244463|450339969|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
125196310|NCT02244463|450339970|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
125196311|NCT02244463|450339971|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
125196312|NCT02244463|450339972|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
125196313|NCT02244463|450339973|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
125196314|NCT02244463|450339974|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
125196315|NCT02244463|450339969|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
125196316|NCT02244463|450339970|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
125196317|NCT02244463|450339971|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
125196318|NCT02244463|450339972|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
125196319|NCT02244463|450339973|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
125196320|NCT02244463|450339974|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
125196321|NCT02244463|450339969|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
125196322|NCT02244463|450339970|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
125196323|NCT02244463|450339971|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
125196324|NCT02244463|450339972|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
125196325|NCT02244463|450339973|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
125196326|NCT02244463|450339974|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
125196327|NCT02244463|450339969|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
125196328|NCT02244463|450339970|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
125196329|NCT02244463|450339971|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
125196330|NCT02244463|450339972|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
125196331|NCT02244463|450339973|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
125196332|NCT02244463|450339974|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
125196333|NCT02244463|450339969|FG000|Period 5: Phase II|Disease Progression|0|||
125196334|NCT02244463|450339970|FG001|Period 5: Phase II|Disease Progression|0|||
125196335|NCT02244463|450339971|FG002|Period 5: Phase II|Disease Progression|0|||
125196336|NCT02244463|450339972|FG003|Period 5: Phase II|Disease Progression|0|||
125196337|NCT02244463|450339973|FG004|Period 5: Phase II|Disease Progression|10|||
125196338|NCT02244463|450339974|FG005|Period 5: Phase II|Disease Progression|11|||
125196339|NCT02244463|450339969|FG000|Period 5: Phase II|Physician Decision|0|||
125196340|NCT02244463|450339970|FG001|Period 5: Phase II|Physician Decision|0|||
125196341|NCT02244463|450339971|FG002|Period 5: Phase II|Physician Decision|0|||
125196342|NCT02244463|450339972|FG003|Period 5: Phase II|Physician Decision|0|||
125196343|NCT02244463|450339973|FG004|Period 5: Phase II|Physician Decision|3|||
125196344|NCT02244463|450339974|FG005|Period 5: Phase II|Physician Decision|2|||
125196345|NCT02244463|450339969|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
125196346|NCT02244463|450339970|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
125196347|NCT02244463|450339971|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
125196348|NCT02244463|450339972|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
125249344|NCT00281580|450538212|FG015|Overall Study|Protocol Violation|3|||
125249345|NCT00281580|450538197|FG000|Overall Study|Withdrawal by Subject|3|||
125249346|NCT00281580|450538198|FG001|Overall Study|Withdrawal by Subject|0|||
125196349|NCT02244463|450339973|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
125196350|NCT02244463|450339974|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
125196351|NCT02244463|450339969|FG000|Period 5: Phase II|Intercurrent Illness|0|||
125196352|NCT02244463|450339970|FG001|Period 5: Phase II|Intercurrent Illness|0|||
125196353|NCT02244463|450339971|FG002|Period 5: Phase II|Intercurrent Illness|0|||
125196354|NCT02244463|450339972|FG003|Period 5: Phase II|Intercurrent Illness|0|||
125196355|NCT02244463|450339973|FG004|Period 5: Phase II|Intercurrent Illness|2|||
125196356|NCT02244463|450339974|FG005|Period 5: Phase II|Intercurrent Illness|0|||
125196357|NCT02244463|450339969|FG000|Period 5: Phase II|Adverse Event|0|||
125196358|NCT02244463|450339970|FG001|Period 5: Phase II|Adverse Event|0|||
125196359|NCT02244463|450339971|FG002|Period 5: Phase II|Adverse Event|0|||
125196360|NCT02244463|450339972|FG003|Period 5: Phase II|Adverse Event|0|||
125196361|NCT02244463|450339973|FG004|Period 5: Phase II|Adverse Event|0|||
125196362|NCT02244463|450339974|FG005|Period 5: Phase II|Adverse Event|2|||
125196363|NCT02244463|450339969|FG000|Period 5: Phase II|Still On treatment|0|||
125196364|NCT02244463|450339970|FG001|Period 5: Phase II|Still On treatment|0|||
125196365|NCT02244463|450339971|FG002|Period 5: Phase II|Still On treatment|0|||
125196366|NCT02244463|450339972|FG003|Period 5: Phase II|Still On treatment|0|||
125196367|NCT02244463|450339973|FG004|Period 5: Phase II|Still On treatment|0|||
125196368|NCT02244463|450339974|FG005|Period 5: Phase II|Still On treatment|3|||
125196369|NCT01769508|450339975|FG000|Overall Study|Death|3|||
125196370|NCT01769508|450339975|FG000|Overall Study|Withdrawal by Subject|1|||
125196371|NCT01769508|450339975|FG000|Overall Study|Adverse Event|1|||
125196372|NCT01769508|450339975|FG000|Overall Study|Lost to Follow-up|1|||
125196373|NCT03615144|450339976|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
125196374|NCT03615144|450339977|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
125196375|NCT04791319|450339980|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
125196376|NCT04791319|450339981|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
125196377|NCT04791319|450339982|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
125196378|NCT04791319|450339983|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
125196379|NCT04791319|450339984|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
125196380|NCT04791319|450339985|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
125196381|NCT04791319|450339986|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
125196382|NCT04791319|450339987|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
125196383|NCT04791319|450339988|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
125196384|NCT04791319|450339989|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
125196385|NCT04791319|450339990|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
125196386|NCT04791319|450339980|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
125196387|NCT04791319|450339981|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
125196388|NCT04791319|450339982|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
125196389|NCT04791319|450339983|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
125196390|NCT04791319|450339984|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
125196391|NCT04791319|450339985|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
125196392|NCT04791319|450339986|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
125196393|NCT04791319|450339987|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
125196394|NCT04791319|450339988|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
125196395|NCT04791319|450339989|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
125196396|NCT04791319|450339990|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
125196397|NCT04791319|450339980|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
125196398|NCT04791319|450339981|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
125196399|NCT04791319|450339982|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
125196400|NCT04791319|450339983|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
125196401|NCT04791319|450339984|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
125196402|NCT04791319|450339985|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
125196403|NCT04791319|450339986|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
125196404|NCT04791319|450339987|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
125196405|NCT04791319|450339988|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
125196406|NCT04791319|450339989|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
125196407|NCT04791319|450339990|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
125196408|NCT04791319|450339980|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
125196409|NCT04791319|450339981|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
125196410|NCT04791319|450339982|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
125196411|NCT04791319|450339983|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
125196412|NCT04791319|450339984|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
125196413|NCT04791319|450339985|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
125196414|NCT04791319|450339986|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
125196415|NCT04791319|450339987|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
125196416|NCT04791319|450339988|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
125196417|NCT04791319|450339989|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
125196418|NCT04791319|450339990|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
125196419|NCT04791319|450339980|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
125196420|NCT04791319|450339981|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
125196421|NCT04791319|450339982|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
125196422|NCT04791319|450339983|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
125196423|NCT04791319|450339984|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
125196424|NCT04791319|450339985|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
125196425|NCT04791319|450339986|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
125196426|NCT04791319|450339987|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
125196427|NCT04791319|450339988|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
125196428|NCT04791319|450339989|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
125196429|NCT04791319|450339990|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
125196430|NCT04791319|450339980|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
125196431|NCT04791319|450339981|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
125196432|NCT04791319|450339982|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
125196433|NCT04791319|450339983|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
125196434|NCT04791319|450339984|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
125196435|NCT04791319|450339985|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
125196436|NCT04791319|450339986|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
125196437|NCT04791319|450339987|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
125196438|NCT04791319|450339988|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
125196439|NCT04791319|450339989|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
125196440|NCT04791319|450339990|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
125196441|NCT04791319|450339980|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
125196442|NCT04791319|450339981|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
125196443|NCT04791319|450339982|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
125196444|NCT04791319|450339983|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
125196445|NCT04791319|450339984|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
125196446|NCT04791319|450339985|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
125196447|NCT04791319|450339986|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
125196448|NCT04791319|450339987|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
125196449|NCT04791319|450339988|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
125196450|NCT04791319|450339989|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
125196451|NCT04791319|450339990|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
125196452|NCT04791319|450339980|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
125196453|NCT04791319|450339981|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
125196454|NCT04791319|450339982|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
125196455|NCT04791319|450339983|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
125196456|NCT04791319|450339984|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
125196457|NCT04791319|450339985|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
125196458|NCT04791319|450339986|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
125196459|NCT04791319|450339987|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
125196460|NCT04791319|450339988|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
125196461|NCT04791319|450339989|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
125196462|NCT04791319|450339990|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
125196463|NCT04791319|450339980|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
125196464|NCT04791319|450339981|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
125196465|NCT04791319|450339982|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
125196466|NCT04791319|450339983|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
125196467|NCT04791319|450339984|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
125196468|NCT04791319|450339985|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
125196469|NCT04791319|450339986|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
125196470|NCT04791319|450339987|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
125196471|NCT04791319|450339988|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
125196472|NCT04791319|450339989|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
125249347|NCT00281580|450538199|FG002|Overall Study|Withdrawal by Subject|1|||
125249348|NCT00281580|450538200|FG003|Overall Study|Withdrawal by Subject|1|||
125249349|NCT00281580|450538201|FG004|Overall Study|Withdrawal by Subject|1|||
125249350|NCT00281580|450538202|FG005|Overall Study|Withdrawal by Subject|2|||
125249351|NCT00281580|450538203|FG006|Overall Study|Withdrawal by Subject|2|||
125249352|NCT00281580|450538204|FG007|Overall Study|Withdrawal by Subject|0|||
125249353|NCT00281580|450538205|FG008|Overall Study|Withdrawal by Subject|1|||
125249354|NCT00281580|450538206|FG009|Overall Study|Withdrawal by Subject|4|||
125249355|NCT00281580|450538207|FG010|Overall Study|Withdrawal by Subject|1|||
125249356|NCT00281580|450538208|FG011|Overall Study|Withdrawal by Subject|1|||
125249357|NCT00281580|450538209|FG012|Overall Study|Withdrawal by Subject|2|||
125249358|NCT00281580|450538210|FG013|Overall Study|Withdrawal by Subject|2|||
125249359|NCT00281580|450538211|FG014|Overall Study|Withdrawal by Subject|1|||
125249360|NCT00281580|450538212|FG015|Overall Study|Withdrawal by Subject|5|||
125249361|NCT00281580|450538197|FG000|Overall Study|Lack of Efficacy|2|||
125249362|NCT00281580|450538198|FG001|Overall Study|Lack of Efficacy|1|||
125249363|NCT00281580|450538199|FG002|Overall Study|Lack of Efficacy|1|||
125249364|NCT00281580|450538200|FG003|Overall Study|Lack of Efficacy|6|||
125249365|NCT00281580|450538201|FG004|Overall Study|Lack of Efficacy|2|||
125249366|NCT00281580|450538202|FG005|Overall Study|Lack of Efficacy|0|||
125249367|NCT00281580|450538203|FG006|Overall Study|Lack of Efficacy|0|||
125249368|NCT00281580|450538204|FG007|Overall Study|Lack of Efficacy|0|||
125249369|NCT00281580|450538205|FG008|Overall Study|Lack of Efficacy|0|||
125249370|NCT00281580|450538206|FG009|Overall Study|Lack of Efficacy|0|||
125249371|NCT00281580|450538207|FG010|Overall Study|Lack of Efficacy|0|||
125249372|NCT00281580|450538208|FG011|Overall Study|Lack of Efficacy|1|||
125249373|NCT00281580|450538209|FG012|Overall Study|Lack of Efficacy|0|||
125249374|NCT00281580|450538210|FG013|Overall Study|Lack of Efficacy|2|||
125249375|NCT00281580|450538211|FG014|Overall Study|Lack of Efficacy|1|||
125249376|NCT00281580|450538212|FG015|Overall Study|Lack of Efficacy|0|||
125249377|NCT00281580|450538197|FG000|Overall Study|Lost to Follow-up|0|||
125249378|NCT00281580|450538198|FG001|Overall Study|Lost to Follow-up|0|||
125249379|NCT00281580|450538199|FG002|Overall Study|Lost to Follow-up|0|||
125249380|NCT00281580|450538200|FG003|Overall Study|Lost to Follow-up|3|||
125249381|NCT00281580|450538201|FG004|Overall Study|Lost to Follow-up|0|||
125249382|NCT00281580|450538202|FG005|Overall Study|Lost to Follow-up|1|||
125249383|NCT00281580|450538203|FG006|Overall Study|Lost to Follow-up|0|||
125249384|NCT00281580|450538204|FG007|Overall Study|Lost to Follow-up|1|||
125249385|NCT00281580|450538205|FG008|Overall Study|Lost to Follow-up|2|||
125249386|NCT00281580|450538206|FG009|Overall Study|Lost to Follow-up|1|||
125249387|NCT00281580|450538207|FG010|Overall Study|Lost to Follow-up|1|||
125249388|NCT00281580|450538208|FG011|Overall Study|Lost to Follow-up|0|||
125249389|NCT00281580|450538209|FG012|Overall Study|Lost to Follow-up|1|||
125249390|NCT00281580|450538210|FG013|Overall Study|Lost to Follow-up|0|||
125249391|NCT00281580|450538211|FG014|Overall Study|Lost to Follow-up|0|||
125249392|NCT00281580|450538212|FG015|Overall Study|Lost to Follow-up|0|||
125249393|NCT00281580|450538197|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
125249394|NCT00281580|450538198|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
125249395|NCT00281580|450538199|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
125249396|NCT00281580|450538200|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
125249397|NCT00281580|450538201|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
125249398|NCT00281580|450538202|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
125249399|NCT00281580|450538203|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
125249400|NCT00281580|450538204|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
125249401|NCT00281580|450538205|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
125249402|NCT00281580|450538206|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
125249403|NCT00281580|450538207|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
125249404|NCT00281580|450538208|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
125249405|NCT00281580|450538209|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
125249406|NCT00281580|450538210|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
125249407|NCT00281580|450538211|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
125249408|NCT00281580|450538212|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
125249409|NCT01122680|450538213|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
125249410|NCT01122680|450538214|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
125249411|NCT01122680|450538215|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
125249412|NCT01122680|450538216|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
125249413|NCT01122680|450538213|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
125249414|NCT01122680|450538214|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
125249415|NCT01122680|450538215|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
125249416|NCT01122680|450538216|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
125249417|NCT01122680|450538213|FG000|Period 1 (4 Weeks)|Other|1|||
125249418|NCT01122680|450538214|FG001|Period 1 (4 Weeks)|Other|1|||
125249419|NCT01122680|450538215|FG002|Period 1 (4 Weeks)|Other|0|||
125249420|NCT01122680|450538216|FG003|Period 1 (4 Weeks)|Other|0|||
125249421|NCT01122680|450538213|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
125249422|NCT01122680|450538214|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
125249423|NCT01122680|450538215|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
125249424|NCT01122680|450538216|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
125249425|NCT01122680|450538213|FG000|Period 2 (4 Weeks)|Other|1|||
125249426|NCT01122680|450538214|FG001|Period 2 (4 Weeks)|Other|0|||
125249427|NCT01122680|450538215|FG002|Period 2 (4 Weeks)|Other|0|||
125249428|NCT01122680|450538216|FG003|Period 2 (4 Weeks)|Other|0|||
125249429|NCT01122680|450538213|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
125249430|NCT01122680|450538214|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
125249431|NCT01122680|450538215|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
125249432|NCT01122680|450538216|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
125249433|NCT01122680|450538213|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
125249434|NCT01122680|450538214|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
125249435|NCT01122680|450538215|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
125249436|NCT01122680|450538216|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
125249437|NCT01550965|450538217|FG000|Overall Study|Adverse Event|26|||
125249438|NCT01550965|450538217|FG000|Overall Study|Withdrawal by Subject|10|||
125249439|NCT01550965|450538217|FG000|Overall Study|Lost to Follow-up|2|||
125249440|NCT01550965|450538217|FG000|Overall Study|Lack of Efficacy|59|||
125249441|NCT01550965|450538217|FG000|Overall Study|Other|13|||
125249442|NCT03016403|450538220|FG000|Baseline|Death|5|||
125249443|NCT03016403|450538221|FG001|Baseline|Death|8|||
125249444|NCT03016403|450538222|FG002|Baseline|Death|1|||
125249445|NCT03016403|450538223|FG003|Baseline|Death|0|||
125249446|NCT03016403|450538220|FG000|Baseline|Withdrawal by Subject|2|||
125249447|NCT03016403|450538221|FG001|Baseline|Withdrawal by Subject|8|||
125249448|NCT03016403|450538222|FG002|Baseline|Withdrawal by Subject|4|||
125249449|NCT03016403|450538223|FG003|Baseline|Withdrawal by Subject|10|||
125249450|NCT03016403|450538220|FG000|Baseline|Lost to Follow-up|9|||
125249451|NCT03016403|450538221|FG001|Baseline|Lost to Follow-up|11|||
125249452|NCT03016403|450538222|FG002|Baseline|Lost to Follow-up|6|||
125249453|NCT03016403|450538223|FG003|Baseline|Lost to Follow-up|24|||
125249454|NCT03016403|450538220|FG000|6-week Follow-up|Death|1|||
125249455|NCT03016403|450538221|FG001|6-week Follow-up|Death|4|||
125249456|NCT03016403|450538222|FG002|6-week Follow-up|Death|0|||
125249457|NCT03016403|450538223|FG003|6-week Follow-up|Death|0|||
125249458|NCT03016403|450538220|FG000|6-week Follow-up|Lost to Follow-up|2|||
125249459|NCT03016403|450538221|FG001|6-week Follow-up|Lost to Follow-up|7|||
125249460|NCT03016403|450538222|FG002|6-week Follow-up|Lost to Follow-up|4|||
125249461|NCT03016403|450538223|FG003|6-week Follow-up|Lost to Follow-up|8|||
125249462|NCT03016403|450538220|FG000|6-week Follow-up|Withdrawal by Subject|0|||
125249463|NCT03016403|450538221|FG001|6-week Follow-up|Withdrawal by Subject|2|||
125249464|NCT03016403|450538222|FG002|6-week Follow-up|Withdrawal by Subject|0|||
125249465|NCT03016403|450538223|FG003|6-week Follow-up|Withdrawal by Subject|1|||
125249466|NCT03016403|450538220|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
125249467|NCT03016403|450538221|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
125249468|NCT03016403|450538222|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
125249469|NCT03016403|450538223|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
125249470|NCT03016403|450538220|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
125249471|NCT03016403|450538221|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
125249472|NCT03016403|450538222|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
125249473|NCT03016403|450538223|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
125249474|NCT03016403|450538220|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
125249475|NCT03016403|450538221|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
125249476|NCT03016403|450538222|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
125249477|NCT03016403|450538223|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
125249478|NCT00225758|450538224|FG000|Overall Study|Adverse Event|4|||
125249479|NCT00564070|450538225|FG000|Overall Study|Lost to Follow-up|9|||
125249480|NCT00564070|450538226|FG001|Overall Study|Lost to Follow-up|7|||
125249481|NCT00564070|450538225|FG000|Overall Study|Worsening depression, referred to care|3|||
125249482|NCT00564070|450538226|FG001|Overall Study|Worsening depression, referred to care|0|||
125249483|NCT03142334|450538230|FG000|Overall Study|Death|18|||
125249484|NCT03142334|450538231|FG001|Overall Study|Death|33|||
125249485|NCT03142334|450538230|FG000|Overall Study|Withdrawal by Subject|15|||
125249486|NCT03142334|450538231|FG001|Overall Study|Withdrawal by Subject|11|||
125249487|NCT03142334|450538230|FG000|Overall Study|Ongoing on trial follow up|463|||
125249488|NCT03142334|450538231|FG001|Overall Study|Ongoing on trial follow up|454|||
125249489|NCT03071965|450538232|FG000|Overall Study|Adverse Event|0|||
125249490|NCT03071965|450538233|FG001|Overall Study|Adverse Event|0|||
125249491|NCT03071965|450538234|FG002|Overall Study|Adverse Event|1|||
125249492|NCT03071965|450538235|FG003|Overall Study|Adverse Event|0|||
125249493|NCT03071965|450538232|FG000|Overall Study|Death|0|||
125249494|NCT03071965|450538233|FG001|Overall Study|Death|0|||
125249495|NCT03071965|450538234|FG002|Overall Study|Death|1|||
125249496|NCT03071965|450538235|FG003|Overall Study|Death|1|||
125249497|NCT03071965|450538232|FG000|Overall Study|COVID-19|0|||
125249498|NCT03071965|450538233|FG001|Overall Study|COVID-19|1|||
125249499|NCT03071965|450538234|FG002|Overall Study|COVID-19|0|||
125249500|NCT03071965|450538235|FG003|Overall Study|COVID-19|1|||
125249501|NCT03071965|450538232|FG000|Overall Study|Other Health Reason|0|||
125249502|NCT03071965|450538233|FG001|Overall Study|Other Health Reason|0|||
125249503|NCT03071965|450538234|FG002|Overall Study|Other Health Reason|0|||
125249504|NCT03071965|450538235|FG003|Overall Study|Other Health Reason|1|||
125249505|NCT01217047|450538236|FG000|Overall Study|Lost to Follow-up|0|||
125249506|NCT01217047|450538237|FG001|Overall Study|Lost to Follow-up|1|||
125249507|NCT01217047|450538238|FG002|Overall Study|Lost to Follow-up|0|||
125249508|NCT05529173|450538239|FG000|Overall Study|Physician Decision|3|||
125249509|NCT05529173|450538240|FG001|Overall Study|Physician Decision|6|||
125249510|NCT05529173|450538239|FG000|Overall Study|Sample shipment delay more than one day|4|||
125249511|NCT05529173|450538240|FG001|Overall Study|Sample shipment delay more than one day|0|||
125249512|NCT05587998|450538241|FG000|Overall Study|Withdrawal by Subject|1|||
125249513|NCT05587998|450538242|FG001|Overall Study|Withdrawal by Subject|1|||
125249514|NCT05587998|450538241|FG000|Overall Study|Not treated|3|||
125249515|NCT05587998|450538242|FG001|Overall Study|Not treated|1|||
125249516|NCT05587998|450538241|FG000|Overall Study|Non-compliance with study procedures|0|||
125249517|NCT05587998|450538242|FG001|Overall Study|Non-compliance with study procedures|1|||
125249518|NCT03892915|450538246|FG000|Overall Study|Lost to Follow-up|6|||
125249519|NCT03892915|450538247|FG001|Overall Study|Lost to Follow-up|12|||
125249520|NCT03892915|450538246|FG000|Overall Study|Death|0|||
125249521|NCT03892915|450538247|FG001|Overall Study|Death|2|||
125249522|NCT03892915|450538246|FG000|Overall Study|Withdrawal by Subject|1|||
125249523|NCT03892915|450538247|FG001|Overall Study|Withdrawal by Subject|1|||
125249524|NCT03892915|450538246|FG000|Overall Study|unsuccessful delivery|13|||
125249525|NCT03892915|450538247|FG001|Overall Study|unsuccessful delivery|18|||
125249526|NCT01181128|450538248|FG000|Overall Study|Withdrawal by Subject|2|||
125249527|NCT01181128|450538249|FG001|Overall Study|Withdrawal by Subject|2|||
125249528|NCT01181128|450538250|FG002|Overall Study|Withdrawal by Subject|0|||
125249529|NCT01181128|450538248|FG000|Overall Study|Death|1|||
125249530|NCT01181128|450538249|FG001|Overall Study|Death|0|||
125249531|NCT01181128|450538250|FG002|Overall Study|Death|0|||
125249532|NCT01181128|450538248|FG000|Overall Study|Physician Decision|2|||
125249533|NCT01181128|450538249|FG001|Overall Study|Physician Decision|0|||
125249534|NCT01181128|450538250|FG002|Overall Study|Physician Decision|0|||
125249535|NCT01181128|450538248|FG000|Overall Study|Adverse Event|0|||
125249536|NCT01181128|450538249|FG001|Overall Study|Adverse Event|2|||
125249537|NCT01181128|450538250|FG002|Overall Study|Adverse Event|0|||
125249538|NCT01181128|450538248|FG000|Overall Study|Other|1|||
125249539|NCT01181128|450538249|FG001|Overall Study|Other|1|||
125249540|NCT01181128|450538250|FG002|Overall Study|Other|1|||
125249541|NCT01362270|450538253|FG000|Overall Study|Withdrawal by Subject|1|||
125249542|NCT01362270|450538254|FG001|Overall Study|Withdrawal by Subject|0|||
125249543|NCT01362270|450538253|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
125249544|NCT01362270|450538254|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
125249545|NCT01362270|450538253|FG000|Overall Study|Met excl. criteria before 1st session|1|||
125249546|NCT01362270|450538254|FG001|Overall Study|Met excl. criteria before 1st session|1|||
125249547|NCT02318277|450538255|FG000|Overall Study|Physician Decision|0|||
125249548|NCT02318277|450538256|FG001|Overall Study|Physician Decision|0|||
125249549|NCT02318277|450538257|FG002|Overall Study|Physician Decision|0|||
125249550|NCT02318277|450538258|FG003|Overall Study|Physician Decision|0|||
125249551|NCT02318277|450538259|FG004|Overall Study|Physician Decision|0|||
125249552|NCT02318277|450538260|FG005|Overall Study|Physician Decision|0|||
125249553|NCT02318277|450538261|FG006|Overall Study|Physician Decision|0|||
125249554|NCT02318277|450538262|FG007|Overall Study|Physician Decision|1|||
125249555|NCT02318277|450538255|FG000|Overall Study|Other|0|||
125249556|NCT02318277|450538256|FG001|Overall Study|Other|0|||
125249557|NCT02318277|450538257|FG002|Overall Study|Other|0|||
125249558|NCT02318277|450538258|FG003|Overall Study|Other|0|||
125249559|NCT02318277|450538259|FG004|Overall Study|Other|0|||
125249560|NCT02318277|450538260|FG005|Overall Study|Other|0|||
125249561|NCT02318277|450538261|FG006|Overall Study|Other|1|||
125249562|NCT02318277|450538262|FG007|Overall Study|Other|0|||
125249563|NCT02318277|450538255|FG000|Overall Study|Withdrawal by Subject|0|||
125249564|NCT02318277|450538256|FG001|Overall Study|Withdrawal by Subject|0|||
125249565|NCT02318277|450538257|FG002|Overall Study|Withdrawal by Subject|1|||
125249566|NCT02318277|450538258|FG003|Overall Study|Withdrawal by Subject|0|||
125249567|NCT02318277|450538259|FG004|Overall Study|Withdrawal by Subject|1|||
125249568|NCT02318277|450538260|FG005|Overall Study|Withdrawal by Subject|1|||
125249569|NCT02318277|450538261|FG006|Overall Study|Withdrawal by Subject|6|||
125249570|NCT02318277|450538262|FG007|Overall Study|Withdrawal by Subject|14|||
125249571|NCT02318277|450538255|FG000|Overall Study|Participant trial terminated by sponsor|0|||
125249572|NCT02318277|450538256|FG001|Overall Study|Participant trial terminated by sponsor|0|||
125249573|NCT02318277|450538257|FG002|Overall Study|Participant trial terminated by sponsor|1|||
125249574|NCT02318277|450538258|FG003|Overall Study|Participant trial terminated by sponsor|0|||
125249575|NCT02318277|450538259|FG004|Overall Study|Participant trial terminated by sponsor|1|||
125249576|NCT02318277|450538260|FG005|Overall Study|Participant trial terminated by sponsor|2|||
125249577|NCT02318277|450538261|FG006|Overall Study|Participant trial terminated by sponsor|5|||
125249578|NCT02318277|450538262|FG007|Overall Study|Participant trial terminated by sponsor|16|||
125249579|NCT02318277|450538255|FG000|Overall Study|Lost to Follow-up|1|||
125249580|NCT02318277|450538256|FG001|Overall Study|Lost to Follow-up|0|||
125196473|NCT04791319|450339990|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
125249581|NCT02318277|450538257|FG002|Overall Study|Lost to Follow-up|1|||
125249582|NCT02318277|450538258|FG003|Overall Study|Lost to Follow-up|0|||
125249583|NCT02318277|450538259|FG004|Overall Study|Lost to Follow-up|0|||
125249584|NCT02318277|450538260|FG005|Overall Study|Lost to Follow-up|0|||
125249585|NCT02318277|450538261|FG006|Overall Study|Lost to Follow-up|3|||
125249586|NCT02318277|450538262|FG007|Overall Study|Lost to Follow-up|4|||
125249587|NCT02318277|450538255|FG000|Overall Study|Death|5|||
125249588|NCT02318277|450538256|FG001|Overall Study|Death|3|||
125249589|NCT02318277|450538257|FG002|Overall Study|Death|1|||
125249590|NCT02318277|450538258|FG003|Overall Study|Death|4|||
125249591|NCT02318277|450538259|FG004|Overall Study|Death|6|||
125249592|NCT02318277|450538260|FG005|Overall Study|Death|5|||
125249593|NCT02318277|450538261|FG006|Overall Study|Death|34|||
125196474|NCT02587598|450339991|FG000|Overall Study|Death|4|||
125196475|NCT02587598|450339992|FG001|Overall Study|Death|8|||
125196476|NCT02587598|450339993|FG002|Overall Study|Death|4|||
125196477|NCT02587598|450339994|FG003|Overall Study|Death|16|||
125196478|NCT02587598|450339995|FG004|Overall Study|Death|9|||
125196479|NCT02587598|450339996|FG005|Overall Study|Death|4|||
125196480|NCT02587598|450339997|FG006|Overall Study|Death|6|||
125196481|NCT02587598|450339998|FG007|Overall Study|Death|7|||
125196482|NCT02587598|450339999|FG008|Overall Study|Death|9|||
125196483|NCT02587598|450340000|FG009|Overall Study|Death|1|||
125196484|NCT02587598|450340001|FG010|Overall Study|Death|3|||
125196485|NCT02587598|450339991|FG000|Overall Study|Study Terminated by the Sponsor|0|||
125196486|NCT02587598|450339992|FG001|Overall Study|Study Terminated by the Sponsor|1|||
125196487|NCT02587598|450339993|FG002|Overall Study|Study Terminated by the Sponsor|0|||
125196488|NCT02587598|450339994|FG003|Overall Study|Study Terminated by the Sponsor|3|||
125196489|NCT02587598|450339995|FG004|Overall Study|Study Terminated by the Sponsor|0|||
125196490|NCT02587598|450339996|FG005|Overall Study|Study Terminated by the Sponsor|1|||
125196491|NCT02587598|450339997|FG006|Overall Study|Study Terminated by the Sponsor|0|||
125196492|NCT02587598|450339998|FG007|Overall Study|Study Terminated by the Sponsor|0|||
125196493|NCT02587598|450339999|FG008|Overall Study|Study Terminated by the Sponsor|0|||
125196494|NCT02587598|450340000|FG009|Overall Study|Study Terminated by the Sponsor|1|||
125196495|NCT02587598|450340001|FG010|Overall Study|Study Terminated by the Sponsor|6|||
125196496|NCT02587598|450339991|FG000|Overall Study|Reason for study withdrawal not specified|0|||
125196497|NCT02587598|450339992|FG001|Overall Study|Reason for study withdrawal not specified|1|||
125196498|NCT02587598|450339993|FG002|Overall Study|Reason for study withdrawal not specified|0|||
125196499|NCT02587598|450339994|FG003|Overall Study|Reason for study withdrawal not specified|0|||
125196500|NCT02587598|450339995|FG004|Overall Study|Reason for study withdrawal not specified|0|||
125196501|NCT02587598|450339996|FG005|Overall Study|Reason for study withdrawal not specified|0|||
125196502|NCT02587598|450339997|FG006|Overall Study|Reason for study withdrawal not specified|0|||
125196503|NCT02587598|450339998|FG007|Overall Study|Reason for study withdrawal not specified|0|||
125196504|NCT02587598|450339999|FG008|Overall Study|Reason for study withdrawal not specified|0|||
125196505|NCT02587598|450340000|FG009|Overall Study|Reason for study withdrawal not specified|0|||
125196506|NCT02587598|450340001|FG010|Overall Study|Reason for study withdrawal not specified|0|||
125196507|NCT02587598|450339991|FG000|Overall Study|Withdrawal by Subject|0|||
125196508|NCT02587598|450339992|FG001|Overall Study|Withdrawal by Subject|1|||
125196509|NCT02587598|450339993|FG002|Overall Study|Withdrawal by Subject|0|||
125196510|NCT02587598|450339994|FG003|Overall Study|Withdrawal by Subject|2|||
125196511|NCT02587598|450339995|FG004|Overall Study|Withdrawal by Subject|3|||
125249594|NCT02318277|450538262|FG007|Overall Study|Death|58|||
125249595|NCT02318277|450538255|FG000|Overall Study|Transitioned to Hospice|0|||
125249596|NCT02318277|450538256|FG001|Overall Study|Transitioned to Hospice|0|||
125249597|NCT02318277|450538257|FG002|Overall Study|Transitioned to Hospice|0|||
125249598|NCT02318277|450538258|FG003|Overall Study|Transitioned to Hospice|0|||
125196512|NCT02587598|450339996|FG005|Overall Study|Withdrawal by Subject|1|||
125196513|NCT02587598|450339997|FG006|Overall Study|Withdrawal by Subject|0|||
125196514|NCT02587598|450339998|FG007|Overall Study|Withdrawal by Subject|0|||
125249599|NCT02318277|450538259|FG004|Overall Study|Transitioned to Hospice|0|||
125196515|NCT02587598|450339999|FG008|Overall Study|Withdrawal by Subject|0|||
125196516|NCT02587598|450340000|FG009|Overall Study|Withdrawal by Subject|1|||
125196517|NCT02587598|450340001|FG010|Overall Study|Withdrawal by Subject|2|||
125196518|NCT02587598|450339991|FG000|Overall Study|Physician Decision|0|||
125196519|NCT02587598|450339992|FG001|Overall Study|Physician Decision|0|||
125196520|NCT02587598|450339993|FG002|Overall Study|Physician Decision|0|||
125196521|NCT02587598|450339994|FG003|Overall Study|Physician Decision|0|||
125196522|NCT02587598|450339995|FG004|Overall Study|Physician Decision|0|||
125196523|NCT02587598|450339996|FG005|Overall Study|Physician Decision|0|||
125196524|NCT02587598|450339997|FG006|Overall Study|Physician Decision|0|||
125196525|NCT02587598|450339998|FG007|Overall Study|Physician Decision|0|||
125196526|NCT02587598|450339999|FG008|Overall Study|Physician Decision|0|||
125196527|NCT02587598|450340000|FG009|Overall Study|Physician Decision|0|||
125196528|NCT02587598|450340001|FG010|Overall Study|Physician Decision|3|||
125196529|NCT02353442|450340004|FG000|Overall Study|Withdrawal by Subject|3|||
125196530|NCT02353442|450340005|FG001|Overall Study|Withdrawal by Subject|4|||
125196531|NCT00679289|450340007|FG000|Overall Study|Progressive disease|4|||
125196532|NCT00679289|450340008|FG001|Overall Study|Progressive disease|5|||
125196533|NCT00679289|450340009|FG002|Overall Study|Progressive disease|18|||
125196534|NCT00679289|450340007|FG000|Overall Study|Withdrawal by Subject|0|||
125196535|NCT00679289|450340008|FG001|Overall Study|Withdrawal by Subject|1|||
125196536|NCT00679289|450340009|FG002|Overall Study|Withdrawal by Subject|1|||
125196537|NCT00679289|450340007|FG000|Overall Study|Adverse Event|0|||
125196538|NCT00679289|450340008|FG001|Overall Study|Adverse Event|0|||
125196539|NCT00679289|450340009|FG002|Overall Study|Adverse Event|3|||
125196540|NCT00679289|450340007|FG000|Overall Study|Physician Decision|1|||
125196541|NCT00679289|450340008|FG001|Overall Study|Physician Decision|0|||
125249600|NCT02318277|450538260|FG005|Overall Study|Transitioned to Hospice|1|||
125249601|NCT02318277|450538261|FG006|Overall Study|Transitioned to Hospice|0|||
125249602|NCT02318277|450538262|FG007|Overall Study|Transitioned to Hospice|0|||
125249603|NCT01520714|450538263|FG000|Overall Study|Protocol Violation|0|||
125249604|NCT01520714|450538264|FG001|Overall Study|Protocol Violation|3|||
125249605|NCT01520714|450538263|FG000|Overall Study|Adverse Event|0|||
125249606|NCT01520714|450538264|FG001|Overall Study|Adverse Event|2|||
125249607|NCT01520714|450538263|FG000|Overall Study|Lack of Efficacy|0|||
125249608|NCT01520714|450538264|FG001|Overall Study|Lack of Efficacy|1|||
125249609|NCT00395512|450538265|FG000|Overall Study|Adverse Event|3|||
125249610|NCT00395512|450538266|FG001|Overall Study|Adverse Event|8|||
125249611|NCT00395512|450538267|FG002|Overall Study|Adverse Event|6|||
125249612|NCT00395512|450538268|FG003|Overall Study|Adverse Event|6|||
125249613|NCT00395512|450538265|FG000|Overall Study|Protocol Violation|2|||
125249614|NCT00395512|450538266|FG001|Overall Study|Protocol Violation|3|||
125249615|NCT00395512|450538267|FG002|Overall Study|Protocol Violation|6|||
125249616|NCT00395512|450538268|FG003|Overall Study|Protocol Violation|7|||
125249617|NCT00395512|450538265|FG000|Overall Study|Lost to Follow-up|2|||
125249618|NCT00395512|450538266|FG001|Overall Study|Lost to Follow-up|6|||
125249619|NCT00395512|450538267|FG002|Overall Study|Lost to Follow-up|5|||
125249620|NCT00395512|450538268|FG003|Overall Study|Lost to Follow-up|5|||
125249621|NCT00395512|450538265|FG000|Overall Study|Withdrawal by Subject|6|||
125249622|NCT00395512|450538266|FG001|Overall Study|Withdrawal by Subject|5|||
125249623|NCT00395512|450538267|FG002|Overall Study|Withdrawal by Subject|5|||
125249624|NCT00395512|450538268|FG003|Overall Study|Withdrawal by Subject|12|||
125249625|NCT00395512|450538265|FG000|Overall Study|Physician Decision|6|||
125249626|NCT00395512|450538266|FG001|Overall Study|Physician Decision|4|||
125249627|NCT00395512|450538267|FG002|Overall Study|Physician Decision|2|||
125249628|NCT00395512|450538268|FG003|Overall Study|Physician Decision|2|||
125249629|NCT00395512|450538265|FG000|Overall Study|Other|1|||
125249630|NCT00395512|450538266|FG001|Overall Study|Other|1|||
125249631|NCT00395512|450538267|FG002|Overall Study|Other|0|||
125249632|NCT00395512|450538268|FG003|Overall Study|Other|0|||
125249633|NCT00395512|450538265|FG000|Overall Study|Hyperglycemic Rescue|18|||
125249634|NCT00395512|450538266|FG001|Overall Study|Hyperglycemic Rescue|10|||
125249635|NCT00395512|450538267|FG002|Overall Study|Hyperglycemic Rescue|4|||
125249636|NCT00395512|450538268|FG003|Overall Study|Hyperglycemic Rescue|6|||
125249637|NCT00754559|450538271|FG000|Overall Study|Adverse Event|15|||
125249638|NCT00754559|450538271|FG000|Overall Study|Protocol Violation|11|||
125249639|NCT00754559|450538271|FG000|Overall Study|Lack of Efficacy|10|||
125249640|NCT00754559|450538271|FG000|Overall Study|Lost to Follow-up|2|||
125249641|NCT00754559|450538271|FG000|Overall Study|Administrative reason|1|||
125249642|NCT00754559|450538271|FG000|Overall Study|Other|5|||
125249643|NCT00754559|450538271|FG000|Overall Study|Withdrawal by Subject|3|||
125249644|NCT01663987|450538272|FG000|Overall Study|Adverse Event|7|||
125249645|NCT01663987|450538273|FG001|Overall Study|Adverse Event|2|||
125249646|NCT01663987|450538272|FG000|Overall Study|Lost to Follow-up|1|||
125249647|NCT01663987|450538273|FG001|Overall Study|Lost to Follow-up|1|||
125249648|NCT01663987|450538272|FG000|Overall Study|Withdrawal by Subject|2|||
125249649|NCT01663987|450538273|FG001|Overall Study|Withdrawal by Subject|3|||
125249650|NCT01663987|450538272|FG000|Overall Study|Other reason not defined above|3|||
125249651|NCT01663987|450538273|FG001|Overall Study|Other reason not defined above|0|||
125249652|NCT03721965|450538275|FG000|Overall Study|Death|1|||
125249653|NCT03721965|450538275|FG000|Overall Study|Study Terminated by Sponsor|1|||
125249654|NCT04913675|450538276|FG000|Main Study (Up to Week 36)|Death|0|||
125249655|NCT04913675|450538277|FG001|Main Study (Up to Week 36)|Death|2|||
125249656|NCT04913675|450538278|FG002|Main Study (Up to Week 36)|Death|2|||
125249657|NCT04913675|450538279|FG003|Main Study (Up to Week 36)|Death|0|||
125249658|NCT04913675|450538276|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
125249659|NCT04913675|450538277|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
125249660|NCT04913675|450538278|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
125249661|NCT04913675|450538279|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
125249662|NCT04913675|450538276|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
125249663|NCT04913675|450538277|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
125249664|NCT04913675|450538278|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
125249665|NCT04913675|450538279|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
125249666|NCT04913675|450538276|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
125249667|NCT04913675|450538277|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
125249668|NCT04913675|450538278|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
125249669|NCT04913675|450538279|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
125249670|NCT04913675|450538276|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
125249671|NCT04913675|450538277|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
125249672|NCT04913675|450538278|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
125249673|NCT04913675|450538279|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
125196542|NCT00679289|450340009|FG002|Overall Study|Physician Decision|1|||
125196543|NCT01355575|450340011|FG000|Overall Study|Withdrawal by Subject|2|||
125196544|NCT01094301|450340016|FG000|Trial Stage|Withdrawal by Subject|1|||
125196545|NCT01094301|450340016|FG000|Implant Stage|Adverse Event|1|||
125196546|NCT01094301|450340016|FG000|Implant Stage|Protocol Violation|1|||
125196547|NCT01094301|450340016|FG000|Implant Stage|Withdrawal by Subject|2|||
125196548|NCT01094301|450340016|FG000|Implant Stage|No return of pain|4|||
125196549|NCT00582608|450340017|FG000|Overall Study|Not Treated|7|||
125196550|NCT00582608|450340017|FG000|Overall Study|Patient Ineligible|1|||
125196551|NCT00582608|450340017|FG000|Overall Study|Lack of accrual|4|||
125196552|NCT03386994|450340022|FG000|Overall Study|Lung transplant|1|||
125196553|NCT03386994|450340022|FG000|Overall Study|Adverse Event|14|||
125196554|NCT03386994|450340022|FG000|Overall Study|Lost to Follow-up|4|||
125196555|NCT03386994|450340022|FG000|Overall Study|Withdrawal by Subject|3|||
125196556|NCT03386994|450340022|FG000|Overall Study|Death|16|||
125196557|NCT01732640|450340023|FG000|Overall Study|Adverse Event|0|||
125196558|NCT01732640|450340024|FG001|Overall Study|Adverse Event|1|||
125196559|NCT01732640|450340023|FG000|Overall Study|Death|0|||
125196560|NCT01732640|450340024|FG001|Overall Study|Death|1|||
125196561|NCT00712543|450340025|FG000|Day 8-14|Lost to Follow-up|0|||
125196562|NCT00712543|450340026|FG001|Day 8-14|Lost to Follow-up|2|||
125196563|NCT02702388|450340027|FG000|Overall Study|Disease Progression|18|||
125196564|NCT02702388|450340028|FG001|Overall Study|Disease Progression|25|||
125196565|NCT02702388|450340027|FG000|Overall Study|Withdrawal by Subject|9|||
125196566|NCT02702388|450340028|FG001|Overall Study|Withdrawal by Subject|7|||
125196567|NCT02702388|450340027|FG000|Overall Study|Adverse Event|11|||
125196568|NCT02702388|450340028|FG001|Overall Study|Adverse Event|15|||
125196569|NCT02702388|450340027|FG000|Overall Study|Other|2|||
125249674|NCT02489045|450538280|FG000|Overall Study|unable to collect usable data|53|||
125249675|NCT02489045|450538280|FG000|Follow-up|Lost to Follow-up|10|||
125249676|NCT01341990|450538281|FG000|Overall Study|Adverse Event|0|||
125249677|NCT01341990|450538282|FG001|Overall Study|Adverse Event|1|||
125249678|NCT01341990|450538281|FG000|Overall Study|Torn Study Lens|1|||
125249679|NCT01341990|450538282|FG001|Overall Study|Torn Study Lens|0|||
125249680|NCT01341990|450538281|FG000|Overall Study|Withdrawal by Subject|2|||
125249681|NCT01341990|450538282|FG001|Overall Study|Withdrawal by Subject|0|||
125249682|NCT01751685|450538284|FG000|6-mo Followup|Missed study visit|1|||
125249683|NCT01751685|450538285|FG001|6-mo Followup|Missed study visit|0|||
125249684|NCT01751685|450538284|FG000|6-mo Followup|Withdrawal by Subject|2|||
125249685|NCT01751685|450538285|FG001|6-mo Followup|Withdrawal by Subject|2|||
125249686|NCT01751685|450538284|FG000|6-mo Followup|Lost to Follow-up|0|||
125249687|NCT01751685|450538285|FG001|6-mo Followup|Lost to Follow-up|1|||
125249688|NCT01751685|450538284|FG000|12-mo Followup|Lost to Follow-up|5|||
125249689|NCT01751685|450538285|FG001|12-mo Followup|Lost to Follow-up|0|||
125249690|NCT01348490|450538292|FG000|Overall Study|Death|1|||
125249691|NCT01348490|450538292|FG000|Overall Study|Adverse Event|3|||
125249692|NCT01348490|450538292|FG000|Overall Study|Consent withdrawn|7|||
125249693|NCT01348490|450538292|FG000|Overall Study|Disease progression|3|||
125249694|NCT01348490|450538292|FG000|Overall Study|Lost to Follow-up|1|||
125249695|NCT01348490|450538292|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
125249696|NCT01348490|450538292|FG000|Overall Study|Other Unspecified|8|||
125249697|NCT01117350|450538294|FG000|Comparative Period|Not Treated|5|||
125249698|NCT01117350|450538295|FG001|Comparative Period|Not Treated|8|||
125249699|NCT01117350|450538294|FG000|Comparative Period|Adverse Event|6|||
125249700|NCT01117350|450538295|FG001|Comparative Period|Adverse Event|33|||
125249701|NCT01117350|450538294|FG000|Comparative Period|Lost to Follow-up|11|||
125249702|NCT01117350|450538295|FG001|Comparative Period|Lost to Follow-up|7|||
125249703|NCT01117350|450538294|FG000|Comparative Period|Withdrawal by Subject|9|||
125249704|NCT01117350|450538295|FG001|Comparative Period|Withdrawal by Subject|13|||
125249705|NCT01117350|450538294|FG000|Comparative Period|Protocol Violation|8|||
125249706|NCT01117350|450538295|FG001|Comparative Period|Protocol Violation|12|||
125249707|NCT01117350|450538294|FG000|Comparative Period|Lack of Efficacy|1|||
125249708|NCT01117350|450538295|FG001|Comparative Period|Lack of Efficacy|0|||
125196570|NCT02702388|450340028|FG001|Overall Study|Other|4|||
125196571|NCT02729051|450340029|FG000|Overall Study|Adverse Event|21|||
125196572|NCT02729051|450340030|FG001|Overall Study|Adverse Event|11|||
125196573|NCT02729051|450340029|FG000|Overall Study|Lack of Efficacy|1|||
125196574|NCT02729051|450340030|FG001|Overall Study|Lack of Efficacy|1|||
125196575|NCT02729051|450340029|FG000|Overall Study|Lost to Follow-up|1|||
125196576|NCT02729051|450340030|FG001|Overall Study|Lost to Follow-up|2|||
125196577|NCT02729051|450340029|FG000|Overall Study|Physician Decision|1|||
125196578|NCT02729051|450340030|FG001|Overall Study|Physician Decision|1|||
125196579|NCT02729051|450340029|FG000|Overall Study|Withdrawal by Subject|6|||
125196580|NCT02729051|450340030|FG001|Overall Study|Withdrawal by Subject|17|||
125196581|NCT02147158|450340040|FG000|Treatment Course 1|Adverse Event|1|||
125196582|NCT02147158|450340041|FG001|Treatment Course 1|Adverse Event|4|||
125196583|NCT02147158|450340042|FG002|Treatment Course 1|Adverse Event|3|||
125196584|NCT02147158|450340043|FG003|Treatment Course 1|Adverse Event|4|||
125196585|NCT02147158|450340044|FG004|Treatment Course 1|Adverse Event|1|||
125196586|NCT02147158|450340045|FG005|Treatment Course 1|Adverse Event|2|||
125196587|NCT02147158|450340040|FG000|Treatment Course 1|Lost to Follow-up|2|||
125196588|NCT02147158|450340041|FG001|Treatment Course 1|Lost to Follow-up|4|||
125196589|NCT02147158|450340042|FG002|Treatment Course 1|Lost to Follow-up|3|||
125196590|NCT02147158|450340043|FG003|Treatment Course 1|Lost to Follow-up|3|||
125196591|NCT02147158|450340044|FG004|Treatment Course 1|Lost to Follow-up|2|||
125196592|NCT02147158|450340045|FG005|Treatment Course 1|Lost to Follow-up|4|||
125196593|NCT02147158|450340040|FG000|Treatment Course 1|Protocol Violation|0|||
125196594|NCT02147158|450340041|FG001|Treatment Course 1|Protocol Violation|0|||
125196595|NCT02147158|450340042|FG002|Treatment Course 1|Protocol Violation|1|||
125196596|NCT02147158|450340043|FG003|Treatment Course 1|Protocol Violation|1|||
125196597|NCT02147158|450340044|FG004|Treatment Course 1|Protocol Violation|0|||
125196598|NCT02147158|450340045|FG005|Treatment Course 1|Protocol Violation|0|||
125196599|NCT02147158|450340040|FG000|Treatment Course 1|Withdrawal of Consent|1|||
125196600|NCT02147158|450340041|FG001|Treatment Course 1|Withdrawal of Consent|1|||
125196601|NCT02147158|450340042|FG002|Treatment Course 1|Withdrawal of Consent|1|||
125196602|NCT02147158|450340043|FG003|Treatment Course 1|Withdrawal of Consent|5|||
125196603|NCT02147158|450340044|FG004|Treatment Course 1|Withdrawal of Consent|3|||
125196604|NCT02147158|450340045|FG005|Treatment Course 1|Withdrawal of Consent|2|||
125196605|NCT02147158|450340040|FG000|Off-Treatment Interval 1|Adverse Event|1|||
125196606|NCT02147158|450340041|FG001|Off-Treatment Interval 1|Adverse Event|0|||
125196607|NCT02147158|450340042|FG002|Off-Treatment Interval 1|Adverse Event|0|||
125196608|NCT02147158|450340043|FG003|Off-Treatment Interval 1|Adverse Event|1|||
125196609|NCT02147158|450340044|FG004|Off-Treatment Interval 1|Adverse Event|0|||
125196610|NCT02147158|450340045|FG005|Off-Treatment Interval 1|Adverse Event|0|||
125196611|NCT02147158|450340040|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
125196612|NCT02147158|450340041|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
125196613|NCT02147158|450340042|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
125196614|NCT02147158|450340043|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
125196615|NCT02147158|450340044|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
125196616|NCT02147158|450340045|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
125196617|NCT02147158|450340040|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
125196618|NCT02147158|450340041|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
125249709|NCT01117350|450538294|FG000|Comparative Period|Physician Decision|0|||
125249710|NCT01117350|450538295|FG001|Comparative Period|Physician Decision|1|||
125196619|NCT02147158|450340042|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
125196620|NCT02147158|450340043|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
125196621|NCT02147158|450340044|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
125196622|NCT02147158|450340045|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
125196623|NCT02147158|450340040|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
125196624|NCT02147158|450340041|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
125196625|NCT02147158|450340042|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
125196626|NCT02147158|450340043|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
125196627|NCT02147158|450340044|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
125196628|NCT02147158|450340045|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
125249711|NCT01117350|450538294|FG000|Comparative Period|Move to another city/country|2|||
125249712|NCT01117350|450538295|FG001|Comparative Period|Move to another city/country|1|||
125249713|NCT01117350|450538294|FG000|Extension Period|Not included in extension, not treated|0|||
125249714|NCT01117350|450538295|FG001|Extension Period|Not included in extension, not treated|50|||
125249715|NCT01117350|450538294|FG000|Extension Period|Adverse Event|0|||
125249716|NCT01117350|450538295|FG001|Extension Period|Adverse Event|2|||
125196629|NCT02147158|450340040|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
125196630|NCT02147158|450340041|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
125196631|NCT02147158|450340042|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
125196632|NCT02147158|450340043|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
125196633|NCT02147158|450340044|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
125196634|NCT02147158|450340045|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
125196635|NCT02147158|450340040|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
125196636|NCT02147158|450340041|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
125196637|NCT02147158|450340042|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
125196638|NCT02147158|450340043|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
125196639|NCT02147158|450340044|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
125196640|NCT02147158|450340045|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
125196641|NCT02147158|450340040|FG000|Treatment Course 2|Adverse Event|0|||
125196642|NCT02147158|450340041|FG001|Treatment Course 2|Adverse Event|4|||
125196643|NCT02147158|450340042|FG002|Treatment Course 2|Adverse Event|2|||
125196644|NCT02147158|450340043|FG003|Treatment Course 2|Adverse Event|1|||
125196645|NCT02147158|450340044|FG004|Treatment Course 2|Adverse Event|0|||
125196646|NCT02147158|450340045|FG005|Treatment Course 2|Adverse Event|1|||
125196647|NCT02147158|450340040|FG000|Treatment Course 2|Withdrawal of Consent|0|||
125196648|NCT02147158|450340041|FG001|Treatment Course 2|Withdrawal of Consent|1|||
125196649|NCT02147158|450340042|FG002|Treatment Course 2|Withdrawal of Consent|2|||
125196650|NCT02147158|450340043|FG003|Treatment Course 2|Withdrawal of Consent|3|||
125196651|NCT02147158|450340044|FG004|Treatment Course 2|Withdrawal of Consent|0|||
125196652|NCT02147158|450340045|FG005|Treatment Course 2|Withdrawal of Consent|0|||
125196653|NCT02147158|450340040|FG000|Treatment Course 2|Lost to Follow-up|1|||
125196654|NCT02147158|450340041|FG001|Treatment Course 2|Lost to Follow-up|0|||
125196655|NCT02147158|450340042|FG002|Treatment Course 2|Lost to Follow-up|1|||
125196656|NCT02147158|450340043|FG003|Treatment Course 2|Lost to Follow-up|1|||
125196657|NCT02147158|450340044|FG004|Treatment Course 2|Lost to Follow-up|0|||
125196658|NCT02147158|450340045|FG005|Treatment Course 2|Lost to Follow-up|1|||
125196659|NCT02147158|450340040|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
125196660|NCT02147158|450340041|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
125196661|NCT02147158|450340042|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
125196662|NCT02147158|450340043|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
125196663|NCT02147158|450340044|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
125196664|NCT02147158|450340045|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
125196665|NCT02147158|450340040|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
125196666|NCT02147158|450340041|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
125196667|NCT02147158|450340042|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
125196668|NCT02147158|450340043|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
125196669|NCT02147158|450340044|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
125196670|NCT02147158|450340045|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
125196671|NCT02147158|450340040|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
125196672|NCT02147158|450340041|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
125196673|NCT02147158|450340042|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
125196674|NCT02147158|450340043|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
125196675|NCT02147158|450340044|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
125196676|NCT02147158|450340045|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
125196677|NCT02147158|450340040|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
125196678|NCT02147158|450340041|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
125196679|NCT02147158|450340042|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
125196680|NCT02147158|450340043|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
125196681|NCT02147158|450340044|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
125196682|NCT02147158|450340045|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
125196683|NCT02147158|450340040|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
125196684|NCT02147158|450340041|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
125196685|NCT02147158|450340042|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
125196686|NCT02147158|450340043|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
125196687|NCT02147158|450340044|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
125196688|NCT02147158|450340045|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
125196689|NCT03033602|450340046|FG000|Overall Study|Withdrawal by Subject|11|||
125196690|NCT03033602|450340047|FG001|Overall Study|Withdrawal by Subject|21|||
125196691|NCT03033602|450340046|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
125196692|NCT03033602|450340047|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
125196693|NCT01441765|450340048|FG000|Overall Study|Death|1|||
125196694|NCT01441765|450340049|FG001|Overall Study|Death|0|||
125196695|NCT04445714|450340050|FG000|Overall Study|Discontinuation of the study|14|||
125196696|NCT04445714|450340050|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
125196697|NCT04445714|450340050|FG000|Overall Study|Withdrawal of Informed Consent|8|||
125196698|NCT02805660|450340051|FG000|Overall Study|Death|5|||
125196699|NCT02805660|450340052|FG001|Overall Study|Death|2|||
125196700|NCT02805660|450340053|FG002|Overall Study|Death|9|||
125196701|NCT02805660|450340054|FG003|Overall Study|Death|5|||
125196702|NCT02805660|450340055|FG004|Overall Study|Death|0|||
125196703|NCT02805660|450340056|FG005|Overall Study|Death|14|||
125196704|NCT02805660|450340057|FG006|Overall Study|Death|12|||
125196705|NCT02805660|450340051|FG000|Overall Study|Lost to Follow-up|0|||
125196706|NCT02805660|450340052|FG001|Overall Study|Lost to Follow-up|1|||
125196707|NCT02805660|450340053|FG002|Overall Study|Lost to Follow-up|1|||
125196708|NCT02805660|450340054|FG003|Overall Study|Lost to Follow-up|2|||
125196709|NCT02805660|450340055|FG004|Overall Study|Lost to Follow-up|0|||
125196710|NCT02805660|450340056|FG005|Overall Study|Lost to Follow-up|0|||
125196711|NCT02805660|450340057|FG006|Overall Study|Lost to Follow-up|0|||
125196712|NCT02805660|450340051|FG000|Overall Study|Withdrawal by Subject|0|||
125196713|NCT02805660|450340052|FG001|Overall Study|Withdrawal by Subject|0|||
125196714|NCT02805660|450340053|FG002|Overall Study|Withdrawal by Subject|0|||
125196715|NCT02805660|450340054|FG003|Overall Study|Withdrawal by Subject|3|||
125196716|NCT02805660|450340055|FG004|Overall Study|Withdrawal by Subject|1|||
125196717|NCT02805660|450340056|FG005|Overall Study|Withdrawal by Subject|0|||
125196718|NCT02805660|450340057|FG006|Overall Study|Withdrawal by Subject|2|||
125196719|NCT02805660|450340051|FG000|Overall Study|Study terminated by Sponsor|0|||
125196720|NCT02805660|450340052|FG001|Overall Study|Study terminated by Sponsor|0|||
125196721|NCT02805660|450340053|FG002|Overall Study|Study terminated by Sponsor|1|||
125196722|NCT02805660|450340054|FG003|Overall Study|Study terminated by Sponsor|4|||
125196723|NCT02805660|450340055|FG004|Overall Study|Study terminated by Sponsor|2|||
125196724|NCT02805660|450340056|FG005|Overall Study|Study terminated by Sponsor|3|||
125196725|NCT02805660|450340057|FG006|Overall Study|Study terminated by Sponsor|1|||
125196726|NCT02805660|450340051|FG000|Overall Study|Miscellaneous|0|||
125196727|NCT02805660|450340052|FG001|Overall Study|Miscellaneous|1|||
125196728|NCT02805660|450340053|FG002|Overall Study|Miscellaneous|0|||
125196729|NCT02805660|450340054|FG003|Overall Study|Miscellaneous|4|||
125196730|NCT02805660|450340055|FG004|Overall Study|Miscellaneous|0|||
125196731|NCT02805660|450340056|FG005|Overall Study|Miscellaneous|6|||
125196732|NCT02805660|450340057|FG006|Overall Study|Miscellaneous|4|||
125196733|NCT01684943|450340058|FG000|Overall Study|Inadequate Venous Access|3|||
125196734|NCT01684943|450340059|FG001|Overall Study|Inadequate Venous Access|0|||
125196735|NCT01684943|450340060|FG002|Overall Study|Inadequate Venous Access|0|||
125196736|NCT01684943|450340058|FG000|Overall Study|Principal Investigator Determination|1|||
125196737|NCT01684943|450340059|FG001|Overall Study|Principal Investigator Determination|0|||
125196738|NCT01684943|450340060|FG002|Overall Study|Principal Investigator Determination|0|||
125196739|NCT01684943|450340058|FG000|Overall Study|Excluded from Analysis|1|||
125196740|NCT01684943|450340059|FG001|Overall Study|Excluded from Analysis|1|||
125196741|NCT01684943|450340060|FG002|Overall Study|Excluded from Analysis|1|||
125196742|NCT01684943|450340058|FG000|Overall Study|Lost to Follow-up|3|||
125196743|NCT01684943|450340059|FG001|Overall Study|Lost to Follow-up|0|||
125196744|NCT01684943|450340060|FG002|Overall Study|Lost to Follow-up|0|||
125196745|NCT01684943|450340058|FG000|Overall Study|Planning Pregnancy|1|||
125196746|NCT01684943|450340059|FG001|Overall Study|Planning Pregnancy|0|||
125196747|NCT01684943|450340060|FG002|Overall Study|Planning Pregnancy|0|||
125196748|NCT01190410|450341943|FG000|Overall Study|Adverse Event|0|||
125196749|NCT01190410|450341944|FG001|Overall Study|Adverse Event|3|||
125196750|NCT01190410|450341943|FG000|Overall Study|Lack of Efficacy|0|||
125196751|NCT01190410|450341944|FG001|Overall Study|Lack of Efficacy|2|||
125196752|NCT01190410|450341943|FG000|Overall Study|Withdrawal by Subject|0|||
125196753|NCT01190410|450341944|FG001|Overall Study|Withdrawal by Subject|2|||
125196754|NCT01190410|450341943|FG000|Overall Study|Administrative decision|1|||
125196755|NCT01190410|450341944|FG001|Overall Study|Administrative decision|0|||
125196756|NCT01190410|450341943|FG000|Overall Study|PI discretion|0|||
125196757|NCT01190410|450341944|FG001|Overall Study|PI discretion|2|||
125196758|NCT01399047|450341945|FG000|Overall Study|Withdrawal by Subject|0|||
125196759|NCT01399047|450341946|FG001|Overall Study|Withdrawal by Subject|1|||
125196760|NCT00504725|450341954|FG000|Overall Study|Protocol Violation|1|||
125196761|NCT00504725|450341955|FG001|Overall Study|Protocol Violation|0|||
125196762|NCT00769067|450341957|FG000|Overall Study|Death|89|||
125196763|NCT00769067|450341958|FG001|Overall Study|Death|86|||
125196764|NCT00769067|450341957|FG000|Overall Study|Lost to Follow-up|3|||
125196765|NCT00769067|450341958|FG001|Overall Study|Lost to Follow-up|1|||
125196766|NCT00769067|450341957|FG000|Overall Study|Study terminated by sponsor|1|||
125196767|NCT00769067|450341958|FG001|Overall Study|Study terminated by sponsor|3|||
125196768|NCT00769067|450341957|FG000|Overall Study|Other|1|||
125196769|NCT00769067|450341958|FG001|Overall Study|Other|3|||
125196770|NCT00769067|450341957|FG000|Overall Study|Withdrawal by Subject|0|||
125196771|NCT00769067|450341958|FG001|Overall Study|Withdrawal by Subject|1|||
125196772|NCT03625466|450341959|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
125249717|NCT01117350|450538294|FG000|Extension Period|Protocol Violation|0|||
125249718|NCT01117350|450538295|FG001|Extension Period|Protocol Violation|2|||
125249719|NCT01117350|450538294|FG000|Extension Period|Lost to Follow-up|0|||
125249720|NCT01117350|450538295|FG001|Extension Period|Lost to Follow-up|2|||
125249721|NCT01117350|450538294|FG000|Extension Period|Withdrawal by Subject|0|||
125249722|NCT01117350|450538295|FG001|Extension Period|Withdrawal by Subject|3|||
125249723|NCT01117350|450538294|FG000|Extension Period|Lack of Efficacy|0|||
125249724|NCT01117350|450538295|FG001|Extension Period|Lack of Efficacy|2|||
125196773|NCT03625466|450341960|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
125196774|NCT03625466|450341961|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
125196775|NCT03625466|450341959|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
125196776|NCT03625466|450341960|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
125196777|NCT03625466|450341961|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
125196778|NCT03625466|450341959|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
125196779|NCT03625466|450341960|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
125196780|NCT03625466|450341961|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
125196781|NCT00809471|450341962|FG000|Overall Study|Protocol non-compliance|15|||
125196782|NCT00809471|450341963|FG001|Overall Study|Protocol non-compliance|15|||
125196783|NCT00809471|450341964|FG002|Overall Study|Protocol non-compliance|6|||
125196784|NCT00809471|450341962|FG000|Overall Study|Lost to Follow-up|4|||
125196785|NCT00809471|450341963|FG001|Overall Study|Lost to Follow-up|2|||
125196786|NCT00809471|450341964|FG002|Overall Study|Lost to Follow-up|9|||
125196787|NCT00809471|450341962|FG000|Overall Study|Adverse Event|0|||
125196788|NCT00809471|450341963|FG001|Overall Study|Adverse Event|2|||
125196789|NCT00809471|450341964|FG002|Overall Study|Adverse Event|2|||
125196790|NCT00809471|450341962|FG000|Overall Study|Requirement for restricted medication|1|||
125196791|NCT00809471|450341963|FG001|Overall Study|Requirement for restricted medication|1|||
125196792|NCT00809471|450341964|FG002|Overall Study|Requirement for restricted medication|0|||
125196793|NCT00956592|450341968|FG000|Overall Study|Protocol Violation|1|||
125196794|NCT00956592|450341969|FG001|Overall Study|Protocol Violation|3|||
125196795|NCT02028767|450341971|FG000|Treatment Period 2|Non compliant with protocol|1|||
125196796|NCT02028767|450341972|FG001|Treatment Period 2|Non compliant with protocol|0|||
125196797|NCT02028767|450341971|FG000|Treatment Period 2|Reason other than those specified above|1|||
125196798|NCT02028767|450341972|FG001|Treatment Period 2|Reason other than those specified above|0|||
125196799|NCT01942486|450341973|FG000|Overall Study|Lost to Follow-up|27|||
125196800|NCT03521115|450341974|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
125196801|NCT03521115|450341975|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
125196802|NCT03521115|450341974|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
125196803|NCT03521115|450341975|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
125196804|NCT01471340|450341976|FG000|Overall Study|Death|5|||
125196805|NCT01471340|450341977|FG001|Overall Study|Death|4|||
125196806|NCT01471340|450341976|FG000|Overall Study|Lost to Follow-up|0|||
125196807|NCT01471340|450341977|FG001|Overall Study|Lost to Follow-up|1|||
125196808|NCT01471340|450341976|FG000|Overall Study|Investigational site closure|0|||
125196809|NCT01471340|450341977|FG001|Overall Study|Investigational site closure|1|||
125196810|NCT01471340|450341976|FG000|Overall Study|Invalid informed consent|1|||
125196811|NCT01471340|450341977|FG001|Overall Study|Invalid informed consent|0|||
125196812|NCT00526669|450341978|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
125196813|NCT00526669|450341979|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
125196814|NCT00526669|450341978|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
125196815|NCT00526669|450341979|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
125196816|NCT00526669|450341978|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
125196817|NCT00526669|450341979|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
125196818|NCT00526669|450341978|FG000|Combined Treatment Phase|Death|0|||
125196819|NCT00526669|450341979|FG001|Combined Treatment Phase|Death|2|||
125196820|NCT03499899|450341981|FG000|Overall Study|Adverse Event|2|||
125196821|NCT03499899|450341982|FG001|Overall Study|Adverse Event|3|||
125196822|NCT03499899|450341983|FG002|Overall Study|Adverse Event|3|||
125196823|NCT03499899|450341981|FG000|Overall Study|Death|0|||
125196824|NCT03499899|450341982|FG001|Overall Study|Death|0|||
125196825|NCT03499899|450341983|FG002|Overall Study|Death|1|||
125196826|NCT03499899|450341981|FG000|Overall Study|Physician Decision|3|||
125196827|NCT03499899|450341982|FG001|Overall Study|Physician Decision|6|||
125196828|NCT03499899|450341983|FG002|Overall Study|Physician Decision|6|||
125196829|NCT03499899|450341981|FG000|Overall Study|Progressive disease|15|||
125196830|NCT03499899|450341982|FG001|Overall Study|Progressive disease|23|||
125196831|NCT03499899|450341983|FG002|Overall Study|Progressive disease|23|||
125249725|NCT01117350|450538294|FG000|Extension Period|Inclusion criteria not respected|0|||
125249726|NCT01117350|450538295|FG001|Extension Period|Inclusion criteria not respected|1|||
125196832|NCT03499899|450341981|FG000|Overall Study|Patient decision|0|||
125196833|NCT03499899|450341982|FG001|Overall Study|Patient decision|1|||
125249727|NCT01117350|450538294|FG000|Extension Period|Prohibited medication|0|||
125249728|NCT01117350|450538295|FG001|Extension Period|Prohibited medication|1|||
125249729|NCT00800384|450538297|FG000|Overall Study|Withdrawal by Subject|24|||
125249730|NCT00800384|450538298|FG001|Overall Study|Withdrawal by Subject|17|||
125249731|NCT00800384|450538297|FG000|Overall Study|Lost to Follow-up|17|||
125249732|NCT00800384|450538298|FG001|Overall Study|Lost to Follow-up|26|||
125196834|NCT03499899|450341983|FG002|Overall Study|Patient decision|1|||
125196835|NCT03499899|450341981|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
125196836|NCT03499899|450341982|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
125196837|NCT03499899|450341983|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
125196838|NCT01893281|450341984|FG000|Overall Study|Adverse Event|1|||
125196839|NCT01893281|450341984|FG000|Overall Study|Protocol Violation|1|||
125196840|NCT01893281|450341984|FG000|Overall Study|Withdrawal by Subject|1|||
125196841|NCT04016779|450341991|FG000|Overall Study|Adverse Event|9|||
125196842|NCT04016779|450341992|FG001|Overall Study|Adverse Event|17|||
125196843|NCT04016779|450341991|FG000|Overall Study|Lack of Efficacy|4|||
125196844|NCT04016779|450341992|FG001|Overall Study|Lack of Efficacy|1|||
125196845|NCT04016779|450341991|FG000|Overall Study|Lost to Follow-up|5|||
125196846|NCT04016779|450341992|FG001|Overall Study|Lost to Follow-up|14|||
125196847|NCT04016779|450341991|FG000|Overall Study|Physician Decision|1|||
125196848|NCT04016779|450341992|FG001|Overall Study|Physician Decision|3|||
125249733|NCT01027754|450539585|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
125249734|NCT01027754|450539586|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
125249735|NCT01027754|450539585|FG000|Overall Study|Withdrawal by Subject|0|||
125249736|NCT01027754|450539586|FG001|Overall Study|Withdrawal by Subject|5|||
125249737|NCT00326495|450539587|FG000|Overall Study|Switched to alternative treatment|1|||
125249738|NCT00326495|450539587|FG000|Overall Study|Disease progression before treatment|1|||
125249739|NCT00326495|450539587|FG000|Overall Study|Refused further treatment|2|||
125249740|NCT00326495|450539587|FG000|Overall Study|Subject off study before assessment|1|||
125249741|NCT03280615|450539589|FG000|Overall Study|Lost to Follow-up|1|||
125249742|NCT03280615|450539590|FG001|Overall Study|Lost to Follow-up|2|||
125249743|NCT03280615|450539589|FG000|Overall Study|Adverse Event|1|||
125249744|NCT03280615|450539590|FG001|Overall Study|Adverse Event|1|||
125249745|NCT03280615|450539589|FG000|Overall Study|Withdrawal by Subject|2|||
125249746|NCT03280615|450539590|FG001|Overall Study|Withdrawal by Subject|2|||
125249747|NCT00432991|450539593|FG000|Overall Study|Protocol Violation|7|||
125249748|NCT00432991|450539594|FG001|Overall Study|Protocol Violation|12|||
125249749|NCT01755156|450539595|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
125249750|NCT01755156|450539596|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
125249751|NCT01755156|450539595|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
125249752|NCT01755156|450539596|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
125249753|NCT01755156|450539595|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
125249754|NCT01755156|450539596|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
125249755|NCT01755156|450539595|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
125249756|NCT01755156|450539596|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
125249757|NCT01755156|450539595|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
125249758|NCT01755156|450539596|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
125249759|NCT01755156|450539595|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
125249760|NCT01755156|450539596|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
125249761|NCT01755156|450539595|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
125249762|NCT01755156|450539596|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
125249763|NCT01755156|450539595|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
125249764|NCT01755156|450539596|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
125249765|NCT01755156|450539595|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
125249766|NCT01755156|450539596|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
125249767|NCT01755156|450539595|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
125249768|NCT01755156|450539596|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
125249769|NCT01755156|450539595|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
125249770|NCT01755156|450539596|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
125249771|NCT00090402|450539597|FG000|Overall Study|Death|1|||
125249772|NCT00090402|450539598|FG001|Overall Study|Death|1|||
125249773|NCT00090402|450539599|FG002|Overall Study|Death|0|||
125249774|NCT00090402|450539597|FG000|Overall Study|subject moved|0|||
125249775|NCT00090402|450539598|FG001|Overall Study|subject moved|1|||
125249776|NCT00090402|450539599|FG002|Overall Study|subject moved|0|||
125196849|NCT04016779|450341991|FG000|Overall Study|Withdrawal by Subject|6|||
125196850|NCT04016779|450341992|FG001|Overall Study|Withdrawal by Subject|8|||
125196851|NCT04016779|450341991|FG000|Overall Study|Non-compliance with Study Drug|2|||
125196852|NCT04016779|450341992|FG001|Overall Study|Non-compliance with Study Drug|3|||
125196853|NCT04016779|450341991|FG000|Overall Study|Other, Multiple categories|17|||
125196854|NCT04016779|450341992|FG001|Overall Study|Other, Multiple categories|17|||
125196855|NCT02295020|450341996|FG000|Overall Study|Adverse Event|0|||
125196856|NCT02295020|450341997|FG001|Overall Study|Adverse Event|1|||
125196857|NCT02295020|450341996|FG000|Overall Study|Withdrawal by Subject|3|||
125196858|NCT02295020|450341997|FG001|Overall Study|Withdrawal by Subject|2|||
125196859|NCT00355147|450342000|FG000|Overall Study|Lost to Follow-up|10|||
125196860|NCT00355147|450342001|FG001|Overall Study|Lost to Follow-up|8|||
125196861|NCT00355147|450342000|FG000|Overall Study|Withdrawal by Subject|8|||
125196862|NCT00355147|450342001|FG001|Overall Study|Withdrawal by Subject|12|||
125196863|NCT02828124|450342002|FG000|Overall Study|Disease Progression|1|||
125196864|NCT02828124|450342003|FG001|Overall Study|Disease Progression|2|||
125196865|NCT02828124|450342004|FG002|Overall Study|Disease Progression|1|||
125196866|NCT02828124|450342005|FG003|Overall Study|Disease Progression|4|||
125196867|NCT02828124|450342002|FG000|Overall Study|AE Unrelated to Study Drug|0|||
125196868|NCT02828124|450342003|FG001|Overall Study|AE Unrelated to Study Drug|0|||
125196869|NCT02828124|450342004|FG002|Overall Study|AE Unrelated to Study Drug|0|||
125196870|NCT02828124|450342005|FG003|Overall Study|AE Unrelated to Study Drug|1|||
125196871|NCT02828124|450342002|FG000|Overall Study|Subject Withdrew Consent|0|||
125196872|NCT02828124|450342003|FG001|Overall Study|Subject Withdrew Consent|0|||
125196873|NCT02828124|450342004|FG002|Overall Study|Subject Withdrew Consent|0|||
125249777|NCT00090402|450539597|FG000|Overall Study|stopped taking study medication|1|||
125249778|NCT00090402|450539598|FG001|Overall Study|stopped taking study medication|0|||
125249779|NCT00090402|450539599|FG002|Overall Study|stopped taking study medication|1|||
125249780|NCT03048019|450539603|FG000|Overall Study|Adverse Event|1|||
125249781|NCT03048019|450539604|FG001|Overall Study|Adverse Event|0|||
125249782|NCT02004275|450539605|FG000|Phase 1|Ineligible|0|||
125196874|NCT02828124|450342005|FG003|Overall Study|Subject Withdrew Consent|1|||
125249783|NCT02004275|450539606|FG001|Phase 1|Ineligible|0|||
125249784|NCT02004275|450539607|FG002|Phase 1|Ineligible|0|||
125249785|NCT02004275|450539608|FG003|Phase 1|Ineligible|1|||
125249786|NCT02004275|450539609|FG004|Phase 1|Ineligible|1|||
125249787|NCT02004275|450539610|FG005|Phase 1|Ineligible|0|||
125249788|NCT02004275|450539605|FG000|Phase 1|Protocol Violation|0|||
125249789|NCT02004275|450539606|FG001|Phase 1|Protocol Violation|0|||
125249790|NCT02004275|450539607|FG002|Phase 1|Protocol Violation|0|||
125249791|NCT02004275|450539608|FG003|Phase 1|Protocol Violation|1|||
125249792|NCT02004275|450539609|FG004|Phase 1|Protocol Violation|0|||
125249793|NCT02004275|450539610|FG005|Phase 1|Protocol Violation|5|||
125249794|NCT02004275|450539605|FG000|Phase 2 Part 1|Ineligible|6|||
125249795|NCT02004275|450539606|FG001|Phase 2 Part 1|Ineligible|9|||
125249796|NCT02004275|450539607|FG002|Phase 2 Part 1|Ineligible|0|||
125249797|NCT02004275|450539608|FG003|Phase 2 Part 1|Ineligible|0|||
125249798|NCT02004275|450539609|FG004|Phase 2 Part 1|Ineligible|0|||
125249799|NCT02004275|450539610|FG005|Phase 2 Part 1|Ineligible|0|||
125249800|NCT02004275|450539605|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
125249801|NCT02004275|450539606|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
125249802|NCT02004275|450539607|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
125249803|NCT02004275|450539608|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
125249804|NCT02004275|450539609|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
125249805|NCT02004275|450539610|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
125249806|NCT00292370|450539611|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
125249807|NCT00292370|450539612|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
125249808|NCT00292370|450539613|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
125249809|NCT00292370|450539611|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
125249810|NCT00292370|450539612|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
125249811|NCT00292370|450539613|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
125249812|NCT00292370|450539611|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
125249813|NCT00292370|450539612|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
125249814|NCT00292370|450539613|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
125249815|NCT00292370|450539611|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
125249816|NCT00292370|450539612|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
125249817|NCT00292370|450539613|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
125249818|NCT00292370|450539611|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
125249819|NCT00292370|450539612|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
125249820|NCT00292370|450539613|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
125249821|NCT00292370|450539611|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
125249822|NCT00292370|450539612|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
125249823|NCT00292370|450539613|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
125249824|NCT01716559|450539614|FG000|Overall Study|Adverse Event|11|||
125249825|NCT01716559|450539614|FG000|Overall Study|Death|21|||
125249826|NCT01716559|450539614|FG000|Overall Study|Withdrawal by Subject|4|||
125249827|NCT01716559|450539614|FG000|Overall Study|Other withdrawal reason|75|||
125249828|NCT04821245|450539616|FG000|Overall Study|Withdrawal by Subject|3|||
125249829|NCT04821245|450539616|FG000|Overall Study|Physician Decision|1|||
125249830|NCT04821245|450539616|FG000|Overall Study|Protocol Violation|5|||
125249831|NCT01133977|450539619|FG000|Overall Study|Adverse Event|0|||
125249832|NCT01133977|450539620|FG001|Overall Study|Adverse Event|0|||
125249833|NCT01133977|450539621|FG002|Overall Study|Adverse Event|1|||
125249834|NCT01133977|450539622|FG003|Overall Study|Adverse Event|0|||
125249835|NCT01133977|450539623|FG004|Overall Study|Adverse Event|0|||
125249836|NCT01133977|450539619|FG000|Overall Study|Death|1|||
125249837|NCT01133977|450539620|FG001|Overall Study|Death|1|||
125249838|NCT01133977|450539621|FG002|Overall Study|Death|1|||
125249839|NCT01133977|450539622|FG003|Overall Study|Death|7|||
125249840|NCT01133977|450539623|FG004|Overall Study|Death|3|||
125249841|NCT01133977|450539619|FG000|Overall Study|Started a New Line of Therapy|2|||
125249842|NCT01133977|450539620|FG001|Overall Study|Started a New Line of Therapy|6|||
125249843|NCT01133977|450539621|FG002|Overall Study|Started a New Line of Therapy|4|||
125249844|NCT01133977|450539622|FG003|Overall Study|Started a New Line of Therapy|25|||
125249845|NCT01133977|450539623|FG004|Overall Study|Started a New Line of Therapy|33|||
125249846|NCT01133977|450539619|FG000|Overall Study|Lost to Follow-up|0|||
125249847|NCT01133977|450539620|FG001|Overall Study|Lost to Follow-up|0|||
125249848|NCT01133977|450539621|FG002|Overall Study|Lost to Follow-up|0|||
125249849|NCT01133977|450539622|FG003|Overall Study|Lost to Follow-up|2|||
125249850|NCT01133977|450539623|FG004|Overall Study|Lost to Follow-up|1|||
125249851|NCT01133977|450539619|FG000|Overall Study|Withdrawal by Subject|0|||
125249852|NCT01133977|450539620|FG001|Overall Study|Withdrawal by Subject|0|||
125249853|NCT01133977|450539621|FG002|Overall Study|Withdrawal by Subject|0|||
125249854|NCT01133977|450539622|FG003|Overall Study|Withdrawal by Subject|5|||
125249855|NCT01133977|450539623|FG004|Overall Study|Withdrawal by Subject|1|||
125249856|NCT00662038|450539624|FG000|Overall Study|Reason not specified|3|||
125249857|NCT00662038|450539624|FG000|Overall Study|Withdrawn consent|22|||
125249858|NCT00662038|450539624|FG000|Overall Study|Withdrawal by Subject|83|||
125249859|NCT00662038|450539624|FG000|Overall Study|Sponsor decision|1|||
125249860|NCT00662038|450539624|FG000|Overall Study|Physician Decision|19|||
125249861|NCT00662038|450539624|FG000|Overall Study|Lung transplantation|44|||
125249862|NCT00662038|450539624|FG000|Overall Study|Lost to Follow-up|1|||
125249863|NCT00662038|450539624|FG000|Overall Study|Death|95|||
125249864|NCT00662038|450539624|FG000|Overall Study|Adverse Event|358|||
125249865|NCT00662038|450539624|FG000|Overall Study|Continued treatment|5|||
125249866|NCT00397046|450539629|FG000|Overall Study|Disease Progression|3|||
125249867|NCT00397046|450539630|FG001|Overall Study|Disease Progression|3|||
125249868|NCT00397046|450539631|FG002|Overall Study|Disease Progression|10|||
125249869|NCT00397046|450539632|FG003|Overall Study|Disease Progression|5|||
125249870|NCT04189588|450539637|FG000|Overall Study|Death|0|||
125249871|NCT04189588|450539638|FG001|Overall Study|Death|1|||
125249872|NCT04189588|450539637|FG000|Overall Study|Lost to Follow-up|0|||
125249873|NCT04189588|450539638|FG001|Overall Study|Lost to Follow-up|1|||
125249874|NCT00576407|450539639|FG000|Overall Study|Death|7|||
125249875|NCT00576407|450539639|FG000|Overall Study|Physician Decision|1|||
125249876|NCT00621322|450539640|FG000|Overall Study|Lost to Follow-up|0|||
125249877|NCT00621322|450539641|FG001|Overall Study|Lost to Follow-up|0|||
125249878|NCT00621322|450539642|FG002|Overall Study|Lost to Follow-up|0|||
125249879|NCT00621322|450539643|FG003|Overall Study|Lost to Follow-up|0|||
125249880|NCT00621322|450539644|FG004|Overall Study|Lost to Follow-up|1|||
125249881|NCT00621322|450539645|FG005|Overall Study|Lost to Follow-up|0|||
125249882|NCT00621322|450539640|FG000|Overall Study|Physician Decision|0|||
125249883|NCT00621322|450539641|FG001|Overall Study|Physician Decision|0|||
125249884|NCT00621322|450539642|FG002|Overall Study|Physician Decision|1|||
125249885|NCT00621322|450539643|FG003|Overall Study|Physician Decision|1|||
125249886|NCT00621322|450539644|FG004|Overall Study|Physician Decision|0|||
125249887|NCT00621322|450539645|FG005|Overall Study|Physician Decision|0|||
125249888|NCT00621322|450539640|FG000|Overall Study|Withdrawal by Subject|0|||
125249889|NCT00621322|450539641|FG001|Overall Study|Withdrawal by Subject|0|||
125249890|NCT00621322|450539642|FG002|Overall Study|Withdrawal by Subject|0|||
125249891|NCT00621322|450539643|FG003|Overall Study|Withdrawal by Subject|1|||
125249892|NCT00621322|450539644|FG004|Overall Study|Withdrawal by Subject|0|||
125249893|NCT00621322|450539645|FG005|Overall Study|Withdrawal by Subject|2|||
125249894|NCT00621322|450539640|FG000|Overall Study|Migrated/moved from study area|1|||
125249895|NCT00621322|450539641|FG001|Overall Study|Migrated/moved from study area|0|||
125249896|NCT00621322|450539642|FG002|Overall Study|Migrated/moved from study area|1|||
125249897|NCT00621322|450539643|FG003|Overall Study|Migrated/moved from study area|1|||
125249898|NCT00621322|450539644|FG004|Overall Study|Migrated/moved from study area|0|||
125249899|NCT00621322|450539645|FG005|Overall Study|Migrated/moved from study area|2|||
125249900|NCT00756444|450539646|FG000|Overall Study|Adverse Event|1|||
125249901|NCT00756444|450539647|FG001|Overall Study|Adverse Event|1|||
125249902|NCT00756444|450539646|FG000|Overall Study|Withdrawal by Subject|6|||
125249903|NCT00756444|450539647|FG001|Overall Study|Withdrawal by Subject|8|||
125249904|NCT00756444|450539646|FG000|Overall Study|Lost to Follow-up|0|||
125249905|NCT00756444|450539647|FG001|Overall Study|Lost to Follow-up|1|||
125249906|NCT00756444|450539646|FG000|Overall Study|Death|5|||
125249907|NCT00756444|450539647|FG001|Overall Study|Death|4|||
125249908|NCT00756444|450539646|FG000|Overall Study|Disease Progression|2|||
125249909|NCT00756444|450539647|FG001|Overall Study|Disease Progression|7|||
125249910|NCT00756444|450539646|FG000|Overall Study|Ineligibility Determined|1|||
125249911|NCT00756444|450539647|FG001|Overall Study|Ineligibility Determined|0|||
125249912|NCT01655069|450539651|FG000|Overall Study|Physician Decision|0|||
125249913|NCT01655069|450539652|FG001|Overall Study|Physician Decision|0|||
125249914|NCT01655069|450539653|FG002|Overall Study|Physician Decision|0|||
125249915|NCT01655069|450539654|FG003|Overall Study|Physician Decision|1|||
125249916|NCT01655069|450539651|FG000|Overall Study|Adverse Event|6|||
125249917|NCT01655069|450539652|FG001|Overall Study|Adverse Event|7|||
125249918|NCT01655069|450539653|FG002|Overall Study|Adverse Event|2|||
125249919|NCT01655069|450539654|FG003|Overall Study|Adverse Event|3|||
125249920|NCT01655069|450539651|FG000|Overall Study|Lack of Efficacy|0|||
125249921|NCT01655069|450539652|FG001|Overall Study|Lack of Efficacy|1|||
125249922|NCT01655069|450539653|FG002|Overall Study|Lack of Efficacy|0|||
125249923|NCT01655069|450539654|FG003|Overall Study|Lack of Efficacy|0|||
125249924|NCT01655069|450539651|FG000|Overall Study|No Treatment Needed|0|||
125249925|NCT01655069|450539652|FG001|Overall Study|No Treatment Needed|1|||
125249926|NCT01655069|450539653|FG002|Overall Study|No Treatment Needed|0|||
125249927|NCT01655069|450539654|FG003|Overall Study|No Treatment Needed|0|||
125249928|NCT01655069|450539651|FG000|Overall Study|Withdrawal by Subject|2|||
125249929|NCT01655069|450539652|FG001|Overall Study|Withdrawal by Subject|3|||
125249930|NCT01655069|450539653|FG002|Overall Study|Withdrawal by Subject|0|||
125249931|NCT01655069|450539654|FG003|Overall Study|Withdrawal by Subject|0|||
125249932|NCT06399471|450539655|FG000|Overall Study|Withdrawal by Subject|1|||
125249933|NCT04034056|450539656|FG000|Overall Study|Withdrawal by Subject|2|||
125249934|NCT04034056|450539656|FG000|Overall Study|Reason Not Specified|13|||
125249935|NCT04034056|450539656|FG000|Overall Study|Adverse Event|56|||
125196875|NCT06586788|450342008|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
125196876|NCT03514485|450342009|FG000|Overall Study|Lost to Follow-up|5|||
125196877|NCT03514485|450342010|FG001|Overall Study|Lost to Follow-up|3|||
125196878|NCT03514485|450342011|FG002|Overall Study|Lost to Follow-up|2|||
125196879|NCT03514485|450342012|FG003|Overall Study|Lost to Follow-up|0|||
125196880|NCT03514485|450342013|FG004|Overall Study|Lost to Follow-up|1|||
125196881|NCT03514485|450342014|FG005|Overall Study|Lost to Follow-up|4|||
125196882|NCT03514485|450342009|FG000|Overall Study|Withdrawal by Subject|0|||
125196883|NCT03514485|450342010|FG001|Overall Study|Withdrawal by Subject|1|||
125196884|NCT03514485|450342011|FG002|Overall Study|Withdrawal by Subject|3|||
125196885|NCT03514485|450342012|FG003|Overall Study|Withdrawal by Subject|1|||
125196886|NCT03514485|450342013|FG004|Overall Study|Withdrawal by Subject|2|||
125196887|NCT03514485|450342014|FG005|Overall Study|Withdrawal by Subject|1|||
125196888|NCT00791661|450342015|FG000|7 Day Wash-out|Adverse Event|0|||
125196889|NCT00791661|450342016|FG001|7 Day Wash-out|Adverse Event|0|||
125196890|NCT00791661|450342017|FG002|7 Day Wash-out|Adverse Event|1|||
125196891|NCT00791661|450342015|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
125196892|NCT00791661|450342016|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
125196893|NCT00791661|450342017|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
125196894|NCT00492648|450342018|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
125196895|NCT00492648|450342019|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
125196896|NCT00595517|450342022|FG000|Overall Study|Adverse Event|6|||
125196897|NCT00595517|450342022|FG000|Overall Study|Withdrawal by Subject|4|||
125196898|NCT00595517|450342022|FG000|Overall Study|Protocol Violation|2|||
125196899|NCT00595517|450342022|FG000|Overall Study|Recurrence of ulcer|5|||
125196900|NCT00595517|450342022|FG000|Overall Study|usage of prohibited treatment|1|||
125196901|NCT00595517|450342022|FG000|Overall Study|No intention to attend regularly|1|||
125196902|NCT04105218|450342028|FG000|Overall Study|Withdrawal by Subject|3|||
125196903|NCT04105218|450342029|FG001|Overall Study|Withdrawal by Subject|2|||
125196904|NCT04105218|450342028|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
125196905|NCT04105218|450342029|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
125196906|NCT04105218|450342028|FG000|Overall Study|Failed screening tests|2|||
125196907|NCT04105218|450342029|FG001|Overall Study|Failed screening tests|1|||
125196908|NCT01167881|450342032|FG000|Overall Study|Adverse Event|47|||
125196909|NCT01167881|450342033|FG001|Overall Study|Adverse Event|51|||
125196910|NCT01167881|450342032|FG000|Overall Study|Lack of Efficacy|4|||
125196911|NCT01167881|450342033|FG001|Overall Study|Lack of Efficacy|7|||
125196912|NCT01167881|450342032|FG000|Overall Study|Non compliant with protocol|9|||
125196913|NCT01167881|450342033|FG001|Overall Study|Non compliant with protocol|18|||
125196914|NCT01167881|450342032|FG000|Overall Study|Lost to Follow-up|19|||
125196915|NCT01167881|450342033|FG001|Overall Study|Lost to Follow-up|20|||
125196916|NCT01167881|450342032|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
125196917|NCT01167881|450342033|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
125196918|NCT01167881|450342032|FG000|Overall Study|Not treated|4|||
125196919|NCT01167881|450342033|FG001|Overall Study|Not treated|0|||
125196920|NCT01167881|450342032|FG000|Overall Study|Other not defined above|31|||
125196921|NCT01167881|450342033|FG001|Overall Study|Other not defined above|55|||
125196922|NCT01435460|450342034|FG000|Overall Study|Adverse Event|2|||
125196923|NCT01435460|450342035|FG001|Overall Study|Adverse Event|1|||
125196924|NCT01435460|450342034|FG000|Overall Study|Lost to Follow-up|6|||
125196925|NCT01435460|450342035|FG001|Overall Study|Lost to Follow-up|1|||
125196926|NCT01435460|450342034|FG000|Overall Study|Withdrawal by Subject|1|||
125196927|NCT01435460|450342035|FG001|Overall Study|Withdrawal by Subject|3|||
125196928|NCT01435460|450342034|FG000|Overall Study|Protocol Violation|0|||
125196929|NCT01435460|450342035|FG001|Overall Study|Protocol Violation|1|||
125196930|NCT01435460|450342034|FG000|Overall Study|Did not meet eligibility criteria|2|||
125196931|NCT01435460|450342035|FG001|Overall Study|Did not meet eligibility criteria|0|||
125196932|NCT01706939|450342036|FG000|Pre Randomization|Screen Failure|1|||
125196933|NCT01706939|450342037|FG001|Pre Randomization|Screen Failure|0|||
125196934|NCT01706939|450342038|FG002|Pre Randomization|Screen Failure|0|||
125249936|NCT03225989|450539657|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
125196935|NCT01706939|450342036|FG000|Pre Randomization|Ineligible for Randomization|1|||
125196936|NCT01706939|450342037|FG001|Pre Randomization|Ineligible for Randomization|0|||
125196937|NCT01706939|450342038|FG002|Pre Randomization|Ineligible for Randomization|0|||
125196938|NCT01706939|450342036|FG000|Pre Randomization|Withdrawal by Subject|1|||
125196939|NCT01706939|450342037|FG001|Pre Randomization|Withdrawal by Subject|0|||
125196940|NCT01706939|450342038|FG002|Pre Randomization|Withdrawal by Subject|0|||
125196941|NCT01706939|450342036|FG000|Randomization|Insufficient QoL survey compliance|0|||
125196942|NCT01706939|450342037|FG001|Randomization|Insufficient QoL survey compliance|1|||
125196943|NCT01706939|450342038|FG002|Randomization|Insufficient QoL survey compliance|1|||
125249937|NCT03225989|450539658|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
125249938|NCT03225989|450539659|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
125249939|NCT03225989|450539657|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
125249940|NCT03225989|450539658|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
125249941|NCT03225989|450539659|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
125249942|NCT03225989|450539657|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
125249943|NCT03225989|450539658|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
125249944|NCT03225989|450539659|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
125249945|NCT03225989|450539657|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
125249946|NCT03225989|450539658|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
125249947|NCT03225989|450539659|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
125249948|NCT03225989|450539657|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
125249949|NCT03225989|450539658|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
125249950|NCT03225989|450539659|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
125196944|NCT01706939|450342036|FG000|Randomization|Progression of disease|0|||
125196945|NCT01706939|450342037|FG001|Randomization|Progression of disease|2|||
125249951|NCT03225989|450539657|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
125249952|NCT03225989|450539658|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
125249953|NCT03225989|450539659|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
125249954|NCT03225989|450539657|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
125249955|NCT03225989|450539658|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
125249956|NCT03225989|450539659|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
125249957|NCT03225989|450539657|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
125249958|NCT03225989|450539658|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
125249959|NCT03225989|450539659|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
125249960|NCT03225989|450539657|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
125249961|NCT03225989|450539658|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
125249962|NCT03225989|450539659|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
125249963|NCT03225989|450539657|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
125249964|NCT03225989|450539658|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
125249965|NCT03225989|450539659|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
125249966|NCT03225989|450539657|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
125249967|NCT03225989|450539658|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
125249968|NCT03225989|450539659|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
125249969|NCT03225989|450539657|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
125249970|NCT03225989|450539658|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
125249971|NCT03225989|450539659|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
125249972|NCT00601107|450539660|FG000|Overall Study|Adverse Event|0|||
125249973|NCT00601107|450539661|FG001|Overall Study|Adverse Event|1|||
125249974|NCT00601107|450539662|FG002|Overall Study|Adverse Event|3|||
125249975|NCT00601107|450539663|FG003|Overall Study|Adverse Event|0|||
125249976|NCT00601107|450539660|FG000|Overall Study|Withdrawal by Subject|5|||
125249977|NCT00601107|450539661|FG001|Overall Study|Withdrawal by Subject|4|||
125249978|NCT00601107|450539662|FG002|Overall Study|Withdrawal by Subject|7|||
125249979|NCT00601107|450539663|FG003|Overall Study|Withdrawal by Subject|4|||
125249980|NCT00601107|450539660|FG000|Overall Study|Lost to Follow-up|3|||
125249981|NCT00601107|450539661|FG001|Overall Study|Lost to Follow-up|3|||
125249982|NCT00601107|450539662|FG002|Overall Study|Lost to Follow-up|0|||
125249983|NCT00601107|450539663|FG003|Overall Study|Lost to Follow-up|3|||
125249984|NCT00601107|450539660|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
125249985|NCT00601107|450539661|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
125249986|NCT00601107|450539662|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
125249987|NCT00601107|450539663|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
125249988|NCT00601107|450539660|FG000|Overall Study|Worsening of Psoriasis|4|||
125249989|NCT00601107|450539661|FG001|Overall Study|Worsening of Psoriasis|1|||
125196946|NCT01706939|450342038|FG002|Randomization|Progression of disease|1|||
125196947|NCT01894100|450342047|FG000|Overall Study|Lost to Follow-up|0|||
125196948|NCT01894100|450342048|FG001|Overall Study|Lost to Follow-up|1|||
125196949|NCT01894100|450342047|FG000|Overall Study|Withdrawal by Subject|3|||
125196950|NCT01894100|450342048|FG001|Overall Study|Withdrawal by Subject|0|||
125196951|NCT02235077|450342053|FG000|Overall Study|Death|5|||
125196952|NCT02235077|450342054|FG001|Overall Study|Death|7|||
125196953|NCT02235077|450342053|FG000|Overall Study|Lost to Follow-up|5|||
125196954|NCT02235077|450342054|FG001|Overall Study|Lost to Follow-up|6|||
125196955|NCT02235077|450342053|FG000|Overall Study|Withdrawal by Subject|8|||
125196956|NCT02235077|450342054|FG001|Overall Study|Withdrawal by Subject|5|||
125196957|NCT02235077|450342053|FG000|Overall Study|Physician Decision|0|||
125196958|NCT02235077|450342054|FG001|Overall Study|Physician Decision|1|||
125196959|NCT04013672|450342055|FG000|Overall Study|Withdrawal by Subject|3|||
125196960|NCT04013672|450342056|FG001|Overall Study|Withdrawal by Subject|0|||
125196961|NCT04013672|450342055|FG000|Overall Study|Death|1|||
125196962|NCT04013672|450342056|FG001|Overall Study|Death|0|||
125196963|NCT04013672|450342055|FG000|Overall Study|Physician Decision|5|||
125196964|NCT04013672|450342056|FG001|Overall Study|Physician Decision|0|||
125196965|NCT00586820|450342057|FG000|Overall Study|Unsuccessful PCI|1|||
125196966|NCT00586820|450342058|FG001|Overall Study|Unsuccessful PCI|0|||
125196967|NCT00101166|450342061|FG000|Overall Study|progressive disease|10|||
125196968|NCT01868022|450342062|FG000|Overall Study|Withdrawal by Subject|0|||
125196969|NCT01868022|450342063|FG001|Overall Study|Withdrawal by Subject|0|||
125196970|NCT01868022|450342064|FG002|Overall Study|Withdrawal by Subject|1|||
125196971|NCT01868022|450342065|FG003|Overall Study|Withdrawal by Subject|1|||
125196972|NCT01868022|450342066|FG004|Overall Study|Withdrawal by Subject|0|||
125196973|NCT01868022|450342067|FG005|Overall Study|Withdrawal by Subject|0|||
125196974|NCT01868022|450342068|FG006|Overall Study|Withdrawal by Subject|0|||
125196975|NCT01868022|450342069|FG007|Overall Study|Withdrawal by Subject|1|||
125196976|NCT01868022|450342070|FG008|Overall Study|Withdrawal by Subject|0|||
125196977|NCT01868022|450342062|FG000|Overall Study|Adverse Event|0|||
125196978|NCT01868022|450342063|FG001|Overall Study|Adverse Event|0|||
125196979|NCT01868022|450342064|FG002|Overall Study|Adverse Event|0|||
125196980|NCT01868022|450342065|FG003|Overall Study|Adverse Event|0|||
125196981|NCT01868022|450342066|FG004|Overall Study|Adverse Event|2|||
125196982|NCT01868022|450342067|FG005|Overall Study|Adverse Event|0|||
125196983|NCT01868022|450342068|FG006|Overall Study|Adverse Event|0|||
125196984|NCT01868022|450342069|FG007|Overall Study|Adverse Event|2|||
125196985|NCT01868022|450342070|FG008|Overall Study|Adverse Event|2|||
125196986|NCT01868022|450342062|FG000|Overall Study|Physician Decision|0|||
125196987|NCT01868022|450342063|FG001|Overall Study|Physician Decision|0|||
125196988|NCT01868022|450342064|FG002|Overall Study|Physician Decision|0|||
125196989|NCT01868022|450342065|FG003|Overall Study|Physician Decision|0|||
125196990|NCT01868022|450342066|FG004|Overall Study|Physician Decision|0|||
125196991|NCT01868022|450342067|FG005|Overall Study|Physician Decision|1|||
125196992|NCT01868022|450342068|FG006|Overall Study|Physician Decision|0|||
125196993|NCT01868022|450342069|FG007|Overall Study|Physician Decision|2|||
125196994|NCT01868022|450342070|FG008|Overall Study|Physician Decision|0|||
125196995|NCT01868022|450342062|FG000|Overall Study|Study closed/terminated|0|||
125196996|NCT01868022|450342063|FG001|Overall Study|Study closed/terminated|0|||
125196997|NCT01868022|450342064|FG002|Overall Study|Study closed/terminated|0|||
125196998|NCT01868022|450342065|FG003|Overall Study|Study closed/terminated|0|||
125196999|NCT01868022|450342066|FG004|Overall Study|Study closed/terminated|0|||
125197000|NCT01868022|450342067|FG005|Overall Study|Study closed/terminated|0|||
125197001|NCT01868022|450342068|FG006|Overall Study|Study closed/terminated|0|||
125197002|NCT01868022|450342069|FG007|Overall Study|Study closed/terminated|1|||
125197003|NCT01868022|450342070|FG008|Overall Study|Study closed/terminated|0|||
125197004|NCT01868022|450342062|FG000|Overall Study|Ongoing|0|||
125197005|NCT01868022|450342063|FG001|Overall Study|Ongoing|0|||
125197006|NCT01868022|450342064|FG002|Overall Study|Ongoing|0|||
125197007|NCT01868022|450342065|FG003|Overall Study|Ongoing|0|||
125197008|NCT01868022|450342066|FG004|Overall Study|Ongoing|0|||
125197009|NCT01868022|450342067|FG005|Overall Study|Ongoing|0|||
125249990|NCT00601107|450539662|FG002|Overall Study|Worsening of Psoriasis|1|||
125249991|NCT00601107|450539663|FG003|Overall Study|Worsening of Psoriasis|4|||
125249992|NCT00601107|450539660|FG000|Overall Study|Undefined|1|||
125249993|NCT00601107|450539661|FG001|Overall Study|Undefined|0|||
125249994|NCT00601107|450539662|FG002|Overall Study|Undefined|1|||
125249995|NCT00601107|450539663|FG003|Overall Study|Undefined|0|||
125249996|NCT03722030|450539665|FG000|Overall Study|Withdrawal by Subject|1|||
125249997|NCT03722030|450539666|FG001|Overall Study|Withdrawal by Subject|0|||
125249998|NCT00147537|450539667|FG000|Phase 1b|Death|0|||
125249999|NCT00147537|450539668|FG001|Phase 1b|Death|1|||
125250000|NCT00147537|450539669|FG002|Phase 1b|Death|2|||
125250001|NCT00147537|450539670|FG003|Phase 1b|Death|1|||
125250002|NCT00147537|450539671|FG004|Phase 1b|Death|2|||
125250003|NCT00147537|450539672|FG005|Phase 1b|Death|2|||
125250004|NCT00147537|450539673|FG006|Phase 1b|Death|1|||
125197010|NCT01868022|450342068|FG006|Overall Study|Ongoing|0|||
125197011|NCT01868022|450342069|FG007|Overall Study|Ongoing|3|||
125197012|NCT01868022|450342070|FG008|Overall Study|Ongoing|0|||
125197013|NCT00686829|450342071|FG000|Overall Study|Adverse Event|5|||
125197014|NCT00686829|450342071|FG000|Overall Study|Lack of Efficacy|6|||
125197015|NCT00686829|450342071|FG000|Overall Study|Lost to Follow-up|4|||
125250005|NCT00147537|450539674|FG007|Phase 1b|Death|3|||
125250006|NCT00147537|450539675|FG008|Phase 1b|Death|9|||
125250007|NCT00147537|450539676|FG009|Phase 1b|Death|0|||
125250008|NCT00147537|450539677|FG010|Phase 1b|Death|0|||
125197016|NCT00686829|450342071|FG000|Overall Study|Withdrawal by Subject|14|||
125250009|NCT00147537|450539667|FG000|Phase 1b|Lost to Follow-up|2|||
125250010|NCT00147537|450539668|FG001|Phase 1b|Lost to Follow-up|1|||
125250011|NCT00147537|450539669|FG002|Phase 1b|Lost to Follow-up|0|||
125197017|NCT00686829|450342071|FG000|Overall Study|Protocol Violation|3|||
125197018|NCT00686829|450342071|FG000|Overall Study|Sponsor discontinued VCV|47|||
125197019|NCT01217476|450342074|FG000|Overall Study|Adverse Event|6|||
125197020|NCT01217476|450342075|FG001|Overall Study|Adverse Event|1|||
125197021|NCT01217476|450342074|FG000|Overall Study|Physician Decision|0|||
125197022|NCT01217476|450342075|FG001|Overall Study|Physician Decision|1|||
125197023|NCT01217476|450342074|FG000|Overall Study|Withdrawal by Subject|3|||
125197024|NCT01217476|450342075|FG001|Overall Study|Withdrawal by Subject|3|||
125197025|NCT01217476|450342074|FG000|Overall Study|Surgery on the Target Limb|0|||
125197026|NCT01217476|450342075|FG001|Overall Study|Surgery on the Target Limb|2|||
125197027|NCT01217476|450342074|FG000|Overall Study|Protocol Deviation|1|||
125197028|NCT01217476|450342075|FG001|Overall Study|Protocol Deviation|0|||
125197029|NCT01217476|450342074|FG000|Overall Study|Other|2|||
125197030|NCT01217476|450342075|FG001|Overall Study|Other|0|||
125197031|NCT01672710|450342076|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
125197032|NCT01672710|450342077|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
125197033|NCT01672710|450342076|FG000|3 Month Follow up|Lost to Follow-up|2|||
125197034|NCT01672710|450342077|FG001|3 Month Follow up|Lost to Follow-up|3|||
125197035|NCT01672710|450342076|FG000|3 Month Follow up|follow up due after termination date|4|||
125197036|NCT01672710|450342077|FG001|3 Month Follow up|follow up due after termination date|1|||
125197037|NCT02122887|450342078|FG000|Overall Study|Withdrawal by Subject|20|||
125197038|NCT02122887|450342079|FG001|Overall Study|Withdrawal by Subject|2|||
125197039|NCT03652636|450343854|FG000|Overall Study|Withdrawal by Subject|7|||
125197040|NCT00076752|450343858|FG000|Overall Study|Death|2|||
125197041|NCT00076752|450343858|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
125197042|NCT03728426|450343859|FG000|Overall Study|Death|3|||
125197043|NCT02048826|450343862|FG000|Overall Study|Withdrawal by Subject|1|||
125197044|NCT02048826|450343863|FG001|Overall Study|Withdrawal by Subject|0|||
125197045|NCT04470544|450343864|FG000|Overall Study|Withdrawal by Subject|4|||
125197046|NCT04470544|450343865|FG001|Overall Study|Withdrawal by Subject|6|||
125197047|NCT03436693|450343866|FG000|Overall Study|Adverse Event|22|||
125197048|NCT03436693|450343867|FG001|Overall Study|Adverse Event|10|||
125197049|NCT03436693|450343866|FG000|Overall Study|Physician Decision|3|||
125197050|NCT03436693|450343867|FG001|Overall Study|Physician Decision|3|||
125197051|NCT03436693|450343866|FG000|Overall Study|Withdrawal by Subject|4|||
125197052|NCT03436693|450343867|FG001|Overall Study|Withdrawal by Subject|13|||
125197053|NCT03436693|450343866|FG000|Overall Study|Progressive Disease|1|||
125197054|NCT03436693|450343867|FG001|Overall Study|Progressive Disease|1|||
125197055|NCT00654875|450343870|FG000|Overall Study|Adverse Event|5|||
125197056|NCT00654875|450343871|FG001|Overall Study|Adverse Event|5|||
125197057|NCT00654875|450343870|FG000|Overall Study|Withdrawal by Subject|4|||
125197058|NCT00654875|450343871|FG001|Overall Study|Withdrawal by Subject|4|||
125197059|NCT00654875|450343870|FG000|Overall Study|Protocol Violation|3|||
125197060|NCT00654875|450343871|FG001|Overall Study|Protocol Violation|3|||
125197061|NCT00654875|450343870|FG000|Overall Study|Lack of Efficacy|2|||
125197062|NCT00654875|450343871|FG001|Overall Study|Lack of Efficacy|2|||
125197063|NCT00654875|450343870|FG000|Overall Study|Lost to Follow-up|1|||
125197064|NCT00654875|450343871|FG001|Overall Study|Lost to Follow-up|3|||
125197065|NCT00654875|450343870|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
125197066|NCT00654875|450343871|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
125197067|NCT00654875|450343870|FG000|Overall Study|Administrative Problems|1|||
125197068|NCT00654875|450343871|FG001|Overall Study|Administrative Problems|0|||
125197069|NCT04967885|450343872|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
125197070|NCT04967885|450343873|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
125197071|NCT04967885|450343872|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
125197072|NCT04967885|450343873|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
125197073|NCT04967885|450343872|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
125197074|NCT04967885|450343873|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
125197075|NCT04967885|450343872|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
125197076|NCT04967885|450343873|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
125197077|NCT04967885|450343872|FG000|EMI-II Intervention|Lost to Follow-up|14|||
125197078|NCT04967885|450343873|FG001|EMI-II Intervention|Lost to Follow-up|10|||
125197079|NCT01011465|450343874|FG000|Overall Study|Withdrawal by Subject|2|||
125197080|NCT01011465|450343875|FG001|Overall Study|Withdrawal by Subject|1|||
125197081|NCT01011465|450343876|FG002|Overall Study|Withdrawal by Subject|0|||
125197082|NCT01011465|450343877|FG003|Overall Study|Withdrawal by Subject|0|||
125197083|NCT01011465|450343878|FG004|Overall Study|Withdrawal by Subject|1|||
125197084|NCT01011465|450343879|FG005|Overall Study|Withdrawal by Subject|0|||
125197085|NCT01011465|450343880|FG006|Overall Study|Withdrawal by Subject|1|||
125197086|NCT01011465|450343881|FG007|Overall Study|Withdrawal by Subject|0|||
125197087|NCT00723008|450343883|FG000|Enrollment|Lost to Follow-up|1|||
125197088|NCT00723008|450343884|FG001|Enrollment|Lost to Follow-up|0|||
125197089|NCT00723008|450343883|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
125197090|NCT00723008|450343884|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
125197091|NCT00723008|450343883|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
125197092|NCT00723008|450343884|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
125197093|NCT00723008|450343883|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
125197094|NCT00723008|450343884|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
125197095|NCT00723008|450343883|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
125197096|NCT00723008|450343884|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
125197097|NCT00723008|450343883|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
125197098|NCT00723008|450343884|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
125197099|NCT01014988|450343886|FG000|Overall Study|Adverse Event|20|||
125197100|NCT01014988|450343887|FG001|Overall Study|Adverse Event|0|||
125197101|NCT01014988|450343888|FG002|Overall Study|Adverse Event|1|||
125197102|NCT01014988|450343889|FG003|Overall Study|Adverse Event|0|||
125197103|NCT01014988|450343890|FG004|Overall Study|Adverse Event|1|||
125197104|NCT01014988|450343891|FG005|Overall Study|Adverse Event|3|||
125197105|NCT01014988|450343886|FG000|Overall Study|Lost to Follow-up|1|||
125197106|NCT01014988|450343887|FG001|Overall Study|Lost to Follow-up|0|||
125197107|NCT01014988|450343888|FG002|Overall Study|Lost to Follow-up|1|||
125197108|NCT01014988|450343889|FG003|Overall Study|Lost to Follow-up|0|||
125197109|NCT01014988|450343890|FG004|Overall Study|Lost to Follow-up|0|||
125197110|NCT01014988|450343891|FG005|Overall Study|Lost to Follow-up|0|||
125197111|NCT01014988|450343886|FG000|Overall Study|Physician Decision|1|||
125197112|NCT01014988|450343887|FG001|Overall Study|Physician Decision|0|||
125197113|NCT01014988|450343888|FG002|Overall Study|Physician Decision|0|||
125250012|NCT00147537|450539670|FG003|Phase 1b|Lost to Follow-up|0|||
125197114|NCT01014988|450343889|FG003|Overall Study|Physician Decision|0|||
125197115|NCT01014988|450343890|FG004|Overall Study|Physician Decision|0|||
125197116|NCT01014988|450343891|FG005|Overall Study|Physician Decision|0|||
125197117|NCT01014988|450343886|FG000|Overall Study|Withdrawal by Subject|1|||
125197118|NCT01014988|450343887|FG001|Overall Study|Withdrawal by Subject|0|||
125197119|NCT01014988|450343888|FG002|Overall Study|Withdrawal by Subject|0|||
125197120|NCT01014988|450343889|FG003|Overall Study|Withdrawal by Subject|0|||
125197121|NCT01014988|450343890|FG004|Overall Study|Withdrawal by Subject|0|||
125197122|NCT01014988|450343891|FG005|Overall Study|Withdrawal by Subject|0|||
125197123|NCT01683266|450343893|FG000|Overall Study|Adverse Event|5|||
125197124|NCT01683266|450343894|FG001|Overall Study|Adverse Event|4|||
125197125|NCT01683266|450343893|FG000|Overall Study|Lack of Efficacy|5|||
125197126|NCT01683266|450343894|FG001|Overall Study|Lack of Efficacy|2|||
125197127|NCT01683266|450343893|FG000|Overall Study|Protocol Violation|13|||
125197128|NCT01683266|450343894|FG001|Overall Study|Protocol Violation|6|||
125197129|NCT01683266|450343893|FG000|Overall Study|Personal Reason|17|||
125197130|NCT01683266|450343894|FG001|Overall Study|Personal Reason|25|||
125197131|NCT01683266|450343893|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
125197132|NCT01683266|450343894|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
125197133|NCT01683266|450343893|FG000|Overall Study|Lost to Follow-up|5|||
125197134|NCT01683266|450343894|FG001|Overall Study|Lost to Follow-up|0|||
125197135|NCT01683266|450343893|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
125197136|NCT01683266|450343894|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
125197137|NCT01683266|450343893|FG000|Overall Study|Nonserious Hypoglycemia|0|||
125197138|NCT01683266|450343894|FG001|Overall Study|Nonserious Hypoglycemia|3|||
125197139|NCT01683266|450343893|FG000|Overall Study|Perceived Lack of Efficacy|1|||
125197140|NCT01683266|450343894|FG001|Overall Study|Perceived Lack of Efficacy|1|||
125197141|NCT01683266|450343893|FG000|Overall Study|Possibly Hypoglycemia|1|||
125197142|NCT01683266|450343894|FG001|Overall Study|Possibly Hypoglycemia|0|||
125197143|NCT01683266|450343893|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
125197144|NCT01683266|450343894|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
125197145|NCT00886743|450343897|FG000|Overall Study|Adverse Event|3|||
125197146|NCT00886743|450343897|FG000|Overall Study|Other|1|||
125197147|NCT05217641|450343901|FG000|Overall Study|Lost to Follow-up|1|||
125197148|NCT05217641|450343902|FG001|Overall Study|Lost to Follow-up|1|||
125197149|NCT05217641|450343903|FG002|Overall Study|Lost to Follow-up|0|||
125197150|NCT05217641|450343904|FG003|Overall Study|Lost to Follow-up|1|||
125197151|NCT05217641|450343905|FG004|Overall Study|Lost to Follow-up|1|||
125197152|NCT05217641|450343906|FG005|Overall Study|Lost to Follow-up|0|||
125197153|NCT05217641|450343901|FG000|Overall Study|Withdrawal by Subject|0|||
125197154|NCT05217641|450343902|FG001|Overall Study|Withdrawal by Subject|0|||
125197155|NCT05217641|450343903|FG002|Overall Study|Withdrawal by Subject|0|||
125197156|NCT05217641|450343904|FG003|Overall Study|Withdrawal by Subject|3|||
125197157|NCT05217641|450343905|FG004|Overall Study|Withdrawal by Subject|1|||
125197158|NCT05217641|450343906|FG005|Overall Study|Withdrawal by Subject|0|||
125197159|NCT05217641|450343901|FG000|Overall Study|Other: participant did not specify reason|0|||
125197160|NCT05217641|450343902|FG001|Overall Study|Other: participant did not specify reason|0|||
125197161|NCT05217641|450343903|FG002|Overall Study|Other: participant did not specify reason|0|||
125197162|NCT05217641|450343904|FG003|Overall Study|Other: participant did not specify reason|0|||
125197163|NCT05217641|450343905|FG004|Overall Study|Other: participant did not specify reason|1|||
125250013|NCT00147537|450539671|FG004|Phase 1b|Lost to Follow-up|0|||
125197164|NCT05217641|450343906|FG005|Overall Study|Other: participant did not specify reason|0|||
125197165|NCT05217641|450343901|FG000|Overall Study|Extended Follow up|1|||
125250014|NCT00147537|450539672|FG005|Phase 1b|Lost to Follow-up|0|||
125197166|NCT05217641|450343902|FG001|Overall Study|Extended Follow up|1|||
125197167|NCT05217641|450343903|FG002|Overall Study|Extended Follow up|0|||
125197168|NCT05217641|450343904|FG003|Overall Study|Extended Follow up|0|||
125197169|NCT05217641|450343905|FG004|Overall Study|Extended Follow up|1|||
125197170|NCT05217641|450343906|FG005|Overall Study|Extended Follow up|0|||
125197171|NCT00626821|450343911|FG000|Overall Study|Adverse Event|44|||
125197172|NCT00626821|450343911|FG000|Overall Study|Protocol Violation|33|||
125197173|NCT00626821|450343911|FG000|Overall Study|Withdrawal by Subject|10|||
125197174|NCT00626821|450343911|FG000|Overall Study|Physician Decision|9|||
125197175|NCT00626821|450343911|FG000|Overall Study|Product dysfunction|21|||
125197176|NCT00626821|450343911|FG000|Overall Study|other/unknown reason|104|||
125197177|NCT02632409|450343912|FG000|Randomized|AE unrelated to study Drug|0|||
125197178|NCT02632409|450343913|FG001|Randomized|AE unrelated to study Drug|1|||
125197179|NCT02632409|450343912|FG000|Randomized|Participant withdrew consent|2|||
125197180|NCT02632409|450343913|FG001|Randomized|Participant withdrew consent|1|||
125197181|NCT02632409|450343912|FG000|Randomized|No Longer meets study criteria|5|||
125197182|NCT02632409|450343913|FG001|Randomized|No Longer meets study criteria|0|||
125197183|NCT02632409|450343912|FG000|Randomized|other reasons|1|||
125197184|NCT02632409|450343913|FG001|Randomized|other reasons|0|||
125197185|NCT02632409|450343912|FG000|Treatment Period|Ongoing Treatment|20|||
125197186|NCT02632409|450343913|FG001|Treatment Period|Ongoing Treatment|21|||
125197187|NCT02632409|450343912|FG000|Treatment Period|Disease Recurrence|147|||
125197188|NCT02632409|450343913|FG001|Treatment Period|Disease Recurrence|90|||
125197189|NCT02632409|450343912|FG000|Treatment Period|Study Drug Toxicity|8|||
125197190|NCT02632409|450343913|FG001|Treatment Period|Study Drug Toxicity|49|||
125197191|NCT02632409|450343912|FG000|Treatment Period|Death|1|||
125197192|NCT02632409|450343913|FG001|Treatment Period|Death|0|||
125197193|NCT02632409|450343912|FG000|Treatment Period|AE unrelated to study drug|15|||
125197194|NCT02632409|450343913|FG001|Treatment Period|AE unrelated to study drug|16|||
125197195|NCT02632409|450343912|FG000|Treatment Period|Request to discontinue treatment|4|||
125197196|NCT02632409|450343913|FG001|Treatment Period|Request to discontinue treatment|19|||
125197197|NCT02632409|450343912|FG000|Treatment Period|Participant withdrew consent|7|||
125197198|NCT02632409|450343913|FG001|Treatment Period|Participant withdrew consent|5|||
125197199|NCT02632409|450343912|FG000|Treatment Period|Lost to Follow-up|0|||
125197200|NCT02632409|450343913|FG001|Treatment Period|Lost to Follow-up|1|||
125197201|NCT02632409|450343912|FG000|Treatment Period|Maximum clinical benefit|1|||
125197202|NCT02632409|450343913|FG001|Treatment Period|Maximum clinical benefit|0|||
125197203|NCT02632409|450343912|FG000|Treatment Period|No longer meets study criteria|3|||
125197204|NCT02632409|450343913|FG001|Treatment Period|No longer meets study criteria|0|||
125197205|NCT02632409|450343912|FG000|Treatment Period|Administrative Reason by sponsor|0|||
125197206|NCT02632409|450343913|FG001|Treatment Period|Administrative Reason by sponsor|1|||
125197207|NCT02632409|450343912|FG000|Treatment Period|Other Reasons|10|||
125197208|NCT02632409|450343913|FG001|Treatment Period|Other Reasons|6|||
125197209|NCT00537316|450343914|FG000|Part 1|Adverse Event|7|||
125197210|NCT00537316|450343915|FG001|Part 1|Adverse Event|11|||
125197211|NCT00537316|450343916|FG002|Part 1|Adverse Event|8|||
125197212|NCT00537316|450343917|FG003|Part 1|Adverse Event|0|||
125197213|NCT00537316|450343918|FG004|Part 1|Adverse Event|0|||
125197214|NCT00537316|450343919|FG005|Part 1|Adverse Event|0|||
125197215|NCT00537316|450343920|FG006|Part 1|Adverse Event|0|||
125197216|NCT00537316|450343914|FG000|Part 1|Protocol defined clinical event|1|||
125197217|NCT00537316|450343915|FG001|Part 1|Protocol defined clinical event|0|||
125197218|NCT00537316|450343916|FG002|Part 1|Protocol defined clinical event|0|||
125197219|NCT00537316|450343917|FG003|Part 1|Protocol defined clinical event|0|||
125197220|NCT00537316|450343918|FG004|Part 1|Protocol defined clinical event|0|||
125197221|NCT00537316|450343919|FG005|Part 1|Protocol defined clinical event|0|||
125197222|NCT00537316|450343920|FG006|Part 1|Protocol defined clinical event|0|||
125197223|NCT00537316|450343914|FG000|Part 1|Lost to Follow-up|1|||
125197224|NCT00537316|450343915|FG001|Part 1|Lost to Follow-up|0|||
125197225|NCT00537316|450343916|FG002|Part 1|Lost to Follow-up|0|||
125197226|NCT00537316|450343917|FG003|Part 1|Lost to Follow-up|0|||
125250015|NCT00147537|450539673|FG006|Phase 1b|Lost to Follow-up|2|||
125250016|NCT00147537|450539674|FG007|Phase 1b|Lost to Follow-up|0|||
125250017|NCT00147537|450539675|FG008|Phase 1b|Lost to Follow-up|1|||
125250018|NCT00147537|450539676|FG009|Phase 1b|Lost to Follow-up|0|||
125250019|NCT00147537|450539677|FG010|Phase 1b|Lost to Follow-up|0|||
125250020|NCT00147537|450539667|FG000|Phase 1b|Other|0|||
125250021|NCT00147537|450539668|FG001|Phase 1b|Other|0|||
125250022|NCT00147537|450539669|FG002|Phase 1b|Other|2|||
125250023|NCT00147537|450539670|FG003|Phase 1b|Other|1|||
125250024|NCT00147537|450539671|FG004|Phase 1b|Other|1|||
125250025|NCT00147537|450539672|FG005|Phase 1b|Other|1|||
125250026|NCT00147537|450539673|FG006|Phase 1b|Other|14|||
125250027|NCT00147537|450539674|FG007|Phase 1b|Other|4|||
125250028|NCT00147537|450539675|FG008|Phase 1b|Other|4|||
125250029|NCT00147537|450539676|FG009|Phase 1b|Other|0|||
125250030|NCT00147537|450539677|FG010|Phase 1b|Other|0|||
125250031|NCT00147537|450539667|FG000|Phase 1b|Withdrawal by Subject|0|||
125250032|NCT00147537|450539668|FG001|Phase 1b|Withdrawal by Subject|0|||
125250033|NCT00147537|450539669|FG002|Phase 1b|Withdrawal by Subject|0|||
125250034|NCT00147537|450539670|FG003|Phase 1b|Withdrawal by Subject|0|||
125250035|NCT00147537|450539671|FG004|Phase 1b|Withdrawal by Subject|0|||
125250036|NCT00147537|450539672|FG005|Phase 1b|Withdrawal by Subject|0|||
125250037|NCT00147537|450539673|FG006|Phase 1b|Withdrawal by Subject|0|||
125250038|NCT00147537|450539674|FG007|Phase 1b|Withdrawal by Subject|0|||
125250039|NCT00147537|450539675|FG008|Phase 1b|Withdrawal by Subject|2|||
125250040|NCT00147537|450539676|FG009|Phase 1b|Withdrawal by Subject|0|||
125250041|NCT00147537|450539677|FG010|Phase 1b|Withdrawal by Subject|0|||
125250042|NCT00147537|450539667|FG000|Phase 1b|Randomized but not treated|0|||
125250043|NCT00147537|450539668|FG001|Phase 1b|Randomized but not treated|0|||
125250044|NCT00147537|450539669|FG002|Phase 1b|Randomized but not treated|0|||
125250045|NCT00147537|450539670|FG003|Phase 1b|Randomized but not treated|0|||
125250046|NCT00147537|450539671|FG004|Phase 1b|Randomized but not treated|0|||
125250047|NCT00147537|450539672|FG005|Phase 1b|Randomized but not treated|0|||
125250048|NCT00147537|450539673|FG006|Phase 1b|Randomized but not treated|1|||
125250049|NCT00147537|450539674|FG007|Phase 1b|Randomized but not treated|0|||
125250050|NCT00147537|450539675|FG008|Phase 1b|Randomized but not treated|1|||
125250051|NCT00147537|450539676|FG009|Phase 1b|Randomized but not treated|0|||
125250052|NCT00147537|450539677|FG010|Phase 1b|Randomized but not treated|0|||
125250053|NCT00147537|450539667|FG000|Phase 2|Death|0|||
125250054|NCT00147537|450539668|FG001|Phase 2|Death|0|||
125250055|NCT00147537|450539669|FG002|Phase 2|Death|0|||
125250056|NCT00147537|450539670|FG003|Phase 2|Death|0|||
125250057|NCT00147537|450539671|FG004|Phase 2|Death|0|||
125250058|NCT00147537|450539672|FG005|Phase 2|Death|0|||
125250059|NCT00147537|450539673|FG006|Phase 2|Death|0|||
125250060|NCT00147537|450539674|FG007|Phase 2|Death|0|||
125250061|NCT00147537|450539675|FG008|Phase 2|Death|0|||
125250062|NCT00147537|450539676|FG009|Phase 2|Death|85|||
125250063|NCT00147537|450539677|FG010|Phase 2|Death|31|||
125250064|NCT00147537|450539667|FG000|Phase 2|Lost to Follow-up|0|||
125250065|NCT00147537|450539668|FG001|Phase 2|Lost to Follow-up|0|||
125250066|NCT00147537|450539669|FG002|Phase 2|Lost to Follow-up|0|||
125250067|NCT00147537|450539670|FG003|Phase 2|Lost to Follow-up|0|||
125250068|NCT00147537|450539671|FG004|Phase 2|Lost to Follow-up|0|||
125250069|NCT00147537|450539672|FG005|Phase 2|Lost to Follow-up|0|||
125250070|NCT00147537|450539673|FG006|Phase 2|Lost to Follow-up|0|||
125250071|NCT00147537|450539674|FG007|Phase 2|Lost to Follow-up|0|||
125250072|NCT00147537|450539675|FG008|Phase 2|Lost to Follow-up|0|||
125250073|NCT00147537|450539676|FG009|Phase 2|Lost to Follow-up|12|||
125250074|NCT00147537|450539677|FG010|Phase 2|Lost to Follow-up|4|||
125250075|NCT00147537|450539667|FG000|Phase 2|Other|0|||
125250076|NCT00147537|450539668|FG001|Phase 2|Other|0|||
125250077|NCT00147537|450539669|FG002|Phase 2|Other|0|||
125250078|NCT00147537|450539670|FG003|Phase 2|Other|0|||
125250079|NCT00147537|450539671|FG004|Phase 2|Other|0|||
125250080|NCT00147537|450539672|FG005|Phase 2|Other|0|||
125250081|NCT00147537|450539673|FG006|Phase 2|Other|0|||
125250082|NCT00147537|450539674|FG007|Phase 2|Other|0|||
125250083|NCT00147537|450539675|FG008|Phase 2|Other|0|||
125250084|NCT00147537|450539676|FG009|Phase 2|Other|47|||
125250085|NCT00147537|450539677|FG010|Phase 2|Other|12|||
125250086|NCT00147537|450539667|FG000|Phase 2|Withdrawal by Subject|0|||
125250087|NCT00147537|450539668|FG001|Phase 2|Withdrawal by Subject|0|||
125250088|NCT00147537|450539669|FG002|Phase 2|Withdrawal by Subject|0|||
125250089|NCT00147537|450539670|FG003|Phase 2|Withdrawal by Subject|0|||
125250090|NCT00147537|450539671|FG004|Phase 2|Withdrawal by Subject|0|||
125250091|NCT00147537|450539672|FG005|Phase 2|Withdrawal by Subject|0|||
125250092|NCT00147537|450539673|FG006|Phase 2|Withdrawal by Subject|0|||
125250093|NCT00147537|450539674|FG007|Phase 2|Withdrawal by Subject|0|||
125250094|NCT00147537|450539675|FG008|Phase 2|Withdrawal by Subject|0|||
125250095|NCT00147537|450539676|FG009|Phase 2|Withdrawal by Subject|16|||
125250096|NCT00147537|450539677|FG010|Phase 2|Withdrawal by Subject|4|||
125250097|NCT00147537|450539667|FG000|Phase 2|Randomized but not treated|0|||
125250098|NCT00147537|450539668|FG001|Phase 2|Randomized but not treated|0|||
125250099|NCT00147537|450539669|FG002|Phase 2|Randomized but not treated|0|||
125250100|NCT00147537|450539670|FG003|Phase 2|Randomized but not treated|0|||
125250101|NCT00147537|450539671|FG004|Phase 2|Randomized but not treated|0|||
125250102|NCT00147537|450539672|FG005|Phase 2|Randomized but not treated|0|||
125250103|NCT00147537|450539673|FG006|Phase 2|Randomized but not treated|0|||
125250104|NCT00147537|450539674|FG007|Phase 2|Randomized but not treated|0|||
125250105|NCT00147537|450539675|FG008|Phase 2|Randomized but not treated|0|||
125250106|NCT00147537|450539676|FG009|Phase 2|Randomized but not treated|1|||
125250107|NCT00147537|450539677|FG010|Phase 2|Randomized but not treated|1|||
125250108|NCT02006654|450539679|FG000|Overall Study|Withdrawal before treatment|4|||
125250109|NCT02006654|450539680|FG001|Overall Study|Withdrawal before treatment|2|||
125250110|NCT02006654|450539679|FG000|Overall Study|Adverse Event|16|||
125250111|NCT02006654|450539680|FG001|Overall Study|Adverse Event|17|||
125250112|NCT02006654|450539679|FG000|Overall Study|Death|1|||
125250113|NCT02006654|450539680|FG001|Overall Study|Death|0|||
125250114|NCT02006654|450539679|FG000|Overall Study|Withdrawal by Subject|14|||
125250115|NCT02006654|450539680|FG001|Overall Study|Withdrawal by Subject|12|||
125250116|NCT02006654|450539679|FG000|Overall Study|Protocol Violation|5|||
125250117|NCT02006654|450539680|FG001|Overall Study|Protocol Violation|8|||
125250118|NCT02006654|450539679|FG000|Overall Study|Lost to Follow-up|1|||
125250119|NCT02006654|450539680|FG001|Overall Study|Lost to Follow-up|0|||
125250120|NCT02006654|450539679|FG000|Overall Study|patient's will|2|||
125250121|NCT02006654|450539680|FG001|Overall Study|patient's will|1|||
125250122|NCT02006654|450539679|FG000|Overall Study|insufficient compliance|1|||
125250123|NCT02006654|450539680|FG001|Overall Study|insufficient compliance|0|||
125250124|NCT02006654|450539679|FG000|Overall Study|worsening cognitive condition|0|||
125250125|NCT02006654|450539680|FG001|Overall Study|worsening cognitive condition|1|||
125250126|NCT02006654|450539679|FG000|Overall Study|faecal incontinence|0|||
125250127|NCT02006654|450539680|FG001|Overall Study|faecal incontinence|1|||
125250128|NCT02006654|450539679|FG000|Overall Study|mood disorder|0|||
125250129|NCT02006654|450539680|FG001|Overall Study|mood disorder|1|||
125250130|NCT02006654|450539679|FG000|Overall Study|disallowed medication|1|||
125250131|NCT02006654|450539680|FG001|Overall Study|disallowed medication|0|||
125250132|NCT02006654|450539679|FG000|Overall Study|moving out of state|0|||
125250133|NCT02006654|450539680|FG001|Overall Study|moving out of state|1|||
125250134|NCT00478140|450539681|FG000|Overall Study|Clinical Disease Progression|1|||
125250135|NCT00676689|450539684|FG000|Overall Study|Screen Failure|2|||
125250136|NCT00676689|450539684|FG000|Overall Study|Death|2|||
125250137|NCT00676689|450539684|FG000|Overall Study|Lost to Follow-up|4|||
125250138|NCT00676689|450539684|FG000|Overall Study|Physician Decision|1|||
125250139|NCT00676689|450539684|FG000|Overall Study|Withdrawal by Subject|3|||
125250140|NCT00676689|450539684|FG000|Overall Study|Continuing FU|49|||
125250141|NCT03438656|450539685|FG000|Overall Study|Lost to Follow-up|2|||
125250142|NCT00563316|450539688|FG000|Overall Study|Adverse Event|2|||
125250143|NCT00563316|450539688|FG000|Overall Study|Physician Decision|1|||
125250144|NCT00563316|450539688|FG000|Overall Study|Lost to Follow-up|2|||
125250145|NCT00563316|450539688|FG000|Overall Study|Death|1|||
125250146|NCT00563316|450539688|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
125250147|NCT00563316|450539688|FG000|Overall Study|Other|1|||
125250148|NCT04401293|450539694|FG000|Overall Study|Withdrawal by Subject|1|||
125250149|NCT04401293|450539695|FG001|Overall Study|Withdrawal by Subject|3|||
125250150|NCT00694161|450539696|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
125250151|NCT00694161|450539696|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
125250152|NCT00694161|450539696|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
125250153|NCT03111732|450539697|FG000|Overall Study|Enrolled in different study|1|||
125250154|NCT03111732|450539697|FG000|Overall Study|Progressive disease|3|||
125250155|NCT03111732|450539697|FG000|Overall Study|Withdrawal by Subject|1|||
125250156|NCT01108055|450539698|FG000|Overall Study|Ineligible|11|||
125250157|NCT01108055|450539698|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
125250158|NCT03339453|450539701|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
125250159|NCT03339453|450539702|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
125250160|NCT02151604|450539705|FG000|Overall Study|Lost to Follow-up|3|||
125250161|NCT02151604|450539705|FG000|Overall Study|Withdrawal by Subject|2|||
125250162|NCT02151604|450539705|FG000|Overall Study|Physician Decision|3|||
125250163|NCT02151604|450539705|FG000|Overall Study|Death|1|||
125250164|NCT04495478|450539706|FG000|Overall Study|Withdrawal by Subject|0|||
125250165|NCT04495478|450539707|FG001|Overall Study|Withdrawal by Subject|0|||
125250166|NCT04495478|450539708|FG002|Overall Study|Withdrawal by Subject|0|||
125250167|NCT04495478|450539709|FG003|Overall Study|Withdrawal by Subject|1|||
125250168|NCT04495478|450539710|FG004|Overall Study|Withdrawal by Subject|0|||
125250169|NCT04495478|450539711|FG005|Overall Study|Withdrawal by Subject|0|||
125250170|NCT04495478|450539712|FG006|Overall Study|Withdrawal by Subject|0|||
125250171|NCT04495478|450539706|FG000|Overall Study|Physician Decision|0|||
125250172|NCT04495478|450539707|FG001|Overall Study|Physician Decision|1|||
125250173|NCT04495478|450539708|FG002|Overall Study|Physician Decision|0|||
125250174|NCT04495478|450539709|FG003|Overall Study|Physician Decision|0|||
125250175|NCT04495478|450539710|FG004|Overall Study|Physician Decision|1|||
125250176|NCT04495478|450539711|FG005|Overall Study|Physician Decision|0|||
125250177|NCT04495478|450539712|FG006|Overall Study|Physician Decision|0|||
125250178|NCT03312114|450541673|FG000|Overall Study|All the five enrolled dropped out of the|5|||
125250179|NCT00944645|450541674|FG000|Period 2|Adverse Event|1|||
125250180|NCT00944645|450541675|FG001|Period 2|Adverse Event|0|||
125250181|NCT00944645|450541674|FG000|Period 2|Lost to Follow-up|0|||
125250182|NCT00944645|450541675|FG001|Period 2|Lost to Follow-up|3|||
125250183|NCT00944645|450541674|FG000|Period 2|Withdrawal by Subject|7|||
125250184|NCT00944645|450541675|FG001|Period 2|Withdrawal by Subject|6|||
125250185|NCT03537729|450541676|FG000|Overall Study|Death|2|||
125250186|NCT03537729|450541677|FG001|Overall Study|Death|2|||
125250187|NCT03537729|450541678|FG002|Overall Study|Death|7|||
125250188|NCT03537729|450541676|FG000|Overall Study|Withdrawal by Subject|3|||
125250189|NCT03537729|450541677|FG001|Overall Study|Withdrawal by Subject|3|||
125250190|NCT03537729|450541678|FG002|Overall Study|Withdrawal by Subject|0|||
125250191|NCT03537729|450541676|FG000|Overall Study|Subject Moved|8|||
125250192|NCT03537729|450541677|FG001|Overall Study|Subject Moved|5|||
125250193|NCT03537729|450541678|FG002|Overall Study|Subject Moved|4|||
125250194|NCT03537729|450541676|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
125250195|NCT03537729|450541677|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
125250196|NCT03537729|450541678|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
125250197|NCT03537729|450541676|FG000|Overall Study|COVID-19 Site Restrictions|11|||
125250198|NCT03537729|450541677|FG001|Overall Study|COVID-19 Site Restrictions|15|||
125250199|NCT03537729|450541678|FG002|Overall Study|COVID-19 Site Restrictions|18|||
125250200|NCT03537729|450541676|FG000|Overall Study|Decline in Health|5|||
125250201|NCT03537729|450541677|FG001|Overall Study|Decline in Health|9|||
125250202|NCT03537729|450541678|FG002|Overall Study|Decline in Health|4|||
125250203|NCT03537729|450541676|FG000|Overall Study|Determined Ineligible|0|||
125250204|NCT03537729|450541677|FG001|Overall Study|Determined Ineligible|0|||
125250205|NCT03537729|450541678|FG002|Overall Study|Determined Ineligible|1|||
125250206|NCT02562040|450541680|FG000|Overall Study|Lost to Follow-up|20|||
125250207|NCT02562040|450541681|FG001|Overall Study|Lost to Follow-up|28|||
125250208|NCT02562040|450541680|FG000|Overall Study|Withdrawal by Subject|8|||
125250209|NCT02562040|450541681|FG001|Overall Study|Withdrawal by Subject|7|||
125250210|NCT02562040|450541680|FG000|Overall Study|Adverse Event|1|||
125250211|NCT02562040|450541681|FG001|Overall Study|Adverse Event|0|||
125250212|NCT01654250|450541682|FG000|Overall Study|Lost to Follow-up|1|||
125250213|NCT01654250|450541683|FG001|Overall Study|Lost to Follow-up|0|||
125250214|NCT01862029|450541684|FG000|Overall Study|Physician Decision|1|||
125250215|NCT00504556|450541685|FG000|Overall Study|Adverse Event|11|||
125250216|NCT00504556|450541686|FG001|Overall Study|Adverse Event|11|||
125250217|NCT00504556|450541687|FG002|Overall Study|Adverse Event|14|||
125250218|NCT00504556|450541688|FG003|Overall Study|Adverse Event|13|||
125250219|NCT00504556|450541689|FG004|Overall Study|Adverse Event|5|||
125250220|NCT00504556|450541685|FG000|Overall Study|Death|3|||
125250221|NCT00504556|450541686|FG001|Overall Study|Death|3|||
125250222|NCT00504556|450541687|FG002|Overall Study|Death|1|||
125250223|NCT00504556|450541688|FG003|Overall Study|Death|0|||
125250224|NCT00504556|450541689|FG004|Overall Study|Death|2|||
125250225|NCT00504556|450541685|FG000|Overall Study|Protocol Violation|1|||
125250226|NCT00504556|450541686|FG001|Overall Study|Protocol Violation|3|||
125250227|NCT00504556|450541687|FG002|Overall Study|Protocol Violation|2|||
125250228|NCT00504556|450541688|FG003|Overall Study|Protocol Violation|1|||
125250229|NCT00504556|450541689|FG004|Overall Study|Protocol Violation|2|||
125250230|NCT00504556|450541685|FG000|Overall Study|Lost to Follow-up|0|||
125250231|NCT00504556|450541686|FG001|Overall Study|Lost to Follow-up|0|||
125250232|NCT00504556|450541687|FG002|Overall Study|Lost to Follow-up|1|||
125250233|NCT00504556|450541688|FG003|Overall Study|Lost to Follow-up|1|||
125250234|NCT00504556|450541689|FG004|Overall Study|Lost to Follow-up|1|||
125250235|NCT00504556|450541685|FG000|Overall Study|Withdrawal by Subject|16|||
125250236|NCT00504556|450541686|FG001|Overall Study|Withdrawal by Subject|16|||
125250237|NCT00504556|450541687|FG002|Overall Study|Withdrawal by Subject|7|||
125250238|NCT00504556|450541688|FG003|Overall Study|Withdrawal by Subject|8|||
125250239|NCT00504556|450541689|FG004|Overall Study|Withdrawal by Subject|12|||
125250240|NCT00504556|450541685|FG000|Overall Study|administrative reasons|0|||
125250241|NCT00504556|450541686|FG001|Overall Study|administrative reasons|2|||
125250242|NCT00504556|450541687|FG002|Overall Study|administrative reasons|2|||
125250243|NCT00504556|450541688|FG003|Overall Study|administrative reasons|1|||
125250244|NCT00504556|450541689|FG004|Overall Study|administrative reasons|2|||
125250245|NCT00504556|450541685|FG000|Overall Study|did not meet entry criteria|2|||
125250246|NCT00504556|450541686|FG001|Overall Study|did not meet entry criteria|0|||
125250247|NCT00504556|450541687|FG002|Overall Study|did not meet entry criteria|1|||
125250248|NCT00504556|450541688|FG003|Overall Study|did not meet entry criteria|1|||
125250249|NCT00504556|450541689|FG004|Overall Study|did not meet entry criteria|0|||
125250250|NCT00504556|450541685|FG000|Overall Study|data monitor committee decision|0|||
125250251|NCT00504556|450541686|FG001|Overall Study|data monitor committee decision|0|||
125250252|NCT00504556|450541687|FG002|Overall Study|data monitor committee decision|0|||
125250253|NCT00504556|450541688|FG003|Overall Study|data monitor committee decision|100|||
125250254|NCT00504556|450541689|FG004|Overall Study|data monitor committee decision|0|||
125250255|NCT00504556|450541685|FG000|Overall Study|Other|2|||
125250256|NCT00504556|450541686|FG001|Overall Study|Other|2|||
125250257|NCT00504556|450541687|FG002|Overall Study|Other|2|||
125250258|NCT00504556|450541688|FG003|Overall Study|Other|3|||
125250259|NCT00504556|450541689|FG004|Overall Study|Other|0|||
125250260|NCT00504556|450541685|FG000|Overall Study|not in safety analysis set|0|||
125250261|NCT00504556|450541686|FG001|Overall Study|not in safety analysis set|1|||
125250262|NCT00504556|450541687|FG002|Overall Study|not in safety analysis set|1|||
125250263|NCT00504556|450541688|FG003|Overall Study|not in safety analysis set|0|||
125250264|NCT00504556|450541689|FG004|Overall Study|not in safety analysis set|1|||
125250265|NCT01013870|450541690|FG000|Overall Study|Lost to Follow-up|1|||
125250266|NCT01013870|450541691|FG001|Overall Study|Lost to Follow-up|3|||
125250267|NCT01386645|450541692|FG000|Overall Study|Physician Decision|0|||
125250268|NCT01386645|450541693|FG001|Overall Study|Physician Decision|0|||
125250269|NCT01386645|450541694|FG002|Overall Study|Physician Decision|1|||
125250270|NCT01386645|450541692|FG000|Overall Study|Withdrawal by Subject|0|||
125250271|NCT01386645|450541693|FG001|Overall Study|Withdrawal by Subject|1|||
125250272|NCT01386645|450541694|FG002|Overall Study|Withdrawal by Subject|1|||
125250273|NCT03142451|450541704|FG000|Overall Study|Adverse Event|5|||
125250274|NCT03142451|450541705|FG001|Overall Study|Adverse Event|2|||
125250275|NCT03142451|450541704|FG000|Overall Study|Lost to Follow-up|25|||
125250276|NCT03142451|450541705|FG001|Overall Study|Lost to Follow-up|8|||
125250277|NCT03142451|450541704|FG000|Overall Study|Participant request|24|||
125250278|NCT03142451|450541705|FG001|Overall Study|Participant request|12|||
125250279|NCT03142451|450541704|FG000|Overall Study|Protocol Violation|3|||
125250280|NCT03142451|450541705|FG001|Overall Study|Protocol Violation|1|||
125250281|NCT03142451|450541704|FG000|Overall Study|Other|1|||
125250282|NCT03142451|450541705|FG001|Overall Study|Other|1|||
125250283|NCT02773537|450541723|FG000|Overall Study|Lost to Follow-up|0|||
125250284|NCT02773537|450541724|FG001|Overall Study|Lost to Follow-up|1|||
125250285|NCT02773537|450541725|FG002|Overall Study|Lost to Follow-up|4|||
125250286|NCT01840163|450541726|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
125250287|NCT01840163|450541727|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
125250288|NCT01840163|450541726|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
125250289|NCT01840163|450541727|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
125250290|NCT01840163|450541726|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
125250291|NCT01840163|450541727|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
125250292|NCT03636269|450541732|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
125250293|NCT03636269|450541733|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
125250294|NCT03636269|450541734|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
125250295|NCT03636269|450541732|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
125250296|NCT03636269|450541733|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
125250297|NCT03636269|450541734|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
125250298|NCT03636269|450541732|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
125250299|NCT03636269|450541733|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
125250300|NCT03636269|450541734|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
125250301|NCT03636269|450541732|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
125250302|NCT03636269|450541733|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
125250303|NCT03636269|450541734|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
125250304|NCT03636269|450541732|FG000|Period 1: Double-blind Phase|Other|6|||
125250305|NCT03636269|450541733|FG001|Period 1: Double-blind Phase|Other|3|||
125250306|NCT03636269|450541734|FG002|Period 1: Double-blind Phase|Other|0|||
125250307|NCT03636269|450541732|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
125250308|NCT03636269|450541733|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
125250309|NCT03636269|450541734|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
125250310|NCT03636269|450541732|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
125250311|NCT03636269|450541733|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
125250312|NCT03636269|450541734|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
125250313|NCT03636269|450541732|FG000|Period 2: Open-label Phase|Adverse Event|0|||
125250314|NCT03636269|450541733|FG001|Period 2: Open-label Phase|Adverse Event|0|||
125250315|NCT03636269|450541734|FG002|Period 2: Open-label Phase|Adverse Event|21|||
125250316|NCT03636269|450541732|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
125250317|NCT03636269|450541733|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
125250318|NCT03636269|450541734|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
125250319|NCT03636269|450541732|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
125250320|NCT03636269|450541733|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
125250321|NCT03636269|450541734|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
125250322|NCT03636269|450541732|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
125250323|NCT03636269|450541733|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
125250324|NCT03636269|450541734|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
125197227|NCT00537316|450343918|FG004|Part 1|Lost to Follow-up|0|||
125197228|NCT00537316|450343919|FG005|Part 1|Lost to Follow-up|0|||
125197229|NCT00537316|450343920|FG006|Part 1|Lost to Follow-up|0|||
125197230|NCT00537316|450343914|FG000|Part 1|Withdrawal by Subject|3|||
125197231|NCT00537316|450343915|FG001|Part 1|Withdrawal by Subject|8|||
125197232|NCT00537316|450343916|FG002|Part 1|Withdrawal by Subject|4|||
125197233|NCT00537316|450343917|FG003|Part 1|Withdrawal by Subject|0|||
125197234|NCT00537316|450343918|FG004|Part 1|Withdrawal by Subject|0|||
125197235|NCT00537316|450343919|FG005|Part 1|Withdrawal by Subject|0|||
125197236|NCT00537316|450343920|FG006|Part 1|Withdrawal by Subject|0|||
125197237|NCT00537316|450343914|FG000|Part 1|Protocol Violation|1|||
125197238|NCT00537316|450343915|FG001|Part 1|Protocol Violation|5|||
125197239|NCT00537316|450343916|FG002|Part 1|Protocol Violation|1|||
125197240|NCT00537316|450343917|FG003|Part 1|Protocol Violation|0|||
125197241|NCT00537316|450343918|FG004|Part 1|Protocol Violation|0|||
125197242|NCT00537316|450343919|FG005|Part 1|Protocol Violation|0|||
125197243|NCT00537316|450343920|FG006|Part 1|Protocol Violation|0|||
125197244|NCT00537316|450343914|FG000|Part 1|Did not meet protocol eligibility|1|||
125197245|NCT00537316|450343915|FG001|Part 1|Did not meet protocol eligibility|3|||
125197246|NCT00537316|450343916|FG002|Part 1|Did not meet protocol eligibility|2|||
125197247|NCT00537316|450343917|FG003|Part 1|Did not meet protocol eligibility|0|||
125197248|NCT00537316|450343918|FG004|Part 1|Did not meet protocol eligibility|0|||
125197249|NCT00537316|450343919|FG005|Part 1|Did not meet protocol eligibility|0|||
125197250|NCT00537316|450343920|FG006|Part 1|Did not meet protocol eligibility|0|||
125197251|NCT00537316|450343914|FG000|Part 1|Administrative|0|||
125197252|NCT00537316|450343915|FG001|Part 1|Administrative|0|||
125197253|NCT00537316|450343916|FG002|Part 1|Administrative|2|||
125197254|NCT00537316|450343917|FG003|Part 1|Administrative|0|||
125197255|NCT00537316|450343918|FG004|Part 1|Administrative|0|||
125197256|NCT00537316|450343919|FG005|Part 1|Administrative|0|||
125197257|NCT00537316|450343920|FG006|Part 1|Administrative|0|||
125197258|NCT00537316|450343914|FG000|Part 2|Never entered follow-up|0|||
125197259|NCT00537316|450343915|FG001|Part 2|Never entered follow-up|0|||
125197260|NCT00537316|450343916|FG002|Part 2|Never entered follow-up|0|||
125197261|NCT00537316|450343917|FG003|Part 2|Never entered follow-up|0|||
125197262|NCT00537316|450343918|FG004|Part 2|Never entered follow-up|0|||
125197263|NCT00537316|450343919|FG005|Part 2|Never entered follow-up|0|||
125197264|NCT00537316|450343920|FG006|Part 2|Never entered follow-up|1|||
125197265|NCT00537316|450343914|FG000|Part 2|Adverse Event|4|||
125197266|NCT00537316|450343915|FG001|Part 2|Adverse Event|0|||
125197267|NCT00537316|450343916|FG002|Part 2|Adverse Event|2|||
125197268|NCT00537316|450343917|FG003|Part 2|Adverse Event|0|||
125197269|NCT00537316|450343918|FG004|Part 2|Adverse Event|0|||
125197270|NCT00537316|450343919|FG005|Part 2|Adverse Event|0|||
125197271|NCT00537316|450343920|FG006|Part 2|Adverse Event|0|||
125197272|NCT00537316|450343914|FG000|Part 2|Lost to Follow-up|1|||
125197273|NCT00537316|450343915|FG001|Part 2|Lost to Follow-up|0|||
125197274|NCT00537316|450343916|FG002|Part 2|Lost to Follow-up|2|||
125197275|NCT00537316|450343917|FG003|Part 2|Lost to Follow-up|0|||
125197276|NCT00537316|450343918|FG004|Part 2|Lost to Follow-up|0|||
125197277|NCT00537316|450343919|FG005|Part 2|Lost to Follow-up|0|||
125197278|NCT00537316|450343920|FG006|Part 2|Lost to Follow-up|0|||
125197279|NCT00537316|450343914|FG000|Part 2|Withdrawal by Subject|5|||
125197280|NCT00537316|450343915|FG001|Part 2|Withdrawal by Subject|1|||
125197281|NCT00537316|450343916|FG002|Part 2|Withdrawal by Subject|4|||
125197282|NCT00537316|450343917|FG003|Part 2|Withdrawal by Subject|0|||
125197283|NCT00537316|450343918|FG004|Part 2|Withdrawal by Subject|0|||
125197284|NCT00537316|450343919|FG005|Part 2|Withdrawal by Subject|0|||
125197285|NCT00537316|450343920|FG006|Part 2|Withdrawal by Subject|0|||
125197286|NCT00537316|450343914|FG000|Part 2|Administrative|16|||
125197287|NCT00537316|450343915|FG001|Part 2|Administrative|8|||
125197288|NCT00537316|450343916|FG002|Part 2|Administrative|24|||
125197289|NCT00537316|450343917|FG003|Part 2|Administrative|3|||
125197290|NCT00537316|450343918|FG004|Part 2|Administrative|1|||
125197291|NCT00537316|450343919|FG005|Part 2|Administrative|4|||
125197292|NCT00537316|450343920|FG006|Part 2|Administrative|1|||
125197293|NCT01867710|450343921|FG000|Overall Study|Death|25|||
125197294|NCT01867710|450343922|FG001|Overall Study|Death|15|||
125197295|NCT01867710|450343923|FG002|Overall Study|Death|27|||
125197296|NCT01867710|450343924|FG003|Overall Study|Death|20|||
125197297|NCT01867710|450343921|FG000|Overall Study|Lost to Follow-up|3|||
125197298|NCT01867710|450343922|FG001|Overall Study|Lost to Follow-up|4|||
125197299|NCT01867710|450343923|FG002|Overall Study|Lost to Follow-up|3|||
125197300|NCT01867710|450343924|FG003|Overall Study|Lost to Follow-up|2|||
125197301|NCT01867710|450343921|FG000|Overall Study|Withdrawal of consent|2|||
125197302|NCT01867710|450343922|FG001|Overall Study|Withdrawal of consent|5|||
125197303|NCT01867710|450343923|FG002|Overall Study|Withdrawal of consent|1|||
125197304|NCT01867710|450343924|FG003|Overall Study|Withdrawal of consent|2|||
125197305|NCT01867710|450343921|FG000|Overall Study|Study Terminated by Sponsor|9|||
125250325|NCT03636269|450541732|FG000|Period 2: Open-label Phase|Administrative|0|||
125197306|NCT01867710|450343922|FG001|Overall Study|Study Terminated by Sponsor|13|||
125197307|NCT01867710|450343923|FG002|Overall Study|Study Terminated by Sponsor|8|||
125197308|NCT01867710|450343924|FG003|Overall Study|Study Terminated by Sponsor|16|||
125250326|NCT03636269|450541733|FG001|Period 2: Open-label Phase|Administrative|0|||
125250327|NCT03636269|450541734|FG002|Period 2: Open-label Phase|Administrative|36|||
125250328|NCT03636269|450541732|FG000|Period 2: Open-label Phase|Other|0|||
125250329|NCT03636269|450541733|FG001|Period 2: Open-label Phase|Other|0|||
125250330|NCT03636269|450541734|FG002|Period 2: Open-label Phase|Other|9|||
125250331|NCT03636269|450541732|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
125250332|NCT03636269|450541733|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
125250333|NCT03636269|450541734|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
125250334|NCT03774810|450541736|FG000|Phase 1|Lack of Efficacy|21|||
125250335|NCT03774810|450541737|FG001|Phase 1|Lack of Efficacy|0|||
125250336|NCT03774810|450541738|FG002|Phase 1|Lack of Efficacy|0|||
125250337|NCT03774810|450541739|FG003|Phase 1|Lack of Efficacy|0|||
125250338|NCT03774810|450541740|FG004|Phase 1|Lack of Efficacy|0|||
125250339|NCT03774810|450541736|FG000|Phase 1|Withdrawal by Subject|9|||
125250340|NCT03774810|450541737|FG001|Phase 1|Withdrawal by Subject|0|||
125250341|NCT03774810|450541738|FG002|Phase 1|Withdrawal by Subject|0|||
125250342|NCT03774810|450541739|FG003|Phase 1|Withdrawal by Subject|0|||
125250343|NCT03774810|450541740|FG004|Phase 1|Withdrawal by Subject|0|||
125250344|NCT03774810|450541736|FG000|Phase 1|Lost to Follow-up|2|||
125250345|NCT03774810|450541737|FG001|Phase 1|Lost to Follow-up|0|||
125250346|NCT03774810|450541738|FG002|Phase 1|Lost to Follow-up|0|||
125250347|NCT03774810|450541739|FG003|Phase 1|Lost to Follow-up|0|||
125250348|NCT03774810|450541740|FG004|Phase 1|Lost to Follow-up|0|||
125250349|NCT03774810|450541736|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
125250350|NCT03774810|450541737|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
125250351|NCT03774810|450541738|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
125250352|NCT03774810|450541739|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
125250353|NCT03774810|450541740|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
125250354|NCT03774810|450541736|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
125250355|NCT03774810|450541737|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
125250356|NCT03774810|450541738|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
125250357|NCT03774810|450541739|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
125250358|NCT03774810|450541740|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
125250359|NCT03774810|450541736|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
125250360|NCT03774810|450541737|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
125250361|NCT03774810|450541738|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
125250362|NCT03774810|450541739|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
125250363|NCT03774810|450541740|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
125250364|NCT03774810|450541736|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
125250365|NCT03774810|450541737|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
125250366|NCT03774810|450541738|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
125250367|NCT03774810|450541739|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
125250368|NCT03774810|450541740|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
125250369|NCT03774810|450541736|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
125250370|NCT03774810|450541737|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
125250371|NCT03774810|450541738|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
125250372|NCT03774810|450541739|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
125250373|NCT03774810|450541740|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
125250374|NCT03774810|450541736|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
125250375|NCT03774810|450541737|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
125250376|NCT03774810|450541738|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
125250377|NCT03774810|450541739|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
125250378|NCT03774810|450541740|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
125250379|NCT00290758|450541743|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
125250380|NCT00290758|450541744|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
125250381|NCT00290758|450541743|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
125250382|NCT00290758|450541744|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
125250383|NCT00290758|450541743|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
125250384|NCT00290758|450541744|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
125250385|NCT00290758|450541743|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
125250386|NCT00290758|450541744|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
125250387|NCT00290758|450541743|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
125250388|NCT00290758|450541744|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
125250389|NCT00290758|450541743|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
125250390|NCT00290758|450541744|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
125250391|NCT00290758|450541743|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
125250392|NCT00290758|450541744|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
125250393|NCT00290758|450541743|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
125250394|NCT00290758|450541744|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
125250395|NCT03436420|450541745|FG000|Overall Study|Lack of Efficacy|3|||
125250396|NCT04914000|450541746|FG000|Overall Study|Lost to Follow-up|8|||
125250397|NCT04914000|450541746|FG000|Overall Study|Withdrawal by Subject|1|||
125250398|NCT01429623|450541747|FG000|Overall Study|Death|1|||
125250399|NCT01429623|450541748|FG001|Overall Study|Death|0|||
125250400|NCT01429623|450541747|FG000|Overall Study|Adverse Event|7|||
125250401|NCT01429623|450541748|FG001|Overall Study|Adverse Event|14|||
125250402|NCT01429623|450541747|FG000|Overall Study|Withdrawal by Subject|19|||
125250403|NCT01429623|450541748|FG001|Overall Study|Withdrawal by Subject|13|||
125250404|NCT01429623|450541747|FG000|Overall Study|Physician Decision|2|||
125250405|NCT01429623|450541748|FG001|Overall Study|Physician Decision|3|||
125250406|NCT01429623|450541747|FG000|Overall Study|Protocol Violation|3|||
125250407|NCT01429623|450541748|FG001|Overall Study|Protocol Violation|2|||
125250408|NCT01429623|450541747|FG000|Overall Study|Assorted|1|||
125250409|NCT01429623|450541748|FG001|Overall Study|Assorted|2|||
125250410|NCT01429623|450541747|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
125250411|NCT01429623|450541748|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
125250412|NCT01429623|450541747|FG000|Overall Study|No post baseline data|4|||
125250413|NCT01429623|450541748|FG001|Overall Study|No post baseline data|4|||
125250414|NCT01896986|450541750|FG000|Overall Study|samples lost|14|||
125250415|NCT01896986|450541751|FG001|Overall Study|samples lost|23|||
125250416|NCT01061710|450541757|FG000|Overall Study|Protocol Violation|14|||
125250417|NCT03757715|450541758|FG000|Overall Study|Lost to Follow-up|4|||
125250418|NCT03757715|450541759|FG001|Overall Study|Lost to Follow-up|9|||
125250419|NCT03757715|450541758|FG000|Overall Study|Withdrawal by Subject|1|||
125250420|NCT03757715|450541759|FG001|Overall Study|Withdrawal by Subject|1|||
125250421|NCT03156621|450541760|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
125250422|NCT03156621|450541761|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
125250423|NCT03156621|450541760|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125250424|NCT03156621|450541761|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
125250425|NCT03302936|450541762|FG000|Overall Study|Protocol Violation|3|||
125250426|NCT03302936|450541763|FG001|Overall Study|Protocol Violation|4|||
125250427|NCT01259024|450541767|FG000|Overall Study|Physician Decision|1|||
125250428|NCT01657500|450541768|FG000|Overall Study|set impropperly matched|3|||
125250429|NCT01657500|450541769|FG001|Overall Study|set impropperly matched|3|||
125250430|NCT01657500|450541768|FG000|Overall Study|Lost to Follow-up|2|||
125250431|NCT01657500|450541769|FG001|Overall Study|Lost to Follow-up|2|||
125250432|NCT00986102|450541773|FG000|Overall Study|Lost to Follow-up|0|||
125250433|NCT00986102|450541774|FG001|Overall Study|Lost to Follow-up|1|||
125250434|NCT00986102|450541775|FG002|Overall Study|Lost to Follow-up|0|||
125250435|NCT00986102|450541776|FG003|Overall Study|Lost to Follow-up|1|||
125250436|NCT00986102|450541773|FG000|Overall Study|Withdrawal by Subject|1|||
125250437|NCT00986102|450541774|FG001|Overall Study|Withdrawal by Subject|1|||
125250438|NCT00986102|450541775|FG002|Overall Study|Withdrawal by Subject|0|||
125250439|NCT00986102|450541776|FG003|Overall Study|Withdrawal by Subject|0|||
125250440|NCT06083493|450541777|FG000|Overall Study|Technical issues with the interventional device|2|||
125250441|NCT06083493|450541778|FG001|Overall Study|Technical issues with the interventional device|2|||
125250442|NCT06083493|450541777|FG000|Overall Study|Performed incorrect visual task|1|||
125250443|NCT06083493|450541778|FG001|Overall Study|Performed incorrect visual task|0|||
125250444|NCT06083493|450541777|FG000|Overall Study|Insufficient baseline performance|0|||
125250445|NCT06083493|450541778|FG001|Overall Study|Insufficient baseline performance|1|||
125250446|NCT03093870|450541779|FG000|Overall Study|Withdrawal by Subject|2|||
125250447|NCT03093870|450541780|FG001|Overall Study|Withdrawal by Subject|6|||
125250448|NCT03093870|450541781|FG002|Overall Study|Withdrawal by Subject|5|||
125250449|NCT03093870|450541779|FG000|Overall Study|Death|1|||
125250450|NCT03093870|450541780|FG001|Overall Study|Death|35|||
125250451|NCT03093870|450541781|FG002|Overall Study|Death|35|||
125250452|NCT03093870|450541779|FG000|Overall Study|Radiographic disease progression|10|||
125250453|NCT03093870|450541780|FG001|Overall Study|Radiographic disease progression|0|||
125250454|NCT03093870|450541781|FG002|Overall Study|Radiographic disease progression|0|||
125250455|NCT03093870|450541779|FG000|Overall Study|Clinical disease progression|1|||
125250456|NCT03093870|450541780|FG001|Overall Study|Clinical disease progression|0|||
125250457|NCT03093870|450541781|FG002|Overall Study|Clinical disease progression|0|||
125250458|NCT03093870|450541779|FG000|Overall Study|Physician Decision|2|||
125250459|NCT03093870|450541780|FG001|Overall Study|Physician Decision|0|||
125250460|NCT03093870|450541781|FG002|Overall Study|Physician Decision|0|||
125250461|NCT03093870|450541779|FG000|Overall Study|Adverse Event|7|||
125250462|NCT03093870|450541780|FG001|Overall Study|Adverse Event|0|||
125250463|NCT03093870|450541781|FG002|Overall Study|Adverse Event|0|||
125250464|NCT03093870|450541779|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
125250465|NCT03093870|450541780|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
125250466|NCT03093870|450541781|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
125250467|NCT03093870|450541779|FG000|Overall Study|Lost to Follow-up|0|||
125250468|NCT03093870|450541780|FG001|Overall Study|Lost to Follow-up|0|||
125250469|NCT03093870|450541781|FG002|Overall Study|Lost to Follow-up|1|||
125250470|NCT04008069|450541782|FG000|Open-Label Period|Adverse Event|1|||
125250471|NCT04008069|450541783|FG001|Open-Label Period|Adverse Event|0|||
125250472|NCT04008069|450541784|FG002|Open-Label Period|Adverse Event|0|||
125250473|NCT04008069|450541782|FG000|Open-Label Period|Lack of Efficacy|4|||
125250474|NCT04008069|450541783|FG001|Open-Label Period|Lack of Efficacy|0|||
125250475|NCT04008069|450541784|FG002|Open-Label Period|Lack of Efficacy|0|||
125250476|NCT04008069|450541782|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
125250477|NCT04008069|450541783|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
125250478|NCT04008069|450541784|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
125250479|NCT04008069|450541782|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
125250480|NCT04008069|450541783|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
125250481|NCT04008069|450541784|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
125250482|NCT02134028|450541785|FG000|Overall Study|Lack of Efficacy|1|||
125250483|NCT02134028|450541786|FG001|Overall Study|Lack of Efficacy|0|||
125250484|NCT02134028|450541787|FG002|Overall Study|Lack of Efficacy|3|||
125250485|NCT02134028|450541788|FG003|Overall Study|Lack of Efficacy|2|||
125250486|NCT02134028|450541789|FG004|Overall Study|Lack of Efficacy|1|||
125250487|NCT02134028|450541790|FG005|Overall Study|Lack of Efficacy|2|||
125250488|NCT02134028|450541791|FG006|Overall Study|Lack of Efficacy|1|||
125250489|NCT02134028|450541792|FG007|Overall Study|Lack of Efficacy|0|||
125250490|NCT02134028|450541785|FG000|Overall Study|Poor compliance to protocol|1|||
125250491|NCT02134028|450541786|FG001|Overall Study|Poor compliance to protocol|1|||
125250492|NCT02134028|450541787|FG002|Overall Study|Poor compliance to protocol|3|||
125250493|NCT02134028|450541788|FG003|Overall Study|Poor compliance to protocol|7|||
125250494|NCT02134028|450541789|FG004|Overall Study|Poor compliance to protocol|1|||
125250495|NCT02134028|450541790|FG005|Overall Study|Poor compliance to protocol|1|||
125250496|NCT02134028|450541791|FG006|Overall Study|Poor compliance to protocol|0|||
125250497|NCT02134028|450541792|FG007|Overall Study|Poor compliance to protocol|0|||
125250498|NCT02134028|450541785|FG000|Overall Study|Other unspecified|4|||
125250499|NCT02134028|450541786|FG001|Overall Study|Other unspecified|22|||
125250500|NCT02134028|450541787|FG002|Overall Study|Other unspecified|33|||
125250501|NCT02134028|450541788|FG003|Overall Study|Other unspecified|64|||
125250502|NCT02134028|450541789|FG004|Overall Study|Other unspecified|8|||
125250503|NCT02134028|450541790|FG005|Overall Study|Other unspecified|6|||
125250504|NCT02134028|450541791|FG006|Overall Study|Other unspecified|2|||
125250505|NCT02134028|450541792|FG007|Overall Study|Other unspecified|1|||
125250506|NCT02134028|450541785|FG000|Overall Study|Adverse Event|3|||
125250507|NCT02134028|450541786|FG001|Overall Study|Adverse Event|19|||
125250508|NCT02134028|450541787|FG002|Overall Study|Adverse Event|13|||
125250509|NCT02134028|450541788|FG003|Overall Study|Adverse Event|32|||
125250510|NCT02134028|450541789|FG004|Overall Study|Adverse Event|4|||
125250511|NCT02134028|450541790|FG005|Overall Study|Adverse Event|5|||
125250512|NCT02134028|450541791|FG006|Overall Study|Adverse Event|1|||
125250513|NCT02134028|450541792|FG007|Overall Study|Adverse Event|2|||
125250514|NCT00819832|450541795|FG000|Overall Study|Sponsor Termination of Study|3|||
125250515|NCT00819832|450541796|FG001|Overall Study|Sponsor Termination of Study|0|||
125250516|NCT00819832|450541797|FG002|Overall Study|Sponsor Termination of Study|0|||
125250517|NCT00819832|450541798|FG003|Overall Study|Sponsor Termination of Study|0|||
125250518|NCT00819832|450541799|FG004|Overall Study|Sponsor Termination of Study|0|||
125250519|NCT00819832|450541800|FG005|Overall Study|Sponsor Termination of Study|0|||
125250520|NCT01260311|450541808|FG000|Overall Study|Adverse Event|11|||
125250521|NCT01260311|450541808|FG000|Overall Study|Lack of Efficacy|4|||
125250522|NCT01260311|450541808|FG000|Overall Study|Lost to Follow-up|25|||
125250523|NCT01260311|450541808|FG000|Overall Study|Withdrawal by Subject|6|||
125250524|NCT01260311|450541808|FG000|Overall Study|Financial Constraints|77|||
125250525|NCT01260311|450541808|FG000|Overall Study|Gone to Province|2|||
125250526|NCT01260311|450541808|FG000|Overall Study|Medication Stopped|1|||
125250527|NCT01260311|450541808|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
125250528|NCT01452789|450541809|FG000|Overall Study|Withdrawal by Subject|3|||
125250529|NCT01452789|450541810|FG001|Overall Study|Withdrawal by Subject|2|||
125250530|NCT00066170|450541811|FG000|Overall Study|Adverse Event|2|||
125250531|NCT00066170|450541812|FG001|Overall Study|Adverse Event|4|||
125250532|NCT00066170|450541813|FG002|Overall Study|Adverse Event|1|||
125250533|NCT00066170|450541814|FG003|Overall Study|Adverse Event|7|||
125250534|NCT00066170|450541811|FG000|Overall Study|Serious Adverse Event|0|||
125250535|NCT00066170|450541812|FG001|Overall Study|Serious Adverse Event|0|||
125250536|NCT00066170|450541813|FG002|Overall Study|Serious Adverse Event|1|||
125250537|NCT00066170|450541814|FG003|Overall Study|Serious Adverse Event|1|||
125250538|NCT00066170|450541811|FG000|Overall Study|Lost to Follow-up|0|||
125250539|NCT00066170|450541812|FG001|Overall Study|Lost to Follow-up|1|||
125250540|NCT00066170|450541813|FG002|Overall Study|Lost to Follow-up|0|||
125250541|NCT00066170|450541814|FG003|Overall Study|Lost to Follow-up|0|||
125250542|NCT00066170|450541811|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
125250543|NCT00066170|450541812|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
125250544|NCT00066170|450541813|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
125250545|NCT00066170|450541814|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
125250546|NCT00066170|450541811|FG000|Overall Study|Protocol Violation|3|||
125250547|NCT00066170|450541812|FG001|Overall Study|Protocol Violation|0|||
125250548|NCT00066170|450541813|FG002|Overall Study|Protocol Violation|0|||
125250549|NCT00066170|450541814|FG003|Overall Study|Protocol Violation|0|||
125250550|NCT00066170|450541811|FG000|Overall Study|Other|1|||
125250551|NCT00066170|450541812|FG001|Overall Study|Other|5|||
125250552|NCT00066170|450541813|FG002|Overall Study|Other|2|||
125250553|NCT00066170|450541814|FG003|Overall Study|Other|0|||
125250554|NCT00098293|450541815|FG000|Double-blind (DB) Phase|Adverse Event|14|||
125250555|NCT00098293|450541816|FG001|Double-blind (DB) Phase|Adverse Event|27|||
125250556|NCT00098293|450541817|FG002|Double-blind (DB) Phase|Adverse Event|60|||
125250557|NCT00098293|450541818|FG003|Double-blind (DB) Phase|Adverse Event|0|||
125197309|NCT01867710|450343921|FG000|Overall Study|Biochemical progression|0|||
125197310|NCT01867710|450343922|FG001|Overall Study|Biochemical progression|1|||
125197311|NCT01867710|450343923|FG002|Overall Study|Biochemical progression|0|||
125197312|NCT01867710|450343924|FG003|Overall Study|Biochemical progression|0|||
125197313|NCT01867710|450343921|FG000|Overall Study|Clinical progression|0|||
125197314|NCT01867710|450343922|FG001|Overall Study|Clinical progression|0|||
125197315|NCT01867710|450343923|FG002|Overall Study|Clinical progression|1|||
125197316|NCT01867710|450343924|FG003|Overall Study|Clinical progression|0|||
125197317|NCT01867710|450343921|FG000|Overall Study|Disease progression|1|||
125197318|NCT01867710|450343922|FG001|Overall Study|Disease progression|0|||
125197319|NCT01867710|450343923|FG002|Overall Study|Disease progression|0|||
125197320|NCT01867710|450343924|FG003|Overall Study|Disease progression|0|||
125197321|NCT01867710|450343921|FG000|Overall Study|Patient decision|0|||
125197322|NCT01867710|450343922|FG001|Overall Study|Patient decision|0|||
125197323|NCT01867710|450343923|FG002|Overall Study|Patient decision|0|||
125197324|NCT01867710|450343924|FG003|Overall Study|Patient decision|1|||
125197325|NCT01867710|450343921|FG000|Overall Study|Patient to follow subsequent treatment|0|||
125197326|NCT01867710|450343922|FG001|Overall Study|Patient to follow subsequent treatment|1|||
125197327|NCT01867710|450343923|FG002|Overall Study|Patient to follow subsequent treatment|0|||
125197328|NCT01867710|450343924|FG003|Overall Study|Patient to follow subsequent treatment|0|||
125197329|NCT01867710|450343921|FG000|Overall Study|Progressive disease|1|||
125197330|NCT01867710|450343922|FG001|Overall Study|Progressive disease|0|||
125197331|NCT01867710|450343923|FG002|Overall Study|Progressive disease|0|||
125197332|NCT01867710|450343924|FG003|Overall Study|Progressive disease|0|||
125197333|NCT01867710|450343921|FG000|Overall Study|Protocol Violation|0|||
125197334|NCT01867710|450343922|FG001|Overall Study|Protocol Violation|0|||
125197335|NCT01867710|450343923|FG002|Overall Study|Protocol Violation|0|||
125197336|NCT01867710|450343924|FG003|Overall Study|Protocol Violation|1|||
125197337|NCT01867710|450343921|FG000|Overall Study|PSA-progression|0|||
125197338|NCT01867710|450343922|FG001|Overall Study|PSA-progression|1|||
125197339|NCT01867710|450343923|FG002|Overall Study|PSA-progression|0|||
125197340|NCT01867710|450343924|FG003|Overall Study|PSA-progression|0|||
125197341|NCT01867710|450343921|FG000|Overall Study|Study medication no longer effective|0|||
125197342|NCT01867710|450343922|FG001|Overall Study|Study medication no longer effective|1|||
125197343|NCT01867710|450343923|FG002|Overall Study|Study medication no longer effective|0|||
125197344|NCT01867710|450343924|FG003|Overall Study|Study medication no longer effective|0|||
125197345|NCT01062113|450343925|FG000|Overall Study|Adverse Event|1|||
125197346|NCT01062113|450343926|FG001|Overall Study|Adverse Event|0|||
125197347|NCT01062113|450343927|FG002|Overall Study|Adverse Event|0|||
125197348|NCT01062113|450343925|FG000|Overall Study|Lack of Efficacy|38|||
125197349|NCT01062113|450343926|FG001|Overall Study|Lack of Efficacy|22|||
125197350|NCT01062113|450343927|FG002|Overall Study|Lack of Efficacy|31|||
125197351|NCT01062113|450343925|FG000|Overall Study|Withdrawal by Subject|1|||
125197352|NCT01062113|450343926|FG001|Overall Study|Withdrawal by Subject|0|||
125197353|NCT01062113|450343927|FG002|Overall Study|Withdrawal by Subject|0|||
125197354|NCT01082211|450343938|FG000|Overall Study|Protocol Violation|4|||
125197355|NCT01082211|450343938|FG000|Overall Study|No protocol treatment received|3|||
125197356|NCT03702010|450343941|FG000|Follow-up (30days)|Lack of Efficacy|2|||
125197357|NCT03702010|450343942|FG001|Follow-up (30days)|Lack of Efficacy|2|||
125197358|NCT01137110|450343949|FG000|Overall Study|Protocol Violation|1|||
125197359|NCT01137110|450343950|FG001|Overall Study|Protocol Violation|0|||
125197360|NCT02394340|450343957|FG000|Overall Study|Failed drug screen test|1|||
125197361|NCT02394340|450343957|FG000|Overall Study|Adverse Event|1|||
125197362|NCT00256854|450343958|FG000|Overall Study|Withdrawal by Subject|2|||
125197363|NCT00256854|450343959|FG001|Overall Study|Withdrawal by Subject|3|||
125197364|NCT00256854|450343960|FG002|Overall Study|Withdrawal by Subject|0|||
125197365|NCT00256854|450343961|FG003|Overall Study|Withdrawal by Subject|0|||
125197366|NCT00256854|450343962|FG004|Overall Study|Withdrawal by Subject|0|||
125197367|NCT00256854|450343963|FG005|Overall Study|Withdrawal by Subject|0|||
125197368|NCT00256854|450343958|FG000|Overall Study|Lack of Efficacy|1|||
125197369|NCT00256854|450343959|FG001|Overall Study|Lack of Efficacy|0|||
125197370|NCT00256854|450343960|FG002|Overall Study|Lack of Efficacy|0|||
125197371|NCT00256854|450343961|FG003|Overall Study|Lack of Efficacy|0|||
125197372|NCT00256854|450343962|FG004|Overall Study|Lack of Efficacy|0|||
125197373|NCT00256854|450343963|FG005|Overall Study|Lack of Efficacy|0|||
125197374|NCT00256854|450343958|FG000|Overall Study|Protocol Violation|0|||
125197375|NCT00256854|450343959|FG001|Overall Study|Protocol Violation|1|||
125197376|NCT00256854|450343960|FG002|Overall Study|Protocol Violation|1|||
125197377|NCT00256854|450343961|FG003|Overall Study|Protocol Violation|1|||
125197378|NCT00256854|450343962|FG004|Overall Study|Protocol Violation|0|||
125197379|NCT00256854|450343963|FG005|Overall Study|Protocol Violation|0|||
125197380|NCT00256854|450343958|FG000|Overall Study|Adverse Event|0|||
125197381|NCT00256854|450343959|FG001|Overall Study|Adverse Event|0|||
125197382|NCT00256854|450343960|FG002|Overall Study|Adverse Event|2|||
125197383|NCT00256854|450343961|FG003|Overall Study|Adverse Event|2|||
125250558|NCT00098293|450541819|FG004|Double-blind (DB) Phase|Adverse Event|0|||
125250559|NCT00098293|450541815|FG000|Double-blind (DB) Phase|Pregnancy|0|||
125250560|NCT00098293|450541816|FG001|Double-blind (DB) Phase|Pregnancy|7|||
125250561|NCT00098293|450541817|FG002|Double-blind (DB) Phase|Pregnancy|9|||
125250562|NCT00098293|450541818|FG003|Double-blind (DB) Phase|Pregnancy|0|||
125250563|NCT00098293|450541819|FG004|Double-blind (DB) Phase|Pregnancy|0|||
125250564|NCT00098293|450541815|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
125250565|NCT00098293|450541816|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
125250566|NCT00098293|450541817|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
125250567|NCT00098293|450541818|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
125250568|NCT00098293|450541819|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
125250569|NCT00098293|450541815|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
125250570|NCT00098293|450541816|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
125250571|NCT00098293|450541817|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
125250572|NCT00098293|450541818|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
125250573|NCT00098293|450541819|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
125250574|NCT00098293|450541815|FG000|Double-blind (DB) Phase|Death|1|||
125250575|NCT00098293|450541816|FG001|Double-blind (DB) Phase|Death|2|||
125250576|NCT00098293|450541817|FG002|Double-blind (DB) Phase|Death|2|||
125250577|NCT00098293|450541818|FG003|Double-blind (DB) Phase|Death|0|||
125250578|NCT00098293|450541819|FG004|Double-blind (DB) Phase|Death|0|||
125250579|NCT00098293|450541815|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
125250580|NCT00098293|450541816|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
125250581|NCT00098293|450541817|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
125250582|NCT00098293|450541818|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
125250583|NCT00098293|450541819|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
125250584|NCT00098293|450541815|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
125250585|NCT00098293|450541816|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
125250586|NCT00098293|450541817|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
125250587|NCT00098293|450541818|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
125250588|NCT00098293|450541819|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
125250589|NCT00098293|450541815|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
125250590|NCT00098293|450541816|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
125250591|NCT00098293|450541817|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
125250592|NCT00098293|450541818|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
125250593|NCT00098293|450541819|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
125250594|NCT00098293|450541815|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
125250595|NCT00098293|450541816|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
125250596|NCT00098293|450541817|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
125250597|NCT00098293|450541818|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
125250598|NCT00098293|450541819|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
125250599|NCT00098293|450541815|FG000|Open-label (OL) Phase|Adverse Event|0|||
125250600|NCT00098293|450541816|FG001|Open-label (OL) Phase|Adverse Event|3|||
125250601|NCT00098293|450541817|FG002|Open-label (OL) Phase|Adverse Event|7|||
125250602|NCT00098293|450541818|FG003|Open-label (OL) Phase|Adverse Event|6|||
125250603|NCT00098293|450541819|FG004|Open-label (OL) Phase|Adverse Event|0|||
125250604|NCT00098293|450541815|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
125250605|NCT00098293|450541816|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
125250606|NCT00098293|450541817|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
125250607|NCT00098293|450541818|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
125250608|NCT00098293|450541819|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
125250609|NCT00098293|450541815|FG000|Open-label (OL) Phase|Pregnancy|0|||
125250610|NCT00098293|450541816|FG001|Open-label (OL) Phase|Pregnancy|1|||
125250611|NCT00098293|450541817|FG002|Open-label (OL) Phase|Pregnancy|0|||
125250612|NCT00098293|450541818|FG003|Open-label (OL) Phase|Pregnancy|3|||
125250613|NCT00098293|450541819|FG004|Open-label (OL) Phase|Pregnancy|0|||
125250614|NCT00098293|450541815|FG000|Open-label (OL) Phase|Protocol Violation|0|||
125250615|NCT00098293|450541816|FG001|Open-label (OL) Phase|Protocol Violation|6|||
125250616|NCT00098293|450541817|FG002|Open-label (OL) Phase|Protocol Violation|13|||
125250617|NCT00098293|450541818|FG003|Open-label (OL) Phase|Protocol Violation|16|||
125250618|NCT00098293|450541819|FG004|Open-label (OL) Phase|Protocol Violation|0|||
125250619|NCT00098293|450541815|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
125250620|NCT00098293|450541816|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
125250621|NCT00098293|450541817|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
125250622|NCT00098293|450541818|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
125250623|NCT00098293|450541819|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
125250624|NCT00098293|450541815|FG000|Open-label (OL) Phase|Death|0|||
125250625|NCT00098293|450541816|FG001|Open-label (OL) Phase|Death|2|||
125250626|NCT00098293|450541817|FG002|Open-label (OL) Phase|Death|3|||
125250627|NCT00098293|450541818|FG003|Open-label (OL) Phase|Death|0|||
125250628|NCT00098293|450541819|FG004|Open-label (OL) Phase|Death|0|||
125250629|NCT00098293|450541815|FG000|Supplemental Phase (SP)|Death|0|||
125250630|NCT00098293|450541816|FG001|Supplemental Phase (SP)|Death|0|||
125250631|NCT00098293|450541817|FG002|Supplemental Phase (SP)|Death|0|||
125250632|NCT00098293|450541818|FG003|Supplemental Phase (SP)|Death|0|||
125250633|NCT00098293|450541819|FG004|Supplemental Phase (SP)|Death|1|||
125250634|NCT00098293|450541815|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
125250635|NCT00098293|450541816|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
125250636|NCT00098293|450541817|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
125250637|NCT00098293|450541818|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
125250638|NCT00098293|450541819|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
125250639|NCT00098293|450541815|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
125250640|NCT00098293|450541816|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
125250641|NCT00098293|450541817|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
125250642|NCT00098293|450541818|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
125250643|NCT00098293|450541819|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
125250644|NCT00098293|450541815|FG000|Supplemental Phase (SP)|Other|0|||
125250645|NCT00098293|450541816|FG001|Supplemental Phase (SP)|Other|0|||
125250646|NCT00098293|450541817|FG002|Supplemental Phase (SP)|Other|0|||
125250647|NCT00098293|450541818|FG003|Supplemental Phase (SP)|Other|0|||
125250648|NCT00098293|450541819|FG004|Supplemental Phase (SP)|Other|22|||
125250649|NCT01370642|450541820|FG000|Overall Study|Adverse Event|2|||
125250650|NCT01370642|450541821|FG001|Overall Study|Adverse Event|1|||
125250651|NCT01370642|450541822|FG002|Overall Study|Adverse Event|1|||
125250652|NCT01370642|450541820|FG000|Overall Study|Detectable HCV RNA|0|||
125250653|NCT01370642|450541821|FG001|Overall Study|Detectable HCV RNA|0|||
125250654|NCT01370642|450541822|FG002|Overall Study|Detectable HCV RNA|22|||
125250655|NCT01370642|450541820|FG000|Overall Study|Lost to Follow-up|0|||
125250656|NCT01370642|450541821|FG001|Overall Study|Lost to Follow-up|0|||
125250657|NCT01370642|450541822|FG002|Overall Study|Lost to Follow-up|1|||
125250658|NCT01370642|450541820|FG000|Overall Study|Physician Decision|4|||
125250659|NCT01370642|450541821|FG001|Overall Study|Physician Decision|1|||
125250660|NCT01370642|450541822|FG002|Overall Study|Physician Decision|2|||
125250661|NCT01370642|450541820|FG000|Overall Study|Withdrawal by Subject|2|||
125250662|NCT01370642|450541821|FG001|Overall Study|Withdrawal by Subject|4|||
125250663|NCT01370642|450541822|FG002|Overall Study|Withdrawal by Subject|3|||
125250664|NCT01796470|450541823|FG000|Overall Study|Adverse Event|4|||
125250665|NCT01796470|450541824|FG001|Overall Study|Adverse Event|2|||
125250666|NCT01796470|450541825|FG002|Overall Study|Adverse Event|2|||
125250667|NCT01796470|450541826|FG003|Overall Study|Adverse Event|1|||
125250668|NCT01796470|450541827|FG004|Overall Study|Adverse Event|3|||
125250669|NCT01796470|450541823|FG000|Overall Study|Death|2|||
125250670|NCT01796470|450541824|FG001|Overall Study|Death|0|||
125250671|NCT01796470|450541825|FG002|Overall Study|Death|0|||
125250672|NCT01796470|450541826|FG003|Overall Study|Death|0|||
125250673|NCT01796470|450541827|FG004|Overall Study|Death|1|||
125250674|NCT01796470|450541823|FG000|Overall Study|Initiated New Therapy|9|||
125250675|NCT01796470|450541824|FG001|Overall Study|Initiated New Therapy|0|||
125250676|NCT01796470|450541825|FG002|Overall Study|Initiated New Therapy|0|||
125250677|NCT01796470|450541826|FG003|Overall Study|Initiated New Therapy|0|||
125250678|NCT01796470|450541827|FG004|Overall Study|Initiated New Therapy|2|||
125250679|NCT01796470|450541823|FG000|Overall Study|Lost to Follow-up|0|||
125250680|NCT01796470|450541824|FG001|Overall Study|Lost to Follow-up|1|||
125250681|NCT01796470|450541825|FG002|Overall Study|Lost to Follow-up|0|||
125250682|NCT01796470|450541826|FG003|Overall Study|Lost to Follow-up|0|||
125250683|NCT01796470|450541827|FG004|Overall Study|Lost to Follow-up|0|||
125250684|NCT01796470|450541823|FG000|Overall Study|Physician Decision|5|||
125250685|NCT01796470|450541824|FG001|Overall Study|Physician Decision|4|||
125250686|NCT01796470|450541825|FG002|Overall Study|Physician Decision|1|||
125250687|NCT01796470|450541826|FG003|Overall Study|Physician Decision|0|||
125250688|NCT01796470|450541827|FG004|Overall Study|Physician Decision|1|||
125250689|NCT01796470|450541823|FG000|Overall Study|Progressive Disease|7|||
125250690|NCT01796470|450541824|FG001|Overall Study|Progressive Disease|7|||
125250691|NCT01796470|450541825|FG002|Overall Study|Progressive Disease|3|||
125250692|NCT01796470|450541826|FG003|Overall Study|Progressive Disease|2|||
125250693|NCT01796470|450541827|FG004|Overall Study|Progressive Disease|0|||
125250694|NCT01796470|450541823|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
125250695|NCT01796470|450541824|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
125250696|NCT01796470|450541825|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
125250697|NCT01796470|450541826|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
125250698|NCT01796470|450541827|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
125250699|NCT01796470|450541823|FG000|Overall Study|Withdrawal by Subject|7|||
125250700|NCT01796470|450541824|FG001|Overall Study|Withdrawal by Subject|0|||
125250701|NCT01796470|450541825|FG002|Overall Study|Withdrawal by Subject|0|||
125250702|NCT01796470|450541826|FG003|Overall Study|Withdrawal by Subject|0|||
125250703|NCT01796470|450541827|FG004|Overall Study|Withdrawal by Subject|1|||
125250704|NCT01927861|450541834|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
125250705|NCT01927861|450541835|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
125250706|NCT01927861|450541834|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
125250707|NCT01927861|450541835|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
125250708|NCT00987935|450541836|FG000|Overall Study|Progressive disease|3|||
125250709|NCT00987935|450541837|FG001|Overall Study|Progressive disease|2|||
125250710|NCT00987935|450541838|FG002|Overall Study|Progressive disease|3|||
125250711|NCT00987935|450541839|FG003|Overall Study|Progressive disease|2|||
125250712|NCT00987935|450541840|FG004|Overall Study|Progressive disease|5|||
125250713|NCT00987935|450541841|FG005|Overall Study|Progressive disease|3|||
125250714|NCT00987935|450541842|FG006|Overall Study|Progressive disease|9|||
125250715|NCT00987935|450541843|FG007|Overall Study|Progressive disease|48|||
125250716|NCT00987935|450541844|FG008|Overall Study|Progressive disease|23|||
125250717|NCT00987935|450541836|FG000|Overall Study|Adverse Event|0|||
125250718|NCT00987935|450541837|FG001|Overall Study|Adverse Event|1|||
125250719|NCT00987935|450541838|FG002|Overall Study|Adverse Event|0|||
125250720|NCT00987935|450541839|FG003|Overall Study|Adverse Event|1|||
125250721|NCT00987935|450541840|FG004|Overall Study|Adverse Event|1|||
125250722|NCT00987935|450541841|FG005|Overall Study|Adverse Event|0|||
125250723|NCT00987935|450541842|FG006|Overall Study|Adverse Event|2|||
125250724|NCT00987935|450541843|FG007|Overall Study|Adverse Event|10|||
125250725|NCT00987935|450541844|FG008|Overall Study|Adverse Event|6|||
125250726|NCT00987935|450541836|FG000|Overall Study|Refused to continue taking trial med.|1|||
125250727|NCT00987935|450541837|FG001|Overall Study|Refused to continue taking trial med.|0|||
125250728|NCT00987935|450541838|FG002|Overall Study|Refused to continue taking trial med.|0|||
125250729|NCT00987935|450541839|FG003|Overall Study|Refused to continue taking trial med.|0|||
125250730|NCT00987935|450541840|FG004|Overall Study|Refused to continue taking trial med.|1|||
125250731|NCT00987935|450541841|FG005|Overall Study|Refused to continue taking trial med.|0|||
125250732|NCT00987935|450541842|FG006|Overall Study|Refused to continue taking trial med.|4|||
125250733|NCT00987935|450541843|FG007|Overall Study|Refused to continue taking trial med.|4|||
125250734|NCT00987935|450541844|FG008|Overall Study|Refused to continue taking trial med.|2|||
125250735|NCT00987935|450541836|FG000|Overall Study|Reason other than those specified above|0|||
125250736|NCT00987935|450541837|FG001|Overall Study|Reason other than those specified above|0|||
125250737|NCT00987935|450541838|FG002|Overall Study|Reason other than those specified above|0|||
125250738|NCT00987935|450541839|FG003|Overall Study|Reason other than those specified above|0|||
125250739|NCT00987935|450541840|FG004|Overall Study|Reason other than those specified above|0|||
125250740|NCT00987935|450541841|FG005|Overall Study|Reason other than those specified above|0|||
125250741|NCT00987935|450541842|FG006|Overall Study|Reason other than those specified above|0|||
125250742|NCT00987935|450541843|FG007|Overall Study|Reason other than those specified above|0|||
125250743|NCT00987935|450541844|FG008|Overall Study|Reason other than those specified above|1|||
125250744|NCT01089543|450541845|FG000|Overall Study|Withdrawal by Subject|2|||
125250745|NCT01089543|450541846|FG001|Overall Study|Withdrawal by Subject|3|||
125250746|NCT01089543|450541847|FG002|Overall Study|Withdrawal by Subject|3|||
125250747|NCT01089543|450541848|FG003|Overall Study|Withdrawal by Subject|1|||
125250748|NCT01089543|450541845|FG000|Overall Study|Physician Decision|1|||
125250749|NCT01089543|450541846|FG001|Overall Study|Physician Decision|0|||
125250750|NCT01089543|450541847|FG002|Overall Study|Physician Decision|0|||
125250751|NCT01089543|450541848|FG003|Overall Study|Physician Decision|1|||
125250752|NCT01089543|450541845|FG000|Overall Study|Adverse Event|0|||
125250753|NCT01089543|450541846|FG001|Overall Study|Adverse Event|1|||
125250754|NCT01089543|450541847|FG002|Overall Study|Adverse Event|0|||
125250755|NCT01089543|450541848|FG003|Overall Study|Adverse Event|0|||
125250756|NCT01248468|450541850|FG000|Overall Study|Administrative problem|1|||
125250757|NCT01248468|450541851|FG001|Overall Study|Administrative problem|0|||
125250758|NCT01248468|450541852|FG002|Overall Study|Administrative problem|0|||
125250759|NCT01248468|450541850|FG000|Overall Study|Lost to Follow-up|9|||
125250760|NCT01248468|450541851|FG001|Overall Study|Lost to Follow-up|12|||
125250761|NCT01248468|450541852|FG002|Overall Study|Lost to Follow-up|4|||
125250762|NCT01248468|450541850|FG000|Overall Study|Pregnancy|1|||
125250763|NCT01248468|450541851|FG001|Overall Study|Pregnancy|0|||
125250764|NCT01248468|450541852|FG002|Overall Study|Pregnancy|0|||
125250765|NCT01248468|450541850|FG000|Overall Study|Withdrawal by Subject|4|||
125250766|NCT01248468|450541851|FG001|Overall Study|Withdrawal by Subject|2|||
125250767|NCT01248468|450541852|FG002|Overall Study|Withdrawal by Subject|0|||
125250768|NCT00345592|450541853|FG000|Overall Study|Death|14|||
125250769|NCT00345592|450541854|FG001|Overall Study|Death|16|||
125250770|NCT00345592|450541853|FG000|Overall Study|Withdrawal by Subject|11|||
125250771|NCT00345592|450541854|FG001|Overall Study|Withdrawal by Subject|8|||
125250772|NCT02176525|450541856|FG000|Overall Study|Adverse Event|0|||
125250773|NCT02176525|450541857|FG001|Overall Study|Adverse Event|0|||
125250774|NCT02176525|450541858|FG002|Overall Study|Adverse Event|0|||
125250775|NCT02176525|450541859|FG003|Overall Study|Adverse Event|1|||
125250776|NCT02176525|450541860|FG004|Overall Study|Adverse Event|1|||
125250777|NCT02176525|450541861|FG005|Overall Study|Adverse Event|0|||
125250778|NCT02176525|450541862|FG006|Overall Study|Adverse Event|1|||
125250779|NCT02176525|450541863|FG007|Overall Study|Adverse Event|0|||
125250780|NCT02176525|450541856|FG000|Overall Study|not treated|1|||
125250781|NCT02176525|450541857|FG001|Overall Study|not treated|0|||
125250782|NCT02176525|450541858|FG002|Overall Study|not treated|0|||
125250783|NCT02176525|450541859|FG003|Overall Study|not treated|0|||
125250784|NCT02176525|450541860|FG004|Overall Study|not treated|0|||
125250785|NCT02176525|450541861|FG005|Overall Study|not treated|1|||
125250786|NCT02176525|450541862|FG006|Overall Study|not treated|0|||
125250787|NCT02176525|450541863|FG007|Overall Study|not treated|0|||
125250788|NCT00468546|450541864|FG000|Week 24 Analysis|Lack of Efficacy|83|||
125250789|NCT00468546|450541865|FG001|Week 24 Analysis|Lack of Efficacy|37|||
125250790|NCT00468546|450541864|FG000|Week 24 Analysis|Refused treatment|5|||
125250791|NCT00468546|450541865|FG001|Week 24 Analysis|Refused treatment|5|||
125250792|NCT00468546|450541864|FG000|Week 24 Analysis|Adverse Event|1|||
125250793|NCT00468546|450541865|FG001|Week 24 Analysis|Adverse Event|8|||
125250794|NCT00468546|450541864|FG000|Week 24 Analysis|Failure to return|3|||
125250795|NCT00468546|450541865|FG001|Week 24 Analysis|Failure to return|4|||
125250796|NCT00468546|450541864|FG000|Week 24 Analysis|Rescue therapy|2|||
125250797|NCT00468546|450541865|FG001|Week 24 Analysis|Rescue therapy|0|||
125250798|NCT00468546|450541864|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
125250799|NCT00468546|450541865|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
125250800|NCT00468546|450541864|FG000|Week 24 Analysis|Due to clinical hold|1|||
125250801|NCT00468546|450541865|FG001|Week 24 Analysis|Due to clinical hold|0|||
125250802|NCT00468546|450541864|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
125250803|NCT00468546|450541865|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
125250804|NCT00468546|450541864|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
125250805|NCT00468546|450541865|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
125250806|NCT00468546|450541864|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
125250807|NCT00468546|450541865|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
125250808|NCT00468546|450541864|FG000|Week 24 to Week 104 Analysis|Death|1|||
125250809|NCT00468546|450541865|FG001|Week 24 to Week 104 Analysis|Death|0|||
125250810|NCT00468546|450541864|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
125250811|NCT00468546|450541865|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
125250812|NCT00468546|450541864|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
125250813|NCT00468546|450541865|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
125250814|NCT00468546|450541864|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
125250815|NCT00468546|450541865|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
125250816|NCT00468546|450541864|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
125250817|NCT00468546|450541865|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
125250818|NCT00468546|450541864|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
125250819|NCT00468546|450541865|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
125250820|NCT00468546|450541864|FG000|Week 24 to Week 104 Analysis|Other|17|||
125250821|NCT00468546|450541865|FG001|Week 24 to Week 104 Analysis|Other|14|||
125250822|NCT00450749|450541871|FG000|Overall Study|Withdrawal by Subject|0|||
125250823|NCT00450749|450541872|FG001|Overall Study|Withdrawal by Subject|0|||
125250824|NCT00450749|450541873|FG002|Overall Study|Withdrawal by Subject|2|||
125250825|NCT00450749|450541871|FG000|Overall Study|Noncompliant|0|||
125250826|NCT00450749|450541872|FG001|Overall Study|Noncompliant|1|||
125250827|NCT00450749|450541873|FG002|Overall Study|Noncompliant|0|||
125250828|NCT01245049|450541874|FG000|Overall Study|Migrated/moved from study area|0|||
125250829|NCT01245049|450541875|FG001|Overall Study|Migrated/moved from study area|1|||
125250830|NCT01245049|450541874|FG000|Overall Study|Withdrawal by Subject|0|||
125250831|NCT01245049|450541875|FG001|Overall Study|Withdrawal by Subject|1|||
125250832|NCT01245049|450541874|FG000|Overall Study|Lost to Follow-up|1|||
125250833|NCT01245049|450541875|FG001|Overall Study|Lost to Follow-up|2|||
125250834|NCT01213251|450544041|FG000|Overall Study|Death|2|||
125250835|NCT01213251|450544042|FG001|Overall Study|Death|1|||
125250836|NCT01213251|450544043|FG002|Overall Study|Death|2|||
125250837|NCT01213251|450544041|FG000|Overall Study|Exit|3|||
125250838|NCT01213251|450544042|FG001|Overall Study|Exit|2|||
125250839|NCT01213251|450544043|FG002|Overall Study|Exit|8|||
125250840|NCT01213251|450544041|FG000|Overall Study|Protocol Violation|1|||
125250841|NCT01213251|450544042|FG001|Overall Study|Protocol Violation|1|||
125250842|NCT01213251|450544043|FG002|Overall Study|Protocol Violation|0|||
125250843|NCT01213251|450544041|FG000|Overall Study|Missed 18-Month Follow-up|0|||
125250844|NCT01213251|450544042|FG001|Overall Study|Missed 18-Month Follow-up|0|||
125250845|NCT01213251|450544043|FG002|Overall Study|Missed 18-Month Follow-up|1|||
125250846|NCT02529488|450544044|FG000|Overall Study|Adverse Event|1|||
125250847|NCT02529488|450544044|FG000|Overall Study|Death|3|||
125250848|NCT01557244|450544049|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
125250849|NCT01557244|450544050|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
125250850|NCT01557244|450544051|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
125250851|NCT01557244|450544052|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
125250852|NCT01557244|450544053|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
125250853|NCT01557244|450544054|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
125250854|NCT01557244|450544055|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
125250855|NCT01557244|450544049|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
125250856|NCT01557244|450544050|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
125197384|NCT00256854|450343962|FG004|Overall Study|Adverse Event|0|||
125250857|NCT01557244|450544051|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
125250858|NCT01557244|450544052|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
125250859|NCT01557244|450544053|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
125250860|NCT01557244|450544054|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
125250861|NCT01557244|450544055|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
125250862|NCT01557244|450544049|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
125250863|NCT01557244|450544050|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
125250864|NCT01557244|450544051|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
125250865|NCT01557244|450544052|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
125250866|NCT01557244|450544053|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
125250867|NCT01557244|450544054|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
125250868|NCT01557244|450544055|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
125250869|NCT01557244|450544049|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
125250870|NCT01557244|450544050|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
125250871|NCT01557244|450544051|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
125197385|NCT00256854|450343963|FG005|Overall Study|Adverse Event|1|||
125197386|NCT00256854|450343958|FG000|Overall Study|Not compliant with the study drug|0|||
125197387|NCT00256854|450343959|FG001|Overall Study|Not compliant with the study drug|0|||
125197388|NCT00256854|450343960|FG002|Overall Study|Not compliant with the study drug|0|||
125197389|NCT00256854|450343961|FG003|Overall Study|Not compliant with the study drug|0|||
125197390|NCT00256854|450343962|FG004|Overall Study|Not compliant with the study drug|1|||
125197391|NCT00256854|450343963|FG005|Overall Study|Not compliant with the study drug|0|||
125197392|NCT02004886|450343964|FG000|Overall Study|Adverse Event|0|||
125197393|NCT02004886|450343965|FG001|Overall Study|Adverse Event|1|||
125197394|NCT02004886|450343966|FG002|Overall Study|Adverse Event|0|||
125197395|NCT02004886|450343967|FG003|Overall Study|Adverse Event|0|||
125197396|NCT02004886|450343964|FG000|Overall Study|Unable to attend future visits|1|||
125197397|NCT02004886|450343965|FG001|Overall Study|Unable to attend future visits|0|||
125197398|NCT02004886|450343966|FG002|Overall Study|Unable to attend future visits|0|||
125197399|NCT02004886|450343967|FG003|Overall Study|Unable to attend future visits|0|||
125197400|NCT01876784|450343970|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
125197401|NCT01876784|450343971|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
125197402|NCT01876784|450343970|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
125197403|NCT01876784|450343971|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
125197404|NCT01876784|450343970|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
125250872|NCT01557244|450544052|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
125250873|NCT01557244|450544053|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
125250874|NCT01557244|450544054|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
125250875|NCT01557244|450544055|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
125250876|NCT01557244|450544049|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
125250877|NCT01557244|450544050|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
125250878|NCT01557244|450544051|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
125250879|NCT01557244|450544052|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
125250880|NCT01557244|450544053|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
125250881|NCT01557244|450544054|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
125250882|NCT01557244|450544055|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
125250883|NCT01557244|450544049|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
125250884|NCT01557244|450544050|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
125250885|NCT01557244|450544051|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
125250886|NCT01557244|450544052|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
125250887|NCT01557244|450544053|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
125250888|NCT01557244|450544054|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
125250889|NCT01557244|450544055|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
125250890|NCT01557244|450544049|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
125250891|NCT01557244|450544050|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
125250892|NCT01557244|450544051|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
125250893|NCT01557244|450544052|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
125250894|NCT01557244|450544053|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
125250895|NCT01557244|450544054|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
125250896|NCT01557244|450544055|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
125250897|NCT01557244|450544049|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
125250898|NCT01557244|450544050|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
125250899|NCT01557244|450544051|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
125250900|NCT01557244|450544052|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
125250901|NCT01557244|450544053|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
125250902|NCT01557244|450544054|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
125250903|NCT01557244|450544055|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
125250904|NCT01557244|450544049|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
125250905|NCT01557244|450544050|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
125250906|NCT01557244|450544051|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
125250907|NCT01557244|450544052|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
125250908|NCT01557244|450544053|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
125250909|NCT01557244|450544054|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
125250910|NCT01557244|450544055|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
125250911|NCT01557244|450544049|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
125250912|NCT01557244|450544050|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
125250913|NCT01557244|450544051|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
125250914|NCT01557244|450544052|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
125250915|NCT01557244|450544053|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
125250916|NCT01557244|450544054|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
125250917|NCT01557244|450544055|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
125250918|NCT01557244|450544049|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
125250919|NCT01557244|450544050|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
125250920|NCT01557244|450544051|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
125250921|NCT01557244|450544052|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
125250922|NCT01557244|450544053|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
125250923|NCT01557244|450544054|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
125250924|NCT01557244|450544055|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
125250925|NCT01557244|450544049|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
125250926|NCT01557244|450544050|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
125250927|NCT01557244|450544051|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
125250928|NCT01557244|450544052|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
125250929|NCT01557244|450544053|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
125250930|NCT01557244|450544054|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
125250931|NCT01557244|450544055|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
125250932|NCT01428713|450544056|FG000|Overall Study|Non-compliance|2|||
125250933|NCT01428713|450544057|FG001|Overall Study|Non-compliance|2|||
125250934|NCT01428713|450544056|FG000|Overall Study|Withdrawal by Subject|1|||
125250935|NCT01428713|450544057|FG001|Overall Study|Withdrawal by Subject|1|||
125250936|NCT01428713|450544056|FG000|Overall Study|Adverse Event|0|||
125250937|NCT01428713|450544057|FG001|Overall Study|Adverse Event|2|||
125250938|NCT00862277|450544058|FG000|Overall Study|Protocol Violation|1|||
125250939|NCT00862277|450544059|FG001|Overall Study|Protocol Violation|2|||
125250940|NCT00862277|450544060|FG002|Overall Study|Protocol Violation|5|||
125250941|NCT00871000|450544061|FG000|Overall Study|Withdrawal by Subject|1|||
125250942|NCT00871000|450544062|FG001|Overall Study|Withdrawal by Subject|0|||
125250943|NCT01052428|450544063|FG000|Overall Study|Death|1|||
125250944|NCT01052428|450544064|FG001|Overall Study|Death|0|||
125250945|NCT01052428|450544063|FG000|Overall Study|Withdrawal by Subject|0|||
125250946|NCT01052428|450544064|FG001|Overall Study|Withdrawal by Subject|1|||
125250947|NCT03400787|450544065|FG000|Overall Study|Lost to Follow-up|1|||
125250948|NCT03400787|450544066|FG001|Overall Study|Lost to Follow-up|0|||
125250949|NCT03400787|450544065|FG000|Overall Study|Death|1|||
125250950|NCT03400787|450544066|FG001|Overall Study|Death|0|||
125250951|NCT03400787|450544065|FG000|Overall Study|Protocol Violation|0|||
125250952|NCT03400787|450544066|FG001|Overall Study|Protocol Violation|2|||
125250953|NCT03400787|450544065|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
125250954|NCT03400787|450544066|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
125250955|NCT04432298|450544072|FG000|Overall Study|Other than specified|1|||
125250956|NCT04432298|450544073|FG001|Overall Study|Other than specified|0|||
125250957|NCT04432298|450544072|FG000|Overall Study|Lost to Follow-up|0|||
125250958|NCT04432298|450544073|FG001|Overall Study|Lost to Follow-up|1|||
125250959|NCT04432298|450544072|FG000|Overall Study|Death|3|||
125250960|NCT04432298|450544073|FG001|Overall Study|Death|2|||
125250961|NCT04432298|450544072|FG000|Overall Study|Withdrawal by Subject|2|||
125250962|NCT04432298|450544073|FG001|Overall Study|Withdrawal by Subject|0|||
125250963|NCT02365064|450544076|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
125250964|NCT02365064|450544077|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
125250965|NCT02365064|450544076|FG000|Overall Study|Withdrawal by Subject|6|||
125250966|NCT02365064|450544077|FG001|Overall Study|Withdrawal by Subject|9|||
125250967|NCT02365064|450544076|FG000|Overall Study|Treatment intolerance|2|||
125250968|NCT02365064|450544077|FG001|Overall Study|Treatment intolerance|4|||
125250969|NCT02451007|450544080|FG000|Overall Study|Withdrawal by Subject|4|||
125250970|NCT02451007|450544080|FG000|Overall Study|Adverse Event|1|||
125250971|NCT02451007|450544080|FG000|Overall Study|Disease Progression|2|||
125250972|NCT00348374|450544081|FG000|Overall Study|Adverse Event|1|||
125250973|NCT00348374|450544082|FG001|Overall Study|Adverse Event|4|||
125250974|NCT00348374|450544081|FG000|Overall Study|Lost to Follow-up|1|||
125250975|NCT00348374|450544082|FG001|Overall Study|Lost to Follow-up|3|||
125250976|NCT00348374|450544081|FG000|Overall Study|Withdrawal by Subject|5|||
125250977|NCT00348374|450544082|FG001|Overall Study|Withdrawal by Subject|5|||
125250978|NCT00348374|450544081|FG000|Overall Study|Other|11|||
125250979|NCT00348374|450544082|FG001|Overall Study|Other|12|||
125250980|NCT00348374|450544081|FG000|Overall Study|ongoing at date of cutoff|1|||
125250981|NCT00348374|450544082|FG001|Overall Study|ongoing at date of cutoff|1|||
125250982|NCT00348374|450544081|FG000|Overall Study|randomized but did not receive treatment|0|||
125250983|NCT00348374|450544082|FG001|Overall Study|randomized but did not receive treatment|7|||
125250984|NCT02595437|450544091|FG000|Triferic Via IV|Withdrawal by Subject|1|||
125250985|NCT02070380|450544092|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
125250986|NCT02070380|450544093|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
125250987|NCT02070380|450544094|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
125250988|NCT02070380|450544095|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
125250989|NCT02070380|450544092|FG000|Second Injection|Image sets missing or technically inadeq|0|||
125250990|NCT02070380|450544093|FG001|Second Injection|Image sets missing or technically inadeq|1|||
125250991|NCT02070380|450544094|FG002|Second Injection|Image sets missing or technically inadeq|0|||
125250992|NCT02070380|450544095|FG003|Second Injection|Image sets missing or technically inadeq|0|||
125250993|NCT02070380|450544092|FG000|Second Injection|Protocol Violation|0|||
125250994|NCT02070380|450544093|FG001|Second Injection|Protocol Violation|1|||
125250995|NCT02070380|450544094|FG002|Second Injection|Protocol Violation|1|||
125250996|NCT02070380|450544095|FG003|Second Injection|Protocol Violation|5|||
125250997|NCT02242903|450544099|FG000|Overall Study|Withdrawal by Subject|1|||
125250998|NCT02242903|450544100|FG001|Overall Study|Withdrawal by Subject|0|||
125250999|NCT02242903|450544101|FG002|Overall Study|Withdrawal by Subject|0|||
125251000|NCT02242903|450544102|FG003|Overall Study|Withdrawal by Subject|0|||
125251001|NCT02242903|450544103|FG004|Overall Study|Withdrawal by Subject|0|||
125251002|NCT02242903|450544104|FG005|Overall Study|Withdrawal by Subject|0|||
125251003|NCT02242903|450544105|FG006|Overall Study|Withdrawal by Subject|0|||
125251004|NCT02105012|450544108|FG000|Overall Study|Withdrawal by Subject|11|||
125251005|NCT02105012|450544108|FG000|Overall Study|Protocol Specified Criteria|9|||
125251006|NCT02105012|450544108|FG000|Overall Study|Lost to Follow-up|4|||
125251007|NCT02105012|450544108|FG000|Overall Study|Protocol Violation|4|||
125251008|NCT02105012|450544108|FG000|Overall Study|Physician Decision|3|||
125251009|NCT02105012|450544108|FG000|Overall Study|Adverse Event|1|||
125251010|NCT02105012|450544108|FG000|Overall Study|Lack of Efficacy|1|||
125251011|NCT00493285|450544109|FG000|Overall Study|Lost to Follow-up|0|||
125251012|NCT00493285|450544110|FG001|Overall Study|Lost to Follow-up|0|||
125251013|NCT00493285|450544111|FG002|Overall Study|Lost to Follow-up|0|||
125251014|NCT00493285|450544112|FG003|Overall Study|Lost to Follow-up|0|||
125251015|NCT00493285|450544113|FG004|Overall Study|Lost to Follow-up|1|||
125251016|NCT00493285|450544114|FG005|Overall Study|Lost to Follow-up|0|||
125251017|NCT04535362|450544115|FG000|Overall Study|Lost to Follow-up|3|||
125251018|NCT04535362|450544116|FG001|Overall Study|Lost to Follow-up|1|||
125251019|NCT03791060|450544117|FG000|Overall Study|Withdrawal by Subject|1|||
125251020|NCT02619812|450544122|FG000|Overall Study|Withdrawal by Subject|0|||
125251021|NCT02619812|450544123|FG001|Overall Study|Withdrawal by Subject|0|||
125251022|NCT02619812|450544124|FG002|Overall Study|Withdrawal by Subject|1|||
125251023|NCT02619812|450544125|FG003|Overall Study|Withdrawal by Subject|2|||
125251024|NCT00981175|450544126|FG000|Primary Dose Vaccination|Adverse Event|1|||
125251025|NCT00981175|450544127|FG001|Primary Dose Vaccination|Adverse Event|0|||
125251026|NCT00981175|450544126|FG000|Primary Dose Vaccination|Protocol Violation|0|||
125251027|NCT00981175|450544127|FG001|Primary Dose Vaccination|Protocol Violation|1|||
125251028|NCT00981175|450544126|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
125251029|NCT00981175|450544127|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
125251030|NCT00981175|450544126|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
125251031|NCT00981175|450544127|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
125251032|NCT01658735|450544130|FG000|Overall Study|Lack of Efficacy|1|||
125251033|NCT01658735|450544131|FG001|Overall Study|Lack of Efficacy|0|||
125251034|NCT01658735|450544132|FG002|Overall Study|Lack of Efficacy|1|||
125251035|NCT01658735|450544130|FG000|Overall Study|Lost to Follow-up|1|||
125251036|NCT01658735|450544131|FG001|Overall Study|Lost to Follow-up|1|||
125251037|NCT01658735|450544132|FG002|Overall Study|Lost to Follow-up|0|||
125251038|NCT01658735|450544130|FG000|Overall Study|Protocol Violation|0|||
125251039|NCT01658735|450544131|FG001|Overall Study|Protocol Violation|1|||
125251040|NCT01658735|450544132|FG002|Overall Study|Protocol Violation|0|||
125251041|NCT01658735|450544130|FG000|Overall Study|Withdrawal by Subject|3|||
125251042|NCT01658735|450544131|FG001|Overall Study|Withdrawal by Subject|5|||
125251043|NCT01658735|450544132|FG002|Overall Study|Withdrawal by Subject|3|||
125251044|NCT01379937|450544133|FG000|Overall Study|Protocol Violation|0|||
125251045|NCT01379937|450544134|FG001|Overall Study|Protocol Violation|0|||
125251046|NCT01379937|450544135|FG002|Overall Study|Protocol Violation|0|||
125251047|NCT01379937|450544136|FG003|Overall Study|Protocol Violation|1|||
125251048|NCT01379937|450544133|FG000|Overall Study|Consent withdrawal|0|||
125251049|NCT01379937|450544134|FG001|Overall Study|Consent withdrawal|1|||
125251050|NCT01379937|450544135|FG002|Overall Study|Consent withdrawal|0|||
125251051|NCT01379937|450544136|FG003|Overall Study|Consent withdrawal|0|||
125251052|NCT01379937|450544133|FG000|Overall Study|Lost to Follow-up|1|||
125251053|NCT01379937|450544134|FG001|Overall Study|Lost to Follow-up|2|||
125251054|NCT01379937|450544135|FG002|Overall Study|Lost to Follow-up|2|||
125251055|NCT01379937|450544136|FG003|Overall Study|Lost to Follow-up|0|||
125251056|NCT01104870|450544137|FG000|Overall Study|Adverse Event|1|||
125251057|NCT01104870|450544138|FG001|Overall Study|Adverse Event|1|||
125251058|NCT01104870|450544139|FG002|Overall Study|Adverse Event|0|||
125251059|NCT01104870|450544137|FG000|Overall Study|Death|0|||
125251060|NCT01104870|450544138|FG001|Overall Study|Death|0|||
125251061|NCT01104870|450544139|FG002|Overall Study|Death|1|||
125251062|NCT01104870|450544137|FG000|Overall Study|Withdrawal by Subject|0|||
125251063|NCT01104870|450544138|FG001|Overall Study|Withdrawal by Subject|0|||
125251064|NCT01104870|450544139|FG002|Overall Study|Withdrawal by Subject|1|||
125251065|NCT00079781|450544151|FG000|Pre-implant Period|Withdrawal by Subject|2|||
125251066|NCT00079781|450544152|FG001|Pre-implant Period|Withdrawal by Subject|0|||
125251067|NCT00079781|450544153|FG002|Pre-implant Period|Withdrawal by Subject|0|||
125251068|NCT00079781|450544151|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
125251069|NCT00079781|450544152|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
125251070|NCT00079781|450544153|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
125251071|NCT00079781|450544151|FG000|Follow-up Period|Withdrawal by Subject|3|||
125251072|NCT00079781|450544152|FG001|Follow-up Period|Withdrawal by Subject|0|||
125251073|NCT00079781|450544153|FG002|Follow-up Period|Withdrawal by Subject|1|||
125251074|NCT00079781|450544151|FG000|Follow-up Period|Lost to Follow-up|1|||
125251075|NCT00079781|450544152|FG001|Follow-up Period|Lost to Follow-up|0|||
125251076|NCT00079781|450544153|FG002|Follow-up Period|Lost to Follow-up|0|||
125251077|NCT00079781|450544151|FG000|Follow-up Period|Death|0|||
125251078|NCT00079781|450544152|FG001|Follow-up Period|Death|0|||
125251079|NCT00079781|450544153|FG002|Follow-up Period|Death|1|||
125251080|NCT04641975|450544154|FG000|Overall Study|Protocol Violation|1|||
125251081|NCT04641975|450544155|FG001|Overall Study|Protocol Violation|2|||
125251082|NCT04641975|450544156|FG002|Overall Study|Protocol Violation|0|||
125251083|NCT04641975|450544157|FG003|Overall Study|Protocol Violation|0|||
125251084|NCT04641975|450544154|FG000|Overall Study|Adverse Event|0|||
125251085|NCT04641975|450544155|FG001|Overall Study|Adverse Event|0|||
125251086|NCT04641975|450544156|FG002|Overall Study|Adverse Event|1|||
125251087|NCT04641975|450544157|FG003|Overall Study|Adverse Event|1|||
125251088|NCT04641975|450544154|FG000|Overall Study|Withdrawal by Subject|1|||
125251089|NCT04641975|450544155|FG001|Overall Study|Withdrawal by Subject|0|||
125251090|NCT04641975|450544156|FG002|Overall Study|Withdrawal by Subject|0|||
125251091|NCT04641975|450544157|FG003|Overall Study|Withdrawal by Subject|0|||
125251092|NCT02067156|450544160|FG000|Overall Study|Lost to Follow-up|4|||
125251093|NCT03596983|450544161|FG000|Overall Study|Withdrawal by Subject|3|||
125251094|NCT05287685|450544162|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
125251095|NCT05287685|450544163|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
125251096|NCT05287685|450544162|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
125251097|NCT05287685|450544163|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
125251098|NCT01340170|450544170|FG000|Overall Study|Lost to Follow-up|2|||
125251099|NCT01340170|450544171|FG001|Overall Study|Lost to Follow-up|4|||
125251100|NCT01340170|450544172|FG002|Overall Study|Lost to Follow-up|0|||
125251101|NCT01340170|450544170|FG000|Overall Study|Implant failure|1|||
125251102|NCT01340170|450544171|FG001|Overall Study|Implant failure|3|||
125251103|NCT01340170|450544172|FG002|Overall Study|Implant failure|0|||
125251104|NCT00472641|450544174|FG000|Overall Study|Lack of Efficacy|3|||
125251105|NCT00472641|450544174|FG000|Overall Study|Adverse Event|3|||
125251106|NCT00472641|450544174|FG000|Overall Study|Lost to Follow-up|1|||
125251107|NCT03721107|450544175|FG000|Overall Study|Adverse Event|1|||
125251108|NCT03721107|450544176|FG001|Overall Study|Adverse Event|1|||
125251109|NCT03721107|450544177|FG002|Overall Study|Adverse Event|6|||
125251110|NCT03721107|450544178|FG003|Overall Study|Adverse Event|5|||
125251111|NCT03721107|450544175|FG000|Overall Study|Lost to Follow-up|2|||
125251112|NCT03721107|450544176|FG001|Overall Study|Lost to Follow-up|0|||
125251113|NCT03721107|450544177|FG002|Overall Study|Lost to Follow-up|3|||
125251114|NCT03721107|450544178|FG003|Overall Study|Lost to Follow-up|0|||
125251115|NCT03721107|450544175|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
125251116|NCT03721107|450544176|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
125251117|NCT03721107|450544177|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
125251118|NCT03721107|450544178|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
125251119|NCT03721107|450544175|FG000|Overall Study|Physician Decision|0|||
125251120|NCT03721107|450544176|FG001|Overall Study|Physician Decision|1|||
125251121|NCT03721107|450544177|FG002|Overall Study|Physician Decision|0|||
125251122|NCT03721107|450544178|FG003|Overall Study|Physician Decision|0|||
125251123|NCT03721107|450544175|FG000|Overall Study|Pregnancy|0|||
125251124|NCT03721107|450544176|FG001|Overall Study|Pregnancy|0|||
125251125|NCT03721107|450544177|FG002|Overall Study|Pregnancy|1|||
125251126|NCT03721107|450544178|FG003|Overall Study|Pregnancy|0|||
125251127|NCT03721107|450544175|FG000|Overall Study|Withdrawal by Subject|1|||
125251128|NCT03721107|450544176|FG001|Overall Study|Withdrawal by Subject|1|||
125251129|NCT03721107|450544177|FG002|Overall Study|Withdrawal by Subject|5|||
125251130|NCT03721107|450544178|FG003|Overall Study|Withdrawal by Subject|5|||
125251131|NCT03721107|450544175|FG000|Overall Study|Other|1|||
125251132|NCT03721107|450544176|FG001|Overall Study|Other|0|||
125251133|NCT03721107|450544177|FG002|Overall Study|Other|0|||
125251134|NCT03721107|450544178|FG003|Overall Study|Other|1|||
125251135|NCT01189227|450544179|FG000|Overall Study|Study terminated due to low accrual|6|||
125251136|NCT01189227|450544180|FG001|Overall Study|Study terminated due to low accrual|3|||
125251137|NCT01608308|450544186|FG000|Overall Study|pretreatment medical and billing reasons|0|||
125251138|NCT01608308|450544187|FG001|Overall Study|pretreatment medical and billing reasons|2|||
125251139|NCT04648241|450544188|FG000|Overall Study|Lost to Follow-up|1|||
125251140|NCT04648241|450544189|FG001|Overall Study|Lost to Follow-up|0|||
125251141|NCT05259722|450544190|FG000|Overall Study|Adverse Event|2|||
125251142|NCT05259722|450544191|FG001|Overall Study|Adverse Event|24|||
125251143|NCT05259722|450544190|FG000|Overall Study|Lost to Follow-up|5|||
125251144|NCT05259722|450544191|FG001|Overall Study|Lost to Follow-up|1|||
125251145|NCT05259722|450544190|FG000|Overall Study|Lack of Efficacy|8|||
125251146|NCT05259722|450544191|FG001|Overall Study|Lack of Efficacy|26|||
125251147|NCT05259722|450544190|FG000|Overall Study|Withdrawal by Subject|15|||
125251148|NCT05259722|450544191|FG001|Overall Study|Withdrawal by Subject|33|||
125251149|NCT05259722|450544190|FG000|Overall Study|Various reasons|3|||
125251150|NCT05259722|450544191|FG001|Overall Study|Various reasons|9|||
125251151|NCT05259722|450544190|FG000|Overall Study|Not exposed to IMP|1|||
125251152|NCT05259722|450544191|FG001|Overall Study|Not exposed to IMP|12|||
125251153|NCT05259722|450544190|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
125251154|NCT05259722|450544191|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
125251155|NCT00962650|450544192|FG000|Overall Study|Transgastric DP was not completed|2|||
125251156|NCT02268851|450544194|FG000|Overall Study|Death|0|||
125251157|NCT02268851|450544195|FG001|Overall Study|Death|0|||
125251158|NCT02268851|450544196|FG002|Overall Study|Death|0|||
125251159|NCT02268851|450544197|FG003|Overall Study|Death|1|||
125251160|NCT02268851|450544198|FG004|Overall Study|Death|2|||
125251161|NCT02268851|450544199|FG005|Overall Study|Death|1|||
125251162|NCT02268851|450544194|FG000|Overall Study|Adverse Event|0|||
125251163|NCT02268851|450544195|FG001|Overall Study|Adverse Event|0|||
125251164|NCT02268851|450544196|FG002|Overall Study|Adverse Event|0|||
125251165|NCT02268851|450544197|FG003|Overall Study|Adverse Event|0|||
125251166|NCT02268851|450544198|FG004|Overall Study|Adverse Event|2|||
125251167|NCT02268851|450544199|FG005|Overall Study|Adverse Event|2|||
125251168|NCT02268851|450544194|FG000|Overall Study|Withdrawal by Subject|0|||
125251169|NCT02268851|450544195|FG001|Overall Study|Withdrawal by Subject|0|||
125251170|NCT02268851|450544196|FG002|Overall Study|Withdrawal by Subject|0|||
125251171|NCT02268851|450544197|FG003|Overall Study|Withdrawal by Subject|2|||
125251172|NCT02268851|450544198|FG004|Overall Study|Withdrawal by Subject|0|||
125251173|NCT02268851|450544199|FG005|Overall Study|Withdrawal by Subject|1|||
125251174|NCT02268851|450544194|FG000|Overall Study|Progressive Disease|1|||
125251175|NCT02268851|450544195|FG001|Overall Study|Progressive Disease|3|||
125251176|NCT02268851|450544196|FG002|Overall Study|Progressive Disease|0|||
125251177|NCT02268851|450544197|FG003|Overall Study|Progressive Disease|0|||
125251178|NCT02268851|450544198|FG004|Overall Study|Progressive Disease|1|||
125251179|NCT02268851|450544199|FG005|Overall Study|Progressive Disease|4|||
125251180|NCT02268851|450544194|FG000|Overall Study|Physician Decision|0|||
125251181|NCT02268851|450544195|FG001|Overall Study|Physician Decision|0|||
125251182|NCT02268851|450544196|FG002|Overall Study|Physician Decision|1|||
125251183|NCT02268851|450544197|FG003|Overall Study|Physician Decision|0|||
125251184|NCT02268851|450544198|FG004|Overall Study|Physician Decision|0|||
125251185|NCT02268851|450544199|FG005|Overall Study|Physician Decision|1|||
125251186|NCT02268851|450544194|FG000|Overall Study|Patient Compliance|0|||
125251187|NCT02268851|450544195|FG001|Overall Study|Patient Compliance|0|||
125251188|NCT02268851|450544196|FG002|Overall Study|Patient Compliance|0|||
125251189|NCT02268851|450544197|FG003|Overall Study|Patient Compliance|0|||
125251190|NCT02268851|450544198|FG004|Overall Study|Patient Compliance|1|||
125251191|NCT02268851|450544199|FG005|Overall Study|Patient Compliance|1|||
125251192|NCT02268851|450544194|FG000|Overall Study|Co-Morbid Condition|0|||
125251193|NCT02268851|450544195|FG001|Overall Study|Co-Morbid Condition|0|||
125251194|NCT02268851|450544196|FG002|Overall Study|Co-Morbid Condition|0|||
125251195|NCT02268851|450544197|FG003|Overall Study|Co-Morbid Condition|0|||
125251196|NCT02268851|450544198|FG004|Overall Study|Co-Morbid Condition|1|||
125251197|NCT02268851|450544199|FG005|Overall Study|Co-Morbid Condition|1|||
125251198|NCT02539394|450544200|FG000|Overall Study|Protocol Violation|1|||
125251199|NCT02539394|450544201|FG001|Overall Study|Protocol Violation|3|||
125251200|NCT02539394|450544200|FG000|Overall Study|Lost to Follow-up|1|||
125251201|NCT02539394|450544201|FG001|Overall Study|Lost to Follow-up|2|||
125251202|NCT02539394|450544200|FG000|Overall Study|Incomplete dataset|6|||
125251203|NCT02539394|450544201|FG001|Overall Study|Incomplete dataset|6|||
125251204|NCT02205359|450544202|FG000|Overall Study|Death|293|||
125251205|NCT02205359|450544203|FG001|Overall Study|Death|327|||
125251206|NCT02205359|450544202|FG000|Overall Study|Lost to Follow-up|182|||
125251207|NCT02205359|450544203|FG001|Overall Study|Lost to Follow-up|162|||
125251208|NCT02205359|450544202|FG000|Overall Study|Physician Decision|51|||
125251209|NCT02205359|450544203|FG001|Overall Study|Physician Decision|53|||
125251210|NCT02205359|450544202|FG000|Overall Study|Withdrawal by Subject|167|||
125251211|NCT02205359|450544203|FG001|Overall Study|Withdrawal by Subject|169|||
125251212|NCT00236197|450544204|FG000|Overall Study|Withdrawal by Subject|3|||
125251213|NCT00236197|450544205|FG001|Overall Study|Withdrawal by Subject|2|||
125251214|NCT00236197|450544204|FG000|Overall Study|Lost to Follow-up|1|||
125251215|NCT00236197|450544205|FG001|Overall Study|Lost to Follow-up|5|||
125251216|NCT00236197|450544204|FG000|Overall Study|Protocol Violation|0|||
125251217|NCT00236197|450544205|FG001|Overall Study|Protocol Violation|3|||
125251218|NCT00236197|450544204|FG000|Overall Study|Medication non-compliance|1|||
125251219|NCT00236197|450544205|FG001|Overall Study|Medication non-compliance|2|||
125251220|NCT00236197|450544204|FG000|Overall Study|Other|0|||
125251221|NCT00236197|450544205|FG001|Overall Study|Other|2|||
125251222|NCT00992394|450544208|FG000|Overall Study|Lack of Efficacy|6|||
125251223|NCT00992394|450544209|FG001|Overall Study|Lack of Efficacy|3|||
125251224|NCT00992394|450544208|FG000|Overall Study|Adverse Event|4|||
125251225|NCT00992394|450544209|FG001|Overall Study|Adverse Event|5|||
125251226|NCT00992394|450544208|FG000|Overall Study|Withdrawal by Subject|8|||
125251227|NCT00992394|450544209|FG001|Overall Study|Withdrawal by Subject|2|||
125251228|NCT00992394|450544208|FG000|Overall Study|Physician Decision|1|||
125251229|NCT00992394|450544209|FG001|Overall Study|Physician Decision|0|||
125251230|NCT00992394|450544208|FG000|Overall Study|Protocol Violation|2|||
125251231|NCT00992394|450544209|FG001|Overall Study|Protocol Violation|4|||
125251232|NCT00992394|450544208|FG000|Overall Study|Lost to Follow-up|2|||
125251233|NCT00992394|450544209|FG001|Overall Study|Lost to Follow-up|0|||
125251234|NCT00992394|450544208|FG000|Overall Study|Other event|1|||
125251235|NCT00992394|450544209|FG001|Overall Study|Other event|0|||
125251236|NCT00537082|450544210|FG000|Overall Study|Adverse Event|6|||
125251237|NCT00537082|450544211|FG001|Overall Study|Adverse Event|6|||
125251238|NCT00537082|450544212|FG002|Overall Study|Adverse Event|3|||
125251239|NCT00537082|450544210|FG000|Overall Study|Protocol Violation|0|||
125251240|NCT00537082|450544211|FG001|Overall Study|Protocol Violation|2|||
125251241|NCT00537082|450544212|FG002|Overall Study|Protocol Violation|1|||
125251242|NCT00537082|450544210|FG000|Overall Study|Lack of Efficacy|0|||
125251243|NCT00537082|450544211|FG001|Overall Study|Lack of Efficacy|0|||
125251244|NCT00537082|450544212|FG002|Overall Study|Lack of Efficacy|2|||
125251245|NCT00537082|450544210|FG000|Overall Study|Withdrawal by Subject|0|||
125251246|NCT00537082|450544211|FG001|Overall Study|Withdrawal by Subject|1|||
125251247|NCT00537082|450544212|FG002|Overall Study|Withdrawal by Subject|0|||
125251248|NCT00537082|450544210|FG000|Overall Study|Discontinued before initiating treatment|3|||
125251249|NCT00537082|450544211|FG001|Overall Study|Discontinued before initiating treatment|0|||
125251250|NCT00537082|450544212|FG002|Overall Study|Discontinued before initiating treatment|0|||
125251251|NCT00655746|450544213|FG000|Overall Study|Withdrawal by Subject|1|||
125251252|NCT01793129|450545936|FG000|Overall Study|Lost to Follow-up|3|||
125251253|NCT01793129|450545937|FG001|Overall Study|Lost to Follow-up|7|||
125251254|NCT01793129|450545936|FG000|Overall Study|Withdrawal by Subject|0|||
125251255|NCT01793129|450545937|FG001|Overall Study|Withdrawal by Subject|2|||
125251256|NCT01926509|450545940|FG000|Overall Study|vital sign met discontinuation criteria|1|||
125251257|NCT01926509|450545941|FG001|Overall Study|vital sign met discontinuation criteria|0|||
125251258|NCT01926509|450545942|FG002|Overall Study|vital sign met discontinuation criteria|0|||
125251259|NCT01926509|450545943|FG003|Overall Study|vital sign met discontinuation criteria|0|||
125251260|NCT03004183|450545944|FG000|Overall Study|Adverse Event|7|||
125251261|NCT03004183|450545944|FG000|Overall Study|Lost to Follow-up|1|||
125251262|NCT03004183|450545944|FG000|Overall Study|Physician Decision|40|||
125251263|NCT03004183|450545944|FG000|Overall Study|Withdrawal by Subject|1|||
125251264|NCT03004183|450545944|FG000|Overall Study|COVID-19|1|||
125197405|NCT01876784|450343971|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
125197406|NCT01876784|450343970|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
125197407|NCT01876784|450343971|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
125197408|NCT01876784|450343970|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
125197409|NCT01876784|450343971|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
125197410|NCT01876784|450343970|FG000|Randomized Treatment Period (40 Months)|Death|1|||
125197411|NCT01876784|450343971|FG001|Randomized Treatment Period (40 Months)|Death|0|||
125197412|NCT01876784|450343970|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
125197413|NCT01876784|450343971|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
125197414|NCT01876784|450343970|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
125197415|NCT01876784|450343971|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
125197416|NCT01876784|450343970|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
125197417|NCT01876784|450343971|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
125197418|NCT01876784|450343970|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
125197419|NCT01876784|450343971|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
125197420|NCT01876784|450343970|FG000|Open-label Period (31 Months)|Adverse Event|2|||
125197421|NCT01876784|450343971|FG001|Open-label Period (31 Months)|Adverse Event|6|||
125197422|NCT01876784|450343970|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
125197423|NCT01876784|450343971|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
125197424|NCT01876784|450343970|FG000|Open-label Period (31 Months)|Progressive disease|4|||
125197425|NCT01876784|450343971|FG001|Open-label Period (31 Months)|Progressive disease|35|||
125197426|NCT01876784|450343970|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
125197427|NCT01876784|450343971|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
125197428|NCT01876784|450343970|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
125197429|NCT01876784|450343971|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
125197430|NCT01876784|450343970|FG000|Open-label Period (31 Months)|Death|0|||
125197431|NCT01876784|450343971|FG001|Open-label Period (31 Months)|Death|1|||
125197432|NCT01876784|450343970|FG000|Open-label Period (31 Months)|Other than specified above|9|||
125197433|NCT01876784|450343971|FG001|Open-label Period (31 Months)|Other than specified above|18|||
125197434|NCT03605862|450343972|FG000|Overall Study|Withdrawal by Subject|12|||
125197435|NCT03605862|450343973|FG001|Overall Study|Withdrawal by Subject|9|||
125197436|NCT03605862|450343972|FG000|Overall Study|Adverse Event|2|||
125197437|NCT03605862|450343973|FG001|Overall Study|Adverse Event|1|||
125197438|NCT03605862|450343972|FG000|Overall Study|Physician Decision|3|||
125197439|NCT03605862|450343973|FG001|Overall Study|Physician Decision|1|||
125197440|NCT03605862|450343972|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
125197441|NCT03605862|450343973|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
125197442|NCT01194531|450343974|FG000|Overall Study|Withdrawal by Subject|1|||
125197443|NCT01194531|450343975|FG001|Overall Study|Withdrawal by Subject|0|||
125197444|NCT01194531|450343974|FG000|Overall Study|Protocol Violation|4|||
125197445|NCT01194531|450343975|FG001|Overall Study|Protocol Violation|1|||
125197446|NCT01194531|450343974|FG000|Overall Study|Physician Decision|0|||
125197447|NCT01194531|450343975|FG001|Overall Study|Physician Decision|2|||
125197448|NCT03891862|450343976|FG000|Open-label Period|Adverse Event|2|||
125197449|NCT03891862|450343977|FG001|Open-label Period|Adverse Event|0|||
125197450|NCT03891862|450343978|FG002|Open-label Period|Adverse Event|0|||
125197451|NCT03891862|450343976|FG000|Open-label Period|Protocol Violation|5|||
125197452|NCT03891862|450343977|FG001|Open-label Period|Protocol Violation|0|||
125197453|NCT03891862|450343978|FG002|Open-label Period|Protocol Violation|0|||
125197454|NCT03891862|450343976|FG000|Open-label Period|Withdrawal by Subject|6|||
125197455|NCT03891862|450343977|FG001|Open-label Period|Withdrawal by Subject|0|||
125197456|NCT03891862|450343978|FG002|Open-label Period|Withdrawal by Subject|0|||
125251265|NCT03681093|450545945|FG000|Overall Study|Subject decision|0|||
125251266|NCT03681093|450545946|FG001|Overall Study|Subject decision|2|||
125251267|NCT03681093|450545947|FG002|Overall Study|Subject decision|1|||
125251268|NCT02698787|450545948|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
125251269|NCT02698787|450545949|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
125251270|NCT01882829|450545953|FG000|Overall Study|Adverse Event|4|||
125251271|NCT01882829|450545953|FG000|Overall Study|Protocol Violation|1|||
125251272|NCT01882829|450545953|FG000|Overall Study|Withdrawal by Subject|1|||
125251273|NCT01313676|450545956|FG000|Overall Study|Adverse Event|395|||
125251274|NCT01313676|450545957|FG001|Overall Study|Adverse Event|365|||
125251275|NCT01313676|450545958|FG002|Overall Study|Adverse Event|372|||
125251276|NCT01313676|450545959|FG003|Overall Study|Adverse Event|333|||
125251277|NCT01313676|450545956|FG000|Overall Study|Lack of Efficacy|98|||
125251278|NCT01313676|450545957|FG001|Overall Study|Lack of Efficacy|90|||
125251279|NCT01313676|450545958|FG002|Overall Study|Lack of Efficacy|65|||
125251280|NCT01313676|450545959|FG003|Overall Study|Lack of Efficacy|46|||
125251281|NCT01313676|450545956|FG000|Overall Study|Protocol Violation|37|||
125251282|NCT01313676|450545957|FG001|Overall Study|Protocol Violation|44|||
125251283|NCT01313676|450545958|FG002|Overall Study|Protocol Violation|46|||
125251284|NCT01313676|450545959|FG003|Overall Study|Protocol Violation|44|||
125251285|NCT01313676|450545956|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
125251286|NCT01313676|450545957|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
125251287|NCT01313676|450545958|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
125251288|NCT01313676|450545959|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
125251289|NCT01313676|450545956|FG000|Overall Study|Study Closed/terminated|7|||
125251290|NCT01313676|450545957|FG001|Overall Study|Study Closed/terminated|6|||
125251291|NCT01313676|450545958|FG002|Overall Study|Study Closed/terminated|9|||
125251292|NCT01313676|450545959|FG003|Overall Study|Study Closed/terminated|9|||
125251293|NCT01313676|450545956|FG000|Overall Study|Lost to Follow-up|0|||
125251294|NCT01313676|450545957|FG001|Overall Study|Lost to Follow-up|0|||
125251295|NCT01313676|450545958|FG002|Overall Study|Lost to Follow-up|1|||
125251296|NCT01313676|450545959|FG003|Overall Study|Lost to Follow-up|0|||
125251297|NCT01313676|450545956|FG000|Overall Study|Physician Decision|53|||
125251298|NCT01313676|450545957|FG001|Overall Study|Physician Decision|64|||
125251299|NCT01313676|450545958|FG002|Overall Study|Physician Decision|62|||
125251300|NCT01313676|450545959|FG003|Overall Study|Physician Decision|48|||
125251301|NCT01313676|450545956|FG000|Overall Study|Decision by Participant or Proxy|643|||
125251302|NCT01313676|450545957|FG001|Overall Study|Decision by Participant or Proxy|527|||
125251303|NCT01313676|450545958|FG002|Overall Study|Decision by Participant or Proxy|515|||
125251304|NCT01313676|450545959|FG003|Overall Study|Decision by Participant or Proxy|492|||
125251305|NCT01313676|450545956|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
125251306|NCT01313676|450545957|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
125251307|NCT01313676|450545958|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
125251308|NCT01313676|450545959|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
125251309|NCT01313676|450545956|FG000|Overall Study|Investigator Site Closed|12|||
125251310|NCT01313676|450545957|FG001|Overall Study|Investigator Site Closed|11|||
125251311|NCT01313676|450545958|FG002|Overall Study|Investigator Site Closed|15|||
125251312|NCT01313676|450545959|FG003|Overall Study|Investigator Site Closed|10|||
125251313|NCT01313676|450545956|FG000|Overall Study|Missing|1|||
125251314|NCT01313676|450545957|FG001|Overall Study|Missing|1|||
125251315|NCT01313676|450545958|FG002|Overall Study|Missing|1|||
125251316|NCT01313676|450545959|FG003|Overall Study|Missing|0|||
125251317|NCT02469961|450545961|FG000|Overall Study|Physician Decision|4|||
125251318|NCT02469961|450545962|FG001|Overall Study|Physician Decision|1|||
125251319|NCT05130281|450545966|FG000|Overall Study|Withdrawal by Subject|0|||
125251320|NCT05130281|450545967|FG001|Overall Study|Withdrawal by Subject|0|||
125251321|NCT05130281|450545968|FG002|Overall Study|Withdrawal by Subject|1|||
125251322|NCT06844812|450545969|FG000|Overall Study|Lost to Follow-up|5|||
125251323|NCT06844812|450545969|FG000|Overall Study|stigmatization concerns|2|||
125251324|NCT06844812|450545969|FG000|Overall Study|medication refusal|2|||
125251325|NCT06844812|450545969|FG000|Overall Study|concerns about possible side effects|2|||
125251326|NCT06844812|450545969|FG000|Overall Study|wanting to seek another specialist opinion|2|||
125251327|NCT06844812|450545969|FG000|Overall Study|side effects (dizziness)|1|||
125251328|NCT00368849|450545972|FG000|Overall Study|Withdrawal by Subject|0|||
125251329|NCT00368849|450545973|FG001|Overall Study|Withdrawal by Subject|1|||
125251330|NCT00368849|450545972|FG000|Overall Study|Physician Decision|0|||
125251331|NCT00368849|450545973|FG001|Overall Study|Physician Decision|1|||
125251332|NCT01699685|450545977|FG000|Period 1|Adverse Event|1|||
125251333|NCT01699685|450545978|FG001|Period 1|Adverse Event|1|||
125251334|NCT01699685|450545977|FG000|Period 1|Medical or ethical, noncompliance|2|||
125251335|NCT01699685|450545978|FG001|Period 1|Medical or ethical, noncompliance|0|||
125251336|NCT01699685|450545977|FG000|Period 1|Other|0|||
125251337|NCT01699685|450545978|FG001|Period 1|Other|1|||
125251338|NCT01699685|450545977|FG000|Period 1|Patient request|0|||
125251339|NCT01699685|450545978|FG001|Period 1|Patient request|1|||
125251340|NCT01699685|450545977|FG000|Period 2|Lost to Follow-up|1|||
125251341|NCT01699685|450545978|FG001|Period 2|Lost to Follow-up|0|||
125251342|NCT03635996|450545979|FG000|Overall Study|Study terminated by Sponsor|94|||
125251343|NCT03635996|450545979|FG000|Overall Study|Withdrawal by Subject|20|||
125251344|NCT03635996|450545979|FG000|Overall Study|Ablation|26|||
125251345|NCT03635996|450545979|FG000|Overall Study|Adverse Event|7|||
125251346|NCT03635996|450545979|FG000|Overall Study|Physician Decision|3|||
125251347|NCT03635996|450545979|FG000|Overall Study|Prohibited medication|5|||
125251348|NCT03635996|450545979|FG000|Overall Study|Did not meet eligibility criteria|5|||
125251349|NCT03635996|450545979|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
125251350|NCT03635996|450545979|FG000|Overall Study|Protocol Violation|1|||
125251351|NCT03635996|450545979|FG000|Overall Study|Lost to Follow-up|1|||
125251352|NCT05058456|450545980|FG000|Overall Study|Death|1|||
125251353|NCT05058456|450545980|FG000|Overall Study|End of Study data not yet due for release|34|||
125251354|NCT02933151|450545981|FG000|Overall Study|Lost to Follow-up|19|||
125251355|NCT02933151|450545982|FG001|Overall Study|Lost to Follow-up|18|||
125251356|NCT02933151|450545981|FG000|Overall Study|Death|1732|||
125251357|NCT02933151|450545982|FG001|Overall Study|Death|1827|||
125251358|NCT02933151|450545981|FG000|Overall Study|Transplant|210|||
125251359|NCT02933151|450545982|FG001|Overall Study|Transplant|278|||
125251360|NCT02933151|450545981|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
125251361|NCT02933151|450545982|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
125251362|NCT02933151|450545981|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
125251363|NCT02933151|450545982|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
125251364|NCT02933151|450545981|FG000|Overall Study|Recovered Kidney Function|47|||
125251365|NCT02933151|450545982|FG001|Overall Study|Recovered Kidney Function|29|||
125251366|NCT01034657|450545996|FG000|Core Phase|Withdrawal by Subject|1|||
125251367|NCT01034657|450545997|FG001|Core Phase|Withdrawal by Subject|0|||
125251368|NCT01034657|450545998|FG002|Core Phase|Withdrawal by Subject|0|||
125251369|NCT01034657|450545996|FG000|Core Phase|Lack of Efficacy|2|||
125251370|NCT01034657|450545997|FG001|Core Phase|Lack of Efficacy|0|||
125251371|NCT01034657|450545998|FG002|Core Phase|Lack of Efficacy|0|||
125251372|NCT01034657|450545996|FG000|Core Phase|Abnormal laboratory value|1|||
125251373|NCT01034657|450545997|FG001|Core Phase|Abnormal laboratory value|0|||
125251374|NCT01034657|450545998|FG002|Core Phase|Abnormal laboratory value|0|||
125251375|NCT01034657|450545996|FG000|Core Phase|Adverse Event|8|||
125251376|NCT01034657|450545997|FG001|Core Phase|Adverse Event|0|||
125251377|NCT01034657|450545998|FG002|Core Phase|Adverse Event|0|||
125251378|NCT01034657|450545996|FG000|Core Phase|Protocol Violation|2|||
125251379|NCT01034657|450545997|FG001|Core Phase|Protocol Violation|0|||
125251380|NCT01034657|450545998|FG002|Core Phase|Protocol Violation|0|||
125251381|NCT01034657|450545996|FG000|Randomized Phase|Withdrawal by Subject|0|||
125251382|NCT01034657|450545997|FG001|Randomized Phase|Withdrawal by Subject|2|||
125251383|NCT01034657|450545998|FG002|Randomized Phase|Withdrawal by Subject|0|||
125251384|NCT01034657|450545996|FG000|Randomized Phase|Lack of Efficacy|5|||
125251385|NCT01034657|450545997|FG001|Randomized Phase|Lack of Efficacy|1|||
125251386|NCT01034657|450545998|FG002|Randomized Phase|Lack of Efficacy|0|||
125251387|NCT01034657|450545996|FG000|Randomized Phase|Abnormal laboratory value|0|||
125251388|NCT01034657|450545997|FG001|Randomized Phase|Abnormal laboratory value|1|||
125251389|NCT01034657|450545998|FG002|Randomized Phase|Abnormal laboratory value|0|||
125251390|NCT01034657|450545996|FG000|Randomized Phase|Adverse Event|0|||
125251391|NCT01034657|450545997|FG001|Randomized Phase|Adverse Event|2|||
125251392|NCT01034657|450545998|FG002|Randomized Phase|Adverse Event|1|||
125251393|NCT01791205|450545999|FG000|Phase II|Lack of Efficacy|6|||
125251394|NCT01791205|450546000|FG001|Phase II|Lack of Efficacy|0|||
125251395|NCT01791205|450545999|FG000|Phase II|Adverse Event|2|||
125251396|NCT01791205|450546000|FG001|Phase II|Adverse Event|0|||
125251397|NCT01791205|450545999|FG000|Phase II|Safety|1|||
125251398|NCT01791205|450546000|FG001|Phase II|Safety|0|||
125251399|NCT01791205|450545999|FG000|Phase II|Lost to Follow-up|1|||
125251400|NCT01791205|450546000|FG001|Phase II|Lost to Follow-up|0|||
125251401|NCT01791205|450545999|FG000|Phase II|Remission of disease|1|||
125251402|NCT01791205|450546000|FG001|Phase II|Remission of disease|0|||
125251403|NCT01791205|450545999|FG000|Phase II|Physician's decision|1|||
125251404|NCT01791205|450546000|FG001|Phase II|Physician's decision|0|||
125251405|NCT04985682|450546003|FG000|Overall Study|Withdrawal by Subject|1|||
125251406|NCT01546987|450546006|FG000|Overall Study|Protocol Violation|3|||
125251407|NCT01546987|450546007|FG001|Overall Study|Protocol Violation|4|||
125251408|NCT03878602|450546012|FG000|Overall Study|cord blood donation|7|||
125251409|NCT03878602|450546013|FG001|Overall Study|cord blood donation|1|||
125251410|NCT03878602|450546012|FG000|Overall Study|incomplete data collection|2|||
125251411|NCT03878602|450546013|FG001|Overall Study|incomplete data collection|0|||
125251412|NCT00452530|450546014|FG000|Overall Study|Death|1|||
125251413|NCT00452530|450546015|FG001|Overall Study|Death|0|||
125251414|NCT00452530|450546014|FG000|Overall Study|Adverse Event|40|||
125251415|NCT00452530|450546015|FG001|Overall Study|Adverse Event|44|||
125251416|NCT00452530|450546014|FG000|Overall Study|Withdrawal by Subject|68|||
125251417|NCT00452530|450546015|FG001|Overall Study|Withdrawal by Subject|57|||
125251418|NCT00452530|450546014|FG000|Overall Study|Lost to Follow-up|1|||
125251419|NCT00452530|450546015|FG001|Overall Study|Lost to Follow-up|0|||
125251420|NCT00452530|450546014|FG000|Overall Study|Poor compliance/noncompliance|1|||
125251421|NCT00452530|450546015|FG001|Overall Study|Poor compliance/noncompliance|2|||
125251422|NCT00452530|450546014|FG000|Overall Study|No longer met study criteria|18|||
125251423|NCT00452530|450546015|FG001|Overall Study|No longer met study criteria|22|||
125251424|NCT00452530|450546014|FG000|Overall Study|Other|7|||
125251425|NCT00452530|450546015|FG001|Overall Study|Other|11|||
125251426|NCT02191397|450546016|FG000|Overall Study|Adverse Event|28|||
125251427|NCT02191397|450546017|FG001|Overall Study|Adverse Event|17|||
125251428|NCT02191397|450546016|FG000|Overall Study|Lack of Efficacy|10|||
125251429|NCT02191397|450546017|FG001|Overall Study|Lack of Efficacy|5|||
125251430|NCT02191397|450546016|FG000|Overall Study|Protocol Violation|0|||
125251431|NCT02191397|450546017|FG001|Overall Study|Protocol Violation|3|||
125251432|NCT02191397|450546016|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
125251433|NCT02191397|450546017|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
125251434|NCT02191397|450546016|FG000|Overall Study|Lost to Follow-up|10|||
125251435|NCT02191397|450546017|FG001|Overall Study|Lost to Follow-up|11|||
125251436|NCT02191397|450546016|FG000|Overall Study|Physician Decision|8|||
125251437|NCT02191397|450546017|FG001|Overall Study|Physician Decision|3|||
125251438|NCT02191397|450546016|FG000|Overall Study|Withdrawal by Subject|22|||
125251439|NCT02191397|450546017|FG001|Overall Study|Withdrawal by Subject|27|||
125251440|NCT04629521|450546018|FG000|Overall Study|Death|1|||
125251441|NCT04629521|450546018|FG000|Overall Study|Lost to Follow-up|3|||
125251442|NCT04629521|450546018|FG000|Overall Study|Subject withdrew consent|3|||
125251443|NCT04629521|450546018|FG000|Overall Study|Enrolled in error|1|||
125251444|NCT01618708|450546019|FG000|Overall Study|Adverse Event|10|||
125251445|NCT01618708|450546020|FG001|Overall Study|Adverse Event|10|||
125251446|NCT01618708|450546019|FG000|Overall Study|Lost to Follow-up|3|||
125251447|NCT01618708|450546020|FG001|Overall Study|Lost to Follow-up|3|||
125251448|NCT01618708|450546019|FG000|Overall Study|Withdrawal by Subject|17|||
125251449|NCT01618708|450546020|FG001|Overall Study|Withdrawal by Subject|22|||
125251450|NCT01618708|450546019|FG000|Overall Study|Lack of Efficacy|8|||
125251451|NCT01618708|450546020|FG001|Overall Study|Lack of Efficacy|8|||
125251452|NCT01618708|450546019|FG000|Overall Study|Technical problems|2|||
125251453|NCT01618708|450546020|FG001|Overall Study|Technical problems|0|||
125251454|NCT01618708|450546019|FG000|Overall Study|Other than specified above|1|||
125251455|NCT01618708|450546020|FG001|Overall Study|Other than specified above|1|||
125251456|NCT01618708|450546019|FG000|Overall Study|Randomized but not treated|3|||
125251457|NCT01618708|450546020|FG001|Overall Study|Randomized but not treated|2|||
125251458|NCT02554474|450546023|FG000|Overall Study|Protocol Violation|1|||
125251459|NCT02554474|450546024|FG001|Overall Study|Protocol Violation|1|||
125251460|NCT02554474|450546023|FG000|Overall Study|Health issue not related to the study|1|||
125251461|NCT02554474|450546024|FG001|Overall Study|Health issue not related to the study|0|||
125251462|NCT02554474|450546023|FG000|Overall Study|Withdrawal by Subject|1|||
125251463|NCT02554474|450546024|FG001|Overall Study|Withdrawal by Subject|1|||
125251464|NCT03211832|450546025|FG000|Overall Study|No longer with agency|32|||
125251465|NCT03211832|450546026|FG001|Overall Study|No longer with agency|49|||
125251466|NCT03211832|450546027|FG002|Overall Study|No longer with agency|30|||
125251467|NCT03211832|450546025|FG000|Overall Study|Declined survey|3|||
125251468|NCT03211832|450546026|FG001|Overall Study|Declined survey|3|||
125251469|NCT03211832|450546027|FG002|Overall Study|Declined survey|2|||
125251470|NCT03211832|450546025|FG000|Overall Study|Not available during data collection|1|||
125251471|NCT03211832|450546026|FG001|Overall Study|Not available during data collection|0|||
125251472|NCT03211832|450546027|FG002|Overall Study|Not available during data collection|2|||
125251473|NCT02991859|450546031|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251474|NCT02991859|450546032|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
125251475|NCT02991859|450546033|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251476|NCT02991859|450546034|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251477|NCT02991859|450546035|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
125251478|NCT02991859|450546036|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251479|NCT02991859|450546037|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251480|NCT02991859|450546038|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251481|NCT02991859|450546039|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251482|NCT02991859|450546040|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251483|NCT02991859|450546041|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251484|NCT02991859|450546042|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251485|NCT02991859|450546043|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251486|NCT02991859|450546044|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251487|NCT02991859|450546045|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251488|NCT02991859|450546046|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251489|NCT02991859|450546047|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251490|NCT02991859|450546031|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251491|NCT02991859|450546032|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251492|NCT02991859|450546033|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251493|NCT02991859|450546034|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251494|NCT02991859|450546035|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251495|NCT02991859|450546036|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251496|NCT02991859|450546037|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251497|NCT02991859|450546038|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251498|NCT02991859|450546039|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251499|NCT02991859|450546040|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251500|NCT02991859|450546041|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251501|NCT02991859|450546042|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251502|NCT02991859|450546043|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
125251503|NCT02991859|450546044|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
125251504|NCT02991859|450546045|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251505|NCT02991859|450546046|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251506|NCT02991859|450546047|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251507|NCT02991859|450546031|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251508|NCT02991859|450546032|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251509|NCT02991859|450546033|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251510|NCT02991859|450546034|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251511|NCT02991859|450546035|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251512|NCT02991859|450546036|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
125251513|NCT02991859|450546037|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251514|NCT02991859|450546038|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251515|NCT02991859|450546039|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251516|NCT02991859|450546040|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251517|NCT02991859|450546041|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251518|NCT02991859|450546042|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251519|NCT02991859|450546043|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251520|NCT02991859|450546044|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251521|NCT02991859|450546045|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251522|NCT02991859|450546046|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251523|NCT02991859|450546047|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251524|NCT02991859|450546031|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251525|NCT02991859|450546032|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251526|NCT02991859|450546033|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251527|NCT02991859|450546034|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251528|NCT02991859|450546035|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251529|NCT02991859|450546036|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251530|NCT02991859|450546037|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251531|NCT02991859|450546038|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251532|NCT02991859|450546039|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251533|NCT02991859|450546040|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
125251534|NCT02991859|450546041|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251535|NCT02991859|450546042|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251536|NCT02991859|450546043|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251537|NCT02991859|450546044|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251538|NCT02991859|450546045|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251539|NCT02991859|450546046|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251540|NCT02991859|450546047|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251541|NCT02991859|450546031|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251542|NCT02991859|450546032|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251543|NCT02991859|450546033|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251544|NCT02991859|450546034|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251545|NCT02991859|450546035|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251546|NCT02991859|450546036|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251547|NCT02991859|450546037|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251548|NCT02991859|450546038|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251549|NCT02991859|450546039|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
125251550|NCT02991859|450546040|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251551|NCT02991859|450546041|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251552|NCT02991859|450546042|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251553|NCT02991859|450546043|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251554|NCT02991859|450546044|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251555|NCT02991859|450546045|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251556|NCT02991859|450546046|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251557|NCT02991859|450546047|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251558|NCT01065766|450546048|FG000|Overall Study|Assessed before the contracted date|1|||
125251559|NCT01065766|450546048|FG000|Overall Study|Contraindication to administration|6|||
125251560|NCT01065766|450546048|FG000|Overall Study|Violated dosage/administration|25|||
125251561|NCT04223687|450546055|FG000|Overall Study|Missing primary outcome|1|||
125251562|NCT04223687|450546056|FG001|Overall Study|Missing primary outcome|0|||
125251563|NCT00425854|450546057|FG000|Overall Study|Progressive Disease|19|||
125251564|NCT00425854|450546058|FG001|Overall Study|Progressive Disease|12|||
125251565|NCT00425854|450546057|FG000|Overall Study|Dose reduction toxicity AE|8|||
125251566|NCT00425854|450546058|FG001|Overall Study|Dose reduction toxicity AE|7|||
125251567|NCT00425854|450546057|FG000|Overall Study|Other Adverse Event|2|||
125251568|NCT00425854|450546058|FG001|Overall Study|Other Adverse Event|2|||
125251569|NCT05652140|450546062|FG000|Overall Study|Lost to Follow-up|7|||
125251570|NCT05652140|450546063|FG001|Overall Study|Lost to Follow-up|16|||
125251571|NCT05652140|450546064|FG002|Overall Study|Lost to Follow-up|22|||
125251572|NCT05652140|450546065|FG003|Overall Study|Lost to Follow-up|31|||
125251573|NCT06048705|450546068|FG000|Overall Study|Physician Decision|1|||
125251574|NCT06048705|450546069|FG001|Overall Study|Physician Decision|0|||
125251575|NCT06048705|450546070|FG002|Overall Study|Physician Decision|0|||
125251576|NCT06048705|450546068|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
125251577|NCT06048705|450546069|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
125251578|NCT06048705|450546070|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
125251579|NCT06048705|450546068|FG000|Overall Study|Death prior to lymphodepletion|0|||
125251580|NCT06048705|450546069|FG001|Overall Study|Death prior to lymphodepletion|0|||
125251581|NCT06048705|450546070|FG002|Overall Study|Death prior to lymphodepletion|1|||
125251582|NCT01016015|450546071|FG000|Overall Study|Not Treated|3|||
125251583|NCT01016015|450546071|FG000|Overall Study|Withdrawal by Subject|1|||
125251584|NCT01016015|450546071|FG000|Overall Study|Adverse Event|15|||
125251585|NCT02057666|450546072|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
125251586|NCT02057666|450546073|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
125251587|NCT02057666|450546072|FG000|Double Blind Treatment Period|Poor tolerability|7|||
125251588|NCT02057666|450546073|FG001|Double Blind Treatment Period|Poor tolerability|2|||
125251589|NCT02057666|450546072|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
125251590|NCT02057666|450546073|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
125251591|NCT02057666|450546072|FG000|Double Blind Treatment Period|Physician Decision|1|||
125251592|NCT02057666|450546073|FG001|Double Blind Treatment Period|Physician Decision|0|||
125251593|NCT02057666|450546072|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
125251594|NCT02057666|450546073|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
125251595|NCT02057666|450546072|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
125251596|NCT02057666|450546073|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
125251597|NCT02057666|450546072|FG000|Double Blind Treatment Period|Sponsor's request|70|||
125251598|NCT02057666|450546073|FG001|Double Blind Treatment Period|Sponsor's request|34|||
125251599|NCT02057666|450546072|FG000|Open-Label Treatment Period|Poor tolerability|0|||
125251600|NCT02057666|450546073|FG001|Open-Label Treatment Period|Poor tolerability|1|||
125251601|NCT02057666|450546072|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
125251602|NCT02057666|450546073|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
125251603|NCT02057666|450546072|FG000|Open-Label Treatment Period|Sponsor's request|0|||
125251604|NCT02057666|450546073|FG001|Open-Label Treatment Period|Sponsor's request|4|||
125251605|NCT00498485|450546078|FG000|Overall Study|Adverse Event|1|||
125251606|NCT00498485|450546079|FG001|Overall Study|Adverse Event|5|||
125251607|NCT01539525|450546080|FG000|Overall Study|Lost to Follow-up|19|||
125251608|NCT01539525|450546081|FG001|Overall Study|Lost to Follow-up|12|||
125251609|NCT01539525|450546082|FG002|Overall Study|Lost to Follow-up|11|||
125251610|NCT01539525|450546080|FG000|Overall Study|Withdrawal by Subject|0|||
125251611|NCT01539525|450546081|FG001|Overall Study|Withdrawal by Subject|3|||
125251612|NCT01539525|450546082|FG002|Overall Study|Withdrawal by Subject|2|||
125251613|NCT01539525|450546080|FG000|Overall Study|Protocol Violation|1|||
125251614|NCT01539525|450546081|FG001|Overall Study|Protocol Violation|1|||
125251615|NCT01539525|450546082|FG002|Overall Study|Protocol Violation|4|||
125251616|NCT01712074|450546083|FG000|Placebo Run-in Period|Adverse Event|2|||
125251617|NCT01712074|450546084|FG001|Placebo Run-in Period|Adverse Event|0|||
125251618|NCT01712074|450546085|FG002|Placebo Run-in Period|Adverse Event|0|||
125251619|NCT01712074|450546083|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
125251620|NCT01712074|450546084|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
125251621|NCT01712074|450546085|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
125251622|NCT01712074|450546083|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
125251623|NCT01712074|450546084|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
125251624|NCT01712074|450546085|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
125251625|NCT01712074|450546083|FG000|Placebo Run-in Period|Other|1|||
125251626|NCT01712074|450546084|FG001|Placebo Run-in Period|Other|0|||
125251627|NCT01712074|450546085|FG002|Placebo Run-in Period|Other|0|||
125251628|NCT01712074|450546083|FG000|Placebo Run-in Period|No longer willing to participate|1|||
125251629|NCT01712074|450546084|FG001|Placebo Run-in Period|No longer willing to participate|0|||
125251630|NCT01712074|450546085|FG002|Placebo Run-in Period|No longer willing to participate|0|||
125251631|NCT01712074|450546083|FG000|Double Blind Period|Adverse Event|0|||
125251632|NCT01712074|450546084|FG001|Double Blind Period|Adverse Event|2|||
125251633|NCT01712074|450546085|FG002|Double Blind Period|Adverse Event|1|||
125251634|NCT01712074|450546083|FG000|Double Blind Period|No longer willing to participate|0|||
125251635|NCT01712074|450546084|FG001|Double Blind Period|No longer willing to participate|2|||
125251636|NCT01712074|450546085|FG002|Double Blind Period|No longer willing to participate|4|||
125251637|NCT01712074|450546083|FG000|Double Blind Period|Death|0|||
125251638|NCT01712074|450546084|FG001|Double Blind Period|Death|1|||
125251639|NCT01712074|450546085|FG002|Double Blind Period|Death|0|||
125251640|NCT01712074|450546083|FG000|Double Blind Period|Lost to Follow-up|0|||
125251641|NCT01712074|450546084|FG001|Double Blind Period|Lost to Follow-up|2|||
125251642|NCT01712074|450546085|FG002|Double Blind Period|Lost to Follow-up|1|||
125251643|NCT01712074|450546083|FG000|Double Blind Period|Other|0|||
125251644|NCT01712074|450546084|FG001|Double Blind Period|Other|4|||
125251645|NCT01712074|450546085|FG002|Double Blind Period|Other|1|||
125251646|NCT01712074|450546083|FG000|Double Blind Period|Protocol Violation|0|||
125251647|NCT01712074|450546084|FG001|Double Blind Period|Protocol Violation|0|||
125251648|NCT01712074|450546085|FG002|Double Blind Period|Protocol Violation|1|||
125251649|NCT01712074|450546083|FG000|Double Blind Period|No longer met eligibility criteria|0|||
125251650|NCT01712074|450546084|FG001|Double Blind Period|No longer met eligibility criteria|3|||
125251651|NCT01712074|450546085|FG002|Double Blind Period|No longer met eligibility criteria|0|||
125251652|NCT01472835|450546088|FG000|Overall Study|Lost to Follow-up|2|||
125251653|NCT01472835|450546089|FG001|Overall Study|Lost to Follow-up|0|||
125251654|NCT02792257|450546095|FG000|Overall Study|Lost to Follow-up|3|||
125251655|NCT02792257|450546096|FG001|Overall Study|Lost to Follow-up|4|||
125251656|NCT02792257|450546095|FG000|Overall Study|Allergy|0|||
125251657|NCT02792257|450546096|FG001|Overall Study|Allergy|1|||
125251658|NCT02792257|450546095|FG000|Overall Study|Protocol Violation|2|||
125251659|NCT02792257|450546096|FG001|Overall Study|Protocol Violation|0|||
125251660|NCT02792257|450546095|FG000|Overall Study|Excessive Agitation|0|||
125251661|NCT02792257|450546096|FG001|Overall Study|Excessive Agitation|1|||
125251662|NCT02792257|450546095|FG000|Overall Study|Not Feeling Well|0|||
125251663|NCT02792257|450546096|FG001|Overall Study|Not Feeling Well|1|||
125251664|NCT00553475|450546097|FG000|Overall Study|Adverse Event|7|||
125251665|NCT00553475|450546098|FG001|Overall Study|Adverse Event|17|||
125251666|NCT00553475|450546099|FG002|Overall Study|Adverse Event|13|||
125251667|NCT00553475|450546097|FG000|Overall Study|Lack of Efficacy|7|||
125251668|NCT00553475|450546098|FG001|Overall Study|Lack of Efficacy|1|||
125251669|NCT00553475|450546099|FG002|Overall Study|Lack of Efficacy|0|||
125251670|NCT00553475|450546097|FG000|Overall Study|Withdrawal by Subject|1|||
125251671|NCT00553475|450546098|FG001|Overall Study|Withdrawal by Subject|1|||
125251672|NCT00553475|450546099|FG002|Overall Study|Withdrawal by Subject|0|||
125251673|NCT00553475|450546097|FG000|Overall Study|Physician Decision|1|||
125251674|NCT00553475|450546098|FG001|Overall Study|Physician Decision|0|||
125251675|NCT00553475|450546099|FG002|Overall Study|Physician Decision|0|||
125251676|NCT00553475|450546097|FG000|Overall Study|Due to moving|0|||
125251677|NCT00553475|450546098|FG001|Overall Study|Due to moving|1|||
125251678|NCT00553475|450546099|FG002|Overall Study|Due to moving|0|||
125251679|NCT01905683|450546102|FG000|Overall Study|Protocol Violation|1|||
125251680|NCT01905683|450546102|FG000|Overall Study|Re-injection criteria not met; others|13|||
125251681|NCT01905683|450546102|FG000|Overall Study|Physician Decision|1|||
125251682|NCT01905683|450546102|FG000|Overall Study|Lack of Efficacy|8|||
125251683|NCT01905683|450546102|FG000|Overall Study|Withdrawal by Subject|20|||
125251684|NCT01905683|450546102|FG000|Overall Study|Adverse Event|4|||
125251685|NCT01905683|450546102|FG000|Overall Study|Lost to Follow-up|4|||
125251686|NCT02568254|450546104|FG000|Period 2|Adverse Event|0|||
125251687|NCT02568254|450546105|FG001|Period 2|Adverse Event|0|||
125251688|NCT02568254|450546106|FG002|Period 2|Adverse Event|1|||
125251689|NCT02568254|450546107|FG003|Period 2|Adverse Event|0|||
125251690|NCT02568254|450546108|FG004|Period 2|Adverse Event|0|||
125251691|NCT02568254|450546109|FG005|Period 2|Adverse Event|0|||
125251692|NCT02568254|450546104|FG000|Period 3|Unstatisfactory Lens fitting|0|||
125251693|NCT02568254|450546105|FG001|Period 3|Unstatisfactory Lens fitting|0|||
125251694|NCT02568254|450546106|FG002|Period 3|Unstatisfactory Lens fitting|0|||
125251695|NCT02568254|450546107|FG003|Period 3|Unstatisfactory Lens fitting|0|||
125251696|NCT02568254|450546108|FG004|Period 3|Unstatisfactory Lens fitting|1|||
125251697|NCT02568254|450546109|FG005|Period 3|Unstatisfactory Lens fitting|0|||
125251698|NCT01832038|450548041|FG000|Overall Study|Death|5|||
125251699|NCT01832038|450548041|FG000|Overall Study|Adverse Event|50|||
125251700|NCT01832038|450548041|FG000|Overall Study|Lack of Efficacy|81|||
125251701|NCT01832038|450548041|FG000|Overall Study|Protocol Violation|7|||
125251702|NCT01832038|450548041|FG000|Overall Study|Lost to Follow-up|10|||
125251703|NCT01832038|450548041|FG000|Overall Study|Withdrawal by Subject|49|||
125251704|NCT01832038|450548041|FG000|Overall Study|Visit non-compliance|2|||
125251705|NCT01832038|450548041|FG000|Overall Study|Subject refused to return visit|2|||
125251706|NCT01832038|450548041|FG000|Overall Study|Not convenient to come back to site|2|||
125251707|NCT01832038|450548041|FG000|Overall Study|Participant was asked to quit|5|||
125251708|NCT01832038|450548041|FG000|Overall Study|Back home|1|||
125251709|NCT01832038|450548041|FG000|Overall Study|Pregnancy|1|||
125251710|NCT01832038|450548041|FG000|Overall Study|Low compliance|3|||
125251711|NCT01832038|450548041|FG000|Overall Study|Prohibit procedure|2|||
125251712|NCT01832038|450548041|FG000|Overall Study|Not possible to visit the hospital|1|||
125251713|NCT01832038|450548041|FG000|Overall Study|Changes of implementation system|3|||
125251714|NCT01832038|450548041|FG000|Overall Study|Plan to pregnancy|7|||
125251715|NCT01832038|450548041|FG000|Overall Study|Bad mood and has suicidal thought|1|||
125251716|NCT01832038|450548041|FG000|Overall Study|Prohibited concomitant medication|1|||
125251717|NCT01832038|450548041|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
125251718|NCT01832038|450548041|FG000|Overall Study|Subject considered the efficacy was poor|1|||
125251719|NCT00101400|450548046|FG000|Survival Follow-Up|Alive|7|||
125251720|NCT05333965|450548067|FG000|First Intervention|Adverse Event|0|||
125251721|NCT05333965|450548068|FG001|First Intervention|Adverse Event|1|||
125251722|NCT05333965|450548067|FG000|First Intervention|Withdrawal by Subject|0|||
125251723|NCT05333965|450548068|FG001|First Intervention|Withdrawal by Subject|1|||
125251724|NCT00382863|450548069|FG000|Overall Study|Death|9|||
125251725|NCT00382863|450548070|FG001|Overall Study|Death|9|||
125251726|NCT00382863|450548069|FG000|Overall Study|Lost to Follow-up|1|||
125251727|NCT00382863|450548070|FG001|Overall Study|Lost to Follow-up|2|||
125251728|NCT00382863|450548069|FG000|Overall Study|Withdrawal by Subject|5|||
125251729|NCT00382863|450548070|FG001|Overall Study|Withdrawal by Subject|25|||
125251730|NCT02168439|450548071|FG000|Overall Study|Protocol Violation|0|||
125251731|NCT02168439|450548072|FG001|Overall Study|Protocol Violation|2|||
125251732|NCT00605657|450548074|FG000|Overall Study|Adverse Event|1|||
125251733|NCT00605657|450548074|FG000|Overall Study|Protocol Violation|1|||
125251734|NCT02180672|450548075|FG000|Overall Study|Lost to Follow-up|5|||
125251735|NCT02180672|450548076|FG001|Overall Study|Lost to Follow-up|7|||
125251736|NCT02837952|450548077|FG000|Overall Study|Adverse Event|0|||
125251737|NCT02837952|450548078|FG001|Overall Study|Adverse Event|1|||
125251738|NCT02837952|450548077|FG000|Overall Study|Withdrawal by Subject|4|||
125251739|NCT02837952|450548078|FG001|Overall Study|Withdrawal by Subject|5|||
125251740|NCT02837952|450548077|FG000|Overall Study|Medication Error|1|||
125251741|NCT02837952|450548078|FG001|Overall Study|Medication Error|0|||
125251742|NCT01362530|450548079|FG000|Base Study (Cycle 1)|Adverse Event|2|||
125251743|NCT01362530|450548080|FG001|Base Study (Cycle 1)|Adverse Event|0|||
125251744|NCT01362530|450548079|FG000|Base Study (Cycle 1)|Physician Decision|0|||
125251745|NCT01362530|450548080|FG001|Base Study (Cycle 1)|Physician Decision|1|||
125251746|NCT01362530|450548079|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
125251747|NCT01362530|450548080|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
125251748|NCT01362530|450548079|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
125251749|NCT01362530|450548080|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
125251750|NCT01362530|450548079|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
125251751|NCT01362530|450548080|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
125251752|NCT01362530|450548079|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
125251753|NCT01362530|450548080|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
125251754|NCT01362530|450548079|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
125251755|NCT01362530|450548080|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
125251756|NCT01362530|450548079|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
125251757|NCT01362530|450548080|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
125251758|NCT01362530|450548079|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
125251759|NCT01362530|450548080|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
125251760|NCT01362530|450548079|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
125251761|NCT01362530|450548080|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
125251762|NCT01362530|450548079|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
125251763|NCT01362530|450548080|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
125251764|NCT01362530|450548079|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
125251765|NCT01362530|450548080|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
125251766|NCT01362530|450548079|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
125251767|NCT01362530|450548080|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
125251768|NCT03021005|450548092|FG000|Overall Study|Lost to Follow-up|39|||
125251769|NCT03021005|450548093|FG001|Overall Study|Lost to Follow-up|26|||
125251770|NCT00276380|450548094|FG000|Overall Study|Adverse Event|5|||
125251771|NCT00276380|450548095|FG001|Overall Study|Adverse Event|3|||
125251772|NCT00276380|450548094|FG000|Overall Study|Lost to Follow-up|1|||
125251773|NCT00276380|450548095|FG001|Overall Study|Lost to Follow-up|1|||
125251774|NCT00276380|450548094|FG000|Overall Study|Withdrawal by Subject|3|||
125251775|NCT00276380|450548095|FG001|Overall Study|Withdrawal by Subject|6|||
125251776|NCT00276380|450548094|FG000|Overall Study|Death|5|||
125251777|NCT00276380|450548095|FG001|Overall Study|Death|3|||
125251778|NCT00276380|450548094|FG000|Overall Study|Abnormal aPPT Levels|0|||
125251779|NCT00276380|450548095|FG001|Overall Study|Abnormal aPPT Levels|1|||
125251780|NCT03473301|450548096|FG000|Overall Study|Protocol Violation|4|||
125251781|NCT03473301|450548097|FG001|Overall Study|Protocol Violation|0|||
125251782|NCT03473301|450548098|FG002|Overall Study|Protocol Violation|0|||
125251783|NCT03473301|450548096|FG000|Overall Study|Withdrawal by Subject|0|||
125251784|NCT03473301|450548097|FG001|Overall Study|Withdrawal by Subject|1|||
125251785|NCT03473301|450548098|FG002|Overall Study|Withdrawal by Subject|0|||
125251786|NCT03473301|450548096|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
125251787|NCT03473301|450548097|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
125251788|NCT03473301|450548098|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
125251789|NCT04829214|450548099|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
125251790|NCT04829214|450548100|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
125251791|NCT04829214|450548099|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
125251792|NCT04829214|450548100|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
125251793|NCT02571244|450548102|FG000|Overall Study|Lost to Follow-up|0|||
125251794|NCT02571244|450548103|FG001|Overall Study|Lost to Follow-up|1|||
125251795|NCT02571244|450548102|FG000|Overall Study|Unable to reach out post discharge|3|||
125251796|NCT02571244|450548103|FG001|Overall Study|Unable to reach out post discharge|0|||
125251797|NCT01696214|450548105|FG000|Overall Study|Lost to Follow-up|1|||
125251798|NCT01696214|450548106|FG001|Overall Study|Lost to Follow-up|0|||
125251799|NCT01696214|450548107|FG002|Overall Study|Lost to Follow-up|0|||
125251800|NCT01696214|450548108|FG003|Overall Study|Lost to Follow-up|0|||
125251801|NCT01905267|450548110|FG000|Overall Study|Physician Decision|2|||
125251802|NCT01905267|450548111|FG001|Overall Study|Physician Decision|2|||
125251803|NCT03888482|450548112|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
125251804|NCT03888482|450548113|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
125251805|NCT03888482|450548112|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
125251806|NCT03888482|450548113|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
125251807|NCT01630811|450548116|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
125251808|NCT01630811|450548117|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
125251809|NCT04818086|450548120|FG000|Overall Study|Physician Decision|1|||
125251810|NCT04818086|450548121|FG001|Overall Study|Physician Decision|0|||
125251811|NCT04818086|450548120|FG000|Overall Study|Withdrawal by Subject|0|||
125251812|NCT04818086|450548121|FG001|Overall Study|Withdrawal by Subject|1|||
125251813|NCT01725308|450548123|FG000|Treatment Period I|Did Not Receive Drug|1|||
125251814|NCT01725308|450548124|FG001|Treatment Period I|Did Not Receive Drug|0|||
125251815|NCT01725308|450548125|FG002|Treatment Period I|Did Not Receive Drug|0|||
125251816|NCT01725308|450548123|FG000|Treatment Period I|Adverse Event|5|||
125251817|NCT01725308|450548124|FG001|Treatment Period I|Adverse Event|4|||
125251818|NCT01725308|450548125|FG002|Treatment Period I|Adverse Event|21|||
125251819|NCT01725308|450548123|FG000|Treatment Period I|Insufficient Response|7|||
125251820|NCT01725308|450548124|FG001|Treatment Period I|Insufficient Response|0|||
125251821|NCT01725308|450548125|FG002|Treatment Period I|Insufficient Response|5|||
125251822|NCT01725308|450548123|FG000|Treatment Period I|Worsening of the Target Disease|8|||
125251823|NCT01725308|450548124|FG001|Treatment Period I|Worsening of the Target Disease|0|||
125251824|NCT01725308|450548125|FG002|Treatment Period I|Worsening of the Target Disease|2|||
125251825|NCT01725308|450548123|FG000|Treatment Period I|Changes in the Episodes|3|||
125197457|NCT03891862|450343976|FG000|Open-label Period|Death|1|||
125197458|NCT03891862|450343977|FG001|Open-label Period|Death|0|||
125197459|NCT03891862|450343978|FG002|Open-label Period|Death|0|||
125197460|NCT03891862|450343976|FG000|Open-label Period|Lost to Follow-up|2|||
125197461|NCT03891862|450343977|FG001|Open-label Period|Lost to Follow-up|0|||
125197462|NCT03891862|450343978|FG002|Open-label Period|Lost to Follow-up|0|||
125197463|NCT03891862|450343976|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
125197464|NCT03891862|450343977|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
125197465|NCT03891862|450343978|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
125197466|NCT03891862|450343976|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
125197467|NCT03891862|450343977|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
125197468|NCT03891862|450343978|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
125197469|NCT03891862|450343976|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
125197470|NCT03891862|450343977|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
125197471|NCT03891862|450343978|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
125197472|NCT03891862|450343976|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
125197473|NCT03891862|450343977|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
125197474|NCT03891862|450343978|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
125197475|NCT05239494|450343979|FG000|Overall Study|Lost to Follow-up|1|||
125197476|NCT01053962|450343980|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
125251826|NCT01725308|450548124|FG001|Treatment Period I|Changes in the Episodes|0|||
125251827|NCT01725308|450548125|FG002|Treatment Period I|Changes in the Episodes|2|||
125251828|NCT01725308|450548123|FG000|Treatment Period I|Withdrawal of Consent|12|||
125251829|NCT01725308|450548124|FG001|Treatment Period I|Withdrawal of Consent|7|||
125251830|NCT01725308|450548125|FG002|Treatment Period I|Withdrawal of Consent|5|||
125251831|NCT01725308|450548123|FG000|Treatment Period I|Lost to Follow-up|3|||
125251832|NCT01725308|450548124|FG001|Treatment Period I|Lost to Follow-up|2|||
125251833|NCT01725308|450548125|FG002|Treatment Period I|Lost to Follow-up|2|||
125251834|NCT01725308|450548123|FG000|Treatment Period I|Protocol Deviations|3|||
125251835|NCT01725308|450548124|FG001|Treatment Period I|Protocol Deviations|1|||
125251836|NCT01725308|450548125|FG002|Treatment Period I|Protocol Deviations|1|||
125251837|NCT01725308|450548123|FG000|Treatment Period I|Miscellaneous|2|||
125251838|NCT01725308|450548124|FG001|Treatment Period I|Miscellaneous|0|||
125251839|NCT01725308|450548125|FG002|Treatment Period I|Miscellaneous|3|||
125251840|NCT01725308|450548123|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
125251841|NCT01725308|450548124|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
125251842|NCT01725308|450548125|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
125251843|NCT01725308|450548123|FG000|Treatment Period II|Did Not Receive Drug|4|||
125251844|NCT01725308|450548124|FG001|Treatment Period II|Did Not Receive Drug|0|||
125251845|NCT01725308|450548125|FG002|Treatment Period II|Did Not Receive Drug|0|||
125251846|NCT01725308|450548123|FG000|Treatment Period II|Adverse Event|13|||
125251847|NCT01725308|450548124|FG001|Treatment Period II|Adverse Event|8|||
125251848|NCT01725308|450548125|FG002|Treatment Period II|Adverse Event|20|||
125251849|NCT01725308|450548123|FG000|Treatment Period II|Insufficient Response|2|||
125251850|NCT01725308|450548124|FG001|Treatment Period II|Insufficient Response|4|||
125251851|NCT01725308|450548125|FG002|Treatment Period II|Insufficient Response|6|||
125251852|NCT01725308|450548123|FG000|Treatment Period II|Worsening of the Target Disease|1|||
125251853|NCT01725308|450548124|FG001|Treatment Period II|Worsening of the Target Disease|4|||
125251854|NCT01725308|450548125|FG002|Treatment Period II|Worsening of the Target Disease|2|||
125251855|NCT01725308|450548123|FG000|Treatment Period II|Changes in the Episodes|1|||
125251856|NCT01725308|450548124|FG001|Treatment Period II|Changes in the Episodes|0|||
125251857|NCT01725308|450548125|FG002|Treatment Period II|Changes in the Episodes|5|||
125251858|NCT01725308|450548123|FG000|Treatment Period II|Withdrawal of Consent|28|||
125251859|NCT01725308|450548124|FG001|Treatment Period II|Withdrawal of Consent|2|||
125251860|NCT01725308|450548125|FG002|Treatment Period II|Withdrawal of Consent|16|||
125251861|NCT01725308|450548123|FG000|Treatment Period II|Lost to Follow-up|1|||
125251862|NCT01725308|450548124|FG001|Treatment Period II|Lost to Follow-up|5|||
125251863|NCT01725308|450548125|FG002|Treatment Period II|Lost to Follow-up|3|||
125251864|NCT01725308|450548123|FG000|Treatment Period II|Protocol Deviations|0|||
125251865|NCT01725308|450548124|FG001|Treatment Period II|Protocol Deviations|0|||
125251866|NCT01725308|450548125|FG002|Treatment Period II|Protocol Deviations|1|||
125251867|NCT01725308|450548123|FG000|Treatment Period II|Miscellaneous|5|||
125251868|NCT01725308|450548124|FG001|Treatment Period II|Miscellaneous|3|||
125251869|NCT01725308|450548125|FG002|Treatment Period II|Miscellaneous|7|||
125251870|NCT04128228|450548126|FG000|Overall Study|Withdrawal by Subject|3|||
125251871|NCT04128228|450548127|FG001|Overall Study|Withdrawal by Subject|3|||
125251872|NCT04128228|450548128|FG002|Overall Study|Withdrawal by Subject|0|||
125251873|NCT04128228|450548129|FG003|Overall Study|Withdrawal by Subject|0|||
125251874|NCT04128228|450548126|FG000|Overall Study|noncompliance|2|||
125251875|NCT04128228|450548127|FG001|Overall Study|noncompliance|2|||
125251876|NCT04128228|450548128|FG002|Overall Study|noncompliance|0|||
125251877|NCT04128228|450548129|FG003|Overall Study|noncompliance|0|||
125251878|NCT03511209|450548130|FG000|Overall Study|Withdrawal by Subject|2|||
125251879|NCT03511209|450548131|FG001|Overall Study|Withdrawal by Subject|4|||
125251880|NCT03511209|450548130|FG000|Overall Study|Death|1|||
125251881|NCT03511209|450548131|FG001|Overall Study|Death|0|||
125251882|NCT03511209|450548130|FG000|Overall Study|Lost to Follow-up|0|||
125251883|NCT03511209|450548131|FG001|Overall Study|Lost to Follow-up|2|||
125251884|NCT03163264|450548132|FG000|Overall Study|Withdrawal by Subject|13|||
125251885|NCT03163264|450548133|FG001|Overall Study|Withdrawal by Subject|3|||
125251886|NCT03163264|450548134|FG002|Overall Study|Withdrawal by Subject|4|||
125251887|NCT03163264|450548135|FG003|Overall Study|Withdrawal by Subject|2|||
125251888|NCT03163264|450548132|FG000|Overall Study|Lost to Follow-up|17|||
125251889|NCT03163264|450548133|FG001|Overall Study|Lost to Follow-up|20|||
125251890|NCT03163264|450548134|FG002|Overall Study|Lost to Follow-up|0|||
125251891|NCT03163264|450548135|FG003|Overall Study|Lost to Follow-up|0|||
125251892|NCT03163264|450548132|FG000|Overall Study|Death|0|||
125251893|NCT03163264|450548133|FG001|Overall Study|Death|2|||
125251894|NCT03163264|450548134|FG002|Overall Study|Death|0|||
125251895|NCT03163264|450548135|FG003|Overall Study|Death|0|||
125251896|NCT01602666|450548136|FG000|Induction Chemotherapy|Death|2|||
125251897|NCT01602666|450548137|FG001|Induction Chemotherapy|Death|1|||
125251898|NCT01602666|450548136|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
125251899|NCT01602666|450548137|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
125251900|NCT01602666|450548136|FG000|Induction Chemotherapy|Physician Decision|12|||
125251901|NCT01602666|450548137|FG001|Induction Chemotherapy|Physician Decision|5|||
125251902|NCT01602666|450548136|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
125251903|NCT01602666|450548137|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
125251904|NCT01602666|450548136|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
125251905|NCT01602666|450548137|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
125251906|NCT01602666|450548136|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
125251907|NCT01602666|450548137|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
125251908|NCT01602666|450548136|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
125251909|NCT01602666|450548137|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
125251910|NCT01602666|450548136|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
125251911|NCT01602666|450548137|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
125251912|NCT01602666|450548136|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
125251913|NCT01602666|450548137|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
125251914|NCT01602666|450548136|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
125251915|NCT01602666|450548137|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
125251916|NCT01602666|450548136|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
125251917|NCT01602666|450548137|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
125251918|NCT00215657|450548142|FG000|Overall Study|Adverse Event|5|||
125251919|NCT00215657|450548143|FG001|Overall Study|Adverse Event|1|||
125251920|NCT00215657|450548144|FG002|Overall Study|Adverse Event|3|||
125251921|NCT00215657|450548145|FG003|Overall Study|Adverse Event|0|||
125251922|NCT00215657|450548146|FG004|Overall Study|Adverse Event|3|||
125251923|NCT00215657|450548147|FG005|Overall Study|Adverse Event|1|||
125251924|NCT00215657|450548148|FG006|Overall Study|Adverse Event|0|||
125251925|NCT00215657|450548149|FG007|Overall Study|Adverse Event|3|||
125251926|NCT00215657|450548142|FG000|Overall Study|Withdrawal by Subject|6|||
125251927|NCT00215657|450548143|FG001|Overall Study|Withdrawal by Subject|3|||
125251928|NCT00215657|450548144|FG002|Overall Study|Withdrawal by Subject|3|||
125251929|NCT00215657|450548145|FG003|Overall Study|Withdrawal by Subject|1|||
125251930|NCT00215657|450548146|FG004|Overall Study|Withdrawal by Subject|6|||
125251931|NCT00215657|450548147|FG005|Overall Study|Withdrawal by Subject|1|||
125251932|NCT00215657|450548148|FG006|Overall Study|Withdrawal by Subject|10|||
125251933|NCT00215657|450548149|FG007|Overall Study|Withdrawal by Subject|3|||
125251934|NCT00215657|450548142|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
125197477|NCT01053962|450343981|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
125197478|NCT01053962|450343982|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
125197479|NCT01053962|450343983|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
125197480|NCT01053962|450343984|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
125197481|NCT01053962|450343980|FG000|Pretreatment Period|Venipuncture Failure|0|||
125197482|NCT01053962|450343981|FG001|Pretreatment Period|Venipuncture Failure|0|||
125197483|NCT01053962|450343982|FG002|Pretreatment Period|Venipuncture Failure|1|||
125197484|NCT01053962|450343983|FG003|Pretreatment Period|Venipuncture Failure|0|||
125197485|NCT01053962|450343984|FG004|Pretreatment Period|Venipuncture Failure|0|||
125197486|NCT01053962|450343980|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
125197487|NCT01053962|450343981|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
125197488|NCT01053962|450343982|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
125197489|NCT01053962|450343983|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
125197490|NCT01053962|450343984|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
125197491|NCT01053962|450343980|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
125197492|NCT01053962|450343981|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
125197493|NCT01053962|450343982|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
125197494|NCT01053962|450343983|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
125197495|NCT01053962|450343984|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
125197496|NCT01053962|450343980|FG000|Treatment Period|Lack of Efficacy|0|||
125197497|NCT01053962|450343981|FG001|Treatment Period|Lack of Efficacy|0|||
125197498|NCT01053962|450343982|FG002|Treatment Period|Lack of Efficacy|0|||
125197499|NCT01053962|450343983|FG003|Treatment Period|Lack of Efficacy|0|||
125197500|NCT01053962|450343984|FG004|Treatment Period|Lack of Efficacy|1|||
125197501|NCT01053962|450343980|FG000|Treatment Period|Adverse Event|0|||
125197502|NCT01053962|450343981|FG001|Treatment Period|Adverse Event|0|||
125197503|NCT01053962|450343982|FG002|Treatment Period|Adverse Event|0|||
125197504|NCT01053962|450343983|FG003|Treatment Period|Adverse Event|0|||
125197505|NCT01053962|450343984|FG004|Treatment Period|Adverse Event|1|||
125197506|NCT01053962|450343980|FG000|Treatment Period|Withdrawal by Subject|0|||
125251935|NCT00215657|450548143|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
125251936|NCT00215657|450548144|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
125251937|NCT00215657|450548145|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
125251938|NCT00215657|450548146|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
125251939|NCT00215657|450548147|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
125251940|NCT00215657|450548148|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
125251941|NCT00215657|450548149|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
125251942|NCT00215657|450548142|FG000|Overall Study|Insufficient testosterone response|5|||
125251943|NCT00215657|450548143|FG001|Overall Study|Insufficient testosterone response|4|||
125251944|NCT00215657|450548144|FG002|Overall Study|Insufficient testosterone response|1|||
125251945|NCT00215657|450548145|FG003|Overall Study|Insufficient testosterone response|12|||
125251946|NCT00215657|450548146|FG004|Overall Study|Insufficient testosterone response|8|||
125251947|NCT00215657|450548147|FG005|Overall Study|Insufficient testosterone response|12|||
125251948|NCT00215657|450548148|FG006|Overall Study|Insufficient testosterone response|4|||
125197507|NCT01053962|450343981|FG001|Treatment Period|Withdrawal by Subject|0|||
125251949|NCT00215657|450548149|FG007|Overall Study|Insufficient testosterone response|7|||
125251950|NCT00215657|450548142|FG000|Overall Study|Other|3|||
125251951|NCT00215657|450548143|FG001|Overall Study|Other|1|||
125251952|NCT00215657|450548144|FG002|Overall Study|Other|2|||
125251953|NCT00215657|450548145|FG003|Overall Study|Other|3|||
125251954|NCT00215657|450548146|FG004|Overall Study|Other|5|||
125251955|NCT00215657|450548147|FG005|Overall Study|Other|4|||
125251956|NCT00215657|450548148|FG006|Overall Study|Other|6|||
125251957|NCT00215657|450548149|FG007|Overall Study|Other|1|||
125251958|NCT03769467|450548150|FG000|Overall Study|Adverse Event|1|||
125251959|NCT03769467|450548151|FG001|Overall Study|Adverse Event|1|||
125251960|NCT03769467|450548152|FG002|Overall Study|Adverse Event|0|||
125251961|NCT03769467|450548150|FG000|Overall Study|Death|3|||
125251962|NCT03769467|450548151|FG001|Overall Study|Death|3|||
125251963|NCT03769467|450548152|FG002|Overall Study|Death|0|||
125251964|NCT03769467|450548150|FG000|Overall Study|Study Terminated By Sponsor|2|||
125251965|NCT03769467|450548151|FG001|Overall Study|Study Terminated By Sponsor|1|||
125251966|NCT03769467|450548152|FG002|Overall Study|Study Terminated By Sponsor|0|||
125251967|NCT03769467|450548150|FG000|Overall Study|Withdrawal by Subject|0|||
125251968|NCT03769467|450548151|FG001|Overall Study|Withdrawal by Subject|1|||
125251969|NCT03769467|450548152|FG002|Overall Study|Withdrawal by Subject|0|||
125251970|NCT02614066|450548153|FG000|Overall Study|Death|6|||
125251971|NCT02614066|450548154|FG001|Overall Study|Death|14|||
125251972|NCT02614066|450548155|FG002|Overall Study|Death|11|||
125251973|NCT02614066|450548156|FG003|Overall Study|Death|29|||
125251974|NCT02614066|450548153|FG000|Overall Study|Full consent withdrawn|0|||
125251975|NCT02614066|450548154|FG001|Overall Study|Full consent withdrawn|1|||
125251976|NCT02614066|450548155|FG002|Overall Study|Full consent withdrawn|0|||
125251977|NCT02614066|450548156|FG003|Overall Study|Full consent withdrawn|8|||
125251978|NCT02614066|450548153|FG000|Overall Study|Lost to Follow-up|0|||
125251979|NCT02614066|450548154|FG001|Overall Study|Lost to Follow-up|2|||
125251980|NCT02614066|450548155|FG002|Overall Study|Lost to Follow-up|2|||
125251981|NCT02614066|450548156|FG003|Overall Study|Lost to Follow-up|2|||
125251982|NCT02614066|450548153|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
125251983|NCT02614066|450548154|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
125251984|NCT02614066|450548155|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
125251985|NCT02614066|450548156|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
125251986|NCT02614066|450548153|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
125251987|NCT02614066|450548154|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
125251988|NCT02614066|450548155|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
125251989|NCT02614066|450548156|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
125251990|NCT02614066|450548153|FG000|Overall Study|Reason not specified|0|||
125251991|NCT02614066|450548154|FG001|Overall Study|Reason not specified|2|||
125251992|NCT02614066|450548155|FG002|Overall Study|Reason not specified|1|||
125251993|NCT02614066|450548156|FG003|Overall Study|Reason not specified|1|||
125251994|NCT04565756|450548157|FG000|Overall Study|Withdrawal by Subject|0|||
125251995|NCT04565756|450548158|FG001|Overall Study|Withdrawal by Subject|0|||
125251996|NCT04565756|450548159|FG002|Overall Study|Withdrawal by Subject|0|||
125251997|NCT04565756|450548160|FG003|Overall Study|Withdrawal by Subject|0|||
125197508|NCT01053962|450343982|FG002|Treatment Period|Withdrawal by Subject|0|||
125197509|NCT01053962|450343983|FG003|Treatment Period|Withdrawal by Subject|0|||
125197510|NCT01053962|450343984|FG004|Treatment Period|Withdrawal by Subject|1|||
125197511|NCT01053962|450343980|FG000|Treatment Period|Noncompliance with protocol|1|||
125197512|NCT01053962|450343981|FG001|Treatment Period|Noncompliance with protocol|0|||
125197513|NCT01053962|450343982|FG002|Treatment Period|Noncompliance with protocol|0|||
125197514|NCT01053962|450343983|FG003|Treatment Period|Noncompliance with protocol|0|||
125197515|NCT01053962|450343984|FG004|Treatment Period|Noncompliance with protocol|0|||
125197516|NCT00937040|450343985|FG000|Overall Study|Adverse Event|5|||
125197517|NCT00937040|450343986|FG001|Overall Study|Adverse Event|8|||
125197518|NCT00937040|450343985|FG000|Overall Study|Lost to Follow-up|12|||
125197519|NCT00937040|450343986|FG001|Overall Study|Lost to Follow-up|12|||
125251998|NCT04565756|450548161|FG004|Overall Study|Withdrawal by Subject|1|||
125251999|NCT04565756|450548162|FG005|Overall Study|Withdrawal by Subject|0|||
125252000|NCT04565756|450548157|FG000|Overall Study|Protocol Violation|0|||
125252001|NCT04565756|450548158|FG001|Overall Study|Protocol Violation|0|||
125197520|NCT00937040|450343985|FG000|Overall Study|Protocol Violation|3|||
125197521|NCT00937040|450343986|FG001|Overall Study|Protocol Violation|0|||
125197522|NCT00937040|450343985|FG000|Overall Study|Withdrawal by Subject|13|||
125252002|NCT04565756|450548159|FG002|Overall Study|Protocol Violation|0|||
125252003|NCT04565756|450548160|FG003|Overall Study|Protocol Violation|0|||
125252004|NCT04565756|450548161|FG004|Overall Study|Protocol Violation|0|||
125252005|NCT04565756|450548162|FG005|Overall Study|Protocol Violation|1|||
125252006|NCT03069937|450548171|FG000|Overall Study|Second primary malignancy noted|1|||
125252007|NCT00968968|450548172|FG000|Overall Study|Study closed/terminated|10|||
125252008|NCT00968968|450548173|FG001|Overall Study|Study closed/terminated|10|||
125252009|NCT00968968|450548172|FG000|Overall Study|Protocol defined stopping criteria|3|||
125252010|NCT00968968|450548173|FG001|Overall Study|Protocol defined stopping criteria|1|||
125252011|NCT00968968|450548172|FG000|Overall Study|Withdrawal by Subject|2|||
125252012|NCT00968968|450548173|FG001|Overall Study|Withdrawal by Subject|0|||
125252013|NCT00968968|450548172|FG000|Overall Study|Physician Decision|1|||
125252014|NCT00968968|450548173|FG001|Overall Study|Physician Decision|2|||
125252015|NCT00968968|450548172|FG000|Overall Study|Lost to Follow-up|0|||
125252016|NCT00968968|450548173|FG001|Overall Study|Lost to Follow-up|1|||
125252017|NCT03624036|450548174|FG000|Overall Study|Death|2|||
125252018|NCT03624036|450548175|FG001|Overall Study|Death|3|||
125252019|NCT03624036|450548176|FG002|Overall Study|Death|0|||
125252020|NCT03624036|450548177|FG003|Overall Study|Death|1|||
125252021|NCT03624036|450548174|FG000|Overall Study|Withdrawal by Subject|1|||
125252022|NCT03624036|450548175|FG001|Overall Study|Withdrawal by Subject|0|||
125252023|NCT03624036|450548176|FG002|Overall Study|Withdrawal by Subject|1|||
125252024|NCT03624036|450548177|FG003|Overall Study|Withdrawal by Subject|0|||
125252025|NCT03624036|450548174|FG000|Overall Study|Enrolled but Never Treated|1|||
125252026|NCT03624036|450548175|FG001|Overall Study|Enrolled but Never Treated|0|||
125252027|NCT03624036|450548176|FG002|Overall Study|Enrolled but Never Treated|0|||
125252028|NCT03624036|450548177|FG003|Overall Study|Enrolled but Never Treated|0|||
125252029|NCT03624036|450548174|FG000|Overall Study|Reason not Specified|3|||
125252030|NCT03624036|450548175|FG001|Overall Study|Reason not Specified|0|||
125252031|NCT03624036|450548176|FG002|Overall Study|Reason not Specified|2|||
125252032|NCT03624036|450548177|FG003|Overall Study|Reason not Specified|2|||
125252033|NCT01185366|450548178|FG000|First Line Therapy|Insurance Coverage Denied|1|||
125252034|NCT01185366|450548179|FG001|First Line Therapy|Insurance Coverage Denied|1|||
125252035|NCT01185366|450548178|FG000|First Line Therapy|Withdrawal by Subject|1|||
125252036|NCT01185366|450548179|FG001|First Line Therapy|Withdrawal by Subject|0|||
125252037|NCT01185366|450548178|FG000|First Line Therapy|Lack of Metastatic Site|1|||
125252038|NCT01185366|450548179|FG001|First Line Therapy|Lack of Metastatic Site|0|||
125252039|NCT01185366|450548178|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
125252040|NCT01185366|450548179|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
125252041|NCT01185366|450548178|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
125252042|NCT01185366|450548179|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
125252043|NCT01185366|450548178|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
125252044|NCT01185366|450548179|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
125252045|NCT01185366|450548178|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
125252046|NCT01185366|450548179|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
125252047|NCT02774278|450548180|FG000|Overall Study|Lack of Efficacy|199|||
125252048|NCT02774278|450548180|FG000|Overall Study|Death|29|||
125252049|NCT02774278|450548180|FG000|Overall Study|Adverse event/intercurrent illness|16|||
125252050|NCT02774278|450548180|FG000|Overall Study|Refused treatment/did not cooperate|9|||
125252051|NCT02774278|450548180|FG000|Overall Study|Administrative reasons|6|||
125252052|NCT02774278|450548180|FG000|Overall Study|Withdrawal by Subject|3|||
125252053|NCT02774278|450548180|FG000|Overall Study|Protocol Violation|2|||
125252054|NCT00127933|450548187|FG000|Overall Study|Randomized but not dosed|1|||
125252055|NCT00127933|450548188|FG001|Overall Study|Randomized but not dosed|0|||
125252056|NCT01783938|450548190|FG000|Overall Study|Disease Progression|18|||
125252057|NCT01783938|450548191|FG001|Overall Study|Disease Progression|41|||
125252058|NCT01783938|450548190|FG000|Overall Study|Study Drug Toxicity|27|||
125252059|NCT01783938|450548191|FG001|Overall Study|Study Drug Toxicity|14|||
125252060|NCT01783938|450548190|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
125252061|NCT01783938|450548191|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
125252062|NCT01783938|450548190|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
125197523|NCT00937040|450343986|FG001|Overall Study|Withdrawal by Subject|7|||
125197524|NCT00937040|450343985|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
125197525|NCT00937040|450343986|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
125197526|NCT00937040|450343985|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
125197527|NCT00937040|450343986|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
125197528|NCT02294396|450343987|FG000|Overall Study|Adverse Event|26|||
125197529|NCT02294396|450343988|FG001|Overall Study|Adverse Event|25|||
125197530|NCT02294396|450343989|FG002|Overall Study|Adverse Event|21|||
125197531|NCT02294396|450343990|FG003|Overall Study|Adverse Event|24|||
125197532|NCT02294396|450343987|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
125197533|NCT02294396|450343988|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
125197534|NCT02294396|450343989|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
125197535|NCT02294396|450343990|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
125197536|NCT02294396|450343987|FG000|Overall Study|Withdrawal by Subject|8|||
125197537|NCT02294396|450343988|FG001|Overall Study|Withdrawal by Subject|6|||
125197538|NCT02294396|450343989|FG002|Overall Study|Withdrawal by Subject|6|||
125252063|NCT01783938|450548191|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
125252064|NCT01783938|450548190|FG000|Overall Study|Participant Withdrew Consent|2|||
125252065|NCT01783938|450548191|FG001|Overall Study|Participant Withdrew Consent|0|||
125197539|NCT02294396|450343990|FG003|Overall Study|Withdrawal by Subject|8|||
125252066|NCT01783938|450548190|FG000|Overall Study|Maximum Clinical Benefit|1|||
125252067|NCT01783938|450548191|FG001|Overall Study|Maximum Clinical Benefit|0|||
125252068|NCT01783938|450548190|FG000|Overall Study|Other Reasons|3|||
125252069|NCT01783938|450548191|FG001|Overall Study|Other Reasons|1|||
125252070|NCT03072875|450548196|FG000|Overall Study|Lost to Follow-up|1|||
125252071|NCT03478787|450548197|FG000|Overall Study|Adverse Event|5|||
125252072|NCT03478787|450548198|FG001|Overall Study|Adverse Event|1|||
125252073|NCT03478787|450548197|FG000|Overall Study|Protocol Violation|3|||
125252074|NCT03478787|450548198|FG001|Overall Study|Protocol Violation|0|||
125252075|NCT03478787|450548197|FG000|Overall Study|Lack of Efficacy|7|||
125252076|NCT03478787|450548198|FG001|Overall Study|Lack of Efficacy|1|||
125252077|NCT03478787|450548197|FG000|Overall Study|Lost to Follow-up|9|||
125252078|NCT03478787|450548198|FG001|Overall Study|Lost to Follow-up|5|||
125252079|NCT03478787|450548197|FG000|Overall Study|Withdrawal by Subject|2|||
125252080|NCT03478787|450548198|FG001|Overall Study|Withdrawal by Subject|6|||
125252081|NCT03478787|450548197|FG000|Overall Study|Other, Not Specified|3|||
125252082|NCT03478787|450548198|FG001|Overall Study|Other, Not Specified|0|||
125252083|NCT02413346|450548201|FG000|Overall Study|Adverse Event|6|||
125252084|NCT02413346|450548202|FG001|Overall Study|Adverse Event|6|||
125252085|NCT02413346|450548201|FG000|Overall Study|Withdrawal by Subject|30|||
125252086|NCT02413346|450548202|FG001|Overall Study|Withdrawal by Subject|40|||
125252087|NCT02413346|450548201|FG000|Overall Study|Lost to Follow-up|17|||
125252088|NCT02413346|450548202|FG001|Overall Study|Lost to Follow-up|21|||
125252089|NCT02413346|450548201|FG000|Overall Study|Protocol Violation|2|||
125252090|NCT02413346|450548202|FG001|Overall Study|Protocol Violation|0|||
125252091|NCT02413346|450548201|FG000|Overall Study|Other Miscellaneous Reasons|4|||
125252092|NCT02413346|450548202|FG001|Overall Study|Other Miscellaneous Reasons|3|||
125252093|NCT01316900|450548221|FG000|Overall Study|Adverse Event|10|||
125252094|NCT01316900|450548222|FG001|Overall Study|Adverse Event|10|||
125252095|NCT01316900|450548223|FG002|Overall Study|Adverse Event|15|||
125252096|NCT01316900|450548224|FG003|Overall Study|Adverse Event|9|||
125252097|NCT01316900|450548221|FG000|Overall Study|Lack of Efficacy|17|||
125252098|NCT01316900|450548222|FG001|Overall Study|Lack of Efficacy|9|||
125252099|NCT01316900|450548223|FG002|Overall Study|Lack of Efficacy|5|||
125252100|NCT01316900|450548224|FG003|Overall Study|Lack of Efficacy|7|||
125252101|NCT01316900|450548221|FG000|Overall Study|Protocol Violation|7|||
125252102|NCT01316900|450548222|FG001|Overall Study|Protocol Violation|1|||
125252103|NCT01316900|450548223|FG002|Overall Study|Protocol Violation|4|||
125252104|NCT01316900|450548224|FG003|Overall Study|Protocol Violation|0|||
125252105|NCT01316900|450548221|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
125252106|NCT01316900|450548222|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
125252107|NCT01316900|450548223|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
125252108|NCT01316900|450548224|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
125252109|NCT01316900|450548221|FG000|Overall Study|Lost to Follow-up|1|||
125252110|NCT01316900|450548222|FG001|Overall Study|Lost to Follow-up|0|||
125252111|NCT01316900|450548223|FG002|Overall Study|Lost to Follow-up|1|||
125252112|NCT01316900|450548224|FG003|Overall Study|Lost to Follow-up|1|||
125252113|NCT01316900|450548221|FG000|Overall Study|Withdrawal by Subject|7|||
125252114|NCT01316900|450548222|FG001|Overall Study|Withdrawal by Subject|8|||
125252115|NCT01316900|450548223|FG002|Overall Study|Withdrawal by Subject|6|||
125252116|NCT01316900|450548224|FG003|Overall Study|Withdrawal by Subject|9|||
125252117|NCT01684033|450548227|FG000|Period 1, First 30 Days|Adverse Event|1|||
125252118|NCT01684033|450548228|FG001|Period 1, First 30 Days|Adverse Event|1|||
125252119|NCT01684033|450548227|FG000|Period 1, First 30 Days|Noncompliance|1|||
125252120|NCT01684033|450548228|FG001|Period 1, First 30 Days|Noncompliance|0|||
125252121|NCT01684033|450548227|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
125252122|NCT01684033|450548228|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
125252123|NCT01684033|450548227|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
125252124|NCT01684033|450548228|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
125252125|NCT01684033|450548227|FG000|Period 2, Second 30 Days|Adverse Event|1|||
125252126|NCT01684033|450548228|FG001|Period 2, Second 30 Days|Adverse Event|0|||
125252127|NCT00089583|450548231|FG000|Overall Study|Adverse Event|0|||
125252128|NCT00089583|450548232|FG001|Overall Study|Adverse Event|3|||
125252129|NCT00089583|450548231|FG000|Overall Study|Insufficient Viral Load Response|5|||
125252130|NCT00089583|450548232|FG001|Overall Study|Insufficient Viral Load Response|5|||
125252131|NCT00089583|450548231|FG000|Overall Study|Withdrawal by Subject|0|||
125252132|NCT00089583|450548232|FG001|Overall Study|Withdrawal by Subject|4|||
125252133|NCT00089583|450548231|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
125252134|NCT00089583|450548232|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
125252135|NCT00089583|450548231|FG000|Overall Study|Participant Refused Study Medication|0|||
125252136|NCT00089583|450548232|FG001|Overall Study|Participant Refused Study Medication|2|||
125252137|NCT00089583|450548231|FG000|Overall Study|Non-Compliance|0|||
125252138|NCT00089583|450548232|FG001|Overall Study|Non-Compliance|4|||
125252139|NCT00089583|450548231|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
125252140|NCT00089583|450548232|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
125252141|NCT00089583|450548231|FG000|Overall Study|Participant Management Criteria Met|0|||
125252142|NCT00089583|450548232|FG001|Overall Study|Participant Management Criteria Met|1|||
125252143|NCT00089583|450548231|FG000|Overall Study|Reason Not Provided|0|||
125252144|NCT00089583|450548232|FG001|Overall Study|Reason Not Provided|1|||
125252145|NCT00089583|450548231|FG000|Overall Study|Protocol Violation|0|||
125252146|NCT00089583|450548232|FG001|Overall Study|Protocol Violation|3|||
125252147|NCT00089583|450548231|FG000|Overall Study|Principal Investigator Decision|0|||
125252148|NCT00089583|450548232|FG001|Overall Study|Principal Investigator Decision|10|||
125252149|NCT00089583|450548231|FG000|Overall Study|Start of Disallowed Medication|0|||
125252150|NCT00089583|450548232|FG001|Overall Study|Start of Disallowed Medication|1|||
125252151|NCT00089583|450548231|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
125252152|NCT00089583|450548232|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
125252153|NCT00089583|450548231|FG000|Overall Study|Participant Incarcerated|0|||
125252154|NCT00089583|450548232|FG001|Overall Study|Participant Incarcerated|1|||
125252155|NCT00507507|450548233|FG000|Treatment Period|Lost to Follow-up|0|||
125252156|NCT00507507|450548234|FG001|Treatment Period|Lost to Follow-up|2|||
125252157|NCT00507507|450548233|FG000|Treatment Period|Physician Decision|4|||
125252158|NCT00507507|450548234|FG001|Treatment Period|Physician Decision|1|||
125252159|NCT00507507|450548233|FG000|Treatment Period|Protocol Violation|1|||
125252160|NCT00507507|450548234|FG001|Treatment Period|Protocol Violation|2|||
125252161|NCT00507507|450548233|FG000|Treatment Period|Adverse Event|1|||
125252162|NCT00507507|450548234|FG001|Treatment Period|Adverse Event|1|||
125252163|NCT00507507|450548233|FG000|Treatment Period|Withdrawal by Subject|46|||
125252164|NCT00507507|450548234|FG001|Treatment Period|Withdrawal by Subject|47|||
125252165|NCT00507507|450548233|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
125252166|NCT00507507|450548234|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
125252167|NCT00507507|450548233|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
125252168|NCT00507507|450548234|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
125252169|NCT00507507|450548233|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
125252170|NCT00507507|450548234|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
125252171|NCT02916433|450548235|FG000|Overall Study|Withdrawal by Subject|1|||
125252172|NCT02916433|450548236|FG001|Overall Study|Withdrawal by Subject|0|||
125252173|NCT02916433|450548235|FG000|Overall Study|Physician Decision|1|||
125252174|NCT02916433|450548236|FG001|Overall Study|Physician Decision|0|||
125252175|NCT01412983|450548237|FG000|1st Period|Ineligible|0|||
125252176|NCT01412983|450548238|FG001|1st Period|Ineligible|1|||
125252177|NCT01412983|450548237|FG000|1st Period|Positive slit lamp finding|0|||
125252178|NCT01412983|450548238|FG001|1st Period|Positive slit lamp finding|1|||
125252179|NCT01412983|450548237|FG000|1st Period|Unacceptable lens movement|0|||
125252180|NCT01412983|450548238|FG001|1st Period|Unacceptable lens movement|1|||
125252181|NCT01412983|450548237|FG000|1st Period|Inability to maintain wear|0|||
125252182|NCT01412983|450548238|FG001|1st Period|Inability to maintain wear|1|||
125252183|NCT01623154|450548239|FG000|Overall Study|Did not drink Pranactin Citric|4|||
125252184|NCT00890097|450548240|FG000|Overall Study|Adverse Event|21|||
125252185|NCT00890097|450548241|FG001|Overall Study|Adverse Event|32|||
125252186|NCT00890097|450548242|FG002|Overall Study|Adverse Event|28|||
125252187|NCT00890097|450548240|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
125252188|NCT00890097|450548241|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
125252189|NCT00890097|450548242|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
125252190|NCT00890097|450548240|FG000|Overall Study|Withdrew Consent|9|||
125252191|NCT00890097|450548241|FG001|Overall Study|Withdrew Consent|6|||
125252192|NCT00890097|450548242|FG002|Overall Study|Withdrew Consent|9|||
125252193|NCT00890097|450548240|FG000|Overall Study|Lost to Follow-up|5|||
125252194|NCT00890097|450548241|FG001|Overall Study|Lost to Follow-up|5|||
125252195|NCT00890097|450548242|FG002|Overall Study|Lost to Follow-up|5|||
125252196|NCT00890097|450548240|FG000|Overall Study|Noncompliance|0|||
125252197|NCT00890097|450548241|FG001|Overall Study|Noncompliance|4|||
125252198|NCT00890097|450548242|FG002|Overall Study|Noncompliance|4|||
125252199|NCT00890097|450548240|FG000|Overall Study|Sponsor Decision|7|||
125252200|NCT00890097|450548241|FG001|Overall Study|Sponsor Decision|11|||
125252201|NCT00890097|450548242|FG002|Overall Study|Sponsor Decision|7|||
125252202|NCT00890097|450548240|FG000|Overall Study|Did not attend final visit|2|||
125252203|NCT00890097|450548241|FG001|Overall Study|Did not attend final visit|3|||
125252204|NCT00890097|450548242|FG002|Overall Study|Did not attend final visit|0|||
125252205|NCT00890097|450548240|FG000|Overall Study|Subject Decision|3|||
125252206|NCT00890097|450548241|FG001|Overall Study|Subject Decision|2|||
125252207|NCT00890097|450548242|FG002|Overall Study|Subject Decision|6|||
125252208|NCT00890097|450548240|FG000|Overall Study|Randomization Error|2|||
125252209|NCT00890097|450548241|FG001|Overall Study|Randomization Error|0|||
125252210|NCT00890097|450548242|FG002|Overall Study|Randomization Error|0|||
125252211|NCT00890097|450548240|FG000|Overall Study|Failed inclusion criteria|3|||
125252212|NCT00890097|450548241|FG001|Overall Study|Failed inclusion criteria|4|||
125252213|NCT00890097|450548242|FG002|Overall Study|Failed inclusion criteria|0|||
125252214|NCT00890097|450548240|FG000|Overall Study|Transportation|0|||
125252215|NCT00890097|450548241|FG001|Overall Study|Transportation|2|||
125252216|NCT00890097|450548242|FG002|Overall Study|Transportation|0|||
125252217|NCT00890097|450548240|FG000|Overall Study|Subject Moved|0|||
125252218|NCT00890097|450548241|FG001|Overall Study|Subject Moved|4|||
125252219|NCT00890097|450548242|FG002|Overall Study|Subject Moved|0|||
125252220|NCT00890097|450548240|FG000|Overall Study|Protocol Deviation|1|||
125252221|NCT00890097|450548241|FG001|Overall Study|Protocol Deviation|1|||
125252222|NCT00890097|450548242|FG002|Overall Study|Protocol Deviation|1|||
125252223|NCT00954538|450548243|FG000|Part III|Withdrawal by Subject|0|||
125252224|NCT00954538|450548244|FG001|Part III|Withdrawal by Subject|0|||
125252225|NCT00954538|450548245|FG002|Part III|Withdrawal by Subject|0|||
125252226|NCT00954538|450548246|FG003|Part III|Withdrawal by Subject|0|||
125252227|NCT00954538|450548247|FG004|Part III|Withdrawal by Subject|1|||
125252228|NCT00954538|450548248|FG005|Part III|Withdrawal by Subject|0|||
125252229|NCT03178942|450548252|FG000|Overall Study|Withdrawal by Subject|2|||
125252230|NCT03178942|450548253|FG001|Overall Study|Withdrawal by Subject|0|||
125252231|NCT03178942|450548252|FG000|Overall Study|Lost to Follow-up|1|||
125252232|NCT03178942|450548253|FG001|Overall Study|Lost to Follow-up|2|||
125252233|NCT01657942|450548254|FG000|Overall Study|Alternative Treatment|7|||
125252234|NCT01657942|450548254|FG000|Overall Study|Lost to Follow-up|1|||
125252235|NCT03061214|450548258|FG000|Overall Study|Withdrawal by Subject|21|||
125252236|NCT03061214|450548259|FG001|Overall Study|Withdrawal by Subject|26|||
125252237|NCT03061214|450548260|FG002|Overall Study|Withdrawal by Subject|9|||
125252238|NCT03061214|450548258|FG000|Overall Study|Lost to Follow-up|3|||
125252239|NCT03061214|450548259|FG001|Overall Study|Lost to Follow-up|1|||
125252240|NCT03061214|450548260|FG002|Overall Study|Lost to Follow-up|1|||
125252241|NCT03061214|450548258|FG000|Overall Study|Death|1|||
125252242|NCT03061214|450548259|FG001|Overall Study|Death|1|||
125252243|NCT03061214|450548260|FG002|Overall Study|Death|0|||
125252244|NCT00107614|450550206|FG000|Overall Study|Physician Decision|10|||
125252245|NCT00107614|450550206|FG000|Overall Study|Death|2|||
125252246|NCT02715856|450550210|FG000|Overall Study|Software Issues|12|||
125252247|NCT02715856|450550211|FG001|Overall Study|Software Issues|7|||
125252248|NCT02715856|450550210|FG000|Overall Study|Death|6|||
125252249|NCT02715856|450550211|FG001|Overall Study|Death|5|||
125252250|NCT02715856|450550210|FG000|Overall Study|Non- Compliant|0|||
125252251|NCT02715856|450550211|FG001|Overall Study|Non- Compliant|40|||
125252252|NCT01772693|450550212|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
125252253|NCT01772693|450550213|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
125252254|NCT01772693|450550212|FG000|Overall Study|Withdrawal by Subject|2|||
125252255|NCT01772693|450550213|FG001|Overall Study|Withdrawal by Subject|0|||
125252256|NCT01772693|450550212|FG000|Overall Study|Alternative Treatment|2|||
125252257|NCT01772693|450550213|FG001|Overall Study|Alternative Treatment|0|||
125252258|NCT02094885|450550216|FG000|Overall Study|Death|1|||
125252259|NCT02094885|450550217|FG001|Overall Study|Death|5|||
125252260|NCT02094885|450550216|FG000|Overall Study|Withdrawn due to age|1|||
125252261|NCT02094885|450550217|FG001|Overall Study|Withdrawn due to age|0|||
125252262|NCT00215553|450550226|FG000|Overall Study|Adverse Event|0|||
125252263|NCT00215553|450550227|FG001|Overall Study|Adverse Event|1|||
125252264|NCT00215553|450550228|FG002|Overall Study|Adverse Event|2|||
125252265|NCT00215553|450550229|FG003|Overall Study|Adverse Event|1|||
125252266|NCT00215553|450550230|FG004|Overall Study|Adverse Event|2|||
125252267|NCT00215553|450550231|FG005|Overall Study|Adverse Event|6|||
125252268|NCT00215553|450550232|FG006|Overall Study|Adverse Event|0|||
125252269|NCT00756314|450550233|FG000|Overall Study|Lost to Follow-up|2|||
125252270|NCT00756314|450550234|FG001|Overall Study|Lost to Follow-up|59|||
125252271|NCT02605967|450550236|FG000|Overall Study|subject / guardian decision|1|||
125252272|NCT02605967|450550237|FG001|Overall Study|subject / guardian decision|2|||
125252273|NCT02605967|450550236|FG000|Overall Study|Physician Decision|10|||
125252274|NCT02605967|450550237|FG001|Overall Study|Physician Decision|1|||
125252275|NCT02605967|450550236|FG000|Overall Study|Death|4|||
125252276|NCT02605967|450550237|FG001|Overall Study|Death|2|||
125252277|NCT02605967|450550236|FG000|Overall Study|Adverse Event|1|||
125252278|NCT02605967|450550237|FG001|Overall Study|Adverse Event|0|||
125252279|NCT02605967|450550236|FG000|Overall Study|progressive disease|66|||
125252280|NCT02605967|450550237|FG001|Overall Study|progressive disease|35|||
125252281|NCT00159874|450550242|FG000|Overall Study|Adverse Event|2|||
125252282|NCT00159874|450550243|FG001|Overall Study|Adverse Event|2|||
125252283|NCT00159874|450550244|FG002|Overall Study|Adverse Event|5|||
125252284|NCT00159874|450550245|FG003|Overall Study|Adverse Event|1|||
125252285|NCT00159874|450550246|FG004|Overall Study|Adverse Event|1|||
125252286|NCT00159874|450550247|FG005|Overall Study|Adverse Event|2|||
125252287|NCT00159874|450550248|FG006|Overall Study|Adverse Event|0|||
125252288|NCT00159874|450550242|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
125252289|NCT00159874|450550243|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
125252290|NCT00159874|450550244|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
125252291|NCT00159874|450550245|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
125252292|NCT00159874|450550246|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
125252293|NCT00159874|450550247|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
125252294|NCT00159874|450550248|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
125252295|NCT00159874|450550242|FG000|Overall Study|Lack of Efficacy|2|||
125252296|NCT00159874|450550243|FG001|Overall Study|Lack of Efficacy|0|||
125252297|NCT00159874|450550244|FG002|Overall Study|Lack of Efficacy|1|||
125252298|NCT00159874|450550245|FG003|Overall Study|Lack of Efficacy|1|||
125252299|NCT00159874|450550246|FG004|Overall Study|Lack of Efficacy|0|||
125252300|NCT00159874|450550247|FG005|Overall Study|Lack of Efficacy|3|||
125252301|NCT00159874|450550248|FG006|Overall Study|Lack of Efficacy|0|||
125252302|NCT00159874|450550242|FG000|Overall Study|Lost to Follow-up|1|||
125252303|NCT00159874|450550243|FG001|Overall Study|Lost to Follow-up|0|||
125252304|NCT00159874|450550244|FG002|Overall Study|Lost to Follow-up|3|||
125252305|NCT00159874|450550245|FG003|Overall Study|Lost to Follow-up|0|||
125252306|NCT00159874|450550246|FG004|Overall Study|Lost to Follow-up|1|||
125197540|NCT02294396|450343987|FG000|Overall Study|Lost to Follow-up|0|||
125197541|NCT02294396|450343988|FG001|Overall Study|Lost to Follow-up|0|||
125197542|NCT02294396|450343989|FG002|Overall Study|Lost to Follow-up|1|||
125197543|NCT02294396|450343990|FG003|Overall Study|Lost to Follow-up|1|||
125197544|NCT02294396|450343987|FG000|Overall Study|Protocol Deviation|3|||
125197545|NCT02294396|450343988|FG001|Overall Study|Protocol Deviation|2|||
125197546|NCT02294396|450343989|FG002|Overall Study|Protocol Deviation|2|||
125197547|NCT02294396|450343990|FG003|Overall Study|Protocol Deviation|1|||
125197548|NCT02294396|450343987|FG000|Overall Study|Miscellaneous|2|||
125197549|NCT02294396|450343988|FG001|Overall Study|Miscellaneous|0|||
125197550|NCT02294396|450343989|FG002|Overall Study|Miscellaneous|5|||
125197551|NCT02294396|450343990|FG003|Overall Study|Miscellaneous|2|||
125197552|NCT02120833|450343991|FG000|Overall Study|Adverse Event|1|||
125197553|NCT02120833|450343992|FG001|Overall Study|Adverse Event|0|||
125197554|NCT02120833|450343991|FG000|Overall Study|Withdrawal by Subject|2|||
125197555|NCT02120833|450343992|FG001|Overall Study|Withdrawal by Subject|0|||
125197556|NCT02120833|450343991|FG000|Overall Study|Lost to Follow-up|1|||
125197557|NCT02120833|450343992|FG001|Overall Study|Lost to Follow-up|1|||
125197558|NCT03502070|450343993|FG000|Overall Study|Withdrawal by Subject|1|||
125197559|NCT03502070|450343993|FG000|Overall Study|Screen Failure|1|||
125197560|NCT01046903|450343998|FG000|Overall Study|Lost to Follow-up|16|||
125197561|NCT01046903|450343998|FG000|Overall Study|Adverse Event|4|||
125197562|NCT01046903|450343998|FG000|Overall Study|Withdrawal by Subject|3|||
125197563|NCT01046903|450343998|FG000|Overall Study|Other|5|||
125197564|NCT01668173|450344004|FG000|Overall Study|Adverse Event|3|||
125197565|NCT01668173|450344004|FG000|Overall Study|Trial suspension|4|||
125197566|NCT01628198|450344005|FG000|Overall Study|Lost to Follow-up|7|||
125197567|NCT01628198|450344005|FG000|Overall Study|Withdrawal by Subject|10|||
125197568|NCT01628198|450344005|FG000|Overall Study|Screen failure|1|||
125197569|NCT04999163|450344006|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
125197570|NCT04999163|450344007|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
125197571|NCT04999163|450344006|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
125197572|NCT04999163|450344007|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
125197573|NCT04999163|450344006|FG000|Overall Study|Withdrawal by Subject|1|||
125197574|NCT04999163|450344007|FG001|Overall Study|Withdrawal by Subject|0|||
125197575|NCT00378508|450345818|FG000|Overall Study|Withdrawal by Subject|1|||
125197576|NCT00378508|450345819|FG001|Overall Study|Withdrawal by Subject|3|||
125197577|NCT00378508|450345818|FG000|Overall Study|Lost to Follow-up|1|||
125197578|NCT00378508|450345819|FG001|Overall Study|Lost to Follow-up|0|||
125197579|NCT01283334|450345820|FG000|Overall Study|Withdrawal by Subject|1|||
125197580|NCT01283334|450345820|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
125197581|NCT01283334|450345820|FG000|Overall Study|Adverse Event|4|||
125197582|NCT01283334|450345820|FG000|Overall Study|Physician Decision|1|||
125197583|NCT03467217|450345821|FG000|Overall Study|Trial stopped early|5|||
125197584|NCT03467217|450345822|FG001|Overall Study|Trial stopped early|2|||
125197585|NCT03467217|450345821|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
125197586|NCT03467217|450345822|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
125197587|NCT03467217|450345821|FG000|Overall Study|Lost to Follow-up|0|||
125197588|NCT03467217|450345822|FG001|Overall Study|Lost to Follow-up|2|||
125197589|NCT03233529|450345826|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
125197590|NCT03233529|450345826|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
125197591|NCT01177293|450345827|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
125197592|NCT01177293|450345828|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
125197593|NCT01905553|450345831|FG000|Period 2|Adverse Event|1|||
125197594|NCT01905553|450345832|FG001|Period 2|Adverse Event|0|||
125197595|NCT03854370|450345836|FG000|Overall Study|samples not collected|1|||
125197596|NCT03854370|450345837|FG001|Overall Study|samples not collected|1|||
125197597|NCT03854370|450345838|FG002|Overall Study|samples not collected|1|||
125197598|NCT03854370|450345839|FG003|Overall Study|samples not collected|1|||
125197599|NCT00452673|450345840|FG000|Dose Escalation Period|Disease Progression|6|||
125252307|NCT00159874|450550247|FG005|Overall Study|Lost to Follow-up|2|||
125197600|NCT00452673|450345841|FG001|Dose Escalation Period|Disease Progression|6|||
125197601|NCT00452673|450345842|FG002|Dose Escalation Period|Disease Progression|2|||
125197602|NCT00452673|450345843|FG003|Dose Escalation Period|Disease Progression|6|||
125197603|NCT00452673|450345844|FG004|Dose Escalation Period|Disease Progression|0|||
125197604|NCT00452673|450345840|FG000|Dose Escalation Period|study drug toxicity|1|||
125197605|NCT00452673|450345841|FG001|Dose Escalation Period|study drug toxicity|3|||
125197606|NCT00452673|450345842|FG002|Dose Escalation Period|study drug toxicity|3|||
125197607|NCT00452673|450345843|FG003|Dose Escalation Period|study drug toxicity|1|||
125197608|NCT00452673|450345844|FG004|Dose Escalation Period|study drug toxicity|0|||
125197609|NCT00452673|450345840|FG000|Dose Escalation Period|Other|0|||
125197610|NCT00452673|450345841|FG001|Dose Escalation Period|Other|0|||
125252308|NCT00159874|450550248|FG006|Overall Study|Lost to Follow-up|1|||
125252309|NCT00159874|450550242|FG000|Overall Study|Other|8|||
125252310|NCT00159874|450550243|FG001|Overall Study|Other|8|||
125252311|NCT00159874|450550244|FG002|Overall Study|Other|8|||
125252312|NCT00159874|450550245|FG003|Overall Study|Other|0|||
125252313|NCT00159874|450550246|FG004|Overall Study|Other|2|||
125197611|NCT00452673|450345842|FG002|Dose Escalation Period|Other|1|||
125197612|NCT00452673|450345843|FG003|Dose Escalation Period|Other|0|||
125197613|NCT00452673|450345844|FG004|Dose Escalation Period|Other|0|||
125197614|NCT00452673|450345840|FG000|Dose Escalation Period|Adverse Event|0|||
125197615|NCT00452673|450345841|FG001|Dose Escalation Period|Adverse Event|0|||
125197616|NCT00452673|450345842|FG002|Dose Escalation Period|Adverse Event|0|||
125197617|NCT00452673|450345843|FG003|Dose Escalation Period|Adverse Event|1|||
125197618|NCT00452673|450345844|FG004|Dose Escalation Period|Adverse Event|0|||
125197619|NCT00452673|450345840|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
125197620|NCT00452673|450345841|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
125197621|NCT00452673|450345842|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
125197622|NCT00452673|450345843|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
125197623|NCT00452673|450345844|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
125197624|NCT00452673|450345840|FG000|Dose Expansion Period|Disease Progression|0|||
125197625|NCT00452673|450345841|FG001|Dose Expansion Period|Disease Progression|0|||
125197626|NCT00452673|450345842|FG002|Dose Expansion Period|Disease Progression|0|||
125197627|NCT00452673|450345843|FG003|Dose Expansion Period|Disease Progression|0|||
125197628|NCT00452673|450345844|FG004|Dose Expansion Period|Disease Progression|19|||
125197629|NCT00452673|450345840|FG000|Dose Expansion Period|Other|0|||
125197630|NCT00452673|450345841|FG001|Dose Expansion Period|Other|0|||
125197631|NCT00452673|450345842|FG002|Dose Expansion Period|Other|0|||
125197632|NCT00452673|450345843|FG003|Dose Expansion Period|Other|0|||
125197633|NCT00452673|450345844|FG004|Dose Expansion Period|Other|2|||
125197634|NCT02656290|450345845|FG000|Overall Study|Lost to Follow-up|1|||
125197635|NCT02656290|450345845|FG000|Overall Study|Reintervention|3|||
125197636|NCT01608087|450345848|FG000|Overall Study|Lost to Follow-up|0|||
125197637|NCT01608087|450345849|FG001|Overall Study|Lost to Follow-up|1|||
125197638|NCT01608087|450345850|FG002|Overall Study|Lost to Follow-up|0|||
125197639|NCT01608087|450345848|FG000|Overall Study|Other Reason|0|||
125197640|NCT01608087|450345849|FG001|Overall Study|Other Reason|1|||
125197641|NCT01608087|450345850|FG002|Overall Study|Other Reason|0|||
125197642|NCT00348595|450345851|FG000|Overall Study|Adverse Event|5|||
125197643|NCT00348595|450345852|FG001|Overall Study|Adverse Event|8|||
125197644|NCT03991299|450345855|FG000|Overall Study|Study closed, sponsor decision|3|||
125197645|NCT03991299|450345855|FG000|Overall Study|Withdrawal by Subject|1|||
125197646|NCT04304235|450345856|FG000|Overall Study|incomplete triage data|0|||
125197647|NCT04304235|450345857|FG001|Overall Study|incomplete triage data|69|||
125197648|NCT04304235|450345858|FG002|Overall Study|incomplete triage data|0|||
125197649|NCT04304235|450345859|FG003|Overall Study|incomplete triage data|0|||
125197650|NCT04304235|450345860|FG004|Overall Study|incomplete triage data|289|||
125197651|NCT04304235|450345861|FG005|Overall Study|incomplete triage data|123|||
125197652|NCT04304235|450345862|FG006|Overall Study|incomplete triage data|65|||
125197653|NCT04429555|450345867|FG000|Overall Study|Death|0|||
125197654|NCT04429555|450345868|FG001|Overall Study|Death|2|||
125197655|NCT04429555|450345867|FG000|Overall Study|Other|2|||
125197656|NCT04429555|450345868|FG001|Overall Study|Other|0|||
125197657|NCT00231114|450345869|FG000|Randomized|Withdrawal by Subject|6|||
125197658|NCT00231114|450345870|FG001|Randomized|Withdrawal by Subject|3|||
125197659|NCT00231114|450345869|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
125197660|NCT00231114|450345870|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
125197661|NCT00231114|450345869|FG000|Post-Treatment Period|Lost to Follow-up|6|||
125197662|NCT00231114|450345870|FG001|Post-Treatment Period|Lost to Follow-up|1|||
125197663|NCT00231114|450345869|FG000|Post-Treatment Period|Physician Decision|1|||
125197664|NCT00231114|450345870|FG001|Post-Treatment Period|Physician Decision|0|||
125197665|NCT00231114|450345869|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
125197666|NCT00231114|450345870|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
125197667|NCT00712881|450345872|FG000|Overall Study|Adverse Event|3|||
125197668|NCT00712881|450345873|FG001|Overall Study|Adverse Event|3|||
125197669|NCT00712881|450345872|FG000|Overall Study|Withdrawal by Subject|1|||
125197670|NCT00712881|450345873|FG001|Overall Study|Withdrawal by Subject|1|||
125197671|NCT00712881|450345872|FG000|Overall Study|Disease Progression|2|||
125197672|NCT00712881|450345873|FG001|Overall Study|Disease Progression|1|||
125197673|NCT00712881|450345872|FG000|Overall Study|Lost to Follow-up|1|||
125197674|NCT00712881|450345873|FG001|Overall Study|Lost to Follow-up|1|||
125197675|NCT00712881|450345872|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
125197676|NCT00712881|450345873|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
125197677|NCT00712881|450345872|FG000|Overall Study|Protocol Violation|1|||
125252314|NCT00159874|450550247|FG005|Overall Study|Other|1|||
125252315|NCT00159874|450550248|FG006|Overall Study|Other|3|||
125252316|NCT00159874|450550242|FG000|Overall Study|Protocol Violation|0|||
125252317|NCT00159874|450550243|FG001|Overall Study|Protocol Violation|5|||
125252318|NCT00159874|450550244|FG002|Overall Study|Protocol Violation|2|||
125252319|NCT00159874|450550245|FG003|Overall Study|Protocol Violation|0|||
125252320|NCT00159874|450550246|FG004|Overall Study|Protocol Violation|0|||
125252321|NCT00159874|450550247|FG005|Overall Study|Protocol Violation|0|||
125252322|NCT00159874|450550248|FG006|Overall Study|Protocol Violation|0|||
125252323|NCT00159874|450550242|FG000|Overall Study|Death|3|||
125252324|NCT00159874|450550243|FG001|Overall Study|Death|8|||
125252325|NCT00159874|450550244|FG002|Overall Study|Death|15|||
125252326|NCT00159874|450550245|FG003|Overall Study|Death|0|||
125252327|NCT00159874|450550246|FG004|Overall Study|Death|1|||
125252328|NCT00159874|450550247|FG005|Overall Study|Death|2|||
125252329|NCT00159874|450550248|FG006|Overall Study|Death|0|||
125252330|NCT00159874|450550242|FG000|Overall Study|Withdrawal by Subject|2|||
125252331|NCT00159874|450550243|FG001|Overall Study|Withdrawal by Subject|6|||
125252332|NCT00159874|450550244|FG002|Overall Study|Withdrawal by Subject|8|||
125252333|NCT00159874|450550245|FG003|Overall Study|Withdrawal by Subject|4|||
125252334|NCT00159874|450550246|FG004|Overall Study|Withdrawal by Subject|3|||
125252335|NCT00159874|450550247|FG005|Overall Study|Withdrawal by Subject|2|||
125252336|NCT00159874|450550248|FG006|Overall Study|Withdrawal by Subject|1|||
125252337|NCT00159874|450550242|FG000|Overall Study|Pregnancy|1|||
125252338|NCT00159874|450550243|FG001|Overall Study|Pregnancy|1|||
125252339|NCT00159874|450550244|FG002|Overall Study|Pregnancy|0|||
125252340|NCT00159874|450550245|FG003|Overall Study|Pregnancy|0|||
125252341|NCT00159874|450550246|FG004|Overall Study|Pregnancy|0|||
125252342|NCT00159874|450550247|FG005|Overall Study|Pregnancy|0|||
125252343|NCT00159874|450550248|FG006|Overall Study|Pregnancy|0|||
125252344|NCT01475825|450550252|FG000|Overall Study|Adverse Event|41|||
125252345|NCT01475825|450550253|FG001|Overall Study|Adverse Event|15|||
125252346|NCT01475825|450550254|FG002|Overall Study|Adverse Event|27|||
125252347|NCT01475825|450550255|FG003|Overall Study|Adverse Event|11|||
125252348|NCT01475825|450550252|FG000|Overall Study|Death|1|||
125252349|NCT01475825|450550253|FG001|Overall Study|Death|0|||
125252350|NCT01475825|450550254|FG002|Overall Study|Death|1|||
125252351|NCT01475825|450550255|FG003|Overall Study|Death|0|||
125252352|NCT01475825|450550252|FG000|Overall Study|Lack of Efficacy|0|||
125252353|NCT01475825|450550253|FG001|Overall Study|Lack of Efficacy|0|||
125252354|NCT01475825|450550254|FG002|Overall Study|Lack of Efficacy|1|||
125252355|NCT01475825|450550255|FG003|Overall Study|Lack of Efficacy|0|||
125252356|NCT01475825|450550252|FG000|Overall Study|Lost to Follow-up|0|||
125252357|NCT01475825|450550253|FG001|Overall Study|Lost to Follow-up|0|||
125252358|NCT01475825|450550254|FG002|Overall Study|Lost to Follow-up|3|||
125252359|NCT01475825|450550255|FG003|Overall Study|Lost to Follow-up|1|||
125252360|NCT01475825|450550252|FG000|Overall Study|Non-compliance with Study Drug|1|||
125252361|NCT01475825|450550253|FG001|Overall Study|Non-compliance with Study Drug|2|||
125252362|NCT01475825|450550254|FG002|Overall Study|Non-compliance with Study Drug|4|||
125252363|NCT01475825|450550255|FG003|Overall Study|Non-compliance with Study Drug|0|||
125252364|NCT01475825|450550252|FG000|Overall Study|Other: Not available|0|||
125252365|NCT01475825|450550253|FG001|Overall Study|Other: Not available|0|||
125252366|NCT01475825|450550254|FG002|Overall Study|Other: Not available|2|||
125252367|NCT01475825|450550255|FG003|Overall Study|Other: Not available|0|||
125252368|NCT01475825|450550252|FG000|Overall Study|Protocol Violation|1|||
125252369|NCT01475825|450550253|FG001|Overall Study|Protocol Violation|0|||
125252370|NCT01475825|450550254|FG002|Overall Study|Protocol Violation|0|||
125252371|NCT01475825|450550255|FG003|Overall Study|Protocol Violation|0|||
125252372|NCT01475825|450550252|FG000|Overall Study|Physician Decision|0|||
125252373|NCT01475825|450550253|FG001|Overall Study|Physician Decision|1|||
125252374|NCT01475825|450550254|FG002|Overall Study|Physician Decision|0|||
125252375|NCT01475825|450550255|FG003|Overall Study|Physician Decision|0|||
125252376|NCT01475825|450550252|FG000|Overall Study|Withdrawal by Subject|8|||
125252377|NCT01475825|450550253|FG001|Overall Study|Withdrawal by Subject|3|||
125252378|NCT01475825|450550254|FG002|Overall Study|Withdrawal by Subject|11|||
125252379|NCT01475825|450550255|FG003|Overall Study|Withdrawal by Subject|7|||
125252380|NCT01475825|450550252|FG000|Overall Study|Did not enter OLC|15|||
125252381|NCT01475825|450550253|FG001|Overall Study|Did not enter OLC|11|||
125252382|NCT01475825|450550254|FG002|Overall Study|Did not enter OLC|15|||
125252383|NCT01475825|450550255|FG003|Overall Study|Did not enter OLC|11|||
125252384|NCT00309946|450550258|FG000|Overall Study|Withdrawal by Subject|1|||
125252385|NCT05071027|450550259|FG000|Overall Study|Lost to Follow-up|1|||
125252386|NCT05071027|450550260|FG001|Overall Study|Lost to Follow-up|4|||
125252387|NCT04135352|450550261|FG000|Overall Study|Not treated-randomization error|0|||
125252388|NCT04135352|450550262|FG001|Overall Study|Not treated-randomization error|0|||
125252389|NCT04135352|450550263|FG002|Overall Study|Not treated-randomization error|1|||
125252390|NCT04135352|450550264|FG003|Overall Study|Not treated-randomization error|0|||
125252391|NCT04135352|450550265|FG004|Overall Study|Not treated-randomization error|0|||
125252392|NCT04135352|450550266|FG005|Overall Study|Not treated-randomization error|0|||
125252393|NCT04135352|450550267|FG006|Overall Study|Not treated-randomization error|0|||
125252394|NCT04135352|450550268|FG007|Overall Study|Not treated-randomization error|0|||
125252395|NCT04135352|450550261|FG000|Overall Study|Withdrawal by Subject|0|||
125252396|NCT04135352|450550262|FG001|Overall Study|Withdrawal by Subject|0|||
125252397|NCT04135352|450550263|FG002|Overall Study|Withdrawal by Subject|2|||
125252398|NCT04135352|450550264|FG003|Overall Study|Withdrawal by Subject|0|||
125252399|NCT04135352|450550265|FG004|Overall Study|Withdrawal by Subject|0|||
125252400|NCT04135352|450550266|FG005|Overall Study|Withdrawal by Subject|0|||
125252401|NCT04135352|450550267|FG006|Overall Study|Withdrawal by Subject|0|||
125252402|NCT04135352|450550268|FG007|Overall Study|Withdrawal by Subject|0|||
125252403|NCT04135352|450550261|FG000|Overall Study|Sponsor Decision|0|||
125252404|NCT04135352|450550262|FG001|Overall Study|Sponsor Decision|0|||
125252405|NCT04135352|450550263|FG002|Overall Study|Sponsor Decision|2|||
125252406|NCT04135352|450550264|FG003|Overall Study|Sponsor Decision|5|||
125252407|NCT04135352|450550265|FG004|Overall Study|Sponsor Decision|1|||
125252408|NCT04135352|450550266|FG005|Overall Study|Sponsor Decision|4|||
125252409|NCT04135352|450550267|FG006|Overall Study|Sponsor Decision|0|||
125252410|NCT04135352|450550268|FG007|Overall Study|Sponsor Decision|0|||
125252411|NCT04135352|450550261|FG000|Overall Study|Physician Decision|0|||
125252412|NCT04135352|450550262|FG001|Overall Study|Physician Decision|0|||
125252413|NCT04135352|450550263|FG002|Overall Study|Physician Decision|1|||
125252414|NCT04135352|450550264|FG003|Overall Study|Physician Decision|0|||
125252415|NCT04135352|450550265|FG004|Overall Study|Physician Decision|1|||
125252416|NCT04135352|450550266|FG005|Overall Study|Physician Decision|0|||
125252417|NCT04135352|450550267|FG006|Overall Study|Physician Decision|0|||
125252418|NCT04135352|450550268|FG007|Overall Study|Physician Decision|0|||
125197678|NCT00712881|450345873|FG001|Overall Study|Protocol Violation|1|||
125197679|NCT00712881|450345872|FG000|Overall Study|Randomized but not treated|1|||
125197680|NCT00712881|450345873|FG001|Overall Study|Randomized but not treated|0|||
125197681|NCT03990571|450345875|FG000|Overall Study|Withdrawal by Subject|1|||
125197682|NCT03990571|450345875|FG000|Overall Study|Insurance Issues|3|||
125197683|NCT03990571|450345875|FG000|Overall Study|Covid Restrictions|2|||
125197684|NCT04143594|450345877|FG000|Overall Study|Withdrew consent|3|||
125197685|NCT04143594|450345878|FG001|Overall Study|Withdrew consent|10|||
125197686|NCT04143594|450345879|FG002|Overall Study|Withdrew consent|3|||
125197687|NCT04143594|450345880|FG003|Overall Study|Withdrew consent|1|||
125197688|NCT04143594|450345877|FG000|Overall Study|Lost to Follow-up|3|||
125197689|NCT04143594|450345878|FG001|Overall Study|Lost to Follow-up|5|||
125197690|NCT04143594|450345879|FG002|Overall Study|Lost to Follow-up|11|||
125197691|NCT04143594|450345880|FG003|Overall Study|Lost to Follow-up|0|||
125197692|NCT04143594|450345877|FG000|Overall Study|Investigator's discretion|2|||
125197693|NCT04143594|450345878|FG001|Overall Study|Investigator's discretion|2|||
125197694|NCT04143594|450345879|FG002|Overall Study|Investigator's discretion|0|||
125197695|NCT04143594|450345880|FG003|Overall Study|Investigator's discretion|0|||
125197696|NCT04143594|450345877|FG000|Overall Study|Randomized but never treated|0|||
125197697|NCT04143594|450345878|FG001|Overall Study|Randomized but never treated|0|||
125197698|NCT04143594|450345879|FG002|Overall Study|Randomized but never treated|0|||
125197699|NCT04143594|450345880|FG003|Overall Study|Randomized but never treated|1|||
125197700|NCT04143594|450345877|FG000|Overall Study|Death|1|||
125197701|NCT04143594|450345878|FG001|Overall Study|Death|0|||
125197702|NCT04143594|450345879|FG002|Overall Study|Death|1|||
125197703|NCT04143594|450345880|FG003|Overall Study|Death|0|||
125197704|NCT04143594|450345877|FG000|Overall Study|Adverse Event|1|||
125197705|NCT04143594|450345878|FG001|Overall Study|Adverse Event|0|||
125197706|NCT04143594|450345879|FG002|Overall Study|Adverse Event|0|||
125197707|NCT04143594|450345880|FG003|Overall Study|Adverse Event|0|||
125197708|NCT04143594|450345877|FG000|Overall Study|Pregnancy|0|||
125197709|NCT04143594|450345878|FG001|Overall Study|Pregnancy|0|||
125197710|NCT04143594|450345879|FG002|Overall Study|Pregnancy|1|||
125197711|NCT04143594|450345880|FG003|Overall Study|Pregnancy|0|||
125197712|NCT04143594|450345877|FG000|Overall Study|Lack of Efficacy|1|||
125197713|NCT04143594|450345878|FG001|Overall Study|Lack of Efficacy|1|||
125197714|NCT04143594|450345879|FG002|Overall Study|Lack of Efficacy|0|||
125197715|NCT04143594|450345880|FG003|Overall Study|Lack of Efficacy|0|||
125197716|NCT00638443|450345881|FG000|First Intervention|Adverse Event|2|||
125197717|NCT00638443|450345882|FG001|First Intervention|Adverse Event|1|||
125197718|NCT00834639|450345884|FG000|Second Intervention|Physician Decision|0|||
125197719|NCT00834639|450345885|FG001|Second Intervention|Physician Decision|2|||
125197720|NCT04603482|450345886|FG000|Overall Study|Lost to Follow-up|15|||
125197721|NCT04603482|450345887|FG001|Overall Study|Lost to Follow-up|15|||
125197722|NCT04603482|450345888|FG002|Overall Study|Lost to Follow-up|15|||
125197723|NCT01054196|450345890|FG000|Overall Study|Physician Decision|0|||
125197724|NCT01054196|450345891|FG001|Overall Study|Physician Decision|0|||
125197725|NCT01054196|450345892|FG002|Overall Study|Physician Decision|0|||
125197726|NCT01054196|450345893|FG003|Overall Study|Physician Decision|1|||
125252419|NCT04135352|450550261|FG000|Overall Study|Death|3|||
125252420|NCT04135352|450550262|FG001|Overall Study|Death|4|||
125252421|NCT04135352|450550263|FG002|Overall Study|Death|7|||
125252422|NCT04135352|450550264|FG003|Overall Study|Death|0|||
125197727|NCT01054196|450345894|FG004|Overall Study|Physician Decision|0|||
125252423|NCT04135352|450550265|FG004|Overall Study|Death|3|||
125252424|NCT04135352|450550266|FG005|Overall Study|Death|1|||
125252425|NCT04135352|450550267|FG006|Overall Study|Death|0|||
125252426|NCT04135352|450550268|FG007|Overall Study|Death|0|||
125252427|NCT00511199|450550269|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
125252428|NCT00511199|450550270|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
125252429|NCT00511199|450550269|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
125252430|NCT00511199|450550270|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
125252431|NCT00511199|450550269|FG000|Overall Study|Withdrawal of Informed Consent|19|||
125252432|NCT00511199|450550270|FG001|Overall Study|Withdrawal of Informed Consent|4|||
125252433|NCT00511199|450550269|FG000|Overall Study|Pregnancy|6|||
125252434|NCT00511199|450550270|FG001|Overall Study|Pregnancy|3|||
125252435|NCT00511199|450550269|FG000|Overall Study|Pregnancy Wish|16|||
125252436|NCT00511199|450550270|FG001|Overall Study|Pregnancy Wish|8|||
125252437|NCT00511199|450550269|FG000|Overall Study|Lost to Follow-up|40|||
125252438|NCT00511199|450550270|FG001|Overall Study|Lost to Follow-up|17|||
125252439|NCT00511199|450550269|FG000|Overall Study|Other Reason|78|||
125252440|NCT00511199|450550270|FG001|Overall Study|Other Reason|37|||
125252441|NCT02739828|450550276|FG000|Overall Study|Adverse Event|1|||
125252442|NCT02739828|450550276|FG000|Overall Study|Lost to Follow-up|4|||
125252443|NCT02314247|450550277|FG000|Overall Study|Adverse Event|2|||
125252444|NCT02314247|450550278|FG001|Overall Study|Adverse Event|1|||
125252445|NCT02314247|450550279|FG002|Overall Study|Adverse Event|0|||
125252446|NCT02314247|450550277|FG000|Overall Study|Withdrawal by Subject|1|||
125252447|NCT02314247|450550278|FG001|Overall Study|Withdrawal by Subject|3|||
125252448|NCT02314247|450550279|FG002|Overall Study|Withdrawal by Subject|1|||
125252449|NCT02314247|450550277|FG000|Overall Study|Progression of Disease|6|||
125252450|NCT02314247|450550278|FG001|Overall Study|Progression of Disease|2|||
125252451|NCT02314247|450550279|FG002|Overall Study|Progression of Disease|0|||
125252452|NCT01953354|450550280|FG000|Overall Study|Withdrawal by Subject|0|||
125252453|NCT01953354|450550281|FG001|Overall Study|Withdrawal by Subject|1|||
125252454|NCT01953354|450550280|FG000|Overall Study|Decision of Sponsor|0|||
125252455|NCT01953354|450550281|FG001|Overall Study|Decision of Sponsor|1|||
125252456|NCT01953354|450550280|FG000|Overall Study|Disease Exacerbation|1|||
125252457|NCT01953354|450550281|FG001|Overall Study|Disease Exacerbation|0|||
125252458|NCT01392495|450550282|FG000|Overall Study|Death|3|||
125252459|NCT01392495|450550282|FG000|Overall Study|Administrative problems|8|||
125252460|NCT01392495|450550282|FG000|Overall Study|Withdrawal by Subject|2|||
125252461|NCT01392495|450550282|FG000|Overall Study|Adverse Event|3|||
125252462|NCT01570192|450550283|FG000|Overall Study|no qualifying organism|6|||
125252463|NCT01570192|450550284|FG001|Overall Study|no qualifying organism|12|||
125252464|NCT01570192|450550283|FG000|Overall Study|changed to palliative care|1|||
125252465|NCT01570192|450550284|FG001|Overall Study|changed to palliative care|0|||
125252466|NCT01570192|450550283|FG000|Overall Study|Physician Decision|0|||
125252467|NCT01570192|450550284|FG001|Overall Study|Physician Decision|1|||
125252468|NCT02965976|450550285|FG000|Overall Study|Withdrawal by Subject|2|||
125252469|NCT02965976|450550286|FG001|Overall Study|Withdrawal by Subject|0|||
125252470|NCT00806026|450550287|FG000|Overall Study|Death|0|||
125252471|NCT00806026|450550288|FG001|Overall Study|Death|0|||
125252472|NCT00806026|450550289|FG002|Overall Study|Death|0|||
125252473|NCT00806026|450550290|FG003|Overall Study|Death|1|||
125252474|NCT00806026|450550291|FG004|Overall Study|Death|0|||
125252475|NCT00806026|450550292|FG005|Overall Study|Death|0|||
125252476|NCT00806026|450550287|FG000|Overall Study|Did not meet entrance criteria|4|||
125252477|NCT00806026|450550288|FG001|Overall Study|Did not meet entrance criteria|1|||
125252478|NCT00806026|450550289|FG002|Overall Study|Did not meet entrance criteria|2|||
125252479|NCT00806026|450550290|FG003|Overall Study|Did not meet entrance criteria|1|||
125252480|NCT00806026|450550291|FG004|Overall Study|Did not meet entrance criteria|0|||
125252481|NCT00806026|450550292|FG005|Overall Study|Did not meet entrance criteria|0|||
125252482|NCT00806026|450550287|FG000|Overall Study|Lack of Efficacy|5|||
125252483|NCT00806026|450550288|FG001|Overall Study|Lack of Efficacy|18|||
125252484|NCT00806026|450550289|FG002|Overall Study|Lack of Efficacy|13|||
125252485|NCT00806026|450550290|FG003|Overall Study|Lack of Efficacy|4|||
125252486|NCT00806026|450550291|FG004|Overall Study|Lack of Efficacy|8|||
125252487|NCT00806026|450550292|FG005|Overall Study|Lack of Efficacy|7|||
125252488|NCT00806026|450550287|FG000|Overall Study|Lost to Follow-up|8|||
125252489|NCT00806026|450550288|FG001|Overall Study|Lost to Follow-up|15|||
125252490|NCT00806026|450550289|FG002|Overall Study|Lost to Follow-up|8|||
125252491|NCT00806026|450550290|FG003|Overall Study|Lost to Follow-up|2|||
125252492|NCT00806026|450550291|FG004|Overall Study|Lost to Follow-up|6|||
125252493|NCT00806026|450550292|FG005|Overall Study|Lost to Follow-up|6|||
125252494|NCT00806026|450550287|FG000|Overall Study|Withdrawal by Subject|14|||
125252495|NCT00806026|450550288|FG001|Overall Study|Withdrawal by Subject|17|||
125252496|NCT00806026|450550289|FG002|Overall Study|Withdrawal by Subject|9|||
125252497|NCT00806026|450550290|FG003|Overall Study|Withdrawal by Subject|2|||
125252498|NCT00806026|450550291|FG004|Overall Study|Withdrawal by Subject|5|||
125252499|NCT00806026|450550292|FG005|Overall Study|Withdrawal by Subject|3|||
125252500|NCT00806026|450550287|FG000|Overall Study|Other|3|||
125252501|NCT00806026|450550288|FG001|Overall Study|Other|6|||
125252502|NCT00806026|450550289|FG002|Overall Study|Other|8|||
125252503|NCT00806026|450550290|FG003|Overall Study|Other|2|||
125252504|NCT00806026|450550291|FG004|Overall Study|Other|0|||
125252505|NCT00806026|450550292|FG005|Overall Study|Other|4|||
125252506|NCT00806026|450550287|FG000|Overall Study|Protocol Violation|6|||
125252507|NCT00806026|450550288|FG001|Overall Study|Protocol Violation|9|||
125252508|NCT00806026|450550289|FG002|Overall Study|Protocol Violation|9|||
125252509|NCT00806026|450550290|FG003|Overall Study|Protocol Violation|0|||
125252510|NCT00806026|450550291|FG004|Overall Study|Protocol Violation|2|||
125252511|NCT00806026|450550292|FG005|Overall Study|Protocol Violation|3|||
125252512|NCT00806026|450550287|FG000|Overall Study|Adverse Event|52|||
125252513|NCT00806026|450550288|FG001|Overall Study|Adverse Event|35|||
125252514|NCT00806026|450550289|FG002|Overall Study|Adverse Event|44|||
125252515|NCT00806026|450550290|FG003|Overall Study|Adverse Event|17|||
125252516|NCT00806026|450550291|FG004|Overall Study|Adverse Event|9|||
125252517|NCT00806026|450550292|FG005|Overall Study|Adverse Event|9|||
125252518|NCT01687595|450550293|FG000|Overall Study|Withdrawal by Subject|8|||
125197728|NCT01054196|450345895|FG005|Overall Study|Physician Decision|0|||
125197729|NCT01054196|450345896|FG006|Overall Study|Physician Decision|1|||
125197730|NCT00179673|450345897|FG000|Overall Study|Adverse Event|7|||
125197731|NCT00179673|450345897|FG000|Overall Study|Lack of Efficacy|15|||
125197732|NCT00179673|450345897|FG000|Overall Study|Withdrawal by Subject|3|||
125197733|NCT00179673|450345897|FG000|Overall Study|Death|4|||
125197734|NCT00179673|450345897|FG000|Overall Study|Other Observations and options|14|||
125197735|NCT00282113|450345898|FG000|Overall Study|Removed at parents request|1|||
125197736|NCT00282113|450345899|FG001|Overall Study|Removed at parents request|0|||
125197737|NCT00282113|450345900|FG002|Overall Study|Removed at parents request|0|||
125197738|NCT02949843|450345901|FG000|Overall Study|Withdrawal by Subject|0|||
125197739|NCT02949843|450345902|FG001|Overall Study|Withdrawal by Subject|1|||
125197740|NCT02949843|450345903|FG002|Overall Study|Withdrawal by Subject|1|||
125197741|NCT02253316|450345905|FG000|Consolidation|Progression|4|||
125197742|NCT02253316|450345906|FG001|Consolidation|Progression|0|||
125197743|NCT02253316|450345907|FG002|Consolidation|Progression|0|||
125197744|NCT02253316|450345905|FG000|Consolidation|Non-Compliance|1|||
125197745|NCT02253316|450345906|FG001|Consolidation|Non-Compliance|0|||
125197746|NCT02253316|450345907|FG002|Consolidation|Non-Compliance|0|||
125197747|NCT02253316|450345905|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
125197748|NCT02253316|450345906|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
125197749|NCT02253316|450345907|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
125197750|NCT02253316|450345905|FG000|Consolidation|Secondary Malignancy|2|||
125197751|NCT02253316|450345906|FG001|Consolidation|Secondary Malignancy|0|||
125197752|NCT02253316|450345907|FG002|Consolidation|Secondary Malignancy|0|||
125197753|NCT02253316|450345905|FG000|Consolidation|Adverse Event|7|||
125197754|NCT02253316|450345906|FG001|Consolidation|Adverse Event|0|||
125197755|NCT02253316|450345907|FG002|Consolidation|Adverse Event|0|||
125197756|NCT02253316|450345905|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
125197757|NCT02253316|450345906|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
125197758|NCT02253316|450345907|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
125197759|NCT02253316|450345905|FG000|Maintenance|Physician Decision|0|||
125197760|NCT02253316|450345906|FG001|Maintenance|Physician Decision|7|||
125197761|NCT02253316|450345907|FG002|Maintenance|Physician Decision|16|||
125197762|NCT02253316|450345905|FG000|Maintenance|Non-Compliance|0|||
125197763|NCT02253316|450345906|FG001|Maintenance|Non-Compliance|1|||
125197764|NCT02253316|450345907|FG002|Maintenance|Non-Compliance|1|||
125197765|NCT02253316|450345905|FG000|Maintenance|Secondary Malignancy|0|||
125197766|NCT02253316|450345906|FG001|Maintenance|Secondary Malignancy|2|||
125197767|NCT02253316|450345907|FG002|Maintenance|Secondary Malignancy|6|||
125197768|NCT02253316|450345905|FG000|Maintenance|Adverse Event|0|||
125197769|NCT02253316|450345906|FG001|Maintenance|Adverse Event|8|||
125197770|NCT02253316|450345907|FG002|Maintenance|Adverse Event|12|||
125197771|NCT02253316|450345905|FG000|Maintenance|Still receiving active treatment|0|||
125197772|NCT02253316|450345906|FG001|Maintenance|Still receiving active treatment|5|||
125197773|NCT02253316|450345907|FG002|Maintenance|Still receiving active treatment|0|||
125197774|NCT02107859|450345915|FG000|Overall Study|Withdrawal by Subject|14|||
125197775|NCT02107859|450345915|FG000|Overall Study|Adverse Event|3|||
125197776|NCT02107859|450345915|FG000|Overall Study|Study closure|41|||
125197777|NCT02107859|450345915|FG000|Overall Study|Other than specified|3|||
125197778|NCT00135512|450345916|FG000|Overall Study|Adverse Event|56|||
125197779|NCT00135512|450345916|FG000|Overall Study|Lack of Efficacy|25|||
125197780|NCT00135512|450345916|FG000|Overall Study|Other|42|||
125197781|NCT04439214|450345917|FG000|Overall Study|Adverse Event|13|||
125197782|NCT04439214|450345917|FG000|Overall Study|Disease progression|16|||
125197783|NCT04439214|450345917|FG000|Overall Study|Death|1|||
125197784|NCT04439214|450345917|FG000|Overall Study|Withdrawal by Subject|2|||
125197785|NCT04439214|450345917|FG000|Overall Study|Declining health|1|||
125197786|NCT04439214|450345917|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
125197787|NCT04439214|450345917|FG000|Overall Study|Ineligible|5|||
125197788|NCT04152837|450345918|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
125252519|NCT01687595|450550294|FG001|Overall Study|Withdrawal by Subject|0|||
125252520|NCT01687595|450550293|FG000|Overall Study|Lost to Follow-up|3|||
125252521|NCT01687595|450550294|FG001|Overall Study|Lost to Follow-up|1|||
125252522|NCT01687595|450550293|FG000|Overall Study|Investigator's decision|1|||
125252523|NCT01687595|450550294|FG001|Overall Study|Investigator's decision|0|||
125252524|NCT01687595|450550293|FG000|Overall Study|Sponsor's decision|1|||
125252525|NCT01687595|450550294|FG001|Overall Study|Sponsor's decision|0|||
125252526|NCT01687595|450550293|FG000|Overall Study|Noncompliance|1|||
125252527|NCT01687595|450550294|FG001|Overall Study|Noncompliance|2|||
125252528|NCT01687595|450550293|FG000|Overall Study|Other than specified|56|||
125252529|NCT01687595|450550294|FG001|Overall Study|Other than specified|7|||
125252530|NCT00489359|450550297|FG000|Overall Study|Death|0|||
125252531|NCT00489359|450550298|FG001|Overall Study|Death|2|||
125252532|NCT00489359|450550297|FG000|Overall Study|Progressive Disease|5|||
125252533|NCT00489359|450550298|FG001|Overall Study|Progressive Disease|6|||
125252534|NCT00489359|450550297|FG000|Overall Study|Lost to Follow-up|1|||
125252535|NCT00489359|450550298|FG001|Overall Study|Lost to Follow-up|0|||
125252536|NCT00489359|450550297|FG000|Overall Study|Withdrawal by Subject|1|||
125252537|NCT00489359|450550298|FG001|Overall Study|Withdrawal by Subject|5|||
125252538|NCT00489359|450550297|FG000|Overall Study|Adverse Event|0|||
125252539|NCT00489359|450550298|FG001|Overall Study|Adverse Event|16|||
125252540|NCT03180138|450550299|FG000|Overall Study|Mobile-phone could not be verified|2|||
125252541|NCT03180138|450550300|FG001|Overall Study|Mobile-phone could not be verified|13|||
125252542|NCT03180138|450550301|FG002|Overall Study|Mobile-phone could not be verified|15|||
125252543|NCT03180138|450550299|FG000|Overall Study|No prior immunization records|17|||
125252544|NCT03180138|450550300|FG001|Overall Study|No prior immunization records|0|||
125252545|NCT03180138|450550301|FG002|Overall Study|No prior immunization records|6|||
125252546|NCT03180138|450550299|FG000|Overall Study|Found to be >24 mon after randomization|3|||
125252547|NCT03180138|450550300|FG001|Overall Study|Found to be >24 mon after randomization|0|||
125252548|NCT03180138|450550301|FG002|Overall Study|Found to be >24 mon after randomization|3|||
125252549|NCT02100644|450550303|FG000|LTG Escalation Phase|Adverse Event|9|||
125252550|NCT02100644|450550304|FG001|LTG Escalation Phase|Adverse Event|0|||
125252551|NCT02100644|450550305|FG002|LTG Escalation Phase|Adverse Event|0|||
125252552|NCT02100644|450550303|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
125252553|NCT02100644|450550304|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
125252554|NCT02100644|450550305|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
125252555|NCT02100644|450550303|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
125252556|NCT02100644|450550304|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
125252557|NCT02100644|450550305|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
125252558|NCT00728182|450550306|FG000|Overall Study|Adverse Event|1|||
125252559|NCT00728182|450550307|FG001|Overall Study|Adverse Event|0|||
125252560|NCT00728182|450550306|FG000|Overall Study|Lost to Follow-up|2|||
125252561|NCT00728182|450550307|FG001|Overall Study|Lost to Follow-up|0|||
125252562|NCT00728182|450550306|FG000|Overall Study|Death|0|||
125252563|NCT00728182|450550307|FG001|Overall Study|Death|2|||
125252564|NCT00728182|450550306|FG000|Overall Study|Protocol Noncompliance|0|||
125252565|NCT00728182|450550307|FG001|Overall Study|Protocol Noncompliance|1|||
125252566|NCT01898091|450550309|FG000|Overall Study|Lost to Follow-up|1|||
125252567|NCT01898091|450550310|FG001|Overall Study|Lost to Follow-up|1|||
125252568|NCT01898091|450550309|FG000|Overall Study|Withdrawal by Subject|1|||
125252569|NCT01898091|450550310|FG001|Overall Study|Withdrawal by Subject|5|||
125252570|NCT04754399|450550314|FG000|Overall Study|Adverse Event|5|||
125252571|NCT04754399|450550314|FG000|Overall Study|Withdrawal by Subject|6|||
125252572|NCT00231465|450550315|FG000|Overall Study|Completed only one cycle|1|||
125252573|NCT00231465|450550315|FG000|Overall Study|Did not have follow up CT scans|1|||
125252574|NCT00025233|450550316|FG000|Overall Study|Ineligible: wrong cell type|1|||
125252575|NCT00025233|450550316|FG000|Overall Study|Ineligible: wrong primary|1|||
125252576|NCT00025233|450550316|FG000|Overall Study|Ineligible: improper prior treatment|1|||
125252577|NCT00025233|450550316|FG000|Overall Study|Never treated|1|||
125252578|NCT00930176|450550318|FG000|Overall Study|Death|1|||
125252579|NCT00401830|450550322|FG000|Overall Study|Adverse Event|10|||
125252580|NCT00401830|450550323|FG001|Overall Study|Adverse Event|18|||
125252581|NCT00401830|450550322|FG000|Overall Study|Lack of Efficacy|11|||
125252582|NCT00401830|450550323|FG001|Overall Study|Lack of Efficacy|5|||
125252583|NCT00401830|450550322|FG000|Overall Study|Withdrawal by Subject|4|||
125252584|NCT00401830|450550323|FG001|Overall Study|Withdrawal by Subject|3|||
125252585|NCT00401830|450550322|FG000|Overall Study|Protocol Violation|3|||
125252586|NCT00401830|450550323|FG001|Overall Study|Protocol Violation|3|||
125252587|NCT00401830|450550322|FG000|Overall Study|Non-compliance with drug study|1|||
125252588|NCT00401830|450550323|FG001|Overall Study|Non-compliance with drug study|0|||
125252589|NCT00401830|450550322|FG000|Overall Study|Lost to Follow-up|1|||
125252590|NCT00401830|450550323|FG001|Overall Study|Lost to Follow-up|3|||
125252591|NCT00401830|450550322|FG000|Overall Study|Other: Personal / Family problems|1|||
125252592|NCT00401830|450550323|FG001|Overall Study|Other: Personal / Family problems|0|||
125252593|NCT01943825|450550324|FG000|Overall Study|Lost to Follow-up|9|||
125252594|NCT01943825|450550325|FG001|Overall Study|Lost to Follow-up|3|||
125252595|NCT01943825|450550326|FG002|Overall Study|Lost to Follow-up|12|||
125252596|NCT01943825|450550327|FG003|Overall Study|Lost to Follow-up|8|||
125252597|NCT01943825|450550324|FG000|Overall Study|Withdrawal by Subject|1|||
125252598|NCT01943825|450550325|FG001|Overall Study|Withdrawal by Subject|0|||
125252599|NCT01943825|450550326|FG002|Overall Study|Withdrawal by Subject|3|||
125252600|NCT01943825|450550327|FG003|Overall Study|Withdrawal by Subject|2|||
125252601|NCT01943825|450550324|FG000|Overall Study|Other than specified above|0|||
125252602|NCT01943825|450550325|FG001|Overall Study|Other than specified above|1|||
125252603|NCT01943825|450550326|FG002|Overall Study|Other than specified above|0|||
125252604|NCT01943825|450550327|FG003|Overall Study|Other than specified above|1|||
125252605|NCT00452400|450550328|FG000|Overall Study|Adverse Event|1|||
125252606|NCT00452400|450550329|FG001|Overall Study|Adverse Event|1|||
125252607|NCT00452400|450550330|FG002|Overall Study|Adverse Event|5|||
125252608|NCT00452400|450550331|FG003|Overall Study|Adverse Event|0|||
125252609|NCT00452400|450550332|FG004|Overall Study|Adverse Event|2|||
125252610|NCT00452400|450550328|FG000|Overall Study|Protocol Violation|0|||
125252611|NCT00452400|450550329|FG001|Overall Study|Protocol Violation|0|||
125252612|NCT00452400|450550330|FG002|Overall Study|Protocol Violation|1|||
125252613|NCT00452400|450550331|FG003|Overall Study|Protocol Violation|0|||
125252614|NCT00452400|450550332|FG004|Overall Study|Protocol Violation|0|||
125252615|NCT00452400|450550328|FG000|Overall Study|Lost to Follow-up|1|||
125252616|NCT00452400|450550329|FG001|Overall Study|Lost to Follow-up|0|||
125252617|NCT00452400|450550330|FG002|Overall Study|Lost to Follow-up|0|||
125252618|NCT00452400|450550331|FG003|Overall Study|Lost to Follow-up|0|||
125252619|NCT00452400|450550332|FG004|Overall Study|Lost to Follow-up|0|||
125252620|NCT00452400|450550328|FG000|Overall Study|Withdrawal by Subject|1|||
125252621|NCT00452400|450550329|FG001|Overall Study|Withdrawal by Subject|0|||
125252622|NCT00452400|450550330|FG002|Overall Study|Withdrawal by Subject|1|||
125252623|NCT00452400|450550331|FG003|Overall Study|Withdrawal by Subject|0|||
125252624|NCT00452400|450550332|FG004|Overall Study|Withdrawal by Subject|0|||
125252625|NCT00452400|450550328|FG000|Overall Study|Lack of Efficacy|2|||
125252626|NCT00452400|450550329|FG001|Overall Study|Lack of Efficacy|0|||
125252627|NCT00452400|450550330|FG002|Overall Study|Lack of Efficacy|0|||
125252628|NCT00452400|450550331|FG003|Overall Study|Lack of Efficacy|0|||
125252629|NCT00452400|450550332|FG004|Overall Study|Lack of Efficacy|0|||
125252630|NCT00452400|450550328|FG000|Overall Study|Other reasons not listed above|0|||
125252631|NCT00452400|450550329|FG001|Overall Study|Other reasons not listed above|0|||
125252632|NCT00452400|450550330|FG002|Overall Study|Other reasons not listed above|0|||
125252633|NCT00452400|450550331|FG003|Overall Study|Other reasons not listed above|1|||
125252634|NCT00452400|450550332|FG004|Overall Study|Other reasons not listed above|1|||
125252635|NCT01720602|450550333|FG000|Overall Study|Adverse Event|3|||
125252636|NCT01720602|450550333|FG000|Overall Study|Progressive disease on therapy|2|||
125252637|NCT03378635|450550335|FG000|Overall Study|Adverse Event|1|||
125252638|NCT03378635|450550336|FG001|Overall Study|Adverse Event|0|||
125252639|NCT03378635|450550337|FG002|Overall Study|Adverse Event|0|||
125252640|NCT03378635|450550335|FG000|Overall Study|Withdrawal by Subject|1|||
125252641|NCT03378635|450550336|FG001|Overall Study|Withdrawal by Subject|0|||
125252642|NCT03378635|450550337|FG002|Overall Study|Withdrawal by Subject|0|||
125252643|NCT03425188|450550339|FG000|Overall Study|Withdrawal by Subject|1|||
125252644|NCT00562861|450550342|FG000|Overall Study|Adverse Event|1|||
125252645|NCT00562861|450550343|FG001|Overall Study|Adverse Event|1|||
125252646|NCT00562861|450550342|FG000|Overall Study|Lack of Efficacy|5|||
125252647|NCT00562861|450550343|FG001|Overall Study|Lack of Efficacy|5|||
125252648|NCT00562861|450550342|FG000|Overall Study|noncompliance, moved|7|||
125252649|NCT00562861|450550343|FG001|Overall Study|noncompliance, moved|2|||
125252650|NCT00562861|450550342|FG000|Overall Study|Lost to Follow-up|7|||
125197789|NCT04152837|450345918|FG000|Maintenance Period|Adverse Event|1|||
125197790|NCT04152837|450345918|FG000|Maintenance Period|Withdrawal by Subject|1|||
125197791|NCT04152837|450345918|FG000|Maintenance Period|Sponsor Termination of Study|2|||
125197792|NCT01295827|450345923|FG000|Overall Study|Adverse Event|1|||
125197793|NCT01295827|450345924|FG001|Overall Study|Adverse Event|2|||
125197794|NCT01295827|450345925|FG002|Overall Study|Adverse Event|2|||
125197795|NCT01295827|450345926|FG003|Overall Study|Adverse Event|1|||
125252651|NCT00562861|450550343|FG001|Overall Study|Lost to Follow-up|3|||
125197796|NCT01295827|450345927|FG004|Overall Study|Adverse Event|1|||
125197797|NCT01295827|450345928|FG005|Overall Study|Adverse Event|4|||
125197798|NCT01295827|450345929|FG006|Overall Study|Adverse Event|15|||
125252652|NCT01694771|450550344|FG000|Overall Study|Adverse Event|18|||
125252653|NCT01694771|450550345|FG001|Overall Study|Adverse Event|16|||
125252654|NCT01694771|450550344|FG000|Overall Study|Lack of Efficacy|1|||
125252655|NCT01694771|450550345|FG001|Overall Study|Lack of Efficacy|0|||
125252656|NCT01694771|450550344|FG000|Overall Study|Non compliance protocol|7|||
125252657|NCT01694771|450550345|FG001|Overall Study|Non compliance protocol|6|||
125252658|NCT01694771|450550344|FG000|Overall Study|Lost to Follow-up|2|||
125252659|NCT01694771|450550345|FG001|Overall Study|Lost to Follow-up|3|||
125252660|NCT01694771|450550344|FG000|Overall Study|Consent withdrawn|7|||
125252661|NCT01694771|450550345|FG001|Overall Study|Consent withdrawn|9|||
125252662|NCT01694771|450550344|FG000|Overall Study|Other reasons|5|||
125252663|NCT01694771|450550345|FG001|Overall Study|Other reasons|6|||
125197799|NCT01295827|450345930|FG007|Overall Study|Adverse Event|49|||
125197800|NCT01295827|450345931|FG008|Overall Study|Adverse Event|22|||
125197801|NCT01295827|450345932|FG009|Overall Study|Adverse Event|7|||
125197802|NCT01295827|450345933|FG010|Overall Study|Adverse Event|50|||
125197803|NCT01295827|450345934|FG011|Overall Study|Adverse Event|21|||
125197804|NCT01295827|450345935|FG012|Overall Study|Adverse Event|0|||
125197805|NCT01295827|450345936|FG013|Overall Study|Adverse Event|0|||
125197806|NCT01295827|450345937|FG014|Overall Study|Adverse Event|0|||
125197807|NCT01295827|450345923|FG000|Overall Study|Lost to Follow-up|0|||
125197808|NCT01295827|450345924|FG001|Overall Study|Lost to Follow-up|0|||
125197809|NCT01295827|450345925|FG002|Overall Study|Lost to Follow-up|3|||
125197810|NCT01295827|450345926|FG003|Overall Study|Lost to Follow-up|0|||
125197811|NCT01295827|450345927|FG004|Overall Study|Lost to Follow-up|1|||
125197812|NCT01295827|450345928|FG005|Overall Study|Lost to Follow-up|0|||
125197813|NCT01295827|450345929|FG006|Overall Study|Lost to Follow-up|4|||
125197814|NCT01295827|450345930|FG007|Overall Study|Lost to Follow-up|8|||
125197815|NCT01295827|450345931|FG008|Overall Study|Lost to Follow-up|7|||
125197816|NCT01295827|450345932|FG009|Overall Study|Lost to Follow-up|4|||
125197817|NCT01295827|450345933|FG010|Overall Study|Lost to Follow-up|7|||
125197818|NCT01295827|450345934|FG011|Overall Study|Lost to Follow-up|3|||
125197819|NCT01295827|450345935|FG012|Overall Study|Lost to Follow-up|0|||
125197820|NCT01295827|450345936|FG013|Overall Study|Lost to Follow-up|0|||
125197821|NCT01295827|450345937|FG014|Overall Study|Lost to Follow-up|0|||
125197822|NCT01295827|450345923|FG000|Overall Study|Not Reported|0|||
125197823|NCT01295827|450345924|FG001|Overall Study|Not Reported|0|||
125197824|NCT01295827|450345925|FG002|Overall Study|Not Reported|0|||
125197825|NCT01295827|450345926|FG003|Overall Study|Not Reported|1|||
125197826|NCT01295827|450345927|FG004|Overall Study|Not Reported|0|||
125197827|NCT01295827|450345928|FG005|Overall Study|Not Reported|0|||
125197828|NCT01295827|450345929|FG006|Overall Study|Not Reported|24|||
125197829|NCT01295827|450345930|FG007|Overall Study|Not Reported|58|||
125197830|NCT01295827|450345931|FG008|Overall Study|Not Reported|41|||
125197831|NCT01295827|450345932|FG009|Overall Study|Not Reported|2|||
125197832|NCT01295827|450345933|FG010|Overall Study|Not Reported|23|||
125197833|NCT01295827|450345934|FG011|Overall Study|Not Reported|13|||
125197834|NCT01295827|450345935|FG012|Overall Study|Not Reported|0|||
125197835|NCT01295827|450345936|FG013|Overall Study|Not Reported|0|||
125197836|NCT01295827|450345937|FG014|Overall Study|Not Reported|0|||
125197837|NCT01295827|450345923|FG000|Overall Study|Progressive Disease|2|||
125197838|NCT01295827|450345924|FG001|Overall Study|Progressive Disease|1|||
125197839|NCT01295827|450345925|FG002|Overall Study|Progressive Disease|5|||
125197840|NCT01295827|450345926|FG003|Overall Study|Progressive Disease|2|||
125197841|NCT01295827|450345927|FG004|Overall Study|Progressive Disease|0|||
125197842|NCT01295827|450345928|FG005|Overall Study|Progressive Disease|1|||
125197843|NCT01295827|450345929|FG006|Overall Study|Progressive Disease|87|||
125252664|NCT00289900|450550349|FG000|Overall Study|Adverse Event|28|||
125252665|NCT00289900|450550350|FG001|Overall Study|Adverse Event|40|||
125252666|NCT00289900|450550351|FG002|Overall Study|Adverse Event|13|||
125252667|NCT00289900|450550352|FG003|Overall Study|Adverse Event|19|||
125252668|NCT00289900|450550353|FG004|Overall Study|Adverse Event|20|||
125252669|NCT00289900|450550354|FG005|Overall Study|Adverse Event|33|||
125252670|NCT00289900|450550349|FG000|Overall Study|Lost to Follow-up|7|||
125252671|NCT00289900|450550350|FG001|Overall Study|Lost to Follow-up|7|||
125252672|NCT00289900|450550351|FG002|Overall Study|Lost to Follow-up|8|||
125252673|NCT00289900|450550352|FG003|Overall Study|Lost to Follow-up|8|||
125252674|NCT00289900|450550353|FG004|Overall Study|Lost to Follow-up|4|||
125252675|NCT00289900|450550354|FG005|Overall Study|Lost to Follow-up|8|||
125197844|NCT01295827|450345930|FG007|Overall Study|Progressive Disease|144|||
125197845|NCT01295827|450345931|FG008|Overall Study|Progressive Disease|85|||
125197846|NCT01295827|450345932|FG009|Overall Study|Progressive Disease|40|||
125197847|NCT01295827|450345933|FG010|Overall Study|Progressive Disease|175|||
125197848|NCT01295827|450345934|FG011|Overall Study|Progressive Disease|136|||
125252676|NCT00289900|450550349|FG000|Overall Study|Participant had flushing|18|||
125252677|NCT00289900|450550350|FG001|Overall Study|Participant had flushing|42|||
125197849|NCT01295827|450345935|FG012|Overall Study|Progressive Disease|0|||
125197850|NCT01295827|450345936|FG013|Overall Study|Progressive Disease|0|||
125197851|NCT01295827|450345937|FG014|Overall Study|Progressive Disease|0|||
125197852|NCT01295827|450345923|FG000|Overall Study|Screen Failure|0|||
125197853|NCT01295827|450345924|FG001|Overall Study|Screen Failure|0|||
125197854|NCT01295827|450345925|FG002|Overall Study|Screen Failure|0|||
125197855|NCT01295827|450345926|FG003|Overall Study|Screen Failure|0|||
125197856|NCT01295827|450345927|FG004|Overall Study|Screen Failure|0|||
125197857|NCT01295827|450345928|FG005|Overall Study|Screen Failure|0|||
125197858|NCT01295827|450345929|FG006|Overall Study|Screen Failure|2|||
125197859|NCT01295827|450345930|FG007|Overall Study|Screen Failure|2|||
125252678|NCT00289900|450550351|FG002|Overall Study|Participant had flushing|1|||
125252679|NCT00289900|450550352|FG003|Overall Study|Participant had flushing|2|||
125197860|NCT01295827|450345931|FG008|Overall Study|Screen Failure|2|||
125197861|NCT01295827|450345932|FG009|Overall Study|Screen Failure|0|||
125197862|NCT01295827|450345933|FG010|Overall Study|Screen Failure|1|||
125252680|NCT00289900|450550353|FG004|Overall Study|Participant had flushing|0|||
125197863|NCT01295827|450345934|FG011|Overall Study|Screen Failure|0|||
125197864|NCT01295827|450345935|FG012|Overall Study|Screen Failure|0|||
125197865|NCT01295827|450345936|FG013|Overall Study|Screen Failure|0|||
125197866|NCT01295827|450345937|FG014|Overall Study|Screen Failure|0|||
125197867|NCT01295827|450345923|FG000|Overall Study|Withdrawal by Subject|1|||
125197868|NCT01295827|450345924|FG001|Overall Study|Withdrawal by Subject|0|||
125197869|NCT01295827|450345925|FG002|Overall Study|Withdrawal by Subject|2|||
125197870|NCT01295827|450345926|FG003|Overall Study|Withdrawal by Subject|0|||
125197871|NCT01295827|450345927|FG004|Overall Study|Withdrawal by Subject|0|||
125197872|NCT01295827|450345928|FG005|Overall Study|Withdrawal by Subject|1|||
125197873|NCT01295827|450345929|FG006|Overall Study|Withdrawal by Subject|13|||
125197874|NCT01295827|450345930|FG007|Overall Study|Withdrawal by Subject|35|||
125197875|NCT01295827|450345931|FG008|Overall Study|Withdrawal by Subject|11|||
125197876|NCT01295827|450345932|FG009|Overall Study|Withdrawal by Subject|2|||
125197877|NCT01295827|450345933|FG010|Overall Study|Withdrawal by Subject|18|||
125197878|NCT01295827|450345934|FG011|Overall Study|Withdrawal by Subject|13|||
125197879|NCT01295827|450345935|FG012|Overall Study|Withdrawal by Subject|0|||
125197880|NCT01295827|450345936|FG013|Overall Study|Withdrawal by Subject|0|||
125197881|NCT01295827|450345937|FG014|Overall Study|Withdrawal by Subject|0|||
125197882|NCT01295827|450345923|FG000|Overall Study|Other|0|||
125197883|NCT01295827|450345924|FG001|Overall Study|Other|0|||
125197884|NCT01295827|450345925|FG002|Overall Study|Other|0|||
125197885|NCT01295827|450345926|FG003|Overall Study|Other|0|||
125197886|NCT01295827|450345927|FG004|Overall Study|Other|0|||
125197887|NCT01295827|450345928|FG005|Overall Study|Other|0|||
125197888|NCT01295827|450345929|FG006|Overall Study|Other|1|||
125197889|NCT01295827|450345930|FG007|Overall Study|Other|1|||
125197890|NCT01295827|450345931|FG008|Overall Study|Other|1|||
125197891|NCT01295827|450345932|FG009|Overall Study|Other|0|||
125197892|NCT01295827|450345933|FG010|Overall Study|Other|2|||
125197893|NCT01295827|450345934|FG011|Overall Study|Other|0|||
125197894|NCT01295827|450345935|FG012|Overall Study|Other|0|||
125197895|NCT01295827|450345936|FG013|Overall Study|Other|0|||
125197896|NCT01295827|450345937|FG014|Overall Study|Other|0|||
125197897|NCT00746564|450345938|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
125197898|NCT03226769|450345942|FG000|Overall Study|Withdrawal by Subject|0|||
125197899|NCT03226769|450345943|FG001|Overall Study|Withdrawal by Subject|1|||
125197900|NCT01827267|450345944|FG000|Overall Study|Did not receive study drug|1|||
125197901|NCT01827267|450345945|FG001|Overall Study|Did not receive study drug|1|||
125197902|NCT01827267|450345944|FG000|Overall Study|Physician Decision|1|||
125197903|NCT01827267|450345945|FG001|Overall Study|Physician Decision|0|||
125197904|NCT01827267|450345944|FG000|Overall Study|Disease Progression|1|||
125197905|NCT01827267|450345945|FG001|Overall Study|Disease Progression|1|||
125197906|NCT01827267|450345944|FG000|Overall Study|Sponsor Discontinued Study|2|||
125197907|NCT01827267|450345945|FG001|Overall Study|Sponsor Discontinued Study|8|||
125197908|NCT01827267|450345944|FG000|Overall Study|Still on study|0|||
125197909|NCT01827267|450345945|FG001|Overall Study|Still on study|2|||
125197910|NCT01516008|450345952|FG000|Overall Study|Adverse Event|0|||
125197911|NCT01516008|450345953|FG001|Overall Study|Adverse Event|2|||
125197912|NCT01516008|450345954|FG002|Overall Study|Adverse Event|7|||
125197913|NCT01516008|450345952|FG000|Overall Study|Lack of Efficacy|44|||
125197914|NCT01516008|450345953|FG001|Overall Study|Lack of Efficacy|14|||
125197915|NCT01516008|450345954|FG002|Overall Study|Lack of Efficacy|10|||
125197916|NCT01516008|450345952|FG000|Overall Study|Protocol Violation|1|||
125197917|NCT01516008|450345953|FG001|Overall Study|Protocol Violation|0|||
125197918|NCT01516008|450345954|FG002|Overall Study|Protocol Violation|0|||
125197919|NCT01516008|450345952|FG000|Overall Study|Reason not specified|0|||
125197920|NCT01516008|450345953|FG001|Overall Study|Reason not specified|0|||
125197921|NCT01516008|450345954|FG002|Overall Study|Reason not specified|1|||
125197922|NCT00813813|450345957|FG000|Overall Study|Withdrawal by Subject|1|||
125197923|NCT00813813|450345958|FG001|Overall Study|Withdrawal by Subject|1|||
125197924|NCT00813813|450345957|FG000|Overall Study|Lost to Follow-up|2|||
125197925|NCT00813813|450345958|FG001|Overall Study|Lost to Follow-up|7|||
125197926|NCT00813813|450345957|FG000|Overall Study|Other|0|||
125197927|NCT00813813|450345958|FG001|Overall Study|Other|1|||
125197928|NCT00986921|450345959|FG000|Overall Study|Physician Decision|1|||
125197929|NCT00986921|450345960|FG001|Overall Study|Physician Decision|0|||
125197930|NCT00833482|450345961|FG000|Days 11-20|Adverse Event|0|||
125197931|NCT00833482|450345962|FG001|Days 11-20|Adverse Event|2|||
125197932|NCT00833482|450345963|FG002|Days 11-20|Adverse Event|0|||
125197933|NCT00833482|450345964|FG003|Days 11-20|Adverse Event|0|||
125197934|NCT00833482|450345965|FG004|Days 11-20|Adverse Event|0|||
125197935|NCT00833482|450345966|FG005|Days 11-20|Adverse Event|0|||
125197936|NCT00833482|450345961|FG000|Days 11-20|Withdrawal by Subject|0|||
125197937|NCT00833482|450345962|FG001|Days 11-20|Withdrawal by Subject|1|||
125197938|NCT00833482|450345963|FG002|Days 11-20|Withdrawal by Subject|0|||
125197939|NCT00833482|450345964|FG003|Days 11-20|Withdrawal by Subject|0|||
125197940|NCT00833482|450345965|FG004|Days 11-20|Withdrawal by Subject|0|||
125197941|NCT00833482|450345966|FG005|Days 11-20|Withdrawal by Subject|0|||
125197942|NCT00833482|450345961|FG000|Days 21-30|Adverse Event|0|||
125197943|NCT00833482|450345962|FG001|Days 21-30|Adverse Event|0|||
125197944|NCT00833482|450345963|FG002|Days 21-30|Adverse Event|1|||
125197945|NCT00833482|450345964|FG003|Days 21-30|Adverse Event|0|||
125252681|NCT00289900|450550354|FG005|Overall Study|Participant had flushing|4|||
125252682|NCT00289900|450550349|FG000|Overall Study|Other|0|||
125252683|NCT00289900|450550350|FG001|Overall Study|Other|0|||
125252684|NCT00289900|450550351|FG002|Overall Study|Other|0|||
125252685|NCT00289900|450550352|FG003|Overall Study|Other|5|||
125252686|NCT00289900|450550353|FG004|Overall Study|Other|1|||
125252687|NCT00289900|450550354|FG005|Overall Study|Other|0|||
125252688|NCT00289900|450550349|FG000|Overall Study|Participant moved|1|||
125252689|NCT00289900|450550350|FG001|Overall Study|Participant moved|0|||
125252690|NCT00289900|450550351|FG002|Overall Study|Participant moved|0|||
125252691|NCT00289900|450550352|FG003|Overall Study|Participant moved|1|||
125252692|NCT00289900|450550353|FG004|Overall Study|Participant moved|1|||
125252693|NCT00289900|450550354|FG005|Overall Study|Participant moved|1|||
125252694|NCT00289900|450550349|FG000|Overall Study|Withdrawal by Subject|10|||
125252695|NCT00289900|450550350|FG001|Overall Study|Withdrawal by Subject|21|||
125252696|NCT00289900|450550351|FG002|Overall Study|Withdrawal by Subject|8|||
125252697|NCT00289900|450550352|FG003|Overall Study|Withdrawal by Subject|18|||
125252698|NCT00289900|450550353|FG004|Overall Study|Withdrawal by Subject|12|||
125252699|NCT00289900|450550354|FG005|Overall Study|Withdrawal by Subject|11|||
125252700|NCT00289900|450550349|FG000|Overall Study|Protocol Violation|3|||
125252701|NCT00289900|450550350|FG001|Overall Study|Protocol Violation|9|||
125252702|NCT00289900|450550351|FG002|Overall Study|Protocol Violation|2|||
125252703|NCT00289900|450550352|FG003|Overall Study|Protocol Violation|6|||
125252704|NCT00289900|450550353|FG004|Overall Study|Protocol Violation|7|||
125252705|NCT00289900|450550354|FG005|Overall Study|Protocol Violation|4|||
125252706|NCT00289900|450550349|FG000|Overall Study|site terminated|1|||
125252707|NCT00289900|450550350|FG001|Overall Study|site terminated|0|||
125252708|NCT00289900|450550351|FG002|Overall Study|site terminated|1|||
125252709|NCT00289900|450550352|FG003|Overall Study|site terminated|0|||
125252710|NCT00289900|450550353|FG004|Overall Study|site terminated|0|||
125252711|NCT00289900|450550354|FG005|Overall Study|site terminated|0|||
125252712|NCT00289900|450550349|FG000|Overall Study|Not treated|0|||
125252713|NCT00289900|450550350|FG001|Overall Study|Not treated|1|||
125252714|NCT00289900|450550351|FG002|Overall Study|Not treated|0|||
125252715|NCT00289900|450550352|FG003|Overall Study|Not treated|0|||
125252716|NCT00289900|450550353|FG004|Overall Study|Not treated|0|||
125252717|NCT00289900|450550354|FG005|Overall Study|Not treated|0|||
125252718|NCT01152385|450550355|FG000|Overall Study|Withdrawal by Subject|3|||
125197946|NCT00833482|450345965|FG004|Days 21-30|Adverse Event|0|||
125197947|NCT00833482|450345966|FG005|Days 21-30|Adverse Event|0|||
125197948|NCT00833482|450345961|FG000|Days 21-30|Withdrawal by Subject|0|||
125197949|NCT00833482|450345962|FG001|Days 21-30|Withdrawal by Subject|0|||
125197950|NCT00833482|450345963|FG002|Days 21-30|Withdrawal by Subject|0|||
125197951|NCT00833482|450345964|FG003|Days 21-30|Withdrawal by Subject|0|||
125197952|NCT00833482|450345965|FG004|Days 21-30|Withdrawal by Subject|1|||
125197953|NCT00833482|450345966|FG005|Days 21-30|Withdrawal by Subject|0|||
125197954|NCT02778074|450345967|FG000|Overall Study|Lost to Follow-up|7|||
125197955|NCT02778074|450345968|FG001|Overall Study|Lost to Follow-up|10|||
125197956|NCT03489707|450345975|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
125197957|NCT03489707|450345976|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
125197958|NCT03489707|450345975|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
125197959|NCT03489707|450345976|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
125197960|NCT01817582|450345977|FG000|Overall Study|Withdrawal by Subject|0|||
125197961|NCT01817582|450345978|FG001|Overall Study|Withdrawal by Subject|1|||
125197962|NCT01817582|450345979|FG002|Overall Study|Withdrawal by Subject|0|||
125197963|NCT01817582|450345977|FG000|Overall Study|Participant revealed masked treatment|1|||
125197964|NCT01817582|450345978|FG001|Overall Study|Participant revealed masked treatment|0|||
125197965|NCT01817582|450345979|FG002|Overall Study|Participant revealed masked treatment|0|||
125197966|NCT01817582|450345977|FG000|Overall Study|Randomized but exclusion criteria met|1|||
125197967|NCT01817582|450345978|FG001|Overall Study|Randomized but exclusion criteria met|0|||
125197968|NCT01817582|450345979|FG002|Overall Study|Randomized but exclusion criteria met|0|||
125197969|NCT03963232|450345982|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
125197970|NCT03963232|450345983|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
125197971|NCT03963232|450345982|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
125197972|NCT03963232|450345983|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
125197973|NCT03963232|450345982|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
125197974|NCT03963232|450345983|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
125252719|NCT01152385|450550356|FG001|Overall Study|Withdrawal by Subject|1|||
125252720|NCT01152385|450550357|FG002|Overall Study|Withdrawal by Subject|1|||
125252721|NCT01152385|450550358|FG003|Overall Study|Withdrawal by Subject|1|||
125252722|NCT01152385|450550355|FG000|Overall Study|Protocol Violation|0|||
125252723|NCT01152385|450550356|FG001|Overall Study|Protocol Violation|0|||
125252724|NCT01152385|450550357|FG002|Overall Study|Protocol Violation|0|||
125252725|NCT01152385|450550358|FG003|Overall Study|Protocol Violation|1|||
125197975|NCT03963232|450345982|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
125197976|NCT03963232|450345983|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
125197977|NCT03963232|450345982|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
125197978|NCT03963232|450345983|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
125197979|NCT03963232|450345982|FG000|Open-Label Treatment Phase|Adverse Event|1|||
125197980|NCT03963232|450345983|FG001|Open-Label Treatment Phase|Adverse Event|2|||
125197981|NCT03963232|450345982|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
125197982|NCT03963232|450345983|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
125197983|NCT03963232|450345982|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
125197984|NCT03963232|450345983|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
125197985|NCT03963232|450345982|FG000|Open-Label Treatment Phase|Pregnancy|1|||
125197986|NCT03963232|450345983|FG001|Open-Label Treatment Phase|Pregnancy|0|||
125197987|NCT03963232|450345982|FG000|Follow-up Phase|Withdrawal by Subject|7|||
125197988|NCT03963232|450345983|FG001|Follow-up Phase|Withdrawal by Subject|5|||
125197989|NCT03963232|450345982|FG000|Follow-up Phase|Protocol Violation|0|||
125197990|NCT03963232|450345983|FG001|Follow-up Phase|Protocol Violation|2|||
125197991|NCT03963232|450345982|FG000|Follow-up Phase|Adverse Event|0|||
125197992|NCT03963232|450345983|FG001|Follow-up Phase|Adverse Event|1|||
125197993|NCT03963232|450345982|FG000|Follow-up Phase|Lost to Follow-up|0|||
125197994|NCT03963232|450345983|FG001|Follow-up Phase|Lost to Follow-up|1|||
125197995|NCT03617770|450345984|FG000|Overall Study|Lost to Follow-up|1|||
125197996|NCT03617770|450345985|FG001|Overall Study|Lost to Follow-up|0|||
125197997|NCT00356135|450345986|FG000|Overall Study|Protocol Violation|1|||
125197998|NCT00356135|450345987|FG001|Overall Study|Protocol Violation|0|||
125197999|NCT00356135|450345988|FG002|Overall Study|Protocol Violation|0|||
125198000|NCT00356135|450345986|FG000|Overall Study|Adverse Event|1|||
125198001|NCT00356135|450345987|FG001|Overall Study|Adverse Event|0|||
125198002|NCT00356135|450345988|FG002|Overall Study|Adverse Event|0|||
125198003|NCT00356135|450345986|FG000|Overall Study|Lost to Follow-up|0|||
125198004|NCT00356135|450345987|FG001|Overall Study|Lost to Follow-up|0|||
125198005|NCT00356135|450345988|FG002|Overall Study|Lost to Follow-up|1|||
125198006|NCT00356135|450345986|FG000|Overall Study|Physician Decision|1|||
125198007|NCT00356135|450345987|FG001|Overall Study|Physician Decision|1|||
125198008|NCT00356135|450345988|FG002|Overall Study|Physician Decision|1|||
125198009|NCT00356135|450345986|FG000|Overall Study|Subject non-compliance|1|||
125198010|NCT00356135|450345987|FG001|Overall Study|Subject non-compliance|1|||
125198011|NCT00356135|450345988|FG002|Overall Study|Subject non-compliance|3|||
125198012|NCT03512210|450345990|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
125198013|NCT03512210|450345990|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
125198014|NCT03512210|450345990|FG000|Step 2:Post-MINMON|Death|2|||
125198015|NCT03512210|450345990|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
125198016|NCT03512210|450345990|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
125198017|NCT05270395|450345999|FG000|Overall Study|Lost to Follow-up|2|||
125198018|NCT05270395|450346000|FG001|Overall Study|Lost to Follow-up|2|||
125198019|NCT05270395|450345999|FG000|Overall Study|Death|1|||
125198020|NCT05270395|450346000|FG001|Overall Study|Death|2|||
125198021|NCT05270395|450345999|FG000|Overall Study|Study Team Withdrew|1|||
125198022|NCT05270395|450346000|FG001|Overall Study|Study Team Withdrew|0|||
125198023|NCT03725761|450346001|FG000|Overall Study|still on study|1|||
125198024|NCT01936181|450348015|FG000|Randomised, Double-blind|Adverse Event|27|||
125252726|NCT01152385|450550355|FG000|Overall Study|Adverse Event|1|||
125252727|NCT01152385|450550356|FG001|Overall Study|Adverse Event|1|||
125252728|NCT01152385|450550357|FG002|Overall Study|Adverse Event|0|||
125252729|NCT01152385|450550358|FG003|Overall Study|Adverse Event|0|||
125198025|NCT01936181|450348016|FG001|Randomised, Double-blind|Adverse Event|21|||
125198026|NCT01936181|450348017|FG002|Randomised, Double-blind|Adverse Event|0|||
125198027|NCT01936181|450348018|FG003|Randomised, Double-blind|Adverse Event|0|||
125198028|NCT01936181|450348015|FG000|Randomised, Double-blind|Protocol Violation|1|||
125198029|NCT01936181|450348016|FG001|Randomised, Double-blind|Protocol Violation|5|||
125198030|NCT01936181|450348017|FG002|Randomised, Double-blind|Protocol Violation|0|||
125252730|NCT01152385|450550355|FG000|Overall Study|Study-specific withdrawal criteria|1|||
125252731|NCT01152385|450550356|FG001|Overall Study|Study-specific withdrawal criteria|1|||
125252732|NCT01152385|450550357|FG002|Overall Study|Study-specific withdrawal criteria|2|||
125198031|NCT01936181|450348018|FG003|Randomised, Double-blind|Protocol Violation|0|||
125252733|NCT01152385|450550358|FG003|Overall Study|Study-specific withdrawal criteria|0|||
125252734|NCT01152385|450550355|FG000|Overall Study|Other|4|||
125252735|NCT01152385|450550356|FG001|Overall Study|Other|3|||
125252736|NCT01152385|450550357|FG002|Overall Study|Other|2|||
125252737|NCT01152385|450550358|FG003|Overall Study|Other|3|||
125198032|NCT01936181|450348015|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
125198033|NCT01936181|450348016|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
125198034|NCT01936181|450348017|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
125198035|NCT01936181|450348018|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
125198036|NCT01936181|450348015|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
125198037|NCT01936181|450348016|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
125252738|NCT02656173|450550359|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
125252739|NCT02656173|450550360|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
125252740|NCT02656173|450550359|FG000|Overall Study|Adverse Event|7|||
125252741|NCT02656173|450550360|FG001|Overall Study|Adverse Event|5|||
125252742|NCT02656173|450550359|FG000|Overall Study|Withdrawal by Subject|1|||
125252743|NCT02656173|450550360|FG001|Overall Study|Withdrawal by Subject|3|||
125252744|NCT02656173|450550359|FG000|Overall Study|Protocol Violation|0|||
125252745|NCT02656173|450550360|FG001|Overall Study|Protocol Violation|1|||
125252746|NCT02656173|450550359|FG000|Overall Study|Miscellaneous|2|||
125252747|NCT02656173|450550360|FG001|Overall Study|Miscellaneous|0|||
125252748|NCT01064622|450550361|FG000|Randomized Phase II|Withdrawal by Subject|2|||
125252749|NCT01064622|450550362|FG001|Randomized Phase II|Withdrawal by Subject|2|||
125252750|NCT01064622|450550361|FG000|Randomized Phase II|Protocol Violation|0|||
125252751|NCT01064622|450550362|FG001|Randomized Phase II|Protocol Violation|1|||
125252752|NCT03927846|450550368|FG000|Overall Study|Lost to Follow-up|10|||
125252753|NCT03927846|450550369|FG001|Overall Study|Lost to Follow-up|11|||
125252754|NCT03289741|450550370|FG000|Overall Study|Adverse Event|1|||
125252755|NCT03289741|450550371|FG001|Overall Study|Adverse Event|1|||
125252756|NCT03289741|450550370|FG000|Overall Study|Physician Decision|2|||
125252757|NCT03289741|450550371|FG001|Overall Study|Physician Decision|2|||
125252758|NCT03289741|450550370|FG000|Overall Study|Withdrawal by Subject|1|||
125252759|NCT03289741|450550371|FG001|Overall Study|Withdrawal by Subject|0|||
125252760|NCT02037984|450550376|FG000|Overall Study|Lack of Efficacy|0|||
125252761|NCT02037984|450550377|FG001|Overall Study|Lack of Efficacy|0|||
125198038|NCT01936181|450348017|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
125198039|NCT01936181|450348018|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
125198040|NCT01936181|450348015|FG000|Randomised, Double-blind|Pregnancy|0|||
125198041|NCT01936181|450348016|FG001|Randomised, Double-blind|Pregnancy|1|||
125198042|NCT01936181|450348017|FG002|Randomised, Double-blind|Pregnancy|0|||
125198043|NCT01936181|450348018|FG003|Randomised, Double-blind|Pregnancy|0|||
125198044|NCT01936181|450348015|FG000|Randomised, Double-blind|Physician Decision|4|||
125198045|NCT01936181|450348016|FG001|Randomised, Double-blind|Physician Decision|4|||
125198046|NCT01936181|450348017|FG002|Randomised, Double-blind|Physician Decision|0|||
125198047|NCT01936181|450348018|FG003|Randomised, Double-blind|Physician Decision|0|||
125198048|NCT01936181|450348015|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
125198049|NCT01936181|450348016|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
125198050|NCT01936181|450348017|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
125198051|NCT01936181|450348018|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
125198052|NCT01936181|450348015|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
125198053|NCT01936181|450348016|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
125198054|NCT01936181|450348017|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
125198055|NCT01936181|450348018|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
125198056|NCT01936181|450348015|FG000|Transition-extension|Adverse Event|3|||
125198057|NCT01936181|450348016|FG001|Transition-extension|Adverse Event|0|||
125198058|NCT01936181|450348017|FG002|Transition-extension|Adverse Event|3|||
125198059|NCT01936181|450348018|FG003|Transition-extension|Adverse Event|1|||
125198060|NCT01936181|450348015|FG000|Transition-extension|Lost to Follow-up|3|||
125198061|NCT01936181|450348016|FG001|Transition-extension|Lost to Follow-up|0|||
125198062|NCT01936181|450348017|FG002|Transition-extension|Lost to Follow-up|1|||
125198063|NCT01936181|450348018|FG003|Transition-extension|Lost to Follow-up|2|||
125198064|NCT01936181|450348015|FG000|Transition-extension|Physician Decision|2|||
125198065|NCT01936181|450348016|FG001|Transition-extension|Physician Decision|0|||
125198066|NCT01936181|450348017|FG002|Transition-extension|Physician Decision|0|||
125198067|NCT01936181|450348018|FG003|Transition-extension|Physician Decision|1|||
125198068|NCT01936181|450348015|FG000|Transition-extension|Withdrawal by Subject|7|||
125198069|NCT01936181|450348016|FG001|Transition-extension|Withdrawal by Subject|0|||
125198070|NCT01936181|450348017|FG002|Transition-extension|Withdrawal by Subject|2|||
125198071|NCT01936181|450348018|FG003|Transition-extension|Withdrawal by Subject|1|||
125198072|NCT00970632|450348019|FG000|Overall Study|Adverse Event|2|||
125198073|NCT00970632|450348020|FG001|Overall Study|Adverse Event|2|||
125198074|NCT00970632|450348021|FG002|Overall Study|Adverse Event|1|||
125198075|NCT00970632|450348019|FG000|Overall Study|Lack of Efficacy|3|||
125198076|NCT00970632|450348020|FG001|Overall Study|Lack of Efficacy|0|||
125198077|NCT00970632|450348021|FG002|Overall Study|Lack of Efficacy|0|||
125198078|NCT00970632|450348019|FG000|Overall Study|Lost to Follow-up|3|||
125198079|NCT00970632|450348020|FG001|Overall Study|Lost to Follow-up|0|||
125252762|NCT02037984|450550378|FG002|Overall Study|Lack of Efficacy|3|||
125252763|NCT02037984|450550379|FG003|Overall Study|Lack of Efficacy|10|||
125252764|NCT02037984|450550380|FG004|Overall Study|Lack of Efficacy|2|||
125252765|NCT02037984|450550381|FG005|Overall Study|Lack of Efficacy|2|||
125252766|NCT02037984|450550382|FG006|Overall Study|Lack of Efficacy|4|||
125252767|NCT02037984|450550383|FG007|Overall Study|Lack of Efficacy|3|||
125252768|NCT02037984|450550376|FG000|Overall Study|Lost to Follow-up|1|||
125252769|NCT02037984|450550377|FG001|Overall Study|Lost to Follow-up|0|||
125198080|NCT00970632|450348021|FG002|Overall Study|Lost to Follow-up|2|||
125198081|NCT00970632|450348019|FG000|Overall Study|Protocol Violation|8|||
125252770|NCT02037984|450550378|FG002|Overall Study|Lost to Follow-up|3|||
125198082|NCT00970632|450348020|FG001|Overall Study|Protocol Violation|5|||
125198083|NCT00970632|450348021|FG002|Overall Study|Protocol Violation|8|||
125198084|NCT00970632|450348019|FG000|Overall Study|Withdrawal by Subject|7|||
125198085|NCT00970632|450348020|FG001|Overall Study|Withdrawal by Subject|6|||
125198086|NCT00970632|450348021|FG002|Overall Study|Withdrawal by Subject|4|||
125198087|NCT00970632|450348019|FG000|Overall Study|Entry criteria not met|0|||
125198088|NCT00970632|450348020|FG001|Overall Study|Entry criteria not met|2|||
125198089|NCT00970632|450348021|FG002|Overall Study|Entry criteria not met|2|||
125198090|NCT00970632|450348019|FG000|Overall Study|Sponsor decision|1|||
125198091|NCT00970632|450348020|FG001|Overall Study|Sponsor decision|0|||
125198092|NCT00970632|450348021|FG002|Overall Study|Sponsor decision|1|||
125198093|NCT02817516|450348022|FG000|Overall Study|Other|0|||
125198094|NCT02817516|450348023|FG001|Overall Study|Other|0|||
125198095|NCT02817516|450348024|FG002|Overall Study|Other|1|||
125198096|NCT02817516|450348025|FG003|Overall Study|Other|0|||
125198097|NCT00748189|450348026|FG000|Overall Study|Death|99|||
125198098|NCT00748189|450348027|FG001|Overall Study|Death|84|||
125198099|NCT00748189|450348026|FG000|Overall Study|Withdrawal by Subject|23|||
125198100|NCT00748189|450348027|FG001|Overall Study|Withdrawal by Subject|29|||
125198101|NCT00748189|450348026|FG000|Overall Study|Physician Decision|16|||
125198102|NCT00748189|450348027|FG001|Overall Study|Physician Decision|5|||
125198103|NCT00748189|450348026|FG000|Overall Study|Lost to Follow-up|8|||
125198104|NCT00748189|450348027|FG001|Overall Study|Lost to Follow-up|15|||
125198105|NCT00748189|450348026|FG000|Overall Study|Study terminated by Sponsor|70|||
125198106|NCT00748189|450348027|FG001|Overall Study|Study terminated by Sponsor|79|||
125198107|NCT01424514|450348028|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
125198108|NCT01424514|450348029|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
125198109|NCT01424514|450348028|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
125198110|NCT01424514|450348029|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
125198111|NCT02653170|450348030|FG000|Overall Study|Withdrawal by Subject|3|||
125198112|NCT02653170|450348031|FG001|Overall Study|Withdrawal by Subject|8|||
125198113|NCT02653170|450348032|FG002|Overall Study|Withdrawal by Subject|3|||
125198114|NCT02653170|450348030|FG000|Overall Study|withdrawn by study team|2|||
125198115|NCT02653170|450348031|FG001|Overall Study|withdrawn by study team|4|||
125198116|NCT02653170|450348032|FG002|Overall Study|withdrawn by study team|5|||
125198117|NCT02653170|450348030|FG000|Overall Study|Lost to Follow-up|12|||
125198118|NCT02653170|450348031|FG001|Overall Study|Lost to Follow-up|4|||
125198119|NCT02653170|450348032|FG002|Overall Study|Lost to Follow-up|10|||
125198120|NCT01194999|450348038|FG000|Overall Study|Lost to Follow-up|17|||
125198121|NCT05835011|450348039|FG000|Overall Study|Study Terminated by the Sponsor|1|||
125198122|NCT05835011|450348039|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
125198123|NCT04720911|450348044|FG000|Overall Study|Withdrawal by Subject|0|||
125198124|NCT04720911|450348045|FG001|Overall Study|Withdrawal by Subject|1|||
125198125|NCT04720911|450348046|FG002|Overall Study|Withdrawal by Subject|0|||
125198126|NCT00090220|450348047|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
125198127|NCT00090220|450348048|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
125198128|NCT00090220|450348049|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
125198129|NCT00090220|450348050|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
125198130|NCT00090220|450348051|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
125198131|NCT00090220|450348052|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
125198132|NCT00090220|450348047|FG000|Base Study Vaccination Period|Adverse Event|6|||
125198133|NCT00090220|450348048|FG001|Base Study Vaccination Period|Adverse Event|1|||
125198134|NCT00090220|450348049|FG002|Base Study Vaccination Period|Adverse Event|0|||
125198135|NCT00090220|450348050|FG003|Base Study Vaccination Period|Adverse Event|0|||
125198136|NCT00090220|450348051|FG004|Base Study Vaccination Period|Adverse Event|0|||
125198137|NCT00090220|450348052|FG005|Base Study Vaccination Period|Adverse Event|0|||
125198138|NCT00090220|450348047|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
125252771|NCT02037984|450550379|FG003|Overall Study|Lost to Follow-up|5|||
125252772|NCT02037984|450550380|FG004|Overall Study|Lost to Follow-up|2|||
125252773|NCT02037984|450550381|FG005|Overall Study|Lost to Follow-up|2|||
125252774|NCT02037984|450550382|FG006|Overall Study|Lost to Follow-up|2|||
125252775|NCT02037984|450550383|FG007|Overall Study|Lost to Follow-up|4|||
125252776|NCT02037984|450550376|FG000|Overall Study|Physician Decision|0|||
125252777|NCT02037984|450550377|FG001|Overall Study|Physician Decision|0|||
125198139|NCT00090220|450348048|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
125198140|NCT00090220|450348049|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
125198141|NCT00090220|450348050|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
125198142|NCT00090220|450348051|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
125198143|NCT00090220|450348052|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
125198144|NCT00090220|450348047|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
125198145|NCT00090220|450348048|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
125198146|NCT00090220|450348049|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
125252778|NCT02037984|450550378|FG002|Overall Study|Physician Decision|0|||
125252779|NCT02037984|450550379|FG003|Overall Study|Physician Decision|0|||
125198147|NCT00090220|450348050|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
125198148|NCT00090220|450348051|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
125198149|NCT00090220|450348052|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
125198150|NCT00090220|450348047|FG000|Base Study Vaccination Period|Patient Moved|6|||
125198151|NCT00090220|450348048|FG001|Base Study Vaccination Period|Patient Moved|2|||
125198152|NCT00090220|450348049|FG002|Base Study Vaccination Period|Patient Moved|0|||
125198153|NCT00090220|450348050|FG003|Base Study Vaccination Period|Patient Moved|0|||
125198154|NCT00090220|450348051|FG004|Base Study Vaccination Period|Patient Moved|0|||
125198155|NCT00090220|450348052|FG005|Base Study Vaccination Period|Patient Moved|0|||
125198156|NCT00090220|450348047|FG000|Base Study Vaccination Period|Other|4|||
125198157|NCT00090220|450348048|FG001|Base Study Vaccination Period|Other|4|||
125198158|NCT00090220|450348049|FG002|Base Study Vaccination Period|Other|0|||
125198159|NCT00090220|450348050|FG003|Base Study Vaccination Period|Other|0|||
125198160|NCT00090220|450348051|FG004|Base Study Vaccination Period|Other|0|||
125198161|NCT00090220|450348052|FG005|Base Study Vaccination Period|Other|0|||
125198162|NCT00090220|450348047|FG000|Base Study Follow-up Period|Adverse Event|6|||
125198163|NCT00090220|450348048|FG001|Base Study Follow-up Period|Adverse Event|1|||
125198164|NCT00090220|450348049|FG002|Base Study Follow-up Period|Adverse Event|0|||
125198165|NCT00090220|450348050|FG003|Base Study Follow-up Period|Adverse Event|0|||
125198166|NCT00090220|450348051|FG004|Base Study Follow-up Period|Adverse Event|0|||
125198167|NCT00090220|450348052|FG005|Base Study Follow-up Period|Adverse Event|0|||
125198168|NCT00090220|450348047|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
125198169|NCT00090220|450348048|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
125198170|NCT00090220|450348049|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
125198171|NCT00090220|450348050|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
125198172|NCT00090220|450348051|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
125198173|NCT00090220|450348052|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
125198174|NCT00090220|450348047|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
125198175|NCT00090220|450348048|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
125198176|NCT00090220|450348049|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
125198177|NCT00090220|450348050|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
125198178|NCT00090220|450348051|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
125198179|NCT00090220|450348052|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
125198180|NCT00090220|450348047|FG000|Base Study Follow-up Period|Patient Moved|20|||
125198181|NCT00090220|450348048|FG001|Base Study Follow-up Period|Patient Moved|28|||
125198182|NCT00090220|450348049|FG002|Base Study Follow-up Period|Patient Moved|0|||
125198183|NCT00090220|450348050|FG003|Base Study Follow-up Period|Patient Moved|0|||
125198184|NCT00090220|450348051|FG004|Base Study Follow-up Period|Patient Moved|0|||
125198185|NCT00090220|450348052|FG005|Base Study Follow-up Period|Patient Moved|0|||
125198186|NCT00090220|450348047|FG000|Base Study Follow-up Period|Other|19|||
125198187|NCT00090220|450348048|FG001|Base Study Follow-up Period|Other|21|||
125198188|NCT00090220|450348049|FG002|Base Study Follow-up Period|Other|0|||
125198189|NCT00090220|450348050|FG003|Base Study Follow-up Period|Other|0|||
125198190|NCT00090220|450348051|FG004|Base Study Follow-up Period|Other|0|||
125198191|NCT00090220|450348052|FG005|Base Study Follow-up Period|Other|0|||
125198192|NCT00090220|450348047|FG000|Extension 1 (EXT1)|Adverse Event|0|||
125198193|NCT00090220|450348048|FG001|Extension 1 (EXT1)|Adverse Event|0|||
125198194|NCT00090220|450348049|FG002|Extension 1 (EXT1)|Adverse Event|4|||
125198195|NCT00090220|450348050|FG003|Extension 1 (EXT1)|Adverse Event|0|||
125198196|NCT00090220|450348051|FG004|Extension 1 (EXT1)|Adverse Event|0|||
125198197|NCT00090220|450348052|FG005|Extension 1 (EXT1)|Adverse Event|0|||
125198198|NCT00090220|450348047|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
125198199|NCT00090220|450348048|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
125198200|NCT00090220|450348049|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
125198201|NCT00090220|450348050|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
125198202|NCT00090220|450348051|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
125198203|NCT00090220|450348052|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
125198204|NCT00090220|450348047|FG000|Extension 1 (EXT1)|Moved|0|||
125198205|NCT00090220|450348048|FG001|Extension 1 (EXT1)|Moved|0|||
125198206|NCT00090220|450348049|FG002|Extension 1 (EXT1)|Moved|2|||
125198207|NCT00090220|450348050|FG003|Extension 1 (EXT1)|Moved|1|||
125198208|NCT00090220|450348051|FG004|Extension 1 (EXT1)|Moved|0|||
125198209|NCT00090220|450348052|FG005|Extension 1 (EXT1)|Moved|0|||
125198210|NCT00090220|450348047|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
125198211|NCT00090220|450348048|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
125198212|NCT00090220|450348049|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
125198213|NCT00090220|450348050|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
125252780|NCT02037984|450550380|FG004|Overall Study|Physician Decision|0|||
125198214|NCT00090220|450348051|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
125198215|NCT00090220|450348052|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
125198216|NCT00090220|450348047|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
125198217|NCT00090220|450348048|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
125198218|NCT00090220|450348049|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
125198219|NCT00090220|450348050|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
125198220|NCT00090220|450348051|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
125198221|NCT00090220|450348052|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
125198222|NCT00090220|450348047|FG000|Extension 1 (EXT1)|Other reason|0|||
125198223|NCT00090220|450348048|FG001|Extension 1 (EXT1)|Other reason|0|||
125198224|NCT00090220|450348049|FG002|Extension 1 (EXT1)|Other reason|2|||
125198225|NCT00090220|450348050|FG003|Extension 1 (EXT1)|Other reason|0|||
125198226|NCT00090220|450348051|FG004|Extension 1 (EXT1)|Other reason|0|||
125198227|NCT00090220|450348052|FG005|Extension 1 (EXT1)|Other reason|0|||
125198228|NCT00090220|450348047|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
125198229|NCT00090220|450348048|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
125198230|NCT00090220|450348049|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
125198231|NCT00090220|450348050|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
125198232|NCT00090220|450348051|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
125198233|NCT00090220|450348052|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
125198234|NCT00090220|450348047|FG000|Long-term Follow-up (EXT2)|Death|0|||
125198235|NCT00090220|450348048|FG001|Long-term Follow-up (EXT2)|Death|0|||
125198236|NCT00090220|450348049|FG002|Long-term Follow-up (EXT2)|Death|0|||
125198237|NCT00090220|450348050|FG003|Long-term Follow-up (EXT2)|Death|0|||
125198238|NCT00090220|450348051|FG004|Long-term Follow-up (EXT2)|Death|1|||
125198239|NCT00090220|450348052|FG005|Long-term Follow-up (EXT2)|Death|1|||
125198240|NCT00090220|450348047|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
125198241|NCT00090220|450348048|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
125198242|NCT00090220|450348049|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
125198243|NCT00090220|450348050|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
125198244|NCT00090220|450348051|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
125198245|NCT00090220|450348052|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
125198246|NCT00090220|450348047|FG000|Long-term Follow-up (EXT2)|Other|0|||
125198247|NCT00090220|450348048|FG001|Long-term Follow-up (EXT2)|Other|0|||
125198248|NCT00090220|450348049|FG002|Long-term Follow-up (EXT2)|Other|0|||
125198249|NCT00090220|450348050|FG003|Long-term Follow-up (EXT2)|Other|0|||
125198250|NCT00090220|450348051|FG004|Long-term Follow-up (EXT2)|Other|1|||
125198251|NCT00090220|450348052|FG005|Long-term Follow-up (EXT2)|Other|0|||
125198252|NCT00941863|450348053|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
125198253|NCT00941863|450348054|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
125198254|NCT00941863|450348055|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
125198255|NCT00941863|450348056|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
125198256|NCT00941863|450348057|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
125198257|NCT00941863|450348053|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
125198258|NCT00941863|450348054|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
125198259|NCT00941863|450348055|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
125198260|NCT00941863|450348056|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
125198261|NCT00941863|450348057|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
125198262|NCT00941863|450348053|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
125198263|NCT00941863|450348054|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
125198264|NCT00941863|450348055|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
125198265|NCT00941863|450348056|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
125198266|NCT00941863|450348057|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
125198267|NCT00941863|450348053|FG000|Until Primary Completion Date (PCD)|Death|0|||
125198268|NCT00941863|450348054|FG001|Until Primary Completion Date (PCD)|Death|0|||
125198269|NCT00941863|450348055|FG002|Until Primary Completion Date (PCD)|Death|1|||
125198270|NCT00941863|450348056|FG003|Until Primary Completion Date (PCD)|Death|2|||
125198271|NCT00941863|450348057|FG004|Until Primary Completion Date (PCD)|Death|7|||
125198272|NCT00941863|450348053|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
125198273|NCT00941863|450348054|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
125198274|NCT00941863|450348055|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
125198275|NCT00941863|450348056|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
125198276|NCT00941863|450348057|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
125198277|NCT00941863|450348053|FG000|Continued After PCD|Withdrawal by Subject|0|||
125198278|NCT00941863|450348054|FG001|Continued After PCD|Withdrawal by Subject|0|||
125198279|NCT00941863|450348055|FG002|Continued After PCD|Withdrawal by Subject|0|||
125198280|NCT00941863|450348056|FG003|Continued After PCD|Withdrawal by Subject|0|||
125198281|NCT00941863|450348057|FG004|Continued After PCD|Withdrawal by Subject|1|||
125198282|NCT00941863|450348053|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
125198283|NCT00941863|450348054|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
125198284|NCT00941863|450348055|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
125198285|NCT00941863|450348056|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
125198286|NCT00941863|450348057|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
125198287|NCT05113979|450348060|FG000|Overall Study|Death|2|||
125198288|NCT05113979|450348060|FG000|Overall Study|Lost to Follow-up|1|||
125198289|NCT03557931|450348063|FG000|Overall Study|Adverse Event|4|||
125198290|NCT03557931|450348064|FG001|Overall Study|Adverse Event|6|||
125198291|NCT03557931|450348065|FG002|Overall Study|Adverse Event|1|||
125198292|NCT03557931|450348063|FG000|Overall Study|Lost to Follow-up|4|||
125198293|NCT03557931|450348064|FG001|Overall Study|Lost to Follow-up|4|||
125198294|NCT03557931|450348065|FG002|Overall Study|Lost to Follow-up|1|||
125198295|NCT03557931|450348063|FG000|Overall Study|Protocol Violation|1|||
125198296|NCT03557931|450348064|FG001|Overall Study|Protocol Violation|4|||
125198297|NCT03557931|450348065|FG002|Overall Study|Protocol Violation|1|||
125198298|NCT03557931|450348063|FG000|Overall Study|Withdrawal by Subject|14|||
125198299|NCT03557931|450348064|FG001|Overall Study|Withdrawal by Subject|0|||
125198300|NCT03557931|450348065|FG002|Overall Study|Withdrawal by Subject|7|||
125198301|NCT03557931|450348063|FG000|Overall Study|Miscellaneous|8|||
125198302|NCT03557931|450348064|FG001|Overall Study|Miscellaneous|5|||
125198303|NCT03557931|450348065|FG002|Overall Study|Miscellaneous|3|||
125198304|NCT02829723|450348068|FG000|Overall Study|Adverse Event|0|||
125198305|NCT02829723|450348069|FG001|Overall Study|Adverse Event|0|||
125198306|NCT02829723|450348070|FG002|Overall Study|Adverse Event|1|||
125198307|NCT02829723|450348071|FG003|Overall Study|Adverse Event|1|||
125198308|NCT02829723|450348072|FG004|Overall Study|Adverse Event|0|||
125198309|NCT02829723|450348073|FG005|Overall Study|Adverse Event|0|||
125198310|NCT02829723|450348074|FG006|Overall Study|Adverse Event|0|||
125198311|NCT02829723|450348075|FG007|Overall Study|Adverse Event|1|||
125198312|NCT02829723|450348076|FG008|Overall Study|Adverse Event|0|||
125198313|NCT02829723|450348077|FG009|Overall Study|Adverse Event|0|||
125198314|NCT02829723|450348078|FG010|Overall Study|Adverse Event|0|||
125198315|NCT02829723|450348079|FG011|Overall Study|Adverse Event|0|||
125198316|NCT02829723|450348080|FG012|Overall Study|Adverse Event|0|||
125198317|NCT02829723|450348081|FG013|Overall Study|Adverse Event|0|||
125198318|NCT02829723|450348082|FG014|Overall Study|Adverse Event|1|||
125198319|NCT02829723|450348083|FG015|Overall Study|Adverse Event|1|||
125198320|NCT02829723|450348084|FG016|Overall Study|Adverse Event|1|||
125198321|NCT02829723|450348085|FG017|Overall Study|Adverse Event|2|||
125198322|NCT02829723|450348086|FG018|Overall Study|Adverse Event|1|||
125198323|NCT02829723|450348087|FG019|Overall Study|Adverse Event|1|||
125198324|NCT02829723|450348088|FG020|Overall Study|Adverse Event|3|||
125198325|NCT02829723|450348089|FG021|Overall Study|Adverse Event|0|||
125198326|NCT02829723|450348090|FG022|Overall Study|Adverse Event|0|||
125198327|NCT02829723|450348091|FG023|Overall Study|Adverse Event|1|||
125198328|NCT02829723|450348092|FG024|Overall Study|Adverse Event|1|||
125198329|NCT02829723|450348093|FG025|Overall Study|Adverse Event|3|||
125198330|NCT02829723|450348094|FG026|Overall Study|Adverse Event|5|||
125198331|NCT02829723|450348068|FG000|Overall Study|Death|1|||
125198332|NCT02829723|450348069|FG001|Overall Study|Death|0|||
125198333|NCT02829723|450348070|FG002|Overall Study|Death|1|||
125198334|NCT02829723|450348071|FG003|Overall Study|Death|1|||
125198335|NCT02829723|450348072|FG004|Overall Study|Death|0|||
125198336|NCT02829723|450348073|FG005|Overall Study|Death|0|||
125198337|NCT02829723|450348074|FG006|Overall Study|Death|2|||
125198338|NCT02829723|450348075|FG007|Overall Study|Death|0|||
125198339|NCT02829723|450348076|FG008|Overall Study|Death|1|||
125198340|NCT02829723|450348077|FG009|Overall Study|Death|0|||
125198341|NCT02829723|450348078|FG010|Overall Study|Death|0|||
125198342|NCT02829723|450348079|FG011|Overall Study|Death|0|||
125198343|NCT02829723|450348080|FG012|Overall Study|Death|2|||
125198344|NCT02829723|450348081|FG013|Overall Study|Death|1|||
125198345|NCT02829723|450348082|FG014|Overall Study|Death|0|||
125198346|NCT02829723|450348083|FG015|Overall Study|Death|0|||
125198347|NCT02829723|450348084|FG016|Overall Study|Death|0|||
125198348|NCT02829723|450348085|FG017|Overall Study|Death|0|||
125198349|NCT02829723|450348086|FG018|Overall Study|Death|0|||
125198350|NCT02829723|450348087|FG019|Overall Study|Death|0|||
125198351|NCT02829723|450348088|FG020|Overall Study|Death|0|||
125198352|NCT02829723|450348089|FG021|Overall Study|Death|2|||
125198353|NCT02829723|450348090|FG022|Overall Study|Death|0|||
125198354|NCT02829723|450348091|FG023|Overall Study|Death|0|||
125198355|NCT02829723|450348092|FG024|Overall Study|Death|0|||
125198356|NCT02829723|450348093|FG025|Overall Study|Death|1|||
125198357|NCT02829723|450348094|FG026|Overall Study|Death|2|||
125198358|NCT02829723|450348068|FG000|Overall Study|Physician Decision|0|||
125198359|NCT02829723|450348069|FG001|Overall Study|Physician Decision|0|||
125198360|NCT02829723|450348070|FG002|Overall Study|Physician Decision|0|||
125198361|NCT02829723|450348071|FG003|Overall Study|Physician Decision|0|||
125198362|NCT02829723|450348072|FG004|Overall Study|Physician Decision|0|||
125198363|NCT02829723|450348073|FG005|Overall Study|Physician Decision|0|||
125198364|NCT02829723|450348074|FG006|Overall Study|Physician Decision|0|||
125198365|NCT02829723|450348075|FG007|Overall Study|Physician Decision|0|||
125198366|NCT02829723|450348076|FG008|Overall Study|Physician Decision|0|||
125198367|NCT02829723|450348077|FG009|Overall Study|Physician Decision|1|||
125198368|NCT02829723|450348078|FG010|Overall Study|Physician Decision|1|||
125198369|NCT02829723|450348079|FG011|Overall Study|Physician Decision|0|||
125198370|NCT02829723|450348080|FG012|Overall Study|Physician Decision|0|||
125198371|NCT02829723|450348081|FG013|Overall Study|Physician Decision|1|||
125198372|NCT02829723|450348082|FG014|Overall Study|Physician Decision|0|||
125198373|NCT02829723|450348083|FG015|Overall Study|Physician Decision|0|||
125198374|NCT02829723|450348084|FG016|Overall Study|Physician Decision|2|||
125252781|NCT02037984|450550381|FG005|Overall Study|Physician Decision|0|||
125252782|NCT02037984|450550382|FG006|Overall Study|Physician Decision|1|||
125252783|NCT02037984|450550383|FG007|Overall Study|Physician Decision|0|||
125252784|NCT02037984|450550376|FG000|Overall Study|Protocol Violation|0|||
125252785|NCT02037984|450550377|FG001|Overall Study|Protocol Violation|0|||
125252786|NCT02037984|450550378|FG002|Overall Study|Protocol Violation|0|||
125252787|NCT02037984|450550379|FG003|Overall Study|Protocol Violation|0|||
125252788|NCT02037984|450550380|FG004|Overall Study|Protocol Violation|0|||
125252789|NCT02037984|450550381|FG005|Overall Study|Protocol Violation|1|||
125252790|NCT02037984|450550382|FG006|Overall Study|Protocol Violation|2|||
125198375|NCT02829723|450348085|FG017|Overall Study|Physician Decision|0|||
125198376|NCT02829723|450348086|FG018|Overall Study|Physician Decision|0|||
125198377|NCT02829723|450348087|FG019|Overall Study|Physician Decision|0|||
125198378|NCT02829723|450348088|FG020|Overall Study|Physician Decision|0|||
125198379|NCT02829723|450348089|FG021|Overall Study|Physician Decision|0|||
125198380|NCT02829723|450348090|FG022|Overall Study|Physician Decision|1|||
125198381|NCT02829723|450348091|FG023|Overall Study|Physician Decision|1|||
125198382|NCT02829723|450348092|FG024|Overall Study|Physician Decision|1|||
125198383|NCT02829723|450348093|FG025|Overall Study|Physician Decision|1|||
125198384|NCT02829723|450348094|FG026|Overall Study|Physician Decision|3|||
125198385|NCT02829723|450348068|FG000|Overall Study|Progressive disease|4|||
125198386|NCT02829723|450348069|FG001|Overall Study|Progressive disease|6|||
125198387|NCT02829723|450348070|FG002|Overall Study|Progressive disease|3|||
125198388|NCT02829723|450348071|FG003|Overall Study|Progressive disease|3|||
125198389|NCT02829723|450348072|FG004|Overall Study|Progressive disease|3|||
125198390|NCT02829723|450348073|FG005|Overall Study|Progressive disease|5|||
125198391|NCT02829723|450348074|FG006|Overall Study|Progressive disease|4|||
125198392|NCT02829723|450348075|FG007|Overall Study|Progressive disease|6|||
125198393|NCT02829723|450348076|FG008|Overall Study|Progressive disease|8|||
125198394|NCT02829723|450348077|FG009|Overall Study|Progressive disease|4|||
125198395|NCT02829723|450348078|FG010|Overall Study|Progressive disease|9|||
125198396|NCT02829723|450348079|FG011|Overall Study|Progressive disease|0|||
125198397|NCT02829723|450348080|FG012|Overall Study|Progressive disease|3|||
125198398|NCT02829723|450348081|FG013|Overall Study|Progressive disease|4|||
125198399|NCT02829723|450348082|FG014|Overall Study|Progressive disease|2|||
125198400|NCT02829723|450348083|FG015|Overall Study|Progressive disease|4|||
125198401|NCT02829723|450348084|FG016|Overall Study|Progressive disease|5|||
125198402|NCT02829723|450348085|FG017|Overall Study|Progressive disease|3|||
125198403|NCT02829723|450348086|FG018|Overall Study|Progressive disease|4|||
125198404|NCT02829723|450348087|FG019|Overall Study|Progressive disease|4|||
125198405|NCT02829723|450348088|FG020|Overall Study|Progressive disease|7|||
125198406|NCT02829723|450348089|FG021|Overall Study|Progressive disease|6|||
125198407|NCT02829723|450348090|FG022|Overall Study|Progressive disease|3|||
125198408|NCT02829723|450348091|FG023|Overall Study|Progressive disease|3|||
125198409|NCT02829723|450348092|FG024|Overall Study|Progressive disease|3|||
125198410|NCT02829723|450348093|FG025|Overall Study|Progressive disease|16|||
125198411|NCT02829723|450348094|FG026|Overall Study|Progressive disease|10|||
125198412|NCT02829723|450348068|FG000|Overall Study|Subject/guardian decision|0|||
125198413|NCT02829723|450348069|FG001|Overall Study|Subject/guardian decision|1|||
125198414|NCT02829723|450348070|FG002|Overall Study|Subject/guardian decision|0|||
125252791|NCT02037984|450550383|FG007|Overall Study|Protocol Violation|0|||
125252792|NCT02037984|450550376|FG000|Overall Study|Technical Problems|0|||
125252793|NCT02037984|450550377|FG001|Overall Study|Technical Problems|0|||
125252794|NCT02037984|450550378|FG002|Overall Study|Technical Problems|3|||
125252795|NCT02037984|450550379|FG003|Overall Study|Technical Problems|3|||
125252796|NCT02037984|450550380|FG004|Overall Study|Technical Problems|2|||
125252797|NCT02037984|450550381|FG005|Overall Study|Technical Problems|3|||
125252798|NCT02037984|450550382|FG006|Overall Study|Technical Problems|4|||
125252799|NCT02037984|450550383|FG007|Overall Study|Technical Problems|2|||
125252800|NCT02037984|450550376|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125252801|NCT02037984|450550377|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125252802|NCT02037984|450550378|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
125252803|NCT02037984|450550379|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
125252804|NCT02037984|450550380|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
125252805|NCT02037984|450550381|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
125252806|NCT02037984|450550382|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
125252807|NCT02037984|450550383|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
125252808|NCT02037984|450550376|FG000|Overall Study|Withdrawal by Subject|0|||
125252809|NCT02037984|450550377|FG001|Overall Study|Withdrawal by Subject|0|||
125252810|NCT02037984|450550378|FG002|Overall Study|Withdrawal by Subject|0|||
125252811|NCT02037984|450550379|FG003|Overall Study|Withdrawal by Subject|1|||
125252812|NCT02037984|450550380|FG004|Overall Study|Withdrawal by Subject|1|||
125252813|NCT02037984|450550381|FG005|Overall Study|Withdrawal by Subject|3|||
125252814|NCT02037984|450550382|FG006|Overall Study|Withdrawal by Subject|0|||
125252815|NCT02037984|450550383|FG007|Overall Study|Withdrawal by Subject|1|||
125252816|NCT00974233|450550384|FG000|Induction Chemoimmunotherapy|Death|2|||
125252817|NCT00974233|450550384|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
125252818|NCT00974233|450550384|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
125252819|NCT00974233|450550384|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
125252820|NCT00974233|450550384|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
125252821|NCT00974233|450550384|FG000|Maintenance Lenalidomide|Adverse Event|8|||
125252822|NCT01691092|450550385|FG000|Overall Study|Lost to Follow-up|10|||
125252823|NCT01691092|450550385|FG000|Overall Study|Physician Decision|4|||
125252824|NCT01691092|450550385|FG000|Overall Study|Withdrawal by Subject|3|||
125252825|NCT01691092|450550385|FG000|Overall Study|non-compliance|3|||
125252826|NCT01691092|450550385|FG000|Overall Study|used for different study|2|||
125252827|NCT01691092|450550385|FG000|Overall Study|screen fail|19|||
125252828|NCT01569763|450552116|FG000|Overall Study|Lack of Efficacy|2|||
125252829|NCT01569763|450552117|FG001|Overall Study|Lack of Efficacy|7|||
125252830|NCT01569763|450552116|FG000|Overall Study|Adverse Event|1|||
125252831|NCT01569763|450552117|FG001|Overall Study|Adverse Event|0|||
125252832|NCT03211858|450552119|FG000|Overall Study|Adverse Event|8|||
125252833|NCT03211858|450552120|FG001|Overall Study|Adverse Event|6|||
125252834|NCT03211858|450552119|FG000|Overall Study|Lack of Efficacy|0|||
125252835|NCT03211858|450552120|FG001|Overall Study|Lack of Efficacy|4|||
125252836|NCT03211858|450552119|FG000|Overall Study|Poor compliance to protocol|6|||
125252837|NCT03211858|450552120|FG001|Overall Study|Poor compliance to protocol|2|||
125252838|NCT03211858|450552119|FG000|Overall Study|Non-serious Hypoglycemia|1|||
125252839|NCT03211858|450552120|FG001|Overall Study|Non-serious Hypoglycemia|0|||
125252840|NCT03211858|450552119|FG000|Overall Study|Other than specified above|22|||
125252841|NCT03211858|450552120|FG001|Overall Study|Other than specified above|21|||
125252842|NCT03810365|450552122|FG000|Overall Study|Lost to Follow-up|2|||
125252843|NCT03810365|450552123|FG001|Overall Study|Lost to Follow-up|2|||
125252844|NCT03810365|450552122|FG000|Overall Study|Withdrawal by Subject|4|||
125252845|NCT03810365|450552123|FG001|Overall Study|Withdrawal by Subject|5|||
125252846|NCT00185614|450552128|FG000|Inter-treatment Period|Physician Decision|1|||
125252847|NCT00185614|450552128|FG000|Inter-treatment Period|Relapse|2|||
125252848|NCT00185614|450552128|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
125252849|NCT03160573|450552129|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
125252850|NCT03160573|450552130|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
125252851|NCT03160573|450552131|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
125252852|NCT03160573|450552132|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
125252853|NCT02402907|450552136|FG000|Overall Study|Delivered vaginally|9|||
125252854|NCT02402907|450552137|FG001|Overall Study|Delivered vaginally|3|||
125252855|NCT02402907|450552136|FG000|Overall Study|Delivered outside of Sinai|1|||
125252856|NCT02402907|450552137|FG001|Overall Study|Delivered outside of Sinai|1|||
125252857|NCT02402907|450552136|FG000|Overall Study|Lost to follow up after C-Section|10|||
125252858|NCT02402907|450552137|FG001|Overall Study|Lost to follow up after C-Section|23|||
125252859|NCT01423084|450552140|FG000|Overall Study|Adverse Event|0|||
125252860|NCT01423084|450552141|FG001|Overall Study|Adverse Event|1|||
125252861|NCT01423084|450552140|FG000|Overall Study|Withdrawal by Subject|2|||
125252862|NCT01423084|450552141|FG001|Overall Study|Withdrawal by Subject|3|||
125252863|NCT00661687|450552142|FG000|Overall Study|Study related symptoms and complaints|5|||
125252864|NCT00661687|450552142|FG000|Overall Study|Positive slit lamp findings|4|||
125252865|NCT00661687|450552142|FG000|Overall Study|Inability to maintain wearing schedule|3|||
125252866|NCT00661687|450552142|FG000|Overall Study|Physician Decision|1|||
125252867|NCT00661687|450552142|FG000|Overall Study|Adverse Event|2|||
125252868|NCT02462057|450552143|FG000|Overall Study|Left Vitality|32|||
125252869|NCT02462057|450552144|FG001|Overall Study|Left Vitality|27|||
125252870|NCT02462057|450552145|FG002|Overall Study|Left Vitality|23|||
125252871|NCT02462057|450552146|FG003|Overall Study|Left Vitality|35|||
125252872|NCT02462057|450552147|FG004|Overall Study|Left Vitality|33|||
125252873|NCT02462057|450552143|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
125252874|NCT02462057|450552144|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
125252875|NCT02462057|450552145|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
125252876|NCT02462057|450552146|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
125252877|NCT02462057|450552147|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
125252878|NCT02336555|450552148|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125252879|NCT02336555|450552149|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
125252880|NCT02336555|450552148|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
125252881|NCT02336555|450552149|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
125252882|NCT02336555|450552148|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
125252883|NCT02336555|450552149|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
125252884|NCT01633112|450552150|FG000|Overall Study|Lack of Efficacy|1|||
125252885|NCT01633112|450552151|FG001|Overall Study|Lack of Efficacy|6|||
125252886|NCT01633112|450552152|FG002|Overall Study|Lack of Efficacy|13|||
125252887|NCT01633112|450552150|FG000|Overall Study|Abnormal laboratory value(s)|3|||
125252888|NCT01633112|450552151|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125252889|NCT01633112|450552152|FG002|Overall Study|Abnormal laboratory value(s)|0|||
125252890|NCT01633112|450552150|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125252891|NCT01633112|450552151|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125252892|NCT01633112|450552152|FG002|Overall Study|Abnormal test procedure result(s)|0|||
125252893|NCT01633112|450552150|FG000|Overall Study|Administrative problems|1|||
125252894|NCT01633112|450552151|FG001|Overall Study|Administrative problems|2|||
125252895|NCT01633112|450552152|FG002|Overall Study|Administrative problems|5|||
125252896|NCT01633112|450552150|FG000|Overall Study|Adverse Event|16|||
125252897|NCT01633112|450552151|FG001|Overall Study|Adverse Event|18|||
125252898|NCT01633112|450552152|FG002|Overall Study|Adverse Event|20|||
125252899|NCT01633112|450552150|FG000|Overall Study|Lost to Follow-up|7|||
125252900|NCT01633112|450552151|FG001|Overall Study|Lost to Follow-up|19|||
125252901|NCT01633112|450552152|FG002|Overall Study|Lost to Follow-up|6|||
125252902|NCT01633112|450552150|FG000|Overall Study|Protocol Violation|4|||
125252903|NCT01633112|450552151|FG001|Overall Study|Protocol Violation|0|||
125252904|NCT01633112|450552152|FG002|Overall Study|Protocol Violation|2|||
125252905|NCT01633112|450552150|FG000|Overall Study|Subject no longer requires study drug|0|||
125252906|NCT01633112|450552151|FG001|Overall Study|Subject no longer requires study drug|0|||
125252907|NCT01633112|450552152|FG002|Overall Study|Subject no longer requires study drug|1|||
125252908|NCT01633112|450552150|FG000|Overall Study|Withdrawal by Subject|20|||
125252909|NCT01633112|450552151|FG001|Overall Study|Withdrawal by Subject|12|||
125252910|NCT01633112|450552152|FG002|Overall Study|Withdrawal by Subject|41|||
125252911|NCT01633112|450552150|FG000|Overall Study|missing Study Completion CRF|1|||
125252912|NCT01633112|450552151|FG001|Overall Study|missing Study Completion CRF|1|||
125252913|NCT01633112|450552152|FG002|Overall Study|missing Study Completion CRF|4|||
125252914|NCT01959919|450552153|FG000|Overall Study|Did not meet the eligibility criteria|2|||
125252915|NCT01908699|450552154|FG000|Overall Study|Adverse Event|8|||
125252916|NCT01908699|450552155|FG001|Overall Study|Adverse Event|12|||
125252917|NCT01908699|450552154|FG000|Overall Study|Lack of Efficacy|2|||
125252918|NCT01908699|450552155|FG001|Overall Study|Lack of Efficacy|2|||
125252919|NCT01908699|450552154|FG000|Overall Study|Lost to Follow-up|2|||
125252920|NCT01908699|450552155|FG001|Overall Study|Lost to Follow-up|4|||
125252921|NCT01908699|450552154|FG000|Overall Study|Physician Decision|8|||
125252922|NCT01908699|450552155|FG001|Overall Study|Physician Decision|8|||
125252923|NCT01908699|450552154|FG000|Overall Study|Withdrawal by Subject|15|||
125252924|NCT01908699|450552155|FG001|Overall Study|Withdrawal by Subject|10|||
125252925|NCT01908699|450552154|FG000|Overall Study|Pregnancy|0|||
125252926|NCT01908699|450552155|FG001|Overall Study|Pregnancy|1|||
125252927|NCT01908699|450552154|FG000|Overall Study|Randomized in Error|1|||
125252928|NCT01908699|450552155|FG001|Overall Study|Randomized in Error|0|||
125252929|NCT01908699|450552154|FG000|Overall Study|Death|9|||
125252930|NCT01908699|450552155|FG001|Overall Study|Death|12|||
125252931|NCT01908699|450552154|FG000|Overall Study|Progressive Disease|30|||
125252932|NCT01908699|450552155|FG001|Overall Study|Progressive Disease|29|||
125252933|NCT01697501|450552156|FG000|Overall Study|Protocol Violation|2|||
125252934|NCT00889005|450552159|FG000|Overall Study|Lost to Follow-up|4|||
125252935|NCT00889005|450552160|FG001|Overall Study|Lost to Follow-up|2|||
125252936|NCT00889005|450552159|FG000|Overall Study|Withdrawal by Subject|4|||
125252937|NCT00889005|450552160|FG001|Overall Study|Withdrawal by Subject|0|||
125252938|NCT00128492|450552161|FG000|Overall Study|AE unrelated to study|2|||
125252939|NCT00128492|450552162|FG001|Overall Study|AE unrelated to study|9|||
125252940|NCT00128492|450552161|FG000|Overall Study|Study drug intolerance (AE)|2|||
125252941|NCT00128492|450552162|FG001|Overall Study|Study drug intolerance (AE)|8|||
125252942|NCT00128492|450552161|FG000|Overall Study|AE related to study|1|||
125252943|NCT00128492|450552162|FG001|Overall Study|AE related to study|4|||
125252944|NCT00128492|450552161|FG000|Overall Study|Death|1|||
125252945|NCT00128492|450552162|FG001|Overall Study|Death|0|||
125252946|NCT00128492|450552161|FG000|Overall Study|Lost to Follow-up|1|||
125252947|NCT00128492|450552162|FG001|Overall Study|Lost to Follow-up|5|||
125252948|NCT00128492|450552161|FG000|Overall Study|Noncompliance|0|||
125252949|NCT00128492|450552162|FG001|Overall Study|Noncompliance|5|||
125252950|NCT00128492|450552161|FG000|Overall Study|Personal or administrative|10|||
125252951|NCT00128492|450552162|FG001|Overall Study|Personal or administrative|22|||
125252952|NCT00128492|450552161|FG000|Overall Study|Withdrawal by Subject|3|||
125252953|NCT00128492|450552162|FG001|Overall Study|Withdrawal by Subject|5|||
125252954|NCT00128492|450552161|FG000|Overall Study|Pregnancy|0|||
125252955|NCT00128492|450552162|FG001|Overall Study|Pregnancy|1|||
125252956|NCT00692237|450552166|FG000|Overall Study|Withdrawal by Subject|1|||
125252957|NCT00692237|450552167|FG001|Overall Study|Withdrawal by Subject|3|||
125252958|NCT00692237|450552166|FG000|Overall Study|Adverse Event|0|||
125252959|NCT00692237|450552167|FG001|Overall Study|Adverse Event|1|||
125252960|NCT01347086|450552171|FG000|Overall Study|failed screening visit|0|||
125252961|NCT01347086|450552172|FG001|Overall Study|failed screening visit|0|||
125252962|NCT01347086|450552173|FG002|Overall Study|failed screening visit|1|||
125252963|NCT01347086|450552174|FG003|Overall Study|failed screening visit|0|||
125252964|NCT01347086|450552175|FG004|Overall Study|failed screening visit|0|||
125252965|NCT01347086|450552176|FG005|Overall Study|failed screening visit|0|||
125252966|NCT01347086|450552177|FG006|Overall Study|failed screening visit|1|||
125252967|NCT01347086|450552178|FG007|Overall Study|failed screening visit|1|||
125252968|NCT01347086|450552179|FG008|Overall Study|failed screening visit|0|||
125252969|NCT01347086|450552180|FG009|Overall Study|failed screening visit|1|||
125252970|NCT00395447|450552182|FG000|Overall Study|Death|37|||
125252971|NCT00395447|450552183|FG001|Overall Study|Death|32|||
125252972|NCT00395447|450552182|FG000|Overall Study|Lost to Follow-up|52|||
125252973|NCT00395447|450552183|FG001|Overall Study|Lost to Follow-up|43|||
125252974|NCT00395447|450552182|FG000|Overall Study|Withdrawal by Subject|24|||
125252975|NCT00395447|450552183|FG001|Overall Study|Withdrawal by Subject|19|||
125252976|NCT00395447|450552182|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
125252977|NCT00395447|450552183|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
125252978|NCT03111108|450552185|FG000|Overall Study|Death|0|||
125252979|NCT03111108|450552186|FG001|Overall Study|Death|1|||
125252980|NCT03111108|450552185|FG000|Overall Study|Withdrawal by Subject|1|||
125252981|NCT03111108|450552186|FG001|Overall Study|Withdrawal by Subject|0|||
125252982|NCT02771145|450552187|FG000|Overall Study|Adverse Event|3|||
125252983|NCT02771145|450552187|FG000|Overall Study|Lost to Follow-up|1|||
125252984|NCT02264821|450552188|FG000|Overall Study|Protocol Violation|1|||
125252985|NCT02264821|450552189|FG001|Overall Study|Protocol Violation|3|||
125252986|NCT02264821|450552190|FG002|Overall Study|Protocol Violation|6|||
125252987|NCT02662582|450552191|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
125252988|NCT02662582|450552192|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
125252989|NCT02662582|450552191|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
125252990|NCT02662582|450552192|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
125252991|NCT02662582|450552191|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
125252992|NCT02662582|450552192|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
125252993|NCT02662582|450552191|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
125252994|NCT02662582|450552192|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
125252995|NCT01903733|450552193|FG000|Overall Study|Death|23|||
125252996|NCT01903733|450552194|FG001|Overall Study|Death|54|||
125252997|NCT01903733|450552195|FG002|Overall Study|Death|30|||
125252998|NCT01903733|450552196|FG003|Overall Study|Death|98|||
125252999|NCT01903733|450552193|FG000|Overall Study|Participant refused further follow-up|35|||
125253000|NCT01903733|450552194|FG001|Overall Study|Participant refused further follow-up|38|||
125253001|NCT01903733|450552195|FG002|Overall Study|Participant refused further follow-up|13|||
125253002|NCT01903733|450552196|FG003|Overall Study|Participant refused further follow-up|9|||
125253003|NCT01903733|450552193|FG000|Overall Study|Lost to Follow-up|18|||
125253004|NCT01903733|450552194|FG001|Overall Study|Lost to Follow-up|19|||
125253005|NCT01903733|450552195|FG002|Overall Study|Lost to Follow-up|6|||
125253006|NCT01903733|450552196|FG003|Overall Study|Lost to Follow-up|9|||
125253007|NCT01903733|450552193|FG000|Overall Study|Other|10|||
125253008|NCT01903733|450552194|FG001|Overall Study|Other|15|||
125253009|NCT01903733|450552195|FG002|Overall Study|Other|12|||
125253010|NCT01903733|450552196|FG003|Overall Study|Other|3|||
125253011|NCT01903733|450552193|FG000|Overall Study|Missing|2|||
125253012|NCT01903733|450552194|FG001|Overall Study|Missing|0|||
125253013|NCT01903733|450552195|FG002|Overall Study|Missing|0|||
125253014|NCT01903733|450552196|FG003|Overall Study|Missing|0|||
125253015|NCT01903733|450552193|FG000|Overall Study|Investigator request|18|||
125253016|NCT01903733|450552194|FG001|Overall Study|Investigator request|0|||
125253017|NCT01903733|450552195|FG002|Overall Study|Investigator request|0|||
125253018|NCT01903733|450552196|FG003|Overall Study|Investigator request|0|||
125253019|NCT02395627|450552197|FG000|Overall Study|Withdrawal by Subject|0|||
125253020|NCT02395627|450552198|FG001|Overall Study|Withdrawal by Subject|2|||
125253021|NCT02395627|450552199|FG002|Overall Study|Withdrawal by Subject|0|||
125253022|NCT02395627|450552197|FG000|Overall Study|Did not receive pembrolizumab|3|||
125253023|NCT02395627|450552198|FG001|Overall Study|Did not receive pembrolizumab|1|||
125253024|NCT02395627|450552199|FG002|Overall Study|Did not receive pembrolizumab|0|||
125253025|NCT02852005|450552201|FG000|Overall Study|Lost to Follow-up|0|||
125253026|NCT02852005|450552202|FG001|Overall Study|Lost to Follow-up|0|||
125253027|NCT02852005|450552203|FG002|Overall Study|Lost to Follow-up|0|||
125253028|NCT02852005|450552204|FG003|Overall Study|Lost to Follow-up|0|||
125253029|NCT02852005|450552205|FG004|Overall Study|Lost to Follow-up|1|||
125253030|NCT02852005|450552201|FG000|Overall Study|Withdrawal by Subject|1|||
125253031|NCT02852005|450552202|FG001|Overall Study|Withdrawal by Subject|0|||
125253032|NCT02852005|450552203|FG002|Overall Study|Withdrawal by Subject|0|||
125253033|NCT02852005|450552204|FG003|Overall Study|Withdrawal by Subject|0|||
125253034|NCT02852005|450552205|FG004|Overall Study|Withdrawal by Subject|0|||
125253035|NCT02294019|450552207|FG000|Overall Study|Adverse Event|2|||
125253036|NCT02294019|450552207|FG000|Overall Study|Protocol Violation|68|||
125253037|NCT02294019|450552207|FG000|Overall Study|Lost to Follow-up|31|||
125253038|NCT02294019|450552207|FG000|Overall Study|Other|1|||
125253039|NCT02294019|450552207|FG000|Overall Study|Withdrawal by Subject|1|||
125253040|NCT02369159|450552208|FG000|Overall Study|Adverse Event|0|||
125253041|NCT02369159|450552209|FG001|Overall Study|Adverse Event|1|||
125253042|NCT02369159|450552208|FG000|Overall Study|Lost to Follow-up|1|||
125253043|NCT02369159|450552209|FG001|Overall Study|Lost to Follow-up|1|||
125253044|NCT02369159|450552208|FG000|Overall Study|Withdrawal by Subject|7|||
125253045|NCT02369159|450552209|FG001|Overall Study|Withdrawal by Subject|0|||
125253046|NCT03769116|450552210|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
125253047|NCT03769116|450552211|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
125253048|NCT03769116|450552210|FG000|Part 3 - Open Label|Physician Decision|1|||
125253049|NCT03769116|450552211|FG001|Part 3 - Open Label|Physician Decision|0|||
125253050|NCT03769116|450552210|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
125253051|NCT03769116|450552211|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
125253052|NCT01887600|450552219|FG000|Overall Study|Death|39|||
125253053|NCT01887600|450552220|FG001|Overall Study|Death|16|||
125253054|NCT01887600|450552219|FG000|Overall Study|Lack of Efficacy|3|||
125253055|NCT01887600|450552220|FG001|Overall Study|Lack of Efficacy|26|||
125253056|NCT01887600|450552219|FG000|Overall Study|Lost to Follow-up|5|||
125253057|NCT01887600|450552220|FG001|Overall Study|Lost to Follow-up|1|||
125253058|NCT01887600|450552219|FG000|Overall Study|Physician Decision|7|||
125253059|NCT01887600|450552220|FG001|Overall Study|Physician Decision|8|||
125253060|NCT01887600|450552219|FG000|Overall Study|Protocol Deviation|3|||
125253061|NCT01887600|450552220|FG001|Overall Study|Protocol Deviation|0|||
125253062|NCT01887600|450552219|FG000|Overall Study|Withdrawal by Subject|58|||
125253063|NCT01887600|450552220|FG001|Overall Study|Withdrawal by Subject|52|||
125253064|NCT01887600|450552219|FG000|Overall Study|Adverse Event|21|||
125253065|NCT01887600|450552220|FG001|Overall Study|Adverse Event|9|||
125253066|NCT01887600|450552219|FG000|Overall Study|Non-compliance with study drug|3|||
125253067|NCT01887600|450552220|FG001|Overall Study|Non-compliance with study drug|0|||
125253068|NCT01887600|450552219|FG000|Overall Study|Miscellaneous|6|||
125253069|NCT01887600|450552220|FG001|Overall Study|Miscellaneous|2|||
125253070|NCT01887600|450552219|FG000|Overall Study|Progressive Disease|1|||
125253071|NCT01887600|450552220|FG001|Overall Study|Progressive Disease|0|||
125253072|NCT03688139|450552221|FG000|Overall Study|Lost to Follow-up|2|||
125253073|NCT03688139|450552222|FG001|Overall Study|Lost to Follow-up|0|||
125253074|NCT03688139|450552221|FG000|Overall Study|Physician Decision|0|||
125253075|NCT03688139|450552222|FG001|Overall Study|Physician Decision|1|||
125253076|NCT03688139|450552221|FG000|Overall Study|Withdrawal by Subject|2|||
125253077|NCT03688139|450552222|FG001|Overall Study|Withdrawal by Subject|3|||
125253078|NCT01390584|450552229|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
125253079|NCT01390584|450552230|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
125253080|NCT01390584|450552231|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
125253081|NCT01835431|450552232|FG000|Overall Study|Adverse Event|1|||
125253082|NCT01835431|450552233|FG001|Overall Study|Adverse Event|0|||
125253083|NCT01835431|450552232|FG000|Overall Study|other|0|||
125253084|NCT01835431|450552233|FG001|Overall Study|other|2|||
125253085|NCT01835431|450552232|FG000|Overall Study|Withdrawal by Subject|6|||
125253086|NCT01835431|450552233|FG001|Overall Study|Withdrawal by Subject|10|||
125253087|NCT01835431|450552232|FG000|Overall Study|Protocol Violation|1|||
125253088|NCT01835431|450552233|FG001|Overall Study|Protocol Violation|0|||
125253089|NCT00655356|450552234|FG000|Overall Study|Withdrawal by Subject|3|||
125253090|NCT00655356|450552235|FG001|Overall Study|Withdrawal by Subject|4|||
125253091|NCT00655356|450552234|FG000|Overall Study|Sponsor Request|10|||
125253092|NCT00655356|450552235|FG001|Overall Study|Sponsor Request|4|||
125253093|NCT00655356|450552234|FG000|Overall Study|Adverse Event|1|||
125253094|NCT00655356|450552235|FG001|Overall Study|Adverse Event|1|||
125253095|NCT00655356|450552234|FG000|Overall Study|Protocol Violation|2|||
125253096|NCT00655356|450552235|FG001|Overall Study|Protocol Violation|1|||
125253097|NCT00655356|450552234|FG000|Overall Study|Other Reason|1|||
125253098|NCT00655356|450552235|FG001|Overall Study|Other Reason|0|||
125253099|NCT04634331|450552236|FG000|Overall Study|Withdrawal by Subject|2|||
125253100|NCT04634331|450552237|FG001|Overall Study|Withdrawal by Subject|2|||
125253101|NCT02496156|450552238|FG000|Overall Study|Lost to Follow-up|5|||
125253102|NCT02496156|450552239|FG001|Overall Study|Lost to Follow-up|0|||
125253103|NCT02496156|450552238|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
125253104|NCT02496156|450552239|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
125253105|NCT03760666|450552240|FG000|Overall Study|Adverse Event|2|||
125253106|NCT03760666|450552241|FG001|Overall Study|Adverse Event|4|||
125253107|NCT03760666|450552242|FG002|Overall Study|Adverse Event|1|||
125253108|NCT03760666|450552240|FG000|Overall Study|AML Disease Progression|3|||
125253109|NCT03760666|450552241|FG001|Overall Study|AML Disease Progression|3|||
125253110|NCT03760666|450552242|FG002|Overall Study|AML Disease Progression|0|||
125253111|NCT03760666|450552240|FG000|Overall Study|Physician Decision|0|||
125253112|NCT03760666|450552241|FG001|Overall Study|Physician Decision|3|||
125253113|NCT03760666|450552242|FG002|Overall Study|Physician Decision|0|||
125253114|NCT03760666|450552240|FG000|Overall Study|Withdrawal by Subject|0|||
125253115|NCT03760666|450552241|FG001|Overall Study|Withdrawal by Subject|1|||
125253116|NCT03760666|450552242|FG002|Overall Study|Withdrawal by Subject|0|||
125253117|NCT04349098|450552243|FG000|Overall Study|Death|16|||
125253118|NCT04349098|450552244|FG001|Overall Study|Death|8|||
125253119|NCT04349098|450552243|FG000|Overall Study|Lost to Follow-up|11|||
125253120|NCT04349098|450552244|FG001|Overall Study|Lost to Follow-up|8|||
125253121|NCT04349098|450552243|FG000|Overall Study|Withdrawal by Subject|8|||
125253122|NCT04349098|450552244|FG001|Overall Study|Withdrawal by Subject|5|||
125253123|NCT04349098|450552243|FG000|Overall Study|Other|3|||
125253124|NCT04349098|450552244|FG001|Overall Study|Other|5|||
125253125|NCT01703221|450552245|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
125253126|NCT01703221|450552246|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
125253127|NCT01703221|450552247|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
125253128|NCT01703221|450552245|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
125253129|NCT01703221|450552246|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
125253130|NCT01703221|450552247|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
125253131|NCT01703221|450552245|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
125253132|NCT01703221|450552246|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
125253133|NCT01703221|450552247|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
125253134|NCT01703221|450552245|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
125253135|NCT01703221|450552246|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
125253136|NCT01703221|450552247|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
125253137|NCT01703221|450552245|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
125253138|NCT01703221|450552246|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
125253139|NCT01703221|450552247|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
125253140|NCT01703221|450552245|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
125253141|NCT01703221|450552246|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
125253142|NCT01703221|450552247|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
125253143|NCT01703221|450552245|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
125253144|NCT01703221|450552246|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
125253145|NCT01703221|450552247|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
125253146|NCT01703221|450552245|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
125253147|NCT01703221|450552246|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
125253148|NCT01703221|450552247|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
125253149|NCT05486065|450552248|FG000|Overall Study|Withdrawal by Subject|1|||
125253150|NCT05486065|450552249|FG001|Overall Study|Withdrawal by Subject|5|||
125253151|NCT05486065|450552250|FG002|Overall Study|Withdrawal by Subject|4|||
125253152|NCT05486065|450552251|FG003|Overall Study|Withdrawal by Subject|3|||
125253153|NCT05486065|450552248|FG000|Overall Study|Lost to Follow-up|4|||
125253154|NCT05486065|450552249|FG001|Overall Study|Lost to Follow-up|2|||
125253155|NCT05486065|450552250|FG002|Overall Study|Lost to Follow-up|2|||
125253156|NCT05486065|450552251|FG003|Overall Study|Lost to Follow-up|2|||
125253157|NCT05486065|450552248|FG000|Overall Study|Physician Decision|0|||
125253158|NCT05486065|450552249|FG001|Overall Study|Physician Decision|1|||
125253159|NCT05486065|450552250|FG002|Overall Study|Physician Decision|1|||
125253160|NCT05486065|450552251|FG003|Overall Study|Physician Decision|0|||
125253161|NCT05486065|450552248|FG000|Overall Study|Failure to meet randomization criteria|0|||
125253162|NCT05486065|450552249|FG001|Overall Study|Failure to meet randomization criteria|0|||
125253163|NCT05486065|450552250|FG002|Overall Study|Failure to meet randomization criteria|0|||
125253164|NCT05486065|450552251|FG003|Overall Study|Failure to meet randomization criteria|1|||
125253165|NCT03878069|450552252|FG000|Overall Study|Death|0|||
125253166|NCT03878069|450552253|FG001|Overall Study|Death|1|||
125253167|NCT03878069|450552254|FG002|Overall Study|Death|0|||
125253168|NCT00834587|450552255|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
125253169|NCT00834587|450552256|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
125253170|NCT00176254|450552257|FG000|Overall Study|Lost to Follow-up|1|||
125253171|NCT03810495|450552258|FG000|Overall Study|Lost to Follow-up|2|||
125253172|NCT03810495|450552258|FG000|Overall Study|Withdrawal by Subject|1|||
125253173|NCT02536339|450552260|FG000|Overall Study|Death|20|||
125253174|NCT02536339|450552260|FG000|Overall Study|Withdrawal by Subject|3|||
125253175|NCT02536339|450552260|FG000|Overall Study|Lost to Follow-up|2|||
125253176|NCT02536339|450552260|FG000|Overall Study|Treatment discontinued|2|||
125253177|NCT02536339|450552260|FG000|Overall Study|Physician Decision|1|||
125253178|NCT03449147|450552261|FG000|52-week Treatment Period|Death|0|||
125253179|NCT03449147|450552262|FG001|52-week Treatment Period|Death|1|||
125253180|NCT03449147|450552263|FG002|52-week Treatment Period|Death|0|||
125253181|NCT03449147|450552261|FG000|52-week Treatment Period|Lost to Follow-up|6|||
125253182|NCT03449147|450552262|FG001|52-week Treatment Period|Lost to Follow-up|2|||
125253183|NCT03449147|450552263|FG002|52-week Treatment Period|Lost to Follow-up|5|||
125253184|NCT03449147|450552261|FG000|52-week Treatment Period|Other|0|||
125253185|NCT03449147|450552262|FG001|52-week Treatment Period|Other|1|||
125253186|NCT03449147|450552263|FG002|52-week Treatment Period|Other|2|||
125253187|NCT03449147|450552261|FG000|52-week Treatment Period|Physician Decision|1|||
125253188|NCT03449147|450552262|FG001|52-week Treatment Period|Physician Decision|0|||
125253189|NCT03449147|450552263|FG002|52-week Treatment Period|Physician Decision|3|||
125253190|NCT03449147|450552261|FG000|52-week Treatment Period|Screen Failure|1|||
125253191|NCT03449147|450552262|FG001|52-week Treatment Period|Screen Failure|2|||
125253192|NCT03449147|450552263|FG002|52-week Treatment Period|Screen Failure|0|||
125253193|NCT03449147|450552261|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
125253194|NCT03449147|450552262|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
125253195|NCT03449147|450552263|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
125253196|NCT03449147|450552261|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
125253197|NCT03449147|450552262|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
125253198|NCT03449147|450552263|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
125253199|NCT03449147|450552261|FG000|12-Week Off-Treatment Durability Period|Other|0|||
125253200|NCT03449147|450552262|FG001|12-Week Off-Treatment Durability Period|Other|1|||
125253201|NCT03449147|450552263|FG002|12-Week Off-Treatment Durability Period|Other|0|||
125253202|NCT02931539|450552266|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
125253203|NCT02931539|450552267|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
125253204|NCT02931539|450552268|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
125253205|NCT02931539|450552266|FG000|Period 1: Treatment Phase|Adverse Event|5|||
125253206|NCT02931539|450552267|FG001|Period 1: Treatment Phase|Adverse Event|1|||
125253207|NCT02931539|450552268|FG002|Period 1: Treatment Phase|Adverse Event|0|||
125253208|NCT02931539|450552266|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
125253209|NCT02931539|450552267|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
125253210|NCT02931539|450552268|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
125253211|NCT02931539|450552266|FG000|Period 1: Treatment Phase|Death|8|||
125253212|NCT02931539|450552267|FG001|Period 1: Treatment Phase|Death|24|||
125253213|NCT02931539|450552268|FG002|Period 1: Treatment Phase|Death|0|||
125253214|NCT02931539|450552266|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
125253215|NCT02931539|450552267|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
125253216|NCT02931539|450552268|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
125253217|NCT02931539|450552266|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
125253218|NCT02931539|450552267|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
125253219|NCT02931539|450552268|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
125253220|NCT02931539|450552266|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
125253221|NCT02931539|450552267|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
125253222|NCT02931539|450552268|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
125253223|NCT02931539|450552266|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
125253224|NCT02931539|450552267|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
125253225|NCT02931539|450552268|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
125253226|NCT02730169|450553678|FG000|Overall Study|Protocol Violation|1|||
125253227|NCT02730169|450553679|FG001|Overall Study|Protocol Violation|0|||
125253228|NCT02730169|450553680|FG002|Overall Study|Protocol Violation|0|||
125253229|NCT02730169|450553681|FG003|Overall Study|Protocol Violation|1|||
125253230|NCT02730169|450553678|FG000|Overall Study|Adverse Event|2|||
125253231|NCT02730169|450553679|FG001|Overall Study|Adverse Event|3|||
125253232|NCT02730169|450553680|FG002|Overall Study|Adverse Event|3|||
125253233|NCT02730169|450553681|FG003|Overall Study|Adverse Event|0|||
125253234|NCT02730169|450553678|FG000|Overall Study|Adverse Event of Special Interest|0|||
125253235|NCT02730169|450553679|FG001|Overall Study|Adverse Event of Special Interest|1|||
125253236|NCT02730169|450553680|FG002|Overall Study|Adverse Event of Special Interest|2|||
125253237|NCT02730169|450553681|FG003|Overall Study|Adverse Event of Special Interest|0|||
125253238|NCT02730169|450553678|FG000|Overall Study|Withdrawal by Subject|6|||
125253239|NCT02730169|450553679|FG001|Overall Study|Withdrawal by Subject|11|||
125253240|NCT02730169|450553680|FG002|Overall Study|Withdrawal by Subject|6|||
125253241|NCT02730169|450553681|FG003|Overall Study|Withdrawal by Subject|8|||
125253242|NCT02730169|450553678|FG000|Overall Study|Lost to Follow-up|5|||
125253243|NCT02730169|450553679|FG001|Overall Study|Lost to Follow-up|6|||
125253244|NCT02730169|450553680|FG002|Overall Study|Lost to Follow-up|5|||
125253245|NCT02730169|450553681|FG003|Overall Study|Lost to Follow-up|6|||
125253246|NCT02730169|450553678|FG000|Overall Study|Other|0|||
125253247|NCT02730169|450553679|FG001|Overall Study|Other|0|||
125253248|NCT02730169|450553680|FG002|Overall Study|Other|1|||
125253249|NCT02730169|450553681|FG003|Overall Study|Other|1|||
125253250|NCT02144337|450553688|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
125253251|NCT02144337|450553689|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
125253252|NCT02144337|450553688|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
125253253|NCT02144337|450553689|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
125253254|NCT02144337|450553688|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
125253255|NCT02144337|450553689|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
125253256|NCT02144337|450553688|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
125253257|NCT02144337|450553689|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
125253258|NCT02144337|450553688|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
125253259|NCT02144337|450553689|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
125253260|NCT01730729|450553690|FG000|Overall Study|Adverse Event|1|||
125253261|NCT01730729|450553690|FG000|Overall Study|Death|1|||
125253262|NCT01730729|450553690|FG000|Overall Study|Progressive Disease|12|||
125253263|NCT00449787|450553691|FG000|Overall Study|Lost to Follow-up|10|||
125253264|NCT00449787|450553692|FG001|Overall Study|Lost to Follow-up|8|||
125253265|NCT00449787|450553691|FG000|Overall Study|Did not require medication|95|||
125253266|NCT00449787|450553692|FG001|Overall Study|Did not require medication|92|||
125253267|NCT03701074|450553693|FG000|Overall Study|Physician Decision|1|||
125253268|NCT03701074|450553694|FG001|Overall Study|Physician Decision|0|||
125253269|NCT03574389|450553698|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
125253270|NCT03574389|450553699|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
125253271|NCT03574389|450553700|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
125253272|NCT03574389|450553701|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
125253273|NCT03574389|450553702|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
125253274|NCT03574389|450553703|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
125253275|NCT03574389|450553704|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
125253276|NCT03574389|450553698|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
125253277|NCT03574389|450553699|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
125253278|NCT03574389|450553700|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
125253279|NCT03574389|450553701|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
125253280|NCT03574389|450553702|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
125253281|NCT03574389|450553703|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
125253282|NCT03574389|450553704|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
125253283|NCT03574389|450553698|FG000|Vaccination Period|Other|6|||
125253284|NCT03574389|450553699|FG001|Vaccination Period|Other|0|||
125253285|NCT03574389|450553700|FG002|Vaccination Period|Other|0|||
125253286|NCT03574389|450553701|FG003|Vaccination Period|Other|0|||
125253287|NCT03574389|450553702|FG004|Vaccination Period|Other|0|||
125253288|NCT03574389|450553703|FG005|Vaccination Period|Other|0|||
125253289|NCT03574389|450553704|FG006|Vaccination Period|Other|0|||
125253290|NCT03574389|450553698|FG000|Vaccination Period|Adverse Event|0|||
125253291|NCT03574389|450553699|FG001|Vaccination Period|Adverse Event|1|||
125253292|NCT03574389|450553700|FG002|Vaccination Period|Adverse Event|0|||
125253293|NCT03574389|450553701|FG003|Vaccination Period|Adverse Event|0|||
125253294|NCT03574389|450553702|FG004|Vaccination Period|Adverse Event|0|||
125253295|NCT03574389|450553703|FG005|Vaccination Period|Adverse Event|0|||
125253296|NCT03574389|450553704|FG006|Vaccination Period|Adverse Event|0|||
125253297|NCT03574389|450553698|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
125253298|NCT03574389|450553699|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
125253299|NCT03574389|450553700|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
125253300|NCT03574389|450553701|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
125253301|NCT03574389|450553702|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
125253302|NCT03574389|450553703|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
125253303|NCT03574389|450553704|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
125253304|NCT01682603|450553705|FG000|Overall Study|Lost to Follow-up|3|||
125253305|NCT00993473|450553706|FG000|Overall Study|Adverse Event|0|||
125253306|NCT00993473|450553707|FG001|Overall Study|Adverse Event|2|||
125253307|NCT00993473|450553706|FG000|Overall Study|Protocol Violation|1|||
125253308|NCT00993473|450553707|FG001|Overall Study|Protocol Violation|2|||
125253309|NCT00993473|450553706|FG000|Overall Study|Lost to Follow-up|1|||
125253310|NCT00993473|450553707|FG001|Overall Study|Lost to Follow-up|0|||
125253311|NCT00993473|450553706|FG000|Overall Study|Withdrawal by Subject|1|||
125253312|NCT00993473|450553707|FG001|Overall Study|Withdrawal by Subject|5|||
125253313|NCT00993473|450553706|FG000|Overall Study|Technical problem with CGM device|0|||
125253314|NCT00993473|450553707|FG001|Overall Study|Technical problem with CGM device|1|||
125253315|NCT00993473|450553706|FG000|Overall Study|Family event|1|||
125253316|NCT00993473|450553707|FG001|Overall Study|Family event|0|||
125253317|NCT03707821|450553708|FG000|Overall Study|Protocol Violation|0|||
125253318|NCT03707821|450553709|FG001|Overall Study|Protocol Violation|1|||
125253319|NCT03707821|450553708|FG000|Overall Study|Unsatisfactory Visual Response|1|||
125253320|NCT03707821|450553709|FG001|Overall Study|Unsatisfactory Visual Response|0|||
125253321|NCT03707821|450553708|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
125253322|NCT03707821|450553709|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
125253323|NCT05122143|450553710|FG000|Overall Study|Adverse Event|1|||
125253324|NCT05122143|450553711|FG001|Overall Study|Adverse Event|0|||
125253325|NCT05122143|450553712|FG002|Overall Study|Adverse Event|0|||
125253326|NCT05122143|450553713|FG003|Overall Study|Adverse Event|0|||
125253327|NCT05122143|450553714|FG004|Overall Study|Adverse Event|1|||
125253328|NCT05122143|450553715|FG005|Overall Study|Adverse Event|0|||
125253329|NCT05122143|450553710|FG000|Overall Study|Protocol non-compliance|0|||
125253330|NCT05122143|450553711|FG001|Overall Study|Protocol non-compliance|0|||
125253331|NCT05122143|450553712|FG002|Overall Study|Protocol non-compliance|1|||
125253332|NCT05122143|450553713|FG003|Overall Study|Protocol non-compliance|0|||
125253333|NCT05122143|450553714|FG004|Overall Study|Protocol non-compliance|0|||
125253334|NCT05122143|450553715|FG005|Overall Study|Protocol non-compliance|0|||
125253335|NCT05122143|450553710|FG000|Overall Study|Covid contact|0|||
125253336|NCT05122143|450553711|FG001|Overall Study|Covid contact|0|||
125253337|NCT05122143|450553712|FG002|Overall Study|Covid contact|0|||
125253338|NCT05122143|450553713|FG003|Overall Study|Covid contact|0|||
125253339|NCT05122143|450553714|FG004|Overall Study|Covid contact|1|||
125253340|NCT05122143|450553715|FG005|Overall Study|Covid contact|0|||
125253341|NCT03766906|450553716|FG000|Overall Study|Withdrawal by Subject|6|||
125253342|NCT02624687|450553717|FG000|Overall Study|Withdrawal by Subject|1|||
125253343|NCT02624687|450553718|FG001|Overall Study|Withdrawal by Subject|1|||
125253344|NCT02624687|450553717|FG000|Overall Study|medical leave from work|0|||
125253345|NCT02624687|450553718|FG001|Overall Study|medical leave from work|1|||
125253346|NCT00552279|450553719|FG000|Overall Study|Adverse Event|0|||
125253347|NCT00552279|450553720|FG001|Overall Study|Adverse Event|1|||
125253348|NCT00552279|450553719|FG000|Overall Study|Withdrawal by Subject|12|||
125253349|NCT00552279|450553720|FG001|Overall Study|Withdrawal by Subject|1|||
125253350|NCT00552279|450553719|FG000|Overall Study|Lost to Follow-up|1|||
125253351|NCT00552279|450553720|FG001|Overall Study|Lost to Follow-up|0|||
125253352|NCT00552279|450553719|FG000|Overall Study|Other|1|||
125253353|NCT00552279|450553720|FG001|Overall Study|Other|1|||
125253354|NCT01651208|450553722|FG000|Overall Study|Lost to Follow-up|14|||
125253355|NCT01651208|450553723|FG001|Overall Study|Lost to Follow-up|16|||
125253356|NCT00836901|450553724|FG000|First Intervention|Withdrawal by Subject|1|||
125253357|NCT00836901|450553725|FG001|First Intervention|Withdrawal by Subject|0|||
125253358|NCT05463952|450553726|FG000|Treatment|Progressive disease|4|||
125253359|NCT05463952|450553726|FG000|Treatment|Ongoing|2|||
125253360|NCT05261490|450553727|FG000|Overall Study|Other|1|||
125253361|NCT05261490|450553728|FG001|Overall Study|Other|0|||
125253362|NCT05261490|450553729|FG002|Overall Study|Other|0|||
125253363|NCT05261490|450553727|FG000|Overall Study|Study Terminated by Sponsor|1|||
125253364|NCT05261490|450553728|FG001|Overall Study|Study Terminated by Sponsor|1|||
125253365|NCT05261490|450553729|FG002|Overall Study|Study Terminated by Sponsor|4|||
125253366|NCT05261490|450553727|FG000|Overall Study|Death|1|||
125253367|NCT05261490|450553728|FG001|Overall Study|Death|2|||
125253368|NCT05261490|450553729|FG002|Overall Study|Death|0|||
125253369|NCT04191733|450553742|FG000|Overall Study|Withdrawn due to study closure|13|||
125253370|NCT04191733|450553743|FG001|Overall Study|Withdrawn due to study closure|14|||
125253371|NCT04191733|450553742|FG000|Overall Study|Withdrawal by Subject|2|||
125253372|NCT04191733|450553743|FG001|Overall Study|Withdrawal by Subject|4|||
125253373|NCT04191733|450553742|FG000|Overall Study|Physician Decision|1|||
125253374|NCT04191733|450553743|FG001|Overall Study|Physician Decision|1|||
125253375|NCT04191733|450553742|FG000|Overall Study|Lost to Follow-up|5|||
125253376|NCT04191733|450553743|FG001|Overall Study|Lost to Follow-up|6|||
125253377|NCT04191733|450553742|FG000|Overall Study|Death|0|||
125253378|NCT04191733|450553743|FG001|Overall Study|Death|1|||
125253379|NCT01714063|450553749|FG000|Overall Study|Equipment malfunction|2|||
125253380|NCT01646216|450553750|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
125253381|NCT01646216|450553751|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
125253382|NCT01646216|450553750|FG000|Overall Study|Did not complete training|0|||
125253383|NCT01646216|450553751|FG001|Overall Study|Did not complete training|2|||
125253384|NCT01646216|450553750|FG000|Overall Study|Investigator decision|1|||
125253385|NCT01646216|450553751|FG001|Overall Study|Investigator decision|1|||
125253386|NCT02633527|450553752|FG000|Overall Study|Failed to meet eligibility|0|||
125253387|NCT02633527|450553753|FG001|Overall Study|Failed to meet eligibility|1|||
125253388|NCT02633527|450553754|FG002|Overall Study|Failed to meet eligibility|1|||
125253389|NCT02633527|450553755|FG003|Overall Study|Failed to meet eligibility|0|||
125253390|NCT02633527|450553756|FG004|Overall Study|Failed to meet eligibility|1|||
125253391|NCT02633527|450553752|FG000|Overall Study|Adverse Event|0|||
125253392|NCT02633527|450553753|FG001|Overall Study|Adverse Event|4|||
125253393|NCT02633527|450553754|FG002|Overall Study|Adverse Event|3|||
125253394|NCT02633527|450553755|FG003|Overall Study|Adverse Event|1|||
125253395|NCT02633527|450553756|FG004|Overall Study|Adverse Event|5|||
125253396|NCT02633527|450553752|FG000|Overall Study|Lost to Follow-up|1|||
125253397|NCT02633527|450553753|FG001|Overall Study|Lost to Follow-up|2|||
125253398|NCT02633527|450553754|FG002|Overall Study|Lost to Follow-up|5|||
125253399|NCT02633527|450553755|FG003|Overall Study|Lost to Follow-up|5|||
125253400|NCT02633527|450553756|FG004|Overall Study|Lost to Follow-up|4|||
125253401|NCT02633527|450553752|FG000|Overall Study|Withdrawal by Subject|0|||
125253402|NCT02633527|450553753|FG001|Overall Study|Withdrawal by Subject|3|||
125253403|NCT02633527|450553754|FG002|Overall Study|Withdrawal by Subject|5|||
125253404|NCT02633527|450553755|FG003|Overall Study|Withdrawal by Subject|4|||
125253405|NCT02633527|450553756|FG004|Overall Study|Withdrawal by Subject|4|||
125253406|NCT02633527|450553752|FG000|Overall Study|Protocol Violation|0|||
125253407|NCT02633527|450553753|FG001|Overall Study|Protocol Violation|1|||
125253408|NCT02633527|450553754|FG002|Overall Study|Protocol Violation|1|||
125253409|NCT02633527|450553755|FG003|Overall Study|Protocol Violation|1|||
125253410|NCT02633527|450553756|FG004|Overall Study|Protocol Violation|1|||
125253411|NCT02633527|450553752|FG000|Overall Study|Physician Decision|0|||
125253412|NCT02633527|450553753|FG001|Overall Study|Physician Decision|0|||
125253413|NCT02633527|450553754|FG002|Overall Study|Physician Decision|0|||
125253414|NCT02633527|450553755|FG003|Overall Study|Physician Decision|0|||
125253415|NCT02633527|450553756|FG004|Overall Study|Physician Decision|1|||
125253416|NCT02633527|450553752|FG000|Overall Study|Administrative reason|1|||
125253417|NCT02633527|450553753|FG001|Overall Study|Administrative reason|0|||
125253418|NCT02633527|450553754|FG002|Overall Study|Administrative reason|0|||
125253419|NCT02633527|450553755|FG003|Overall Study|Administrative reason|1|||
125253420|NCT02633527|450553756|FG004|Overall Study|Administrative reason|0|||
125253421|NCT02633527|450553752|FG000|Overall Study|Multiple reasons|1|||
125253422|NCT02633527|450553753|FG001|Overall Study|Multiple reasons|0|||
125253423|NCT02633527|450553754|FG002|Overall Study|Multiple reasons|2|||
125253424|NCT02633527|450553755|FG003|Overall Study|Multiple reasons|2|||
125253425|NCT02633527|450553756|FG004|Overall Study|Multiple reasons|1|||
125253426|NCT01681849|450553759|FG000|Overall Study|Protocol Violation|2|||
125253427|NCT01681849|450553760|FG001|Overall Study|Protocol Violation|0|||
125253428|NCT01681849|450553761|FG002|Overall Study|Protocol Violation|0|||
125253429|NCT01681849|450553759|FG000|Overall Study|Withdrawal by Subject|3|||
125253430|NCT01681849|450553760|FG001|Overall Study|Withdrawal by Subject|5|||
125253431|NCT01681849|450553761|FG002|Overall Study|Withdrawal by Subject|33|||
125253432|NCT01681849|450553759|FG000|Overall Study|Lost to Follow-up|3|||
125253433|NCT01681849|450553760|FG001|Overall Study|Lost to Follow-up|2|||
125253434|NCT01681849|450553761|FG002|Overall Study|Lost to Follow-up|6|||
125253435|NCT02420314|450553764|FG000|Overall Study|Withdrawal by Subject|1|||
125253436|NCT02420314|450553764|FG000|Overall Study|Protocol Violation|1|||
125253437|NCT03760068|450553765|FG000|Overall Study|Withdrawal by Subject|7|||
125253438|NCT03760068|450553766|FG001|Overall Study|Withdrawal by Subject|8|||
125253439|NCT03760068|450553765|FG000|Overall Study|Adverse Event|1|||
125253440|NCT03760068|450553766|FG001|Overall Study|Adverse Event|2|||
125253441|NCT03760068|450553765|FG000|Overall Study|Administrative Decision by Sponsor|0|||
125253442|NCT03760068|450553766|FG001|Overall Study|Administrative Decision by Sponsor|2|||
125253443|NCT03760068|450553765|FG000|Overall Study|Physician Decision|1|||
125253444|NCT03760068|450553766|FG001|Overall Study|Physician Decision|2|||
125253445|NCT03760068|450553765|FG000|Overall Study|Lost to Follow-up|4|||
125253446|NCT03760068|450553766|FG001|Overall Study|Lost to Follow-up|9|||
125253447|NCT03760068|450553765|FG000|Overall Study|Subject Moved Out of State|1|||
125253448|NCT03760068|450553766|FG001|Overall Study|Subject Moved Out of State|0|||
125253449|NCT03460704|450553770|FG000|Overall Study|Withdrawal by Subject|11|||
125253450|NCT03460704|450553771|FG001|Overall Study|Withdrawal by Subject|14|||
125253451|NCT03460704|450553770|FG000|Overall Study|Study terminated by the Sponsor|29|||
125253452|NCT03460704|450553771|FG001|Overall Study|Study terminated by the Sponsor|19|||
125253453|NCT03460704|450553770|FG000|Overall Study|Adverse Event|10|||
125253454|NCT03460704|450553771|FG001|Overall Study|Adverse Event|5|||
125253455|NCT03460704|450553770|FG000|Overall Study|Death|3|||
125253456|NCT03460704|450553771|FG001|Overall Study|Death|2|||
125253457|NCT03460704|450553770|FG000|Overall Study|Non-Compliance with Study Drug|3|||
125253458|NCT03460704|450553771|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125253459|NCT03460704|450553770|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125253460|NCT03460704|450553771|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
125253461|NCT03460704|450553770|FG000|Overall Study|Other|2|||
125253462|NCT03460704|450553771|FG001|Overall Study|Other|1|||
125253463|NCT02913326|450553776|FG000|Overall Study|Reason not listed|0|||
125253464|NCT02913326|450553777|FG001|Overall Study|Reason not listed|1|||
125253465|NCT02913326|450553776|FG000|Overall Study|Lost to Follow-up|0|||
125253466|NCT02913326|450553777|FG001|Overall Study|Lost to Follow-up|1|||
125253467|NCT02913326|450553776|FG000|Overall Study|Adverse Event|1|||
125253468|NCT02913326|450553777|FG001|Overall Study|Adverse Event|0|||
125253469|NCT01767857|450553778|FG000|Overall Study|Adverse Event|27|||
125253470|NCT01767857|450553779|FG001|Overall Study|Adverse Event|7|||
125253471|NCT01767857|450553778|FG000|Overall Study|Death|28|||
125253472|NCT01767857|450553779|FG001|Overall Study|Death|13|||
125253473|NCT01767857|450553778|FG000|Overall Study|Lack of Efficacy|299|||
125253474|NCT01767857|450553779|FG001|Overall Study|Lack of Efficacy|151|||
125253475|NCT01767857|450553778|FG000|Overall Study|Lost to Follow-up|1|||
125253476|NCT01767857|450553779|FG001|Overall Study|Lost to Follow-up|1|||
125253477|NCT01767857|450553778|FG000|Overall Study|Withdrawal by Subject|38|||
125253478|NCT01767857|450553779|FG001|Overall Study|Withdrawal by Subject|18|||
125253479|NCT01767857|450553778|FG000|Overall Study|Physician Decision|17|||
125253480|NCT01767857|450553779|FG001|Overall Study|Physician Decision|10|||
125253481|NCT01767857|450553778|FG000|Overall Study|Protocol Terminated|1|||
125253482|NCT01767857|450553779|FG001|Overall Study|Protocol Terminated|0|||
125253483|NCT01767857|450553778|FG000|Overall Study|Randomized But Never Treated|19|||
125253484|NCT01767857|450553779|FG001|Overall Study|Randomized But Never Treated|13|||
125253485|NCT04126174|450553780|FG000|Overall Study|Lost to Follow-up|3|||
125253486|NCT04126174|450553781|FG001|Overall Study|Lost to Follow-up|3|||
125253487|NCT01514422|450553784|FG000|Overall Study|Lost to Follow-up|1|||
125253488|NCT00420056|450553797|FG000|Overall Study|Objective progression or relapse|17|||
125253489|NCT01044459|450553806|FG000|Overall Study|Withdrawal by Subject|21|||
125253490|NCT01044459|450553807|FG001|Overall Study|Withdrawal by Subject|28|||
125253491|NCT01044459|450553806|FG000|Overall Study|Terminated by Sponsor|22|||
125253492|NCT01044459|450553807|FG001|Overall Study|Terminated by Sponsor|21|||
125253493|NCT01044459|450553806|FG000|Overall Study|Adverse Event|22|||
125253494|NCT01044459|450553807|FG001|Overall Study|Adverse Event|20|||
125253495|NCT01044459|450553806|FG000|Overall Study|Lack of Efficacy|23|||
125253496|NCT01044459|450553807|FG001|Overall Study|Lack of Efficacy|12|||
125253497|NCT01044459|450553806|FG000|Overall Study|Protocol Violation|11|||
125253498|NCT01044459|450553807|FG001|Overall Study|Protocol Violation|16|||
125253499|NCT01044459|450553806|FG000|Overall Study|Other Reason|7|||
125253500|NCT01044459|450553807|FG001|Overall Study|Other Reason|14|||
125253501|NCT01044459|450553806|FG000|Overall Study|COPD exacerbation|9|||
125253502|NCT01044459|450553807|FG001|Overall Study|COPD exacerbation|8|||
125253503|NCT01044459|450553806|FG000|Overall Study|Lost to Follow-up|18|||
125253504|NCT01044459|450553807|FG001|Overall Study|Lost to Follow-up|12|||
125253505|NCT04105725|450553808|FG000|Primary Intervention|Lost to Follow-up|0|||
125253506|NCT04105725|450553809|FG001|Primary Intervention|Lost to Follow-up|2|||
125253507|NCT04105725|450553808|FG000|Primary Intervention|Withdrawal by Subject|0|||
125253508|NCT04105725|450553809|FG001|Primary Intervention|Withdrawal by Subject|1|||
125253509|NCT00480025|450553810|FG000|Overall Study|Protocol Violation|12|||
125253510|NCT00480025|450553811|FG001|Overall Study|Protocol Violation|7|||
125253511|NCT00480025|450553810|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
125253512|NCT00480025|450553811|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
125253513|NCT00480025|450553810|FG000|Overall Study|Disease Progression / Recurrence|449|||
125253514|NCT00480025|450553811|FG001|Overall Study|Disease Progression / Recurrence|224|||
125253515|NCT00480025|450553810|FG000|Overall Study|Adverse Event|44|||
125253516|NCT00480025|450553811|FG001|Overall Study|Adverse Event|12|||
125253517|NCT00480025|450553810|FG000|Overall Study|Other|70|||
125253518|NCT00480025|450553811|FG001|Overall Study|Other|29|||
125253519|NCT00480025|450553810|FG000|Overall Study|SAE including intercurrent illness|76|||
125253520|NCT00480025|450553811|FG001|Overall Study|SAE including intercurrent illness|42|||
125253521|NCT03726879|450553816|FG000|Overall Study|Death|11|||
125253522|NCT03726879|450553817|FG001|Overall Study|Death|13|||
125253523|NCT03726879|450553816|FG000|Overall Study|Physician Decision|0|||
125253524|NCT03726879|450553817|FG001|Overall Study|Physician Decision|2|||
125253525|NCT03726879|450553816|FG000|Overall Study|Protocol Violation|0|||
125253526|NCT03726879|450553817|FG001|Overall Study|Protocol Violation|1|||
125253527|NCT03726879|450553816|FG000|Overall Study|Withdrawal by Subject|5|||
125253528|NCT03726879|450553817|FG001|Overall Study|Withdrawal by Subject|6|||
125253529|NCT03726879|450553816|FG000|Overall Study|TSH result is unstable|0|||
125253530|NCT03726879|450553817|FG001|Overall Study|TSH result is unstable|1|||
125253531|NCT03726879|450553816|FG000|Overall Study|Disease relapse|1|||
125253532|NCT03726879|450553817|FG001|Overall Study|Disease relapse|0|||
125253533|NCT03726879|450553816|FG000|Overall Study|Lost to Follow-up|3|||
125253534|NCT03726879|450553817|FG001|Overall Study|Lost to Follow-up|0|||
125253535|NCT02766478|450553818|FG000|Overall Study|Withdrawal by Subject|1|||
125253536|NCT02766478|450553819|FG001|Overall Study|Withdrawal by Subject|1|||
125253537|NCT05626686|450553820|FG000|Overall Study|Protocol Violation|3|||
125253538|NCT05626686|450553820|FG000|Overall Study|Withdrawal by Subject|3|||
125253539|NCT01093573|450553821|FG000|Overall Study|Physician Decision|0|||
125253540|NCT01093573|450553822|FG001|Overall Study|Physician Decision|0|||
125253541|NCT01093573|450553823|FG002|Overall Study|Physician Decision|1|||
125253542|NCT01093573|450553821|FG000|Overall Study|Insurance Denied|0|||
125253543|NCT01093573|450553822|FG001|Overall Study|Insurance Denied|0|||
125253544|NCT01093573|450553823|FG002|Overall Study|Insurance Denied|1|||
125253545|NCT02457546|450555474|FG000|Overall Study|Other reasons|4|||
125253546|NCT02457546|450555475|FG001|Overall Study|Other reasons|1|||
125253547|NCT02457546|450555474|FG000|Overall Study|Refused to complete study/procedures|1|||
125253548|NCT02457546|450555475|FG001|Overall Study|Refused to complete study/procedures|1|||
125253549|NCT02457546|450555474|FG000|Overall Study|Lost to Follow-up|4|||
125253550|NCT02457546|450555475|FG001|Overall Study|Lost to Follow-up|1|||
125253551|NCT02457546|450555474|FG000|Overall Study|Adverse Event|0|||
125253552|NCT02457546|450555475|FG001|Overall Study|Adverse Event|1|||
125253553|NCT05069415|450555476|FG000|Overall Study|Withdrawal by Subject|2|||
125253554|NCT05069415|450555477|FG001|Overall Study|Withdrawal by Subject|0|||
125253555|NCT05069415|450555476|FG000|Overall Study|Adverse Event|2|||
125253556|NCT05069415|450555477|FG001|Overall Study|Adverse Event|0|||
125253557|NCT00203242|450555480|FG000|Overall Study|Lost to Follow-up|1|||
125253558|NCT00866775|450555481|FG000|Overall Study|Adverse Event|5|||
125253559|NCT00866775|450555482|FG001|Overall Study|Adverse Event|19|||
125253560|NCT00866775|450555481|FG000|Overall Study|Death|1|||
125253561|NCT00866775|450555482|FG001|Overall Study|Death|0|||
125253562|NCT00866775|450555481|FG000|Overall Study|Lost to Follow-up|0|||
125253563|NCT00866775|450555482|FG001|Overall Study|Lost to Follow-up|4|||
125253564|NCT00866775|450555481|FG000|Overall Study|Physician Decision|0|||
125253565|NCT00866775|450555482|FG001|Overall Study|Physician Decision|3|||
125253566|NCT00866775|450555481|FG000|Overall Study|Protocol Violation|3|||
125253567|NCT00866775|450555482|FG001|Overall Study|Protocol Violation|4|||
125253568|NCT00866775|450555481|FG000|Overall Study|Withdrawal by Subject|4|||
125253569|NCT00866775|450555482|FG001|Overall Study|Withdrawal by Subject|4|||
125253570|NCT00866775|450555481|FG000|Overall Study|met exit criteria|23|||
125253571|NCT00866775|450555482|FG001|Overall Study|met exit criteria|17|||
125253572|NCT00866775|450555481|FG000|Overall Study|discontinued due to communication error|0|||
125253573|NCT00866775|450555482|FG001|Overall Study|discontinued due to communication error|1|||
125253574|NCT01500135|450555483|FG000|Overall Study|Withdrawal of Consent|4|||
125253575|NCT01500135|450555484|FG001|Overall Study|Withdrawal of Consent|0|||
125253576|NCT01500135|450555483|FG000|Overall Study|Lost to Follow-up|6|||
125253577|NCT01500135|450555484|FG001|Overall Study|Lost to Follow-up|4|||
125253578|NCT01500135|450555483|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
125253579|NCT01500135|450555484|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
125253580|NCT01500135|450555483|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
125253581|NCT01500135|450555484|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
125253582|NCT01500135|450555483|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
125253583|NCT01500135|450555484|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
125253584|NCT01500135|450555483|FG000|Overall Study|Participant was a Safety Concern|1|||
125253585|NCT01500135|450555484|FG001|Overall Study|Participant was a Safety Concern|0|||
125253586|NCT01500135|450555483|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
125253587|NCT01500135|450555484|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
125253588|NCT01661595|450555485|FG000|Phase 1: Week 0-4|Adverse Event|1|||
125253589|NCT01661595|450555486|FG001|Phase 1: Week 0-4|Adverse Event|0|||
125253590|NCT01661595|450555487|FG002|Phase 1: Week 0-4|Adverse Event|0|||
125253591|NCT01661595|450555488|FG003|Phase 1: Week 0-4|Adverse Event|0|||
125253592|NCT01661595|450555485|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
125253593|NCT01661595|450555486|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
125253594|NCT01661595|450555487|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
125253595|NCT01661595|450555488|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
125253596|NCT00912509|450555489|FG000|Overall Study|Lost to Follow-up|1|||
125253597|NCT00912509|450555490|FG001|Overall Study|Lost to Follow-up|0|||
125253598|NCT00912509|450555489|FG000|Overall Study|Lack of Efficacy|4|||
125253599|NCT00912509|450555490|FG001|Overall Study|Lack of Efficacy|3|||
125253600|NCT03439072|450555491|FG000|Overall Study|Withdrawal by Subject|2|||
125253601|NCT03439072|450555492|FG001|Overall Study|Withdrawal by Subject|3|||
125253602|NCT03439072|450555491|FG000|Overall Study|Physician Decision|0|||
125253603|NCT03439072|450555492|FG001|Overall Study|Physician Decision|1|||
125253604|NCT01537432|450555494|FG000|Overall Study|Lost to Follow-up|3|||
125253605|NCT01537432|450555495|FG001|Overall Study|Lost to Follow-up|1|||
125253606|NCT01537432|450555494|FG000|Overall Study|Withdrawal by Subject|0|||
125253607|NCT01537432|450555495|FG001|Overall Study|Withdrawal by Subject|1|||
125253608|NCT01537432|450555494|FG000|Overall Study|Administrative problems|1|||
125253609|NCT01537432|450555495|FG001|Overall Study|Administrative problems|0|||
125253610|NCT01537432|450555494|FG000|Overall Study|Adverse Event|1|||
125253611|NCT01537432|450555495|FG001|Overall Study|Adverse Event|0|||
125253612|NCT01537432|450555494|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125253613|NCT01537432|450555495|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125253614|NCT05166902|450555496|FG000|First Intervention|Lost to Follow-up|0|||
125253615|NCT05166902|450555497|FG001|First Intervention|Lost to Follow-up|1|||
125253616|NCT01998477|450555498|FG000|Overall Study|Lost to Follow-up|4|||
125253617|NCT01998477|450555499|FG001|Overall Study|Lost to Follow-up|5|||
125253618|NCT01998477|450555498|FG000|Overall Study|Withdrawal by Subject|6|||
125253619|NCT01998477|450555499|FG001|Overall Study|Withdrawal by Subject|0|||
125253620|NCT00779909|450555500|FG000|Overall Study|Lost to Follow-up|1|||
125253621|NCT00779909|450555501|FG001|Overall Study|Lost to Follow-up|0|||
125253622|NCT00779909|450555502|FG002|Overall Study|Lost to Follow-up|0|||
125253623|NCT00779909|450555503|FG003|Overall Study|Lost to Follow-up|1|||
125253624|NCT00779909|450555500|FG000|Overall Study|Withdrawal by Subject|0|||
125253625|NCT00779909|450555501|FG001|Overall Study|Withdrawal by Subject|1|||
125253626|NCT00779909|450555502|FG002|Overall Study|Withdrawal by Subject|0|||
125253627|NCT00779909|450555503|FG003|Overall Study|Withdrawal by Subject|0|||
125253628|NCT03523585|450555504|FG000|Overall Study|Progressive Disease|174|||
125253629|NCT03523585|450555505|FG001|Overall Study|Progressive Disease|64|||
125253630|NCT03523585|450555506|FG002|Overall Study|Progressive Disease|77|||
125253631|NCT03523585|450555504|FG000|Overall Study|Adverse Event|74|||
125253632|NCT03523585|450555505|FG001|Overall Study|Adverse Event|5|||
125253633|NCT03523585|450555506|FG002|Overall Study|Adverse Event|9|||
125253634|NCT03523585|450555504|FG000|Overall Study|Withdrawal by Subject|30|||
125253635|NCT03523585|450555505|FG001|Overall Study|Withdrawal by Subject|11|||
125253636|NCT03523585|450555506|FG002|Overall Study|Withdrawal by Subject|6|||
125253637|NCT03523585|450555504|FG000|Overall Study|Clinical Progression|23|||
125253638|NCT03523585|450555505|FG001|Overall Study|Clinical Progression|5|||
125253639|NCT03523585|450555506|FG002|Overall Study|Clinical Progression|10|||
125253640|NCT03523585|450555504|FG000|Overall Study|Death|4|||
125253641|NCT03523585|450555505|FG001|Overall Study|Death|0|||
125253642|NCT03523585|450555506|FG002|Overall Study|Death|1|||
125253643|NCT03523585|450555504|FG000|Overall Study|Physician Decision|2|||
125253644|NCT03523585|450555505|FG001|Overall Study|Physician Decision|1|||
125253645|NCT03523585|450555506|FG002|Overall Study|Physician Decision|0|||
125253646|NCT03523585|450555504|FG000|Overall Study|Lost to Follow-up|1|||
125253647|NCT03523585|450555505|FG001|Overall Study|Lost to Follow-up|0|||
125253648|NCT03523585|450555506|FG002|Overall Study|Lost to Follow-up|0|||
125253649|NCT03523585|450555504|FG000|Overall Study|Miscellaneous|1|||
125253650|NCT03523585|450555505|FG001|Overall Study|Miscellaneous|0|||
125253651|NCT03523585|450555506|FG002|Overall Study|Miscellaneous|0|||
125253652|NCT03523585|450555504|FG000|Overall Study|Protocol Deviation|1|||
125253653|NCT03523585|450555505|FG001|Overall Study|Protocol Deviation|0|||
125253654|NCT03523585|450555506|FG002|Overall Study|Protocol Deviation|1|||
125253655|NCT03523585|450555504|FG000|Overall Study|Randomized But Not Treated|2|||
125253656|NCT03523585|450555505|FG001|Overall Study|Randomized But Not Treated|4|||
125253657|NCT03523585|450555506|FG002|Overall Study|Randomized But Not Treated|3|||
125253658|NCT05345405|450555507|FG000|Overall Study|Withdrawal by Subject|2|||
125253659|NCT05345405|450555508|FG001|Overall Study|Withdrawal by Subject|0|||
125253660|NCT05345405|450555509|FG002|Overall Study|Withdrawal by Subject|0|||
125253661|NCT05345405|450555507|FG000|Overall Study|Did not meet eligibility criteria|0|||
125253662|NCT05345405|450555508|FG001|Overall Study|Did not meet eligibility criteria|2|||
125253663|NCT05345405|450555509|FG002|Overall Study|Did not meet eligibility criteria|0|||
125253664|NCT05345405|450555507|FG000|Overall Study|Lost to Follow-up|0|||
125253665|NCT05345405|450555508|FG001|Overall Study|Lost to Follow-up|0|||
125253666|NCT05345405|450555509|FG002|Overall Study|Lost to Follow-up|1|||
125253667|NCT02872142|450555519|FG000|Overall Study|Adverse Event|2|||
125253668|NCT02872142|450555519|FG000|Overall Study|Death|1|||
125253669|NCT02872142|450555519|FG000|Overall Study|Participant Decision|3|||
125253670|NCT01903720|450555520|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
125253671|NCT01903720|450555520|FG000|Overall Study|Adverse Event|1|||
125253672|NCT01903720|450555520|FG000|Overall Study|Rescinding of informed consent|2|||
125253673|NCT01903720|450555520|FG000|Overall Study|Lost to Follow-up|2|||
125253674|NCT01903720|450555520|FG000|Overall Study|Treatment with alternative drug|1|||
125253675|NCT02244957|450555521|FG000|Overall Study|Lack of Efficacy|1|||
125253676|NCT02244957|450555522|FG001|Overall Study|Lack of Efficacy|0|||
125253677|NCT02150863|450555523|FG000|Overall Study|Lost to Follow-up|0|||
125253678|NCT02150863|450555524|FG001|Overall Study|Lost to Follow-up|1|||
125253679|NCT02150863|450555525|FG002|Overall Study|Lost to Follow-up|0|||
125253680|NCT00830336|450555526|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
125253681|NCT00830336|450555527|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
125253682|NCT01853280|450555534|FG000|Overall Study|Lack of Efficacy|2|||
125253683|NCT01853280|450555535|FG001|Overall Study|Lack of Efficacy|2|||
125253684|NCT01853280|450555534|FG000|Overall Study|Lost to Follow-up|0|||
125253685|NCT01853280|450555535|FG001|Overall Study|Lost to Follow-up|1|||
125253686|NCT01853280|450555534|FG000|Overall Study|Physician Decision|0|||
125253687|NCT01853280|450555535|FG001|Overall Study|Physician Decision|1|||
125253688|NCT01853280|450555534|FG000|Overall Study|Withdrawal by Subject|0|||
125253689|NCT01853280|450555535|FG001|Overall Study|Withdrawal by Subject|1|||
125253690|NCT01853280|450555534|FG000|Overall Study|Ineligible|0|||
125253691|NCT01853280|450555535|FG001|Overall Study|Ineligible|1|||
125253692|NCT00104884|450555536|FG000|Overall Study|Disease progression|4|||
125253693|NCT03032484|450555537|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
125253694|NCT03032484|450555538|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
125253695|NCT03032484|450555537|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
125253696|NCT03032484|450555538|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
125253697|NCT01229111|450555539|FG000|Overall Study|Death|1|||
125253698|NCT01689649|450555542|FG000|Overall Study|Lack of Efficacy|3|||
125253699|NCT01689649|450555542|FG000|Overall Study|Non-compliance|11|||
125253700|NCT01689649|450555542|FG000|Overall Study|Protocol Violation|3|||
125253701|NCT01689649|450555542|FG000|Overall Study|Lost to Follow-up|5|||
125253702|NCT04893811|450555543|FG000|Vaccination Phase|Death|1|||
125253703|NCT04893811|450555544|FG001|Vaccination Phase|Death|0|||
125253704|NCT04893811|450555543|FG000|Vaccination Phase|Lost to Follow-up|1|||
125253705|NCT04893811|450555544|FG001|Vaccination Phase|Lost to Follow-up|1|||
125253706|NCT04893811|450555543|FG000|Vaccination Phase|Protocol Violation|2|||
125253707|NCT04893811|450555544|FG001|Vaccination Phase|Protocol Violation|0|||
125253708|NCT04893811|450555543|FG000|Vaccination Phase|Withdrawal by Subject|2|||
125253709|NCT04893811|450555544|FG001|Vaccination Phase|Withdrawal by Subject|1|||
125253710|NCT04893811|450555543|FG000|Vaccination Phase|Other|0|||
125253711|NCT04893811|450555544|FG001|Vaccination Phase|Other|1|||
125253712|NCT04893811|450555543|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
125253713|NCT04893811|450555544|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
125253714|NCT04893811|450555543|FG000|Follow-up Phase|Lost to Follow-up|0|||
125253715|NCT04893811|450555544|FG001|Follow-up Phase|Lost to Follow-up|1|||
125253716|NCT03268499|450555545|FG000|Overall Study|Withdrawal by Subject|2|||
125253717|NCT03268499|450555546|FG001|Overall Study|Withdrawal by Subject|1|||
125253718|NCT03760081|450555550|FG000|Overall Study|Miscellaneous|0|||
125253719|NCT03760081|450555551|FG001|Overall Study|Miscellaneous|1|||
125253720|NCT03760081|450555550|FG000|Overall Study|Progressive Disease|5|||
125253721|NCT03760081|450555551|FG001|Overall Study|Progressive Disease|10|||
125253722|NCT03760081|450555550|FG000|Overall Study|Death|1|||
125253723|NCT03760081|450555551|FG001|Overall Study|Death|1|||
125253724|NCT03533491|450555552|FG000|Overall Study|Lost to Follow-up|2|||
125253725|NCT01725282|450555558|FG000|Overall Study|Adverse Event|1|||
125253726|NCT01725282|450555559|FG001|Overall Study|Adverse Event|3|||
125253727|NCT01725282|450555560|FG002|Overall Study|Adverse Event|6|||
125253728|NCT01725282|450555561|FG003|Overall Study|Adverse Event|4|||
125253729|NCT01725282|450555558|FG000|Overall Study|Exacerbation of Target Disease|1|||
125253730|NCT01725282|450555559|FG001|Overall Study|Exacerbation of Target Disease|0|||
125253731|NCT01725282|450555560|FG002|Overall Study|Exacerbation of Target Disease|0|||
125253732|NCT01725282|450555561|FG003|Overall Study|Exacerbation of Target Disease|1|||
125253733|NCT01725282|450555558|FG000|Overall Study|Met Exclusion Criteria|0|||
125253734|NCT01725282|450555559|FG001|Overall Study|Met Exclusion Criteria|0|||
125253735|NCT01725282|450555560|FG002|Overall Study|Met Exclusion Criteria|1|||
125253736|NCT01725282|450555561|FG003|Overall Study|Met Exclusion Criteria|0|||
125253737|NCT01725282|450555558|FG000|Overall Study|Study Site Withdrawal|0|||
125253738|NCT01725282|450555559|FG001|Overall Study|Study Site Withdrawal|1|||
125253739|NCT01725282|450555560|FG002|Overall Study|Study Site Withdrawal|0|||
125253740|NCT01725282|450555561|FG003|Overall Study|Study Site Withdrawal|0|||
125253741|NCT01725282|450555558|FG000|Overall Study|Withdrawal by Subject|0|||
125253742|NCT01725282|450555559|FG001|Overall Study|Withdrawal by Subject|0|||
125253743|NCT01725282|450555560|FG002|Overall Study|Withdrawal by Subject|1|||
125253744|NCT01725282|450555561|FG003|Overall Study|Withdrawal by Subject|1|||
125253745|NCT01725282|450555558|FG000|Overall Study|Lack of Efficacy|0|||
125253746|NCT01725282|450555559|FG001|Overall Study|Lack of Efficacy|1|||
125253747|NCT01725282|450555560|FG002|Overall Study|Lack of Efficacy|0|||
125253748|NCT01725282|450555561|FG003|Overall Study|Lack of Efficacy|1|||
125253749|NCT04064567|450555562|FG000|Overall Study|Lost to Follow-up|23|||
125253750|NCT04064567|450555563|FG001|Overall Study|Lost to Follow-up|22|||
125253751|NCT04064567|450555562|FG000|Overall Study|Withdrawal by Subject|0|||
125253752|NCT04064567|450555563|FG001|Overall Study|Withdrawal by Subject|1|||
125253753|NCT04064567|450555562|FG000|Overall Study|Reincarcerated|7|||
125253754|NCT04064567|450555563|FG001|Overall Study|Reincarcerated|10|||
125253755|NCT04064567|450555562|FG000|Overall Study|Moved out of U.S.|0|||
125253756|NCT04064567|450555563|FG001|Overall Study|Moved out of U.S.|1|||
125253757|NCT04576481|450555564|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
125253758|NCT04576481|450555565|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
125253759|NCT04576481|450555566|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
125253760|NCT04576481|450555567|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
125253761|NCT00595075|450555569|FG000|Overall Study|Withdrawal by Subject|1|||
125253762|NCT00595075|450555570|FG001|Overall Study|Withdrawal by Subject|0|||
125253763|NCT01946880|450555571|FG000|Overall Study|Lost to Follow-up|1|||
125253764|NCT01946880|450555572|FG001|Overall Study|Lost to Follow-up|0|||
125253765|NCT01946880|450555571|FG000|Overall Study|Physician Decision|1|||
125253766|NCT01946880|450555572|FG001|Overall Study|Physician Decision|1|||
125253767|NCT01946880|450555571|FG000|Overall Study|Withdrawal by Subject|3|||
125253768|NCT01946880|450555572|FG001|Overall Study|Withdrawal by Subject|2|||
125253769|NCT01946880|450555571|FG000|Overall Study|Met Primary Endpoint|1|||
125253770|NCT01946880|450555572|FG001|Overall Study|Met Primary Endpoint|0|||
125253771|NCT01946880|450555571|FG000|Overall Study|Personal and Family Issues|1|||
125253772|NCT01946880|450555572|FG001|Overall Study|Personal and Family Issues|0|||
125253773|NCT01682720|450555575|FG000|Overall Study|Randomized but Not Treated|0|||
125253774|NCT01682720|450555576|FG001|Overall Study|Randomized but Not Treated|1|||
125253775|NCT01682720|450555577|FG002|Overall Study|Randomized but Not Treated|1|||
125253776|NCT01682720|450555578|FG003|Overall Study|Randomized but Not Treated|0|||
125253777|NCT01682720|450555575|FG000|Overall Study|Terminated by Sponsor|83|||
125253778|NCT01682720|450555576|FG001|Overall Study|Terminated by Sponsor|0|||
125253779|NCT01682720|450555577|FG002|Overall Study|Terminated by Sponsor|0|||
125253780|NCT01682720|450555578|FG003|Overall Study|Terminated by Sponsor|0|||
125253781|NCT01682720|450555575|FG000|Overall Study|Efficacy Failure|0|||
125253782|NCT01682720|450555576|FG001|Overall Study|Efficacy Failure|3|||
125253783|NCT01682720|450555577|FG002|Overall Study|Efficacy Failure|3|||
125253784|NCT01682720|450555578|FG003|Overall Study|Efficacy Failure|30|||
125253785|NCT01682720|450555575|FG000|Overall Study|Lost to Follow-up|1|||
125253786|NCT01682720|450555576|FG001|Overall Study|Lost to Follow-up|1|||
125253787|NCT01682720|450555577|FG002|Overall Study|Lost to Follow-up|0|||
125253788|NCT01682720|450555578|FG003|Overall Study|Lost to Follow-up|6|||
125253789|NCT01682720|450555575|FG000|Overall Study|Subject Withdrew Consent|0|||
125253790|NCT01682720|450555576|FG001|Overall Study|Subject Withdrew Consent|0|||
125253791|NCT01682720|450555577|FG002|Overall Study|Subject Withdrew Consent|2|||
125253792|NCT01682720|450555578|FG003|Overall Study|Subject Withdrew Consent|2|||
125253793|NCT01682720|450555575|FG000|Overall Study|Adverse Event|1|||
125253794|NCT01682720|450555576|FG001|Overall Study|Adverse Event|0|||
125253795|NCT01682720|450555577|FG002|Overall Study|Adverse Event|1|||
125253796|NCT01682720|450555578|FG003|Overall Study|Adverse Event|1|||
125253797|NCT04204902|450555579|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
125253798|NCT04204902|450555580|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
125253799|NCT06091956|450555583|FG000|Overall Study|Withdrawal by Subject|1|||
125253800|NCT06091956|450555583|FG000|Overall Study|Complicating Disease|1|||
125253801|NCT04525183|450555592|FG000|Overall Study|Withdrawal by Subject|0|||
125253802|NCT04525183|450555593|FG001|Overall Study|Withdrawal by Subject|0|||
125253803|NCT04525183|450555594|FG002|Overall Study|Withdrawal by Subject|3|||
125253804|NCT04525183|450555592|FG000|Overall Study|Study non-compliance|0|||
125253805|NCT04525183|450555593|FG001|Overall Study|Study non-compliance|0|||
125253806|NCT04525183|450555594|FG002|Overall Study|Study non-compliance|1|||
125253807|NCT04525183|450555592|FG000|Overall Study|Recurrent disease before starting on study|0|||
125253808|NCT04525183|450555593|FG001|Overall Study|Recurrent disease before starting on study|0|||
125253809|NCT04525183|450555594|FG002|Overall Study|Recurrent disease before starting on study|1|||
125253810|NCT00979407|450555595|FG000|Overall Study|Withdrawal by Subject|3|||
125253811|NCT00979407|450555596|FG001|Overall Study|Withdrawal by Subject|4|||
125253812|NCT00979407|450555595|FG000|Overall Study|Lost to Follow-up|3|||
125253813|NCT00979407|450555596|FG001|Overall Study|Lost to Follow-up|3|||
125253814|NCT01166646|450555597|FG000|Overall Study|Protocol Violation|0|||
125253815|NCT01166646|450555598|FG001|Overall Study|Protocol Violation|1|||
125253816|NCT01166646|450555597|FG000|Overall Study|Adverse Event|1|||
125253817|NCT01166646|450555598|FG001|Overall Study|Adverse Event|0|||
125253818|NCT01335685|450555600|FG000|Overall Study|Study Terminated by Sponsor|2|||
125253819|NCT01335685|450555601|FG001|Overall Study|Study Terminated by Sponsor|1|||
125253820|NCT01335685|450555602|FG002|Overall Study|Study Terminated by Sponsor|1|||
125253821|NCT01335685|450555603|FG003|Overall Study|Study Terminated by Sponsor|10|||
125253822|NCT01335685|450555604|FG004|Overall Study|Study Terminated by Sponsor|0|||
125253823|NCT01335685|450555605|FG005|Overall Study|Study Terminated by Sponsor|4|||
125253824|NCT01335685|450555606|FG006|Overall Study|Study Terminated by Sponsor|2|||
125253825|NCT01335685|450555607|FG007|Overall Study|Study Terminated by Sponsor|3|||
125253826|NCT01335685|450555600|FG000|Overall Study|Withdrawal by Subject|1|||
125253827|NCT01335685|450555601|FG001|Overall Study|Withdrawal by Subject|0|||
125253828|NCT01335685|450555602|FG002|Overall Study|Withdrawal by Subject|0|||
125253829|NCT01335685|450555603|FG003|Overall Study|Withdrawal by Subject|1|||
125253830|NCT01335685|450555604|FG004|Overall Study|Withdrawal by Subject|0|||
125253831|NCT01335685|450555605|FG005|Overall Study|Withdrawal by Subject|0|||
125253832|NCT01335685|450555606|FG006|Overall Study|Withdrawal by Subject|0|||
125253833|NCT01335685|450555607|FG007|Overall Study|Withdrawal by Subject|0|||
125253834|NCT01335685|450555600|FG000|Overall Study|Reason not Specified|0|||
125253835|NCT01335685|450555601|FG001|Overall Study|Reason not Specified|0|||
125253836|NCT01335685|450555602|FG002|Overall Study|Reason not Specified|1|||
125253837|NCT01335685|450555603|FG003|Overall Study|Reason not Specified|0|||
125253838|NCT01335685|450555604|FG004|Overall Study|Reason not Specified|0|||
125253839|NCT01335685|450555605|FG005|Overall Study|Reason not Specified|1|||
125253840|NCT01335685|450555606|FG006|Overall Study|Reason not Specified|0|||
125253841|NCT01335685|450555607|FG007|Overall Study|Reason not Specified|0|||
125253842|NCT03777020|450555612|FG000|Overall Study|Withdrawal by Subject|4|||
125253843|NCT03777020|450555613|FG001|Overall Study|Withdrawal by Subject|4|||
125253844|NCT03777020|450555612|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
125253845|NCT03777020|450555613|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
125253846|NCT00489476|450555614|FG000|Overall Study|Lost to Follow-up|0|||
125253847|NCT00489476|450555615|FG001|Overall Study|Lost to Follow-up|1|||
125253848|NCT00489476|450555616|FG002|Overall Study|Lost to Follow-up|0|||
125253849|NCT00489476|450555617|FG003|Overall Study|Lost to Follow-up|0|||
125253850|NCT00581100|450556894|FG000|Overall Study|Death|1|||
125253851|NCT00581100|450556895|FG001|Overall Study|Death|0|||
125253852|NCT00581100|450556894|FG000|Overall Study|Adverse Event|2|||
125253853|NCT00581100|450556895|FG001|Overall Study|Adverse Event|1|||
125253854|NCT00581100|450556894|FG000|Overall Study|Withdrawal by Subject|1|||
125253855|NCT00581100|450556895|FG001|Overall Study|Withdrawal by Subject|4|||
125253856|NCT00581100|450556894|FG000|Overall Study|Other|3|||
125253857|NCT00581100|450556895|FG001|Overall Study|Other|0|||
125253858|NCT04744831|450556896|FG000|Overall Study|Progressive Disease|31|||
125253859|NCT04744831|450556897|FG001|Overall Study|Progressive Disease|27|||
125253860|NCT04744831|450556898|FG002|Overall Study|Progressive Disease|25|||
125253861|NCT04744831|450556896|FG000|Overall Study|Adverse Event|3|||
125253862|NCT04744831|450556897|FG001|Overall Study|Adverse Event|3|||
125253863|NCT04744831|450556898|FG002|Overall Study|Adverse Event|3|||
125253864|NCT04744831|450556896|FG000|Overall Study|Clinical Progression|3|||
125253865|NCT04744831|450556897|FG001|Overall Study|Clinical Progression|2|||
125253866|NCT04744831|450556898|FG002|Overall Study|Clinical Progression|5|||
125253867|NCT04744831|450556896|FG000|Overall Study|Other|0|||
125253868|NCT04744831|450556897|FG001|Overall Study|Other|2|||
125253869|NCT04744831|450556898|FG002|Overall Study|Other|1|||
125253870|NCT04744831|450556896|FG000|Overall Study|Death|0|||
125253871|NCT04744831|450556897|FG001|Overall Study|Death|2|||
125253872|NCT04744831|450556898|FG002|Overall Study|Death|1|||
125253873|NCT04616196|450556908|FG000|Overall Study|Progressive Disease|3|||
125253874|NCT04616196|450556909|FG001|Overall Study|Progressive Disease|0|||
125253875|NCT04616196|450556910|FG002|Overall Study|Progressive Disease|4|||
125253876|NCT04616196|450556911|FG003|Overall Study|Progressive Disease|1|||
125253877|NCT04616196|450556908|FG000|Overall Study|Death|2|||
125253878|NCT04616196|450556909|FG001|Overall Study|Death|4|||
125253879|NCT04616196|450556910|FG002|Overall Study|Death|1|||
125253880|NCT04616196|450556911|FG003|Overall Study|Death|0|||
125253881|NCT04616196|450556908|FG000|Overall Study|Withdrawal by Subject|0|||
125253882|NCT04616196|450556909|FG001|Overall Study|Withdrawal by Subject|2|||
125253883|NCT04616196|450556910|FG002|Overall Study|Withdrawal by Subject|0|||
125253884|NCT04616196|450556911|FG003|Overall Study|Withdrawal by Subject|0|||
125253885|NCT04616196|450556908|FG000|Overall Study|Lost to Follow-up|1|||
125253886|NCT04616196|450556909|FG001|Overall Study|Lost to Follow-up|0|||
125253887|NCT04616196|450556910|FG002|Overall Study|Lost to Follow-up|0|||
125253888|NCT04616196|450556911|FG003|Overall Study|Lost to Follow-up|0|||
125253889|NCT04616196|450556908|FG000|Overall Study|Sponsor request|2|||
125253890|NCT04616196|450556909|FG001|Overall Study|Sponsor request|1|||
125253891|NCT04616196|450556910|FG002|Overall Study|Sponsor request|1|||
125253892|NCT04616196|450556911|FG003|Overall Study|Sponsor request|2|||
125253893|NCT05401409|450556912|FG000|Overall Study|Lost to Follow-up|1|||
125253894|NCT05401409|450556913|FG001|Overall Study|Lost to Follow-up|0|||
125253895|NCT02371889|450556914|FG000|Overall Study|Adverse medication effect|11|||
125253896|NCT02371889|450556915|FG001|Overall Study|Adverse medication effect|2|||
125253897|NCT02371889|450556914|FG000|Overall Study|Lost to Follow-up|6|||
125253898|NCT02371889|450556915|FG001|Overall Study|Lost to Follow-up|5|||
125253899|NCT02371889|450556914|FG000|Overall Study|Personal time constraints|2|||
125253900|NCT02371889|450556915|FG001|Overall Study|Personal time constraints|4|||
125253901|NCT02371889|450556914|FG000|Overall Study|Lack of Efficacy|0|||
125253902|NCT02371889|450556915|FG001|Overall Study|Lack of Efficacy|2|||
125253903|NCT02371889|450556914|FG000|Overall Study|Relapse|0|||
125253904|NCT02371889|450556915|FG001|Overall Study|Relapse|1|||
125253905|NCT05520333|450556916|FG000|Overall Study|Lost to Follow-up|3|||
125253906|NCT05520333|450556917|FG001|Overall Study|Lost to Follow-up|6|||
125253907|NCT02579759|450556918|FG000|Overall Study|Protocol Violation|2|||
125253908|NCT02579759|450556919|FG001|Overall Study|Protocol Violation|0|||
125253909|NCT02579759|450556920|FG002|Overall Study|Protocol Violation|0|||
125253910|NCT02579759|450556918|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
125253911|NCT02579759|450556919|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
125253912|NCT02579759|450556920|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
125253913|NCT02579759|450556918|FG000|Overall Study|BfArM hold|13|||
125253914|NCT02579759|450556919|FG001|Overall Study|BfArM hold|12|||
125253915|NCT02579759|450556920|FG002|Overall Study|BfArM hold|12|||
125253916|NCT02579759|450556918|FG000|Overall Study|Sponsor stopped Dose 2|0|||
125253917|NCT02579759|450556919|FG001|Overall Study|Sponsor stopped Dose 2|41|||
125253918|NCT02579759|450556920|FG002|Overall Study|Sponsor stopped Dose 2|0|||
125253919|NCT02579759|450556918|FG000|Overall Study|Non compliance|0|||
125253920|NCT02579759|450556919|FG001|Overall Study|Non compliance|1|||
125253921|NCT02579759|450556920|FG002|Overall Study|Non compliance|0|||
125253922|NCT02579759|450556918|FG000|Overall Study|Pregnancy|0|||
125253923|NCT02579759|450556919|FG001|Overall Study|Pregnancy|1|||
125253924|NCT02579759|450556920|FG002|Overall Study|Pregnancy|0|||
125253925|NCT02579759|450556918|FG000|Overall Study|Inclusion/exclusion criteria|0|||
125253926|NCT02579759|450556919|FG001|Overall Study|Inclusion/exclusion criteria|0|||
125253927|NCT02579759|450556920|FG002|Overall Study|Inclusion/exclusion criteria|1|||
125253928|NCT02579759|450556918|FG000|Overall Study|Adverse Event|4|||
125253929|NCT02579759|450556919|FG001|Overall Study|Adverse Event|3|||
125253930|NCT02579759|450556920|FG002|Overall Study|Adverse Event|1|||
125253931|NCT02579759|450556918|FG000|Overall Study|Withdrawal by Subject|3|||
125253932|NCT02579759|450556919|FG001|Overall Study|Withdrawal by Subject|3|||
125253933|NCT02579759|450556920|FG002|Overall Study|Withdrawal by Subject|5|||
125253934|NCT02579759|450556918|FG000|Overall Study|Lost to Follow-up|2|||
125253935|NCT02579759|450556919|FG001|Overall Study|Lost to Follow-up|2|||
125253936|NCT02579759|450556920|FG002|Overall Study|Lost to Follow-up|2|||
125253937|NCT02410200|450556923|FG000|Overall Study|Adverse Event|2|||
125253938|NCT03412591|450556924|FG000|Overall Study|Withdrawal by Subject|1|||
125253939|NCT03412591|450556925|FG001|Overall Study|Withdrawal by Subject|8|||
125253940|NCT03412591|450556924|FG000|Overall Study|Adverse Event|0|||
125253941|NCT03412591|450556925|FG001|Overall Study|Adverse Event|1|||
125253942|NCT00814983|450556926|FG000|Overall Study|Screen failure|1|||
125253943|NCT00814983|450556927|FG001|Overall Study|Screen failure|0|||
125253944|NCT00814983|450556926|FG000|Overall Study|Withdrawal by Subject|1|||
125253945|NCT00814983|450556927|FG001|Overall Study|Withdrawal by Subject|0|||
125253946|NCT00814983|450556926|FG000|Overall Study|Graft failure|1|||
125253947|NCT00814983|450556927|FG001|Overall Study|Graft failure|0|||
125253948|NCT04157738|450556928|FG000|Overall Study|Moved out of state|0|||
125253949|NCT04157738|450556929|FG001|Overall Study|Moved out of state|2|||
125253950|NCT04157738|450556928|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
125253951|NCT04157738|450556929|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
125253952|NCT00160563|450556930|FG000|Overall Study|Adverse Event|1|||
125253953|NCT00160563|450556931|FG001|Overall Study|Adverse Event|1|||
125253954|NCT00160563|450556932|FG002|Overall Study|Adverse Event|1|||
125253955|NCT00160563|450556930|FG000|Overall Study|Lost to Follow-up|1|||
125253956|NCT00160563|450556931|FG001|Overall Study|Lost to Follow-up|1|||
125253957|NCT00160563|450556932|FG002|Overall Study|Lost to Follow-up|2|||
125253958|NCT00160563|450556930|FG000|Overall Study|Protocol Violation|0|||
125253959|NCT00160563|450556931|FG001|Overall Study|Protocol Violation|0|||
125253960|NCT00160563|450556932|FG002|Overall Study|Protocol Violation|3|||
125253961|NCT00160563|450556930|FG000|Overall Study|Withdrawal by Subject|1|||
125253962|NCT00160563|450556931|FG001|Overall Study|Withdrawal by Subject|2|||
125253963|NCT00160563|450556932|FG002|Overall Study|Withdrawal by Subject|3|||
125253964|NCT00160563|450556930|FG000|Overall Study|Other (listed in the study report)|48|||
125253965|NCT00160563|450556931|FG001|Overall Study|Other (listed in the study report)|40|||
125253966|NCT00160563|450556932|FG002|Overall Study|Other (listed in the study report)|81|||
125253967|NCT00160563|450556930|FG000|Overall Study|Missing reason|0|||
125253968|NCT00160563|450556931|FG001|Overall Study|Missing reason|1|||
125253969|NCT00160563|450556932|FG002|Overall Study|Missing reason|0|||
125253970|NCT00347269|450556938|FG000|Overall Study|Lost to Follow-up|74|||
125253971|NCT00347269|450556939|FG001|Overall Study|Lost to Follow-up|65|||
125253972|NCT00347269|450556938|FG000|Overall Study|Withdrawal by Subject|18|||
125253973|NCT00347269|450556939|FG001|Overall Study|Withdrawal by Subject|38|||
125253974|NCT00347269|450556938|FG000|Overall Study|Death|2|||
125253975|NCT00347269|450556939|FG001|Overall Study|Death|3|||
125253976|NCT00456365|450556953|FG000|Overall Study|Lost to Follow-up|1|||
125253977|NCT00456365|450556954|FG001|Overall Study|Lost to Follow-up|3|||
125253978|NCT00456365|450556953|FG000|Overall Study|Withdrawal by Subject|4|||
125253979|NCT00456365|450556954|FG001|Overall Study|Withdrawal by Subject|7|||
125253980|NCT00456365|450556953|FG000|Overall Study|Pregnancy|1|||
125253981|NCT00456365|450556954|FG001|Overall Study|Pregnancy|1|||
125253982|NCT00456365|450556953|FG000|Overall Study|oncologic diagnosis|1|||
125253983|NCT00456365|450556954|FG001|Overall Study|oncologic diagnosis|1|||
125253984|NCT05451329|450556955|FG000|Overall Study|Adverse Event|1|||
125253985|NCT05451329|450556956|FG001|Overall Study|Adverse Event|1|||
125253986|NCT05451329|450556957|FG002|Overall Study|Adverse Event|0|||
125253987|NCT05451329|450556955|FG000|Overall Study|Withdrawal by Subject|1|||
125253988|NCT05451329|450556956|FG001|Overall Study|Withdrawal by Subject|0|||
125253989|NCT05451329|450556957|FG002|Overall Study|Withdrawal by Subject|0|||
125253990|NCT05451329|450556955|FG000|Overall Study|Investigational Product Lot exchange|1|||
125253991|NCT05451329|450556956|FG001|Overall Study|Investigational Product Lot exchange|1|||
125253992|NCT05451329|450556957|FG002|Overall Study|Investigational Product Lot exchange|0|||
125253993|NCT02202577|450556958|FG000|Overall Study|Lost to Follow-up|6|||
125253994|NCT02202577|450556959|FG001|Overall Study|Lost to Follow-up|16|||
125253995|NCT02202577|450556958|FG000|Overall Study|Protocol Violation|7|||
125253996|NCT02202577|450556959|FG001|Overall Study|Protocol Violation|3|||
125253997|NCT00069953|450556960|FG000|Overall Study|Protocol Violation|2|||
125253998|NCT02034565|450556961|FG000|Overall Study|Adverse Event|1|||
125253999|NCT02034565|450556962|FG001|Overall Study|Adverse Event|0|||
125254000|NCT00113373|450556963|FG000|Overall Study|Ineligible: wrong primary|1|||
125254001|NCT00113373|450556963|FG000|Overall Study|Ineligible: second primary|1|||
125254002|NCT00113373|450556963|FG000|Overall Study|Never Treated|1|||
125254003|NCT00829868|450556964|FG000|Washout|Physician Decision|1|||
125254004|NCT00829868|450556965|FG001|Washout|Physician Decision|0|||
125254005|NCT02799043|450556967|FG000|Overall Study|Adverse Event|0|||
125254006|NCT02799043|450556968|FG001|Overall Study|Adverse Event|1|||
125254007|NCT02799043|450556967|FG000|Overall Study|Death|1|||
125254008|NCT02799043|450556968|FG001|Overall Study|Death|1|||
125254009|NCT02799043|450556967|FG000|Overall Study|Lost to Follow-up|3|||
125254010|NCT02799043|450556968|FG001|Overall Study|Lost to Follow-up|6|||
125254011|NCT02799043|450556967|FG000|Overall Study|Withdrawal by Subject|4|||
125254012|NCT02799043|450556968|FG001|Overall Study|Withdrawal by Subject|4|||
125254013|NCT02799043|450556967|FG000|Overall Study|Moved to different country|0|||
125254014|NCT02799043|450556968|FG001|Overall Study|Moved to different country|1|||
125254015|NCT02799043|450556967|FG000|Overall Study|Trial Screen Failure|1|||
125254016|NCT02799043|450556968|FG001|Overall Study|Trial Screen Failure|0|||
125254017|NCT02799043|450556967|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
125254018|NCT02799043|450556968|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
125254019|NCT01848457|450556973|FG000|Overall Study|Death|1|||
125254020|NCT01848457|450556974|FG001|Overall Study|Death|0|||
125254021|NCT01848457|450556975|FG002|Overall Study|Death|0|||
125254022|NCT01848457|450556976|FG003|Overall Study|Death|0|||
125254023|NCT00803049|450556977|FG000|Overall Study|Adverse Event|21|||
125254024|NCT00803049|450556978|FG001|Overall Study|Adverse Event|33|||
125254025|NCT00803049|450556979|FG002|Overall Study|Adverse Event|13|||
125254026|NCT00803049|450556980|FG003|Overall Study|Adverse Event|27|||
125254027|NCT00803049|450556977|FG000|Overall Study|Lack of Efficacy|10|||
125254028|NCT00803049|450556978|FG001|Overall Study|Lack of Efficacy|19|||
125254029|NCT00803049|450556979|FG002|Overall Study|Lack of Efficacy|6|||
125254030|NCT00803049|450556980|FG003|Overall Study|Lack of Efficacy|13|||
125254031|NCT00803049|450556977|FG000|Overall Study|Lost to Follow-up|0|||
125254032|NCT00803049|450556978|FG001|Overall Study|Lost to Follow-up|2|||
125254033|NCT00803049|450556979|FG002|Overall Study|Lost to Follow-up|0|||
125254034|NCT00803049|450556980|FG003|Overall Study|Lost to Follow-up|3|||
125254035|NCT00803049|450556977|FG000|Overall Study|Death|2|||
125254036|NCT00803049|450556978|FG001|Overall Study|Death|1|||
125254037|NCT00803049|450556979|FG002|Overall Study|Death|0|||
125254038|NCT00803049|450556980|FG003|Overall Study|Death|2|||
125254039|NCT00803049|450556977|FG000|Overall Study|Progressive Disease|6|||
125254040|NCT00803049|450556978|FG001|Overall Study|Progressive Disease|10|||
125254041|NCT00803049|450556979|FG002|Overall Study|Progressive Disease|6|||
125254042|NCT00803049|450556980|FG003|Overall Study|Progressive Disease|6|||
125254043|NCT00803049|450556977|FG000|Overall Study|Withdrawal by Subject|19|||
125254044|NCT00803049|450556978|FG001|Overall Study|Withdrawal by Subject|43|||
125254045|NCT00803049|450556979|FG002|Overall Study|Withdrawal by Subject|16|||
125254046|NCT00803049|450556980|FG003|Overall Study|Withdrawal by Subject|44|||
125254047|NCT00803049|450556977|FG000|Overall Study|Protocol Violation|0|||
125254048|NCT00803049|450556978|FG001|Overall Study|Protocol Violation|1|||
125254049|NCT00803049|450556979|FG002|Overall Study|Protocol Violation|1|||
125254050|NCT00803049|450556980|FG003|Overall Study|Protocol Violation|0|||
125254051|NCT00803049|450556977|FG000|Overall Study|Randomized and Not Treated|0|||
125254052|NCT00803049|450556978|FG001|Overall Study|Randomized and Not Treated|0|||
125254053|NCT00803049|450556979|FG002|Overall Study|Randomized and Not Treated|0|||
125254054|NCT00803049|450556980|FG003|Overall Study|Randomized and Not Treated|2|||
125254055|NCT00803049|450556977|FG000|Overall Study|Other than Specified Above|3|||
125254056|NCT00803049|450556978|FG001|Overall Study|Other than Specified Above|9|||
125254057|NCT00803049|450556979|FG002|Overall Study|Other than Specified Above|2|||
125254058|NCT00803049|450556980|FG003|Overall Study|Other than Specified Above|5|||
125254059|NCT01421459|450556981|FG000|Overall Study|Adverse Event|6|||
125254060|NCT01421459|450556982|FG001|Overall Study|Adverse Event|10|||
125254061|NCT01421459|450556981|FG000|Overall Study|Death|1|||
125254062|NCT01421459|450556982|FG001|Overall Study|Death|1|||
125254063|NCT01421459|450556981|FG000|Overall Study|Lack of Efficacy|1|||
125254064|NCT01421459|450556982|FG001|Overall Study|Lack of Efficacy|2|||
125254065|NCT01421459|450556981|FG000|Overall Study|Lost to Follow-up|8|||
125254066|NCT01421459|450556982|FG001|Overall Study|Lost to Follow-up|9|||
125254067|NCT01421459|450556981|FG000|Overall Study|Physician Decision|9|||
125254068|NCT01421459|450556982|FG001|Overall Study|Physician Decision|9|||
125254069|NCT01421459|450556981|FG000|Overall Study|Protocol Violation|8|||
125254070|NCT01421459|450556982|FG001|Overall Study|Protocol Violation|5|||
125254071|NCT01421459|450556981|FG000|Overall Study|Withdrawal by Subject|12|||
125254072|NCT01421459|450556982|FG001|Overall Study|Withdrawal by Subject|16|||
125254073|NCT04439903|450556993|FG000|Overall Study|Withdrawal by Subject|2|||
125254074|NCT04439903|450556993|FG000|Overall Study|Screen Failure|1|||
125254075|NCT04003142|450556998|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
125254076|NCT04003142|450556999|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
125254077|NCT04003142|450557000|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
125254078|NCT04003142|450557001|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
125254079|NCT04003142|450557002|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
125254080|NCT04003142|450556998|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
125254081|NCT04003142|450556999|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
125254082|NCT04003142|450557000|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
125254083|NCT04003142|450557001|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
125254084|NCT04003142|450557002|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
125254085|NCT04003142|450556998|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
125254086|NCT04003142|450556999|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
125254087|NCT04003142|450557000|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
125254088|NCT04003142|450557001|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
125254089|NCT04003142|450557002|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
125254090|NCT04003142|450556998|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
125254091|NCT04003142|450556999|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
125254092|NCT04003142|450557000|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
125254093|NCT04003142|450557001|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
125254094|NCT04003142|450557002|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
125254095|NCT04003142|450556998|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
125254096|NCT04003142|450556999|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
125254097|NCT04003142|450557000|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
125254098|NCT04003142|450557001|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
125254099|NCT04003142|450557002|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
125254100|NCT04003142|450556998|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
125254101|NCT04003142|450556999|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
125254102|NCT04003142|450557000|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
125254103|NCT04003142|450557001|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
125254104|NCT04003142|450557002|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
125254105|NCT04003142|450556998|FG000|Extension Period (40 Weeks)|Death|0|||
125254106|NCT04003142|450556999|FG001|Extension Period (40 Weeks)|Death|0|||
125254107|NCT04003142|450557000|FG002|Extension Period (40 Weeks)|Death|0|||
125254108|NCT04003142|450557001|FG003|Extension Period (40 Weeks)|Death|0|||
125254109|NCT04003142|450557002|FG004|Extension Period (40 Weeks)|Death|1|||
125254110|NCT04003142|450556998|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
125254111|NCT04003142|450556999|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
125254112|NCT04003142|450557000|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
125254113|NCT04003142|450557001|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
125254114|NCT04003142|450557002|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
125254115|NCT04003142|450556998|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
125254116|NCT04003142|450556999|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
125254117|NCT04003142|450557000|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
125254118|NCT04003142|450557001|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
125254119|NCT04003142|450557002|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
125254120|NCT04003142|450556998|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
125254121|NCT04003142|450556999|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
125254122|NCT04003142|450557000|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
125254123|NCT04003142|450557001|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
125254124|NCT04003142|450557002|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
125254125|NCT04003142|450556998|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
125254126|NCT04003142|450556999|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
125254127|NCT04003142|450557000|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
125254128|NCT04003142|450557001|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
125254129|NCT04003142|450557002|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
125254130|NCT04042311|450557003|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
125254131|NCT04042311|450557003|FG000|Overall Study|Unable to tolerate|4|||
125254132|NCT04042311|450557003|FG000|Overall Study|Concurrent illness|2|||
125254133|NCT04042311|450557003|FG000|Overall Study|Adverse Event|2|||
125254134|NCT04042311|450557003|FG000|Overall Study|No longer meeting inclusion criteria|2|||
125254135|NCT04042311|450557003|FG000|Overall Study|No reason given|1|||
125254136|NCT04042311|450557003|FG000|Overall Study|Withdrawal by Subject|4|||
125254137|NCT03382873|450557004|FG000|Overall Study|Lost to Follow-up|9|||
125254138|NCT03382873|450557005|FG001|Overall Study|Lost to Follow-up|10|||
125254139|NCT03382873|450557004|FG000|Overall Study|Withdrawal by Subject|6|||
125254140|NCT03382873|450557005|FG001|Overall Study|Withdrawal by Subject|11|||
125254141|NCT03382873|450557004|FG000|Overall Study|Visit not completed due to pandemic|16|||
125254142|NCT03382873|450557005|FG001|Overall Study|Visit not completed due to pandemic|41|||
125254143|NCT03996395|450557008|FG000|Overall Study|Lost to Follow-up|4|||
125254144|NCT03996395|450557008|FG000|Overall Study|Withdrawal by Subject|1|||
125254145|NCT03996395|450557008|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
125254146|NCT02061085|450557011|FG000|Overall Study|Adverse Event|8|||
125254147|NCT03247673|450557012|FG000|Overall Study|Withdrawal by Subject|1|||
125254148|NCT03247673|450557013|FG001|Overall Study|Withdrawal by Subject|0|||
125254149|NCT03247673|450557014|FG002|Overall Study|Withdrawal by Subject|3|||
125254150|NCT03247673|450557012|FG000|Overall Study|Lost to Follow-up|0|||
125254151|NCT03247673|450557013|FG001|Overall Study|Lost to Follow-up|0|||
125254152|NCT03247673|450557014|FG002|Overall Study|Lost to Follow-up|1|||
125254153|NCT02097225|450557015|FG000|Dose Level 4|Adverse Event|0|||
125254154|NCT02097225|450557016|FG001|Dose Level 4|Adverse Event|0|||
125254155|NCT02097225|450557017|FG002|Dose Level 4|Adverse Event|0|||
125254156|NCT02097225|450557018|FG003|Dose Level 4|Adverse Event|0|||
125254157|NCT02097225|450557019|FG004|Dose Level 4|Adverse Event|1|||
125254158|NCT01027351|450557021|FG000|Overall Study|Withdrawal by Subject|1|||
125254159|NCT01027351|450557022|FG001|Overall Study|Withdrawal by Subject|0|||
125254160|NCT01027351|450557023|FG002|Overall Study|Withdrawal by Subject|1|||
125254161|NCT01027351|450557024|FG003|Overall Study|Withdrawal by Subject|0|||
125254162|NCT01027351|450557025|FG004|Overall Study|Withdrawal by Subject|3|||
125254163|NCT01027351|450557026|FG005|Overall Study|Withdrawal by Subject|5|||
125254164|NCT01027351|450557021|FG000|Overall Study|Lost to Follow-up|1|||
125254165|NCT01027351|450557022|FG001|Overall Study|Lost to Follow-up|1|||
125254166|NCT01027351|450557023|FG002|Overall Study|Lost to Follow-up|0|||
125254167|NCT01027351|450557024|FG003|Overall Study|Lost to Follow-up|1|||
125254168|NCT01027351|450557025|FG004|Overall Study|Lost to Follow-up|6|||
125254169|NCT01027351|450557026|FG005|Overall Study|Lost to Follow-up|0|||
125254170|NCT01027351|450557021|FG000|Overall Study|Inappropriate enrollment|0|||
125254171|NCT01027351|450557022|FG001|Overall Study|Inappropriate enrollment|0|||
125254172|NCT01027351|450557023|FG002|Overall Study|Inappropriate enrollment|0|||
125254173|NCT01027351|450557024|FG003|Overall Study|Inappropriate enrollment|0|||
125254174|NCT01027351|450557025|FG004|Overall Study|Inappropriate enrollment|1|||
125254175|NCT01027351|450557026|FG005|Overall Study|Inappropriate enrollment|0|||
125254176|NCT01027351|450557021|FG000|Overall Study|Protocol Violation|1|||
125254177|NCT01027351|450557022|FG001|Overall Study|Protocol Violation|0|||
125254178|NCT01027351|450557023|FG002|Overall Study|Protocol Violation|0|||
125254179|NCT01027351|450557024|FG003|Overall Study|Protocol Violation|1|||
125254180|NCT01027351|450557025|FG004|Overall Study|Protocol Violation|1|||
125254181|NCT01027351|450557026|FG005|Overall Study|Protocol Violation|0|||
125254182|NCT02757963|450557027|FG000|Overall Study|Adverse Event|3|||
125254183|NCT02757963|450557027|FG000|Overall Study|Reached Stopping Criteria|1054|||
125254184|NCT02757963|450557027|FG000|Overall Study|Lost to Follow-up|5|||
125254185|NCT02757963|450557027|FG000|Overall Study|Physician Decision|1|||
125254186|NCT02757963|450557027|FG000|Overall Study|Withdrawal by Subject|34|||
125254187|NCT02971137|450557028|FG000|Overall Study|Lost to Follow-up|44|||
125254188|NCT02971137|450557029|FG001|Overall Study|Lost to Follow-up|56|||
125254189|NCT00911157|450557030|FG000|Overall Study|Adverse Event|4|||
125254190|NCT00911157|450557031|FG001|Overall Study|Adverse Event|1|||
125254191|NCT00911157|450557030|FG000|Overall Study|Withdrawal by Subject|1|||
125254192|NCT00911157|450557031|FG001|Overall Study|Withdrawal by Subject|1|||
125254193|NCT00911157|450557030|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
125254194|NCT00911157|450557031|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
125254195|NCT00911157|450557030|FG000|Overall Study|Need to treat for lung cancer|1|||
125254196|NCT00911157|450557031|FG001|Overall Study|Need to treat for lung cancer|0|||
125254197|NCT04755231|450557032|FG000|Overall Study|Lost to Follow-up|5|||
125254198|NCT04755231|450557032|FG000|Overall Study|Withdrawal by Subject|5|||
125254199|NCT04650893|450557033|FG000|Overall Study|Lost to Follow-up|11|||
125254200|NCT04650893|450557034|FG001|Overall Study|Lost to Follow-up|10|||
125254201|NCT04650893|450557035|FG002|Overall Study|Lost to Follow-up|11|||
125254202|NCT05346640|450557043|FG000|Overall Study|Lack of Efficacy|2|||
125254203|NCT05346640|450557043|FG000|Overall Study|Lost to Follow-up|14|||
125254204|NCT05346640|450557043|FG000|Overall Study|Protocol Violation|4|||
125254205|NCT05346640|450557043|FG000|Overall Study|Withdrawal by Subject|2|||
125254206|NCT05346640|450557043|FG000|Overall Study|Physiological Complications|3|||
125254207|NCT05346640|450557043|FG000|Overall Study|Other Reason|3|||
125254208|NCT01197300|450558950|FG000|Overall Study|Lost to Follow-up|0|||
125254209|NCT01197300|450558951|FG001|Overall Study|Lost to Follow-up|1|||
125254210|NCT01197300|450558950|FG000|Overall Study|Protocol Violation|0|||
125254211|NCT01197300|450558951|FG001|Overall Study|Protocol Violation|1|||
125254212|NCT02113878|450558952|FG000|Overall Study|Adverse Event|1|||
125254213|NCT02113878|450558953|FG001|Overall Study|Adverse Event|0|||
125254214|NCT02113878|450558952|FG000|Overall Study|Withdrawal by Subject|1|||
125254215|NCT02113878|450558953|FG001|Overall Study|Withdrawal by Subject|0|||
125254216|NCT02113878|450558952|FG000|Overall Study|patient non-compliance|1|||
125254217|NCT02113878|450558953|FG001|Overall Study|patient non-compliance|0|||
125254218|NCT04129398|450558956|FG000|Overall Study|Physician Decision|2|||
125254219|NCT03058952|450558957|FG000|Overall Study|Adverse Event|1|||
125254220|NCT03058952|450558958|FG001|Overall Study|Adverse Event|0|||
125254221|NCT03058952|450558957|FG000|Overall Study|Lost to Follow-up|15|||
125254222|NCT03058952|450558958|FG001|Overall Study|Lost to Follow-up|15|||
125254223|NCT03058952|450558957|FG000|Overall Study|Withdrawal by Subject|7|||
125254224|NCT03058952|450558958|FG001|Overall Study|Withdrawal by Subject|11|||
125254225|NCT03837509|450558961|FG000|Phase 1|Death|5|||
125254226|NCT03837509|450558962|FG001|Phase 1|Death|2|||
125254227|NCT03837509|450558963|FG002|Phase 1|Death|0|||
125254228|NCT03837509|450558964|FG003|Phase 1|Death|0|||
125254229|NCT03837509|450558965|FG004|Phase 1|Death|0|||
125254230|NCT03837509|450558961|FG000|Phase 2|Death|0|||
125254231|NCT03837509|450558962|FG001|Phase 2|Death|0|||
125254232|NCT03837509|450558963|FG002|Phase 2|Death|0|||
125254233|NCT03837509|450558964|FG003|Phase 2|Death|1|||
125254234|NCT03837509|450558965|FG004|Phase 2|Death|1|||
125254235|NCT01251965|450558966|FG000|Overall Study|Participant/physician decision|1|||
125254236|NCT01251965|450558967|FG001|Overall Study|Participant/physician decision|2|||
125254237|NCT01251965|450558968|FG002|Overall Study|Participant/physician decision|0|||
125254238|NCT01251965|450558966|FG000|Overall Study|Death|0|||
125254239|NCT01251965|450558967|FG001|Overall Study|Death|0|||
125254240|NCT01251965|450558968|FG002|Overall Study|Death|11|||
125254241|NCT02363283|450558969|FG000|Overall Study|Withdrawal by Subject|1|||
125254242|NCT02363283|450558969|FG000|Overall Study|Not eligible due to transaminitis|1|||
125254243|NCT00530257|450558975|FG000|Overall Study|Lost to Follow-up|1|||
125254244|NCT01897896|450558976|FG000|Overall Study|Death|1|||
125254245|NCT01897896|450558977|FG001|Overall Study|Death|0|||
125254246|NCT01897896|450558976|FG000|Overall Study|Adverse Event|11|||
125254247|NCT01897896|450558977|FG001|Overall Study|Adverse Event|1|||
125254248|NCT01897896|450558976|FG000|Overall Study|Lost to Follow-up|1|||
125254249|NCT01897896|450558977|FG001|Overall Study|Lost to Follow-up|0|||
125254250|NCT01897896|450558976|FG000|Overall Study|Non-compliance with study drug dosing|1|||
125254251|NCT01897896|450558977|FG001|Overall Study|Non-compliance with study drug dosing|1|||
125254252|NCT01897896|450558976|FG000|Overall Study|Withdrawal by Subject|7|||
125254253|NCT01897896|450558977|FG001|Overall Study|Withdrawal by Subject|1|||
125254254|NCT01897896|450558976|FG000|Overall Study|Require drug that interfere with study|1|||
125254255|NCT01897896|450558977|FG001|Overall Study|Require drug that interfere with study|4|||
125254256|NCT01897896|450558976|FG000|Overall Study|Protocol Violation|1|||
125254257|NCT01897896|450558977|FG001|Overall Study|Protocol Violation|1|||
125254258|NCT01897896|450558976|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
125254259|NCT01897896|450558977|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
125254260|NCT01897896|450558976|FG000|Overall Study|Caregiver can no longer participate|0|||
125254261|NCT01897896|450558977|FG001|Overall Study|Caregiver can no longer participate|2|||
125254262|NCT01897896|450558976|FG000|Overall Study|Other than specified|2|||
125254263|NCT01897896|450558977|FG001|Overall Study|Other than specified|1|||
125254264|NCT02801578|450558996|FG000|Overall Study|Adverse Event|2|||
125254265|NCT00668642|450558997|FG000|First Off-cycle|Cancer progression|1|||
125254266|NCT00668642|450558998|FG001|First Off-cycle|Cancer progression|0|||
125254267|NCT00668642|450558997|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
125254268|NCT00668642|450558998|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
125254269|NCT02003898|450558999|FG000|Overall Study|Death|3|||
125254270|NCT02003898|450558999|FG000|Overall Study|Lost to Follow-up|12|||
125254271|NCT02003898|450558999|FG000|Overall Study|Withdrawal by Subject|52|||
125254272|NCT02272985|450559000|FG000|Overall Study|Withdrawal by Subject|1|||
125254273|NCT02272985|450559000|FG000|Overall Study|hip fracture|1|||
125254274|NCT02272985|450559000|FG000|Overall Study|kidney transplantation|1|||
125254275|NCT03682367|450559003|FG000|Overall Study|Protocol Violation|2|||
125254276|NCT03682367|450559004|FG001|Overall Study|Protocol Violation|1|||
125254277|NCT03682367|450559003|FG000|Overall Study|Closed Study Early|0|||
125254278|NCT03682367|450559004|FG001|Overall Study|Closed Study Early|3|||
125254279|NCT00770679|450559005|FG000|Overall Study|Lost to Follow-up|3|||
125254280|NCT00770679|450559005|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
125254281|NCT00129974|450559006|FG000|Overall Study|Other|1|||
125254282|NCT00414609|450559007|FG000|Core Study|Adverse Event|9|||
125254283|NCT00414609|450559008|FG001|Core Study|Adverse Event|11|||
125254284|NCT00414609|450559009|FG002|Core Study|Adverse Event|0|||
125254285|NCT00414609|450559007|FG000|Core Study|Abnormal laboratory values|0|||
125254286|NCT00414609|450559008|FG001|Core Study|Abnormal laboratory values|1|||
125254287|NCT00414609|450559009|FG002|Core Study|Abnormal laboratory values|0|||
125254288|NCT00414609|450559007|FG000|Core Study|Abnormal test procedure results|1|||
125254289|NCT00414609|450559008|FG001|Core Study|Abnormal test procedure results|1|||
125254290|NCT00414609|450559009|FG002|Core Study|Abnormal test procedure results|0|||
125254291|NCT00414609|450559007|FG000|Core Study|Protocol deviation|0|||
125254292|NCT00414609|450559008|FG001|Core Study|Protocol deviation|1|||
125254293|NCT00414609|450559009|FG002|Core Study|Protocol deviation|0|||
125254294|NCT00414609|450559007|FG000|Core Study|Patient withdrew consent|10|||
125254295|NCT00414609|450559008|FG001|Core Study|Patient withdrew consent|11|||
125254296|NCT00414609|450559009|FG002|Core Study|Patient withdrew consent|0|||
125254297|NCT00414609|450559007|FG000|Core Study|Lost to Follow-up|7|||
125254298|NCT00414609|450559008|FG001|Core Study|Lost to Follow-up|4|||
125254299|NCT00414609|450559009|FG002|Core Study|Lost to Follow-up|0|||
125254300|NCT00414609|450559007|FG000|Core Study|Administrative problems|0|||
125254301|NCT00414609|450559008|FG001|Core Study|Administrative problems|2|||
125254302|NCT00414609|450559009|FG002|Core Study|Administrative problems|0|||
125254303|NCT00414609|450559007|FG000|Core Study|Death|7|||
125254304|NCT00414609|450559008|FG001|Core Study|Death|14|||
125254305|NCT00414609|450559009|FG002|Core Study|Death|0|||
125254306|NCT00414609|450559007|FG000|Extension Study|Adverse Event|0|||
125254307|NCT00414609|450559008|FG001|Extension Study|Adverse Event|0|||
125254308|NCT00414609|450559009|FG002|Extension Study|Adverse Event|14|||
125254309|NCT00414609|450559007|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
125254310|NCT00414609|450559008|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
125254311|NCT00414609|450559009|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
125254312|NCT00414609|450559007|FG000|Extension Study|Withdrawal by Subject|0|||
125254313|NCT00414609|450559008|FG001|Extension Study|Withdrawal by Subject|0|||
125254314|NCT00414609|450559009|FG002|Extension Study|Withdrawal by Subject|13|||
125254315|NCT00414609|450559007|FG000|Extension Study|Lost to Follow-up|0|||
125254316|NCT00414609|450559008|FG001|Extension Study|Lost to Follow-up|0|||
125254317|NCT00414609|450559009|FG002|Extension Study|Lost to Follow-up|10|||
125254318|NCT00414609|450559007|FG000|Extension Study|Administrative problems|0|||
125254319|NCT00414609|450559008|FG001|Extension Study|Administrative problems|0|||
125254320|NCT00414609|450559009|FG002|Extension Study|Administrative problems|1|||
125254321|NCT00414609|450559007|FG000|Extension Study|Death|0|||
125254322|NCT00414609|450559008|FG001|Extension Study|Death|0|||
125254323|NCT00414609|450559009|FG002|Extension Study|Death|17|||
125254324|NCT03627468|450559014|FG000|Overall Study|Adverse Event|5|||
125254325|NCT03627468|450559015|FG001|Overall Study|Adverse Event|33|||
125254326|NCT03627468|450559014|FG000|Overall Study|Withdrawal by Subject|13|||
125254327|NCT03627468|450559015|FG001|Overall Study|Withdrawal by Subject|23|||
125254328|NCT03627468|450559014|FG000|Overall Study|Physician Decision|1|||
125254329|NCT03627468|450559015|FG001|Overall Study|Physician Decision|0|||
125254330|NCT03627468|450559014|FG000|Overall Study|Protocol Violation|0|||
125254331|NCT03627468|450559015|FG001|Overall Study|Protocol Violation|2|||
125254332|NCT03627468|450559014|FG000|Overall Study|Lost to Follow-up|10|||
125254333|NCT03627468|450559015|FG001|Overall Study|Lost to Follow-up|16|||
125254334|NCT03627468|450559014|FG000|Overall Study|Death|1|||
125254335|NCT03627468|450559015|FG001|Overall Study|Death|0|||
125254336|NCT03627468|450559014|FG000|Overall Study|Pregnancy|1|||
125254337|NCT03627468|450559015|FG001|Overall Study|Pregnancy|1|||
125254338|NCT03627468|450559014|FG000|Overall Study|Lack of Efficacy|0|||
125254339|NCT03627468|450559015|FG001|Overall Study|Lack of Efficacy|2|||
125254340|NCT03627468|450559014|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
125254341|NCT03627468|450559015|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
125254342|NCT01047540|450559016|FG000|Overall Study|Protocol Violation|1|||
125254343|NCT01047540|450559017|FG001|Overall Study|Protocol Violation|0|||
125254344|NCT01047540|450559018|FG002|Overall Study|Protocol Violation|0|||
125254345|NCT01047540|450559019|FG003|Overall Study|Protocol Violation|0|||
125254346|NCT01047540|450559020|FG004|Overall Study|Protocol Violation|0|||
125254347|NCT01047540|450559016|FG000|Overall Study|Lost to Follow-up|1|||
125254348|NCT01047540|450559017|FG001|Overall Study|Lost to Follow-up|0|||
125254349|NCT01047540|450559018|FG002|Overall Study|Lost to Follow-up|0|||
125254350|NCT01047540|450559019|FG003|Overall Study|Lost to Follow-up|0|||
125254351|NCT01047540|450559020|FG004|Overall Study|Lost to Follow-up|0|||
125254352|NCT01047540|450559016|FG000|Overall Study|Withdrawal by Subject|1|||
125254353|NCT01047540|450559017|FG001|Overall Study|Withdrawal by Subject|0|||
125254354|NCT01047540|450559018|FG002|Overall Study|Withdrawal by Subject|3|||
125254355|NCT01047540|450559019|FG003|Overall Study|Withdrawal by Subject|0|||
125254356|NCT01047540|450559020|FG004|Overall Study|Withdrawal by Subject|1|||
125254357|NCT01047540|450559016|FG000|Overall Study|Pregnancy|1|||
125254358|NCT01047540|450559017|FG001|Overall Study|Pregnancy|0|||
125254359|NCT01047540|450559018|FG002|Overall Study|Pregnancy|0|||
125254360|NCT01047540|450559019|FG003|Overall Study|Pregnancy|0|||
125254361|NCT01047540|450559020|FG004|Overall Study|Pregnancy|0|||
125254362|NCT01047540|450559016|FG000|Overall Study|Adverse Event|1|||
125254363|NCT01047540|450559017|FG001|Overall Study|Adverse Event|0|||
125254364|NCT01047540|450559018|FG002|Overall Study|Adverse Event|0|||
125254365|NCT01047540|450559019|FG003|Overall Study|Adverse Event|0|||
125254366|NCT01047540|450559020|FG004|Overall Study|Adverse Event|0|||
125254367|NCT01437189|450559024|FG000|Overall Study|Adverse Event|3|||
125254368|NCT01437189|450559024|FG000|Overall Study|Lack of Efficacy|4|||
125254369|NCT01437189|450559024|FG000|Overall Study|Withdrawal by Subject|8|||
125254370|NCT03654326|450559025|FG000|Overall Study|Withdrawal by Subject|5|||
125254371|NCT03654326|450559026|FG001|Overall Study|Withdrawal by Subject|3|||
125254372|NCT03654326|450559025|FG000|Overall Study|Physician Decision|0|||
125254373|NCT03654326|450559026|FG001|Overall Study|Physician Decision|1|||
125254374|NCT03654326|450559025|FG000|Overall Study|Unable to adhere to study schedule|0|||
125254375|NCT03654326|450559026|FG001|Overall Study|Unable to adhere to study schedule|1|||
125254376|NCT03654326|450559025|FG000|Overall Study|Lost to Follow-up|1|||
125254377|NCT03654326|450559026|FG001|Overall Study|Lost to Follow-up|1|||
125254378|NCT04102514|450559027|FG000|Overall Study|Death|3|||
125254379|NCT04102514|450559028|FG001|Overall Study|Death|0|||
125254380|NCT04102514|450559029|FG002|Overall Study|Death|0|||
125254381|NCT04102514|450559030|FG003|Overall Study|Death|0|||
125254382|NCT04102514|450559027|FG000|Overall Study|Lost to Follow-up|0|||
125254383|NCT04102514|450559028|FG001|Overall Study|Lost to Follow-up|0|||
125254384|NCT04102514|450559029|FG002|Overall Study|Lost to Follow-up|3|||
125254385|NCT04102514|450559030|FG003|Overall Study|Lost to Follow-up|0|||
125254386|NCT04102514|450559027|FG000|Overall Study|Physician Decision|0|||
125254387|NCT04102514|450559028|FG001|Overall Study|Physician Decision|0|||
125254388|NCT04102514|450559029|FG002|Overall Study|Physician Decision|1|||
125254389|NCT04102514|450559030|FG003|Overall Study|Physician Decision|0|||
125254390|NCT04102514|450559027|FG000|Overall Study|Withdrawal by Subject|7|||
125254391|NCT04102514|450559028|FG001|Overall Study|Withdrawal by Subject|13|||
125254392|NCT04102514|450559029|FG002|Overall Study|Withdrawal by Subject|7|||
125254393|NCT04102514|450559030|FG003|Overall Study|Withdrawal by Subject|14|||
125254394|NCT04102514|450559027|FG000|Overall Study|Moved to longterm care facility|6|||
125254395|NCT04102514|450559028|FG001|Overall Study|Moved to longterm care facility|0|||
125254396|NCT04102514|450559029|FG002|Overall Study|Moved to longterm care facility|4|||
125254397|NCT04102514|450559030|FG003|Overall Study|Moved to longterm care facility|0|||
125254398|NCT00835549|450559031|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
125254399|NCT00835549|450559032|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
125254400|NCT00835042|450559033|FG000|First Intervention|Withdrawal by Subject|3|||
125254401|NCT00835042|450559034|FG001|First Intervention|Withdrawal by Subject|0|||
125254402|NCT00835042|450559033|FG000|First Intervention|Adverse Event|1|||
125254403|NCT00835042|450559034|FG001|First Intervention|Adverse Event|2|||
125254404|NCT00835042|450559033|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
125254405|NCT00835042|450559034|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
125254406|NCT00619918|450559035|FG000|Overall Study|Withdrawal by Subject|4|||
125254407|NCT00619918|450559036|FG001|Overall Study|Withdrawal by Subject|3|||
125254408|NCT00619918|450559035|FG000|Overall Study|Physician Decision|2|||
125254409|NCT00619918|450559036|FG001|Overall Study|Physician Decision|4|||
125254410|NCT00619918|450559035|FG000|Overall Study|Transfer to outside facility|3|||
125254411|NCT00619918|450559036|FG001|Overall Study|Transfer to outside facility|3|||
125254412|NCT00619918|450559035|FG000|Overall Study|Left before receiving first dose|7|||
125254413|NCT00619918|450559036|FG001|Overall Study|Left before receiving first dose|6|||
125254414|NCT00619918|450559035|FG000|Overall Study|ICU admission|4|||
125254415|NCT00619918|450559036|FG001|Overall Study|ICU admission|6|||
125254416|NCT05524948|450559056|FG000|Overall Study|Withdrawal by Subject|1|||
125254417|NCT05524948|450559057|FG001|Overall Study|Withdrawal by Subject|0|||
125254418|NCT05524948|450559056|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
125254419|NCT05524948|450559057|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
125254420|NCT04661839|450559062|FG000|Overall Study|Not Treated|0|||
125254421|NCT04661839|450559063|FG001|Overall Study|Not Treated|0|||
125254422|NCT04661839|450559064|FG002|Overall Study|Not Treated|1|||
125254423|NCT04661839|450559065|FG003|Overall Study|Not Treated|0|||
125254424|NCT04661839|450559062|FG000|Overall Study|Lost to Follow-up|1|||
125254425|NCT04661839|450559063|FG001|Overall Study|Lost to Follow-up|0|||
125254426|NCT04661839|450559064|FG002|Overall Study|Lost to Follow-up|0|||
125254427|NCT04661839|450559065|FG003|Overall Study|Lost to Follow-up|1|||
125254428|NCT02758626|450559067|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
125254429|NCT02758626|450559068|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
125254430|NCT02758626|450559067|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
125254431|NCT02758626|450559068|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
125254432|NCT02758626|450559067|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
125254433|NCT02758626|450559068|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
125254434|NCT02758626|450559067|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
125254435|NCT02758626|450559068|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
125254436|NCT00855166|450559069|FG000|Overall Study|Adverse Event|0|||
125254437|NCT00855166|450559070|FG001|Overall Study|Adverse Event|2|||
125254438|NCT00855166|450559069|FG000|Overall Study|Death|0|||
125254439|NCT00855166|450559070|FG001|Overall Study|Death|1|||
125254440|NCT00855166|450559069|FG000|Overall Study|Withdrawal by Subject|1|||
125254441|NCT00855166|450559070|FG001|Overall Study|Withdrawal by Subject|4|||
125254442|NCT00855166|450559069|FG000|Overall Study|Poor/non-compliance|2|||
125254443|NCT00855166|450559070|FG001|Overall Study|Poor/non-compliance|0|||
125254444|NCT00855166|450559069|FG000|Overall Study|Administrative reasons by sponsor|1|||
125254445|NCT00855166|450559070|FG001|Overall Study|Administrative reasons by sponsor|0|||
125254446|NCT00855166|450559069|FG000|Overall Study|Subject no longer meets study criteria|1|||
125254447|NCT00855166|450559070|FG001|Overall Study|Subject no longer meets study criteria|1|||
125254448|NCT01272219|450559073|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
125254449|NCT01272219|450559074|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
125254450|NCT01272219|450559075|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
125254451|NCT01272219|450559076|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
125254452|NCT01272219|450559077|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
125254453|NCT01272219|450559078|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
125254454|NCT01272219|450559073|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
125254455|NCT01272219|450559074|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
125254456|NCT01272219|450559075|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
125254457|NCT01272219|450559076|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
125254458|NCT01272219|450559077|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
125254459|NCT01272219|450559078|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
125254460|NCT01272219|450559073|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
125254461|NCT01272219|450559074|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
125254462|NCT01272219|450559075|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
125254463|NCT01272219|450559076|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
125254464|NCT01272219|450559077|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
125254465|NCT01272219|450559078|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
125254466|NCT01272219|450559073|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
125254467|NCT01272219|450559074|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
125254468|NCT01272219|450559075|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
125254469|NCT01272219|450559076|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
125254470|NCT01272219|450559077|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
125254471|NCT01272219|450559078|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
125254472|NCT01272219|450559073|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
125254473|NCT01272219|450559074|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
125254474|NCT01272219|450559075|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
125254475|NCT01272219|450559076|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
125254476|NCT01272219|450559077|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
125254477|NCT01272219|450559078|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
125254478|NCT01272219|450559073|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
125254479|NCT01272219|450559074|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
125254480|NCT01272219|450559075|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
125254481|NCT01272219|450559076|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
125254482|NCT01272219|450559077|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
125254483|NCT01272219|450559078|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
125254484|NCT01272219|450559073|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
125254485|NCT01272219|450559074|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
125254486|NCT01272219|450559075|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
125254487|NCT01272219|450559076|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
125254488|NCT01272219|450559077|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
125254489|NCT01272219|450559078|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
125254490|NCT01272219|450559073|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
125254491|NCT01272219|450559074|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
125254492|NCT01272219|450559075|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
125254493|NCT01272219|450559076|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
125254494|NCT01272219|450559077|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
125254495|NCT01272219|450559078|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
125254496|NCT01272219|450559073|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
125254497|NCT01272219|450559074|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
125254498|NCT01272219|450559075|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
125254499|NCT01272219|450559076|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
125254500|NCT01272219|450559077|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
125254501|NCT01272219|450559078|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
125254502|NCT01272219|450559073|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
125254503|NCT01272219|450559074|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
125254504|NCT01272219|450559075|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
125254505|NCT01272219|450559076|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
125254506|NCT01272219|450559077|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
125254507|NCT01272219|450559078|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
125254508|NCT01272219|450559073|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
125254509|NCT01272219|450559074|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
125254510|NCT01272219|450559075|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
125254511|NCT01272219|450559076|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
125254512|NCT01272219|450559077|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
125254513|NCT01272219|450559078|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
125254514|NCT01272219|450559073|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
125254515|NCT01272219|450559074|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
125254516|NCT01272219|450559075|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
125254517|NCT01272219|450559076|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
125254518|NCT01272219|450559077|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
125254519|NCT01272219|450559078|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
125254520|NCT01272219|450559073|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
125254521|NCT01272219|450559074|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
125254522|NCT01272219|450559075|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
125254523|NCT01272219|450559076|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
125254524|NCT01272219|450559077|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
125254525|NCT01272219|450559078|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
125254526|NCT01272219|450559073|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
125254527|NCT01272219|450559074|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
125254528|NCT01272219|450559075|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
125254529|NCT01272219|450559076|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
125254530|NCT01272219|450559077|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
125254531|NCT01272219|450559078|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
125254532|NCT01272219|450559073|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
125254533|NCT01272219|450559074|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
125254534|NCT01272219|450559075|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
125254535|NCT01272219|450559076|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
125254536|NCT01272219|450559077|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
125254537|NCT01272219|450559078|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
125254538|NCT01272219|450559073|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
125254539|NCT01272219|450559074|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
125254540|NCT01272219|450559075|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
125254541|NCT01272219|450559076|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
125254542|NCT01272219|450559077|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
125254543|NCT01272219|450559078|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
125254544|NCT03131479|450559079|FG000|Overall Study|Adverse Event|0|||
125254545|NCT03131479|450559080|FG001|Overall Study|Adverse Event|0|||
125254546|NCT03131479|450559081|FG002|Overall Study|Adverse Event|1|||
125254547|NCT03131479|450559082|FG003|Overall Study|Adverse Event|1|||
125254548|NCT03131479|450559083|FG004|Overall Study|Adverse Event|0|||
125254549|NCT03131479|450559079|FG000|Overall Study|Subject/Guardian Decision|0|||
125254550|NCT03131479|450559080|FG001|Overall Study|Subject/Guardian Decision|0|||
125254551|NCT03131479|450559081|FG002|Overall Study|Subject/Guardian Decision|0|||
125254552|NCT03131479|450559082|FG003|Overall Study|Subject/Guardian Decision|1|||
125254553|NCT03131479|450559083|FG004|Overall Study|Subject/Guardian Decision|0|||
125254554|NCT02899754|450559086|FG000|Overall Study|Lost to Follow-up|7|||
125254555|NCT02899754|450559087|FG001|Overall Study|Lost to Follow-up|9|||
125254556|NCT04818229|450559088|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
125254557|NCT04818229|450559089|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
125254558|NCT04818229|450559090|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
125254559|NCT04818229|450559088|FG000|Overall Study|Adverse Event|3|||
125254560|NCT04818229|450559089|FG001|Overall Study|Adverse Event|1|||
125254561|NCT04818229|450559090|FG002|Overall Study|Adverse Event|1|||
125254562|NCT04818229|450559088|FG000|Overall Study|Withdrawal by Subject|0|||
125254563|NCT04818229|450559089|FG001|Overall Study|Withdrawal by Subject|0|||
125254564|NCT04818229|450559090|FG002|Overall Study|Withdrawal by Subject|2|||
125254565|NCT04818229|450559088|FG000|Overall Study|Lost to Follow-up|0|||
125254566|NCT04818229|450559089|FG001|Overall Study|Lost to Follow-up|0|||
125254567|NCT04818229|450559090|FG002|Overall Study|Lost to Follow-up|1|||
125254568|NCT03186378|450559091|FG000|Overall Study|Lost to Follow-up|1|||
125254569|NCT03186378|450559092|FG001|Overall Study|Lost to Follow-up|0|||
125254570|NCT02514746|450559093|FG000|Overall Study|Chronically Ill|1|||
125254571|NCT02514746|450559094|FG001|Overall Study|Chronically Ill|2|||
125254572|NCT02514746|450559093|FG000|Overall Study|Physician Decision|4|||
125254573|NCT02514746|450559094|FG001|Overall Study|Physician Decision|2|||
125254574|NCT02514746|450559093|FG000|Overall Study|Withdrawal by Subject|12|||
125254575|NCT02514746|450559094|FG001|Overall Study|Withdrawal by Subject|10|||
125254576|NCT02514746|450559093|FG000|Overall Study|Other|5|||
125254577|NCT02514746|450559094|FG001|Overall Study|Other|1|||
125254578|NCT02181413|450559095|FG000|Overall Study|Withdrawal by Subject|45|||
125254579|NCT02181413|450559096|FG001|Overall Study|Withdrawal by Subject|61|||
125254580|NCT02181413|450559095|FG000|Overall Study|Reason Not Specified|2|||
125254581|NCT02181413|450559096|FG001|Overall Study|Reason Not Specified|5|||
125254582|NCT02181413|450559095|FG000|Overall Study|Lost to Follow-up|8|||
125254583|NCT02181413|450559096|FG001|Overall Study|Lost to Follow-up|7|||
125254584|NCT00050011|450559098|FG000|Overall Study|Adverse Event|41|||
125254585|NCT00050011|450559099|FG001|Overall Study|Adverse Event|46|||
125254586|NCT00050011|450559098|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125254587|NCT00050011|450559099|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125254588|NCT00050011|450559098|FG000|Overall Study|Abnormal test procedure results|0|||
125254589|NCT00050011|450559099|FG001|Overall Study|Abnormal test procedure results|1|||
125254590|NCT00050011|450559098|FG000|Overall Study|Lack of Efficacy|16|||
125254591|NCT00050011|450559099|FG001|Overall Study|Lack of Efficacy|21|||
125254592|NCT00050011|450559098|FG000|Overall Study|Participant condition no longer required|1|||
125254593|NCT00050011|450559099|FG001|Overall Study|Participant condition no longer required|0|||
125254594|NCT00050011|450559098|FG000|Overall Study|Protocol Violation|4|||
125254595|NCT00050011|450559099|FG001|Overall Study|Protocol Violation|10|||
125254596|NCT00050011|450559098|FG000|Overall Study|Withdrawal by Subject|34|||
125254597|NCT00050011|450559099|FG001|Overall Study|Withdrawal by Subject|26|||
125254598|NCT00050011|450559098|FG000|Overall Study|Lost to Follow-up|7|||
125254599|NCT00050011|450559099|FG001|Overall Study|Lost to Follow-up|9|||
125254600|NCT00050011|450559098|FG000|Overall Study|Administrative problems|10|||
125254601|NCT00050011|450559099|FG001|Overall Study|Administrative problems|6|||
125254602|NCT00050011|450559098|FG000|Overall Study|Death|7|||
125254603|NCT00050011|450559099|FG001|Overall Study|Death|4|||
125254604|NCT00050011|450559098|FG000|Overall Study|Unknown - Reason is missing|0|||
125254605|NCT00050011|450559099|FG001|Overall Study|Unknown - Reason is missing|2|||
125254606|NCT04903093|450559106|FG000|Overall Study|Withdrawal by Subject|0|||
125254607|NCT04903093|450559107|FG001|Overall Study|Withdrawal by Subject|0|||
125254608|NCT04903093|450559108|FG002|Overall Study|Withdrawal by Subject|0|||
125254609|NCT04903093|450559109|FG003|Overall Study|Withdrawal by Subject|1|||
125254610|NCT04903093|450559110|FG004|Overall Study|Withdrawal by Subject|0|||
125254611|NCT04903093|450559111|FG005|Overall Study|Withdrawal by Subject|0|||
125254612|NCT03973489|450559117|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
125254613|NCT03973489|450559118|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
125254614|NCT03973489|450559119|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
125254615|NCT03973489|450559120|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
125254616|NCT03973489|450559121|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
125254617|NCT03973489|450559122|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
125254618|NCT03973489|450559123|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
125254619|NCT03973489|450559124|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
125254620|NCT03973489|450559117|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
125254621|NCT03973489|450559118|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
125254622|NCT03973489|450559119|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
125254623|NCT03973489|450559120|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
125254624|NCT03973489|450559121|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
125254625|NCT03973489|450559122|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
125254626|NCT03973489|450559123|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
125254627|NCT03973489|450559124|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
125254628|NCT03973489|450559117|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
125254629|NCT03973489|450559118|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
125254630|NCT03973489|450559119|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
125254631|NCT03973489|450559120|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
125254632|NCT03973489|450559121|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
125254633|NCT03973489|450559122|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
125254634|NCT03973489|450559123|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
125254635|NCT03973489|450559124|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
125254636|NCT03973489|450559117|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
125254637|NCT03973489|450559118|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
125254638|NCT03973489|450559119|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
125254639|NCT03973489|450559120|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
125254640|NCT03973489|450559121|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
125254641|NCT03973489|450559122|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
125254642|NCT03973489|450559123|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
125254643|NCT03973489|450559124|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
125254644|NCT03973489|450559117|FG000|Second Intervention (1 Day)|Adverse Event|0|||
125254645|NCT03973489|450559118|FG001|Second Intervention (1 Day)|Adverse Event|0|||
125254646|NCT03973489|450559119|FG002|Second Intervention (1 Day)|Adverse Event|0|||
125254647|NCT03973489|450559120|FG003|Second Intervention (1 Day)|Adverse Event|1|||
125254648|NCT03973489|450559121|FG004|Second Intervention (1 Day)|Adverse Event|0|||
125254649|NCT03973489|450559122|FG005|Second Intervention (1 Day)|Adverse Event|0|||
125254650|NCT03973489|450559123|FG006|Second Intervention (1 Day)|Adverse Event|0|||
125254651|NCT03973489|450559124|FG007|Second Intervention (1 Day)|Adverse Event|0|||
125254652|NCT00392288|450559125|FG000|Overall Study|Adverse Event|17|||
125254653|NCT00392288|450559126|FG001|Overall Study|Adverse Event|7|||
125254654|NCT00392288|450559127|FG002|Overall Study|Adverse Event|8|||
125254655|NCT00392288|450559125|FG000|Overall Study|Lack of Efficacy|8|||
125254656|NCT00392288|450559126|FG001|Overall Study|Lack of Efficacy|5|||
125254657|NCT00392288|450559127|FG002|Overall Study|Lack of Efficacy|3|||
125254658|NCT00392288|450559125|FG000|Overall Study|Protocol Violation|1|||
125254659|NCT00392288|450559126|FG001|Overall Study|Protocol Violation|3|||
125254660|NCT00392288|450559127|FG002|Overall Study|Protocol Violation|1|||
125254661|NCT00392288|450559125|FG000|Overall Study|Lost to Follow-up|1|||
125254662|NCT00392288|450559126|FG001|Overall Study|Lost to Follow-up|1|||
125254663|NCT00392288|450559127|FG002|Overall Study|Lost to Follow-up|1|||
125254664|NCT00392288|450559125|FG000|Overall Study|Withdrawal by Subject|1|||
125254665|NCT00392288|450559126|FG001|Overall Study|Withdrawal by Subject|0|||
125254666|NCT00392288|450559127|FG002|Overall Study|Withdrawal by Subject|2|||
125254667|NCT00392288|450559125|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
125254668|NCT00392288|450559126|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
125254669|NCT00392288|450559127|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
125254670|NCT00392288|450559125|FG000|Overall Study|Other|3|||
125254671|NCT00392288|450559126|FG001|Overall Study|Other|4|||
125254672|NCT00392288|450559127|FG002|Overall Study|Other|1|||
125254673|NCT02544763|450559128|FG000|Overall Study|Adverse Event|8|||
125254674|NCT02544763|450559129|FG001|Overall Study|Adverse Event|8|||
125254675|NCT02544763|450559130|FG002|Overall Study|Adverse Event|0|||
125254676|NCT02544763|450559128|FG000|Overall Study|Withdrawn by parent/guardian|1|||
125254677|NCT02544763|450559129|FG001|Overall Study|Withdrawn by parent/guardian|1|||
125254678|NCT02544763|450559130|FG002|Overall Study|Withdrawn by parent/guardian|1|||
125254679|NCT02544763|450559128|FG000|Overall Study|Met withdrawal criteria|0|||
125254680|NCT02544763|450559129|FG001|Overall Study|Met withdrawal criteria|2|||
125254681|NCT02544763|450559130|FG002|Overall Study|Met withdrawal criteria|0|||
125254682|NCT02544763|450559128|FG000|Overall Study|Physician Decision|0|||
125254683|NCT02544763|450559129|FG001|Overall Study|Physician Decision|1|||
125254684|NCT02544763|450559130|FG002|Overall Study|Physician Decision|0|||
125254685|NCT02544763|450559128|FG000|Overall Study|Difficulties taking IMP|1|||
125254686|NCT02544763|450559129|FG001|Overall Study|Difficulties taking IMP|0|||
125254687|NCT02544763|450559130|FG002|Overall Study|Difficulties taking IMP|0|||
125254688|NCT02613507|450559137|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
125254689|NCT02613507|450559138|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
125254690|NCT02613507|450559137|FG000|Pre-Treamtent|Participant withdrew consent|0|||
125254691|NCT02613507|450559138|FG001|Pre-Treamtent|Participant withdrew consent|4|||
125254692|NCT02613507|450559137|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
125254693|NCT02613507|450559138|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
125254694|NCT02613507|450559137|FG000|Treatment|Not reported|3|||
125254695|NCT02613507|450559138|FG001|Treatment|Not reported|0|||
125254696|NCT02613507|450559137|FG000|Treatment|Other reasons|8|||
125254697|NCT02613507|450559138|FG001|Treatment|Other reasons|0|||
125254698|NCT02613507|450559137|FG000|Treatment|Participant no longer meets criteria|3|||
125254699|NCT02613507|450559138|FG001|Treatment|Participant no longer meets criteria|0|||
125254700|NCT02613507|450559137|FG000|Treatment|Maximum clinical benefit|5|||
125254701|NCT02613507|450559138|FG001|Treatment|Maximum clinical benefit|10|||
125254702|NCT02613507|450559137|FG000|Treatment|Lost to Follow-up|1|||
125254703|NCT02613507|450559138|FG001|Treatment|Lost to Follow-up|0|||
125254704|NCT02613507|450559137|FG000|Treatment|Participant withdrew consent|0|||
125254705|NCT02613507|450559138|FG001|Treatment|Participant withdrew consent|2|||
125254706|NCT02613507|450559137|FG000|Treatment|Participant request to discontinue study treatment|13|||
125254707|NCT02613507|450559138|FG001|Treatment|Participant request to discontinue study treatment|17|||
125254708|NCT02613507|450559137|FG000|Treatment|Adverse event unrelated to study drug|20|||
125254709|NCT02613507|450559138|FG001|Treatment|Adverse event unrelated to study drug|3|||
125254710|NCT02613507|450559137|FG000|Treatment|Death|2|||
125254711|NCT02613507|450559138|FG001|Treatment|Death|0|||
125254712|NCT02613507|450559137|FG000|Treatment|Study drug toxicity|19|||
125254713|NCT02613507|450559138|FG001|Treatment|Study drug toxicity|14|||
125254714|NCT02613507|450559137|FG000|Treatment|Disease progression|263|||
125254715|NCT02613507|450559138|FG001|Treatment|Disease progression|110|||
125254716|NCT03941093|450559139|FG000|Overall Study|Protocol Violation|0|||
125254717|NCT03941093|450559140|FG001|Overall Study|Protocol Violation|1|||
125254718|NCT03941093|450559139|FG000|Overall Study|Withdrawal by Subject|9|||
125254719|NCT03941093|450559140|FG001|Overall Study|Withdrawal by Subject|6|||
125254720|NCT00590317|450560471|FG000|Overall Study|Lack of Efficacy|1|||
125254721|NCT00590317|450560472|FG001|Overall Study|Lack of Efficacy|5|||
125254722|NCT00003907|450560479|FG000|Overall Study|Adverse Event|2|||
125254723|NCT00003907|450560480|FG001|Overall Study|Adverse Event|11|||
125254724|NCT00003907|450560479|FG000|Overall Study|Death|2|||
125254725|NCT00003907|450560480|FG001|Overall Study|Death|0|||
125254726|NCT00003907|450560479|FG000|Overall Study|Withdrawal by Subject|1|||
125254727|NCT00003907|450560480|FG001|Overall Study|Withdrawal by Subject|3|||
125254728|NCT00003907|450560479|FG000|Overall Study|Progressive disease|4|||
125254729|NCT00003907|450560480|FG001|Overall Study|Progressive disease|4|||
125254730|NCT00003907|450560479|FG000|Overall Study|Complicating disease|1|||
125254731|NCT00003907|450560480|FG001|Overall Study|Complicating disease|0|||
125254732|NCT00003907|450560479|FG000|Overall Study|Other|1|||
125254733|NCT00003907|450560480|FG001|Overall Study|Other|3|||
125254734|NCT00003907|450560479|FG000|Overall Study|ineligible or not treated|2|||
125254735|NCT00003907|450560480|FG001|Overall Study|ineligible or not treated|2|||
125254736|NCT01517178|450560481|FG000|Period 1|Adverse Event|1|||
125254737|NCT01517178|450560482|FG001|Period 1|Adverse Event|2|||
125254738|NCT01517178|450560481|FG000|Period 1|Lack of Efficacy|0|||
125254739|NCT01517178|450560482|FG001|Period 1|Lack of Efficacy|1|||
125254740|NCT01517178|450560481|FG000|Period 1|E.g. study termination|3|||
125254741|NCT01517178|450560482|FG001|Period 1|E.g. study termination|1|||
125254742|NCT01517178|450560481|FG000|Period 1|Withdrawal by Subject|0|||
125254743|NCT01517178|450560482|FG001|Period 1|Withdrawal by Subject|1|||
125254744|NCT01517178|450560481|FG000|Period 2|Adverse Event|1|||
125254745|NCT01517178|450560482|FG001|Period 2|Adverse Event|0|||
125254746|NCT01517178|450560481|FG000|Period 2|Withdrawal by Subject|3|||
125254747|NCT01517178|450560482|FG001|Period 2|Withdrawal by Subject|0|||
125254748|NCT01517178|450560481|FG000|Period 2|E.g. study termination|2|||
125254749|NCT01517178|450560482|FG001|Period 2|E.g. study termination|2|||
125254750|NCT01050218|450560489|FG000|Overall Study|Adverse Event|37|||
125254751|NCT01050218|450560489|FG000|Overall Study|Lack of Efficacy|8|||
125254752|NCT01050218|450560489|FG000|Overall Study|Protocol Violation|3|||
125254753|NCT01050218|450560489|FG000|Overall Study|Withdrawal by Subject|18|||
125254754|NCT01050218|450560489|FG000|Overall Study|Discontinued by sponsor|18|||
125254755|NCT01050218|450560489|FG000|Overall Study|Compliance|2|||
125254756|NCT01050218|450560489|FG000|Overall Study|Failed to return|7|||
125254757|NCT01050218|450560489|FG000|Overall Study|Serious Adverse Event|1|||
125254758|NCT01050218|450560489|FG000|Overall Study|Family emergency|1|||
125254759|NCT01149460|450560490|FG000|Overall Study|Withdrawal by Subject|0|||
125254760|NCT01149460|450560491|FG001|Overall Study|Withdrawal by Subject|2|||
125254761|NCT00266032|450560492|FG000|Treatment|Adverse Event|42|||
125254762|NCT00266032|450560493|FG001|Treatment|Adverse Event|26|||
125254763|NCT00266032|450560494|FG002|Treatment|Adverse Event|10|||
125254764|NCT00266032|450560492|FG000|Treatment|Lost to Follow-up|19|||
125254765|NCT00266032|450560493|FG001|Treatment|Lost to Follow-up|4|||
125254766|NCT00266032|450560494|FG002|Treatment|Lost to Follow-up|2|||
125254767|NCT00266032|450560492|FG000|Treatment|Pregnancy|3|||
125254768|NCT00266032|450560493|FG001|Treatment|Pregnancy|2|||
125254769|NCT00266032|450560494|FG002|Treatment|Pregnancy|2|||
125254770|NCT00266032|450560492|FG000|Treatment|Protocol Violation|6|||
125254771|NCT00266032|450560493|FG001|Treatment|Protocol Violation|14|||
125254772|NCT00266032|450560494|FG002|Treatment|Protocol Violation|13|||
125254773|NCT00266032|450560492|FG000|Treatment|Withdrawal by Subject|28|||
125254774|NCT00266032|450560493|FG001|Treatment|Withdrawal by Subject|13|||
125254775|NCT00266032|450560494|FG002|Treatment|Withdrawal by Subject|12|||
125254776|NCT00266032|450560492|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
125254777|NCT00266032|450560493|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
125254778|NCT00266032|450560494|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
125254779|NCT00266032|450560492|FG000|Open-label Safety Extension|Adverse Event|5|||
125254780|NCT00266032|450560493|FG001|Open-label Safety Extension|Adverse Event|0|||
125254781|NCT00266032|450560494|FG002|Open-label Safety Extension|Adverse Event|4|||
125254782|NCT00266032|450560492|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
125254783|NCT00266032|450560493|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
125254784|NCT00266032|450560494|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
125254785|NCT00266032|450560492|FG000|Open-label Safety Extension|Pregnancy|4|||
125254786|NCT00266032|450560493|FG001|Open-label Safety Extension|Pregnancy|1|||
125254787|NCT00266032|450560494|FG002|Open-label Safety Extension|Pregnancy|2|||
125254788|NCT00266032|450560492|FG000|Open-label Safety Extension|Protocol Violation|1|||
125254789|NCT00266032|450560493|FG001|Open-label Safety Extension|Protocol Violation|3|||
125254790|NCT00266032|450560494|FG002|Open-label Safety Extension|Protocol Violation|2|||
125254791|NCT00266032|450560492|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
125254792|NCT00266032|450560493|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
125254793|NCT00266032|450560494|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
125254794|NCT00266032|450560492|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
125254795|NCT00266032|450560493|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
125254796|NCT00266032|450560494|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
125254797|NCT01514357|450560498|FG000|Overall Study|Screen failure|2|||
125254798|NCT01514357|450560499|FG001|Overall Study|Screen failure|0|||
125254799|NCT01514357|450560498|FG000|Overall Study|Withdrawal by Subject|2|||
125254800|NCT01514357|450560499|FG001|Overall Study|Withdrawal by Subject|0|||
125254801|NCT00752219|450560500|FG000|Overall Study|Clinical failure|0|||
125254802|NCT00752219|450560501|FG001|Overall Study|Clinical failure|1|||
125254803|NCT00752219|450560500|FG000|Overall Study|Adverse Event|5|||
125254804|NCT00752219|450560501|FG001|Overall Study|Adverse Event|3|||
125254805|NCT00752219|450560500|FG000|Overall Study|Protocol deviation|1|||
125254806|NCT00752219|450560501|FG001|Overall Study|Protocol deviation|0|||
125254807|NCT00752219|450560500|FG000|Overall Study|Lost to Follow-up|1|||
125254808|NCT00752219|450560501|FG001|Overall Study|Lost to Follow-up|2|||
125254809|NCT00752219|450560500|FG000|Overall Study|Randomized but not treated|1|||
125254810|NCT00752219|450560501|FG001|Overall Study|Randomized but not treated|0|||
125254811|NCT00752219|450560500|FG000|Overall Study|Other|3|||
125254812|NCT00752219|450560501|FG001|Overall Study|Other|0|||
125254813|NCT04691115|450560504|FG000|Overall Study|Withdrawal by Subject|0|||
125254814|NCT04691115|450560505|FG001|Overall Study|Withdrawal by Subject|0|||
125254815|NCT04691115|450560506|FG002|Overall Study|Withdrawal by Subject|0|||
125254816|NCT04691115|450560507|FG003|Overall Study|Withdrawal by Subject|0|||
125254817|NCT04691115|450560508|FG004|Overall Study|Withdrawal by Subject|0|||
125254818|NCT04691115|450560509|FG005|Overall Study|Withdrawal by Subject|1|||
125254819|NCT04691115|450560510|FG006|Overall Study|Withdrawal by Subject|0|||
125254820|NCT04691115|450560511|FG007|Overall Study|Withdrawal by Subject|0|||
125254821|NCT04691115|450560512|FG008|Overall Study|Withdrawal by Subject|0|||
125254822|NCT04691115|450560513|FG009|Overall Study|Withdrawal by Subject|0|||
125254823|NCT04691115|450560514|FG010|Overall Study|Withdrawal by Subject|0|||
125254824|NCT04691115|450560515|FG011|Overall Study|Withdrawal by Subject|0|||
125254825|NCT04691115|450560516|FG012|Overall Study|Withdrawal by Subject|0|||
125254826|NCT04691115|450560517|FG013|Overall Study|Withdrawal by Subject|0|||
125254827|NCT02096354|450560522|FG000|Overall Study|Physician Decision|4|||
125254828|NCT02096354|450560523|FG001|Overall Study|Physician Decision|5|||
125254829|NCT02096354|450560524|FG002|Overall Study|Physician Decision|0|||
125254830|NCT02096354|450560522|FG000|Overall Study|Withdrawal by Subject|3|||
125254831|NCT02096354|450560523|FG001|Overall Study|Withdrawal by Subject|1|||
125254832|NCT02096354|450560524|FG002|Overall Study|Withdrawal by Subject|0|||
125254833|NCT02096354|450560522|FG000|Overall Study|Adverse Event|7|||
125254834|NCT02096354|450560523|FG001|Overall Study|Adverse Event|4|||
125254835|NCT02096354|450560524|FG002|Overall Study|Adverse Event|0|||
125254836|NCT02096354|450560522|FG000|Overall Study|Ineligible|0|||
125254837|NCT02096354|450560523|FG001|Overall Study|Ineligible|0|||
125254838|NCT02096354|450560524|FG002|Overall Study|Ineligible|11|||
125254839|NCT03715829|450560525|FG000|Dose Ranging Period|Adverse Event|2|||
125254840|NCT03715829|450560526|FG001|Dose Ranging Period|Adverse Event|4|||
125254841|NCT03715829|450560527|FG002|Dose Ranging Period|Adverse Event|5|||
125254842|NCT03715829|450560528|FG003|Dose Ranging Period|Adverse Event|2|||
125254843|NCT03715829|450560529|FG004|Dose Ranging Period|Adverse Event|3|||
125254844|NCT03715829|450560530|FG005|Dose Ranging Period|Adverse Event|3|||
125254845|NCT03715829|450560531|FG006|Dose Ranging Period|Adverse Event|0|||
125254846|NCT03715829|450560532|FG007|Dose Ranging Period|Adverse Event|0|||
125254847|NCT03715829|450560533|FG008|Dose Ranging Period|Adverse Event|0|||
125254848|NCT03715829|450560534|FG009|Dose Ranging Period|Adverse Event|0|||
125254849|NCT03715829|450560535|FG010|Dose Ranging Period|Adverse Event|0|||
125254850|NCT03715829|450560525|FG000|Dose Ranging Period|Lack of Efficacy|0|||
125254851|NCT03715829|450560526|FG001|Dose Ranging Period|Lack of Efficacy|1|||
125254852|NCT03715829|450560527|FG002|Dose Ranging Period|Lack of Efficacy|0|||
125254853|NCT03715829|450560528|FG003|Dose Ranging Period|Lack of Efficacy|1|||
125254854|NCT03715829|450560529|FG004|Dose Ranging Period|Lack of Efficacy|0|||
125254855|NCT03715829|450560530|FG005|Dose Ranging Period|Lack of Efficacy|0|||
125254856|NCT03715829|450560531|FG006|Dose Ranging Period|Lack of Efficacy|0|||
125254857|NCT03715829|450560532|FG007|Dose Ranging Period|Lack of Efficacy|0|||
125254858|NCT03715829|450560533|FG008|Dose Ranging Period|Lack of Efficacy|0|||
125254859|NCT03715829|450560534|FG009|Dose Ranging Period|Lack of Efficacy|0|||
125254860|NCT03715829|450560535|FG010|Dose Ranging Period|Lack of Efficacy|0|||
125254861|NCT03715829|450560525|FG000|Dose Ranging Period|Lost to Follow-up|2|||
125254862|NCT03715829|450560526|FG001|Dose Ranging Period|Lost to Follow-up|0|||
125254863|NCT03715829|450560527|FG002|Dose Ranging Period|Lost to Follow-up|1|||
125254864|NCT03715829|450560528|FG003|Dose Ranging Period|Lost to Follow-up|1|||
125254865|NCT03715829|450560529|FG004|Dose Ranging Period|Lost to Follow-up|1|||
125254866|NCT03715829|450560530|FG005|Dose Ranging Period|Lost to Follow-up|2|||
125254867|NCT03715829|450560531|FG006|Dose Ranging Period|Lost to Follow-up|0|||
125254868|NCT03715829|450560532|FG007|Dose Ranging Period|Lost to Follow-up|0|||
125254869|NCT03715829|450560533|FG008|Dose Ranging Period|Lost to Follow-up|0|||
125254870|NCT03715829|450560534|FG009|Dose Ranging Period|Lost to Follow-up|0|||
125254871|NCT03715829|450560535|FG010|Dose Ranging Period|Lost to Follow-up|0|||
125254872|NCT03715829|450560525|FG000|Dose Ranging Period|Protocol Violation|0|||
125254873|NCT03715829|450560526|FG001|Dose Ranging Period|Protocol Violation|0|||
125254874|NCT03715829|450560527|FG002|Dose Ranging Period|Protocol Violation|0|||
125254875|NCT03715829|450560528|FG003|Dose Ranging Period|Protocol Violation|1|||
125254876|NCT03715829|450560529|FG004|Dose Ranging Period|Protocol Violation|0|||
125254877|NCT03715829|450560530|FG005|Dose Ranging Period|Protocol Violation|0|||
125254878|NCT03715829|450560531|FG006|Dose Ranging Period|Protocol Violation|0|||
125254879|NCT03715829|450560532|FG007|Dose Ranging Period|Protocol Violation|0|||
125254880|NCT03715829|450560533|FG008|Dose Ranging Period|Protocol Violation|0|||
125254881|NCT03715829|450560534|FG009|Dose Ranging Period|Protocol Violation|0|||
125254882|NCT03715829|450560535|FG010|Dose Ranging Period|Protocol Violation|0|||
125254883|NCT03715829|450560525|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
125254884|NCT03715829|450560526|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
125254885|NCT03715829|450560527|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
125254886|NCT03715829|450560528|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
125254887|NCT03715829|450560529|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
125254888|NCT03715829|450560530|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
125254889|NCT03715829|450560531|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
125254890|NCT03715829|450560532|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
125254891|NCT03715829|450560533|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
125254892|NCT03715829|450560534|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
125254893|NCT03715829|450560535|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
125254894|NCT03715829|450560525|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
125254895|NCT03715829|450560526|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
125254896|NCT03715829|450560527|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
125254897|NCT03715829|450560528|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
125254898|NCT03715829|450560529|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
125254899|NCT03715829|450560530|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
125254900|NCT03715829|450560531|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
125254901|NCT03715829|450560532|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
125254902|NCT03715829|450560533|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
125254903|NCT03715829|450560534|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
125254904|NCT03715829|450560535|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
125254905|NCT03715829|450560525|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
125254906|NCT03715829|450560526|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
125254907|NCT03715829|450560527|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
125254908|NCT03715829|450560528|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
125254909|NCT03715829|450560529|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
125254910|NCT03715829|450560530|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
125254911|NCT03715829|450560531|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
125254912|NCT03715829|450560532|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
125254913|NCT03715829|450560533|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
125254914|NCT03715829|450560534|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
125254915|NCT03715829|450560535|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
125254916|NCT03715829|450560525|FG000|Dose Ranging Period|Other|0|||
125254917|NCT03715829|450560526|FG001|Dose Ranging Period|Other|0|||
125254918|NCT03715829|450560527|FG002|Dose Ranging Period|Other|2|||
125254919|NCT03715829|450560528|FG003|Dose Ranging Period|Other|0|||
125254920|NCT03715829|450560529|FG004|Dose Ranging Period|Other|0|||
125254921|NCT03715829|450560530|FG005|Dose Ranging Period|Other|3|||
125254922|NCT03715829|450560531|FG006|Dose Ranging Period|Other|0|||
125254923|NCT03715829|450560532|FG007|Dose Ranging Period|Other|0|||
125254924|NCT03715829|450560533|FG008|Dose Ranging Period|Other|0|||
125254925|NCT03715829|450560534|FG009|Dose Ranging Period|Other|0|||
125254926|NCT03715829|450560535|FG010|Dose Ranging Period|Other|0|||
125254927|NCT03715829|450560525|FG000|Extension Period|Adverse Event|0|||
125254928|NCT03715829|450560526|FG001|Extension Period|Adverse Event|0|||
125254929|NCT03715829|450560527|FG002|Extension Period|Adverse Event|0|||
125254930|NCT03715829|450560528|FG003|Extension Period|Adverse Event|0|||
125254931|NCT03715829|450560529|FG004|Extension Period|Adverse Event|0|||
125254932|NCT03715829|450560530|FG005|Extension Period|Adverse Event|0|||
125254933|NCT03715829|450560531|FG006|Extension Period|Adverse Event|3|||
125254934|NCT03715829|450560532|FG007|Extension Period|Adverse Event|1|||
125254935|NCT03715829|450560533|FG008|Extension Period|Adverse Event|6|||
125254936|NCT03715829|450560534|FG009|Extension Period|Adverse Event|0|||
125254937|NCT03715829|450560535|FG010|Extension Period|Adverse Event|0|||
125254938|NCT03715829|450560525|FG000|Extension Period|Lack of Efficacy|0|||
125254939|NCT03715829|450560526|FG001|Extension Period|Lack of Efficacy|0|||
125254940|NCT03715829|450560527|FG002|Extension Period|Lack of Efficacy|0|||
125254941|NCT03715829|450560528|FG003|Extension Period|Lack of Efficacy|0|||
125254942|NCT03715829|450560529|FG004|Extension Period|Lack of Efficacy|0|||
125254943|NCT03715829|450560530|FG005|Extension Period|Lack of Efficacy|0|||
125254944|NCT03715829|450560531|FG006|Extension Period|Lack of Efficacy|1|||
125254945|NCT03715829|450560532|FG007|Extension Period|Lack of Efficacy|9|||
125254946|NCT03715829|450560533|FG008|Extension Period|Lack of Efficacy|2|||
125254947|NCT03715829|450560534|FG009|Extension Period|Lack of Efficacy|0|||
125254948|NCT03715829|450560535|FG010|Extension Period|Lack of Efficacy|0|||
125254949|NCT03715829|450560525|FG000|Extension Period|Lost to Follow-up|0|||
125254950|NCT03715829|450560526|FG001|Extension Period|Lost to Follow-up|0|||
125254951|NCT03715829|450560527|FG002|Extension Period|Lost to Follow-up|0|||
125254952|NCT03715829|450560528|FG003|Extension Period|Lost to Follow-up|0|||
125254953|NCT03715829|450560529|FG004|Extension Period|Lost to Follow-up|0|||
125254954|NCT03715829|450560530|FG005|Extension Period|Lost to Follow-up|0|||
125254955|NCT03715829|450560531|FG006|Extension Period|Lost to Follow-up|0|||
125254956|NCT03715829|450560532|FG007|Extension Period|Lost to Follow-up|0|||
125254957|NCT03715829|450560533|FG008|Extension Period|Lost to Follow-up|2|||
125254958|NCT03715829|450560534|FG009|Extension Period|Lost to Follow-up|0|||
125254959|NCT03715829|450560535|FG010|Extension Period|Lost to Follow-up|0|||
125254960|NCT03715829|450560525|FG000|Extension Period|Protocol Violation|0|||
125254961|NCT03715829|450560526|FG001|Extension Period|Protocol Violation|0|||
125254962|NCT03715829|450560527|FG002|Extension Period|Protocol Violation|0|||
125254963|NCT03715829|450560528|FG003|Extension Period|Protocol Violation|0|||
125254964|NCT03715829|450560529|FG004|Extension Period|Protocol Violation|0|||
125254965|NCT03715829|450560530|FG005|Extension Period|Protocol Violation|0|||
125254966|NCT03715829|450560531|FG006|Extension Period|Protocol Violation|0|||
125254967|NCT03715829|450560532|FG007|Extension Period|Protocol Violation|0|||
125254968|NCT03715829|450560533|FG008|Extension Period|Protocol Violation|1|||
125254969|NCT03715829|450560534|FG009|Extension Period|Protocol Violation|0|||
125254970|NCT03715829|450560535|FG010|Extension Period|Protocol Violation|0|||
125254971|NCT03715829|450560525|FG000|Extension Period|Withdrawal by Subject|0|||
125254972|NCT03715829|450560526|FG001|Extension Period|Withdrawal by Subject|0|||
125254973|NCT03715829|450560527|FG002|Extension Period|Withdrawal by Subject|0|||
125254974|NCT03715829|450560528|FG003|Extension Period|Withdrawal by Subject|0|||
125254975|NCT03715829|450560529|FG004|Extension Period|Withdrawal by Subject|0|||
125254976|NCT03715829|450560530|FG005|Extension Period|Withdrawal by Subject|0|||
125254977|NCT03715829|450560531|FG006|Extension Period|Withdrawal by Subject|3|||
125254978|NCT03715829|450560532|FG007|Extension Period|Withdrawal by Subject|3|||
125254979|NCT03715829|450560533|FG008|Extension Period|Withdrawal by Subject|12|||
125254980|NCT03715829|450560534|FG009|Extension Period|Withdrawal by Subject|3|||
125254981|NCT03715829|450560535|FG010|Extension Period|Withdrawal by Subject|0|||
125254982|NCT03715829|450560525|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
125254983|NCT03715829|450560526|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
125254984|NCT03715829|450560527|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
125254985|NCT03715829|450560528|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
125254986|NCT03715829|450560529|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
125254987|NCT03715829|450560530|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
125254988|NCT03715829|450560531|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
125254989|NCT03715829|450560532|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
125254990|NCT03715829|450560533|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
125254991|NCT03715829|450560534|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
125254992|NCT03715829|450560535|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
125254993|NCT03715829|450560525|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
125254994|NCT03715829|450560526|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
125254995|NCT03715829|450560527|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
125254996|NCT03715829|450560528|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
125254997|NCT03715829|450560529|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
125254998|NCT03715829|450560530|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
125254999|NCT03715829|450560531|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
125255000|NCT03715829|450560532|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
125255001|NCT03715829|450560533|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
125255002|NCT03715829|450560534|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
125255003|NCT03715829|450560535|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
125255004|NCT03715829|450560525|FG000|Extension Period|Other|0|||
125255005|NCT03715829|450560526|FG001|Extension Period|Other|0|||
125255006|NCT03715829|450560527|FG002|Extension Period|Other|0|||
125255007|NCT03715829|450560528|FG003|Extension Period|Other|0|||
125255008|NCT03715829|450560529|FG004|Extension Period|Other|0|||
125255009|NCT03715829|450560530|FG005|Extension Period|Other|0|||
125255010|NCT03715829|450560531|FG006|Extension Period|Other|1|||
125255011|NCT03715829|450560532|FG007|Extension Period|Other|2|||
125255012|NCT03715829|450560533|FG008|Extension Period|Other|4|||
125255013|NCT03715829|450560534|FG009|Extension Period|Other|0|||
125255014|NCT03715829|450560535|FG010|Extension Period|Other|0|||
125255015|NCT03579719|450560536|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
125255016|NCT03253627|450560539|FG000|Overall Study|Lost to Follow-up|1|||
125255017|NCT03253627|450560540|FG001|Overall Study|Lost to Follow-up|2|||
125255018|NCT03253627|450560539|FG000|Overall Study|Withdrawal by Subject|0|||
125255019|NCT03253627|450560540|FG001|Overall Study|Withdrawal by Subject|2|||
125255020|NCT03253627|450560539|FG000|Overall Study|Inability to complete MRI|1|||
125255021|NCT03253627|450560540|FG001|Overall Study|Inability to complete MRI|0|||
125255022|NCT01922895|450560544|FG000|Overall Study|Death|0|||
125255023|NCT01922895|450560545|FG001|Overall Study|Death|1|||
125255024|NCT01922895|450560544|FG000|Overall Study|Withdrawal by Subject|1|||
125255025|NCT01922895|450560545|FG001|Overall Study|Withdrawal by Subject|2|||
125255026|NCT01922895|450560544|FG000|Overall Study|Lost to Follow-up|5|||
125255027|NCT01922895|450560545|FG001|Overall Study|Lost to Follow-up|11|||
125255028|NCT01916226|450560546|FG000|Overall Study|Adverse Event|1|||
125255029|NCT01916226|450560547|FG001|Overall Study|Adverse Event|0|||
125255030|NCT01916226|450560548|FG002|Overall Study|Adverse Event|1|||
125255031|NCT01916226|450560549|FG003|Overall Study|Adverse Event|1|||
125255032|NCT01916226|450560546|FG000|Overall Study|Lack of Efficacy|0|||
125255033|NCT01916226|450560547|FG001|Overall Study|Lack of Efficacy|0|||
125255034|NCT01916226|450560548|FG002|Overall Study|Lack of Efficacy|2|||
125255035|NCT01916226|450560549|FG003|Overall Study|Lack of Efficacy|1|||
125255036|NCT01916226|450560546|FG000|Overall Study|Protocol Violation|0|||
125255037|NCT01916226|450560547|FG001|Overall Study|Protocol Violation|1|||
125255038|NCT01916226|450560548|FG002|Overall Study|Protocol Violation|0|||
125255039|NCT01916226|450560549|FG003|Overall Study|Protocol Violation|1|||
125255040|NCT01916226|450560546|FG000|Overall Study|Physician Decision|0|||
125255041|NCT01916226|450560547|FG001|Overall Study|Physician Decision|0|||
125255042|NCT01916226|450560548|FG002|Overall Study|Physician Decision|0|||
125255043|NCT01916226|450560549|FG003|Overall Study|Physician Decision|1|||
125255044|NCT03163667|450560550|FG000|Overall Study|Death|15|||
125255045|NCT03163667|450560551|FG001|Overall Study|Death|27|||
125255046|NCT03163667|450560550|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
125255047|NCT03163667|450560551|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
125255048|NCT02940223|450560557|FG000|Overall Study|Failed Requirement|2|||
125255049|NCT02940223|450560558|FG001|Overall Study|Failed Requirement|0|||
125255050|NCT01422382|450560562|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
125255051|NCT01813357|450560563|FG000|Overall Study|Lost to Follow-up|5|||
125255052|NCT01813357|450560564|FG001|Overall Study|Lost to Follow-up|6|||
125255053|NCT03773562|450560565|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
125255054|NCT03773562|450560565|FG000|Overall Study|Lost to Follow-up|10|||
125255055|NCT03773562|450560565|FG000|Overall Study|Withdrawal by Subject|1|||
125255056|NCT04082364|450560568|FG000|Overall Study|Death|23|||
125255057|NCT04082364|450560569|FG001|Overall Study|Death|1|||
125255058|NCT04082364|450560570|FG002|Overall Study|Death|1|||
125255059|NCT04082364|450560571|FG003|Overall Study|Death|2|||
125255060|NCT04082364|450560572|FG004|Overall Study|Death|1|||
125255061|NCT04082364|450560568|FG000|Overall Study|Lost to Follow-up|1|||
125255062|NCT04082364|450560569|FG001|Overall Study|Lost to Follow-up|0|||
125255063|NCT04082364|450560570|FG002|Overall Study|Lost to Follow-up|0|||
125255064|NCT04082364|450560571|FG003|Overall Study|Lost to Follow-up|0|||
125255065|NCT04082364|450560572|FG004|Overall Study|Lost to Follow-up|1|||
125255066|NCT04082364|450560568|FG000|Overall Study|Physician Decision|1|||
125255067|NCT04082364|450560569|FG001|Overall Study|Physician Decision|1|||
125255068|NCT04082364|450560570|FG002|Overall Study|Physician Decision|0|||
125255069|NCT04082364|450560571|FG003|Overall Study|Physician Decision|2|||
125255070|NCT04082364|450560572|FG004|Overall Study|Physician Decision|1|||
125255071|NCT04082364|450560568|FG000|Overall Study|Withdrawal by Subject|1|||
125255072|NCT04082364|450560569|FG001|Overall Study|Withdrawal by Subject|1|||
125255073|NCT04082364|450560570|FG002|Overall Study|Withdrawal by Subject|0|||
125255074|NCT04082364|450560571|FG003|Overall Study|Withdrawal by Subject|0|||
125255075|NCT04082364|450560572|FG004|Overall Study|Withdrawal by Subject|1|||
125255076|NCT04082364|450560568|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
125255077|NCT04082364|450560569|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
125255078|NCT04082364|450560570|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
125255079|NCT04082364|450560571|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
125255080|NCT04082364|450560572|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
125255081|NCT04082364|450560568|FG000|Overall Study|Disease progression|0|||
125255082|NCT04082364|450560569|FG001|Overall Study|Disease progression|0|||
125255083|NCT04082364|450560570|FG002|Overall Study|Disease progression|0|||
125255084|NCT04082364|450560571|FG003|Overall Study|Disease progression|1|||
125255085|NCT04082364|450560572|FG004|Overall Study|Disease progression|0|||
125255086|NCT04806373|450560574|FG000|Overall Study|Withdrawal by Subject|1|||
125255087|NCT04806373|450560575|FG001|Overall Study|Withdrawal by Subject|1|||
125255088|NCT03301415|450560578|FG000|Overall Study|Lost to Follow-up|2|||
125255089|NCT03301415|450560578|FG000|Overall Study|Unable to comply with visit schedule|2|||
125255090|NCT00421408|450560582|FG000|Overall Study|Lost to Follow-up|30|||
125255091|NCT00421408|450560583|FG001|Overall Study|Lost to Follow-up|20|||
125255092|NCT00421408|450560582|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
125255093|NCT00421408|450560583|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
125255094|NCT04091438|450560584|FG000|Treatment Period 1 (1 Day)|Other|1|||
125255095|NCT04091438|450560585|FG001|Treatment Period 1 (1 Day)|Other|0|||
125255096|NCT04091438|450560584|FG000|Washout Period (1 Day)|Protocol deviation|0|||
125255097|NCT04091438|450560585|FG001|Washout Period (1 Day)|Protocol deviation|1|||
125255098|NCT04091438|450560584|FG000|Washout Period (1 Day)|Other|0|||
125255099|NCT04091438|450560585|FG001|Washout Period (1 Day)|Other|1|||
125255100|NCT00787800|450560589|FG000|Overall Study|Withdrawal by Subject|3|||
125255101|NCT00787800|450560590|FG001|Overall Study|Withdrawal by Subject|5|||
125255102|NCT00787800|450560589|FG000|Overall Study|Death|0|||
125255103|NCT00787800|450560590|FG001|Overall Study|Death|2|||
125255104|NCT04309500|450560593|FG000|Overall Study|Lost to Follow-up|1|||
125255105|NCT04309500|450560594|FG001|Overall Study|Lost to Follow-up|0|||
125255106|NCT04309500|450560595|FG002|Overall Study|Lost to Follow-up|0|||
125255107|NCT04309500|450560596|FG003|Overall Study|Lost to Follow-up|0|||
125255108|NCT00913835|450560597|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
125255109|NCT00913835|450560598|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
125255110|NCT00913835|450560597|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
125255111|NCT00913835|450560598|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
125255112|NCT00913835|450560597|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
125255113|NCT00913835|450560598|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
125255114|NCT00913835|450560597|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
125255115|NCT00913835|450560598|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
125255116|NCT00913835|450560597|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
125255117|NCT00913835|450560598|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
125255118|NCT01308788|450560599|FG000|2-year Treatment|medication change by treating physician|4|||
125255119|NCT01308788|450560600|FG001|2-year Treatment|medication change by treating physician|11|||
125255120|NCT02414841|450560601|FG000|Overall Study|Withdrawal by Subject|7|||
125255121|NCT02414841|450560602|FG001|Overall Study|Withdrawal by Subject|5|||
125255122|NCT02414841|450560601|FG000|Overall Study|Lost to Follow-up|13|||
125255123|NCT02414841|450560602|FG001|Overall Study|Lost to Follow-up|6|||
125255124|NCT02414841|450560601|FG000|Overall Study|Death|17|||
125255125|NCT02414841|450560602|FG001|Overall Study|Death|14|||
125255126|NCT02414841|450560601|FG000|Overall Study|Received a Kidney Transplant|13|||
125255127|NCT02414841|450560602|FG001|Overall Study|Received a Kidney Transplant|4|||
125255128|NCT02414841|450560601|FG000|Overall Study|Randomized But Not Treated|6|||
125255129|NCT02414841|450560602|FG001|Overall Study|Randomized But Not Treated|4|||
125255130|NCT03249558|450560605|FG000|Overall Study|Lost to Follow-up|2|||
125255131|NCT03249558|450560606|FG001|Overall Study|Lost to Follow-up|1|||
125255132|NCT03249558|450560607|FG002|Overall Study|Lost to Follow-up|4|||
125255133|NCT03249558|450560605|FG000|Overall Study|Physician Decision|1|||
125255134|NCT03249558|450560606|FG001|Overall Study|Physician Decision|0|||
125255135|NCT03249558|450560607|FG002|Overall Study|Physician Decision|0|||
125255136|NCT03249558|450560605|FG000|Overall Study|Withdrawal by Subject|6|||
125255137|NCT03249558|450560606|FG001|Overall Study|Withdrawal by Subject|5|||
125255138|NCT03249558|450560607|FG002|Overall Study|Withdrawal by Subject|7|||
125255139|NCT03249558|450560605|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
125255140|NCT03249558|450560606|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
125255141|NCT03249558|450560607|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
125255142|NCT03249558|450560605|FG000|Overall Study|Protocol Violation|1|||
125255143|NCT03249558|450560606|FG001|Overall Study|Protocol Violation|1|||
125255144|NCT03249558|450560607|FG002|Overall Study|Protocol Violation|2|||
125255145|NCT05943990|450560608|FG000|Overall Study|Study Terminated by Sponsor|0|||
125255146|NCT05943990|450560609|FG001|Overall Study|Study Terminated by Sponsor|0|||
125255147|NCT05943990|450560610|FG002|Overall Study|Study Terminated by Sponsor|1|||
125255148|NCT02657356|450561564|FG000|Overall Study|Death|1|||
125255149|NCT02657356|450561565|FG001|Overall Study|Death|0|||
125255150|NCT02657356|450561564|FG000|Overall Study|Withdrawal by Subject|5|||
125255151|NCT02657356|450561565|FG001|Overall Study|Withdrawal by Subject|6|||
125255152|NCT02657356|450561564|FG000|Overall Study|Terminated by Sponsor|8|||
125255153|NCT02657356|450561565|FG001|Overall Study|Terminated by Sponsor|5|||
125255154|NCT02657356|450561564|FG000|Overall Study|Rolled over to EAP study|6|||
125255155|NCT02657356|450561565|FG001|Overall Study|Rolled over to EAP study|4|||
125255156|NCT03379870|450561566|FG000|Overall Study|Lost to Follow-up|1|||
125255157|NCT03379870|450561567|FG001|Overall Study|Lost to Follow-up|0|||
125255158|NCT03379870|450561566|FG000|Overall Study|Protocol Violation|1|||
125255159|NCT03379870|450561567|FG001|Overall Study|Protocol Violation|1|||
125255160|NCT01394185|450561568|FG000|Overall Study|Withdrawal by Subject|2|||
125255161|NCT01394185|450561569|FG001|Overall Study|Withdrawal by Subject|0|||
125255162|NCT01394185|450561570|FG002|Overall Study|Withdrawal by Subject|0|||
125255163|NCT01394185|450561571|FG003|Overall Study|Withdrawal by Subject|0|||
125255164|NCT01394185|450561572|FG004|Overall Study|Withdrawal by Subject|1|||
125255165|NCT01394185|450561573|FG005|Overall Study|Withdrawal by Subject|0|||
125255166|NCT01394185|450561568|FG000|Overall Study|Change in protocol|3|||
125255167|NCT01394185|450561569|FG001|Overall Study|Change in protocol|0|||
125255168|NCT01394185|450561570|FG002|Overall Study|Change in protocol|0|||
125255169|NCT01394185|450561571|FG003|Overall Study|Change in protocol|0|||
125255170|NCT01394185|450561572|FG004|Overall Study|Change in protocol|3|||
125255171|NCT01394185|450561573|FG005|Overall Study|Change in protocol|0|||
125255172|NCT01394185|450561568|FG000|Overall Study|Protocol Violation|1|||
125255173|NCT01394185|450561569|FG001|Overall Study|Protocol Violation|0|||
125255174|NCT01394185|450561570|FG002|Overall Study|Protocol Violation|0|||
125255175|NCT01394185|450561571|FG003|Overall Study|Protocol Violation|1|||
125255176|NCT01394185|450561572|FG004|Overall Study|Protocol Violation|0|||
125255177|NCT01394185|450561573|FG005|Overall Study|Protocol Violation|1|||
125255178|NCT02904265|450561574|FG000|Overall Study|Physician Decision|1|||
125255179|NCT02904265|450561575|FG001|Overall Study|Physician Decision|2|||
125255180|NCT00267488|450561580|FG000|Overall Study|Sponsor Terminated Study|9|||
125255181|NCT00267488|450561580|FG000|Overall Study|Protocol Violation|1|||
125255182|NCT00267488|450561580|FG000|Overall Study|Other (Disease Progression)|1|||
125255183|NCT01557569|450561581|FG000|Overall Study|Adverse Event|2|||
125255184|NCT01557569|450561582|FG001|Overall Study|Adverse Event|0|||
125255185|NCT01557569|450561581|FG000|Overall Study|high blood pressure|0|||
125255186|NCT01557569|450561582|FG001|Overall Study|high blood pressure|1|||
125255187|NCT01557569|450561581|FG000|Overall Study|Withdrawal by Subject|3|||
125255188|NCT01557569|450561582|FG001|Overall Study|Withdrawal by Subject|5|||
125255189|NCT01557569|450561581|FG000|Overall Study|noncompliance with rules of residential|0|||
125255190|NCT01557569|450561582|FG001|Overall Study|noncompliance with rules of residential|1|||
125255191|NCT02254460|450561583|FG000|Overall Study|Adverse Event|1|||
125255192|NCT02254460|450561584|FG001|Overall Study|Adverse Event|0|||
125255193|NCT01817777|450561587|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
125255194|NCT01817777|450561588|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
125255195|NCT01817777|450561589|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
125255196|NCT01817777|450561587|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
125255197|NCT01817777|450561588|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
125255198|NCT01817777|450561589|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
125255199|NCT01817777|450561587|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
125255200|NCT01817777|450561588|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
125255201|NCT01817777|450561589|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
125255202|NCT01817777|450561587|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
125255203|NCT01817777|450561588|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
125255204|NCT01817777|450561589|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
125255205|NCT01817777|450561587|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
125255206|NCT01817777|450561588|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
125255207|NCT01817777|450561589|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
125255208|NCT00557440|450561590|FG000|Treatment Period 1|Adverse Event|0|||
125255209|NCT00557440|450561591|FG001|Treatment Period 1|Adverse Event|0|||
125255210|NCT00557440|450561592|FG002|Treatment Period 1|Adverse Event|1|||
125255211|NCT03524157|450561593|FG000|Overall Study|cytology not readable|0|||
125255212|NCT03524157|450561594|FG001|Overall Study|cytology not readable|0|||
125255213|NCT03524157|450561595|FG002|Overall Study|cytology not readable|1|||
125255214|NCT01592747|450561596|FG000|Overall Study|Loss of Therapeutic Response|107|||
125255215|NCT01592747|450561597|FG001|Overall Study|Loss of Therapeutic Response|108|||
125255216|NCT01592747|450561598|FG002|Overall Study|Loss of Therapeutic Response|100|||
125255217|NCT01592747|450561596|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
125255218|NCT01592747|450561597|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
125255219|NCT01592747|450561598|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
125255220|NCT01592747|450561596|FG000|Overall Study|Adverse Event|1|||
125255221|NCT01592747|450561597|FG001|Overall Study|Adverse Event|0|||
125255222|NCT01592747|450561598|FG002|Overall Study|Adverse Event|0|||
125255223|NCT01592747|450561596|FG000|Overall Study|Protocol Violation|4|||
125255224|NCT01592747|450561597|FG001|Overall Study|Protocol Violation|0|||
125255225|NCT01592747|450561598|FG002|Overall Study|Protocol Violation|4|||
125255226|NCT01592747|450561596|FG000|Overall Study|Lack of Efficacy|0|||
125255227|NCT01592747|450561597|FG001|Overall Study|Lack of Efficacy|1|||
125255228|NCT01592747|450561598|FG002|Overall Study|Lack of Efficacy|0|||
125255229|NCT01592747|450561596|FG000|Overall Study|Withdrawal by Subject|2|||
125255230|NCT01592747|450561597|FG001|Overall Study|Withdrawal by Subject|0|||
125255231|NCT01592747|450561598|FG002|Overall Study|Withdrawal by Subject|2|||
125255232|NCT01592747|450561596|FG000|Overall Study|Lost to Follow-up|1|||
125255233|NCT01592747|450561597|FG001|Overall Study|Lost to Follow-up|0|||
125255234|NCT01592747|450561598|FG002|Overall Study|Lost to Follow-up|1|||
125255235|NCT01592747|450561596|FG000|Overall Study|Other Reasons|1|||
125255236|NCT01592747|450561597|FG001|Overall Study|Other Reasons|1|||
125255237|NCT01592747|450561598|FG002|Overall Study|Other Reasons|0|||
125255238|NCT02853136|450561599|FG000|Wash-out|Adverse Event|0|||
125255239|NCT02853136|450561600|FG001|Wash-out|Adverse Event|0|||
125255240|NCT02853136|450561601|FG002|Wash-out|Adverse Event|0|||
125255241|NCT02853136|450561602|FG003|Wash-out|Adverse Event|1|||
125255242|NCT00867334|450561603|FG000|Overall Study|Withdrawal by Subject|0|||
125255243|NCT00867334|450561604|FG001|Overall Study|Withdrawal by Subject|1|||
125255244|NCT00867334|450561603|FG000|Overall Study|Withdrawal by Subject|1|||
125255245|NCT00867334|450561604|FG001|Overall Study|Withdrawal by Subject|0|||
125255246|NCT00867334|450561603|FG000|Overall Study|Withdrawal by Subject|1|||
125255247|NCT00867334|450561604|FG001|Overall Study|Withdrawal by Subject|0|||
125255248|NCT05418426|450561606|FG000|Overall Study|Adverse Event|0|||
125255249|NCT05418426|450561607|FG001|Overall Study|Adverse Event|1|||
125255250|NCT05418426|450561608|FG002|Overall Study|Adverse Event|0|||
125255251|NCT05418426|450561606|FG000|Overall Study|Withdrawal by Subject|0|||
125255252|NCT05418426|450561607|FG001|Overall Study|Withdrawal by Subject|1|||
125255253|NCT05418426|450561608|FG002|Overall Study|Withdrawal by Subject|0|||
125255254|NCT05418426|450561606|FG000|Overall Study|Protocol Violation|0|||
125255255|NCT05418426|450561607|FG001|Overall Study|Protocol Violation|0|||
125255256|NCT05418426|450561608|FG002|Overall Study|Protocol Violation|1|||
125255257|NCT04620668|450561609|FG000|Overall Study|Withdrawal by Subject|2|||
125255258|NCT04620668|450561610|FG001|Overall Study|Withdrawal by Subject|0|||
125255259|NCT04620668|450561609|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
125255260|NCT04620668|450561610|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
125255261|NCT04620668|450561609|FG000|Overall Study|Removed before analysis: missing data|2|||
125255262|NCT04620668|450561610|FG001|Overall Study|Removed before analysis: missing data|0|||
125255263|NCT04620668|450561609|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
125255264|NCT04620668|450561610|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
125255265|NCT04620668|450561609|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
125255266|NCT04620668|450561610|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
125255267|NCT02951819|450561615|FG000|Overall Study|Death|9|||
125255268|NCT02951819|450561616|FG001|Overall Study|Death|7|||
125255269|NCT02951819|450561615|FG000|Overall Study|Withdrawal by Subject|3|||
125255270|NCT02951819|450561616|FG001|Overall Study|Withdrawal by Subject|0|||
125255271|NCT02951819|450561615|FG000|Overall Study|Adverse Event|1|||
125255272|NCT02951819|450561616|FG001|Overall Study|Adverse Event|0|||
125255273|NCT02951819|450561615|FG000|Overall Study|Lack of Efficacy|4|||
125255274|NCT02951819|450561616|FG001|Overall Study|Lack of Efficacy|0|||
125255275|NCT02951819|450561615|FG000|Overall Study|Lost to Follow-up|1|||
125255276|NCT02951819|450561616|FG001|Overall Study|Lost to Follow-up|0|||
125255277|NCT02951819|450561615|FG000|Overall Study|Progressive Disease|1|||
125255278|NCT02951819|450561616|FG001|Overall Study|Progressive Disease|0|||
125255279|NCT02951819|450561615|FG000|Overall Study|Other|9|||
125255280|NCT02951819|450561616|FG001|Overall Study|Other|0|||
125255281|NCT05810597|450561619|FG000|Period 1|Adverse Event|2|||
125255282|NCT05810597|450561620|FG001|Period 1|Adverse Event|0|||
125255283|NCT05810597|450561619|FG000|Period 1|Physician Decision|1|||
125255284|NCT05810597|450561620|FG001|Period 1|Physician Decision|0|||
125255285|NCT05021224|450561621|FG000|Overall Study|Did not complete all survey items|4|||
125255286|NCT05021224|450561622|FG001|Overall Study|Did not complete all survey items|1|||
125255287|NCT05021224|450561623|FG002|Overall Study|Did not complete all survey items|0|||
125255288|NCT05021224|450561624|FG003|Overall Study|Did not complete all survey items|2|||
125255289|NCT02412436|450561625|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
125255290|NCT02412436|450561625|FG000|Overall Study|Lost to Follow-up|6|||
125255291|NCT02412436|450561625|FG000|Overall Study|Unable to get to clinic|3|||
125255292|NCT02412436|450561625|FG000|Overall Study|Death|1|||
125255293|NCT02412436|450561625|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
125255294|NCT01111552|450561626|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
125255295|NCT01111552|450561627|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
125255296|NCT01111552|450561628|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
125255297|NCT01111552|450561629|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
125255298|NCT01111552|450561630|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
125255299|NCT01111552|450561626|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
125255300|NCT01111552|450561627|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
125255301|NCT01111552|450561628|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
125255302|NCT01111552|450561629|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
125255303|NCT01111552|450561630|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
125255304|NCT01111552|450561626|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
125255305|NCT01111552|450561627|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
125255306|NCT01111552|450561628|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
125255307|NCT01111552|450561629|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
125255308|NCT01111552|450561630|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
125255309|NCT01111552|450561626|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
125255310|NCT01111552|450561627|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
125255311|NCT01111552|450561628|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
125255312|NCT01111552|450561629|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
125255313|NCT01111552|450561630|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
125255314|NCT01111552|450561626|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
125255315|NCT01111552|450561627|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
125255316|NCT01111552|450561628|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
125255317|NCT01111552|450561629|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
125255318|NCT01111552|450561630|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
125255319|NCT01111552|450561626|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
125255320|NCT01111552|450561627|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
125255321|NCT01111552|450561628|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
125255322|NCT01111552|450561629|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
125255323|NCT01111552|450561630|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
125255324|NCT01111552|450561626|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
125255325|NCT01111552|450561627|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
125255326|NCT01111552|450561628|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
125255327|NCT01111552|450561629|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
125255328|NCT01111552|450561630|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
125255329|NCT01111552|450561626|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
125255330|NCT01111552|450561627|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
125255331|NCT01111552|450561628|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
125255332|NCT01111552|450561629|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
125255333|NCT01111552|450561630|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
125255334|NCT01111552|450561626|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125255335|NCT01111552|450561627|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125255336|NCT01111552|450561628|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125255337|NCT01111552|450561629|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
125255338|NCT01111552|450561630|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125255339|NCT01111552|450561626|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
125255340|NCT01111552|450561627|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
125255341|NCT01111552|450561628|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
125255342|NCT01111552|450561629|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
125255343|NCT01111552|450561630|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
125255344|NCT01111552|450561626|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
125255345|NCT01111552|450561627|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
125255346|NCT01111552|450561628|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
125255347|NCT01111552|450561629|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
125255348|NCT01111552|450561630|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
125255349|NCT01111552|450561626|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
125255350|NCT01111552|450561627|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
125255351|NCT01111552|450561628|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
125255352|NCT01111552|450561629|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
125255353|NCT01111552|450561630|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
125255354|NCT01111552|450561626|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
125255355|NCT01111552|450561627|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
125255356|NCT01111552|450561628|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
125255357|NCT01111552|450561629|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
125255358|NCT01111552|450561630|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
125255359|NCT01111552|450561626|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
125255360|NCT01111552|450561627|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
125255361|NCT01111552|450561628|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
125255362|NCT01111552|450561629|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
125255363|NCT01111552|450561630|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
125255364|NCT04090749|450561631|FG000|Open Label Pilot|Lost to Follow-up|1|||
125255365|NCT04090749|450561632|FG001|Open Label Pilot|Lost to Follow-up|0|||
125255366|NCT04090749|450561633|FG002|Open Label Pilot|Lost to Follow-up|0|||
125255367|NCT04090749|450561631|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
125255368|NCT04090749|450561632|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
125255369|NCT04090749|450561633|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
125255370|NCT04090749|450561631|FG000|Pilot Trial|Lost to Follow-up|0|||
125255371|NCT04090749|450561632|FG001|Pilot Trial|Lost to Follow-up|1|||
125255372|NCT04090749|450561633|FG002|Pilot Trial|Lost to Follow-up|1|||
125255373|NCT02528305|450561634|FG000|Overall Study|Withdrawal by Subject|1|||
125255374|NCT02528305|450561634|FG000|Overall Study|Adverse Event|1|||
125255375|NCT02528305|450561634|FG000|Overall Study|Physician Decision|1|||
125255376|NCT02184442|450561635|FG000|Overall Study|Death|61|||
125255377|NCT02184442|450561636|FG001|Overall Study|Death|65|||
125255378|NCT02184442|450561635|FG000|Overall Study|Withdrawal by Subject|3|||
125255379|NCT02184442|450561636|FG001|Overall Study|Withdrawal by Subject|11|||
125255380|NCT01852214|450561637|FG000|Period 1|Adverse Event|1|||
125255381|NCT01852214|450561638|FG001|Period 1|Adverse Event|2|||
125255382|NCT01852214|450561637|FG000|Period 1|Withdrawal by Subject|0|||
125255383|NCT01852214|450561638|FG001|Period 1|Withdrawal by Subject|1|||
125255384|NCT01852214|450561637|FG000|Washout Period|Withdrawal by Subject|0|||
125255385|NCT01852214|450561638|FG001|Washout Period|Withdrawal by Subject|1|||
125255386|NCT02691494|450561641|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
125255387|NCT02691494|450561642|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
125255388|NCT02691494|450561643|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
125255389|NCT02691494|450561641|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
125255390|NCT02691494|450561642|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
125255391|NCT02691494|450561643|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
125255392|NCT02691494|450561641|FG000|Post-Treatment Follow-Up Period|Other|2|||
125255393|NCT02691494|450561642|FG001|Post-Treatment Follow-Up Period|Other|1|||
125255394|NCT02691494|450561643|FG002|Post-Treatment Follow-Up Period|Other|1|||
125255395|NCT02691494|450561641|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
125255396|NCT02691494|450561642|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
125255397|NCT02691494|450561643|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
125255398|NCT02691494|450561641|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
125255399|NCT02691494|450561642|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
125255400|NCT02691494|450561643|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
125255401|NCT00637156|450561644|FG000|Overall Study|Withdrawal by Subject|0|||
125255402|NCT00637156|450561645|FG001|Overall Study|Withdrawal by Subject|7|||
125255403|NCT00637156|450561644|FG000|Overall Study|Death|0|||
125255404|NCT00637156|450561645|FG001|Overall Study|Death|1|||
125255405|NCT00637156|450561644|FG000|Overall Study|Lost to Follow-up|10|||
125255406|NCT00637156|450561645|FG001|Overall Study|Lost to Follow-up|16|||
125255407|NCT00461812|450561646|FG000|Overall Study|study terminated|10|||
125255408|NCT03193437|450561647|FG000|Overall Study|Adverse Event|4|||
125255409|NCT03193437|450561647|FG000|Overall Study|Withdrawal by Subject|2|||
125255410|NCT03193437|450561647|FG000|Overall Study|Disease Progression|2|||
125255411|NCT05487378|450561648|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
125255412|NCT05487378|450561649|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
125255413|NCT05487378|450561648|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
125255414|NCT05487378|450561649|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
125255415|NCT00964678|450561664|FG000|Overall Study|Physician Decision|4|||
125255416|NCT03359395|450561667|FG000|First Intervention A / B|Withdrawal by Subject|1|||
125255417|NCT03359395|450561668|FG001|First Intervention A / B|Withdrawal by Subject|0|||
125255418|NCT03359395|450561667|FG000|First Intervention A / B|Lost to Follow-up|2|||
125255419|NCT03359395|450561668|FG001|First Intervention A / B|Lost to Follow-up|3|||
125255420|NCT03359395|450561667|FG000|Second Intervention B/A|Exclusion criteria|0|||
125255421|NCT03359395|450561668|FG001|Second Intervention B/A|Exclusion criteria|1|||
125255422|NCT03359395|450561667|FG000|Second Intervention B/A|Lost to Follow-up|3|||
125255423|NCT03359395|450561668|FG001|Second Intervention B/A|Lost to Follow-up|2|||
125255424|NCT03164356|450561669|FG000|Overall Study|Lost to Follow-up|1|||
125255425|NCT03164356|450561670|FG001|Overall Study|Lost to Follow-up|1|||
125255426|NCT03164356|450561671|FG002|Overall Study|Lost to Follow-up|2|||
125255427|NCT03164356|450561672|FG003|Overall Study|Lost to Follow-up|1|||
125255428|NCT03164356|450561669|FG000|Overall Study|Physician Decision|0|||
125255429|NCT03164356|450561670|FG001|Overall Study|Physician Decision|0|||
125255430|NCT03164356|450561671|FG002|Overall Study|Physician Decision|3|||
125255431|NCT03164356|450561672|FG003|Overall Study|Physician Decision|0|||
125255432|NCT03164356|450561669|FG000|Overall Study|Protocol Violation|2|||
125255433|NCT03164356|450561670|FG001|Overall Study|Protocol Violation|1|||
125255434|NCT03164356|450561671|FG002|Overall Study|Protocol Violation|0|||
125255435|NCT03164356|450561672|FG003|Overall Study|Protocol Violation|0|||
125255436|NCT03164356|450561669|FG000|Overall Study|Withdrawal by Subject|1|||
125255437|NCT03164356|450561670|FG001|Overall Study|Withdrawal by Subject|0|||
125255438|NCT03164356|450561671|FG002|Overall Study|Withdrawal by Subject|0|||
125255439|NCT03164356|450561672|FG003|Overall Study|Withdrawal by Subject|0|||
125255440|NCT03164356|450561669|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
125255441|NCT03164356|450561670|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
125255442|NCT03164356|450561671|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
125255443|NCT03164356|450561672|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
125255444|NCT03164356|450561669|FG000|Overall Study|Subject Incarcerated|0|||
125255445|NCT03164356|450561670|FG001|Overall Study|Subject Incarcerated|1|||
125255446|NCT03164356|450561671|FG002|Overall Study|Subject Incarcerated|0|||
125255447|NCT03164356|450561672|FG003|Overall Study|Subject Incarcerated|0|||
125255448|NCT03164356|450561669|FG000|Overall Study|Prosthetist unable to participate|0|||
125255449|NCT03164356|450561670|FG001|Overall Study|Prosthetist unable to participate|2|||
125255450|NCT03164356|450561671|FG002|Overall Study|Prosthetist unable to participate|1|||
125255451|NCT03164356|450561672|FG003|Overall Study|Prosthetist unable to participate|0|||
125255452|NCT00561821|450561673|FG000|Overall Study|Not treated|0|||
125255453|NCT00561821|450561674|FG001|Overall Study|Not treated|0|||
125255454|NCT00561821|450561675|FG002|Overall Study|Not treated|1|||
125255455|NCT00561821|450561676|FG003|Overall Study|Not treated|0|||
125255456|NCT00561821|450561673|FG000|Overall Study|Withdrawal by Subject|0|||
125255457|NCT00561821|450561674|FG001|Overall Study|Withdrawal by Subject|1|||
125255458|NCT00561821|450561675|FG002|Overall Study|Withdrawal by Subject|0|||
125255459|NCT00561821|450561676|FG003|Overall Study|Withdrawal by Subject|2|||
125255460|NCT00561821|450561673|FG000|Overall Study|Reasons not related to trial|2|||
125255461|NCT00561821|450561674|FG001|Overall Study|Reasons not related to trial|1|||
125255462|NCT00561821|450561675|FG002|Overall Study|Reasons not related to trial|0|||
125255463|NCT00561821|450561676|FG003|Overall Study|Reasons not related to trial|0|||
125255464|NCT00561821|450561673|FG000|Overall Study|Other (reason not specified)|1|||
125255465|NCT00561821|450561674|FG001|Overall Study|Other (reason not specified)|1|||
125255466|NCT00561821|450561675|FG002|Overall Study|Other (reason not specified)|0|||
125255467|NCT00561821|450561676|FG003|Overall Study|Other (reason not specified)|0|||
125255468|NCT00561821|450561673|FG000|Overall Study|Adverse Event|2|||
125255469|NCT00561821|450561674|FG001|Overall Study|Adverse Event|3|||
125255470|NCT00561821|450561675|FG002|Overall Study|Adverse Event|1|||
125255471|NCT00561821|450561676|FG003|Overall Study|Adverse Event|1|||
125255472|NCT02520154|450561678|FG000|Overall Study|Death|1|||
125255473|NCT02520154|450561678|FG000|Overall Study|Withdrawal by Subject|2|||
125255474|NCT02520154|450561678|FG000|Overall Study|Physician Decision|2|||
125303085|NCT03100058|450736673|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
125303086|NCT03100058|450736661|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125303087|NCT03100058|450736662|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125303088|NCT03100058|450736663|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125303089|NCT03100058|450736664|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
125303090|NCT03100058|450736665|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125303091|NCT03100058|450736666|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125303092|NCT03100058|450736667|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125303093|NCT03100058|450736668|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
125303094|NCT03100058|450736669|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125303095|NCT03100058|450736670|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125303096|NCT03100058|450736671|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125303097|NCT03100058|450736672|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125255475|NCT03443401|450562973|FG000|Overall Study|Lost to Follow-up|13|||
125255476|NCT03443401|450562973|FG000|Overall Study|Influential outlier|1|||
125255477|NCT00137449|450562974|FG000|Overall Study|Disease Progression|8|||
125255478|NCT00137449|450562975|FG001|Overall Study|Disease Progression|13|||
125255479|NCT00137449|450562974|FG000|Overall Study|Death|4|||
125255480|NCT00137449|450562975|FG001|Overall Study|Death|3|||
125255481|NCT00137449|450562974|FG000|Overall Study|Adverse Event|3|||
125255482|NCT00137449|450562975|FG001|Overall Study|Adverse Event|1|||
125255483|NCT00137449|450562974|FG000|Overall Study|Withdrawal by Subject|1|||
125255484|NCT00137449|450562975|FG001|Overall Study|Withdrawal by Subject|1|||
125255485|NCT01356940|450562976|FG000|First Intervention (28 Days)|Adverse Event|1|||
125255486|NCT01356940|450562977|FG001|First Intervention (28 Days)|Adverse Event|0|||
125255487|NCT01356940|450562976|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
125255488|NCT01356940|450562977|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
125255489|NCT00505687|450562980|FG000|Overall Study|Important protocol violation|2|||
125255490|NCT00505687|450562980|FG000|Overall Study|Lack of Efficacy|15|||
125255491|NCT00505687|450562980|FG000|Overall Study|Adverse Event|48|||
125255492|NCT00505687|450562980|FG000|Overall Study|Subject withdrew consent|15|||
125255493|NCT00505687|450562980|FG000|Overall Study|Lost to Follow-up|1|||
125255494|NCT00505687|450562980|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
125255495|NCT00505687|450562980|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
125255496|NCT00505687|450562980|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
125255497|NCT00505687|450562980|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
125255498|NCT00505687|450562980|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
125255499|NCT00505687|450562980|FG000|Overall Study|Other: Disease Progression|1|||
125255500|NCT00505687|450562980|FG000|Overall Study|Other: As Per Sponsor|8|||
125255501|NCT00278161|450562981|FG000|Overall Study|Death|11|||
125255502|NCT00443456|450562982|FG000|Overall Study|Adverse Event|16|||
125255503|NCT00443456|450562982|FG000|Overall Study|Move|1|||
125255504|NCT00443456|450562982|FG000|Overall Study|Withdrawal by Subject|1|||
125255505|NCT02157610|450562983|FG000|Overall Study|Death|4|||
125255506|NCT02157610|450562984|FG001|Overall Study|Death|4|||
125255507|NCT00124657|450562985|FG000|Overall Study|Toxicity|0|||
125255508|NCT00124657|450562986|FG001|Overall Study|Toxicity|0|||
125255509|NCT00124657|450562987|FG002|Overall Study|Toxicity|1|||
125255510|NCT00124657|450562985|FG000|Overall Study|Non-compliance|1|||
125255511|NCT00124657|450562986|FG001|Overall Study|Non-compliance|0|||
125255512|NCT00124657|450562987|FG002|Overall Study|Non-compliance|4|||
125255513|NCT00124657|450562985|FG000|Overall Study|Progressive disease|14|||
125255514|NCT00124657|450562986|FG001|Overall Study|Progressive disease|5|||
125255515|NCT00124657|450562987|FG002|Overall Study|Progressive disease|27|||
125255516|NCT00124657|450562985|FG000|Overall Study|Intercurrent illness|1|||
125255517|NCT00124657|450562986|FG001|Overall Study|Intercurrent illness|0|||
125255518|NCT00124657|450562987|FG002|Overall Study|Intercurrent illness|0|||
125255519|NCT01935947|450562988|FG000|Overall Study|Adverse Event|0|||
125255520|NCT01935947|450562989|FG001|Overall Study|Adverse Event|2|||
125255521|NCT01935947|450562990|FG002|Overall Study|Adverse Event|0|||
125255522|NCT01935947|450562988|FG000|Overall Study|Diease Progression|2|||
125255523|NCT01935947|450562989|FG001|Overall Study|Diease Progression|2|||
125255524|NCT01935947|450562990|FG002|Overall Study|Diease Progression|2|||
125255525|NCT01935947|450562988|FG000|Overall Study|Death|1|||
125255526|NCT01935947|450562989|FG001|Overall Study|Death|0|||
125255527|NCT01935947|450562990|FG002|Overall Study|Death|0|||
125255528|NCT04507763|450562991|FG000|Overall Study|Participants did not meet entrance criteria|201|||
125255529|NCT03427619|450562992|FG000|Overall Study|Physician Decision|3|||
125255530|NCT03427619|450562992|FG000|Overall Study|Withdrawal by Subject|4|||
125255531|NCT03427619|450562992|FG000|Overall Study|Lost to Follow-up|5|||
125255532|NCT03427619|450562992|FG000|Overall Study|Administrative|4|||
125255533|NCT03427619|450562992|FG000|Overall Study|Other|2|||
125255534|NCT03427619|450562992|FG000|Overall Study|Unknown or Missing Completion Status|48|||
125255535|NCT00425555|450562993|FG000|Overall Study|Withdrawal by Subject|11|||
125255536|NCT00425555|450562994|FG001|Overall Study|Withdrawal by Subject|8|||
125255537|NCT00425555|450562993|FG000|Overall Study|Lost to Follow-up|0|||
125255538|NCT00425555|450562994|FG001|Overall Study|Lost to Follow-up|1|||
125255539|NCT00425555|450562993|FG000|Overall Study|Administrative problems|3|||
125255540|NCT00425555|450562994|FG001|Overall Study|Administrative problems|0|||
125255541|NCT00425555|450562993|FG000|Overall Study|Death|1|||
125255542|NCT00425555|450562994|FG001|Overall Study|Death|2|||
125255543|NCT00425555|450562993|FG000|Overall Study|New cancer therapy|2|||
125255544|NCT00425555|450562994|FG001|Overall Study|New cancer therapy|1|||
125255545|NCT00425555|450562993|FG000|Overall Study|Disease progression|36|||
125255546|NCT00425555|450562994|FG001|Overall Study|Disease progression|33|||
125255547|NCT00425555|450562993|FG000|Overall Study|Adverse Event|25|||
125255548|NCT00425555|450562994|FG001|Overall Study|Adverse Event|15|||
125255549|NCT00425555|450562993|FG000|Overall Study|Protocol Violation|1|||
125255550|NCT00425555|450562994|FG001|Overall Study|Protocol Violation|0|||
125255551|NCT05763381|450562995|FG000|Overall Study|Lost to Follow-up|2|||
125255552|NCT05763381|450562996|FG001|Overall Study|Lost to Follow-up|3|||
125255553|NCT05763381|450562995|FG000|Overall Study|Withdrawal by Subject|1|||
125255554|NCT05763381|450562996|FG001|Overall Study|Withdrawal by Subject|2|||
125255555|NCT01674062|450562997|FG000|Overall Study|Insufficient Therapeutic Response|56|||
125255556|NCT01674062|450562998|FG001|Overall Study|Insufficient Therapeutic Response|26|||
125255557|NCT01674062|450562997|FG000|Overall Study|Other|8|||
125255558|NCT01674062|450562998|FG001|Overall Study|Other|1|||
125255559|NCT01674062|450562997|FG000|Overall Study|Adverse Event|1|||
125255560|NCT01674062|450562998|FG001|Overall Study|Adverse Event|1|||
125255561|NCT01674062|450562997|FG000|Overall Study|Death|0|||
125255562|NCT01674062|450562998|FG001|Overall Study|Death|1|||
125255563|NCT01674062|450562997|FG000|Overall Study|Programming Error|1|||
125255564|NCT01674062|450562998|FG001|Overall Study|Programming Error|0|||
125255565|NCT01443026|450563002|FG000|Overall Study|Physician Decision|1|||
125255566|NCT01443026|450563003|FG001|Overall Study|Physician Decision|0|||
125255567|NCT01443026|450563002|FG000|Overall Study|Death|0|||
125255568|NCT01443026|450563003|FG001|Overall Study|Death|1|||
125255569|NCT01443026|450563002|FG000|Overall Study|Withdrawal by Subject|0|||
125255570|NCT01443026|450563003|FG001|Overall Study|Withdrawal by Subject|3|||
125255571|NCT01443026|450563002|FG000|Overall Study|Lost to Follow-up|2|||
125255572|NCT01443026|450563003|FG001|Overall Study|Lost to Follow-up|1|||
125255573|NCT00581919|450563004|FG000|Overall Study|Adverse Event|8|||
125255574|NCT00581919|450563004|FG000|Overall Study|Death|1|||
125255575|NCT00581919|450563004|FG000|Overall Study|Disease Progression|10|||
125255576|NCT00581919|450563004|FG000|Overall Study|Physician Decision|1|||
125255577|NCT00581919|450563004|FG000|Overall Study|Other Complicating Disease|1|||
125255578|NCT00581919|450563004|FG000|Overall Study|Started Non-Protocol Therapy|2|||
125255579|NCT00581919|450563004|FG000|Overall Study|Withdrawal by Subject|1|||
125255580|NCT02655601|450563005|FG000|Overall Study|Adverse Event|0|||
125255581|NCT02655601|450563006|FG001|Overall Study|Adverse Event|0|||
125255582|NCT02655601|450563007|FG002|Overall Study|Adverse Event|0|||
125255583|NCT02655601|450563008|FG003|Overall Study|Adverse Event|1|||
125255584|NCT02655601|450563009|FG004|Overall Study|Adverse Event|1|||
125255585|NCT02655601|450563010|FG005|Overall Study|Adverse Event|0|||
125255586|NCT02655601|450563005|FG000|Overall Study|Physician Decision|0|||
125255587|NCT02655601|450563006|FG001|Overall Study|Physician Decision|0|||
125255588|NCT02655601|450563007|FG002|Overall Study|Physician Decision|0|||
125255589|NCT02655601|450563008|FG003|Overall Study|Physician Decision|0|||
125255590|NCT02655601|450563009|FG004|Overall Study|Physician Decision|1|||
125255591|NCT02655601|450563010|FG005|Overall Study|Physician Decision|1|||
125255592|NCT02655601|450563005|FG000|Overall Study|Withdrawal by Subject|0|||
125255593|NCT02655601|450563006|FG001|Overall Study|Withdrawal by Subject|0|||
125255594|NCT02655601|450563007|FG002|Overall Study|Withdrawal by Subject|0|||
125255595|NCT02655601|450563008|FG003|Overall Study|Withdrawal by Subject|0|||
125255596|NCT02655601|450563009|FG004|Overall Study|Withdrawal by Subject|4|||
125255597|NCT02655601|450563010|FG005|Overall Study|Withdrawal by Subject|8|||
125255598|NCT02655601|450563005|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
125255599|NCT02655601|450563006|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
125255600|NCT02655601|450563007|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
125255601|NCT02655601|450563008|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
125255602|NCT02655601|450563009|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
125255603|NCT02655601|450563010|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
125255604|NCT03829683|450563015|FG000|Overall Study|Lost to Follow-up|1|||
125255605|NCT03829683|450563016|FG001|Overall Study|Lost to Follow-up|0|||
125255606|NCT03829683|450563015|FG000|Overall Study|Physician Decision|3|||
125255607|NCT03829683|450563016|FG001|Overall Study|Physician Decision|1|||
125255608|NCT03829683|450563015|FG000|Overall Study|Withdrawal by Subject|0|||
125255609|NCT03829683|450563016|FG001|Overall Study|Withdrawal by Subject|1|||
125255610|NCT03829683|450563015|FG000|Overall Study|Discharge from hospital|1|||
125255611|NCT03829683|450563016|FG001|Overall Study|Discharge from hospital|0|||
125255612|NCT02796651|450563020|FG000|Overall Study|Adverse Event|6|||
125255613|NCT02796651|450563020|FG000|Overall Study|Lost to Follow-up|1|||
125255614|NCT02796651|450563020|FG000|Overall Study|Withdrawal by Subject|4|||
125255615|NCT02796651|450563020|FG000|Overall Study|Protocol Violation|4|||
125255616|NCT02796651|450563020|FG000|Overall Study|Lack of Efficacy|1|||
125255617|NCT02796651|450563020|FG000|Overall Study|Other|10|||
125255618|NCT05430919|450563024|FG000|Overall Study|Protocol Violation|0|||
125255619|NCT05430919|450563025|FG001|Overall Study|Protocol Violation|0|||
125255620|NCT05430919|450563026|FG002|Overall Study|Protocol Violation|1|||
125255621|NCT05430919|450563027|FG003|Overall Study|Protocol Violation|0|||
125255622|NCT05430919|450563024|FG000|Overall Study|Lost to Follow-up|0|||
125255623|NCT05430919|450563025|FG001|Overall Study|Lost to Follow-up|1|||
125255624|NCT05430919|450563026|FG002|Overall Study|Lost to Follow-up|0|||
125255625|NCT05430919|450563027|FG003|Overall Study|Lost to Follow-up|0|||
125255626|NCT05430919|450563024|FG000|Overall Study|Withdrawal by Subject|3|||
125255627|NCT05430919|450563025|FG001|Overall Study|Withdrawal by Subject|0|||
125255628|NCT05430919|450563026|FG002|Overall Study|Withdrawal by Subject|0|||
125255629|NCT05430919|450563027|FG003|Overall Study|Withdrawal by Subject|1|||
125255630|NCT05014919|450563028|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
125255631|NCT05014919|450563029|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
125255632|NCT05014919|450563030|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
125255633|NCT05014919|450563028|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
125255634|NCT05014919|450563029|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
125255635|NCT05014919|450563030|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
125255636|NCT05014919|450563028|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
125255637|NCT05014919|450563029|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
125255638|NCT05014919|450563030|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
125255639|NCT05014919|450563028|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
125255640|NCT05014919|450563029|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
125255641|NCT05014919|450563030|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
125255642|NCT05014919|450563028|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
125255643|NCT05014919|450563029|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
125255644|NCT05014919|450563030|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
125255645|NCT05014919|450563028|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
125255646|NCT05014919|450563029|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
125255647|NCT05014919|450563030|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
125255648|NCT05014919|450563028|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
125255649|NCT05014919|450563029|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
125255650|NCT05014919|450563030|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
125255651|NCT05014919|450563028|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
125255652|NCT05014919|450563029|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
125255653|NCT05014919|450563030|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
125255654|NCT02971163|450563033|FG000|Overall Study|Lost to Follow-up|4|||
125255655|NCT02971163|450563034|FG001|Overall Study|Lost to Follow-up|2|||
125255656|NCT01491919|450563035|FG000|Overall Study|Insufficient PK sampling|1|||
125255657|NCT01491919|450563036|FG001|Overall Study|Insufficient PK sampling|2|||
125255658|NCT01491919|450563037|FG002|Overall Study|Insufficient PK sampling|1|||
125255659|NCT02871219|450563038|FG000|Overall Study|Adverse Event|15|||
125255660|NCT02871219|450563038|FG000|Overall Study|Death|3|||
125255661|NCT02871219|450563038|FG000|Overall Study|Progression|3|||
125255662|NCT02871219|450563038|FG000|Overall Study|Infections|7|||
125255663|NCT02871219|450563038|FG000|Overall Study|Infusion Related|4|||
125255664|NCT02298946|450563042|FG000|Overall Study|Did not receive treatment|2|||
125255665|NCT02298946|450563043|FG001|Overall Study|Did not receive treatment|0|||
125255666|NCT02298946|450563042|FG000|Overall Study|Unevaluable|2|||
125255667|NCT02298946|450563043|FG001|Overall Study|Unevaluable|1|||
125255668|NCT05375929|450563051|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
125255669|NCT05375929|450563052|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
125255670|NCT05375929|450563053|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
125255671|NCT05375929|450563054|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
125255672|NCT05375929|450563051|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
125255673|NCT05375929|450563052|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
125255674|NCT05375929|450563053|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
125255675|NCT05375929|450563054|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
125255676|NCT05375929|450563051|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
125255677|NCT05375929|450563052|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
125255678|NCT05375929|450563053|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
125255679|NCT05375929|450563054|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
125255680|NCT05375929|450563051|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
125255681|NCT05375929|450563052|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
125255682|NCT05375929|450563053|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
125255683|NCT05375929|450563054|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
125255684|NCT05375929|450563051|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
125255685|NCT05375929|450563052|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
125255686|NCT05375929|450563053|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
125255687|NCT05375929|450563054|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
125255688|NCT05375929|450563051|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
125255689|NCT05375929|450563052|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
125255690|NCT05375929|450563053|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
125255691|NCT05375929|450563054|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
125255692|NCT05375929|450563051|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
125255693|NCT05375929|450563052|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
125255694|NCT05375929|450563053|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
125255695|NCT05375929|450563054|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
125255696|NCT05375929|450563051|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
125255697|NCT05375929|450563052|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
125255698|NCT05375929|450563053|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
125255699|NCT05375929|450563054|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
125255700|NCT05375929|450563051|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
125255701|NCT05375929|450563052|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
125255702|NCT05375929|450563053|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
125255703|NCT05375929|450563054|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
125255704|NCT05375929|450563051|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
125255705|NCT05375929|450563052|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
125255706|NCT05375929|450563053|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
125255707|NCT05375929|450563054|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
125255708|NCT00773461|450563059|FG000|Overall Study|Adverse Event|1|||
125255709|NCT00773461|450563060|FG001|Overall Study|Adverse Event|3|||
125255710|NCT00773461|450563059|FG000|Overall Study|Withdrawal by Subject|4|||
125255711|NCT00773461|450563060|FG001|Overall Study|Withdrawal by Subject|1|||
125255712|NCT00322218|450563063|FG000|Overall Study|Death|3|||
125255713|NCT00322218|450563064|FG001|Overall Study|Death|6|||
125255714|NCT01385995|450563066|FG000|Period 1, 2 Months|Physician Decision|1|||
125255715|NCT01385995|450563067|FG001|Period 1, 2 Months|Physician Decision|0|||
125255716|NCT00112385|450563068|FG000|Overall Study|Lost to Follow-up|1|||
125255717|NCT00112385|450563069|FG001|Overall Study|Lost to Follow-up|0|||
125255718|NCT00112385|450563068|FG000|Overall Study|Withdrawal by Subject|0|||
125255719|NCT00112385|450563069|FG001|Overall Study|Withdrawal by Subject|1|||
125255720|NCT00908141|450563081|FG000|Overall Study|Withdrawal by Subject|0|||
125255721|NCT00908141|450563082|FG001|Overall Study|Withdrawal by Subject|1|||
125255722|NCT00980044|450564440|FG000|Overall Study|Withdrawal by Subject|5|||
125255723|NCT00980044|450564441|FG001|Overall Study|Withdrawal by Subject|7|||
125255724|NCT00980044|450564442|FG002|Overall Study|Withdrawal by Subject|3|||
125255725|NCT00980044|450564440|FG000|Overall Study|Protocol Violation|0|||
125255726|NCT00980044|450564441|FG001|Overall Study|Protocol Violation|0|||
125255727|NCT00980044|450564442|FG002|Overall Study|Protocol Violation|2|||
125255728|NCT02254291|450564443|FG000|Overall Study|Withdrawal by Subject|0|||
125255729|NCT02254291|450564444|FG001|Overall Study|Withdrawal by Subject|3|||
125255730|NCT02254291|450564445|FG002|Overall Study|Withdrawal by Subject|1|||
125255731|NCT02254291|450564443|FG000|Overall Study|Missing follow-up information|0|||
125255732|NCT02254291|450564444|FG001|Overall Study|Missing follow-up information|0|||
125255733|NCT02254291|450564445|FG002|Overall Study|Missing follow-up information|1|||
125255734|NCT00833703|450564457|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
125255735|NCT00833703|450564458|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
125255736|NCT01904279|450564459|FG000|Overall Study|Lack of Efficacy|2|||
125255737|NCT01904279|450564460|FG001|Overall Study|Lack of Efficacy|3|||
125255738|NCT01904279|450564459|FG000|Overall Study|Withdrawal by Subject|1|||
125255739|NCT01904279|450564460|FG001|Overall Study|Withdrawal by Subject|0|||
125255740|NCT02489279|450564463|FG000|Overall Study|Lost to Follow-up|12|||
125255741|NCT02489279|450564464|FG001|Overall Study|Lost to Follow-up|10|||
125255742|NCT02263547|450564465|FG000|Overall Study|Adverse Event|1|||
125255743|NCT02263547|450564465|FG000|Overall Study|Lost to Follow-up|2|||
125255744|NCT00095576|450564466|FG000|Overall Study|Adverse Event|5|||
125255745|NCT00095576|450564467|FG001|Overall Study|Adverse Event|3|||
125255746|NCT00095576|450564466|FG000|Overall Study|Lost to Follow-up|233|||
125255747|NCT00095576|450564467|FG001|Overall Study|Lost to Follow-up|229|||
125255748|NCT00095576|450564466|FG000|Overall Study|Protocol Violation|1|||
125255749|NCT00095576|450564467|FG001|Overall Study|Protocol Violation|0|||
125255750|NCT00095576|450564466|FG000|Overall Study|Withdrawal by Subject|34|||
125255751|NCT00095576|450564467|FG001|Overall Study|Withdrawal by Subject|47|||
125255752|NCT00095576|450564466|FG000|Overall Study|Option to switch to a rollover study|1097|||
125255753|NCT00095576|450564467|FG001|Overall Study|Option to switch to a rollover study|1099|||
125255754|NCT00095576|450564466|FG000|Overall Study|Site terminated|75|||
125255755|NCT00095576|450564467|FG001|Overall Study|Site terminated|67|||
125255756|NCT00095576|450564466|FG000|Overall Study|Subject moved|30|||
125255757|NCT00095576|450564467|FG001|Overall Study|Subject moved|36|||
125255758|NCT01344356|450564468|FG000|Overall Study|Physician Decision|0|||
125255759|NCT01344356|450564469|FG001|Overall Study|Physician Decision|3|||
125255760|NCT01344356|450564468|FG000|Overall Study|Lost to Follow-up|0|||
125255761|NCT01344356|450564469|FG001|Overall Study|Lost to Follow-up|6|||
125255762|NCT00586157|450564470|FG000|First Intervention|Worsening behavior|1|||
125255763|NCT00586157|450564471|FG001|First Intervention|Worsening behavior|0|||
125255764|NCT00586157|450564470|FG000|Second Intervention|Withdrawal by Subject|1|||
125255765|NCT00586157|450564471|FG001|Second Intervention|Withdrawal by Subject|0|||
125255766|NCT00586157|450564470|FG000|Second Intervention|Worsening behavior|1|||
125255767|NCT00586157|450564471|FG001|Second Intervention|Worsening behavior|0|||
125255768|NCT00586157|450564470|FG000|Second Intervention|Adverse Event|0|||
125255769|NCT00586157|450564471|FG001|Second Intervention|Adverse Event|1|||
125255770|NCT02014467|450564474|FG000|Overall Study|Adverse Event|4|||
125255771|NCT02014467|450564475|FG001|Overall Study|Adverse Event|0|||
125255772|NCT02014467|450564474|FG000|Overall Study|Protocol Violation|3|||
125255773|NCT02014467|450564475|FG001|Overall Study|Protocol Violation|0|||
125255774|NCT02014467|450564474|FG000|Overall Study|Physician Decision|2|||
125255775|NCT02014467|450564475|FG001|Overall Study|Physician Decision|3|||
125255776|NCT02014467|450564474|FG000|Overall Study|Withdrawal by Subject|16|||
125255777|NCT02014467|450564475|FG001|Overall Study|Withdrawal by Subject|4|||
125255778|NCT00831389|450564479|FG000|Overall Study|Withdrawal by Subject|0|||
125255779|NCT00831389|450564480|FG001|Overall Study|Withdrawal by Subject|1|||
125255780|NCT01378195|450564482|FG000|Overall Study|Lost to Follow-up|29|||
125255781|NCT01378195|450564483|FG001|Overall Study|Lost to Follow-up|18|||
125255782|NCT00841815|450564490|FG000|Washout|Withdrawal by Subject|0|||
125255783|NCT00841815|450564491|FG001|Washout|Withdrawal by Subject|1|||
125255784|NCT01148771|450564493|FG000|Washout Period|Withdrawal by Subject|0|||
125255785|NCT01148771|450564494|FG001|Washout Period|Withdrawal by Subject|1|||
125255786|NCT03787615|450564495|FG000|Overall Study|Withdrawal by Subject|2|||
125255787|NCT03787615|450564495|FG000|Overall Study|Lost to Follow-up|2|||
125255788|NCT03464461|450564496|FG000|Overall Study|exclusionary medication given ,|1|||
125255789|NCT03464461|450564497|FG001|Overall Study|exclusionary medication given ,|2|||
125255790|NCT03464461|450564498|FG002|Overall Study|exclusionary medication given ,|0|||
125255791|NCT03464461|450564496|FG000|Overall Study|Physician Decision|0|||
125255792|NCT03464461|450564497|FG001|Overall Study|Physician Decision|1|||
125255793|NCT03464461|450564498|FG002|Overall Study|Physician Decision|0|||
125255794|NCT03685149|450564500|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
125255795|NCT03685149|450564501|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
125255796|NCT03685149|450564500|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
125255797|NCT03685149|450564501|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
125255798|NCT03685149|450564500|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
125255799|NCT03685149|450564501|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
125255800|NCT02609503|450564502|FG000|Overall Study|Adverse Event|1|||
125255801|NCT02609503|450564502|FG000|Overall Study|Death|1|||
125255802|NCT02609503|450564502|FG000|Overall Study|Withdrawal by Subject|1|||
125255803|NCT02609503|450564502|FG000|Overall Study|Disease progression|1|||
125255804|NCT03647137|450564503|FG000|Overall Study|Scan Limitation|2|||
125255805|NCT03647137|450564504|FG001|Overall Study|Scan Limitation|1|||
125255806|NCT03647137|450564505|FG002|Overall Study|Scan Limitation|1|||
125255807|NCT03647137|450564506|FG003|Overall Study|Scan Limitation|2|||
125255808|NCT02226653|450564507|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
125255809|NCT02226653|450564508|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
125255810|NCT02226653|450564507|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
125255811|NCT02226653|450564508|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
125255812|NCT04876391|450564510|FG000|Overall Study|Withdrawal by Subject|1|||
125255813|NCT04876391|450564511|FG001|Overall Study|Withdrawal by Subject|10|||
125255814|NCT04876391|450564510|FG000|Overall Study|Lost to Follow-up|2|||
125255815|NCT04876391|450564511|FG001|Overall Study|Lost to Follow-up|4|||
125255816|NCT04876391|450564510|FG000|Overall Study|Lack of Efficacy|0|||
125255817|NCT04876391|450564511|FG001|Overall Study|Lack of Efficacy|2|||
125255818|NCT04876391|450564510|FG000|Overall Study|Adverse Event|3|||
125255819|NCT04876391|450564511|FG001|Overall Study|Adverse Event|1|||
125255820|NCT04876391|450564510|FG000|Overall Study|Patient non-compliance|0|||
125255821|NCT04876391|450564511|FG001|Overall Study|Patient non-compliance|1|||
125255822|NCT04876391|450564510|FG000|Overall Study|Personal reasons|0|||
125255823|NCT04876391|450564511|FG001|Overall Study|Personal reasons|1|||
125255824|NCT04876391|450564510|FG000|Overall Study|Withdrawn as per protocol|2|||
125255825|NCT04876391|450564511|FG001|Overall Study|Withdrawn as per protocol|2|||
125255826|NCT00209131|450564517|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
125255827|NCT00209131|450564518|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
125255828|NCT05360784|450564519|FG000|Overall Study|Discontinued|25|||
125255829|NCT05360784|450564520|FG001|Overall Study|Discontinued|11|||
125255830|NCT05142306|450564521|FG000|Overall Study|Withdrawal by Subject|0|||
125255831|NCT05142306|450564522|FG001|Overall Study|Withdrawal by Subject|0|||
125255832|NCT05142306|450564523|FG002|Overall Study|Withdrawal by Subject|1|||
125255833|NCT02251041|450564524|FG000|Overall Study|Did not receive intervention|15|||
125255834|NCT02251041|450564525|FG001|Overall Study|Did not receive intervention|4|||
125255835|NCT04079920|450564526|FG000|Overall Study|Adverse event, not related to study drug|2|||
125255836|NCT04079920|450564526|FG000|Overall Study|Adverse event related to study drug|10|||
125255837|NCT04079920|450564526|FG000|Overall Study|Death|2|||
125255838|NCT04079920|450564526|FG000|Overall Study|Lost to Follow-up|22|||
125255839|NCT04079920|450564526|FG000|Overall Study|Physician Decision|1|||
125255840|NCT04079920|450564526|FG000|Overall Study|Withdrawal by Subject|11|||
125255841|NCT04918771|450564527|FG000|Overall Study|Withdrawal by Subject|4|||
125255842|NCT04918771|450564528|FG001|Overall Study|Withdrawal by Subject|5|||
125255843|NCT04918771|450564527|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
125255844|NCT04918771|450564528|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
125255845|NCT00680914|450564533|FG000|Overall Study|Consent withdrawal|6|||
125255846|NCT00680914|450564534|FG001|Overall Study|Consent withdrawal|3|||
125255847|NCT00680914|450564533|FG000|Overall Study|Lost to Follow-up|4|||
125255848|NCT00680914|450564534|FG001|Overall Study|Lost to Follow-up|0|||
125255849|NCT00680914|450564533|FG000|Overall Study|serious adverse event (SAE)|0|||
125255850|NCT00680914|450564534|FG001|Overall Study|serious adverse event (SAE)|1|||
125255851|NCT00539500|450564535|FG000|Overall Study|Disease Progression|1|||
125255852|NCT00539500|450564535|FG000|Overall Study|Lost to Follow-up|2|||
125255853|NCT01299961|450564538|FG000|Overall Study|Adverse Event|3|||
125255854|NCT01299961|450564538|FG000|Overall Study|Lack of Efficacy|2|||
125255855|NCT01299961|450564538|FG000|Overall Study|Lost to Follow-up|1|||
125255856|NCT02904096|450564539|FG000|Overall Study|Adverse Event|1|||
125255857|NCT02904096|450564540|FG001|Overall Study|Adverse Event|0|||
125255858|NCT02904096|450564539|FG000|Overall Study|Withdrawal by Subject|4|||
125255859|NCT02904096|450564540|FG001|Overall Study|Withdrawal by Subject|3|||
125255860|NCT02904096|450564539|FG000|Overall Study|Lost to Follow-up|10|||
125255861|NCT02904096|450564540|FG001|Overall Study|Lost to Follow-up|17|||
125255862|NCT02904096|450564539|FG000|Overall Study|Non-compliant|3|||
125255863|NCT02904096|450564540|FG001|Overall Study|Non-compliant|1|||
125255864|NCT02904096|450564539|FG000|Overall Study|Sponsor instructed|1|||
125255865|NCT02904096|450564540|FG001|Overall Study|Sponsor instructed|0|||
125255866|NCT05305651|450564541|FG000|Overall Study|Death|1|||
125255867|NCT05305651|450564541|FG000|Overall Study|Withdrawal by Subject|4|||
125255868|NCT05305651|450564541|FG000|Overall Study|Lost to Follow-up|4|||
125255869|NCT00526799|450564542|FG000|Overall Study|Withdrawal by Subject|1|||
125255870|NCT00526799|450564543|FG001|Overall Study|Withdrawal by Subject|0|||
125255871|NCT00526799|450564542|FG000|Overall Study|Intercurrent Complicating Disease|0|||
125255872|NCT00526799|450564543|FG001|Overall Study|Intercurrent Complicating Disease|1|||
125255873|NCT04003389|450564544|FG000|Overall Study|Adverse Event|27|||
125255874|NCT04003389|450564545|FG001|Overall Study|Adverse Event|34|||
125255875|NCT04003389|450564546|FG002|Overall Study|Adverse Event|28|||
125255876|NCT04003389|450564544|FG000|Overall Study|Lost to Follow-up|39|||
125255877|NCT04003389|450564545|FG001|Overall Study|Lost to Follow-up|30|||
125255878|NCT04003389|450564546|FG002|Overall Study|Lost to Follow-up|33|||
125255879|NCT04003389|450564544|FG000|Overall Study|Protocol Violation|1|||
125255880|NCT04003389|450564545|FG001|Overall Study|Protocol Violation|6|||
125255881|NCT04003389|450564546|FG002|Overall Study|Protocol Violation|5|||
125255882|NCT04003389|450564544|FG000|Overall Study|Withdrawal by Subject|119|||
125255883|NCT04003389|450564545|FG001|Overall Study|Withdrawal by Subject|79|||
125255884|NCT04003389|450564546|FG002|Overall Study|Withdrawal by Subject|85|||
125255885|NCT04003389|450564544|FG000|Overall Study|Miscellaneous|14|||
125255886|NCT04003389|450564545|FG001|Overall Study|Miscellaneous|11|||
125255887|NCT04003389|450564546|FG002|Overall Study|Miscellaneous|14|||
125255888|NCT04003389|450564544|FG000|Overall Study|Participant did not receive study drug|1|||
125255889|NCT04003389|450564545|FG001|Overall Study|Participant did not receive study drug|0|||
125255890|NCT04003389|450564546|FG002|Overall Study|Participant did not receive study drug|0|||
125255891|NCT04629196|450564547|FG000|Overall Study|Subject discontinued study drug|1|||
125255892|NCT04629196|450564548|FG001|Overall Study|Subject discontinued study drug|0|||
125255893|NCT04629196|450564547|FG000|Overall Study|Subject study drug dosing increased|1|||
125255894|NCT04629196|450564548|FG001|Overall Study|Subject study drug dosing increased|1|||
125255895|NCT04629196|450564547|FG000|Overall Study|Withdrawal by Subject|1|||
125255896|NCT04629196|450564548|FG001|Overall Study|Withdrawal by Subject|2|||
125255897|NCT01450631|450564552|FG000|Overall Study|Lost to Follow-up|2|||
125255898|NCT01450631|450564553|FG001|Overall Study|Lost to Follow-up|4|||
125255899|NCT01450631|450564552|FG000|Overall Study|Withdrawal by Subject|1|||
125255900|NCT01450631|450564553|FG001|Overall Study|Withdrawal by Subject|0|||
125255901|NCT00835354|450564554|FG000|First Intervention|Adverse Event|0|||
125255902|NCT00835354|450564555|FG001|First Intervention|Adverse Event|1|||
125255903|NCT04551053|450564556|FG000|Overall Study|Death|9|||
125255904|NCT04551053|450564557|FG001|Overall Study|Death|9|||
125255905|NCT04551053|450564556|FG000|Overall Study|Lost to Follow-up|0|||
125255906|NCT04551053|450564557|FG001|Overall Study|Lost to Follow-up|2|||
125255907|NCT04551053|450564556|FG000|Overall Study|Study Terminated by Sponsor|53|||
125255908|NCT04551053|450564557|FG001|Overall Study|Study Terminated by Sponsor|63|||
125255909|NCT04551053|450564556|FG000|Overall Study|Withdrawal by Subject|12|||
125255910|NCT04551053|450564557|FG001|Overall Study|Withdrawal by Subject|5|||
125255911|NCT04551053|450564556|FG000|Overall Study|Adverse Event|1|||
125255912|NCT04551053|450564557|FG001|Overall Study|Adverse Event|0|||
125255913|NCT04551053|450564556|FG000|Overall Study|Lack of Efficacy|2|||
125255914|NCT04551053|450564557|FG001|Overall Study|Lack of Efficacy|0|||
125255915|NCT04551053|450564556|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
125255916|NCT04551053|450564557|FG001|Overall Study|Transitioned to Rollover per Protocol|3|||
125255917|NCT04551053|450564556|FG000|Overall Study|Splenapendectomi|1|||
125255918|NCT04551053|450564557|FG001|Overall Study|Splenapendectomi|0|||
125255919|NCT04551053|450564556|FG000|Overall Study|Cytomegalovirus pneumonia|1|||
125255920|NCT04551053|450564557|FG001|Overall Study|Cytomegalovirus pneumonia|0|||
125255921|NCT04551053|450564556|FG000|Overall Study|Medical Decision|0|||
125255922|NCT04551053|450564557|FG001|Overall Study|Medical Decision|1|||
125255923|NCT04551053|450564556|FG000|Overall Study|Ongoing|6|||
125255924|NCT04551053|450564557|FG001|Overall Study|Ongoing|4|||
125255925|NCT03204812|450564558|FG000|Overall Study|Adverse Event|3|||
125255926|NCT03648372|450564559|FG000|Overall Study|Withdrawal by Subject|2|||
125255927|NCT03648372|450564560|FG001|Overall Study|Withdrawal by Subject|0|||
125255928|NCT03648372|450564561|FG002|Overall Study|Withdrawal by Subject|0|||
125255929|NCT03648372|450564562|FG003|Overall Study|Withdrawal by Subject|0|||
125255930|NCT03648372|450564563|FG004|Overall Study|Withdrawal by Subject|0|||
125255931|NCT03648372|450564564|FG005|Overall Study|Withdrawal by Subject|1|||
125255932|NCT03648372|450564565|FG006|Overall Study|Withdrawal by Subject|2|||
125255933|NCT03648372|450564566|FG007|Overall Study|Withdrawal by Subject|0|||
125255934|NCT03648372|450564567|FG008|Overall Study|Withdrawal by Subject|0|||
125255935|NCT03648372|450564568|FG009|Overall Study|Withdrawal by Subject|0|||
125255936|NCT03648372|450564569|FG010|Overall Study|Withdrawal by Subject|2|||
125255937|NCT03648372|450564570|FG011|Overall Study|Withdrawal by Subject|0|||
125255938|NCT03648372|450564571|FG012|Overall Study|Withdrawal by Subject|2|||
125255939|NCT03648372|450564572|FG013|Overall Study|Withdrawal by Subject|0|||
125255940|NCT03648372|450564573|FG014|Overall Study|Withdrawal by Subject|0|||
125255941|NCT03648372|450564574|FG015|Overall Study|Withdrawal by Subject|0|||
125255942|NCT03648372|450564575|FG016|Overall Study|Withdrawal by Subject|1|||
125255943|NCT03648372|450564576|FG017|Overall Study|Withdrawal by Subject|0|||
125255944|NCT03648372|450564577|FG018|Overall Study|Withdrawal by Subject|0|||
125255945|NCT03648372|450564578|FG019|Overall Study|Withdrawal by Subject|0|||
125255946|NCT03648372|450564579|FG020|Overall Study|Withdrawal by Subject|0|||
125255947|NCT03648372|450564559|FG000|Overall Study|Progressive Disease|2|||
125255948|NCT03648372|450564560|FG001|Overall Study|Progressive Disease|3|||
125255949|NCT03648372|450564561|FG002|Overall Study|Progressive Disease|4|||
125255950|NCT03648372|450564562|FG003|Overall Study|Progressive Disease|3|||
125255951|NCT03648372|450564563|FG004|Overall Study|Progressive Disease|2|||
125255952|NCT03648372|450564564|FG005|Overall Study|Progressive Disease|2|||
125255953|NCT03648372|450564565|FG006|Overall Study|Progressive Disease|3|||
125255954|NCT03648372|450564566|FG007|Overall Study|Progressive Disease|3|||
125255955|NCT03648372|450564567|FG008|Overall Study|Progressive Disease|5|||
125255956|NCT03648372|450564568|FG009|Overall Study|Progressive Disease|5|||
125255957|NCT03648372|450564569|FG010|Overall Study|Progressive Disease|2|||
125255958|NCT03648372|450564570|FG011|Overall Study|Progressive Disease|3|||
125255959|NCT03648372|450564571|FG012|Overall Study|Progressive Disease|3|||
125255960|NCT03648372|450564572|FG013|Overall Study|Progressive Disease|3|||
125255961|NCT03648372|450564573|FG014|Overall Study|Progressive Disease|6|||
125255962|NCT03648372|450564574|FG015|Overall Study|Progressive Disease|0|||
125255963|NCT03648372|450564575|FG016|Overall Study|Progressive Disease|0|||
125255964|NCT03648372|450564576|FG017|Overall Study|Progressive Disease|0|||
125255965|NCT03648372|450564577|FG018|Overall Study|Progressive Disease|0|||
125255966|NCT03648372|450564578|FG019|Overall Study|Progressive Disease|0|||
125255967|NCT03648372|450564579|FG020|Overall Study|Progressive Disease|0|||
125255968|NCT03648372|450564559|FG000|Overall Study|Other|0|||
125255969|NCT03648372|450564560|FG001|Overall Study|Other|0|||
125255970|NCT03648372|450564561|FG002|Overall Study|Other|0|||
125255971|NCT03648372|450564562|FG003|Overall Study|Other|0|||
125255972|NCT03648372|450564563|FG004|Overall Study|Other|1|||
125255973|NCT03648372|450564564|FG005|Overall Study|Other|0|||
125255974|NCT03648372|450564565|FG006|Overall Study|Other|0|||
125255975|NCT03648372|450564566|FG007|Overall Study|Other|0|||
125255976|NCT03648372|450564567|FG008|Overall Study|Other|0|||
125255977|NCT03648372|450564568|FG009|Overall Study|Other|0|||
125255978|NCT03648372|450564569|FG010|Overall Study|Other|1|||
125255979|NCT03648372|450564570|FG011|Overall Study|Other|2|||
125255980|NCT03648372|450564571|FG012|Overall Study|Other|1|||
125255981|NCT03648372|450564572|FG013|Overall Study|Other|3|||
125255982|NCT03648372|450564573|FG014|Overall Study|Other|0|||
125255983|NCT03648372|450564574|FG015|Overall Study|Other|5|||
125255984|NCT03648372|450564575|FG016|Overall Study|Other|1|||
125255985|NCT03648372|450564576|FG017|Overall Study|Other|5|||
125255986|NCT03648372|450564577|FG018|Overall Study|Other|0|||
125255987|NCT03648372|450564578|FG019|Overall Study|Other|1|||
125255988|NCT03648372|450564579|FG020|Overall Study|Other|0|||
125255989|NCT03648372|450564559|FG000|Overall Study|Lost to Follow-up|0|||
125255990|NCT03648372|450564560|FG001|Overall Study|Lost to Follow-up|0|||
125255991|NCT03648372|450564561|FG002|Overall Study|Lost to Follow-up|0|||
125255992|NCT03648372|450564562|FG003|Overall Study|Lost to Follow-up|0|||
125255993|NCT03648372|450564563|FG004|Overall Study|Lost to Follow-up|0|||
125255994|NCT03648372|450564564|FG005|Overall Study|Lost to Follow-up|0|||
125255995|NCT03648372|450564565|FG006|Overall Study|Lost to Follow-up|0|||
125255996|NCT03648372|450564566|FG007|Overall Study|Lost to Follow-up|0|||
125255997|NCT03648372|450564567|FG008|Overall Study|Lost to Follow-up|0|||
125255998|NCT03648372|450564568|FG009|Overall Study|Lost to Follow-up|0|||
125255999|NCT03648372|450564569|FG010|Overall Study|Lost to Follow-up|0|||
125256000|NCT03648372|450564570|FG011|Overall Study|Lost to Follow-up|0|||
125256001|NCT03648372|450564571|FG012|Overall Study|Lost to Follow-up|0|||
125256002|NCT03648372|450564572|FG013|Overall Study|Lost to Follow-up|1|||
125256003|NCT03648372|450564573|FG014|Overall Study|Lost to Follow-up|0|||
125256004|NCT03648372|450564574|FG015|Overall Study|Lost to Follow-up|1|||
125256005|NCT03648372|450564575|FG016|Overall Study|Lost to Follow-up|0|||
125256006|NCT03648372|450564576|FG017|Overall Study|Lost to Follow-up|1|||
125256007|NCT03648372|450564577|FG018|Overall Study|Lost to Follow-up|0|||
125256008|NCT03648372|450564578|FG019|Overall Study|Lost to Follow-up|0|||
125256009|NCT03648372|450564579|FG020|Overall Study|Lost to Follow-up|0|||
125256010|NCT03648372|450564559|FG000|Overall Study|Start of a New Systemic Treatment|0|||
125256011|NCT03648372|450564560|FG001|Overall Study|Start of a New Systemic Treatment|0|||
125256012|NCT03648372|450564561|FG002|Overall Study|Start of a New Systemic Treatment|0|||
125256013|NCT03648372|450564562|FG003|Overall Study|Start of a New Systemic Treatment|0|||
125256014|NCT03648372|450564563|FG004|Overall Study|Start of a New Systemic Treatment|0|||
125256015|NCT03648372|450564564|FG005|Overall Study|Start of a New Systemic Treatment|0|||
125256016|NCT03648372|450564565|FG006|Overall Study|Start of a New Systemic Treatment|0|||
125256017|NCT03648372|450564566|FG007|Overall Study|Start of a New Systemic Treatment|2|||
125256018|NCT03648372|450564567|FG008|Overall Study|Start of a New Systemic Treatment|0|||
125256019|NCT03648372|450564568|FG009|Overall Study|Start of a New Systemic Treatment|0|||
125256020|NCT03648372|450564569|FG010|Overall Study|Start of a New Systemic Treatment|1|||
125256021|NCT03648372|450564570|FG011|Overall Study|Start of a New Systemic Treatment|0|||
125256022|NCT03648372|450564571|FG012|Overall Study|Start of a New Systemic Treatment|0|||
125256023|NCT03648372|450564572|FG013|Overall Study|Start of a New Systemic Treatment|0|||
125256024|NCT03648372|450564573|FG014|Overall Study|Start of a New Systemic Treatment|0|||
125256025|NCT03648372|450564574|FG015|Overall Study|Start of a New Systemic Treatment|0|||
125256026|NCT03648372|450564575|FG016|Overall Study|Start of a New Systemic Treatment|0|||
125256027|NCT03648372|450564576|FG017|Overall Study|Start of a New Systemic Treatment|0|||
125256028|NCT03648372|450564577|FG018|Overall Study|Start of a New Systemic Treatment|0|||
125256029|NCT03648372|450564578|FG019|Overall Study|Start of a New Systemic Treatment|0|||
125256030|NCT03648372|450564579|FG020|Overall Study|Start of a New Systemic Treatment|0|||
125256031|NCT04280783|450565973|FG000|Overall Study|Family issues unrelated to the study.|1|||
125256032|NCT04280783|450565974|FG001|Overall Study|Family issues unrelated to the study.|0|||
125256033|NCT04280783|450565973|FG000|Overall Study|Withdrawal by Subject|0|||
125256034|NCT04280783|450565974|FG001|Overall Study|Withdrawal by Subject|1|||
125256035|NCT05654181|450565975|FG000|Overall Study|Adverse Event|1|||
125256036|NCT05654181|450565976|FG001|Overall Study|Adverse Event|0|||
125256037|NCT05654181|450565977|FG002|Overall Study|Adverse Event|0|||
125256038|NCT05654181|450565978|FG003|Overall Study|Adverse Event|0|||
125256039|NCT05654181|450565979|FG004|Overall Study|Adverse Event|0|||
125256040|NCT05654181|450565980|FG005|Overall Study|Adverse Event|0|||
125256041|NCT05654181|450565981|FG006|Overall Study|Adverse Event|0|||
125256042|NCT05654181|450565982|FG007|Overall Study|Adverse Event|1|||
125256043|NCT05654181|450565983|FG008|Overall Study|Adverse Event|0|||
125256044|NCT05654181|450565984|FG009|Overall Study|Adverse Event|0|||
125256045|NCT05654181|450565975|FG000|Overall Study|Withdrawal by Subject|0|||
125256046|NCT05654181|450565976|FG001|Overall Study|Withdrawal by Subject|0|||
125256047|NCT05654181|450565977|FG002|Overall Study|Withdrawal by Subject|0|||
125256048|NCT05654181|450565978|FG003|Overall Study|Withdrawal by Subject|0|||
125256049|NCT05654181|450565979|FG004|Overall Study|Withdrawal by Subject|0|||
125256050|NCT05654181|450565980|FG005|Overall Study|Withdrawal by Subject|0|||
125256051|NCT05654181|450565981|FG006|Overall Study|Withdrawal by Subject|0|||
125256052|NCT05654181|450565982|FG007|Overall Study|Withdrawal by Subject|1|||
125256053|NCT05654181|450565983|FG008|Overall Study|Withdrawal by Subject|0|||
125256054|NCT05654181|450565984|FG009|Overall Study|Withdrawal by Subject|0|||
125256055|NCT05654181|450565975|FG000|Overall Study|Other|0|||
125256056|NCT05654181|450565976|FG001|Overall Study|Other|0|||
125256057|NCT05654181|450565977|FG002|Overall Study|Other|0|||
125256058|NCT05654181|450565978|FG003|Overall Study|Other|0|||
125256059|NCT05654181|450565979|FG004|Overall Study|Other|1|||
125256060|NCT05654181|450565980|FG005|Overall Study|Other|1|||
125256061|NCT05654181|450565981|FG006|Overall Study|Other|0|||
125256062|NCT05654181|450565982|FG007|Overall Study|Other|0|||
125256063|NCT05654181|450565983|FG008|Overall Study|Other|0|||
125256064|NCT05654181|450565984|FG009|Overall Study|Other|0|||
125256065|NCT04101331|450565985|FG000|Overall Study|Adverse Event|9|||
125256066|NCT04101331|450565985|FG000|Overall Study|Disease progression|82|||
125256067|NCT04101331|450565985|FG000|Overall Study|Withdrawal by Subject|1|||
125256068|NCT04101331|450565985|FG000|Overall Study|Investigator decision|6|||
125256069|NCT04101331|450565985|FG000|Overall Study|Death|6|||
125256070|NCT04101331|450565985|FG000|Overall Study|Allogenic transplant|1|||
125256071|NCT04110145|450565986|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
125256072|NCT04110145|450565987|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
125256073|NCT04110145|450565988|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
125256074|NCT04110145|450565989|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
125256075|NCT04110145|450565990|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
125256076|NCT00488293|450565994|FG000|Overall Study|Lost to Follow-up|28|||
125256077|NCT00488293|450565995|FG001|Overall Study|Lost to Follow-up|25|||
125256078|NCT00488293|450565994|FG000|Overall Study|Withdrawal by Subject|5|||
125256079|NCT00488293|450565995|FG001|Overall Study|Withdrawal by Subject|3|||
125256080|NCT00488293|450565994|FG000|Overall Study|Death|2|||
125256081|NCT00488293|450565995|FG001|Overall Study|Death|1|||
125256082|NCT00488293|450565994|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
125256083|NCT00488293|450565995|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
125256084|NCT00500331|450565996|FG000|Overall Study|Adverse Event|0|||
125256085|NCT00500331|450565997|FG001|Overall Study|Adverse Event|2|||
125256086|NCT00500331|450565998|FG002|Overall Study|Adverse Event|0|||
125256087|NCT00500331|450565999|FG003|Overall Study|Adverse Event|1|||
125256088|NCT00500331|450566000|FG004|Overall Study|Adverse Event|2|||
125256089|NCT00500331|450566001|FG005|Overall Study|Adverse Event|2|||
125256090|NCT00500331|450566002|FG006|Overall Study|Adverse Event|0|||
125256091|NCT00500331|450565996|FG000|Overall Study|Lost to Follow-up|1|||
125256092|NCT00500331|450565997|FG001|Overall Study|Lost to Follow-up|1|||
125256093|NCT00500331|450565998|FG002|Overall Study|Lost to Follow-up|1|||
125256094|NCT00500331|450565999|FG003|Overall Study|Lost to Follow-up|2|||
125256095|NCT00500331|450566000|FG004|Overall Study|Lost to Follow-up|1|||
125256096|NCT00500331|450566001|FG005|Overall Study|Lost to Follow-up|0|||
125256097|NCT00500331|450566002|FG006|Overall Study|Lost to Follow-up|0|||
125256098|NCT00500331|450565996|FG000|Overall Study|Protocol Violation|3|||
125256099|NCT00500331|450565997|FG001|Overall Study|Protocol Violation|1|||
125256100|NCT00500331|450565998|FG002|Overall Study|Protocol Violation|1|||
125256101|NCT00500331|450565999|FG003|Overall Study|Protocol Violation|0|||
125256102|NCT00500331|450566000|FG004|Overall Study|Protocol Violation|1|||
125256103|NCT00500331|450566001|FG005|Overall Study|Protocol Violation|1|||
125256104|NCT00500331|450566002|FG006|Overall Study|Protocol Violation|1|||
125256105|NCT00500331|450565996|FG000|Overall Study|Withdrawal by Subject|4|||
125256106|NCT00500331|450565997|FG001|Overall Study|Withdrawal by Subject|0|||
125256107|NCT00500331|450565998|FG002|Overall Study|Withdrawal by Subject|1|||
125256108|NCT00500331|450565999|FG003|Overall Study|Withdrawal by Subject|5|||
125256109|NCT00500331|450566000|FG004|Overall Study|Withdrawal by Subject|0|||
125256110|NCT00500331|450566001|FG005|Overall Study|Withdrawal by Subject|1|||
125256111|NCT00500331|450566002|FG006|Overall Study|Withdrawal by Subject|1|||
125256112|NCT00500331|450565996|FG000|Overall Study|Lack of Efficacy|3|||
125256113|NCT00500331|450565997|FG001|Overall Study|Lack of Efficacy|1|||
125256114|NCT00500331|450565998|FG002|Overall Study|Lack of Efficacy|0|||
125256115|NCT00500331|450565999|FG003|Overall Study|Lack of Efficacy|0|||
125256116|NCT00500331|450566000|FG004|Overall Study|Lack of Efficacy|0|||
125256117|NCT00500331|450566001|FG005|Overall Study|Lack of Efficacy|0|||
125256118|NCT00500331|450566002|FG006|Overall Study|Lack of Efficacy|0|||
125256119|NCT00500331|450565996|FG000|Overall Study|Liver function test abnormality|0|||
125256120|NCT00500331|450565997|FG001|Overall Study|Liver function test abnormality|0|||
125256121|NCT00500331|450565998|FG002|Overall Study|Liver function test abnormality|1|||
125256122|NCT00500331|450565999|FG003|Overall Study|Liver function test abnormality|0|||
125256123|NCT00500331|450566000|FG004|Overall Study|Liver function test abnormality|0|||
125256124|NCT00500331|450566001|FG005|Overall Study|Liver function test abnormality|0|||
125256125|NCT00500331|450566002|FG006|Overall Study|Liver function test abnormality|0|||
125256126|NCT00500331|450565996|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
125256127|NCT00500331|450565997|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
125256128|NCT00500331|450565998|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
125256129|NCT00500331|450565999|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
125256130|NCT00500331|450566000|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
125256131|NCT00500331|450566001|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
125256132|NCT00500331|450566002|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
125256133|NCT00500331|450565996|FG000|Overall Study|Didn't return for continuation of study|1|||
125256134|NCT00500331|450565997|FG001|Overall Study|Didn't return for continuation of study|0|||
125256135|NCT00500331|450565998|FG002|Overall Study|Didn't return for continuation of study|0|||
125256136|NCT00500331|450565999|FG003|Overall Study|Didn't return for continuation of study|0|||
125256137|NCT00500331|450566000|FG004|Overall Study|Didn't return for continuation of study|0|||
125256138|NCT00500331|450566001|FG005|Overall Study|Didn't return for continuation of study|0|||
125256139|NCT00500331|450566002|FG006|Overall Study|Didn't return for continuation of study|0|||
125256140|NCT00500331|450565996|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
125256141|NCT00500331|450565997|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
125256142|NCT00500331|450565998|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
125256143|NCT00500331|450565999|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
125256144|NCT00500331|450566000|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
125256145|NCT00500331|450566001|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
125256146|NCT00500331|450566002|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
125256147|NCT00500331|450565996|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
125256148|NCT00500331|450565997|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
125256149|NCT00500331|450565998|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
125256150|NCT00500331|450565999|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
125256151|NCT00500331|450566000|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
125256152|NCT00500331|450566001|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
125256153|NCT00500331|450566002|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
125256154|NCT00500331|450565996|FG000|Overall Study|Participant was randomized by mistake|1|||
125256155|NCT00500331|450565997|FG001|Overall Study|Participant was randomized by mistake|0|||
125256156|NCT00500331|450565998|FG002|Overall Study|Participant was randomized by mistake|0|||
125256157|NCT00500331|450565999|FG003|Overall Study|Participant was randomized by mistake|0|||
125256158|NCT00500331|450566000|FG004|Overall Study|Participant was randomized by mistake|0|||
125256159|NCT00500331|450566001|FG005|Overall Study|Participant was randomized by mistake|0|||
125256160|NCT00500331|450566002|FG006|Overall Study|Participant was randomized by mistake|0|||
125256161|NCT00500331|450565996|FG000|Overall Study|Diabetologist nurse in the study|0|||
125256162|NCT00500331|450565997|FG001|Overall Study|Diabetologist nurse in the study|0|||
125256163|NCT00500331|450565998|FG002|Overall Study|Diabetologist nurse in the study|1|||
125256164|NCT00500331|450565999|FG003|Overall Study|Diabetologist nurse in the study|0|||
125256165|NCT00500331|450566000|FG004|Overall Study|Diabetologist nurse in the study|0|||
125256166|NCT00500331|450566001|FG005|Overall Study|Diabetologist nurse in the study|0|||
125256167|NCT00500331|450566002|FG006|Overall Study|Diabetologist nurse in the study|0|||
125256168|NCT00500331|450565996|FG000|Overall Study|State ban of biological samples export|0|||
125256169|NCT00500331|450565997|FG001|Overall Study|State ban of biological samples export|0|||
125256170|NCT00500331|450565998|FG002|Overall Study|State ban of biological samples export|0|||
125256171|NCT00500331|450565999|FG003|Overall Study|State ban of biological samples export|1|||
125256172|NCT00500331|450566000|FG004|Overall Study|State ban of biological samples export|0|||
125256173|NCT00500331|450566001|FG005|Overall Study|State ban of biological samples export|0|||
125256174|NCT00500331|450566002|FG006|Overall Study|State ban of biological samples export|0|||
125256175|NCT00500331|450565996|FG000|Overall Study|Protocol violated|0|||
125256176|NCT00500331|450565997|FG001|Overall Study|Protocol violated|0|||
125256177|NCT00500331|450565998|FG002|Overall Study|Protocol violated|0|||
125256178|NCT00500331|450565999|FG003|Overall Study|Protocol violated|1|||
125256179|NCT00500331|450566000|FG004|Overall Study|Protocol violated|0|||
125256180|NCT00500331|450566001|FG005|Overall Study|Protocol violated|0|||
125256181|NCT00500331|450566002|FG006|Overall Study|Protocol violated|0|||
125256182|NCT03436732|450566003|FG000|Overall Study|Not treated-enrolled in different study|1|||
125256183|NCT03436732|450566004|FG001|Overall Study|Not treated-enrolled in different study|0|||
125256184|NCT03436732|450566003|FG000|Overall Study|Off study after cycle 1|1|||
125256185|NCT03436732|450566004|FG001|Overall Study|Off study after cycle 1|0|||
125256186|NCT03436732|450566003|FG000|Overall Study|Adverse Event|2|||
125256187|NCT03436732|450566004|FG001|Overall Study|Adverse Event|0|||
125256188|NCT03436732|450566003|FG000|Overall Study|Death|0|||
125256189|NCT03436732|450566004|FG001|Overall Study|Death|1|||
125256190|NCT03345550|450566005|FG000|Overall Study|Withdrawal by Subject|1|||
125256191|NCT03345550|450566006|FG001|Overall Study|Withdrawal by Subject|0|||
125256192|NCT03345550|450566005|FG000|Overall Study|Lost to Follow-up|4|||
125256193|NCT03345550|450566006|FG001|Overall Study|Lost to Follow-up|5|||
125256194|NCT05538728|450566007|FG000|Overall Study|Withdrawal by Subject|1|||
125256195|NCT05538728|450566008|FG001|Overall Study|Withdrawal by Subject|1|||
125256196|NCT00959049|450566009|FG000|Overall Study|Adverse Event|1|||
125256197|NCT00959049|450566010|FG001|Overall Study|Adverse Event|0|||
125256198|NCT00959049|450566011|FG002|Overall Study|Adverse Event|0|||
125256199|NCT00959049|450566012|FG003|Overall Study|Adverse Event|0|||
125256200|NCT00959049|450566013|FG004|Overall Study|Adverse Event|0|||
125256201|NCT00959049|450566014|FG005|Overall Study|Adverse Event|0|||
125256202|NCT00959049|450566009|FG000|Overall Study|Lost to Follow-up|17|||
125256203|NCT00959049|450566010|FG001|Overall Study|Lost to Follow-up|5|||
125256204|NCT00959049|450566011|FG002|Overall Study|Lost to Follow-up|1|||
125256205|NCT00959049|450566012|FG003|Overall Study|Lost to Follow-up|10|||
125256206|NCT00959049|450566013|FG004|Overall Study|Lost to Follow-up|9|||
125256207|NCT00959049|450566014|FG005|Overall Study|Lost to Follow-up|1|||
125256208|NCT00959049|450566009|FG000|Overall Study|Contraindicated medication|0|||
125256209|NCT00959049|450566010|FG001|Overall Study|Contraindicated medication|0|||
125256210|NCT00959049|450566011|FG002|Overall Study|Contraindicated medication|0|||
125256211|NCT00959049|450566012|FG003|Overall Study|Contraindicated medication|1|||
125256212|NCT00959049|450566013|FG004|Overall Study|Contraindicated medication|0|||
125256213|NCT00959049|450566014|FG005|Overall Study|Contraindicated medication|0|||
125256214|NCT00959049|450566009|FG000|Overall Study|Withdrawal by Subject|0|||
125256215|NCT00959049|450566010|FG001|Overall Study|Withdrawal by Subject|2|||
125256216|NCT00959049|450566011|FG002|Overall Study|Withdrawal by Subject|0|||
125256217|NCT00959049|450566012|FG003|Overall Study|Withdrawal by Subject|0|||
125256218|NCT00959049|450566013|FG004|Overall Study|Withdrawal by Subject|0|||
125256219|NCT00959049|450566014|FG005|Overall Study|Withdrawal by Subject|0|||
125256220|NCT00567502|450566015|FG000|Overall Study|Lost to Follow-up|91|||
125256221|NCT00567502|450566016|FG001|Overall Study|Lost to Follow-up|14|||
125256222|NCT00567502|450566017|FG002|Overall Study|Lost to Follow-up|351|||
125256223|NCT00567502|450566018|FG003|Overall Study|Lost to Follow-up|2|||
125256224|NCT00567502|450566015|FG000|Overall Study|Death|65|||
125256225|NCT00567502|450566016|FG001|Overall Study|Death|16|||
125256226|NCT00567502|450566017|FG002|Overall Study|Death|360|||
125256227|NCT00567502|450566018|FG003|Overall Study|Death|5|||
125256228|NCT00567502|450566015|FG000|Overall Study|Other|64|||
125256229|NCT00567502|450566016|FG001|Overall Study|Other|2|||
125256230|NCT00567502|450566017|FG002|Overall Study|Other|134|||
125256231|NCT00567502|450566018|FG003|Overall Study|Other|6|||
125256232|NCT00567502|450566015|FG000|Overall Study|Participant request|12|||
125256233|NCT00567502|450566016|FG001|Overall Study|Participant request|1|||
125256234|NCT00567502|450566017|FG002|Overall Study|Participant request|33|||
125256235|NCT00567502|450566018|FG003|Overall Study|Participant request|1|||
125256236|NCT00567502|450566015|FG000|Overall Study|Sponsor request|9|||
125256237|NCT00567502|450566016|FG001|Overall Study|Sponsor request|0|||
125256238|NCT00567502|450566017|FG002|Overall Study|Sponsor request|30|||
125256239|NCT00567502|450566018|FG003|Overall Study|Sponsor request|1|||
125256240|NCT00567502|450566015|FG000|Overall Study|Never Initiated Treatment|0|||
125256241|NCT00567502|450566016|FG001|Overall Study|Never Initiated Treatment|0|||
125256242|NCT00567502|450566017|FG002|Overall Study|Never Initiated Treatment|0|||
125256243|NCT00567502|450566018|FG003|Overall Study|Never Initiated Treatment|72|||
125256244|NCT00337168|450566019|FG000|Overall Study|Death|5|||
125256245|NCT00337168|450566019|FG000|Overall Study|Not protocol specified|2|||
125256246|NCT00337168|450566019|FG000|Overall Study|Did not start therapy|1|||
125256247|NCT01230060|450566025|FG000|Overall Study|Withdrawal by Subject|1|||
125256248|NCT01052779|450566027|FG000|Overall Study|Adverse Event|1|||
125256249|NCT01052779|450566028|FG001|Overall Study|Adverse Event|4|||
125256250|NCT01052779|450566027|FG000|Overall Study|Withdrawal by Subject|1|||
125256251|NCT01052779|450566028|FG001|Overall Study|Withdrawal by Subject|2|||
125256252|NCT01052779|450566027|FG000|Overall Study|Other-Protocol Violation|1|||
125256253|NCT01052779|450566028|FG001|Overall Study|Other-Protocol Violation|1|||
125256254|NCT01052779|450566027|FG000|Overall Study|Other-Surgery|0|||
125256255|NCT01052779|450566028|FG001|Overall Study|Other-Surgery|2|||
125256256|NCT01052779|450566027|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
125256257|NCT01052779|450566028|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
125256258|NCT03802916|450566029|FG000|Overall Study|Adverse Event|0|||
125256259|NCT03802916|450566030|FG001|Overall Study|Adverse Event|1|||
125256260|NCT03802916|450566029|FG000|Overall Study|Withdrawal by Subject|0|||
125256261|NCT03802916|450566030|FG001|Overall Study|Withdrawal by Subject|1|||
125256262|NCT03663582|450566031|FG000|Overall Study|Physician Decision|1|||
125256263|NCT00480532|450566032|FG000|Overall Study|Withdrawal by Subject|2|||
125256264|NCT00480532|450566033|FG001|Overall Study|Withdrawal by Subject|4|||
125256265|NCT00480532|450566034|FG002|Overall Study|Withdrawal by Subject|3|||
125256266|NCT00480532|450566035|FG003|Overall Study|Withdrawal by Subject|1|||
125256267|NCT00480532|450566032|FG000|Overall Study|Protocol Violation|0|||
125256268|NCT00480532|450566033|FG001|Overall Study|Protocol Violation|0|||
125256269|NCT00480532|450566034|FG002|Overall Study|Protocol Violation|1|||
125256270|NCT00480532|450566035|FG003|Overall Study|Protocol Violation|0|||
125256271|NCT03242434|450566045|FG000|Overall Study|Death|0|||
125256272|NCT03242434|450566046|FG001|Overall Study|Death|2|||
125256273|NCT02367885|450566047|FG000|Overall Study|Lost to Follow-up|1|||
125256274|NCT02367885|450566048|FG001|Overall Study|Lost to Follow-up|0|||
125256275|NCT02367885|450566049|FG002|Overall Study|Lost to Follow-up|0|||
125256276|NCT02367885|450566047|FG000|Overall Study|Withdrawal by Subject|1|||
125256277|NCT02367885|450566048|FG001|Overall Study|Withdrawal by Subject|0|||
125256278|NCT02367885|450566049|FG002|Overall Study|Withdrawal by Subject|0|||
125256279|NCT01602484|450566050|FG000|Overall Study|Airway issues unrelated to study|0|||
125256280|NCT01602484|450566051|FG001|Overall Study|Airway issues unrelated to study|1|||
125256281|NCT03729609|450566052|FG000|Overall Study|Protocol Violation|1|||
125256282|NCT00605189|450566059|FG000|Overall Study|Adverse Event|1|||
125256283|NCT00605189|450566060|FG001|Overall Study|Adverse Event|0|||
125256284|NCT00605189|450566061|FG002|Overall Study|Adverse Event|0|||
125256285|NCT00605189|450566059|FG000|Overall Study|Other|2|||
125256286|NCT00605189|450566060|FG001|Overall Study|Other|2|||
125256287|NCT00605189|450566061|FG002|Overall Study|Other|0|||
125256288|NCT02697448|450566062|FG000|Overall Study|Protocol Violation|2|||
125256289|NCT02697448|450566063|FG001|Overall Study|Protocol Violation|4|||
125256290|NCT02697448|450566062|FG000|Overall Study|Clinical concerns during ablation|1|||
125256291|NCT02697448|450566063|FG001|Overall Study|Clinical concerns during ablation|1|||
125256292|NCT02697448|450566062|FG000|Overall Study|No data collected|2|||
125256293|NCT02697448|450566063|FG001|Overall Study|No data collected|0|||
125256294|NCT05473715|450566064|FG000|Overall Study|Trial terminate|2|||
125256295|NCT05473715|450566065|FG001|Overall Study|Trial terminate|1|||
125256296|NCT02919618|450566069|FG000|Overall Study|Death|1|||
125256297|NCT02592863|450566070|FG000|Overall Study|Withdrawal by Subject|2|||
125256298|NCT02592863|450566071|FG001|Overall Study|Withdrawal by Subject|2|||
125256299|NCT02592863|450566070|FG000|Overall Study|Lost to Follow-up|1|||
125256300|NCT02592863|450566071|FG001|Overall Study|Lost to Follow-up|1|||
125256301|NCT02743221|450566072|FG000|Overall Study|Progressive disease|29|||
125256302|NCT02743221|450566073|FG001|Overall Study|Progressive disease|38|||
125256303|NCT02743221|450566072|FG000|Overall Study|Adverse Event|17|||
125256304|NCT02743221|450566073|FG001|Overall Study|Adverse Event|14|||
125256305|NCT02743221|450566072|FG000|Overall Study|non medical reason|8|||
125256306|NCT02743221|450566073|FG001|Overall Study|non medical reason|2|||
125256307|NCT02743221|450566072|FG000|Overall Study|Physician Decision|2|||
125256308|NCT02743221|450566073|FG001|Overall Study|Physician Decision|5|||
125256309|NCT02743221|450566072|FG000|Overall Study|Patient not eligible, not treated|0|||
125256310|NCT02743221|450566073|FG001|Overall Study|Patient not eligible, not treated|1|||
125256311|NCT04770285|450566075|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
125256312|NCT04770285|450566076|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
125256313|NCT04770285|450566075|FG000|Overall Study|Lack of Efficacy|0|||
125256314|NCT04770285|450566076|FG001|Overall Study|Lack of Efficacy|1|||
125256315|NCT04770285|450566075|FG000|Overall Study|Lost to Follow-up|11|||
125256316|NCT04770285|450566076|FG001|Overall Study|Lost to Follow-up|8|||
125256317|NCT04770285|450566075|FG000|Overall Study|Protocol Deviation|6|||
125256318|NCT04770285|450566076|FG001|Overall Study|Protocol Deviation|6|||
125256319|NCT04770285|450566075|FG000|Overall Study|Technical Problem|0|||
125256320|NCT04770285|450566076|FG001|Overall Study|Technical Problem|1|||
125256321|NCT04770285|450566075|FG000|Overall Study|Withdrawal by Subject|9|||
125256322|NCT04770285|450566076|FG001|Overall Study|Withdrawal by Subject|8|||
125256323|NCT04770285|450566075|FG000|Overall Study|Reason Not Specified|0|||
125256324|NCT04770285|450566076|FG001|Overall Study|Reason Not Specified|1|||
125256325|NCT03766399|450566077|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256326|NCT03766399|450566078|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256327|NCT03766399|450566079|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256328|NCT03766399|450566080|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256329|NCT03766399|450566081|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256330|NCT03766399|450566082|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256331|NCT03766399|450566083|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256332|NCT03766399|450566084|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256333|NCT03766399|450566085|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256334|NCT03766399|450566086|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256335|NCT03766399|450566087|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256336|NCT03766399|450566088|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256337|NCT03766399|450566089|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256338|NCT03766399|450566090|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
125256339|NCT03766399|450566091|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256340|NCT03766399|450566092|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256341|NCT03766399|450566093|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256342|NCT03766399|450566094|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256343|NCT03411044|450566095|FG000|Overall Study|Death|30|||
125256344|NCT03411044|450566095|FG000|Overall Study|Withdrawal by Subject|48|||
125256345|NCT03411044|450566095|FG000|Overall Study|Lost to Follow-up|78|||
125256346|NCT03411044|450566095|FG000|Overall Study|Adverse Event|30|||
125256347|NCT03411044|450566095|FG000|Overall Study|Missing status|4|||
125256348|NCT01969409|450566096|FG000|Overall Study|Death|2|||
125256349|NCT01969409|450566097|FG001|Overall Study|Death|2|||
125256350|NCT01969409|450566096|FG000|Overall Study|Transplant|1|||
125256351|NCT01969409|450566097|FG001|Overall Study|Transplant|1|||
125256352|NCT01969409|450566096|FG000|Overall Study|Withdrawal by Subject|0|||
125256353|NCT01969409|450566097|FG001|Overall Study|Withdrawal by Subject|1|||
125256354|NCT03078868|450566100|FG000|Overall Study|Physician Decision|3|||
125256355|NCT01435356|450566101|FG000|Overall Study|Adverse Event|2|||
125256356|NCT01435356|450566102|FG001|Overall Study|Adverse Event|0|||
125256357|NCT01435356|450566101|FG000|Overall Study|Disease progression/recurrence|17|||
125256358|NCT01435356|450566102|FG001|Overall Study|Disease progression/recurrence|10|||
125256359|NCT01435356|450566101|FG000|Overall Study|Protocol Violation|0|||
125256360|NCT01435356|450566102|FG001|Overall Study|Protocol Violation|1|||
125256361|NCT01435356|450566101|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
125256362|NCT01435356|450566102|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
125256363|NCT01435356|450566101|FG000|Overall Study|Withdrawal by Subject|1|||
125256364|NCT01435356|450566102|FG001|Overall Study|Withdrawal by Subject|1|||
125256365|NCT01435356|450566101|FG000|Overall Study|Facial palsy|1|||
125256366|NCT01435356|450566102|FG001|Overall Study|Facial palsy|0|||
125256367|NCT01435356|450566101|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
125256368|NCT01435356|450566102|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
125256369|NCT01435356|450566101|FG000|Overall Study|Physician Decision|1|||
125256370|NCT01435356|450566102|FG001|Overall Study|Physician Decision|0|||
125256371|NCT01435356|450566101|FG000|Overall Study|Patient decision|3|||
125256372|NCT01435356|450566102|FG001|Overall Study|Patient decision|0|||
125256373|NCT01435356|450566101|FG000|Overall Study|Patient moved to another city|1|||
125256374|NCT01435356|450566102|FG001|Overall Study|Patient moved to another city|1|||
125256375|NCT00437073|450566103|FG000|Overall Study|Sponsor Terminated Study|1|||
125256376|NCT00437073|450566104|FG001|Overall Study|Sponsor Terminated Study|0|||
125256377|NCT00437073|450566103|FG000|Overall Study|Physician Decision|0|||
125256378|NCT00437073|450566104|FG001|Overall Study|Physician Decision|1|||
125256379|NCT04221438|450566107|FG000|Overall Study|Adverse Event|1|||
125256380|NCT04221438|450566107|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
125256381|NCT03673176|450568027|FG000|Overall Study|Death prior to intervention|1|||
125256382|NCT03673176|450568027|FG000|Overall Study|Death following intervention|3|||
125256383|NCT03673176|450568027|FG000|Overall Study|Withdrawal by Subject|1|||
125256384|NCT02439957|450568028|FG000|Overall Study|Study Terminated|3|||
125256385|NCT02439957|450568029|FG001|Overall Study|Study Terminated|3|||
125256386|NCT00666263|450568030|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
125256387|NCT00666263|450568031|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
125256388|NCT00666263|450568030|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
125256389|NCT00666263|450568031|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
125256390|NCT00666263|450568030|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
125256391|NCT00666263|450568031|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
125256392|NCT01225952|450568033|FG000|Overall Study|Lost to Follow-up|1|||
125256393|NCT01225952|450568034|FG001|Overall Study|Lost to Follow-up|0|||
125256394|NCT01225952|450568035|FG002|Overall Study|Lost to Follow-up|0|||
125256395|NCT01225952|450568033|FG000|Overall Study|Study Eye Explanted|0|||
125256396|NCT01225952|450568034|FG001|Overall Study|Study Eye Explanted|0|||
125256397|NCT01225952|450568035|FG002|Overall Study|Study Eye Explanted|1|||
125256398|NCT01225952|450568033|FG000|Overall Study|Withdrawal by Subject|4|||
125256399|NCT01225952|450568034|FG001|Overall Study|Withdrawal by Subject|4|||
125256400|NCT01225952|450568035|FG002|Overall Study|Withdrawal by Subject|5|||
125256401|NCT01225952|450568033|FG000|Overall Study|Surgical complications|1|||
125256402|NCT01225952|450568034|FG001|Overall Study|Surgical complications|0|||
125256403|NCT01225952|450568035|FG002|Overall Study|Surgical complications|0|||
125256404|NCT02378480|450568036|FG000|Overall Study|Physician Decision|1|||
125256405|NCT02378480|450568037|FG001|Overall Study|Physician Decision|1|||
125256406|NCT02378480|450568036|FG000|Overall Study|Death|1|||
125256407|NCT02378480|450568037|FG001|Overall Study|Death|2|||
125256408|NCT02378480|450568036|FG000|Overall Study|Randomized, but Not Treated|6|||
125256409|NCT02378480|450568037|FG001|Overall Study|Randomized, but Not Treated|4|||
125256410|NCT02378480|450568036|FG000|Overall Study|Adverse Event|0|||
125256411|NCT02378480|450568037|FG001|Overall Study|Adverse Event|1|||
125256412|NCT02378480|450568036|FG000|Overall Study|Missed EOT/PTE Visit|1|||
125256413|NCT02378480|450568037|FG001|Overall Study|Missed EOT/PTE Visit|2|||
125256414|NCT02378480|450568036|FG000|Overall Study|Withdrawal by Subject|9|||
125256415|NCT02378480|450568037|FG001|Overall Study|Withdrawal by Subject|4|||
125256416|NCT02378480|450568036|FG000|Overall Study|Lost to Follow-up|10|||
125256417|NCT02378480|450568037|FG001|Overall Study|Lost to Follow-up|18|||
125256418|NCT01217892|450568038|FG000|Overall Study|Adverse Event|1|||
125256419|NCT01217892|450568039|FG001|Overall Study|Adverse Event|1|||
125256420|NCT01217892|450568040|FG002|Overall Study|Adverse Event|1|||
125256421|NCT01217892|450568041|FG003|Overall Study|Adverse Event|0|||
125256422|NCT01217892|450568038|FG000|Overall Study|Withdrawal by Subject|0|||
125256423|NCT01217892|450568039|FG001|Overall Study|Withdrawal by Subject|2|||
125256424|NCT01217892|450568040|FG002|Overall Study|Withdrawal by Subject|1|||
125256425|NCT01217892|450568041|FG003|Overall Study|Withdrawal by Subject|0|||
125256426|NCT01217892|450568038|FG000|Overall Study|Lab value|1|||
125256427|NCT01217892|450568039|FG001|Overall Study|Lab value|0|||
125256428|NCT01217892|450568040|FG002|Overall Study|Lab value|1|||
125256429|NCT01217892|450568041|FG003|Overall Study|Lab value|0|||
125256430|NCT01217892|450568038|FG000|Overall Study|Subject no longer meets study criteria|5|||
125256431|NCT01217892|450568039|FG001|Overall Study|Subject no longer meets study criteria|2|||
125256432|NCT01217892|450568040|FG002|Overall Study|Subject no longer meets study criteria|4|||
125256433|NCT01217892|450568041|FG003|Overall Study|Subject no longer meets study criteria|8|||
125256434|NCT01217892|450568038|FG000|Overall Study|Incorrect enrollment|0|||
125256435|NCT01217892|450568039|FG001|Overall Study|Incorrect enrollment|1|||
125256436|NCT01217892|450568040|FG002|Overall Study|Incorrect enrollment|1|||
125256437|NCT01217892|450568041|FG003|Overall Study|Incorrect enrollment|0|||
125256438|NCT01217892|450568038|FG000|Overall Study|Poor/Non-Compliance|0|||
125256439|NCT01217892|450568039|FG001|Overall Study|Poor/Non-Compliance|0|||
125256440|NCT01217892|450568040|FG002|Overall Study|Poor/Non-Compliance|1|||
125256441|NCT01217892|450568041|FG003|Overall Study|Poor/Non-Compliance|0|||
125256442|NCT01285102|450568042|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
125256443|NCT01905540|450568043|FG000|Period 3|Other|1|||
125256444|NCT01905540|450568044|FG001|Period 3|Other|0|||
125256445|NCT01905540|450568045|FG002|Period 3|Other|1|||
125256446|NCT01905540|450568046|FG003|Period 3|Other|1|||
125256447|NCT02743962|450568049|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
125256448|NCT02743962|450568050|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
125256449|NCT02327169|450568054|FG000|Overall Study|Progressive Disease|1|||
125256450|NCT02327169|450568055|FG001|Overall Study|Progressive Disease|3|||
125256451|NCT02327169|450568056|FG002|Overall Study|Progressive Disease|4|||
125256452|NCT02327169|450568057|FG003|Overall Study|Progressive Disease|3|||
125256453|NCT02327169|450568058|FG004|Overall Study|Progressive Disease|4|||
125256454|NCT02327169|450568059|FG005|Overall Study|Progressive Disease|3|||
125256455|NCT02327169|450568060|FG006|Overall Study|Progressive Disease|3|||
125256456|NCT02327169|450568061|FG007|Overall Study|Progressive Disease|3|||
125256457|NCT02327169|450568062|FG008|Overall Study|Progressive Disease|4|||
125256458|NCT02327169|450568063|FG009|Overall Study|Progressive Disease|4|||
125256459|NCT02327169|450568064|FG010|Overall Study|Progressive Disease|4|||
125256460|NCT02327169|450568065|FG011|Overall Study|Progressive Disease|3|||
125256461|NCT02327169|450568066|FG012|Overall Study|Progressive Disease|1|||
125256462|NCT02327169|450568067|FG013|Overall Study|Progressive Disease|3|||
125256463|NCT02327169|450568068|FG014|Overall Study|Progressive Disease|3|||
125256464|NCT02327169|450568054|FG000|Overall Study|Adverse Event|2|||
125256465|NCT02327169|450568055|FG001|Overall Study|Adverse Event|0|||
125256466|NCT02327169|450568056|FG002|Overall Study|Adverse Event|1|||
125256467|NCT02327169|450568057|FG003|Overall Study|Adverse Event|0|||
125256468|NCT02327169|450568058|FG004|Overall Study|Adverse Event|1|||
125256469|NCT02327169|450568059|FG005|Overall Study|Adverse Event|0|||
125256470|NCT02327169|450568060|FG006|Overall Study|Adverse Event|0|||
125256471|NCT02327169|450568061|FG007|Overall Study|Adverse Event|0|||
125256472|NCT02327169|450568062|FG008|Overall Study|Adverse Event|0|||
125256473|NCT02327169|450568063|FG009|Overall Study|Adverse Event|2|||
125256474|NCT02327169|450568064|FG010|Overall Study|Adverse Event|0|||
125256475|NCT02327169|450568065|FG011|Overall Study|Adverse Event|3|||
125256476|NCT02327169|450568066|FG012|Overall Study|Adverse Event|0|||
125256477|NCT02327169|450568067|FG013|Overall Study|Adverse Event|2|||
125256478|NCT02327169|450568068|FG014|Overall Study|Adverse Event|1|||
125256479|NCT02327169|450568054|FG000|Overall Study|Symptomatic Deterioration|0|||
125256480|NCT02327169|450568055|FG001|Overall Study|Symptomatic Deterioration|0|||
125256481|NCT02327169|450568056|FG002|Overall Study|Symptomatic Deterioration|1|||
125256482|NCT02327169|450568057|FG003|Overall Study|Symptomatic Deterioration|0|||
125256483|NCT02327169|450568058|FG004|Overall Study|Symptomatic Deterioration|1|||
125256484|NCT02327169|450568059|FG005|Overall Study|Symptomatic Deterioration|1|||
125256485|NCT02327169|450568060|FG006|Overall Study|Symptomatic Deterioration|0|||
125256486|NCT02327169|450568061|FG007|Overall Study|Symptomatic Deterioration|0|||
125256487|NCT02327169|450568062|FG008|Overall Study|Symptomatic Deterioration|2|||
125256488|NCT02327169|450568063|FG009|Overall Study|Symptomatic Deterioration|1|||
125256489|NCT02327169|450568064|FG010|Overall Study|Symptomatic Deterioration|0|||
125256490|NCT02327169|450568065|FG011|Overall Study|Symptomatic Deterioration|0|||
125256491|NCT02327169|450568066|FG012|Overall Study|Symptomatic Deterioration|0|||
125256492|NCT02327169|450568067|FG013|Overall Study|Symptomatic Deterioration|2|||
125256493|NCT02327169|450568068|FG014|Overall Study|Symptomatic Deterioration|1|||
125256494|NCT02327169|450568054|FG000|Overall Study|Reason Not Specified|0|||
125256495|NCT02327169|450568055|FG001|Overall Study|Reason Not Specified|0|||
125256496|NCT02327169|450568056|FG002|Overall Study|Reason Not Specified|1|||
125256497|NCT02327169|450568057|FG003|Overall Study|Reason Not Specified|0|||
125256498|NCT02327169|450568058|FG004|Overall Study|Reason Not Specified|0|||
125256499|NCT02327169|450568059|FG005|Overall Study|Reason Not Specified|0|||
125256500|NCT02327169|450568060|FG006|Overall Study|Reason Not Specified|0|||
125256501|NCT02327169|450568061|FG007|Overall Study|Reason Not Specified|0|||
125256502|NCT02327169|450568062|FG008|Overall Study|Reason Not Specified|0|||
125256503|NCT02327169|450568063|FG009|Overall Study|Reason Not Specified|1|||
125256504|NCT02327169|450568064|FG010|Overall Study|Reason Not Specified|2|||
125256505|NCT02327169|450568065|FG011|Overall Study|Reason Not Specified|1|||
125256506|NCT02327169|450568066|FG012|Overall Study|Reason Not Specified|0|||
125256507|NCT02327169|450568067|FG013|Overall Study|Reason Not Specified|0|||
125256508|NCT02327169|450568068|FG014|Overall Study|Reason Not Specified|2|||
125256509|NCT02327169|450568054|FG000|Overall Study|Withdrawal by Subject|1|||
125256510|NCT02327169|450568055|FG001|Overall Study|Withdrawal by Subject|0|||
125256511|NCT02327169|450568056|FG002|Overall Study|Withdrawal by Subject|0|||
125256512|NCT02327169|450568057|FG003|Overall Study|Withdrawal by Subject|0|||
125256513|NCT02327169|450568058|FG004|Overall Study|Withdrawal by Subject|1|||
125256514|NCT02327169|450568059|FG005|Overall Study|Withdrawal by Subject|0|||
125256515|NCT02327169|450568060|FG006|Overall Study|Withdrawal by Subject|0|||
125256516|NCT02327169|450568061|FG007|Overall Study|Withdrawal by Subject|1|||
125256517|NCT02327169|450568062|FG008|Overall Study|Withdrawal by Subject|0|||
125256518|NCT02327169|450568063|FG009|Overall Study|Withdrawal by Subject|0|||
125256519|NCT02327169|450568064|FG010|Overall Study|Withdrawal by Subject|0|||
125256520|NCT02327169|450568065|FG011|Overall Study|Withdrawal by Subject|0|||
125256521|NCT02327169|450568066|FG012|Overall Study|Withdrawal by Subject|0|||
125256522|NCT02327169|450568067|FG013|Overall Study|Withdrawal by Subject|0|||
125256523|NCT02327169|450568068|FG014|Overall Study|Withdrawal by Subject|3|||
125256524|NCT02327169|450568054|FG000|Overall Study|Lost to Follow-up|0|||
125256525|NCT02327169|450568055|FG001|Overall Study|Lost to Follow-up|0|||
125256526|NCT02327169|450568056|FG002|Overall Study|Lost to Follow-up|0|||
125256527|NCT02327169|450568057|FG003|Overall Study|Lost to Follow-up|0|||
125256528|NCT02327169|450568058|FG004|Overall Study|Lost to Follow-up|1|||
125256529|NCT02327169|450568059|FG005|Overall Study|Lost to Follow-up|0|||
125256530|NCT02327169|450568060|FG006|Overall Study|Lost to Follow-up|0|||
125256531|NCT02327169|450568061|FG007|Overall Study|Lost to Follow-up|0|||
125256532|NCT02327169|450568062|FG008|Overall Study|Lost to Follow-up|0|||
125256533|NCT02327169|450568063|FG009|Overall Study|Lost to Follow-up|0|||
125256534|NCT02327169|450568064|FG010|Overall Study|Lost to Follow-up|0|||
125256535|NCT02327169|450568065|FG011|Overall Study|Lost to Follow-up|0|||
125256536|NCT02327169|450568066|FG012|Overall Study|Lost to Follow-up|0|||
125256537|NCT02327169|450568067|FG013|Overall Study|Lost to Follow-up|0|||
125256538|NCT02327169|450568068|FG014|Overall Study|Lost to Follow-up|0|||
125256539|NCT01381679|450568072|FG000|Overall Study|Adverse Event|3|||
125256540|NCT01381679|450568072|FG000|Overall Study|Lost to Follow-up|885|||
125256541|NCT04023487|450568073|FG000|Overall Study|Lost to Follow-up|5|||
125256542|NCT04023487|450568074|FG001|Overall Study|Lost to Follow-up|4|||
125256543|NCT04023487|450568073|FG000|Overall Study|Pregnancy|1|||
125256544|NCT04023487|450568074|FG001|Overall Study|Pregnancy|2|||
125256545|NCT04023487|450568073|FG000|Overall Study|Withdrawal by Subject|4|||
125256546|NCT04023487|450568074|FG001|Overall Study|Withdrawal by Subject|5|||
125256547|NCT04023487|450568073|FG000|Overall Study|Partially completed testing|8|||
125256548|NCT04023487|450568074|FG001|Overall Study|Partially completed testing|4|||
125256549|NCT02014376|450568077|FG000|Overall Study|Adverse Event|1|||
125256550|NCT02014376|450568078|FG001|Overall Study|Adverse Event|1|||
125256551|NCT02014376|450568079|FG002|Overall Study|Adverse Event|0|||
125256552|NCT02014376|450568077|FG000|Overall Study|Lost to Follow-up|2|||
125256553|NCT02014376|450568078|FG001|Overall Study|Lost to Follow-up|0|||
125256554|NCT02014376|450568079|FG002|Overall Study|Lost to Follow-up|0|||
125256555|NCT01051661|450568085|FG000|Overall Study|Adverse Event|1|||
125256556|NCT01051661|450568086|FG001|Overall Study|Adverse Event|1|||
125256557|NCT01051661|450568087|FG002|Overall Study|Adverse Event|1|||
125256558|NCT01051661|450568088|FG003|Overall Study|Adverse Event|1|||
125256559|NCT01051661|450568089|FG004|Overall Study|Adverse Event|0|||
125256560|NCT01051661|450568090|FG005|Overall Study|Adverse Event|0|||
125256561|NCT01051661|450568085|FG000|Overall Study|Lost to Follow-up|13|||
125256562|NCT01051661|450568086|FG001|Overall Study|Lost to Follow-up|22|||
125256563|NCT01051661|450568087|FG002|Overall Study|Lost to Follow-up|15|||
125256564|NCT01051661|450568088|FG003|Overall Study|Lost to Follow-up|17|||
125256565|NCT01051661|450568089|FG004|Overall Study|Lost to Follow-up|10|||
125256566|NCT01051661|450568090|FG005|Overall Study|Lost to Follow-up|24|||
125256567|NCT01051661|450568085|FG000|Overall Study|Migrated/moved from study area|1|||
125256568|NCT01051661|450568086|FG001|Overall Study|Migrated/moved from study area|6|||
125256569|NCT01051661|450568087|FG002|Overall Study|Migrated/moved from study area|6|||
125256570|NCT01051661|450568088|FG003|Overall Study|Migrated/moved from study area|8|||
125256571|NCT01051661|450568089|FG004|Overall Study|Migrated/moved from study area|7|||
125256572|NCT01051661|450568090|FG005|Overall Study|Migrated/moved from study area|3|||
125256573|NCT01051661|450568085|FG000|Overall Study|Refused blood sampling|0|||
125256574|NCT01051661|450568086|FG001|Overall Study|Refused blood sampling|0|||
125256575|NCT01051661|450568087|FG002|Overall Study|Refused blood sampling|0|||
125256576|NCT01051661|450568088|FG003|Overall Study|Refused blood sampling|0|||
125256577|NCT01051661|450568089|FG004|Overall Study|Refused blood sampling|0|||
125256578|NCT01051661|450568090|FG005|Overall Study|Refused blood sampling|1|||
125256579|NCT01051661|450568085|FG000|Overall Study|Data not reliable|1|||
125256580|NCT01051661|450568086|FG001|Overall Study|Data not reliable|0|||
125256581|NCT01051661|450568087|FG002|Overall Study|Data not reliable|0|||
125256582|NCT01051661|450568088|FG003|Overall Study|Data not reliable|0|||
125256583|NCT01051661|450568089|FG004|Overall Study|Data not reliable|0|||
125256584|NCT01051661|450568090|FG005|Overall Study|Data not reliable|1|||
125256585|NCT01051661|450568085|FG000|Overall Study|Unable to attend visit(s)|2|||
125256586|NCT01051661|450568086|FG001|Overall Study|Unable to attend visit(s)|4|||
125256587|NCT01051661|450568087|FG002|Overall Study|Unable to attend visit(s)|2|||
125256588|NCT01051661|450568088|FG003|Overall Study|Unable to attend visit(s)|1|||
125256589|NCT01051661|450568089|FG004|Overall Study|Unable to attend visit(s)|3|||
125256590|NCT01051661|450568090|FG005|Overall Study|Unable to attend visit(s)|2|||
125256591|NCT01051661|450568085|FG000|Overall Study|Consent not received from both parents|0|||
125256592|NCT01051661|450568086|FG001|Overall Study|Consent not received from both parents|0|||
125256593|NCT01051661|450568087|FG002|Overall Study|Consent not received from both parents|0|||
125256594|NCT01051661|450568088|FG003|Overall Study|Consent not received from both parents|0|||
125256595|NCT01051661|450568089|FG004|Overall Study|Consent not received from both parents|0|||
125256596|NCT01051661|450568090|FG005|Overall Study|Consent not received from both parents|1|||
125256597|NCT01051661|450568085|FG000|Overall Study|Failure to comply with protocol|0|||
125256598|NCT01051661|450568086|FG001|Overall Study|Failure to comply with protocol|0|||
125256599|NCT01051661|450568087|FG002|Overall Study|Failure to comply with protocol|2|||
125256600|NCT01051661|450568088|FG003|Overall Study|Failure to comply with protocol|0|||
125256601|NCT01051661|450568089|FG004|Overall Study|Failure to comply with protocol|0|||
125256602|NCT01051661|450568090|FG005|Overall Study|Failure to comply with protocol|0|||
125256603|NCT01051661|450568085|FG000|Overall Study|Subject lost legal representation|0|||
125256604|NCT01051661|450568086|FG001|Overall Study|Subject lost legal representation|0|||
125256605|NCT01051661|450568087|FG002|Overall Study|Subject lost legal representation|0|||
125256606|NCT01051661|450568088|FG003|Overall Study|Subject lost legal representation|0|||
125256607|NCT01051661|450568089|FG004|Overall Study|Subject lost legal representation|1|||
125256608|NCT01051661|450568090|FG005|Overall Study|Subject lost legal representation|0|||
125256609|NCT01051661|450568085|FG000|Overall Study|Protocol Violation|0|||
125256610|NCT01051661|450568086|FG001|Overall Study|Protocol Violation|0|||
125256611|NCT01051661|450568087|FG002|Overall Study|Protocol Violation|0|||
125256612|NCT01051661|450568088|FG003|Overall Study|Protocol Violation|1|||
125256613|NCT01051661|450568089|FG004|Overall Study|Protocol Violation|2|||
125256614|NCT01051661|450568090|FG005|Overall Study|Protocol Violation|1|||
125256615|NCT01051661|450568085|FG000|Overall Study|Withdrawal by Subject|16|||
125256616|NCT01051661|450568086|FG001|Overall Study|Withdrawal by Subject|30|||
125256617|NCT01051661|450568087|FG002|Overall Study|Withdrawal by Subject|13|||
125256618|NCT01051661|450568088|FG003|Overall Study|Withdrawal by Subject|28|||
125256619|NCT01051661|450568089|FG004|Overall Study|Withdrawal by Subject|12|||
125256620|NCT01051661|450568090|FG005|Overall Study|Withdrawal by Subject|34|||
125256621|NCT04642079|450568091|FG000|Overall Study|Lost to Follow-up|2|||
125256622|NCT04642079|450568092|FG001|Overall Study|Lost to Follow-up|5|||
125256623|NCT04642079|450568093|FG002|Overall Study|Lost to Follow-up|2|||
125256624|NCT04642079|450568094|FG003|Overall Study|Lost to Follow-up|0|||
125256625|NCT04642079|450568091|FG000|Overall Study|Withdrawal by Subject|0|||
125256626|NCT04642079|450568092|FG001|Overall Study|Withdrawal by Subject|4|||
125256627|NCT04642079|450568093|FG002|Overall Study|Withdrawal by Subject|1|||
125256628|NCT04642079|450568094|FG003|Overall Study|Withdrawal by Subject|2|||
125256629|NCT04642079|450568091|FG000|Overall Study|Other|0|||
125256630|NCT04642079|450568092|FG001|Overall Study|Other|0|||
125256631|NCT04642079|450568093|FG002|Overall Study|Other|0|||
125256632|NCT04642079|450568094|FG003|Overall Study|Other|1|||
125256633|NCT04642079|450568091|FG000|Overall Study|No longer met eligibility criteria|1|||
125256634|NCT04642079|450568092|FG001|Overall Study|No longer met eligibility criteria|0|||
125256635|NCT04642079|450568093|FG002|Overall Study|No longer met eligibility criteria|1|||
125256636|NCT04642079|450568094|FG003|Overall Study|No longer met eligibility criteria|1|||
125256637|NCT03038620|450568097|FG000|Overall Study|Lost to Follow-up|18|||
125256638|NCT03038620|450568098|FG001|Overall Study|Lost to Follow-up|23|||
125256639|NCT03038620|450568097|FG000|Overall Study|Withdrawal by Subject|0|||
125256640|NCT03038620|450568098|FG001|Overall Study|Withdrawal by Subject|15|||
125256641|NCT03038620|450568097|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
125256642|NCT03038620|450568098|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
125256643|NCT04875533|450568104|FG000|Overall Study|Adverse Event|6|||
125256644|NCT04875533|450568105|FG001|Overall Study|Adverse Event|4|||
125256645|NCT04875533|450568104|FG000|Overall Study|Protocol Violation|4|||
125256646|NCT04875533|450568105|FG001|Overall Study|Protocol Violation|0|||
125256647|NCT04875533|450568104|FG000|Overall Study|Withdrawal by Subject|8|||
125256648|NCT04875533|450568105|FG001|Overall Study|Withdrawal by Subject|5|||
125256649|NCT04875533|450568104|FG000|Overall Study|No longer meets eligibility criteria|1|||
125256650|NCT04875533|450568105|FG001|Overall Study|No longer meets eligibility criteria|0|||
125256651|NCT04875533|450568104|FG000|Overall Study|Other|0|||
125256652|NCT04875533|450568105|FG001|Overall Study|Other|2|||
125256653|NCT02657343|450568109|FG000|Overall Study|Death|0|||
125256654|NCT02657343|450568110|FG001|Overall Study|Death|2|||
125256655|NCT02657343|450568111|FG002|Overall Study|Death|0|||
125256656|NCT02657343|450568112|FG003|Overall Study|Death|0|||
125256657|NCT02657343|450568113|FG004|Overall Study|Death|0|||
125256658|NCT02657343|450568114|FG005|Overall Study|Death|0|||
125256659|NCT02657343|450568109|FG000|Overall Study|Patient went to hospice|1|||
125256660|NCT02657343|450568110|FG001|Overall Study|Patient went to hospice|0|||
125256661|NCT02657343|450568111|FG002|Overall Study|Patient went to hospice|0|||
125256662|NCT02657343|450568112|FG003|Overall Study|Patient went to hospice|0|||
125256663|NCT02657343|450568113|FG004|Overall Study|Patient went to hospice|0|||
125256664|NCT02657343|450568114|FG005|Overall Study|Patient went to hospice|0|||
125256665|NCT02657343|450568109|FG000|Overall Study|Withdrawal by Subject|0|||
125256666|NCT02657343|450568110|FG001|Overall Study|Withdrawal by Subject|0|||
125256667|NCT02657343|450568111|FG002|Overall Study|Withdrawal by Subject|0|||
125256668|NCT02657343|450568112|FG003|Overall Study|Withdrawal by Subject|0|||
125256669|NCT02657343|450568113|FG004|Overall Study|Withdrawal by Subject|1|||
125256670|NCT02657343|450568114|FG005|Overall Study|Withdrawal by Subject|0|||
125256671|NCT02011542|450568116|FG000|Overall Study|Physician Decision|1|||
125256672|NCT00982280|450568120|FG000|Observation Period|Not eligible to be dosed|19|||
125256673|NCT00982280|450568120|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
125256674|NCT00982280|450568120|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
125256675|NCT00982280|450568120|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
125256676|NCT00982280|450568120|FG000|Maintenance Period|Adverse Event|1|||
125256677|NCT01979185|450568121|FG000|Period 2|Other|0|||
125256678|NCT01979185|450568122|FG001|Period 2|Other|1|||
125256679|NCT00980798|450568123|FG000|Overall Study|Adverse Event|7|||
125256680|NCT00980798|450568124|FG001|Overall Study|Adverse Event|36|||
125256681|NCT00980798|450568123|FG000|Overall Study|Lack of Efficacy|16|||
125256682|NCT00980798|450568124|FG001|Overall Study|Lack of Efficacy|5|||
125256683|NCT00980798|450568123|FG000|Overall Study|Lost to Follow-up|0|||
125256684|NCT00980798|450568124|FG001|Overall Study|Lost to Follow-up|1|||
125256685|NCT00980798|450568123|FG000|Overall Study|Physician Decision|2|||
125256686|NCT00980798|450568124|FG001|Overall Study|Physician Decision|1|||
125256687|NCT00980798|450568123|FG000|Overall Study|Withdrawal by Subject|8|||
125256688|NCT00980798|450568124|FG001|Overall Study|Withdrawal by Subject|11|||
125256689|NCT00980798|450568123|FG000|Overall Study|Other|0|||
125256690|NCT00980798|450568124|FG001|Overall Study|Other|1|||
125256691|NCT04724837|450568125|FG000|Overall Study|Other|4|||
125256692|NCT04724837|450568126|FG001|Overall Study|Other|16|||
125256693|NCT04724837|450568127|FG002|Overall Study|Other|0|||
125256694|NCT04724837|450568125|FG000|Overall Study|Withdrawal by Subject|2|||
125256695|NCT04724837|450568126|FG001|Overall Study|Withdrawal by Subject|9|||
125256696|NCT04724837|450568127|FG002|Overall Study|Withdrawal by Subject|9|||
125256697|NCT04724837|450568125|FG000|Overall Study|Adverse Event|2|||
125256698|NCT04724837|450568126|FG001|Overall Study|Adverse Event|7|||
125256699|NCT04724837|450568127|FG002|Overall Study|Adverse Event|4|||
125256700|NCT04724837|450568125|FG000|Overall Study|Lost to Follow-up|0|||
125256701|NCT04724837|450568126|FG001|Overall Study|Lost to Follow-up|1|||
125256702|NCT04724837|450568127|FG002|Overall Study|Lost to Follow-up|3|||
125256703|NCT04724837|450568125|FG000|Overall Study|Physician Decision|1|||
125256704|NCT04724837|450568126|FG001|Overall Study|Physician Decision|2|||
125256705|NCT04724837|450568127|FG002|Overall Study|Physician Decision|0|||
125256706|NCT04724837|450568125|FG000|Overall Study|Death|0|||
125256707|NCT04724837|450568126|FG001|Overall Study|Death|0|||
125256708|NCT04724837|450568127|FG002|Overall Study|Death|1|||
125256709|NCT04724837|450568125|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
125256710|NCT04724837|450568126|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
125256711|NCT04724837|450568127|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
125256712|NCT04724837|450568125|FG000|Overall Study|Study Terminated by Sponsor|0|||
125256713|NCT04724837|450568126|FG001|Overall Study|Study Terminated by Sponsor|1|||
125256714|NCT04724837|450568127|FG002|Overall Study|Study Terminated by Sponsor|0|||
125256715|NCT00522379|450568128|FG000|Overall Study|Adverse Event|12|||
125256716|NCT00522379|450568129|FG001|Overall Study|Adverse Event|15|||
125256717|NCT00522379|450568130|FG002|Overall Study|Adverse Event|12|||
125256718|NCT00522379|450568131|FG003|Overall Study|Adverse Event|5|||
125256719|NCT00522379|450568132|FG004|Overall Study|Adverse Event|17|||
125256720|NCT00522379|450568128|FG000|Overall Study|Lack of Efficacy|3|||
125256721|NCT00522379|450568129|FG001|Overall Study|Lack of Efficacy|0|||
125256722|NCT00522379|450568130|FG002|Overall Study|Lack of Efficacy|2|||
125256723|NCT00522379|450568131|FG003|Overall Study|Lack of Efficacy|2|||
125256724|NCT00522379|450568132|FG004|Overall Study|Lack of Efficacy|7|||
125256725|NCT00522379|450568128|FG000|Overall Study|Withdrawal by Subject|2|||
125256726|NCT00522379|450568129|FG001|Overall Study|Withdrawal by Subject|3|||
125256727|NCT00522379|450568130|FG002|Overall Study|Withdrawal by Subject|1|||
125256728|NCT00522379|450568131|FG003|Overall Study|Withdrawal by Subject|2|||
125256729|NCT00522379|450568132|FG004|Overall Study|Withdrawal by Subject|0|||
125256730|NCT00522379|450568128|FG000|Overall Study|Protocol Violation|1|||
125256731|NCT00522379|450568129|FG001|Overall Study|Protocol Violation|1|||
125256732|NCT00522379|450568130|FG002|Overall Study|Protocol Violation|2|||
125256733|NCT00522379|450568131|FG003|Overall Study|Protocol Violation|0|||
125256734|NCT00522379|450568132|FG004|Overall Study|Protocol Violation|0|||
125256735|NCT00522379|450568128|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
125256736|NCT00522379|450568129|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
125256737|NCT00522379|450568130|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
125256738|NCT00522379|450568131|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
125256739|NCT00522379|450568132|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
125256740|NCT00522379|450568128|FG000|Overall Study|Lost to Follow-up|1|||
125256741|NCT00522379|450568129|FG001|Overall Study|Lost to Follow-up|0|||
125256742|NCT00522379|450568130|FG002|Overall Study|Lost to Follow-up|4|||
125256743|NCT00522379|450568131|FG003|Overall Study|Lost to Follow-up|2|||
125256744|NCT00522379|450568132|FG004|Overall Study|Lost to Follow-up|2|||
125256745|NCT00522379|450568128|FG000|Overall Study|Randomization error|0|||
125256746|NCT00522379|450568129|FG001|Overall Study|Randomization error|0|||
125256747|NCT00522379|450568130|FG002|Overall Study|Randomization error|0|||
125256748|NCT00522379|450568131|FG003|Overall Study|Randomization error|0|||
125256749|NCT00522379|450568132|FG004|Overall Study|Randomization error|1|||
125256750|NCT00522379|450568128|FG000|Overall Study|Dispensing error|1|||
125256751|NCT00522379|450568129|FG001|Overall Study|Dispensing error|0|||
125256752|NCT00522379|450568130|FG002|Overall Study|Dispensing error|0|||
125256753|NCT00522379|450568131|FG003|Overall Study|Dispensing error|1|||
125256754|NCT00522379|450568132|FG004|Overall Study|Dispensing error|0|||
125256755|NCT00522379|450568128|FG000|Overall Study|Subject Moved|1|||
125256756|NCT00522379|450568129|FG001|Overall Study|Subject Moved|1|||
125256757|NCT00522379|450568130|FG002|Overall Study|Subject Moved|0|||
125256758|NCT00522379|450568131|FG003|Overall Study|Subject Moved|0|||
125256759|NCT00522379|450568132|FG004|Overall Study|Subject Moved|0|||
125256760|NCT00522379|450568128|FG000|Overall Study|Sponsor Request|0|||
125256761|NCT00522379|450568129|FG001|Overall Study|Sponsor Request|1|||
125256762|NCT00522379|450568130|FG002|Overall Study|Sponsor Request|0|||
125256763|NCT00522379|450568131|FG003|Overall Study|Sponsor Request|0|||
125256764|NCT00522379|450568132|FG004|Overall Study|Sponsor Request|0|||
125256765|NCT00522379|450568128|FG000|Overall Study|Family Problem|0|||
125256766|NCT00522379|450568129|FG001|Overall Study|Family Problem|0|||
125256767|NCT00522379|450568130|FG002|Overall Study|Family Problem|1|||
125256768|NCT00522379|450568131|FG003|Overall Study|Family Problem|0|||
125256769|NCT00522379|450568132|FG004|Overall Study|Family Problem|0|||
125256770|NCT00522379|450568128|FG000|Overall Study|Site Closed|0|||
125256771|NCT00522379|450568129|FG001|Overall Study|Site Closed|0|||
125256772|NCT00522379|450568130|FG002|Overall Study|Site Closed|0|||
125256773|NCT00522379|450568131|FG003|Overall Study|Site Closed|1|||
125256774|NCT00522379|450568132|FG004|Overall Study|Site Closed|0|||
125256775|NCT00522379|450568128|FG000|Overall Study|Subject Withdrawal|0|||
125256776|NCT00522379|450568129|FG001|Overall Study|Subject Withdrawal|0|||
125256777|NCT00522379|450568130|FG002|Overall Study|Subject Withdrawal|0|||
125256778|NCT00522379|450568131|FG003|Overall Study|Subject Withdrawal|1|||
125256779|NCT00522379|450568132|FG004|Overall Study|Subject Withdrawal|0|||
125256780|NCT00967499|450568137|FG000|Overall Study|Adverse Event|0|||
125256781|NCT00967499|450568138|FG001|Overall Study|Adverse Event|1|||
125256782|NCT00967499|450568137|FG000|Overall Study|Protocol Violation|1|||
125256783|NCT00967499|450568138|FG001|Overall Study|Protocol Violation|0|||
125256784|NCT00967499|450568137|FG000|Overall Study|Sponsor Decision|1|||
125256785|NCT00967499|450568138|FG001|Overall Study|Sponsor Decision|0|||
125256786|NCT00967499|450568137|FG000|Overall Study|Randomized but not treated|63|||
125256787|NCT00967499|450568138|FG001|Overall Study|Randomized but not treated|59|||
125256788|NCT02607722|450568140|FG000|Overall Study|No data reliability|1|||
125256789|NCT02607722|450568140|FG000|Overall Study|no patient visit|18|||
125256790|NCT02607722|450568140|FG000|Overall Study|missing info in CRF|13|||
125256791|NCT02607722|450568140|FG000|Overall Study|Withdrawal by Subject|616|||
125256792|NCT02607722|450568140|FG000|Overall Study|Lost to Follow-up|312|||
125256793|NCT02607722|450568140|FG000|Overall Study|Improved|22|||
125256794|NCT02607722|450568140|FG000|Overall Study|Lack of Efficacy|316|||
125256795|NCT02607722|450568140|FG000|Overall Study|Adverse Event|2553|||
125256796|NCT02607722|450568140|FG000|Overall Study|Not treated|1|||
125256797|NCT02607722|450568140|FG000|Overall Study|No CRF collected|138|||
125256798|NCT02607722|450568140|FG000|Overall Study|without CRF|4225|||
125256799|NCT02607722|450568140|FG000|Overall Study|Physician Decision|367|||
125256800|NCT04562090|450568141|FG000|Overall Study|Withdrawal by Subject|3|||
125256801|NCT04562090|450568142|FG001|Overall Study|Withdrawal by Subject|4|||
125256802|NCT04562090|450568141|FG000|Overall Study|Protocol Violation|2|||
125256803|NCT04562090|450568142|FG001|Overall Study|Protocol Violation|0|||
125256804|NCT04562090|450568141|FG000|Overall Study|Lack of Efficacy|0|||
125256805|NCT04562090|450568142|FG001|Overall Study|Lack of Efficacy|1|||
125256806|NCT04562090|450568141|FG000|Overall Study|Adverse Event|1|||
125256807|NCT04562090|450568142|FG001|Overall Study|Adverse Event|4|||
125256808|NCT04562090|450568141|FG000|Overall Study|Miscellaneous|0|||
125256809|NCT04562090|450568142|FG001|Overall Study|Miscellaneous|3|||
125256810|NCT03633058|450568143|FG000|Overall Study|Adverse Event|0|||
125256811|NCT03633058|450568144|FG001|Overall Study|Adverse Event|0|||
125256812|NCT03633058|450568145|FG002|Overall Study|Adverse Event|1|||
125256813|NCT03633058|450568146|FG003|Overall Study|Adverse Event|0|||
125256814|NCT03034044|450568147|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
125256815|NCT03312543|450568148|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
125256816|NCT03312543|450568149|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
125256817|NCT03312543|450568148|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
125256818|NCT03312543|450568149|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
125256819|NCT03312543|450568148|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
125256820|NCT03312543|450568149|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
125256821|NCT03312543|450568148|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
125256822|NCT03312543|450568149|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
125256823|NCT03312543|450568148|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
125256824|NCT03312543|450568149|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
125256825|NCT03312543|450568148|FG000|Regression (Week 12 to Week 24)|Death|0|||
125256826|NCT03312543|450568149|FG001|Regression (Week 12 to Week 24)|Death|1|||
125256827|NCT05535972|450568150|FG000|Overall Study|Withdrawal by Subject|31|||
125256828|NCT05535972|450568150|FG000|Overall Study|Lost to Follow-up|5|||
125256829|NCT05535972|450568150|FG000|Overall Study|Adverse Event|6|||
125256830|NCT05535972|450568150|FG000|Overall Study|Protocol Deviation|2|||
125256831|NCT02402647|450568153|FG000|Overall Study|Lost to Follow-up|13|||
125256832|NCT02402647|450568154|FG001|Overall Study|Lost to Follow-up|7|||
125256833|NCT02402647|450568153|FG000|Overall Study|Protocol Violation|1|||
125256834|NCT02402647|450568154|FG001|Overall Study|Protocol Violation|1|||
125256835|NCT02402647|450568153|FG000|Overall Study|scheduled and timed out|2|||
125256836|NCT02402647|450568154|FG001|Overall Study|scheduled and timed out|1|||
125256837|NCT02402647|450568153|FG000|Overall Study|medical illness|2|||
125256838|NCT02402647|450568154|FG001|Overall Study|medical illness|4|||
125256839|NCT02402647|450568153|FG000|Overall Study|Moved|2|||
125256840|NCT02402647|450568154|FG001|Overall Study|Moved|0|||
125256841|NCT02402647|450568153|FG000|Overall Study|loved one illness|1|||
125256842|NCT02402647|450568154|FG001|Overall Study|loved one illness|0|||
125256843|NCT02402647|450568153|FG000|Overall Study|deceased preexisting condition|2|||
125256844|NCT02402647|450568154|FG001|Overall Study|deceased preexisting condition|0|||
125256845|NCT02402647|450568153|FG000|Overall Study|Other|2|||
125256846|NCT02402647|450568154|FG001|Overall Study|Other|1|||
125256847|NCT04197583|450568155|FG000|Overall Study|Study Stent Replacement|34|||
125256848|NCT04197583|450568156|FG001|Overall Study|Study Stent Replacement|8|||
125256849|NCT04197583|450568155|FG000|Overall Study|Lost to Follow-up|14|||
125256850|NCT04197583|450568156|FG001|Overall Study|Lost to Follow-up|3|||
125256851|NCT04197583|450568155|FG000|Overall Study|Death|3|||
125256852|NCT04197583|450568156|FG001|Overall Study|Death|0|||
125256853|NCT04197583|450568155|FG000|Overall Study|Physician Decision|1|||
125256854|NCT04197583|450568156|FG001|Overall Study|Physician Decision|0|||
125256855|NCT04197583|450568155|FG000|Overall Study|Withdrawal by Subject|1|||
125256856|NCT04197583|450568156|FG001|Overall Study|Withdrawal by Subject|1|||
125256857|NCT04197583|450568155|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
125256858|NCT04197583|450568156|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
125256859|NCT04197583|450568155|FG000|Overall Study|Screen Failure|0|||
125256860|NCT04197583|450568156|FG001|Overall Study|Screen Failure|20|||
125256861|NCT05852470|450568158|FG000|Overall Study|Withdrawal by Subject|0|||
125256862|NCT05852470|450568159|FG001|Overall Study|Withdrawal by Subject|1|||
125256863|NCT04134936|450568160|FG000|Overall Study|Adverse Event|3|||
125256864|NCT04134936|450568161|FG001|Overall Study|Adverse Event|2|||
125256865|NCT04134936|450568160|FG000|Overall Study|Withdrawal by Subject|2|||
125256866|NCT04134936|450568161|FG001|Overall Study|Withdrawal by Subject|3|||
125256867|NCT04134936|450568160|FG000|Overall Study|Physician Decision|0|||
125256868|NCT04134936|450568161|FG001|Overall Study|Physician Decision|1|||
125256869|NCT04134936|450568160|FG000|Overall Study|Progressive disease, joined another trial|1|||
125256870|NCT04134936|450568161|FG001|Overall Study|Progressive disease, joined another trial|0|||
125256871|NCT04134936|450568160|FG000|Overall Study|Progressive disease|1|||
125256872|NCT04134936|450568161|FG001|Overall Study|Progressive disease|0|||
125256873|NCT00323622|450568164|FG000|Overall Study|Other|30|||
125256874|NCT00323622|450568165|FG001|Overall Study|Other|91|||
125256875|NCT00323622|450568166|FG002|Overall Study|Other|4|||
125256876|NCT00323622|450568167|FG003|Overall Study|Other|12|||
125256877|NCT00323622|450568168|FG004|Overall Study|Other|32|||
125256878|NCT00323622|450568169|FG005|Overall Study|Other|74|||
125256879|NCT00323622|450568170|FG006|Overall Study|Other|5|||
125256880|NCT00323622|450568171|FG007|Overall Study|Other|13|||
125256881|NCT00323622|450568164|FG000|Overall Study|Death|1|||
125256882|NCT00323622|450568165|FG001|Overall Study|Death|1|||
125256883|NCT00323622|450568166|FG002|Overall Study|Death|0|||
125256884|NCT00323622|450568167|FG003|Overall Study|Death|0|||
125256885|NCT00323622|450568168|FG004|Overall Study|Death|7|||
125256886|NCT00323622|450568169|FG005|Overall Study|Death|0|||
125256887|NCT00323622|450568170|FG006|Overall Study|Death|0|||
125256888|NCT00323622|450568171|FG007|Overall Study|Death|2|||
125256889|NCT02420717|450568172|FG000|Overall Study|Did not receive all study medication|2|||
125256890|NCT02420717|450568173|FG001|Overall Study|Did not receive all study medication|0|||
125256891|NCT02420717|450568174|FG002|Overall Study|Did not receive all study medication|0|||
125256892|NCT04191135|450568185|FG000|Induction Treatment|Not Treated|2|||
125256893|NCT04191135|450568186|FG001|Induction Treatment|Not Treated|0|||
125256894|NCT04191135|450568187|FG002|Induction Treatment|Not Treated|0|||
125256895|NCT04191135|450568185|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
125256896|NCT04191135|450568186|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
125256897|NCT04191135|450568187|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
125256898|NCT04191135|450568185|FG000|Induction Treatment|Adverse Event|25|||
125256899|NCT04191135|450568186|FG001|Induction Treatment|Adverse Event|0|||
125256900|NCT04191135|450568187|FG002|Induction Treatment|Adverse Event|0|||
125256901|NCT04191135|450568185|FG000|Induction Treatment|Clinical Progression|8|||
125256902|NCT04191135|450568186|FG001|Induction Treatment|Clinical Progression|0|||
125256903|NCT04191135|450568187|FG002|Induction Treatment|Clinical Progression|0|||
125256904|NCT04191135|450568185|FG000|Induction Treatment|Excluded Medication|1|||
125256905|NCT04191135|450568186|FG001|Induction Treatment|Excluded Medication|0|||
125256906|NCT04191135|450568187|FG002|Induction Treatment|Excluded Medication|0|||
125256907|NCT04191135|450568185|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
125256908|NCT04191135|450568186|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
125256909|NCT04191135|450568187|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
125256910|NCT04191135|450568185|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
125256911|NCT04191135|450568186|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
125256912|NCT04191135|450568187|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
125256913|NCT04191135|450568185|FG000|Induction Treatment|Physician Decision|2|||
125256914|NCT04191135|450568186|FG001|Induction Treatment|Physician Decision|0|||
125256915|NCT04191135|450568187|FG002|Induction Treatment|Physician Decision|0|||
125256916|NCT04191135|450568185|FG000|Induction Treatment|Progressive Disease|135|||
125256917|NCT04191135|450568186|FG001|Induction Treatment|Progressive Disease|0|||
125256918|NCT04191135|450568187|FG002|Induction Treatment|Progressive Disease|0|||
125256919|NCT04191135|450568185|FG000|Induction Treatment|Protocol Violation|10|||
125256920|NCT04191135|450568186|FG001|Induction Treatment|Protocol Violation|0|||
125256921|NCT04191135|450568187|FG002|Induction Treatment|Protocol Violation|0|||
125256922|NCT04191135|450568185|FG000|Induction Treatment|Withdrawal by Subject|4|||
125256923|NCT04191135|450568186|FG001|Induction Treatment|Withdrawal by Subject|0|||
125256924|NCT04191135|450568187|FG002|Induction Treatment|Withdrawal by Subject|0|||
125256925|NCT04191135|450568185|FG000|Randomized Treatment|Death|0|||
125256926|NCT04191135|450568186|FG001|Randomized Treatment|Death|50|||
125256927|NCT04191135|450568187|FG002|Randomized Treatment|Death|54|||
125256928|NCT04191135|450568185|FG000|Randomized Treatment|Lost to Follow-up|0|||
125256929|NCT04191135|450568186|FG001|Randomized Treatment|Lost to Follow-up|0|||
125256930|NCT04191135|450568187|FG002|Randomized Treatment|Lost to Follow-up|1|||
125256931|NCT04191135|450568185|FG000|Randomized Treatment|Withdrawal by Subject|0|||
125256932|NCT04191135|450568186|FG001|Randomized Treatment|Withdrawal by Subject|2|||
125256933|NCT04191135|450568187|FG002|Randomized Treatment|Withdrawal by Subject|0|||
125256934|NCT04191135|450568185|FG000|Randomized Treatment|Ongoing in Trial|0|||
125256935|NCT04191135|450568186|FG001|Randomized Treatment|Ongoing in Trial|83|||
125256936|NCT04191135|450568187|FG002|Randomized Treatment|Ongoing in Trial|81|||
125256937|NCT03514134|450569587|FG000|Overall Study|Lost to Follow-up|0|||
125256938|NCT03514134|450569588|FG001|Overall Study|Lost to Follow-up|1|||
125256939|NCT02471144|450569589|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
125256940|NCT02471144|450569590|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
125256941|NCT02471144|450569591|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
125256942|NCT02471144|450569592|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
125256943|NCT02471144|450569593|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
125256944|NCT02471144|450569594|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
125256945|NCT02471144|450569595|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
125256946|NCT02471144|450569596|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
125256947|NCT02471144|450569597|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
125256948|NCT02471144|450569598|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
125256949|NCT02471144|450569599|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
125256950|NCT02471144|450569589|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
125256951|NCT02471144|450569590|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
125256952|NCT02471144|450569591|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
125256953|NCT02471144|450569592|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
125256954|NCT02471144|450569593|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
125256955|NCT02471144|450569594|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
125256956|NCT02471144|450569595|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
125256957|NCT02471144|450569596|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
125256958|NCT02471144|450569597|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
125256959|NCT02471144|450569598|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
125256960|NCT02471144|450569599|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
125256961|NCT02471144|450569589|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
125256962|NCT02471144|450569590|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
125256963|NCT02471144|450569591|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
125256964|NCT02471144|450569592|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
125256965|NCT02471144|450569593|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
125256966|NCT02471144|450569594|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
125256967|NCT02471144|450569595|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
125256968|NCT02471144|450569596|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
125256969|NCT02471144|450569597|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
125256970|NCT02471144|450569598|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
125256971|NCT02471144|450569599|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
125256972|NCT02471144|450569589|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
125256973|NCT02471144|450569590|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
125256974|NCT02471144|450569591|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
125256975|NCT02471144|450569592|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
125256976|NCT02471144|450569593|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
125256977|NCT02471144|450569594|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
125256978|NCT02471144|450569595|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
125256979|NCT02471144|450569596|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
125256980|NCT02471144|450569597|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
125256981|NCT02471144|450569598|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
125256982|NCT02471144|450569599|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
125256983|NCT02471144|450569589|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
125256984|NCT02471144|450569590|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
125256985|NCT02471144|450569591|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
125256986|NCT02471144|450569592|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
125256987|NCT02471144|450569593|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
125256988|NCT02471144|450569594|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
125256989|NCT02471144|450569595|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
125256990|NCT02471144|450569596|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
125256991|NCT02471144|450569597|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
125256992|NCT02471144|450569598|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
125256993|NCT02471144|450569599|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
125256994|NCT02471144|450569589|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
125256995|NCT02471144|450569590|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
125256996|NCT02471144|450569591|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
125256997|NCT02471144|450569592|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
125256998|NCT02471144|450569593|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
125256999|NCT02471144|450569594|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
125257000|NCT02471144|450569595|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
125257001|NCT02471144|450569596|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
125257002|NCT02471144|450569597|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
125257003|NCT02471144|450569598|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
125257004|NCT02471144|450569599|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
125257005|NCT02471144|450569589|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
125257006|NCT02471144|450569590|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
125257007|NCT02471144|450569591|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
125257008|NCT02471144|450569592|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
125257009|NCT02471144|450569593|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
125257010|NCT02471144|450569594|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
125257011|NCT02471144|450569595|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
125257012|NCT02471144|450569596|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
125257013|NCT02471144|450569597|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
125257014|NCT02471144|450569598|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
125257015|NCT02471144|450569599|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
125257016|NCT02471144|450569589|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
125257017|NCT02471144|450569590|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
125257018|NCT02471144|450569591|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
125257019|NCT02471144|450569592|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
125257020|NCT02471144|450569593|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
125257021|NCT02471144|450569594|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
125257022|NCT02471144|450569595|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
125257023|NCT02471144|450569596|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
125257024|NCT02471144|450569597|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
125257025|NCT02471144|450569598|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
125257026|NCT02471144|450569599|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
125257027|NCT02471144|450569589|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
125257028|NCT02471144|450569590|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
125257029|NCT02471144|450569591|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
125257030|NCT02471144|450569592|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
125257031|NCT02471144|450569593|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
125257032|NCT02471144|450569594|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
125257033|NCT02471144|450569595|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
125257034|NCT02471144|450569596|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
125257035|NCT02471144|450569597|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
125257036|NCT02471144|450569598|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
125257037|NCT02471144|450569599|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
125257038|NCT02471144|450569589|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
125257039|NCT02471144|450569590|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
125257040|NCT02471144|450569591|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
125257041|NCT02471144|450569592|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
125257042|NCT02471144|450569593|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
125257043|NCT02471144|450569594|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
125257044|NCT02471144|450569595|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
125257045|NCT02471144|450569596|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
125257046|NCT02471144|450569597|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
125257047|NCT02471144|450569598|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
125257048|NCT02471144|450569599|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
125257049|NCT02471144|450569589|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
125257050|NCT02471144|450569590|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
125257051|NCT02471144|450569591|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
125257052|NCT02471144|450569592|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
125257053|NCT02471144|450569593|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
125257054|NCT02471144|450569594|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
125257055|NCT02471144|450569595|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
125257056|NCT02471144|450569596|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
125257057|NCT02471144|450569597|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
125257058|NCT02471144|450569598|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
125257059|NCT02471144|450569599|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
125257060|NCT02471144|450569589|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
125257061|NCT02471144|450569590|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
125257062|NCT02471144|450569591|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
125257063|NCT02471144|450569592|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
125257064|NCT02471144|450569593|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
125257065|NCT02471144|450569594|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
125257066|NCT02471144|450569595|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
125257067|NCT02471144|450569596|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
125257068|NCT02471144|450569597|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
125257069|NCT02471144|450569598|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
125257070|NCT02471144|450569599|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
125257071|NCT02471144|450569589|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
125257072|NCT02471144|450569590|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
125257073|NCT02471144|450569591|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
125257074|NCT02471144|450569592|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
125257075|NCT02471144|450569593|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
125257076|NCT02471144|450569594|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
125257077|NCT02471144|450569595|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
125257078|NCT02471144|450569596|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
125257079|NCT02471144|450569597|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
125257080|NCT02471144|450569598|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
125257081|NCT02471144|450569599|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
125257082|NCT02471144|450569589|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
125257083|NCT02471144|450569590|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
125257084|NCT02471144|450569591|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
125257085|NCT02471144|450569592|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
125257086|NCT02471144|450569593|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
125257087|NCT02471144|450569594|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
125257088|NCT02471144|450569595|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
125257089|NCT02471144|450569596|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
125257090|NCT02471144|450569597|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
125257091|NCT02471144|450569598|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
125257092|NCT02471144|450569599|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
125257093|NCT00003645|450569600|FG000|Overall Study|Death|4|||
125257094|NCT00003645|450569601|FG001|Overall Study|Death|1|||
125257095|NCT00003645|450569600|FG000|Overall Study|Lost to Follow-up|7|||
125257096|NCT00003645|450569601|FG001|Overall Study|Lost to Follow-up|8|||
125257097|NCT00003645|450569600|FG000|Overall Study|Withdrawal by Subject|1|||
125257098|NCT00003645|450569601|FG001|Overall Study|Withdrawal by Subject|3|||
125257099|NCT03768336|450569604|FG000|Overall Study|Lost to Follow-up|3|||
125257100|NCT03768336|450569605|FG001|Overall Study|Lost to Follow-up|2|||
125257101|NCT03768336|450569604|FG000|Overall Study|Became Ineligible|2|||
125257102|NCT03768336|450569605|FG001|Overall Study|Became Ineligible|0|||
125257103|NCT03768336|450569604|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
125257104|NCT03768336|450569605|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
125257105|NCT03768336|450569604|FG000|Overall Study|Missed final survey (post-treatment|0|||
125257106|NCT03768336|450569605|FG001|Overall Study|Missed final survey (post-treatment|1|||
125257107|NCT03502681|450569608|FG000|Overall Study|Adverse Event|1|||
125257108|NCT03502681|450569609|FG001|Overall Study|Adverse Event|1|||
125257109|NCT03502681|450569608|FG000|Overall Study|Disease Progression|2|||
125257110|NCT03502681|450569609|FG001|Overall Study|Disease Progression|1|||
125257111|NCT06790303|450569610|FG000|Overall Study|Study Terminated by sponsor|4|||
125257112|NCT06790303|450569610|FG000|Overall Study|Death|4|||
125257113|NCT02374255|450569619|FG000|Overall Study|Withdrawal by Subject|2|||
125257114|NCT02374255|450569620|FG001|Overall Study|Withdrawal by Subject|0|||
125257115|NCT02374255|450569621|FG002|Overall Study|Withdrawal by Subject|0|||
125257116|NCT02374255|450569622|FG003|Overall Study|Withdrawal by Subject|0|||
125257117|NCT02093520|450569623|FG000|Overall Study|Not treated|6|||
125257118|NCT02093520|450569624|FG001|Overall Study|Not treated|22|||
125257119|NCT03014089|450569625|FG000|Overall Study|Withdrawal by Subject|0|||
125257120|NCT03014089|450569626|FG001|Overall Study|Withdrawal by Subject|1|||
125257121|NCT03014089|450569627|FG002|Overall Study|Withdrawal by Subject|1|||
125257122|NCT03014089|450569628|FG003|Overall Study|Withdrawal by Subject|1|||
125257123|NCT03014089|450569625|FG000|Overall Study|Lost to Follow-up|1|||
125257124|NCT03014089|450569626|FG001|Overall Study|Lost to Follow-up|0|||
125257125|NCT03014089|450569627|FG002|Overall Study|Lost to Follow-up|0|||
125257126|NCT03014089|450569628|FG003|Overall Study|Lost to Follow-up|0|||
125257127|NCT03014089|450569625|FG000|Overall Study|Adverse Event|1|||
125257128|NCT03014089|450569626|FG001|Overall Study|Adverse Event|0|||
125257129|NCT03014089|450569627|FG002|Overall Study|Adverse Event|1|||
125257130|NCT03014089|450569628|FG003|Overall Study|Adverse Event|0|||
125257131|NCT00321932|450569630|FG000|Overall Study|Death|3|||
125257132|NCT00321932|450569631|FG001|Overall Study|Death|6|||
125257133|NCT00321932|450569630|FG000|Overall Study|Withdrawal by Subject|3|||
125257134|NCT00321932|450569631|FG001|Overall Study|Withdrawal by Subject|6|||
125257135|NCT00321932|450569630|FG000|Overall Study|Early relapse|2|||
125257136|NCT00321932|450569631|FG001|Overall Study|Early relapse|8|||
125257137|NCT00321932|450569630|FG000|Overall Study|Missing data|2|||
125257138|NCT00321932|450569631|FG001|Overall Study|Missing data|1|||
125257139|NCT03257657|450569632|FG000|Overall Study|Lost to Follow-up|0|||
125257140|NCT03257657|450569633|FG001|Overall Study|Lost to Follow-up|3|||
125257141|NCT03257657|450569632|FG000|Overall Study|Withdrawn|0|||
125257142|NCT03257657|450569633|FG001|Overall Study|Withdrawn|1|||
125257143|NCT03257657|450569632|FG000|Overall Study|Noted not eligible right after enrolled|0|||
125257144|NCT03257657|450569633|FG001|Overall Study|Noted not eligible right after enrolled|1|||
125257145|NCT01992757|450569648|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
125257146|NCT04992273|450569649|FG000|Overall Study|Lost to Follow-up|0|||
125257147|NCT04992273|450569650|FG001|Overall Study|Lost to Follow-up|1|||
125257148|NCT00688740|450569651|FG000|Overall Study|Adverse Event|45|||
125257149|NCT00688740|450569652|FG001|Overall Study|Adverse Event|8|||
125257150|NCT00688740|450569651|FG000|Overall Study|Death|2|||
125257151|NCT00688740|450569652|FG001|Overall Study|Death|2|||
125257152|NCT00688740|450569651|FG000|Overall Study|Lost to Follow-up|0|||
125257153|NCT00688740|450569652|FG001|Overall Study|Lost to Follow-up|1|||
125257154|NCT00688740|450569651|FG000|Overall Study|Consent Withdrawn|17|||
125257155|NCT00688740|450569652|FG001|Overall Study|Consent Withdrawn|17|||
125257156|NCT00688740|450569651|FG000|Overall Study|Breast Cancer Relapse|1|||
125257157|NCT00688740|450569652|FG001|Overall Study|Breast Cancer Relapse|4|||
125257158|NCT00688740|450569651|FG000|Overall Study|Violation of Inclusion Criteria|1|||
125257159|NCT00688740|450569652|FG001|Overall Study|Violation of Inclusion Criteria|3|||
125257160|NCT00856557|450569655|FG000|Overall Study|No patients with contextual flags|12|||
125257161|NCT00856557|450569656|FG001|Overall Study|No patients with contextual flags|16|||
125257162|NCT01432444|450569657|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
125257163|NCT01432444|450569658|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
125257164|NCT01432444|450569659|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
125257165|NCT01432444|450569657|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
125257166|NCT01432444|450569658|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
125257167|NCT01432444|450569659|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
125257168|NCT01432444|450569657|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
125257169|NCT01432444|450569658|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
125257170|NCT01432444|450569659|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
125257171|NCT01432444|450569657|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
125257172|NCT01432444|450569658|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
125257173|NCT01432444|450569659|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
125257174|NCT01432444|450569657|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
125257175|NCT01432444|450569658|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
125257176|NCT01432444|450569659|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
125257177|NCT01432444|450569657|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
125257178|NCT01432444|450569658|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
125257179|NCT01432444|450569659|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
125257180|NCT01432444|450569657|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
125257181|NCT01432444|450569658|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
125257182|NCT01432444|450569659|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
125257183|NCT01432444|450569657|FG000|Treatment Phase|Lost to Follow-up|0|||
125257184|NCT01432444|450569658|FG001|Treatment Phase|Lost to Follow-up|33|||
125257185|NCT01432444|450569659|FG002|Treatment Phase|Lost to Follow-up|0|||
125257186|NCT01432444|450569657|FG000|Treatment Phase|Adverse Event|0|||
125257187|NCT01432444|450569658|FG001|Treatment Phase|Adverse Event|37|||
125257188|NCT01432444|450569659|FG002|Treatment Phase|Adverse Event|0|||
125257189|NCT01432444|450569657|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
125257190|NCT01432444|450569658|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
125257191|NCT01432444|450569659|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
125257192|NCT01432444|450569657|FG000|Treatment Phase|Physician Decision|0|||
125257193|NCT01432444|450569658|FG001|Treatment Phase|Physician Decision|5|||
125257194|NCT01432444|450569659|FG002|Treatment Phase|Physician Decision|0|||
125257195|NCT01432444|450569657|FG000|Treatment Phase|Withdrawal by Subject|0|||
125257196|NCT01432444|450569658|FG001|Treatment Phase|Withdrawal by Subject|41|||
125257197|NCT01432444|450569659|FG002|Treatment Phase|Withdrawal by Subject|0|||
125257198|NCT01432444|450569657|FG000|Treatment Phase|Protocol Deviation|0|||
125257199|NCT01432444|450569658|FG001|Treatment Phase|Protocol Deviation|3|||
125257200|NCT01432444|450569659|FG002|Treatment Phase|Protocol Deviation|0|||
125257201|NCT01432444|450569657|FG000|Treatment Phase|Lack of Efficacy|0|||
125257202|NCT01432444|450569658|FG001|Treatment Phase|Lack of Efficacy|10|||
125257203|NCT01432444|450569659|FG002|Treatment Phase|Lack of Efficacy|0|||
125257204|NCT01432444|450569657|FG000|Extension Phase|Lost to Follow-up|0|||
125257205|NCT01432444|450569658|FG001|Extension Phase|Lost to Follow-up|0|||
125257206|NCT01432444|450569659|FG002|Extension Phase|Lost to Follow-up|17|||
125257207|NCT01432444|450569657|FG000|Extension Phase|Adverse Event|0|||
125257208|NCT01432444|450569658|FG001|Extension Phase|Adverse Event|0|||
125257209|NCT01432444|450569659|FG002|Extension Phase|Adverse Event|10|||
125257210|NCT01432444|450569657|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
125257211|NCT01432444|450569658|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
125257212|NCT01432444|450569659|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
125257213|NCT01432444|450569657|FG000|Extension Phase|Met Withdrawal Criteria|0|||
125257214|NCT01432444|450569658|FG001|Extension Phase|Met Withdrawal Criteria|0|||
125257215|NCT01432444|450569659|FG002|Extension Phase|Met Withdrawal Criteria|144|||
125257216|NCT01432444|450569657|FG000|Extension Phase|Physician Decision|0|||
125257217|NCT01432444|450569658|FG001|Extension Phase|Physician Decision|0|||
125257218|NCT01432444|450569659|FG002|Extension Phase|Physician Decision|1|||
125257219|NCT01432444|450569657|FG000|Extension Phase|Withdrawal by Subject|0|||
125257220|NCT01432444|450569658|FG001|Extension Phase|Withdrawal by Subject|0|||
125257221|NCT01432444|450569659|FG002|Extension Phase|Withdrawal by Subject|13|||
125257222|NCT02301897|450569660|FG000|Treatment Course 1|Non-Compliance|0|||
125257223|NCT02301897|450569661|FG001|Treatment Course 1|Non-Compliance|0|||
125257224|NCT02301897|450569662|FG002|Treatment Course 1|Non-Compliance|1|||
125257225|NCT02301897|450569660|FG000|Treatment Course 1|Adverse Event|1|||
125257226|NCT02301897|450569661|FG001|Treatment Course 1|Adverse Event|1|||
125257227|NCT02301897|450569662|FG002|Treatment Course 1|Adverse Event|0|||
125257228|NCT02301897|450569660|FG000|Treatment Course 1|Lost to Follow-up|1|||
125257229|NCT02301897|450569661|FG001|Treatment Course 1|Lost to Follow-up|2|||
125257230|NCT02301897|450569662|FG002|Treatment Course 1|Lost to Follow-up|1|||
125257231|NCT02301897|450569660|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
125257232|NCT02301897|450569661|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
125257233|NCT02301897|450569662|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
125257234|NCT02301897|450569660|FG000|Treatment Course 1|Withdrawal by Subject|0|||
125257235|NCT02301897|450569661|FG001|Treatment Course 1|Withdrawal by Subject|0|||
125257236|NCT02301897|450569662|FG002|Treatment Course 1|Withdrawal by Subject|2|||
125257237|NCT02301897|450569660|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
125257238|NCT02301897|450569661|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
125257239|NCT02301897|450569662|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
125257240|NCT02301897|450569660|FG000|Treatment Course 2|Lost to Follow-up|0|||
125257241|NCT02301897|450569661|FG001|Treatment Course 2|Lost to Follow-up|2|||
125257242|NCT02301897|450569662|FG002|Treatment Course 2|Lost to Follow-up|0|||
125257243|NCT02301897|450569660|FG000|Treatment Course 2|Pregnancy|0|||
125257244|NCT02301897|450569661|FG001|Treatment Course 2|Pregnancy|1|||
125257245|NCT02301897|450569662|FG002|Treatment Course 2|Pregnancy|1|||
125257246|NCT02301897|450569660|FG000|Treatment Course 2|Withdrawal by Subject|0|||
125257247|NCT02301897|450569661|FG001|Treatment Course 2|Withdrawal by Subject|2|||
125257248|NCT02301897|450569662|FG002|Treatment Course 2|Withdrawal by Subject|0|||
125257249|NCT02301897|450569660|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
125257250|NCT02301897|450569661|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
125257251|NCT02301897|450569662|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
125257252|NCT03283241|450569663|FG000|Overall Study|Adverse Event|4|||
125257253|NCT03283241|450569664|FG001|Overall Study|Adverse Event|1|||
125257254|NCT03283241|450569663|FG000|Overall Study|Withdrawal by Subject|0|||
125257255|NCT03283241|450569664|FG001|Overall Study|Withdrawal by Subject|1|||
125257256|NCT03283241|450569663|FG000|Overall Study|Subject relocated to Finland|0|||
125257257|NCT03283241|450569664|FG001|Overall Study|Subject relocated to Finland|1|||
125257258|NCT00478257|450569665|FG000|Overall Study|Withdrawal by Subject|8|||
125257259|NCT00478257|450569666|FG001|Overall Study|Withdrawal by Subject|3|||
125257260|NCT03931330|450569667|FG000|Overall Study|Physician Decision|1|||
125257261|NCT03412929|450569668|FG000|Overall Study|Protocol Violation|3|||
125257262|NCT00023595|450569673|FG000|5 Year Follow up|Lost to Follow-up|2|||
125257263|NCT00023595|450569674|FG001|5 Year Follow up|Lost to Follow-up|2|||
125257264|NCT00023595|450569675|FG002|5 Year Follow up|Lost to Follow-up|1|||
125257265|NCT00023595|450569676|FG003|5 Year Follow up|Lost to Follow-up|7|||
125257266|NCT00023595|450569677|FG004|5 Year Follow up|Lost to Follow-up|3|||
125257267|NCT00023595|450569673|FG000|10 Year Follow up|Lost to Follow-up|12|||
125257268|NCT00023595|450569674|FG001|10 Year Follow up|Lost to Follow-up|10|||
125257269|NCT00023595|450569675|FG002|10 Year Follow up|Lost to Follow-up|3|||
125257270|NCT00023595|450569676|FG003|10 Year Follow up|Lost to Follow-up|0|||
125257271|NCT00023595|450569677|FG004|10 Year Follow up|Lost to Follow-up|0|||
125257272|NCT01472185|450569678|FG000|Overall Study|Randomized but Not Treated|0|||
125257273|NCT01472185|450569679|FG001|Overall Study|Randomized but Not Treated|1|||
125257274|NCT01472185|450569678|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
125257275|NCT01472185|450569679|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
125257276|NCT01472185|450569678|FG000|Overall Study|Hyperglycemia|5|||
125257277|NCT01472185|450569679|FG001|Overall Study|Hyperglycemia|2|||
125257278|NCT01472185|450569678|FG000|Overall Study|Investigator's Discretion|3|||
125257279|NCT01472185|450569679|FG001|Overall Study|Investigator's Discretion|1|||
125257280|NCT01472185|450569678|FG000|Overall Study|Lost to Follow-up|4|||
125257281|NCT01472185|450569679|FG001|Overall Study|Lost to Follow-up|1|||
125257282|NCT01472185|450569678|FG000|Overall Study|Protocol Violation|5|||
125257283|NCT01472185|450569679|FG001|Overall Study|Protocol Violation|1|||
125257284|NCT01472185|450569678|FG000|Overall Study|Subject Noncompliance|8|||
125257285|NCT01472185|450569679|FG001|Overall Study|Subject Noncompliance|15|||
125257286|NCT01472185|450569678|FG000|Overall Study|Subject Withdrew Consent|6|||
125257287|NCT01472185|450569679|FG001|Overall Study|Subject Withdrew Consent|3|||
125257288|NCT00635050|450569684|FG000|Overall Study|Withdrawal by Subject|1|||
125257289|NCT00759395|450569685|FG000|Overall Study|Adverse Event|1|||
125257290|NCT00759395|450569686|FG001|Overall Study|Adverse Event|0|||
125257291|NCT00759395|450569685|FG000|Overall Study|Withdrawal by Subject|1|||
125257292|NCT00759395|450569686|FG001|Overall Study|Withdrawal by Subject|0|||
125257293|NCT00759395|450569685|FG000|Overall Study|Lack of Efficacy|0|||
125257294|NCT00759395|450569686|FG001|Overall Study|Lack of Efficacy|2|||
125257295|NCT00086515|450569687|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
125257296|NCT00086515|450569688|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
125257297|NCT00086515|450569687|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
125257298|NCT00086515|450569688|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
125257299|NCT00086515|450569687|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
125257300|NCT00086515|450569688|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
125257301|NCT00086515|450569687|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
125257302|NCT00086515|450569688|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
125257303|NCT00086515|450569687|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
125257304|NCT00086515|450569688|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
125257305|NCT00086515|450569687|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
125257306|NCT00086515|450569688|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
125257307|NCT00086515|450569687|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
125257308|NCT00086515|450569688|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
125257309|NCT00086515|450569687|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
125257310|NCT00086515|450569688|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
125257311|NCT00086515|450569687|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
125257312|NCT00086515|450569688|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
125257313|NCT00086515|450569687|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
125257314|NCT00086515|450569688|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
125257315|NCT00086515|450569687|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
125257316|NCT00086515|450569688|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
125257317|NCT00086515|450569687|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
125257318|NCT00086515|450569688|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
125257319|NCT00086515|450569687|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
125257320|NCT00086515|450569688|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
125257321|NCT00086515|450569687|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
125257322|NCT00086515|450569688|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
125257323|NCT00086515|450569687|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
125257324|NCT00086515|450569688|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
125257325|NCT00086515|450569687|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
125303098|NCT03100058|450736673|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125303099|NCT03100058|450736661|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
125303100|NCT03100058|450736662|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
125303101|NCT03100058|450736663|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
125303102|NCT03100058|450736664|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
125303103|NCT03100058|450736665|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
125303104|NCT03100058|450736666|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
125257326|NCT00086515|450569688|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
125257327|NCT00086515|450569687|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
125257328|NCT00086515|450569688|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
125257329|NCT00086515|450569687|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
125257330|NCT00086515|450569688|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
125257331|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
125257332|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
125257333|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
125257334|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
125257335|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
125257336|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
125257337|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
125257338|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
125257339|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
125257340|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
125257341|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
125257342|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
125257343|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
125257344|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
125257345|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
125257346|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
125257347|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
125257348|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
125257349|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
125257350|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
125257351|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
125257352|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
125257353|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
125257354|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
125257355|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
125257356|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
125257357|NCT00049543|450569689|FG000|Overall Study|still on treatment|2|||
125257358|NCT00049543|450569690|FG001|Overall Study|still on treatment|9|||
125257359|NCT02106832|450569691|FG000|Overall Study|Adverse Event|1|||
125257360|NCT02106832|450569692|FG001|Overall Study|Adverse Event|2|||
125257361|NCT02106832|450569693|FG002|Overall Study|Adverse Event|3|||
125257362|NCT02106832|450569694|FG003|Overall Study|Adverse Event|0|||
125257363|NCT02106832|450569691|FG000|Overall Study|Death|4|||
125257364|NCT02106832|450569692|FG001|Overall Study|Death|4|||
125257365|NCT02106832|450569693|FG002|Overall Study|Death|1|||
125257366|NCT02106832|450569694|FG003|Overall Study|Death|4|||
125257367|NCT02106832|450569691|FG000|Overall Study|Deterioration of general conditions|0|||
125257368|NCT02106832|450569692|FG001|Overall Study|Deterioration of general conditions|0|||
125257369|NCT02106832|450569693|FG002|Overall Study|Deterioration of general conditions|1|||
125257370|NCT02106832|450569694|FG003|Overall Study|Deterioration of general conditions|0|||
125257371|NCT02106832|450569691|FG000|Overall Study|Lost to Follow-up|0|||
125257372|NCT02106832|450569692|FG001|Overall Study|Lost to Follow-up|1|||
125257373|NCT02106832|450569693|FG002|Overall Study|Lost to Follow-up|1|||
125257374|NCT02106832|450569694|FG003|Overall Study|Lost to Follow-up|3|||
125257375|NCT02106832|450569691|FG000|Overall Study|Physician Decision|1|||
125257376|NCT02106832|450569692|FG001|Overall Study|Physician Decision|0|||
125257377|NCT02106832|450569693|FG002|Overall Study|Physician Decision|0|||
125257378|NCT02106832|450569694|FG003|Overall Study|Physician Decision|0|||
125257379|NCT02106832|450569691|FG000|Overall Study|Protocol Violation|0|||
125257380|NCT02106832|450569692|FG001|Overall Study|Protocol Violation|0|||
125257381|NCT02106832|450569693|FG002|Overall Study|Protocol Violation|0|||
125257382|NCT02106832|450569694|FG003|Overall Study|Protocol Violation|1|||
125257383|NCT02106832|450569691|FG000|Overall Study|Withdrawal by Subject|17|||
125257384|NCT02106832|450569692|FG001|Overall Study|Withdrawal by Subject|17|||
125257385|NCT02106832|450569693|FG002|Overall Study|Withdrawal by Subject|10|||
125257386|NCT02106832|450569694|FG003|Overall Study|Withdrawal by Subject|7|||
125257387|NCT02106832|450569691|FG000|Overall Study|Technical problems|0|||
125257388|NCT02106832|450569692|FG001|Overall Study|Technical problems|1|||
125257389|NCT02106832|450569693|FG002|Overall Study|Technical problems|0|||
125257390|NCT02106832|450569694|FG003|Overall Study|Technical problems|0|||
125257391|NCT03485157|450569695|FG000|Double Blind Phase|Lost to Follow-up|4|||
125257392|NCT03485157|450569696|FG001|Double Blind Phase|Lost to Follow-up|4|||
125257393|NCT03485157|450569695|FG000|Double Blind Phase|Adverse Event|2|||
125257394|NCT03485157|450569696|FG001|Double Blind Phase|Adverse Event|1|||
125257395|NCT03485157|450569695|FG000|Double Blind Phase|Withdrawal by Subject|6|||
125257396|NCT03485157|450569696|FG001|Double Blind Phase|Withdrawal by Subject|9|||
125257397|NCT03485157|450569695|FG000|Double Blind Phase|Removal by PI|3|||
125257398|NCT03485157|450569696|FG001|Double Blind Phase|Removal by PI|7|||
125257399|NCT03485157|450569695|FG000|Open Label Phase|Lost to Follow-up|1|||
125257400|NCT03485157|450569696|FG001|Open Label Phase|Lost to Follow-up|2|||
125257401|NCT03485157|450569695|FG000|Open Label Phase|Adverse Event|0|||
125257402|NCT03485157|450569696|FG001|Open Label Phase|Adverse Event|1|||
125257403|NCT03485157|450569695|FG000|Open Label Phase|Withdrawal by Subject|1|||
125257404|NCT03485157|450569696|FG001|Open Label Phase|Withdrawal by Subject|2|||
125257405|NCT03485157|450569695|FG000|Open Label Phase|Removal by PI|2|||
125257406|NCT03485157|450569696|FG001|Open Label Phase|Removal by PI|0|||
125257407|NCT00265122|450569697|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
125257408|NCT00265122|450569698|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
125257409|NCT00265122|450569699|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
125257410|NCT00265122|450569700|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
125257411|NCT00265122|450569701|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
125257412|NCT00265122|450569702|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
125257413|NCT00265122|450569697|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
125257414|NCT00265122|450569698|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
125257415|NCT00265122|450569699|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
125257416|NCT00265122|450569700|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
125257417|NCT00265122|450569701|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
125257418|NCT00265122|450569702|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
125257419|NCT00265122|450569697|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
125257420|NCT00265122|450569698|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
125257421|NCT00265122|450569699|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
125257422|NCT00265122|450569700|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
125257423|NCT00265122|450569701|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
125257424|NCT00265122|450569702|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
125257425|NCT00265122|450569697|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
125257426|NCT00265122|450569698|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
125257427|NCT00265122|450569699|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
125257428|NCT00265122|450569700|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
125257429|NCT00265122|450569701|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
125257430|NCT00265122|450569702|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
125257431|NCT00265122|450569697|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
125257432|NCT00265122|450569698|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
125257433|NCT00265122|450569699|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
125257434|NCT00265122|450569700|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
125257435|NCT00265122|450569701|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
125257436|NCT00265122|450569702|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
125257437|NCT00265122|450569697|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
125257438|NCT00265122|450569698|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
125257439|NCT00265122|450569699|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
125257440|NCT00265122|450569700|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
125257441|NCT00265122|450569701|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
125257442|NCT00265122|450569702|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
125257443|NCT05205616|450569709|FG000|Overall Study|Lost to Follow-up|4|||
125257444|NCT05205616|450569710|FG001|Overall Study|Lost to Follow-up|4|||
125257445|NCT00663260|450569716|FG000|Overall Study|Lack of Efficacy|2|||
125257446|NCT00663260|450569717|FG001|Overall Study|Lack of Efficacy|0|||
125257447|NCT00663260|450569718|FG002|Overall Study|Lack of Efficacy|0|||
125257448|NCT00663260|450569716|FG000|Overall Study|Adverse Event|12|||
125257449|NCT00663260|450569717|FG001|Overall Study|Adverse Event|7|||
125257450|NCT00663260|450569718|FG002|Overall Study|Adverse Event|6|||
125257451|NCT00663260|450569716|FG000|Overall Study|Withdrawal by Subject|3|||
125257452|NCT00663260|450569717|FG001|Overall Study|Withdrawal by Subject|1|||
125257453|NCT00663260|450569718|FG002|Overall Study|Withdrawal by Subject|6|||
125257454|NCT00663260|450569716|FG000|Overall Study|Death|1|||
125257455|NCT00663260|450569717|FG001|Overall Study|Death|0|||
125257456|NCT00663260|450569718|FG002|Overall Study|Death|1|||
125257457|NCT00663260|450569716|FG000|Overall Study|Lost to Follow-up|0|||
125257458|NCT00663260|450569717|FG001|Overall Study|Lost to Follow-up|1|||
125257459|NCT00663260|450569718|FG002|Overall Study|Lost to Follow-up|0|||
125257460|NCT00663260|450569716|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
125257461|NCT00663260|450569717|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
125257462|NCT00663260|450569718|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
125257463|NCT02231580|450569727|FG000|Overall Study|Adverse Event|5|||
125257464|NCT02231580|450569728|FG001|Overall Study|Adverse Event|0|||
125257465|NCT03620981|450569729|FG000|Overall Study|Adverse Event|14|||
125257466|NCT03620981|450569730|FG001|Overall Study|Adverse Event|38|||
125257467|NCT03620981|450569731|FG002|Overall Study|Adverse Event|25|||
125257468|NCT03620981|450569729|FG000|Overall Study|Lack of Efficacy|2|||
125257469|NCT03620981|450569730|FG001|Overall Study|Lack of Efficacy|1|||
125257470|NCT03620981|450569731|FG002|Overall Study|Lack of Efficacy|1|||
125257471|NCT03620981|450569729|FG000|Overall Study|Physician Decision|7|||
125257472|NCT03620981|450569730|FG001|Overall Study|Physician Decision|4|||
125257473|NCT03620981|450569731|FG002|Overall Study|Physician Decision|4|||
125257474|NCT03620981|450569729|FG000|Overall Study|Protocol Violation|1|||
125257475|NCT03620981|450569730|FG001|Overall Study|Protocol Violation|2|||
125257476|NCT03620981|450569731|FG002|Overall Study|Protocol Violation|1|||
125257477|NCT03620981|450569729|FG000|Overall Study|Withdrawal by Legal Representative|2|||
125257478|NCT03620981|450569730|FG001|Overall Study|Withdrawal by Legal Representative|1|||
125257479|NCT03620981|450569731|FG002|Overall Study|Withdrawal by Legal Representative|1|||
125257480|NCT03620981|450569729|FG000|Overall Study|Withdrawal by Care Giver|2|||
125257481|NCT03620981|450569730|FG001|Overall Study|Withdrawal by Care Giver|0|||
125257482|NCT03620981|450569731|FG002|Overall Study|Withdrawal by Care Giver|1|||
125257483|NCT03620981|450569729|FG000|Overall Study|Non-compliance with Study Drug|1|||
125257484|NCT03620981|450569730|FG001|Overall Study|Non-compliance with Study Drug|1|||
125257485|NCT03620981|450569731|FG002|Overall Study|Non-compliance with Study Drug|0|||
125257486|NCT03238196|450569734|FG000|Overall Study|Adverse Event|3|||
125257487|NCT03238196|450569735|FG001|Overall Study|Adverse Event|0|||
125257488|NCT03238196|450569736|FG002|Overall Study|Adverse Event|2|||
125257489|NCT03238196|450569737|FG003|Overall Study|Adverse Event|2|||
125257490|NCT03238196|450569734|FG000|Overall Study|Withdrawal by Subject|4|||
125257491|NCT03238196|450569735|FG001|Overall Study|Withdrawal by Subject|1|||
125257492|NCT03238196|450569736|FG002|Overall Study|Withdrawal by Subject|1|||
125257493|NCT03238196|450569737|FG003|Overall Study|Withdrawal by Subject|0|||
125257494|NCT03238196|450569734|FG000|Overall Study|Disease progression|14|||
125257495|NCT03238196|450569735|FG001|Overall Study|Disease progression|2|||
125257496|NCT03238196|450569736|FG002|Overall Study|Disease progression|3|||
125257497|NCT03238196|450569737|FG003|Overall Study|Disease progression|2|||
125257498|NCT03238196|450569734|FG000|Overall Study|Still on treatment|1|||
125257499|NCT03238196|450569735|FG001|Overall Study|Still on treatment|0|||
125257500|NCT03238196|450569736|FG002|Overall Study|Still on treatment|0|||
125257501|NCT03238196|450569737|FG003|Overall Study|Still on treatment|0|||
125257502|NCT04938427|450569738|FG000|Overall Study|Adverse Event|5|||
125257503|NCT04938427|450569739|FG001|Overall Study|Adverse Event|19|||
125257504|NCT04938427|450569738|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
125257505|NCT04938427|450569739|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125257506|NCT04938427|450569738|FG000|Overall Study|Withdrawal by Subject|1|||
125257507|NCT04938427|450569739|FG001|Overall Study|Withdrawal by Subject|0|||
125257508|NCT04938427|450569738|FG000|Overall Study|Reason Not Specified|2|||
125257509|NCT04938427|450569739|FG001|Overall Study|Reason Not Specified|1|||
125257510|NCT03977155|450571538|FG000|Overall Study|Adverse Event|3|||
125257511|NCT03977155|450571539|FG001|Overall Study|Adverse Event|0|||
125257512|NCT03977155|450571540|FG002|Overall Study|Adverse Event|0|||
125257513|NCT03977155|450571538|FG000|Overall Study|Lost to Follow-up|0|||
125257514|NCT03977155|450571539|FG001|Overall Study|Lost to Follow-up|1|||
125257515|NCT03977155|450571540|FG002|Overall Study|Lost to Follow-up|0|||
125257516|NCT03977155|450571538|FG000|Overall Study|Withdrawal by Subject|1|||
125257517|NCT03977155|450571539|FG001|Overall Study|Withdrawal by Subject|1|||
125257518|NCT03977155|450571540|FG002|Overall Study|Withdrawal by Subject|2|||
125257519|NCT03977155|450571538|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
125257520|NCT03977155|450571539|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
125257521|NCT03977155|450571540|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
125257522|NCT00936936|450571541|FG000|Overall Study|Adverse Event|7|||
125257523|NCT00936936|450571542|FG001|Overall Study|Adverse Event|1|||
125257524|NCT00936936|450571541|FG000|Overall Study|Disease Progression|2|||
125257525|NCT00936936|450571542|FG001|Overall Study|Disease Progression|2|||
125257526|NCT00936936|450571541|FG000|Overall Study|Unrelated|3|||
125257527|NCT00936936|450571542|FG001|Overall Study|Unrelated|1|||
125257528|NCT01373281|450571543|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
125257529|NCT01373281|450571544|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
125257530|NCT01373281|450571543|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
125257531|NCT01373281|450571544|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
125257532|NCT01373281|450571543|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
125257533|NCT01373281|450571544|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
125257534|NCT01373281|450571543|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
125257535|NCT01373281|450571544|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
125257536|NCT01373281|450571543|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
125257537|NCT01373281|450571544|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
125257538|NCT01373281|450571543|FG000|Surveillance Expansion Period|Protocol Violation|9|||
125257539|NCT01373281|450571544|FG001|Surveillance Expansion Period|Protocol Violation|1|||
125257540|NCT01373281|450571543|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
125257541|NCT01373281|450571544|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
125257542|NCT01373281|450571543|FG000|Surveillance Expansion Period|Serious adverse event|3|||
125257543|NCT01373281|450571544|FG001|Surveillance Expansion Period|Serious adverse event|4|||
125257544|NCT01444781|450571545|FG000|Overall Study|Lost to Follow-up|0|||
125257545|NCT01444781|450571546|FG001|Overall Study|Lost to Follow-up|3|||
125257546|NCT01444781|450571547|FG002|Overall Study|Lost to Follow-up|1|||
125257547|NCT01444781|450571545|FG000|Overall Study|Withdrawal by Subject|3|||
125257548|NCT01444781|450571546|FG001|Overall Study|Withdrawal by Subject|1|||
125257549|NCT01444781|450571547|FG002|Overall Study|Withdrawal by Subject|2|||
125257550|NCT03033784|450571548|FG000|Overall Study|Anxiety related to MRI scanner|0|||
125257551|NCT03033784|450571549|FG001|Overall Study|Anxiety related to MRI scanner|1|||
125257552|NCT03033784|450571550|FG002|Overall Study|Anxiety related to MRI scanner|0|||
125257553|NCT03033784|450571551|FG003|Overall Study|Anxiety related to MRI scanner|0|||
125257554|NCT03033784|450571552|FG004|Overall Study|Anxiety related to MRI scanner|0|||
125257555|NCT03033784|450571553|FG005|Overall Study|Anxiety related to MRI scanner|0|||
125257556|NCT03033784|450571554|FG006|Overall Study|Anxiety related to MRI scanner|0|||
125257557|NCT03033784|450571555|FG007|Overall Study|Anxiety related to MRI scanner|0|||
125257558|NCT03033784|450571556|FG008|Overall Study|Anxiety related to MRI scanner|0|||
125257559|NCT03033784|450571557|FG009|Overall Study|Anxiety related to MRI scanner|0|||
125257560|NCT03033784|450571558|FG010|Overall Study|Anxiety related to MRI scanner|0|||
125257561|NCT03033784|450571559|FG011|Overall Study|Anxiety related to MRI scanner|0|||
125257562|NCT03033784|450571560|FG012|Overall Study|Anxiety related to MRI scanner|0|||
125257563|NCT03033784|450571548|FG000|Overall Study|Withdrawal by Subject|0|||
125257564|NCT03033784|450571549|FG001|Overall Study|Withdrawal by Subject|0|||
125257565|NCT03033784|450571550|FG002|Overall Study|Withdrawal by Subject|0|||
125257566|NCT03033784|450571551|FG003|Overall Study|Withdrawal by Subject|0|||
125257567|NCT03033784|450571552|FG004|Overall Study|Withdrawal by Subject|0|||
125257568|NCT03033784|450571553|FG005|Overall Study|Withdrawal by Subject|0|||
125257569|NCT03033784|450571554|FG006|Overall Study|Withdrawal by Subject|0|||
125257570|NCT03033784|450571555|FG007|Overall Study|Withdrawal by Subject|0|||
125257571|NCT03033784|450571556|FG008|Overall Study|Withdrawal by Subject|0|||
125257572|NCT03033784|450571557|FG009|Overall Study|Withdrawal by Subject|0|||
125257573|NCT03033784|450571558|FG010|Overall Study|Withdrawal by Subject|0|||
125257574|NCT03033784|450571559|FG011|Overall Study|Withdrawal by Subject|0|||
125257575|NCT03033784|450571560|FG012|Overall Study|Withdrawal by Subject|2|||
125257576|NCT03332056|450571561|FG000|Overall Study|Incomplete questionnaires|8|||
125257577|NCT03332056|450571562|FG001|Overall Study|Incomplete questionnaires|9|||
125257578|NCT03332056|450571561|FG000|Overall Study|Passed stone prior to surgery date|1|||
125257579|NCT03332056|450571562|FG001|Overall Study|Passed stone prior to surgery date|0|||
125257580|NCT03332056|450571561|FG000|Overall Study|Did not require a ureteral stent|0|||
125257581|NCT03332056|450571562|FG001|Overall Study|Did not require a ureteral stent|1|||
125257582|NCT00851084|450571563|FG000|Overall Study|Randomized but not treated|1|||
125257583|NCT00851084|450571564|FG001|Overall Study|Randomized but not treated|0|||
125257584|NCT00851084|450571563|FG000|Overall Study|Adverse Event|26|||
125257585|NCT00851084|450571564|FG001|Overall Study|Adverse Event|36|||
125257586|NCT00851084|450571563|FG000|Overall Study|Disease progression|52|||
125257587|NCT00851084|450571564|FG001|Overall Study|Disease progression|47|||
125257588|NCT00851084|450571563|FG000|Overall Study|Poor compliance to protocol|1|||
125257589|NCT00851084|450571564|FG001|Overall Study|Poor compliance to protocol|1|||
125257590|NCT00851084|450571563|FG000|Overall Study|Physician Decision|13|||
125257591|NCT00851084|450571564|FG001|Overall Study|Physician Decision|14|||
125257592|NCT00851084|450571563|FG000|Overall Study|Consent withdrawn|0|||
125257593|NCT00851084|450571564|FG001|Overall Study|Consent withdrawn|2|||
125257594|NCT00851084|450571563|FG000|Overall Study|Withdrawal by Subject|11|||
125257595|NCT00851084|450571564|FG001|Overall Study|Withdrawal by Subject|12|||
125257596|NCT00851084|450571563|FG000|Overall Study|Metastatic surgery|6|||
125257597|NCT00851084|450571564|FG001|Overall Study|Metastatic surgery|6|||
125257598|NCT00851084|450571563|FG000|Overall Study|Other|7|||
125257599|NCT00851084|450571564|FG001|Overall Study|Other|1|||
125257600|NCT00734032|450571565|FG000|Overall Study|Adverse Event|0|||
125257601|NCT00734032|450571566|FG001|Overall Study|Adverse Event|1|||
125257602|NCT00734032|450571567|FG002|Overall Study|Adverse Event|0|||
125257603|NCT00734032|450571568|FG003|Overall Study|Adverse Event|0|||
125257604|NCT03360344|450571573|FG000|Overall Study|Withdrawal by Subject|0|||
125257605|NCT03360344|450571574|FG001|Overall Study|Withdrawal by Subject|1|||
125257606|NCT03360344|450571575|FG002|Overall Study|Withdrawal by Subject|1|||
125257607|NCT00133705|450571580|FG000|Overall Study|Withdrawal by Subject|2|||
125257608|NCT00133705|450571581|FG001|Overall Study|Withdrawal by Subject|3|||
125257609|NCT03847519|450571591|FG000|Overall Study|Death|5|||
125257610|NCT03847519|450571592|FG001|Overall Study|Death|8|||
125257611|NCT03847519|450571593|FG002|Overall Study|Death|1|||
125257612|NCT03847519|450571591|FG000|Overall Study|Lost to Follow-up|1|||
125257613|NCT03847519|450571592|FG001|Overall Study|Lost to Follow-up|2|||
125257614|NCT03847519|450571593|FG002|Overall Study|Lost to Follow-up|0|||
125257615|NCT03847519|450571591|FG000|Overall Study|Study Terminated by Sponsor|0|||
125257616|NCT03847519|450571592|FG001|Overall Study|Study Terminated by Sponsor|3|||
125257617|NCT03847519|450571593|FG002|Overall Study|Study Terminated by Sponsor|2|||
125257618|NCT02314923|450571594|FG000|Overall Study|Death|0|||
125257619|NCT02314923|450571595|FG001|Overall Study|Death|0|||
125257620|NCT02314923|450571596|FG002|Overall Study|Death|0|||
125257621|NCT02314923|450571597|FG003|Overall Study|Death|1|||
125257622|NCT02314923|450571598|FG004|Overall Study|Death|0|||
125257623|NCT02314923|450571599|FG005|Overall Study|Death|0|||
125257624|NCT02314923|450571600|FG006|Overall Study|Death|0|||
125257625|NCT02314923|450571601|FG007|Overall Study|Death|0|||
125257626|NCT02314923|450571602|FG008|Overall Study|Death|0|||
125257627|NCT02314923|450571603|FG009|Overall Study|Death|0|||
125257628|NCT02314923|450571594|FG000|Overall Study|Lost to Follow-up|2|||
125257629|NCT02314923|450571595|FG001|Overall Study|Lost to Follow-up|3|||
125257630|NCT02314923|450571596|FG002|Overall Study|Lost to Follow-up|1|||
125257631|NCT02314923|450571597|FG003|Overall Study|Lost to Follow-up|0|||
125257632|NCT02314923|450571598|FG004|Overall Study|Lost to Follow-up|0|||
125257633|NCT02314923|450571599|FG005|Overall Study|Lost to Follow-up|0|||
125257634|NCT02314923|450571600|FG006|Overall Study|Lost to Follow-up|3|||
125257635|NCT02314923|450571601|FG007|Overall Study|Lost to Follow-up|4|||
125257636|NCT02314923|450571602|FG008|Overall Study|Lost to Follow-up|2|||
125257637|NCT02314923|450571603|FG009|Overall Study|Lost to Follow-up|0|||
125257638|NCT02314923|450571594|FG000|Overall Study|Withdrawal by Subject|0|||
125257639|NCT02314923|450571595|FG001|Overall Study|Withdrawal by Subject|0|||
125257640|NCT02314923|450571596|FG002|Overall Study|Withdrawal by Subject|1|||
125257641|NCT02314923|450571597|FG003|Overall Study|Withdrawal by Subject|0|||
125257642|NCT02314923|450571598|FG004|Overall Study|Withdrawal by Subject|1|||
125257643|NCT02314923|450571599|FG005|Overall Study|Withdrawal by Subject|0|||
125257644|NCT02314923|450571600|FG006|Overall Study|Withdrawal by Subject|1|||
125257645|NCT02314923|450571601|FG007|Overall Study|Withdrawal by Subject|0|||
125257646|NCT02314923|450571602|FG008|Overall Study|Withdrawal by Subject|0|||
125257647|NCT02314923|450571603|FG009|Overall Study|Withdrawal by Subject|0|||
125257648|NCT02314923|450571594|FG000|Overall Study|Physician Decision|0|||
125257649|NCT02314923|450571595|FG001|Overall Study|Physician Decision|1|||
125257650|NCT02314923|450571596|FG002|Overall Study|Physician Decision|0|||
125257651|NCT02314923|450571597|FG003|Overall Study|Physician Decision|0|||
125257652|NCT02314923|450571598|FG004|Overall Study|Physician Decision|0|||
125257653|NCT02314923|450571599|FG005|Overall Study|Physician Decision|0|||
125257654|NCT02314923|450571600|FG006|Overall Study|Physician Decision|0|||
125257655|NCT02314923|450571601|FG007|Overall Study|Physician Decision|0|||
125257656|NCT02314923|450571602|FG008|Overall Study|Physician Decision|0|||
125257657|NCT02314923|450571603|FG009|Overall Study|Physician Decision|0|||
125257658|NCT02314923|450571594|FG000|Overall Study|Participant unavailable|0|||
125257659|NCT02314923|450571595|FG001|Overall Study|Participant unavailable|0|||
125257660|NCT02314923|450571596|FG002|Overall Study|Participant unavailable|0|||
125257661|NCT02314923|450571597|FG003|Overall Study|Participant unavailable|0|||
125257662|NCT02314923|450571598|FG004|Overall Study|Participant unavailable|0|||
125257663|NCT02314923|450571599|FG005|Overall Study|Participant unavailable|1|||
125257664|NCT02314923|450571600|FG006|Overall Study|Participant unavailable|0|||
125257665|NCT02314923|450571601|FG007|Overall Study|Participant unavailable|0|||
125257666|NCT02314923|450571602|FG008|Overall Study|Participant unavailable|0|||
125257667|NCT02314923|450571603|FG009|Overall Study|Participant unavailable|0|||
125257668|NCT02314923|450571594|FG000|Overall Study|Screen failure|0|||
125257669|NCT02314923|450571595|FG001|Overall Study|Screen failure|0|||
125257670|NCT02314923|450571596|FG002|Overall Study|Screen failure|0|||
125257671|NCT02314923|450571597|FG003|Overall Study|Screen failure|0|||
125257672|NCT02314923|450571598|FG004|Overall Study|Screen failure|0|||
125257673|NCT02314923|450571599|FG005|Overall Study|Screen failure|0|||
125257674|NCT02314923|450571600|FG006|Overall Study|Screen failure|1|||
125257675|NCT02314923|450571601|FG007|Overall Study|Screen failure|0|||
125257676|NCT02314923|450571602|FG008|Overall Study|Screen failure|0|||
125257677|NCT02314923|450571603|FG009|Overall Study|Screen failure|0|||
125257678|NCT02314923|450571594|FG000|Overall Study|Participant relocation|1|||
125257679|NCT02314923|450571595|FG001|Overall Study|Participant relocation|0|||
125257680|NCT02314923|450571596|FG002|Overall Study|Participant relocation|0|||
125257681|NCT02314923|450571597|FG003|Overall Study|Participant relocation|0|||
125257682|NCT02314923|450571598|FG004|Overall Study|Participant relocation|0|||
125257683|NCT02314923|450571599|FG005|Overall Study|Participant relocation|0|||
125257684|NCT02314923|450571600|FG006|Overall Study|Participant relocation|0|||
125257685|NCT02314923|450571601|FG007|Overall Study|Participant relocation|1|||
125257686|NCT02314923|450571602|FG008|Overall Study|Participant relocation|0|||
125257687|NCT02314923|450571603|FG009|Overall Study|Participant relocation|0|||
125257688|NCT00725985|450571604|FG000|ITP- Treatment Disposition|Adverse Event|20|||
125257689|NCT00725985|450571605|FG001|ITP- Treatment Disposition|Adverse Event|10|||
125257690|NCT00725985|450571606|FG002|ITP- Treatment Disposition|Adverse Event|5|||
125257691|NCT00725985|450571607|FG003|ITP- Treatment Disposition|Adverse Event|0|||
125257692|NCT00725985|450571608|FG004|ITP- Treatment Disposition|Adverse Event|0|||
125257693|NCT00725985|450571609|FG005|ITP- Treatment Disposition|Adverse Event|0|||
125257694|NCT00725985|450571610|FG006|ITP- Treatment Disposition|Adverse Event|0|||
125257695|NCT00725985|450571611|FG007|ITP- Treatment Disposition|Adverse Event|0|||
125257696|NCT00725985|450571612|FG008|ITP- Treatment Disposition|Adverse Event|0|||
125257697|NCT00725985|450571613|FG009|ITP- Treatment Disposition|Adverse Event|0|||
125257698|NCT00725985|450571614|FG010|ITP- Treatment Disposition|Adverse Event|0|||
125257699|NCT00725985|450571615|FG011|ITP- Treatment Disposition|Adverse Event|0|||
125257700|NCT00725985|450571604|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257701|NCT00725985|450571605|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257702|NCT00725985|450571606|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
125257703|NCT00725985|450571607|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257704|NCT00725985|450571608|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257705|NCT00725985|450571609|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257706|NCT00725985|450571610|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257707|NCT00725985|450571611|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257708|NCT00725985|450571612|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257709|NCT00725985|450571613|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257710|NCT00725985|450571614|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257711|NCT00725985|450571615|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257712|NCT00725985|450571604|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
125257713|NCT00725985|450571605|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
125257714|NCT00725985|450571606|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
125257715|NCT00725985|450571607|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
125257716|NCT00725985|450571608|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
125257717|NCT00725985|450571609|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
125257718|NCT00725985|450571610|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
125257719|NCT00725985|450571611|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
125257720|NCT00725985|450571612|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
125257721|NCT00725985|450571613|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
125257722|NCT00725985|450571614|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
125257723|NCT00725985|450571615|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
125257724|NCT00725985|450571604|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
125257725|NCT00725985|450571605|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
125257726|NCT00725985|450571606|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
125257727|NCT00725985|450571607|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
125257728|NCT00725985|450571608|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
125257729|NCT00725985|450571609|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
125257730|NCT00725985|450571610|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
125257731|NCT00725985|450571611|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
125257732|NCT00725985|450571612|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
125257733|NCT00725985|450571613|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
125257734|NCT00725985|450571614|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
125257735|NCT00725985|450571615|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
125257736|NCT00725985|450571604|FG000|ITP- Treatment Disposition|Other|50|||
125257737|NCT00725985|450571605|FG001|ITP- Treatment Disposition|Other|38|||
125257738|NCT00725985|450571606|FG002|ITP- Treatment Disposition|Other|24|||
125257739|NCT00725985|450571607|FG003|ITP- Treatment Disposition|Other|0|||
125257740|NCT00725985|450571608|FG004|ITP- Treatment Disposition|Other|0|||
125257741|NCT00725985|450571609|FG005|ITP- Treatment Disposition|Other|0|||
125257742|NCT00725985|450571610|FG006|ITP- Treatment Disposition|Other|0|||
125257743|NCT00725985|450571611|FG007|ITP- Treatment Disposition|Other|0|||
125257744|NCT00725985|450571612|FG008|ITP- Treatment Disposition|Other|0|||
125257745|NCT00725985|450571613|FG009|ITP- Treatment Disposition|Other|0|||
125257746|NCT00725985|450571614|FG010|ITP- Treatment Disposition|Other|0|||
125257747|NCT00725985|450571615|FG011|ITP- Treatment Disposition|Other|0|||
125257748|NCT00725985|450571604|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
125257749|NCT00725985|450571605|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
125257750|NCT00725985|450571606|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
125257751|NCT00725985|450571607|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
125257752|NCT00725985|450571608|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
125257753|NCT00725985|450571609|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
125257754|NCT00725985|450571610|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
125257755|NCT00725985|450571611|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
125257756|NCT00725985|450571612|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
125257757|NCT00725985|450571613|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
125257758|NCT00725985|450571614|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
125257759|NCT00725985|450571615|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
125257760|NCT00725985|450571604|FG000|OLMP (Up to 96 Weeks)|Death|0|||
125257761|NCT00725985|450571605|FG001|OLMP (Up to 96 Weeks)|Death|0|||
125257762|NCT00725985|450571606|FG002|OLMP (Up to 96 Weeks)|Death|0|||
125257763|NCT00725985|450571607|FG003|OLMP (Up to 96 Weeks)|Death|0|||
125257764|NCT00725985|450571608|FG004|OLMP (Up to 96 Weeks)|Death|1|||
125257765|NCT00725985|450571609|FG005|OLMP (Up to 96 Weeks)|Death|0|||
125257766|NCT00725985|450571610|FG006|OLMP (Up to 96 Weeks)|Death|0|||
125257767|NCT00725985|450571611|FG007|OLMP (Up to 96 Weeks)|Death|0|||
125257768|NCT00725985|450571612|FG008|OLMP (Up to 96 Weeks)|Death|0|||
125257769|NCT00725985|450571613|FG009|OLMP (Up to 96 Weeks)|Death|0|||
125257770|NCT00725985|450571614|FG010|OLMP (Up to 96 Weeks)|Death|0|||
125257771|NCT00725985|450571615|FG011|OLMP (Up to 96 Weeks)|Death|0|||
125257772|NCT00725985|450571604|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257773|NCT00725985|450571605|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257774|NCT00725985|450571606|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257775|NCT00725985|450571607|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
125257776|NCT00725985|450571608|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257777|NCT00725985|450571609|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257778|NCT00725985|450571610|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257779|NCT00725985|450571611|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257780|NCT00725985|450571612|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257781|NCT00725985|450571613|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257782|NCT00725985|450571614|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257783|NCT00725985|450571615|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257784|NCT00725985|450571604|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257785|NCT00725985|450571605|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257786|NCT00725985|450571606|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257787|NCT00725985|450571607|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257788|NCT00725985|450571608|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257789|NCT00725985|450571609|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
125257790|NCT00725985|450571610|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257791|NCT00725985|450571611|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257792|NCT00725985|450571612|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257793|NCT00725985|450571613|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257794|NCT00725985|450571614|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257795|NCT00725985|450571615|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257796|NCT00725985|450571604|FG000|OLMP (Up to 96 Weeks)|Other|0|||
125257797|NCT00725985|450571605|FG001|OLMP (Up to 96 Weeks)|Other|0|||
125257798|NCT00725985|450571606|FG002|OLMP (Up to 96 Weeks)|Other|0|||
125257799|NCT00725985|450571607|FG003|OLMP (Up to 96 Weeks)|Other|15|||
125257800|NCT00725985|450571608|FG004|OLMP (Up to 96 Weeks)|Other|20|||
125257801|NCT00725985|450571609|FG005|OLMP (Up to 96 Weeks)|Other|44|||
125257802|NCT00725985|450571610|FG006|OLMP (Up to 96 Weeks)|Other|0|||
125257803|NCT00725985|450571611|FG007|OLMP (Up to 96 Weeks)|Other|0|||
125257804|NCT00725985|450571612|FG008|OLMP (Up to 96 Weeks)|Other|0|||
125257805|NCT00725985|450571613|FG009|OLMP (Up to 96 Weeks)|Other|0|||
125257806|NCT00725985|450571614|FG010|OLMP (Up to 96 Weeks)|Other|0|||
125257807|NCT00725985|450571615|FG011|OLMP (Up to 96 Weeks)|Other|0|||
125257808|NCT00725985|450571604|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125257809|NCT00725985|450571605|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125257810|NCT00725985|450571606|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125257811|NCT00725985|450571607|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125257812|NCT00725985|450571608|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125257813|NCT00725985|450571609|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125257814|NCT00725985|450571610|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125257815|NCT00725985|450571611|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
125257816|NCT00725985|450571612|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125257817|NCT00725985|450571613|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125257818|NCT00725985|450571614|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125257819|NCT00725985|450571615|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125257820|NCT00725985|450571604|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257821|NCT00725985|450571605|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257822|NCT00725985|450571606|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257823|NCT00725985|450571607|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257824|NCT00725985|450571608|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257825|NCT00725985|450571609|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257826|NCT00725985|450571610|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257827|NCT00725985|450571611|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257828|NCT00725985|450571612|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
125257829|NCT00725985|450571613|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257830|NCT00725985|450571614|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257831|NCT00725985|450571615|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257832|NCT00725985|450571604|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
125257833|NCT00725985|450571605|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
125257834|NCT00725985|450571606|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
125257835|NCT00725985|450571607|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
125257836|NCT00725985|450571608|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
125257837|NCT00725985|450571609|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
125257838|NCT00725985|450571610|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
125257839|NCT00725985|450571611|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
125257840|NCT00725985|450571612|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
125257841|NCT00725985|450571613|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
125257842|NCT00725985|450571614|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
125257843|NCT00725985|450571615|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
125257844|NCT00725985|450571604|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
125257845|NCT00725985|450571605|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
125257846|NCT00725985|450571606|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
125257847|NCT00725985|450571607|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
125257848|NCT00725985|450571608|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
125257849|NCT00725985|450571609|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
125257850|NCT00725985|450571610|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
125257851|NCT00725985|450571611|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
125257852|NCT00725985|450571612|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
125257853|NCT00725985|450571613|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
125257854|NCT00725985|450571614|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
125257855|NCT00725985|450571615|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
125257856|NCT04476784|450571616|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
125257857|NCT04476784|450571617|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
125257858|NCT00863304|450571618|FG000|Overall Study|Adverse Event|10|||
125257859|NCT00863304|450571619|FG001|Overall Study|Adverse Event|4|||
125257860|NCT00863304|450571620|FG002|Overall Study|Adverse Event|14|||
125257861|NCT00863304|450571621|FG003|Overall Study|Adverse Event|16|||
125257862|NCT00863304|450571618|FG000|Overall Study|Lost to Follow-up|1|||
125257863|NCT00863304|450571619|FG001|Overall Study|Lost to Follow-up|5|||
125257864|NCT00863304|450571620|FG002|Overall Study|Lost to Follow-up|4|||
125257865|NCT00863304|450571621|FG003|Overall Study|Lost to Follow-up|2|||
125257866|NCT00863304|450571618|FG000|Overall Study|Lack of Efficacy|57|||
125257867|NCT00863304|450571619|FG001|Overall Study|Lack of Efficacy|26|||
125257868|NCT00863304|450571620|FG002|Overall Study|Lack of Efficacy|30|||
125257869|NCT00863304|450571621|FG003|Overall Study|Lack of Efficacy|28|||
125257870|NCT00863304|450571618|FG000|Overall Study|Withdrawal by Subject|19|||
125257871|NCT00863304|450571619|FG001|Overall Study|Withdrawal by Subject|14|||
125257872|NCT00863304|450571620|FG002|Overall Study|Withdrawal by Subject|20|||
125257873|NCT00863304|450571621|FG003|Overall Study|Withdrawal by Subject|18|||
125257874|NCT00863304|450571618|FG000|Overall Study|Other|1|||
125257875|NCT00863304|450571619|FG001|Overall Study|Other|0|||
125257876|NCT00863304|450571620|FG002|Overall Study|Other|0|||
125257877|NCT00863304|450571621|FG003|Overall Study|Other|1|||
125257878|NCT00863304|450571618|FG000|Overall Study|Protocol Violation|2|||
125257879|NCT00863304|450571619|FG001|Overall Study|Protocol Violation|6|||
125257880|NCT00863304|450571620|FG002|Overall Study|Protocol Violation|2|||
125257881|NCT00863304|450571621|FG003|Overall Study|Protocol Violation|0|||
125257882|NCT00863304|450571618|FG000|Overall Study|Randomized, but not Treated|3|||
125257883|NCT00863304|450571619|FG001|Overall Study|Randomized, but not Treated|1|||
125257884|NCT00863304|450571620|FG002|Overall Study|Randomized, but not Treated|4|||
125257885|NCT00863304|450571621|FG003|Overall Study|Randomized, but not Treated|1|||
125257886|NCT00863304|450571618|FG000|Overall Study|Entered extension study|101|||
125257887|NCT00863304|450571619|FG001|Overall Study|Entered extension study|129|||
125257888|NCT00863304|450571620|FG002|Overall Study|Entered extension study|113|||
125257889|NCT00863304|450571621|FG003|Overall Study|Entered extension study|125|||
125257890|NCT06582732|450571622|FG000|Initial Study Period|Adverse Event|0|||
125257891|NCT06582732|450571623|FG001|Initial Study Period|Adverse Event|0|||
125257892|NCT06582732|450571624|FG002|Initial Study Period|Adverse Event|0|||
125257893|NCT06582732|450571625|FG003|Initial Study Period|Adverse Event|2|||
125257894|NCT06582732|450571626|FG004|Initial Study Period|Adverse Event|0|||
125257895|NCT06582732|450571627|FG005|Initial Study Period|Adverse Event|0|||
125257896|NCT06582732|450571628|FG006|Initial Study Period|Adverse Event|0|||
125257897|NCT06582732|450571622|FG000|Initial Study Period|Death|1|||
125257898|NCT06582732|450571623|FG001|Initial Study Period|Death|0|||
125257899|NCT06582732|450571624|FG002|Initial Study Period|Death|0|||
125257900|NCT06582732|450571625|FG003|Initial Study Period|Death|0|||
125257901|NCT06582732|450571626|FG004|Initial Study Period|Death|1|||
125257902|NCT06582732|450571627|FG005|Initial Study Period|Death|0|||
125257903|NCT06582732|450571628|FG006|Initial Study Period|Death|0|||
125257904|NCT06582732|450571622|FG000|Initial Study Period|Lost to Follow-up|0|||
125257905|NCT06582732|450571623|FG001|Initial Study Period|Lost to Follow-up|0|||
125257906|NCT06582732|450571624|FG002|Initial Study Period|Lost to Follow-up|2|||
125257907|NCT06582732|450571625|FG003|Initial Study Period|Lost to Follow-up|0|||
125257908|NCT06582732|450571626|FG004|Initial Study Period|Lost to Follow-up|0|||
125257909|NCT06582732|450571627|FG005|Initial Study Period|Lost to Follow-up|0|||
125257910|NCT06582732|450571628|FG006|Initial Study Period|Lost to Follow-up|0|||
125257911|NCT06582732|450571622|FG000|Initial Study Period|Withdrawal by Subject|0|||
125257912|NCT06582732|450571623|FG001|Initial Study Period|Withdrawal by Subject|1|||
125257913|NCT06582732|450571624|FG002|Initial Study Period|Withdrawal by Subject|0|||
125257914|NCT06582732|450571625|FG003|Initial Study Period|Withdrawal by Subject|1|||
125257915|NCT06582732|450571626|FG004|Initial Study Period|Withdrawal by Subject|3|||
125257916|NCT06582732|450571627|FG005|Initial Study Period|Withdrawal by Subject|1|||
125257917|NCT06582732|450571628|FG006|Initial Study Period|Withdrawal by Subject|2|||
125257918|NCT06582732|450571622|FG000|Initial Study Period|Moved Away|0|||
125257919|NCT06582732|450571623|FG001|Initial Study Period|Moved Away|0|||
125257920|NCT06582732|450571624|FG002|Initial Study Period|Moved Away|0|||
125257921|NCT06582732|450571625|FG003|Initial Study Period|Moved Away|0|||
125257922|NCT06582732|450571626|FG004|Initial Study Period|Moved Away|1|||
125257923|NCT06582732|450571627|FG005|Initial Study Period|Moved Away|0|||
125257924|NCT06582732|450571628|FG006|Initial Study Period|Moved Away|0|||
125257925|NCT02507934|450571629|FG000|Overall Study|Lost to Follow-up|2|||
125257926|NCT02507934|450571630|FG001|Overall Study|Lost to Follow-up|0|||
125257927|NCT02507934|450571629|FG000|Overall Study|Withdrawal by Subject|2|||
125257928|NCT02507934|450571630|FG001|Overall Study|Withdrawal by Subject|0|||
125257929|NCT03528902|450571633|FG000|Overall Study|Adverse Event|1|||
125257930|NCT03528902|450571634|FG001|Overall Study|Adverse Event|0|||
125257931|NCT05030766|450571635|FG000|Phase 1 Participants|Lost to Follow-up|12|||
125257932|NCT05030766|450571636|FG001|Phase 1 Participants|Lost to Follow-up|22|||
125257933|NCT05030766|450571637|FG002|Phase 1 Participants|Lost to Follow-up|0|||
125257934|NCT05030766|450571638|FG003|Phase 1 Participants|Lost to Follow-up|0|||
125257935|NCT05030766|450571635|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
125257936|NCT05030766|450571636|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
125257937|NCT05030766|450571637|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
125257938|NCT05030766|450571638|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
125257939|NCT05030766|450571635|FG000|Phase 2 Participants|Lost to Follow-up|0|||
125257940|NCT05030766|450571636|FG001|Phase 2 Participants|Lost to Follow-up|0|||
125257941|NCT05030766|450571637|FG002|Phase 2 Participants|Lost to Follow-up|6|||
125257942|NCT05030766|450571638|FG003|Phase 2 Participants|Lost to Follow-up|2|||
125257943|NCT00645658|450571639|FG000|Overall Study|Withdrawal by Subject|1|||
125257944|NCT00645658|450571640|FG001|Overall Study|Withdrawal by Subject|0|||
125257945|NCT00645658|450571639|FG000|Overall Study|Did not complete all assesments|0|||
125257946|NCT00645658|450571640|FG001|Overall Study|Did not complete all assesments|2|||
125257947|NCT03605693|450571647|FG000|Overall Study|Lost to Follow-up|4|||
125257948|NCT03605693|450571648|FG001|Overall Study|Lost to Follow-up|0|||
125257949|NCT03605693|450571647|FG000|Overall Study|Physician Decision|1|||
125257950|NCT03605693|450571648|FG001|Overall Study|Physician Decision|0|||
125257951|NCT03093415|450571651|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
125257952|NCT03093415|450571652|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
125257953|NCT03093415|450571653|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
125257954|NCT03093415|450571651|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
125257955|NCT03093415|450571652|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
125257956|NCT03093415|450571653|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
125257957|NCT03093415|450571651|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
125257958|NCT03093415|450571652|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
125257959|NCT03093415|450571653|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
125257960|NCT03093415|450571651|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
125257961|NCT03093415|450571652|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
125257962|NCT03093415|450571653|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
125257963|NCT03093415|450571651|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
125257964|NCT03093415|450571652|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
125257965|NCT03093415|450571653|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
125257966|NCT03093415|450571651|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
125257967|NCT03093415|450571652|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
125257968|NCT03093415|450571653|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
125257969|NCT03093415|450571651|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
125257970|NCT03093415|450571652|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
125257971|NCT03093415|450571653|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
125257972|NCT03093415|450571651|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
125257973|NCT03093415|450571652|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
125257974|NCT03093415|450571653|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
125257975|NCT03093415|450571651|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
125257976|NCT03093415|450571652|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
125257977|NCT03093415|450571653|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
125257978|NCT03093415|450571651|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
125257979|NCT03093415|450571652|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
125257980|NCT03093415|450571653|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
125257981|NCT03093415|450571651|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
125257982|NCT03093415|450571652|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
125257983|NCT03093415|450571653|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
125257984|NCT03895372|450571654|FG000|Investigational Treatment Period|Adverse Event|1|||
125257985|NCT03895372|450571655|FG001|Investigational Treatment Period|Adverse Event|0|||
125257986|NCT03895372|450571656|FG002|Investigational Treatment Period|Adverse Event|0|||
125257987|NCT03895372|450571657|FG003|Investigational Treatment Period|Adverse Event|0|||
125257988|NCT03895372|450571658|FG004|Investigational Treatment Period|Adverse Event|0|||
125257989|NCT03895372|450571659|FG005|Investigational Treatment Period|Adverse Event|0|||
125257990|NCT03895372|450571660|FG006|Investigational Treatment Period|Adverse Event|4|||
125257991|NCT03895372|450571661|FG007|Investigational Treatment Period|Adverse Event|3|||
125257992|NCT03895372|450571654|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
125257993|NCT03895372|450571655|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
125257994|NCT03895372|450571656|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
125257995|NCT03895372|450571657|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
125257996|NCT03895372|450571658|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
125257997|NCT03895372|450571659|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
125257998|NCT03895372|450571660|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
125257999|NCT03895372|450571661|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
125258000|NCT03895372|450571654|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
125258001|NCT03895372|450571655|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
125258002|NCT03895372|450571656|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
125258003|NCT03895372|450571657|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
125258004|NCT03895372|450571658|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
125258005|NCT03895372|450571659|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
125258006|NCT03895372|450571660|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
125258007|NCT03895372|450571661|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
125258008|NCT03895372|450571654|FG000|Investigational Treatment Period|Other|0|||
125258009|NCT03895372|450571655|FG001|Investigational Treatment Period|Other|0|||
125258010|NCT03895372|450571656|FG002|Investigational Treatment Period|Other|0|||
125258011|NCT03895372|450571657|FG003|Investigational Treatment Period|Other|0|||
125258012|NCT03895372|450571658|FG004|Investigational Treatment Period|Other|0|||
125258013|NCT03895372|450571659|FG005|Investigational Treatment Period|Other|1|||
125258014|NCT03895372|450571660|FG006|Investigational Treatment Period|Other|0|||
125258015|NCT03895372|450571661|FG007|Investigational Treatment Period|Other|2|||
125258016|NCT03895372|450571654|FG000|Investigational Treatment Period|Protocol Violation|0|||
125258017|NCT03895372|450571655|FG001|Investigational Treatment Period|Protocol Violation|0|||
125258018|NCT03895372|450571656|FG002|Investigational Treatment Period|Protocol Violation|0|||
125258019|NCT03895372|450571657|FG003|Investigational Treatment Period|Protocol Violation|1|||
125258020|NCT03895372|450571658|FG004|Investigational Treatment Period|Protocol Violation|0|||
125258021|NCT03895372|450571659|FG005|Investigational Treatment Period|Protocol Violation|0|||
125258022|NCT03895372|450571660|FG006|Investigational Treatment Period|Protocol Violation|0|||
125258023|NCT03895372|450571661|FG007|Investigational Treatment Period|Protocol Violation|0|||
125258024|NCT03895372|450571654|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
125258025|NCT03895372|450571655|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
125258026|NCT03895372|450571656|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
125258027|NCT03895372|450571657|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
125258028|NCT03895372|450571658|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
125258029|NCT03895372|450571659|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
125258030|NCT03895372|450571660|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
125258031|NCT03895372|450571661|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
125258032|NCT03895372|450571654|FG000|Extension Treatment Period|Adverse Event|0|||
125258033|NCT03895372|450571655|FG001|Extension Treatment Period|Adverse Event|1|||
125258034|NCT03895372|450571656|FG002|Extension Treatment Period|Adverse Event|0|||
125258035|NCT03895372|450571657|FG003|Extension Treatment Period|Adverse Event|1|||
125258036|NCT03895372|450571658|FG004|Extension Treatment Period|Adverse Event|0|||
125258037|NCT03895372|450571659|FG005|Extension Treatment Period|Adverse Event|0|||
125258038|NCT03895372|450571660|FG006|Extension Treatment Period|Adverse Event|3|||
125258039|NCT03895372|450571661|FG007|Extension Treatment Period|Adverse Event|3|||
125258040|NCT03895372|450571654|FG000|Extension Treatment Period|Other|1|||
125258041|NCT03895372|450571655|FG001|Extension Treatment Period|Other|3|||
125258042|NCT03895372|450571656|FG002|Extension Treatment Period|Other|0|||
125258043|NCT03895372|450571657|FG003|Extension Treatment Period|Other|0|||
125258044|NCT03895372|450571658|FG004|Extension Treatment Period|Other|1|||
125258045|NCT03895372|450571659|FG005|Extension Treatment Period|Other|0|||
125258046|NCT03895372|450571660|FG006|Extension Treatment Period|Other|0|||
125258047|NCT03895372|450571661|FG007|Extension Treatment Period|Other|2|||
125258048|NCT03895372|450571654|FG000|Extension Treatment Period|Pregnancy|0|||
125258049|NCT03895372|450571655|FG001|Extension Treatment Period|Pregnancy|0|||
125258050|NCT03895372|450571656|FG002|Extension Treatment Period|Pregnancy|0|||
125258051|NCT03895372|450571657|FG003|Extension Treatment Period|Pregnancy|0|||
125258052|NCT03895372|450571658|FG004|Extension Treatment Period|Pregnancy|1|||
125258053|NCT03895372|450571659|FG005|Extension Treatment Period|Pregnancy|0|||
125258054|NCT03895372|450571660|FG006|Extension Treatment Period|Pregnancy|0|||
125258055|NCT03895372|450571661|FG007|Extension Treatment Period|Pregnancy|0|||
125258056|NCT03895372|450571654|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
125258057|NCT03895372|450571655|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
125258058|NCT03895372|450571656|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
125258059|NCT03895372|450571657|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
125258060|NCT03895372|450571658|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
125258061|NCT03895372|450571659|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
125258062|NCT03895372|450571660|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
125258063|NCT03895372|450571661|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
125258064|NCT03331354|450571664|FG000|Overall Study|Withdrawal by Subject|1|||
125258065|NCT03331354|450571665|FG001|Overall Study|Withdrawal by Subject|3|||
125258066|NCT03331354|450571664|FG000|Overall Study|Lost to Follow-up|3|||
125258067|NCT03331354|450571665|FG001|Overall Study|Lost to Follow-up|3|||
125258068|NCT03331354|450571664|FG000|Overall Study|Found employment before initiated active intervention|0|||
125258069|NCT03331354|450571665|FG001|Overall Study|Found employment before initiated active intervention|4|||
125258070|NCT05889468|450571672|FG000|Overall Study|Lost to Follow-up|9|||
125258071|NCT05889468|450571673|FG001|Overall Study|Lost to Follow-up|2|||
125258072|NCT05889468|450571672|FG000|Overall Study|Withdrawal by Subject|2|||
125258073|NCT05889468|450571673|FG001|Overall Study|Withdrawal by Subject|2|||
125258074|NCT01309230|450571674|FG000|Overall Study|Withdrawal by Subject|0|||
125258075|NCT01309230|450571675|FG001|Overall Study|Withdrawal by Subject|2|||
125258076|NCT01309230|450571674|FG000|Overall Study|Observation arm closed|0|||
125258077|NCT01309230|450571675|FG001|Overall Study|Observation arm closed|2|||
125258078|NCT03900650|450571680|FG000|Overall Study|Withdrawal by Subject|1|||
125258079|NCT03900650|450571681|FG001|Overall Study|Withdrawal by Subject|1|||
125258080|NCT03900650|450571682|FG002|Overall Study|Withdrawal by Subject|0|||
125258081|NCT03900650|450571683|FG003|Overall Study|Withdrawal by Subject|0|||
125258082|NCT03900650|450571680|FG000|Overall Study|Withdrawn by staff|1|||
125258083|NCT03900650|450571681|FG001|Overall Study|Withdrawn by staff|0|||
125258084|NCT03900650|450571682|FG002|Overall Study|Withdrawn by staff|0|||
125258085|NCT03900650|450571683|FG003|Overall Study|Withdrawn by staff|0|||
125258086|NCT00427700|450571684|FG000|Overall Study|Lost to Follow-up|2|||
125258087|NCT00427700|450571685|FG001|Overall Study|Lost to Follow-up|5|||
125258088|NCT00427700|450571684|FG000|Overall Study|no induction of menses|1|||
125258089|NCT00427700|450571685|FG001|Overall Study|no induction of menses|4|||
125258090|NCT00427700|450571684|FG000|Overall Study|Pregnancy|0|||
125258091|NCT00427700|450571685|FG001|Overall Study|Pregnancy|2|||
125258092|NCT04581395|450571686|FG000|Overall Study|Protocol Violation|4|||
125258093|NCT04581395|450571687|FG001|Overall Study|Protocol Violation|3|||
125258094|NCT04581395|450571688|FG002|Overall Study|Protocol Violation|2|||
125258095|NCT04581395|450571686|FG000|Overall Study|Physician Decision|0|||
125258096|NCT04581395|450571687|FG001|Overall Study|Physician Decision|1|||
125258097|NCT04581395|450571688|FG002|Overall Study|Physician Decision|0|||
125258098|NCT00815633|450571691|FG000|Overall Study|study terminated|1|||
125258099|NCT00721110|450571692|FG000|Overall Study|Ultram use|1|||
125258100|NCT00721110|450571693|FG001|Overall Study|Ultram use|0|||
125258101|NCT00721110|450571694|FG002|Overall Study|Ultram use|0|||
125258102|NCT00721110|450571695|FG003|Overall Study|Ultram use|0|||
125258103|NCT00721110|450571692|FG000|Overall Study|vertical incision|0|||
125258104|NCT00721110|450571693|FG001|Overall Study|vertical incision|0|||
125258105|NCT00721110|450571694|FG002|Overall Study|vertical incision|1|||
125258106|NCT00721110|450571695|FG003|Overall Study|vertical incision|0|||
125258107|NCT01554904|450571696|FG000|Overall Study|Withdrawal by Subject|3|||
125258108|NCT01554904|450571696|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
125258109|NCT01605097|450571697|FG000|Overall Study|Protocol Violation|1|||
125258110|NCT02038647|450571698|FG000|Overall Study|Progressive Disease|50|||
125258111|NCT02038647|450571699|FG001|Overall Study|Progressive Disease|59|||
125258112|NCT02038647|450571698|FG000|Overall Study|Adverse Event|18|||
125258113|NCT02038647|450571699|FG001|Overall Study|Adverse Event|10|||
125258114|NCT02038647|450571698|FG000|Overall Study|Symptomatic Deterioration|7|||
125258115|NCT02038647|450571699|FG001|Overall Study|Symptomatic Deterioration|7|||
125258116|NCT02038647|450571698|FG000|Overall Study|Withdrawal by Subject|5|||
125258117|NCT02038647|450571699|FG001|Overall Study|Withdrawal by Subject|2|||
125258118|NCT02038647|450571698|FG000|Overall Study|Not Reported|0|||
125258119|NCT02038647|450571699|FG001|Overall Study|Not Reported|1|||
125258120|NCT02038647|450571698|FG000|Overall Study|Ongoing at Datacut|9|||
125258121|NCT02038647|450571699|FG001|Overall Study|Ongoing at Datacut|10|||
125258122|NCT02757430|450571700|FG000|Overall Study|Physician Decision|6|||
125258123|NCT02757430|450571700|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
125258124|NCT02757430|450571700|FG000|Overall Study|No informed consent|1|||
125258125|NCT02757430|450571700|FG000|Overall Study|No procedure performed|2|||
125258126|NCT02082977|450571701|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
125258127|NCT02082977|450571702|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
125258128|NCT02082977|450571703|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
125258129|NCT02082977|450571704|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
125258130|NCT02082977|450571705|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
125258131|NCT02082977|450571706|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
125258132|NCT02082977|450571707|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
125258133|NCT02082977|450571708|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
125258134|NCT02082977|450571709|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
125258135|NCT02082977|450571710|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
125258136|NCT02082977|450571701|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
125258137|NCT02082977|450571702|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
125258138|NCT02082977|450571703|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
125258139|NCT02082977|450571704|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
125258140|NCT02082977|450571705|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
125258141|NCT02082977|450571706|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
125258142|NCT02082977|450571707|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
125258143|NCT02082977|450571708|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
125258144|NCT02082977|450571709|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
125258145|NCT02082977|450571710|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
125258146|NCT02082977|450571701|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
125258147|NCT02082977|450571702|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
125258148|NCT02082977|450571703|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
125258149|NCT02082977|450571704|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
125258150|NCT02082977|450571705|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
125258151|NCT02082977|450571706|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
125258152|NCT02082977|450571707|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
125258153|NCT02082977|450571708|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
125258154|NCT02082977|450571709|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
125258155|NCT02082977|450571710|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
125258156|NCT02082977|450571701|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
125258157|NCT02082977|450571702|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
125258158|NCT02082977|450571703|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
125258159|NCT02082977|450571704|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
125258160|NCT02082977|450571705|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
125258161|NCT02082977|450571706|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
125258162|NCT02082977|450571707|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
125258163|NCT02082977|450571708|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
125258164|NCT02082977|450571709|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
125258165|NCT02082977|450571710|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
125258166|NCT02082977|450571701|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
125258167|NCT02082977|450571702|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
125258168|NCT02082977|450571703|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
125258169|NCT02082977|450571704|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
125258170|NCT02082977|450571705|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
125258171|NCT02082977|450571706|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
125258172|NCT02082977|450571707|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
125258173|NCT02082977|450571708|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
125258174|NCT02082977|450571709|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
125258175|NCT02082977|450571710|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
125258176|NCT05852340|450571711|FG000|Period 5|Not completing the meal|0|||
125258177|NCT05852340|450571712|FG001|Period 5|Not completing the meal|1|||
125258178|NCT05852340|450571713|FG002|Period 5|Not completing the meal|0|||
125258179|NCT05852340|450571714|FG003|Period 5|Not completing the meal|0|||
125258180|NCT05852340|450571711|FG000|Period 5|Adverse Event|0|||
125258181|NCT05852340|450571712|FG001|Period 5|Adverse Event|0|||
125258182|NCT05852340|450571713|FG002|Period 5|Adverse Event|0|||
125258183|NCT05852340|450571714|FG003|Period 5|Adverse Event|1|||
125258184|NCT01903863|450571715|FG000|Overall Study|Physician Decision|2|||
125258185|NCT01903863|450571716|FG001|Overall Study|Physician Decision|0|||
125258186|NCT01397253|450573019|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
125258187|NCT01397253|450573020|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
125258188|NCT01892189|450573021|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
125258189|NCT01892189|450573022|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
125258190|NCT01892189|450573023|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
125258191|NCT01892189|450573024|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
125258192|NCT01892189|450573025|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
125258193|NCT01892189|450573026|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
125258194|NCT01892189|450573027|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
125258195|NCT01892189|450573028|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
125258196|NCT01892189|450573029|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
125258197|NCT01892189|450573021|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125258198|NCT01892189|450573022|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125258199|NCT01892189|450573023|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
125258200|NCT01892189|450573024|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
125258201|NCT01892189|450573025|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125258202|NCT01892189|450573026|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125258203|NCT01892189|450573027|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
125258204|NCT01892189|450573028|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125258205|NCT01892189|450573029|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
125258206|NCT01892189|450573021|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
125258207|NCT01892189|450573022|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
125258208|NCT01892189|450573023|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
125258209|NCT01892189|450573024|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
125258210|NCT01892189|450573025|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
125258211|NCT01892189|450573026|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
125258212|NCT01892189|450573027|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
125258213|NCT01892189|450573028|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
125258214|NCT01892189|450573029|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
125258215|NCT03440411|450573030|FG000|Overall Study|Adverse Event|0|||
125258216|NCT03440411|450573031|FG001|Overall Study|Adverse Event|0|||
125258217|NCT03440411|450573032|FG002|Overall Study|Adverse Event|1|||
125258218|NCT03440411|450573033|FG003|Overall Study|Adverse Event|0|||
125258219|NCT03440411|450573030|FG000|Overall Study|PD|2|||
125258220|NCT03440411|450573031|FG001|Overall Study|PD|1|||
125258221|NCT03440411|450573032|FG002|Overall Study|PD|1|||
125258222|NCT03440411|450573033|FG003|Overall Study|PD|1|||
125258223|NCT03440411|450573030|FG000|Overall Study|Withdrawal by Subject|1|||
125258224|NCT03440411|450573031|FG001|Overall Study|Withdrawal by Subject|0|||
125258225|NCT03440411|450573032|FG002|Overall Study|Withdrawal by Subject|0|||
125258226|NCT03440411|450573033|FG003|Overall Study|Withdrawal by Subject|0|||
125258227|NCT03440411|450573030|FG000|Overall Study|Closed study by sponsor|0|||
125258228|NCT03440411|450573031|FG001|Overall Study|Closed study by sponsor|0|||
125258229|NCT03440411|450573032|FG002|Overall Study|Closed study by sponsor|0|||
125258230|NCT03440411|450573033|FG003|Overall Study|Closed study by sponsor|1|||
125258231|NCT04484857|450573043|FG000|Overall Study|Adverse Event|2|||
125258232|NCT04484857|450573043|FG000|Overall Study|Death|10|||
125258233|NCT04484857|450573043|FG000|Overall Study|Withdrawal by Subject|3|||
125258234|NCT04484857|450573043|FG000|Overall Study|Transferred/Relocation|5|||
125258235|NCT04484857|450573043|FG000|Overall Study|Kidney Transplant|7|||
125258236|NCT04484857|450573043|FG000|Overall Study|Other than specified|4|||
125258237|NCT04484857|450573043|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
125258238|NCT01358734|450573045|FG000|Overall Study|Adverse Event|4|||
125258239|NCT01358734|450573046|FG001|Overall Study|Adverse Event|7|||
125258240|NCT01358734|450573047|FG002|Overall Study|Adverse Event|3|||
125258241|NCT01358734|450573045|FG000|Overall Study|Lack of Efficacy|0|||
125258242|NCT01358734|450573046|FG001|Overall Study|Lack of Efficacy|1|||
125258243|NCT01358734|450573047|FG002|Overall Study|Lack of Efficacy|3|||
125258244|NCT01358734|450573045|FG000|Overall Study|Withdrawal by Subject|1|||
125258245|NCT01358734|450573046|FG001|Overall Study|Withdrawal by Subject|6|||
125258246|NCT01358734|450573047|FG002|Overall Study|Withdrawal by Subject|3|||
125258247|NCT01358734|450573045|FG000|Overall Study|Death|3|||
125258248|NCT01358734|450573046|FG001|Overall Study|Death|7|||
125258249|NCT01358734|450573047|FG002|Overall Study|Death|2|||
125258250|NCT01358734|450573045|FG000|Overall Study|Progressive Disease|5|||
125258251|NCT01358734|450573046|FG001|Overall Study|Progressive Disease|13|||
125258252|NCT01358734|450573047|FG002|Overall Study|Progressive Disease|16|||
125258253|NCT01358734|450573045|FG000|Overall Study|Non-compliance with study drug|0|||
125258254|NCT01358734|450573046|FG001|Overall Study|Non-compliance with study drug|0|||
125258255|NCT01358734|450573047|FG002|Overall Study|Non-compliance with study drug|1|||
125258256|NCT01358734|450573045|FG000|Overall Study|Other|2|||
125258257|NCT01358734|450573046|FG001|Overall Study|Other|5|||
125258258|NCT01358734|450573047|FG002|Overall Study|Other|4|||
125258259|NCT01358734|450573045|FG000|Overall Study|Protocol Violation|0|||
125258260|NCT01358734|450573046|FG001|Overall Study|Protocol Violation|0|||
125258261|NCT01358734|450573047|FG002|Overall Study|Protocol Violation|2|||
125258262|NCT03322566|450573054|FG000|Overall Study|Death|34|||
125258263|NCT03322566|450573055|FG001|Overall Study|Death|35|||
125258264|NCT03322566|450573056|FG002|Overall Study|Death|23|||
125258265|NCT03322566|450573054|FG000|Overall Study|Physician Decision|6|||
125258266|NCT03322566|450573055|FG001|Overall Study|Physician Decision|7|||
125258267|NCT03322566|450573056|FG002|Overall Study|Physician Decision|2|||
125258268|NCT03322566|450573054|FG000|Overall Study|Withdrawal by Subject|4|||
125258269|NCT03322566|450573055|FG001|Overall Study|Withdrawal by Subject|3|||
125258270|NCT03322566|450573056|FG002|Overall Study|Withdrawal by Subject|6|||
125258271|NCT03322566|450573054|FG000|Overall Study|Lost to Follow-up|0|||
125258272|NCT03322566|450573055|FG001|Overall Study|Lost to Follow-up|0|||
125258273|NCT03322566|450573056|FG002|Overall Study|Lost to Follow-up|1|||
125258274|NCT03322566|450573054|FG000|Overall Study|Study terminated by sponsor|1|||
125258275|NCT03322566|450573055|FG001|Overall Study|Study terminated by sponsor|0|||
125258276|NCT03322566|450573056|FG002|Overall Study|Study terminated by sponsor|1|||
125258277|NCT02546323|450573060|FG000|Overall Study|Withdrawal by Subject|36|||
125258278|NCT02546323|450573061|FG001|Overall Study|Withdrawal by Subject|33|||
125258279|NCT02546323|450573060|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
125258280|NCT02546323|450573061|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
125258281|NCT02546323|450573060|FG000|Overall Study|Adverse Event|17|||
125258282|NCT02546323|450573061|FG001|Overall Study|Adverse Event|11|||
125258283|NCT02546323|450573060|FG000|Overall Study|Patient Specific Reasons|1|||
125258284|NCT02546323|450573061|FG001|Overall Study|Patient Specific Reasons|2|||
125258285|NCT02546323|450573060|FG000|Overall Study|Lost to Follow-up|2|||
125258286|NCT02546323|450573061|FG001|Overall Study|Lost to Follow-up|3|||
125258287|NCT02546323|450573060|FG000|Overall Study|Non-compliance with Study Drug|2|||
125258288|NCT02546323|450573061|FG001|Overall Study|Non-compliance with Study Drug|2|||
125258289|NCT02546323|450573060|FG000|Overall Study|Met Withdrawal Criteria|2|||
125258290|NCT02546323|450573061|FG001|Overall Study|Met Withdrawal Criteria|14|||
125258291|NCT01055028|450573062|FG000|Screening|Screen Failure|1|||
125258292|NCT01055028|450573063|FG001|Screening|Screen Failure|1|||
125258293|NCT01055028|450573062|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
125258294|NCT01055028|450573063|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
125258295|NCT01055028|450573062|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
125258296|NCT01055028|450573063|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
125258297|NCT01055028|450573062|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
125258298|NCT01055028|450573063|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
125258299|NCT03559530|450573064|FG000|Overall Study|non-location of medical records|44|||
125258300|NCT03559530|450573065|FG001|Overall Study|non-location of medical records|0|||
125258301|NCT03559530|450573064|FG000|Overall Study|culture results not considered for treat|29|||
125258302|NCT03559530|450573065|FG001|Overall Study|culture results not considered for treat|0|||
125258303|NCT03559530|450573064|FG000|Overall Study|duplicate cases|8|||
125258304|NCT03559530|450573065|FG001|Overall Study|duplicate cases|0|||
125258305|NCT03559530|450573064|FG000|Overall Study|other species of Acinetobacte|7|||
125258306|NCT03559530|450573065|FG001|Overall Study|other species of Acinetobacte|0|||
125258307|NCT03559530|450573064|FG000|Overall Study|contamination / colonization|3|||
125258308|NCT03559530|450573065|FG001|Overall Study|contamination / colonization|0|||
125258309|NCT01362790|450573066|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
125258310|NCT01362790|450573067|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
125258311|NCT01362790|450573068|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
125258312|NCT01362790|450573069|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
125258313|NCT01362790|450573070|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
125258314|NCT01362790|450573071|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
125258315|NCT01362790|450573072|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
125258316|NCT01362790|450573066|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
125258317|NCT01362790|450573067|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
125258318|NCT01362790|450573068|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
125258319|NCT01362790|450573069|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
125258320|NCT01362790|450573070|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
125258321|NCT01362790|450573071|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
125258322|NCT01362790|450573072|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
125258323|NCT01362790|450573066|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
125258324|NCT01362790|450573067|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
125258325|NCT01362790|450573068|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
125258326|NCT01362790|450573069|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
125258327|NCT01362790|450573070|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
125258328|NCT01362790|450573071|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
125258329|NCT01362790|450573072|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
125258330|NCT01362790|450573066|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
125258331|NCT01362790|450573067|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
125258332|NCT01362790|450573068|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
125258333|NCT01362790|450573069|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
125258334|NCT01362790|450573070|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
125258335|NCT01362790|450573071|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
125258336|NCT01362790|450573072|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
125258337|NCT01362790|450573066|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
125258338|NCT01362790|450573067|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
125258339|NCT01362790|450573068|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
125258340|NCT01362790|450573069|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
125258341|NCT01362790|450573070|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
125258342|NCT01362790|450573071|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
125258343|NCT01362790|450573072|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
125258344|NCT01362790|450573066|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
125258345|NCT01362790|450573067|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
125258346|NCT01362790|450573068|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
125258347|NCT01362790|450573069|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
125258348|NCT01362790|450573070|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
125258349|NCT01362790|450573071|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
125258350|NCT01362790|450573072|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
125258351|NCT01362790|450573066|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
125258352|NCT01362790|450573067|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
125258353|NCT01362790|450573068|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
125258354|NCT01362790|450573069|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
125258355|NCT01362790|450573070|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
125258356|NCT01362790|450573071|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
125258357|NCT01362790|450573072|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
125258358|NCT01362790|450573066|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
125258359|NCT01362790|450573067|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
125258360|NCT01362790|450573068|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
125258361|NCT01362790|450573069|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
125258362|NCT01362790|450573070|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
125258363|NCT01362790|450573071|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
125258364|NCT01362790|450573072|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
125258365|NCT01362790|450573066|FG000|Pilot Phase & Phase 2|Death on study|0|||
125258366|NCT01362790|450573067|FG001|Pilot Phase & Phase 2|Death on study|0|||
125258367|NCT01362790|450573068|FG002|Pilot Phase & Phase 2|Death on study|0|||
125258368|NCT01362790|450573069|FG003|Pilot Phase & Phase 2|Death on study|1|||
125258369|NCT01362790|450573070|FG004|Pilot Phase & Phase 2|Death on study|0|||
125258370|NCT01362790|450573071|FG005|Pilot Phase & Phase 2|Death on study|0|||
125258371|NCT01362790|450573072|FG006|Pilot Phase & Phase 2|Death on study|0|||
125258372|NCT01362790|450573066|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
125258373|NCT01362790|450573067|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
125258374|NCT01362790|450573068|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
125258375|NCT01362790|450573069|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
125258376|NCT01362790|450573070|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
125258377|NCT01362790|450573071|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
125258378|NCT01362790|450573072|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
125258379|NCT01362790|450573066|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
125258380|NCT01362790|450573067|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
125258381|NCT01362790|450573068|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
125258382|NCT01362790|450573069|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
125258383|NCT01362790|450573070|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
125258384|NCT01362790|450573071|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
125258385|NCT01362790|450573072|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
125258386|NCT01362790|450573066|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
125258387|NCT01362790|450573067|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
125258388|NCT01362790|450573068|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
125258389|NCT01362790|450573069|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
125258390|NCT01362790|450573070|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
125258391|NCT01362790|450573071|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
125258392|NCT01362790|450573072|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
125258393|NCT02457065|450573073|FG000|Overall Study|Lost to Follow-up|9|||
125258394|NCT02457065|450573074|FG001|Overall Study|Lost to Follow-up|11|||
125258395|NCT05805150|450573076|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
125258396|NCT05805150|450573077|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
125258397|NCT01506726|450573083|FG000|Overall Study|Adverse Event|1|||
125258398|NCT01506726|450573084|FG001|Overall Study|Adverse Event|2|||
125258399|NCT04347538|450573088|FG000|Overall Study|Lost to Follow-up|4|||
125258400|NCT04347538|450573089|FG001|Overall Study|Lost to Follow-up|5|||
125258401|NCT04347538|450573090|FG002|Overall Study|Lost to Follow-up|7|||
125258402|NCT02135133|450573091|FG000|Overall Study|Adverse Event|10|||
125258403|NCT02135133|450573091|FG000|Overall Study|regulatory mandate|5|||
125258404|NCT05081843|450573092|FG000|Overall Study|Lost to Follow-up|135|||
125258405|NCT05081843|450573093|FG001|Overall Study|Lost to Follow-up|145|||
125258406|NCT02303821|450573094|FG000|Overall Study|Withdrawal by Subject|0|||
125258407|NCT02303821|450573095|FG001|Overall Study|Withdrawal by Subject|0|||
125258408|NCT02303821|450573096|FG002|Overall Study|Withdrawal by Subject|0|||
125258409|NCT02303821|450573097|FG003|Overall Study|Withdrawal by Subject|0|||
125258410|NCT02303821|450573098|FG004|Overall Study|Withdrawal by Subject|0|||
125258411|NCT02303821|450573099|FG005|Overall Study|Withdrawal by Subject|0|||
125258412|NCT02303821|450573100|FG006|Overall Study|Withdrawal by Subject|0|||
125258413|NCT02303821|450573101|FG007|Overall Study|Withdrawal by Subject|2|||
125258414|NCT02303821|450573094|FG000|Overall Study|Death|0|||
125258415|NCT02303821|450573095|FG001|Overall Study|Death|2|||
125258416|NCT02303821|450573096|FG002|Overall Study|Death|0|||
125258417|NCT02303821|450573097|FG003|Overall Study|Death|0|||
125258418|NCT02303821|450573098|FG004|Overall Study|Death|0|||
125258419|NCT02303821|450573099|FG005|Overall Study|Death|3|||
125258420|NCT02303821|450573100|FG006|Overall Study|Death|41|||
125258421|NCT02303821|450573101|FG007|Overall Study|Death|29|||
125258422|NCT02303821|450573094|FG000|Overall Study|Lost to Follow-up|0|||
125258423|NCT02303821|450573095|FG001|Overall Study|Lost to Follow-up|0|||
125258424|NCT02303821|450573096|FG002|Overall Study|Lost to Follow-up|0|||
125258425|NCT02303821|450573097|FG003|Overall Study|Lost to Follow-up|0|||
125258426|NCT02303821|450573098|FG004|Overall Study|Lost to Follow-up|0|||
125258427|NCT02303821|450573099|FG005|Overall Study|Lost to Follow-up|0|||
125258428|NCT02303821|450573100|FG006|Overall Study|Lost to Follow-up|1|||
125258429|NCT02303821|450573101|FG007|Overall Study|Lost to Follow-up|0|||
125258430|NCT02303821|450573094|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
125258431|NCT02303821|450573095|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
125258432|NCT02303821|450573096|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
125258433|NCT02303821|450573097|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
125258434|NCT02303821|450573098|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
125258435|NCT02303821|450573099|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
125258436|NCT02303821|450573100|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
125258437|NCT02303821|450573101|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
125258438|NCT02303821|450573094|FG000|Overall Study|Decision by sponsor|0|||
125258439|NCT02303821|450573095|FG001|Overall Study|Decision by sponsor|0|||
125258440|NCT02303821|450573096|FG002|Overall Study|Decision by sponsor|0|||
125258441|NCT02303821|450573097|FG003|Overall Study|Decision by sponsor|0|||
125258442|NCT02303821|450573098|FG004|Overall Study|Decision by sponsor|0|||
125258443|NCT02303821|450573099|FG005|Overall Study|Decision by sponsor|1|||
125258444|NCT02303821|450573100|FG006|Overall Study|Decision by sponsor|0|||
125258445|NCT02303821|450573101|FG007|Overall Study|Decision by sponsor|0|||
125258446|NCT02303821|450573094|FG000|Overall Study|Protocol-specified criteria|0|||
125258447|NCT02303821|450573095|FG001|Overall Study|Protocol-specified criteria|1|||
125258448|NCT02303821|450573096|FG002|Overall Study|Protocol-specified criteria|0|||
125258449|NCT02303821|450573097|FG003|Overall Study|Protocol-specified criteria|0|||
125258450|NCT02303821|450573098|FG004|Overall Study|Protocol-specified criteria|0|||
125258451|NCT02303821|450573099|FG005|Overall Study|Protocol-specified criteria|1|||
125258452|NCT02303821|450573100|FG006|Overall Study|Protocol-specified criteria|0|||
125258453|NCT02303821|450573101|FG007|Overall Study|Protocol-specified criteria|0|||
125258454|NCT04116489|450573114|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
125258455|NCT04116489|450573114|FG000|Overall Study|Withdrawal by Subject|1|||
125258456|NCT03734536|450573115|FG000|Overall Study|Withdrew Consent|1|||
125258457|NCT03734536|450573116|FG001|Overall Study|Withdrew Consent|5|||
125258458|NCT03734536|450573115|FG000|Overall Study|Lost to Follow-up|10|||
125258459|NCT03734536|450573116|FG001|Overall Study|Lost to Follow-up|7|||
125258460|NCT04727151|450573117|FG000|Overall Study|Death|0|||
125258461|NCT04727151|450573118|FG001|Overall Study|Death|0|||
125258462|NCT04727151|450573119|FG002|Overall Study|Death|0|||
125258463|NCT04727151|450573120|FG003|Overall Study|Death|0|||
125258464|NCT04727151|450573121|FG004|Overall Study|Death|3|||
125258465|NCT04727151|450573117|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
125258466|NCT04727151|450573118|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
125258467|NCT04727151|450573119|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
125258468|NCT04727151|450573120|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
125258469|NCT04727151|450573121|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
125258470|NCT01346592|450573123|FG000|Overall Study|Lost to Follow-up|62|||
125258471|NCT01346592|450573124|FG001|Overall Study|Lost to Follow-up|29|||
125258472|NCT01346592|450573125|FG002|Overall Study|Lost to Follow-up|29|||
125258473|NCT01346592|450573123|FG000|Overall Study|Protocol Violation|2|||
125258474|NCT01346592|450573124|FG001|Overall Study|Protocol Violation|1|||
125258475|NCT01346592|450573125|FG002|Overall Study|Protocol Violation|0|||
125258476|NCT01346592|450573123|FG000|Overall Study|Death|1|||
125258477|NCT01346592|450573124|FG001|Overall Study|Death|3|||
125258478|NCT01346592|450573125|FG002|Overall Study|Death|4|||
125258479|NCT01346592|450573123|FG000|Overall Study|Adverse Event|0|||
125258480|NCT01346592|450573124|FG001|Overall Study|Adverse Event|1|||
125258481|NCT01346592|450573125|FG002|Overall Study|Adverse Event|0|||
125258482|NCT01346592|450573123|FG000|Overall Study|Withdrawal by Subject|77|||
125258483|NCT01346592|450573124|FG001|Overall Study|Withdrawal by Subject|51|||
125258484|NCT01346592|450573125|FG002|Overall Study|Withdrawal by Subject|38|||
125258485|NCT01346592|450573123|FG000|Overall Study|Inappropriate enrollment|3|||
125258486|NCT01346592|450573124|FG001|Overall Study|Inappropriate enrollment|1|||
125258487|NCT01346592|450573125|FG002|Overall Study|Inappropriate enrollment|1|||
125258488|NCT01346592|450573123|FG000|Overall Study|Administrative reason|1|||
125258489|NCT01346592|450573124|FG001|Overall Study|Administrative reason|0|||
125258490|NCT01346592|450573125|FG002|Overall Study|Administrative reason|0|||
125258491|NCT01346592|450573123|FG000|Overall Study|Unable to Classify|7|||
125258492|NCT01346592|450573124|FG001|Overall Study|Unable to Classify|3|||
125258493|NCT01346592|450573125|FG002|Overall Study|Unable to Classify|6|||
125258494|NCT02679274|450573126|FG000|Overall Study|Withdrawal by Subject|1|||
125258495|NCT02679274|450573127|FG001|Overall Study|Withdrawal by Subject|0|||
125258496|NCT02038036|450573132|FG000|Core Study|Adverse Event|7|||
125258497|NCT02038036|450573133|FG001|Core Study|Adverse Event|7|||
125258498|NCT02038036|450573132|FG000|Core Study|Death|1|||
125258499|NCT02038036|450573133|FG001|Core Study|Death|1|||
125258500|NCT02038036|450573132|FG000|Core Study|Disease progression|2|||
125258501|NCT02038036|450573133|FG001|Core Study|Disease progression|2|||
125258502|NCT02038036|450573132|FG000|Core Study|Lost to Follow-up|0|||
125258503|NCT02038036|450573133|FG001|Core Study|Lost to Follow-up|1|||
125258504|NCT02038036|450573132|FG000|Core Study|Physician Decision|2|||
125258505|NCT02038036|450573133|FG001|Core Study|Physician Decision|1|||
125258506|NCT02038036|450573132|FG000|Core Study|Subject/guardian decision|0|||
125258507|NCT02038036|450573133|FG001|Core Study|Subject/guardian decision|1|||
125258508|NCT02038036|450573132|FG000|Core Study|Withdrawal by Subject|3|||
125258509|NCT02038036|450573133|FG001|Core Study|Withdrawal by Subject|1|||
125258510|NCT02038036|450573132|FG000|Crossover Period|Withdrawal by Subject|0|||
125258511|NCT02038036|450573133|FG001|Crossover Period|Withdrawal by Subject|3|||
125258512|NCT02038036|450573132|FG000|Crossover Period|Adverse Event|0|||
125258513|NCT02038036|450573133|FG001|Crossover Period|Adverse Event|9|||
125258514|NCT02038036|450573132|FG000|Crossover Period|Death|0|||
125258515|NCT02038036|450573133|FG001|Crossover Period|Death|2|||
125258516|NCT02038036|450573132|FG000|Crossover Period|Disease progression|0|||
125258517|NCT02038036|450573133|FG001|Crossover Period|Disease progression|3|||
125258518|NCT02038036|450573132|FG000|Crossover Period|Lost to Follow-up|0|||
125258519|NCT02038036|450573133|FG001|Crossover Period|Lost to Follow-up|1|||
125258520|NCT02038036|450573132|FG000|Crossover Period|Physician Decision|0|||
125258521|NCT02038036|450573133|FG001|Crossover Period|Physician Decision|2|||
125258522|NCT03537508|450573141|FG000|Overall Study|Adverse Event|2|||
125258523|NCT03537508|450573142|FG001|Overall Study|Adverse Event|1|||
125258524|NCT03537508|450573141|FG000|Overall Study|Protocol Violation|65|||
125258525|NCT03537508|450573142|FG001|Overall Study|Protocol Violation|48|||
125258526|NCT03537508|450573141|FG000|Overall Study|Lost to Follow-up|86|||
125258527|NCT03537508|450573142|FG001|Overall Study|Lost to Follow-up|60|||
125258528|NCT03537508|450573141|FG000|Overall Study|Withdrawal by parent/guardian|263|||
125258529|NCT03537508|450573142|FG001|Overall Study|Withdrawal by parent/guardian|149|||
125258530|NCT01972659|450573143|FG000|Overall Study|Protocol Violation|2|||
125258531|NCT01972659|450573144|FG001|Overall Study|Protocol Violation|2|||
125258532|NCT01972659|450573143|FG000|Overall Study|problems realted to acceleromyograph|2|||
125258533|NCT01972659|450573144|FG001|Overall Study|problems realted to acceleromyograph|1|||
125258534|NCT04144517|450573148|FG000|Overall Study|Physician Decision|0|||
125258535|NCT04144517|450573149|FG001|Overall Study|Physician Decision|1|||
125258536|NCT04144517|450573148|FG000|Overall Study|Other|2|||
125258537|NCT04144517|450573149|FG001|Overall Study|Other|2|||
125258538|NCT04144517|450573148|FG000|Overall Study|Death|6|||
125258539|NCT04144517|450573149|FG001|Overall Study|Death|3|||
125258540|NCT00835367|450573155|FG000|Washout|Adverse Event|2|||
125258541|NCT00835367|450573156|FG001|Washout|Adverse Event|0|||
125258542|NCT00835367|450573155|FG000|Washout|Withdrawal by Subject|1|||
125258543|NCT00835367|450573156|FG001|Washout|Withdrawal by Subject|0|||
125258544|NCT00835367|450573155|FG000|Second Intervention|Adverse Event|1|||
125258545|NCT00835367|450573156|FG001|Second Intervention|Adverse Event|1|||
125258546|NCT02495883|450573157|FG000|Overall Study|Excessive head motion|1|||
125258547|NCT02495883|450573158|FG001|Overall Study|Excessive head motion|0|||
125258548|NCT00791648|450575127|FG000|Overall Study|Physician Decision|0|||
125258549|NCT00791648|450575128|FG001|Overall Study|Physician Decision|1|||
125258550|NCT00791648|450575127|FG000|Overall Study|Withdrawal by Subject|0|||
125258551|NCT00791648|450575128|FG001|Overall Study|Withdrawal by Subject|1|||
125258552|NCT04976777|450575129|FG000|Overall Study|COVID-19 Infection|1|||
125258553|NCT04976777|450575130|FG001|Overall Study|COVID-19 Infection|0|||
125258554|NCT00462826|450575131|FG000|Overall Study|Ineligible - second primary|1|||
125258555|NCT00462826|450575131|FG000|Overall Study|Ineligible - wrong cell type|1|||
125258556|NCT00462826|450575131|FG000|Overall Study|Ineligible - wrong primary|2|||
125258557|NCT00462826|450575131|FG000|Overall Study|Never treated|1|||
125258558|NCT02278003|450575132|FG000|Overall Study|Withdrawal by Subject|11|||
125258559|NCT02278003|450575133|FG001|Overall Study|Withdrawal by Subject|0|||
125258560|NCT02278003|450575132|FG000|Overall Study|Not Treated|1|||
125258561|NCT02278003|450575133|FG001|Overall Study|Not Treated|0|||
125258562|NCT02278003|450575132|FG000|Overall Study|Recognition task improperly completed|7|||
125258563|NCT02278003|450575133|FG001|Overall Study|Recognition task improperly completed|0|||
125258564|NCT03440385|450575148|FG000|Overall Study|Other Reason|4|||
125258565|NCT03440385|450575149|FG001|Overall Study|Other Reason|1|||
125258566|NCT03440385|450575148|FG000|Overall Study|Site Closed|1|||
125258567|NCT03440385|450575149|FG001|Overall Study|Site Closed|0|||
125258568|NCT03440385|450575148|FG000|Overall Study|Lost to Follow-up|2|||
125258569|NCT03440385|450575149|FG001|Overall Study|Lost to Follow-up|0|||
125258570|NCT03440385|450575148|FG000|Overall Study|Withdrawal by Subject|12|||
125258571|NCT03440385|450575149|FG001|Overall Study|Withdrawal by Subject|6|||
125258572|NCT03440385|450575148|FG000|Overall Study|Lack of Efficacy|9|||
125258573|NCT03440385|450575149|FG001|Overall Study|Lack of Efficacy|2|||
125258574|NCT03440385|450575148|FG000|Overall Study|Adverse Event|15|||
125258575|NCT03440385|450575149|FG001|Overall Study|Adverse Event|11|||
125258576|NCT04123704|450575150|FG000|Overall Study|Disease progression|2|||
125258577|NCT00939185|450575151|FG000|Overall Study|Adverse Event|3|||
125258578|NCT00939185|450575151|FG000|Overall Study|Lack of Efficacy|1|||
125258579|NCT00939185|450575151|FG000|Overall Study|Lost to Follow-up|6|||
125258580|NCT00939185|450575151|FG000|Overall Study|Other|3|||
125258581|NCT00939185|450575151|FG000|Overall Study|Withdrawal by Subject|2|||
125258582|NCT00939185|450575151|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
125258583|NCT00363298|450575152|FG000|First Study Week|Lack of Efficacy|6|||
125258584|NCT00363298|450575153|FG001|First Study Week|Lack of Efficacy|5|||
125258585|NCT00363298|450575152|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
125258586|NCT00363298|450575153|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
125258587|NCT00836706|450575157|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
125258588|NCT00836706|450575158|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
125258589|NCT02390076|450575163|FG000|Overall Study|Lost to Follow-up|2|||
125258590|NCT02390076|450575164|FG001|Overall Study|Lost to Follow-up|1|||
125258591|NCT02390076|450575165|FG002|Overall Study|Lost to Follow-up|4|||
125258592|NCT01822925|450575167|FG000|Overall Study|Adverse Event|1|||
125258593|NCT01822925|450575168|FG001|Overall Study|Adverse Event|1|||
125258594|NCT01822925|450575169|FG002|Overall Study|Adverse Event|1|||
125258595|NCT01822925|450575170|FG003|Overall Study|Adverse Event|1|||
125258596|NCT01822925|450575167|FG000|Overall Study|Lost to Follow-up|0|||
125258597|NCT01822925|450575168|FG001|Overall Study|Lost to Follow-up|1|||
125258598|NCT01822925|450575169|FG002|Overall Study|Lost to Follow-up|0|||
125258599|NCT01822925|450575170|FG003|Overall Study|Lost to Follow-up|0|||
125258600|NCT01822925|450575167|FG000|Overall Study|Protocol Violation|1|||
125258601|NCT01822925|450575168|FG001|Overall Study|Protocol Violation|0|||
125258602|NCT01822925|450575169|FG002|Overall Study|Protocol Violation|0|||
125258603|NCT01822925|450575170|FG003|Overall Study|Protocol Violation|1|||
125258604|NCT01822925|450575167|FG000|Overall Study|Withdrawal by Subject|2|||
125258605|NCT01822925|450575168|FG001|Overall Study|Withdrawal by Subject|0|||
125258606|NCT01822925|450575169|FG002|Overall Study|Withdrawal by Subject|2|||
125258607|NCT01822925|450575170|FG003|Overall Study|Withdrawal by Subject|2|||
125258608|NCT01822925|450575167|FG000|Overall Study|Taking prohibited medication|2|||
125258609|NCT01822925|450575168|FG001|Overall Study|Taking prohibited medication|0|||
125258610|NCT01822925|450575169|FG002|Overall Study|Taking prohibited medication|0|||
125258611|NCT01822925|450575170|FG003|Overall Study|Taking prohibited medication|1|||
125258612|NCT04617860|450575171|FG000|Overall Study|Adverse Event|0|||
125258613|NCT04617860|450575172|FG001|Overall Study|Adverse Event|2|||
125258614|NCT04617860|450575173|FG002|Overall Study|Adverse Event|2|||
125258615|NCT04617860|450575171|FG000|Overall Study|Withdrawal by Subject|0|||
125258616|NCT04617860|450575172|FG001|Overall Study|Withdrawal by Subject|0|||
125258617|NCT04617860|450575173|FG002|Overall Study|Withdrawal by Subject|2|||
125258618|NCT04617860|450575171|FG000|Overall Study|Physician Decision|0|||
125258619|NCT04617860|450575172|FG001|Overall Study|Physician Decision|1|||
125258620|NCT04617860|450575173|FG002|Overall Study|Physician Decision|0|||
125258621|NCT04617860|450575171|FG000|Overall Study|Sponsor Decision|0|||
125258622|NCT04617860|450575172|FG001|Overall Study|Sponsor Decision|3|||
125258623|NCT04617860|450575173|FG002|Overall Study|Sponsor Decision|1|||
125258624|NCT04617860|450575171|FG000|Overall Study|Termination of Study by Sponsor|8|||
125258625|NCT04617860|450575172|FG001|Overall Study|Termination of Study by Sponsor|4|||
125258626|NCT04617860|450575173|FG002|Overall Study|Termination of Study by Sponsor|13|||
125258627|NCT01182350|450575174|FG000|Overall Study|Adverse Event|5|||
125258628|NCT01182350|450575175|FG001|Overall Study|Adverse Event|0|||
125258629|NCT01182350|450575176|FG002|Overall Study|Adverse Event|0|||
125258630|NCT01182350|450575177|FG003|Overall Study|Adverse Event|0|||
125258631|NCT01182350|450575178|FG004|Overall Study|Adverse Event|0|||
125258632|NCT01182350|450575174|FG000|Overall Study|Disease Progression|15|||
125258633|NCT01182350|450575175|FG001|Overall Study|Disease Progression|12|||
125258634|NCT01182350|450575176|FG002|Overall Study|Disease Progression|0|||
125258635|NCT01182350|450575177|FG003|Overall Study|Disease Progression|1|||
125258636|NCT01182350|450575178|FG004|Overall Study|Disease Progression|0|||
125258637|NCT01182350|450575174|FG000|Overall Study|Death|0|||
125258638|NCT01182350|450575175|FG001|Overall Study|Death|1|||
125258639|NCT01182350|450575176|FG002|Overall Study|Death|1|||
125258640|NCT01182350|450575177|FG003|Overall Study|Death|0|||
125258641|NCT01182350|450575178|FG004|Overall Study|Death|0|||
125258642|NCT01182350|450575174|FG000|Overall Study|Withdrawal by Subject|3|||
125258643|NCT01182350|450575175|FG001|Overall Study|Withdrawal by Subject|1|||
125258644|NCT01182350|450575176|FG002|Overall Study|Withdrawal by Subject|0|||
125258645|NCT01182350|450575177|FG003|Overall Study|Withdrawal by Subject|1|||
125258646|NCT01182350|450575178|FG004|Overall Study|Withdrawal by Subject|0|||
125258647|NCT01182350|450575174|FG000|Overall Study|Alternative Therapy|2|||
125258648|NCT01182350|450575175|FG001|Overall Study|Alternative Therapy|0|||
125258649|NCT01182350|450575176|FG002|Overall Study|Alternative Therapy|1|||
125258650|NCT01182350|450575177|FG003|Overall Study|Alternative Therapy|0|||
125258651|NCT01182350|450575178|FG004|Overall Study|Alternative Therapy|0|||
125258652|NCT01182350|450575174|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
125258653|NCT01182350|450575175|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
125258654|NCT01182350|450575176|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
125258655|NCT01182350|450575177|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
125258656|NCT01182350|450575178|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
125258657|NCT01182350|450575174|FG000|Overall Study|Unevaluable for Biopsy|0|||
125258658|NCT01182350|450575175|FG001|Overall Study|Unevaluable for Biopsy|0|||
125258659|NCT01182350|450575176|FG002|Overall Study|Unevaluable for Biopsy|0|||
125258660|NCT01182350|450575177|FG003|Overall Study|Unevaluable for Biopsy|0|||
125258661|NCT01182350|450575178|FG004|Overall Study|Unevaluable for Biopsy|3|||
125258662|NCT03898180|450575179|FG000|Overall Study|Death|178|||
125258663|NCT03898180|450575180|FG001|Overall Study|Death|173|||
125258664|NCT03898180|450575179|FG000|Overall Study|Physician Decision|1|||
125258665|NCT03898180|450575180|FG001|Overall Study|Physician Decision|0|||
125258666|NCT03898180|450575179|FG000|Overall Study|Sponsor Decision|3|||
125258667|NCT03898180|450575180|FG001|Overall Study|Sponsor Decision|0|||
125258668|NCT03898180|450575179|FG000|Overall Study|Lost to Follow-up|1|||
125258669|NCT03898180|450575180|FG001|Overall Study|Lost to Follow-up|0|||
125258670|NCT03898180|450575179|FG000|Overall Study|Withdrawal by Subject|5|||
125258671|NCT03898180|450575180|FG001|Overall Study|Withdrawal by Subject|4|||
125258672|NCT01646827|450575181|FG000|Overall Study|Lost to Follow-up|0|||
125258673|NCT01646827|450575182|FG001|Overall Study|Lost to Follow-up|3|||
125258674|NCT01646827|450575181|FG000|Overall Study|Physician Decision|1|||
125258675|NCT01646827|450575182|FG001|Overall Study|Physician Decision|2|||
125258676|NCT01646827|450575181|FG000|Overall Study|Withdrawal by Subject|1|||
125258677|NCT01646827|450575182|FG001|Overall Study|Withdrawal by Subject|0|||
125258678|NCT00928668|450575183|FG000|Overall Study|Adverse Event|1|||
125258679|NCT00928668|450575184|FG001|Overall Study|Adverse Event|0|||
125258680|NCT00928668|450575185|FG002|Overall Study|Adverse Event|0|||
125258681|NCT00928668|450575186|FG003|Overall Study|Adverse Event|0|||
125258682|NCT00928668|450575187|FG004|Overall Study|Adverse Event|0|||
125258683|NCT00928668|450575183|FG000|Overall Study|Protocol Violation|0|||
125258684|NCT00928668|450575184|FG001|Overall Study|Protocol Violation|0|||
125258685|NCT00928668|450575185|FG002|Overall Study|Protocol Violation|0|||
125258686|NCT00928668|450575186|FG003|Overall Study|Protocol Violation|0|||
125258687|NCT00928668|450575187|FG004|Overall Study|Protocol Violation|1|||
125258688|NCT00928668|450575183|FG000|Overall Study|Withdrawal by Subject|0|||
125258689|NCT00928668|450575184|FG001|Overall Study|Withdrawal by Subject|1|||
125258690|NCT00928668|450575185|FG002|Overall Study|Withdrawal by Subject|1|||
125258691|NCT00928668|450575186|FG003|Overall Study|Withdrawal by Subject|0|||
125258692|NCT00928668|450575187|FG004|Overall Study|Withdrawal by Subject|0|||
125258693|NCT00928668|450575183|FG000|Overall Study|Other reasons not listed above|0|||
125258694|NCT00928668|450575184|FG001|Overall Study|Other reasons not listed above|0|||
125258695|NCT00928668|450575185|FG002|Overall Study|Other reasons not listed above|0|||
125258696|NCT00928668|450575186|FG003|Overall Study|Other reasons not listed above|1|||
125258697|NCT00928668|450575187|FG004|Overall Study|Other reasons not listed above|0|||
125258698|NCT01767987|450575191|FG000|Overall Study|Physician Decision|4|||
125258699|NCT01767987|450575192|FG001|Overall Study|Physician Decision|1|||
125258700|NCT03232567|450575193|FG000|Overall Study|Withdrawal by Subject|0|||
125258701|NCT03232567|450575194|FG001|Overall Study|Withdrawal by Subject|1|||
125258702|NCT03232567|450575195|FG002|Overall Study|Withdrawal by Subject|0|||
125258703|NCT03232567|450575196|FG003|Overall Study|Withdrawal by Subject|0|||
125258704|NCT05837481|450575197|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
125258705|NCT05837481|450575198|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
125258706|NCT03038087|450575201|FG000|Overall Study|lost data|1|||
125258707|NCT02284893|450575210|FG000|26 Week (Short Term)|Adverse Event|1|||
125258708|NCT02284893|450575211|FG001|26 Week (Short Term)|Adverse Event|9|||
125258709|NCT02284893|450575210|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
125258710|NCT02284893|450575211|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
125258711|NCT02284893|450575210|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
125258712|NCT02284893|450575211|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
125258713|NCT02284893|450575210|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
125258714|NCT02284893|450575211|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
125258715|NCT02284893|450575210|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
125258716|NCT02284893|450575211|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
125258717|NCT02284893|450575210|FG000|26 Week (Short Term)|Other|1|||
125258718|NCT02284893|450575211|FG001|26 Week (Short Term)|Other|1|||
125258719|NCT02284893|450575210|FG000|52 Week (Long Term)|Adverse Event|3|||
125258720|NCT02284893|450575211|FG001|52 Week (Long Term)|Adverse Event|1|||
125258721|NCT02284893|450575210|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
125258722|NCT02284893|450575211|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
125258723|NCT02284893|450575210|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
125258724|NCT02284893|450575211|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
125258725|NCT02284893|450575210|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
125258726|NCT02284893|450575211|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
125258727|NCT02284893|450575210|FG000|52 Week (Long Term)|Non-Compliance|2|||
125258728|NCT02284893|450575211|FG001|52 Week (Long Term)|Non-Compliance|3|||
125258729|NCT00105066|450575212|FG000|Overall Study|Adverse Event|2|||
125258730|NCT00105066|450575213|FG001|Overall Study|Adverse Event|5|||
125258731|NCT02259231|450575246|FG000|Overall Study|Adverse Event|1|||
125258732|NCT02259231|450575247|FG001|Overall Study|Adverse Event|1|||
125258733|NCT02259231|450575248|FG002|Overall Study|Adverse Event|2|||
125258734|NCT02259231|450575249|FG003|Overall Study|Adverse Event|0|||
125258735|NCT02259231|450575250|FG004|Overall Study|Adverse Event|0|||
125258736|NCT02259231|450575251|FG005|Overall Study|Adverse Event|0|||
125258737|NCT02259231|450575252|FG006|Overall Study|Adverse Event|0|||
125258738|NCT02259231|450575246|FG000|Overall Study|Progressive Disease|4|||
125258739|NCT02259231|450575247|FG001|Overall Study|Progressive Disease|5|||
125258740|NCT02259231|450575248|FG002|Overall Study|Progressive Disease|4|||
125258741|NCT02259231|450575249|FG003|Overall Study|Progressive Disease|5|||
125258742|NCT02259231|450575250|FG004|Overall Study|Progressive Disease|4|||
125258743|NCT02259231|450575251|FG005|Overall Study|Progressive Disease|5|||
125258744|NCT02259231|450575252|FG006|Overall Study|Progressive Disease|4|||
125258745|NCT02259231|450575246|FG000|Overall Study|Sponsor termination of study|1|||
125258746|NCT02259231|450575247|FG001|Overall Study|Sponsor termination of study|0|||
125258747|NCT02259231|450575248|FG002|Overall Study|Sponsor termination of study|0|||
125258748|NCT02259231|450575249|FG003|Overall Study|Sponsor termination of study|1|||
125258749|NCT02259231|450575250|FG004|Overall Study|Sponsor termination of study|2|||
125258750|NCT02259231|450575251|FG005|Overall Study|Sponsor termination of study|1|||
125258751|NCT02259231|450575252|FG006|Overall Study|Sponsor termination of study|1|||
125258752|NCT00847730|450575256|FG000|Overall Study|Multiple interruptions in therapy|8|||
125258753|NCT04507269|450575261|FG000|Overall Study|Withdrawal by Subject|1|||
125258754|NCT04507269|450575262|FG001|Overall Study|Withdrawal by Subject|1|||
125258755|NCT04507269|450575263|FG002|Overall Study|Withdrawal by Subject|0|||
125258756|NCT04507269|450575264|FG003|Overall Study|Withdrawal by Subject|0|||
125258757|NCT04507269|450575265|FG004|Overall Study|Withdrawal by Subject|0|||
125258758|NCT04507269|450575266|FG005|Overall Study|Withdrawal by Subject|0|||
125258759|NCT04507269|450575261|FG000|Overall Study|Lost to Follow-up|0|||
125258760|NCT04507269|450575262|FG001|Overall Study|Lost to Follow-up|0|||
125258761|NCT04507269|450575263|FG002|Overall Study|Lost to Follow-up|0|||
125258762|NCT04507269|450575264|FG003|Overall Study|Lost to Follow-up|0|||
125258763|NCT04507269|450575265|FG004|Overall Study|Lost to Follow-up|1|||
125258764|NCT04507269|450575266|FG005|Overall Study|Lost to Follow-up|0|||
125258765|NCT00071032|450575269|FG000|Overall Study|Lost to Follow-up|1|||
125258766|NCT00071032|450575270|FG001|Overall Study|Lost to Follow-up|1|||
125258767|NCT00071032|450575269|FG000|Overall Study|Withdrawal by Subject|8|||
125258768|NCT00071032|450575270|FG001|Overall Study|Withdrawal by Subject|6|||
125258769|NCT00071032|450575269|FG000|Overall Study|Missing Primary Outcome|0|||
125258770|NCT00071032|450575270|FG001|Overall Study|Missing Primary Outcome|1|||
125258771|NCT06071104|450575272|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
125258772|NCT03518060|450575273|FG000|Overall Study|Death|1|||
125258773|NCT03518060|450575273|FG000|Overall Study|Poor adherence|1|||
125258774|NCT03518060|450575273|FG000|Overall Study|Withdrawal of informed consent|2|||
125258775|NCT03518060|450575273|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
125258776|NCT03518060|450575273|FG000|Overall Study|Physician Decision|7|||
125258777|NCT03518060|450575273|FG000|Overall Study|Adverse drug reactions|23|||
125258778|NCT03518060|450575273|FG000|Overall Study|Withdrawal by Subject|25|||
125258779|NCT03518060|450575273|FG000|Overall Study|Lost to Follow-up|13|||
125258780|NCT02757768|450575289|FG000|Overall Study|Randomized Never Received Study Drug|3|||
125258781|NCT02757768|450575290|FG001|Overall Study|Randomized Never Received Study Drug|4|||
125258782|NCT02757768|450575289|FG000|Overall Study|Adverse Event|5|||
125258783|NCT02757768|450575290|FG001|Overall Study|Adverse Event|3|||
125258784|NCT02757768|450575289|FG000|Overall Study|Lack of Efficacy|2|||
125258785|NCT02757768|450575290|FG001|Overall Study|Lack of Efficacy|1|||
125258786|NCT02757768|450575289|FG000|Overall Study|Lost to Follow-up|1|||
125258787|NCT02757768|450575290|FG001|Overall Study|Lost to Follow-up|0|||
125258788|NCT02757768|450575289|FG000|Overall Study|Protocol Deviation|2|||
125258789|NCT02757768|450575290|FG001|Overall Study|Protocol Deviation|9|||
125258790|NCT02757768|450575289|FG000|Overall Study|Withdrawal by Subject|16|||
125258791|NCT02757768|450575290|FG001|Overall Study|Withdrawal by Subject|9|||
125258792|NCT02757768|450575289|FG000|Overall Study|Miscellaneous|4|||
125258793|NCT02757768|450575290|FG001|Overall Study|Miscellaneous|2|||
125258794|NCT00618787|450575304|FG000|Overall Study|Adverse Event|0|||
125258795|NCT00618787|450575305|FG001|Overall Study|Adverse Event|1|||
125258796|NCT00618787|450575304|FG000|Overall Study|Withdrawal by Subject|2|||
125258797|NCT00618787|450575305|FG001|Overall Study|Withdrawal by Subject|1|||
125258798|NCT00618787|450575304|FG000|Overall Study|Lost to Follow-up|1|||
125258799|NCT00618787|450575305|FG001|Overall Study|Lost to Follow-up|0|||
125258800|NCT01107886|450575306|FG000|Overall Study|Lost to Follow-up|15|||
125258801|NCT01107886|450575307|FG001|Overall Study|Lost to Follow-up|13|||
125258802|NCT01107886|450575306|FG000|Overall Study|Withdrawal by Subject|180|||
125258803|NCT01107886|450575307|FG001|Overall Study|Withdrawal by Subject|196|||
125258804|NCT01107886|450575306|FG000|Overall Study|Administrative withdrawal of consent|7|||
125258805|NCT01107886|450575307|FG001|Overall Study|Administrative withdrawal of consent|5|||
125258806|NCT01649869|450575312|FG000|Overall Study|Family member illness|1|||
125258807|NCT01649869|450575313|FG001|Overall Study|Family member illness|0|||
125258808|NCT01649869|450575312|FG000|Overall Study|Required treatment outside protocol|1|||
125258809|NCT01649869|450575313|FG001|Overall Study|Required treatment outside protocol|0|||
125258810|NCT01649869|450575312|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
125258811|NCT01649869|450575313|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
125258812|NCT02776735|450575314|FG000|Overall Study|Adverse Event|0|||
125258813|NCT02776735|450575315|FG001|Overall Study|Adverse Event|0|||
125258814|NCT02776735|450575316|FG002|Overall Study|Adverse Event|0|||
125258815|NCT02776735|450575317|FG003|Overall Study|Adverse Event|1|||
125258816|NCT02776735|450575318|FG004|Overall Study|Adverse Event|0|||
125258817|NCT02776735|450575319|FG005|Overall Study|Adverse Event|1|||
125258818|NCT02776735|450575314|FG000|Overall Study|Lost to Follow-up|0|||
125258819|NCT02776735|450575315|FG001|Overall Study|Lost to Follow-up|0|||
125258820|NCT02776735|450575316|FG002|Overall Study|Lost to Follow-up|0|||
125258821|NCT02776735|450575317|FG003|Overall Study|Lost to Follow-up|1|||
125258822|NCT02776735|450575318|FG004|Overall Study|Lost to Follow-up|0|||
125258823|NCT02776735|450575319|FG005|Overall Study|Lost to Follow-up|0|||
125258824|NCT02776735|450575314|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125258825|NCT02776735|450575315|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125258826|NCT02776735|450575316|FG002|Overall Study|Withdrawal by parent/guardian|2|||
125258827|NCT02776735|450575317|FG003|Overall Study|Withdrawal by parent/guardian|2|||
125258828|NCT02776735|450575318|FG004|Overall Study|Withdrawal by parent/guardian|0|||
125258829|NCT02776735|450575319|FG005|Overall Study|Withdrawal by parent/guardian|0|||
125258830|NCT02776735|450575314|FG000|Overall Study|Withdrawal by Subject|1|||
125258831|NCT02776735|450575315|FG001|Overall Study|Withdrawal by Subject|0|||
125258832|NCT02776735|450575316|FG002|Overall Study|Withdrawal by Subject|0|||
125258833|NCT02776735|450575317|FG003|Overall Study|Withdrawal by Subject|0|||
125258834|NCT02776735|450575318|FG004|Overall Study|Withdrawal by Subject|0|||
125258835|NCT02776735|450575319|FG005|Overall Study|Withdrawal by Subject|1|||
125258836|NCT02776735|450575314|FG000|Overall Study|Other|0|||
125258837|NCT02776735|450575315|FG001|Overall Study|Other|0|||
125258838|NCT02776735|450575316|FG002|Overall Study|Other|3|||
125258839|NCT02776735|450575317|FG003|Overall Study|Other|0|||
125258840|NCT02776735|450575318|FG004|Overall Study|Other|0|||
125258841|NCT02776735|450575319|FG005|Overall Study|Other|0|||
125258842|NCT03556891|450575322|FG000|Overall Study|Adverse Event|4|||
125258843|NCT03556891|450575322|FG000|Overall Study|MRI Need|3|||
125258844|NCT03556891|450575322|FG000|Overall Study|Device Failure|1|||
125258845|NCT03556891|450575322|FG000|Overall Study|Death|1|||
125258846|NCT03556891|450575322|FG000|Overall Study|Lost to Follow-up|1|||
125258847|NCT03556891|450575322|FG000|Overall Study|Missing at random|1|||
125258848|NCT03556891|450575322|FG000|Overall Study|Missing due to COVID|1|||
125258849|NCT03556891|450575322|FG000|Overall Study|Protocol Violation|1|||
125258850|NCT03552029|450576969|FG000|Overall Study|Death|3|||
125258851|NCT03552029|450576970|FG001|Overall Study|Death|0|||
125258852|NCT03552029|450576969|FG000|Overall Study|Adverse Event|1|||
125258853|NCT03552029|450576970|FG001|Overall Study|Adverse Event|0|||
125258854|NCT03552029|450576969|FG000|Overall Study|Lack of Efficacy|0|||
125258855|NCT03552029|450576970|FG001|Overall Study|Lack of Efficacy|2|||
125258856|NCT03552029|450576969|FG000|Overall Study|Physician Decision|0|||
125258857|NCT03552029|450576970|FG001|Overall Study|Physician Decision|1|||
125258858|NCT03552029|450576969|FG000|Overall Study|Study terminated by Sponsor|0|||
125258859|NCT03552029|450576970|FG001|Overall Study|Study terminated by Sponsor|1|||
125258860|NCT03552029|450576969|FG000|Overall Study|Other|0|||
125258861|NCT03552029|450576970|FG001|Overall Study|Other|2|||
125258862|NCT03468998|450576973|FG000|Overall Study|Withdrawal by Subject|1|||
125258863|NCT03468998|450576974|FG001|Overall Study|Withdrawal by Subject|1|||
125258864|NCT03468998|450576975|FG002|Overall Study|Withdrawal by Subject|0|||
125258865|NCT03468998|450576976|FG003|Overall Study|Withdrawal by Subject|4|||
125258866|NCT03468998|450576977|FG004|Overall Study|Withdrawal by Subject|1|||
125258867|NCT03468998|450576978|FG005|Overall Study|Withdrawal by Subject|0|||
125258868|NCT00633126|450576983|FG000|Overall Study|Did not receive full dose|1|||
125258869|NCT02297516|450576988|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
125258870|NCT02297516|450576989|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
125258871|NCT02297516|450576988|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
125258872|NCT02297516|450576989|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
125258873|NCT02297516|450576988|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
125258874|NCT02297516|450576989|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
125258875|NCT02332928|450576991|FG000|Overall Study|Withdrawal by Subject|0|||
125258876|NCT02332928|450576992|FG001|Overall Study|Withdrawal by Subject|2|||
125258877|NCT02332928|450576991|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
125258878|NCT02332928|450576992|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
125258879|NCT01425814|450576993|FG000|Period 1|Stability criteria not fulfilled|0|||
125258880|NCT01425814|450576994|FG001|Period 1|Stability criteria not fulfilled|1|||
125258881|NCT01425814|450576995|FG002|Period 1|Stability criteria not fulfilled|0|||
125258882|NCT01425814|450576996|FG003|Period 1|Stability criteria not fulfilled|0|||
125258883|NCT01425814|450576997|FG004|Period 1|Stability criteria not fulfilled|0|||
125258884|NCT01425814|450576998|FG005|Period 1|Stability criteria not fulfilled|0|||
125258885|NCT01425814|450576993|FG000|Period 2|Stability criteria not fulfilled|0|||
125258886|NCT01425814|450576994|FG001|Period 2|Stability criteria not fulfilled|1|||
125258887|NCT01425814|450576995|FG002|Period 2|Stability criteria not fulfilled|0|||
125258888|NCT01425814|450576996|FG003|Period 2|Stability criteria not fulfilled|0|||
125258889|NCT01425814|450576997|FG004|Period 2|Stability criteria not fulfilled|0|||
125258890|NCT01425814|450576998|FG005|Period 2|Stability criteria not fulfilled|0|||
125258891|NCT01425814|450576993|FG000|Period 3|Adverse Event|0|||
125258892|NCT01425814|450576994|FG001|Period 3|Adverse Event|0|||
125258893|NCT01425814|450576995|FG002|Period 3|Adverse Event|0|||
125258894|NCT01425814|450576996|FG003|Period 3|Adverse Event|0|||
125258895|NCT01425814|450576997|FG004|Period 3|Adverse Event|0|||
125258896|NCT01425814|450576998|FG005|Period 3|Adverse Event|1|||
125258897|NCT01425814|450576993|FG000|Period 4|Adverse Event|1|||
125258898|NCT01425814|450576994|FG001|Period 4|Adverse Event|0|||
125258899|NCT01425814|450576995|FG002|Period 4|Adverse Event|1|||
125258900|NCT01425814|450576996|FG003|Period 4|Adverse Event|0|||
125258901|NCT01425814|450576997|FG004|Period 4|Adverse Event|0|||
125258902|NCT01425814|450576998|FG005|Period 4|Adverse Event|0|||
125258903|NCT01425814|450576993|FG000|Period 5|Stability criteria not fulfilled|0|||
125258904|NCT01425814|450576994|FG001|Period 5|Stability criteria not fulfilled|0|||
125258905|NCT01425814|450576995|FG002|Period 5|Stability criteria not fulfilled|1|||
125258906|NCT01425814|450576996|FG003|Period 5|Stability criteria not fulfilled|0|||
125258907|NCT01425814|450576997|FG004|Period 5|Stability criteria not fulfilled|0|||
125258908|NCT01425814|450576998|FG005|Period 5|Stability criteria not fulfilled|1|||
125258909|NCT00573768|450577003|FG000|Overall Study|Adverse Event|1|||
125258910|NCT00573768|450577004|FG001|Overall Study|Adverse Event|1|||
125258911|NCT00573768|450577005|FG002|Overall Study|Adverse Event|2|||
125258912|NCT00573768|450577003|FG000|Overall Study|Protocol Violation|1|||
125258913|NCT00573768|450577004|FG001|Overall Study|Protocol Violation|0|||
125258914|NCT00573768|450577005|FG002|Overall Study|Protocol Violation|1|||
125258915|NCT00573768|450577003|FG000|Overall Study|Withdrawal by Subject|0|||
125258916|NCT00573768|450577004|FG001|Overall Study|Withdrawal by Subject|1|||
125258917|NCT00573768|450577005|FG002|Overall Study|Withdrawal by Subject|0|||
125258918|NCT00573768|450577003|FG000|Overall Study|Lost to Follow-up|0|||
125258919|NCT00573768|450577004|FG001|Overall Study|Lost to Follow-up|0|||
125258920|NCT00573768|450577005|FG002|Overall Study|Lost to Follow-up|1|||
125258921|NCT03243084|450577006|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
125258922|NCT03243084|450577007|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
125258923|NCT02090764|450577010|FG000|Overall Study|Adverse Event|1|||
125258924|NCT02090764|450577011|FG001|Overall Study|Adverse Event|3|||
125258925|NCT02090764|450577010|FG000|Overall Study|Lack of Efficacy|0|||
125258926|NCT02090764|450577011|FG001|Overall Study|Lack of Efficacy|13|||
125258927|NCT02090764|450577010|FG000|Overall Study|Withdrawal by Subject|2|||
125258928|NCT02090764|450577011|FG001|Overall Study|Withdrawal by Subject|1|||
125258929|NCT02090764|450577010|FG000|Overall Study|Intercurrent illness and other|1|||
125258930|NCT02090764|450577011|FG001|Overall Study|Intercurrent illness and other|1|||
125258931|NCT02090764|450577010|FG000|Overall Study|Lost to Follow-up|2|||
125258932|NCT02090764|450577011|FG001|Overall Study|Lost to Follow-up|2|||
125258933|NCT02300233|450577013|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
125258934|NCT02300233|450577014|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
125258935|NCT02300233|450577015|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
125258936|NCT02300233|450577013|FG000|Overall Study|Withdrawal by Subject|1|||
125258937|NCT02300233|450577014|FG001|Overall Study|Withdrawal by Subject|0|||
125258938|NCT02300233|450577015|FG002|Overall Study|Withdrawal by Subject|3|||
125258939|NCT02300233|450577013|FG000|Overall Study|Investigator Judgement|0|||
125258940|NCT02300233|450577014|FG001|Overall Study|Investigator Judgement|0|||
125258941|NCT02300233|450577015|FG002|Overall Study|Investigator Judgement|1|||
125258942|NCT02300233|450577013|FG000|Overall Study|Reason Not Specified|0|||
125258943|NCT02300233|450577014|FG001|Overall Study|Reason Not Specified|0|||
125258944|NCT02300233|450577015|FG002|Overall Study|Reason Not Specified|5|||
125258945|NCT00833690|450577016|FG000|Overall Study|Withdrawal by Subject|1|||
125258946|NCT00833690|450577017|FG001|Overall Study|Withdrawal by Subject|0|||
125258947|NCT00833690|450577018|FG002|Overall Study|Withdrawal by Subject|0|||
125258948|NCT00833690|450577016|FG000|Overall Study|Discontinued study drug|3|||
125258949|NCT00833690|450577017|FG001|Overall Study|Discontinued study drug|2|||
125258950|NCT00833690|450577018|FG002|Overall Study|Discontinued study drug|0|||
125258951|NCT04752566|450577019|FG000|Overall Study|Protocol Violation|0|||
125258952|NCT04752566|450577020|FG001|Overall Study|Protocol Violation|1|||
125258953|NCT04752566|450577019|FG000|Overall Study|Death|1|||
125258954|NCT04752566|450577020|FG001|Overall Study|Death|0|||
125258955|NCT04752566|450577019|FG000|Overall Study|Adverse Event|1|||
125258956|NCT04752566|450577020|FG001|Overall Study|Adverse Event|0|||
125258957|NCT04752566|450577019|FG000|Overall Study|Withdrawal by Subject|2|||
125258958|NCT04752566|450577020|FG001|Overall Study|Withdrawal by Subject|0|||
125258959|NCT04752566|450577019|FG000|Overall Study|Physician Decision|1|||
125258960|NCT04752566|450577020|FG001|Overall Study|Physician Decision|1|||
125258961|NCT02661815|450577021|FG000|Overall Study|Withdrawal by Subject|1|||
125258962|NCT02661815|450577022|FG001|Overall Study|Withdrawal by Subject|0|||
125258963|NCT02661815|450577023|FG002|Overall Study|Withdrawal by Subject|0|||
125258964|NCT02661815|450577024|FG003|Overall Study|Withdrawal by Subject|0|||
125258965|NCT01153516|450577025|FG000|Overall Study|Both subjects refused surgery|2|||
125258966|NCT01153516|450577026|FG001|Overall Study|Both subjects refused surgery|0|||
125258967|NCT00654355|450577032|FG000|Overall Study|Lost to Follow-up|2|||
125258968|NCT00654355|450577033|FG001|Overall Study|Lost to Follow-up|2|||
125258969|NCT01728246|450577034|FG000|Overall Study|Participant needed rescue medication|1|||
125258970|NCT01728246|450577035|FG001|Overall Study|Participant needed rescue medication|5|||
125258971|NCT01728246|450577034|FG000|Overall Study|Protocol Violation|1|||
125258972|NCT01728246|450577035|FG001|Overall Study|Protocol Violation|0|||
125258973|NCT01728246|450577034|FG000|Overall Study|Withdrawal by Subject|2|||
125258974|NCT01728246|450577035|FG001|Overall Study|Withdrawal by Subject|3|||
125258975|NCT01728246|450577034|FG000|Overall Study|Lost to Follow-up|23|||
125258976|NCT01728246|450577035|FG001|Overall Study|Lost to Follow-up|22|||
125258977|NCT01728246|450577034|FG000|Overall Study|Lack of Efficacy|1|||
125258978|NCT01728246|450577035|FG001|Overall Study|Lack of Efficacy|1|||
125258979|NCT01728246|450577034|FG000|Overall Study|Adverse Event|8|||
125258980|NCT01728246|450577035|FG001|Overall Study|Adverse Event|5|||
125258981|NCT01983111|450577036|FG000|Overall Study|Withdrawal by Subject|8|||
125258982|NCT01983111|450577037|FG001|Overall Study|Withdrawal by Subject|6|||
125258983|NCT01983111|450577036|FG000|Overall Study|Adverse Event|4|||
125258984|NCT01983111|450577037|FG001|Overall Study|Adverse Event|0|||
125258985|NCT01983111|450577036|FG000|Overall Study|Protocol Violation|0|||
125258986|NCT01983111|450577037|FG001|Overall Study|Protocol Violation|1|||
125258987|NCT03502200|450577038|FG000|Overall Study|Adverse Event|1|||
125258988|NCT03502200|450577039|FG001|Overall Study|Adverse Event|0|||
125258989|NCT03502200|450577038|FG000|Overall Study|Lost to Follow-up|36|||
125258990|NCT03502200|450577039|FG001|Overall Study|Lost to Follow-up|38|||
125258991|NCT03502200|450577038|FG000|Overall Study|Study Team Decision|1|||
125258992|NCT03502200|450577039|FG001|Overall Study|Study Team Decision|1|||
125258993|NCT03502200|450577038|FG000|Overall Study|Withdrawal by Subject|5|||
125258994|NCT03502200|450577039|FG001|Overall Study|Withdrawal by Subject|7|||
125258995|NCT03502200|450577038|FG000|Overall Study|Death|0|||
125258996|NCT03502200|450577039|FG001|Overall Study|Death|2|||
125258997|NCT00855335|450577040|FG000|Overall Study|Lost to Follow-up|0|||
125258998|NCT00855335|450577041|FG001|Overall Study|Lost to Follow-up|0|||
125258999|NCT00855335|450577042|FG002|Overall Study|Lost to Follow-up|3|||
125259000|NCT00855335|450577043|FG003|Overall Study|Lost to Follow-up|1|||
125259001|NCT00855335|450577044|FG004|Overall Study|Lost to Follow-up|0|||
125259002|NCT00855335|450577040|FG000|Overall Study|Withdrawal by Subject|0|||
125259003|NCT00855335|450577041|FG001|Overall Study|Withdrawal by Subject|0|||
125259004|NCT00855335|450577042|FG002|Overall Study|Withdrawal by Subject|0|||
125259005|NCT00855335|450577043|FG003|Overall Study|Withdrawal by Subject|1|||
125259006|NCT00855335|450577044|FG004|Overall Study|Withdrawal by Subject|0|||
125259007|NCT00855335|450577040|FG000|Overall Study|Adverse Event|2|||
125259008|NCT00855335|450577041|FG001|Overall Study|Adverse Event|0|||
125259009|NCT00855335|450577042|FG002|Overall Study|Adverse Event|0|||
125259010|NCT00855335|450577043|FG003|Overall Study|Adverse Event|0|||
125259011|NCT00855335|450577044|FG004|Overall Study|Adverse Event|0|||
125259012|NCT00855335|450577040|FG000|Overall Study|Physician Decision|1|||
125259013|NCT00855335|450577041|FG001|Overall Study|Physician Decision|1|||
125259014|NCT00855335|450577042|FG002|Overall Study|Physician Decision|0|||
125259015|NCT00855335|450577043|FG003|Overall Study|Physician Decision|0|||
125259016|NCT00855335|450577044|FG004|Overall Study|Physician Decision|0|||
125259017|NCT00855335|450577040|FG000|Overall Study|Other|2|||
125259018|NCT00855335|450577041|FG001|Overall Study|Other|1|||
125259019|NCT00855335|450577042|FG002|Overall Study|Other|2|||
125259020|NCT00855335|450577043|FG003|Overall Study|Other|5|||
125259021|NCT00855335|450577044|FG004|Overall Study|Other|1|||
125259022|NCT04380142|450577050|FG000|LD/CD Stabilization Period|Adverse Event|3|||
125259023|NCT04380142|450577051|FG001|LD/CD Stabilization Period|Adverse Event|0|||
125259024|NCT04380142|450577052|FG002|LD/CD Stabilization Period|Adverse Event|0|||
125259025|NCT04380142|450577050|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
125259026|NCT04380142|450577051|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
125259027|NCT04380142|450577052|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
125259028|NCT04380142|450577050|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
125259029|NCT04380142|450577051|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
125259030|NCT04380142|450577052|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
125259031|NCT04380142|450577050|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
125259032|NCT04380142|450577051|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
125259033|NCT04380142|450577052|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
125259034|NCT04380142|450577050|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
125259035|NCT04380142|450577051|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
125259036|NCT04380142|450577052|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
125259037|NCT04380142|450577050|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
125259038|NCT04380142|450577051|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
125259039|NCT04380142|450577052|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
125259040|NCT04380142|450577050|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125259041|NCT04380142|450577051|FG001|Double-Blind Treatment Period|Adverse Event|1|||
125259042|NCT04380142|450577052|FG002|Double-Blind Treatment Period|Adverse Event|14|||
125259043|NCT04380142|450577050|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
125259044|NCT04380142|450577051|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
125259045|NCT04380142|450577052|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
125259046|NCT04380142|450577050|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
125259047|NCT04380142|450577051|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
125259048|NCT04380142|450577052|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
125259049|NCT04380142|450577050|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
125259050|NCT04380142|450577051|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
125259051|NCT04380142|450577052|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
125259052|NCT04380142|450577050|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
125259053|NCT04380142|450577051|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
125259054|NCT04380142|450577052|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
125259055|NCT04380142|450577050|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
125259056|NCT04380142|450577051|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
125259057|NCT04380142|450577052|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
125259058|NCT04716894|450577057|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
125259059|NCT04716894|450577057|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
125259060|NCT03773484|450577058|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
125259061|NCT01889251|450577059|FG000|Overall Study|Adverse Event|1|||
125259062|NCT01889251|450577060|FG001|Overall Study|Adverse Event|0|||
125259063|NCT01344226|450577068|FG000|Overall Study|Protocol Violation|2|||
125259064|NCT01344226|450577068|FG000|Overall Study|Withdrawal by Subject|3|||
125259065|NCT01344226|450577068|FG000|Overall Study|Lack of Efficacy|3|||
125259066|NCT03211416|450577070|FG000|Overall Study|Adverse Event|7|||
125259067|NCT03211416|450577070|FG000|Overall Study|Lack of Efficacy|2|||
125259068|NCT03211416|450577070|FG000|Overall Study|Physician Decision|1|||
125259069|NCT02302222|450577071|FG000|Overall Study|Physician Decision|0|||
125259070|NCT02302222|450577072|FG001|Overall Study|Physician Decision|4|||
125259071|NCT02302222|450577071|FG000|Overall Study|Lost to Follow-up|1|||
125259072|NCT02302222|450577072|FG001|Overall Study|Lost to Follow-up|0|||
125259073|NCT02302222|450577071|FG000|Overall Study|Treatment discontinued before day 5|0|||
125259074|NCT02302222|450577072|FG001|Overall Study|Treatment discontinued before day 5|1|||
125259075|NCT02302222|450577071|FG000|Overall Study|Withdrawn prior to any treatment|0|||
125259076|NCT02302222|450577072|FG001|Overall Study|Withdrawn prior to any treatment|1|||
125259077|NCT03781570|450577078|FG000|Overall Study|Technical Issues (equipment failure)|31|||
125259078|NCT03781570|450577078|FG000|Overall Study|Withdrawal by Subject|7|||
125259079|NCT03781570|450577078|FG000|Overall Study|Physical Constraints|11|||
125259080|NCT01107496|450577079|FG000|Overall Study|Adverse Event|1|||
125259081|NCT01107496|450577080|FG001|Overall Study|Adverse Event|0|||
125259082|NCT01107496|450577079|FG000|Overall Study|Lack of Efficacy|1|||
125259083|NCT01107496|450577080|FG001|Overall Study|Lack of Efficacy|0|||
125259084|NCT01107496|450577079|FG000|Overall Study|Protocol Violation|0|||
125259085|NCT01107496|450577080|FG001|Overall Study|Protocol Violation|1|||
125259086|NCT01107496|450577079|FG000|Overall Study|Lost to Follow-up|0|||
125259087|NCT01107496|450577080|FG001|Overall Study|Lost to Follow-up|1|||
125259088|NCT03709472|450577081|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
125259089|NCT03709472|450577082|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
125259090|NCT03709472|450577081|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
125259091|NCT03709472|450577082|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
125259092|NCT02496000|450577085|FG000|Overall Study|Withdrawal by Subject|1|||
125259093|NCT02496000|450577086|FG001|Overall Study|Withdrawal by Subject|2|||
125259094|NCT02496000|450577087|FG002|Overall Study|Withdrawal by Subject|0|||
125259095|NCT02496000|450577085|FG000|Overall Study|Lost to Follow-up|1|||
125259096|NCT02496000|450577086|FG001|Overall Study|Lost to Follow-up|0|||
125259097|NCT02496000|450577087|FG002|Overall Study|Lost to Follow-up|1|||
125259098|NCT02496000|450577085|FG000|Overall Study|Protocol Violation|0|||
125259099|NCT02496000|450577086|FG001|Overall Study|Protocol Violation|0|||
125259100|NCT02496000|450577087|FG002|Overall Study|Protocol Violation|1|||
125259101|NCT02496000|450577085|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
125259102|NCT02496000|450577086|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
125259103|NCT02496000|450577087|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
125259104|NCT02496000|450577085|FG000|Overall Study|undetermined|0|||
125259105|NCT02496000|450577086|FG001|Overall Study|undetermined|1|||
125259106|NCT02496000|450577087|FG002|Overall Study|undetermined|0|||
125259107|NCT02255656|450577088|FG000|Overall Study|Adverse Event|11|||
125259108|NCT02255656|450577088|FG000|Overall Study|Poor compliance to protocol|3|||
125259109|NCT02255656|450577088|FG000|Overall Study|Lost to Follow-up|30|||
125259110|NCT02255656|450577088|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
125259111|NCT02255656|450577088|FG000|Overall Study|Other|126|||
125259112|NCT01877278|450577089|FG000|Overall Study|Lost to Follow-up|3|||
125259113|NCT01877278|450577090|FG001|Overall Study|Lost to Follow-up|3|||
125259114|NCT01969058|450577091|FG000|Overall Study|Withdrawal by Subject|2|||
125259115|NCT01969058|450577092|FG001|Overall Study|Withdrawal by Subject|0|||
125259116|NCT01969058|450577091|FG000|Overall Study|Adverse Event|1|||
125259117|NCT01969058|450577092|FG001|Overall Study|Adverse Event|0|||
125259118|NCT04976855|450577093|FG000|Part I|Withdrawal by Subject|0|||
125259119|NCT04976855|450577094|FG001|Part I|Withdrawal by Subject|1|||
125259120|NCT04976855|450577095|FG002|Part I|Withdrawal by Subject|0|||
125259121|NCT04976855|450577096|FG003|Part I|Withdrawal by Subject|0|||
125259122|NCT04976855|450577097|FG004|Part I|Withdrawal by Subject|0|||
125259123|NCT04976855|450577098|FG005|Part I|Withdrawal by Subject|0|||
125259124|NCT04976855|450577099|FG006|Part I|Withdrawal by Subject|0|||
125259125|NCT04976855|450577093|FG000|Part II|Adverse Event|0|||
125259126|NCT04976855|450577094|FG001|Part II|Adverse Event|0|||
125259127|NCT04976855|450577095|FG002|Part II|Adverse Event|0|||
125259128|NCT04976855|450577096|FG003|Part II|Adverse Event|1|||
125259129|NCT04976855|450577097|FG004|Part II|Adverse Event|0|||
125259130|NCT04976855|450577098|FG005|Part II|Adverse Event|0|||
125259131|NCT04976855|450577099|FG006|Part II|Adverse Event|0|||
125259132|NCT04976855|450577093|FG000|Part II|Withdrawal by Subject|0|||
125259133|NCT04976855|450577094|FG001|Part II|Withdrawal by Subject|0|||
125259134|NCT04976855|450577095|FG002|Part II|Withdrawal by Subject|0|||
125259135|NCT04976855|450577096|FG003|Part II|Withdrawal by Subject|0|||
125259136|NCT04976855|450577097|FG004|Part II|Withdrawal by Subject|1|||
125259137|NCT04976855|450577098|FG005|Part II|Withdrawal by Subject|0|||
125259138|NCT04976855|450577099|FG006|Part II|Withdrawal by Subject|0|||
125259139|NCT04976855|450577093|FG000|Part II|Lost to Follow-up|0|||
125259140|NCT04976855|450577094|FG001|Part II|Lost to Follow-up|0|||
125259141|NCT04976855|450577095|FG002|Part II|Lost to Follow-up|0|||
125259142|NCT04976855|450577096|FG003|Part II|Lost to Follow-up|0|||
125259143|NCT04976855|450577097|FG004|Part II|Lost to Follow-up|0|||
125259144|NCT04976855|450577098|FG005|Part II|Lost to Follow-up|1|||
125259145|NCT04976855|450577099|FG006|Part II|Lost to Follow-up|0|||
125259146|NCT05318287|450577100|FG000|Overall Study|Lost to Follow-up|8|||
125259147|NCT05185453|450577101|FG000|Overall Study|Lost to Follow-up|13|||
125259148|NCT05185453|450577102|FG001|Overall Study|Lost to Follow-up|3|||
125259149|NCT02457793|450577109|FG000|Overall Study|Reason not specified|0|||
125259150|NCT02457793|450577110|FG001|Overall Study|Reason not specified|0|||
125259151|NCT02457793|450577111|FG002|Overall Study|Reason not specified|0|||
125259152|NCT02457793|450577112|FG003|Overall Study|Reason not specified|1|||
125259153|NCT02457793|450577113|FG004|Overall Study|Reason not specified|1|||
125259154|NCT02457793|450577114|FG005|Overall Study|Reason not specified|1|||
125259155|NCT02457793|450577109|FG000|Overall Study|Withdrawal by Subject|0|||
125259156|NCT02457793|450577110|FG001|Overall Study|Withdrawal by Subject|4|||
125259157|NCT02457793|450577111|FG002|Overall Study|Withdrawal by Subject|2|||
125259158|NCT02457793|450577112|FG003|Overall Study|Withdrawal by Subject|2|||
125259159|NCT02457793|450577113|FG004|Overall Study|Withdrawal by Subject|2|||
125259160|NCT02457793|450577114|FG005|Overall Study|Withdrawal by Subject|2|||
125259161|NCT02457793|450577109|FG000|Overall Study|Adverse Event|0|||
125259162|NCT02457793|450577110|FG001|Overall Study|Adverse Event|0|||
125259163|NCT02457793|450577111|FG002|Overall Study|Adverse Event|0|||
125259164|NCT02457793|450577112|FG003|Overall Study|Adverse Event|1|||
125259165|NCT02457793|450577113|FG004|Overall Study|Adverse Event|0|||
125259166|NCT02457793|450577114|FG005|Overall Study|Adverse Event|0|||
125259167|NCT02457793|450577109|FG000|Overall Study|Physician Decision|1|||
125259168|NCT02457793|450577110|FG001|Overall Study|Physician Decision|0|||
125259169|NCT02457793|450577111|FG002|Overall Study|Physician Decision|1|||
125259170|NCT02457793|450577112|FG003|Overall Study|Physician Decision|1|||
125259171|NCT02457793|450577113|FG004|Overall Study|Physician Decision|1|||
125259172|NCT02457793|450577114|FG005|Overall Study|Physician Decision|3|||
125259173|NCT00835172|450577121|FG000|Washout|Protocol Violation|0|||
125259174|NCT00835172|450577122|FG001|Washout|Protocol Violation|1|||
125259175|NCT04890509|450577123|FG000|Overall Study|Death|4|||
125259176|NCT04890509|450577124|FG001|Overall Study|Death|4|||
125259177|NCT03274466|450577125|FG000|Overall Study|Withdrawal by Subject|7|||
125259178|NCT03274466|450577126|FG001|Overall Study|Withdrawal by Subject|3|||
125259179|NCT03274466|450577125|FG000|Overall Study|Protocol Specified Withdrawal|5|||
125259180|NCT03274466|450577126|FG001|Overall Study|Protocol Specified Withdrawal|11|||
125259181|NCT03274466|450577125|FG000|Overall Study|Lost to Follow-up|5|||
125259182|NCT03274466|450577126|FG001|Overall Study|Lost to Follow-up|7|||
125259183|NCT03274466|450577125|FG000|Overall Study|Subject Non-compliance|0|||
125259184|NCT03274466|450577126|FG001|Overall Study|Subject Non-compliance|1|||
125259185|NCT03274466|450577125|FG000|Overall Study|Adverse Event|3|||
125259186|NCT03274466|450577126|FG001|Overall Study|Adverse Event|3|||
125259187|NCT03274466|450577125|FG000|Overall Study|Physician Decision|0|||
125259188|NCT03274466|450577126|FG001|Overall Study|Physician Decision|1|||
125259189|NCT03274466|450577125|FG000|Overall Study|Protocol Violation|3|||
125259190|NCT03274466|450577126|FG001|Overall Study|Protocol Violation|3|||
125259191|NCT00730327|450579362|FG000|Overall Study|Lost to Follow-up|14|||
125259192|NCT00730327|450579363|FG001|Overall Study|Lost to Follow-up|16|||
125259193|NCT00730327|450579362|FG000|Overall Study|Adverse Event|8|||
125259194|NCT00730327|450579363|FG001|Overall Study|Adverse Event|1|||
125259195|NCT00730327|450579362|FG000|Overall Study|Withdrawal by Subject|3|||
125259196|NCT00730327|450579363|FG001|Overall Study|Withdrawal by Subject|13|||
125259197|NCT00730327|450579362|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
125259198|NCT00730327|450579363|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
125259199|NCT02552225|450579364|FG000|Overall Study|Withdrawal by Subject|1|||
125259200|NCT02552225|450579365|FG001|Overall Study|Withdrawal by Subject|0|||
125259201|NCT02989857|450579366|FG000|Randomization Phase|Not Treated|3|||
125259202|NCT02989857|450579367|FG001|Randomization Phase|Not Treated|2|||
125259203|NCT02989857|450579368|FG002|Randomization Phase|Not Treated|0|||
125259204|NCT01168596|450579373|FG000|Overall Study|Withdrawal by Subject|3|||
125259205|NCT01168596|450579374|FG001|Overall Study|Withdrawal by Subject|1|||
125259206|NCT00876447|450579377|FG000|Overall Study|Other miscellaneous reasons|3|||
125259207|NCT00876447|450579378|FG001|Overall Study|Other miscellaneous reasons|8|||
125259208|NCT00876447|450579377|FG000|Overall Study|Site closure|19|||
125259209|NCT00876447|450579378|FG001|Overall Study|Site closure|14|||
125259210|NCT00876447|450579377|FG000|Overall Study|Protocol Violation|9|||
125259211|NCT00876447|450579378|FG001|Overall Study|Protocol Violation|3|||
125259212|NCT00876447|450579377|FG000|Overall Study|Personal reasons|30|||
125259213|NCT00876447|450579378|FG001|Overall Study|Personal reasons|28|||
125259214|NCT00876447|450579377|FG000|Overall Study|Lost to Follow-up|6|||
125259215|NCT00876447|450579378|FG001|Overall Study|Lost to Follow-up|15|||
125259216|NCT00876447|450579377|FG000|Overall Study|Pregnancy|4|||
125259217|NCT00876447|450579378|FG001|Overall Study|Pregnancy|2|||
125259218|NCT00876447|450579377|FG000|Overall Study|Lack of Efficacy|5|||
125259219|NCT00876447|450579378|FG001|Overall Study|Lack of Efficacy|3|||
125259220|NCT00876447|450579377|FG000|Overall Study|Adverse Event|4|||
125259221|NCT00876447|450579378|FG001|Overall Study|Adverse Event|8|||
125259222|NCT00366457|450579384|FG000|Overall Study|never began study therapy|2|||
125259223|NCT02538614|450579385|FG000|Overall Study|Progressive Disease|2|||
125259224|NCT00189423|450579390|FG000|Overall Study|Death|746|||
125259225|NCT00189423|450579391|FG001|Overall Study|Death|747|||
125259226|NCT00189423|450579390|FG000|Overall Study|Withdrawal by Subject|9|||
125259227|NCT00189423|450579391|FG001|Overall Study|Withdrawal by Subject|9|||
125259228|NCT00189423|450579390|FG000|Overall Study|Lost to Follow-up|10|||
125259229|NCT00189423|450579391|FG001|Overall Study|Lost to Follow-up|10|||
125259230|NCT04622592|450579394|FG000|Overall Study|Death|0|||
125259231|NCT04622592|450579395|FG001|Overall Study|Death|0|||
125259232|NCT04622592|450579396|FG002|Overall Study|Death|1|||
125259233|NCT04622592|450579397|FG003|Overall Study|Death|0|||
125259234|NCT04622592|450579398|FG004|Overall Study|Death|0|||
125259235|NCT04622592|450579399|FG005|Overall Study|Death|0|||
125259236|NCT04622592|450579400|FG006|Overall Study|Death|0|||
125259237|NCT04622592|450579401|FG007|Overall Study|Death|1|||
125259238|NCT04622592|450579394|FG000|Overall Study|Lost to Follow-up|0|||
125259239|NCT04622592|450579395|FG001|Overall Study|Lost to Follow-up|0|||
125259240|NCT04622592|450579396|FG002|Overall Study|Lost to Follow-up|0|||
125259241|NCT04622592|450579397|FG003|Overall Study|Lost to Follow-up|3|||
125259242|NCT04622592|450579398|FG004|Overall Study|Lost to Follow-up|1|||
125259243|NCT04622592|450579399|FG005|Overall Study|Lost to Follow-up|0|||
125259244|NCT04622592|450579400|FG006|Overall Study|Lost to Follow-up|2|||
125259245|NCT04622592|450579401|FG007|Overall Study|Lost to Follow-up|2|||
125259246|NCT04622592|450579394|FG000|Overall Study|Physician Decision|0|||
125259247|NCT04622592|450579395|FG001|Overall Study|Physician Decision|0|||
125259248|NCT04622592|450579396|FG002|Overall Study|Physician Decision|0|||
125259249|NCT04622592|450579397|FG003|Overall Study|Physician Decision|0|||
125259250|NCT04622592|450579398|FG004|Overall Study|Physician Decision|1|||
125259251|NCT04622592|450579399|FG005|Overall Study|Physician Decision|0|||
125259252|NCT04622592|450579400|FG006|Overall Study|Physician Decision|0|||
125259253|NCT04622592|450579401|FG007|Overall Study|Physician Decision|0|||
125259254|NCT04622592|450579394|FG000|Overall Study|Withdrawal by Subject|1|||
125259255|NCT04622592|450579395|FG001|Overall Study|Withdrawal by Subject|0|||
125259256|NCT04622592|450579396|FG002|Overall Study|Withdrawal by Subject|2|||
125259257|NCT04622592|450579397|FG003|Overall Study|Withdrawal by Subject|0|||
125259258|NCT04622592|450579398|FG004|Overall Study|Withdrawal by Subject|0|||
125259259|NCT04622592|450579399|FG005|Overall Study|Withdrawal by Subject|0|||
125259260|NCT04622592|450579400|FG006|Overall Study|Withdrawal by Subject|1|||
125259261|NCT04622592|450579401|FG007|Overall Study|Withdrawal by Subject|4|||
125259262|NCT04622592|450579394|FG000|Overall Study|Other than specified above|0|||
125259263|NCT04622592|450579395|FG001|Overall Study|Other than specified above|0|||
125259264|NCT04622592|450579396|FG002|Overall Study|Other than specified above|1|||
125259265|NCT04622592|450579397|FG003|Overall Study|Other than specified above|0|||
125259266|NCT04622592|450579398|FG004|Overall Study|Other than specified above|0|||
125259267|NCT04622592|450579399|FG005|Overall Study|Other than specified above|0|||
125259268|NCT04622592|450579400|FG006|Overall Study|Other than specified above|0|||
125259269|NCT04622592|450579401|FG007|Overall Study|Other than specified above|0|||
125259270|NCT01497197|450579402|FG000|Overall Study|Lost to Follow-up|1|||
125259271|NCT01497197|450579403|FG001|Overall Study|Lost to Follow-up|0|||
125259272|NCT01497197|450579402|FG000|Overall Study|Protocol Violation|0|||
125259273|NCT01497197|450579403|FG001|Overall Study|Protocol Violation|2|||
125259274|NCT01497197|450579402|FG000|Overall Study|Withdrawal by Subject|2|||
125259275|NCT01497197|450579403|FG001|Overall Study|Withdrawal by Subject|1|||
125259276|NCT01497197|450579402|FG000|Overall Study|Excessive/lack of response to treatment|1|||
125259277|NCT01497197|450579403|FG001|Overall Study|Excessive/lack of response to treatment|0|||
125259278|NCT01497197|450579402|FG000|Overall Study|Risk of OHSS|1|||
125259279|NCT01497197|450579403|FG001|Overall Study|Risk of OHSS|0|||
125259280|NCT01497197|450579402|FG000|Overall Study|No oocytes retrieved|3|||
125259281|NCT01497197|450579403|FG001|Overall Study|No oocytes retrieved|2|||
125259282|NCT01497197|450579402|FG000|Overall Study|No fertilisation|6|||
125259283|NCT01497197|450579403|FG001|Overall Study|No fertilisation|5|||
125259284|NCT01497197|450579402|FG000|Overall Study|Intention to freeze all embryos|0|||
125259285|NCT01497197|450579403|FG001|Overall Study|Intention to freeze all embryos|1|||
125259286|NCT01497197|450579402|FG000|Overall Study|All embryos discarded|0|||
125259287|NCT01497197|450579403|FG001|Overall Study|All embryos discarded|3|||
125259288|NCT01497197|450579402|FG000|Overall Study|Other|3|||
125259289|NCT01497197|450579403|FG001|Overall Study|Other|1|||
125259290|NCT00565747|450579409|FG000|Overall Study|No embryo transfer|67|||
125259291|NCT00565747|450579410|FG001|Overall Study|No embryo transfer|73|||
125259292|NCT00183248|450579411|FG000|Overall Study|Lost to Follow-up|0|||
125259293|NCT00183248|450579412|FG001|Overall Study|Lost to Follow-up|1|||
125259294|NCT00183248|450579411|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
125259295|NCT00183248|450579412|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
125259296|NCT03309202|450579413|FG000|Overall Study|Lost to Follow-up|1|||
125259297|NCT03309202|450579414|FG001|Overall Study|Lost to Follow-up|0|||
125259298|NCT03309202|450579415|FG002|Overall Study|Lost to Follow-up|0|||
125259299|NCT03309202|450579416|FG003|Overall Study|Lost to Follow-up|0|||
125259300|NCT00415636|450579419|FG000|Overall Study|Symptomatic deterioration|1|||
125259301|NCT00415636|450579420|FG001|Overall Study|Symptomatic deterioration|0|||
125259302|NCT00415636|450579421|FG002|Overall Study|Symptomatic deterioration|1|||
125259303|NCT00415636|450579422|FG003|Overall Study|Symptomatic deterioration|2|||
125259304|NCT00415636|450579423|FG004|Overall Study|Symptomatic deterioration|0|||
125259305|NCT00415636|450579424|FG005|Overall Study|Symptomatic deterioration|1|||
125259306|NCT00415636|450579419|FG000|Overall Study|Adverse Event|0|||
125259307|NCT00415636|450579420|FG001|Overall Study|Adverse Event|0|||
125259308|NCT00415636|450579421|FG002|Overall Study|Adverse Event|0|||
125259309|NCT00415636|450579422|FG003|Overall Study|Adverse Event|1|||
125259310|NCT00415636|450579423|FG004|Overall Study|Adverse Event|1|||
125259311|NCT00415636|450579424|FG005|Overall Study|Adverse Event|0|||
125259312|NCT00415636|450579419|FG000|Overall Study|Withdrawal by Subject|0|||
125259313|NCT00415636|450579420|FG001|Overall Study|Withdrawal by Subject|0|||
125259314|NCT00415636|450579421|FG002|Overall Study|Withdrawal by Subject|0|||
125259315|NCT00415636|450579422|FG003|Overall Study|Withdrawal by Subject|0|||
125259316|NCT00415636|450579423|FG004|Overall Study|Withdrawal by Subject|1|||
125259317|NCT00415636|450579424|FG005|Overall Study|Withdrawal by Subject|0|||
125259318|NCT00415636|450579419|FG000|Overall Study|Disease progression|0|||
125259319|NCT00415636|450579420|FG001|Overall Study|Disease progression|0|||
125259320|NCT00415636|450579421|FG002|Overall Study|Disease progression|0|||
125259321|NCT00415636|450579422|FG003|Overall Study|Disease progression|3|||
125259322|NCT00415636|450579423|FG004|Overall Study|Disease progression|0|||
125259323|NCT00415636|450579424|FG005|Overall Study|Disease progression|1|||
125259324|NCT04734210|450579425|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
125259325|NCT04734210|450579426|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
125259326|NCT04734210|450579427|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
125259327|NCT04734210|450579425|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
125259328|NCT04734210|450579426|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
125259329|NCT04734210|450579427|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
125259330|NCT04734210|450579425|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
125259331|NCT04734210|450579426|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
125259332|NCT04734210|450579427|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
125259333|NCT04734210|450579425|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
125259334|NCT04734210|450579426|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
125259335|NCT04734210|450579427|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
125259336|NCT02684461|450579428|FG000|Overall Study|Adverse Event|1|||
125259337|NCT02684461|450579429|FG001|Overall Study|Adverse Event|0|||
125259338|NCT02684461|450579430|FG002|Overall Study|Adverse Event|0|||
125259339|NCT02684461|450579428|FG000|Overall Study|Lack of Efficacy|1|||
125259340|NCT02684461|450579429|FG001|Overall Study|Lack of Efficacy|2|||
125259341|NCT02684461|450579430|FG002|Overall Study|Lack of Efficacy|0|||
125259342|NCT02138825|450579431|FG000|Main Study Treatment|Adverse Event|11|||
125259343|NCT02138825|450579432|FG001|Main Study Treatment|Adverse Event|3|||
125259344|NCT02138825|450579431|FG000|Main Study Treatment|Death|1|||
125259345|NCT02138825|450579432|FG001|Main Study Treatment|Death|2|||
125259346|NCT02138825|450579431|FG000|Main Study Treatment|Protocol Violation|2|||
125259347|NCT02138825|450579432|FG001|Main Study Treatment|Protocol Violation|2|||
125259348|NCT02138825|450579431|FG000|Main Study Treatment|Sponsor decision|12|||
125259349|NCT02138825|450579432|FG001|Main Study Treatment|Sponsor decision|18|||
125259350|NCT02138825|450579431|FG000|Main Study Treatment|Study terminated by sponsor|10|||
125259351|NCT02138825|450579432|FG001|Main Study Treatment|Study terminated by sponsor|9|||
125259352|NCT02138825|450579431|FG000|Main Study Treatment|Withdrawal by Subject|3|||
125259353|NCT02138825|450579432|FG001|Main Study Treatment|Withdrawal by Subject|1|||
125259354|NCT02138825|450579431|FG000|Main Study Treatment|Medical decision|1|||
125259355|NCT02138825|450579432|FG001|Main Study Treatment|Medical decision|0|||
125259356|NCT02138825|450579431|FG000|Long-term Extension|Study termination by sponsor|32|||
125259357|NCT02138825|450579432|FG001|Long-term Extension|Study termination by sponsor|38|||
125259358|NCT02138825|450579431|FG000|Safety Follow-up|Adverse Event|4|||
125259359|NCT02138825|450579432|FG001|Safety Follow-up|Adverse Event|3|||
125259360|NCT02138825|450579431|FG000|Safety Follow-up|Death|11|||
125259361|NCT02138825|450579432|FG001|Safety Follow-up|Death|5|||
125259362|NCT02138825|450579431|FG000|Safety Follow-up|Withdrawal by Subject|5|||
125259363|NCT02138825|450579432|FG001|Safety Follow-up|Withdrawal by Subject|3|||
125259364|NCT02138825|450579431|FG000|Safety Follow-up|clinic worsening|1|||
125259365|NCT02138825|450579432|FG001|Safety Follow-up|clinic worsening|0|||
125259366|NCT02138825|450579431|FG000|Safety Follow-up|withdrawal by PI|1|||
125259367|NCT02138825|450579432|FG001|Safety Follow-up|withdrawal by PI|0|||
125259368|NCT02138825|450579431|FG000|Safety Follow-up|logistical difficulties|0|||
125259369|NCT02138825|450579432|FG001|Safety Follow-up|logistical difficulties|1|||
125259370|NCT02138825|450579431|FG000|Safety Follow-up|progressive disease|0|||
125259371|NCT02138825|450579432|FG001|Safety Follow-up|progressive disease|2|||
125259372|NCT02138825|450579431|FG000|Safety Follow-up|too unwell to attend the visit|0|||
125259373|NCT02138825|450579432|FG001|Safety Follow-up|too unwell to attend the visit|1|||
125259374|NCT02138825|450579431|FG000|Safety Follow-up|treatment unblinded|0|||
125259375|NCT02138825|450579432|FG001|Safety Follow-up|treatment unblinded|1|||
125259376|NCT02138825|450579431|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
125259377|NCT02138825|450579432|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
125259378|NCT05201807|450579436|FG000|Overall Study|Adverse Event|1|||
125259379|NCT05201807|450579436|FG000|Overall Study|COVID-19 Related|1|||
125259380|NCT01209767|450579437|FG000|Overall Study|Withdrawal by Subject|1|||
125259381|NCT01209767|450579437|FG000|Overall Study|Lost to Follow-up|3|||
125259382|NCT01702298|450579438|FG000|Overall Study|Withdrawal by Subject|1|||
125259383|NCT01029535|450579442|FG000|Overall Study|Lost to Follow-up|24|||
125259384|NCT01029535|450579442|FG000|Overall Study|Protocol Violation|2|||
125259385|NCT01029535|450579442|FG000|Overall Study|Participant Withdrew Consent|2|||
125259386|NCT01029535|450579442|FG000|Overall Study|Adverse Event|1|||
125259387|NCT01029535|450579442|FG000|Overall Study|Use of Another Treatment|1|||
125259388|NCT01029535|450579442|FG000|Overall Study|Death|1|||
125259389|NCT00904371|450579447|FG000|Overall Study|Adverse Event|2|||
125259390|NCT00904371|450579447|FG000|Overall Study|Lost to Follow-up|4|||
125259391|NCT00904371|450579447|FG000|Overall Study|Discontinued at target blood pressure|2|||
125259392|NCT00904371|450579447|FG000|Overall Study|Continued with Tritace|1|||
125259393|NCT00583219|450579448|FG000|Phase 2|Withdrawal by Subject|1|||
125259394|NCT05448950|450579449|FG000|Overall Study|Death|2|||
125259395|NCT05448950|450579449|FG000|Overall Study|Withdrawal by Subject|1|||
125259396|NCT05448950|450579449|FG000|Overall Study|AVG abandoned|4|||
125259397|NCT02836249|450579450|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
125259398|NCT02836249|450579451|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
125259399|NCT02836249|450579452|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
125259400|NCT02836249|450579453|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
125259401|NCT02836249|450579450|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
125259402|NCT02836249|450579451|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
125259403|NCT02836249|450579452|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
125259404|NCT02836249|450579453|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
125259405|NCT02836249|450579450|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
125259406|NCT02836249|450579451|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
125259407|NCT02836249|450579452|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
125259408|NCT02836249|450579453|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
125259409|NCT02836249|450579450|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125259410|NCT02836249|450579451|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
125259411|NCT02836249|450579452|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125259412|NCT02836249|450579453|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125259413|NCT02836249|450579450|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
125259414|NCT02836249|450579451|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
125259415|NCT02836249|450579452|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
125259416|NCT02836249|450579453|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
125259417|NCT02836249|450579450|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
125259418|NCT02836249|450579451|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
125259419|NCT02836249|450579452|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
125259420|NCT02836249|450579453|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
125259421|NCT02836249|450579450|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
125259422|NCT02836249|450579451|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
125259423|NCT02836249|450579452|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
125259424|NCT02836249|450579453|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
125259425|NCT02836249|450579450|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
125259426|NCT02836249|450579451|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
125259427|NCT02836249|450579452|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
125259428|NCT02836249|450579453|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
125259429|NCT02836249|450579450|FG000|Open-Label TAF Treatment Phase|Death|0|||
125259430|NCT02836249|450579451|FG001|Open-Label TAF Treatment Phase|Death|0|||
125259431|NCT02836249|450579452|FG002|Open-Label TAF Treatment Phase|Death|1|||
125259432|NCT02836249|450579453|FG003|Open-Label TAF Treatment Phase|Death|0|||
125259433|NCT02836249|450579450|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
125259434|NCT02836249|450579451|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
125259435|NCT02836249|450579452|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
125259436|NCT02836249|450579453|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
125259437|NCT02836249|450579450|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
125259438|NCT02836249|450579451|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
125259439|NCT02836249|450579452|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
125259440|NCT02836249|450579453|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
125259441|NCT02706392|450579455|FG000|Overall Study|Death|1|||
125259442|NCT02706392|450579456|FG001|Overall Study|Death|0|||
125259443|NCT02706392|450579457|FG002|Overall Study|Death|2|||
125259444|NCT02706392|450579458|FG003|Overall Study|Death|2|||
125259445|NCT02706392|450579459|FG004|Overall Study|Death|5|||
125259446|NCT02706392|450579460|FG005|Overall Study|Death|2|||
125259447|NCT00619866|450579463|FG000|Weeks 1 - 12|Adverse Event|0|||
125259448|NCT00619866|450579464|FG001|Weeks 1 - 12|Adverse Event|1|||
125259449|NCT00619866|450579465|FG002|Weeks 1 - 12|Adverse Event|2|||
125259450|NCT00619866|450579466|FG003|Weeks 1 - 12|Adverse Event|0|||
125259451|NCT00619866|450579467|FG004|Weeks 1 - 12|Adverse Event|0|||
125259452|NCT00619866|450579463|FG000|Weeks 1 - 12|Non-compliance|0|||
125259453|NCT00619866|450579464|FG001|Weeks 1 - 12|Non-compliance|0|||
125259454|NCT00619866|450579465|FG002|Weeks 1 - 12|Non-compliance|1|||
125259455|NCT00619866|450579466|FG003|Weeks 1 - 12|Non-compliance|0|||
125259456|NCT00619866|450579467|FG004|Weeks 1 - 12|Non-compliance|0|||
125259457|NCT00619866|450579463|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
125259458|NCT00619866|450579464|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
125259459|NCT00619866|450579465|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
125259460|NCT00619866|450579466|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
125259461|NCT00619866|450579467|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
125259462|NCT00619866|450579463|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
125259463|NCT00619866|450579464|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
125259464|NCT00619866|450579465|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
125259465|NCT00619866|450579466|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
125259466|NCT00619866|450579467|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
125259467|NCT00619866|450579463|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
125259468|NCT00619866|450579464|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
125259469|NCT00619866|450579465|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
125259470|NCT00619866|450579466|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
125259471|NCT00619866|450579467|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
125259472|NCT00619866|450579463|FG000|Weeks 1 - 12|Sponsor Decision|0|||
125259473|NCT00619866|450579464|FG001|Weeks 1 - 12|Sponsor Decision|1|||
125259474|NCT00619866|450579465|FG002|Weeks 1 - 12|Sponsor Decision|0|||
125259475|NCT00619866|450579466|FG003|Weeks 1 - 12|Sponsor Decision|0|||
125259476|NCT00619866|450579467|FG004|Weeks 1 - 12|Sponsor Decision|0|||
125259477|NCT00619866|450579463|FG000|Weeks 13 - 24|Adverse Event|0|||
125259478|NCT00619866|450579464|FG001|Weeks 13 - 24|Adverse Event|0|||
125259479|NCT00619866|450579465|FG002|Weeks 13 - 24|Adverse Event|2|||
125259480|NCT00619866|450579466|FG003|Weeks 13 - 24|Adverse Event|1|||
125259481|NCT00619866|450579467|FG004|Weeks 13 - 24|Adverse Event|0|||
125259482|NCT00619866|450579463|FG000|Weeks 13 - 24|Protocol Deviation|0|||
125259483|NCT00619866|450579464|FG001|Weeks 13 - 24|Protocol Deviation|0|||
125259484|NCT00619866|450579465|FG002|Weeks 13 - 24|Protocol Deviation|0|||
125259485|NCT00619866|450579466|FG003|Weeks 13 - 24|Protocol Deviation|1|||
125259486|NCT00619866|450579467|FG004|Weeks 13 - 24|Protocol Deviation|0|||
125259487|NCT00619866|450579463|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
125259488|NCT00619866|450579464|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
125259489|NCT00619866|450579465|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
125259490|NCT00619866|450579466|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
125259491|NCT00619866|450579467|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
125259492|NCT00619866|450579463|FG000|Weeks 13 - 24|Non-compliance|0|||
125259493|NCT00619866|450579464|FG001|Weeks 13 - 24|Non-compliance|1|||
125259494|NCT00619866|450579465|FG002|Weeks 13 - 24|Non-compliance|1|||
125259495|NCT00619866|450579466|FG003|Weeks 13 - 24|Non-compliance|0|||
125259496|NCT00619866|450579467|FG004|Weeks 13 - 24|Non-compliance|0|||
125259497|NCT00619866|450579463|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
125259498|NCT00619866|450579464|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
125259499|NCT00619866|450579465|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
125259500|NCT00619866|450579466|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
125259501|NCT00619866|450579467|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
125259502|NCT01968980|450579471|FG000|Overall Study|Death|0|||
125259503|NCT01968980|450579472|FG001|Overall Study|Death|1|||
125259504|NCT01968980|450579471|FG000|Overall Study|Adverse Event|1|||
125259505|NCT01968980|450579472|FG001|Overall Study|Adverse Event|3|||
125259506|NCT01968980|450579471|FG000|Overall Study|Does not meet entry criteria|1|||
125259507|NCT01968980|450579472|FG001|Overall Study|Does not meet entry criteria|3|||
125259508|NCT01968980|450579471|FG000|Overall Study|Withdrawal by Subject|13|||
125259509|NCT01968980|450579472|FG001|Overall Study|Withdrawal by Subject|5|||
125259510|NCT01968980|450579471|FG000|Overall Study|Other unspecified|1|||
125259511|NCT01968980|450579472|FG001|Overall Study|Other unspecified|2|||
125259512|NCT02589938|450579476|FG000|Overall Study|Withdrawal by Subject|11|||
125259513|NCT02589938|450579477|FG001|Overall Study|Withdrawal by Subject|5|||
125259514|NCT02589938|450579478|FG002|Overall Study|Withdrawal by Subject|6|||
125259515|NCT02589938|450579476|FG000|Overall Study|Lost to Follow-up|3|||
125259516|NCT02589938|450579477|FG001|Overall Study|Lost to Follow-up|3|||
125259517|NCT02589938|450579478|FG002|Overall Study|Lost to Follow-up|3|||
125259518|NCT02589938|450579476|FG000|Overall Study|Death|1|||
125259519|NCT02589938|450579477|FG001|Overall Study|Death|0|||
125259520|NCT02589938|450579478|FG002|Overall Study|Death|1|||
125259521|NCT02589938|450579476|FG000|Overall Study|Protocol Violation|6|||
125259522|NCT02589938|450579477|FG001|Overall Study|Protocol Violation|2|||
125259523|NCT02589938|450579478|FG002|Overall Study|Protocol Violation|3|||
125259524|NCT02589938|450579476|FG000|Overall Study|Physician Decision|1|||
125259525|NCT02589938|450579477|FG001|Overall Study|Physician Decision|0|||
125259526|NCT02589938|450579478|FG002|Overall Study|Physician Decision|0|||
125259527|NCT02589938|450579476|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
125259528|NCT02589938|450579477|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
125259529|NCT02589938|450579478|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
125259530|NCT02521285|450579479|FG000|Overall Study|Lost to Follow-up|1|||
125259531|NCT02521285|450579480|FG001|Overall Study|Lost to Follow-up|1|||
125259532|NCT02521285|450579479|FG000|Overall Study|Withdrawal by Subject|1|||
125259533|NCT02521285|450579480|FG001|Overall Study|Withdrawal by Subject|1|||
125259534|NCT02521285|450579479|FG000|Overall Study|Adverse Event|0|||
125259535|NCT02521285|450579480|FG001|Overall Study|Adverse Event|1|||
125259536|NCT00787150|450579481|FG000|Overall Study|Adverse Event|4|||
125259537|NCT00787150|450579482|FG001|Overall Study|Adverse Event|4|||
125259538|NCT00787150|450579483|FG002|Overall Study|Adverse Event|4|||
125259539|NCT00787150|450579481|FG000|Overall Study|Physician Decision|1|||
125259540|NCT00787150|450579482|FG001|Overall Study|Physician Decision|2|||
125259541|NCT00787150|450579483|FG002|Overall Study|Physician Decision|1|||
125259542|NCT00787150|450579481|FG000|Overall Study|Withdrawal by Subject|2|||
125259543|NCT00787150|450579482|FG001|Overall Study|Withdrawal by Subject|1|||
125259544|NCT00787150|450579483|FG002|Overall Study|Withdrawal by Subject|0|||
125259545|NCT00787150|450579481|FG000|Overall Study|Dosing incorrect study durg|2|||
125259546|NCT00787150|450579482|FG001|Overall Study|Dosing incorrect study durg|0|||
125259547|NCT00787150|450579483|FG002|Overall Study|Dosing incorrect study durg|0|||
125259548|NCT01849276|450579490|FG000|Followed for Survival for 5 Years|Death|1|||
125259549|NCT01849276|450579490|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
125259550|NCT00879398|450579493|FG000|Overall Study|Visit Stop|399|||
125259551|NCT00879398|450579493|FG000|Overall Study|Lack of Efficacy|64|||
125259552|NCT00879398|450579493|FG000|Overall Study|Adverse Event|41|||
125259553|NCT00879398|450579493|FG000|Overall Study|Other Reasons|171|||
125259554|NCT01722669|450579496|FG000|Overall Study|Withdrawal by Subject|0|||
125259555|NCT01722669|450579497|FG001|Overall Study|Withdrawal by Subject|0|||
125259556|NCT01722669|450579498|FG002|Overall Study|Withdrawal by Subject|0|||
125259557|NCT01722669|450579499|FG003|Overall Study|Withdrawal by Subject|0|||
125259558|NCT01722669|450579500|FG004|Overall Study|Withdrawal by Subject|0|||
125259559|NCT01722669|450579501|FG005|Overall Study|Withdrawal by Subject|2|||
125259560|NCT03559556|450579503|FG000|Overall Study|Withdrawal by Subject|1|||
125259561|NCT03012880|450579510|FG000|Overall Study|Withdrawal by Subject|1|||
125259562|NCT03012880|450579511|FG001|Overall Study|Withdrawal by Subject|0|||
125259563|NCT03012880|450579510|FG000|Overall Study|Ineligible|1|||
125259564|NCT03012880|450579511|FG001|Overall Study|Ineligible|0|||
125259565|NCT01587196|450579512|FG000|Overall Study|Lost to Follow-up|50|||
125259566|NCT01587196|450579512|FG000|Overall Study|Withdrawal by Subject|4|||
125259567|NCT02769481|450579513|FG000|Overall Study|Protocol Violation|1|||
125259568|NCT02769481|450579514|FG001|Overall Study|Protocol Violation|0|||
125259569|NCT02769481|450579513|FG000|Overall Study|Adverse Event|3|||
125259570|NCT02769481|450579514|FG001|Overall Study|Adverse Event|6|||
125259571|NCT02769481|450579513|FG000|Overall Study|Entry Criteria Not Met|1|||
125259572|NCT02769481|450579514|FG001|Overall Study|Entry Criteria Not Met|2|||
125259573|NCT02769481|450579513|FG000|Overall Study|Withdrawal by Subject|14|||
125259574|NCT02769481|450579514|FG001|Overall Study|Withdrawal by Subject|16|||
125259575|NCT02769481|450579513|FG000|Overall Study|Lost to Follow-up|9|||
125259576|NCT02769481|450579514|FG001|Overall Study|Lost to Follow-up|9|||
125259577|NCT02769481|450579513|FG000|Overall Study|Physician Decision|0|||
125259578|NCT02769481|450579514|FG001|Overall Study|Physician Decision|1|||
125259579|NCT02769481|450579513|FG000|Overall Study|Terminated by Sponsor|1|||
125259580|NCT02769481|450579514|FG001|Overall Study|Terminated by Sponsor|0|||
125259581|NCT02769481|450579513|FG000|Overall Study|Death|0|||
125259582|NCT02769481|450579514|FG001|Overall Study|Death|1|||
125259583|NCT02769481|450579513|FG000|Overall Study|Undefined|4|||
125259584|NCT02769481|450579514|FG001|Overall Study|Undefined|1|||
125259585|NCT03510715|450579515|FG000|Overall Study|Adverse Event|1|||
125259586|NCT03510715|450579516|FG001|Overall Study|Adverse Event|0|||
125259587|NCT00643279|450579527|FG000|Overall Study|Death|13|||
125259588|NCT00643279|450579528|FG001|Overall Study|Death|11|||
125259589|NCT00643279|450579527|FG000|Overall Study|Withdrawal by Subject|3|||
125259590|NCT00643279|450579528|FG001|Overall Study|Withdrawal by Subject|0|||
125259591|NCT00643279|450579527|FG000|Overall Study|Lost to Follow-up|0|||
125259592|NCT00643279|450579528|FG001|Overall Study|Lost to Follow-up|1|||
125259593|NCT00643279|450579527|FG000|Overall Study|Physician Decision|0|||
125259594|NCT00643279|450579528|FG001|Overall Study|Physician Decision|1|||
125259595|NCT05715827|450579529|FG000|Overall Study|Physician Decision|0|||
125259596|NCT05715827|450579530|FG001|Overall Study|Physician Decision|1|||
125259597|NCT05715827|450579529|FG000|Overall Study|console communication error|0|||
125259598|NCT05715827|450579530|FG001|Overall Study|console communication error|1|||
125259599|NCT03814044|450579531|FG000|Overall Study|Protocol deviation|1|||
125259600|NCT05929326|450579532|FG000|Overall Study|unqualified sample|2|||
125259601|NCT05929326|450579533|FG001|Overall Study|unqualified sample|3|||
125259602|NCT05929326|450579534|FG002|Overall Study|unqualified sample|7|||
125259603|NCT03557502|450579543|FG000|Protocol 2|Withdrawal by Subject|1|||
125259604|NCT03557502|450579544|FG001|Protocol 2|Withdrawal by Subject|1|||
125259605|NCT03557502|450579543|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
125259606|NCT03557502|450579544|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
125259607|NCT02333799|450580913|FG000|Treatment Period|Withdrawal by Subject|1|||
125259608|NCT02333799|450580913|FG000|Treatment Period|Death|6|||
125259609|NCT02333799|450580913|FG000|6 Month Follow Up Period|Physician Decision|1|||
125259610|NCT02333799|450580913|FG000|6 Month Follow Up Period|Death|1|||
125259611|NCT02333799|450580913|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
125259612|NCT02333799|450580913|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
125259613|NCT01657370|450580917|FG000|Overall Study|Withdrawal by Subject|0|||
125259614|NCT01657370|450580918|FG001|Overall Study|Withdrawal by Subject|0|||
125259615|NCT01657370|450580919|FG002|Overall Study|Withdrawal by Subject|1|||
125259616|NCT01657370|450580920|FG003|Overall Study|Withdrawal by Subject|0|||
125259617|NCT01657370|450580921|FG004|Overall Study|Withdrawal by Subject|0|||
125259618|NCT01657370|450580922|FG005|Overall Study|Withdrawal by Subject|1|||
125259619|NCT01657370|450580917|FG000|Overall Study|Physician Decision|2|||
125259620|NCT01657370|450580918|FG001|Overall Study|Physician Decision|3|||
125259621|NCT01657370|450580919|FG002|Overall Study|Physician Decision|1|||
125259622|NCT01657370|450580920|FG003|Overall Study|Physician Decision|2|||
125259623|NCT01657370|450580921|FG004|Overall Study|Physician Decision|5|||
125259624|NCT01657370|450580922|FG005|Overall Study|Physician Decision|0|||
125259625|NCT01657370|450580917|FG000|Overall Study|Lack of Qualifying Event|1|||
125259626|NCT01657370|450580918|FG001|Overall Study|Lack of Qualifying Event|0|||
125259627|NCT01657370|450580919|FG002|Overall Study|Lack of Qualifying Event|3|||
125259628|NCT01657370|450580920|FG003|Overall Study|Lack of Qualifying Event|2|||
125259629|NCT01657370|450580921|FG004|Overall Study|Lack of Qualifying Event|1|||
125259630|NCT01657370|450580922|FG005|Overall Study|Lack of Qualifying Event|2|||
125259631|NCT01657370|450580917|FG000|Overall Study|Adverse Event|0|||
125259632|NCT01657370|450580918|FG001|Overall Study|Adverse Event|0|||
125259633|NCT01657370|450580919|FG002|Overall Study|Adverse Event|0|||
125259634|NCT01657370|450580920|FG003|Overall Study|Adverse Event|0|||
125259635|NCT01657370|450580921|FG004|Overall Study|Adverse Event|1|||
125259636|NCT01657370|450580922|FG005|Overall Study|Adverse Event|0|||
125259637|NCT01657370|450580917|FG000|Overall Study|Protocol Violation|1|||
125259638|NCT01657370|450580918|FG001|Overall Study|Protocol Violation|1|||
125259639|NCT01657370|450580919|FG002|Overall Study|Protocol Violation|1|||
125259640|NCT01657370|450580920|FG003|Overall Study|Protocol Violation|1|||
125259641|NCT01657370|450580921|FG004|Overall Study|Protocol Violation|0|||
125259642|NCT01657370|450580922|FG005|Overall Study|Protocol Violation|0|||
125259643|NCT01657370|450580917|FG000|Overall Study|Lost to Follow-up|2|||
125259644|NCT01657370|450580918|FG001|Overall Study|Lost to Follow-up|0|||
125259645|NCT01657370|450580919|FG002|Overall Study|Lost to Follow-up|1|||
125259646|NCT01657370|450580920|FG003|Overall Study|Lost to Follow-up|0|||
125259647|NCT01657370|450580921|FG004|Overall Study|Lost to Follow-up|0|||
125259648|NCT01657370|450580922|FG005|Overall Study|Lost to Follow-up|1|||
125259649|NCT03021486|450580923|FG000|Overall Study|Withdrawal by Subject|1|||
125259650|NCT03021486|450580924|FG001|Overall Study|Withdrawal by Subject|1|||
125259651|NCT03021486|450580925|FG002|Overall Study|Withdrawal by Subject|3|||
125259652|NCT03021486|450580923|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
125259653|NCT03021486|450580924|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
125259654|NCT03021486|450580925|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
125259655|NCT04795531|450580926|FG000|Overall Study|Withdrawal by Subject|4|||
125259656|NCT04795531|450580927|FG001|Overall Study|Withdrawal by Subject|4|||
125259657|NCT04795531|450580926|FG000|Overall Study|Lost to Follow-up|0|||
125259658|NCT04795531|450580927|FG001|Overall Study|Lost to Follow-up|1|||
125259659|NCT04795531|450580926|FG000|Overall Study|Physician Decision|0|||
125259660|NCT04795531|450580927|FG001|Overall Study|Physician Decision|2|||
125259661|NCT04795531|450580926|FG000|Overall Study|Death|2|||
125259662|NCT04795531|450580927|FG001|Overall Study|Death|1|||
125259663|NCT04887831|450580928|FG000|Overall Study|Death|26|||
125259664|NCT04887831|450580929|FG001|Overall Study|Death|26|||
125259665|NCT04887831|450580928|FG000|Overall Study|Lost to Follow-up|0|||
125259666|NCT04887831|450580929|FG001|Overall Study|Lost to Follow-up|1|||
125259667|NCT04887831|450580928|FG000|Overall Study|Withdrawal by Subject|2|||
125259668|NCT04887831|450580929|FG001|Overall Study|Withdrawal by Subject|1|||
125259669|NCT04887831|450580928|FG000|Overall Study|Study Terminated by Sponsor|18|||
125259670|NCT04887831|450580929|FG001|Overall Study|Study Terminated by Sponsor|17|||
125259671|NCT04887831|450580928|FG000|Overall Study|Other|1|||
125259672|NCT04887831|450580929|FG001|Overall Study|Other|0|||
125259673|NCT04507204|450580932|FG000|Overall Study|Adverse Event|8|||
125259674|NCT04507204|450580933|FG001|Overall Study|Adverse Event|13|||
125259675|NCT04507204|450580932|FG000|Overall Study|Death|0|||
125259676|NCT04507204|450580933|FG001|Overall Study|Death|1|||
125259677|NCT04507204|450580932|FG000|Overall Study|Lost to Follow-up|15|||
125259678|NCT04507204|450580933|FG001|Overall Study|Lost to Follow-up|14|||
125259679|NCT04507204|450580932|FG000|Overall Study|Poor Compliance with Protocol|2|||
125259680|NCT04507204|450580933|FG001|Overall Study|Poor Compliance with Protocol|4|||
125259681|NCT04507204|450580932|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
125259682|NCT04507204|450580933|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
125259683|NCT04507204|450580932|FG000|Overall Study|Withdrawal of Patient Consent|21|||
125259684|NCT04507204|450580933|FG001|Overall Study|Withdrawal of Patient Consent|13|||
125259685|NCT01206517|450580936|FG000|Overall Study|Withdrawal by Subject|0|||
125259686|NCT01206517|450580937|FG001|Overall Study|Withdrawal by Subject|0|||
125259687|NCT01206517|450580938|FG002|Overall Study|Withdrawal by Subject|2|||
125259688|NCT01206517|450580939|FG003|Overall Study|Withdrawal by Subject|0|||
125259689|NCT01206517|450580940|FG004|Overall Study|Withdrawal by Subject|1|||
125259690|NCT01206517|450580941|FG005|Overall Study|Withdrawal by Subject|0|||
125259691|NCT03493958|450580942|FG000|Overall Study|Withdrawal by Subject|6|||
125259692|NCT03493958|450580942|FG000|Overall Study|Lost to Follow-up|7|||
125259693|NCT03493958|450580942|FG000|Overall Study|Did not complete all required study procedures|2|||
125259694|NCT04047446|450580943|FG000|Overall Study|Physician Decision|1|||
125259695|NCT04047446|450580944|FG001|Overall Study|Physician Decision|0|||
125259696|NCT02367456|450580945|FG000|Overall Study|Death|8|||
125259697|NCT02367456|450580946|FG001|Overall Study|Death|24|||
125259698|NCT02367456|450580947|FG002|Overall Study|Death|17|||
125259699|NCT02367456|450580945|FG000|Overall Study|Lost to Follow-up|1|||
125259700|NCT02367456|450580946|FG001|Overall Study|Lost to Follow-up|3|||
125259701|NCT02367456|450580947|FG002|Overall Study|Lost to Follow-up|1|||
125259702|NCT02367456|450580945|FG000|Overall Study|Other reason|3|||
125259703|NCT02367456|450580946|FG001|Overall Study|Other reason|3|||
125259704|NCT02367456|450580947|FG002|Overall Study|Other reason|9|||
125259705|NCT02367456|450580945|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
125259706|NCT02367456|450580946|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
125259707|NCT02367456|450580947|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
125259708|NCT01198587|450580953|FG000|Overall Study|Lost to Follow-up|8|||
125259709|NCT01198587|450580954|FG001|Overall Study|Lost to Follow-up|0|||
125259710|NCT01198587|450580955|FG002|Overall Study|Lost to Follow-up|9|||
125259711|NCT01198587|450580956|FG003|Overall Study|Lost to Follow-up|0|||
125259712|NCT02095106|450580959|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
125259713|NCT02095106|450580960|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
125259714|NCT00553254|450580963|FG000|Overall Study|Death|3|||
125259715|NCT00553254|450580964|FG001|Overall Study|Death|6|||
125259716|NCT00553254|450580965|FG002|Overall Study|Death|25|||
125259717|NCT00553254|450580963|FG000|Overall Study|Lost to Follow-up|0|||
125259718|NCT00553254|450580964|FG001|Overall Study|Lost to Follow-up|0|||
125259719|NCT00553254|450580965|FG002|Overall Study|Lost to Follow-up|2|||
125259720|NCT00553254|450580963|FG000|Overall Study|Withdrawal by Subject|2|||
125259721|NCT00553254|450580964|FG001|Overall Study|Withdrawal by Subject|0|||
125259722|NCT00553254|450580965|FG002|Overall Study|Withdrawal by Subject|2|||
125259723|NCT00553254|450580963|FG000|Overall Study|Study terminated by Sponsor|0|||
125259724|NCT00553254|450580964|FG001|Overall Study|Study terminated by Sponsor|0|||
125259725|NCT00553254|450580965|FG002|Overall Study|Study terminated by Sponsor|1|||
125259726|NCT00553254|450580963|FG000|Overall Study|Other|1|||
125259727|NCT00553254|450580964|FG001|Overall Study|Other|0|||
125259728|NCT00553254|450580965|FG002|Overall Study|Other|13|||
125259729|NCT00754572|450580973|FG000|Overall Study|Adverse Event|19|||
125259730|NCT00754572|450580973|FG000|Overall Study|Other|39|||
125259731|NCT00754572|450580973|FG000|Overall Study|Protocol Violation|3|||
125259732|NCT00754572|450580973|FG000|Overall Study|Withdrawal by Subject|3|||
125259733|NCT00754572|450580973|FG000|Overall Study|Lack of Efficacy|2|||
125259734|NCT00754572|450580973|FG000|Overall Study|Death|1|||
125259735|NCT00754572|450580973|FG000|Overall Study|Administrative Reason|3|||
125259736|NCT00754572|450580973|FG000|Overall Study|Lost to Follow-up|1|||
125259737|NCT05134649|450580977|FG000|Overall Study|Lost to Follow-up|12|||
125259738|NCT05134649|450580977|FG000|Overall Study|Withdrawal by Subject|14|||
125259739|NCT05134649|450580977|FG000|Overall Study|Pregnancy|1|||
125259740|NCT05134649|450580977|FG000|Overall Study|Other, not specified|3|||
125259741|NCT01559935|450580978|FG000|Car Phase|Toxicity|4|||
125259742|NCT01559935|450580978|FG000|Car Phase|Death|1|||
125259743|NCT01559935|450580978|FG000|Car Phase|Lack of Efficacy|2|||
125259744|NCT01559935|450580978|FG000|Car Phase|Lost to Follow-up|1|||
125259745|NCT01559935|450580978|FG000|Car Phase|Physician Decision|1|||
125259746|NCT01559935|450580978|FG000|Car Phase|Withdrawal by Subject|2|||
125259747|NCT01559935|450580978|FG000|Car Phase|Per protocol|1|||
125259748|NCT01559935|450580978|FG000|Car Phase|Insurance|1|||
125259749|NCT01559935|450580978|FG000|Car Phase|non-compliance|1|||
125259750|NCT01559935|450580978|FG000|BiRD Phase|Toxicity|1|||
125259751|NCT01559935|450580978|FG000|BiRD Phase|Lack of Efficacy|1|||
125259752|NCT01559935|450580978|FG000|BiRD Phase|Withdrawal by Subject|2|||
125259753|NCT01559935|450580978|FG000|Maintenance Phase|Remains on study|28|||
125259754|NCT01559935|450580978|FG000|Maintenance Phase|Toxicity|1|||
125259755|NCT01559935|450580978|FG000|Maintenance Phase|Lack of Efficacy|18|||
125259756|NCT01559935|450580978|FG000|Maintenance Phase|Withdrawal by Subject|5|||
125259757|NCT01559935|450580978|FG000|Maintenance Phase|Non-compliance|2|||
125259758|NCT02958865|450580979|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259759|NCT02958865|450580980|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
125259760|NCT02958865|450580981|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259761|NCT02958865|450580982|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
125259762|NCT02958865|450580983|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
125259763|NCT02958865|450580984|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
125259764|NCT02958865|450580985|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
125259765|NCT02958865|450580986|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259766|NCT02958865|450580987|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259767|NCT02958865|450580988|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259768|NCT02958865|450580989|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259769|NCT02958865|450580990|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259770|NCT02958865|450580991|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259771|NCT02958865|450580992|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259772|NCT02958865|450580993|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259773|NCT02958865|450580994|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259774|NCT02958865|450580979|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
125259775|NCT02958865|450580980|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
125259776|NCT02958865|450580981|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
125259777|NCT02958865|450580982|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
125259778|NCT02958865|450580983|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
125259779|NCT02958865|450580984|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
125259780|NCT02958865|450580985|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
125259781|NCT02958865|450580986|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
125259782|NCT02958865|450580987|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
125259783|NCT02958865|450580988|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
125259784|NCT02958865|450580989|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
125259785|NCT02958865|450580990|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
125259786|NCT02958865|450580991|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
125259787|NCT02958865|450580992|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
125259788|NCT02958865|450580993|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
125259789|NCT02958865|450580994|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
125259790|NCT02958865|450580979|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
125259791|NCT02958865|450580980|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
125259792|NCT02958865|450580981|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259793|NCT02958865|450580982|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259794|NCT02958865|450580983|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259795|NCT02958865|450580984|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259796|NCT02958865|450580985|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259797|NCT02958865|450580986|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259798|NCT02958865|450580987|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259799|NCT02958865|450580988|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259800|NCT02958865|450580989|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259801|NCT02958865|450580990|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259802|NCT02958865|450580991|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259803|NCT02958865|450580992|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259804|NCT02958865|450580993|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259805|NCT02958865|450580994|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259806|NCT02958865|450580979|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
125259807|NCT02958865|450580980|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125259808|NCT02958865|450580981|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
125259809|NCT02958865|450580982|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
125259810|NCT02958865|450580983|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
125259811|NCT02958865|450580984|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
125259812|NCT02958865|450580985|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
125259813|NCT02958865|450580986|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125259814|NCT02958865|450580987|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125259815|NCT02958865|450580988|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125259816|NCT02958865|450580989|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125259817|NCT02958865|450580990|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125259818|NCT02958865|450580991|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125259819|NCT02958865|450580992|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125259820|NCT02958865|450580993|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125259821|NCT02958865|450580994|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125259822|NCT02958865|450580979|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259823|NCT02958865|450580980|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259824|NCT02958865|450580981|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259825|NCT02958865|450580982|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
125259826|NCT02958865|450580983|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259827|NCT02958865|450580984|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259828|NCT02958865|450580985|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
125259829|NCT02958865|450580986|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259830|NCT02958865|450580987|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259831|NCT02958865|450580988|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259832|NCT02958865|450580989|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259833|NCT02958865|450580990|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259834|NCT02958865|450580991|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259835|NCT02958865|450580992|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259836|NCT02958865|450580993|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259837|NCT02958865|450580994|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259838|NCT02958865|450580979|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259839|NCT02958865|450580980|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259840|NCT02958865|450580981|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
125259841|NCT02958865|450580982|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259842|NCT02958865|450580983|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259843|NCT02958865|450580984|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259844|NCT02958865|450580985|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259845|NCT02958865|450580986|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259846|NCT02958865|450580987|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259847|NCT02958865|450580988|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259848|NCT02958865|450580989|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259849|NCT02958865|450580990|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259850|NCT02958865|450580991|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259851|NCT02958865|450580992|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259852|NCT02958865|450580993|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259853|NCT02958865|450580994|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259854|NCT02958865|450580979|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
125259855|NCT02958865|450580980|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
125259856|NCT02958865|450580981|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
125259857|NCT02958865|450580982|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259858|NCT02958865|450580983|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259859|NCT02958865|450580984|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259860|NCT02958865|450580985|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259861|NCT02958865|450580986|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259862|NCT02958865|450580987|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259863|NCT02958865|450580988|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259864|NCT02958865|450580989|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259865|NCT02958865|450580990|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259866|NCT02958865|450580991|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259867|NCT02958865|450580992|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259868|NCT02958865|450580993|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259869|NCT02958865|450580994|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259870|NCT02958865|450580979|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
125259871|NCT02958865|450580980|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
125259872|NCT02958865|450580981|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
125259873|NCT02958865|450580982|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
125259874|NCT02958865|450580983|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
125259875|NCT02958865|450580984|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
125259876|NCT02958865|450580985|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
125259877|NCT02958865|450580986|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
125259878|NCT02958865|450580987|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
125259879|NCT02958865|450580988|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
125259880|NCT02958865|450580989|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
125259881|NCT02958865|450580990|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
125259882|NCT02958865|450580991|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
125259883|NCT02958865|450580992|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
125259884|NCT02958865|450580993|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
125259885|NCT02958865|450580994|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
125259886|NCT02958865|450580979|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259887|NCT02958865|450580980|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259888|NCT02958865|450580981|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259889|NCT02958865|450580982|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259890|NCT02958865|450580983|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
125259891|NCT02958865|450580984|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259892|NCT02958865|450580985|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259893|NCT02958865|450580986|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259894|NCT02958865|450580987|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259895|NCT02958865|450580988|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259896|NCT02958865|450580989|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259897|NCT02958865|450580990|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259898|NCT02958865|450580991|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259899|NCT02958865|450580992|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259900|NCT02958865|450580993|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259901|NCT02958865|450580994|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259902|NCT02958865|450580979|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
125259903|NCT02958865|450580980|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
125259904|NCT02958865|450580981|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
125259905|NCT02958865|450580982|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
125259906|NCT02958865|450580983|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
125259907|NCT02958865|450580984|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
125259908|NCT02958865|450580985|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
125259909|NCT02958865|450580986|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
125259910|NCT02958865|450580987|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
125259911|NCT02958865|450580988|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
125259912|NCT02958865|450580989|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
125259913|NCT02958865|450580990|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
125259914|NCT02958865|450580991|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
125259915|NCT02958865|450580992|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
125259916|NCT02958865|450580993|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
125259917|NCT02958865|450580994|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
125259918|NCT02958865|450580979|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259919|NCT02958865|450580980|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259920|NCT02958865|450580981|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259921|NCT02958865|450580982|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259922|NCT02958865|450580983|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259923|NCT02958865|450580984|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259924|NCT02958865|450580985|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259925|NCT02958865|450580986|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259926|NCT02958865|450580987|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
125259927|NCT02958865|450580988|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
125259928|NCT02958865|450580989|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259929|NCT02958865|450580990|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
125259930|NCT02958865|450580991|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259931|NCT02958865|450580992|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
125259932|NCT02958865|450580993|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259933|NCT02958865|450580994|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
125259934|NCT02958865|450580979|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259935|NCT02958865|450580980|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259936|NCT02958865|450580981|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259937|NCT02958865|450580982|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259938|NCT02958865|450580983|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259939|NCT02958865|450580984|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259940|NCT02958865|450580985|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259941|NCT02958865|450580986|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259942|NCT02958865|450580987|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259943|NCT02958865|450580988|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
125259944|NCT02958865|450580989|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259945|NCT02958865|450580990|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259946|NCT02958865|450580991|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259947|NCT02958865|450580992|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259948|NCT02958865|450580993|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259949|NCT02958865|450580994|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
125259950|NCT02958865|450580979|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259951|NCT02958865|450580980|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259952|NCT02958865|450580981|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259953|NCT02958865|450580982|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259954|NCT02958865|450580983|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259955|NCT02958865|450580984|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259956|NCT02958865|450580985|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259957|NCT02958865|450580986|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259958|NCT02958865|450580987|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259959|NCT02958865|450580988|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259960|NCT02958865|450580989|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259961|NCT02958865|450580990|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
125259962|NCT02958865|450580991|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
125259963|NCT02958865|450580992|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
125259964|NCT02958865|450580993|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
125259965|NCT02958865|450580994|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
125259966|NCT02958865|450580979|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
125259967|NCT02958865|450580980|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
125259968|NCT02958865|450580981|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
125259969|NCT02958865|450580982|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
125259970|NCT02958865|450580983|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
125259971|NCT02958865|450580984|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
125259972|NCT02958865|450580985|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
125259973|NCT02958865|450580986|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
125259974|NCT02958865|450580987|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
125259975|NCT02958865|450580988|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
125259976|NCT02958865|450580989|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
125259977|NCT02958865|450580990|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
125259978|NCT02958865|450580991|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
125259979|NCT02958865|450580992|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
125259980|NCT02958865|450580993|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
125259981|NCT02958865|450580994|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
125259982|NCT02958865|450580979|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259983|NCT02958865|450580980|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259984|NCT02958865|450580981|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259985|NCT02958865|450580982|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259986|NCT02958865|450580983|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259987|NCT02958865|450580984|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259988|NCT02958865|450580985|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259989|NCT02958865|450580986|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259990|NCT02958865|450580987|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259991|NCT02958865|450580988|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259992|NCT02958865|450580989|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259993|NCT02958865|450580990|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259994|NCT02958865|450580991|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259995|NCT02958865|450580992|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
125259996|NCT02958865|450580993|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259997|NCT02958865|450580994|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259998|NCT02958865|450580979|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125259999|NCT02958865|450580980|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260000|NCT02958865|450580981|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260001|NCT02958865|450580982|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260002|NCT02958865|450580983|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260003|NCT02958865|450580984|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260004|NCT02958865|450580985|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260005|NCT02958865|450580986|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260006|NCT02958865|450580987|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260007|NCT02958865|450580988|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260008|NCT02958865|450580989|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260009|NCT02958865|450580990|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260010|NCT02958865|450580991|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260011|NCT02958865|450580992|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
125260012|NCT02958865|450580993|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260013|NCT02958865|450580994|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260014|NCT02958865|450580979|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260015|NCT02958865|450580980|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260016|NCT02958865|450580981|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260017|NCT02958865|450580982|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260018|NCT02958865|450580983|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260019|NCT02958865|450580984|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260020|NCT02958865|450580985|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260021|NCT02958865|450580986|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260022|NCT02958865|450580987|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260023|NCT02958865|450580988|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
125260024|NCT02958865|450580989|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260025|NCT02958865|450580990|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260026|NCT02958865|450580991|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260027|NCT02958865|450580992|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260028|NCT02958865|450580993|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260029|NCT02958865|450580994|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260030|NCT01038323|450581008|FG000|Overall Study|Withdrawal by Subject|3|||
125260031|NCT01038323|450581009|FG001|Overall Study|Withdrawal by Subject|2|||
125260032|NCT01038323|450581010|FG002|Overall Study|Withdrawal by Subject|4|||
125260033|NCT01143402|450581011|FG000|Overall Study|Rapid clinical decline|1|||
125260034|NCT01143402|450581012|FG001|Overall Study|Rapid clinical decline|1|||
125260035|NCT01143402|450581013|FG002|Overall Study|Rapid clinical decline|0|||
125260036|NCT01143402|450581011|FG000|Overall Study|Not Treated|0|||
125260037|NCT01143402|450581012|FG001|Overall Study|Not Treated|0|||
125260038|NCT01143402|450581013|FG002|Overall Study|Not Treated|1|||
125260039|NCT02526290|450581014|FG000|Overall Study|Adverse Event|3|||
125260040|NCT02526290|450581014|FG000|Overall Study|Withdrawal by Subject|4|||
125260041|NCT02526290|450581014|FG000|Overall Study|Physician Decision|1|||
125260042|NCT01380080|450581016|FG000|Overall Study|Death|36|||
125260043|NCT01380080|450581017|FG001|Overall Study|Death|44|||
125260044|NCT01380080|450581016|FG000|Overall Study|Site is closing|28|||
125260045|NCT01380080|450581017|FG001|Overall Study|Site is closing|31|||
125260046|NCT01380080|450581016|FG000|Overall Study|Not able to get to clinic|7|||
125260047|NCT01380080|450581017|FG001|Overall Study|Not able to get to clinic|1|||
125260048|NCT01380080|450581016|FG000|Overall Study|Not willing to adhere to requirements|6|||
125260049|NCT01380080|450581017|FG001|Overall Study|Not willing to adhere to requirements|2|||
125260050|NCT01380080|450581016|FG000|Overall Study|Withdrawal by Subject|5|||
125260051|NCT01380080|450581017|FG001|Overall Study|Withdrawal by Subject|2|||
125260052|NCT01380080|450581016|FG000|Overall Study|Lost to Follow-up|3|||
125260053|NCT01380080|450581017|FG001|Overall Study|Lost to Follow-up|3|||
125260054|NCT00210132|450581022|FG000|Overall Study|Protocol Violation|1|||
125260055|NCT00210132|450581023|FG001|Overall Study|Protocol Violation|4|||
125260056|NCT00432965|450581024|FG000|Overall Study|Lost to Follow-up|22|||
125260057|NCT00432965|450581025|FG001|Overall Study|Lost to Follow-up|19|||
125260058|NCT00432965|450581024|FG000|Overall Study|Withdrawal by Subject|13|||
125260059|NCT00432965|450581025|FG001|Overall Study|Withdrawal by Subject|13|||
125260060|NCT00432965|450581024|FG000|Overall Study|Physician Decision|14|||
125260061|NCT00432965|450581025|FG001|Overall Study|Physician Decision|13|||
125260062|NCT00432965|450581024|FG000|Overall Study|Lack of Efficacy|8|||
125260063|NCT00432965|450581025|FG001|Overall Study|Lack of Efficacy|13|||
125260064|NCT00432965|450581024|FG000|Overall Study|Non-compliance|7|||
125260065|NCT00432965|450581025|FG001|Overall Study|Non-compliance|0|||
125260066|NCT00432965|450581024|FG000|Overall Study|Adverse Event|22|||
125260067|NCT00432965|450581025|FG001|Overall Study|Adverse Event|19|||
125260068|NCT00432965|450581024|FG000|Overall Study|Death|3|||
125260069|NCT00432965|450581025|FG001|Overall Study|Death|4|||
125260070|NCT00432965|450581024|FG000|Overall Study|Exclusionary Methods|1|||
125260071|NCT00432965|450581025|FG001|Overall Study|Exclusionary Methods|2|||
125260072|NCT00432965|450581024|FG000|Overall Study|Incomplete Data|4|||
125260073|NCT00432965|450581025|FG001|Overall Study|Incomplete Data|3|||
125260074|NCT03636022|450581030|FG000|Overall Study|Withdrawal by Subject|1|||
125260075|NCT03636022|450581031|FG001|Overall Study|Withdrawal by Subject|3|||
125260076|NCT04532749|450581032|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
125260077|NCT04532749|450581033|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
125260078|NCT04532749|450581032|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
125260079|NCT04532749|450581033|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
125260080|NCT04532749|450581032|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
125260081|NCT04532749|450581033|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
125260082|NCT04532749|450581032|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
125260083|NCT04532749|450581033|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
125260084|NCT04532749|450581032|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
125260085|NCT04532749|450581033|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
125260086|NCT04532749|450581032|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
125260087|NCT04532749|450581033|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
125260088|NCT04532749|450581032|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
125260089|NCT04532749|450581033|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
125260090|NCT04532749|450581032|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
125260091|NCT04532749|450581033|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
125260092|NCT04532749|450581032|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
125260093|NCT04532749|450581033|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
125260094|NCT04532749|450581032|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
125260095|NCT04532749|450581033|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
125260096|NCT00642759|450581034|FG000|Overall Study|Protocol Violation|1|||
125260097|NCT03612570|450581039|FG000|Overall Study|Lost to Follow-up|1|||
125260098|NCT02255435|450582376|FG000|Overall Study|Patient's Limited Time Availability|0|||
125260099|NCT02255435|450582377|FG001|Overall Study|Patient's Limited Time Availability|0|||
125260100|NCT02255435|450582378|FG002|Overall Study|Patient's Limited Time Availability|0|||
125260101|NCT02255435|450582379|FG003|Overall Study|Patient's Limited Time Availability|0|||
125260102|NCT02255435|450582380|FG004|Overall Study|Patient's Limited Time Availability|0|||
125260103|NCT02255435|450582381|FG005|Overall Study|Patient's Limited Time Availability|0|||
125260104|NCT02255435|450582382|FG006|Overall Study|Patient's Limited Time Availability|0|||
125260105|NCT02255435|450582383|FG007|Overall Study|Patient's Limited Time Availability|1|||
125260106|NCT02255435|450582384|FG008|Overall Study|Patient's Limited Time Availability|0|||
125260107|NCT02255435|450582385|FG009|Overall Study|Patient's Limited Time Availability|0|||
125260108|NCT02255435|450582376|FG000|Overall Study|Withdrawal by Subject|0|||
125260109|NCT02255435|450582377|FG001|Overall Study|Withdrawal by Subject|0|||
125260110|NCT02255435|450582378|FG002|Overall Study|Withdrawal by Subject|0|||
125260111|NCT02255435|450582379|FG003|Overall Study|Withdrawal by Subject|0|||
125260112|NCT02255435|450582380|FG004|Overall Study|Withdrawal by Subject|0|||
125260113|NCT02255435|450582381|FG005|Overall Study|Withdrawal by Subject|0|||
125260114|NCT02255435|450582382|FG006|Overall Study|Withdrawal by Subject|0|||
125260115|NCT02255435|450582383|FG007|Overall Study|Withdrawal by Subject|0|||
125260116|NCT02255435|450582384|FG008|Overall Study|Withdrawal by Subject|1|||
125260117|NCT02255435|450582385|FG009|Overall Study|Withdrawal by Subject|4|||
125260118|NCT02255435|450582376|FG000|Overall Study|Administrative reasons|0|||
125260119|NCT02255435|450582377|FG001|Overall Study|Administrative reasons|0|||
125260120|NCT02255435|450582378|FG002|Overall Study|Administrative reasons|0|||
125260121|NCT02255435|450582379|FG003|Overall Study|Administrative reasons|0|||
125260122|NCT02255435|450582380|FG004|Overall Study|Administrative reasons|0|||
125260123|NCT02255435|450582381|FG005|Overall Study|Administrative reasons|0|||
125260124|NCT02255435|450582382|FG006|Overall Study|Administrative reasons|0|||
125260125|NCT02255435|450582383|FG007|Overall Study|Administrative reasons|0|||
125260126|NCT02255435|450582384|FG008|Overall Study|Administrative reasons|0|||
125260127|NCT02255435|450582385|FG009|Overall Study|Administrative reasons|2|||
125260128|NCT00442702|450582386|FG000|Titration Period|Adverse Event|2|||
125260129|NCT00442702|450582387|FG001|Titration Period|Adverse Event|0|||
125260130|NCT00442702|450582386|FG000|Titration Period|Death|3|||
125260131|NCT00442702|450582387|FG001|Titration Period|Death|2|||
125260132|NCT00442702|450582386|FG000|Titration Period|Insufficient Therapeutic Response|1|||
125260133|NCT00442702|450582387|FG001|Titration Period|Insufficient Therapeutic Response|0|||
125260134|NCT00442702|450582386|FG000|Titration Period|Refused Treatment|4|||
125260135|NCT00442702|450582387|FG001|Titration Period|Refused Treatment|1|||
125260136|NCT00442702|450582386|FG000|Titration Period|Failure to return|1|||
125260137|NCT00442702|450582387|FG001|Titration Period|Failure to return|0|||
125260138|NCT00442702|450582386|FG000|Titration Period|Hospitalized in another hospital|1|||
125260139|NCT00442702|450582387|FG001|Titration Period|Hospitalized in another hospital|0|||
125260140|NCT00442702|450582386|FG000|Evaluation Period|Adverse Event|1|||
125260141|NCT00442702|450582387|FG001|Evaluation Period|Adverse Event|0|||
125260142|NCT00442702|450582386|FG000|Evaluation Period|Death|1|||
125260143|NCT00442702|450582387|FG001|Evaluation Period|Death|1|||
125260144|NCT00442702|450582386|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
125260145|NCT00442702|450582387|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
125260146|NCT00442702|450582386|FG000|Evaluation Period|Refused treatment|1|||
125260147|NCT00442702|450582387|FG001|Evaluation Period|Refused treatment|1|||
125260148|NCT00442702|450582386|FG000|Evaluation Period|Renal transplant|0|||
125260149|NCT00442702|450582387|FG001|Evaluation Period|Renal transplant|1|||
125260150|NCT00442702|450582386|FG000|Evaluation Period|Failure to return|1|||
125260151|NCT00442702|450582387|FG001|Evaluation Period|Failure to return|0|||
125260152|NCT00442702|450582386|FG000|Evaluation Period|Site closure|0|||
125260153|NCT00442702|450582387|FG001|Evaluation Period|Site closure|1|||
125260154|NCT03580044|450582388|FG000|Overall Study|Death|2|||
125260155|NCT03580044|450582389|FG001|Overall Study|Death|1|||
125260156|NCT03580044|450582388|FG000|Overall Study|Withdrawal by Subject|1|||
125260157|NCT03580044|450582389|FG001|Overall Study|Withdrawal by Subject|1|||
125260158|NCT01664624|450582390|FG000|Overall Study|Adverse Event|0|||
125260159|NCT01664624|450582391|FG001|Overall Study|Adverse Event|1|||
125260160|NCT01664624|450582392|FG002|Overall Study|Adverse Event|0|||
125260161|NCT01664624|450582393|FG003|Overall Study|Adverse Event|0|||
125260162|NCT01500317|450582396|FG000|Overall Study|Withdrawal by Subject|3|||
125260163|NCT01500317|450582397|FG001|Overall Study|Withdrawal by Subject|2|||
125260164|NCT01500317|450582398|FG002|Overall Study|Withdrawal by Subject|0|||
125260165|NCT00335829|450582399|FG000|Overall Study|Withdrawal by Subject|1|||
125260166|NCT00335829|450582399|FG000|Overall Study|Lost to Follow-up|1|||
125260167|NCT00335829|450582399|FG000|Overall Study|Adverse Event|1|||
125260168|NCT04067011|450582401|FG000|Overall Study|Not Treated|8|||
125260169|NCT04067011|450582402|FG001|Overall Study|Not Treated|7|||
125260170|NCT04067011|450582403|FG002|Overall Study|Not Treated|5|||
125260171|NCT04067011|450582401|FG000|Overall Study|Adverse Event|2|||
125260172|NCT04067011|450582402|FG001|Overall Study|Adverse Event|1|||
125260173|NCT04067011|450582403|FG002|Overall Study|Adverse Event|0|||
125260174|NCT04067011|450582401|FG000|Overall Study|Withdrawal by Subject|6|||
125260175|NCT04067011|450582402|FG001|Overall Study|Withdrawal by Subject|2|||
125260176|NCT04067011|450582403|FG002|Overall Study|Withdrawal by Subject|1|||
125260177|NCT04067011|450582401|FG000|Overall Study|Lost to Follow-up|0|||
125260178|NCT04067011|450582402|FG001|Overall Study|Lost to Follow-up|0|||
125260179|NCT04067011|450582403|FG002|Overall Study|Lost to Follow-up|1|||
125260180|NCT04067011|450582401|FG000|Overall Study|Physician Decision|1|||
125260181|NCT04067011|450582402|FG001|Overall Study|Physician Decision|1|||
125260182|NCT04067011|450582403|FG002|Overall Study|Physician Decision|0|||
125260183|NCT04067011|450582401|FG000|Overall Study|Other Reasons|2|||
125260184|NCT04067011|450582402|FG001|Overall Study|Other Reasons|0|||
125260185|NCT04067011|450582403|FG002|Overall Study|Other Reasons|1|||
125260186|NCT04067011|450582401|FG000|Overall Study|Missing|0|||
125260187|NCT04067011|450582402|FG001|Overall Study|Missing|2|||
125260188|NCT04067011|450582403|FG002|Overall Study|Missing|0|||
125260189|NCT03746015|450582404|FG000|Overall Study|Withdrawal of Consent|1|||
125260190|NCT03746015|450582405|FG001|Overall Study|Withdrawal of Consent|0|||
125260191|NCT03746015|450582406|FG002|Overall Study|Withdrawal of Consent|0|||
125260192|NCT05209386|450582407|FG000|Overall Study|Withdrawal by Subject|8|||
125260193|NCT05209386|450582407|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
125260194|NCT04462471|450582408|FG000|Overall Study|Adverse Event|0|||
125260195|NCT04462471|450582409|FG001|Overall Study|Adverse Event|1|||
125260196|NCT04462471|450582410|FG002|Overall Study|Adverse Event|0|||
125260197|NCT04462471|450582411|FG003|Overall Study|Adverse Event|0|||
125260198|NCT04462471|450582408|FG000|Overall Study|Disease progression|1|||
125260199|NCT04462471|450582409|FG001|Overall Study|Disease progression|0|||
125260200|NCT04462471|450582410|FG002|Overall Study|Disease progression|0|||
125260201|NCT04462471|450582411|FG003|Overall Study|Disease progression|0|||
125260202|NCT01121757|450582420|FG000|First Drug|Death|1|||
125260203|NCT01121757|450582421|FG001|First Drug|Death|0|||
125260204|NCT01121757|450582420|FG000|First Drug|Disease Progression|0|||
125260205|NCT01121757|450582421|FG001|First Drug|Disease Progression|2|||
125260206|NCT01121757|450582420|FG000|Combination|Physician Decision|0|||
125260207|NCT01121757|450582421|FG001|Combination|Physician Decision|1|||
125260208|NCT01121757|450582420|FG000|Combination|Disease Progression|2|||
125260209|NCT01121757|450582421|FG001|Combination|Disease Progression|0|||
125260210|NCT04251533|450582422|FG000|Overall Study|Progressive disease|33|||
125260211|NCT04251533|450582423|FG001|Overall Study|Progressive disease|29|||
125260212|NCT04251533|450582424|FG002|Overall Study|Progressive disease|22|||
125260213|NCT04251533|450582422|FG000|Overall Study|Death|5|||
125260214|NCT04251533|450582423|FG001|Overall Study|Death|1|||
125260215|NCT04251533|450582424|FG002|Overall Study|Death|3|||
125260216|NCT04251533|450582422|FG000|Overall Study|Physician Decision|3|||
125260217|NCT04251533|450582423|FG001|Overall Study|Physician Decision|2|||
125260218|NCT04251533|450582424|FG002|Overall Study|Physician Decision|4|||
125260219|NCT04251533|450582422|FG000|Overall Study|Participant decision|1|||
125260220|NCT04251533|450582423|FG001|Overall Study|Participant decision|3|||
125260221|NCT04251533|450582424|FG002|Overall Study|Participant decision|1|||
125260222|NCT04251533|450582422|FG000|Overall Study|Adverse Event|2|||
125260223|NCT04251533|450582423|FG001|Overall Study|Adverse Event|1|||
125260224|NCT04251533|450582424|FG002|Overall Study|Adverse Event|1|||
125260225|NCT05901636|450582425|FG000|Overall Study|Lost to Follow-up|0|||
125260226|NCT05901636|450582426|FG001|Overall Study|Lost to Follow-up|1|||
125260227|NCT05901636|450582427|FG002|Overall Study|Lost to Follow-up|0|||
125260228|NCT05901636|450582428|FG003|Overall Study|Lost to Follow-up|1|||
125260229|NCT05901636|450582429|FG004|Overall Study|Lost to Follow-up|1|||
125260230|NCT05901636|450582430|FG005|Overall Study|Lost to Follow-up|3|||
125260231|NCT05901636|450582431|FG006|Overall Study|Lost to Follow-up|1|||
125260232|NCT05901636|450582425|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
125260233|NCT05901636|450582426|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
125260234|NCT05901636|450582427|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
125260235|NCT05901636|450582428|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
125260236|NCT05901636|450582429|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
125260237|NCT05901636|450582430|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
125260238|NCT05901636|450582431|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
125260239|NCT05901636|450582425|FG000|Overall Study|Withdrawal by Subject|1|||
125260240|NCT05901636|450582426|FG001|Overall Study|Withdrawal by Subject|1|||
125260241|NCT05901636|450582427|FG002|Overall Study|Withdrawal by Subject|0|||
125260242|NCT05901636|450582428|FG003|Overall Study|Withdrawal by Subject|0|||
125260243|NCT05901636|450582429|FG004|Overall Study|Withdrawal by Subject|1|||
125260244|NCT05901636|450582430|FG005|Overall Study|Withdrawal by Subject|1|||
125260245|NCT05901636|450582431|FG006|Overall Study|Withdrawal by Subject|0|||
125260246|NCT05901636|450582425|FG000|Overall Study|Other|0|||
125260247|NCT05901636|450582426|FG001|Overall Study|Other|0|||
125260248|NCT05901636|450582427|FG002|Overall Study|Other|1|||
125260249|NCT05901636|450582428|FG003|Overall Study|Other|1|||
125260250|NCT05901636|450582429|FG004|Overall Study|Other|0|||
125260251|NCT05901636|450582430|FG005|Overall Study|Other|0|||
125260252|NCT05901636|450582431|FG006|Overall Study|Other|0|||
125260253|NCT04583618|450582432|FG000|Overall Study|Adverse Event|0|||
125260254|NCT04583618|450582433|FG001|Overall Study|Adverse Event|0|||
125260255|NCT04583618|450582434|FG002|Overall Study|Adverse Event|1|||
125260256|NCT04583618|450582435|FG003|Overall Study|Adverse Event|0|||
125260257|NCT04583618|450582436|FG004|Overall Study|Adverse Event|0|||
125260258|NCT04583618|450582432|FG000|Overall Study|Protocol deviation|1|||
125260259|NCT04583618|450582433|FG001|Overall Study|Protocol deviation|1|||
125260260|NCT04583618|450582434|FG002|Overall Study|Protocol deviation|1|||
125260261|NCT04583618|450582435|FG003|Overall Study|Protocol deviation|0|||
125260262|NCT04583618|450582436|FG004|Overall Study|Protocol deviation|0|||
125260263|NCT04583618|450582432|FG000|Overall Study|Withdrawal by Subject|2|||
125260264|NCT04583618|450582433|FG001|Overall Study|Withdrawal by Subject|1|||
125260265|NCT04583618|450582434|FG002|Overall Study|Withdrawal by Subject|3|||
125260266|NCT04583618|450582435|FG003|Overall Study|Withdrawal by Subject|1|||
125260267|NCT04583618|450582436|FG004|Overall Study|Withdrawal by Subject|1|||
125260268|NCT04583618|450582432|FG000|Overall Study|Lost to Follow-up|0|||
125260269|NCT04583618|450582433|FG001|Overall Study|Lost to Follow-up|1|||
125260270|NCT04583618|450582434|FG002|Overall Study|Lost to Follow-up|3|||
125260271|NCT04583618|450582435|FG003|Overall Study|Lost to Follow-up|1|||
125260272|NCT04583618|450582436|FG004|Overall Study|Lost to Follow-up|1|||
125260273|NCT02711202|450582437|FG000|Overall Study|Adverse Event|3|||
125260274|NCT02711202|450582438|FG001|Overall Study|Adverse Event|0|||
125260275|NCT02711202|450582437|FG000|Overall Study|graft loss|1|||
125260276|NCT02711202|450582438|FG001|Overall Study|graft loss|0|||
125260277|NCT03189719|450582442|FG000|Overall Study|Death|325|||
125260278|NCT03189719|450582443|FG001|Overall Study|Death|361|||
125260279|NCT03189719|450582442|FG000|Overall Study|Physician Decision|1|||
125260280|NCT03189719|450582443|FG001|Overall Study|Physician Decision|0|||
125260281|NCT03189719|450582442|FG000|Overall Study|Sponsor Decision|40|||
125260282|NCT03189719|450582443|FG001|Overall Study|Sponsor Decision|12|||
125260283|NCT03189719|450582442|FG000|Overall Study|Withdrawal by Subject|7|||
125260284|NCT03189719|450582443|FG001|Overall Study|Withdrawal by Subject|3|||
125260285|NCT03448393|450582444|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
125260286|NCT03448393|450582445|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
125260287|NCT03448393|450582446|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
125260288|NCT03448393|450582447|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
125260289|NCT03448393|450582448|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
125260290|NCT03448393|450582449|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
125260291|NCT03448393|450582450|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
125260292|NCT03448393|450582451|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
125260293|NCT03448393|450582452|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
125260294|NCT03448393|450582444|FG000|Dose Expansion|Not treated - screen failure|0|||
125260295|NCT03448393|450582445|FG001|Dose Expansion|Not treated - screen failure|0|||
125260296|NCT03448393|450582446|FG002|Dose Expansion|Not treated - screen failure|0|||
125260297|NCT03448393|450582447|FG003|Dose Expansion|Not treated - screen failure|0|||
125260298|NCT03448393|450582448|FG004|Dose Expansion|Not treated - screen failure|0|||
125260299|NCT03448393|450582449|FG005|Dose Expansion|Not treated - screen failure|0|||
125260300|NCT03448393|450582450|FG006|Dose Expansion|Not treated - screen failure|0|||
125260301|NCT03448393|450582451|FG007|Dose Expansion|Not treated - screen failure|0|||
125260302|NCT03448393|450582452|FG008|Dose Expansion|Not treated - screen failure|7|||
125260303|NCT03330847|450582453|FG000|Overall Study|Patients ongoing study|62|||
125260304|NCT03330847|450582454|FG001|Overall Study|Patients ongoing study|65|||
125260305|NCT03330847|450582455|FG002|Overall Study|Patients ongoing study|15|||
125260306|NCT01355627|450582456|FG000|Overall Study|Request By the Patient to Discontinue|5|||
125260307|NCT01355627|450582457|FG001|Overall Study|Request By the Patient to Discontinue|7|||
125260308|NCT01355627|450582456|FG000|Overall Study|Lost to Follow-up|8|||
125260309|NCT01355627|450582457|FG001|Overall Study|Lost to Follow-up|7|||
125260310|NCT01355627|450582456|FG000|Overall Study|Fatal Adverse Event|19|||
125260311|NCT01355627|450582457|FG001|Overall Study|Fatal Adverse Event|23|||
125260312|NCT01355627|450582456|FG000|Overall Study|Other|1|||
125260313|NCT01355627|450582457|FG001|Overall Study|Other|1|||
125260314|NCT02293551|450582460|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
125260315|NCT02293551|450582461|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
125260316|NCT02293551|450582462|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
125260317|NCT02293551|450582463|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
125260318|NCT02293551|450582464|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
125260319|NCT02293551|450582465|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
125260320|NCT02293551|450582460|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
125260321|NCT02293551|450582461|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
125260322|NCT02293551|450582462|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
125260323|NCT02293551|450582463|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
125260324|NCT02293551|450582464|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
125260325|NCT02293551|450582465|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
125260326|NCT02293551|450582460|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
125260327|NCT02293551|450582461|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
125260328|NCT02293551|450582462|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
125260329|NCT02293551|450582463|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
125260330|NCT02293551|450582464|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
125260331|NCT02293551|450582465|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
125260332|NCT04756531|450582471|FG000|Overall Study|Adverse Event|0|||
125260333|NCT04756531|450582472|FG001|Overall Study|Adverse Event|0|||
125260334|NCT04756531|450582473|FG002|Overall Study|Adverse Event|0|||
125260335|NCT04756531|450582474|FG003|Overall Study|Adverse Event|0|||
125260336|NCT04756531|450582475|FG004|Overall Study|Adverse Event|1|||
125260337|NCT04756531|450582476|FG005|Overall Study|Adverse Event|0|||
125260338|NCT04756531|450582477|FG006|Overall Study|Adverse Event|0|||
125260339|NCT04756531|450582478|FG007|Overall Study|Adverse Event|0|||
125260340|NCT04756531|450582479|FG008|Overall Study|Adverse Event|0|||
125260341|NCT04756531|450582480|FG009|Overall Study|Adverse Event|0|||
125260342|NCT04756531|450582481|FG010|Overall Study|Adverse Event|0|||
125260343|NCT04756531|450582482|FG011|Overall Study|Adverse Event|0|||
125260344|NCT04756531|450582483|FG012|Overall Study|Adverse Event|0|||
125260345|NCT04756531|450582484|FG013|Overall Study|Adverse Event|0|||
125260346|NCT04756531|450582485|FG014|Overall Study|Adverse Event|0|||
125260347|NCT04756531|450582486|FG015|Overall Study|Adverse Event|0|||
125260348|NCT04756531|450582487|FG016|Overall Study|Adverse Event|0|||
125260349|NCT04756531|450582488|FG017|Overall Study|Adverse Event|0|||
125260350|NCT04756531|450582471|FG000|Overall Study|Withdrawal by Subject|0|||
125260351|NCT04756531|450582472|FG001|Overall Study|Withdrawal by Subject|0|||
125260352|NCT04756531|450582473|FG002|Overall Study|Withdrawal by Subject|0|||
125260353|NCT04756531|450582474|FG003|Overall Study|Withdrawal by Subject|0|||
125260354|NCT04756531|450582475|FG004|Overall Study|Withdrawal by Subject|0|||
125260355|NCT04756531|450582476|FG005|Overall Study|Withdrawal by Subject|0|||
125260356|NCT04756531|450582477|FG006|Overall Study|Withdrawal by Subject|1|||
125260357|NCT04756531|450582478|FG007|Overall Study|Withdrawal by Subject|0|||
125260358|NCT04756531|450582479|FG008|Overall Study|Withdrawal by Subject|0|||
125260359|NCT04756531|450582480|FG009|Overall Study|Withdrawal by Subject|0|||
125260360|NCT04756531|450582481|FG010|Overall Study|Withdrawal by Subject|0|||
125260361|NCT04756531|450582482|FG011|Overall Study|Withdrawal by Subject|0|||
125260362|NCT04756531|450582483|FG012|Overall Study|Withdrawal by Subject|0|||
125260363|NCT04756531|450582484|FG013|Overall Study|Withdrawal by Subject|0|||
125260364|NCT04756531|450582485|FG014|Overall Study|Withdrawal by Subject|0|||
125260365|NCT04756531|450582486|FG015|Overall Study|Withdrawal by Subject|0|||
125260366|NCT04756531|450582487|FG016|Overall Study|Withdrawal by Subject|0|||
125260367|NCT04756531|450582488|FG017|Overall Study|Withdrawal by Subject|0|||
125260368|NCT05643495|450582489|FG000|Overall Study|Adverse Event|0|||
125260369|NCT05643495|450582490|FG001|Overall Study|Adverse Event|1|||
125260370|NCT05643495|450582489|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
125260371|NCT05643495|450582490|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
125260372|NCT02257528|450582491|FG000|Overall Study|Never received study treatment|1|||
125260373|NCT06272383|450582492|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
125260374|NCT06272383|450582493|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
125260375|NCT04569084|450582498|FG000|Overall Study|Adverse Event|10|||
125260376|NCT04569084|450582499|FG001|Overall Study|Adverse Event|14|||
125260377|NCT04569084|450582498|FG000|Overall Study|Death|2|||
125260378|NCT04569084|450582499|FG001|Overall Study|Death|3|||
125260379|NCT04569084|450582498|FG000|Overall Study|Lost to Follow-up|1|||
125260380|NCT04569084|450582499|FG001|Overall Study|Lost to Follow-up|1|||
125260381|NCT04569084|450582498|FG000|Overall Study|Physician Decision|3|||
125260382|NCT04569084|450582499|FG001|Overall Study|Physician Decision|3|||
125260383|NCT04569084|450582498|FG000|Overall Study|Protocol Violation|2|||
125260384|NCT04569084|450582499|FG001|Overall Study|Protocol Violation|1|||
125260385|NCT04569084|450582498|FG000|Overall Study|Withdrawal by Subject|20|||
125260386|NCT04569084|450582499|FG001|Overall Study|Withdrawal by Subject|21|||
125260387|NCT04569084|450582498|FG000|Overall Study|Study terminated by sponsor|26|||
125260388|NCT04569084|450582499|FG001|Overall Study|Study terminated by sponsor|23|||
125260389|NCT04569084|450582498|FG000|Overall Study|Other|3|||
125260390|NCT04569084|450582499|FG001|Overall Study|Other|5|||
125260391|NCT01346176|450582500|FG000|Recruited|Protocol Violation|1|||
125260392|NCT01346176|450582501|FG001|Recruited|Protocol Violation|0|||
125260393|NCT01346176|450582502|FG002|Recruited|Protocol Violation|0|||
125260394|NCT01346176|450582500|FG000|Completed Advance Directive|Death|3|||
125260395|NCT01346176|450582501|FG001|Completed Advance Directive|Death|2|||
125260396|NCT01346176|450582502|FG002|Completed Advance Directive|Death|2|||
125260397|NCT01346176|450582500|FG000|Completed Advance Directive|Became Ineligible|3|||
125260398|NCT01346176|450582501|FG001|Completed Advance Directive|Became Ineligible|0|||
125260399|NCT01346176|450582502|FG002|Completed Advance Directive|Became Ineligible|1|||
125260400|NCT01346176|450582500|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
125260401|NCT01346176|450582501|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
125260402|NCT01346176|450582502|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
125260403|NCT01346176|450582500|FG000|Completed Satisfaction Survey|Death|3|||
125260404|NCT01346176|450582501|FG001|Completed Satisfaction Survey|Death|0|||
125260405|NCT01346176|450582502|FG002|Completed Satisfaction Survey|Death|2|||
125260406|NCT01346176|450582500|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
125260407|NCT01346176|450582501|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
125260408|NCT01346176|450582502|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
125260409|NCT01994876|450582503|FG000|Test Period 1|Withdrawal by Subject|0|||
125260410|NCT01994876|450582504|FG001|Test Period 1|Withdrawal by Subject|1|||
125260411|NCT01994876|450582503|FG000|Test Period 1|Adverse Event|0|||
125260412|NCT01994876|450582504|FG001|Test Period 1|Adverse Event|1|||
125260413|NCT01994876|450582503|FG000|Test Period 2|Adverse Event|1|||
125260414|NCT01994876|450582504|FG001|Test Period 2|Adverse Event|0|||
125260415|NCT01994876|450582503|FG000|Test Period 2|Protocol Violation|0|||
125260416|NCT01994876|450582504|FG001|Test Period 2|Protocol Violation|1|||
125260417|NCT01400412|450582505|FG000|Overall Study|Lost to Follow-up|4|||
125260418|NCT01400412|450582506|FG001|Overall Study|Lost to Follow-up|7|||
125260419|NCT01400412|450582505|FG000|Overall Study|Withdrawal by Subject|3|||
125260420|NCT01400412|450582506|FG001|Overall Study|Withdrawal by Subject|4|||
125260421|NCT01400412|450582505|FG000|Overall Study|Unable to complete|3|||
125260422|NCT01400412|450582506|FG001|Overall Study|Unable to complete|3|||
125260423|NCT01400412|450582505|FG000|Overall Study|Never started study treatment|0|||
125260424|NCT01400412|450582506|FG001|Overall Study|Never started study treatment|3|||
125260425|NCT04043286|450583951|FG000|Overall Study|Withdrawal by Subject|2|||
125260426|NCT04043286|450583952|FG001|Overall Study|Withdrawal by Subject|2|||
125260427|NCT01323192|450583953|FG000|Overall Study|Adverse Event|6|||
125260428|NCT01323192|450583954|FG001|Overall Study|Adverse Event|1|||
125260429|NCT01323192|450583953|FG000|Overall Study|Withdrawal by Subject|3|||
125260430|NCT01323192|450583954|FG001|Overall Study|Withdrawal by Subject|1|||
125260431|NCT01323192|450583953|FG000|Overall Study|Noncompliance with study medication|0|||
125260432|NCT01323192|450583954|FG001|Overall Study|Noncompliance with study medication|3|||
125260433|NCT01323192|450583953|FG000|Overall Study|Nonmedical reasons|0|||
125260434|NCT01323192|450583954|FG001|Overall Study|Nonmedical reasons|1|||
125260435|NCT02296476|450583955|FG000|Overall Study|Disease Progression|6|||
125260436|NCT02296476|450583956|FG001|Overall Study|Disease Progression|4|||
125260437|NCT02296476|450583957|FG002|Overall Study|Disease Progression|2|||
125260438|NCT03122184|450583964|FG000|Overall Study|Lost to Follow-up|4|||
125260439|NCT03122184|450583965|FG001|Overall Study|Lost to Follow-up|6|||
125260440|NCT03122184|450583964|FG000|Overall Study|Withdrawal by Subject|3|||
125260441|NCT03122184|450583965|FG001|Overall Study|Withdrawal by Subject|0|||
125260442|NCT03122184|450583964|FG000|Overall Study|Terminated due to cognitive problem|1|||
125260443|NCT03122184|450583965|FG001|Overall Study|Terminated due to cognitive problem|0|||
125260444|NCT02835690|450583966|FG000|Overall Study|Death|12|||
125260445|NCT02835690|450583967|FG001|Overall Study|Death|11|||
125260446|NCT02835690|450583968|FG002|Overall Study|Death|13|||
125260447|NCT02835690|450583966|FG000|Overall Study|Transferred to Extension Study|2|||
125260448|NCT02835690|450583967|FG001|Overall Study|Transferred to Extension Study|2|||
125260449|NCT02835690|450583968|FG002|Overall Study|Transferred to Extension Study|1|||
125260450|NCT02835690|450583966|FG000|Overall Study|Did Not Continue on Extension Study|0|||
125260451|NCT02835690|450583967|FG001|Overall Study|Did Not Continue on Extension Study|0|||
125260452|NCT02835690|450583968|FG002|Overall Study|Did Not Continue on Extension Study|1|||
125260453|NCT02835690|450583966|FG000|Overall Study|Not Treated|0|||
125260454|NCT02835690|450583967|FG001|Overall Study|Not Treated|2|||
125260455|NCT02835690|450583968|FG002|Overall Study|Not Treated|0|||
125260456|NCT03674281|450583969|FG000|Overall Study|screen failure|2|||
125260457|NCT03674281|450583970|FG001|Overall Study|screen failure|0|||
125260458|NCT03674281|450583971|FG002|Overall Study|screen failure|0|||
125260459|NCT03674281|450583969|FG000|Overall Study|Withdrawal by Subject|1|||
125260460|NCT03674281|450583970|FG001|Overall Study|Withdrawal by Subject|3|||
125260461|NCT03674281|450583971|FG002|Overall Study|Withdrawal by Subject|3|||
125260462|NCT00710593|450583972|FG000|Overall Study|Incarceration|1|||
125260463|NCT00710593|450583973|FG001|Overall Study|Incarceration|0|||
125260464|NCT00710593|450583972|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
125260465|NCT00710593|450583973|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
125260466|NCT00710593|450583972|FG000|Overall Study|Lost to Follow-up|3|||
125260467|NCT00710593|450583973|FG001|Overall Study|Lost to Follow-up|1|||
125260468|NCT00710593|450583972|FG000|Overall Study|Moved out of area|1|||
125260469|NCT00710593|450583973|FG001|Overall Study|Moved out of area|0|||
125260470|NCT00710593|450583972|FG000|Overall Study|Failure to adhere or complete study eval|1|||
125260471|NCT00710593|450583973|FG001|Overall Study|Failure to adhere or complete study eval|1|||
125260472|NCT00710593|450583972|FG000|Overall Study|Protocol Violation|1|||
125260473|NCT00710593|450583973|FG001|Overall Study|Protocol Violation|1|||
125260474|NCT00710593|450583972|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
125260475|NCT00710593|450583973|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
125260476|NCT04490278|450583974|FG000|Overall Study|Lost to Follow-up|6|||
125260477|NCT02829996|450583977|FG000|Overall Study|Withdrawal by Subject|1|||
125260478|NCT02829996|450583978|FG001|Overall Study|Withdrawal by Subject|0|||
125260479|NCT02829996|450583979|FG002|Overall Study|Withdrawal by Subject|0|||
125260480|NCT02829996|450583980|FG003|Overall Study|Withdrawal by Subject|0|||
125260481|NCT02829996|450583981|FG004|Overall Study|Withdrawal by Subject|0|||
125260482|NCT01441960|450583982|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
125260483|NCT01441960|450583983|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
125260484|NCT01441960|450583982|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
125260485|NCT01441960|450583983|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
125260486|NCT01441960|450583982|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
125260487|NCT01441960|450583983|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
125260488|NCT02986074|450583985|FG000|First Trial Period|Adverse Event|1|||
125260489|NCT02986074|450583986|FG001|First Trial Period|Adverse Event|0|||
125260490|NCT02986074|450583987|FG002|First Trial Period|Adverse Event|0|||
125260491|NCT02986074|450583988|FG003|First Trial Period|Adverse Event|0|||
125260492|NCT02986074|450583985|FG000|Follow up Period|system explant|0|||
125260493|NCT02986074|450583986|FG001|Follow up Period|system explant|0|||
125260494|NCT02986074|450583987|FG002|Follow up Period|system explant|1|||
125260495|NCT02986074|450583988|FG003|Follow up Period|system explant|2|||
125260496|NCT02986074|450583985|FG000|Follow up Period|Physician Decision|0|||
125260497|NCT02986074|450583986|FG001|Follow up Period|Physician Decision|0|||
125260498|NCT02986074|450583987|FG002|Follow up Period|Physician Decision|0|||
125260499|NCT02986074|450583988|FG003|Follow up Period|Physician Decision|1|||
125260500|NCT00069641|450583993|FG000|Overall Study|Death|1|||
125260501|NCT00069641|450583994|FG001|Overall Study|Death|0|||
125260502|NCT00069641|450583995|FG002|Overall Study|Death|1|||
125260503|NCT03186638|450583996|FG000|Overall Study|Withdrawal by Subject|4|||
125260504|NCT03186638|450583997|FG001|Overall Study|Withdrawal by Subject|4|||
125260505|NCT03186638|450583996|FG000|Overall Study|Withdrawn due to medical problem|3|||
125260506|NCT03186638|450583997|FG001|Overall Study|Withdrawn due to medical problem|2|||
125260507|NCT03186638|450583996|FG000|Overall Study|Lost to Follow-up|1|||
125260508|NCT03186638|450583997|FG001|Overall Study|Lost to Follow-up|0|||
125260509|NCT01263119|450583998|FG000|Period 1|Protocol Violation|2|||
125260510|NCT01263119|450583998|FG000|Period 2|Adverse Event|2|||
125260511|NCT04573972|450583999|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
125260512|NCT04573972|450584000|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
125260513|NCT05067335|450584001|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
125260514|NCT05067335|450584002|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
125260515|NCT05067335|450584003|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
125260516|NCT05067335|450584004|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
125260517|NCT05067335|450584001|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
125260518|NCT05067335|450584002|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
125260519|NCT05067335|450584003|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
125260520|NCT05067335|450584004|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
125260521|NCT05067335|450584001|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
125260522|NCT05067335|450584002|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
125260523|NCT05067335|450584003|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
125260524|NCT05067335|450584004|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
125260525|NCT05067335|450584001|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
125260526|NCT05067335|450584002|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
125260527|NCT05067335|450584003|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
125260528|NCT05067335|450584004|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
125260529|NCT05067335|450584001|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
125260530|NCT05067335|450584002|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
125260531|NCT05067335|450584003|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
125260532|NCT05067335|450584004|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
125260533|NCT05067335|450584001|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
125260534|NCT05067335|450584002|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
125260535|NCT05067335|450584003|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
125260536|NCT05067335|450584004|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
125260537|NCT05067335|450584001|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
125260538|NCT05067335|450584002|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
125260539|NCT05067335|450584003|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
125260540|NCT05067335|450584004|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
125260541|NCT05067335|450584001|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
125260542|NCT05067335|450584002|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
125260543|NCT05067335|450584003|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
125260544|NCT05067335|450584004|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
125260545|NCT05067335|450584001|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
125260546|NCT05067335|450584002|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
125260547|NCT05067335|450584003|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
125260548|NCT05067335|450584004|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
125260549|NCT05067335|450584001|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
125260550|NCT05067335|450584002|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
125260551|NCT05067335|450584003|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
125260552|NCT05067335|450584004|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
125260553|NCT00261833|450584005|FG000|Overall Study|Death|1|||
125260554|NCT00261833|450584006|FG001|Overall Study|Death|3|||
125260555|NCT00261833|450584005|FG000|Overall Study|Adverse Event|1|||
125260556|NCT00261833|450584006|FG001|Overall Study|Adverse Event|4|||
125260557|NCT00261833|450584005|FG000|Overall Study|Withdrawal by Subject|5|||
125260558|NCT00261833|450584006|FG001|Overall Study|Withdrawal by Subject|7|||
125260559|NCT00261833|450584005|FG000|Overall Study|Protocol Violation|0|||
125260560|NCT00261833|450584006|FG001|Overall Study|Protocol Violation|1|||
125260561|NCT00261833|450584005|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
125260562|NCT00261833|450584006|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
125260563|NCT00261833|450584005|FG000|Overall Study|Lung transplantation|1|||
125260564|NCT00261833|450584006|FG001|Overall Study|Lung transplantation|1|||
125260565|NCT00261833|450584005|FG000|Overall Study|Missing reason|1|||
125260566|NCT00261833|450584006|FG001|Overall Study|Missing reason|0|||
125260567|NCT00261833|450584005|FG000|Overall Study|Not interested in being participant|0|||
125260568|NCT00261833|450584006|FG001|Overall Study|Not interested in being participant|1|||
125260569|NCT00622726|450584007|FG000|March, 2008 to August, 2010|Death|5|||
125260570|NCT00622726|450584008|FG001|March, 2008 to August, 2010|Death|2|||
125260571|NCT00622726|450584007|FG000|August, 2010 to April, 2013|Death|1|||
125260572|NCT00622726|450584008|FG001|August, 2010 to April, 2013|Death|5|||
125260573|NCT01948427|450584009|FG000|Overall Study|Serious Adverse Event|3|||
125260574|NCT01948427|450584010|FG001|Overall Study|Serious Adverse Event|0|||
125260575|NCT01948427|450584011|FG002|Overall Study|Serious Adverse Event|0|||
125260576|NCT01948427|450584012|FG003|Overall Study|Serious Adverse Event|0|||
125260577|NCT01948427|450584013|FG004|Overall Study|Serious Adverse Event|1|||
125260578|NCT01948427|450584009|FG000|Overall Study|Investigator Request|0|||
125260579|NCT01948427|450584010|FG001|Overall Study|Investigator Request|8|||
125260580|NCT01948427|450584011|FG002|Overall Study|Investigator Request|0|||
125260581|NCT01948427|450584012|FG003|Overall Study|Investigator Request|0|||
125260582|NCT01948427|450584013|FG004|Overall Study|Investigator Request|6|||
125260583|NCT01948427|450584009|FG000|Overall Study|Lost to Follow-up|1|||
125260584|NCT01948427|450584010|FG001|Overall Study|Lost to Follow-up|0|||
125260585|NCT01948427|450584011|FG002|Overall Study|Lost to Follow-up|0|||
125260586|NCT01948427|450584012|FG003|Overall Study|Lost to Follow-up|0|||
125260587|NCT01948427|450584013|FG004|Overall Study|Lost to Follow-up|4|||
125260588|NCT01948427|450584009|FG000|Overall Study|Withdrawal by Subject|2|||
125260589|NCT01948427|450584010|FG001|Overall Study|Withdrawal by Subject|0|||
125260590|NCT01948427|450584011|FG002|Overall Study|Withdrawal by Subject|0|||
125260591|NCT01948427|450584012|FG003|Overall Study|Withdrawal by Subject|0|||
125260592|NCT01948427|450584013|FG004|Overall Study|Withdrawal by Subject|1|||
125260593|NCT01948427|450584009|FG000|Overall Study|Other, Not Specified|1|||
125260594|NCT01948427|450584010|FG001|Overall Study|Other, Not Specified|9|||
125260595|NCT01948427|450584011|FG002|Overall Study|Other, Not Specified|0|||
125260596|NCT01948427|450584012|FG003|Overall Study|Other, Not Specified|0|||
125260597|NCT01948427|450584013|FG004|Overall Study|Other, Not Specified|2|||
125260598|NCT00402987|450584014|FG000|Overall Study|Lack of Efficacy|0|||
125260599|NCT00402987|450584015|FG001|Overall Study|Lack of Efficacy|0|||
125260600|NCT00402987|450584016|FG002|Overall Study|Lack of Efficacy|1|||
125260601|NCT00402987|450584017|FG003|Overall Study|Lack of Efficacy|0|||
125260602|NCT05200845|450584029|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
125260603|NCT05200845|450584030|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
125260604|NCT05200845|450584031|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
125260605|NCT05200845|450584032|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
125260606|NCT05200845|450584029|FG000|Overall Study|Withdrawal by Subject|0|||
125260607|NCT05200845|450584030|FG001|Overall Study|Withdrawal by Subject|1|||
125260608|NCT05200845|450584031|FG002|Overall Study|Withdrawal by Subject|1|||
125260609|NCT05200845|450584032|FG003|Overall Study|Withdrawal by Subject|0|||
125260610|NCT02303262|450584033|FG000|Overall Study|Withdrawal by Subject|2|||
125260611|NCT04138056|450584034|FG000|Primary Study|Lost to Follow-up|3|||
125260612|NCT04138056|450584035|FG001|Primary Study|Lost to Follow-up|4|||
125260613|NCT04138056|450584036|FG002|Primary Study|Lost to Follow-up|1|||
125260614|NCT04138056|450584037|FG003|Primary Study|Lost to Follow-up|1|||
125260615|NCT04138056|450584038|FG004|Primary Study|Lost to Follow-up|4|||
125260616|NCT04138056|450584034|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
125260617|NCT04138056|450584035|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
125260618|NCT04138056|450584036|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
125260619|NCT04138056|450584037|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
125260620|NCT04138056|450584038|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
125260621|NCT04138056|450584034|FG000|Extension Study|Lost to Follow-up|1|||
125260622|NCT04138056|450584035|FG001|Extension Study|Lost to Follow-up|2|||
125260623|NCT04138056|450584036|FG002|Extension Study|Lost to Follow-up|1|||
125260624|NCT04138056|450584037|FG003|Extension Study|Lost to Follow-up|0|||
125260625|NCT04138056|450584038|FG004|Extension Study|Lost to Follow-up|1|||
125260626|NCT01215851|450584039|FG000|Treatment Period|Adverse Event|1|||
125260627|NCT01215851|450584040|FG001|Treatment Period|Adverse Event|1|||
125260628|NCT01215851|450584041|FG002|Treatment Period|Adverse Event|1|||
125260629|NCT01215851|450584042|FG003|Treatment Period|Adverse Event|3|||
125260630|NCT01215851|450584043|FG004|Treatment Period|Adverse Event|0|||
125260631|NCT01215851|450584044|FG005|Treatment Period|Adverse Event|1|||
125260632|NCT01215851|450584039|FG000|Follow up Period|Lost to Follow-up|0|||
125260633|NCT01215851|450584040|FG001|Follow up Period|Lost to Follow-up|0|||
125260634|NCT01215851|450584041|FG002|Follow up Period|Lost to Follow-up|0|||
125260635|NCT01215851|450584042|FG003|Follow up Period|Lost to Follow-up|0|||
125260636|NCT01215851|450584043|FG004|Follow up Period|Lost to Follow-up|0|||
125260637|NCT01215851|450584044|FG005|Follow up Period|Lost to Follow-up|1|||
125260638|NCT00862940|450584048|FG000|Overall Study|Adverse Event|15|||
125260639|NCT00862940|450584049|FG001|Overall Study|Adverse Event|12|||
125260640|NCT00862940|450584048|FG000|Overall Study|Lack of Efficacy|1|||
125260641|NCT00862940|450584049|FG001|Overall Study|Lack of Efficacy|3|||
125260642|NCT00862940|450584048|FG000|Overall Study|Protocol Violation|2|||
125260643|NCT00862940|450584049|FG001|Overall Study|Protocol Violation|5|||
125260644|NCT00862940|450584048|FG000|Overall Study|Withdrawal by Subject|4|||
125260645|NCT00862940|450584049|FG001|Overall Study|Withdrawal by Subject|6|||
125260646|NCT00862940|450584048|FG000|Overall Study|Non-compliance|4|||
125260647|NCT00862940|450584049|FG001|Overall Study|Non-compliance|0|||
125260648|NCT00862940|450584048|FG000|Overall Study|Lost to Follow-up|0|||
125260649|NCT00862940|450584049|FG001|Overall Study|Lost to Follow-up|1|||
125260650|NCT00862940|450584048|FG000|Overall Study|Administrative or other reason(s)|4|||
125260651|NCT00862940|450584049|FG001|Overall Study|Administrative or other reason(s)|3|||
125260652|NCT05552859|450584050|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
125260653|NCT05552859|450584051|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
125260654|NCT02581930|450584060|FG000|Overall Study|Withdrawal by Subject|1|||
125260655|NCT02581930|450584060|FG000|Overall Study|patient declined further treatment|1|||
125260656|NCT03983421|450585378|FG000|Overall Study|Lost to Follow-up|1|||
125260657|NCT03386773|450585379|FG000|Overall Study|Lost to Follow-up|24|||
125260658|NCT03386773|450585380|FG001|Overall Study|Lost to Follow-up|33|||
125260659|NCT03386773|450585379|FG000|Overall Study|Withdrawal by Subject|3|||
125260660|NCT03386773|450585380|FG001|Overall Study|Withdrawal by Subject|2|||
125260661|NCT03639610|450585381|FG000|Overall Study|Adverse Event|7|||
125260662|NCT03639610|450585382|FG001|Overall Study|Adverse Event|1|||
125260663|NCT03639610|450585383|FG002|Overall Study|Adverse Event|0|||
125260664|NCT03639610|450585381|FG000|Overall Study|Physician Decision|3|||
125260665|NCT03639610|450585382|FG001|Overall Study|Physician Decision|1|||
125260666|NCT03639610|450585383|FG002|Overall Study|Physician Decision|0|||
125260667|NCT03639610|450585381|FG000|Overall Study|Disease progression|8|||
125260668|NCT03639610|450585382|FG001|Overall Study|Disease progression|5|||
125260669|NCT03639610|450585383|FG002|Overall Study|Disease progression|3|||
125260670|NCT03639610|450585381|FG000|Overall Study|Study terminated by sponsor|2|||
125260671|NCT03639610|450585382|FG001|Overall Study|Study terminated by sponsor|1|||
125260672|NCT03639610|450585383|FG002|Overall Study|Study terminated by sponsor|1|||
125260673|NCT03639610|450585381|FG000|Overall Study|Patient request to stop treatment|1|||
125260674|NCT03639610|450585382|FG001|Overall Study|Patient request to stop treatment|2|||
125260675|NCT03639610|450585383|FG002|Overall Study|Patient request to stop treatment|0|||
125260676|NCT02410772|450585386|FG000|Overall Study|Death|3|||
125260677|NCT02410772|450585387|FG001|Overall Study|Death|4|||
125260678|NCT02410772|450585388|FG002|Overall Study|Death|8|||
125260679|NCT02410772|450585386|FG000|Overall Study|Lost to Follow-up|31|||
125260680|NCT02410772|450585387|FG001|Overall Study|Lost to Follow-up|23|||
125260681|NCT02410772|450585388|FG002|Overall Study|Lost to Follow-up|22|||
125260682|NCT02410772|450585386|FG000|Overall Study|Pregnancy|8|||
125260683|NCT02410772|450585387|FG001|Overall Study|Pregnancy|4|||
125260684|NCT02410772|450585388|FG002|Overall Study|Pregnancy|5|||
125260685|NCT02410772|450585386|FG000|Overall Study|Protocol Violation|8|||
125260686|NCT02410772|450585387|FG001|Overall Study|Protocol Violation|8|||
125260687|NCT02410772|450585388|FG002|Overall Study|Protocol Violation|4|||
125260688|NCT02410772|450585386|FG000|Overall Study|Baseline Drug Resistance|49|||
125260689|NCT02410772|450585387|FG001|Overall Study|Baseline Drug Resistance|40|||
125260690|NCT02410772|450585388|FG002|Overall Study|Baseline Drug Resistance|51|||
125260691|NCT02410772|450585386|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
125260692|NCT02410772|450585387|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
125260693|NCT02410772|450585388|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
125260694|NCT02410772|450585386|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
125260695|NCT02410772|450585387|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
125260696|NCT02410772|450585388|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
125260697|NCT01517984|450585391|FG000|Overall Study|Lost to Follow-up|0|||
125260698|NCT01517984|450585392|FG001|Overall Study|Lost to Follow-up|1|||
125260699|NCT01517984|450585393|FG002|Overall Study|Lost to Follow-up|0|||
125260700|NCT01517984|450585394|FG003|Overall Study|Lost to Follow-up|0|||
125260701|NCT01517984|450585391|FG000|Overall Study|Withdrawal by Subject|1|||
125260702|NCT01517984|450585392|FG001|Overall Study|Withdrawal by Subject|8|||
125260703|NCT01517984|450585393|FG002|Overall Study|Withdrawal by Subject|4|||
125260704|NCT01517984|450585394|FG003|Overall Study|Withdrawal by Subject|1|||
125260705|NCT01517984|450585391|FG000|Overall Study|Screen Failure|4|||
125260706|NCT01517984|450585392|FG001|Overall Study|Screen Failure|0|||
125260707|NCT01517984|450585393|FG002|Overall Study|Screen Failure|0|||
125260708|NCT01517984|450585394|FG003|Overall Study|Screen Failure|0|||
125260709|NCT01517984|450585391|FG000|Overall Study|Ineligible for randomization|0|||
125260710|NCT01517984|450585392|FG001|Overall Study|Ineligible for randomization|14|||
125260711|NCT01517984|450585393|FG002|Overall Study|Ineligible for randomization|0|||
125260712|NCT01517984|450585394|FG003|Overall Study|Ineligible for randomization|0|||
125260713|NCT01645176|450585395|FG000|Overall Study|Lack of Efficacy|4|||
125260714|NCT01645176|450585395|FG000|Overall Study|did not complete final MRI|1|||
125260715|NCT02234362|450585396|FG000|Overall Study|Not eligible after first screening visit|17|||
125260716|NCT02234362|450585396|FG000|Overall Study|Lost to Follow-up|6|||
125260717|NCT02234362|450585396|FG000|Overall Study|Withdrawal by Subject|3|||
125260718|NCT00560417|450585397|FG000|Overall Study|Adverse Event|3|||
125260719|NCT00560417|450585398|FG001|Overall Study|Adverse Event|2|||
125260720|NCT00560417|450585397|FG000|Overall Study|Entry Criteria Not Met|1|||
125260721|NCT00560417|450585398|FG001|Overall Study|Entry Criteria Not Met|0|||
125260722|NCT00560417|450585397|FG000|Overall Study|Lost to Follow-up|0|||
125260723|NCT00560417|450585398|FG001|Overall Study|Lost to Follow-up|1|||
125260724|NCT00560417|450585397|FG000|Overall Study|Physician Decision|2|||
125260725|NCT00560417|450585398|FG001|Overall Study|Physician Decision|6|||
125260726|NCT00560417|450585397|FG000|Overall Study|Protocol Violation|6|||
125260727|NCT00560417|450585398|FG001|Overall Study|Protocol Violation|5|||
125260728|NCT00560417|450585397|FG000|Overall Study|Sponsor Decision|2|||
125260729|NCT00560417|450585398|FG001|Overall Study|Sponsor Decision|0|||
125260730|NCT00560417|450585397|FG000|Overall Study|Withdrawal by Subject|3|||
125260731|NCT00560417|450585398|FG001|Overall Study|Withdrawal by Subject|3|||
125260732|NCT02164864|450585401|FG000|Overall Study|Trial disease worsening|7|||
125260733|NCT02164864|450585402|FG001|Overall Study|Trial disease worsening|5|||
125260734|NCT02164864|450585403|FG002|Overall Study|Trial disease worsening|1|||
125260735|NCT02164864|450585401|FG000|Overall Study|Other pre-existing disease worsening|6|||
125260736|NCT02164864|450585402|FG001|Overall Study|Other pre-existing disease worsening|4|||
125260737|NCT02164864|450585403|FG002|Overall Study|Other pre-existing disease worsening|9|||
125260738|NCT02164864|450585401|FG000|Overall Study|Other Adverse Event (AE)|52|||
125260739|NCT02164864|450585402|FG001|Overall Study|Other Adverse Event (AE)|32|||
125260740|NCT02164864|450585403|FG002|Overall Study|Other Adverse Event (AE)|49|||
125260741|NCT02164864|450585401|FG000|Overall Study|Protocol Violation|2|||
125260742|NCT02164864|450585402|FG001|Overall Study|Protocol Violation|4|||
125260743|NCT02164864|450585403|FG002|Overall Study|Protocol Violation|1|||
125260744|NCT02164864|450585401|FG000|Overall Study|Lost to Follow-up|4|||
125260745|NCT02164864|450585402|FG001|Overall Study|Lost to Follow-up|3|||
125260746|NCT02164864|450585403|FG002|Overall Study|Lost to Follow-up|2|||
125260747|NCT02164864|450585401|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
125260748|NCT02164864|450585402|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
125260749|NCT02164864|450585403|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
125260750|NCT02164864|450585401|FG000|Overall Study|Other than stated|3|||
125260751|NCT02164864|450585402|FG001|Overall Study|Other than stated|4|||
125260752|NCT02164864|450585403|FG002|Overall Study|Other than stated|14|||
125260753|NCT02569853|450585404|FG000|Overall Study|Adverse Event|2|||
125260754|NCT02569853|450585405|FG001|Overall Study|Adverse Event|0|||
125260755|NCT02569853|450585404|FG000|Overall Study|Withdrawal by Subject|3|||
125260756|NCT02569853|450585405|FG001|Overall Study|Withdrawal by Subject|2|||
125260757|NCT02569853|450585404|FG000|Overall Study|Lost to Follow-up|3|||
125260758|NCT02569853|450585405|FG001|Overall Study|Lost to Follow-up|3|||
125260759|NCT02569853|450585404|FG000|Overall Study|Protocol Violation|1|||
125260760|NCT02569853|450585405|FG001|Overall Study|Protocol Violation|1|||
125260761|NCT02569853|450585404|FG000|Overall Study|Did not experience migraine attack|10|||
125260762|NCT02569853|450585405|FG001|Overall Study|Did not experience migraine attack|7|||
125260763|NCT02569853|450585404|FG000|Overall Study|Physician Decision|1|||
125260764|NCT02569853|450585405|FG001|Overall Study|Physician Decision|1|||
125260765|NCT02434081|450585408|FG000|Overall Study|Death (never started treatment)|2|||
125260766|NCT02434081|450585408|FG000|Overall Study|Death|2|||
125260767|NCT02434081|450585408|FG000|Overall Study|Progression|20|||
125260768|NCT02434081|450585408|FG000|Overall Study|Adverse Event|20|||
125260769|NCT02434081|450585408|FG000|Overall Study|Physician Decision|2|||
125260770|NCT02434081|450585408|FG000|Overall Study|Withdrawal by Subject|1|||
125260771|NCT02434081|450585408|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
125260772|NCT01668004|450585409|FG000|Overall Study|Adverse Event|7|||
125260773|NCT01668004|450585409|FG000|Overall Study|Withdrawal by Subject|2|||
125260774|NCT01668004|450585409|FG000|Overall Study|Lost to Follow-up|5|||
125260775|NCT01668004|450585409|FG000|Overall Study|Lack of Efficacy|9|||
125260776|NCT01668004|450585409|FG000|Overall Study|Non-compliance with treatment|2|||
125260777|NCT00419744|450585410|FG000|Overall Study|Adverse Event|39|||
125260778|NCT00419744|450585411|FG001|Overall Study|Adverse Event|40|||
125260779|NCT00419744|450585412|FG002|Overall Study|Adverse Event|50|||
125260780|NCT00419744|450585410|FG000|Overall Study|Withdrawal by Subject|45|||
125260781|NCT00419744|450585411|FG001|Overall Study|Withdrawal by Subject|49|||
125260782|NCT00419744|450585412|FG002|Overall Study|Withdrawal by Subject|52|||
125260783|NCT00419744|450585410|FG000|Overall Study|Lost to Follow-up|8|||
125260784|NCT00419744|450585411|FG001|Overall Study|Lost to Follow-up|10|||
125260785|NCT00419744|450585412|FG002|Overall Study|Lost to Follow-up|6|||
125260786|NCT00419744|450585410|FG000|Overall Study|Protocol Violation|4|||
125260787|NCT00419744|450585411|FG001|Overall Study|Protocol Violation|7|||
125260788|NCT00419744|450585412|FG002|Overall Study|Protocol Violation|8|||
125260789|NCT00419744|450585410|FG000|Overall Study|Randomized in error|9|||
125260790|NCT00419744|450585411|FG001|Overall Study|Randomized in error|6|||
125260791|NCT00419744|450585412|FG002|Overall Study|Randomized in error|7|||
125260792|NCT00419744|450585410|FG000|Overall Study|Moving out of state|2|||
125260793|NCT00419744|450585411|FG001|Overall Study|Moving out of state|0|||
125260794|NCT00419744|450585412|FG002|Overall Study|Moving out of state|1|||
125260795|NCT00419744|450585410|FG000|Overall Study|Physician Decision|10|||
125260796|NCT00419744|450585411|FG001|Overall Study|Physician Decision|5|||
125260797|NCT00419744|450585412|FG002|Overall Study|Physician Decision|6|||
125260798|NCT00419744|450585410|FG000|Overall Study|Spirometry mouthpiece issues|0|||
125260799|NCT00419744|450585411|FG001|Overall Study|Spirometry mouthpiece issues|1|||
125260800|NCT00419744|450585412|FG002|Overall Study|Spirometry mouthpiece issues|2|||
125260801|NCT00419744|450585410|FG000|Overall Study|Incorrect medication kit dispensed|0|||
125260802|NCT00419744|450585411|FG001|Overall Study|Incorrect medication kit dispensed|0|||
125260803|NCT00419744|450585412|FG002|Overall Study|Incorrect medication kit dispensed|1|||
125260804|NCT02448381|450585417|FG000|Overall Study|Adverse Event|2|||
125260805|NCT02448381|450585418|FG001|Overall Study|Adverse Event|0|||
125260806|NCT02448381|450585417|FG000|Overall Study|Lost to Follow-up|16|||
125260807|NCT02448381|450585418|FG001|Overall Study|Lost to Follow-up|9|||
125260808|NCT02448381|450585417|FG000|Overall Study|Physician Decision|1|||
125260809|NCT02448381|450585418|FG001|Overall Study|Physician Decision|1|||
125260810|NCT02448381|450585417|FG000|Overall Study|Pregnancy|1|||
125260811|NCT02448381|450585418|FG001|Overall Study|Pregnancy|0|||
125260812|NCT02448381|450585417|FG000|Overall Study|Withdrawal by Subject|13|||
125260813|NCT02448381|450585418|FG001|Overall Study|Withdrawal by Subject|9|||
125260814|NCT02448381|450585417|FG000|Overall Study|Noncompliance with Study Procedures|2|||
125260815|NCT02448381|450585418|FG001|Overall Study|Noncompliance with Study Procedures|0|||
125260816|NCT02006927|450585419|FG000|Overall Study|Adverse Event|2|||
125260817|NCT02006927|450585419|FG000|Overall Study|Withdrawal by Subject|1|||
125260818|NCT02735200|450585420|FG000|Overall Study|Lost to Follow-up|0|||
125260819|NCT02735200|450585421|FG001|Overall Study|Lost to Follow-up|5|||
125260820|NCT02735200|450585420|FG000|Overall Study|Withdrawal by Subject|8|||
125260821|NCT02735200|450585421|FG001|Overall Study|Withdrawal by Subject|0|||
125260822|NCT00673920|450585422|FG000|Baseline up to Week 48|Withdrew consent|1|||
125260823|NCT00673920|450585423|FG001|Baseline up to Week 48|Withdrew consent|0|||
125260824|NCT00673920|450585424|FG002|Baseline up to Week 48|Withdrew consent|2|||
125260825|NCT00673920|450585425|FG003|Baseline up to Week 48|Withdrew consent|0|||
125260826|NCT00673920|450585426|FG004|Baseline up to Week 48|Withdrew consent|0|||
125260827|NCT00673920|450585427|FG005|Baseline up to Week 48|Withdrew consent|0|||
125260828|NCT00673920|450585428|FG006|Baseline up to Week 48|Withdrew consent|0|||
125260829|NCT00673920|450585429|FG007|Baseline up to Week 48|Withdrew consent|0|||
125260830|NCT00673920|450585422|FG000|Baseline up to Week 48|Refused treatment|1|||
125260831|NCT00673920|450585423|FG001|Baseline up to Week 48|Refused treatment|0|||
125260832|NCT00673920|450585424|FG002|Baseline up to Week 48|Refused treatment|0|||
125260833|NCT00673920|450585425|FG003|Baseline up to Week 48|Refused treatment|0|||
125260834|NCT00673920|450585426|FG004|Baseline up to Week 48|Refused treatment|0|||
125260835|NCT00673920|450585427|FG005|Baseline up to Week 48|Refused treatment|0|||
125260836|NCT00673920|450585428|FG006|Baseline up to Week 48|Refused treatment|0|||
125260837|NCT00673920|450585429|FG007|Baseline up to Week 48|Refused treatment|0|||
125260838|NCT00673920|450585422|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
125260839|NCT00673920|450585423|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
125260840|NCT00673920|450585424|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
125260841|NCT00673920|450585425|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
125260842|NCT00673920|450585426|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
125260843|NCT00673920|450585427|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
125260844|NCT00673920|450585428|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
125260845|NCT00673920|450585429|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
125260846|NCT00673920|450585422|FG000|Baseline up to Week 48|Protocol Violation|0|||
125260847|NCT00673920|450585423|FG001|Baseline up to Week 48|Protocol Violation|0|||
125260848|NCT00673920|450585424|FG002|Baseline up to Week 48|Protocol Violation|1|||
125260849|NCT00673920|450585425|FG003|Baseline up to Week 48|Protocol Violation|0|||
125260850|NCT00673920|450585426|FG004|Baseline up to Week 48|Protocol Violation|0|||
125260851|NCT00673920|450585427|FG005|Baseline up to Week 48|Protocol Violation|0|||
125260852|NCT00673920|450585428|FG006|Baseline up to Week 48|Protocol Violation|0|||
125260853|NCT00673920|450585429|FG007|Baseline up to Week 48|Protocol Violation|0|||
125260854|NCT00673920|450585422|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
125260855|NCT00673920|450585423|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
125260856|NCT00673920|450585424|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
125260857|NCT00673920|450585425|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
125260858|NCT00673920|450585426|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
125260859|NCT00673920|450585427|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
125260860|NCT00673920|450585428|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
125260861|NCT00673920|450585429|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
125260862|NCT00673920|450585422|FG000|Baseline up to Week 48|Administrative/Other|0|||
125260863|NCT00673920|450585423|FG001|Baseline up to Week 48|Administrative/Other|1|||
125260864|NCT00673920|450585424|FG002|Baseline up to Week 48|Administrative/Other|2|||
125260865|NCT00673920|450585425|FG003|Baseline up to Week 48|Administrative/Other|0|||
125260866|NCT00673920|450585426|FG004|Baseline up to Week 48|Administrative/Other|0|||
125260867|NCT00673920|450585427|FG005|Baseline up to Week 48|Administrative/Other|0|||
125260868|NCT00673920|450585428|FG006|Baseline up to Week 48|Administrative/Other|0|||
125260869|NCT00673920|450585429|FG007|Baseline up to Week 48|Administrative/Other|0|||
125260870|NCT00673920|450585422|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
125260871|NCT00673920|450585423|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
125260872|NCT00673920|450585424|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
125260873|NCT00673920|450585425|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
125260874|NCT00673920|450585426|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
125260875|NCT00673920|450585427|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
125260876|NCT00673920|450585428|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
125260877|NCT00673920|450585429|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
125260878|NCT00673920|450585422|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
125260879|NCT00673920|450585423|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
125260880|NCT00673920|450585424|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
125260881|NCT00673920|450585425|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
125260882|NCT00673920|450585426|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
125260883|NCT00673920|450585427|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
125260884|NCT00673920|450585428|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
125260885|NCT00673920|450585429|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
125260886|NCT00673920|450585422|FG000|Week 24 to Week 48|Failure to return|0|||
125260887|NCT00673920|450585423|FG001|Week 24 to Week 48|Failure to return|0|||
125260888|NCT00673920|450585424|FG002|Week 24 to Week 48|Failure to return|0|||
125260889|NCT00673920|450585425|FG003|Week 24 to Week 48|Failure to return|0|||
125260890|NCT00673920|450585426|FG004|Week 24 to Week 48|Failure to return|0|||
125260891|NCT00673920|450585427|FG005|Week 24 to Week 48|Failure to return|1|||
125260892|NCT00673920|450585428|FG006|Week 24 to Week 48|Failure to return|0|||
125260893|NCT00673920|450585429|FG007|Week 24 to Week 48|Failure to return|0|||
125260894|NCT00673920|450585422|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
125260895|NCT00673920|450585423|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
125260896|NCT00673920|450585424|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
125260897|NCT00673920|450585425|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
125260898|NCT00673920|450585426|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
125260899|NCT00673920|450585427|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
125260900|NCT00673920|450585428|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
125260901|NCT00673920|450585429|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
125260902|NCT00673920|450585422|FG000|Week 24 to Week 48|Death|0|||
125260903|NCT00673920|450585423|FG001|Week 24 to Week 48|Death|0|||
125260904|NCT00673920|450585424|FG002|Week 24 to Week 48|Death|0|||
125260905|NCT00673920|450585425|FG003|Week 24 to Week 48|Death|0|||
125260906|NCT00673920|450585426|FG004|Week 24 to Week 48|Death|0|||
125260907|NCT00673920|450585427|FG005|Week 24 to Week 48|Death|1|||
125260908|NCT00673920|450585428|FG006|Week 24 to Week 48|Death|0|||
125260909|NCT00673920|450585429|FG007|Week 24 to Week 48|Death|0|||
125260910|NCT00673920|450585422|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
125260911|NCT00673920|450585423|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
125260912|NCT00673920|450585424|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
125260913|NCT00673920|450585425|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
125260914|NCT00673920|450585426|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
125260915|NCT00673920|450585427|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
125260916|NCT00673920|450585428|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
125260917|NCT00673920|450585429|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
125260918|NCT01164007|450585430|FG000|Overall Study|Adverse Event|5|||
125260919|NCT01164007|450585430|FG000|Overall Study|Progression of Disease|30|||
125260920|NCT01164007|450585430|FG000|Overall Study|Protocol Violation|1|||
125260921|NCT01164007|450585430|FG000|Overall Study|Withdrawal by Subject|1|||
125260922|NCT01164007|450585430|FG000|Overall Study|Medical Decision|3|||
125260923|NCT04856527|450585431|FG000|Overall Study|Unable to complete experimental task|2|||
125260924|NCT04856527|450585432|FG001|Overall Study|Unable to complete experimental task|0|||
125260925|NCT01816295|450585433|FG000|Double Blind Phase|Adverse Event|11|||
125260926|NCT01816295|450585434|FG001|Double Blind Phase|Adverse Event|8|||
125260927|NCT01816295|450585433|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
125260928|NCT01816295|450585434|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
125260929|NCT01816295|450585433|FG000|Double Blind Phase|Lost to Follow-up|3|||
125260930|NCT01816295|450585434|FG001|Double Blind Phase|Lost to Follow-up|5|||
125260931|NCT01816295|450585433|FG000|Double Blind Phase|Physician Decision|2|||
125260932|NCT01816295|450585434|FG001|Double Blind Phase|Physician Decision|2|||
125260933|NCT01816295|450585433|FG000|Double Blind Phase|Protocol Violation|17|||
125260934|NCT01816295|450585434|FG001|Double Blind Phase|Protocol Violation|11|||
125260935|NCT01816295|450585433|FG000|Double Blind Phase|Sponsor Decision|8|||
125260936|NCT01816295|450585434|FG001|Double Blind Phase|Sponsor Decision|8|||
125260937|NCT01816295|450585433|FG000|Double Blind Phase|Withdrawal by Subject|22|||
125260938|NCT01816295|450585434|FG001|Double Blind Phase|Withdrawal by Subject|20|||
125260939|NCT01816295|450585433|FG000|OLE Phase|Adverse Event|17|||
125260940|NCT01816295|450585434|FG001|OLE Phase|Adverse Event|15|||
125260941|NCT01816295|450585433|FG000|OLE Phase|Death|1|||
125260942|NCT01816295|450585434|FG001|OLE Phase|Death|0|||
125260943|NCT01816295|450585433|FG000|OLE Phase|Entry Criteria Not Met|3|||
125260944|NCT01816295|450585434|FG001|OLE Phase|Entry Criteria Not Met|5|||
125260945|NCT01816295|450585433|FG000|OLE Phase|Lost to Follow-up|5|||
125260946|NCT01816295|450585434|FG001|OLE Phase|Lost to Follow-up|5|||
125260947|NCT01816295|450585433|FG000|OLE Phase|Physician Decision|3|||
125260948|NCT01816295|450585434|FG001|OLE Phase|Physician Decision|1|||
125260949|NCT01816295|450585433|FG000|OLE Phase|Protocol Violation|4|||
125260950|NCT01816295|450585434|FG001|OLE Phase|Protocol Violation|4|||
125260951|NCT01816295|450585433|FG000|OLE Phase|Sponsor Decision|7|||
125260952|NCT01816295|450585434|FG001|OLE Phase|Sponsor Decision|9|||
125260953|NCT01816295|450585433|FG000|OLE Phase|Withdrawal by Subject|10|||
125260954|NCT01816295|450585434|FG001|OLE Phase|Withdrawal by Subject|10|||
125260955|NCT01816295|450585433|FG000|OLE Phase|Lack of Efficacy|3|||
125260956|NCT01816295|450585434|FG001|OLE Phase|Lack of Efficacy|7|||
125260957|NCT04165824|450585435|FG000|Overall Study|Adverse Event|23|||
125260958|NCT04165824|450585435|FG000|Overall Study|Physician Decision|1|||
125260959|NCT04165824|450585435|FG000|Overall Study|Withdrawal by Subject|17|||
125260960|NCT04165824|450585435|FG000|Overall Study|Other|5|||
125260961|NCT01823289|450585436|FG000|Overall Study|Lost to Follow-up|5|||
125260962|NCT01823289|450585436|FG000|Overall Study|Adverse Event|5|||
125260963|NCT01823289|450585436|FG000|Overall Study|Lack of Efficacy|1|||
125260964|NCT01823289|450585436|FG000|Overall Study|Physician Decision|9|||
125260965|NCT01823289|450585436|FG000|Overall Study|Administered contraindicated medicine|1|||
125260966|NCT01823289|450585436|FG000|Overall Study|Transaminase increased more than 3 times|1|||
125260967|NCT01823289|450585436|FG000|Overall Study|Drug affected efficacy and safety|1|||
125260968|NCT01823289|450585436|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
125260969|NCT01656161|450585444|FG000|Overall Study|Death|3|||
125260970|NCT01656161|450585444|FG000|Overall Study|Adverse Event|2|||
125260971|NCT01656161|450585444|FG000|Overall Study|Protocol Violation|1|||
125260972|NCT01656161|450585444|FG000|Overall Study|Withdrawal by Subject|1|||
125260973|NCT03510273|450585445|FG000|Overall Study|Withdrawal by Subject|2|||
125260974|NCT03510273|450585445|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
125260975|NCT03510273|450585445|FG000|Overall Study|Moved away from study area|4|||
125260976|NCT01276106|450585446|FG000|Overall Study|Adverse Event|3|||
125260977|NCT01276106|450585447|FG001|Overall Study|Adverse Event|3|||
125260978|NCT01276106|450585448|FG002|Overall Study|Adverse Event|11|||
125260979|NCT01276106|450585449|FG003|Overall Study|Adverse Event|3|||
125260980|NCT01276106|450585446|FG000|Overall Study|Withdrawal by Subject|6|||
125260981|NCT01276106|450585447|FG001|Overall Study|Withdrawal by Subject|3|||
125260982|NCT01276106|450585448|FG002|Overall Study|Withdrawal by Subject|1|||
125260983|NCT01276106|450585449|FG003|Overall Study|Withdrawal by Subject|6|||
125260984|NCT01276106|450585446|FG000|Overall Study|Lack of Efficacy|0|||
125260985|NCT01276106|450585447|FG001|Overall Study|Lack of Efficacy|1|||
125260986|NCT01276106|450585448|FG002|Overall Study|Lack of Efficacy|0|||
125260987|NCT01276106|450585449|FG003|Overall Study|Lack of Efficacy|1|||
125260988|NCT01276106|450585446|FG000|Overall Study|Lost to Follow-up|2|||
125260989|NCT01276106|450585447|FG001|Overall Study|Lost to Follow-up|1|||
125260990|NCT01276106|450585448|FG002|Overall Study|Lost to Follow-up|1|||
125260991|NCT01276106|450585449|FG003|Overall Study|Lost to Follow-up|0|||
125260992|NCT01276106|450585446|FG000|Overall Study|Physician Decision|0|||
125260993|NCT01276106|450585447|FG001|Overall Study|Physician Decision|0|||
125260994|NCT01276106|450585448|FG002|Overall Study|Physician Decision|1|||
125260995|NCT01276106|450585449|FG003|Overall Study|Physician Decision|1|||
125260996|NCT01276106|450585446|FG000|Overall Study|Protocol Violation|1|||
125260997|NCT01276106|450585447|FG001|Overall Study|Protocol Violation|1|||
125260998|NCT01276106|450585448|FG002|Overall Study|Protocol Violation|0|||
125260999|NCT01276106|450585449|FG003|Overall Study|Protocol Violation|2|||
125261000|NCT01276106|450585446|FG000|Overall Study|Insufficient therapeutic effects|0|||
125261001|NCT01276106|450585447|FG001|Overall Study|Insufficient therapeutic effects|0|||
125261002|NCT01276106|450585448|FG002|Overall Study|Insufficient therapeutic effects|2|||
125261003|NCT01276106|450585449|FG003|Overall Study|Insufficient therapeutic effects|0|||
125261004|NCT04079738|450585452|FG000|Study Treatment|Death|1|||
125261005|NCT04079738|450585453|FG001|Study Treatment|Death|0|||
125261006|NCT04079738|450585454|FG002|Study Treatment|Death|0|||
125261007|NCT04079738|450585455|FG003|Study Treatment|Death|0|||
125261008|NCT04079738|450585452|FG000|Study Treatment|Adverse Event|2|||
125261009|NCT04079738|450585453|FG001|Study Treatment|Adverse Event|0|||
125261010|NCT04079738|450585454|FG002|Study Treatment|Adverse Event|0|||
125261011|NCT04079738|450585455|FG003|Study Treatment|Adverse Event|0|||
125261012|NCT04079738|450585452|FG000|Study Treatment|withdrawal before treatment|1|||
125261013|NCT04079738|450585453|FG001|Study Treatment|withdrawal before treatment|0|||
125261014|NCT04079738|450585454|FG002|Study Treatment|withdrawal before treatment|0|||
125261015|NCT04079738|450585455|FG003|Study Treatment|withdrawal before treatment|0|||
125261016|NCT04079738|450585452|FG000|Study Treatment|symptomatic deterioration|2|||
125261017|NCT04079738|450585453|FG001|Study Treatment|symptomatic deterioration|0|||
125261018|NCT04079738|450585454|FG002|Study Treatment|symptomatic deterioration|0|||
125261019|NCT04079738|450585455|FG003|Study Treatment|symptomatic deterioration|0|||
125261020|NCT04079738|450585452|FG000|Study Treatment|Disease Progression|1|||
125261021|NCT04079738|450585453|FG001|Study Treatment|Disease Progression|0|||
125261022|NCT04079738|450585454|FG002|Study Treatment|Disease Progression|0|||
125261023|NCT04079738|450585455|FG003|Study Treatment|Disease Progression|0|||
125261024|NCT04079738|450585452|FG000|Study Treatment|withdrawal after treatment|1|||
125261025|NCT04079738|450585453|FG001|Study Treatment|withdrawal after treatment|0|||
125261026|NCT04079738|450585454|FG002|Study Treatment|withdrawal after treatment|0|||
125261027|NCT04079738|450585455|FG003|Study Treatment|withdrawal after treatment|0|||
125261028|NCT04079738|450585452|FG000|Follow up|Withdrawal by Subject|3|||
125261029|NCT04079738|450585453|FG001|Follow up|Withdrawal by Subject|0|||
125261030|NCT04079738|450585454|FG002|Follow up|Withdrawal by Subject|0|||
125261031|NCT04079738|450585455|FG003|Follow up|Withdrawal by Subject|0|||
125261032|NCT04079738|450585452|FG000|Follow up|Death|5|||
125261033|NCT04079738|450585453|FG001|Follow up|Death|0|||
125261034|NCT04079738|450585454|FG002|Follow up|Death|0|||
125261035|NCT04079738|450585455|FG003|Follow up|Death|0|||
125261036|NCT00867035|450585458|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
125261037|NCT00867035|450585459|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
125261038|NCT00867035|450585458|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
125261039|NCT00867035|450585459|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
125261040|NCT00789555|450585460|FG000|Overall Study|Protocol Amendment|78|||
125261041|NCT00789555|450585461|FG001|Overall Study|Protocol Amendment|76|||
125261042|NCT00789555|450585462|FG002|Overall Study|Protocol Amendment|80|||
125261043|NCT00789555|450585460|FG000|Overall Study|Adverse Event|17|||
125261044|NCT00789555|450585461|FG001|Overall Study|Adverse Event|7|||
125261045|NCT00789555|450585462|FG002|Overall Study|Adverse Event|10|||
125261046|NCT00789555|450585460|FG000|Overall Study|Lost to Follow-up|9|||
125261047|NCT00789555|450585461|FG001|Overall Study|Lost to Follow-up|10|||
125261048|NCT00789555|450585462|FG002|Overall Study|Lost to Follow-up|18|||
125261049|NCT00789555|450585460|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
125261050|NCT00789555|450585461|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
125261051|NCT00789555|450585462|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
125261052|NCT00789555|450585460|FG000|Overall Study|Treatment failure|11|||
125261053|NCT00789555|450585461|FG001|Overall Study|Treatment failure|8|||
125261054|NCT00789555|450585462|FG002|Overall Study|Treatment failure|12|||
125261055|NCT00789555|450585460|FG000|Overall Study|Protocol Violation|6|||
125261056|NCT00789555|450585461|FG001|Overall Study|Protocol Violation|9|||
125261057|NCT00789555|450585462|FG002|Overall Study|Protocol Violation|13|||
125261058|NCT00404248|450585463|FG000|Overall Study|pts declining status|0|||
125261059|NCT00404248|450585464|FG001|Overall Study|pts declining status|1|||
125261060|NCT00404248|450585465|FG002|Overall Study|pts declining status|0|||
125261061|NCT00404248|450585466|FG003|Overall Study|pts declining status|0|||
125261062|NCT00404248|450585467|FG004|Overall Study|pts declining status|0|||
125261063|NCT00404248|450585468|FG005|Overall Study|pts declining status|0|||
125261064|NCT00404248|450585469|FG006|Overall Study|pts declining status|0|||
125261065|NCT00404248|450585470|FG007|Overall Study|pts declining status|0|||
125261066|NCT00404248|450585471|FG008|Overall Study|pts declining status|0|||
125261067|NCT04646005|450585472|FG000|Overall Study|Adverse Event|1|||
125261068|NCT04646005|450585472|FG000|Overall Study|Progressive Disease|71|||
125261069|NCT04646005|450585472|FG000|Overall Study|Death|20|||
125261070|NCT04646005|450585472|FG000|Overall Study|Withdrawal by Subject|12|||
125261071|NCT04646005|450585472|FG000|Overall Study|Sponsor Request|9|||
125261072|NCT04398706|450585473|FG000|Overall Study|Adverse Event|0|||
125261073|NCT04398706|450585474|FG001|Overall Study|Adverse Event|0|||
125261074|NCT04398706|450585475|FG002|Overall Study|Adverse Event|0|||
125261075|NCT04398706|450585476|FG003|Overall Study|Adverse Event|0|||
125261076|NCT04398706|450585477|FG004|Overall Study|Adverse Event|0|||
125261077|NCT04398706|450585478|FG005|Overall Study|Adverse Event|1|||
125261078|NCT04398706|450585479|FG006|Overall Study|Adverse Event|1|||
125261079|NCT04398706|450585480|FG007|Overall Study|Adverse Event|0|||
125261080|NCT04398706|450585473|FG000|Overall Study|Lost to Follow-up|0|||
125261081|NCT04398706|450585474|FG001|Overall Study|Lost to Follow-up|1|||
125261082|NCT04398706|450585475|FG002|Overall Study|Lost to Follow-up|2|||
125261083|NCT04398706|450585476|FG003|Overall Study|Lost to Follow-up|1|||
125261084|NCT04398706|450585477|FG004|Overall Study|Lost to Follow-up|6|||
125261085|NCT04398706|450585478|FG005|Overall Study|Lost to Follow-up|3|||
125261086|NCT04398706|450585479|FG006|Overall Study|Lost to Follow-up|8|||
125261087|NCT04398706|450585480|FG007|Overall Study|Lost to Follow-up|2|||
125261088|NCT04398706|450585473|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125261089|NCT04398706|450585474|FG001|Overall Study|Withdrawal by parent/guardian|2|||
125261090|NCT04398706|450585475|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125261091|NCT04398706|450585476|FG003|Overall Study|Withdrawal by parent/guardian|2|||
125261092|NCT04398706|450585477|FG004|Overall Study|Withdrawal by parent/guardian|19|||
125261093|NCT04398706|450585478|FG005|Overall Study|Withdrawal by parent/guardian|23|||
125261094|NCT04398706|450585479|FG006|Overall Study|Withdrawal by parent/guardian|13|||
125261095|NCT04398706|450585480|FG007|Overall Study|Withdrawal by parent/guardian|11|||
125261096|NCT04398706|450585473|FG000|Overall Study|Protocol deviation|0|||
125261097|NCT04398706|450585474|FG001|Overall Study|Protocol deviation|1|||
125261098|NCT04398706|450585475|FG002|Overall Study|Protocol deviation|0|||
125261099|NCT04398706|450585476|FG003|Overall Study|Protocol deviation|0|||
125261100|NCT04398706|450585477|FG004|Overall Study|Protocol deviation|6|||
125261101|NCT04398706|450585478|FG005|Overall Study|Protocol deviation|4|||
125261102|NCT04398706|450585479|FG006|Overall Study|Protocol deviation|6|||
125261103|NCT04398706|450585480|FG007|Overall Study|Protocol deviation|3|||
125261104|NCT02611037|450585481|FG000|Overall Study|Withdrawal prior to treatment|2|||
125261105|NCT02611037|450585482|FG001|Overall Study|Withdrawal prior to treatment|0|||
125261106|NCT04577404|450585483|FG000|Overall Study|Adverse Event|31|||
125261107|NCT04577404|450585483|FG000|Overall Study|Death|1|||
125261108|NCT04577404|450585483|FG000|Overall Study|Lack of Efficacy|3|||
125261109|NCT04577404|450585483|FG000|Overall Study|Physician Decision|7|||
125261110|NCT04577404|450585483|FG000|Overall Study|Withdrawal by Subject|21|||
125261111|NCT04577404|450585483|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
125261112|NCT04237584|450585490|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
125261113|NCT04237584|450585491|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
125261114|NCT04237584|450585492|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
125261115|NCT04237584|450585493|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
125261116|NCT04237584|450585490|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
125261117|NCT04237584|450585491|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
125261118|NCT04237584|450585492|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
125261119|NCT04237584|450585493|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
125261120|NCT04237584|450585490|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
125261121|NCT04237584|450585491|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
125261122|NCT04237584|450585492|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
125261123|NCT04237584|450585493|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
125261124|NCT04237584|450585490|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
125261125|NCT04237584|450585491|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
125261126|NCT04237584|450585492|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
125261127|NCT04237584|450585493|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
125261128|NCT04237584|450585490|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
125261129|NCT04237584|450585491|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
125261130|NCT04237584|450585492|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
125261131|NCT04237584|450585493|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
125261132|NCT03586973|450585494|FG000|Overall Study|Death|15|||
125261133|NCT03586973|450585495|FG001|Overall Study|Death|8|||
125261134|NCT03586973|450585494|FG000|Overall Study|Site Terminated by Sponsor|3|||
125261135|NCT03586973|450585495|FG001|Overall Study|Site Terminated by Sponsor|6|||
125261136|NCT03586973|450585494|FG000|Overall Study|Withdrawal by Subject|1|||
125261137|NCT03586973|450585495|FG001|Overall Study|Withdrawal by Subject|0|||
125261138|NCT03586973|450585494|FG000|Overall Study|Lost to Follow-up|1|||
125261139|NCT03586973|450585495|FG001|Overall Study|Lost to Follow-up|0|||
125261140|NCT03423979|450585496|FG000|Overall Study|Death|1|||
125261141|NCT05239221|450585497|FG000|Overall Study|Adverse Event|0|||
125261142|NCT05239221|450585498|FG001|Overall Study|Adverse Event|0|||
125261143|NCT05239221|450585499|FG002|Overall Study|Adverse Event|0|||
125261144|NCT05239221|450585500|FG003|Overall Study|Adverse Event|0|||
125261145|NCT05239221|450585501|FG004|Overall Study|Adverse Event|0|||
125261146|NCT05239221|450585502|FG005|Overall Study|Adverse Event|0|||
125261147|NCT05239221|450585503|FG006|Overall Study|Adverse Event|1|||
125261148|NCT05239221|450585504|FG007|Overall Study|Adverse Event|0|||
125261149|NCT05239221|450585505|FG008|Overall Study|Adverse Event|0|||
125261150|NCT05239221|450585506|FG009|Overall Study|Adverse Event|0|||
125261151|NCT05239221|450585507|FG010|Overall Study|Adverse Event|1|||
125261152|NCT05239221|450585508|FG011|Overall Study|Adverse Event|1|||
125261153|NCT05239221|450585509|FG012|Overall Study|Adverse Event|0|||
125261154|NCT05239221|450585510|FG013|Overall Study|Adverse Event|0|||
125261155|NCT05239221|450585511|FG014|Overall Study|Adverse Event|0|||
125261156|NCT05239221|450585512|FG015|Overall Study|Adverse Event|0|||
125261157|NCT05239221|450585497|FG000|Overall Study|Withdrawal by Subject|0|||
125261158|NCT05239221|450585498|FG001|Overall Study|Withdrawal by Subject|0|||
125261159|NCT05239221|450585499|FG002|Overall Study|Withdrawal by Subject|0|||
125261160|NCT05239221|450585500|FG003|Overall Study|Withdrawal by Subject|0|||
125261161|NCT05239221|450585501|FG004|Overall Study|Withdrawal by Subject|0|||
125261162|NCT05239221|450585502|FG005|Overall Study|Withdrawal by Subject|0|||
125261163|NCT05239221|450585503|FG006|Overall Study|Withdrawal by Subject|0|||
125261164|NCT05239221|450585504|FG007|Overall Study|Withdrawal by Subject|0|||
125261165|NCT05239221|450585505|FG008|Overall Study|Withdrawal by Subject|0|||
125261166|NCT05239221|450585506|FG009|Overall Study|Withdrawal by Subject|0|||
125261167|NCT05239221|450585507|FG010|Overall Study|Withdrawal by Subject|1|||
125261168|NCT05239221|450585508|FG011|Overall Study|Withdrawal by Subject|0|||
125261169|NCT05239221|450585509|FG012|Overall Study|Withdrawal by Subject|0|||
125261170|NCT05239221|450585510|FG013|Overall Study|Withdrawal by Subject|0|||
125261171|NCT05239221|450585511|FG014|Overall Study|Withdrawal by Subject|0|||
125261172|NCT05239221|450585512|FG015|Overall Study|Withdrawal by Subject|1|||
125261173|NCT02661672|450585513|FG000|Overall Study|Lost to Follow-up|1|||
125261174|NCT02661672|450585513|FG000|Overall Study|Death|4|||
125261175|NCT04696146|450587084|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
125261176|NCT04696146|450587085|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
125261177|NCT04696146|450587084|FG000|Overall Study|Off hours issue with product|1|||
125261178|NCT04696146|450587085|FG001|Overall Study|Off hours issue with product|0|||
125261179|NCT00529633|450587090|FG000|Overall Study|Withdrawal by Subject|1|||
125261180|NCT00529633|450587091|FG001|Overall Study|Withdrawal by Subject|1|||
125261181|NCT01576783|450587092|FG000|Overall Study|Change in Medical Care|1|||
125261182|NCT01576783|450587093|FG001|Overall Study|Change in Medical Care|0|||
125261183|NCT01576783|450587092|FG000|Overall Study|Lost to Follow-up|14|||
125261184|NCT01576783|450587093|FG001|Overall Study|Lost to Follow-up|16|||
125261185|NCT01576783|450587092|FG000|Overall Study|Withdrawal by Subject|5|||
125261186|NCT01576783|450587093|FG001|Overall Study|Withdrawal by Subject|1|||
125261187|NCT01897493|450587095|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
125261188|NCT05489328|450587096|FG000|Overall Study|Lost to Follow-up|0|||
125261189|NCT05489328|450587097|FG001|Overall Study|Lost to Follow-up|0|||
125261190|NCT05489328|450587098|FG002|Overall Study|Lost to Follow-up|1|||
125261191|NCT05489328|450587099|FG003|Overall Study|Lost to Follow-up|0|||
125261192|NCT05489328|450587100|FG004|Overall Study|Lost to Follow-up|2|||
125261193|NCT05489328|450587101|FG005|Overall Study|Lost to Follow-up|0|||
125261194|NCT05489328|450587102|FG006|Overall Study|Lost to Follow-up|0|||
125261195|NCT05489328|450587103|FG007|Overall Study|Lost to Follow-up|1|||
125261196|NCT05489328|450587104|FG008|Overall Study|Lost to Follow-up|0|||
125261197|NCT05489328|450587096|FG000|Overall Study|Withdrawal by Subject|0|||
125261198|NCT05489328|450587097|FG001|Overall Study|Withdrawal by Subject|0|||
125261199|NCT05489328|450587098|FG002|Overall Study|Withdrawal by Subject|0|||
125261200|NCT05489328|450587099|FG003|Overall Study|Withdrawal by Subject|0|||
125261201|NCT05489328|450587100|FG004|Overall Study|Withdrawal by Subject|0|||
125261202|NCT05489328|450587101|FG005|Overall Study|Withdrawal by Subject|0|||
125261203|NCT05489328|450587102|FG006|Overall Study|Withdrawal by Subject|1|||
125261204|NCT05489328|450587103|FG007|Overall Study|Withdrawal by Subject|1|||
125261205|NCT05489328|450587104|FG008|Overall Study|Withdrawal by Subject|0|||
125261206|NCT05489328|450587096|FG000|Overall Study|Other|0|||
125261207|NCT05489328|450587097|FG001|Overall Study|Other|0|||
125261208|NCT05489328|450587098|FG002|Overall Study|Other|0|||
125261209|NCT05489328|450587099|FG003|Overall Study|Other|0|||
125261210|NCT05489328|450587100|FG004|Overall Study|Other|0|||
125261211|NCT05489328|450587101|FG005|Overall Study|Other|0|||
125261212|NCT05489328|450587102|FG006|Overall Study|Other|0|||
125261213|NCT05489328|450587103|FG007|Overall Study|Other|1|||
125261214|NCT05489328|450587104|FG008|Overall Study|Other|1|||
125261215|NCT01083602|450587105|FG000|Overall Study|Adverse Event|11|||
125261216|NCT01083602|450587105|FG000|Overall Study|New Cancer Therapy|2|||
125261217|NCT01083602|450587105|FG000|Overall Study|Death|1|||
125261218|NCT01083602|450587105|FG000|Overall Study|Withdrawal by Subject|5|||
125261219|NCT01083602|450587105|FG000|Overall Study|Lack of Efficacy|36|||
125261220|NCT03698279|450587106|FG000|Overall Study|Withdrawal by parent/guardian|1|||
125261221|NCT03698279|450587107|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125261222|NCT03698279|450587108|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125261223|NCT03698279|450587109|FG003|Overall Study|Withdrawal by parent/guardian|1|||
125261224|NCT03698279|450587110|FG004|Overall Study|Withdrawal by parent/guardian|0|||
125261225|NCT03698279|450587111|FG005|Overall Study|Withdrawal by parent/guardian|0|||
125261226|NCT03698279|450587106|FG000|Overall Study|Protocol deviation|1|||
125261227|NCT03698279|450587107|FG001|Overall Study|Protocol deviation|0|||
125261228|NCT03698279|450587108|FG002|Overall Study|Protocol deviation|1|||
125261229|NCT03698279|450587109|FG003|Overall Study|Protocol deviation|0|||
125261230|NCT03698279|450587110|FG004|Overall Study|Protocol deviation|0|||
125261231|NCT03698279|450587111|FG005|Overall Study|Protocol deviation|0|||
125261232|NCT03698279|450587106|FG000|Overall Study|Withdrawal by Subject|0|||
125261233|NCT03698279|450587107|FG001|Overall Study|Withdrawal by Subject|0|||
125261234|NCT03698279|450587108|FG002|Overall Study|Withdrawal by Subject|1|||
125261235|NCT03698279|450587109|FG003|Overall Study|Withdrawal by Subject|0|||
125261236|NCT03698279|450587110|FG004|Overall Study|Withdrawal by Subject|0|||
125261237|NCT03698279|450587111|FG005|Overall Study|Withdrawal by Subject|0|||
125261238|NCT03698279|450587106|FG000|Overall Study|Lost to Follow-up|3|||
125261239|NCT03698279|450587107|FG001|Overall Study|Lost to Follow-up|1|||
125261240|NCT03698279|450587108|FG002|Overall Study|Lost to Follow-up|4|||
125261241|NCT03698279|450587109|FG003|Overall Study|Lost to Follow-up|5|||
125261242|NCT03698279|450587110|FG004|Overall Study|Lost to Follow-up|0|||
125261243|NCT03698279|450587111|FG005|Overall Study|Lost to Follow-up|0|||
125261244|NCT01276704|450587114|FG000|Overall Study|Lost to Follow-up|2|||
125261245|NCT01276704|450587115|FG001|Overall Study|Lost to Follow-up|3|||
125261246|NCT01276704|450587114|FG000|Overall Study|Non-compliant|2|||
125261247|NCT01276704|450587115|FG001|Overall Study|Non-compliant|2|||
125261248|NCT01276704|450587114|FG000|Overall Study|Withdrawal by Subject|7|||
125261249|NCT01276704|450587115|FG001|Overall Study|Withdrawal by Subject|1|||
125261250|NCT01276704|450587114|FG000|Overall Study|Physician Decision|3|||
125261251|NCT01276704|450587115|FG001|Overall Study|Physician Decision|5|||
125261252|NCT02276040|450587116|FG000|Overall Study|Physician Decision|15|||
125261253|NCT02239926|450587117|FG000|Overall Study|Withdrawal by Subject|0|||
125261254|NCT02239926|450587118|FG001|Overall Study|Withdrawal by Subject|1|||
125261255|NCT03801525|450587119|FG000|Overall Study|Adverse Event|17|||
125261256|NCT03801525|450587120|FG001|Overall Study|Adverse Event|1|||
125261257|NCT03801525|450587121|FG002|Overall Study|Adverse Event|0|||
125261258|NCT03801525|450587119|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
125261259|NCT03801525|450587120|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
125261260|NCT03801525|450587121|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
125261261|NCT03801525|450587119|FG000|Overall Study|Death|29|||
125261262|NCT03801525|450587120|FG001|Overall Study|Death|1|||
125261263|NCT03801525|450587121|FG002|Overall Study|Death|4|||
125261264|NCT03801525|450587119|FG000|Overall Study|Disease Progression|6|||
125261265|NCT03801525|450587120|FG001|Overall Study|Disease Progression|0|||
125261266|NCT03801525|450587121|FG002|Overall Study|Disease Progression|1|||
125261267|NCT03801525|450587119|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
125261268|NCT03801525|450587120|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
125261269|NCT03801525|450587121|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
125261270|NCT03801525|450587119|FG000|Overall Study|Investigator Decision|18|||
125261271|NCT03801525|450587120|FG001|Overall Study|Investigator Decision|1|||
125261272|NCT03801525|450587121|FG002|Overall Study|Investigator Decision|0|||
125261273|NCT03801525|450587119|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
125261274|NCT03801525|450587120|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
125261275|NCT03801525|450587121|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
125261276|NCT03801525|450587119|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
125261277|NCT03801525|450587120|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
125261278|NCT03801525|450587121|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
125261279|NCT03801525|450587119|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
125261280|NCT03801525|450587120|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
125261281|NCT03801525|450587121|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
125261282|NCT03801525|450587119|FG000|Overall Study|Withdrawal of Subject Consent|38|||
125261283|NCT03801525|450587120|FG001|Overall Study|Withdrawal of Subject Consent|2|||
125261284|NCT03801525|450587121|FG002|Overall Study|Withdrawal of Subject Consent|1|||
125261285|NCT03801525|450587119|FG000|Overall Study|Reason not Specified|4|||
125261286|NCT03801525|450587120|FG001|Overall Study|Reason not Specified|0|||
125261287|NCT03801525|450587121|FG002|Overall Study|Reason not Specified|4|||
125261288|NCT04388826|450587125|FG000|Overall Study|Lost to Follow-up|3|||
125261289|NCT04388826|450587126|FG001|Overall Study|Lost to Follow-up|2|||
125261290|NCT04388826|450587125|FG000|Overall Study|Adverse Event|1|||
125261291|NCT04388826|450587126|FG001|Overall Study|Adverse Event|0|||
125261292|NCT00329420|450587127|FG000|Re-induction Phase|Lack of Efficacy|0|||
125261293|NCT00329420|450587128|FG001|Re-induction Phase|Lack of Efficacy|1|||
125261294|NCT00329420|450587129|FG002|Re-induction Phase|Lack of Efficacy|0|||
125261295|NCT00329420|450587127|FG000|Re-induction Phase|Withdrawal of Consent|0|||
125261296|NCT00329420|450587128|FG001|Re-induction Phase|Withdrawal of Consent|0|||
125261297|NCT00329420|450587129|FG002|Re-induction Phase|Withdrawal of Consent|1|||
125261298|NCT00329420|450587127|FG000|Re-induction Phase|Did not respond to re-induction|6|||
125261299|NCT00329420|450587128|FG001|Re-induction Phase|Did not respond to re-induction|5|||
125261300|NCT00329420|450587129|FG002|Re-induction Phase|Did not respond to re-induction|7|||
125261301|NCT00329420|450587127|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
125261302|NCT00329420|450587128|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
125261303|NCT00329420|450587129|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
125261304|NCT00329420|450587127|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
125261305|NCT00329420|450587128|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
125261306|NCT00329420|450587129|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
125261307|NCT00329420|450587127|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
125261308|NCT00329420|450587128|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
125261309|NCT00329420|450587129|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
125261310|NCT02862574|450587130|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125261311|NCT02862574|450587131|FG001|Double-Blind Treatment Period|Adverse Event|1|||
125261312|NCT02862574|450587132|FG002|Double-Blind Treatment Period|Adverse Event|0|||
125261313|NCT02862574|450587130|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
125261314|NCT02862574|450587131|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
125261315|NCT02862574|450587132|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
125261316|NCT02862574|450587130|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
125261317|NCT02862574|450587131|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
125261318|NCT02862574|450587132|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
125261319|NCT00320606|450587142|FG000|Overall Study|Adverse Event|1|||
125261320|NCT00320606|450587142|FG000|Overall Study|Protocol Violation|1|||
125261321|NCT00320606|450587142|FG000|Overall Study|Withdrawal by Subject|1|||
125261322|NCT03984825|450587143|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
125261323|NCT03984825|450587143|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
125261324|NCT03984825|450587143|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
125261325|NCT00399035|450587146|FG000|Overall Study|Death|289|||
125261326|NCT00399035|450587147|FG001|Overall Study|Death|141|||
125261327|NCT00399035|450587148|FG002|Overall Study|Death|234|||
125261328|NCT00399035|450587146|FG000|Overall Study|Lost to Follow-up|2|||
125261329|NCT00399035|450587147|FG001|Overall Study|Lost to Follow-up|1|||
125261330|NCT00399035|450587148|FG002|Overall Study|Lost to Follow-up|5|||
125261331|NCT00399035|450587146|FG000|Overall Study|Withdrawal by Subject|19|||
125261332|NCT00399035|450587147|FG001|Overall Study|Withdrawal by Subject|15|||
125261333|NCT00399035|450587148|FG002|Overall Study|Withdrawal by Subject|12|||
125261334|NCT00399035|450587146|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
125261335|NCT00399035|450587147|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
125261336|NCT00399035|450587148|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
125261337|NCT00399035|450587146|FG000|Overall Study|Severe non-compliance with protocol|2|||
125261338|NCT00399035|450587147|FG001|Overall Study|Severe non-compliance with protocol|1|||
125261339|NCT00399035|450587148|FG002|Overall Study|Severe non-compliance with protocol|0|||
125261340|NCT02921256|450587155|FG000|Arm 1a v. Arm II|Adverse Event|6|||
125261341|NCT02921256|450587156|FG001|Arm 1a v. Arm II|Adverse Event|15|||
125261342|NCT02921256|450587157|FG002|Arm 1a v. Arm II|Adverse Event|0|||
125261343|NCT02921256|450587155|FG000|Arm 1a v. Arm II|Death|0|||
125261344|NCT02921256|450587156|FG001|Arm 1a v. Arm II|Death|2|||
125261345|NCT02921256|450587157|FG002|Arm 1a v. Arm II|Death|0|||
125261346|NCT02921256|450587155|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
125261347|NCT02921256|450587156|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
125261348|NCT02921256|450587157|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
125261349|NCT02921256|450587155|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
125261350|NCT02921256|450587156|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
125261351|NCT02921256|450587157|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
125261352|NCT02921256|450587155|FG000|Arm 1a v. Arm II|Physician Decision|1|||
125261353|NCT02921256|450587156|FG001|Arm 1a v. Arm II|Physician Decision|1|||
125261354|NCT02921256|450587157|FG002|Arm 1a v. Arm II|Physician Decision|0|||
125261355|NCT02921256|450587155|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
125261356|NCT02921256|450587156|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
125261357|NCT02921256|450587157|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
125261358|NCT02921256|450587155|FG000|Arm Ib v Arm III|Adverse Event|9|||
125261359|NCT02921256|450587156|FG001|Arm Ib v Arm III|Adverse Event|0|||
125261360|NCT02921256|450587157|FG002|Arm Ib v Arm III|Adverse Event|4|||
125261361|NCT02921256|450587155|FG000|Arm Ib v Arm III|Death|1|||
125261362|NCT02921256|450587156|FG001|Arm Ib v Arm III|Death|0|||
125261363|NCT02921256|450587157|FG002|Arm Ib v Arm III|Death|1|||
125261364|NCT02921256|450587155|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
125261365|NCT02921256|450587156|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
125261366|NCT02921256|450587157|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
125261367|NCT02921256|450587155|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
125261368|NCT02921256|450587156|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
125261369|NCT02921256|450587157|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
125261370|NCT02921256|450587155|FG000|Arm Ib v Arm III|Physician Decision|4|||
125261371|NCT02921256|450587156|FG001|Arm Ib v Arm III|Physician Decision|0|||
125261372|NCT02921256|450587157|FG002|Arm Ib v Arm III|Physician Decision|1|||
125261373|NCT02921256|450587155|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
125261374|NCT02921256|450587156|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
125261375|NCT02921256|450587157|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
125261376|NCT02943473|450587158|FG000|Overall Study|enrolled but not dosed|1|||
125261377|NCT02943473|450587158|FG000|Overall Study|screen failure|1|||
125261378|NCT02943473|450587158|FG000|Overall Study|Physician Decision|4|||
125261379|NCT04211363|450587159|FG000|Overall Study|Adverse Event|5|||
125261380|NCT04211363|450587160|FG001|Overall Study|Adverse Event|2|||
125261381|NCT04211363|450587159|FG000|Overall Study|Physician Decision|0|||
125261382|NCT04211363|450587160|FG001|Overall Study|Physician Decision|1|||
125261383|NCT04211363|450587159|FG000|Overall Study|Protocol Violation|1|||
125261384|NCT04211363|450587160|FG001|Overall Study|Protocol Violation|0|||
125261385|NCT04211363|450587159|FG000|Overall Study|Pregnancy|1|||
125261386|NCT04211363|450587160|FG001|Overall Study|Pregnancy|0|||
125261387|NCT04211363|450587159|FG000|Overall Study|Lost to Follow-up|12|||
125261388|NCT04211363|450587160|FG001|Overall Study|Lost to Follow-up|4|||
125261389|NCT04211363|450587159|FG000|Overall Study|Withdrawal by Subject|11|||
125261390|NCT04211363|450587160|FG001|Overall Study|Withdrawal by Subject|11|||
125261391|NCT04211363|450587159|FG000|Overall Study|Other|1|||
125261392|NCT04211363|450587160|FG001|Overall Study|Other|2|||
125261393|NCT03097289|450587161|FG000|Overall Study|Adverse Event|1|||
125261394|NCT03097289|450587161|FG000|Overall Study|Equipment failure|2|||
125261395|NCT03097289|450587161|FG000|Overall Study|Collected platelet product unusable|3|||
125261396|NCT01736917|450587162|FG000|Overall Study|Adverse Event|1|||
125261397|NCT01736917|450587162|FG000|Overall Study|Protocol Violation|10|||
125261398|NCT01911260|450587163|FG000|Supplementation Period|transference or evasion of school|7|||
125261399|NCT01911260|450587164|FG001|Supplementation Period|transference or evasion of school|9|||
125261400|NCT01911260|450587165|FG002|Supplementation Period|transference or evasion of school|7|||
125261401|NCT01911260|450587166|FG003|Supplementation Period|transference or evasion of school|6|||
125261402|NCT01911260|450587163|FG000|Supplementation Period|Adverse Event|2|||
125261403|NCT01911260|450587164|FG001|Supplementation Period|Adverse Event|0|||
125261404|NCT01911260|450587165|FG002|Supplementation Period|Adverse Event|1|||
125261405|NCT01911260|450587166|FG003|Supplementation Period|Adverse Event|0|||
125261406|NCT01911260|450587163|FG000|Supplementation Period|refused to receive supplement|1|||
125261407|NCT01911260|450587164|FG001|Supplementation Period|refused to receive supplement|0|||
125261408|NCT01911260|450587165|FG002|Supplementation Period|refused to receive supplement|1|||
125261409|NCT01911260|450587166|FG003|Supplementation Period|refused to receive supplement|0|||
125261410|NCT01911260|450587163|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
125261411|NCT01911260|450587164|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
125261412|NCT01911260|450587165|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
125261413|NCT01911260|450587166|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
125261414|NCT01911260|450587163|FG000|Follow-up Period|transference or evasion of school|13|||
125261415|NCT01911260|450587164|FG001|Follow-up Period|transference or evasion of school|20|||
125261416|NCT01911260|450587165|FG002|Follow-up Period|transference or evasion of school|15|||
125261417|NCT01911260|450587166|FG003|Follow-up Period|transference or evasion of school|12|||
125261418|NCT01734902|450587171|FG000|Overall Study|Other than listed|0|||
125261419|NCT01734902|450587172|FG001|Overall Study|Other than listed|2|||
125261420|NCT01959932|450587173|FG000|Overall Study|Withdrawal by Subject|1|||
125261421|NCT01959932|450587174|FG001|Overall Study|Withdrawal by Subject|0|||
125261422|NCT01959932|450587175|FG002|Overall Study|Withdrawal by Subject|0|||
125261423|NCT00060944|450587178|FG000|Overall Study|Adverse Event|12|||
125261424|NCT00060944|450587179|FG001|Overall Study|Adverse Event|10|||
125261425|NCT00060944|450587178|FG000|Overall Study|Death|2|||
125261426|NCT00060944|450587179|FG001|Overall Study|Death|3|||
125261427|NCT00060944|450587178|FG000|Overall Study|Withdrawal by Subject|18|||
125261428|NCT00060944|450587179|FG001|Overall Study|Withdrawal by Subject|5|||
125261429|NCT00060944|450587178|FG000|Overall Study|Disease Progression|93|||
125261430|NCT00060944|450587179|FG001|Overall Study|Disease Progression|94|||
125261431|NCT00060944|450587178|FG000|Overall Study|Lost to Follow-up|1|||
125261432|NCT00060944|450587179|FG001|Overall Study|Lost to Follow-up|0|||
125261433|NCT00060944|450587178|FG000|Overall Study|Subject Ineligible To Continue|2|||
125261434|NCT00060944|450587179|FG001|Overall Study|Subject Ineligible To Continue|1|||
125261435|NCT00060944|450587178|FG000|Overall Study|Treatment Switch|0|||
125261436|NCT00060944|450587179|FG001|Overall Study|Treatment Switch|13|||
125261437|NCT00060944|450587178|FG000|Overall Study|Other|2|||
125261438|NCT00060944|450587179|FG001|Overall Study|Other|4|||
125261439|NCT00060944|450587178|FG000|Overall Study|randomized but not treated|6|||
125261440|NCT00060944|450587179|FG001|Overall Study|randomized but not treated|4|||
125261441|NCT00776230|450587183|FG000|Overall Study|Lost to Follow-up|2|||
125261442|NCT00776230|450587184|FG001|Overall Study|Lost to Follow-up|1|||
125261443|NCT00776230|450587185|FG002|Overall Study|Lost to Follow-up|5|||
125261444|NCT00776230|450587183|FG000|Overall Study|Not vaccinated at Day 0|1|||
125261445|NCT00776230|450587184|FG001|Overall Study|Not vaccinated at Day 0|0|||
125261446|NCT00776230|450587185|FG002|Overall Study|Not vaccinated at Day 0|0|||
125261447|NCT00776230|450587183|FG000|Overall Study|Withdrawal by Subject|0|||
125261448|NCT00776230|450587184|FG001|Overall Study|Withdrawal by Subject|1|||
125261449|NCT00776230|450587185|FG002|Overall Study|Withdrawal by Subject|0|||
125261450|NCT00776230|450587183|FG000|Overall Study|Subject missed Visit 4|0|||
125261451|NCT00776230|450587184|FG001|Overall Study|Subject missed Visit 4|1|||
125261452|NCT00776230|450587185|FG002|Overall Study|Subject missed Visit 4|0|||
125261453|NCT01242514|450587187|FG000|Overall Study|e.g., project closure|1042|||
125261454|NCT01242514|450587188|FG001|Overall Study|e.g., project closure|305|||
125261455|NCT01242514|450587189|FG002|Overall Study|e.g., project closure|171|||
125261456|NCT01242514|450587187|FG000|Overall Study|Subject decision|33|||
125261457|NCT01242514|450587188|FG001|Overall Study|Subject decision|8|||
125261458|NCT01242514|450587189|FG002|Overall Study|Subject decision|2|||
125261459|NCT01242514|450587187|FG000|Overall Study|Severe non-compliance to protocol|5|||
125261460|NCT01242514|450587188|FG001|Overall Study|Severe non-compliance to protocol|2|||
125261461|NCT01242514|450587189|FG002|Overall Study|Severe non-compliance to protocol|1|||
125261462|NCT01242514|450587187|FG000|Overall Study|Lack of therapeutic response|99|||
125261463|NCT01242514|450587188|FG001|Overall Study|Lack of therapeutic response|16|||
125261464|NCT01242514|450587189|FG002|Overall Study|Lack of therapeutic response|10|||
125261465|NCT01242514|450587187|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
125261466|NCT01242514|450587188|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
125261467|NCT01242514|450587189|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
125261468|NCT01242514|450587187|FG000|Overall Study|Lost to Follow-up|14|||
125261469|NCT01242514|450587188|FG001|Overall Study|Lost to Follow-up|5|||
125261470|NCT01242514|450587189|FG002|Overall Study|Lost to Follow-up|4|||
125261471|NCT01242514|450587187|FG000|Overall Study|Adverse Event|129|||
125261472|NCT01242514|450587188|FG001|Overall Study|Adverse Event|18|||
125261473|NCT01242514|450587189|FG002|Overall Study|Adverse Event|19|||
125261474|NCT03110562|450587205|FG000|Initial Treatment Period|Disease Progression|1|||
125261475|NCT03110562|450587206|FG001|Initial Treatment Period|Disease Progression|1|||
125261476|NCT03110562|450587207|FG002|Initial Treatment Period|Disease Progression|0|||
125261477|NCT03110562|450587208|FG003|Initial Treatment Period|Disease Progression|0|||
125261478|NCT03110562|450587205|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
125261479|NCT03110562|450587206|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
125261480|NCT03110562|450587207|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
125261481|NCT03110562|450587208|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
125261482|NCT03110562|450587205|FG000|Initial Treatment Period|Adverse Event|1|||
125261483|NCT03110562|450587206|FG001|Initial Treatment Period|Adverse Event|0|||
125261484|NCT03110562|450587207|FG002|Initial Treatment Period|Adverse Event|0|||
125261485|NCT03110562|450587208|FG003|Initial Treatment Period|Adverse Event|0|||
125261486|NCT03110562|450587205|FG000|Initial Treatment Period|Death|74|||
125261487|NCT03110562|450587206|FG001|Initial Treatment Period|Death|82|||
125261488|NCT03110562|450587207|FG002|Initial Treatment Period|Death|0|||
125261489|NCT03110562|450587208|FG003|Initial Treatment Period|Death|0|||
125261490|NCT03110562|450587205|FG000|Initial Treatment Period|Lost to Follow-up|13|||
125261491|NCT03110562|450587206|FG001|Initial Treatment Period|Lost to Follow-up|8|||
125261492|NCT03110562|450587207|FG002|Initial Treatment Period|Lost to Follow-up|0|||
125261493|NCT03110562|450587208|FG003|Initial Treatment Period|Lost to Follow-up|0|||
125261494|NCT03110562|450587205|FG000|Initial Treatment Period|Protocol Deviation|1|||
125261495|NCT03110562|450587206|FG001|Initial Treatment Period|Protocol Deviation|0|||
125261496|NCT03110562|450587207|FG002|Initial Treatment Period|Protocol Deviation|0|||
125261497|NCT03110562|450587208|FG003|Initial Treatment Period|Protocol Deviation|0|||
125261498|NCT03110562|450587205|FG000|Initial Treatment Period|Physician Decision|2|||
125261499|NCT03110562|450587206|FG001|Initial Treatment Period|Physician Decision|1|||
125261500|NCT03110562|450587207|FG002|Initial Treatment Period|Physician Decision|0|||
125261501|NCT03110562|450587208|FG003|Initial Treatment Period|Physician Decision|0|||
125261502|NCT03110562|450587205|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
125261503|NCT03110562|450587206|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
125261504|NCT03110562|450587207|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
125261505|NCT03110562|450587208|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
125261506|NCT03110562|450587205|FG000|Initial Treatment Period|Other|5|||
125261507|NCT03110562|450587206|FG001|Initial Treatment Period|Other|4|||
125261508|NCT03110562|450587207|FG002|Initial Treatment Period|Other|0|||
125261509|NCT03110562|450587208|FG003|Initial Treatment Period|Other|0|||
125261510|NCT03110562|450587205|FG000|Initial Treatment Period|Randomized but never treated|0|||
125261511|NCT03110562|450587206|FG001|Initial Treatment Period|Randomized but never treated|3|||
125261512|NCT03110562|450587207|FG002|Initial Treatment Period|Randomized but never treated|0|||
125261513|NCT03110562|450587208|FG003|Initial Treatment Period|Randomized but never treated|0|||
125261514|NCT03110562|450587205|FG000|Crossover Period|Disease Progression|0|||
125261515|NCT03110562|450587206|FG001|Crossover Period|Disease Progression|0|||
125261516|NCT03110562|450587207|FG002|Crossover Period|Disease Progression|1|||
125261517|NCT03110562|450587208|FG003|Crossover Period|Disease Progression|0|||
125261518|NCT03110562|450587205|FG000|Crossover Period|Withdrawal by Subject|0|||
125261519|NCT03110562|450587206|FG001|Crossover Period|Withdrawal by Subject|0|||
125261520|NCT03110562|450587207|FG002|Crossover Period|Withdrawal by Subject|8|||
125261521|NCT03110562|450587208|FG003|Crossover Period|Withdrawal by Subject|6|||
125261522|NCT03110562|450587205|FG000|Crossover Period|Death|0|||
125261523|NCT03110562|450587206|FG001|Crossover Period|Death|0|||
125261524|NCT03110562|450587207|FG002|Crossover Period|Death|37|||
125261525|NCT03110562|450587208|FG003|Crossover Period|Death|3|||
125261526|NCT03110562|450587205|FG000|Crossover Period|Lost to Follow-up|0|||
125261527|NCT03110562|450587206|FG001|Crossover Period|Lost to Follow-up|0|||
125261528|NCT03110562|450587207|FG002|Crossover Period|Lost to Follow-up|0|||
125261529|NCT03110562|450587208|FG003|Crossover Period|Lost to Follow-up|1|||
125261530|NCT03110562|450587205|FG000|Crossover Period|Other|0|||
125261531|NCT03110562|450587206|FG001|Crossover Period|Other|0|||
125261532|NCT03110562|450587207|FG002|Crossover Period|Other|1|||
125261533|NCT03110562|450587208|FG003|Crossover Period|Other|1|||
125261534|NCT03110562|450587205|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
125261535|NCT03110562|450587206|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
125261536|NCT03110562|450587207|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
125261537|NCT03110562|450587208|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
125261538|NCT02936323|450587209|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
125261539|NCT02936323|450587210|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
125261540|NCT02936323|450587211|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
125261541|NCT02936323|450587212|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
125261542|NCT02936323|450587213|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
125261543|NCT02936323|450587214|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
125261544|NCT02936323|450587215|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
125261545|NCT02936323|450587216|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
125261546|NCT02936323|450587217|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
125261547|NCT02936323|450587218|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
125261548|NCT02936323|450587209|FG000|Phase 1 Dose Escalation|Death|2|||
125261549|NCT02936323|450587210|FG001|Phase 1 Dose Escalation|Death|1|||
125261550|NCT02936323|450587211|FG002|Phase 1 Dose Escalation|Death|3|||
125261551|NCT02936323|450587212|FG003|Phase 1 Dose Escalation|Death|1|||
125261552|NCT02936323|450587213|FG004|Phase 1 Dose Escalation|Death|2|||
125261553|NCT02936323|450587214|FG005|Phase 1 Dose Escalation|Death|3|||
125261554|NCT02936323|450587215|FG006|Phase 1 Dose Escalation|Death|3|||
125261555|NCT02936323|450587216|FG007|Phase 1 Dose Escalation|Death|0|||
125261556|NCT02936323|450587217|FG008|Phase 1 Dose Escalation|Death|0|||
125261557|NCT02936323|450587218|FG009|Phase 1 Dose Escalation|Death|0|||
125261558|NCT02936323|450587209|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
125261559|NCT02936323|450587210|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
125261560|NCT02936323|450587211|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
125261561|NCT02936323|450587212|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
125261562|NCT02936323|450587213|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
125261563|NCT02936323|450587214|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
125261564|NCT02936323|450587215|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
125261565|NCT02936323|450587216|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
125261566|NCT02936323|450587217|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
125261567|NCT02936323|450587218|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
125261568|NCT02936323|450587209|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
125261569|NCT02936323|450587210|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
125261570|NCT02936323|450587211|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
125261571|NCT02936323|450587212|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
125261572|NCT02936323|450587213|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
125261573|NCT02936323|450587214|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
125261574|NCT02936323|450587215|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
125261575|NCT02936323|450587216|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
125261576|NCT02936323|450587217|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
125261577|NCT02936323|450587218|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
125261578|NCT02936323|450587209|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
125261579|NCT02936323|450587210|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
125261580|NCT02936323|450587211|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
125261581|NCT02936323|450587212|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
125261582|NCT02936323|450587213|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
125261583|NCT02936323|450587214|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
125261584|NCT02936323|450587215|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
125261585|NCT02936323|450587216|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
125261586|NCT02936323|450587217|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
125261587|NCT02936323|450587218|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
125261588|NCT02936323|450587209|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
125261589|NCT02936323|450587210|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
125261590|NCT02936323|450587211|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
125261591|NCT02936323|450587212|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
125261592|NCT02936323|450587213|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
125261593|NCT02936323|450587214|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
125261594|NCT02936323|450587215|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
125261595|NCT02936323|450587216|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
125261596|NCT02936323|450587217|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
125261597|NCT02936323|450587218|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
125261598|NCT02936323|450587209|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
125261599|NCT02936323|450587210|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
125261600|NCT02936323|450587211|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
125261601|NCT02936323|450587212|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
125261602|NCT02936323|450587213|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
125261603|NCT02936323|450587214|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
125261604|NCT02936323|450587215|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
125261605|NCT02936323|450587216|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
125261606|NCT02936323|450587217|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
125261607|NCT02936323|450587218|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
125261608|NCT02936323|450587209|FG000|Phase 2a Dose Expansion|Death|0|||
125261609|NCT02936323|450587210|FG001|Phase 2a Dose Expansion|Death|0|||
125261610|NCT02936323|450587211|FG002|Phase 2a Dose Expansion|Death|0|||
125261611|NCT02936323|450587212|FG003|Phase 2a Dose Expansion|Death|0|||
125261612|NCT02936323|450587213|FG004|Phase 2a Dose Expansion|Death|0|||
125261613|NCT02936323|450587214|FG005|Phase 2a Dose Expansion|Death|0|||
125261614|NCT02936323|450587215|FG006|Phase 2a Dose Expansion|Death|0|||
125261615|NCT02936323|450587216|FG007|Phase 2a Dose Expansion|Death|4|||
125261616|NCT02936323|450587217|FG008|Phase 2a Dose Expansion|Death|8|||
125261617|NCT02936323|450587218|FG009|Phase 2a Dose Expansion|Death|10|||
125261618|NCT05788991|450587219|FG000|Overall Study|Not treated with study medication|1|||
125261619|NCT05788991|450587220|FG001|Overall Study|Not treated with study medication|3|||
125261620|NCT05788991|450587219|FG000|Overall Study|Withdrawal by Subject|1|||
125261621|NCT05788991|450587220|FG001|Overall Study|Withdrawal by Subject|0|||
125261622|NCT05788991|450587219|FG000|Overall Study|Lack of Efficacy|0|||
125261623|NCT05788991|450587220|FG001|Overall Study|Lack of Efficacy|1|||
125261624|NCT05788991|450587219|FG000|Overall Study|Protocol Violation|1|||
125261625|NCT05788991|450587220|FG001|Overall Study|Protocol Violation|2|||
125261626|NCT05270863|450587221|FG000|Visit 2 First Intervention|Randomization error|0|||
125261627|NCT05270863|450587222|FG001|Visit 2 First Intervention|Randomization error|0|||
125261628|NCT05270863|450587223|FG002|Visit 2 First Intervention|Randomization error|0|||
125261629|NCT05270863|450587224|FG003|Visit 2 First Intervention|Randomization error|1|||
125261630|NCT05270863|450587225|FG004|Visit 2 First Intervention|Randomization error|0|||
125261631|NCT05270863|450587226|FG005|Visit 2 First Intervention|Randomization error|0|||
125261632|NCT05270863|450587221|FG000|First Washout|Withdrawal by Subject|0|||
125261633|NCT05270863|450587222|FG001|First Washout|Withdrawal by Subject|0|||
125261634|NCT05270863|450587223|FG002|First Washout|Withdrawal by Subject|0|||
125261635|NCT05270863|450587224|FG003|First Washout|Withdrawal by Subject|0|||
125261636|NCT05270863|450587225|FG004|First Washout|Withdrawal by Subject|1|||
125261637|NCT05270863|450587226|FG005|First Washout|Withdrawal by Subject|1|||
125261638|NCT05270863|450587221|FG000|First Washout|Lost to Follow-up|0|||
125261639|NCT05270863|450587222|FG001|First Washout|Lost to Follow-up|0|||
125261640|NCT05270863|450587223|FG002|First Washout|Lost to Follow-up|0|||
125261641|NCT05270863|450587224|FG003|First Washout|Lost to Follow-up|0|||
125261642|NCT05270863|450587225|FG004|First Washout|Lost to Follow-up|0|||
125261643|NCT05270863|450587226|FG005|First Washout|Lost to Follow-up|1|||
125261644|NCT05270863|450587221|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
125261645|NCT05270863|450587222|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
125261646|NCT05270863|450587223|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
125261647|NCT05270863|450587224|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
125261648|NCT05270863|450587225|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
125261649|NCT05270863|450587226|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
125261650|NCT05270863|450587221|FG000|Second Washout|Withdrawal by Subject|1|||
125261651|NCT05270863|450587222|FG001|Second Washout|Withdrawal by Subject|1|||
125261652|NCT05270863|450587223|FG002|Second Washout|Withdrawal by Subject|0|||
125261653|NCT05270863|450587224|FG003|Second Washout|Withdrawal by Subject|0|||
125261654|NCT05270863|450587225|FG004|Second Washout|Withdrawal by Subject|0|||
125261655|NCT05270863|450587226|FG005|Second Washout|Withdrawal by Subject|0|||
125261656|NCT05270863|450587221|FG000|Second Washout|Lost to Follow-up|0|||
125261657|NCT05270863|450587222|FG001|Second Washout|Lost to Follow-up|0|||
125261658|NCT05270863|450587223|FG002|Second Washout|Lost to Follow-up|0|||
125261659|NCT05270863|450587224|FG003|Second Washout|Lost to Follow-up|1|||
125261660|NCT05270863|450587225|FG004|Second Washout|Lost to Follow-up|0|||
125261661|NCT05270863|450587226|FG005|Second Washout|Lost to Follow-up|0|||
125261662|NCT04464473|450587227|FG000|Overall Study|New piercing could not be removed for scanning|0|||
125261663|NCT04464473|450587228|FG001|Overall Study|New piercing could not be removed for scanning|0|||
125261664|NCT04464473|450587229|FG002|Overall Study|New piercing could not be removed for scanning|0|||
125261665|NCT04464473|450587230|FG003|Overall Study|New piercing could not be removed for scanning|1|||
125261666|NCT04464473|450587231|FG004|Overall Study|New piercing could not be removed for scanning|0|||
125261667|NCT04464473|450587232|FG005|Overall Study|New piercing could not be removed for scanning|0|||
125261668|NCT04464473|450587227|FG000|Overall Study|Adverse Event|0|||
125261669|NCT04464473|450587228|FG001|Overall Study|Adverse Event|0|||
125261670|NCT04464473|450587229|FG002|Overall Study|Adverse Event|0|||
125261671|NCT04464473|450587230|FG003|Overall Study|Adverse Event|1|||
125261672|NCT04464473|450587231|FG004|Overall Study|Adverse Event|0|||
125261673|NCT04464473|450587232|FG005|Overall Study|Adverse Event|0|||
125261674|NCT04464473|450587227|FG000|Overall Study|Lost to Follow-up|0|||
125261675|NCT04464473|450587228|FG001|Overall Study|Lost to Follow-up|0|||
125261676|NCT04464473|450587229|FG002|Overall Study|Lost to Follow-up|0|||
125261677|NCT04464473|450587230|FG003|Overall Study|Lost to Follow-up|1|||
125261678|NCT04464473|450587231|FG004|Overall Study|Lost to Follow-up|0|||
125261679|NCT04464473|450587232|FG005|Overall Study|Lost to Follow-up|0|||
125261680|NCT01334918|450588392|FG000|Overall Study|Did not receive study drug|6|||
125261681|NCT01334918|450588393|FG001|Overall Study|Did not receive study drug|0|||
125261682|NCT01334918|450588392|FG000|Overall Study|Adverse Event|2|||
125261683|NCT01334918|450588393|FG001|Overall Study|Adverse Event|0|||
125261684|NCT01334918|450588392|FG000|Overall Study|Withdrawal by Subject|0|||
125261685|NCT01334918|450588393|FG001|Overall Study|Withdrawal by Subject|1|||
125261686|NCT00805389|450588394|FG000|Overall Study|Adverse Event|0|||
125261687|NCT00805389|450588395|FG001|Overall Study|Adverse Event|0|||
125261688|NCT00805389|450588396|FG002|Overall Study|Adverse Event|1|||
125261689|NCT00805389|450588397|FG003|Overall Study|Adverse Event|2|||
125261690|NCT00805389|450588398|FG004|Overall Study|Adverse Event|0|||
125261691|NCT00805389|450588394|FG000|Overall Study|Lost to Follow-up|4|||
125261692|NCT00805389|450588395|FG001|Overall Study|Lost to Follow-up|3|||
125261693|NCT00805389|450588396|FG002|Overall Study|Lost to Follow-up|6|||
125261694|NCT00805389|450588397|FG003|Overall Study|Lost to Follow-up|10|||
125261695|NCT00805389|450588398|FG004|Overall Study|Lost to Follow-up|9|||
125261696|NCT00805389|450588394|FG000|Overall Study|Protocol Violation|0|||
125261697|NCT00805389|450588395|FG001|Overall Study|Protocol Violation|0|||
125261698|NCT00805389|450588396|FG002|Overall Study|Protocol Violation|1|||
125261699|NCT00805389|450588397|FG003|Overall Study|Protocol Violation|0|||
125261700|NCT00805389|450588398|FG004|Overall Study|Protocol Violation|0|||
125261701|NCT00805389|450588394|FG000|Overall Study|Withdrawal by Subject|3|||
125261702|NCT00805389|450588395|FG001|Overall Study|Withdrawal by Subject|2|||
125261703|NCT00805389|450588396|FG002|Overall Study|Withdrawal by Subject|4|||
125261704|NCT00805389|450588397|FG003|Overall Study|Withdrawal by Subject|5|||
125261705|NCT00805389|450588398|FG004|Overall Study|Withdrawal by Subject|4|||
125261706|NCT02704208|450588401|FG000|Overall Study|Lost to Follow-up|42|||
125261707|NCT02704208|450588402|FG001|Overall Study|Lost to Follow-up|37|||
125261708|NCT02724839|450588405|FG000|Overall Study|Withdrawal by Subject|1|||
125261709|NCT02724839|450588406|FG001|Overall Study|Withdrawal by Subject|1|||
125261710|NCT02724839|450588407|FG002|Overall Study|Withdrawal by Subject|0|||
125261711|NCT02724839|450588405|FG000|Overall Study|Lost to Follow-up|0|||
125261712|NCT02724839|450588406|FG001|Overall Study|Lost to Follow-up|3|||
125261713|NCT02724839|450588407|FG002|Overall Study|Lost to Follow-up|2|||
125261714|NCT02724839|450588405|FG000|Overall Study|Physician Decision|0|||
125261715|NCT02724839|450588406|FG001|Overall Study|Physician Decision|0|||
125261716|NCT02724839|450588407|FG002|Overall Study|Physician Decision|3|||
125261717|NCT05878067|450588408|FG000|Overall Study|Lost to Follow-up|2|||
125261718|NCT00949533|450588409|FG000|Overall Study|Lost to Follow-up|0|||
125261719|NCT00949533|450588410|FG001|Overall Study|Lost to Follow-up|1|||
125261720|NCT00557193|450588411|FG000|Induction|Adverse Event|2|||
125261721|NCT00557193|450588412|FG001|Induction|Adverse Event|0|||
125261722|NCT00557193|450588413|FG002|Induction|Adverse Event|0|||
125261723|NCT00557193|450588414|FG003|Induction|Adverse Event|0|||
125261724|NCT00557193|450588415|FG004|Induction|Adverse Event|0|||
125261725|NCT00557193|450588416|FG005|Induction|Adverse Event|0|||
125261726|NCT00557193|450588411|FG000|Induction|Death|6|||
125261727|NCT00557193|450588412|FG001|Induction|Death|0|||
125261728|NCT00557193|450588413|FG002|Induction|Death|0|||
125261729|NCT00557193|450588414|FG003|Induction|Death|0|||
125261730|NCT00557193|450588415|FG004|Induction|Death|0|||
125261731|NCT00557193|450588416|FG005|Induction|Death|0|||
125261732|NCT00557193|450588411|FG000|Induction|Physician Decision|3|||
125261733|NCT00557193|450588412|FG001|Induction|Physician Decision|0|||
125261734|NCT00557193|450588413|FG002|Induction|Physician Decision|0|||
125261735|NCT00557193|450588414|FG003|Induction|Physician Decision|0|||
125261736|NCT00557193|450588415|FG004|Induction|Physician Decision|0|||
125261737|NCT00557193|450588416|FG005|Induction|Physician Decision|0|||
125261738|NCT00557193|450588411|FG000|Induction|Withdrawal by Subject|1|||
125261739|NCT00557193|450588412|FG001|Induction|Withdrawal by Subject|0|||
125261740|NCT00557193|450588413|FG002|Induction|Withdrawal by Subject|0|||
125261741|NCT00557193|450588414|FG003|Induction|Withdrawal by Subject|0|||
125261742|NCT00557193|450588415|FG004|Induction|Withdrawal by Subject|0|||
125261743|NCT00557193|450588416|FG005|Induction|Withdrawal by Subject|0|||
125261744|NCT00557193|450588411|FG000|Induction|Refusal of Further Protocol Therapy|2|||
125261745|NCT00557193|450588412|FG001|Induction|Refusal of Further Protocol Therapy|0|||
125261746|NCT00557193|450588413|FG002|Induction|Refusal of Further Protocol Therapy|0|||
125261747|NCT00557193|450588414|FG003|Induction|Refusal of Further Protocol Therapy|0|||
125261748|NCT00557193|450588415|FG004|Induction|Refusal of Further Protocol Therapy|0|||
125261749|NCT00557193|450588416|FG005|Induction|Refusal of Further Protocol Therapy|0|||
125261750|NCT00557193|450588411|FG000|Induction|Ineligible|8|||
125261751|NCT00557193|450588412|FG001|Induction|Ineligible|0|||
125261752|NCT00557193|450588413|FG002|Induction|Ineligible|0|||
125261753|NCT00557193|450588414|FG003|Induction|Ineligible|0|||
125261754|NCT00557193|450588415|FG004|Induction|Ineligible|0|||
125261755|NCT00557193|450588416|FG005|Induction|Ineligible|0|||
125261756|NCT00557193|450588411|FG000|Induction|Inevaluable for post Induction|2|||
125261757|NCT00557193|450588412|FG001|Induction|Inevaluable for post Induction|0|||
125261758|NCT00557193|450588413|FG002|Induction|Inevaluable for post Induction|0|||
125261759|NCT00557193|450588414|FG003|Induction|Inevaluable for post Induction|0|||
125261760|NCT00557193|450588415|FG004|Induction|Inevaluable for post Induction|0|||
125261761|NCT00557193|450588416|FG005|Induction|Inevaluable for post Induction|0|||
125261762|NCT00557193|450588411|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
125261763|NCT00557193|450588412|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
125261764|NCT00557193|450588413|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
125261765|NCT00557193|450588414|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
125261766|NCT00557193|450588415|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
125261767|NCT00557193|450588416|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
125261768|NCT00557193|450588411|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
125261769|NCT00557193|450588412|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
125261770|NCT00557193|450588413|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
125261771|NCT00557193|450588414|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
125261772|NCT00557193|450588415|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
125261773|NCT00557193|450588416|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
125261774|NCT00557193|450588411|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
125261775|NCT00557193|450588412|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
125261776|NCT00557193|450588413|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
125261777|NCT00557193|450588414|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
125261778|NCT00557193|450588415|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
125261779|NCT00557193|450588416|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
125261780|NCT00557193|450588411|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
125261781|NCT00557193|450588412|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
125261782|NCT00557193|450588413|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
125261783|NCT00557193|450588414|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
125261784|NCT00557193|450588415|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
125261785|NCT00557193|450588416|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
125261786|NCT00557193|450588411|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
125261787|NCT00557193|450588412|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
125261788|NCT00557193|450588413|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
125261789|NCT00557193|450588414|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
125261790|NCT00557193|450588415|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
125261791|NCT00557193|450588416|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
125261792|NCT00557193|450588411|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
125261793|NCT00557193|450588412|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
125261794|NCT00557193|450588413|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
125261795|NCT00557193|450588414|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
125261796|NCT00557193|450588415|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
125261797|NCT00557193|450588416|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
125261798|NCT00557193|450588411|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
125261799|NCT00557193|450588412|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
125261800|NCT00557193|450588413|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
125261801|NCT00557193|450588414|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
125261802|NCT00557193|450588415|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
125261803|NCT00557193|450588416|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
125261804|NCT00557193|450588411|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
125261805|NCT00557193|450588412|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
125261806|NCT00557193|450588413|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
125261807|NCT00557193|450588414|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
125261808|NCT00557193|450588415|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
125261809|NCT00557193|450588416|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
125261810|NCT00557193|450588411|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
125261811|NCT00557193|450588412|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
125261812|NCT00557193|450588413|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
125261813|NCT00557193|450588414|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
125261814|NCT00557193|450588415|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
125261815|NCT00557193|450588416|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
125261816|NCT00976456|450588417|FG000|Overall Study|Adverse Event|17|||
125261817|NCT00976456|450588418|FG001|Overall Study|Adverse Event|22|||
125261818|NCT00976456|450588417|FG000|Overall Study|Death|7|||
125261819|NCT00976456|450588418|FG001|Overall Study|Death|9|||
125261820|NCT00976456|450588417|FG000|Overall Study|Lack of Efficacy|5|||
125261821|NCT00976456|450588418|FG001|Overall Study|Lack of Efficacy|2|||
125261822|NCT00976456|450588417|FG000|Overall Study|Withdrawal by Subject|3|||
125261823|NCT00976456|450588418|FG001|Overall Study|Withdrawal by Subject|1|||
125261824|NCT00976456|450588417|FG000|Overall Study|screening failure, unknown|11|||
125261825|NCT00976456|450588418|FG001|Overall Study|screening failure, unknown|4|||
125261826|NCT02037529|450588419|FG000|Overall Study|Withdrawal by Subject|1|||
125261827|NCT02037529|450588420|FG001|Overall Study|Withdrawal by Subject|3|||
125261828|NCT02037529|450588419|FG000|Overall Study|Adverse Event|0|||
125261829|NCT02037529|450588420|FG001|Overall Study|Adverse Event|1|||
125261830|NCT02131766|450588421|FG000|Overall Study|Withdrawal by Subject|4|||
125261831|NCT00718315|450588422|FG000|Overall Study|Adverse Event|1|||
125261832|NCT00718315|450588423|FG001|Overall Study|Adverse Event|2|||
125261833|NCT00718315|450588424|FG002|Overall Study|Adverse Event|3|||
125261834|NCT00718315|450588422|FG000|Overall Study|Death|6|||
125261835|NCT00718315|450588423|FG001|Overall Study|Death|6|||
125261836|NCT00718315|450588424|FG002|Overall Study|Death|5|||
125261837|NCT00718315|450588422|FG000|Overall Study|Lost to Follow-up|2|||
125261838|NCT00718315|450588423|FG001|Overall Study|Lost to Follow-up|3|||
125261839|NCT00718315|450588424|FG002|Overall Study|Lost to Follow-up|4|||
125261840|NCT00718315|450588422|FG000|Overall Study|Protocol Violation|5|||
125261841|NCT00718315|450588423|FG001|Overall Study|Protocol Violation|5|||
125261842|NCT00718315|450588424|FG002|Overall Study|Protocol Violation|3|||
125261843|NCT00718315|450588422|FG000|Overall Study|Erlotinib dose decreased|4|||
125261844|NCT00718315|450588423|FG001|Overall Study|Erlotinib dose decreased|3|||
125261845|NCT00718315|450588424|FG002|Overall Study|Erlotinib dose decreased|1|||
125261846|NCT00718315|450588422|FG000|Overall Study|Use of Minocyclin|1|||
125261847|NCT00718315|450588423|FG001|Overall Study|Use of Minocyclin|1|||
125261848|NCT00718315|450588424|FG002|Overall Study|Use of Minocyclin|1|||
125261849|NCT00718315|450588422|FG000|Overall Study|Disease progression|0|||
125261850|NCT00718315|450588423|FG001|Overall Study|Disease progression|1|||
125261851|NCT00718315|450588424|FG002|Overall Study|Disease progression|1|||
125261852|NCT00718315|450588422|FG000|Overall Study|Other|0|||
125261853|NCT00718315|450588423|FG001|Overall Study|Other|0|||
125261854|NCT00718315|450588424|FG002|Overall Study|Other|1|||
125261855|NCT00718315|450588422|FG000|Overall Study|Use of ATB and Corticoids|0|||
125261856|NCT00718315|450588423|FG001|Overall Study|Use of ATB and Corticoids|1|||
125261857|NCT00718315|450588424|FG002|Overall Study|Use of ATB and Corticoids|2|||
125261858|NCT01170663|450588425|FG000|Overall Study|Lost to Follow-up|3|||
125261859|NCT01170663|450588426|FG001|Overall Study|Lost to Follow-up|9|||
125261860|NCT01170663|450588425|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
125261861|NCT01170663|450588426|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
125261862|NCT02746809|450588429|FG000|Enrollment|Inclusion Exclusion not met|9|||
125261863|NCT02746809|450588429|FG000|Enrollment|Withdrawal by Subject|1|||
125261864|NCT02746809|450588429|FG000|Enrollment|Expected Enrollment Met|2|||
125261865|NCT02746809|450588429|FG000|Procedure|Death|1|||
125261866|NCT02746809|450588429|FG000|1-Month|Death|5|||
125261867|NCT02746809|450588429|FG000|6-Month|Death|2|||
125261868|NCT02746809|450588429|FG000|6-Month|Withdrawal by Subject|1|||
125261869|NCT02746809|450588429|FG000|12-Month|Death|3|||
125261870|NCT02746809|450588429|FG000|12-Month|Withdrawal by Subject|2|||
125261871|NCT02746809|450588429|FG000|24-Month|Death|1|||
125261872|NCT02746809|450588429|FG000|24-Month|Withdrawal by Subject|1|||
125261873|NCT02746809|450588429|FG000|36-Month|Death|8|||
125261874|NCT02746809|450588429|FG000|36-Month|Withdrawal by Subject|1|||
125261875|NCT02746809|450588429|FG000|48-Month|Death|7|||
125261876|NCT02746809|450588429|FG000|48-Month|Withdrawal by Subject|1|||
125261877|NCT02746809|450588429|FG000|60-Month|Death|1|||
125261878|NCT02746809|450588429|FG000|60-Month|Lost to Follow-up|2|||
125261879|NCT00894387|450588432|FG000|Overall Study|Adverse Event|44|||
125261880|NCT00894387|450588433|FG001|Overall Study|Adverse Event|45|||
125261881|NCT00894387|450588432|FG000|Overall Study|Abnormal Laboratory values|2|||
125261882|NCT00894387|450588433|FG001|Overall Study|Abnormal Laboratory values|2|||
125261883|NCT00894387|450588432|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125261884|NCT00894387|450588433|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125261885|NCT00894387|450588432|FG000|Overall Study|Lost to Follow-up|3|||
125261886|NCT00894387|450588433|FG001|Overall Study|Lost to Follow-up|5|||
125261887|NCT00894387|450588432|FG000|Overall Study|Administrative problems|2|||
125261888|NCT00894387|450588433|FG001|Overall Study|Administrative problems|2|||
125261889|NCT00894387|450588432|FG000|Overall Study|Death|77|||
125261890|NCT00894387|450588433|FG001|Overall Study|Death|76|||
125261891|NCT00894387|450588432|FG000|Overall Study|Protocol Deviation|4|||
125261892|NCT00894387|450588433|FG001|Overall Study|Protocol Deviation|0|||
125261893|NCT00894387|450588432|FG000|Overall Study|Patient's request|25|||
125261894|NCT00894387|450588433|FG001|Overall Study|Patient's request|30|||
125261895|NCT00894387|450588432|FG000|Overall Study|Other (Missing)|5|||
125261896|NCT00894387|450588433|FG001|Overall Study|Other (Missing)|3|||
125261897|NCT00894387|450588432|FG000|Overall Study|Mis-randomized|13|||
125261898|NCT00894387|450588433|FG001|Overall Study|Mis-randomized|9|||
125261899|NCT00894387|450588432|FG000|Overall Study|GCP non-compliance|0|||
125261900|NCT00894387|450588433|FG001|Overall Study|GCP non-compliance|2|||
125261901|NCT01128569|450588434|FG000|Washout Period 1|Adverse Event|0|||
125261902|NCT01128569|450588435|FG001|Washout Period 1|Adverse Event|0|||
125261903|NCT01128569|450588436|FG002|Washout Period 1|Adverse Event|1|||
125261904|NCT01128569|450588437|FG003|Washout Period 1|Adverse Event|0|||
125261905|NCT01128569|450588438|FG004|Washout Period 1|Adverse Event|0|||
125261906|NCT01128569|450588439|FG005|Washout Period 1|Adverse Event|0|||
125261907|NCT01128569|450588434|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125261908|NCT01128569|450588435|FG001|Treatment Period 2|Withdrawal by Subject|1|||
125261909|NCT01128569|450588436|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125261910|NCT01128569|450588437|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125261911|NCT01128569|450588438|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125261912|NCT01128569|450588439|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125261913|NCT02519842|450588440|FG000|Base Study: Cycle 1|Screening Failure|1|||
125261914|NCT02519842|450588441|FG001|Base Study: Cycle 1|Screening Failure|1|||
125261915|NCT02519842|450588442|FG002|Base Study: Cycle 1|Screening Failure|0|||
125261916|NCT02519842|450588440|FG000|Base Study: Cycle 1|Adverse Event|1|||
125261917|NCT02519842|450588441|FG001|Base Study: Cycle 1|Adverse Event|0|||
125261918|NCT02519842|450588442|FG002|Base Study: Cycle 1|Adverse Event|0|||
125261919|NCT02519842|450588440|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
125261920|NCT02519842|450588441|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
125261921|NCT02519842|450588442|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
125261922|NCT02519842|450588440|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
125261923|NCT02519842|450588441|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
125261924|NCT02519842|450588442|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
125261925|NCT02519842|450588440|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
125261926|NCT02519842|450588441|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
125261927|NCT02519842|450588442|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
125261928|NCT02519842|450588440|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
125261929|NCT02519842|450588441|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
125261930|NCT02519842|450588442|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
125261931|NCT02519842|450588440|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
125261932|NCT02519842|450588441|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
125261933|NCT02519842|450588442|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
125261934|NCT02519842|450588440|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
125261935|NCT02519842|450588441|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
125261936|NCT02519842|450588442|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
125261937|NCT02519842|450588440|FG000|Optional Extension: Cycles 2-6|Death|0|||
125261938|NCT02519842|450588441|FG001|Optional Extension: Cycles 2-6|Death|0|||
125261939|NCT02519842|450588442|FG002|Optional Extension: Cycles 2-6|Death|1|||
125261940|NCT02519842|450588440|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
125261941|NCT02519842|450588441|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
125261942|NCT02519842|450588442|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
125261943|NCT02519842|450588440|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
125261944|NCT02519842|450588441|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
125261945|NCT02519842|450588442|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
125261946|NCT02519842|450588440|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
125261947|NCT02519842|450588441|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
125261948|NCT02519842|450588442|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
125261949|NCT02519842|450588440|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
125261950|NCT02519842|450588441|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
125261951|NCT02519842|450588442|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
125261952|NCT01493414|450588448|FG000|Overall Study|Adverse Event|405|||
125261953|NCT01493414|450588448|FG000|Overall Study|Disease progression|204|||
125261954|NCT01493414|450588448|FG000|Overall Study|Death|101|||
125261955|NCT01493414|450588448|FG000|Overall Study|Physician Decision|93|||
125261956|NCT01493414|450588448|FG000|Overall Study|Withdrawal by Subject|79|||
125261957|NCT01493414|450588448|FG000|Overall Study|Protocol deviation|27|||
125261958|NCT01493414|450588448|FG000|Overall Study|Administrative problems|25|||
125261959|NCT01493414|450588448|FG000|Overall Study|Lost to Follow-up|16|||
125261960|NCT01977222|450588453|FG000|Overall Study|Withdrawal by Subject|1|||
125261961|NCT00945659|450588463|FG000|Overall Study|Lost to Follow-up|7|||
125261962|NCT00945659|450588464|FG001|Overall Study|Lost to Follow-up|20|||
125261963|NCT00945659|450588465|FG002|Overall Study|Lost to Follow-up|17|||
125261964|NCT04562116|450588466|FG000|Overall Study|Lost to Follow-up|1|||
125261965|NCT04562116|450588466|FG000|Overall Study|Withdrawal by Subject|3|||
125261966|NCT02412670|450588469|FG000|Overall Study|Adverse Event|4|||
125261967|NCT02412670|450588470|FG001|Overall Study|Adverse Event|1|||
125261968|NCT02412670|450588469|FG000|Overall Study|Physician Decision|1|||
125261969|NCT02412670|450588470|FG001|Overall Study|Physician Decision|0|||
125261970|NCT02412670|450588469|FG000|Overall Study|Withdrawal by Subject|1|||
125261971|NCT02412670|450588470|FG001|Overall Study|Withdrawal by Subject|0|||
125261972|NCT02412670|450588469|FG000|Overall Study|Ineligible|1|||
125261973|NCT02412670|450588470|FG001|Overall Study|Ineligible|0|||
125261974|NCT00654732|450588475|FG000|Overall Study|Adverse Event|4|||
125261975|NCT00654732|450588476|FG001|Overall Study|Adverse Event|6|||
125261976|NCT03342560|450588477|FG000|Overall Study|Lost to Follow-up|2|||
125261977|NCT03213509|450588478|FG000|Overall Study|Did not consent for verbal autopsy|4|||
125261978|NCT03213509|450588479|FG001|Overall Study|Did not consent for verbal autopsy|5|||
125261979|NCT04549454|450588490|FG000|T1 to T2|Lost to Follow-up|22|||
125261980|NCT04549454|450588491|FG001|T1 to T2|Lost to Follow-up|26|||
125261981|NCT04549454|450588490|FG000|T1 to T3|Lost to Follow-up|31|||
125261982|NCT04549454|450588491|FG001|T1 to T3|Lost to Follow-up|36|||
125261983|NCT00016354|450588494|FG000|Overall Study|Lack of Efficacy|0|||
125261984|NCT00016354|450588495|FG001|Overall Study|Lack of Efficacy|0|||
125261985|NCT00016354|450588496|FG002|Overall Study|Lack of Efficacy|0|||
125261986|NCT00016354|450588497|FG003|Overall Study|Lack of Efficacy|0|||
125261987|NCT00016354|450588498|FG004|Overall Study|Lack of Efficacy|0|||
125261988|NCT00016354|450588499|FG005|Overall Study|Lack of Efficacy|0|||
125261989|NCT00016354|450588500|FG006|Overall Study|Lack of Efficacy|0|||
125261990|NCT00016354|450588501|FG007|Overall Study|Lack of Efficacy|1|||
125261991|NCT02993263|450588504|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
125261992|NCT01405196|450588505|FG000|Overall Study|Study Terminated by Sponsor|0|||
125261993|NCT01405196|450588506|FG001|Overall Study|Study Terminated by Sponsor|0|||
125261994|NCT01405196|450588507|FG002|Overall Study|Study Terminated by Sponsor|9|||
125261995|NCT01405196|450588508|FG003|Overall Study|Study Terminated by Sponsor|0|||
125261996|NCT01405196|450588505|FG000|Overall Study|Other|2|||
125261997|NCT01405196|450588506|FG001|Overall Study|Other|2|||
125261998|NCT01405196|450588507|FG002|Overall Study|Other|5|||
125261999|NCT01405196|450588508|FG003|Overall Study|Other|0|||
125262000|NCT01405196|450588505|FG000|Overall Study|Withdrawal by Subject|4|||
125262001|NCT01405196|450588506|FG001|Overall Study|Withdrawal by Subject|6|||
125262002|NCT01405196|450588507|FG002|Overall Study|Withdrawal by Subject|3|||
125262003|NCT01405196|450588508|FG003|Overall Study|Withdrawal by Subject|6|||
125262004|NCT01405196|450588505|FG000|Overall Study|Adverse Event|2|||
125262005|NCT01405196|450588506|FG001|Overall Study|Adverse Event|2|||
125262006|NCT01405196|450588507|FG002|Overall Study|Adverse Event|0|||
125262007|NCT01405196|450588508|FG003|Overall Study|Adverse Event|2|||
125262008|NCT01405196|450588505|FG000|Overall Study|Death|1|||
125262009|NCT01405196|450588506|FG001|Overall Study|Death|0|||
125262010|NCT01405196|450588507|FG002|Overall Study|Death|3|||
125262011|NCT01405196|450588508|FG003|Overall Study|Death|0|||
125262012|NCT01405196|450588505|FG000|Overall Study|Lost to Follow-up|2|||
125262013|NCT01405196|450588506|FG001|Overall Study|Lost to Follow-up|2|||
125262014|NCT01405196|450588507|FG002|Overall Study|Lost to Follow-up|3|||
125262015|NCT01405196|450588508|FG003|Overall Study|Lost to Follow-up|1|||
125262016|NCT01729039|450588509|FG000|Overall Study|disqualified|2|||
125262017|NCT01729039|450588510|FG001|Overall Study|disqualified|5|||
125262018|NCT01729039|450588509|FG000|Overall Study|Withdrawal by Subject|8|||
125262019|NCT01729039|450588510|FG001|Overall Study|Withdrawal by Subject|7|||
125262020|NCT00698841|450588511|FG000|Overall Study|Withdrawal by Subject|2|||
125262021|NCT00698841|450588511|FG000|Overall Study|Adverse Event|3|||
125262022|NCT00698841|450588511|FG000|Overall Study|Disease progression|7|||
125262023|NCT00698841|450588511|FG000|Overall Study|Failure to meet eligibility criteria|2|||
125262024|NCT00698841|450588511|FG000|Overall Study|Study drug toxicity|2|||
125262025|NCT00698841|450588511|FG000|Overall Study|Other|2|||
125262026|NCT02114177|450589758|FG000|Overall Study|Lost to Follow-up|1|||
125262027|NCT02114177|450589759|FG001|Overall Study|Lost to Follow-up|2|||
125262028|NCT02114177|450589758|FG000|Overall Study|Withdrawal by Subject|6|||
125262029|NCT02114177|450589759|FG001|Overall Study|Withdrawal by Subject|1|||
125262030|NCT02114177|450589758|FG000|Overall Study|Other|2|||
125262031|NCT02114177|450589759|FG001|Overall Study|Other|1|||
125262032|NCT01585025|450589760|FG000|Overall Study|Withdrawal by Subject|0|||
125262033|NCT01585025|450589761|FG001|Overall Study|Withdrawal by Subject|3|||
125262034|NCT01585025|450589762|FG002|Overall Study|Withdrawal by Subject|4|||
125262035|NCT00582907|450589763|FG000|1st Course|Withdrawal by Subject|1|||
125262036|NCT00582907|450589764|FG001|1st Course|Withdrawal by Subject|0|||
125262037|NCT00582907|450589765|FG002|1st Course|Withdrawal by Subject|0|||
125262038|NCT00582907|450589766|FG003|1st Course|Withdrawal by Subject|0|||
125262039|NCT00582907|450589763|FG000|1st Course|Lost to Follow-up|0|||
125262040|NCT00582907|450589764|FG001|1st Course|Lost to Follow-up|0|||
125262041|NCT00582907|450589765|FG002|1st Course|Lost to Follow-up|0|||
125262042|NCT00582907|450589766|FG003|1st Course|Lost to Follow-up|1|||
125262043|NCT00582907|450589763|FG000|2nd Course|Lack of Efficacy|1|||
125262044|NCT00582907|450589764|FG001|2nd Course|Lack of Efficacy|0|||
125262045|NCT00582907|450589765|FG002|2nd Course|Lack of Efficacy|0|||
125262046|NCT00582907|450589766|FG003|2nd Course|Lack of Efficacy|0|||
125262047|NCT03610048|450589773|FG000|Overall Study|Study terminated by sponsor|84|||
125262048|NCT03610048|450589773|FG000|Overall Study|Adverse Event|32|||
125262049|NCT03610048|450589773|FG000|Overall Study|Withdrawal by Subject|31|||
125262050|NCT03610048|450589773|FG000|Overall Study|Lost to Follow-up|8|||
125262051|NCT03610048|450589773|FG000|Overall Study|Other|4|||
125262052|NCT03610048|450589773|FG000|Overall Study|Physician Decision|1|||
125262053|NCT03610048|450589773|FG000|Overall Study|Pregnancy|1|||
125262054|NCT01155050|450589774|FG000|Overall Study|Lost to Follow-up|15|||
125262055|NCT01155050|450589775|FG001|Overall Study|Lost to Follow-up|20|||
125262056|NCT01155050|450589776|FG002|Overall Study|Lost to Follow-up|19|||
125262057|NCT01155050|450589777|FG003|Overall Study|Lost to Follow-up|22|||
125262058|NCT01146613|450589779|FG000|Overall Study|Lost to Follow-up|3|||
125262059|NCT01146613|450589780|FG001|Overall Study|Lost to Follow-up|8|||
125262060|NCT01146613|450589779|FG000|Overall Study|Lack of Efficacy|0|||
125262061|NCT01146613|450589780|FG001|Overall Study|Lack of Efficacy|1|||
125262062|NCT01146613|450589779|FG000|Overall Study|Death|1|||
125262063|NCT01146613|450589780|FG001|Overall Study|Death|0|||
125262064|NCT01146613|450589779|FG000|Overall Study|Physician Decision|1|||
125262065|NCT01146613|450589780|FG001|Overall Study|Physician Decision|0|||
125262066|NCT01146613|450589779|FG000|Overall Study|Withdrawal by Subject|0|||
125262067|NCT01146613|450589780|FG001|Overall Study|Withdrawal by Subject|3|||
125262068|NCT01146613|450589779|FG000|Overall Study|schedule conflict|1|||
125262069|NCT01146613|450589780|FG001|Overall Study|schedule conflict|0|||
125262070|NCT01146613|450589779|FG000|Overall Study|Outpatient detox|1|||
125262071|NCT01146613|450589780|FG001|Overall Study|Outpatient detox|0|||
125262072|NCT01959529|450589781|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
125262073|NCT01959529|450589782|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
125262074|NCT01959529|450589781|FG000|Overall Study|Lost to Follow-up|4|||
125262075|NCT01959529|450589782|FG001|Overall Study|Lost to Follow-up|1|||
125262076|NCT01959529|450589781|FG000|Overall Study|Other|70|||
125262077|NCT01959529|450589782|FG001|Overall Study|Other|68|||
125262078|NCT01959529|450589781|FG000|Overall Study|Hypoglycaemia|1|||
125262079|NCT01959529|450589782|FG001|Overall Study|Hypoglycaemia|1|||
125262080|NCT01959529|450589781|FG000|Overall Study|Lack of glycaemic control|1|||
125262081|NCT01959529|450589782|FG001|Overall Study|Lack of glycaemic control|1|||
125262082|NCT00652834|450589783|FG000|Overall Study|Withdrawal by Subject|3|||
125262083|NCT00652834|450589783|FG000|Overall Study|Lost to Follow-up|2|||
125262084|NCT00854360|450589791|FG000|Overall Study|Adverse Event|0|||
125262085|NCT00854360|450589792|FG001|Overall Study|Adverse Event|1|||
125262086|NCT00854360|450589793|FG002|Overall Study|Adverse Event|2|||
125262087|NCT00854360|450589794|FG003|Overall Study|Adverse Event|6|||
125262088|NCT00854360|450589791|FG000|Overall Study|Withdrawal by Subject|0|||
125262089|NCT00854360|450589792|FG001|Overall Study|Withdrawal by Subject|0|||
125262090|NCT00854360|450589793|FG002|Overall Study|Withdrawal by Subject|0|||
125262091|NCT00854360|450589794|FG003|Overall Study|Withdrawal by Subject|1|||
125262092|NCT00854360|450589791|FG000|Overall Study|Pregnancy|0|||
125262093|NCT00854360|450589792|FG001|Overall Study|Pregnancy|1|||
125262094|NCT00854360|450589793|FG002|Overall Study|Pregnancy|0|||
125262095|NCT00854360|450589794|FG003|Overall Study|Pregnancy|0|||
125262096|NCT00854360|450589791|FG000|Overall Study|Lack of Efficacy|2|||
125262097|NCT00854360|450589792|FG001|Overall Study|Lack of Efficacy|1|||
125262098|NCT00854360|450589793|FG002|Overall Study|Lack of Efficacy|0|||
125262099|NCT00854360|450589794|FG003|Overall Study|Lack of Efficacy|0|||
125262100|NCT00854360|450589791|FG000|Overall Study|Other|0|||
125262101|NCT00854360|450589792|FG001|Overall Study|Other|0|||
125262102|NCT00854360|450589793|FG002|Overall Study|Other|0|||
125262103|NCT00854360|450589794|FG003|Overall Study|Other|3|||
125262104|NCT02441218|450589795|FG000|Overall Study|Death|503|||
125262105|NCT02441218|450589796|FG001|Overall Study|Death|553|||
125262106|NCT02441218|450589795|FG000|Overall Study|Withdrawal by Subject|73|||
125262107|NCT02441218|450589796|FG001|Overall Study|Withdrawal by Subject|58|||
125262108|NCT02441218|450589795|FG000|Overall Study|Lost to Follow-up|2|||
125262109|NCT02441218|450589796|FG001|Overall Study|Lost to Follow-up|1|||
125262110|NCT01541371|450589797|FG000|Overall Study|Withdrawal by Subject|14|||
125262111|NCT01541371|450589797|FG000|Overall Study|Lost to Follow-up|21|||
125262112|NCT01541371|450589797|FG000|Overall Study|Adverse Event|15|||
125262113|NCT01541371|450589797|FG000|Overall Study|Lack of Efficacy|12|||
125262114|NCT01541371|450589797|FG000|Overall Study|Protocol Violation|6|||
125262115|NCT01541371|450589797|FG000|Overall Study|Study medication non-compliance|3|||
125262116|NCT01541371|450589797|FG000|Overall Study|Other|6|||
125262117|NCT02271880|450589801|FG000|Overall Study|Premature discontinuation of study|3|||
125262118|NCT02271880|450589802|FG001|Overall Study|Premature discontinuation of study|4|||
125262119|NCT00806585|450589803|FG000|Overall Study|Study terminated by Sponsor|0|||
125262120|NCT00806585|450589804|FG001|Overall Study|Study terminated by Sponsor|0|||
125262121|NCT00806585|450589805|FG002|Overall Study|Study terminated by Sponsor|1|||
125262122|NCT00806585|450589806|FG003|Overall Study|Study terminated by Sponsor|2|||
125262123|NCT00806585|450589807|FG004|Overall Study|Study terminated by Sponsor|0|||
125262124|NCT00806585|450589803|FG000|Overall Study|Protocol Violation|3|||
125262125|NCT00806585|450589804|FG001|Overall Study|Protocol Violation|1|||
125262126|NCT00806585|450589805|FG002|Overall Study|Protocol Violation|2|||
125262127|NCT00806585|450589806|FG003|Overall Study|Protocol Violation|0|||
125262128|NCT00806585|450589807|FG004|Overall Study|Protocol Violation|0|||
125262129|NCT00806585|450589803|FG000|Overall Study|Physician Decision|0|||
125262130|NCT00806585|450589804|FG001|Overall Study|Physician Decision|2|||
125262131|NCT00806585|450589805|FG002|Overall Study|Physician Decision|3|||
125262132|NCT00806585|450589806|FG003|Overall Study|Physician Decision|0|||
125262133|NCT00806585|450589807|FG004|Overall Study|Physician Decision|1|||
125262134|NCT00806585|450589803|FG000|Overall Study|Lost to Follow-up|2|||
125262135|NCT00806585|450589804|FG001|Overall Study|Lost to Follow-up|1|||
125262136|NCT00806585|450589805|FG002|Overall Study|Lost to Follow-up|2|||
125262137|NCT00806585|450589806|FG003|Overall Study|Lost to Follow-up|2|||
125262138|NCT00806585|450589807|FG004|Overall Study|Lost to Follow-up|5|||
125262139|NCT00806585|450589803|FG000|Overall Study|Lack of Efficacy|1|||
125262140|NCT00806585|450589804|FG001|Overall Study|Lack of Efficacy|0|||
125262141|NCT00806585|450589805|FG002|Overall Study|Lack of Efficacy|0|||
125262142|NCT00806585|450589806|FG003|Overall Study|Lack of Efficacy|0|||
125262143|NCT00806585|450589807|FG004|Overall Study|Lack of Efficacy|0|||
125262144|NCT00806585|450589803|FG000|Overall Study|Adverse Event|1|||
125262145|NCT00806585|450589804|FG001|Overall Study|Adverse Event|5|||
125262146|NCT00806585|450589805|FG002|Overall Study|Adverse Event|3|||
125262147|NCT00806585|450589806|FG003|Overall Study|Adverse Event|4|||
125262148|NCT00806585|450589807|FG004|Overall Study|Adverse Event|2|||
125262149|NCT00806585|450589803|FG000|Overall Study|Withdrawal by Subject|10|||
125262150|NCT00806585|450589804|FG001|Overall Study|Withdrawal by Subject|8|||
125262151|NCT00806585|450589805|FG002|Overall Study|Withdrawal by Subject|9|||
125262152|NCT00806585|450589806|FG003|Overall Study|Withdrawal by Subject|3|||
125262153|NCT00806585|450589807|FG004|Overall Study|Withdrawal by Subject|11|||
125262154|NCT00806585|450589803|FG000|Overall Study|Completion status unknown|15|||
125262155|NCT00806585|450589804|FG001|Overall Study|Completion status unknown|14|||
125262156|NCT00806585|450589805|FG002|Overall Study|Completion status unknown|12|||
125262157|NCT00806585|450589806|FG003|Overall Study|Completion status unknown|4|||
125262158|NCT00806585|450589807|FG004|Overall Study|Completion status unknown|12|||
125262159|NCT00474903|450589808|FG000|Overall Study|Protocol Violation|1|||
125262160|NCT00474903|450589809|FG001|Overall Study|Protocol Violation|5|||
125262161|NCT00474903|450589810|FG002|Overall Study|Protocol Violation|2|||
125262162|NCT01936831|450589811|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
125262163|NCT01936831|450589812|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
125262164|NCT01936831|450589813|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
125262165|NCT01936831|450589814|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
125262166|NCT01936831|450589815|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
125262167|NCT01936831|450589816|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
125262168|NCT01936831|450589817|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
125262169|NCT01936831|450589818|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
125262170|NCT01936831|450589819|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
125262171|NCT03435380|450589820|FG000|Overall Study|Death|1|||
125262172|NCT03435380|450589821|FG001|Overall Study|Death|2|||
125262173|NCT03435380|450589822|FG002|Overall Study|Death|1|||
125262174|NCT03435380|450589820|FG000|Overall Study|Lost to Follow-up|12|||
125262175|NCT03435380|450589821|FG001|Overall Study|Lost to Follow-up|8|||
125262176|NCT03435380|450589822|FG002|Overall Study|Lost to Follow-up|6|||
125262177|NCT03435380|450589820|FG000|Overall Study|Physician Decision|1|||
125262178|NCT03435380|450589821|FG001|Overall Study|Physician Decision|0|||
125262179|NCT03435380|450589822|FG002|Overall Study|Physician Decision|0|||
125262180|NCT03435380|450589820|FG000|Overall Study|Withdrawal by Subject|0|||
125262181|NCT03435380|450589821|FG001|Overall Study|Withdrawal by Subject|1|||
125262182|NCT03435380|450589822|FG002|Overall Study|Withdrawal by Subject|1|||
125262183|NCT03435380|450589820|FG000|Overall Study|Ineligible|0|||
125262184|NCT03435380|450589821|FG001|Overall Study|Ineligible|1|||
125262185|NCT03435380|450589822|FG002|Overall Study|Ineligible|1|||
125262186|NCT02115321|450589832|FG000|Overall Study|Death|1|||
125262187|NCT02115321|450589833|FG001|Overall Study|Death|0|||
125262188|NCT02493764|450589834|FG000|Overall Study|Adverse Event|2|||
125262189|NCT02493764|450589835|FG001|Overall Study|Adverse Event|2|||
125262190|NCT02493764|450589834|FG000|Overall Study|Death|44|||
125262191|NCT02493764|450589835|FG001|Overall Study|Death|58|||
125262192|NCT02493764|450589834|FG000|Overall Study|Lost to Follow-up|2|||
125262193|NCT02493764|450589835|FG001|Overall Study|Lost to Follow-up|1|||
125262194|NCT02493764|450589834|FG000|Overall Study|Protocol Violation|6|||
125262195|NCT02493764|450589835|FG001|Overall Study|Protocol Violation|7|||
125262196|NCT02493764|450589834|FG000|Overall Study|Physician Decision|1|||
125262197|NCT02493764|450589835|FG001|Overall Study|Physician Decision|1|||
125262198|NCT02493764|450589834|FG000|Overall Study|Participant moved|17|||
125262199|NCT02493764|450589835|FG001|Overall Study|Participant moved|5|||
125262200|NCT02493764|450589834|FG000|Overall Study|Withdrawal parent/guardian|0|||
125262201|NCT02493764|450589835|FG001|Overall Study|Withdrawal parent/guardian|1|||
125262202|NCT02493764|450589834|FG000|Overall Study|Withdrawal by Subject|11|||
125262203|NCT02493764|450589835|FG001|Overall Study|Withdrawal by Subject|7|||
125262204|NCT03218917|450589837|FG000|Overall Study|Adverse Event|3|||
125262205|NCT03218917|450589838|FG001|Overall Study|Adverse Event|3|||
125262206|NCT03218917|450589839|FG002|Overall Study|Adverse Event|2|||
125262207|NCT03218917|450589837|FG000|Overall Study|Subject withdrew consent|2|||
125262208|NCT03218917|450589838|FG001|Overall Study|Subject withdrew consent|4|||
125262209|NCT03218917|450589839|FG002|Overall Study|Subject withdrew consent|10|||
125262210|NCT03218917|450589837|FG000|Overall Study|Physician Decision|0|||
125262211|NCT03218917|450589838|FG001|Overall Study|Physician Decision|1|||
125262212|NCT03218917|450589839|FG002|Overall Study|Physician Decision|1|||
125262213|NCT03218917|450589837|FG000|Overall Study|Lost to Follow-up|1|||
125262214|NCT03218917|450589838|FG001|Overall Study|Lost to Follow-up|0|||
125262215|NCT03218917|450589839|FG002|Overall Study|Lost to Follow-up|0|||
125262216|NCT03218917|450589837|FG000|Overall Study|Reason Missing|0|||
125262217|NCT03218917|450589838|FG001|Overall Study|Reason Missing|2|||
125262218|NCT03218917|450589839|FG002|Overall Study|Reason Missing|0|||
125262219|NCT03218917|450589837|FG000|Overall Study|Death|0|||
125262220|NCT03218917|450589838|FG001|Overall Study|Death|1|||
125262221|NCT03218917|450589839|FG002|Overall Study|Death|0|||
125262222|NCT03218917|450589837|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125262223|NCT03218917|450589838|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125262224|NCT03218917|450589839|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125262225|NCT01307449|450589840|FG000|Overall Study|Adverse Event|1|||
125262226|NCT01307449|450589841|FG001|Overall Study|Adverse Event|0|||
125262227|NCT01307449|450589842|FG002|Overall Study|Adverse Event|0|||
125262228|NCT01307449|450589843|FG003|Overall Study|Adverse Event|0|||
125262229|NCT01561976|450589844|FG000|Period 1|Adverse Event|0|||
125262230|NCT01561976|450589845|FG001|Period 1|Adverse Event|0|||
125262231|NCT01561976|450589846|FG002|Period 1|Adverse Event|1|||
125262232|NCT01561976|450589847|FG003|Period 1|Adverse Event|0|||
125262233|NCT01561976|450589848|FG004|Period 1|Adverse Event|0|||
125262234|NCT01561976|450589849|FG005|Period 1|Adverse Event|0|||
125262235|NCT01561976|450589844|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
125262236|NCT01561976|450589845|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
125262237|NCT01561976|450589846|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
125262238|NCT01561976|450589847|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
125262239|NCT01561976|450589848|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
125262240|NCT01561976|450589849|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
125262241|NCT01561976|450589844|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125262242|NCT01561976|450589845|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125262243|NCT01561976|450589846|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125262244|NCT01561976|450589847|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125262245|NCT01561976|450589848|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125262246|NCT01561976|450589849|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
125262247|NCT01561976|450589844|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
125262248|NCT01561976|450589845|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
125262249|NCT01561976|450589846|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
125262250|NCT01561976|450589847|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
125262251|NCT01561976|450589848|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
125262252|NCT01561976|450589849|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
125262253|NCT01463527|450589854|FG000|Overall Study|Protocol Violation|1|||
125262254|NCT01463527|450589855|FG001|Overall Study|Protocol Violation|1|||
125262255|NCT01463527|450589854|FG000|Overall Study|Crying >20% of sedation|5|||
125262256|NCT01463527|450589855|FG001|Overall Study|Crying >20% of sedation|6|||
125262257|NCT05136170|450589856|FG000|Overall Study|Withdrawal by Subject|2|||
125262258|NCT05136170|450589857|FG001|Overall Study|Withdrawal by Subject|2|||
125262259|NCT05136170|450589856|FG000|Overall Study|Can no longer make office visits|1|||
125262260|NCT05136170|450589857|FG001|Overall Study|Can no longer make office visits|0|||
125262261|NCT01788943|450589858|FG000|Overall Study|Withdrawal by Subject|1|||
125262262|NCT01788943|450589859|FG001|Overall Study|Withdrawal by Subject|0|||
125262263|NCT01119287|450589860|FG000|Overall Study|Patient Decision, not related to AE|0|||
125262264|NCT01119287|450589861|FG001|Overall Study|Patient Decision, not related to AE|0|||
125262265|NCT01119287|450589862|FG002|Overall Study|Patient Decision, not related to AE|2|||
125262266|NCT01119287|450589863|FG003|Overall Study|Patient Decision, not related to AE|2|||
125262267|NCT01119287|450589864|FG004|Overall Study|Patient Decision, not related to AE|1|||
125262268|NCT01119287|450589865|FG005|Overall Study|Patient Decision, not related to AE|0|||
125262269|NCT04403919|450589870|FG000|Overall Study|Lost to Follow-up|0|||
125262270|NCT04403919|450589871|FG001|Overall Study|Lost to Follow-up|0|||
125262271|NCT04403919|450589872|FG002|Overall Study|Lost to Follow-up|0|||
125262272|NCT04403919|450589873|FG003|Overall Study|Lost to Follow-up|1|||
125262273|NCT01612676|450589874|FG000|Overall Study|Adverse Event|2|||
125262274|NCT01612676|450589875|FG001|Overall Study|Adverse Event|3|||
125262275|NCT01612676|450589876|FG002|Overall Study|Adverse Event|1|||
125262276|NCT01612676|450589877|FG003|Overall Study|Adverse Event|3|||
125262277|NCT01612676|450589874|FG000|Overall Study|Protocol Violation|0|||
125262278|NCT01612676|450589875|FG001|Overall Study|Protocol Violation|1|||
125262279|NCT01612676|450589876|FG002|Overall Study|Protocol Violation|0|||
125262280|NCT01612676|450589877|FG003|Overall Study|Protocol Violation|0|||
125262281|NCT01156844|450589880|FG000|Overall Study|Adverse Event|0|||
125262282|NCT01156844|450589881|FG001|Overall Study|Adverse Event|0|||
125262283|NCT01156844|450589882|FG002|Overall Study|Adverse Event|1|||
125262284|NCT01156844|450589883|FG003|Overall Study|Adverse Event|1|||
125262285|NCT01156844|450589880|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125262286|NCT01156844|450589881|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125262287|NCT01156844|450589882|FG002|Overall Study|Abnormal test procedure result(s)|2|||
125262288|NCT01156844|450589883|FG003|Overall Study|Abnormal test procedure result(s)|2|||
125262289|NCT01156844|450589880|FG000|Overall Study|Withdrawal by Subject|0|||
125262290|NCT01156844|450589881|FG001|Overall Study|Withdrawal by Subject|0|||
125262291|NCT01156844|450589882|FG002|Overall Study|Withdrawal by Subject|2|||
125262292|NCT01156844|450589883|FG003|Overall Study|Withdrawal by Subject|2|||
125262293|NCT01156844|450589880|FG000|Overall Study|Lost to Follow-up|0|||
125262294|NCT01156844|450589881|FG001|Overall Study|Lost to Follow-up|0|||
125262295|NCT01156844|450589882|FG002|Overall Study|Lost to Follow-up|1|||
125262296|NCT01156844|450589883|FG003|Overall Study|Lost to Follow-up|0|||
125262297|NCT01156844|450589880|FG000|Overall Study|Administrative problems|0|||
125262298|NCT01156844|450589881|FG001|Overall Study|Administrative problems|1|||
125262299|NCT01156844|450589882|FG002|Overall Study|Administrative problems|0|||
125262300|NCT01156844|450589883|FG003|Overall Study|Administrative problems|1|||
125262301|NCT01156844|450589880|FG000|Overall Study|Protocol deviation|2|||
125262302|NCT01156844|450589881|FG001|Overall Study|Protocol deviation|0|||
125262303|NCT01156844|450589882|FG002|Overall Study|Protocol deviation|0|||
125262304|NCT01156844|450589883|FG003|Overall Study|Protocol deviation|0|||
125262305|NCT00107276|450589887|FG000|Overall Study|Progression|46|||
125262306|NCT00107276|450589887|FG000|Overall Study|Adverse Event|6|||
125262307|NCT00107276|450589887|FG000|Overall Study|M.D. decision|2|||
125262308|NCT00107276|450589887|FG000|Overall Study|Patient refusal|1|||
125262309|NCT00107276|450589887|FG000|Overall Study|Death|1|||
125262310|NCT00107276|450589887|FG000|Overall Study|Ineligible|16|||
125262311|NCT04846231|450589888|FG000|Overall Study|Lost to Follow-up|1|||
125262312|NCT04846231|450589889|FG001|Overall Study|Lost to Follow-up|0|||
125262313|NCT04846231|450589890|FG002|Overall Study|Lost to Follow-up|0|||
125262314|NCT04846231|450589891|FG003|Overall Study|Lost to Follow-up|0|||
125262315|NCT04846231|450589892|FG004|Overall Study|Lost to Follow-up|0|||
125262316|NCT04846231|450589893|FG005|Overall Study|Lost to Follow-up|0|||
125262317|NCT04846231|450589894|FG006|Overall Study|Lost to Follow-up|0|||
125262318|NCT04846231|450589895|FG007|Overall Study|Lost to Follow-up|1|||
125262319|NCT04846231|450589888|FG000|Overall Study|Withdrawal by Subject|0|||
125262320|NCT04846231|450589889|FG001|Overall Study|Withdrawal by Subject|1|||
125262321|NCT04846231|450589890|FG002|Overall Study|Withdrawal by Subject|2|||
125262322|NCT04846231|450589891|FG003|Overall Study|Withdrawal by Subject|1|||
125262323|NCT04846231|450589892|FG004|Overall Study|Withdrawal by Subject|0|||
125262324|NCT04846231|450589893|FG005|Overall Study|Withdrawal by Subject|0|||
125262325|NCT04846231|450589894|FG006|Overall Study|Withdrawal by Subject|0|||
125262326|NCT04846231|450589895|FG007|Overall Study|Withdrawal by Subject|0|||
125262327|NCT04846231|450589888|FG000|Overall Study|Protocol Violation|0|||
125262328|NCT04846231|450589889|FG001|Overall Study|Protocol Violation|1|||
125262329|NCT04846231|450589890|FG002|Overall Study|Protocol Violation|0|||
125262330|NCT04846231|450589891|FG003|Overall Study|Protocol Violation|0|||
125262331|NCT04846231|450589892|FG004|Overall Study|Protocol Violation|0|||
125262332|NCT04846231|450589893|FG005|Overall Study|Protocol Violation|0|||
125262333|NCT04846231|450589894|FG006|Overall Study|Protocol Violation|0|||
125262334|NCT04846231|450589895|FG007|Overall Study|Protocol Violation|0|||
125262335|NCT04846231|450589888|FG000|Overall Study|Adverse Event|0|||
125262336|NCT04846231|450589889|FG001|Overall Study|Adverse Event|0|||
125262337|NCT04846231|450589890|FG002|Overall Study|Adverse Event|0|||
125262338|NCT04846231|450589891|FG003|Overall Study|Adverse Event|0|||
125262339|NCT04846231|450589892|FG004|Overall Study|Adverse Event|0|||
125262340|NCT04846231|450589893|FG005|Overall Study|Adverse Event|0|||
125262341|NCT04846231|450589894|FG006|Overall Study|Adverse Event|1|||
125262342|NCT04846231|450589895|FG007|Overall Study|Adverse Event|1|||
125262343|NCT02980107|450589896|FG000|Overall Study|Withdrawal by Subject|51|||
125262344|NCT02980107|450589897|FG001|Overall Study|Withdrawal by Subject|62|||
125262345|NCT01448616|450589899|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
125262346|NCT01448616|450589900|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
125262347|NCT01448616|450589901|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
125262348|NCT01448616|450589902|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
125262349|NCT01448616|450589899|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
125262350|NCT01448616|450589900|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
125262351|NCT01448616|450589901|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
125262352|NCT01448616|450589902|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
125262353|NCT01448616|450589899|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
125262354|NCT01448616|450589900|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
125262355|NCT01448616|450589901|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
125262356|NCT01448616|450589902|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
125262357|NCT01448616|450589899|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
125262358|NCT01448616|450589900|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
125262359|NCT01448616|450589901|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
125262360|NCT01448616|450589902|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
125262361|NCT01448616|450589899|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
125262362|NCT01448616|450589900|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
125262363|NCT01448616|450589901|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
125262364|NCT01448616|450589902|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
125262365|NCT00397540|450589905|FG000|Overall Study|short follow-up duration < 12 months|1|||
125262366|NCT00397540|450589906|FG001|Overall Study|short follow-up duration < 12 months|0|||
125262367|NCT00485173|450589910|FG000|Overall Study|Death|4|||
125262368|NCT00485173|450589911|FG001|Overall Study|Death|3|||
125262369|NCT00485173|450589910|FG000|Overall Study|Lost to Follow-up|32|||
125262370|NCT00485173|450589911|FG001|Overall Study|Lost to Follow-up|61|||
125262371|NCT00746811|450589912|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
125262372|NCT00746811|450589913|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
125262373|NCT00829998|450589916|FG000|Washout|Adverse Event|0|||
125262374|NCT00829998|450589917|FG001|Washout|Adverse Event|1|||
125262375|NCT04712669|450589920|FG000|Double Blind Phase|Adverse Event|4|||
125262376|NCT04712669|450589921|FG001|Double Blind Phase|Adverse Event|4|||
125262377|NCT04712669|450589922|FG002|Double Blind Phase|Adverse Event|3|||
125262378|NCT04712669|450589923|FG003|Double Blind Phase|Adverse Event|0|||
125262379|NCT04712669|450589924|FG004|Double Blind Phase|Adverse Event|0|||
125262380|NCT04712669|450589925|FG005|Double Blind Phase|Adverse Event|0|||
125262381|NCT04712669|450589926|FG006|Double Blind Phase|Adverse Event|0|||
125262382|NCT04712669|450589927|FG007|Double Blind Phase|Adverse Event|0|||
125262383|NCT04712669|450589920|FG000|Double Blind Phase|Physician Decision|1|||
125262384|NCT04712669|450589921|FG001|Double Blind Phase|Physician Decision|0|||
125262385|NCT04712669|450589922|FG002|Double Blind Phase|Physician Decision|0|||
125262386|NCT04712669|450589923|FG003|Double Blind Phase|Physician Decision|0|||
125262387|NCT04712669|450589924|FG004|Double Blind Phase|Physician Decision|0|||
125262388|NCT04712669|450589925|FG005|Double Blind Phase|Physician Decision|0|||
125262389|NCT04712669|450589926|FG006|Double Blind Phase|Physician Decision|0|||
125262390|NCT04712669|450589927|FG007|Double Blind Phase|Physician Decision|0|||
125262391|NCT04712669|450589920|FG000|Double Blind Phase|Withdrawal by Subject|3|||
125262392|NCT04712669|450589921|FG001|Double Blind Phase|Withdrawal by Subject|6|||
125262393|NCT04712669|450589922|FG002|Double Blind Phase|Withdrawal by Subject|0|||
125262394|NCT04712669|450589923|FG003|Double Blind Phase|Withdrawal by Subject|0|||
125262395|NCT04712669|450589924|FG004|Double Blind Phase|Withdrawal by Subject|0|||
125262396|NCT04712669|450589925|FG005|Double Blind Phase|Withdrawal by Subject|0|||
125262397|NCT04712669|450589926|FG006|Double Blind Phase|Withdrawal by Subject|0|||
125262398|NCT04712669|450589927|FG007|Double Blind Phase|Withdrawal by Subject|0|||
125262399|NCT04712669|450589920|FG000|Double Blind Phase|Termination by Sponsor|0|||
125262400|NCT04712669|450589921|FG001|Double Blind Phase|Termination by Sponsor|0|||
125262401|NCT04712669|450589922|FG002|Double Blind Phase|Termination by Sponsor|1|||
125262402|NCT04712669|450589923|FG003|Double Blind Phase|Termination by Sponsor|0|||
125262403|NCT04712669|450589924|FG004|Double Blind Phase|Termination by Sponsor|0|||
125262404|NCT04712669|450589925|FG005|Double Blind Phase|Termination by Sponsor|0|||
125262405|NCT04712669|450589926|FG006|Double Blind Phase|Termination by Sponsor|0|||
125262406|NCT04712669|450589927|FG007|Double Blind Phase|Termination by Sponsor|0|||
125262407|NCT04712669|450589920|FG000|Open Label Phase|Adverse Event|0|||
125262408|NCT04712669|450589921|FG001|Open Label Phase|Adverse Event|0|||
125262409|NCT04712669|450589922|FG002|Open Label Phase|Adverse Event|0|||
125262410|NCT04712669|450589923|FG003|Open Label Phase|Adverse Event|1|||
125262411|NCT04712669|450589924|FG004|Open Label Phase|Adverse Event|1|||
125262412|NCT04712669|450589925|FG005|Open Label Phase|Adverse Event|3|||
125262413|NCT04712669|450589926|FG006|Open Label Phase|Adverse Event|1|||
125262414|NCT04712669|450589927|FG007|Open Label Phase|Adverse Event|2|||
125262415|NCT04712669|450589920|FG000|Open Label Phase|Death|0|||
125262416|NCT04712669|450589921|FG001|Open Label Phase|Death|0|||
125262417|NCT04712669|450589922|FG002|Open Label Phase|Death|0|||
125262418|NCT04712669|450589923|FG003|Open Label Phase|Death|1|||
125262419|NCT04712669|450589924|FG004|Open Label Phase|Death|0|||
125262420|NCT04712669|450589925|FG005|Open Label Phase|Death|0|||
125262421|NCT04712669|450589926|FG006|Open Label Phase|Death|0|||
125262422|NCT04712669|450589927|FG007|Open Label Phase|Death|0|||
125262423|NCT04712669|450589920|FG000|Open Label Phase|Lack of Efficacy|0|||
125262424|NCT04712669|450589921|FG001|Open Label Phase|Lack of Efficacy|0|||
125262425|NCT04712669|450589922|FG002|Open Label Phase|Lack of Efficacy|0|||
125262426|NCT04712669|450589923|FG003|Open Label Phase|Lack of Efficacy|0|||
125262427|NCT04712669|450589924|FG004|Open Label Phase|Lack of Efficacy|1|||
125262428|NCT04712669|450589925|FG005|Open Label Phase|Lack of Efficacy|0|||
125262429|NCT04712669|450589926|FG006|Open Label Phase|Lack of Efficacy|0|||
125262430|NCT04712669|450589927|FG007|Open Label Phase|Lack of Efficacy|0|||
125262431|NCT04712669|450589920|FG000|Open Label Phase|Lost to Follow-up|0|||
125262432|NCT04712669|450589921|FG001|Open Label Phase|Lost to Follow-up|0|||
125262433|NCT04712669|450589922|FG002|Open Label Phase|Lost to Follow-up|0|||
125262434|NCT04712669|450589923|FG003|Open Label Phase|Lost to Follow-up|0|||
125262435|NCT04712669|450589924|FG004|Open Label Phase|Lost to Follow-up|0|||
125262436|NCT04712669|450589925|FG005|Open Label Phase|Lost to Follow-up|0|||
125262437|NCT04712669|450589926|FG006|Open Label Phase|Lost to Follow-up|1|||
125262438|NCT04712669|450589927|FG007|Open Label Phase|Lost to Follow-up|1|||
125262439|NCT04712669|450589920|FG000|Open Label Phase|Physician Decision|0|||
125262440|NCT04712669|450589921|FG001|Open Label Phase|Physician Decision|0|||
125262441|NCT04712669|450589922|FG002|Open Label Phase|Physician Decision|0|||
125262442|NCT04712669|450589923|FG003|Open Label Phase|Physician Decision|1|||
125262443|NCT04712669|450589924|FG004|Open Label Phase|Physician Decision|0|||
125262444|NCT04712669|450589925|FG005|Open Label Phase|Physician Decision|0|||
125262445|NCT04712669|450589926|FG006|Open Label Phase|Physician Decision|0|||
125262446|NCT04712669|450589927|FG007|Open Label Phase|Physician Decision|0|||
125262447|NCT04712669|450589920|FG000|Open Label Phase|Withdrawal by Subject|0|||
125262448|NCT04712669|450589921|FG001|Open Label Phase|Withdrawal by Subject|0|||
125262449|NCT04712669|450589922|FG002|Open Label Phase|Withdrawal by Subject|0|||
125262450|NCT04712669|450589923|FG003|Open Label Phase|Withdrawal by Subject|1|||
125262451|NCT04712669|450589924|FG004|Open Label Phase|Withdrawal by Subject|5|||
125262452|NCT04712669|450589925|FG005|Open Label Phase|Withdrawal by Subject|5|||
125262453|NCT04712669|450589926|FG006|Open Label Phase|Withdrawal by Subject|0|||
125262454|NCT04712669|450589927|FG007|Open Label Phase|Withdrawal by Subject|4|||
125262455|NCT04712669|450589920|FG000|Open Label Phase|Termination by Sponsor|0|||
125262456|NCT04712669|450589921|FG001|Open Label Phase|Termination by Sponsor|0|||
125262457|NCT04712669|450589922|FG002|Open Label Phase|Termination by Sponsor|0|||
125262458|NCT04712669|450589923|FG003|Open Label Phase|Termination by Sponsor|11|||
125262459|NCT04712669|450589924|FG004|Open Label Phase|Termination by Sponsor|9|||
125262460|NCT04712669|450589925|FG005|Open Label Phase|Termination by Sponsor|14|||
125262461|NCT04712669|450589926|FG006|Open Label Phase|Termination by Sponsor|0|||
125262462|NCT04712669|450589927|FG007|Open Label Phase|Termination by Sponsor|14|||
125262463|NCT01819272|450591928|FG000|Overall Study|Adverse Event|1|||
125262464|NCT01819272|450591929|FG001|Overall Study|Adverse Event|0|||
125262465|NCT01819272|450591930|FG002|Overall Study|Adverse Event|0|||
125262466|NCT01819272|450591931|FG003|Overall Study|Adverse Event|2|||
125262467|NCT01819272|450591932|FG004|Overall Study|Adverse Event|0|||
125262468|NCT01819272|450591933|FG005|Overall Study|Adverse Event|0|||
125262469|NCT01819272|450591928|FG000|Overall Study|Lost to Follow-up|3|||
125262470|NCT01819272|450591929|FG001|Overall Study|Lost to Follow-up|0|||
125262471|NCT01819272|450591930|FG002|Overall Study|Lost to Follow-up|1|||
125262472|NCT01819272|450591931|FG003|Overall Study|Lost to Follow-up|0|||
125262473|NCT01819272|450591932|FG004|Overall Study|Lost to Follow-up|0|||
125262474|NCT01819272|450591933|FG005|Overall Study|Lost to Follow-up|3|||
125262475|NCT01819272|450591928|FG000|Overall Study|Protocol Violation|0|||
125262476|NCT01819272|450591929|FG001|Overall Study|Protocol Violation|0|||
125262477|NCT01819272|450591930|FG002|Overall Study|Protocol Violation|0|||
125262478|NCT01819272|450591931|FG003|Overall Study|Protocol Violation|1|||
125262479|NCT01819272|450591932|FG004|Overall Study|Protocol Violation|2|||
125262480|NCT01819272|450591933|FG005|Overall Study|Protocol Violation|3|||
125262481|NCT01819272|450591928|FG000|Overall Study|Physician Decision|0|||
125262482|NCT01819272|450591929|FG001|Overall Study|Physician Decision|1|||
125262483|NCT01819272|450591930|FG002|Overall Study|Physician Decision|0|||
125262484|NCT01819272|450591931|FG003|Overall Study|Physician Decision|0|||
125262485|NCT01819272|450591932|FG004|Overall Study|Physician Decision|0|||
125262486|NCT01819272|450591933|FG005|Overall Study|Physician Decision|0|||
125262487|NCT01819272|450591928|FG000|Overall Study|Withdrawal of Consent|0|||
125262488|NCT01819272|450591929|FG001|Overall Study|Withdrawal of Consent|1|||
125262489|NCT01819272|450591930|FG002|Overall Study|Withdrawal of Consent|2|||
125262490|NCT01819272|450591931|FG003|Overall Study|Withdrawal of Consent|1|||
125262491|NCT01819272|450591932|FG004|Overall Study|Withdrawal of Consent|0|||
125262492|NCT01819272|450591933|FG005|Overall Study|Withdrawal of Consent|1|||
125262493|NCT01819272|450591928|FG000|Overall Study|Loss of Glucose Control|2|||
125262494|NCT01819272|450591929|FG001|Overall Study|Loss of Glucose Control|1|||
125262495|NCT01819272|450591930|FG002|Overall Study|Loss of Glucose Control|0|||
125262496|NCT01819272|450591931|FG003|Overall Study|Loss of Glucose Control|1|||
125262497|NCT01819272|450591932|FG004|Overall Study|Loss of Glucose Control|2|||
125262498|NCT01819272|450591933|FG005|Overall Study|Loss of Glucose Control|0|||
125262499|NCT00503984|450591934|FG000|Overall Study|Protocol Violation|0|||
125262500|NCT00503984|450591935|FG001|Overall Study|Protocol Violation|1|||
125262501|NCT00503984|450591936|FG002|Overall Study|Protocol Violation|0|||
125262502|NCT00503984|450591937|FG003|Overall Study|Protocol Violation|0|||
125262503|NCT00503984|450591938|FG004|Overall Study|Protocol Violation|0|||
125262504|NCT00503984|450591939|FG005|Overall Study|Protocol Violation|0|||
125262505|NCT00503984|450591934|FG000|Overall Study|Adverse Event|0|||
125262506|NCT00503984|450591935|FG001|Overall Study|Adverse Event|1|||
125262507|NCT00503984|450591936|FG002|Overall Study|Adverse Event|0|||
125262508|NCT00503984|450591937|FG003|Overall Study|Adverse Event|0|||
125262509|NCT00503984|450591938|FG004|Overall Study|Adverse Event|0|||
125262510|NCT00503984|450591939|FG005|Overall Study|Adverse Event|0|||
125262511|NCT00503984|450591934|FG000|Overall Study|Death|0|||
125262512|NCT00503984|450591935|FG001|Overall Study|Death|0|||
125262513|NCT00503984|450591936|FG002|Overall Study|Death|0|||
125262514|NCT00503984|450591937|FG003|Overall Study|Death|0|||
125262515|NCT00503984|450591938|FG004|Overall Study|Death|1|||
125262516|NCT00503984|450591939|FG005|Overall Study|Death|0|||
125262517|NCT01246960|450591942|FG000|Overall Study|Lost to Follow-up|3|||
125262518|NCT01246960|450591943|FG001|Overall Study|Lost to Follow-up|1|||
125262519|NCT01246960|450591942|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
125262520|NCT01246960|450591943|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
125262521|NCT00140140|450591948|FG000|Overall Study|Unacceptable toxicity|1|||
125262522|NCT00140140|450591949|FG001|Overall Study|Unacceptable toxicity|1|||
125262523|NCT00140140|450591950|FG002|Overall Study|Unacceptable toxicity|2|||
125262524|NCT00140140|450591948|FG000|Overall Study|Physician Decision|1|||
125262525|NCT00140140|450591949|FG001|Overall Study|Physician Decision|1|||
125262526|NCT00140140|450591950|FG002|Overall Study|Physician Decision|0|||
125262527|NCT03376516|450591951|FG000|Overall Study|Not treated|1|||
125262528|NCT03376516|450591951|FG000|Overall Study|Consent withdrawn|1|||
125262529|NCT01359956|450591952|FG000|Overall Study|Death|58|||
125262530|NCT01359956|450591953|FG001|Overall Study|Death|60|||
125262531|NCT01359956|450591954|FG002|Overall Study|Death|66|||
125262532|NCT01359956|450591955|FG003|Overall Study|Death|57|||
125262533|NCT01359956|450591952|FG000|Overall Study|Lost to Follow-up|3|||
125262534|NCT01359956|450591953|FG001|Overall Study|Lost to Follow-up|4|||
125262535|NCT01359956|450591954|FG002|Overall Study|Lost to Follow-up|1|||
125262536|NCT01359956|450591955|FG003|Overall Study|Lost to Follow-up|1|||
125262537|NCT01784029|450591956|FG000|Overall Study|Lost to Follow-up|19|||
125262538|NCT01784029|450591957|FG001|Overall Study|Lost to Follow-up|20|||
125262539|NCT01784029|450591958|FG002|Overall Study|Lost to Follow-up|22|||
125262540|NCT00639457|450591959|FG000|Overall Study|Withdrawal by Subject|2|||
125262541|NCT00639457|450591960|FG001|Overall Study|Withdrawal by Subject|3|||
125262542|NCT00370292|450591961|FG000|Overall Study|Disease Progression|4|||
125262543|NCT00370292|450591961|FG000|Overall Study|Adverse Event|7|||
125262544|NCT00370292|450591961|FG000|Overall Study|Physician Decision|2|||
125262545|NCT00276419|450591962|FG000|First Intervention|Adverse Event|1|||
125262546|NCT00276419|450591963|FG001|First Intervention|Adverse Event|0|||
125262547|NCT00276419|450591962|FG000|First Intervention|Withdrawal by Subject|0|||
125262548|NCT00276419|450591963|FG001|First Intervention|Withdrawal by Subject|2|||
125262549|NCT04778592|450591970|FG000|Overall Study|Adverse Event|1|||
125262550|NCT04778592|450591971|FG001|Overall Study|Adverse Event|2|||
125262551|NCT04778592|450591970|FG000|Overall Study|Withdrawal by Subject|1|||
125262552|NCT04778592|450591971|FG001|Overall Study|Withdrawal by Subject|2|||
125262553|NCT01192126|450591972|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
125262554|NCT01192126|450591973|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
125262555|NCT01192126|450591972|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
125262556|NCT01192126|450591973|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
125262557|NCT02660229|450591974|FG000|Overall Study|Adverse Event|2|||
125262558|NCT02660229|450591975|FG001|Overall Study|Adverse Event|0|||
125262559|NCT02660229|450591974|FG000|Overall Study|Withdrawal by Subject|0|||
125262560|NCT02660229|450591975|FG001|Overall Study|Withdrawal by Subject|1|||
125262561|NCT00399529|450591976|FG000|Overall Study|Off Study Prior to Treatment|2|||
125262562|NCT02133573|450591977|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
125262563|NCT02133573|450591978|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
125262564|NCT02133573|450591977|FG000|Overall Study|Child Deaths|3|||
125262565|NCT02133573|450591978|FG001|Overall Study|Child Deaths|5|||
125262566|NCT02133573|450591977|FG000|Overall Study|Child Declined Follow Ups|2|||
125262567|NCT02133573|450591978|FG001|Overall Study|Child Declined Follow Ups|1|||
125262568|NCT02133573|450591977|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
125262569|NCT02133573|450591978|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
125262570|NCT02431325|450591981|FG000|Overall Study|Adverse Event|3|||
125262571|NCT02431325|450591982|FG001|Overall Study|Adverse Event|0|||
125262572|NCT02431325|450591981|FG000|Overall Study|Lost to Follow-up|0|||
125262573|NCT02431325|450591982|FG001|Overall Study|Lost to Follow-up|1|||
125262574|NCT02431325|450591981|FG000|Overall Study|Withdrawal by Subject|1|||
125262575|NCT02431325|450591982|FG001|Overall Study|Withdrawal by Subject|2|||
125262576|NCT02431325|450591981|FG000|Overall Study|Declined to take study medication|1|||
125262577|NCT02431325|450591982|FG001|Overall Study|Declined to take study medication|0|||
125262578|NCT02431325|450591981|FG000|Overall Study|Withdrew before starting study medication|1|||
125262579|NCT02431325|450591982|FG001|Overall Study|Withdrew before starting study medication|0|||
125262580|NCT02431325|450591981|FG000|Overall Study|Placebo shortage|2|||
125262581|NCT02431325|450591982|FG001|Overall Study|Placebo shortage|0|||
125262582|NCT00744861|450591983|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
125262583|NCT00744861|450591984|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
125262584|NCT00744861|450591985|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
125262585|NCT00744861|450591986|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
125262586|NCT00744861|450591983|FG000|Feasibility Stage 1|Pregnancy|0|||
125262587|NCT00744861|450591984|FG001|Feasibility Stage 1|Pregnancy|1|||
125262588|NCT00744861|450591985|FG002|Feasibility Stage 1|Pregnancy|0|||
125262589|NCT00744861|450591986|FG003|Feasibility Stage 1|Pregnancy|0|||
125262590|NCT00744861|450591983|FG000|Pivotal Stage 2|Adverse Event|0|||
125262591|NCT00744861|450591984|FG001|Pivotal Stage 2|Adverse Event|0|||
125262592|NCT00744861|450591985|FG002|Pivotal Stage 2|Adverse Event|6|||
125262593|NCT00744861|450591986|FG003|Pivotal Stage 2|Adverse Event|11|||
125262594|NCT00744861|450591983|FG000|Pivotal Stage 2|Death|0|||
125262595|NCT00744861|450591984|FG001|Pivotal Stage 2|Death|0|||
125262596|NCT00744861|450591985|FG002|Pivotal Stage 2|Death|0|||
125262597|NCT00744861|450591986|FG003|Pivotal Stage 2|Death|1|||
125262598|NCT00744861|450591983|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
125262599|NCT00744861|450591984|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
125262600|NCT00744861|450591985|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
125262601|NCT00744861|450591986|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
125262602|NCT00744861|450591983|FG000|Pivotal Stage 2|Physician Decision|0|||
125262603|NCT00744861|450591984|FG001|Pivotal Stage 2|Physician Decision|0|||
125262604|NCT00744861|450591985|FG002|Pivotal Stage 2|Physician Decision|3|||
125262605|NCT00744861|450591986|FG003|Pivotal Stage 2|Physician Decision|1|||
125262606|NCT00744861|450591983|FG000|Pivotal Stage 2|Protocol Violation|0|||
125262607|NCT00744861|450591984|FG001|Pivotal Stage 2|Protocol Violation|0|||
125262608|NCT00744861|450591985|FG002|Pivotal Stage 2|Protocol Violation|0|||
125262609|NCT00744861|450591986|FG003|Pivotal Stage 2|Protocol Violation|1|||
125262610|NCT00744861|450591983|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
125262611|NCT00744861|450591984|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
125262612|NCT00744861|450591985|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
125262613|NCT00744861|450591986|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
125262614|NCT00744861|450591983|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
125262615|NCT00744861|450591984|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
125262616|NCT00744861|450591985|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
125262617|NCT00744861|450591986|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
125262618|NCT01567722|450591997|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
125262619|NCT01567722|450591998|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
125262620|NCT01567722|450591999|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
125262621|NCT01567722|450591997|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
125262622|NCT01567722|450591998|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
125262623|NCT01567722|450591999|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
125262624|NCT01567722|450591997|FG000|Overall Study|Protocol closure by the OCG|2|||
125262625|NCT01567722|450591998|FG001|Overall Study|Protocol closure by the OCG|0|||
125262626|NCT01567722|450591999|FG002|Overall Study|Protocol closure by the OCG|0|||
125262627|NCT01567722|450591997|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
125262628|NCT01567722|450591998|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
125262629|NCT01567722|450591999|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
125262630|NCT00382174|450592000|FG000|Overall Study|Lost to Follow-up|1|||
125262631|NCT00382174|450592001|FG001|Overall Study|Lost to Follow-up|4|||
125262632|NCT00382174|450592002|FG002|Overall Study|Lost to Follow-up|5|||
125262633|NCT00382174|450592000|FG000|Overall Study|Adverse Event|1|||
125262634|NCT00382174|450592001|FG001|Overall Study|Adverse Event|4|||
125262635|NCT00382174|450592002|FG002|Overall Study|Adverse Event|5|||
125262636|NCT00382174|450592000|FG000|Overall Study|Withdrawal by Subject|1|||
125262637|NCT00382174|450592001|FG001|Overall Study|Withdrawal by Subject|4|||
125262638|NCT00382174|450592002|FG002|Overall Study|Withdrawal by Subject|5|||
125262639|NCT00382174|450592000|FG000|Overall Study|Non compliance|1|||
125262640|NCT00382174|450592001|FG001|Overall Study|Non compliance|0|||
125262641|NCT00382174|450592002|FG002|Overall Study|Non compliance|1|||
125262642|NCT00382174|450592000|FG000|Overall Study|Physician Decision|0|||
125262643|NCT00382174|450592001|FG001|Overall Study|Physician Decision|2|||
125262644|NCT00382174|450592002|FG002|Overall Study|Physician Decision|2|||
125262645|NCT00382174|450592000|FG000|Overall Study|Failed to meet criteria|0|||
125262646|NCT00382174|450592001|FG001|Overall Study|Failed to meet criteria|1|||
125262647|NCT00382174|450592002|FG002|Overall Study|Failed to meet criteria|1|||
125262648|NCT00382174|450592000|FG000|Overall Study|Wounds merged|0|||
125262649|NCT00382174|450592001|FG001|Overall Study|Wounds merged|2|||
125262650|NCT00382174|450592002|FG002|Overall Study|Wounds merged|2|||
125262651|NCT02170064|450592008|FG000|Overall Study|Withdrawal by Subject|5|||
125262652|NCT02170064|450592009|FG001|Overall Study|Withdrawal by Subject|1|||
125262653|NCT02170064|450592010|FG002|Overall Study|Withdrawal by Subject|1|||
125262654|NCT02170064|450592008|FG000|Overall Study|Physician Decision|1|||
125262655|NCT02170064|450592009|FG001|Overall Study|Physician Decision|1|||
125262656|NCT02170064|450592010|FG002|Overall Study|Physician Decision|0|||
125262657|NCT03323164|450592011|FG000|Overall Study|Poor quality imaging/scans|2|||
125262658|NCT03323164|450592012|FG001|Overall Study|Poor quality imaging/scans|2|||
125262659|NCT03434834|450592013|FG000|Overall Study|unable to swallow OCT probe|16|||
125262660|NCT03508050|450592021|FG000|Overall Study|Pleural adhesions|1|||
125262661|NCT03508050|450592022|FG001|Overall Study|Pleural adhesions|0|||
125262662|NCT03508050|450592021|FG000|Overall Study|Mucus plug|1|||
125262663|NCT03508050|450592022|FG001|Overall Study|Mucus plug|0|||
125262664|NCT03508050|450592021|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
125262665|NCT03508050|450592022|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
125262666|NCT03508050|450592021|FG000|Overall Study|Sustained desaturation|0|||
125262667|NCT03508050|450592022|FG001|Overall Study|Sustained desaturation|1|||
125262668|NCT03710889|450592026|FG000|Overall Study|Adverse Event|2|||
125262669|NCT03710889|450592026|FG000|Overall Study|Protocol Deviation|1|||
125262670|NCT00570713|450592027|FG000|Overall Study|Adverse Event|16|||
125262671|NCT00570713|450592028|FG001|Overall Study|Adverse Event|9|||
125262672|NCT00570713|450592027|FG000|Overall Study|Death|7|||
125262673|NCT00570713|450592028|FG001|Overall Study|Death|7|||
125262674|NCT00570713|450592027|FG000|Overall Study|Lack of Efficacy|40|||
125262675|NCT00570713|450592028|FG001|Overall Study|Lack of Efficacy|49|||
125262676|NCT00570713|450592027|FG000|Overall Study|Physician Decision|2|||
125262677|NCT00570713|450592028|FG001|Overall Study|Physician Decision|2|||
125262678|NCT00570713|450592027|FG000|Overall Study|Withdrawal by Subject|3|||
125262679|NCT00570713|450592028|FG001|Overall Study|Withdrawal by Subject|3|||
125262680|NCT00570713|450592027|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
125262681|NCT00570713|450592028|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
125262682|NCT04881760|450592029|FG000|Overall Study|Adverse Event|0|||
125262683|NCT04881760|450592030|FG001|Overall Study|Adverse Event|1|||
125262684|NCT04881760|450592031|FG002|Overall Study|Adverse Event|1|||
125262685|NCT04881760|450592032|FG003|Overall Study|Adverse Event|0|||
125262686|NCT04881760|450592033|FG004|Overall Study|Adverse Event|1|||
125262687|NCT04881760|450592034|FG005|Overall Study|Adverse Event|1|||
125262688|NCT04881760|450592035|FG006|Overall Study|Adverse Event|2|||
125262689|NCT04881760|450592029|FG000|Overall Study|Death|0|||
125262690|NCT04881760|450592030|FG001|Overall Study|Death|0|||
125262691|NCT04881760|450592031|FG002|Overall Study|Death|0|||
125262692|NCT04881760|450592032|FG003|Overall Study|Death|1|||
125262693|NCT04881760|450592033|FG004|Overall Study|Death|0|||
125262694|NCT04881760|450592034|FG005|Overall Study|Death|0|||
125262695|NCT04881760|450592035|FG006|Overall Study|Death|0|||
125262696|NCT04881760|450592029|FG000|Overall Study|Lost to Follow-up|5|||
125262697|NCT04881760|450592030|FG001|Overall Study|Lost to Follow-up|7|||
125262698|NCT04881760|450592031|FG002|Overall Study|Lost to Follow-up|5|||
125262699|NCT04881760|450592032|FG003|Overall Study|Lost to Follow-up|1|||
125262700|NCT04881760|450592033|FG004|Overall Study|Lost to Follow-up|2|||
125262701|NCT04881760|450592034|FG005|Overall Study|Lost to Follow-up|4|||
125262702|NCT04881760|450592035|FG006|Overall Study|Lost to Follow-up|4|||
125262703|NCT04881760|450592029|FG000|Overall Study|Withdrawal by Subject|13|||
125262704|NCT04881760|450592030|FG001|Overall Study|Withdrawal by Subject|1|||
125262705|NCT04881760|450592031|FG002|Overall Study|Withdrawal by Subject|1|||
125262706|NCT04881760|450592032|FG003|Overall Study|Withdrawal by Subject|4|||
125262707|NCT04881760|450592033|FG004|Overall Study|Withdrawal by Subject|2|||
125262708|NCT04881760|450592034|FG005|Overall Study|Withdrawal by Subject|1|||
125262709|NCT04881760|450592035|FG006|Overall Study|Withdrawal by Subject|2|||
125262710|NCT04881760|450592029|FG000|Overall Study|Randomized but Never Treated|0|||
125262711|NCT04881760|450592030|FG001|Overall Study|Randomized but Never Treated|0|||
125262712|NCT04881760|450592031|FG002|Overall Study|Randomized but Never Treated|0|||
125262713|NCT04881760|450592032|FG003|Overall Study|Randomized but Never Treated|1|||
125262714|NCT04881760|450592033|FG004|Overall Study|Randomized but Never Treated|0|||
125262715|NCT04881760|450592034|FG005|Overall Study|Randomized but Never Treated|0|||
125262716|NCT04881760|450592035|FG006|Overall Study|Randomized but Never Treated|0|||
125262717|NCT04881760|450592029|FG000|Overall Study|Inadvertent Enrollment|2|||
125262718|NCT04881760|450592030|FG001|Overall Study|Inadvertent Enrollment|0|||
125262719|NCT04881760|450592031|FG002|Overall Study|Inadvertent Enrollment|0|||
125262720|NCT04881760|450592032|FG003|Overall Study|Inadvertent Enrollment|0|||
125262721|NCT04881760|450592033|FG004|Overall Study|Inadvertent Enrollment|0|||
125262722|NCT04881760|450592034|FG005|Overall Study|Inadvertent Enrollment|0|||
125262723|NCT04881760|450592035|FG006|Overall Study|Inadvertent Enrollment|0|||
125262724|NCT04881760|450592029|FG000|Overall Study|Site Closure|0|||
125262725|NCT04881760|450592030|FG001|Overall Study|Site Closure|0|||
125262726|NCT04881760|450592031|FG002|Overall Study|Site Closure|0|||
125262727|NCT04881760|450592032|FG003|Overall Study|Site Closure|1|||
125262728|NCT04881760|450592033|FG004|Overall Study|Site Closure|0|||
125262729|NCT04881760|450592034|FG005|Overall Study|Site Closure|0|||
125262730|NCT04881760|450592035|FG006|Overall Study|Site Closure|0|||
125262731|NCT01538199|450592039|FG000|Overall Study|Lost to Follow-up|1|||
125262732|NCT01538199|450592040|FG001|Overall Study|Lost to Follow-up|2|||
125262733|NCT01538199|450592041|FG002|Overall Study|Lost to Follow-up|1|||
125262734|NCT01538199|450592042|FG003|Overall Study|Lost to Follow-up|0|||
125262735|NCT01538199|450592039|FG000|Overall Study|participant did not have time|1|||
125262736|NCT01538199|450592040|FG001|Overall Study|participant did not have time|0|||
125262737|NCT01538199|450592041|FG002|Overall Study|participant did not have time|0|||
125262738|NCT01538199|450592042|FG003|Overall Study|participant did not have time|2|||
125262739|NCT01538199|450592039|FG000|Overall Study|Lack of Efficacy|0|||
125262740|NCT01538199|450592040|FG001|Overall Study|Lack of Efficacy|1|||
125262741|NCT01538199|450592041|FG002|Overall Study|Lack of Efficacy|0|||
125262742|NCT01538199|450592042|FG003|Overall Study|Lack of Efficacy|0|||
125262743|NCT02081586|450592043|FG000|Overall Study|Lost to Follow-up|0|||
125262744|NCT02081586|450592044|FG001|Overall Study|Lost to Follow-up|1|||
125262745|NCT02081586|450592045|FG002|Overall Study|Lost to Follow-up|0|||
125262746|NCT02081586|450592046|FG003|Overall Study|Lost to Follow-up|1|||
125262747|NCT02081586|450592043|FG000|Overall Study|Head injury not related to study|0|||
125262748|NCT02081586|450592044|FG001|Overall Study|Head injury not related to study|0|||
125262749|NCT02081586|450592045|FG002|Overall Study|Head injury not related to study|1|||
125262750|NCT02081586|450592046|FG003|Overall Study|Head injury not related to study|0|||
125262751|NCT01677988|450592049|FG000|Overall Study|Lack of Efficacy|2|||
125262752|NCT00659425|450592053|FG000|Overall Study|Disease progression|1|||
125262753|NCT00659425|450592054|FG001|Overall Study|Disease progression|0|||
125262754|NCT00659425|450592055|FG002|Overall Study|Disease progression|0|||
125262755|NCT00659425|450592056|FG003|Overall Study|Disease progression|1|||
125262756|NCT00659425|450592057|FG004|Overall Study|Disease progression|0|||
125262757|NCT00659425|450592058|FG005|Overall Study|Disease progression|2|||
125262758|NCT00659425|450592059|FG006|Overall Study|Disease progression|4|||
125262759|NCT00659425|450592060|FG007|Overall Study|Disease progression|3|||
125262760|NCT00659425|450592061|FG008|Overall Study|Disease progression|5|||
125262761|NCT00659425|450592062|FG009|Overall Study|Disease progression|3|||
125262762|NCT00659425|450592053|FG000|Overall Study|Death|0|||
125262763|NCT00659425|450592054|FG001|Overall Study|Death|0|||
125262764|NCT00659425|450592055|FG002|Overall Study|Death|0|||
125262765|NCT00659425|450592056|FG003|Overall Study|Death|1|||
125262766|NCT00659425|450592057|FG004|Overall Study|Death|0|||
125262767|NCT00659425|450592058|FG005|Overall Study|Death|0|||
125262768|NCT00659425|450592059|FG006|Overall Study|Death|1|||
125262769|NCT00659425|450592060|FG007|Overall Study|Death|0|||
125262770|NCT00659425|450592061|FG008|Overall Study|Death|0|||
125262771|NCT00659425|450592062|FG009|Overall Study|Death|0|||
125262772|NCT00659425|450592053|FG000|Overall Study|Adverse Event|0|||
125262773|NCT00659425|450592054|FG001|Overall Study|Adverse Event|0|||
125262774|NCT00659425|450592055|FG002|Overall Study|Adverse Event|0|||
125262775|NCT00659425|450592056|FG003|Overall Study|Adverse Event|0|||
125262776|NCT00659425|450592057|FG004|Overall Study|Adverse Event|0|||
125262777|NCT00659425|450592058|FG005|Overall Study|Adverse Event|1|||
125262778|NCT00659425|450592059|FG006|Overall Study|Adverse Event|0|||
125262779|NCT00659425|450592060|FG007|Overall Study|Adverse Event|3|||
125262780|NCT00659425|450592061|FG008|Overall Study|Adverse Event|1|||
125262781|NCT00659425|450592062|FG009|Overall Study|Adverse Event|4|||
125262782|NCT00659425|450592053|FG000|Overall Study|Investigator Discretion|0|||
125262783|NCT00659425|450592054|FG001|Overall Study|Investigator Discretion|0|||
125262784|NCT00659425|450592055|FG002|Overall Study|Investigator Discretion|0|||
125262785|NCT00659425|450592056|FG003|Overall Study|Investigator Discretion|0|||
125262786|NCT00659425|450592057|FG004|Overall Study|Investigator Discretion|0|||
125262787|NCT00659425|450592058|FG005|Overall Study|Investigator Discretion|1|||
125262788|NCT00659425|450592059|FG006|Overall Study|Investigator Discretion|0|||
125262789|NCT00659425|450592060|FG007|Overall Study|Investigator Discretion|3|||
125262790|NCT00659425|450592061|FG008|Overall Study|Investigator Discretion|0|||
125262791|NCT00659425|450592062|FG009|Overall Study|Investigator Discretion|0|||
125262792|NCT00659425|450592053|FG000|Overall Study|Other|0|||
125262793|NCT00659425|450592054|FG001|Overall Study|Other|1|||
125262794|NCT00659425|450592055|FG002|Overall Study|Other|1|||
125262795|NCT00659425|450592056|FG003|Overall Study|Other|2|||
125262796|NCT00659425|450592057|FG004|Overall Study|Other|4|||
125262797|NCT00659425|450592058|FG005|Overall Study|Other|0|||
125262798|NCT00659425|450592059|FG006|Overall Study|Other|3|||
125262799|NCT00659425|450592060|FG007|Overall Study|Other|2|||
125262800|NCT00659425|450592061|FG008|Overall Study|Other|0|||
125262801|NCT00659425|450592062|FG009|Overall Study|Other|6|||
125262802|NCT00271544|450592063|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
125262803|NCT00271544|450592063|FG000|Overall Study|Model 4196 lead not attempted|9|||
125262804|NCT00271544|450592063|FG000|Overall Study|Implant not attempted|4|||
125262805|NCT03358030|450592064|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
125262806|NCT03358030|450592065|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
125262807|NCT03358030|450592066|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
125262808|NCT03358030|450592067|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
125262809|NCT03358030|450592064|FG000|Overall Study|Ineligibility|0|||
125262810|NCT03358030|450592065|FG001|Overall Study|Ineligibility|0|||
125262811|NCT03358030|450592066|FG002|Overall Study|Ineligibility|0|||
125262812|NCT03358030|450592067|FG003|Overall Study|Ineligibility|2|||
125262813|NCT03358030|450592064|FG000|Overall Study|Voluntary Withdrawal|1|||
125262814|NCT03358030|450592065|FG001|Overall Study|Voluntary Withdrawal|1|||
125262815|NCT03358030|450592066|FG002|Overall Study|Voluntary Withdrawal|3|||
125262816|NCT03358030|450592067|FG003|Overall Study|Voluntary Withdrawal|1|||
125262817|NCT03358030|450592064|FG000|Overall Study|Other|0|||
125262818|NCT03358030|450592065|FG001|Overall Study|Other|0|||
125262819|NCT03358030|450592066|FG002|Overall Study|Other|1|||
125262820|NCT03358030|450592067|FG003|Overall Study|Other|0|||
125262821|NCT00829244|450592068|FG000|Overall Study|Adverse Event|1|||
125262822|NCT00829244|450592069|FG001|Overall Study|Adverse Event|3|||
125262823|NCT00829244|450592068|FG000|Overall Study|Protocol Violation|1|||
125262824|NCT00829244|450592069|FG001|Overall Study|Protocol Violation|0|||
125262825|NCT00829244|450592068|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
125262826|NCT00829244|450592069|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
125262827|NCT00829244|450592068|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
125262828|NCT00829244|450592069|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
125262829|NCT00829244|450592068|FG000|Overall Study|No fertilization|2|||
125262830|NCT00829244|450592069|FG001|Overall Study|No fertilization|2|||
125262831|NCT00829244|450592068|FG000|Overall Study|All embryos discarded|0|||
125262832|NCT00829244|450592069|FG001|Overall Study|All embryos discarded|3|||
125262833|NCT00829244|450592068|FG000|Overall Study|No embryo cleavage|0|||
125262834|NCT00829244|450592069|FG001|Overall Study|No embryo cleavage|2|||
125262835|NCT02604511|450592070|FG000|Overall Study|Adverse Event|3|||
125262836|NCT02604511|450592070|FG000|Overall Study|Disease Progression|4|||
125262837|NCT02604511|450592070|FG000|Overall Study|Withdrawal by Subject|3|||
125262838|NCT02604511|450592070|FG000|Overall Study|Participant ineligible|1|||
125262839|NCT02604511|450592070|FG000|Overall Study|Intercurrent illness|1|||
125262840|NCT03770286|450592071|FG000|Overall Study|Lost to Follow-up|6|||
125262841|NCT03770286|450592072|FG001|Overall Study|Lost to Follow-up|4|||
125262842|NCT03770286|450592073|FG002|Overall Study|Lost to Follow-up|3|||
125262843|NCT03770286|450592071|FG000|Overall Study|Protocol Violation|1|||
125262844|NCT03770286|450592072|FG001|Overall Study|Protocol Violation|0|||
125262845|NCT03770286|450592073|FG002|Overall Study|Protocol Violation|2|||
125262846|NCT02505425|450592074|FG000|Overall Study|Lost to Follow-up|41|||
125262847|NCT02505425|450592075|FG001|Overall Study|Lost to Follow-up|61|||
125262848|NCT02505425|450592076|FG002|Overall Study|Lost to Follow-up|31|||
125262849|NCT02505425|450592077|FG003|Overall Study|Lost to Follow-up|19|||
125262850|NCT02505425|450592074|FG000|Overall Study|Withdrawal by Subject|39|||
125262851|NCT02505425|450592075|FG001|Overall Study|Withdrawal by Subject|9|||
125262852|NCT02505425|450592076|FG002|Overall Study|Withdrawal by Subject|19|||
125262853|NCT02505425|450592077|FG003|Overall Study|Withdrawal by Subject|7|||
125262854|NCT02505425|450592074|FG000|Overall Study|Death|8|||
125262855|NCT02505425|450592075|FG001|Overall Study|Death|12|||
125262856|NCT02505425|450592076|FG002|Overall Study|Death|0|||
125262857|NCT02505425|450592077|FG003|Overall Study|Death|0|||
125262858|NCT02297412|450592078|FG000|Overall Study|Canceled|1|||
125262859|NCT02297412|450592079|FG001|Overall Study|Canceled|1|||
125262860|NCT02031302|450592080|FG000|Overall Study|Death|115|||
125262861|NCT02031302|450592081|FG001|Overall Study|Death|0|||
125262862|NCT02031302|450592080|FG000|Overall Study|Not treated with study valve system|18|||
125262863|NCT02031302|450592081|FG001|Overall Study|Not treated with study valve system|0|||
125262864|NCT02031302|450592080|FG000|Overall Study|Missed Follow Up|27|||
125262865|NCT02031302|450592081|FG001|Overall Study|Missed Follow Up|0|||
125262866|NCT02031302|450592080|FG000|Overall Study|Lost to Follow-up|4|||
125262867|NCT02031302|450592081|FG001|Overall Study|Lost to Follow-up|0|||
125262868|NCT03950856|450592085|FG000|Overall Study|Death|1|||
125262869|NCT03950856|450592086|FG001|Overall Study|Death|2|||
125262870|NCT03950856|450592087|FG002|Overall Study|Death|0|||
125262871|NCT03950856|450592088|FG003|Overall Study|Death|0|||
125262872|NCT03950856|450592085|FG000|Overall Study|Lost to Follow-up|5|||
125262873|NCT03950856|450592086|FG001|Overall Study|Lost to Follow-up|6|||
125262874|NCT03950856|450592087|FG002|Overall Study|Lost to Follow-up|8|||
125262875|NCT03950856|450592088|FG003|Overall Study|Lost to Follow-up|2|||
125262876|NCT03950856|450592085|FG000|Overall Study|Protocol Violation|2|||
125262877|NCT03950856|450592086|FG001|Overall Study|Protocol Violation|0|||
125262878|NCT03950856|450592087|FG002|Overall Study|Protocol Violation|0|||
125262879|NCT03950856|450592088|FG003|Overall Study|Protocol Violation|1|||
125262880|NCT03950856|450592085|FG000|Overall Study|Withdrawal by Subject|4|||
125262881|NCT03950856|450592086|FG001|Overall Study|Withdrawal by Subject|1|||
125262882|NCT03950856|450592087|FG002|Overall Study|Withdrawal by Subject|3|||
125262883|NCT03950856|450592088|FG003|Overall Study|Withdrawal by Subject|1|||
125262884|NCT03950856|450592085|FG000|Overall Study|Unable to phone|7|||
125262885|NCT03950856|450592086|FG001|Overall Study|Unable to phone|6|||
125262886|NCT03950856|450592087|FG002|Overall Study|Unable to phone|7|||
125262887|NCT03950856|450592088|FG003|Overall Study|Unable to phone|2|||
125262888|NCT05899829|450592089|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
125262889|NCT05899829|450592090|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
125262890|NCT05899829|450592089|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
125262891|NCT05899829|450592090|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
125262892|NCT02781558|450592094|FG000|Overall Study|Lost to Follow-up|2|||
125262893|NCT02781558|450592095|FG001|Overall Study|Lost to Follow-up|2|||
125262894|NCT02781558|450592094|FG000|Overall Study|Adverse Event|1|||
125262895|NCT02781558|450592095|FG001|Overall Study|Adverse Event|0|||
125262896|NCT00545779|450592096|FG000|Overall Study|Violation of selection criteria at entry|8|||
125262897|NCT00545779|450592096|FG000|Overall Study|Other protocol violation|1|||
125262898|NCT00545779|450592096|FG000|Overall Study|Did not cooperate|7|||
125262899|NCT00545779|450592096|FG000|Overall Study|Withdrawal by Subject|20|||
125262900|NCT00545779|450592096|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
125262901|NCT00545779|450592096|FG000|Overall Study|Failure to return|3|||
125262902|NCT03802396|450592097|FG000|Overall Study|Withdrawal by Subject|2|||
125262903|NCT03802396|450592098|FG001|Overall Study|Withdrawal by Subject|0|||
125262904|NCT03802396|450592097|FG000|Overall Study|Surgery Cancelled|1|||
125262905|NCT03802396|450592098|FG001|Overall Study|Surgery Cancelled|0|||
125262906|NCT02561962|450592102|FG000|Overall Study|Withdrawal by Subject|1|||
125262907|NCT02561962|450592103|FG001|Overall Study|Withdrawal by Subject|0|||
125262908|NCT02561962|450592104|FG002|Overall Study|Withdrawal by Subject|0|||
125262909|NCT02561962|450592105|FG003|Overall Study|Withdrawal by Subject|0|||
125262910|NCT02561962|450592106|FG004|Overall Study|Withdrawal by Subject|1|||
125262911|NCT02561962|450592107|FG005|Overall Study|Withdrawal by Subject|1|||
125262912|NCT02561962|450592108|FG006|Overall Study|Withdrawal by Subject|2|||
125262913|NCT02561962|450592109|FG007|Overall Study|Withdrawal by Subject|1|||
125262914|NCT02561962|450592110|FG008|Overall Study|Withdrawal by Subject|0|||
125262915|NCT02561962|450592102|FG000|Overall Study|Decision by sponsor|0|||
125262916|NCT02561962|450592103|FG001|Overall Study|Decision by sponsor|0|||
125262917|NCT02561962|450592104|FG002|Overall Study|Decision by sponsor|0|||
125262918|NCT02561962|450592105|FG003|Overall Study|Decision by sponsor|0|||
125262919|NCT02561962|450592106|FG004|Overall Study|Decision by sponsor|1|||
125262920|NCT02561962|450592107|FG005|Overall Study|Decision by sponsor|1|||
125262921|NCT02561962|450592108|FG006|Overall Study|Decision by sponsor|0|||
125262922|NCT02561962|450592109|FG007|Overall Study|Decision by sponsor|3|||
125262923|NCT02561962|450592110|FG008|Overall Study|Decision by sponsor|0|||
125262924|NCT02561962|450592102|FG000|Overall Study|Lost to Follow-up|0|||
125262925|NCT02561962|450592103|FG001|Overall Study|Lost to Follow-up|0|||
125262926|NCT02561962|450592104|FG002|Overall Study|Lost to Follow-up|0|||
125262927|NCT02561962|450592105|FG003|Overall Study|Lost to Follow-up|0|||
125262928|NCT02561962|450592106|FG004|Overall Study|Lost to Follow-up|0|||
125262929|NCT02561962|450592107|FG005|Overall Study|Lost to Follow-up|1|||
125262930|NCT02561962|450592108|FG006|Overall Study|Lost to Follow-up|0|||
125262931|NCT02561962|450592109|FG007|Overall Study|Lost to Follow-up|0|||
125262932|NCT02561962|450592110|FG008|Overall Study|Lost to Follow-up|0|||
125262933|NCT01150357|450592111|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
125262934|NCT01150357|450592112|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
125262935|NCT01150357|450592113|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
125262936|NCT01150357|450592111|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
125262937|NCT01150357|450592112|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
125262938|NCT01150357|450592113|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
125262939|NCT01150357|450592111|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
125262940|NCT01150357|450592112|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
125262941|NCT01150357|450592113|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
125262942|NCT01150357|450592111|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
125262943|NCT01150357|450592112|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
125262944|NCT01150357|450592113|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
125262945|NCT01150357|450592111|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
125262946|NCT01150357|450592112|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
125262947|NCT01150357|450592113|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
125262948|NCT01150357|450592111|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
125262949|NCT01150357|450592112|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
125262950|NCT01150357|450592113|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
125262951|NCT01150357|450592111|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
125262952|NCT01150357|450592112|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
125262953|NCT01150357|450592113|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
125262954|NCT01732536|450593743|FG000|Overall Study|Withdrawal by Subject|1|||
125262955|NCT01732536|450593744|FG001|Overall Study|Withdrawal by Subject|1|||
125262956|NCT01581684|450593747|FG000|Overall Study|Other reason not defined|0|||
125262957|NCT01581684|450593748|FG001|Overall Study|Other reason not defined|0|||
125262958|NCT01581684|450593749|FG002|Overall Study|Other reason not defined|0|||
125262959|NCT01581684|450593750|FG003|Overall Study|Other reason not defined|0|||
125262960|NCT01581684|450593751|FG004|Overall Study|Other reason not defined|0|||
125262961|NCT01581684|450593752|FG005|Overall Study|Other reason not defined|0|||
125262962|NCT01581684|450593753|FG006|Overall Study|Other reason not defined|0|||
125262963|NCT01581684|450593754|FG007|Overall Study|Other reason not defined|0|||
125262964|NCT01581684|450593755|FG008|Overall Study|Other reason not defined|1|||
125262965|NCT01581684|450593756|FG009|Overall Study|Other reason not defined|0|||
125262966|NCT03728933|450593757|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
125262967|NCT03728933|450593758|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125262968|NCT03728933|450593759|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
125262969|NCT03728933|450593757|FG000|Overall Study|Withdrawal by Subject|0|||
125262970|NCT03728933|450593758|FG001|Overall Study|Withdrawal by Subject|0|||
125262971|NCT03728933|450593759|FG002|Overall Study|Withdrawal by Subject|1|||
125262972|NCT03728933|450593757|FG000|Overall Study|Lost to Follow-up|0|||
125262973|NCT03728933|450593758|FG001|Overall Study|Lost to Follow-up|1|||
125262974|NCT03728933|450593759|FG002|Overall Study|Lost to Follow-up|0|||
125262975|NCT03728933|450593757|FG000|Overall Study|Adverse Event|1|||
125262976|NCT03728933|450593758|FG001|Overall Study|Adverse Event|0|||
125262977|NCT03728933|450593759|FG002|Overall Study|Adverse Event|0|||
125262978|NCT03235050|450593760|FG000|Overall Study|Adverse Event|0|||
125262979|NCT03235050|450593761|FG001|Overall Study|Adverse Event|0|||
125262980|NCT03235050|450593762|FG002|Overall Study|Adverse Event|1|||
125262981|NCT03235050|450593763|FG003|Overall Study|Adverse Event|4|||
125262982|NCT03235050|450593764|FG004|Overall Study|Adverse Event|1|||
125262983|NCT03235050|450593760|FG000|Overall Study|Death|0|||
125262984|NCT03235050|450593761|FG001|Overall Study|Death|0|||
125262985|NCT03235050|450593762|FG002|Overall Study|Death|0|||
125262986|NCT03235050|450593763|FG003|Overall Study|Death|2|||
125262987|NCT03235050|450593764|FG004|Overall Study|Death|1|||
125262988|NCT03235050|450593760|FG000|Overall Study|Lost to Follow-up|1|||
125262989|NCT03235050|450593761|FG001|Overall Study|Lost to Follow-up|2|||
125262990|NCT03235050|450593762|FG002|Overall Study|Lost to Follow-up|1|||
125262991|NCT03235050|450593763|FG003|Overall Study|Lost to Follow-up|2|||
125262992|NCT03235050|450593764|FG004|Overall Study|Lost to Follow-up|0|||
125262993|NCT03235050|450593760|FG000|Overall Study|Withdrawal by Subject|3|||
125262994|NCT03235050|450593761|FG001|Overall Study|Withdrawal by Subject|2|||
125262995|NCT03235050|450593762|FG002|Overall Study|Withdrawal by Subject|2|||
125262996|NCT03235050|450593763|FG003|Overall Study|Withdrawal by Subject|5|||
125262997|NCT03235050|450593764|FG004|Overall Study|Withdrawal by Subject|7|||
125262998|NCT03235050|450593760|FG000|Overall Study|Other reasons|0|||
125262999|NCT03235050|450593761|FG001|Overall Study|Other reasons|1|||
125263000|NCT03235050|450593762|FG002|Overall Study|Other reasons|0|||
125263001|NCT03235050|450593763|FG003|Overall Study|Other reasons|1|||
125263002|NCT03235050|450593764|FG004|Overall Study|Other reasons|2|||
125263003|NCT03545672|450593765|FG000|Overall Study|Uncertain diagnosis|2|||
125263004|NCT03545672|450593766|FG001|Overall Study|Uncertain diagnosis|1|||
125263005|NCT03545672|450593765|FG000|Overall Study|Protocol Violation|2|||
125263006|NCT03545672|450593766|FG001|Overall Study|Protocol Violation|2|||
125263007|NCT01628913|450593767|FG000|Overall Study|Adverse Event|12|||
125263008|NCT01628913|450593768|FG001|Overall Study|Adverse Event|5|||
125263009|NCT01628913|450593767|FG000|Overall Study|Disease Progression|11|||
125263010|NCT01628913|450593768|FG001|Overall Study|Disease Progression|14|||
125263011|NCT01628913|450593767|FG000|Overall Study|Protocol Violation|1|||
125263012|NCT01628913|450593768|FG001|Overall Study|Protocol Violation|0|||
125263013|NCT01628913|450593767|FG000|Overall Study|Death|1|||
125263014|NCT01628913|450593768|FG001|Overall Study|Death|0|||
125263015|NCT01628913|450593767|FG000|Overall Study|study terminated by Sponsor|4|||
125263016|NCT01628913|450593768|FG001|Overall Study|study terminated by Sponsor|9|||
125263017|NCT01628913|450593767|FG000|Overall Study|Withdrawal by Subject|1|||
125263018|NCT01628913|450593768|FG001|Overall Study|Withdrawal by Subject|0|||
125263019|NCT01628913|450593767|FG000|Overall Study|Physician Decision|1|||
125263020|NCT01628913|450593768|FG001|Overall Study|Physician Decision|3|||
125263021|NCT02415556|450593769|FG000|Overall Study|Adverse Event|3|||
125263022|NCT02415556|450593770|FG001|Overall Study|Adverse Event|4|||
125263023|NCT02415556|450593771|FG002|Overall Study|Adverse Event|2|||
125263024|NCT02415556|450593772|FG003|Overall Study|Adverse Event|4|||
125263025|NCT02415556|450593769|FG000|Overall Study|Lost to Follow-up|4|||
125263026|NCT02415556|450593770|FG001|Overall Study|Lost to Follow-up|5|||
125263027|NCT02415556|450593771|FG002|Overall Study|Lost to Follow-up|4|||
125263028|NCT02415556|450593772|FG003|Overall Study|Lost to Follow-up|1|||
125263029|NCT02415556|450593769|FG000|Overall Study|Withdrawal by Subject|13|||
125263030|NCT02415556|450593770|FG001|Overall Study|Withdrawal by Subject|4|||
125263031|NCT02415556|450593771|FG002|Overall Study|Withdrawal by Subject|14|||
125263032|NCT02415556|450593772|FG003|Overall Study|Withdrawal by Subject|12|||
125263033|NCT02415556|450593769|FG000|Overall Study|Physician Decision|1|||
125263034|NCT02415556|450593770|FG001|Overall Study|Physician Decision|3|||
125263035|NCT02415556|450593771|FG002|Overall Study|Physician Decision|1|||
125263036|NCT02415556|450593772|FG003|Overall Study|Physician Decision|2|||
125263037|NCT02415556|450593769|FG000|Overall Study|Censored - study completion|4|||
125263038|NCT02415556|450593770|FG001|Overall Study|Censored - study completion|5|||
125263039|NCT02415556|450593771|FG002|Overall Study|Censored - study completion|1|||
125263040|NCT02415556|450593772|FG003|Overall Study|Censored - study completion|0|||
125263041|NCT02415556|450593769|FG000|Overall Study|Family-related issues|0|||
125263042|NCT02415556|450593770|FG001|Overall Study|Family-related issues|0|||
125263043|NCT02415556|450593771|FG002|Overall Study|Family-related issues|0|||
125263044|NCT02415556|450593772|FG003|Overall Study|Family-related issues|1|||
125263045|NCT00105534|450593773|FG000|Overall Study|Adverse Event|2|||
125263046|NCT00105534|450593774|FG001|Overall Study|Adverse Event|5|||
125263047|NCT00105534|450593773|FG000|Overall Study|Protocol Violation|1|||
125263048|NCT00105534|450593774|FG001|Overall Study|Protocol Violation|4|||
125263049|NCT00105534|450593773|FG000|Overall Study|Withdrawal by Subject|6|||
125263050|NCT00105534|450593774|FG001|Overall Study|Withdrawal by Subject|6|||
125263051|NCT00105534|450593773|FG000|Overall Study|Lost to Follow-up|5|||
125263052|NCT00105534|450593774|FG001|Overall Study|Lost to Follow-up|1|||
125263053|NCT00105534|450593773|FG000|Overall Study|Lack of Efficacy|7|||
125263054|NCT00105534|450593774|FG001|Overall Study|Lack of Efficacy|15|||
125263055|NCT00105534|450593773|FG000|Overall Study|Treatment unmasked|1|||
125263056|NCT00105534|450593774|FG001|Overall Study|Treatment unmasked|0|||
125263057|NCT00105534|450593773|FG000|Overall Study|Other Reason|0|||
125263058|NCT00105534|450593774|FG001|Overall Study|Other Reason|2|||
125263059|NCT01621178|450593775|FG000|Overall Study|Adverse Event|5|||
125263060|NCT01621178|450593776|FG001|Overall Study|Adverse Event|2|||
125263061|NCT01621178|450593777|FG002|Overall Study|Adverse Event|8|||
125263062|NCT01621178|450593775|FG000|Overall Study|Death|6|||
125263063|NCT01621178|450593776|FG001|Overall Study|Death|7|||
125263064|NCT01621178|450593777|FG002|Overall Study|Death|2|||
125263065|NCT01621178|450593775|FG000|Overall Study|Lost to Follow-up|1|||
125263066|NCT01621178|450593776|FG001|Overall Study|Lost to Follow-up|2|||
125263067|NCT01621178|450593777|FG002|Overall Study|Lost to Follow-up|1|||
125263068|NCT01621178|450593775|FG000|Overall Study|Withdrawal by Subject|14|||
125263069|NCT01621178|450593776|FG001|Overall Study|Withdrawal by Subject|17|||
125263070|NCT01621178|450593777|FG002|Overall Study|Withdrawal by Subject|18|||
125263071|NCT01621178|450593775|FG000|Overall Study|Physician Decision|5|||
125263072|NCT01621178|450593776|FG001|Overall Study|Physician Decision|2|||
125263073|NCT01621178|450593777|FG002|Overall Study|Physician Decision|7|||
125263074|NCT02935192|450593778|FG000|Overall Study|Withdrawal by Subject|8|||
125263075|NCT02935192|450593779|FG001|Overall Study|Withdrawal by Subject|4|||
125263076|NCT02465931|450593780|FG000|Overall Study|Lost to Follow-up|9|||
125263077|NCT02465931|450593781|FG001|Overall Study|Lost to Follow-up|11|||
125263078|NCT02465931|450593780|FG000|Overall Study|Protocol Violation|1|||
125263079|NCT02465931|450593781|FG001|Overall Study|Protocol Violation|0|||
125263080|NCT02465931|450593780|FG000|Overall Study|Withdrawal by Subject|1|||
125263081|NCT02465931|450593781|FG001|Overall Study|Withdrawal by Subject|0|||
125263082|NCT02896257|450593783|FG000|Providers|Without eligible patients|21|||
125263083|NCT02896257|450593784|FG001|Providers|Without eligible patients|28|||
125263084|NCT02896257|450593783|FG000|Patients|PFT entry criteria not met|43|||
125263085|NCT02896257|450593784|FG001|Patients|PFT entry criteria not met|50|||
125263086|NCT02896257|450593783|FG000|Patients|No capacity to review|8|||
125263087|NCT02896257|450593784|FG001|Patients|No capacity to review|11|||
125263088|NCT02896257|450593783|FG000|Patients|Appointment rescheduled/cancelled|5|||
125263089|NCT02896257|450593784|FG001|Patients|Appointment rescheduled/cancelled|7|||
125263090|NCT02896257|450593783|FG000|Patients|PCP not assigned a clinic|4|||
125263091|NCT02896257|450593784|FG001|Patients|PCP not assigned a clinic|0|||
125263092|NCT02896257|450593783|FG000|Patients|No history of COPD|0|||
125263093|NCT02896257|450593784|FG001|Patients|No history of COPD|1|||
125263094|NCT02896257|450593783|FG000|Patients|Deceased between review and index date|0|||
125263095|NCT02896257|450593784|FG001|Patients|Deceased between review and index date|1|||
125263096|NCT02896257|450593783|FG000|Patients|No ICS Rx upon review|1|||
125263097|NCT02896257|450593784|FG001|Patients|No ICS Rx upon review|1|||
125263098|NCT02896257|450593783|FG000|Patients|Protocol Violation|2|||
125263099|NCT02896257|450593784|FG001|Patients|Protocol Violation|1|||
125263100|NCT02896257|450593783|FG000|Patients|Hospice care|0|||
125263101|NCT02896257|450593784|FG001|Patients|Hospice care|1|||
125263102|NCT00492557|450593785|FG000|Overall Study|Subject request|12|||
125263103|NCT00492557|450593786|FG001|Overall Study|Subject request|11|||
125263104|NCT00492557|450593785|FG000|Overall Study|Protocol Violation|7|||
125263105|NCT00492557|450593786|FG001|Overall Study|Protocol Violation|8|||
125263106|NCT00492557|450593785|FG000|Overall Study|Other|2|||
125263107|NCT00492557|450593786|FG001|Overall Study|Other|2|||
125263108|NCT00492557|450593785|FG000|Overall Study|Death|1|||
125263109|NCT00492557|450593786|FG001|Overall Study|Death|1|||
125263110|NCT00492557|450593785|FG000|Overall Study|Adverse Event|1|||
125263111|NCT00492557|450593786|FG001|Overall Study|Adverse Event|0|||
125263112|NCT00492557|450593785|FG000|Overall Study|Failed to return|1|||
125263113|NCT00492557|450593786|FG001|Overall Study|Failed to return|0|||
125263114|NCT00492557|450593785|FG000|Overall Study|Lost to Follow-up|0|||
125263115|NCT00492557|450593786|FG001|Overall Study|Lost to Follow-up|1|||
125263116|NCT04102007|450593788|FG000|Overall Study|Adverse Event|4|||
125263117|NCT04102007|450593788|FG000|Overall Study|Lost to Follow-up|3|||
125263118|NCT04102007|450593788|FG000|Overall Study|Withdrawal by Subject|12|||
125263119|NCT04102007|450593788|FG000|Overall Study|Eligibility Violation|5|||
125263120|NCT04102007|450593788|FG000|Overall Study|Lack of Efficacy|6|||
125263121|NCT04102007|450593788|FG000|Overall Study|Protocol Deviation|5|||
125263122|NCT04102007|450593788|FG000|Overall Study|Protocol Compliance|1|||
125263123|NCT04102007|450593788|FG000|Overall Study|Withdrew Treatment|2|||
125263124|NCT04102007|450593788|FG000|Overall Study|Pregnancy|1|||
125263125|NCT00892008|450593791|FG000|Overall Study|Death|5|||
125263126|NCT00892008|450593791|FG000|Overall Study|Lack of Efficacy|3|||
125263127|NCT00892008|450593791|FG000|Overall Study|Lost to Follow-up|142|||
125263128|NCT00892008|450593791|FG000|Overall Study|Other|378|||
125263129|NCT00892008|450593791|FG000|Overall Study|Adverse Event|37|||
125263130|NCT00329030|450593792|FG000|Overall Study|Withdrawal by Subject|1|||
125263131|NCT00329030|450593793|FG001|Overall Study|Withdrawal by Subject|3|||
125263132|NCT00329030|450593792|FG000|Overall Study|Progressive Disease|6|||
125263133|NCT00329030|450593793|FG001|Overall Study|Progressive Disease|2|||
125263134|NCT00329030|450593792|FG000|Overall Study|Ineligible Pathology|1|||
125263135|NCT00329030|450593793|FG001|Overall Study|Ineligible Pathology|1|||
125263136|NCT01627691|450593794|FG000|Overall Study|Death|11|||
125263137|NCT01627691|450593794|FG000|Overall Study|Lost to Follow-up|3|||
125263138|NCT01627691|450593794|FG000|Overall Study|Withdrawal by Subject|1|||
125263139|NCT01627691|450593794|FG000|Overall Study|Missed the visit|3|||
125263140|NCT00181844|450593795|FG000|Signed Consent|Withdrawal by Subject|5|||
125263141|NCT00181844|450593795|FG000|Signed Consent|Did not meet entrance criteria|7|||
125263142|NCT00181844|450593795|FG000|Exposed to Study Medication|Adverse Event|10|||
125263143|NCT00181844|450593795|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
125263144|NCT00181844|450593795|FG000|Exposed to Study Medication|Non-compliance|2|||
125263145|NCT00181844|450593795|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
125263146|NCT00181844|450593795|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
125263147|NCT04661033|450593796|FG000|Overall Study|Adverse Event|0|||
125263148|NCT04661033|450593797|FG001|Overall Study|Adverse Event|0|||
125263149|NCT04661033|450593798|FG002|Overall Study|Adverse Event|1|||
125263150|NCT04661033|450593799|FG003|Overall Study|Adverse Event|0|||
125263151|NCT04661033|450593796|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
125263152|NCT04661033|450593797|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
125263153|NCT04661033|450593798|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
125263154|NCT04661033|450593799|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
125263155|NCT04661033|450593796|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
125263156|NCT04661033|450593797|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
125263157|NCT04661033|450593798|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
125263158|NCT04661033|450593799|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
125263159|NCT04661033|450593796|FG000|Overall Study|Early discontinuation as per PI|1|||
125263160|NCT04661033|450593797|FG001|Overall Study|Early discontinuation as per PI|0|||
125263161|NCT04661033|450593798|FG002|Overall Study|Early discontinuation as per PI|0|||
125263162|NCT04661033|450593799|FG003|Overall Study|Early discontinuation as per PI|0|||
125263163|NCT00565409|450593802|FG000|Period 1 Open Label|Adverse Event|17|||
125263164|NCT00565409|450593803|FG001|Period 1 Open Label|Adverse Event|0|||
125263165|NCT00565409|450593804|FG002|Period 1 Open Label|Adverse Event|0|||
125263166|NCT00565409|450593805|FG003|Period 1 Open Label|Adverse Event|0|||
125263167|NCT00565409|450593802|FG000|Period 1 Open Label|Death|2|||
125263168|NCT00565409|450593803|FG001|Period 1 Open Label|Death|0|||
125263169|NCT00565409|450593804|FG002|Period 1 Open Label|Death|0|||
125263170|NCT00565409|450593805|FG003|Period 1 Open Label|Death|0|||
125263171|NCT00565409|450593802|FG000|Period 1 Open Label|Lost to Follow-up|1|||
125263172|NCT00565409|450593803|FG001|Period 1 Open Label|Lost to Follow-up|0|||
125263173|NCT00565409|450593804|FG002|Period 1 Open Label|Lost to Follow-up|0|||
125263174|NCT00565409|450593805|FG003|Period 1 Open Label|Lost to Follow-up|0|||
125263175|NCT00565409|450593802|FG000|Period 1 Open Label|Other|21|||
125263176|NCT00565409|450593803|FG001|Period 1 Open Label|Other|0|||
125263177|NCT00565409|450593804|FG002|Period 1 Open Label|Other|0|||
125263178|NCT00565409|450593805|FG003|Period 1 Open Label|Other|0|||
125263179|NCT00565409|450593802|FG000|Period 1 Open Label|Protocol Violation|14|||
125263180|NCT00565409|450593803|FG001|Period 1 Open Label|Protocol Violation|0|||
125263181|NCT00565409|450593804|FG002|Period 1 Open Label|Protocol Violation|0|||
125263182|NCT00565409|450593805|FG003|Period 1 Open Label|Protocol Violation|0|||
125263183|NCT00565409|450593802|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
125263184|NCT00565409|450593803|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
125263185|NCT00565409|450593804|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
125263186|NCT00565409|450593805|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
125263187|NCT00565409|450593802|FG000|Period 1 Open Label|no conclusion of participation record|1|||
125263188|NCT00565409|450593803|FG001|Period 1 Open Label|no conclusion of participation record|0|||
125263189|NCT00565409|450593804|FG002|Period 1 Open Label|no conclusion of participation record|0|||
125263190|NCT00565409|450593805|FG003|Period 1 Open Label|no conclusion of participation record|0|||
125263191|NCT00565409|450593802|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
125263192|NCT00565409|450593803|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
125263193|NCT00565409|450593804|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
125263194|NCT00565409|450593805|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
125263195|NCT00565409|450593802|FG000|Period 2 Double-Blind|Adverse Event|0|||
125263196|NCT00565409|450593803|FG001|Period 2 Double-Blind|Adverse Event|7|||
125263197|NCT00565409|450593804|FG002|Period 2 Double-Blind|Adverse Event|4|||
125263198|NCT00565409|450593805|FG003|Period 2 Double-Blind|Adverse Event|5|||
125263199|NCT00565409|450593802|FG000|Period 2 Double-Blind|Death|0|||
125263200|NCT00565409|450593803|FG001|Period 2 Double-Blind|Death|2|||
125263201|NCT00565409|450593804|FG002|Period 2 Double-Blind|Death|0|||
125263202|NCT00565409|450593805|FG003|Period 2 Double-Blind|Death|0|||
125263203|NCT00565409|450593802|FG000|Period 2 Double-Blind|Protocol Violation|0|||
125263204|NCT00565409|450593803|FG001|Period 2 Double-Blind|Protocol Violation|4|||
125263205|NCT00565409|450593804|FG002|Period 2 Double-Blind|Protocol Violation|6|||
125263206|NCT00565409|450593805|FG003|Period 2 Double-Blind|Protocol Violation|2|||
125263207|NCT00565409|450593802|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
125263208|NCT00565409|450593803|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
125263209|NCT00565409|450593804|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
125263210|NCT00565409|450593805|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
125263211|NCT00565409|450593802|FG000|Period 2 Double-Blind|Other|0|||
125263212|NCT00565409|450593803|FG001|Period 2 Double-Blind|Other|4|||
125263213|NCT00565409|450593804|FG002|Period 2 Double-Blind|Other|5|||
125263214|NCT00565409|450593805|FG003|Period 2 Double-Blind|Other|9|||
125263215|NCT00565409|450593802|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
125263216|NCT00565409|450593803|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
125263217|NCT00565409|450593804|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
125263218|NCT00565409|450593805|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
125263219|NCT04064905|450593821|FG000|Overall Study|Lost to Follow-up|0|||
125263220|NCT04064905|450593822|FG001|Overall Study|Lost to Follow-up|3|||
125263221|NCT04064905|450593823|FG002|Overall Study|Lost to Follow-up|1|||
125263222|NCT04064905|450593824|FG003|Overall Study|Lost to Follow-up|4|||
125263223|NCT04064905|450593825|FG004|Overall Study|Lost to Follow-up|2|||
125263224|NCT02257684|450593828|FG000|Overall Study|Adverse Event|2|||
125263225|NCT02257684|450593828|FG000|Overall Study|Lack of Efficacy|1|||
125263226|NCT02257684|450593828|FG000|Overall Study|Sponsor's Decision|1|||
125263227|NCT01570387|450593829|FG000|Overall Study|Adverse Event|1|||
125263228|NCT01570387|450593830|FG001|Overall Study|Adverse Event|0|||
125263229|NCT01570387|450593831|FG002|Overall Study|Adverse Event|0|||
125263230|NCT01570387|450593832|FG003|Overall Study|Adverse Event|0|||
125263231|NCT01570387|450593829|FG000|Overall Study|Death|0|||
125263232|NCT01570387|450593830|FG001|Overall Study|Death|0|||
125263233|NCT01570387|450593831|FG002|Overall Study|Death|0|||
125263234|NCT01570387|450593832|FG003|Overall Study|Death|1|||
125263235|NCT01570387|450593829|FG000|Overall Study|Withdrawal by Subject|0|||
125263236|NCT01570387|450593830|FG001|Overall Study|Withdrawal by Subject|0|||
125263237|NCT01570387|450593831|FG002|Overall Study|Withdrawal by Subject|0|||
125263238|NCT01570387|450593832|FG003|Overall Study|Withdrawal by Subject|1|||
125263239|NCT01987557|450593833|FG000|Overall Study|Protocol Violation|1|||
125263240|NCT01987557|450593834|FG001|Overall Study|Protocol Violation|0|||
125263241|NCT01987557|450593835|FG002|Overall Study|Protocol Violation|1|||
125263242|NCT01987557|450593833|FG000|Overall Study|Withdrawal by Subject|2|||
125263243|NCT01987557|450593834|FG001|Overall Study|Withdrawal by Subject|1|||
125263244|NCT01987557|450593835|FG002|Overall Study|Withdrawal by Subject|2|||
125263245|NCT01987557|450593833|FG000|Overall Study|Adverse Event|0|||
125263246|NCT01987557|450593834|FG001|Overall Study|Adverse Event|2|||
125263247|NCT01987557|450593835|FG002|Overall Study|Adverse Event|0|||
125263248|NCT00431964|450593836|FG000|Overall Study|Adverse Event|1|||
125263249|NCT00431964|450593837|FG001|Overall Study|Adverse Event|0|||
125263250|NCT00431964|450593836|FG000|Overall Study|Lost to Follow-up|1|||
125263251|NCT00431964|450593837|FG001|Overall Study|Lost to Follow-up|2|||
125263252|NCT00431964|450593836|FG000|Overall Study|Physician Decision|2|||
125263253|NCT00431964|450593837|FG001|Overall Study|Physician Decision|2|||
125263254|NCT00431964|450593836|FG000|Overall Study|Withdrawal by Subject|2|||
125263255|NCT00431964|450593837|FG001|Overall Study|Withdrawal by Subject|1|||
125263256|NCT00431964|450593836|FG000|Overall Study|Parental Consent Withdrawn|0|||
125263257|NCT00431964|450593837|FG001|Overall Study|Parental Consent Withdrawn|2|||
125263258|NCT00431964|450593836|FG000|Overall Study|Due to Unstable Health|0|||
125263259|NCT00431964|450593837|FG001|Overall Study|Due to Unstable Health|1|||
125263260|NCT01657305|450593839|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
125263261|NCT01657305|450593839|FG000|Overall Study|Withdrawal by Subject|4|||
125263262|NCT01657305|450593839|FG000|Overall Study|Adverse Event|1|||
125263263|NCT01657305|450593839|FG000|Overall Study|Lost to Follow-up|1|||
125263264|NCT01657305|450593839|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
125263265|NCT04103450|450593840|FG000|Overall Study|Adverse Event|4|||
125263266|NCT04103450|450593841|FG001|Overall Study|Adverse Event|2|||
125263267|NCT04103450|450593840|FG000|Overall Study|Lack of Efficacy|3|||
125263268|NCT04103450|450593841|FG001|Overall Study|Lack of Efficacy|0|||
125263269|NCT04103450|450593840|FG000|Overall Study|Withdrawal by Subject|5|||
125263270|NCT04103450|450593841|FG001|Overall Study|Withdrawal by Subject|3|||
125263271|NCT04103450|450593840|FG000|Overall Study|Lost to Follow-up|1|||
125263272|NCT04103450|450593841|FG001|Overall Study|Lost to Follow-up|2|||
125263273|NCT04103450|450593840|FG000|Overall Study|Physician Decision|1|||
125263274|NCT04103450|450593841|FG001|Overall Study|Physician Decision|2|||
125263275|NCT04103450|450593840|FG000|Overall Study|Protocol Violation|1|||
125263276|NCT04103450|450593841|FG001|Overall Study|Protocol Violation|0|||
125263277|NCT04103450|450593840|FG000|Overall Study|Other|1|||
125263278|NCT04103450|450593841|FG001|Overall Study|Other|1|||
125263279|NCT01696643|450593851|FG000|Overall Study|Adverse Event|15|||
125263280|NCT01696643|450593852|FG001|Overall Study|Adverse Event|7|||
125263281|NCT01696643|450593851|FG000|Overall Study|Death|1|||
125263282|NCT01696643|450593852|FG001|Overall Study|Death|2|||
125263283|NCT01696643|450593851|FG000|Overall Study|Lack of Efficacy|3|||
125263284|NCT01696643|450593852|FG001|Overall Study|Lack of Efficacy|0|||
125263285|NCT01696643|450593851|FG000|Overall Study|Lost to Follow-up|67|||
125263286|NCT01696643|450593852|FG001|Overall Study|Lost to Follow-up|67|||
125263287|NCT01696643|450593851|FG000|Overall Study|Physician Decision|3|||
125263288|NCT01696643|450593852|FG001|Overall Study|Physician Decision|2|||
125263289|NCT01696643|450593851|FG000|Overall Study|Pregnancy|0|||
125263290|NCT01696643|450593852|FG001|Overall Study|Pregnancy|1|||
125263291|NCT01696643|450593851|FG000|Overall Study|Protocol Violation|7|||
125263292|NCT01696643|450593852|FG001|Overall Study|Protocol Violation|7|||
125263293|NCT01696643|450593851|FG000|Overall Study|Study Terminated by Sponsor|286|||
125263294|NCT01696643|450593852|FG001|Overall Study|Study Terminated by Sponsor|294|||
125263295|NCT01696643|450593851|FG000|Overall Study|Withdrawal by Subject|142|||
125263296|NCT01696643|450593852|FG001|Overall Study|Withdrawal by Subject|149|||
125263297|NCT01696643|450593851|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
125263298|NCT01696643|450593852|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
125263299|NCT01696643|450593851|FG000|Overall Study|Site Error|2|||
125263300|NCT01696643|450593852|FG001|Overall Study|Site Error|1|||
125263301|NCT01696643|450593851|FG000|Overall Study|Participant Incarcerated|0|||
125263302|NCT01696643|450593852|FG001|Overall Study|Participant Incarcerated|1|||
125263303|NCT01696643|450593851|FG000|Overall Study|Medical Monitor Decision|0|||
125263304|NCT01696643|450593852|FG001|Overall Study|Medical Monitor Decision|2|||
125263305|NCT01696643|450593851|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
125263306|NCT01696643|450593852|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
125263307|NCT00518180|450593853|FG000|Overall Study|Withdrawal by Subject|29|||
125263308|NCT00518180|450593854|FG001|Overall Study|Withdrawal by Subject|30|||
125263309|NCT00518180|450593855|FG002|Overall Study|Withdrawal by Subject|42|||
125263310|NCT00518180|450593853|FG000|Overall Study|Lost to Follow-up|30|||
125263311|NCT00518180|450593854|FG001|Overall Study|Lost to Follow-up|28|||
125263312|NCT00518180|450593855|FG002|Overall Study|Lost to Follow-up|34|||
125263313|NCT00518180|450593853|FG000|Overall Study|Administrative reason|0|||
125263314|NCT00518180|450593854|FG001|Overall Study|Administrative reason|2|||
125263315|NCT00518180|450593855|FG002|Overall Study|Administrative reason|2|||
125263316|NCT00518180|450593853|FG000|Overall Study|Protocol Violation|5|||
125263317|NCT00518180|450593854|FG001|Overall Study|Protocol Violation|7|||
125263318|NCT00518180|450593855|FG002|Overall Study|Protocol Violation|4|||
125263319|NCT00518180|450593853|FG000|Overall Study|Unable to classify|0|||
125263320|NCT00518180|450593854|FG001|Overall Study|Unable to classify|2|||
125263321|NCT00518180|450593855|FG002|Overall Study|Unable to classify|0|||
125263322|NCT00518180|450593853|FG000|Overall Study|Adverse Event|1|||
125263323|NCT00518180|450593854|FG001|Overall Study|Adverse Event|0|||
125263324|NCT00518180|450593855|FG002|Overall Study|Adverse Event|0|||
125263325|NCT00956293|450593859|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
125263326|NCT00956293|450593860|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
125263327|NCT00956293|450593861|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
125263328|NCT00956293|450593859|FG000|Main Period (Pre-randomization)|Death|0|||
125263329|NCT00956293|450593860|FG001|Main Period (Pre-randomization)|Death|0|||
125263330|NCT00956293|450593861|FG002|Main Period (Pre-randomization)|Death|1|||
125263331|NCT00956293|450593859|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
125263332|NCT00956293|450593860|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
125263333|NCT00956293|450593861|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
125263334|NCT00956293|450593859|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
125263335|NCT00956293|450593860|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
125263336|NCT00956293|450593861|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
125263337|NCT00956293|450593859|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
125263338|NCT00956293|450593860|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
125263339|NCT00956293|450593861|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
125263340|NCT00956293|450593859|FG000|Main Period (Pre-randomization)|Graft loss|0|||
125263341|NCT00956293|450593860|FG001|Main Period (Pre-randomization)|Graft loss|0|||
125263342|NCT00956293|450593861|FG002|Main Period (Pre-randomization)|Graft loss|7|||
125263343|NCT00956293|450593859|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
125263344|NCT00956293|450593860|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
125263345|NCT00956293|450593861|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
125263346|NCT00956293|450593859|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
125263347|NCT00956293|450593860|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
125263348|NCT00956293|450593861|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
125263349|NCT00956293|450593859|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
125263350|NCT00956293|450593860|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
125263351|NCT00956293|450593861|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
125263352|NCT00956293|450593859|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
125263353|NCT00956293|450593860|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
125263354|NCT00956293|450593861|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
125263355|NCT00956293|450593859|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
125263356|NCT00956293|450593860|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
125263357|NCT00956293|450593861|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
125263358|NCT00956293|450593859|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
125263359|NCT00956293|450593860|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
125263360|NCT00956293|450593861|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
125263361|NCT00956293|450593859|FG000|Main Period (Randomization)|Adverse Event|0|||
125263362|NCT00956293|450593860|FG001|Main Period (Randomization)|Adverse Event|15|||
125263363|NCT00956293|450593861|FG002|Main Period (Randomization)|Adverse Event|0|||
125263364|NCT00956293|450593859|FG000|Follow-up Period|Follow-up period was terminated.|20|||
125263365|NCT00956293|450593860|FG001|Follow-up Period|Follow-up period was terminated.|32|||
125263366|NCT00956293|450593861|FG002|Follow-up Period|Follow-up period was terminated.|0|||
125263367|NCT02536664|450593862|FG000|Overall Study|Inadequate completion of documentation|2|||
125263368|NCT02536664|450593863|FG001|Overall Study|Inadequate completion of documentation|4|||
125263369|NCT02536664|450593862|FG000|Overall Study|Progression|13|||
125263370|NCT02536664|450593863|FG001|Overall Study|Progression|18|||
125263371|NCT02536664|450593862|FG000|Overall Study|Death due to lymphoma|2|||
125263372|NCT02536664|450593863|FG001|Overall Study|Death due to lymphoma|1|||
125263373|NCT02536664|450593862|FG000|Overall Study|Death due to other reason|3|||
125263374|NCT02536664|450593863|FG001|Overall Study|Death due to other reason|2|||
125263375|NCT02536664|450593862|FG000|Overall Study|Intolerability|8|||
125263376|NCT02536664|450593863|FG001|Overall Study|Intolerability|6|||
125263377|NCT02536664|450593862|FG000|Overall Study|Withdrawal by Subject|8|||
125263378|NCT02536664|450593863|FG001|Overall Study|Withdrawal by Subject|5|||
125263379|NCT02536664|450593862|FG000|Overall Study|Other|18|||
125263380|NCT02536664|450593863|FG001|Overall Study|Other|24|||
125263381|NCT02536664|450593862|FG000|Overall Study|Missing|53|||
125263382|NCT02536664|450593863|FG001|Overall Study|Missing|20|||
125263383|NCT03383666|450593864|FG000|Overall Study|Withdrawal by Subject|2|||
125263384|NCT03383666|450593864|FG000|Overall Study|Lost to Follow-up|2|||
125263385|NCT03961308|450593871|FG000|Overall Study|Withdrawal by Subject|1|||
125263386|NCT03961308|450593872|FG001|Overall Study|Withdrawal by Subject|0|||
125263387|NCT03961308|450593871|FG000|Overall Study|Other|1|||
125263388|NCT03961308|450593872|FG001|Overall Study|Other|0|||
125263389|NCT03961308|450593871|FG000|Overall Study|Lost to Follow-up|0|||
125263390|NCT03961308|450593872|FG001|Overall Study|Lost to Follow-up|1|||
125263391|NCT03961308|450593871|FG000|Overall Study|Adverse Event|0|||
125263392|NCT03961308|450593872|FG001|Overall Study|Adverse Event|1|||
125263393|NCT01174563|450593879|FG000|Overall Study|Progressive Disease|45|||
125263394|NCT01174563|450593879|FG000|Overall Study|Death|5|||
125263395|NCT01174563|450593879|FG000|Overall Study|Investigator's Discretion|5|||
125263396|NCT01174563|450593879|FG000|Overall Study|Participant Withdrew Consent|3|||
125263397|NCT01174563|450593879|FG000|Overall Study|Rash Adverse Event|1|||
125263398|NCT01174563|450593879|FG000|Overall Study|Sponsor's decision|1|||
125263399|NCT03402841|450593880|FG000|Overall Study|Withdrawal by Subject|3|||
125263400|NCT03402841|450593880|FG000|Overall Study|Lost to Follow-up|2|||
125263401|NCT03402841|450593880|FG000|Overall Study|Death|146|||
125263402|NCT01542788|450593885|FG000|Overall Study|Randomized but Not Treated|2|||
125263403|NCT01542788|450593886|FG001|Overall Study|Randomized but Not Treated|0|||
125263404|NCT01542788|450593885|FG000|Overall Study|Lack of Efficacy|41|||
125263405|NCT01542788|450593886|FG001|Overall Study|Lack of Efficacy|71|||
125263406|NCT01542788|450593885|FG000|Overall Study|Lost to Follow-up|5|||
125263407|NCT01542788|450593886|FG001|Overall Study|Lost to Follow-up|0|||
125263408|NCT01542788|450593885|FG000|Overall Study|Death|3|||
125263409|NCT01542788|450593886|FG001|Overall Study|Death|0|||
125263410|NCT01542788|450593885|FG000|Overall Study|Protocol Violation|2|||
125263411|NCT01542788|450593886|FG001|Overall Study|Protocol Violation|0|||
125263412|NCT01542788|450593885|FG000|Overall Study|Physician Decision|1|||
125263413|NCT01542788|450593886|FG001|Overall Study|Physician Decision|0|||
125263414|NCT01542788|450593885|FG000|Overall Study|Withdrawal by Subject|1|||
125263415|NCT01542788|450593886|FG001|Overall Study|Withdrawal by Subject|0|||
125263416|NCT01280968|450593887|FG000|Overall Study|Lost to Follow-up|8|||
125263417|NCT01280968|450593888|FG001|Overall Study|Lost to Follow-up|2|||
125263418|NCT01280968|450593887|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
125263419|NCT01280968|450593888|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
125263420|NCT01280968|450593887|FG000|Overall Study|Commuting Problems|2|||
125263421|NCT01280968|450593888|FG001|Overall Study|Commuting Problems|0|||
125263422|NCT01280968|450593887|FG000|Overall Study|Anxiety|2|||
125263423|NCT01280968|450593888|FG001|Overall Study|Anxiety|0|||
125263424|NCT01280968|450593887|FG000|Overall Study|Adverse Event|1|||
125263425|NCT01280968|450593888|FG001|Overall Study|Adverse Event|0|||
125263426|NCT01280968|450593887|FG000|Overall Study|Scheduling Conflicts|1|||
125263427|NCT01280968|450593888|FG001|Overall Study|Scheduling Conflicts|1|||
125263428|NCT01280968|450593887|FG000|Overall Study|Pre-existing Neurological Condition|1|||
125263429|NCT01280968|450593888|FG001|Overall Study|Pre-existing Neurological Condition|0|||
125263430|NCT01280968|450593887|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
125263431|NCT01280968|450593888|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
125263432|NCT04704193|450593889|FG000|Overall Study|Withdrawal by Subject|1|||
125263433|NCT00542178|450593890|FG000|Overall Study|did not complete year 4 follow-up|75|||
125263434|NCT00542178|450593891|FG001|Overall Study|did not complete year 4 follow-up|80|||
125263435|NCT00542178|450593892|FG002|Overall Study|did not complete year 4 follow-up|74|||
125263436|NCT00542178|450593893|FG003|Overall Study|did not complete year 4 follow-up|62|||
125263437|NCT00542178|450593894|FG004|Overall Study|did not complete year 4 follow-up|64|||
125263438|NCT00542178|450593895|FG005|Overall Study|did not complete year 4 follow-up|89|||
125263439|NCT00542178|450593896|FG006|Overall Study|did not complete year 4 follow-up|87|||
125263440|NCT00542178|450593897|FG007|Overall Study|did not complete year 4 follow-up|85|||
125263441|NCT03984188|450593903|FG000|Overall Study|Death|2|||
125263442|NCT03984188|450593904|FG001|Overall Study|Death|4|||
125263443|NCT03984188|450593903|FG000|Overall Study|Physician Decision|0|||
125263444|NCT03984188|450593904|FG001|Overall Study|Physician Decision|2|||
125263445|NCT03984188|450593903|FG000|Overall Study|Lost to Follow-up|3|||
125263446|NCT03984188|450593904|FG001|Overall Study|Lost to Follow-up|2|||
125263447|NCT03984188|450593903|FG000|Overall Study|Withdrawal by Subject|6|||
125263448|NCT03984188|450593904|FG001|Overall Study|Withdrawal by Subject|0|||
125263449|NCT01173679|450595333|FG000|Overall Study|Death|1|||
125263450|NCT01250054|450595334|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
125263451|NCT01250054|450595335|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
125263452|NCT02777086|450595336|FG000|Overall Study|Lost to Follow-up|96|||
125263453|NCT02777086|450595337|FG001|Overall Study|Lost to Follow-up|99|||
125263454|NCT01133665|450595342|FG000|Overall Study|Physician Decision|2|||
125263455|NCT02122380|450595343|FG000|First Intervention (30 Days)|Adverse Event|1|||
125263456|NCT02122380|450595344|FG001|First Intervention (30 Days)|Adverse Event|0|||
125263457|NCT02122380|450595343|FG000|First Intervention (30 Days)|Physician Decision|0|||
125263458|NCT02122380|450595344|FG001|First Intervention (30 Days)|Physician Decision|1|||
125263459|NCT02122380|450595343|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
125263460|NCT02122380|450595344|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
125263461|NCT02122380|450595343|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
125263462|NCT02122380|450595344|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
125263463|NCT02122380|450595343|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
125263464|NCT02122380|450595344|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
125263465|NCT00272792|450595345|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
125263466|NCT00272792|450595346|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
125263467|NCT00272792|450595345|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
125263468|NCT00272792|450595346|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
125263469|NCT00272792|450595345|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
125263470|NCT00272792|450595346|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
125263471|NCT00272792|450595345|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
125263472|NCT00272792|450595346|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
125263473|NCT02921789|450595347|FG000|Overall Study|Adverse Event|0|||
125263474|NCT02921789|450595348|FG001|Overall Study|Adverse Event|1|||
125263475|NCT02921789|450595347|FG000|Overall Study|Lost to Follow-up|1|||
125263476|NCT02921789|450595348|FG001|Overall Study|Lost to Follow-up|0|||
125263477|NCT02921789|450595347|FG000|Overall Study|Protocol Deviation|2|||
125263478|NCT02921789|450595348|FG001|Overall Study|Protocol Deviation|0|||
125263479|NCT02921789|450595347|FG000|Overall Study|Withdrawal by Subject|2|||
125263480|NCT02921789|450595348|FG001|Overall Study|Withdrawal by Subject|1|||
125263481|NCT02921789|450595347|FG000|Overall Study|Miscellaneous|3|||
125263482|NCT02921789|450595348|FG001|Overall Study|Miscellaneous|2|||
125263483|NCT04099277|450595349|FG000|Overall Study|Physician Decision|1|||
125263484|NCT04099277|450595349|FG000|Overall Study|Withdrawal by Subject|1|||
125263485|NCT00598650|450595352|FG000|Overall Study|Withdrawal by Subject|3|||
125263486|NCT00598650|450595352|FG000|Overall Study|Adverse Event|18|||
125263487|NCT00598650|450595352|FG000|Overall Study|No treatment for 3 weeks|1|||
125263488|NCT00598650|450595352|FG000|Overall Study|Not eligible|1|||
125263489|NCT00598650|450595352|FG000|Overall Study|Prohibited Concomitant Medication|2|||
125263490|NCT00598650|450595352|FG000|Overall Study|Physician Decision|2|||
125263491|NCT03423602|450595353|FG000|Overall Study|Death|1|||
125263492|NCT03423602|450595353|FG000|Overall Study|Lost to Follow-up|6|||
125263493|NCT03423602|450595353|FG000|Overall Study|Protocol Violation|1|||
125263494|NCT03423602|450595353|FG000|Overall Study|Withdrawal by Subject|4|||
125263495|NCT03423121|450595354|FG000|Overall Study|Lost to Follow-up|2|||
125263496|NCT03423121|450595355|FG001|Overall Study|Lost to Follow-up|6|||
125263497|NCT03423121|450595354|FG000|Overall Study|Adverse Event|1|||
125263498|NCT03423121|450595355|FG001|Overall Study|Adverse Event|0|||
125263499|NCT00560508|450595356|FG000|12 Week Double-blind Period|Adverse Event|3|||
125263500|NCT00560508|450595357|FG001|12 Week Double-blind Period|Adverse Event|2|||
125263501|NCT00560508|450595356|FG000|12 Week Double-blind Period|Protocol Violation|1|||
125263502|NCT00560508|450595357|FG001|12 Week Double-blind Period|Protocol Violation|0|||
125263503|NCT00560508|450595356|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
125263504|NCT00560508|450595357|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
125263505|NCT00560508|450595356|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
125263506|NCT00560508|450595357|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
125263507|NCT00560508|450595356|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
125263508|NCT00560508|450595357|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
125263509|NCT00560508|450595356|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
125263510|NCT00560508|450595357|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
125263511|NCT00560508|450595356|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
125263512|NCT00560508|450595357|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
125263513|NCT01354223|450595358|FG000|Overall Study|Withdrawal by Subject|3|||
125263514|NCT01354223|450595359|FG001|Overall Study|Withdrawal by Subject|1|||
125263515|NCT00948688|450595367|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
125263516|NCT00948688|450595368|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
125263517|NCT00948688|450595367|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
125263518|NCT00948688|450595368|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
125263519|NCT00948688|450595367|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
125263520|NCT00948688|450595368|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
125263521|NCT01493089|450595369|FG000|Overall Study|Protocol Violation|2|||
125263522|NCT01493089|450595370|FG001|Overall Study|Protocol Violation|2|||
125263523|NCT01493089|450595369|FG000|Overall Study|Withdrawal by Subject|1|||
125263524|NCT01493089|450595370|FG001|Overall Study|Withdrawal by Subject|0|||
125263525|NCT01493089|450595369|FG000|Overall Study|Physician Decision|0|||
125263526|NCT01493089|450595370|FG001|Overall Study|Physician Decision|1|||
125263527|NCT03012334|450595371|FG000|Period 1|Withdrawal by Subject|0|||
125263528|NCT03012334|450595372|FG001|Period 1|Withdrawal by Subject|0|||
125263529|NCT03012334|450595373|FG002|Period 1|Withdrawal by Subject|0|||
125263530|NCT03012334|450595374|FG003|Period 1|Withdrawal by Subject|0|||
125263531|NCT03012334|450595375|FG004|Period 1|Withdrawal by Subject|0|||
125263532|NCT03012334|450595376|FG005|Period 1|Withdrawal by Subject|0|||
125263533|NCT03012334|450595377|FG006|Period 1|Withdrawal by Subject|0|||
125263534|NCT03012334|450595378|FG007|Period 1|Withdrawal by Subject|0|||
125263535|NCT03012334|450595379|FG008|Period 1|Withdrawal by Subject|0|||
125263536|NCT03012334|450595380|FG009|Period 1|Withdrawal by Subject|1|||
125263537|NCT03012334|450595371|FG000|Period 2|Withdrawal by Subject|0|||
125263538|NCT03012334|450595372|FG001|Period 2|Withdrawal by Subject|1|||
125263539|NCT03012334|450595373|FG002|Period 2|Withdrawal by Subject|0|||
125263540|NCT03012334|450595374|FG003|Period 2|Withdrawal by Subject|0|||
125263541|NCT03012334|450595375|FG004|Period 2|Withdrawal by Subject|0|||
125263542|NCT03012334|450595376|FG005|Period 2|Withdrawal by Subject|0|||
125263543|NCT03012334|450595377|FG006|Period 2|Withdrawal by Subject|0|||
125263544|NCT03012334|450595378|FG007|Period 2|Withdrawal by Subject|0|||
125263545|NCT03012334|450595379|FG008|Period 2|Withdrawal by Subject|0|||
125263546|NCT03012334|450595380|FG009|Period 2|Withdrawal by Subject|0|||
125263547|NCT03012334|450595371|FG000|Period 2|Protocol Violation|0|||
125263548|NCT03012334|450595372|FG001|Period 2|Protocol Violation|0|||
125263549|NCT03012334|450595373|FG002|Period 2|Protocol Violation|1|||
125263550|NCT03012334|450595374|FG003|Period 2|Protocol Violation|0|||
125263551|NCT03012334|450595375|FG004|Period 2|Protocol Violation|0|||
125263552|NCT03012334|450595376|FG005|Period 2|Protocol Violation|0|||
125263553|NCT03012334|450595377|FG006|Period 2|Protocol Violation|0|||
125263554|NCT03012334|450595378|FG007|Period 2|Protocol Violation|1|||
125263555|NCT03012334|450595379|FG008|Period 2|Protocol Violation|0|||
125263556|NCT03012334|450595380|FG009|Period 2|Protocol Violation|0|||
125263557|NCT03012334|450595371|FG000|Period 4|Non-Compliance|0|||
125263558|NCT03012334|450595372|FG001|Period 4|Non-Compliance|0|||
125263559|NCT03012334|450595373|FG002|Period 4|Non-Compliance|0|||
125263560|NCT03012334|450595374|FG003|Period 4|Non-Compliance|0|||
125263561|NCT03012334|450595375|FG004|Period 4|Non-Compliance|0|||
125263562|NCT03012334|450595376|FG005|Period 4|Non-Compliance|0|||
125263563|NCT03012334|450595377|FG006|Period 4|Non-Compliance|1|||
125263564|NCT03012334|450595378|FG007|Period 4|Non-Compliance|0|||
125263565|NCT03012334|450595379|FG008|Period 4|Non-Compliance|0|||
125263566|NCT03012334|450595380|FG009|Period 4|Non-Compliance|0|||
125263567|NCT03012334|450595371|FG000|Period 4|Adverse Event|0|||
125263568|NCT03012334|450595372|FG001|Period 4|Adverse Event|0|||
125263569|NCT03012334|450595373|FG002|Period 4|Adverse Event|0|||
125263570|NCT03012334|450595374|FG003|Period 4|Adverse Event|0|||
125263571|NCT03012334|450595375|FG004|Period 4|Adverse Event|0|||
125263572|NCT03012334|450595376|FG005|Period 4|Adverse Event|0|||
125263573|NCT03012334|450595377|FG006|Period 4|Adverse Event|0|||
125263574|NCT03012334|450595378|FG007|Period 4|Adverse Event|0|||
125263575|NCT03012334|450595379|FG008|Period 4|Adverse Event|1|||
125263576|NCT03012334|450595380|FG009|Period 4|Adverse Event|0|||
125263577|NCT00325143|450595381|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
125263578|NCT00325143|450595381|FG000|Overall Study|Migrated/moved from study area|1|||
125263579|NCT00325143|450595381|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
125263580|NCT00325143|450595381|FG000|Overall Study|Withdrawal by Subject|8|||
125263581|NCT01870869|450595382|FG000|Overall Study|Implanted with nonstudy device|1|||
125263582|NCT01870869|450595383|FG001|Overall Study|Implanted with nonstudy device|3|||
125263583|NCT01870869|450595384|FG002|Overall Study|Implanted with nonstudy device|14|||
125263584|NCT01870869|450595385|FG003|Overall Study|Implanted with nonstudy device|4|||
125263585|NCT01870869|450595382|FG000|Overall Study|Death|0|||
125263586|NCT01870869|450595383|FG001|Overall Study|Death|0|||
125263587|NCT01870869|450595384|FG002|Overall Study|Death|7|||
125263588|NCT01870869|450595385|FG003|Overall Study|Death|1|||
125263589|NCT01870869|450595382|FG000|Overall Study|Subject choice|6|||
125263590|NCT01870869|450595383|FG001|Overall Study|Subject choice|2|||
125263591|NCT01870869|450595384|FG002|Overall Study|Subject choice|22|||
125263592|NCT01870869|450595385|FG003|Overall Study|Subject choice|8|||
125263593|NCT01870869|450595382|FG000|Overall Study|Lost to Follow-up|10|||
125263594|NCT01870869|450595383|FG001|Overall Study|Lost to Follow-up|2|||
125263595|NCT01870869|450595384|FG002|Overall Study|Lost to Follow-up|25|||
125263596|NCT01870869|450595385|FG003|Overall Study|Lost to Follow-up|3|||
125263597|NCT01870869|450595382|FG000|Overall Study|Reason not Specified|1|||
125263598|NCT01870869|450595383|FG001|Overall Study|Reason not Specified|2|||
125263599|NCT01870869|450595384|FG002|Overall Study|Reason not Specified|20|||
125263600|NCT01870869|450595385|FG003|Overall Study|Reason not Specified|4|||
125263601|NCT01870869|450595382|FG000|Overall Study|Not evaluable|10|||
125263602|NCT01870869|450595383|FG001|Overall Study|Not evaluable|5|||
125263603|NCT01870869|450595384|FG002|Overall Study|Not evaluable|42|||
125263604|NCT01870869|450595385|FG003|Overall Study|Not evaluable|10|||
125263605|NCT02286895|450595386|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
125263606|NCT02286895|450595387|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
125263607|NCT02286895|450595386|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
125263608|NCT02286895|450595387|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
125263609|NCT02286895|450595386|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
125263610|NCT02286895|450595387|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
125263611|NCT01073293|450595388|FG000|Overall Study|Lost to Follow-up|0|||
125263612|NCT01073293|450595389|FG001|Overall Study|Lost to Follow-up|1|||
125263613|NCT01073293|450595388|FG000|Overall Study|Withdrawal by Subject|5|||
125263614|NCT01073293|450595389|FG001|Overall Study|Withdrawal by Subject|10|||
125263615|NCT03036852|450595390|FG000|Overall Study|Death|2|||
125263616|NCT03036852|450595390|FG000|Overall Study|Lack of Efficacy|2|||
125263617|NCT03036852|450595390|FG000|Overall Study|Adverse Event|1|||
125263618|NCT03036852|450595390|FG000|Overall Study|Lost to Follow-up|1|||
125263619|NCT00002766|450595393|FG000|Overall Study|Withdrawal by Subject|0|||
125263620|NCT00002766|450595394|FG001|Overall Study|Withdrawal by Subject|1|||
125263621|NCT00002766|450595393|FG000|Overall Study|Patient Not Treated|1|||
125263622|NCT00002766|450595394|FG001|Overall Study|Patient Not Treated|2|||
125263623|NCT00002766|450595393|FG000|Overall Study|Adverse Event|1|||
125263624|NCT00002766|450595394|FG001|Overall Study|Adverse Event|1|||
125263625|NCT00002766|450595393|FG000|Overall Study|Protocol Violation|1|||
125263626|NCT00002766|450595394|FG001|Overall Study|Protocol Violation|0|||
125263627|NCT00077974|450595397|FG000|Overall Study|Adverse Event|22|||
125263628|NCT00077974|450595397|FG000|Overall Study|Protocol Violation|1|||
125263629|NCT00077974|450595397|FG000|Overall Study|Withdrawal by Subject|3|||
125263630|NCT00077974|450595397|FG000|Overall Study|Lack of Efficacy|76|||
125263631|NCT00077974|450595397|FG000|Overall Study|Decision of Sponsor|2|||
125263632|NCT00256126|450595398|FG000|Overall Study|Adverse Event|1|||
125263633|NCT00256126|450595399|FG001|Overall Study|Adverse Event|0|||
125263634|NCT00256126|450595398|FG000|Overall Study|Other|1|||
125263635|NCT00256126|450595399|FG001|Overall Study|Other|2|||
125263636|NCT02949011|450595408|FG000|Overall Study|Adverse Event|6|||
125263637|NCT02949011|450595409|FG001|Overall Study|Adverse Event|7|||
125263638|NCT02949011|450595410|FG002|Overall Study|Adverse Event|3|||
125263639|NCT02949011|450595408|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
125263640|NCT02949011|450595409|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
125263641|NCT02949011|450595410|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
125263642|NCT02949011|450595408|FG000|Overall Study|Protocol Deviation|5|||
125263643|NCT02949011|450595409|FG001|Overall Study|Protocol Deviation|3|||
125263644|NCT02949011|450595410|FG002|Overall Study|Protocol Deviation|3|||
125263645|NCT02949011|450595408|FG000|Overall Study|Lack of Efficacy|0|||
125263646|NCT02949011|450595409|FG001|Overall Study|Lack of Efficacy|2|||
125263647|NCT02949011|450595410|FG002|Overall Study|Lack of Efficacy|0|||
125263648|NCT02949011|450595408|FG000|Overall Study|Withdrawal by Subject|13|||
125263649|NCT02949011|450595409|FG001|Overall Study|Withdrawal by Subject|13|||
125263650|NCT02949011|450595410|FG002|Overall Study|Withdrawal by Subject|21|||
125263651|NCT02949011|450595408|FG000|Overall Study|Lost to Follow-up|7|||
125263652|NCT02949011|450595409|FG001|Overall Study|Lost to Follow-up|5|||
125263653|NCT02949011|450595410|FG002|Overall Study|Lost to Follow-up|5|||
125263654|NCT02949011|450595408|FG000|Overall Study|Death|0|||
125263655|NCT02949011|450595409|FG001|Overall Study|Death|0|||
125263656|NCT02949011|450595410|FG002|Overall Study|Death|1|||
125263657|NCT02949011|450595408|FG000|Overall Study|Miscellaneous|2|||
125263658|NCT02949011|450595409|FG001|Overall Study|Miscellaneous|4|||
125263659|NCT02949011|450595410|FG002|Overall Study|Miscellaneous|6|||
125263660|NCT00163189|450595411|FG000|Overall Study|Other|6|||
125263661|NCT00163189|450595411|FG000|Overall Study|Lost to Follow-up|1|||
125263662|NCT00163189|450595411|FG000|Overall Study|Protocol Violation|2|||
125263663|NCT00163189|450595411|FG000|Overall Study|Death|3|||
125263664|NCT00163189|450595411|FG000|Overall Study|Adverse Event|6|||
125263665|NCT00163189|450595411|FG000|Overall Study|Lack of Efficacy|7|||
125263666|NCT00163189|450595411|FG000|Overall Study|Study terminated by sponsor|11|||
125263667|NCT00163189|450595411|FG000|Overall Study|Withdrawal by Subject|11|||
125263668|NCT00163189|450595411|FG000|Overall Study|Did not meet continuation criterion|16|||
125263669|NCT02154061|450595412|FG000|Overall Study|Pregnancy|1|||
125263670|NCT02154061|450595413|FG001|Overall Study|Pregnancy|0|||
125263671|NCT02154061|450595412|FG000|Overall Study|enrolled but not vaccinated|1|||
125263672|NCT02154061|450595413|FG001|Overall Study|enrolled but not vaccinated|0|||
125263673|NCT00506142|450595414|FG000|Overall Study|Adverse Event|8|||
125263674|NCT00506142|450595415|FG001|Overall Study|Adverse Event|7|||
125263675|NCT00506142|450595414|FG000|Overall Study|Lack of Efficacy|21|||
125263676|NCT00506142|450595415|FG001|Overall Study|Lack of Efficacy|7|||
125263677|NCT00506142|450595414|FG000|Overall Study|Withdrawal by Subject|4|||
125263678|NCT00506142|450595415|FG001|Overall Study|Withdrawal by Subject|5|||
125263679|NCT00506142|450595414|FG000|Overall Study|Physician Decision|1|||
125263680|NCT00506142|450595415|FG001|Overall Study|Physician Decision|0|||
125263681|NCT00506142|450595414|FG000|Overall Study|New health condition|1|||
125263682|NCT00506142|450595415|FG001|Overall Study|New health condition|0|||
125263683|NCT00454116|450595416|FG000|Overall Study|Adverse Event|5|||
125263684|NCT00454116|450595417|FG001|Overall Study|Adverse Event|11|||
125263685|NCT00454116|450595418|FG002|Overall Study|Adverse Event|9|||
125263686|NCT00454116|450595416|FG000|Overall Study|Condition under investigation worsened|17|||
125263687|NCT00454116|450595417|FG001|Overall Study|Condition under investigation worsened|13|||
125263688|NCT00454116|450595418|FG002|Overall Study|Condition under investigation worsened|18|||
125263689|NCT00454116|450595416|FG000|Overall Study|Withdrawal by Subject|3|||
125263690|NCT00454116|450595417|FG001|Overall Study|Withdrawal by Subject|3|||
125263691|NCT00454116|450595418|FG002|Overall Study|Withdrawal by Subject|1|||
125263692|NCT00454116|450595416|FG000|Overall Study|Other|2|||
125263693|NCT00454116|450595417|FG001|Overall Study|Other|2|||
125263694|NCT00454116|450595418|FG002|Overall Study|Other|0|||
125263695|NCT01917318|450595421|FG000|First Treatment|Withdrawal by Subject|0|||
125263696|NCT01917318|450595422|FG001|First Treatment|Withdrawal by Subject|1|||
125263697|NCT01008618|450595423|FG000|Period 1 (Titration Period)|Physician Decision|2|||
125263698|NCT01008618|450595424|FG001|Period 1 (Titration Period)|Physician Decision|0|||
125263699|NCT01008618|450595425|FG002|Period 1 (Titration Period)|Physician Decision|0|||
125263700|NCT01008618|450595423|FG000|Period 1 (Titration Period)|Adverse Event|33|||
125263701|NCT01008618|450595424|FG001|Period 1 (Titration Period)|Adverse Event|0|||
125263702|NCT01008618|450595425|FG002|Period 1 (Titration Period)|Adverse Event|0|||
125263703|NCT01008618|450595423|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
125263704|NCT01008618|450595424|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
125263705|NCT01008618|450595425|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
125263706|NCT01008618|450595423|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
125263707|NCT01008618|450595424|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
125263708|NCT01008618|450595425|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
125263709|NCT01008618|450595423|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
125263710|NCT01008618|450595424|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
125263711|NCT01008618|450595425|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
125263712|NCT01008618|450595423|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
125263713|NCT01008618|450595424|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
125263714|NCT01008618|450595425|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
125263715|NCT01008618|450595423|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
125263716|NCT01008618|450595424|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
125263717|NCT01008618|450595425|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
125263718|NCT01008618|450595423|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
125263719|NCT01008618|450595424|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
125263720|NCT01008618|450595425|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
125263721|NCT01008618|450595423|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
125263722|NCT01008618|450595424|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
125263723|NCT01008618|450595425|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
125263724|NCT01008618|450595423|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
125263725|NCT01008618|450595424|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
125263726|NCT01008618|450595425|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
125263727|NCT01008618|450595423|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
125263728|NCT01008618|450595424|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
125263729|NCT01008618|450595425|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
125263730|NCT01008618|450595423|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
125263731|NCT01008618|450595424|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
125263732|NCT01008618|450595425|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
125263733|NCT00742625|450595426|FG000|Remission Induction|Progression|6|||
125263734|NCT00742625|450595426|FG000|Remission Induction|Failed induction|8|||
125263735|NCT00742625|450595426|FG000|Remission Induction|Adverse Event|3|||
125263736|NCT00742625|450595426|FG000|Remission Induction|Death|10|||
125263737|NCT00742625|450595426|FG000|Remission Induction|Refusal|5|||
125263738|NCT00742625|450595426|FG000|Remission Induction|Non protocol treatment|17|||
125263739|NCT00742625|450595426|FG000|Remission Induction|Other, not specified|5|||
125263740|NCT00742625|450595426|FG000|Consolidation|Progression|5|||
125263741|NCT00742625|450595426|FG000|Consolidation|Adverse Event|1|||
125263742|NCT00742625|450595426|FG000|Consolidation|Death|1|||
125263743|NCT00742625|450595426|FG000|Consolidation|Refused|1|||
125263744|NCT00742625|450595426|FG000|Consolidation|Non protocol therapy|13|||
125263745|NCT03338400|450595427|FG000|Overall Study|Lost to Follow-up|1|||
125263746|NCT03338400|450595428|FG001|Overall Study|Lost to Follow-up|2|||
125263747|NCT01865487|450595431|FG000|Overall Study|Lost to Follow-up|0|||
125263748|NCT01865487|450595432|FG001|Overall Study|Lost to Follow-up|0|||
125263749|NCT01865487|450595433|FG002|Overall Study|Lost to Follow-up|0|||
125263750|NCT01865487|450595434|FG003|Overall Study|Lost to Follow-up|1|||
125263751|NCT01865487|450595435|FG004|Overall Study|Lost to Follow-up|0|||
125263752|NCT01865487|450595436|FG005|Overall Study|Lost to Follow-up|0|||
125263753|NCT01865487|450595437|FG006|Overall Study|Lost to Follow-up|1|||
125263754|NCT01865487|450595438|FG007|Overall Study|Lost to Follow-up|0|||
125263755|NCT01865487|450595439|FG008|Overall Study|Lost to Follow-up|0|||
125263756|NCT01865487|450595440|FG009|Overall Study|Lost to Follow-up|0|||
125263757|NCT01865487|450595431|FG000|Overall Study|Withdrawal by Subject|0|||
125263758|NCT01865487|450595432|FG001|Overall Study|Withdrawal by Subject|0|||
125263759|NCT01865487|450595433|FG002|Overall Study|Withdrawal by Subject|0|||
125263760|NCT01865487|450595434|FG003|Overall Study|Withdrawal by Subject|0|||
125263761|NCT01865487|450595435|FG004|Overall Study|Withdrawal by Subject|1|||
125263762|NCT01865487|450595436|FG005|Overall Study|Withdrawal by Subject|0|||
125263763|NCT01865487|450595437|FG006|Overall Study|Withdrawal by Subject|0|||
125263764|NCT01865487|450595438|FG007|Overall Study|Withdrawal by Subject|0|||
125263765|NCT01865487|450595439|FG008|Overall Study|Withdrawal by Subject|0|||
125263766|NCT01865487|450595440|FG009|Overall Study|Withdrawal by Subject|0|||
125263767|NCT01213082|450595441|FG000|Overall Study|Lost to Follow-up|6|||
125263768|NCT01213082|450595442|FG001|Overall Study|Lost to Follow-up|7|||
125263769|NCT01213082|450595443|FG002|Overall Study|Lost to Follow-up|4|||
125263770|NCT01213082|450595441|FG000|Overall Study|Physician Decision|0|||
125263771|NCT01213082|450595442|FG001|Overall Study|Physician Decision|0|||
125263772|NCT01213082|450595443|FG002|Overall Study|Physician Decision|1|||
125263773|NCT03848416|450595449|FG000|Overall Study|Withdrawal by Subject|1|||
125263774|NCT03848416|450595450|FG001|Overall Study|Withdrawal by Subject|0|||
125263775|NCT03848416|450595451|FG002|Overall Study|Withdrawal by Subject|0|||
125263776|NCT03848416|450595449|FG000|Overall Study|Death|0|||
125263777|NCT03848416|450595450|FG001|Overall Study|Death|0|||
125263778|NCT03848416|450595451|FG002|Overall Study|Death|1|||
125263779|NCT02639390|450595452|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
125263780|NCT02639390|450595453|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
125263781|NCT01908140|450595454|FG000|Overall Study|Other or Progressive Disease|5|||
125263782|NCT01908140|450595455|FG001|Overall Study|Other or Progressive Disease|12|||
125263783|NCT01908140|450595454|FG000|Overall Study|Lack of Efficacy|7|||
125263784|NCT01908140|450595455|FG001|Overall Study|Lack of Efficacy|5|||
125263785|NCT01908140|450595454|FG000|Overall Study|Withdrawal by Subject|23|||
125263786|NCT01908140|450595455|FG001|Overall Study|Withdrawal by Subject|24|||
125263787|NCT01908140|450595454|FG000|Overall Study|Lost to Follow-up|1|||
125263788|NCT01908140|450595455|FG001|Overall Study|Lost to Follow-up|6|||
125263789|NCT01908140|450595454|FG000|Overall Study|Protocol Violation|8|||
125263790|NCT01908140|450595455|FG001|Overall Study|Protocol Violation|9|||
125263791|NCT01908140|450595454|FG000|Overall Study|Adverse Event|22|||
125263792|NCT01908140|450595455|FG001|Overall Study|Adverse Event|23|||
125263793|NCT01436110|450595456|FG000|Overall Study|Lack of Efficacy|23|||
125263794|NCT01436110|450595457|FG001|Overall Study|Lack of Efficacy|14|||
125263795|NCT01436110|450595458|FG002|Overall Study|Lack of Efficacy|9|||
125263796|NCT01436110|450595456|FG000|Overall Study|Withdrawal by Subject|6|||
125263797|NCT01436110|450595457|FG001|Overall Study|Withdrawal by Subject|8|||
125263798|NCT01436110|450595458|FG002|Overall Study|Withdrawal by Subject|4|||
125263799|NCT01436110|450595456|FG000|Overall Study|Adverse Event|2|||
125263800|NCT01436110|450595457|FG001|Overall Study|Adverse Event|1|||
125263801|NCT01436110|450595458|FG002|Overall Study|Adverse Event|2|||
125263802|NCT01436110|450595456|FG000|Overall Study|Physician Decision|3|||
125263803|NCT01436110|450595457|FG001|Overall Study|Physician Decision|1|||
125263804|NCT01436110|450595458|FG002|Overall Study|Physician Decision|1|||
125263805|NCT01436110|450595456|FG000|Overall Study|Lost to Follow-up|1|||
125263806|NCT01436110|450595457|FG001|Overall Study|Lost to Follow-up|1|||
125263807|NCT01436110|450595458|FG002|Overall Study|Lost to Follow-up|3|||
125263808|NCT01436110|450595456|FG000|Overall Study|Protocol Violation|3|||
125263809|NCT01436110|450595457|FG001|Overall Study|Protocol Violation|1|||
125263810|NCT01436110|450595458|FG002|Overall Study|Protocol Violation|1|||
125263811|NCT01436110|450595456|FG000|Overall Study|Did Not Receive Trial Medication|1|||
125263812|NCT01436110|450595457|FG001|Overall Study|Did Not Receive Trial Medication|0|||
125263813|NCT01436110|450595458|FG002|Overall Study|Did Not Receive Trial Medication|3|||
125263814|NCT01088503|450595460|FG000|Overall Study|Withdrawal by Subject|118|||
125263815|NCT01088503|450595461|FG001|Overall Study|Withdrawal by Subject|327|||
125263816|NCT01088503|450595462|FG002|Overall Study|Withdrawal by Subject|10|||
125263817|NCT01088503|450595460|FG000|Overall Study|Death|64|||
125263818|NCT01088503|450595461|FG001|Overall Study|Death|358|||
125263819|NCT01088503|450595462|FG002|Overall Study|Death|7|||
125263820|NCT01531998|450595463|FG000|Overall Study|Withdrawal by Subject|3|||
125263821|NCT00186628|450595468|FG000|Overall Study|Death|2|||
125263822|NCT00186628|450595468|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
125263823|NCT02927795|450595469|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
125263824|NCT02927795|450595469|FG000|Overall Study|Not Treated|4|||
125263825|NCT01076010|450595470|FG000|Overall Study|Death|15|||
125263826|NCT01076010|450595471|FG001|Overall Study|Death|1|||
125263827|NCT01076010|450595472|FG002|Overall Study|Death|0|||
125263828|NCT01076010|450595470|FG000|Overall Study|Adverse Event|7|||
125263829|NCT01076010|450595471|FG001|Overall Study|Adverse Event|2|||
125263830|NCT01076010|450595472|FG002|Overall Study|Adverse Event|0|||
125263831|NCT01076010|450595470|FG000|Overall Study|Progressive disease|90|||
125263832|NCT01076010|450595471|FG001|Overall Study|Progressive disease|30|||
125263833|NCT01076010|450595472|FG002|Overall Study|Progressive disease|1|||
125263834|NCT01076010|450595470|FG000|Overall Study|Lack of Efficacy|4|||
125263835|NCT01076010|450595471|FG001|Overall Study|Lack of Efficacy|0|||
125263836|NCT01076010|450595472|FG002|Overall Study|Lack of Efficacy|0|||
125263837|NCT01076010|450595470|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
125263838|NCT01076010|450595471|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
125263839|NCT01076010|450595472|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
125263840|NCT01076010|450595470|FG000|Overall Study|Significant Surgical Procedure|0|||
125263841|NCT01076010|450595471|FG001|Overall Study|Significant Surgical Procedure|1|||
125263842|NCT01076010|450595472|FG002|Overall Study|Significant Surgical Procedure|0|||
125263843|NCT01076010|450595470|FG000|Overall Study|Protocol Violation|0|||
125263844|NCT01076010|450595471|FG001|Overall Study|Protocol Violation|1|||
125263845|NCT01076010|450595472|FG002|Overall Study|Protocol Violation|0|||
125263846|NCT01076010|450595470|FG000|Overall Study|Noncompliance|1|||
125263847|NCT01076010|450595471|FG001|Overall Study|Noncompliance|1|||
125263848|NCT01076010|450595472|FG002|Overall Study|Noncompliance|0|||
125263849|NCT01076010|450595470|FG000|Overall Study|Withdrawal by Subject|3|||
125263850|NCT01076010|450595471|FG001|Overall Study|Withdrawal by Subject|0|||
125263851|NCT01076010|450595472|FG002|Overall Study|Withdrawal by Subject|1|||
125263852|NCT01076010|450595470|FG000|Overall Study|Other|5|||
125263853|NCT01076010|450595471|FG001|Overall Study|Other|2|||
125263854|NCT01076010|450595472|FG002|Overall Study|Other|0|||
125263855|NCT03440008|450595475|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
125263856|NCT03440008|450595476|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
125263857|NCT03440008|450595475|FG000|Overall Study|Withdrawal by Subject|1|||
125263858|NCT03440008|450595476|FG001|Overall Study|Withdrawal by Subject|0|||
125263859|NCT03498716|450595482|FG000|Overall Study|Withdrawal by Subject|88|||
125263860|NCT03498716|450595483|FG001|Overall Study|Withdrawal by Subject|73|||
125263861|NCT03498716|450595482|FG000|Overall Study|Study Terminated By Sponsor|933|||
125263862|NCT03498716|450595483|FG001|Overall Study|Study Terminated By Sponsor|927|||
125263863|NCT03498716|450595482|FG000|Overall Study|Lost to Follow-up|15|||
125263864|NCT03498716|450595483|FG001|Overall Study|Lost to Follow-up|26|||
125263865|NCT03498716|450595482|FG000|Overall Study|Disease Relapse|0|||
125263866|NCT03498716|450595483|FG001|Overall Study|Disease Relapse|1|||
125263867|NCT03498716|450595482|FG000|Overall Study|Death|58|||
125263868|NCT03498716|450595483|FG001|Overall Study|Death|72|||
125263869|NCT03498716|450595482|FG000|Overall Study|Physician Decision|4|||
125263870|NCT03498716|450595483|FG001|Overall Study|Physician Decision|2|||
125263871|NCT00760552|450595487|FG000|Overall Study|Death|2|||
125263872|NCT00760552|450595488|FG001|Overall Study|Death|0|||
125263873|NCT00760552|450595487|FG000|Overall Study|Lost to Follow-up|11|||
125263874|NCT00760552|450595488|FG001|Overall Study|Lost to Follow-up|10|||
125263875|NCT03507127|450595496|FG000|Overall Study|Withdrawal by Subject|1|||
125263876|NCT03507127|450595497|FG001|Overall Study|Withdrawal by Subject|0|||
125263877|NCT03507127|450595496|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
125263878|NCT03507127|450595497|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
125263879|NCT02271529|450595498|FG000|Overall Study|Withdrawal by Subject|1|||
125263880|NCT01492426|450597606|FG000|Treatment|Death|0|||
125263881|NCT01492426|450597607|FG001|Treatment|Death|1|||
125263882|NCT01492426|450597606|FG000|Treatment|Other|1|||
125263883|NCT01492426|450597607|FG001|Treatment|Other|0|||
125263884|NCT01492426|450597606|FG000|Treatment|Adverse Event|25|||
125263885|NCT01492426|450597607|FG001|Treatment|Adverse Event|25|||
125263886|NCT01492426|450597606|FG000|Treatment|Lack of Efficacy|38|||
125263887|NCT01492426|450597607|FG001|Treatment|Lack of Efficacy|5|||
125263888|NCT01492426|450597606|FG000|Treatment|Participant withdrew consent|1|||
125263889|NCT01492426|450597607|FG001|Treatment|Participant withdrew consent|2|||
125263890|NCT01492426|450597606|FG000|Treatment|Poor compliance/noncompliance|1|||
125263891|NCT01492426|450597607|FG001|Treatment|Poor compliance/noncompliance|0|||
125263892|NCT01492426|450597606|FG000|Treatment|Subject requested discontinue study drug|7|||
125263893|NCT01492426|450597607|FG001|Treatment|Subject requested discontinue study drug|3|||
125263894|NCT01492426|450597606|FG000|Treatment|Lost to Follow-up|9|||
125263895|NCT01492426|450597607|FG001|Treatment|Lost to Follow-up|4|||
125263896|NCT01492426|450597606|FG000|Treatment|Participant does not meet study criteria|1|||
125263897|NCT01492426|450597607|FG001|Treatment|Participant does not meet study criteria|0|||
125263898|NCT01492426|450597606|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
125263899|NCT01492426|450597607|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
125263900|NCT01492426|450597606|FG000|Follow-Up|Death|1|||
125263901|NCT01492426|450597607|FG001|Follow-Up|Death|0|||
125263902|NCT01492426|450597606|FG000|Follow-Up|Other|4|||
125263903|NCT01492426|450597607|FG001|Follow-Up|Other|2|||
125263904|NCT01492426|450597606|FG000|Follow-Up|Participant Withdrew Consent|6|||
125263905|NCT01492426|450597607|FG001|Follow-Up|Participant Withdrew Consent|1|||
125263906|NCT01492426|450597606|FG000|Follow-Up|Lost to Follow-up|12|||
125263907|NCT01492426|450597607|FG001|Follow-Up|Lost to Follow-up|6|||
125263908|NCT00322049|450597608|FG000|Overall Study|Moved out of area|0|||
125263909|NCT00322049|450597609|FG001|Overall Study|Moved out of area|0|||
125263910|NCT00322049|450597610|FG002|Overall Study|Moved out of area|0|||
125263911|NCT00322049|450597611|FG003|Overall Study|Moved out of area|1|||
125263912|NCT00322049|450597608|FG000|Overall Study|Infected with Dengue during study|0|||
125263913|NCT00322049|450597609|FG001|Overall Study|Infected with Dengue during study|1|||
125263914|NCT00322049|450597610|FG002|Overall Study|Infected with Dengue during study|0|||
125263915|NCT00322049|450597611|FG003|Overall Study|Infected with Dengue during study|0|||
125263916|NCT01978145|450597612|FG000|Treatment Period 1|Adverse Event|1|||
125263917|NCT01978145|450597613|FG001|Treatment Period 1|Adverse Event|9|||
125263918|NCT01978145|450597612|FG000|Treatment Period 1|Physician Decision|1|||
125263919|NCT01978145|450597613|FG001|Treatment Period 1|Physician Decision|0|||
125263920|NCT01978145|450597612|FG000|Treatment Period 1|Withdrawal by Subject|5|||
125263921|NCT01978145|450597613|FG001|Treatment Period 1|Withdrawal by Subject|4|||
125263922|NCT01978145|450597612|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
125263923|NCT01978145|450597613|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
125263924|NCT01978145|450597612|FG000|Washout Period 1|Adverse Event|0|||
125263925|NCT01978145|450597613|FG001|Washout Period 1|Adverse Event|1|||
125263926|NCT01978145|450597612|FG000|Washout Period 1|Withdrawal by Subject|1|||
125263927|NCT01978145|450597613|FG001|Washout Period 1|Withdrawal by Subject|1|||
125263928|NCT01978145|450597612|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
125263929|NCT01978145|450597613|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
125263930|NCT01978145|450597612|FG000|Treatment Period 2|Adverse Event|3|||
125263931|NCT01978145|450597613|FG001|Treatment Period 2|Adverse Event|3|||
125263932|NCT01978145|450597612|FG000|Treatment Period 2|Protocol Violation|0|||
125263933|NCT01978145|450597613|FG001|Treatment Period 2|Protocol Violation|1|||
125263934|NCT01978145|450597612|FG000|Treatment Period 2|Lost to Follow-up|1|||
125263935|NCT01978145|450597613|FG001|Treatment Period 2|Lost to Follow-up|1|||
125263936|NCT01978145|450597612|FG000|Treatment Period 2|Withdrawal by Subject|7|||
125263937|NCT01978145|450597613|FG001|Treatment Period 2|Withdrawal by Subject|4|||
125263938|NCT01978145|450597612|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
125263939|NCT01978145|450597613|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
125263940|NCT02026011|450597614|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
125263941|NCT02026011|450597615|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
125263942|NCT02026011|450597614|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
125263943|NCT02026011|450597615|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
125263944|NCT02026011|450597614|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
125263945|NCT02026011|450597615|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
125263946|NCT02026011|450597614|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
125263947|NCT02026011|450597615|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
125263948|NCT01770743|450597616|FG000|Overall Study|Adverse Event|1|||
125263949|NCT01770743|450597617|FG001|Overall Study|Adverse Event|0|||
125263950|NCT01770743|450597618|FG002|Overall Study|Adverse Event|0|||
125263951|NCT01770743|450597619|FG003|Overall Study|Adverse Event|0|||
125263952|NCT01770743|450597620|FG004|Overall Study|Adverse Event|0|||
125263953|NCT01770743|450597616|FG000|Overall Study|Withdrawal by Subject|0|||
125263954|NCT01770743|450597617|FG001|Overall Study|Withdrawal by Subject|0|||
125263955|NCT01770743|450597618|FG002|Overall Study|Withdrawal by Subject|1|||
125263956|NCT01770743|450597619|FG003|Overall Study|Withdrawal by Subject|1|||
125263957|NCT01770743|450597620|FG004|Overall Study|Withdrawal by Subject|1|||
125263958|NCT01770743|450597616|FG000|Overall Study|Lost to Follow-up|0|||
125263959|NCT01770743|450597617|FG001|Overall Study|Lost to Follow-up|2|||
125263960|NCT01770743|450597618|FG002|Overall Study|Lost to Follow-up|0|||
125263961|NCT01770743|450597619|FG003|Overall Study|Lost to Follow-up|0|||
125263962|NCT01770743|450597620|FG004|Overall Study|Lost to Follow-up|1|||
125263963|NCT01770743|450597616|FG000|Overall Study|Sponsor Terminated Subject|1|||
125263964|NCT01770743|450597617|FG001|Overall Study|Sponsor Terminated Subject|0|||
125263965|NCT01770743|450597618|FG002|Overall Study|Sponsor Terminated Subject|0|||
125263966|NCT01770743|450597619|FG003|Overall Study|Sponsor Terminated Subject|1|||
125263967|NCT01770743|450597620|FG004|Overall Study|Sponsor Terminated Subject|0|||
125263968|NCT01770743|450597616|FG000|Overall Study|Moving Out of State|0|||
125263969|NCT01770743|450597617|FG001|Overall Study|Moving Out of State|1|||
125263970|NCT01770743|450597618|FG002|Overall Study|Moving Out of State|0|||
125263971|NCT01770743|450597619|FG003|Overall Study|Moving Out of State|0|||
125263972|NCT01770743|450597620|FG004|Overall Study|Moving Out of State|0|||
125263973|NCT00529243|450597621|FG000|Overall Study|Adverse Event|1|||
125263974|NCT00529243|450597621|FG000|Overall Study|Death|1|||
125263975|NCT00529243|450597621|FG000|Overall Study|Relocated|1|||
125263976|NCT02852967|450597626|FG000|Overall Study|Adverse Event|3|||
125263977|NCT02852967|450597627|FG001|Overall Study|Adverse Event|1|||
125263978|NCT02852967|450597628|FG002|Overall Study|Adverse Event|0|||
125263979|NCT02852967|450597629|FG003|Overall Study|Adverse Event|1|||
125263980|NCT02852967|450597630|FG004|Overall Study|Adverse Event|0|||
125263981|NCT02852967|450597626|FG000|Overall Study|Death|1|||
125263982|NCT02852967|450597627|FG001|Overall Study|Death|0|||
125263983|NCT02852967|450597628|FG002|Overall Study|Death|0|||
125263984|NCT02852967|450597629|FG003|Overall Study|Death|0|||
125263985|NCT02852967|450597630|FG004|Overall Study|Death|0|||
125263986|NCT02852967|450597626|FG000|Overall Study|Lost to Follow-up|1|||
125263987|NCT02852967|450597627|FG001|Overall Study|Lost to Follow-up|2|||
125263988|NCT02852967|450597628|FG002|Overall Study|Lost to Follow-up|3|||
125263989|NCT02852967|450597629|FG003|Overall Study|Lost to Follow-up|4|||
125263990|NCT02852967|450597630|FG004|Overall Study|Lost to Follow-up|4|||
125263991|NCT02852967|450597626|FG000|Overall Study|Withdrawal by Subject|6|||
125263992|NCT02852967|450597627|FG001|Overall Study|Withdrawal by Subject|12|||
125263993|NCT02852967|450597628|FG002|Overall Study|Withdrawal by Subject|7|||
125263994|NCT02852967|450597629|FG003|Overall Study|Withdrawal by Subject|10|||
125263995|NCT02852967|450597630|FG004|Overall Study|Withdrawal by Subject|10|||
125263996|NCT02852967|450597626|FG000|Overall Study|SAE|0|||
125263997|NCT02852967|450597627|FG001|Overall Study|SAE|0|||
125263998|NCT02852967|450597628|FG002|Overall Study|SAE|0|||
125263999|NCT02852967|450597629|FG003|Overall Study|SAE|3|||
125264000|NCT02852967|450597630|FG004|Overall Study|SAE|0|||
125264001|NCT02852967|450597626|FG000|Overall Study|Elevated Liver Enzymes|2|||
125264002|NCT02852967|450597627|FG001|Overall Study|Elevated Liver Enzymes|0|||
125264003|NCT02852967|450597628|FG002|Overall Study|Elevated Liver Enzymes|0|||
125264004|NCT02852967|450597629|FG003|Overall Study|Elevated Liver Enzymes|2|||
125264005|NCT02852967|450597630|FG004|Overall Study|Elevated Liver Enzymes|2|||
125264006|NCT02852967|450597626|FG000|Overall Study|Physician Decision|0|||
125264007|NCT02852967|450597627|FG001|Overall Study|Physician Decision|0|||
125264008|NCT02852967|450597628|FG002|Overall Study|Physician Decision|0|||
125264009|NCT02852967|450597629|FG003|Overall Study|Physician Decision|1|||
125264010|NCT02852967|450597630|FG004|Overall Study|Physician Decision|0|||
125264011|NCT02852967|450597626|FG000|Overall Study|Lack of Efficacy|0|||
125264012|NCT02852967|450597627|FG001|Overall Study|Lack of Efficacy|1|||
125264013|NCT02852967|450597628|FG002|Overall Study|Lack of Efficacy|0|||
125264014|NCT02852967|450597629|FG003|Overall Study|Lack of Efficacy|0|||
125264015|NCT02852967|450597630|FG004|Overall Study|Lack of Efficacy|0|||
125264016|NCT02852967|450597626|FG000|Overall Study|Non-compliance|0|||
125264017|NCT02852967|450597627|FG001|Overall Study|Non-compliance|0|||
125264018|NCT02852967|450597628|FG002|Overall Study|Non-compliance|1|||
125264019|NCT02852967|450597629|FG003|Overall Study|Non-compliance|1|||
125264020|NCT02852967|450597630|FG004|Overall Study|Non-compliance|0|||
125264021|NCT02852967|450597626|FG000|Overall Study|Dispensing Drug Violation|0|||
125264022|NCT02852967|450597627|FG001|Overall Study|Dispensing Drug Violation|0|||
125264023|NCT02852967|450597628|FG002|Overall Study|Dispensing Drug Violation|1|||
125264024|NCT02852967|450597629|FG003|Overall Study|Dispensing Drug Violation|0|||
125264025|NCT02852967|450597630|FG004|Overall Study|Dispensing Drug Violation|0|||
125264026|NCT02852967|450597626|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
125264027|NCT02852967|450597627|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
125264028|NCT02852967|450597628|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
125264029|NCT02852967|450597629|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
125264030|NCT02852967|450597630|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
125264031|NCT01693367|450597631|FG000|Overall Study|Withdrawal by Subject|1|||
125264032|NCT01693367|450597632|FG001|Overall Study|Withdrawal by Subject|1|||
125264033|NCT01693367|450597631|FG000|Overall Study|Physician Decision|0|||
125264034|NCT01693367|450597632|FG001|Overall Study|Physician Decision|1|||
125264035|NCT02136914|450597633|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
125264036|NCT02136914|450597634|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
125264037|NCT02136914|450597633|FG000|Overall Study|Withdrawal by Subject|3|||
125264038|NCT02136914|450597634|FG001|Overall Study|Withdrawal by Subject|10|||
125264039|NCT02136914|450597633|FG000|Overall Study|Subject Unwilling to Proceed|7|||
125264040|NCT02136914|450597634|FG001|Overall Study|Subject Unwilling to Proceed|2|||
125264041|NCT02136914|450597633|FG000|Overall Study|Lost to Follow-up|1|||
125264042|NCT02136914|450597634|FG001|Overall Study|Lost to Follow-up|1|||
125264043|NCT02136914|450597633|FG000|Overall Study|Did Not Receive Study Drug|2|||
125264044|NCT02136914|450597634|FG001|Overall Study|Did Not Receive Study Drug|0|||
125264045|NCT02136914|450597633|FG000|Overall Study|Lack of Efficacy|1|||
125264046|NCT02136914|450597634|FG001|Overall Study|Lack of Efficacy|0|||
125264047|NCT02136914|450597633|FG000|Overall Study|Death|0|||
125264048|NCT02136914|450597634|FG001|Overall Study|Death|1|||
125264049|NCT05518461|450597641|FG000|Overall Study|Lost to Follow-up|25|||
125264050|NCT03179761|450597642|FG000|Overall Study|Death|2|||
125264051|NCT03179761|450597643|FG001|Overall Study|Death|5|||
125264052|NCT03179761|450597642|FG000|Overall Study|Lost to Follow-up|2|||
125264053|NCT03179761|450597643|FG001|Overall Study|Lost to Follow-up|2|||
125264054|NCT03179761|450597642|FG000|Overall Study|Protocol Violation|1|||
125264055|NCT03179761|450597643|FG001|Overall Study|Protocol Violation|0|||
125264056|NCT03179761|450597642|FG000|Overall Study|Withdrawal by Subject|1|||
125264057|NCT03179761|450597643|FG001|Overall Study|Withdrawal by Subject|4|||
125264058|NCT03179761|450597642|FG000|Overall Study|Investigator Request|0|||
125264059|NCT03179761|450597643|FG001|Overall Study|Investigator Request|2|||
125264060|NCT00448448|450597645|FG000|Overall Study|Withdrawal by Subject|13|||
125264061|NCT00448448|450597646|FG001|Overall Study|Withdrawal by Subject|2|||
125264062|NCT00448448|450597645|FG000|Overall Study|On protocol when study ended|83|||
125264063|NCT00448448|450597646|FG001|Overall Study|On protocol when study ended|36|||
125264064|NCT00448448|450597645|FG000|Overall Study|Lost to Follow-up|2|||
125264065|NCT00448448|450597646|FG001|Overall Study|Lost to Follow-up|1|||
125264066|NCT00448448|450597645|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
125264067|NCT00448448|450597646|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
125264068|NCT00448448|450597645|FG000|Overall Study|Signed consent lost|0|||
125264069|NCT00448448|450597646|FG001|Overall Study|Signed consent lost|1|||
125264070|NCT02284191|450597647|FG000|Overall Study|Withdrawal by Subject|1|||
125264071|NCT02284191|450597648|FG001|Overall Study|Withdrawal by Subject|3|||
125264072|NCT02284191|450597647|FG000|Overall Study|Lost to Follow-up|1|||
125264073|NCT02284191|450597648|FG001|Overall Study|Lost to Follow-up|0|||
125264074|NCT01188967|450597649|FG000|Overall Study|Withdrawal by Subject|1|||
125264075|NCT01188967|450597650|FG001|Overall Study|Withdrawal by Subject|1|||
125264076|NCT01188967|450597649|FG000|Overall Study|Physician Decision|1|||
125264077|NCT01188967|450597650|FG001|Overall Study|Physician Decision|1|||
125264078|NCT01188967|450597649|FG000|Overall Study|Lost to Follow-up|3|||
125264079|NCT01188967|450597650|FG001|Overall Study|Lost to Follow-up|2|||
125264080|NCT01832727|450597655|FG000|Overall Study|Adverse Event|4|||
125264081|NCT01832727|450597656|FG001|Overall Study|Adverse Event|6|||
125264082|NCT01832727|450597657|FG002|Overall Study|Adverse Event|1|||
125264083|NCT01832727|450597658|FG003|Overall Study|Adverse Event|0|||
125264084|NCT01832727|450597659|FG004|Overall Study|Adverse Event|1|||
125264085|NCT01832727|450597660|FG005|Overall Study|Adverse Event|1|||
125264086|NCT01832727|450597661|FG006|Overall Study|Adverse Event|2|||
125264087|NCT01832727|450597662|FG007|Overall Study|Adverse Event|1|||
125264088|NCT01832727|450597663|FG008|Overall Study|Adverse Event|9|||
125264089|NCT01832727|450597655|FG000|Overall Study|Disease progression|3|||
125264090|NCT01832727|450597656|FG001|Overall Study|Disease progression|0|||
125264091|NCT01832727|450597657|FG002|Overall Study|Disease progression|2|||
125264092|NCT01832727|450597658|FG003|Overall Study|Disease progression|1|||
125264093|NCT01832727|450597659|FG004|Overall Study|Disease progression|3|||
125264094|NCT01832727|450597660|FG005|Overall Study|Disease progression|3|||
125264095|NCT01832727|450597661|FG006|Overall Study|Disease progression|6|||
125264096|NCT01832727|450597662|FG007|Overall Study|Disease progression|2|||
125264097|NCT01832727|450597663|FG008|Overall Study|Disease progression|7|||
125264098|NCT01832727|450597655|FG000|Overall Study|Lost to Follow-up|0|||
125264099|NCT01832727|450597656|FG001|Overall Study|Lost to Follow-up|0|||
125264100|NCT01832727|450597657|FG002|Overall Study|Lost to Follow-up|0|||
125264101|NCT01832727|450597658|FG003|Overall Study|Lost to Follow-up|1|||
125264102|NCT01832727|450597659|FG004|Overall Study|Lost to Follow-up|0|||
125264103|NCT01832727|450597660|FG005|Overall Study|Lost to Follow-up|0|||
125264104|NCT01832727|450597661|FG006|Overall Study|Lost to Follow-up|0|||
125264105|NCT01832727|450597662|FG007|Overall Study|Lost to Follow-up|0|||
125264106|NCT01832727|450597663|FG008|Overall Study|Lost to Follow-up|0|||
125264107|NCT01832727|450597655|FG000|Overall Study|Physician Decision|1|||
125264108|NCT01832727|450597656|FG001|Overall Study|Physician Decision|0|||
125264109|NCT01832727|450597657|FG002|Overall Study|Physician Decision|0|||
125264110|NCT01832727|450597658|FG003|Overall Study|Physician Decision|1|||
125264111|NCT01832727|450597659|FG004|Overall Study|Physician Decision|0|||
125264112|NCT01832727|450597660|FG005|Overall Study|Physician Decision|1|||
125264113|NCT01832727|450597661|FG006|Overall Study|Physician Decision|0|||
125264114|NCT01832727|450597662|FG007|Overall Study|Physician Decision|0|||
125264115|NCT01832727|450597663|FG008|Overall Study|Physician Decision|0|||
125264116|NCT01832727|450597655|FG000|Overall Study|Withdrawal by Subject|1|||
125264117|NCT01832727|450597656|FG001|Overall Study|Withdrawal by Subject|1|||
125264118|NCT01832727|450597657|FG002|Overall Study|Withdrawal by Subject|0|||
125264119|NCT01832727|450597658|FG003|Overall Study|Withdrawal by Subject|1|||
125264120|NCT01832727|450597659|FG004|Overall Study|Withdrawal by Subject|0|||
125264121|NCT01832727|450597660|FG005|Overall Study|Withdrawal by Subject|1|||
125264122|NCT01832727|450597661|FG006|Overall Study|Withdrawal by Subject|0|||
125264123|NCT01832727|450597662|FG007|Overall Study|Withdrawal by Subject|2|||
125264124|NCT01832727|450597663|FG008|Overall Study|Withdrawal by Subject|1|||
125264125|NCT01832727|450597655|FG000|Overall Study|Study terminated by sponsor|0|||
125264126|NCT01832727|450597656|FG001|Overall Study|Study terminated by sponsor|0|||
125264127|NCT01832727|450597657|FG002|Overall Study|Study terminated by sponsor|0|||
125264128|NCT01832727|450597658|FG003|Overall Study|Study terminated by sponsor|0|||
125264129|NCT01832727|450597659|FG004|Overall Study|Study terminated by sponsor|0|||
125264130|NCT01832727|450597660|FG005|Overall Study|Study terminated by sponsor|0|||
125264131|NCT01832727|450597661|FG006|Overall Study|Study terminated by sponsor|0|||
125264132|NCT01832727|450597662|FG007|Overall Study|Study terminated by sponsor|1|||
125264133|NCT01832727|450597663|FG008|Overall Study|Study terminated by sponsor|1|||
125264134|NCT02216526|450597664|FG000|Overall Study|Adverse Event|1|||
125264135|NCT02216526|450597665|FG001|Overall Study|Adverse Event|1|||
125264136|NCT02216526|450597666|FG002|Overall Study|Adverse Event|0|||
125264137|NCT02216526|450597664|FG000|Overall Study|Death|0|||
125264138|NCT02216526|450597665|FG001|Overall Study|Death|1|||
125264139|NCT02216526|450597666|FG002|Overall Study|Death|3|||
125264140|NCT02216526|450597664|FG000|Overall Study|Protocol Violation|2|||
125264141|NCT02216526|450597665|FG001|Overall Study|Protocol Violation|0|||
125264142|NCT02216526|450597666|FG002|Overall Study|Protocol Violation|2|||
125264143|NCT02216526|450597664|FG000|Overall Study|Hospitalization|2|||
125264144|NCT02216526|450597665|FG001|Overall Study|Hospitalization|1|||
125264145|NCT02216526|450597666|FG002|Overall Study|Hospitalization|3|||
125264146|NCT04436744|450597670|FG000|Overall Study|Adverse Event|1|||
125264147|NCT04436744|450597671|FG001|Overall Study|Adverse Event|1|||
125264148|NCT04436744|450597670|FG000|Overall Study|Death|1|||
125264149|NCT04436744|450597671|FG001|Overall Study|Death|0|||
125264150|NCT04436744|450597670|FG000|Overall Study|Lost to Follow-up|0|||
125264151|NCT04436744|450597671|FG001|Overall Study|Lost to Follow-up|2|||
125264152|NCT04436744|450597670|FG000|Overall Study|Physician Decision|0|||
125264153|NCT04436744|450597671|FG001|Overall Study|Physician Decision|1|||
125264154|NCT04436744|450597670|FG000|Overall Study|Progressive Disease|0|||
125264155|NCT04436744|450597671|FG001|Overall Study|Progressive Disease|4|||
125264156|NCT04436744|450597670|FG000|Overall Study|Protocol Deviation|1|||
125264157|NCT04436744|450597671|FG001|Overall Study|Protocol Deviation|1|||
125264158|NCT04436744|450597670|FG000|Overall Study|Withdrawal by Subject|1|||
125264159|NCT04436744|450597671|FG001|Overall Study|Withdrawal by Subject|2|||
125264160|NCT01133847|450597675|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
125264161|NCT01133847|450597676|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
125264162|NCT01133847|450597677|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
125264163|NCT01133847|450597675|FG000|Follow-Up Phase|Lost to Follow-up|1|||
125264164|NCT01133847|450597676|FG001|Follow-Up Phase|Lost to Follow-up|3|||
125264165|NCT01133847|450597677|FG002|Follow-Up Phase|Lost to Follow-up|7|||
125264166|NCT01463033|450597678|FG000|Overall Study|Lost to Follow-up|4|||
125264167|NCT01463033|450597679|FG001|Overall Study|Lost to Follow-up|4|||
125264168|NCT01463033|450597678|FG000|Overall Study|Death|3|||
125264169|NCT01463033|450597679|FG001|Overall Study|Death|2|||
125264170|NCT00967616|450597680|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
125264171|NCT00967616|450597681|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
125264172|NCT00967616|450597680|FG000|Overall Study|Death|0|||
125264173|NCT00967616|450597681|FG001|Overall Study|Death|3|||
125264174|NCT00967616|450597680|FG000|Overall Study|Withdrawal by Subject|8|||
125264175|NCT00967616|450597681|FG001|Overall Study|Withdrawal by Subject|4|||
125264176|NCT00967616|450597680|FG000|Overall Study|Progressive Disease|31|||
125264177|NCT00967616|450597681|FG001|Overall Study|Progressive Disease|18|||
125264178|NCT00967616|450597680|FG000|Overall Study|Other|8|||
125264179|NCT00967616|450597681|FG001|Overall Study|Other|8|||
125264180|NCT00967616|450597680|FG000|Overall Study|Protocol Violation|1|||
125264181|NCT00967616|450597681|FG001|Overall Study|Protocol Violation|0|||
125264182|NCT01368614|450597682|FG000|Screening Period|Screen Failure|58|||
125264183|NCT01368614|450597683|FG001|Screening Period|Screen Failure|0|||
125264184|NCT01368614|450597684|FG002|Screening Period|Screen Failure|0|||
125264185|NCT01368614|450597685|FG003|Screening Period|Screen Failure|0|||
125264186|NCT01368614|450597682|FG000|Study Period|Withdrawal by Subject|0|||
125264187|NCT01368614|450597683|FG001|Study Period|Withdrawal by Subject|1|||
125264188|NCT01368614|450597684|FG002|Study Period|Withdrawal by Subject|1|||
125264189|NCT01368614|450597685|FG003|Study Period|Withdrawal by Subject|3|||
125264190|NCT01368614|450597682|FG000|Study Period|Lost to Follow-up|0|||
125264191|NCT01368614|450597683|FG001|Study Period|Lost to Follow-up|0|||
125264192|NCT01368614|450597684|FG002|Study Period|Lost to Follow-up|1|||
125264193|NCT01368614|450597685|FG003|Study Period|Lost to Follow-up|0|||
125264194|NCT02951780|450597686|FG000|Period 1|Adverse Event|0|||
125264195|NCT02951780|450597687|FG001|Period 1|Adverse Event|0|||
125264196|NCT02951780|450597688|FG002|Period 1|Adverse Event|0|||
125264197|NCT02951780|450597689|FG003|Period 1|Adverse Event|1|||
125264198|NCT02951780|450597690|FG004|Period 1|Adverse Event|0|||
125264199|NCT02951780|450597691|FG005|Period 1|Adverse Event|0|||
125264200|NCT02951780|450597692|FG006|Period 1|Adverse Event|0|||
125264201|NCT02951780|450597693|FG007|Period 1|Adverse Event|0|||
125264202|NCT02951780|450597694|FG008|Period 1|Adverse Event|0|||
125264203|NCT02951780|450597686|FG000|Period 1|Scheduling Conflicts|0|||
125264204|NCT02951780|450597687|FG001|Period 1|Scheduling Conflicts|0|||
125264205|NCT02951780|450597688|FG002|Period 1|Scheduling Conflicts|0|||
125264206|NCT02951780|450597689|FG003|Period 1|Scheduling Conflicts|0|||
125264207|NCT02951780|450597690|FG004|Period 1|Scheduling Conflicts|0|||
125264208|NCT02951780|450597691|FG005|Period 1|Scheduling Conflicts|0|||
125264209|NCT02951780|450597692|FG006|Period 1|Scheduling Conflicts|0|||
125264210|NCT02951780|450597693|FG007|Period 1|Scheduling Conflicts|1|||
125264211|NCT02951780|450597694|FG008|Period 1|Scheduling Conflicts|0|||
125264212|NCT02951780|450597686|FG000|Period 2|Scheduling Conflicts|0|||
125264213|NCT02951780|450597687|FG001|Period 2|Scheduling Conflicts|0|||
125264214|NCT02951780|450597688|FG002|Period 2|Scheduling Conflicts|0|||
125264215|NCT02951780|450597689|FG003|Period 2|Scheduling Conflicts|0|||
125264216|NCT02951780|450597690|FG004|Period 2|Scheduling Conflicts|0|||
125264217|NCT02951780|450597691|FG005|Period 2|Scheduling Conflicts|0|||
125264218|NCT02951780|450597692|FG006|Period 2|Scheduling Conflicts|0|||
125264219|NCT02951780|450597693|FG007|Period 2|Scheduling Conflicts|1|||
125264220|NCT02951780|450597694|FG008|Period 2|Scheduling Conflicts|0|||
125264221|NCT01374425|450597695|FG000|Overall Study|Radiographic Disease Progression|86|||
125264222|NCT01374425|450597696|FG001|Overall Study|Radiographic Disease Progression|81|||
125264223|NCT01374425|450597695|FG000|Overall Study|Clinical Disease Progression|9|||
125264224|NCT01374425|450597696|FG001|Overall Study|Clinical Disease Progression|6|||
125264225|NCT01374425|450597695|FG000|Overall Study|Adverse Event|29|||
125264226|NCT01374425|450597696|FG001|Overall Study|Adverse Event|18|||
125264227|NCT01374425|450597695|FG000|Overall Study|Death (Progression of Disease)|1|||
125264228|NCT01374425|450597696|FG001|Overall Study|Death (Progression of Disease)|0|||
125264229|NCT01374425|450597695|FG000|Overall Study|Death (Adverse Event)|2|||
125264230|NCT01374425|450597696|FG001|Overall Study|Death (Adverse Event)|4|||
125264231|NCT01374425|450597695|FG000|Overall Study|Withdrawal by Subject|6|||
125264232|NCT01374425|450597696|FG001|Overall Study|Withdrawal by Subject|7|||
125264233|NCT01374425|450597695|FG000|Overall Study|Refused Treatment|10|||
125264234|NCT01374425|450597696|FG001|Overall Study|Refused Treatment|24|||
125264235|NCT01374425|450597695|FG000|Overall Study|Protocol Violation|2|||
125264236|NCT01374425|450597696|FG001|Overall Study|Protocol Violation|3|||
125264237|NCT01374425|450597695|FG000|Overall Study|Sponsor Decision|0|||
125264238|NCT01374425|450597696|FG001|Overall Study|Sponsor Decision|1|||
125264239|NCT01374425|450597695|FG000|Overall Study|Lost to Follow-up|2|||
125264240|NCT01374425|450597696|FG001|Overall Study|Lost to Follow-up|1|||
125264241|NCT01374425|450597695|FG000|Overall Study|Other|41|||
125264242|NCT01374425|450597696|FG001|Overall Study|Other|43|||
125264243|NCT02359903|450597697|FG000|Overall Study|Adverse Event|0|||
125264244|NCT02359903|450597698|FG001|Overall Study|Adverse Event|2|||
125264245|NCT00546481|450597699|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
125264246|NCT00546481|450597700|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
125264247|NCT00546481|450597701|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
125264248|NCT00546481|450597699|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
125264249|NCT00546481|450597700|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
125264250|NCT00546481|450597701|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
125264251|NCT00546481|450597699|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
125264252|NCT00546481|450597700|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
125264253|NCT00546481|450597701|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
125264254|NCT00546481|450597699|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
125264255|NCT00546481|450597700|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
125264256|NCT00546481|450597701|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
125264257|NCT00546481|450597699|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
125264258|NCT00546481|450597700|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
125264259|NCT00546481|450597701|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
125264260|NCT00546481|450597699|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
125264261|NCT00546481|450597700|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
125264262|NCT00546481|450597701|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
125264263|NCT00546481|450597699|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
125264264|NCT00546481|450597700|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
125264265|NCT00546481|450597701|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
125264266|NCT00546481|450597699|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
125264267|NCT00546481|450597700|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
125264268|NCT00546481|450597701|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
125264269|NCT00546481|450597699|FG000|Maintenance Phase (CERA)|Other Reason|0|||
125264270|NCT00546481|450597700|FG001|Maintenance Phase (CERA)|Other Reason|0|||
125264271|NCT00546481|450597701|FG002|Maintenance Phase (CERA)|Other Reason|1|||
125264272|NCT01240863|450597704|FG000|Open-label Titration Period|Adverse Event|47|||
125264273|NCT01240863|450597705|FG001|Open-label Titration Period|Adverse Event|0|||
125264274|NCT01240863|450597706|FG002|Open-label Titration Period|Adverse Event|0|||
125264275|NCT01240863|450597704|FG000|Open-label Titration Period|Lack of Efficacy|19|||
125264276|NCT01240863|450597705|FG001|Open-label Titration Period|Lack of Efficacy|0|||
125264277|NCT01240863|450597706|FG002|Open-label Titration Period|Lack of Efficacy|0|||
125264278|NCT01240863|450597704|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
125264279|NCT01240863|450597705|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
125264280|NCT01240863|450597706|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
125264281|NCT01240863|450597704|FG000|Open-label Titration Period|Protocol Violation|7|||
125264282|NCT01240863|450597705|FG001|Open-label Titration Period|Protocol Violation|0|||
125264283|NCT01240863|450597706|FG002|Open-label Titration Period|Protocol Violation|0|||
125264284|NCT01240863|450597704|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
125264285|NCT01240863|450597705|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
125264286|NCT01240863|450597706|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
125264287|NCT01240863|450597704|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
125264288|NCT01240863|450597705|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
125264289|NCT01240863|450597706|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
125264290|NCT01240863|450597704|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
125264291|NCT01240863|450597705|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
125264292|NCT01240863|450597706|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
125264293|NCT01240863|450597704|FG000|Open-label Titration Period|Other|7|||
125264294|NCT01240863|450597705|FG001|Open-label Titration Period|Other|0|||
125264295|NCT01240863|450597706|FG002|Open-label Titration Period|Other|0|||
125264296|NCT01240863|450597704|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
125264297|NCT01240863|450597705|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
125264298|NCT01240863|450597706|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
125264299|NCT01240863|450597704|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
125264300|NCT01240863|450597705|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
125264301|NCT01240863|450597706|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
125264302|NCT01240863|450597704|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
125264303|NCT01240863|450597705|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
125264304|NCT01240863|450597706|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
125264305|NCT01240863|450597704|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
125264306|NCT01240863|450597705|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
125264307|NCT01240863|450597706|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
125264308|NCT01240863|450597704|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
125264309|NCT01240863|450597705|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
125264310|NCT01240863|450597706|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
125264311|NCT01240863|450597704|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
125264312|NCT01240863|450597705|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
125264313|NCT01240863|450597706|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
125264314|NCT01240863|450597704|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
125264315|NCT01240863|450597705|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
125264316|NCT01240863|450597706|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
125264317|NCT01240863|450597704|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
125264318|NCT01240863|450597705|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
125264319|NCT01240863|450597706|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
125264320|NCT03783780|450597711|FG000|Overall Study|Withdrawn prior to completion|1|||
125264321|NCT03768427|450597712|FG000|Overall Study|Death|0|||
125264322|NCT03768427|450597713|FG001|Overall Study|Death|0|||
125264323|NCT03768427|450597714|FG002|Overall Study|Death|1|||
125264324|NCT03768427|450597715|FG003|Overall Study|Death|0|||
125264325|NCT03768427|450597712|FG000|Overall Study|Lost to Follow-up|2|||
125264326|NCT03768427|450597713|FG001|Overall Study|Lost to Follow-up|0|||
125264327|NCT03768427|450597714|FG002|Overall Study|Lost to Follow-up|0|||
125264328|NCT03768427|450597715|FG003|Overall Study|Lost to Follow-up|0|||
125264329|NCT03768427|450597712|FG000|Overall Study|Physician Decision|3|||
125264330|NCT03768427|450597713|FG001|Overall Study|Physician Decision|2|||
125264331|NCT03768427|450597714|FG002|Overall Study|Physician Decision|4|||
125264332|NCT03768427|450597715|FG003|Overall Study|Physician Decision|4|||
125264333|NCT03768427|450597712|FG000|Overall Study|Withdrawal by Subject|7|||
125264334|NCT03768427|450597713|FG001|Overall Study|Withdrawal by Subject|2|||
125264335|NCT03768427|450597714|FG002|Overall Study|Withdrawal by Subject|6|||
125264336|NCT03768427|450597715|FG003|Overall Study|Withdrawal by Subject|7|||
125264337|NCT00776789|450597716|FG000|Overall Study|Consent refusal|2|||
125264338|NCT00776789|450597717|FG001|Overall Study|Consent refusal|2|||
125264339|NCT00776789|450597716|FG000|Overall Study|Poor quality video|1|||
125264340|NCT00776789|450597717|FG001|Overall Study|Poor quality video|1|||
125264341|NCT02629861|450597723|FG000|Overall Study|Adverse Event|7|||
125264342|NCT02629861|450597724|FG001|Overall Study|Adverse Event|5|||
125264343|NCT02629861|450597725|FG002|Overall Study|Adverse Event|4|||
125264344|NCT02629861|450597723|FG000|Overall Study|Withdrawal by Subject|5|||
125264345|NCT02629861|450597724|FG001|Overall Study|Withdrawal by Subject|8|||
125264346|NCT02629861|450597725|FG002|Overall Study|Withdrawal by Subject|13|||
125264347|NCT02629861|450597723|FG000|Overall Study|Protocol Violation|2|||
125264348|NCT02629861|450597724|FG001|Overall Study|Protocol Violation|3|||
125264349|NCT02629861|450597725|FG002|Overall Study|Protocol Violation|7|||
125264350|NCT02629861|450597723|FG000|Overall Study|Lost to Follow-up|12|||
125264351|NCT02629861|450597724|FG001|Overall Study|Lost to Follow-up|9|||
125264352|NCT02629861|450597725|FG002|Overall Study|Lost to Follow-up|4|||
125264353|NCT02629861|450597723|FG000|Overall Study|Other|1|||
125264354|NCT02629861|450597724|FG001|Overall Study|Other|1|||
125264355|NCT02629861|450597725|FG002|Overall Study|Other|0|||
125264356|NCT02629861|450597723|FG000|Overall Study|Pregnancy|2|||
125264357|NCT02629861|450597724|FG001|Overall Study|Pregnancy|1|||
125264358|NCT02629861|450597725|FG002|Overall Study|Pregnancy|0|||
125264359|NCT00907621|450597729|FG000|Overall Study|Lost to Follow-up|6|||
125264360|NCT00907621|450597730|FG001|Overall Study|Lost to Follow-up|3|||
125264361|NCT00907621|450597729|FG000|Overall Study|intercurrent febrile illness|1|||
125264362|NCT00907621|450597730|FG001|Overall Study|intercurrent febrile illness|1|||
125264363|NCT00902330|450597733|FG000|Overall Study|Too overwhelmed by treatment|2|||
125264364|NCT00902330|450597734|FG001|Overall Study|Too overwhelmed by treatment|5|||
125264365|NCT00902330|450597733|FG000|Overall Study|Adverse Event|1|||
125264366|NCT00902330|450597734|FG001|Overall Study|Adverse Event|0|||
125264367|NCT00902330|450597733|FG000|Overall Study|No post baseline data|1|||
125264368|NCT00902330|450597734|FG001|Overall Study|No post baseline data|0|||
125264369|NCT00165789|450597735|FG000|Overall Study|Adverse Event|0|||
125264370|NCT00165789|450597736|FG001|Overall Study|Adverse Event|3|||
125264371|NCT00165789|450597737|FG002|Overall Study|Adverse Event|0|||
125264372|NCT00165789|450597738|FG003|Overall Study|Adverse Event|12|||
125264373|NCT00165789|450597735|FG000|Overall Study|Withdrawal by Subject|0|||
125264374|NCT00165789|450597736|FG001|Overall Study|Withdrawal by Subject|1|||
125264375|NCT00165789|450597737|FG002|Overall Study|Withdrawal by Subject|1|||
125264376|NCT00165789|450597738|FG003|Overall Study|Withdrawal by Subject|2|||
125264377|NCT01816048|450597739|FG000|Overall Study|Adverse Event|1|||
125264378|NCT01816048|450597739|FG000|Overall Study|Death|1|||
125264379|NCT01816048|450597739|FG000|Overall Study|Withdrawal by Subject|1|||
125264380|NCT01816048|450597739|FG000|Overall Study|Disease Progression|3|||
125264381|NCT04290624|450597740|FG000|Overall Study|Adverse Event|1|||
125264382|NCT04290624|450597741|FG001|Overall Study|Adverse Event|0|||
125264383|NCT00656370|450597746|FG000|Overall Study|Screen Failures|7|||
125264384|NCT00656370|450597746|FG000|Overall Study|Alternates|3|||
125264385|NCT01816984|450597747|FG000|Overall Study|declining health status|1|||
125264386|NCT01342094|450597750|FG000|Overall Study|Adverse Event|5|||
125264387|NCT01342094|450597751|FG001|Overall Study|Adverse Event|0|||
125264388|NCT01342094|450597750|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
125264389|NCT01342094|450597751|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
125264390|NCT01342094|450597750|FG000|Overall Study|Withdrawal by Subject|0|||
125264391|NCT01342094|450597751|FG001|Overall Study|Withdrawal by Subject|2|||
125264392|NCT02121509|450597752|FG000|Washout Period (35 Days)|Adverse Event|1|||
125264393|NCT02121509|450597753|FG001|Washout Period (35 Days)|Adverse Event|1|||
125264394|NCT02121509|450597754|FG002|Washout Period (35 Days)|Adverse Event|0|||
125264395|NCT02121509|450597755|FG003|Washout Period (35 Days)|Adverse Event|0|||
125264396|NCT02121509|450597752|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
125264397|NCT02121509|450597753|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
125264398|NCT02121509|450597754|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
125264399|NCT02121509|450597755|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
125264400|NCT02121509|450597752|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
125264401|NCT02121509|450597753|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
125264402|NCT02121509|450597754|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
125264403|NCT02121509|450597755|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
125264404|NCT04021290|450597762|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
125264405|NCT04021290|450597763|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
125264406|NCT04021290|450597764|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
125264407|NCT04021290|450597762|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
125264408|NCT04021290|450597763|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
125264409|NCT04021290|450597764|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
125264410|NCT04021290|450597762|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
125264411|NCT04021290|450597763|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
125264412|NCT04021290|450597764|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
125264413|NCT04021290|450597762|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
125264414|NCT04021290|450597763|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
125264415|NCT04021290|450597764|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
125264416|NCT04021290|450597762|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
125264417|NCT04021290|450597763|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
125264418|NCT04021290|450597764|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
125264419|NCT04021290|450597762|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
125264420|NCT04021290|450597763|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
125264421|NCT04021290|450597764|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
125264422|NCT04021290|450597762|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
125264423|NCT04021290|450597763|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
125264424|NCT04021290|450597764|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
125264425|NCT04021290|450597762|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
125264426|NCT04021290|450597763|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
125264427|NCT04021290|450597764|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
125264428|NCT04021290|450597762|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
125264429|NCT04021290|450597763|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
125264430|NCT04021290|450597764|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
125264431|NCT04021290|450597762|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
125264432|NCT04021290|450597763|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
125264433|NCT04021290|450597764|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
125264434|NCT04021290|450597762|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
125264435|NCT04021290|450597763|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
125264436|NCT04021290|450597764|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
125264437|NCT04021290|450597762|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
125264438|NCT04021290|450597763|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
125264439|NCT04021290|450597764|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
125264440|NCT00636181|450597765|FG000|Overall Study|Withdrawal by Subject|8|||
125264441|NCT00636181|450597766|FG001|Overall Study|Withdrawal by Subject|6|||
125264442|NCT00636181|450597767|FG002|Overall Study|Withdrawal by Subject|10|||
125264443|NCT03069716|450597770|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
125264444|NCT03069716|450597771|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
125264445|NCT03069716|450597772|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
125264446|NCT03069716|450597770|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
125264447|NCT03069716|450597771|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
125264448|NCT03069716|450597772|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
125264449|NCT03069716|450597770|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
125264450|NCT03069716|450597771|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
125264451|NCT03069716|450597772|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
125264452|NCT03069716|450597770|FG000|Randomized Treatment|Withdrawal by Subject|0|||
125264453|NCT03069716|450597771|FG001|Randomized Treatment|Withdrawal by Subject|2|||
125264454|NCT03069716|450597772|FG002|Randomized Treatment|Withdrawal by Subject|0|||
125264455|NCT05076045|450597778|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
125264456|NCT05076045|450597779|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
125264457|NCT03391882|450597780|FG000|Study Overall|Adverse Event|3|||
125264458|NCT03391882|450597781|FG001|Study Overall|Adverse Event|6|||
125264459|NCT03391882|450597782|FG002|Study Overall|Adverse Event|1|||
125264460|NCT03391882|450597783|FG003|Study Overall|Adverse Event|1|||
125264461|NCT03391882|450597784|FG004|Study Overall|Adverse Event|3|||
125264462|NCT03391882|450597785|FG005|Study Overall|Adverse Event|1|||
125264463|NCT03391882|450597780|FG000|Study Overall|Lack of Efficacy|13|||
125264464|NCT03391882|450597781|FG001|Study Overall|Lack of Efficacy|9|||
125264465|NCT03391882|450597782|FG002|Study Overall|Lack of Efficacy|0|||
125264466|NCT03391882|450597783|FG003|Study Overall|Lack of Efficacy|0|||
125264467|NCT03391882|450597784|FG004|Study Overall|Lack of Efficacy|0|||
125264468|NCT03391882|450597785|FG005|Study Overall|Lack of Efficacy|0|||
125264469|NCT03391882|450597780|FG000|Study Overall|Withdrawal by Subject|3|||
125264470|NCT03391882|450597781|FG001|Study Overall|Withdrawal by Subject|3|||
125264471|NCT03391882|450597782|FG002|Study Overall|Withdrawal by Subject|2|||
125264472|NCT03391882|450597783|FG003|Study Overall|Withdrawal by Subject|2|||
125264473|NCT03391882|450597784|FG004|Study Overall|Withdrawal by Subject|1|||
125264474|NCT03391882|450597785|FG005|Study Overall|Withdrawal by Subject|3|||
125264475|NCT03391882|450597780|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
125264476|NCT03391882|450597781|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
125264477|NCT03391882|450597782|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
125264478|NCT03391882|450597783|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
125264479|NCT03391882|450597784|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
125264480|NCT03391882|450597785|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
125264481|NCT03391882|450597780|FG000|Study Overall|Protocol Violation|1|||
125264482|NCT03391882|450597781|FG001|Study Overall|Protocol Violation|0|||
125264483|NCT03391882|450597782|FG002|Study Overall|Protocol Violation|0|||
125264484|NCT03391882|450597783|FG003|Study Overall|Protocol Violation|0|||
125264485|NCT03391882|450597784|FG004|Study Overall|Protocol Violation|0|||
125264486|NCT03391882|450597785|FG005|Study Overall|Protocol Violation|0|||
125264487|NCT03391882|450597780|FG000|Part A - Titration Phase|Adverse Event|3|||
125264488|NCT03391882|450597781|FG001|Part A - Titration Phase|Adverse Event|6|||
125264489|NCT03391882|450597782|FG002|Part A - Titration Phase|Adverse Event|0|||
125264490|NCT03391882|450597783|FG003|Part A - Titration Phase|Adverse Event|0|||
125264491|NCT03391882|450597784|FG004|Part A - Titration Phase|Adverse Event|0|||
125264492|NCT03391882|450597785|FG005|Part A - Titration Phase|Adverse Event|0|||
125264493|NCT03391882|450597780|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
125264494|NCT03391882|450597781|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
125264495|NCT03391882|450597782|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
125264496|NCT03391882|450597783|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
125264497|NCT03391882|450597784|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
125264498|NCT03391882|450597785|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
125264499|NCT03391882|450597780|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
125264500|NCT03391882|450597781|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
125264501|NCT03391882|450597782|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
125264502|NCT03391882|450597783|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
125264503|NCT03391882|450597784|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
125264504|NCT03391882|450597785|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
125264505|NCT03391882|450597780|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
125264506|NCT03391882|450597781|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
125264507|NCT03391882|450597782|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
125264508|NCT03391882|450597783|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
125264509|NCT03391882|450597784|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
125264510|NCT03391882|450597785|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
125264511|NCT03391882|450597780|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
125264512|NCT03391882|450597781|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
125264513|NCT03391882|450597782|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
125264514|NCT03391882|450597783|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
125264515|NCT03391882|450597784|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
125264516|NCT03391882|450597785|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
125264517|NCT03391882|450597780|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
125264518|NCT03391882|450597781|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
125264519|NCT03391882|450597782|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
125264520|NCT03391882|450597783|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
125264521|NCT03391882|450597784|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
125264522|NCT03391882|450597785|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
125264523|NCT03391882|450597780|FG000|Part B - Treatment Phase|Adverse Event|0|||
125264524|NCT03391882|450597781|FG001|Part B - Treatment Phase|Adverse Event|0|||
125264525|NCT03391882|450597782|FG002|Part B - Treatment Phase|Adverse Event|1|||
125264526|NCT03391882|450597783|FG003|Part B - Treatment Phase|Adverse Event|1|||
125264527|NCT03391882|450597784|FG004|Part B - Treatment Phase|Adverse Event|3|||
125264528|NCT03391882|450597785|FG005|Part B - Treatment Phase|Adverse Event|1|||
125264529|NCT03391882|450597780|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
125264530|NCT03391882|450597781|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
125264531|NCT03391882|450597782|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
125264532|NCT03391882|450597783|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
125264533|NCT03391882|450597784|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
125264534|NCT03391882|450597785|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
125264535|NCT03913130|450597786|FG000|Overall Study|Sponsor Decision|1|||
125264536|NCT01085214|450597789|FG000|Overall Study|Alternate treatment required|1|||
125264537|NCT01634152|450597790|FG000|Overall Study|Adverse Event|2|||
125264538|NCT01634152|450597791|FG001|Overall Study|Adverse Event|0|||
125264539|NCT01634152|450597792|FG002|Overall Study|Adverse Event|2|||
125264540|NCT01634152|450597790|FG000|Overall Study|Consent withdrawn not due to AE|1|||
125264541|NCT01634152|450597791|FG001|Overall Study|Consent withdrawn not due to AE|0|||
125264542|NCT01634152|450597792|FG002|Overall Study|Consent withdrawn not due to AE|1|||
125264543|NCT01634152|450597790|FG000|Overall Study|Not treated|0|||
125264544|NCT01634152|450597791|FG001|Overall Study|Not treated|1|||
125264545|NCT01634152|450597792|FG002|Overall Study|Not treated|0|||
125264546|NCT01634152|450597790|FG000|Overall Study|Other reason not defined above|1|||
125264547|NCT01634152|450597791|FG001|Overall Study|Other reason not defined above|0|||
125264548|NCT01634152|450597792|FG002|Overall Study|Other reason not defined above|1|||
125264549|NCT01152437|450597809|FG000|Overall Study|Other Adverse Event|8|||
125264550|NCT01152437|450597810|FG001|Overall Study|Other Adverse Event|1|||
125264551|NCT01152437|450597811|FG002|Overall Study|Other Adverse Event|7|||
125264552|NCT01152437|450597809|FG000|Overall Study|Not treated|0|||
125264553|NCT01152437|450597810|FG001|Overall Study|Not treated|1|||
125264554|NCT01152437|450597811|FG002|Overall Study|Not treated|2|||
125264555|NCT01152437|450597809|FG000|Overall Study|Progressive disease|27|||
125264556|NCT01152437|450597810|FG001|Overall Study|Progressive disease|13|||
125264557|NCT01152437|450597811|FG002|Overall Study|Progressive disease|32|||
125264558|NCT01152437|450597809|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
125264559|NCT01152437|450597810|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
125264560|NCT01152437|450597811|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
125264561|NCT01985022|450597812|FG000|Overall Study|Lost to Follow-up|0|||
125264562|NCT01985022|450597813|FG001|Overall Study|Lost to Follow-up|1|||
125264563|NCT01985022|450597812|FG000|Overall Study|Protocol Violation|0|||
125264564|NCT01985022|450597813|FG001|Overall Study|Protocol Violation|1|||
125264565|NCT01985022|450597812|FG000|Overall Study|Withdrawal by Subject|4|||
125264566|NCT01985022|450597813|FG001|Overall Study|Withdrawal by Subject|1|||
125264567|NCT00279214|450597814|FG000|Overall Study|Physician Decision|3|||
125264568|NCT00279214|450597815|FG001|Overall Study|Physician Decision|2|||
125264569|NCT01214837|450597816|FG000|Overall Study|Death|0|||
125264570|NCT01214837|450597817|FG001|Overall Study|Death|0|||
125264571|NCT01214837|450597818|FG002|Overall Study|Death|1|||
125264572|NCT01214837|450597816|FG000|Overall Study|Adverse Event|1|||
125264573|NCT01214837|450597817|FG001|Overall Study|Adverse Event|2|||
125264574|NCT01214837|450597818|FG002|Overall Study|Adverse Event|1|||
125264575|NCT01214837|450597816|FG000|Overall Study|Withdrawal by Subject|27|||
125264576|NCT01214837|450597817|FG001|Overall Study|Withdrawal by Subject|36|||
125264577|NCT01214837|450597818|FG002|Overall Study|Withdrawal by Subject|28|||
125264578|NCT01214837|450597816|FG000|Overall Study|Lost to Follow-up|20|||
125264579|NCT01214837|450597817|FG001|Overall Study|Lost to Follow-up|15|||
125264580|NCT01214837|450597818|FG002|Overall Study|Lost to Follow-up|21|||
125264581|NCT01214837|450597816|FG000|Overall Study|Inappropriate Enrolment|0|||
125264582|NCT01214837|450597817|FG001|Overall Study|Inappropriate Enrolment|1|||
125264583|NCT01214837|450597818|FG002|Overall Study|Inappropriate Enrolment|2|||
125264584|NCT01214837|450597816|FG000|Overall Study|Administrative Reason|2|||
125264585|NCT01214837|450597817|FG001|Overall Study|Administrative Reason|6|||
125264586|NCT01214837|450597818|FG002|Overall Study|Administrative Reason|4|||
125264587|NCT01214837|450597816|FG000|Overall Study|Protocol Violation|3|||
125264588|NCT01214837|450597817|FG001|Overall Study|Protocol Violation|1|||
125264589|NCT01214837|450597818|FG002|Overall Study|Protocol Violation|5|||
125264590|NCT01214837|450597816|FG000|Overall Study|Unable to Classify|1|||
125264591|NCT01214837|450597817|FG001|Overall Study|Unable to Classify|3|||
125264592|NCT01214837|450597818|FG002|Overall Study|Unable to Classify|0|||
125264593|NCT00457626|450597819|FG000|Overall Study|Adverse Event|3|||
125264594|NCT00457626|450597819|FG000|Overall Study|Administrative Problems|2|||
125264595|NCT00457626|450597819|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
125264596|NCT03549338|450599887|FG000|Overall Study|Progressive Disease|1|||
125264597|NCT03549338|450599888|FG001|Overall Study|Progressive Disease|0|||
125264598|NCT03549338|450599889|FG002|Overall Study|Progressive Disease|0|||
125264599|NCT03549338|450599887|FG000|Overall Study|Clinical Progression|0|||
125264600|NCT03549338|450599888|FG001|Overall Study|Clinical Progression|1|||
125264601|NCT03549338|450599889|FG002|Overall Study|Clinical Progression|0|||
125264602|NCT00269113|450599890|FG000|Overall Study|Adverse Event|14|||
125264603|NCT00269113|450599891|FG001|Overall Study|Adverse Event|7|||
125264604|NCT00269113|450599890|FG000|Overall Study|Lack of Efficacy|35|||
125264605|NCT00269113|450599891|FG001|Overall Study|Lack of Efficacy|18|||
125264606|NCT00269113|450599890|FG000|Overall Study|Early Improvement|2|||
125264607|NCT00269113|450599891|FG001|Overall Study|Early Improvement|0|||
125264608|NCT00269113|450599890|FG000|Overall Study|Withdrawal by Subject|0|||
125264609|NCT00269113|450599891|FG001|Overall Study|Withdrawal by Subject|2|||
125264610|NCT00269113|450599890|FG000|Overall Study|Death|6|||
125264611|NCT00269113|450599891|FG001|Overall Study|Death|2|||
125264612|NCT00269113|450599890|FG000|Overall Study|Lost to Follow-up|2|||
125264613|NCT00269113|450599891|FG001|Overall Study|Lost to Follow-up|1|||
125264614|NCT00269113|450599890|FG000|Overall Study|Protocol Violation|15|||
125264615|NCT00269113|450599891|FG001|Overall Study|Protocol Violation|5|||
125264616|NCT00269113|450599890|FG000|Overall Study|Other|0|||
125264617|NCT00269113|450599891|FG001|Overall Study|Other|2|||
125264618|NCT00652743|450599892|FG000|Months 12-18|Lost to Follow-up|1|||
125264619|NCT00652743|450599893|FG001|Months 12-18|Lost to Follow-up|2|||
125264620|NCT00652743|450599894|FG002|Months 12-18|Lost to Follow-up|7|||
125264621|NCT00652743|450599892|FG000|Months 24-30|Other|5|||
125264622|NCT00652743|450599893|FG001|Months 24-30|Other|1|||
125264623|NCT00652743|450599894|FG002|Months 24-30|Other|11|||
125264624|NCT00652743|450599892|FG000|Months 36-42|Serious Adverse Events|0|||
125264625|NCT00652743|450599893|FG001|Months 36-42|Serious Adverse Events|1|||
125264626|NCT00652743|450599894|FG002|Months 36-42|Serious Adverse Events|1|||
125264627|NCT00652743|450599892|FG000|Months 36-42|Withdrawal by Subject|1|||
125264628|NCT00652743|450599893|FG001|Months 36-42|Withdrawal by Subject|1|||
125264629|NCT00652743|450599894|FG002|Months 36-42|Withdrawal by Subject|0|||
125264630|NCT00652743|450599892|FG000|Months 36-42|Lost to Follow-up|0|||
125264631|NCT00652743|450599893|FG001|Months 36-42|Lost to Follow-up|1|||
125264632|NCT00652743|450599894|FG002|Months 36-42|Lost to Follow-up|0|||
125264633|NCT00652743|450599892|FG000|Months 36-42|Migrated/moved from study area|1|||
125264634|NCT00652743|450599893|FG001|Months 36-42|Migrated/moved from study area|0|||
125264635|NCT00652743|450599894|FG002|Months 36-42|Migrated/moved from study area|0|||
125264636|NCT00652743|450599892|FG000|Months 36-42|Other|4|||
125264637|NCT00652743|450599893|FG001|Months 36-42|Other|2|||
125264638|NCT00652743|450599894|FG002|Months 36-42|Other|8|||
125264639|NCT00755807|450599897|FG000|Acute Phase|Adverse Event|16|||
125264640|NCT00755807|450599898|FG001|Acute Phase|Adverse Event|5|||
125264641|NCT00755807|450599897|FG000|Acute Phase|Protocol Violation|1|||
125264642|NCT00755807|450599898|FG001|Acute Phase|Protocol Violation|3|||
125264643|NCT00755807|450599897|FG000|Acute Phase|Withdrawal by Subject|1|||
125264644|NCT00755807|450599898|FG001|Acute Phase|Withdrawal by Subject|2|||
125264645|NCT00755807|450599897|FG000|Acute Phase|Lack of Efficacy|0|||
125264646|NCT00755807|450599898|FG001|Acute Phase|Lack of Efficacy|1|||
125264647|NCT00755807|450599897|FG000|Acute Phase|Physician Decision|0|||
125264648|NCT00755807|450599898|FG001|Acute Phase|Physician Decision|1|||
125264649|NCT00755807|450599897|FG000|Open-label Extension Phase|Adverse Event|7|||
125264650|NCT00755807|450599898|FG001|Open-label Extension Phase|Adverse Event|7|||
125264651|NCT00755807|450599897|FG000|Open-label Extension Phase|Protocol Violation|5|||
125264652|NCT00755807|450599898|FG001|Open-label Extension Phase|Protocol Violation|2|||
125264653|NCT00755807|450599897|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
125264654|NCT00755807|450599898|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
125264655|NCT00755807|450599897|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
125264656|NCT00755807|450599898|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
125264657|NCT00755807|450599897|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
125264658|NCT00755807|450599898|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
125264659|NCT00755807|450599897|FG000|Open-label Extension Phase|Sponsor Decision|0|||
125264660|NCT00755807|450599898|FG001|Open-label Extension Phase|Sponsor Decision|1|||
125264661|NCT05111145|450599903|FG000|Overall Study|Commercial drug is available for participant|76|||
125264662|NCT05111145|450599903|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
125264663|NCT02336815|450599904|FG000|Overall Study|Disease Progression|45|||
125264664|NCT02336815|450599905|FG001|Overall Study|Disease Progression|70|||
125264665|NCT02336815|450599904|FG000|Overall Study|Adverse Event|18|||
125264666|NCT02336815|450599905|FG001|Overall Study|Adverse Event|39|||
125264667|NCT02336815|450599904|FG000|Overall Study|Physician Decision|11|||
125264668|NCT02336815|450599905|FG001|Overall Study|Physician Decision|4|||
125264669|NCT02336815|450599904|FG000|Overall Study|Withdrawal by Subject|3|||
125264670|NCT02336815|450599905|FG001|Overall Study|Withdrawal by Subject|2|||
125264671|NCT02336815|450599904|FG000|Overall Study|Lost to Follow-up|1|||
125264672|NCT02336815|450599905|FG001|Overall Study|Lost to Follow-up|3|||
125264673|NCT02336815|450599904|FG000|Overall Study|Other|1|||
125264674|NCT02336815|450599905|FG001|Overall Study|Other|5|||
125264675|NCT00952705|450599906|FG000|Overall Study|Lost to Follow-up|24|||
125264676|NCT00952705|450599907|FG001|Overall Study|Lost to Follow-up|8|||
125264677|NCT00952705|450599908|FG002|Overall Study|Lost to Follow-up|9|||
125264678|NCT00952705|450599906|FG000|Overall Study|Withdrawal by Subject|2|||
125264679|NCT00952705|450599907|FG001|Overall Study|Withdrawal by Subject|1|||
125264680|NCT00952705|450599908|FG002|Overall Study|Withdrawal by Subject|1|||
125264681|NCT00952705|450599906|FG000|Overall Study|Death|2|||
125264682|NCT00952705|450599907|FG001|Overall Study|Death|0|||
125264683|NCT00952705|450599908|FG002|Overall Study|Death|0|||
125264684|NCT00952705|450599906|FG000|Overall Study|Incarcerated post dose|5|||
125264685|NCT00952705|450599907|FG001|Overall Study|Incarcerated post dose|0|||
125264686|NCT00952705|450599908|FG002|Overall Study|Incarcerated post dose|0|||
125264687|NCT00952705|450599906|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
125264688|NCT00952705|450599907|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
125264689|NCT00952705|450599908|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
125264690|NCT03759600|450599910|FG000|Overall Study|Adverse Event|2|||
125264691|NCT03759600|450599910|FG000|Overall Study|Progressive Disease|15|||
125264692|NCT03759600|450599910|FG000|Overall Study|Site Terminated by Sponsor|3|||
125264693|NCT05173974|450599911|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
125264694|NCT05173974|450599912|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
125264695|NCT05173974|450599913|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
125264696|NCT05173974|450599914|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
125264697|NCT05173974|450599911|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
125264698|NCT05173974|450599912|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
125264699|NCT05173974|450599913|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
125264700|NCT05173974|450599914|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
125264701|NCT03289143|450599916|FG000|Overall Study|Caregiver Unavailability|1|||
125264702|NCT03289143|450599917|FG001|Overall Study|Caregiver Unavailability|1|||
125264703|NCT03289143|450599918|FG002|Overall Study|Caregiver Unavailability|0|||
125264704|NCT03289143|450599919|FG003|Overall Study|Caregiver Unavailability|0|||
125264705|NCT03289143|450599916|FG000|Overall Study|Research Department Closure|0|||
125264706|NCT03289143|450599917|FG001|Overall Study|Research Department Closure|0|||
125264707|NCT03289143|450599918|FG002|Overall Study|Research Department Closure|1|||
125264708|NCT03289143|450599919|FG003|Overall Study|Research Department Closure|0|||
125264709|NCT03289143|450599916|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
125264710|NCT03289143|450599917|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
125264711|NCT03289143|450599918|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
125264712|NCT03289143|450599919|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
125264713|NCT03289143|450599916|FG000|Overall Study|Medical Monitor Decision|1|||
125264714|NCT03289143|450599917|FG001|Overall Study|Medical Monitor Decision|0|||
125264715|NCT03289143|450599918|FG002|Overall Study|Medical Monitor Decision|0|||
125264716|NCT03289143|450599919|FG003|Overall Study|Medical Monitor Decision|0|||
125264717|NCT03289143|450599916|FG000|Overall Study|Participant Non-Compliance|0|||
125264718|NCT03289143|450599917|FG001|Overall Study|Participant Non-Compliance|0|||
125264719|NCT03289143|450599918|FG002|Overall Study|Participant Non-Compliance|1|||
125264720|NCT03289143|450599919|FG003|Overall Study|Participant Non-Compliance|0|||
125264721|NCT03289143|450599916|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
125264722|NCT03289143|450599917|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
125264723|NCT03289143|450599918|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
125264724|NCT03289143|450599919|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
125264725|NCT03289143|450599916|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
125264726|NCT03289143|450599917|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
125264727|NCT03289143|450599918|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
125264728|NCT03289143|450599919|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
125264729|NCT03289143|450599916|FG000|Overall Study|Caregiver Passed Away|1|||
125264730|NCT03289143|450599917|FG001|Overall Study|Caregiver Passed Away|0|||
125264731|NCT03289143|450599918|FG002|Overall Study|Caregiver Passed Away|0|||
125264732|NCT03289143|450599919|FG003|Overall Study|Caregiver Passed Away|0|||
125264733|NCT03289143|450599916|FG000|Overall Study|Physician Decision|0|||
125264734|NCT03289143|450599917|FG001|Overall Study|Physician Decision|2|||
125264735|NCT03289143|450599918|FG002|Overall Study|Physician Decision|2|||
125264736|NCT03289143|450599919|FG003|Overall Study|Physician Decision|2|||
125264737|NCT03289143|450599916|FG000|Overall Study|Protocol Deviation|2|||
125264738|NCT03289143|450599917|FG001|Overall Study|Protocol Deviation|1|||
125264739|NCT03289143|450599918|FG002|Overall Study|Protocol Deviation|3|||
125264740|NCT03289143|450599919|FG003|Overall Study|Protocol Deviation|1|||
125264741|NCT03289143|450599916|FG000|Overall Study|Study Terminated By Sponsor|101|||
125264742|NCT03289143|450599917|FG001|Overall Study|Study Terminated By Sponsor|75|||
125264743|NCT03289143|450599918|FG002|Overall Study|Study Terminated By Sponsor|100|||
125264744|NCT03289143|450599919|FG003|Overall Study|Study Terminated By Sponsor|69|||
125264745|NCT03289143|450599916|FG000|Overall Study|Withdrawal by Subject|14|||
125264746|NCT03289143|450599917|FG001|Overall Study|Withdrawal by Subject|6|||
125264747|NCT03289143|450599918|FG002|Overall Study|Withdrawal by Subject|14|||
125264748|NCT03289143|450599919|FG003|Overall Study|Withdrawal by Subject|12|||
125264749|NCT03289143|450599916|FG000|Overall Study|Adverse Event|10|||
125264750|NCT03289143|450599917|FG001|Overall Study|Adverse Event|7|||
125264751|NCT03289143|450599918|FG002|Overall Study|Adverse Event|6|||
125264752|NCT03289143|450599919|FG003|Overall Study|Adverse Event|5|||
125264753|NCT03289143|450599916|FG000|Overall Study|Death|2|||
125264754|NCT03289143|450599917|FG001|Overall Study|Death|0|||
125264755|NCT03289143|450599918|FG002|Overall Study|Death|2|||
125264756|NCT03289143|450599919|FG003|Overall Study|Death|1|||
125264757|NCT03289143|450599916|FG000|Overall Study|Lost to Follow-up|2|||
125264758|NCT03289143|450599917|FG001|Overall Study|Lost to Follow-up|1|||
125264759|NCT03289143|450599918|FG002|Overall Study|Lost to Follow-up|1|||
125264760|NCT03289143|450599919|FG003|Overall Study|Lost to Follow-up|0|||
125264761|NCT03289143|450599916|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
125264762|NCT03289143|450599917|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
125264763|NCT03289143|450599918|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
125264764|NCT03289143|450599919|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
125264765|NCT03289143|450599916|FG000|Overall Study|Withdrawal by Caregiver|0|||
125264766|NCT03289143|450599917|FG001|Overall Study|Withdrawal by Caregiver|1|||
125264767|NCT03289143|450599918|FG002|Overall Study|Withdrawal by Caregiver|0|||
125264768|NCT03289143|450599919|FG003|Overall Study|Withdrawal by Caregiver|0|||
125264769|NCT03289143|450599916|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
125264770|NCT03289143|450599917|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
125264771|NCT03289143|450599918|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
125264772|NCT03289143|450599919|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
125264773|NCT03289143|450599916|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
125264774|NCT03289143|450599917|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
125264775|NCT03289143|450599918|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
125264776|NCT03289143|450599919|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
125264777|NCT03257358|450599920|FG000|Overall Study|Adverse Event|25|||
125264778|NCT03257358|450599921|FG001|Overall Study|Adverse Event|12|||
125264779|NCT03257358|450599920|FG000|Overall Study|Lack of Efficacy|1|||
125264780|NCT03257358|450599921|FG001|Overall Study|Lack of Efficacy|1|||
125264781|NCT03257358|450599920|FG000|Overall Study|Lost to Follow-up|12|||
125264782|NCT03257358|450599921|FG001|Overall Study|Lost to Follow-up|4|||
125264783|NCT03257358|450599920|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
125264784|NCT03257358|450599921|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
125264785|NCT03257358|450599920|FG000|Overall Study|Physician Decision|2|||
125264786|NCT03257358|450599921|FG001|Overall Study|Physician Decision|2|||
125264787|NCT03257358|450599920|FG000|Overall Study|Protocol Violation|5|||
125264788|NCT03257358|450599921|FG001|Overall Study|Protocol Violation|3|||
125264789|NCT03257358|450599920|FG000|Overall Study|Technical problems|4|||
125264790|NCT03257358|450599921|FG001|Overall Study|Technical problems|1|||
125264791|NCT03257358|450599920|FG000|Overall Study|Withdrawal by Subject|8|||
125264792|NCT03257358|450599921|FG001|Overall Study|Withdrawal by Subject|3|||
125264793|NCT03257358|450599920|FG000|Overall Study|Withdrawal of informed consent|9|||
125264794|NCT03257358|450599921|FG001|Overall Study|Withdrawal of informed consent|5|||
125264795|NCT03257358|450599920|FG000|Overall Study|New therapy for study indication|1|||
125264796|NCT03257358|450599921|FG001|Overall Study|New therapy for study indication|0|||
125264797|NCT03257358|450599920|FG000|Overall Study|No longer requires treatment|0|||
125264798|NCT03257358|450599921|FG001|Overall Study|No longer requires treatment|1|||
125264799|NCT00730756|450599922|FG000|Overall Study|Adverse Event|2|||
125264800|NCT00730756|450599923|FG001|Overall Study|Adverse Event|0|||
125264801|NCT00730756|450599922|FG000|Overall Study|Lack of Efficacy|1|||
125264802|NCT00730756|450599923|FG001|Overall Study|Lack of Efficacy|1|||
125264803|NCT00730756|450599922|FG000|Overall Study|Protocol Deviation|1|||
125264804|NCT00730756|450599923|FG001|Overall Study|Protocol Deviation|2|||
125264805|NCT00730756|450599922|FG000|Overall Study|Lost to Follow-up|0|||
125264806|NCT00730756|450599923|FG001|Overall Study|Lost to Follow-up|1|||
125264807|NCT00730756|450599922|FG000|Overall Study|Withdrew Consent|0|||
125264808|NCT00730756|450599923|FG001|Overall Study|Withdrew Consent|1|||
125264809|NCT00305877|450599924|FG000|Overall Study|Lack of Efficacy|6|||
125264810|NCT00305877|450599925|FG001|Overall Study|Lack of Efficacy|9|||
125264811|NCT00305877|450599924|FG000|Overall Study|Adverse Event|9|||
125264812|NCT00305877|450599925|FG001|Overall Study|Adverse Event|14|||
125264813|NCT00305877|450599924|FG000|Overall Study|Death|0|||
125264814|NCT00305877|450599925|FG001|Overall Study|Death|1|||
125264815|NCT00305877|450599924|FG000|Overall Study|Withdrawal by Subject|4|||
125264816|NCT00305877|450599925|FG001|Overall Study|Withdrawal by Subject|2|||
125264817|NCT00305877|450599924|FG000|Overall Study|Physician Decision|1|||
125264818|NCT00305877|450599925|FG001|Overall Study|Physician Decision|1|||
125264819|NCT00305877|450599924|FG000|Overall Study|Never start treatment|2|||
125264820|NCT00305877|450599925|FG001|Overall Study|Never start treatment|5|||
125264821|NCT00305877|450599924|FG000|Overall Study|Ineligible|2|||
125264822|NCT00305877|450599925|FG001|Overall Study|Ineligible|1|||
125264823|NCT00305877|450599924|FG000|Overall Study|Transportation issue with daily RT|0|||
125264824|NCT00305877|450599925|FG001|Overall Study|Transportation issue with daily RT|1|||
125264825|NCT01126190|450599928|FG000|Double-Blind Phase|Death|0|||
125264826|NCT01126190|450599929|FG001|Double-Blind Phase|Death|1|||
125264827|NCT01126190|450599930|FG002|Double-Blind Phase|Death|0|||
125264828|NCT01126190|450599928|FG000|Double-Blind Phase|Adverse Event|1|||
125264829|NCT01126190|450599929|FG001|Double-Blind Phase|Adverse Event|2|||
125264830|NCT01126190|450599930|FG002|Double-Blind Phase|Adverse Event|0|||
125264831|NCT01126190|450599928|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
125264832|NCT01126190|450599929|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
125264833|NCT01126190|450599930|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
125264834|NCT01126190|450599928|FG000|Double-Blind Phase|Request of Investigator|1|||
125264835|NCT01126190|450599929|FG001|Double-Blind Phase|Request of Investigator|0|||
125264836|NCT01126190|450599930|FG002|Double-Blind Phase|Request of Investigator|0|||
125264837|NCT01126190|450599928|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
125264838|NCT01126190|450599929|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
125264839|NCT01126190|450599930|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
125264840|NCT01126190|450599928|FG000|Double-Blind Phase|Non-compliance|1|||
125264841|NCT01126190|450599929|FG001|Double-Blind Phase|Non-compliance|0|||
125264842|NCT01126190|450599930|FG002|Double-Blind Phase|Non-compliance|0|||
125264843|NCT01126190|450599928|FG000|Double-Blind Phase|Lost to Follow-up|1|||
125264844|NCT01126190|450599929|FG001|Double-Blind Phase|Lost to Follow-up|3|||
125264845|NCT01126190|450599930|FG002|Double-Blind Phase|Lost to Follow-up|0|||
125264846|NCT01126190|450599928|FG000|Open-Label Phase|Death|0|||
125264847|NCT01126190|450599929|FG001|Open-Label Phase|Death|0|||
125264848|NCT01126190|450599930|FG002|Open-Label Phase|Death|1|||
125264849|NCT01126190|450599928|FG000|Open-Label Phase|Adverse Event|0|||
125264850|NCT01126190|450599929|FG001|Open-Label Phase|Adverse Event|0|||
125264851|NCT01126190|450599930|FG002|Open-Label Phase|Adverse Event|4|||
125264852|NCT01126190|450599928|FG000|Open-Label Phase|Withdrawal by Subject|0|||
125264853|NCT01126190|450599929|FG001|Open-Label Phase|Withdrawal by Subject|0|||
125264854|NCT01126190|450599930|FG002|Open-Label Phase|Withdrawal by Subject|6|||
125264855|NCT00524121|450599931|FG000|Overall Study|Disease progression|6|||
125264856|NCT00524121|450599931|FG000|Overall Study|Adverse Event|4|||
125264857|NCT00524121|450599931|FG000|Overall Study|Patient refused|2|||
125264858|NCT00524121|450599931|FG000|Overall Study|Other|1|||
125264859|NCT00524121|450599931|FG000|Overall Study|Death|1|||
125264860|NCT00524121|450599931|FG000|Overall Study|Not treated (became ineligible)|4|||
125264861|NCT00524121|450599931|FG000|Overall Study|Not treated (changed mind)|1|||
125264862|NCT01114737|450599932|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
125264863|NCT01114737|450599933|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
125264864|NCT01114737|450599932|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
125264865|NCT01114737|450599933|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
125264866|NCT01114737|450599932|FG000|Randomized Treatment Period|Pregnancy|1|||
125264867|NCT01114737|450599933|FG001|Randomized Treatment Period|Pregnancy|0|||
125264868|NCT01114737|450599932|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
125264869|NCT01114737|450599933|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
125264870|NCT01114737|450599932|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
125264871|NCT01114737|450599933|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
125264872|NCT01114737|450599932|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
125264873|NCT01114737|450599933|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
125264874|NCT01446874|450599934|FG000|Overall Study|Not eligible|1|||
125264875|NCT01446874|450599935|FG001|Overall Study|Not eligible|0|||
125264876|NCT01446874|450599936|FG002|Overall Study|Not eligible|0|||
125264877|NCT01446874|450599934|FG000|Overall Study|No surgery/No qualifying surgery|1|||
125264878|NCT01446874|450599935|FG001|Overall Study|No surgery/No qualifying surgery|0|||
125264879|NCT01446874|450599936|FG002|Overall Study|No surgery/No qualifying surgery|12|||
125264880|NCT01446874|450599934|FG000|Overall Study|Non-compliance|0|||
125264881|NCT01446874|450599935|FG001|Overall Study|Non-compliance|4|||
125264882|NCT01446874|450599936|FG002|Overall Study|Non-compliance|0|||
125264883|NCT01446874|450599934|FG000|Overall Study|Antibiotics for pre-op infection|0|||
125264884|NCT01446874|450599935|FG001|Overall Study|Antibiotics for pre-op infection|0|||
125264885|NCT01446874|450599936|FG002|Overall Study|Antibiotics for pre-op infection|2|||
125264886|NCT01446874|450599934|FG000|Overall Study|Withdrawal by Subject|0|||
125264887|NCT01446874|450599935|FG001|Overall Study|Withdrawal by Subject|0|||
125264888|NCT01446874|450599936|FG002|Overall Study|Withdrawal by Subject|4|||
125264889|NCT00457392|450599937|FG000|Overall Study|Objective Progression or Relapse|229|||
125264890|NCT00457392|450599938|FG001|Overall Study|Objective Progression or Relapse|296|||
125264891|NCT00457392|450599937|FG000|Overall Study|Death|106|||
125264892|NCT00457392|450599938|FG001|Overall Study|Death|106|||
125264893|NCT00457392|450599937|FG000|Overall Study|Adverse Event|84|||
125264894|NCT00457392|450599938|FG001|Overall Study|Adverse Event|41|||
125264895|NCT00457392|450599937|FG000|Overall Study|Global Deterioration of Health Status|22|||
125264896|NCT00457392|450599938|FG001|Overall Study|Global Deterioration of Health Status|8|||
125264897|NCT00457392|450599937|FG000|Overall Study|Withdrawal by Subject|14|||
125264898|NCT00457392|450599938|FG001|Overall Study|Withdrawal by Subject|8|||
125264899|NCT00457392|450599937|FG000|Overall Study|Lost to Follow-up|6|||
125264900|NCT00457392|450599938|FG001|Overall Study|Lost to Follow-up|7|||
125264901|NCT00457392|450599937|FG000|Overall Study|Protocol Violation|4|||
125264902|NCT00457392|450599938|FG001|Overall Study|Protocol Violation|3|||
125264903|NCT00457392|450599937|FG000|Overall Study|Other|7|||
125264904|NCT00457392|450599938|FG001|Overall Study|Other|4|||
125264905|NCT00457392|450599937|FG000|Overall Study|Study Terminated by Sponsor|1|||
125264906|NCT00457392|450599938|FG001|Overall Study|Study Terminated by Sponsor|4|||
125264907|NCT00457392|450599937|FG000|Overall Study|Randomized, Not Treated|7|||
125264908|NCT00457392|450599938|FG001|Overall Study|Randomized, Not Treated|3|||
125264909|NCT01135992|450599939|FG000|Overall Study|Adverse Event|1|||
125264910|NCT01135992|450599939|FG000|Overall Study|Lack of Efficacy|1|||
125264911|NCT01135992|450599939|FG000|Overall Study|Protocol Violation|2|||
125264912|NCT01135992|450599939|FG000|Overall Study|Withdrawal criteria|10|||
125264913|NCT01135992|450599939|FG000|Overall Study|Unclassified|7|||
125264914|NCT01977898|450599940|FG000|Overall Study|Non functioning catheter|1|||
125264915|NCT01977898|450599941|FG001|Overall Study|Non functioning catheter|1|||
125264916|NCT01466491|450599943|FG000|Overall Study|Protocol Violation|0|||
125264917|NCT01466491|450599944|FG001|Overall Study|Protocol Violation|3|||
125264918|NCT01466491|450599945|FG002|Overall Study|Protocol Violation|2|||
125264919|NCT01466491|450599946|FG003|Overall Study|Protocol Violation|0|||
125264920|NCT01466491|450599943|FG000|Overall Study|Missing Data|0|||
125264921|NCT01466491|450599944|FG001|Overall Study|Missing Data|0|||
125264922|NCT01466491|450599945|FG002|Overall Study|Missing Data|1|||
125264923|NCT01466491|450599946|FG003|Overall Study|Missing Data|0|||
125264924|NCT02727322|450599947|FG000|Overall Study|Withdrawal by Subject|1|||
125264925|NCT02727322|450599948|FG001|Overall Study|Withdrawal by Subject|1|||
125264926|NCT02727322|450599947|FG000|Overall Study|Protocol Violation|1|||
125264927|NCT02727322|450599948|FG001|Overall Study|Protocol Violation|0|||
125264928|NCT01123148|450599955|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
125264929|NCT01123148|450599955|FG000|Overall Study|Didn't meet milestone criteria|1|||
125264930|NCT00355030|450599956|FG000|Study Period 1 Treatment|Adverse Event|1|||
125264931|NCT00355030|450599957|FG001|Study Period 1 Treatment|Adverse Event|1|||
125264932|NCT00355030|450599956|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
125264933|NCT00355030|450599957|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
125264934|NCT00355030|450599956|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
125264935|NCT00355030|450599957|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
125264936|NCT00355030|450599956|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
125264937|NCT00355030|450599957|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
125264938|NCT00355030|450599956|FG000|Study Period 1 Treatment|Physician Decision|0|||
125264939|NCT00355030|450599957|FG001|Study Period 1 Treatment|Physician Decision|1|||
125264940|NCT00355030|450599956|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
125264941|NCT00355030|450599957|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
125264942|NCT00355030|450599956|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
125264943|NCT00355030|450599957|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
125264944|NCT00355030|450599956|FG000|Study Period 1 Treatment|Other|2|||
125264945|NCT00355030|450599957|FG001|Study Period 1 Treatment|Other|6|||
125264946|NCT00355030|450599956|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
125264947|NCT00355030|450599957|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
125264948|NCT00355030|450599956|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
125264949|NCT00355030|450599957|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
125264950|NCT01049373|450599958|FG000|Overall Study|Protocol Violation|9|||
125264951|NCT01049373|450599959|FG001|Overall Study|Protocol Violation|9|||
125264952|NCT01049373|450599958|FG000|Overall Study|Withdrawal by Subject|8|||
125264953|NCT01049373|450599959|FG001|Overall Study|Withdrawal by Subject|5|||
125264954|NCT01049373|450599958|FG000|Overall Study|Adverse Event|3|||
125264955|NCT01049373|450599959|FG001|Overall Study|Adverse Event|3|||
125264956|NCT01049373|450599958|FG000|Overall Study|Lost to Follow-up|9|||
125264957|NCT01049373|450599959|FG001|Overall Study|Lost to Follow-up|4|||
125264958|NCT01049373|450599958|FG000|Overall Study|no evaluable study values|9|||
125264959|NCT01049373|450599959|FG001|Overall Study|no evaluable study values|21|||
125264960|NCT01049373|450599958|FG000|Overall Study|Other|1|||
125264961|NCT01049373|450599959|FG001|Overall Study|Other|1|||
125264962|NCT01049373|450599958|FG000|Overall Study|Non-cooperation|0|||
125264963|NCT01049373|450599959|FG001|Overall Study|Non-cooperation|1|||
125264964|NCT00339040|450599960|FG000|Stage I|Not able to attend clinic|1|||
125264965|NCT00339040|450599961|FG001|Stage I|Not able to attend clinic|0|||
125264966|NCT00339040|450599960|FG000|Stage I|Protocol Violation|1|||
125264967|NCT00339040|450599961|FG001|Stage I|Protocol Violation|1|||
125264968|NCT00339040|450599960|FG000|Stage II|Lost to Follow-up|3|||
125264969|NCT00339040|450599961|FG001|Stage II|Lost to Follow-up|0|||
125264970|NCT00339040|450599960|FG000|Stage II|Withdrawal by Subject|1|||
125264971|NCT00339040|450599961|FG001|Stage II|Withdrawal by Subject|2|||
125264972|NCT00339040|450599960|FG000|Stage II|Protocol Violation|3|||
125264973|NCT00339040|450599961|FG001|Stage II|Protocol Violation|0|||
125264974|NCT00339040|450599960|FG000|Stage II|Not able to attend clinic|1|||
125264975|NCT00339040|450599961|FG001|Stage II|Not able to attend clinic|0|||
125264976|NCT00339040|450599960|FG000|Stage II|Site closing|2|||
125264977|NCT00339040|450599961|FG001|Stage II|Site closing|0|||
125264978|NCT00812955|450599966|FG000|Overall Study|Adverse Event|7|||
125264979|NCT00812955|450599967|FG001|Overall Study|Adverse Event|6|||
125264980|NCT00812955|450599968|FG002|Overall Study|Adverse Event|3|||
125264981|NCT00812955|450599969|FG003|Overall Study|Adverse Event|4|||
125264982|NCT00812955|450599966|FG000|Overall Study|Lost to Follow-up|2|||
125264983|NCT00812955|450599967|FG001|Overall Study|Lost to Follow-up|1|||
125264984|NCT00812955|450599968|FG002|Overall Study|Lost to Follow-up|1|||
125264985|NCT00812955|450599969|FG003|Overall Study|Lost to Follow-up|2|||
125264986|NCT00812955|450599966|FG000|Overall Study|Withdrawal by Subject|1|||
125264987|NCT00812955|450599967|FG001|Overall Study|Withdrawal by Subject|0|||
125264988|NCT00812955|450599968|FG002|Overall Study|Withdrawal by Subject|1|||
125264989|NCT00812955|450599969|FG003|Overall Study|Withdrawal by Subject|2|||
125264990|NCT00812955|450599966|FG000|Overall Study|randomized in error|0|||
125264991|NCT00812955|450599967|FG001|Overall Study|randomized in error|0|||
125264992|NCT00812955|450599968|FG002|Overall Study|randomized in error|1|||
125264993|NCT00812955|450599969|FG003|Overall Study|randomized in error|0|||
125264994|NCT02391311|450599970|FG000|Overall Study|Lost to Follow-up|2|||
125264995|NCT02391311|450599971|FG001|Overall Study|Lost to Follow-up|1|||
125264996|NCT02391311|450599970|FG000|Overall Study|deemed ineligible after baseline|1|||
125264997|NCT02391311|450599971|FG001|Overall Study|deemed ineligible after baseline|1|||
125264998|NCT01815424|450599974|FG000|Week 0 to 16|Adverse Event|1|||
125264999|NCT01815424|450599975|FG001|Week 0 to 16|Adverse Event|3|||
125265000|NCT01815424|450599976|FG002|Week 0 to 16|Adverse Event|3|||
125265001|NCT01815424|450599977|FG003|Week 0 to 16|Adverse Event|0|||
125265002|NCT01815424|450599978|FG004|Week 0 to 16|Adverse Event|0|||
125265003|NCT01815424|450599974|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
125265004|NCT01815424|450599975|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
125265005|NCT01815424|450599976|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
125265006|NCT01815424|450599977|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
125265007|NCT01815424|450599978|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
125265008|NCT01815424|450599974|FG000|Week 0 to 16|Lost to Follow-up|0|||
125265009|NCT01815424|450599975|FG001|Week 0 to 16|Lost to Follow-up|1|||
125265010|NCT01815424|450599976|FG002|Week 0 to 16|Lost to Follow-up|0|||
125265011|NCT01815424|450599977|FG003|Week 0 to 16|Lost to Follow-up|0|||
125265012|NCT01815424|450599978|FG004|Week 0 to 16|Lost to Follow-up|0|||
125265013|NCT01815424|450599974|FG000|Week 0 to 16|Withdrawal by Subject|0|||
125265014|NCT01815424|450599975|FG001|Week 0 to 16|Withdrawal by Subject|0|||
125265015|NCT01815424|450599976|FG002|Week 0 to 16|Withdrawal by Subject|1|||
125265016|NCT01815424|450599977|FG003|Week 0 to 16|Withdrawal by Subject|0|||
125265017|NCT01815424|450599978|FG004|Week 0 to 16|Withdrawal by Subject|0|||
125265018|NCT01815424|450599974|FG000|Week 0 to 16|Other|1|||
125265019|NCT01815424|450599975|FG001|Week 0 to 16|Other|0|||
125265020|NCT01815424|450599976|FG002|Week 0 to 16|Other|3|||
125265021|NCT01815424|450599977|FG003|Week 0 to 16|Other|0|||
125265022|NCT01815424|450599978|FG004|Week 0 to 16|Other|0|||
125265023|NCT01815424|450599974|FG000|Week 0 to 16|Protocol Violation|1|||
125265024|NCT01815424|450599975|FG001|Week 0 to 16|Protocol Violation|0|||
125265025|NCT01815424|450599976|FG002|Week 0 to 16|Protocol Violation|0|||
125265026|NCT01815424|450599977|FG003|Week 0 to 16|Protocol Violation|0|||
125265027|NCT01815424|450599978|FG004|Week 0 to 16|Protocol Violation|0|||
125265028|NCT01815424|450599974|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
125265029|NCT01815424|450599975|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
125265030|NCT01815424|450599976|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
125265031|NCT01815424|450599977|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
125265032|NCT01815424|450599978|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
125265033|NCT01815424|450599974|FG000|Week 16 to 52|Other|0|||
125265034|NCT01815424|450599975|FG001|Week 16 to 52|Other|1|||
125265035|NCT01815424|450599976|FG002|Week 16 to 52|Other|0|||
125265036|NCT01815424|450599977|FG003|Week 16 to 52|Other|0|||
125265037|NCT01815424|450599978|FG004|Week 16 to 52|Other|0|||
125265038|NCT01815424|450599974|FG000|Week 16 to 52|Adverse Event|0|||
125265039|NCT01815424|450599975|FG001|Week 16 to 52|Adverse Event|0|||
125265040|NCT01815424|450599976|FG002|Week 16 to 52|Adverse Event|0|||
125265041|NCT01815424|450599977|FG003|Week 16 to 52|Adverse Event|0|||
125265042|NCT01815424|450599978|FG004|Week 16 to 52|Adverse Event|1|||
125265043|NCT01815424|450599974|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
125265044|NCT01815424|450599975|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
125265045|NCT01815424|450599976|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
125265046|NCT01815424|450599977|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
125265047|NCT01815424|450599978|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
125265048|NCT01815424|450599974|FG000|Week 16 to 52|Lost to Follow-up|0|||
125265049|NCT01815424|450599975|FG001|Week 16 to 52|Lost to Follow-up|2|||
125265050|NCT01815424|450599976|FG002|Week 16 to 52|Lost to Follow-up|0|||
125265051|NCT01815424|450599977|FG003|Week 16 to 52|Lost to Follow-up|2|||
125265052|NCT01815424|450599978|FG004|Week 16 to 52|Lost to Follow-up|1|||
125265053|NCT01815424|450599974|FG000|Week 16 to 52|Withdrawal by Subject|1|||
125265054|NCT01815424|450599975|FG001|Week 16 to 52|Withdrawal by Subject|2|||
125265055|NCT01815424|450599976|FG002|Week 16 to 52|Withdrawal by Subject|0|||
125265056|NCT01815424|450599977|FG003|Week 16 to 52|Withdrawal by Subject|0|||
125265057|NCT01815424|450599978|FG004|Week 16 to 52|Withdrawal by Subject|0|||
125265058|NCT01309204|450599979|FG000|Overall Study|Adverse Event|48|||
125265059|NCT01309204|450599980|FG001|Overall Study|Adverse Event|58|||
125265060|NCT01309204|450599979|FG000|Overall Study|Lost to Follow-up|2|||
125265061|NCT01309204|450599980|FG001|Overall Study|Lost to Follow-up|2|||
125265062|NCT01309204|450599979|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
125265063|NCT01309204|450599980|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
125265064|NCT01309204|450599979|FG000|Overall Study|Inadequate control of IOP|4|||
125265065|NCT01309204|450599980|FG001|Overall Study|Inadequate control of IOP|4|||
125265066|NCT01309204|450599979|FG000|Overall Study|Other|4|||
125265067|NCT01309204|450599980|FG001|Overall Study|Other|1|||
125265068|NCT03046446|450599981|FG000|Overall Study|Lack of Efficacy|7|||
125265069|NCT03046446|450599981|FG000|Overall Study|Adverse Event|6|||
125265070|NCT03046446|450599981|FG000|Overall Study|Lost to Follow-up|3|||
125265071|NCT03046446|450599981|FG000|Overall Study|Withdrawal by Subject|14|||
125265072|NCT03046446|450599981|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
125265073|NCT03046446|450599981|FG000|Overall Study|Disease Progression (see caveats)|25|||
125265074|NCT03046446|450599981|FG000|Overall Study|Non OA related knee surgery|1|||
125265075|NCT00925002|450599982|FG000|Overall Study|Other|1|||
125265076|NCT00925002|450599983|FG001|Overall Study|Other|4|||
125265077|NCT00925002|450599984|FG002|Overall Study|Other|0|||
125265078|NCT00925002|450599982|FG000|Overall Study|Death|1|||
125265079|NCT00925002|450599983|FG001|Overall Study|Death|1|||
125265080|NCT00925002|450599984|FG002|Overall Study|Death|5|||
125265081|NCT00925002|450599982|FG000|Overall Study|Adverse Event|3|||
125265082|NCT00925002|450599983|FG001|Overall Study|Adverse Event|1|||
125265083|NCT00925002|450599984|FG002|Overall Study|Adverse Event|2|||
125265084|NCT00925002|450599982|FG000|Overall Study|Participant withdrew consent|1|||
125265085|NCT00925002|450599983|FG001|Overall Study|Participant withdrew consent|3|||
125265086|NCT00925002|450599984|FG002|Overall Study|Participant withdrew consent|3|||
125265087|NCT02808897|450599985|FG000|Overall Study|Lost to Follow-up|9|||
125265088|NCT02808897|450599986|FG001|Overall Study|Lost to Follow-up|11|||
125265089|NCT01496287|450599987|FG000|Overall Study|Lost to Follow-up|1|||
125265090|NCT01496287|450599987|FG000|Overall Study|Incomplete anesthesia|5|||
125265091|NCT00305448|450599988|FG000|Overall Study|Protocol Violation|0|||
125265092|NCT00305448|450599989|FG001|Overall Study|Protocol Violation|1|||
125265093|NCT00305448|450599990|FG002|Overall Study|Protocol Violation|0|||
125265094|NCT00305448|450599988|FG000|Overall Study|Withdrawal by Subject|2|||
125265095|NCT00305448|450599989|FG001|Overall Study|Withdrawal by Subject|0|||
125265096|NCT00305448|450599990|FG002|Overall Study|Withdrawal by Subject|1|||
125265097|NCT00305448|450599988|FG000|Overall Study|Adverse Event|1|||
125265098|NCT00305448|450599989|FG001|Overall Study|Adverse Event|0|||
125265099|NCT00305448|450599990|FG002|Overall Study|Adverse Event|1|||
125265100|NCT00305448|450599988|FG000|Overall Study|Disease Progression|27|||
125265101|NCT00305448|450599989|FG001|Overall Study|Disease Progression|31|||
125265102|NCT00305448|450599990|FG002|Overall Study|Disease Progression|28|||
125265103|NCT00305448|450599988|FG000|Overall Study|Subjective Disease Progression|1|||
125265104|NCT00305448|450599989|FG001|Overall Study|Subjective Disease Progression|2|||
125265105|NCT00305448|450599990|FG002|Overall Study|Subjective Disease Progression|2|||
125265106|NCT00305448|450599988|FG000|Overall Study|Tumor Marker Elevation|0|||
125265107|NCT00305448|450599989|FG001|Overall Study|Tumor Marker Elevation|0|||
125265108|NCT00305448|450599990|FG002|Overall Study|Tumor Marker Elevation|1|||
125265109|NCT00328172|450599991|FG000|Overall Study|Adverse Event|3|||
125265110|NCT00328172|450599992|FG001|Overall Study|Adverse Event|2|||
125265111|NCT00328172|450599993|FG002|Overall Study|Adverse Event|1|||
125265112|NCT00328172|450599994|FG003|Overall Study|Adverse Event|2|||
125265113|NCT00328172|450599995|FG004|Overall Study|Adverse Event|1|||
125265114|NCT00328172|450599991|FG000|Overall Study|Protocol Violation|0|||
125265115|NCT00328172|450599992|FG001|Overall Study|Protocol Violation|1|||
125265116|NCT00328172|450599993|FG002|Overall Study|Protocol Violation|1|||
125265117|NCT00328172|450599994|FG003|Overall Study|Protocol Violation|0|||
125265118|NCT00328172|450599995|FG004|Overall Study|Protocol Violation|0|||
125265119|NCT00328172|450599991|FG000|Overall Study|Lost to Follow-up|1|||
125265120|NCT00328172|450599992|FG001|Overall Study|Lost to Follow-up|1|||
125265121|NCT00328172|450599993|FG002|Overall Study|Lost to Follow-up|2|||
125265122|NCT00328172|450599994|FG003|Overall Study|Lost to Follow-up|1|||
125265123|NCT00328172|450599995|FG004|Overall Study|Lost to Follow-up|1|||
125265124|NCT00328172|450599991|FG000|Overall Study|Withdrawal by Subject|1|||
125265125|NCT00328172|450599992|FG001|Overall Study|Withdrawal by Subject|1|||
125265126|NCT00328172|450599993|FG002|Overall Study|Withdrawal by Subject|1|||
125265127|NCT00328172|450599994|FG003|Overall Study|Withdrawal by Subject|6|||
125265128|NCT00328172|450599995|FG004|Overall Study|Withdrawal by Subject|0|||
125265129|NCT00328172|450599991|FG000|Overall Study|Lack of Efficacy|14|||
125265130|NCT00328172|450599992|FG001|Overall Study|Lack of Efficacy|9|||
125265131|NCT00328172|450599993|FG002|Overall Study|Lack of Efficacy|4|||
125265132|NCT00328172|450599994|FG003|Overall Study|Lack of Efficacy|4|||
125265133|NCT00328172|450599995|FG004|Overall Study|Lack of Efficacy|3|||
125265134|NCT00328172|450599991|FG000|Overall Study|Other reason (not specified)|3|||
125265135|NCT00328172|450599992|FG001|Overall Study|Other reason (not specified)|0|||
125265136|NCT00328172|450599993|FG002|Overall Study|Other reason (not specified)|1|||
125265137|NCT00328172|450599994|FG003|Overall Study|Other reason (not specified)|0|||
125265138|NCT00328172|450599995|FG004|Overall Study|Other reason (not specified)|0|||
125265139|NCT00558636|450600000|FG000|Treatment|Adverse Event|9|||
125265140|NCT00558636|450600001|FG001|Treatment|Adverse Event|2|||
125265141|NCT00558636|450600000|FG000|Treatment|Withdrawal by Subject|2|||
125265142|NCT00558636|450600001|FG001|Treatment|Withdrawal by Subject|0|||
125265143|NCT00558636|450600000|FG000|Treatment|Premature termination of the study|35|||
125265144|NCT00558636|450600001|FG001|Treatment|Premature termination of the study|37|||
125265145|NCT00558636|450600000|FG000|Treatment|Disease progression|1|||
125265146|NCT00558636|450600001|FG001|Treatment|Disease progression|5|||
125265147|NCT00558636|450600000|FG000|Follow-up|Premature termination of the study|12|||
125265148|NCT00558636|450600001|FG001|Follow-up|Premature termination of the study|7|||
125265149|NCT01990742|450600002|FG000|Overall Study|Withdrawal by facility|407|||
125265150|NCT01990742|450600003|FG001|Overall Study|Withdrawal by facility|1083|||
125265151|NCT01990742|450600002|FG000|Overall Study|Facility closed|0|||
125265152|NCT01990742|450600003|FG001|Overall Study|Facility closed|270|||
125265153|NCT03443687|450600004|FG000|Overall Study|Lost to Follow-up|3|||
125265154|NCT03443687|450600005|FG001|Overall Study|Lost to Follow-up|5|||
125265155|NCT03443687|450600004|FG000|Overall Study|Withdrawal by Subject|1|||
125265156|NCT03443687|450600005|FG001|Overall Study|Withdrawal by Subject|0|||
125265157|NCT03443687|450600004|FG000|Overall Study|Discontinued intervention|1|||
125265158|NCT03443687|450600005|FG001|Overall Study|Discontinued intervention|1|||
125265159|NCT04108273|450600006|FG000|Overall Study|COVID Pandemic|1|||
125265160|NCT04108273|450600007|FG001|Overall Study|COVID Pandemic|0|||
125265161|NCT02897115|450600011|FG000|Overall Study|Early termination of study by sponsor|11|||
125265162|NCT02897115|450600012|FG001|Overall Study|Early termination of study by sponsor|8|||
125265163|NCT00487981|450600013|FG000|Overall Study|Hypothyroidism diagnosis|1|||
125265164|NCT02808429|450600018|FG000|Overall Study|Lost to Follow-up|1|||
125265165|NCT02808429|450600019|FG001|Overall Study|Lost to Follow-up|0|||
125265166|NCT02808429|450600020|FG002|Overall Study|Lost to Follow-up|0|||
125265167|NCT02808429|450600018|FG000|Overall Study|Protocol Violation|0|||
125265168|NCT02808429|450600019|FG001|Overall Study|Protocol Violation|1|||
125265169|NCT02808429|450600020|FG002|Overall Study|Protocol Violation|0|||
125265170|NCT02808429|450600018|FG000|Overall Study|Premature study termination by sponsor|2|||
125265171|NCT02808429|450600019|FG001|Overall Study|Premature study termination by sponsor|0|||
125265172|NCT02808429|450600020|FG002|Overall Study|Premature study termination by sponsor|1|||
125265173|NCT02808429|450600018|FG000|Overall Study|Relocation|0|||
125265174|NCT02808429|450600019|FG001|Overall Study|Relocation|0|||
125265175|NCT02808429|450600020|FG002|Overall Study|Relocation|1|||
125265176|NCT00698828|450600024|FG000|Overall Study|Adverse Event|3|||
125265177|NCT00698828|450600025|FG001|Overall Study|Adverse Event|4|||
125265178|NCT00698828|450600026|FG002|Overall Study|Adverse Event|4|||
125265179|NCT00698828|450600024|FG000|Overall Study|Death|0|||
125265180|NCT00698828|450600025|FG001|Overall Study|Death|0|||
125265181|NCT00698828|450600026|FG002|Overall Study|Death|1|||
125265182|NCT00698828|450600024|FG000|Overall Study|Exacerbation of COPD|1|||
125265183|NCT00698828|450600025|FG001|Overall Study|Exacerbation of COPD|3|||
125265184|NCT00698828|450600026|FG002|Overall Study|Exacerbation of COPD|0|||
125265185|NCT00698828|450600024|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
125265186|NCT00698828|450600025|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
125265187|NCT00698828|450600026|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
125265188|NCT00698828|450600024|FG000|Overall Study|Investigator/Sponsor decision|1|||
125265189|NCT00698828|450600025|FG001|Overall Study|Investigator/Sponsor decision|0|||
125265190|NCT00698828|450600026|FG002|Overall Study|Investigator/Sponsor decision|2|||
125265191|NCT00698828|450600024|FG000|Overall Study|Lost to Follow-up|1|||
125265192|NCT00698828|450600025|FG001|Overall Study|Lost to Follow-up|1|||
125265193|NCT00698828|450600026|FG002|Overall Study|Lost to Follow-up|0|||
125265194|NCT00698828|450600024|FG000|Overall Study|Withdrew consent|0|||
125265195|NCT00698828|450600025|FG001|Overall Study|Withdrew consent|7|||
125265196|NCT00698828|450600026|FG002|Overall Study|Withdrew consent|4|||
125265197|NCT00698828|450600024|FG000|Overall Study|Withdrew consent (not treated)|2|||
125265198|NCT00698828|450600025|FG001|Overall Study|Withdrew consent (not treated)|0|||
125265199|NCT00698828|450600026|FG002|Overall Study|Withdrew consent (not treated)|0|||
125265200|NCT02013609|450600027|FG000|Overall Study|Withdrawal by Subject|9|||
125265201|NCT02013609|450600027|FG000|Overall Study|Lost to Follow-up|3|||
125265202|NCT02013609|450600027|FG000|Overall Study|Adverse Event|3|||
125265203|NCT02013609|450600027|FG000|Overall Study|Met Withdrawal Criteria|3|||
125265204|NCT00856609|450600028|FG000|Overall Study|Adverse Event|1|||
125265205|NCT00856609|450600029|FG001|Overall Study|Adverse Event|0|||
125265206|NCT00783432|450600030|FG000|Overall Study|Adverse Event|22|||
125265207|NCT00783432|450600031|FG001|Overall Study|Adverse Event|17|||
125265208|NCT00783432|450600030|FG000|Overall Study|Lack of Efficacy|20|||
125265209|NCT00783432|450600031|FG001|Overall Study|Lack of Efficacy|21|||
125265210|NCT00783432|450600030|FG000|Overall Study|Lost to Follow-up|11|||
125265211|NCT00783432|450600031|FG001|Overall Study|Lost to Follow-up|6|||
125265212|NCT00783432|450600030|FG000|Overall Study|Withdrawal by Subject|23|||
125265213|NCT00783432|450600031|FG001|Overall Study|Withdrawal by Subject|20|||
125265214|NCT00783432|450600030|FG000|Overall Study|subject moved|3|||
125265215|NCT00783432|450600031|FG001|Overall Study|subject moved|5|||
125265216|NCT00783432|450600030|FG000|Overall Study|Protocol Violation|6|||
125265217|NCT00783432|450600031|FG001|Overall Study|Protocol Violation|9|||
125265218|NCT03273907|450600032|FG000|Overall Study|Death|1|||
125265219|NCT03273907|450600032|FG000|Overall Study|Lost to Follow-up|4|||
125265220|NCT03273907|450600032|FG000|Overall Study|Withdrawal by Subject|2|||
125265221|NCT03273907|450600032|FG000|Overall Study|COVID 19|2|||
125265222|NCT02581891|450600034|FG000|Overall Study|Adverse Event|4|||
125265223|NCT02581891|450600035|FG001|Overall Study|Adverse Event|6|||
125265224|NCT02581891|450600034|FG000|Overall Study|Death|3|||
125265225|NCT02581891|450600035|FG001|Overall Study|Death|4|||
125265226|NCT02581891|450600034|FG000|Overall Study|Lost to Follow-up|1|||
125265227|NCT02581891|450600035|FG001|Overall Study|Lost to Follow-up|2|||
125265228|NCT02581891|450600034|FG000|Overall Study|Physician Decision|0|||
125265229|NCT02581891|450600035|FG001|Overall Study|Physician Decision|1|||
125265230|NCT02581891|450600034|FG000|Overall Study|Withdrawal by Subject|4|||
125265231|NCT02581891|450600035|FG001|Overall Study|Withdrawal by Subject|5|||
125265232|NCT02581891|450600034|FG000|Overall Study|Other Reasons|3|||
125265233|NCT02581891|450600035|FG001|Overall Study|Other Reasons|1|||
125265234|NCT02581891|450600034|FG000|Overall Study|Discontinued during followup|1|||
125265235|NCT02581891|450600035|FG001|Overall Study|Discontinued during followup|0|||
125265236|NCT04828707|450600036|FG000|Overall Study|Lost to Follow-up|3|||
125265237|NCT04828707|450600037|FG001|Overall Study|Lost to Follow-up|2|||
125265238|NCT04828707|450600036|FG000|Overall Study|Withdrawal by Subject|2|||
125265239|NCT04828707|450600037|FG001|Overall Study|Withdrawal by Subject|1|||
125265240|NCT03139448|450600038|FG000|Overall Study|Lack of Efficacy|6|||
125265241|NCT03139448|450600039|FG001|Overall Study|Lack of Efficacy|7|||
125265242|NCT03139448|450600038|FG000|Overall Study|Location of procedure changed|2|||
125265243|NCT03139448|450600039|FG001|Overall Study|Location of procedure changed|8|||
125265244|NCT03139448|450600038|FG000|Overall Study|Withdrawal by Subject|3|||
125265245|NCT03139448|450600039|FG001|Overall Study|Withdrawal by Subject|6|||
125265246|NCT03139448|450600038|FG000|Overall Study|Screen fail|1|||
125265247|NCT03139448|450600039|FG001|Overall Study|Screen fail|3|||
125265248|NCT03139448|450600038|FG000|Overall Study|Physician Decision|0|||
125265249|NCT03139448|450600039|FG001|Overall Study|Physician Decision|2|||
125265250|NCT00523978|450600040|FG000|Overall Study|Withdrawal by Subject|3|||
125265251|NCT00523978|450600041|FG001|Overall Study|Withdrawal by Subject|7|||
125265252|NCT00523978|450600040|FG000|Overall Study|Screen Failures|5|||
125265253|NCT00523978|450600041|FG001|Overall Study|Screen Failures|1|||
125265254|NCT00523978|450600040|FG000|Overall Study|Death|1|||
125265255|NCT00523978|450600041|FG001|Overall Study|Death|0|||
125265256|NCT00696878|450600042|FG000|Overall Study|Adverse Event|8|||
125265257|NCT00696878|450600042|FG000|Overall Study|Withdrawal by Subject|87|||
125265258|NCT00696878|450600042|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
125265259|NCT00696878|450600042|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
125265260|NCT00696878|450600042|FG000|Overall Study|Trial stopped|32|||
125265261|NCT00696878|450600042|FG000|Overall Study|Other reason (not specified)|55|||
125265262|NCT02712788|450600043|FG000|Overall Study|Physician Decision|1|||
125265263|NCT02712788|450600044|FG001|Overall Study|Physician Decision|0|||
125265264|NCT02712788|450600043|FG000|Overall Study|Protocol Violation|1|||
125265265|NCT02712788|450600044|FG001|Overall Study|Protocol Violation|0|||
125265266|NCT00940602|450600045|FG000|Overall Study|Administrative problems|1|||
125265267|NCT00940602|450600046|FG001|Overall Study|Administrative problems|1|||
125265268|NCT00940602|450600045|FG000|Overall Study|Patient/guardian decision|13|||
125265269|NCT00940602|450600046|FG001|Overall Study|Patient/guardian decision|28|||
125265270|NCT00940602|450600045|FG000|Overall Study|Physician Decision|8|||
125265271|NCT00940602|450600046|FG001|Overall Study|Physician Decision|5|||
125265272|NCT00940602|450600045|FG000|Overall Study|Pregnancy|1|||
125265273|NCT00940602|450600046|FG001|Overall Study|Pregnancy|0|||
125265274|NCT00940602|450600045|FG000|Overall Study|Protocol Deviation (untreated)|1|||
125265275|NCT00940602|450600046|FG001|Overall Study|Protocol Deviation (untreated)|0|||
125265276|NCT00940602|450600045|FG000|Overall Study|Disease progression|8|||
125265277|NCT00940602|450600046|FG001|Overall Study|Disease progression|2|||
125265278|NCT00940602|450600045|FG000|Overall Study|Death|38|||
125265279|NCT00940602|450600046|FG001|Overall Study|Death|19|||
125265280|NCT00940602|450600045|FG000|Overall Study|Lost to Follow-up|3|||
125265281|NCT00940602|450600046|FG001|Overall Study|Lost to Follow-up|1|||
125265282|NCT00940602|450600045|FG000|Overall Study|Patient withdrew consent|26|||
125265283|NCT00940602|450600046|FG001|Overall Study|Patient withdrew consent|13|||
125265284|NCT00940602|450600045|FG000|Overall Study|Adverse Event|7|||
125265285|NCT00940602|450600046|FG001|Overall Study|Adverse Event|2|||
125265286|NCT00940602|450600045|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
125265287|NCT00940602|450600046|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
125265288|NCT01880957|450600047|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
125265289|NCT01880957|450600048|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
125265290|NCT01880957|450600047|FG000|Overall Study|Lost to Follow-up|11|||
125265291|NCT01880957|450600048|FG001|Overall Study|Lost to Follow-up|0|||
125265292|NCT01880957|450600047|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
125265293|NCT01880957|450600048|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
125265294|NCT00575666|450600051|FG000|Overall Study|Withdrawal by Subject|3|||
125265295|NCT00575666|450600052|FG001|Overall Study|Withdrawal by Subject|2|||
125265296|NCT00575666|450600051|FG000|Overall Study|Physician Decision|1|||
125265297|NCT00575666|450600052|FG001|Overall Study|Physician Decision|1|||
125265298|NCT00508482|450600053|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
125265299|NCT00508482|450600054|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
125265300|NCT00508482|450600055|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
125265301|NCT00508482|450600053|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
125265302|NCT00508482|450600054|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
125265303|NCT00508482|450600055|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
125265304|NCT00508482|450600053|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
125265305|NCT00508482|450600054|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
125265306|NCT00508482|450600055|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
125265307|NCT02289469|450600056|FG000|Overall Study|Unable to match a control|6|||
125265308|NCT02289469|450600057|FG001|Overall Study|Unable to match a control|0|||
125265309|NCT01944020|450601657|FG000|Overall Study|Withdrawal by Subject|5|||
125265310|NCT01944020|450601658|FG001|Overall Study|Withdrawal by Subject|0|||
125265311|NCT00110214|450601663|FG000|Overall Study|Never started treatment|21|||
125265312|NCT00110214|450601664|FG001|Overall Study|Never started treatment|20|||
125265313|NCT00110214|450601663|FG000|Overall Study|Disease progression or death|260|||
125265314|NCT00110214|450601664|FG001|Overall Study|Disease progression or death|151|||
125265315|NCT00110214|450601663|FG000|Overall Study|Adverse Event|115|||
125265316|NCT00110214|450601664|FG001|Overall Study|Adverse Event|192|||
125265317|NCT00110214|450601663|FG000|Overall Study|Refused further treatment|52|||
125265318|NCT00110214|450601664|FG001|Overall Study|Refused further treatment|65|||
125265319|NCT00110214|450601663|FG000|Overall Study|Other (not specified)|61|||
125265320|NCT00110214|450601664|FG001|Overall Study|Other (not specified)|75|||
125265321|NCT00811954|450601666|FG000|Overall Study|Death|10|||
125265322|NCT00811954|450601667|FG001|Overall Study|Death|6|||
125265323|NCT00811954|450601668|FG002|Overall Study|Death|13|||
125265324|NCT00811954|450601666|FG000|Overall Study|Lost to Follow-up|29|||
125265325|NCT00811954|450601667|FG001|Overall Study|Lost to Follow-up|23|||
125265326|NCT00811954|450601668|FG002|Overall Study|Lost to Follow-up|34|||
125265327|NCT00811954|450601666|FG000|Overall Study|Not able to get to clinic|28|||
125265328|NCT00811954|450601667|FG001|Overall Study|Not able to get to clinic|35|||
125265329|NCT00811954|450601668|FG002|Overall Study|Not able to get to clinic|30|||
125265330|NCT00811954|450601666|FG000|Overall Study|Not willing to adhere to requirements|12|||
125265331|NCT00811954|450601667|FG001|Overall Study|Not willing to adhere to requirements|2|||
125265332|NCT00811954|450601668|FG002|Overall Study|Not willing to adhere to requirements|16|||
125265333|NCT00811954|450601666|FG000|Overall Study|Withdraw consent prior study completion|4|||
125265334|NCT00811954|450601667|FG001|Overall Study|Withdraw consent prior study completion|6|||
125265335|NCT00811954|450601668|FG002|Overall Study|Withdraw consent prior study completion|5|||
125265336|NCT00811954|450601666|FG000|Overall Study|Site Closure|4|||
125265337|NCT00811954|450601667|FG001|Overall Study|Site Closure|0|||
125265338|NCT00811954|450601668|FG002|Overall Study|Site Closure|1|||
125265339|NCT00811954|450601666|FG000|Overall Study|Severe Debilitation|2|||
125265340|NCT00811954|450601667|FG001|Overall Study|Severe Debilitation|0|||
125265341|NCT00811954|450601668|FG002|Overall Study|Severe Debilitation|1|||
125265342|NCT00811954|450601666|FG000|Overall Study|Complete Protocol: No follow-up|0|||
125265343|NCT00811954|450601667|FG001|Overall Study|Complete Protocol: No follow-up|0|||
125265344|NCT00811954|450601668|FG002|Overall Study|Complete Protocol: No follow-up|1|||
125265345|NCT01016067|450601669|FG000|Overall Study|Lost to Follow-up|1|||
125265346|NCT01016067|450601670|FG001|Overall Study|Lost to Follow-up|2|||
125265347|NCT01016067|450601669|FG000|Overall Study|Physician Decision|1|||
125265348|NCT01016067|450601670|FG001|Overall Study|Physician Decision|1|||
125265349|NCT01016067|450601669|FG000|Overall Study|Withdrew due to Relocation|0|||
125265350|NCT01016067|450601670|FG001|Overall Study|Withdrew due to Relocation|1|||
125265351|NCT01534481|450601677|FG000|Overall Study|Lost to Follow-up|29|||
125265352|NCT01534481|450601678|FG001|Overall Study|Lost to Follow-up|24|||
125265353|NCT01534481|450601677|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
125265354|NCT01534481|450601678|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
125265355|NCT01130337|450601679|FG000|Overall Study|Withdrawal by Subject|3|||
125265356|NCT01130337|450601679|FG000|Overall Study|Principal investigator decision|1|||
125265357|NCT01130337|450601679|FG000|Overall Study|Death|1|||
125265358|NCT01130337|450601679|FG000|Overall Study|Disease progression|1|||
125265359|NCT01130337|450601679|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
125265360|NCT01130337|450601679|FG000|Overall Study|Surgical resection (R2)|1|||
125265361|NCT05525910|450601680|FG000|Period 4|Per sponsor due to study timelines|0|||
125265362|NCT05525910|450601681|FG001|Period 4|Per sponsor due to study timelines|0|||
125265363|NCT05525910|450601682|FG002|Period 4|Per sponsor due to study timelines|1|||
125265364|NCT05525910|450601683|FG003|Period 4|Per sponsor due to study timelines|1|||
125265365|NCT05525910|450601684|FG004|Period 4|Per sponsor due to study timelines|1|||
125265366|NCT03886493|450601685|FG000|Overall Study|Adverse Event|1|||
125265367|NCT03326063|450601686|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
125265368|NCT03326063|450601687|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
125265369|NCT02750514|450601688|FG000|Track 1|Disease progression|20|||
125265370|NCT02750514|450601689|FG001|Track 1|Disease progression|1|||
125265371|NCT02750514|450601690|FG002|Track 1|Disease progression|0|||
125265372|NCT02750514|450601691|FG003|Track 1|Disease progression|1|||
125265373|NCT02750514|450601692|FG004|Track 1|Disease progression|0|||
125265374|NCT02750514|450601688|FG000|Track 1|Adverse event unrelated to study drug|1|||
125265375|NCT02750514|450601689|FG001|Track 1|Adverse event unrelated to study drug|0|||
125265376|NCT02750514|450601690|FG002|Track 1|Adverse event unrelated to study drug|0|||
125265377|NCT02750514|450601691|FG003|Track 1|Adverse event unrelated to study drug|0|||
125265378|NCT02750514|450601692|FG004|Track 1|Adverse event unrelated to study drug|0|||
125265379|NCT02750514|450601688|FG000|Track 1|Study drug toxicity|4|||
125265380|NCT02750514|450601689|FG001|Track 1|Study drug toxicity|1|||
125265381|NCT02750514|450601690|FG002|Track 1|Study drug toxicity|0|||
125265382|NCT02750514|450601691|FG003|Track 1|Study drug toxicity|1|||
125265383|NCT02750514|450601692|FG004|Track 1|Study drug toxicity|0|||
125265384|NCT02750514|450601688|FG000|Track 1|Participant request to discontinue|1|||
125265385|NCT02750514|450601689|FG001|Track 1|Participant request to discontinue|0|||
125265386|NCT02750514|450601690|FG002|Track 1|Participant request to discontinue|0|||
125265387|NCT02750514|450601691|FG003|Track 1|Participant request to discontinue|0|||
125265388|NCT02750514|450601692|FG004|Track 1|Participant request to discontinue|0|||
125265389|NCT02750514|450601688|FG000|Track 1|Other reasons|1|||
125265390|NCT02750514|450601689|FG001|Track 1|Other reasons|0|||
125265391|NCT02750514|450601690|FG002|Track 1|Other reasons|0|||
125265392|NCT02750514|450601691|FG003|Track 1|Other reasons|0|||
125265393|NCT02750514|450601692|FG004|Track 1|Other reasons|0|||
125265394|NCT02750514|450601688|FG000|Track 2|Disease progression|4|||
125265395|NCT02750514|450601689|FG001|Track 2|Disease progression|5|||
125265396|NCT02750514|450601690|FG002|Track 2|Disease progression|2|||
125265397|NCT02750514|450601691|FG003|Track 2|Disease progression|5|||
125265398|NCT02750514|450601692|FG004|Track 2|Disease progression|0|||
125265399|NCT02750514|450601688|FG000|Track 2|Adverse event unrelated to study drug|1|||
125265400|NCT02750514|450601689|FG001|Track 2|Adverse event unrelated to study drug|0|||
125265401|NCT02750514|450601690|FG002|Track 2|Adverse event unrelated to study drug|0|||
125265402|NCT02750514|450601691|FG003|Track 2|Adverse event unrelated to study drug|0|||
125265403|NCT02750514|450601692|FG004|Track 2|Adverse event unrelated to study drug|0|||
125265404|NCT02750514|450601688|FG000|Track 2|Study drug toxicity|1|||
125265405|NCT02750514|450601689|FG001|Track 2|Study drug toxicity|2|||
125265406|NCT02750514|450601690|FG002|Track 2|Study drug toxicity|0|||
125265407|NCT02750514|450601691|FG003|Track 2|Study drug toxicity|2|||
125265408|NCT02750514|450601692|FG004|Track 2|Study drug toxicity|0|||
125265409|NCT02750514|450601688|FG000|Track 2|Participant withdrew consent|0|||
125265410|NCT02750514|450601689|FG001|Track 2|Participant withdrew consent|1|||
125265411|NCT02750514|450601690|FG002|Track 2|Participant withdrew consent|0|||
125265412|NCT02750514|450601691|FG003|Track 2|Participant withdrew consent|0|||
125265413|NCT02750514|450601692|FG004|Track 2|Participant withdrew consent|0|||
125265414|NCT02750514|450601688|FG000|Track 3|Disease progression|0|||
125265415|NCT02750514|450601689|FG001|Track 3|Disease progression|24|||
125265416|NCT02750514|450601690|FG002|Track 3|Disease progression|13|||
125265417|NCT02750514|450601691|FG003|Track 3|Disease progression|14|||
125265418|NCT02750514|450601692|FG004|Track 3|Disease progression|0|||
125265419|NCT02750514|450601688|FG000|Track 3|Adverse event unrelated to study drug|0|||
125265420|NCT02750514|450601689|FG001|Track 3|Adverse event unrelated to study drug|1|||
125265421|NCT02750514|450601690|FG002|Track 3|Adverse event unrelated to study drug|1|||
125265422|NCT02750514|450601691|FG003|Track 3|Adverse event unrelated to study drug|1|||
125265423|NCT02750514|450601692|FG004|Track 3|Adverse event unrelated to study drug|0|||
125265424|NCT02750514|450601688|FG000|Track 3|Study drug toxicity|0|||
125265425|NCT02750514|450601689|FG001|Track 3|Study drug toxicity|3|||
125265426|NCT02750514|450601690|FG002|Track 3|Study drug toxicity|0|||
125265427|NCT02750514|450601691|FG003|Track 3|Study drug toxicity|1|||
125265428|NCT02750514|450601692|FG004|Track 3|Study drug toxicity|0|||
125265429|NCT02750514|450601688|FG000|Track 3|Participant request to discontinue|0|||
125265430|NCT02750514|450601689|FG001|Track 3|Participant request to discontinue|2|||
125265431|NCT02750514|450601690|FG002|Track 3|Participant request to discontinue|0|||
125265432|NCT02750514|450601691|FG003|Track 3|Participant request to discontinue|0|||
125265433|NCT02750514|450601692|FG004|Track 3|Participant request to discontinue|0|||
125265434|NCT02750514|450601688|FG000|Track 3|Participant withdrew consent|0|||
125265435|NCT02750514|450601689|FG001|Track 3|Participant withdrew consent|3|||
125265436|NCT02750514|450601690|FG002|Track 3|Participant withdrew consent|1|||
125265437|NCT02750514|450601691|FG003|Track 3|Participant withdrew consent|0|||
125265438|NCT02750514|450601692|FG004|Track 3|Participant withdrew consent|0|||
125265439|NCT02750514|450601688|FG000|Track 3|Other reasons|0|||
125265440|NCT02750514|450601689|FG001|Track 3|Other reasons|3|||
125265441|NCT02750514|450601690|FG002|Track 3|Other reasons|0|||
125265442|NCT02750514|450601691|FG003|Track 3|Other reasons|0|||
125265443|NCT02750514|450601692|FG004|Track 3|Other reasons|0|||
125265444|NCT02750514|450601688|FG000|Track 4|Study drug toxicity|0|||
125265445|NCT02750514|450601689|FG001|Track 4|Study drug toxicity|6|||
125265446|NCT02750514|450601690|FG002|Track 4|Study drug toxicity|0|||
125265447|NCT02750514|450601691|FG003|Track 4|Study drug toxicity|5|||
125265448|NCT02750514|450601692|FG004|Track 4|Study drug toxicity|0|||
125265449|NCT02750514|450601688|FG000|Track 4|Participant request to discontinue|0|||
125265450|NCT02750514|450601689|FG001|Track 4|Participant request to discontinue|1|||
125265451|NCT02750514|450601690|FG002|Track 4|Participant request to discontinue|0|||
125265452|NCT02750514|450601691|FG003|Track 4|Participant request to discontinue|1|||
125265453|NCT02750514|450601692|FG004|Track 4|Participant request to discontinue|0|||
125265454|NCT02750514|450601688|FG000|Track 4|Participant withdrew consent|0|||
125265455|NCT02750514|450601689|FG001|Track 4|Participant withdrew consent|1|||
125265456|NCT02750514|450601690|FG002|Track 4|Participant withdrew consent|0|||
125265457|NCT02750514|450601691|FG003|Track 4|Participant withdrew consent|0|||
125265458|NCT02750514|450601692|FG004|Track 4|Participant withdrew consent|0|||
125265459|NCT02750514|450601688|FG000|Track 4|Other reasons|0|||
125265460|NCT02750514|450601689|FG001|Track 4|Other reasons|5|||
125265461|NCT02750514|450601690|FG002|Track 4|Other reasons|0|||
125265462|NCT02750514|450601691|FG003|Track 4|Other reasons|3|||
125265463|NCT02750514|450601692|FG004|Track 4|Other reasons|0|||
125265464|NCT02750514|450601688|FG000|Track 4|Disease progression|0|||
125265465|NCT02750514|450601689|FG001|Track 4|Disease progression|33|||
125265466|NCT02750514|450601690|FG002|Track 4|Disease progression|0|||
125265467|NCT02750514|450601691|FG003|Track 4|Disease progression|32|||
125265468|NCT02750514|450601692|FG004|Track 4|Disease progression|0|||
125265469|NCT02750514|450601688|FG000|Track 4|Adverse event unrelated to study drug|0|||
125265470|NCT02750514|450601689|FG001|Track 4|Adverse event unrelated to study drug|5|||
125265471|NCT02750514|450601690|FG002|Track 4|Adverse event unrelated to study drug|0|||
125265472|NCT02750514|450601691|FG003|Track 4|Adverse event unrelated to study drug|0|||
125265473|NCT02750514|450601692|FG004|Track 4|Adverse event unrelated to study drug|0|||
125265474|NCT02750514|450601688|FG000|Track 4|Death|0|||
125265475|NCT02750514|450601689|FG001|Track 4|Death|0|||
125265476|NCT02750514|450601690|FG002|Track 4|Death|0|||
125265477|NCT02750514|450601691|FG003|Track 4|Death|1|||
125265478|NCT02750514|450601692|FG004|Track 4|Death|0|||
125265479|NCT02750514|450601688|FG000|Track 5|Disease progression|0|||
125265480|NCT02750514|450601689|FG001|Track 5|Disease progression|0|||
125265481|NCT02750514|450601690|FG002|Track 5|Disease progression|0|||
125265482|NCT02750514|450601691|FG003|Track 5|Disease progression|0|||
125265483|NCT02750514|450601692|FG004|Track 5|Disease progression|34|||
125265484|NCT02750514|450601688|FG000|Track 5|Adverse event unrelated to study drug|0|||
125265485|NCT02750514|450601689|FG001|Track 5|Adverse event unrelated to study drug|0|||
125265486|NCT02750514|450601690|FG002|Track 5|Adverse event unrelated to study drug|0|||
125265487|NCT02750514|450601691|FG003|Track 5|Adverse event unrelated to study drug|0|||
125265488|NCT02750514|450601692|FG004|Track 5|Adverse event unrelated to study drug|2|||
125265489|NCT02750514|450601688|FG000|Track 5|Study drug toxicity|0|||
125265490|NCT02750514|450601689|FG001|Track 5|Study drug toxicity|0|||
125265491|NCT02750514|450601690|FG002|Track 5|Study drug toxicity|0|||
125265492|NCT02750514|450601691|FG003|Track 5|Study drug toxicity|0|||
125265493|NCT02750514|450601692|FG004|Track 5|Study drug toxicity|2|||
125265494|NCT02750514|450601688|FG000|Track 5|Participant request to discontinue|0|||
125265495|NCT02750514|450601689|FG001|Track 5|Participant request to discontinue|0|||
125265496|NCT02750514|450601690|FG002|Track 5|Participant request to discontinue|0|||
125265497|NCT02750514|450601691|FG003|Track 5|Participant request to discontinue|0|||
125265498|NCT02750514|450601692|FG004|Track 5|Participant request to discontinue|3|||
125265499|NCT02750514|450601688|FG000|Track 5|Other reasons|0|||
125265500|NCT02750514|450601689|FG001|Track 5|Other reasons|0|||
125265501|NCT02750514|450601690|FG002|Track 5|Other reasons|0|||
125265502|NCT02750514|450601691|FG003|Track 5|Other reasons|0|||
125265503|NCT02750514|450601692|FG004|Track 5|Other reasons|2|||
125265504|NCT02553629|450601693|FG000|Overall Study|Logistic reasons|3|||
125265505|NCT02553629|450601694|FG001|Overall Study|Logistic reasons|6|||
125265506|NCT01812057|450601695|FG000|Overall Study|Protocol Violation|1|||
125265507|NCT01812057|450601696|FG001|Overall Study|Protocol Violation|0|||
125265508|NCT01812057|450601695|FG000|Overall Study|Physician Decision|1|||
125265509|NCT01812057|450601696|FG001|Overall Study|Physician Decision|0|||
125265510|NCT01882465|450601699|FG000|Period 1|Lens Discomfort|0|||
125265511|NCT01882465|450601700|FG001|Period 1|Lens Discomfort|0|||
125265512|NCT01882465|450601701|FG002|Period 1|Lens Discomfort|0|||
125265513|NCT01882465|450601702|FG003|Period 1|Lens Discomfort|1|||
125265514|NCT01882465|450601703|FG004|Period 1|Lens Discomfort|0|||
125265515|NCT01882465|450601704|FG005|Period 1|Lens Discomfort|0|||
125265516|NCT01882465|450601705|FG006|Period 1|Lens Discomfort|0|||
125265517|NCT01882465|450601699|FG000|Period 1|Withdrawal by Subject|0|||
125265518|NCT01882465|450601700|FG001|Period 1|Withdrawal by Subject|0|||
125265519|NCT01882465|450601701|FG002|Period 1|Withdrawal by Subject|0|||
125265520|NCT01882465|450601702|FG003|Period 1|Withdrawal by Subject|0|||
125265521|NCT01882465|450601703|FG004|Period 1|Withdrawal by Subject|0|||
125265522|NCT01882465|450601704|FG005|Period 1|Withdrawal by Subject|0|||
125265523|NCT01882465|450601705|FG006|Period 1|Withdrawal by Subject|1|||
125265524|NCT01882465|450601699|FG000|Period 2|Protocol Violation|0|||
125265525|NCT01882465|450601700|FG001|Period 2|Protocol Violation|0|||
125265526|NCT01882465|450601701|FG002|Period 2|Protocol Violation|0|||
125265527|NCT01882465|450601702|FG003|Period 2|Protocol Violation|0|||
125265528|NCT01882465|450601703|FG004|Period 2|Protocol Violation|1|||
125265529|NCT01882465|450601704|FG005|Period 2|Protocol Violation|0|||
125265530|NCT01882465|450601705|FG006|Period 2|Protocol Violation|0|||
125265531|NCT02259114|450601710|FG000|Overall Study|Progressive Disease|14|||
125265532|NCT02259114|450601711|FG001|Overall Study|Progressive Disease|2|||
125265533|NCT02259114|450601712|FG002|Overall Study|Progressive Disease|10|||
125265534|NCT02259114|450601713|FG003|Overall Study|Progressive Disease|2|||
125265535|NCT02259114|450601714|FG004|Overall Study|Progressive Disease|5|||
125265536|NCT02259114|450601710|FG000|Overall Study|Adverse Event|2|||
125265537|NCT02259114|450601711|FG001|Overall Study|Adverse Event|1|||
125265538|NCT02259114|450601712|FG002|Overall Study|Adverse Event|0|||
125265539|NCT02259114|450601713|FG003|Overall Study|Adverse Event|0|||
125265540|NCT02259114|450601714|FG004|Overall Study|Adverse Event|1|||
125265541|NCT02259114|450601710|FG000|Overall Study|Death|3|||
125265542|NCT02259114|450601711|FG001|Overall Study|Death|0|||
125265543|NCT02259114|450601712|FG002|Overall Study|Death|1|||
125265544|NCT02259114|450601713|FG003|Overall Study|Death|0|||
125265545|NCT02259114|450601714|FG004|Overall Study|Death|0|||
125265546|NCT02259114|450601710|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
125265547|NCT02259114|450601711|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
125265548|NCT02259114|450601712|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
125265549|NCT02259114|450601713|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
125265550|NCT02259114|450601714|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
125265551|NCT02259114|450601710|FG000|Overall Study|Withdrawal by Subject|0|||
125265552|NCT02259114|450601711|FG001|Overall Study|Withdrawal by Subject|0|||
125265553|NCT02259114|450601712|FG002|Overall Study|Withdrawal by Subject|1|||
125265554|NCT02259114|450601713|FG003|Overall Study|Withdrawal by Subject|1|||
125265555|NCT02259114|450601714|FG004|Overall Study|Withdrawal by Subject|0|||
125265556|NCT02259114|450601710|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
125265557|NCT02259114|450601711|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
125265558|NCT02259114|450601712|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
125265559|NCT02259114|450601713|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
125265560|NCT02259114|450601714|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
125265561|NCT02259114|450601710|FG000|Overall Study|Not Treated|1|||
125265562|NCT02259114|450601711|FG001|Overall Study|Not Treated|0|||
125265563|NCT02259114|450601712|FG002|Overall Study|Not Treated|0|||
125265564|NCT02259114|450601713|FG003|Overall Study|Not Treated|0|||
125265565|NCT02259114|450601714|FG004|Overall Study|Not Treated|0|||
125265566|NCT03937479|450601715|FG000|Overall Study|Adverse Event|2|||
125265567|NCT03937479|450601716|FG001|Overall Study|Adverse Event|3|||
125265568|NCT03937479|450601717|FG002|Overall Study|Adverse Event|0|||
125265569|NCT03937479|450601718|FG003|Overall Study|Adverse Event|0|||
125265570|NCT03937479|450601719|FG004|Overall Study|Adverse Event|1|||
125265571|NCT03937479|450601715|FG000|Overall Study|Withdrawal by Subject|3|||
125265572|NCT03937479|450601716|FG001|Overall Study|Withdrawal by Subject|5|||
125265573|NCT03937479|450601717|FG002|Overall Study|Withdrawal by Subject|2|||
125265574|NCT03937479|450601718|FG003|Overall Study|Withdrawal by Subject|2|||
125265575|NCT03937479|450601719|FG004|Overall Study|Withdrawal by Subject|1|||
125265576|NCT03937479|450601715|FG000|Overall Study|Protocol Violation|5|||
125265577|NCT03937479|450601716|FG001|Overall Study|Protocol Violation|6|||
125265578|NCT03937479|450601717|FG002|Overall Study|Protocol Violation|4|||
125265579|NCT03937479|450601718|FG003|Overall Study|Protocol Violation|3|||
125265580|NCT03937479|450601719|FG004|Overall Study|Protocol Violation|2|||
125265581|NCT03937479|450601715|FG000|Overall Study|Lost to Follow-up|0|||
125265582|NCT03937479|450601716|FG001|Overall Study|Lost to Follow-up|1|||
125265583|NCT03937479|450601717|FG002|Overall Study|Lost to Follow-up|0|||
125265584|NCT03937479|450601718|FG003|Overall Study|Lost to Follow-up|1|||
125265585|NCT03937479|450601719|FG004|Overall Study|Lost to Follow-up|0|||
125265586|NCT03937479|450601715|FG000|Overall Study|Physician Decision|0|||
125265587|NCT03937479|450601716|FG001|Overall Study|Physician Decision|0|||
125265588|NCT03937479|450601717|FG002|Overall Study|Physician Decision|1|||
125265589|NCT03937479|450601718|FG003|Overall Study|Physician Decision|0|||
125265590|NCT03937479|450601719|FG004|Overall Study|Physician Decision|1|||
125265591|NCT01378117|450601723|FG000|Overall Study|withdrawal|2|||
125265592|NCT01378117|450601724|FG001|Overall Study|withdrawal|1|||
125265593|NCT01378117|450601725|FG002|Overall Study|withdrawal|2|||
125265594|NCT01378117|450601723|FG000|Overall Study|discharged before med given|2|||
125265595|NCT01378117|450601724|FG001|Overall Study|discharged before med given|0|||
125265596|NCT01378117|450601725|FG002|Overall Study|discharged before med given|1|||
125265597|NCT02961244|450601726|FG000|Overall Study|Protocol Violation|0|||
125265598|NCT02961244|450601727|FG001|Overall Study|Protocol Violation|1|||
125265599|NCT02961244|450601726|FG000|Overall Study|Withdrawal by Subject|1|||
125265600|NCT02961244|450601727|FG001|Overall Study|Withdrawal by Subject|2|||
125265601|NCT02961244|450601726|FG000|Overall Study|Surgery plan change after study approval|0|||
125265602|NCT02961244|450601727|FG001|Overall Study|Surgery plan change after study approval|2|||
125265603|NCT02961244|450601726|FG000|Overall Study|Lost to Follow-up|0|||
125265604|NCT02961244|450601727|FG001|Overall Study|Lost to Follow-up|2|||
125265605|NCT02961244|450601726|FG000|Overall Study|İnadequate data|0|||
125265606|NCT02961244|450601727|FG001|Overall Study|İnadequate data|2|||
125265607|NCT01854528|450601728|FG000|Overall Study|Adverse Event|0|||
125265608|NCT01854528|450601729|FG001|Overall Study|Adverse Event|4|||
125265609|NCT01854528|450601728|FG000|Overall Study|Withdrawal by Subject|0|||
125265610|NCT01854528|450601729|FG001|Overall Study|Withdrawal by Subject|2|||
125265611|NCT01854528|450601728|FG000|Overall Study|Virologic Failure|0|||
125265612|NCT01854528|450601729|FG001|Overall Study|Virologic Failure|9|||
125265613|NCT03789292|450601730|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
125265614|NCT03789292|450601731|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
125265615|NCT03789292|450601732|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
125265616|NCT03789292|450601730|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
125265617|NCT03789292|450601731|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
125265618|NCT03789292|450601732|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
125265619|NCT03789292|450601730|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
125265620|NCT03789292|450601731|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
125265621|NCT03789292|450601732|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
125265622|NCT03789292|450601730|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
125265623|NCT03789292|450601731|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
125265624|NCT03789292|450601732|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
125265625|NCT03789292|450601730|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
125265626|NCT03789292|450601731|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
125265627|NCT03789292|450601732|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
125265628|NCT03789292|450601730|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
125265629|NCT03789292|450601731|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
125265630|NCT03789292|450601732|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
125265631|NCT03789292|450601730|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
125265632|NCT03789292|450601731|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
125265633|NCT03789292|450601732|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
125265634|NCT03789292|450601730|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
125265635|NCT03789292|450601731|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
125265636|NCT03789292|450601732|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
125265637|NCT03789292|450601730|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
125265638|NCT03789292|450601731|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
125265639|NCT03789292|450601732|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
125265640|NCT03789292|450601730|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
125265641|NCT03789292|450601731|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
125265642|NCT03789292|450601732|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
125265643|NCT03789292|450601730|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
125265644|NCT03789292|450601731|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
125265645|NCT03789292|450601732|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
125265646|NCT03789292|450601730|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
125265647|NCT03789292|450601731|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
125265648|NCT03789292|450601732|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
125265649|NCT03789292|450601730|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
125265650|NCT03789292|450601731|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
125265651|NCT03789292|450601732|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
125265652|NCT01904721|450601734|FG000|Overall Study|Other Reasons|0|||
125265653|NCT01904721|450601735|FG001|Overall Study|Other Reasons|0|||
125265654|NCT01904721|450601736|FG002|Overall Study|Other Reasons|1|||
125265655|NCT01904721|450601737|FG003|Overall Study|Other Reasons|1|||
125265656|NCT01904721|450601738|FG004|Overall Study|Other Reasons|2|||
125265657|NCT01904721|450601739|FG005|Overall Study|Other Reasons|2|||
125265658|NCT01904721|450601740|FG006|Overall Study|Other Reasons|2|||
125265659|NCT01904721|450601734|FG000|Overall Study|Personal Reasons|0|||
125265660|NCT01904721|450601735|FG001|Overall Study|Personal Reasons|0|||
125265661|NCT01904721|450601736|FG002|Overall Study|Personal Reasons|0|||
125265662|NCT01904721|450601737|FG003|Overall Study|Personal Reasons|0|||
125265663|NCT01904721|450601738|FG004|Overall Study|Personal Reasons|2|||
125265664|NCT01904721|450601739|FG005|Overall Study|Personal Reasons|3|||
125265665|NCT01904721|450601740|FG006|Overall Study|Personal Reasons|3|||
125265666|NCT01904721|450601734|FG000|Overall Study|Lost to Follow-up|0|||
125265667|NCT01904721|450601735|FG001|Overall Study|Lost to Follow-up|0|||
125265668|NCT01904721|450601736|FG002|Overall Study|Lost to Follow-up|0|||
125265669|NCT01904721|450601737|FG003|Overall Study|Lost to Follow-up|0|||
125265670|NCT01904721|450601738|FG004|Overall Study|Lost to Follow-up|1|||
125265671|NCT01904721|450601739|FG005|Overall Study|Lost to Follow-up|3|||
125265672|NCT01904721|450601740|FG006|Overall Study|Lost to Follow-up|1|||
125265673|NCT01904721|450601734|FG000|Overall Study|Lack of Efficacy|0|||
125265674|NCT01904721|450601735|FG001|Overall Study|Lack of Efficacy|0|||
125265675|NCT01904721|450601736|FG002|Overall Study|Lack of Efficacy|0|||
125265676|NCT01904721|450601737|FG003|Overall Study|Lack of Efficacy|0|||
125265677|NCT01904721|450601738|FG004|Overall Study|Lack of Efficacy|0|||
125265678|NCT01904721|450601739|FG005|Overall Study|Lack of Efficacy|0|||
125265679|NCT01904721|450601740|FG006|Overall Study|Lack of Efficacy|1|||
125265680|NCT01904721|450601734|FG000|Overall Study|Adverse Event|0|||
125265681|NCT01904721|450601735|FG001|Overall Study|Adverse Event|0|||
125265682|NCT01904721|450601736|FG002|Overall Study|Adverse Event|0|||
125265683|NCT01904721|450601737|FG003|Overall Study|Adverse Event|0|||
125265684|NCT01904721|450601738|FG004|Overall Study|Adverse Event|3|||
125265685|NCT01904721|450601739|FG005|Overall Study|Adverse Event|1|||
125265686|NCT01904721|450601740|FG006|Overall Study|Adverse Event|0|||
125265687|NCT01082614|450601741|FG000|Overall Study|Adverse Event|1|||
125265688|NCT01082614|450601742|FG001|Overall Study|Adverse Event|4|||
125265689|NCT01082614|450601741|FG000|Overall Study|Equipment Malfunction|0|||
125265690|NCT01082614|450601742|FG001|Overall Study|Equipment Malfunction|1|||
125265691|NCT01082614|450601741|FG000|Overall Study|Physician Decision|2|||
125265692|NCT01082614|450601742|FG001|Overall Study|Physician Decision|0|||
125265693|NCT00811720|450601746|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
125265694|NCT00811720|450601747|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
125265695|NCT00811720|450601746|FG000|All Treated Patients|Adverse Event|20|||
125265696|NCT00811720|450601747|FG001|All Treated Patients|Adverse Event|62|||
125265697|NCT00811720|450601746|FG000|All Treated Patients|Lack of Efficacy|22|||
125265698|NCT00811720|450601747|FG001|All Treated Patients|Lack of Efficacy|18|||
125265699|NCT00811720|450601746|FG000|All Treated Patients|Non-compliance|0|||
125265700|NCT00811720|450601747|FG001|All Treated Patients|Non-compliance|14|||
125265701|NCT00811720|450601746|FG000|All Treated Patients|Protocol Violation|9|||
125265702|NCT00811720|450601747|FG001|All Treated Patients|Protocol Violation|16|||
125265703|NCT00811720|450601746|FG000|All Treated Patients|Withdrawal by Subject|28|||
125265704|NCT00811720|450601747|FG001|All Treated Patients|Withdrawal by Subject|34|||
125265705|NCT00811720|450601746|FG000|All Treated Patients|Lost to Follow-up|10|||
125265706|NCT00811720|450601747|FG001|All Treated Patients|Lost to Follow-up|16|||
125265707|NCT00811720|450601746|FG000|All Treated Patients|Other Reason|7|||
125265708|NCT00811720|450601747|FG001|All Treated Patients|Other Reason|4|||
125265709|NCT01077063|450601748|FG000|Overall Study|Adverse Event|3|||
125265710|NCT01077063|450601749|FG001|Overall Study|Adverse Event|0|||
125265711|NCT01077063|450601748|FG000|Overall Study|Death|1|||
125265712|NCT01077063|450601749|FG001|Overall Study|Death|1|||
125265713|NCT01077063|450601748|FG000|Overall Study|Withdrawal by Subject|0|||
125265714|NCT01077063|450601749|FG001|Overall Study|Withdrawal by Subject|2|||
125265715|NCT02750930|450601750|FG000|Overall Study|Study closed/terminated|8|||
125265716|NCT03894891|450601751|FG000|Overall Study|Withdrawal by Subject|1|||
125265717|NCT03894891|450601751|FG000|Overall Study|Completed protocol treatment per protocol|5|||
125265718|NCT00553631|450601753|FG000|Overall Study|Withdrawal by Subject|0|||
125265719|NCT00553631|450601754|FG001|Overall Study|Withdrawal by Subject|1|||
125265720|NCT00553631|450601753|FG000|Overall Study|Lost to Follow-up|1|||
125265721|NCT00553631|450601754|FG001|Overall Study|Lost to Follow-up|0|||
125265722|NCT02761642|450601755|FG000|Overall Study|Did not Receive Study Treatment|3|||
125265723|NCT02761642|450601755|FG000|Overall Study|Adverse Event|13|||
125265724|NCT02761642|450601755|FG000|Overall Study|Withdrawal by Subject|2|||
125265725|NCT02761642|450601755|FG000|Overall Study|Non-compliant|7|||
125265726|NCT02761642|450601755|FG000|Overall Study|Death|3|||
125265727|NCT02761642|450601755|FG000|Overall Study|Lack of Efficacy|20|||
125265728|NCT02761642|450601755|FG000|Overall Study|Physician Decision|1|||
125265729|NCT02761642|450601755|FG000|Overall Study|Reason Unspecified|21|||
125265730|NCT00950651|450601756|FG000|Overall Study|Adverse Event|17|||
125265731|NCT00950651|450601757|FG001|Overall Study|Adverse Event|20|||
125265732|NCT00950651|450601756|FG000|Overall Study|Death|1|||
125265733|NCT00950651|450601757|FG001|Overall Study|Death|0|||
125265734|NCT00950651|450601756|FG000|Overall Study|Lack of Efficacy|2|||
125265735|NCT00950651|450601757|FG001|Overall Study|Lack of Efficacy|2|||
125265736|NCT00950651|450601756|FG000|Overall Study|Protocol Violation|3|||
125265737|NCT00950651|450601757|FG001|Overall Study|Protocol Violation|4|||
125265738|NCT00950651|450601756|FG000|Overall Study|Withdrawal by Subject|8|||
125265739|NCT00950651|450601757|FG001|Overall Study|Withdrawal by Subject|9|||
125265740|NCT02850978|450601762|FG000|Overall Study|Uncollectable CRF|27|||
125265741|NCT02850978|450601762|FG000|Overall Study|No visit since the first visit|35|||
125265742|NCT02850978|450601762|FG000|Overall Study|Adverse Event|81|||
125265743|NCT02850978|450601762|FG000|Overall Study|Lack of Efficacy|40|||
125265744|NCT02850978|450601762|FG000|Overall Study|Improvement in condition|34|||
125265745|NCT02850978|450601762|FG000|Overall Study|Lost to Follow-up|121|||
125265746|NCT02850978|450601762|FG000|Overall Study|Reason not listed|88|||
125265747|NCT03188263|450601766|FG000|Overall Study|Withdrawal by Subject|3|||
125265748|NCT03188263|450601767|FG001|Overall Study|Withdrawal by Subject|0|||
125265749|NCT03188263|450601766|FG000|Overall Study|Physician Decision|1|||
125265750|NCT03188263|450601767|FG001|Overall Study|Physician Decision|0|||
125265751|NCT01030822|450601768|FG000|Overall Study|Moved/migrated from study area|6|||
125265752|NCT01030822|450601769|FG001|Overall Study|Moved/migrated from study area|7|||
125265753|NCT01030822|450601770|FG002|Overall Study|Moved/migrated from study area|3|||
125265754|NCT01030822|450601768|FG000|Overall Study|Withdrawal by Subject|16|||
125265755|NCT01030822|450601769|FG001|Overall Study|Withdrawal by Subject|13|||
125265756|NCT01030822|450601770|FG002|Overall Study|Withdrawal by Subject|16|||
125265757|NCT01030822|450601768|FG000|Overall Study|Lost to Follow-up|9|||
125265758|NCT01030822|450601769|FG001|Overall Study|Lost to Follow-up|4|||
125265759|NCT01030822|450601770|FG002|Overall Study|Lost to Follow-up|7|||
125265760|NCT00539240|450601771|FG000|Overall Study|Withdrawal by Subject|0|||
125265761|NCT00539240|450601772|FG001|Overall Study|Withdrawal by Subject|2|||
125265762|NCT00539240|450601773|FG002|Overall Study|Withdrawal by Subject|0|||
125265763|NCT00539240|450601771|FG000|Overall Study|Protocol Violation|1|||
125265764|NCT00539240|450601772|FG001|Overall Study|Protocol Violation|1|||
125265765|NCT00539240|450601773|FG002|Overall Study|Protocol Violation|4|||
125265766|NCT00539240|450601771|FG000|Overall Study|Lost to Follow-up|2|||
125265767|NCT00539240|450601772|FG001|Overall Study|Lost to Follow-up|3|||
125265768|NCT00539240|450601773|FG002|Overall Study|Lost to Follow-up|1|||
125265769|NCT00539240|450601771|FG000|Overall Study|Adverse Event|3|||
125265770|NCT00539240|450601772|FG001|Overall Study|Adverse Event|1|||
125265771|NCT00539240|450601773|FG002|Overall Study|Adverse Event|10|||
125265772|NCT01055613|450601775|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
125265773|NCT01055613|450601776|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
125265774|NCT01055613|450601775|FG000|Overall Study|Unacceptable lens fit|1|||
125265775|NCT01055613|450601776|FG001|Overall Study|Unacceptable lens fit|0|||
125265776|NCT01055613|450601775|FG000|Overall Study|Discomfort|2|||
125265777|NCT01055613|450601776|FG001|Overall Study|Discomfort|1|||
125265778|NCT01055613|450601775|FG000|Overall Study|Lost to Follow-up|1|||
125265779|NCT01055613|450601776|FG001|Overall Study|Lost to Follow-up|1|||
125265780|NCT01055613|450601775|FG000|Overall Study|Protocol Violation|1|||
125265781|NCT01055613|450601776|FG001|Overall Study|Protocol Violation|1|||
125265782|NCT01055613|450601775|FG000|Overall Study|Subject Disinterest|1|||
125265783|NCT01055613|450601776|FG001|Overall Study|Subject Disinterest|1|||
125265784|NCT02765399|450601777|FG000|Overall Study|Nausea|1|||
125265785|NCT02765399|450601778|FG001|Overall Study|Nausea|0|||
125265786|NCT01182298|450601787|FG000|Overall Study|Lack of Efficacy|4|||
125265787|NCT01182298|450601787|FG000|Overall Study|Withdrawal by Subject|2|||
125265788|NCT04540367|450601801|FG000|Overall Study|Withdrawal by Subject|0|||
125265789|NCT04540367|450601802|FG001|Overall Study|Withdrawal by Subject|0|||
125265790|NCT04540367|450601803|FG002|Overall Study|Withdrawal by Subject|0|||
125265791|NCT04540367|450601804|FG003|Overall Study|Withdrawal by Subject|2|||
125265792|NCT04540367|450601801|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
125265793|NCT04540367|450601802|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
125265794|NCT04540367|450601803|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
125265795|NCT04540367|450601804|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
125265796|NCT04540367|450601801|FG000|Overall Study|Adverse Event|0|||
125265797|NCT04540367|450601802|FG001|Overall Study|Adverse Event|0|||
125265798|NCT04540367|450601803|FG002|Overall Study|Adverse Event|1|||
125265799|NCT04540367|450601804|FG003|Overall Study|Adverse Event|1|||
125265800|NCT03958331|450601806|FG000|Overall Study|Withdrawal by Subject|3|||
125265801|NCT03958331|450601807|FG001|Overall Study|Withdrawal by Subject|1|||
125265802|NCT03958331|450601808|FG002|Overall Study|Withdrawal by Subject|5|||
125265803|NCT03958331|450601806|FG000|Overall Study|Weaned from medicine|2|||
125265804|NCT03958331|450601807|FG001|Overall Study|Weaned from medicine|0|||
125265805|NCT03958331|450601808|FG002|Overall Study|Weaned from medicine|0|||
125265806|NCT03958331|450601806|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
125265807|NCT03958331|450601807|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
125265808|NCT03958331|450601808|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
125265809|NCT04422431|450601811|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
125265810|NCT04422431|450601811|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
125265811|NCT04422431|450601811|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
125265812|NCT04422431|450601811|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
125265813|NCT04422431|450601811|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
125265814|NCT04422431|450601811|FG000|Extension Period (48 Weeks)|Other than specified|2|||
125265815|NCT02317627|450601814|FG000|Overall Study|Withdrawal by Subject|0|||
125265816|NCT02317627|450601815|FG001|Overall Study|Withdrawal by Subject|1|||
125265817|NCT02317627|450601816|FG002|Overall Study|Withdrawal by Subject|1|||
125265818|NCT02317627|450601814|FG000|Overall Study|Lost to Follow-up|2|||
125265819|NCT02317627|450601815|FG001|Overall Study|Lost to Follow-up|0|||
125265820|NCT02317627|450601816|FG002|Overall Study|Lost to Follow-up|0|||
125265821|NCT02317627|450601814|FG000|Overall Study|Stopped by Investigator|0|||
125265822|NCT02317627|450601815|FG001|Overall Study|Stopped by Investigator|1|||
125265823|NCT02317627|450601816|FG002|Overall Study|Stopped by Investigator|0|||
125265824|NCT02317627|450601814|FG000|Overall Study|Adverse Event|0|||
125265825|NCT02317627|450601815|FG001|Overall Study|Adverse Event|2|||
125265826|NCT02317627|450601816|FG002|Overall Study|Adverse Event|3|||
125265827|NCT02317627|450601814|FG000|Overall Study|Non-compliance with study drug|0|||
125265828|NCT02317627|450601815|FG001|Overall Study|Non-compliance with study drug|1|||
125265829|NCT02317627|450601816|FG002|Overall Study|Non-compliance with study drug|0|||
125265830|NCT01088906|450601818|FG000|Overall Study|Inclusion error|1|||
125265831|NCT01088906|450601818|FG000|Overall Study|Did not receive study treatment|3|||
125265832|NCT01088906|450601818|FG000|Overall Study|Missing data|1|||
125265833|NCT00027560|450601819|FG000|Overall Study|Withdrawal by Subject|1|||
125265834|NCT03384875|450601820|FG000|Overall Study|Death|1|||
125265835|NCT03384875|450601821|FG001|Overall Study|Death|1|||
125265836|NCT03384875|450601822|FG002|Overall Study|Death|0|||
125265837|NCT03384875|450601820|FG000|Overall Study|Reason not provided|1|||
125265838|NCT03384875|450601821|FG001|Overall Study|Reason not provided|0|||
125265839|NCT03384875|450601822|FG002|Overall Study|Reason not provided|0|||
125265840|NCT01772550|450603182|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
125265841|NCT01772550|450603183|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
125265842|NCT01772550|450603184|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
125265843|NCT01772550|450603182|FG000|Overall Study|Adverse Event|0|||
125265844|NCT01772550|450603183|FG001|Overall Study|Adverse Event|0|||
125265845|NCT01772550|450603184|FG002|Overall Study|Adverse Event|1|||
125265846|NCT03374358|450603187|FG000|Overall Study|Withdrawal by Subject|0|||
125265847|NCT03374358|450603188|FG001|Overall Study|Withdrawal by Subject|2|||
125265848|NCT03183063|450603189|FG000|Overall Study|Withdrawal by Subject|2|||
125265849|NCT03183063|450603190|FG001|Overall Study|Withdrawal by Subject|0|||
125265850|NCT03183063|450603191|FG002|Overall Study|Withdrawal by Subject|0|||
125265851|NCT03183063|450603189|FG000|Overall Study|Physician Decision|3|||
125265852|NCT03183063|450603190|FG001|Overall Study|Physician Decision|4|||
125265853|NCT03183063|450603191|FG002|Overall Study|Physician Decision|4|||
125265854|NCT01127633|450603192|FG000|Overall Study|Adverse Event|74|||
125265855|NCT01127633|450603193|FG001|Overall Study|Adverse Event|73|||
125265856|NCT01127633|450603192|FG000|Overall Study|Death|40|||
125265857|NCT01127633|450603193|FG001|Overall Study|Death|43|||
125265858|NCT01127633|450603192|FG000|Overall Study|Lost to Follow-up|4|||
125265859|NCT01127633|450603193|FG001|Overall Study|Lost to Follow-up|0|||
125265860|NCT01127633|450603192|FG000|Overall Study|Parent/Caregiver Decision|246|||
125265861|NCT01127633|450603193|FG001|Overall Study|Parent/Caregiver Decision|228|||
125265862|NCT01127633|450603192|FG000|Overall Study|Physician Decision|60|||
125265863|NCT01127633|450603193|FG001|Overall Study|Physician Decision|45|||
125265864|NCT01127633|450603192|FG000|Overall Study|Withdrawal by Subject|57|||
125265865|NCT01127633|450603193|FG001|Overall Study|Withdrawal by Subject|72|||
125265866|NCT01127633|450603192|FG000|Overall Study|Sponsor Decision|163|||
125265867|NCT01127633|450603193|FG001|Overall Study|Sponsor Decision|195|||
125265868|NCT01127633|450603192|FG000|Overall Study|Protocol Violation|8|||
125265869|NCT01127633|450603193|FG001|Overall Study|Protocol Violation|16|||
125265870|NCT01127633|450603192|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
125265871|NCT01127633|450603193|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
125265872|NCT01127633|450603192|FG000|Overall Study|Not treated|1|||
125265873|NCT01127633|450603193|FG001|Overall Study|Not treated|0|||
125265874|NCT00688467|450603195|FG000|Treatment Period 1|Adverse Event|2|||
125265875|NCT00688467|450603196|FG001|Treatment Period 1|Adverse Event|1|||
125265876|NCT00688467|450603195|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
125265877|NCT00688467|450603196|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
125265878|NCT00688467|450603195|FG000|Treatment Period 2|Protocol Violation|0|||
125265879|NCT00688467|450603196|FG001|Treatment Period 2|Protocol Violation|1|||
125265880|NCT00688467|450603195|FG000|Treatment Period 2|Adverse Event|0|||
125265881|NCT00688467|450603196|FG001|Treatment Period 2|Adverse Event|1|||
125265882|NCT00690794|450603199|FG000|Overall Study|Adverse Event|12|||
125265883|NCT00690794|450603200|FG001|Overall Study|Adverse Event|10|||
125265884|NCT00690794|450603199|FG000|Overall Study|Lost to Follow-up|1|||
125265885|NCT00690794|450603200|FG001|Overall Study|Lost to Follow-up|4|||
125265886|NCT00690794|450603199|FG000|Overall Study|Withdrawal by Subject|0|||
125265887|NCT00690794|450603200|FG001|Overall Study|Withdrawal by Subject|9|||
125265888|NCT00690794|450603199|FG000|Overall Study|Protocol Violation|6|||
125265889|NCT00690794|450603200|FG001|Overall Study|Protocol Violation|7|||
125265890|NCT00690794|450603199|FG000|Overall Study|Noncompliance|1|||
125265891|NCT00690794|450603200|FG001|Overall Study|Noncompliance|2|||
125265892|NCT00690794|450603199|FG000|Overall Study|Other not specified|1|||
125265893|NCT00690794|450603200|FG001|Overall Study|Other not specified|3|||
125265894|NCT01823107|450603201|FG000|Overall Study|Withdrawal by Subject|1|||
125265895|NCT01343888|450603202|FG000|Overall Study|Adverse Event|12|||
125265896|NCT01343888|450603203|FG001|Overall Study|Adverse Event|22|||
125265897|NCT01343888|450603204|FG002|Overall Study|Adverse Event|5|||
125265898|NCT01343888|450603202|FG000|Overall Study|Lack of Efficacy|9|||
125265899|NCT01343888|450603203|FG001|Overall Study|Lack of Efficacy|9|||
125265900|NCT01343888|450603204|FG002|Overall Study|Lack of Efficacy|13|||
125265901|NCT01343888|450603202|FG000|Overall Study|Lost to Follow-up|0|||
125265902|NCT01343888|450603203|FG001|Overall Study|Lost to Follow-up|2|||
125265903|NCT01343888|450603204|FG002|Overall Study|Lost to Follow-up|1|||
125265904|NCT01343888|450603202|FG000|Overall Study|Protocol Violation|0|||
125265905|NCT01343888|450603203|FG001|Overall Study|Protocol Violation|2|||
125265906|NCT01343888|450603204|FG002|Overall Study|Protocol Violation|0|||
125265907|NCT01343888|450603202|FG000|Overall Study|Withdrawal by Subject|4|||
125265908|NCT01343888|450603203|FG001|Overall Study|Withdrawal by Subject|4|||
125265909|NCT01343888|450603204|FG002|Overall Study|Withdrawal by Subject|2|||
125265910|NCT01343888|450603202|FG000|Overall Study|other than stated above|0|||
125265911|NCT01343888|450603203|FG001|Overall Study|other than stated above|0|||
125265912|NCT01343888|450603204|FG002|Overall Study|other than stated above|1|||
125265913|NCT00800735|450603207|FG000|Overall Study|Administrative/Other|2|||
125265914|NCT00800735|450603207|FG000|Overall Study|Insufficient Therapeutic Response|2|||
125265915|NCT00800735|450603207|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
125265916|NCT00800735|450603207|FG000|Overall Study|Withdrew Consent|3|||
125265917|NCT02805790|450603208|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
125265918|NCT02805790|450603209|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
125265919|NCT04460183|450603210|FG000|Overall Study|Lost to Follow-up|3|||
125265920|NCT04460183|450603211|FG001|Overall Study|Lost to Follow-up|1|||
125265921|NCT04460183|450603210|FG000|Overall Study|Withdrawal by Subject|1|||
125265922|NCT04460183|450603211|FG001|Overall Study|Withdrawal by Subject|0|||
125265923|NCT00856323|450603212|FG000|Overall Study|Withdrawal by Subject|2|||
125265924|NCT01847092|450603213|FG000|Overall Study|Adverse Event|12|||
125265925|NCT01847092|450603214|FG001|Overall Study|Adverse Event|3|||
125265926|NCT01847092|450603213|FG000|Overall Study|Withdrawal by Subject|5|||
125265927|NCT01847092|450603214|FG001|Overall Study|Withdrawal by Subject|5|||
125265928|NCT01847092|450603213|FG000|Overall Study|Protocol Specified|8|||
125265929|NCT01847092|450603214|FG001|Overall Study|Protocol Specified|0|||
125265930|NCT01847092|450603213|FG000|Overall Study|Physician Decision|1|||
125265931|NCT01847092|450603214|FG001|Overall Study|Physician Decision|1|||
125265932|NCT01847092|450603213|FG000|Overall Study|Protocol Violation|0|||
125265933|NCT01847092|450603214|FG001|Overall Study|Protocol Violation|2|||
125265934|NCT00825994|450603215|FG000|Overall Study|Withdrawal by Subject|2|||
125265935|NCT00825994|450603215|FG000|Overall Study|Lost to Follow-up|1|||
125265936|NCT00825994|450603215|FG000|Overall Study|Protocol Violation|1|||
125265937|NCT00825994|450603215|FG000|Overall Study|Placebo Responder at V2|1|||
125265938|NCT01331681|450603216|FG000|Overall Study|Adverse Event|10|||
125265939|NCT01331681|450603217|FG001|Overall Study|Adverse Event|13|||
125265940|NCT01331681|450603218|FG002|Overall Study|Adverse Event|10|||
125265941|NCT01331681|450603216|FG000|Overall Study|Death|6|||
125265942|NCT01331681|450603217|FG001|Overall Study|Death|6|||
125265943|NCT01331681|450603218|FG002|Overall Study|Death|2|||
125265944|NCT01331681|450603216|FG000|Overall Study|Lack of Efficacy|0|||
125265945|NCT01331681|450603217|FG001|Overall Study|Lack of Efficacy|1|||
125265946|NCT01331681|450603218|FG002|Overall Study|Lack of Efficacy|0|||
125265947|NCT01331681|450603216|FG000|Overall Study|Withdrawal by Subject|12|||
125265948|NCT01331681|450603217|FG001|Overall Study|Withdrawal by Subject|8|||
125265949|NCT01331681|450603218|FG002|Overall Study|Withdrawal by Subject|15|||
125265950|NCT01331681|450603216|FG000|Overall Study|Protocol Violation|1|||
125265951|NCT01331681|450603217|FG001|Overall Study|Protocol Violation|1|||
125265952|NCT01331681|450603218|FG002|Overall Study|Protocol Violation|0|||
125265953|NCT01331681|450603216|FG000|Overall Study|Lost to Follow-up|2|||
125265954|NCT01331681|450603217|FG001|Overall Study|Lost to Follow-up|4|||
125265955|NCT01331681|450603218|FG002|Overall Study|Lost to Follow-up|1|||
125265956|NCT01331681|450603216|FG000|Overall Study|Physician Decision|2|||
125265957|NCT01331681|450603217|FG001|Overall Study|Physician Decision|0|||
125265958|NCT01331681|450603218|FG002|Overall Study|Physician Decision|4|||
125265959|NCT01331681|450603216|FG000|Overall Study|Therapeutic procedure required|1|||
125265960|NCT01331681|450603217|FG001|Overall Study|Therapeutic procedure required|0|||
125265961|NCT01331681|450603218|FG002|Overall Study|Therapeutic procedure required|0|||
125265962|NCT01331681|450603216|FG000|Overall Study|Sponsor decision|1|||
125265963|NCT01331681|450603217|FG001|Overall Study|Sponsor decision|1|||
125265964|NCT01331681|450603218|FG002|Overall Study|Sponsor decision|0|||
125265965|NCT01331681|450603216|FG000|Overall Study|Switching to other therapy|0|||
125265966|NCT01331681|450603217|FG001|Overall Study|Switching to other therapy|0|||
125265967|NCT01331681|450603218|FG002|Overall Study|Switching to other therapy|1|||
125265968|NCT01331681|450603216|FG000|Overall Study|Not Received Study Treatment|0|||
125265969|NCT01331681|450603217|FG001|Overall Study|Not Received Study Treatment|0|||
125265970|NCT01331681|450603218|FG002|Overall Study|Not Received Study Treatment|2|||
125265971|NCT00658541|450603220|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
125265972|NCT00658541|450603221|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
125265973|NCT00658541|450603220|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
125265974|NCT00658541|450603221|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
125265975|NCT01063348|450603222|FG000|Overall Study|Lost to Follow-up|3|||
125265976|NCT01063348|450603223|FG001|Overall Study|Lost to Follow-up|10|||
125265977|NCT01876381|450603224|FG000|Overall Study|Lack of Efficacy|5|||
125265978|NCT01876381|450603224|FG000|Overall Study|Physician Decision|1|||
125265979|NCT01876381|450603224|FG000|Overall Study|Withdrawal by Subject|1|||
125265980|NCT02394561|450603225|FG000|CORE Phase|Adverse Event|7|||
125265981|NCT02394561|450603226|FG001|CORE Phase|Adverse Event|9|||
125265982|NCT02394561|450603225|FG000|CORE Phase|Death|0|||
125265983|NCT02394561|450603226|FG001|CORE Phase|Death|1|||
125265984|NCT02394561|450603225|FG000|CORE Phase|Pregnancy|1|||
125265985|NCT02394561|450603226|FG001|CORE Phase|Pregnancy|0|||
125265986|NCT02394561|450603225|FG000|CORE Phase|Lost to Follow-up|1|||
125265987|NCT02394561|450603226|FG001|CORE Phase|Lost to Follow-up|0|||
125265988|NCT02394561|450603225|FG000|CORE Phase|Physician Decision|1|||
125265989|NCT02394561|450603226|FG001|CORE Phase|Physician Decision|1|||
125265990|NCT02394561|450603225|FG000|CORE Phase|Withdrawal by Subject|2|||
125265991|NCT02394561|450603226|FG001|CORE Phase|Withdrawal by Subject|2|||
125265992|NCT02394561|450603225|FG000|CORE Phase|Lack of Efficacy|1|||
125265993|NCT02394561|450603226|FG001|CORE Phase|Lack of Efficacy|6|||
125265994|NCT02394561|450603225|FG000|Extension Phase|Adverse Event|6|||
125265995|NCT02394561|450603226|FG001|Extension Phase|Adverse Event|1|||
125265996|NCT02394561|450603225|FG000|Extension Phase|Death|0|||
125265997|NCT02394561|450603226|FG001|Extension Phase|Death|1|||
125265998|NCT02394561|450603225|FG000|Extension Phase|Protocol Violation|1|||
125265999|NCT02394561|450603226|FG001|Extension Phase|Protocol Violation|0|||
125266000|NCT02394561|450603225|FG000|Extension Phase|Lost to Follow-up|1|||
125266001|NCT02394561|450603226|FG001|Extension Phase|Lost to Follow-up|0|||
125266002|NCT02394561|450603225|FG000|Extension Phase|Physician Decision|0|||
125266003|NCT02394561|450603226|FG001|Extension Phase|Physician Decision|2|||
125266004|NCT02394561|450603225|FG000|Extension Phase|Withdrawal by Subject|0|||
125266005|NCT02394561|450603226|FG001|Extension Phase|Withdrawal by Subject|5|||
125266006|NCT02394561|450603225|FG000|Extension Phase|Lack of Efficacy|3|||
125266007|NCT02394561|450603226|FG001|Extension Phase|Lack of Efficacy|3|||
125266008|NCT00501644|450603227|FG000|Overall Study|Adverse Event|4|||
125266009|NCT00501644|450603227|FG000|Overall Study|Withdrawal by Subject|1|||
125266010|NCT04577781|450603228|FG000|Overall Study|Adverse Event|2|||
125266011|NCT04577781|450603229|FG001|Overall Study|Adverse Event|2|||
125266012|NCT04577781|450603228|FG000|Overall Study|Physician Decision|1|||
125266013|NCT04577781|450603229|FG001|Overall Study|Physician Decision|0|||
125266014|NCT01957865|450603230|FG000|Overall Study|Found HIV negative|0|||
125266015|NCT01957865|450603231|FG001|Overall Study|Found HIV negative|0|||
125266016|NCT01957865|450603232|FG002|Overall Study|Found HIV negative|1|||
125266017|NCT01957865|450603230|FG000|Overall Study|Lost to Follow-up|0|||
125266018|NCT01957865|450603231|FG001|Overall Study|Lost to Follow-up|2|||
125266019|NCT01957865|450603232|FG002|Overall Study|Lost to Follow-up|2|||
125266020|NCT02756403|450603240|FG000|Overall Study|Unable to swallow medication|0|||
125266021|NCT02756403|450603241|FG001|Overall Study|Unable to swallow medication|1|||
125266022|NCT02756403|450603242|FG002|Overall Study|Unable to swallow medication|1|||
125266023|NCT02756403|450603243|FG003|Overall Study|Unable to swallow medication|1|||
125266024|NCT02756403|450603240|FG000|Overall Study|Did not complete Procedure|0|||
125266025|NCT02756403|450603241|FG001|Overall Study|Did not complete Procedure|1|||
125266026|NCT02756403|450603242|FG002|Overall Study|Did not complete Procedure|0|||
125266027|NCT02756403|450603243|FG003|Overall Study|Did not complete Procedure|0|||
125266028|NCT02756403|450603240|FG000|Overall Study|Changed Mind About Procedure|0|||
125266029|NCT02756403|450603241|FG001|Overall Study|Changed Mind About Procedure|0|||
125266030|NCT02756403|450603242|FG002|Overall Study|Changed Mind About Procedure|1|||
125266031|NCT02756403|450603243|FG003|Overall Study|Changed Mind About Procedure|0|||
125266032|NCT02756403|450603240|FG000|Overall Study|Protocol Violation|0|||
125266033|NCT02756403|450603241|FG001|Overall Study|Protocol Violation|1|||
125266034|NCT02756403|450603242|FG002|Overall Study|Protocol Violation|0|||
125266035|NCT02756403|450603243|FG003|Overall Study|Protocol Violation|1|||
125266036|NCT01644643|450603244|FG000|Overall Study|Death|1|||
125266037|NCT01644643|450603245|FG001|Overall Study|Death|0|||
125266038|NCT01644643|450603246|FG002|Overall Study|Death|3|||
125266039|NCT01644643|450603247|FG003|Overall Study|Death|3|||
125266040|NCT01644643|450603244|FG000|Overall Study|Lost to Follow-up|0|||
125266041|NCT01644643|450603245|FG001|Overall Study|Lost to Follow-up|0|||
125266042|NCT01644643|450603246|FG002|Overall Study|Lost to Follow-up|0|||
125266043|NCT01644643|450603247|FG003|Overall Study|Lost to Follow-up|4|||
125266044|NCT01644643|450603244|FG000|Overall Study|Withdrawal by Subject|1|||
125266045|NCT01644643|450603245|FG001|Overall Study|Withdrawal by Subject|0|||
125266046|NCT01644643|450603246|FG002|Overall Study|Withdrawal by Subject|2|||
125266047|NCT01644643|450603247|FG003|Overall Study|Withdrawal by Subject|1|||
125266048|NCT01644643|450603244|FG000|Overall Study|Other Eligibility criteria|0|||
125266049|NCT01644643|450603245|FG001|Overall Study|Other Eligibility criteria|0|||
125266050|NCT01644643|450603246|FG002|Overall Study|Other Eligibility criteria|0|||
125266051|NCT01644643|450603247|FG003|Overall Study|Other Eligibility criteria|2|||
125266052|NCT00114127|450603249|FG000|Overall Study|Adverse Event|2|||
125266053|NCT00114127|450603250|FG001|Overall Study|Adverse Event|1|||
125266054|NCT00114127|450603249|FG000|Overall Study|Lost to Follow-up|1|||
125266055|NCT00114127|450603250|FG001|Overall Study|Lost to Follow-up|0|||
125266056|NCT00114127|450603249|FG000|Overall Study|Withdrawal by Subject|1|||
125266057|NCT00114127|450603250|FG001|Overall Study|Withdrawal by Subject|3|||
125266058|NCT00699413|450603251|FG000|Overall Study|Withdrawal by Subject|0|||
125266059|NCT00699413|450603252|FG001|Overall Study|Withdrawal by Subject|2|||
125266060|NCT00699413|450603251|FG000|Overall Study|Study terminated by sponsor|4|||
125266061|NCT00699413|450603252|FG001|Overall Study|Study terminated by sponsor|2|||
125266062|NCT00881894|450603253|FG000|Overall Study|Consent withdrawn|0|||
125266063|NCT00881894|450603254|FG001|Overall Study|Consent withdrawn|1|||
125266064|NCT00881894|450603253|FG000|Overall Study|Other reasons for premature termination|1|||
125266065|NCT00881894|450603254|FG001|Overall Study|Other reasons for premature termination|2|||
125266066|NCT00421148|450603255|FG000|Overall Study|Lost to Follow-up|0|||
125266067|NCT00421148|450603256|FG001|Overall Study|Lost to Follow-up|0|||
125266068|NCT00421148|450603257|FG002|Overall Study|Lost to Follow-up|0|||
125266069|NCT00421148|450603258|FG003|Overall Study|Lost to Follow-up|0|||
125266070|NCT00421148|450603259|FG004|Overall Study|Lost to Follow-up|0|||
125266071|NCT00421148|450603260|FG005|Overall Study|Lost to Follow-up|0|||
125266072|NCT00421148|450603261|FG006|Overall Study|Lost to Follow-up|0|||
125266073|NCT00421148|450603262|FG007|Overall Study|Lost to Follow-up|0|||
125266074|NCT00421148|450603263|FG008|Overall Study|Lost to Follow-up|0|||
125266075|NCT00421148|450603264|FG009|Overall Study|Lost to Follow-up|0|||
125266076|NCT00421148|450603265|FG010|Overall Study|Lost to Follow-up|0|||
125266077|NCT00421148|450603266|FG011|Overall Study|Lost to Follow-up|0|||
125266078|NCT00421148|450603267|FG012|Overall Study|Lost to Follow-up|0|||
125266079|NCT00421148|450603268|FG013|Overall Study|Lost to Follow-up|0|||
125266080|NCT00421148|450603269|FG014|Overall Study|Lost to Follow-up|0|||
125266081|NCT00421148|450603270|FG015|Overall Study|Lost to Follow-up|0|||
125266082|NCT00421148|450603271|FG016|Overall Study|Lost to Follow-up|0|||
125266083|NCT00421148|450603272|FG017|Overall Study|Lost to Follow-up|1|||
125266084|NCT00421148|450603273|FG018|Overall Study|Lost to Follow-up|0|||
125266085|NCT00421148|450603274|FG019|Overall Study|Lost to Follow-up|0|||
125266086|NCT00421148|450603255|FG000|Overall Study|Withdrawal by Subject|0|||
125266087|NCT00421148|450603256|FG001|Overall Study|Withdrawal by Subject|0|||
125266088|NCT00421148|450603257|FG002|Overall Study|Withdrawal by Subject|0|||
125266089|NCT00421148|450603258|FG003|Overall Study|Withdrawal by Subject|0|||
125266090|NCT00421148|450603259|FG004|Overall Study|Withdrawal by Subject|0|||
125266091|NCT00421148|450603260|FG005|Overall Study|Withdrawal by Subject|0|||
125266092|NCT00421148|450603261|FG006|Overall Study|Withdrawal by Subject|0|||
125266093|NCT00421148|450603262|FG007|Overall Study|Withdrawal by Subject|0|||
125266094|NCT00421148|450603263|FG008|Overall Study|Withdrawal by Subject|0|||
125266095|NCT00421148|450603264|FG009|Overall Study|Withdrawal by Subject|0|||
125266096|NCT00421148|450603265|FG010|Overall Study|Withdrawal by Subject|0|||
125266097|NCT00421148|450603266|FG011|Overall Study|Withdrawal by Subject|0|||
125266098|NCT00421148|450603267|FG012|Overall Study|Withdrawal by Subject|0|||
125266099|NCT00421148|450603268|FG013|Overall Study|Withdrawal by Subject|0|||
125266100|NCT00421148|450603269|FG014|Overall Study|Withdrawal by Subject|0|||
125266101|NCT00421148|450603270|FG015|Overall Study|Withdrawal by Subject|0|||
125266102|NCT00421148|450603271|FG016|Overall Study|Withdrawal by Subject|0|||
125266103|NCT00421148|450603272|FG017|Overall Study|Withdrawal by Subject|1|||
125266104|NCT00421148|450603273|FG018|Overall Study|Withdrawal by Subject|0|||
125266105|NCT00421148|450603274|FG019|Overall Study|Withdrawal by Subject|0|||
125266106|NCT00421148|450603255|FG000|Overall Study|Protocol Violation|0|||
125266107|NCT00421148|450603256|FG001|Overall Study|Protocol Violation|0|||
125266108|NCT00421148|450603257|FG002|Overall Study|Protocol Violation|0|||
125266109|NCT00421148|450603258|FG003|Overall Study|Protocol Violation|0|||
125266110|NCT00421148|450603259|FG004|Overall Study|Protocol Violation|0|||
125266111|NCT00421148|450603260|FG005|Overall Study|Protocol Violation|1|||
125266112|NCT00421148|450603261|FG006|Overall Study|Protocol Violation|0|||
125266113|NCT00421148|450603262|FG007|Overall Study|Protocol Violation|0|||
125266114|NCT00421148|450603263|FG008|Overall Study|Protocol Violation|0|||
125266115|NCT00421148|450603264|FG009|Overall Study|Protocol Violation|0|||
125266116|NCT00421148|450603265|FG010|Overall Study|Protocol Violation|0|||
125266117|NCT00421148|450603266|FG011|Overall Study|Protocol Violation|0|||
125266118|NCT00421148|450603267|FG012|Overall Study|Protocol Violation|0|||
125266119|NCT00421148|450603268|FG013|Overall Study|Protocol Violation|0|||
125266120|NCT00421148|450603269|FG014|Overall Study|Protocol Violation|0|||
125266121|NCT00421148|450603270|FG015|Overall Study|Protocol Violation|0|||
125266122|NCT00421148|450603271|FG016|Overall Study|Protocol Violation|0|||
125266123|NCT00421148|450603272|FG017|Overall Study|Protocol Violation|0|||
125266124|NCT00421148|450603273|FG018|Overall Study|Protocol Violation|1|||
125266125|NCT00421148|450603274|FG019|Overall Study|Protocol Violation|0|||
125266126|NCT00469833|450603276|FG000|Overall Study|No IV access|2|||
125266127|NCT01253369|450603277|FG000|Overall Study|Adverse Event|4|||
125266128|NCT01253369|450603277|FG000|Overall Study|Withdrawal by Subject|2|||
125266129|NCT01253369|450603277|FG000|Overall Study|Death|1|||
125266130|NCT01253369|450603277|FG000|Overall Study|Progressive disease|23|||
125266131|NCT01253369|450603277|FG000|Overall Study|Not Evaluable|3|||
125266132|NCT03289533|450603278|FG000|Overall Study|Death|12|||
125266133|NCT03289533|450603278|FG000|Overall Study|Terminated from study by sponsor|10|||
125266134|NCT04016714|450603279|FG000|Overall Study|Death|1|||
125266135|NCT04016714|450603280|FG001|Overall Study|Death|0|||
125266136|NCT04016714|450603279|FG000|Overall Study|Lost to Follow-up|3|||
125266137|NCT04016714|450603280|FG001|Overall Study|Lost to Follow-up|1|||
125266138|NCT04016714|450603279|FG000|Overall Study|Physician Decision|3|||
125266139|NCT04016714|450603280|FG001|Overall Study|Physician Decision|3|||
125266140|NCT04016714|450603279|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
125266141|NCT04016714|450603280|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
125266142|NCT01822665|450603287|FG000|Overall Study|Adverse Event|3|||
125266143|NCT01822665|450603287|FG000|Overall Study|Other Reason|5|||
125266144|NCT00959907|450603289|FG000|Overall Study|Protocol Violation|0|||
125266145|NCT00959907|450603290|FG001|Overall Study|Protocol Violation|1|||
125266146|NCT00959907|450603289|FG000|Overall Study|Adverse Event|1|||
125266147|NCT00959907|450603290|FG001|Overall Study|Adverse Event|0|||
125266148|NCT00959907|450603289|FG000|Overall Study|Withdrawal by Subject|2|||
125266149|NCT00959907|450603290|FG001|Overall Study|Withdrawal by Subject|0|||
125266150|NCT01171677|450603292|FG000|Overall Study|Withdrawal by Subject|0|||
125266151|NCT01171677|450603293|FG001|Overall Study|Withdrawal by Subject|3|||
125266152|NCT01171677|450603292|FG000|Overall Study|Adverse Event|1|||
125266153|NCT01171677|450603293|FG001|Overall Study|Adverse Event|0|||
125266154|NCT01171677|450603292|FG000|Overall Study|completed <70% IntenSati classes|5|||
125266155|NCT01171677|450603293|FG001|Overall Study|completed <70% IntenSati classes|0|||
125266156|NCT01847443|450603294|FG000|Study Period 1|Withdrawal by Subject|0|||
125266157|NCT01847443|450603295|FG001|Study Period 1|Withdrawal by Subject|1|||
125266158|NCT01847443|450603296|FG002|Study Period 1|Withdrawal by Subject|0|||
125266159|NCT01847443|450603297|FG003|Study Period 1|Withdrawal by Subject|0|||
125266160|NCT01847443|450603294|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
125266161|NCT01847443|450603295|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
125266162|NCT01847443|450603296|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
125266163|NCT01847443|450603297|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
125266164|NCT01847443|450603294|FG000|Washout Period Before Study Period 2|Other reason|1|||
125266165|NCT01847443|450603295|FG001|Washout Period Before Study Period 2|Other reason|0|||
125266166|NCT01847443|450603296|FG002|Washout Period Before Study Period 2|Other reason|0|||
125266167|NCT01847443|450603297|FG003|Washout Period Before Study Period 2|Other reason|0|||
125266168|NCT01847443|450603294|FG000|Washout Period Before Study Period 3|Other reason|1|||
125266169|NCT01847443|450603295|FG001|Washout Period Before Study Period 3|Other reason|0|||
125266170|NCT01847443|450603296|FG002|Washout Period Before Study Period 3|Other reason|0|||
125266171|NCT01847443|450603297|FG003|Washout Period Before Study Period 3|Other reason|0|||
125266172|NCT01847443|450603294|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
125266173|NCT01847443|450603295|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
125266174|NCT01847443|450603296|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
125266175|NCT01847443|450603297|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
125266176|NCT01847443|450603294|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
125266177|NCT01847443|450603295|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
125266178|NCT01847443|450603296|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
125266179|NCT01847443|450603297|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
125266180|NCT03571971|450603298|FG000|Overall Study|Lost to Follow-up|2|||
125266181|NCT03571971|450603299|FG001|Overall Study|Lost to Follow-up|2|||
125266182|NCT03571971|450603298|FG000|Overall Study|Protocol Violation|2|||
125266183|NCT03571971|450603299|FG001|Overall Study|Protocol Violation|3|||
125266184|NCT03571971|450603298|FG000|Overall Study|Withdrawal by Subject|2|||
125266185|NCT03571971|450603299|FG001|Overall Study|Withdrawal by Subject|0|||
125266186|NCT03571971|450603298|FG000|Overall Study|Incomplete primary outcome data|2|||
125266187|NCT03571971|450603299|FG001|Overall Study|Incomplete primary outcome data|0|||
125266188|NCT04046939|450603309|FG000|Primary Assessment Period|Adverse Event|1|||
125266189|NCT04046939|450603310|FG001|Primary Assessment Period|Adverse Event|0|||
125266190|NCT04046939|450603311|FG002|Primary Assessment Period|Adverse Event|0|||
125266191|NCT04046939|450603312|FG003|Primary Assessment Period|Adverse Event|0|||
125266192|NCT04046939|450603309|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
125266193|NCT04046939|450603310|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
125266194|NCT04046939|450603311|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
125266195|NCT04046939|450603312|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
125266196|NCT04046939|450603309|FG000|Primary Assessment Period|Physician Decision|0|||
125266197|NCT04046939|450603310|FG001|Primary Assessment Period|Physician Decision|0|||
125266198|NCT04046939|450603311|FG002|Primary Assessment Period|Physician Decision|1|||
125266199|NCT04046939|450603312|FG003|Primary Assessment Period|Physician Decision|0|||
125266200|NCT04046939|450603309|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
125266201|NCT04046939|450603310|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
125266202|NCT04046939|450603311|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
125266203|NCT04046939|450603312|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
125266204|NCT00403130|450603313|FG000|2 Years From Start of Treatment|Not Eligible|3|||
125266205|NCT00403130|450603313|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
125266206|NCT00403130|450603313|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
125266207|NCT00403130|450603313|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
125266208|NCT00806260|450603314|FG000|Period 1 (1 Day)|Adverse Event|0|||
125266209|NCT00806260|450603315|FG001|Period 1 (1 Day)|Adverse Event|0|||
125266210|NCT00806260|450603316|FG002|Period 1 (1 Day)|Adverse Event|0|||
125266211|NCT00806260|450603317|FG003|Period 1 (1 Day)|Adverse Event|0|||
125266212|NCT00806260|450603318|FG004|Period 1 (1 Day)|Adverse Event|3|||
125266213|NCT00806260|450603319|FG005|Period 1 (1 Day)|Adverse Event|0|||
125266214|NCT00806260|450603314|FG000|Period 2|Adverse Event|0|||
125266215|NCT00806260|450603315|FG001|Period 2|Adverse Event|0|||
125266216|NCT00806260|450603316|FG002|Period 2|Adverse Event|0|||
125266217|NCT00806260|450603317|FG003|Period 2|Adverse Event|1|||
125266218|NCT00806260|450603318|FG004|Period 2|Adverse Event|0|||
125266219|NCT00806260|450603319|FG005|Period 2|Adverse Event|0|||
125266220|NCT00806260|450603314|FG000|Period 2|Protocol Violation|1|||
125266221|NCT00806260|450603315|FG001|Period 2|Protocol Violation|0|||
125266222|NCT00806260|450603316|FG002|Period 2|Protocol Violation|1|||
125266223|NCT00806260|450603317|FG003|Period 2|Protocol Violation|0|||
125266224|NCT00806260|450603318|FG004|Period 2|Protocol Violation|0|||
125266225|NCT00806260|450603319|FG005|Period 2|Protocol Violation|0|||
125266226|NCT00806260|450603314|FG000|Period 2|Need to take concomitant medication|1|||
125266227|NCT00806260|450603315|FG001|Period 2|Need to take concomitant medication|0|||
125266228|NCT00806260|450603316|FG002|Period 2|Need to take concomitant medication|0|||
125266229|NCT00806260|450603317|FG003|Period 2|Need to take concomitant medication|0|||
125266230|NCT00806260|450603318|FG004|Period 2|Need to take concomitant medication|0|||
125266231|NCT00806260|450603319|FG005|Period 2|Need to take concomitant medication|0|||
125266232|NCT00806260|450603314|FG000|Period 2|sponsor request|0|||
125266233|NCT00806260|450603315|FG001|Period 2|sponsor request|0|||
125266234|NCT00806260|450603316|FG002|Period 2|sponsor request|1|||
125266235|NCT00806260|450603317|FG003|Period 2|sponsor request|1|||
125266236|NCT00806260|450603318|FG004|Period 2|sponsor request|0|||
125266237|NCT00806260|450603319|FG005|Period 2|sponsor request|0|||
125266238|NCT00806260|450603314|FG000|Period 3|Protocol Violation|0|||
125266239|NCT00806260|450603315|FG001|Period 3|Protocol Violation|1|||
125266240|NCT00806260|450603316|FG002|Period 3|Protocol Violation|1|||
125266241|NCT00806260|450603317|FG003|Period 3|Protocol Violation|0|||
125266242|NCT00806260|450603318|FG004|Period 3|Protocol Violation|0|||
125266243|NCT00806260|450603319|FG005|Period 3|Protocol Violation|0|||
125266244|NCT00806260|450603314|FG000|Period 3|Pregnancy|1|||
125266245|NCT00806260|450603315|FG001|Period 3|Pregnancy|0|||
125266246|NCT00806260|450603316|FG002|Period 3|Pregnancy|0|||
125266247|NCT00806260|450603317|FG003|Period 3|Pregnancy|0|||
125266248|NCT00806260|450603318|FG004|Period 3|Pregnancy|0|||
125266249|NCT00806260|450603319|FG005|Period 3|Pregnancy|0|||
125266250|NCT03559270|450603320|FG000|Overall Study|Adverse Event|6|||
125266251|NCT03559270|450603321|FG001|Overall Study|Adverse Event|5|||
125266252|NCT03559270|450603322|FG002|Overall Study|Adverse Event|3|||
125266253|NCT03559270|450603323|FG003|Overall Study|Adverse Event|0|||
125266254|NCT03559270|450603320|FG000|Overall Study|Lack of Efficacy|34|||
125266255|NCT03559270|450603321|FG001|Overall Study|Lack of Efficacy|52|||
125266256|NCT03559270|450603322|FG002|Overall Study|Lack of Efficacy|37|||
125266257|NCT03559270|450603323|FG003|Overall Study|Lack of Efficacy|2|||
125266258|NCT03559270|450603320|FG000|Overall Study|Death|0|||
125266259|NCT03559270|450603321|FG001|Overall Study|Death|2|||
125266260|NCT03559270|450603322|FG002|Overall Study|Death|0|||
125266261|NCT03559270|450603323|FG003|Overall Study|Death|0|||
125266262|NCT03559270|450603320|FG000|Overall Study|Lost to Follow-up|16|||
125266263|NCT03559270|450603321|FG001|Overall Study|Lost to Follow-up|4|||
125266264|NCT03559270|450603322|FG002|Overall Study|Lost to Follow-up|12|||
125266265|NCT03559270|450603323|FG003|Overall Study|Lost to Follow-up|3|||
125266266|NCT03559270|450603320|FG000|Overall Study|Sponsor Decision|38|||
125266267|NCT03559270|450603321|FG001|Overall Study|Sponsor Decision|31|||
125266268|NCT03559270|450603322|FG002|Overall Study|Sponsor Decision|35|||
125266269|NCT03559270|450603323|FG003|Overall Study|Sponsor Decision|18|||
125266270|NCT03559270|450603320|FG000|Overall Study|Withdrawal by Subject|19|||
125266271|NCT03559270|450603321|FG001|Overall Study|Withdrawal by Subject|21|||
125266272|NCT03559270|450603322|FG002|Overall Study|Withdrawal by Subject|18|||
125266273|NCT03559270|450603323|FG003|Overall Study|Withdrawal by Subject|7|||
125266274|NCT03559270|450603320|FG000|Overall Study|Physician Decision|3|||
125266275|NCT03559270|450603321|FG001|Overall Study|Physician Decision|2|||
125266276|NCT03559270|450603322|FG002|Overall Study|Physician Decision|1|||
125266277|NCT03559270|450603323|FG003|Overall Study|Physician Decision|0|||
125266278|NCT03559270|450603320|FG000|Overall Study|Pregnancy|0|||
125266279|NCT03559270|450603321|FG001|Overall Study|Pregnancy|1|||
125266280|NCT03559270|450603322|FG002|Overall Study|Pregnancy|0|||
125266281|NCT03559270|450603323|FG003|Overall Study|Pregnancy|0|||
125266282|NCT03559270|450603320|FG000|Overall Study|Protocol Violation|1|||
125266283|NCT03559270|450603321|FG001|Overall Study|Protocol Violation|0|||
125266284|NCT03559270|450603322|FG002|Overall Study|Protocol Violation|2|||
125266285|NCT03559270|450603323|FG003|Overall Study|Protocol Violation|0|||
125266286|NCT02735421|450604841|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
125266287|NCT02735421|450604841|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
125266288|NCT02735421|450604841|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
125266289|NCT02735421|450604841|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
125266290|NCT02735421|450604841|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
125266291|NCT02735421|450604841|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
125266292|NCT02735421|450604841|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
125266293|NCT05010070|450604842|FG000|Overall Study|Lost to Follow-up|1|||
125266294|NCT05010070|450604842|FG000|Overall Study|Withdrawal by Subject|1|||
125266295|NCT00939107|450604843|FG000|Overall Study|Lost to Follow-up|14|||
125266296|NCT00939107|450604844|FG001|Overall Study|Lost to Follow-up|12|||
125266297|NCT03247829|450604850|FG000|Overall Study|Death|3|||
125266298|NCT03247829|450604851|FG001|Overall Study|Death|4|||
125266299|NCT03247829|450604850|FG000|Overall Study|Enter Hospice Care|1|||
125266300|NCT03247829|450604851|FG001|Overall Study|Enter Hospice Care|0|||
125266301|NCT03247829|450604850|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
125266302|NCT03247829|450604851|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
125266303|NCT03247829|450604850|FG000|Overall Study|LVAD Explant|1|||
125266304|NCT03247829|450604851|FG001|Overall Study|LVAD Explant|1|||
125266305|NCT03247829|450604850|FG000|Overall Study|Transplant|1|||
125266306|NCT03247829|450604851|FG001|Overall Study|Transplant|1|||
125266307|NCT01783444|450604852|FG000|Treatment Phase|Adverse Event|9|||
125266308|NCT01783444|450604853|FG001|Treatment Phase|Adverse Event|20|||
125266309|NCT01783444|450604854|FG002|Treatment Phase|Adverse Event|19|||
125266310|NCT01783444|450604852|FG000|Treatment Phase|Disease Progression|76|||
125266311|NCT01783444|450604853|FG001|Treatment Phase|Disease Progression|66|||
125266312|NCT01783444|450604854|FG002|Treatment Phase|Disease Progression|64|||
125266313|NCT01783444|450604852|FG000|Treatment Phase|Death|2|||
125266314|NCT01783444|450604853|FG001|Treatment Phase|Death|2|||
125266315|NCT01783444|450604854|FG002|Treatment Phase|Death|2|||
125266316|NCT01783444|450604852|FG000|Treatment Phase|Protocol Violation|1|||
125266317|NCT01783444|450604853|FG001|Treatment Phase|Protocol Violation|1|||
125266318|NCT01783444|450604854|FG002|Treatment Phase|Protocol Violation|2|||
125266319|NCT01783444|450604852|FG000|Treatment Phase|Withdrawal by Subject|6|||
125266320|NCT01783444|450604853|FG001|Treatment Phase|Withdrawal by Subject|8|||
125266321|NCT01783444|450604854|FG002|Treatment Phase|Withdrawal by Subject|9|||
125266322|NCT01783444|450604852|FG000|Treatment Phase|Administrative problems|2|||
125266323|NCT01783444|450604853|FG001|Treatment Phase|Administrative problems|0|||
125266324|NCT01783444|450604854|FG002|Treatment Phase|Administrative problems|1|||
125266325|NCT01783444|450604852|FG000|Treatment Phase|Physician Decision|8|||
125266326|NCT01783444|450604853|FG001|Treatment Phase|Physician Decision|6|||
125266327|NCT01783444|450604854|FG002|Treatment Phase|Physician Decision|5|||
125266328|NCT01783444|450604852|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
125266329|NCT01783444|450604853|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
125266330|NCT01783444|450604854|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
125266331|NCT01783444|450604852|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
125266332|NCT01783444|450604853|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
125266333|NCT01783444|450604854|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
125266334|NCT01783444|450604852|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
125266335|NCT01783444|450604853|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
125266336|NCT01783444|450604854|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
125266337|NCT01783444|450604852|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
125266338|NCT01783444|450604853|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
125266339|NCT01783444|450604854|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
125266340|NCT01783444|450604852|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
125266341|NCT01783444|450604853|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
125266342|NCT01783444|450604854|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
125266343|NCT01783444|450604852|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
125266344|NCT01783444|450604853|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
125266345|NCT01783444|450604854|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
125266346|NCT00427011|450604863|FG000|Overall Study|Adverse Event|10|||
125266347|NCT00427011|450604863|FG000|Overall Study|Withdrawal by Subject|1|||
125266348|NCT00427011|450604863|FG000|Overall Study|Lack of Efficacy|2|||
125266349|NCT00427011|450604863|FG000|Overall Study|Other|12|||
125266350|NCT01047007|450604864|FG000|Overall Study|Adverse Event|0|||
125266351|NCT01047007|450604865|FG001|Overall Study|Adverse Event|2|||
125266352|NCT01047007|450604866|FG002|Overall Study|Adverse Event|1|||
125266353|NCT01047007|450604867|FG003|Overall Study|Adverse Event|0|||
125266354|NCT01047007|450604864|FG000|Overall Study|Progressive Disease|2|||
125266355|NCT01047007|450604865|FG001|Overall Study|Progressive Disease|4|||
125266356|NCT01047007|450604866|FG002|Overall Study|Progressive Disease|1|||
125266357|NCT01047007|450604867|FG003|Overall Study|Progressive Disease|0|||
125266358|NCT04776161|450604868|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
125266359|NCT04776161|450604869|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
125266360|NCT04776161|450604870|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
125266361|NCT04776161|450604868|FG000|Overall Study|Withdrawal by Subject|1|||
125266362|NCT04776161|450604869|FG001|Overall Study|Withdrawal by Subject|0|||
125266363|NCT04776161|450604870|FG002|Overall Study|Withdrawal by Subject|1|||
125266364|NCT04776161|450604868|FG000|Overall Study|Adverse Event|0|||
125266365|NCT04776161|450604869|FG001|Overall Study|Adverse Event|1|||
125266366|NCT04776161|450604870|FG002|Overall Study|Adverse Event|1|||
125266367|NCT01334554|450604871|FG000|Overall Study|Adverse Event|4|||
125266368|NCT01334554|450604872|FG001|Overall Study|Adverse Event|2|||
125266369|NCT02393859|450604874|FG000|Overall Study|Decision by Sponsor|2|||
125266370|NCT02393859|450604875|FG001|Overall Study|Decision by Sponsor|4|||
125266371|NCT02393859|450604874|FG000|Overall Study|Withdrawal by Subject|11|||
125266372|NCT02393859|450604875|FG001|Overall Study|Withdrawal by Subject|6|||
125266373|NCT02393859|450604874|FG000|Overall Study|Death|27|||
125266374|NCT02393859|450604875|FG001|Overall Study|Death|10|||
125266375|NCT02393859|450604874|FG000|Overall Study|Lost to Follow-up|1|||
125266376|NCT02393859|450604875|FG001|Overall Study|Lost to Follow-up|1|||
125266377|NCT00954447|450604876|FG000|Overall Study|Adverse Event|33|||
125266378|NCT00954447|450604877|FG001|Overall Study|Adverse Event|25|||
125266379|NCT00954447|450604876|FG000|Overall Study|Lack of Efficacy|17|||
125266380|NCT00954447|450604877|FG001|Overall Study|Lack of Efficacy|3|||
125266381|NCT00954447|450604876|FG000|Overall Study|Protocol Violation|5|||
125266382|NCT00954447|450604877|FG001|Overall Study|Protocol Violation|7|||
125266383|NCT00954447|450604876|FG000|Overall Study|Lost to Follow-up|8|||
125266384|NCT00954447|450604877|FG001|Overall Study|Lost to Follow-up|14|||
125266385|NCT00954447|450604876|FG000|Overall Study|Withdrawal by Subject|26|||
125266386|NCT00954447|450604877|FG001|Overall Study|Withdrawal by Subject|21|||
125266387|NCT00954447|450604876|FG000|Overall Study|Other|21|||
125266388|NCT00954447|450604877|FG001|Overall Study|Other|18|||
125266389|NCT04592341|450604878|FG000|Overall Study|Physician Decision|5|||
125266390|NCT04592341|450604878|FG000|Overall Study|Study Terminated by Sponsor|5|||
125266391|NCT04592341|450604878|FG000|Overall Study|Withdrawal by Subject|53|||
125266392|NCT04592341|450604878|FG000|Overall Study|Lost to Follow-up|3|||
125266393|NCT04592341|450604878|FG000|Overall Study|Death|1|||
125266394|NCT04592341|450604878|FG000|Overall Study|Adverse Event|5|||
125266395|NCT04592341|450604878|FG000|Overall Study|other|4|||
125266396|NCT00692003|450604879|FG000|Overall Study|Sponsor Decision|5|||
125266397|NCT00692003|450604880|FG001|Overall Study|Sponsor Decision|1|||
125266398|NCT01248793|450604881|FG000|Overall Study|Lost to Follow-up|0|||
125266399|NCT01248793|450604882|FG001|Overall Study|Lost to Follow-up|1|||
125266400|NCT01248793|450604881|FG000|Overall Study|Adverse Event|1|||
125266401|NCT01248793|450604882|FG001|Overall Study|Adverse Event|1|||
125266402|NCT01248793|450604881|FG000|Overall Study|Protocol Violation|0|||
125266403|NCT01248793|450604882|FG001|Overall Study|Protocol Violation|1|||
125266404|NCT01248793|450604881|FG000|Overall Study|Withdrawal by Subject|3|||
125266405|NCT01248793|450604882|FG001|Overall Study|Withdrawal by Subject|3|||
125266406|NCT00517699|450604883|FG000|Overall Study|Withdrawal by Subject|1|||
125266407|NCT00517699|450604883|FG000|Overall Study|Lack of Efficacy|1|||
125266408|NCT00517699|450604883|FG000|Overall Study|Administrative error|1|||
125266409|NCT00517699|450604883|FG000|Overall Study|Study terminated by Sponsor|2|||
125266410|NCT02332187|450604886|FG000|Overall Study|Withdrawal by Subject|2|||
125266411|NCT02332187|450604887|FG001|Overall Study|Withdrawal by Subject|2|||
125266412|NCT02332187|450604886|FG000|Overall Study|Adverse Event|0|||
125266413|NCT02332187|450604887|FG001|Overall Study|Adverse Event|1|||
125266414|NCT01840943|450604888|FG000|Overall Study|Withdrawal by Subject|5|||
125266415|NCT01840943|450604889|FG001|Overall Study|Withdrawal by Subject|6|||
125266416|NCT01840943|450604888|FG000|Overall Study|Physician Decision|4|||
125266417|NCT01840943|450604889|FG001|Overall Study|Physician Decision|2|||
125266418|NCT01840943|450604888|FG000|Overall Study|Lost to Follow-up|4|||
125266419|NCT01840943|450604889|FG001|Overall Study|Lost to Follow-up|4|||
125266420|NCT02580877|450604892|FG000|Overall Study|Withdrawal by Subject|1|||
125266421|NCT02580877|450604893|FG001|Overall Study|Withdrawal by Subject|3|||
125266422|NCT02580877|450604892|FG000|Overall Study|Adverse Event|0|||
125266423|NCT02580877|450604893|FG001|Overall Study|Adverse Event|1|||
125266424|NCT00980148|450604894|FG000|Overall Study|Discharged from facility|89|||
125266425|NCT00980148|450604895|FG001|Overall Study|Discharged from facility|96|||
125266426|NCT00980148|450604894|FG000|Overall Study|Received other antichlamydia treatment|20|||
125266427|NCT00980148|450604895|FG001|Overall Study|Received other antichlamydia treatment|14|||
125266428|NCT00980148|450604894|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
125266429|NCT00980148|450604895|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
125266430|NCT00980148|450604894|FG000|Overall Study|Various other reasons|8|||
125266431|NCT00980148|450604895|FG001|Overall Study|Various other reasons|9|||
125266432|NCT00551031|450604896|FG000|Overall Study|Adverse Event|0|||
125266433|NCT00551031|450604897|FG001|Overall Study|Adverse Event|1|||
125266434|NCT00551031|450604898|FG002|Overall Study|Adverse Event|0|||
125266435|NCT00551031|450604899|FG003|Overall Study|Adverse Event|0|||
125266436|NCT00551031|450604900|FG004|Overall Study|Adverse Event|0|||
125266437|NCT00551031|450604896|FG000|Overall Study|Protocol Violation|1|||
125266438|NCT00551031|450604897|FG001|Overall Study|Protocol Violation|1|||
125266439|NCT00551031|450604898|FG002|Overall Study|Protocol Violation|0|||
125266440|NCT00551031|450604899|FG003|Overall Study|Protocol Violation|0|||
125266441|NCT00551031|450604900|FG004|Overall Study|Protocol Violation|0|||
125266442|NCT00551031|450604896|FG000|Overall Study|Lost to Follow-up|0|||
125266443|NCT00551031|450604897|FG001|Overall Study|Lost to Follow-up|1|||
125266444|NCT00551031|450604898|FG002|Overall Study|Lost to Follow-up|0|||
125266445|NCT00551031|450604899|FG003|Overall Study|Lost to Follow-up|1|||
125266446|NCT00551031|450604900|FG004|Overall Study|Lost to Follow-up|1|||
125266447|NCT00551031|450604896|FG000|Overall Study|Withdrawal by Subject|0|||
125266448|NCT00551031|450604897|FG001|Overall Study|Withdrawal by Subject|4|||
125266449|NCT00551031|450604898|FG002|Overall Study|Withdrawal by Subject|1|||
125266450|NCT00551031|450604899|FG003|Overall Study|Withdrawal by Subject|2|||
125266451|NCT00551031|450604900|FG004|Overall Study|Withdrawal by Subject|0|||
125266452|NCT00551031|450604896|FG000|Overall Study|Serious Adverse Event|0|||
125266453|NCT00551031|450604897|FG001|Overall Study|Serious Adverse Event|2|||
125266454|NCT00551031|450604898|FG002|Overall Study|Serious Adverse Event|1|||
125266455|NCT00551031|450604899|FG003|Overall Study|Serious Adverse Event|0|||
125266456|NCT00551031|450604900|FG004|Overall Study|Serious Adverse Event|0|||
125266457|NCT00551031|450604896|FG000|Overall Study|Did not receive vaccine|1|||
125266458|NCT00551031|450604897|FG001|Overall Study|Did not receive vaccine|2|||
125266459|NCT00551031|450604898|FG002|Overall Study|Did not receive vaccine|0|||
125266460|NCT00551031|450604899|FG003|Overall Study|Did not receive vaccine|0|||
125266461|NCT00551031|450604900|FG004|Overall Study|Did not receive vaccine|0|||
125266462|NCT02903823|450604901|FG000|Overall Study|Physician Decision|5|||
125266463|NCT02903823|450604901|FG000|Overall Study|Could not advance catheter|1|||
125266464|NCT02903823|450604901|FG000|Overall Study|Catheter dislodgement|1|||
125266465|NCT01747915|450604902|FG000|Overall Study|Other|1|||
125266466|NCT01747915|450604903|FG001|Overall Study|Other|1|||
125266467|NCT01747915|450604904|FG002|Overall Study|Other|1|||
125266468|NCT01747915|450604902|FG000|Overall Study|Adverse Event|8|||
125266469|NCT01747915|450604903|FG001|Overall Study|Adverse Event|5|||
125266470|NCT01747915|450604904|FG002|Overall Study|Adverse Event|2|||
125266471|NCT01747915|450604902|FG000|Overall Study|Death|0|||
125266472|NCT01747915|450604903|FG001|Overall Study|Death|0|||
125266473|NCT01747915|450604904|FG002|Overall Study|Death|1|||
125266474|NCT01747915|450604902|FG000|Overall Study|Lack of Efficacy|0|||
125266475|NCT01747915|450604903|FG001|Overall Study|Lack of Efficacy|1|||
125266476|NCT01747915|450604904|FG002|Overall Study|Lack of Efficacy|0|||
125266477|NCT01747915|450604902|FG000|Overall Study|Lost to Follow-up|1|||
125266478|NCT01747915|450604903|FG001|Overall Study|Lost to Follow-up|0|||
125266479|NCT01747915|450604904|FG002|Overall Study|Lost to Follow-up|0|||
125266480|NCT01747915|450604902|FG000|Overall Study|Withdrawal by Subject|4|||
125266481|NCT01747915|450604903|FG001|Overall Study|Withdrawal by Subject|4|||
125266482|NCT01747915|450604904|FG002|Overall Study|Withdrawal by Subject|1|||
125266483|NCT01747915|450604902|FG000|Overall Study|Protocol Violation|1|||
125266484|NCT01747915|450604903|FG001|Overall Study|Protocol Violation|0|||
125266485|NCT01747915|450604904|FG002|Overall Study|Protocol Violation|0|||
125266486|NCT01747915|450604902|FG000|Overall Study|Pregnancy|0|||
125266487|NCT01747915|450604903|FG001|Overall Study|Pregnancy|0|||
125266488|NCT01747915|450604904|FG002|Overall Study|Pregnancy|1|||
125266489|NCT03341637|450604905|FG000|Overall Study|Lost to Follow-up|1|||
125266490|NCT03341637|450604906|FG001|Overall Study|Lost to Follow-up|0|||
125266491|NCT03341637|450604905|FG000|Overall Study|Withdrawal by Subject|3|||
125266492|NCT03341637|450604906|FG001|Overall Study|Withdrawal by Subject|3|||
125266493|NCT03341637|450604905|FG000|Overall Study|Reason not Specified|1|||
125266494|NCT03341637|450604906|FG001|Overall Study|Reason not Specified|1|||
125266495|NCT00887159|450604907|FG000|Overall Study|Disease progression|6|||
125266496|NCT00887159|450604908|FG001|Overall Study|Disease progression|39|||
125266497|NCT00887159|450604909|FG002|Overall Study|Disease progression|33|||
125266498|NCT00887159|450604907|FG000|Overall Study|Adverse Event|3|||
125266499|NCT00887159|450604908|FG001|Overall Study|Adverse Event|4|||
125266500|NCT00887159|450604909|FG002|Overall Study|Adverse Event|17|||
125266501|NCT00887159|450604907|FG000|Overall Study|Death|2|||
125266502|NCT00887159|450604908|FG001|Overall Study|Death|2|||
125266503|NCT00887159|450604909|FG002|Overall Study|Death|0|||
125266504|NCT00887159|450604907|FG000|Overall Study|Withdrawal by Subject|4|||
125266505|NCT00887159|450604908|FG001|Overall Study|Withdrawal by Subject|4|||
125266506|NCT00887159|450604909|FG002|Overall Study|Withdrawal by Subject|2|||
125266507|NCT00887159|450604907|FG000|Overall Study|Alternative therapy|2|||
125266508|NCT00887159|450604908|FG001|Overall Study|Alternative therapy|0|||
125266509|NCT00887159|450604909|FG002|Overall Study|Alternative therapy|0|||
125266510|NCT00887159|450604907|FG000|Overall Study|Physician Decision|1|||
125266511|NCT00887159|450604908|FG001|Overall Study|Physician Decision|1|||
125266512|NCT00887159|450604909|FG002|Overall Study|Physician Decision|0|||
125266513|NCT00887159|450604907|FG000|Overall Study|Sympomatic deterioration|1|||
125266514|NCT00887159|450604908|FG001|Overall Study|Sympomatic deterioration|0|||
125266515|NCT00887159|450604909|FG002|Overall Study|Sympomatic deterioration|0|||
125266516|NCT00887159|450604907|FG000|Overall Study|Treatment delayed|1|||
125266517|NCT00887159|450604908|FG001|Overall Study|Treatment delayed|1|||
125266518|NCT00887159|450604909|FG002|Overall Study|Treatment delayed|0|||
125266519|NCT00887159|450604907|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
125266520|NCT00887159|450604908|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
125266521|NCT00887159|450604909|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
125266522|NCT00887159|450604907|FG000|Overall Study|Received more tx instead of observation|1|||
125266523|NCT00887159|450604908|FG001|Overall Study|Received more tx instead of observation|0|||
125266524|NCT00887159|450604909|FG002|Overall Study|Received more tx instead of observation|0|||
125266525|NCT00887159|450604907|FG000|Overall Study|Ineligible|5|||
125266526|NCT00887159|450604908|FG001|Overall Study|Ineligible|1|||
125266527|NCT00887159|450604909|FG002|Overall Study|Ineligible|0|||
125266528|NCT00887159|450604907|FG000|Overall Study|Never started assigned therapy|3|||
125266529|NCT00887159|450604908|FG001|Overall Study|Never started assigned therapy|3|||
125266530|NCT00887159|450604909|FG002|Overall Study|Never started assigned therapy|4|||
125266531|NCT03500211|450604914|FG000|Overall Study|Withdrawal by Subject|1|||
125266532|NCT03500211|450604915|FG001|Overall Study|Withdrawal by Subject|1|||
125266533|NCT01119443|450604920|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
125266534|NCT01119443|450604921|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
125266535|NCT00775268|450604922|FG000|Baseline|Drug not synthesize dose|1|||
125266536|NCT00775268|450604923|FG001|Baseline|Drug not synthesize dose|0|||
125266537|NCT00775268|450604922|FG000|Baseline|Not treated-ineligible per CT|0|||
125266538|NCT00775268|450604923|FG001|Baseline|Not treated-ineligible per CT|1|||
125266539|NCT00775268|450604922|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
125266540|NCT00775268|450604923|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
125266541|NCT00775268|450604922|FG000|After Completion|Participant missed scan appointment|1|||
125266542|NCT00775268|450604923|FG001|After Completion|Participant missed scan appointment|0|||
125266543|NCT03604497|450604924|FG000|Overall Study|Protocol Violation|52|||
125266544|NCT01194245|450604926|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
125266545|NCT01194245|450604927|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
125266546|NCT01194245|450604928|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
125266547|NCT01194245|450604929|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
125266548|NCT01194245|450604930|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
125266549|NCT01194245|450604926|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
125266550|NCT01194245|450604927|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
125266551|NCT01194245|450604928|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
125266552|NCT01194245|450604929|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
125266553|NCT01194245|450604930|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
125266554|NCT01194245|450604926|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
125266555|NCT01194245|450604927|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
125266556|NCT01194245|450604928|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
125266557|NCT01194245|450604929|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
125266558|NCT01194245|450604930|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
125266559|NCT01194245|450604926|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
125266560|NCT01194245|450604927|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
125266561|NCT01194245|450604928|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
125266562|NCT01194245|450604929|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
125266563|NCT01194245|450604930|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
125266564|NCT01194245|450604926|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125266565|NCT01194245|450604927|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125266566|NCT01194245|450604928|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125266567|NCT01194245|450604929|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125266568|NCT01194245|450604930|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
125266569|NCT01194245|450604926|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125266570|NCT01194245|450604927|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125266571|NCT01194245|450604928|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
125266572|NCT01194245|450604929|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
125266573|NCT01194245|450604930|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
125266574|NCT00269087|450604931|FG000|Overall Study|Adverse Event|20|||
125266575|NCT00269087|450604931|FG000|Overall Study|Withdrawal by Subject|1|||
125266576|NCT00269087|450604931|FG000|Overall Study|Exacerbation of COPD|13|||
125266577|NCT00041470|450604935|FG000|Overall Study|Loss of Funding|38|||
125266578|NCT00461708|450604936|FG000|Overall Study|Adverse Event|17|||
125266579|NCT00461708|450604937|FG001|Overall Study|Adverse Event|7|||
125266580|NCT00461708|450604936|FG000|Overall Study|Lack of Efficacy|68|||
125266581|NCT00461708|450604937|FG001|Overall Study|Lack of Efficacy|20|||
125266582|NCT00461708|450604936|FG000|Overall Study|Physician Decision|10|||
125266583|NCT00461708|450604937|FG001|Overall Study|Physician Decision|4|||
125266584|NCT00461708|450604936|FG000|Overall Study|Withdrawal by Subject|8|||
125266585|NCT00461708|450604937|FG001|Overall Study|Withdrawal by Subject|2|||
125266586|NCT00461708|450604936|FG000|Overall Study|Other|4|||
125266587|NCT00461708|450604937|FG001|Overall Study|Other|4|||
125266588|NCT00461708|450604936|FG000|Overall Study|Death|8|||
125266589|NCT00461708|450604937|FG001|Overall Study|Death|1|||
125266590|NCT02803203|450604938|FG000|Overall Study|Adverse Event|4|||
125266591|NCT02803203|450604938|FG000|Overall Study|Death|4|||
125266592|NCT02803203|450604938|FG000|Overall Study|Progressive disease|29|||
125266593|NCT02803203|450604938|FG000|Overall Study|Withdrawal by Subject|8|||
125266594|NCT02803203|450604938|FG000|Overall Study|Complete resection of target disease|2|||
125266595|NCT02803203|450604938|FG000|Overall Study|Switched to commercial Osi|1|||
125266596|NCT02803203|450604938|FG000|Overall Study|Participant moved away|1|||
125266597|NCT02230189|450604945|FG000|Overall Study|Withdrawal by Subject|3|||
125266598|NCT02230189|450604946|FG001|Overall Study|Withdrawal by Subject|0|||
125266599|NCT02230189|450604947|FG002|Overall Study|Withdrawal by Subject|1|||
125266600|NCT02230189|450604945|FG000|Overall Study|Lost to Follow-up|1|||
125266601|NCT02230189|450604946|FG001|Overall Study|Lost to Follow-up|0|||
125266602|NCT02230189|450604947|FG002|Overall Study|Lost to Follow-up|0|||
125266603|NCT02230189|450604945|FG000|Overall Study|Physician Decision|1|||
125266604|NCT02230189|450604946|FG001|Overall Study|Physician Decision|0|||
125266605|NCT02230189|450604947|FG002|Overall Study|Physician Decision|0|||
125266606|NCT01193101|450604951|FG000|Overall Study|Adverse Event|0|||
125266607|NCT01193101|450604952|FG001|Overall Study|Adverse Event|1|||
125266608|NCT01193101|450604953|FG002|Overall Study|Adverse Event|1|||
125266609|NCT01193101|450604954|FG003|Overall Study|Adverse Event|3|||
125266610|NCT01193101|450604951|FG000|Overall Study|Lack of Efficacy|3|||
125266611|NCT01193101|450604952|FG001|Overall Study|Lack of Efficacy|1|||
125266612|NCT01193101|450604953|FG002|Overall Study|Lack of Efficacy|0|||
125266613|NCT01193101|450604954|FG003|Overall Study|Lack of Efficacy|8|||
125266614|NCT01193101|450604951|FG000|Overall Study|Withdrawal by Subject|2|||
125266615|NCT01193101|450604952|FG001|Overall Study|Withdrawal by Subject|4|||
125266616|NCT01193101|450604953|FG002|Overall Study|Withdrawal by Subject|1|||
125266617|NCT01193101|450604954|FG003|Overall Study|Withdrawal by Subject|1|||
125266618|NCT01193101|450604951|FG000|Overall Study|Administrative problems|0|||
125266619|NCT01193101|450604952|FG001|Overall Study|Administrative problems|0|||
125266620|NCT01193101|450604953|FG002|Overall Study|Administrative problems|1|||
125266621|NCT01193101|450604954|FG003|Overall Study|Administrative problems|0|||
125266622|NCT01193101|450604951|FG000|Overall Study|Abnormal test procedure results|0|||
125266623|NCT01193101|450604952|FG001|Overall Study|Abnormal test procedure results|1|||
125266624|NCT01193101|450604953|FG002|Overall Study|Abnormal test procedure results|0|||
125266625|NCT01193101|450604954|FG003|Overall Study|Abnormal test procedure results|0|||
125266626|NCT02347085|450604957|FG000|Overall Study|Adverse Event|2|||
125266627|NCT02347085|450604957|FG000|Overall Study|Lack of Efficacy|1|||
125266628|NCT02347085|450604957|FG000|Overall Study|Withdrawal by Subject|4|||
125266629|NCT02347085|450604957|FG000|Overall Study|Lost to Follow-up|1|||
125266630|NCT02347085|450604957|FG000|Overall Study|Protocol Criteria|2|||
125266631|NCT02834819|450604958|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
125266632|NCT02834819|450604959|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
125266633|NCT00527618|450604962|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
125266634|NCT00527618|450604963|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
125266635|NCT00527618|450604962|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
125266636|NCT00527618|450604963|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
125266637|NCT00527618|450604962|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
125266638|NCT00527618|450604963|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
125266639|NCT00527618|450604962|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
125266640|NCT00527618|450604963|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
125266641|NCT00527618|450604962|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
125266642|NCT00527618|450604963|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
125266643|NCT00527618|450604962|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
125266644|NCT00527618|450604963|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
125266645|NCT00363311|450604974|FG000|Overall Study|Adverse Event|6|||
125266646|NCT00363311|450604975|FG001|Overall Study|Adverse Event|4|||
125266647|NCT00363311|450604974|FG000|Overall Study|Lost to Follow-up|3|||
125266648|NCT00363311|450604975|FG001|Overall Study|Lost to Follow-up|0|||
125266649|NCT00363311|450604974|FG000|Overall Study|Protocol Violation|1|||
125266650|NCT00363311|450604975|FG001|Overall Study|Protocol Violation|2|||
125266651|NCT00363311|450604974|FG000|Overall Study|Withdrawal by Subject|12|||
125266652|NCT00363311|450604975|FG001|Overall Study|Withdrawal by Subject|6|||
125266653|NCT00363311|450604974|FG000|Overall Study|Physician Decision|1|||
125266654|NCT00363311|450604975|FG001|Overall Study|Physician Decision|1|||
125266655|NCT00363311|450604974|FG000|Overall Study|Sponsor Terminated Study|2|||
125266656|NCT00363311|450604975|FG001|Overall Study|Sponsor Terminated Study|2|||
125266657|NCT00363311|450604974|FG000|Overall Study|Disease Progression|46|||
125266658|NCT00363311|450604975|FG001|Overall Study|Disease Progression|26|||
125266659|NCT00363311|450604974|FG000|Overall Study|Non-Compliance|1|||
125266660|NCT00363311|450604975|FG001|Overall Study|Non-Compliance|1|||
125266661|NCT00363311|450604974|FG000|Overall Study|Participant Refused Biopsy|1|||
125266662|NCT00363311|450604975|FG001|Overall Study|Participant Refused Biopsy|0|||
125266663|NCT00363311|450604974|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
125266664|NCT00363311|450604975|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
125266665|NCT00363311|450604974|FG000|Overall Study|Participant Opted for Treatment|1|||
125266666|NCT00363311|450604975|FG001|Overall Study|Participant Opted for Treatment|0|||
125266667|NCT00363311|450604974|FG000|Overall Study|Participant Moved to Another Country|1|||
125266668|NCT00363311|450604975|FG001|Overall Study|Participant Moved to Another Country|0|||
125266669|NCT00363311|450604974|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
125266670|NCT00363311|450604975|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
125266671|NCT00363311|450604974|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
125266672|NCT00363311|450604975|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
125266673|NCT00363311|450604974|FG000|Overall Study|Participant Moved to Louisiana|0|||
125266674|NCT00363311|450604975|FG001|Overall Study|Participant Moved to Louisiana|1|||
125266675|NCT00120627|450604978|FG000|Overall Study|Withdrawal by Subject|5|||
125266676|NCT00120627|450604979|FG001|Overall Study|Withdrawal by Subject|5|||
125266677|NCT01508910|450604980|FG000|Treatment|Death|2|||
125266678|NCT01508910|450604981|FG001|Treatment|Death|3|||
125266679|NCT01508910|450604982|FG002|Treatment|Death|2|||
125266680|NCT01508910|450604983|FG003|Treatment|Death|0|||
125266681|NCT01508910|450604980|FG000|Treatment|Lost to Follow-up|0|||
125266682|NCT01508910|450604981|FG001|Treatment|Lost to Follow-up|0|||
125266683|NCT01508910|450604982|FG002|Treatment|Lost to Follow-up|2|||
125266684|NCT01508910|450604983|FG003|Treatment|Lost to Follow-up|1|||
125266685|NCT01508910|450604980|FG000|Treatment|Withdrawal by Subject|0|||
125266686|NCT01508910|450604981|FG001|Treatment|Withdrawal by Subject|1|||
125266687|NCT01508910|450604982|FG002|Treatment|Withdrawal by Subject|6|||
125266688|NCT01508910|450604983|FG003|Treatment|Withdrawal by Subject|1|||
125266689|NCT01508910|450604980|FG000|Treatment|Sponsor Decision|0|||
125266690|NCT01508910|450604981|FG001|Treatment|Sponsor Decision|0|||
125266691|NCT01508910|450604982|FG002|Treatment|Sponsor Decision|0|||
125266692|NCT01508910|450604983|FG003|Treatment|Sponsor Decision|1|||
125266693|NCT01595529|450604984|FG000|Overall Study|Adverse Event|2|||
125266694|NCT01595529|450604985|FG001|Overall Study|Adverse Event|0|||
125266695|NCT01595529|450604984|FG000|Overall Study|Subject Non-Compliant|2|||
125266696|NCT01595529|450604985|FG001|Overall Study|Subject Non-Compliant|0|||
125266697|NCT01595529|450604984|FG000|Overall Study|Lost to Follow-up|8|||
125266698|NCT01595529|450604985|FG001|Overall Study|Lost to Follow-up|14|||
125266699|NCT01595529|450604984|FG000|Overall Study|Protocol Violation|1|||
125266700|NCT01595529|450604985|FG001|Overall Study|Protocol Violation|2|||
125266701|NCT01595529|450604984|FG000|Overall Study|Physician Decision|1|||
125266702|NCT01595529|450604985|FG001|Overall Study|Physician Decision|0|||
125266703|NCT01595529|450604984|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
125266704|NCT01595529|450604985|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
125266705|NCT01595529|450604984|FG000|Overall Study|Administrative Decision|1|||
125266706|NCT01595529|450604985|FG001|Overall Study|Administrative Decision|0|||
125266707|NCT01595529|450604984|FG000|Overall Study|Entry Failure/Screening Failure|6|||
125266708|NCT01595529|450604985|FG001|Overall Study|Entry Failure/Screening Failure|1|||
125266709|NCT00730886|450604986|FG000|Overall Study|Lost to Follow-up|1|||
125266710|NCT00730886|450604987|FG001|Overall Study|Lost to Follow-up|0|||
125266711|NCT00730886|450604986|FG000|Overall Study|Physician Decision|1|||
125266712|NCT00730886|450604987|FG001|Overall Study|Physician Decision|0|||
125266713|NCT01991483|450604988|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
125266714|NCT01991483|450604989|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
125266715|NCT01991483|450604990|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
125266716|NCT01991483|450604991|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
125266717|NCT01991483|450604988|FG000|Dose Level 600 mg|Physician Decision|0|||
125266718|NCT01991483|450604989|FG001|Dose Level 600 mg|Physician Decision|0|||
125266719|NCT01991483|450604990|FG002|Dose Level 600 mg|Physician Decision|1|||
125266720|NCT01991483|450604991|FG003|Dose Level 600 mg|Physician Decision|0|||
125266721|NCT01991483|450604988|FG000|Dose Level 1000 mg|Protocol Violation|0|||
125266722|NCT01991483|450604989|FG001|Dose Level 1000 mg|Protocol Violation|0|||
125266723|NCT01991483|450604990|FG002|Dose Level 1000 mg|Protocol Violation|0|||
125266724|NCT01991483|450604991|FG003|Dose Level 1000 mg|Protocol Violation|1|||
125266725|NCT01932788|450604998|FG000|Overall Study|Protocol Violation|18|||
125266726|NCT01932788|450604999|FG001|Overall Study|Protocol Violation|0|||
125266727|NCT01932788|450604998|FG000|Overall Study|Lost to Follow-up|18|||
125266728|NCT01932788|450604999|FG001|Overall Study|Lost to Follow-up|46|||
125266729|NCT01932788|450604998|FG000|Overall Study|Lack of Efficacy|2|||
125266730|NCT01932788|450604999|FG001|Overall Study|Lack of Efficacy|0|||
125266731|NCT01932788|450604998|FG000|Overall Study|Withdrawal by Subject|0|||
125266732|NCT01932788|450604999|FG001|Overall Study|Withdrawal by Subject|5|||
125266733|NCT04819113|450605000|FG000|Overall Study|Withdrawal by parent/guardian|3|||
125266734|NCT04819113|450605000|FG000|Overall Study|Lost to Follow-up|1|||
125266735|NCT04819113|450605000|FG000|Overall Study|Withdrawn before vaccination|2|||
125266736|NCT00833027|450605001|FG000|Overall Study|Adverse Event|33|||
125266737|NCT00833027|450605001|FG000|Overall Study|Death|1|||
125266738|NCT00833027|450605001|FG000|Overall Study|Lack of Efficacy|12|||
125266739|NCT00833027|450605001|FG000|Overall Study|Lost to Follow-up|24|||
125266740|NCT00833027|450605001|FG000|Overall Study|Protocol Violation|115|||
125266741|NCT00833027|450605001|FG000|Overall Study|Withdrawal by Subject|16|||
125266742|NCT00833027|450605001|FG000|Overall Study|Missing|10|||
125266743|NCT02806414|450605008|FG000|Overall Study|Lost to Follow-up|2|||
125266744|NCT03092479|450605011|FG000|Overall Study|Lost to Follow-up|3|||
125266745|NCT03092479|450605012|FG001|Overall Study|Lost to Follow-up|2|||
125266746|NCT03092479|450605011|FG000|Overall Study|Withdrawal by Subject|4|||
125266747|NCT03092479|450605012|FG001|Overall Study|Withdrawal by Subject|0|||
125266748|NCT00441272|450606908|FG000|Overall Study|Study terminated prior to enrollment|25|||
125266749|NCT00441272|450606909|FG001|Overall Study|Study terminated prior to enrollment|25|||
125266750|NCT01856322|450606910|FG000|Overall Study|off study due to lack of accrual|0|||
125266751|NCT01856322|450606911|FG001|Overall Study|off study due to lack of accrual|0|||
125266752|NCT01856322|450606912|FG002|Overall Study|off study due to lack of accrual|3|||
125266753|NCT02364037|450606916|FG000|Overall Study|Withdrawal by Subject|7|||
125266754|NCT02364037|450606917|FG001|Overall Study|Withdrawal by Subject|4|||
125266755|NCT02364037|450606916|FG000|Overall Study|Lost to Follow-up|37|||
125266756|NCT02364037|450606917|FG001|Overall Study|Lost to Follow-up|49|||
125266757|NCT04567524|450606918|FG000|Overall Study|Adverse Event|1|||
125266758|NCT04567524|450606919|FG001|Overall Study|Adverse Event|1|||
125266759|NCT04567524|450606920|FG002|Overall Study|Adverse Event|0|||
125266760|NCT04567524|450606921|FG003|Overall Study|Adverse Event|0|||
125266761|NCT04567524|450606918|FG000|Overall Study|Withdrawal by Subject|2|||
125266762|NCT04567524|450606919|FG001|Overall Study|Withdrawal by Subject|0|||
125266763|NCT04567524|450606920|FG002|Overall Study|Withdrawal by Subject|0|||
125266764|NCT04567524|450606921|FG003|Overall Study|Withdrawal by Subject|1|||
125266765|NCT01639469|450606925|FG000|Overall Study|Death|4|||
125266766|NCT01639469|450606926|FG001|Overall Study|Death|2|||
125266767|NCT01639469|450606925|FG000|Overall Study|Lost to Follow-up|1|||
125266768|NCT01639469|450606926|FG001|Overall Study|Lost to Follow-up|1|||
125266769|NCT00420381|450606927|FG000|Overall Study|Protocol Violation|1|||
125266770|NCT02078752|450606930|FG000|Overall Study|Death|0|||
125266771|NCT02078752|450606931|FG001|Overall Study|Death|3|||
125266772|NCT02078752|450606932|FG002|Overall Study|Death|0|||
125266773|NCT02078752|450606933|FG003|Overall Study|Death|0|||
125266774|NCT02078752|450606934|FG004|Overall Study|Death|0|||
125266775|NCT02078752|450606935|FG005|Overall Study|Death|1|||
125266776|NCT02078752|450606936|FG006|Overall Study|Death|0|||
125266777|NCT02078752|450606937|FG007|Overall Study|Death|1|||
125266778|NCT02078752|450606938|FG008|Overall Study|Death|0|||
125266779|NCT02078752|450606939|FG009|Overall Study|Death|4|||
125266780|NCT02078752|450606930|FG000|Overall Study|Lost to Follow-up|1|||
125266781|NCT02078752|450606931|FG001|Overall Study|Lost to Follow-up|0|||
125266782|NCT02078752|450606932|FG002|Overall Study|Lost to Follow-up|0|||
125266783|NCT02078752|450606933|FG003|Overall Study|Lost to Follow-up|1|||
125266784|NCT02078752|450606934|FG004|Overall Study|Lost to Follow-up|0|||
125266785|NCT02078752|450606935|FG005|Overall Study|Lost to Follow-up|0|||
125266786|NCT02078752|450606936|FG006|Overall Study|Lost to Follow-up|0|||
125266787|NCT02078752|450606937|FG007|Overall Study|Lost to Follow-up|0|||
125266788|NCT02078752|450606938|FG008|Overall Study|Lost to Follow-up|0|||
125266789|NCT02078752|450606939|FG009|Overall Study|Lost to Follow-up|0|||
125266790|NCT02078752|450606930|FG000|Overall Study|Withdrawal by Subject|1|||
125266791|NCT02078752|450606931|FG001|Overall Study|Withdrawal by Subject|1|||
125266792|NCT02078752|450606932|FG002|Overall Study|Withdrawal by Subject|1|||
125266793|NCT02078752|450606933|FG003|Overall Study|Withdrawal by Subject|1|||
125266794|NCT02078752|450606934|FG004|Overall Study|Withdrawal by Subject|0|||
125266795|NCT02078752|450606935|FG005|Overall Study|Withdrawal by Subject|3|||
125266796|NCT02078752|450606936|FG006|Overall Study|Withdrawal by Subject|2|||
125266797|NCT02078752|450606937|FG007|Overall Study|Withdrawal by Subject|1|||
125266798|NCT02078752|450606938|FG008|Overall Study|Withdrawal by Subject|0|||
125266799|NCT02078752|450606939|FG009|Overall Study|Withdrawal by Subject|1|||
125266800|NCT02078752|450606930|FG000|Overall Study|Other|0|||
125266801|NCT02078752|450606931|FG001|Overall Study|Other|3|||
125266802|NCT02078752|450606932|FG002|Overall Study|Other|0|||
125266803|NCT02078752|450606933|FG003|Overall Study|Other|0|||
125266804|NCT02078752|450606934|FG004|Overall Study|Other|1|||
125266805|NCT02078752|450606935|FG005|Overall Study|Other|0|||
125266806|NCT02078752|450606936|FG006|Overall Study|Other|0|||
125266807|NCT02078752|450606937|FG007|Overall Study|Other|1|||
125266808|NCT02078752|450606938|FG008|Overall Study|Other|0|||
125266809|NCT02078752|450606939|FG009|Overall Study|Other|0|||
125266810|NCT02078752|450606930|FG000|Overall Study|Study terminated by sponsor|0|||
125266811|NCT02078752|450606931|FG001|Overall Study|Study terminated by sponsor|0|||
125266812|NCT02078752|450606932|FG002|Overall Study|Study terminated by sponsor|0|||
125266813|NCT02078752|450606933|FG003|Overall Study|Study terminated by sponsor|0|||
125266814|NCT02078752|450606934|FG004|Overall Study|Study terminated by sponsor|0|||
125266815|NCT02078752|450606935|FG005|Overall Study|Study terminated by sponsor|0|||
125266816|NCT02078752|450606936|FG006|Overall Study|Study terminated by sponsor|0|||
125266817|NCT02078752|450606937|FG007|Overall Study|Study terminated by sponsor|0|||
125266818|NCT02078752|450606938|FG008|Overall Study|Study terminated by sponsor|0|||
125266819|NCT02078752|450606939|FG009|Overall Study|Study terminated by sponsor|5|||
125266820|NCT00616642|450606949|FG000|Overall Study|Withdrawal by Subject|0|||
125266821|NCT00616642|450606950|FG001|Overall Study|Withdrawal by Subject|1|||
125266822|NCT00589797|450606957|FG000|Overall Study|Death|1|||
125266823|NCT00589797|450606958|FG001|Overall Study|Death|0|||
125266824|NCT00589797|450606957|FG000|Overall Study|Lost to Follow-up|12|||
125266825|NCT00589797|450606958|FG001|Overall Study|Lost to Follow-up|9|||
125266826|NCT00589797|450606957|FG000|Overall Study|Physician Decision|8|||
125266827|NCT00589797|450606958|FG001|Overall Study|Physician Decision|3|||
125266828|NCT00589797|450606957|FG000|Overall Study|Withdrawal by Subject|6|||
125266829|NCT00589797|450606958|FG001|Overall Study|Withdrawal by Subject|5|||
125266830|NCT00589797|450606957|FG000|Overall Study|Non-Randomized Training Subjects|46|||
125266831|NCT00589797|450606958|FG001|Overall Study|Non-Randomized Training Subjects|6|||
125266832|NCT01881009|450606959|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
125266833|NCT01881009|450606960|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
125266834|NCT02141672|450606961|FG000|Overall Study|Adverse Event|0|||
125266835|NCT02141672|450606962|FG001|Overall Study|Adverse Event|1|||
125266836|NCT02141672|450606963|FG002|Overall Study|Adverse Event|0|||
125266837|NCT02141672|450606961|FG000|Overall Study|Death|10|||
125266838|NCT02141672|450606962|FG001|Overall Study|Death|2|||
125266839|NCT02141672|450606963|FG002|Overall Study|Death|1|||
125266840|NCT02141672|450606961|FG000|Overall Study|Lack of Efficacy|0|||
125266841|NCT02141672|450606962|FG001|Overall Study|Lack of Efficacy|0|||
125266842|NCT02141672|450606963|FG002|Overall Study|Lack of Efficacy|2|||
125266843|NCT02141672|450606961|FG000|Overall Study|Lost to Follow-up|1|||
125266844|NCT02141672|450606962|FG001|Overall Study|Lost to Follow-up|1|||
125266845|NCT02141672|450606963|FG002|Overall Study|Lost to Follow-up|3|||
125266846|NCT02141672|450606961|FG000|Overall Study|Physician Decision|1|||
125266847|NCT02141672|450606962|FG001|Overall Study|Physician Decision|2|||
125266848|NCT02141672|450606963|FG002|Overall Study|Physician Decision|5|||
125266849|NCT02141672|450606961|FG000|Overall Study|Protocol Violation|0|||
125266850|NCT02141672|450606962|FG001|Overall Study|Protocol Violation|0|||
125266851|NCT02141672|450606963|FG002|Overall Study|Protocol Violation|1|||
125266852|NCT02141672|450606961|FG000|Overall Study|Withdrawal by Subject|3|||
125266853|NCT02141672|450606962|FG001|Overall Study|Withdrawal by Subject|2|||
125266854|NCT02141672|450606963|FG002|Overall Study|Withdrawal by Subject|5|||
125266855|NCT02141672|450606961|FG000|Overall Study|refused to follow-up|1|||
125266856|NCT02141672|450606962|FG001|Overall Study|refused to follow-up|0|||
125266857|NCT02141672|450606963|FG002|Overall Study|refused to follow-up|1|||
125266858|NCT00332696|450606971|FG000|Overall Study|Death|24|||
125266859|NCT00332696|450606972|FG001|Overall Study|Death|14|||
125266860|NCT00332696|450606971|FG000|Overall Study|Insufficient therapeutic effect|4|||
125266861|NCT00332696|450606972|FG001|Overall Study|Insufficient therapeutic effect|11|||
125266862|NCT00332696|450606971|FG000|Overall Study|Adverse Event|1|||
125266863|NCT00332696|450606972|FG001|Overall Study|Adverse Event|2|||
125266864|NCT00332696|450606971|FG000|Overall Study|Condition does not justify treatment|0|||
125266865|NCT00332696|450606972|FG001|Overall Study|Condition does not justify treatment|2|||
125266866|NCT00332696|450606971|FG000|Overall Study|Lost to Follow-up|0|||
125266867|NCT00332696|450606972|FG001|Overall Study|Lost to Follow-up|1|||
125266868|NCT00332696|450606971|FG000|Overall Study|Withdrawal by Subject|1|||
125266869|NCT00332696|450606972|FG001|Overall Study|Withdrawal by Subject|0|||
125266870|NCT01061385|450606974|FG000|Overall Study|Lost to Follow-up|1|||
125266871|NCT01061385|450606975|FG001|Overall Study|Lost to Follow-up|0|||
125266872|NCT01061385|450606974|FG000|Overall Study|subject decision not related to AE|0|||
125266873|NCT01061385|450606975|FG001|Overall Study|subject decision not related to AE|1|||
125266874|NCT00533429|450606976|FG000|Overall Study|Adverse Event|3|||
125266875|NCT00533429|450606977|FG001|Overall Study|Adverse Event|1|||
125266876|NCT00533429|450606976|FG000|Overall Study|Death|1|||
125266877|NCT00533429|450606977|FG001|Overall Study|Death|0|||
125266878|NCT00533429|450606976|FG000|Overall Study|Withdrawal by Subject|2|||
125266879|NCT00533429|450606977|FG001|Overall Study|Withdrawal by Subject|0|||
125266880|NCT00533429|450606976|FG000|Overall Study|Progressive Disease|12|||
125266881|NCT00533429|450606977|FG001|Overall Study|Progressive Disease|13|||
125266882|NCT00533429|450606976|FG000|Overall Study|Symptomatic deterioration|1|||
125266883|NCT00533429|450606977|FG001|Overall Study|Symptomatic deterioration|2|||
125266884|NCT01464879|450606978|FG000|Overall Study|Physician Decision|1|||
125266885|NCT01464879|450606978|FG000|Overall Study|Non-compliance|1|||
125266886|NCT00244621|450606979|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
125266887|NCT00244621|450606980|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
125266888|NCT00244621|450606981|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
125266889|NCT00244621|450606979|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
125266890|NCT00244621|450606980|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
125266891|NCT00244621|450606981|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
125266892|NCT00244621|450606979|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
125266893|NCT00244621|450606980|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
125266894|NCT00244621|450606981|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
125266895|NCT00244621|450606979|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
125266896|NCT00244621|450606980|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
125266897|NCT00244621|450606981|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
125266898|NCT00244621|450606979|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
125266899|NCT00244621|450606980|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
125266900|NCT00244621|450606981|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
125266901|NCT00244621|450606979|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
125266902|NCT00244621|450606980|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
125266903|NCT00244621|450606981|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
125266904|NCT00244621|450606979|FG000|Open-label Treatment Period|Adverse Event|0|||
125266905|NCT00244621|450606980|FG001|Open-label Treatment Period|Adverse Event|0|||
125266906|NCT00244621|450606981|FG002|Open-label Treatment Period|Adverse Event|1|||
125266907|NCT00244621|450606979|FG000|Open-label Treatment Period|Moved abroad|0|||
125266908|NCT00244621|450606980|FG001|Open-label Treatment Period|Moved abroad|0|||
125266909|NCT00244621|450606981|FG002|Open-label Treatment Period|Moved abroad|1|||
125266910|NCT01824290|450606982|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
125266911|NCT01824290|450606983|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
125266912|NCT01824290|450606984|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
125266913|NCT01824290|450606985|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
125266914|NCT01824290|450606982|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
125266915|NCT01824290|450606983|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
125266916|NCT01824290|450606984|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
125266917|NCT01824290|450606985|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
125266918|NCT01824290|450606982|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
125266919|NCT01824290|450606983|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
125266920|NCT01824290|450606984|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
125266921|NCT01824290|450606985|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
125266922|NCT01824290|450606982|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
125266923|NCT01824290|450606983|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
125266924|NCT01824290|450606984|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
125266925|NCT01824290|450606985|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
125266926|NCT01824290|450606982|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
125266927|NCT01824290|450606983|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
125266928|NCT01824290|450606984|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
125266929|NCT01824290|450606985|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
125266930|NCT01824290|450606982|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
125266931|NCT01824290|450606983|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
125266932|NCT01824290|450606984|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
125266933|NCT01824290|450606985|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
125266934|NCT00800982|450606986|FG000|Overall Study|Lost to Follow-up|1|||
125266935|NCT00800982|450606987|FG001|Overall Study|Lost to Follow-up|2|||
125266936|NCT00800982|450606986|FG000|Overall Study|Withdrawal by Subject|0|||
125266937|NCT00800982|450606987|FG001|Overall Study|Withdrawal by Subject|1|||
125266938|NCT00800982|450606986|FG000|Overall Study|Patient moved out of state|1|||
125266939|NCT00800982|450606987|FG001|Overall Study|Patient moved out of state|0|||
125266940|NCT00648037|450606990|FG000|Overall Study|Not Treated|1|||
125266941|NCT00648037|450606990|FG000|Overall Study|Withdrawal by Subject|1|||
125266942|NCT00648037|450606990|FG000|Overall Study|Adverse Event|11|||
125266943|NCT00648037|450606990|FG000|Overall Study|Relapse|2|||
125266944|NCT00648037|450606990|FG000|Overall Study|Other|1|||
125266945|NCT02967679|450606991|FG000|Overall Study|Adverse Event|1|||
125266946|NCT00003631|450606994|FG000|Overall Study|Patient not treated|1|||
125266947|NCT00003631|450606995|FG001|Overall Study|Patient not treated|0|||
125266948|NCT00003631|450606996|FG002|Overall Study|Patient not treated|1|||
125266949|NCT00003631|450606994|FG000|Overall Study|Protocol Violation|1|||
125266950|NCT00003631|450606995|FG001|Overall Study|Protocol Violation|0|||
125266951|NCT00003631|450606996|FG002|Overall Study|Protocol Violation|0|||
125266952|NCT00003631|450606994|FG000|Overall Study|Adverse Event|1|||
125266953|NCT00003631|450606995|FG001|Overall Study|Adverse Event|1|||
125266954|NCT00003631|450606996|FG002|Overall Study|Adverse Event|5|||
125266955|NCT00003631|450606994|FG000|Overall Study|Death|0|||
125266956|NCT00003631|450606995|FG001|Overall Study|Death|0|||
125266957|NCT00003631|450606996|FG002|Overall Study|Death|1|||
125266958|NCT00003631|450606994|FG000|Overall Study|Evaluable for toxicity only|0|||
125266959|NCT00003631|450606995|FG001|Overall Study|Evaluable for toxicity only|0|||
125266960|NCT00003631|450606996|FG002|Overall Study|Evaluable for toxicity only|2|||
125266961|NCT00600067|450606997|FG000|Overall Study|Adverse Event|0|||
125266962|NCT00600067|450606998|FG001|Overall Study|Adverse Event|1|||
125266963|NCT00600067|450606997|FG000|Overall Study|Lost to Follow-up|2|||
125266964|NCT00600067|450606998|FG001|Overall Study|Lost to Follow-up|3|||
125266965|NCT00600067|450606997|FG000|Overall Study|protocol non-compliance|0|||
125266966|NCT00600067|450606998|FG001|Overall Study|protocol non-compliance|3|||
125266967|NCT00600067|450606997|FG000|Overall Study|Lack of Efficacy|1|||
125266968|NCT00600067|450606998|FG001|Overall Study|Lack of Efficacy|0|||
125266969|NCT04339413|450607001|FG000|Overall Study|Reason Not Specified|2|||
125266970|NCT04339413|450607002|FG001|Overall Study|Reason Not Specified|7|||
125266971|NCT04339413|450607001|FG000|Overall Study|Study Terminated by Sponsor|30|||
125266972|NCT04339413|450607002|FG001|Overall Study|Study Terminated by Sponsor|33|||
125266973|NCT04339413|450607001|FG000|Overall Study|Progressive Disease|9|||
125266974|NCT04339413|450607002|FG001|Overall Study|Progressive Disease|6|||
125266975|NCT04339413|450607001|FG000|Overall Study|Withdrawal by Subject|9|||
125266976|NCT04339413|450607002|FG001|Overall Study|Withdrawal by Subject|10|||
125266977|NCT04339413|450607001|FG000|Overall Study|Physician Decision|3|||
125266978|NCT04339413|450607002|FG001|Overall Study|Physician Decision|1|||
125266979|NCT04339413|450607001|FG000|Overall Study|Death|2|||
125266980|NCT04339413|450607002|FG001|Overall Study|Death|0|||
125266981|NCT04339413|450607001|FG000|Overall Study|Adverse Event|3|||
125266982|NCT04339413|450607002|FG001|Overall Study|Adverse Event|0|||
125266983|NCT00401843|450607006|FG000|Overall Study|Achieved Complete Response|1|||
125266984|NCT00401843|450607007|FG001|Overall Study|Achieved Complete Response|5|||
125266985|NCT00401843|450607008|FG002|Overall Study|Achieved Complete Response|11|||
125266986|NCT00401843|450607006|FG000|Overall Study|Adverse Event|7|||
125266987|NCT00401843|450607007|FG001|Overall Study|Adverse Event|26|||
125266988|NCT00401843|450607008|FG002|Overall Study|Adverse Event|27|||
125266989|NCT00401843|450607006|FG000|Overall Study|Death|0|||
125266990|NCT00401843|450607007|FG001|Overall Study|Death|8|||
125266991|NCT00401843|450607008|FG002|Overall Study|Death|10|||
125266992|NCT00401843|450607006|FG000|Overall Study|Disease progression|10|||
125266993|NCT00401843|450607007|FG001|Overall Study|Disease progression|60|||
125266994|NCT00401843|450607008|FG002|Overall Study|Disease progression|49|||
125266995|NCT00401843|450607006|FG000|Overall Study|End of Study|1|||
125266996|NCT00401843|450607007|FG001|Overall Study|End of Study|1|||
125266997|NCT00401843|450607008|FG002|Overall Study|End of Study|2|||
125266998|NCT00401843|450607006|FG000|Overall Study|Lost to Follow-up|0|||
125266999|NCT00401843|450607007|FG001|Overall Study|Lost to Follow-up|0|||
125267000|NCT00401843|450607008|FG002|Overall Study|Lost to Follow-up|2|||
125267001|NCT00401843|450607006|FG000|Overall Study|Other Unspecified|0|||
125267002|NCT00401843|450607007|FG001|Overall Study|Other Unspecified|3|||
125267003|NCT00401843|450607008|FG002|Overall Study|Other Unspecified|5|||
125267004|NCT00401843|450607006|FG000|Overall Study|Physician Decision|0|||
125267005|NCT00401843|450607007|FG001|Overall Study|Physician Decision|16|||
125267006|NCT00401843|450607008|FG002|Overall Study|Physician Decision|10|||
125267007|NCT00401843|450607006|FG000|Overall Study|Protocol Violation|0|||
125267008|NCT00401843|450607007|FG001|Overall Study|Protocol Violation|0|||
125267009|NCT00401843|450607008|FG002|Overall Study|Protocol Violation|1|||
125267010|NCT00401843|450607006|FG000|Overall Study|Withdrawal by Subject|1|||
125267011|NCT00401843|450607007|FG001|Overall Study|Withdrawal by Subject|5|||
125267012|NCT00401843|450607008|FG002|Overall Study|Withdrawal by Subject|5|||
125267013|NCT00401843|450607006|FG000|Overall Study|Withdrawal of consent to study agent|1|||
125267014|NCT00401843|450607007|FG001|Overall Study|Withdrawal of consent to study agent|15|||
125267015|NCT00401843|450607008|FG002|Overall Study|Withdrawal of consent to study agent|17|||
125267016|NCT00401843|450607006|FG000|Overall Study|Randomized but not Treated|0|||
125267017|NCT00401843|450607007|FG001|Overall Study|Randomized but not Treated|2|||
125267018|NCT00401843|450607008|FG002|Overall Study|Randomized but not Treated|3|||
125267019|NCT00401843|450607006|FG000|Overall Study|Received incorrect treatment|0|||
125267020|NCT00401843|450607007|FG001|Overall Study|Received incorrect treatment|3|||
125267021|NCT00401843|450607008|FG002|Overall Study|Received incorrect treatment|0|||
125267022|NCT02103062|450607009|FG000|Overall Study|Adverse Event|1|||
125267023|NCT02103062|450607010|FG001|Overall Study|Adverse Event|2|||
125267024|NCT02103062|450607009|FG000|Overall Study|Progressive Disease|17|||
125267025|NCT02103062|450607010|FG001|Overall Study|Progressive Disease|20|||
125267026|NCT02103062|450607009|FG000|Overall Study|Death|0|||
125267027|NCT02103062|450607010|FG001|Overall Study|Death|1|||
125267028|NCT02030821|450607012|FG000|Overall Study|Physician Decision|2|||
125267029|NCT02030821|450607013|FG001|Overall Study|Physician Decision|2|||
125267030|NCT02030821|450607014|FG002|Overall Study|Physician Decision|5|||
125267031|NCT02030821|450607015|FG003|Overall Study|Physician Decision|2|||
125267032|NCT03192137|450607016|FG000|Overall Study|Adverse Event|10|||
125267033|NCT03192137|450607017|FG001|Overall Study|Adverse Event|11|||
125267034|NCT03192137|450607016|FG000|Overall Study|Physician Decision|1|||
125267035|NCT03192137|450607017|FG001|Overall Study|Physician Decision|0|||
125267036|NCT03192137|450607016|FG000|Overall Study|Lack of Efficacy|20|||
125267037|NCT03192137|450607017|FG001|Overall Study|Lack of Efficacy|37|||
125267038|NCT03192137|450607016|FG000|Overall Study|Withdrawal by Subject|3|||
125267039|NCT03192137|450607017|FG001|Overall Study|Withdrawal by Subject|3|||
125267040|NCT03192137|450607016|FG000|Overall Study|Protocol Violation|4|||
125267041|NCT03192137|450607017|FG001|Overall Study|Protocol Violation|3|||
125267042|NCT03192137|450607016|FG000|Overall Study|Surgery Cancelled|4|||
125267043|NCT03192137|450607017|FG001|Overall Study|Surgery Cancelled|1|||
125267044|NCT03192137|450607016|FG000|Overall Study|Other - Various Administrative Reasons|8|||
125267045|NCT03192137|450607017|FG001|Overall Study|Other - Various Administrative Reasons|3|||
125267046|NCT00657267|450607020|FG000|Overall Study|Progressive disease|45|||
125267047|NCT00657267|450607020|FG000|Overall Study|Adverse Event|9|||
125267048|NCT02737501|450607024|FG000|Randomized Phase|Died|41|||
125267049|NCT02737501|450607025|FG001|Randomized Phase|Died|29|||
125267050|NCT02737501|450607026|FG002|Randomized Phase|Died|0|||
125267051|NCT02737501|450607024|FG000|Randomized Phase|Withdrawal by Subject|16|||
125267052|NCT02737501|450607025|FG001|Randomized Phase|Withdrawal by Subject|6|||
125267053|NCT02737501|450607026|FG002|Randomized Phase|Withdrawal by Subject|0|||
125267054|NCT02737501|450607024|FG000|Randomized Phase|Lost to Follow-up|0|||
125267055|NCT02737501|450607025|FG001|Randomized Phase|Lost to Follow-up|1|||
125267056|NCT02737501|450607026|FG002|Randomized Phase|Lost to Follow-up|0|||
125267057|NCT02737501|450607024|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
125267058|NCT02737501|450607025|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
125267059|NCT02737501|450607026|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
125267060|NCT02737501|450607024|FG000|Randomized Phase|Reason not Specified|1|||
125267061|NCT02737501|450607025|FG001|Randomized Phase|Reason not Specified|1|||
125267062|NCT02737501|450607026|FG002|Randomized Phase|Reason not Specified|0|||
125267063|NCT02737501|450607024|FG000|Randomized Phase|Never Treated|1|||
125267064|NCT02737501|450607025|FG001|Randomized Phase|Never Treated|1|||
125267065|NCT02737501|450607026|FG002|Randomized Phase|Never Treated|0|||
125267066|NCT02737501|450607024|FG000|Crossover Phase|Died|0|||
125267067|NCT02737501|450607025|FG001|Crossover Phase|Died|0|||
125267068|NCT02737501|450607026|FG002|Crossover Phase|Died|22|||
125267069|NCT02737501|450607024|FG000|Crossover Phase|Withdrew Consent|0|||
125267070|NCT02737501|450607025|FG001|Crossover Phase|Withdrew Consent|0|||
125267071|NCT02737501|450607026|FG002|Crossover Phase|Withdrew Consent|9|||
125267072|NCT02737501|450607024|FG000|Crossover Phase|Physician Decision|0|||
125267073|NCT02737501|450607025|FG001|Crossover Phase|Physician Decision|0|||
125267074|NCT02737501|450607026|FG002|Crossover Phase|Physician Decision|1|||
125267075|NCT02737501|450607024|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
125267076|NCT02737501|450607025|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
125267077|NCT02737501|450607026|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
125267078|NCT01261975|450607027|FG000|Overall Study|Surgical complication|1|||
125267079|NCT00716274|450607028|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
125267080|NCT00716274|450607029|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
125267081|NCT00716274|450607030|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
125267082|NCT00716274|450607031|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
125267083|NCT00716274|450607032|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
125267084|NCT00716274|450607033|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
125267085|NCT00716274|450607028|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
125267086|NCT00716274|450607029|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
125267087|NCT00716274|450607030|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
125267088|NCT00716274|450607031|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
125267089|NCT00716274|450607032|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
125267090|NCT00716274|450607033|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
125267091|NCT00716274|450607028|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
125267092|NCT00716274|450607029|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
125267093|NCT00716274|450607030|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
125267094|NCT00716274|450607031|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
125267095|NCT00716274|450607032|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
125267096|NCT00716274|450607033|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
125267097|NCT00716274|450607028|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
125267098|NCT00716274|450607029|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
125267099|NCT00716274|450607030|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
125267100|NCT00716274|450607031|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
125267101|NCT00716274|450607032|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
125267102|NCT00716274|450607033|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
125267103|NCT00716274|450607028|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
125267104|NCT00716274|450607029|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
125267105|NCT00716274|450607030|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
125267106|NCT00716274|450607031|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
125267107|NCT00716274|450607032|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
125267108|NCT00716274|450607033|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
125267109|NCT00716274|450607028|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
125267110|NCT00716274|450607029|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
125267111|NCT00716274|450607030|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
125267112|NCT00716274|450607031|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
125267113|NCT00716274|450607032|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
125267114|NCT00716274|450607033|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
125267115|NCT00716274|450607028|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
125267116|NCT00716274|450607029|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
125267117|NCT00716274|450607030|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
125267118|NCT00716274|450607031|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
125267119|NCT00716274|450607032|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
125267120|NCT00716274|450607033|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
125267121|NCT00716274|450607028|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
125267122|NCT00716274|450607029|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
125267123|NCT00716274|450607030|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
125267124|NCT00716274|450607031|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
125267125|NCT00716274|450607032|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
125267126|NCT00716274|450607033|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
125267127|NCT00716274|450607028|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
125267128|NCT00716274|450607029|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
125267129|NCT00716274|450607030|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
125267130|NCT00716274|450607031|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
125267131|NCT00716274|450607032|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
125267132|NCT00716274|450607033|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
125267133|NCT00716274|450607028|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
125267134|NCT00716274|450607029|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
125267135|NCT00716274|450607030|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
125267136|NCT00716274|450607031|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
125267137|NCT00716274|450607032|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
125267138|NCT00716274|450607033|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
125267139|NCT04067492|450607036|FG000|Overall Study|Lost to Follow-up|0|||
125267140|NCT04067492|450607037|FG001|Overall Study|Lost to Follow-up|0|||
125267141|NCT04067492|450607038|FG002|Overall Study|Lost to Follow-up|0|||
125267142|NCT04067492|450607039|FG003|Overall Study|Lost to Follow-up|0|||
125267143|NCT04067492|450607040|FG004|Overall Study|Lost to Follow-up|0|||
125267144|NCT04067492|450607041|FG005|Overall Study|Lost to Follow-up|1|||
125267145|NCT04067492|450607036|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
125267146|NCT04067492|450607037|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
125267147|NCT04067492|450607038|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
125267148|NCT04067492|450607039|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
125267149|NCT04067492|450607040|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
125267150|NCT04067492|450607041|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
125267151|NCT04067492|450607036|FG000|Overall Study|COVID-19 epidemiological situation|0|||
125267152|NCT04067492|450607037|FG001|Overall Study|COVID-19 epidemiological situation|0|||
125267153|NCT04067492|450607038|FG002|Overall Study|COVID-19 epidemiological situation|0|||
125267154|NCT04067492|450607039|FG003|Overall Study|COVID-19 epidemiological situation|1|||
125267155|NCT04067492|450607040|FG004|Overall Study|COVID-19 epidemiological situation|0|||
125267156|NCT04067492|450607041|FG005|Overall Study|COVID-19 epidemiological situation|0|||
125267157|NCT00786422|450607042|FG000|Rivaroxaban Treatment|Death|2|||
125267158|NCT00786422|450607042|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
125267159|NCT00786422|450607042|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
125267160|NCT00786422|450607042|FG000|Rivaroxaban Treatment|Physician Decision|1|||
125267161|NCT00786422|450607042|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
125267162|NCT00786422|450607042|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
125267163|NCT00786422|450607042|FG000|Rivaroxaban Treatment|Adverse Event|2|||
125267164|NCT00786422|450607042|FG000|Follow-up Period|Death|1|||
125267165|NCT00786422|450607042|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
125267166|NCT00543985|450607045|FG000|Overall Study|Withdrawal by Subject|4|||
125267167|NCT02015039|450607046|FG000|Overall Study|Not eligible|0|||
125267168|NCT02015039|450607047|FG001|Overall Study|Not eligible|1|||
125267169|NCT04570384|450607048|FG000|Overall Study|Adverse Event|2|||
125267170|NCT04570384|450607049|FG001|Overall Study|Adverse Event|1|||
125267171|NCT04570384|450607048|FG000|Overall Study|Death|2|||
125267172|NCT04570384|450607049|FG001|Overall Study|Death|5|||
125267173|NCT04570384|450607048|FG000|Overall Study|Lost to Follow-up|1|||
125267174|NCT04570384|450607049|FG001|Overall Study|Lost to Follow-up|0|||
125267175|NCT04570384|450607048|FG000|Overall Study|Other|1|||
125267176|NCT04570384|450607049|FG001|Overall Study|Other|0|||
125267177|NCT04570384|450607048|FG000|Overall Study|Protocol Violation|0|||
125267178|NCT04570384|450607049|FG001|Overall Study|Protocol Violation|1|||
125267179|NCT04570384|450607048|FG000|Overall Study|Sponsor Decision|1|||
125267180|NCT04570384|450607049|FG001|Overall Study|Sponsor Decision|0|||
125267181|NCT04570384|450607048|FG000|Overall Study|Withdrawal by Subject|4|||
125267182|NCT04570384|450607049|FG001|Overall Study|Withdrawal by Subject|2|||
125267183|NCT01673126|450607050|FG000|Overall Study|change of diagnosis|4|||
125267184|NCT01673126|450607051|FG001|Overall Study|change of diagnosis|3|||
125267185|NCT00237042|450607052|FG000|Treatment|Became ineligible post-randomization|0|||
125267186|NCT00237042|450607053|FG001|Treatment|Became ineligible post-randomization|1|||
125267187|NCT00237042|450607054|FG002|Treatment|Became ineligible post-randomization|16|||
125267188|NCT00237042|450607052|FG000|Treatment|Moved out of state|1|||
125267189|NCT00237042|450607053|FG001|Treatment|Moved out of state|1|||
125267190|NCT00237042|450607054|FG002|Treatment|Moved out of state|1|||
125267191|NCT00237042|450607052|FG000|Treatment|Completed no treatment|5|||
125267192|NCT00237042|450607053|FG001|Treatment|Completed no treatment|5|||
125267193|NCT00237042|450607054|FG002|Treatment|Completed no treatment|21|||
125267194|NCT00237042|450607052|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
125267195|NCT00237042|450607053|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
125267196|NCT00237042|450607054|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
125267197|NCT00237042|450607052|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
125267198|NCT00237042|450607053|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
125267199|NCT00237042|450607054|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
125267200|NCT01897532|450607061|FG000|Discontinuation From Treatment|Not Treated|7|||
125267201|NCT01897532|450607062|FG001|Discontinuation From Treatment|Not Treated|5|||
125267202|NCT01897532|450607061|FG000|Discontinuation From Treatment|Other reason than specified|196|||
125267203|NCT01897532|450607062|FG001|Discontinuation From Treatment|Other reason than specified|176|||
125267204|NCT01897532|450607061|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
125267205|NCT01897532|450607062|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
125267206|NCT01897532|450607061|FG000|Discontinuation From Treatment|Non compliance|24|||
125267207|NCT01897532|450607062|FG001|Discontinuation From Treatment|Non compliance|15|||
125267208|NCT01897532|450607061|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
125267209|NCT01897532|450607062|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
125267210|NCT01897532|450607061|FG000|Discontinuation From Trial|Not Treated|7|||
125267211|NCT01897532|450607062|FG001|Discontinuation From Trial|Not Treated|5|||
125267212|NCT01897532|450607061|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
125267213|NCT01897532|450607062|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
125267214|NCT03132467|450607063|FG000|Overall Study|Adverse Event|2|||
125267215|NCT03132467|450607063|FG000|Overall Study|Withdrawal by Subject|2|||
125267216|NCT00038948|450607064|FG000|Overall Study|Adverse Event|131|||
125267217|NCT00038948|450607065|FG001|Overall Study|Adverse Event|43|||
125267218|NCT00038948|450607064|FG000|Overall Study|Lost to Follow-up|4|||
125267219|NCT00038948|450607065|FG001|Overall Study|Lost to Follow-up|4|||
125267220|NCT00038948|450607064|FG000|Overall Study|Nonmedical event|5|||
125267221|NCT00038948|450607065|FG001|Overall Study|Nonmedical event|7|||
125267222|NCT00038948|450607064|FG000|Overall Study|Withdrawal by Subject|23|||
125267223|NCT00038948|450607065|FG001|Overall Study|Withdrawal by Subject|10|||
125267224|NCT00038948|450607064|FG000|Overall Study|Protocol Violation|3|||
125267225|NCT00038948|450607065|FG001|Overall Study|Protocol Violation|7|||
125267226|NCT00038948|450607064|FG000|Overall Study|Lack of Efficacy|3|||
125267227|NCT00038948|450607065|FG001|Overall Study|Lack of Efficacy|6|||
125267228|NCT01404234|450607068|FG000|Overall Study|Withdrawal by Subject|2|||
125267229|NCT02670473|450607069|FG000|Overall Study|Withdrawal by Subject|1|||
125267230|NCT05223673|450607070|FG000|Overall Study|Protocol Violation|1|||
125267231|NCT05223673|450607070|FG000|Overall Study|Study termination|6|||
125267232|NCT00937495|450608885|FG000|Overall Study|Protocol Violation|2|||
125267233|NCT00443703|450608886|FG000|Overall Study|Never Treated|3|||
125267234|NCT00443703|450608887|FG001|Overall Study|Never Treated|1|||
125267235|NCT00443703|450608886|FG000|Overall Study|Adverse Event|7|||
125267236|NCT00443703|450608887|FG001|Overall Study|Adverse Event|3|||
125267237|NCT00443703|450608886|FG000|Overall Study|Lack of Efficacy|3|||
125267238|NCT00443703|450608887|FG001|Overall Study|Lack of Efficacy|1|||
125267239|NCT00443703|450608886|FG000|Overall Study|Lost to Follow-up|0|||
125267240|NCT00443703|450608887|FG001|Overall Study|Lost to Follow-up|4|||
125267241|NCT00443703|450608886|FG000|Overall Study|Physician Decision|4|||
125267242|NCT00443703|450608887|FG001|Overall Study|Physician Decision|2|||
125267243|NCT00443703|450608886|FG000|Overall Study|Protocol Violation|1|||
125267244|NCT00443703|450608887|FG001|Overall Study|Protocol Violation|1|||
125267245|NCT00443703|450608886|FG000|Overall Study|Withdrawal by Subject|9|||
125267246|NCT00443703|450608887|FG001|Overall Study|Withdrawal by Subject|6|||
125267247|NCT00443703|450608886|FG000|Overall Study|Progressive Disease|1|||
125267248|NCT00443703|450608887|FG001|Overall Study|Progressive Disease|0|||
125267249|NCT00661830|450608890|FG000|Overall Study|Death|37|||
125267250|NCT00661830|450608891|FG001|Overall Study|Death|33|||
125267251|NCT00661830|450608890|FG000|Overall Study|Lost to Follow-up|1|||
125267252|NCT00661830|450608891|FG001|Overall Study|Lost to Follow-up|3|||
125267253|NCT00661830|450608890|FG000|Overall Study|Withdrawal by Subject|1|||
125267254|NCT00661830|450608891|FG001|Overall Study|Withdrawal by Subject|1|||
125267255|NCT00661830|450608890|FG000|Overall Study|Other reason|1|||
125267256|NCT00661830|450608891|FG001|Overall Study|Other reason|5|||
125267257|NCT00488514|450608892|FG000|Overall Study|Adverse Event|41|||
125267258|NCT00488514|450608892|FG000|Overall Study|Lost to Follow-up|44|||
125267259|NCT00488514|450608892|FG000|Overall Study|Protocol Violation|32|||
125267260|NCT00488514|450608892|FG000|Overall Study|Withdrawal by Subject|106|||
125267261|NCT00488514|450608892|FG000|Overall Study|Lack of Efficacy|28|||
125267262|NCT00488514|450608892|FG000|Overall Study|Did not meet criteria for treatment|30|||
125267263|NCT00488514|450608892|FG000|Overall Study|Postive drug screen|1|||
125267264|NCT00488514|450608892|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
125267265|NCT00488514|450608892|FG000|Overall Study|Investigator decision|1|||
125267266|NCT00488514|450608892|FG000|Overall Study|Participant had too few migraines|5|||
125267267|NCT00488514|450608892|FG000|Overall Study|Increase in number of migraines|2|||
125267268|NCT00488514|450608892|FG000|Overall Study|Increased use of concomitant medication|1|||
125267269|NCT01669902|450608893|FG000|Overall Study|Adverse Event|11|||
125267270|NCT01669902|450608893|FG000|Overall Study|Lack of Efficacy|10|||
125267271|NCT01669902|450608893|FG000|Overall Study|Other|8|||
125267272|NCT01535287|450608896|FG000|Overall Study|drug not prepared in time|5|||
125267273|NCT01535287|450608897|FG001|Overall Study|drug not prepared in time|6|||
125267274|NCT01475721|450608904|FG000|Overall Study|Death|3|||
125267275|NCT01475721|450608905|FG001|Overall Study|Death|6|||
125267276|NCT01475721|450608904|FG000|Overall Study|Withdrawal by Subject|8|||
125267277|NCT01475721|450608905|FG001|Overall Study|Withdrawal by Subject|8|||
125267278|NCT00803738|450608906|FG000|Overall Study|Adverse Event|3|||
125267279|NCT00803738|450608907|FG001|Overall Study|Adverse Event|5|||
125267280|NCT00803738|450608906|FG000|Overall Study|Lost to Follow-up|4|||
125267281|NCT00803738|450608907|FG001|Overall Study|Lost to Follow-up|4|||
125267282|NCT00803738|450608906|FG000|Overall Study|Protocol Violation|18|||
125267283|NCT00803738|450608907|FG001|Overall Study|Protocol Violation|10|||
125267284|NCT00803738|450608906|FG000|Overall Study|Withdrawal by Subject|1|||
125267285|NCT00803738|450608907|FG001|Overall Study|Withdrawal by Subject|4|||
125267286|NCT00803738|450608906|FG000|Overall Study|Lack of Efficacy|10|||
125267287|NCT00803738|450608907|FG001|Overall Study|Lack of Efficacy|16|||
125267288|NCT00803738|450608906|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
125267289|NCT00803738|450608907|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
125267290|NCT00803738|450608906|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
125267291|NCT00803738|450608907|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
125267292|NCT00387088|450608908|FG000|Overall Study|Adverse Event|143|||
125267293|NCT00387088|450608909|FG001|Overall Study|Adverse Event|156|||
125267294|NCT00387088|450608908|FG000|Overall Study|Protocol Violation|47|||
125267295|NCT00387088|450608909|FG001|Overall Study|Protocol Violation|35|||
125267296|NCT00387088|450608908|FG000|Overall Study|Withdrawal by Subject|20|||
125267297|NCT00387088|450608909|FG001|Overall Study|Withdrawal by Subject|35|||
125267298|NCT00387088|450608908|FG000|Overall Study|Lack of Efficacy|28|||
125267299|NCT00387088|450608909|FG001|Overall Study|Lack of Efficacy|67|||
125267300|NCT00387088|450608908|FG000|Overall Study|Lost to Follow-up|22|||
125267301|NCT00387088|450608909|FG001|Overall Study|Lost to Follow-up|28|||
125267302|NCT00387088|450608908|FG000|Overall Study|Other|58|||
125267303|NCT00387088|450608909|FG001|Overall Study|Other|52|||
125267304|NCT02848092|450608912|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
125267305|NCT02848092|450608913|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
125267306|NCT02848092|450608912|FG000|1-month Post-training Follow-up|Adverse Event|2|||
125267307|NCT02848092|450608913|FG001|1-month Post-training Follow-up|Adverse Event|1|||
125267308|NCT02848092|450608912|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
125267309|NCT02848092|450608913|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
125267310|NCT02848092|450608912|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
125267311|NCT02848092|450608913|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
125267312|NCT02848092|450608912|FG000|1-month Post-training Follow-up|fatigue|0|||
125267313|NCT02848092|450608913|FG001|1-month Post-training Follow-up|fatigue|1|||
125267314|NCT02848092|450608912|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
125267315|NCT02848092|450608913|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
125267316|NCT02848092|450608912|FG000|6-month Post-training Follow-up|Adverse Event|1|||
125267317|NCT02848092|450608913|FG001|6-month Post-training Follow-up|Adverse Event|1|||
125267318|NCT02848092|450608912|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
125267319|NCT02848092|450608913|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
125267320|NCT02848092|450608912|FG000|6-month Post-training Follow-up|frustrated with task|1|||
125267321|NCT02848092|450608913|FG001|6-month Post-training Follow-up|frustrated with task|0|||
125267322|NCT02848092|450608912|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
125267323|NCT02848092|450608913|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
125267324|NCT02848092|450608912|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
125267325|NCT02848092|450608913|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
125267326|NCT02329743|450608917|FG000|Overall Study|Adverse Event|1|||
125267327|NCT02329743|450608918|FG001|Overall Study|Adverse Event|1|||
125267328|NCT02329743|450608919|FG002|Overall Study|Adverse Event|3|||
125267329|NCT02329743|450608917|FG000|Overall Study|Lost to Follow-up|1|||
125267330|NCT02329743|450608918|FG001|Overall Study|Lost to Follow-up|0|||
125267331|NCT02329743|450608919|FG002|Overall Study|Lost to Follow-up|1|||
125267332|NCT02329743|450608917|FG000|Overall Study|Withdrawal by Subject|4|||
125267333|NCT02329743|450608918|FG001|Overall Study|Withdrawal by Subject|4|||
125267334|NCT02329743|450608919|FG002|Overall Study|Withdrawal by Subject|1|||
125267335|NCT02329743|450608917|FG000|Overall Study|Other|0|||
125267336|NCT02329743|450608918|FG001|Overall Study|Other|2|||
125267337|NCT02329743|450608919|FG002|Overall Study|Other|3|||
125267338|NCT01428219|450608931|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
125267339|NCT00592631|450608934|FG000|Overall Study|Lost to Follow-up|0|||
125267340|NCT00592631|450608935|FG001|Overall Study|Lost to Follow-up|2|||
125267341|NCT03745768|450608937|FG000|Overall Study|discontinued study|2|||
125267342|NCT03745768|450608938|FG001|Overall Study|discontinued study|0|||
125267343|NCT00443118|450608939|FG000|Overall Study|unknown primary outcome|3|||
125267344|NCT00443118|450608940|FG001|Overall Study|unknown primary outcome|1|||
125267345|NCT00443118|450608941|FG002|Overall Study|unknown primary outcome|0|||
125267346|NCT00443118|450608939|FG000|Overall Study|Withdrawal by Subject|1|||
125267347|NCT00443118|450608940|FG001|Overall Study|Withdrawal by Subject|0|||
125267348|NCT00443118|450608941|FG002|Overall Study|Withdrawal by Subject|0|||
125267349|NCT01023217|450608944|FG000|Overall Study|Withdrawal by Subject|1|||
125267350|NCT01023217|450608945|FG001|Overall Study|Withdrawal by Subject|0|||
125267351|NCT01106157|450608946|FG000|Overall Study|Withdrawal by Subject|1|||
125267352|NCT01106157|450608947|FG001|Overall Study|Withdrawal by Subject|0|||
125267353|NCT01673646|450608951|FG000|Overall Study|Adverse Event|2|||
125267354|NCT01673646|450608952|FG001|Overall Study|Adverse Event|1|||
125267355|NCT01673646|450608953|FG002|Overall Study|Adverse Event|1|||
125267356|NCT01673646|450608951|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125267357|NCT01673646|450608952|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125267358|NCT01673646|450608953|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
125267359|NCT01673646|450608951|FG000|Overall Study|Condition no longer requires study drug|0|||
125267360|NCT01673646|450608952|FG001|Overall Study|Condition no longer requires study drug|1|||
125267361|NCT01673646|450608953|FG002|Overall Study|Condition no longer requires study drug|0|||
125267362|NCT01673646|450608951|FG000|Overall Study|Withdrawal by Subject|0|||
125267363|NCT01673646|450608952|FG001|Overall Study|Withdrawal by Subject|2|||
125267364|NCT01673646|450608953|FG002|Overall Study|Withdrawal by Subject|2|||
125267365|NCT01673646|450608951|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
125267366|NCT01673646|450608952|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
125267367|NCT01673646|450608953|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
125267368|NCT02651116|450608954|FG000|Overall Study|Adverse Event|0|||
125267369|NCT02651116|450608955|FG001|Overall Study|Adverse Event|1|||
125267370|NCT02651116|450608954|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
125267371|NCT02651116|450608955|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
125267372|NCT02457247|450608956|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
125267373|NCT02457247|450608957|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
125267374|NCT02457247|450608958|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
125267375|NCT02457247|450608959|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
125267376|NCT02457247|450608956|FG000|Period 1|Significant Protocol Deviation|1|||
125267377|NCT02457247|450608957|FG001|Period 1|Significant Protocol Deviation|1|||
125267378|NCT02457247|450608958|FG002|Period 1|Significant Protocol Deviation|0|||
125267379|NCT02457247|450608959|FG003|Period 1|Significant Protocol Deviation|0|||
125267380|NCT02457247|450608956|FG000|Period 1|Voluntary Withdrawal|1|||
125267381|NCT02457247|450608957|FG001|Period 1|Voluntary Withdrawal|0|||
125267382|NCT02457247|450608958|FG002|Period 1|Voluntary Withdrawal|0|||
125267383|NCT02457247|450608959|FG003|Period 1|Voluntary Withdrawal|0|||
125267384|NCT02457247|450608956|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
125267385|NCT02457247|450608957|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
125267386|NCT02457247|450608958|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
125267387|NCT02457247|450608959|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
125267388|NCT02457247|450608956|FG000|Period 2|Significant Protocol Deviation|1|||
125267389|NCT02457247|450608957|FG001|Period 2|Significant Protocol Deviation|0|||
125267390|NCT02457247|450608958|FG002|Period 2|Significant Protocol Deviation|0|||
125267391|NCT02457247|450608959|FG003|Period 2|Significant Protocol Deviation|0|||
125267392|NCT02457247|450608956|FG000|Period 2|Lost to Follow-up|0|||
125267393|NCT02457247|450608957|FG001|Period 2|Lost to Follow-up|1|||
125267394|NCT02457247|450608958|FG002|Period 2|Lost to Follow-up|0|||
125267395|NCT02457247|450608959|FG003|Period 2|Lost to Follow-up|0|||
125267396|NCT02457247|450608956|FG000|Period 2|Voluntary Withdrawal|1|||
125267397|NCT02457247|450608957|FG001|Period 2|Voluntary Withdrawal|1|||
125267398|NCT02457247|450608958|FG002|Period 2|Voluntary Withdrawal|0|||
125267399|NCT02457247|450608959|FG003|Period 2|Voluntary Withdrawal|0|||
125267400|NCT01492088|450608960|FG000|Overall Study|Withdrawal by Patient|0|||
125267401|NCT01492088|450608961|FG001|Overall Study|Withdrawal by Patient|2|||
125267402|NCT01492088|450608962|FG002|Overall Study|Withdrawal by Patient|0|||
125267403|NCT01492088|450608960|FG000|Overall Study|Death|1|||
125267404|NCT01492088|450608961|FG001|Overall Study|Death|6|||
125267405|NCT01492088|450608962|FG002|Overall Study|Death|2|||
125267406|NCT01492088|450608960|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
125267407|NCT01492088|450608961|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
125267408|NCT01492088|450608962|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
125267409|NCT01492088|450608960|FG000|Overall Study|Alive at Last Follow-up|0|||
125267410|NCT01492088|450608961|FG001|Overall Study|Alive at Last Follow-up|6|||
125267411|NCT01492088|450608962|FG002|Overall Study|Alive at Last Follow-up|11|||
125267412|NCT03824392|450608963|FG000|Overall Study|Adverse Event|1|||
125267413|NCT03824392|450608964|FG001|Overall Study|Adverse Event|0|||
125267414|NCT03824392|450608965|FG002|Overall Study|Adverse Event|0|||
125267415|NCT03824392|450608966|FG003|Overall Study|Adverse Event|0|||
125267416|NCT03824392|450608963|FG000|Overall Study|Investigator Decision|0|||
125267417|NCT03824392|450608964|FG001|Overall Study|Investigator Decision|1|||
125267418|NCT03824392|450608965|FG002|Overall Study|Investigator Decision|0|||
125267419|NCT03824392|450608966|FG003|Overall Study|Investigator Decision|0|||
125267420|NCT03824392|450608963|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
125267421|NCT03824392|450608964|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
125267422|NCT03824392|450608965|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
125267423|NCT03824392|450608966|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
125267424|NCT00127855|450608967|FG000|Primary Vaccination Course|Adverse Event|0|||
125267425|NCT00127855|450608968|FG001|Primary Vaccination Course|Adverse Event|0|||
125267426|NCT00127855|450608969|FG002|Primary Vaccination Course|Adverse Event|1|||
125267427|NCT00127855|450608970|FG003|Primary Vaccination Course|Adverse Event|0|||
125267428|NCT00127855|450608971|FG004|Primary Vaccination Course|Adverse Event|0|||
125267429|NCT00127855|450608967|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
125267430|NCT00127855|450608968|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
125267431|NCT00127855|450608969|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
125267432|NCT00127855|450608970|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
125267433|NCT00127855|450608971|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
125267434|NCT00127855|450608967|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
125267435|NCT00127855|450608968|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
125267436|NCT00127855|450608969|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
125267437|NCT00127855|450608970|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
125267438|NCT00127855|450608971|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
125267439|NCT00127855|450608967|FG000|Primary Vaccination Course|Other|0|||
125267440|NCT00127855|450608968|FG001|Primary Vaccination Course|Other|0|||
125267441|NCT00127855|450608969|FG002|Primary Vaccination Course|Other|0|||
125267442|NCT00127855|450608970|FG003|Primary Vaccination Course|Other|0|||
125267443|NCT00127855|450608971|FG004|Primary Vaccination Course|Other|1|||
125267444|NCT02343302|450608972|FG000|Overall Study|Physician Decision|1|||
125267445|NCT02343302|450608973|FG001|Overall Study|Physician Decision|1|||
125267446|NCT01887717|450608974|FG000|Overall Study|Withdrawal by Subject|1|||
125267447|NCT01887717|450608975|FG001|Overall Study|Withdrawal by Subject|7|||
125267448|NCT01887717|450608974|FG000|Overall Study|Physician Decision|0|||
125267449|NCT01887717|450608975|FG001|Overall Study|Physician Decision|2|||
125267450|NCT01887717|450608974|FG000|Overall Study|Administrative reasons|5|||
125267451|NCT01887717|450608975|FG001|Overall Study|Administrative reasons|2|||
125267452|NCT02655887|450608976|FG000|Overall Study|Lost to Follow-up|3|||
125267453|NCT02655887|450608976|FG000|Overall Study|Death|4|||
125267454|NCT02655887|450608976|FG000|Overall Study|Withdrawal by Subject|3|||
125267455|NCT02655887|450608976|FG000|Overall Study|Missed 12-month follow-up visit|4|||
125267456|NCT03637491|450608977|FG000|Overall Study|Death|9|||
125267457|NCT03637491|450608978|FG001|Overall Study|Death|9|||
125267458|NCT03637491|450608979|FG002|Overall Study|Death|5|||
125267459|NCT03637491|450608980|FG003|Overall Study|Death|3|||
125267460|NCT03637491|450608977|FG000|Overall Study|Lost to Follow-up|0|||
125267461|NCT03637491|450608978|FG001|Overall Study|Lost to Follow-up|1|||
125267462|NCT03637491|450608979|FG002|Overall Study|Lost to Follow-up|0|||
125267463|NCT03637491|450608980|FG003|Overall Study|Lost to Follow-up|1|||
125267464|NCT03637491|450608977|FG000|Overall Study|Study Terminated By Sponsor|0|||
125267465|NCT03637491|450608978|FG001|Overall Study|Study Terminated By Sponsor|2|||
125267466|NCT03637491|450608979|FG002|Overall Study|Study Terminated By Sponsor|1|||
125267467|NCT03637491|450608980|FG003|Overall Study|Study Terminated By Sponsor|0|||
125267468|NCT03637491|450608977|FG000|Overall Study|Withdrawal by Subject|1|||
125267469|NCT03637491|450608978|FG001|Overall Study|Withdrawal by Subject|0|||
125267470|NCT03637491|450608979|FG002|Overall Study|Withdrawal by Subject|1|||
125267471|NCT03637491|450608980|FG003|Overall Study|Withdrawal by Subject|2|||
125267472|NCT00532844|450608981|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
125267473|NCT00532844|450608982|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
125267474|NCT00532844|450608981|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
125267475|NCT00532844|450608982|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
125267476|NCT00532844|450608981|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
125267477|NCT00532844|450608982|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
125267478|NCT00532844|450608981|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
125267479|NCT00532844|450608982|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
125267480|NCT00532844|450608981|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
125267481|NCT00532844|450608982|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
125267482|NCT04389866|450608986|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
125267483|NCT04389866|450608987|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
125267484|NCT03465722|450608991|FG000|Overall Study|Withdrawal by Subject|21|||
125267485|NCT03465722|450608992|FG001|Overall Study|Withdrawal by Subject|14|||
125267486|NCT03465722|450608991|FG000|Overall Study|Death|89|||
125267487|NCT03465722|450608992|FG001|Overall Study|Death|87|||
125267488|NCT03465722|450608991|FG000|Overall Study|Lost to Follow-up|5|||
125267489|NCT03465722|450608992|FG001|Overall Study|Lost to Follow-up|3|||
125267490|NCT03465722|450608991|FG000|Overall Study|Administrative/Other|33|||
125267491|NCT03465722|450608992|FG001|Overall Study|Administrative/Other|32|||
125267492|NCT03465722|450608991|FG000|Overall Study|Not treated|1|||
125267493|NCT03465722|450608992|FG001|Overall Study|Not treated|2|||
125267494|NCT03465722|450608991|FG000|Overall Study|Sponsor decision|91|||
125267495|NCT03465722|450608992|FG001|Overall Study|Sponsor decision|98|||
125267496|NCT01490918|450608993|FG000|Overall Study|Lost to Follow-up|2|||
125267497|NCT01490918|450608994|FG001|Overall Study|Lost to Follow-up|1|||
125267498|NCT01490918|450608995|FG002|Overall Study|Lost to Follow-up|0|||
125267499|NCT01490918|450608993|FG000|Overall Study|Withdrawal by Subject|7|||
125267500|NCT01490918|450608994|FG001|Overall Study|Withdrawal by Subject|8|||
125267501|NCT01490918|450608995|FG002|Overall Study|Withdrawal by Subject|3|||
125267502|NCT01490918|450608993|FG000|Overall Study|Adverse Event|0|||
125267503|NCT01490918|450608994|FG001|Overall Study|Adverse Event|0|||
125267504|NCT01490918|450608995|FG002|Overall Study|Adverse Event|1|||
125267505|NCT01490918|450608993|FG000|Overall Study|other cause|4|||
125267506|NCT01490918|450608994|FG001|Overall Study|other cause|5|||
125267507|NCT01490918|450608995|FG002|Overall Study|other cause|8|||
125267508|NCT04940130|450609003|FG000|Overall Study|Travel|1|||
125267509|NCT04940130|450609004|FG001|Overall Study|Travel|0|||
125267510|NCT04940130|450609005|FG002|Overall Study|Travel|2|||
125267511|NCT04940130|450609003|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
125267512|NCT04940130|450609004|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
125267513|NCT04940130|450609005|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
125267514|NCT04940130|450609003|FG000|Overall Study|Adverse Event|0|||
125267515|NCT04940130|450609004|FG001|Overall Study|Adverse Event|0|||
125267516|NCT04940130|450609005|FG002|Overall Study|Adverse Event|2|||
125267517|NCT04940130|450609003|FG000|Overall Study|Disease progression/treatment failure|0|||
125267518|NCT04940130|450609004|FG001|Overall Study|Disease progression/treatment failure|0|||
125267519|NCT04940130|450609005|FG002|Overall Study|Disease progression/treatment failure|1|||
125267520|NCT04940130|450609003|FG000|Overall Study|Participant refusal|0|||
125267521|NCT04940130|450609004|FG001|Overall Study|Participant refusal|0|||
125267522|NCT04940130|450609005|FG002|Overall Study|Participant refusal|1|||
125267523|NCT02240121|450609006|FG000|Overall Study|Protocol Violation|1|||
125267524|NCT02240121|450609007|FG001|Overall Study|Protocol Violation|2|||
125267525|NCT02240121|450609006|FG000|Overall Study|Physician Decision|0|||
125267526|NCT02240121|450609007|FG001|Overall Study|Physician Decision|1|||
125267527|NCT02240121|450609006|FG000|Overall Study|Change in protocol interpretation|1|||
125267528|NCT02240121|450609007|FG001|Overall Study|Change in protocol interpretation|0|||
125267529|NCT02240121|450609006|FG000|Overall Study|Lack of Efficacy|2|||
125267530|NCT02240121|450609007|FG001|Overall Study|Lack of Efficacy|3|||
125267531|NCT02240121|450609006|FG000|Overall Study|Site closed|1|||
125267532|NCT02240121|450609007|FG001|Overall Study|Site closed|1|||
125267533|NCT02240121|450609006|FG000|Overall Study|Pregnancy|1|||
125267534|NCT02240121|450609007|FG001|Overall Study|Pregnancy|0|||
125267535|NCT02240121|450609006|FG000|Overall Study|Adverse Event|2|||
125267536|NCT02240121|450609007|FG001|Overall Study|Adverse Event|4|||
125267537|NCT02240121|450609006|FG000|Overall Study|Withdrawal by Subject|6|||
125267538|NCT02240121|450609007|FG001|Overall Study|Withdrawal by Subject|2|||
125267539|NCT02240121|450609006|FG000|Overall Study|Lost to Follow-up|3|||
125267540|NCT02240121|450609007|FG001|Overall Study|Lost to Follow-up|4|||
125267541|NCT02240121|450609006|FG000|Overall Study|Other than specified|1|||
125267542|NCT02240121|450609007|FG001|Overall Study|Other than specified|3|||
125267543|NCT01925768|450609010|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
125267544|NCT01925768|450609011|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125267545|NCT01925768|450609010|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
125267546|NCT01925768|450609011|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
125267547|NCT01925768|450609010|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
125267548|NCT01925768|450609011|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
125267549|NCT01925768|450609010|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
125267550|NCT01925768|450609011|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
125267551|NCT01925768|450609010|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
125267552|NCT01925768|450609011|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
125267553|NCT01925768|450609010|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
125267554|NCT01925768|450609011|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
125267555|NCT01925768|450609010|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
125267556|NCT01925768|450609011|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
125267557|NCT01925768|450609010|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
125267558|NCT01925768|450609011|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
125267559|NCT01925768|450609010|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
125267560|NCT01925768|450609011|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
125267561|NCT01925768|450609010|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
125267562|NCT01925768|450609011|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
125267563|NCT01925768|450609010|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
125267564|NCT01925768|450609011|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
125267565|NCT00251693|450609014|FG000|Overall Study|Adverse Event|17|||
125267566|NCT00251693|450609015|FG001|Overall Study|Adverse Event|9|||
125267567|NCT00251693|450609016|FG002|Overall Study|Adverse Event|9|||
125267568|NCT00251693|450609014|FG000|Overall Study|Protocol Violation|2|||
125267569|NCT00251693|450609015|FG001|Overall Study|Protocol Violation|0|||
125267570|NCT00251693|450609016|FG002|Overall Study|Protocol Violation|2|||
125267571|NCT00251693|450609014|FG000|Overall Study|Lost to Follow-up|12|||
125267572|NCT00251693|450609015|FG001|Overall Study|Lost to Follow-up|7|||
125267573|NCT00251693|450609016|FG002|Overall Study|Lost to Follow-up|8|||
125267574|NCT00251693|450609014|FG000|Overall Study|Withdrawal by Subject|11|||
125267575|NCT00251693|450609015|FG001|Overall Study|Withdrawal by Subject|17|||
125267576|NCT00251693|450609016|FG002|Overall Study|Withdrawal by Subject|14|||
125267577|NCT00251693|450609014|FG000|Overall Study|Lack of Efficacy|0|||
125267578|NCT00251693|450609015|FG001|Overall Study|Lack of Efficacy|1|||
125267579|NCT00251693|450609016|FG002|Overall Study|Lack of Efficacy|0|||
125267580|NCT00251693|450609014|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
125267581|NCT00251693|450609015|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
125267582|NCT00251693|450609016|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
125267583|NCT00251693|450609014|FG000|Overall Study|Noncompliant|0|||
125267584|NCT00251693|450609015|FG001|Overall Study|Noncompliant|0|||
125267585|NCT00251693|450609016|FG002|Overall Study|Noncompliant|2|||
125267586|NCT00251693|450609014|FG000|Overall Study|Possible Barrett's esophagus|3|||
125267587|NCT00251693|450609015|FG001|Overall Study|Possible Barrett's esophagus|5|||
125267588|NCT00251693|450609016|FG002|Overall Study|Possible Barrett's esophagus|2|||
125267589|NCT00251693|450609014|FG000|Overall Study|Subject request/subject unavailable|1|||
125267590|NCT00251693|450609015|FG001|Overall Study|Subject request/subject unavailable|2|||
125267591|NCT00251693|450609016|FG002|Overall Study|Subject request/subject unavailable|0|||
125267592|NCT00251693|450609014|FG000|Overall Study|Abnormal laboratory findings|0|||
125267593|NCT00251693|450609015|FG001|Overall Study|Abnormal laboratory findings|0|||
125267594|NCT00251693|450609016|FG002|Overall Study|Abnormal laboratory findings|1|||
125267595|NCT02779777|450609017|FG000|Overall Study|Disease Progression|1|||
125267596|NCT02779777|450609018|FG001|Overall Study|Disease Progression|0|||
125267597|NCT02779777|450609019|FG002|Overall Study|Disease Progression|0|||
125267598|NCT02779777|450609017|FG000|Overall Study|Adverse Event|3|||
125267599|NCT02779777|450609018|FG001|Overall Study|Adverse Event|1|||
125267600|NCT02779777|450609019|FG002|Overall Study|Adverse Event|0|||
125267601|NCT02779777|450609017|FG000|Overall Study|Physician Decision|9|||
125267602|NCT02779777|450609018|FG001|Overall Study|Physician Decision|0|||
125267603|NCT02779777|450609019|FG002|Overall Study|Physician Decision|1|||
125267604|NCT02779777|450609017|FG000|Overall Study|Withdrawal by Subject|1|||
125267605|NCT02779777|450609018|FG001|Overall Study|Withdrawal by Subject|0|||
125267606|NCT02779777|450609019|FG002|Overall Study|Withdrawal by Subject|0|||
125267607|NCT04571060|450609020|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
125267608|NCT04571060|450609021|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
125267609|NCT04571060|450609020|FG000|Overall Study|Never treated migraine|47|||
125267610|NCT04571060|450609021|FG001|Overall Study|Never treated migraine|36|||
125267611|NCT04571060|450609020|FG000|Overall Study|Protocol Violation|4|||
125267612|NCT04571060|450609021|FG001|Overall Study|Protocol Violation|2|||
125267613|NCT04571060|450609020|FG000|Overall Study|Withdrawal by Subject|6|||
125267614|NCT04571060|450609021|FG001|Overall Study|Withdrawal by Subject|2|||
125267615|NCT04571060|450609020|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
125267616|NCT04571060|450609021|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
125267617|NCT00087698|450609027|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
125267618|NCT00087698|450609027|FG000|Overall Study|Death from Other Causes|3|||
125267619|NCT00087698|450609027|FG000|Overall Study|Adverse Event|4|||
125267620|NCT00087698|450609027|FG000|Overall Study|Withdrawal by Subject|4|||
125267621|NCT00087698|450609027|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
125267622|NCT00087698|450609027|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
125267623|NCT00087698|450609027|FG000|Overall Study|Clinical Relapse|1|||
125267624|NCT00087698|450609027|FG000|Overall Study|Death from Study Disease|2|||
125267625|NCT00087698|450609027|FG000|Overall Study|Death from Study Drug Toxicity|2|||
125267626|NCT00087698|450609027|FG000|Overall Study|Protocol Violation|1|||
125267627|NCT01900665|450609042|FG000|Placebo Controlled Period|Death|9|||
125267628|NCT01900665|450609043|FG001|Placebo Controlled Period|Death|16|||
125267629|NCT01900665|450609042|FG000|Placebo Controlled Period|Adverse Event|48|||
125267630|NCT01900665|450609043|FG001|Placebo Controlled Period|Adverse Event|39|||
125267631|NCT01900665|450609042|FG000|Placebo Controlled Period|Protocol Violation|1|||
125267632|NCT01900665|450609043|FG001|Placebo Controlled Period|Protocol Violation|7|||
125267633|NCT01900665|450609042|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
125267634|NCT01900665|450609043|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
125267635|NCT01900665|450609042|FG000|Placebo Controlled Period|Physician Decision|11|||
125267636|NCT01900665|450609043|FG001|Placebo Controlled Period|Physician Decision|7|||
125267637|NCT01900665|450609042|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
125267638|NCT01900665|450609043|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
125267639|NCT01900665|450609042|FG000|Placebo Controlled Period|Caregiver Decision|33|||
125267640|NCT01900665|450609043|FG001|Placebo Controlled Period|Caregiver Decision|41|||
125267641|NCT01900665|450609042|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
125267642|NCT01900665|450609043|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
125267643|NCT01900665|450609042|FG000|Open Label Period|Adverse Event|16|||
125267644|NCT01900665|450609043|FG001|Open Label Period|Adverse Event|20|||
125267645|NCT01900665|450609042|FG000|Open Label Period|Death|5|||
125267646|NCT01900665|450609043|FG001|Open Label Period|Death|6|||
125267647|NCT01900665|450609042|FG000|Open Label Period|Lost to Follow-up|1|||
125267648|NCT01900665|450609043|FG001|Open Label Period|Lost to Follow-up|1|||
125267649|NCT01900665|450609042|FG000|Open Label Period|Parent/Caregiver Decision|33|||
125267650|NCT01900665|450609043|FG001|Open Label Period|Parent/Caregiver Decision|34|||
125267651|NCT01900665|450609042|FG000|Open Label Period|Physician Decision|4|||
125267652|NCT01900665|450609043|FG001|Open Label Period|Physician Decision|4|||
125267653|NCT01900665|450609042|FG000|Open Label Period|Protocol Violation|0|||
125267654|NCT01900665|450609043|FG001|Open Label Period|Protocol Violation|1|||
125267655|NCT01900665|450609042|FG000|Open Label Period|Sponsor Decision|802|||
125267656|NCT01900665|450609043|FG001|Open Label Period|Sponsor Decision|765|||
125267657|NCT01900665|450609042|FG000|Open Label Period|Withdrawal by Subject|20|||
125267658|NCT01900665|450609043|FG001|Open Label Period|Withdrawal by Subject|28|||
125267659|NCT04749745|450609047|FG000|Overall Study|Withdrawal by Subject|1|||
125267660|NCT04749745|450609048|FG001|Overall Study|Withdrawal by Subject|0|||
125267661|NCT03816176|450609053|FG000|Overall Study|Miscellaneous|5|||
125267662|NCT03816176|450609053|FG000|Overall Study|Lack of Efficacy|4|||
125267663|NCT03816176|450609053|FG000|Overall Study|Adverse Event|3|||
125267664|NCT04472650|450610128|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
125267665|NCT04472650|450610129|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
125267666|NCT00288015|450610134|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
125267667|NCT00288015|450610134|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
125267668|NCT00288015|450610134|FG000|First Response Assessment|Withdrawal by Subject|1|||
125267669|NCT00288015|450610134|FG000|First Response Assessment|Death|1|||
125267670|NCT00288015|450610134|FG000|First Response Assessment|Physician Decision|2|||
125267671|NCT00288015|450610134|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
125267672|NCT00288015|450610134|FG000|Follow up for Survival x 2 Years|Death|13|||
125267673|NCT00288015|450610134|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
125267674|NCT00288015|450610134|FG000|Follow up for Survival x 2 Years|Other|9|||
125267675|NCT01333722|450610135|FG000|Overall Study|Lack of Efficacy|0|||
125267676|NCT01333722|450610136|FG001|Overall Study|Lack of Efficacy|2|||
125267677|NCT01333722|450610135|FG000|Overall Study|Withdrawal by Subject|0|||
125267678|NCT01333722|450610136|FG001|Overall Study|Withdrawal by Subject|1|||
125267679|NCT02477527|450610139|FG000|Overall Study|Lost to Follow-up|2|||
125267680|NCT02477527|450610139|FG000|Overall Study|Withdrawal by Subject|1|||
125267681|NCT02477527|450610139|FG000|Overall Study|Screen Failure|3|||
125267682|NCT02383862|450610142|FG000|3 Month Follow up|Lost to Follow-up|23|||
125267683|NCT02383862|450610143|FG001|3 Month Follow up|Lost to Follow-up|21|||
125267684|NCT01833494|450610144|FG000|Overall Study|Adverse Event|24|||
125267685|NCT01833494|450610144|FG000|Overall Study|Physician Decision|6|||
125267686|NCT01833494|450610144|FG000|Overall Study|Withdrawal by Subject|6|||
125267687|NCT01833494|450610144|FG000|Overall Study|Decrease in serum phosphorus|4|||
125267688|NCT01833494|450610144|FG000|Overall Study|Decrease in serum calcium|4|||
125267689|NCT01833494|450610144|FG000|Overall Study|Increase in serum ferritin|1|||
125267690|NCT01694433|450610145|FG000|Overall Study|Adverse Event|7|||
125267691|NCT01694433|450610146|FG001|Overall Study|Adverse Event|0|||
125267692|NCT01694433|450610145|FG000|Overall Study|Physician Decision|1|||
125267693|NCT01694433|450610146|FG001|Overall Study|Physician Decision|0|||
125267694|NCT01694433|450610145|FG000|Overall Study|Withdrawal by Subject|3|||
125267695|NCT01694433|450610146|FG001|Overall Study|Withdrawal by Subject|4|||
125267696|NCT00374595|450610149|FG000|Overall Study|Death|23|||
125267697|NCT00374595|450610149|FG000|Overall Study|Withdrawal by Subject|39|||
125267698|NCT00374595|450610149|FG000|Overall Study|Lost to Follow-up|3|||
125267699|NCT00374595|450610149|FG000|Overall Study|too much time commitment|1|||
125267700|NCT00374595|450610149|FG000|Overall Study|transfer care to other clinical site|1|||
125267701|NCT00374595|450610149|FG000|Overall Study|relocation|3|||
125267702|NCT01664247|450610151|FG000|Overall Study|Adverse Event|5|||
125267703|NCT01664247|450610152|FG001|Overall Study|Adverse Event|3|||
125267704|NCT01664247|450610151|FG000|Overall Study|Protocol Violation|3|||
125267705|NCT01664247|450610152|FG001|Overall Study|Protocol Violation|5|||
125267706|NCT01664247|450610151|FG000|Overall Study|Withdrawal Criteria|1|||
125267707|NCT01664247|450610152|FG001|Overall Study|Withdrawal Criteria|4|||
125267708|NCT01664247|450610151|FG000|Overall Study|Unclassified|5|||
125267709|NCT01664247|450610152|FG001|Overall Study|Unclassified|29|||
125267710|NCT03064074|450610157|FG000|Overall Study|Physician Decision|0|||
125267711|NCT03064074|450610158|FG001|Overall Study|Physician Decision|0|||
125267712|NCT03064074|450610159|FG002|Overall Study|Physician Decision|0|||
125267713|NCT03064074|450610160|FG003|Overall Study|Physician Decision|1|||
125267714|NCT01118780|450610165|FG000|Overall Study|Adverse Event|15|||
125267715|NCT01118780|450610166|FG001|Overall Study|Adverse Event|15|||
125267716|NCT01118780|450610165|FG000|Overall Study|Death|1|||
125267717|NCT01118780|450610166|FG001|Overall Study|Death|0|||
125267718|NCT01118780|450610165|FG000|Overall Study|Lack of Efficacy|2|||
125267719|NCT01118780|450610166|FG001|Overall Study|Lack of Efficacy|6|||
125267720|NCT01118780|450610165|FG000|Overall Study|Physician Decision|2|||
125267721|NCT01118780|450610166|FG001|Overall Study|Physician Decision|0|||
125267722|NCT01118780|450610165|FG000|Overall Study|Protocol Violation|3|||
125267723|NCT01118780|450610166|FG001|Overall Study|Protocol Violation|6|||
125267724|NCT01118780|450610165|FG000|Overall Study|Withdrawal by Subject|13|||
125267725|NCT01118780|450610166|FG001|Overall Study|Withdrawal by Subject|8|||
125267726|NCT03962855|450610177|FG000|Overall Study|Death|0|||
125267727|NCT03962855|450610178|FG001|Overall Study|Death|1|||
125267728|NCT03962855|450610177|FG000|Overall Study|Lost to Follow-up|0|||
125267729|NCT03962855|450610178|FG001|Overall Study|Lost to Follow-up|1|||
125267730|NCT03962855|450610177|FG000|Overall Study|Adverse Event|0|||
125267731|NCT03962855|450610178|FG001|Overall Study|Adverse Event|1|||
125267732|NCT03962855|450610177|FG000|Overall Study|Physician Decision|0|||
125267733|NCT03962855|450610178|FG001|Overall Study|Physician Decision|2|||
125267734|NCT02379052|450610179|FG000|Overall Study|Protocol Violation|0|||
125267735|NCT02379052|450610180|FG001|Overall Study|Protocol Violation|1|||
125267736|NCT02379052|450610179|FG000|Overall Study|Adverse Event|0|||
125267737|NCT02379052|450610180|FG001|Overall Study|Adverse Event|1|||
125267738|NCT02379052|450610179|FG000|Overall Study|Physician Decision|1|||
125267739|NCT02379052|450610180|FG001|Overall Study|Physician Decision|1|||
125267740|NCT02379052|450610179|FG000|Overall Study|Withdrawal by Subject|2|||
125267741|NCT02379052|450610180|FG001|Overall Study|Withdrawal by Subject|0|||
125267742|NCT02379052|450610179|FG000|Overall Study|Lost to Follow-up|2|||
125267743|NCT02379052|450610180|FG001|Overall Study|Lost to Follow-up|1|||
125267744|NCT02379052|450610179|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
125267745|NCT02379052|450610180|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
125267746|NCT02379052|450610179|FG000|Overall Study|Subject was Incarcerated|0|||
125267747|NCT02379052|450610180|FG001|Overall Study|Subject was Incarcerated|1|||
125267748|NCT04419467|450610183|FG000|Overall Study|Not treated with IP|0|||
125267749|NCT04419467|450610184|FG001|Overall Study|Not treated with IP|0|||
125267750|NCT04419467|450610185|FG002|Overall Study|Not treated with IP|2|||
125267751|NCT04419467|450610183|FG000|Overall Study|Adverse Event|0|||
125267752|NCT04419467|450610184|FG001|Overall Study|Adverse Event|2|||
125267753|NCT04419467|450610185|FG002|Overall Study|Adverse Event|0|||
125267754|NCT04419467|450610183|FG000|Overall Study|Death|1|||
125267755|NCT04419467|450610184|FG001|Overall Study|Death|0|||
125267756|NCT04419467|450610185|FG002|Overall Study|Death|0|||
125267757|NCT04419467|450610183|FG000|Overall Study|Lost to Follow-up|0|||
125267758|NCT04419467|450610184|FG001|Overall Study|Lost to Follow-up|1|||
125267759|NCT04419467|450610185|FG002|Overall Study|Lost to Follow-up|2|||
125267760|NCT04419467|450610183|FG000|Overall Study|Withdrawal by Subject|0|||
125267761|NCT04419467|450610184|FG001|Overall Study|Withdrawal by Subject|0|||
125267762|NCT04419467|450610185|FG002|Overall Study|Withdrawal by Subject|4|||
125267763|NCT04419467|450610183|FG000|Overall Study|Pandemic related|0|||
125267764|NCT04419467|450610184|FG001|Overall Study|Pandemic related|0|||
125267765|NCT04419467|450610185|FG002|Overall Study|Pandemic related|1|||
125267766|NCT04419467|450610183|FG000|Overall Study|Reason not known|1|||
125267767|NCT04419467|450610184|FG001|Overall Study|Reason not known|0|||
125267768|NCT04419467|450610185|FG002|Overall Study|Reason not known|0|||
125267769|NCT00442416|450610188|FG000|Overall Study|Adverse Event|4|||
125267770|NCT00442416|450610189|FG001|Overall Study|Adverse Event|1|||
125267771|NCT00442416|450610188|FG000|Overall Study|Death|1|||
125267772|NCT00442416|450610189|FG001|Overall Study|Death|0|||
125267773|NCT00442416|450610188|FG000|Overall Study|Lack of Efficacy|2|||
125267774|NCT00442416|450610189|FG001|Overall Study|Lack of Efficacy|0|||
125267775|NCT00442416|450610188|FG000|Overall Study|Protocol Violation|2|||
125267776|NCT00442416|450610189|FG001|Overall Study|Protocol Violation|3|||
125267777|NCT00442416|450610188|FG000|Overall Study|Withdrew consent|1|||
125267778|NCT00442416|450610189|FG001|Overall Study|Withdrew consent|2|||
125267779|NCT00442416|450610188|FG000|Overall Study|Administrative/Other|27|||
125267780|NCT00442416|450610189|FG001|Overall Study|Administrative/Other|33|||
125267781|NCT01284959|450610192|FG000|Overall Study|Withdrawal by Subject|1|||
125267782|NCT01284959|450610193|FG001|Overall Study|Withdrawal by Subject|0|||
125267783|NCT01284959|450610194|FG002|Overall Study|Withdrawal by Subject|0|||
125267784|NCT01284959|450610192|FG000|Overall Study|Adverse Event|0|||
125267785|NCT01284959|450610193|FG001|Overall Study|Adverse Event|0|||
125267786|NCT01284959|450610194|FG002|Overall Study|Adverse Event|1|||
125267787|NCT00003869|450610196|FG000|Overall Study|Adverse Event|14|||
125267788|NCT00003869|450610197|FG001|Overall Study|Adverse Event|3|||
125267789|NCT00003869|450610196|FG000|Overall Study|Withdrawal by Subject|21|||
125267790|NCT00003869|450610197|FG001|Overall Study|Withdrawal by Subject|3|||
125267791|NCT00003869|450610196|FG000|Overall Study|Death|1|||
125267792|NCT00003869|450610197|FG001|Overall Study|Death|2|||
125267793|NCT00003869|450610196|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
125267794|NCT00003869|450610197|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
125267795|NCT03364231|450610198|FG000|Overall Study|Adverse Event|1|||
125267796|NCT03364231|450610199|FG001|Overall Study|Adverse Event|4|||
125267797|NCT03364231|450610198|FG000|Overall Study|Death|1|||
125267798|NCT03364231|450610199|FG001|Overall Study|Death|0|||
125267799|NCT03364231|450610198|FG000|Overall Study|Investigator Decision|2|||
125267800|NCT03364231|450610199|FG001|Overall Study|Investigator Decision|2|||
125267801|NCT03364231|450610198|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
125267802|NCT03364231|450610199|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
125267803|NCT03364231|450610198|FG000|Overall Study|Withdrawal of Subject Consent|1|||
125267804|NCT03364231|450610199|FG001|Overall Study|Withdrawal of Subject Consent|0|||
125267805|NCT03364231|450610198|FG000|Overall Study|Reason Not Specified|1|||
125267806|NCT03364231|450610199|FG001|Overall Study|Reason Not Specified|0|||
125267807|NCT03364231|450610198|FG000|Overall Study|Disease Progression|0|||
125267808|NCT03364231|450610199|FG001|Overall Study|Disease Progression|6|||
125267809|NCT04068922|450610200|FG000|Overall Study|Lost to Follow-up|5|||
125267810|NCT04068922|450610200|FG000|Overall Study|Withdrawal by Subject|7|||
125267811|NCT04068922|450610200|FG000|Overall Study|Adverse Event|1|||
125267812|NCT01070979|450610208|FG000|Overall Study|Adverse Event|2|||
125267813|NCT01070979|450610209|FG001|Overall Study|Adverse Event|3|||
125267814|NCT01070979|450610210|FG002|Overall Study|Adverse Event|3|||
125267815|NCT01070979|450610208|FG000|Overall Study|Lost to Follow-up|2|||
125267816|NCT01070979|450610209|FG001|Overall Study|Lost to Follow-up|1|||
125267817|NCT01070979|450610210|FG002|Overall Study|Lost to Follow-up|1|||
125267818|NCT01070979|450610208|FG000|Overall Study|Protocol Violation|0|||
125267819|NCT01070979|450610209|FG001|Overall Study|Protocol Violation|2|||
125267820|NCT01070979|450610210|FG002|Overall Study|Protocol Violation|6|||
125267821|NCT01070979|450610208|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
125267822|NCT01070979|450610209|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
125267823|NCT01070979|450610210|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
125267824|NCT01070979|450610208|FG000|Overall Study|Withdrawal by Subject|3|||
125267825|NCT01070979|450610209|FG001|Overall Study|Withdrawal by Subject|1|||
125267826|NCT01070979|450610210|FG002|Overall Study|Withdrawal by Subject|1|||
125267827|NCT01070979|450610208|FG000|Overall Study|No study drug taken|0|||
125267828|NCT01070979|450610209|FG001|Overall Study|No study drug taken|1|||
125267829|NCT01070979|450610210|FG002|Overall Study|No study drug taken|0|||
125267830|NCT00444106|450610213|FG000|Overall Study|Lost to Follow-up|2|||
125267831|NCT00444106|450610214|FG001|Overall Study|Lost to Follow-up|1|||
125267832|NCT00444106|450610215|FG002|Overall Study|Lost to Follow-up|0|||
125267833|NCT00444106|450610213|FG000|Overall Study|Abnormal Test Procedure Results|0|||
125267834|NCT00444106|450610214|FG001|Overall Study|Abnormal Test Procedure Results|0|||
125267835|NCT00444106|450610215|FG002|Overall Study|Abnormal Test Procedure Results|1|||
125267836|NCT04749914|450610216|FG000|Period 1|Adverse Event|1|||
125267837|NCT04749914|450610217|FG001|Period 1|Adverse Event|0|||
125267838|NCT04749914|450610218|FG002|Period 1|Adverse Event|0|||
125267839|NCT04749914|450610219|FG003|Period 1|Adverse Event|0|||
125267840|NCT04749914|450610216|FG000|Period 1|Withdrawal by Subject|1|||
125267841|NCT04749914|450610217|FG001|Period 1|Withdrawal by Subject|0|||
125267842|NCT04749914|450610218|FG002|Period 1|Withdrawal by Subject|1|||
125267843|NCT04749914|450610219|FG003|Period 1|Withdrawal by Subject|0|||
125267844|NCT01913327|450610222|FG000|Overall Study|Withdrawal by Subject|0|||
125267845|NCT01913327|450610223|FG001|Overall Study|Withdrawal by Subject|1|||
125267846|NCT01074931|450610228|FG000|Overall Study|Economic reasons|1|||
125267847|NCT01074931|450610228|FG000|Overall Study|Death|5|||
125267848|NCT00953706|450610229|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
125267849|NCT00953706|450610230|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
125267850|NCT00953706|450610231|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
125267851|NCT00953706|450610232|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
125267852|NCT00953706|450610229|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
125267853|NCT00953706|450610230|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
125267854|NCT00953706|450610231|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
125267855|NCT00953706|450610232|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
125267856|NCT00953706|450610229|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
125267857|NCT00953706|450610230|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
125267858|NCT00953706|450610231|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
125267859|NCT00953706|450610232|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
125267860|NCT00953706|450610229|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
125267861|NCT00953706|450610230|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
125267862|NCT00953706|450610231|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
125267863|NCT00953706|450610232|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
125267864|NCT00953706|450610229|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
125267865|NCT00953706|450610230|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
125267866|NCT00953706|450610231|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
125267867|NCT00953706|450610232|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
125267868|NCT00953706|450610229|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
125267869|NCT00953706|450610230|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
125267870|NCT00953706|450610231|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
125267871|NCT00953706|450610232|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
125267872|NCT00953706|450610229|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
125267873|NCT00953706|450610230|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
125267874|NCT00953706|450610231|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
125267875|NCT00953706|450610232|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
125267876|NCT00953706|450610229|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
125267877|NCT00953706|450610230|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
125267878|NCT00953706|450610231|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
125267879|NCT00953706|450610232|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
125267880|NCT00953706|450610229|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
125267881|NCT00953706|450610230|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
125267882|NCT00953706|450610231|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
125267883|NCT00953706|450610232|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
125267884|NCT00953706|450610229|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
125267885|NCT00953706|450610230|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
125267886|NCT00953706|450610231|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
125267887|NCT00953706|450610232|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
125267888|NCT00953706|450610229|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
125267889|NCT00953706|450610230|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
125267890|NCT00953706|450610231|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
125267891|NCT00953706|450610232|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
125267892|NCT02137070|450610234|FG000|Overall Study|Adverse Event|12|||
125267893|NCT02137070|450610235|FG001|Overall Study|Adverse Event|3|||
125267894|NCT02137070|450610234|FG000|Overall Study|Death|2|||
125267895|NCT02137070|450610235|FG001|Overall Study|Death|0|||
125267896|NCT02137070|450610234|FG000|Overall Study|Lost to Follow-up|24|||
125267897|NCT02137070|450610235|FG001|Overall Study|Lost to Follow-up|9|||
125267898|NCT02137070|450610234|FG000|Overall Study|Physician Decision|0|||
125267899|NCT02137070|450610235|FG001|Overall Study|Physician Decision|1|||
125267900|NCT02137070|450610234|FG000|Overall Study|Protocol Violation|18|||
125267901|NCT02137070|450610235|FG001|Overall Study|Protocol Violation|4|||
125267902|NCT02137070|450610234|FG000|Overall Study|Withdrawal by Subject|18|||
125267903|NCT02137070|450610235|FG001|Overall Study|Withdrawal by Subject|1|||
125267904|NCT02112656|450610236|FG000|Overall Study|Death|78|||
125267905|NCT02112656|450610237|FG001|Overall Study|Death|82|||
125267906|NCT02112656|450610236|FG000|Overall Study|Withdrawal by Subject|9|||
125267907|NCT02112656|450610237|FG001|Overall Study|Withdrawal by Subject|11|||
125267908|NCT02112656|450610236|FG000|Overall Study|Lost to Follow-up|2|||
125267909|NCT02112656|450610237|FG001|Overall Study|Lost to Follow-up|4|||
125267910|NCT02112656|450610236|FG000|Overall Study|Noncompliance|1|||
125267911|NCT02112656|450610237|FG001|Overall Study|Noncompliance|2|||
125267912|NCT03761056|450610238|FG000|Overall Study|Death|8|||
125267913|NCT03761056|450610238|FG000|Overall Study|Enrolled but never treated|2|||
125267914|NCT03761056|450610238|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
125267915|NCT03761056|450610238|FG000|Overall Study|Investigator decision|1|||
125267916|NCT03965403|450610243|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
125267917|NCT01979614|450611594|FG000|Overall Study|Adverse Event|1|||
125267918|NCT01979614|450611595|FG001|Overall Study|Adverse Event|1|||
125267919|NCT00756275|450611596|FG000|Overall Study|Lost to Follow-up|25|||
125267920|NCT00756275|450611597|FG001|Overall Study|Lost to Follow-up|21|||
125267921|NCT00756275|450611596|FG000|Overall Study|Withdrawal by Subject|4|||
125267922|NCT00756275|450611597|FG001|Overall Study|Withdrawal by Subject|7|||
125267923|NCT00938912|450611600|FG000|Overall Study|Withdrawal by Subject|28|||
125267924|NCT00938912|450611600|FG000|Overall Study|Lost to Follow-up|4|||
125267925|NCT00938912|450611600|FG000|Overall Study|Lack of Efficacy|43|||
125267926|NCT00938912|450611600|FG000|Overall Study|Adverse event, non-fatal|24|||
125267927|NCT00938912|450611600|FG000|Overall Study|Adverse event, fatal|1|||
125267928|NCT00938912|450611600|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
125267929|NCT00938912|450611600|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
125267930|NCT00938912|450611600|FG000|Overall Study|Participant needed prohibit medication|1|||
125267931|NCT00938912|450611600|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
125267932|NCT00938912|450611600|FG000|Overall Study|Did not meet Eligibility criteria|1|||
125267933|NCT00938912|450611600|FG000|Overall Study|Participant relocated not related to AE|1|||
125267934|NCT00938912|450611600|FG000|Overall Study|Participant moved to another city|1|||
125267935|NCT00938912|450611600|FG000|Overall Study|Participant experienced break through seizures|1|||
125267936|NCT00938912|450611600|FG000|Overall Study|No longer wished to participate in the study|1|||
125267937|NCT00938912|450611600|FG000|Overall Study|Protocol Deviation|2|||
125267938|NCT00456755|450611601|FG000|Overall Study|Lost to Follow-up|2|||
125267939|NCT00456755|450611602|FG001|Overall Study|Lost to Follow-up|1|||
125267940|NCT06164691|450611603|FG000|Overall Study|Withdrawal by Subject|2|||
125267941|NCT06164691|450611604|FG001|Overall Study|Withdrawal by Subject|0|||
125267942|NCT06164691|450611605|FG002|Overall Study|Withdrawal by Subject|0|||
125267943|NCT03432494|450611624|FG000|Overall Study|Death|1|||
125267944|NCT03432494|450611624|FG000|Overall Study|Noncompliance|1|||
125267945|NCT00856635|450611625|FG000|Overall Study|Lost to Follow-up|2|||
125267946|NCT00856635|450611626|FG001|Overall Study|Lost to Follow-up|5|||
125267947|NCT00856635|450611625|FG000|Overall Study|Pregnancy|1|||
125267948|NCT00856635|450611626|FG001|Overall Study|Pregnancy|0|||
125267949|NCT00856635|450611625|FG000|Overall Study|Withdrawal by Subject|3|||
125267950|NCT00856635|450611626|FG001|Overall Study|Withdrawal by Subject|1|||
125267951|NCT00856635|450611625|FG000|Overall Study|Serious Adverse Event|1|||
125267952|NCT00856635|450611626|FG001|Overall Study|Serious Adverse Event|0|||
125267953|NCT00856635|450611625|FG000|Overall Study|Other|1|||
125267954|NCT00856635|450611626|FG001|Overall Study|Other|0|||
125267955|NCT00856635|450611625|FG000|Overall Study|Discontinued at Randomization|2|||
125267956|NCT00856635|450611626|FG001|Overall Study|Discontinued at Randomization|2|||
125267957|NCT01244035|450611627|FG000|Part 1: Period 1|Adverse Event|0|||
125267958|NCT01244035|450611628|FG001|Part 1: Period 1|Adverse Event|0|||
125267959|NCT01244035|450611629|FG002|Part 1: Period 1|Adverse Event|0|||
125267960|NCT01244035|450611630|FG003|Part 1: Period 1|Adverse Event|0|||
125267961|NCT01244035|450611631|FG004|Part 1: Period 1|Adverse Event|0|||
125267962|NCT01244035|450611632|FG005|Part 1: Period 1|Adverse Event|1|||
125267963|NCT01244035|450611627|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
125267964|NCT01244035|450611628|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
125267965|NCT01244035|450611629|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
125267966|NCT01244035|450611630|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
125267967|NCT01244035|450611631|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
125267968|NCT01244035|450611632|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
125267969|NCT01244035|450611627|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
125267970|NCT01244035|450611628|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
125267971|NCT01244035|450611629|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
125267972|NCT01244035|450611630|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
125267973|NCT01244035|450611631|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
125267974|NCT01244035|450611632|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
125267975|NCT01244035|450611627|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
125267976|NCT01244035|450611628|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
125267977|NCT01244035|450611629|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
125267978|NCT01244035|450611630|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
125267979|NCT01244035|450611631|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
125267980|NCT01244035|450611632|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
125267981|NCT01244035|450611627|FG000|Part 1: Period 3|Adverse Event|0|||
125267982|NCT01244035|450611628|FG001|Part 1: Period 3|Adverse Event|0|||
125267983|NCT01244035|450611629|FG002|Part 1: Period 3|Adverse Event|0|||
125267984|NCT01244035|450611630|FG003|Part 1: Period 3|Adverse Event|0|||
125267985|NCT01244035|450611631|FG004|Part 1: Period 3|Adverse Event|0|||
125267986|NCT01244035|450611632|FG005|Part 1: Period 3|Adverse Event|1|||
125267987|NCT01244035|450611627|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
125267988|NCT01244035|450611628|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
125267989|NCT01244035|450611629|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
125267990|NCT01244035|450611630|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
125267991|NCT01244035|450611631|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
125267992|NCT01244035|450611632|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
125267993|NCT01244035|450611627|FG000|Part 1: Period 3|Protocol Deviation|0|||
125267994|NCT01244035|450611628|FG001|Part 1: Period 3|Protocol Deviation|1|||
125267995|NCT01244035|450611629|FG002|Part 1: Period 3|Protocol Deviation|0|||
125267996|NCT01244035|450611630|FG003|Part 1: Period 3|Protocol Deviation|0|||
125267997|NCT01244035|450611631|FG004|Part 1: Period 3|Protocol Deviation|0|||
125267998|NCT01244035|450611632|FG005|Part 1: Period 3|Protocol Deviation|0|||
125267999|NCT01696773|450611633|FG000|Days 15-27, Washout|Adverse Event|1|||
125268000|NCT01696773|450611634|FG001|Days 15-27, Washout|Adverse Event|0|||
125268001|NCT02370368|450611637|FG000|Overall Study|Adverse Event|1|||
125268002|NCT02370368|450611638|FG001|Overall Study|Adverse Event|2|||
125268003|NCT02370368|450611637|FG000|Overall Study|Withdrawal by Subject|5|||
125268004|NCT02370368|450611638|FG001|Overall Study|Withdrawal by Subject|4|||
125268005|NCT00347932|450611641|FG000|Overall Study|Adverse Event|4|||
125268006|NCT00347932|450611642|FG001|Overall Study|Adverse Event|5|||
125268007|NCT00347932|450611641|FG000|Overall Study|Lack of Efficacy|3|||
125268008|NCT00347932|450611642|FG001|Overall Study|Lack of Efficacy|14|||
125268009|NCT00347932|450611641|FG000|Overall Study|Lost to Follow-up|10|||
125268010|NCT00347932|450611642|FG001|Overall Study|Lost to Follow-up|9|||
125268011|NCT00347932|450611641|FG000|Overall Study|Withdrawal by Subject|10|||
125268012|NCT00347932|450611642|FG001|Overall Study|Withdrawal by Subject|16|||
125268013|NCT00347932|450611641|FG000|Overall Study|Did not meet inclusion criteria|4|||
125268014|NCT00347932|450611642|FG001|Overall Study|Did not meet inclusion criteria|8|||
125268015|NCT04512001|450611643|FG000|Week 0 to Week 24|Adverse Event|14|||
125268016|NCT04512001|450611644|FG001|Week 0 to Week 24|Adverse Event|10|||
125268017|NCT04512001|450611645|FG002|Week 0 to Week 24|Adverse Event|0|||
125268018|NCT04512001|450611646|FG003|Week 0 to Week 24|Adverse Event|0|||
125268019|NCT04512001|450611647|FG004|Week 0 to Week 24|Adverse Event|0|||
125268020|NCT04512001|450611643|FG000|Week 0 to Week 24|Death|0|||
125268021|NCT04512001|450611644|FG001|Week 0 to Week 24|Death|2|||
125268022|NCT04512001|450611645|FG002|Week 0 to Week 24|Death|0|||
125268023|NCT04512001|450611646|FG003|Week 0 to Week 24|Death|0|||
125268024|NCT04512001|450611647|FG004|Week 0 to Week 24|Death|0|||
125268025|NCT04512001|450611643|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
125268026|NCT04512001|450611644|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
125268027|NCT04512001|450611645|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
125268028|NCT04512001|450611646|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
125268029|NCT04512001|450611647|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
125268030|NCT04512001|450611643|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
125268031|NCT04512001|450611644|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
125268032|NCT04512001|450611645|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
125268033|NCT04512001|450611646|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
125268034|NCT04512001|450611647|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
125268035|NCT04512001|450611643|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
125268036|NCT04512001|450611644|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
125268037|NCT04512001|450611645|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
125268038|NCT04512001|450611646|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
125268039|NCT04512001|450611647|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
125268040|NCT04512001|450611643|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
125268041|NCT04512001|450611644|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
125268042|NCT04512001|450611645|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
125268043|NCT04512001|450611646|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
125268044|NCT04512001|450611647|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
125268045|NCT04512001|450611643|FG000|Week 24 to Week 63|Adverse Event|0|||
125268046|NCT04512001|450611644|FG001|Week 24 to Week 63|Adverse Event|0|||
125268047|NCT04512001|450611645|FG002|Week 24 to Week 63|Adverse Event|13|||
125268048|NCT04512001|450611646|FG003|Week 24 to Week 63|Adverse Event|8|||
125268049|NCT04512001|450611647|FG004|Week 24 to Week 63|Adverse Event|6|||
125268050|NCT04512001|450611643|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
125268051|NCT04512001|450611644|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
125268052|NCT04512001|450611645|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
125268053|NCT04512001|450611646|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
125268054|NCT04512001|450611647|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
125268055|NCT04512001|450611643|FG000|Week 24 to Week 63|Death|0|||
125268056|NCT04512001|450611644|FG001|Week 24 to Week 63|Death|0|||
125268057|NCT04512001|450611645|FG002|Week 24 to Week 63|Death|0|||
125268058|NCT04512001|450611646|FG003|Week 24 to Week 63|Death|1|||
125268059|NCT04512001|450611647|FG004|Week 24 to Week 63|Death|1|||
125268060|NCT04512001|450611643|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
125268061|NCT04512001|450611644|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
125268062|NCT04512001|450611645|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
125268063|NCT04512001|450611646|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
125268064|NCT04512001|450611647|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
125268065|NCT04512001|450611643|FG000|Week 24 to Week 63|Miscellaneous|0|||
125268066|NCT04512001|450611644|FG001|Week 24 to Week 63|Miscellaneous|0|||
125268067|NCT04512001|450611645|FG002|Week 24 to Week 63|Miscellaneous|3|||
125268068|NCT04512001|450611646|FG003|Week 24 to Week 63|Miscellaneous|2|||
125268069|NCT04512001|450611647|FG004|Week 24 to Week 63|Miscellaneous|1|||
125268070|NCT03389308|450611650|FG000|Overall Study|Withdrawal by Subject|5|||
125268071|NCT03389308|450611650|FG000|Overall Study|Lost to Follow-up|3|||
125268072|NCT03389308|450611650|FG000|Overall Study|Adverse Event|2|||
125268073|NCT03389308|450611650|FG000|Overall Study|Sponsor Request|2|||
125268074|NCT03198767|450611651|FG000|Overall Study|Protocol Violation|0|||
125268075|NCT03198767|450611652|FG001|Overall Study|Protocol Violation|0|||
125268076|NCT03198767|450611653|FG002|Overall Study|Protocol Violation|0|||
125268077|NCT03198767|450611654|FG003|Overall Study|Protocol Violation|6|||
125268078|NCT03198767|450611655|FG004|Overall Study|Protocol Violation|0|||
125268079|NCT03198767|450611656|FG005|Overall Study|Protocol Violation|0|||
125268080|NCT03198767|450611657|FG006|Overall Study|Protocol Violation|0|||
125268081|NCT00570323|450611658|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
125268082|NCT00570323|450611659|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
125268083|NCT00570323|450611658|FG000|Started Treatment After Randomization|Protocol Violation|1|||
125268084|NCT00570323|450611659|FG001|Started Treatment After Randomization|Protocol Violation|0|||
125268085|NCT00570323|450611658|FG000|Started Treatment After Randomization|Physician Decision|1|||
125268086|NCT00570323|450611659|FG001|Started Treatment After Randomization|Physician Decision|0|||
125268087|NCT00570323|450611658|FG000|Complete Study After Start|Lost to Follow-up|0|||
125268088|NCT00570323|450611659|FG001|Complete Study After Start|Lost to Follow-up|1|||
125268089|NCT00570323|450611658|FG000|Complete Study After Start|Withdrawal by Subject|2|||
125268090|NCT00570323|450611659|FG001|Complete Study After Start|Withdrawal by Subject|0|||
125268091|NCT00570323|450611658|FG000|Complete Study After Start|Physician Decision|1|||
125268092|NCT00570323|450611659|FG001|Complete Study After Start|Physician Decision|0|||
125268093|NCT04232943|450611660|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
125268094|NCT04232943|450611661|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
125268095|NCT04232943|450611662|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
125268096|NCT04232943|450611660|FG000|Overall Study|Withdrawal by Subject|1|||
125268097|NCT04232943|450611661|FG001|Overall Study|Withdrawal by Subject|1|||
125268098|NCT04232943|450611662|FG002|Overall Study|Withdrawal by Subject|0|||
125268099|NCT03896477|450611665|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
125268100|NCT03896477|450611666|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
125268101|NCT03896477|450611667|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
125268102|NCT03896477|450611665|FG000|Overall Study|Parent Requested Withdrawal|8|||
125268103|NCT03896477|450611666|FG001|Overall Study|Parent Requested Withdrawal|12|||
125268104|NCT03896477|450611667|FG002|Overall Study|Parent Requested Withdrawal|9|||
125268105|NCT03896477|450611665|FG000|Overall Study|Adverse Event|0|||
125268106|NCT03896477|450611666|FG001|Overall Study|Adverse Event|0|||
125268107|NCT03896477|450611667|FG002|Overall Study|Adverse Event|1|||
125268108|NCT03896477|450611665|FG000|Overall Study|Death|1|||
125268109|NCT03896477|450611666|FG001|Overall Study|Death|0|||
125268110|NCT03896477|450611667|FG002|Overall Study|Death|0|||
125268111|NCT03896477|450611665|FG000|Overall Study|Other|5|||
125268112|NCT03896477|450611666|FG001|Overall Study|Other|6|||
125268113|NCT03896477|450611667|FG002|Overall Study|Other|7|||
125268114|NCT03896477|450611665|FG000|Overall Study|Lost to Follow-up|2|||
125268115|NCT03896477|450611666|FG001|Overall Study|Lost to Follow-up|1|||
125268116|NCT03896477|450611667|FG002|Overall Study|Lost to Follow-up|1|||
125268117|NCT01791517|450611668|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
125268118|NCT01791517|450611669|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
125268119|NCT01791517|450611670|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
125268120|NCT01791517|450611671|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
125268121|NCT01791517|450611672|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
125268122|NCT01791517|450611673|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
125268123|NCT01791517|450611674|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
125268124|NCT01791517|450611675|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
125268125|NCT01791517|450611676|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
125268126|NCT01791517|450611677|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
125268127|NCT01791517|450611678|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
125268128|NCT01791517|450611679|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
125268129|NCT01791517|450611668|FG000|Phase I: Period 1|Adverse Event|0|||
125268130|NCT01791517|450611669|FG001|Phase I: Period 1|Adverse Event|0|||
125268131|NCT01791517|450611670|FG002|Phase I: Period 1|Adverse Event|1|||
125268132|NCT01791517|450611671|FG003|Phase I: Period 1|Adverse Event|1|||
125268133|NCT01791517|450611672|FG004|Phase I: Period 1|Adverse Event|0|||
125268134|NCT01791517|450611673|FG005|Phase I: Period 1|Adverse Event|0|||
125268135|NCT01791517|450611674|FG006|Phase I: Period 1|Adverse Event|0|||
125268136|NCT01791517|450611675|FG007|Phase I: Period 1|Adverse Event|0|||
125268137|NCT01791517|450611676|FG008|Phase I: Period 1|Adverse Event|0|||
125268138|NCT01791517|450611677|FG009|Phase I: Period 1|Adverse Event|0|||
125268139|NCT01791517|450611678|FG010|Phase I: Period 1|Adverse Event|0|||
125268140|NCT01791517|450611679|FG011|Phase I: Period 1|Adverse Event|0|||
125268141|NCT01791517|450611668|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
125268142|NCT01791517|450611669|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125268143|NCT01791517|450611670|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125268144|NCT01791517|450611671|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125268145|NCT01791517|450611672|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125268146|NCT01791517|450611673|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125268147|NCT01791517|450611674|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125268148|NCT01791517|450611675|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125268149|NCT01791517|450611676|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125268150|NCT01791517|450611677|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125268151|NCT01791517|450611678|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125268152|NCT01791517|450611679|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125268153|NCT01791517|450611668|FG000|Phase I: Period 1|Protocol Violation|0|||
125268154|NCT01791517|450611669|FG001|Phase I: Period 1|Protocol Violation|1|||
125268155|NCT01791517|450611670|FG002|Phase I: Period 1|Protocol Violation|0|||
125268156|NCT01791517|450611671|FG003|Phase I: Period 1|Protocol Violation|0|||
125268157|NCT01791517|450611672|FG004|Phase I: Period 1|Protocol Violation|0|||
125268158|NCT01791517|450611673|FG005|Phase I: Period 1|Protocol Violation|0|||
125268159|NCT01791517|450611674|FG006|Phase I: Period 1|Protocol Violation|0|||
125268160|NCT01791517|450611675|FG007|Phase I: Period 1|Protocol Violation|0|||
125268161|NCT01791517|450611676|FG008|Phase I: Period 1|Protocol Violation|0|||
125268162|NCT01791517|450611677|FG009|Phase I: Period 1|Protocol Violation|0|||
125268163|NCT01791517|450611678|FG010|Phase I: Period 1|Protocol Violation|0|||
125268164|NCT01791517|450611679|FG011|Phase I: Period 1|Protocol Violation|0|||
125268165|NCT01791517|450611668|FG000|Phase I: Period 1|Lost to Follow-up|0|||
125268166|NCT01791517|450611669|FG001|Phase I: Period 1|Lost to Follow-up|0|||
125268167|NCT01791517|450611670|FG002|Phase I: Period 1|Lost to Follow-up|0|||
125268168|NCT01791517|450611671|FG003|Phase I: Period 1|Lost to Follow-up|1|||
125268169|NCT01791517|450611672|FG004|Phase I: Period 1|Lost to Follow-up|0|||
125268170|NCT01791517|450611673|FG005|Phase I: Period 1|Lost to Follow-up|0|||
125268171|NCT01791517|450611674|FG006|Phase I: Period 1|Lost to Follow-up|1|||
125268172|NCT01791517|450611675|FG007|Phase I: Period 1|Lost to Follow-up|0|||
125268173|NCT01791517|450611676|FG008|Phase I: Period 1|Lost to Follow-up|1|||
125268174|NCT01791517|450611677|FG009|Phase I: Period 1|Lost to Follow-up|1|||
125268175|NCT01791517|450611678|FG010|Phase I: Period 1|Lost to Follow-up|0|||
125268176|NCT01791517|450611679|FG011|Phase I: Period 1|Lost to Follow-up|0|||
125268177|NCT01791517|450611668|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268178|NCT01791517|450611669|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268179|NCT01791517|450611670|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268180|NCT01791517|450611671|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268181|NCT01791517|450611672|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268182|NCT01791517|450611673|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268183|NCT01791517|450611674|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268184|NCT01791517|450611675|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268185|NCT01791517|450611676|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268186|NCT01791517|450611677|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268187|NCT01791517|450611678|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268188|NCT01791517|450611679|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
125268189|NCT01791517|450611668|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
125268190|NCT01791517|450611669|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268191|NCT01791517|450611670|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268192|NCT01791517|450611671|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268193|NCT01791517|450611672|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268194|NCT01791517|450611673|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268195|NCT01791517|450611674|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268196|NCT01791517|450611675|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268197|NCT01791517|450611676|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268198|NCT01791517|450611677|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268199|NCT01791517|450611678|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268200|NCT01791517|450611679|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268201|NCT01791517|450611668|FG000|Phase I: Period 2|Protocol Violation|0|||
125268202|NCT01791517|450611669|FG001|Phase I: Period 2|Protocol Violation|0|||
125268203|NCT01791517|450611670|FG002|Phase I: Period 2|Protocol Violation|0|||
125268204|NCT01791517|450611671|FG003|Phase I: Period 2|Protocol Violation|1|||
125268205|NCT01791517|450611672|FG004|Phase I: Period 2|Protocol Violation|0|||
125268206|NCT01791517|450611673|FG005|Phase I: Period 2|Protocol Violation|0|||
125268207|NCT01791517|450611674|FG006|Phase I: Period 2|Protocol Violation|0|||
125268208|NCT01791517|450611675|FG007|Phase I: Period 2|Protocol Violation|0|||
125268209|NCT01791517|450611676|FG008|Phase I: Period 2|Protocol Violation|0|||
125268210|NCT01791517|450611677|FG009|Phase I: Period 2|Protocol Violation|0|||
125268211|NCT01791517|450611678|FG010|Phase I: Period 2|Protocol Violation|0|||
125268212|NCT01791517|450611679|FG011|Phase I: Period 2|Protocol Violation|0|||
125268213|NCT01791517|450611668|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
125268214|NCT01791517|450611669|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
125268215|NCT01791517|450611670|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
125268216|NCT01791517|450611671|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
125268217|NCT01791517|450611672|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
125268218|NCT01791517|450611673|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
125268219|NCT01791517|450611674|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
125268220|NCT01791517|450611675|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
125268221|NCT01791517|450611676|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
125268222|NCT01791517|450611677|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
125268223|NCT01791517|450611678|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
125268224|NCT01791517|450611679|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
125268225|NCT01791517|450611668|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268226|NCT01791517|450611669|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268227|NCT01791517|450611670|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268228|NCT01791517|450611671|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268229|NCT01791517|450611672|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268230|NCT01791517|450611673|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268231|NCT01791517|450611674|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268232|NCT01791517|450611675|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268233|NCT01791517|450611676|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268234|NCT01791517|450611677|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268235|NCT01791517|450611678|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
125268236|NCT01791517|450611679|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268237|NCT01791517|450611668|FG000|Phase I: Period 2|Lens Discomfort|0|||
125268238|NCT01791517|450611669|FG001|Phase I: Period 2|Lens Discomfort|0|||
125268239|NCT01791517|450611670|FG002|Phase I: Period 2|Lens Discomfort|0|||
125268240|NCT01791517|450611671|FG003|Phase I: Period 2|Lens Discomfort|0|||
125268241|NCT01791517|450611672|FG004|Phase I: Period 2|Lens Discomfort|0|||
125268242|NCT01791517|450611673|FG005|Phase I: Period 2|Lens Discomfort|1|||
125268243|NCT01791517|450611674|FG006|Phase I: Period 2|Lens Discomfort|0|||
125268244|NCT01791517|450611675|FG007|Phase I: Period 2|Lens Discomfort|0|||
125268245|NCT01791517|450611676|FG008|Phase I: Period 2|Lens Discomfort|0|||
125268246|NCT01791517|450611677|FG009|Phase I: Period 2|Lens Discomfort|0|||
125268247|NCT01791517|450611678|FG010|Phase I: Period 2|Lens Discomfort|0|||
125268248|NCT01791517|450611679|FG011|Phase I: Period 2|Lens Discomfort|0|||
125268249|NCT01791517|450611668|FG000|Phase I: Period 2|Lost to Follow-up|0|||
125268250|NCT01791517|450611669|FG001|Phase I: Period 2|Lost to Follow-up|3|||
125268251|NCT01791517|450611670|FG002|Phase I: Period 2|Lost to Follow-up|2|||
125268252|NCT01791517|450611671|FG003|Phase I: Period 2|Lost to Follow-up|0|||
125268253|NCT01791517|450611672|FG004|Phase I: Period 2|Lost to Follow-up|0|||
125268254|NCT01791517|450611673|FG005|Phase I: Period 2|Lost to Follow-up|0|||
125268255|NCT01791517|450611674|FG006|Phase I: Period 2|Lost to Follow-up|0|||
125268256|NCT01791517|450611675|FG007|Phase I: Period 2|Lost to Follow-up|0|||
125268257|NCT01791517|450611676|FG008|Phase I: Period 2|Lost to Follow-up|0|||
125268258|NCT01791517|450611677|FG009|Phase I: Period 2|Lost to Follow-up|0|||
125268259|NCT01791517|450611678|FG010|Phase I: Period 2|Lost to Follow-up|0|||
125268260|NCT01791517|450611679|FG011|Phase I: Period 2|Lost to Follow-up|0|||
125268261|NCT01791517|450611668|FG000|Phase I: Period 3|Lens Discomfort|0|||
125268262|NCT01791517|450611669|FG001|Phase I: Period 3|Lens Discomfort|0|||
125268263|NCT01791517|450611670|FG002|Phase I: Period 3|Lens Discomfort|0|||
125268264|NCT01791517|450611671|FG003|Phase I: Period 3|Lens Discomfort|0|||
125268265|NCT01791517|450611672|FG004|Phase I: Period 3|Lens Discomfort|0|||
125268266|NCT01791517|450611673|FG005|Phase I: Period 3|Lens Discomfort|0|||
125268267|NCT01791517|450611674|FG006|Phase I: Period 3|Lens Discomfort|0|||
125268268|NCT01791517|450611675|FG007|Phase I: Period 3|Lens Discomfort|0|||
125268269|NCT01791517|450611676|FG008|Phase I: Period 3|Lens Discomfort|0|||
125268270|NCT01791517|450611677|FG009|Phase I: Period 3|Lens Discomfort|0|||
125268271|NCT01791517|450611678|FG010|Phase I: Period 3|Lens Discomfort|0|||
125268272|NCT01791517|450611679|FG011|Phase I: Period 3|Lens Discomfort|1|||
125268273|NCT01791517|450611668|FG000|Phase I: Period 3|Lost to Follow-up|0|||
125268274|NCT01791517|450611669|FG001|Phase I: Period 3|Lost to Follow-up|1|||
125268275|NCT01791517|450611670|FG002|Phase I: Period 3|Lost to Follow-up|0|||
125268276|NCT01791517|450611671|FG003|Phase I: Period 3|Lost to Follow-up|0|||
125268277|NCT01791517|450611672|FG004|Phase I: Period 3|Lost to Follow-up|1|||
125268278|NCT01791517|450611673|FG005|Phase I: Period 3|Lost to Follow-up|0|||
125268279|NCT01791517|450611674|FG006|Phase I: Period 3|Lost to Follow-up|0|||
125268280|NCT01791517|450611675|FG007|Phase I: Period 3|Lost to Follow-up|0|||
125268281|NCT01791517|450611676|FG008|Phase I: Period 3|Lost to Follow-up|0|||
125268282|NCT01791517|450611677|FG009|Phase I: Period 3|Lost to Follow-up|0|||
125268283|NCT01791517|450611678|FG010|Phase I: Period 3|Lost to Follow-up|0|||
125268284|NCT01791517|450611679|FG011|Phase I: Period 3|Lost to Follow-up|0|||
125268285|NCT01791517|450611668|FG000|Phase I: Period 3|Adverse Event|0|||
125268286|NCT01791517|450611669|FG001|Phase I: Period 3|Adverse Event|0|||
125268287|NCT01791517|450611670|FG002|Phase I: Period 3|Adverse Event|0|||
125268288|NCT01791517|450611671|FG003|Phase I: Period 3|Adverse Event|1|||
125268289|NCT01791517|450611672|FG004|Phase I: Period 3|Adverse Event|0|||
125268290|NCT01791517|450611673|FG005|Phase I: Period 3|Adverse Event|0|||
125268291|NCT01791517|450611674|FG006|Phase I: Period 3|Adverse Event|0|||
125268292|NCT01791517|450611675|FG007|Phase I: Period 3|Adverse Event|0|||
125268293|NCT01791517|450611676|FG008|Phase I: Period 3|Adverse Event|0|||
125268294|NCT01791517|450611677|FG009|Phase I: Period 3|Adverse Event|0|||
125268295|NCT01791517|450611678|FG010|Phase I: Period 3|Adverse Event|0|||
125268296|NCT01791517|450611679|FG011|Phase I: Period 3|Adverse Event|0|||
125268297|NCT01791517|450611668|FG000|Phase II|Lost to Follow-up|1|||
125268298|NCT01791517|450611669|FG001|Phase II|Lost to Follow-up|0|||
125268299|NCT01791517|450611670|FG002|Phase II|Lost to Follow-up|1|||
125268300|NCT01791517|450611671|FG003|Phase II|Lost to Follow-up|0|||
125268301|NCT01791517|450611672|FG004|Phase II|Lost to Follow-up|1|||
125268302|NCT01791517|450611673|FG005|Phase II|Lost to Follow-up|2|||
125268303|NCT01791517|450611674|FG006|Phase II|Lost to Follow-up|0|||
125268304|NCT01791517|450611675|FG007|Phase II|Lost to Follow-up|1|||
125268305|NCT01791517|450611676|FG008|Phase II|Lost to Follow-up|1|||
125268306|NCT01791517|450611677|FG009|Phase II|Lost to Follow-up|1|||
125268307|NCT01791517|450611678|FG010|Phase II|Lost to Follow-up|0|||
125268308|NCT01791517|450611679|FG011|Phase II|Lost to Follow-up|0|||
125268309|NCT01791517|450611668|FG000|Phase II|Withdrawal by Subject|1|||
125268310|NCT01791517|450611669|FG001|Phase II|Withdrawal by Subject|0|||
125268311|NCT01791517|450611670|FG002|Phase II|Withdrawal by Subject|0|||
125268312|NCT01791517|450611671|FG003|Phase II|Withdrawal by Subject|0|||
125268313|NCT01791517|450611672|FG004|Phase II|Withdrawal by Subject|0|||
125268314|NCT01791517|450611673|FG005|Phase II|Withdrawal by Subject|2|||
125268315|NCT01791517|450611674|FG006|Phase II|Withdrawal by Subject|0|||
125268316|NCT01791517|450611675|FG007|Phase II|Withdrawal by Subject|1|||
125268317|NCT01791517|450611676|FG008|Phase II|Withdrawal by Subject|0|||
125268318|NCT01791517|450611677|FG009|Phase II|Withdrawal by Subject|0|||
125268319|NCT01791517|450611678|FG010|Phase II|Withdrawal by Subject|1|||
125268320|NCT01791517|450611679|FG011|Phase II|Withdrawal by Subject|0|||
125268321|NCT01791517|450611668|FG000|Phase II|Lack of Efficacy|0|||
125268322|NCT01791517|450611669|FG001|Phase II|Lack of Efficacy|0|||
125268323|NCT01791517|450611670|FG002|Phase II|Lack of Efficacy|0|||
125268324|NCT01791517|450611671|FG003|Phase II|Lack of Efficacy|0|||
125268325|NCT01791517|450611672|FG004|Phase II|Lack of Efficacy|1|||
125268326|NCT01791517|450611673|FG005|Phase II|Lack of Efficacy|0|||
125268327|NCT01791517|450611674|FG006|Phase II|Lack of Efficacy|0|||
125268328|NCT01791517|450611675|FG007|Phase II|Lack of Efficacy|0|||
125268329|NCT01791517|450611676|FG008|Phase II|Lack of Efficacy|0|||
125268330|NCT01791517|450611677|FG009|Phase II|Lack of Efficacy|0|||
125268331|NCT01791517|450611678|FG010|Phase II|Lack of Efficacy|0|||
125268332|NCT01791517|450611679|FG011|Phase II|Lack of Efficacy|0|||
125268333|NCT01791517|450611668|FG000|Phase II|Adverse Event|0|||
125268334|NCT01791517|450611669|FG001|Phase II|Adverse Event|0|||
125268335|NCT01791517|450611670|FG002|Phase II|Adverse Event|0|||
125268336|NCT01791517|450611671|FG003|Phase II|Adverse Event|0|||
125268337|NCT01791517|450611672|FG004|Phase II|Adverse Event|0|||
125268338|NCT01791517|450611673|FG005|Phase II|Adverse Event|0|||
125268339|NCT01791517|450611674|FG006|Phase II|Adverse Event|2|||
125268340|NCT01791517|450611675|FG007|Phase II|Adverse Event|1|||
125268341|NCT01791517|450611676|FG008|Phase II|Adverse Event|0|||
125268342|NCT01791517|450611677|FG009|Phase II|Adverse Event|1|||
125268343|NCT01791517|450611678|FG010|Phase II|Adverse Event|0|||
125268344|NCT01791517|450611679|FG011|Phase II|Adverse Event|0|||
125268345|NCT01791517|450611668|FG000|Phase II|Lens Handling Difficulties|0|||
125268346|NCT01791517|450611669|FG001|Phase II|Lens Handling Difficulties|0|||
125268347|NCT01791517|450611670|FG002|Phase II|Lens Handling Difficulties|0|||
125268348|NCT01791517|450611671|FG003|Phase II|Lens Handling Difficulties|0|||
125268349|NCT01791517|450611672|FG004|Phase II|Lens Handling Difficulties|0|||
125268350|NCT01791517|450611673|FG005|Phase II|Lens Handling Difficulties|0|||
125268351|NCT01791517|450611674|FG006|Phase II|Lens Handling Difficulties|0|||
125268352|NCT01791517|450611675|FG007|Phase II|Lens Handling Difficulties|0|||
125268353|NCT01791517|450611676|FG008|Phase II|Lens Handling Difficulties|1|||
125268354|NCT01791517|450611677|FG009|Phase II|Lens Handling Difficulties|0|||
125268355|NCT01791517|450611678|FG010|Phase II|Lens Handling Difficulties|0|||
125268356|NCT01791517|450611679|FG011|Phase II|Lens Handling Difficulties|0|||
125268357|NCT01791517|450611668|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
125268358|NCT01791517|450611669|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
125268359|NCT01791517|450611670|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
125268360|NCT01791517|450611671|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
125268361|NCT01791517|450611672|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
125268362|NCT01791517|450611673|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
125268363|NCT01791517|450611674|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
125268364|NCT01791517|450611675|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
125268365|NCT01791517|450611676|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
125268366|NCT01791517|450611677|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
125268367|NCT01791517|450611678|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
125268368|NCT01791517|450611679|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
125268369|NCT01791517|450611668|FG000|Phase II|Pre-Existing Ocular Issue|0|||
125268370|NCT01791517|450611669|FG001|Phase II|Pre-Existing Ocular Issue|0|||
125268371|NCT01791517|450611670|FG002|Phase II|Pre-Existing Ocular Issue|0|||
125268372|NCT01791517|450611671|FG003|Phase II|Pre-Existing Ocular Issue|0|||
125268373|NCT01791517|450611672|FG004|Phase II|Pre-Existing Ocular Issue|0|||
125268374|NCT01791517|450611673|FG005|Phase II|Pre-Existing Ocular Issue|0|||
125268375|NCT01791517|450611674|FG006|Phase II|Pre-Existing Ocular Issue|0|||
125268376|NCT01791517|450611675|FG007|Phase II|Pre-Existing Ocular Issue|0|||
125268377|NCT01791517|450611676|FG008|Phase II|Pre-Existing Ocular Issue|0|||
125268378|NCT01791517|450611677|FG009|Phase II|Pre-Existing Ocular Issue|0|||
125268379|NCT01791517|450611678|FG010|Phase II|Pre-Existing Ocular Issue|0|||
125268380|NCT01791517|450611679|FG011|Phase II|Pre-Existing Ocular Issue|1|||
125268381|NCT04011735|450611680|FG000|Overall Study|Withdrawal by Subject|1|||
125268382|NCT04011735|450611681|FG001|Overall Study|Withdrawal by Subject|0|||
125268383|NCT04011735|450611682|FG002|Overall Study|Withdrawal by Subject|1|||
125268384|NCT04011735|450611680|FG000|Overall Study|Met exclusion criteria after study entry|0|||
125268385|NCT04011735|450611681|FG001|Overall Study|Met exclusion criteria after study entry|1|||
125268386|NCT04011735|450611682|FG002|Overall Study|Met exclusion criteria after study entry|0|||
125268387|NCT02298868|450611683|FG000|Overall Study|Adverse Event|1|||
125268388|NCT02298868|450611683|FG000|Overall Study|Death|1|||
125268389|NCT02298868|450611683|FG000|Overall Study|Patient underwent transplant|1|||
125268390|NCT01000506|450611684|FG000|Overall Study|Adverse Event|6|||
125268391|NCT01000506|450611685|FG001|Overall Study|Adverse Event|5|||
125268392|NCT01000506|450611686|FG002|Overall Study|Adverse Event|8|||
125268393|NCT01000506|450611687|FG003|Overall Study|Adverse Event|9|||
125268394|NCT01000506|450611684|FG000|Overall Study|Lack of Efficacy|8|||
125268395|NCT01000506|450611685|FG001|Overall Study|Lack of Efficacy|6|||
125268396|NCT01000506|450611686|FG002|Overall Study|Lack of Efficacy|4|||
125268397|NCT01000506|450611687|FG003|Overall Study|Lack of Efficacy|4|||
125268398|NCT01000506|450611684|FG000|Overall Study|Protocol Violation|1|||
125268399|NCT01000506|450611685|FG001|Overall Study|Protocol Violation|1|||
125268400|NCT01000506|450611686|FG002|Overall Study|Protocol Violation|0|||
125268401|NCT01000506|450611687|FG003|Overall Study|Protocol Violation|0|||
125268402|NCT01000506|450611684|FG000|Overall Study|Lost to Follow-up|1|||
125268403|NCT01000506|450611685|FG001|Overall Study|Lost to Follow-up|1|||
125268404|NCT01000506|450611686|FG002|Overall Study|Lost to Follow-up|4|||
125268405|NCT01000506|450611687|FG003|Overall Study|Lost to Follow-up|0|||
125268406|NCT01000506|450611684|FG000|Overall Study|Physician Decision|1|||
125268407|NCT01000506|450611685|FG001|Overall Study|Physician Decision|3|||
125268408|NCT01000506|450611686|FG002|Overall Study|Physician Decision|3|||
125268409|NCT01000506|450611687|FG003|Overall Study|Physician Decision|3|||
125268410|NCT01000506|450611684|FG000|Overall Study|Withdrawal by Subject|11|||
125268411|NCT01000506|450611685|FG001|Overall Study|Withdrawal by Subject|8|||
125268412|NCT01000506|450611686|FG002|Overall Study|Withdrawal by Subject|2|||
125268413|NCT01000506|450611687|FG003|Overall Study|Withdrawal by Subject|7|||
125268414|NCT00739310|450611688|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
125268415|NCT00739310|450611688|FG000|Overall Study|Withdrawal by Subject|1|||
125268416|NCT00739310|450611688|FG000|Overall Study|Lost to Follow-up|2|||
125268417|NCT01071954|450611689|FG000|Overall Study|Noncompliance|4|||
125268418|NCT01071954|450611689|FG000|Overall Study|Adverse Event|1|||
125268419|NCT01071954|450611689|FG000|Overall Study|Withdrawal by Subject|11|||
125268420|NCT01071954|450611689|FG000|Overall Study|Requirement for Alternative Therapy|5|||
125268421|NCT01071954|450611689|FG000|Overall Study|Administrative Decision|5|||
125268422|NCT01071954|450611689|FG000|Overall Study|Protocol Specified Criteria|1|||
125268423|NCT00590967|450611690|FG000|Overall Study|Withdrawal by Subject|1|||
125268424|NCT00590967|450611691|FG001|Overall Study|Withdrawal by Subject|1|||
125268425|NCT00590967|450611690|FG000|Overall Study|Ineligible|1|||
125268426|NCT00590967|450611691|FG001|Overall Study|Ineligible|0|||
125268427|NCT00590967|450611690|FG000|Overall Study|Poor performance status|0|||
125268428|NCT00590967|450611691|FG001|Overall Study|Poor performance status|1|||
125268429|NCT00590967|450611690|FG000|Overall Study|Non-compliant|0|||
125268430|NCT00590967|450611691|FG001|Overall Study|Non-compliant|2|||
125268431|NCT00590967|450611690|FG000|Overall Study|Did not sign consent form|0|||
125268432|NCT00590967|450611691|FG001|Overall Study|Did not sign consent form|1|||
125268433|NCT00590967|450611690|FG000|Overall Study|Did not receive chemo per protocol|1|||
125268434|NCT00590967|450611691|FG001|Overall Study|Did not receive chemo per protocol|0|||
125268435|NCT01847755|450611692|FG000|Overall Study|Adverse Event|2|||
125268436|NCT01847755|450611692|FG000|Overall Study|Withdrawal by Subject|2|||
125268437|NCT01847755|450611692|FG000|Overall Study|Physician Decision|1|||
125268438|NCT00920556|450611693|FG000|Overall Study|Adverse Event|16|||
125268439|NCT00920556|450611693|FG000|Overall Study|Physician Decision|7|||
125268440|NCT00920556|450611693|FG000|Overall Study|Withdrawal by Subject|1|||
125268441|NCT04245709|450611694|FG000|Overall Study|Adverse Event|13|||
125268442|NCT04245709|450611694|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
125268443|NCT02185534|450611696|FG000|First Period|Withdrawal by Subject|0|||
125268444|NCT02185534|450611697|FG001|First Period|Withdrawal by Subject|0|||
125268445|NCT02185534|450611698|FG002|First Period|Withdrawal by Subject|0|||
125268446|NCT02185534|450611699|FG003|First Period|Withdrawal by Subject|1|||
125268447|NCT02185534|450611700|FG004|First Period|Withdrawal by Subject|0|||
125268448|NCT02185534|450611701|FG005|First Period|Withdrawal by Subject|0|||
125268449|NCT02185534|450611696|FG000|First Washout Period|Withdrawal by Subject|1|||
125268450|NCT02185534|450611697|FG001|First Washout Period|Withdrawal by Subject|0|||
125268451|NCT02185534|450611698|FG002|First Washout Period|Withdrawal by Subject|0|||
125268452|NCT02185534|450611699|FG003|First Washout Period|Withdrawal by Subject|0|||
125268453|NCT02185534|450611700|FG004|First Washout Period|Withdrawal by Subject|1|||
125268454|NCT02185534|450611701|FG005|First Washout Period|Withdrawal by Subject|0|||
125268455|NCT02185534|450611696|FG000|First Washout Period|Protocol Violation|0|||
125268456|NCT02185534|450611697|FG001|First Washout Period|Protocol Violation|0|||
125268457|NCT02185534|450611698|FG002|First Washout Period|Protocol Violation|0|||
125268458|NCT02185534|450611699|FG003|First Washout Period|Protocol Violation|0|||
125268459|NCT02185534|450611700|FG004|First Washout Period|Protocol Violation|0|||
125268460|NCT02185534|450611701|FG005|First Washout Period|Protocol Violation|1|||
125268461|NCT02041299|450611702|FG000|Overall Study|Adverse Event|9|||
125268462|NCT02041299|450611703|FG001|Overall Study|Adverse Event|3|||
125268463|NCT02041299|450611702|FG000|Overall Study|Lost to Follow-up|4|||
125268464|NCT02041299|450611703|FG001|Overall Study|Lost to Follow-up|1|||
125268465|NCT02041299|450611702|FG000|Overall Study|Physician Decision|1|||
125268466|NCT02041299|450611703|FG001|Overall Study|Physician Decision|1|||
125268467|NCT02041299|450611702|FG000|Overall Study|Withdrawal by Subject|13|||
125268468|NCT02041299|450611703|FG001|Overall Study|Withdrawal by Subject|7|||
125268469|NCT02041299|450611702|FG000|Overall Study|Protocol Violation|11|||
125268470|NCT02041299|450611703|FG001|Overall Study|Protocol Violation|4|||
125268471|NCT02041299|450611702|FG000|Overall Study|Termination of the study|7|||
125268472|NCT02041299|450611703|FG001|Overall Study|Termination of the study|3|||
125268473|NCT02041299|450611702|FG000|Overall Study|Required bone marrow transplant|0|||
125268474|NCT02041299|450611703|FG001|Overall Study|Required bone marrow transplant|1|||
125268475|NCT02041299|450611702|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
125268476|NCT02041299|450611703|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
125268477|NCT02389465|450611704|FG000|Overall Study|Lost to Follow-up|1|||
125268478|NCT02389465|450611705|FG001|Overall Study|Lost to Follow-up|3|||
125268479|NCT02389465|450611706|FG002|Overall Study|Lost to Follow-up|3|||
125268480|NCT02389465|450611707|FG003|Overall Study|Lost to Follow-up|0|||
125268481|NCT02389465|450611704|FG000|Overall Study|Physician Decision|0|||
125268482|NCT02389465|450611705|FG001|Overall Study|Physician Decision|0|||
125268483|NCT02389465|450611706|FG002|Overall Study|Physician Decision|0|||
125268484|NCT02389465|450611707|FG003|Overall Study|Physician Decision|1|||
125268485|NCT02389465|450611704|FG000|Overall Study|Withdrawal by Subject|0|||
125268486|NCT02389465|450611705|FG001|Overall Study|Withdrawal by Subject|1|||
125268487|NCT02389465|450611706|FG002|Overall Study|Withdrawal by Subject|2|||
125268488|NCT02389465|450611707|FG003|Overall Study|Withdrawal by Subject|2|||
125268489|NCT00846846|450611708|FG000|Overall Study|Death|56|||
125268490|NCT00846846|450611708|FG000|Overall Study|Withdrawal by Subject|19|||
125268491|NCT04179305|450611714|FG000|Overall Study|Death|1|||
125268492|NCT04179305|450611715|FG001|Overall Study|Death|1|||
125268493|NCT04179305|450611716|FG002|Overall Study|Death|0|||
125268494|NCT04179305|450611717|FG003|Overall Study|Death|0|||
125268495|NCT04179305|450611714|FG000|Overall Study|Lost to Follow-up|1|||
125268496|NCT04179305|450611715|FG001|Overall Study|Lost to Follow-up|1|||
125268497|NCT04179305|450611716|FG002|Overall Study|Lost to Follow-up|0|||
125268498|NCT04179305|450611717|FG003|Overall Study|Lost to Follow-up|0|||
125268499|NCT04179305|450611714|FG000|Overall Study|Withdrawal by Subject|0|||
125268500|NCT04179305|450611715|FG001|Overall Study|Withdrawal by Subject|1|||
125268501|NCT04179305|450611716|FG002|Overall Study|Withdrawal by Subject|0|||
125268502|NCT04179305|450611717|FG003|Overall Study|Withdrawal by Subject|0|||
125268503|NCT04179305|450611714|FG000|Overall Study|Did not have scan|1|||
125268504|NCT04179305|450611715|FG001|Overall Study|Did not have scan|0|||
125268505|NCT04179305|450611716|FG002|Overall Study|Did not have scan|0|||
125268506|NCT04179305|450611717|FG003|Overall Study|Did not have scan|0|||
125268507|NCT04179305|450611714|FG000|Overall Study|In hospice care|3|||
125268508|NCT04179305|450611715|FG001|Overall Study|In hospice care|0|||
125268509|NCT04179305|450611716|FG002|Overall Study|In hospice care|0|||
125268510|NCT04179305|450611717|FG003|Overall Study|In hospice care|0|||
125268511|NCT00503425|450611720|FG000|Overall Study|Participant files lost|6|||
125268512|NCT00503425|450611720|FG000|Overall Study|Adverse Event|5|||
125268513|NCT00503425|450611720|FG000|Overall Study|Lack of Efficacy|25|||
125268514|NCT00503425|450611720|FG000|Overall Study|Withdrawal by Subject|8|||
125268515|NCT00503425|450611720|FG000|Overall Study|Lost to Follow-up|3|||
125268516|NCT00503425|450611720|FG000|Overall Study|Death|3|||
125268517|NCT00503425|450611720|FG000|Overall Study|Missing Data/Unknown|4|||
125268518|NCT00326599|450611721|FG000|Overall Study|Withdrawal by Subject|1|||
125268519|NCT00326599|450611722|FG001|Overall Study|Withdrawal by Subject|0|||
125268520|NCT00326599|450611723|FG002|Overall Study|Withdrawal by Subject|5|||
125268521|NCT00326599|450611724|FG003|Overall Study|Withdrawal by Subject|2|||
125268522|NCT00326599|450611721|FG000|Overall Study|Adverse Event|1|||
125268523|NCT00326599|450611722|FG001|Overall Study|Adverse Event|0|||
125268524|NCT00326599|450611723|FG002|Overall Study|Adverse Event|32|||
125268525|NCT00326599|450611724|FG003|Overall Study|Adverse Event|3|||
125268526|NCT00326599|450611721|FG000|Overall Study|Disease Progression|3|||
125268527|NCT00326599|450611722|FG001|Overall Study|Disease Progression|1|||
125268528|NCT00326599|450611723|FG002|Overall Study|Disease Progression|13|||
125268529|NCT00326599|450611724|FG003|Overall Study|Disease Progression|11|||
125268530|NCT00326599|450611721|FG000|Overall Study|Alternate Treatment|1|||
125268531|NCT00326599|450611722|FG001|Overall Study|Alternate Treatment|0|||
125268532|NCT00326599|450611723|FG002|Overall Study|Alternate Treatment|0|||
125268533|NCT00326599|450611724|FG003|Overall Study|Alternate Treatment|0|||
125268534|NCT00326599|450611721|FG000|Overall Study|Death|0|||
125268535|NCT00326599|450611722|FG001|Overall Study|Death|0|||
125268536|NCT00326599|450611723|FG002|Overall Study|Death|1|||
125268537|NCT00326599|450611724|FG003|Overall Study|Death|2|||
125268538|NCT00326599|450611721|FG000|Overall Study|Other Unspecified Reason|0|||
125268539|NCT00326599|450611722|FG001|Overall Study|Other Unspecified Reason|0|||
125268540|NCT00326599|450611723|FG002|Overall Study|Other Unspecified Reason|2|||
125268541|NCT00326599|450611724|FG003|Overall Study|Other Unspecified Reason|1|||
125268542|NCT00142792|450611725|FG000|Overall Study|Death|0|||
125268543|NCT00142792|450611726|FG001|Overall Study|Death|0|||
125268544|NCT00142792|450611727|FG002|Overall Study|Death|1|||
125268545|NCT00142792|450611725|FG000|Overall Study|Withdrawal by Subject|3|||
125268546|NCT00142792|450611726|FG001|Overall Study|Withdrawal by Subject|2|||
125268547|NCT00142792|450611727|FG002|Overall Study|Withdrawal by Subject|3|||
125268548|NCT00142792|450611725|FG000|Overall Study|Lost to Follow-up|8|||
125268549|NCT00142792|450611726|FG001|Overall Study|Lost to Follow-up|11|||
125268550|NCT00142792|450611727|FG002|Overall Study|Lost to Follow-up|7|||
125268551|NCT00142792|450611725|FG000|Overall Study|No category|1|||
125268552|NCT00142792|450611726|FG001|Overall Study|No category|2|||
125268553|NCT00142792|450611727|FG002|Overall Study|No category|1|||
125268554|NCT00437268|450611728|FG000|Overall Study|Adverse Event|1|||
125268555|NCT00437268|450611729|FG001|Overall Study|Adverse Event|1|||
125268556|NCT00437268|450611728|FG000|Overall Study|Withdrawal by Subject|2|||
125268557|NCT00437268|450611729|FG001|Overall Study|Withdrawal by Subject|2|||
125268558|NCT00437268|450611728|FG000|Overall Study|Progressive disease|9|||
125268559|NCT00437268|450611729|FG001|Overall Study|Progressive disease|9|||
125268560|NCT00437268|450611728|FG000|Overall Study|Physician Decision|1|||
125268561|NCT00437268|450611729|FG001|Overall Study|Physician Decision|0|||
125268562|NCT00437268|450611728|FG000|Overall Study|Death|0|||
125268563|NCT00437268|450611729|FG001|Overall Study|Death|1|||
125268564|NCT00444925|450611730|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
125268565|NCT00444925|450611731|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
125268566|NCT00444925|450611732|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
125268567|NCT00444925|450611730|FG000|Double-blind Treatment Period|Death|2|||
125268568|NCT00444925|450611731|FG001|Double-blind Treatment Period|Death|0|||
125268569|NCT00444925|450611732|FG002|Double-blind Treatment Period|Death|0|||
125268570|NCT00444925|450611730|FG000|Double-blind Treatment Period|Adverse Event|6|||
125268571|NCT00444925|450611731|FG001|Double-blind Treatment Period|Adverse Event|28|||
125268572|NCT00444925|450611732|FG002|Double-blind Treatment Period|Adverse Event|44|||
125268573|NCT00444925|450611730|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
125268574|NCT00444925|450611731|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
125268575|NCT00444925|450611732|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
125268576|NCT00444925|450611730|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
125268577|NCT00444925|450611731|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
125268578|NCT00444925|450611732|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
125268579|NCT00444925|450611730|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
125268580|NCT00444925|450611731|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
125268581|NCT00444925|450611732|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
125268582|NCT00444925|450611730|FG000|Double-blind Treatment Period|Other|7|||
125268583|NCT00444925|450611731|FG001|Double-blind Treatment Period|Other|7|||
125268584|NCT00444925|450611732|FG002|Double-blind Treatment Period|Other|12|||
125268585|NCT03484429|450611736|FG000|Overall Study|Withdrawal by Subject|1|||
125268586|NCT03484429|450611737|FG001|Overall Study|Withdrawal by Subject|0|||
125268587|NCT03484429|450611736|FG000|Overall Study|Adverse Event|2|||
125268588|NCT03484429|450611737|FG001|Overall Study|Adverse Event|0|||
125268589|NCT00943761|450611738|FG000|Overall Study|Lost to Follow-up|2|||
125268590|NCT00943761|450611739|FG001|Overall Study|Lost to Follow-up|0|||
125268591|NCT00943761|450611738|FG000|Overall Study|Withdrawal by Subject|2|||
125268592|NCT00943761|450611739|FG001|Overall Study|Withdrawal by Subject|1|||
125268593|NCT00714948|450611742|FG000|Overall Study|Adverse Event|2|||
125268594|NCT01342926|450611743|FG000|Overall Study|Adverse Event|5|||
125268595|NCT01342926|450611744|FG001|Overall Study|Adverse Event|8|||
125268596|NCT01342926|450611745|FG002|Overall Study|Adverse Event|10|||
125268597|NCT01342926|450611746|FG003|Overall Study|Adverse Event|7|||
125268598|NCT01342926|450611743|FG000|Overall Study|Lost to Follow-up|0|||
125268599|NCT01342926|450611744|FG001|Overall Study|Lost to Follow-up|1|||
125268600|NCT01342926|450611745|FG002|Overall Study|Lost to Follow-up|1|||
125268601|NCT01342926|450611746|FG003|Overall Study|Lost to Follow-up|0|||
125268602|NCT01342926|450611743|FG000|Overall Study|Investigator Discretion|2|||
125268603|NCT01342926|450611744|FG001|Overall Study|Investigator Discretion|2|||
125268604|NCT01342926|450611745|FG002|Overall Study|Investigator Discretion|0|||
125268605|NCT01342926|450611746|FG003|Overall Study|Investigator Discretion|0|||
125268606|NCT01342926|450611743|FG000|Overall Study|Withdrawal by Subject|2|||
125268607|NCT01342926|450611744|FG001|Overall Study|Withdrawal by Subject|4|||
125268608|NCT01342926|450611745|FG002|Overall Study|Withdrawal by Subject|3|||
125268609|NCT01342926|450611746|FG003|Overall Study|Withdrawal by Subject|5|||
125268610|NCT03382912|450611747|FG000|Overall Study|Physician Decision|0|||
125268611|NCT03382912|450611748|FG001|Overall Study|Physician Decision|1|||
125268612|NCT03382912|450611747|FG000|Overall Study|Sponsor Decision|6|||
125268613|NCT03382912|450611748|FG001|Overall Study|Sponsor Decision|6|||
125268614|NCT03382912|450611747|FG000|Overall Study|Withdrawal by Subject|0|||
125268615|NCT03382912|450611748|FG001|Overall Study|Withdrawal by Subject|5|||
125268616|NCT05653700|450611749|FG000|Overall Study|Non Responders|9|||
125268617|NCT05653700|450611750|FG001|Overall Study|Non Responders|0|||
125268618|NCT02573948|450611753|FG000|Longitudinal Cohort|Death|9|||
125268619|NCT02573948|450611753|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
125268620|NCT02573948|450611753|FG000|Longitudinal Cohort|Incarcerated|25|||
125268621|NCT00707993|450611754|FG000|Overall Study|Adverse Event|16|||
125268622|NCT00707993|450611755|FG001|Overall Study|Adverse Event|20|||
125268623|NCT00707993|450611754|FG000|Overall Study|Protocol Violation|4|||
125268624|NCT00707993|450611755|FG001|Overall Study|Protocol Violation|7|||
125268625|NCT00707993|450611754|FG000|Overall Study|Lost to Follow-up|0|||
125268626|NCT00707993|450611755|FG001|Overall Study|Lost to Follow-up|4|||
125268627|NCT00707993|450611754|FG000|Overall Study|Withdrawal by Subject|12|||
125268628|NCT00707993|450611755|FG001|Overall Study|Withdrawal by Subject|16|||
125268629|NCT00707993|450611754|FG000|Overall Study|Hyperglycemic Rescue|55|||
125268630|NCT00707993|450611755|FG001|Overall Study|Hyperglycemic Rescue|47|||
125268631|NCT00707993|450611754|FG000|Overall Study|Other|2|||
125268632|NCT00707993|450611755|FG001|Overall Study|Other|0|||
125268633|NCT05414175|450611760|FG000|Overall Study|Withdrawal by Subject|1|||
125268634|NCT05414175|450611760|FG000|Overall Study|Other Reasons|1|||
125268635|NCT00552071|450613587|FG000|Overall Study|Adverse Event|1|||
125268636|NCT00552071|450613588|FG001|Overall Study|Adverse Event|0|||
125268637|NCT00552071|450613587|FG000|Overall Study|Lack of Efficacy|1|||
125268638|NCT00552071|450613588|FG001|Overall Study|Lack of Efficacy|0|||
125268639|NCT00552071|450613587|FG000|Overall Study|Physician Decision|1|||
125268640|NCT00552071|450613588|FG001|Overall Study|Physician Decision|0|||
125268641|NCT00552071|450613587|FG000|Overall Study|Pregnancy|1|||
125268642|NCT00552071|450613588|FG001|Overall Study|Pregnancy|0|||
125268643|NCT00552071|450613587|FG000|Overall Study|Death|0|||
125268644|NCT00552071|450613588|FG001|Overall Study|Death|1|||
125268645|NCT00552071|450613587|FG000|Overall Study|Withdrawal by Subject|0|||
125268646|NCT00552071|450613588|FG001|Overall Study|Withdrawal by Subject|1|||
125268647|NCT00532129|450613589|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
125268648|NCT00532129|450613589|FG000|Treatment Period|Physician Decision|15|||
125268649|NCT00532129|450613589|FG000|Treatment Period|Disease progression|3|||
125268650|NCT00532129|450613589|FG000|Treatment Period|Protocol Violation|1|||
125268651|NCT00532129|450613589|FG000|Treatment Period|Other|5|||
125268652|NCT00532129|450613589|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
125268653|NCT00532129|450613589|FG000|Follow-up Period|Disease progression|57|||
125268654|NCT00532129|450613589|FG000|Follow-up Period|Lost to Follow-up|1|||
125268655|NCT00532129|450613589|FG000|Follow-up Period|Other|6|||
125268656|NCT02237001|450613590|FG000|Overall Study|Lost to Follow-up|2|||
125268657|NCT02237001|450613590|FG000|Overall Study|Withdrawal by Subject|1|||
125268658|NCT02237001|450613590|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
125268659|NCT02237001|450613590|FG000|Overall Study|Re-operation|4|||
125268660|NCT02237001|450613590|FG000|Overall Study|Incarceration|1|||
125268661|NCT00342628|450613591|FG000|Overall Study|Withdrawal by Subject|19|||
125268662|NCT00342628|450613592|FG001|Overall Study|Withdrawal by Subject|19|||
125268663|NCT00342628|450613593|FG002|Overall Study|Withdrawal by Subject|18|||
125268664|NCT00342628|450613591|FG000|Overall Study|Death|1|||
125268665|NCT00342628|450613592|FG001|Overall Study|Death|1|||
125268666|NCT00342628|450613593|FG002|Overall Study|Death|0|||
125268667|NCT00342628|450613591|FG000|Overall Study|moved residence|0|||
125268668|NCT00342628|450613592|FG001|Overall Study|moved residence|1|||
125268669|NCT00342628|450613593|FG002|Overall Study|moved residence|1|||
125268670|NCT03427814|450613594|FG000|Overall Study|Withdrawal by Subject|4|||
125268671|NCT03427814|450613595|FG001|Overall Study|Withdrawal by Subject|4|||
125268672|NCT03427814|450613594|FG000|Overall Study|Lost to Follow-up|0|||
125268673|NCT03427814|450613595|FG001|Overall Study|Lost to Follow-up|2|||
125268674|NCT03427814|450613594|FG000|Overall Study|Death|42|||
125268675|NCT03427814|450613595|FG001|Overall Study|Death|31|||
125268676|NCT03427814|450613594|FG000|Overall Study|Sponsor's Decision|1|||
125268677|NCT03427814|450613595|FG001|Overall Study|Sponsor's Decision|0|||
125268678|NCT03427814|450613594|FG000|Overall Study|Investigator's Decision|1|||
125268679|NCT03427814|450613595|FG001|Overall Study|Investigator's Decision|2|||
125268680|NCT03427814|450613594|FG000|Overall Study|Disease progression|1|||
125268681|NCT03427814|450613595|FG001|Overall Study|Disease progression|0|||
125268682|NCT03427814|450613594|FG000|Overall Study|Treatment Completed|0|||
125268683|NCT03427814|450613595|FG001|Overall Study|Treatment Completed|1|||
125268684|NCT03427814|450613594|FG000|Overall Study|Sponsor's Decision to End study|21|||
125268685|NCT03427814|450613595|FG001|Overall Study|Sponsor's Decision to End study|25|||
125268686|NCT03427814|450613594|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
125268687|NCT03427814|450613595|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
125268688|NCT03145064|450613596|FG000|Overall Study|Death|24|||
125268689|NCT03145064|450613596|FG000|Overall Study|Lost to Follow-up|3|||
125268690|NCT03145064|450613596|FG000|Overall Study|Withdrawal by Subject|6|||
125268691|NCT03145064|450613596|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
125268692|NCT03145064|450613596|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
125268693|NCT03846427|450613597|FG000|Overall Study|Death|13|||
125268694|NCT03846427|450613597|FG000|Overall Study|Withdrawal by Subject|3|||
125268695|NCT03846427|450613597|FG000|Overall Study|Physician Decision|1|||
125268696|NCT01693250|450613598|FG000|Overall Study|Lost to Follow-up|2|||
125268697|NCT01693250|450613599|FG001|Overall Study|Lost to Follow-up|2|||
125268698|NCT00628446|450613600|FG000|Overall Study|Lost to Follow-up|3|||
125268699|NCT00628446|450613600|FG000|Overall Study|Withdrawal by Subject|1|||
125268700|NCT00628446|450613600|FG000|Overall Study|Protocol Violation|3|||
125268701|NCT01396187|450613601|FG000|Overall Study|Adverse Event|0|||
125268702|NCT01396187|450613602|FG001|Overall Study|Adverse Event|1|||
125268703|NCT01396187|450613603|FG002|Overall Study|Adverse Event|0|||
125268704|NCT01396187|450613604|FG003|Overall Study|Adverse Event|0|||
125268705|NCT01396187|450613605|FG004|Overall Study|Adverse Event|0|||
125268706|NCT01396187|450613601|FG000|Overall Study|Withdrawal by Subject|0|||
125268707|NCT01396187|450613602|FG001|Overall Study|Withdrawal by Subject|1|||
125268708|NCT01396187|450613603|FG002|Overall Study|Withdrawal by Subject|1|||
125268709|NCT01396187|450613604|FG003|Overall Study|Withdrawal by Subject|0|||
125268710|NCT01396187|450613605|FG004|Overall Study|Withdrawal by Subject|0|||
125268711|NCT01396187|450613601|FG000|Overall Study|Other|1|||
125268712|NCT01396187|450613602|FG001|Overall Study|Other|1|||
125268713|NCT01396187|450613603|FG002|Overall Study|Other|0|||
125268714|NCT01396187|450613604|FG003|Overall Study|Other|0|||
125268715|NCT01396187|450613605|FG004|Overall Study|Other|1|||
125268716|NCT04971967|450613609|FG000|Overall Study|Lost to Follow-up|6|||
125268717|NCT04971967|450613610|FG001|Overall Study|Lost to Follow-up|7|||
125268718|NCT00682929|450613613|FG000|Overall Study|Adverse Event|4|||
125268719|NCT00682929|450613614|FG001|Overall Study|Adverse Event|1|||
125268720|NCT00682929|450613615|FG002|Overall Study|Adverse Event|1|||
125268721|NCT00682929|450613613|FG000|Overall Study|Withdrawal by Subject|1|||
125268722|NCT00682929|450613614|FG001|Overall Study|Withdrawal by Subject|2|||
125268723|NCT00682929|450613615|FG002|Overall Study|Withdrawal by Subject|1|||
125268724|NCT00682929|450613613|FG000|Overall Study|dosing compliance < 80%|0|||
125268725|NCT00682929|450613614|FG001|Overall Study|dosing compliance < 80%|2|||
125268726|NCT00682929|450613615|FG002|Overall Study|dosing compliance < 80%|0|||
125268727|NCT00682929|450613613|FG000|Overall Study|lag in DEA renewal|1|||
125268728|NCT00682929|450613614|FG001|Overall Study|lag in DEA renewal|0|||
125268729|NCT00682929|450613615|FG002|Overall Study|lag in DEA renewal|0|||
125268730|NCT01462929|450613616|FG000|Overall Study|Adverse Event|3|||
125268731|NCT01462929|450613617|FG001|Overall Study|Adverse Event|3|||
125268732|NCT01462929|450613618|FG002|Overall Study|Adverse Event|4|||
125268733|NCT01462929|450613616|FG000|Overall Study|Withdrawal by Subject|2|||
125268734|NCT01462929|450613617|FG001|Overall Study|Withdrawal by Subject|1|||
125268735|NCT01462929|450613618|FG002|Overall Study|Withdrawal by Subject|0|||
125268736|NCT01462929|450613616|FG000|Overall Study|Lack of Efficacy|0|||
125268737|NCT01462929|450613617|FG001|Overall Study|Lack of Efficacy|0|||
125268738|NCT01462929|450613618|FG002|Overall Study|Lack of Efficacy|1|||
125268739|NCT04072835|450613619|FG000|Overall Study|Overall trial ended|603|||
125268740|NCT04072835|450613619|FG000|Overall Study|Ablation|97|||
125268741|NCT04072835|450613619|FG000|Overall Study|Withdrawal of consent|66|||
125268742|NCT04072835|450613619|FG000|Overall Study|Physician Decision|50|||
125268743|NCT04072835|450613619|FG000|Overall Study|Lost to Follow-up|39|||
125268744|NCT04072835|450613619|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
125268745|NCT04072835|450613619|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
125268746|NCT04072835|450613619|FG000|Overall Study|Adverse Event|25|||
125268747|NCT04072835|450613619|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
125268748|NCT04072835|450613619|FG000|Overall Study|Death|11|||
125268749|NCT04072835|450613619|FG000|Overall Study|Participant felt the drug did not work|8|||
125268750|NCT04072835|450613619|FG000|Overall Study|Participant tolerability|5|||
125268751|NCT04072835|450613619|FG000|Overall Study|Missing|5|||
125268752|NCT04072835|450613619|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
125268753|NCT04072835|450613619|FG000|Overall Study|Pregnancy|3|||
125268754|NCT04723355|450613620|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
125268755|NCT04723355|450613620|FG000|Overall Study|Errors in the informed consent form|2|||
125268756|NCT00841776|450613623|FG000|Overall Study|Lack of Efficacy|0|||
125268757|NCT00841776|450613624|FG001|Overall Study|Lack of Efficacy|1|||
125268758|NCT00841776|450613623|FG000|Overall Study|Lost to Follow-up|2|||
125268759|NCT00841776|450613624|FG001|Overall Study|Lost to Follow-up|1|||
125268760|NCT00841776|450613623|FG000|Overall Study|Withdrawal by Subject|0|||
125268761|NCT00841776|450613624|FG001|Overall Study|Withdrawal by Subject|1|||
125268762|NCT01306643|450613626|FG000|Overall Study|Adverse Event|5|||
125268763|NCT01306643|450613626|FG000|Overall Study|Disease Progression|7|||
125268764|NCT01306643|450613626|FG000|Overall Study|Other: Change in Eligibility Status|1|||
125268765|NCT02071771|450613627|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
125268766|NCT02071771|450613628|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
125268767|NCT02071771|450613627|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
125268768|NCT02071771|450613628|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
125268769|NCT02479880|450613632|FG000|Overall Study|Study Terminated by Sponsor|13|||
125268770|NCT02479880|450613633|FG001|Overall Study|Study Terminated by Sponsor|12|||
125268771|NCT02479880|450613632|FG000|Overall Study|Pregnancy|0|||
125268772|NCT02479880|450613633|FG001|Overall Study|Pregnancy|1|||
125268773|NCT00355368|450613634|FG000|Overall Study|Protocol Violation|8|||
125268774|NCT00355368|450613635|FG001|Overall Study|Protocol Violation|7|||
125268775|NCT00355368|450613634|FG000|Overall Study|cardiac arrest prior to intubation|2|||
125268776|NCT00355368|450613635|FG001|Overall Study|cardiac arrest prior to intubation|2|||
125268777|NCT01349673|450613636|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
125268778|NCT01349673|450613636|FG000|Overall Study|No Longer Qualified For Study|1|||
125268779|NCT01349673|450613636|FG000|Overall Study|Site Closure|10|||
125268780|NCT01349673|450613636|FG000|Overall Study|Withdrawal by Subject|21|||
125268781|NCT01349673|450613636|FG000|Overall Study|Lost to Follow-up|6|||
125268782|NCT01349673|450613636|FG000|Overall Study|Adverse Event|17|||
125268783|NCT01349673|450613636|FG000|Overall Study|Study Terminated By Sponsor|50|||
125268784|NCT01349673|450613636|FG000|Overall Study|Lack of Efficacy|8|||
125268785|NCT03688919|450613639|FG000|Overall Study|Lost to Follow-up|2|||
125268786|NCT03688919|450613640|FG001|Overall Study|Lost to Follow-up|1|||
125268787|NCT03688919|450613639|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
125268788|NCT03688919|450613640|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
125268789|NCT00506779|450613644|FG000|Overall Study|Withdrawal by Subject|1|||
125268790|NCT00506779|450613645|FG001|Overall Study|Withdrawal by Subject|0|||
125268791|NCT00506779|450613646|FG002|Overall Study|Withdrawal by Subject|1|||
125268792|NCT00506779|450613647|FG003|Overall Study|Withdrawal by Subject|0|||
125268793|NCT00506779|450613644|FG000|Overall Study|Adverse Event|0|||
125268794|NCT00506779|450613645|FG001|Overall Study|Adverse Event|1|||
125268795|NCT00506779|450613646|FG002|Overall Study|Adverse Event|1|||
125268796|NCT00506779|450613647|FG003|Overall Study|Adverse Event|1|||
125268797|NCT02639247|450613648|FG000|Overall Study|Lost to Follow-up|2|||
125268798|NCT02639247|450613649|FG001|Overall Study|Lost to Follow-up|1|||
125268799|NCT02639247|450613648|FG000|Overall Study|Death|2|||
125268800|NCT02639247|450613649|FG001|Overall Study|Death|0|||
125268801|NCT02639247|450613648|FG000|Overall Study|Withdrew Consent|0|||
125268802|NCT02639247|450613649|FG001|Overall Study|Withdrew Consent|1|||
125268803|NCT02639247|450613648|FG000|Overall Study|Protocol Violation|1|||
125268804|NCT02639247|450613649|FG001|Overall Study|Protocol Violation|0|||
125268805|NCT03462758|450613650|FG000|Overall Study|Chose no or other method of contraception|20|||
125268806|NCT03462758|450613651|FG001|Overall Study|Chose no or other method of contraception|23|||
125268807|NCT03462758|450613650|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
125268808|NCT03462758|450613651|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
125268809|NCT03462758|450613650|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
125268810|NCT03462758|450613651|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
125268811|NCT03462758|450613650|FG000|Overall Study|Medical contraindication|2|||
125268812|NCT03462758|450613651|FG001|Overall Study|Medical contraindication|2|||
125268813|NCT03462758|450613650|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
125268814|NCT03462758|450613651|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
125268815|NCT02820844|450613652|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
125268816|NCT02820844|450613653|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
125268817|NCT02820844|450613654|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
125268818|NCT02820844|450613655|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
125268819|NCT02820844|450613656|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
125268820|NCT02820844|450613657|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
125268821|NCT02820844|450613652|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
125268822|NCT02820844|450613653|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
125268823|NCT02820844|450613654|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
125268824|NCT02820844|450613655|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
125268825|NCT02820844|450613656|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
125268826|NCT02820844|450613657|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
125268827|NCT02820844|450613652|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
125268828|NCT02820844|450613653|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
125268829|NCT02820844|450613654|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
125268830|NCT02820844|450613655|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
125268831|NCT02820844|450613656|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
125268832|NCT02820844|450613657|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
125268833|NCT02820844|450613652|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
125268834|NCT02820844|450613653|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
125268835|NCT02820844|450613654|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
125268836|NCT02820844|450613655|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
125268837|NCT02820844|450613656|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
125268838|NCT02820844|450613657|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
125268839|NCT02820844|450613652|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
125268840|NCT02820844|450613653|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
125268841|NCT02820844|450613654|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
125268842|NCT02820844|450613655|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
125268843|NCT02820844|450613656|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
125268844|NCT02820844|450613657|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
125268845|NCT02820844|450613652|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
125268846|NCT02820844|450613653|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
125268847|NCT02820844|450613654|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
125268848|NCT02820844|450613655|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
125268849|NCT02820844|450613656|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
125268850|NCT02820844|450613657|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
125268851|NCT02820844|450613652|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
125268852|NCT02820844|450613653|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
125268853|NCT02820844|450613654|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
125268854|NCT02820844|450613655|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
125268855|NCT02820844|450613656|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
125268856|NCT02820844|450613657|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
125268857|NCT02820844|450613652|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
125268858|NCT02820844|450613653|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
125268859|NCT02820844|450613654|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
125268860|NCT02820844|450613655|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
125268861|NCT02820844|450613656|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
125268862|NCT02820844|450613657|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
125268863|NCT02820844|450613652|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
125268864|NCT02820844|450613653|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
125268865|NCT02820844|450613654|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
125268866|NCT02820844|450613655|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
125268867|NCT02820844|450613656|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
125268868|NCT02820844|450613657|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
125268869|NCT02820844|450613652|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
125268870|NCT02820844|450613653|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
125268871|NCT02820844|450613654|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
125268872|NCT02820844|450613655|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
125268873|NCT02820844|450613656|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
125268874|NCT02820844|450613657|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
125268875|NCT02266147|450613658|FG000|PART 1: Dose Escalation|Physician Decision|0|||
125268876|NCT02266147|450613659|FG001|PART 1: Dose Escalation|Physician Decision|0|||
125268877|NCT02266147|450613660|FG002|PART 1: Dose Escalation|Physician Decision|1|||
125268878|NCT02266147|450613661|FG003|PART 1: Dose Escalation|Physician Decision|0|||
125268879|NCT02266147|450613658|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
125268880|NCT02266147|450613659|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
125268881|NCT02266147|450613660|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
125268882|NCT02266147|450613661|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
125268883|NCT02266147|450613658|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
125268884|NCT02266147|450613659|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
125268885|NCT02266147|450613660|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
125268886|NCT02266147|450613661|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
125268887|NCT02266147|450613658|FG000|PART 1: Dose Escalation|Other|1|||
125268888|NCT02266147|450613659|FG001|PART 1: Dose Escalation|Other|1|||
125268889|NCT02266147|450613660|FG002|PART 1: Dose Escalation|Other|0|||
125268890|NCT02266147|450613661|FG003|PART 1: Dose Escalation|Other|0|||
125268891|NCT02266147|450613658|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
125268892|NCT02266147|450613659|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
125268893|NCT02266147|450613660|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
125268894|NCT02266147|450613661|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
125268895|NCT02266147|450613658|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
125268896|NCT02266147|450613659|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
125268897|NCT02266147|450613660|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
125268898|NCT02266147|450613661|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
125268899|NCT00413660|450613662|FG000|Up To Week 12|Adverse Event|1|||
125268900|NCT00413660|450613663|FG001|Up To Week 12|Adverse Event|3|||
125268901|NCT00413660|450613664|FG002|Up To Week 12|Adverse Event|1|||
125268902|NCT00413660|450613665|FG003|Up To Week 12|Adverse Event|4|||
125268903|NCT00413660|450613666|FG004|Up To Week 12|Adverse Event|6|||
125268904|NCT00413660|450613667|FG005|Up To Week 12|Adverse Event|4|||
125268905|NCT00413660|450613668|FG006|Up To Week 12|Adverse Event|1|||
125268906|NCT00413660|450613669|FG007|Up To Week 12|Adverse Event|0|||
125268907|NCT00413660|450613670|FG008|Up To Week 12|Adverse Event|0|||
125268908|NCT00413660|450613671|FG009|Up To Week 12|Adverse Event|0|||
125268909|NCT00413660|450613672|FG010|Up To Week 12|Adverse Event|0|||
125268910|NCT00413660|450613662|FG000|Up To Week 12|Lack of Efficacy|2|||
125268911|NCT00413660|450613663|FG001|Up To Week 12|Lack of Efficacy|0|||
125268912|NCT00413660|450613664|FG002|Up To Week 12|Lack of Efficacy|0|||
125268913|NCT00413660|450613665|FG003|Up To Week 12|Lack of Efficacy|0|||
125268914|NCT00413660|450613666|FG004|Up To Week 12|Lack of Efficacy|0|||
125268915|NCT00413660|450613667|FG005|Up To Week 12|Lack of Efficacy|0|||
125268916|NCT00413660|450613668|FG006|Up To Week 12|Lack of Efficacy|5|||
125268917|NCT00413660|450613669|FG007|Up To Week 12|Lack of Efficacy|0|||
125268918|NCT00413660|450613670|FG008|Up To Week 12|Lack of Efficacy|0|||
125268919|NCT00413660|450613671|FG009|Up To Week 12|Lack of Efficacy|0|||
125268920|NCT00413660|450613672|FG010|Up To Week 12|Lack of Efficacy|0|||
125268921|NCT00413660|450613662|FG000|Up To Week 12|Lost to Follow-up|0|||
125268922|NCT00413660|450613663|FG001|Up To Week 12|Lost to Follow-up|1|||
125268923|NCT00413660|450613664|FG002|Up To Week 12|Lost to Follow-up|0|||
125268924|NCT00413660|450613665|FG003|Up To Week 12|Lost to Follow-up|0|||
125268925|NCT00413660|450613666|FG004|Up To Week 12|Lost to Follow-up|1|||
125268926|NCT00413660|450613667|FG005|Up To Week 12|Lost to Follow-up|0|||
125268927|NCT00413660|450613668|FG006|Up To Week 12|Lost to Follow-up|0|||
125268928|NCT00413660|450613669|FG007|Up To Week 12|Lost to Follow-up|0|||
125268929|NCT00413660|450613670|FG008|Up To Week 12|Lost to Follow-up|0|||
125268930|NCT00413660|450613671|FG009|Up To Week 12|Lost to Follow-up|0|||
125268931|NCT00413660|450613672|FG010|Up To Week 12|Lost to Follow-up|0|||
125268932|NCT00413660|450613662|FG000|Up To Week 12|Withdrawal by Subject|0|||
125268933|NCT00413660|450613663|FG001|Up To Week 12|Withdrawal by Subject|2|||
125268934|NCT00413660|450613664|FG002|Up To Week 12|Withdrawal by Subject|0|||
125268935|NCT00413660|450613665|FG003|Up To Week 12|Withdrawal by Subject|2|||
125268936|NCT00413660|450613666|FG004|Up To Week 12|Withdrawal by Subject|0|||
125268937|NCT00413660|450613667|FG005|Up To Week 12|Withdrawal by Subject|2|||
125268938|NCT00413660|450613668|FG006|Up To Week 12|Withdrawal by Subject|2|||
125268939|NCT00413660|450613669|FG007|Up To Week 12|Withdrawal by Subject|0|||
125268940|NCT00413660|450613670|FG008|Up To Week 12|Withdrawal by Subject|0|||
125268941|NCT00413660|450613671|FG009|Up To Week 12|Withdrawal by Subject|0|||
125268942|NCT00413660|450613672|FG010|Up To Week 12|Withdrawal by Subject|0|||
125268943|NCT00413660|450613662|FG000|Up To Week 12|Randomized, Not Treated|1|||
125268944|NCT00413660|450613663|FG001|Up To Week 12|Randomized, Not Treated|0|||
125268945|NCT00413660|450613664|FG002|Up To Week 12|Randomized, Not Treated|0|||
125268946|NCT00413660|450613665|FG003|Up To Week 12|Randomized, Not Treated|1|||
125268947|NCT00413660|450613666|FG004|Up To Week 12|Randomized, Not Treated|0|||
125268948|NCT00413660|450613667|FG005|Up To Week 12|Randomized, Not Treated|0|||
125268949|NCT00413660|450613668|FG006|Up To Week 12|Randomized, Not Treated|0|||
125268950|NCT00413660|450613669|FG007|Up To Week 12|Randomized, Not Treated|0|||
125268951|NCT00413660|450613670|FG008|Up To Week 12|Randomized, Not Treated|0|||
125268952|NCT00413660|450613671|FG009|Up To Week 12|Randomized, Not Treated|0|||
125268953|NCT00413660|450613672|FG010|Up To Week 12|Randomized, Not Treated|0|||
125268954|NCT00413660|450613662|FG000|Up To Week 12|Other|3|||
125268955|NCT00413660|450613663|FG001|Up To Week 12|Other|1|||
125268956|NCT00413660|450613664|FG002|Up To Week 12|Other|6|||
125268957|NCT00413660|450613665|FG003|Up To Week 12|Other|1|||
125268958|NCT00413660|450613666|FG004|Up To Week 12|Other|2|||
125268959|NCT00413660|450613667|FG005|Up To Week 12|Other|4|||
125268960|NCT00413660|450613668|FG006|Up To Week 12|Other|3|||
125268961|NCT00413660|450613669|FG007|Up To Week 12|Other|0|||
125268962|NCT00413660|450613670|FG008|Up To Week 12|Other|0|||
125268963|NCT00413660|450613671|FG009|Up To Week 12|Other|0|||
125268964|NCT00413660|450613672|FG010|Up To Week 12|Other|0|||
125268965|NCT00413660|450613662|FG000|Post Week 12|Adverse Event|2|||
125268966|NCT00413660|450613663|FG001|Post Week 12|Adverse Event|0|||
125268967|NCT00413660|450613664|FG002|Post Week 12|Adverse Event|2|||
125268968|NCT00413660|450613665|FG003|Post Week 12|Adverse Event|1|||
125268969|NCT00413660|450613666|FG004|Post Week 12|Adverse Event|4|||
125268970|NCT00413660|450613667|FG005|Post Week 12|Adverse Event|2|||
125268971|NCT00413660|450613668|FG006|Post Week 12|Adverse Event|2|||
125268972|NCT00413660|450613669|FG007|Post Week 12|Adverse Event|0|||
125268973|NCT00413660|450613670|FG008|Post Week 12|Adverse Event|0|||
125268974|NCT00413660|450613671|FG009|Post Week 12|Adverse Event|0|||
125268975|NCT00413660|450613672|FG010|Post Week 12|Adverse Event|0|||
125268976|NCT00413660|450613662|FG000|Post Week 12|Lack of Efficacy|0|||
125268977|NCT00413660|450613663|FG001|Post Week 12|Lack of Efficacy|0|||
125268978|NCT00413660|450613664|FG002|Post Week 12|Lack of Efficacy|1|||
125268979|NCT00413660|450613665|FG003|Post Week 12|Lack of Efficacy|0|||
125268980|NCT00413660|450613666|FG004|Post Week 12|Lack of Efficacy|0|||
125268981|NCT00413660|450613667|FG005|Post Week 12|Lack of Efficacy|0|||
125268982|NCT00413660|450613668|FG006|Post Week 12|Lack of Efficacy|0|||
125268983|NCT00413660|450613669|FG007|Post Week 12|Lack of Efficacy|0|||
125268984|NCT00413660|450613670|FG008|Post Week 12|Lack of Efficacy|0|||
125268985|NCT00413660|450613671|FG009|Post Week 12|Lack of Efficacy|1|||
125268986|NCT00413660|450613672|FG010|Post Week 12|Lack of Efficacy|0|||
125268987|NCT00413660|450613662|FG000|Post Week 12|Lost to Follow-up|0|||
125268988|NCT00413660|450613663|FG001|Post Week 12|Lost to Follow-up|1|||
125268989|NCT00413660|450613664|FG002|Post Week 12|Lost to Follow-up|1|||
125268990|NCT00413660|450613665|FG003|Post Week 12|Lost to Follow-up|0|||
125268991|NCT00413660|450613666|FG004|Post Week 12|Lost to Follow-up|0|||
125268992|NCT00413660|450613667|FG005|Post Week 12|Lost to Follow-up|0|||
125268993|NCT00413660|450613668|FG006|Post Week 12|Lost to Follow-up|0|||
125268994|NCT00413660|450613669|FG007|Post Week 12|Lost to Follow-up|0|||
125268995|NCT00413660|450613670|FG008|Post Week 12|Lost to Follow-up|0|||
125268996|NCT00413660|450613671|FG009|Post Week 12|Lost to Follow-up|0|||
125268997|NCT00413660|450613672|FG010|Post Week 12|Lost to Follow-up|0|||
125268998|NCT00413660|450613662|FG000|Post Week 12|Withdrawal by Subject|0|||
125268999|NCT00413660|450613663|FG001|Post Week 12|Withdrawal by Subject|1|||
125269000|NCT00413660|450613664|FG002|Post Week 12|Withdrawal by Subject|1|||
125269001|NCT00413660|450613665|FG003|Post Week 12|Withdrawal by Subject|0|||
125269002|NCT00413660|450613666|FG004|Post Week 12|Withdrawal by Subject|1|||
125269003|NCT00413660|450613667|FG005|Post Week 12|Withdrawal by Subject|0|||
125269004|NCT00413660|450613668|FG006|Post Week 12|Withdrawal by Subject|0|||
125269005|NCT00413660|450613669|FG007|Post Week 12|Withdrawal by Subject|0|||
125269006|NCT00413660|450613670|FG008|Post Week 12|Withdrawal by Subject|0|||
125269007|NCT00413660|450613671|FG009|Post Week 12|Withdrawal by Subject|0|||
125269008|NCT00413660|450613672|FG010|Post Week 12|Withdrawal by Subject|1|||
125269009|NCT00413660|450613662|FG000|Post Week 12|Other|1|||
125269010|NCT00413660|450613663|FG001|Post Week 12|Other|2|||
125269011|NCT00413660|450613664|FG002|Post Week 12|Other|3|||
125269012|NCT00413660|450613665|FG003|Post Week 12|Other|0|||
125269013|NCT00413660|450613666|FG004|Post Week 12|Other|1|||
125269014|NCT00413660|450613667|FG005|Post Week 12|Other|1|||
125269015|NCT00413660|450613668|FG006|Post Week 12|Other|1|||
125269016|NCT00413660|450613669|FG007|Post Week 12|Other|0|||
125269017|NCT00413660|450613670|FG008|Post Week 12|Other|0|||
125269018|NCT00413660|450613671|FG009|Post Week 12|Other|0|||
125269019|NCT00413660|450613672|FG010|Post Week 12|Other|0|||
125269020|NCT02831855|450613675|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
125269021|NCT02831855|450613676|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
125269022|NCT02831855|450613677|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
125269023|NCT02831855|450613675|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
125269024|NCT02831855|450613676|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
125269025|NCT02831855|450613677|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
125269026|NCT02831855|450613675|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
125269027|NCT02831855|450613676|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
125269028|NCT02831855|450613677|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
125269029|NCT02831855|450613675|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
125269030|NCT02831855|450613676|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
125269031|NCT02831855|450613677|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
125269032|NCT02831855|450613675|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
125269033|NCT02831855|450613676|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
125269034|NCT02831855|450613677|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
125269035|NCT02831855|450613675|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
125269036|NCT02831855|450613676|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
125269037|NCT02831855|450613677|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
125269038|NCT02831855|450613675|FG000|Open Label Phase (24 Weeks)|Other|4|||
125269039|NCT02831855|450613676|FG001|Open Label Phase (24 Weeks)|Other|0|||
125269040|NCT02831855|450613677|FG002|Open Label Phase (24 Weeks)|Other|0|||
125269041|NCT02831855|450613675|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
125269042|NCT02831855|450613676|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
125269043|NCT02831855|450613677|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
125269044|NCT02831855|450613675|FG000|Double Blind Phase (24 Weeks)|Death|0|||
125269045|NCT02831855|450613676|FG001|Double Blind Phase (24 Weeks)|Death|0|||
125269046|NCT02831855|450613677|FG002|Double Blind Phase (24 Weeks)|Death|2|||
125269047|NCT02831855|450613675|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
125269048|NCT02831855|450613676|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
125269049|NCT02831855|450613677|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
125269050|NCT02831855|450613675|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
125269051|NCT02831855|450613676|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
125269052|NCT02831855|450613677|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
125269053|NCT02831855|450613675|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
125269054|NCT02831855|450613676|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
125269055|NCT02831855|450613677|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
125269056|NCT02831855|450613675|FG000|Double Blind Phase (24 Weeks)|Other|0|||
125269057|NCT02831855|450613676|FG001|Double Blind Phase (24 Weeks)|Other|2|||
125269058|NCT02831855|450613677|FG002|Double Blind Phase (24 Weeks)|Other|5|||
125269059|NCT02831855|450613675|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
125269060|NCT02831855|450613676|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
125269061|NCT02831855|450613677|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
125269062|NCT02831855|450613675|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
125269063|NCT02831855|450613676|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
125269064|NCT02831855|450613677|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
125269065|NCT02831855|450613675|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
125269066|NCT02831855|450613676|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
125269067|NCT02831855|450613677|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
125269068|NCT01722994|450613678|FG000|Overall Study|Missing data|25|||
125269069|NCT01722994|450613679|FG001|Overall Study|Missing data|17|||
125269070|NCT01803880|450613683|FG000|Overall Study|Adverse Event|1|||
125269071|NCT01803880|450613684|FG001|Overall Study|Adverse Event|0|||
125269072|NCT01803880|450613685|FG002|Overall Study|Adverse Event|0|||
125269073|NCT01803880|450613683|FG000|Overall Study|Withdrawal by Subject|1|||
125269074|NCT01803880|450613684|FG001|Overall Study|Withdrawal by Subject|1|||
125269075|NCT01803880|450613685|FG002|Overall Study|Withdrawal by Subject|4|||
125269076|NCT01803880|450613683|FG000|Overall Study|Physician Decision|0|||
125269077|NCT01803880|450613684|FG001|Overall Study|Physician Decision|0|||
125269078|NCT01803880|450613685|FG002|Overall Study|Physician Decision|1|||
125269079|NCT01803880|450613683|FG000|Overall Study|Unable to return for follow-up visits|0|||
125269080|NCT01803880|450613684|FG001|Overall Study|Unable to return for follow-up visits|1|||
125269081|NCT01803880|450613685|FG002|Overall Study|Unable to return for follow-up visits|2|||
125269082|NCT01803880|450613683|FG000|Overall Study|Lost to Follow-up|1|||
125269083|NCT01803880|450613684|FG001|Overall Study|Lost to Follow-up|2|||
125269084|NCT01803880|450613685|FG002|Overall Study|Lost to Follow-up|3|||
125269085|NCT01803880|450613683|FG000|Overall Study|Protocol Violation|1|||
125269086|NCT01803880|450613684|FG001|Overall Study|Protocol Violation|0|||
125269087|NCT01803880|450613685|FG002|Overall Study|Protocol Violation|0|||
125269088|NCT01803880|450613683|FG000|Overall Study|Early study termination|0|||
125269089|NCT01803880|450613684|FG001|Overall Study|Early study termination|6|||
125269090|NCT01803880|450613685|FG002|Overall Study|Early study termination|5|||
125269091|NCT01803880|450613683|FG000|Overall Study|Incomplete data entry by sites|2|||
125269092|NCT01803880|450613684|FG001|Overall Study|Incomplete data entry by sites|0|||
125269093|NCT01803880|450613685|FG002|Overall Study|Incomplete data entry by sites|0|||
125269094|NCT02954887|450613686|FG000|Overall Study|Withdrawal by Subject|3|||
125269095|NCT02954887|450613686|FG000|Overall Study|Lack of Efficacy|3|||
125269096|NCT02954887|450613686|FG000|Overall Study|Other|1|||
125269097|NCT01459666|450613688|FG000|Overall Study|PI left institution|5|||
125269098|NCT01459666|450613689|FG001|Overall Study|PI left institution|4|||
125269099|NCT01152788|450613691|FG000|Overall Study|Withdrawal by Subject|0|||
125269100|NCT01152788|450613692|FG001|Overall Study|Withdrawal by Subject|3|||
125269101|NCT01152788|450613691|FG000|Overall Study|No treatment|0|||
125269102|NCT01152788|450613692|FG001|Overall Study|No treatment|1|||
125269103|NCT00889707|450613695|FG000|Overall Study|Adverse Event|1|||
125269104|NCT00889707|450613696|FG001|Overall Study|Adverse Event|0|||
125269105|NCT00889707|450613695|FG000|Overall Study|Withdrawal by Subject|4|||
125269106|NCT00889707|450613696|FG001|Overall Study|Withdrawal by Subject|3|||
125269107|NCT00889707|450613695|FG000|Overall Study|Lost to Follow-up|0|||
125269108|NCT00889707|450613696|FG001|Overall Study|Lost to Follow-up|2|||
125269109|NCT00889707|450613695|FG000|Overall Study|Lack of Efficacy|2|||
125269110|NCT00889707|450613696|FG001|Overall Study|Lack of Efficacy|5|||
125269111|NCT02268383|450613704|FG000|Overall Study|Death|12|||
125269112|NCT02268383|450613704|FG000|Overall Study|Lost to Follow-up|2|||
125269113|NCT02268383|450613704|FG000|Overall Study|Withdrawal by Subject|9|||
125269114|NCT02268383|450613704|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
125269115|NCT02268383|450613704|FG000|Overall Study|Protocol deviation|3|||
125269116|NCT02268383|450613704|FG000|Overall Study|Sponsor decision|22|||
125269117|NCT02268383|450613704|FG000|Overall Study|Not reported|12|||
125269118|NCT02708680|450613705|FG000|Overall Study|Withdrawal by Subject|4|||
125269119|NCT02708680|450613706|FG001|Overall Study|Withdrawal by Subject|12|||
125269120|NCT02708680|450613707|FG002|Overall Study|Withdrawal by Subject|12|||
125269121|NCT02708680|450613705|FG000|Overall Study|Death|4|||
125269122|NCT02708680|450613706|FG001|Overall Study|Death|19|||
125269123|NCT02708680|450613707|FG002|Overall Study|Death|21|||
125269124|NCT02708680|450613705|FG000|Overall Study|Lost to Follow-up|0|||
125269125|NCT02708680|450613706|FG001|Overall Study|Lost to Follow-up|3|||
125269126|NCT02708680|450613707|FG002|Overall Study|Lost to Follow-up|3|||
125269127|NCT02708680|450613705|FG000|Overall Study|Study Terminated By Sponsor|0|||
125269128|NCT02708680|450613706|FG001|Overall Study|Study Terminated By Sponsor|5|||
125269129|NCT02708680|450613707|FG002|Overall Study|Study Terminated By Sponsor|4|||
125269130|NCT02708680|450613705|FG000|Overall Study|Other than Specified|0|||
125269131|NCT02708680|450613706|FG001|Overall Study|Other than Specified|0|||
125269132|NCT02708680|450613707|FG002|Overall Study|Other than Specified|1|||
125269133|NCT02708680|450613705|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
125269134|NCT02708680|450613706|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
125269135|NCT02708680|450613707|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
125269136|NCT04162470|450613708|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
125269137|NCT05588440|450613711|FG000|Overall Study|Sponsor Decision|2|||
125269138|NCT05588440|450613712|FG001|Overall Study|Sponsor Decision|0|||
125269139|NCT05588440|450613713|FG002|Overall Study|Sponsor Decision|1|||
125269140|NCT05588440|450613711|FG000|Overall Study|Death|1|||
125269141|NCT05588440|450613712|FG001|Overall Study|Death|1|||
125269142|NCT05588440|450613713|FG002|Overall Study|Death|1|||
125269143|NCT05588440|450613711|FG000|Overall Study|Screen Fail|0|||
125269144|NCT05588440|450613712|FG001|Overall Study|Screen Fail|1|||
125269145|NCT05588440|450613713|FG002|Overall Study|Screen Fail|1|||
125269146|NCT05588440|450613711|FG000|Overall Study|Withdrawal by Subject|0|||
125269147|NCT05588440|450613712|FG001|Overall Study|Withdrawal by Subject|0|||
125269148|NCT05588440|450613713|FG002|Overall Study|Withdrawal by Subject|1|||
125269149|NCT01544348|450613718|FG000|Overall Study|Lost to Follow-up|1|||
125269150|NCT01544348|450613719|FG001|Overall Study|Lost to Follow-up|0|||
125269151|NCT01544348|450613720|FG002|Overall Study|Lost to Follow-up|0|||
125269152|NCT01544348|450613721|FG003|Overall Study|Lost to Follow-up|0|||
125269153|NCT01544348|450613722|FG004|Overall Study|Lost to Follow-up|0|||
125269154|NCT01544348|450613723|FG005|Overall Study|Lost to Follow-up|0|||
125269155|NCT01544348|450613724|FG006|Overall Study|Lost to Follow-up|1|||
125269156|NCT01544348|450613725|FG007|Overall Study|Lost to Follow-up|0|||
125269157|NCT01544348|450613718|FG000|Overall Study|Withdrawal by Subject|1|||
125269158|NCT01544348|450613719|FG001|Overall Study|Withdrawal by Subject|0|||
125269159|NCT01544348|450613720|FG002|Overall Study|Withdrawal by Subject|0|||
125269160|NCT01544348|450613721|FG003|Overall Study|Withdrawal by Subject|0|||
125269161|NCT01544348|450613722|FG004|Overall Study|Withdrawal by Subject|1|||
125269162|NCT01544348|450613723|FG005|Overall Study|Withdrawal by Subject|2|||
125269163|NCT01544348|450613724|FG006|Overall Study|Withdrawal by Subject|1|||
125269164|NCT01544348|450613725|FG007|Overall Study|Withdrawal by Subject|0|||
125269165|NCT01544348|450613718|FG000|Overall Study|Physician Decision|0|||
125269166|NCT01544348|450613719|FG001|Overall Study|Physician Decision|0|||
125269167|NCT01544348|450613720|FG002|Overall Study|Physician Decision|0|||
125269168|NCT01544348|450613721|FG003|Overall Study|Physician Decision|0|||
125269169|NCT01544348|450613722|FG004|Overall Study|Physician Decision|0|||
125269170|NCT01544348|450613723|FG005|Overall Study|Physician Decision|1|||
125269171|NCT01544348|450613724|FG006|Overall Study|Physician Decision|0|||
125269172|NCT01544348|450613725|FG007|Overall Study|Physician Decision|0|||
125269173|NCT01445847|450613726|FG000|Overall Study|Protocol Violation|13|||
125269174|NCT01445847|450613727|FG001|Overall Study|Protocol Violation|14|||
125269175|NCT01445847|450613726|FG000|Overall Study|Missed Data|1|||
125269176|NCT01445847|450613727|FG001|Overall Study|Missed Data|0|||
125269177|NCT04790279|450615641|FG000|Overall Study|Did not meet medication start criteria|27|||
125269178|NCT04790279|450615642|FG001|Overall Study|Did not meet medication start criteria|15|||
125269179|NCT04790279|450615641|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
125269180|NCT04790279|450615642|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
125269181|NCT04790279|450615641|FG000|Overall Study|Protocol Violation|8|||
125269182|NCT04790279|450615642|FG001|Overall Study|Protocol Violation|3|||
125269183|NCT04790279|450615641|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
125269184|NCT04790279|450615642|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
125269185|NCT00810277|450615655|FG000|Overall Study|Adverse Event|1|||
125269186|NCT00678288|450615662|FG000|Overall Study|Adverse Event|0|||
125269187|NCT00678288|450615663|FG001|Overall Study|Adverse Event|2|||
125269188|NCT00678288|450615662|FG000|Overall Study|Withdrawal by Subject|1|||
125269189|NCT00678288|450615663|FG001|Overall Study|Withdrawal by Subject|1|||
125269190|NCT00678288|450615662|FG000|Overall Study|Study terminated by the sponsor|2|||
125269191|NCT00678288|450615663|FG001|Overall Study|Study terminated by the sponsor|0|||
125269192|NCT00678288|450615662|FG000|Overall Study|Not compliant with study medication|0|||
125269193|NCT00678288|450615663|FG001|Overall Study|Not compliant with study medication|1|||
125269194|NCT00678288|450615662|FG000|Overall Study|Switch to commercial drug|0|||
125269195|NCT00678288|450615663|FG001|Overall Study|Switch to commercial drug|1|||
125269196|NCT00678288|450615662|FG000|Overall Study|Reason not reported|1|||
125269197|NCT00678288|450615663|FG001|Overall Study|Reason not reported|0|||
125269198|NCT00678288|450615662|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
125269199|NCT00678288|450615663|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
125269200|NCT02549989|450615664|FG000|Overall Study|Adverse Event|4|||
125269201|NCT02549989|450615664|FG000|Overall Study|Death|1|||
125269202|NCT02549989|450615664|FG000|Overall Study|Lack of Efficacy|19|||
125269203|NCT02549989|450615664|FG000|Overall Study|Withdrawal by Subject|3|||
125269204|NCT00972023|450615665|FG000|Overall Study|Withdrawal by Subject|1|||
125269205|NCT02628444|450615666|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
125269206|NCT02628444|450615667|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
125269207|NCT02628444|450615668|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
125269208|NCT02628444|450615669|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
125269209|NCT02628444|450615670|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
125269210|NCT02628444|450615671|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
125269211|NCT02628444|450615672|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
125269212|NCT02628444|450615673|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
125269213|NCT02628444|450615674|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
125269214|NCT02628444|450615666|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
125269215|NCT02628444|450615667|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
125269216|NCT02628444|450615668|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
125269217|NCT02628444|450615669|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
125269218|NCT02628444|450615670|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
125269219|NCT02628444|450615671|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
125269220|NCT02628444|450615672|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
125269221|NCT02628444|450615673|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
125269222|NCT02628444|450615674|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
125269223|NCT02628444|450615666|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
125269224|NCT02628444|450615667|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
125269225|NCT02628444|450615668|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
125269226|NCT02628444|450615669|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
125269227|NCT02628444|450615670|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
125269228|NCT02628444|450615671|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
125269229|NCT02628444|450615672|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
125269230|NCT02628444|450615673|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
125269231|NCT02628444|450615674|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
125269232|NCT02628444|450615666|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
125269233|NCT02628444|450615667|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
125269234|NCT02628444|450615668|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
125269235|NCT02628444|450615669|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
125269236|NCT02628444|450615670|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
125269237|NCT02628444|450615671|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
125269238|NCT02628444|450615672|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
125269239|NCT02628444|450615673|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
125269240|NCT02628444|450615674|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
125269241|NCT02628444|450615666|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
125269242|NCT02628444|450615667|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
125269243|NCT02628444|450615668|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
125269244|NCT02628444|450615669|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
125269245|NCT02628444|450615670|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
125269246|NCT02628444|450615671|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
125269247|NCT02628444|450615672|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
125269248|NCT02628444|450615673|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
125269249|NCT02628444|450615674|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
125269250|NCT02628444|450615666|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
125269251|NCT02628444|450615667|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
125269252|NCT02628444|450615668|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
125269253|NCT02628444|450615669|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
125269254|NCT02628444|450615670|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
125269255|NCT02628444|450615671|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
125269256|NCT02628444|450615672|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
125269257|NCT02628444|450615673|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
125269258|NCT02628444|450615674|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
125269259|NCT02628444|450615666|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
125269260|NCT02628444|450615667|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
125269261|NCT02628444|450615668|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
125269262|NCT02628444|450615669|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
125269263|NCT02628444|450615670|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
125269264|NCT02628444|450615671|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
125269265|NCT02628444|450615672|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
125269266|NCT02628444|450615673|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
125269267|NCT02628444|450615674|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
125269268|NCT02628444|450615666|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
125269269|NCT02628444|450615667|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
125269270|NCT02628444|450615668|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
125269271|NCT02628444|450615669|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
125269272|NCT02628444|450615670|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
125269273|NCT02628444|450615671|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
125269274|NCT02628444|450615672|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
125269275|NCT02628444|450615673|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
125269276|NCT02628444|450615674|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
125269277|NCT02628444|450615666|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
125269278|NCT02628444|450615667|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
125269279|NCT02628444|450615668|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
125269280|NCT02628444|450615669|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
125269281|NCT02628444|450615670|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
125269282|NCT02628444|450615671|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
125269283|NCT02628444|450615672|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
125269284|NCT02628444|450615673|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
125269285|NCT02628444|450615674|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
125269286|NCT02628444|450615666|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
125269287|NCT02628444|450615667|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
125269288|NCT02628444|450615668|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
125269289|NCT02628444|450615669|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
125269290|NCT02628444|450615670|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
125269291|NCT02628444|450615671|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
125269292|NCT02628444|450615672|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
125269293|NCT02628444|450615673|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
125269294|NCT02628444|450615674|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
125269295|NCT00784368|450615677|FG000|Overall Study|Physician Decision|0|||
125269296|NCT00784368|450615678|FG001|Overall Study|Physician Decision|0|||
125269297|NCT00784368|450615679|FG002|Overall Study|Physician Decision|6|||
125269298|NCT00784368|450615677|FG000|Overall Study|Lack of Efficacy|2|||
125269299|NCT00784368|450615678|FG001|Overall Study|Lack of Efficacy|0|||
125269300|NCT00784368|450615679|FG002|Overall Study|Lack of Efficacy|1|||
125269301|NCT00784368|450615677|FG000|Overall Study|Adverse Event|6|||
125269302|NCT00784368|450615678|FG001|Overall Study|Adverse Event|9|||
125269303|NCT00784368|450615679|FG002|Overall Study|Adverse Event|2|||
125269304|NCT00784368|450615677|FG000|Overall Study|Diagnosis of fever|0|||
125269305|NCT00784368|450615678|FG001|Overall Study|Diagnosis of fever|0|||
125269306|NCT00784368|450615679|FG002|Overall Study|Diagnosis of fever|1|||
125269307|NCT00784368|450615677|FG000|Overall Study|Worsening of complications|0|||
125269308|NCT00784368|450615678|FG001|Overall Study|Worsening of complications|0|||
125269309|NCT00784368|450615679|FG002|Overall Study|Worsening of complications|1|||
125269310|NCT00784368|450615677|FG000|Overall Study|Worsening of symptoms|0|||
125269311|NCT00784368|450615678|FG001|Overall Study|Worsening of symptoms|1|||
125269312|NCT00784368|450615679|FG002|Overall Study|Worsening of symptoms|0|||
125269313|NCT00784368|450615677|FG000|Overall Study|Withdrawal of informed consent|0|||
125269314|NCT00784368|450615678|FG001|Overall Study|Withdrawal of informed consent|1|||
125269315|NCT00784368|450615679|FG002|Overall Study|Withdrawal of informed consent|0|||
125269316|NCT02079909|450615680|FG000|Overall Study|Adverse Event|23|||
125269317|NCT02079909|450615681|FG001|Overall Study|Adverse Event|23|||
125269318|NCT02079909|450615682|FG002|Overall Study|Adverse Event|7|||
125269319|NCT02079909|450615680|FG000|Overall Study|Withdrawal by Subject|9|||
125269320|NCT02079909|450615681|FG001|Overall Study|Withdrawal by Subject|17|||
125269321|NCT02079909|450615682|FG002|Overall Study|Withdrawal by Subject|4|||
125269322|NCT02079909|450615680|FG000|Overall Study|Lost to Follow-up|2|||
125269323|NCT02079909|450615681|FG001|Overall Study|Lost to Follow-up|3|||
125269324|NCT02079909|450615682|FG002|Overall Study|Lost to Follow-up|1|||
125269325|NCT02079909|450615680|FG000|Overall Study|Death|2|||
125269326|NCT02079909|450615681|FG001|Overall Study|Death|2|||
125269327|NCT02079909|450615682|FG002|Overall Study|Death|0|||
125269328|NCT02079909|450615680|FG000|Overall Study|Lack of Efficacy|0|||
125269329|NCT02079909|450615681|FG001|Overall Study|Lack of Efficacy|0|||
125269330|NCT02079909|450615682|FG002|Overall Study|Lack of Efficacy|1|||
125269331|NCT02079909|450615680|FG000|Overall Study|Protocol Violation|0|||
125269332|NCT02079909|450615681|FG001|Overall Study|Protocol Violation|1|||
125269333|NCT02079909|450615682|FG002|Overall Study|Protocol Violation|1|||
125269334|NCT02079909|450615680|FG000|Overall Study|Physician Decision|0|||
125269335|NCT02079909|450615681|FG001|Overall Study|Physician Decision|1|||
125269336|NCT02079909|450615682|FG002|Overall Study|Physician Decision|1|||
125269337|NCT02079909|450615680|FG000|Overall Study|Relocation etc.|2|||
125269338|NCT02079909|450615681|FG001|Overall Study|Relocation etc.|2|||
125269339|NCT02079909|450615682|FG002|Overall Study|Relocation etc.|3|||
125269340|NCT00720356|450615687|FG000|Registration to Study|Determined to have methylated MGMT|67|||
125269341|NCT00720356|450615687|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
125269342|NCT00720356|450615687|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
125269343|NCT00720356|450615687|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
125269344|NCT00720356|450615687|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
125269345|NCT00720356|450615687|FG000|Follow up Until Death|Withdrawal by Subject|1|||
125269346|NCT00720356|450615687|FG000|Follow up Until Death|Alive at last data collection|4|||
125269347|NCT01713582|450615690|FG000|Overall Study|Disease progression|3|||
125269348|NCT01713582|450615691|FG001|Overall Study|Disease progression|3|||
125269349|NCT01713582|450615692|FG002|Overall Study|Disease progression|3|||
125269350|NCT01713582|450615693|FG003|Overall Study|Disease progression|2|||
125269351|NCT01713582|450615694|FG004|Overall Study|Disease progression|3|||
125269352|NCT01713582|450615695|FG005|Overall Study|Disease progression|3|||
125269353|NCT01713582|450615696|FG006|Overall Study|Disease progression|3|||
125269354|NCT01713582|450615697|FG007|Overall Study|Disease progression|3|||
125269355|NCT01713582|450615698|FG008|Overall Study|Disease progression|3|||
125269356|NCT01713582|450615699|FG009|Overall Study|Disease progression|11|||
125269357|NCT01713582|450615700|FG010|Overall Study|Disease progression|10|||
125269358|NCT01713582|450615701|FG011|Overall Study|Disease progression|5|||
125269359|NCT01713582|450615702|FG012|Overall Study|Disease progression|3|||
125269360|NCT01713582|450615703|FG013|Overall Study|Disease progression|3|||
125269361|NCT01713582|450615704|FG014|Overall Study|Disease progression|6|||
125269362|NCT01713582|450615705|FG015|Overall Study|Disease progression|6|||
125269363|NCT01713582|450615706|FG016|Overall Study|Disease progression|5|||
125269364|NCT01713582|450615707|FG017|Overall Study|Disease progression|2|||
125269365|NCT01713582|450615708|FG018|Overall Study|Disease progression|3|||
125269366|NCT01713582|450615709|FG019|Overall Study|Disease progression|5|||
125269367|NCT01713582|450615710|FG020|Overall Study|Disease progression|15|||
125269368|NCT01713582|450615690|FG000|Overall Study|Death|0|||
125269369|NCT01713582|450615691|FG001|Overall Study|Death|0|||
125269370|NCT01713582|450615692|FG002|Overall Study|Death|0|||
125269371|NCT01713582|450615693|FG003|Overall Study|Death|1|||
125269372|NCT01713582|450615694|FG004|Overall Study|Death|1|||
125269373|NCT01713582|450615695|FG005|Overall Study|Death|3|||
125269374|NCT01713582|450615696|FG006|Overall Study|Death|3|||
125269375|NCT01713582|450615697|FG007|Overall Study|Death|2|||
125269376|NCT01713582|450615698|FG008|Overall Study|Death|3|||
125269377|NCT01713582|450615699|FG009|Overall Study|Death|4|||
125269378|NCT01713582|450615700|FG010|Overall Study|Death|3|||
125269379|NCT01713582|450615701|FG011|Overall Study|Death|0|||
125269380|NCT01713582|450615702|FG012|Overall Study|Death|0|||
125269381|NCT01713582|450615703|FG013|Overall Study|Death|0|||
125269382|NCT01713582|450615704|FG014|Overall Study|Death|0|||
125269383|NCT01713582|450615705|FG015|Overall Study|Death|0|||
125269384|NCT01713582|450615706|FG016|Overall Study|Death|0|||
125269385|NCT01713582|450615707|FG017|Overall Study|Death|0|||
125269386|NCT01713582|450615708|FG018|Overall Study|Death|0|||
125269387|NCT01713582|450615709|FG019|Overall Study|Death|0|||
125269388|NCT01713582|450615710|FG020|Overall Study|Death|0|||
125269389|NCT01713582|450615690|FG000|Overall Study|Adverse event-related|0|||
125269390|NCT01713582|450615691|FG001|Overall Study|Adverse event-related|0|||
125269391|NCT01713582|450615692|FG002|Overall Study|Adverse event-related|0|||
125269392|NCT01713582|450615693|FG003|Overall Study|Adverse event-related|0|||
125269393|NCT01713582|450615694|FG004|Overall Study|Adverse event-related|0|||
125269394|NCT01713582|450615695|FG005|Overall Study|Adverse event-related|0|||
125269395|NCT01713582|450615696|FG006|Overall Study|Adverse event-related|0|||
125269396|NCT01713582|450615697|FG007|Overall Study|Adverse event-related|0|||
125269397|NCT01713582|450615698|FG008|Overall Study|Adverse event-related|0|||
125269398|NCT01713582|450615699|FG009|Overall Study|Adverse event-related|1|||
125269399|NCT01713582|450615700|FG010|Overall Study|Adverse event-related|1|||
125269400|NCT01713582|450615701|FG011|Overall Study|Adverse event-related|0|||
125269401|NCT01713582|450615702|FG012|Overall Study|Adverse event-related|0|||
125269402|NCT01713582|450615703|FG013|Overall Study|Adverse event-related|0|||
125269403|NCT01713582|450615704|FG014|Overall Study|Adverse event-related|0|||
125269404|NCT01713582|450615705|FG015|Overall Study|Adverse event-related|0|||
125269405|NCT01713582|450615706|FG016|Overall Study|Adverse event-related|0|||
125269406|NCT01713582|450615707|FG017|Overall Study|Adverse event-related|0|||
125269407|NCT01713582|450615708|FG018|Overall Study|Adverse event-related|1|||
125269408|NCT01713582|450615709|FG019|Overall Study|Adverse event-related|0|||
125269409|NCT01713582|450615710|FG020|Overall Study|Adverse event-related|0|||
125269410|NCT01713582|450615690|FG000|Overall Study|Adverse event-unrelated|0|||
125269411|NCT01713582|450615691|FG001|Overall Study|Adverse event-unrelated|0|||
125269412|NCT01713582|450615692|FG002|Overall Study|Adverse event-unrelated|0|||
125269413|NCT01713582|450615693|FG003|Overall Study|Adverse event-unrelated|0|||
125269414|NCT01713582|450615694|FG004|Overall Study|Adverse event-unrelated|0|||
125269415|NCT01713582|450615695|FG005|Overall Study|Adverse event-unrelated|1|||
125269416|NCT01713582|450615696|FG006|Overall Study|Adverse event-unrelated|1|||
125269417|NCT01713582|450615697|FG007|Overall Study|Adverse event-unrelated|1|||
125269418|NCT01713582|450615698|FG008|Overall Study|Adverse event-unrelated|0|||
125269419|NCT01713582|450615699|FG009|Overall Study|Adverse event-unrelated|0|||
125269420|NCT01713582|450615700|FG010|Overall Study|Adverse event-unrelated|0|||
125269421|NCT01713582|450615701|FG011|Overall Study|Adverse event-unrelated|0|||
125269422|NCT01713582|450615702|FG012|Overall Study|Adverse event-unrelated|0|||
125269423|NCT01713582|450615703|FG013|Overall Study|Adverse event-unrelated|1|||
125269424|NCT01713582|450615704|FG014|Overall Study|Adverse event-unrelated|1|||
125269425|NCT01713582|450615705|FG015|Overall Study|Adverse event-unrelated|0|||
125269426|NCT01713582|450615706|FG016|Overall Study|Adverse event-unrelated|0|||
125269427|NCT01713582|450615707|FG017|Overall Study|Adverse event-unrelated|0|||
125269428|NCT01713582|450615708|FG018|Overall Study|Adverse event-unrelated|0|||
125269429|NCT01713582|450615709|FG019|Overall Study|Adverse event-unrelated|0|||
125269430|NCT01713582|450615710|FG020|Overall Study|Adverse event-unrelated|0|||
125269431|NCT01713582|450615690|FG000|Overall Study|Withdrawal of consent|0|||
125269432|NCT01713582|450615691|FG001|Overall Study|Withdrawal of consent|0|||
125269433|NCT01713582|450615692|FG002|Overall Study|Withdrawal of consent|1|||
125269434|NCT01713582|450615693|FG003|Overall Study|Withdrawal of consent|0|||
125269435|NCT01713582|450615694|FG004|Overall Study|Withdrawal of consent|0|||
125269436|NCT01713582|450615695|FG005|Overall Study|Withdrawal of consent|1|||
125269437|NCT01713582|450615696|FG006|Overall Study|Withdrawal of consent|0|||
125269438|NCT01713582|450615697|FG007|Overall Study|Withdrawal of consent|0|||
125269439|NCT01713582|450615698|FG008|Overall Study|Withdrawal of consent|0|||
125269440|NCT01713582|450615699|FG009|Overall Study|Withdrawal of consent|1|||
125269441|NCT01713582|450615700|FG010|Overall Study|Withdrawal of consent|0|||
125269442|NCT01713582|450615701|FG011|Overall Study|Withdrawal of consent|0|||
125269443|NCT01713582|450615702|FG012|Overall Study|Withdrawal of consent|0|||
125269444|NCT01713582|450615703|FG013|Overall Study|Withdrawal of consent|0|||
125269445|NCT01713582|450615704|FG014|Overall Study|Withdrawal of consent|0|||
125269446|NCT01713582|450615705|FG015|Overall Study|Withdrawal of consent|0|||
125269447|NCT01713582|450615706|FG016|Overall Study|Withdrawal of consent|0|||
125269448|NCT01713582|450615707|FG017|Overall Study|Withdrawal of consent|0|||
125269449|NCT01713582|450615708|FG018|Overall Study|Withdrawal of consent|1|||
125269450|NCT01713582|450615709|FG019|Overall Study|Withdrawal of consent|0|||
125269451|NCT01713582|450615710|FG020|Overall Study|Withdrawal of consent|0|||
125269452|NCT01713582|450615690|FG000|Overall Study|Lack of Efficacy|0|||
125269453|NCT01713582|450615691|FG001|Overall Study|Lack of Efficacy|0|||
125269454|NCT01713582|450615692|FG002|Overall Study|Lack of Efficacy|0|||
125269455|NCT01713582|450615693|FG003|Overall Study|Lack of Efficacy|0|||
125269456|NCT01713582|450615694|FG004|Overall Study|Lack of Efficacy|0|||
125269457|NCT01713582|450615695|FG005|Overall Study|Lack of Efficacy|0|||
125269458|NCT01713582|450615696|FG006|Overall Study|Lack of Efficacy|0|||
125269459|NCT01713582|450615697|FG007|Overall Study|Lack of Efficacy|0|||
125269460|NCT01713582|450615698|FG008|Overall Study|Lack of Efficacy|0|||
125269461|NCT01713582|450615699|FG009|Overall Study|Lack of Efficacy|1|||
125269462|NCT01713582|450615700|FG010|Overall Study|Lack of Efficacy|2|||
125269463|NCT01713582|450615701|FG011|Overall Study|Lack of Efficacy|0|||
125269464|NCT01713582|450615702|FG012|Overall Study|Lack of Efficacy|0|||
125269465|NCT01713582|450615703|FG013|Overall Study|Lack of Efficacy|0|||
125269466|NCT01713582|450615704|FG014|Overall Study|Lack of Efficacy|0|||
125269467|NCT01713582|450615705|FG015|Overall Study|Lack of Efficacy|0|||
125269468|NCT01713582|450615706|FG016|Overall Study|Lack of Efficacy|0|||
125269469|NCT01713582|450615707|FG017|Overall Study|Lack of Efficacy|0|||
125269470|NCT01713582|450615708|FG018|Overall Study|Lack of Efficacy|0|||
125269471|NCT01713582|450615709|FG019|Overall Study|Lack of Efficacy|0|||
125269472|NCT01713582|450615710|FG020|Overall Study|Lack of Efficacy|0|||
125269473|NCT01713582|450615690|FG000|Overall Study|Withdrawal by Subject|0|||
125269474|NCT01713582|450615691|FG001|Overall Study|Withdrawal by Subject|0|||
125269475|NCT01713582|450615692|FG002|Overall Study|Withdrawal by Subject|0|||
125269476|NCT01713582|450615693|FG003|Overall Study|Withdrawal by Subject|0|||
125269477|NCT01713582|450615694|FG004|Overall Study|Withdrawal by Subject|0|||
125269478|NCT01713582|450615695|FG005|Overall Study|Withdrawal by Subject|0|||
125269479|NCT01713582|450615696|FG006|Overall Study|Withdrawal by Subject|0|||
125269480|NCT01713582|450615697|FG007|Overall Study|Withdrawal by Subject|0|||
125269481|NCT01713582|450615698|FG008|Overall Study|Withdrawal by Subject|0|||
125269482|NCT01713582|450615699|FG009|Overall Study|Withdrawal by Subject|0|||
125269483|NCT01713582|450615700|FG010|Overall Study|Withdrawal by Subject|0|||
125269484|NCT01713582|450615701|FG011|Overall Study|Withdrawal by Subject|0|||
125269485|NCT01713582|450615702|FG012|Overall Study|Withdrawal by Subject|0|||
125269486|NCT01713582|450615703|FG013|Overall Study|Withdrawal by Subject|0|||
125269487|NCT01713582|450615704|FG014|Overall Study|Withdrawal by Subject|0|||
125269488|NCT01713582|450615705|FG015|Overall Study|Withdrawal by Subject|0|||
125269489|NCT01713582|450615706|FG016|Overall Study|Withdrawal by Subject|0|||
125269490|NCT01713582|450615707|FG017|Overall Study|Withdrawal by Subject|1|||
125269491|NCT01713582|450615708|FG018|Overall Study|Withdrawal by Subject|0|||
125269492|NCT01713582|450615709|FG019|Overall Study|Withdrawal by Subject|0|||
125269493|NCT01713582|450615710|FG020|Overall Study|Withdrawal by Subject|0|||
125269494|NCT01713582|450615690|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
125269495|NCT01713582|450615691|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
125269496|NCT01713582|450615692|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
125269497|NCT01713582|450615693|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
125269498|NCT01713582|450615694|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
125269499|NCT01713582|450615695|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
125269500|NCT01713582|450615696|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
125269501|NCT01713582|450615697|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
125269502|NCT01713582|450615698|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
125269503|NCT01713582|450615699|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
125269504|NCT01713582|450615700|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
125269505|NCT01713582|450615701|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
125269506|NCT01713582|450615702|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
125269507|NCT01713582|450615703|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
125269508|NCT01713582|450615704|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
125269509|NCT01713582|450615705|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
125269510|NCT01713582|450615706|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
125269511|NCT01713582|450615707|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
125269512|NCT01713582|450615708|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
125269513|NCT01713582|450615709|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
125269514|NCT01713582|450615710|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
125269515|NCT01713582|450615690|FG000|Overall Study|Disease progression and adverse event|0|||
125269516|NCT01713582|450615691|FG001|Overall Study|Disease progression and adverse event|0|||
125269517|NCT01713582|450615692|FG002|Overall Study|Disease progression and adverse event|0|||
125269518|NCT01713582|450615693|FG003|Overall Study|Disease progression and adverse event|0|||
125269519|NCT01713582|450615694|FG004|Overall Study|Disease progression and adverse event|0|||
125269520|NCT01713582|450615695|FG005|Overall Study|Disease progression and adverse event|0|||
125269521|NCT01713582|450615696|FG006|Overall Study|Disease progression and adverse event|0|||
125269522|NCT01713582|450615697|FG007|Overall Study|Disease progression and adverse event|0|||
125269523|NCT01713582|450615698|FG008|Overall Study|Disease progression and adverse event|0|||
125269524|NCT01713582|450615699|FG009|Overall Study|Disease progression and adverse event|0|||
125269525|NCT01713582|450615700|FG010|Overall Study|Disease progression and adverse event|0|||
125269526|NCT01713582|450615701|FG011|Overall Study|Disease progression and adverse event|0|||
125269527|NCT01713582|450615702|FG012|Overall Study|Disease progression and adverse event|0|||
125269528|NCT01713582|450615703|FG013|Overall Study|Disease progression and adverse event|0|||
125269529|NCT01713582|450615704|FG014|Overall Study|Disease progression and adverse event|0|||
125269530|NCT01713582|450615705|FG015|Overall Study|Disease progression and adverse event|0|||
125269531|NCT01713582|450615706|FG016|Overall Study|Disease progression and adverse event|1|||
125269532|NCT01713582|450615707|FG017|Overall Study|Disease progression and adverse event|0|||
125269533|NCT01713582|450615708|FG018|Overall Study|Disease progression and adverse event|0|||
125269534|NCT01713582|450615709|FG019|Overall Study|Disease progression and adverse event|0|||
125269535|NCT01713582|450615710|FG020|Overall Study|Disease progression and adverse event|0|||
125269536|NCT04551898|450615713|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
125269537|NCT04551898|450615714|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
125269538|NCT04551898|450615715|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
125269539|NCT04551898|450615716|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
125269540|NCT04551898|450615713|FG000|Overall Study|Withdrawal by Subject|5|||
125269541|NCT04551898|450615714|FG001|Overall Study|Withdrawal by Subject|1|||
125269542|NCT04551898|450615715|FG002|Overall Study|Withdrawal by Subject|2|||
125269543|NCT04551898|450615716|FG003|Overall Study|Withdrawal by Subject|2|||
125269544|NCT04551898|450615713|FG000|Overall Study|Lost to Follow-up|2|||
125269545|NCT04551898|450615714|FG001|Overall Study|Lost to Follow-up|1|||
125269546|NCT04551898|450615715|FG002|Overall Study|Lost to Follow-up|2|||
125269547|NCT04551898|450615716|FG003|Overall Study|Lost to Follow-up|2|||
125269548|NCT04551898|450615713|FG000|Overall Study|Death|1|||
125269549|NCT04551898|450615714|FG001|Overall Study|Death|0|||
125269550|NCT04551898|450615715|FG002|Overall Study|Death|0|||
125269551|NCT04551898|450615716|FG003|Overall Study|Death|0|||
125269552|NCT04551898|450615713|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
125269553|NCT04551898|450615714|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
125269554|NCT04551898|450615715|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
125269555|NCT04551898|450615716|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
125269556|NCT01898286|450615719|FG000|Overall Study|Withdrawal by Subject|1|||
125269557|NCT01898286|450615719|FG000|Overall Study|Protocol Violation|1|||
125269558|NCT01898286|450615719|FG000|Overall Study|Lost to Follow-up|1|||
125269559|NCT02257242|450615720|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
125269560|NCT02257242|450615721|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
125269561|NCT02257242|450615722|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
125269562|NCT02257242|450615723|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
125269563|NCT02257242|450615724|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
125269564|NCT02257242|450615725|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
125269565|NCT02257242|450615726|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
125269566|NCT02257242|450615727|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
125269567|NCT02257242|450615728|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
125269568|NCT01650831|450615734|FG000|Overall Study|Screen failure|1|||
125269569|NCT01048242|450615738|FG000|Overall Study|See study flow chart|4|||
125269570|NCT01048242|450615739|FG001|Overall Study|See study flow chart|2|||
125269571|NCT02964273|450615740|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
125269572|NCT02964273|450615741|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
125269573|NCT02964273|450615742|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
125269574|NCT02964273|450615743|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
125269575|NCT02964273|450615740|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
125269576|NCT02964273|450615741|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
125269577|NCT02964273|450615742|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
125269578|NCT02964273|450615743|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
125269579|NCT02964273|450615740|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
125269580|NCT02964273|450615741|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
125269581|NCT02964273|450615742|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
125269582|NCT02964273|450615743|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
125269583|NCT02964273|450615740|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
125269584|NCT02964273|450615741|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
125269585|NCT02964273|450615742|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
125269586|NCT02964273|450615743|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
125269587|NCT02964273|450615740|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
125269588|NCT02964273|450615741|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
125269589|NCT02964273|450615742|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
125269590|NCT02964273|450615743|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
125269591|NCT02964273|450615740|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
125269592|NCT02964273|450615741|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
125269593|NCT02964273|450615742|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
125269594|NCT02964273|450615743|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
125269595|NCT03333928|450615745|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
125269596|NCT03333928|450615746|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
125269597|NCT03333928|450615747|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
125269598|NCT03333928|450615745|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
125269599|NCT03333928|450615746|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
125269600|NCT03333928|450615747|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
125269601|NCT03333928|450615745|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
125269602|NCT03333928|450615746|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
125269603|NCT03333928|450615747|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
125269604|NCT03333928|450615745|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
125269605|NCT03333928|450615746|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
125269606|NCT03333928|450615747|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
125269607|NCT03333928|450615745|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
125269608|NCT03333928|450615746|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
125269609|NCT03333928|450615747|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
125269610|NCT03333928|450615745|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
125269611|NCT03333928|450615746|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
125269612|NCT03333928|450615747|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
125269613|NCT03333928|450615745|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
125269614|NCT03333928|450615746|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
125269615|NCT03333928|450615747|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
125269616|NCT03333928|450615745|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
125269617|NCT03333928|450615746|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
125269618|NCT03333928|450615747|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
125269619|NCT01453036|450615748|FG000|Overall Study|Lost to Follow-up|26|||
125269620|NCT01453036|450615749|FG001|Overall Study|Lost to Follow-up|115|||
125269621|NCT01453036|450615750|FG002|Overall Study|Lost to Follow-up|31|||
125269622|NCT00559104|450615751|FG000|Overall Study|Lack of Efficacy|9|||
125269623|NCT00559104|450615752|FG001|Overall Study|Lack of Efficacy|0|||
125269624|NCT01336712|450615753|FG000|Overall Study|Death|2|||
125269625|NCT01336712|450615753|FG000|Overall Study|Lack of Efficacy|1|||
125269626|NCT00620373|450615755|FG000|Overall Study|Unverified cancer status|33|||
125269627|NCT00399568|450615756|FG000|Overall Study|Adverse Event|1|||
125269628|NCT00399568|450615757|FG001|Overall Study|Adverse Event|2|||
125269629|NCT00399568|450615756|FG000|Overall Study|Withdrawal by Subject|7|||
125269630|NCT00399568|450615757|FG001|Overall Study|Withdrawal by Subject|3|||
125269631|NCT00399568|450615756|FG000|Overall Study|Protocol non-compliance|2|||
125269632|NCT00399568|450615757|FG001|Overall Study|Protocol non-compliance|2|||
125269633|NCT00399568|450615756|FG000|Overall Study|Lost to Follow-up|2|||
125269634|NCT00399568|450615757|FG001|Overall Study|Lost to Follow-up|2|||
125269635|NCT03073525|450615758|FG000|Overall Study|Withdrawal by Subject|0|||
125269636|NCT03073525|450615759|FG001|Overall Study|Withdrawal by Subject|0|||
125269637|NCT03073525|450615760|FG002|Overall Study|Withdrawal by Subject|3|||
125269638|NCT03692403|450615761|FG000|Overall Study|Withdrawal by Subject|1|||
125269639|NCT03692403|450615762|FG001|Overall Study|Withdrawal by Subject|0|||
125269640|NCT03692403|450615763|FG002|Overall Study|Withdrawal by Subject|1|||
125269641|NCT03692403|450615764|FG003|Overall Study|Withdrawal by Subject|0|||
125269642|NCT03692403|450615761|FG000|Overall Study|Adverse Event|0|||
125269643|NCT03692403|450615762|FG001|Overall Study|Adverse Event|0|||
125269644|NCT03692403|450615763|FG002|Overall Study|Adverse Event|0|||
125269645|NCT03692403|450615764|FG003|Overall Study|Adverse Event|1|||
125269646|NCT03692403|450615761|FG000|Overall Study|Pregnancy|0|||
125269647|NCT03692403|450615762|FG001|Overall Study|Pregnancy|1|||
125269648|NCT03692403|450615763|FG002|Overall Study|Pregnancy|0|||
125269649|NCT03692403|450615764|FG003|Overall Study|Pregnancy|0|||
125269650|NCT03692403|450615761|FG000|Overall Study|Other|0|||
125269651|NCT03692403|450615762|FG001|Overall Study|Other|0|||
125269652|NCT03692403|450615763|FG002|Overall Study|Other|1|||
125269653|NCT03692403|450615764|FG003|Overall Study|Other|0|||
125269654|NCT02776683|450615765|FG000|Pre-switch Period|Protocol Violation|1|||
125269655|NCT02776683|450615766|FG001|Pre-switch Period|Protocol Violation|0|||
125269656|NCT02776683|450615765|FG000|Pre-switch Period|Adverse Event|21|||
125269657|NCT02776683|450615766|FG001|Pre-switch Period|Adverse Event|0|||
125269658|NCT02776683|450615765|FG000|Pre-switch Period|Withdrawal by Subject|9|||
125269659|NCT02776683|450615766|FG001|Pre-switch Period|Withdrawal by Subject|0|||
125269660|NCT02776683|450615765|FG000|Pre-switch Period|Physician Decision|7|||
125269661|NCT02776683|450615766|FG001|Pre-switch Period|Physician Decision|0|||
125269662|NCT02776683|450615765|FG000|Pre-switch Period|Progressive disease|39|||
125269663|NCT02776683|450615766|FG001|Pre-switch Period|Progressive disease|0|||
125269664|NCT02776683|450615765|FG000|Pre-switch Period|Other than listed|3|||
125269665|NCT02776683|450615766|FG001|Pre-switch Period|Other than listed|0|||
125269666|NCT02776683|450615765|FG000|Post-switch Period|Adverse Event|0|||
125269667|NCT02776683|450615766|FG001|Post-switch Period|Adverse Event|3|||
125269668|NCT02776683|450615765|FG000|Post-switch Period|Withdrawal by Subject|0|||
125269669|NCT02776683|450615766|FG001|Post-switch Period|Withdrawal by Subject|2|||
125269670|NCT02776683|450615765|FG000|Post-switch Period|Physician Decision|0|||
125269671|NCT02776683|450615766|FG001|Post-switch Period|Physician Decision|3|||
125269672|NCT02776683|450615765|FG000|Post-switch Period|Progressive disease|0|||
125269673|NCT02776683|450615766|FG001|Post-switch Period|Progressive disease|20|||
125269674|NCT02776683|450615765|FG000|Post-switch Period|Other than listed|0|||
125269675|NCT02776683|450615766|FG001|Post-switch Period|Other than listed|15|||
125269676|NCT01891396|450615769|FG000|Overall Study|Withdrawal by Subject|4|||
125269677|NCT01891396|450615770|FG001|Overall Study|Withdrawal by Subject|4|||
125269678|NCT01891396|450615771|FG002|Overall Study|Withdrawal by Subject|3|||
125269679|NCT01891396|450615769|FG000|Overall Study|Lost to Follow-up|0|||
125269680|NCT01891396|450615770|FG001|Overall Study|Lost to Follow-up|1|||
125269681|NCT01891396|450615771|FG002|Overall Study|Lost to Follow-up|0|||
125269682|NCT00400517|450615773|FG000|Overall Study|Withdrawal by Subject|1|||
125269683|NCT00400517|450615773|FG000|Overall Study|Physician Decision|1|||
125269684|NCT01881789|450615775|FG000|Overall Study|Withdrawal by Subject|0|||
125269685|NCT01881789|450615776|FG001|Overall Study|Withdrawal by Subject|2|||
125269686|NCT01881789|450615777|FG002|Overall Study|Withdrawal by Subject|1|||
125269687|NCT01881789|450615778|FG003|Overall Study|Withdrawal by Subject|0|||
125269688|NCT01881789|450615779|FG004|Overall Study|Withdrawal by Subject|1|||
125269689|NCT01881789|450615780|FG005|Overall Study|Withdrawal by Subject|1|||
125269690|NCT01881789|450615775|FG000|Overall Study|Study Terminated by Sponsor|0|||
125269691|NCT01881789|450615776|FG001|Overall Study|Study Terminated by Sponsor|0|||
125269692|NCT01881789|450615777|FG002|Overall Study|Study Terminated by Sponsor|0|||
125269693|NCT01881789|450615778|FG003|Overall Study|Study Terminated by Sponsor|0|||
125269694|NCT01881789|450615779|FG004|Overall Study|Study Terminated by Sponsor|0|||
125269695|NCT01881789|450615780|FG005|Overall Study|Study Terminated by Sponsor|1|||
125269696|NCT01881789|450615775|FG000|Overall Study|Other|3|||
125269697|NCT01881789|450615776|FG001|Overall Study|Other|5|||
125269698|NCT01881789|450615777|FG002|Overall Study|Other|2|||
125269699|NCT01881789|450615778|FG003|Overall Study|Other|3|||
125269700|NCT01881789|450615779|FG004|Overall Study|Other|1|||
125269701|NCT01881789|450615780|FG005|Overall Study|Other|1|||
125269702|NCT01964378|450615784|FG000|Overall Study|Disc. due to death before first dosing|0|||
125269703|NCT01964378|450615785|FG001|Overall Study|Disc. due to death before first dosing|1|||
125269704|NCT01964378|450615784|FG000|Overall Study|Disc. due to AE before first dosing|1|||
125269705|NCT01964378|450615785|FG001|Overall Study|Disc. due to AE before first dosing|0|||
125269706|NCT01964378|450615784|FG000|Overall Study|Death|3|||
125269707|NCT01964378|450615785|FG001|Overall Study|Death|2|||
125269708|NCT01964378|450615784|FG000|Overall Study|Adverse Event|12|||
125269709|NCT01964378|450615785|FG001|Overall Study|Adverse Event|5|||
125269710|NCT01964378|450615784|FG000|Overall Study|Lack of Efficacy|0|||
125269711|NCT01964378|450615785|FG001|Overall Study|Lack of Efficacy|1|||
125269712|NCT01964378|450615784|FG000|Overall Study|Protocol Violation|0|||
125269713|NCT01964378|450615785|FG001|Overall Study|Protocol Violation|1|||
125269714|NCT01964378|450615784|FG000|Overall Study|Lost to Follow-up|0|||
125269715|NCT01964378|450615785|FG001|Overall Study|Lost to Follow-up|1|||
125269716|NCT01964378|450615784|FG000|Overall Study|Withdrawal by Subject|7|||
125269717|NCT01964378|450615785|FG001|Overall Study|Withdrawal by Subject|5|||
125269718|NCT01964378|450615784|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
125269719|NCT01964378|450615785|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
125269720|NCT01964378|450615784|FG000|Overall Study|Other|1|||
125269721|NCT01964378|450615785|FG001|Overall Study|Other|2|||
125269722|NCT03542266|450615786|FG000|Treatment Phase|Withdrawal by Subject|1|||
125269723|NCT03542266|450615786|FG000|Treatment Phase|Adverse Event|1|||
125269724|NCT03542266|450615786|FG000|Treatment Phase|PD|1|||
125269725|NCT01162473|450615791|FG000|Overall Study|Adverse Event|2|||
125269726|NCT01162473|450615792|FG001|Overall Study|Adverse Event|1|||
125269727|NCT01162473|450615791|FG000|Overall Study|Withdrawal by Subject|0|||
125269728|NCT01162473|450615792|FG001|Overall Study|Withdrawal by Subject|4|||
125269729|NCT01392573|450615801|FG000|Overall Study|Adverse Event|1|||
125269730|NCT01392573|450615802|FG001|Overall Study|Adverse Event|3|||
125269731|NCT01392573|450615801|FG000|Overall Study|Lack of Efficacy|1|||
125269732|NCT01392573|450615802|FG001|Overall Study|Lack of Efficacy|2|||
125269733|NCT01392573|450615801|FG000|Overall Study|Protocol Violation|0|||
125269734|NCT01392573|450615802|FG001|Overall Study|Protocol Violation|2|||
125269735|NCT01392573|450615801|FG000|Overall Study|Withdrawal Criteria|13|||
125269736|NCT01392573|450615802|FG001|Overall Study|Withdrawal Criteria|15|||
125269737|NCT01392573|450615801|FG000|Overall Study|Site closure|8|||
125269738|NCT01392573|450615802|FG001|Overall Study|Site closure|7|||
125269739|NCT01392573|450615801|FG000|Overall Study|Unclassified|9|||
125269740|NCT01392573|450615802|FG001|Overall Study|Unclassified|6|||
125269741|NCT03008070|450615803|FG000|Overall Study|Adverse Event|3|||
125269742|NCT03008070|450615804|FG001|Overall Study|Adverse Event|3|||
125269743|NCT03008070|450615805|FG002|Overall Study|Adverse Event|3|||
125269744|NCT03008070|450615803|FG000|Overall Study|Lost to Follow-up|1|||
125269745|NCT03008070|450615804|FG001|Overall Study|Lost to Follow-up|1|||
125269746|NCT03008070|450615805|FG002|Overall Study|Lost to Follow-up|0|||
125269747|NCT03008070|450615803|FG000|Overall Study|Non compliance|0|||
125269748|NCT03008070|450615804|FG001|Overall Study|Non compliance|1|||
125269749|NCT03008070|450615805|FG002|Overall Study|Non compliance|1|||
125269750|NCT03008070|450615803|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
125269751|NCT03008070|450615804|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
125269752|NCT03008070|450615805|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
125269753|NCT03008070|450615803|FG000|Overall Study|Withdrawal by Subject|2|||
125269754|NCT03008070|450615804|FG001|Overall Study|Withdrawal by Subject|0|||
125269755|NCT03008070|450615805|FG002|Overall Study|Withdrawal by Subject|1|||
125269756|NCT03008070|450615803|FG000|Overall Study|Use of prohibited drug|0|||
125269757|NCT03008070|450615804|FG001|Overall Study|Use of prohibited drug|0|||
125269758|NCT03008070|450615805|FG002|Overall Study|Use of prohibited drug|2|||
125269759|NCT04409834|450615808|FG000|Overall Study|Death|55|||
125269760|NCT04409834|450615809|FG001|Overall Study|Death|62|||
125269761|NCT01365455|450615810|FG000|Induction Period|Adverse Event|5|||
125269762|NCT01365455|450615811|FG001|Induction Period|Adverse Event|3|||
125269763|NCT01365455|450615812|FG002|Induction Period|Adverse Event|4|||
125269764|NCT01365455|450615813|FG003|Induction Period|Adverse Event|0|||
125269765|NCT01365455|450615814|FG004|Induction Period|Adverse Event|0|||
125269766|NCT01365455|450615810|FG000|Induction Period|Lack of Efficacy|1|||
125269767|NCT01365455|450615811|FG001|Induction Period|Lack of Efficacy|1|||
125269768|NCT01365455|450615812|FG002|Induction Period|Lack of Efficacy|0|||
125269769|NCT01365455|450615813|FG003|Induction Period|Lack of Efficacy|0|||
125269770|NCT01365455|450615814|FG004|Induction Period|Lack of Efficacy|0|||
125269771|NCT01365455|450615810|FG000|Induction Period|Pregnancy|0|||
125269772|NCT01365455|450615811|FG001|Induction Period|Pregnancy|1|||
125269773|NCT01365455|450615812|FG002|Induction Period|Pregnancy|0|||
125269774|NCT01365455|450615813|FG003|Induction Period|Pregnancy|0|||
125269775|NCT01365455|450615814|FG004|Induction Period|Pregnancy|0|||
125269776|NCT01365455|450615810|FG000|Induction Period|Protocol deviation|0|||
125269777|NCT01365455|450615811|FG001|Induction Period|Protocol deviation|1|||
125269778|NCT01365455|450615812|FG002|Induction Period|Protocol deviation|1|||
125269779|NCT01365455|450615813|FG003|Induction Period|Protocol deviation|0|||
125269780|NCT01365455|450615814|FG004|Induction Period|Protocol deviation|0|||
125269781|NCT01365455|450615810|FG000|Induction Period|Subject/guardian decision|9|||
125269782|NCT01365455|450615811|FG001|Induction Period|Subject/guardian decision|1|||
125269783|NCT01365455|450615812|FG002|Induction Period|Subject/guardian decision|8|||
125269784|NCT01365455|450615813|FG003|Induction Period|Subject/guardian decision|0|||
125269785|NCT01365455|450615814|FG004|Induction Period|Subject/guardian decision|0|||
125269786|NCT01365455|450615810|FG000|Induction Period|Lost to Follow-up|0|||
125269787|NCT01365455|450615811|FG001|Induction Period|Lost to Follow-up|0|||
125269788|NCT01365455|450615812|FG002|Induction Period|Lost to Follow-up|3|||
125269789|NCT01365455|450615813|FG003|Induction Period|Lost to Follow-up|0|||
125269790|NCT01365455|450615814|FG004|Induction Period|Lost to Follow-up|0|||
125269791|NCT01365455|450615810|FG000|Maintenance Period|Adverse Event|12|||
125269792|NCT01365455|450615811|FG001|Maintenance Period|Adverse Event|5|||
125269793|NCT01365455|450615812|FG002|Maintenance Period|Adverse Event|1|||
125269794|NCT01365455|450615813|FG003|Maintenance Period|Adverse Event|2|||
125269795|NCT01365455|450615814|FG004|Maintenance Period|Adverse Event|4|||
125269796|NCT01365455|450615810|FG000|Maintenance Period|Lack of Efficacy|10|||
125269797|NCT01365455|450615811|FG001|Maintenance Period|Lack of Efficacy|2|||
125269798|NCT01365455|450615812|FG002|Maintenance Period|Lack of Efficacy|0|||
125269799|NCT01365455|450615813|FG003|Maintenance Period|Lack of Efficacy|2|||
125269800|NCT01365455|450615814|FG004|Maintenance Period|Lack of Efficacy|2|||
125269801|NCT01365455|450615810|FG000|Maintenance Period|Lost to Follow-up|2|||
125269802|NCT01365455|450615811|FG001|Maintenance Period|Lost to Follow-up|4|||
125269803|NCT01365455|450615812|FG002|Maintenance Period|Lost to Follow-up|0|||
125269804|NCT01365455|450615813|FG003|Maintenance Period|Lost to Follow-up|0|||
125269805|NCT01365455|450615814|FG004|Maintenance Period|Lost to Follow-up|3|||
125269806|NCT01365455|450615810|FG000|Maintenance Period|Non-compliance with study treatment|0|||
125269807|NCT01365455|450615811|FG001|Maintenance Period|Non-compliance with study treatment|0|||
125269808|NCT01365455|450615812|FG002|Maintenance Period|Non-compliance with study treatment|0|||
125269809|NCT01365455|450615813|FG003|Maintenance Period|Non-compliance with study treatment|1|||
125269810|NCT01365455|450615814|FG004|Maintenance Period|Non-compliance with study treatment|0|||
125269811|NCT01365455|450615810|FG000|Maintenance Period|Physician Decision|0|||
125269812|NCT01365455|450615811|FG001|Maintenance Period|Physician Decision|1|||
125269813|NCT01365455|450615812|FG002|Maintenance Period|Physician Decision|0|||
125269814|NCT01365455|450615813|FG003|Maintenance Period|Physician Decision|0|||
125269815|NCT01365455|450615814|FG004|Maintenance Period|Physician Decision|1|||
125269816|NCT01365455|450615810|FG000|Maintenance Period|Pregnancy|0|||
125269817|NCT01365455|450615811|FG001|Maintenance Period|Pregnancy|4|||
125269818|NCT01365455|450615812|FG002|Maintenance Period|Pregnancy|0|||
125269819|NCT01365455|450615813|FG003|Maintenance Period|Pregnancy|0|||
125269820|NCT01365455|450615814|FG004|Maintenance Period|Pregnancy|2|||
125269821|NCT01365455|450615810|FG000|Maintenance Period|Protocol deviation|1|||
125269822|NCT01365455|450615811|FG001|Maintenance Period|Protocol deviation|1|||
125269823|NCT01365455|450615812|FG002|Maintenance Period|Protocol deviation|0|||
125269824|NCT01365455|450615813|FG003|Maintenance Period|Protocol deviation|0|||
125269825|NCT01365455|450615814|FG004|Maintenance Period|Protocol deviation|0|||
125269826|NCT01365455|450615810|FG000|Maintenance Period|Subject/guardian decision|4|||
125269827|NCT01365455|450615811|FG001|Maintenance Period|Subject/guardian decision|6|||
125269828|NCT01365455|450615812|FG002|Maintenance Period|Subject/guardian decision|2|||
125269829|NCT01365455|450615813|FG003|Maintenance Period|Subject/guardian decision|4|||
125269830|NCT01365455|450615814|FG004|Maintenance Period|Subject/guardian decision|1|||
125269831|NCT00928187|450615815|FG000|Overall Study|Death|1|||
125269832|NCT00928187|450615816|FG001|Overall Study|Death|2|||
125269833|NCT00928187|450615817|FG002|Overall Study|Death|3|||
125269834|NCT00928187|450615815|FG000|Overall Study|Lost to Follow-up|1|||
125269835|NCT00928187|450615816|FG001|Overall Study|Lost to Follow-up|2|||
125269836|NCT00928187|450615817|FG002|Overall Study|Lost to Follow-up|1|||
125269837|NCT00928187|450615815|FG000|Overall Study|Withdrawal by Subject|0|||
125269838|NCT00928187|450615816|FG001|Overall Study|Withdrawal by Subject|1|||
125269839|NCT00928187|450615817|FG002|Overall Study|Withdrawal by Subject|1|||
125269840|NCT00928187|450615815|FG000|Overall Study|Protocol Violation|0|||
125269841|NCT00928187|450615816|FG001|Overall Study|Protocol Violation|1|||
125269842|NCT00928187|450615817|FG002|Overall Study|Protocol Violation|0|||
125269843|NCT01273038|450617412|FG000|Second Intervention (14 Days)|Adverse Event|0|||
125269844|NCT01273038|450617413|FG001|Second Intervention (14 Days)|Adverse Event|1|||
125269845|NCT01273038|450617412|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
125269846|NCT01273038|450617413|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
125269847|NCT01976299|450617414|FG000|Overall Study|Withdrawal by Subject|3|||
125269848|NCT01976299|450617415|FG001|Overall Study|Withdrawal by Subject|1|||
125269849|NCT01976299|450617414|FG000|Overall Study|Death|4|||
125269850|NCT01976299|450617415|FG001|Overall Study|Death|2|||
125269851|NCT01976299|450617414|FG000|Overall Study|Lost to Follow-up|7|||
125269852|NCT01976299|450617415|FG001|Overall Study|Lost to Follow-up|1|||
125269853|NCT01976299|450617414|FG000|Overall Study|See clarification above in comments|9|||
125269854|NCT01976299|450617415|FG001|Overall Study|See clarification above in comments|2|||
125269855|NCT00540592|450617418|FG000|Overall Study|Adverse Event|0|||
125269856|NCT00540592|450617419|FG001|Overall Study|Adverse Event|1|||
125269857|NCT00540592|450617420|FG002|Overall Study|Adverse Event|0|||
125269858|NCT00540592|450617421|FG003|Overall Study|Adverse Event|0|||
125269859|NCT00540592|450617422|FG004|Overall Study|Adverse Event|1|||
125269860|NCT00540592|450617423|FG005|Overall Study|Adverse Event|0|||
125269861|NCT00540592|450617424|FG006|Overall Study|Adverse Event|0|||
125269862|NCT00540592|450617425|FG007|Overall Study|Adverse Event|1|||
125269863|NCT00540592|450617426|FG008|Overall Study|Adverse Event|1|||
125269864|NCT00540592|450617427|FG009|Overall Study|Adverse Event|2|||
125269865|NCT00540592|450617418|FG000|Overall Study|Lost to Follow-up|2|||
125269866|NCT00540592|450617419|FG001|Overall Study|Lost to Follow-up|0|||
125269867|NCT00540592|450617420|FG002|Overall Study|Lost to Follow-up|0|||
125269868|NCT00540592|450617421|FG003|Overall Study|Lost to Follow-up|0|||
125269869|NCT00540592|450617422|FG004|Overall Study|Lost to Follow-up|0|||
125269870|NCT00540592|450617423|FG005|Overall Study|Lost to Follow-up|0|||
125269871|NCT00540592|450617424|FG006|Overall Study|Lost to Follow-up|0|||
125269872|NCT00540592|450617425|FG007|Overall Study|Lost to Follow-up|0|||
125269873|NCT00540592|450617426|FG008|Overall Study|Lost to Follow-up|0|||
125269874|NCT00540592|450617427|FG009|Overall Study|Lost to Follow-up|0|||
125269875|NCT00540592|450617418|FG000|Overall Study|Withdrawal by Subject|0|||
125269876|NCT00540592|450617419|FG001|Overall Study|Withdrawal by Subject|0|||
125269877|NCT00540592|450617420|FG002|Overall Study|Withdrawal by Subject|1|||
125269878|NCT00540592|450617421|FG003|Overall Study|Withdrawal by Subject|1|||
125269879|NCT00540592|450617422|FG004|Overall Study|Withdrawal by Subject|0|||
125269880|NCT00540592|450617423|FG005|Overall Study|Withdrawal by Subject|0|||
125269881|NCT00540592|450617424|FG006|Overall Study|Withdrawal by Subject|0|||
125269882|NCT00540592|450617425|FG007|Overall Study|Withdrawal by Subject|0|||
125269883|NCT00540592|450617426|FG008|Overall Study|Withdrawal by Subject|0|||
125269884|NCT00540592|450617427|FG009|Overall Study|Withdrawal by Subject|0|||
125269885|NCT01456130|450617428|FG000|Overall Study|Adverse Event|4|||
125269886|NCT01456130|450617428|FG000|Overall Study|Voluntary Withdrawal|1|||
125269887|NCT01456130|450617428|FG000|Overall Study|Lack of Efficacy|4|||
125269888|NCT01456130|450617428|FG000|Overall Study|Other|1|||
125269889|NCT02688192|450617433|FG000|Overall Study|Lost to Follow-up|11|||
125269890|NCT02688192|450617434|FG001|Overall Study|Lost to Follow-up|5|||
125269891|NCT02688192|450617433|FG000|Overall Study|Physician Decision|1|||
125269892|NCT02688192|450617434|FG001|Overall Study|Physician Decision|0|||
125269893|NCT05384834|450617435|FG000|Overall Study|Lost to Follow-up|43|||
125269894|NCT05384834|450617435|FG000|Overall Study|Withdrawal by Subject|5|||
125269895|NCT01282866|450617439|FG000|Overall Study|Adverse Event|1|||
125269896|NCT01299389|450617440|FG000|Double-blind|Adverse Event|45|||
125269897|NCT01299389|450617441|FG001|Double-blind|Adverse Event|27|||
125269898|NCT01299389|450617442|FG002|Double-blind|Adverse Event|0|||
125269899|NCT01299389|450617443|FG003|Double-blind|Adverse Event|0|||
125269900|NCT01299389|450617440|FG000|Double-blind|Lack of Efficacy|45|||
125269901|NCT01299389|450617441|FG001|Double-blind|Lack of Efficacy|21|||
125269902|NCT01299389|450617442|FG002|Double-blind|Lack of Efficacy|0|||
125269903|NCT01299389|450617443|FG003|Double-blind|Lack of Efficacy|0|||
125269904|NCT01299389|450617440|FG000|Double-blind|Lost to Follow-up|2|||
125269905|NCT01299389|450617441|FG001|Double-blind|Lost to Follow-up|1|||
125269906|NCT01299389|450617442|FG002|Double-blind|Lost to Follow-up|0|||
125269907|NCT01299389|450617443|FG003|Double-blind|Lost to Follow-up|0|||
125269908|NCT01299389|450617440|FG000|Double-blind|Withdrawal by Subject|16|||
125269909|NCT01299389|450617441|FG001|Double-blind|Withdrawal by Subject|13|||
125269910|NCT01299389|450617442|FG002|Double-blind|Withdrawal by Subject|0|||
125269911|NCT01299389|450617443|FG003|Double-blind|Withdrawal by Subject|0|||
125269912|NCT01299389|450617440|FG000|Double-blind|Other|1|||
125269913|NCT01299389|450617441|FG001|Double-blind|Other|1|||
125269914|NCT01299389|450617442|FG002|Double-blind|Other|0|||
125269915|NCT01299389|450617443|FG003|Double-blind|Other|0|||
125269916|NCT01299389|450617440|FG000|Double-blind|"fail to meet study population criteria"|0|||
125269917|NCT01299389|450617441|FG001|Double-blind|"fail to meet study population criteria"|1|||
125269918|NCT01299389|450617442|FG002|Double-blind|"fail to meet study population criteria"|0|||
125269919|NCT01299389|450617443|FG003|Double-blind|"fail to meet study population criteria"|0|||
125269920|NCT01299389|450617440|FG000|Post-observational|Other|0|||
125269921|NCT01299389|450617441|FG001|Post-observational|Other|0|||
125269922|NCT01299389|450617442|FG002|Post-observational|Other|12|||
125269923|NCT01299389|450617443|FG003|Post-observational|Other|6|||
125269924|NCT01151020|450617444|FG000|Overall Study|Death|25|||
125269925|NCT01151020|450617444|FG000|Overall Study|Conversion to open repair|1|||
125269926|NCT01151020|450617444|FG000|Overall Study|Lost to Follow-up|4|||
125269927|NCT01151020|450617444|FG000|Overall Study|Withdrawal by Subject|22|||
125269928|NCT01151020|450617444|FG000|Overall Study|Patients did not receive the device|2|||
125269929|NCT01635998|450617445|FG000|Overall Study|Death|1|||
125269930|NCT01635998|450617446|FG001|Overall Study|Death|1|||
125269931|NCT01635998|450617445|FG000|Overall Study|Lost to Follow-up|2|||
125269932|NCT01635998|450617446|FG001|Overall Study|Lost to Follow-up|1|||
125269933|NCT01635998|450617445|FG000|Overall Study|Withdrawal by Subject|1|||
125269934|NCT01635998|450617446|FG001|Overall Study|Withdrawal by Subject|5|||
125269935|NCT01220401|450617457|FG000|Overall Study|Withdrawal by Subject|2|||
125269936|NCT01220401|450617457|FG000|Overall Study|Protocol Violation|1|||
125269937|NCT03386435|450617460|FG000|Overall Study|Protocol Violation|5|||
125269938|NCT03386435|450617461|FG001|Overall Study|Protocol Violation|7|||
125269939|NCT00625586|450617462|FG000|Overall Study|Adverse Event|1|||
125269940|NCT00625586|450617462|FG000|Overall Study|Progressive disease|1|||
125269941|NCT00124072|450617465|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
125269942|NCT00124072|450617466|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
125269943|NCT00124072|450617467|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
125269944|NCT00124072|450617468|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
125269945|NCT00124072|450617465|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
125269946|NCT00124072|450617466|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
125269947|NCT00124072|450617467|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
125269948|NCT00124072|450617468|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
125269949|NCT00124072|450617465|FG000|Overall Study|Death|499|||
125269950|NCT00124072|450617466|FG001|Overall Study|Death|484|||
125269951|NCT00124072|450617467|FG002|Overall Study|Death|471|||
125269952|NCT00124072|450617468|FG003|Overall Study|Death|480|||
125269953|NCT02534883|450617469|FG000|Overall Study|Early Termination|8|||
125269954|NCT02534883|450617470|FG001|Overall Study|Early Termination|3|||
125269955|NCT00886769|450617471|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
125269956|NCT00886769|450617472|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
125269957|NCT03328832|450617473|FG000|Overall Study|Lost to Follow-up|0|||
125269958|NCT03328832|450617474|FG001|Overall Study|Lost to Follow-up|1|||
125269959|NCT00778336|450617477|FG000|Index Procedure-Discharge|Death|6|||
125269960|NCT00778336|450617478|FG001|Index Procedure-Discharge|Death|3|||
125269961|NCT00778336|450617479|FG002|Index Procedure-Discharge|Death|2|||
125269962|NCT00778336|450617480|FG003|Index Procedure-Discharge|Death|0|||
125269963|NCT00778336|450617477|FG000|3 Month Follow Up|Lost to Follow-up|15|||
125269964|NCT00778336|450617478|FG001|3 Month Follow Up|Lost to Follow-up|20|||
125269965|NCT00778336|450617479|FG002|3 Month Follow Up|Lost to Follow-up|3|||
125269966|NCT00778336|450617480|FG003|3 Month Follow Up|Lost to Follow-up|0|||
125269967|NCT00778336|450617477|FG000|3 Month Follow Up|Death|8|||
125269968|NCT00778336|450617478|FG001|3 Month Follow Up|Death|3|||
125269969|NCT00778336|450617479|FG002|3 Month Follow Up|Death|2|||
125269970|NCT00778336|450617480|FG003|3 Month Follow Up|Death|0|||
125269971|NCT00414076|450617481|FG000|Overall Study|Progression|1|||
125269972|NCT00414076|450617482|FG001|Overall Study|Progression|2|||
125269973|NCT00414076|450617481|FG000|Overall Study|Withdrawal by Subject|1|||
125269974|NCT00414076|450617482|FG001|Overall Study|Withdrawal by Subject|3|||
125269975|NCT00414076|450617481|FG000|Overall Study|Adverse Event|1|||
125269976|NCT00414076|450617482|FG001|Overall Study|Adverse Event|0|||
125269977|NCT00049257|450617483|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
125269978|NCT00049257|450617483|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
125269979|NCT00049257|450617483|FG000|Carboplatin, Paclitaxel|Death|2|||
125269980|NCT00049257|450617483|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
125269981|NCT04721158|450617484|FG000|Overall Study|Lost to Follow-up|4|||
125269982|NCT04721158|450617484|FG000|Overall Study|Device did not connect|1|||
125269983|NCT04872569|450617485|FG000|Overall Study|Withdrawal by Subject|2|||
125269984|NCT02382991|450617486|FG000|Overall Study|Adverse Event|1|||
125269985|NCT02382991|450617487|FG001|Overall Study|Adverse Event|2|||
125269986|NCT02382991|450617486|FG000|Overall Study|Lost to Follow-up|1|||
125269987|NCT02382991|450617487|FG001|Overall Study|Lost to Follow-up|0|||
125269988|NCT02382991|450617486|FG000|Overall Study|Withdrawal by Subject|0|||
125269989|NCT02382991|450617487|FG001|Overall Study|Withdrawal by Subject|1|||
125269990|NCT04466384|450617488|FG000|First Phase|Protocol Violation|1|||
125269991|NCT04466384|450617489|FG001|First Phase|Protocol Violation|0|||
125269992|NCT04466384|450617488|FG000|First Phase|Missing data|1|||
125269993|NCT04466384|450617489|FG001|First Phase|Missing data|0|||
125269994|NCT04466384|450617488|FG000|Cross Over Phase|Physician Decision|1|||
125269995|NCT04466384|450617489|FG001|Cross Over Phase|Physician Decision|0|||
125269996|NCT04466384|450617488|FG000|Cross Over Phase|Withdrawal by Subject|0|||
125269997|NCT04466384|450617489|FG001|Cross Over Phase|Withdrawal by Subject|1|||
125269998|NCT03666988|450617490|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
125269999|NCT03666988|450617491|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
125270000|NCT03666988|450617492|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
125270001|NCT03666988|450617493|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
125270002|NCT03666988|450617494|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
125270003|NCT03666988|450617495|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
125270004|NCT03666988|450617490|FG000|Part 1 (Up to 28 Months)|Other|0|||
125270005|NCT03666988|450617491|FG001|Part 1 (Up to 28 Months)|Other|1|||
125270006|NCT03666988|450617492|FG002|Part 1 (Up to 28 Months)|Other|1|||
125270007|NCT03666988|450617493|FG003|Part 1 (Up to 28 Months)|Other|0|||
125270008|NCT03666988|450617494|FG004|Part 1 (Up to 28 Months)|Other|0|||
125270009|NCT03666988|450617495|FG005|Part 1 (Up to 28 Months)|Other|0|||
125270010|NCT03666988|450617490|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
125270011|NCT03666988|450617491|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
125270012|NCT03666988|450617492|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
125270013|NCT03666988|450617493|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
125270014|NCT03666988|450617494|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
125270015|NCT03666988|450617495|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
125270016|NCT03666988|450617490|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
125270017|NCT03666988|450617491|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
125270018|NCT03666988|450617492|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
125270019|NCT03666988|450617493|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
125270020|NCT03666988|450617494|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
125270021|NCT03666988|450617495|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
125270022|NCT03666988|450617490|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
125270023|NCT03666988|450617491|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
125270024|NCT03666988|450617492|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
125270025|NCT03666988|450617493|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
125270026|NCT03666988|450617494|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
125270027|NCT03666988|450617495|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
125270028|NCT03554018|450617498|FG000|Overall Study|Lost to Follow-up|3|||
125270029|NCT03554018|450617499|FG001|Overall Study|Lost to Follow-up|7|||
125270030|NCT02891226|450617502|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
125270031|NCT02891226|450617503|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
125270032|NCT02891226|450617504|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
125270033|NCT02891226|450617505|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270034|NCT02891226|450617506|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270035|NCT02891226|450617507|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270036|NCT02891226|450617508|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270037|NCT02891226|450617509|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270038|NCT02891226|450617510|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270039|NCT02891226|450617511|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270040|NCT02891226|450617512|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270041|NCT02891226|450617513|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270042|NCT02891226|450617514|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270043|NCT02891226|450617515|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270044|NCT02891226|450617516|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270045|NCT02891226|450617517|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270046|NCT02891226|450617502|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
125270047|NCT02891226|450617503|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
125270048|NCT02891226|450617504|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270049|NCT02891226|450617505|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270050|NCT02891226|450617506|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270051|NCT02891226|450617507|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270052|NCT02891226|450617508|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270053|NCT02891226|450617509|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270054|NCT02891226|450617510|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270055|NCT02891226|450617511|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270056|NCT02891226|450617512|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270057|NCT02891226|450617513|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270058|NCT02891226|450617514|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270059|NCT02891226|450617515|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270060|NCT02891226|450617516|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270061|NCT02891226|450617517|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270062|NCT02891226|450617502|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270063|NCT02891226|450617503|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270064|NCT02891226|450617504|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270065|NCT02891226|450617505|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
125270066|NCT02891226|450617506|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270067|NCT02891226|450617507|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270068|NCT02891226|450617508|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270069|NCT02891226|450617509|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270070|NCT02891226|450617510|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270071|NCT02891226|450617511|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270072|NCT02891226|450617512|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270073|NCT02891226|450617513|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270074|NCT02891226|450617514|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270075|NCT02891226|450617515|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270076|NCT02891226|450617516|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270077|NCT02891226|450617517|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270078|NCT02891226|450617502|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270079|NCT02891226|450617503|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270080|NCT02891226|450617504|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
125270081|NCT02891226|450617505|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270082|NCT02891226|450617506|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270083|NCT02891226|450617507|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270084|NCT02891226|450617508|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270085|NCT02891226|450617509|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270086|NCT02891226|450617510|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270087|NCT02891226|450617511|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270088|NCT02891226|450617512|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270089|NCT02891226|450617513|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270090|NCT02891226|450617514|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270091|NCT02891226|450617515|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270092|NCT02891226|450617516|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270093|NCT02891226|450617517|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270094|NCT02891226|450617502|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270095|NCT02891226|450617503|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270096|NCT02891226|450617504|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270097|NCT02891226|450617505|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
125270098|NCT02891226|450617506|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270099|NCT02891226|450617507|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270100|NCT02891226|450617508|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270101|NCT02891226|450617509|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270102|NCT02891226|450617510|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270103|NCT02891226|450617511|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270104|NCT02891226|450617512|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270105|NCT02891226|450617513|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270106|NCT02891226|450617514|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270107|NCT02891226|450617515|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270108|NCT02891226|450617516|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270109|NCT02891226|450617517|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270110|NCT02891226|450617502|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270111|NCT02891226|450617503|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270112|NCT02891226|450617504|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270113|NCT02891226|450617505|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
125270114|NCT02891226|450617506|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270115|NCT02891226|450617507|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270116|NCT02891226|450617508|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270117|NCT02891226|450617509|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270118|NCT02891226|450617510|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270119|NCT02891226|450617511|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270120|NCT02891226|450617512|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270121|NCT02891226|450617513|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270122|NCT02891226|450617514|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270123|NCT02891226|450617515|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270124|NCT02891226|450617516|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270125|NCT02891226|450617517|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270126|NCT02891226|450617502|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270127|NCT02891226|450617503|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270128|NCT02891226|450617504|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270129|NCT02891226|450617505|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270130|NCT02891226|450617506|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270131|NCT02891226|450617507|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270132|NCT02891226|450617508|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
125270133|NCT02891226|450617509|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
125270134|NCT02891226|450617510|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
125270135|NCT02891226|450617511|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
125270136|NCT02891226|450617512|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270137|NCT02891226|450617513|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270138|NCT02891226|450617514|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270139|NCT02891226|450617515|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270140|NCT02891226|450617516|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270141|NCT02891226|450617517|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270142|NCT02891226|450617502|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270143|NCT02891226|450617503|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270144|NCT02891226|450617504|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270145|NCT02891226|450617505|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270146|NCT02891226|450617506|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270147|NCT02891226|450617507|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
125270148|NCT02891226|450617508|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270149|NCT02891226|450617509|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270150|NCT02891226|450617510|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270151|NCT02891226|450617511|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
125270152|NCT02891226|450617512|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270153|NCT02891226|450617513|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270154|NCT02891226|450617514|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270155|NCT02891226|450617515|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270156|NCT02891226|450617516|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270157|NCT02891226|450617517|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270158|NCT02891226|450617502|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270159|NCT02891226|450617503|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270160|NCT02891226|450617504|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270161|NCT02891226|450617505|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270162|NCT02891226|450617506|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270163|NCT02891226|450617507|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270164|NCT02891226|450617508|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
125270165|NCT02891226|450617509|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
125270166|NCT02891226|450617510|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
125270167|NCT02891226|450617511|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
125270168|NCT02891226|450617512|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270169|NCT02891226|450617513|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270170|NCT02891226|450617514|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270171|NCT02891226|450617515|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270172|NCT02891226|450617516|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270173|NCT02891226|450617517|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270174|NCT02891226|450617502|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270175|NCT02891226|450617503|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270176|NCT02891226|450617504|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270177|NCT02891226|450617505|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270178|NCT02891226|450617506|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
125270179|NCT02891226|450617507|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270180|NCT02891226|450617508|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270181|NCT02891226|450617509|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270182|NCT02891226|450617510|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270183|NCT02891226|450617511|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270184|NCT02891226|450617512|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270185|NCT02891226|450617513|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270186|NCT02891226|450617514|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270187|NCT02891226|450617515|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270188|NCT02891226|450617516|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270189|NCT02891226|450617517|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270190|NCT02891226|450617502|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270191|NCT02891226|450617503|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270192|NCT02891226|450617504|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270193|NCT02891226|450617505|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270194|NCT02891226|450617506|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270195|NCT02891226|450617507|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270196|NCT02891226|450617508|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
125270197|NCT02891226|450617509|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270198|NCT02891226|450617510|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270199|NCT02891226|450617511|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270200|NCT02891226|450617512|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270201|NCT02891226|450617513|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270202|NCT02891226|450617514|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270203|NCT02891226|450617515|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270204|NCT02891226|450617516|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270205|NCT02891226|450617517|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270206|NCT02891226|450617502|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270207|NCT02891226|450617503|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270208|NCT02891226|450617504|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270209|NCT02891226|450617505|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270210|NCT02891226|450617506|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270211|NCT02891226|450617507|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270212|NCT02891226|450617508|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270213|NCT02891226|450617509|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
125270214|NCT02891226|450617510|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
125270215|NCT02891226|450617511|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
125270216|NCT02891226|450617512|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270217|NCT02891226|450617513|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270218|NCT02891226|450617514|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270219|NCT02891226|450617515|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270220|NCT02891226|450617516|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270221|NCT02891226|450617517|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270222|NCT02891226|450617502|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270223|NCT02891226|450617503|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270224|NCT02891226|450617504|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270225|NCT02891226|450617505|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270226|NCT02891226|450617506|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270227|NCT02891226|450617507|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270228|NCT02891226|450617508|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270229|NCT02891226|450617509|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
125270230|NCT02891226|450617510|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270231|NCT02891226|450617511|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270232|NCT02891226|450617512|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270233|NCT02891226|450617513|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270234|NCT02891226|450617514|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270235|NCT02891226|450617515|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270236|NCT02891226|450617516|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270237|NCT02891226|450617517|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270238|NCT02891226|450617502|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270239|NCT02891226|450617503|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270240|NCT02891226|450617504|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270241|NCT02891226|450617505|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270242|NCT02891226|450617506|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270243|NCT02891226|450617507|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270244|NCT02891226|450617508|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270245|NCT02891226|450617509|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270246|NCT02891226|450617510|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
125270247|NCT02891226|450617511|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270248|NCT02891226|450617512|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270249|NCT02891226|450617513|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270250|NCT02891226|450617514|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270251|NCT02891226|450617515|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270252|NCT02891226|450617516|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270253|NCT02891226|450617517|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270254|NCT02891226|450617502|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270255|NCT02891226|450617503|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270256|NCT02891226|450617504|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270257|NCT02891226|450617505|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270258|NCT02891226|450617506|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270259|NCT02891226|450617507|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270260|NCT02891226|450617508|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270261|NCT02891226|450617509|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270262|NCT02891226|450617510|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270263|NCT02891226|450617511|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
125270264|NCT02891226|450617512|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270265|NCT02891226|450617513|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270266|NCT02891226|450617514|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270267|NCT02891226|450617515|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270268|NCT02891226|450617516|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270269|NCT02891226|450617517|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270270|NCT02891226|450617502|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270271|NCT02891226|450617503|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270272|NCT02891226|450617504|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270273|NCT02891226|450617505|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270274|NCT02891226|450617506|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270275|NCT02891226|450617507|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270276|NCT02891226|450617508|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270277|NCT02891226|450617509|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270278|NCT02891226|450617510|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270279|NCT02891226|450617511|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
125270280|NCT02891226|450617512|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270281|NCT02891226|450617513|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270282|NCT02891226|450617514|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270283|NCT02891226|450617515|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270284|NCT02891226|450617516|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270285|NCT02891226|450617517|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270286|NCT02891226|450617502|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270287|NCT02891226|450617503|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270288|NCT02891226|450617504|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270289|NCT02891226|450617505|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270290|NCT02891226|450617506|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270291|NCT02891226|450617507|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270292|NCT02891226|450617508|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270293|NCT02891226|450617509|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270294|NCT02891226|450617510|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270295|NCT02891226|450617511|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270296|NCT02891226|450617512|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
125270297|NCT02891226|450617513|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270298|NCT02891226|450617514|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270299|NCT02891226|450617515|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270300|NCT02891226|450617516|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270301|NCT02891226|450617517|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270302|NCT02891226|450617502|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270303|NCT02891226|450617503|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270304|NCT02891226|450617504|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270305|NCT02891226|450617505|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270306|NCT02891226|450617506|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270307|NCT02891226|450617507|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270308|NCT02891226|450617508|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270309|NCT02891226|450617509|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270310|NCT02891226|450617510|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270311|NCT02891226|450617511|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270312|NCT02891226|450617512|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
125270313|NCT02891226|450617513|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270314|NCT02891226|450617514|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270315|NCT02891226|450617515|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270316|NCT02891226|450617516|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270317|NCT02891226|450617517|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270318|NCT02891226|450617502|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270319|NCT02891226|450617503|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270320|NCT02891226|450617504|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270321|NCT02891226|450617505|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270322|NCT02891226|450617506|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270323|NCT02891226|450617507|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270324|NCT02891226|450617508|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270325|NCT02891226|450617509|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270326|NCT02891226|450617510|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270327|NCT02891226|450617511|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270328|NCT02891226|450617512|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
125270329|NCT02891226|450617513|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270330|NCT02891226|450617514|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270331|NCT02891226|450617515|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270332|NCT02891226|450617516|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270333|NCT02891226|450617517|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270334|NCT02891226|450617502|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270335|NCT02891226|450617503|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270336|NCT02891226|450617504|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270337|NCT02891226|450617505|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270338|NCT02891226|450617506|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270339|NCT02891226|450617507|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270340|NCT02891226|450617508|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270341|NCT02891226|450617509|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270342|NCT02891226|450617510|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270343|NCT02891226|450617511|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270344|NCT02891226|450617512|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
125270345|NCT02891226|450617513|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270346|NCT02891226|450617514|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270347|NCT02891226|450617515|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270348|NCT02891226|450617516|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270349|NCT02891226|450617517|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270350|NCT02891226|450617502|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270351|NCT02891226|450617503|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270352|NCT02891226|450617504|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270353|NCT02891226|450617505|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270354|NCT02891226|450617506|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270355|NCT02891226|450617507|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270356|NCT02891226|450617508|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270357|NCT02891226|450617509|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270358|NCT02891226|450617510|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270359|NCT02891226|450617511|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270360|NCT02891226|450617512|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
125270361|NCT02891226|450617513|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270362|NCT02891226|450617514|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270363|NCT02891226|450617515|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270364|NCT02891226|450617516|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270365|NCT02891226|450617517|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270366|NCT02891226|450617502|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270367|NCT02891226|450617503|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270368|NCT02891226|450617504|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270369|NCT02891226|450617505|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270370|NCT02891226|450617506|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270371|NCT02891226|450617507|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270372|NCT02891226|450617508|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270373|NCT02891226|450617509|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270374|NCT02891226|450617510|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270375|NCT02891226|450617511|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270376|NCT02891226|450617512|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
125270377|NCT02891226|450617513|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270378|NCT02891226|450617514|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270379|NCT02891226|450617515|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270380|NCT02891226|450617516|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270381|NCT02891226|450617517|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270382|NCT02891226|450617502|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270383|NCT02891226|450617503|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270384|NCT02891226|450617504|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270385|NCT02891226|450617505|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270386|NCT02891226|450617506|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270387|NCT02891226|450617507|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270388|NCT02891226|450617508|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270389|NCT02891226|450617509|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270390|NCT02891226|450617510|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270391|NCT02891226|450617511|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270392|NCT02891226|450617512|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
125270393|NCT02891226|450617513|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270394|NCT02891226|450617514|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270395|NCT02891226|450617515|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270396|NCT02891226|450617516|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270397|NCT02891226|450617517|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270398|NCT02891226|450617502|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270399|NCT02891226|450617503|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270400|NCT02891226|450617504|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270401|NCT02891226|450617505|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270402|NCT02891226|450617506|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270403|NCT02891226|450617507|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270404|NCT02891226|450617508|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270405|NCT02891226|450617509|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270406|NCT02891226|450617510|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270407|NCT02891226|450617511|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270408|NCT02891226|450617512|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
125270409|NCT02891226|450617513|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270410|NCT02891226|450617514|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270411|NCT02891226|450617515|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270412|NCT02891226|450617516|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270413|NCT02891226|450617517|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270414|NCT02891226|450617502|FG000|Follow-up Period|Withdrawal by Subject|0|||
125270415|NCT02891226|450617503|FG001|Follow-up Period|Withdrawal by Subject|0|||
125270416|NCT02891226|450617504|FG002|Follow-up Period|Withdrawal by Subject|0|||
125270417|NCT02891226|450617505|FG003|Follow-up Period|Withdrawal by Subject|0|||
125270418|NCT02891226|450617506|FG004|Follow-up Period|Withdrawal by Subject|0|||
125270419|NCT02891226|450617507|FG005|Follow-up Period|Withdrawal by Subject|0|||
125270420|NCT02891226|450617508|FG006|Follow-up Period|Withdrawal by Subject|0|||
125270421|NCT02891226|450617509|FG007|Follow-up Period|Withdrawal by Subject|0|||
125270422|NCT02891226|450617510|FG008|Follow-up Period|Withdrawal by Subject|0|||
125270423|NCT02891226|450617511|FG009|Follow-up Period|Withdrawal by Subject|0|||
125270424|NCT02891226|450617512|FG010|Follow-up Period|Withdrawal by Subject|0|||
125270425|NCT02891226|450617513|FG011|Follow-up Period|Withdrawal by Subject|1|||
125270426|NCT02891226|450617514|FG012|Follow-up Period|Withdrawal by Subject|0|||
125270427|NCT02891226|450617515|FG013|Follow-up Period|Withdrawal by Subject|0|||
125270428|NCT02891226|450617516|FG014|Follow-up Period|Withdrawal by Subject|1|||
125270429|NCT02891226|450617517|FG015|Follow-up Period|Withdrawal by Subject|1|||
125270430|NCT01928433|450617518|FG000|Overall Study|Adverse Event|5|||
125270431|NCT01928433|450617519|FG001|Overall Study|Adverse Event|2|||
125270432|NCT01928433|450617520|FG002|Overall Study|Adverse Event|5|||
125270433|NCT01928433|450617518|FG000|Overall Study|Protocol Violation|0|||
125270434|NCT01928433|450617519|FG001|Overall Study|Protocol Violation|0|||
125270435|NCT01928433|450617520|FG002|Overall Study|Protocol Violation|2|||
125270436|NCT01928433|450617518|FG000|Overall Study|Lack of Efficacy|5|||
125270437|NCT01928433|450617519|FG001|Overall Study|Lack of Efficacy|4|||
125270438|NCT01928433|450617520|FG002|Overall Study|Lack of Efficacy|4|||
125270439|NCT01928433|450617518|FG000|Overall Study|Withdrawal by Subject|0|||
125270440|NCT01928433|450617519|FG001|Overall Study|Withdrawal by Subject|4|||
125270441|NCT01928433|450617520|FG002|Overall Study|Withdrawal by Subject|0|||
125270442|NCT01928433|450617518|FG000|Overall Study|Negative screening urine culture|7|||
125270443|NCT01928433|450617519|FG001|Overall Study|Negative screening urine culture|6|||
125270444|NCT01928433|450617520|FG002|Overall Study|Negative screening urine culture|10|||
125270445|NCT01928433|450617518|FG000|Overall Study|Lost to Follow-up|0|||
125270446|NCT01928433|450617519|FG001|Overall Study|Lost to Follow-up|2|||
125270447|NCT01928433|450617520|FG002|Overall Study|Lost to Follow-up|3|||
125270448|NCT01928433|450617518|FG000|Overall Study|Other reasons|3|||
125270449|NCT01928433|450617519|FG001|Overall Study|Other reasons|3|||
125270450|NCT01928433|450617520|FG002|Overall Study|Other reasons|4|||
125270451|NCT00145626|450617521|FG000|Overall Study|Did not have NK infusions|2|||
125270452|NCT00145626|450617521|FG000|Overall Study|Turned 2 years old before treatment|1|||
125270453|NCT00145626|450617521|FG000|Overall Study|Death|1|||
125270454|NCT00145626|450617521|FG000|Overall Study|Withdrawal by Subject|1|||
125270455|NCT00436436|450617522|FG000|Overall Study|Progression|4|||
125270456|NCT00436436|450617522|FG000|Overall Study|Adverse Event|2|||
125270457|NCT00436436|450617522|FG000|Overall Study|Death|6|||
125270458|NCT03654274|450617527|FG000|Overall Study|Adverse Event|19|||
125270459|NCT03654274|450617528|FG001|Overall Study|Adverse Event|23|||
125270460|NCT03654274|450617529|FG002|Overall Study|Adverse Event|24|||
125270461|NCT03654274|450617527|FG000|Overall Study|Protocol Deviation|0|||
125270462|NCT03654274|450617528|FG001|Overall Study|Protocol Deviation|2|||
125270463|NCT03654274|450617529|FG002|Overall Study|Protocol Deviation|0|||
125270464|NCT03654274|450617527|FG000|Overall Study|Lost to Follow-up|8|||
125270465|NCT03654274|450617528|FG001|Overall Study|Lost to Follow-up|6|||
125270466|NCT03654274|450617529|FG002|Overall Study|Lost to Follow-up|5|||
125270467|NCT03654274|450617527|FG000|Overall Study|Withdrawal by Subject|46|||
125270468|NCT03654274|450617528|FG001|Overall Study|Withdrawal by Subject|25|||
125270469|NCT03654274|450617529|FG002|Overall Study|Withdrawal by Subject|33|||
125270470|NCT03654274|450617527|FG000|Overall Study|Lack of Efficacy|4|||
125270471|NCT03654274|450617528|FG001|Overall Study|Lack of Efficacy|5|||
125270472|NCT03654274|450617529|FG002|Overall Study|Lack of Efficacy|7|||
125270473|NCT03654274|450617527|FG000|Overall Study|Pregnancy|2|||
125270474|NCT03654274|450617528|FG001|Overall Study|Pregnancy|2|||
125270475|NCT03654274|450617529|FG002|Overall Study|Pregnancy|1|||
125270476|NCT03654274|450617527|FG000|Overall Study|Other|27|||
125270477|NCT03654274|450617528|FG001|Overall Study|Other|29|||
125270478|NCT03654274|450617529|FG002|Overall Study|Other|32|||
125270479|NCT03654274|450617527|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
125270480|NCT03654274|450617528|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
125270481|NCT03654274|450617529|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
125270482|NCT05005273|450617532|FG000|Overall Study|Study Terminated|1|||
125270483|NCT05005273|450617533|FG001|Overall Study|Study Terminated|0|||
125270484|NCT02151786|450617534|FG000|Overall Study|Unavailability of Case Report Form|26|||
125270485|NCT02151786|450617534|FG000|Overall Study|Outside the Contract Period|1|||
125270486|NCT02151786|450617534|FG000|Overall Study|Randomized, not Treated|1|||
125270487|NCT02151786|450617534|FG000|Overall Study|Unavailability of Information|8|||
125270488|NCT03533660|450617535|FG000|Overall Study|Withdrawal by Subject|2|||
125270489|NCT03533660|450617536|FG001|Overall Study|Withdrawal by Subject|2|||
125270490|NCT03533660|450617535|FG000|Overall Study|Death|2|||
125270491|NCT03533660|450617536|FG001|Overall Study|Death|4|||
125270492|NCT03533660|450617535|FG000|Overall Study|Adverse Event|0|||
125270493|NCT03533660|450617536|FG001|Overall Study|Adverse Event|2|||
125270494|NCT00996658|450617537|FG000|Overall Study|Adverse Event|2|||
125270495|NCT00996658|450617538|FG001|Overall Study|Adverse Event|5|||
125270496|NCT00996658|450617537|FG000|Overall Study|Protocol Violation|0|||
125270497|NCT00996658|450617538|FG001|Overall Study|Protocol Violation|1|||
125270498|NCT00996658|450617537|FG000|Overall Study|Lost to Follow-up|2|||
125270499|NCT00996658|450617538|FG001|Overall Study|Lost to Follow-up|5|||
125270500|NCT00996658|450617537|FG000|Overall Study|Non-compliance issues|3|||
125270501|NCT00996658|450617538|FG001|Overall Study|Non-compliance issues|3|||
125270502|NCT00996658|450617537|FG000|Overall Study|Other|9|||
125270503|NCT00996658|450617538|FG001|Overall Study|Other|7|||
125270504|NCT03154476|450617547|FG000|Overall Study|Lost to Follow-up|4|||
125270505|NCT03154476|450617548|FG001|Overall Study|Lost to Follow-up|4|||
125270506|NCT02685826|450617549|FG000|Overall Study|Adverse Event|2|||
125270507|NCT02685826|450617550|FG001|Overall Study|Adverse Event|0|||
125270508|NCT02685826|450617551|FG002|Overall Study|Adverse Event|1|||
125270509|NCT02685826|450617549|FG000|Overall Study|Progressive Disease|2|||
125270510|NCT02685826|450617550|FG001|Overall Study|Progressive Disease|1|||
125270511|NCT02685826|450617551|FG002|Overall Study|Progressive Disease|0|||
125270512|NCT02685826|450617549|FG000|Overall Study|Withdrawal by Subject|2|||
125270513|NCT02685826|450617550|FG001|Overall Study|Withdrawal by Subject|0|||
125270514|NCT02685826|450617551|FG002|Overall Study|Withdrawal by Subject|0|||
125270515|NCT02685826|450617549|FG000|Overall Study|Full Clinical Hold by FDA|19|||
125270516|NCT02685826|450617550|FG001|Overall Study|Full Clinical Hold by FDA|9|||
125270517|NCT02685826|450617551|FG002|Overall Study|Full Clinical Hold by FDA|20|||
125270518|NCT00200967|450617554|FG000|First Treatment Period|Withdrawal by Subject|5|||
125270519|NCT00200967|450617555|FG001|First Treatment Period|Withdrawal by Subject|1|||
125270520|NCT00200967|450617554|FG000|First Treatment Period|Pregnancy|1|||
125270521|NCT00200967|450617555|FG001|First Treatment Period|Pregnancy|0|||
125270522|NCT00200967|450617554|FG000|Wash-out Period|Lost to Follow-up|0|||
125270523|NCT00200967|450617555|FG001|Wash-out Period|Lost to Follow-up|1|||
125270524|NCT00200967|450617554|FG000|Second Treatment Period|Withdrawal by Subject|1|||
125270525|NCT00200967|450617555|FG001|Second Treatment Period|Withdrawal by Subject|2|||
125270526|NCT00200967|450617554|FG000|Run-out Period|Lost to Follow-up|1|||
125270527|NCT00200967|450617555|FG001|Run-out Period|Lost to Follow-up|0|||
125270528|NCT01444430|450617558|FG000|Overall Study|Withdrawal by Subject|53|||
125270529|NCT01444430|450617559|FG001|Overall Study|Withdrawal by Subject|72|||
125270530|NCT01444430|450617558|FG000|Overall Study|Death|6|||
125270531|NCT01444430|450617559|FG001|Overall Study|Death|8|||
125270532|NCT01444430|450617558|FG000|Overall Study|Lost to Follow-up|2|||
125270533|NCT01444430|450617559|FG001|Overall Study|Lost to Follow-up|0|||
125270534|NCT01444430|450617558|FG000|Overall Study|CRF termination module not completed.|0|||
125270535|NCT01444430|450617559|FG001|Overall Study|CRF termination module not completed.|1|||
125270536|NCT00662831|450618973|FG000|Overall Study|Death|4|||
125270537|NCT00662831|450618974|FG001|Overall Study|Death|1|||
125270538|NCT00662831|450618973|FG000|Overall Study|Lack of Efficacy|6|||
125270539|NCT00662831|450618974|FG001|Overall Study|Lack of Efficacy|6|||
125270540|NCT00662831|450618973|FG000|Overall Study|Lost to Follow-up|1|||
125270541|NCT00662831|450618974|FG001|Overall Study|Lost to Follow-up|0|||
125270542|NCT00662831|450618973|FG000|Overall Study|Withdrawal by Subject|2|||
125270543|NCT00662831|450618974|FG001|Overall Study|Withdrawal by Subject|1|||
125270544|NCT00662831|450618973|FG000|Overall Study|Other|62|||
125270545|NCT00662831|450618974|FG001|Overall Study|Other|31|||
125270546|NCT00662831|450618973|FG000|Overall Study|Protocol Violation|8|||
125270547|NCT00662831|450618974|FG001|Overall Study|Protocol Violation|4|||
125270548|NCT00662831|450618973|FG000|Overall Study|Adverse Event|23|||
125270549|NCT00662831|450618974|FG001|Overall Study|Adverse Event|16|||
125270550|NCT01061723|450618976|FG000|Overall Study|Adverse Event|0|||
125270551|NCT01061723|450618977|FG001|Overall Study|Adverse Event|2|||
125270552|NCT01061723|450618978|FG002|Overall Study|Adverse Event|5|||
125270553|NCT01061723|450618979|FG003|Overall Study|Adverse Event|5|||
125270554|NCT01061723|450618980|FG004|Overall Study|Adverse Event|2|||
125270555|NCT01061723|450618981|FG005|Overall Study|Adverse Event|6|||
125270556|NCT01061723|450618976|FG000|Overall Study|Lack of Efficacy|2|||
125270557|NCT01061723|450618977|FG001|Overall Study|Lack of Efficacy|3|||
125270558|NCT01061723|450618978|FG002|Overall Study|Lack of Efficacy|4|||
125270559|NCT01061723|450618979|FG003|Overall Study|Lack of Efficacy|2|||
125270560|NCT01061723|450618980|FG004|Overall Study|Lack of Efficacy|1|||
125270561|NCT01061723|450618981|FG005|Overall Study|Lack of Efficacy|1|||
125270562|NCT01061723|450618976|FG000|Overall Study|Randomized but not treated|0|||
125270563|NCT01061723|450618977|FG001|Overall Study|Randomized but not treated|0|||
125270564|NCT01061723|450618978|FG002|Overall Study|Randomized but not treated|0|||
125270565|NCT01061723|450618979|FG003|Overall Study|Randomized but not treated|0|||
125270566|NCT01061723|450618980|FG004|Overall Study|Randomized but not treated|0|||
125270567|NCT01061723|450618981|FG005|Overall Study|Randomized but not treated|1|||
125270568|NCT01061723|450618976|FG000|Overall Study|Other than specified above|2|||
125270569|NCT01061723|450618977|FG001|Overall Study|Other than specified above|1|||
125270570|NCT01061723|450618978|FG002|Overall Study|Other than specified above|1|||
125270571|NCT01061723|450618979|FG003|Overall Study|Other than specified above|1|||
125270572|NCT01061723|450618980|FG004|Overall Study|Other than specified above|0|||
125270573|NCT01061723|450618981|FG005|Overall Study|Other than specified above|1|||
125270574|NCT04245449|450618985|FG000|Overall Study|COVID shutdown|7|||
125270575|NCT01147393|450618988|FG000|Dose Level 1|Dose limiting Toxicity|2|||
125270576|NCT01147393|450618988|FG000|Dose Level -1|Dose Limited Toxicity|1|||
125270577|NCT01408277|450618992|FG000|Overall Study|Adverse Event|3|||
125270578|NCT01408277|450618993|FG001|Overall Study|Adverse Event|4|||
125270579|NCT01408277|450618992|FG000|Overall Study|Lost to Follow-up|1|||
125270580|NCT01408277|450618993|FG001|Overall Study|Lost to Follow-up|0|||
125270581|NCT01408277|450618992|FG000|Overall Study|Withdrawal by Subject|2|||
125270582|NCT01408277|450618993|FG001|Overall Study|Withdrawal by Subject|0|||
125270583|NCT01408277|450618992|FG000|Overall Study|Protocol Violation|2|||
125270584|NCT01408277|450618993|FG001|Overall Study|Protocol Violation|0|||
125270585|NCT03801928|450618996|FG000|Overall Study|Adverse Event|1|||
125270586|NCT03801928|450618997|FG001|Overall Study|Adverse Event|0|||
125270587|NCT03801928|450618998|FG002|Overall Study|Adverse Event|1|||
125270588|NCT03801928|450618999|FG003|Overall Study|Adverse Event|2|||
125270589|NCT03801928|450619000|FG004|Overall Study|Adverse Event|0|||
125270590|NCT03801928|450619001|FG005|Overall Study|Adverse Event|2|||
125270591|NCT03801928|450618996|FG000|Overall Study|Lack of Efficacy|0|||
125270592|NCT03801928|450618997|FG001|Overall Study|Lack of Efficacy|0|||
125270593|NCT03801928|450618998|FG002|Overall Study|Lack of Efficacy|1|||
125270594|NCT03801928|450618999|FG003|Overall Study|Lack of Efficacy|0|||
125270595|NCT03801928|450619000|FG004|Overall Study|Lack of Efficacy|0|||
125270596|NCT03801928|450619001|FG005|Overall Study|Lack of Efficacy|0|||
125270597|NCT03801928|450618996|FG000|Overall Study|Lost to Follow-up|5|||
125270598|NCT03801928|450618997|FG001|Overall Study|Lost to Follow-up|1|||
125270599|NCT03801928|450618998|FG002|Overall Study|Lost to Follow-up|1|||
125270600|NCT03801928|450618999|FG003|Overall Study|Lost to Follow-up|4|||
125270601|NCT03801928|450619000|FG004|Overall Study|Lost to Follow-up|4|||
125270602|NCT03801928|450619001|FG005|Overall Study|Lost to Follow-up|2|||
125270603|NCT03801928|450618996|FG000|Overall Study|Withdrawal by Subject|0|||
125270604|NCT03801928|450618997|FG001|Overall Study|Withdrawal by Subject|0|||
125270605|NCT03801928|450618998|FG002|Overall Study|Withdrawal by Subject|2|||
125270606|NCT03801928|450618999|FG003|Overall Study|Withdrawal by Subject|1|||
125270607|NCT03801928|450619000|FG004|Overall Study|Withdrawal by Subject|0|||
125270608|NCT03801928|450619001|FG005|Overall Study|Withdrawal by Subject|0|||
125270609|NCT03801928|450618996|FG000|Overall Study|Other|0|||
125270610|NCT03801928|450618997|FG001|Overall Study|Other|2|||
125270611|NCT03801928|450618998|FG002|Overall Study|Other|0|||
125270612|NCT03801928|450618999|FG003|Overall Study|Other|1|||
125270613|NCT03801928|450619000|FG004|Overall Study|Other|0|||
125270614|NCT03801928|450619001|FG005|Overall Study|Other|1|||
125270615|NCT04263766|450619002|FG000|Overall Study|Withdrawal by Subject|6|||
125270616|NCT04263766|450619003|FG001|Overall Study|Withdrawal by Subject|4|||
125270617|NCT04263766|450619002|FG000|Overall Study|Lack of Efficacy|1|||
125270618|NCT04263766|450619003|FG001|Overall Study|Lack of Efficacy|3|||
125270619|NCT03369665|450619005|FG000|Overall Study|Adverse Event|3|||
125270620|NCT03369665|450619005|FG000|Overall Study|Lost to Follow-up|7|||
125270621|NCT03369665|450619005|FG000|Overall Study|Withdrawal by Subject|15|||
125270622|NCT03369665|450619005|FG000|Overall Study|Progression Disease|2|||
125270623|NCT03369665|450619005|FG000|Overall Study|Not classified|3|||
125270624|NCT02553928|450619006|FG000|Overall Study|Adverse Event|2|||
125270625|NCT02553928|450619007|FG001|Overall Study|Adverse Event|1|||
125270626|NCT02553928|450619006|FG000|Overall Study|Lost to Follow-up|0|||
125270627|NCT02553928|450619007|FG001|Overall Study|Lost to Follow-up|1|||
125270628|NCT02553928|450619006|FG000|Overall Study|Administrative reason(s)|0|||
125270629|NCT02553928|450619007|FG001|Overall Study|Administrative reason(s)|1|||
125270630|NCT03230318|450619008|FG000|Overall Study|Radiographic disease progression|72|||
125270631|NCT03230318|450619009|FG001|Overall Study|Radiographic disease progression|19|||
125270632|NCT03230318|450619008|FG000|Overall Study|Clinical progression|17|||
125270633|NCT03230318|450619009|FG001|Overall Study|Clinical progression|7|||
125270634|NCT03230318|450619008|FG000|Overall Study|Adverse Event|5|||
125270635|NCT03230318|450619009|FG001|Overall Study|Adverse Event|3|||
125270636|NCT03230318|450619008|FG000|Overall Study|Physician Decision|2|||
125270637|NCT03230318|450619009|FG001|Overall Study|Physician Decision|3|||
125270638|NCT03230318|450619008|FG000|Overall Study|Death|3|||
125270639|NCT03230318|450619009|FG001|Overall Study|Death|2|||
125270640|NCT03230318|450619008|FG000|Overall Study|Lost to Follow-up|1|||
125270641|NCT03230318|450619009|FG001|Overall Study|Lost to Follow-up|0|||
125270642|NCT03230318|450619008|FG000|Overall Study|Withdrawal by Subject|1|||
125270643|NCT03230318|450619009|FG001|Overall Study|Withdrawal by Subject|3|||
125270644|NCT03230318|450619008|FG000|Overall Study|Other|3|||
125270645|NCT03230318|450619009|FG001|Overall Study|Other|7|||
125270646|NCT00075764|450619016|FG000|Overall Study|Adverse Event|5|||
125270647|NCT00075764|450619017|FG001|Overall Study|Adverse Event|12|||
125270648|NCT00075764|450619016|FG000|Overall Study|Death|4|||
125270649|NCT00075764|450619017|FG001|Overall Study|Death|8|||
125270650|NCT00075764|450619016|FG000|Overall Study|Withdrawal by Subject|28|||
125270651|NCT00075764|450619017|FG001|Overall Study|Withdrawal by Subject|18|||
125270652|NCT00075764|450619016|FG000|Overall Study|Progression|269|||
125270653|NCT00075764|450619017|FG001|Overall Study|Progression|274|||
125270654|NCT00075764|450619016|FG000|Overall Study|Still on treatment|8|||
125270655|NCT00075764|450619017|FG001|Overall Study|Still on treatment|15|||
125270656|NCT00075764|450619016|FG000|Overall Study|Delinquent|4|||
125270657|NCT00075764|450619017|FG001|Overall Study|Delinquent|2|||
125270658|NCT00075764|450619016|FG000|Overall Study|Not protocol specified|27|||
125270659|NCT00075764|450619017|FG001|Overall Study|Not protocol specified|19|||
125270660|NCT00075764|450619016|FG000|Overall Study|Under review|0|||
125270661|NCT00075764|450619017|FG001|Overall Study|Under review|1|||
125270662|NCT02817594|450619018|FG000|Overall Study|Withdrawal by Subject|1|||
125270663|NCT02817594|450619018|FG000|Overall Study|Other|1|||
125270664|NCT02817594|450619018|FG000|Overall Study|Did Not Receive Treatment|1|||
125270665|NCT02010593|450619019|FG000|Overall Study|Lost to Follow-up|1|||
125270666|NCT02010593|450619020|FG001|Overall Study|Lost to Follow-up|0|||
125270667|NCT02010593|450619019|FG000|Overall Study|Physician Decision|1|||
125270668|NCT02010593|450619020|FG001|Overall Study|Physician Decision|0|||
125270669|NCT02010593|450619019|FG000|Overall Study|Unable to adhere to visit schedule|0|||
125270670|NCT02010593|450619020|FG001|Overall Study|Unable to adhere to visit schedule|2|||
125270671|NCT01773967|450619021|FG000|Overall Study|Lost to Follow-up|15|||
125270672|NCT01773967|450619022|FG001|Overall Study|Lost to Follow-up|13|||
125270673|NCT01135459|450619023|FG000|Overall Study|Adverse Event|8|||
125270674|NCT01135459|450619024|FG001|Overall Study|Adverse Event|10|||
125270675|NCT01135459|450619023|FG000|Overall Study|Lack of Efficacy|3|||
125270676|NCT01135459|450619024|FG001|Overall Study|Lack of Efficacy|1|||
125270677|NCT01135459|450619023|FG000|Overall Study|Withdrawal by Subject|2|||
125270678|NCT01135459|450619024|FG001|Overall Study|Withdrawal by Subject|3|||
125270679|NCT01135459|450619023|FG000|Overall Study|Protocol Violation|5|||
125270680|NCT01135459|450619024|FG001|Overall Study|Protocol Violation|3|||
125270681|NCT01135459|450619023|FG000|Overall Study|Lost to Follow-up|2|||
125270682|NCT01135459|450619024|FG001|Overall Study|Lost to Follow-up|1|||
125270683|NCT01135459|450619023|FG000|Overall Study|Non-compliance to study procedures|0|||
125270684|NCT01135459|450619024|FG001|Overall Study|Non-compliance to study procedures|1|||
125270685|NCT01135459|450619023|FG000|Overall Study|Other than specified|1|||
125270686|NCT01135459|450619024|FG001|Overall Study|Other than specified|1|||
125270687|NCT01766037|450619025|FG000|Overall Study|Adverse Event|1|||
125270688|NCT01766037|450619026|FG001|Overall Study|Adverse Event|0|||
125270689|NCT01766037|450619025|FG000|Overall Study|Lack of Efficacy|1|||
125270690|NCT01766037|450619026|FG001|Overall Study|Lack of Efficacy|0|||
125270691|NCT01766037|450619025|FG000|Overall Study|Lost to Follow-up|0|||
125270692|NCT01766037|450619026|FG001|Overall Study|Lost to Follow-up|10|||
125270693|NCT01766037|450619025|FG000|Overall Study|Physician Decision|0|||
125270694|NCT01766037|450619026|FG001|Overall Study|Physician Decision|1|||
125270695|NCT01766037|450619025|FG000|Overall Study|Withdrawal by Subject|18|||
125270696|NCT01766037|450619026|FG001|Overall Study|Withdrawal by Subject|16|||
125270697|NCT01766037|450619025|FG000|Overall Study|Moved from area|5|||
125270698|NCT01766037|450619026|FG001|Overall Study|Moved from area|0|||
125270699|NCT01766037|450619025|FG000|Overall Study|medical - unrelated|1|||
125270700|NCT01766037|450619026|FG001|Overall Study|medical - unrelated|2|||
125270701|NCT01766037|450619025|FG000|Overall Study|nausea / discomfort|3|||
125270702|NCT01766037|450619026|FG001|Overall Study|nausea / discomfort|0|||
125270703|NCT02413996|450619027|FG000|Overall Study|not comfortable with the intervention|9|||
125270704|NCT02413996|450619028|FG001|Overall Study|not comfortable with the intervention|2|||
125270705|NCT01672879|450619029|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
125270706|NCT01672879|450619030|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
125270707|NCT01672879|450619031|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
125270708|NCT01672879|450619029|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
125270709|NCT01672879|450619030|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
125270710|NCT01672879|450619031|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
125270711|NCT01672879|450619029|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
125270712|NCT01672879|450619030|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
125270713|NCT01672879|450619031|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
125270714|NCT01672879|450619029|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
125270715|NCT01672879|450619030|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
125270716|NCT01672879|450619031|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
125270717|NCT01672879|450619029|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
125270718|NCT01672879|450619030|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
125270719|NCT01672879|450619031|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
125270720|NCT01672879|450619029|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
125270721|NCT01672879|450619030|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
125270722|NCT01672879|450619031|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
125270723|NCT01672879|450619029|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
125270724|NCT01672879|450619030|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
125270725|NCT01672879|450619031|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
125270726|NCT01672879|450619029|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
125270727|NCT01672879|450619030|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
125270728|NCT01672879|450619031|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
125270729|NCT01672879|450619029|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
125270730|NCT01672879|450619030|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
125270731|NCT01672879|450619031|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
125270732|NCT01672879|450619029|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
125270733|NCT01672879|450619030|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
125270734|NCT01672879|450619031|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
125270735|NCT01672879|450619029|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
125270736|NCT01672879|450619030|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
125270737|NCT01672879|450619031|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
125270738|NCT01672879|450619029|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
125270739|NCT01672879|450619030|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
125270740|NCT01672879|450619031|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
125270741|NCT01672879|450619029|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
125270742|NCT01672879|450619030|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
125270743|NCT01672879|450619031|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
125270744|NCT01871545|450619032|FG000|Overall Study|Death|2|||
125270745|NCT01871545|450619033|FG001|Overall Study|Death|0|||
125270746|NCT01871545|450619032|FG000|Overall Study|Lack of Efficacy|11|||
125270747|NCT01871545|450619033|FG001|Overall Study|Lack of Efficacy|2|||
125270748|NCT01871545|450619032|FG000|Overall Study|Physician Decision|4|||
125270749|NCT01871545|450619033|FG001|Overall Study|Physician Decision|0|||
125270750|NCT01871545|450619032|FG000|Overall Study|Withdrawal by Subject|0|||
125270751|NCT01871545|450619033|FG001|Overall Study|Withdrawal by Subject|1|||
125270752|NCT04834726|450619036|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
125270753|NCT04834726|450619037|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
125270754|NCT04834726|450619038|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
125270755|NCT04834726|450619039|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
125270756|NCT04834726|450619040|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
125270757|NCT04834726|450619041|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
125270758|NCT04834726|450619042|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
125270759|NCT04834726|450619043|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
125270760|NCT04834726|450619044|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
125270761|NCT02948582|450619047|FG000|Washout Period 1|Adverse Event|0|||
125270762|NCT02948582|450619048|FG001|Washout Period 1|Adverse Event|2|||
125270763|NCT02948582|450619049|FG002|Washout Period 1|Adverse Event|0|||
125270764|NCT02948582|450619050|FG003|Washout Period 1|Adverse Event|0|||
125270765|NCT02948582|450619051|FG004|Washout Period 1|Adverse Event|0|||
125270766|NCT02948582|450619052|FG005|Washout Period 1|Adverse Event|0|||
125270767|NCT02948582|450619047|FG000|Washout Period 1|Protocol Violation|0|||
125270768|NCT02948582|450619048|FG001|Washout Period 1|Protocol Violation|0|||
125270769|NCT02948582|450619049|FG002|Washout Period 1|Protocol Violation|0|||
125270770|NCT02948582|450619050|FG003|Washout Period 1|Protocol Violation|0|||
125270771|NCT02948582|450619051|FG004|Washout Period 1|Protocol Violation|0|||
125270772|NCT02948582|450619052|FG005|Washout Period 1|Protocol Violation|1|||
125270773|NCT02948582|450619047|FG000|Washout Period 2|Adverse Event|0|||
125270774|NCT02948582|450619048|FG001|Washout Period 2|Adverse Event|1|||
125270775|NCT02948582|450619049|FG002|Washout Period 2|Adverse Event|0|||
125270776|NCT02948582|450619050|FG003|Washout Period 2|Adverse Event|0|||
125270777|NCT02948582|450619051|FG004|Washout Period 2|Adverse Event|0|||
125270778|NCT02948582|450619052|FG005|Washout Period 2|Adverse Event|0|||
125270779|NCT02948582|450619047|FG000|Washout Period 2|personal reasons|0|||
125270780|NCT02948582|450619048|FG001|Washout Period 2|personal reasons|0|||
125270781|NCT02948582|450619049|FG002|Washout Period 2|personal reasons|0|||
125270782|NCT02948582|450619050|FG003|Washout Period 2|personal reasons|1|||
125270783|NCT02948582|450619051|FG004|Washout Period 2|personal reasons|0|||
125270784|NCT02948582|450619052|FG005|Washout Period 2|personal reasons|0|||
125270785|NCT02948582|450619047|FG000|Washout Period 4|Adverse Event|1|||
125270786|NCT02948582|450619048|FG001|Washout Period 4|Adverse Event|0|||
125270787|NCT02948582|450619049|FG002|Washout Period 4|Adverse Event|1|||
125270788|NCT02948582|450619050|FG003|Washout Period 4|Adverse Event|0|||
125270789|NCT02948582|450619051|FG004|Washout Period 4|Adverse Event|0|||
125270790|NCT02948582|450619052|FG005|Washout Period 4|Adverse Event|0|||
125270791|NCT03810014|450619053|FG000|Overall Study|Pregnancy|2|||
125270792|NCT03810014|450619054|FG001|Overall Study|Pregnancy|2|||
125270793|NCT03810014|450619055|FG002|Overall Study|Pregnancy|0|||
125270794|NCT03810014|450619056|FG003|Overall Study|Pregnancy|2|||
125270795|NCT01853462|450619060|FG000|Overall Study|Withdrawal by Subject|1|||
125270796|NCT01853462|450619061|FG001|Overall Study|Withdrawal by Subject|1|||
125270797|NCT02148263|450619062|FG000|Overall Study|Withdrawal by Subject|3|||
125270798|NCT02148263|450619063|FG001|Overall Study|Withdrawal by Subject|2|||
125270799|NCT00132301|450619064|FG000|Overall Study|Death|7|||
125270800|NCT00132301|450619065|FG001|Overall Study|Death|6|||
125270801|NCT00132301|450619064|FG000|Overall Study|Withdrawal by Subject|5|||
125270802|NCT00132301|450619065|FG001|Overall Study|Withdrawal by Subject|2|||
125270803|NCT00132301|450619064|FG000|Overall Study|Physician Decision|1|||
125270804|NCT00132301|450619065|FG001|Overall Study|Physician Decision|1|||
125270805|NCT00132301|450619064|FG000|Overall Study|Lost to Follow-up|5|||
125270806|NCT00132301|450619065|FG001|Overall Study|Lost to Follow-up|3|||
125270807|NCT00132301|450619064|FG000|Overall Study|Other|1|||
125270808|NCT00132301|450619065|FG001|Overall Study|Other|1|||
125270809|NCT00132301|450619064|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
125270810|NCT00132301|450619065|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
125270811|NCT02012218|450619066|FG000|Overall Study|Withdrawal by Subject|1|||
125270812|NCT02012218|450619067|FG001|Overall Study|Withdrawal by Subject|0|||
125270813|NCT02012218|450619068|FG002|Overall Study|Withdrawal by Subject|1|||
125270814|NCT02012218|450619069|FG003|Overall Study|Withdrawal by Subject|1|||
125270815|NCT02012218|450619070|FG004|Overall Study|Withdrawal by Subject|1|||
125270816|NCT02012218|450619066|FG000|Overall Study|Adverse Event|1|||
125270817|NCT02012218|450619067|FG001|Overall Study|Adverse Event|0|||
125270818|NCT02012218|450619068|FG002|Overall Study|Adverse Event|0|||
125270819|NCT02012218|450619069|FG003|Overall Study|Adverse Event|1|||
125270820|NCT02012218|450619070|FG004|Overall Study|Adverse Event|0|||
125270821|NCT02012218|450619066|FG000|Overall Study|Lost to Follow-up|0|||
125270822|NCT02012218|450619067|FG001|Overall Study|Lost to Follow-up|1|||
125270823|NCT02012218|450619068|FG002|Overall Study|Lost to Follow-up|1|||
125270824|NCT02012218|450619069|FG003|Overall Study|Lost to Follow-up|0|||
125270825|NCT02012218|450619070|FG004|Overall Study|Lost to Follow-up|0|||
125270826|NCT02012218|450619066|FG000|Overall Study|Protocol Specified|1|||
125270827|NCT02012218|450619067|FG001|Overall Study|Protocol Specified|0|||
125270828|NCT02012218|450619068|FG002|Overall Study|Protocol Specified|0|||
125270829|NCT02012218|450619069|FG003|Overall Study|Protocol Specified|0|||
125270830|NCT02012218|450619070|FG004|Overall Study|Protocol Specified|0|||
125270831|NCT02012218|450619066|FG000|Overall Study|Protocol Deviation|1|||
125270832|NCT02012218|450619067|FG001|Overall Study|Protocol Deviation|0|||
125270833|NCT02012218|450619068|FG002|Overall Study|Protocol Deviation|0|||
125270834|NCT02012218|450619069|FG003|Overall Study|Protocol Deviation|0|||
125270835|NCT02012218|450619070|FG004|Overall Study|Protocol Deviation|0|||
125270836|NCT02720523|450619076|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
125270837|NCT02720523|450619077|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
125270838|NCT02720523|450619078|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
125270839|NCT02720523|450619079|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
125270840|NCT02720523|450619080|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
125270841|NCT02720523|450619081|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
125270842|NCT02720523|450619082|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
125270843|NCT02720523|450619076|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
125270844|NCT02720523|450619077|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
125270845|NCT02720523|450619078|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
125270846|NCT02720523|450619079|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
125270847|NCT02720523|450619080|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
125270848|NCT02720523|450619081|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
125270849|NCT02720523|450619082|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
125270850|NCT02720523|450619076|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
125270851|NCT02720523|450619077|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
125270852|NCT02720523|450619078|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
125270853|NCT02720523|450619079|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
125270854|NCT02720523|450619080|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
125270855|NCT02720523|450619081|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
125270856|NCT02720523|450619082|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
125270857|NCT02720523|450619076|FG000|Period 1: Placebo-controlled Period|Other|0|||
125270858|NCT02720523|450619077|FG001|Period 1: Placebo-controlled Period|Other|0|||
125270859|NCT02720523|450619078|FG002|Period 1: Placebo-controlled Period|Other|1|||
125270860|NCT02720523|450619079|FG003|Period 1: Placebo-controlled Period|Other|1|||
125270861|NCT02720523|450619080|FG004|Period 1: Placebo-controlled Period|Other|0|||
125270862|NCT02720523|450619081|FG005|Period 1: Placebo-controlled Period|Other|0|||
125270863|NCT02720523|450619082|FG006|Period 1: Placebo-controlled Period|Other|0|||
125270864|NCT02720523|450619076|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
125270865|NCT02720523|450619077|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
125270866|NCT02720523|450619078|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
125270867|NCT02720523|450619079|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
125270868|NCT02720523|450619080|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
125270869|NCT02720523|450619081|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
125270870|NCT02720523|450619082|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
125270871|NCT02720523|450619076|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
125270872|NCT02720523|450619077|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
125270873|NCT02720523|450619078|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
125270874|NCT02720523|450619079|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
125270875|NCT02720523|450619080|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
125270876|NCT02720523|450619081|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
125270877|NCT02720523|450619082|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
125270878|NCT02720523|450619076|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
125270879|NCT02720523|450619077|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
125270880|NCT02720523|450619078|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
125270881|NCT02720523|450619079|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
125270882|NCT02720523|450619080|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
125270883|NCT02720523|450619081|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
125270884|NCT02720523|450619082|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
125270885|NCT02720523|450619076|FG000|Period 2: Long-term Extension Period|Other|0|||
125270886|NCT02720523|450619077|FG001|Period 2: Long-term Extension Period|Other|0|||
125270887|NCT02720523|450619078|FG002|Period 2: Long-term Extension Period|Other|0|||
125270888|NCT02720523|450619079|FG003|Period 2: Long-term Extension Period|Other|0|||
125270889|NCT02720523|450619080|FG004|Period 2: Long-term Extension Period|Other|2|||
125270890|NCT02720523|450619081|FG005|Period 2: Long-term Extension Period|Other|0|||
125270891|NCT02720523|450619082|FG006|Period 2: Long-term Extension Period|Other|3|||
125270892|NCT03929913|450619086|FG000|Overall Study|Death|4|||
125270893|NCT03929913|450619086|FG000|Overall Study|Lost to Follow-up|1|||
125270894|NCT03929913|450619086|FG000|Overall Study|Failed Procedure|2|||
125270895|NCT01154452|450619087|FG000|Phase Ib|Not Treated|1|||
125270896|NCT01154452|450619088|FG001|Phase Ib|Not Treated|0|||
125270897|NCT01154452|450619089|FG002|Phase Ib|Not Treated|0|||
125270898|NCT01154452|450619090|FG003|Phase Ib|Not Treated|0|||
125270899|NCT01154452|450619087|FG000|Phase Ib|Adverse Event|2|||
125270900|NCT01154452|450619088|FG001|Phase Ib|Adverse Event|1|||
125270901|NCT01154452|450619089|FG002|Phase Ib|Adverse Event|0|||
125270902|NCT01154452|450619090|FG003|Phase Ib|Adverse Event|0|||
125270903|NCT01154452|450619087|FG000|Phase II|Withdrawal by Subject|0|||
125270904|NCT01154452|450619088|FG001|Phase II|Withdrawal by Subject|0|||
125270905|NCT01154452|450619089|FG002|Phase II|Withdrawal by Subject|1|||
125270906|NCT01154452|450619090|FG003|Phase II|Withdrawal by Subject|2|||
125270907|NCT01154452|450619087|FG000|Phase II|Adverse Event|0|||
125270908|NCT01154452|450619088|FG001|Phase II|Adverse Event|0|||
125270909|NCT01154452|450619089|FG002|Phase II|Adverse Event|4|||
125270910|NCT01154452|450619090|FG003|Phase II|Adverse Event|4|||
125270911|NCT03381287|450619091|FG000|Overall Study|Withdrawal by Subject|0|||
125270912|NCT03381287|450619092|FG001|Overall Study|Withdrawal by Subject|1|||
125270913|NCT03381287|450619093|FG002|Overall Study|Withdrawal by Subject|0|||
125270914|NCT03381287|450619094|FG003|Overall Study|Withdrawal by Subject|0|||
125270915|NCT03381287|450619091|FG000|Overall Study|Adverse Event|0|||
125270916|NCT03381287|450619092|FG001|Overall Study|Adverse Event|0|||
125270917|NCT03381287|450619093|FG002|Overall Study|Adverse Event|0|||
125270918|NCT03381287|450619094|FG003|Overall Study|Adverse Event|1|||
125270919|NCT03381287|450619091|FG000|Overall Study|Physician Decision|0|||
125270920|NCT03381287|450619092|FG001|Overall Study|Physician Decision|0|||
125270921|NCT03381287|450619093|FG002|Overall Study|Physician Decision|0|||
125270922|NCT03381287|450619094|FG003|Overall Study|Physician Decision|1|||
125270923|NCT01102491|450619095|FG000|Overall Study|Protocol Violation|11|||
125270924|NCT01102491|450619096|FG001|Overall Study|Protocol Violation|12|||
125270925|NCT01265992|450619097|FG000|Overall Study|Lost to Follow-up|1|||
125270926|NCT01265992|450619097|FG000|Overall Study|Withdrawal by Subject|1|||
125270927|NCT01265992|450619097|FG000|Overall Study|Adverse Event|1|||
125270928|NCT01265992|450619097|FG000|Overall Study|Administrative reasons|2|||
125270929|NCT01265992|450619097|FG000|Overall Study|Stopped treatment|3|||
125270930|NCT01265992|450619097|FG000|Overall Study|Did not receive treatment|1|||
125270931|NCT01837680|450619100|FG000|Overall Study|Lost to Follow-up|2|||
125270932|NCT01837680|450619101|FG001|Overall Study|Lost to Follow-up|2|||
125270933|NCT01837680|450619100|FG000|Overall Study|lack of insurance|0|||
125270934|NCT01837680|450619101|FG001|Overall Study|lack of insurance|2|||
125270935|NCT01837680|450619100|FG000|Overall Study|allergic reaction|6|||
125270936|NCT01837680|450619101|FG001|Overall Study|allergic reaction|0|||
125270937|NCT01837680|450619100|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
125270938|NCT01837680|450619101|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
125270939|NCT02297815|450620447|FG000|Overall Study|Lost to Follow-up|236|||
125270940|NCT02297815|450620448|FG001|Overall Study|Lost to Follow-up|140|||
125270941|NCT00566982|450620449|FG000|Overall Study|Adverse Event|6|||
125270942|NCT00566982|450620450|FG001|Overall Study|Adverse Event|48|||
125270943|NCT00566982|450620449|FG000|Overall Study|Withdrawal by Subject|1|||
125270944|NCT00566982|450620450|FG001|Overall Study|Withdrawal by Subject|14|||
125270945|NCT00566982|450620449|FG000|Overall Study|Protocol Violation|1|||
125270946|NCT00566982|450620450|FG001|Overall Study|Protocol Violation|4|||
125270947|NCT00566982|450620449|FG000|Overall Study|Lost to Follow-up|0|||
125270948|NCT00566982|450620450|FG001|Overall Study|Lost to Follow-up|1|||
125270949|NCT00566982|450620449|FG000|Overall Study|Other-family problems & doctor's request|0|||
125270950|NCT00566982|450620450|FG001|Overall Study|Other-family problems & doctor's request|2|||
125270951|NCT02197572|450620453|FG000|Overall Study|Progressive Disease|28|||
125270952|NCT02197572|450620453|FG000|Overall Study|Withdrawal by Subject|9|||
125270953|NCT02197572|450620453|FG000|Overall Study|Adverse Event|3|||
125270954|NCT02197572|450620453|FG000|Overall Study|Reason Not Specified|4|||
125270955|NCT02840253|450620454|FG000|Overall Study|Unsuccessful block|4|||
125270956|NCT00473889|450620455|FG000|Overall Study|Did not receive study medication|1|||
125270957|NCT00473889|450620456|FG001|Overall Study|Did not receive study medication|4|||
125270958|NCT00473889|450620455|FG000|Overall Study|Adverse Event|30|||
125270959|NCT00473889|450620456|FG001|Overall Study|Adverse Event|17|||
125270960|NCT00473889|450620455|FG000|Overall Study|Protocol Violation|4|||
125270961|NCT00473889|450620456|FG001|Overall Study|Protocol Violation|2|||
125270962|NCT00473889|450620455|FG000|Overall Study|Lack of Efficacy|28|||
125270963|NCT00473889|450620456|FG001|Overall Study|Lack of Efficacy|29|||
125270964|NCT00473889|450620455|FG000|Overall Study|Lost to Follow-up|2|||
125270965|NCT00473889|450620456|FG001|Overall Study|Lost to Follow-up|1|||
125270966|NCT00473889|450620455|FG000|Overall Study|Physician Decision|10|||
125270967|NCT00473889|450620456|FG001|Overall Study|Physician Decision|5|||
125270968|NCT00473889|450620455|FG000|Overall Study|Trial Terminated|3|||
125270969|NCT00473889|450620456|FG001|Overall Study|Trial Terminated|6|||
125270970|NCT00473889|450620455|FG000|Overall Study|Withdrawal by Subject|5|||
125270971|NCT00473889|450620456|FG001|Overall Study|Withdrawal by Subject|0|||
125270972|NCT03783962|450620457|FG000|Overall Study|Lost to Follow-up|3|||
125270973|NCT03783962|450620458|FG001|Overall Study|Lost to Follow-up|6|||
125270974|NCT03783962|450620457|FG000|Overall Study|Protocol Violation|0|||
125270975|NCT03783962|450620458|FG001|Overall Study|Protocol Violation|1|||
125270976|NCT03458325|450620459|FG000|Overall Study|Withdrawal by Subject|1|||
125270977|NCT01724216|450620468|FG000|Overall Study|Scan was not completed|1|||
125270978|NCT00175916|450620469|FG000|Overall Study|Death|19|||
125270979|NCT00175916|450620469|FG000|Overall Study|Adverse Event|81|||
125270980|NCT00175916|450620469|FG000|Overall Study|Lack of Efficacy|354|||
125270981|NCT00175916|450620469|FG000|Overall Study|Lost to Follow-up|17|||
125270982|NCT00175916|450620469|FG000|Overall Study|Subject Choice|98|||
125270983|NCT00175916|450620469|FG000|Overall Study|Lack of compliance|8|||
125270984|NCT00175916|450620469|FG000|Overall Study|Patient cannot record seizures|1|||
125270985|NCT00175916|450620469|FG000|Overall Study|Sponsor decision|17|||
125270986|NCT00175916|450620469|FG000|Overall Study|Vigabatrin intake|1|||
125270987|NCT00175916|450620469|FG000|Overall Study|Suicidal behaviour|1|||
125270988|NCT00175916|450620469|FG000|Overall Study|Withdrawal by Subject|1|||
125270989|NCT00175916|450620469|FG000|Overall Study|Seizure - free|4|||
125270990|NCT00175916|450620469|FG000|Overall Study|Administrative reason|1|||
125270991|NCT00175916|450620469|FG000|Overall Study|Pregnancy|1|||
125270992|NCT00175916|450620469|FG000|Overall Study|Patient's request|2|||
125270993|NCT00175916|450620469|FG000|Overall Study|Treating physiciant's choice|1|||
125270994|NCT00175916|450620469|FG000|Overall Study|Moved overseas|1|||
125270995|NCT00175916|450620469|FG000|Overall Study|Loss of job and economic burden|1|||
125270996|NCT00175916|450620469|FG000|Overall Study|Site was closed|9|||
125270997|NCT00175916|450620469|FG000|Overall Study|Patient went to prison|1|||
125270998|NCT01014767|450620470|FG000|Overall Study|PI left institution, data unavailable|12|||
125270999|NCT01014767|450620471|FG001|Overall Study|PI left institution, data unavailable|1|||
125271000|NCT01014767|450620472|FG002|Overall Study|PI left institution, data unavailable|4|||
125271001|NCT01014767|450620473|FG003|Overall Study|PI left institution, data unavailable|1|||
125271002|NCT00564733|450620474|FG000|Overall Study|Withdrawal by Subject|4|||
125271003|NCT00564733|450620474|FG000|Overall Study|Ineligible|5|||
125271004|NCT00310375|450620479|FG000|Primary Reporting Phase|Adverse Event|28|||
125271005|NCT00310375|450620480|FG001|Primary Reporting Phase|Adverse Event|22|||
125271006|NCT00310375|450620481|FG002|Primary Reporting Phase|Adverse Event|0|||
125271007|NCT00310375|450620479|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
125271008|NCT00310375|450620480|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
125271009|NCT00310375|450620481|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
125271010|NCT00310375|450620479|FG000|Primary Reporting Phase|Pregnancy|2|||
125271011|NCT00310375|450620480|FG001|Primary Reporting Phase|Pregnancy|2|||
125271012|NCT00310375|450620481|FG002|Primary Reporting Phase|Pregnancy|0|||
125271013|NCT00310375|450620479|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
125271014|NCT00310375|450620480|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
125271015|NCT00310375|450620481|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
125271016|NCT00310375|450620479|FG000|Primary Reporting Phase|Protocol Violation|8|||
125271017|NCT00310375|450620480|FG001|Primary Reporting Phase|Protocol Violation|5|||
125271018|NCT00310375|450620481|FG002|Primary Reporting Phase|Protocol Violation|0|||
125271019|NCT00310375|450620479|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
125271020|NCT00310375|450620480|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
125271021|NCT00310375|450620481|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
125271022|NCT00310375|450620479|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
125271023|NCT00310375|450620480|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
125271024|NCT00310375|450620481|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
125271025|NCT00310375|450620479|FG000|Primary Reporting Phase|Physician Decision|5|||
125271026|NCT00310375|450620480|FG001|Primary Reporting Phase|Physician Decision|3|||
125271027|NCT00310375|450620481|FG002|Primary Reporting Phase|Physician Decision|0|||
125271028|NCT00310375|450620479|FG000|Primary Reporting Phase|Request of the sponsor|2|||
125271029|NCT00310375|450620480|FG001|Primary Reporting Phase|Request of the sponsor|2|||
125271030|NCT00310375|450620481|FG002|Primary Reporting Phase|Request of the sponsor|0|||
125271031|NCT00310375|450620479|FG000|Primary Reporting Phase|Failed to return|1|||
125271032|NCT00310375|450620480|FG001|Primary Reporting Phase|Failed to return|3|||
125271033|NCT00310375|450620481|FG002|Primary Reporting Phase|Failed to return|0|||
125271034|NCT00310375|450620479|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
125271035|NCT00310375|450620480|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
125271036|NCT00310375|450620481|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
125271037|NCT00310375|450620479|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
125271038|NCT00310375|450620480|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
125271039|NCT00310375|450620481|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
125271040|NCT00310375|450620479|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
125271041|NCT00310375|450620480|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
125271042|NCT00310375|450620481|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
125271043|NCT00310375|450620479|FG000|Primary Reporting Phase|Site closure|3|||
125271044|NCT00310375|450620480|FG001|Primary Reporting Phase|Site closure|0|||
125271045|NCT00310375|450620481|FG002|Primary Reporting Phase|Site closure|0|||
125271046|NCT00310375|450620479|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
125271047|NCT00310375|450620480|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
125271048|NCT00310375|450620481|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
125271049|NCT00310375|450620479|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
125271050|NCT00310375|450620480|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
125271051|NCT00310375|450620481|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
125271052|NCT00310375|450620479|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
125271053|NCT00310375|450620480|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
125271054|NCT00310375|450620481|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
125271055|NCT00310375|450620479|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
125271056|NCT00310375|450620480|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
125271057|NCT00310375|450620481|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
125271058|NCT00573391|450620482|FG000|Overall Study|study stopped|2|||
125271059|NCT00573391|450620483|FG001|Overall Study|study stopped|2|||
125271060|NCT00573391|450620482|FG000|Overall Study|Death|1|||
125271061|NCT00573391|450620483|FG001|Overall Study|Death|0|||
125271062|NCT00131352|450620484|FG000|Initial Treatment Period|Adverse Event|1|||
125271063|NCT00131352|450620485|FG001|Initial Treatment Period|Adverse Event|3|||
125271064|NCT00131352|450620484|FG000|Initial Treatment Period|Non-compliant|1|||
125271065|NCT00131352|450620485|FG001|Initial Treatment Period|Non-compliant|2|||
125271066|NCT00131352|450620484|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
125271067|NCT00131352|450620485|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
125271068|NCT00131352|450620484|FG000|Initial Treatment Period|Lack of Efficacy|6|||
125271069|NCT00131352|450620485|FG001|Initial Treatment Period|Lack of Efficacy|4|||
125271070|NCT00131352|450620484|FG000|Initial Treatment Period|Other|0|||
125271071|NCT00131352|450620485|FG001|Initial Treatment Period|Other|2|||
125271072|NCT00131352|450620484|FG000|Repeat Treatment Period|Adverse Event|1|||
125271073|NCT00131352|450620485|FG001|Repeat Treatment Period|Adverse Event|0|||
125271074|NCT00131352|450620484|FG000|Repeat Treatment Period|Other|1|||
125271075|NCT00131352|450620485|FG001|Repeat Treatment Period|Other|0|||
125271076|NCT01194219|450620486|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
125271077|NCT01194219|450620487|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
125271078|NCT01194219|450620488|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
125271079|NCT01194219|450620489|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
125271080|NCT01194219|450620490|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
125271081|NCT01194219|450620491|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
125271082|NCT01194219|450620492|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
125271083|NCT01194219|450620493|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
125271084|NCT01194219|450620494|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
125271085|NCT01194219|450620495|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
125271086|NCT01194219|450620486|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
125271087|NCT01194219|450620487|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
125271088|NCT01194219|450620488|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
125271089|NCT01194219|450620489|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
125271090|NCT01194219|450620490|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
125271091|NCT01194219|450620491|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
125271092|NCT01194219|450620492|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
125271093|NCT01194219|450620493|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
125271094|NCT01194219|450620494|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
125271095|NCT01194219|450620495|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
125271096|NCT01194219|450620486|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
125271097|NCT01194219|450620487|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
125271098|NCT01194219|450620488|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
125271099|NCT01194219|450620489|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
125271100|NCT01194219|450620490|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
125271101|NCT01194219|450620491|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
125271102|NCT01194219|450620492|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
125271103|NCT01194219|450620493|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
125271104|NCT01194219|450620494|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
125271105|NCT01194219|450620495|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
125271106|NCT01194219|450620486|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
125271107|NCT01194219|450620487|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
125271108|NCT01194219|450620488|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
125271109|NCT01194219|450620489|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
125271110|NCT01194219|450620490|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
125271111|NCT01194219|450620491|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
125271112|NCT01194219|450620492|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
125271113|NCT01194219|450620493|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
125271114|NCT01194219|450620494|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
125271115|NCT01194219|450620495|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
125271116|NCT01194219|450620486|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
125271117|NCT01194219|450620487|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
125271118|NCT01194219|450620488|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
125271119|NCT01194219|450620489|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
125271120|NCT01194219|450620490|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
125271121|NCT01194219|450620491|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
125271122|NCT01194219|450620492|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
125271123|NCT01194219|450620493|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
125271124|NCT01194219|450620494|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
125271125|NCT01194219|450620495|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
125271126|NCT01194219|450620486|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
125271127|NCT01194219|450620487|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
125271128|NCT01194219|450620488|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
125271129|NCT01194219|450620489|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
125271130|NCT01194219|450620490|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
125271131|NCT01194219|450620491|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
125271132|NCT01194219|450620492|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
125271133|NCT01194219|450620493|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
125271134|NCT01194219|450620494|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
125271135|NCT01194219|450620495|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
125271136|NCT01194219|450620486|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
125271137|NCT01194219|450620487|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
125271138|NCT01194219|450620488|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
125271139|NCT01194219|450620489|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
125271140|NCT01194219|450620490|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
125271141|NCT01194219|450620491|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
125271142|NCT01194219|450620492|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
125271143|NCT01194219|450620493|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
125271144|NCT01194219|450620494|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
125271145|NCT01194219|450620495|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
125271146|NCT01194219|450620486|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
125271147|NCT01194219|450620487|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
125271148|NCT01194219|450620488|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
125271149|NCT01194219|450620489|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
125271150|NCT01194219|450620490|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
125271151|NCT01194219|450620491|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
125271152|NCT01194219|450620492|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
125271153|NCT01194219|450620493|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
125271154|NCT01194219|450620494|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
125271155|NCT01194219|450620495|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
125271156|NCT01194219|450620486|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
125271157|NCT01194219|450620487|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
125271158|NCT01194219|450620488|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
125271159|NCT01194219|450620489|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
125271160|NCT01194219|450620490|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
125271161|NCT01194219|450620491|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
125271162|NCT01194219|450620492|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
125271163|NCT01194219|450620493|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
125271164|NCT01194219|450620494|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
125271165|NCT01194219|450620495|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
125271166|NCT01194219|450620486|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
125271167|NCT01194219|450620487|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
125271168|NCT01194219|450620488|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
125271169|NCT01194219|450620489|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
125271170|NCT01194219|450620490|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
125271171|NCT01194219|450620491|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
125271172|NCT01194219|450620492|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
125271173|NCT01194219|450620493|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
125271174|NCT01194219|450620494|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
125271175|NCT01194219|450620495|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
125271176|NCT01194219|450620486|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
125271177|NCT01194219|450620487|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
125271178|NCT01194219|450620488|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
125271179|NCT01194219|450620489|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
125271180|NCT01194219|450620490|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
125271181|NCT01194219|450620491|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
125271182|NCT01194219|450620492|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
125271183|NCT01194219|450620493|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
125271184|NCT01194219|450620494|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
125271185|NCT01194219|450620495|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
125271186|NCT01194219|450620486|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
125271187|NCT01194219|450620487|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
125271188|NCT01194219|450620488|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
125271189|NCT01194219|450620489|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
125271190|NCT01194219|450620490|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
125271191|NCT01194219|450620491|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
125271192|NCT01194219|450620492|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
125271193|NCT01194219|450620493|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
125271194|NCT01194219|450620494|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
125271195|NCT01194219|450620495|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
125271196|NCT01194219|450620486|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
125271197|NCT01194219|450620487|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
125271198|NCT01194219|450620488|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
125271199|NCT01194219|450620489|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
125271200|NCT01194219|450620490|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
125271201|NCT01194219|450620491|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
125271202|NCT01194219|450620492|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
125271203|NCT01194219|450620493|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
125271204|NCT01194219|450620494|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
125271205|NCT01194219|450620495|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
125271206|NCT01194219|450620486|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
125271207|NCT01194219|450620487|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
125271208|NCT01194219|450620488|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
125271209|NCT01194219|450620489|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
125271210|NCT01194219|450620490|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
125271211|NCT01194219|450620491|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
125271212|NCT01194219|450620492|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
125271213|NCT01194219|450620493|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
125271214|NCT01194219|450620494|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
125271215|NCT01194219|450620495|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
125271216|NCT01194219|450620486|FG000|Maintenance Phase Weeks16-32|Other|0|||
125271217|NCT01194219|450620487|FG001|Maintenance Phase Weeks16-32|Other|0|||
125271218|NCT01194219|450620488|FG002|Maintenance Phase Weeks16-32|Other|2|||
125271219|NCT01194219|450620489|FG003|Maintenance Phase Weeks16-32|Other|1|||
125271220|NCT01194219|450620490|FG004|Maintenance Phase Weeks16-32|Other|0|||
125271221|NCT01194219|450620491|FG005|Maintenance Phase Weeks16-32|Other|0|||
125271222|NCT01194219|450620492|FG006|Maintenance Phase Weeks16-32|Other|0|||
125271223|NCT01194219|450620493|FG007|Maintenance Phase Weeks16-32|Other|0|||
125271224|NCT01194219|450620494|FG008|Maintenance Phase Weeks16-32|Other|0|||
125271225|NCT01194219|450620495|FG009|Maintenance Phase Weeks16-32|Other|0|||
125271226|NCT01194219|450620486|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
125271227|NCT01194219|450620487|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
125271228|NCT01194219|450620488|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
125271229|NCT01194219|450620489|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
125271230|NCT01194219|450620490|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
125271231|NCT01194219|450620491|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
125271232|NCT01194219|450620492|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
125271233|NCT01194219|450620493|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
125271234|NCT01194219|450620494|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
125271235|NCT01194219|450620495|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
125271236|NCT01194219|450620486|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
125271237|NCT01194219|450620487|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
125271238|NCT01194219|450620488|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
125271239|NCT01194219|450620489|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
125271240|NCT01194219|450620490|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
125271241|NCT01194219|450620491|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
125271242|NCT01194219|450620492|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
125271243|NCT01194219|450620493|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
125271244|NCT01194219|450620494|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
125271245|NCT01194219|450620495|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
125271246|NCT01194219|450620486|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
125271247|NCT01194219|450620487|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
125271248|NCT01194219|450620488|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
125271249|NCT01194219|450620489|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
125271250|NCT01194219|450620490|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
125271251|NCT01194219|450620491|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
125271252|NCT01194219|450620492|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
125271253|NCT01194219|450620493|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
125271254|NCT01194219|450620494|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
125271255|NCT01194219|450620495|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
125271256|NCT01194219|450620486|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
125271257|NCT01194219|450620487|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
125271258|NCT01194219|450620488|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
125271259|NCT01194219|450620489|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
125271260|NCT01194219|450620490|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
125271261|NCT01194219|450620491|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
125271262|NCT01194219|450620492|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
125271263|NCT01194219|450620493|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
125271264|NCT01194219|450620494|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
125271265|NCT01194219|450620495|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
125271266|NCT01194219|450620486|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
125271267|NCT01194219|450620487|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
125271268|NCT01194219|450620488|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
125271269|NCT01194219|450620489|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
125271270|NCT01194219|450620490|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
125271271|NCT01194219|450620491|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
125271272|NCT01194219|450620492|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
125271273|NCT01194219|450620493|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
125271274|NCT01194219|450620494|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
125271275|NCT01194219|450620495|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
125271276|NCT01194219|450620486|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
125271277|NCT01194219|450620487|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
125271278|NCT01194219|450620488|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
125271279|NCT01194219|450620489|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
125271280|NCT01194219|450620490|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
125271281|NCT01194219|450620491|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
125271282|NCT01194219|450620492|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
125271283|NCT01194219|450620493|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
125271284|NCT01194219|450620494|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
125271285|NCT01194219|450620495|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
125271286|NCT01194219|450620486|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
125271287|NCT01194219|450620487|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
125271288|NCT01194219|450620488|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
125271289|NCT01194219|450620489|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
125271290|NCT01194219|450620490|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
125271291|NCT01194219|450620491|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
125271292|NCT01194219|450620492|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
125271293|NCT01194219|450620493|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
125271294|NCT01194219|450620494|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
125271295|NCT01194219|450620495|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
125271296|NCT01194219|450620486|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
125271297|NCT01194219|450620487|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
125271298|NCT01194219|450620488|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
125271299|NCT01194219|450620489|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
125271300|NCT01194219|450620490|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
125271301|NCT01194219|450620491|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
125271302|NCT01194219|450620492|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
125271303|NCT01194219|450620493|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
125271304|NCT01194219|450620494|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
125271305|NCT01194219|450620495|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
125271306|NCT01194219|450620486|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
125271307|NCT01194219|450620487|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
125271308|NCT01194219|450620488|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
125271309|NCT01194219|450620489|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
125271310|NCT01194219|450620490|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
125271311|NCT01194219|450620491|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
125271312|NCT01194219|450620492|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
125271313|NCT01194219|450620493|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
125271314|NCT01194219|450620494|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
125271315|NCT01194219|450620495|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
125271316|NCT01194219|450620486|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
125271317|NCT01194219|450620487|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
125271318|NCT01194219|450620488|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
125271319|NCT01194219|450620489|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
125271320|NCT01194219|450620490|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
125271321|NCT01194219|450620491|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
125271322|NCT01194219|450620492|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
125271323|NCT01194219|450620493|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
125271324|NCT01194219|450620494|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
125271325|NCT01194219|450620495|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
125271326|NCT01194219|450620486|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
125271327|NCT01194219|450620487|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
125271328|NCT01194219|450620488|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
125271329|NCT01194219|450620489|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
125271330|NCT01194219|450620490|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
125271331|NCT01194219|450620491|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
125271332|NCT01194219|450620492|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
125271333|NCT01194219|450620493|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
125271334|NCT01194219|450620494|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
125271335|NCT01194219|450620495|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
125271336|NCT01194219|450620486|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
125271337|NCT01194219|450620487|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
125271338|NCT01194219|450620488|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
125271339|NCT01194219|450620489|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
125271340|NCT01194219|450620490|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
125271341|NCT01194219|450620491|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
125271342|NCT01194219|450620492|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
125271343|NCT01194219|450620493|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
125271344|NCT01194219|450620494|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
125271345|NCT01194219|450620495|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
125271346|NCT01194219|450620486|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
125271347|NCT01194219|450620487|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
125271348|NCT01194219|450620488|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
125271349|NCT01194219|450620489|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
125271350|NCT01194219|450620490|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
125271351|NCT01194219|450620491|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
125271352|NCT01194219|450620492|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
125271353|NCT01194219|450620493|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
125271354|NCT01194219|450620494|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
125271355|NCT01194219|450620495|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
125271356|NCT01194219|450620486|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
125271357|NCT01194219|450620487|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
125271358|NCT01194219|450620488|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
125271359|NCT01194219|450620489|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
125271360|NCT01194219|450620490|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
125271361|NCT01194219|450620491|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
125271362|NCT01194219|450620492|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
125271363|NCT01194219|450620493|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
125271364|NCT01194219|450620494|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
125271365|NCT01194219|450620495|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
125271366|NCT01194219|450620486|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
125271367|NCT01194219|450620487|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
125271368|NCT01194219|450620488|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
125271369|NCT01194219|450620489|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
125271370|NCT01194219|450620490|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
125271371|NCT01194219|450620491|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
125271372|NCT01194219|450620492|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
125271373|NCT01194219|450620493|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
125271374|NCT01194219|450620494|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
125271375|NCT01194219|450620495|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
125271376|NCT00292045|450620498|FG000|Core Study (Through Week 13)|Adverse Event|1|||
125271377|NCT00292045|450620498|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
125271378|NCT04474197|450620499|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
125271379|NCT04474197|450620500|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
125271380|NCT04474197|450620501|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
125271381|NCT04474197|450620502|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
125271382|NCT02443337|450620503|FG000|Overall Study|Adverse Event|0|||
125271383|NCT02443337|450620504|FG001|Overall Study|Adverse Event|1|||
125271384|NCT02443337|450620503|FG000|Overall Study|Clinical Progressive Disease|3|||
125271385|NCT02443337|450620504|FG001|Overall Study|Clinical Progressive Disease|0|||
125271386|NCT02443337|450620503|FG000|Overall Study|Withdrawal by Subject|2|||
125271387|NCT02443337|450620504|FG001|Overall Study|Withdrawal by Subject|1|||
125271388|NCT00635349|450620506|FG000|Overall Study|Other|8|||
125271389|NCT00635349|450620507|FG001|Overall Study|Other|6|||
125271390|NCT00635349|450620506|FG000|Overall Study|Protocol Violation|18|||
125271391|NCT00635349|450620507|FG001|Overall Study|Protocol Violation|22|||
125271392|NCT00635349|450620506|FG000|Overall Study|Withdrawal by Subject|3|||
125271393|NCT00635349|450620507|FG001|Overall Study|Withdrawal by Subject|8|||
125271394|NCT00635349|450620506|FG000|Overall Study|Lost to Follow-up|4|||
125271395|NCT00635349|450620507|FG001|Overall Study|Lost to Follow-up|3|||
125271396|NCT00635349|450620506|FG000|Overall Study|Adverse Event|11|||
125271397|NCT00635349|450620507|FG001|Overall Study|Adverse Event|9|||
125271398|NCT04860869|450620513|FG000|Overall Study|Withdrawal by Subject|1|||
125271399|NCT04860869|450620514|FG001|Overall Study|Withdrawal by Subject|0|||
125271400|NCT03951766|450620515|FG000|Treatment Phase|Lost to Follow-up|1|||
125271401|NCT03951766|450620515|FG000|Follow-up Phase|Lost to Follow-up|10|||
125271402|NCT03606486|450620518|FG000|Overall Study|Unable to collect sample|5|||
125271403|NCT00049322|450620519|FG000|Overall Study|disease burden|0|||
125271404|NCT00049322|450620520|FG001|Overall Study|disease burden|3|||
125271405|NCT00049322|450620519|FG000|Overall Study|Adverse Event|1|||
125271406|NCT00049322|450620520|FG001|Overall Study|Adverse Event|0|||
125271407|NCT00049322|450620519|FG000|Overall Study|refused angio|0|||
125271408|NCT00049322|450620520|FG001|Overall Study|refused angio|3|||
125271409|NCT03943290|450620523|FG000|Overall Study|Sponsor Terminated Study|6|||
125271410|NCT03943290|450620524|FG001|Overall Study|Sponsor Terminated Study|1|||
125271411|NCT03943290|450620525|FG002|Overall Study|Sponsor Terminated Study|11|||
125271412|NCT03943290|450620526|FG003|Overall Study|Sponsor Terminated Study|6|||
125271413|NCT03943290|450620527|FG004|Overall Study|Sponsor Terminated Study|7|||
125271414|NCT03943290|450620528|FG005|Overall Study|Sponsor Terminated Study|6|||
125271415|NCT03943290|450620529|FG006|Overall Study|Sponsor Terminated Study|6|||
125271416|NCT03943290|450620530|FG007|Overall Study|Sponsor Terminated Study|7|||
125271417|NCT03943290|450620531|FG008|Overall Study|Sponsor Terminated Study|8|||
125271418|NCT03943290|450620523|FG000|Overall Study|Lost to Follow-up|1|||
125271419|NCT03943290|450620524|FG001|Overall Study|Lost to Follow-up|0|||
125271420|NCT03943290|450620525|FG002|Overall Study|Lost to Follow-up|1|||
125271421|NCT03943290|450620526|FG003|Overall Study|Lost to Follow-up|0|||
125271422|NCT03943290|450620527|FG004|Overall Study|Lost to Follow-up|0|||
125271423|NCT03943290|450620528|FG005|Overall Study|Lost to Follow-up|0|||
125271424|NCT03943290|450620529|FG006|Overall Study|Lost to Follow-up|0|||
125271425|NCT03943290|450620530|FG007|Overall Study|Lost to Follow-up|1|||
125271426|NCT03943290|450620531|FG008|Overall Study|Lost to Follow-up|0|||
125271427|NCT03943290|450620523|FG000|Overall Study|Withdrawal by Subject|0|||
125271428|NCT03943290|450620524|FG001|Overall Study|Withdrawal by Subject|0|||
125271429|NCT03943290|450620525|FG002|Overall Study|Withdrawal by Subject|1|||
125271430|NCT03943290|450620526|FG003|Overall Study|Withdrawal by Subject|0|||
125271431|NCT03943290|450620527|FG004|Overall Study|Withdrawal by Subject|0|||
125271432|NCT03943290|450620528|FG005|Overall Study|Withdrawal by Subject|0|||
125271433|NCT03943290|450620529|FG006|Overall Study|Withdrawal by Subject|0|||
125271434|NCT03943290|450620530|FG007|Overall Study|Withdrawal by Subject|0|||
125271435|NCT03943290|450620531|FG008|Overall Study|Withdrawal by Subject|0|||
125271436|NCT00295646|450620538|FG000|Overall Study|Protocol Violation|18|||
125271437|NCT00295646|450620539|FG001|Overall Study|Protocol Violation|20|||
125271438|NCT00295646|450620540|FG002|Overall Study|Protocol Violation|20|||
125271439|NCT00295646|450620541|FG003|Overall Study|Protocol Violation|18|||
125271440|NCT00295646|450620538|FG000|Overall Study|Withdrawal by Subject|8|||
125271441|NCT00295646|450620539|FG001|Overall Study|Withdrawal by Subject|9|||
125271442|NCT00295646|450620540|FG002|Overall Study|Withdrawal by Subject|11|||
125271443|NCT00295646|450620541|FG003|Overall Study|Withdrawal by Subject|14|||
125271444|NCT00295646|450620538|FG000|Overall Study|Lost to Follow-up|0|||
125271445|NCT00295646|450620539|FG001|Overall Study|Lost to Follow-up|5|||
125271446|NCT00295646|450620540|FG002|Overall Study|Lost to Follow-up|1|||
125271447|NCT00295646|450620541|FG003|Overall Study|Lost to Follow-up|5|||
125271448|NCT00295646|450620538|FG000|Overall Study|Death|9|||
125271449|NCT00295646|450620539|FG001|Overall Study|Death|7|||
125271450|NCT00295646|450620540|FG002|Overall Study|Death|18|||
125271451|NCT00295646|450620541|FG003|Overall Study|Death|8|||
125271452|NCT02441101|450620546|FG000|Overall Study|Withdrawal by Subject|1|||
125271453|NCT02441101|450620547|FG001|Overall Study|Withdrawal by Subject|0|||
125271454|NCT02441101|450620546|FG000|Overall Study|Lost to Follow-up|1|||
125271455|NCT02441101|450620547|FG001|Overall Study|Lost to Follow-up|0|||
125271456|NCT02441101|450620546|FG000|Overall Study|PI relocated and study terminated|1|||
125271457|NCT02441101|450620547|FG001|Overall Study|PI relocated and study terminated|0|||
125271458|NCT00955474|450620548|FG000|Overall Study|Physician Decision|7|||
125271459|NCT00955474|450620549|FG001|Overall Study|Physician Decision|5|||
125271460|NCT01737762|450620552|FG000|Overall Study|Adverse Event|2|||
125271461|NCT01737762|450620553|FG001|Overall Study|Adverse Event|2|||
125271462|NCT01737762|450620552|FG000|Overall Study|Lost to Follow-up|1|||
125271463|NCT01737762|450620553|FG001|Overall Study|Lost to Follow-up|0|||
125271464|NCT01737762|450620552|FG000|Overall Study|Withdrawal by Subject|2|||
125271465|NCT01737762|450620553|FG001|Overall Study|Withdrawal by Subject|2|||
125271466|NCT01737762|450620552|FG000|Overall Study|Progressive disease|1|||
125271467|NCT01737762|450620553|FG001|Overall Study|Progressive disease|2|||
125271468|NCT01737762|450620552|FG000|Overall Study|Physician Decision|1|||
125271469|NCT01737762|450620553|FG001|Overall Study|Physician Decision|1|||
125271470|NCT01737762|450620552|FG000|Overall Study|Moved from area|2|||
125271471|NCT01737762|450620553|FG001|Overall Study|Moved from area|1|||
125271472|NCT01737762|450620552|FG000|Overall Study|Trial termination|11|||
125271473|NCT01737762|450620553|FG001|Overall Study|Trial termination|9|||
125271474|NCT03083665|450620555|FG000|Double-Blind Period|Adverse Event|5|||
125271475|NCT03083665|450620556|FG001|Double-Blind Period|Adverse Event|4|||
125271476|NCT03083665|450620557|FG002|Double-Blind Period|Adverse Event|5|||
125271477|NCT03083665|450620558|FG003|Double-Blind Period|Adverse Event|0|||
125271478|NCT03083665|450620559|FG004|Double-Blind Period|Adverse Event|0|||
125271479|NCT03083665|450620560|FG005|Double-Blind Period|Adverse Event|0|||
125271480|NCT03083665|450620555|FG000|Double-Blind Period|Lack of Efficacy|0|||
125271481|NCT03083665|450620556|FG001|Double-Blind Period|Lack of Efficacy|0|||
125271482|NCT03083665|450620557|FG002|Double-Blind Period|Lack of Efficacy|1|||
125271483|NCT03083665|450620558|FG003|Double-Blind Period|Lack of Efficacy|0|||
125271484|NCT03083665|450620559|FG004|Double-Blind Period|Lack of Efficacy|0|||
125271485|NCT03083665|450620560|FG005|Double-Blind Period|Lack of Efficacy|0|||
125271486|NCT03083665|450620555|FG000|Double-Blind Period|Protocol Violation|1|||
125271487|NCT03083665|450620556|FG001|Double-Blind Period|Protocol Violation|0|||
125271488|NCT03083665|450620557|FG002|Double-Blind Period|Protocol Violation|1|||
125271489|NCT03083665|450620558|FG003|Double-Blind Period|Protocol Violation|0|||
125271490|NCT03083665|450620559|FG004|Double-Blind Period|Protocol Violation|0|||
125271491|NCT03083665|450620560|FG005|Double-Blind Period|Protocol Violation|0|||
125271492|NCT03083665|450620555|FG000|Double-Blind Period|Lost to Follow-up|1|||
125271493|NCT03083665|450620556|FG001|Double-Blind Period|Lost to Follow-up|0|||
125271494|NCT03083665|450620557|FG002|Double-Blind Period|Lost to Follow-up|1|||
125271495|NCT03083665|450620558|FG003|Double-Blind Period|Lost to Follow-up|0|||
125271496|NCT03083665|450620559|FG004|Double-Blind Period|Lost to Follow-up|0|||
125271497|NCT03083665|450620560|FG005|Double-Blind Period|Lost to Follow-up|0|||
125271498|NCT03083665|450620555|FG000|Double-Blind Period|Withdrawal by Subject|3|||
125271499|NCT03083665|450620556|FG001|Double-Blind Period|Withdrawal by Subject|0|||
125271500|NCT03083665|450620557|FG002|Double-Blind Period|Withdrawal by Subject|0|||
125271501|NCT03083665|450620558|FG003|Double-Blind Period|Withdrawal by Subject|0|||
125271502|NCT03083665|450620559|FG004|Double-Blind Period|Withdrawal by Subject|0|||
125271503|NCT03083665|450620560|FG005|Double-Blind Period|Withdrawal by Subject|0|||
125271504|NCT03083665|450620555|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
125271505|NCT03083665|450620556|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
125271506|NCT03083665|450620557|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
125271507|NCT03083665|450620558|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
125271508|NCT03083665|450620559|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
125271509|NCT03083665|450620560|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
125271510|NCT03083665|450620555|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
125271511|NCT03083665|450620556|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
125271512|NCT03083665|450620557|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
125271513|NCT03083665|450620558|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
125271514|NCT03083665|450620559|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
125271515|NCT03083665|450620560|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
125271516|NCT03083665|450620555|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
125271517|NCT03083665|450620556|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
125271518|NCT03083665|450620557|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
125271519|NCT03083665|450620558|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
125271520|NCT03083665|450620559|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
125271521|NCT03083665|450620560|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
125271522|NCT03083665|450620555|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
125271523|NCT03083665|450620556|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
125271524|NCT03083665|450620557|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
125271525|NCT03083665|450620558|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
125271526|NCT03083665|450620559|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
125271527|NCT03083665|450620560|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
125271528|NCT03083665|450620555|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
125271529|NCT03083665|450620556|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
125271530|NCT03083665|450620557|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
125271531|NCT03083665|450620558|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
125271532|NCT03083665|450620559|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
125271533|NCT03083665|450620560|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
125271534|NCT03083665|450620555|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
125271535|NCT03083665|450620556|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
125271536|NCT03083665|450620557|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
125271537|NCT03083665|450620558|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
125271538|NCT03083665|450620559|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
125271539|NCT03083665|450620560|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
125271540|NCT03083665|450620555|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
125271541|NCT03083665|450620556|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
125271542|NCT03083665|450620557|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
125271543|NCT03083665|450620558|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
125271544|NCT03083665|450620559|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
125271545|NCT03083665|450620560|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
125271546|NCT03083665|450620555|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
125271547|NCT03083665|450620556|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
125271548|NCT03083665|450620557|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
125271549|NCT03083665|450620558|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
125271550|NCT03083665|450620559|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
125271551|NCT03083665|450620560|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
125271552|NCT03083665|450620555|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
125271553|NCT03083665|450620556|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
125271554|NCT03083665|450620557|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
125271555|NCT03083665|450620558|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
125271556|NCT03083665|450620559|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
125271557|NCT03083665|450620560|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
125271558|NCT01467466|450620561|FG000|Overall Study|Withdrawal by Subject|15|||
125271559|NCT01467466|450620562|FG001|Overall Study|Withdrawal by Subject|18|||
125271560|NCT01467466|450620563|FG002|Overall Study|Withdrawal by Subject|13|||
125271561|NCT01467466|450620564|FG003|Overall Study|Withdrawal by Subject|11|||
125271562|NCT01467466|450620561|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
125271563|NCT01467466|450620562|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
125271564|NCT01467466|450620563|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
125271565|NCT01467466|450620564|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
125271566|NCT01467466|450620561|FG000|Overall Study|Procedure Cancelled|46|||
125271567|NCT01467466|450620562|FG001|Overall Study|Procedure Cancelled|45|||
125271568|NCT01467466|450620563|FG002|Overall Study|Procedure Cancelled|25|||
125271569|NCT01467466|450620564|FG003|Overall Study|Procedure Cancelled|29|||
125271570|NCT01467466|450620561|FG000|Overall Study|No Endpoint Blood Draw|38|||
125271571|NCT01467466|450620562|FG001|Overall Study|No Endpoint Blood Draw|32|||
125271572|NCT01467466|450620563|FG002|Overall Study|No Endpoint Blood Draw|51|||
125271573|NCT01467466|450620564|FG003|Overall Study|No Endpoint Blood Draw|43|||
125271574|NCT01144416|450620571|FG000|Intervention Period|Adverse Event|5|||
125271575|NCT01144416|450620572|FG001|Intervention Period|Adverse Event|6|||
125271576|NCT01144416|450620571|FG000|Intervention Period|Insufficient ovarian response|11|||
125271577|NCT01144416|450620572|FG001|Intervention Period|Insufficient ovarian response|17|||
125271578|NCT01144416|450620571|FG000|Intervention Period|Risk of OHSS|0|||
125271579|NCT01144416|450620572|FG001|Intervention Period|Risk of OHSS|1|||
125271580|NCT01144416|450620571|FG000|Intervention Period|Too high ovarian response|4|||
125271581|NCT01144416|450620572|FG001|Intervention Period|Too high ovarian response|2|||
125271582|NCT01144416|450620571|FG000|Intervention Period|No/too few/bad oocytes|7|||
125271583|NCT01144416|450620572|FG001|Intervention Period|No/too few/bad oocytes|5|||
125271584|NCT01144416|450620571|FG000|Intervention Period|No or abnormal fertilization|25|||
125271585|NCT01144416|450620572|FG001|Intervention Period|No or abnormal fertilization|10|||
125271586|NCT01144416|450620571|FG000|Intervention Period|No/too few/bad quality embryos|3|||
125271587|NCT01144416|450620572|FG001|Intervention Period|No/too few/bad quality embryos|3|||
125271588|NCT01144416|450620571|FG000|Intervention Period|Other|7|||
125271589|NCT01144416|450620572|FG001|Intervention Period|Other|5|||
125271590|NCT02131662|450620577|FG000|Overall Study|Protocol Violation|1|||
125271591|NCT02131662|450620578|FG001|Overall Study|Protocol Violation|0|||
125271592|NCT02131662|450620579|FG002|Overall Study|Protocol Violation|0|||
125271593|NCT02131662|450620580|FG003|Overall Study|Protocol Violation|0|||
125271594|NCT02131662|450620581|FG004|Overall Study|Protocol Violation|0|||
125271595|NCT02131662|450620577|FG000|Overall Study|Other|2|||
125271596|NCT02131662|450620578|FG001|Overall Study|Other|4|||
125271597|NCT02131662|450620579|FG002|Overall Study|Other|3|||
125271598|NCT02131662|450620580|FG003|Overall Study|Other|3|||
125271599|NCT02131662|450620581|FG004|Overall Study|Other|4|||
125271600|NCT02131662|450620577|FG000|Overall Study|Adverse Event|0|||
125271601|NCT02131662|450620578|FG001|Overall Study|Adverse Event|1|||
125271602|NCT02131662|450620579|FG002|Overall Study|Adverse Event|1|||
125271603|NCT02131662|450620580|FG003|Overall Study|Adverse Event|1|||
125271604|NCT02131662|450620581|FG004|Overall Study|Adverse Event|3|||
125271605|NCT02131662|450620577|FG000|Overall Study|Pregnancy|0|||
125271606|NCT02131662|450620578|FG001|Overall Study|Pregnancy|1|||
125271607|NCT02131662|450620579|FG002|Overall Study|Pregnancy|0|||
125271608|NCT02131662|450620580|FG003|Overall Study|Pregnancy|1|||
125271609|NCT02131662|450620581|FG004|Overall Study|Pregnancy|0|||
125271610|NCT02131662|450620577|FG000|Overall Study|Wish for pregnancy|0|||
125271611|NCT02131662|450620578|FG001|Overall Study|Wish for pregnancy|0|||
125271612|NCT02131662|450620579|FG002|Overall Study|Wish for pregnancy|0|||
125271613|NCT02131662|450620580|FG003|Overall Study|Wish for pregnancy|0|||
125271614|NCT02131662|450620581|FG004|Overall Study|Wish for pregnancy|1|||
125271615|NCT02131662|450620577|FG000|Overall Study|Lack of Efficacy|1|||
125271616|NCT02131662|450620578|FG001|Overall Study|Lack of Efficacy|0|||
125271617|NCT02131662|450620579|FG002|Overall Study|Lack of Efficacy|0|||
125271618|NCT02131662|450620580|FG003|Overall Study|Lack of Efficacy|0|||
125271619|NCT02131662|450620581|FG004|Overall Study|Lack of Efficacy|1|||
125271620|NCT02131662|450620577|FG000|Overall Study|Withdrawal by Subject|1|||
125271621|NCT02131662|450620578|FG001|Overall Study|Withdrawal by Subject|5|||
125271622|NCT02131662|450620579|FG002|Overall Study|Withdrawal by Subject|1|||
125271623|NCT02131662|450620580|FG003|Overall Study|Withdrawal by Subject|5|||
125271624|NCT02131662|450620581|FG004|Overall Study|Withdrawal by Subject|6|||
125271625|NCT02131662|450620577|FG000|Overall Study|Lost to Follow-up|1|||
125271626|NCT02131662|450620578|FG001|Overall Study|Lost to Follow-up|3|||
125271627|NCT02131662|450620579|FG002|Overall Study|Lost to Follow-up|0|||
125271628|NCT02131662|450620580|FG003|Overall Study|Lost to Follow-up|9|||
125271629|NCT02131662|450620581|FG004|Overall Study|Lost to Follow-up|0|||
125271630|NCT02131662|450620577|FG000|Overall Study|Not treated|2|||
125271631|NCT02131662|450620578|FG001|Overall Study|Not treated|0|||
125271632|NCT02131662|450620579|FG002|Overall Study|Not treated|2|||
125271633|NCT02131662|450620580|FG003|Overall Study|Not treated|2|||
125271634|NCT02131662|450620581|FG004|Overall Study|Not treated|3|||
125271635|NCT01402869|450620582|FG000|Overall Study|Required Tooth Extraction|0|||
125271636|NCT01402869|450620583|FG001|Overall Study|Required Tooth Extraction|0|||
125271637|NCT01402869|450620584|FG002|Overall Study|Required Tooth Extraction|1|||
125271638|NCT01740687|450620585|FG000|Overall Study|Lost to Follow-up|11|||
125271639|NCT01740687|450620585|FG000|Overall Study|Withdrawal by Subject|2|||
125271640|NCT01740687|450620585|FG000|Overall Study|other reason|22|||
125271641|NCT01740687|450620585|FG000|Overall Study|treatment not received|2|||
125271642|NCT00104728|450620587|FG000|Overall Study|screen failures|19|||
125271643|NCT01963767|450620588|FG000|Overall Study|Withdrawal by Subject|4|||
125271644|NCT01963767|450620589|FG001|Overall Study|Withdrawal by Subject|2|||
125271645|NCT01963767|450620588|FG000|Overall Study|Adverse Event|2|||
125271646|NCT01963767|450620589|FG001|Overall Study|Adverse Event|0|||
125271647|NCT03960684|450620590|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
125271648|NCT03941483|450620594|FG000|Overall Study|Miscellaneous|2|||
125271649|NCT03941483|450620595|FG001|Overall Study|Miscellaneous|3|||
125271650|NCT03941483|450620596|FG002|Overall Study|Miscellaneous|0|||
125271651|NCT03941483|450620594|FG000|Overall Study|Study Terminated by Sponsor|1|||
125271652|NCT03941483|450620595|FG001|Overall Study|Study Terminated by Sponsor|0|||
125271653|NCT03941483|450620596|FG002|Overall Study|Study Terminated by Sponsor|0|||
125271654|NCT03941483|450620594|FG000|Overall Study|Withdrawal by Subject|1|||
125271655|NCT03941483|450620595|FG001|Overall Study|Withdrawal by Subject|4|||
125271656|NCT03941483|450620596|FG002|Overall Study|Withdrawal by Subject|1|||
125271657|NCT03941483|450620594|FG000|Overall Study|Lost to Follow-up|2|||
125271658|NCT03941483|450620595|FG001|Overall Study|Lost to Follow-up|1|||
125271659|NCT03941483|450620596|FG002|Overall Study|Lost to Follow-up|8|||
125271660|NCT03941483|450620594|FG000|Overall Study|Death|3|||
125271661|NCT03941483|450620595|FG001|Overall Study|Death|2|||
125271662|NCT03941483|450620596|FG002|Overall Study|Death|6|||
125271663|NCT01082081|450620597|FG000|Overall Study|Lost to Follow-up|0|||
125271664|NCT01082081|450620598|FG001|Overall Study|Lost to Follow-up|0|||
125271665|NCT01082081|450620599|FG002|Overall Study|Lost to Follow-up|1|||
125271666|NCT01082081|450620597|FG000|Overall Study|Withdrawal by Subject|0|||
125271667|NCT01082081|450620598|FG001|Overall Study|Withdrawal by Subject|0|||
125271668|NCT01082081|450620599|FG002|Overall Study|Withdrawal by Subject|1|||
125271669|NCT01082081|450620597|FG000|Overall Study|Other Reason|0|||
125271670|NCT01082081|450620598|FG001|Overall Study|Other Reason|1|||
125271671|NCT01082081|450620599|FG002|Overall Study|Other Reason|0|||
125271672|NCT00670930|450620602|FG000|Overall Study|Adminstrative Problem|0|||
125271673|NCT00670930|450620603|FG001|Overall Study|Adminstrative Problem|1|||
125271674|NCT00670930|450620602|FG000|Overall Study|Lost to Follow-up|1|||
125271675|NCT00670930|450620603|FG001|Overall Study|Lost to Follow-up|0|||
125271676|NCT03493451|450622059|FG000|Overall Study|Death|11|||
125271677|NCT03493451|450622060|FG001|Overall Study|Death|26|||
125271678|NCT03493451|450622061|FG002|Overall Study|Death|3|||
125271679|NCT03493451|450622059|FG000|Overall Study|Lost to Follow-up|1|||
125271680|NCT03493451|450622060|FG001|Overall Study|Lost to Follow-up|4|||
125271681|NCT03493451|450622061|FG002|Overall Study|Lost to Follow-up|1|||
125271682|NCT03493451|450622059|FG000|Overall Study|Withdrawal by Subject|1|||
125271683|NCT03493451|450622060|FG001|Overall Study|Withdrawal by Subject|1|||
125271684|NCT03493451|450622061|FG002|Overall Study|Withdrawal by Subject|2|||
125271685|NCT03493451|450622059|FG000|Overall Study|Progressive Disease|1|||
125271686|NCT03493451|450622060|FG001|Overall Study|Progressive Disease|0|||
125271687|NCT03493451|450622061|FG002|Overall Study|Progressive Disease|0|||
125271688|NCT03493451|450622059|FG000|Overall Study|Transferred to long term extension study|8|||
125271689|NCT03493451|450622060|FG001|Overall Study|Transferred to long term extension study|13|||
125271690|NCT03493451|450622061|FG002|Overall Study|Transferred to long term extension study|5|||
125271691|NCT00600106|450622067|FG000|Overall Study|Withdrawal by Subject|1|||
125271692|NCT00600106|450622068|FG001|Overall Study|Withdrawal by Subject|1|||
125271693|NCT03015363|450622071|FG000|Overall Study|Physician Decision|14|||
125271694|NCT03015363|450622071|FG000|Overall Study|Withdrawal by Subject|3|||
125271695|NCT00833469|450622074|FG000|Overall Study|Withdrawal by Subject|1|||
125271696|NCT00833469|450622074|FG000|Overall Study|Lost to Follow-up|1|||
125271697|NCT01665911|450622075|FG000|Overall Study|Protocol Violation|4|||
125271698|NCT01665911|450622075|FG000|Overall Study|Withdrawal by Subject|1|||
125271699|NCT01665911|450622075|FG000|Overall Study|Adverse Event|1|||
125271700|NCT03650413|450622076|FG000|Overall Study|Adverse Event|1|||
125271701|NCT03650413|450622076|FG000|Overall Study|Lack of Efficacy|17|||
125271702|NCT03650413|450622076|FG000|Overall Study|Other|9|||
125271703|NCT03650413|450622076|FG000|Overall Study|Physician Decision|2|||
125271704|NCT03650413|450622076|FG000|Overall Study|Study Terminated By Sponsor|16|||
125271705|NCT03650413|450622076|FG000|Overall Study|Withdrawal by Subject|16|||
125271706|NCT01206140|450622077|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
125271707|NCT01206140|450622078|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
125271708|NCT00211172|450622079|FG000|Overall Study|Died or lost health plan eligibility|39|||
125271709|NCT00211172|450622080|FG001|Overall Study|Died or lost health plan eligibility|32|||
125271710|NCT00770562|450622084|FG000|Overall Study|Did not take treatment|1|||
125271711|NCT00770562|450622085|FG001|Overall Study|Did not take treatment|1|||
125271712|NCT01643408|450622088|FG000|Overall Study|Adverse Event|12|||
125271713|NCT01643408|450622088|FG000|Overall Study|Other|2|||
125271714|NCT02236572|450622089|FG000|Overall Study|Withdrawal by Subject|1|||
125271715|NCT02236572|450622089|FG000|Overall Study|Protocol Violation|1|||
125271716|NCT02236572|450622089|FG000|Overall Study|Lost to Follow-up|1|||
125271717|NCT01057693|450622090|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
125271718|NCT01057693|450622091|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
125271719|NCT01057693|450622092|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
125271720|NCT01057693|450622090|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
125271721|NCT01057693|450622091|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
125271722|NCT01057693|450622092|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
125271723|NCT01057693|450622090|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
125271724|NCT01057693|450622091|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
125271725|NCT01057693|450622092|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
125271726|NCT01057693|450622090|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
125271727|NCT01057693|450622091|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
125271728|NCT01057693|450622092|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
125271729|NCT01057693|450622090|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
125271730|NCT01057693|450622091|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
125271731|NCT01057693|450622092|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
125271732|NCT01057693|450622090|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
125271733|NCT01057693|450622091|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
125271734|NCT01057693|450622092|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
125271735|NCT01057693|450622090|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
125271736|NCT01057693|450622091|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
125271737|NCT01057693|450622092|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
125271738|NCT01057693|450622090|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
125271739|NCT01057693|450622091|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
125271740|NCT01057693|450622092|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
125271741|NCT01057693|450622090|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
125271742|NCT01057693|450622091|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
125271743|NCT01057693|450622092|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
125271744|NCT01057693|450622090|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
125271745|NCT01057693|450622091|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
125271746|NCT01057693|450622092|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
125271747|NCT01057693|450622090|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
125271748|NCT01057693|450622091|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
125271749|NCT01057693|450622092|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
125271750|NCT01057693|450622090|FG000|Between Single-Blind and Double-Blind|Other|6|||
125271751|NCT01057693|450622091|FG001|Between Single-Blind and Double-Blind|Other|0|||
125271752|NCT01057693|450622092|FG002|Between Single-Blind and Double-Blind|Other|0|||
125271753|NCT01057693|450622090|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
125271754|NCT01057693|450622091|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
125271755|NCT01057693|450622092|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
125271756|NCT01057693|450622090|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
125271757|NCT01057693|450622091|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
125271758|NCT01057693|450622092|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
125271759|NCT01057693|450622090|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
125271760|NCT01057693|450622091|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
125271761|NCT01057693|450622092|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
125271762|NCT01057693|450622090|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
125271763|NCT01057693|450622091|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
125271764|NCT01057693|450622092|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
125271765|NCT01057693|450622090|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
125271766|NCT01057693|450622091|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
125271767|NCT01057693|450622092|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
125271768|NCT01057693|450622090|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
125271769|NCT01057693|450622091|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
125271770|NCT01057693|450622092|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
125271771|NCT01057693|450622090|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
125271772|NCT01057693|450622091|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
125271773|NCT01057693|450622092|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
125271774|NCT00709319|450622094|FG000|Overall Study|Death|4|||
125271775|NCT00709319|450622094|FG000|Overall Study|Withdrawal by Subject|2|||
125271776|NCT00579553|450622095|FG000|Overall Study|Lost to Follow-up|16|||
125271777|NCT00579553|450622096|FG001|Overall Study|Lost to Follow-up|13|||
125271778|NCT00363142|450622099|FG000|Overall Study|Adverse Event|2|||
125271779|NCT00363142|450622100|FG001|Overall Study|Adverse Event|0|||
125271780|NCT00363142|450622099|FG000|Overall Study|Lack of Efficacy|0|||
125271781|NCT00363142|450622100|FG001|Overall Study|Lack of Efficacy|1|||
125271782|NCT00363142|450622099|FG000|Overall Study|Lost to Follow-up|1|||
125271783|NCT00363142|450622100|FG001|Overall Study|Lost to Follow-up|0|||
125271784|NCT00363142|450622099|FG000|Overall Study|Non-compliance|1|||
125271785|NCT00363142|450622100|FG001|Overall Study|Non-compliance|1|||
125271786|NCT00363142|450622099|FG000|Overall Study|Withdrawal by Subject|3|||
125271787|NCT00363142|450622100|FG001|Overall Study|Withdrawal by Subject|1|||
125271788|NCT01541865|450622101|FG000|Overall Study|Lost to Follow-up|11|||
125271789|NCT01541865|450622101|FG000|Overall Study|Withdrawal by Subject|9|||
125271790|NCT01541865|450622101|FG000|Overall Study|Adverse Event|1|||
125271791|NCT01541865|450622101|FG000|Overall Study|Protocol Violation|1|||
125271792|NCT03072043|450622104|FG000|Overall Study|Death|0|||
125271793|NCT03072043|450622105|FG001|Overall Study|Death|0|||
125271794|NCT03072043|450622106|FG002|Overall Study|Death|3|||
125271795|NCT03072043|450622104|FG000|Overall Study|Adverse Event|0|||
125271796|NCT03072043|450622105|FG001|Overall Study|Adverse Event|0|||
125271797|NCT03072043|450622106|FG002|Overall Study|Adverse Event|2|||
125271798|NCT03072043|450622104|FG000|Overall Study|Withdrawal by Subject|0|||
125271799|NCT03072043|450622105|FG001|Overall Study|Withdrawal by Subject|0|||
125271800|NCT03072043|450622106|FG002|Overall Study|Withdrawal by Subject|4|||
125271801|NCT01340664|450622107|FG000|Overall Study|Adverse Event|0|||
125271802|NCT01340664|450622108|FG001|Overall Study|Adverse Event|1|||
125271803|NCT01340664|450622109|FG002|Overall Study|Adverse Event|7|||
125271804|NCT01340664|450622107|FG000|Overall Study|Lost to Follow-up|2|||
125271805|NCT01340664|450622108|FG001|Overall Study|Lost to Follow-up|0|||
125271806|NCT01340664|450622109|FG002|Overall Study|Lost to Follow-up|2|||
125271807|NCT01340664|450622107|FG000|Overall Study|Withdrawal by Subject|2|||
125271808|NCT01340664|450622108|FG001|Overall Study|Withdrawal by Subject|4|||
125271809|NCT01340664|450622109|FG002|Overall Study|Withdrawal by Subject|0|||
125271810|NCT01340664|450622107|FG000|Overall Study|Glycemic withdrawal criteria|2|||
125271811|NCT01340664|450622108|FG001|Overall Study|Glycemic withdrawal criteria|0|||
125271812|NCT01340664|450622109|FG002|Overall Study|Glycemic withdrawal criteria|0|||
125271813|NCT01340664|450622107|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
125271814|NCT01340664|450622108|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
125271815|NCT01340664|450622109|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
125271816|NCT01340664|450622107|FG000|Overall Study|Other|1|||
125271817|NCT01340664|450622108|FG001|Overall Study|Other|2|||
125271818|NCT01340664|450622109|FG002|Overall Study|Other|2|||
125271819|NCT02997865|450622111|FG000|Overall Study|Death|2|||
125271820|NCT02997865|450622112|FG001|Overall Study|Death|1|||
125271821|NCT02997865|450622111|FG000|Overall Study|Lost to Follow-up|6|||
125271822|NCT02997865|450622112|FG001|Overall Study|Lost to Follow-up|3|||
125271823|NCT02997865|450622111|FG000|Overall Study|Withdrawal by Subject|5|||
125271824|NCT02997865|450622112|FG001|Overall Study|Withdrawal by Subject|0|||
125271825|NCT01926444|450622113|FG000|Overall Study|Colonoscopy not performed|0|||
125271826|NCT01926444|450622114|FG001|Overall Study|Colonoscopy not performed|0|||
125271827|NCT01926444|450622115|FG002|Overall Study|Colonoscopy not performed|4|||
125271828|NCT01926444|450622116|FG003|Overall Study|Colonoscopy not performed|2|||
125271829|NCT02528942|450622117|FG000|Overall Study|Did not meet imaging criteria|9|||
125271830|NCT02528942|450622117|FG000|Overall Study|Lost to Follow-up|25|||
125271831|NCT00881530|450622118|FG000|Overall Study|Adverse Event|5|||
125271832|NCT00881530|450622119|FG001|Overall Study|Adverse Event|1|||
125271833|NCT00881530|450622120|FG002|Overall Study|Adverse Event|1|||
125271834|NCT00881530|450622121|FG003|Overall Study|Adverse Event|4|||
125271835|NCT00881530|450622122|FG004|Overall Study|Adverse Event|10|||
125271836|NCT00881530|450622123|FG005|Overall Study|Adverse Event|2|||
125271837|NCT00881530|450622118|FG000|Overall Study|Lack of Efficacy|1|||
125271838|NCT00881530|450622119|FG001|Overall Study|Lack of Efficacy|0|||
125271839|NCT00881530|450622120|FG002|Overall Study|Lack of Efficacy|0|||
125271840|NCT00881530|450622121|FG003|Overall Study|Lack of Efficacy|0|||
125271841|NCT00881530|450622122|FG004|Overall Study|Lack of Efficacy|1|||
125271842|NCT00881530|450622123|FG005|Overall Study|Lack of Efficacy|1|||
125271843|NCT00881530|450622118|FG000|Overall Study|Not compliant with the protocol|0|||
125271844|NCT00881530|450622119|FG001|Overall Study|Not compliant with the protocol|0|||
125271845|NCT00881530|450622120|FG002|Overall Study|Not compliant with the protocol|0|||
125271846|NCT00881530|450622121|FG003|Overall Study|Not compliant with the protocol|0|||
125271847|NCT00881530|450622122|FG004|Overall Study|Not compliant with the protocol|2|||
125271848|NCT00881530|450622123|FG005|Overall Study|Not compliant with the protocol|0|||
125271849|NCT00881530|450622118|FG000|Overall Study|Lost to Follow-up|0|||
125271850|NCT00881530|450622119|FG001|Overall Study|Lost to Follow-up|1|||
125271851|NCT00881530|450622120|FG002|Overall Study|Lost to Follow-up|1|||
125271852|NCT00881530|450622121|FG003|Overall Study|Lost to Follow-up|3|||
125271853|NCT00881530|450622122|FG004|Overall Study|Lost to Follow-up|1|||
125271854|NCT00881530|450622123|FG005|Overall Study|Lost to Follow-up|0|||
125271855|NCT00881530|450622118|FG000|Overall Study|Refused to continue medication|7|||
125271856|NCT00881530|450622119|FG001|Overall Study|Refused to continue medication|2|||
125271857|NCT00881530|450622120|FG002|Overall Study|Refused to continue medication|1|||
125271858|NCT00881530|450622121|FG003|Overall Study|Refused to continue medication|2|||
125271859|NCT00881530|450622122|FG004|Overall Study|Refused to continue medication|0|||
125271860|NCT00881530|450622123|FG005|Overall Study|Refused to continue medication|0|||
125271861|NCT00881530|450622118|FG000|Overall Study|Other reason not defined above|1|||
125271862|NCT00881530|450622119|FG001|Overall Study|Other reason not defined above|1|||
125271863|NCT00881530|450622120|FG002|Overall Study|Other reason not defined above|2|||
125271864|NCT00881530|450622121|FG003|Overall Study|Other reason not defined above|0|||
125271865|NCT00881530|450622122|FG004|Overall Study|Other reason not defined above|0|||
125271866|NCT00881530|450622123|FG005|Overall Study|Other reason not defined above|2|||
125271867|NCT01509846|450622124|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
125271868|NCT01509846|450622125|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
125271869|NCT01509846|450622126|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
125271870|NCT01509846|450622127|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
125271871|NCT01509846|450622128|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
125271872|NCT01509846|450622124|FG000|Received Vaccination 2|Illness|0|||
125271873|NCT01509846|450622125|FG001|Received Vaccination 2|Illness|0|||
125271874|NCT01509846|450622126|FG002|Received Vaccination 2|Illness|0|||
125271875|NCT01509846|450622127|FG003|Received Vaccination 2|Illness|0|||
125271876|NCT01509846|450622128|FG004|Received Vaccination 2|Illness|1|||
125271877|NCT01509846|450622124|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
125271878|NCT01509846|450622125|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
125271879|NCT01509846|450622126|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
125271880|NCT01509846|450622127|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
125271881|NCT01509846|450622128|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
125271882|NCT01509846|450622124|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
125271883|NCT01509846|450622125|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
125271884|NCT01509846|450622126|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
125271885|NCT01509846|450622127|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
125271886|NCT01509846|450622128|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
125271887|NCT01509846|450622124|FG000|Received Vaccination 3|Pregnancy|0|||
125271888|NCT01509846|450622125|FG001|Received Vaccination 3|Pregnancy|0|||
125271889|NCT01509846|450622126|FG002|Received Vaccination 3|Pregnancy|0|||
125271890|NCT01509846|450622127|FG003|Received Vaccination 3|Pregnancy|1|||
125271891|NCT01509846|450622128|FG004|Received Vaccination 3|Pregnancy|0|||
125271892|NCT01509846|450622124|FG000|Received Vaccination 3|Lost to Follow-up|0|||
125271893|NCT01509846|450622125|FG001|Received Vaccination 3|Lost to Follow-up|0|||
125271894|NCT01509846|450622126|FG002|Received Vaccination 3|Lost to Follow-up|1|||
125271895|NCT01509846|450622127|FG003|Received Vaccination 3|Lost to Follow-up|0|||
125271896|NCT01509846|450622128|FG004|Received Vaccination 3|Lost to Follow-up|0|||
125271897|NCT01637584|450622129|FG000|Overall Study|Withdrawal by Subject|1|||
125271898|NCT01637584|450622130|FG001|Overall Study|Withdrawal by Subject|3|||
125271899|NCT02484443|450622131|FG000|Overall Study|Lack of Efficacy|28|||
125271900|NCT02484443|450622131|FG000|Overall Study|Physician Decision|2|||
125271901|NCT02484443|450622131|FG000|Overall Study|Ineligible|2|||
125271902|NCT02969915|450622132|FG000|Overall Study|Death|104|||
125271903|NCT02969915|450622133|FG001|Overall Study|Death|125|||
125271904|NCT02969915|450622132|FG000|Overall Study|Lost to Follow-up|108|||
125271905|NCT02969915|450622133|FG001|Overall Study|Lost to Follow-up|112|||
125271906|NCT02969915|450622132|FG000|Overall Study|Censored due to COVID-19|481|||
125271907|NCT02969915|450622133|FG001|Overall Study|Censored due to COVID-19|471|||
125271908|NCT03799952|450622134|FG000|Overall Study|Program was too easy, discontinued|1|||
125271909|NCT03799952|450622135|FG001|Overall Study|Program was too easy, discontinued|0|||
125271910|NCT03799952|450622134|FG000|Overall Study|Lost to Follow-up|0|||
125271911|NCT03799952|450622135|FG001|Overall Study|Lost to Follow-up|2|||
125271912|NCT01393899|450622136|FG000|Overall Study|Study terminated by sponsor|1|||
125271913|NCT01393899|450622137|FG001|Overall Study|Study terminated by sponsor|0|||
125271914|NCT01393899|450622138|FG002|Overall Study|Study terminated by sponsor|1|||
125271915|NCT01393899|450622136|FG000|Overall Study|Other|1|||
125271916|NCT01393899|450622137|FG001|Overall Study|Other|0|||
125271917|NCT01393899|450622138|FG002|Overall Study|Other|0|||
125271918|NCT01393899|450622136|FG000|Overall Study|Withdrawal by Subject|2|||
125271919|NCT01393899|450622137|FG001|Overall Study|Withdrawal by Subject|2|||
125271920|NCT01393899|450622138|FG002|Overall Study|Withdrawal by Subject|1|||
125271921|NCT01393899|450622136|FG000|Overall Study|Lost to Follow-up|0|||
125271922|NCT01393899|450622137|FG001|Overall Study|Lost to Follow-up|0|||
125271923|NCT01393899|450622138|FG002|Overall Study|Lost to Follow-up|1|||
125271924|NCT01393899|450622136|FG000|Overall Study|Does not meet entrance criteria|1|||
125271925|NCT01393899|450622137|FG001|Overall Study|Does not meet entrance criteria|0|||
125271926|NCT01393899|450622138|FG002|Overall Study|Does not meet entrance criteria|1|||
125271927|NCT01393899|450622136|FG000|Overall Study|Lack of Efficacy|26|||
125271928|NCT01393899|450622137|FG001|Overall Study|Lack of Efficacy|21|||
125271929|NCT01393899|450622138|FG002|Overall Study|Lack of Efficacy|16|||
125271930|NCT01393899|450622136|FG000|Overall Study|Adverse Event|1|||
125271931|NCT01393899|450622137|FG001|Overall Study|Adverse Event|5|||
125271932|NCT01393899|450622138|FG002|Overall Study|Adverse Event|3|||
125271933|NCT02503085|450622139|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
125271934|NCT02503085|450622140|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
125271935|NCT02503085|450622141|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
125271936|NCT02503085|450622142|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
125271937|NCT02595866|450622143|FG000|Overall Study|Adverse Event|2|||
125271938|NCT02595866|450622144|FG001|Overall Study|Adverse Event|5|||
125271939|NCT02595866|450622143|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
125271940|NCT02595866|450622144|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
125271941|NCT02595866|450622143|FG000|Overall Study|Death|0|||
125271942|NCT02595866|450622144|FG001|Overall Study|Death|1|||
125271943|NCT02595866|450622143|FG000|Overall Study|Incarceration|1|||
125271944|NCT02595866|450622144|FG001|Overall Study|Incarceration|0|||
125271945|NCT02595866|450622143|FG000|Overall Study|Lack of Efficacy|17|||
125271946|NCT02595866|450622144|FG001|Overall Study|Lack of Efficacy|7|||
125271947|NCT02595866|450622143|FG000|Overall Study|Physician Decision|4|||
125271948|NCT02595866|450622144|FG001|Overall Study|Physician Decision|3|||
125271949|NCT02595866|450622143|FG000|Overall Study|Switched to Alternative Treatment|1|||
125271950|NCT02595866|450622144|FG001|Overall Study|Switched to Alternative Treatment|0|||
125271951|NCT02595866|450622143|FG000|Overall Study|Study Terminated|0|||
125271952|NCT02595866|450622144|FG001|Overall Study|Study Terminated|4|||
125271953|NCT02595866|450622143|FG000|Overall Study|Withdrawal by Subject|6|||
125271954|NCT02595866|450622144|FG001|Overall Study|Withdrawal by Subject|1|||
125271955|NCT02520388|450622145|FG000|Overall Study|Physician Decision|1|||
125271956|NCT02520388|450622146|FG001|Overall Study|Physician Decision|0|||
125271957|NCT02520388|450622145|FG000|Overall Study|Subject or parent/guardian request|0|||
125271958|NCT02520388|450622146|FG001|Overall Study|Subject or parent/guardian request|6|||
125271959|NCT02520388|450622145|FG000|Overall Study|Adverse Event|1|||
125271960|NCT02520388|450622146|FG001|Overall Study|Adverse Event|4|||
125271961|NCT02520388|450622145|FG000|Overall Study|Lost to Follow-up|3|||
125271962|NCT02520388|450622146|FG001|Overall Study|Lost to Follow-up|2|||
125271963|NCT02520388|450622145|FG000|Overall Study|Other (reason not defined)|4|||
125271964|NCT02520388|450622146|FG001|Overall Study|Other (reason not defined)|4|||
125271965|NCT01232127|450622147|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
125271966|NCT01232127|450622148|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
125271967|NCT01232127|450622149|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
125271968|NCT03035864|450622155|FG000|Treatment Period|Adverse Event|1|||
125271969|NCT03035864|450622156|FG001|Treatment Period|Adverse Event|0|||
125271970|NCT03035864|450622155|FG000|Treatment Period|Other|3|||
125271971|NCT03035864|450622156|FG001|Treatment Period|Other|1|||
125271972|NCT03035864|450622155|FG000|Follow-up Period|Adverse Event|1|||
125271973|NCT03035864|450622156|FG001|Follow-up Period|Adverse Event|0|||
125271974|NCT03035864|450622155|FG000|Follow-up Period|Lost to Follow-up|6|||
125271975|NCT03035864|450622156|FG001|Follow-up Period|Lost to Follow-up|2|||
125271976|NCT03035864|450622155|FG000|Follow-up Period|Physician Decision|1|||
125271977|NCT03035864|450622156|FG001|Follow-up Period|Physician Decision|0|||
125271978|NCT03035864|450622155|FG000|Follow-up Period|Other|3|||
125271979|NCT03035864|450622156|FG001|Follow-up Period|Other|2|||
125271980|NCT02375373|450622161|FG000|Overall Study|Withdrawal by Subject|11|||
125271981|NCT01890265|450622162|FG000|Overall Study|Other (Unspecified reason)|0|||
125271982|NCT01890265|450622163|FG001|Overall Study|Other (Unspecified reason)|1|||
125271983|NCT01890265|450622164|FG002|Overall Study|Other (Unspecified reason)|0|||
125271984|NCT01890265|450622165|FG003|Overall Study|Other (Unspecified reason)|0|||
125271985|NCT01890265|450622166|FG004|Overall Study|Other (Unspecified reason)|0|||
125271986|NCT01890265|450622167|FG005|Overall Study|Other (Unspecified reason)|0|||
125271987|NCT01890265|450622162|FG000|Overall Study|Progressive disease|6|||
125271988|NCT01890265|450622163|FG001|Overall Study|Progressive disease|6|||
125271989|NCT01890265|450622164|FG002|Overall Study|Progressive disease|0|||
125271990|NCT01890265|450622165|FG003|Overall Study|Progressive disease|0|||
125271991|NCT01890265|450622166|FG004|Overall Study|Progressive disease|0|||
125271992|NCT01890265|450622167|FG005|Overall Study|Progressive disease|0|||
125271993|NCT01890265|450622162|FG000|Overall Study|Adverse Event|2|||
125271994|NCT01890265|450622163|FG001|Overall Study|Adverse Event|1|||
125271995|NCT01890265|450622164|FG002|Overall Study|Adverse Event|0|||
125271996|NCT01890265|450622165|FG003|Overall Study|Adverse Event|0|||
125271997|NCT01890265|450622166|FG004|Overall Study|Adverse Event|0|||
125271998|NCT01890265|450622167|FG005|Overall Study|Adverse Event|0|||
125271999|NCT01890265|450622162|FG000|Overall Study|Death|2|||
125272000|NCT01890265|450622163|FG001|Overall Study|Death|3|||
125272001|NCT01890265|450622164|FG002|Overall Study|Death|1|||
125272002|NCT01890265|450622165|FG003|Overall Study|Death|0|||
125272003|NCT01890265|450622166|FG004|Overall Study|Death|0|||
125272004|NCT01890265|450622167|FG005|Overall Study|Death|0|||
125272005|NCT01890265|450622162|FG000|Overall Study|Withdrawal by Subject|0|||
125272006|NCT01890265|450622163|FG001|Overall Study|Withdrawal by Subject|2|||
125272007|NCT01890265|450622164|FG002|Overall Study|Withdrawal by Subject|3|||
125272008|NCT01890265|450622165|FG003|Overall Study|Withdrawal by Subject|0|||
125272009|NCT01890265|450622166|FG004|Overall Study|Withdrawal by Subject|2|||
125272010|NCT01890265|450622167|FG005|Overall Study|Withdrawal by Subject|0|||
125272011|NCT01445613|450622168|FG000|30-day Follow-up|Withdrawal by Subject|6|||
125272012|NCT01445613|450622168|FG000|30-day Follow-up|Physician Decision|3|||
125272013|NCT01445613|450622168|FG000|30-day Follow-up|Missed visit|23|||
125272014|NCT01445613|450622168|FG000|30-day Follow-up|Death|3|||
125272015|NCT01445613|450622168|FG000|1-year Follow-up|Withdrawal by Subject|12|||
125272016|NCT01445613|450622168|FG000|1-year Follow-up|Missed visit|29|||
125272017|NCT01445613|450622168|FG000|1-year Follow-up|Lost to Follow-up|2|||
125272018|NCT01445613|450622168|FG000|1-year Follow-up|Death|30|||
125272019|NCT01445613|450622168|FG000|1-year Follow-up|Physician Decision|2|||
125272020|NCT01445613|450622168|FG000|1-year Follow-up|Received a non-study stent|2|||
125272021|NCT00809926|450622171|FG000|Overall Study|Adverse Event|18|||
125272022|NCT00809926|450622172|FG001|Overall Study|Adverse Event|10|||
125272023|NCT00809926|450622171|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
125272024|NCT00809926|450622172|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
125272025|NCT00809926|450622171|FG000|Overall Study|Patient withdrew consent|8|||
125272026|NCT00809926|450622172|FG001|Overall Study|Patient withdrew consent|6|||
125272027|NCT00809926|450622171|FG000|Overall Study|Lost to Follow-up|2|||
125272028|NCT00809926|450622172|FG001|Overall Study|Lost to Follow-up|1|||
125272029|NCT00809926|450622171|FG000|Overall Study|Administrative Problems|0|||
125272030|NCT00809926|450622172|FG001|Overall Study|Administrative Problems|1|||
125272031|NCT00809926|450622171|FG000|Overall Study|Protocol deviation|0|||
125272032|NCT00809926|450622172|FG001|Overall Study|Protocol deviation|2|||
125272033|NCT00642707|450622173|FG000|Overall Study|Adverse Event|0|||
125272034|NCT00642707|450622174|FG001|Overall Study|Adverse Event|0|||
125272035|NCT00642707|450622175|FG002|Overall Study|Adverse Event|0|||
125272036|NCT00642707|450622176|FG003|Overall Study|Adverse Event|2|||
125272037|NCT00642707|450622173|FG000|Overall Study|Withdrawal by Subject|1|||
125272038|NCT00642707|450622174|FG001|Overall Study|Withdrawal by Subject|0|||
125272039|NCT00642707|450622175|FG002|Overall Study|Withdrawal by Subject|0|||
125272040|NCT00642707|450622176|FG003|Overall Study|Withdrawal by Subject|0|||
125272041|NCT00130039|450622177|FG000|Overall Study|Withdrawal by Subject|15|||
125272042|NCT00130039|450622178|FG001|Overall Study|Withdrawal by Subject|11|||
125272043|NCT00130039|450622177|FG000|Overall Study|Lost to Follow-up|3|||
125272044|NCT00130039|450622178|FG001|Overall Study|Lost to Follow-up|1|||
125272045|NCT00130039|450622177|FG000|Overall Study|Adverse Event|4|||
125272046|NCT00130039|450622178|FG001|Overall Study|Adverse Event|2|||
125272047|NCT00130039|450622177|FG000|Overall Study|Physician Decision|3|||
125272048|NCT00130039|450622178|FG001|Overall Study|Physician Decision|0|||
125272049|NCT00130039|450622177|FG000|Overall Study|clinical events without follow up MRI|5|||
125272050|NCT00130039|450622178|FG001|Overall Study|clinical events without follow up MRI|4|||
125272051|NCT00100802|450622186|FG000|Overall Study|Adverse Event|9|||
125272052|NCT00100802|450622186|FG000|Overall Study|Death|1|||
125272053|NCT00100802|450622186|FG000|Overall Study|Lack of Efficacy|47|||
125272054|NCT00100802|450622186|FG000|Overall Study|Physician Decision|5|||
125272055|NCT00100802|450622186|FG000|Overall Study|Protocol Violation|1|||
125272056|NCT00100802|450622186|FG000|Overall Study|Withdrawal by Subject|5|||
125272057|NCT00100802|450622186|FG000|Overall Study|Ineligible|12|||
125272058|NCT02709720|450622187|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
125272059|NCT02709720|450622187|FG000|Overall Study|Protocol Violation|1|||
125272060|NCT02709720|450622187|FG000|Overall Study|Not take study medication|1|||
125272061|NCT01198574|450622188|FG000|Overall Study|Resigned from schools|4|||
125272062|NCT01198574|450622189|FG001|Overall Study|Resigned from schools|1|||
125272063|NCT01198574|450622190|FG002|Overall Study|Resigned from schools|1|||
125272064|NCT01198574|450622191|FG003|Overall Study|Resigned from schools|4|||
125272065|NCT00325130|450622220|FG000|Overall Study|Lost to Follow-up|6|||
125272066|NCT00325130|450622221|FG001|Overall Study|Lost to Follow-up|14|||
125272067|NCT00325130|450622220|FG000|Overall Study|Withdrawal by Subject|12|||
125272068|NCT00325130|450622221|FG001|Overall Study|Withdrawal by Subject|14|||
125272069|NCT00325130|450622220|FG000|Overall Study|Protocol Deviation|0|||
125272070|NCT00325130|450622221|FG001|Overall Study|Protocol Deviation|1|||
125272071|NCT00325130|450622220|FG000|Overall Study|Moved|0|||
125272072|NCT00325130|450622221|FG001|Overall Study|Moved|1|||
125272073|NCT00325130|450622220|FG000|Overall Study|Patient Discontinued for Other|1|||
125272074|NCT00325130|450622221|FG001|Overall Study|Patient Discontinued for Other|0|||
125272075|NCT00326001|450622222|FG000|Overall Study|Adverse Event|4|||
125272076|NCT00326001|450622223|FG001|Overall Study|Adverse Event|5|||
125272077|NCT00326001|450622222|FG000|Overall Study|Physician Decision|3|||
125272078|NCT00326001|450622223|FG001|Overall Study|Physician Decision|3|||
125272079|NCT01042158|450622224|FG000|Overall Study|Physician Decision|1|||
125272080|NCT03640325|450623517|FG000|Overall Study|Withdrawal by Subject|4|||
125272081|NCT03640325|450623518|FG001|Overall Study|Withdrawal by Subject|1|||
125272082|NCT03640325|450623519|FG002|Overall Study|Withdrawal by Subject|0|||
125272083|NCT03640325|450623517|FG000|Overall Study|Lost to Follow-up|4|||
125272084|NCT03640325|450623518|FG001|Overall Study|Lost to Follow-up|5|||
125272085|NCT03640325|450623519|FG002|Overall Study|Lost to Follow-up|21|||
125272086|NCT03640325|450623517|FG000|Overall Study|Death|5|||
125272087|NCT03640325|450623518|FG001|Overall Study|Death|5|||
125272088|NCT03640325|450623519|FG002|Overall Study|Death|0|||
125272089|NCT01133756|450623523|FG000|Overall Study|Adverse Event|1|||
125272090|NCT01133756|450623524|FG001|Overall Study|Adverse Event|2|||
125272091|NCT01133756|450623525|FG002|Overall Study|Adverse Event|1|||
125272092|NCT01133756|450623523|FG000|Overall Study|Investigator Decision|1|||
125272093|NCT01133756|450623524|FG001|Overall Study|Investigator Decision|0|||
125272094|NCT01133756|450623525|FG002|Overall Study|Investigator Decision|0|||
125272095|NCT01133756|450623523|FG000|Overall Study|Withdrawal by Subject|0|||
125272096|NCT01133756|450623524|FG001|Overall Study|Withdrawal by Subject|1|||
125272097|NCT01133756|450623525|FG002|Overall Study|Withdrawal by Subject|0|||
125272098|NCT01133756|450623523|FG000|Overall Study|Progression of Disease|0|||
125272099|NCT01133756|450623524|FG001|Overall Study|Progression of Disease|0|||
125272100|NCT01133756|450623525|FG002|Overall Study|Progression of Disease|1|||
125272101|NCT01566149|450623526|FG000|Overall Study|Adverse Event|0|||
125272102|NCT01566149|450623527|FG001|Overall Study|Adverse Event|1|||
125272103|NCT01566149|450623526|FG000|Overall Study|Non-compliance with study medication|2|||
125272104|NCT01566149|450623527|FG001|Overall Study|Non-compliance with study medication|0|||
125272105|NCT01566149|450623526|FG000|Overall Study|Protocol Violation|0|||
125272106|NCT01566149|450623527|FG001|Overall Study|Protocol Violation|1|||
125272107|NCT01566149|450623526|FG000|Overall Study|Withdrawal by Subject|1|||
125272108|NCT01566149|450623527|FG001|Overall Study|Withdrawal by Subject|0|||
125272109|NCT03276728|450623530|FG000|Overall Study|Lost to Follow-up|0|||
125272110|NCT03276728|450623531|FG001|Overall Study|Lost to Follow-up|0|||
125272111|NCT03276728|450623532|FG002|Overall Study|Lost to Follow-up|2|||
125272112|NCT03276728|450623533|FG003|Overall Study|Lost to Follow-up|2|||
125272113|NCT03276728|450623534|FG004|Overall Study|Lost to Follow-up|0|||
125272114|NCT03276728|450623535|FG005|Overall Study|Lost to Follow-up|0|||
125272115|NCT03276728|450623536|FG006|Overall Study|Lost to Follow-up|0|||
125272116|NCT03276728|450623537|FG007|Overall Study|Lost to Follow-up|0|||
125272117|NCT03276728|450623530|FG000|Overall Study|Withdrawal by Subject|0|||
125272118|NCT03276728|450623531|FG001|Overall Study|Withdrawal by Subject|0|||
125272119|NCT03276728|450623532|FG002|Overall Study|Withdrawal by Subject|0|||
125272120|NCT03276728|450623533|FG003|Overall Study|Withdrawal by Subject|3|||
125272121|NCT03276728|450623534|FG004|Overall Study|Withdrawal by Subject|0|||
125272122|NCT03276728|450623535|FG005|Overall Study|Withdrawal by Subject|0|||
125272123|NCT03276728|450623536|FG006|Overall Study|Withdrawal by Subject|0|||
125272124|NCT03276728|450623537|FG007|Overall Study|Withdrawal by Subject|0|||
125272125|NCT03276728|450623530|FG000|Overall Study|Decision by sponsor|0|||
125272126|NCT03276728|450623531|FG001|Overall Study|Decision by sponsor|0|||
125272127|NCT03276728|450623532|FG002|Overall Study|Decision by sponsor|0|||
125272128|NCT03276728|450623533|FG003|Overall Study|Decision by sponsor|0|||
125272129|NCT03276728|450623534|FG004|Overall Study|Decision by sponsor|1|||
125272130|NCT03276728|450623535|FG005|Overall Study|Decision by sponsor|0|||
125272131|NCT03276728|450623536|FG006|Overall Study|Decision by sponsor|2|||
125272132|NCT03276728|450623537|FG007|Overall Study|Decision by sponsor|1|||
125272133|NCT03941873|450623544|FG000|Overall Study|Death|0|||
125272134|NCT03941873|450623545|FG001|Overall Study|Death|12|||
125272135|NCT03941873|450623546|FG002|Overall Study|Death|2|||
125272136|NCT03941873|450623547|FG003|Overall Study|Death|53|||
125272137|NCT03941873|450623544|FG000|Overall Study|Withdrawal by Subject|1|||
125272138|NCT03941873|450623545|FG001|Overall Study|Withdrawal by Subject|1|||
125272139|NCT03941873|450623546|FG002|Overall Study|Withdrawal by Subject|0|||
125272140|NCT03941873|450623547|FG003|Overall Study|Withdrawal by Subject|5|||
125272141|NCT03941873|450623544|FG000|Overall Study|Lost to Follow-up|1|||
125272142|NCT03941873|450623545|FG001|Overall Study|Lost to Follow-up|2|||
125272143|NCT03941873|450623546|FG002|Overall Study|Lost to Follow-up|0|||
125272144|NCT03941873|450623547|FG003|Overall Study|Lost to Follow-up|0|||
125272145|NCT03941873|450623544|FG000|Overall Study|Sponsor Decision|0|||
125272146|NCT03941873|450623545|FG001|Overall Study|Sponsor Decision|6|||
125272147|NCT03941873|450623546|FG002|Overall Study|Sponsor Decision|0|||
125272148|NCT03941873|450623547|FG003|Overall Study|Sponsor Decision|15|||
125272149|NCT01234480|450623548|FG000|Overall Study|Pregnancy|88|||
125272150|NCT01234480|450623548|FG000|Overall Study|>36/Normal History|50|||
125272151|NCT01234480|450623548|FG000|Overall Study|Age|3|||
125272152|NCT01234480|450623548|FG000|Overall Study|HPV Vaccine History|28|||
125272153|NCT01234480|450623548|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
125272154|NCT01234480|450623548|FG000|Overall Study|Hysterectomy|2|||
125272155|NCT01234480|450623548|FG000|Overall Study|Hysterectomy post enrollment|1|||
125272156|NCT01234480|450623548|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
125272157|NCT01234480|450623548|FG000|Overall Study|Informed Consent Form Violation|30|||
125272158|NCT01234480|450623548|FG000|Overall Study|Incorrect Visit|3|||
125272159|NCT01234480|450623548|FG000|Overall Study|No Florida Lab License|20|||
125272160|NCT01234480|450623548|FG000|Overall Study|Out of Window|42|||
125272161|NCT01234480|450623548|FG000|Overall Study|Sample Processing/Storage|92|||
125272162|NCT01234480|450623548|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
125272163|NCT01234480|450623548|FG000|Overall Study|Site/Subject non-compliance|44|||
125272164|NCT01234480|450623548|FG000|Overall Study|Missing Sample|9|||
125272165|NCT02982772|450623549|FG000|Intervention|Lost to Follow-up|19|||
125272166|NCT02982772|450623550|FG001|Intervention|Lost to Follow-up|13|||
125272167|NCT02982772|450623549|FG000|1M Follow-Up|Lost to Follow-up|21|||
125272168|NCT02982772|450623550|FG001|1M Follow-Up|Lost to Follow-up|18|||
125272169|NCT02982772|450623549|FG000|3M Follow-Up|Lost to Follow-up|17|||
125272170|NCT02982772|450623550|FG001|3M Follow-Up|Lost to Follow-up|11|||
125272171|NCT02982772|450623549|FG000|6M Follow-Up|Lost to Follow-up|11|||
125272172|NCT02982772|450623550|FG001|6M Follow-Up|Lost to Follow-up|9|||
125272173|NCT02982772|450623549|FG000|12M Follow-Up|Lost to Follow-up|11|||
125272174|NCT02982772|450623550|FG001|12M Follow-Up|Lost to Follow-up|5|||
125272175|NCT01238991|450623553|FG000|Overall Study|Adverse Event|1|||
125272176|NCT01238991|450623554|FG001|Overall Study|Adverse Event|0|||
125272177|NCT01238991|450623555|FG002|Overall Study|Adverse Event|3|||
125272178|NCT01238991|450623556|FG003|Overall Study|Adverse Event|1|||
125272179|NCT01238991|450623557|FG004|Overall Study|Adverse Event|1|||
125272180|NCT01238991|450623558|FG005|Overall Study|Adverse Event|0|||
125272181|NCT01238991|450623559|FG006|Overall Study|Adverse Event|1|||
125272182|NCT01238991|450623560|FG007|Overall Study|Adverse Event|1|||
125272183|NCT01238991|450623561|FG008|Overall Study|Adverse Event|0|||
125272184|NCT01238991|450623562|FG009|Overall Study|Adverse Event|0|||
125272185|NCT01238991|450623553|FG000|Overall Study|Death|0|||
125272186|NCT01238991|450623554|FG001|Overall Study|Death|0|||
125272187|NCT01238991|450623555|FG002|Overall Study|Death|0|||
125272188|NCT01238991|450623556|FG003|Overall Study|Death|1|||
125272189|NCT01238991|450623557|FG004|Overall Study|Death|0|||
125272190|NCT01238991|450623558|FG005|Overall Study|Death|0|||
125272191|NCT01238991|450623559|FG006|Overall Study|Death|0|||
125272192|NCT01238991|450623560|FG007|Overall Study|Death|0|||
125272193|NCT01238991|450623561|FG008|Overall Study|Death|0|||
125272194|NCT01238991|450623562|FG009|Overall Study|Death|0|||
125272195|NCT01238991|450623553|FG000|Overall Study|Lack of Efficacy|0|||
125272196|NCT01238991|450623554|FG001|Overall Study|Lack of Efficacy|0|||
125272197|NCT01238991|450623555|FG002|Overall Study|Lack of Efficacy|1|||
125272198|NCT01238991|450623556|FG003|Overall Study|Lack of Efficacy|0|||
125272199|NCT01238991|450623557|FG004|Overall Study|Lack of Efficacy|0|||
125272200|NCT01238991|450623558|FG005|Overall Study|Lack of Efficacy|0|||
125272201|NCT01238991|450623559|FG006|Overall Study|Lack of Efficacy|0|||
125272202|NCT01238991|450623560|FG007|Overall Study|Lack of Efficacy|0|||
125272203|NCT01238991|450623561|FG008|Overall Study|Lack of Efficacy|1|||
125272204|NCT01238991|450623562|FG009|Overall Study|Lack of Efficacy|0|||
125272205|NCT01238991|450623553|FG000|Overall Study|Withdrawal by Subject|0|||
125272206|NCT01238991|450623554|FG001|Overall Study|Withdrawal by Subject|0|||
125272207|NCT01238991|450623555|FG002|Overall Study|Withdrawal by Subject|1|||
125272208|NCT01238991|450623556|FG003|Overall Study|Withdrawal by Subject|0|||
125272209|NCT01238991|450623557|FG004|Overall Study|Withdrawal by Subject|0|||
125272210|NCT01238991|450623558|FG005|Overall Study|Withdrawal by Subject|0|||
125272211|NCT01238991|450623559|FG006|Overall Study|Withdrawal by Subject|0|||
125272212|NCT01238991|450623560|FG007|Overall Study|Withdrawal by Subject|0|||
125272213|NCT01238991|450623561|FG008|Overall Study|Withdrawal by Subject|0|||
125272214|NCT01238991|450623562|FG009|Overall Study|Withdrawal by Subject|0|||
125272215|NCT01238991|450623553|FG000|Overall Study|Study Terminated by Sponsor|0|||
125272216|NCT01238991|450623554|FG001|Overall Study|Study Terminated by Sponsor|0|||
125272217|NCT01238991|450623555|FG002|Overall Study|Study Terminated by Sponsor|0|||
125272218|NCT01238991|450623556|FG003|Overall Study|Study Terminated by Sponsor|0|||
125272219|NCT01238991|450623557|FG004|Overall Study|Study Terminated by Sponsor|1|||
125272220|NCT01238991|450623558|FG005|Overall Study|Study Terminated by Sponsor|0|||
125272221|NCT01238991|450623559|FG006|Overall Study|Study Terminated by Sponsor|7|||
125272222|NCT01238991|450623560|FG007|Overall Study|Study Terminated by Sponsor|4|||
125272223|NCT01238991|450623561|FG008|Overall Study|Study Terminated by Sponsor|2|||
125272224|NCT01238991|450623562|FG009|Overall Study|Study Terminated by Sponsor|2|||
125272225|NCT01238991|450623553|FG000|Overall Study|Caregiver's request|0|||
125272226|NCT01238991|450623554|FG001|Overall Study|Caregiver's request|0|||
125272227|NCT01238991|450623555|FG002|Overall Study|Caregiver's request|0|||
125272228|NCT01238991|450623556|FG003|Overall Study|Caregiver's request|0|||
125272229|NCT01238991|450623557|FG004|Overall Study|Caregiver's request|0|||
125272230|NCT01238991|450623558|FG005|Overall Study|Caregiver's request|0|||
125272231|NCT01238991|450623559|FG006|Overall Study|Caregiver's request|0|||
125272232|NCT01238991|450623560|FG007|Overall Study|Caregiver's request|0|||
125272233|NCT01238991|450623561|FG008|Overall Study|Caregiver's request|1|||
125272234|NCT01238991|450623562|FG009|Overall Study|Caregiver's request|0|||
125272235|NCT01238991|450623553|FG000|Overall Study|Admission to a nursing home|1|||
125272236|NCT01238991|450623554|FG001|Overall Study|Admission to a nursing home|0|||
125272237|NCT01238991|450623555|FG002|Overall Study|Admission to a nursing home|1|||
125272238|NCT01238991|450623556|FG003|Overall Study|Admission to a nursing home|0|||
125272239|NCT01238991|450623557|FG004|Overall Study|Admission to a nursing home|0|||
125272240|NCT01238991|450623558|FG005|Overall Study|Admission to a nursing home|0|||
125272241|NCT01238991|450623559|FG006|Overall Study|Admission to a nursing home|0|||
125272242|NCT01238991|450623560|FG007|Overall Study|Admission to a nursing home|0|||
125272243|NCT01238991|450623561|FG008|Overall Study|Admission to a nursing home|0|||
125272244|NCT01238991|450623562|FG009|Overall Study|Admission to a nursing home|0|||
125272245|NCT03370419|450623563|FG000|Overall Study|Lost to Follow-up|16|||
125272246|NCT01897727|450623568|FG000|Overall Study|Exclusion: central sleep apnea|0|||
125272247|NCT01897727|450623569|FG001|Overall Study|Exclusion: central sleep apnea|1|||
125272248|NCT02013778|450623572|FG000|Overall Study|Death|4|||
125272249|NCT02013778|450623572|FG000|Overall Study|Withdrawal by Subject|1|||
125272250|NCT02013778|450623572|FG000|Overall Study|Physician Decision|1|||
125272251|NCT02013778|450623572|FG000|Overall Study|Adverse Event|1|||
125272252|NCT00293813|450623573|FG000|Overall Study|Physician Decision|0|||
125272253|NCT00293813|450623574|FG001|Overall Study|Physician Decision|1|||
125272254|NCT00293813|450623575|FG002|Overall Study|Physician Decision|0|||
125272255|NCT00293813|450623573|FG000|Overall Study|Adverse Event|3|||
125272256|NCT00293813|450623574|FG001|Overall Study|Adverse Event|1|||
125272257|NCT00293813|450623575|FG002|Overall Study|Adverse Event|1|||
125272258|NCT00293813|450623573|FG000|Overall Study|Withdrawal by Subject|7|||
125272259|NCT00293813|450623574|FG001|Overall Study|Withdrawal by Subject|4|||
125272260|NCT00293813|450623575|FG002|Overall Study|Withdrawal by Subject|4|||
125272261|NCT00293813|450623573|FG000|Overall Study|Lost to Follow-up|3|||
125272262|NCT00293813|450623574|FG001|Overall Study|Lost to Follow-up|2|||
125272263|NCT00293813|450623575|FG002|Overall Study|Lost to Follow-up|3|||
125272264|NCT00293813|450623573|FG000|Overall Study|Noncompliance|0|||
125272265|NCT00293813|450623574|FG001|Overall Study|Noncompliance|1|||
125272266|NCT00293813|450623575|FG002|Overall Study|Noncompliance|0|||
125272267|NCT01521923|450623578|FG000|Overall Study|AE, serious fatal|1|||
125272268|NCT01521923|450623579|FG001|Overall Study|AE, serious fatal|0|||
125272269|NCT01521923|450623580|FG002|Overall Study|AE, serious fatal|0|||
125272270|NCT01521923|450623581|FG003|Overall Study|AE, serious fatal|0|||
125272271|NCT01521923|450623578|FG000|Overall Study|SAE, non-fatal|0|||
125272272|NCT01521923|450623579|FG001|Overall Study|SAE, non-fatal|2|||
125272273|NCT01521923|450623580|FG002|Overall Study|SAE, non-fatal|2|||
125272274|NCT01521923|450623581|FG003|Overall Study|SAE, non-fatal|0|||
125272275|NCT01521923|450623578|FG000|Overall Study|AE, non-serious, non-fatal|1|||
125272276|NCT01521923|450623579|FG001|Overall Study|AE, non-serious, non-fatal|3|||
125272277|NCT01521923|450623580|FG002|Overall Study|AE, non-serious, non-fatal|6|||
125272278|NCT01521923|450623581|FG003|Overall Study|AE, non-serious, non-fatal|2|||
125272279|NCT01521923|450623578|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
125272280|NCT01521923|450623579|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
125272281|NCT01521923|450623580|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
125272282|NCT01521923|450623581|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
125272283|NCT01521923|450623578|FG000|Overall Study|Lack of Efficacy|1|||
125272284|NCT01521923|450623579|FG001|Overall Study|Lack of Efficacy|1|||
125272285|NCT01521923|450623580|FG002|Overall Study|Lack of Efficacy|0|||
125272286|NCT01521923|450623581|FG003|Overall Study|Lack of Efficacy|0|||
125272287|NCT01521923|450623578|FG000|Overall Study|Protocol Violation|0|||
125272288|NCT01521923|450623579|FG001|Overall Study|Protocol Violation|0|||
125272289|NCT01521923|450623580|FG002|Overall Study|Protocol Violation|1|||
125272290|NCT01521923|450623581|FG003|Overall Study|Protocol Violation|0|||
125272291|NCT01521923|450623578|FG000|Overall Study|Lost to Follow-up|1|||
125272292|NCT01521923|450623579|FG001|Overall Study|Lost to Follow-up|0|||
125272293|NCT01521923|450623580|FG002|Overall Study|Lost to Follow-up|2|||
125272294|NCT01521923|450623581|FG003|Overall Study|Lost to Follow-up|1|||
125272295|NCT01521923|450623578|FG000|Overall Study|Withdrawal by Subject|1|||
125272296|NCT01521923|450623579|FG001|Overall Study|Withdrawal by Subject|1|||
125272297|NCT01521923|450623580|FG002|Overall Study|Withdrawal by Subject|1|||
125272298|NCT01521923|450623581|FG003|Overall Study|Withdrawal by Subject|2|||
125272299|NCT01521923|450623578|FG000|Overall Study|Other|2|||
125272300|NCT01521923|450623579|FG001|Overall Study|Other|1|||
125272301|NCT01521923|450623580|FG002|Overall Study|Other|3|||
125272302|NCT01521923|450623581|FG003|Overall Study|Other|6|||
125272303|NCT01521923|450623578|FG000|Overall Study|AE, captured in Period 1|0|||
125272304|NCT01521923|450623579|FG001|Overall Study|AE, captured in Period 1|1|||
125272305|NCT01521923|450623580|FG002|Overall Study|AE, captured in Period 1|0|||
125272306|NCT01521923|450623581|FG003|Overall Study|AE, captured in Period 1|1|||
125272307|NCT01465386|450623585|FG000|Overall Study|Lack of Efficacy|3|||
125272308|NCT01465386|450623585|FG000|Overall Study|Adverse Event|1|||
125272309|NCT01279044|450623586|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
125272310|NCT01279044|450623587|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
125272311|NCT01279044|450623588|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
125272312|NCT01279044|450623586|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
125272313|NCT01279044|450623587|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
125272314|NCT01279044|450623588|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
125272315|NCT01279044|450623586|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
125272316|NCT01279044|450623587|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
125272317|NCT01279044|450623588|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
125272318|NCT01582009|450623589|FG000|Overall Study|Withdrawal by Subject|1|||
125272319|NCT01582009|450623589|FG000|Overall Study|Physician Decision|1|||
125272320|NCT01947283|450623594|FG000|Overall Study|Death|1|||
125272321|NCT01947283|450623595|FG001|Overall Study|Death|1|||
125272322|NCT01947283|450623596|FG002|Overall Study|Death|1|||
125272323|NCT01947283|450623597|FG003|Overall Study|Death|0|||
125272324|NCT01947283|450623598|FG004|Overall Study|Death|0|||
125272325|NCT01947283|450623599|FG005|Overall Study|Death|0|||
125272326|NCT01947283|450623600|FG006|Overall Study|Death|0|||
125272327|NCT01947283|450623594|FG000|Overall Study|Lost to Follow-up|4|||
125272328|NCT01947283|450623595|FG001|Overall Study|Lost to Follow-up|6|||
125272329|NCT01947283|450623596|FG002|Overall Study|Lost to Follow-up|5|||
125272330|NCT01947283|450623597|FG003|Overall Study|Lost to Follow-up|5|||
125272331|NCT01947283|450623598|FG004|Overall Study|Lost to Follow-up|0|||
125272332|NCT01947283|450623599|FG005|Overall Study|Lost to Follow-up|2|||
125272333|NCT01947283|450623600|FG006|Overall Study|Lost to Follow-up|5|||
125272334|NCT01947283|450623594|FG000|Overall Study|Withdrawal by Subject|10|||
125272335|NCT01947283|450623595|FG001|Overall Study|Withdrawal by Subject|8|||
125272336|NCT01947283|450623596|FG002|Overall Study|Withdrawal by Subject|4|||
125272337|NCT01947283|450623597|FG003|Overall Study|Withdrawal by Subject|1|||
125272338|NCT01947283|450623598|FG004|Overall Study|Withdrawal by Subject|0|||
125272339|NCT01947283|450623599|FG005|Overall Study|Withdrawal by Subject|0|||
125272340|NCT01947283|450623600|FG006|Overall Study|Withdrawal by Subject|2|||
125272341|NCT01947283|450623594|FG000|Overall Study|No Clinical Recording|12|||
125272342|NCT01947283|450623595|FG001|Overall Study|No Clinical Recording|6|||
125272343|NCT01947283|450623596|FG002|Overall Study|No Clinical Recording|8|||
125272344|NCT01947283|450623597|FG003|Overall Study|No Clinical Recording|10|||
125272345|NCT01947283|450623598|FG004|Overall Study|No Clinical Recording|0|||
125272346|NCT01947283|450623599|FG005|Overall Study|No Clinical Recording|0|||
125272347|NCT01947283|450623600|FG006|Overall Study|No Clinical Recording|0|||
125272348|NCT01947283|450623594|FG000|Overall Study|Non-coding Clinical Recording language|0|||
125272349|NCT01947283|450623595|FG001|Overall Study|Non-coding Clinical Recording language|0|||
125272350|NCT01947283|450623596|FG002|Overall Study|Non-coding Clinical Recording language|0|||
125272351|NCT01947283|450623597|FG003|Overall Study|Non-coding Clinical Recording language|1|||
125272352|NCT01947283|450623598|FG004|Overall Study|Non-coding Clinical Recording language|0|||
125272353|NCT01947283|450623599|FG005|Overall Study|Non-coding Clinical Recording language|0|||
125272354|NCT01947283|450623600|FG006|Overall Study|Non-coding Clinical Recording language|0|||
125272355|NCT01947283|450623594|FG000|Overall Study|Missing Follow-up Assessment|2|||
125272356|NCT01947283|450623595|FG001|Overall Study|Missing Follow-up Assessment|2|||
125272357|NCT01947283|450623596|FG002|Overall Study|Missing Follow-up Assessment|3|||
125272358|NCT01947283|450623597|FG003|Overall Study|Missing Follow-up Assessment|0|||
125272359|NCT01947283|450623598|FG004|Overall Study|Missing Follow-up Assessment|0|||
125272360|NCT01947283|450623599|FG005|Overall Study|Missing Follow-up Assessment|2|||
125272361|NCT01947283|450623600|FG006|Overall Study|Missing Follow-up Assessment|0|||
125272362|NCT01947283|450623594|FG000|Overall Study|No patients were enrolled in study|0|||
125272363|NCT01947283|450623595|FG001|Overall Study|No patients were enrolled in study|0|||
125272364|NCT01947283|450623596|FG002|Overall Study|No patients were enrolled in study|0|||
125272365|NCT01947283|450623597|FG003|Overall Study|No patients were enrolled in study|0|||
125272366|NCT01947283|450623598|FG004|Overall Study|No patients were enrolled in study|0|||
125272367|NCT01947283|450623599|FG005|Overall Study|No patients were enrolled in study|3|||
125272368|NCT01947283|450623600|FG006|Overall Study|No patients were enrolled in study|1|||
125272369|NCT00460655|450623601|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
125272370|NCT00460655|450623602|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
125272371|NCT00460655|450623603|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
125272372|NCT00460655|450623604|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
125272373|NCT00460655|450623601|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
125272374|NCT00460655|450623602|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
125272375|NCT00460655|450623603|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
125272376|NCT00460655|450623604|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
125272377|NCT00460655|450623601|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
125272378|NCT00460655|450623602|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
125272379|NCT00460655|450623603|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
125272380|NCT00460655|450623604|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
125272381|NCT00460655|450623601|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
125272382|NCT00460655|450623602|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
125272383|NCT00460655|450623603|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
125272384|NCT00460655|450623604|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
125272385|NCT00460655|450623601|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
125272386|NCT00460655|450623602|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
125272387|NCT00460655|450623603|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
125272388|NCT00460655|450623604|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
125272389|NCT00460655|450623601|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
125272390|NCT00460655|450623602|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
125272391|NCT00460655|450623603|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
125272392|NCT00460655|450623604|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
125272393|NCT03592771|450623605|FG000|Overall Study|Adverse Event|2|||
125272394|NCT03592771|450623606|FG001|Overall Study|Adverse Event|0|||
125272395|NCT03592771|450623607|FG002|Overall Study|Adverse Event|1|||
125272396|NCT03592771|450623605|FG000|Overall Study|Death|0|||
125272397|NCT03592771|450623606|FG001|Overall Study|Death|1|||
125272398|NCT03592771|450623607|FG002|Overall Study|Death|1|||
125272399|NCT03592771|450623605|FG000|Overall Study|Lost to Follow-up|5|||
125272400|NCT03592771|450623606|FG001|Overall Study|Lost to Follow-up|11|||
125272401|NCT03592771|450623607|FG002|Overall Study|Lost to Follow-up|15|||
125272402|NCT03592771|450623605|FG000|Overall Study|Withdrawal by Subject|0|||
125272403|NCT03592771|450623606|FG001|Overall Study|Withdrawal by Subject|2|||
125272404|NCT03592771|450623607|FG002|Overall Study|Withdrawal by Subject|0|||
125272405|NCT00735553|450623608|FG000|Overall Study|Study prematurely terminated|77|||
125272406|NCT03654040|450623609|FG000|Overall Study|Death|1|||
125272407|NCT03654040|450623610|FG001|Overall Study|Death|0|||
125272408|NCT03654040|450623609|FG000|Overall Study|Withdrawal by Subject|1|||
125272409|NCT03654040|450623610|FG001|Overall Study|Withdrawal by Subject|0|||
125272410|NCT03654040|450623609|FG000|Overall Study|Study terminated by sponsor|8|||
125272411|NCT03654040|450623610|FG001|Overall Study|Study terminated by sponsor|2|||
125272412|NCT03654040|450623609|FG000|Overall Study|Failure to initiate study therapy|2|||
125272413|NCT03654040|450623610|FG001|Overall Study|Failure to initiate study therapy|0|||
125272414|NCT03654040|450623609|FG000|Overall Study|Transplanted at another center|2|||
125272415|NCT03654040|450623610|FG001|Overall Study|Transplanted at another center|0|||
125272416|NCT03654040|450623609|FG000|Overall Study|Failure to meet eligibility criteria|14|||
125272417|NCT03654040|450623610|FG001|Overall Study|Failure to meet eligibility criteria|2|||
125272418|NCT03654040|450623609|FG000|Overall Study|No longer transplant candidate|1|||
125272419|NCT03654040|450623610|FG001|Overall Study|No longer transplant candidate|0|||
125272420|NCT03654040|450623609|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
125272421|NCT03654040|450623610|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
125272422|NCT03654040|450623609|FG000|Overall Study|Recipient ineligible|0|||
125272423|NCT03654040|450623610|FG001|Overall Study|Recipient ineligible|2|||
125272424|NCT03654040|450623609|FG000|Overall Study|Received deceased liver|0|||
125272425|NCT03654040|450623610|FG001|Overall Study|Received deceased liver|1|||
125272426|NCT01484496|450623614|FG000|Period 1|Protocol Violation|3|||
125272427|NCT01484496|450623615|FG001|Period 1|Protocol Violation|4|||
125272428|NCT01484496|450623616|FG002|Period 1|Protocol Violation|0|||
125272429|NCT01484496|450623617|FG003|Period 1|Protocol Violation|0|||
125272430|NCT01484496|450623614|FG000|Period 1|Physician Decision|5|||
125272431|NCT01484496|450623615|FG001|Period 1|Physician Decision|1|||
125272432|NCT01484496|450623616|FG002|Period 1|Physician Decision|0|||
125272433|NCT01484496|450623617|FG003|Period 1|Physician Decision|0|||
125272434|NCT01484496|450623614|FG000|Period 1|Lack of Efficacy|10|||
125272435|NCT01484496|450623615|FG001|Period 1|Lack of Efficacy|15|||
125272436|NCT01484496|450623616|FG002|Period 1|Lack of Efficacy|0|||
125272437|NCT01484496|450623617|FG003|Period 1|Lack of Efficacy|0|||
125272438|NCT01484496|450623614|FG000|Period 1|Adverse Event|25|||
125272439|NCT01484496|450623615|FG001|Period 1|Adverse Event|40|||
125272440|NCT01484496|450623616|FG002|Period 1|Adverse Event|0|||
125272441|NCT01484496|450623617|FG003|Period 1|Adverse Event|0|||
125272442|NCT01484496|450623614|FG000|Period 1|Withdrawal by Subject|15|||
125272443|NCT01484496|450623615|FG001|Period 1|Withdrawal by Subject|12|||
125272444|NCT01484496|450623616|FG002|Period 1|Withdrawal by Subject|0|||
125272445|NCT01484496|450623617|FG003|Period 1|Withdrawal by Subject|0|||
125272446|NCT01484496|450623614|FG000|Period 1|Lost to Follow-up|2|||
125272447|NCT01484496|450623615|FG001|Period 1|Lost to Follow-up|6|||
125272448|NCT01484496|450623616|FG002|Period 1|Lost to Follow-up|0|||
125272449|NCT01484496|450623617|FG003|Period 1|Lost to Follow-up|0|||
125272450|NCT01484496|450623614|FG000|Period 1|Positive Pregnancy|1|||
125272451|NCT01484496|450623615|FG001|Period 1|Positive Pregnancy|6|||
125272452|NCT01484496|450623616|FG002|Period 1|Positive Pregnancy|0|||
125272453|NCT01484496|450623617|FG003|Period 1|Positive Pregnancy|0|||
125272454|NCT01484496|450623614|FG000|Period 1|Treatment Failure|3|||
125272455|NCT01484496|450623615|FG001|Period 1|Treatment Failure|6|||
125272456|NCT01484496|450623616|FG002|Period 1|Treatment Failure|0|||
125272457|NCT01484496|450623617|FG003|Period 1|Treatment Failure|0|||
125272458|NCT01484496|450623614|FG000|Period 1|Lack of Compliance|2|||
125272459|NCT01484496|450623615|FG001|Period 1|Lack of Compliance|1|||
125272460|NCT01484496|450623616|FG002|Period 1|Lack of Compliance|0|||
125272461|NCT01484496|450623617|FG003|Period 1|Lack of Compliance|0|||
125272462|NCT01484496|450623614|FG000|Period 1|Unable to Visit Site|0|||
125272463|NCT01484496|450623615|FG001|Period 1|Unable to Visit Site|2|||
125272464|NCT01484496|450623616|FG002|Period 1|Unable to Visit Site|0|||
125272465|NCT01484496|450623617|FG003|Period 1|Unable to Visit Site|0|||
125272466|NCT01484496|450623614|FG000|Period 2|Lack of Efficacy|0|||
125272467|NCT01484496|450623615|FG001|Period 2|Lack of Efficacy|0|||
125272468|NCT01484496|450623616|FG002|Period 2|Lack of Efficacy|1|||
125272469|NCT01484496|450623617|FG003|Period 2|Lack of Efficacy|3|||
125272470|NCT01484496|450623614|FG000|Period 2|Adverse Event|0|||
125272471|NCT01484496|450623615|FG001|Period 2|Adverse Event|0|||
125272472|NCT01484496|450623616|FG002|Period 2|Adverse Event|5|||
125272473|NCT01484496|450623617|FG003|Period 2|Adverse Event|13|||
125272474|NCT01484496|450623614|FG000|Period 2|Other|0|||
125272475|NCT01484496|450623615|FG001|Period 2|Other|0|||
125272476|NCT01484496|450623616|FG002|Period 2|Other|9|||
125272477|NCT01484496|450623617|FG003|Period 2|Other|6|||
125272478|NCT01645735|450623618|FG000|Overall Study|Physician Decision|2|||
125272479|NCT01645735|450623619|FG001|Overall Study|Physician Decision|0|||
125272480|NCT01645735|450623618|FG000|Overall Study|Withdrawal by Subject|1|||
125272481|NCT01645735|450623619|FG001|Overall Study|Withdrawal by Subject|0|||
125272482|NCT01645735|450623618|FG000|Overall Study|Protocol Violation|1|||
125272483|NCT01645735|450623619|FG001|Overall Study|Protocol Violation|0|||
125272484|NCT01645735|450623618|FG000|Overall Study|Adverse Event|0|||
125272485|NCT01645735|450623619|FG001|Overall Study|Adverse Event|1|||
125272486|NCT04830215|450623620|FG000|Overall Study|Adverse Event|6|||
125272487|NCT04830215|450623620|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
125272488|NCT04830215|450623620|FG000|Overall Study|Withdrawal by Subject|3|||
125272489|NCT04830215|450623620|FG000|Overall Study|Protocol Deviation|1|||
125272490|NCT03782064|450623621|FG000|Overall Study|Lack of Efficacy|2|||
125272491|NCT03782064|450623621|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
125272492|NCT02446769|450623622|FG000|Screening Period|Screen Failure|11|||
125272493|NCT02446769|450623623|FG001|Screening Period|Screen Failure|0|||
125272494|NCT02446769|450623624|FG002|Screening Period|Screen Failure|0|||
125272495|NCT02446769|450623622|FG000|Study Period|Randomized in Error|0|||
125272496|NCT02446769|450623623|FG001|Study Period|Randomized in Error|2|||
125272497|NCT02446769|450623624|FG002|Study Period|Randomized in Error|0|||
125272498|NCT00645840|450623625|FG000|Overall Study|Protocol Violation|3|||
125272499|NCT03994211|450623626|FG000|Core Phase|Adverse Event|0|||
125272500|NCT03994211|450623627|FG001|Core Phase|Adverse Event|1|||
125272501|NCT03994211|450623628|FG002|Core Phase|Adverse Event|0|||
125272502|NCT03994211|450623626|FG000|Extension Phase|Adverse Event|0|||
125272503|NCT03994211|450623627|FG001|Extension Phase|Adverse Event|0|||
125272504|NCT03994211|450623628|FG002|Extension Phase|Adverse Event|1|||
125272505|NCT03994211|450623626|FG000|Extension Phase|Physician Decision|0|||
125272506|NCT03994211|450623627|FG001|Extension Phase|Physician Decision|0|||
125272507|NCT03994211|450623628|FG002|Extension Phase|Physician Decision|1|||
125272508|NCT03994211|450623626|FG000|Extension Phase|Progressive Disease|0|||
125272509|NCT03994211|450623627|FG001|Extension Phase|Progressive Disease|0|||
125272510|NCT03994211|450623628|FG002|Extension Phase|Progressive Disease|20|||
125272511|NCT03994211|450623626|FG000|Extension Phase|Withdrawal by Subject|0|||
125272512|NCT03994211|450623627|FG001|Extension Phase|Withdrawal by Subject|0|||
125272513|NCT03994211|450623628|FG002|Extension Phase|Withdrawal by Subject|2|||
125272514|NCT00271856|450623634|FG000|Overall Study|Withdrawal by Subject|1|||
125272515|NCT00271856|450623635|FG001|Overall Study|Withdrawal by Subject|7|||
125272516|NCT00271856|450623634|FG000|Overall Study|Lost to Follow-up|10|||
125272517|NCT00271856|450623635|FG001|Overall Study|Lost to Follow-up|11|||
125272518|NCT04599803|450623636|FG000|Overall Study|Withdrawal by Subject|5|||
125272519|NCT04599803|450623636|FG000|Overall Study|Lost to Follow-up|26|||
125272520|NCT04677543|450623637|FG000|Overall Study|Withdrawal by Subject|4|||
125272521|NCT04677543|450623638|FG001|Overall Study|Withdrawal by Subject|1|||
125272522|NCT04677543|450623637|FG000|Overall Study|Physician Decision|0|||
125272523|NCT04677543|450623638|FG001|Overall Study|Physician Decision|1|||
125272524|NCT04677543|450623637|FG000|Overall Study|Adverse Event|0|||
125272525|NCT04677543|450623638|FG001|Overall Study|Adverse Event|1|||
125272526|NCT00995436|450623643|FG000|Overall Study|Withdrawal by Subject|2|||
125272527|NCT00995436|450623644|FG001|Overall Study|Withdrawal by Subject|5|||
125272528|NCT00995436|450623645|FG002|Overall Study|Withdrawal by Subject|0|||
125272529|NCT00771927|450623647|FG000|Overall Study|Adverse Event|100|||
125272530|NCT00771927|450623648|FG001|Overall Study|Adverse Event|105|||
125272531|NCT00771927|450623647|FG000|Overall Study|Lack of Efficacy|70|||
125272532|NCT00771927|450623648|FG001|Overall Study|Lack of Efficacy|42|||
125272533|NCT00771927|450623647|FG000|Overall Study|Lost to Follow-up|46|||
125272534|NCT00771927|450623648|FG001|Overall Study|Lost to Follow-up|46|||
125272535|NCT00771927|450623647|FG000|Overall Study|Withdrawal by Subject|16|||
125272536|NCT00771927|450623648|FG001|Overall Study|Withdrawal by Subject|17|||
125272537|NCT00771927|450623647|FG000|Overall Study|Other reason|23|||
125272538|NCT00771927|450623648|FG001|Overall Study|Other reason|27|||
125272539|NCT03299244|450623652|FG000|Overall Study|Withdrawal by Subject|34|||
125272540|NCT03299244|450623653|FG001|Overall Study|Withdrawal by Subject|29|||
125272541|NCT03299244|450623652|FG000|Overall Study|Decision by Sponsor|4|||
125272542|NCT03299244|450623653|FG001|Overall Study|Decision by Sponsor|5|||
125272543|NCT03299244|450623652|FG000|Overall Study|Death|9|||
125272544|NCT03299244|450623653|FG001|Overall Study|Death|4|||
125272545|NCT02712996|450623655|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
125272546|NCT02712996|450623656|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
125272547|NCT01016132|450623657|FG000|Overall Study|Discomfort|1|||
125272548|NCT01451749|450623660|FG000|Overall Study|Protocol Violation|14|||
125272549|NCT01451749|450623661|FG001|Overall Study|Protocol Violation|7|||
125272550|NCT01451749|450623660|FG000|Overall Study|Lost to Follow-up|15|||
125272551|NCT01451749|450623661|FG001|Overall Study|Lost to Follow-up|5|||
125272552|NCT01451749|450623660|FG000|Overall Study|Meet the exclusion criteria,and|1|||
125272553|NCT01451749|450623661|FG001|Overall Study|Meet the exclusion criteria,and|1|||
125272554|NCT01451749|450623660|FG000|Overall Study|Adverse Event|2|||
125272555|NCT01451749|450623661|FG001|Overall Study|Adverse Event|0|||
125272556|NCT01451749|450623660|FG000|Overall Study|Withdrawal by Subject|0|||
125272557|NCT01451749|450623661|FG001|Overall Study|Withdrawal by Subject|1|||
125272558|NCT02454530|450623668|FG000|Overall Study|Other|8|||
125272559|NCT02454530|450623669|FG001|Overall Study|Other|13|||
125272560|NCT02454530|450623668|FG000|Overall Study|Missing information|56|||
125272561|NCT02454530|450623669|FG001|Overall Study|Missing information|69|||
125272562|NCT02454530|450623668|FG000|Overall Study|Death|2|||
125272563|NCT02454530|450623669|FG001|Overall Study|Death|41|||
125272564|NCT02454530|450623668|FG000|Overall Study|Lost to Follow-up|4|||
125272565|NCT02454530|450623669|FG001|Overall Study|Lost to Follow-up|4|||
125272566|NCT03265145|450623670|FG000|Overall Study|Protocol Violation|2|||
125272567|NCT03265145|450623671|FG001|Overall Study|Protocol Violation|0|||
125272568|NCT03265145|450623670|FG000|Overall Study|Adverse Event|1|||
125272569|NCT03265145|450623671|FG001|Overall Study|Adverse Event|0|||
125272570|NCT03265145|450623670|FG000|Overall Study|Withdrawal by Subject|23|||
125272571|NCT03265145|450623671|FG001|Overall Study|Withdrawal by Subject|19|||
125272572|NCT03265145|450623670|FG000|Overall Study|Death|12|||
125272573|NCT03265145|450623671|FG001|Overall Study|Death|12|||
125272574|NCT03265145|450623670|FG000|Overall Study|Lost to Follow-up|13|||
125272575|NCT03265145|450623671|FG001|Overall Study|Lost to Follow-up|9|||
125272576|NCT03265145|450623670|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
125272577|NCT03265145|450623671|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
125272578|NCT03265145|450623670|FG000|Overall Study|Switched back to previous medication|1|||
125272579|NCT03265145|450623671|FG001|Overall Study|Switched back to previous medication|0|||
125272580|NCT03265145|450623670|FG000|Overall Study|Did not want to take medication|1|||
125272581|NCT03265145|450623671|FG001|Overall Study|Did not want to take medication|0|||
125272582|NCT03265145|450623670|FG000|Overall Study|Subject could not afford medication|0|||
125272583|NCT03265145|450623671|FG001|Overall Study|Subject could not afford medication|1|||
125272584|NCT03265145|450623670|FG000|Overall Study|Site closed|2|||
125272585|NCT03265145|450623671|FG001|Overall Study|Site closed|3|||
125272586|NCT03265145|450623670|FG000|Overall Study|Incorrectly randomized|16|||
125272587|NCT03265145|450623671|FG001|Overall Study|Incorrectly randomized|6|||
125272588|NCT03265145|450623670|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
125272589|NCT03265145|450623671|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
125272590|NCT03265145|450623670|FG000|Overall Study|Physician Decision|0|||
125272591|NCT03265145|450623671|FG001|Overall Study|Physician Decision|3|||
125272592|NCT03265145|450623670|FG000|Overall Study|Subject transferred to another facility|0|||
125272593|NCT03265145|450623671|FG001|Overall Study|Subject transferred to another facility|1|||
125272594|NCT03159468|450623672|FG000|Overall Study|Withdrawal by Subject|0|||
125272595|NCT03159468|450623673|FG001|Overall Study|Withdrawal by Subject|0|||
125272596|NCT03159468|450623674|FG002|Overall Study|Withdrawal by Subject|3|||
125272597|NCT03159468|450623675|FG003|Overall Study|Withdrawal by Subject|0|||
125272598|NCT03159468|450623676|FG004|Overall Study|Withdrawal by Subject|0|||
125272599|NCT03159468|450623677|FG005|Overall Study|Withdrawal by Subject|0|||
125272600|NCT03280303|450625160|FG000|Overall Study|Death|505|||
125272601|NCT03280303|450625160|FG000|Overall Study|Study terminated by sponsor|383|||
125272602|NCT03280303|450625160|FG000|Overall Study|Other|148|||
125272603|NCT03280303|450625160|FG000|Overall Study|No longer willing to participate in study|101|||
125272604|NCT03280303|450625160|FG000|Overall Study|Lost to follow up|39|||
125272605|NCT03280303|450625160|FG000|Overall Study|Adverse Event|20|||
125272606|NCT02974140|450625167|FG000|Overall Study|Adverse Event|2|||
125272607|NCT02974140|450625167|FG000|Overall Study|Lost to Follow-up|1|||
125272608|NCT02974140|450625167|FG000|Overall Study|Study Terminated by Sponsor|36|||
125272609|NCT00617084|450625168|FG000|Overall Study|Withdrawal by Subject|5|||
125272610|NCT00617084|450625169|FG001|Overall Study|Withdrawal by Subject|7|||
125272611|NCT00617084|450625168|FG000|Overall Study|Missed 12 Months visit|16|||
125272612|NCT00617084|450625169|FG001|Overall Study|Missed 12 Months visit|19|||
125272613|NCT02222688|450625173|FG000|Overall Study|Withdrawal by Subject|0|||
125272614|NCT02222688|450625174|FG001|Overall Study|Withdrawal by Subject|0|||
125272615|NCT02222688|450625175|FG002|Overall Study|Withdrawal by Subject|0|||
125272616|NCT02222688|450625176|FG003|Overall Study|Withdrawal by Subject|2|||
125272617|NCT02222688|450625177|FG004|Overall Study|Withdrawal by Subject|1|||
125272618|NCT02222688|450625178|FG005|Overall Study|Withdrawal by Subject|0|||
125272619|NCT02222688|450625179|FG006|Overall Study|Withdrawal by Subject|1|||
125272620|NCT02222688|450625173|FG000|Overall Study|Disease progression|1|||
125272621|NCT02222688|450625174|FG001|Overall Study|Disease progression|0|||
125272622|NCT02222688|450625175|FG002|Overall Study|Disease progression|0|||
125272623|NCT02222688|450625176|FG003|Overall Study|Disease progression|0|||
125272624|NCT02222688|450625177|FG004|Overall Study|Disease progression|0|||
125272625|NCT02222688|450625178|FG005|Overall Study|Disease progression|0|||
125272626|NCT02222688|450625179|FG006|Overall Study|Disease progression|0|||
125272627|NCT02522429|450625188|FG000|Overall Study|Lost to Follow-up|8|||
125272628|NCT02522429|450625188|FG000|Overall Study|Adverse Event|2|||
125272629|NCT02522429|450625188|FG000|Overall Study|Death|1|||
125272630|NCT02522429|450625188|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
125272631|NCT00500357|450625192|FG000|Overall Study|Death|1|||
125272632|NCT00078806|450625193|FG000|Part 1A|Adverse Event|2|||
125272633|NCT00078806|450625194|FG001|Part 1A|Adverse Event|0|||
125272634|NCT00078806|450625195|FG002|Part 1A|Adverse Event|0|||
125272635|NCT00078806|450625196|FG003|Part 1A|Adverse Event|0|||
125272636|NCT00078806|450625193|FG000|Part 1A|Lack of Efficacy|7|||
125272637|NCT00078806|450625194|FG001|Part 1A|Lack of Efficacy|0|||
125272638|NCT00078806|450625195|FG002|Part 1A|Lack of Efficacy|0|||
125272639|NCT00078806|450625196|FG003|Part 1A|Lack of Efficacy|0|||
125272640|NCT00078806|450625193|FG000|Part 1A|Other|1|||
125272641|NCT00078806|450625194|FG001|Part 1A|Other|0|||
125272642|NCT00078806|450625195|FG002|Part 1A|Other|0|||
125272643|NCT00078806|450625196|FG003|Part 1A|Other|0|||
125272644|NCT00078806|450625193|FG000|Part 1B|Adverse Event|1|||
125272645|NCT00078806|450625194|FG001|Part 1B|Adverse Event|0|||
125272646|NCT00078806|450625195|FG002|Part 1B|Adverse Event|0|||
125272647|NCT00078806|450625196|FG003|Part 1B|Adverse Event|0|||
125272648|NCT00078806|450625193|FG000|Part 1B|Lack of Efficacy|7|||
125272649|NCT00078806|450625194|FG001|Part 1B|Lack of Efficacy|0|||
125272650|NCT00078806|450625195|FG002|Part 1B|Lack of Efficacy|0|||
125272651|NCT00078806|450625196|FG003|Part 1B|Lack of Efficacy|0|||
125272652|NCT00078806|450625193|FG000|Part 2|Adverse Event|0|||
125272653|NCT00078806|450625194|FG001|Part 2|Adverse Event|1|||
125272654|NCT00078806|450625195|FG002|Part 2|Adverse Event|0|||
125272655|NCT00078806|450625196|FG003|Part 2|Adverse Event|0|||
125272656|NCT01734785|450625197|FG000|Open-Label Period|Adverse Event|0|||
125272657|NCT01734785|450625198|FG001|Open-Label Period|Adverse Event|0|||
125272658|NCT01734785|450625199|FG002|Open-Label Period|Adverse Event|0|||
125272659|NCT01734785|450625200|FG003|Open-Label Period|Adverse Event|9|||
125272660|NCT01734785|450625197|FG000|Open-Label Period|Lack of Efficacy|0|||
125272661|NCT01734785|450625198|FG001|Open-Label Period|Lack of Efficacy|0|||
125272662|NCT01734785|450625199|FG002|Open-Label Period|Lack of Efficacy|0|||
125272663|NCT01734785|450625200|FG003|Open-Label Period|Lack of Efficacy|1|||
125272664|NCT01734785|450625197|FG000|Open-Label Period|Protocol Violation|0|||
125272665|NCT01734785|450625198|FG001|Open-Label Period|Protocol Violation|0|||
125272666|NCT01734785|450625199|FG002|Open-Label Period|Protocol Violation|0|||
125272667|NCT01734785|450625200|FG003|Open-Label Period|Protocol Violation|13|||
125272668|NCT01734785|450625197|FG000|Open-Label Period|Lost to Follow-up|0|||
125272669|NCT01734785|450625198|FG001|Open-Label Period|Lost to Follow-up|0|||
125272670|NCT01734785|450625199|FG002|Open-Label Period|Lost to Follow-up|0|||
125272671|NCT01734785|450625200|FG003|Open-Label Period|Lost to Follow-up|14|||
125272672|NCT01734785|450625197|FG000|Open-Label Period|Withdrawal by Subject|0|||
125272673|NCT01734785|450625198|FG001|Open-Label Period|Withdrawal by Subject|0|||
125272674|NCT01734785|450625199|FG002|Open-Label Period|Withdrawal by Subject|0|||
125272675|NCT01734785|450625200|FG003|Open-Label Period|Withdrawal by Subject|12|||
125272676|NCT01734785|450625197|FG000|Open-Label Period|Other Reasons|0|||
125272677|NCT01734785|450625198|FG001|Open-Label Period|Other Reasons|0|||
125272678|NCT01734785|450625199|FG002|Open-Label Period|Other Reasons|0|||
125272679|NCT01734785|450625200|FG003|Open-Label Period|Other Reasons|224|||
125272680|NCT01734785|450625197|FG000|Double-Blind Period|Adverse Event|0|||
125272681|NCT01734785|450625198|FG001|Double-Blind Period|Adverse Event|3|||
125272682|NCT01734785|450625199|FG002|Double-Blind Period|Adverse Event|2|||
125272683|NCT01734785|450625200|FG003|Double-Blind Period|Adverse Event|0|||
125272684|NCT01734785|450625197|FG000|Double-Blind Period|Lack of Efficacy|0|||
125272685|NCT01734785|450625198|FG001|Double-Blind Period|Lack of Efficacy|1|||
125272686|NCT01734785|450625199|FG002|Double-Blind Period|Lack of Efficacy|0|||
125272687|NCT01734785|450625200|FG003|Double-Blind Period|Lack of Efficacy|0|||
125272688|NCT01734785|450625197|FG000|Double-Blind Period|Protocol Violation|0|||
125272689|NCT01734785|450625198|FG001|Double-Blind Period|Protocol Violation|1|||
125272690|NCT01734785|450625199|FG002|Double-Blind Period|Protocol Violation|1|||
125272691|NCT01734785|450625200|FG003|Double-Blind Period|Protocol Violation|0|||
125272692|NCT01734785|450625197|FG000|Double-Blind Period|Lost to Follow-up|2|||
125272693|NCT01734785|450625198|FG001|Double-Blind Period|Lost to Follow-up|4|||
125272694|NCT01734785|450625199|FG002|Double-Blind Period|Lost to Follow-up|2|||
125272695|NCT01734785|450625200|FG003|Double-Blind Period|Lost to Follow-up|0|||
125272696|NCT01734785|450625197|FG000|Double-Blind Period|Withdrawal by Subject|2|||
125272697|NCT01734785|450625198|FG001|Double-Blind Period|Withdrawal by Subject|0|||
125272698|NCT01734785|450625199|FG002|Double-Blind Period|Withdrawal by Subject|0|||
125272699|NCT01734785|450625200|FG003|Double-Blind Period|Withdrawal by Subject|0|||
125272700|NCT01734785|450625197|FG000|Double-Blind Period|Not treated|1|||
125272701|NCT01734785|450625198|FG001|Double-Blind Period|Not treated|0|||
125272702|NCT01734785|450625199|FG002|Double-Blind Period|Not treated|0|||
125272703|NCT01734785|450625200|FG003|Double-Blind Period|Not treated|0|||
125272704|NCT00161616|450625201|FG000|Overall Study|Withdrawal by Subject|6|||
125272705|NCT00161616|450625202|FG001|Overall Study|Withdrawal by Subject|5|||
125272706|NCT00161616|450625201|FG000|Overall Study|Physician Decision|1|||
125272707|NCT00161616|450625202|FG001|Overall Study|Physician Decision|0|||
125272708|NCT00161616|450625201|FG000|Overall Study|Death|1|||
125272709|NCT00161616|450625202|FG001|Overall Study|Death|1|||
125272710|NCT00161616|450625201|FG000|Overall Study|Lost to Follow-up|17|||
125272711|NCT00161616|450625202|FG001|Overall Study|Lost to Follow-up|13|||
125272712|NCT00161616|450625201|FG000|Overall Study|Protocol deviation|1|||
125272713|NCT00161616|450625202|FG001|Overall Study|Protocol deviation|0|||
125272714|NCT00854724|450625203|FG000|First Intervention|Withdrawal by Subject|1|||
125272715|NCT00854724|450625204|FG001|First Intervention|Withdrawal by Subject|1|||
125272716|NCT00854724|450625203|FG000|Washout|Protocol Violation|1|||
125272717|NCT00854724|450625204|FG001|Washout|Protocol Violation|0|||
125272718|NCT00854724|450625203|FG000|Washout|Withdrawal by Subject|0|||
125272719|NCT00854724|450625204|FG001|Washout|Withdrawal by Subject|1|||
125272720|NCT00854724|450625203|FG000|Second Intervention|Protocol Violation|1|||
125272721|NCT00854724|450625204|FG001|Second Intervention|Protocol Violation|0|||
125272722|NCT00854724|450625203|FG000|Second Intervention|Physician Decision|0|||
125272723|NCT00854724|450625204|FG001|Second Intervention|Physician Decision|1|||
125272724|NCT00861757|450625206|FG000|Overall Study|Adverse Event|1|||
125272725|NCT00861757|450625207|FG001|Overall Study|Adverse Event|5|||
125272726|NCT00861757|450625208|FG002|Overall Study|Adverse Event|7|||
125272727|NCT00861757|450625209|FG003|Overall Study|Adverse Event|2|||
125272728|NCT00861757|450625206|FG000|Overall Study|Entry Criteria Not Met|1|||
125272729|NCT00861757|450625207|FG001|Overall Study|Entry Criteria Not Met|2|||
125272730|NCT00861757|450625208|FG002|Overall Study|Entry Criteria Not Met|1|||
125272731|NCT00861757|450625209|FG003|Overall Study|Entry Criteria Not Met|1|||
125272732|NCT00861757|450625206|FG000|Overall Study|Lack of Efficacy|3|||
125272733|NCT00861757|450625207|FG001|Overall Study|Lack of Efficacy|1|||
125272734|NCT00861757|450625208|FG002|Overall Study|Lack of Efficacy|0|||
125272735|NCT00861757|450625209|FG003|Overall Study|Lack of Efficacy|1|||
125272736|NCT00861757|450625206|FG000|Overall Study|Lost to Follow-up|1|||
125272737|NCT00861757|450625207|FG001|Overall Study|Lost to Follow-up|0|||
125272738|NCT00861757|450625208|FG002|Overall Study|Lost to Follow-up|1|||
125272739|NCT00861757|450625209|FG003|Overall Study|Lost to Follow-up|1|||
125272740|NCT00861757|450625206|FG000|Overall Study|Physician Decision|0|||
125272741|NCT00861757|450625207|FG001|Overall Study|Physician Decision|0|||
125272742|NCT00861757|450625208|FG002|Overall Study|Physician Decision|0|||
125272743|NCT00861757|450625209|FG003|Overall Study|Physician Decision|1|||
125272744|NCT00861757|450625206|FG000|Overall Study|Protocol Violation|2|||
125272745|NCT00861757|450625207|FG001|Overall Study|Protocol Violation|2|||
125272746|NCT00861757|450625208|FG002|Overall Study|Protocol Violation|4|||
125272747|NCT00861757|450625209|FG003|Overall Study|Protocol Violation|1|||
125272748|NCT00861757|450625206|FG000|Overall Study|Withdrawal by Subject|1|||
125272749|NCT00861757|450625207|FG001|Overall Study|Withdrawal by Subject|5|||
125272750|NCT00861757|450625208|FG002|Overall Study|Withdrawal by Subject|5|||
125272751|NCT00861757|450625209|FG003|Overall Study|Withdrawal by Subject|2|||
125272752|NCT02140970|450625212|FG000|Overall Study|Lost to Follow-up|1|||
125272753|NCT02140970|450625213|FG001|Overall Study|Lost to Follow-up|2|||
125272754|NCT02140970|450625212|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
125272755|NCT02140970|450625213|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
125272756|NCT02140970|450625212|FG000|Overall Study|Did not meet inclusion criteria|0|||
125272757|NCT02140970|450625213|FG001|Overall Study|Did not meet inclusion criteria|1|||
125272758|NCT02705105|450625214|FG000|Treatment|Objective Disease Progression|1|||
125272759|NCT02705105|450625215|FG001|Treatment|Objective Disease Progression|50|||
125272760|NCT02705105|450625214|FG000|Treatment|Withdrawal by Subject|3|||
125272761|NCT02705105|450625215|FG001|Treatment|Withdrawal by Subject|5|||
125272762|NCT02705105|450625214|FG000|Treatment|Adverse Event|0|||
125272763|NCT02705105|450625215|FG001|Treatment|Adverse Event|17|||
125272764|NCT02705105|450625214|FG000|Treatment|Clinical Disease Progression|0|||
125272765|NCT02705105|450625215|FG001|Treatment|Clinical Disease Progression|32|||
125272766|NCT02705105|450625214|FG000|Treatment|Physician Decision|0|||
125272767|NCT02705105|450625215|FG001|Treatment|Physician Decision|3|||
125272768|NCT02705105|450625214|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
125272769|NCT02705105|450625215|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
125272770|NCT02705105|450625214|FG000|Follow-Up|Death|3|||
125272771|NCT02705105|450625215|FG001|Follow-Up|Death|68|||
125272772|NCT02705105|450625214|FG000|Follow-Up|Withdrawal by Subject|1|||
125272773|NCT02705105|450625215|FG001|Follow-Up|Withdrawal by Subject|14|||
125272774|NCT02705105|450625214|FG000|Follow-Up|Study Terminated|0|||
125272775|NCT02705105|450625215|FG001|Follow-Up|Study Terminated|26|||
125272776|NCT02705105|450625214|FG000|Follow-Up|Discontinued per Amendment 3|0|||
125272777|NCT02705105|450625215|FG001|Follow-Up|Discontinued per Amendment 3|2|||
125272778|NCT01709110|450625218|FG000|Overall Study|Adverse Event|56|||
125272779|NCT01709110|450625219|FG001|Overall Study|Adverse Event|48|||
125272780|NCT01709110|450625218|FG000|Overall Study|Death|14|||
125272781|NCT01709110|450625219|FG001|Overall Study|Death|6|||
125272782|NCT01709110|450625218|FG000|Overall Study|Lost to Follow-up|7|||
125272783|NCT01709110|450625219|FG001|Overall Study|Lost to Follow-up|5|||
125272784|NCT01709110|450625218|FG000|Overall Study|Protocol Violation|4|||
125272785|NCT01709110|450625219|FG001|Overall Study|Protocol Violation|6|||
125272786|NCT01709110|450625218|FG000|Overall Study|Withdrawal by Subject|96|||
125272787|NCT01709110|450625219|FG001|Overall Study|Withdrawal by Subject|89|||
125272788|NCT01709110|450625218|FG000|Overall Study|Physician Decision|4|||
125272789|NCT01709110|450625219|FG001|Overall Study|Physician Decision|10|||
125272790|NCT01709110|450625218|FG000|Overall Study|Sponsor Decision|2|||
125272791|NCT01709110|450625219|FG001|Overall Study|Sponsor Decision|2|||
125272792|NCT01709110|450625218|FG000|Overall Study|Lack of Efficacy|1|||
125272793|NCT01709110|450625219|FG001|Overall Study|Lack of Efficacy|1|||
125272794|NCT01709110|450625218|FG000|Overall Study|Caregiver Decision|1|||
125272795|NCT01709110|450625219|FG001|Overall Study|Caregiver Decision|1|||
125272796|NCT03332173|450625220|FG000|Overall Study|Death|7|||
125272797|NCT03332173|450625220|FG000|Overall Study|Withdrawal by Subject|6|||
125272798|NCT03332173|450625220|FG000|Overall Study|Lost to Follow-up|2|||
125272799|NCT03332173|450625220|FG000|Overall Study|Transferred to long-term extension study|29|||
125272800|NCT02168101|450625221|FG000|Overall Study|Death|2|||
125272801|NCT02168101|450625222|FG001|Overall Study|Death|2|||
125272802|NCT02168101|450625223|FG002|Overall Study|Death|1|||
125272803|NCT00910910|450625224|FG000|Overall Study|Adverse Event|63|||
125272804|NCT00910910|450625225|FG001|Overall Study|Adverse Event|35|||
125272805|NCT00910910|450625224|FG000|Overall Study|PD without histologic change|27|||
125272806|NCT00910910|450625225|FG001|Overall Study|PD without histologic change|23|||
125272807|NCT00910910|450625224|FG000|Overall Study|PD with histologic change|0|||
125272808|NCT00910910|450625225|FG001|Overall Study|PD with histologic change|2|||
125272809|NCT00910910|450625224|FG000|Overall Study|Withdrawal by Subject|7|||
125272810|NCT00910910|450625225|FG001|Overall Study|Withdrawal by Subject|5|||
125272811|NCT00910910|450625224|FG000|Overall Study|Lost to Follow-up|2|||
125272812|NCT00910910|450625225|FG001|Overall Study|Lost to Follow-up|2|||
125272813|NCT00910910|450625224|FG000|Overall Study|Death|9|||
125272814|NCT00910910|450625225|FG001|Overall Study|Death|3|||
125272815|NCT00910910|450625224|FG000|Overall Study|Protocol Violation|2|||
125272816|NCT00910910|450625225|FG001|Overall Study|Protocol Violation|2|||
125272817|NCT00910910|450625224|FG000|Overall Study|Completed 13 cycles of treatment|0|||
125272818|NCT00910910|450625225|FG001|Overall Study|Completed 13 cycles of treatment|118|||
125272819|NCT00910910|450625224|FG000|Overall Study|Other|114|||
125272820|NCT00910910|450625225|FG001|Overall Study|Other|32|||
125272821|NCT00910910|450625224|FG000|Overall Study|Untreated before cycle 1|1|||
125272822|NCT00910910|450625225|FG001|Overall Study|Untreated before cycle 1|2|||
125272823|NCT01973231|450625226|FG000|Overall Study|Protocol Violation|1|||
125272824|NCT01973231|450625227|FG001|Overall Study|Protocol Violation|1|||
125272825|NCT01973231|450625226|FG000|Overall Study|Lost to Follow-up|1|||
125272826|NCT01973231|450625227|FG001|Overall Study|Lost to Follow-up|1|||
125272827|NCT01973231|450625226|FG000|Overall Study|unclassified|2|||
125272828|NCT01973231|450625227|FG001|Overall Study|unclassified|1|||
125272829|NCT01973231|450625226|FG000|Overall Study|Withdrawal by Subject|7|||
125272830|NCT01973231|450625227|FG001|Overall Study|Withdrawal by Subject|9|||
125272831|NCT01485796|450625228|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
125272832|NCT01485796|450625228|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
125272833|NCT01485796|450625228|FG000|Period 2: Epoch 2|Adverse Event|3|||
125272834|NCT01485796|450625228|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
125272835|NCT01485796|450625228|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
125272836|NCT01485796|450625228|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
125272837|NCT01485796|450625228|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
125272838|NCT01485796|450625228|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
125272839|NCT01775553|450625233|FG000|Overall Study|Adverse Event|1|||
125272840|NCT01775553|450625233|FG000|Overall Study|Disease Progression|12|||
125272841|NCT00988052|450625234|FG000|Overall Study|Missing|1|||
125272842|NCT00988052|450625235|FG001|Overall Study|Missing|0|||
125272843|NCT00988052|450625234|FG000|Overall Study|Teva requested subject withdrawal|3|||
125272844|NCT00988052|450625235|FG001|Overall Study|Teva requested subject withdrawal|1|||
125272845|NCT00988052|450625234|FG000|Overall Study|Death|1|||
125272846|NCT00988052|450625235|FG001|Overall Study|Death|3|||
125272847|NCT00988052|450625234|FG000|Overall Study|Protocol Violation|6|||
125272848|NCT00988052|450625235|FG001|Overall Study|Protocol Violation|5|||
125272849|NCT00988052|450625234|FG000|Overall Study|Pregnancy|6|||
125272850|NCT00988052|450625235|FG001|Overall Study|Pregnancy|6|||
125272851|NCT00988052|450625234|FG000|Overall Study|Lack of Efficacy|8|||
125272852|NCT00988052|450625235|FG001|Overall Study|Lack of Efficacy|7|||
125272853|NCT00988052|450625234|FG000|Overall Study|Lost to Follow-up|6|||
125272854|NCT00988052|450625235|FG001|Overall Study|Lost to Follow-up|11|||
125272855|NCT00988052|450625234|FG000|Overall Study|Physician Decision|27|||
125272856|NCT00988052|450625235|FG001|Overall Study|Physician Decision|28|||
125272857|NCT00988052|450625234|FG000|Overall Study|Adverse Event|35|||
125272858|NCT00988052|450625235|FG001|Overall Study|Adverse Event|28|||
125272859|NCT00988052|450625234|FG000|Overall Study|Withdrawal by Subject|90|||
125272860|NCT00988052|450625235|FG001|Overall Study|Withdrawal by Subject|91|||
125272861|NCT00988052|450625234|FG000|Overall Study|Study terminated by sponsor|240|||
125272862|NCT00988052|450625235|FG001|Overall Study|Study terminated by sponsor|236|||
125272863|NCT01523743|450625236|FG000|Period 1|Adverse Event|1|||
125272864|NCT01523743|450625237|FG001|Period 1|Adverse Event|0|||
125272865|NCT01523743|450625236|FG000|Period 1|Withdrawal by Subject|6|||
125272866|NCT01523743|450625237|FG001|Period 1|Withdrawal by Subject|2|||
125272867|NCT01523743|450625236|FG000|Period 1|Lost to Follow-up|1|||
125272868|NCT01523743|450625237|FG001|Period 1|Lost to Follow-up|0|||
125272869|NCT01523743|450625236|FG000|Period 1|Lack of Efficacy|1|||
125272870|NCT01523743|450625237|FG001|Period 1|Lack of Efficacy|0|||
125272871|NCT01523743|450625236|FG000|Period 1|Felt unable to empty bladder|1|||
125272872|NCT01523743|450625237|FG001|Period 1|Felt unable to empty bladder|0|||
125272873|NCT01523743|450625236|FG000|Period 2|Withdrawal by Subject|0|||
125272874|NCT01523743|450625237|FG001|Period 2|Withdrawal by Subject|2|||
125272875|NCT01523743|450625236|FG000|Period 2|Adverse Event|1|||
125272876|NCT01523743|450625237|FG001|Period 2|Adverse Event|0|||
125272877|NCT02569476|450625238|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
125272878|NCT02569476|450625238|FG000|Overall Study|Death|33|||
125272879|NCT02569476|450625238|FG000|Overall Study|Withdrawal by Subject|9|||
125272880|NCT02569476|450625238|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
125272881|NCT02569476|450625238|FG000|Overall Study|Palliative care|1|||
125272882|NCT02569476|450625238|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
125272883|NCT02569476|450625238|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
125272884|NCT01434654|450625239|FG000|Overall Study|Withdrawal by Subject|1|||
125272885|NCT01434654|450625240|FG001|Overall Study|Withdrawal by Subject|0|||
125272886|NCT01434654|450625239|FG000|Overall Study|Lost to Follow-up|1|||
125272887|NCT01434654|450625240|FG001|Overall Study|Lost to Follow-up|0|||
125272888|NCT00703963|450625243|FG000|Overall Study|Withdrawal by Subject|7|||
125272889|NCT00703963|450625244|FG001|Overall Study|Withdrawal by Subject|13|||
125272890|NCT00703963|450625243|FG000|Overall Study|Physician Decision|0|||
125272891|NCT00703963|450625244|FG001|Overall Study|Physician Decision|1|||
125272892|NCT00402324|450625247|FG000|Overall Study|Lost to Follow-up|11|||
125272893|NCT00402324|450625248|FG001|Overall Study|Lost to Follow-up|11|||
125272894|NCT00402324|450625247|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
125272895|NCT00402324|450625248|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
125272896|NCT00402324|450625247|FG000|Overall Study|Protocol Violation|8|||
125272897|NCT00402324|450625248|FG001|Overall Study|Protocol Violation|7|||
125272898|NCT00402324|450625247|FG000|Overall Study|Withdrawal by Subject|5|||
125272899|NCT00402324|450625248|FG001|Overall Study|Withdrawal by Subject|2|||
125272900|NCT00402324|450625247|FG000|Overall Study|Physician Decision|2|||
125272901|NCT00402324|450625248|FG001|Overall Study|Physician Decision|4|||
125272902|NCT00402324|450625247|FG000|Overall Study|Sponsor Decision|4|||
125272903|NCT00402324|450625248|FG001|Overall Study|Sponsor Decision|5|||
125272904|NCT00402324|450625247|FG000|Overall Study|Lack of Efficacy|1|||
125272905|NCT00402324|450625248|FG001|Overall Study|Lack of Efficacy|4|||
125272906|NCT00402324|450625247|FG000|Overall Study|Adverse Event|6|||
125272907|NCT00402324|450625248|FG001|Overall Study|Adverse Event|4|||
125272908|NCT00402324|450625247|FG000|Overall Study|Death|1|||
125272909|NCT00402324|450625248|FG001|Overall Study|Death|0|||
125272910|NCT01277822|450625249|FG000|Overall Study|Adverse Event|2|||
125272911|NCT01277822|450625250|FG001|Overall Study|Adverse Event|1|||
125272912|NCT01277822|450625249|FG000|Overall Study|Withdrawal by Subject|6|||
125272913|NCT01277822|450625250|FG001|Overall Study|Withdrawal by Subject|7|||
125272914|NCT01277822|450625249|FG000|Overall Study|Physician Decision|1|||
125272915|NCT01277822|450625250|FG001|Overall Study|Physician Decision|1|||
125272916|NCT01277822|450625249|FG000|Overall Study|Protocol Violation|1|||
125272917|NCT01277822|450625250|FG001|Overall Study|Protocol Violation|0|||
125272918|NCT01277822|450625249|FG000|Overall Study|Lost to Follow-up|2|||
125272919|NCT01277822|450625250|FG001|Overall Study|Lost to Follow-up|1|||
125272920|NCT01277822|450625249|FG000|Overall Study|Contraindicated medication used|2|||
125272921|NCT01277822|450625250|FG001|Overall Study|Contraindicated medication used|1|||
125272922|NCT01277822|450625249|FG000|Overall Study|Participant moved|1|||
125272923|NCT01277822|450625250|FG001|Overall Study|Participant moved|0|||
125272924|NCT02625220|450625251|FG000|Overall Study|Adverse Event|2|||
125272925|NCT02625220|450625251|FG000|Overall Study|Lost to Follow-up|2|||
125272926|NCT02625220|450625251|FG000|Overall Study|Protocol Violation|1|||
125272927|NCT02625220|450625251|FG000|Overall Study|Study discontinued at site|2|||
125272928|NCT02923531|450625252|FG000|Overall Study|Adverse Event|4|||
125272929|NCT02923531|450625252|FG000|Overall Study|Clinical Deterioration|1|||
125272930|NCT02923531|450625252|FG000|Overall Study|Disease Progression|3|||
125272931|NCT02923531|450625252|FG000|Overall Study|Study Termination|1|||
125272932|NCT00997984|450625253|FG000|Overall Study|Adverse Event|1|||
125272933|NCT00997984|450625254|FG001|Overall Study|Adverse Event|8|||
125272934|NCT00997984|450625255|FG002|Overall Study|Adverse Event|8|||
125272935|NCT00997984|450625253|FG000|Overall Study|Protocol Violation|1|||
125272936|NCT00997984|450625254|FG001|Overall Study|Protocol Violation|3|||
125272937|NCT00997984|450625255|FG002|Overall Study|Protocol Violation|0|||
125272938|NCT00997984|450625253|FG000|Overall Study|Withdrawal by Subject|6|||
125272939|NCT00997984|450625254|FG001|Overall Study|Withdrawal by Subject|9|||
125272940|NCT00997984|450625255|FG002|Overall Study|Withdrawal by Subject|5|||
125272941|NCT00997984|450625253|FG000|Overall Study|Lost to Follow-up|8|||
125272942|NCT00997984|450625254|FG001|Overall Study|Lost to Follow-up|5|||
125272943|NCT00997984|450625255|FG002|Overall Study|Lost to Follow-up|4|||
125272944|NCT00997984|450625253|FG000|Overall Study|Lack of Efficacy|20|||
125272945|NCT00997984|450625254|FG001|Overall Study|Lack of Efficacy|6|||
125272946|NCT00997984|450625255|FG002|Overall Study|Lack of Efficacy|3|||
125272947|NCT00997984|450625253|FG000|Overall Study|Met exclusion criteria|1|||
125272948|NCT00997984|450625254|FG001|Overall Study|Met exclusion criteria|0|||
125272949|NCT00997984|450625255|FG002|Overall Study|Met exclusion criteria|0|||
125272950|NCT00997984|450625253|FG000|Overall Study|non-compliance|0|||
125272951|NCT00997984|450625254|FG001|Overall Study|non-compliance|2|||
125272952|NCT00997984|450625255|FG002|Overall Study|non-compliance|3|||
125272953|NCT00997984|450625253|FG000|Overall Study|Wrong medication dispensed|0|||
125272954|NCT00997984|450625254|FG001|Overall Study|Wrong medication dispensed|1|||
125272955|NCT00997984|450625255|FG002|Overall Study|Wrong medication dispensed|0|||
125272956|NCT00997984|450625253|FG000|Overall Study|Suicidal ideation|0|||
125272957|NCT00997984|450625254|FG001|Overall Study|Suicidal ideation|0|||
125272958|NCT00997984|450625255|FG002|Overall Study|Suicidal ideation|1|||
125272959|NCT00997984|450625253|FG000|Overall Study|Work schedule|0|||
125272960|NCT00997984|450625254|FG001|Overall Study|Work schedule|0|||
125272961|NCT00997984|450625255|FG002|Overall Study|Work schedule|2|||
125272962|NCT01140867|450625256|FG000|Overall Study|Adverse Event|22|||
125272963|NCT01140867|450625256|FG000|Overall Study|Lack of Efficacy|3|||
125272964|NCT01140867|450625256|FG000|Overall Study|Lost to Follow-up|2|||
125272965|NCT01140867|450625256|FG000|Overall Study|Withdrawal by Subject|1|||
125272966|NCT01140867|450625256|FG000|Overall Study|Protocol Violation|1|||
125272967|NCT01140867|450625256|FG000|Overall Study|Uncooperative patient|2|||
125272968|NCT01140867|450625256|FG000|Overall Study|Medication Noncompliance|2|||
125272969|NCT01119066|450625258|FG000|Overall Study|Withdrawal by Subject|4|||
125272970|NCT01119066|450625259|FG001|Overall Study|Withdrawal by Subject|6|||
125272971|NCT01119066|450625260|FG002|Overall Study|Withdrawal by Subject|0|||
125272972|NCT01119066|450625261|FG003|Overall Study|Withdrawal by Subject|0|||
125272973|NCT01119066|450625258|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
125272974|NCT01119066|450625259|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
125272975|NCT01119066|450625260|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
125272976|NCT01119066|450625261|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
125272977|NCT01119066|450625258|FG000|Overall Study|Relapse identified before transplant|1|||
125272978|NCT01119066|450625259|FG001|Overall Study|Relapse identified before transplant|0|||
125272979|NCT01119066|450625260|FG002|Overall Study|Relapse identified before transplant|0|||
125272980|NCT01119066|450625261|FG003|Overall Study|Relapse identified before transplant|0|||
125272981|NCT01119066|450625258|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
125272982|NCT01119066|450625259|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
125272983|NCT01119066|450625260|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
125272984|NCT01119066|450625261|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
125272985|NCT01119066|450625258|FG000|Overall Study|Relapse identified before transplant|0|||
125272986|NCT01119066|450625259|FG001|Overall Study|Relapse identified before transplant|4|||
125272987|NCT01119066|450625260|FG002|Overall Study|Relapse identified before transplant|0|||
125272988|NCT01119066|450625261|FG003|Overall Study|Relapse identified before transplant|0|||
125272989|NCT02366923|450625262|FG000|Overall Study|Withdrawal by Subject|1|||
125272990|NCT02366923|450625262|FG000|Overall Study|Positive Slit Lamp Findings|2|||
125272991|NCT02366923|450625262|FG000|Overall Study|High Astigmatism|3|||
125272992|NCT03902392|450625263|FG000|Overall Study|Lost to Follow-up|7|||
125272993|NCT03902392|450625264|FG001|Overall Study|Lost to Follow-up|7|||
125272994|NCT01437111|450625265|FG000|Overall Study|Adverse Event|2|||
125272995|NCT01437111|450625265|FG000|Overall Study|Withdrawal by Subject|4|||
125272996|NCT01437111|450625265|FG000|Overall Study|Not reported|5|||
125272997|NCT01437111|450625265|FG000|Overall Study|Physician Decision|1|||
125272998|NCT01437111|450625265|FG000|Overall Study|Lost to Follow-up|5|||
125272999|NCT01437111|450625265|FG000|Overall Study|Protocol Violation|1|||
125273000|NCT00577707|450625266|FG000|Overall Study|Withdrawal by Subject|3|||
125273001|NCT00431444|450625267|FG000|Overall Study|Protocol Violation|1|||
125273002|NCT00431444|450625268|FG001|Overall Study|Protocol Violation|4|||
125273003|NCT00431444|450625267|FG000|Overall Study|Adverse Event|2|||
125273004|NCT00431444|450625268|FG001|Overall Study|Adverse Event|1|||
125273005|NCT00431444|450625267|FG000|Overall Study|Withdrawal by Subject|1|||
125273006|NCT00431444|450625268|FG001|Overall Study|Withdrawal by Subject|1|||
125273007|NCT00431444|450625267|FG000|Overall Study|Lost to Follow-up|1|||
125273008|NCT00431444|450625268|FG001|Overall Study|Lost to Follow-up|0|||
125273009|NCT00431444|450625267|FG000|Overall Study|Administrative Problems|0|||
125273010|NCT00431444|450625268|FG001|Overall Study|Administrative Problems|1|||
125273011|NCT01603043|450625269|FG000|Overall Study|Study Futility|7|||
125273012|NCT01603043|450625270|FG001|Overall Study|Study Futility|3|||
125273013|NCT00556439|450625300|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
125273014|NCT00556439|450625301|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
125273015|NCT00556439|450625302|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
125273016|NCT00556439|450625303|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
125273017|NCT00556439|450625300|FG000|Study Entry to Week 12|Physician Decision|1|||
125273018|NCT00556439|450625301|FG001|Study Entry to Week 12|Physician Decision|0|||
125273019|NCT00556439|450625302|FG002|Study Entry to Week 12|Physician Decision|0|||
125273020|NCT00556439|450625303|FG003|Study Entry to Week 12|Physician Decision|0|||
125273021|NCT00556439|450625300|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
125273022|NCT00556439|450625301|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
125273023|NCT00556439|450625302|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
125273024|NCT00556439|450625303|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
125273025|NCT00556439|450625300|FG000|Study Entry to Week 12|Recurrent infection|1|||
125273026|NCT00556439|450625301|FG001|Study Entry to Week 12|Recurrent infection|0|||
125273027|NCT00556439|450625302|FG002|Study Entry to Week 12|Recurrent infection|0|||
125273028|NCT00556439|450625303|FG003|Study Entry to Week 12|Recurrent infection|0|||
125273029|NCT00556439|450625300|FG000|Study Entry to Week 12|Malignancy|0|||
125273030|NCT00556439|450625301|FG001|Study Entry to Week 12|Malignancy|0|||
125273031|NCT00556439|450625302|FG002|Study Entry to Week 12|Malignancy|1|||
125273032|NCT00556439|450625303|FG003|Study Entry to Week 12|Malignancy|0|||
125273033|NCT00556439|450625300|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
125273034|NCT00556439|450625301|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
125273035|NCT00556439|450625302|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
125273036|NCT00556439|450625303|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
125273037|NCT00556439|450625300|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
125273038|NCT00556439|450625301|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
125273039|NCT00556439|450625302|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
125273040|NCT00556439|450625303|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
125273041|NCT00556439|450625300|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
125273042|NCT00556439|450625301|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
125273043|NCT00556439|450625302|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
125273044|NCT00556439|450625303|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
125273045|NCT00556439|450625300|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
125273046|NCT00556439|450625301|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
125273047|NCT00556439|450625302|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
125273048|NCT00556439|450625303|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
125273049|NCT02100423|450625304|FG000|Overall Study|Death|1|||
125273050|NCT02100423|450625304|FG000|Overall Study|Withdrawal by Subject|3|||
125273051|NCT02100423|450625304|FG000|Overall Study|Adverse Event|1|||
125273052|NCT02100423|450625304|FG000|Overall Study|Physician Decision|1|||
125273053|NCT02931838|450625305|FG000|Overall Study|Reason not provided by investigator|1|||
125273054|NCT02931838|450625306|FG001|Overall Study|Reason not provided by investigator|0|||
125273055|NCT02931838|450625307|FG002|Overall Study|Reason not provided by investigator|1|||
125273056|NCT02931838|450625308|FG003|Overall Study|Reason not provided by investigator|0|||
125273057|NCT02931838|450625309|FG004|Overall Study|Reason not provided by investigator|0|||
125273058|NCT02931838|450625310|FG005|Overall Study|Reason not provided by investigator|0|||
125273059|NCT02931838|450625305|FG000|Overall Study|Poor/non-compliance|0|||
125273060|NCT02931838|450625306|FG001|Overall Study|Poor/non-compliance|0|||
125273061|NCT02931838|450625307|FG002|Overall Study|Poor/non-compliance|1|||
125273062|NCT02931838|450625308|FG003|Overall Study|Poor/non-compliance|0|||
125273063|NCT02931838|450625309|FG004|Overall Study|Poor/non-compliance|0|||
125273064|NCT02931838|450625310|FG005|Overall Study|Poor/non-compliance|0|||
125273065|NCT02931838|450625305|FG000|Overall Study|Lack of Efficacy|5|||
125273066|NCT02931838|450625306|FG001|Overall Study|Lack of Efficacy|4|||
125273067|NCT02931838|450625307|FG002|Overall Study|Lack of Efficacy|0|||
125273068|NCT02931838|450625308|FG003|Overall Study|Lack of Efficacy|0|||
125273069|NCT02931838|450625309|FG004|Overall Study|Lack of Efficacy|0|||
125273070|NCT02931838|450625310|FG005|Overall Study|Lack of Efficacy|1|||
125273071|NCT02931838|450625305|FG000|Overall Study|Lost to Follow-up|1|||
125273072|NCT02931838|450625306|FG001|Overall Study|Lost to Follow-up|0|||
125273073|NCT02931838|450625307|FG002|Overall Study|Lost to Follow-up|1|||
125273074|NCT02931838|450625308|FG003|Overall Study|Lost to Follow-up|1|||
125273075|NCT02931838|450625309|FG004|Overall Study|Lost to Follow-up|2|||
125273076|NCT02931838|450625310|FG005|Overall Study|Lost to Follow-up|0|||
125273077|NCT02931838|450625305|FG000|Overall Study|Subject request to discontinue treatment|4|||
125273078|NCT02931838|450625306|FG001|Overall Study|Subject request to discontinue treatment|3|||
125273079|NCT02931838|450625307|FG002|Overall Study|Subject request to discontinue treatment|3|||
125273080|NCT02931838|450625308|FG003|Overall Study|Subject request to discontinue treatment|0|||
125273081|NCT02931838|450625309|FG004|Overall Study|Subject request to discontinue treatment|1|||
125273082|NCT02931838|450625310|FG005|Overall Study|Subject request to discontinue treatment|0|||
125273083|NCT02931838|450625305|FG000|Overall Study|Withdrawal by Subject|1|||
125273084|NCT02931838|450625306|FG001|Overall Study|Withdrawal by Subject|2|||
125273085|NCT02931838|450625307|FG002|Overall Study|Withdrawal by Subject|0|||
125273086|NCT02931838|450625308|FG003|Overall Study|Withdrawal by Subject|1|||
125273087|NCT02931838|450625309|FG004|Overall Study|Withdrawal by Subject|0|||
125273088|NCT02931838|450625310|FG005|Overall Study|Withdrawal by Subject|0|||
125273089|NCT02931838|450625305|FG000|Overall Study|Adverse Event|2|||
125273090|NCT02931838|450625306|FG001|Overall Study|Adverse Event|1|||
125273091|NCT02931838|450625307|FG002|Overall Study|Adverse Event|2|||
125273092|NCT02931838|450625308|FG003|Overall Study|Adverse Event|1|||
125273093|NCT02931838|450625309|FG004|Overall Study|Adverse Event|3|||
125273094|NCT02931838|450625310|FG005|Overall Study|Adverse Event|1|||
125273095|NCT02701764|450625311|FG000|Overall Study|Lost to Follow-up|0|||
125273096|NCT02701764|450625312|FG001|Overall Study|Lost to Follow-up|1|||
125273097|NCT02949024|450625315|FG000|Overall Study|Withdrawal by Subject|0|||
125273098|NCT02949024|450625316|FG001|Overall Study|Withdrawal by Subject|1|||
125273099|NCT01027650|450625317|FG000|Overall Study|Personal Reasons|0|||
125273100|NCT01027650|450625318|FG001|Overall Study|Personal Reasons|0|||
125273101|NCT01027650|450625319|FG002|Overall Study|Personal Reasons|0|||
125273102|NCT01027650|450625320|FG003|Overall Study|Personal Reasons|0|||
125273103|NCT01027650|450625321|FG004|Overall Study|Personal Reasons|2|||
125273104|NCT01027650|450625322|FG005|Overall Study|Personal Reasons|1|||
125273105|NCT01027650|450625323|FG006|Overall Study|Personal Reasons|0|||
125273106|NCT01027650|450625324|FG007|Overall Study|Personal Reasons|0|||
125273107|NCT01027650|450625317|FG000|Overall Study|Lost to Follow-up|0|||
125273108|NCT01027650|450625318|FG001|Overall Study|Lost to Follow-up|0|||
125273109|NCT01027650|450625319|FG002|Overall Study|Lost to Follow-up|0|||
125273110|NCT01027650|450625320|FG003|Overall Study|Lost to Follow-up|0|||
125273111|NCT01027650|450625321|FG004|Overall Study|Lost to Follow-up|0|||
125273112|NCT01027650|450625322|FG005|Overall Study|Lost to Follow-up|0|||
125273113|NCT01027650|450625323|FG006|Overall Study|Lost to Follow-up|1|||
125273114|NCT01027650|450625324|FG007|Overall Study|Lost to Follow-up|0|||
125273115|NCT01027650|450625317|FG000|Overall Study|Lack of Efficacy|0|||
125273116|NCT01027650|450625318|FG001|Overall Study|Lack of Efficacy|0|||
125273117|NCT01027650|450625319|FG002|Overall Study|Lack of Efficacy|0|||
125273118|NCT01027650|450625320|FG003|Overall Study|Lack of Efficacy|0|||
125273119|NCT01027650|450625321|FG004|Overall Study|Lack of Efficacy|0|||
125273120|NCT01027650|450625322|FG005|Overall Study|Lack of Efficacy|1|||
125273121|NCT01027650|450625323|FG006|Overall Study|Lack of Efficacy|0|||
125273122|NCT01027650|450625324|FG007|Overall Study|Lack of Efficacy|0|||
125273123|NCT00912782|450625325|FG000|Overall Study|Death|2|||
125273124|NCT00912782|450625326|FG001|Overall Study|Death|1|||
125273125|NCT00912782|450625325|FG000|Overall Study|Lost to Follow-up|0|||
125273126|NCT00912782|450625326|FG001|Overall Study|Lost to Follow-up|1|||
125273127|NCT00912782|450625325|FG000|Overall Study|Did not receive vascular access type|1|||
125273128|NCT00912782|450625326|FG001|Overall Study|Did not receive vascular access type|2|||
125273129|NCT00912782|450625325|FG000|Overall Study|Relocated before study completion|0|||
125273130|NCT00912782|450625326|FG001|Overall Study|Relocated before study completion|1|||
125273131|NCT03419897|450627203|FG000|Overall Study|Death|180|||
125273132|NCT03419897|450627203|FG000|Overall Study|Lost to Follow-up|1|||
125273133|NCT03419897|450627203|FG000|Overall Study|Withdrawal by Subject|6|||
125273134|NCT03419897|450627203|FG000|Overall Study|Sponsor Decision|61|||
125273135|NCT03419897|450627203|FG000|Overall Study|Physician Decision|1|||
125273136|NCT00958360|450627205|FG000|Overall Study|Withdrawal by Subject|3|||
125273137|NCT00958360|450627206|FG001|Overall Study|Withdrawal by Subject|1|||
125273138|NCT00958360|450627205|FG000|Overall Study|Death|6|||
125273139|NCT00958360|450627206|FG001|Overall Study|Death|7|||
125273140|NCT00958360|450627205|FG000|Overall Study|Physician Decision|2|||
125273141|NCT00958360|450627206|FG001|Overall Study|Physician Decision|1|||
125273142|NCT00958360|450627205|FG000|Overall Study|Lost to Follow-up|0|||
125273143|NCT00958360|450627206|FG001|Overall Study|Lost to Follow-up|1|||
125273144|NCT02719691|450627207|FG000|Overall Study|Physician Decision|0|||
125273145|NCT02719691|450627208|FG001|Overall Study|Physician Decision|0|||
125273146|NCT02719691|450627209|FG002|Overall Study|Physician Decision|1|||
125273147|NCT02719691|450627210|FG003|Overall Study|Physician Decision|0|||
125273148|NCT02719691|450627211|FG004|Overall Study|Physician Decision|0|||
125273149|NCT02719691|450627212|FG005|Overall Study|Physician Decision|0|||
125273150|NCT02719691|450627213|FG006|Overall Study|Physician Decision|0|||
125273151|NCT02719691|450627207|FG000|Overall Study|Withdrawal by Subject|0|||
125273152|NCT02719691|450627208|FG001|Overall Study|Withdrawal by Subject|0|||
125273153|NCT02719691|450627209|FG002|Overall Study|Withdrawal by Subject|0|||
125273154|NCT02719691|450627210|FG003|Overall Study|Withdrawal by Subject|0|||
125273155|NCT02719691|450627211|FG004|Overall Study|Withdrawal by Subject|0|||
125273156|NCT02719691|450627212|FG005|Overall Study|Withdrawal by Subject|1|||
125273157|NCT02719691|450627213|FG006|Overall Study|Withdrawal by Subject|0|||
125273158|NCT00336284|450627214|FG000|Overall Study|Death|52|||
125273159|NCT00336284|450627215|FG001|Overall Study|Death|26|||
125273160|NCT00336284|450627214|FG000|Overall Study|Lost to Follow-up|82|||
125273161|NCT00336284|450627215|FG001|Overall Study|Lost to Follow-up|61|||
125273162|NCT00336284|450627214|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
125273163|NCT00336284|450627215|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
125273164|NCT03308968|450627220|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
125273165|NCT03308968|450627221|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
125273166|NCT03308968|450627222|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
125273167|NCT03308968|450627220|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
125273168|NCT03308968|450627221|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
125273169|NCT03308968|450627222|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
125273170|NCT03308968|450627220|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
125273171|NCT03308968|450627221|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
125273172|NCT03308968|450627222|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
125273173|NCT03308968|450627220|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
125273174|NCT03308968|450627221|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
125273175|NCT03308968|450627222|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
125273176|NCT03308968|450627220|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
125273177|NCT03308968|450627221|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
125273178|NCT03308968|450627222|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
125273179|NCT03308968|450627220|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
125273180|NCT03308968|450627221|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
125273181|NCT03308968|450627222|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
125273182|NCT03308968|450627220|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
125273183|NCT03308968|450627221|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
125273184|NCT03308968|450627222|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
125273185|NCT03308968|450627220|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
125273186|NCT03308968|450627221|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
125273187|NCT03308968|450627222|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
125273188|NCT03308968|450627220|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
125273189|NCT03308968|450627221|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
125273190|NCT03308968|450627222|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
125273191|NCT03308968|450627220|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
125273192|NCT03308968|450627221|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
125273193|NCT03308968|450627222|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
125273194|NCT03308968|450627220|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
125273195|NCT03308968|450627221|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
125273196|NCT03308968|450627222|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
125273197|NCT03308968|450627220|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
125273198|NCT03308968|450627221|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
125273199|NCT03308968|450627222|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
125273200|NCT03308968|450627220|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
125273201|NCT03308968|450627221|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
125273202|NCT03308968|450627222|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
125273203|NCT03308968|450627220|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
125273204|NCT03308968|450627221|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
125273205|NCT03308968|450627222|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
125273206|NCT01961297|450627228|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
125273207|NCT01961297|450627229|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
125273208|NCT02141633|450627230|FG000|Overall Study|Physician Decision|1|||
125273209|NCT02141633|450627231|FG001|Overall Study|Physician Decision|0|||
125273210|NCT02482298|450627232|FG000|Overall Study|Withdrawal by Subject|2|||
125273211|NCT02482298|450627233|FG001|Overall Study|Withdrawal by Subject|1|||
125273212|NCT02482298|450627234|FG002|Overall Study|Withdrawal by Subject|2|||
125273213|NCT02482298|450627232|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
125273214|NCT02482298|450627233|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
125273215|NCT02482298|450627234|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
125273216|NCT02482298|450627232|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
125273217|NCT02482298|450627233|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
125273218|NCT02482298|450627234|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
125273219|NCT02482298|450627232|FG000|Overall Study|Lost to Follow-up|0|||
125273220|NCT02482298|450627233|FG001|Overall Study|Lost to Follow-up|1|||
125273221|NCT02482298|450627234|FG002|Overall Study|Lost to Follow-up|0|||
125273222|NCT01188551|450627239|FG000|Overall Study|Pharmacy issues|1|||
125273223|NCT01188551|450627240|FG001|Overall Study|Pharmacy issues|0|||
125273224|NCT01188551|450627241|FG002|Overall Study|Pharmacy issues|0|||
125273225|NCT01188551|450627242|FG003|Overall Study|Pharmacy issues|0|||
125273226|NCT03782259|450627245|FG000|Overall Study|Lost to Follow-up|1|||
125273227|NCT03782259|450627246|FG001|Overall Study|Lost to Follow-up|1|||
125273228|NCT03782259|450627245|FG000|Overall Study|Moved out of state|0|||
125273229|NCT03782259|450627246|FG001|Overall Study|Moved out of state|2|||
125273230|NCT03782259|450627245|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
125273231|NCT03782259|450627246|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
125273232|NCT03782259|450627245|FG000|Overall Study|Subject discontinued intervention|1|||
125273233|NCT03782259|450627246|FG001|Overall Study|Subject discontinued intervention|0|||
125273234|NCT00603941|450627247|FG000|Overall Study|Disease progression|6|||
125273235|NCT00603941|450627248|FG001|Overall Study|Disease progression|7|||
125273236|NCT00603941|450627249|FG002|Overall Study|Disease progression|1|||
125273237|NCT00603941|450627247|FG000|Overall Study|Adverse Event|1|||
125273238|NCT00603941|450627248|FG001|Overall Study|Adverse Event|0|||
125273239|NCT00603941|450627249|FG002|Overall Study|Adverse Event|1|||
125273240|NCT00603941|450627247|FG000|Overall Study|Physician Decision|0|||
125273241|NCT00603941|450627248|FG001|Overall Study|Physician Decision|1|||
125273242|NCT00603941|450627249|FG002|Overall Study|Physician Decision|0|||
125273243|NCT00603941|450627247|FG000|Overall Study|Withdrawal by Subject|0|||
125273244|NCT00603941|450627248|FG001|Overall Study|Withdrawal by Subject|2|||
125273245|NCT00603941|450627249|FG002|Overall Study|Withdrawal by Subject|0|||
125273246|NCT05069597|450627250|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
125273247|NCT05069597|450627251|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
125273248|NCT05507567|450627252|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
125273249|NCT05507567|450627253|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
125273250|NCT05507567|450627254|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
125273251|NCT05507567|450627252|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
125273252|NCT05507567|450627253|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
125273253|NCT05507567|450627254|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
125273254|NCT05507567|450627252|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
125273255|NCT05507567|450627253|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
125273256|NCT05507567|450627254|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
125273257|NCT05507567|450627252|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
125273258|NCT05507567|450627253|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
125273259|NCT05507567|450627254|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
125273260|NCT00375427|450627255|FG000|Overall Study|Adverse Event|21|||
125273261|NCT00375427|450627256|FG001|Overall Study|Adverse Event|27|||
125273262|NCT00375427|450627255|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125273263|NCT00375427|450627256|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125273264|NCT00375427|450627255|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125273265|NCT00375427|450627256|FG001|Overall Study|Abnormal laboratory value(s)|2|||
125273266|NCT00375427|450627255|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
125273267|NCT00375427|450627256|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
125273268|NCT00375427|450627255|FG000|Overall Study|Patient no longer requires study drug|3|||
125273269|NCT00375427|450627256|FG001|Overall Study|Patient no longer requires study drug|7|||
125273270|NCT00375427|450627255|FG000|Overall Study|Protocol Violation|10|||
125273271|NCT00375427|450627256|FG001|Overall Study|Protocol Violation|8|||
125273272|NCT00375427|450627255|FG000|Overall Study|Withdrawal by Subject|9|||
125273273|NCT00375427|450627256|FG001|Overall Study|Withdrawal by Subject|13|||
125273274|NCT00375427|450627255|FG000|Overall Study|Lost to Follow-up|1|||
125273275|NCT00375427|450627256|FG001|Overall Study|Lost to Follow-up|1|||
125273276|NCT00375427|450627255|FG000|Overall Study|Administrative reasons|0|||
125273277|NCT00375427|450627256|FG001|Overall Study|Administrative reasons|1|||
125273278|NCT00375427|450627255|FG000|Overall Study|Death|11|||
125273279|NCT00375427|450627256|FG001|Overall Study|Death|10|||
125273280|NCT00606411|450627267|FG000|Overall Study|Adverse Event|1|||
125273281|NCT00606411|450627268|FG001|Overall Study|Adverse Event|2|||
125273282|NCT00606411|450627267|FG000|Overall Study|Lack of Adherence|1|||
125273283|NCT00606411|450627268|FG001|Overall Study|Lack of Adherence|1|||
125273284|NCT00606411|450627267|FG000|Overall Study|Lack of Efficacy|1|||
125273285|NCT00606411|450627268|FG001|Overall Study|Lack of Efficacy|1|||
125273286|NCT00606411|450627267|FG000|Overall Study|Withdrawal by Subject|2|||
125273287|NCT00606411|450627268|FG001|Overall Study|Withdrawal by Subject|0|||
125273288|NCT00606411|450627267|FG000|Overall Study|Lost to Follow-up|1|||
125273289|NCT00606411|450627268|FG001|Overall Study|Lost to Follow-up|2|||
125273290|NCT00606411|450627267|FG000|Overall Study|Move out of state|0|||
125273291|NCT00606411|450627268|FG001|Overall Study|Move out of state|1|||
125273292|NCT03726658|450627269|FG000|Overall Study|Lost to Follow-up|0|||
125273293|NCT03726658|450627270|FG001|Overall Study|Lost to Follow-up|0|||
125273294|NCT03726658|450627271|FG002|Overall Study|Lost to Follow-up|2|||
125273295|NCT03726658|450627272|FG003|Overall Study|Lost to Follow-up|0|||
125273296|NCT03726658|450627273|FG004|Overall Study|Lost to Follow-up|0|||
125273297|NCT03726658|450627274|FG005|Overall Study|Lost to Follow-up|1|||
125273298|NCT03726658|450627275|FG006|Overall Study|Lost to Follow-up|1|||
125273299|NCT03726658|450627269|FG000|Overall Study|Withdrawal by Subject|1|||
125273300|NCT03726658|450627270|FG001|Overall Study|Withdrawal by Subject|0|||
125273301|NCT03726658|450627271|FG002|Overall Study|Withdrawal by Subject|0|||
125273302|NCT03726658|450627272|FG003|Overall Study|Withdrawal by Subject|0|||
125273303|NCT03726658|450627273|FG004|Overall Study|Withdrawal by Subject|6|||
125273304|NCT03726658|450627274|FG005|Overall Study|Withdrawal by Subject|4|||
125273305|NCT03726658|450627275|FG006|Overall Study|Withdrawal by Subject|2|||
125273306|NCT03726658|450627269|FG000|Overall Study|Pregnancy|0|||
125273307|NCT03726658|450627270|FG001|Overall Study|Pregnancy|0|||
125273308|NCT03726658|450627271|FG002|Overall Study|Pregnancy|0|||
125273309|NCT03726658|450627272|FG003|Overall Study|Pregnancy|0|||
125273310|NCT03726658|450627273|FG004|Overall Study|Pregnancy|0|||
125273311|NCT03726658|450627274|FG005|Overall Study|Pregnancy|0|||
125273312|NCT03726658|450627275|FG006|Overall Study|Pregnancy|1|||
125273313|NCT03726658|450627269|FG000|Overall Study|Not Reported|0|||
125273314|NCT03726658|450627270|FG001|Overall Study|Not Reported|0|||
125273315|NCT03726658|450627271|FG002|Overall Study|Not Reported|0|||
125273316|NCT03726658|450627272|FG003|Overall Study|Not Reported|0|||
125273317|NCT03726658|450627273|FG004|Overall Study|Not Reported|0|||
125273318|NCT03726658|450627274|FG005|Overall Study|Not Reported|0|||
125273319|NCT03726658|450627275|FG006|Overall Study|Not Reported|1|||
125273320|NCT00412958|450627276|FG000|Overall Study|Withdrawal by Subject|3|||
125273321|NCT00412958|450627277|FG001|Overall Study|Withdrawal by Subject|0|||
125273322|NCT00412958|450627278|FG002|Overall Study|Withdrawal by Subject|0|||
125273323|NCT00412958|450627279|FG003|Overall Study|Withdrawal by Subject|1|||
125273324|NCT00412958|450627276|FG000|Overall Study|Adverse Event|0|||
125273325|NCT00412958|450627277|FG001|Overall Study|Adverse Event|1|||
125273326|NCT00412958|450627278|FG002|Overall Study|Adverse Event|0|||
125273327|NCT00412958|450627279|FG003|Overall Study|Adverse Event|0|||
125273328|NCT00412958|450627276|FG000|Overall Study|Lost to Follow-up|0|||
125273329|NCT00412958|450627277|FG001|Overall Study|Lost to Follow-up|1|||
125273330|NCT00412958|450627278|FG002|Overall Study|Lost to Follow-up|0|||
125273331|NCT00412958|450627279|FG003|Overall Study|Lost to Follow-up|0|||
125273332|NCT00412958|450627276|FG000|Overall Study|Death|0|||
125273333|NCT00412958|450627277|FG001|Overall Study|Death|1|||
125273334|NCT00412958|450627278|FG002|Overall Study|Death|0|||
125273335|NCT00412958|450627279|FG003|Overall Study|Death|0|||
125273336|NCT00412958|450627276|FG000|Overall Study|Transport issue|0|||
125273337|NCT00412958|450627277|FG001|Overall Study|Transport issue|1|||
125273338|NCT00412958|450627278|FG002|Overall Study|Transport issue|0|||
125273339|NCT00412958|450627279|FG003|Overall Study|Transport issue|0|||
125273340|NCT00090779|450627280|FG000|Step 1|Withdrawal by Subject|4|||
125273341|NCT00090779|450627281|FG001|Step 1|Withdrawal by Subject|2|||
125273342|NCT00090779|450627280|FG000|Step 1|Lost to Follow-up|3|||
125273343|NCT00090779|450627281|FG001|Step 1|Lost to Follow-up|2|||
125273344|NCT00090779|450627280|FG000|Step 1|Death|0|||
125273345|NCT00090779|450627281|FG001|Step 1|Death|2|||
125273346|NCT00090779|450627280|FG000|Step 1|Physician Decision|1|||
125273347|NCT00090779|450627281|FG001|Step 1|Physician Decision|0|||
125273348|NCT00090779|450627280|FG000|Step 1|Pregnancy|1|||
125273349|NCT00090779|450627281|FG001|Step 1|Pregnancy|0|||
125273350|NCT00090779|450627280|FG000|Step 1|Non-compliance to study requirements|0|||
125273351|NCT00090779|450627281|FG001|Step 1|Non-compliance to study requirements|1|||
125273352|NCT00090779|450627280|FG000|Step 1|Subject relocated|2|||
125273353|NCT00090779|450627281|FG001|Step 1|Subject relocated|8|||
125273354|NCT00090779|450627280|FG000|Step 2|Off study per study closure|6|||
125273355|NCT00090779|450627281|FG001|Step 2|Off study per study closure|16|||
125273356|NCT00090779|450627280|FG000|Step 2|Subject relocated|0|||
125273357|NCT00090779|450627281|FG001|Step 2|Subject relocated|1|||
125273358|NCT00090779|450627280|FG000|Step 2|Non-compliance to study requirements|0|||
125273359|NCT00090779|450627281|FG001|Step 2|Non-compliance to study requirements|1|||
125273360|NCT00090779|450627280|FG000|Step 3|Initiation of ART and off extended study|3|||
125273361|NCT00090779|450627281|FG001|Step 3|Initiation of ART and off extended study|2|||
125273362|NCT00090779|450627280|FG000|Step 3|Off extended study due to study closure|4|||
125273363|NCT00090779|450627281|FG001|Step 3|Off extended study due to study closure|3|||
125273364|NCT01318135|450627282|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
125273365|NCT01318135|450627283|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125273366|NCT01318135|450627284|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125273367|NCT01318135|450627285|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125273368|NCT01318135|450627286|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125273369|NCT01318135|450627287|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125273370|NCT01318135|450627288|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125273371|NCT01318135|450627289|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125273372|NCT01318135|450627282|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
125273373|NCT01318135|450627283|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
125273374|NCT01318135|450627284|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
125273375|NCT01318135|450627285|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
125273376|NCT01318135|450627286|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
125273377|NCT01318135|450627287|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
125273378|NCT01318135|450627288|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
125273379|NCT01318135|450627289|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
125273380|NCT01318135|450627282|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
125273381|NCT01318135|450627283|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
125273382|NCT01318135|450627284|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
125273383|NCT01318135|450627285|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
125273384|NCT01318135|450627286|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
125273385|NCT01318135|450627287|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
125273386|NCT01318135|450627288|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
125273387|NCT01318135|450627289|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
125273388|NCT01318135|450627282|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
125273389|NCT01318135|450627283|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
125273390|NCT01318135|450627284|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
125273391|NCT01318135|450627285|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
125273392|NCT01318135|450627286|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
125273393|NCT01318135|450627287|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
125273394|NCT01318135|450627288|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
125273395|NCT01318135|450627289|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
125273396|NCT01318135|450627282|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
125273397|NCT01318135|450627283|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
125273398|NCT01318135|450627284|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
125273399|NCT01318135|450627285|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
125273400|NCT01318135|450627286|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
125273401|NCT01318135|450627287|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
125273402|NCT01318135|450627288|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
125273403|NCT01318135|450627289|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
125273404|NCT01318135|450627282|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
125273405|NCT01318135|450627283|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
125273406|NCT01318135|450627284|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
125273407|NCT01318135|450627285|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
125273408|NCT01318135|450627286|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
125273409|NCT01318135|450627287|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
125273410|NCT01318135|450627288|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
125273411|NCT01318135|450627289|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
125273412|NCT01318135|450627282|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
125273413|NCT01318135|450627283|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
125273414|NCT01318135|450627284|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
125273415|NCT01318135|450627285|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
125273416|NCT01318135|450627286|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
125273417|NCT01318135|450627287|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
125273418|NCT01318135|450627288|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
125273419|NCT01318135|450627289|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
125273420|NCT03012828|450627298|FG000|Overall Study|Lost to Follow-up|1|||
125273421|NCT03012828|450627299|FG001|Overall Study|Lost to Follow-up|0|||
125273422|NCT03012828|450627300|FG002|Overall Study|Lost to Follow-up|1|||
125273423|NCT03012828|450627301|FG003|Overall Study|Lost to Follow-up|0|||
125273424|NCT03012828|450627302|FG004|Overall Study|Lost to Follow-up|1|||
125273425|NCT03012828|450627303|FG005|Overall Study|Lost to Follow-up|0|||
125273426|NCT03012828|450627298|FG000|Overall Study|Withdrawal by Subject|0|||
125273427|NCT03012828|450627299|FG001|Overall Study|Withdrawal by Subject|0|||
125273428|NCT03012828|450627300|FG002|Overall Study|Withdrawal by Subject|1|||
125273429|NCT03012828|450627301|FG003|Overall Study|Withdrawal by Subject|0|||
125273430|NCT03012828|450627302|FG004|Overall Study|Withdrawal by Subject|0|||
125273431|NCT03012828|450627303|FG005|Overall Study|Withdrawal by Subject|1|||
125273432|NCT03012828|450627298|FG000|Overall Study|Non-compliance with protocol|0|||
125273433|NCT03012828|450627299|FG001|Overall Study|Non-compliance with protocol|0|||
125273434|NCT03012828|450627300|FG002|Overall Study|Non-compliance with protocol|0|||
125273435|NCT03012828|450627301|FG003|Overall Study|Non-compliance with protocol|0|||
125273436|NCT03012828|450627302|FG004|Overall Study|Non-compliance with protocol|1|||
125273437|NCT03012828|450627303|FG005|Overall Study|Non-compliance with protocol|0|||
125273438|NCT03012828|450627298|FG000|Overall Study|Delay to last visit would delay DBL|0|||
125273439|NCT03012828|450627299|FG001|Overall Study|Delay to last visit would delay DBL|0|||
125273440|NCT03012828|450627300|FG002|Overall Study|Delay to last visit would delay DBL|0|||
125273441|NCT03012828|450627301|FG003|Overall Study|Delay to last visit would delay DBL|0|||
125273442|NCT03012828|450627302|FG004|Overall Study|Delay to last visit would delay DBL|0|||
125273443|NCT03012828|450627303|FG005|Overall Study|Delay to last visit would delay DBL|1|||
125273444|NCT04396795|450627308|FG000|Month 1|Lost to Follow-up|2|||
125273445|NCT04396795|450627309|FG001|Month 1|Lost to Follow-up|3|||
125273446|NCT04396795|450627308|FG000|Month 3|Lost to Follow-up|1|||
125273447|NCT04396795|450627309|FG001|Month 3|Lost to Follow-up|3|||
125273448|NCT04396795|450627308|FG000|Month 6|Lost to Follow-up|3|||
125273449|NCT04396795|450627309|FG001|Month 6|Lost to Follow-up|3|||
125273450|NCT03472495|450627313|FG000|Overall Study|Treatment no longer indicated|1|||
125273451|NCT03472495|450627314|FG001|Overall Study|Treatment no longer indicated|2|||
125273452|NCT03472495|450627313|FG000|Overall Study|Physician Decision|0|||
125273453|NCT03472495|450627314|FG001|Overall Study|Physician Decision|2|||
125273454|NCT01107392|450627316|FG000|Overall Study|Adverse Event|2|||
125273455|NCT01107392|450627317|FG001|Overall Study|Adverse Event|0|||
125273456|NCT01107392|450627316|FG000|Overall Study|Personal Reasons|2|||
125273457|NCT01107392|450627317|FG001|Overall Study|Personal Reasons|3|||
125273458|NCT01107392|450627316|FG000|Overall Study|Administrative decision|1|||
125273459|NCT01107392|450627317|FG001|Overall Study|Administrative decision|0|||
125273460|NCT02998671|450627320|FG000|Period 1|Study Terminated By Sponsor|2|||
125273461|NCT02998671|450627321|FG001|Period 1|Study Terminated By Sponsor|1|||
125273462|NCT02998671|450627322|FG002|Period 1|Study Terminated By Sponsor|0|||
125273463|NCT02998671|450627323|FG003|Period 1|Study Terminated By Sponsor|0|||
125273464|NCT02998671|450627324|FG004|Period 1|Study Terminated By Sponsor|1|||
125273465|NCT02998671|450627320|FG000|Period 1|Withdrawal by Subject|1|||
125273466|NCT02998671|450627321|FG001|Period 1|Withdrawal by Subject|2|||
125273467|NCT02998671|450627322|FG002|Period 1|Withdrawal by Subject|0|||
125273468|NCT02998671|450627323|FG003|Period 1|Withdrawal by Subject|0|||
125273469|NCT02998671|450627324|FG004|Period 1|Withdrawal by Subject|2|||
125273470|NCT02998671|450627320|FG000|Period 1|Pregnancy|1|||
125273471|NCT02998671|450627321|FG001|Period 1|Pregnancy|0|||
125273472|NCT02998671|450627322|FG002|Period 1|Pregnancy|0|||
125273473|NCT02998671|450627323|FG003|Period 1|Pregnancy|0|||
125273474|NCT02998671|450627324|FG004|Period 1|Pregnancy|0|||
125273475|NCT02998671|450627320|FG000|Period 1|Adverse Event|0|||
125273476|NCT02998671|450627321|FG001|Period 1|Adverse Event|0|||
125273477|NCT02998671|450627322|FG002|Period 1|Adverse Event|0|||
125273478|NCT02998671|450627323|FG003|Period 1|Adverse Event|0|||
125273479|NCT02998671|450627324|FG004|Period 1|Adverse Event|1|||
125273480|NCT02998671|450627320|FG000|Period 2|Adverse Event|0|||
125273481|NCT02998671|450627321|FG001|Period 2|Adverse Event|1|||
125273482|NCT02998671|450627322|FG002|Period 2|Adverse Event|0|||
125273483|NCT02998671|450627323|FG003|Period 2|Adverse Event|0|||
125273484|NCT02998671|450627324|FG004|Period 2|Adverse Event|0|||
125273485|NCT02998671|450627320|FG000|Period 2|Study Terminated By Sponsor|3|||
125273486|NCT02998671|450627321|FG001|Period 2|Study Terminated By Sponsor|5|||
125273487|NCT02998671|450627322|FG002|Period 2|Study Terminated By Sponsor|1|||
125273488|NCT02998671|450627323|FG003|Period 2|Study Terminated By Sponsor|3|||
125273489|NCT02998671|450627324|FG004|Period 2|Study Terminated By Sponsor|0|||
125273490|NCT02998671|450627320|FG000|Period 2|Withdrawal by Subject|0|||
125273491|NCT02998671|450627321|FG001|Period 2|Withdrawal by Subject|1|||
125273492|NCT02998671|450627322|FG002|Period 2|Withdrawal by Subject|0|||
125273493|NCT02998671|450627323|FG003|Period 2|Withdrawal by Subject|0|||
125273494|NCT02998671|450627324|FG004|Period 2|Withdrawal by Subject|0|||
125273495|NCT02998671|450627320|FG000|Period 2|Lost to Follow-up|0|||
125273496|NCT02998671|450627321|FG001|Period 2|Lost to Follow-up|0|||
125273497|NCT02998671|450627322|FG002|Period 2|Lost to Follow-up|0|||
125273498|NCT02998671|450627323|FG003|Period 2|Lost to Follow-up|1|||
125273499|NCT02998671|450627324|FG004|Period 2|Lost to Follow-up|0|||
125273500|NCT02038946|450627326|FG000|Overall Study|Death|5|||
125273501|NCT02038946|450627326|FG000|Overall Study|Withdrawal by Subject|3|||
125273502|NCT02038946|450627326|FG000|Overall Study|Lost to Follow-up|2|||
125273503|NCT02038946|450627326|FG000|Overall Study|Other reasons|2|||
125273504|NCT02623205|450627327|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
125273505|NCT02623205|450627328|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
125273506|NCT03162796|450627329|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
125273507|NCT03162796|450627330|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
125273508|NCT03162796|450627331|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
125273509|NCT03162796|450627329|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
125273510|NCT03162796|450627330|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
125273511|NCT03162796|450627331|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
125273512|NCT03162796|450627329|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
125273513|NCT03162796|450627330|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
125273514|NCT03162796|450627331|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
125273515|NCT03162796|450627329|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
125273516|NCT03162796|450627330|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
125273517|NCT03162796|450627331|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
125273518|NCT03162796|450627329|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
125273519|NCT03162796|450627330|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
125273520|NCT03162796|450627331|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
125273521|NCT03162796|450627329|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
125273522|NCT03162796|450627330|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
125273523|NCT03162796|450627331|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
125273524|NCT03162796|450627329|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
125273525|NCT03162796|450627330|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
125273526|NCT03162796|450627331|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
125273527|NCT03162796|450627329|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
125273528|NCT03162796|450627330|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
125273529|NCT03162796|450627331|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
125273530|NCT03162796|450627329|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
125273531|NCT03162796|450627330|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
125273532|NCT03162796|450627331|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
125273533|NCT03162796|450627329|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
125273534|NCT03162796|450627330|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
125273535|NCT03162796|450627331|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
125273536|NCT03162796|450627329|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
125273537|NCT03162796|450627330|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
125273538|NCT03162796|450627331|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
125273539|NCT02473471|450627332|FG000|Overall Study|poor oral hygiene|2|||
125273540|NCT02473471|450627332|FG000|Overall Study|Lost to Follow-up|1|||
125273541|NCT02342288|450627335|FG000|Overall Study|no protocol anesthesiologist available|3|||
125273542|NCT02342288|450627336|FG001|Overall Study|no protocol anesthesiologist available|2|||
125273543|NCT02342288|450627335|FG000|Overall Study|anesthesia leak in system|1|||
125273544|NCT02342288|450627336|FG001|Overall Study|anesthesia leak in system|0|||
125273545|NCT02342288|450627335|FG000|Overall Study|Withdrawal by Subject|1|||
125273546|NCT02342288|450627336|FG001|Overall Study|Withdrawal by Subject|0|||
125273547|NCT02342288|450627335|FG000|Overall Study|coordinator contaminated with blood|0|||
125273548|NCT02342288|450627336|FG001|Overall Study|coordinator contaminated with blood|1|||
125273549|NCT02342288|450627335|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
125273550|NCT02342288|450627336|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
125273551|NCT02342288|450627335|FG000|Overall Study|coordinator not available|0|||
125273552|NCT02342288|450627336|FG001|Overall Study|coordinator not available|2|||
125273553|NCT03082677|450627337|FG000|Overall Study|Not Treated|2|||
125273554|NCT01916824|450627342|FG000|Overall Study|Lost to Follow-up|3|||
125273555|NCT01916824|450627343|FG001|Overall Study|Lost to Follow-up|6|||
125273556|NCT01916824|450627342|FG000|Overall Study|Physician Decision|2|||
125273557|NCT01916824|450627343|FG001|Overall Study|Physician Decision|0|||
125273558|NCT01916824|450627342|FG000|Overall Study|Withdrawal by Subject|2|||
125273559|NCT01916824|450627343|FG001|Overall Study|Withdrawal by Subject|3|||
125273560|NCT02063984|450627346|FG000|Overall Study|Lost to Follow-up|6|||
125273561|NCT02063984|450627347|FG001|Overall Study|Lost to Follow-up|5|||
125273562|NCT02455336|450627351|FG000|Overall Study|Withdrawal by Subject|0|||
125273563|NCT02455336|450627352|FG001|Overall Study|Withdrawal by Subject|2|||
125273564|NCT02455336|450627351|FG000|Overall Study|Adverse Event|3|||
125273565|NCT02455336|450627352|FG001|Overall Study|Adverse Event|0|||
125273566|NCT02455336|450627351|FG000|Overall Study|Non-responder to treatment|2|||
125273567|NCT02455336|450627352|FG001|Overall Study|Non-responder to treatment|0|||
125273568|NCT02467192|450627355|FG000|Overall Study|Death|1|||
125273569|NCT02467192|450627355|FG000|Overall Study|revealed to have pneumonia before|2|||
125273570|NCT02517398|450627357|FG000|Overall Study|Death|2|||
125273571|NCT02517398|450627358|FG001|Overall Study|Death|3|||
125273572|NCT02517398|450627359|FG002|Overall Study|Death|4|||
125273573|NCT02517398|450627360|FG003|Overall Study|Death|2|||
125273574|NCT02517398|450627361|FG004|Overall Study|Death|3|||
125273575|NCT02517398|450627362|FG005|Overall Study|Death|8|||
125273576|NCT02517398|450627363|FG006|Overall Study|Death|3|||
125273577|NCT02517398|450627364|FG007|Overall Study|Death|2|||
125273578|NCT02517398|450627365|FG008|Overall Study|Death|6|||
125273579|NCT02517398|450627366|FG009|Overall Study|Death|24|||
125273580|NCT02517398|450627367|FG010|Overall Study|Death|53|||
125273581|NCT02517398|450627368|FG011|Overall Study|Death|25|||
125273582|NCT02517398|450627369|FG012|Overall Study|Death|73|||
125273583|NCT02517398|450627370|FG013|Overall Study|Death|29|||
125273584|NCT02517398|450627371|FG014|Overall Study|Death|26|||
125273585|NCT02517398|450627372|FG015|Overall Study|Death|23|||
125273586|NCT02517398|450627373|FG016|Overall Study|Death|26|||
125273587|NCT02517398|450627374|FG017|Overall Study|Death|25|||
125273588|NCT02517398|450627375|FG018|Overall Study|Death|22|||
125273589|NCT02517398|450627376|FG019|Overall Study|Death|7|||
125273590|NCT02517398|450627377|FG020|Overall Study|Death|26|||
125273591|NCT02517398|450627378|FG021|Overall Study|Death|30|||
125273592|NCT02517398|450627379|FG022|Overall Study|Death|20|||
125273593|NCT02517398|450627357|FG000|Overall Study|Other|0|||
125273594|NCT02517398|450627358|FG001|Overall Study|Other|0|||
125273595|NCT02517398|450627359|FG002|Overall Study|Other|0|||
125273596|NCT02517398|450627360|FG003|Overall Study|Other|1|||
125273597|NCT02517398|450627361|FG004|Overall Study|Other|0|||
125273598|NCT02517398|450627362|FG005|Overall Study|Other|0|||
125273599|NCT02517398|450627363|FG006|Overall Study|Other|0|||
125273600|NCT02517398|450627364|FG007|Overall Study|Other|0|||
125273601|NCT02517398|450627365|FG008|Overall Study|Other|0|||
125273602|NCT02517398|450627366|FG009|Overall Study|Other|1|||
125273603|NCT02517398|450627367|FG010|Overall Study|Other|0|||
125273604|NCT02517398|450627368|FG011|Overall Study|Other|0|||
125273605|NCT02517398|450627369|FG012|Overall Study|Other|0|||
125273606|NCT02517398|450627370|FG013|Overall Study|Other|1|||
125273607|NCT02517398|450627371|FG014|Overall Study|Other|0|||
125273608|NCT02517398|450627372|FG015|Overall Study|Other|1|||
125273609|NCT02517398|450627373|FG016|Overall Study|Other|1|||
125273610|NCT02517398|450627374|FG017|Overall Study|Other|0|||
125273611|NCT02517398|450627375|FG018|Overall Study|Other|0|||
125273612|NCT02517398|450627376|FG019|Overall Study|Other|1|||
125273613|NCT02517398|450627377|FG020|Overall Study|Other|0|||
125273614|NCT02517398|450627378|FG021|Overall Study|Other|0|||
125273615|NCT02517398|450627379|FG022|Overall Study|Other|0|||
125273616|NCT02517398|450627357|FG000|Overall Study|Lost to Follow-up|0|||
125273617|NCT02517398|450627358|FG001|Overall Study|Lost to Follow-up|0|||
125273618|NCT02517398|450627359|FG002|Overall Study|Lost to Follow-up|0|||
125273619|NCT02517398|450627360|FG003|Overall Study|Lost to Follow-up|0|||
125273620|NCT02517398|450627361|FG004|Overall Study|Lost to Follow-up|0|||
125273621|NCT02517398|450627362|FG005|Overall Study|Lost to Follow-up|0|||
125273622|NCT02517398|450627363|FG006|Overall Study|Lost to Follow-up|0|||
125273623|NCT02517398|450627364|FG007|Overall Study|Lost to Follow-up|0|||
125273624|NCT02517398|450627365|FG008|Overall Study|Lost to Follow-up|0|||
125273625|NCT02517398|450627366|FG009|Overall Study|Lost to Follow-up|1|||
125273626|NCT02517398|450627367|FG010|Overall Study|Lost to Follow-up|0|||
125273627|NCT02517398|450627368|FG011|Overall Study|Lost to Follow-up|2|||
125273628|NCT02517398|450627369|FG012|Overall Study|Lost to Follow-up|2|||
125273629|NCT02517398|450627370|FG013|Overall Study|Lost to Follow-up|0|||
125273630|NCT02517398|450627371|FG014|Overall Study|Lost to Follow-up|1|||
125273631|NCT02517398|450627372|FG015|Overall Study|Lost to Follow-up|1|||
125273632|NCT02517398|450627373|FG016|Overall Study|Lost to Follow-up|0|||
125273633|NCT02517398|450627374|FG017|Overall Study|Lost to Follow-up|3|||
125273634|NCT02517398|450627375|FG018|Overall Study|Lost to Follow-up|1|||
125273635|NCT02517398|450627376|FG019|Overall Study|Lost to Follow-up|0|||
125273636|NCT02517398|450627377|FG020|Overall Study|Lost to Follow-up|1|||
125273637|NCT02517398|450627378|FG021|Overall Study|Lost to Follow-up|0|||
125273638|NCT02517398|450627379|FG022|Overall Study|Lost to Follow-up|2|||
125273639|NCT02517398|450627357|FG000|Overall Study|Withdrew Consent|0|||
125273640|NCT02517398|450627358|FG001|Overall Study|Withdrew Consent|0|||
125273641|NCT02517398|450627359|FG002|Overall Study|Withdrew Consent|0|||
125273642|NCT02517398|450627360|FG003|Overall Study|Withdrew Consent|0|||
125273643|NCT02517398|450627361|FG004|Overall Study|Withdrew Consent|0|||
125273644|NCT02517398|450627362|FG005|Overall Study|Withdrew Consent|0|||
125273645|NCT02517398|450627363|FG006|Overall Study|Withdrew Consent|1|||
125273646|NCT02517398|450627364|FG007|Overall Study|Withdrew Consent|0|||
125273647|NCT02517398|450627365|FG008|Overall Study|Withdrew Consent|0|||
125273648|NCT02517398|450627366|FG009|Overall Study|Withdrew Consent|2|||
125273649|NCT02517398|450627367|FG010|Overall Study|Withdrew Consent|7|||
125273650|NCT02517398|450627368|FG011|Overall Study|Withdrew Consent|1|||
125273651|NCT02517398|450627369|FG012|Overall Study|Withdrew Consent|5|||
125273652|NCT02517398|450627370|FG013|Overall Study|Withdrew Consent|4|||
125273653|NCT02517398|450627371|FG014|Overall Study|Withdrew Consent|2|||
125273654|NCT02517398|450627372|FG015|Overall Study|Withdrew Consent|5|||
125273655|NCT02517398|450627373|FG016|Overall Study|Withdrew Consent|4|||
125273656|NCT02517398|450627374|FG017|Overall Study|Withdrew Consent|2|||
125273657|NCT02517398|450627375|FG018|Overall Study|Withdrew Consent|3|||
125273658|NCT02517398|450627376|FG019|Overall Study|Withdrew Consent|2|||
125273659|NCT02517398|450627377|FG020|Overall Study|Withdrew Consent|9|||
125273660|NCT02517398|450627378|FG021|Overall Study|Withdrew Consent|3|||
125273661|NCT02517398|450627379|FG022|Overall Study|Withdrew Consent|1|||
125273662|NCT00005947|450627383|FG000|Overall Study|Death|54|||
125273663|NCT00005947|450627384|FG001|Overall Study|Death|40|||
125273664|NCT00005947|450627383|FG000|Overall Study|Patient Refused to Continue|2|||
125273665|NCT00005947|450627384|FG001|Overall Study|Patient Refused to Continue|1|||
125273666|NCT00005947|450627383|FG000|Overall Study|Site Closure|1|||
125273667|NCT00005947|450627384|FG001|Overall Study|Site Closure|0|||
125273668|NCT02195700|450627389|FG000|Overall Study|Protocol Violation|0|||
125273669|NCT02195700|450627390|FG001|Overall Study|Protocol Violation|2|||
125273670|NCT02195700|450627389|FG000|Overall Study|Noncompliance|1|||
125273671|NCT02195700|450627390|FG001|Overall Study|Noncompliance|0|||
125273672|NCT02195700|450627389|FG000|Overall Study|Adverse Event|1|||
125273673|NCT02195700|450627390|FG001|Overall Study|Adverse Event|2|||
125273674|NCT02195700|450627389|FG000|Overall Study|Withdrawal by Subject|3|||
125273675|NCT02195700|450627390|FG001|Overall Study|Withdrawal by Subject|2|||
125273676|NCT02195700|450627389|FG000|Overall Study|Lost to Follow-up|1|||
125273677|NCT02195700|450627390|FG001|Overall Study|Lost to Follow-up|1|||
125273678|NCT03110029|450627391|FG000|Overall Study|Withdrawal by Subject|1|||
125273679|NCT03110029|450627392|FG001|Overall Study|Withdrawal by Subject|1|||
125273680|NCT02524145|450627394|FG000|Overall Study|Withdrawal by Subject|2|||
125273681|NCT02524145|450627395|FG001|Overall Study|Withdrawal by Subject|2|||
125273682|NCT02524145|450627396|FG002|Overall Study|Withdrawal by Subject|3|||
125273683|NCT00283803|450629195|FG000|Overall Study|Physician Decision|9|||
125273684|NCT00283803|450629195|FG000|Overall Study|Withdrawal by Subject|4|||
125273685|NCT01127607|450629196|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
125273686|NCT01127607|450629197|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
125273687|NCT01127607|450629196|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
125273688|NCT01127607|450629197|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
125273689|NCT02220855|450629198|FG000|Overall Study|Adverse Event|8|||
125273690|NCT02220855|450629198|FG000|Overall Study|Disease Progression|5|||
125273691|NCT02220855|450629198|FG000|Overall Study|Withdrawal by Subject|1|||
125273692|NCT03107052|450629211|FG000|Overall Study|Adverse Event|6|||
125273693|NCT03107052|450629212|FG001|Overall Study|Adverse Event|1|||
125273694|NCT03107052|450629213|FG002|Overall Study|Adverse Event|2|||
125273695|NCT03107052|450629211|FG000|Overall Study|Withdrawal by Subject|9|||
125273696|NCT03107052|450629212|FG001|Overall Study|Withdrawal by Subject|5|||
125273697|NCT03107052|450629213|FG002|Overall Study|Withdrawal by Subject|8|||
125273698|NCT03107052|450629211|FG000|Overall Study|Protocol Violation|6|||
125273699|NCT03107052|450629212|FG001|Overall Study|Protocol Violation|0|||
125273700|NCT03107052|450629213|FG002|Overall Study|Protocol Violation|3|||
125273701|NCT03107052|450629211|FG000|Overall Study|Lost to Follow-up|4|||
125273702|NCT03107052|450629212|FG001|Overall Study|Lost to Follow-up|0|||
125273703|NCT03107052|450629213|FG002|Overall Study|Lost to Follow-up|1|||
125273704|NCT03107052|450629211|FG000|Overall Study|Lack of Efficacy|23|||
125273705|NCT03107052|450629212|FG001|Overall Study|Lack of Efficacy|7|||
125273706|NCT03107052|450629213|FG002|Overall Study|Lack of Efficacy|4|||
125273707|NCT03107052|450629211|FG000|Overall Study|Other than specified|4|||
125273708|NCT03107052|450629212|FG001|Overall Study|Other than specified|2|||
125273709|NCT03107052|450629213|FG002|Overall Study|Other than specified|0|||
125273710|NCT03107052|450629211|FG000|Overall Study|Study terminated due to futility|67|||
125273711|NCT03107052|450629212|FG001|Overall Study|Study terminated due to futility|31|||
125273712|NCT03107052|450629213|FG002|Overall Study|Study terminated due to futility|23|||
125273713|NCT02263326|450629214|FG000|Overall Study|Lost to Follow-up|1|||
125273714|NCT02263326|450629215|FG001|Overall Study|Lost to Follow-up|1|||
125273715|NCT02397915|450629216|FG000|Period 1|Protocol Violation|0|||
125273716|NCT02397915|450629217|FG001|Period 1|Protocol Violation|1|||
125273717|NCT02397915|450629218|FG002|Period 1|Protocol Violation|0|||
125273718|NCT02397915|450629219|FG003|Period 1|Protocol Violation|0|||
125273719|NCT02397915|450629216|FG000|Period 1|Physician Decision|1|||
125273720|NCT02397915|450629217|FG001|Period 1|Physician Decision|0|||
125273721|NCT02397915|450629218|FG002|Period 1|Physician Decision|0|||
125273722|NCT02397915|450629219|FG003|Period 1|Physician Decision|0|||
125273723|NCT00933608|450629220|FG000|Overall Study|Adverse Event|4|||
125273724|NCT00933608|450629221|FG001|Overall Study|Adverse Event|2|||
125273725|NCT00933608|450629220|FG000|Overall Study|Physician Decision|1|||
125273726|NCT00933608|450629221|FG001|Overall Study|Physician Decision|0|||
125273727|NCT00391053|450629224|FG000|Overall Study|Serious Adverse Events|1|||
125273728|NCT00391053|450629225|FG001|Overall Study|Serious Adverse Events|0|||
125273729|NCT00391053|450629226|FG002|Overall Study|Serious Adverse Events|1|||
125273730|NCT00391053|450629227|FG003|Overall Study|Serious Adverse Events|4|||
125273731|NCT00391053|450629224|FG000|Overall Study|Protocol Violation|2|||
125273732|NCT00391053|450629225|FG001|Overall Study|Protocol Violation|0|||
125273733|NCT00391053|450629226|FG002|Overall Study|Protocol Violation|0|||
125273734|NCT00391053|450629227|FG003|Overall Study|Protocol Violation|0|||
125273735|NCT00391053|450629224|FG000|Overall Study|Lost to Follow-up|1|||
125273736|NCT00391053|450629225|FG001|Overall Study|Lost to Follow-up|0|||
125273737|NCT00391053|450629226|FG002|Overall Study|Lost to Follow-up|0|||
125273738|NCT00391053|450629227|FG003|Overall Study|Lost to Follow-up|5|||
125273739|NCT00391053|450629224|FG000|Overall Study|Withdrawal by Subject|5|||
125273740|NCT00391053|450629225|FG001|Overall Study|Withdrawal by Subject|1|||
125273741|NCT00391053|450629226|FG002|Overall Study|Withdrawal by Subject|1|||
125273742|NCT00391053|450629227|FG003|Overall Study|Withdrawal by Subject|1|||
125273743|NCT04908384|450629228|FG000|Overall Study|Lost to Follow-up|4|||
125273744|NCT04908384|450629229|FG001|Overall Study|Lost to Follow-up|4|||
125273745|NCT04908384|450629230|FG002|Overall Study|Lost to Follow-up|0|||
125273746|NCT04908384|450629231|FG003|Overall Study|Lost to Follow-up|0|||
125273747|NCT05002985|450629232|FG000|Overall Study|Withdrawal by Subject|1|||
125273748|NCT01642901|450629236|FG000|12-month Follow-up|Withdrawal by Subject|1|||
125273749|NCT01642901|450629237|FG001|12-month Follow-up|Withdrawal by Subject|0|||
125273750|NCT02943070|450629239|FG000|Overall Study|Physician Decision|1|||
125273751|NCT02943070|450629239|FG000|Overall Study|Adverse Event|2|||
125273752|NCT02943070|450629239|FG000|Overall Study|Death|2|||
125273753|NCT02943070|450629239|FG000|Overall Study|Withdrawal by Subject|3|||
125273754|NCT02943070|450629239|FG000|Overall Study|Lost to Follow-up|4|||
125273755|NCT02943070|450629239|FG000|Overall Study|Retreatment or TURP|13|||
125273756|NCT02943070|450629239|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
125273757|NCT04123093|450629244|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
125273758|NCT04123093|450629245|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
125273759|NCT04123093|450629244|FG000|Phase 2|Physician Decision|0|||
125273760|NCT04123093|450629245|FG001|Phase 2|Physician Decision|1|||
125273761|NCT04123093|450629244|FG000|Phase 2|Withdrawal by Subject|0|||
125273762|NCT04123093|450629245|FG001|Phase 2|Withdrawal by Subject|1|||
125273763|NCT04556591|450629246|FG000|Overall Study|Lost to Follow-up|1|||
125273764|NCT04556591|450629247|FG001|Overall Study|Lost to Follow-up|0|||
125273765|NCT04556591|450629246|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
125273766|NCT04556591|450629247|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
125273767|NCT04551963|450629248|FG000|Overall Study|Physician Decision|1|||
125273768|NCT04551963|450629249|FG001|Overall Study|Physician Decision|1|||
125273769|NCT04551963|450629248|FG000|Overall Study|Death|1|||
125273770|NCT04551963|450629249|FG001|Overall Study|Death|0|||
125273771|NCT03379259|450629250|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
125273772|NCT03379259|450629251|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
125273773|NCT03379259|450629252|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
125273774|NCT03379259|450629253|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
125273775|NCT03379259|450629254|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
125273776|NCT03379259|450629255|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
125273777|NCT03379259|450629250|FG000|Overall Study|Death|0|||
125273778|NCT03379259|450629251|FG001|Overall Study|Death|1|||
125273779|NCT03379259|450629252|FG002|Overall Study|Death|2|||
125273780|NCT03379259|450629253|FG003|Overall Study|Death|1|||
125273781|NCT03379259|450629254|FG004|Overall Study|Death|4|||
125273782|NCT03379259|450629255|FG005|Overall Study|Death|2|||
125273783|NCT03379259|450629250|FG000|Overall Study|Withdrawal by Subject|0|||
125273784|NCT03379259|450629251|FG001|Overall Study|Withdrawal by Subject|0|||
125273785|NCT03379259|450629252|FG002|Overall Study|Withdrawal by Subject|1|||
125273786|NCT03379259|450629253|FG003|Overall Study|Withdrawal by Subject|0|||
125273787|NCT03379259|450629254|FG004|Overall Study|Withdrawal by Subject|2|||
125273788|NCT03379259|450629255|FG005|Overall Study|Withdrawal by Subject|0|||
125273789|NCT03379259|450629250|FG000|Overall Study|Study terminated by sponsor|0|||
125273790|NCT03379259|450629251|FG001|Overall Study|Study terminated by sponsor|0|||
125273791|NCT03379259|450629252|FG002|Overall Study|Study terminated by sponsor|0|||
125273792|NCT03379259|450629253|FG003|Overall Study|Study terminated by sponsor|1|||
125273793|NCT03379259|450629254|FG004|Overall Study|Study terminated by sponsor|1|||
125273794|NCT03379259|450629255|FG005|Overall Study|Study terminated by sponsor|4|||
125273795|NCT03379259|450629250|FG000|Overall Study|Disease progression|0|||
125273796|NCT03379259|450629251|FG001|Overall Study|Disease progression|0|||
125273797|NCT03379259|450629252|FG002|Overall Study|Disease progression|0|||
125273798|NCT03379259|450629253|FG003|Overall Study|Disease progression|1|||
125273799|NCT03379259|450629254|FG004|Overall Study|Disease progression|0|||
125273800|NCT03379259|450629255|FG005|Overall Study|Disease progression|1|||
125273801|NCT03379259|450629250|FG000|Overall Study|Lost to Follow-up|0|||
125273802|NCT03379259|450629251|FG001|Overall Study|Lost to Follow-up|0|||
125273803|NCT03379259|450629252|FG002|Overall Study|Lost to Follow-up|0|||
125273804|NCT03379259|450629253|FG003|Overall Study|Lost to Follow-up|0|||
125273805|NCT03379259|450629254|FG004|Overall Study|Lost to Follow-up|1|||
125273806|NCT03379259|450629255|FG005|Overall Study|Lost to Follow-up|0|||
125273807|NCT03379259|450629250|FG000|Overall Study|Deteriorating condition|0|||
125273808|NCT03379259|450629251|FG001|Overall Study|Deteriorating condition|0|||
125273809|NCT03379259|450629252|FG002|Overall Study|Deteriorating condition|0|||
125273810|NCT03379259|450629253|FG003|Overall Study|Deteriorating condition|0|||
125273811|NCT03379259|450629254|FG004|Overall Study|Deteriorating condition|1|||
125273812|NCT03379259|450629255|FG005|Overall Study|Deteriorating condition|0|||
125273813|NCT00700622|450629257|FG000|Overall Study|Adverse Event|4|||
125273814|NCT00700622|450629258|FG001|Overall Study|Adverse Event|0|||
125273815|NCT00700622|450629257|FG000|Overall Study|Lost to Follow-up|0|||
125273816|NCT00700622|450629258|FG001|Overall Study|Lost to Follow-up|1|||
125273817|NCT00700622|450629257|FG000|Overall Study|Physician Decision|2|||
125273818|NCT00700622|450629258|FG001|Overall Study|Physician Decision|1|||
125273819|NCT00700622|450629257|FG000|Overall Study|Protocol Violation|0|||
125273820|NCT00700622|450629258|FG001|Overall Study|Protocol Violation|1|||
125273821|NCT00700622|450629257|FG000|Overall Study|Withdrawal by Subject|4|||
125273822|NCT00700622|450629258|FG001|Overall Study|Withdrawal by Subject|1|||
125273823|NCT00700622|450629257|FG000|Overall Study|Other|3|||
125273824|NCT00700622|450629258|FG001|Overall Study|Other|1|||
125273825|NCT02526212|450629262|FG000|Overall Study|Incarceration|1|||
125273826|NCT02526212|450629263|FG001|Overall Study|Incarceration|0|||
125273827|NCT02526212|450629262|FG000|Overall Study|Lost to Follow-up|1|||
125273828|NCT02526212|450629263|FG001|Overall Study|Lost to Follow-up|0|||
125273829|NCT02526212|450629262|FG000|Overall Study|Death|0|||
125273830|NCT02526212|450629263|FG001|Overall Study|Death|1|||
125273831|NCT00040742|450629270|FG000|Overall Study|Death|0|||
125273832|NCT00040742|450629271|FG001|Overall Study|Death|0|||
125273833|NCT00040742|450629272|FG002|Overall Study|Death|1|||
125273834|NCT00040742|450629273|FG003|Overall Study|Death|0|||
125273835|NCT00040742|450629270|FG000|Overall Study|Adverse Event|15|||
125273836|NCT00040742|450629271|FG001|Overall Study|Adverse Event|16|||
125273837|NCT00040742|450629272|FG002|Overall Study|Adverse Event|21|||
125273838|NCT00040742|450629273|FG003|Overall Study|Adverse Event|9|||
125273839|NCT00040742|450629270|FG000|Overall Study|Withdrawal by Subject|7|||
125273840|NCT00040742|450629271|FG001|Overall Study|Withdrawal by Subject|15|||
125273841|NCT00040742|450629272|FG002|Overall Study|Withdrawal by Subject|10|||
125273842|NCT00040742|450629273|FG003|Overall Study|Withdrawal by Subject|13|||
125273843|NCT00040742|450629270|FG000|Overall Study|Chemotoxicity|4|||
125273844|NCT00040742|450629271|FG001|Overall Study|Chemotoxicity|3|||
125273845|NCT00040742|450629272|FG002|Overall Study|Chemotoxicity|5|||
125273846|NCT00040742|450629273|FG003|Overall Study|Chemotoxicity|2|||
125273847|NCT00040742|450629270|FG000|Overall Study|Incomplete Forms|6|||
125273848|NCT00040742|450629271|FG001|Overall Study|Incomplete Forms|10|||
125273849|NCT00040742|450629272|FG002|Overall Study|Incomplete Forms|4|||
125273850|NCT00040742|450629273|FG003|Overall Study|Incomplete Forms|5|||
125273851|NCT00040742|450629270|FG000|Overall Study|Other medical|7|||
125273852|NCT00040742|450629271|FG001|Overall Study|Other medical|5|||
125273853|NCT00040742|450629272|FG002|Overall Study|Other medical|5|||
125273854|NCT00040742|450629273|FG003|Overall Study|Other medical|5|||
125273855|NCT03520920|450629276|FG000|Overall Study|Death|13|||
125273856|NCT03520920|450629277|FG001|Overall Study|Death|1|||
125273857|NCT03520920|450629278|FG002|Overall Study|Death|0|||
125273858|NCT03520920|450629276|FG000|Overall Study|Withdrawal by Subject|2|||
125273859|NCT03520920|450629277|FG001|Overall Study|Withdrawal by Subject|1|||
125273860|NCT03520920|450629278|FG002|Overall Study|Withdrawal by Subject|0|||
125273861|NCT03520920|450629276|FG000|Overall Study|Study Terminated by the Sponsor|5|||
125273862|NCT03520920|450629277|FG001|Overall Study|Study Terminated by the Sponsor|14|||
125273863|NCT03520920|450629278|FG002|Overall Study|Study Terminated by the Sponsor|5|||
125273864|NCT00405392|450629279|FG000|Overall Study|Adverse Event|15|||
125273865|NCT00405392|450629280|FG001|Overall Study|Adverse Event|14|||
125273866|NCT00405392|450629279|FG000|Overall Study|Did not meet Eligibility criteria|7|||
125273867|NCT00405392|450629280|FG001|Overall Study|Did not meet Eligibility criteria|2|||
125273868|NCT00405392|450629279|FG000|Overall Study|Withdrawal by Subject|4|||
125273869|NCT00405392|450629280|FG001|Overall Study|Withdrawal by Subject|3|||
125273870|NCT00405392|450629279|FG000|Overall Study|Lost to Follow-up|1|||
125273871|NCT00405392|450629280|FG001|Overall Study|Lost to Follow-up|2|||
125273872|NCT00405392|450629279|FG000|Overall Study|Data missing|2|||
125273873|NCT00405392|450629280|FG001|Overall Study|Data missing|0|||
125273874|NCT00405392|450629279|FG000|Overall Study|Non-compliance|0|||
125273875|NCT00405392|450629280|FG001|Overall Study|Non-compliance|1|||
125273876|NCT00405392|450629279|FG000|Overall Study|Other|1|||
125273877|NCT00405392|450629280|FG001|Overall Study|Other|5|||
125273878|NCT01703091|450629283|FG000|Overall Study|Adverse Event|5|||
125273879|NCT01703091|450629284|FG001|Overall Study|Adverse Event|3|||
125273880|NCT01703091|450629283|FG000|Overall Study|Physician Decision|2|||
125273881|NCT01703091|450629284|FG001|Overall Study|Physician Decision|1|||
125273882|NCT01703091|450629283|FG000|Overall Study|Withdrawal by Subject|1|||
125273883|NCT01703091|450629284|FG001|Overall Study|Withdrawal by Subject|0|||
125273884|NCT01703091|450629283|FG000|Overall Study|Sponsor Decision|1|||
125273885|NCT01703091|450629284|FG001|Overall Study|Sponsor Decision|0|||
125273886|NCT02550288|450629288|FG000|Overall Study|Adverse Event|0|||
125273887|NCT02550288|450629289|FG001|Overall Study|Adverse Event|1|||
125273888|NCT02550288|450629290|FG002|Overall Study|Adverse Event|0|||
125273889|NCT02550288|450629291|FG003|Overall Study|Adverse Event|0|||
125273890|NCT02550288|450629292|FG004|Overall Study|Adverse Event|0|||
125273891|NCT02550288|450629288|FG000|Overall Study|Physician Decision|0|||
125273892|NCT02550288|450629289|FG001|Overall Study|Physician Decision|0|||
125273893|NCT02550288|450629290|FG002|Overall Study|Physician Decision|0|||
125273894|NCT02550288|450629291|FG003|Overall Study|Physician Decision|1|||
125273895|NCT02550288|450629292|FG004|Overall Study|Physician Decision|0|||
125273896|NCT02550288|450629288|FG000|Overall Study|Protocol Violation|2|||
125273897|NCT02550288|450629289|FG001|Overall Study|Protocol Violation|2|||
125273898|NCT02550288|450629290|FG002|Overall Study|Protocol Violation|1|||
125273899|NCT02550288|450629291|FG003|Overall Study|Protocol Violation|0|||
125273900|NCT02550288|450629292|FG004|Overall Study|Protocol Violation|3|||
125273901|NCT02550288|450629288|FG000|Overall Study|Participant moved|0|||
125273902|NCT02550288|450629289|FG001|Overall Study|Participant moved|0|||
125273903|NCT02550288|450629290|FG002|Overall Study|Participant moved|0|||
125273904|NCT02550288|450629291|FG003|Overall Study|Participant moved|1|||
125273905|NCT02550288|450629292|FG004|Overall Study|Participant moved|0|||
125273906|NCT02550288|450629288|FG000|Overall Study|Withdrawal by Subject|0|||
125273907|NCT02550288|450629289|FG001|Overall Study|Withdrawal by Subject|0|||
125273908|NCT02550288|450629290|FG002|Overall Study|Withdrawal by Subject|0|||
125273909|NCT02550288|450629291|FG003|Overall Study|Withdrawal by Subject|1|||
125273910|NCT02550288|450629292|FG004|Overall Study|Withdrawal by Subject|0|||
125273911|NCT02819297|450629293|FG000|Overall Study|Withdrawal by Subject|25|||
125273912|NCT02819297|450629294|FG001|Overall Study|Withdrawal by Subject|13|||
125273913|NCT02819297|450629293|FG000|Overall Study|Lost to Follow-up|12|||
125273914|NCT02819297|450629294|FG001|Overall Study|Lost to Follow-up|14|||
125273915|NCT02819297|450629293|FG000|Overall Study|Adverse Event|12|||
125273916|NCT02819297|450629294|FG001|Overall Study|Adverse Event|10|||
125273917|NCT02819297|450629293|FG000|Overall Study|Physician Decision|5|||
125273918|NCT02819297|450629294|FG001|Overall Study|Physician Decision|5|||
125273919|NCT02819297|450629293|FG000|Overall Study|Lack of Efficacy|5|||
125273920|NCT02819297|450629294|FG001|Overall Study|Lack of Efficacy|8|||
125273921|NCT02819297|450629293|FG000|Overall Study|Protocol Violation|1|||
125273922|NCT02819297|450629294|FG001|Overall Study|Protocol Violation|2|||
125273923|NCT01071252|450629296|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
125273924|NCT01071252|450629297|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
125273925|NCT01071252|450629298|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
125273926|NCT01071252|450629299|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
125273927|NCT01071252|450629300|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
125273928|NCT01071252|450629296|FG000|Overall Study|Withdrawal by Subject|8|||
125273929|NCT01071252|450629297|FG001|Overall Study|Withdrawal by Subject|2|||
125273930|NCT01071252|450629298|FG002|Overall Study|Withdrawal by Subject|1|||
125273931|NCT01071252|450629299|FG003|Overall Study|Withdrawal by Subject|2|||
125273932|NCT01071252|450629300|FG004|Overall Study|Withdrawal by Subject|3|||
125273933|NCT01071252|450629296|FG000|Overall Study|administrative problems|1|||
125273934|NCT01071252|450629297|FG001|Overall Study|administrative problems|1|||
125273935|NCT01071252|450629298|FG002|Overall Study|administrative problems|0|||
125273936|NCT01071252|450629299|FG003|Overall Study|administrative problems|2|||
125273937|NCT01071252|450629300|FG004|Overall Study|administrative problems|1|||
125273938|NCT01071252|450629296|FG000|Overall Study|Lost to Follow-up|1|||
125273939|NCT01071252|450629297|FG001|Overall Study|Lost to Follow-up|0|||
125273940|NCT01071252|450629298|FG002|Overall Study|Lost to Follow-up|1|||
125273941|NCT01071252|450629299|FG003|Overall Study|Lost to Follow-up|2|||
125273942|NCT01071252|450629300|FG004|Overall Study|Lost to Follow-up|0|||
125273943|NCT01071252|450629296|FG000|Overall Study|Adverse Event|1|||
125273944|NCT01071252|450629297|FG001|Overall Study|Adverse Event|1|||
125273945|NCT01071252|450629298|FG002|Overall Study|Adverse Event|0|||
125273946|NCT01071252|450629299|FG003|Overall Study|Adverse Event|1|||
125273947|NCT01071252|450629300|FG004|Overall Study|Adverse Event|0|||
125273948|NCT01071252|450629296|FG000|Overall Study|Death|0|||
125273949|NCT01071252|450629297|FG001|Overall Study|Death|0|||
125273950|NCT01071252|450629298|FG002|Overall Study|Death|0|||
125273951|NCT01071252|450629299|FG003|Overall Study|Death|0|||
125273952|NCT01071252|450629300|FG004|Overall Study|Death|1|||
125273953|NCT01945996|450629301|FG000|Overall Study|Lost to Follow-up|3|||
125273954|NCT01945996|450629302|FG001|Overall Study|Lost to Follow-up|5|||
125273955|NCT03928418|450629303|FG000|Overall Study|Lost to Follow-up|5|||
125273956|NCT03928418|450629304|FG001|Overall Study|Lost to Follow-up|3|||
125273957|NCT03928418|450629305|FG002|Overall Study|Lost to Follow-up|5|||
125273958|NCT03928418|450629303|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
125273959|NCT03928418|450629304|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
125273960|NCT03928418|450629305|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
125273961|NCT00763256|450629306|FG000|Overall Study|Didn't return for appointments|7|||
125273962|NCT00763256|450629307|FG001|Overall Study|Didn't return for appointments|10|||
125273963|NCT02544750|450629308|FG000|Overall Study|Physician Decision|3|||
125273964|NCT02544750|450629309|FG001|Overall Study|Physician Decision|1|||
125273965|NCT02544750|450629308|FG000|Overall Study|Other reasons|69|||
125273966|NCT02544750|450629309|FG001|Overall Study|Other reasons|39|||
125273967|NCT02544750|450629308|FG000|Overall Study|Met withdrawal criteria|2|||
125273968|NCT02544750|450629309|FG001|Overall Study|Met withdrawal criteria|2|||
125273969|NCT02544750|450629308|FG000|Overall Study|Transition To Commercial Product|1|||
125273970|NCT02544750|450629309|FG001|Overall Study|Transition To Commercial Product|0|||
125273971|NCT02544750|450629308|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
125273972|NCT02544750|450629309|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
125273973|NCT02544750|450629308|FG000|Overall Study|Adverse Event|8|||
125273974|NCT02544750|450629309|FG001|Overall Study|Adverse Event|10|||
125273975|NCT02544750|450629308|FG000|Overall Study|Withdrawal by Subject|10|||
125273976|NCT02544750|450629309|FG001|Overall Study|Withdrawal by Subject|4|||
125273977|NCT02544750|450629308|FG000|Overall Study|Lost to Follow-up|1|||
125273978|NCT02544750|450629309|FG001|Overall Study|Lost to Follow-up|0|||
125273979|NCT00244725|450629310|FG000|Overall Study|Lost to Follow-up|3|||
125273980|NCT00244725|450629311|FG001|Overall Study|Lost to Follow-up|4|||
125273981|NCT00244725|450629312|FG002|Overall Study|Lost to Follow-up|9|||
125273982|NCT00244725|450629313|FG003|Overall Study|Lost to Follow-up|2|||
125273983|NCT00244725|450629310|FG000|Overall Study|Withdrawal by Subject|9|||
125273984|NCT00244725|450629311|FG001|Overall Study|Withdrawal by Subject|7|||
125273985|NCT00244725|450629312|FG002|Overall Study|Withdrawal by Subject|7|||
125273986|NCT00244725|450629313|FG003|Overall Study|Withdrawal by Subject|8|||
125273987|NCT00244725|450629310|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
125273988|NCT00244725|450629311|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
125273989|NCT00244725|450629312|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
125273990|NCT00244725|450629313|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
125273991|NCT00244725|450629310|FG000|Overall Study|Physician Decision|3|||
125273992|NCT00244725|450629311|FG001|Overall Study|Physician Decision|0|||
125273993|NCT00244725|450629312|FG002|Overall Study|Physician Decision|1|||
125273994|NCT00244725|450629313|FG003|Overall Study|Physician Decision|2|||
125273995|NCT00244725|450629310|FG000|Overall Study|Adverse Events|3|||
125273996|NCT00244725|450629311|FG001|Overall Study|Adverse Events|1|||
125273997|NCT00244725|450629312|FG002|Overall Study|Adverse Events|4|||
125273998|NCT00244725|450629313|FG003|Overall Study|Adverse Events|4|||
125273999|NCT00244725|450629310|FG000|Overall Study|Withdrwal by participant|1|||
125274000|NCT00244725|450629311|FG001|Overall Study|Withdrwal by participant|0|||
125274001|NCT00244725|450629312|FG002|Overall Study|Withdrwal by participant|0|||
125274002|NCT00244725|450629313|FG003|Overall Study|Withdrwal by participant|1|||
125274003|NCT00244725|450629310|FG000|Overall Study|Liver function test abnormality|2|||
125274004|NCT00244725|450629311|FG001|Overall Study|Liver function test abnormality|0|||
125274005|NCT00244725|450629312|FG002|Overall Study|Liver function test abnormality|0|||
125274006|NCT00244725|450629313|FG003|Overall Study|Liver function test abnormality|1|||
125274007|NCT00244725|450629310|FG000|Overall Study|Sponsor withdrew the participant|1|||
125274008|NCT00244725|450629311|FG001|Overall Study|Sponsor withdrew the participant|0|||
125274009|NCT00244725|450629312|FG002|Overall Study|Sponsor withdrew the participant|0|||
125274010|NCT00244725|450629313|FG003|Overall Study|Sponsor withdrew the participant|1|||
125274011|NCT00244725|450629310|FG000|Overall Study|Mediciation Error|0|||
125274012|NCT00244725|450629311|FG001|Overall Study|Mediciation Error|1|||
125274013|NCT00244725|450629312|FG002|Overall Study|Mediciation Error|0|||
125274014|NCT00244725|450629313|FG003|Overall Study|Mediciation Error|0|||
125274015|NCT00244725|450629310|FG000|Overall Study|Rehab Refused to allow participantion|0|||
125274016|NCT00244725|450629311|FG001|Overall Study|Rehab Refused to allow participantion|1|||
125274017|NCT00244725|450629312|FG002|Overall Study|Rehab Refused to allow participantion|0|||
125274018|NCT00244725|450629313|FG003|Overall Study|Rehab Refused to allow participantion|0|||
125274019|NCT00244725|450629310|FG000|Overall Study|Headache|0|||
125274020|NCT00244725|450629311|FG001|Overall Study|Headache|1|||
125274021|NCT00244725|450629312|FG002|Overall Study|Headache|0|||
125274022|NCT00244725|450629313|FG003|Overall Study|Headache|0|||
125274023|NCT00244725|450629310|FG000|Overall Study|Received prohibited medication|0|||
125274024|NCT00244725|450629311|FG001|Overall Study|Received prohibited medication|1|||
125274025|NCT00244725|450629312|FG002|Overall Study|Received prohibited medication|0|||
125274026|NCT00244725|450629313|FG003|Overall Study|Received prohibited medication|1|||
125274027|NCT00244725|450629310|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
125274028|NCT00244725|450629311|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
125274029|NCT00244725|450629312|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
125274030|NCT00244725|450629313|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
125274031|NCT00244725|450629310|FG000|Overall Study|Administrative reason|0|||
125274032|NCT00244725|450629311|FG001|Overall Study|Administrative reason|0|||
125274033|NCT00244725|450629312|FG002|Overall Study|Administrative reason|1|||
125274034|NCT00244725|450629313|FG003|Overall Study|Administrative reason|0|||
125274035|NCT00244725|450629310|FG000|Overall Study|Vomit|0|||
125274036|NCT00244725|450629311|FG001|Overall Study|Vomit|0|||
125274037|NCT00244725|450629312|FG002|Overall Study|Vomit|1|||
125274038|NCT00244725|450629313|FG003|Overall Study|Vomit|0|||
125274039|NCT00244725|450629310|FG000|Overall Study|Failed to follow-up|0|||
125274040|NCT00244725|450629311|FG001|Overall Study|Failed to follow-up|0|||
125274041|NCT00244725|450629312|FG002|Overall Study|Failed to follow-up|1|||
125274042|NCT00244725|450629313|FG003|Overall Study|Failed to follow-up|1|||
125274043|NCT02131311|450629314|FG000|Overall Study|Adverse Event|2|||
125274044|NCT02131311|450629314|FG000|Overall Study|Protocol Violation|1|||
125274045|NCT02131311|450629314|FG000|Overall Study|Lost to Follow-up|1|||
125274046|NCT00255723|450629317|FG000|Overall Study|Adverse Event|1|||
125274047|NCT00255723|450629318|FG001|Overall Study|Adverse Event|1|||
125274048|NCT00255723|450629317|FG000|Overall Study|Death|0|||
125274049|NCT00255723|450629318|FG001|Overall Study|Death|1|||
125274050|NCT00255723|450629317|FG000|Overall Study|Response Data Not Available|1|||
125274051|NCT00255723|450629318|FG001|Overall Study|Response Data Not Available|0|||
125274052|NCT03711370|450629322|FG000|Overall Study|Lost to Follow-up|16|||
125274053|NCT03711370|450629323|FG001|Overall Study|Lost to Follow-up|10|||
125274054|NCT03711370|450629322|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
125274055|NCT03711370|450629323|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
125274056|NCT00407602|450629324|FG000|Overall Study|Death - unrelated to device|1|||
125274057|NCT00407602|450629324|FG000|Overall Study|Device explanted|5|||
125274058|NCT00407602|450629324|FG000|Overall Study|Withdrawal by Subject|1|||
125274059|NCT01169701|450629325|FG000|Overall Study|Lost to Follow-up|1|||
125274060|NCT01169701|450629326|FG001|Overall Study|Lost to Follow-up|1|||
125274061|NCT01169701|450629325|FG000|Overall Study|Withdrawal by Subject|1|||
125274062|NCT01169701|450629326|FG001|Overall Study|Withdrawal by Subject|3|||
125274063|NCT01169701|450629325|FG000|Overall Study|Adverse Event|1|||
125274064|NCT01169701|450629326|FG001|Overall Study|Adverse Event|2|||
125274065|NCT01169701|450629325|FG000|Overall Study|Exclusion criteria|2|||
125274066|NCT01169701|450629326|FG001|Overall Study|Exclusion criteria|0|||
125274067|NCT01169701|450629325|FG000|Overall Study|Death|0|||
125274068|NCT01169701|450629326|FG001|Overall Study|Death|1|||
125274069|NCT01169701|450629325|FG000|Overall Study|Administrative problems|0|||
125274070|NCT01169701|450629326|FG001|Overall Study|Administrative problems|1|||
125274071|NCT01169701|450629325|FG000|Overall Study|Serious adverse event|0|||
125274072|NCT01169701|450629326|FG001|Overall Study|Serious adverse event|1|||
125274073|NCT01169701|450629325|FG000|Overall Study|Sponsor decision|0|||
125274074|NCT01169701|450629326|FG001|Overall Study|Sponsor decision|1|||
125274075|NCT00553436|450629327|FG000|Overall Study|Conversion to another procedure|1|||
125274076|NCT01814046|450629328|FG000|Drug Administration|Death due to complications of RSV|1|||
125274077|NCT01814046|450629329|FG001|Drug Administration|Death due to complications of RSV|0|||
125274078|NCT01814046|450629330|FG002|Drug Administration|Death due to complications of RSV|0|||
125274079|NCT03146663|450629333|FG000|Overall Study|Did not receive study treatment|1|||
125274080|NCT03146663|450629334|FG001|Overall Study|Did not receive study treatment|1|||
125274081|NCT03089047|450629335|FG000|Overall Study|Lost to Follow-up|1|||
125274082|NCT03089047|450629336|FG001|Overall Study|Lost to Follow-up|0|||
125274083|NCT03599518|450629337|FG000|Overall Study|Clinical progression|0|||
125274084|NCT03599518|450629338|FG001|Overall Study|Clinical progression|0|||
125274085|NCT03599518|450629339|FG002|Overall Study|Clinical progression|0|||
125274086|NCT03599518|450629340|FG003|Overall Study|Clinical progression|0|||
125274087|NCT03599518|450629341|FG004|Overall Study|Clinical progression|1|||
125274088|NCT03599518|450629337|FG000|Overall Study|Adverse Event|0|||
125274089|NCT03599518|450629338|FG001|Overall Study|Adverse Event|0|||
125274090|NCT03599518|450629339|FG002|Overall Study|Adverse Event|0|||
125274091|NCT03599518|450629340|FG003|Overall Study|Adverse Event|0|||
125274092|NCT03599518|450629341|FG004|Overall Study|Adverse Event|1|||
125274093|NCT03599518|450629337|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
125274094|NCT03599518|450629338|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
125274095|NCT03599518|450629339|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
125274096|NCT03599518|450629340|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
125274097|NCT03599518|450629341|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
125274098|NCT03599518|450629337|FG000|Overall Study|Participant withdrawal from study treatment|0|||
125274099|NCT03599518|450629338|FG001|Overall Study|Participant withdrawal from study treatment|0|||
125274100|NCT03599518|450629339|FG002|Overall Study|Participant withdrawal from study treatment|1|||
125274101|NCT03599518|450629340|FG003|Overall Study|Participant withdrawal from study treatment|0|||
125274102|NCT03599518|450629341|FG004|Overall Study|Participant withdrawal from study treatment|0|||
125274103|NCT00429182|450629344|FG000|Overall Study|Not evaluable, Disease Progression|2|||
125274104|NCT00429182|450629344|FG000|Overall Study|Not eligible|5|||
125274105|NCT02311881|450629355|FG000|Overall Study|Did not meet the study criteria|2|||
125274106|NCT02311881|450629356|FG001|Overall Study|Did not meet the study criteria|2|||
125274107|NCT02311881|450629357|FG002|Overall Study|Did not meet the study criteria|0|||
125274108|NCT02311881|450629355|FG000|Overall Study|Adverse Event|7|||
125274109|NCT02311881|450629356|FG001|Overall Study|Adverse Event|15|||
125274110|NCT02311881|450629357|FG002|Overall Study|Adverse Event|8|||
125274111|NCT02311881|450629355|FG000|Overall Study|Lost to Follow-up|3|||
125274112|NCT02311881|450629356|FG001|Overall Study|Lost to Follow-up|3|||
125274113|NCT02311881|450629357|FG002|Overall Study|Lost to Follow-up|2|||
125274114|NCT02311881|450629355|FG000|Overall Study|Protocol Violation|1|||
125274115|NCT02311881|450629356|FG001|Overall Study|Protocol Violation|2|||
125274116|NCT02311881|450629357|FG002|Overall Study|Protocol Violation|3|||
125274117|NCT02311881|450629355|FG000|Overall Study|Withdrawal of consent|14|||
125274118|NCT02311881|450629356|FG001|Overall Study|Withdrawal of consent|16|||
125274119|NCT02311881|450629357|FG002|Overall Study|Withdrawal of consent|17|||
125274120|NCT02311881|450629355|FG000|Overall Study|Other|0|||
125274121|NCT02311881|450629356|FG001|Overall Study|Other|0|||
125274122|NCT02311881|450629357|FG002|Overall Study|Other|1|||
125274123|NCT02311881|450629355|FG000|Overall Study|Lack of Efficacy|1|||
125274124|NCT02311881|450629356|FG001|Overall Study|Lack of Efficacy|2|||
125274125|NCT02311881|450629357|FG002|Overall Study|Lack of Efficacy|0|||
125274126|NCT02311881|450629355|FG000|Overall Study|Subject has border line pregnancy test|1|||
125274127|NCT02311881|450629356|FG001|Overall Study|Subject has border line pregnancy test|0|||
125274128|NCT02311881|450629357|FG002|Overall Study|Subject has border line pregnancy test|0|||
125274129|NCT02311881|450629355|FG000|Overall Study|Withdrawal by Subject|3|||
125274130|NCT02311881|450629356|FG001|Overall Study|Withdrawal by Subject|1|||
125274131|NCT02311881|450629357|FG002|Overall Study|Withdrawal by Subject|4|||
125274132|NCT02311881|450629355|FG000|Overall Study|Sponsor Decision|1|||
125274133|NCT02311881|450629356|FG001|Overall Study|Sponsor Decision|1|||
125274134|NCT02311881|450629357|FG002|Overall Study|Sponsor Decision|1|||
125274135|NCT02311881|450629355|FG000|Overall Study|Protocol Deviation|1|||
125274136|NCT02311881|450629356|FG001|Overall Study|Protocol Deviation|0|||
125274137|NCT02311881|450629357|FG002|Overall Study|Protocol Deviation|0|||
125274138|NCT02311881|450629355|FG000|Overall Study|Non-Compliance|1|||
125274139|NCT02311881|450629356|FG001|Overall Study|Non-Compliance|0|||
125274140|NCT02311881|450629357|FG002|Overall Study|Non-Compliance|2|||
125274141|NCT02311881|450629355|FG000|Overall Study|Physician Decision|0|||
125274142|NCT02311881|450629356|FG001|Overall Study|Physician Decision|0|||
125274143|NCT02311881|450629357|FG002|Overall Study|Physician Decision|1|||
125274144|NCT02311881|450629355|FG000|Overall Study|Medical Monitor Discretion|0|||
125274145|NCT02311881|450629356|FG001|Overall Study|Medical Monitor Discretion|0|||
125274146|NCT02311881|450629357|FG002|Overall Study|Medical Monitor Discretion|1|||
125274147|NCT02311881|450629355|FG000|Overall Study|Participant taking another medication|0|||
125274148|NCT02311881|450629356|FG001|Overall Study|Participant taking another medication|0|||
125274149|NCT02311881|450629357|FG002|Overall Study|Participant taking another medication|1|||
125274150|NCT02311881|450629355|FG000|Overall Study|Serious Adverse Event|0|||
125274151|NCT02311881|450629356|FG001|Overall Study|Serious Adverse Event|1|||
125274152|NCT02311881|450629357|FG002|Overall Study|Serious Adverse Event|0|||
125274153|NCT00819156|450629358|FG000|Overall Study|Adverse Event|1|||
125274154|NCT00819156|450629359|FG001|Overall Study|Adverse Event|4|||
125274155|NCT00819156|450629360|FG002|Overall Study|Adverse Event|2|||
125274156|NCT00819156|450629361|FG003|Overall Study|Adverse Event|1|||
125274157|NCT00819156|450629362|FG004|Overall Study|Adverse Event|2|||
125274158|NCT00819156|450629363|FG005|Overall Study|Adverse Event|3|||
125274159|NCT00819156|450629358|FG000|Overall Study|Withdrawal by Subject|0|||
125274160|NCT00819156|450629359|FG001|Overall Study|Withdrawal by Subject|3|||
125274161|NCT00819156|450629360|FG002|Overall Study|Withdrawal by Subject|2|||
125274162|NCT00819156|450629361|FG003|Overall Study|Withdrawal by Subject|0|||
125274163|NCT00819156|450629362|FG004|Overall Study|Withdrawal by Subject|1|||
125274164|NCT00819156|450629363|FG005|Overall Study|Withdrawal by Subject|0|||
125274165|NCT00819156|450629358|FG000|Overall Study|Protocol Violation|1|||
125274166|NCT00819156|450629359|FG001|Overall Study|Protocol Violation|0|||
125274167|NCT00819156|450629360|FG002|Overall Study|Protocol Violation|1|||
125274168|NCT00819156|450629361|FG003|Overall Study|Protocol Violation|0|||
125274169|NCT00819156|450629362|FG004|Overall Study|Protocol Violation|0|||
125274170|NCT00819156|450629363|FG005|Overall Study|Protocol Violation|1|||
125274171|NCT00819156|450629358|FG000|Overall Study|Lost to Follow-up|0|||
125274172|NCT00819156|450629359|FG001|Overall Study|Lost to Follow-up|1|||
125274173|NCT00819156|450629360|FG002|Overall Study|Lost to Follow-up|0|||
125274174|NCT00819156|450629361|FG003|Overall Study|Lost to Follow-up|0|||
125274175|NCT00819156|450629362|FG004|Overall Study|Lost to Follow-up|0|||
125274176|NCT00819156|450629363|FG005|Overall Study|Lost to Follow-up|2|||
125274177|NCT00819156|450629358|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
125274178|NCT00819156|450629359|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
125274179|NCT00819156|450629360|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
125274180|NCT00819156|450629361|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
125274181|NCT00819156|450629362|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
125274182|NCT00819156|450629363|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
125274183|NCT00819156|450629358|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
125274184|NCT00819156|450629359|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
125274185|NCT00819156|450629360|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
125274186|NCT00819156|450629361|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
125274187|NCT00819156|450629362|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
125274188|NCT00819156|450629363|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
125274189|NCT00819156|450629358|FG000|Overall Study|Prostate-specific antigen progression|0|||
125274190|NCT00819156|450629359|FG001|Overall Study|Prostate-specific antigen progression|0|||
125274191|NCT00819156|450629360|FG002|Overall Study|Prostate-specific antigen progression|0|||
125274192|NCT00819156|450629361|FG003|Overall Study|Prostate-specific antigen progression|0|||
125274193|NCT00819156|450629362|FG004|Overall Study|Prostate-specific antigen progression|1|||
125274194|NCT00819156|450629363|FG005|Overall Study|Prostate-specific antigen progression|0|||
125274195|NCT00790582|450629364|FG000|Overall Study|Death|14|||
125274196|NCT00790582|450629365|FG001|Overall Study|Death|32|||
125274197|NCT00790582|450629364|FG000|Overall Study|Physician Decision|7|||
125274198|NCT00790582|450629365|FG001|Overall Study|Physician Decision|1|||
125274199|NCT00790582|450629364|FG000|Overall Study|Lost to Follow-up|3|||
125274200|NCT00790582|450629365|FG001|Overall Study|Lost to Follow-up|3|||
125274201|NCT00790582|450629364|FG000|Overall Study|Withdrawal by Subject|7|||
125274202|NCT00790582|450629365|FG001|Overall Study|Withdrawal by Subject|51|||
125274203|NCT01575808|450629368|FG000|Overall Study|Death|2|||
125274204|NCT01575808|450629369|FG001|Overall Study|Death|0|||
125274205|NCT01575808|450629368|FG000|Overall Study|Withdrawal by Subject|1|||
125274206|NCT01575808|450629369|FG001|Overall Study|Withdrawal by Subject|0|||
125274207|NCT05823974|450631716|FG000|Overall Study|Lost to Follow-up|0|||
125274208|NCT05823974|450631717|FG001|Overall Study|Lost to Follow-up|3|||
125274209|NCT05823974|450631718|FG002|Overall Study|Lost to Follow-up|1|||
125274210|NCT05823974|450631719|FG003|Overall Study|Lost to Follow-up|0|||
125274211|NCT05823974|450631720|FG004|Overall Study|Lost to Follow-up|1|||
125274212|NCT05823974|450631721|FG005|Overall Study|Lost to Follow-up|0|||
125274213|NCT05823974|450631722|FG006|Overall Study|Lost to Follow-up|1|||
125274214|NCT05823974|450631723|FG007|Overall Study|Lost to Follow-up|0|||
125274215|NCT05823974|450631724|FG008|Overall Study|Lost to Follow-up|0|||
125274216|NCT05823974|450631725|FG009|Overall Study|Lost to Follow-up|1|||
125274217|NCT05823974|450631726|FG010|Overall Study|Lost to Follow-up|1|||
125274218|NCT05823974|450631727|FG011|Overall Study|Lost to Follow-up|0|||
125274219|NCT05823974|450631728|FG012|Overall Study|Lost to Follow-up|1|||
125274220|NCT05823974|450631729|FG013|Overall Study|Lost to Follow-up|2|||
125274221|NCT05823974|450631730|FG014|Overall Study|Lost to Follow-up|1|||
125274222|NCT05823974|450631731|FG015|Overall Study|Lost to Follow-up|1|||
125274223|NCT05823974|450631732|FG016|Overall Study|Lost to Follow-up|1|||
125274224|NCT05823974|450631733|FG017|Overall Study|Lost to Follow-up|0|||
125274225|NCT05823974|450631734|FG018|Overall Study|Lost to Follow-up|0|||
125274226|NCT05823974|450631735|FG019|Overall Study|Lost to Follow-up|2|||
125274227|NCT05823974|450631736|FG020|Overall Study|Lost to Follow-up|0|||
125274228|NCT05823974|450631716|FG000|Overall Study|Physician Decision|0|||
125274229|NCT05823974|450631717|FG001|Overall Study|Physician Decision|0|||
125274230|NCT05823974|450631718|FG002|Overall Study|Physician Decision|0|||
125274231|NCT05823974|450631719|FG003|Overall Study|Physician Decision|0|||
125274232|NCT05823974|450631720|FG004|Overall Study|Physician Decision|0|||
125274233|NCT05823974|450631721|FG005|Overall Study|Physician Decision|0|||
125274234|NCT05823974|450631722|FG006|Overall Study|Physician Decision|0|||
125274235|NCT05823974|450631723|FG007|Overall Study|Physician Decision|0|||
125274236|NCT05823974|450631724|FG008|Overall Study|Physician Decision|0|||
125274237|NCT05823974|450631725|FG009|Overall Study|Physician Decision|0|||
125274238|NCT05823974|450631726|FG010|Overall Study|Physician Decision|0|||
125274239|NCT05823974|450631727|FG011|Overall Study|Physician Decision|0|||
125274240|NCT05823974|450631728|FG012|Overall Study|Physician Decision|0|||
125274241|NCT05823974|450631729|FG013|Overall Study|Physician Decision|0|||
125274242|NCT05823974|450631730|FG014|Overall Study|Physician Decision|0|||
125274243|NCT05823974|450631731|FG015|Overall Study|Physician Decision|1|||
125274244|NCT05823974|450631732|FG016|Overall Study|Physician Decision|0|||
125274245|NCT05823974|450631733|FG017|Overall Study|Physician Decision|1|||
125274246|NCT05823974|450631734|FG018|Overall Study|Physician Decision|1|||
125274247|NCT05823974|450631735|FG019|Overall Study|Physician Decision|0|||
125274248|NCT05823974|450631736|FG020|Overall Study|Physician Decision|0|||
125274249|NCT05823974|450631716|FG000|Overall Study|Withdrawal by Subject|1|||
125274250|NCT05823974|450631717|FG001|Overall Study|Withdrawal by Subject|1|||
125274251|NCT05823974|450631718|FG002|Overall Study|Withdrawal by Subject|2|||
125274252|NCT05823974|450631719|FG003|Overall Study|Withdrawal by Subject|0|||
125274253|NCT05823974|450631720|FG004|Overall Study|Withdrawal by Subject|2|||
125274254|NCT05823974|450631721|FG005|Overall Study|Withdrawal by Subject|3|||
125274255|NCT05823974|450631722|FG006|Overall Study|Withdrawal by Subject|1|||
125274256|NCT05823974|450631723|FG007|Overall Study|Withdrawal by Subject|1|||
125274257|NCT05823974|450631724|FG008|Overall Study|Withdrawal by Subject|2|||
125274258|NCT05823974|450631725|FG009|Overall Study|Withdrawal by Subject|1|||
125274259|NCT05823974|450631726|FG010|Overall Study|Withdrawal by Subject|1|||
125274260|NCT05823974|450631727|FG011|Overall Study|Withdrawal by Subject|0|||
125274261|NCT05823974|450631728|FG012|Overall Study|Withdrawal by Subject|0|||
125274262|NCT05823974|450631729|FG013|Overall Study|Withdrawal by Subject|1|||
125274263|NCT05823974|450631730|FG014|Overall Study|Withdrawal by Subject|1|||
125274264|NCT05823974|450631731|FG015|Overall Study|Withdrawal by Subject|3|||
125274265|NCT05823974|450631732|FG016|Overall Study|Withdrawal by Subject|0|||
125274266|NCT05823974|450631733|FG017|Overall Study|Withdrawal by Subject|2|||
125274267|NCT05823974|450631734|FG018|Overall Study|Withdrawal by Subject|2|||
125274268|NCT05823974|450631735|FG019|Overall Study|Withdrawal by Subject|0|||
125274269|NCT05823974|450631736|FG020|Overall Study|Withdrawal by Subject|1|||
125274270|NCT05823974|450631716|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274271|NCT05823974|450631717|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274272|NCT05823974|450631718|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125274273|NCT05823974|450631719|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274274|NCT05823974|450631720|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274275|NCT05823974|450631721|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274276|NCT05823974|450631722|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274277|NCT05823974|450631723|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274278|NCT05823974|450631724|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274279|NCT05823974|450631725|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274280|NCT05823974|450631726|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274281|NCT05823974|450631727|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274282|NCT05823974|450631728|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274283|NCT05823974|450631729|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274284|NCT05823974|450631730|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125274285|NCT05823974|450631731|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274286|NCT05823974|450631732|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274287|NCT05823974|450631733|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274288|NCT05823974|450631734|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274289|NCT05823974|450631735|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274290|NCT05823974|450631736|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274291|NCT05823974|450631716|FG000|Overall Study|Other|0|||
125274292|NCT05823974|450631717|FG001|Overall Study|Other|1|||
125274293|NCT05823974|450631718|FG002|Overall Study|Other|1|||
125274294|NCT05823974|450631719|FG003|Overall Study|Other|1|||
125274295|NCT05823974|450631720|FG004|Overall Study|Other|0|||
125274296|NCT05823974|450631721|FG005|Overall Study|Other|1|||
125274297|NCT05823974|450631722|FG006|Overall Study|Other|1|||
125274298|NCT05823974|450631723|FG007|Overall Study|Other|1|||
125274299|NCT05823974|450631724|FG008|Overall Study|Other|1|||
125274300|NCT05823974|450631725|FG009|Overall Study|Other|0|||
125274301|NCT05823974|450631726|FG010|Overall Study|Other|0|||
125274302|NCT05823974|450631727|FG011|Overall Study|Other|0|||
125274303|NCT05823974|450631728|FG012|Overall Study|Other|2|||
125274304|NCT05823974|450631729|FG013|Overall Study|Other|1|||
125274305|NCT05823974|450631730|FG014|Overall Study|Other|0|||
125274306|NCT05823974|450631731|FG015|Overall Study|Other|1|||
125274307|NCT05823974|450631732|FG016|Overall Study|Other|0|||
125274308|NCT05823974|450631733|FG017|Overall Study|Other|0|||
125274309|NCT05823974|450631734|FG018|Overall Study|Other|0|||
125274310|NCT05823974|450631735|FG019|Overall Study|Other|0|||
125274311|NCT05823974|450631736|FG020|Overall Study|Other|0|||
125274312|NCT00316706|450631737|FG000|Overall Study|Lost to Follow-up|38|||
125274313|NCT00316706|450631738|FG001|Overall Study|Lost to Follow-up|48|||
125274314|NCT03292874|450631742|FG000|Overall Study|Due to pandemic|5|||
125274315|NCT00485758|450631750|FG000|Overall Study|Adverse Event|102|||
125274316|NCT00485758|450631751|FG001|Overall Study|Adverse Event|31|||
125274317|NCT00485758|450631750|FG000|Overall Study|Death|0|||
125274318|NCT00485758|450631751|FG001|Overall Study|Death|1|||
125274319|NCT00485758|450631750|FG000|Overall Study|Lost to Follow-up|5|||
125274320|NCT00485758|450631751|FG001|Overall Study|Lost to Follow-up|1|||
125274321|NCT00485758|450631750|FG000|Overall Study|Physician Decision|3|||
125274322|NCT00485758|450631751|FG001|Overall Study|Physician Decision|3|||
125274323|NCT00485758|450631750|FG000|Overall Study|Protocol Violation|11|||
125274324|NCT00485758|450631751|FG001|Overall Study|Protocol Violation|2|||
125274325|NCT00485758|450631750|FG000|Overall Study|Withdrawal by Subject|32|||
125274326|NCT00485758|450631751|FG001|Overall Study|Withdrawal by Subject|27|||
125274327|NCT00485758|450631750|FG000|Overall Study|Study Terminated by Sponsor|3|||
125274328|NCT00485758|450631751|FG001|Overall Study|Study Terminated by Sponsor|0|||
125274329|NCT00654745|450631752|FG000|Overall Study|Adverse Event|12|||
125274330|NCT00654745|450631752|FG000|Overall Study|Lost to Follow-up|7|||
125274331|NCT00654745|450631752|FG000|Overall Study|Protocol Violation|11|||
125274332|NCT00654745|450631752|FG000|Overall Study|Withdrawal by Subject|10|||
125274333|NCT00654745|450631752|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
125274334|NCT01995526|450631753|FG000|Overall Study|Physician Decision|1|||
125274335|NCT00383331|450631754|FG000|Overall Study|Protocol Violation|0|||
125274336|NCT00383331|450631755|FG001|Overall Study|Protocol Violation|1|||
125274337|NCT02229825|450631763|FG000|Overall Study|Personal Reasons|0|||
125274338|NCT02229825|450631764|FG001|Overall Study|Personal Reasons|1|||
125274339|NCT02229825|450631763|FG000|Overall Study|Refused continuing medication|7|||
125274340|NCT02229825|450631764|FG001|Overall Study|Refused continuing medication|6|||
125274341|NCT02229825|450631763|FG000|Overall Study|Lost to Follow-up|1|||
125274342|NCT02229825|450631764|FG001|Overall Study|Lost to Follow-up|2|||
125274343|NCT02229825|450631763|FG000|Overall Study|Protocol Violation|1|||
125274344|NCT02229825|450631764|FG001|Overall Study|Protocol Violation|1|||
125274345|NCT02229825|450631763|FG000|Overall Study|Lack of Efficacy|4|||
125274346|NCT02229825|450631764|FG001|Overall Study|Lack of Efficacy|10|||
125274347|NCT02229825|450631763|FG000|Overall Study|Adverse Event|11|||
125274348|NCT02229825|450631764|FG001|Overall Study|Adverse Event|9|||
125274349|NCT02229825|450631763|FG000|Overall Study|Not treated|0|||
125274350|NCT02229825|450631764|FG001|Overall Study|Not treated|1|||
125274351|NCT01532921|450631767|FG000|Overall Study|Death|3|||
125274352|NCT01532921|450631767|FG000|Overall Study|Withdrawal by Subject|2|||
125274353|NCT01532921|450631767|FG000|Overall Study|Lost to Follow-up|3|||
125274354|NCT01532921|450631767|FG000|Overall Study|Physician Decision|7|||
125274355|NCT01532921|450631767|FG000|Overall Study|Device was explanted during procedure|1|||
125274356|NCT00070109|450631768|FG000|Overall Study|Death|1|||
125274357|NCT00070109|450631769|FG001|Overall Study|Death|1|||
125274358|NCT00070109|450631770|FG002|Overall Study|Death|0|||
125274359|NCT00070109|450631771|FG003|Overall Study|Death|0|||
125274360|NCT00070109|450631772|FG004|Overall Study|Death|1|||
125274361|NCT00070109|450631768|FG000|Overall Study|Lack of Efficacy|6|||
125274362|NCT00070109|450631769|FG001|Overall Study|Lack of Efficacy|4|||
125274363|NCT00070109|450631770|FG002|Overall Study|Lack of Efficacy|5|||
125274364|NCT00070109|450631771|FG003|Overall Study|Lack of Efficacy|15|||
125274365|NCT00070109|450631772|FG004|Overall Study|Lack of Efficacy|5|||
125274366|NCT00070109|450631768|FG000|Overall Study|Physician Decision|1|||
125274367|NCT00070109|450631769|FG001|Overall Study|Physician Decision|0|||
125274368|NCT00070109|450631770|FG002|Overall Study|Physician Decision|0|||
125274369|NCT00070109|450631771|FG003|Overall Study|Physician Decision|0|||
125274370|NCT00070109|450631772|FG004|Overall Study|Physician Decision|0|||
125274371|NCT00070109|450631768|FG000|Overall Study|Withdrawal by Subject|0|||
125274372|NCT00070109|450631769|FG001|Overall Study|Withdrawal by Subject|1|||
125274373|NCT00070109|450631770|FG002|Overall Study|Withdrawal by Subject|1|||
125274374|NCT00070109|450631771|FG003|Overall Study|Withdrawal by Subject|0|||
125274375|NCT00070109|450631772|FG004|Overall Study|Withdrawal by Subject|0|||
125274376|NCT00070109|450631768|FG000|Overall Study|Adverse Event|0|||
125274377|NCT00070109|450631769|FG001|Overall Study|Adverse Event|0|||
125274378|NCT00070109|450631770|FG002|Overall Study|Adverse Event|2|||
125274379|NCT00070109|450631771|FG003|Overall Study|Adverse Event|4|||
125274380|NCT00070109|450631772|FG004|Overall Study|Adverse Event|2|||
125274381|NCT00070109|450631768|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
125274382|NCT00070109|450631769|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
125274383|NCT00070109|450631770|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
125274384|NCT00070109|450631771|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
125274385|NCT00070109|450631772|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
125274386|NCT01390298|450631775|FG000|Overall Study|Death|1|||
125274387|NCT01390298|450631775|FG000|Overall Study|long term ICU admission|1|||
125274388|NCT01390298|450631775|FG000|Overall Study|Withdrawal by Subject|14|||
125274389|NCT01390298|450631775|FG000|Overall Study|Lost to Follow-up|7|||
125274390|NCT01390298|450631775|FG000|Overall Study|Surgery cancelled|1|||
125274391|NCT00624468|450631779|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
125274392|NCT00624468|450631780|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
125274393|NCT00624468|450631781|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
125274394|NCT00624468|450631782|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
125274395|NCT00624468|450631779|FG000|Double-blind Period|Withdrew Prematurely|1|||
125274396|NCT00624468|450631780|FG001|Double-blind Period|Withdrew Prematurely|1|||
125274397|NCT00624468|450631781|FG002|Double-blind Period|Withdrew Prematurely|0|||
125274398|NCT00624468|450631782|FG003|Double-blind Period|Withdrew Prematurely|0|||
125274399|NCT00624468|450631779|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
125274400|NCT00624468|450631780|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
125274401|NCT00624468|450631781|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
125274402|NCT00624468|450631782|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
125274403|NCT00624468|450631779|FG000|Safety Follow-up (SFU) Period|Other|0|||
125274404|NCT00624468|450631780|FG001|Safety Follow-up (SFU) Period|Other|0|||
125274405|NCT00624468|450631781|FG002|Safety Follow-up (SFU) Period|Other|1|||
125274406|NCT00624468|450631782|FG003|Safety Follow-up (SFU) Period|Other|1|||
125274407|NCT01524224|450631793|FG000|Overall Study|Progressive Disease|1|||
125274408|NCT01524224|450631794|FG001|Overall Study|Progressive Disease|0|||
125274409|NCT01524224|450631795|FG002|Overall Study|Progressive Disease|2|||
125274410|NCT01524224|450631796|FG003|Overall Study|Progressive Disease|1|||
125274411|NCT01524224|450631797|FG004|Overall Study|Progressive Disease|2|||
125274412|NCT01524224|450631798|FG005|Overall Study|Progressive Disease|1|||
125274413|NCT01524224|450631799|FG006|Overall Study|Progressive Disease|1|||
125274414|NCT01524224|450631800|FG007|Overall Study|Progressive Disease|5|||
125274415|NCT01524224|450631793|FG000|Overall Study|Withdrawal by Subject|2|||
125274416|NCT01524224|450631794|FG001|Overall Study|Withdrawal by Subject|0|||
125274417|NCT01524224|450631795|FG002|Overall Study|Withdrawal by Subject|0|||
125274418|NCT01524224|450631796|FG003|Overall Study|Withdrawal by Subject|0|||
125274419|NCT01524224|450631797|FG004|Overall Study|Withdrawal by Subject|0|||
125274420|NCT01524224|450631798|FG005|Overall Study|Withdrawal by Subject|0|||
125274421|NCT01524224|450631799|FG006|Overall Study|Withdrawal by Subject|2|||
125274422|NCT01524224|450631800|FG007|Overall Study|Withdrawal by Subject|0|||
125274423|NCT01524224|450631793|FG000|Overall Study|Adverse Event|0|||
125274424|NCT01524224|450631794|FG001|Overall Study|Adverse Event|1|||
125274425|NCT01524224|450631795|FG002|Overall Study|Adverse Event|0|||
125274426|NCT01524224|450631796|FG003|Overall Study|Adverse Event|0|||
125274427|NCT01524224|450631797|FG004|Overall Study|Adverse Event|0|||
125274428|NCT01524224|450631798|FG005|Overall Study|Adverse Event|1|||
125274429|NCT01524224|450631799|FG006|Overall Study|Adverse Event|0|||
125274430|NCT01524224|450631800|FG007|Overall Study|Adverse Event|0|||
125274431|NCT01524224|450631793|FG000|Overall Study|Physician Decision|0|||
125274432|NCT01524224|450631794|FG001|Overall Study|Physician Decision|0|||
125274433|NCT01524224|450631795|FG002|Overall Study|Physician Decision|0|||
125274434|NCT01524224|450631796|FG003|Overall Study|Physician Decision|1|||
125274435|NCT01524224|450631797|FG004|Overall Study|Physician Decision|1|||
125274436|NCT01524224|450631798|FG005|Overall Study|Physician Decision|0|||
125274437|NCT01524224|450631799|FG006|Overall Study|Physician Decision|0|||
125274438|NCT01524224|450631800|FG007|Overall Study|Physician Decision|1|||
125274439|NCT01524224|450631793|FG000|Overall Study|Sponsor Decision|0|||
125274440|NCT01524224|450631794|FG001|Overall Study|Sponsor Decision|0|||
125274441|NCT01524224|450631795|FG002|Overall Study|Sponsor Decision|0|||
125274442|NCT01524224|450631796|FG003|Overall Study|Sponsor Decision|0|||
125274443|NCT01524224|450631797|FG004|Overall Study|Sponsor Decision|1|||
125274444|NCT01524224|450631798|FG005|Overall Study|Sponsor Decision|0|||
125274445|NCT01524224|450631799|FG006|Overall Study|Sponsor Decision|0|||
125274446|NCT01524224|450631800|FG007|Overall Study|Sponsor Decision|0|||
125274447|NCT00803361|450631802|FG000|Overall Study|Adverse Event|13|||
125274448|NCT00803361|450631803|FG001|Overall Study|Adverse Event|3|||
125274449|NCT00803361|450631802|FG000|Overall Study|Lack of Efficacy|4|||
125274450|NCT00803361|450631803|FG001|Overall Study|Lack of Efficacy|13|||
125274451|NCT00803361|450631802|FG000|Overall Study|Lost to Follow-up|1|||
125274452|NCT00803361|450631803|FG001|Overall Study|Lost to Follow-up|2|||
125274453|NCT00803361|450631802|FG000|Overall Study|Physician Decision|1|||
125274454|NCT00803361|450631803|FG001|Overall Study|Physician Decision|0|||
125274455|NCT00803361|450631802|FG000|Overall Study|Protocol Violation|2|||
125274456|NCT00803361|450631803|FG001|Overall Study|Protocol Violation|4|||
125274457|NCT00803361|450631802|FG000|Overall Study|Withdrawal by Subject|5|||
125274458|NCT00803361|450631803|FG001|Overall Study|Withdrawal by Subject|6|||
125274459|NCT02858440|450631804|FG000|Overall Study|Lost to Follow-up|3|||
125274460|NCT02858440|450631804|FG000|Overall Study|Protocol Violation|2|||
125274461|NCT02858440|450631804|FG000|Overall Study|Consent withdrawal|3|||
125274462|NCT02858440|450631804|FG000|Overall Study|Migrated/moved from study area|4|||
125274463|NCT01670279|450631805|FG000|Overall Study|Adverse Event|0|||
125274464|NCT01670279|450631806|FG001|Overall Study|Adverse Event|1|||
125274465|NCT01670279|450631807|FG002|Overall Study|Adverse Event|0|||
125274466|NCT01670279|450631808|FG003|Overall Study|Adverse Event|0|||
125274467|NCT01670279|450631805|FG000|Overall Study|Physician Decision|0|||
125274468|NCT01670279|450631806|FG001|Overall Study|Physician Decision|1|||
125274469|NCT01670279|450631807|FG002|Overall Study|Physician Decision|0|||
125274470|NCT01670279|450631808|FG003|Overall Study|Physician Decision|0|||
125274471|NCT01670279|450631805|FG000|Overall Study|Participant met withdrawal criteria|0|||
125274472|NCT01670279|450631806|FG001|Overall Study|Participant met withdrawal criteria|0|||
125274473|NCT01670279|450631807|FG002|Overall Study|Participant met withdrawal criteria|0|||
125274474|NCT01670279|450631808|FG003|Overall Study|Participant met withdrawal criteria|1|||
125274475|NCT01901614|450631809|FG000|Overall Study|Adverse Event|0|||
125274476|NCT01901614|450631810|FG001|Overall Study|Adverse Event|1|||
125274477|NCT01901614|450631809|FG000|Overall Study|Lost to Follow-up|1|||
125274478|NCT01901614|450631810|FG001|Overall Study|Lost to Follow-up|0|||
125274479|NCT01901614|450631809|FG000|Overall Study|Screen Fail|1|||
125274480|NCT01901614|450631810|FG001|Overall Study|Screen Fail|0|||
125274481|NCT01823198|450631811|FG000|Overall Study|Physician Decision|0|||
125274482|NCT01823198|450631812|FG001|Overall Study|Physician Decision|1|||
125274483|NCT01823198|450631813|FG002|Overall Study|Physician Decision|0|||
125274484|NCT01823198|450631814|FG003|Overall Study|Physician Decision|0|||
125274485|NCT01823198|450631815|FG004|Overall Study|Physician Decision|0|||
125274486|NCT01823198|450631816|FG005|Overall Study|Physician Decision|3|||
125274487|NCT01823198|450631817|FG006|Overall Study|Physician Decision|3|||
125274488|NCT02674464|450631818|FG000|Overall Study|Death|10|||
125274489|NCT02674464|450631819|FG001|Overall Study|Death|21|||
125274490|NCT02674464|450631818|FG000|Overall Study|Withdrawal by Subject|24|||
125274491|NCT02674464|450631819|FG001|Overall Study|Withdrawal by Subject|44|||
125274492|NCT02674464|450631818|FG000|Overall Study|Lost to Follow-up|97|||
125274493|NCT02674464|450631819|FG001|Overall Study|Lost to Follow-up|92|||
125274494|NCT02674464|450631818|FG000|Overall Study|Outside survey window|6|||
125274495|NCT02674464|450631819|FG001|Overall Study|Outside survey window|3|||
125274496|NCT00783835|450631820|FG000|Overall Study|Adverse Event|3|||
125274497|NCT00783835|450631820|FG000|Overall Study|Medical Criteria|1|||
125274498|NCT00783835|450631820|FG000|Overall Study|Withdrawal by Subject|2|||
125274499|NCT00783835|450631820|FG000|Overall Study|Lost to Follow-up|1|||
125274500|NCT00783835|450631820|FG000|Overall Study|Participant not Adherent|3|||
125274501|NCT01262638|450631821|FG000|Overall Study|Adverse Event|3|||
125274502|NCT01262638|450631822|FG001|Overall Study|Adverse Event|4|||
125274503|NCT01262638|450631823|FG002|Overall Study|Adverse Event|3|||
125274504|NCT01262638|450631824|FG003|Overall Study|Adverse Event|4|||
125274505|NCT01262638|450631821|FG000|Overall Study|Protocol Violation|1|||
125274506|NCT01262638|450631822|FG001|Overall Study|Protocol Violation|0|||
125274507|NCT01262638|450631823|FG002|Overall Study|Protocol Violation|0|||
125274508|NCT01262638|450631824|FG003|Overall Study|Protocol Violation|1|||
125274509|NCT01262638|450631821|FG000|Overall Study|Withdrawal by Subject|2|||
125274510|NCT01262638|450631822|FG001|Overall Study|Withdrawal by Subject|1|||
125274511|NCT01262638|450631823|FG002|Overall Study|Withdrawal by Subject|0|||
125274512|NCT01262638|450631824|FG003|Overall Study|Withdrawal by Subject|1|||
125274513|NCT01262638|450631821|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
125274514|NCT01262638|450631822|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
125274515|NCT01262638|450631823|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
125274516|NCT01262638|450631824|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
125274517|NCT01262638|450631821|FG000|Overall Study|Lost to Follow-up|1|||
125274518|NCT01262638|450631822|FG001|Overall Study|Lost to Follow-up|1|||
125274519|NCT01262638|450631823|FG002|Overall Study|Lost to Follow-up|1|||
125274520|NCT01262638|450631824|FG003|Overall Study|Lost to Follow-up|1|||
125274521|NCT01262638|450631821|FG000|Overall Study|Participant Went Out of Town|0|||
125274522|NCT01262638|450631822|FG001|Overall Study|Participant Went Out of Town|0|||
125274523|NCT01262638|450631823|FG002|Overall Study|Participant Went Out of Town|1|||
125274524|NCT01262638|450631824|FG003|Overall Study|Participant Went Out of Town|0|||
125274525|NCT02243371|450631829|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
125274526|NCT02243371|450631830|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
125274527|NCT02243371|450631829|FG000|Overall Study|Death (unrelated)|2|||
125274528|NCT02243371|450631830|FG001|Overall Study|Death (unrelated)|4|||
125274529|NCT02243371|450631829|FG000|Overall Study|Adverse Event (unrelated)|0|||
125274530|NCT02243371|450631830|FG001|Overall Study|Adverse Event (unrelated)|1|||
125274531|NCT02243371|450631829|FG000|Overall Study|Lack of Clinical Benefit|0|||
125274532|NCT02243371|450631830|FG001|Overall Study|Lack of Clinical Benefit|1|||
125274533|NCT02243371|450631829|FG000|Overall Study|Withdrawal by Subject|0|||
125274534|NCT02243371|450631830|FG001|Overall Study|Withdrawal by Subject|2|||
125274535|NCT01369199|450631831|FG000|Overall Study|Withdrawal by Subject|1|||
125274536|NCT01369199|450631831|FG000|Overall Study|Lost to Follow-up|2|||
125274537|NCT01066104|450631832|FG000|Overall Study|Adverse Event|1|||
125274538|NCT01066104|450631833|FG001|Overall Study|Adverse Event|1|||
125274539|NCT01066104|450631832|FG000|Overall Study|Protocol Violation|1|||
125274540|NCT01066104|450631833|FG001|Overall Study|Protocol Violation|0|||
125274541|NCT02091362|450631841|FG000|Period 1|Protocol Violation|1|||
125274542|NCT02091362|450631842|FG001|Period 1|Protocol Violation|0|||
125274543|NCT02091362|450631841|FG000|Period 1|Withdrawal by Subject|2|||
125274544|NCT02091362|450631842|FG001|Period 1|Withdrawal by Subject|3|||
125274545|NCT02091362|450631841|FG000|Period 1|Lost to Follow-up|0|||
125274546|NCT02091362|450631842|FG001|Period 1|Lost to Follow-up|1|||
125274547|NCT02091362|450631841|FG000|Period 1|Adverse Event|2|||
125274548|NCT02091362|450631842|FG001|Period 1|Adverse Event|0|||
125274549|NCT02091362|450631841|FG000|Wash-out|Lost to Follow-up|1|||
125274550|NCT02091362|450631842|FG001|Wash-out|Lost to Follow-up|1|||
125274551|NCT02091362|450631841|FG000|Wash-out|Withdrawal by Subject|0|||
125274552|NCT02091362|450631842|FG001|Wash-out|Withdrawal by Subject|2|||
125274553|NCT02091362|450631841|FG000|Period 2|Adverse Event|1|||
125274554|NCT02091362|450631842|FG001|Period 2|Adverse Event|0|||
125274555|NCT02091362|450631841|FG000|Period 2|Lost to Follow-up|0|||
125274556|NCT02091362|450631842|FG001|Period 2|Lost to Follow-up|1|||
125274557|NCT02091362|450631841|FG000|Period 2|Withdrawal by Subject|1|||
125274558|NCT02091362|450631842|FG001|Period 2|Withdrawal by Subject|1|||
125274559|NCT00470262|450631843|FG000|Overall Study|Withdrawal by Subject|2|||
125274560|NCT00470262|450631844|FG001|Overall Study|Withdrawal by Subject|0|||
125274561|NCT03900728|450631845|FG000|Overall Study|No text responses|0|||
125274562|NCT03900728|450631846|FG001|Overall Study|No text responses|0|||
125274563|NCT03900728|450631847|FG002|Overall Study|No text responses|4|||
125274564|NCT03248167|450631858|FG000|Overall Study|Withdrawal by Subject|2|||
125274565|NCT03248167|450631859|FG001|Overall Study|Withdrawal by Subject|2|||
125274566|NCT03248167|450631858|FG000|Overall Study|Physician Decision|0|||
125274567|NCT03248167|450631859|FG001|Overall Study|Physician Decision|1|||
125274568|NCT03248167|450631858|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
125274569|NCT03248167|450631859|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
125274570|NCT03248167|450631858|FG000|Overall Study|Lost to Follow-up|1|||
125274571|NCT03248167|450631859|FG001|Overall Study|Lost to Follow-up|0|||
125274572|NCT02122146|450631860|FG000|Part 1: Dose Escalation|Death|0|||
125274573|NCT02122146|450631861|FG001|Part 1: Dose Escalation|Death|1|||
125274574|NCT02122146|450631862|FG002|Part 1: Dose Escalation|Death|1|||
125274575|NCT02122146|450631863|FG003|Part 1: Dose Escalation|Death|0|||
125274576|NCT02122146|450631864|FG004|Part 1: Dose Escalation|Death|0|||
125274577|NCT02122146|450631865|FG005|Part 1: Dose Escalation|Death|0|||
125274578|NCT02122146|450631866|FG006|Part 1: Dose Escalation|Death|0|||
125274579|NCT02122146|450631867|FG007|Part 1: Dose Escalation|Death|0|||
125274580|NCT02122146|450631860|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
125274581|NCT02122146|450631861|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
125274582|NCT02122146|450631862|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
125274583|NCT02122146|450631863|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
125274584|NCT02122146|450631864|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
125274585|NCT02122146|450631865|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
125274586|NCT02122146|450631866|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
125274587|NCT02122146|450631867|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
125274588|NCT02122146|450631860|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125274589|NCT02122146|450631861|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125274590|NCT02122146|450631862|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125274591|NCT02122146|450631863|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
125274592|NCT02122146|450631864|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125274593|NCT02122146|450631865|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125274594|NCT02122146|450631866|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125274595|NCT02122146|450631867|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125274596|NCT02122146|450631860|FG000|Part 1: Dose Escalation|Other|1|||
125274597|NCT02122146|450631861|FG001|Part 1: Dose Escalation|Other|0|||
125274598|NCT02122146|450631862|FG002|Part 1: Dose Escalation|Other|0|||
125274599|NCT02122146|450631863|FG003|Part 1: Dose Escalation|Other|0|||
125274600|NCT02122146|450631864|FG004|Part 1: Dose Escalation|Other|0|||
125274601|NCT02122146|450631865|FG005|Part 1: Dose Escalation|Other|1|||
125274602|NCT02122146|450631866|FG006|Part 1: Dose Escalation|Other|1|||
125274603|NCT02122146|450631867|FG007|Part 1: Dose Escalation|Other|2|||
125274604|NCT03835481|450631868|FG000|Double-blind Period|Other not stated below|0|||
125274605|NCT03835481|450631869|FG001|Double-blind Period|Other not stated below|0|||
125274606|NCT03835481|450631870|FG002|Double-blind Period|Other not stated below|0|||
125274607|NCT03835481|450631871|FG003|Double-blind Period|Other not stated below|1|||
125274608|NCT03835481|450631872|FG004|Double-blind Period|Other not stated below|1|||
125274609|NCT03835481|450631868|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
125274610|NCT03835481|450631869|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
125274611|NCT03835481|450631870|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
125274612|NCT03835481|450631871|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
125274613|NCT03835481|450631872|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
125274614|NCT03835481|450631868|FG000|Double-blind Period|Withdrawal by Subject|0|||
125274615|NCT03835481|450631869|FG001|Double-blind Period|Withdrawal by Subject|0|||
125274616|NCT03835481|450631870|FG002|Double-blind Period|Withdrawal by Subject|1|||
125274617|NCT03835481|450631871|FG003|Double-blind Period|Withdrawal by Subject|0|||
125274618|NCT03835481|450631872|FG004|Double-blind Period|Withdrawal by Subject|5|||
125274619|NCT03835481|450631868|FG000|Double-blind Period|Lost to Follow-up|0|||
125274620|NCT03835481|450631869|FG001|Double-blind Period|Lost to Follow-up|0|||
125274621|NCT03835481|450631870|FG002|Double-blind Period|Lost to Follow-up|0|||
125274622|NCT03835481|450631871|FG003|Double-blind Period|Lost to Follow-up|1|||
125274623|NCT03835481|450631872|FG004|Double-blind Period|Lost to Follow-up|0|||
125274624|NCT03835481|450631868|FG000|Double-blind Period|Protocol Violation|0|||
125274625|NCT03835481|450631869|FG001|Double-blind Period|Protocol Violation|2|||
125274626|NCT03835481|450631870|FG002|Double-blind Period|Protocol Violation|0|||
125274627|NCT03835481|450631871|FG003|Double-blind Period|Protocol Violation|1|||
125274628|NCT03835481|450631872|FG004|Double-blind Period|Protocol Violation|0|||
125274629|NCT03835481|450631868|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
125274630|NCT03835481|450631869|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
125274631|NCT03835481|450631870|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
125274632|NCT03835481|450631871|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
125274633|NCT03835481|450631872|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
125274634|NCT03835481|450631868|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
125274635|NCT03835481|450631869|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
125274636|NCT03835481|450631870|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
125274637|NCT03835481|450631871|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
125274638|NCT03835481|450631872|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
125274639|NCT03835481|450631868|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
125274640|NCT03835481|450631869|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
125274641|NCT03835481|450631870|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
125274642|NCT03835481|450631871|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
125274643|NCT03835481|450631872|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
125274644|NCT03835481|450631868|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
125274645|NCT03835481|450631869|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
125274646|NCT03835481|450631870|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
125274647|NCT03835481|450631871|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
125274648|NCT03835481|450631872|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
125274649|NCT03835481|450631868|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
125274650|NCT03835481|450631869|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
125274651|NCT03835481|450631870|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
125274652|NCT03835481|450631871|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
125274653|NCT03835481|450631872|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
125274654|NCT03835481|450631868|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
125274655|NCT03835481|450631869|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
125274656|NCT03835481|450631870|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
125274657|NCT03835481|450631871|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
125274658|NCT03835481|450631872|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
125274659|NCT00191945|450631874|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
125274660|NCT00191945|450631875|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
125274661|NCT00191945|450631874|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
125274662|NCT00191945|450631875|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
125274663|NCT00191945|450631874|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
125274664|NCT00191945|450631875|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
125274665|NCT00191945|450631874|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
125274666|NCT00191945|450631875|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
125274667|NCT02725476|450631876|FG000|Overall Study|Physician Decision|2|||
125274668|NCT02725476|450631877|FG001|Overall Study|Physician Decision|0|||
125274669|NCT02725476|450631876|FG000|Overall Study|Adverse Event|1|||
125274670|NCT02725476|450631877|FG001|Overall Study|Adverse Event|1|||
125274671|NCT04188834|450631888|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
125274672|NCT01030952|450631889|FG000|Overall Study|Protocol Violation|0|||
125274673|NCT01030952|450631890|FG001|Overall Study|Protocol Violation|1|||
125274674|NCT01030952|450631889|FG000|Overall Study|Informed consent withdrawal|1|||
125274675|NCT01030952|450631890|FG001|Overall Study|Informed consent withdrawal|0|||
125274676|NCT01030952|450631889|FG000|Overall Study|Lost to Follow-up|0|||
125274677|NCT01030952|450631890|FG001|Overall Study|Lost to Follow-up|1|||
125274678|NCT01030952|450631889|FG000|Overall Study|Unexplained|1|||
125274679|NCT01030952|450631890|FG001|Overall Study|Unexplained|1|||
125274680|NCT00391430|450631891|FG000|Overall Study|Withdrawal by Subject|3|||
125274681|NCT00391430|450631892|FG001|Overall Study|Withdrawal by Subject|0|||
125274682|NCT00391430|450631893|FG002|Overall Study|Withdrawal by Subject|12|||
125274683|NCT02470585|450631902|FG000|Overall Study|Death|224|||
125274684|NCT02470585|450631903|FG001|Overall Study|Death|227|||
125274685|NCT02470585|450631904|FG002|Overall Study|Death|199|||
125274686|NCT02470585|450631902|FG000|Overall Study|Withdrew consent|21|||
125274687|NCT02470585|450631903|FG001|Overall Study|Withdrew consent|22|||
125274688|NCT02470585|450631904|FG002|Overall Study|Withdrew consent|31|||
125274689|NCT02470585|450631902|FG000|Overall Study|Lost to Follow-up|8|||
125274690|NCT02470585|450631903|FG001|Overall Study|Lost to Follow-up|15|||
125274691|NCT02470585|450631904|FG002|Overall Study|Lost to Follow-up|13|||
125274692|NCT02470585|450631902|FG000|Overall Study|Sponsor discontinued study|117|||
125274693|NCT02470585|450631903|FG001|Overall Study|Sponsor discontinued study|110|||
125274694|NCT02470585|450631904|FG002|Overall Study|Sponsor discontinued study|122|||
125274695|NCT02470585|450631902|FG000|Overall Study|Other, not specified|5|||
125274696|NCT02470585|450631903|FG001|Overall Study|Other, not specified|7|||
125274697|NCT02470585|450631904|FG002|Overall Study|Other, not specified|14|||
125274698|NCT02470585|450631902|FG000|Overall Study|Missing due to site non-compliance|0|||
125274699|NCT02470585|450631903|FG001|Overall Study|Missing due to site non-compliance|2|||
125274700|NCT02470585|450631904|FG002|Overall Study|Missing due to site non-compliance|3|||
125274701|NCT03497039|450631905|FG000|Overall Study|Withdrawal by Subject|1|||
125274702|NCT03497039|450631906|FG001|Overall Study|Withdrawal by Subject|0|||
125274703|NCT03497039|450631905|FG000|Overall Study|Protocol Violation|0|||
125274704|NCT03497039|450631906|FG001|Overall Study|Protocol Violation|1|||
125274705|NCT00465972|450631909|FG000|Overall Study|Withdrawal by Subject|2|||
125274706|NCT00465972|450631910|FG001|Overall Study|Withdrawal by Subject|1|||
125274707|NCT03292640|450631911|FG000|Overall Study|Withdrawal by Subject|17|||
125274708|NCT03292640|450631912|FG001|Overall Study|Withdrawal by Subject|16|||
125274709|NCT03292640|450631911|FG000|Overall Study|Adverse Event|20|||
125274710|NCT03292640|450631912|FG001|Overall Study|Adverse Event|2|||
125274711|NCT03292640|450631911|FG000|Overall Study|Lost to Follow-up|24|||
125274712|NCT03292640|450631912|FG001|Overall Study|Lost to Follow-up|24|||
125274713|NCT02218697|450631913|FG000|Overall Study|Adverse Event|0|||
125274714|NCT02218697|450631914|FG001|Overall Study|Adverse Event|2|||
125274715|NCT02218697|450631913|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
125274716|NCT02218697|450631914|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
125274717|NCT02218697|450631913|FG000|Overall Study|Withdrawal by Subject|2|||
125274718|NCT02218697|450631914|FG001|Overall Study|Withdrawal by Subject|3|||
125274719|NCT03306433|450631917|FG000|Overall Study|Lost to Follow-up|3|||
125274720|NCT03306433|450631917|FG000|Overall Study|Patient did not have teeth extracted|1|||
125274721|NCT03306433|450631917|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
125274722|NCT00294671|450633411|FG000|Overall Study|Lack of Efficacy|11|||
125274723|NCT00294671|450633412|FG001|Overall Study|Lack of Efficacy|23|||
125274724|NCT00294671|450633411|FG000|Overall Study|Liver transplant|7|||
125274725|NCT00294671|450633412|FG001|Overall Study|Liver transplant|9|||
125274726|NCT00294671|450633411|FG000|Overall Study|Drug related adverse event (AE)|4|||
125274727|NCT00294671|450633412|FG001|Overall Study|Drug related adverse event (AE)|2|||
125274728|NCT00294671|450633411|FG000|Overall Study|Non-drug related AE|3|||
125274729|NCT00294671|450633412|FG001|Overall Study|Non-drug related AE|2|||
125274730|NCT00294671|450633411|FG000|Overall Study|Lost to Follow-up|1|||
125274731|NCT00294671|450633412|FG001|Overall Study|Lost to Follow-up|3|||
125274732|NCT00294671|450633411|FG000|Overall Study|Non-compliance|1|||
125274733|NCT00294671|450633412|FG001|Overall Study|Non-compliance|0|||
125274734|NCT00294671|450633411|FG000|Overall Study|Death|0|||
125274735|NCT00294671|450633412|FG001|Overall Study|Death|1|||
125274736|NCT01893411|450633416|FG000|Overall Study|Protocol Violation|1|||
125274737|NCT01893411|450633417|FG001|Overall Study|Protocol Violation|0|||
125274738|NCT01893411|450633418|FG002|Overall Study|Protocol Violation|0|||
125274739|NCT01893411|450633416|FG000|Overall Study|Physician Decision|1|||
125274740|NCT01893411|450633417|FG001|Overall Study|Physician Decision|1|||
125274741|NCT01893411|450633418|FG002|Overall Study|Physician Decision|2|||
125274742|NCT01893411|450633416|FG000|Overall Study|Lack of Efficacy|2|||
125274743|NCT01893411|450633417|FG001|Overall Study|Lack of Efficacy|1|||
125274744|NCT01893411|450633418|FG002|Overall Study|Lack of Efficacy|0|||
125274745|NCT01893411|450633416|FG000|Overall Study|Other|3|||
125274746|NCT01893411|450633417|FG001|Overall Study|Other|1|||
125274747|NCT01893411|450633418|FG002|Overall Study|Other|3|||
125274748|NCT01893411|450633416|FG000|Overall Study|Adverse Event|1|||
125274749|NCT01893411|450633417|FG001|Overall Study|Adverse Event|0|||
125274750|NCT01893411|450633418|FG002|Overall Study|Adverse Event|0|||
125274751|NCT01893411|450633416|FG000|Overall Study|Withdrawal by Subject|7|||
125274752|NCT01893411|450633417|FG001|Overall Study|Withdrawal by Subject|4|||
125274753|NCT01893411|450633418|FG002|Overall Study|Withdrawal by Subject|3|||
125274754|NCT01893411|450633416|FG000|Overall Study|Lost to Follow-up|2|||
125274755|NCT01893411|450633417|FG001|Overall Study|Lost to Follow-up|0|||
125274756|NCT01893411|450633418|FG002|Overall Study|Lost to Follow-up|1|||
125274757|NCT02403817|450633421|FG000|Overall Study|Withdrawal by Subject|5|||
125274758|NCT02403817|450633422|FG001|Overall Study|Withdrawal by Subject|0|||
125274759|NCT03053440|450633423|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
125274760|NCT03053440|450633424|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
125274761|NCT03053440|450633423|FG000|Overall Study|Death|18|||
125274762|NCT03053440|450633424|FG001|Overall Study|Death|14|||
125274763|NCT03053440|450633423|FG000|Overall Study|Withdrawal by Subject|9|||
125274764|NCT03053440|450633424|FG001|Overall Study|Withdrawal by Subject|8|||
125274765|NCT03053440|450633423|FG000|Overall Study|Lost to Follow-up|1|||
125274766|NCT03053440|450633424|FG001|Overall Study|Lost to Follow-up|0|||
125274767|NCT03053440|450633423|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
125274768|NCT03053440|450633424|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
125274769|NCT03053440|450633423|FG000|Overall Study|Physician Decision|2|||
125274770|NCT03053440|450633424|FG001|Overall Study|Physician Decision|1|||
125274771|NCT03053440|450633423|FG000|Overall Study|Participant Randomized but died before dosing|1|||
125274772|NCT03053440|450633424|FG001|Overall Study|Participant Randomized but died before dosing|0|||
125274773|NCT00430989|450633425|FG000|Overall Study|Lost to Follow-up|2|||
125274774|NCT00430989|450633426|FG001|Overall Study|Lost to Follow-up|3|||
125274775|NCT00430989|450633425|FG000|Overall Study|Withdrawal by Subject|15|||
125274776|NCT00430989|450633426|FG001|Overall Study|Withdrawal by Subject|14|||
125274777|NCT00430989|450633425|FG000|Overall Study|Protocol Violation|30|||
125274778|NCT00430989|450633426|FG001|Overall Study|Protocol Violation|37|||
125274779|NCT00430989|450633425|FG000|Overall Study|Not eligible|13|||
125274780|NCT00430989|450633426|FG001|Overall Study|Not eligible|6|||
125274781|NCT01701362|450633427|FG000|Overall Study|Adverse events not related to study drug|1|||
125274782|NCT01701362|450633428|FG001|Overall Study|Adverse events not related to study drug|6|||
125274783|NCT01701362|450633427|FG000|Overall Study|Adverse events related to study drug|12|||
125274784|NCT01701362|450633428|FG001|Overall Study|Adverse events related to study drug|10|||
125274785|NCT01701362|450633427|FG000|Overall Study|Protocol Violation|5|||
125274786|NCT01701362|450633428|FG001|Overall Study|Protocol Violation|3|||
125274787|NCT01701362|450633427|FG000|Overall Study|No longer willing to participate|8|||
125274788|NCT01701362|450633428|FG001|Overall Study|No longer willing to participate|14|||
125274789|NCT01701362|450633427|FG000|Overall Study|Lost to Follow-up|6|||
125274790|NCT01701362|450633428|FG001|Overall Study|Lost to Follow-up|9|||
125274791|NCT01701362|450633427|FG000|Overall Study|Insufficient clinical response|6|||
125274792|NCT01701362|450633428|FG001|Overall Study|Insufficient clinical response|6|||
125274793|NCT01701362|450633427|FG000|Overall Study|Death|0|||
125274794|NCT01701362|450633428|FG001|Overall Study|Death|1|||
125274795|NCT01701362|450633427|FG000|Overall Study|Randomized but not treated|1|||
125274796|NCT01701362|450633428|FG001|Overall Study|Randomized but not treated|2|||
125274797|NCT01701362|450633427|FG000|Overall Study|Reasons other than those mentioned above|3|||
125274798|NCT01701362|450633428|FG001|Overall Study|Reasons other than those mentioned above|5|||
125274799|NCT00570778|450633429|FG000|Overall Study|Protocol deviation|2|||
125274800|NCT00570778|450633430|FG001|Overall Study|Protocol deviation|1|||
125274801|NCT00570778|450633431|FG002|Overall Study|Protocol deviation|2|||
125274802|NCT00570778|450633432|FG003|Overall Study|Protocol deviation|2|||
125274803|NCT00570778|450633429|FG000|Overall Study|Adverse Event|0|||
125274804|NCT00570778|450633430|FG001|Overall Study|Adverse Event|1|||
125274805|NCT00570778|450633431|FG002|Overall Study|Adverse Event|4|||
125274806|NCT00570778|450633432|FG003|Overall Study|Adverse Event|1|||
125274807|NCT00570778|450633429|FG000|Overall Study|Subject withdrew consent|0|||
125274808|NCT00570778|450633430|FG001|Overall Study|Subject withdrew consent|1|||
125274809|NCT00570778|450633431|FG002|Overall Study|Subject withdrew consent|0|||
125274810|NCT00570778|450633432|FG003|Overall Study|Subject withdrew consent|1|||
125274811|NCT00570778|450633429|FG000|Overall Study|Abnormal test procedure|1|||
125274812|NCT00570778|450633430|FG001|Overall Study|Abnormal test procedure|0|||
125274813|NCT00570778|450633431|FG002|Overall Study|Abnormal test procedure|0|||
125274814|NCT00570778|450633432|FG003|Overall Study|Abnormal test procedure|0|||
125274815|NCT00570778|450633429|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125274816|NCT00570778|450633430|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125274817|NCT00570778|450633431|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
125274818|NCT00570778|450633432|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
125274819|NCT00570778|450633429|FG000|Overall Study|Lost to Follow-up|0|||
125274820|NCT00570778|450633430|FG001|Overall Study|Lost to Follow-up|0|||
125274821|NCT00570778|450633431|FG002|Overall Study|Lost to Follow-up|1|||
125274822|NCT00570778|450633432|FG003|Overall Study|Lost to Follow-up|0|||
125274823|NCT00570778|450633429|FG000|Overall Study|Subject no longer requires study drug|0|||
125274824|NCT00570778|450633430|FG001|Overall Study|Subject no longer requires study drug|1|||
125274825|NCT00570778|450633431|FG002|Overall Study|Subject no longer requires study drug|0|||
125274826|NCT00570778|450633432|FG003|Overall Study|Subject no longer requires study drug|0|||
125274827|NCT02120781|450633437|FG000|Overall Study|Physician Decision|2|||
125274828|NCT02120781|450633438|FG001|Overall Study|Physician Decision|0|||
125274829|NCT02120781|450633437|FG000|Overall Study|Completion not documented|2|||
125274830|NCT02120781|450633438|FG001|Overall Study|Completion not documented|1|||
125274831|NCT00984165|450633439|FG000|Overall Study|Death on study|2|||
125274832|NCT00984165|450633440|FG001|Overall Study|Death on study|0|||
125274833|NCT00984165|450633441|FG002|Overall Study|Death on study|0|||
125274834|NCT00984165|450633442|FG003|Overall Study|Death on study|0|||
125274835|NCT00984165|450633439|FG000|Overall Study|Disease progression on study|5|||
125274836|NCT00984165|450633440|FG001|Overall Study|Disease progression on study|1|||
125274837|NCT00984165|450633441|FG002|Overall Study|Disease progression on study|0|||
125274838|NCT00984165|450633442|FG003|Overall Study|Disease progression on study|0|||
125274839|NCT00984165|450633439|FG000|Overall Study|Death of recipient|0|||
125274840|NCT00984165|450633440|FG001|Overall Study|Death of recipient|0|||
125274841|NCT00984165|450633441|FG002|Overall Study|Death of recipient|0|||
125274842|NCT00984165|450633442|FG003|Overall Study|Death of recipient|1|||
125274843|NCT00984165|450633439|FG000|Overall Study|New protocol|0|||
125274844|NCT00984165|450633440|FG001|Overall Study|New protocol|0|||
125274845|NCT00984165|450633441|FG002|Overall Study|New protocol|0|||
125274846|NCT00984165|450633442|FG003|Overall Study|New protocol|1|||
125274847|NCT00984165|450633439|FG000|Overall Study|P+/donor pair removed from protocol|0|||
125274848|NCT00984165|450633440|FG001|Overall Study|P+/donor pair removed from protocol|0|||
125274849|NCT00984165|450633441|FG002|Overall Study|P+/donor pair removed from protocol|0|||
125274850|NCT00984165|450633442|FG003|Overall Study|P+/donor pair removed from protocol|1|||
125274851|NCT00984165|450633439|FG000|Overall Study|removed with a pair recipient|0|||
125274852|NCT00984165|450633440|FG001|Overall Study|removed with a pair recipient|0|||
125274853|NCT00984165|450633441|FG002|Overall Study|removed with a pair recipient|0|||
125274854|NCT00984165|450633442|FG003|Overall Study|removed with a pair recipient|1|||
125274855|NCT00466947|450633443|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
125274856|NCT00466947|450633444|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
125274857|NCT00466947|450633443|FG000|Study End Analysis Period|Adverse Event|35|||
125274858|NCT00466947|450633444|FG001|Study End Analysis Period|Adverse Event|43|||
125274859|NCT00466947|450633443|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
125274860|NCT00466947|450633444|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
125274861|NCT00466947|450633443|FG000|Study End Analysis Period|Physician Decision|29|||
125274862|NCT00466947|450633444|FG001|Study End Analysis Period|Physician Decision|29|||
125274863|NCT00466947|450633443|FG000|Study End Analysis Period|Protocol Violation|9|||
125274864|NCT00466947|450633444|FG001|Study End Analysis Period|Protocol Violation|17|||
125274865|NCT00466947|450633443|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
125274866|NCT00466947|450633444|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
125274867|NCT00466947|450633443|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
125274868|NCT00466947|450633444|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
125274869|NCT00466947|450633443|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
125274870|NCT00466947|450633444|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
125274871|NCT00466947|450633443|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
125274872|NCT00466947|450633444|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
125274873|NCT03850093|450633445|FG000|Overall Study|Withdrawal by Subject|1|||
125274874|NCT03850093|450633446|FG001|Overall Study|Withdrawal by Subject|0|||
125274875|NCT03850093|450633447|FG002|Overall Study|Withdrawal by Subject|2|||
125274876|NCT03226249|450633448|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
125274877|NCT03226249|450633448|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
125274878|NCT03226249|450633448|FG000|Survival Follow-up|Patients still in follow-up.|30|||
125274879|NCT02096952|450633451|FG000|Overall Study|Adverse Event|1|||
125274880|NCT00066222|450633452|FG000|Overall Study|No protocol treatment received|1|||
125274881|NCT02684617|450633453|FG000|Overall Study|Adverse Event|1|||
125274882|NCT02684617|450633454|FG001|Overall Study|Adverse Event|0|||
125274883|NCT02684617|450633455|FG002|Overall Study|Adverse Event|1|||
125274884|NCT02684617|450633453|FG000|Overall Study|Death|8|||
125274885|NCT02684617|450633454|FG001|Overall Study|Death|16|||
125274886|NCT02684617|450633455|FG002|Overall Study|Death|28|||
125274887|NCT02684617|450633453|FG000|Overall Study|Withdrawal by Subject|2|||
125274888|NCT02684617|450633454|FG001|Overall Study|Withdrawal by Subject|0|||
125274889|NCT02684617|450633455|FG002|Overall Study|Withdrawal by Subject|4|||
125274890|NCT02684617|450633453|FG000|Overall Study|Screen Failure|1|||
125274891|NCT02684617|450633454|FG001|Overall Study|Screen Failure|0|||
125274892|NCT02684617|450633455|FG002|Overall Study|Screen Failure|2|||
125274893|NCT02684617|450633453|FG000|Overall Study|Study Terminated by Sponsor|6|||
125274894|NCT02684617|450633454|FG001|Overall Study|Study Terminated by Sponsor|1|||
125274895|NCT02684617|450633455|FG002|Overall Study|Study Terminated by Sponsor|5|||
125274896|NCT00615719|450633466|FG000|Overall Study|Physician Decision|5|||
125274897|NCT02201329|450633467|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
125274898|NCT02201329|450633467|FG000|Overall Study|Withdrawal by Subject|2|||
125274899|NCT03629223|450633468|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
125274900|NCT03629223|450633469|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
125274901|NCT03629223|450633470|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
125274902|NCT03629223|450633471|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
125274903|NCT03629223|450633472|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
125274904|NCT03629223|450633473|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
125274905|NCT03629223|450633468|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
125274906|NCT03629223|450633469|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
125274907|NCT03629223|450633470|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
125274908|NCT03629223|450633471|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
125274909|NCT03629223|450633472|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
125274910|NCT03629223|450633473|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
125274911|NCT03629223|450633468|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
125274912|NCT03629223|450633469|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
125274913|NCT03629223|450633470|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
125274914|NCT03629223|450633471|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
125274915|NCT03629223|450633472|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
125274916|NCT03629223|450633473|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
125274917|NCT03629223|450633468|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
125274918|NCT03629223|450633469|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
125274919|NCT03629223|450633470|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
125274920|NCT03629223|450633471|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
125274921|NCT03629223|450633472|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
125274922|NCT03629223|450633473|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
125274923|NCT03629223|450633468|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
125274924|NCT03629223|450633469|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
125274925|NCT03629223|450633470|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
125274926|NCT03629223|450633471|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
125274927|NCT03629223|450633472|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
125274928|NCT03629223|450633473|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
125274929|NCT01534351|450633474|FG000|Overall Study|Study Terminated Early|1|||
125274930|NCT01534351|450633475|FG001|Overall Study|Study Terminated Early|0|||
125274931|NCT01534351|450633476|FG002|Overall Study|Study Terminated Early|0|||
125274932|NCT02702609|450633477|FG000|Overall Study|Lost to Follow-up|8|||
125274933|NCT02702609|450633478|FG001|Overall Study|Lost to Follow-up|4|||
125274934|NCT02702609|450633477|FG000|Overall Study|Physician Decision|1|||
125274935|NCT02702609|450633478|FG001|Overall Study|Physician Decision|0|||
125274936|NCT00690430|450633480|FG000|Core Phase|Abnormal Laboratory value|0|||
125274937|NCT00690430|450633481|FG001|Core Phase|Abnormal Laboratory value|1|||
125274938|NCT00690430|450633482|FG002|Core Phase|Abnormal Laboratory value|0|||
125274939|NCT00690430|450633480|FG000|Core Phase|Adverse Event|5|||
125274940|NCT00690430|450633481|FG001|Core Phase|Adverse Event|1|||
125274941|NCT00690430|450633482|FG002|Core Phase|Adverse Event|0|||
125274942|NCT00690430|450633480|FG000|Core Phase|Death|0|||
125274943|NCT00690430|450633481|FG001|Core Phase|Death|2|||
125274944|NCT00690430|450633482|FG002|Core Phase|Death|0|||
125274945|NCT00690430|450633480|FG000|Core Phase|Protocol Violation|1|||
125274946|NCT00690430|450633481|FG001|Core Phase|Protocol Violation|0|||
125274947|NCT00690430|450633482|FG002|Core Phase|Protocol Violation|0|||
125274948|NCT00690430|450633480|FG000|Core Phase|Withdrawal by Subject|3|||
125274949|NCT00690430|450633481|FG001|Core Phase|Withdrawal by Subject|3|||
125274950|NCT00690430|450633482|FG002|Core Phase|Withdrawal by Subject|0|||
125274951|NCT00690430|450633480|FG000|Core Phase|Subject no longer requires study drug|1|||
125274952|NCT00690430|450633481|FG001|Core Phase|Subject no longer requires study drug|0|||
125274953|NCT00690430|450633482|FG002|Core Phase|Subject no longer requires study drug|0|||
125274954|NCT00690430|450633480|FG000|Core Phase|Lack of Efficacy|8|||
125274955|NCT00690430|450633481|FG001|Core Phase|Lack of Efficacy|10|||
125274956|NCT00690430|450633482|FG002|Core Phase|Lack of Efficacy|0|||
125274957|NCT00690430|450633480|FG000|Core Phase|Administrative Problems|0|||
125274958|NCT00690430|450633481|FG001|Core Phase|Administrative Problems|1|||
125274959|NCT00690430|450633482|FG002|Core Phase|Administrative Problems|0|||
125274960|NCT00690430|450633480|FG000|Core Phase|Early Termination|0|||
125274961|NCT00690430|450633481|FG001|Core Phase|Early Termination|5|||
125274962|NCT00690430|450633482|FG002|Core Phase|Early Termination|0|||
125274963|NCT00690430|450633480|FG000|Extension Phase|Lack of Efficacy|3|||
125274964|NCT00690430|450633481|FG001|Extension Phase|Lack of Efficacy|1|||
125274965|NCT00690430|450633482|FG002|Extension Phase|Lack of Efficacy|4|||
125274966|NCT00690430|450633480|FG000|Extension Phase|Abnormal Lab Values|1|||
125274967|NCT00690430|450633481|FG001|Extension Phase|Abnormal Lab Values|0|||
125274968|NCT00690430|450633482|FG002|Extension Phase|Abnormal Lab Values|0|||
125274969|NCT00690430|450633480|FG000|Extension Phase|Abnormal test procedure results|1|||
125274970|NCT00690430|450633481|FG001|Extension Phase|Abnormal test procedure results|0|||
125274971|NCT00690430|450633482|FG002|Extension Phase|Abnormal test procedure results|0|||
125274972|NCT00690430|450633480|FG000|Extension Phase|Administrative Problems|0|||
125274973|NCT00690430|450633481|FG001|Extension Phase|Administrative Problems|1|||
125274974|NCT00690430|450633482|FG002|Extension Phase|Administrative Problems|1|||
125274975|NCT00690430|450633480|FG000|Extension Phase|Adverse Event|2|||
125274976|NCT00690430|450633481|FG001|Extension Phase|Adverse Event|1|||
125274977|NCT00690430|450633482|FG002|Extension Phase|Adverse Event|2|||
125274978|NCT00690430|450633480|FG000|Extension Phase|Death|1|||
125274979|NCT00690430|450633481|FG001|Extension Phase|Death|1|||
125274980|NCT00690430|450633482|FG002|Extension Phase|Death|1|||
125274981|NCT00690430|450633480|FG000|Extension Phase|Withdrawal by Subject|0|||
125274982|NCT00690430|450633481|FG001|Extension Phase|Withdrawal by Subject|0|||
125274983|NCT00690430|450633482|FG002|Extension Phase|Withdrawal by Subject|2|||
125274984|NCT00690430|450633480|FG000|Extension Phase|Early Termination|10|||
125274985|NCT00690430|450633481|FG001|Extension Phase|Early Termination|1|||
125274986|NCT00690430|450633482|FG002|Extension Phase|Early Termination|3|||
125274987|NCT02125838|450633485|FG000|Overall Study|Lost to Follow-up|4|||
125274988|NCT02125838|450633486|FG001|Overall Study|Lost to Follow-up|4|||
125274989|NCT00787839|450633487|FG000|Overall Study|Failure to have the OGTT was most common|404|||
125274990|NCT00335738|450633490|FG000|Overall Study|Physician Decision|6|||
125274991|NCT00335738|450633491|FG001|Overall Study|Physician Decision|0|||
125274992|NCT00335738|450633490|FG000|Overall Study|Withdrawal by Subject|2|||
125274993|NCT00335738|450633491|FG001|Overall Study|Withdrawal by Subject|0|||
125274994|NCT00335738|450633490|FG000|Overall Study|Ineligible|3|||
125274995|NCT00335738|450633491|FG001|Overall Study|Ineligible|4|||
125274996|NCT01970241|450633498|FG000|Overall Study|Withdrawal by Subject|2|||
125274997|NCT01970241|450633499|FG001|Overall Study|Withdrawal by Subject|0|||
125274998|NCT01970241|450633498|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
125274999|NCT01970241|450633499|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
125275000|NCT00992056|450633502|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
125275001|NCT00992056|450633503|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
125275002|NCT00992056|450633502|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
125275003|NCT00992056|450633503|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
125275004|NCT00958347|450633507|FG000|Overall Study|Death|43|||
125275005|NCT00958347|450633507|FG000|Overall Study|Withdrawal by Subject|23|||
125275006|NCT00958347|450633507|FG000|Overall Study|Lost to Follow-up|15|||
125275007|NCT00958347|450633507|FG000|Overall Study|revision/removal|10|||
125275008|NCT00958347|450633507|FG000|Overall Study|study termination|135|||
125275009|NCT00375505|450633512|FG000|Overall Study|Adverse Event|1|||
125275010|NCT00375505|450633513|FG001|Overall Study|Adverse Event|2|||
125275011|NCT02146131|450633514|FG000|Overall Study|Physician Decision|61|||
125275012|NCT02146131|450633515|FG001|Overall Study|Physician Decision|56|||
125275013|NCT02567799|450633516|FG000|Concurrent Chemoradiotherapy|Death|1|||
125275014|NCT02567799|450633517|FG001|Concurrent Chemoradiotherapy|Death|0|||
125275015|NCT02567799|450633518|FG002|Concurrent Chemoradiotherapy|Death|0|||
125275016|NCT02567799|450633516|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
125275017|NCT02567799|450633517|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
125275018|NCT02567799|450633518|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
125275019|NCT02567799|450633516|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
125275020|NCT02567799|450633517|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
125275021|NCT02567799|450633518|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
125275022|NCT02567799|450633516|FG000|Follow-up|Death|1|||
125275023|NCT02567799|450633517|FG001|Follow-up|Death|0|||
125275024|NCT02567799|450633518|FG002|Follow-up|Death|1|||
125275025|NCT02567799|450633516|FG000|Follow-up|Progressive Disease|1|||
125275026|NCT02567799|450633517|FG001|Follow-up|Progressive Disease|1|||
125275027|NCT02567799|450633518|FG002|Follow-up|Progressive Disease|3|||
125275028|NCT00349349|450633520|FG000|Overall Study|Adverse Event|5|||
125275029|NCT00349349|450633521|FG001|Overall Study|Adverse Event|6|||
125275030|NCT00349349|450633522|FG002|Overall Study|Adverse Event|2|||
125275031|NCT00349349|450633520|FG000|Overall Study|Withdrawal by Subject|5|||
125275032|NCT00349349|450633521|FG001|Overall Study|Withdrawal by Subject|2|||
125275033|NCT00349349|450633522|FG002|Overall Study|Withdrawal by Subject|1|||
125275034|NCT00349349|450633520|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
125275035|NCT00349349|450633521|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
125275036|NCT00349349|450633522|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
125275037|NCT00349349|450633520|FG000|Overall Study|Death|13|||
125275038|NCT00349349|450633521|FG001|Overall Study|Death|10|||
125275039|NCT00349349|450633522|FG002|Overall Study|Death|1|||
125275040|NCT00349349|450633520|FG000|Overall Study|Other Treatment Selected|2|||
125275041|NCT00349349|450633521|FG001|Overall Study|Other Treatment Selected|0|||
125275042|NCT00349349|450633522|FG002|Overall Study|Other Treatment Selected|0|||
125275043|NCT00349349|450633520|FG000|Overall Study|Participant Reduced General Condition|0|||
125275044|NCT00349349|450633521|FG001|Overall Study|Participant Reduced General Condition|1|||
125275045|NCT00349349|450633522|FG002|Overall Study|Participant Reduced General Condition|0|||
125275046|NCT00349349|450633520|FG000|Overall Study|Physician Decision|1|||
125275047|NCT00349349|450633521|FG001|Overall Study|Physician Decision|2|||
125275048|NCT00349349|450633522|FG002|Overall Study|Physician Decision|1|||
125275049|NCT00349349|450633520|FG000|Overall Study|No Response|0|||
125275050|NCT00349349|450633521|FG001|Overall Study|No Response|3|||
125275051|NCT00349349|450633522|FG002|Overall Study|No Response|0|||
125275052|NCT00349349|450633520|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
125275053|NCT00349349|450633521|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
125275054|NCT00349349|450633522|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
125275055|NCT00861692|450633524|FG000|Overall Study|Death|6|||
125275056|NCT05111002|450633527|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
125275057|NCT05111002|450633528|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
125275058|NCT05111002|450633527|FG000|Secondary Outcome|Lost to Follow-up|1|||
125275059|NCT05111002|450633528|FG001|Secondary Outcome|Lost to Follow-up|0|||
125275060|NCT04380753|450633529|FG000|Overall Study|Participants continuing study|4|||
125275061|NCT04380753|450633529|FG000|Overall Study|Death|2|||
125275062|NCT00972517|450633532|FG000|Overall Study|Adverse Event|0|||
125275063|NCT00972517|450633533|FG001|Overall Study|Adverse Event|0|||
125275064|NCT00972517|450633534|FG002|Overall Study|Adverse Event|0|||
125275065|NCT00972517|450633535|FG003|Overall Study|Adverse Event|1|||
125275066|NCT00972517|450633536|FG004|Overall Study|Adverse Event|0|||
125275067|NCT00972517|450633537|FG005|Overall Study|Adverse Event|0|||
125275068|NCT00972517|450633532|FG000|Overall Study|Withdrawal by Subject|0|||
125275069|NCT00972517|450633533|FG001|Overall Study|Withdrawal by Subject|1|||
125275070|NCT00972517|450633534|FG002|Overall Study|Withdrawal by Subject|0|||
125275071|NCT00972517|450633535|FG003|Overall Study|Withdrawal by Subject|2|||
125275072|NCT00972517|450633536|FG004|Overall Study|Withdrawal by Subject|1|||
125275073|NCT00972517|450633537|FG005|Overall Study|Withdrawal by Subject|0|||
125275074|NCT00851890|450633538|FG000|Overall Study|Lost to Follow-up|0|||
125275075|NCT00851890|450633539|FG001|Overall Study|Lost to Follow-up|1|||
125275076|NCT00851890|450633540|FG002|Overall Study|Lost to Follow-up|0|||
125275077|NCT00851890|450633541|FG003|Overall Study|Lost to Follow-up|1|||
125275078|NCT03135431|450633542|FG000|Overall Study|Study Surgeon not available|2|||
125275079|NCT03135431|450633543|FG001|Overall Study|Study Surgeon not available|0|||
125275080|NCT02709577|450633544|FG000|Overall Study|non-accommodating anatomy|0|||
125275081|NCT02709577|450633545|FG001|Overall Study|non-accommodating anatomy|1|||
125275082|NCT02709577|450633546|FG002|Overall Study|non-accommodating anatomy|0|||
125275083|NCT02709577|450633547|FG003|Overall Study|non-accommodating anatomy|0|||
125275084|NCT02709577|450633544|FG000|Overall Study|procedural complication|0|||
125275085|NCT02709577|450633545|FG001|Overall Study|procedural complication|1|||
125275086|NCT02709577|450633546|FG002|Overall Study|procedural complication|0|||
125275087|NCT02709577|450633547|FG003|Overall Study|procedural complication|0|||
125275088|NCT02709577|450633544|FG000|Overall Study|Withdrawal by Subject|2|||
125275089|NCT02709577|450633545|FG001|Overall Study|Withdrawal by Subject|3|||
125275090|NCT02709577|450633546|FG002|Overall Study|Withdrawal by Subject|2|||
125275091|NCT02709577|450633547|FG003|Overall Study|Withdrawal by Subject|0|||
125275092|NCT00375674|450633548|FG000|Overall Study|Other|26|||
125275093|NCT00375674|450633549|FG001|Overall Study|Other|18|||
125275094|NCT00375674|450633548|FG000|Overall Study|Death|67|||
125275095|NCT00375674|450633549|FG001|Overall Study|Death|76|||
125275096|NCT00375674|450633548|FG000|Overall Study|Participants refused further follow-up|31|||
125275097|NCT00375674|450633549|FG001|Overall Study|Participants refused further follow-up|30|||
125275098|NCT00375674|450633548|FG000|Overall Study|Lost to Follow-up|17|||
125275099|NCT00375674|450633549|FG001|Overall Study|Lost to Follow-up|15|||
125275100|NCT00375674|450633548|FG000|Overall Study|Enrolled but not treated|3|||
125275101|NCT00375674|450633549|FG001|Overall Study|Enrolled but not treated|2|||
125275102|NCT03744910|450636030|FG000|Overall Study|Withdrew Consent|1|||
125275103|NCT03744910|450636031|FG001|Overall Study|Withdrew Consent|8|||
125275104|NCT03744910|450636030|FG000|Overall Study|Physician Decision|5|||
125275105|NCT03744910|450636031|FG001|Overall Study|Physician Decision|4|||
125275106|NCT03744910|450636030|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
125275107|NCT03744910|450636031|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
125275108|NCT03744910|450636030|FG000|Overall Study|Lost to Follow-up|0|||
125275109|NCT03744910|450636031|FG001|Overall Study|Lost to Follow-up|1|||
125275110|NCT03744910|450636030|FG000|Overall Study|Other-unspecified|4|||
125275111|NCT03744910|450636031|FG001|Overall Study|Other-unspecified|1|||
125275112|NCT00064259|450636032|FG000|Overall Study|Adverse Event|1|||
125275113|NCT00064259|450636033|FG001|Overall Study|Adverse Event|0|||
125275114|NCT00064259|450636034|FG002|Overall Study|Adverse Event|0|||
125275115|NCT00064259|450636035|FG003|Overall Study|Adverse Event|1|||
125275116|NCT01132651|450636038|FG000|Overall Study|Lost to Follow-up|1|||
125275117|NCT01132651|450636039|FG001|Overall Study|Lost to Follow-up|1|||
125275118|NCT00948857|450636040|FG000|Overall Study|Lost to Follow-up|1|||
125275119|NCT00948857|450636041|FG001|Overall Study|Lost to Follow-up|0|||
125275120|NCT03430843|450636044|FG000|Overall Study|Death|233|||
125275121|NCT03430843|450636045|FG001|Overall Study|Death|233|||
125275122|NCT03430843|450636044|FG000|Overall Study|Sponsor Decision|17|||
125275123|NCT03430843|450636045|FG001|Overall Study|Sponsor Decision|6|||
125275124|NCT03430843|450636044|FG000|Overall Study|Withdrawal by Subject|5|||
125275125|NCT03430843|450636045|FG001|Overall Study|Withdrawal by Subject|14|||
125275126|NCT03430843|450636044|FG000|Overall Study|Lost to Follow-up|1|||
125275127|NCT03430843|450636045|FG001|Overall Study|Lost to Follow-up|3|||
125275128|NCT00590122|450636054|FG000|Overall Study|swallowed oral dissolving dose|1|||
125275129|NCT00590122|450636055|FG001|Overall Study|swallowed oral dissolving dose|0|||
125275130|NCT03050450|450636056|FG000|Overall Study|Physician Decision|1|||
125275131|NCT03050450|450636057|FG001|Overall Study|Physician Decision|0|||
125275132|NCT03050450|450636058|FG002|Overall Study|Physician Decision|0|||
125275133|NCT03050450|450636059|FG003|Overall Study|Physician Decision|0|||
125275134|NCT03050450|450636060|FG004|Overall Study|Physician Decision|0|||
125275135|NCT00711594|450636061|FG000|Overall Study|Progressive disease|2|||
125275136|NCT00711594|450636062|FG001|Overall Study|Progressive disease|2|||
125275137|NCT00711594|450636063|FG002|Overall Study|Progressive disease|6|||
125275138|NCT00711594|450636064|FG003|Overall Study|Progressive disease|44|||
125275139|NCT00711594|450636061|FG000|Overall Study|Other Adverse Event|1|||
125275140|NCT00711594|450636062|FG001|Overall Study|Other Adverse Event|0|||
125275141|NCT00711594|450636063|FG002|Overall Study|Other Adverse Event|0|||
125275142|NCT00711594|450636064|FG003|Overall Study|Other Adverse Event|16|||
125275143|NCT00711594|450636061|FG000|Overall Study|Withdrawal by Subject|0|||
125275144|NCT00711594|450636062|FG001|Overall Study|Withdrawal by Subject|1|||
125275145|NCT00711594|450636063|FG002|Overall Study|Withdrawal by Subject|0|||
125275146|NCT00711594|450636064|FG003|Overall Study|Withdrawal by Subject|2|||
125275147|NCT00443872|450636065|FG000|Overall Study|Protocol Violation|7|||
125275148|NCT00443872|450636065|FG000|Overall Study|Lost to Follow-up|2|||
125275149|NCT00443872|450636065|FG000|Overall Study|Adverse Event|8|||
125275150|NCT00135330|450636066|FG000|Overall Study|Adverse Event|2|||
125275151|NCT00135330|450636067|FG001|Overall Study|Adverse Event|5|||
125275152|NCT00135330|450636068|FG002|Overall Study|Adverse Event|1|||
125275153|NCT00135330|450636066|FG000|Overall Study|Lost to Follow-up|0|||
125275154|NCT00135330|450636067|FG001|Overall Study|Lost to Follow-up|2|||
125275155|NCT00135330|450636068|FG002|Overall Study|Lost to Follow-up|3|||
125275156|NCT00135330|450636066|FG000|Overall Study|Physician Decision|1|||
125275157|NCT00135330|450636067|FG001|Overall Study|Physician Decision|1|||
125275158|NCT00135330|450636068|FG002|Overall Study|Physician Decision|0|||
125275159|NCT00135330|450636066|FG000|Overall Study|Protocol Violation|4|||
125275160|NCT00135330|450636067|FG001|Overall Study|Protocol Violation|3|||
125275161|NCT00135330|450636068|FG002|Overall Study|Protocol Violation|3|||
125275162|NCT00135330|450636066|FG000|Overall Study|Patient Decision|5|||
125275163|NCT00135330|450636067|FG001|Overall Study|Patient Decision|1|||
125275164|NCT00135330|450636068|FG002|Overall Study|Patient Decision|4|||
125275165|NCT00135330|450636066|FG000|Overall Study|Sponsor Decision|0|||
125275166|NCT00135330|450636067|FG001|Overall Study|Sponsor Decision|1|||
125275167|NCT00135330|450636068|FG002|Overall Study|Sponsor Decision|0|||
125275168|NCT00104416|450636072|FG000|Double-Blind Phase|Adverse Event|2|||
125275169|NCT00104416|450636073|FG001|Double-Blind Phase|Adverse Event|1|||
125275170|NCT00104416|450636074|FG002|Double-Blind Phase|Adverse Event|0|||
125275171|NCT00104416|450636075|FG003|Double-Blind Phase|Adverse Event|0|||
125275172|NCT00104416|450636076|FG004|Double-Blind Phase|Adverse Event|0|||
125275173|NCT00104416|450636072|FG000|Double-Blind Phase|Lost to Follow-up|0|||
125275174|NCT00104416|450636073|FG001|Double-Blind Phase|Lost to Follow-up|1|||
125275175|NCT00104416|450636074|FG002|Double-Blind Phase|Lost to Follow-up|0|||
125275176|NCT00104416|450636075|FG003|Double-Blind Phase|Lost to Follow-up|0|||
125275177|NCT00104416|450636076|FG004|Double-Blind Phase|Lost to Follow-up|0|||
125275178|NCT00104416|450636072|FG000|Double-Blind Phase|Protocol Violation|0|||
125275179|NCT00104416|450636073|FG001|Double-Blind Phase|Protocol Violation|1|||
125275180|NCT00104416|450636074|FG002|Double-Blind Phase|Protocol Violation|0|||
125275181|NCT00104416|450636075|FG003|Double-Blind Phase|Protocol Violation|0|||
125275182|NCT00104416|450636076|FG004|Double-Blind Phase|Protocol Violation|0|||
125275183|NCT00104416|450636072|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
125275184|NCT00104416|450636073|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
125275185|NCT00104416|450636074|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
125275186|NCT00104416|450636075|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
125275187|NCT00104416|450636076|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
125275188|NCT00104416|450636072|FG000|Double-Blind Phase|Pregnancy|1|||
125275189|NCT00104416|450636073|FG001|Double-Blind Phase|Pregnancy|0|||
125275190|NCT00104416|450636074|FG002|Double-Blind Phase|Pregnancy|0|||
125275191|NCT00104416|450636075|FG003|Double-Blind Phase|Pregnancy|0|||
125275192|NCT00104416|450636076|FG004|Double-Blind Phase|Pregnancy|0|||
125275193|NCT00104416|450636072|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
125275194|NCT00104416|450636073|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
125275195|NCT00104416|450636074|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
125275196|NCT00104416|450636075|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
125275197|NCT00104416|450636076|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
125275198|NCT00104416|450636072|FG000|Continuation Phase|Adverse Event|0|||
125275199|NCT00104416|450636073|FG001|Continuation Phase|Adverse Event|0|||
125275200|NCT00104416|450636074|FG002|Continuation Phase|Adverse Event|2|||
125275201|NCT00104416|450636075|FG003|Continuation Phase|Adverse Event|0|||
125275202|NCT00104416|450636076|FG004|Continuation Phase|Adverse Event|2|||
125275203|NCT00104416|450636072|FG000|Continuation Phase|Lost to Follow-up|0|||
125275204|NCT00104416|450636073|FG001|Continuation Phase|Lost to Follow-up|0|||
125275205|NCT00104416|450636074|FG002|Continuation Phase|Lost to Follow-up|1|||
125275206|NCT00104416|450636075|FG003|Continuation Phase|Lost to Follow-up|0|||
125275207|NCT00104416|450636076|FG004|Continuation Phase|Lost to Follow-up|1|||
125275208|NCT00104416|450636072|FG000|Continuation Phase|Withdrawal by Subject|0|||
125275209|NCT00104416|450636073|FG001|Continuation Phase|Withdrawal by Subject|0|||
125275210|NCT00104416|450636074|FG002|Continuation Phase|Withdrawal by Subject|2|||
125275211|NCT00104416|450636075|FG003|Continuation Phase|Withdrawal by Subject|1|||
125275212|NCT00104416|450636076|FG004|Continuation Phase|Withdrawal by Subject|1|||
125275213|NCT00104416|450636072|FG000|Continuation Phase|Pregnancy|0|||
125275214|NCT00104416|450636073|FG001|Continuation Phase|Pregnancy|0|||
125275215|NCT00104416|450636074|FG002|Continuation Phase|Pregnancy|1|||
125275216|NCT00104416|450636075|FG003|Continuation Phase|Pregnancy|1|||
125275217|NCT00104416|450636076|FG004|Continuation Phase|Pregnancy|0|||
125275218|NCT00104416|450636072|FG000|Continuation Phase|Non-compliance|0|||
125275219|NCT00104416|450636073|FG001|Continuation Phase|Non-compliance|0|||
125275220|NCT00104416|450636074|FG002|Continuation Phase|Non-compliance|0|||
125275221|NCT00104416|450636075|FG003|Continuation Phase|Non-compliance|0|||
125275222|NCT00104416|450636076|FG004|Continuation Phase|Non-compliance|1|||
125275223|NCT01309997|450636077|FG000|Overall Study|Adverse Event|1|||
125275224|NCT01309997|450636078|FG001|Overall Study|Adverse Event|0|||
125275225|NCT01309997|450636077|FG000|Overall Study|Death|1|||
125275226|NCT01309997|450636078|FG001|Overall Study|Death|3|||
125275227|NCT01309997|450636077|FG000|Overall Study|Lack of Efficacy|2|||
125275228|NCT01309997|450636078|FG001|Overall Study|Lack of Efficacy|2|||
125275229|NCT01309997|450636077|FG000|Overall Study|Withdrawal by Subject|1|||
125275230|NCT01309997|450636078|FG001|Overall Study|Withdrawal by Subject|1|||
125275231|NCT03462641|450636079|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
125275232|NCT03462641|450636080|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
125275233|NCT03462641|450636079|FG000|Visit 2|Withdrawal by Subject|0|||
125275234|NCT03462641|450636080|FG001|Visit 2|Withdrawal by Subject|1|||
125275235|NCT00372619|450636081|FG000|Overall Study|Ineligible|0|||
125275236|NCT00372619|450636082|FG001|Overall Study|Ineligible|0|||
125275237|NCT00372619|450636083|FG002|Overall Study|Ineligible|0|||
125275238|NCT00372619|450636084|FG003|Overall Study|Ineligible|0|||
125275239|NCT00372619|450636085|FG004|Overall Study|Ineligible|0|||
125275240|NCT00372619|450636086|FG005|Overall Study|Ineligible|2|||
125275241|NCT00372619|450636087|FG006|Overall Study|Ineligible|0|||
125275242|NCT00372619|450636081|FG000|Overall Study|Inevaluable|0|||
125275243|NCT00372619|450636082|FG001|Overall Study|Inevaluable|0|||
125275244|NCT00372619|450636083|FG002|Overall Study|Inevaluable|0|||
125275245|NCT00372619|450636084|FG003|Overall Study|Inevaluable|0|||
125275246|NCT00372619|450636085|FG004|Overall Study|Inevaluable|0|||
125275247|NCT00372619|450636086|FG005|Overall Study|Inevaluable|1|||
125275248|NCT00372619|450636087|FG006|Overall Study|Inevaluable|0|||
125275249|NCT03748706|450636092|FG000|Overall Study|Lost to Follow-up|1|||
125275250|NCT03517371|450636095|FG000|Overall Study|Adverse Event|8|||
125275251|NCT03517371|450636096|FG001|Overall Study|Adverse Event|9|||
125275252|NCT03517371|450636095|FG000|Overall Study|Lost to Follow-up|1|||
125275253|NCT03517371|450636096|FG001|Overall Study|Lost to Follow-up|2|||
125275254|NCT03517371|450636095|FG000|Overall Study|Withdrawal by Subject|4|||
125275255|NCT03517371|450636096|FG001|Overall Study|Withdrawal by Subject|4|||
125275256|NCT03517371|450636095|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
125275257|NCT03517371|450636096|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
125275258|NCT03517371|450636095|FG000|Overall Study|COVID restrictions|2|||
125275259|NCT03517371|450636096|FG001|Overall Study|COVID restrictions|0|||
125275260|NCT03517371|450636095|FG000|Overall Study|Receiving DBS Surgery|0|||
125275261|NCT03517371|450636096|FG001|Overall Study|Receiving DBS Surgery|1|||
125275262|NCT05420961|450636097|FG000|Overall Study|Withdrawal by Subject|2|||
125275263|NCT05420961|450636098|FG001|Overall Study|Withdrawal by Subject|1|||
125275264|NCT05420961|450636099|FG002|Overall Study|Withdrawal by Subject|1|||
125275265|NCT05420961|450636100|FG003|Overall Study|Withdrawal by Subject|0|||
125275266|NCT05420961|450636101|FG004|Overall Study|Withdrawal by Subject|0|||
125275267|NCT05420961|450636097|FG000|Overall Study|Lost to Follow-up|0|||
125275268|NCT05420961|450636098|FG001|Overall Study|Lost to Follow-up|0|||
125275269|NCT05420961|450636099|FG002|Overall Study|Lost to Follow-up|1|||
125275270|NCT05420961|450636100|FG003|Overall Study|Lost to Follow-up|0|||
125275271|NCT05420961|450636101|FG004|Overall Study|Lost to Follow-up|0|||
125275272|NCT05420961|450636097|FG000|Overall Study|Randomized by mistake without study treatment|0|||
125275273|NCT05420961|450636098|FG001|Overall Study|Randomized by mistake without study treatment|0|||
125275274|NCT05420961|450636099|FG002|Overall Study|Randomized by mistake without study treatment|1|||
125275275|NCT05420961|450636100|FG003|Overall Study|Randomized by mistake without study treatment|0|||
125275276|NCT05420961|450636101|FG004|Overall Study|Randomized by mistake without study treatment|1|||
125275277|NCT04283656|450636102|FG000|Overall Study|Adverse Event|1|||
125275278|NCT04283656|450636103|FG001|Overall Study|Adverse Event|0|||
125275279|NCT04283656|450636102|FG000|Overall Study|Lost to Follow-up|0|||
125275280|NCT04283656|450636103|FG001|Overall Study|Lost to Follow-up|1|||
125275281|NCT04482439|450636108|FG000|Overall Study|Lost to Follow-up|1|||
125275282|NCT04482439|450636108|FG000|Overall Study|Unrelated illness|1|||
125275283|NCT02318368|450636109|FG000|Overall Study|Withdrawal by Subject|2|||
125275284|NCT02318368|450636110|FG001|Overall Study|Withdrawal by Subject|0|||
125275285|NCT02318368|450636109|FG000|Overall Study|Study terminated by the sponsor|5|||
125275286|NCT02318368|450636110|FG001|Overall Study|Study terminated by the sponsor|2|||
125275287|NCT02318368|450636109|FG000|Overall Study|Death|0|||
125275288|NCT02318368|450636110|FG001|Overall Study|Death|1|||
125275289|NCT01555073|450636111|FG000|Overall Study|Lost to Follow-up|1|||
125275290|NCT01555073|450636112|FG001|Overall Study|Lost to Follow-up|2|||
125275291|NCT01555073|450636113|FG002|Overall Study|Lost to Follow-up|0|||
125275292|NCT01555073|450636114|FG003|Overall Study|Lost to Follow-up|5|||
125275293|NCT04660552|450636115|FG000|Overall Study|Withdrawal by Subject|3|||
125275294|NCT04660552|450636116|FG001|Overall Study|Withdrawal by Subject|1|||
125275295|NCT03490292|450636117|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
125275296|NCT03490292|450636118|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
125275297|NCT03490292|450636117|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
125275298|NCT03490292|450636118|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
125275299|NCT03490292|450636117|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
125275300|NCT03490292|450636118|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
125275301|NCT03490292|450636117|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
125275302|NCT03490292|450636118|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
125275303|NCT03490292|450636117|FG000|1 Year Follow Up Post Last Dose|Death|1|||
125275304|NCT03490292|450636118|FG001|1 Year Follow Up Post Last Dose|Death|1|||
125275305|NCT02565147|450636119|FG000|Overall Study|Withdrawal by Subject|5|||
125275306|NCT02565147|450636120|FG001|Overall Study|Withdrawal by Subject|1|||
125275307|NCT02565147|450636119|FG000|Overall Study|Lost to Follow-up|0|||
125275308|NCT02565147|450636120|FG001|Overall Study|Lost to Follow-up|1|||
125275309|NCT02565147|450636119|FG000|Overall Study|Death|1|||
125275310|NCT02565147|450636120|FG001|Overall Study|Death|1|||
125275311|NCT01001767|450636123|FG000|Overall Study|no baseline study performed|1|||
125275312|NCT01001767|450636124|FG001|Overall Study|no baseline study performed|0|||
125275313|NCT01001767|450636123|FG000|Overall Study|Protocol Violation|1|||
125275314|NCT01001767|450636124|FG001|Overall Study|Protocol Violation|0|||
125275315|NCT01001767|450636123|FG000|Overall Study|Lost to Follow-up|1|||
125275316|NCT01001767|450636124|FG001|Overall Study|Lost to Follow-up|0|||
125275317|NCT01001767|450636123|FG000|Overall Study|Physician Decision|1|||
125275318|NCT01001767|450636124|FG001|Overall Study|Physician Decision|0|||
125275319|NCT03098433|450636125|FG000|Overall Study|Withdrawal by Subject|10|||
125275320|NCT01667133|450636127|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
125275321|NCT01667133|450636128|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
125275322|NCT01667133|450636129|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
125275323|NCT01667133|450636130|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
125275324|NCT01667133|450636131|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
125275325|NCT01667133|450636132|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
125275326|NCT01667133|450636133|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
125275327|NCT01667133|450636134|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
125275328|NCT01667133|450636135|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
125275329|NCT01667133|450636136|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
125275330|NCT01667133|450636137|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
125275331|NCT01667133|450636138|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
125275332|NCT01667133|450636127|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275333|NCT01667133|450636128|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275334|NCT01667133|450636129|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
125275335|NCT01667133|450636130|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275336|NCT01667133|450636131|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275337|NCT01667133|450636132|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275338|NCT01667133|450636133|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275339|NCT01667133|450636134|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275340|NCT01667133|450636135|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275341|NCT01667133|450636136|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275342|NCT01667133|450636137|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275343|NCT01667133|450636138|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275344|NCT01667133|450636127|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
125275345|NCT01667133|450636128|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
125275346|NCT01667133|450636129|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
125275347|NCT01667133|450636130|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
125275348|NCT01667133|450636131|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
125275349|NCT01667133|450636132|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
125275350|NCT01667133|450636133|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
125275351|NCT01667133|450636134|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
125275352|NCT01667133|450636135|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
125275353|NCT01667133|450636136|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
125275354|NCT01667133|450636137|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
125275355|NCT01667133|450636138|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
125275356|NCT01667133|450636127|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275357|NCT01667133|450636128|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275358|NCT01667133|450636129|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275359|NCT01667133|450636130|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
125275360|NCT01667133|450636131|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275361|NCT01667133|450636132|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275362|NCT01667133|450636133|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275363|NCT01667133|450636134|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275364|NCT01667133|450636135|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275365|NCT01667133|450636136|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275366|NCT01667133|450636137|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275367|NCT01667133|450636138|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275368|NCT01667133|450636127|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
125275369|NCT01667133|450636128|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
125275370|NCT01667133|450636129|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
125275371|NCT01667133|450636130|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
125275372|NCT01667133|450636131|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
125275373|NCT01667133|450636132|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
125275374|NCT01667133|450636133|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
125275375|NCT01667133|450636134|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
125275376|NCT01667133|450636135|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
125275377|NCT01667133|450636136|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
125275378|NCT01667133|450636137|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
125275379|NCT01667133|450636138|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
125275380|NCT01667133|450636127|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125275381|NCT01667133|450636128|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125275382|NCT01667133|450636129|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125275383|NCT01667133|450636130|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125275384|NCT01667133|450636131|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125275385|NCT01667133|450636132|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125275386|NCT01667133|450636133|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125275387|NCT01667133|450636134|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125275388|NCT01667133|450636135|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125275389|NCT01667133|450636136|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
125275390|NCT01667133|450636137|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125275391|NCT01667133|450636138|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125275392|NCT01667133|450636127|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
125275393|NCT01667133|450636128|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
125275394|NCT01667133|450636129|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
125275395|NCT01667133|450636130|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
125275396|NCT01667133|450636131|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
125275397|NCT01667133|450636132|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
125275398|NCT01667133|450636133|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
125275399|NCT01667133|450636134|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
125275400|NCT01667133|450636135|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
125275401|NCT01667133|450636136|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
125275402|NCT01667133|450636137|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
125275403|NCT01667133|450636138|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
125275404|NCT01667133|450636127|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275405|NCT01667133|450636128|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275406|NCT01667133|450636129|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275407|NCT01667133|450636130|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275408|NCT01667133|450636131|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275409|NCT01667133|450636132|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275410|NCT01667133|450636133|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275411|NCT01667133|450636134|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275412|NCT01667133|450636135|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275413|NCT01667133|450636136|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
125275414|NCT01667133|450636137|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275415|NCT01667133|450636138|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275416|NCT01667133|450636127|FG000|Phase 2: Dose-expansion|Death|0|||
125275417|NCT01667133|450636128|FG001|Phase 2: Dose-expansion|Death|0|||
125275418|NCT01667133|450636129|FG002|Phase 2: Dose-expansion|Death|0|||
125275419|NCT01667133|450636130|FG003|Phase 2: Dose-expansion|Death|0|||
125275420|NCT01667133|450636131|FG004|Phase 2: Dose-expansion|Death|0|||
125275421|NCT01667133|450636132|FG005|Phase 2: Dose-expansion|Death|0|||
125275422|NCT01667133|450636133|FG006|Phase 2: Dose-expansion|Death|0|||
125275423|NCT01667133|450636134|FG007|Phase 2: Dose-expansion|Death|0|||
125275424|NCT01667133|450636135|FG008|Phase 2: Dose-expansion|Death|0|||
125275425|NCT01667133|450636136|FG009|Phase 2: Dose-expansion|Death|1|||
125275426|NCT01667133|450636137|FG010|Phase 2: Dose-expansion|Death|0|||
125275427|NCT01667133|450636138|FG011|Phase 2: Dose-expansion|Death|0|||
125275428|NCT01667133|450636127|FG000|Phase 2: Dose-expansion|Other|0|||
125275429|NCT01667133|450636128|FG001|Phase 2: Dose-expansion|Other|0|||
125275430|NCT01667133|450636129|FG002|Phase 2: Dose-expansion|Other|0|||
125275431|NCT01667133|450636130|FG003|Phase 2: Dose-expansion|Other|0|||
125275432|NCT01667133|450636131|FG004|Phase 2: Dose-expansion|Other|0|||
125275433|NCT01667133|450636132|FG005|Phase 2: Dose-expansion|Other|0|||
125275434|NCT01667133|450636133|FG006|Phase 2: Dose-expansion|Other|0|||
125275435|NCT01667133|450636134|FG007|Phase 2: Dose-expansion|Other|0|||
125275436|NCT01667133|450636135|FG008|Phase 2: Dose-expansion|Other|0|||
125275437|NCT01667133|450636136|FG009|Phase 2: Dose-expansion|Other|0|||
125275438|NCT01667133|450636137|FG010|Phase 2: Dose-expansion|Other|0|||
125275439|NCT01667133|450636138|FG011|Phase 2: Dose-expansion|Other|1|||
125275440|NCT01104545|450636141|FG000|Overall Study|Adverse Event|0|||
125275441|NCT01104545|450636142|FG001|Overall Study|Adverse Event|1|||
125275442|NCT01104545|450636143|FG002|Overall Study|Adverse Event|2|||
125275443|NCT02676895|450636145|FG000|Overall Study|Administrative reason|1|||
125275444|NCT02676895|450636146|FG001|Overall Study|Administrative reason|0|||
125275445|NCT02676895|450636147|FG002|Overall Study|Administrative reason|0|||
125275446|NCT02676895|450636145|FG000|Overall Study|Protocol Violation|1|||
125275447|NCT02676895|450636146|FG001|Overall Study|Protocol Violation|0|||
125275448|NCT02676895|450636147|FG002|Overall Study|Protocol Violation|0|||
125275449|NCT02676895|450636145|FG000|Overall Study|Adverse Event|0|||
125275450|NCT02676895|450636146|FG001|Overall Study|Adverse Event|3|||
125275451|NCT02676895|450636147|FG002|Overall Study|Adverse Event|1|||
125275452|NCT02676895|450636145|FG000|Overall Study|Lost to Follow-up|0|||
125275453|NCT02676895|450636146|FG001|Overall Study|Lost to Follow-up|0|||
125275454|NCT02676895|450636147|FG002|Overall Study|Lost to Follow-up|1|||
125275455|NCT02676895|450636145|FG000|Overall Study|Withdrawal by Subject|0|||
125275456|NCT02676895|450636146|FG001|Overall Study|Withdrawal by Subject|0|||
125275457|NCT02676895|450636147|FG002|Overall Study|Withdrawal by Subject|1|||
125275458|NCT00289289|450636148|FG000|Overall Study|Withdrawal by Subject|5|||
125275459|NCT00289289|450636149|FG001|Overall Study|Withdrawal by Subject|3|||
125275460|NCT00289289|450636150|FG002|Overall Study|Withdrawal by Subject|15|||
125275461|NCT00289289|450636148|FG000|Overall Study|Lost to Follow-up|1|||
125275462|NCT00289289|450636149|FG001|Overall Study|Lost to Follow-up|0|||
125275463|NCT00289289|450636150|FG002|Overall Study|Lost to Follow-up|1|||
125275464|NCT00289289|450636148|FG000|Overall Study|Death|4|||
125275465|NCT00289289|450636149|FG001|Overall Study|Death|2|||
125275466|NCT00289289|450636150|FG002|Overall Study|Death|5|||
125275467|NCT00289289|450636148|FG000|Overall Study|No implant attempted|0|||
125275468|NCT00289289|450636149|FG001|Overall Study|No implant attempted|0|||
125275469|NCT00289289|450636150|FG002|Overall Study|No implant attempted|1|||
125275470|NCT00289289|450636148|FG000|Overall Study|Physician Decision|1|||
125275471|NCT00289289|450636149|FG001|Overall Study|Physician Decision|0|||
125275472|NCT00289289|450636150|FG002|Overall Study|Physician Decision|6|||
125275473|NCT00289289|450636148|FG000|Overall Study|Non-study device implanted|2|||
125275474|NCT00289289|450636149|FG001|Overall Study|Non-study device implanted|1|||
125275475|NCT00289289|450636150|FG002|Overall Study|Non-study device implanted|3|||
125275476|NCT00289289|450636148|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
125275477|NCT00289289|450636149|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
125275478|NCT00289289|450636150|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
125275479|NCT00289289|450636148|FG000|Overall Study|Other Exit Reason|6|||
125275480|NCT00289289|450636149|FG001|Overall Study|Other Exit Reason|4|||
125275481|NCT00289289|450636150|FG002|Overall Study|Other Exit Reason|12|||
125275482|NCT03028129|450636158|FG000|Overall Study|Adverse Event|13|||
125275483|NCT03028129|450636159|FG001|Overall Study|Adverse Event|2|||
125275484|NCT03028129|450636158|FG000|Overall Study|Lost to Follow-up|50|||
125275485|NCT03028129|450636159|FG001|Overall Study|Lost to Follow-up|38|||
125275486|NCT03028129|450636158|FG000|Overall Study|Physician Decision|0|||
125275487|NCT03028129|450636159|FG001|Overall Study|Physician Decision|1|||
125275488|NCT03028129|450636158|FG000|Overall Study|Protocol Violation|1|||
125275489|NCT03028129|450636159|FG001|Overall Study|Protocol Violation|1|||
125275490|NCT03028129|450636158|FG000|Overall Study|Withdrawal by Subject|62|||
125275491|NCT03028129|450636159|FG001|Overall Study|Withdrawal by Subject|45|||
125275492|NCT00564902|450636169|FG000|Overall Study|Withdrawal by Subject|0|||
125275493|NCT00564902|450636170|FG001|Overall Study|Withdrawal by Subject|3|||
125275494|NCT00564902|450636171|FG002|Overall Study|Withdrawal by Subject|4|||
125275495|NCT00564902|450636169|FG000|Overall Study|Death|1|||
125275496|NCT00564902|450636170|FG001|Overall Study|Death|1|||
125275497|NCT00564902|450636171|FG002|Overall Study|Death|0|||
125275498|NCT03583359|450636172|FG000|Overall Study|Withdrawal by Subject|15|||
125275499|NCT03583359|450636173|FG001|Overall Study|Withdrawal by Subject|6|||
125275500|NCT03583359|450636172|FG000|Overall Study|Lost to Follow-up|12|||
125275501|NCT03583359|450636173|FG001|Overall Study|Lost to Follow-up|3|||
125275502|NCT03583359|450636172|FG000|Overall Study|Adverse Event|0|||
125275503|NCT03583359|450636173|FG001|Overall Study|Adverse Event|1|||
125275504|NCT03583359|450636172|FG000|Overall Study|Protocol Violation|0|||
125275505|NCT03583359|450636173|FG001|Overall Study|Protocol Violation|1|||
125275506|NCT03583359|450636172|FG000|Overall Study|Other|2|||
125275507|NCT03583359|450636173|FG001|Overall Study|Other|1|||
125275508|NCT01831466|450636174|FG000|Overall Study|Protocol Violation|1|||
125275509|NCT01831466|450636175|FG001|Overall Study|Protocol Violation|1|||
125275510|NCT01831466|450636176|FG002|Overall Study|Protocol Violation|2|||
125275511|NCT01831466|450636177|FG003|Overall Study|Protocol Violation|0|||
125275512|NCT01831466|450636178|FG004|Overall Study|Protocol Violation|0|||
125275513|NCT01831466|450636179|FG005|Overall Study|Protocol Violation|1|||
125275514|NCT01831466|450636180|FG006|Overall Study|Protocol Violation|0|||
125275515|NCT01831466|450636181|FG007|Overall Study|Protocol Violation|0|||
125275516|NCT01831466|450636182|FG008|Overall Study|Protocol Violation|0|||
125275517|NCT01831466|450636183|FG009|Overall Study|Protocol Violation|0|||
125275518|NCT01831466|450636184|FG010|Overall Study|Protocol Violation|0|||
125275519|NCT01831466|450636185|FG011|Overall Study|Protocol Violation|0|||
125275520|NCT01831466|450636174|FG000|Overall Study|Other|2|||
125275521|NCT01831466|450636175|FG001|Overall Study|Other|3|||
125275522|NCT01831466|450636176|FG002|Overall Study|Other|2|||
125275523|NCT01831466|450636177|FG003|Overall Study|Other|2|||
125275524|NCT01831466|450636178|FG004|Overall Study|Other|2|||
125275525|NCT01831466|450636179|FG005|Overall Study|Other|1|||
125275526|NCT01831466|450636180|FG006|Overall Study|Other|0|||
125275527|NCT01831466|450636181|FG007|Overall Study|Other|0|||
125275528|NCT01831466|450636182|FG008|Overall Study|Other|0|||
125275529|NCT01831466|450636183|FG009|Overall Study|Other|0|||
125275530|NCT01831466|450636184|FG010|Overall Study|Other|0|||
125275531|NCT01831466|450636185|FG011|Overall Study|Other|0|||
125275532|NCT01831466|450636174|FG000|Overall Study|Non-compliance with study treatment|2|||
125275533|NCT01831466|450636175|FG001|Overall Study|Non-compliance with study treatment|1|||
125275534|NCT01831466|450636176|FG002|Overall Study|Non-compliance with study treatment|1|||
125275535|NCT01831466|450636177|FG003|Overall Study|Non-compliance with study treatment|0|||
125275536|NCT01831466|450636178|FG004|Overall Study|Non-compliance with study treatment|0|||
125275537|NCT01831466|450636179|FG005|Overall Study|Non-compliance with study treatment|1|||
125275538|NCT01831466|450636180|FG006|Overall Study|Non-compliance with study treatment|0|||
125275539|NCT01831466|450636181|FG007|Overall Study|Non-compliance with study treatment|0|||
125275540|NCT01831466|450636182|FG008|Overall Study|Non-compliance with study treatment|0|||
125275541|NCT01831466|450636183|FG009|Overall Study|Non-compliance with study treatment|0|||
125275542|NCT01831466|450636184|FG010|Overall Study|Non-compliance with study treatment|0|||
125275543|NCT01831466|450636185|FG011|Overall Study|Non-compliance with study treatment|0|||
125275544|NCT01831466|450636174|FG000|Overall Study|Death|0|||
125275545|NCT01831466|450636175|FG001|Overall Study|Death|1|||
125275546|NCT01831466|450636176|FG002|Overall Study|Death|0|||
125275547|NCT01831466|450636177|FG003|Overall Study|Death|0|||
125275548|NCT01831466|450636178|FG004|Overall Study|Death|0|||
125275549|NCT01831466|450636179|FG005|Overall Study|Death|0|||
125275550|NCT01831466|450636180|FG006|Overall Study|Death|0|||
125275551|NCT01831466|450636181|FG007|Overall Study|Death|0|||
125275552|NCT01831466|450636182|FG008|Overall Study|Death|0|||
125275553|NCT01831466|450636183|FG009|Overall Study|Death|0|||
125275554|NCT01831466|450636184|FG010|Overall Study|Death|0|||
125275555|NCT01831466|450636185|FG011|Overall Study|Death|0|||
125275556|NCT01831466|450636174|FG000|Overall Study|Withdrawal by Subject|6|||
125275557|NCT01831466|450636175|FG001|Overall Study|Withdrawal by Subject|3|||
125275558|NCT01831466|450636176|FG002|Overall Study|Withdrawal by Subject|3|||
125275559|NCT01831466|450636177|FG003|Overall Study|Withdrawal by Subject|3|||
125275560|NCT01831466|450636178|FG004|Overall Study|Withdrawal by Subject|3|||
125275561|NCT01831466|450636179|FG005|Overall Study|Withdrawal by Subject|5|||
125275562|NCT01831466|450636180|FG006|Overall Study|Withdrawal by Subject|0|||
125275563|NCT01831466|450636181|FG007|Overall Study|Withdrawal by Subject|0|||
125275564|NCT01831466|450636182|FG008|Overall Study|Withdrawal by Subject|0|||
125275565|NCT01831466|450636183|FG009|Overall Study|Withdrawal by Subject|1|||
125275566|NCT01831466|450636184|FG010|Overall Study|Withdrawal by Subject|0|||
125275567|NCT01831466|450636185|FG011|Overall Study|Withdrawal by Subject|1|||
125275568|NCT01831466|450636174|FG000|Overall Study|Lost to Follow-up|0|||
125275569|NCT01831466|450636175|FG001|Overall Study|Lost to Follow-up|1|||
125275570|NCT01831466|450636176|FG002|Overall Study|Lost to Follow-up|4|||
125275571|NCT01831466|450636177|FG003|Overall Study|Lost to Follow-up|2|||
125275572|NCT01831466|450636178|FG004|Overall Study|Lost to Follow-up|0|||
125275573|NCT01831466|450636179|FG005|Overall Study|Lost to Follow-up|3|||
125275574|NCT01831466|450636180|FG006|Overall Study|Lost to Follow-up|0|||
125275575|NCT01831466|450636181|FG007|Overall Study|Lost to Follow-up|0|||
125275576|NCT01831466|450636182|FG008|Overall Study|Lost to Follow-up|0|||
125275577|NCT01831466|450636183|FG009|Overall Study|Lost to Follow-up|1|||
125275578|NCT01831466|450636184|FG010|Overall Study|Lost to Follow-up|0|||
125275579|NCT01831466|450636185|FG011|Overall Study|Lost to Follow-up|1|||
125275580|NCT01831466|450636174|FG000|Overall Study|Lack of Efficacy|5|||
125275581|NCT01831466|450636175|FG001|Overall Study|Lack of Efficacy|8|||
125275582|NCT01831466|450636176|FG002|Overall Study|Lack of Efficacy|7|||
125275583|NCT01831466|450636177|FG003|Overall Study|Lack of Efficacy|6|||
125275584|NCT01831466|450636178|FG004|Overall Study|Lack of Efficacy|9|||
125275585|NCT01831466|450636179|FG005|Overall Study|Lack of Efficacy|8|||
125275586|NCT01831466|450636180|FG006|Overall Study|Lack of Efficacy|1|||
125275587|NCT01831466|450636181|FG007|Overall Study|Lack of Efficacy|1|||
125275588|NCT01831466|450636182|FG008|Overall Study|Lack of Efficacy|2|||
125275589|NCT01831466|450636183|FG009|Overall Study|Lack of Efficacy|2|||
125275590|NCT01831466|450636184|FG010|Overall Study|Lack of Efficacy|2|||
125275591|NCT01831466|450636185|FG011|Overall Study|Lack of Efficacy|0|||
125275592|NCT01831466|450636174|FG000|Overall Study|Adverse Event|0|||
125275593|NCT01831466|450636175|FG001|Overall Study|Adverse Event|0|||
125275594|NCT01831466|450636176|FG002|Overall Study|Adverse Event|4|||
125275595|NCT01831466|450636177|FG003|Overall Study|Adverse Event|6|||
125275596|NCT01831466|450636178|FG004|Overall Study|Adverse Event|3|||
125275597|NCT01831466|450636179|FG005|Overall Study|Adverse Event|7|||
125275598|NCT01831466|450636180|FG006|Overall Study|Adverse Event|0|||
125275599|NCT01831466|450636181|FG007|Overall Study|Adverse Event|1|||
125275600|NCT01831466|450636182|FG008|Overall Study|Adverse Event|1|||
125275601|NCT01831466|450636183|FG009|Overall Study|Adverse Event|1|||
125275602|NCT01831466|450636184|FG010|Overall Study|Adverse Event|0|||
125275603|NCT01831466|450636185|FG011|Overall Study|Adverse Event|2|||
125275604|NCT04776720|450636188|FG000|Overall Study|COVID Related|4|||
125275605|NCT04776720|450636189|FG001|Overall Study|COVID Related|2|||
125275606|NCT04776720|450636188|FG000|Overall Study|Adverse Event|2|||
125275607|NCT04776720|450636189|FG001|Overall Study|Adverse Event|0|||
125275608|NCT04776720|450636188|FG000|Overall Study|Serious Adverse Event|0|||
125275609|NCT04776720|450636189|FG001|Overall Study|Serious Adverse Event|1|||
125275610|NCT04776720|450636188|FG000|Overall Study|Too Busy|3|||
125275611|NCT04776720|450636189|FG001|Overall Study|Too Busy|1|||
125275612|NCT04776720|450636188|FG000|Overall Study|Lost to Follow-up|1|||
125275613|NCT04776720|450636189|FG001|Overall Study|Lost to Follow-up|2|||
125275614|NCT04776720|450636188|FG000|Overall Study|Family|2|||
125275615|NCT04776720|450636189|FG001|Overall Study|Family|2|||
125275616|NCT04776720|450636188|FG000|Overall Study|No remote technology access|0|||
125275617|NCT04776720|450636189|FG001|Overall Study|No remote technology access|1|||
125275618|NCT04776720|450636188|FG000|Overall Study|Withdrawal by Subject|1|||
125275619|NCT04776720|450636189|FG001|Overall Study|Withdrawal by Subject|0|||
125275620|NCT04776720|450636188|FG000|Overall Study|Cannot tolerate intervention|1|||
125275621|NCT04776720|450636189|FG001|Overall Study|Cannot tolerate intervention|0|||
125275622|NCT04776720|450636188|FG000|Overall Study|Incomplete outcome data|6|||
125275623|NCT04776720|450636189|FG001|Overall Study|Incomplete outcome data|1|||
125275624|NCT05356910|450636190|FG000|Overall Study|Lost to Follow-up|10|||
125275625|NCT05356910|450636191|FG001|Overall Study|Lost to Follow-up|19|||
125275626|NCT05356910|450636192|FG002|Overall Study|Lost to Follow-up|0|||
125275627|NCT05356910|450636193|FG003|Overall Study|Lost to Follow-up|0|||
125275628|NCT05356910|450636190|FG000|Overall Study|Withdrawal by Subject|4|||
125275629|NCT05356910|450636191|FG001|Overall Study|Withdrawal by Subject|2|||
125275630|NCT05356910|450636192|FG002|Overall Study|Withdrawal by Subject|0|||
125275631|NCT05356910|450636193|FG003|Overall Study|Withdrawal by Subject|0|||
125275632|NCT00803595|450636194|FG000|Overall Study|Adverse Event|3|||
125275633|NCT00803595|450636195|FG001|Overall Study|Adverse Event|4|||
125275634|NCT00803595|450636196|FG002|Overall Study|Adverse Event|1|||
125275635|NCT00803595|450636194|FG000|Overall Study|Protocol Violation|7|||
125275636|NCT00803595|450636195|FG001|Overall Study|Protocol Violation|2|||
125275637|NCT00803595|450636196|FG002|Overall Study|Protocol Violation|12|||
125275638|NCT00803595|450636194|FG000|Overall Study|Withdrawal by Subject|5|||
125275639|NCT00803595|450636195|FG001|Overall Study|Withdrawal by Subject|2|||
125275640|NCT00803595|450636196|FG002|Overall Study|Withdrawal by Subject|3|||
125275641|NCT00984594|450636197|FG000|Overall Study|Lost to Follow-up|1|||
125275642|NCT00984594|450636198|FG001|Overall Study|Lost to Follow-up|0|||
125275643|NCT00984594|450636197|FG000|Overall Study|Withdrawal by Subject|0|||
125275644|NCT00984594|450636198|FG001|Overall Study|Withdrawal by Subject|1|||
125275645|NCT03122145|450636199|FG000|Overall Study|Concurrent respiratory disease|3|||
125275646|NCT03122145|450636200|FG001|Overall Study|Concurrent respiratory disease|0|||
125275647|NCT01597908|450636201|FG000|Randomized Phase|Death|217|||
125275648|NCT01597908|450636202|FG001|Randomized Phase|Death|238|||
125275649|NCT01597908|450636203|FG002|Randomized Phase|Death|0|||
125275650|NCT01597908|450636201|FG000|Randomized Phase|Sponsor Decision|93|||
125275651|NCT01597908|450636202|FG001|Randomized Phase|Sponsor Decision|39|||
125275652|NCT01597908|450636203|FG002|Randomized Phase|Sponsor Decision|0|||
125275653|NCT01597908|450636201|FG000|Randomized Phase|Lost to Follow-up|9|||
125275654|NCT01597908|450636202|FG001|Randomized Phase|Lost to Follow-up|16|||
125275655|NCT01597908|450636203|FG002|Randomized Phase|Lost to Follow-up|0|||
125275656|NCT01597908|450636201|FG000|Randomized Phase|Physician Decision|6|||
125275657|NCT01597908|450636202|FG001|Randomized Phase|Physician Decision|3|||
125275658|NCT01597908|450636203|FG002|Randomized Phase|Physician Decision|0|||
125275659|NCT01597908|450636201|FG000|Randomized Phase|Withdrawal by Subject|26|||
125275660|NCT01597908|450636202|FG001|Randomized Phase|Withdrawal by Subject|22|||
125275661|NCT01597908|450636203|FG002|Randomized Phase|Withdrawal by Subject|0|||
125275662|NCT01597908|450636201|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
125275663|NCT01597908|450636202|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
125275664|NCT01597908|450636203|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
125275665|NCT01597908|450636201|FG000|Crossover Phase|Death|0|||
125275666|NCT01597908|450636202|FG001|Crossover Phase|Death|0|||
125275667|NCT01597908|450636203|FG002|Crossover Phase|Death|11|||
125275668|NCT01597908|450636201|FG000|Crossover Phase|Withdrawal by Subject|0|||
125275669|NCT01597908|450636202|FG001|Crossover Phase|Withdrawal by Subject|0|||
125275670|NCT01597908|450636203|FG002|Crossover Phase|Withdrawal by Subject|3|||
125275671|NCT01597908|450636201|FG000|Crossover Phase|Sponsor Decision|0|||
125275672|NCT01597908|450636202|FG001|Crossover Phase|Sponsor Decision|0|||
125275673|NCT01597908|450636203|FG002|Crossover Phase|Sponsor Decision|20|||
125275674|NCT00837161|450636206|FG000|Overall Study|refused hysterectomy|2|||
125275675|NCT01659996|450636209|FG000|Overall Study|Protocol Violation|3|||
125275676|NCT01659996|450636210|FG001|Overall Study|Protocol Violation|3|||
125275677|NCT01659996|450636211|FG002|Overall Study|Protocol Violation|3|||
125275678|NCT01659996|450636209|FG000|Overall Study|Lost to Follow-up|1|||
125275679|NCT01659996|450636210|FG001|Overall Study|Lost to Follow-up|3|||
125275680|NCT01659996|450636211|FG002|Overall Study|Lost to Follow-up|2|||
125275681|NCT01659996|450636209|FG000|Overall Study|Adverse Event|0|||
125275682|NCT01659996|450636210|FG001|Overall Study|Adverse Event|0|||
125275683|NCT01659996|450636211|FG002|Overall Study|Adverse Event|1|||
125275684|NCT01659996|450636209|FG000|Overall Study|Withdrawal by Subject|4|||
125275685|NCT01659996|450636210|FG001|Overall Study|Withdrawal by Subject|1|||
125275686|NCT01659996|450636211|FG002|Overall Study|Withdrawal by Subject|5|||
125275687|NCT01059864|450636218|FG000|Open-Label Run-In Phase|Adverse Event|7|||
125275688|NCT01059864|450636219|FG001|Open-Label Run-In Phase|Adverse Event|0|||
125275689|NCT01059864|450636220|FG002|Open-Label Run-In Phase|Adverse Event|0|||
125275690|NCT01059864|450636218|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
125275691|NCT01059864|450636219|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
125275692|NCT01059864|450636220|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
125275693|NCT01059864|450636218|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
125275694|NCT01059864|450636219|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
125275695|NCT01059864|450636220|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
125275696|NCT01059864|450636218|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
125275697|NCT01059864|450636219|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
125275698|NCT01059864|450636220|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
125275699|NCT01059864|450636218|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
125275700|NCT01059864|450636219|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
125275701|NCT01059864|450636220|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
125275702|NCT01059864|450636218|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
125275703|NCT01059864|450636219|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
125275704|NCT01059864|450636220|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
125275705|NCT00451958|450636221|FG000|CS21A (NCT00451958)|Adverse Event|21|||
125275706|NCT00451958|450636222|FG001|CS21A (NCT00451958)|Adverse Event|34|||
125275707|NCT00451958|450636223|FG002|CS21A (NCT00451958)|Adverse Event|14|||
125275708|NCT00451958|450636224|FG003|CS21A (NCT00451958)|Adverse Event|17|||
125275709|NCT00451958|450636225|FG004|CS21A (NCT00451958)|Adverse Event|0|||
125275710|NCT00451958|450636221|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
125275711|NCT00451958|450636222|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
125275712|NCT00451958|450636223|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
125275713|NCT00451958|450636224|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
125275714|NCT00451958|450636225|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
125275715|NCT00451958|450636221|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
125275716|NCT00451958|450636222|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
125275717|NCT00451958|450636223|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
125275718|NCT00451958|450636224|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
125275719|NCT00451958|450636225|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
125275720|NCT00451958|450636221|FG000|CS21A (NCT00451958)|Physician Decision|2|||
125275721|NCT00451958|450636222|FG001|CS21A (NCT00451958)|Physician Decision|4|||
125275722|NCT00451958|450636223|FG002|CS21A (NCT00451958)|Physician Decision|4|||
125275723|NCT00451958|450636224|FG003|CS21A (NCT00451958)|Physician Decision|4|||
125275724|NCT00451958|450636225|FG004|CS21A (NCT00451958)|Physician Decision|0|||
125275725|NCT00451958|450636221|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
125275726|NCT00451958|450636222|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
125275727|NCT00451958|450636223|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
125275728|NCT00451958|450636224|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
125275729|NCT00451958|450636225|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
125275730|NCT00451958|450636221|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
125275731|NCT00451958|450636222|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
125275732|NCT00451958|450636223|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
125275733|NCT00451958|450636224|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
125275734|NCT00451958|450636225|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
125275735|NCT03281629|450636235|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
125275736|NCT03281629|450636236|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
125275737|NCT03281629|450636235|FG000|Overall Study|Death|0|||
125275738|NCT03281629|450636236|FG001|Overall Study|Death|1|||
125275739|NCT03281629|450636235|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
125275740|NCT03281629|450636236|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
125275741|NCT02175277|450636237|FG000|Overall Study|Protocol-specified Criteria|1|||
125275742|NCT01905943|450637906|FG000|Overall Study|Withdrawal of consent|90|||
125275743|NCT01905943|450637906|FG000|Overall Study|Lost to Follow-up|16|||
125275744|NCT01905943|450637906|FG000|Overall Study|Investigator discretion|7|||
125275745|NCT01905943|450637906|FG000|Overall Study|Death|186|||
125275746|NCT01905943|450637906|FG000|Overall Study|Adverse Event|3|||
125275747|NCT01905943|450637906|FG000|Overall Study|Other|12|||
125275748|NCT02574078|450637907|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125275749|NCT02574078|450637908|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125275750|NCT02574078|450637909|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125275751|NCT02574078|450637910|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125275752|NCT02574078|450637911|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125275753|NCT02574078|450637912|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
125275754|NCT02574078|450637913|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
125275755|NCT02574078|450637914|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125275756|NCT02574078|450637915|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
125275757|NCT02574078|450637916|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125275758|NCT02574078|450637917|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125275759|NCT02574078|450637918|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125275760|NCT02574078|450637919|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125275761|NCT02574078|450637907|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
125275762|NCT02574078|450637908|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
125275763|NCT02574078|450637909|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
125275764|NCT02574078|450637910|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
125275765|NCT02574078|450637911|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
125275766|NCT02574078|450637912|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
125275767|NCT02574078|450637913|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
125275768|NCT02574078|450637914|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
125275769|NCT02574078|450637915|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
125275770|NCT02574078|450637916|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
125275771|NCT02574078|450637917|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
125275772|NCT02574078|450637918|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
125275773|NCT02574078|450637919|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
125275774|NCT02574078|450637907|FG000|Pre-Treatment Period|Other reasons|0|||
125275775|NCT02574078|450637908|FG001|Pre-Treatment Period|Other reasons|0|||
125275776|NCT02574078|450637909|FG002|Pre-Treatment Period|Other reasons|0|||
125275777|NCT02574078|450637910|FG003|Pre-Treatment Period|Other reasons|0|||
125275778|NCT02574078|450637911|FG004|Pre-Treatment Period|Other reasons|0|||
125275779|NCT02574078|450637912|FG005|Pre-Treatment Period|Other reasons|0|||
125275780|NCT02574078|450637913|FG006|Pre-Treatment Period|Other reasons|2|||
125275781|NCT02574078|450637914|FG007|Pre-Treatment Period|Other reasons|0|||
125275782|NCT02574078|450637915|FG008|Pre-Treatment Period|Other reasons|0|||
125275783|NCT02574078|450637916|FG009|Pre-Treatment Period|Other reasons|0|||
125275784|NCT02574078|450637917|FG010|Pre-Treatment Period|Other reasons|2|||
125275785|NCT02574078|450637918|FG011|Pre-Treatment Period|Other reasons|0|||
125275786|NCT02574078|450637919|FG012|Pre-Treatment Period|Other reasons|0|||
125275787|NCT02574078|450637907|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
125275788|NCT02574078|450637908|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
125275789|NCT02574078|450637909|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
125275790|NCT02574078|450637910|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
125275791|NCT02574078|450637911|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
125275792|NCT02574078|450637912|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
125275793|NCT02574078|450637913|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
125275794|NCT02574078|450637914|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
125275795|NCT02574078|450637915|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
125275796|NCT02574078|450637916|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
125275797|NCT02574078|450637917|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
125275798|NCT02574078|450637918|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
125275799|NCT02574078|450637919|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
125275800|NCT02574078|450637907|FG000|Treatment Period|Disease progression|6|||
125275801|NCT02574078|450637908|FG001|Treatment Period|Disease progression|4|||
125275802|NCT02574078|450637909|FG002|Treatment Period|Disease progression|7|||
125275803|NCT02574078|450637910|FG003|Treatment Period|Disease progression|18|||
125275804|NCT02574078|450637911|FG004|Treatment Period|Disease progression|16|||
125275805|NCT02574078|450637912|FG005|Treatment Period|Disease progression|26|||
125275806|NCT02574078|450637913|FG006|Treatment Period|Disease progression|5|||
125275807|NCT02574078|450637914|FG007|Treatment Period|Disease progression|9|||
125275808|NCT02574078|450637915|FG008|Treatment Period|Disease progression|8|||
125275809|NCT02574078|450637916|FG009|Treatment Period|Disease progression|5|||
125275810|NCT02574078|450637917|FG010|Treatment Period|Disease progression|20|||
125275811|NCT02574078|450637918|FG011|Treatment Period|Disease progression|29|||
125275812|NCT02574078|450637919|FG012|Treatment Period|Disease progression|2|||
125275813|NCT02574078|450637907|FG000|Treatment Period|Study drug toxicity|1|||
125275814|NCT02574078|450637908|FG001|Treatment Period|Study drug toxicity|1|||
125275815|NCT02574078|450637909|FG002|Treatment Period|Study drug toxicity|0|||
125275816|NCT02574078|450637910|FG003|Treatment Period|Study drug toxicity|5|||
125275817|NCT02574078|450637911|FG004|Treatment Period|Study drug toxicity|3|||
125275818|NCT02574078|450637912|FG005|Treatment Period|Study drug toxicity|1|||
125275819|NCT02574078|450637913|FG006|Treatment Period|Study drug toxicity|2|||
125275820|NCT02574078|450637914|FG007|Treatment Period|Study drug toxicity|0|||
125275821|NCT02574078|450637915|FG008|Treatment Period|Study drug toxicity|2|||
125275822|NCT02574078|450637916|FG009|Treatment Period|Study drug toxicity|1|||
125275823|NCT02574078|450637917|FG010|Treatment Period|Study drug toxicity|16|||
125275824|NCT02574078|450637918|FG011|Treatment Period|Study drug toxicity|2|||
125275825|NCT02574078|450637919|FG012|Treatment Period|Study drug toxicity|4|||
125275826|NCT02574078|450637907|FG000|Treatment Period|Death|2|||
125275827|NCT02574078|450637908|FG001|Treatment Period|Death|0|||
125275828|NCT02574078|450637909|FG002|Treatment Period|Death|0|||
125275829|NCT02574078|450637910|FG003|Treatment Period|Death|0|||
125275830|NCT02574078|450637911|FG004|Treatment Period|Death|1|||
125275831|NCT02574078|450637912|FG005|Treatment Period|Death|1|||
125275832|NCT02574078|450637913|FG006|Treatment Period|Death|1|||
125275833|NCT02574078|450637914|FG007|Treatment Period|Death|1|||
125275834|NCT02574078|450637915|FG008|Treatment Period|Death|7|||
125275835|NCT02574078|450637916|FG009|Treatment Period|Death|1|||
125275836|NCT02574078|450637917|FG010|Treatment Period|Death|0|||
125275837|NCT02574078|450637918|FG011|Treatment Period|Death|2|||
125275838|NCT02574078|450637919|FG012|Treatment Period|Death|1|||
125275839|NCT02574078|450637907|FG000|Treatment Period|Adverse event unrelated to drug|0|||
125275840|NCT02574078|450637908|FG001|Treatment Period|Adverse event unrelated to drug|0|||
125275841|NCT02574078|450637909|FG002|Treatment Period|Adverse event unrelated to drug|1|||
125275842|NCT02574078|450637910|FG003|Treatment Period|Adverse event unrelated to drug|0|||
125275843|NCT02574078|450637911|FG004|Treatment Period|Adverse event unrelated to drug|2|||
125275844|NCT02574078|450637912|FG005|Treatment Period|Adverse event unrelated to drug|3|||
125275845|NCT02574078|450637913|FG006|Treatment Period|Adverse event unrelated to drug|0|||
125275846|NCT02574078|450637914|FG007|Treatment Period|Adverse event unrelated to drug|0|||
125275847|NCT02574078|450637915|FG008|Treatment Period|Adverse event unrelated to drug|1|||
125275848|NCT02574078|450637916|FG009|Treatment Period|Adverse event unrelated to drug|2|||
125275849|NCT02574078|450637917|FG010|Treatment Period|Adverse event unrelated to drug|4|||
125275850|NCT02574078|450637918|FG011|Treatment Period|Adverse event unrelated to drug|1|||
125275851|NCT02574078|450637919|FG012|Treatment Period|Adverse event unrelated to drug|0|||
125275852|NCT02574078|450637907|FG000|Treatment Period|Administrative reason by Sponsor|0|||
125275853|NCT02574078|450637908|FG001|Treatment Period|Administrative reason by Sponsor|1|||
125275854|NCT02574078|450637909|FG002|Treatment Period|Administrative reason by Sponsor|0|||
125275855|NCT02574078|450637910|FG003|Treatment Period|Administrative reason by Sponsor|0|||
125275856|NCT02574078|450637911|FG004|Treatment Period|Administrative reason by Sponsor|0|||
125275857|NCT02574078|450637912|FG005|Treatment Period|Administrative reason by Sponsor|0|||
125275858|NCT02574078|450637913|FG006|Treatment Period|Administrative reason by Sponsor|1|||
125275859|NCT02574078|450637914|FG007|Treatment Period|Administrative reason by Sponsor|0|||
125275860|NCT02574078|450637915|FG008|Treatment Period|Administrative reason by Sponsor|0|||
125275861|NCT02574078|450637916|FG009|Treatment Period|Administrative reason by Sponsor|0|||
125275862|NCT02574078|450637917|FG010|Treatment Period|Administrative reason by Sponsor|0|||
125275863|NCT02574078|450637918|FG011|Treatment Period|Administrative reason by Sponsor|0|||
125275864|NCT02574078|450637919|FG012|Treatment Period|Administrative reason by Sponsor|3|||
125275865|NCT02574078|450637907|FG000|Treatment Period|Other reasons|1|||
125275866|NCT02574078|450637908|FG001|Treatment Period|Other reasons|0|||
125275867|NCT02574078|450637909|FG002|Treatment Period|Other reasons|1|||
125275868|NCT02574078|450637910|FG003|Treatment Period|Other reasons|3|||
125275869|NCT02574078|450637911|FG004|Treatment Period|Other reasons|3|||
125275870|NCT02574078|450637912|FG005|Treatment Period|Other reasons|1|||
125275871|NCT02574078|450637913|FG006|Treatment Period|Other reasons|2|||
125275872|NCT02574078|450637914|FG007|Treatment Period|Other reasons|1|||
125275873|NCT02574078|450637915|FG008|Treatment Period|Other reasons|3|||
125275874|NCT02574078|450637916|FG009|Treatment Period|Other reasons|1|||
125275875|NCT02574078|450637917|FG010|Treatment Period|Other reasons|1|||
125275876|NCT02574078|450637918|FG011|Treatment Period|Other reasons|3|||
125275877|NCT02574078|450637919|FG012|Treatment Period|Other reasons|1|||
125275878|NCT02574078|450637907|FG000|Treatment Period|Participant request to stop drug|0|||
125275879|NCT02574078|450637908|FG001|Treatment Period|Participant request to stop drug|0|||
125275880|NCT02574078|450637909|FG002|Treatment Period|Participant request to stop drug|0|||
125275881|NCT02574078|450637910|FG003|Treatment Period|Participant request to stop drug|2|||
125275882|NCT02574078|450637911|FG004|Treatment Period|Participant request to stop drug|4|||
125275883|NCT02574078|450637912|FG005|Treatment Period|Participant request to stop drug|0|||
125275884|NCT02574078|450637913|FG006|Treatment Period|Participant request to stop drug|1|||
125275885|NCT02574078|450637914|FG007|Treatment Period|Participant request to stop drug|0|||
125275886|NCT02574078|450637915|FG008|Treatment Period|Participant request to stop drug|3|||
125275887|NCT02574078|450637916|FG009|Treatment Period|Participant request to stop drug|2|||
125275888|NCT02574078|450637917|FG010|Treatment Period|Participant request to stop drug|2|||
125275889|NCT02574078|450637918|FG011|Treatment Period|Participant request to stop drug|4|||
125275890|NCT02574078|450637919|FG012|Treatment Period|Participant request to stop drug|1|||
125275891|NCT02574078|450637907|FG000|Treatment Period|Participant withdrew consent|0|||
125275892|NCT02574078|450637908|FG001|Treatment Period|Participant withdrew consent|0|||
125275893|NCT02574078|450637909|FG002|Treatment Period|Participant withdrew consent|0|||
125275894|NCT02574078|450637910|FG003|Treatment Period|Participant withdrew consent|0|||
125275895|NCT02574078|450637911|FG004|Treatment Period|Participant withdrew consent|1|||
125275896|NCT02574078|450637912|FG005|Treatment Period|Participant withdrew consent|1|||
125275897|NCT02574078|450637913|FG006|Treatment Period|Participant withdrew consent|0|||
125275898|NCT02574078|450637914|FG007|Treatment Period|Participant withdrew consent|1|||
125275899|NCT02574078|450637915|FG008|Treatment Period|Participant withdrew consent|0|||
125275900|NCT02574078|450637916|FG009|Treatment Period|Participant withdrew consent|2|||
125275901|NCT02574078|450637917|FG010|Treatment Period|Participant withdrew consent|1|||
125275902|NCT02574078|450637918|FG011|Treatment Period|Participant withdrew consent|4|||
125275903|NCT02574078|450637919|FG012|Treatment Period|Participant withdrew consent|1|||
125275904|NCT02574078|450637907|FG000|Treatment Period|Participant no longer meets criteria|0|||
125275905|NCT02574078|450637908|FG001|Treatment Period|Participant no longer meets criteria|0|||
125275906|NCT02574078|450637909|FG002|Treatment Period|Participant no longer meets criteria|0|||
125275907|NCT02574078|450637910|FG003|Treatment Period|Participant no longer meets criteria|0|||
125275908|NCT02574078|450637911|FG004|Treatment Period|Participant no longer meets criteria|1|||
125275909|NCT02574078|450637912|FG005|Treatment Period|Participant no longer meets criteria|0|||
125275910|NCT02574078|450637913|FG006|Treatment Period|Participant no longer meets criteria|0|||
125275911|NCT02574078|450637914|FG007|Treatment Period|Participant no longer meets criteria|0|||
125275912|NCT02574078|450637915|FG008|Treatment Period|Participant no longer meets criteria|0|||
125275913|NCT02574078|450637916|FG009|Treatment Period|Participant no longer meets criteria|1|||
125275914|NCT02574078|450637917|FG010|Treatment Period|Participant no longer meets criteria|1|||
125275915|NCT02574078|450637918|FG011|Treatment Period|Participant no longer meets criteria|1|||
125275916|NCT02574078|450637919|FG012|Treatment Period|Participant no longer meets criteria|0|||
125275917|NCT02574078|450637907|FG000|Treatment Period|Lost to Follow-up|0|||
125275918|NCT02574078|450637908|FG001|Treatment Period|Lost to Follow-up|0|||
125275919|NCT02574078|450637909|FG002|Treatment Period|Lost to Follow-up|0|||
125275920|NCT02574078|450637910|FG003|Treatment Period|Lost to Follow-up|0|||
125275921|NCT02574078|450637911|FG004|Treatment Period|Lost to Follow-up|0|||
125275922|NCT02574078|450637912|FG005|Treatment Period|Lost to Follow-up|0|||
125275923|NCT02574078|450637913|FG006|Treatment Period|Lost to Follow-up|0|||
125275924|NCT02574078|450637914|FG007|Treatment Period|Lost to Follow-up|0|||
125275925|NCT02574078|450637915|FG008|Treatment Period|Lost to Follow-up|0|||
125275926|NCT02574078|450637916|FG009|Treatment Period|Lost to Follow-up|1|||
125275927|NCT02574078|450637917|FG010|Treatment Period|Lost to Follow-up|0|||
125275928|NCT02574078|450637918|FG011|Treatment Period|Lost to Follow-up|1|||
125275929|NCT02574078|450637919|FG012|Treatment Period|Lost to Follow-up|0|||
125275930|NCT02574078|450637907|FG000|Treatment Period|Maximum clinical benefit|0|||
125275931|NCT02574078|450637908|FG001|Treatment Period|Maximum clinical benefit|0|||
125275932|NCT02574078|450637909|FG002|Treatment Period|Maximum clinical benefit|0|||
125275933|NCT02574078|450637910|FG003|Treatment Period|Maximum clinical benefit|0|||
125275934|NCT02574078|450637911|FG004|Treatment Period|Maximum clinical benefit|0|||
125275935|NCT02574078|450637912|FG005|Treatment Period|Maximum clinical benefit|0|||
125275936|NCT02574078|450637913|FG006|Treatment Period|Maximum clinical benefit|0|||
125275937|NCT02574078|450637914|FG007|Treatment Period|Maximum clinical benefit|0|||
125275938|NCT02574078|450637915|FG008|Treatment Period|Maximum clinical benefit|0|||
125275939|NCT02574078|450637916|FG009|Treatment Period|Maximum clinical benefit|1|||
125275940|NCT02574078|450637917|FG010|Treatment Period|Maximum clinical benefit|0|||
125275941|NCT02574078|450637918|FG011|Treatment Period|Maximum clinical benefit|0|||
125275942|NCT02574078|450637919|FG012|Treatment Period|Maximum clinical benefit|0|||
125275943|NCT00301262|450637923|FG000|Double Blind Phase (DB)|Adverse Event|1|||
125275944|NCT00301262|450637924|FG001|Double Blind Phase (DB)|Adverse Event|0|||
125275945|NCT00301262|450637923|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
125275946|NCT00301262|450637924|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
125275947|NCT00301262|450637923|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
125275948|NCT00301262|450637924|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
125275949|NCT00301262|450637923|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
125275950|NCT00301262|450637924|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
125275951|NCT00301262|450637923|FG000|Double Blind Phase (DB)|Other|1|||
125275952|NCT00301262|450637924|FG001|Double Blind Phase (DB)|Other|4|||
125275953|NCT00301262|450637923|FG000|Open Label Phase (OL)|Adverse Event|1|||
125275954|NCT00301262|450637924|FG001|Open Label Phase (OL)|Adverse Event|0|||
125275955|NCT00301262|450637923|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
125275956|NCT00301262|450637924|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
125275957|NCT00301262|450637923|FG000|Open Label Phase (OL)|Other|2|||
125275958|NCT00301262|450637924|FG001|Open Label Phase (OL)|Other|0|||
125275959|NCT00368745|450637925|FG000|Double-blind Treatment Period|Adverse Event|6|||
125275960|NCT00368745|450637926|FG001|Double-blind Treatment Period|Adverse Event|6|||
125275961|NCT00368745|450637925|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
125275962|NCT00368745|450637926|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
125275963|NCT00368745|450637925|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
125275964|NCT00368745|450637926|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
125275965|NCT00368745|450637925|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
125275966|NCT00368745|450637926|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
125275967|NCT00368745|450637925|FG000|Double-blind Treatment Period|Other|7|||
125275968|NCT00368745|450637926|FG001|Double-blind Treatment Period|Other|6|||
125275969|NCT03037476|450637927|FG000|Overall Study|Lost to Follow-up|63|||
125275970|NCT03037476|450637928|FG001|Overall Study|Lost to Follow-up|46|||
125275971|NCT01498692|450637931|FG000|Overall Study|Death|4|||
125275972|NCT01498692|450637931|FG000|Overall Study|Withdrawal by Subject|1|||
125275973|NCT01498692|450637931|FG000|Overall Study|Missed 12-month visit|3|||
125275974|NCT01208324|450637932|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
125275975|NCT01208324|450637933|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
125275976|NCT01208324|450637934|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
125275977|NCT01208324|450637935|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
125275978|NCT02707965|450637936|FG000|Overall Study|Withdrawal by Subject|0|||
125275979|NCT02707965|450637937|FG001|Overall Study|Withdrawal by Subject|0|||
125275980|NCT02707965|450637938|FG002|Overall Study|Withdrawal by Subject|1|||
125275981|NCT02707965|450637939|FG003|Overall Study|Withdrawal by Subject|0|||
125275982|NCT02707965|450637940|FG004|Overall Study|Withdrawal by Subject|0|||
125275983|NCT02707965|450637941|FG005|Overall Study|Withdrawal by Subject|0|||
125275984|NCT02707965|450637942|FG006|Overall Study|Withdrawal by Subject|0|||
125275985|NCT02707965|450637943|FG007|Overall Study|Withdrawal by Subject|2|||
125275986|NCT02707965|450637944|FG008|Overall Study|Withdrawal by Subject|0|||
125275987|NCT02707965|450637945|FG009|Overall Study|Withdrawal by Subject|0|||
125275988|NCT02707965|450637946|FG010|Overall Study|Withdrawal by Subject|0|||
125275989|NCT02707965|450637947|FG011|Overall Study|Withdrawal by Subject|0|||
125275990|NCT02707965|450637948|FG012|Overall Study|Withdrawal by Subject|0|||
125275991|NCT02707965|450637949|FG013|Overall Study|Withdrawal by Subject|0|||
125275992|NCT02707965|450637950|FG014|Overall Study|Withdrawal by Subject|0|||
125275993|NCT02707965|450637951|FG015|Overall Study|Withdrawal by Subject|0|||
125275994|NCT02707965|450637936|FG000|Overall Study|PI decisions|0|||
125275995|NCT02707965|450637937|FG001|Overall Study|PI decisions|0|||
125275996|NCT02707965|450637938|FG002|Overall Study|PI decisions|0|||
125275997|NCT02707965|450637939|FG003|Overall Study|PI decisions|0|||
125275998|NCT02707965|450637940|FG004|Overall Study|PI decisions|0|||
125275999|NCT02707965|450637941|FG005|Overall Study|PI decisions|0|||
125276000|NCT02707965|450637942|FG006|Overall Study|PI decisions|0|||
125276001|NCT02707965|450637943|FG007|Overall Study|PI decisions|0|||
125276002|NCT02707965|450637944|FG008|Overall Study|PI decisions|0|||
125276003|NCT02707965|450637945|FG009|Overall Study|PI decisions|0|||
125276004|NCT02707965|450637946|FG010|Overall Study|PI decisions|0|||
125276005|NCT02707965|450637947|FG011|Overall Study|PI decisions|0|||
125276006|NCT02707965|450637948|FG012|Overall Study|PI decisions|0|||
125276007|NCT02707965|450637949|FG013|Overall Study|PI decisions|0|||
125276008|NCT02707965|450637950|FG014|Overall Study|PI decisions|2|||
125276009|NCT02707965|450637951|FG015|Overall Study|PI decisions|0|||
125276010|NCT02707965|450637936|FG000|Overall Study|Protocol deviation|1|||
125276011|NCT02707965|450637937|FG001|Overall Study|Protocol deviation|1|||
125276012|NCT02707965|450637938|FG002|Overall Study|Protocol deviation|0|||
125276013|NCT02707965|450637939|FG003|Overall Study|Protocol deviation|0|||
125276014|NCT02707965|450637940|FG004|Overall Study|Protocol deviation|0|||
125276015|NCT02707965|450637941|FG005|Overall Study|Protocol deviation|0|||
125276016|NCT02707965|450637942|FG006|Overall Study|Protocol deviation|0|||
125276017|NCT02707965|450637943|FG007|Overall Study|Protocol deviation|1|||
125276018|NCT02707965|450637944|FG008|Overall Study|Protocol deviation|0|||
125276019|NCT02707965|450637945|FG009|Overall Study|Protocol deviation|0|||
125276020|NCT02707965|450637946|FG010|Overall Study|Protocol deviation|0|||
125276021|NCT02707965|450637947|FG011|Overall Study|Protocol deviation|0|||
125276022|NCT02707965|450637948|FG012|Overall Study|Protocol deviation|0|||
125276023|NCT02707965|450637949|FG013|Overall Study|Protocol deviation|0|||
125276024|NCT02707965|450637950|FG014|Overall Study|Protocol deviation|0|||
125276025|NCT02707965|450637951|FG015|Overall Study|Protocol deviation|0|||
125276026|NCT00748618|450637953|FG000|Overall Study|Adverse Event|1|||
125276027|NCT00748618|450637954|FG001|Overall Study|Adverse Event|0|||
125276028|NCT02854436|450637955|FG000|Overall Study|Adverse Event|1|||
125276029|NCT02854436|450637955|FG000|Overall Study|Death|208|||
125276030|NCT02854436|450637955|FG000|Overall Study|Lost to Follow-up|5|||
125276031|NCT02854436|450637955|FG000|Overall Study|Withdrawal by Subject|24|||
125276032|NCT02854436|450637955|FG000|Overall Study|Other|45|||
125276033|NCT02854436|450637955|FG000|Overall Study|Physician Decision|6|||
125276034|NCT01977729|450637956|FG000|Overall Study|Study terminated|1|||
125276035|NCT01268046|450637957|FG000|Overall Study|Withdrawal by Subject|1|||
125276036|NCT01268046|450637958|FG001|Overall Study|Withdrawal by Subject|0|||
125276037|NCT01268046|450637959|FG002|Overall Study|Withdrawal by Subject|0|||
125276038|NCT01268046|450637960|FG003|Overall Study|Withdrawal by Subject|1|||
125276039|NCT01268046|450637957|FG000|Overall Study|Lost to Follow-up|0|||
125276040|NCT01268046|450637958|FG001|Overall Study|Lost to Follow-up|0|||
125276041|NCT01268046|450637959|FG002|Overall Study|Lost to Follow-up|1|||
125276042|NCT01268046|450637960|FG003|Overall Study|Lost to Follow-up|0|||
125276043|NCT00224120|450637961|FG000|Overall Study|Adverse Event|10|||
125276044|NCT00224120|450637962|FG001|Overall Study|Adverse Event|4|||
125276045|NCT00224120|450637961|FG000|Overall Study|Protocol Violation|1|||
125276046|NCT00224120|450637962|FG001|Overall Study|Protocol Violation|0|||
125276047|NCT00224120|450637961|FG000|Overall Study|Withdrawal by Subject|5|||
125276048|NCT00224120|450637962|FG001|Overall Study|Withdrawal by Subject|10|||
125276049|NCT00224120|450637961|FG000|Overall Study|Lack of Efficacy|0|||
125276050|NCT00224120|450637962|FG001|Overall Study|Lack of Efficacy|2|||
125276051|NCT00224120|450637961|FG000|Overall Study|Lost to Follow-up|2|||
125276052|NCT00224120|450637962|FG001|Overall Study|Lost to Follow-up|3|||
125276053|NCT00224120|450637961|FG000|Overall Study|Other|4|||
125276054|NCT00224120|450637962|FG001|Overall Study|Other|5|||
125276055|NCT00282087|450637963|FG000|Overall Study|Death|1|||
125276056|NCT00338286|450637971|FG000|Overall Study|Withdrawal by Subject|50|||
125276057|NCT00338286|450637972|FG001|Overall Study|Withdrawal by Subject|54|||
125276058|NCT00338286|450637971|FG000|Overall Study|Lost to Follow-up|80|||
125276059|NCT00338286|450637972|FG001|Overall Study|Lost to Follow-up|66|||
125276060|NCT00338286|450637971|FG000|Overall Study|Other|103|||
125276061|NCT00338286|450637972|FG001|Overall Study|Other|93|||
125276062|NCT03248531|450637973|FG000|Overall Study|Adverse Event|0|||
125276063|NCT03248531|450637974|FG001|Overall Study|Adverse Event|0|||
125276064|NCT03248531|450637975|FG002|Overall Study|Adverse Event|1|||
125276065|NCT03248531|450637973|FG000|Overall Study|Lost to Follow-up|1|||
125276066|NCT03248531|450637974|FG001|Overall Study|Lost to Follow-up|0|||
125276067|NCT03248531|450637975|FG002|Overall Study|Lost to Follow-up|5|||
125276068|NCT03248531|450637973|FG000|Overall Study|Withdrawal by Subject|3|||
125276069|NCT03248531|450637974|FG001|Overall Study|Withdrawal by Subject|3|||
125276070|NCT03248531|450637975|FG002|Overall Study|Withdrawal by Subject|2|||
125276071|NCT03248531|450637973|FG000|Overall Study|Sponsor Request|0|||
125276072|NCT03248531|450637974|FG001|Overall Study|Sponsor Request|2|||
125276073|NCT03248531|450637975|FG002|Overall Study|Sponsor Request|0|||
125276074|NCT04075513|450637976|FG000|Overall Study|Withdrawal by Subject|2|||
125276075|NCT04075513|450637977|FG001|Overall Study|Withdrawal by Subject|2|||
125276076|NCT04075513|450637976|FG000|Overall Study|Lack of Efficacy|1|||
125276077|NCT04075513|450637977|FG001|Overall Study|Lack of Efficacy|0|||
125276078|NCT04075513|450637976|FG000|Overall Study|Lost to Follow-up|4|||
125276079|NCT04075513|450637977|FG001|Overall Study|Lost to Follow-up|2|||
125276080|NCT04075513|450637976|FG000|Overall Study|Switch to insulin pump|1|||
125276081|NCT04075513|450637977|FG001|Overall Study|Switch to insulin pump|0|||
125276082|NCT01035463|450637978|FG000|Overall Study|Adverse Event|0|||
125276083|NCT01035463|450637979|FG001|Overall Study|Adverse Event|0|||
125276084|NCT01035463|450637980|FG002|Overall Study|Adverse Event|4|||
125276085|NCT01035463|450637981|FG003|Overall Study|Adverse Event|1|||
125276086|NCT01035463|450637982|FG004|Overall Study|Adverse Event|5|||
125276087|NCT01035463|450637983|FG005|Overall Study|Adverse Event|7|||
125276088|NCT01035463|450637978|FG000|Overall Study|Withdrawal by Subject|0|||
125276089|NCT01035463|450637979|FG001|Overall Study|Withdrawal by Subject|2|||
125276090|NCT01035463|450637980|FG002|Overall Study|Withdrawal by Subject|1|||
125276091|NCT01035463|450637981|FG003|Overall Study|Withdrawal by Subject|0|||
125276092|NCT01035463|450637982|FG004|Overall Study|Withdrawal by Subject|1|||
125276093|NCT01035463|450637983|FG005|Overall Study|Withdrawal by Subject|4|||
125276094|NCT01035463|450637978|FG000|Overall Study|Disease progression|0|||
125276095|NCT01035463|450637979|FG001|Overall Study|Disease progression|0|||
125276096|NCT01035463|450637980|FG002|Overall Study|Disease progression|0|||
125276097|NCT01035463|450637981|FG003|Overall Study|Disease progression|0|||
125276098|NCT01035463|450637982|FG004|Overall Study|Disease progression|0|||
125276099|NCT01035463|450637983|FG005|Overall Study|Disease progression|3|||
125276100|NCT01035463|450637978|FG000|Overall Study|Other Malignancy|0|||
125276101|NCT01035463|450637979|FG001|Overall Study|Other Malignancy|0|||
125276102|NCT01035463|450637980|FG002|Overall Study|Other Malignancy|0|||
125276103|NCT01035463|450637981|FG003|Overall Study|Other Malignancy|0|||
125276104|NCT01035463|450637982|FG004|Overall Study|Other Malignancy|0|||
125276105|NCT01035463|450637983|FG005|Overall Study|Other Malignancy|2|||
125276106|NCT01035463|450637978|FG000|Overall Study|Other|0|||
125276107|NCT01035463|450637979|FG001|Overall Study|Other|0|||
125276108|NCT01035463|450637980|FG002|Overall Study|Other|0|||
125276109|NCT01035463|450637981|FG003|Overall Study|Other|1|||
125276110|NCT01035463|450637982|FG004|Overall Study|Other|0|||
125276111|NCT01035463|450637983|FG005|Overall Study|Other|2|||
125276112|NCT00935493|450637993|FG000|Overall Study|Lost to Follow-up|1|||
125276113|NCT00935493|450637994|FG001|Overall Study|Lost to Follow-up|1|||
125276114|NCT00935493|450637995|FG002|Overall Study|Lost to Follow-up|1|||
125276115|NCT00935493|450637993|FG000|Overall Study|Treatment Discontinued|0|||
125276116|NCT00935493|450637994|FG001|Overall Study|Treatment Discontinued|1|||
125276117|NCT00935493|450637995|FG002|Overall Study|Treatment Discontinued|0|||
125276118|NCT04153981|450637996|FG000|Overall Study|Death|1|||
125276119|NCT04153981|450637996|FG000|Overall Study|Withdrawal by Subject|24|||
125276120|NCT04153981|450637996|FG000|Overall Study|Lost to Follow-up|1|||
125276121|NCT04153981|450637996|FG000|Overall Study|Physician Decision|1|||
125276122|NCT04153981|450637996|FG000|Overall Study|Due to Unavailable Glucometer|1|||
125276123|NCT04153981|450637996|FG000|Overall Study|Covid 19|52|||
125276124|NCT04153981|450637996|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
125276125|NCT04153981|450637996|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
125276126|NCT01355679|450637997|FG000|Overall Study|benign tumor types found at biopsy|2|||
125276127|NCT00964002|450638002|FG000|Overall Study|Protocol Violation|8|||
125276128|NCT00904670|450638003|FG000|Open Label Phase|Withdrawal by Subject|2|||
125276129|NCT00904670|450638004|FG001|Open Label Phase|Withdrawal by Subject|0|||
125276130|NCT00904670|450638003|FG000|Open Label Phase|Adverse Event|2|||
125276131|NCT00904670|450638004|FG001|Open Label Phase|Adverse Event|0|||
125276132|NCT00904670|450638003|FG000|Open Label Phase|Lack of Efficacy|1|||
125276133|NCT00904670|450638004|FG001|Open Label Phase|Lack of Efficacy|0|||
125276134|NCT00904670|450638003|FG000|Open Label Phase|Lost to Follow-up|1|||
125276135|NCT00904670|450638004|FG001|Open Label Phase|Lost to Follow-up|0|||
125276136|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
125276137|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
125276138|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
125276139|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
125276140|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Death|58|||
125276141|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Death|65|||
125276142|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Adverse Event|28|||
125276143|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Adverse Event|40|||
125276144|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Disease Progression|22|||
125276145|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Disease Progression|35|||
125276146|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Other|25|||
125276147|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Other|33|||
125276148|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
125276149|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
125276150|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Noncompliance|8|||
125276151|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Noncompliance|8|||
125276152|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
125276153|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
125276154|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
125276155|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
125276156|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
125276157|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
125276158|NCT00286091|450638005|FG000|Open-label Treatment Phase|Physician Decision|24|||
125276159|NCT00286091|450638006|FG001|Open-label Treatment Phase|Physician Decision|21|||
125276160|NCT00286091|450638005|FG000|Open-label Treatment Phase|Adverse Event|5|||
125276161|NCT00286091|450638006|FG001|Open-label Treatment Phase|Adverse Event|16|||
125276162|NCT00286091|450638005|FG000|Open-label Treatment Phase|Other|11|||
125276163|NCT00286091|450638006|FG001|Open-label Treatment Phase|Other|11|||
125276164|NCT00286091|450638005|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
125276165|NCT00286091|450638006|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
125276166|NCT00286091|450638005|FG000|Open-label Treatment Phase|Death|10|||
125276167|NCT00286091|450638006|FG001|Open-label Treatment Phase|Death|7|||
125276168|NCT00286091|450638005|FG000|Open-label Treatment Phase|Disease Progression|9|||
125276169|NCT00286091|450638006|FG001|Open-label Treatment Phase|Disease Progression|3|||
125276170|NCT00286091|450638005|FG000|Open-label Treatment Phase|Noncompliance|3|||
125276171|NCT00286091|450638006|FG001|Open-label Treatment Phase|Noncompliance|1|||
125276172|NCT00286091|450638005|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
125276173|NCT00286091|450638006|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
125276174|NCT00286091|450638005|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
125276175|NCT00286091|450638006|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
125276176|NCT00286091|450638005|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
125276177|NCT00286091|450638006|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
125276178|NCT03423238|450638007|FG000|Overall Study|Lost to Follow-up|1|||
125276179|NCT03423238|450638008|FG001|Overall Study|Lost to Follow-up|0|||
125276180|NCT03423238|450638007|FG000|Overall Study|Withdrawal by Subject|1|||
125276181|NCT03423238|450638008|FG001|Overall Study|Withdrawal by Subject|0|||
125276182|NCT02036580|450638009|FG000|Overall Study|Withdrawal by Subject|0|||
125276183|NCT02036580|450638010|FG001|Overall Study|Withdrawal by Subject|1|||
125276184|NCT02036580|450638011|FG002|Overall Study|Withdrawal by Subject|0|||
125276185|NCT02036580|450638009|FG000|Overall Study|Adverse Event|1|||
125276186|NCT02036580|450638010|FG001|Overall Study|Adverse Event|0|||
125276187|NCT02036580|450638011|FG002|Overall Study|Adverse Event|0|||
125276188|NCT02584452|450638012|FG000|Overall Study|Physician Decision|1|||
125276189|NCT02584452|450638013|FG001|Overall Study|Physician Decision|1|||
125276190|NCT02584452|450638012|FG000|Overall Study|Lost to Follow-up|1|||
125276191|NCT02584452|450638013|FG001|Overall Study|Lost to Follow-up|1|||
125276192|NCT00923351|450638014|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
125276193|NCT00923351|450638015|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
125276194|NCT00923351|450638016|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
125276195|NCT01536561|450638017|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
125276196|NCT01536561|450638017|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
125276197|NCT01536561|450638017|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
125276198|NCT01536561|450638017|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
125276199|NCT01536561|450638017|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
125276200|NCT01536561|450638017|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
125276201|NCT04552288|450638018|FG000|Overall Study|Death|3|||
125276202|NCT04552288|450638018|FG000|Overall Study|Lost to Follow-up|6|||
125276203|NCT04552288|450638018|FG000|Overall Study|Physician Decision|3|||
125276204|NCT04552288|450638018|FG000|Overall Study|Protocol Violation|9|||
125276205|NCT04552288|450638018|FG000|Overall Study|Withdrawal by Subject|6|||
125276206|NCT04552288|450638018|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
125276207|NCT05285644|450638019|FG000|Overall Study|Adverse Event|3|||
125276208|NCT05285644|450638020|FG001|Overall Study|Adverse Event|3|||
125276209|NCT05285644|450638019|FG000|Overall Study|Withdrawal of Consent|2|||
125276210|NCT05285644|450638020|FG001|Overall Study|Withdrawal of Consent|5|||
125276211|NCT05285644|450638019|FG000|Overall Study|Noncompliance|0|||
125276212|NCT05285644|450638020|FG001|Overall Study|Noncompliance|4|||
125276213|NCT05285644|450638019|FG000|Overall Study|Lost to Follow-up|4|||
125276214|NCT05285644|450638020|FG001|Overall Study|Lost to Follow-up|6|||
125276215|NCT05285644|450638019|FG000|Overall Study|Disallowed Concurrent Medication|1|||
125276216|NCT05285644|450638020|FG001|Overall Study|Disallowed Concurrent Medication|1|||
125276217|NCT05285644|450638019|FG000|Overall Study|Investigator Decision|2|||
125276218|NCT05285644|450638020|FG001|Overall Study|Investigator Decision|0|||
125276219|NCT05285644|450638019|FG000|Overall Study|Protocol Deviation|1|||
125276220|NCT05285644|450638020|FG001|Overall Study|Protocol Deviation|0|||
125276221|NCT05285644|450638019|FG000|Overall Study|As specified in the Clinical Study Report|7|||
125276222|NCT05285644|450638020|FG001|Overall Study|As specified in the Clinical Study Report|3|||
125276223|NCT04532294|450638021|FG000|Overall Study|Withdrawal by Subject|0|||
125276224|NCT04532294|450638022|FG001|Overall Study|Withdrawal by Subject|0|||
125276225|NCT04532294|450638023|FG002|Overall Study|Withdrawal by Subject|1|||
125276226|NCT04532294|450638021|FG000|Overall Study|Participants Not Dosed|0|||
125276227|NCT04532294|450638022|FG001|Overall Study|Participants Not Dosed|0|||
125276228|NCT04532294|450638023|FG002|Overall Study|Participants Not Dosed|2|||
125276229|NCT04295759|450638024|FG000|Overall Study|Lack of Efficacy|9|||
125276230|NCT04295759|450638024|FG000|Overall Study|Death|1|||
125276231|NCT04295759|450638024|FG000|Overall Study|Withdrawal by Subject|2|||
125276232|NCT04295759|450638024|FG000|Overall Study|Deemed ineligible|1|||
125276233|NCT01696981|450638025|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
125276234|NCT01696981|450638026|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
125276235|NCT01696981|450638025|FG000|Overall Study|Died Before Randomization|3|||
125276236|NCT01696981|450638026|FG001|Overall Study|Died Before Randomization|8|||
125276237|NCT01696981|450638025|FG000|Overall Study|Died Before ASU (Control)|278|||
125276238|NCT01696981|450638026|FG001|Overall Study|Died Before ASU (Control)|0|||
125276239|NCT01696981|450638025|FG000|Overall Study|Refused ASU (Control)|920|||
125276240|NCT01696981|450638026|FG001|Overall Study|Refused ASU (Control)|0|||
125276241|NCT01696981|450638025|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
125276242|NCT01696981|450638026|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
125276243|NCT02798315|450638027|FG000|Overall Study|Failure to return|1|||
125276244|NCT03335150|450638029|FG000|Overall Study|Withdrawal by Subject|10|||
125276245|NCT03335150|450638030|FG001|Overall Study|Withdrawal by Subject|4|||
125276246|NCT03335150|450638029|FG000|Overall Study|Adverse Event|0|||
125276247|NCT03335150|450638030|FG001|Overall Study|Adverse Event|1|||
125276248|NCT02097719|450638031|FG000|Overall Study|Subject Withdrew Consent|1|||
125276249|NCT02097719|450638032|FG001|Overall Study|Subject Withdrew Consent|0|||
125276250|NCT02097719|450638031|FG000|Overall Study|Lost to Follow-up|0|||
125276251|NCT02097719|450638032|FG001|Overall Study|Lost to Follow-up|1|||
125276252|NCT02097719|450638031|FG000|Overall Study|Adverse Event|2|||
125276253|NCT02097719|450638032|FG001|Overall Study|Adverse Event|0|||
125276254|NCT03028415|450638033|FG000|Overall Study|Lost to Follow-up|6|||
125276255|NCT03028415|450638034|FG001|Overall Study|Lost to Follow-up|3|||
125276256|NCT03028415|450638033|FG000|Overall Study|Withdrawal by Subject|1|||
125276257|NCT03028415|450638034|FG001|Overall Study|Withdrawal by Subject|0|||
125276258|NCT03028415|450638033|FG000|Overall Study|Discontinued due to COVID-19|1|||
125276259|NCT03028415|450638034|FG001|Overall Study|Discontinued due to COVID-19|0|||
125276260|NCT02907216|450638035|FG000|Overall Study|No benefit to be obtained by continuing|0|||
125276261|NCT02907216|450638036|FG001|Overall Study|No benefit to be obtained by continuing|1|||
125276262|NCT02907216|450638035|FG000|Overall Study|Withdrawal by Subject|1|||
125276263|NCT02907216|450638036|FG001|Overall Study|Withdrawal by Subject|0|||
125276264|NCT01854775|450638037|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
125276265|NCT01854775|450638038|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
125276266|NCT01854775|450638039|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
125276267|NCT01854775|450638037|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
125276268|NCT01854775|450638038|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
125276269|NCT01854775|450638039|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
125276270|NCT01854775|450638037|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
125276271|NCT01854775|450638038|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
125276272|NCT01854775|450638039|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
125276273|NCT01854775|450638037|FG000|Extension Phase|Pregnancy|3|||
125276274|NCT01854775|450638038|FG001|Extension Phase|Pregnancy|0|||
125276275|NCT01854775|450638039|FG002|Extension Phase|Pregnancy|0|||
125276276|NCT01854775|450638037|FG000|Extension Phase|Investigator's Discretion|1|||
125276277|NCT01854775|450638038|FG001|Extension Phase|Investigator's Discretion|0|||
125276278|NCT01854775|450638039|FG002|Extension Phase|Investigator's Discretion|0|||
125276279|NCT01854775|450638037|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
125276280|NCT01854775|450638038|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
125276281|NCT01854775|450638039|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
125276282|NCT01854775|450638037|FG000|Extension Phase|Lost to Follow-up|2|||
125276283|NCT01854775|450638038|FG001|Extension Phase|Lost to Follow-up|0|||
125276284|NCT01854775|450638039|FG002|Extension Phase|Lost to Follow-up|0|||
125276285|NCT01854775|450638037|FG000|Extension Phase|Still on Study|32|||
125276286|NCT01854775|450638038|FG001|Extension Phase|Still on Study|47|||
125276287|NCT01854775|450638039|FG002|Extension Phase|Still on Study|18|||
125276288|NCT04601532|450638042|FG000|Overall Study|Lost to Follow-up|1|||
125276289|NCT04601532|450638043|FG001|Overall Study|Lost to Follow-up|2|||
125276290|NCT04601532|450638042|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
125276291|NCT04601532|450638043|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
125276292|NCT03108521|450638044|FG000|Overall Study|Lost to Follow-up|3|||
125276293|NCT03108521|450638045|FG001|Overall Study|Lost to Follow-up|0|||
125276294|NCT03108521|450638044|FG000|Overall Study|Lack of Efficacy|2|||
125276295|NCT03108521|450638045|FG001|Overall Study|Lack of Efficacy|0|||
125276296|NCT03108521|450638044|FG000|Overall Study|Physician Decision|4|||
125276297|NCT03108521|450638045|FG001|Overall Study|Physician Decision|0|||
125276298|NCT03108521|450638044|FG000|Overall Study|Adverse Event|3|||
125276299|NCT03108521|450638045|FG001|Overall Study|Adverse Event|0|||
125276300|NCT06899737|450638046|FG000|Overall Study|Lost to Follow-up|19|||
125276301|NCT06899737|450638047|FG001|Overall Study|Lost to Follow-up|7|||
125276302|NCT01945216|450639922|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
125276303|NCT01945216|450639922|FG000|Overall Study|Protocol Violation|42|||
125276304|NCT01945216|450639922|FG000|Overall Study|CRF not assured by investigators|5|||
125276305|NCT03062280|450639926|FG000|Overall Study|Adverse Event|1|||
125276306|NCT03062280|450639926|FG000|Overall Study|Death|1|||
125276307|NCT03062280|450639926|FG000|Overall Study|Fertility Treatment|2|||
125276308|NCT03062280|450639926|FG000|Overall Study|Physician Decision|2|||
125276309|NCT03062280|450639926|FG000|Overall Study|Pregnancy|5|||
125276310|NCT03062280|450639926|FG000|Overall Study|Withdrawal by Subject|11|||
125276311|NCT04299308|450639927|FG000|Overall Study|Withdrawal by Subject|1|||
125276312|NCT04299308|450639928|FG001|Overall Study|Withdrawal by Subject|0|||
125276313|NCT04299308|450639927|FG000|Overall Study|issue with PET image (1)|1|||
125276314|NCT04299308|450639928|FG001|Overall Study|issue with PET image (1)|0|||
125276315|NCT05258890|450639929|FG000|Overall Study|Patient withdrawal|6|||
125276316|NCT05258890|450639930|FG001|Overall Study|Patient withdrawal|7|||
125276317|NCT05258890|450639929|FG000|Overall Study|Patient lost to follow-up|10|||
125276318|NCT05258890|450639930|FG001|Overall Study|Patient lost to follow-up|3|||
125276319|NCT05258890|450639929|FG000|Overall Study|Social network member withdrawal|1|||
125276320|NCT05258890|450639930|FG001|Overall Study|Social network member withdrawal|0|||
125276321|NCT05258890|450639929|FG000|Overall Study|Social network member lost to follow-up|5|||
125276322|NCT05258890|450639930|FG001|Overall Study|Social network member lost to follow-up|0|||
125276323|NCT05959447|450639933|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
125276324|NCT05959447|450639934|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
125276325|NCT05959447|450639933|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
125276326|NCT05959447|450639934|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
125276327|NCT05959447|450639933|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
125276328|NCT05959447|450639934|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
125276329|NCT05959447|450639933|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
125276330|NCT05959447|450639934|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
125276331|NCT00249808|450639936|FG000|Overall Study|Other|27|||
125276332|NCT00249808|450639936|FG000|Overall Study|Protocol Violation|3|||
125276333|NCT00249808|450639936|FG000|Overall Study|Lost to Follow-up|8|||
125276334|NCT00249808|450639936|FG000|Overall Study|Adverse Event|81|||
125276335|NCT00249808|450639936|FG000|Overall Study|Lack of Efficacy|52|||
125276336|NCT00249808|450639936|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
125276337|NCT02789345|450639937|FG000|Overall Study|Adverse Event|0|||
125276338|NCT02789345|450639938|FG001|Overall Study|Adverse Event|0|||
125276339|NCT02789345|450639939|FG002|Overall Study|Adverse Event|1|||
125276340|NCT02789345|450639937|FG000|Overall Study|Death|0|||
125276341|NCT02789345|450639938|FG001|Overall Study|Death|0|||
125276342|NCT02789345|450639939|FG002|Overall Study|Death|1|||
125276343|NCT02789345|450639937|FG000|Overall Study|Physician Decision|2|||
125276344|NCT02789345|450639938|FG001|Overall Study|Physician Decision|0|||
125276345|NCT02789345|450639939|FG002|Overall Study|Physician Decision|1|||
125276346|NCT02789345|450639937|FG000|Overall Study|Progressive Disease|1|||
125276347|NCT02789345|450639938|FG001|Overall Study|Progressive Disease|3|||
125276348|NCT02789345|450639939|FG002|Overall Study|Progressive Disease|14|||
125276349|NCT01804049|450639940|FG000|Overall Study|Adverse Event|2|||
125276350|NCT01804049|450639941|FG001|Overall Study|Adverse Event|10|||
125276351|NCT01804049|450639940|FG000|Overall Study|Lost to Follow-up|2|||
125276352|NCT01804049|450639941|FG001|Overall Study|Lost to Follow-up|1|||
125276353|NCT01804049|450639940|FG000|Overall Study|Decreased interest/personal|4|||
125276354|NCT01804049|450639941|FG001|Overall Study|Decreased interest/personal|5|||
125276355|NCT01804049|450639940|FG000|Overall Study|Other health concerns|2|||
125276356|NCT01804049|450639941|FG001|Overall Study|Other health concerns|7|||
125276357|NCT01804049|450639940|FG000|Overall Study|Moved out of area|0|||
125276358|NCT01804049|450639941|FG001|Overall Study|Moved out of area|7|||
125276359|NCT01804049|450639940|FG000|Overall Study|other MD recommended|1|||
125276360|NCT01804049|450639941|FG001|Overall Study|other MD recommended|1|||
125276361|NCT01804049|450639940|FG000|Overall Study|Enrollment in dual studies|0|||
125276362|NCT01804049|450639941|FG001|Overall Study|Enrollment in dual studies|1|||
125276363|NCT01147250|450639942|FG000|Overall Study|Lost to Follow-up|14|||
125276364|NCT01147250|450639943|FG001|Overall Study|Lost to Follow-up|11|||
125276365|NCT01147250|450639942|FG000|Overall Study|Withdrawal by Subject|83|||
125276366|NCT01147250|450639943|FG001|Overall Study|Withdrawal by Subject|88|||
125276367|NCT01147250|450639942|FG000|Overall Study|Site termination by sponsor|13|||
125276368|NCT01147250|450639943|FG001|Overall Study|Site termination by sponsor|5|||
125276369|NCT01147250|450639942|FG000|Overall Study|Other than specified|0|||
125276370|NCT01147250|450639943|FG001|Overall Study|Other than specified|1|||
125276371|NCT03985943|450639946|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
125276372|NCT03985943|450639947|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
125276373|NCT03985943|450639948|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
125276374|NCT03985943|450639949|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
125276375|NCT03985943|450639950|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
125276376|NCT03985943|450639951|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
125276377|NCT03985943|450639946|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
125276378|NCT03985943|450639947|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
125276379|NCT03985943|450639948|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
125276380|NCT03985943|450639949|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
125276381|NCT03985943|450639950|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
125276382|NCT03985943|450639951|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
125276383|NCT03985943|450639946|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
125276384|NCT03985943|450639947|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
125276385|NCT03985943|450639948|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
125276386|NCT03985943|450639949|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
125276387|NCT03985943|450639950|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
125276388|NCT03985943|450639951|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
125276389|NCT03985943|450639946|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
125276390|NCT03985943|450639947|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
125276391|NCT03985943|450639948|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
125276392|NCT03985943|450639949|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
125276393|NCT03985943|450639950|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
125276394|NCT03985943|450639951|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
125276395|NCT03985943|450639946|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
125276396|NCT03985943|450639947|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
125276397|NCT03985943|450639948|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
125276398|NCT03985943|450639949|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
125276399|NCT03985943|450639950|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
125276400|NCT03985943|450639951|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
125276401|NCT03985943|450639946|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
125276402|NCT03985943|450639947|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
125276403|NCT03985943|450639948|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
125276404|NCT03985943|450639949|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
125276405|NCT03985943|450639950|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
125276406|NCT03985943|450639951|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
125276407|NCT03985943|450639946|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
125276408|NCT03985943|450639947|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
125276409|NCT03985943|450639948|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
125276410|NCT03985943|450639949|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
125276411|NCT03985943|450639950|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
125276412|NCT03985943|450639951|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
125276413|NCT03985943|450639946|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
125276414|NCT03985943|450639947|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
125276415|NCT03985943|450639948|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
125276416|NCT03985943|450639949|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
125276417|NCT03985943|450639950|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
125276418|NCT03985943|450639951|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
125276419|NCT03985943|450639946|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
125276420|NCT03985943|450639947|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
125276421|NCT03985943|450639948|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
125276422|NCT03985943|450639949|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
125276423|NCT03985943|450639950|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
125276424|NCT03985943|450639951|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
125276425|NCT03985943|450639946|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
125276426|NCT03985943|450639947|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
125276427|NCT03985943|450639948|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
125276428|NCT03985943|450639949|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
125276429|NCT03985943|450639950|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
125276430|NCT03985943|450639951|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
125276431|NCT03985943|450639946|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
125276432|NCT03985943|450639947|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
125276433|NCT03985943|450639948|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
125276434|NCT03985943|450639949|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
125276435|NCT03985943|450639950|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
125276436|NCT03985943|450639951|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
125276437|NCT03985943|450639946|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125276438|NCT03985943|450639947|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125276439|NCT03985943|450639948|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125276440|NCT03985943|450639949|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
125276441|NCT03985943|450639950|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
125276442|NCT03985943|450639951|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
125276443|NCT03985943|450639946|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
125276444|NCT03985943|450639947|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
125276445|NCT03985943|450639948|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
125276446|NCT03985943|450639949|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
125276447|NCT03985943|450639950|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
125276448|NCT03985943|450639951|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
125276449|NCT03985943|450639946|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
125276450|NCT03985943|450639947|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
125276451|NCT03985943|450639948|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
125276452|NCT03985943|450639949|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
125276453|NCT03985943|450639950|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
125276454|NCT03985943|450639951|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
125276455|NCT03985943|450639946|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
125276456|NCT03985943|450639947|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
125276457|NCT03985943|450639948|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
125276458|NCT03985943|450639949|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
125276459|NCT03985943|450639950|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
125276460|NCT03985943|450639951|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
125276461|NCT00022763|450639955|FG000|Overall Study|Adverse Event|1|||
125276462|NCT00022763|450639956|FG001|Overall Study|Adverse Event|2|||
125276463|NCT00022763|450639955|FG000|Overall Study|Injection Site Reactions|0|||
125276464|NCT00022763|450639956|FG001|Overall Study|Injection Site Reactions|2|||
125276465|NCT00022763|450639955|FG000|Overall Study|Death|0|||
125276466|NCT00022763|450639956|FG001|Overall Study|Death|1|||
125276467|NCT00022763|450639955|FG000|Overall Study|Lost to Follow-up|0|||
125276468|NCT00022763|450639956|FG001|Overall Study|Lost to Follow-up|3|||
125276469|NCT00022763|450639955|FG000|Overall Study|Withdrawal by Subject|4|||
125276470|NCT00022763|450639956|FG001|Overall Study|Withdrawal by Subject|7|||
125276471|NCT00022763|450639955|FG000|Overall Study|Insufficient Therapy|1|||
125276472|NCT00022763|450639956|FG001|Overall Study|Insufficient Therapy|0|||
125276473|NCT00022763|450639955|FG000|Overall Study|Admin|3|||
125276474|NCT00022763|450639956|FG001|Overall Study|Admin|2|||
125276475|NCT00716482|450639957|FG000|Overall Study|Lost to Follow-up|6|||
125276476|NCT00716482|450639957|FG000|Overall Study|Inadequate acquisition or analysis|50|||
125276477|NCT00716482|450639957|FG000|Overall Study|no pathology obtained|10|||
125276478|NCT00716482|450639957|FG000|Overall Study|technical/machine error|28|||
125276479|NCT00716482|450639957|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
125276480|NCT01092780|450639958|FG000|Washout Period 1|Adverse Event|0|||
125276481|NCT01092780|450639959|FG001|Washout Period 1|Adverse Event|1|||
125276482|NCT01092780|450639960|FG002|Washout Period 1|Adverse Event|0|||
125276483|NCT01092780|450639961|FG003|Washout Period 1|Adverse Event|0|||
125276484|NCT01092780|450639958|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
125276485|NCT01092780|450639959|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
125276486|NCT01092780|450639960|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
125276487|NCT01092780|450639961|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
125276488|NCT01092780|450639958|FG000|Washout Period 2|Adverse Event|0|||
125276489|NCT01092780|450639959|FG001|Washout Period 2|Adverse Event|1|||
125276490|NCT01092780|450639960|FG002|Washout Period 2|Adverse Event|1|||
125276491|NCT01092780|450639961|FG003|Washout Period 2|Adverse Event|0|||
125276492|NCT01864148|450639962|FG000|Overall Study|Other|2|||
125276493|NCT01864148|450639963|FG001|Overall Study|Other|1|||
125276494|NCT01864148|450639964|FG002|Overall Study|Other|1|||
125276495|NCT01864148|450639965|FG003|Overall Study|Other|3|||
125276496|NCT01864148|450639966|FG004|Overall Study|Other|1|||
125276497|NCT01864148|450639962|FG000|Overall Study|Death|0|||
125276498|NCT01864148|450639963|FG001|Overall Study|Death|0|||
125276499|NCT01864148|450639964|FG002|Overall Study|Death|0|||
125276500|NCT01864148|450639965|FG003|Overall Study|Death|1|||
125276501|NCT01864148|450639966|FG004|Overall Study|Death|0|||
125276502|NCT01864148|450639962|FG000|Overall Study|Investigator Decision|5|||
125276503|NCT01864148|450639963|FG001|Overall Study|Investigator Decision|0|||
125276504|NCT01864148|450639964|FG002|Overall Study|Investigator Decision|0|||
125276505|NCT01864148|450639965|FG003|Overall Study|Investigator Decision|4|||
125276506|NCT01864148|450639966|FG004|Overall Study|Investigator Decision|6|||
125276507|NCT01864148|450639962|FG000|Overall Study|Withdrawal by Subject|9|||
125276508|NCT01864148|450639963|FG001|Overall Study|Withdrawal by Subject|2|||
125276509|NCT01864148|450639964|FG002|Overall Study|Withdrawal by Subject|6|||
125276510|NCT01864148|450639965|FG003|Overall Study|Withdrawal by Subject|8|||
125276511|NCT01864148|450639966|FG004|Overall Study|Withdrawal by Subject|8|||
125276512|NCT01864148|450639962|FG000|Overall Study|Lost to Follow-up|0|||
125276513|NCT01864148|450639963|FG001|Overall Study|Lost to Follow-up|0|||
125276514|NCT01864148|450639964|FG002|Overall Study|Lost to Follow-up|0|||
125276515|NCT01864148|450639965|FG003|Overall Study|Lost to Follow-up|2|||
125276516|NCT01864148|450639966|FG004|Overall Study|Lost to Follow-up|1|||
125276517|NCT01864148|450639962|FG000|Overall Study|Adverse Event|4|||
125276518|NCT01864148|450639963|FG001|Overall Study|Adverse Event|2|||
125276519|NCT01864148|450639964|FG002|Overall Study|Adverse Event|4|||
125276520|NCT01864148|450639965|FG003|Overall Study|Adverse Event|7|||
125276521|NCT01864148|450639966|FG004|Overall Study|Adverse Event|7|||
125276522|NCT01864148|450639962|FG000|Overall Study|Not Dosed|0|||
125276523|NCT01864148|450639963|FG001|Overall Study|Not Dosed|0|||
125276524|NCT01864148|450639964|FG002|Overall Study|Not Dosed|0|||
125276525|NCT01864148|450639965|FG003|Overall Study|Not Dosed|1|||
125276526|NCT01864148|450639966|FG004|Overall Study|Not Dosed|0|||
125276527|NCT02936869|450639975|FG000|Overall Study|Lost to Follow-up|1|||
125276528|NCT02936869|450639976|FG001|Overall Study|Lost to Follow-up|3|||
125276529|NCT02936869|450639975|FG000|Overall Study|Death|0|||
125276530|NCT02936869|450639976|FG001|Overall Study|Death|1|||
125276531|NCT02936869|450639975|FG000|Overall Study|Legal Case|0|||
125276532|NCT02936869|450639976|FG001|Overall Study|Legal Case|1|||
125276533|NCT02936869|450639975|FG000|Overall Study|Protocol Violation|1|||
125276534|NCT02936869|450639976|FG001|Overall Study|Protocol Violation|0|||
125276535|NCT00506454|450639977|FG000|Overall Study|Withdrawal by Subject|1|||
125276536|NCT00506454|450639978|FG001|Overall Study|Withdrawal by Subject|1|||
125276537|NCT00851552|450639979|FG000|Overall Study|Death|2|||
125276538|NCT00851552|450639979|FG000|Overall Study|Adverse Event|1|||
125276539|NCT00851552|450639979|FG000|Overall Study|Disease Progression|4|||
125276540|NCT02689206|450639980|FG000|Overall Study|Adverse Event|0|||
125276541|NCT02689206|450639981|FG001|Overall Study|Adverse Event|0|||
125276542|NCT02689206|450639982|FG002|Overall Study|Adverse Event|1|||
125276543|NCT02689206|450639983|FG003|Overall Study|Adverse Event|0|||
125276544|NCT02689206|450639984|FG004|Overall Study|Adverse Event|2|||
125276545|NCT02689206|450639980|FG000|Overall Study|Protocol Violation|1|||
125276546|NCT02689206|450639981|FG001|Overall Study|Protocol Violation|0|||
125276547|NCT02689206|450639982|FG002|Overall Study|Protocol Violation|0|||
125276548|NCT02689206|450639983|FG003|Overall Study|Protocol Violation|1|||
125276549|NCT02689206|450639984|FG004|Overall Study|Protocol Violation|2|||
125276550|NCT02689206|450639980|FG000|Overall Study|Other: Reached stopping criteria|0|||
125276551|NCT02689206|450639981|FG001|Overall Study|Other: Reached stopping criteria|1|||
125276552|NCT02689206|450639982|FG002|Overall Study|Other: Reached stopping criteria|2|||
125276553|NCT02689206|450639983|FG003|Overall Study|Other: Reached stopping criteria|3|||
125276554|NCT02689206|450639984|FG004|Overall Study|Other: Reached stopping criteria|4|||
125276555|NCT02689206|450639980|FG000|Overall Study|Physician Decision|1|||
125276556|NCT02689206|450639981|FG001|Overall Study|Physician Decision|0|||
125276557|NCT02689206|450639982|FG002|Overall Study|Physician Decision|0|||
125276558|NCT02689206|450639983|FG003|Overall Study|Physician Decision|0|||
125276559|NCT02689206|450639984|FG004|Overall Study|Physician Decision|0|||
125276560|NCT02689206|450639980|FG000|Overall Study|Withdrawal by Subject|1|||
125276561|NCT02689206|450639981|FG001|Overall Study|Withdrawal by Subject|0|||
125276562|NCT02689206|450639982|FG002|Overall Study|Withdrawal by Subject|1|||
125276563|NCT02689206|450639983|FG003|Overall Study|Withdrawal by Subject|0|||
125276564|NCT02689206|450639984|FG004|Overall Study|Withdrawal by Subject|0|||
125276565|NCT01558596|450639985|FG000|Overall Study|Withdrawal by Subject|1|||
125276566|NCT01558596|450639986|FG001|Overall Study|Withdrawal by Subject|0|||
125276567|NCT01558596|450639985|FG000|Overall Study|surgery elsewhere or cancelled|1|||
125276568|NCT01558596|450639986|FG001|Overall Study|surgery elsewhere or cancelled|1|||
125276569|NCT01558596|450639985|FG000|Overall Study|Protocol Violation|1|||
125276570|NCT01558596|450639986|FG001|Overall Study|Protocol Violation|0|||
125276571|NCT01479764|450639990|FG000|Randomized|Adverse Event|1|||
125276572|NCT01479764|450639991|FG001|Randomized|Adverse Event|1|||
125276573|NCT01479764|450639990|FG000|Randomized|Withdrawal by Subject|1|||
125276574|NCT01479764|450639991|FG001|Randomized|Withdrawal by Subject|0|||
125276575|NCT01479764|450639990|FG000|Treated|Lost to Follow-up|0|||
125276576|NCT01479764|450639991|FG001|Treated|Lost to Follow-up|2|||
125276577|NCT00902850|450639993|FG000|Overall Study|Physician Decision|2|||
125276578|NCT00902850|450639994|FG001|Overall Study|Physician Decision|2|||
125276579|NCT00260832|450639995|FG000|Overall Study|Adverse Event|26|||
125276580|NCT00260832|450639996|FG001|Overall Study|Adverse Event|19|||
125276581|NCT00260832|450639995|FG000|Overall Study|Progression|116|||
125276582|NCT00260832|450639996|FG001|Overall Study|Progression|96|||
125276583|NCT00260832|450639995|FG000|Overall Study|Withdrawal by Subject|15|||
125276584|NCT00260832|450639996|FG001|Overall Study|Withdrawal by Subject|17|||
125276585|NCT00260832|450639995|FG000|Overall Study|Physician Decision|15|||
125276586|NCT00260832|450639996|FG001|Overall Study|Physician Decision|9|||
125276587|NCT00260832|450639995|FG000|Overall Study|Death|43|||
125276588|NCT00260832|450639996|FG001|Overall Study|Death|62|||
125276589|NCT00260832|450639995|FG000|Overall Study|Other|10|||
125276590|NCT00260832|450639996|FG001|Overall Study|Other|7|||
125276591|NCT00260832|450639995|FG000|Overall Study|Protocol Violation|3|||
125276592|NCT00260832|450639996|FG001|Overall Study|Protocol Violation|1|||
125276593|NCT03745638|450639997|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
125276594|NCT03745638|450639998|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
125276595|NCT03745638|450639999|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
125276596|NCT03745638|450640000|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
125276597|NCT03745638|450640001|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
125276598|NCT03745638|450640002|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
125276599|NCT03745638|450640003|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
125276600|NCT03745638|450639997|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
125276601|NCT03745638|450639998|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125276602|NCT03745638|450639999|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125276603|NCT03745638|450640000|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125276604|NCT03745638|450640001|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125276605|NCT03745638|450640002|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125276606|NCT03745638|450640003|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125276607|NCT03745638|450639997|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
125276608|NCT03745638|450639998|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
125276609|NCT03745638|450639999|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
125276610|NCT03745638|450640000|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125276611|NCT03745638|450640001|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125276612|NCT03745638|450640002|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125276613|NCT03745638|450640003|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125276614|NCT03745638|450639997|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
125276615|NCT03745638|450639998|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
125276616|NCT03745638|450639999|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
125276617|NCT03745638|450640000|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
125276618|NCT03745638|450640001|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
125276619|NCT03745638|450640002|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
125276620|NCT03745638|450640003|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
125276621|NCT03745638|450639997|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
125276622|NCT03745638|450639998|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
125276623|NCT03745638|450639999|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
125276624|NCT03745638|450640000|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
125276625|NCT03745638|450640001|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
125276626|NCT03745638|450640002|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
125276627|NCT03745638|450640003|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
125276628|NCT03745638|450639997|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
125276629|NCT03745638|450639998|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
125276630|NCT03745638|450639999|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
125276631|NCT03745638|450640000|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
125276632|NCT03745638|450640001|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
125276633|NCT03745638|450640002|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
125276634|NCT03745638|450640003|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
125276635|NCT03745638|450639997|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
125276636|NCT03745638|450639998|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
125276637|NCT03745638|450639999|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
125276638|NCT03745638|450640000|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125276639|NCT03745638|450640001|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125276640|NCT03745638|450640002|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125276641|NCT03745638|450640003|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125276642|NCT03745638|450639997|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
125276643|NCT03745638|450639998|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
125276644|NCT03745638|450639999|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
125276645|NCT03745638|450640000|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
125276646|NCT03745638|450640001|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
125276647|NCT03745638|450640002|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
125276648|NCT03745638|450640003|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
125276649|NCT03745638|450639997|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
125276650|NCT03745638|450639998|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
125276651|NCT03745638|450639999|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
125276652|NCT03745638|450640000|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
125276653|NCT03745638|450640001|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
125276654|NCT03745638|450640002|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
125276655|NCT03745638|450640003|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
125276656|NCT03745638|450639997|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
125276657|NCT03745638|450639998|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
125276658|NCT03745638|450639999|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
125276659|NCT03745638|450640000|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
125276660|NCT03745638|450640001|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
125276661|NCT03745638|450640002|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
125276662|NCT03745638|450640003|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
125276663|NCT03745638|450639997|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
125276664|NCT03745638|450639998|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
125276665|NCT03745638|450639999|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
125276666|NCT03745638|450640000|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
125276667|NCT03745638|450640001|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
125276668|NCT03745638|450640002|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
125276669|NCT03745638|450640003|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
125276670|NCT03745638|450639997|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
125276671|NCT03745638|450639998|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
125276672|NCT03745638|450639999|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
125276673|NCT03745638|450640000|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
125276674|NCT03745638|450640001|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
125276675|NCT03745638|450640002|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
125276676|NCT03745638|450640003|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
125276677|NCT03745638|450639997|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
125276678|NCT03745638|450639998|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
125276679|NCT03745638|450639999|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
125276680|NCT03745638|450640000|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
125276681|NCT03745638|450640001|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
125276682|NCT03745638|450640002|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
125276683|NCT03745638|450640003|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
125276684|NCT03745638|450639997|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
125276685|NCT03745638|450639998|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
125276686|NCT03745638|450639999|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
125276687|NCT03745638|450640000|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
125276688|NCT03745638|450640001|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
125276689|NCT03745638|450640002|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
125276690|NCT03745638|450640003|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
125276691|NCT03745638|450639997|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
125276692|NCT03745638|450639998|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
125276693|NCT03745638|450639999|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
125276694|NCT03745638|450640000|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
125276695|NCT03745638|450640001|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
125276696|NCT03745638|450640002|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
125276697|NCT03745638|450640003|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
125276698|NCT04470050|450640006|FG000|Double-blind Treatment Phase|Adverse Event|0|||
125276699|NCT04470050|450640007|FG001|Double-blind Treatment Phase|Adverse Event|0|||
125276700|NCT04470050|450640008|FG002|Double-blind Treatment Phase|Adverse Event|0|||
125276701|NCT04470050|450640009|FG003|Double-blind Treatment Phase|Adverse Event|1|||
125276702|NCT04470050|450640010|FG004|Double-blind Treatment Phase|Adverse Event|0|||
125276703|NCT04470050|450640011|FG005|Double-blind Treatment Phase|Adverse Event|0|||
125276704|NCT04470050|450640012|FG006|Double-blind Treatment Phase|Adverse Event|0|||
125276705|NCT04470050|450640006|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
125276706|NCT04470050|450640007|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
125276707|NCT04470050|450640008|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
125276708|NCT04470050|450640009|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
125276709|NCT04470050|450640010|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
125276710|NCT04470050|450640011|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
125276711|NCT04470050|450640012|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
125276712|NCT04470050|450640006|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
125276713|NCT04470050|450640007|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
125276714|NCT04470050|450640008|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
125276715|NCT04470050|450640009|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
125276716|NCT04470050|450640010|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
125276717|NCT04470050|450640011|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
125276718|NCT04470050|450640012|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
125276719|NCT03585764|450640015|FG000|Overall Study|Death|3|||
125276720|NCT03585764|450640016|FG001|Overall Study|Death|2|||
125276721|NCT03585764|450640017|FG002|Overall Study|Death|3|||
125276722|NCT03585764|450640018|FG003|Overall Study|Death|0|||
125276723|NCT03585764|450640015|FG000|Overall Study|Lost to Follow-up|0|||
125276724|NCT03585764|450640016|FG001|Overall Study|Lost to Follow-up|1|||
125276725|NCT03585764|450640017|FG002|Overall Study|Lost to Follow-up|0|||
125276726|NCT03585764|450640018|FG003|Overall Study|Lost to Follow-up|0|||
125276727|NCT03585764|450640015|FG000|Overall Study|Physician Decision|0|||
125276728|NCT03585764|450640016|FG001|Overall Study|Physician Decision|0|||
125276729|NCT03585764|450640017|FG002|Overall Study|Physician Decision|2|||
125276730|NCT03585764|450640018|FG003|Overall Study|Physician Decision|0|||
125276731|NCT03640507|450640019|FG000|Overall Study|Withdrawal by Subject|0|||
125276732|NCT03640507|450640020|FG001|Overall Study|Withdrawal by Subject|0|||
125276733|NCT03640507|450640021|FG002|Overall Study|Withdrawal by Subject|1|||
125276734|NCT03604172|450640022|FG000|Overall Study|Lost to Follow-up|1|||
125276735|NCT03604172|450640023|FG001|Overall Study|Lost to Follow-up|2|||
125276736|NCT01270880|450640027|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
125276737|NCT00976716|450640028|FG000|Overall Study|Adverse Event|1|||
125276738|NCT04222699|450640029|FG000|Overall Study|Lost to Follow-up|2|||
125276739|NCT01606176|450640030|FG000|Overall Study|Adverse Event|2|||
125276740|NCT01606176|450640031|FG001|Overall Study|Adverse Event|3|||
125276741|NCT01606176|450640030|FG000|Overall Study|Disease progression|1|||
125276742|NCT01606176|450640031|FG001|Overall Study|Disease progression|0|||
125276743|NCT01606176|450640030|FG000|Overall Study|Withdrawal by Subject|1|||
125276744|NCT01606176|450640031|FG001|Overall Study|Withdrawal by Subject|0|||
125276745|NCT01832493|450640032|FG000|Overall Study|Physician Decision|2|||
125276746|NCT01832493|450640032|FG000|Overall Study|Protocol Violation|4|||
125276747|NCT01832493|450640032|FG000|Overall Study|Unable to place LV lead|2|||
125276748|NCT02993822|450640033|FG000|Overall Study|Lack of Efficacy|1|||
125276749|NCT02993822|450640034|FG001|Overall Study|Lack of Efficacy|1|||
125276750|NCT02993822|450640035|FG002|Overall Study|Lack of Efficacy|0|||
125276751|NCT02993822|450640036|FG003|Overall Study|Lack of Efficacy|0|||
125276752|NCT02993822|450640033|FG000|Overall Study|Protocol Violation|1|||
125276753|NCT02993822|450640034|FG001|Overall Study|Protocol Violation|0|||
125276754|NCT02993822|450640035|FG002|Overall Study|Protocol Violation|0|||
125276755|NCT02993822|450640036|FG003|Overall Study|Protocol Violation|0|||
125276756|NCT02993822|450640033|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
125276757|NCT02993822|450640034|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
125276758|NCT02993822|450640035|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
125276759|NCT02993822|450640036|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
125276760|NCT02993822|450640033|FG000|Overall Study|Adverse Event|3|||
125276761|NCT02993822|450640034|FG001|Overall Study|Adverse Event|1|||
125276762|NCT02993822|450640035|FG002|Overall Study|Adverse Event|7|||
125276763|NCT02993822|450640036|FG003|Overall Study|Adverse Event|0|||
125276764|NCT02993822|450640033|FG000|Overall Study|Withdrawal by Subject|4|||
125276765|NCT02993822|450640034|FG001|Overall Study|Withdrawal by Subject|2|||
125276766|NCT02993822|450640035|FG002|Overall Study|Withdrawal by Subject|2|||
125276767|NCT02993822|450640036|FG003|Overall Study|Withdrawal by Subject|3|||
125276768|NCT02993822|450640033|FG000|Overall Study|Lost to Follow-up|1|||
125276769|NCT02993822|450640034|FG001|Overall Study|Lost to Follow-up|0|||
125276770|NCT02993822|450640035|FG002|Overall Study|Lost to Follow-up|1|||
125276771|NCT02993822|450640036|FG003|Overall Study|Lost to Follow-up|0|||
125276772|NCT01732510|450640037|FG000|Overall Study|Adverse Event|0|||
125276773|NCT01732510|450640038|FG001|Overall Study|Adverse Event|1|||
125276774|NCT01732510|450640039|FG002|Overall Study|Adverse Event|1|||
125276775|NCT01732510|450640040|FG003|Overall Study|Adverse Event|0|||
125276776|NCT01732510|450640041|FG004|Overall Study|Adverse Event|0|||
125276777|NCT01732510|450640042|FG005|Overall Study|Adverse Event|0|||
125276778|NCT01732510|450640043|FG006|Overall Study|Adverse Event|1|||
125276779|NCT01732510|450640037|FG000|Overall Study|Protocol Violation|0|||
125276780|NCT01732510|450640038|FG001|Overall Study|Protocol Violation|0|||
125276781|NCT01732510|450640039|FG002|Overall Study|Protocol Violation|0|||
125276782|NCT01732510|450640040|FG003|Overall Study|Protocol Violation|1|||
125276783|NCT01732510|450640041|FG004|Overall Study|Protocol Violation|0|||
125276784|NCT01732510|450640042|FG005|Overall Study|Protocol Violation|0|||
125276785|NCT01732510|450640043|FG006|Overall Study|Protocol Violation|0|||
125276786|NCT01732510|450640037|FG000|Overall Study|Withdrawal by Subject|1|||
125276787|NCT01732510|450640038|FG001|Overall Study|Withdrawal by Subject|3|||
125276788|NCT01732510|450640039|FG002|Overall Study|Withdrawal by Subject|2|||
125276789|NCT01732510|450640040|FG003|Overall Study|Withdrawal by Subject|1|||
125276790|NCT01732510|450640041|FG004|Overall Study|Withdrawal by Subject|5|||
125276791|NCT01732510|450640042|FG005|Overall Study|Withdrawal by Subject|0|||
125276792|NCT01732510|450640043|FG006|Overall Study|Withdrawal by Subject|1|||
125276793|NCT01732510|450640037|FG000|Overall Study|Lost to Follow-up|0|||
125276794|NCT01732510|450640038|FG001|Overall Study|Lost to Follow-up|0|||
125276795|NCT01732510|450640039|FG002|Overall Study|Lost to Follow-up|1|||
125276796|NCT01732510|450640040|FG003|Overall Study|Lost to Follow-up|1|||
125276797|NCT01732510|450640041|FG004|Overall Study|Lost to Follow-up|0|||
125276798|NCT01732510|450640042|FG005|Overall Study|Lost to Follow-up|1|||
125276799|NCT01732510|450640043|FG006|Overall Study|Lost to Follow-up|0|||
125276800|NCT01732510|450640037|FG000|Overall Study|Physician Decision|0|||
125276801|NCT01732510|450640038|FG001|Overall Study|Physician Decision|1|||
125276802|NCT01732510|450640039|FG002|Overall Study|Physician Decision|0|||
125276803|NCT01732510|450640040|FG003|Overall Study|Physician Decision|0|||
125276804|NCT01732510|450640041|FG004|Overall Study|Physician Decision|0|||
125276805|NCT01732510|450640042|FG005|Overall Study|Physician Decision|0|||
125276806|NCT01732510|450640043|FG006|Overall Study|Physician Decision|0|||
125276807|NCT01732510|450640037|FG000|Overall Study|Pregnancy|0|||
125276808|NCT01732510|450640038|FG001|Overall Study|Pregnancy|0|||
125276809|NCT01732510|450640039|FG002|Overall Study|Pregnancy|0|||
125276810|NCT01732510|450640040|FG003|Overall Study|Pregnancy|1|||
125276811|NCT01732510|450640041|FG004|Overall Study|Pregnancy|0|||
125276812|NCT01732510|450640042|FG005|Overall Study|Pregnancy|0|||
125276813|NCT01732510|450640043|FG006|Overall Study|Pregnancy|0|||
125276814|NCT01732510|450640037|FG000|Overall Study|Study Terminated By Sponsor|0|||
125276815|NCT01732510|450640038|FG001|Overall Study|Study Terminated By Sponsor|0|||
125276816|NCT01732510|450640039|FG002|Overall Study|Study Terminated By Sponsor|0|||
125276817|NCT01732510|450640040|FG003|Overall Study|Study Terminated By Sponsor|1|||
125276818|NCT01732510|450640041|FG004|Overall Study|Study Terminated By Sponsor|0|||
125276819|NCT01732510|450640042|FG005|Overall Study|Study Terminated By Sponsor|12|||
125276820|NCT01732510|450640043|FG006|Overall Study|Study Terminated By Sponsor|6|||
125276821|NCT00313144|450640044|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
125276822|NCT00313144|450640044|FG000|Overall Study|Death|7|||
125276823|NCT00313144|450640044|FG000|Overall Study|Lost to Follow-up|5|||
125276824|NCT00313144|450640044|FG000|Overall Study|Withdrawal by Subject|4|||
125276825|NCT00313144|450640044|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
125276826|NCT00313144|450640044|FG000|Overall Study|Physician Decision|4|||
125276827|NCT00313144|450640044|FG000|Overall Study|Adverse event - transient|5|||
125276828|NCT00313144|450640044|FG000|Overall Study|Liver transplant|1|||
125276829|NCT00313144|450640044|FG000|Overall Study|Insurance (homecare provider) change|1|||
125276830|NCT00313144|450640044|FG000|Overall Study|Change to different product|1|||
125276831|NCT00313144|450640044|FG000|Overall Study|Due to termination of the study|66|||
125276832|NCT01221753|450640045|FG000|Overall Study|Adverse Event|1|||
125276833|NCT01262560|450640051|FG000|Overall Study|Protocol Violation|0|||
125276834|NCT01262560|450640052|FG001|Overall Study|Protocol Violation|1|||
125276835|NCT01262560|450640053|FG002|Overall Study|Protocol Violation|2|||
125276836|NCT03213938|450640054|FG000|Overall Study|Lost to Follow-up|4|||
125276837|NCT03213938|450640055|FG001|Overall Study|Lost to Follow-up|3|||
125276838|NCT03213938|450640054|FG000|Overall Study|Lack of Efficacy|1|||
125276839|NCT03213938|450640055|FG001|Overall Study|Lack of Efficacy|0|||
125276840|NCT03213938|450640054|FG000|Overall Study|Decline to participate|5|||
125276841|NCT03213938|450640055|FG001|Overall Study|Decline to participate|4|||
125276842|NCT03213938|450640054|FG000|Overall Study|Without reason|4|||
125276843|NCT03213938|450640055|FG001|Overall Study|Without reason|5|||
125276844|NCT04238481|450640056|FG000|Overall Study|Miscellaneous|0|||
125276845|NCT04238481|450640057|FG001|Overall Study|Miscellaneous|1|||
125276846|NCT04238481|450640058|FG002|Overall Study|Miscellaneous|0|||
125276847|NCT04238481|450640059|FG003|Overall Study|Miscellaneous|0|||
125276848|NCT00673231|450640060|FG000|Overall Study|Withdrawal by Subject|14|||
125276849|NCT00673231|450640061|FG001|Overall Study|Withdrawal by Subject|10|||
125276850|NCT00673231|450640062|FG002|Overall Study|Withdrawal by Subject|8|||
125276851|NCT00673231|450640063|FG003|Overall Study|Withdrawal by Subject|6|||
125276852|NCT00673231|450640060|FG000|Overall Study|Adverse Event|6|||
125276853|NCT00673231|450640061|FG001|Overall Study|Adverse Event|5|||
125276854|NCT00673231|450640062|FG002|Overall Study|Adverse Event|9|||
125276855|NCT00673231|450640063|FG003|Overall Study|Adverse Event|6|||
125276856|NCT00673231|450640060|FG000|Overall Study|Lost to Follow-up|1|||
125276857|NCT00673231|450640061|FG001|Overall Study|Lost to Follow-up|2|||
125276858|NCT00673231|450640062|FG002|Overall Study|Lost to Follow-up|1|||
125276859|NCT00673231|450640063|FG003|Overall Study|Lost to Follow-up|2|||
125276860|NCT00673231|450640060|FG000|Overall Study|Death|0|||
125276861|NCT00673231|450640061|FG001|Overall Study|Death|0|||
125276862|NCT00673231|450640062|FG002|Overall Study|Death|1|||
125276863|NCT00673231|450640063|FG003|Overall Study|Death|0|||
125276864|NCT00673231|450640060|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
125276865|NCT00673231|450640061|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
125276866|NCT00673231|450640062|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
125276867|NCT00673231|450640063|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
125276868|NCT03594747|450640064|FG000|Overall Study|Death|78|||
125276869|NCT03594747|450640065|FG001|Overall Study|Death|86|||
125276870|NCT03594747|450640066|FG002|Overall Study|Death|87|||
125276871|NCT03594747|450640064|FG000|Overall Study|Withdrawal by Subject|5|||
125276872|NCT03594747|450640065|FG001|Overall Study|Withdrawal by Subject|2|||
125276873|NCT03594747|450640066|FG002|Overall Study|Withdrawal by Subject|11|||
125276874|NCT03594747|450640064|FG000|Overall Study|Lost to Follow-up|4|||
125276875|NCT03594747|450640065|FG001|Overall Study|Lost to Follow-up|1|||
125276876|NCT03594747|450640066|FG002|Overall Study|Lost to Follow-up|1|||
125276877|NCT03594747|450640064|FG000|Overall Study|Physician Decision|0|||
125276878|NCT03594747|450640065|FG001|Overall Study|Physician Decision|1|||
125276879|NCT03594747|450640066|FG002|Overall Study|Physician Decision|0|||
125276880|NCT03594747|450640064|FG000|Overall Study|Sponsor decision|23|||
125276881|NCT03594747|450640065|FG001|Overall Study|Sponsor decision|17|||
125276882|NCT03594747|450640066|FG002|Overall Study|Sponsor decision|16|||
125276883|NCT03594747|450640064|FG000|Overall Study|Did not meet inclusion criteria|0|||
125276884|NCT03594747|450640065|FG001|Overall Study|Did not meet inclusion criteria|0|||
125276885|NCT03594747|450640066|FG002|Overall Study|Did not meet inclusion criteria|1|||
125276886|NCT03594747|450640064|FG000|Overall Study|Transfer to long term extension study|10|||
125276887|NCT03594747|450640065|FG001|Overall Study|Transfer to long term extension study|12|||
125276888|NCT03594747|450640066|FG002|Overall Study|Transfer to long term extension study|5|||
125276889|NCT01063062|450640069|FG000|Overall Study|Patient withdrew consent|0|||
125276890|NCT01063062|450640070|FG001|Overall Study|Patient withdrew consent|1|||
125276891|NCT01063062|450640069|FG000|Overall Study|Adverse Event|2|||
125276892|NCT01063062|450640070|FG001|Overall Study|Adverse Event|4|||
125276893|NCT01063062|450640069|FG000|Overall Study|Protocol Violation|5|||
125276894|NCT01063062|450640070|FG001|Overall Study|Protocol Violation|4|||
125276895|NCT01063062|450640069|FG000|Overall Study|Investigator's request|1|||
125276896|NCT01063062|450640070|FG001|Overall Study|Investigator's request|0|||
125276897|NCT01063062|450640069|FG000|Overall Study|Lost to Follow-up|0|||
125276898|NCT01063062|450640070|FG001|Overall Study|Lost to Follow-up|2|||
125276899|NCT01063062|450640069|FG000|Overall Study|Miscellaneous reason|0|||
125276900|NCT01063062|450640070|FG001|Overall Study|Miscellaneous reason|1|||
125276901|NCT02015481|450640075|FG000|Overall Study|Death|1|||
125276902|NCT02485639|450640076|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
125276903|NCT02485639|450640076|FG000|Overall Study|Early termination|4|||
125276904|NCT02485639|450640076|FG000|Overall Study|Withdrawal by Subject|4|||
125276905|NCT02597452|450640077|FG000|Overall Study|testing incomplete|30|||
125276906|NCT02566785|450640084|FG000|Overall Study|Lost to Follow-up|0|||
125276907|NCT02566785|450640085|FG001|Overall Study|Lost to Follow-up|2|||
125276908|NCT02566785|450640084|FG000|Overall Study|Worsening condition|1|||
125276909|NCT02566785|450640085|FG001|Overall Study|Worsening condition|1|||
125276910|NCT00281099|450640086|FG000|Overall Study|Death|46|||
125276911|NCT00281099|450640087|FG001|Overall Study|Death|57|||
125276912|NCT00281099|450640086|FG000|Overall Study|Lost to Follow-up|10|||
125276913|NCT00281099|450640087|FG001|Overall Study|Lost to Follow-up|19|||
125276914|NCT00281099|450640086|FG000|Overall Study|Withdrawal by Subject|65|||
125276915|NCT00281099|450640087|FG001|Overall Study|Withdrawal by Subject|70|||
125276916|NCT00281099|450640086|FG000|Overall Study|Physician Decision|79|||
125276917|NCT00281099|450640087|FG001|Overall Study|Physician Decision|72|||
125276918|NCT00281099|450640086|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
125276919|NCT00281099|450640087|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
125276920|NCT04621240|450640088|FG000|Overall Study|Withdrawal by Subject|36|||
125276921|NCT02147197|450640089|FG000|Overall Study|Adverse Event|1|||
125276922|NCT02147197|450640090|FG001|Overall Study|Adverse Event|0|||
125276923|NCT02147197|450640091|FG002|Overall Study|Adverse Event|0|||
125276924|NCT02147197|450640089|FG000|Overall Study|Withdrawal of Consent|4|||
125276925|NCT02147197|450640090|FG001|Overall Study|Withdrawal of Consent|3|||
125276926|NCT02147197|450640091|FG002|Overall Study|Withdrawal of Consent|2|||
125276927|NCT02147197|450640089|FG000|Overall Study|Lost to Follow-up|2|||
125276928|NCT02147197|450640090|FG001|Overall Study|Lost to Follow-up|3|||
125276929|NCT02147197|450640091|FG002|Overall Study|Lost to Follow-up|1|||
125276930|NCT02147197|450640089|FG000|Overall Study|Protocol Violation|1|||
125276931|NCT02147197|450640090|FG001|Overall Study|Protocol Violation|0|||
125276932|NCT02147197|450640091|FG002|Overall Study|Protocol Violation|3|||
125276933|NCT02147197|450640089|FG000|Overall Study|Other Miscellaneous Reasons|1|||
125276934|NCT02147197|450640090|FG001|Overall Study|Other Miscellaneous Reasons|0|||
125276935|NCT02147197|450640091|FG002|Overall Study|Other Miscellaneous Reasons|3|||
125276936|NCT02744612|450642103|FG000|Overall Study|Withdrawal by Subject|0|||
125276937|NCT02744612|450642104|FG001|Overall Study|Withdrawal by Subject|2|||
125276938|NCT02712983|450642106|FG000|Treatment Phase|Adverse Event|3|||
125276939|NCT02712983|450642107|FG001|Treatment Phase|Adverse Event|1|||
125276940|NCT02712983|450642108|FG002|Treatment Phase|Adverse Event|1|||
125276941|NCT02712983|450642109|FG003|Treatment Phase|Adverse Event|4|||
125276942|NCT02712983|450642110|FG004|Treatment Phase|Adverse Event|3|||
125276943|NCT02712983|450642111|FG005|Treatment Phase|Adverse Event|0|||
125276944|NCT02712983|450642112|FG006|Treatment Phase|Adverse Event|6|||
125276945|NCT02712983|450642113|FG007|Treatment Phase|Adverse Event|6|||
125276946|NCT02712983|450642114|FG008|Treatment Phase|Adverse Event|1|||
125276947|NCT02712983|450642106|FG000|Treatment Phase|Protocol Deviation|0|||
125276948|NCT02712983|450642107|FG001|Treatment Phase|Protocol Deviation|0|||
125276949|NCT02712983|450642108|FG002|Treatment Phase|Protocol Deviation|0|||
125276950|NCT02712983|450642109|FG003|Treatment Phase|Protocol Deviation|2|||
125276951|NCT02712983|450642110|FG004|Treatment Phase|Protocol Deviation|0|||
125276952|NCT02712983|450642111|FG005|Treatment Phase|Protocol Deviation|0|||
125276953|NCT02712983|450642112|FG006|Treatment Phase|Protocol Deviation|1|||
125276954|NCT02712983|450642113|FG007|Treatment Phase|Protocol Deviation|0|||
125276955|NCT02712983|450642114|FG008|Treatment Phase|Protocol Deviation|0|||
125276956|NCT02712983|450642106|FG000|Treatment Phase|Technical Problems|0|||
125276957|NCT02712983|450642107|FG001|Treatment Phase|Technical Problems|0|||
125276958|NCT02712983|450642108|FG002|Treatment Phase|Technical Problems|0|||
125276959|NCT02712983|450642109|FG003|Treatment Phase|Technical Problems|0|||
125276960|NCT02712983|450642110|FG004|Treatment Phase|Technical Problems|0|||
125276961|NCT02712983|450642111|FG005|Treatment Phase|Technical Problems|0|||
125276962|NCT02712983|450642112|FG006|Treatment Phase|Technical Problems|1|||
125276963|NCT02712983|450642113|FG007|Treatment Phase|Technical Problems|0|||
125276964|NCT02712983|450642114|FG008|Treatment Phase|Technical Problems|0|||
125276965|NCT02712983|450642106|FG000|Treatment Phase|Physician Decision|0|||
125276966|NCT02712983|450642107|FG001|Treatment Phase|Physician Decision|0|||
125276967|NCT02712983|450642108|FG002|Treatment Phase|Physician Decision|0|||
125276968|NCT02712983|450642109|FG003|Treatment Phase|Physician Decision|0|||
125276969|NCT02712983|450642110|FG004|Treatment Phase|Physician Decision|0|||
125276970|NCT02712983|450642111|FG005|Treatment Phase|Physician Decision|0|||
125276971|NCT02712983|450642112|FG006|Treatment Phase|Physician Decision|0|||
125276972|NCT02712983|450642113|FG007|Treatment Phase|Physician Decision|1|||
125276973|NCT02712983|450642114|FG008|Treatment Phase|Physician Decision|1|||
125276974|NCT02712983|450642106|FG000|Treatment Phase|Subject Decision|2|||
125276975|NCT02712983|450642107|FG001|Treatment Phase|Subject Decision|0|||
125276976|NCT02712983|450642108|FG002|Treatment Phase|Subject Decision|0|||
125276977|NCT02712983|450642109|FG003|Treatment Phase|Subject Decision|2|||
125276978|NCT02712983|450642110|FG004|Treatment Phase|Subject Decision|1|||
125276979|NCT02712983|450642111|FG005|Treatment Phase|Subject Decision|0|||
125276980|NCT02712983|450642112|FG006|Treatment Phase|Subject Decision|1|||
125276981|NCT02712983|450642113|FG007|Treatment Phase|Subject Decision|2|||
125276982|NCT02712983|450642114|FG008|Treatment Phase|Subject Decision|0|||
125276983|NCT02712983|450642106|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
125276984|NCT02712983|450642107|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
125276985|NCT02712983|450642108|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
125276986|NCT02712983|450642109|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
125276987|NCT02712983|450642110|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
125276988|NCT02712983|450642111|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
125276989|NCT02712983|450642112|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
125276990|NCT02712983|450642113|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
125276991|NCT02712983|450642114|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
125276992|NCT02712983|450642106|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
125276993|NCT02712983|450642107|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
125276994|NCT02712983|450642108|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
125276995|NCT02712983|450642109|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
125276996|NCT02712983|450642110|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
125276997|NCT02712983|450642111|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
125276998|NCT02712983|450642112|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
125276999|NCT02712983|450642113|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
125277000|NCT02712983|450642114|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
125277001|NCT02712983|450642106|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
125277002|NCT02712983|450642107|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
125277003|NCT02712983|450642108|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
125277004|NCT02712983|450642109|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
125277005|NCT02712983|450642110|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
125277006|NCT02712983|450642111|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
125277007|NCT02712983|450642112|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
125277008|NCT02712983|450642113|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
125277009|NCT02712983|450642114|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
125277010|NCT05360966|450642115|FG000|Overall Study|Adverse Event|5|||
125277011|NCT05360966|450642116|FG001|Overall Study|Adverse Event|5|||
125277012|NCT05360966|450642115|FG000|Overall Study|Withdrawal of Consent|5|||
125277013|NCT05360966|450642116|FG001|Overall Study|Withdrawal of Consent|3|||
125277014|NCT05360966|450642115|FG000|Overall Study|Noncompliance|2|||
125277015|NCT05360966|450642116|FG001|Overall Study|Noncompliance|1|||
125277016|NCT05360966|450642115|FG000|Overall Study|Lost to Follow-up|2|||
125277017|NCT05360966|450642116|FG001|Overall Study|Lost to Follow-up|3|||
125277018|NCT05360966|450642115|FG000|Overall Study|Protocol Deviation|2|||
125277019|NCT05360966|450642116|FG001|Overall Study|Protocol Deviation|1|||
125277020|NCT05360966|450642115|FG000|Overall Study|As specified in the Clinical Study Report|1|||
125277021|NCT05360966|450642116|FG001|Overall Study|As specified in the Clinical Study Report|3|||
125277022|NCT03522246|450642117|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
125277023|NCT03522246|450642118|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
125277024|NCT03522246|450642119|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
125277025|NCT03522246|450642120|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
125277026|NCT03522246|450642121|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
125277027|NCT04683029|450642122|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
125277028|NCT04683029|450642123|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
125277029|NCT04683029|450642124|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
125277030|NCT04683029|450642125|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
125277031|NCT04683029|450642122|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
125277032|NCT04683029|450642123|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
125277033|NCT04683029|450642124|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
125277034|NCT04683029|450642125|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
125277035|NCT04683029|450642122|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
125277036|NCT04683029|450642123|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
125277037|NCT04683029|450642124|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
125277038|NCT04683029|450642125|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
125277039|NCT04493424|450642126|FG000|Overall Study|Termination of the trial by the sponsor|89|||
125277040|NCT04493424|450642126|FG000|Overall Study|Withdrawal by Subject|9|||
125277041|NCT04493424|450642126|FG000|Overall Study|Lost to Follow-up|2|||
125277042|NCT04493424|450642126|FG000|Overall Study|Lack of Efficacy|3|||
125277043|NCT04493424|450642126|FG000|Overall Study|Adverse Event|5|||
125277044|NCT00814580|450642127|FG000|Overall Study|Adverse Event|6|||
125277045|NCT00814580|450642128|FG001|Overall Study|Adverse Event|15|||
125277046|NCT00814580|450642127|FG000|Overall Study|Lack of Efficacy|18|||
125277047|NCT00814580|450642128|FG001|Overall Study|Lack of Efficacy|25|||
125277048|NCT00814580|450642127|FG000|Overall Study|Protocol Violation|2|||
125277049|NCT00814580|450642128|FG001|Overall Study|Protocol Violation|0|||
125277050|NCT00814580|450642127|FG000|Overall Study|Withdrawal by Subject|2|||
125277051|NCT00814580|450642128|FG001|Overall Study|Withdrawal by Subject|2|||
125277052|NCT00814580|450642127|FG000|Overall Study|Other|1|||
125277053|NCT00814580|450642128|FG001|Overall Study|Other|3|||
125277054|NCT00814580|450642127|FG000|Overall Study|Did Not Take Drug|2|||
125277055|NCT00814580|450642128|FG001|Overall Study|Did Not Take Drug|2|||
125277056|NCT02482428|450642129|FG000|Overall Study|Lost to Follow-up|4|||
125277057|NCT02482428|450642130|FG001|Overall Study|Lost to Follow-up|9|||
125277058|NCT02482428|450642131|FG002|Overall Study|Lost to Follow-up|1|||
125277059|NCT02482428|450642132|FG003|Overall Study|Lost to Follow-up|2|||
125277060|NCT02482428|450642133|FG004|Overall Study|Lost to Follow-up|4|||
125277061|NCT02482428|450642129|FG000|Overall Study|Physician Decision|0|||
125277062|NCT02482428|450642130|FG001|Overall Study|Physician Decision|0|||
125277063|NCT02482428|450642131|FG002|Overall Study|Physician Decision|0|||
125277064|NCT02482428|450642132|FG003|Overall Study|Physician Decision|0|||
125277065|NCT02482428|450642133|FG004|Overall Study|Physician Decision|1|||
125277066|NCT02482428|450642129|FG000|Overall Study|protocol deviation|1|||
125277067|NCT02482428|450642130|FG001|Overall Study|protocol deviation|1|||
125277068|NCT02482428|450642131|FG002|Overall Study|protocol deviation|0|||
125277069|NCT02482428|450642132|FG003|Overall Study|protocol deviation|0|||
125277070|NCT02482428|450642133|FG004|Overall Study|protocol deviation|0|||
125277071|NCT02482428|450642129|FG000|Overall Study|subject/guardian decision|4|||
125277072|NCT02482428|450642130|FG001|Overall Study|subject/guardian decision|2|||
125277073|NCT02482428|450642131|FG002|Overall Study|subject/guardian decision|0|||
125277074|NCT02482428|450642132|FG003|Overall Study|subject/guardian decision|0|||
125277075|NCT02482428|450642133|FG004|Overall Study|subject/guardian decision|2|||
125277076|NCT05924165|450642137|FG000|Overall Study|Physician Decision|2|||
125277077|NCT05924165|450642138|FG001|Overall Study|Physician Decision|3|||
125277078|NCT04075292|450642139|FG000|Overall Study|Withdrawal by Subject|1|||
125277079|NCT04075292|450642140|FG001|Overall Study|Withdrawal by Subject|9|||
125277080|NCT04075292|450642139|FG000|Overall Study|Death|2|||
125277081|NCT04075292|450642140|FG001|Overall Study|Death|5|||
125277082|NCT04075292|450642139|FG000|Overall Study|Remained on study at time of DCO|74|||
125277083|NCT04075292|450642140|FG001|Overall Study|Remained on study at time of DCO|64|||
125277084|NCT04308239|450642141|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
125277085|NCT04308239|450642142|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
125277086|NCT04308239|450642141|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
125277087|NCT04308239|450642142|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
125277088|NCT04308239|450642141|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
125277089|NCT04308239|450642142|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
125277090|NCT04308239|450642141|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
125277091|NCT04308239|450642142|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
125277092|NCT00459875|450642145|FG000|Overall Study|Ineligible participant|1|||
125277093|NCT00459875|450642145|FG000|Overall Study|Adverse Event|2|||
125277094|NCT01436656|450642150|FG000|Dose Escalation|Death|1|||
125277095|NCT01436656|450642151|FG001|Dose Escalation|Death|3|||
125277096|NCT01436656|450642152|FG002|Dose Escalation|Death|1|||
125277097|NCT01436656|450642153|FG003|Dose Escalation|Death|0|||
125277098|NCT01436656|450642154|FG004|Dose Escalation|Death|2|||
125277099|NCT01436656|450642155|FG005|Dose Escalation|Death|1|||
125277100|NCT01436656|450642156|FG006|Dose Escalation|Death|1|||
125277101|NCT01436656|450642157|FG007|Dose Escalation|Death|1|||
125277102|NCT01436656|450642158|FG008|Dose Escalation|Death|1|||
125277103|NCT01436656|450642159|FG009|Dose Escalation|Death|0|||
125277104|NCT01436656|450642160|FG010|Dose Escalation|Death|0|||
125277105|NCT01436656|450642161|FG011|Dose Escalation|Death|0|||
125277106|NCT01436656|450642162|FG012|Dose Escalation|Death|0|||
125277107|NCT01436656|450642163|FG013|Dose Escalation|Death|0|||
125277108|NCT01436656|450642164|FG014|Dose Escalation|Death|0|||
125277109|NCT01436656|450642165|FG015|Dose Escalation|Death|0|||
125277110|NCT01436656|450642166|FG016|Dose Escalation|Death|0|||
125277111|NCT01436656|450642167|FG017|Dose Escalation|Death|0|||
125277112|NCT01436656|450642150|FG000|Dose Escalation|Protocol Violation|0|||
125277113|NCT01436656|450642151|FG001|Dose Escalation|Protocol Violation|0|||
125277114|NCT01436656|450642152|FG002|Dose Escalation|Protocol Violation|0|||
125277115|NCT01436656|450642153|FG003|Dose Escalation|Protocol Violation|0|||
125277116|NCT01436656|450642154|FG004|Dose Escalation|Protocol Violation|0|||
125277117|NCT01436656|450642155|FG005|Dose Escalation|Protocol Violation|1|||
125277118|NCT01436656|450642156|FG006|Dose Escalation|Protocol Violation|0|||
125277119|NCT01436656|450642157|FG007|Dose Escalation|Protocol Violation|0|||
125277120|NCT01436656|450642158|FG008|Dose Escalation|Protocol Violation|0|||
125277121|NCT01436656|450642159|FG009|Dose Escalation|Protocol Violation|0|||
125277122|NCT01436656|450642160|FG010|Dose Escalation|Protocol Violation|0|||
125277123|NCT01436656|450642161|FG011|Dose Escalation|Protocol Violation|0|||
125277124|NCT01436656|450642162|FG012|Dose Escalation|Protocol Violation|0|||
125277125|NCT01436656|450642163|FG013|Dose Escalation|Protocol Violation|0|||
125277126|NCT01436656|450642164|FG014|Dose Escalation|Protocol Violation|0|||
125277127|NCT01436656|450642165|FG015|Dose Escalation|Protocol Violation|0|||
125277128|NCT01436656|450642166|FG016|Dose Escalation|Protocol Violation|0|||
125277129|NCT01436656|450642167|FG017|Dose Escalation|Protocol Violation|0|||
125277130|NCT01436656|450642150|FG000|Dose Escalation|Withdrawal by Subject|0|||
125277131|NCT01436656|450642151|FG001|Dose Escalation|Withdrawal by Subject|0|||
125277132|NCT01436656|450642152|FG002|Dose Escalation|Withdrawal by Subject|0|||
125277133|NCT01436656|450642153|FG003|Dose Escalation|Withdrawal by Subject|0|||
125277134|NCT01436656|450642154|FG004|Dose Escalation|Withdrawal by Subject|1|||
125277135|NCT01436656|450642155|FG005|Dose Escalation|Withdrawal by Subject|0|||
125277136|NCT01436656|450642156|FG006|Dose Escalation|Withdrawal by Subject|0|||
125277137|NCT01436656|450642157|FG007|Dose Escalation|Withdrawal by Subject|2|||
125277138|NCT01436656|450642158|FG008|Dose Escalation|Withdrawal by Subject|0|||
125277139|NCT01436656|450642159|FG009|Dose Escalation|Withdrawal by Subject|1|||
125277140|NCT01436656|450642160|FG010|Dose Escalation|Withdrawal by Subject|1|||
125277141|NCT01436656|450642161|FG011|Dose Escalation|Withdrawal by Subject|0|||
125277142|NCT01436656|450642162|FG012|Dose Escalation|Withdrawal by Subject|0|||
125277143|NCT01436656|450642163|FG013|Dose Escalation|Withdrawal by Subject|0|||
125277144|NCT01436656|450642164|FG014|Dose Escalation|Withdrawal by Subject|0|||
125277145|NCT01436656|450642165|FG015|Dose Escalation|Withdrawal by Subject|0|||
125277146|NCT01436656|450642166|FG016|Dose Escalation|Withdrawal by Subject|0|||
125277147|NCT01436656|450642167|FG017|Dose Escalation|Withdrawal by Subject|0|||
125277148|NCT01436656|450642150|FG000|Dose Escalation|Administrative problems|0|||
125277149|NCT01436656|450642151|FG001|Dose Escalation|Administrative problems|1|||
125277150|NCT01436656|450642152|FG002|Dose Escalation|Administrative problems|0|||
125277151|NCT01436656|450642153|FG003|Dose Escalation|Administrative problems|0|||
125277152|NCT01436656|450642154|FG004|Dose Escalation|Administrative problems|0|||
125277153|NCT01436656|450642155|FG005|Dose Escalation|Administrative problems|0|||
125277154|NCT01436656|450642156|FG006|Dose Escalation|Administrative problems|0|||
125277155|NCT01436656|450642157|FG007|Dose Escalation|Administrative problems|0|||
125277156|NCT01436656|450642158|FG008|Dose Escalation|Administrative problems|0|||
125277157|NCT01436656|450642159|FG009|Dose Escalation|Administrative problems|0|||
125277158|NCT01436656|450642160|FG010|Dose Escalation|Administrative problems|0|||
125277159|NCT01436656|450642161|FG011|Dose Escalation|Administrative problems|0|||
125277160|NCT01436656|450642162|FG012|Dose Escalation|Administrative problems|0|||
125277161|NCT01436656|450642163|FG013|Dose Escalation|Administrative problems|0|||
125277162|NCT01436656|450642164|FG014|Dose Escalation|Administrative problems|0|||
125277163|NCT01436656|450642165|FG015|Dose Escalation|Administrative problems|0|||
125277164|NCT01436656|450642166|FG016|Dose Escalation|Administrative problems|0|||
125277165|NCT01436656|450642167|FG017|Dose Escalation|Administrative problems|0|||
125277166|NCT01436656|450642150|FG000|Dose Escalation|Lost to Follow-up|1|||
125277167|NCT01436656|450642151|FG001|Dose Escalation|Lost to Follow-up|0|||
125277168|NCT01436656|450642152|FG002|Dose Escalation|Lost to Follow-up|0|||
125277169|NCT01436656|450642153|FG003|Dose Escalation|Lost to Follow-up|0|||
125277170|NCT01436656|450642154|FG004|Dose Escalation|Lost to Follow-up|1|||
125277171|NCT01436656|450642155|FG005|Dose Escalation|Lost to Follow-up|0|||
125277172|NCT01436656|450642156|FG006|Dose Escalation|Lost to Follow-up|0|||
125277173|NCT01436656|450642157|FG007|Dose Escalation|Lost to Follow-up|0|||
125277174|NCT01436656|450642158|FG008|Dose Escalation|Lost to Follow-up|0|||
125277175|NCT01436656|450642159|FG009|Dose Escalation|Lost to Follow-up|0|||
125277176|NCT01436656|450642160|FG010|Dose Escalation|Lost to Follow-up|0|||
125277177|NCT01436656|450642161|FG011|Dose Escalation|Lost to Follow-up|0|||
125277178|NCT01436656|450642162|FG012|Dose Escalation|Lost to Follow-up|0|||
125277179|NCT01436656|450642163|FG013|Dose Escalation|Lost to Follow-up|0|||
125277180|NCT01436656|450642164|FG014|Dose Escalation|Lost to Follow-up|0|||
125277181|NCT01436656|450642165|FG015|Dose Escalation|Lost to Follow-up|0|||
125277182|NCT01436656|450642166|FG016|Dose Escalation|Lost to Follow-up|0|||
125277183|NCT01436656|450642167|FG017|Dose Escalation|Lost to Follow-up|0|||
125277184|NCT01436656|450642150|FG000|Dose Escalation|New anti-cancer therapy|1|||
125277185|NCT01436656|450642151|FG001|Dose Escalation|New anti-cancer therapy|0|||
125277186|NCT01436656|450642152|FG002|Dose Escalation|New anti-cancer therapy|0|||
125277187|NCT01436656|450642153|FG003|Dose Escalation|New anti-cancer therapy|0|||
125277188|NCT01436656|450642154|FG004|Dose Escalation|New anti-cancer therapy|0|||
125277189|NCT01436656|450642155|FG005|Dose Escalation|New anti-cancer therapy|0|||
125277190|NCT01436656|450642156|FG006|Dose Escalation|New anti-cancer therapy|0|||
125277191|NCT01436656|450642157|FG007|Dose Escalation|New anti-cancer therapy|0|||
125277192|NCT01436656|450642158|FG008|Dose Escalation|New anti-cancer therapy|1|||
125277193|NCT01436656|450642159|FG009|Dose Escalation|New anti-cancer therapy|1|||
125277194|NCT01436656|450642160|FG010|Dose Escalation|New anti-cancer therapy|0|||
125277195|NCT01436656|450642161|FG011|Dose Escalation|New anti-cancer therapy|0|||
125277196|NCT01436656|450642162|FG012|Dose Escalation|New anti-cancer therapy|0|||
125277197|NCT01436656|450642163|FG013|Dose Escalation|New anti-cancer therapy|0|||
125277198|NCT01436656|450642164|FG014|Dose Escalation|New anti-cancer therapy|0|||
125277199|NCT01436656|450642165|FG015|Dose Escalation|New anti-cancer therapy|0|||
125277200|NCT01436656|450642166|FG016|Dose Escalation|New anti-cancer therapy|0|||
125277201|NCT01436656|450642167|FG017|Dose Escalation|New anti-cancer therapy|0|||
125277202|NCT01436656|450642150|FG000|Dose Expansion|Adverse Event|0|||
125277203|NCT01436656|450642151|FG001|Dose Expansion|Adverse Event|0|||
125277204|NCT01436656|450642152|FG002|Dose Expansion|Adverse Event|0|||
125277205|NCT01436656|450642153|FG003|Dose Expansion|Adverse Event|0|||
125277206|NCT01436656|450642154|FG004|Dose Expansion|Adverse Event|0|||
125277207|NCT01436656|450642155|FG005|Dose Expansion|Adverse Event|0|||
125277208|NCT01436656|450642156|FG006|Dose Expansion|Adverse Event|0|||
125277209|NCT01436656|450642157|FG007|Dose Expansion|Adverse Event|0|||
125277210|NCT01436656|450642158|FG008|Dose Expansion|Adverse Event|0|||
125277211|NCT01436656|450642159|FG009|Dose Expansion|Adverse Event|0|||
125277212|NCT01436656|450642160|FG010|Dose Expansion|Adverse Event|0|||
125277213|NCT01436656|450642161|FG011|Dose Expansion|Adverse Event|1|||
125277214|NCT01436656|450642162|FG012|Dose Expansion|Adverse Event|0|||
125277215|NCT01436656|450642163|FG013|Dose Expansion|Adverse Event|0|||
125277216|NCT01436656|450642164|FG014|Dose Expansion|Adverse Event|0|||
125277217|NCT01436656|450642165|FG015|Dose Expansion|Adverse Event|0|||
125277218|NCT01436656|450642166|FG016|Dose Expansion|Adverse Event|0|||
125277219|NCT01436656|450642167|FG017|Dose Expansion|Adverse Event|0|||
125277220|NCT01436656|450642150|FG000|Dose Expansion|Withdrawal by Subject|0|||
125277221|NCT01436656|450642151|FG001|Dose Expansion|Withdrawal by Subject|0|||
125277222|NCT01436656|450642152|FG002|Dose Expansion|Withdrawal by Subject|0|||
125277223|NCT01436656|450642153|FG003|Dose Expansion|Withdrawal by Subject|0|||
125277224|NCT01436656|450642154|FG004|Dose Expansion|Withdrawal by Subject|0|||
125277225|NCT01436656|450642155|FG005|Dose Expansion|Withdrawal by Subject|0|||
125277226|NCT01436656|450642156|FG006|Dose Expansion|Withdrawal by Subject|0|||
125277227|NCT01436656|450642157|FG007|Dose Expansion|Withdrawal by Subject|0|||
125277228|NCT01436656|450642158|FG008|Dose Expansion|Withdrawal by Subject|0|||
125277229|NCT01436656|450642159|FG009|Dose Expansion|Withdrawal by Subject|0|||
125277230|NCT01436656|450642160|FG010|Dose Expansion|Withdrawal by Subject|0|||
125277231|NCT01436656|450642161|FG011|Dose Expansion|Withdrawal by Subject|1|||
125277232|NCT01436656|450642162|FG012|Dose Expansion|Withdrawal by Subject|3|||
125277233|NCT01436656|450642163|FG013|Dose Expansion|Withdrawal by Subject|1|||
125277234|NCT01436656|450642164|FG014|Dose Expansion|Withdrawal by Subject|2|||
125277235|NCT01436656|450642165|FG015|Dose Expansion|Withdrawal by Subject|0|||
125277236|NCT01436656|450642166|FG016|Dose Expansion|Withdrawal by Subject|1|||
125277237|NCT01436656|450642167|FG017|Dose Expansion|Withdrawal by Subject|1|||
125277238|NCT01436656|450642150|FG000|Dose Expansion|Death|0|||
125277239|NCT01436656|450642151|FG001|Dose Expansion|Death|0|||
125277240|NCT01436656|450642152|FG002|Dose Expansion|Death|0|||
125277241|NCT01436656|450642153|FG003|Dose Expansion|Death|0|||
125277242|NCT01436656|450642154|FG004|Dose Expansion|Death|0|||
125277243|NCT01436656|450642155|FG005|Dose Expansion|Death|0|||
125277244|NCT01436656|450642156|FG006|Dose Expansion|Death|0|||
125277245|NCT01436656|450642157|FG007|Dose Expansion|Death|0|||
125277246|NCT01436656|450642158|FG008|Dose Expansion|Death|0|||
125277247|NCT01436656|450642159|FG009|Dose Expansion|Death|0|||
125277248|NCT01436656|450642160|FG010|Dose Expansion|Death|0|||
125277249|NCT01436656|450642161|FG011|Dose Expansion|Death|0|||
125277250|NCT01436656|450642162|FG012|Dose Expansion|Death|1|||
125277251|NCT01436656|450642163|FG013|Dose Expansion|Death|0|||
125277252|NCT01436656|450642164|FG014|Dose Expansion|Death|3|||
125277253|NCT01436656|450642165|FG015|Dose Expansion|Death|0|||
125277254|NCT01436656|450642166|FG016|Dose Expansion|Death|3|||
125277255|NCT01436656|450642167|FG017|Dose Expansion|Death|3|||
125277256|NCT01436656|450642150|FG000|Dose Expansion|Lost to Follow-up|0|||
125277257|NCT01436656|450642151|FG001|Dose Expansion|Lost to Follow-up|0|||
125277258|NCT01436656|450642152|FG002|Dose Expansion|Lost to Follow-up|0|||
125277259|NCT01436656|450642153|FG003|Dose Expansion|Lost to Follow-up|0|||
125277260|NCT01436656|450642154|FG004|Dose Expansion|Lost to Follow-up|0|||
125277261|NCT01436656|450642155|FG005|Dose Expansion|Lost to Follow-up|0|||
125277262|NCT01436656|450642156|FG006|Dose Expansion|Lost to Follow-up|0|||
125277263|NCT01436656|450642157|FG007|Dose Expansion|Lost to Follow-up|0|||
125277264|NCT01436656|450642158|FG008|Dose Expansion|Lost to Follow-up|0|||
125277265|NCT01436656|450642159|FG009|Dose Expansion|Lost to Follow-up|0|||
125277266|NCT01436656|450642160|FG010|Dose Expansion|Lost to Follow-up|0|||
125277267|NCT01436656|450642161|FG011|Dose Expansion|Lost to Follow-up|0|||
125277268|NCT01436656|450642162|FG012|Dose Expansion|Lost to Follow-up|0|||
125277269|NCT01436656|450642163|FG013|Dose Expansion|Lost to Follow-up|0|||
125277270|NCT01436656|450642164|FG014|Dose Expansion|Lost to Follow-up|0|||
125277271|NCT01436656|450642165|FG015|Dose Expansion|Lost to Follow-up|0|||
125277272|NCT01436656|450642166|FG016|Dose Expansion|Lost to Follow-up|0|||
125277273|NCT01436656|450642167|FG017|Dose Expansion|Lost to Follow-up|3|||
125277274|NCT01436656|450642150|FG000|Dose Expansion|Disease progression|0|||
125277275|NCT01436656|450642151|FG001|Dose Expansion|Disease progression|0|||
125277276|NCT01436656|450642152|FG002|Dose Expansion|Disease progression|0|||
125277277|NCT01436656|450642153|FG003|Dose Expansion|Disease progression|0|||
125277278|NCT01436656|450642154|FG004|Dose Expansion|Disease progression|0|||
125277279|NCT01436656|450642155|FG005|Dose Expansion|Disease progression|0|||
125277280|NCT01436656|450642156|FG006|Dose Expansion|Disease progression|0|||
125277281|NCT01436656|450642157|FG007|Dose Expansion|Disease progression|0|||
125277282|NCT01436656|450642158|FG008|Dose Expansion|Disease progression|0|||
125277283|NCT01436656|450642159|FG009|Dose Expansion|Disease progression|0|||
125277284|NCT01436656|450642160|FG010|Dose Expansion|Disease progression|0|||
125277285|NCT01436656|450642161|FG011|Dose Expansion|Disease progression|3|||
125277286|NCT01436656|450642162|FG012|Dose Expansion|Disease progression|1|||
125277287|NCT01436656|450642163|FG013|Dose Expansion|Disease progression|0|||
125277288|NCT01436656|450642164|FG014|Dose Expansion|Disease progression|1|||
125277289|NCT01436656|450642165|FG015|Dose Expansion|Disease progression|0|||
125277290|NCT01436656|450642166|FG016|Dose Expansion|Disease progression|0|||
125277291|NCT01436656|450642167|FG017|Dose Expansion|Disease progression|1|||
125277292|NCT01436656|450642150|FG000|Dose Expansion|New cancer therapy|0|||
125277293|NCT01436656|450642151|FG001|Dose Expansion|New cancer therapy|0|||
125277294|NCT01436656|450642152|FG002|Dose Expansion|New cancer therapy|0|||
125277295|NCT01436656|450642153|FG003|Dose Expansion|New cancer therapy|0|||
125277296|NCT01436656|450642154|FG004|Dose Expansion|New cancer therapy|0|||
125277297|NCT01436656|450642155|FG005|Dose Expansion|New cancer therapy|0|||
125277298|NCT01436656|450642156|FG006|Dose Expansion|New cancer therapy|0|||
125277299|NCT01436656|450642157|FG007|Dose Expansion|New cancer therapy|0|||
125277300|NCT01436656|450642158|FG008|Dose Expansion|New cancer therapy|0|||
125277301|NCT01436656|450642159|FG009|Dose Expansion|New cancer therapy|0|||
125277302|NCT01436656|450642160|FG010|Dose Expansion|New cancer therapy|0|||
125277303|NCT01436656|450642161|FG011|Dose Expansion|New cancer therapy|1|||
125277304|NCT01436656|450642162|FG012|Dose Expansion|New cancer therapy|1|||
125277305|NCT01436656|450642163|FG013|Dose Expansion|New cancer therapy|0|||
125277306|NCT01436656|450642164|FG014|Dose Expansion|New cancer therapy|2|||
125277307|NCT01436656|450642165|FG015|Dose Expansion|New cancer therapy|0|||
125277308|NCT01436656|450642166|FG016|Dose Expansion|New cancer therapy|0|||
125277309|NCT01436656|450642167|FG017|Dose Expansion|New cancer therapy|0|||
125277310|NCT04729972|450642168|FG000|Overall Study|Adverse Event|1|||
125277311|NCT00576628|450642170|FG000|Overall Study|Adverse Event|11|||
125277312|NCT00576628|450642170|FG000|Overall Study|Death|2|||
125277313|NCT00576628|450642170|FG000|Overall Study|Failure to return|1|||
125277314|NCT00576628|450642170|FG000|Overall Study|Refused Treatment|8|||
125277315|NCT00576628|450642170|FG000|Overall Study|Pregnancy|1|||
125277316|NCT00576628|450642170|FG000|Overall Study|RBC transfusion|1|||
125277317|NCT00576628|450642170|FG000|Overall Study|Progression of Kidney Disease|1|||
125277318|NCT00576628|450642170|FG000|Overall Study|Progression of Renal Failure|1|||
125277319|NCT00576628|450642170|FG000|Overall Study|The patient move into other town|1|||
125277320|NCT00576628|450642170|FG000|Overall Study|Transplantation|1|||
125277321|NCT00576628|450642170|FG000|Overall Study|Dialysis|15|||
125277322|NCT03206970|450642171|FG000|Overall Study|Death|21|||
125277323|NCT03206970|450642171|FG000|Overall Study|Withdrawal by Subject|13|||
125277324|NCT03206970|450642171|FG000|Overall Study|Lost to Follow-up|3|||
125277325|NCT03206970|450642171|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
125277326|NCT02516982|450642172|FG000|Overall Study|Called in to antenatal appointment|32|||
125277327|NCT02516982|450642173|FG001|Overall Study|Called in to antenatal appointment|35|||
125277328|NCT02516982|450642174|FG002|Overall Study|Called in to antenatal appointment|0|||
125277329|NCT02516982|450642175|FG003|Overall Study|Called in to antenatal appointment|0|||
125277330|NCT02516982|450642172|FG000|Overall Study|Withdrawal by Subject|0|||
125277331|NCT02516982|450642173|FG001|Overall Study|Withdrawal by Subject|0|||
125277332|NCT02516982|450642174|FG002|Overall Study|Withdrawal by Subject|1|||
125277333|NCT02516982|450642175|FG003|Overall Study|Withdrawal by Subject|2|||
125277334|NCT02516982|450642172|FG000|Overall Study|Protocol Violation|0|||
125277335|NCT02516982|450642173|FG001|Overall Study|Protocol Violation|0|||
125277336|NCT02516982|450642174|FG002|Overall Study|Protocol Violation|1|||
125277337|NCT02516982|450642175|FG003|Overall Study|Protocol Violation|1|||
125277338|NCT02516982|450642172|FG000|Overall Study|Did not install the app|0|||
125277339|NCT02516982|450642173|FG001|Overall Study|Did not install the app|0|||
125277340|NCT02516982|450642174|FG002|Overall Study|Did not install the app|46|||
125277341|NCT02516982|450642175|FG003|Overall Study|Did not install the app|47|||
125277342|NCT00962741|450642181|FG000|Overall Study|Failed to return|3|||
125277343|NCT00962741|450642181|FG000|Overall Study|Lost to Follow-up|2|||
125277344|NCT00962741|450642181|FG000|Overall Study|Withdrawal by Subject|1|||
125277345|NCT00962741|450642181|FG000|Overall Study|Lack of Efficacy|1|||
125277346|NCT00962741|450642181|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
125277347|NCT01814878|450642182|FG000|Overall Study|Adverse Event|16|||
125277348|NCT01814878|450642183|FG001|Overall Study|Adverse Event|5|||
125277349|NCT01814878|450642182|FG000|Overall Study|Withdrawal by Subject|20|||
125277350|NCT01814878|450642183|FG001|Overall Study|Withdrawal by Subject|16|||
125277351|NCT01814878|450642182|FG000|Overall Study|Protocol Violation|5|||
125277352|NCT01814878|450642183|FG001|Overall Study|Protocol Violation|5|||
125277353|NCT01814878|450642182|FG000|Overall Study|Physician Decision|3|||
125277354|NCT01814878|450642183|FG001|Overall Study|Physician Decision|1|||
125277355|NCT01814878|450642182|FG000|Overall Study|Screening failure (drop-out)|0|||
125277356|NCT01814878|450642183|FG001|Overall Study|Screening failure (drop-out)|3|||
125277357|NCT01814878|450642182|FG000|Overall Study|Other|2|||
125277358|NCT01814878|450642183|FG001|Overall Study|Other|0|||
125277359|NCT03645421|450642184|FG000|Overall Study|Adverse Event|0|||
125277360|NCT03645421|450642185|FG001|Overall Study|Adverse Event|0|||
125277361|NCT03645421|450642186|FG002|Overall Study|Adverse Event|4|||
125277362|NCT03645421|450642187|FG003|Overall Study|Adverse Event|1|||
125277363|NCT03645421|450642184|FG000|Overall Study|Withdrawal by patient|0|||
125277364|NCT03645421|450642185|FG001|Overall Study|Withdrawal by patient|0|||
125277365|NCT03645421|450642186|FG002|Overall Study|Withdrawal by patient|0|||
125277366|NCT03645421|450642187|FG003|Overall Study|Withdrawal by patient|3|||
125277367|NCT03645421|450642184|FG000|Overall Study|Study specific withdrawal criteria|0|||
125277368|NCT03645421|450642185|FG001|Overall Study|Study specific withdrawal criteria|0|||
125277369|NCT03645421|450642186|FG002|Overall Study|Study specific withdrawal criteria|1|||
125277370|NCT03645421|450642187|FG003|Overall Study|Study specific withdrawal criteria|0|||
125277371|NCT02253433|450642191|FG000|Overall Study|Unable to Contact|9|||
125277372|NCT02253433|450642192|FG001|Overall Study|Unable to Contact|16|||
125277373|NCT02253433|450642191|FG000|Overall Study|Death|1|||
125277374|NCT02253433|450642192|FG001|Overall Study|Death|1|||
125277375|NCT02253433|450642191|FG000|Overall Study|No Longer Interested|3|||
125277376|NCT02253433|450642192|FG001|Overall Study|No Longer Interested|15|||
125277377|NCT02253433|450642191|FG000|Overall Study|Out of Study Area|2|||
125277378|NCT02253433|450642192|FG001|Overall Study|Out of Study Area|7|||
125277379|NCT02253433|450642191|FG000|Overall Study|Uncomfortable with home visitors|0|||
125277380|NCT02253433|450642192|FG001|Overall Study|Uncomfortable with home visitors|3|||
125277381|NCT02253433|450642191|FG000|Overall Study|Unstable Housing/Homeless|0|||
125277382|NCT02253433|450642192|FG001|Overall Study|Unstable Housing/Homeless|7|||
125277383|NCT02253433|450642191|FG000|Overall Study|Too Busy|0|||
125277384|NCT02253433|450642192|FG001|Overall Study|Too Busy|4|||
125277385|NCT02253433|450642191|FG000|Overall Study|Medical or Other Concerns|1|||
125277386|NCT02253433|450642192|FG001|Overall Study|Medical or Other Concerns|2|||
125277387|NCT00759876|450642200|FG000|Overall Study|Sponsor terminated study early|36|||
125277388|NCT02836717|450642201|FG000|Test Phase|Lack of Efficacy|14|||
125277389|NCT02836717|450642202|FG001|Test Phase|Lack of Efficacy|8|||
125277390|NCT02836717|450642203|FG002|Test Phase|Lack of Efficacy|0|||
125277391|NCT02836717|450642201|FG000|Study Phase|Adverse Event|2|||
125277392|NCT02836717|450642202|FG001|Study Phase|Adverse Event|0|||
125277393|NCT02836717|450642203|FG002|Study Phase|Adverse Event|0|||
125277394|NCT02836717|450642201|FG000|Study Phase|Lack of Efficacy|8|||
125277395|NCT02836717|450642202|FG001|Study Phase|Lack of Efficacy|6|||
125277396|NCT02836717|450642203|FG002|Study Phase|Lack of Efficacy|1|||
125277397|NCT02836717|450642201|FG000|Study Phase|Withdrawal by Subject|1|||
125277398|NCT02836717|450642202|FG001|Study Phase|Withdrawal by Subject|0|||
125277399|NCT02836717|450642203|FG002|Study Phase|Withdrawal by Subject|0|||
125277400|NCT02836717|450642201|FG000|Study Phase|Death|1|||
125277401|NCT02836717|450642202|FG001|Study Phase|Death|0|||
125277402|NCT02836717|450642203|FG002|Study Phase|Death|0|||
125277403|NCT02836717|450642201|FG000|Study Phase|abdominal surgeries|2|||
125277404|NCT02836717|450642202|FG001|Study Phase|abdominal surgeries|1|||
125277405|NCT02836717|450642203|FG002|Study Phase|abdominal surgeries|0|||
125277406|NCT03636893|450642204|FG000|Overall Study|Death|0|||
125277407|NCT03636893|450642205|FG001|Overall Study|Death|1|||
125277408|NCT03636893|450642204|FG000|Overall Study|Protocol Violation|0|||
125277409|NCT03636893|450642205|FG001|Overall Study|Protocol Violation|3|||
125277410|NCT03636893|450642204|FG000|Overall Study|Withdrawal by Subject|1|||
125277411|NCT03636893|450642205|FG001|Overall Study|Withdrawal by Subject|2|||
125277412|NCT03636893|450642204|FG000|Overall Study|Refusal to surgery|4|||
125277413|NCT03636893|450642205|FG001|Overall Study|Refusal to surgery|3|||
125277414|NCT03636893|450642204|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
125277415|NCT03636893|450642205|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
125277416|NCT03636893|450642204|FG000|Overall Study|Adverse Event|1|||
125277417|NCT03636893|450642205|FG001|Overall Study|Adverse Event|1|||
125277418|NCT00438360|450642206|FG000|Overall Study|Adverse Event|6|||
125277419|NCT00438360|450642207|FG001|Overall Study|Adverse Event|1|||
125277420|NCT00438360|450642206|FG000|Overall Study|Lack of Efficacy|42|||
125277421|NCT00438360|450642207|FG001|Overall Study|Lack of Efficacy|27|||
125277422|NCT00438360|450642206|FG000|Overall Study|Other|24|||
125277423|NCT00438360|450642207|FG001|Overall Study|Other|15|||
125277424|NCT04560816|450642209|FG000|Overall Study|Withdrawal by Subject|1|||
125277425|NCT04560816|450642210|FG001|Overall Study|Withdrawal by Subject|1|||
125277426|NCT04560816|450642211|FG002|Overall Study|Withdrawal by Subject|1|||
125277427|NCT04560816|450642212|FG003|Overall Study|Withdrawal by Subject|0|||
125277428|NCT04560816|450642213|FG004|Overall Study|Withdrawal by Subject|3|||
125277429|NCT04560816|450642214|FG005|Overall Study|Withdrawal by Subject|0|||
125277430|NCT04560816|450642209|FG000|Overall Study|Lost to Follow-up|1|||
125277431|NCT04560816|450642210|FG001|Overall Study|Lost to Follow-up|0|||
125277432|NCT04560816|450642211|FG002|Overall Study|Lost to Follow-up|0|||
125277433|NCT04560816|450642212|FG003|Overall Study|Lost to Follow-up|0|||
125277434|NCT04560816|450642213|FG004|Overall Study|Lost to Follow-up|0|||
125277435|NCT04560816|450642214|FG005|Overall Study|Lost to Follow-up|0|||
125277436|NCT04560816|450642209|FG000|Overall Study|Protocol Violation|1|||
125277437|NCT04560816|450642210|FG001|Overall Study|Protocol Violation|0|||
125277438|NCT04560816|450642211|FG002|Overall Study|Protocol Violation|0|||
125277439|NCT04560816|450642212|FG003|Overall Study|Protocol Violation|0|||
125277440|NCT04560816|450642213|FG004|Overall Study|Protocol Violation|0|||
125277441|NCT04560816|450642214|FG005|Overall Study|Protocol Violation|0|||
125277442|NCT02277691|450642215|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
125277443|NCT02277691|450642215|FG000|Overall Study|Voluntary Withdrawal|7|||
125277444|NCT02277691|450642215|FG000|Overall Study|Lack of Efficacy|5|||
125277445|NCT02277691|450642215|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
125277446|NCT03818607|450642216|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
125277447|NCT03818607|450642217|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
125277448|NCT03818607|450642216|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
125277449|NCT03818607|450642217|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
125277450|NCT03818607|450642216|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
125277451|NCT03818607|450642217|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
125277452|NCT05059301|450642219|FG000|Overall Study|Adverse Event|0|||
125277453|NCT05059301|450642220|FG001|Overall Study|Adverse Event|2|||
125277454|NCT05059301|450642221|FG002|Overall Study|Adverse Event|2|||
125277455|NCT05059301|450642219|FG000|Overall Study|Lost to Follow-up|2|||
125277456|NCT05059301|450642220|FG001|Overall Study|Lost to Follow-up|3|||
125277457|NCT05059301|450642221|FG002|Overall Study|Lost to Follow-up|3|||
125277458|NCT01164891|450642222|FG000|Overall Study|Disease Progression|5|||
125277459|NCT01164891|450642222|FG000|Overall Study|Adverse Event|1|||
125277460|NCT00441142|450642223|FG000|Overall Study|Adverse Event|2|||
125277461|NCT00441142|450642224|FG001|Overall Study|Adverse Event|3|||
125277462|NCT00441142|450642225|FG002|Overall Study|Adverse Event|3|||
125277463|NCT00441142|450642226|FG003|Overall Study|Adverse Event|22|||
125277464|NCT00441142|450642223|FG000|Overall Study|Lack of Efficacy|3|||
125277465|NCT00441142|450642224|FG001|Overall Study|Lack of Efficacy|3|||
125277466|NCT00441142|450642225|FG002|Overall Study|Lack of Efficacy|17|||
125277467|NCT00441142|450642226|FG003|Overall Study|Lack of Efficacy|32|||
125277468|NCT00441142|450642223|FG000|Overall Study|Withdrawal by Subject|0|||
125277469|NCT00441142|450642224|FG001|Overall Study|Withdrawal by Subject|0|||
125277470|NCT00441142|450642225|FG002|Overall Study|Withdrawal by Subject|2|||
125277471|NCT00441142|450642226|FG003|Overall Study|Withdrawal by Subject|10|||
125277472|NCT00441142|450642223|FG000|Overall Study|Patient still receiving active study tx|1|||
125277473|NCT00441142|450642224|FG001|Overall Study|Patient still receiving active study tx|0|||
125277474|NCT00441142|450642225|FG002|Overall Study|Patient still receiving active study tx|0|||
125277475|NCT00441142|450642226|FG003|Overall Study|Patient still receiving active study tx|2|||
125277476|NCT00441142|450642223|FG000|Overall Study|Physician Decision|0|||
125277477|NCT00441142|450642224|FG001|Overall Study|Physician Decision|1|||
125277478|NCT00441142|450642225|FG002|Overall Study|Physician Decision|0|||
125277479|NCT00441142|450642226|FG003|Overall Study|Physician Decision|1|||
125277480|NCT00441142|450642223|FG000|Overall Study|Death|0|||
125277481|NCT00441142|450642224|FG001|Overall Study|Death|0|||
125277482|NCT00441142|450642225|FG002|Overall Study|Death|0|||
125277483|NCT00441142|450642226|FG003|Overall Study|Death|1|||
125277484|NCT04952597|450642227|FG000|Overall Study|Death|12|||
125277485|NCT04952597|450642228|FG001|Overall Study|Death|13|||
125277486|NCT04952597|450642229|FG002|Overall Study|Death|14|||
125277487|NCT04952597|450642227|FG000|Overall Study|Withdrawal by Subject|1|||
125277488|NCT04952597|450642228|FG001|Overall Study|Withdrawal by Subject|0|||
125277489|NCT04952597|450642229|FG002|Overall Study|Withdrawal by Subject|3|||
125277490|NCT04952597|450642227|FG000|Overall Study|Lost to Follow-up|0|||
125277491|NCT04952597|450642228|FG001|Overall Study|Lost to Follow-up|1|||
125277492|NCT04952597|450642229|FG002|Overall Study|Lost to Follow-up|1|||
125277493|NCT05730335|450642230|FG000|Overall Study|Lost to Follow-up|8|||
125277494|NCT05730335|450642230|FG000|Overall Study|Withdrawal by Subject|6|||
125277495|NCT05286658|450642237|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
125277496|NCT05286658|450642237|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
125277497|NCT05411822|450642238|FG000|Overall Study|Withdrawal by Subject|2|||
125277498|NCT05411822|450642239|FG001|Overall Study|Withdrawal by Subject|1|||
125277499|NCT04004221|450642241|FG000|Overall Study|Death|89|||
125277500|NCT04004221|450642241|FG000|Overall Study|Withdrawal by Subject|5|||
125277501|NCT04004221|450642241|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
125277502|NCT04004221|450642241|FG000|Overall Study|Sponsor Decision|9|||
125277503|NCT04004221|450642241|FG000|Overall Study|Participant refused to enter LTE|1|||
125277504|NCT01814397|450642243|FG000|Overall Study|Adverse Event|7|||
125277505|NCT01814397|450642243|FG000|Overall Study|Withdrawal by Subject|7|||
125277506|NCT01939977|450642245|FG000|Overall Study|Adverse Event|4|||
125277507|NCT01939977|450642246|FG001|Overall Study|Adverse Event|3|||
125277508|NCT01939977|450642245|FG000|Overall Study|Lack of Efficacy|3|||
125277509|NCT01939977|450642246|FG001|Overall Study|Lack of Efficacy|0|||
125277510|NCT01939977|450642245|FG000|Overall Study|Physician Decision|1|||
125277511|NCT01939977|450642246|FG001|Overall Study|Physician Decision|1|||
125277512|NCT01939977|450642245|FG000|Overall Study|Withdrawal by Subject|0|||
125277513|NCT01939977|450642246|FG001|Overall Study|Withdrawal by Subject|2|||
125277514|NCT01939977|450642245|FG000|Overall Study|Did not meet inclusion criteria|1|||
125277515|NCT01939977|450642246|FG001|Overall Study|Did not meet inclusion criteria|0|||
125277516|NCT01939977|450642245|FG000|Overall Study|Did not receive study medication|0|||
125277517|NCT01939977|450642246|FG001|Overall Study|Did not receive study medication|1|||
125277518|NCT02952313|450642256|FG000|Primary Endpoint|Lost to Follow-up|4|||
125277519|NCT02952313|450642256|FG000|Primary Endpoint|Withdrawal by Subject|1|||
125277520|NCT02952313|450642256|FG000|Primary Endpoint|Lack of Efficacy|1|||
125277521|NCT02952313|450642256|FG000|Primary Endpoint|Missed visit|1|||
125277522|NCT02952313|450642256|FG000|Long-term Follow-up|Lost to Follow-up|12|||
125277523|NCT02952313|450642256|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
125277524|NCT02952313|450642256|FG000|Long-term Follow-up|Lack of Efficacy|6|||
125277525|NCT02952313|450642256|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
125277526|NCT02952313|450642256|FG000|Long-term Follow-up|Physician Decision|1|||
125277527|NCT02952313|450642256|FG000|Long-term Follow-up|Death|1|||
125277528|NCT02095873|450642263|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
125277529|NCT02095873|450642264|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
125277530|NCT02095873|450642263|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
125277531|NCT02095873|450642264|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
125277532|NCT02095873|450642263|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
125277533|NCT02095873|450642264|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
125277534|NCT00792740|450642267|FG000|Overall Study|Disease Worsening|3|||
125277535|NCT00792740|450642268|FG001|Overall Study|Disease Worsening|2|||
125277536|NCT00792740|450642267|FG000|Overall Study|Personal Reason|1|||
125277537|NCT00792740|450642268|FG001|Overall Study|Personal Reason|0|||
125277538|NCT00792740|450642267|FG000|Overall Study|Adverse Event|1|||
125277539|NCT00792740|450642268|FG001|Overall Study|Adverse Event|3|||
125277540|NCT00792740|450642267|FG000|Overall Study|Patient's withdrawal of consent|0|||
125277541|NCT00792740|450642268|FG001|Overall Study|Patient's withdrawal of consent|1|||
125277542|NCT00792740|450642267|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
125277543|NCT00792740|450642268|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
125277544|NCT00792740|450642267|FG000|Overall Study|Other reasons|0|||
125277545|NCT00792740|450642268|FG001|Overall Study|Other reasons|1|||
125277546|NCT03206918|450642271|FG000|Overall Study|Death|11|||
125277547|NCT03206918|450642271|FG000|Overall Study|Withdrawal by Subject|5|||
125277548|NCT03206918|450642271|FG000|Overall Study|Study terminated by sponsor|12|||
125277549|NCT03206918|450642271|FG000|Overall Study|Lost to Follow-up|3|||
125277550|NCT03206918|450642271|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
125277551|NCT03823287|450642272|FG000|Overall Study|Withdrawal by Subject|25|||
125277552|NCT03823287|450642273|FG001|Overall Study|Withdrawal by Subject|17|||
125277553|NCT03823287|450642272|FG000|Overall Study|Death|13|||
125277554|NCT03823287|450642273|FG001|Overall Study|Death|7|||
125277555|NCT03823287|450642272|FG000|Overall Study|Lost to Follow-up|7|||
125277556|NCT03823287|450642273|FG001|Overall Study|Lost to Follow-up|8|||
125277557|NCT03823287|450642272|FG000|Overall Study|Adverse Event|6|||
125277558|NCT03823287|450642273|FG001|Overall Study|Adverse Event|8|||
125277559|NCT03823287|450642272|FG000|Overall Study|Physician Decision|5|||
125277560|NCT03823287|450642273|FG001|Overall Study|Physician Decision|2|||
125277561|NCT03823287|450642272|FG000|Overall Study|Lack of Efficacy|2|||
125277562|NCT03823287|450642273|FG001|Overall Study|Lack of Efficacy|0|||
125277563|NCT03823287|450642272|FG000|Overall Study|Other|2|||
125277564|NCT03823287|450642273|FG001|Overall Study|Other|4|||
125277565|NCT01170273|450642275|FG000|Overall Study|Lost to Follow-up|6|||
125277566|NCT01170273|450642276|FG001|Overall Study|Lost to Follow-up|8|||
125277567|NCT01170273|450642275|FG000|Overall Study|Protocol Violation|1|||
125277568|NCT01170273|450642276|FG001|Overall Study|Protocol Violation|0|||
125277569|NCT01170273|450642275|FG000|Overall Study|Death|1|||
125277570|NCT01170273|450642276|FG001|Overall Study|Death|0|||
125277571|NCT01170273|450642275|FG000|Overall Study|Adverse Event|0|||
125277572|NCT01170273|450642276|FG001|Overall Study|Adverse Event|1|||
125277573|NCT01673854|450642277|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
125277574|NCT01673854|450642277|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
125277575|NCT01673854|450642277|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
125277576|NCT01673854|450642277|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
125277577|NCT01673854|450642277|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
125277578|NCT01673854|450642277|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
125277579|NCT01673854|450642277|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
125277580|NCT01673854|450642277|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
125277581|NCT01673854|450642277|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
125277582|NCT01673854|450642277|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
125277583|NCT01673854|450642277|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
125277584|NCT01673854|450642277|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
125277585|NCT00334737|450642278|FG000|Hospital Phase|Death|1|||
125277586|NCT00334737|450642279|FG001|Hospital Phase|Death|2|||
125277587|NCT00334737|450642280|FG002|Hospital Phase|Death|3|||
125277588|NCT00334737|450642278|FG000|Hospital Phase|Withdrawal by Subject|0|||
125277589|NCT00334737|450642279|FG001|Hospital Phase|Withdrawal by Subject|0|||
125277590|NCT00334737|450642280|FG002|Hospital Phase|Withdrawal by Subject|1|||
125277591|NCT00334737|450642278|FG000|Hospital Phase|Did not receive study drug|1|||
125277592|NCT00334737|450642279|FG001|Hospital Phase|Did not receive study drug|0|||
125277593|NCT00334737|450642280|FG002|Hospital Phase|Did not receive study drug|0|||
125277594|NCT00334737|450642278|FG000|Follow up Phase|Lost to Follow-up|5|||
125277595|NCT00334737|450642279|FG001|Follow up Phase|Lost to Follow-up|3|||
125277596|NCT00334737|450642280|FG002|Follow up Phase|Lost to Follow-up|6|||
125277597|NCT00583752|450642281|FG000|Overall Study|Lost to Follow-up|5|||
125277598|NCT00583752|450642282|FG001|Overall Study|Lost to Follow-up|5|||
125277599|NCT02316353|450642283|FG000|Overall Study|Pregnancy|1|||
125277600|NCT02316353|450642284|FG001|Overall Study|Pregnancy|3|||
125277601|NCT02316353|450642283|FG000|Overall Study|Adverse Event|1|||
125277602|NCT02316353|450642284|FG001|Overall Study|Adverse Event|3|||
125277603|NCT02316353|450642283|FG000|Overall Study|Withdrawal by Subject|6|||
125277604|NCT02316353|450642284|FG001|Overall Study|Withdrawal by Subject|2|||
125277605|NCT02954406|450643907|FG000|Overall Study|Adverse Event|0|||
125277606|NCT02954406|450643908|FG001|Overall Study|Adverse Event|1|||
125277607|NCT02954406|450643909|FG002|Overall Study|Adverse Event|0|||
125277608|NCT02954406|450643910|FG003|Overall Study|Adverse Event|0|||
125277609|NCT02954406|450643911|FG004|Overall Study|Adverse Event|1|||
125277610|NCT02954406|450643912|FG005|Overall Study|Adverse Event|0|||
125277611|NCT02954406|450643913|FG006|Overall Study|Adverse Event|0|||
125277612|NCT02954406|450643914|FG007|Overall Study|Adverse Event|0|||
125277613|NCT02954406|450643915|FG008|Overall Study|Adverse Event|1|||
125277614|NCT02954406|450643916|FG009|Overall Study|Adverse Event|1|||
125277615|NCT02954406|450643917|FG010|Overall Study|Adverse Event|0|||
125277616|NCT02954406|450643907|FG000|Overall Study|Progressive Disease|3|||
125277617|NCT02954406|450643908|FG001|Overall Study|Progressive Disease|4|||
125277618|NCT02954406|450643909|FG002|Overall Study|Progressive Disease|3|||
125277619|NCT02954406|450643910|FG003|Overall Study|Progressive Disease|4|||
125277620|NCT02954406|450643911|FG004|Overall Study|Progressive Disease|3|||
125277621|NCT02954406|450643912|FG005|Overall Study|Progressive Disease|3|||
125277622|NCT02954406|450643913|FG006|Overall Study|Progressive Disease|2|||
125277623|NCT02954406|450643914|FG007|Overall Study|Progressive Disease|2|||
125277624|NCT02954406|450643915|FG008|Overall Study|Progressive Disease|1|||
125277625|NCT02954406|450643916|FG009|Overall Study|Progressive Disease|1|||
125277626|NCT02954406|450643917|FG010|Overall Study|Progressive Disease|0|||
125277627|NCT02954406|450643907|FG000|Overall Study|Symptomatic Deterioration|0|||
125277628|NCT02954406|450643908|FG001|Overall Study|Symptomatic Deterioration|1|||
125277629|NCT02954406|450643909|FG002|Overall Study|Symptomatic Deterioration|0|||
125277630|NCT02954406|450643910|FG003|Overall Study|Symptomatic Deterioration|0|||
125277631|NCT02954406|450643911|FG004|Overall Study|Symptomatic Deterioration|0|||
125277632|NCT02954406|450643912|FG005|Overall Study|Symptomatic Deterioration|0|||
125277633|NCT02954406|450643913|FG006|Overall Study|Symptomatic Deterioration|0|||
125277634|NCT02954406|450643914|FG007|Overall Study|Symptomatic Deterioration|0|||
125277635|NCT02954406|450643915|FG008|Overall Study|Symptomatic Deterioration|0|||
125277636|NCT02954406|450643916|FG009|Overall Study|Symptomatic Deterioration|0|||
125277637|NCT02954406|450643917|FG010|Overall Study|Symptomatic Deterioration|0|||
125277638|NCT02954406|450643907|FG000|Overall Study|Death|0|||
125277639|NCT02954406|450643908|FG001|Overall Study|Death|0|||
125277640|NCT02954406|450643909|FG002|Overall Study|Death|0|||
125277641|NCT02954406|450643910|FG003|Overall Study|Death|0|||
125277642|NCT02954406|450643911|FG004|Overall Study|Death|1|||
125277643|NCT02954406|450643912|FG005|Overall Study|Death|0|||
125277644|NCT02954406|450643913|FG006|Overall Study|Death|0|||
125277645|NCT02954406|450643914|FG007|Overall Study|Death|0|||
125277646|NCT02954406|450643915|FG008|Overall Study|Death|1|||
125277647|NCT02954406|450643916|FG009|Overall Study|Death|1|||
125277648|NCT02954406|450643917|FG010|Overall Study|Death|0|||
125277649|NCT02954406|450643907|FG000|Overall Study|Reason Not Specified|0|||
125277650|NCT02954406|450643908|FG001|Overall Study|Reason Not Specified|0|||
125277651|NCT02954406|450643909|FG002|Overall Study|Reason Not Specified|3|||
125277652|NCT02954406|450643910|FG003|Overall Study|Reason Not Specified|2|||
125277653|NCT02954406|450643911|FG004|Overall Study|Reason Not Specified|2|||
125277654|NCT02954406|450643912|FG005|Overall Study|Reason Not Specified|0|||
125277655|NCT02954406|450643913|FG006|Overall Study|Reason Not Specified|1|||
125277656|NCT02954406|450643914|FG007|Overall Study|Reason Not Specified|0|||
125277657|NCT02954406|450643915|FG008|Overall Study|Reason Not Specified|1|||
125277658|NCT02954406|450643916|FG009|Overall Study|Reason Not Specified|0|||
125277659|NCT02954406|450643917|FG010|Overall Study|Reason Not Specified|0|||
125277660|NCT05396014|450643918|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
125277661|NCT05396014|450643919|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277662|NCT05396014|450643920|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277663|NCT05396014|450643921|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277664|NCT05396014|450643922|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277665|NCT05396014|450643923|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277666|NCT05396014|450643924|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277667|NCT05396014|450643925|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277668|NCT05396014|450643926|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277669|NCT05396014|450643927|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277670|NCT05396014|450643928|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277671|NCT05396014|450643929|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277672|NCT05396014|450643930|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277673|NCT05396014|450643931|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
125277674|NCT05396014|450643932|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277675|NCT05396014|450643933|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277676|NCT05396014|450643934|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277677|NCT05396014|450643935|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277678|NCT05396014|450643936|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277679|NCT05396014|450643937|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277680|NCT05396014|450643938|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277681|NCT05396014|450643939|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277682|NCT05396014|450643940|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277683|NCT05396014|450643941|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277684|NCT05396014|450643942|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277685|NCT05396014|450643943|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277686|NCT05396014|450643944|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
125277687|NCT05396014|450643945|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277688|NCT05396014|450643946|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277689|NCT05396014|450643947|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277690|NCT05396014|450643948|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277691|NCT05396014|450643949|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277692|NCT05396014|450643950|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277693|NCT05396014|450643951|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277694|NCT05396014|450643952|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277695|NCT05396014|450643953|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277696|NCT05396014|450643954|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277697|NCT05396014|450643955|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277698|NCT05396014|450643956|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277699|NCT05396014|450643957|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
125277700|NCT05396014|450643958|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277701|NCT05396014|450643959|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277702|NCT05396014|450643960|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277703|NCT05396014|450643918|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
125277704|NCT05396014|450643919|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277705|NCT05396014|450643920|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277706|NCT05396014|450643921|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277707|NCT05396014|450643922|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277708|NCT05396014|450643923|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277709|NCT05396014|450643924|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277710|NCT05396014|450643925|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277711|NCT05396014|450643926|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277712|NCT05396014|450643927|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277713|NCT05396014|450643928|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277714|NCT05396014|450643929|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277715|NCT05396014|450643930|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277716|NCT05396014|450643931|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
125277717|NCT05396014|450643932|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277718|NCT05396014|450643933|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277719|NCT05396014|450643934|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277720|NCT05396014|450643935|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277721|NCT05396014|450643936|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277722|NCT05396014|450643937|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277723|NCT05396014|450643938|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277724|NCT05396014|450643939|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277725|NCT05396014|450643940|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277726|NCT05396014|450643941|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277727|NCT05396014|450643942|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277728|NCT05396014|450643943|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277729|NCT05396014|450643944|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
125277730|NCT05396014|450643945|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277731|NCT05396014|450643946|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277732|NCT05396014|450643947|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277733|NCT05396014|450643948|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277734|NCT05396014|450643949|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277735|NCT05396014|450643950|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277736|NCT05396014|450643951|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277737|NCT05396014|450643952|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277738|NCT05396014|450643953|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277739|NCT05396014|450643954|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277740|NCT05396014|450643955|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277741|NCT05396014|450643956|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277742|NCT05396014|450643957|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
125277743|NCT05396014|450643958|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277744|NCT05396014|450643959|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277745|NCT05396014|450643960|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277746|NCT05396014|450643918|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
125277747|NCT05396014|450643919|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277748|NCT05396014|450643920|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277749|NCT05396014|450643921|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277750|NCT05396014|450643922|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277751|NCT05396014|450643923|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277752|NCT05396014|450643924|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277753|NCT05396014|450643925|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277754|NCT05396014|450643926|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277755|NCT05396014|450643927|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277756|NCT05396014|450643928|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277757|NCT05396014|450643929|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277758|NCT05396014|450643930|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277759|NCT05396014|450643931|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
125277760|NCT05396014|450643932|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277761|NCT05396014|450643933|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277762|NCT05396014|450643934|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277763|NCT05396014|450643935|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277764|NCT05396014|450643936|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277765|NCT05396014|450643937|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277766|NCT05396014|450643938|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277767|NCT05396014|450643939|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277768|NCT05396014|450643940|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277769|NCT05396014|450643941|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277770|NCT05396014|450643942|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277771|NCT05396014|450643943|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277772|NCT05396014|450643944|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
125277773|NCT05396014|450643945|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277774|NCT05396014|450643946|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277775|NCT05396014|450643947|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277776|NCT05396014|450643948|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277777|NCT05396014|450643949|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277778|NCT05396014|450643950|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277779|NCT05396014|450643951|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277780|NCT05396014|450643952|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277781|NCT05396014|450643953|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277782|NCT05396014|450643954|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277783|NCT05396014|450643955|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277784|NCT05396014|450643956|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277785|NCT05396014|450643957|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
125277786|NCT05396014|450643958|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277787|NCT05396014|450643959|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277788|NCT05396014|450643960|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277789|NCT05396014|450643918|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277790|NCT05396014|450643919|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277791|NCT05396014|450643920|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277792|NCT05396014|450643921|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277793|NCT05396014|450643922|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277794|NCT05396014|450643923|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277795|NCT05396014|450643924|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277796|NCT05396014|450643925|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277797|NCT05396014|450643926|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277798|NCT05396014|450643927|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277799|NCT05396014|450643928|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277800|NCT05396014|450643929|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277801|NCT05396014|450643930|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277802|NCT05396014|450643931|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277803|NCT05396014|450643932|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277804|NCT05396014|450643933|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277805|NCT05396014|450643934|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277806|NCT05396014|450643935|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277807|NCT05396014|450643936|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277808|NCT05396014|450643937|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277809|NCT05396014|450643938|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277810|NCT05396014|450643939|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277811|NCT05396014|450643940|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277812|NCT05396014|450643941|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277813|NCT05396014|450643942|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277814|NCT05396014|450643943|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277815|NCT05396014|450643944|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
125277816|NCT05396014|450643945|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277817|NCT05396014|450643946|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277818|NCT05396014|450643947|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277819|NCT05396014|450643948|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277820|NCT05396014|450643949|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277821|NCT05396014|450643950|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277822|NCT05396014|450643951|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277823|NCT05396014|450643952|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277824|NCT05396014|450643953|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277825|NCT05396014|450643954|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277826|NCT05396014|450643955|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277827|NCT05396014|450643956|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277828|NCT05396014|450643957|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
125277829|NCT05396014|450643958|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277830|NCT05396014|450643959|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277831|NCT05396014|450643960|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277832|NCT05396014|450643918|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277833|NCT05396014|450643919|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277834|NCT05396014|450643920|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277835|NCT05396014|450643921|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277836|NCT05396014|450643922|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277837|NCT05396014|450643923|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277838|NCT05396014|450643924|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277839|NCT05396014|450643925|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277840|NCT05396014|450643926|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277841|NCT05396014|450643927|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277842|NCT05396014|450643928|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277843|NCT05396014|450643929|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277844|NCT05396014|450643930|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277845|NCT05396014|450643931|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277846|NCT05396014|450643932|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277847|NCT05396014|450643933|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277848|NCT05396014|450643934|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277849|NCT05396014|450643935|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277850|NCT05396014|450643936|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277851|NCT05396014|450643937|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277852|NCT05396014|450643938|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277853|NCT05396014|450643939|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277854|NCT05396014|450643940|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277855|NCT05396014|450643941|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277856|NCT05396014|450643942|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277857|NCT05396014|450643943|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277858|NCT05396014|450643944|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
125277859|NCT05396014|450643945|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277860|NCT05396014|450643946|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277861|NCT05396014|450643947|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277862|NCT05396014|450643948|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277863|NCT05396014|450643949|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277864|NCT05396014|450643950|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277865|NCT05396014|450643951|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277866|NCT05396014|450643952|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277867|NCT05396014|450643953|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277868|NCT05396014|450643954|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277869|NCT05396014|450643955|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277870|NCT05396014|450643956|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277871|NCT05396014|450643957|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277872|NCT05396014|450643958|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277873|NCT05396014|450643959|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277874|NCT05396014|450643960|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277875|NCT05396014|450643918|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277876|NCT05396014|450643919|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277877|NCT05396014|450643920|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277878|NCT05396014|450643921|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277879|NCT05396014|450643922|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277880|NCT05396014|450643923|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277881|NCT05396014|450643924|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277882|NCT05396014|450643925|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277883|NCT05396014|450643926|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277884|NCT05396014|450643927|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277885|NCT05396014|450643928|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277886|NCT05396014|450643929|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277887|NCT05396014|450643930|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277888|NCT05396014|450643931|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
125277889|NCT05396014|450643932|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277890|NCT05396014|450643933|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277891|NCT05396014|450643934|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277892|NCT05396014|450643935|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277893|NCT05396014|450643936|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277894|NCT05396014|450643937|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277895|NCT05396014|450643938|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277896|NCT05396014|450643939|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277897|NCT05396014|450643940|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277898|NCT05396014|450643941|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277899|NCT05396014|450643942|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277900|NCT05396014|450643943|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277901|NCT05396014|450643944|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277902|NCT05396014|450643945|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277903|NCT05396014|450643946|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277904|NCT05396014|450643947|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277905|NCT05396014|450643948|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277906|NCT05396014|450643949|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277907|NCT05396014|450643950|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277908|NCT05396014|450643951|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277909|NCT05396014|450643952|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277910|NCT05396014|450643953|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277911|NCT05396014|450643954|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277912|NCT05396014|450643955|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277913|NCT05396014|450643956|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277914|NCT05396014|450643957|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277915|NCT05396014|450643958|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277916|NCT05396014|450643959|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277917|NCT05396014|450643960|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277918|NCT05396014|450643918|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
125277919|NCT05396014|450643919|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277920|NCT05396014|450643920|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277921|NCT05396014|450643921|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277922|NCT05396014|450643922|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277923|NCT05396014|450643923|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277924|NCT05396014|450643924|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277925|NCT05396014|450643925|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277926|NCT05396014|450643926|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277927|NCT05396014|450643927|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277928|NCT05396014|450643928|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277929|NCT05396014|450643929|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277930|NCT05396014|450643930|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277931|NCT05396014|450643931|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
125277932|NCT05396014|450643932|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277933|NCT05396014|450643933|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277934|NCT05396014|450643934|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277935|NCT05396014|450643935|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277936|NCT05396014|450643936|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277937|NCT05396014|450643937|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277938|NCT05396014|450643938|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277939|NCT05396014|450643939|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277940|NCT05396014|450643940|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277941|NCT05396014|450643941|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277942|NCT05396014|450643942|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277943|NCT05396014|450643943|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277944|NCT05396014|450643944|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277945|NCT05396014|450643945|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277946|NCT05396014|450643946|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277947|NCT05396014|450643947|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277948|NCT05396014|450643948|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277949|NCT05396014|450643949|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277950|NCT05396014|450643950|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277951|NCT05396014|450643951|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277952|NCT05396014|450643952|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277953|NCT05396014|450643953|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277954|NCT05396014|450643954|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277955|NCT05396014|450643955|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277956|NCT05396014|450643956|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277957|NCT05396014|450643957|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
125277958|NCT05396014|450643958|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277959|NCT05396014|450643959|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277960|NCT05396014|450643960|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277961|NCT05396014|450643918|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
125277962|NCT05396014|450643919|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277963|NCT05396014|450643920|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277964|NCT05396014|450643921|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277965|NCT05396014|450643922|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277966|NCT05396014|450643923|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277967|NCT05396014|450643924|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277968|NCT05396014|450643925|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277969|NCT05396014|450643926|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277970|NCT05396014|450643927|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277971|NCT05396014|450643928|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277972|NCT05396014|450643929|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277973|NCT05396014|450643930|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277974|NCT05396014|450643931|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277975|NCT05396014|450643932|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277976|NCT05396014|450643933|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277977|NCT05396014|450643934|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277978|NCT05396014|450643935|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277979|NCT05396014|450643936|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277980|NCT05396014|450643937|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277981|NCT05396014|450643938|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277982|NCT05396014|450643939|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277983|NCT05396014|450643940|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277984|NCT05396014|450643941|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277985|NCT05396014|450643942|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277986|NCT05396014|450643943|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277987|NCT05396014|450643944|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
125277988|NCT05396014|450643945|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277989|NCT05396014|450643946|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277990|NCT05396014|450643947|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277991|NCT05396014|450643948|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277992|NCT05396014|450643949|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277993|NCT05396014|450643950|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277994|NCT05396014|450643951|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277995|NCT05396014|450643952|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277996|NCT05396014|450643953|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277997|NCT05396014|450643954|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277998|NCT05396014|450643955|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277999|NCT05396014|450643956|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125278000|NCT05396014|450643957|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125278001|NCT05396014|450643958|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125278002|NCT05396014|450643959|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125278003|NCT05396014|450643960|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125278004|NCT05396014|450643918|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278005|NCT05396014|450643919|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278006|NCT05396014|450643920|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278007|NCT05396014|450643921|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278008|NCT05396014|450643922|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278009|NCT05396014|450643923|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278010|NCT05396014|450643924|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278011|NCT05396014|450643925|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278012|NCT05396014|450643926|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278013|NCT05396014|450643927|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278014|NCT05396014|450643928|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278015|NCT05396014|450643929|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278016|NCT05396014|450643930|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278017|NCT05396014|450643931|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
125278018|NCT05396014|450643932|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278019|NCT05396014|450643933|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278020|NCT05396014|450643934|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278021|NCT05396014|450643935|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278022|NCT05396014|450643936|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278023|NCT05396014|450643937|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278024|NCT05396014|450643938|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278025|NCT05396014|450643939|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278026|NCT05396014|450643940|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278027|NCT05396014|450643941|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278028|NCT05396014|450643942|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278029|NCT05396014|450643943|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278030|NCT05396014|450643944|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278031|NCT05396014|450643945|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278032|NCT05396014|450643946|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278033|NCT05396014|450643947|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278034|NCT05396014|450643948|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278035|NCT05396014|450643949|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278036|NCT05396014|450643950|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278037|NCT05396014|450643951|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278038|NCT05396014|450643952|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278039|NCT05396014|450643953|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278040|NCT05396014|450643954|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278041|NCT05396014|450643955|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278042|NCT05396014|450643956|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278043|NCT05396014|450643957|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278044|NCT05396014|450643958|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278045|NCT05396014|450643959|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278046|NCT05396014|450643960|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278047|NCT05396014|450643918|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278048|NCT05396014|450643919|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278049|NCT05396014|450643920|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278050|NCT05396014|450643921|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
125278051|NCT05396014|450643922|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278052|NCT05396014|450643923|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278053|NCT05396014|450643924|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278054|NCT05396014|450643925|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278055|NCT05396014|450643926|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
125278056|NCT05396014|450643927|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278057|NCT05396014|450643928|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278058|NCT05396014|450643929|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278059|NCT05396014|450643930|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278060|NCT05396014|450643931|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278061|NCT05396014|450643932|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278062|NCT05396014|450643933|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278063|NCT05396014|450643934|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278064|NCT05396014|450643935|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278065|NCT05396014|450643936|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278066|NCT05396014|450643937|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278067|NCT05396014|450643938|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278068|NCT05396014|450643939|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278069|NCT05396014|450643940|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278070|NCT05396014|450643941|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278071|NCT05396014|450643942|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278072|NCT05396014|450643943|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
124781538|NCT02741518|448831089|FG000|Overall Study|Withdrawal by Subject|1|||
124781539|NCT02741518|448831090|FG001|Overall Study|Withdrawal by Subject|1|||
124781540|NCT01139008|448831091|FG000|Overall Study|Withdrawal by Subject|5|||
124781541|NCT01139008|448831091|FG000|Overall Study|Non-compliant, lost product|1|||
124781542|NCT01715857|448831092|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
125278073|NCT05396014|450643944|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278074|NCT05396014|450643945|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278075|NCT05396014|450643946|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278076|NCT05396014|450643947|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278077|NCT05396014|450643948|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278078|NCT05396014|450643949|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278079|NCT05396014|450643950|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278080|NCT05396014|450643951|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278081|NCT05396014|450643952|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278082|NCT05396014|450643953|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278083|NCT05396014|450643954|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278084|NCT05396014|450643955|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278085|NCT05396014|450643956|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278086|NCT05396014|450643957|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278087|NCT05396014|450643958|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
125278088|NCT05396014|450643959|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
125278089|NCT05396014|450643960|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278090|NCT05396014|450643918|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278091|NCT05396014|450643919|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278092|NCT05396014|450643920|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278093|NCT05396014|450643921|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278094|NCT05396014|450643922|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278095|NCT05396014|450643923|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278096|NCT05396014|450643924|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278097|NCT05396014|450643925|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124781543|NCT02785770|448831093|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
124781544|NCT02785770|448831094|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
124781545|NCT02785770|448831095|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
125278098|NCT05396014|450643926|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
125278099|NCT05396014|450643927|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278100|NCT05396014|450643928|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278101|NCT05396014|450643929|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278102|NCT05396014|450643930|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278103|NCT05396014|450643931|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278104|NCT05396014|450643932|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278105|NCT05396014|450643933|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278106|NCT05396014|450643934|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278107|NCT05396014|450643935|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278108|NCT05396014|450643936|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278109|NCT05396014|450643937|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278110|NCT05396014|450643938|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278111|NCT05396014|450643939|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278112|NCT05396014|450643940|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
125278113|NCT05396014|450643941|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278114|NCT05396014|450643942|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278115|NCT05396014|450643943|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278116|NCT05396014|450643944|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278117|NCT05396014|450643945|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278118|NCT05396014|450643946|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278119|NCT05396014|450643947|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278120|NCT05396014|450643948|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278121|NCT05396014|450643949|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278122|NCT05396014|450643950|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278123|NCT05396014|450643951|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278124|NCT05396014|450643952|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278125|NCT05396014|450643953|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
125278126|NCT05396014|450643954|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278127|NCT05396014|450643955|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278128|NCT05396014|450643956|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278129|NCT05396014|450643957|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278130|NCT05396014|450643958|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278131|NCT05396014|450643959|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
125278132|NCT05396014|450643960|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278133|NCT05396014|450643918|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278134|NCT05396014|450643919|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278135|NCT05396014|450643920|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278136|NCT05396014|450643921|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278137|NCT05396014|450643922|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278138|NCT05396014|450643923|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278139|NCT05396014|450643924|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278140|NCT05396014|450643925|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278141|NCT05396014|450643926|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278142|NCT05396014|450643927|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278143|NCT05396014|450643928|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278144|NCT05396014|450643929|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278145|NCT05396014|450643930|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278146|NCT05396014|450643931|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
125278147|NCT05396014|450643932|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278148|NCT05396014|450643933|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278149|NCT05396014|450643934|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278150|NCT05396014|450643935|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278151|NCT05396014|450643936|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278152|NCT05396014|450643937|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278153|NCT05396014|450643938|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278154|NCT05396014|450643939|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278155|NCT05396014|450643940|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124781546|NCT02785770|448831096|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
124781547|NCT02785770|448831093|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
124781548|NCT02785770|448831094|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
124781549|NCT02785770|448831095|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
124781550|NCT02785770|448831096|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
124781551|NCT02785770|448831093|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
125278156|NCT05396014|450643941|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278157|NCT05396014|450643942|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278158|NCT05396014|450643943|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278159|NCT05396014|450643944|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
125278160|NCT05396014|450643945|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278161|NCT05396014|450643946|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278162|NCT05396014|450643947|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278163|NCT05396014|450643948|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278164|NCT05396014|450643949|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278165|NCT05396014|450643950|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278166|NCT05396014|450643951|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278167|NCT05396014|450643952|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
125278168|NCT05396014|450643953|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278169|NCT05396014|450643954|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278170|NCT05396014|450643955|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278171|NCT05396014|450643956|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278172|NCT05396014|450643957|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278173|NCT05396014|450643958|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278174|NCT05396014|450643959|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278175|NCT05396014|450643960|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
125278176|NCT05396014|450643918|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278177|NCT05396014|450643919|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278178|NCT05396014|450643920|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278179|NCT05396014|450643921|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278180|NCT05396014|450643922|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278181|NCT05396014|450643923|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278182|NCT05396014|450643924|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278183|NCT05396014|450643925|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278184|NCT05396014|450643926|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278185|NCT05396014|450643927|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278186|NCT05396014|450643928|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278187|NCT05396014|450643929|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278188|NCT05396014|450643930|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278189|NCT05396014|450643931|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278190|NCT05396014|450643932|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278191|NCT05396014|450643933|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278192|NCT05396014|450643934|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278193|NCT05396014|450643935|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278194|NCT05396014|450643936|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278195|NCT05396014|450643937|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278196|NCT05396014|450643938|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278197|NCT05396014|450643939|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278198|NCT05396014|450643940|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278199|NCT05396014|450643941|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278200|NCT05396014|450643942|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278201|NCT05396014|450643943|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278202|NCT05396014|450643944|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
125278203|NCT05396014|450643945|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278204|NCT05396014|450643946|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278205|NCT05396014|450643947|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278206|NCT05396014|450643948|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278207|NCT05396014|450643949|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278208|NCT05396014|450643950|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278209|NCT05396014|450643951|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278210|NCT05396014|450643952|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278211|NCT05396014|450643953|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278212|NCT05396014|450643954|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278213|NCT05396014|450643955|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278214|NCT05396014|450643956|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278215|NCT05396014|450643957|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278216|NCT05396014|450643958|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278217|NCT05396014|450643959|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278218|NCT05396014|450643960|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278219|NCT00516893|450643969|FG000|Overall Study|Lost to Follow-up|4|||
125278220|NCT00516893|450643969|FG000|Overall Study|Adverse Event|3|||
125278221|NCT00516893|450643969|FG000|Overall Study|Withdrawal by Subject|2|||
125278222|NCT00516893|450643969|FG000|Overall Study|Noncompliance|2|||
125278223|NCT00516893|450643969|FG000|Overall Study|Death|1|||
125278224|NCT00516893|450643969|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
125278225|NCT00516893|450643969|FG000|Overall Study|Relocated|1|||
125278226|NCT00516893|450643969|FG000|Overall Study|Pregnancy|1|||
125278227|NCT00516893|450643969|FG000|Overall Study|Received Medication From Another Study|1|||
125278228|NCT05935878|450643972|FG000|Overall Study|Death|1|||
125278229|NCT05935878|450643973|FG001|Overall Study|Death|2|||
125278230|NCT05935878|450643972|FG000|Overall Study|Withdrawal by Subject|5|||
125278231|NCT05935878|450643973|FG001|Overall Study|Withdrawal by Subject|5|||
125278232|NCT05935878|450643972|FG000|Overall Study|Revision of implant|1|||
125278233|NCT05935878|450643973|FG001|Overall Study|Revision of implant|1|||
125278234|NCT05935878|450643972|FG000|Overall Study|Mobile bearing dislocation|0|||
125278235|NCT05935878|450643973|FG001|Overall Study|Mobile bearing dislocation|1|||
125278236|NCT01443364|450643980|FG000|Overall Study|Lack of Efficacy|14|||
125278237|NCT01443364|450643980|FG000|Overall Study|Lost to Follow-up|3|||
125278238|NCT01443364|450643980|FG000|Overall Study|Withdrawal by Subject|5|||
125278239|NCT01443364|450643980|FG000|Overall Study|Other Reason|4|||
125278240|NCT01443364|450643980|FG000|Overall Study|SAE, non-fatal|6|||
125278241|NCT01443364|450643980|FG000|Overall Study|AE, non-serious non-fatal|8|||
125278242|NCT01443364|450643980|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
125278243|NCT00559845|450643981|FG000|Overall Study|Withdrew Consent|1|||
125278244|NCT00559845|450643981|FG000|Overall Study|Disease Progression|1|||
125278245|NCT00559845|450643981|FG000|Overall Study|Adverse Event|3|||
125278246|NCT00559845|450643981|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
125278247|NCT00559845|450643981|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
125278248|NCT01406938|450643984|FG000|Induction Period|Subject/guardian decision|6|||
125278249|NCT01406938|450643985|FG001|Induction Period|Subject/guardian decision|8|||
125278250|NCT01406938|450643986|FG002|Induction Period|Subject/guardian decision|0|||
125278251|NCT01406938|450643987|FG003|Induction Period|Subject/guardian decision|0|||
125278252|NCT01406938|450643988|FG004|Induction Period|Subject/guardian decision|0|||
125278253|NCT01406938|450643989|FG005|Induction Period|Subject/guardian decision|0|||
125278254|NCT01406938|450643984|FG000|Induction Period|Protocol deviation|1|||
125278255|NCT01406938|450643985|FG001|Induction Period|Protocol deviation|0|||
125278256|NCT01406938|450643986|FG002|Induction Period|Protocol deviation|0|||
125278257|NCT01406938|450643987|FG003|Induction Period|Protocol deviation|0|||
125278258|NCT01406938|450643988|FG004|Induction Period|Protocol deviation|0|||
125278259|NCT01406938|450643989|FG005|Induction Period|Protocol deviation|0|||
125278260|NCT01406938|450643984|FG000|Induction Period|Adverse Event|8|||
125278261|NCT01406938|450643985|FG001|Induction Period|Adverse Event|9|||
125278262|NCT01406938|450643986|FG002|Induction Period|Adverse Event|0|||
125278263|NCT01406938|450643987|FG003|Induction Period|Adverse Event|0|||
125278264|NCT01406938|450643988|FG004|Induction Period|Adverse Event|0|||
125278265|NCT01406938|450643989|FG005|Induction Period|Adverse Event|0|||
125278266|NCT01406938|450643984|FG000|Induction Period|Lack of Efficacy|1|||
125278267|NCT01406938|450643985|FG001|Induction Period|Lack of Efficacy|0|||
125278268|NCT01406938|450643986|FG002|Induction Period|Lack of Efficacy|0|||
125278269|NCT01406938|450643987|FG003|Induction Period|Lack of Efficacy|0|||
125278270|NCT01406938|450643988|FG004|Induction Period|Lack of Efficacy|0|||
125278271|NCT01406938|450643989|FG005|Induction Period|Lack of Efficacy|0|||
125278272|NCT01406938|450643984|FG000|Induction Period|Lost to Follow-up|2|||
125278273|NCT01406938|450643985|FG001|Induction Period|Lost to Follow-up|3|||
125278274|NCT01406938|450643986|FG002|Induction Period|Lost to Follow-up|0|||
125278275|NCT01406938|450643987|FG003|Induction Period|Lost to Follow-up|0|||
125278276|NCT01406938|450643988|FG004|Induction Period|Lost to Follow-up|0|||
125278277|NCT01406938|450643989|FG005|Induction Period|Lost to Follow-up|0|||
125278278|NCT01406938|450643984|FG000|Maintenance Period|Adverse Event|0|||
125278279|NCT01406938|450643985|FG001|Maintenance Period|Adverse Event|0|||
125278280|NCT01406938|450643986|FG002|Maintenance Period|Adverse Event|2|||
125278281|NCT01406938|450643987|FG003|Maintenance Period|Adverse Event|8|||
125278282|NCT01406938|450643988|FG004|Maintenance Period|Adverse Event|4|||
125278283|NCT01406938|450643989|FG005|Maintenance Period|Adverse Event|2|||
125278284|NCT01406938|450643984|FG000|Maintenance Period|Death|0|||
125278285|NCT01406938|450643985|FG001|Maintenance Period|Death|0|||
125278286|NCT01406938|450643986|FG002|Maintenance Period|Death|0|||
125278287|NCT01406938|450643987|FG003|Maintenance Period|Death|0|||
125278288|NCT01406938|450643988|FG004|Maintenance Period|Death|1|||
125278289|NCT01406938|450643989|FG005|Maintenance Period|Death|0|||
125278290|NCT01406938|450643984|FG000|Maintenance Period|Subject/guardian decision|0|||
125278291|NCT01406938|450643985|FG001|Maintenance Period|Subject/guardian decision|0|||
125278292|NCT01406938|450643986|FG002|Maintenance Period|Subject/guardian decision|11|||
125278293|NCT01406938|450643987|FG003|Maintenance Period|Subject/guardian decision|7|||
125278294|NCT01406938|450643988|FG004|Maintenance Period|Subject/guardian decision|10|||
125278295|NCT01406938|450643989|FG005|Maintenance Period|Subject/guardian decision|7|||
125278296|NCT01406938|450643984|FG000|Maintenance Period|Protocol Violation|0|||
125278297|NCT01406938|450643985|FG001|Maintenance Period|Protocol Violation|0|||
125278298|NCT01406938|450643986|FG002|Maintenance Period|Protocol Violation|2|||
125278299|NCT01406938|450643987|FG003|Maintenance Period|Protocol Violation|2|||
125278300|NCT01406938|450643988|FG004|Maintenance Period|Protocol Violation|2|||
125278301|NCT01406938|450643989|FG005|Maintenance Period|Protocol Violation|2|||
125278302|NCT01406938|450643984|FG000|Maintenance Period|Pregnancy|0|||
125278303|NCT01406938|450643985|FG001|Maintenance Period|Pregnancy|0|||
124781552|NCT02785770|448831094|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
124781553|NCT02785770|448831095|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
124781554|NCT02785770|448831096|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
124781555|NCT00505778|448831100|FG000|Overall Study|Adverse Event|2|||
124781556|NCT00505778|448831101|FG001|Overall Study|Adverse Event|7|||
124781557|NCT00505778|448831100|FG000|Overall Study|Physician Decision|8|||
124781558|NCT00505778|448831101|FG001|Overall Study|Physician Decision|14|||
124781559|NCT00505778|448831100|FG000|Overall Study|Lost to Follow-up|17|||
124781560|NCT00505778|448831101|FG001|Overall Study|Lost to Follow-up|23|||
124781561|NCT00505778|448831100|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
124781562|NCT00505778|448831101|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
124781563|NCT00505778|448831100|FG000|Overall Study|Protocol Violation|7|||
124781564|NCT00505778|448831101|FG001|Overall Study|Protocol Violation|9|||
124781565|NCT00505778|448831100|FG000|Overall Study|Withdrawal by Subject|29|||
124781566|NCT00505778|448831101|FG001|Overall Study|Withdrawal by Subject|14|||
124781567|NCT00505778|448831100|FG000|Overall Study|Relapse|65|||
124781568|NCT00505778|448831101|FG001|Overall Study|Relapse|65|||
124781569|NCT00505778|448831100|FG000|Overall Study|Took No Study Drug|2|||
124781570|NCT00505778|448831101|FG001|Overall Study|Took No Study Drug|2|||
124781571|NCT02136069|448831103|FG000|Overall Study|UC flare-up|1|||
124781572|NCT02136069|448831104|FG001|Overall Study|UC flare-up|0|||
124781573|NCT02136069|448831103|FG000|Overall Study|Adverse Event|6|||
124781574|NCT02136069|448831104|FG001|Overall Study|Adverse Event|8|||
124781575|NCT02136069|448831103|FG000|Overall Study|Death|0|||
124781576|NCT02136069|448831104|FG001|Overall Study|Death|1|||
124781577|NCT02136069|448831103|FG000|Overall Study|Lack of Efficacy|10|||
124781578|NCT02136069|448831104|FG001|Overall Study|Lack of Efficacy|4|||
124781579|NCT02136069|448831103|FG000|Overall Study|Lost to Follow-up|1|||
124781580|NCT02136069|448831104|FG001|Overall Study|Lost to Follow-up|0|||
124781581|NCT02136069|448831103|FG000|Overall Study|Non-Compliance|1|||
124781582|NCT02136069|448831104|FG001|Overall Study|Non-Compliance|0|||
124781583|NCT02136069|448831103|FG000|Overall Study|Physician Decision|5|||
124781584|NCT02136069|448831104|FG001|Overall Study|Physician Decision|4|||
124781585|NCT02136069|448831103|FG000|Overall Study|Withdrawal by Subject|10|||
124781586|NCT02136069|448831104|FG001|Overall Study|Withdrawal by Subject|11|||
124781587|NCT01092546|448831105|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
124781588|NCT01667419|448831106|FG000|Overall Study|Reason Not Specified|1|||
125278304|NCT01406938|450643986|FG002|Maintenance Period|Pregnancy|0|||
125278305|NCT01406938|450643987|FG003|Maintenance Period|Pregnancy|0|||
125278306|NCT01406938|450643988|FG004|Maintenance Period|Pregnancy|1|||
125278307|NCT01406938|450643989|FG005|Maintenance Period|Pregnancy|0|||
125278308|NCT01406938|450643984|FG000|Maintenance Period|Lost to Follow-up|0|||
125278309|NCT01406938|450643985|FG001|Maintenance Period|Lost to Follow-up|0|||
125278310|NCT01406938|450643986|FG002|Maintenance Period|Lost to Follow-up|0|||
125278311|NCT01406938|450643987|FG003|Maintenance Period|Lost to Follow-up|0|||
125278312|NCT01406938|450643988|FG004|Maintenance Period|Lost to Follow-up|4|||
125278313|NCT01406938|450643989|FG005|Maintenance Period|Lost to Follow-up|0|||
125278314|NCT01406938|450643984|FG000|Maintenance Period|Lack of Efficacy|0|||
125278315|NCT01406938|450643985|FG001|Maintenance Period|Lack of Efficacy|0|||
125278316|NCT01406938|450643986|FG002|Maintenance Period|Lack of Efficacy|2|||
125278317|NCT01406938|450643987|FG003|Maintenance Period|Lack of Efficacy|1|||
125278318|NCT01406938|450643988|FG004|Maintenance Period|Lack of Efficacy|3|||
125278319|NCT01406938|450643989|FG005|Maintenance Period|Lack of Efficacy|5|||
125278320|NCT01406938|450643984|FG000|Follow up|Lack of Efficacy|3|||
125278321|NCT01406938|450643985|FG001|Follow up|Lack of Efficacy|2|||
125278322|NCT01406938|450643986|FG002|Follow up|Lack of Efficacy|1|||
125278323|NCT01406938|450643987|FG003|Follow up|Lack of Efficacy|0|||
125278324|NCT01406938|450643988|FG004|Follow up|Lack of Efficacy|0|||
125278325|NCT01406938|450643989|FG005|Follow up|Lack of Efficacy|0|||
125278326|NCT01406938|450643984|FG000|Follow up|Patient/guardian decision|4|||
124781589|NCT01667419|448831107|FG001|Overall Study|Reason Not Specified|0|||
124781590|NCT01667419|448831108|FG002|Overall Study|Reason Not Specified|0|||
124781591|NCT01667419|448831109|FG003|Overall Study|Reason Not Specified|0|||
125278327|NCT01406938|450643985|FG001|Follow up|Patient/guardian decision|2|||
124781592|NCT01667419|448831106|FG000|Overall Study|Withdrawal by Subject|16|||
124781593|NCT01667419|448831107|FG001|Overall Study|Withdrawal by Subject|8|||
125278328|NCT01406938|450643986|FG002|Follow up|Patient/guardian decision|4|||
125278329|NCT01406938|450643987|FG003|Follow up|Patient/guardian decision|2|||
125278330|NCT01406938|450643988|FG004|Follow up|Patient/guardian decision|4|||
125278331|NCT01406938|450643989|FG005|Follow up|Patient/guardian decision|1|||
124781594|NCT01667419|448831108|FG002|Overall Study|Withdrawal by Subject|9|||
124781595|NCT01667419|448831109|FG003|Overall Study|Withdrawal by Subject|8|||
125278332|NCT01406938|450643984|FG000|Follow up|Protocol Violation|0|||
125278333|NCT01406938|450643985|FG001|Follow up|Protocol Violation|0|||
125278334|NCT01406938|450643986|FG002|Follow up|Protocol Violation|1|||
125278335|NCT01406938|450643987|FG003|Follow up|Protocol Violation|0|||
125278336|NCT01406938|450643988|FG004|Follow up|Protocol Violation|0|||
125278337|NCT01406938|450643989|FG005|Follow up|Protocol Violation|0|||
124781596|NCT01667419|448831106|FG000|Overall Study|Non-compliance|0|||
124781597|NCT01667419|448831107|FG001|Overall Study|Non-compliance|0|||
124781598|NCT01667419|448831108|FG002|Overall Study|Non-compliance|0|||
125278338|NCT01406938|450643984|FG000|Follow up|Physician Decision|0|||
125278339|NCT01406938|450643985|FG001|Follow up|Physician Decision|0|||
125278340|NCT01406938|450643986|FG002|Follow up|Physician Decision|2|||
125278341|NCT01406938|450643987|FG003|Follow up|Physician Decision|0|||
125278342|NCT01406938|450643988|FG004|Follow up|Physician Decision|3|||
125278343|NCT01406938|450643989|FG005|Follow up|Physician Decision|1|||
125278344|NCT01406938|450643984|FG000|Follow up|Lost to Follow-up|1|||
125278345|NCT01406938|450643985|FG001|Follow up|Lost to Follow-up|1|||
125278346|NCT01406938|450643986|FG002|Follow up|Lost to Follow-up|0|||
125278347|NCT01406938|450643987|FG003|Follow up|Lost to Follow-up|1|||
125278348|NCT01406938|450643988|FG004|Follow up|Lost to Follow-up|2|||
125278349|NCT01406938|450643989|FG005|Follow up|Lost to Follow-up|1|||
125278350|NCT00878254|450643991|FG000|Overall Study|Physician Decision|1|||
125278351|NCT00878254|450643991|FG000|Overall Study|Death|1|||
125278352|NCT00878254|450643991|FG000|Overall Study|Withdrawal by Subject|1|||
125278353|NCT03367403|450643994|FG000|Overall Study|Adverse Event|20|||
125278354|NCT03367403|450643995|FG001|Overall Study|Adverse Event|6|||
125278355|NCT03367403|450643996|FG002|Overall Study|Adverse Event|2|||
125278356|NCT03367403|450643994|FG000|Overall Study|Withdrawal by Subject|12|||
125278357|NCT03367403|450643995|FG001|Overall Study|Withdrawal by Subject|13|||
125278358|NCT03367403|450643996|FG002|Overall Study|Withdrawal by Subject|1|||
125278359|NCT03367403|450643994|FG000|Overall Study|Death|1|||
125278360|NCT03367403|450643995|FG001|Overall Study|Death|2|||
125278361|NCT03367403|450643996|FG002|Overall Study|Death|0|||
125278362|NCT03367403|450643994|FG000|Overall Study|Physician Decision|0|||
125278363|NCT03367403|450643995|FG001|Overall Study|Physician Decision|1|||
125278364|NCT03367403|450643996|FG002|Overall Study|Physician Decision|0|||
125278365|NCT03367403|450643994|FG000|Overall Study|Protocol Violation|1|||
125278366|NCT03367403|450643995|FG001|Overall Study|Protocol Violation|1|||
125278367|NCT03367403|450643996|FG002|Overall Study|Protocol Violation|0|||
125278368|NCT03367403|450643994|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
125278369|NCT03367403|450643995|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
125278370|NCT03367403|450643996|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
125278371|NCT03367403|450643994|FG000|Overall Study|COVID-19|3|||
125278372|NCT03367403|450643995|FG001|Overall Study|COVID-19|6|||
125278373|NCT03367403|450643996|FG002|Overall Study|COVID-19|0|||
125278374|NCT03367403|450643994|FG000|Overall Study|Abuse of Alcohol Intake|0|||
125278375|NCT03367403|450643995|FG001|Overall Study|Abuse of Alcohol Intake|1|||
125278376|NCT03367403|450643996|FG002|Overall Study|Abuse of Alcohol Intake|0|||
125278377|NCT03367403|450643994|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
125278378|NCT03367403|450643995|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
125278379|NCT03367403|450643996|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
125278380|NCT00194077|450643997|FG000|Overall Study|Lack of Efficacy|22|||
125278381|NCT00194077|450643998|FG001|Overall Study|Lack of Efficacy|29|||
125278382|NCT00194077|450643997|FG000|Overall Study|Study nonadherence|1|||
125278383|NCT00194077|450643998|FG001|Overall Study|Study nonadherence|0|||
125278384|NCT00194077|450643997|FG000|Overall Study|Withdrawal by Subject|1|||
125278385|NCT00194077|450643998|FG001|Overall Study|Withdrawal by Subject|1|||
125278386|NCT03470194|450644001|FG000|Overall Study|Lost to Follow-up|11|||
125278387|NCT03470194|450644002|FG001|Overall Study|Lost to Follow-up|17|||
125278388|NCT03286543|450644003|FG000|Consented|Screen failure before randomization|2|||
125278389|NCT03286543|450644004|FG001|Consented|Screen failure before randomization|0|||
125278390|NCT03286543|450644005|FG002|Consented|Screen failure before randomization|0|||
125278391|NCT03286543|450644003|FG000|Consented|Screen failure before enrollment|4|||
125278392|NCT03286543|450644004|FG001|Consented|Screen failure before enrollment|0|||
125278393|NCT03286543|450644005|FG002|Consented|Screen failure before enrollment|0|||
125278394|NCT03286543|450644003|FG000|Consented|TKA cancelled after enrollment|1|||
125278395|NCT03286543|450644004|FG001|Consented|TKA cancelled after enrollment|0|||
125278396|NCT03286543|450644005|FG002|Consented|TKA cancelled after enrollment|0|||
125278397|NCT03286543|450644003|FG000|Consented|Withdrawn from study|12|||
125278398|NCT03286543|450644004|FG001|Consented|Withdrawn from study|0|||
125278399|NCT03286543|450644005|FG002|Consented|Withdrawn from study|0|||
125278400|NCT03286543|450644003|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
124781599|NCT01667419|448831109|FG003|Overall Study|Non-compliance|1|||
125278401|NCT03286543|450644004|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
125278402|NCT03286543|450644005|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
125278403|NCT03286543|450644003|FG000|Study Enrollment|Withdrawn from study|0|||
125278404|NCT03286543|450644004|FG001|Study Enrollment|Withdrawn from study|6|||
125278405|NCT03286543|450644005|FG002|Study Enrollment|Withdrawn from study|6|||
125278406|NCT00758069|450644006|FG000|Overall Study|Lack of Efficacy|0|||
125278407|NCT00758069|450644007|FG001|Overall Study|Lack of Efficacy|0|||
125278408|NCT00758069|450644008|FG002|Overall Study|Lack of Efficacy|1|||
125278409|NCT00758069|450644006|FG000|Overall Study|Incorrect Study Drug|1|||
125278410|NCT00758069|450644007|FG001|Overall Study|Incorrect Study Drug|0|||
125278411|NCT00758069|450644008|FG002|Overall Study|Incorrect Study Drug|0|||
125278412|NCT00588237|450644009|FG000|Overall Study|Evaluable for toxicity only|3|||
125278413|NCT00588237|450644009|FG000|Overall Study|Patien not treated|1|||
125278414|NCT04908865|450644013|FG000|Overall Study|Adverse Event|2|||
125278415|NCT04908865|450644013|FG000|Overall Study|Lack of Efficacy|5|||
125278416|NCT04908865|450644013|FG000|Overall Study|Lost to Follow-up|1|||
125278417|NCT03249909|450644018|FG000|Overall Study|Withdrawal by Subject|3|||
125278418|NCT03249909|450644019|FG001|Overall Study|Withdrawal by Subject|0|||
125278419|NCT03249909|450644020|FG002|Overall Study|Withdrawal by Subject|0|||
125278420|NCT03249909|450644018|FG000|Overall Study|Adverse Event|3|||
125278421|NCT03249909|450644019|FG001|Overall Study|Adverse Event|0|||
125278422|NCT03249909|450644020|FG002|Overall Study|Adverse Event|0|||
125278423|NCT03249909|450644018|FG000|Overall Study|Lost to Follow-up|0|||
125278424|NCT03249909|450644019|FG001|Overall Study|Lost to Follow-up|1|||
125278425|NCT03249909|450644020|FG002|Overall Study|Lost to Follow-up|0|||
125278426|NCT00606034|450644021|FG000|Overall Study|incarceration|1|||
125278427|NCT02027311|450644023|FG000|Overall Study|Protocol Violation|3|||
125278428|NCT02027311|450644024|FG001|Overall Study|Protocol Violation|2|||
125278429|NCT02466425|450644027|FG000|Overall Study|Adverse Event|3|||
125278430|NCT02466425|450644028|FG001|Overall Study|Adverse Event|11|||
125278431|NCT02466425|450644027|FG000|Overall Study|Lack of Efficacy|4|||
125278432|NCT02466425|450644028|FG001|Overall Study|Lack of Efficacy|1|||
125278433|NCT02466425|450644027|FG000|Overall Study|Lost to Follow-up|3|||
125278434|NCT02466425|450644028|FG001|Overall Study|Lost to Follow-up|0|||
125278435|NCT02466425|450644027|FG000|Overall Study|Protocol Violation|1|||
125278436|NCT02466425|450644028|FG001|Overall Study|Protocol Violation|0|||
125278437|NCT02466425|450644027|FG000|Overall Study|Withdrawal by Subject|0|||
125278438|NCT02466425|450644028|FG001|Overall Study|Withdrawal by Subject|1|||
125278439|NCT02466425|450644027|FG000|Overall Study|Other|1|||
125278440|NCT02466425|450644028|FG001|Overall Study|Other|3|||
125278441|NCT02466425|450644027|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
125278442|NCT02466425|450644028|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125278443|NCT01721486|450644033|FG000|Overall Study|Protocol Violation|1|||
125278444|NCT01721486|450644034|FG001|Overall Study|Protocol Violation|0|||
125278445|NCT01721486|450644033|FG000|Overall Study|Physician Decision|0|||
125278446|NCT01721486|450644034|FG001|Overall Study|Physician Decision|1|||
125278447|NCT00582712|450644035|FG000|Overall Study|Adverse Event|1|||
125278448|NCT00582712|450644035|FG000|Overall Study|Lack of Efficacy|1|||
125278449|NCT00582712|450644035|FG000|Overall Study|Withdrawal by Subject|1|||
125278450|NCT00582712|450644035|FG000|Overall Study|Complicating disease requiring treatment|1|||
125278451|NCT05141175|450644036|FG000|Overall Study|Withdrawal by Subject|1|||
125278452|NCT01901289|450644038|FG000|Overall Study|Death|32|||
125278453|NCT01901289|450644038|FG000|Overall Study|Lost to Follow-up|16|||
125278454|NCT01901289|450644038|FG000|Overall Study|Withdrawal by Subject|35|||
125278455|NCT01901289|450644038|FG000|Overall Study|Other type of endpoint met|2|||
125278456|NCT01813058|450644039|FG000|Overall Study|Withdrawal by Subject|5|||
125278457|NCT01813058|450644040|FG001|Overall Study|Withdrawal by Subject|4|||
125278458|NCT00182078|450644042|FG000|Overall Study|Withdrawal by Subject|1|||
125278459|NCT00182078|450644043|FG001|Overall Study|Withdrawal by Subject|0|||
125278460|NCT00395486|450644044|FG000|Overall Study|Adverse Event|1|||
125278461|NCT00395486|450644045|FG001|Overall Study|Adverse Event|2|||
125278462|NCT00395486|450644044|FG000|Overall Study|Withdrawal by Subject|5|||
125278463|NCT00395486|450644045|FG001|Overall Study|Withdrawal by Subject|2|||
125278464|NCT00395486|450644044|FG000|Overall Study|Lost to Follow-up|0|||
125278465|NCT00395486|450644045|FG001|Overall Study|Lost to Follow-up|1|||
125278466|NCT01076205|450644046|FG000|Overall Study|Adverse Drug Reaction|299|||
125278467|NCT01076205|450644046|FG000|Overall Study|Lack of Effectiveness|1423|||
125278468|NCT01076205|450644046|FG000|Overall Study|Other Reason|1075|||
125278469|NCT01076205|450644046|FG000|Overall Study|Unknown Reason|71|||
125278470|NCT01076205|450644046|FG000|Overall Study|Lost to Follow-up|3151|||
125278471|NCT04731298|450644053|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
125278472|NCT04731298|450644054|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
125278473|NCT02443116|450644060|FG000|Part 1|Adverse Event|2|||
125278474|NCT02443116|450644061|FG001|Part 1|Adverse Event|3|||
125278475|NCT02443116|450644062|FG002|Part 1|Adverse Event|0|||
125278476|NCT02443116|450644063|FG003|Part 1|Adverse Event|0|||
125278477|NCT02443116|450644064|FG004|Part 1|Adverse Event|0|||
125278478|NCT02443116|450644065|FG005|Part 1|Adverse Event|0|||
125278479|NCT02443116|450644066|FG006|Part 1|Adverse Event|0|||
125278480|NCT02443116|450644067|FG007|Part 1|Adverse Event|0|||
125278481|NCT02443116|450644068|FG008|Part 1|Adverse Event|0|||
125278482|NCT02443116|450644060|FG000|Part 1|Withdrew informed consent|0|||
125278483|NCT02443116|450644061|FG001|Part 1|Withdrew informed consent|1|||
125278484|NCT02443116|450644062|FG002|Part 1|Withdrew informed consent|0|||
125278485|NCT02443116|450644063|FG003|Part 1|Withdrew informed consent|0|||
125278486|NCT02443116|450644064|FG004|Part 1|Withdrew informed consent|0|||
125278487|NCT02443116|450644065|FG005|Part 1|Withdrew informed consent|0|||
125278488|NCT02443116|450644066|FG006|Part 1|Withdrew informed consent|0|||
125278489|NCT02443116|450644067|FG007|Part 1|Withdrew informed consent|0|||
125278490|NCT02443116|450644068|FG008|Part 1|Withdrew informed consent|0|||
125278491|NCT02443116|450644060|FG000|Part 1|Lost to Follow-up|0|||
125278492|NCT02443116|450644061|FG001|Part 1|Lost to Follow-up|0|||
125278493|NCT02443116|450644062|FG002|Part 1|Lost to Follow-up|2|||
125278494|NCT02443116|450644063|FG003|Part 1|Lost to Follow-up|0|||
125278495|NCT02443116|450644064|FG004|Part 1|Lost to Follow-up|0|||
125278496|NCT02443116|450644065|FG005|Part 1|Lost to Follow-up|0|||
125278497|NCT02443116|450644066|FG006|Part 1|Lost to Follow-up|0|||
125278498|NCT02443116|450644067|FG007|Part 1|Lost to Follow-up|0|||
125278499|NCT02443116|450644068|FG008|Part 1|Lost to Follow-up|0|||
125278500|NCT02443116|450644060|FG000|Part 1|Participant moved out of state|0|||
125278501|NCT02443116|450644061|FG001|Part 1|Participant moved out of state|0|||
125278502|NCT02443116|450644062|FG002|Part 1|Participant moved out of state|1|||
125278503|NCT02443116|450644063|FG003|Part 1|Participant moved out of state|0|||
125278504|NCT02443116|450644064|FG004|Part 1|Participant moved out of state|0|||
125278505|NCT02443116|450644065|FG005|Part 1|Participant moved out of state|0|||
125278506|NCT02443116|450644066|FG006|Part 1|Participant moved out of state|0|||
125278507|NCT02443116|450644067|FG007|Part 1|Participant moved out of state|0|||
125278508|NCT02443116|450644068|FG008|Part 1|Participant moved out of state|0|||
125278509|NCT02443116|450644060|FG000|Part 1|Participant enrolled in another clinical trial|0|||
125278510|NCT02443116|450644061|FG001|Part 1|Participant enrolled in another clinical trial|0|||
125278511|NCT02443116|450644062|FG002|Part 1|Participant enrolled in another clinical trial|1|||
125278512|NCT02443116|450644063|FG003|Part 1|Participant enrolled in another clinical trial|0|||
125278513|NCT02443116|450644064|FG004|Part 1|Participant enrolled in another clinical trial|0|||
125278514|NCT02443116|450644065|FG005|Part 1|Participant enrolled in another clinical trial|0|||
125278515|NCT02443116|450644066|FG006|Part 1|Participant enrolled in another clinical trial|0|||
125278516|NCT02443116|450644067|FG007|Part 1|Participant enrolled in another clinical trial|0|||
125278517|NCT02443116|450644068|FG008|Part 1|Participant enrolled in another clinical trial|0|||
125278518|NCT02443116|450644060|FG000|Part 2|Adverse Event|0|||
125278519|NCT02443116|450644061|FG001|Part 2|Adverse Event|0|||
124781600|NCT01667419|448831106|FG000|Overall Study|Protocol Violation|1|||
124781601|NCT01667419|448831107|FG001|Overall Study|Protocol Violation|0|||
125278520|NCT02443116|450644062|FG002|Part 2|Adverse Event|0|||
125278521|NCT02443116|450644063|FG003|Part 2|Adverse Event|0|||
125278522|NCT02443116|450644064|FG004|Part 2|Adverse Event|1|||
125278523|NCT02443116|450644065|FG005|Part 2|Adverse Event|1|||
125278524|NCT02443116|450644066|FG006|Part 2|Adverse Event|2|||
125278525|NCT02443116|450644067|FG007|Part 2|Adverse Event|0|||
125278526|NCT02443116|450644068|FG008|Part 2|Adverse Event|0|||
125278527|NCT02443116|450644060|FG000|Part 2|Withdrew informed consent|0|||
125278528|NCT02443116|450644061|FG001|Part 2|Withdrew informed consent|0|||
125278529|NCT02443116|450644062|FG002|Part 2|Withdrew informed consent|0|||
125278530|NCT02443116|450644063|FG003|Part 2|Withdrew informed consent|0|||
125278531|NCT02443116|450644064|FG004|Part 2|Withdrew informed consent|0|||
125278532|NCT02443116|450644065|FG005|Part 2|Withdrew informed consent|1|||
125278533|NCT02443116|450644066|FG006|Part 2|Withdrew informed consent|1|||
125278534|NCT02443116|450644067|FG007|Part 2|Withdrew informed consent|0|||
125278535|NCT02443116|450644068|FG008|Part 2|Withdrew informed consent|0|||
125278536|NCT02443116|450644060|FG000|Part 2|Inability to comply with protocol|0|||
125278537|NCT02443116|450644061|FG001|Part 2|Inability to comply with protocol|0|||
125278538|NCT02443116|450644062|FG002|Part 2|Inability to comply with protocol|0|||
125278539|NCT02443116|450644063|FG003|Part 2|Inability to comply with protocol|1|||
125278540|NCT02443116|450644064|FG004|Part 2|Inability to comply with protocol|0|||
125278541|NCT02443116|450644065|FG005|Part 2|Inability to comply with protocol|0|||
125278542|NCT02443116|450644066|FG006|Part 2|Inability to comply with protocol|0|||
125278543|NCT02443116|450644067|FG007|Part 2|Inability to comply with protocol|0|||
125278544|NCT02443116|450644068|FG008|Part 2|Inability to comply with protocol|0|||
125278545|NCT02443116|450644060|FG000|Part 2|Lost to Follow-up|0|||
125278546|NCT02443116|450644061|FG001|Part 2|Lost to Follow-up|0|||
125278547|NCT02443116|450644062|FG002|Part 2|Lost to Follow-up|0|||
125278548|NCT02443116|450644063|FG003|Part 2|Lost to Follow-up|1|||
125278549|NCT02443116|450644064|FG004|Part 2|Lost to Follow-up|0|||
125278550|NCT02443116|450644065|FG005|Part 2|Lost to Follow-up|0|||
125278551|NCT02443116|450644066|FG006|Part 2|Lost to Follow-up|0|||
125278552|NCT02443116|450644067|FG007|Part 2|Lost to Follow-up|0|||
125278553|NCT02443116|450644068|FG008|Part 2|Lost to Follow-up|0|||
125278554|NCT02443116|450644060|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
125278555|NCT02443116|450644061|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
125278556|NCT02443116|450644062|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
125278557|NCT02443116|450644063|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
125278558|NCT02443116|450644064|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
125278559|NCT02443116|450644065|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
125278560|NCT02443116|450644066|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
125278561|NCT02443116|450644067|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
125278562|NCT02443116|450644068|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
125278563|NCT02443116|450644060|FG000|Part 3|Adverse Event|0|||
125278564|NCT02443116|450644061|FG001|Part 3|Adverse Event|0|||
125278565|NCT02443116|450644062|FG002|Part 3|Adverse Event|0|||
125278566|NCT02443116|450644063|FG003|Part 3|Adverse Event|0|||
125278567|NCT02443116|450644064|FG004|Part 3|Adverse Event|0|||
125278568|NCT02443116|450644065|FG005|Part 3|Adverse Event|0|||
125278569|NCT02443116|450644066|FG006|Part 3|Adverse Event|0|||
125278570|NCT02443116|450644067|FG007|Part 3|Adverse Event|0|||
125278571|NCT02443116|450644068|FG008|Part 3|Adverse Event|1|||
125278572|NCT02443116|450644060|FG000|Part 3|Withdrew informed consent|0|||
125278573|NCT02443116|450644061|FG001|Part 3|Withdrew informed consent|0|||
125278574|NCT02443116|450644062|FG002|Part 3|Withdrew informed consent|0|||
125278575|NCT02443116|450644063|FG003|Part 3|Withdrew informed consent|0|||
125278576|NCT02443116|450644064|FG004|Part 3|Withdrew informed consent|0|||
125278577|NCT02443116|450644065|FG005|Part 3|Withdrew informed consent|0|||
125278578|NCT02443116|450644066|FG006|Part 3|Withdrew informed consent|0|||
125278579|NCT02443116|450644067|FG007|Part 3|Withdrew informed consent|3|||
125278580|NCT02443116|450644068|FG008|Part 3|Withdrew informed consent|2|||
125278581|NCT02443116|450644060|FG000|Part 3|Lost to Follow-up|0|||
125278582|NCT02443116|450644061|FG001|Part 3|Lost to Follow-up|0|||
125278583|NCT02443116|450644062|FG002|Part 3|Lost to Follow-up|0|||
125278584|NCT02443116|450644063|FG003|Part 3|Lost to Follow-up|0|||
125278585|NCT02443116|450644064|FG004|Part 3|Lost to Follow-up|0|||
125278586|NCT02443116|450644065|FG005|Part 3|Lost to Follow-up|0|||
125278587|NCT02443116|450644066|FG006|Part 3|Lost to Follow-up|0|||
125278588|NCT02443116|450644067|FG007|Part 3|Lost to Follow-up|1|||
125278589|NCT02443116|450644068|FG008|Part 3|Lost to Follow-up|2|||
125278590|NCT01932372|450644069|FG000|Overall Study|Not meeting eligibility criteria|33|||
125278591|NCT01932372|450644070|FG001|Overall Study|Not meeting eligibility criteria|179|||
125278592|NCT01917929|450644071|FG000|Overall Study|Death|8|||
125278593|NCT01917929|450644071|FG000|Overall Study|Lost to Follow-up|19|||
125278594|NCT01917929|450644071|FG000|Overall Study|Withdrawal by Subject|33|||
125278595|NCT01917929|450644071|FG000|Overall Study|Adverse Event|6|||
125278596|NCT01917929|450644071|FG000|Overall Study|Investigative Site Terminated|35|||
125278597|NCT01917929|450644071|FG000|Overall Study|Censored because study device not implanted|6|||
125278598|NCT01917929|450644071|FG000|Overall Study|Censored because surgery not performed|3|||
125278599|NCT01917929|450644071|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
125278600|NCT01917929|450644071|FG000|Overall Study|Sponsor terminated study|175|||
125278601|NCT02059499|450644079|FG000|Upto Week 20|Lost to Follow-up|2|||
125278602|NCT02059499|450644080|FG001|Upto Week 20|Lost to Follow-up|6|||
125278603|NCT02059499|450644081|FG002|Upto Week 20|Lost to Follow-up|0|||
125278604|NCT02059499|450644079|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
125278605|NCT02059499|450644080|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
125278606|NCT02059499|450644081|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
125278607|NCT02059499|450644079|FG000|Upto Week 20|Withdrawal by Subject|1|||
125278608|NCT02059499|450644080|FG001|Upto Week 20|Withdrawal by Subject|1|||
125278609|NCT02059499|450644081|FG002|Upto Week 20|Withdrawal by Subject|0|||
125278610|NCT02059499|450644079|FG000|Upto Week 20|No treatment per protocol criteria|0|||
125278611|NCT02059499|450644080|FG001|Upto Week 20|No treatment per protocol criteria|0|||
125278612|NCT02059499|450644081|FG002|Upto Week 20|No treatment per protocol criteria|5|||
125278613|NCT02059499|450644079|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
125278614|NCT02059499|450644080|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
125278615|NCT02059499|450644081|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
125278616|NCT02059499|450644079|FG000|Post-week 20|Lost to Follow-up|0|||
125278617|NCT02059499|450644080|FG001|Post-week 20|Lost to Follow-up|2|||
125278618|NCT02059499|450644081|FG002|Post-week 20|Lost to Follow-up|0|||
125278619|NCT02059499|450644079|FG000|Post-week 20|Withdrawal by Subject|0|||
125278620|NCT02059499|450644080|FG001|Post-week 20|Withdrawal by Subject|1|||
125278621|NCT02059499|450644081|FG002|Post-week 20|Withdrawal by Subject|0|||
125278622|NCT02059499|450644079|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
125278623|NCT02059499|450644080|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
125278624|NCT02059499|450644081|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
125278625|NCT00703846|450644082|FG000|Overall Study|Adverse Event|8|||
125278626|NCT00703846|450644082|FG000|Overall Study|Lost to Follow-up|55|||
125278627|NCT00703846|450644082|FG000|Overall Study|Lack of Efficacy|15|||
125278628|NCT00703846|450644082|FG000|Overall Study|Noncompliance with Study Treatment|2|||
125278629|NCT00703846|450644082|FG000|Overall Study|Withdrawal by Subject|40|||
125278630|NCT00703846|450644082|FG000|Overall Study|Death|1|||
125278631|NCT00703846|450644082|FG000|Overall Study|Other|14|||
125278632|NCT00703846|450644082|FG000|Overall Study|Did Not Receive Study Drug|2|||
125278633|NCT00830375|450644087|FG000|Overall Study|Lost to Follow-up|1|||
125278634|NCT01700959|450644088|FG000|Overall Study|Adverse Event|0|||
125278635|NCT01700959|450644089|FG001|Overall Study|Adverse Event|1|||
125278636|NCT01700959|450644090|FG002|Overall Study|Adverse Event|1|||
125278637|NCT01700959|450644091|FG003|Overall Study|Adverse Event|2|||
125278638|NCT01700959|450644092|FG004|Overall Study|Adverse Event|0|||
125278639|NCT01700959|450644093|FG005|Overall Study|Adverse Event|2|||
125278640|NCT01700959|450644088|FG000|Overall Study|Withdrawal by Subject|15|||
125278641|NCT01700959|450644089|FG001|Overall Study|Withdrawal by Subject|9|||
125278642|NCT01700959|450644090|FG002|Overall Study|Withdrawal by Subject|12|||
125278643|NCT01700959|450644091|FG003|Overall Study|Withdrawal by Subject|11|||
125278644|NCT01700959|450644092|FG004|Overall Study|Withdrawal by Subject|8|||
125278645|NCT01700959|450644093|FG005|Overall Study|Withdrawal by Subject|12|||
125278646|NCT01700959|450644088|FG000|Overall Study|Ineligible|2|||
125278647|NCT01700959|450644089|FG001|Overall Study|Ineligible|1|||
125278648|NCT01700959|450644090|FG002|Overall Study|Ineligible|2|||
125278649|NCT01700959|450644091|FG003|Overall Study|Ineligible|0|||
125278650|NCT01700959|450644092|FG004|Overall Study|Ineligible|0|||
125278651|NCT01700959|450644093|FG005|Overall Study|Ineligible|1|||
125278652|NCT01700959|450644088|FG000|Overall Study|Noncompliant|9|||
124781602|NCT01667419|448831108|FG002|Overall Study|Protocol Violation|0|||
124781603|NCT01667419|448831109|FG003|Overall Study|Protocol Violation|0|||
125278653|NCT01700959|450644089|FG001|Overall Study|Noncompliant|9|||
125278654|NCT01700959|450644090|FG002|Overall Study|Noncompliant|17|||
125278655|NCT01700959|450644091|FG003|Overall Study|Noncompliant|18|||
125278656|NCT01700959|450644092|FG004|Overall Study|Noncompliant|15|||
125278657|NCT01700959|450644093|FG005|Overall Study|Noncompliant|9|||
125278658|NCT01700959|450644088|FG000|Overall Study|Side effects|1|||
125278659|NCT01700959|450644089|FG001|Overall Study|Side effects|4|||
124781604|NCT01667419|448831106|FG000|Overall Study|Lost to Follow-up|7|||
125278660|NCT01700959|450644090|FG002|Overall Study|Side effects|8|||
125278661|NCT01700959|450644091|FG003|Overall Study|Side effects|4|||
125278662|NCT01700959|450644092|FG004|Overall Study|Side effects|4|||
125278663|NCT01700959|450644093|FG005|Overall Study|Side effects|1|||
125278664|NCT00782171|450645773|FG000|Overall Study|Lost to Follow-up|2|||
124781605|NCT01667419|448831107|FG001|Overall Study|Lost to Follow-up|6|||
124781606|NCT01667419|448831108|FG002|Overall Study|Lost to Follow-up|2|||
124781607|NCT01667419|448831109|FG003|Overall Study|Lost to Follow-up|4|||
124781608|NCT01667419|448831106|FG000|Overall Study|Death|18|||
125278665|NCT00782171|450645774|FG001|Overall Study|Lost to Follow-up|2|||
124781609|NCT01667419|448831107|FG001|Overall Study|Death|33|||
124781610|NCT01667419|448831108|FG002|Overall Study|Death|25|||
124781611|NCT01667419|448831109|FG003|Overall Study|Death|26|||
124781612|NCT04364984|448831111|FG000|Overall Study|Death|2|||
124781613|NCT04364984|448831112|FG001|Overall Study|Death|2|||
124781614|NCT04364984|448831113|FG002|Overall Study|Death|0|||
124781615|NCT01941186|448831114|FG000|Follow-up|Lost to Follow-up|1|||
124781616|NCT01941186|448831115|FG001|Follow-up|Lost to Follow-up|0|||
124781617|NCT04380519|448831116|FG000|Overall Study|Withdrawal by Subject|4|||
124781618|NCT04380519|448831117|FG001|Overall Study|Withdrawal by Subject|0|||
124781619|NCT04380519|448831118|FG002|Overall Study|Withdrawal by Subject|1|||
124781620|NCT04380519|448831116|FG000|Overall Study|Death|14|||
124781621|NCT04380519|448831117|FG001|Overall Study|Death|9|||
124781622|NCT04380519|448831118|FG002|Overall Study|Death|6|||
124781623|NCT04380519|448831116|FG000|Overall Study|Adverse Event|0|||
124781624|NCT04380519|448831117|FG001|Overall Study|Adverse Event|1|||
124781625|NCT04380519|448831118|FG002|Overall Study|Adverse Event|0|||
124781626|NCT04380519|448831116|FG000|Overall Study|relatives' decision|0|||
124781627|NCT04380519|448831117|FG001|Overall Study|relatives' decision|1|||
124781628|NCT04380519|448831118|FG002|Overall Study|relatives' decision|0|||
125278666|NCT00782171|450645773|FG000|Overall Study|Withdrawal by Subject|2|||
125278667|NCT00782171|450645774|FG001|Overall Study|Withdrawal by Subject|1|||
125278668|NCT00782171|450645773|FG000|Overall Study|complications|3|||
125278669|NCT00782171|450645774|FG001|Overall Study|complications|1|||
125278670|NCT00782171|450645773|FG000|Overall Study|others|7|||
125278671|NCT00782171|450645774|FG001|Overall Study|others|9|||
125278672|NCT00782171|450645773|FG000|Overall Study|not eligible|8|||
125278673|NCT00782171|450645774|FG001|Overall Study|not eligible|6|||
125278674|NCT02582814|450645782|FG000|Overall Study|Study-specific withdrawal criteria|1|||
125278675|NCT02582814|450645783|FG001|Overall Study|Study-specific withdrawal criteria|0|||
125278676|NCT02582814|450645782|FG000|Overall Study|Withdrawal by Subject|4|||
125278677|NCT02582814|450645783|FG001|Overall Study|Withdrawal by Subject|3|||
125278678|NCT02582814|450645782|FG000|Overall Study|Adverse Event|4|||
125278679|NCT02582814|450645783|FG001|Overall Study|Adverse Event|4|||
125278680|NCT03530995|450645784|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
125278681|NCT03530995|450645785|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
125278682|NCT03530995|450645784|FG000|Part 1 Period 3|Protocol Violation|1|||
125278683|NCT03530995|450645785|FG001|Part 1 Period 3|Protocol Violation|0|||
125278684|NCT03530995|450645784|FG000|Part 1 Period 4|Physician Decision|1|||
125278685|NCT03530995|450645785|FG001|Part 1 Period 4|Physician Decision|0|||
125278686|NCT03530995|450645784|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
125278687|NCT03530995|450645785|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
125278688|NCT01986231|450645789|FG000|Overall Study|Adverse Event|1|||
125278689|NCT01558115|450645790|FG000|Overall Study|Withdrawal by Subject|3|||
125278690|NCT01558115|450645790|FG000|Overall Study|Study closed due to poor enrollment|4|||
125278691|NCT01696994|450645791|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
125278692|NCT01696994|450645792|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
125278693|NCT01696994|450645791|FG000|Overall Study|Died Before Randomization|1|||
125278694|NCT01696994|450645792|FG001|Overall Study|Died Before Randomization|2|||
125278695|NCT01696994|450645791|FG000|Overall Study|Died Before ASU (Control)|73|||
125278696|NCT01696994|450645792|FG001|Overall Study|Died Before ASU (Control)|0|||
125278697|NCT01696994|450645791|FG000|Overall Study|No Ovaries at Baseline|4807|||
125278698|NCT01696994|450645792|FG001|Overall Study|No Ovaries at Baseline|4851|||
125278699|NCT01696994|450645791|FG000|Overall Study|Refused ASU (Control)|311|||
125278700|NCT01696994|450645792|FG001|Overall Study|Refused ASU (Control)|0|||
125278701|NCT01696994|450645791|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
125278702|NCT01696994|450645792|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
125278703|NCT04644276|450645793|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
125278704|NCT04644276|450645794|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
125278705|NCT04644276|450645795|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
125278706|NCT00705250|450645796|FG000|Overall Study|Withdrawal by Subject|1|||
125278707|NCT00705250|450645796|FG000|Overall Study|Patient died in car accident|1|||
125278708|NCT01576146|450645797|FG000|Extension Period 1|Adverse Event|2|||
125278709|NCT01576146|450645797|FG000|Extension Period 1|Death|2|||
125278710|NCT01576146|450645797|FG000|Extension Period 1|Physician Decision|2|||
124781629|NCT04173494|448831119|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
125278711|NCT01576146|450645797|FG000|Extension Period 1|Withdrawal by Subject|1|||
125278712|NCT01576146|450645797|FG000|Extension Period 1|Lost to Follow-up|1|||
125278713|NCT01576146|450645797|FG000|Extension Period 1|Parathyroidectomy|1|||
125278714|NCT01576146|450645797|FG000|Extension Period 1|Renal Transplant|1|||
125278715|NCT01576146|450645797|FG000|Extension Period 2|Sponsor Decision|13|||
125278716|NCT01576146|450645797|FG000|Extension Period 2|Death|1|||
125278717|NCT01576146|450645797|FG000|Extension Period 2|Adverse Event|1|||
124781630|NCT04173494|448831120|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
124781631|NCT04173494|448831119|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
124781632|NCT04173494|448831120|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
124781633|NCT04173494|448831119|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
125278718|NCT01576146|450645797|FG000|Extension Period 2|Renal Transplant|1|||
125278719|NCT01576146|450645797|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
125278720|NCT01951586|450645804|FG000|Overall Study|Death|61|||
125278721|NCT01951586|450645805|FG001|Overall Study|Death|120|||
125278722|NCT01951586|450645804|FG000|Overall Study|Withdrawal by Subject|8|||
125278723|NCT01951586|450645805|FG001|Overall Study|Withdrawal by Subject|17|||
125278724|NCT01951586|450645804|FG000|Overall Study|Lost to Follow-up|0|||
125278725|NCT01951586|450645805|FG001|Overall Study|Lost to Follow-up|1|||
125278726|NCT01951586|450645804|FG000|Overall Study|Sponsor Decision|9|||
125278727|NCT01951586|450645805|FG001|Overall Study|Sponsor Decision|10|||
125278728|NCT04995419|450645808|FG000|Overall Study|Withdrawal by Subject|3|||
125278729|NCT04995419|450645808|FG000|Overall Study|Progressive Disease|19|||
125278730|NCT04995419|450645808|FG000|Overall Study|Adverse Event|2|||
125278731|NCT04995419|450645808|FG000|Overall Study|Ongoing|16|||
125278732|NCT01822899|450645809|FG000|Overall Study|Adverse Event|6|||
125278733|NCT01822899|450645810|FG001|Overall Study|Adverse Event|5|||
125278734|NCT01822899|450645809|FG000|Overall Study|Lack of Efficacy|6|||
125278735|NCT01822899|450645810|FG001|Overall Study|Lack of Efficacy|3|||
125278736|NCT01822899|450645809|FG000|Overall Study|Protocol Violation|6|||
125278737|NCT01822899|450645810|FG001|Overall Study|Protocol Violation|3|||
125278738|NCT01822899|450645809|FG000|Overall Study|Lost to Follow-up|1|||
125278739|NCT01822899|450645810|FG001|Overall Study|Lost to Follow-up|0|||
125278740|NCT01822899|450645809|FG000|Overall Study|Withdrawal by Subject|5|||
125278741|NCT01822899|450645810|FG001|Overall Study|Withdrawal by Subject|7|||
125278742|NCT05332392|450645811|FG000|Overall Study|Did not meet inclusion criteria|25|||
125278743|NCT05332392|450645811|FG000|Overall Study|Principal Investigator's decision|17|||
125278744|NCT05332392|450645811|FG000|Overall Study|Adverse Event|1|||
125278745|NCT05332392|450645811|FG000|Overall Study|Subject's decision|1|||
125278746|NCT02752633|450645813|FG000|Overall Study|Withdrawal by Subject|1|||
125278747|NCT02846389|450645814|FG000|Overall Study|Withdrawal by Subject|1|||
125278748|NCT02846389|450645815|FG001|Overall Study|Withdrawal by Subject|1|||
125278749|NCT00853242|450645817|FG000|Overall Study|Adverse Event|0|||
125278750|NCT00853242|450645818|FG001|Overall Study|Adverse Event|1|||
125278751|NCT00853242|450645819|FG002|Overall Study|Adverse Event|1|||
125278752|NCT00853242|450645820|FG003|Overall Study|Adverse Event|0|||
125278753|NCT00853242|450645821|FG004|Overall Study|Adverse Event|3|||
125278754|NCT00853242|450645822|FG005|Overall Study|Adverse Event|1|||
125278755|NCT00853242|450645823|FG006|Overall Study|Adverse Event|1|||
125278756|NCT00853242|450645817|FG000|Overall Study|Noncompliant|0|||
125278757|NCT00853242|450645818|FG001|Overall Study|Noncompliant|0|||
125278758|NCT00853242|450645819|FG002|Overall Study|Noncompliant|0|||
125278759|NCT00853242|450645820|FG003|Overall Study|Noncompliant|0|||
125278760|NCT00853242|450645821|FG004|Overall Study|Noncompliant|1|||
125278761|NCT00853242|450645822|FG005|Overall Study|Noncompliant|0|||
125278762|NCT00853242|450645823|FG006|Overall Study|Noncompliant|0|||
125278763|NCT00853242|450645817|FG000|Overall Study|Withdrawal by Subject|1|||
125278764|NCT00853242|450645818|FG001|Overall Study|Withdrawal by Subject|2|||
125278765|NCT00853242|450645819|FG002|Overall Study|Withdrawal by Subject|0|||
125278766|NCT00853242|450645820|FG003|Overall Study|Withdrawal by Subject|4|||
125278767|NCT00853242|450645821|FG004|Overall Study|Withdrawal by Subject|0|||
125278768|NCT00853242|450645822|FG005|Overall Study|Withdrawal by Subject|0|||
125278769|NCT00853242|450645823|FG006|Overall Study|Withdrawal by Subject|2|||
125278770|NCT00853242|450645817|FG000|Overall Study|Other|2|||
125278771|NCT00853242|450645818|FG001|Overall Study|Other|0|||
125278772|NCT00853242|450645819|FG002|Overall Study|Other|2|||
125278773|NCT00853242|450645820|FG003|Overall Study|Other|0|||
125278774|NCT00853242|450645821|FG004|Overall Study|Other|0|||
125278775|NCT00853242|450645822|FG005|Overall Study|Other|1|||
125278776|NCT00853242|450645823|FG006|Overall Study|Other|2|||
125278777|NCT01265563|450645824|FG000|Overall Study|Withdrawal by Subject|0|||
125278778|NCT01265563|450645825|FG001|Overall Study|Withdrawal by Subject|1|||
125278779|NCT01265563|450645826|FG002|Overall Study|Withdrawal by Subject|1|||
125278780|NCT01265563|450645827|FG003|Overall Study|Withdrawal by Subject|0|||
125278781|NCT01265563|450645828|FG004|Overall Study|Withdrawal by Subject|2|||
125278782|NCT02141399|450645833|FG000|Overall Study|Adverse Event|158|||
125278783|NCT02141399|450645833|FG000|Overall Study|Lack of Efficacy|62|||
125278784|NCT02141399|450645833|FG000|Overall Study|Lost to Follow-up|151|||
125278785|NCT02141399|450645833|FG000|Overall Study|Non-compliance with study drug|18|||
125278786|NCT02141399|450645833|FG000|Overall Study|Other|45|||
125278787|NCT02141399|450645833|FG000|Overall Study|Physician Decision|17|||
125278788|NCT02141399|450645833|FG000|Overall Study|Pregnancy|3|||
125278789|NCT02141399|450645833|FG000|Overall Study|Protocol Violation|38|||
125278790|NCT02141399|450645833|FG000|Overall Study|Withdrawal by Subject|238|||
125278791|NCT02141399|450645833|FG000|Overall Study|Failure to meet eligibility criteria|14|||
125278792|NCT01296711|450645834|FG000|Overall Study|Adverse Event|3|||
125278793|NCT01296711|450645835|FG001|Overall Study|Adverse Event|1|||
125278794|NCT01296711|450645836|FG002|Overall Study|Adverse Event|4|||
125278795|NCT01296711|450645837|FG003|Overall Study|Adverse Event|3|||
125278796|NCT01296711|450645838|FG004|Overall Study|Adverse Event|1|||
125278797|NCT01296711|450645839|FG005|Overall Study|Adverse Event|6|||
125278798|NCT01296711|450645840|FG006|Overall Study|Adverse Event|11|||
125278799|NCT01296711|450645841|FG007|Overall Study|Adverse Event|3|||
124781634|NCT04173494|448831120|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
124781635|NCT04173494|448831119|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
124781636|NCT04173494|448831120|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
124781637|NCT04173494|448831119|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
124781638|NCT04173494|448831120|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
124781639|NCT04173494|448831119|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
124781640|NCT04173494|448831120|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
124781641|NCT04173494|448831119|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
124781642|NCT04173494|448831120|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
125278800|NCT01296711|450645834|FG000|Overall Study|Lack of Efficacy|1|||
125278801|NCT01296711|450645835|FG001|Overall Study|Lack of Efficacy|4|||
124781643|NCT04173494|448831119|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
124781644|NCT04173494|448831120|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
124781645|NCT04173494|448831119|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
124781646|NCT04173494|448831120|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
124781647|NCT04173494|448831119|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
124781648|NCT04173494|448831120|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
124781649|NCT04173494|448831119|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
124781650|NCT04173494|448831120|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
124781651|NCT04173494|448831119|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
124781652|NCT04173494|448831120|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
124781653|NCT04173494|448831119|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
124781654|NCT04173494|448831120|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
124781655|NCT04173494|448831119|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
125278802|NCT01296711|450645836|FG002|Overall Study|Lack of Efficacy|1|||
125278803|NCT01296711|450645837|FG003|Overall Study|Lack of Efficacy|1|||
125278804|NCT01296711|450645838|FG004|Overall Study|Lack of Efficacy|1|||
125278805|NCT01296711|450645839|FG005|Overall Study|Lack of Efficacy|0|||
125278806|NCT01296711|450645840|FG006|Overall Study|Lack of Efficacy|2|||
125278807|NCT01296711|450645841|FG007|Overall Study|Lack of Efficacy|3|||
125278808|NCT01296711|450645834|FG000|Overall Study|Lost to Follow-up|0|||
125278809|NCT01296711|450645835|FG001|Overall Study|Lost to Follow-up|0|||
125278810|NCT01296711|450645836|FG002|Overall Study|Lost to Follow-up|1|||
125278811|NCT01296711|450645837|FG003|Overall Study|Lost to Follow-up|1|||
125278812|NCT01296711|450645838|FG004|Overall Study|Lost to Follow-up|2|||
125278813|NCT01296711|450645839|FG005|Overall Study|Lost to Follow-up|0|||
125278814|NCT01296711|450645840|FG006|Overall Study|Lost to Follow-up|4|||
125278815|NCT01296711|450645841|FG007|Overall Study|Lost to Follow-up|2|||
125278816|NCT01296711|450645834|FG000|Overall Study|Protocol Violation|0|||
125278817|NCT01296711|450645835|FG001|Overall Study|Protocol Violation|0|||
125278818|NCT01296711|450645836|FG002|Overall Study|Protocol Violation|0|||
125278819|NCT01296711|450645837|FG003|Overall Study|Protocol Violation|1|||
125278820|NCT01296711|450645838|FG004|Overall Study|Protocol Violation|1|||
125278821|NCT01296711|450645839|FG005|Overall Study|Protocol Violation|0|||
125278822|NCT01296711|450645840|FG006|Overall Study|Protocol Violation|0|||
125278823|NCT01296711|450645841|FG007|Overall Study|Protocol Violation|0|||
125278824|NCT01296711|450645834|FG000|Overall Study|Withdrawal by Subject|4|||
125278825|NCT01296711|450645835|FG001|Overall Study|Withdrawal by Subject|2|||
125278826|NCT01296711|450645836|FG002|Overall Study|Withdrawal by Subject|2|||
125278827|NCT01296711|450645837|FG003|Overall Study|Withdrawal by Subject|1|||
125278828|NCT01296711|450645838|FG004|Overall Study|Withdrawal by Subject|1|||
125278829|NCT01296711|450645839|FG005|Overall Study|Withdrawal by Subject|1|||
125278830|NCT01296711|450645840|FG006|Overall Study|Withdrawal by Subject|2|||
125278831|NCT01296711|450645841|FG007|Overall Study|Withdrawal by Subject|1|||
124781656|NCT04173494|448831120|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
124781657|NCT04173494|448831119|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
124781658|NCT04173494|448831120|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
124781659|NCT04173494|448831119|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
124781660|NCT04173494|448831120|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
124781661|NCT02474069|448831121|FG000|Selection Phase (SP)|Adverse Event|8|||
124781662|NCT02474069|448831122|FG001|Selection Phase (SP)|Adverse Event|0|||
124781663|NCT02474069|448831123|FG002|Selection Phase (SP)|Adverse Event|0|||
124781664|NCT02474069|448831121|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
125278832|NCT01296711|450645834|FG000|Overall Study|Study termination|8|||
125278833|NCT01296711|450645835|FG001|Overall Study|Study termination|1|||
125278834|NCT01296711|450645836|FG002|Overall Study|Study termination|5|||
125278835|NCT01296711|450645837|FG003|Overall Study|Study termination|4|||
125278836|NCT01296711|450645838|FG004|Overall Study|Study termination|4|||
125278837|NCT01296711|450645839|FG005|Overall Study|Study termination|4|||
125278838|NCT01296711|450645840|FG006|Overall Study|Study termination|8|||
125278839|NCT01296711|450645841|FG007|Overall Study|Study termination|10|||
125278840|NCT01296711|450645834|FG000|Overall Study|Continued elevated liver enzymes|0|||
125278841|NCT01296711|450645835|FG001|Overall Study|Continued elevated liver enzymes|0|||
125278842|NCT01296711|450645836|FG002|Overall Study|Continued elevated liver enzymes|0|||
125278843|NCT01296711|450645837|FG003|Overall Study|Continued elevated liver enzymes|1|||
125278844|NCT01296711|450645838|FG004|Overall Study|Continued elevated liver enzymes|0|||
125278845|NCT01296711|450645839|FG005|Overall Study|Continued elevated liver enzymes|0|||
125278846|NCT01296711|450645840|FG006|Overall Study|Continued elevated liver enzymes|0|||
125278847|NCT01296711|450645841|FG007|Overall Study|Continued elevated liver enzymes|0|||
125278848|NCT01296711|450645834|FG000|Overall Study|Methotrexate discontinued|0|||
125278849|NCT01296711|450645835|FG001|Overall Study|Methotrexate discontinued|0|||
125278850|NCT01296711|450645836|FG002|Overall Study|Methotrexate discontinued|0|||
125278851|NCT01296711|450645837|FG003|Overall Study|Methotrexate discontinued|1|||
125278852|NCT01296711|450645838|FG004|Overall Study|Methotrexate discontinued|0|||
125278853|NCT01296711|450645839|FG005|Overall Study|Methotrexate discontinued|0|||
125278854|NCT01296711|450645840|FG006|Overall Study|Methotrexate discontinued|0|||
125278855|NCT01296711|450645841|FG007|Overall Study|Methotrexate discontinued|0|||
125278856|NCT01296711|450645834|FG000|Overall Study|Investigator discretion|0|||
125278857|NCT01296711|450645835|FG001|Overall Study|Investigator discretion|0|||
125278858|NCT01296711|450645836|FG002|Overall Study|Investigator discretion|0|||
125278859|NCT01296711|450645837|FG003|Overall Study|Investigator discretion|0|||
125278860|NCT01296711|450645838|FG004|Overall Study|Investigator discretion|0|||
125278861|NCT01296711|450645839|FG005|Overall Study|Investigator discretion|0|||
125278862|NCT01296711|450645840|FG006|Overall Study|Investigator discretion|1|||
125278863|NCT01296711|450645841|FG007|Overall Study|Investigator discretion|0|||
125278864|NCT01296711|450645834|FG000|Overall Study|Other|0|||
124781665|NCT02474069|448831122|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
125278865|NCT01296711|450645835|FG001|Overall Study|Other|0|||
125278866|NCT01296711|450645836|FG002|Overall Study|Other|0|||
125278867|NCT01296711|450645837|FG003|Overall Study|Other|0|||
125278868|NCT01296711|450645838|FG004|Overall Study|Other|0|||
125278869|NCT01296711|450645839|FG005|Overall Study|Other|0|||
125278870|NCT01296711|450645840|FG006|Overall Study|Other|1|||
125278871|NCT01296711|450645841|FG007|Overall Study|Other|0|||
125278872|NCT01296711|450645834|FG000|Overall Study|Required restricted steroid injections|0|||
125278873|NCT01296711|450645835|FG001|Overall Study|Required restricted steroid injections|0|||
124781666|NCT02474069|448831123|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
124781667|NCT02474069|448831121|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
125278874|NCT01296711|450645836|FG002|Overall Study|Required restricted steroid injections|0|||
125278875|NCT01296711|450645837|FG003|Overall Study|Required restricted steroid injections|0|||
125278876|NCT01296711|450645838|FG004|Overall Study|Required restricted steroid injections|0|||
125278877|NCT01296711|450645839|FG005|Overall Study|Required restricted steroid injections|0|||
125278878|NCT01296711|450645840|FG006|Overall Study|Required restricted steroid injections|1|||
125278879|NCT01296711|450645841|FG007|Overall Study|Required restricted steroid injections|0|||
125278880|NCT01296711|450645834|FG000|Overall Study|Ongoing missed appointments|0|||
125278881|NCT01296711|450645835|FG001|Overall Study|Ongoing missed appointments|0|||
125278882|NCT01296711|450645836|FG002|Overall Study|Ongoing missed appointments|0|||
125278883|NCT01296711|450645837|FG003|Overall Study|Ongoing missed appointments|0|||
125278884|NCT01296711|450645838|FG004|Overall Study|Ongoing missed appointments|0|||
125278885|NCT01296711|450645839|FG005|Overall Study|Ongoing missed appointments|0|||
125278886|NCT01296711|450645840|FG006|Overall Study|Ongoing missed appointments|1|||
125278887|NCT01296711|450645841|FG007|Overall Study|Ongoing missed appointments|0|||
125278888|NCT01296711|450645834|FG000|Overall Study|Failure to comply with visits|0|||
125278889|NCT01296711|450645835|FG001|Overall Study|Failure to comply with visits|0|||
125278890|NCT01296711|450645836|FG002|Overall Study|Failure to comply with visits|0|||
125278891|NCT01296711|450645837|FG003|Overall Study|Failure to comply with visits|0|||
125278892|NCT01296711|450645838|FG004|Overall Study|Failure to comply with visits|0|||
125278893|NCT01296711|450645839|FG005|Overall Study|Failure to comply with visits|0|||
125278894|NCT01296711|450645840|FG006|Overall Study|Failure to comply with visits|0|||
125278895|NCT01296711|450645841|FG007|Overall Study|Failure to comply with visits|1|||
125278896|NCT01296711|450645834|FG000|Overall Study|Patient decision due to transport|0|||
125278897|NCT01296711|450645835|FG001|Overall Study|Patient decision due to transport|0|||
125278898|NCT01296711|450645836|FG002|Overall Study|Patient decision due to transport|0|||
125278899|NCT01296711|450645837|FG003|Overall Study|Patient decision due to transport|0|||
125278900|NCT01296711|450645838|FG004|Overall Study|Patient decision due to transport|0|||
125278901|NCT01296711|450645839|FG005|Overall Study|Patient decision due to transport|0|||
125278902|NCT01296711|450645840|FG006|Overall Study|Patient decision due to transport|0|||
125278903|NCT01296711|450645841|FG007|Overall Study|Patient decision due to transport|1|||
125278904|NCT01126268|450645842|FG000|Overall Study|Adverse Event|1|||
125278905|NCT04026009|450645843|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125278906|NCT04026009|450645844|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125278907|NCT04026009|450645845|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
125278908|NCT04026009|450645846|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
125278909|NCT04026009|450645847|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
125278910|NCT04026009|450645843|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
125278911|NCT04026009|450645844|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
125278912|NCT04026009|450645845|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
125278913|NCT04026009|450645846|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
125278914|NCT04026009|450645847|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
125278915|NCT00842153|450645850|FG000|Overall Study|Adverse Event|0|||
125278916|NCT00842153|450645851|FG001|Overall Study|Adverse Event|1|||
125278917|NCT00842153|450645850|FG000|Overall Study|Lost to Follow-up|1|||
125278918|NCT00842153|450645851|FG001|Overall Study|Lost to Follow-up|2|||
125278919|NCT00002540|450645852|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
125278920|NCT00002540|450645853|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
125278921|NCT00002540|450645852|FG000|Overall Study|Died Before Randomization|2|||
125278922|NCT00002540|450645853|FG001|Overall Study|Died Before Randomization|6|||
125278923|NCT00002540|450645852|FG000|Overall Study|Died Before ASU (Control)|202|||
125278924|NCT00002540|450645853|FG001|Overall Study|Died Before ASU (Control)|0|||
125278925|NCT00002540|450645852|FG000|Overall Study|Refused ASU (Control)|597|||
125278926|NCT00002540|450645853|FG001|Overall Study|Refused ASU (Control)|0|||
125278927|NCT00002540|450645852|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
125278928|NCT00002540|450645853|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
125278929|NCT01345929|450645854|FG000|Overall Study|Withdrawal by Subject|9|||
125278930|NCT01345929|450645855|FG001|Overall Study|Withdrawal by Subject|8|||
125278931|NCT01345929|450645854|FG000|Overall Study|Lost to Follow-up|9|||
125278932|NCT01345929|450645855|FG001|Overall Study|Lost to Follow-up|9|||
125278933|NCT01345929|450645854|FG000|Overall Study|Adverse Event|0|||
125278934|NCT01345929|450645855|FG001|Overall Study|Adverse Event|1|||
125278935|NCT01345929|450645854|FG000|Overall Study|Didn't meet eligibility criteria|2|||
125278936|NCT01345929|450645855|FG001|Overall Study|Didn't meet eligibility criteria|0|||
125278937|NCT01345929|450645854|FG000|Overall Study|40,000 CFU/ML|1|||
125278938|NCT01345929|450645855|FG001|Overall Study|40,000 CFU/ML|0|||
125278939|NCT01345929|450645854|FG000|Overall Study|Patient withdrawal|0|||
124781668|NCT02474069|448831122|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
124781669|NCT02474069|448831123|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
124781670|NCT02474069|448831121|FG000|Selection Phase (SP)|Physician Decision|1|||
125278940|NCT01345929|450645855|FG001|Overall Study|Patient withdrawal|1|||
125278941|NCT02151903|450645856|FG000|Overall Study|Withdrawal by Subject|1|||
125278942|NCT02151903|450645857|FG001|Overall Study|Withdrawal by Subject|0|||
125278943|NCT02151903|450645856|FG000|Overall Study|Progressive disease|2|||
125278944|NCT02151903|450645857|FG001|Overall Study|Progressive disease|1|||
125278945|NCT01500252|450645860|FG000|Overall Study|Death|4|||
125278946|NCT01500252|450645861|FG001|Overall Study|Death|2|||
125278947|NCT01500252|450645860|FG000|Overall Study|Lost to Follow-up|5|||
125278948|NCT01500252|450645861|FG001|Overall Study|Lost to Follow-up|4|||
125278949|NCT05319600|450645862|FG000|Overall Study|Withdrawal by Subject|1|||
125278950|NCT05319600|450645863|FG001|Overall Study|Withdrawal by Subject|0|||
125278951|NCT05319600|450645862|FG000|Overall Study|Lost to Follow-up|0|||
125278952|NCT05319600|450645863|FG001|Overall Study|Lost to Follow-up|4|||
125278953|NCT03768089|450645867|FG000|Part A|Lost to Follow-up|0|||
125278954|NCT03768089|450645868|FG001|Part A|Lost to Follow-up|0|||
125278955|NCT03768089|450645869|FG002|Part A|Lost to Follow-up|0|||
125278956|NCT03768089|450645870|FG003|Part A|Lost to Follow-up|0|||
125278957|NCT03768089|450645871|FG004|Part A|Lost to Follow-up|1|||
125278958|NCT03768089|450645872|FG005|Part A|Lost to Follow-up|0|||
125278959|NCT03768089|450645873|FG006|Part A|Lost to Follow-up|0|||
125278960|NCT03768089|450645874|FG007|Part A|Lost to Follow-up|0|||
125278961|NCT03768089|450645875|FG008|Part A|Lost to Follow-up|0|||
125278962|NCT03768089|450645876|FG009|Part A|Lost to Follow-up|0|||
125278963|NCT03768089|450645877|FG010|Part A|Lost to Follow-up|0|||
125278964|NCT03768089|450645878|FG011|Part A|Lost to Follow-up|0|||
125278965|NCT03768089|450645879|FG012|Part A|Lost to Follow-up|0|||
125278966|NCT03768089|450645880|FG013|Part A|Lost to Follow-up|0|||
125278967|NCT03768089|450645881|FG014|Part A|Lost to Follow-up|0|||
125278968|NCT03768089|450645882|FG015|Part A|Lost to Follow-up|0|||
125278969|NCT03768089|450645883|FG016|Part A|Lost to Follow-up|0|||
125278970|NCT03768089|450645884|FG017|Part A|Lost to Follow-up|0|||
125278971|NCT03768089|450645867|FG000|Part C|Randomized, Never Dosed|0|||
125278972|NCT03768089|450645868|FG001|Part C|Randomized, Never Dosed|0|||
125278973|NCT03768089|450645869|FG002|Part C|Randomized, Never Dosed|0|||
125278974|NCT03768089|450645870|FG003|Part C|Randomized, Never Dosed|0|||
125278975|NCT03768089|450645871|FG004|Part C|Randomized, Never Dosed|0|||
125278976|NCT03768089|450645872|FG005|Part C|Randomized, Never Dosed|0|||
125278977|NCT03768089|450645873|FG006|Part C|Randomized, Never Dosed|0|||
125278978|NCT03768089|450645874|FG007|Part C|Randomized, Never Dosed|0|||
125278979|NCT03768089|450645875|FG008|Part C|Randomized, Never Dosed|0|||
125278980|NCT03768089|450645876|FG009|Part C|Randomized, Never Dosed|0|||
125278981|NCT03768089|450645877|FG010|Part C|Randomized, Never Dosed|0|||
125278982|NCT03768089|450645878|FG011|Part C|Randomized, Never Dosed|0|||
125278983|NCT03768089|450645879|FG012|Part C|Randomized, Never Dosed|0|||
125278984|NCT03768089|450645880|FG013|Part C|Randomized, Never Dosed|0|||
125278985|NCT03768089|450645881|FG014|Part C|Randomized, Never Dosed|1|||
125278986|NCT03768089|450645882|FG015|Part C|Randomized, Never Dosed|0|||
125278987|NCT03768089|450645883|FG016|Part C|Randomized, Never Dosed|0|||
125278988|NCT03768089|450645884|FG017|Part C|Randomized, Never Dosed|0|||
125278989|NCT02120300|450645887|FG000|Overall Study|Enrolled but Never Treated|2|||
125278990|NCT02120300|450645888|FG001|Overall Study|Enrolled but Never Treated|0|||
125278991|NCT02120300|450645889|FG002|Overall Study|Enrolled but Never Treated|0|||
125278992|NCT02120300|450645890|FG003|Overall Study|Enrolled but Never Treated|0|||
125278993|NCT02120300|450645887|FG000|Overall Study|Lack of Efficacy|0|||
125278994|NCT02120300|450645888|FG001|Overall Study|Lack of Efficacy|0|||
125278995|NCT02120300|450645889|FG002|Overall Study|Lack of Efficacy|0|||
125278996|NCT02120300|450645890|FG003|Overall Study|Lack of Efficacy|1|||
125278997|NCT02120300|450645887|FG000|Overall Study|Lost to Follow-up|1|||
125278998|NCT02120300|450645888|FG001|Overall Study|Lost to Follow-up|0|||
125278999|NCT02120300|450645889|FG002|Overall Study|Lost to Follow-up|0|||
125279000|NCT02120300|450645890|FG003|Overall Study|Lost to Follow-up|0|||
125279001|NCT00361231|450645894|FG000|Overall Study|Physician Decision|3|||
125279002|NCT00361231|450645894|FG000|Overall Study|Symptomatic deterioration|5|||
125279003|NCT00361231|450645894|FG000|Overall Study|Radiographic disease progression|16|||
125279004|NCT00361231|450645894|FG000|Overall Study|Withdrawal by Subject|4|||
125279005|NCT00361231|450645894|FG000|Overall Study|Adverse Event|6|||
125279006|NCT01208961|450645897|FG000|High-Fat Period III|Protocol Violation|1|||
124781671|NCT02474069|448831122|FG001|Selection Phase (SP)|Physician Decision|0|||
125279007|NCT01208961|450645898|FG001|High-Fat Period III|Protocol Violation|0|||
125279008|NCT02241733|450645901|FG000|Overall Study|Lost to Follow-up|9|||
125279009|NCT02241733|450645902|FG001|Overall Study|Lost to Follow-up|4|||
125279010|NCT02241733|450645901|FG000|Overall Study|Physician Decision|6|||
125279011|NCT02241733|450645902|FG001|Overall Study|Physician Decision|2|||
125279012|NCT02241733|450645901|FG000|Overall Study|Withdrawal by Subject|0|||
124781672|NCT02474069|448831123|FG002|Selection Phase (SP)|Physician Decision|0|||
125279013|NCT02241733|450645902|FG001|Overall Study|Withdrawal by Subject|2|||
125279014|NCT02241733|450645901|FG000|Overall Study|Death|0|||
125279015|NCT02241733|450645902|FG001|Overall Study|Death|2|||
125279016|NCT01866111|450645904|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
125279017|NCT01866111|450645905|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
125279018|NCT01866111|450645906|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
124781673|NCT02474069|448831121|FG000|Selection Phase (SP)|Protocol Violation|1|||
125279019|NCT01866111|450645907|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
125279020|NCT01866111|450645904|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
125279021|NCT01866111|450645905|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
125279022|NCT01866111|450645906|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
125279023|NCT01866111|450645907|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
125279024|NCT01866111|450645904|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
124781674|NCT02474069|448831122|FG001|Selection Phase (SP)|Protocol Violation|0|||
124781675|NCT02474069|448831123|FG002|Selection Phase (SP)|Protocol Violation|0|||
125279025|NCT01866111|450645905|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
124781676|NCT02474069|448831121|FG000|Selection Phase (SP)|No longer requires treatment|1|||
125279026|NCT01866111|450645906|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
125279027|NCT01866111|450645907|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
125279028|NCT01866111|450645904|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
125279029|NCT01866111|450645905|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
125279030|NCT01866111|450645906|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
124781677|NCT02474069|448831122|FG001|Selection Phase (SP)|No longer requires treatment|0|||
125279031|NCT01866111|450645907|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
125279032|NCT01866111|450645904|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
125279033|NCT01866111|450645905|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
124781678|NCT02474069|448831123|FG002|Selection Phase (SP)|No longer requires treatment|0|||
124781679|NCT02474069|448831121|FG000|Selection Phase (SP)|Technical Problem|1|||
124781680|NCT02474069|448831122|FG001|Selection Phase (SP)|Technical Problem|0|||
124781681|NCT02474069|448831123|FG002|Selection Phase (SP)|Technical Problem|0|||
124781682|NCT02474069|448831121|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
124781683|NCT02474069|448831122|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
124781684|NCT02474069|448831123|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
124781685|NCT02474069|448831121|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
125279034|NCT01866111|450645906|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
125279035|NCT01866111|450645907|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
125279036|NCT01866111|450645904|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
125279037|NCT01866111|450645905|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
125279038|NCT01866111|450645906|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
125279039|NCT01866111|450645907|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
125279040|NCT01866111|450645904|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
125279041|NCT01866111|450645905|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
125279042|NCT01866111|450645906|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
125279043|NCT01866111|450645907|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
125279044|NCT01866111|450645904|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
125279045|NCT01866111|450645905|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
125279046|NCT01866111|450645906|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
125279047|NCT01866111|450645907|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
125279048|NCT01866111|450645904|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
125279049|NCT01866111|450645905|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
125279050|NCT01866111|450645906|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
125279051|NCT01866111|450645907|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
125279052|NCT01866111|450645904|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
125279053|NCT01866111|450645905|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
125279054|NCT01866111|450645906|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
125279055|NCT01866111|450645907|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
125279056|NCT01866111|450645904|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
125279057|NCT01866111|450645905|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
125279058|NCT01866111|450645906|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
125279059|NCT01866111|450645907|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
125279060|NCT01866111|450645904|FG000|Open-label Extension Study YKP3089C017|Death|1|||
125279061|NCT01866111|450645905|FG001|Open-label Extension Study YKP3089C017|Death|1|||
125279062|NCT01866111|450645906|FG002|Open-label Extension Study YKP3089C017|Death|3|||
125279063|NCT01866111|450645907|FG003|Open-label Extension Study YKP3089C017|Death|2|||
125279064|NCT01866111|450645904|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
125279065|NCT01866111|450645905|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
125279066|NCT01866111|450645906|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
125279067|NCT01866111|450645907|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
125279068|NCT01866111|450645904|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
125279069|NCT01866111|450645905|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
125279070|NCT01866111|450645906|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
125279071|NCT01866111|450645907|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
125279072|NCT01866111|450645904|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
125279073|NCT01866111|450645905|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
125279074|NCT01866111|450645906|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
125279075|NCT01866111|450645907|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
125279076|NCT04576455|450645909|FG000|Overall Study|Ongoing in the Study|48|||
125279077|NCT04576455|450645910|FG001|Overall Study|Ongoing in the Study|58|||
125279078|NCT04576455|450645909|FG000|Overall Study|Death|83|||
125279079|NCT04576455|450645910|FG001|Overall Study|Death|77|||
125279080|NCT04576455|450645909|FG000|Overall Study|Lost to Follow-up|4|||
125279081|NCT04576455|450645910|FG001|Overall Study|Lost to Follow-up|5|||
125279082|NCT04576455|450645909|FG000|Overall Study|Withdrawal by Subject|16|||
125279083|NCT04576455|450645910|FG001|Overall Study|Withdrawal by Subject|12|||
125279084|NCT03989349|450645911|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
125279085|NCT03989349|450645912|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
125279086|NCT03989349|450645913|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
125279087|NCT03989349|450645914|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
125279088|NCT03989349|450645915|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
125279089|NCT03989349|450645916|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
125279090|NCT03989349|450645911|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
124781686|NCT02474069|448831122|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
124781687|NCT02474069|448831123|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
125279091|NCT03989349|450645912|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
125279092|NCT03989349|450645913|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
125279093|NCT03989349|450645914|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
125279094|NCT03989349|450645915|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
125279095|NCT03989349|450645916|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
125279096|NCT03989349|450645911|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
125279097|NCT03989349|450645912|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
125279098|NCT03989349|450645913|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
125279099|NCT03989349|450645914|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
125279100|NCT03989349|450645915|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
125279101|NCT03989349|450645916|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
125279102|NCT03989349|450645911|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
125279103|NCT03989349|450645912|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
125279104|NCT03989349|450645913|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
124781688|NCT02474069|448831121|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
124781689|NCT02474069|448831122|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
125279105|NCT03989349|450645914|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
125279106|NCT03989349|450645915|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
125279107|NCT03989349|450645916|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
125279108|NCT03989349|450645911|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
125279109|NCT03989349|450645912|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
125279110|NCT03989349|450645913|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
125279111|NCT03989349|450645914|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
125279112|NCT03989349|450645915|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
125279113|NCT03989349|450645916|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
125279114|NCT03989349|450645911|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
125279115|NCT03989349|450645912|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
125279116|NCT03989349|450645913|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
125279117|NCT03989349|450645914|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
125279118|NCT03989349|450645915|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
125279119|NCT03989349|450645916|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
125303105|NCT03100058|450736667|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
125303106|NCT03100058|450736668|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
125303107|NCT03100058|450736669|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
125303108|NCT03100058|450736670|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
125303109|NCT03100058|450736671|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
124781690|NCT02474069|448831123|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
124781691|NCT02474069|448831121|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
124781692|NCT02474069|448831122|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
124781693|NCT02474069|448831123|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
124781694|NCT02474069|448831121|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
124781695|NCT02474069|448831122|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
124781696|NCT02474069|448831123|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
124781697|NCT02474069|448831121|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
124781698|NCT02474069|448831122|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
124781699|NCT02474069|448831123|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
124781700|NCT01623050|448831126|FG000|Overall Study|Lost to Follow-up|9|||
124781701|NCT00393861|448831127|FG000|Overall Study|Adverse Event|2|||
125303110|NCT03100058|450736672|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
125303111|NCT03100058|450736673|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
125303112|NCT03100058|450736661|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303113|NCT03100058|450736662|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
125303114|NCT03100058|450736663|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303115|NCT03100058|450736664|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303116|NCT03100058|450736665|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303117|NCT03100058|450736666|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303118|NCT03100058|450736667|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303119|NCT03100058|450736668|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303120|NCT03100058|450736669|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303121|NCT03100058|450736670|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303122|NCT03100058|450736671|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303123|NCT03100058|450736672|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303124|NCT03100058|450736673|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303125|NCT03100058|450736661|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
125303126|NCT03100058|450736662|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303127|NCT03100058|450736663|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
124781702|NCT00393861|448831127|FG000|Overall Study|Disease Progression|24|||
124781703|NCT01388335|448831130|FG000|Period 1|Progressive Disease|1|||
125279120|NCT03989349|450645911|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
125279121|NCT03989349|450645912|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
125279122|NCT03989349|450645913|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
125279123|NCT03989349|450645914|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
125279124|NCT03989349|450645915|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
125279125|NCT03989349|450645916|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
125279126|NCT03989349|450645911|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
125279127|NCT03989349|450645912|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
125279128|NCT03989349|450645913|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
125279129|NCT03989349|450645914|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
125279130|NCT03989349|450645915|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
125279131|NCT03989349|450645916|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
125279132|NCT03989349|450645911|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
125279133|NCT03989349|450645912|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
125279134|NCT03989349|450645913|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
125279135|NCT03989349|450645914|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
125279136|NCT03989349|450645915|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
125279137|NCT03989349|450645916|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
125279138|NCT03989349|450645911|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
125279139|NCT03989349|450645912|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
125279140|NCT03989349|450645913|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
125279141|NCT03989349|450645914|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
125279142|NCT03989349|450645915|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
125279143|NCT03989349|450645916|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
125279144|NCT03989349|450645911|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125279145|NCT03989349|450645912|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125279146|NCT03989349|450645913|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
125279147|NCT03989349|450645914|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125279148|NCT03989349|450645915|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
125279149|NCT03989349|450645916|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125279150|NCT03989349|450645911|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
125279151|NCT03989349|450645912|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
125279152|NCT03989349|450645913|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
125279153|NCT03989349|450645914|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
125279154|NCT03989349|450645915|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
125279155|NCT03989349|450645916|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
125279156|NCT03989349|450645911|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
125279157|NCT03989349|450645912|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
125279158|NCT03989349|450645913|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
125279159|NCT03989349|450645914|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
125279160|NCT03989349|450645915|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
125279161|NCT03989349|450645916|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
124781704|NCT01388335|448831130|FG000|Period 2|Progressive Disease|2|||
124781705|NCT01388335|448831130|FG000|Period 2|Sponsor Decision|1|||
125279162|NCT03989349|450645911|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
125279163|NCT03989349|450645912|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
125279164|NCT03989349|450645913|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
125279165|NCT03989349|450645914|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
125279166|NCT03989349|450645915|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
125279167|NCT03989349|450645916|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
125279168|NCT01352221|450645917|FG000|Double-blind Phase|Adverse Event|6|||
125279169|NCT01352221|450645918|FG001|Double-blind Phase|Adverse Event|4|||
125279170|NCT01352221|450645919|FG002|Double-blind Phase|Adverse Event|0|||
125279171|NCT01352221|450645920|FG003|Double-blind Phase|Adverse Event|0|||
125279172|NCT01352221|450645917|FG000|Double-blind Phase|Withdrawal by Subject|3|||
125279173|NCT01352221|450645918|FG001|Double-blind Phase|Withdrawal by Subject|5|||
125279174|NCT01352221|450645919|FG002|Double-blind Phase|Withdrawal by Subject|0|||
125279175|NCT01352221|450645920|FG003|Double-blind Phase|Withdrawal by Subject|0|||
125279176|NCT01352221|450645917|FG000|Double-blind Phase|Lost to Follow-up|0|||
125279177|NCT01352221|450645918|FG001|Double-blind Phase|Lost to Follow-up|1|||
125279178|NCT01352221|450645919|FG002|Double-blind Phase|Lost to Follow-up|0|||
125279179|NCT01352221|450645920|FG003|Double-blind Phase|Lost to Follow-up|0|||
125279180|NCT01352221|450645917|FG000|Double-blind Phase|Protocol Violation|0|||
125279181|NCT01352221|450645918|FG001|Double-blind Phase|Protocol Violation|1|||
125279182|NCT01352221|450645919|FG002|Double-blind Phase|Protocol Violation|0|||
125279183|NCT01352221|450645920|FG003|Double-blind Phase|Protocol Violation|0|||
125279184|NCT01352221|450645917|FG000|Open-label Phase|Physician Decision|0|||
125279185|NCT01352221|450645918|FG001|Open-label Phase|Physician Decision|0|||
125279186|NCT01352221|450645919|FG002|Open-label Phase|Physician Decision|2|||
125279187|NCT01352221|450645920|FG003|Open-label Phase|Physician Decision|1|||
125279188|NCT01352221|450645917|FG000|Open-label Phase|Pregnancy|0|||
125279189|NCT01352221|450645918|FG001|Open-label Phase|Pregnancy|0|||
125279190|NCT01352221|450645919|FG002|Open-label Phase|Pregnancy|1|||
125279191|NCT01352221|450645920|FG003|Open-label Phase|Pregnancy|0|||
125279192|NCT01352221|450645917|FG000|Open-label Phase|Adverse Event|0|||
125279193|NCT01352221|450645918|FG001|Open-label Phase|Adverse Event|0|||
124781706|NCT01388335|448831130|FG000|Safety Extension|Progressive Disease|7|||
124781707|NCT04413617|448831136|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
124781708|NCT04413617|448831137|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
124781709|NCT04413617|448831138|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
124781710|NCT04413617|448831139|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
124781711|NCT04413617|448831140|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
124781712|NCT04413617|448831136|FG000|Overall Study|Protocol Violation|0|||
124781713|NCT04413617|448831137|FG001|Overall Study|Protocol Violation|1|||
124781714|NCT04413617|448831138|FG002|Overall Study|Protocol Violation|0|||
124781715|NCT04413617|448831139|FG003|Overall Study|Protocol Violation|0|||
124781716|NCT04413617|448831140|FG004|Overall Study|Protocol Violation|1|||
124781717|NCT04413617|448831136|FG000|Overall Study|Lack of Efficacy|2|||
124781718|NCT04413617|448831137|FG001|Overall Study|Lack of Efficacy|0|||
124781719|NCT04413617|448831138|FG002|Overall Study|Lack of Efficacy|2|||
124781720|NCT04413617|448831139|FG003|Overall Study|Lack of Efficacy|1|||
124781721|NCT04413617|448831140|FG004|Overall Study|Lack of Efficacy|0|||
124781722|NCT04413617|448831136|FG000|Overall Study|Withdrawal by Subject|3|||
124781723|NCT04413617|448831137|FG001|Overall Study|Withdrawal by Subject|4|||
124781724|NCT04413617|448831138|FG002|Overall Study|Withdrawal by Subject|2|||
124781725|NCT04413617|448831139|FG003|Overall Study|Withdrawal by Subject|5|||
124781726|NCT04413617|448831140|FG004|Overall Study|Withdrawal by Subject|3|||
124781727|NCT04413617|448831136|FG000|Overall Study|Death|1|||
124781728|NCT04413617|448831137|FG001|Overall Study|Death|0|||
124781729|NCT04413617|448831138|FG002|Overall Study|Death|0|||
124781730|NCT04413617|448831139|FG003|Overall Study|Death|0|||
124781731|NCT04413617|448831140|FG004|Overall Study|Death|0|||
125279194|NCT01352221|450645919|FG002|Open-label Phase|Adverse Event|8|||
125279195|NCT01352221|450645920|FG003|Open-label Phase|Adverse Event|4|||
125279196|NCT01352221|450645917|FG000|Open-label Phase|Withdrawal by Subject|0|||
125279197|NCT01352221|450645918|FG001|Open-label Phase|Withdrawal by Subject|0|||
125279198|NCT01352221|450645919|FG002|Open-label Phase|Withdrawal by Subject|1|||
124781732|NCT04413617|448831136|FG000|Overall Study|Adverse Event|1|||
124781733|NCT04413617|448831137|FG001|Overall Study|Adverse Event|0|||
125279199|NCT01352221|450645920|FG003|Open-label Phase|Withdrawal by Subject|6|||
125279200|NCT01352221|450645917|FG000|Open-label Phase|Worsening of IBD|0|||
124781734|NCT04413617|448831138|FG002|Overall Study|Adverse Event|0|||
124781735|NCT04413617|448831139|FG003|Overall Study|Adverse Event|1|||
124781736|NCT04413617|448831140|FG004|Overall Study|Adverse Event|1|||
124781737|NCT04413617|448831136|FG000|Overall Study|COVID-19|0|||
125279201|NCT01352221|450645918|FG001|Open-label Phase|Worsening of IBD|0|||
125279202|NCT01352221|450645919|FG002|Open-label Phase|Worsening of IBD|1|||
125279203|NCT01352221|450645920|FG003|Open-label Phase|Worsening of IBD|0|||
124781738|NCT04413617|448831137|FG001|Overall Study|COVID-19|1|||
124781739|NCT04413617|448831138|FG002|Overall Study|COVID-19|0|||
125279204|NCT02016716|450645921|FG000|Overall Study|Withdrawal by Subject|5|||
125279205|NCT02016716|450645922|FG001|Overall Study|Withdrawal by Subject|5|||
125279206|NCT02016716|450645923|FG002|Overall Study|Withdrawal by Subject|5|||
125279207|NCT02016716|450645921|FG000|Overall Study|Protocol-specified Criteria|0|||
125279208|NCT02016716|450645922|FG001|Overall Study|Protocol-specified Criteria|1|||
125279209|NCT02016716|450645923|FG002|Overall Study|Protocol-specified Criteria|0|||
125279210|NCT02016716|450645921|FG000|Overall Study|Lost to Follow-up|1|||
125279211|NCT02016716|450645922|FG001|Overall Study|Lost to Follow-up|2|||
125279212|NCT02016716|450645923|FG002|Overall Study|Lost to Follow-up|1|||
125279213|NCT02248649|450645924|FG000|Overall Study|Death|7|||
125279214|NCT02248649|450645925|FG001|Overall Study|Death|11|||
125279215|NCT02248649|450645924|FG000|Overall Study|Lost to Follow-up|14|||
125279216|NCT02248649|450645925|FG001|Overall Study|Lost to Follow-up|10|||
125279217|NCT01439971|450645926|FG000|Overall Study|Required number in cohort dosed|0|||
125279218|NCT01439971|450645927|FG001|Overall Study|Required number in cohort dosed|1|||
125279219|NCT01439971|450645928|FG002|Overall Study|Required number in cohort dosed|2|||
125279220|NCT01439971|450645929|FG003|Overall Study|Required number in cohort dosed|0|||
125279221|NCT01439971|450645930|FG004|Overall Study|Required number in cohort dosed|1|||
125279222|NCT02628600|450645934|FG000|Overall Study|Death|2|||
125279223|NCT02628600|450645935|FG001|Overall Study|Death|1|||
125279224|NCT02628600|450645934|FG000|Overall Study|Adverse Event|3|||
125279225|NCT02628600|450645935|FG001|Overall Study|Adverse Event|20|||
125279226|NCT02628600|450645934|FG000|Overall Study|Protocol Violation|0|||
125279227|NCT02628600|450645935|FG001|Overall Study|Protocol Violation|1|||
125279228|NCT02628600|450645934|FG000|Overall Study|Lack of Efficacy|2|||
125279229|NCT02628600|450645935|FG001|Overall Study|Lack of Efficacy|0|||
125279230|NCT02628600|450645934|FG000|Overall Study|Withdrawal by Subject|13|||
125279231|NCT02628600|450645935|FG001|Overall Study|Withdrawal by Subject|8|||
125279232|NCT02628600|450645934|FG000|Overall Study|Lost to Follow-up|1|||
125279233|NCT02628600|450645935|FG001|Overall Study|Lost to Follow-up|0|||
125279234|NCT02628600|450645934|FG000|Overall Study|Physician Decision|2|||
125279235|NCT02628600|450645935|FG001|Overall Study|Physician Decision|2|||
125279236|NCT02628600|450645934|FG000|Overall Study|Other not specified|1|||
125279237|NCT02628600|450645935|FG001|Overall Study|Other not specified|0|||
125279238|NCT01221623|450645940|FG000|Overall Study|Withdrawal by Subject|19|||
125279239|NCT01221623|450645941|FG001|Overall Study|Withdrawal by Subject|8|||
125279240|NCT01221623|450645940|FG000|Overall Study|Lost to Follow-up|7|||
125279241|NCT01221623|450645941|FG001|Overall Study|Lost to Follow-up|1|||
125279242|NCT01221623|450645940|FG000|Overall Study|Adverse Event|6|||
125279243|NCT01221623|450645941|FG001|Overall Study|Adverse Event|3|||
125279244|NCT01221623|450645940|FG000|Overall Study|Death|1|||
125279245|NCT01221623|450645941|FG001|Overall Study|Death|0|||
125279246|NCT01221623|450645940|FG000|Overall Study|Other|5|||
125279247|NCT01221623|450645941|FG001|Overall Study|Other|2|||
125279248|NCT00875485|450648953|FG000|Challenge Dose Epoch|Pregnancy|1|||
125279249|NCT00875485|450648954|FG001|Challenge Dose Epoch|Pregnancy|0|||
125279250|NCT01271010|450648955|FG000|Overall Study|Reason not specified|11|||
125279251|NCT01271010|450648955|FG000|Overall Study|Start of new CLL therapy|1|||
125279252|NCT01271010|450648955|FG000|Overall Study|Protocol Violation|1|||
125279253|NCT01271010|450648955|FG000|Overall Study|Death|2|||
125279254|NCT01271010|450648955|FG000|Overall Study|Progression and relapse of disease|1|||
125279255|NCT01271010|450648955|FG000|Overall Study|Withdrawal by Subject|18|||
125279256|NCT01271010|450648955|FG000|Overall Study|Disease progression|27|||
125279257|NCT01631747|450648956|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
125279258|NCT01631747|450648957|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
125279259|NCT01631747|450648956|FG000|Live Birth|Pregnancy Termination|1|||
125279260|NCT01631747|450648957|FG001|Live Birth|Pregnancy Termination|0|||
125279261|NCT01631747|450648956|FG000|Live Birth|MIscarriage|2|||
125279262|NCT01631747|450648957|FG001|Live Birth|MIscarriage|0|||
125279263|NCT01631747|450648956|FG000|Live Birth|Stillbirth|1|||
125279264|NCT01631747|450648957|FG001|Live Birth|Stillbirth|1|||
124781740|NCT04413617|448831139|FG003|Overall Study|COVID-19|0|||
125279265|NCT01631747|450648956|FG000|One Year Infant Outcomes|Patient Refused|13|||
125279266|NCT01631747|450648957|FG001|One Year Infant Outcomes|Patient Refused|9|||
125279267|NCT02908685|450648958|FG000|Part 1 OLE|Withdrawal by Subject|0|||
125279268|NCT02908685|450648959|FG001|Part 1 OLE|Withdrawal by Subject|0|||
125279269|NCT02908685|450648960|FG002|Part 1 OLE|Withdrawal by Subject|0|||
125279270|NCT02908685|450648961|FG003|Part 1 OLE|Withdrawal by Subject|0|||
125279271|NCT02908685|450648962|FG004|Part 1 OLE|Withdrawal by Subject|0|||
125279272|NCT02908685|450648963|FG005|Part 1 OLE|Withdrawal by Subject|0|||
125279273|NCT02908685|450648964|FG006|Part 1 OLE|Withdrawal by Subject|0|||
125279274|NCT02908685|450648965|FG007|Part 1 OLE|Withdrawal by Subject|0|||
125279275|NCT02908685|450648966|FG008|Part 1 OLE|Withdrawal by Subject|0|||
125279276|NCT02908685|450648967|FG009|Part 1 OLE|Withdrawal by Subject|0|||
125279277|NCT02908685|450648968|FG010|Part 1 OLE|Withdrawal by Subject|2|||
125279278|NCT02908685|450648969|FG011|Part 1 OLE|Withdrawal by Subject|1|||
125279279|NCT02908685|450648970|FG012|Part 1 OLE|Withdrawal by Subject|0|||
125279280|NCT02908685|450648971|FG013|Part 1 OLE|Withdrawal by Subject|0|||
125279281|NCT02908685|450648958|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279282|NCT02908685|450648959|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279283|NCT02908685|450648960|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279284|NCT02908685|450648961|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279285|NCT02908685|450648962|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279286|NCT02908685|450648963|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279287|NCT02908685|450648964|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279288|NCT02908685|450648965|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279289|NCT02908685|450648966|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279290|NCT02908685|450648967|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279291|NCT02908685|450648968|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279292|NCT02908685|450648969|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279293|NCT02908685|450648970|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
125279294|NCT02908685|450648971|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
125279295|NCT02908685|450648958|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279296|NCT02908685|450648959|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279297|NCT02908685|450648960|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279298|NCT02908685|450648961|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279299|NCT02908685|450648962|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279300|NCT02908685|450648963|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279301|NCT02908685|450648964|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279302|NCT02908685|450648965|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279303|NCT02908685|450648966|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279304|NCT02908685|450648967|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279305|NCT02908685|450648968|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279306|NCT02908685|450648969|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279307|NCT02908685|450648970|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
125279308|NCT02908685|450648971|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279309|NCT02908685|450648958|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279310|NCT02908685|450648959|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279311|NCT02908685|450648960|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279312|NCT02908685|450648961|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279313|NCT02908685|450648962|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279314|NCT02908685|450648963|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279315|NCT02908685|450648964|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279316|NCT02908685|450648965|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279317|NCT02908685|450648966|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279318|NCT02908685|450648967|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279319|NCT02908685|450648968|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279320|NCT02908685|450648969|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279321|NCT02908685|450648970|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
125279322|NCT02908685|450648971|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279323|NCT02908685|450648958|FG000|Part 2 OLE: > Month 24|Death|0|||
125279324|NCT02908685|450648959|FG001|Part 2 OLE: > Month 24|Death|0|||
125279325|NCT02908685|450648960|FG002|Part 2 OLE: > Month 24|Death|0|||
125279326|NCT02908685|450648961|FG003|Part 2 OLE: > Month 24|Death|0|||
125279327|NCT02908685|450648962|FG004|Part 2 OLE: > Month 24|Death|0|||
125279328|NCT02908685|450648963|FG005|Part 2 OLE: > Month 24|Death|0|||
125279329|NCT02908685|450648964|FG006|Part 2 OLE: > Month 24|Death|0|||
125279330|NCT02908685|450648965|FG007|Part 2 OLE: > Month 24|Death|0|||
125279331|NCT02908685|450648966|FG008|Part 2 OLE: > Month 24|Death|0|||
125279332|NCT02908685|450648967|FG009|Part 2 OLE: > Month 24|Death|0|||
125279333|NCT02908685|450648968|FG010|Part 2 OLE: > Month 24|Death|0|||
125279334|NCT02908685|450648969|FG011|Part 2 OLE: > Month 24|Death|0|||
125279335|NCT02908685|450648970|FG012|Part 2 OLE: > Month 24|Death|1|||
125279336|NCT02908685|450648971|FG013|Part 2 OLE: > Month 24|Death|0|||
125279337|NCT02908685|450648958|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
125279338|NCT02908685|450648959|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
125279339|NCT02908685|450648960|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
125279340|NCT02908685|450648961|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
125279341|NCT02908685|450648962|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
125279342|NCT02908685|450648963|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
125279343|NCT02908685|450648964|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
125279344|NCT02908685|450648965|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
125279345|NCT02908685|450648966|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
125279346|NCT02908685|450648967|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
125279347|NCT02908685|450648968|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
125279348|NCT02908685|450648969|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
125279349|NCT02908685|450648970|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
125279350|NCT02908685|450648971|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
125279351|NCT02908685|450648958|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279352|NCT02908685|450648959|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279353|NCT02908685|450648960|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279354|NCT02908685|450648961|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279355|NCT02908685|450648962|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279356|NCT02908685|450648963|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279357|NCT02908685|450648964|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279358|NCT02908685|450648965|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279359|NCT02908685|450648966|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279360|NCT02908685|450648967|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279361|NCT02908685|450648968|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279362|NCT02908685|450648969|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279363|NCT02908685|450648970|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
125279364|NCT02908685|450648971|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
125279365|NCT01691014|450648974|FG000|Overall Study|Premature Termination|1|||
125279366|NCT01691014|450648975|FG001|Overall Study|Premature Termination|6|||
125279367|NCT01691014|450648976|FG002|Overall Study|Premature Termination|0|||
125279368|NCT01691014|450648977|FG003|Overall Study|Premature Termination|3|||
125279369|NCT01691014|450648974|FG000|Overall Study|Other|0|||
125279370|NCT01691014|450648975|FG001|Overall Study|Other|0|||
125279371|NCT01691014|450648976|FG002|Overall Study|Other|2|||
125279372|NCT01691014|450648977|FG003|Overall Study|Other|0|||
125279373|NCT01691014|450648974|FG000|Overall Study|Withdrawal by Subject|0|||
125279374|NCT01691014|450648975|FG001|Overall Study|Withdrawal by Subject|1|||
125279375|NCT01691014|450648976|FG002|Overall Study|Withdrawal by Subject|1|||
125279376|NCT01691014|450648977|FG003|Overall Study|Withdrawal by Subject|1|||
125279377|NCT01691014|450648974|FG000|Overall Study|Adverse Event|0|||
125279378|NCT01691014|450648975|FG001|Overall Study|Adverse Event|5|||
125279379|NCT01691014|450648976|FG002|Overall Study|Adverse Event|1|||
125279380|NCT01691014|450648977|FG003|Overall Study|Adverse Event|1|||
125279381|NCT01691014|450648974|FG000|Overall Study|Lack of Efficacy|2|||
125279382|NCT01691014|450648975|FG001|Overall Study|Lack of Efficacy|3|||
125279383|NCT01691014|450648976|FG002|Overall Study|Lack of Efficacy|7|||
125279384|NCT01691014|450648977|FG003|Overall Study|Lack of Efficacy|0|||
125279385|NCT02370537|450648978|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
125279386|NCT02370537|450648979|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
125279387|NCT02370537|450648980|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
125279388|NCT02370537|450648978|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
125279389|NCT02370537|450648979|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
125279390|NCT02370537|450648980|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
125279391|NCT02370537|450648978|FG000|Part B|Not randomised to receive treatment|1|||
125279392|NCT02370537|450648979|FG001|Part B|Not randomised to receive treatment|2|||
125279393|NCT02370537|450648980|FG002|Part B|Not randomised to receive treatment|259|||
125279394|NCT02370537|450648978|FG000|Part B|Withdrawal by Subject|0|||
125279395|NCT02370537|450648979|FG001|Part B|Withdrawal by Subject|1|||
125279396|NCT02370537|450648980|FG002|Part B|Withdrawal by Subject|0|||
125279397|NCT03100539|450648987|FG000|Overall Study|Lost to Follow-up|60|||
125279398|NCT03100539|450648988|FG001|Overall Study|Lost to Follow-up|54|||
125279399|NCT03100539|450648989|FG002|Overall Study|Lost to Follow-up|17|||
125279400|NCT03100539|450648987|FG000|Overall Study|Uncollected|8|||
125279401|NCT03100539|450648988|FG001|Overall Study|Uncollected|8|||
125279402|NCT03100539|450648989|FG002|Overall Study|Uncollected|0|||
125279403|NCT03100539|450648987|FG000|Overall Study|Ally Health|0|||
125279404|NCT03100539|450648988|FG001|Overall Study|Ally Health|0|||
125279405|NCT03100539|450648989|FG002|Overall Study|Ally Health|3|||
125279406|NCT03100539|450648987|FG000|Overall Study|Disinterest|0|||
125279407|NCT03100539|450648988|FG001|Overall Study|Disinterest|0|||
125279408|NCT03100539|450648989|FG002|Overall Study|Disinterest|22|||
125279409|NCT03100539|450648987|FG000|Overall Study|Veteran Health|0|||
125279410|NCT03100539|450648988|FG001|Overall Study|Veteran Health|0|||
125279411|NCT03100539|450648989|FG002|Overall Study|Veteran Health|8|||
125279412|NCT03100539|450648987|FG000|Overall Study|Moved|0|||
125279413|NCT03100539|450648988|FG001|Overall Study|Moved|0|||
125279414|NCT03100539|450648989|FG002|Overall Study|Moved|1|||
125279415|NCT03100539|450648987|FG000|Overall Study|Scheduling Conflicts|0|||
125279416|NCT03100539|450648988|FG001|Overall Study|Scheduling Conflicts|0|||
125279417|NCT03100539|450648989|FG002|Overall Study|Scheduling Conflicts|12|||
125279418|NCT05897242|450648990|FG000|Overall Study|Lost to Follow-up|6|||
125279419|NCT05897242|450648991|FG001|Overall Study|Lost to Follow-up|1|||
125279420|NCT05897242|450648990|FG000|Overall Study|Incomplete|1|||
125279421|NCT05897242|450648991|FG001|Overall Study|Incomplete|0|||
125279422|NCT05897242|450648990|FG000|Overall Study|Withdrawal by Subject|1|||
125279423|NCT05897242|450648991|FG001|Overall Study|Withdrawal by Subject|0|||
125279424|NCT00809835|450648992|FG000|Overall Study|Lost to Follow-up|7|||
125279425|NCT00809835|450648993|FG001|Overall Study|Lost to Follow-up|6|||
125279426|NCT00809835|450648994|FG002|Overall Study|Lost to Follow-up|10|||
125279427|NCT00809835|450648995|FG003|Overall Study|Lost to Follow-up|2|||
125279428|NCT00809835|450648992|FG000|Overall Study|Withdrawal by Subject|1|||
125279429|NCT00809835|450648993|FG001|Overall Study|Withdrawal by Subject|1|||
125279430|NCT00809835|450648994|FG002|Overall Study|Withdrawal by Subject|1|||
125279431|NCT00809835|450648995|FG003|Overall Study|Withdrawal by Subject|0|||
125279432|NCT00066703|450648996|FG000|Overall Study|Adverse Event|80|||
125279433|NCT00066703|450648997|FG001|Overall Study|Adverse Event|111|||
125279434|NCT00066703|450648996|FG000|Overall Study|Death|3|||
125279435|NCT00066703|450648997|FG001|Overall Study|Death|0|||
125279436|NCT00066703|450648996|FG000|Overall Study|Lack of Efficacy|114|||
125279437|NCT00066703|450648997|FG001|Overall Study|Lack of Efficacy|69|||
125279438|NCT00066703|450648996|FG000|Overall Study|Lost to Follow-up|31|||
125279439|NCT00066703|450648997|FG001|Overall Study|Lost to Follow-up|28|||
125279440|NCT00066703|450648996|FG000|Overall Study|Withdrawal by Subject|38|||
125279441|NCT00066703|450648997|FG001|Overall Study|Withdrawal by Subject|63|||
125279442|NCT00066703|450648996|FG000|Overall Study|Treatment ongoing|346|||
125279443|NCT00066703|450648997|FG001|Overall Study|Treatment ongoing|311|||
125279444|NCT01696968|450648998|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
125279445|NCT01696968|450648999|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
125279446|NCT01696968|450648998|FG000|Overall Study|Died Before Randomization|3|||
125279447|NCT01696968|450648999|FG001|Overall Study|Died Before Randomization|8|||
125279448|NCT01696968|450648998|FG000|Overall Study|Died Before ASU (Control)|278|||
125279449|NCT01696968|450648999|FG001|Overall Study|Died Before ASU (Control)|0|||
125279450|NCT01696968|450648998|FG000|Overall Study|Refused ASU (Control)|920|||
125279451|NCT01696968|450648999|FG001|Overall Study|Refused ASU (Control)|0|||
125279452|NCT01696968|450648998|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
125279453|NCT01696968|450648999|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
125279454|NCT05659719|450649000|FG000|Overall Study|At sponsor's request|0|||
125279455|NCT05659719|450649001|FG001|Overall Study|At sponsor's request|0|||
125279456|NCT05659719|450649002|FG002|Overall Study|At sponsor's request|0|||
125279457|NCT05659719|450649003|FG003|Overall Study|At sponsor's request|95|||
125279458|NCT05659719|450649000|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
125279459|NCT05659719|450649001|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
125279460|NCT05659719|450649002|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
125279461|NCT05659719|450649003|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
125279462|NCT05659719|450649000|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
125279463|NCT05659719|450649001|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
125279464|NCT05659719|450649002|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
125279465|NCT05659719|450649003|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
125279466|NCT05659719|450649000|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
125279467|NCT05659719|450649001|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
125279468|NCT05659719|450649002|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
125279469|NCT05659719|450649003|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
125279470|NCT05659719|450649000|FG000|Overall Study|Lost to Follow-up|0|||
125279471|NCT05659719|450649001|FG001|Overall Study|Lost to Follow-up|0|||
125279472|NCT05659719|450649002|FG002|Overall Study|Lost to Follow-up|0|||
125279473|NCT05659719|450649003|FG003|Overall Study|Lost to Follow-up|2|||
125279474|NCT05659719|450649000|FG000|Overall Study|Moved to another observational study|0|||
125279475|NCT05659719|450649001|FG001|Overall Study|Moved to another observational study|0|||
125279476|NCT05659719|450649002|FG002|Overall Study|Moved to another observational study|0|||
125279477|NCT05659719|450649003|FG003|Overall Study|Moved to another observational study|1|||
125279478|NCT05659719|450649000|FG000|Overall Study|The child was enrolled in an interventional study|0|||
125279479|NCT05659719|450649001|FG001|Overall Study|The child was enrolled in an interventional study|0|||
125279480|NCT05659719|450649002|FG002|Overall Study|The child was enrolled in an interventional study|0|||
125279481|NCT05659719|450649003|FG003|Overall Study|The child was enrolled in an interventional study|55|||
125279482|NCT05659719|450649000|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
125279483|NCT05659719|450649001|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
125279484|NCT05659719|450649002|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
125279485|NCT05659719|450649003|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
125279486|NCT05659719|450649000|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
125279487|NCT05659719|450649001|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
125279488|NCT05659719|450649002|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
125279489|NCT05659719|450649003|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
125279490|NCT01681186|450649004|FG000|Washout Period From Second Intervention|Adverse Event|0|||
125279491|NCT01681186|450649005|FG001|Washout Period From Second Intervention|Adverse Event|0|||
125279492|NCT01681186|450649006|FG002|Washout Period From Second Intervention|Adverse Event|0|||
125279493|NCT01681186|450649007|FG003|Washout Period From Second Intervention|Adverse Event|0|||
125279494|NCT01681186|450649008|FG004|Washout Period From Second Intervention|Adverse Event|0|||
125279495|NCT01681186|450649009|FG005|Washout Period From Second Intervention|Adverse Event|0|||
125279496|NCT01681186|450649010|FG006|Washout Period From Second Intervention|Adverse Event|1|||
125279497|NCT01681186|450649011|FG007|Washout Period From Second Intervention|Adverse Event|0|||
125279498|NCT01681186|450649004|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
125279499|NCT01681186|450649005|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
125279500|NCT01681186|450649006|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
125279501|NCT01681186|450649007|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
125279502|NCT01681186|450649008|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
125279503|NCT01681186|450649009|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
125279504|NCT01681186|450649010|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
125279505|NCT01681186|450649011|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
125279506|NCT01681186|450649004|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
125279507|NCT01681186|450649005|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
125279508|NCT01681186|450649006|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
125279509|NCT01681186|450649007|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
125279510|NCT01681186|450649008|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
125279511|NCT01681186|450649009|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
125279512|NCT01681186|450649010|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
125279513|NCT01681186|450649011|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
125279514|NCT01681186|450649004|FG000|Fourth Intervention|Protocol Violation|0|||
125279515|NCT01681186|450649005|FG001|Fourth Intervention|Protocol Violation|0|||
125279516|NCT01681186|450649006|FG002|Fourth Intervention|Protocol Violation|0|||
125279517|NCT01681186|450649007|FG003|Fourth Intervention|Protocol Violation|0|||
125279518|NCT01681186|450649008|FG004|Fourth Intervention|Protocol Violation|0|||
125279519|NCT01681186|450649009|FG005|Fourth Intervention|Protocol Violation|0|||
125279520|NCT01681186|450649010|FG006|Fourth Intervention|Protocol Violation|0|||
124781741|NCT04413617|448831140|FG004|Overall Study|COVID-19|0|||
124781742|NCT02657408|448831141|FG000|Overall Study|Adverse Event|3|||
124781743|NCT02657408|448831142|FG001|Overall Study|Adverse Event|7|||
124781744|NCT00324961|448831144|FG000|Overall Study|Adverse Event|5|||
124781745|NCT00324961|448831144|FG000|Overall Study|Consent Withdrawn|11|||
124781746|NCT00324961|448831144|FG000|Overall Study|Lost to Follow-up|22|||
124781747|NCT00324961|448831144|FG000|Overall Study|Protocol Violation|3|||
125279521|NCT01681186|450649011|FG007|Fourth Intervention|Protocol Violation|1|||
125279522|NCT05160415|450649012|FG000|Overall Study|Withdrawal by Subject|3|||
125279523|NCT04848220|450649013|FG000|Overall Study|Unable to proceed to study procedure|0|||
125279524|NCT04848220|450649014|FG001|Overall Study|Unable to proceed to study procedure|1|||
124781748|NCT00324961|448831144|FG000|Overall Study|Other|2|||
124781749|NCT03350672|448831148|FG000|Overall Study|Withdrawal by Subject|7|||
124781750|NCT03350672|448831149|FG001|Overall Study|Withdrawal by Subject|0|||
125279525|NCT04848220|450649015|FG002|Overall Study|Unable to proceed to study procedure|0|||
125279526|NCT04848220|450649013|FG000|Overall Study|Fractional flow not significant|0|||
125279527|NCT04848220|450649014|FG001|Overall Study|Fractional flow not significant|1|||
125279528|NCT04848220|450649015|FG002|Overall Study|Fractional flow not significant|0|||
125279529|NCT02923830|450649016|FG000|Overall Study|Physician Decision|13|||
125279530|NCT02923830|450649017|FG001|Overall Study|Physician Decision|15|||
125279531|NCT01751906|450649018|FG000|Overall Study|Lost to Follow-up|151|||
125279532|NCT01751906|450649019|FG001|Overall Study|Lost to Follow-up|68|||
125279533|NCT01751906|450649018|FG000|Overall Study|Withdrawal by Subject|22|||
125279534|NCT01751906|450649019|FG001|Overall Study|Withdrawal by Subject|18|||
125279535|NCT01751906|450649018|FG000|Overall Study|Physician Decision|5|||
125279536|NCT01751906|450649019|FG001|Overall Study|Physician Decision|2|||
125279537|NCT01751906|450649018|FG000|Overall Study|Death|84|||
125279538|NCT01751906|450649019|FG001|Overall Study|Death|43|||
125279539|NCT01751906|450649018|FG000|Overall Study|Denied on premises for follow-up by law|1|||
125279540|NCT01751906|450649019|FG001|Overall Study|Denied on premises for follow-up by law|0|||
125279541|NCT01110330|450649020|FG000|Overall Study|Adverse Event|0|||
125279542|NCT01110330|450649021|FG001|Overall Study|Adverse Event|4|||
125279543|NCT01110330|450649022|FG002|Overall Study|Adverse Event|3|||
125279544|NCT01110330|450649020|FG000|Overall Study|Lack of Efficacy|3|||
125279545|NCT01110330|450649021|FG001|Overall Study|Lack of Efficacy|1|||
125279546|NCT01110330|450649022|FG002|Overall Study|Lack of Efficacy|1|||
125279547|NCT01110330|450649020|FG000|Overall Study|Lost to Follow-up|9|||
125279548|NCT01110330|450649021|FG001|Overall Study|Lost to Follow-up|10|||
125279549|NCT01110330|450649022|FG002|Overall Study|Lost to Follow-up|15|||
125279550|NCT01110330|450649020|FG000|Overall Study|Physician Decision|0|||
125279551|NCT01110330|450649021|FG001|Overall Study|Physician Decision|1|||
125279552|NCT01110330|450649022|FG002|Overall Study|Physician Decision|0|||
125279553|NCT01110330|450649020|FG000|Overall Study|Protocol Violation|2|||
125279554|NCT01110330|450649021|FG001|Overall Study|Protocol Violation|0|||
125279555|NCT01110330|450649022|FG002|Overall Study|Protocol Violation|4|||
125279556|NCT01110330|450649020|FG000|Overall Study|Withdrawal by Subject|0|||
125279557|NCT01110330|450649021|FG001|Overall Study|Withdrawal by Subject|6|||
125279558|NCT01110330|450649022|FG002|Overall Study|Withdrawal by Subject|2|||
125279559|NCT01110330|450649020|FG000|Overall Study|Other|1|||
125279560|NCT01110330|450649021|FG001|Overall Study|Other|1|||
125279561|NCT01110330|450649022|FG002|Overall Study|Other|1|||
125279562|NCT02557100|450649031|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
125279563|NCT02557100|450649032|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
125279564|NCT02557100|450649033|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
125279565|NCT02557100|450649031|FG000|Single Blind Treatment Period|Death|0|||
125279566|NCT02557100|450649032|FG001|Single Blind Treatment Period|Death|1|||
125279567|NCT02557100|450649033|FG002|Single Blind Treatment Period|Death|0|||
125279568|NCT02557100|450649031|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
125279569|NCT02557100|450649032|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
125279570|NCT02557100|450649033|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
125279571|NCT02557100|450649031|FG000|Single Blind Treatment Period|Adverse Event|0|||
125279572|NCT02557100|450649032|FG001|Single Blind Treatment Period|Adverse Event|1|||
125279573|NCT02557100|450649033|FG002|Single Blind Treatment Period|Adverse Event|0|||
125279574|NCT02557100|450649031|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
124781751|NCT03350672|448831150|FG002|Overall Study|Withdrawal by Subject|0|||
124781752|NCT00223080|448831153|FG000|Overall Study|Withdrawal by Subject|253|||
124781753|NCT00223080|448831154|FG001|Overall Study|Withdrawal by Subject|232|||
124781754|NCT00223080|448831153|FG000|Overall Study|Required contraindicated med|0|||
125279575|NCT02557100|450649032|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
124781755|NCT00223080|448831154|FG001|Overall Study|Required contraindicated med|1|||
125279576|NCT02557100|450649033|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
125279577|NCT02557100|450649031|FG000|Cumulative Abatacept Period|Other Reasons|0|||
125279578|NCT02557100|450649032|FG001|Cumulative Abatacept Period|Other Reasons|0|||
125279579|NCT02557100|450649033|FG002|Cumulative Abatacept Period|Other Reasons|1|||
125279580|NCT02557100|450649031|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
125279581|NCT02557100|450649032|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
125279582|NCT02557100|450649033|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
125279583|NCT02557100|450649031|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
125279584|NCT02557100|450649032|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
125279585|NCT02557100|450649033|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
125279586|NCT00510718|450649036|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
125279587|NCT00510718|450649037|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
125279588|NCT00510718|450649036|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
125279589|NCT00510718|450649037|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
125279590|NCT00510718|450649036|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
125279591|NCT00510718|450649037|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
125279592|NCT00510718|450649036|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
125279593|NCT00510718|450649037|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
125279594|NCT00510718|450649036|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
125279595|NCT00510718|450649037|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
125279596|NCT00510718|450649036|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
125279597|NCT00510718|450649037|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
125279598|NCT02150057|450649047|FG000|Overall Study|Lost to Follow-up|6|||
125279599|NCT02150057|450649048|FG001|Overall Study|Lost to Follow-up|4|||
125279600|NCT00489424|450649049|FG000|Overall Study|Adverse Event|3|||
125279601|NCT00489424|450649050|FG001|Overall Study|Adverse Event|3|||
125279602|NCT00489424|450649051|FG002|Overall Study|Adverse Event|4|||
125279603|NCT00489424|450649049|FG000|Overall Study|Lack of Efficacy|1|||
125279604|NCT00489424|450649050|FG001|Overall Study|Lack of Efficacy|0|||
125279605|NCT00489424|450649051|FG002|Overall Study|Lack of Efficacy|0|||
125279606|NCT00489424|450649049|FG000|Overall Study|Administrative problems|0|||
125279607|NCT00489424|450649050|FG001|Overall Study|Administrative problems|2|||
125279608|NCT00489424|450649051|FG002|Overall Study|Administrative problems|1|||
125279609|NCT00394251|450649052|FG000|Overall Study|Adverse Event|7|||
125279610|NCT00394251|450649053|FG001|Overall Study|Adverse Event|5|||
125279611|NCT00394251|450649052|FG000|Overall Study|Unacceptable Toxicity|20|||
125279612|NCT00394251|450649053|FG001|Overall Study|Unacceptable Toxicity|18|||
125279613|NCT00394251|450649052|FG000|Overall Study|Physician Decision|1|||
125279614|NCT00394251|450649053|FG001|Overall Study|Physician Decision|1|||
125279615|NCT00394251|450649052|FG000|Overall Study|Protocol Violation|0|||
125279616|NCT00394251|450649053|FG001|Overall Study|Protocol Violation|1|||
125279617|NCT00394251|450649052|FG000|Overall Study|Withdrawal by Subject|7|||
125279618|NCT00394251|450649053|FG001|Overall Study|Withdrawal by Subject|11|||
125279619|NCT00394251|450649052|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
124781756|NCT00223080|448831153|FG000|Overall Study|Non-compliant|7|||
124781757|NCT00223080|448831154|FG001|Overall Study|Non-compliant|7|||
124781758|NCT00223080|448831153|FG000|Overall Study|Moved from study area|37|||
125279620|NCT00394251|450649053|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
125279621|NCT05791565|450649054|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
125279622|NCT05791565|450649055|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
125279623|NCT02388165|450649056|FG000|Overall Study|Study terminated by sponsor|5|||
125279624|NCT02388165|450649057|FG001|Overall Study|Study terminated by sponsor|5|||
125279625|NCT02388165|450649056|FG000|Overall Study|Other|11|||
125279626|NCT02388165|450649057|FG001|Overall Study|Other|13|||
125279627|NCT02388165|450649056|FG000|Overall Study|No longer meet eligibility criteria|40|||
125279628|NCT02388165|450649057|FG001|Overall Study|No longer meet eligibility criteria|43|||
125279629|NCT02388165|450649056|FG000|Overall Study|Withdrawal of consent|31|||
125279630|NCT02388165|450649057|FG001|Overall Study|Withdrawal of consent|32|||
125279631|NCT02388165|450649056|FG000|Overall Study|Lost to Follow-up|19|||
125279632|NCT02388165|450649057|FG001|Overall Study|Lost to Follow-up|20|||
125279633|NCT02388165|450649056|FG000|Overall Study|Death|13|||
125279634|NCT02388165|450649057|FG001|Overall Study|Death|10|||
125279635|NCT02388165|450649056|FG000|Overall Study|Adverse Event|3|||
125279636|NCT02388165|450649057|FG001|Overall Study|Adverse Event|5|||
125279637|NCT02388165|450649056|FG000|Overall Study|Did not meet entrance criteria|5|||
125279638|NCT02388165|450649057|FG001|Overall Study|Did not meet entrance criteria|2|||
125279639|NCT00880269|450649058|FG000|Overall Study|Protocol Violation|1|||
125279640|NCT00880269|450649059|FG001|Overall Study|Protocol Violation|0|||
125279641|NCT00880269|450649058|FG000|Overall Study|Disease Progression|13|||
125279642|NCT00880269|450649059|FG001|Overall Study|Disease Progression|11|||
125279643|NCT00880269|450649058|FG000|Overall Study|New Cancer Therapy|1|||
125279644|NCT00880269|450649059|FG001|Overall Study|New Cancer Therapy|0|||
125279645|NCT00880269|450649058|FG000|Overall Study|Death|4|||
125279646|NCT00880269|450649059|FG001|Overall Study|Death|2|||
125279647|NCT00880269|450649058|FG000|Overall Study|Lost to Follow-up|0|||
125279648|NCT00880269|450649059|FG001|Overall Study|Lost to Follow-up|1|||
125279649|NCT00880269|450649058|FG000|Overall Study|Withdrawal by Subject|3|||
125279650|NCT00880269|450649059|FG001|Overall Study|Withdrawal by Subject|4|||
125279651|NCT00880269|450649058|FG000|Overall Study|Adverse Event|10|||
125279652|NCT00880269|450649059|FG001|Overall Study|Adverse Event|9|||
125279653|NCT01667224|450649066|FG000|Overall Study|Withdrawal by Subject|3|||
125279654|NCT01667224|450649067|FG001|Overall Study|Withdrawal by Subject|1|||
125279655|NCT01667224|450649066|FG000|Overall Study|Protocol Violation|1|||
125279656|NCT01667224|450649067|FG001|Overall Study|Protocol Violation|1|||
125279657|NCT00316225|450649070|FG000|Overall Study|Adverse Event|2|||
125279658|NCT00316225|450649070|FG000|Overall Study|Physician Decision|3|||
125279659|NCT00316225|450649070|FG000|Overall Study|Progressive Disease|15|||
125279660|NCT00316225|450649070|FG000|Overall Study|Withdrawal by Subject|3|||
125279661|NCT00316225|450649070|FG000|Overall Study|Death|2|||
125279662|NCT06004895|450649080|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
125279663|NCT06004895|450649080|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
125279664|NCT02314156|450649082|FG000|Overall Study|Adverse Event|1|||
125279665|NCT02314156|450649083|FG001|Overall Study|Adverse Event|0|||
125279666|NCT02314156|450649082|FG000|Overall Study|Withdrawal by Subject|1|||
125279667|NCT02314156|450649083|FG001|Overall Study|Withdrawal by Subject|0|||
125279668|NCT03497975|450649087|FG000|Overall Study|Withdrew Consent|34|||
125279669|NCT03497975|450649088|FG001|Overall Study|Withdrew Consent|35|||
125279670|NCT03497975|450649087|FG000|Overall Study|Lost to Follow-up|7|||
125279671|NCT03497975|450649088|FG001|Overall Study|Lost to Follow-up|7|||
125279672|NCT03497975|450649087|FG000|Overall Study|Physician Decision|4|||
125279673|NCT03497975|450649088|FG001|Overall Study|Physician Decision|5|||
125279674|NCT03497975|450649087|FG000|Overall Study|Discontinued|42|||
125279675|NCT03497975|450649088|FG001|Overall Study|Discontinued|39|||
125279676|NCT03497975|450649087|FG000|Overall Study|Reason Not Specified|15|||
125279677|NCT03497975|450649088|FG001|Overall Study|Reason Not Specified|14|||
125279678|NCT01257230|450649089|FG000|Overall Study|Not Treated|0|||
125279679|NCT01257230|450649090|FG001|Overall Study|Not Treated|0|||
125279680|NCT01257230|450649091|FG002|Overall Study|Not Treated|1|||
125279681|NCT01257230|450649089|FG000|Overall Study|Adverse Event|2|||
125279682|NCT01257230|450649090|FG001|Overall Study|Adverse Event|0|||
125279683|NCT01257230|450649091|FG002|Overall Study|Adverse Event|0|||
125279684|NCT01257230|450649089|FG000|Overall Study|Lack of Efficacy|0|||
125279685|NCT01257230|450649090|FG001|Overall Study|Lack of Efficacy|1|||
125279686|NCT01257230|450649091|FG002|Overall Study|Lack of Efficacy|0|||
125279687|NCT01257230|450649089|FG000|Overall Study|Protocol Violation|3|||
125279688|NCT01257230|450649090|FG001|Overall Study|Protocol Violation|0|||
125279689|NCT01257230|450649091|FG002|Overall Study|Protocol Violation|1|||
125279690|NCT01257230|450649089|FG000|Overall Study|Withdrawal by Subject|0|||
125279691|NCT01257230|450649090|FG001|Overall Study|Withdrawal by Subject|4|||
125279692|NCT01257230|450649091|FG002|Overall Study|Withdrawal by Subject|1|||
125279693|NCT01257230|450649089|FG000|Overall Study|Other reason not defined above|1|||
125279694|NCT01257230|450649090|FG001|Overall Study|Other reason not defined above|5|||
125279695|NCT01257230|450649091|FG002|Overall Study|Other reason not defined above|3|||
125279696|NCT01205061|450649094|FG000|Overall Study|Adverse Event|4|||
125279697|NCT01205061|450649094|FG000|Overall Study|Withdrawal by Subject|11|||
125279698|NCT01205061|450649094|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
125279699|NCT01205061|450649094|FG000|Overall Study|Lost to Follow-up|9|||
125279700|NCT01205061|450649094|FG000|Overall Study|Other|1|||
125279701|NCT00765037|450649095|FG000|Overall Study|Lost to Follow-up|5|||
125279702|NCT00765037|450649095|FG000|Overall Study|Adverse Event|1|||
125279703|NCT01988662|450649100|FG000|Overall Study|Subject/guardian decision|1|||
125279704|NCT01988662|450649101|FG001|Overall Study|Subject/guardian decision|1|||
125279705|NCT01988662|450649100|FG000|Overall Study|Adverse Event|3|||
125279706|NCT01988662|450649101|FG001|Overall Study|Adverse Event|1|||
125279707|NCT03070171|450649103|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
125279708|NCT03070171|450649104|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
125279709|NCT03070171|450649103|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
125279710|NCT03070171|450649104|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
125279711|NCT01471028|450649108|FG000|VTI-208|Adverse Event|39|||
125279712|NCT01471028|450649109|FG001|VTI-208|Adverse Event|41|||
125279713|NCT01471028|450649108|FG000|VTI-208|Withdrawal by Subject|0|||
125279714|NCT01471028|450649109|FG001|VTI-208|Withdrawal by Subject|2|||
125279715|NCT01471028|450649108|FG000|VTI-208|Lost to Follow-up|1|||
125279716|NCT01471028|450649109|FG001|VTI-208|Lost to Follow-up|1|||
125279717|NCT01471028|450649108|FG000|VTI-208E|Death|7|||
125279718|NCT01471028|450649109|FG001|VTI-208E|Death|10|||
124781759|NCT00223080|448831154|FG001|Overall Study|Moved from study area|47|||
125279719|NCT01471028|450649108|FG000|VTI-208E|Withdrawal by Subject|1|||
125279720|NCT01471028|450649109|FG001|VTI-208E|Withdrawal by Subject|0|||
125279721|NCT01471028|450649108|FG000|VTI-208E|Lost to Follow-up|0|||
125279722|NCT01471028|450649109|FG001|VTI-208E|Lost to Follow-up|2|||
125279723|NCT00610857|450649111|FG000|Overall Study|Not evaluable for response|2|||
124781760|NCT00223080|448831153|FG000|Overall Study|Lost to Follow-up|259|||
125279724|NCT04826094|450649112|FG000|Overall Study|Lost to Follow-up|2|||
125279725|NCT04826094|450649113|FG001|Overall Study|Lost to Follow-up|1|||
125279726|NCT04826094|450649114|FG002|Overall Study|Lost to Follow-up|0|||
125279727|NCT04826094|450649115|FG003|Overall Study|Lost to Follow-up|0|||
124781761|NCT00223080|448831154|FG001|Overall Study|Lost to Follow-up|284|||
124781762|NCT00223080|448831153|FG000|Overall Study|Death|85|||
125279728|NCT04826094|450649116|FG004|Overall Study|Lost to Follow-up|1|||
125279729|NCT04826094|450649117|FG005|Overall Study|Lost to Follow-up|3|||
125279730|NCT04826094|450649118|FG006|Overall Study|Lost to Follow-up|1|||
124781763|NCT00223080|448831154|FG001|Overall Study|Death|74|||
124781764|NCT00223080|448831153|FG000|Overall Study|Other|14|||
124781765|NCT00223080|448831154|FG001|Overall Study|Other|11|||
124781766|NCT00223080|448831153|FG000|Overall Study|Reason not provided|141|||
124781767|NCT00223080|448831154|FG001|Overall Study|Reason not provided|140|||
124781768|NCT00223080|448831153|FG000|Overall Study|Adverse Event|0|||
124781769|NCT00223080|448831154|FG001|Overall Study|Adverse Event|1|||
124781770|NCT03237286|448831155|FG000|Overall Study|Withdrawal by Subject|1|||
124781771|NCT03237286|448831156|FG001|Overall Study|Withdrawal by Subject|0|||
124781772|NCT03237286|448831157|FG002|Overall Study|Withdrawal by Subject|2|||
124781773|NCT03237286|448831155|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
124781774|NCT03237286|448831156|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
125279731|NCT04826094|450649119|FG007|Overall Study|Lost to Follow-up|1|||
125279732|NCT04826094|450649112|FG000|Overall Study|Participant withdrew consent|1|||
125279733|NCT04826094|450649113|FG001|Overall Study|Participant withdrew consent|0|||
125279734|NCT04826094|450649114|FG002|Overall Study|Participant withdrew consent|0|||
125279735|NCT04826094|450649115|FG003|Overall Study|Participant withdrew consent|1|||
125279736|NCT04826094|450649116|FG004|Overall Study|Participant withdrew consent|1|||
125279737|NCT04826094|450649117|FG005|Overall Study|Participant withdrew consent|1|||
125279738|NCT04826094|450649118|FG006|Overall Study|Participant withdrew consent|0|||
125279739|NCT04826094|450649119|FG007|Overall Study|Participant withdrew consent|1|||
125279740|NCT04826094|450649112|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
125279741|NCT04826094|450649113|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
125279742|NCT04826094|450649114|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
125279743|NCT04826094|450649115|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
125279744|NCT04826094|450649116|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
125279745|NCT04826094|450649117|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
125279746|NCT04826094|450649118|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
124781775|NCT03237286|448831157|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
124781776|NCT00948441|448831165|FG000|Overall Study|no longer meet inclusion criteria|1|||
125279747|NCT04826094|450649119|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
125279748|NCT04826094|450649112|FG000|Overall Study|Withdrawn by Investigator|0|||
125279749|NCT04826094|450649113|FG001|Overall Study|Withdrawn by Investigator|0|||
125279750|NCT04826094|450649114|FG002|Overall Study|Withdrawn by Investigator|0|||
125279751|NCT04826094|450649115|FG003|Overall Study|Withdrawn by Investigator|0|||
125279752|NCT04826094|450649116|FG004|Overall Study|Withdrawn by Investigator|0|||
125279753|NCT04826094|450649117|FG005|Overall Study|Withdrawn by Investigator|1|||
125279754|NCT04826094|450649118|FG006|Overall Study|Withdrawn by Investigator|0|||
125279755|NCT04826094|450649119|FG007|Overall Study|Withdrawn by Investigator|1|||
125279756|NCT04826094|450649112|FG000|Overall Study|Other: Moved from area|1|||
125279757|NCT04826094|450649113|FG001|Overall Study|Other: Moved from area|1|||
125279758|NCT04826094|450649114|FG002|Overall Study|Other: Moved from area|1|||
125279759|NCT04826094|450649115|FG003|Overall Study|Other: Moved from area|0|||
125279760|NCT04826094|450649116|FG004|Overall Study|Other: Moved from area|0|||
125279761|NCT04826094|450649117|FG005|Overall Study|Other: Moved from area|0|||
125279762|NCT04826094|450649118|FG006|Overall Study|Other: Moved from area|0|||
125279763|NCT04826094|450649119|FG007|Overall Study|Other: Moved from area|0|||
124781777|NCT00948441|448831166|FG001|Overall Study|no longer meet inclusion criteria|4|||
125279764|NCT04826094|450649112|FG000|Overall Study|Other: Declined|0|||
125279765|NCT04826094|450649113|FG001|Overall Study|Other: Declined|0|||
125279766|NCT04826094|450649114|FG002|Overall Study|Other: Declined|0|||
125279767|NCT04826094|450649115|FG003|Overall Study|Other: Declined|0|||
125279768|NCT04826094|450649116|FG004|Overall Study|Other: Declined|1|||
125279769|NCT04826094|450649117|FG005|Overall Study|Other: Declined|0|||
125279770|NCT04826094|450649118|FG006|Overall Study|Other: Declined|0|||
125279771|NCT04826094|450649119|FG007|Overall Study|Other: Declined|0|||
125279772|NCT04826094|450649112|FG000|Overall Study|Other: Vaccine not administered|0|||
125279773|NCT04826094|450649113|FG001|Overall Study|Other: Vaccine not administered|0|||
125279774|NCT04826094|450649114|FG002|Overall Study|Other: Vaccine not administered|1|||
125279775|NCT04826094|450649115|FG003|Overall Study|Other: Vaccine not administered|0|||
125279776|NCT04826094|450649116|FG004|Overall Study|Other: Vaccine not administered|0|||
125279777|NCT04826094|450649117|FG005|Overall Study|Other: Vaccine not administered|1|||
125279778|NCT04826094|450649118|FG006|Overall Study|Other: Vaccine not administered|1|||
125279779|NCT04826094|450649119|FG007|Overall Study|Other: Vaccine not administered|3|||
125279780|NCT05312697|450649120|FG000|Overall Study|Sponsor Terminated Trial|2|||
125279781|NCT04445519|450649121|FG000|Overall Study|Due to adaptive design|3|||
125279782|NCT04445519|450649122|FG001|Overall Study|Due to adaptive design|0|||
125279783|NCT04445519|450649123|FG002|Overall Study|Due to adaptive design|0|||
125279784|NCT04445519|450649121|FG000|Overall Study|Lost to Follow-up|0|||
125279785|NCT04445519|450649122|FG001|Overall Study|Lost to Follow-up|1|||
125279786|NCT04445519|450649123|FG002|Overall Study|Lost to Follow-up|4|||
125279787|NCT04445519|450649121|FG000|Overall Study|Sponsor or IRB Decision|0|||
125279788|NCT04445519|450649122|FG001|Overall Study|Sponsor or IRB Decision|1|||
125279789|NCT04445519|450649123|FG002|Overall Study|Sponsor or IRB Decision|2|||
125279790|NCT04445519|450649121|FG000|Overall Study|Withdrawal by Subject|0|||
125279791|NCT04445519|450649122|FG001|Overall Study|Withdrawal by Subject|3|||
125279792|NCT04445519|450649123|FG002|Overall Study|Withdrawal by Subject|3|||
125279793|NCT04445519|450649121|FG000|Overall Study|Adverse Event|0|||
125279794|NCT04445519|450649122|FG001|Overall Study|Adverse Event|8|||
125279795|NCT04445519|450649123|FG002|Overall Study|Adverse Event|6|||
125279796|NCT04445519|450649121|FG000|Overall Study|Other Reason|0|||
125279797|NCT04445519|450649122|FG001|Overall Study|Other Reason|1|||
125279798|NCT04445519|450649123|FG002|Overall Study|Other Reason|1|||
125279799|NCT04445519|450649121|FG000|Overall Study|Protocol Violation|0|||
125279800|NCT04445519|450649122|FG001|Overall Study|Protocol Violation|0|||
124781778|NCT00947882|448831169|FG000|Overall Study|Adverse Event|0|||
124781779|NCT00947882|448831170|FG001|Overall Study|Adverse Event|1|||
124781780|NCT00947882|448831171|FG002|Overall Study|Adverse Event|4|||
124781781|NCT00947882|448831172|FG003|Overall Study|Adverse Event|4|||
125279801|NCT04445519|450649123|FG002|Overall Study|Protocol Violation|1|||
125279802|NCT00177294|450649129|FG000|Overall Study|Withdrawal by Subject|7|||
125279803|NCT00177294|450649130|FG001|Overall Study|Withdrawal by Subject|5|||
125279804|NCT04154605|450649131|FG000|Overall Study|Procedure Canceled|1|||
125279805|NCT04154605|450649132|FG001|Overall Study|Procedure Canceled|1|||
125279806|NCT04154605|450649131|FG000|Overall Study|Missed follow up|1|||
125279807|NCT04154605|450649132|FG001|Overall Study|Missed follow up|1|||
125279808|NCT04154605|450649131|FG000|Overall Study|Withdrawal by Subject|1|||
125279809|NCT04154605|450649132|FG001|Overall Study|Withdrawal by Subject|0|||
125279810|NCT06359028|450649137|FG000|Overall Study|Adverse Event|1|||
125279811|NCT06359028|450649138|FG001|Overall Study|Adverse Event|0|||
125279812|NCT06359028|450649137|FG000|Overall Study|Withdrawal by Subject|1|||
125279813|NCT06359028|450649138|FG001|Overall Study|Withdrawal by Subject|0|||
125279814|NCT00661726|450649140|FG000|Overall Study|Adverse Event|1|||
125279815|NCT02109432|450651075|FG000|Overall Study|Withdrawal by Subject|1|||
125279816|NCT02920528|450651076|FG000|Overall Study|Incomplete Data|1|||
125279817|NCT02920528|450651077|FG001|Overall Study|Incomplete Data|1|||
125279818|NCT02920528|450651078|FG002|Overall Study|Incomplete Data|1|||
125279819|NCT02920528|450651076|FG000|Overall Study|Adverse Event|0|||
125279820|NCT02920528|450651077|FG001|Overall Study|Adverse Event|0|||
125279821|NCT02920528|450651078|FG002|Overall Study|Adverse Event|3|||
125279822|NCT02920528|450651076|FG000|Overall Study|Did not meet inclusion criteria|2|||
125279823|NCT02920528|450651077|FG001|Overall Study|Did not meet inclusion criteria|0|||
125279824|NCT02920528|450651078|FG002|Overall Study|Did not meet inclusion criteria|1|||
125279825|NCT00623233|450651090|FG000|Overall Study|Adverse Event|10|||
125279826|NCT00623233|450651090|FG000|Overall Study|Physician Decision|10|||
125279827|NCT00623233|450651090|FG000|Overall Study|Lost to Follow-up|1|||
125279828|NCT00623233|450651090|FG000|Overall Study|Withdrawal by Subject|3|||
125279829|NCT01811485|450651091|FG000|Overall Study|Adverse Event|1|||
125279830|NCT01811485|450651092|FG001|Overall Study|Adverse Event|3|||
125279831|NCT01811485|450651093|FG002|Overall Study|Adverse Event|2|||
125279832|NCT01811485|450651091|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125279833|NCT01811485|450651092|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125279834|NCT01811485|450651093|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
125279835|NCT01811485|450651091|FG000|Overall Study|Administrative problems|1|||
125279836|NCT01811485|450651092|FG001|Overall Study|Administrative problems|0|||
125279837|NCT01811485|450651093|FG002|Overall Study|Administrative problems|0|||
125279838|NCT01811485|450651091|FG000|Overall Study|Protocol Deviation|0|||
125279839|NCT01811485|450651092|FG001|Overall Study|Protocol Deviation|1|||
125279840|NCT01811485|450651093|FG002|Overall Study|Protocol Deviation|0|||
125279841|NCT01545934|450651094|FG000|Overall Study|Withdrawal by Subject|4|||
125279842|NCT01545934|450651095|FG001|Overall Study|Withdrawal by Subject|3|||
125279843|NCT01545934|450651094|FG000|Overall Study|Lost to Follow-up|1|||
125279844|NCT01545934|450651095|FG001|Overall Study|Lost to Follow-up|0|||
125279845|NCT03654404|450651096|FG000|Overall Study|Death|1|||
125279846|NCT03654404|450651096|FG000|Overall Study|Lost to Follow-up|2|||
125279847|NCT03654404|450651096|FG000|Overall Study|Withdrawal by Subject|5|||
125279848|NCT02003638|450651097|FG000|Overall Study|Withdrawal by Subject|1|||
125279849|NCT02003638|450651098|FG001|Overall Study|Withdrawal by Subject|0|||
125279850|NCT03215758|450651099|FG000|Overall Study|Technical Problems|1|||
125279851|NCT03215758|450651100|FG001|Overall Study|Technical Problems|0|||
125279852|NCT03215758|450651099|FG000|Overall Study|Protocol deviation|0|||
125279853|NCT03215758|450651100|FG001|Overall Study|Protocol deviation|1|||
125279854|NCT03215758|450651099|FG000|Overall Study|Physician Decision|0|||
125279855|NCT03215758|450651100|FG001|Overall Study|Physician Decision|1|||
125279856|NCT03215758|450651099|FG000|Overall Study|Death|0|||
125279857|NCT03215758|450651100|FG001|Overall Study|Death|1|||
125279858|NCT03215758|450651099|FG000|Overall Study|Adverse Event|1|||
125279859|NCT03215758|450651100|FG001|Overall Study|Adverse Event|2|||
125279860|NCT03215758|450651099|FG000|Overall Study|Subject/Guardian Decision|3|||
125279861|NCT03215758|450651100|FG001|Overall Study|Subject/Guardian Decision|3|||
125279862|NCT04115748|450651101|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
125279863|NCT04115748|450651102|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
125279864|NCT04115748|450651103|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
125279865|NCT04115748|450651104|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
125279866|NCT04115748|450651105|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
125279867|NCT04115748|450651106|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
125279868|NCT04115748|450651107|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
125279869|NCT04115748|450651108|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
125279870|NCT04115748|450651109|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
125279871|NCT04115748|450651110|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
125279872|NCT04115748|450651101|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
125279873|NCT04115748|450651102|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
125279874|NCT04115748|450651103|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
125279875|NCT04115748|450651104|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
125279876|NCT04115748|450651105|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
125279877|NCT04115748|450651106|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
125279878|NCT04115748|450651107|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
125279879|NCT04115748|450651108|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
125279880|NCT04115748|450651109|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
125279881|NCT04115748|450651110|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
125279882|NCT04115748|450651101|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
125279883|NCT04115748|450651102|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
125279884|NCT04115748|450651103|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
125279885|NCT04115748|450651104|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
125279886|NCT04115748|450651105|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
125279887|NCT04115748|450651106|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
125279888|NCT04115748|450651107|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
125279889|NCT04115748|450651108|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
125279890|NCT04115748|450651109|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
125279891|NCT04115748|450651110|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
125279892|NCT04115748|450651101|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
125279893|NCT04115748|450651102|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
125279894|NCT04115748|450651103|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
125279895|NCT04115748|450651104|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
125279896|NCT04115748|450651105|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
125279897|NCT04115748|450651106|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
125279898|NCT04115748|450651107|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
125279899|NCT04115748|450651108|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
125279900|NCT04115748|450651109|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
125279901|NCT04115748|450651110|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
125279902|NCT00713349|450651111|FG000|Overall Study|Protocol Violation|1|||
125279903|NCT03764631|450651112|FG000|Overall Study|Personal Reasons|3|||
125279904|NCT03764631|450651113|FG001|Overall Study|Personal Reasons|2|||
125279905|NCT03764631|450651112|FG000|Overall Study|Switching Therapy|3|||
125279906|NCT03764631|450651113|FG001|Overall Study|Switching Therapy|3|||
125279907|NCT03764631|450651112|FG000|Overall Study|Adverse Event|0|||
125279908|NCT03764631|450651113|FG001|Overall Study|Adverse Event|1|||
125279909|NCT03764631|450651112|FG000|Overall Study|Lost to Follow-up|33|||
125279910|NCT03764631|450651113|FG001|Overall Study|Lost to Follow-up|41|||
125279911|NCT03764631|450651112|FG000|Overall Study|No data as study site was closed|2|||
125279912|NCT03764631|450651113|FG001|Overall Study|No data as study site was closed|6|||
125279913|NCT01200407|450651114|FG000|Overall Study|Lost to Follow-up|56|||
125279914|NCT01200407|450651114|FG000|Overall Study|Adverse Event|3|||
125279915|NCT01200407|450651114|FG000|Overall Study|Withdrawal by Subject|4|||
125279916|NCT01200407|450651114|FG000|Overall Study|Other|19|||
125279917|NCT03299881|450651115|FG000|Overall Study|Study Termination|17|||
125279918|NCT03299881|450651116|FG001|Overall Study|Study Termination|13|||
125279919|NCT01549886|450651117|FG000|Overall Study|Sponsor's decision|2|||
125279920|NCT01549886|450651118|FG001|Overall Study|Sponsor's decision|3|||
125279921|NCT00473668|450651121|FG000|Overall Study|Withdrawal by Subject|0|||
125279922|NCT00473668|450651122|FG001|Overall Study|Withdrawal by Subject|2|||
125279923|NCT00473668|450651123|FG002|Overall Study|Withdrawal by Subject|0|||
125279924|NCT00473668|450651121|FG000|Overall Study|Migrated/moved from study area|3|||
125279925|NCT00473668|450651122|FG001|Overall Study|Migrated/moved from study area|2|||
125279926|NCT00473668|450651123|FG002|Overall Study|Migrated/moved from study area|0|||
125279927|NCT00473668|450651121|FG000|Overall Study|Lost to Follow-up|0|||
125279928|NCT00473668|450651122|FG001|Overall Study|Lost to Follow-up|4|||
125279929|NCT00473668|450651123|FG002|Overall Study|Lost to Follow-up|6|||
125279930|NCT00473668|450651121|FG000|Overall Study|Other|2|||
125279931|NCT00473668|450651122|FG001|Overall Study|Other|3|||
125279932|NCT00473668|450651123|FG002|Overall Study|Other|4|||
125279933|NCT03195660|450651124|FG000|Overall Study|The study was terminated|2|||
125279934|NCT05260073|450651126|FG000|Overall Study|Physician Decision|1|||
125279935|NCT05260073|450651126|FG000|Overall Study|Withdrawal by Subject|6|||
125279936|NCT05260073|450651126|FG000|Overall Study|Lost to Follow-up|14|||
125279937|NCT03458910|450651127|FG000|Overall Study|Withdrawal by Subject|7|||
125279938|NCT03458910|450651128|FG001|Overall Study|Withdrawal by Subject|8|||
124781782|NCT00947882|448831169|FG000|Overall Study|Withdrawal by Subject|2|||
124781783|NCT00947882|448831170|FG001|Overall Study|Withdrawal by Subject|0|||
124781784|NCT00947882|448831171|FG002|Overall Study|Withdrawal by Subject|8|||
124781785|NCT00947882|448831172|FG003|Overall Study|Withdrawal by Subject|2|||
124781786|NCT00947882|448831169|FG000|Overall Study|Protocol Violation|0|||
125279939|NCT03458910|450651129|FG002|Overall Study|Withdrawal by Subject|6|||
125279940|NCT03458910|450651130|FG003|Overall Study|Withdrawal by Subject|4|||
125279941|NCT03458910|450651127|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
125279942|NCT03458910|450651128|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
125279943|NCT03458910|450651129|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
125279944|NCT03458910|450651130|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
125279945|NCT04484649|450651131|FG000|Overall Study|Lost to Follow-up|2|||
125279946|NCT04484649|450651132|FG001|Overall Study|Lost to Follow-up|1|||
125279947|NCT04484649|450651131|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
125279948|NCT04484649|450651132|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
125279949|NCT01450696|450651133|FG000|Overall Study|Never Treated|1|||
125279950|NCT01450696|450651134|FG001|Overall Study|Never Treated|1|||
125279951|NCT01450696|450651133|FG000|Overall Study|Death|77|||
125279952|NCT01450696|450651134|FG001|Overall Study|Death|84|||
125279953|NCT01450696|450651133|FG000|Overall Study|Lost to Follow-up|3|||
125279954|NCT01450696|450651134|FG001|Overall Study|Lost to Follow-up|3|||
125279955|NCT01450696|450651133|FG000|Overall Study|Non-Compliance|1|||
125279956|NCT01450696|450651134|FG001|Overall Study|Non-Compliance|0|||
125279957|NCT01450696|450651133|FG000|Overall Study|Withdrawal by Subject|13|||
125279958|NCT01450696|450651134|FG001|Overall Study|Withdrawal by Subject|2|||
125279959|NCT01450696|450651133|FG000|Overall Study|Study Terminated by Sponsor|53|||
125279960|NCT01450696|450651134|FG001|Overall Study|Study Terminated by Sponsor|58|||
125279961|NCT02249091|450651137|FG000|Overall Study|Lack of Efficacy|8|||
125279962|NCT02249091|450651138|FG001|Overall Study|Lack of Efficacy|3|||
125279963|NCT02249091|450651137|FG000|Overall Study|Physician Decision|4|||
125279964|NCT02249091|450651138|FG001|Overall Study|Physician Decision|1|||
125279965|NCT02249091|450651137|FG000|Overall Study|Withdrawal by Subject|2|||
125279966|NCT02249091|450651138|FG001|Overall Study|Withdrawal by Subject|2|||
125279967|NCT02249091|450651137|FG000|Overall Study|Death|3|||
125279968|NCT02249091|450651138|FG001|Overall Study|Death|4|||
125279969|NCT02249091|450651137|FG000|Overall Study|Adverse Event|1|||
125279970|NCT02249091|450651138|FG001|Overall Study|Adverse Event|0|||
125279971|NCT02249091|450651137|FG000|Overall Study|Stable disease with following SCT|0|||
125279972|NCT02249091|450651138|FG001|Overall Study|Stable disease with following SCT|1|||
125279973|NCT02249091|450651137|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
125279974|NCT02249091|450651138|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
125279975|NCT02249091|450651137|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
125279976|NCT02249091|450651138|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
125279977|NCT02249091|450651137|FG000|Overall Study|Refractory AML|1|||
125279978|NCT02249091|450651138|FG001|Overall Study|Refractory AML|1|||
125279979|NCT00433966|450651139|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
125279980|NCT00433966|450651140|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
125279981|NCT00433966|450651141|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
125279982|NCT00433966|450651142|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
125279983|NCT00433966|450651139|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
125279984|NCT00433966|450651140|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
124781787|NCT00947882|448831170|FG001|Overall Study|Protocol Violation|0|||
124781788|NCT00947882|448831171|FG002|Overall Study|Protocol Violation|1|||
125279985|NCT00433966|450651141|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
125279986|NCT00433966|450651142|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
125279987|NCT00433966|450651139|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
125279988|NCT00433966|450651140|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
125279989|NCT00433966|450651141|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
125279990|NCT00433966|450651142|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
125279991|NCT00433966|450651139|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
125279992|NCT00433966|450651140|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
125279993|NCT00433966|450651141|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
125279994|NCT00433966|450651142|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
125279995|NCT00433966|450651139|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
125279996|NCT00433966|450651140|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
125279997|NCT00433966|450651141|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
125279998|NCT00433966|450651142|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
125279999|NCT02570152|450651143|FG000|Overall Study|Protocol Violation|2|||
125280000|NCT02570152|450651143|FG000|Overall Study|Migrated/moved from study area|13|||
125280001|NCT02957747|450651144|FG000|Overall Study|Withdrawal by Subject|0|||
125280002|NCT02957747|450651145|FG001|Overall Study|Withdrawal by Subject|3|||
125280003|NCT02957747|450651144|FG000|Overall Study|Lost to Follow-up|10|||
125280004|NCT02957747|450651145|FG001|Overall Study|Lost to Follow-up|5|||
125280005|NCT00632827|450651146|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
125280006|NCT00632827|450651146|FG000|Overall Study|Death|2|||
125280007|NCT00632827|450651146|FG000|Overall Study|Adverse Event|5|||
125280008|NCT00632827|450651146|FG000|Overall Study|Lost to Follow-up|1|||
125280009|NCT01177553|450651147|FG000|Overall Study|babies not yet 6 months of age|1|||
125280010|NCT01177553|450651148|FG001|Overall Study|babies not yet 6 months of age|0|||
125280011|NCT03931382|450651151|FG000|Overall Study|Equipment malfunction|2|||
125280012|NCT03931382|450651152|FG001|Overall Study|Equipment malfunction|0|||
125280013|NCT03931382|450651153|FG002|Overall Study|Equipment malfunction|2|||
125280014|NCT03931382|450651151|FG000|Overall Study|Withdrawal by Subject|0|||
125280015|NCT03931382|450651152|FG001|Overall Study|Withdrawal by Subject|1|||
125280016|NCT03931382|450651153|FG002|Overall Study|Withdrawal by Subject|0|||
125280017|NCT00778375|450651160|FG000|Overall Study|Ineligible|3|||
125280018|NCT04590404|450651163|FG000|Overall Study|Death|16|||
125280019|NCT04590404|450651164|FG001|Overall Study|Death|17|||
125280020|NCT04590404|450651163|FG000|Overall Study|Withdrawal by Subject|7|||
125280021|NCT04590404|450651164|FG001|Overall Study|Withdrawal by Subject|2|||
125280022|NCT01581021|450651169|FG000|Overall Study|Lost to Follow-up|4|||
125280023|NCT01581021|450651170|FG001|Overall Study|Lost to Follow-up|6|||
125280024|NCT01581021|450651169|FG000|Overall Study|More than 2 hooks in thoracic|3|||
125280025|NCT01581021|450651170|FG001|Overall Study|More than 2 hooks in thoracic|0|||
125280026|NCT01581021|450651169|FG000|Overall Study|Neuromuscular|2|||
125280027|NCT01581021|450651170|FG001|Overall Study|Neuromuscular|1|||
125280028|NCT01581021|450651169|FG000|Overall Study|Not Randomized|1|||
125280029|NCT01581021|450651170|FG001|Overall Study|Not Randomized|2|||
125280030|NCT01581021|450651169|FG000|Overall Study|Lenke 6 Classification|0|||
125280031|NCT01581021|450651170|FG001|Overall Study|Lenke 6 Classification|1|||
125280032|NCT01581021|450651169|FG000|Overall Study|Lack of Efficacy|0|||
125280033|NCT01581021|450651170|FG001|Overall Study|Lack of Efficacy|1|||
125280034|NCT00675441|450651171|FG000|Overall Study|Withdrawal by Subject|2|||
124781789|NCT00947882|448831172|FG003|Overall Study|Protocol Violation|0|||
124781790|NCT00947882|448831169|FG000|Overall Study|Lost to Follow-up|0|||
124781791|NCT00947882|448831170|FG001|Overall Study|Lost to Follow-up|2|||
124781792|NCT00947882|448831171|FG002|Overall Study|Lost to Follow-up|1|||
125280035|NCT00675441|450651171|FG000|Overall Study|Death|1|||
125280036|NCT00054327|450651177|FG000|Overall Study|Engraftment failure|1|||
125280037|NCT00054327|450651178|FG001|Overall Study|Engraftment failure|0|||
125280038|NCT00054327|450651179|FG002|Overall Study|Engraftment failure|0|||
125280039|NCT00054327|450651180|FG003|Overall Study|Engraftment failure|0|||
125280040|NCT00054327|450651181|FG004|Overall Study|Engraftment failure|0|||
125280041|NCT00054327|450651182|FG005|Overall Study|Engraftment failure|0|||
125280042|NCT00700882|450651183|FG000|Overall Study|Never received treatment|6|||
125280043|NCT00700882|450651183|FG000|Overall Study|Ineligible|2|||
125280044|NCT00700882|450651183|FG000|Overall Study|No KIT mutation|51|||
125280045|NCT04154293|450651193|FG000|Overall Study|Withdrawal by Subject|2|||
125280046|NCT04154293|450651194|FG001|Overall Study|Withdrawal by Subject|3|||
125280047|NCT04154293|450651195|FG002|Overall Study|Withdrawal by Subject|1|||
125280048|NCT04154293|450651193|FG000|Overall Study|Physician Decision|0|||
125280049|NCT04154293|450651194|FG001|Overall Study|Physician Decision|0|||
125280050|NCT04154293|450651195|FG002|Overall Study|Physician Decision|1|||
125280051|NCT02152371|450651196|FG000|Overall Study|Adverse Event|6|||
125280052|NCT02152371|450651197|FG001|Overall Study|Adverse Event|2|||
125280053|NCT02152371|450651196|FG000|Overall Study|Withdrawal by Subject|3|||
125280054|NCT02152371|450651197|FG001|Overall Study|Withdrawal by Subject|7|||
125280055|NCT02152371|450651196|FG000|Overall Study|Protocol Violation|2|||
125280056|NCT02152371|450651197|FG001|Overall Study|Protocol Violation|3|||
125280057|NCT02152371|450651196|FG000|Overall Study|Lost to Follow-up|1|||
125280058|NCT02152371|450651197|FG001|Overall Study|Lost to Follow-up|0|||
125280059|NCT02152371|450651196|FG000|Overall Study|Lack of Efficacy|0|||
125280060|NCT02152371|450651197|FG001|Overall Study|Lack of Efficacy|1|||
125280061|NCT02152371|450651196|FG000|Overall Study|Physician Decision|0|||
125280062|NCT02152371|450651197|FG001|Overall Study|Physician Decision|2|||
125280063|NCT02152371|450651196|FG000|Overall Study|Reason Not Given|0|||
125280064|NCT02152371|450651197|FG001|Overall Study|Reason Not Given|1|||
125280065|NCT04382586|450651199|FG000|Overall Study|Death|3|||
125280066|NCT04382586|450651200|FG001|Overall Study|Death|4|||
125280067|NCT04382586|450651199|FG000|Overall Study|Lost to Follow-up|11|||
125280068|NCT04382586|450651200|FG001|Overall Study|Lost to Follow-up|8|||
125280069|NCT04382586|450651199|FG000|Overall Study|Withdrawal by Subject|3|||
125280070|NCT04382586|450651200|FG001|Overall Study|Withdrawal by Subject|1|||
125280071|NCT04382586|450651199|FG000|Overall Study|Physician Decision|0|||
125280072|NCT04382586|450651200|FG001|Overall Study|Physician Decision|3|||
125280073|NCT05596734|450651202|FG000|Substudy A|Withdrawal by Subject|1|||
125280074|NCT05596734|450651203|FG001|Substudy A|Withdrawal by Subject|0|||
125280075|NCT05596734|450651204|FG002|Substudy A|Withdrawal by Subject|0|||
125280076|NCT05596734|450651205|FG003|Substudy A|Withdrawal by Subject|0|||
125280077|NCT05596734|450651206|FG004|Substudy A|Withdrawal by Subject|0|||
125280078|NCT05596734|450651207|FG005|Substudy A|Withdrawal by Subject|0|||
125280079|NCT05596734|450651208|FG006|Substudy A|Withdrawal by Subject|1|||
125280080|NCT05596734|450651209|FG007|Substudy A|Withdrawal by Subject|0|||
125280081|NCT05596734|450651210|FG008|Substudy A|Withdrawal by Subject|0|||
125280082|NCT05596734|450651211|FG009|Substudy A|Withdrawal by Subject|0|||
125280083|NCT05596734|450651212|FG010|Substudy A|Withdrawal by Subject|0|||
125280084|NCT05596734|450651213|FG011|Substudy A|Withdrawal by Subject|0|||
125280085|NCT05596734|450651214|FG012|Substudy A|Withdrawal by Subject|0|||
125280086|NCT05596734|450651215|FG013|Substudy A|Withdrawal by Subject|0|||
125280087|NCT05596734|450651216|FG014|Substudy A|Withdrawal by Subject|0|||
125280088|NCT05596734|450651217|FG015|Substudy A|Withdrawal by Subject|0|||
125280089|NCT05596734|450651218|FG016|Substudy A|Withdrawal by Subject|0|||
125280090|NCT05596734|450651219|FG017|Substudy A|Withdrawal by Subject|0|||
125280091|NCT05596734|450651220|FG018|Substudy A|Withdrawal by Subject|0|||
125280092|NCT05596734|450651221|FG019|Substudy A|Withdrawal by Subject|0|||
125280093|NCT05596734|450651222|FG020|Substudy A|Withdrawal by Subject|0|||
125280094|NCT05596734|450651223|FG021|Substudy A|Withdrawal by Subject|0|||
124781793|NCT00947882|448831172|FG003|Overall Study|Lost to Follow-up|0|||
124781794|NCT00947882|448831169|FG000|Overall Study|Other/Unknown|10|||
124781795|NCT00947882|448831170|FG001|Overall Study|Other/Unknown|13|||
125280095|NCT05596734|450651224|FG022|Substudy A|Withdrawal by Subject|0|||
125280096|NCT05596734|450651225|FG023|Substudy A|Withdrawal by Subject|0|||
125280097|NCT05596734|450651202|FG000|Substudy A|Lost to Follow-up|1|||
125280098|NCT05596734|450651203|FG001|Substudy A|Lost to Follow-up|0|||
125280099|NCT05596734|450651204|FG002|Substudy A|Lost to Follow-up|1|||
125280100|NCT05596734|450651205|FG003|Substudy A|Lost to Follow-up|0|||
125280101|NCT05596734|450651206|FG004|Substudy A|Lost to Follow-up|0|||
125280102|NCT05596734|450651207|FG005|Substudy A|Lost to Follow-up|0|||
125280103|NCT05596734|450651208|FG006|Substudy A|Lost to Follow-up|0|||
125280104|NCT05596734|450651209|FG007|Substudy A|Lost to Follow-up|0|||
125280105|NCT05596734|450651210|FG008|Substudy A|Lost to Follow-up|0|||
125280106|NCT05596734|450651211|FG009|Substudy A|Lost to Follow-up|0|||
125280107|NCT05596734|450651212|FG010|Substudy A|Lost to Follow-up|0|||
124781796|NCT00947882|448831171|FG002|Overall Study|Other/Unknown|3|||
125280108|NCT05596734|450651213|FG011|Substudy A|Lost to Follow-up|0|||
124781797|NCT00947882|448831172|FG003|Overall Study|Other/Unknown|6|||
124781798|NCT00947882|448831169|FG000|Overall Study|Trial Terminated by Sponsor|62|||
125280109|NCT05596734|450651214|FG012|Substudy A|Lost to Follow-up|0|||
125280110|NCT05596734|450651215|FG013|Substudy A|Lost to Follow-up|0|||
125280111|NCT05596734|450651216|FG014|Substudy A|Lost to Follow-up|0|||
125280112|NCT05596734|450651217|FG015|Substudy A|Lost to Follow-up|0|||
124781799|NCT00947882|448831170|FG001|Overall Study|Trial Terminated by Sponsor|61|||
124781800|NCT00947882|448831171|FG002|Overall Study|Trial Terminated by Sponsor|62|||
125280113|NCT05596734|450651218|FG016|Substudy A|Lost to Follow-up|0|||
125280114|NCT05596734|450651219|FG017|Substudy A|Lost to Follow-up|0|||
125280115|NCT05596734|450651220|FG018|Substudy A|Lost to Follow-up|0|||
125280116|NCT05596734|450651221|FG019|Substudy A|Lost to Follow-up|0|||
125280117|NCT05596734|450651222|FG020|Substudy A|Lost to Follow-up|0|||
125280118|NCT05596734|450651223|FG021|Substudy A|Lost to Follow-up|0|||
125280119|NCT05596734|450651224|FG022|Substudy A|Lost to Follow-up|0|||
125280120|NCT05596734|450651225|FG023|Substudy A|Lost to Follow-up|0|||
125280121|NCT05596734|450651202|FG000|Substudy B|Withdrawal by Subject|0|||
125280122|NCT05596734|450651203|FG001|Substudy B|Withdrawal by Subject|0|||
125280123|NCT05596734|450651204|FG002|Substudy B|Withdrawal by Subject|0|||
125280124|NCT05596734|450651205|FG003|Substudy B|Withdrawal by Subject|0|||
125280125|NCT05596734|450651206|FG004|Substudy B|Withdrawal by Subject|0|||
125280126|NCT05596734|450651207|FG005|Substudy B|Withdrawal by Subject|0|||
125280127|NCT05596734|450651208|FG006|Substudy B|Withdrawal by Subject|0|||
125280128|NCT05596734|450651209|FG007|Substudy B|Withdrawal by Subject|0|||
125280129|NCT05596734|450651210|FG008|Substudy B|Withdrawal by Subject|0|||
125280130|NCT05596734|450651211|FG009|Substudy B|Withdrawal by Subject|0|||
125280131|NCT05596734|450651212|FG010|Substudy B|Withdrawal by Subject|0|||
125280132|NCT05596734|450651213|FG011|Substudy B|Withdrawal by Subject|0|||
125280133|NCT05596734|450651214|FG012|Substudy B|Withdrawal by Subject|1|||
125280134|NCT05596734|450651215|FG013|Substudy B|Withdrawal by Subject|0|||
125280135|NCT05596734|450651216|FG014|Substudy B|Withdrawal by Subject|1|||
125280136|NCT05596734|450651217|FG015|Substudy B|Withdrawal by Subject|2|||
125280137|NCT05596734|450651218|FG016|Substudy B|Withdrawal by Subject|2|||
125280138|NCT05596734|450651219|FG017|Substudy B|Withdrawal by Subject|1|||
125280139|NCT05596734|450651220|FG018|Substudy B|Withdrawal by Subject|2|||
125280140|NCT05596734|450651221|FG019|Substudy B|Withdrawal by Subject|0|||
125280141|NCT05596734|450651222|FG020|Substudy B|Withdrawal by Subject|0|||
125280142|NCT05596734|450651223|FG021|Substudy B|Withdrawal by Subject|0|||
125280143|NCT05596734|450651224|FG022|Substudy B|Withdrawal by Subject|0|||
125280144|NCT05596734|450651225|FG023|Substudy B|Withdrawal by Subject|1|||
125280145|NCT05596734|450651202|FG000|Substudy B|Physician Decision|0|||
125280146|NCT05596734|450651203|FG001|Substudy B|Physician Decision|0|||
125280147|NCT05596734|450651204|FG002|Substudy B|Physician Decision|0|||
125280148|NCT05596734|450651205|FG003|Substudy B|Physician Decision|0|||
125280149|NCT05596734|450651206|FG004|Substudy B|Physician Decision|0|||
125280150|NCT05596734|450651207|FG005|Substudy B|Physician Decision|0|||
125280151|NCT05596734|450651208|FG006|Substudy B|Physician Decision|0|||
125280152|NCT05596734|450651209|FG007|Substudy B|Physician Decision|0|||
124781801|NCT00947882|448831172|FG003|Overall Study|Trial Terminated by Sponsor|70|||
124781802|NCT01396057|448831173|FG000|Overall Study|Adverse Event|2|||
125280153|NCT05596734|450651210|FG008|Substudy B|Physician Decision|0|||
124781803|NCT01396057|448831174|FG001|Overall Study|Adverse Event|6|||
125280154|NCT05596734|450651211|FG009|Substudy B|Physician Decision|0|||
125280155|NCT05596734|450651212|FG010|Substudy B|Physician Decision|0|||
125280156|NCT05596734|450651213|FG011|Substudy B|Physician Decision|0|||
125280157|NCT05596734|450651214|FG012|Substudy B|Physician Decision|0|||
125280158|NCT05596734|450651215|FG013|Substudy B|Physician Decision|0|||
125280159|NCT05596734|450651216|FG014|Substudy B|Physician Decision|0|||
125280160|NCT05596734|450651217|FG015|Substudy B|Physician Decision|1|||
125280161|NCT05596734|450651218|FG016|Substudy B|Physician Decision|0|||
125280162|NCT05596734|450651219|FG017|Substudy B|Physician Decision|0|||
125280163|NCT05596734|450651220|FG018|Substudy B|Physician Decision|0|||
125280164|NCT05596734|450651221|FG019|Substudy B|Physician Decision|0|||
125280165|NCT05596734|450651222|FG020|Substudy B|Physician Decision|0|||
125280166|NCT05596734|450651223|FG021|Substudy B|Physician Decision|0|||
125280167|NCT05596734|450651224|FG022|Substudy B|Physician Decision|0|||
125280168|NCT05596734|450651225|FG023|Substudy B|Physician Decision|0|||
125280169|NCT05596734|450651202|FG000|Substudy B|Lost to Follow-up|0|||
125280170|NCT05596734|450651203|FG001|Substudy B|Lost to Follow-up|0|||
125280171|NCT05596734|450651204|FG002|Substudy B|Lost to Follow-up|0|||
125280172|NCT05596734|450651205|FG003|Substudy B|Lost to Follow-up|0|||
125280173|NCT05596734|450651206|FG004|Substudy B|Lost to Follow-up|0|||
125280174|NCT05596734|450651207|FG005|Substudy B|Lost to Follow-up|0|||
125280175|NCT05596734|450651208|FG006|Substudy B|Lost to Follow-up|0|||
125280176|NCT05596734|450651209|FG007|Substudy B|Lost to Follow-up|0|||
125280177|NCT05596734|450651210|FG008|Substudy B|Lost to Follow-up|0|||
125280178|NCT05596734|450651211|FG009|Substudy B|Lost to Follow-up|0|||
125280179|NCT05596734|450651212|FG010|Substudy B|Lost to Follow-up|0|||
125280180|NCT05596734|450651213|FG011|Substudy B|Lost to Follow-up|0|||
125280181|NCT05596734|450651214|FG012|Substudy B|Lost to Follow-up|1|||
125280182|NCT05596734|450651215|FG013|Substudy B|Lost to Follow-up|0|||
125280183|NCT05596734|450651216|FG014|Substudy B|Lost to Follow-up|1|||
125280184|NCT05596734|450651217|FG015|Substudy B|Lost to Follow-up|1|||
125280185|NCT05596734|450651218|FG016|Substudy B|Lost to Follow-up|0|||
125280186|NCT05596734|450651219|FG017|Substudy B|Lost to Follow-up|0|||
125280187|NCT05596734|450651220|FG018|Substudy B|Lost to Follow-up|0|||
125280188|NCT05596734|450651221|FG019|Substudy B|Lost to Follow-up|0|||
125280189|NCT05596734|450651222|FG020|Substudy B|Lost to Follow-up|0|||
125280190|NCT05596734|450651223|FG021|Substudy B|Lost to Follow-up|0|||
125280191|NCT05596734|450651224|FG022|Substudy B|Lost to Follow-up|0|||
125280192|NCT05596734|450651225|FG023|Substudy B|Lost to Follow-up|0|||
125280193|NCT04113018|450651226|FG000|Overall Study|Death|2|||
125280194|NCT04113018|450651226|FG000|Overall Study|Lost to Follow-up|1|||
125280195|NCT04113018|450651226|FG000|Overall Study|Still On Study (on study treatment)|24|||
125280196|NCT04113018|450651226|FG000|Overall Study|Still On Study (in follow up)|12|||
125280197|NCT00079391|450651227|FG000|Overall Study|Withdrawal by Subject|1|||
125280198|NCT02791516|450651232|FG000|Overall Study|Withdrawal by Subject|1|||
125280199|NCT02791516|450651233|FG001|Overall Study|Withdrawal by Subject|1|||
125280200|NCT03479541|450651234|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
125280201|NCT03479541|450651235|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
125280202|NCT03479541|450651236|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
125280203|NCT03479541|450651237|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
125280204|NCT03479541|450651234|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
125280205|NCT03479541|450651235|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
125280206|NCT03479541|450651236|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
125280207|NCT03479541|450651237|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
125280208|NCT03479541|450651234|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
125280209|NCT03479541|450651235|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
125280210|NCT03479541|450651236|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
125280211|NCT03479541|450651237|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
125280212|NCT03479541|450651234|FG000|Home Monitoring|Lost to Follow-up|0|||
125280213|NCT03479541|450651235|FG001|Home Monitoring|Lost to Follow-up|0|||
125280214|NCT03479541|450651236|FG002|Home Monitoring|Lost to Follow-up|8|||
125280215|NCT03479541|450651237|FG003|Home Monitoring|Lost to Follow-up|12|||
125280216|NCT03479541|450651234|FG000|Home Monitoring|Withdrawal by Subject|0|||
125280217|NCT03479541|450651235|FG001|Home Monitoring|Withdrawal by Subject|0|||
125280218|NCT03479541|450651236|FG002|Home Monitoring|Withdrawal by Subject|17|||
125280219|NCT03479541|450651237|FG003|Home Monitoring|Withdrawal by Subject|30|||
125280220|NCT03479541|450651234|FG000|Home Monitoring|Early Termination - PI Decision|0|||
125280221|NCT03479541|450651235|FG001|Home Monitoring|Early Termination - PI Decision|0|||
125280222|NCT03479541|450651236|FG002|Home Monitoring|Early Termination - PI Decision|4|||
125280223|NCT03479541|450651237|FG003|Home Monitoring|Early Termination - PI Decision|6|||
125280224|NCT00107900|450651240|FG000|Overall Study|Adverse Event|3|||
125280225|NCT00107900|450651241|FG001|Overall Study|Adverse Event|2|||
125280226|NCT00107900|450651242|FG002|Overall Study|Adverse Event|10|||
125280227|NCT00107900|450651243|FG003|Overall Study|Adverse Event|3|||
125280228|NCT00107900|450651244|FG004|Overall Study|Adverse Event|5|||
125280229|NCT00107900|450651245|FG005|Overall Study|Adverse Event|3|||
125280230|NCT00107900|450651240|FG000|Overall Study|Death|0|||
125280231|NCT00107900|450651241|FG001|Overall Study|Death|0|||
125280232|NCT00107900|450651242|FG002|Overall Study|Death|0|||
125280233|NCT00107900|450651243|FG003|Overall Study|Death|0|||
125280234|NCT00107900|450651244|FG004|Overall Study|Death|1|||
125280235|NCT00107900|450651245|FG005|Overall Study|Death|0|||
125280236|NCT00107900|450651240|FG000|Overall Study|Lost to Follow-up|4|||
125280237|NCT00107900|450651241|FG001|Overall Study|Lost to Follow-up|1|||
125280238|NCT00107900|450651242|FG002|Overall Study|Lost to Follow-up|3|||
125280239|NCT00107900|450651243|FG003|Overall Study|Lost to Follow-up|2|||
125280240|NCT00107900|450651244|FG004|Overall Study|Lost to Follow-up|5|||
125280241|NCT00107900|450651245|FG005|Overall Study|Lost to Follow-up|5|||
125280242|NCT00107900|450651240|FG000|Overall Study|Protocol Violation|1|||
125280243|NCT00107900|450651241|FG001|Overall Study|Protocol Violation|0|||
125280244|NCT00107900|450651242|FG002|Overall Study|Protocol Violation|5|||
125280245|NCT00107900|450651243|FG003|Overall Study|Protocol Violation|5|||
125280246|NCT00107900|450651244|FG004|Overall Study|Protocol Violation|7|||
125280247|NCT00107900|450651245|FG005|Overall Study|Protocol Violation|0|||
125280248|NCT00107900|450651240|FG000|Overall Study|Withdrawal by Subject|1|||
125280249|NCT00107900|450651241|FG001|Overall Study|Withdrawal by Subject|0|||
125280250|NCT00107900|450651242|FG002|Overall Study|Withdrawal by Subject|5|||
125280251|NCT00107900|450651243|FG003|Overall Study|Withdrawal by Subject|0|||
125280252|NCT00107900|450651244|FG004|Overall Study|Withdrawal by Subject|1|||
125280253|NCT00107900|450651245|FG005|Overall Study|Withdrawal by Subject|1|||
125280254|NCT00107900|450651240|FG000|Overall Study|Administrative Reasons|1|||
125280255|NCT00107900|450651241|FG001|Overall Study|Administrative Reasons|0|||
125280256|NCT00107900|450651242|FG002|Overall Study|Administrative Reasons|2|||
125280257|NCT00107900|450651243|FG003|Overall Study|Administrative Reasons|2|||
125280258|NCT00107900|450651244|FG004|Overall Study|Administrative Reasons|2|||
125280259|NCT00107900|450651245|FG005|Overall Study|Administrative Reasons|0|||
125280260|NCT02644096|450651246|FG000|Overall Study|Withdrawal by Subject|28|||
125280261|NCT02644096|450651247|FG001|Overall Study|Withdrawal by Subject|25|||
125280262|NCT02461290|450651248|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
125280263|NCT02461290|450651248|FG000|Overall Study|Lost to Follow-up|3|||
125280264|NCT00526656|450651249|FG000|Overall Study|Death|1|||
125280265|NCT00526656|450651249|FG000|Overall Study|Refused surgery|1|||
125280266|NCT01456195|450652800|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
125280267|NCT01456195|450652801|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
125280268|NCT01456195|450652802|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
125280269|NCT01456195|450652800|FG000|Overall Study|Lost to Follow-up|3|||
125280270|NCT01456195|450652801|FG001|Overall Study|Lost to Follow-up|1|||
125280271|NCT01456195|450652802|FG002|Overall Study|Lost to Follow-up|3|||
125280272|NCT01456195|450652800|FG000|Overall Study|Voluntary Withdrawal|5|||
125280273|NCT01456195|450652801|FG001|Overall Study|Voluntary Withdrawal|3|||
125280274|NCT01456195|450652802|FG002|Overall Study|Voluntary Withdrawal|7|||
125280275|NCT01456195|450652800|FG000|Overall Study|Lack of Efficacy|0|||
125280276|NCT01456195|450652801|FG001|Overall Study|Lack of Efficacy|1|||
125280277|NCT01456195|450652802|FG002|Overall Study|Lack of Efficacy|0|||
125280278|NCT01456195|450652800|FG000|Overall Study|Other Reasons|2|||
125280279|NCT01456195|450652801|FG001|Overall Study|Other Reasons|1|||
125280280|NCT01456195|450652802|FG002|Overall Study|Other Reasons|3|||
125280281|NCT02547038|450652803|FG000|Overall Study|Lost to Follow-up|3|||
125280282|NCT02547038|450652804|FG001|Overall Study|Lost to Follow-up|2|||
125280283|NCT01340625|450652805|FG000|First Intervention|Adverse Event|1|||
125280284|NCT01340625|450652806|FG001|First Intervention|Adverse Event|0|||
125280285|NCT01340625|450652805|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
125280286|NCT01340625|450652806|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
125280287|NCT00734604|450652813|FG000|Overall Study|Adverse Event|0|||
125280288|NCT00734604|450652814|FG001|Overall Study|Adverse Event|2|||
125280289|NCT00734604|450652815|FG002|Overall Study|Adverse Event|0|||
125280290|NCT00734604|450652816|FG003|Overall Study|Adverse Event|2|||
125280291|NCT00734604|450652817|FG004|Overall Study|Adverse Event|1|||
125280292|NCT00734604|450652818|FG005|Overall Study|Adverse Event|1|||
125280293|NCT00734604|450652813|FG000|Overall Study|Serious Adverse Event|1|||
125280294|NCT00734604|450652814|FG001|Overall Study|Serious Adverse Event|0|||
125280295|NCT00734604|450652815|FG002|Overall Study|Serious Adverse Event|1|||
125280296|NCT00734604|450652816|FG003|Overall Study|Serious Adverse Event|2|||
125280297|NCT00734604|450652817|FG004|Overall Study|Serious Adverse Event|0|||
125280298|NCT00734604|450652818|FG005|Overall Study|Serious Adverse Event|1|||
125280299|NCT00734604|450652813|FG000|Overall Study|Lost to Follow-up|1|||
125280300|NCT00734604|450652814|FG001|Overall Study|Lost to Follow-up|2|||
125280301|NCT00734604|450652815|FG002|Overall Study|Lost to Follow-up|2|||
125280302|NCT00734604|450652816|FG003|Overall Study|Lost to Follow-up|4|||
125280303|NCT00734604|450652817|FG004|Overall Study|Lost to Follow-up|2|||
125280304|NCT00734604|450652818|FG005|Overall Study|Lost to Follow-up|3|||
125280305|NCT00734604|450652813|FG000|Overall Study|Physician Decision|0|||
125280306|NCT00734604|450652814|FG001|Overall Study|Physician Decision|1|||
125280307|NCT00734604|450652815|FG002|Overall Study|Physician Decision|1|||
125280308|NCT00734604|450652816|FG003|Overall Study|Physician Decision|0|||
125280309|NCT00734604|450652817|FG004|Overall Study|Physician Decision|0|||
125280310|NCT00734604|450652818|FG005|Overall Study|Physician Decision|0|||
125280311|NCT00734604|450652813|FG000|Overall Study|Protocol Violation|0|||
125280312|NCT00734604|450652814|FG001|Overall Study|Protocol Violation|2|||
125280313|NCT00734604|450652815|FG002|Overall Study|Protocol Violation|0|||
125280314|NCT00734604|450652816|FG003|Overall Study|Protocol Violation|0|||
125280315|NCT00734604|450652817|FG004|Overall Study|Protocol Violation|1|||
125280316|NCT00734604|450652818|FG005|Overall Study|Protocol Violation|0|||
125280317|NCT00734604|450652813|FG000|Overall Study|Sponsor Decision|1|||
125280318|NCT00734604|450652814|FG001|Overall Study|Sponsor Decision|2|||
125280319|NCT00734604|450652815|FG002|Overall Study|Sponsor Decision|1|||
125280320|NCT00734604|450652816|FG003|Overall Study|Sponsor Decision|0|||
125280321|NCT00734604|450652817|FG004|Overall Study|Sponsor Decision|2|||
125280322|NCT00734604|450652818|FG005|Overall Study|Sponsor Decision|0|||
124781804|NCT01396057|448831173|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124781805|NCT01396057|448831174|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
125280323|NCT00734604|450652813|FG000|Overall Study|Withdrawal by Subject|0|||
124781806|NCT01396057|448831173|FG000|Overall Study|Protocol deviation|4|||
125280324|NCT00734604|450652814|FG001|Overall Study|Withdrawal by Subject|2|||
125280325|NCT00734604|450652815|FG002|Overall Study|Withdrawal by Subject|0|||
125280326|NCT00734604|450652816|FG003|Overall Study|Withdrawal by Subject|1|||
125280327|NCT00734604|450652817|FG004|Overall Study|Withdrawal by Subject|2|||
125280328|NCT00734604|450652818|FG005|Overall Study|Withdrawal by Subject|1|||
125280329|NCT00734604|450652813|FG000|Overall Study|Lack of Efficacy|0|||
125280330|NCT00734604|450652814|FG001|Overall Study|Lack of Efficacy|1|||
125280331|NCT00734604|450652815|FG002|Overall Study|Lack of Efficacy|1|||
125280332|NCT00734604|450652816|FG003|Overall Study|Lack of Efficacy|0|||
125280333|NCT00734604|450652817|FG004|Overall Study|Lack of Efficacy|0|||
125280334|NCT00734604|450652818|FG005|Overall Study|Lack of Efficacy|0|||
125280335|NCT02589665|450652819|FG000|Induction Period|Did not receive drug|0|||
125280336|NCT02589665|450652820|FG001|Induction Period|Did not receive drug|0|||
125280337|NCT02589665|450652821|FG002|Induction Period|Did not receive drug|0|||
125280338|NCT02589665|450652822|FG003|Induction Period|Did not receive drug|1|||
125280339|NCT02589665|450652823|FG004|Induction Period|Did not receive drug|0|||
125280340|NCT02589665|450652824|FG005|Induction Period|Did not receive drug|0|||
125280341|NCT02589665|450652825|FG006|Induction Period|Did not receive drug|0|||
125280342|NCT02589665|450652826|FG007|Induction Period|Did not receive drug|0|||
125280343|NCT02589665|450652827|FG008|Induction Period|Did not receive drug|0|||
125280344|NCT02589665|450652828|FG009|Induction Period|Did not receive drug|0|||
125280345|NCT02589665|450652819|FG000|Induction Period|Adverse Event|3|||
125280346|NCT02589665|450652820|FG001|Induction Period|Adverse Event|0|||
125280347|NCT02589665|450652821|FG002|Induction Period|Adverse Event|2|||
125280348|NCT02589665|450652822|FG003|Induction Period|Adverse Event|2|||
125280349|NCT02589665|450652823|FG004|Induction Period|Adverse Event|0|||
125280350|NCT02589665|450652824|FG005|Induction Period|Adverse Event|0|||
125280351|NCT02589665|450652825|FG006|Induction Period|Adverse Event|0|||
125280352|NCT02589665|450652826|FG007|Induction Period|Adverse Event|0|||
125280353|NCT02589665|450652827|FG008|Induction Period|Adverse Event|0|||
125280354|NCT02589665|450652828|FG009|Induction Period|Adverse Event|0|||
125280355|NCT02589665|450652819|FG000|Induction Period|Withdrawal by Subject|0|||
125280356|NCT02589665|450652820|FG001|Induction Period|Withdrawal by Subject|1|||
125280357|NCT02589665|450652821|FG002|Induction Period|Withdrawal by Subject|0|||
125280358|NCT02589665|450652822|FG003|Induction Period|Withdrawal by Subject|1|||
125280359|NCT02589665|450652823|FG004|Induction Period|Withdrawal by Subject|0|||
125280360|NCT02589665|450652824|FG005|Induction Period|Withdrawal by Subject|0|||
125280361|NCT02589665|450652825|FG006|Induction Period|Withdrawal by Subject|0|||
125280362|NCT02589665|450652826|FG007|Induction Period|Withdrawal by Subject|0|||
125280363|NCT02589665|450652827|FG008|Induction Period|Withdrawal by Subject|0|||
125280364|NCT02589665|450652828|FG009|Induction Period|Withdrawal by Subject|0|||
125280365|NCT02589665|450652819|FG000|Induction Period|Protocol Violation|0|||
125280366|NCT02589665|450652820|FG001|Induction Period|Protocol Violation|1|||
125280367|NCT02589665|450652821|FG002|Induction Period|Protocol Violation|0|||
125280368|NCT02589665|450652822|FG003|Induction Period|Protocol Violation|0|||
125280369|NCT02589665|450652823|FG004|Induction Period|Protocol Violation|0|||
125280370|NCT02589665|450652824|FG005|Induction Period|Protocol Violation|0|||
125280371|NCT02589665|450652825|FG006|Induction Period|Protocol Violation|0|||
125280372|NCT02589665|450652826|FG007|Induction Period|Protocol Violation|0|||
125280373|NCT02589665|450652827|FG008|Induction Period|Protocol Violation|0|||
125280374|NCT02589665|450652828|FG009|Induction Period|Protocol Violation|0|||
125280375|NCT02589665|450652819|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280376|NCT02589665|450652820|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280377|NCT02589665|450652821|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280378|NCT02589665|450652822|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280379|NCT02589665|450652823|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
125280380|NCT02589665|450652824|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
125280381|NCT02589665|450652825|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
125280382|NCT02589665|450652826|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280383|NCT02589665|450652827|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280384|NCT02589665|450652828|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280385|NCT02589665|450652819|FG000|Maintenance Period|Withdrawal by Subject|0|||
125280386|NCT02589665|450652820|FG001|Maintenance Period|Withdrawal by Subject|0|||
125280387|NCT02589665|450652821|FG002|Maintenance Period|Withdrawal by Subject|0|||
125280388|NCT02589665|450652822|FG003|Maintenance Period|Withdrawal by Subject|0|||
125280389|NCT02589665|450652823|FG004|Maintenance Period|Withdrawal by Subject|4|||
125280390|NCT02589665|450652824|FG005|Maintenance Period|Withdrawal by Subject|2|||
125280391|NCT02589665|450652825|FG006|Maintenance Period|Withdrawal by Subject|4|||
125280392|NCT02589665|450652826|FG007|Maintenance Period|Withdrawal by Subject|0|||
125280393|NCT02589665|450652827|FG008|Maintenance Period|Withdrawal by Subject|0|||
125280394|NCT02589665|450652828|FG009|Maintenance Period|Withdrawal by Subject|0|||
125280395|NCT02589665|450652819|FG000|Maintenance Period|Lack of Efficacy|0|||
125280396|NCT02589665|450652820|FG001|Maintenance Period|Lack of Efficacy|0|||
125280397|NCT02589665|450652821|FG002|Maintenance Period|Lack of Efficacy|0|||
125280398|NCT02589665|450652822|FG003|Maintenance Period|Lack of Efficacy|0|||
125280399|NCT02589665|450652823|FG004|Maintenance Period|Lack of Efficacy|2|||
125280400|NCT02589665|450652824|FG005|Maintenance Period|Lack of Efficacy|1|||
125280401|NCT02589665|450652825|FG006|Maintenance Period|Lack of Efficacy|0|||
125280402|NCT02589665|450652826|FG007|Maintenance Period|Lack of Efficacy|0|||
125280403|NCT02589665|450652827|FG008|Maintenance Period|Lack of Efficacy|0|||
125280404|NCT02589665|450652828|FG009|Maintenance Period|Lack of Efficacy|0|||
125280405|NCT02589665|450652819|FG000|Maintenance Period|Adverse Event|0|||
125280406|NCT02589665|450652820|FG001|Maintenance Period|Adverse Event|0|||
125280407|NCT02589665|450652821|FG002|Maintenance Period|Adverse Event|0|||
125280408|NCT02589665|450652822|FG003|Maintenance Period|Adverse Event|0|||
125280409|NCT02589665|450652823|FG004|Maintenance Period|Adverse Event|0|||
125280410|NCT02589665|450652824|FG005|Maintenance Period|Adverse Event|0|||
125280411|NCT02589665|450652825|FG006|Maintenance Period|Adverse Event|2|||
125280412|NCT02589665|450652826|FG007|Maintenance Period|Adverse Event|0|||
125280413|NCT02589665|450652827|FG008|Maintenance Period|Adverse Event|0|||
125280414|NCT02589665|450652828|FG009|Maintenance Period|Adverse Event|0|||
125280415|NCT02589665|450652819|FG000|Maintenance Period|Lost to Follow-up|0|||
125280416|NCT02589665|450652820|FG001|Maintenance Period|Lost to Follow-up|0|||
125280417|NCT02589665|450652821|FG002|Maintenance Period|Lost to Follow-up|0|||
125280418|NCT02589665|450652822|FG003|Maintenance Period|Lost to Follow-up|0|||
125280419|NCT02589665|450652823|FG004|Maintenance Period|Lost to Follow-up|0|||
125280420|NCT02589665|450652824|FG005|Maintenance Period|Lost to Follow-up|1|||
125280421|NCT02589665|450652825|FG006|Maintenance Period|Lost to Follow-up|0|||
125280422|NCT02589665|450652826|FG007|Maintenance Period|Lost to Follow-up|0|||
125280423|NCT02589665|450652827|FG008|Maintenance Period|Lost to Follow-up|0|||
125280424|NCT02589665|450652828|FG009|Maintenance Period|Lost to Follow-up|0|||
125280425|NCT02589665|450652819|FG000|Maintenance Period|Physician Decision|0|||
125280426|NCT02589665|450652820|FG001|Maintenance Period|Physician Decision|0|||
125280427|NCT02589665|450652821|FG002|Maintenance Period|Physician Decision|0|||
125280428|NCT02589665|450652822|FG003|Maintenance Period|Physician Decision|0|||
125280429|NCT02589665|450652823|FG004|Maintenance Period|Physician Decision|0|||
125280430|NCT02589665|450652824|FG005|Maintenance Period|Physician Decision|1|||
125280431|NCT02589665|450652825|FG006|Maintenance Period|Physician Decision|0|||
125280432|NCT02589665|450652826|FG007|Maintenance Period|Physician Decision|0|||
125280433|NCT02589665|450652827|FG008|Maintenance Period|Physician Decision|0|||
125280434|NCT02589665|450652828|FG009|Maintenance Period|Physician Decision|0|||
125280435|NCT02589665|450652819|FG000|Maintenance Period|Reason Not Collected|0|||
125280436|NCT02589665|450652820|FG001|Maintenance Period|Reason Not Collected|0|||
125280437|NCT02589665|450652821|FG002|Maintenance Period|Reason Not Collected|0|||
124781807|NCT01396057|448831174|FG001|Overall Study|Protocol deviation|4|||
125280438|NCT02589665|450652822|FG003|Maintenance Period|Reason Not Collected|0|||
125280439|NCT02589665|450652823|FG004|Maintenance Period|Reason Not Collected|0|||
125280440|NCT02589665|450652824|FG005|Maintenance Period|Reason Not Collected|1|||
125280441|NCT02589665|450652825|FG006|Maintenance Period|Reason Not Collected|1|||
125280442|NCT02589665|450652826|FG007|Maintenance Period|Reason Not Collected|0|||
125280443|NCT02589665|450652827|FG008|Maintenance Period|Reason Not Collected|0|||
125280444|NCT02589665|450652828|FG009|Maintenance Period|Reason Not Collected|0|||
125280445|NCT02589665|450652819|FG000|Induction Extension Period|Adverse Event|0|||
125280446|NCT02589665|450652820|FG001|Induction Extension Period|Adverse Event|0|||
125280447|NCT02589665|450652821|FG002|Induction Extension Period|Adverse Event|0|||
125280448|NCT02589665|450652822|FG003|Induction Extension Period|Adverse Event|0|||
125280449|NCT02589665|450652823|FG004|Induction Extension Period|Adverse Event|0|||
125280450|NCT02589665|450652824|FG005|Induction Extension Period|Adverse Event|0|||
125280451|NCT02589665|450652825|FG006|Induction Extension Period|Adverse Event|0|||
125280452|NCT02589665|450652826|FG007|Induction Extension Period|Adverse Event|0|||
125280453|NCT02589665|450652827|FG008|Induction Extension Period|Adverse Event|4|||
125280454|NCT02589665|450652828|FG009|Induction Extension Period|Adverse Event|0|||
125280455|NCT02589665|450652819|FG000|Induction Extension Period|Lack of Efficacy|0|||
125280456|NCT02589665|450652820|FG001|Induction Extension Period|Lack of Efficacy|0|||
125280457|NCT02589665|450652821|FG002|Induction Extension Period|Lack of Efficacy|0|||
125280458|NCT02589665|450652822|FG003|Induction Extension Period|Lack of Efficacy|0|||
125280459|NCT02589665|450652823|FG004|Induction Extension Period|Lack of Efficacy|0|||
125280460|NCT02589665|450652824|FG005|Induction Extension Period|Lack of Efficacy|0|||
125280461|NCT02589665|450652825|FG006|Induction Extension Period|Lack of Efficacy|0|||
125280462|NCT02589665|450652826|FG007|Induction Extension Period|Lack of Efficacy|0|||
125280463|NCT02589665|450652827|FG008|Induction Extension Period|Lack of Efficacy|3|||
125280464|NCT02589665|450652828|FG009|Induction Extension Period|Lack of Efficacy|0|||
125280465|NCT02589665|450652819|FG000|Induction Extension Period|Withdrawal by Subject|0|||
125280466|NCT02589665|450652820|FG001|Induction Extension Period|Withdrawal by Subject|0|||
125280467|NCT02589665|450652821|FG002|Induction Extension Period|Withdrawal by Subject|0|||
125280468|NCT02589665|450652822|FG003|Induction Extension Period|Withdrawal by Subject|0|||
125280469|NCT02589665|450652823|FG004|Induction Extension Period|Withdrawal by Subject|0|||
125280470|NCT02589665|450652824|FG005|Induction Extension Period|Withdrawal by Subject|0|||
125280471|NCT02589665|450652825|FG006|Induction Extension Period|Withdrawal by Subject|0|||
125280472|NCT02589665|450652826|FG007|Induction Extension Period|Withdrawal by Subject|2|||
125280473|NCT02589665|450652827|FG008|Induction Extension Period|Withdrawal by Subject|3|||
125280474|NCT02589665|450652828|FG009|Induction Extension Period|Withdrawal by Subject|0|||
125280475|NCT02589665|450652819|FG000|Induction Extension Period|Physician Decision|0|||
125280476|NCT02589665|450652820|FG001|Induction Extension Period|Physician Decision|0|||
125280477|NCT02589665|450652821|FG002|Induction Extension Period|Physician Decision|0|||
125280478|NCT02589665|450652822|FG003|Induction Extension Period|Physician Decision|0|||
125280479|NCT02589665|450652823|FG004|Induction Extension Period|Physician Decision|0|||
125280480|NCT02589665|450652824|FG005|Induction Extension Period|Physician Decision|0|||
125280481|NCT02589665|450652825|FG006|Induction Extension Period|Physician Decision|0|||
125280482|NCT02589665|450652826|FG007|Induction Extension Period|Physician Decision|0|||
125280483|NCT02589665|450652827|FG008|Induction Extension Period|Physician Decision|1|||
125280484|NCT02589665|450652828|FG009|Induction Extension Period|Physician Decision|0|||
125280485|NCT02589665|450652819|FG000|Induction Extension Period|Reason Not Collected|0|||
125280486|NCT02589665|450652820|FG001|Induction Extension Period|Reason Not Collected|0|||
125280487|NCT02589665|450652821|FG002|Induction Extension Period|Reason Not Collected|0|||
125280488|NCT02589665|450652822|FG003|Induction Extension Period|Reason Not Collected|0|||
125280489|NCT02589665|450652823|FG004|Induction Extension Period|Reason Not Collected|0|||
125280490|NCT02589665|450652824|FG005|Induction Extension Period|Reason Not Collected|0|||
125280491|NCT02589665|450652825|FG006|Induction Extension Period|Reason Not Collected|0|||
125280492|NCT02589665|450652826|FG007|Induction Extension Period|Reason Not Collected|0|||
125280493|NCT02589665|450652827|FG008|Induction Extension Period|Reason Not Collected|1|||
125280494|NCT02589665|450652828|FG009|Induction Extension Period|Reason Not Collected|0|||
125280495|NCT02589665|450652819|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280496|NCT02589665|450652820|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280497|NCT02589665|450652821|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280498|NCT02589665|450652822|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280499|NCT02589665|450652823|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280500|NCT02589665|450652824|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280501|NCT02589665|450652825|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280502|NCT02589665|450652826|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280503|NCT02589665|450652827|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280504|NCT02589665|450652828|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
125280505|NCT02589665|450652819|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
125280506|NCT02589665|450652820|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
125280507|NCT02589665|450652821|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
125280508|NCT02589665|450652822|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
125280509|NCT02589665|450652823|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
125280510|NCT02589665|450652824|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
125280511|NCT02589665|450652825|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
125280512|NCT02589665|450652826|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
125280513|NCT02589665|450652827|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
125280514|NCT02589665|450652828|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
125280515|NCT02589665|450652819|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
125280516|NCT02589665|450652820|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
125280517|NCT02589665|450652821|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
125280518|NCT02589665|450652822|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
125280519|NCT02589665|450652823|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
125280520|NCT02589665|450652824|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
125280521|NCT02589665|450652825|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
125280522|NCT02589665|450652826|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
125280523|NCT02589665|450652827|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
125280524|NCT02589665|450652828|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
125280525|NCT02589665|450652819|FG000|Maintenance Extension Period|Adverse Event|0|||
125280526|NCT02589665|450652820|FG001|Maintenance Extension Period|Adverse Event|0|||
125280527|NCT02589665|450652821|FG002|Maintenance Extension Period|Adverse Event|0|||
125280528|NCT02589665|450652822|FG003|Maintenance Extension Period|Adverse Event|0|||
125280529|NCT02589665|450652823|FG004|Maintenance Extension Period|Adverse Event|0|||
125280530|NCT02589665|450652824|FG005|Maintenance Extension Period|Adverse Event|0|||
125280531|NCT02589665|450652825|FG006|Maintenance Extension Period|Adverse Event|0|||
125280532|NCT02589665|450652826|FG007|Maintenance Extension Period|Adverse Event|0|||
125280533|NCT02589665|450652827|FG008|Maintenance Extension Period|Adverse Event|0|||
125280534|NCT02589665|450652828|FG009|Maintenance Extension Period|Adverse Event|2|||
125280535|NCT02589665|450652819|FG000|Maintenance Extension Period|Non-responder|0|||
125280536|NCT02589665|450652820|FG001|Maintenance Extension Period|Non-responder|0|||
125280537|NCT02589665|450652821|FG002|Maintenance Extension Period|Non-responder|0|||
125280538|NCT02589665|450652822|FG003|Maintenance Extension Period|Non-responder|0|||
125280539|NCT02589665|450652823|FG004|Maintenance Extension Period|Non-responder|0|||
125280540|NCT02589665|450652824|FG005|Maintenance Extension Period|Non-responder|0|||
125280541|NCT02589665|450652825|FG006|Maintenance Extension Period|Non-responder|0|||
125280542|NCT02589665|450652826|FG007|Maintenance Extension Period|Non-responder|0|||
125280543|NCT02589665|450652827|FG008|Maintenance Extension Period|Non-responder|0|||
125280544|NCT02589665|450652828|FG009|Maintenance Extension Period|Non-responder|1|||
125280545|NCT00978380|450652829|FG000|Overall Study|Protocol Violation|2|||
125280546|NCT00978380|450652829|FG000|Overall Study|Withdrawal criteria|9|||
125280547|NCT00978380|450652829|FG000|Overall Study|Unclassified|8|||
125280548|NCT00327015|450652830|FG000|Overall Study|Lack of Efficacy|18|||
125280549|NCT00327015|450652831|FG001|Overall Study|Lack of Efficacy|18|||
125280550|NCT00327015|450652832|FG002|Overall Study|Lack of Efficacy|35|||
125280551|NCT00327015|450652833|FG003|Overall Study|Lack of Efficacy|29|||
125280552|NCT00327015|450652830|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
125280553|NCT00327015|450652831|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
125280554|NCT00327015|450652832|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
125280555|NCT00327015|450652833|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
125280556|NCT00327015|450652830|FG000|Overall Study|Lost to Follow-up|22|||
125280557|NCT00327015|450652831|FG001|Overall Study|Lost to Follow-up|23|||
125280558|NCT00327015|450652832|FG002|Overall Study|Lost to Follow-up|29|||
125280559|NCT00327015|450652833|FG003|Overall Study|Lost to Follow-up|22|||
125280560|NCT00327015|450652830|FG000|Overall Study|Adverse Event|14|||
125280561|NCT00327015|450652831|FG001|Overall Study|Adverse Event|10|||
125280562|NCT00327015|450652832|FG002|Overall Study|Adverse Event|14|||
125280563|NCT00327015|450652833|FG003|Overall Study|Adverse Event|14|||
125280564|NCT00327015|450652830|FG000|Overall Study|Subject no longer meets study criteria|4|||
125280565|NCT00327015|450652831|FG001|Overall Study|Subject no longer meets study criteria|2|||
125280566|NCT00327015|450652832|FG002|Overall Study|Subject no longer meets study criteria|8|||
125280567|NCT00327015|450652833|FG003|Overall Study|Subject no longer meets study criteria|7|||
125280568|NCT00327015|450652830|FG000|Overall Study|Poor/Noncompliance|11|||
125280569|NCT00327015|450652831|FG001|Overall Study|Poor/Noncompliance|8|||
125280570|NCT00327015|450652832|FG002|Overall Study|Poor/Noncompliance|4|||
125280571|NCT00327015|450652833|FG003|Overall Study|Poor/Noncompliance|5|||
125280572|NCT00327015|450652830|FG000|Overall Study|Physician Decision|0|||
125280573|NCT00327015|450652831|FG001|Overall Study|Physician Decision|1|||
125280574|NCT00327015|450652832|FG002|Overall Study|Physician Decision|3|||
124781808|NCT01396057|448831173|FG000|Overall Study|Consent withdrawn|3|||
125280575|NCT00327015|450652833|FG003|Overall Study|Physician Decision|2|||
125280576|NCT00327015|450652830|FG000|Overall Study|Death|1|||
125280577|NCT00327015|450652831|FG001|Overall Study|Death|2|||
125280578|NCT00327015|450652832|FG002|Overall Study|Death|2|||
125280579|NCT00327015|450652833|FG003|Overall Study|Death|3|||
125280580|NCT00327015|450652830|FG000|Overall Study|Pregnancy|0|||
125280581|NCT00327015|450652831|FG001|Overall Study|Pregnancy|2|||
125280582|NCT00327015|450652832|FG002|Overall Study|Pregnancy|1|||
125280583|NCT00327015|450652833|FG003|Overall Study|Pregnancy|1|||
125280584|NCT00327015|450652830|FG000|Overall Study|Administrative Reason by Sponsor|1|||
125280585|NCT00327015|450652831|FG001|Overall Study|Administrative Reason by Sponsor|2|||
125280586|NCT00327015|450652832|FG002|Overall Study|Administrative Reason by Sponsor|2|||
125280587|NCT00327015|450652833|FG003|Overall Study|Administrative Reason by Sponsor|1|||
125280588|NCT01519791|450652834|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
125280589|NCT01519791|450652835|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
125280590|NCT01519791|450652834|FG000|Overall Study|Protocol Violation|6|||
125280591|NCT01519791|450652835|FG001|Overall Study|Protocol Violation|19|||
125280592|NCT01519791|450652834|FG000|Overall Study|Other Reason|87|||
125280593|NCT01519791|450652835|FG001|Overall Study|Other Reason|222|||
125280594|NCT01519791|450652834|FG000|Overall Study|subjects randomized in error|2|||
125280595|NCT01519791|450652835|FG001|Overall Study|subjects randomized in error|0|||
125280596|NCT01519791|450652834|FG000|Overall Study|Lack of Efficacy|16|||
125280597|NCT01519791|450652835|FG001|Overall Study|Lack of Efficacy|20|||
125280598|NCT01519791|450652834|FG000|Overall Study|SAE, non-fatal|6|||
125280599|NCT01519791|450652835|FG001|Overall Study|SAE, non-fatal|22|||
125280600|NCT01519791|450652834|FG000|Overall Study|AE, serious fatal|0|||
125280601|NCT01519791|450652835|FG001|Overall Study|AE, serious fatal|1|||
125280602|NCT01519791|450652834|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
125280603|NCT01519791|450652835|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
125280604|NCT01519791|450652834|FG000|Overall Study|AE, non-serious non-fatal|12|||
125280605|NCT01519791|450652835|FG001|Overall Study|AE, non-serious non-fatal|31|||
125280606|NCT01519791|450652834|FG000|Overall Study|Withdrawal by Subject|15|||
125280607|NCT01519791|450652835|FG001|Overall Study|Withdrawal by Subject|37|||
125280608|NCT01519791|450652834|FG000|Overall Study|Lost to Follow-up|6|||
125280609|NCT01519791|450652835|FG001|Overall Study|Lost to Follow-up|14|||
125280610|NCT00837265|450652836|FG000|Pilot Phase|Withdrawal by Subject|0|||
125280611|NCT00837265|450652837|FG001|Pilot Phase|Withdrawal by Subject|2|||
125280612|NCT00837265|450652838|FG002|Pilot Phase|Withdrawal by Subject|3|||
125280613|NCT00837265|450652839|FG003|Pilot Phase|Withdrawal by Subject|2|||
125280614|NCT00837265|450652840|FG004|Pilot Phase|Withdrawal by Subject|0|||
125280615|NCT00837265|450652841|FG005|Pilot Phase|Withdrawal by Subject|0|||
125280616|NCT00837265|450652842|FG006|Pilot Phase|Withdrawal by Subject|0|||
125280617|NCT00837265|450652836|FG000|Pilot Phase|Decision of the investigator|2|||
125280618|NCT00837265|450652837|FG001|Pilot Phase|Decision of the investigator|1|||
125280619|NCT00837265|450652838|FG002|Pilot Phase|Decision of the investigator|0|||
125280620|NCT00837265|450652839|FG003|Pilot Phase|Decision of the investigator|0|||
125280621|NCT00837265|450652840|FG004|Pilot Phase|Decision of the investigator|0|||
125280622|NCT00837265|450652841|FG005|Pilot Phase|Decision of the investigator|0|||
125280623|NCT00837265|450652842|FG006|Pilot Phase|Decision of the investigator|0|||
125280624|NCT00837265|450652836|FG000|Pilot Phase|Adverse Event|1|||
125280625|NCT00837265|450652837|FG001|Pilot Phase|Adverse Event|0|||
125280626|NCT00837265|450652838|FG002|Pilot Phase|Adverse Event|0|||
125280627|NCT00837265|450652839|FG003|Pilot Phase|Adverse Event|0|||
125280628|NCT00837265|450652840|FG004|Pilot Phase|Adverse Event|0|||
125280629|NCT00837265|450652841|FG005|Pilot Phase|Adverse Event|0|||
125280630|NCT00837265|450652842|FG006|Pilot Phase|Adverse Event|0|||
125280631|NCT00837265|450652836|FG000|Pilot Phase|Disease progression|0|||
125280632|NCT00837265|450652837|FG001|Pilot Phase|Disease progression|0|||
125280633|NCT00837265|450652838|FG002|Pilot Phase|Disease progression|0|||
125280634|NCT00837265|450652839|FG003|Pilot Phase|Disease progression|1|||
125280635|NCT00837265|450652840|FG004|Pilot Phase|Disease progression|0|||
124781809|NCT01396057|448831174|FG001|Overall Study|Consent withdrawn|2|||
124781810|NCT03037580|448831177|FG000|Overall Study|Withdrawal by Subject|3|||
125280636|NCT00837265|450652841|FG005|Pilot Phase|Disease progression|0|||
125280637|NCT00837265|450652842|FG006|Pilot Phase|Disease progression|0|||
124781811|NCT03037580|448831178|FG001|Overall Study|Withdrawal by Subject|0|||
124781812|NCT03037580|448831177|FG000|Overall Study|Adverse Event|1|||
124781813|NCT03037580|448831178|FG001|Overall Study|Adverse Event|0|||
125280638|NCT00837265|450652836|FG000|Pilot Phase|Participant left the city|0|||
125280639|NCT00837265|450652837|FG001|Pilot Phase|Participant left the city|0|||
125280640|NCT00837265|450652838|FG002|Pilot Phase|Participant left the city|0|||
125280641|NCT00837265|450652839|FG003|Pilot Phase|Participant left the city|1|||
125280642|NCT00837265|450652840|FG004|Pilot Phase|Participant left the city|0|||
125280643|NCT00837265|450652841|FG005|Pilot Phase|Participant left the city|0|||
125280644|NCT00837265|450652842|FG006|Pilot Phase|Participant left the city|0|||
125280645|NCT00837265|450652836|FG000|Main Phase|Withdrawal by Subject|0|||
125280646|NCT00837265|450652837|FG001|Main Phase|Withdrawal by Subject|0|||
125280647|NCT00837265|450652838|FG002|Main Phase|Withdrawal by Subject|0|||
125280648|NCT00837265|450652839|FG003|Main Phase|Withdrawal by Subject|0|||
125280649|NCT00837265|450652840|FG004|Main Phase|Withdrawal by Subject|4|||
125280650|NCT00837265|450652841|FG005|Main Phase|Withdrawal by Subject|2|||
125280651|NCT00837265|450652842|FG006|Main Phase|Withdrawal by Subject|1|||
125280652|NCT00837265|450652836|FG000|Main Phase|Decision of the investigator|0|||
125280653|NCT00837265|450652837|FG001|Main Phase|Decision of the investigator|0|||
125280654|NCT00837265|450652838|FG002|Main Phase|Decision of the investigator|0|||
125280655|NCT00837265|450652839|FG003|Main Phase|Decision of the investigator|0|||
125280656|NCT00837265|450652840|FG004|Main Phase|Decision of the investigator|0|||
125280657|NCT00837265|450652841|FG005|Main Phase|Decision of the investigator|2|||
125280658|NCT00837265|450652842|FG006|Main Phase|Decision of the investigator|1|||
125280659|NCT00837265|450652836|FG000|Main Phase|Adverse Event|0|||
125280660|NCT00837265|450652837|FG001|Main Phase|Adverse Event|0|||
125280661|NCT00837265|450652838|FG002|Main Phase|Adverse Event|0|||
125280662|NCT00837265|450652839|FG003|Main Phase|Adverse Event|0|||
125280663|NCT00837265|450652840|FG004|Main Phase|Adverse Event|0|||
125280664|NCT00837265|450652841|FG005|Main Phase|Adverse Event|1|||
125280665|NCT00837265|450652842|FG006|Main Phase|Adverse Event|0|||
125280666|NCT00837265|450652836|FG000|Main Phase|Death|0|||
125280667|NCT00837265|450652837|FG001|Main Phase|Death|0|||
125280668|NCT00837265|450652838|FG002|Main Phase|Death|0|||
125280669|NCT00837265|450652839|FG003|Main Phase|Death|0|||
125280670|NCT00837265|450652840|FG004|Main Phase|Death|2|||
125280671|NCT00837265|450652841|FG005|Main Phase|Death|0|||
125280672|NCT00837265|450652842|FG006|Main Phase|Death|1|||
125280673|NCT00837265|450652836|FG000|Main Phase|Lost to Follow-up|0|||
125280674|NCT00837265|450652837|FG001|Main Phase|Lost to Follow-up|0|||
125280675|NCT00837265|450652838|FG002|Main Phase|Lost to Follow-up|0|||
125280676|NCT00837265|450652839|FG003|Main Phase|Lost to Follow-up|0|||
125280677|NCT00837265|450652840|FG004|Main Phase|Lost to Follow-up|1|||
125280678|NCT00837265|450652841|FG005|Main Phase|Lost to Follow-up|0|||
125280679|NCT00837265|450652842|FG006|Main Phase|Lost to Follow-up|0|||
125280680|NCT00837265|450652836|FG000|Main Phase|Principal investigator resignation|0|||
125280681|NCT00837265|450652837|FG001|Main Phase|Principal investigator resignation|0|||
125280682|NCT00837265|450652838|FG002|Main Phase|Principal investigator resignation|0|||
125280683|NCT00837265|450652839|FG003|Main Phase|Principal investigator resignation|0|||
125280684|NCT00837265|450652840|FG004|Main Phase|Principal investigator resignation|2|||
125280685|NCT00837265|450652841|FG005|Main Phase|Principal investigator resignation|0|||
125280686|NCT00837265|450652842|FG006|Main Phase|Principal investigator resignation|0|||
125280687|NCT00837265|450652836|FG000|Main Phase|Participant's personal reason|0|||
125280688|NCT00837265|450652837|FG001|Main Phase|Participant's personal reason|0|||
125280689|NCT00837265|450652838|FG002|Main Phase|Participant's personal reason|0|||
125280690|NCT00837265|450652839|FG003|Main Phase|Participant's personal reason|0|||
125280691|NCT00837265|450652840|FG004|Main Phase|Participant's personal reason|1|||
125280692|NCT00837265|450652841|FG005|Main Phase|Participant's personal reason|0|||
125280693|NCT00837265|450652842|FG006|Main Phase|Participant's personal reason|0|||
125280694|NCT01289353|450652843|FG000|Overall Study|Lost to Follow-up|2|||
125280695|NCT02226562|450652844|FG000|Overall Study|Lost to Follow-up|0|||
125280696|NCT02226562|450652845|FG001|Overall Study|Lost to Follow-up|1|||
125280697|NCT01474772|450652847|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
125280698|NCT01474772|450652848|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
125280699|NCT01474772|450652847|FG000|Period 1|AE not Related to Study Drug|1|||
125280700|NCT01474772|450652848|FG001|Period 1|AE not Related to Study Drug|0|||
124781814|NCT03037580|448831177|FG000|Overall Study|Study Terminated by Sponsor|12|||
125280701|NCT01474772|450652847|FG000|Period 1|Withdrawal by Subject|3|||
125280702|NCT01474772|450652848|FG001|Period 1|Withdrawal by Subject|1|||
125280703|NCT01474772|450652847|FG000|Period 1|Lost to Follow-up|1|||
125280704|NCT01474772|450652848|FG001|Period 1|Lost to Follow-up|0|||
125280705|NCT01474772|450652847|FG000|Period 1|Reason not Specified|1|||
125280706|NCT01474772|450652848|FG001|Period 1|Reason not Specified|1|||
125280707|NCT01474772|450652847|FG000|Washout|AE not Related to Study Drug|2|||
125280708|NCT01474772|450652848|FG001|Washout|AE not Related to Study Drug|0|||
125280709|NCT01474772|450652847|FG000|Washout|Withdrawal by Subject|1|||
125280710|NCT01474772|450652848|FG001|Washout|Withdrawal by Subject|0|||
125280711|NCT01474772|450652847|FG000|Washout|Lost to Follow-up|0|||
125280712|NCT01474772|450652848|FG001|Washout|Lost to Follow-up|1|||
125280713|NCT01474772|450652847|FG000|Washout|Reason not Specified|0|||
125280714|NCT01474772|450652848|FG001|Washout|Reason not Specified|1|||
125280715|NCT01474772|450652847|FG000|Period 2|Death|0|||
125280716|NCT01474772|450652848|FG001|Period 2|Death|1|||
125280717|NCT01474772|450652847|FG000|Period 2|AE Related to Study Drug|0|||
125280718|NCT01474772|450652848|FG001|Period 2|AE Related to Study Drug|1|||
125280719|NCT01474772|450652847|FG000|Period 2|AE not Related to Study Drug|4|||
125280720|NCT01474772|450652848|FG001|Period 2|AE not Related to Study Drug|1|||
125280721|NCT01474772|450652847|FG000|Period 2|Lack of Efficacy|1|||
125280722|NCT01474772|450652848|FG001|Period 2|Lack of Efficacy|0|||
125280723|NCT01474772|450652847|FG000|Period 2|Withdrawal by Subject|3|||
125280724|NCT01474772|450652848|FG001|Period 2|Withdrawal by Subject|4|||
125280725|NCT01474772|450652847|FG000|Period 2|Lost to Follow-up|1|||
125280726|NCT01474772|450652848|FG001|Period 2|Lost to Follow-up|1|||
125280727|NCT01474772|450652847|FG000|Period 2|Reason not Specified|0|||
124781815|NCT03037580|448831178|FG001|Overall Study|Study Terminated by Sponsor|15|||
124781816|NCT03037580|448831177|FG000|Overall Study|Death|0|||
124781817|NCT03037580|448831178|FG001|Overall Study|Death|1|||
124781818|NCT02087423|448831179|FG000|Overall Study|Withdrawal by Subject|20|||
124781819|NCT02087423|448831180|FG001|Overall Study|Withdrawal by Subject|20|||
124781820|NCT02087423|448831181|FG002|Overall Study|Withdrawal by Subject|3|||
124781821|NCT02087423|448831179|FG000|Overall Study|Death|68|||
124781822|NCT02087423|448831180|FG001|Overall Study|Death|207|||
124781823|NCT02087423|448831181|FG002|Overall Study|Death|40|||
125280728|NCT01474772|450652848|FG001|Period 2|Reason not Specified|2|||
125280729|NCT01474772|450652847|FG000|Follow-up|AE not Related to Study Drug|0|||
125280730|NCT01474772|450652848|FG001|Follow-up|AE not Related to Study Drug|1|||
125280731|NCT00223808|450652849|FG000|Overall Study|<5 hrs therapy before discharge|3|||
125280732|NCT00223808|450652850|FG001|Overall Study|<5 hrs therapy before discharge|5|||
125280733|NCT00223808|450652851|FG002|Overall Study|<5 hrs therapy before discharge|5|||
125280734|NCT00967694|450652854|FG000|Overall Study|Withdrawal by Subject|6|||
125280735|NCT02321319|450652855|FG000|Overall Study|Product discontinued|5|||
125280736|NCT00152477|450652856|FG000|Chemotherapy Period|Adverse Event|9|||
125280737|NCT00152477|450652857|FG001|Chemotherapy Period|Adverse Event|4|||
125280738|NCT00152477|450652858|FG002|Chemotherapy Period|Adverse Event|5|||
125280739|NCT00152477|450652856|FG000|Chemotherapy Period|Death|1|||
124781824|NCT02087423|448831179|FG000|Overall Study|Lost to Follow-up|0|||
125280740|NCT00152477|450652857|FG001|Chemotherapy Period|Death|3|||
124781825|NCT02087423|448831180|FG001|Overall Study|Lost to Follow-up|2|||
125280741|NCT00152477|450652858|FG002|Chemotherapy Period|Death|3|||
125280742|NCT00152477|450652856|FG000|Chemotherapy Period|Lack of Efficacy|4|||
125280743|NCT00152477|450652857|FG001|Chemotherapy Period|Lack of Efficacy|5|||
125280744|NCT00152477|450652858|FG002|Chemotherapy Period|Lack of Efficacy|6|||
125280745|NCT00152477|450652856|FG000|Chemotherapy Period|Lost to Follow-up|1|||
125280746|NCT00152477|450652857|FG001|Chemotherapy Period|Lost to Follow-up|0|||
125280747|NCT00152477|450652858|FG002|Chemotherapy Period|Lost to Follow-up|1|||
125280748|NCT00152477|450652856|FG000|Chemotherapy Period|Protocol Violation|1|||
124781826|NCT02087423|448831181|FG002|Overall Study|Lost to Follow-up|0|||
124781827|NCT02087423|448831179|FG000|Overall Study|Terminated from study at final DCO|23|||
125280749|NCT00152477|450652857|FG001|Chemotherapy Period|Protocol Violation|1|||
125280750|NCT00152477|450652858|FG002|Chemotherapy Period|Protocol Violation|0|||
125280751|NCT00152477|450652856|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
125280752|NCT00152477|450652857|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
125280753|NCT00152477|450652858|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
125280754|NCT00152477|450652856|FG000|Chemotherapy Period|Progression of Disease|6|||
125280755|NCT00152477|450652857|FG001|Chemotherapy Period|Progression of Disease|8|||
125280756|NCT00152477|450652858|FG002|Chemotherapy Period|Progression of Disease|4|||
125280757|NCT00152477|450652856|FG000|Chemotherapy Period|Investigator decision|0|||
125280758|NCT00152477|450652857|FG001|Chemotherapy Period|Investigator decision|0|||
125280759|NCT00152477|450652858|FG002|Chemotherapy Period|Investigator decision|1|||
125280760|NCT00152477|450652856|FG000|Chemotherapy Period|Patient condition worsened|1|||
125280761|NCT00152477|450652857|FG001|Chemotherapy Period|Patient condition worsened|0|||
125280762|NCT00152477|450652858|FG002|Chemotherapy Period|Patient condition worsened|0|||
125280763|NCT00152477|450652856|FG000|Monotherapy Period|Adverse Event|1|||
125280764|NCT00152477|450652857|FG001|Monotherapy Period|Adverse Event|0|||
125280765|NCT00152477|450652858|FG002|Monotherapy Period|Adverse Event|5|||
125280766|NCT00152477|450652856|FG000|Monotherapy Period|Death|2|||
125280767|NCT00152477|450652857|FG001|Monotherapy Period|Death|0|||
125280768|NCT00152477|450652858|FG002|Monotherapy Period|Death|1|||
125280769|NCT00152477|450652856|FG000|Monotherapy Period|Lack of Efficacy|7|||
125280770|NCT00152477|450652857|FG001|Monotherapy Period|Lack of Efficacy|16|||
125280771|NCT00152477|450652858|FG002|Monotherapy Period|Lack of Efficacy|10|||
125280772|NCT00152477|450652856|FG000|Monotherapy Period|Protocol Violation|0|||
125280773|NCT00152477|450652857|FG001|Monotherapy Period|Protocol Violation|1|||
125280774|NCT00152477|450652858|FG002|Monotherapy Period|Protocol Violation|0|||
125280775|NCT00152477|450652856|FG000|Monotherapy Period|Withdrawal by Subject|0|||
125280776|NCT00152477|450652857|FG001|Monotherapy Period|Withdrawal by Subject|0|||
125280777|NCT00152477|450652858|FG002|Monotherapy Period|Withdrawal by Subject|4|||
125280778|NCT00152477|450652856|FG000|Monotherapy Period|Progression of Disease|5|||
125280779|NCT00152477|450652857|FG001|Monotherapy Period|Progression of Disease|11|||
125280780|NCT00152477|450652858|FG002|Monotherapy Period|Progression of Disease|12|||
125280781|NCT00152477|450652856|FG000|Monotherapy Period|Patient decision|0|||
125280782|NCT00152477|450652857|FG001|Monotherapy Period|Patient decision|1|||
125280783|NCT00152477|450652858|FG002|Monotherapy Period|Patient decision|1|||
125280784|NCT00152477|450652856|FG000|Monotherapy Period|Study personel decision|0|||
125280785|NCT00152477|450652857|FG001|Monotherapy Period|Study personel decision|0|||
125280786|NCT00152477|450652858|FG002|Monotherapy Period|Study personel decision|1|||
125280787|NCT00960011|450652859|FG000|Overall Study|Death|5|||
125280788|NCT00960011|450652860|FG001|Overall Study|Death|0|||
125280789|NCT00960011|450652859|FG000|Overall Study|Lost to Follow-up|6|||
125280790|NCT00960011|450652860|FG001|Overall Study|Lost to Follow-up|2|||
125280791|NCT01626118|450652866|FG000|Overall Study|Lack of Efficacy|1|||
125280792|NCT01626118|450652867|FG001|Overall Study|Lack of Efficacy|0|||
125280793|NCT01626118|450652868|FG002|Overall Study|Lack of Efficacy|1|||
125280794|NCT01626118|450652869|FG003|Overall Study|Lack of Efficacy|3|||
125280795|NCT01626118|450652866|FG000|Overall Study|Lost to Follow-up|1|||
125280796|NCT01626118|450652867|FG001|Overall Study|Lost to Follow-up|0|||
125280797|NCT01626118|450652868|FG002|Overall Study|Lost to Follow-up|0|||
125280798|NCT01626118|450652869|FG003|Overall Study|Lost to Follow-up|0|||
125280799|NCT01626118|450652866|FG000|Overall Study|Adverse Event|0|||
125280800|NCT01626118|450652867|FG001|Overall Study|Adverse Event|1|||
125280801|NCT01626118|450652868|FG002|Overall Study|Adverse Event|1|||
125280802|NCT01626118|450652869|FG003|Overall Study|Adverse Event|0|||
125280803|NCT01626118|450652866|FG000|Overall Study|Investigator Decision|0|||
125280804|NCT01626118|450652867|FG001|Overall Study|Investigator Decision|1|||
125280805|NCT01626118|450652868|FG002|Overall Study|Investigator Decision|0|||
125280806|NCT01626118|450652869|FG003|Overall Study|Investigator Decision|0|||
125280807|NCT00888329|450652870|FG000|Overall Study|Physician Decision|6|||
125280808|NCT00888329|450652871|FG001|Overall Study|Physician Decision|9|||
125280809|NCT00939029|450652872|FG000|Overall Study|Withdrawal by Subject|3|||
125280810|NCT00939029|450652873|FG001|Overall Study|Withdrawal by Subject|7|||
125280811|NCT00939029|450652872|FG000|Overall Study|Lost to Follow-up|3|||
125280812|NCT00939029|450652873|FG001|Overall Study|Lost to Follow-up|4|||
125280813|NCT00939029|450652872|FG000|Overall Study|Adverse Event|0|||
125280814|NCT00939029|450652873|FG001|Overall Study|Adverse Event|1|||
125280815|NCT06003777|450652874|FG000|Period 1|Adverse Event|0|||
125280816|NCT06003777|450652875|FG001|Period 1|Adverse Event|0|||
125280817|NCT06003777|450652876|FG002|Period 1|Adverse Event|1|||
125280818|NCT06003777|450652877|FG003|Period 1|Adverse Event|0|||
125280819|NCT06003777|450652878|FG004|Period 1|Adverse Event|0|||
125280820|NCT06003777|450652879|FG005|Period 1|Adverse Event|0|||
125280821|NCT06003777|450652880|FG006|Period 1|Adverse Event|0|||
125280822|NCT06003777|450652881|FG007|Period 1|Adverse Event|0|||
125280823|NCT06003777|450652882|FG008|Period 1|Adverse Event|0|||
125280824|NCT06003777|450652883|FG009|Period 1|Adverse Event|0|||
125280825|NCT06003777|450652884|FG010|Period 1|Adverse Event|0|||
125280826|NCT06003777|450652885|FG011|Period 1|Adverse Event|0|||
125280827|NCT06003777|450652874|FG000|Period 1|Withdrawal by Subject|0|||
125280828|NCT06003777|450652875|FG001|Period 1|Withdrawal by Subject|0|||
125280829|NCT06003777|450652876|FG002|Period 1|Withdrawal by Subject|0|||
125280830|NCT06003777|450652877|FG003|Period 1|Withdrawal by Subject|0|||
125280831|NCT06003777|450652878|FG004|Period 1|Withdrawal by Subject|1|||
125280832|NCT06003777|450652879|FG005|Period 1|Withdrawal by Subject|0|||
125280833|NCT06003777|450652880|FG006|Period 1|Withdrawal by Subject|0|||
125280834|NCT06003777|450652881|FG007|Period 1|Withdrawal by Subject|0|||
125280835|NCT06003777|450652882|FG008|Period 1|Withdrawal by Subject|0|||
125280836|NCT06003777|450652883|FG009|Period 1|Withdrawal by Subject|0|||
125280837|NCT06003777|450652884|FG010|Period 1|Withdrawal by Subject|0|||
125280838|NCT06003777|450652885|FG011|Period 1|Withdrawal by Subject|0|||
125280839|NCT06003777|450652874|FG000|Period 2|Withdrawal by Subject|0|||
125280840|NCT06003777|450652875|FG001|Period 2|Withdrawal by Subject|0|||
125280841|NCT06003777|450652876|FG002|Period 2|Withdrawal by Subject|0|||
125280842|NCT06003777|450652877|FG003|Period 2|Withdrawal by Subject|0|||
125280843|NCT06003777|450652878|FG004|Period 2|Withdrawal by Subject|0|||
125280844|NCT06003777|450652879|FG005|Period 2|Withdrawal by Subject|0|||
125280845|NCT06003777|450652880|FG006|Period 2|Withdrawal by Subject|0|||
125280846|NCT06003777|450652881|FG007|Period 2|Withdrawal by Subject|0|||
125280847|NCT06003777|450652882|FG008|Period 2|Withdrawal by Subject|1|||
125280848|NCT06003777|450652883|FG009|Period 2|Withdrawal by Subject|0|||
125280849|NCT06003777|450652884|FG010|Period 2|Withdrawal by Subject|0|||
125280850|NCT06003777|450652885|FG011|Period 2|Withdrawal by Subject|0|||
125280851|NCT06003777|450652874|FG000|Period 3|Adverse Event|0|||
125280852|NCT06003777|450652875|FG001|Period 3|Adverse Event|0|||
125280853|NCT06003777|450652876|FG002|Period 3|Adverse Event|0|||
125280854|NCT06003777|450652877|FG003|Period 3|Adverse Event|0|||
125280855|NCT06003777|450652878|FG004|Period 3|Adverse Event|0|||
125280856|NCT06003777|450652879|FG005|Period 3|Adverse Event|0|||
125280857|NCT06003777|450652880|FG006|Period 3|Adverse Event|1|||
125280858|NCT06003777|450652881|FG007|Period 3|Adverse Event|0|||
125280859|NCT06003777|450652882|FG008|Period 3|Adverse Event|0|||
125280860|NCT06003777|450652883|FG009|Period 3|Adverse Event|0|||
125280861|NCT06003777|450652884|FG010|Period 3|Adverse Event|0|||
125280862|NCT06003777|450652885|FG011|Period 3|Adverse Event|0|||
125280863|NCT06003777|450652874|FG000|Period 4|No longer met eligibility criteria|0|||
125280864|NCT06003777|450652875|FG001|Period 4|No longer met eligibility criteria|0|||
125280865|NCT06003777|450652876|FG002|Period 4|No longer met eligibility criteria|1|||
125280866|NCT06003777|450652877|FG003|Period 4|No longer met eligibility criteria|0|||
125280867|NCT06003777|450652878|FG004|Period 4|No longer met eligibility criteria|0|||
125280868|NCT06003777|450652879|FG005|Period 4|No longer met eligibility criteria|0|||
125280869|NCT06003777|450652880|FG006|Period 4|No longer met eligibility criteria|0|||
125280870|NCT06003777|450652881|FG007|Period 4|No longer met eligibility criteria|0|||
125280871|NCT06003777|450652882|FG008|Period 4|No longer met eligibility criteria|0|||
125280872|NCT06003777|450652883|FG009|Period 4|No longer met eligibility criteria|0|||
125280873|NCT06003777|450652884|FG010|Period 4|No longer met eligibility criteria|0|||
125280874|NCT06003777|450652885|FG011|Period 4|No longer met eligibility criteria|0|||
125280875|NCT06003777|450652874|FG000|Period 4|Withdrawal by Subject|0|||
125280876|NCT06003777|450652875|FG001|Period 4|Withdrawal by Subject|1|||
125280877|NCT06003777|450652876|FG002|Period 4|Withdrawal by Subject|0|||
125280878|NCT06003777|450652877|FG003|Period 4|Withdrawal by Subject|0|||
125280879|NCT06003777|450652878|FG004|Period 4|Withdrawal by Subject|0|||
125280880|NCT06003777|450652879|FG005|Period 4|Withdrawal by Subject|0|||
125280881|NCT06003777|450652880|FG006|Period 4|Withdrawal by Subject|0|||
125280882|NCT06003777|450652881|FG007|Period 4|Withdrawal by Subject|0|||
125280883|NCT06003777|450652882|FG008|Period 4|Withdrawal by Subject|0|||
125280884|NCT06003777|450652883|FG009|Period 4|Withdrawal by Subject|0|||
125280885|NCT06003777|450652884|FG010|Period 4|Withdrawal by Subject|0|||
125280886|NCT06003777|450652885|FG011|Period 4|Withdrawal by Subject|0|||
125280887|NCT01106651|450652886|FG000|Overall Study|Adverse Event|17|||
125280888|NCT01106651|450652887|FG001|Overall Study|Adverse Event|9|||
125280889|NCT01106651|450652888|FG002|Overall Study|Adverse Event|23|||
125280890|NCT01106651|450652886|FG000|Overall Study|Lost to Follow-up|8|||
125280891|NCT01106651|450652887|FG001|Overall Study|Lost to Follow-up|2|||
125280892|NCT01106651|450652888|FG002|Overall Study|Lost to Follow-up|6|||
125280893|NCT01106651|450652886|FG000|Overall Study|Physician Decision|4|||
125280894|NCT01106651|450652887|FG001|Overall Study|Physician Decision|3|||
125280895|NCT01106651|450652888|FG002|Overall Study|Physician Decision|1|||
125280896|NCT01106651|450652886|FG000|Overall Study|Protocol Violation|1|||
125280897|NCT01106651|450652887|FG001|Overall Study|Protocol Violation|2|||
125280898|NCT01106651|450652888|FG002|Overall Study|Protocol Violation|1|||
125280899|NCT01106651|450652886|FG000|Overall Study|Withdrawal by Subject|14|||
125280900|NCT01106651|450652887|FG001|Overall Study|Withdrawal by Subject|7|||
125280901|NCT01106651|450652888|FG002|Overall Study|Withdrawal by Subject|4|||
125280902|NCT01106651|450652886|FG000|Overall Study|Noncompliance with study drug|1|||
125280903|NCT01106651|450652887|FG001|Overall Study|Noncompliance with study drug|0|||
125280904|NCT01106651|450652888|FG002|Overall Study|Noncompliance with study drug|2|||
125280905|NCT01106651|450652886|FG000|Overall Study|Other|34|||
125280906|NCT01106651|450652887|FG001|Overall Study|Other|31|||
125280907|NCT01106651|450652888|FG002|Overall Study|Other|21|||
125280908|NCT01106651|450652886|FG000|Overall Study|Death|0|||
125280909|NCT01106651|450652887|FG001|Overall Study|Death|3|||
125280910|NCT01106651|450652888|FG002|Overall Study|Death|0|||
125280911|NCT00613327|450652892|FG000|Overall Study|Adverse Event|38|||
125280912|NCT00613327|450652892|FG000|Overall Study|Lost to Follow-up|8|||
125280913|NCT00613327|450652892|FG000|Overall Study|Withdrawal by Subject|6|||
125280914|NCT00613327|450652892|FG000|Overall Study|Protocol Violation|2|||
125280915|NCT00613327|450652892|FG000|Overall Study|Other|47|||
125280916|NCT00290771|450652897|FG000|Overall Study|Disease progression|95|||
125280917|NCT00290771|450652898|FG001|Overall Study|Disease progression|73|||
125280918|NCT00290771|450652897|FG000|Overall Study|Death|11|||
125280919|NCT00290771|450652898|FG001|Overall Study|Death|10|||
125280920|NCT00290771|450652897|FG000|Overall Study|Adverse Event|12|||
125280921|NCT00290771|450652898|FG001|Overall Study|Adverse Event|6|||
125280922|NCT00290771|450652897|FG000|Overall Study|Withdrawal by Subject|5|||
125280923|NCT00290771|450652898|FG001|Overall Study|Withdrawal by Subject|6|||
125280924|NCT00290771|450652897|FG000|Overall Study|Administrative problems|2|||
125280925|NCT00290771|450652898|FG001|Overall Study|Administrative problems|1|||
125280926|NCT00290771|450652897|FG000|Overall Study|Protocol Violation|2|||
125280927|NCT00290771|450652898|FG001|Overall Study|Protocol Violation|0|||
125280928|NCT00290771|450652897|FG000|Overall Study|Lost to Follow-up|0|||
125280929|NCT00290771|450652898|FG001|Overall Study|Lost to Follow-up|1|||
125280930|NCT03403361|450652902|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
125280931|NCT02487654|450652904|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
125280932|NCT02487654|450652905|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
125280933|NCT02487654|450652904|FG000|Overall Study|Withdrawal by Subject|3|||
125280934|NCT02487654|450652905|FG001|Overall Study|Withdrawal by Subject|7|||
125280935|NCT02247011|450652906|FG000|Overall Study|Poor quality of radiological results|125|||
125280936|NCT00656058|450652907|FG000|Overall Study|Withdrawal by Subject|2|||
125280937|NCT00656058|450652907|FG000|Overall Study|Withdrawal by Subject|4|||
125280938|NCT03718884|450652908|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
125280939|NCT03718884|450652909|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
125280940|NCT03718884|450652908|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
125280941|NCT03718884|450652909|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
125280942|NCT04700540|450652910|FG000|Overall Study|Withdrawal by Subject|12|||
125280943|NCT04700540|450652911|FG001|Overall Study|Withdrawal by Subject|8|||
125280944|NCT04700540|450652910|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
125280945|NCT04700540|450652911|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
125280946|NCT03515551|450652912|FG000|Overall Study|Death|4|||
125280947|NCT03515551|450652913|FG001|Overall Study|Death|1|||
125280948|NCT03515551|450652914|FG002|Overall Study|Death|2|||
125280949|NCT03515551|450652915|FG003|Overall Study|Death|2|||
125280950|NCT03515551|450652916|FG004|Overall Study|Death|2|||
125280951|NCT03515551|450652917|FG005|Overall Study|Death|4|||
125280952|NCT03515551|450652918|FG006|Overall Study|Death|1|||
125280953|NCT03515551|450652912|FG000|Overall Study|Lost to Follow-up|0|||
125280954|NCT03515551|450652913|FG001|Overall Study|Lost to Follow-up|0|||
125280955|NCT03515551|450652914|FG002|Overall Study|Lost to Follow-up|1|||
125280956|NCT03515551|450652915|FG003|Overall Study|Lost to Follow-up|0|||
125280957|NCT03515551|450652916|FG004|Overall Study|Lost to Follow-up|0|||
125280958|NCT03515551|450652917|FG005|Overall Study|Lost to Follow-up|0|||
125280959|NCT03515551|450652918|FG006|Overall Study|Lost to Follow-up|0|||
125280960|NCT03515551|450652912|FG000|Overall Study|Withdrawal by Subject|0|||
125280961|NCT03515551|450652913|FG001|Overall Study|Withdrawal by Subject|1|||
125280962|NCT03515551|450652914|FG002|Overall Study|Withdrawal by Subject|0|||
125280963|NCT03515551|450652915|FG003|Overall Study|Withdrawal by Subject|0|||
125280964|NCT03515551|450652916|FG004|Overall Study|Withdrawal by Subject|0|||
125280965|NCT03515551|450652917|FG005|Overall Study|Withdrawal by Subject|0|||
125280966|NCT03515551|450652918|FG006|Overall Study|Withdrawal by Subject|1|||
125280967|NCT03515551|450652912|FG000|Overall Study|Study ended by sponsor|0|||
125280968|NCT03515551|450652913|FG001|Overall Study|Study ended by sponsor|0|||
125280969|NCT03515551|450652914|FG002|Overall Study|Study ended by sponsor|2|||
125280970|NCT03515551|450652915|FG003|Overall Study|Study ended by sponsor|1|||
125280971|NCT03515551|450652916|FG004|Overall Study|Study ended by sponsor|3|||
125280972|NCT03515551|450652917|FG005|Overall Study|Study ended by sponsor|0|||
125280973|NCT03515551|450652918|FG006|Overall Study|Study ended by sponsor|3|||
125280974|NCT03515551|450652912|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
125280975|NCT03515551|450652913|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
125280976|NCT03515551|450652914|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
125280977|NCT03515551|450652915|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
125280978|NCT03515551|450652916|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
125280979|NCT03515551|450652917|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
125280980|NCT03515551|450652918|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
125280981|NCT02265536|450652932|FG000|Overall Study|Adverse Event|1|||
125280982|NCT02265536|450652933|FG001|Overall Study|Adverse Event|0|||
125280983|NCT02265536|450652934|FG002|Overall Study|Adverse Event|0|||
125280984|NCT02265536|450652935|FG003|Overall Study|Adverse Event|0|||
125280985|NCT02265536|450652936|FG004|Overall Study|Adverse Event|1|||
125280986|NCT02265536|450652937|FG005|Overall Study|Adverse Event|0|||
125280987|NCT02265536|450652932|FG000|Overall Study|Physician Decision|0|||
125280988|NCT02265536|450652933|FG001|Overall Study|Physician Decision|0|||
125280989|NCT02265536|450652934|FG002|Overall Study|Physician Decision|0|||
125280990|NCT02265536|450652935|FG003|Overall Study|Physician Decision|0|||
124781828|NCT02087423|448831180|FG001|Overall Study|Terminated from study at final DCO|36|||
124781829|NCT02087423|448831181|FG002|Overall Study|Terminated from study at final DCO|25|||
125280991|NCT02265536|450652936|FG004|Overall Study|Physician Decision|2|||
125280992|NCT02265536|450652937|FG005|Overall Study|Physician Decision|0|||
125280993|NCT02265536|450652932|FG000|Overall Study|Withdrawal by Subject|0|||
125280994|NCT02265536|450652933|FG001|Overall Study|Withdrawal by Subject|3|||
125280995|NCT02265536|450652934|FG002|Overall Study|Withdrawal by Subject|0|||
125280996|NCT02265536|450652935|FG003|Overall Study|Withdrawal by Subject|0|||
125280997|NCT02265536|450652936|FG004|Overall Study|Withdrawal by Subject|0|||
125280998|NCT02265536|450652937|FG005|Overall Study|Withdrawal by Subject|0|||
125280999|NCT03268954|450652938|FG000|Overall Study|Ongoing|23|||
125281000|NCT03268954|450652939|FG001|Overall Study|Ongoing|31|||
125281001|NCT03268954|450652938|FG000|Overall Study|Adverse Event|53|||
125281002|NCT03268954|450652939|FG001|Overall Study|Adverse Event|62|||
125281003|NCT03268954|450652938|FG000|Overall Study|Withdrawal by Subject|25|||
125281004|NCT03268954|450652939|FG001|Overall Study|Withdrawal by Subject|16|||
125281005|NCT03268954|450652938|FG000|Overall Study|Progressive Disease|61|||
125281006|NCT03268954|450652939|FG001|Overall Study|Progressive Disease|48|||
125281007|NCT03268954|450652938|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
125281008|NCT03268954|450652939|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
125281009|NCT03268954|450652938|FG000|Overall Study|Reason not Specified|40|||
125281010|NCT03268954|450652939|FG001|Overall Study|Reason not Specified|40|||
125281011|NCT03802630|450652940|FG000|Overall Study|Study terminated by sponsor|130|||
125281012|NCT03802630|450652941|FG001|Overall Study|Study terminated by sponsor|134|||
125281013|NCT03802630|450652940|FG000|Overall Study|Subject decision|16|||
125281014|NCT03802630|450652941|FG001|Overall Study|Subject decision|9|||
125281015|NCT03802630|450652940|FG000|Overall Study|Adverse Event|3|||
125281016|NCT03802630|450652941|FG001|Overall Study|Adverse Event|1|||
125281017|NCT03802630|450652940|FG000|Overall Study|Lost to Follow-up|2|||
125281018|NCT03802630|450652941|FG001|Overall Study|Lost to Follow-up|2|||
125281019|NCT03802630|450652940|FG000|Overall Study|Physician Decision|2|||
125281020|NCT03802630|450652941|FG001|Overall Study|Physician Decision|0|||
125281021|NCT03802630|450652940|FG000|Overall Study|Death|0|||
125281022|NCT03802630|450652941|FG001|Overall Study|Death|2|||
125281023|NCT05005013|450652942|FG000|Overall Study|Withdrawal by Subject|5|||
125281024|NCT05005013|450652943|FG001|Overall Study|Withdrawal by Subject|1|||
125281025|NCT05005013|450652942|FG000|Overall Study|Lost to Follow-up|3|||
125281026|NCT05005013|450652943|FG001|Overall Study|Lost to Follow-up|1|||
125281027|NCT05005013|450652942|FG000|Overall Study|Ineligibility|1|||
125281028|NCT05005013|450652943|FG001|Overall Study|Ineligibility|1|||
125281029|NCT06099223|450652944|FG000|Overall Study|Preoperative surveys missed|0|||
125281030|NCT06099223|450652945|FG001|Overall Study|Preoperative surveys missed|1|||
125281031|NCT01802580|450652948|FG000|Overall Study|Physician Decision|1|||
125281032|NCT01802580|450652949|FG001|Overall Study|Physician Decision|0|||
125281033|NCT01802580|450652948|FG000|Overall Study|Protocol Violation|2|||
125281034|NCT01802580|450652949|FG001|Overall Study|Protocol Violation|0|||
125281035|NCT01802580|450652948|FG000|Overall Study|Withdrawal by Subject|5|||
125281036|NCT01802580|450652949|FG001|Overall Study|Withdrawal by Subject|6|||
125281037|NCT01802580|450652948|FG000|Overall Study|Other|1|||
125281038|NCT01802580|450652949|FG001|Overall Study|Other|3|||
125281039|NCT01802580|450652948|FG000|Overall Study|Lack of Efficacy|0|||
125281040|NCT01802580|450652949|FG001|Overall Study|Lack of Efficacy|2|||
125281041|NCT00211757|450652950|FG000|Overall Study|Withdrawal by Subject|1|||
125281042|NCT00211757|450652951|FG001|Overall Study|Withdrawal by Subject|1|||
125281043|NCT00211757|450652950|FG000|Overall Study|Lack of Efficacy|0|||
125281044|NCT00211757|450652951|FG001|Overall Study|Lack of Efficacy|1|||
125281045|NCT04091581|450652953|FG000|Overall Study|Lost to Follow-up|0|||
125281046|NCT04091581|450652954|FG001|Overall Study|Lost to Follow-up|1|||
125281047|NCT03724981|450654881|FG000|First Device|Protocol Violation|1|||
125281048|NCT03724981|450654882|FG001|First Device|Protocol Violation|1|||
125281049|NCT04439539|450654886|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
125281050|NCT04439539|450654887|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
125281051|NCT04439539|450654888|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
125281052|NCT04439539|450654886|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
125281053|NCT04439539|450654887|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
125281054|NCT04439539|450654888|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
125281055|NCT04439539|450654886|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
125281056|NCT04439539|450654887|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
125281057|NCT04439539|450654888|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
125281058|NCT03596047|450654889|FG000|Overall Study|Withdrawal by Subject|7|||
125281059|NCT03596047|450654890|FG001|Overall Study|Withdrawal by Subject|4|||
125281060|NCT03596047|450654889|FG000|Overall Study|Lost to Follow-up|0|||
125281061|NCT03596047|450654890|FG001|Overall Study|Lost to Follow-up|2|||
125281062|NCT03727646|450654891|FG000|Overall Study|Adverse Event|1|||
125281063|NCT03727646|450654892|FG001|Overall Study|Adverse Event|0|||
125281064|NCT02290691|450654895|FG000|Overall Study|Noncompliance|0|||
125281065|NCT02290691|450654896|FG001|Overall Study|Noncompliance|1|||
125281066|NCT02290691|450654895|FG000|Overall Study|Withdrawal by Subject|1|||
125281067|NCT02290691|450654896|FG001|Overall Study|Withdrawal by Subject|1|||
125281068|NCT02290691|450654895|FG000|Overall Study|Lost to Follow-up|7|||
125281069|NCT02290691|450654896|FG001|Overall Study|Lost to Follow-up|7|||
125281070|NCT00923975|450654901|FG000|Overall Study|Did not meet inclusion criteria|1|||
125281071|NCT01328535|450654902|FG000|Overall Study|Ineligible|1|||
125281072|NCT01005316|450654903|FG000|Overall Study|Adverse Event|0|||
125281073|NCT01005316|450654904|FG001|Overall Study|Adverse Event|0|||
125281074|NCT01005316|450654905|FG002|Overall Study|Adverse Event|0|||
125281075|NCT01005316|450654906|FG003|Overall Study|Adverse Event|1|||
125281076|NCT01005316|450654903|FG000|Overall Study|Death|20|||
125281077|NCT01005316|450654904|FG001|Overall Study|Death|5|||
125281078|NCT01005316|450654905|FG002|Overall Study|Death|1|||
125281079|NCT01005316|450654906|FG003|Overall Study|Death|15|||
125281080|NCT01005316|450654903|FG000|Overall Study|Study Termination|5|||
125281081|NCT01005316|450654904|FG001|Overall Study|Study Termination|63|||
125281082|NCT01005316|450654905|FG002|Overall Study|Study Termination|9|||
125281083|NCT01005316|450654906|FG003|Overall Study|Study Termination|85|||
125281084|NCT01005316|450654903|FG000|Overall Study|Lost to Follow-up|1|||
125281085|NCT01005316|450654904|FG001|Overall Study|Lost to Follow-up|3|||
125281086|NCT01005316|450654905|FG002|Overall Study|Lost to Follow-up|0|||
125281087|NCT01005316|450654906|FG003|Overall Study|Lost to Follow-up|2|||
125281088|NCT01005316|450654903|FG000|Overall Study|Physician Decision|6|||
125281089|NCT01005316|450654904|FG001|Overall Study|Physician Decision|0|||
125281090|NCT01005316|450654905|FG002|Overall Study|Physician Decision|0|||
125281091|NCT01005316|450654906|FG003|Overall Study|Physician Decision|0|||
125281092|NCT01005316|450654903|FG000|Overall Study|Sponsor Decision|6|||
125281093|NCT01005316|450654904|FG001|Overall Study|Sponsor Decision|3|||
125281094|NCT01005316|450654905|FG002|Overall Study|Sponsor Decision|0|||
125281095|NCT01005316|450654906|FG003|Overall Study|Sponsor Decision|0|||
125281096|NCT01005316|450654903|FG000|Overall Study|Withdrawal by Subject|1|||
125281097|NCT01005316|450654904|FG001|Overall Study|Withdrawal by Subject|1|||
125281098|NCT01005316|450654905|FG002|Overall Study|Withdrawal by Subject|0|||
125281099|NCT01005316|450654906|FG003|Overall Study|Withdrawal by Subject|2|||
125281100|NCT01005316|450654903|FG000|Overall Study|Consented to Another Study|2|||
125281101|NCT01005316|450654904|FG001|Overall Study|Consented to Another Study|0|||
125281102|NCT01005316|450654905|FG002|Overall Study|Consented to Another Study|0|||
125281103|NCT01005316|450654906|FG003|Overall Study|Consented to Another Study|0|||
125281104|NCT01005316|450654903|FG000|Overall Study|Delisted|8|||
125281105|NCT01005316|450654904|FG001|Overall Study|Delisted|0|||
125281106|NCT01005316|450654905|FG002|Overall Study|Delisted|0|||
125281107|NCT01005316|450654906|FG003|Overall Study|Delisted|0|||
125281108|NCT01005316|450654903|FG000|Overall Study|Transferred Care|1|||
125281109|NCT01005316|450654904|FG001|Overall Study|Transferred Care|0|||
125281110|NCT01005316|450654905|FG002|Overall Study|Transferred Care|1|||
125281111|NCT01005316|450654906|FG003|Overall Study|Transferred Care|3|||
125281112|NCT01005316|450654903|FG000|Overall Study|Retransplanted|0|||
125281113|NCT01005316|450654904|FG001|Overall Study|Retransplanted|1|||
125281114|NCT01005316|450654905|FG002|Overall Study|Retransplanted|0|||
125281115|NCT01005316|450654906|FG003|Overall Study|Retransplanted|0|||
125281116|NCT04417218|450654907|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
125281117|NCT04417218|450654908|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
125281118|NCT00873041|450654911|FG000|Core Study|Adverse Event|2|||
125281119|NCT00873041|450654912|FG001|Core Study|Adverse Event|3|||
125281120|NCT00873041|450654913|FG002|Core Study|Adverse Event|1|||
125281121|NCT00873041|450654911|FG000|Core Study|Withdrawal by Subject|1|||
125281122|NCT00873041|450654912|FG001|Core Study|Withdrawal by Subject|2|||
125281123|NCT00873041|450654913|FG002|Core Study|Withdrawal by Subject|2|||
125281124|NCT00873041|450654911|FG000|Core Study|Lost to Follow-up|3|||
125281125|NCT00873041|450654912|FG001|Core Study|Lost to Follow-up|1|||
125281126|NCT00873041|450654913|FG002|Core Study|Lost to Follow-up|0|||
125281127|NCT00873041|450654911|FG000|Core Study|Abnormal laboratory value|0|||
125281128|NCT00873041|450654912|FG001|Core Study|Abnormal laboratory value|0|||
125281129|NCT00873041|450654913|FG002|Core Study|Abnormal laboratory value|1|||
125281130|NCT00873041|450654911|FG000|Core Study|Protocol deviation|1|||
125281131|NCT00873041|450654912|FG001|Core Study|Protocol deviation|0|||
125281132|NCT00873041|450654913|FG002|Core Study|Protocol deviation|1|||
125281133|NCT00873041|450654911|FG000|Extension Study|Adverse Event|1|||
125281134|NCT00873041|450654912|FG001|Extension Study|Adverse Event|0|||
125281135|NCT00873041|450654913|FG002|Extension Study|Adverse Event|1|||
125281136|NCT00873041|450654911|FG000|Extension Study|Administrative reasons|0|||
125281137|NCT00873041|450654912|FG001|Extension Study|Administrative reasons|0|||
125281138|NCT00873041|450654913|FG002|Extension Study|Administrative reasons|1|||
125281139|NCT01734395|450654916|FG000|Overall Study|Other|65|||
125281140|NCT01734395|450654916|FG000|Overall Study|Lost to Follow-up|287|||
125281141|NCT01734395|450654916|FG000|Overall Study|Lack of Efficacy|5|||
125281142|NCT01734395|450654916|FG000|Overall Study|Adverse Event|40|||
125281143|NCT01734395|450654916|FG000|Overall Study|Withdrawal by Subject|10|||
125281144|NCT01734395|450654916|FG000|Overall Study|Missing the reasons for not completed|3|||
125281145|NCT01032291|450654917|FG000|Safety Lead-in|Adverse Event|1|||
125281146|NCT01032291|450654918|FG001|Safety Lead-in|Adverse Event|0|||
125281147|NCT01032291|450654919|FG002|Safety Lead-in|Adverse Event|0|||
125281148|NCT01032291|450654917|FG000|Safety Lead-in|Death|1|||
125281149|NCT01032291|450654918|FG001|Safety Lead-in|Death|0|||
125281150|NCT01032291|450654919|FG002|Safety Lead-in|Death|0|||
125281151|NCT01032291|450654917|FG000|Proof of Concept|Adverse Event|0|||
125281152|NCT01032291|450654918|FG001|Proof of Concept|Adverse Event|5|||
125281153|NCT01032291|450654919|FG002|Proof of Concept|Adverse Event|1|||
125281154|NCT01032291|450654917|FG000|Proof of Concept|Death|0|||
125281155|NCT01032291|450654918|FG001|Proof of Concept|Death|1|||
125281156|NCT01032291|450654919|FG002|Proof of Concept|Death|2|||
125281157|NCT01032291|450654917|FG000|Proof of Concept|Lack of Efficacy|0|||
125281158|NCT01032291|450654918|FG001|Proof of Concept|Lack of Efficacy|1|||
125281159|NCT01032291|450654919|FG002|Proof of Concept|Lack of Efficacy|0|||
125281160|NCT01032291|450654917|FG000|Proof of Concept|Never Received Study Drug|0|||
125281161|NCT01032291|450654918|FG001|Proof of Concept|Never Received Study Drug|1|||
125281162|NCT01032291|450654919|FG002|Proof of Concept|Never Received Study Drug|0|||
125281163|NCT00313313|450654920|FG000|Overall Study|Lack of Efficacy|14|||
125281164|NCT00313313|450654921|FG001|Overall Study|Lack of Efficacy|9|||
125281165|NCT00313313|450654922|FG002|Overall Study|Lack of Efficacy|20|||
125281166|NCT00313313|450654920|FG000|Overall Study|Withdrawal of consent by subject|18|||
125281167|NCT00313313|450654921|FG001|Overall Study|Withdrawal of consent by subject|17|||
125281168|NCT00313313|450654922|FG002|Overall Study|Withdrawal of consent by subject|31|||
125281169|NCT00313313|450654920|FG000|Overall Study|Lost to Follow-up|10|||
125281170|NCT00313313|450654921|FG001|Overall Study|Lost to Follow-up|7|||
125281171|NCT00313313|450654922|FG002|Overall Study|Lost to Follow-up|9|||
125281172|NCT00313313|450654920|FG000|Overall Study|Adverse Event|15|||
125281173|NCT00313313|450654921|FG001|Overall Study|Adverse Event|16|||
125281174|NCT00313313|450654922|FG002|Overall Study|Adverse Event|12|||
125281175|NCT00313313|450654920|FG000|Overall Study|Physician Decision|2|||
125281176|NCT00313313|450654921|FG001|Overall Study|Physician Decision|6|||
125281177|NCT00313313|450654922|FG002|Overall Study|Physician Decision|4|||
125281178|NCT00313313|450654920|FG000|Overall Study|Poor/Noncompliance|3|||
125281179|NCT00313313|450654921|FG001|Overall Study|Poor/Noncompliance|6|||
125281180|NCT00313313|450654922|FG002|Overall Study|Poor/Noncompliance|2|||
125281181|NCT00313313|450654920|FG000|Overall Study|Pregnancy|1|||
125281182|NCT00313313|450654921|FG001|Overall Study|Pregnancy|2|||
125281183|NCT00313313|450654922|FG002|Overall Study|Pregnancy|0|||
125281184|NCT00313313|450654920|FG000|Overall Study|Death|0|||
125281185|NCT00313313|450654921|FG001|Overall Study|Death|0|||
125281186|NCT00313313|450654922|FG002|Overall Study|Death|2|||
125281187|NCT00313313|450654920|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
125281188|NCT00313313|450654921|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
125281189|NCT00313313|450654922|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
125281190|NCT00758264|450654925|FG000|Active Phase|Withdrawal by Subject|0|||
125281191|NCT00758264|450654926|FG001|Active Phase|Withdrawal by Subject|0|||
125281192|NCT00758264|450654927|FG002|Active Phase|Withdrawal by Subject|1|||
125281193|NCT00758264|450654925|FG000|Active Phase|Lost to Follow-up|1|||
125281194|NCT00758264|450654926|FG001|Active Phase|Lost to Follow-up|0|||
125281195|NCT00758264|450654927|FG002|Active Phase|Lost to Follow-up|0|||
125281196|NCT00758264|450654925|FG000|Active Phase|Other|0|||
125281197|NCT00758264|450654926|FG001|Active Phase|Other|0|||
125281198|NCT00758264|450654927|FG002|Active Phase|Other|4|||
125281199|NCT03425006|450654928|FG000|Overall Study|Withdrawal by Subject|1|||
125281200|NCT03425006|450654928|FG000|Overall Study|Physician Decision|1|||
125281201|NCT03425006|450654928|FG000|Overall Study|Death|1|||
125281202|NCT02300558|450654931|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
125281203|NCT02300558|450654931|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
125281204|NCT02300558|450654931|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
125281205|NCT02300558|450654931|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
125281206|NCT00695955|450654932|FG000|Cohort 1|Adverse Event|26|||
125281207|NCT00695955|450654932|FG000|Cohort 1|Protocol Violation|2|||
125281208|NCT00695955|450654932|FG000|Cohort 1|Lost to Follow-up|30|||
125281209|NCT00695955|450654932|FG000|Cohort 1|Withdrawal by Subject|25|||
125281210|NCT00695955|450654932|FG000|Cohort 1|Lack of Efficacy|3|||
125281211|NCT00695955|450654932|FG000|Cohort 1|Other|16|||
125281212|NCT00695955|450654932|FG000|Cohort 2|Adverse Event|24|||
125281213|NCT00695955|450654932|FG000|Cohort 2|Protocol Violation|5|||
125281214|NCT00695955|450654932|FG000|Cohort 2|Lost to Follow-up|38|||
125281215|NCT00695955|450654932|FG000|Cohort 2|Withdrawal by Subject|28|||
125281216|NCT00695955|450654932|FG000|Cohort 2|Lack of Efficacy|4|||
125281217|NCT00695955|450654932|FG000|Cohort 2|Other|5|||
125281218|NCT03888235|450654935|FG000|Overall Study|Lost to Follow-up|1|||
125281219|NCT03888235|450654936|FG001|Overall Study|Lost to Follow-up|1|||
125281220|NCT03888235|450654937|FG002|Overall Study|Lost to Follow-up|0|||
125281221|NCT01054560|450654938|FG000|Overall Study|Death|10|||
125281222|NCT01054560|450654939|FG001|Overall Study|Death|21|||
125281223|NCT01054560|450654938|FG000|Overall Study|Lost to Follow-up|2|||
125281224|NCT01054560|450654939|FG001|Overall Study|Lost to Follow-up|5|||
125281225|NCT01054560|450654938|FG000|Overall Study|Withdrawal by Subject|0|||
125281226|NCT01054560|450654939|FG001|Overall Study|Withdrawal by Subject|2|||
125281227|NCT01054560|450654938|FG000|Overall Study|Physician Decision|1|||
125281228|NCT01054560|450654939|FG001|Overall Study|Physician Decision|0|||
125281229|NCT01421303|450654940|FG000|Overall Study|Lost to Follow-up|13|||
125281230|NCT01421303|450654940|FG000|Overall Study|Non compliance with study procedure|1|||
125281231|NCT01421303|450654940|FG000|Overall Study|Other|7|||
125281232|NCT01421303|450654940|FG000|Overall Study|Withdrawal by Subject|1|||
125281233|NCT00712725|450654942|FG000|Overall Study|Adverse Event|1|||
125281234|NCT00712725|450654943|FG001|Overall Study|Adverse Event|0|||
125281235|NCT00712725|450654944|FG002|Overall Study|Adverse Event|0|||
125281236|NCT00712725|450654945|FG003|Overall Study|Adverse Event|1|||
125281237|NCT00712725|450654946|FG004|Overall Study|Adverse Event|0|||
125281238|NCT00712725|450654947|FG005|Overall Study|Adverse Event|0|||
125281239|NCT00712725|450654948|FG006|Overall Study|Adverse Event|0|||
125281240|NCT00712725|450654949|FG007|Overall Study|Adverse Event|0|||
125281241|NCT00712725|450654942|FG000|Overall Study|Lost to Follow-up|3|||
125281242|NCT00712725|450654943|FG001|Overall Study|Lost to Follow-up|2|||
125281243|NCT00712725|450654944|FG002|Overall Study|Lost to Follow-up|1|||
125281244|NCT00712725|450654945|FG003|Overall Study|Lost to Follow-up|1|||
125281245|NCT00712725|450654946|FG004|Overall Study|Lost to Follow-up|2|||
125281246|NCT00712725|450654947|FG005|Overall Study|Lost to Follow-up|2|||
125281247|NCT00712725|450654948|FG006|Overall Study|Lost to Follow-up|3|||
125281248|NCT00712725|450654949|FG007|Overall Study|Lost to Follow-up|1|||
125281249|NCT00712725|450654942|FG000|Overall Study|Physician Decision|2|||
125281250|NCT00712725|450654943|FG001|Overall Study|Physician Decision|0|||
125281251|NCT00712725|450654944|FG002|Overall Study|Physician Decision|0|||
125281252|NCT00712725|450654945|FG003|Overall Study|Physician Decision|0|||
125281253|NCT00712725|450654946|FG004|Overall Study|Physician Decision|1|||
125281254|NCT00712725|450654947|FG005|Overall Study|Physician Decision|0|||
125281255|NCT00712725|450654948|FG006|Overall Study|Physician Decision|2|||
125281256|NCT00712725|450654949|FG007|Overall Study|Physician Decision|0|||
125281257|NCT00712725|450654942|FG000|Overall Study|Pregnancy|0|||
125281258|NCT00712725|450654943|FG001|Overall Study|Pregnancy|1|||
125281259|NCT00712725|450654944|FG002|Overall Study|Pregnancy|0|||
125281260|NCT00712725|450654945|FG003|Overall Study|Pregnancy|0|||
125281261|NCT00712725|450654946|FG004|Overall Study|Pregnancy|1|||
125281262|NCT00712725|450654947|FG005|Overall Study|Pregnancy|0|||
125281263|NCT00712725|450654948|FG006|Overall Study|Pregnancy|2|||
125281264|NCT00712725|450654949|FG007|Overall Study|Pregnancy|0|||
125281265|NCT00712725|450654942|FG000|Overall Study|Protocol Violation|2|||
125281266|NCT00712725|450654943|FG001|Overall Study|Protocol Violation|0|||
125281267|NCT00712725|450654944|FG002|Overall Study|Protocol Violation|1|||
125281268|NCT00712725|450654945|FG003|Overall Study|Protocol Violation|3|||
125281269|NCT00712725|450654946|FG004|Overall Study|Protocol Violation|2|||
125281270|NCT00712725|450654947|FG005|Overall Study|Protocol Violation|0|||
125281271|NCT00712725|450654948|FG006|Overall Study|Protocol Violation|1|||
125281272|NCT00712725|450654949|FG007|Overall Study|Protocol Violation|1|||
125281273|NCT00712725|450654942|FG000|Overall Study|Withdrawal by Subject|2|||
125281274|NCT00712725|450654943|FG001|Overall Study|Withdrawal by Subject|1|||
125281275|NCT00712725|450654944|FG002|Overall Study|Withdrawal by Subject|1|||
125281276|NCT00712725|450654945|FG003|Overall Study|Withdrawal by Subject|2|||
125281277|NCT00712725|450654946|FG004|Overall Study|Withdrawal by Subject|1|||
125281278|NCT00712725|450654947|FG005|Overall Study|Withdrawal by Subject|1|||
125281279|NCT00712725|450654948|FG006|Overall Study|Withdrawal by Subject|1|||
125281280|NCT00712725|450654949|FG007|Overall Study|Withdrawal by Subject|2|||
125281281|NCT00712725|450654942|FG000|Overall Study|Lack of Qualifying Event|16|||
125281282|NCT00712725|450654943|FG001|Overall Study|Lack of Qualifying Event|2|||
125281283|NCT00712725|450654944|FG002|Overall Study|Lack of Qualifying Event|6|||
125281284|NCT00712725|450654945|FG003|Overall Study|Lack of Qualifying Event|8|||
125281285|NCT00712725|450654946|FG004|Overall Study|Lack of Qualifying Event|11|||
125281286|NCT00712725|450654947|FG005|Overall Study|Lack of Qualifying Event|13|||
125281287|NCT00712725|450654948|FG006|Overall Study|Lack of Qualifying Event|11|||
125281288|NCT00712725|450654949|FG007|Overall Study|Lack of Qualifying Event|6|||
125281289|NCT00712725|450654942|FG000|Overall Study|Protocol Specified Criteria|3|||
125281290|NCT00712725|450654943|FG001|Overall Study|Protocol Specified Criteria|0|||
125281291|NCT00712725|450654944|FG002|Overall Study|Protocol Specified Criteria|1|||
125281292|NCT00712725|450654945|FG003|Overall Study|Protocol Specified Criteria|2|||
125281293|NCT00712725|450654946|FG004|Overall Study|Protocol Specified Criteria|1|||
125281294|NCT00712725|450654947|FG005|Overall Study|Protocol Specified Criteria|0|||
125281295|NCT00712725|450654948|FG006|Overall Study|Protocol Specified Criteria|2|||
125281296|NCT00712725|450654949|FG007|Overall Study|Protocol Specified Criteria|1|||
125281297|NCT03466099|450654950|FG000|Overall Study|Adverse Event|1|||
125281298|NCT03466099|450654951|FG001|Overall Study|Adverse Event|1|||
125281299|NCT03466099|450654952|FG002|Overall Study|Adverse Event|1|||
125281300|NCT03466099|450654950|FG000|Overall Study|Withdrawal by Subject|2|||
125281301|NCT03466099|450654951|FG001|Overall Study|Withdrawal by Subject|3|||
125281302|NCT03466099|450654952|FG002|Overall Study|Withdrawal by Subject|1|||
125281303|NCT03466099|450654950|FG000|Overall Study|Use of rescue medication|8|||
125281304|NCT03466099|450654951|FG001|Overall Study|Use of rescue medication|9|||
125281305|NCT03466099|450654952|FG002|Overall Study|Use of rescue medication|13|||
125281306|NCT03466099|450654950|FG000|Overall Study|Rescued without meeting criteria|4|||
125281307|NCT03466099|450654951|FG001|Overall Study|Rescued without meeting criteria|1|||
125281308|NCT03466099|450654952|FG002|Overall Study|Rescued without meeting criteria|1|||
125281309|NCT03466099|450654950|FG000|Overall Study|Subject compliance|2|||
125281310|NCT03466099|450654951|FG001|Overall Study|Subject compliance|0|||
125281311|NCT03466099|450654952|FG002|Overall Study|Subject compliance|0|||
125281312|NCT03466099|450654950|FG000|Overall Study|Worsening disease|0|||
125281313|NCT03466099|450654951|FG001|Overall Study|Worsening disease|0|||
125281314|NCT03466099|450654952|FG002|Overall Study|Worsening disease|1|||
125281315|NCT00344318|450654955|FG000|Overall Study|Adverse Event|0|||
125281316|NCT00344318|450654956|FG001|Overall Study|Adverse Event|3|||
125281317|NCT00344318|450654957|FG002|Overall Study|Adverse Event|0|||
125281318|NCT00344318|450654958|FG003|Overall Study|Adverse Event|1|||
125281319|NCT00344318|450654955|FG000|Overall Study|Withdrawal by Subject|2|||
125281320|NCT00344318|450654956|FG001|Overall Study|Withdrawal by Subject|2|||
125281321|NCT00344318|450654957|FG002|Overall Study|Withdrawal by Subject|0|||
125281322|NCT00344318|450654958|FG003|Overall Study|Withdrawal by Subject|2|||
125281323|NCT00344318|450654955|FG000|Overall Study|Lost to Follow-up|2|||
125281324|NCT00344318|450654956|FG001|Overall Study|Lost to Follow-up|0|||
125281325|NCT00344318|450654957|FG002|Overall Study|Lost to Follow-up|1|||
125281326|NCT00344318|450654958|FG003|Overall Study|Lost to Follow-up|0|||
125281327|NCT03832322|450654959|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
125281328|NCT03832322|450654960|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
125281329|NCT01923363|450654961|FG000|Overall Study|Protocol Violation|1|||
125281330|NCT00616018|450654964|FG000|Overall Study|Protocol Violation|3|||
125281331|NCT00404755|450654966|FG000|Phase I (Bupropion)|Adverse Event|3|||
125281332|NCT00404755|450654966|FG000|Phase I (Bupropion)|Other|1|||
125281333|NCT00404755|450654966|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
125281334|NCT00350870|450654967|FG000|Overall Study|Withdrawal by Subject|21|||
125281335|NCT00350870|450654968|FG001|Overall Study|Withdrawal by Subject|17|||
125281336|NCT00350870|450654969|FG002|Overall Study|Withdrawal by Subject|15|||
125281337|NCT00350870|450654970|FG003|Overall Study|Withdrawal by Subject|14|||
125281338|NCT00350870|450654967|FG000|Overall Study|Physician Decision|1|||
125281339|NCT00350870|450654968|FG001|Overall Study|Physician Decision|0|||
125281340|NCT00350870|450654969|FG002|Overall Study|Physician Decision|1|||
125281341|NCT00350870|450654970|FG003|Overall Study|Physician Decision|1|||
125281342|NCT03194568|450654971|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
125281343|NCT05248997|450654972|FG000|Overall Study|Lost to Follow-up|1|||
125281344|NCT05248997|450654973|FG001|Overall Study|Lost to Follow-up|1|||
125281345|NCT05248997|450654972|FG000|Overall Study|Randomized but not treated|32|||
124781830|NCT03500224|448831182|FG000|Overall Study|Withdrawal by Subject|2|||
124781831|NCT01324401|448831185|FG000|Overall Study|Withdrawn before any treatment|0|||
124781832|NCT01324401|448831186|FG001|Overall Study|Withdrawn before any treatment|3|||
124781833|NCT01324401|448831185|FG000|Overall Study|Adverse Event|1|||
124781834|NCT01324401|448831186|FG001|Overall Study|Adverse Event|3|||
124781835|NCT01708902|448831188|FG000|Overall Study|Adverse Event|3|||
124781836|NCT01708902|448831189|FG001|Overall Study|Adverse Event|4|||
124781837|NCT01708902|448831190|FG002|Overall Study|Adverse Event|9|||
124781838|NCT01708902|448831191|FG003|Overall Study|Adverse Event|2|||
124781839|NCT01708902|448831192|FG004|Overall Study|Adverse Event|7|||
124781840|NCT01708902|448831193|FG005|Overall Study|Adverse Event|3|||
124781841|NCT01708902|448831194|FG006|Overall Study|Adverse Event|5|||
124781842|NCT01708902|448831188|FG000|Overall Study|Lack of Efficacy|3|||
124781843|NCT01708902|448831189|FG001|Overall Study|Lack of Efficacy|1|||
124781844|NCT01708902|448831190|FG002|Overall Study|Lack of Efficacy|0|||
124781845|NCT01708902|448831191|FG003|Overall Study|Lack of Efficacy|0|||
124781846|NCT01708902|448831192|FG004|Overall Study|Lack of Efficacy|0|||
124781847|NCT01708902|448831193|FG005|Overall Study|Lack of Efficacy|1|||
124781848|NCT01708902|448831194|FG006|Overall Study|Lack of Efficacy|0|||
124781849|NCT01708902|448831188|FG000|Overall Study|Non compliance with protocol|0|||
124781850|NCT01708902|448831189|FG001|Overall Study|Non compliance with protocol|2|||
124781851|NCT01708902|448831190|FG002|Overall Study|Non compliance with protocol|1|||
124781852|NCT01708902|448831191|FG003|Overall Study|Non compliance with protocol|3|||
124781853|NCT01708902|448831192|FG004|Overall Study|Non compliance with protocol|0|||
125281346|NCT05248997|450654973|FG001|Overall Study|Randomized but not treated|25|||
125281347|NCT01453205|450654974|FG000|Overall Study|Lost to Follow-up|3|||
125281348|NCT01453205|450654975|FG001|Overall Study|Lost to Follow-up|0|||
125281349|NCT01453205|450654976|FG002|Overall Study|Lost to Follow-up|1|||
125281350|NCT01453205|450654974|FG000|Overall Study|Withdrawal by Subject|8|||
125281351|NCT01453205|450654975|FG001|Overall Study|Withdrawal by Subject|3|||
125281352|NCT01453205|450654976|FG002|Overall Study|Withdrawal by Subject|0|||
125281353|NCT01453205|450654974|FG000|Overall Study|Death|24|||
125281354|NCT01453205|450654975|FG001|Overall Study|Death|22|||
125281355|NCT01453205|450654976|FG002|Overall Study|Death|18|||
125281356|NCT01453205|450654974|FG000|Overall Study|Other|45|||
125281357|NCT01453205|450654975|FG001|Overall Study|Other|27|||
125281358|NCT01453205|450654976|FG002|Overall Study|Other|35|||
125281359|NCT02602275|450654984|FG000|Day 1|Physician Decision|0|||
125281360|NCT02602275|450654985|FG001|Day 1|Physician Decision|1|||
125281361|NCT04262882|450654986|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
125281362|NCT04262882|450654987|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
125281363|NCT04262882|450654986|FG000|Overall Study|Lost to Follow-up|1|||
125281364|NCT04262882|450654987|FG001|Overall Study|Lost to Follow-up|0|||
125281365|NCT01301066|450654988|FG000|Overall Study|Lost to Follow-up|5|||
125281366|NCT01301066|450654989|FG001|Overall Study|Lost to Follow-up|11|||
125281367|NCT01301066|450654988|FG000|Overall Study|Protocol Violation|8|||
125281368|NCT01301066|450654989|FG001|Overall Study|Protocol Violation|7|||
125281369|NCT01301066|450654988|FG000|Overall Study|Withdrawal by Subject|4|||
125281370|NCT01301066|450654989|FG001|Overall Study|Withdrawal by Subject|9|||
125281371|NCT01301066|450654988|FG000|Overall Study|Adverse Event|6|||
125281372|NCT01301066|450654989|FG001|Overall Study|Adverse Event|6|||
125281373|NCT01301066|450654988|FG000|Overall Study|Sponsor Decision|2|||
125281374|NCT01301066|450654989|FG001|Overall Study|Sponsor Decision|1|||
125281375|NCT01301066|450654988|FG000|Overall Study|Physician Decision|0|||
125281376|NCT01301066|450654989|FG001|Overall Study|Physician Decision|1|||
125281377|NCT01301066|450654988|FG000|Overall Study|Other|2|||
125281378|NCT01301066|450654989|FG001|Overall Study|Other|0|||
124781854|NCT01708902|448831193|FG005|Overall Study|Non compliance with protocol|0|||
124781855|NCT01708902|448831194|FG006|Overall Study|Non compliance with protocol|0|||
124781856|NCT01708902|448831188|FG000|Overall Study|Lost to Follow-up|2|||
124781857|NCT01708902|448831189|FG001|Overall Study|Lost to Follow-up|1|||
124781858|NCT01708902|448831190|FG002|Overall Study|Lost to Follow-up|2|||
124781859|NCT01708902|448831191|FG003|Overall Study|Lost to Follow-up|2|||
124781860|NCT01708902|448831192|FG004|Overall Study|Lost to Follow-up|0|||
124781861|NCT01708902|448831193|FG005|Overall Study|Lost to Follow-up|0|||
124781862|NCT01708902|448831194|FG006|Overall Study|Lost to Follow-up|1|||
124781863|NCT01708902|448831188|FG000|Overall Study|Refused to continue trial medication|8|||
125281379|NCT01108731|450654996|FG000|Overall Study|Withdrawal by Subject|1|||
124781864|NCT01708902|448831189|FG001|Overall Study|Refused to continue trial medication|0|||
124781865|NCT01708902|448831190|FG002|Overall Study|Refused to continue trial medication|4|||
124781866|NCT01708902|448831191|FG003|Overall Study|Refused to continue trial medication|2|||
125281380|NCT01108731|450654997|FG001|Overall Study|Withdrawal by Subject|1|||
125281381|NCT01108731|450654996|FG000|Overall Study|Adverse Event|3|||
125281382|NCT01108731|450654997|FG001|Overall Study|Adverse Event|3|||
125281383|NCT04210245|450654998|FG000|Overall Study|Adverse Event|0|||
125281384|NCT04210245|450654999|FG001|Overall Study|Adverse Event|3|||
125281385|NCT04210245|450655000|FG002|Overall Study|Adverse Event|6|||
124781867|NCT01708902|448831192|FG004|Overall Study|Refused to continue trial medication|8|||
124781868|NCT01708902|448831193|FG005|Overall Study|Refused to continue trial medication|1|||
124781869|NCT01708902|448831194|FG006|Overall Study|Refused to continue trial medication|1|||
124781870|NCT01708902|448831188|FG000|Overall Study|Other Reason|1|||
124781871|NCT01708902|448831189|FG001|Overall Study|Other Reason|0|||
124781872|NCT01708902|448831190|FG002|Overall Study|Other Reason|1|||
124781873|NCT01708902|448831191|FG003|Overall Study|Other Reason|1|||
124781874|NCT01708902|448831192|FG004|Overall Study|Other Reason|1|||
125281386|NCT04210245|450655001|FG003|Overall Study|Adverse Event|0|||
125281387|NCT04210245|450654998|FG000|Overall Study|Withdrawal by Subject|0|||
125281388|NCT04210245|450654999|FG001|Overall Study|Withdrawal by Subject|1|||
125281389|NCT04210245|450655000|FG002|Overall Study|Withdrawal by Subject|4|||
125281390|NCT04210245|450655001|FG003|Overall Study|Withdrawal by Subject|4|||
125281391|NCT04210245|450654998|FG000|Overall Study|Lost to Follow-up|0|||
125281392|NCT04210245|450654999|FG001|Overall Study|Lost to Follow-up|1|||
125281393|NCT04210245|450655000|FG002|Overall Study|Lost to Follow-up|1|||
125281394|NCT04210245|450655001|FG003|Overall Study|Lost to Follow-up|1|||
125281395|NCT04210245|450654998|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
125281396|NCT04210245|450654999|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
125281397|NCT04210245|450655000|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
125281398|NCT04210245|450655001|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
125281399|NCT01892722|450655002|FG000|Overall Study|Protocol deviation|0|||
125281400|NCT01892722|450655003|FG001|Overall Study|Protocol deviation|1|||
125281401|NCT01892722|450655002|FG000|Overall Study|Administrative problems|0|||
125281402|NCT01892722|450655003|FG001|Overall Study|Administrative problems|1|||
125281403|NCT01892722|450655002|FG000|Overall Study|Patient/guardian decision|0|||
125281404|NCT01892722|450655003|FG001|Overall Study|Patient/guardian decision|2|||
125281405|NCT01892722|450655002|FG000|Overall Study|Physician Decision|1|||
125281406|NCT01892722|450655003|FG001|Overall Study|Physician Decision|2|||
125281407|NCT01892722|450655002|FG000|Overall Study|Adverse Event|3|||
125281408|NCT01892722|450655003|FG001|Overall Study|Adverse Event|2|||
125281409|NCT01892722|450655002|FG000|Overall Study|Lack of Efficacy|0|||
125281410|NCT01892722|450655003|FG001|Overall Study|Lack of Efficacy|7|||
125281411|NCT01892722|450655002|FG000|Overall Study|Withdrawal by Subject|3|||
125281412|NCT01892722|450655003|FG001|Overall Study|Withdrawal by Subject|5|||
125281413|NCT01252186|450655004|FG000|Overall Study|Adverse Event|9|||
125281414|NCT01252186|450655005|FG001|Overall Study|Adverse Event|6|||
125281415|NCT01252186|450655006|FG002|Overall Study|Adverse Event|8|||
125281416|NCT01252186|450655004|FG000|Overall Study|Withdrawal by Subject|2|||
125281417|NCT01252186|450655005|FG001|Overall Study|Withdrawal by Subject|5|||
125281418|NCT01252186|450655006|FG002|Overall Study|Withdrawal by Subject|2|||
125281419|NCT01252186|450655004|FG000|Overall Study|Physician Decision|0|||
125281420|NCT01252186|450655005|FG001|Overall Study|Physician Decision|0|||
125281421|NCT01252186|450655006|FG002|Overall Study|Physician Decision|1|||
125281422|NCT01252186|450655004|FG000|Overall Study|Non-compliance|0|||
125281423|NCT01252186|450655005|FG001|Overall Study|Non-compliance|3|||
125281424|NCT01252186|450655006|FG002|Overall Study|Non-compliance|4|||
125281425|NCT01252186|450655004|FG000|Overall Study|Protocol Violation|0|||
125281426|NCT01252186|450655005|FG001|Overall Study|Protocol Violation|0|||
125281427|NCT01252186|450655006|FG002|Overall Study|Protocol Violation|1|||
125281428|NCT01252186|450655004|FG000|Overall Study|Pregnancy|2|||
125281429|NCT01252186|450655005|FG001|Overall Study|Pregnancy|2|||
125281430|NCT01252186|450655006|FG002|Overall Study|Pregnancy|0|||
125281431|NCT01252186|450655004|FG000|Overall Study|Sponsor Request|2|||
125281432|NCT01252186|450655005|FG001|Overall Study|Sponsor Request|1|||
125281433|NCT01252186|450655006|FG002|Overall Study|Sponsor Request|0|||
125281434|NCT01252186|450655004|FG000|Overall Study|Lost to Follow-up|10|||
125281435|NCT01252186|450655005|FG001|Overall Study|Lost to Follow-up|10|||
125281436|NCT01252186|450655006|FG002|Overall Study|Lost to Follow-up|11|||
125281437|NCT01252186|450655004|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
125281438|NCT01252186|450655005|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
125281439|NCT01252186|450655006|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
124781875|NCT01708902|448831193|FG005|Overall Study|Other Reason|2|||
124781876|NCT01708902|448831194|FG006|Overall Study|Other Reason|0|||
124781877|NCT00530816|448831196|FG000|Overall Study|Progressive Disease|16|||
124781878|NCT00530816|448831197|FG001|Overall Study|Progressive Disease|24|||
124781879|NCT00530816|448831198|FG002|Overall Study|Progressive Disease|24|||
124781880|NCT00530816|448831196|FG000|Overall Study|Adverse Event|6|||
125281440|NCT04283994|450655013|FG000|Overall Study|Death|11|||
125281441|NCT04283994|450655014|FG001|Overall Study|Death|20|||
125281442|NCT04283994|450655015|FG002|Overall Study|Death|11|||
125281443|NCT04283994|450655016|FG003|Overall Study|Death|0|||
125281444|NCT04283994|450655017|FG004|Overall Study|Death|0|||
125281445|NCT04283994|450655018|FG005|Overall Study|Death|0|||
125281446|NCT04283994|450655019|FG006|Overall Study|Death|0|||
125281447|NCT04283994|450655013|FG000|Overall Study|Withdrawal by Subject|16|||
125281448|NCT04283994|450655014|FG001|Overall Study|Withdrawal by Subject|4|||
125281449|NCT04283994|450655015|FG002|Overall Study|Withdrawal by Subject|6|||
125281450|NCT04283994|450655016|FG003|Overall Study|Withdrawal by Subject|1|||
125281451|NCT04283994|450655017|FG004|Overall Study|Withdrawal by Subject|0|||
125281452|NCT04283994|450655018|FG005|Overall Study|Withdrawal by Subject|1|||
125281453|NCT04283994|450655019|FG006|Overall Study|Withdrawal by Subject|0|||
125281454|NCT03763656|450655020|FG000|Overall Study|Physician Decision|1|||
125281455|NCT03763656|450655020|FG000|Overall Study|Protocol Violation|1|||
125281456|NCT03763656|450655020|FG000|Overall Study|Withdrawal by Subject|7|||
125281457|NCT00487942|450655021|FG000|Overall Study|Adverse Event|1|||
125281458|NCT00487942|450655022|FG001|Overall Study|Adverse Event|1|||
125281459|NCT00487942|450655023|FG002|Overall Study|Adverse Event|1|||
125281460|NCT00487942|450655024|FG003|Overall Study|Adverse Event|1|||
125281461|NCT00487942|450655021|FG000|Overall Study|Lost to Follow-up|1|||
125281462|NCT00487942|450655022|FG001|Overall Study|Lost to Follow-up|0|||
125281463|NCT00487942|450655023|FG002|Overall Study|Lost to Follow-up|0|||
125281464|NCT00487942|450655024|FG003|Overall Study|Lost to Follow-up|1|||
125281465|NCT00487942|450655021|FG000|Overall Study|Protocol Violation|1|||
125281466|NCT00487942|450655022|FG001|Overall Study|Protocol Violation|1|||
125281467|NCT00487942|450655023|FG002|Overall Study|Protocol Violation|0|||
125281468|NCT00487942|450655024|FG003|Overall Study|Protocol Violation|0|||
125281469|NCT00487942|450655021|FG000|Overall Study|Withdrawal by Subject|0|||
125281470|NCT00487942|450655022|FG001|Overall Study|Withdrawal by Subject|1|||
125281471|NCT00487942|450655023|FG002|Overall Study|Withdrawal by Subject|2|||
125281472|NCT00487942|450655024|FG003|Overall Study|Withdrawal by Subject|0|||
125281473|NCT00197145|450656330|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
125281474|NCT00197145|450656331|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
125281475|NCT00197145|450656330|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
125281476|NCT00197145|450656331|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
125281477|NCT00197145|450656330|FG000|Period 1: Randomized Treatment Phase|Other|2|||
125281478|NCT00197145|450656331|FG001|Period 1: Randomized Treatment Phase|Other|2|||
125281479|NCT00197145|450656330|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
125281480|NCT00197145|450656331|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
125281481|NCT00197145|450656330|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
125281482|NCT00197145|450656331|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
125281483|NCT00197145|450656330|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
125281484|NCT00197145|450656331|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
125281485|NCT00197145|450656330|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
125281486|NCT00197145|450656331|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
125281487|NCT00197145|450656330|FG000|Period 2 : Open Label Phase|Other|1|||
125281488|NCT00197145|450656331|FG001|Period 2 : Open Label Phase|Other|0|||
125281489|NCT03372551|450656338|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
125281490|NCT03372551|450656339|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
125281491|NCT03285958|450656344|FG000|Overall Study|Lost to Follow-up|1|||
125281492|NCT03285958|450656345|FG001|Overall Study|Lost to Follow-up|1|||
125281493|NCT03285958|450656344|FG000|Overall Study|Withdrawal by Subject|1|||
125281494|NCT03285958|450656345|FG001|Overall Study|Withdrawal by Subject|0|||
125281495|NCT03285958|450656344|FG000|Overall Study|Not able to attend required orientation|3|||
125281496|NCT03285958|450656345|FG001|Overall Study|Not able to attend required orientation|0|||
125281497|NCT02578680|450656346|FG000|Overall Study|Death|329|||
125281498|NCT02578680|450656347|FG001|Overall Study|Death|181|||
125281499|NCT02578680|450656346|FG000|Overall Study|Lost to Follow-up|3|||
125281500|NCT02578680|450656347|FG001|Overall Study|Lost to Follow-up|1|||
125281501|NCT02578680|450656346|FG000|Overall Study|Physician Decision|0|||
125281502|NCT02578680|450656347|FG001|Overall Study|Physician Decision|1|||
125281503|NCT02578680|450656346|FG000|Overall Study|Protocol Violation|1|||
125281504|NCT02578680|450656347|FG001|Overall Study|Protocol Violation|1|||
125281505|NCT02578680|450656346|FG000|Overall Study|Sponsor Decision|64|||
125281506|NCT02578680|450656347|FG001|Overall Study|Sponsor Decision|13|||
125281507|NCT02578680|450656346|FG000|Overall Study|Withdrawal by Subject|13|||
125281508|NCT02578680|450656347|FG001|Overall Study|Withdrawal by Subject|9|||
125281509|NCT03116828|450656348|FG000|Overall Study|Adverse Event|1|||
125281510|NCT03116828|450656349|FG001|Overall Study|Adverse Event|10|||
125281511|NCT03116828|450656348|FG000|Overall Study|Withdrawal by Subject|4|||
125281512|NCT03116828|450656349|FG001|Overall Study|Withdrawal by Subject|8|||
125281513|NCT03116828|450656348|FG000|Overall Study|OTHER|3|||
125281514|NCT03116828|450656349|FG001|Overall Study|OTHER|3|||
125281515|NCT00176488|450656351|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
125281516|NCT00664560|450656367|FG000|Overall Study|Adverse Event|19|||
125281517|NCT00664560|450656368|FG001|Overall Study|Adverse Event|16|||
125281518|NCT00664560|450656369|FG002|Overall Study|Adverse Event|7|||
125281519|NCT00664560|450656367|FG000|Overall Study|Withdrawal by Subject|9|||
125281520|NCT00664560|450656368|FG001|Overall Study|Withdrawal by Subject|13|||
125281521|NCT00664560|450656369|FG002|Overall Study|Withdrawal by Subject|7|||
124781881|NCT00530816|448831197|FG001|Overall Study|Adverse Event|13|||
125281522|NCT00664560|450656367|FG000|Overall Study|Lost to Follow-up|0|||
125281523|NCT00664560|450656368|FG001|Overall Study|Lost to Follow-up|2|||
125281524|NCT00664560|450656369|FG002|Overall Study|Lost to Follow-up|0|||
125281525|NCT00664560|450656367|FG000|Overall Study|Other|11|||
125281526|NCT00664560|450656368|FG001|Overall Study|Other|4|||
125281527|NCT00664560|450656369|FG002|Overall Study|Other|5|||
125281528|NCT03350035|450656370|FG000|Overall Study|Lack of Efficacy|2|||
125281529|NCT03350035|450656371|FG001|Overall Study|Lack of Efficacy|0|||
125281530|NCT03350035|450656372|FG002|Overall Study|Lack of Efficacy|0|||
125281531|NCT03350035|450656370|FG000|Overall Study|Subject discharged to hospice|0|||
125281532|NCT03350035|450656371|FG001|Overall Study|Subject discharged to hospice|0|||
125281533|NCT03350035|450656372|FG002|Overall Study|Subject discharged to hospice|1|||
125281534|NCT03576066|450656373|FG000|Overall Study|Noncompliance with study drug|0|||
125281535|NCT03576066|450656374|FG001|Overall Study|Noncompliance with study drug|1|||
125281536|NCT00006164|450656375|FG000|Overall Study|Withdrew or lost to follow-up|70|||
125281537|NCT00006164|450656376|FG001|Overall Study|Withdrew or lost to follow-up|81|||
125281538|NCT00633074|450656379|FG000|Overall Study|Adverse Event|1|||
125281539|NCT00633074|450656380|FG001|Overall Study|Adverse Event|0|||
125281540|NCT00365105|450656381|FG000|Overall Study|Protocol Violation|5|||
125281541|NCT00365105|450656382|FG001|Overall Study|Protocol Violation|8|||
125281542|NCT06422364|450656383|FG000|Overall Study|Withdrawn due to study closure|0|||
125281543|NCT06422364|450656384|FG001|Overall Study|Withdrawn due to study closure|2|||
125281544|NCT01681069|450656385|FG000|Overall Study|Withdrawal by Subject|4|||
125281545|NCT01681069|450656386|FG001|Overall Study|Withdrawal by Subject|5|||
125281546|NCT01681069|450656385|FG000|Overall Study|Protocol Violation|1|||
125281547|NCT01681069|450656386|FG001|Overall Study|Protocol Violation|1|||
125281548|NCT01681069|450656385|FG000|Overall Study|Adverse Event|0|||
125281549|NCT01681069|450656386|FG001|Overall Study|Adverse Event|1|||
125281550|NCT01463696|450656387|FG000|Overall Study|Adverse Event|0|||
125281551|NCT01463696|450656388|FG001|Overall Study|Adverse Event|1|||
125281552|NCT01463696|450656389|FG002|Overall Study|Adverse Event|0|||
125281553|NCT01463696|450656390|FG003|Overall Study|Adverse Event|2|||
125281554|NCT01463696|450656391|FG004|Overall Study|Adverse Event|0|||
125281555|NCT01463696|450656392|FG005|Overall Study|Adverse Event|1|||
125281556|NCT01463696|450656393|FG006|Overall Study|Adverse Event|3|||
125281557|NCT01463696|450656394|FG007|Overall Study|Adverse Event|2|||
125281558|NCT01463696|450656387|FG000|Overall Study|Lost to Follow-up|0|||
125281559|NCT01463696|450656388|FG001|Overall Study|Lost to Follow-up|0|||
125281560|NCT01463696|450656389|FG002|Overall Study|Lost to Follow-up|1|||
125281561|NCT01463696|450656390|FG003|Overall Study|Lost to Follow-up|0|||
125281562|NCT01463696|450656391|FG004|Overall Study|Lost to Follow-up|0|||
125281563|NCT01463696|450656392|FG005|Overall Study|Lost to Follow-up|0|||
125281564|NCT01463696|450656393|FG006|Overall Study|Lost to Follow-up|0|||
125281565|NCT01463696|450656394|FG007|Overall Study|Lost to Follow-up|0|||
125281566|NCT01463696|450656387|FG000|Overall Study|Progressive Disease|0|||
125281567|NCT01463696|450656388|FG001|Overall Study|Progressive Disease|1|||
125281568|NCT01463696|450656389|FG002|Overall Study|Progressive Disease|0|||
125281569|NCT01463696|450656390|FG003|Overall Study|Progressive Disease|1|||
125281570|NCT01463696|450656391|FG004|Overall Study|Progressive Disease|0|||
125281571|NCT01463696|450656392|FG005|Overall Study|Progressive Disease|1|||
125281572|NCT01463696|450656393|FG006|Overall Study|Progressive Disease|4|||
125281573|NCT01463696|450656394|FG007|Overall Study|Progressive Disease|2|||
125281574|NCT01463696|450656387|FG000|Overall Study|Withdrawal by Subject|0|||
125281575|NCT01463696|450656388|FG001|Overall Study|Withdrawal by Subject|0|||
125281576|NCT01463696|450656389|FG002|Overall Study|Withdrawal by Subject|0|||
125281577|NCT01463696|450656390|FG003|Overall Study|Withdrawal by Subject|1|||
125281578|NCT01463696|450656391|FG004|Overall Study|Withdrawal by Subject|1|||
125281579|NCT01463696|450656392|FG005|Overall Study|Withdrawal by Subject|1|||
125281580|NCT01463696|450656393|FG006|Overall Study|Withdrawal by Subject|2|||
125281581|NCT01463696|450656394|FG007|Overall Study|Withdrawal by Subject|0|||
125281582|NCT01463696|450656387|FG000|Overall Study|Not Treated|0|||
125281583|NCT01463696|450656388|FG001|Overall Study|Not Treated|0|||
125281584|NCT01463696|450656389|FG002|Overall Study|Not Treated|0|||
125281585|NCT01463696|450656390|FG003|Overall Study|Not Treated|0|||
125281586|NCT01463696|450656391|FG004|Overall Study|Not Treated|0|||
125281587|NCT01463696|450656392|FG005|Overall Study|Not Treated|0|||
125281588|NCT01463696|450656393|FG006|Overall Study|Not Treated|1|||
125281589|NCT01463696|450656394|FG007|Overall Study|Not Treated|0|||
125281590|NCT03883165|450656396|FG000|Overall Study|Withdrawal by Subject|4|||
125281591|NCT03883165|450656397|FG001|Overall Study|Withdrawal by Subject|3|||
125281592|NCT00245050|450656401|FG000|Overall Study|Adverse Event|3|||
125281593|NCT00245050|450656402|FG001|Overall Study|Adverse Event|2|||
125281594|NCT01843673|450656403|FG000|Overall Study|Lack of Efficacy|2|||
125281595|NCT01843673|450656403|FG000|Overall Study|Withdrawal by Subject|4|||
125281596|NCT00425698|450656404|FG000|Overall Study|Adverse Event|3|||
125281597|NCT00425698|450656405|FG001|Overall Study|Adverse Event|1|||
125281598|NCT00425698|450656404|FG000|Overall Study|Withdrawal by Subject|0|||
125281599|NCT00425698|450656405|FG001|Overall Study|Withdrawal by Subject|1|||
125281600|NCT03275246|450656412|FG000|Overall Study|Protocol Violation|5|||
125281601|NCT03275246|450656412|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
125281602|NCT03905265|450656415|FG000|Overall Study|Withdrawal by Subject|1|||
125281603|NCT03905265|450656416|FG001|Overall Study|Withdrawal by Subject|1|||
125281604|NCT03905265|450656417|FG002|Overall Study|Withdrawal by Subject|0|||
125281605|NCT03905265|450656418|FG003|Overall Study|Withdrawal by Subject|0|||
125281606|NCT02516098|450656419|FG000|Period 1|Protocol Violation|1|||
125281607|NCT02516098|450656420|FG001|Period 1|Protocol Violation|0|||
125281608|NCT02516098|450656419|FG000|Washout After Period 1|Adverse Event|0|||
125281609|NCT02516098|450656420|FG001|Washout After Period 1|Adverse Event|1|||
125281610|NCT02516098|450656419|FG000|Period 2|Withdrawal by Subject|0|||
125281611|NCT02516098|450656420|FG001|Period 2|Withdrawal by Subject|1|||
125281612|NCT01973387|450656421|FG000|Overall Study|Adverse Event|14|||
125281613|NCT01973387|450656422|FG001|Overall Study|Adverse Event|4|||
125281614|NCT01973387|450656421|FG000|Overall Study|Withdrawal by Subject|7|||
125281615|NCT01973387|450656422|FG001|Overall Study|Withdrawal by Subject|4|||
125281616|NCT01973387|450656421|FG000|Overall Study|Study terminated by sponsor|63|||
125281617|NCT01973387|450656422|FG001|Overall Study|Study terminated by sponsor|0|||
125281618|NCT01973387|450656421|FG000|Overall Study|Progressive disease or relapse|16|||
125281619|NCT01973387|450656422|FG001|Overall Study|Progressive disease or relapse|5|||
125281620|NCT01973387|450656421|FG000|Overall Study|Death|4|||
125281621|NCT01973387|450656422|FG001|Overall Study|Death|3|||
125281622|NCT01973387|450656421|FG000|Overall Study|Randomized, not treated|2|||
125281623|NCT01973387|450656422|FG001|Overall Study|Randomized, not treated|2|||
125281624|NCT03831191|450656425|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
125281625|NCT03831191|450656426|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
125281626|NCT03831191|450656427|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
125281627|NCT03831191|450656428|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
125281628|NCT03831191|450656429|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
125281629|NCT03831191|450656430|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
125281630|NCT03831191|450656431|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
125281631|NCT03831191|450656432|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
125281632|NCT03831191|450656433|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
125281633|NCT03831191|450656434|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
125281634|NCT03831191|450656435|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
125281635|NCT03831191|450656436|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
125281636|NCT03831191|450656437|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
125281637|NCT03831191|450656438|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
125281638|NCT03831191|450656439|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
125281639|NCT03831191|450656425|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
125281640|NCT03831191|450656426|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
125281641|NCT03831191|450656427|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281642|NCT03831191|450656428|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281643|NCT03831191|450656429|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281644|NCT03831191|450656430|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281645|NCT03831191|450656431|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281646|NCT03831191|450656432|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281647|NCT03831191|450656433|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281648|NCT03831191|450656434|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281649|NCT03831191|450656435|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281650|NCT03831191|450656436|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281651|NCT03831191|450656437|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281652|NCT03831191|450656438|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281653|NCT03831191|450656439|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281654|NCT03831191|450656425|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
125281655|NCT03831191|450656426|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
125281656|NCT03831191|450656427|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
125281657|NCT03831191|450656428|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
125281658|NCT03831191|450656429|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
125281659|NCT03831191|450656430|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
125281660|NCT03831191|450656431|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
125281661|NCT03831191|450656432|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
125281662|NCT03831191|450656433|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
125281663|NCT03831191|450656434|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
125281664|NCT03831191|450656435|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
125281665|NCT03831191|450656436|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
125281666|NCT03831191|450656437|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
125281667|NCT03831191|450656438|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
125281668|NCT03831191|450656439|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
125281669|NCT03831191|450656425|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
125281670|NCT03831191|450656426|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
125281671|NCT03831191|450656427|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
125281672|NCT03831191|450656428|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
125281673|NCT03831191|450656429|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
125281674|NCT03831191|450656430|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
125281675|NCT03831191|450656431|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
125281676|NCT03831191|450656432|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
125281677|NCT03831191|450656433|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
125281678|NCT03831191|450656434|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
125281679|NCT03831191|450656435|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
125281680|NCT03831191|450656436|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
125281681|NCT03831191|450656437|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
125281682|NCT03831191|450656438|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
125281683|NCT03831191|450656439|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
125281684|NCT03831191|450656425|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
125281685|NCT03831191|450656426|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
125281686|NCT03831191|450656427|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
125281687|NCT03831191|450656428|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
125281688|NCT03831191|450656429|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281689|NCT03831191|450656430|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281690|NCT03831191|450656431|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281691|NCT03831191|450656432|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281692|NCT03831191|450656433|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281693|NCT03831191|450656434|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281694|NCT03831191|450656435|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281695|NCT03831191|450656436|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281696|NCT03831191|450656437|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281697|NCT03831191|450656438|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281698|NCT03831191|450656439|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281699|NCT03831191|450656425|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
125281700|NCT03831191|450656426|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
125281701|NCT03831191|450656427|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
125281702|NCT03831191|450656428|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
125281703|NCT03831191|450656429|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281704|NCT03831191|450656430|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281705|NCT03831191|450656431|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281706|NCT03831191|450656432|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281707|NCT03831191|450656433|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281708|NCT03831191|450656434|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281709|NCT03831191|450656435|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281710|NCT03831191|450656436|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281711|NCT03831191|450656437|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281712|NCT03831191|450656438|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281713|NCT03831191|450656439|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281714|NCT03831191|450656425|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281715|NCT03831191|450656426|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281716|NCT03831191|450656427|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281717|NCT03831191|450656428|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
125281718|NCT03831191|450656429|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281719|NCT03831191|450656430|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281720|NCT03831191|450656431|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281721|NCT03831191|450656432|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281722|NCT03831191|450656433|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281723|NCT03831191|450656434|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281724|NCT03831191|450656435|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281725|NCT03831191|450656436|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281726|NCT03831191|450656437|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281727|NCT03831191|450656438|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281728|NCT03831191|450656439|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281729|NCT03831191|450656425|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
125281730|NCT03831191|450656426|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
125281731|NCT03831191|450656427|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
125281732|NCT03831191|450656428|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
125281733|NCT03831191|450656429|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
125281734|NCT03831191|450656430|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
125281735|NCT03831191|450656431|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
125281736|NCT03831191|450656432|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
125281737|NCT03831191|450656433|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
125281738|NCT03831191|450656434|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
125281739|NCT03831191|450656435|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
125281740|NCT03831191|450656436|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
125281741|NCT03831191|450656437|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
124781882|NCT00530816|448831198|FG002|Overall Study|Adverse Event|7|||
125281742|NCT03831191|450656438|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
125281743|NCT03831191|450656439|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
125281744|NCT03831191|450656425|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281745|NCT03831191|450656426|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281746|NCT03831191|450656427|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281747|NCT03831191|450656428|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281748|NCT03831191|450656429|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281749|NCT03831191|450656430|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281750|NCT03831191|450656431|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281751|NCT03831191|450656432|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281752|NCT03831191|450656433|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281753|NCT03831191|450656434|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281754|NCT03831191|450656435|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281755|NCT03831191|450656436|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281756|NCT03831191|450656437|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281757|NCT03831191|450656438|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281758|NCT03831191|450656439|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
125281759|NCT03831191|450656425|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281760|NCT03831191|450656426|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281761|NCT03831191|450656427|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281762|NCT03831191|450656428|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281763|NCT03831191|450656429|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281764|NCT03831191|450656430|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281765|NCT03831191|450656431|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281766|NCT03831191|450656432|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281767|NCT03831191|450656433|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281768|NCT03831191|450656434|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281769|NCT03831191|450656435|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281770|NCT03831191|450656436|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281771|NCT03831191|450656437|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281772|NCT03831191|450656438|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281773|NCT03831191|450656439|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
125281774|NCT01562314|450656440|FG000|Overall Study|Adverse Event|10|||
125281775|NCT01562314|450656441|FG001|Overall Study|Adverse Event|5|||
125281776|NCT01562314|450656440|FG000|Overall Study|Met Withdrawal Criteria|3|||
125281777|NCT01562314|450656441|FG001|Overall Study|Met Withdrawal Criteria|2|||
125281778|NCT01562314|450656440|FG000|Overall Study|Withdrawal by Subject|0|||
125281779|NCT01562314|450656441|FG001|Overall Study|Withdrawal by Subject|1|||
125281780|NCT03655054|450656442|FG000|Overall Study|Lost to Follow-up|1|||
125281781|NCT02256384|450656453|FG000|Overall Study|Withdrawal by Subject|12|||
125281782|NCT02256384|450656453|FG000|Overall Study|Equipment not capturing data|2|||
125281783|NCT00244933|450656457|FG000|Overall Study|Not response evaluable|2|||
125281784|NCT00349921|450656458|FG000|First Spinal Injection|Physician Decision|1|||
125281785|NCT00349921|450656459|FG001|First Spinal Injection|Physician Decision|0|||
125281786|NCT00349921|450656460|FG002|First Spinal Injection|Physician Decision|0|||
125281787|NCT00349921|450656461|FG003|First Spinal Injection|Physician Decision|0|||
125281788|NCT00349921|450656458|FG000|First Spinal Injection|Adverse Event|0|||
125281789|NCT00349921|450656459|FG001|First Spinal Injection|Adverse Event|0|||
125281790|NCT00349921|450656460|FG002|First Spinal Injection|Adverse Event|1|||
125281791|NCT00349921|450656461|FG003|First Spinal Injection|Adverse Event|0|||
125281792|NCT00920387|450656462|FG000|Stage 1|Adverse Event|1|||
125281793|NCT00920387|450656463|FG001|Stage 1|Adverse Event|0|||
125281794|NCT00920387|450656464|FG002|Stage 1|Adverse Event|0|||
125281795|NCT00157196|450656465|FG000|Overall Study|Ongoing at data cut-off|9|||
125281796|NCT02524275|450656466|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
125281797|NCT00778258|450656467|FG000|Overall Study|Adverse Event|1|||
125281798|NCT00778258|450656468|FG001|Overall Study|Adverse Event|0|||
125281799|NCT00778258|450656469|FG002|Overall Study|Adverse Event|0|||
125281800|NCT00778258|450656470|FG003|Overall Study|Adverse Event|0|||
125281801|NCT00778258|450656471|FG004|Overall Study|Adverse Event|0|||
125281802|NCT00778258|450656472|FG005|Overall Study|Adverse Event|1|||
125281803|NCT00778258|450656473|FG006|Overall Study|Adverse Event|0|||
125281804|NCT00778258|450656474|FG007|Overall Study|Adverse Event|0|||
125281805|NCT00778258|450656475|FG008|Overall Study|Adverse Event|0|||
125281806|NCT00778258|450656467|FG000|Overall Study|Lost to Follow-up|0|||
125281807|NCT00778258|450656468|FG001|Overall Study|Lost to Follow-up|0|||
125281808|NCT00778258|450656469|FG002|Overall Study|Lost to Follow-up|2|||
125281809|NCT00778258|450656470|FG003|Overall Study|Lost to Follow-up|0|||
125281810|NCT00778258|450656471|FG004|Overall Study|Lost to Follow-up|0|||
125281811|NCT00778258|450656472|FG005|Overall Study|Lost to Follow-up|3|||
125281812|NCT00778258|450656473|FG006|Overall Study|Lost to Follow-up|2|||
125281813|NCT00778258|450656474|FG007|Overall Study|Lost to Follow-up|2|||
125281814|NCT00778258|450656475|FG008|Overall Study|Lost to Follow-up|0|||
125281815|NCT00778258|450656467|FG000|Overall Study|Withdrawal by Subject|6|||
125281816|NCT00778258|450656468|FG001|Overall Study|Withdrawal by Subject|2|||
125281817|NCT00778258|450656469|FG002|Overall Study|Withdrawal by Subject|8|||
125281818|NCT00778258|450656470|FG003|Overall Study|Withdrawal by Subject|2|||
125281819|NCT00778258|450656471|FG004|Overall Study|Withdrawal by Subject|0|||
125281820|NCT00778258|450656472|FG005|Overall Study|Withdrawal by Subject|6|||
125281821|NCT00778258|450656473|FG006|Overall Study|Withdrawal by Subject|12|||
125281822|NCT00778258|450656474|FG007|Overall Study|Withdrawal by Subject|12|||
125281823|NCT00778258|450656475|FG008|Overall Study|Withdrawal by Subject|4|||
125281824|NCT00778258|450656467|FG000|Overall Study|New Contraindication|0|||
125281825|NCT00778258|450656468|FG001|Overall Study|New Contraindication|0|||
125281826|NCT00778258|450656469|FG002|Overall Study|New Contraindication|0|||
125281827|NCT00778258|450656470|FG003|Overall Study|New Contraindication|0|||
125281828|NCT00778258|450656471|FG004|Overall Study|New Contraindication|0|||
125281829|NCT00778258|450656472|FG005|Overall Study|New Contraindication|0|||
125281830|NCT00778258|450656473|FG006|Overall Study|New Contraindication|0|||
125281831|NCT00778258|450656474|FG007|Overall Study|New Contraindication|1|||
125281832|NCT00778258|450656475|FG008|Overall Study|New Contraindication|0|||
125281833|NCT00778258|450656467|FG000|Overall Study|Non-compliance|0|||
125281834|NCT00778258|450656468|FG001|Overall Study|Non-compliance|0|||
125281835|NCT00778258|450656469|FG002|Overall Study|Non-compliance|0|||
125281836|NCT00778258|450656470|FG003|Overall Study|Non-compliance|1|||
125281837|NCT00778258|450656471|FG004|Overall Study|Non-compliance|0|||
125281838|NCT00778258|450656472|FG005|Overall Study|Non-compliance|0|||
125281839|NCT00778258|450656473|FG006|Overall Study|Non-compliance|0|||
125281840|NCT00778258|450656474|FG007|Overall Study|Non-compliance|0|||
125281841|NCT00778258|450656475|FG008|Overall Study|Non-compliance|0|||
125281842|NCT00778258|450656467|FG000|Overall Study|Other|0|||
125281843|NCT00778258|450656468|FG001|Overall Study|Other|0|||
125281844|NCT00778258|450656469|FG002|Overall Study|Other|0|||
125281845|NCT00778258|450656470|FG003|Overall Study|Other|0|||
125281846|NCT00778258|450656471|FG004|Overall Study|Other|0|||
125281847|NCT00778258|450656472|FG005|Overall Study|Other|0|||
125281848|NCT00778258|450656473|FG006|Overall Study|Other|1|||
125281849|NCT00778258|450656474|FG007|Overall Study|Other|0|||
125281850|NCT00778258|450656475|FG008|Overall Study|Other|0|||
125281851|NCT00780143|450656484|FG000|Overall Study|Progressive disease|1|||
125281852|NCT00780143|450656484|FG000|Overall Study|Toxicity|1|||
125281853|NCT00780143|450656484|FG000|Overall Study|Adverse Event|1|||
125281854|NCT00082368|450656487|FG000|Overall Study|Not treated-pt had poor IV access|1|||
125281855|NCT00322452|450656488|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125281856|NCT00322452|450656489|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
125281857|NCT00322452|450656488|FG000|Overall Study|Lost to Follow-up|5|||
125281858|NCT00322452|450656489|FG001|Overall Study|Lost to Follow-up|2|||
125281859|NCT00322452|450656488|FG000|Overall Study|Withdrawal by Subject|19|||
125281860|NCT00322452|450656489|FG001|Overall Study|Withdrawal by Subject|46|||
125281861|NCT00322452|450656488|FG000|Overall Study|Death|223|||
125281862|NCT00322452|450656489|FG001|Overall Study|Death|227|||
125281863|NCT00882583|450658336|FG000|Overall Study|Physician Decision|1|||
125281864|NCT00882583|450658337|FG001|Overall Study|Physician Decision|0|||
125281865|NCT00882583|450658336|FG000|Overall Study|Adverse Event|0|||
125281866|NCT00882583|450658337|FG001|Overall Study|Adverse Event|1|||
125281867|NCT04753658|450658338|FG000|Overall Study|Progressive disease|7|||
125281868|NCT04753658|450658338|FG000|Overall Study|Other|7|||
125281869|NCT04753658|450658338|FG000|Overall Study|Adverse Event|1|||
125281870|NCT00218634|450658339|FG000|Overall Study|Lost to Follow-up|8|||
125281871|NCT00218634|450658340|FG001|Overall Study|Lost to Follow-up|15|||
125281872|NCT05243745|450658341|FG000|Overall Study|Withdrawal by Subject|0|||
125281873|NCT05243745|450658342|FG001|Overall Study|Withdrawal by Subject|0|||
125281874|NCT05243745|450658343|FG002|Overall Study|Withdrawal by Subject|0|||
125281875|NCT05243745|450658344|FG003|Overall Study|Withdrawal by Subject|1|||
125281876|NCT05243745|450658341|FG000|Overall Study|Unable to Attend Visit 6|0|||
125281877|NCT05243745|450658342|FG001|Overall Study|Unable to Attend Visit 6|0|||
125281878|NCT05243745|450658343|FG002|Overall Study|Unable to Attend Visit 6|1|||
125281879|NCT05243745|450658344|FG003|Overall Study|Unable to Attend Visit 6|0|||
125281880|NCT03842969|450658355|FG000|Overall Study|Participant declined follow-up visit|0|||
125281881|NCT03842969|450658356|FG001|Overall Study|Participant declined follow-up visit|1|||
125281882|NCT03842969|450658357|FG002|Overall Study|Participant declined follow-up visit|0|||
125281883|NCT03842969|450658355|FG000|Overall Study|Sponsor's decision|12|||
125281884|NCT03842969|450658356|FG001|Overall Study|Sponsor's decision|99|||
125281885|NCT03842969|450658357|FG002|Overall Study|Sponsor's decision|61|||
125281886|NCT03842969|450658355|FG000|Overall Study|Pregnancy|0|||
125281887|NCT03842969|450658356|FG001|Overall Study|Pregnancy|0|||
125281888|NCT03842969|450658357|FG002|Overall Study|Pregnancy|1|||
125281889|NCT03842969|450658355|FG000|Overall Study|Death|1|||
125281890|NCT03842969|450658356|FG001|Overall Study|Death|0|||
125281891|NCT03842969|450658357|FG002|Overall Study|Death|1|||
125281892|NCT03842969|450658355|FG000|Overall Study|Withdrawal by Subject|3|||
125281893|NCT03842969|450658356|FG001|Overall Study|Withdrawal by Subject|30|||
125281894|NCT03842969|450658357|FG002|Overall Study|Withdrawal by Subject|18|||
125281895|NCT03842969|450658355|FG000|Overall Study|Protocol Violation|1|||
125281896|NCT03842969|450658356|FG001|Overall Study|Protocol Violation|1|||
125281897|NCT03842969|450658357|FG002|Overall Study|Protocol Violation|0|||
125281898|NCT03842969|450658355|FG000|Overall Study|Physician Decision|0|||
125281899|NCT03842969|450658356|FG001|Overall Study|Physician Decision|3|||
125281900|NCT03842969|450658357|FG002|Overall Study|Physician Decision|0|||
125281901|NCT03842969|450658355|FG000|Overall Study|Lost to Follow-up|0|||
125281902|NCT03842969|450658356|FG001|Overall Study|Lost to Follow-up|2|||
125281903|NCT03842969|450658357|FG002|Overall Study|Lost to Follow-up|0|||
125281904|NCT03842969|450658355|FG000|Overall Study|Adverse Event|0|||
125281905|NCT03842969|450658356|FG001|Overall Study|Adverse Event|2|||
125281906|NCT03842969|450658357|FG002|Overall Study|Adverse Event|0|||
125281907|NCT01044745|450658358|FG000|Overall Study|Ineiligible|2|||
125281908|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Adverse Event|76|||
125281909|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Adverse Event|0|||
125281910|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Adverse Event|0|||
125281911|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Death|3|||
125281912|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Death|0|||
125281913|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Death|0|||
125281914|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
125281915|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
125281916|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
125281917|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Physician Decision|9|||
125281918|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Physician Decision|0|||
125281919|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Physician Decision|0|||
125281920|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
125281921|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
125281922|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
125281923|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Disease progression|45|||
125281924|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Disease progression|0|||
125281925|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Disease progression|0|||
125281926|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
125281927|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
125281928|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
125281929|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
125281930|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
125281931|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
125281932|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
125281933|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
125281934|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
125281935|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
125281936|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
125281937|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
125281938|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
125281939|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
125281940|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
125281941|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
125281942|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
125281943|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
125281944|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
125281945|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
125281946|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
125281947|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
125281948|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
125281949|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
125281950|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
125281951|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
125281952|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
125281953|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Promotor request|1|||
125281954|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Promotor request|0|||
125281955|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Promotor request|0|||
125281956|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
125281957|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
125281958|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
125281959|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
125281960|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
125281961|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
125281962|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Death|3|||
124781883|NCT00530816|448831196|FG000|Overall Study|Other|3|||
124781884|NCT00530816|448831197|FG001|Overall Study|Other|3|||
124781885|NCT00530816|448831198|FG002|Overall Study|Other|4|||
124781886|NCT00530816|448831196|FG000|Overall Study|Withdrawal by Subject|1|||
124781887|NCT00530816|448831197|FG001|Overall Study|Withdrawal by Subject|2|||
124781888|NCT00530816|448831198|FG002|Overall Study|Withdrawal by Subject|6|||
124781889|NCT01388985|448831201|FG000|Overall Study|Death|0|||
124781890|NCT01388985|448831202|FG001|Overall Study|Death|1|||
124781891|NCT01388985|448831201|FG000|Overall Study|Lost to Follow-up|30|||
124781892|NCT01388985|448831202|FG001|Overall Study|Lost to Follow-up|30|||
124781893|NCT01388985|448831201|FG000|Overall Study|Withdrawal by Subject|13|||
124781894|NCT01388985|448831202|FG001|Overall Study|Withdrawal by Subject|4|||
125281963|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Death|0|||
125281964|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Death|0|||
125281965|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
125281966|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
125281967|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
125281968|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
124781895|NCT01388985|448831201|FG000|Overall Study|Subject unavailable|1|||
124781896|NCT01388985|448831202|FG001|Overall Study|Subject unavailable|1|||
124781897|NCT01388985|448831201|FG000|Overall Study|Other (no reason)|0|||
124781898|NCT01388985|448831202|FG001|Overall Study|Other (no reason)|1|||
124781899|NCT01388985|448831201|FG000|Overall Study|Error of nurse|5|||
124781900|NCT01388985|448831202|FG001|Overall Study|Error of nurse|1|||
125281969|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
125281970|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
125281971|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Diseases progression|91|||
125281972|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Diseases progression|0|||
125281973|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Diseases progression|0|||
125281974|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Adverse Event|70|||
125281975|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Adverse Event|0|||
125281976|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Adverse Event|0|||
125281977|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Physician Decision|9|||
125281978|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Physician Decision|0|||
125281979|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Physician Decision|0|||
125281980|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
125281981|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
125281982|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
125281983|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
125281984|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
125281985|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
125281986|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
124781901|NCT01057589|448831203|FG000|Overall Study|Disease Progression|35|||
125281987|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
125281988|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
125281989|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Not compliant|1|||
125281990|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Not compliant|0|||
125281991|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Not compliant|0|||
125281992|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
125281993|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
125281994|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
125281995|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Adverse Event|0|||
125281996|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Adverse Event|2|||
125281997|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Adverse Event|0|||
125281998|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Death|0|||
125281999|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Death|10|||
125282000|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Death|8|||
125282001|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Physician Decision|0|||
125282002|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Physician Decision|0|||
125282003|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Physician Decision|4|||
125282004|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
125282005|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
125282006|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
125282007|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Moved to another town|0|||
125282008|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Moved to another town|1|||
125282009|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Moved to another town|0|||
125282010|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Disease progression|0|||
125282011|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Disease progression|0|||
125282012|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Disease progression|3|||
125282013|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
125282014|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
125282015|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
125282016|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
125282017|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
125282018|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
125282019|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
125282020|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
125282021|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
125282022|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
125282023|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
125282024|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
125282025|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
125282026|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
125282027|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
125282028|NCT01159171|450658365|FG000|Overall Study|Adverse Event|11|||
125282029|NCT01159171|450658365|FG000|Overall Study|Progression of Disease|28|||
125282030|NCT01159171|450658365|FG000|Overall Study|Protocol Violation|1|||
125282031|NCT01159171|450658365|FG000|Overall Study|Need for Surgery|5|||
125282032|NCT01159171|450658365|FG000|Overall Study|Medical Decision|4|||
125282033|NCT01159171|450658365|FG000|Overall Study|Death|1|||
125282034|NCT01892436|450658366|FG000|Overall Study|Withdrawal by Subject|8|||
125282035|NCT01892436|450658367|FG001|Overall Study|Withdrawal by Subject|15|||
125282036|NCT01892436|450658368|FG002|Overall Study|Withdrawal by Subject|4|||
125282037|NCT01892436|450658369|FG003|Overall Study|Withdrawal by Subject|4|||
125282038|NCT01892436|450658366|FG000|Overall Study|Death|1|||
125282039|NCT01892436|450658367|FG001|Overall Study|Death|1|||
125282040|NCT01892436|450658368|FG002|Overall Study|Death|0|||
125282041|NCT01892436|450658369|FG003|Overall Study|Death|0|||
125282042|NCT01892436|450658366|FG000|Overall Study|Physician Decision|2|||
125282043|NCT01892436|450658367|FG001|Overall Study|Physician Decision|1|||
125282044|NCT01892436|450658368|FG002|Overall Study|Physician Decision|0|||
125282045|NCT01892436|450658369|FG003|Overall Study|Physician Decision|1|||
125282046|NCT01892436|450658366|FG000|Overall Study|Pregnancy|0|||
125282047|NCT01892436|450658367|FG001|Overall Study|Pregnancy|2|||
125282048|NCT01892436|450658368|FG002|Overall Study|Pregnancy|1|||
125282049|NCT01892436|450658369|FG003|Overall Study|Pregnancy|0|||
125282050|NCT01892436|450658366|FG000|Overall Study|Technical problems|2|||
125282051|NCT01892436|450658367|FG001|Overall Study|Technical problems|1|||
125282052|NCT01892436|450658368|FG002|Overall Study|Technical problems|1|||
125282053|NCT01892436|450658369|FG003|Overall Study|Technical problems|1|||
125282054|NCT01892436|450658366|FG000|Overall Study|Lack of Efficacy|1|||
125282055|NCT01892436|450658367|FG001|Overall Study|Lack of Efficacy|2|||
125282056|NCT01892436|450658368|FG002|Overall Study|Lack of Efficacy|2|||
125282057|NCT01892436|450658369|FG003|Overall Study|Lack of Efficacy|2|||
125282058|NCT01892436|450658366|FG000|Overall Study|Lost to Follow-up|1|||
125282059|NCT01892436|450658367|FG001|Overall Study|Lost to Follow-up|1|||
125282060|NCT01892436|450658368|FG002|Overall Study|Lost to Follow-up|1|||
125282061|NCT01892436|450658369|FG003|Overall Study|Lost to Follow-up|3|||
125282062|NCT01892436|450658366|FG000|Overall Study|non-compliance with treatment|1|||
125282063|NCT01892436|450658367|FG001|Overall Study|non-compliance with treatment|0|||
125282064|NCT01892436|450658368|FG002|Overall Study|non-compliance with treatment|0|||
125282065|NCT01892436|450658369|FG003|Overall Study|non-compliance with treatment|0|||
125282066|NCT01892436|450658366|FG000|Overall Study|Adverse Event|7|||
125282067|NCT01892436|450658367|FG001|Overall Study|Adverse Event|6|||
125282068|NCT01892436|450658368|FG002|Overall Study|Adverse Event|2|||
125282069|NCT01892436|450658369|FG003|Overall Study|Adverse Event|3|||
125282070|NCT00733291|450658371|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
125282071|NCT00733291|450658372|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
125282072|NCT00733291|450658373|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
125282073|NCT00733291|450658374|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
125282074|NCT02242435|450658385|FG000|Overall Study|Lost to Follow-up|3|||
125282075|NCT02242435|450658386|FG001|Overall Study|Lost to Follow-up|4|||
125282076|NCT02242435|450658385|FG000|Overall Study|Adverse Event|3|||
125282077|NCT02242435|450658386|FG001|Overall Study|Adverse Event|2|||
125282078|NCT02242435|450658385|FG000|Overall Study|Withdrawal by Subject|13|||
125282079|NCT02242435|450658386|FG001|Overall Study|Withdrawal by Subject|8|||
125282080|NCT02242435|450658385|FG000|Overall Study|Death|0|||
125282081|NCT02242435|450658386|FG001|Overall Study|Death|1|||
125282082|NCT02242435|450658385|FG000|Overall Study|Protocol Violation|1|||
125282083|NCT02242435|450658386|FG001|Overall Study|Protocol Violation|0|||
125282084|NCT02242435|450658385|FG000|Overall Study|Physician Decision|0|||
125282085|NCT02242435|450658386|FG001|Overall Study|Physician Decision|1|||
125282086|NCT03895086|450658388|FG000|Overall Study|Early termination study|1|||
125282087|NCT03895086|450658389|FG001|Overall Study|Early termination study|0|||
125282088|NCT01089413|450658393|FG000|Overall Study|Lost to Follow-up|1|||
125282089|NCT01089413|450658393|FG000|Overall Study|Progressive Disease|93|||
125282090|NCT01089413|450658393|FG000|Overall Study|Participant Withdrew Consent|1|||
125282091|NCT01089413|450658393|FG000|Overall Study|Unacceptable Toxicity|12|||
125282092|NCT01089413|450658393|FG000|Overall Study|Death|10|||
125282093|NCT01089413|450658393|FG000|Overall Study|Metastasectomy|13|||
125282094|NCT01089413|450658393|FG000|Overall Study|Other|71|||
125282095|NCT00420004|450658403|FG000|Overall Study|Adverse Event|4|||
125282096|NCT00420004|450658404|FG001|Overall Study|Adverse Event|1|||
125282097|NCT00420004|450658405|FG002|Overall Study|Adverse Event|1|||
125282098|NCT00420004|450658403|FG000|Overall Study|Lack of Efficacy|5|||
125282099|NCT00420004|450658404|FG001|Overall Study|Lack of Efficacy|4|||
125282100|NCT00420004|450658405|FG002|Overall Study|Lack of Efficacy|1|||
125282101|NCT00420004|450658403|FG000|Overall Study|Lost to Follow-up|31|||
125282102|NCT00420004|450658404|FG001|Overall Study|Lost to Follow-up|12|||
125282103|NCT00420004|450658405|FG002|Overall Study|Lost to Follow-up|10|||
125282104|NCT00420004|450658403|FG000|Overall Study|Entry Criteria Not Met|0|||
125282105|NCT00420004|450658404|FG001|Overall Study|Entry Criteria Not Met|1|||
125282106|NCT00420004|450658405|FG002|Overall Study|Entry Criteria Not Met|0|||
125282107|NCT00420004|450658403|FG000|Overall Study|Physician Decision|14|||
125282108|NCT00420004|450658404|FG001|Overall Study|Physician Decision|4|||
125282109|NCT00420004|450658405|FG002|Overall Study|Physician Decision|2|||
125282110|NCT00420004|450658403|FG000|Overall Study|Protocol Violation|5|||
125282111|NCT00420004|450658404|FG001|Overall Study|Protocol Violation|4|||
125282112|NCT00420004|450658405|FG002|Overall Study|Protocol Violation|3|||
125282113|NCT00420004|450658403|FG000|Overall Study|Withdrawal by Subject|67|||
125282114|NCT00420004|450658404|FG001|Overall Study|Withdrawal by Subject|42|||
125282115|NCT00420004|450658405|FG002|Overall Study|Withdrawal by Subject|14|||
125282116|NCT00420004|450658403|FG000|Overall Study|Sponsor Decision|3|||
125282117|NCT00420004|450658404|FG001|Overall Study|Sponsor Decision|3|||
125282118|NCT00420004|450658405|FG002|Overall Study|Sponsor Decision|1|||
125282119|NCT00591149|450658407|FG000|Overall Study|Adverse Event|4|||
125282120|NCT00591149|450658407|FG000|Overall Study|Withdrawal by Subject|1|||
125282121|NCT00470093|450658408|FG000|Overall Study|Adverse Event|2|||
124781902|NCT01057589|448831203|FG000|Overall Study|Adverse Event|10|||
125282122|NCT02456636|450658409|FG000|Overall Study|Death|0|||
125282123|NCT02456636|450658410|FG001|Overall Study|Death|3|||
125282124|NCT02456636|450658411|FG002|Overall Study|Death|0|||
125282125|NCT02456636|450658409|FG000|Overall Study|Pregnancy|1|||
125282126|NCT02456636|450658410|FG001|Overall Study|Pregnancy|3|||
125282127|NCT02456636|450658411|FG002|Overall Study|Pregnancy|5|||
125282128|NCT02456636|450658409|FG000|Overall Study|Physician Decision|4|||
124781903|NCT01057589|448831203|FG000|Overall Study|Physician Decision|8|||
124781904|NCT01057589|448831203|FG000|Overall Study|Withdrawal by Subject|3|||
125282129|NCT02456636|450658410|FG001|Overall Study|Physician Decision|5|||
125282130|NCT02456636|450658411|FG002|Overall Study|Physician Decision|4|||
125282131|NCT02456636|450658409|FG000|Overall Study|Withdrawal by Subject|13|||
125282132|NCT02456636|450658410|FG001|Overall Study|Withdrawal by Subject|14|||
125282133|NCT02456636|450658411|FG002|Overall Study|Withdrawal by Subject|16|||
125282134|NCT02456636|450658409|FG000|Overall Study|Lost to Follow-up|50|||
125282135|NCT02456636|450658410|FG001|Overall Study|Lost to Follow-up|44|||
124781905|NCT01057589|448831203|FG000|Overall Study|Sponsor Decision|1|||
124781906|NCT01057589|448831203|FG000|Overall Study|Death|8|||
124781907|NCT01057589|448831203|FG000|Overall Study|Lost to Follow-up|1|||
125282136|NCT02456636|450658411|FG002|Overall Study|Lost to Follow-up|50|||
125282137|NCT02379221|450658412|FG000|Overall Study|Lost to Follow-up|1|||
125282138|NCT01610557|450658413|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
125282139|NCT01610557|450658414|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
125282140|NCT01610557|450658415|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
125282141|NCT01610557|450658416|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
125282142|NCT01610557|450658417|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
125282143|NCT01610557|450658413|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
124781908|NCT00899431|448831206|FG000|Overall Study|Physician Decision|1|||
124781909|NCT00899431|448831207|FG001|Overall Study|Physician Decision|0|||
124781910|NCT00899431|448831208|FG002|Overall Study|Physician Decision|0|||
124781911|NCT03304249|448831212|FG000|Overall Study|Lost to Follow-up|8|||
124781912|NCT03304249|448831213|FG001|Overall Study|Lost to Follow-up|10|||
124781913|NCT03304249|448831212|FG000|Overall Study|Withdrawal by Subject|12|||
124781914|NCT03304249|448831213|FG001|Overall Study|Withdrawal by Subject|2|||
124781915|NCT03304249|448831212|FG000|Overall Study|Moved Out of District|4|||
124781916|NCT03304249|448831213|FG001|Overall Study|Moved Out of District|2|||
124781917|NCT01253577|448831214|FG000|Overall Study|Lost to Follow-up|3|||
125282144|NCT01610557|450658414|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
125282145|NCT01610557|450658415|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
125282146|NCT01610557|450658416|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
125282147|NCT01610557|450658417|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
125282148|NCT00519376|450658420|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282149|NCT00519376|450658421|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282150|NCT00519376|450658422|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282151|NCT00519376|450658423|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282152|NCT00519376|450658424|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282153|NCT00519376|450658425|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282154|NCT00519376|450658426|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282155|NCT00519376|450658427|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282156|NCT00519376|450658428|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
124781918|NCT00334113|448831215|FG000|Overall Study|Lost to Follow-up|2|||
124781919|NCT00334113|448831216|FG001|Overall Study|Lost to Follow-up|2|||
124781920|NCT00334113|448831215|FG000|Overall Study|Withdrawal by Subject|0|||
124781921|NCT00334113|448831216|FG001|Overall Study|Withdrawal by Subject|1|||
124781922|NCT04189224|448831217|FG000|Period 2|Adverse Event|0|||
124781923|NCT04189224|448831218|FG001|Period 2|Adverse Event|1|||
124781924|NCT02509026|448831219|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
124781925|NCT02509026|448831219|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
124781926|NCT02509026|448831219|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
125282157|NCT00519376|450658429|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282158|NCT00519376|450658430|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282159|NCT00519376|450658431|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
124781927|NCT02509026|448831219|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
124781928|NCT02509026|448831219|FG000|Induction Period (24 Weeks)|Other|2|||
124781929|NCT02509026|448831219|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
124781930|NCT02509026|448831219|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
124781931|NCT02509026|448831219|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
124781932|NCT02509026|448831219|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
124781933|NCT02509026|448831219|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
124781934|NCT02509026|448831219|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
124781935|NCT02509026|448831219|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
124781936|NCT02509026|448831219|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
124781937|NCT00721968|448831220|FG000|Overall Study|Lost to Follow-up|2|||
124781938|NCT00721968|448831221|FG001|Overall Study|Lost to Follow-up|0|||
124781939|NCT04198714|448831222|FG000|Overall Study|Physician Decision|0|||
124781940|NCT04198714|448831223|FG001|Overall Study|Physician Decision|1|||
124781941|NCT01064947|448831224|FG000|Overall Study|negative culture|41|||
124781942|NCT02970942|448831225|FG000|Overall Study|Death|0|||
124781943|NCT02970942|448831226|FG001|Overall Study|Death|1|||
124781944|NCT02970942|448831227|FG002|Overall Study|Death|0|||
124781945|NCT02970942|448831228|FG003|Overall Study|Death|0|||
124781946|NCT02970942|448831225|FG000|Overall Study|Lost to Follow-up|1|||
124781947|NCT02970942|448831226|FG001|Overall Study|Lost to Follow-up|0|||
124781948|NCT02970942|448831227|FG002|Overall Study|Lost to Follow-up|2|||
124781949|NCT02970942|448831228|FG003|Overall Study|Lost to Follow-up|1|||
124781950|NCT02970942|448831225|FG000|Overall Study|Withdrawal by Subject|3|||
124781951|NCT02970942|448831226|FG001|Overall Study|Withdrawal by Subject|5|||
124781952|NCT02970942|448831227|FG002|Overall Study|Withdrawal by Subject|3|||
124781953|NCT02970942|448831228|FG003|Overall Study|Withdrawal by Subject|2|||
124781954|NCT02529553|448831231|FG000|Overall Study|Progressive Disease|1|||
124781955|NCT02529553|448831232|FG001|Overall Study|Progressive Disease|0|||
124781956|NCT02529553|448831233|FG002|Overall Study|Progressive Disease|1|||
125282160|NCT00519376|450658432|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
125282161|NCT00519376|450658433|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282162|NCT00519376|450658434|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282163|NCT00519376|450658435|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282164|NCT00519376|450658420|FG000|Treatment Period 4|Lost to Follow-up|0|||
125282165|NCT00519376|450658421|FG001|Treatment Period 4|Lost to Follow-up|0|||
125282166|NCT00519376|450658422|FG002|Treatment Period 4|Lost to Follow-up|1|||
125282167|NCT00519376|450658423|FG003|Treatment Period 4|Lost to Follow-up|0|||
125282168|NCT00519376|450658424|FG004|Treatment Period 4|Lost to Follow-up|0|||
125282169|NCT00519376|450658425|FG005|Treatment Period 4|Lost to Follow-up|0|||
125282170|NCT00519376|450658426|FG006|Treatment Period 4|Lost to Follow-up|0|||
125282171|NCT00519376|450658427|FG007|Treatment Period 4|Lost to Follow-up|0|||
125282172|NCT00519376|450658428|FG008|Treatment Period 4|Lost to Follow-up|0|||
125282173|NCT00519376|450658429|FG009|Treatment Period 4|Lost to Follow-up|0|||
125282174|NCT00519376|450658430|FG010|Treatment Period 4|Lost to Follow-up|0|||
125282175|NCT00519376|450658431|FG011|Treatment Period 4|Lost to Follow-up|0|||
125282176|NCT00519376|450658432|FG012|Treatment Period 4|Lost to Follow-up|0|||
125282177|NCT00519376|450658433|FG013|Treatment Period 4|Lost to Follow-up|0|||
125282178|NCT00519376|450658434|FG014|Treatment Period 4|Lost to Follow-up|0|||
125282179|NCT00519376|450658435|FG015|Treatment Period 4|Lost to Follow-up|0|||
125282180|NCT02039219|450658436|FG000|Treatment|Withdrawal by Subject|1|||
125282181|NCT02039219|450658437|FG001|Treatment|Withdrawal by Subject|0|||
125282182|NCT02039219|450658436|FG000|Treatment|Adverse Event|0|||
125282183|NCT02039219|450658437|FG001|Treatment|Adverse Event|1|||
125282184|NCT02039219|450658436|FG000|Treatment|Physician Decision|1|||
125282185|NCT02039219|450658437|FG001|Treatment|Physician Decision|0|||
125282186|NCT02039219|450658436|FG000|Treatment|Lost to Follow-up|0|||
125282187|NCT02039219|450658437|FG001|Treatment|Lost to Follow-up|1|||
125282188|NCT02039219|450658436|FG000|Treatment|Protocol Violation|1|||
125282189|NCT02039219|450658437|FG001|Treatment|Protocol Violation|0|||
125282190|NCT02039219|450658436|FG000|Treatment|Death|1|||
125282191|NCT02039219|450658437|FG001|Treatment|Death|0|||
125282192|NCT02039219|450658436|FG000|Follow up|Adverse Event|0|||
125282193|NCT02039219|450658437|FG001|Follow up|Adverse Event|1|||
125282194|NCT02974855|450658438|FG000|Overall Study|Adverse Event|0|||
125282195|NCT02974855|450658439|FG001|Overall Study|Adverse Event|1|||
125282196|NCT02974855|450658440|FG002|Overall Study|Adverse Event|0|||
125282197|NCT02974855|450658441|FG003|Overall Study|Adverse Event|1|||
125282198|NCT00129701|450658442|FG000|Overall Study|Withdrawal by Subject|33|||
125282199|NCT02750345|450658443|FG000|Intervention 1|Adverse Event|0|||
125282200|NCT02750345|450658444|FG001|Intervention 1|Adverse Event|0|||
125282201|NCT02750345|450658445|FG002|Intervention 1|Adverse Event|0|||
125282202|NCT02750345|450658446|FG003|Intervention 1|Adverse Event|0|||
125282203|NCT02750345|450658447|FG004|Intervention 1|Adverse Event|1|||
125282204|NCT02750345|450658448|FG005|Intervention 1|Adverse Event|0|||
125282205|NCT02650128|450658449|FG000|Overall Study|Death|2|||
125282206|NCT00608023|450658452|FG000|Overall Study|Withdrawal by Subject|8|||
125282207|NCT00608023|450658453|FG001|Overall Study|Withdrawal by Subject|10|||
125282208|NCT00608023|450658454|FG002|Overall Study|Withdrawal by Subject|7|||
125282209|NCT00608023|450658452|FG000|Overall Study|Adverse Event|1|||
125282210|NCT00608023|450658453|FG001|Overall Study|Adverse Event|4|||
125282211|NCT00608023|450658454|FG002|Overall Study|Adverse Event|5|||
125282212|NCT00608023|450658452|FG000|Overall Study|Lost to Follow-up|2|||
125282213|NCT00608023|450658453|FG001|Overall Study|Lost to Follow-up|2|||
125282214|NCT00608023|450658454|FG002|Overall Study|Lost to Follow-up|1|||
125282215|NCT00608023|450658452|FG000|Overall Study|Protocol Violation|1|||
125282216|NCT00608023|450658453|FG001|Overall Study|Protocol Violation|3|||
124781957|NCT02529553|448831234|FG003|Overall Study|Progressive Disease|3|||
124781958|NCT02529553|448831235|FG004|Overall Study|Progressive Disease|2|||
125282217|NCT00608023|450658454|FG002|Overall Study|Protocol Violation|1|||
125282218|NCT00608023|450658452|FG000|Overall Study|Unknown reason|0|||
125282219|NCT00608023|450658453|FG001|Overall Study|Unknown reason|3|||
125282220|NCT00608023|450658454|FG002|Overall Study|Unknown reason|0|||
125282221|NCT01801436|450658474|FG000|Overall Study|Withdrawal by Subject|3|||
125282222|NCT01801436|450658474|FG000|Overall Study|Adverse Event|2|||
125282223|NCT01801436|450658474|FG000|Overall Study|Progressive disease|4|||
125282224|NCT01126437|450658479|FG000|Overall Study|Not treated|11|||
125282225|NCT01126437|450658480|FG001|Overall Study|Not treated|18|||
125282226|NCT01126437|450658481|FG002|Overall Study|Not treated|19|||
125282227|NCT01126437|450658479|FG000|Overall Study|Sites with data irregularities/fraud|6|||
125282228|NCT01126437|450658480|FG001|Overall Study|Sites with data irregularities/fraud|6|||
125282229|NCT01126437|450658481|FG002|Overall Study|Sites with data irregularities/fraud|7|||
125282230|NCT01126437|450658479|FG000|Overall Study|Adverse Event|602|||
125282231|NCT01126437|450658480|FG001|Overall Study|Adverse Event|606|||
125282232|NCT01126437|450658481|FG002|Overall Study|Adverse Event|635|||
125282233|NCT01126437|450658479|FG000|Overall Study|Lack of Efficacy|65|||
125282234|NCT01126437|450658480|FG001|Overall Study|Lack of Efficacy|60|||
125282235|NCT01126437|450658481|FG002|Overall Study|Lack of Efficacy|59|||
125282236|NCT01126437|450658479|FG000|Overall Study|Protocol Violation|64|||
125282237|NCT01126437|450658480|FG001|Overall Study|Protocol Violation|66|||
125282238|NCT01126437|450658481|FG002|Overall Study|Protocol Violation|41|||
125282239|NCT01126437|450658479|FG000|Overall Study|Lost to Follow-up|52|||
125282240|NCT01126437|450658480|FG001|Overall Study|Lost to Follow-up|63|||
125282241|NCT01126437|450658481|FG002|Overall Study|Lost to Follow-up|55|||
125282242|NCT01126437|450658479|FG000|Overall Study|Withdrawal by Subject|331|||
125282243|NCT01126437|450658480|FG001|Overall Study|Withdrawal by Subject|335|||
125282244|NCT01126437|450658481|FG002|Overall Study|Withdrawal by Subject|319|||
125282245|NCT01126437|450658479|FG000|Overall Study|Other reason not specified|210|||
125282246|NCT01126437|450658480|FG001|Overall Study|Other reason not specified|176|||
125282247|NCT01126437|450658481|FG002|Overall Study|Other reason not specified|178|||
125282248|NCT01846663|450658488|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
125282249|NCT01846663|450658489|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
125282250|NCT01846663|450658488|FG000|Overall Study|Withdrawal by Subject|1|||
125282251|NCT01846663|450658489|FG001|Overall Study|Withdrawal by Subject|0|||
125282252|NCT01846663|450658488|FG000|Overall Study|Adverse Event|1|||
125282253|NCT01846663|450658489|FG001|Overall Study|Adverse Event|2|||
125282254|NCT00813865|450658495|FG000|Overall Study|Failure to Respond|3|||
125282255|NCT00813865|450658495|FG000|Overall Study|Lost to Follow-up|3|||
125282256|NCT00813865|450658495|FG000|Overall Study|Withdrawal by Subject|1|||
125282257|NCT03525600|450658496|FG000|Overall Study|Adverse Event|9|||
125282258|NCT03525600|450658497|FG001|Overall Study|Adverse Event|6|||
125282259|NCT03525600|450658498|FG002|Overall Study|Adverse Event|5|||
125282260|NCT03525600|450658499|FG003|Overall Study|Adverse Event|3|||
125282261|NCT03525600|450658496|FG000|Overall Study|Lost to Follow-up|2|||
125282262|NCT03525600|450658497|FG001|Overall Study|Lost to Follow-up|4|||
125282263|NCT03525600|450658498|FG002|Overall Study|Lost to Follow-up|4|||
125282264|NCT03525600|450658499|FG003|Overall Study|Lost to Follow-up|0|||
125282265|NCT03525600|450658496|FG000|Overall Study|Physician Decision|1|||
125282266|NCT03525600|450658497|FG001|Overall Study|Physician Decision|0|||
125282267|NCT03525600|450658498|FG002|Overall Study|Physician Decision|2|||
125282268|NCT03525600|450658499|FG003|Overall Study|Physician Decision|0|||
125282269|NCT03525600|450658496|FG000|Overall Study|Consent withdrawal|36|||
125282270|NCT03525600|450658497|FG001|Overall Study|Consent withdrawal|20|||
125282271|NCT03525600|450658498|FG002|Overall Study|Consent withdrawal|6|||
125282272|NCT03525600|450658499|FG003|Overall Study|Consent withdrawal|13|||
125282273|NCT03525600|450658496|FG000|Overall Study|Death|7|||
125282274|NCT03525600|450658497|FG001|Overall Study|Death|6|||
125282275|NCT03525600|450658498|FG002|Overall Study|Death|4|||
125282276|NCT03525600|450658499|FG003|Overall Study|Death|3|||
125282277|NCT03525600|450658496|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
125282278|NCT03525600|450658497|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
125282279|NCT03525600|450658498|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
125282280|NCT03525600|450658499|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
125282281|NCT03525600|450658496|FG000|Overall Study|Other|0|||
125282282|NCT03525600|450658497|FG001|Overall Study|Other|1|||
125282283|NCT03525600|450658498|FG002|Overall Study|Other|0|||
125282284|NCT03525600|450658499|FG003|Overall Study|Other|0|||
125282285|NCT03703817|450658507|FG000|Overall Study|Not meeting eligibility criteria|7|||
125282286|NCT03703817|450658508|FG001|Overall Study|Not meeting eligibility criteria|4|||
125282287|NCT03255967|450658511|FG000|Overall Study|Adverse Event|26|||
125282288|NCT03255967|450658512|FG001|Overall Study|Adverse Event|30|||
125282289|NCT03255967|450658511|FG000|Overall Study|Withdrawal by Subject|6|||
125282290|NCT03255967|450658512|FG001|Overall Study|Withdrawal by Subject|6|||
125282291|NCT03255967|450658511|FG000|Overall Study|Schedule conflict|6|||
125282292|NCT03255967|450658512|FG001|Overall Study|Schedule conflict|4|||
125282293|NCT03255967|450658511|FG000|Overall Study|POA did not sign consent form|2|||
125282294|NCT03255967|450658512|FG001|Overall Study|POA did not sign consent form|0|||
125282295|NCT01202188|450658513|FG000|Overall Study|Protocol deviation|14|||
125282296|NCT01202188|450658514|FG001|Overall Study|Protocol deviation|8|||
125282297|NCT01202188|450658515|FG002|Overall Study|Protocol deviation|12|||
125282298|NCT01202188|450658516|FG003|Overall Study|Protocol deviation|10|||
125282299|NCT01202188|450658517|FG004|Overall Study|Protocol deviation|11|||
125282300|NCT01202188|450658513|FG000|Overall Study|Subject withdrew consent|12|||
125282301|NCT01202188|450658514|FG001|Overall Study|Subject withdrew consent|13|||
125282302|NCT01202188|450658515|FG002|Overall Study|Subject withdrew consent|22|||
125282303|NCT01202188|450658516|FG003|Overall Study|Subject withdrew consent|11|||
125282304|NCT01202188|450658517|FG004|Overall Study|Subject withdrew consent|13|||
124781959|NCT02529553|448831236|FG005|Overall Study|Progressive Disease|3|||
124781960|NCT02529553|448831237|FG006|Overall Study|Progressive Disease|3|||
124781961|NCT02529553|448831238|FG007|Overall Study|Progressive Disease|5|||
124781962|NCT02529553|448831239|FG008|Overall Study|Progressive Disease|3|||
124781963|NCT02529553|448831231|FG000|Overall Study|Physician Decision|0|||
124781964|NCT02529553|448831232|FG001|Overall Study|Physician Decision|1|||
124781965|NCT02529553|448831233|FG002|Overall Study|Physician Decision|0|||
124781966|NCT02529553|448831234|FG003|Overall Study|Physician Decision|0|||
124781967|NCT02529553|448831235|FG004|Overall Study|Physician Decision|1|||
124781968|NCT02529553|448831236|FG005|Overall Study|Physician Decision|0|||
124781969|NCT02529553|448831237|FG006|Overall Study|Physician Decision|0|||
124781970|NCT02529553|448831238|FG007|Overall Study|Physician Decision|0|||
124781971|NCT02529553|448831239|FG008|Overall Study|Physician Decision|0|||
124781972|NCT02529553|448831231|FG000|Overall Study|Withdrawal by Subject|0|||
124781973|NCT02529553|448831232|FG001|Overall Study|Withdrawal by Subject|0|||
124781974|NCT02529553|448831233|FG002|Overall Study|Withdrawal by Subject|0|||
124781975|NCT02529553|448831234|FG003|Overall Study|Withdrawal by Subject|0|||
124781976|NCT02529553|448831235|FG004|Overall Study|Withdrawal by Subject|0|||
124781977|NCT02529553|448831236|FG005|Overall Study|Withdrawal by Subject|1|||
124781978|NCT02529553|448831237|FG006|Overall Study|Withdrawal by Subject|0|||
124781979|NCT02529553|448831238|FG007|Overall Study|Withdrawal by Subject|1|||
124781980|NCT02529553|448831239|FG008|Overall Study|Withdrawal by Subject|0|||
125282305|NCT01202188|450658513|FG000|Overall Study|Adverse Event|5|||
125282306|NCT01202188|450658514|FG001|Overall Study|Adverse Event|23|||
125282307|NCT01202188|450658515|FG002|Overall Study|Adverse Event|13|||
125282308|NCT01202188|450658516|FG003|Overall Study|Adverse Event|10|||
125282309|NCT01202188|450658517|FG004|Overall Study|Adverse Event|10|||
125282310|NCT01202188|450658513|FG000|Overall Study|Administrative problems|3|||
125282311|NCT01202188|450658514|FG001|Overall Study|Administrative problems|2|||
125282312|NCT01202188|450658515|FG002|Overall Study|Administrative problems|1|||
125282313|NCT01202188|450658516|FG003|Overall Study|Administrative problems|1|||
125282314|NCT01202188|450658517|FG004|Overall Study|Administrative problems|2|||
125282315|NCT01202188|450658513|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125282316|NCT01202188|450658514|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
125282317|NCT01202188|450658515|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
125282318|NCT01202188|450658516|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
125282319|NCT01202188|450658517|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
125282320|NCT01202188|450658513|FG000|Overall Study|Lost to Follow-up|1|||
125282321|NCT01202188|450658514|FG001|Overall Study|Lost to Follow-up|1|||
125282322|NCT01202188|450658515|FG002|Overall Study|Lost to Follow-up|0|||
125282323|NCT01202188|450658516|FG003|Overall Study|Lost to Follow-up|4|||
125282324|NCT01202188|450658517|FG004|Overall Study|Lost to Follow-up|1|||
125282325|NCT01202188|450658513|FG000|Overall Study|Death|1|||
125282326|NCT01202188|450658514|FG001|Overall Study|Death|1|||
125282327|NCT01202188|450658515|FG002|Overall Study|Death|1|||
125282328|NCT01202188|450658516|FG003|Overall Study|Death|1|||
125282329|NCT01202188|450658517|FG004|Overall Study|Death|0|||
125282330|NCT01202188|450658513|FG000|Overall Study|Abnormal test procedure result (s)|0|||
125282331|NCT01202188|450658514|FG001|Overall Study|Abnormal test procedure result (s)|0|||
125282332|NCT01202188|450658515|FG002|Overall Study|Abnormal test procedure result (s)|2|||
125282333|NCT01202188|450658516|FG003|Overall Study|Abnormal test procedure result (s)|0|||
125282334|NCT01202188|450658517|FG004|Overall Study|Abnormal test procedure result (s)|0|||
125282335|NCT02438384|450658520|FG000|Overall Study|Lost to Follow-up|8|||
125282336|NCT02438384|450658521|FG001|Overall Study|Lost to Follow-up|6|||
125282337|NCT02438384|450658522|FG002|Overall Study|Lost to Follow-up|4|||
125282338|NCT03319953|450658523|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
124781981|NCT04549545|448832722|FG000|Initial Period|Withdrawal by Subject|4|||
124781982|NCT04549545|448832723|FG001|Initial Period|Withdrawal by Subject|0|||
124781983|NCT04549545|448832722|FG000|Initial Period|Additional ENT Procedure|3|||
124781984|NCT04549545|448832723|FG001|Initial Period|Additional ENT Procedure|0|||
124781985|NCT04549545|448832722|FG000|Initial Period|Lost to Follow-up|3|||
125282339|NCT03319953|450658524|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
125282340|NCT03319953|450658525|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
125282341|NCT03319953|450658526|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
125282342|NCT03319953|450658523|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
124781986|NCT04549545|448832723|FG001|Initial Period|Lost to Follow-up|1|||
124781987|NCT04549545|448832722|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
124781988|NCT04549545|448832723|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
124781989|NCT04549545|448832722|FG000|Crossover Period|Additional ENT Procedure|0|||
125282343|NCT03319953|450658524|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
125282344|NCT03319953|450658525|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
125282345|NCT03319953|450658526|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
125282346|NCT03315793|450658527|FG000|Overall Study|Adverse Event|4|||
125282347|NCT03315793|450658528|FG001|Overall Study|Adverse Event|2|||
125282348|NCT03315793|450658527|FG000|Overall Study|Protocol Deviation|1|||
125282349|NCT03315793|450658528|FG001|Overall Study|Protocol Deviation|0|||
125282350|NCT03315793|450658527|FG000|Overall Study|Difficult for regular visit|0|||
125282351|NCT03315793|450658528|FG001|Overall Study|Difficult for regular visit|1|||
125282352|NCT01331837|450658529|FG000|Overall Study|Death|30|||
125282353|NCT01331837|450658530|FG001|Overall Study|Death|34|||
125282354|NCT01331837|450658529|FG000|Overall Study|Lost to Follow-up|3|||
125282355|NCT01331837|450658530|FG001|Overall Study|Lost to Follow-up|1|||
125282356|NCT01331837|450658529|FG000|Overall Study|Info not recorded|10|||
125282357|NCT01331837|450658530|FG001|Overall Study|Info not recorded|16|||
125282358|NCT01331837|450658529|FG000|Overall Study|Withdrawal by Subject|13|||
125282359|NCT01331837|450658530|FG001|Overall Study|Withdrawal by Subject|16|||
125282360|NCT02640625|450660237|FG000|Overall Study|Adverse Event|1|||
125282361|NCT00511433|450660238|FG000|Overall Study|Adverse Event|5|||
125282362|NCT00511433|450660239|FG001|Overall Study|Adverse Event|0|||
125282363|NCT00511433|450660238|FG000|Overall Study|Other Reason|1|||
125282364|NCT00511433|450660239|FG001|Overall Study|Other Reason|1|||
125282365|NCT01740089|450660240|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
125282366|NCT01740089|450660241|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
125282367|NCT01740089|450660242|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
125282368|NCT01740089|450660240|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
125282369|NCT01740089|450660241|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
125282370|NCT01740089|450660242|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
125282371|NCT01740089|450660240|FG000|After 12 Weeks|Lack of Efficacy|3|||
125282372|NCT01740089|450660241|FG001|After 12 Weeks|Lack of Efficacy|1|||
125282373|NCT01740089|450660242|FG002|After 12 Weeks|Lack of Efficacy|4|||
125282374|NCT01740089|450660240|FG000|After 12 Weeks|Adverse Event|2|||
125282375|NCT01740089|450660241|FG001|After 12 Weeks|Adverse Event|0|||
125282376|NCT01740089|450660242|FG002|After 12 Weeks|Adverse Event|5|||
125282377|NCT01740089|450660240|FG000|After 12 Weeks|Protocol Violation|1|||
125282378|NCT01740089|450660241|FG001|After 12 Weeks|Protocol Violation|1|||
125282379|NCT01740089|450660242|FG002|After 12 Weeks|Protocol Violation|1|||
125282380|NCT01740089|450660240|FG000|After 12 Weeks|Withdrawal by Subject|1|||
125282381|NCT01740089|450660241|FG001|After 12 Weeks|Withdrawal by Subject|1|||
125282382|NCT01740089|450660242|FG002|After 12 Weeks|Withdrawal by Subject|1|||
125282383|NCT00790868|450660243|FG000|Overall Study|Withdrawal by Subject|4|||
125282384|NCT00790868|450660244|FG001|Overall Study|Withdrawal by Subject|5|||
125282385|NCT00790868|450660243|FG000|Overall Study|Lost to Follow-up|2|||
125282386|NCT00790868|450660244|FG001|Overall Study|Lost to Follow-up|12|||
125282387|NCT01380535|450660245|FG000|Overall Study|Adverse Event|3|||
125282388|NCT01380535|450660246|FG001|Overall Study|Adverse Event|3|||
125282389|NCT01380535|450660245|FG000|Overall Study|Death|3|||
125282390|NCT01380535|450660246|FG001|Overall Study|Death|0|||
125282391|NCT01380535|450660245|FG000|Overall Study|Study site closed|0|||
125282392|NCT01380535|450660246|FG001|Overall Study|Study site closed|5|||
125282393|NCT01380535|450660245|FG000|Overall Study|Withdrawal by Subject|1|||
125282394|NCT01380535|450660246|FG001|Overall Study|Withdrawal by Subject|2|||
125282395|NCT01380535|450660245|FG000|Overall Study|Protocol Violation|0|||
125282396|NCT01380535|450660246|FG001|Overall Study|Protocol Violation|2|||
125282397|NCT01380535|450660245|FG000|Overall Study|Lack of Efficacy|0|||
125282398|NCT01380535|450660246|FG001|Overall Study|Lack of Efficacy|3|||
125282399|NCT02013206|450660247|FG000|Overall Study|Progressive disease (PD)|14|||
125282400|NCT02013206|450660248|FG001|Overall Study|Progressive disease (PD)|17|||
125282401|NCT02013206|450660247|FG000|Overall Study|Symptomatic deterioration|3|||
125282402|NCT02013206|450660248|FG001|Overall Study|Symptomatic deterioration|1|||
125282403|NCT02013206|450660247|FG000|Overall Study|Adverse Event|1|||
125282404|NCT02013206|450660248|FG001|Overall Study|Adverse Event|0|||
125282405|NCT02013206|450660247|FG000|Overall Study|Patient refusal|2|||
125282406|NCT02013206|450660248|FG001|Overall Study|Patient refusal|0|||
125282407|NCT02013206|450660247|FG000|Overall Study|Patient non-compliance|1|||
125282408|NCT02013206|450660248|FG001|Overall Study|Patient non-compliance|0|||
125282409|NCT02013206|450660247|FG000|Overall Study|Death|1|||
125282410|NCT02013206|450660248|FG001|Overall Study|Death|2|||
125282411|NCT02013206|450660247|FG000|Overall Study|Other reasons off treatment|5|||
125282412|NCT02013206|450660248|FG001|Overall Study|Other reasons off treatment|2|||
125282413|NCT02791191|450660249|FG000|Overall Study|Adverse Event|2|||
125282414|NCT02791191|450660250|FG001|Overall Study|Adverse Event|4|||
125282415|NCT02791191|450660251|FG002|Overall Study|Adverse Event|5|||
125282416|NCT02791191|450660249|FG000|Overall Study|Lack of Efficacy|0|||
125282417|NCT02791191|450660250|FG001|Overall Study|Lack of Efficacy|1|||
125282418|NCT02791191|450660251|FG002|Overall Study|Lack of Efficacy|0|||
125282419|NCT02791191|450660249|FG000|Overall Study|Study Drug Non-Compliance|0|||
125282420|NCT02791191|450660250|FG001|Overall Study|Study Drug Non-Compliance|2|||
125282421|NCT02791191|450660251|FG002|Overall Study|Study Drug Non-Compliance|0|||
125282422|NCT02791191|450660249|FG000|Overall Study|Site Closed by Sponsor|1|||
125282423|NCT02791191|450660250|FG001|Overall Study|Site Closed by Sponsor|1|||
125282424|NCT02791191|450660251|FG002|Overall Study|Site Closed by Sponsor|3|||
125282425|NCT02791191|450660249|FG000|Overall Study|Progressive Disease|1|||
125282426|NCT02791191|450660250|FG001|Overall Study|Progressive Disease|0|||
125282427|NCT02791191|450660251|FG002|Overall Study|Progressive Disease|0|||
125282428|NCT02791191|450660249|FG000|Overall Study|Study Terminated by Sponsor|29|||
125282429|NCT02791191|450660250|FG001|Overall Study|Study Terminated by Sponsor|101|||
125282430|NCT02791191|450660251|FG002|Overall Study|Study Terminated by Sponsor|109|||
125282431|NCT02791191|450660249|FG000|Overall Study|Withdrawal by Subject|3|||
125282432|NCT02791191|450660250|FG001|Overall Study|Withdrawal by Subject|1|||
125282433|NCT02791191|450660251|FG002|Overall Study|Withdrawal by Subject|3|||
125282434|NCT02791191|450660249|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
125282435|NCT02791191|450660250|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
125282436|NCT02791191|450660251|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
125282437|NCT01952665|450660252|FG000|Overall Study|Physician Decision|3|||
125282438|NCT01952665|450660253|FG001|Overall Study|Physician Decision|2|||
125282439|NCT01952665|450660252|FG000|Overall Study|Lost to Follow-up|1|||
125282440|NCT01952665|450660253|FG001|Overall Study|Lost to Follow-up|2|||
125282441|NCT01952665|450660252|FG000|Overall Study|Adverse Event|2|||
125282442|NCT01952665|450660253|FG001|Overall Study|Adverse Event|1|||
125282443|NCT01952665|450660252|FG000|Overall Study|Protocol Violation|0|||
125282444|NCT01952665|450660253|FG001|Overall Study|Protocol Violation|1|||
125282445|NCT01537081|450660254|FG000|Overall Study|Adverse Event|5|||
125282446|NCT01537081|450660255|FG001|Overall Study|Adverse Event|2|||
125282447|NCT01537081|450660256|FG002|Overall Study|Adverse Event|2|||
125282448|NCT01537081|450660254|FG000|Overall Study|Lack of Efficacy|2|||
125282449|NCT01537081|450660255|FG001|Overall Study|Lack of Efficacy|1|||
125282450|NCT01537081|450660256|FG002|Overall Study|Lack of Efficacy|0|||
125282451|NCT01537081|450660254|FG000|Overall Study|Lost to Follow-up|17|||
125282452|NCT01537081|450660255|FG001|Overall Study|Lost to Follow-up|15|||
125282453|NCT01537081|450660256|FG002|Overall Study|Lost to Follow-up|9|||
125282454|NCT01537081|450660254|FG000|Overall Study|Protocol Violation|3|||
125282455|NCT01537081|450660255|FG001|Overall Study|Protocol Violation|2|||
125282456|NCT01537081|450660256|FG002|Overall Study|Protocol Violation|2|||
125282457|NCT01537081|450660254|FG000|Overall Study|Withdrawal by Subject|6|||
125282458|NCT01537081|450660255|FG001|Overall Study|Withdrawal by Subject|11|||
125282459|NCT01537081|450660256|FG002|Overall Study|Withdrawal by Subject|3|||
125282460|NCT01537081|450660254|FG000|Overall Study|Physician Decision|5|||
125282461|NCT01537081|450660255|FG001|Overall Study|Physician Decision|6|||
125282462|NCT01537081|450660256|FG002|Overall Study|Physician Decision|0|||
125282463|NCT01537081|450660254|FG000|Overall Study|Sponsor decision|0|||
125282464|NCT01537081|450660255|FG001|Overall Study|Sponsor decision|1|||
125282465|NCT01537081|450660256|FG002|Overall Study|Sponsor decision|0|||
125282466|NCT01537081|450660254|FG000|Overall Study|Assigned but never dosed|1|||
125282467|NCT01537081|450660255|FG001|Overall Study|Assigned but never dosed|0|||
125282468|NCT01537081|450660256|FG002|Overall Study|Assigned but never dosed|0|||
125282469|NCT01463111|450660259|FG000|Overall Study|Withdrawal by Subject|2|||
125282470|NCT01463111|450660259|FG000|Overall Study|Lost to Follow-up|5|||
125282471|NCT01463111|450660259|FG000|Overall Study|Physician Decision|2|||
125282472|NCT02596958|450660262|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
125282473|NCT02596958|450660262|FG000|Overall Study|Cancer Progression|441|||
125282474|NCT02596958|450660262|FG000|Overall Study|Death From Cancer|112|||
125282475|NCT02596958|450660262|FG000|Overall Study|Death From Other Cause|33|||
125282476|NCT02596958|450660262|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
125282477|NCT02596958|450660262|FG000|Overall Study|Administrative Reasons/Other|231|||
125282478|NCT02596958|450660262|FG000|Overall Study|Lost to Follow-up|33|||
125282479|NCT02596958|450660262|FG000|Overall Study|Missing|32|||
125282480|NCT02596958|450660262|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
125282481|NCT01559259|450660263|FG000|Overall Study|Withdrawal by Subject|0|||
125282482|NCT01559259|450660264|FG001|Overall Study|Withdrawal by Subject|0|||
125282483|NCT01559259|450660265|FG002|Overall Study|Withdrawal by Subject|0|||
125282484|NCT01559259|450660266|FG003|Overall Study|Withdrawal by Subject|1|||
125282485|NCT01559259|450660267|FG004|Overall Study|Withdrawal by Subject|0|||
125282486|NCT01559259|450660263|FG000|Overall Study|Adverse Event|0|||
125282487|NCT01559259|450660264|FG001|Overall Study|Adverse Event|1|||
125282488|NCT01559259|450660265|FG002|Overall Study|Adverse Event|1|||
125282489|NCT01559259|450660266|FG003|Overall Study|Adverse Event|0|||
125282490|NCT01559259|450660267|FG004|Overall Study|Adverse Event|0|||
125282491|NCT05425732|450660268|FG000|Overall Study|Death|4|||
125282492|NCT05425732|450660269|FG001|Overall Study|Death|2|||
125282493|NCT05425732|450660270|FG002|Overall Study|Death|0|||
125282494|NCT05425732|450660271|FG003|Overall Study|Death|0|||
125282495|NCT05425732|450660268|FG000|Overall Study|Lost to Follow-up|10|||
125282496|NCT05425732|450660269|FG001|Overall Study|Lost to Follow-up|15|||
125282497|NCT05425732|450660270|FG002|Overall Study|Lost to Follow-up|5|||
125282498|NCT05425732|450660271|FG003|Overall Study|Lost to Follow-up|3|||
125282499|NCT05425732|450660268|FG000|Overall Study|Physician Decision|0|||
125282500|NCT05425732|450660269|FG001|Overall Study|Physician Decision|2|||
125282501|NCT05425732|450660270|FG002|Overall Study|Physician Decision|0|||
125282502|NCT05425732|450660271|FG003|Overall Study|Physician Decision|0|||
125282503|NCT05425732|450660268|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
125282504|NCT05425732|450660269|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
125282505|NCT05425732|450660270|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125282506|NCT05425732|450660271|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125282507|NCT05425732|450660268|FG000|Overall Study|Withdrawal by Subject|4|||
125282508|NCT05425732|450660269|FG001|Overall Study|Withdrawal by Subject|8|||
125282509|NCT05425732|450660270|FG002|Overall Study|Withdrawal by Subject|1|||
125282510|NCT05425732|450660271|FG003|Overall Study|Withdrawal by Subject|1|||
125282511|NCT05425732|450660268|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
125282512|NCT05425732|450660269|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
125282513|NCT05425732|450660270|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
125282514|NCT05425732|450660271|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
125282515|NCT00306293|450660273|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
125282516|NCT00306293|450660274|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
125282517|NCT00306293|450660273|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
125282518|NCT00306293|450660274|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
125282519|NCT00306293|450660273|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
125282520|NCT00306293|450660274|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
125282521|NCT00306293|450660273|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
125282522|NCT00306293|450660274|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
125282523|NCT00306293|450660273|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
125282524|NCT00306293|450660274|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
125282525|NCT00306293|450660273|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
125282526|NCT00306293|450660274|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
125282527|NCT00306293|450660273|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
125282528|NCT00306293|450660274|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
125282529|NCT00306293|450660273|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
125282530|NCT00306293|450660274|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
125282531|NCT00185380|450660275|FG000|Overall Study|Adverse Event|41|||
125282532|NCT00185380|450660276|FG001|Overall Study|Adverse Event|43|||
125282533|NCT00185380|450660277|FG002|Overall Study|Adverse Event|48|||
125282534|NCT00185380|450660275|FG000|Overall Study|Lost to Follow-up|0|||
125282535|NCT00185380|450660276|FG001|Overall Study|Lost to Follow-up|4|||
125282536|NCT00185380|450660277|FG002|Overall Study|Lost to Follow-up|3|||
125282537|NCT00185380|450660275|FG000|Overall Study|Pregnancy|1|||
125282538|NCT00185380|450660276|FG001|Overall Study|Pregnancy|4|||
125282539|NCT00185380|450660277|FG002|Overall Study|Pregnancy|0|||
125282540|NCT00185380|450660275|FG000|Overall Study|Protocol Violation|2|||
125282541|NCT00185380|450660276|FG001|Overall Study|Protocol Violation|2|||
125282542|NCT00185380|450660277|FG002|Overall Study|Protocol Violation|1|||
125282543|NCT00185380|450660275|FG000|Overall Study|Withdrawal by Subject|1|||
125282544|NCT00185380|450660276|FG001|Overall Study|Withdrawal by Subject|2|||
125282545|NCT00185380|450660277|FG002|Overall Study|Withdrawal by Subject|0|||
125282546|NCT00185380|450660275|FG000|Overall Study|Failed insertion|1|||
125282547|NCT00185380|450660276|FG001|Overall Study|Failed insertion|1|||
125282548|NCT00185380|450660277|FG002|Overall Study|Failed insertion|2|||
125282549|NCT00185380|450660275|FG000|Overall Study|Planned pregnancy|9|||
125282550|NCT00185380|450660276|FG001|Overall Study|Planned pregnancy|12|||
125282551|NCT00185380|450660277|FG002|Overall Study|Planned pregnancy|12|||
125282552|NCT00185380|450660275|FG000|Overall Study|No need for contraception|3|||
125282553|NCT00185380|450660276|FG001|Overall Study|No need for contraception|3|||
125282554|NCT00185380|450660277|FG002|Overall Study|No need for contraception|3|||
125282555|NCT00185380|450660275|FG000|Overall Study|Could not attend visits|2|||
125282556|NCT00185380|450660276|FG001|Overall Study|Could not attend visits|0|||
125282557|NCT00185380|450660277|FG002|Overall Study|Could not attend visits|4|||
125282558|NCT00185380|450660275|FG000|Overall Study|personal reason|6|||
125282559|NCT00185380|450660276|FG001|Overall Study|personal reason|1|||
125282560|NCT00185380|450660277|FG002|Overall Study|personal reason|1|||
125282561|NCT02199314|450660280|FG000|Overall Study|Withdrawal by Subject|6|||
125282562|NCT02199314|450660280|FG000|Overall Study|Physician Decision|10|||
125282563|NCT04187144|450660281|FG000|Overall Study|Lost to Follow-up|12|||
125282564|NCT04187144|450660282|FG001|Overall Study|Lost to Follow-up|11|||
125282565|NCT04187144|450660281|FG000|Overall Study|Withdrawal by Subject|20|||
125282566|NCT04187144|450660282|FG001|Overall Study|Withdrawal by Subject|18|||
125282567|NCT04187144|450660281|FG000|Overall Study|Adverse Event|19|||
125282568|NCT04187144|450660282|FG001|Overall Study|Adverse Event|4|||
125282569|NCT04187144|450660281|FG000|Overall Study|Physician Decision|5|||
125282570|NCT04187144|450660282|FG001|Overall Study|Physician Decision|3|||
125282571|NCT04187144|450660281|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
125282572|NCT04187144|450660282|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
125282573|NCT04187144|450660281|FG000|Overall Study|Protocol Deviation|1|||
125282574|NCT04187144|450660282|FG001|Overall Study|Protocol Deviation|4|||
125282575|NCT02650804|450660283|FG000|Overall Study|Adverse Event|3|||
125282576|NCT02650804|450660284|FG001|Overall Study|Adverse Event|2|||
125282577|NCT02650804|450660283|FG000|Overall Study|Death|1|||
125282578|NCT02650804|450660284|FG001|Overall Study|Death|2|||
125282579|NCT02650804|450660283|FG000|Overall Study|Progressive Disease|7|||
125282580|NCT02650804|450660284|FG001|Overall Study|Progressive Disease|10|||
125282581|NCT02650804|450660283|FG000|Overall Study|Physician Decision|0|||
125282582|NCT02650804|450660284|FG001|Overall Study|Physician Decision|2|||
125282583|NCT02650804|450660283|FG000|Overall Study|Withdrawal by Subject|1|||
125282584|NCT02650804|450660284|FG001|Overall Study|Withdrawal by Subject|4|||
125282585|NCT02650804|450660283|FG000|Overall Study|Symptomatic deterioration|5|||
124781990|NCT04549545|448832723|FG001|Crossover Period|Additional ENT Procedure|6|||
124781991|NCT04549545|448832722|FG000|Crossover Period|Lost to Follow-up|0|||
124781992|NCT04549545|448832723|FG001|Crossover Period|Lost to Follow-up|1|||
124781993|NCT04549545|448832722|FG000|Crossover Period|Withdrawal by Subject|0|||
124781994|NCT04549545|448832723|FG001|Crossover Period|Withdrawal by Subject|4|||
125282586|NCT02650804|450660284|FG001|Overall Study|Symptomatic deterioration|7|||
125282587|NCT02650804|450660283|FG000|Overall Study|Protocol Violation|0|||
125282588|NCT02650804|450660284|FG001|Overall Study|Protocol Violation|1|||
125282589|NCT02759107|450660285|FG000|Overall Study|Adverse Event|0|||
125282590|NCT02759107|450660286|FG001|Overall Study|Adverse Event|0|||
125282591|NCT02759107|450660287|FG002|Overall Study|Adverse Event|0|||
125282592|NCT02759107|450660288|FG003|Overall Study|Adverse Event|0|||
125282593|NCT02759107|450660289|FG004|Overall Study|Adverse Event|0|||
125282594|NCT02759107|450660290|FG005|Overall Study|Adverse Event|0|||
125282595|NCT02759107|450660291|FG006|Overall Study|Adverse Event|0|||
125282596|NCT02759107|450660292|FG007|Overall Study|Adverse Event|0|||
125282597|NCT02759107|450660293|FG008|Overall Study|Adverse Event|0|||
125282598|NCT02759107|450660294|FG009|Overall Study|Adverse Event|0|||
125282599|NCT02759107|450660295|FG010|Overall Study|Adverse Event|0|||
125282600|NCT02759107|450660296|FG011|Overall Study|Adverse Event|0|||
125282601|NCT02759107|450660297|FG012|Overall Study|Adverse Event|2|||
125282602|NCT02759107|450660298|FG013|Overall Study|Adverse Event|0|||
125282603|NCT02759107|450660299|FG014|Overall Study|Adverse Event|0|||
125282604|NCT02759107|450660300|FG015|Overall Study|Adverse Event|1|||
125282605|NCT02759107|450660301|FG016|Overall Study|Adverse Event|0|||
125282606|NCT02759107|450660302|FG017|Overall Study|Adverse Event|2|||
125282607|NCT02759107|450660285|FG000|Overall Study|Scheduling Conflict|0|||
125282608|NCT02759107|450660286|FG001|Overall Study|Scheduling Conflict|0|||
125282609|NCT02759107|450660287|FG002|Overall Study|Scheduling Conflict|0|||
125282610|NCT02759107|450660288|FG003|Overall Study|Scheduling Conflict|0|||
125282611|NCT02759107|450660289|FG004|Overall Study|Scheduling Conflict|0|||
125282612|NCT02759107|450660290|FG005|Overall Study|Scheduling Conflict|0|||
125282613|NCT02759107|450660291|FG006|Overall Study|Scheduling Conflict|0|||
125282614|NCT02759107|450660292|FG007|Overall Study|Scheduling Conflict|0|||
125282615|NCT02759107|450660293|FG008|Overall Study|Scheduling Conflict|0|||
125282616|NCT02759107|450660294|FG009|Overall Study|Scheduling Conflict|1|||
125282617|NCT02759107|450660295|FG010|Overall Study|Scheduling Conflict|0|||
125282618|NCT02759107|450660296|FG011|Overall Study|Scheduling Conflict|0|||
125282619|NCT02759107|450660297|FG012|Overall Study|Scheduling Conflict|0|||
125282620|NCT02759107|450660298|FG013|Overall Study|Scheduling Conflict|0|||
125282621|NCT02759107|450660299|FG014|Overall Study|Scheduling Conflict|0|||
125282622|NCT02759107|450660300|FG015|Overall Study|Scheduling Conflict|0|||
125282623|NCT02759107|450660301|FG016|Overall Study|Scheduling Conflict|0|||
125282624|NCT02759107|450660302|FG017|Overall Study|Scheduling Conflict|0|||
125282625|NCT02513485|450660306|FG000|Overall Study|Adverse Event|1|||
125282626|NCT02513485|450660307|FG001|Overall Study|Adverse Event|0|||
125282627|NCT02526524|450660308|FG000|Overall Study|Withdrawal by Subject|3|||
125282628|NCT02526524|450660309|FG001|Overall Study|Withdrawal by Subject|3|||
125282629|NCT02526524|450660310|FG002|Overall Study|Withdrawal by Subject|6|||
125282630|NCT02526524|450660311|FG003|Overall Study|Withdrawal by Subject|1|||
125282631|NCT02526524|450660312|FG004|Overall Study|Withdrawal by Subject|9|||
125282632|NCT02526524|450660313|FG005|Overall Study|Withdrawal by Subject|5|||
125282633|NCT02526524|450660308|FG000|Overall Study|Adverse Event|3|||
124781995|NCT01006291|448832727|FG000|Overall Study|Adverse Event|2|||
125282634|NCT02526524|450660309|FG001|Overall Study|Adverse Event|2|||
125282635|NCT02526524|450660310|FG002|Overall Study|Adverse Event|4|||
125282636|NCT02526524|450660311|FG003|Overall Study|Adverse Event|2|||
125282637|NCT02526524|450660312|FG004|Overall Study|Adverse Event|6|||
124781996|NCT01006291|448832728|FG001|Overall Study|Adverse Event|1|||
125282638|NCT02526524|450660313|FG005|Overall Study|Adverse Event|8|||
125282639|NCT02526524|450660308|FG000|Overall Study|Lost to Follow-up|2|||
125282640|NCT02526524|450660309|FG001|Overall Study|Lost to Follow-up|3|||
125282641|NCT02526524|450660310|FG002|Overall Study|Lost to Follow-up|8|||
124781997|NCT01006291|448832729|FG002|Overall Study|Adverse Event|2|||
125282642|NCT02526524|450660311|FG003|Overall Study|Lost to Follow-up|1|||
125282643|NCT02526524|450660312|FG004|Overall Study|Lost to Follow-up|2|||
125282644|NCT02526524|450660313|FG005|Overall Study|Lost to Follow-up|5|||
125282645|NCT02526524|450660308|FG000|Overall Study|Protocol Violation|3|||
125282646|NCT02526524|450660309|FG001|Overall Study|Protocol Violation|1|||
125282647|NCT02526524|450660310|FG002|Overall Study|Protocol Violation|5|||
125282648|NCT02526524|450660311|FG003|Overall Study|Protocol Violation|3|||
125282649|NCT02526524|450660312|FG004|Overall Study|Protocol Violation|4|||
125282650|NCT02526524|450660313|FG005|Overall Study|Protocol Violation|3|||
125282651|NCT02526524|450660308|FG000|Overall Study|Loss of Glucose Control|0|||
125282652|NCT02526524|450660309|FG001|Overall Study|Loss of Glucose Control|0|||
125282653|NCT02526524|450660310|FG002|Overall Study|Loss of Glucose Control|3|||
125282654|NCT02526524|450660311|FG003|Overall Study|Loss of Glucose Control|0|||
125282655|NCT02526524|450660312|FG004|Overall Study|Loss of Glucose Control|2|||
125282656|NCT02526524|450660313|FG005|Overall Study|Loss of Glucose Control|0|||
125282657|NCT02526524|450660308|FG000|Overall Study|Physician Decision|0|||
125282658|NCT02526524|450660309|FG001|Overall Study|Physician Decision|0|||
125282659|NCT02526524|450660310|FG002|Overall Study|Physician Decision|0|||
125282660|NCT02526524|450660311|FG003|Overall Study|Physician Decision|0|||
125282661|NCT02526524|450660312|FG004|Overall Study|Physician Decision|1|||
125282662|NCT02526524|450660313|FG005|Overall Study|Physician Decision|0|||
125282663|NCT02526524|450660308|FG000|Overall Study|Sponsor Decision|1|||
125282664|NCT02526524|450660309|FG001|Overall Study|Sponsor Decision|0|||
125282665|NCT02526524|450660310|FG002|Overall Study|Sponsor Decision|0|||
125282666|NCT02526524|450660311|FG003|Overall Study|Sponsor Decision|0|||
125282667|NCT02526524|450660312|FG004|Overall Study|Sponsor Decision|0|||
125282668|NCT02526524|450660313|FG005|Overall Study|Sponsor Decision|0|||
125282669|NCT05312632|450660318|FG000|Overall Study|Adverse Event|12|||
125282670|NCT05312632|450660318|FG000|Overall Study|Withdrawal by Subject|10|||
125282671|NCT05312632|450660318|FG000|Overall Study|Lack of Efficacy|4|||
125282672|NCT05312632|450660318|FG000|Overall Study|Non-compliance with study procedures|9|||
125282673|NCT05312632|450660318|FG000|Overall Study|Other|4|||
125282674|NCT02019108|450660319|FG000|Overall Study|Lost to Follow-up|5|||
125282675|NCT02019108|450660320|FG001|Overall Study|Lost to Follow-up|7|||
125282676|NCT04569136|450660326|FG000|Overall Study|Lost to Follow-up|2|||
125282677|NCT04569136|450660327|FG001|Overall Study|Lost to Follow-up|0|||
125282678|NCT04569136|450660328|FG002|Overall Study|Lost to Follow-up|1|||
125282679|NCT01466660|450660333|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
125282680|NCT01466660|450660334|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
125282681|NCT01466660|450660333|FG000|Overall Study|Worsening of underlying cancer disease|5|||
125282682|NCT01466660|450660334|FG001|Overall Study|Worsening of underlying cancer disease|2|||
125282683|NCT01466660|450660333|FG000|Overall Study|Other adverse event|19|||
125282684|NCT01466660|450660334|FG001|Overall Study|Other adverse event|18|||
125282685|NCT01466660|450660333|FG000|Overall Study|Protocol Violation|2|||
125282686|NCT01466660|450660334|FG001|Overall Study|Protocol Violation|1|||
125282687|NCT01466660|450660333|FG000|Overall Study|Refused continuation of trial medication|4|||
125282688|NCT01466660|450660334|FG001|Overall Study|Refused continuation of trial medication|3|||
125282689|NCT01466660|450660333|FG000|Overall Study|Other reason not defined above|10|||
125282690|NCT01466660|450660334|FG001|Overall Study|Other reason not defined above|8|||
125282691|NCT00191724|450660335|FG000|Overall Study|Adverse Event|0|||
125282692|NCT00191724|450660336|FG001|Overall Study|Adverse Event|0|||
125282693|NCT00191724|450660337|FG002|Overall Study|Adverse Event|1|||
125282694|NCT00191724|450660338|FG003|Overall Study|Adverse Event|0|||
125282695|NCT00191724|450660339|FG004|Overall Study|Adverse Event|0|||
125282696|NCT00191724|450660335|FG000|Overall Study|Lost to Follow-up|1|||
125282697|NCT00191724|450660336|FG001|Overall Study|Lost to Follow-up|1|||
125282698|NCT00191724|450660337|FG002|Overall Study|Lost to Follow-up|0|||
125282699|NCT00191724|450660338|FG003|Overall Study|Lost to Follow-up|2|||
125282700|NCT00191724|450660339|FG004|Overall Study|Lost to Follow-up|3|||
125282701|NCT00191724|450660335|FG000|Overall Study|Withdrawal by Subject|0|||
125282702|NCT00191724|450660336|FG001|Overall Study|Withdrawal by Subject|0|||
125282703|NCT00191724|450660337|FG002|Overall Study|Withdrawal by Subject|0|||
125282704|NCT00191724|450660338|FG003|Overall Study|Withdrawal by Subject|1|||
125282705|NCT00191724|450660339|FG004|Overall Study|Withdrawal by Subject|0|||
125282706|NCT02301546|450660340|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
125282707|NCT02301546|450660341|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
125282708|NCT02301546|450660340|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
125282709|NCT02301546|450660341|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
125282710|NCT02301546|450660340|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
125282711|NCT02301546|450660341|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
125282712|NCT02301546|450660340|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
125282713|NCT02301546|450660341|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
125282714|NCT02301546|450660340|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
125282715|NCT02301546|450660341|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
125282716|NCT02301546|450660340|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
125282717|NCT02301546|450660341|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
125282718|NCT02301546|450660340|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
125282719|NCT02301546|450660341|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
125282720|NCT02447250|450660344|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
125282721|NCT02447250|450660344|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
125282722|NCT02447250|450660344|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
125282723|NCT01885208|450660345|FG000|Overall Study|Unclassified|32|||
125282724|NCT01885208|450660346|FG001|Overall Study|Unclassified|38|||
125282725|NCT01498575|450660349|FG000|Overall Sample|Withdrawal by Subject|60|||
125282726|NCT01498575|450660350|FG001|Overall Sample|Withdrawal by Subject|14|||
125282727|NCT01498575|450660349|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
125282728|NCT01498575|450660350|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
125282729|NCT01498575|450660349|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
125282730|NCT01498575|450660350|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
125282731|NCT01972308|450660352|FG000|Overall Study|Withdrawal by Subject|0|||
125282732|NCT01972308|450660353|FG001|Overall Study|Withdrawal by Subject|1|||
125282733|NCT01972308|450660352|FG000|Overall Study|Lost to Follow-up|4|||
124781998|NCT01006291|448832727|FG000|Overall Study|Lack of Efficacy|2|||
124781999|NCT01006291|448832728|FG001|Overall Study|Lack of Efficacy|2|||
124782000|NCT01006291|448832729|FG002|Overall Study|Lack of Efficacy|1|||
124782001|NCT01006291|448832727|FG000|Overall Study|Protocol Violation|3|||
125282734|NCT01972308|450660353|FG001|Overall Study|Lost to Follow-up|6|||
125282735|NCT01972308|450660352|FG000|Overall Study|Death|4|||
125282736|NCT01972308|450660353|FG001|Overall Study|Death|1|||
125282737|NCT02851797|450660358|FG000|Overall Study|Withdrawal by Subject|4|||
125282738|NCT02851797|450660359|FG001|Overall Study|Withdrawal by Subject|2|||
125282739|NCT02851797|450660358|FG000|Overall Study|Adverse Event|3|||
125282740|NCT02851797|450660359|FG001|Overall Study|Adverse Event|0|||
125282741|NCT00543803|450660369|FG000|Overall Study|Adverse Event|14|||
125282742|NCT00543803|450660369|FG000|Overall Study|Lack of Efficacy|22|||
125282743|NCT00543803|450660369|FG000|Overall Study|Lost to Follow-up|20|||
125282744|NCT00543803|450660369|FG000|Overall Study|Other|86|||
125282745|NCT04295681|450660370|FG000|Overall Study|Eligibility error|1|||
125282746|NCT04295681|450660371|FG001|Overall Study|Eligibility error|3|||
125282747|NCT02135029|450660380|FG000|Overall Study|Adverse Event|2|||
125282748|NCT02135029|450660381|FG001|Overall Study|Adverse Event|2|||
125282749|NCT02135029|450660382|FG002|Overall Study|Adverse Event|2|||
125282750|NCT02135029|450660380|FG000|Overall Study|Lost to Follow-up|0|||
125282751|NCT02135029|450660381|FG001|Overall Study|Lost to Follow-up|1|||
125282752|NCT02135029|450660382|FG002|Overall Study|Lost to Follow-up|0|||
125282753|NCT02135029|450660380|FG000|Overall Study|Withdrawal by Subject|2|||
125282754|NCT02135029|450660381|FG001|Overall Study|Withdrawal by Subject|0|||
125282755|NCT02135029|450660382|FG002|Overall Study|Withdrawal by Subject|1|||
125282756|NCT02135029|450660380|FG000|Overall Study|Other|0|||
125282757|NCT02135029|450660381|FG001|Overall Study|Other|1|||
125282758|NCT02135029|450660382|FG002|Overall Study|Other|0|||
125282759|NCT02135029|450660380|FG000|Overall Study|Death|0|||
125282760|NCT02135029|450660381|FG001|Overall Study|Death|1|||
125282761|NCT02135029|450660382|FG002|Overall Study|Death|0|||
125282762|NCT05129449|450660387|FG000|Overall Study|Protocol Violation|1|||
125282763|NCT02839720|450660390|FG000|Overall Study|Adverse Event|2|||
125282764|NCT02839720|450660390|FG000|Overall Study|Non-compliance|2|||
125282765|NCT02839720|450660390|FG000|Overall Study|Intercurrent Illness|1|||
125282766|NCT02839720|450660390|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
125282767|NCT00516906|450660391|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
125282768|NCT00516906|450660392|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
125282769|NCT01974206|450660393|FG000|Overall Study|Did Not Take Study Drug|0|||
125282770|NCT01974206|450660394|FG001|Overall Study|Did Not Take Study Drug|1|||
125282771|NCT01974206|450660393|FG000|Overall Study|Physician Decision|1|||
125282772|NCT01974206|450660394|FG001|Overall Study|Physician Decision|0|||
125282773|NCT01974206|450660393|FG000|Overall Study|Withdrawal by Subject|3|||
125282774|NCT01974206|450660394|FG001|Overall Study|Withdrawal by Subject|0|||
125282775|NCT01974206|450660393|FG000|Overall Study|Lost to Follow-up|1|||
125282776|NCT01974206|450660394|FG001|Overall Study|Lost to Follow-up|0|||
125282777|NCT01974206|450660393|FG000|Overall Study|Death|1|||
125282778|NCT01974206|450660394|FG001|Overall Study|Death|0|||
125282779|NCT05463744|450660407|FG000|Treatment Period|Withdrawal by Subject|19|||
125282780|NCT05463744|450660408|FG001|Treatment Period|Withdrawal by Subject|16|||
125282781|NCT05463744|450660407|FG000|Treatment Period|Adverse Event|4|||
125282782|NCT05463744|450660408|FG001|Treatment Period|Adverse Event|4|||
125282783|NCT05463744|450660407|FG000|Treatment Period|Pregnancy|0|||
125282784|NCT05463744|450660408|FG001|Treatment Period|Pregnancy|3|||
125282785|NCT05463744|450660407|FG000|Treatment Period|Lost to Follow-up|1|||
125282786|NCT05463744|450660408|FG001|Treatment Period|Lost to Follow-up|3|||
125282787|NCT05463744|450660407|FG000|Treatment Period|Inadvertent enrollment|2|||
125282788|NCT05463744|450660408|FG001|Treatment Period|Inadvertent enrollment|1|||
124782002|NCT01006291|448832728|FG001|Overall Study|Protocol Violation|3|||
125282789|NCT05463744|450660407|FG000|Treatment Period|Death|0|||
125282790|NCT05463744|450660408|FG001|Treatment Period|Death|1|||
125282791|NCT05463744|450660407|FG000|Treatment Period|Non-compliance with Study Drug|1|||
125282792|NCT05463744|450660408|FG001|Treatment Period|Non-compliance with Study Drug|0|||
125282793|NCT05463744|450660407|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
125282794|NCT05463744|450660408|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
125282795|NCT05463744|450660407|FG000|Treatment Period|Physician Decision|0|||
125282796|NCT05463744|450660408|FG001|Treatment Period|Physician Decision|1|||
125282797|NCT05463744|450660407|FG000|Follow-Up Period|Withdrawal by Subject|3|||
125282798|NCT05463744|450660408|FG001|Follow-Up Period|Withdrawal by Subject|1|||
125282799|NCT05463744|450660407|FG000|Follow-Up Period|Lost to Follow-up|1|||
125282800|NCT05463744|450660408|FG001|Follow-Up Period|Lost to Follow-up|1|||
125282801|NCT01795495|450660409|FG000|Overall Study|Protocol Violation|1|||
125282802|NCT01795495|450660410|FG001|Overall Study|Protocol Violation|0|||
125282803|NCT01795495|450660411|FG002|Overall Study|Protocol Violation|1|||
125282804|NCT01795495|450660409|FG000|Overall Study|Physician Decision|0|||
125282805|NCT01795495|450660410|FG001|Overall Study|Physician Decision|0|||
125282806|NCT01795495|450660411|FG002|Overall Study|Physician Decision|1|||
125282807|NCT01579565|450662465|FG000|Randomized|Adverse Event|1|||
125282808|NCT01579565|450662466|FG001|Randomized|Adverse Event|3|||
125282809|NCT01579565|450662465|FG000|Randomized|Withdrawal by Subject|3|||
125282810|NCT01579565|450662466|FG001|Randomized|Withdrawal by Subject|0|||
125282811|NCT01579565|450662465|FG000|Randomized|inadequate preoperative pupil dilation|0|||
125282812|NCT01579565|450662466|FG001|Randomized|inadequate preoperative pupil dilation|1|||
125282813|NCT01579565|450662465|FG000|Randomized|prohibited preoperative eating|1|||
125282814|NCT01579565|450662466|FG001|Randomized|prohibited preoperative eating|0|||
125282815|NCT01579565|450662465|FG000|Randomized|prohibited preoperative medication|0|||
125282816|NCT01579565|450662466|FG001|Randomized|prohibited preoperative medication|1|||
125282817|NCT01579565|450662465|FG000|Treated|Physician Decision|0|||
125282818|NCT01579565|450662466|FG001|Treated|Physician Decision|1|||
125282819|NCT01579565|450662465|FG000|Treated|Lost to Follow-up|2|||
125282820|NCT01579565|450662466|FG001|Treated|Lost to Follow-up|1|||
125282821|NCT01579565|450662465|FG000|Treated|declined to return for final visit|0|||
125282822|NCT01579565|450662466|FG001|Treated|declined to return for final visit|1|||
125282823|NCT02867813|450662467|FG000|Overall Study|Withdrawal by Subject|57|||
125282824|NCT02867813|450662468|FG001|Overall Study|Withdrawal by Subject|56|||
125282825|NCT02867813|450662467|FG000|Overall Study|Decision by Sponsor|7|||
125282826|NCT02867813|450662468|FG001|Overall Study|Decision by Sponsor|7|||
125282827|NCT02867813|450662467|FG000|Overall Study|Lost to Follow-up|91|||
125282828|NCT02867813|450662468|FG001|Overall Study|Lost to Follow-up|78|||
125282829|NCT02867813|450662467|FG000|Overall Study|Missing|2|||
125282830|NCT02867813|450662468|FG001|Overall Study|Missing|1|||
125282831|NCT02867813|450662467|FG000|Overall Study|Death|294|||
125282832|NCT02867813|450662468|FG001|Overall Study|Death|268|||
125282833|NCT01448824|450662469|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
125282834|NCT01448824|450662470|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
125282835|NCT01448824|450662471|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
125282836|NCT01448824|450662472|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
125282837|NCT01448824|450662473|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
125282838|NCT01448824|450662474|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
125282839|NCT01448824|450662475|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
125282840|NCT01448824|450662476|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
125282841|NCT01448824|450662469|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
125282842|NCT01448824|450662470|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
125282843|NCT01448824|450662471|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
125282844|NCT01448824|450662472|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
125282845|NCT01448824|450662473|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
125282846|NCT01448824|450662474|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
125282847|NCT01448824|450662475|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
125282848|NCT01448824|450662476|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
125282849|NCT01448824|450662469|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
125282850|NCT01448824|450662470|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
125282851|NCT01448824|450662471|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
125282852|NCT01448824|450662472|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
125282853|NCT01448824|450662473|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
125282854|NCT01448824|450662474|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
125282855|NCT01448824|450662475|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
125282856|NCT01448824|450662476|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
124782003|NCT01006291|448832729|FG002|Overall Study|Protocol Violation|3|||
124782004|NCT01006291|448832727|FG000|Overall Study|Withdrawal criteria|5|||
124782005|NCT01006291|448832728|FG001|Overall Study|Withdrawal criteria|4|||
125282857|NCT01448824|450662469|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
125282858|NCT01448824|450662470|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
125282859|NCT01448824|450662471|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
125282860|NCT01448824|450662472|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
124782006|NCT01006291|448832729|FG002|Overall Study|Withdrawal criteria|4|||
124782007|NCT01006291|448832727|FG000|Overall Study|Other|14|||
124782008|NCT01006291|448832728|FG001|Overall Study|Other|14|||
124782009|NCT01006291|448832729|FG002|Overall Study|Other|17|||
125282861|NCT01448824|450662473|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
125282862|NCT01448824|450662474|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
125282863|NCT01448824|450662475|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
124782010|NCT02102204|448832730|FG000|Overall Study|Withdrawal by Subject|137|||
124782011|NCT02102204|448832730|FG000|Overall Study|Death|92|||
124782012|NCT02102204|448832730|FG000|Overall Study|Lost to Follow-up|65|||
124782013|NCT02102204|448832730|FG000|Overall Study|Sponsor Decision|5|||
124782014|NCT02102204|448832730|FG000|Overall Study|Ongoing|5|||
124782015|NCT01865552|448832731|FG000|Period 1|Adverse Event|1|||
124782016|NCT01865552|448832732|FG001|Period 1|Adverse Event|0|||
124782017|NCT01865552|448832733|FG002|Period 1|Adverse Event|0|||
124782018|NCT01865552|448832734|FG003|Period 1|Adverse Event|1|||
124782019|NCT01865552|448832735|FG004|Period 1|Adverse Event|1|||
124782020|NCT01865552|448832736|FG005|Period 1|Adverse Event|1|||
124782021|NCT01865552|448832731|FG000|Period 1|Pathological lab|0|||
124782022|NCT01865552|448832732|FG001|Period 1|Pathological lab|0|||
124782023|NCT01865552|448832733|FG002|Period 1|Pathological lab|0|||
125282864|NCT01448824|450662476|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
125282865|NCT01448824|450662469|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
125282866|NCT01448824|450662470|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
125282867|NCT01448824|450662471|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
125282868|NCT01448824|450662472|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
125282869|NCT01448824|450662473|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
125282870|NCT01448824|450662474|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
125282871|NCT01448824|450662475|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
125282872|NCT01448824|450662476|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
125282873|NCT01448824|450662469|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
125282874|NCT01448824|450662470|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
125282875|NCT01448824|450662471|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
125282876|NCT01448824|450662472|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
125282877|NCT01448824|450662473|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
125282878|NCT01448824|450662474|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
125282879|NCT01448824|450662475|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
125282880|NCT01448824|450662476|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
125282881|NCT01448824|450662469|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
125282882|NCT01448824|450662470|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
125282883|NCT01448824|450662471|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
125282884|NCT01448824|450662472|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
125282885|NCT01448824|450662473|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
125282886|NCT01448824|450662474|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
125282887|NCT01448824|450662475|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
125282888|NCT01448824|450662476|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
125282889|NCT01448824|450662469|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
125282890|NCT01448824|450662470|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
125282891|NCT01448824|450662471|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
125282892|NCT01448824|450662472|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
125282893|NCT01448824|450662473|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
125282894|NCT01448824|450662474|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
125282895|NCT01448824|450662475|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
125282896|NCT01448824|450662476|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
125282897|NCT01995669|450662488|FG000|Overall Study|Progression|2|||
125282898|NCT01995669|450662489|FG001|Overall Study|Progression|1|||
125282899|NCT01995669|450662490|FG002|Overall Study|Progression|1|||
125282900|NCT01995669|450662491|FG003|Overall Study|Progression|13|||
125282901|NCT01995669|450662488|FG000|Overall Study|Adverse Event|0|||
124782024|NCT01865552|448832734|FG003|Period 1|Pathological lab|0|||
124782025|NCT01865552|448832735|FG004|Period 1|Pathological lab|1|||
124782026|NCT01865552|448832736|FG005|Period 1|Pathological lab|0|||
124782027|NCT01865552|448832731|FG000|Period 1|Other|0|||
124782028|NCT01865552|448832732|FG001|Period 1|Other|0|||
125282902|NCT01995669|450662489|FG001|Overall Study|Adverse Event|0|||
125282903|NCT01995669|450662490|FG002|Overall Study|Adverse Event|0|||
125282904|NCT01995669|450662491|FG003|Overall Study|Adverse Event|3|||
125282905|NCT01995669|450662488|FG000|Overall Study|Death|0|||
125282906|NCT01995669|450662489|FG001|Overall Study|Death|0|||
124782029|NCT01865552|448832733|FG002|Period 1|Other|0|||
124782030|NCT01865552|448832734|FG003|Period 1|Other|0|||
124782031|NCT01865552|448832735|FG004|Period 1|Other|1|||
124782032|NCT01865552|448832736|FG005|Period 1|Other|0|||
124782033|NCT03079102|448832737|FG000|Overall Study|Physician Decision|0|||
124782034|NCT03079102|448832738|FG001|Overall Study|Physician Decision|1|||
124782035|NCT02923921|448832739|FG000|Overall Study|Sponsor Decision|39|||
124782036|NCT02923921|448832740|FG001|Overall Study|Sponsor Decision|38|||
125282907|NCT01995669|450662490|FG002|Overall Study|Death|0|||
125282908|NCT01995669|450662491|FG003|Overall Study|Death|6|||
125282909|NCT01995669|450662488|FG000|Overall Study|Withdrawal by Subject|0|||
125282910|NCT01995669|450662489|FG001|Overall Study|Withdrawal by Subject|0|||
125282911|NCT01995669|450662490|FG002|Overall Study|Withdrawal by Subject|0|||
125282912|NCT01995669|450662491|FG003|Overall Study|Withdrawal by Subject|6|||
125282913|NCT01995669|450662488|FG000|Overall Study|Insurance Expired|0|||
125282914|NCT01995669|450662489|FG001|Overall Study|Insurance Expired|0|||
125282915|NCT01995669|450662490|FG002|Overall Study|Insurance Expired|0|||
125282916|NCT01995669|450662491|FG003|Overall Study|Insurance Expired|1|||
125282917|NCT02998203|450662492|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
125282918|NCT02998203|450662493|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
125282919|NCT02998203|450662492|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
125282920|NCT02998203|450662493|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
125282921|NCT03389555|450662494|FG000|Overall Study|Protocol Violation|1|||
125282922|NCT03389555|450662495|FG001|Overall Study|Protocol Violation|3|||
125282923|NCT03389555|450662494|FG000|Overall Study|Death|1|||
125282924|NCT03389555|450662495|FG001|Overall Study|Death|0|||
125282925|NCT00920218|450662498|FG000|Overall Study|Serious Adverse Event|2|||
125282926|NCT00920218|450662499|FG001|Overall Study|Serious Adverse Event|0|||
125282927|NCT00920218|450662500|FG002|Overall Study|Serious Adverse Event|2|||
125282928|NCT00920218|450662501|FG003|Overall Study|Serious Adverse Event|1|||
125282929|NCT00920218|450662498|FG000|Overall Study|Withdrawal by Subject|0|||
125282930|NCT00920218|450662499|FG001|Overall Study|Withdrawal by Subject|3|||
125282931|NCT00920218|450662500|FG002|Overall Study|Withdrawal by Subject|2|||
125282932|NCT00920218|450662501|FG003|Overall Study|Withdrawal by Subject|0|||
125282933|NCT00920218|450662498|FG000|Overall Study|Migrated/moved from study area|0|||
125282934|NCT00920218|450662499|FG001|Overall Study|Migrated/moved from study area|0|||
125282935|NCT00920218|450662500|FG002|Overall Study|Migrated/moved from study area|1|||
125282936|NCT00920218|450662501|FG003|Overall Study|Migrated/moved from study area|0|||
125282937|NCT00920218|450662498|FG000|Overall Study|Lost to Follow-up|0|||
125282938|NCT00920218|450662499|FG001|Overall Study|Lost to Follow-up|1|||
125282939|NCT00920218|450662500|FG002|Overall Study|Lost to Follow-up|0|||
125282940|NCT00920218|450662501|FG003|Overall Study|Lost to Follow-up|3|||
125282941|NCT00920218|450662498|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
125282942|NCT00920218|450662499|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
125282943|NCT00920218|450662500|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
125282944|NCT00920218|450662501|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
125282945|NCT00920218|450662498|FG000|Overall Study|Other|0|||
125282946|NCT00920218|450662499|FG001|Overall Study|Other|0|||
125282947|NCT00920218|450662500|FG002|Overall Study|Other|1|||
125282948|NCT00920218|450662501|FG003|Overall Study|Other|0|||
125282949|NCT03224507|450662505|FG000|Overall Study|Death|3|||
125282950|NCT03224507|450662506|FG001|Overall Study|Death|0|||
125282951|NCT03224507|450662505|FG000|Overall Study|Lack of Efficacy|6|||
125282952|NCT03224507|450662506|FG001|Overall Study|Lack of Efficacy|0|||
125282953|NCT03224507|450662505|FG000|Overall Study|Withdrawal by Subject|6|||
125282954|NCT03224507|450662506|FG001|Overall Study|Withdrawal by Subject|0|||
125282955|NCT01007435|450662507|FG000|Overall Study|Adverse Event|16|||
125282956|NCT01007435|450662508|FG001|Overall Study|Adverse Event|25|||
125282957|NCT01007435|450662509|FG002|Overall Study|Adverse Event|47|||
125282958|NCT01007435|450662510|FG003|Overall Study|Adverse Event|31|||
125282959|NCT01007435|450662507|FG000|Overall Study|Death|2|||
125282960|NCT01007435|450662508|FG001|Overall Study|Death|4|||
125282961|NCT01007435|450662509|FG002|Overall Study|Death|2|||
125282962|NCT01007435|450662510|FG003|Overall Study|Death|1|||
125282963|NCT01007435|450662507|FG000|Overall Study|Insufficient Therapeutic Response|21|||
125282964|NCT01007435|450662508|FG001|Overall Study|Insufficient Therapeutic Response|7|||
125282965|NCT01007435|450662509|FG002|Overall Study|Insufficient Therapeutic Response|2|||
125282966|NCT01007435|450662510|FG003|Overall Study|Insufficient Therapeutic Response|9|||
125282967|NCT01007435|450662507|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
125282968|NCT01007435|450662508|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
125282969|NCT01007435|450662509|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
125282970|NCT01007435|450662510|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
125282971|NCT01007435|450662507|FG000|Overall Study|Other Protocol Violation|2|||
125282972|NCT01007435|450662508|FG001|Overall Study|Other Protocol Violation|0|||
125282973|NCT01007435|450662509|FG002|Overall Study|Other Protocol Violation|1|||
125282974|NCT01007435|450662510|FG003|Overall Study|Other Protocol Violation|0|||
125282975|NCT01007435|450662507|FG000|Overall Study|Refused Treatment|13|||
125282976|NCT01007435|450662508|FG001|Overall Study|Refused Treatment|13|||
125282977|NCT01007435|450662509|FG002|Overall Study|Refused Treatment|5|||
125282978|NCT01007435|450662510|FG003|Overall Study|Refused Treatment|8|||
125282979|NCT01007435|450662507|FG000|Overall Study|Failure to Return|5|||
125282980|NCT01007435|450662508|FG001|Overall Study|Failure to Return|4|||
125282981|NCT01007435|450662509|FG002|Overall Study|Failure to Return|3|||
125282982|NCT01007435|450662510|FG003|Overall Study|Failure to Return|6|||
125282983|NCT01007435|450662507|FG000|Overall Study|Reason not Specified|1|||
125282984|NCT01007435|450662508|FG001|Overall Study|Reason not Specified|1|||
125282985|NCT01007435|450662509|FG002|Overall Study|Reason not Specified|2|||
125282986|NCT01007435|450662510|FG003|Overall Study|Reason not Specified|1|||
125282987|NCT01345591|450662513|FG000|Overall Study|Lost to Follow-up|1|||
125282988|NCT00847665|450662520|FG000|Overall Study|Withdrawal by Subject|1|||
125282989|NCT00847665|450662521|FG001|Overall Study|Withdrawal by Subject|0|||
125282990|NCT00624585|450662522|FG000|Overall Study|Death|3|||
125282991|NCT00624585|450662522|FG000|Overall Study|Disease Progression|6|||
125282992|NCT00624585|450662522|FG000|Overall Study|Adverse Event|3|||
125282993|NCT00676520|450662524|FG000|Overall Study|Withdrawal by Subject|163|||
125282994|NCT00676520|450662524|FG000|Overall Study|Lost to Follow-up|162|||
125282995|NCT00676520|450662524|FG000|Overall Study|Death|159|||
125282996|NCT00676520|450662524|FG000|Overall Study|Physician Decision|20|||
125282997|NCT00676520|450662524|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
125282998|NCT00676520|450662524|FG000|Overall Study|Other Reason|18|||
125282999|NCT01425359|450662525|FG000|Overall Study|Randomized but Not Treated|2|||
125283000|NCT01425359|450662526|FG001|Overall Study|Randomized but Not Treated|3|||
125283001|NCT01425359|450662525|FG000|Overall Study|Adverse Event|9|||
125283002|NCT01425359|450662526|FG001|Overall Study|Adverse Event|8|||
125283003|NCT01425359|450662525|FG000|Overall Study|Revascularization|0|||
125283004|NCT01425359|450662526|FG001|Overall Study|Revascularization|1|||
125283005|NCT01425359|450662525|FG000|Overall Study|Death|0|||
125283006|NCT01425359|450662526|FG001|Overall Study|Death|1|||
125283007|NCT01425359|450662525|FG000|Overall Study|Unsatisfactory Response|1|||
125283008|NCT01425359|450662526|FG001|Overall Study|Unsatisfactory Response|0|||
125283009|NCT01425359|450662525|FG000|Overall Study|Protocol Violation|1|||
125283010|NCT01425359|450662526|FG001|Overall Study|Protocol Violation|2|||
125283011|NCT01425359|450662525|FG000|Overall Study|Subject Withdrew Consent|1|||
125283012|NCT01425359|450662526|FG001|Overall Study|Subject Withdrew Consent|2|||
125283013|NCT01425359|450662525|FG000|Overall Study|Investigator's Discretion|2|||
125283014|NCT01425359|450662526|FG001|Overall Study|Investigator's Discretion|0|||
125283015|NCT01425359|450662525|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
125283016|NCT01425359|450662526|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
125283017|NCT03172325|450662527|FG000|Overall Study|Adverse Event|2|||
125283018|NCT03172325|450662528|FG001|Overall Study|Adverse Event|3|||
125283019|NCT03172325|450662527|FG000|Overall Study|Positive PPD|1|||
125283020|NCT03172325|450662528|FG001|Overall Study|Positive PPD|0|||
125283021|NCT03172325|450662527|FG000|Overall Study|Poor Compliance|1|||
125283022|NCT03172325|450662528|FG001|Overall Study|Poor Compliance|1|||
125283023|NCT03305419|450662533|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
125283024|NCT03305419|450662534|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
125283025|NCT03305419|450662535|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
125283026|NCT03305419|450662536|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
125283027|NCT03305419|450662537|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
125283028|NCT03305419|450662538|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
125283029|NCT03305419|450662539|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
125283030|NCT03305419|450662540|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
125283031|NCT03305419|450662533|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
125283032|NCT03305419|450662534|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
125283033|NCT03305419|450662535|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
125283034|NCT03305419|450662536|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
125283035|NCT03305419|450662537|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
125283036|NCT03305419|450662538|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
124782037|NCT02923921|448832739|FG000|Overall Study|Lost to Follow-up|1|||
125283037|NCT03305419|450662539|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
125283038|NCT03305419|450662540|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
125283039|NCT03305419|450662533|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
125283040|NCT03305419|450662534|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
125283041|NCT03305419|450662535|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
125283042|NCT03305419|450662536|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
125283043|NCT03305419|450662537|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
125283044|NCT03305419|450662538|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
125283045|NCT03305419|450662539|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
125283046|NCT03305419|450662540|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
125283047|NCT03305419|450662533|FG000|Part B (14 Days)|Adverse Event|0|||
125283048|NCT03305419|450662534|FG001|Part B (14 Days)|Adverse Event|0|||
125283049|NCT03305419|450662535|FG002|Part B (14 Days)|Adverse Event|0|||
125283050|NCT03305419|450662536|FG003|Part B (14 Days)|Adverse Event|0|||
125283051|NCT03305419|450662537|FG004|Part B (14 Days)|Adverse Event|1|||
125283052|NCT03305419|450662538|FG005|Part B (14 Days)|Adverse Event|2|||
125283053|NCT03305419|450662539|FG006|Part B (14 Days)|Adverse Event|4|||
125283054|NCT03305419|450662540|FG007|Part B (14 Days)|Adverse Event|0|||
125283055|NCT03305419|450662533|FG000|Part B (14 Days)|Physician Decision|0|||
125283056|NCT03305419|450662534|FG001|Part B (14 Days)|Physician Decision|0|||
125283057|NCT03305419|450662535|FG002|Part B (14 Days)|Physician Decision|0|||
125283058|NCT03305419|450662536|FG003|Part B (14 Days)|Physician Decision|0|||
125283059|NCT03305419|450662537|FG004|Part B (14 Days)|Physician Decision|2|||
125283060|NCT03305419|450662538|FG005|Part B (14 Days)|Physician Decision|8|||
125283061|NCT03305419|450662539|FG006|Part B (14 Days)|Physician Decision|1|||
125283062|NCT03305419|450662540|FG007|Part B (14 Days)|Physician Decision|0|||
125283063|NCT00075946|450662541|FG000|Overall Study|Path ineligible: undetermined histology|0|||
125283064|NCT00075946|450662542|FG001|Overall Study|Path ineligible: undetermined histology|0|||
125283065|NCT00075946|450662543|FG002|Overall Study|Path ineligible: undetermined histology|0|||
125283066|NCT00075946|450662544|FG003|Overall Study|Path ineligible: undetermined histology|0|||
125283067|NCT00075946|450662545|FG004|Overall Study|Path ineligible: undetermined histology|6|||
125283068|NCT00075946|450662541|FG000|Overall Study|Did not achieve response after induction|0|||
125283069|NCT00075946|450662542|FG001|Overall Study|Did not achieve response after induction|0|||
125283070|NCT00075946|450662543|FG002|Overall Study|Did not achieve response after induction|0|||
125283071|NCT00075946|450662544|FG003|Overall Study|Did not achieve response after induction|0|||
125283072|NCT00075946|450662545|FG004|Overall Study|Did not achieve response after induction|182|||
125283073|NCT00075946|450662541|FG000|Overall Study|Incorrectly randomized (no response)|5|||
125283074|NCT00075946|450662542|FG001|Overall Study|Incorrectly randomized (no response)|5|||
125283075|NCT00075946|450662543|FG002|Overall Study|Incorrectly randomized (no response)|5|||
125283076|NCT00075946|450662544|FG003|Overall Study|Incorrectly randomized (no response)|1|||
125283077|NCT00075946|450662545|FG004|Overall Study|Incorrectly randomized (no response)|0|||
125283078|NCT00075946|450662541|FG000|Overall Study|Adverse Event|2|||
125283079|NCT00075946|450662542|FG001|Overall Study|Adverse Event|10|||
125283080|NCT00075946|450662543|FG002|Overall Study|Adverse Event|0|||
125283081|NCT00075946|450662544|FG003|Overall Study|Adverse Event|2|||
125283082|NCT00075946|450662545|FG004|Overall Study|Adverse Event|0|||
125283083|NCT00075946|450662541|FG000|Overall Study|Death|0|||
125283084|NCT00075946|450662542|FG001|Overall Study|Death|1|||
125283085|NCT00075946|450662543|FG002|Overall Study|Death|0|||
125283086|NCT00075946|450662544|FG003|Overall Study|Death|0|||
125283087|NCT00075946|450662545|FG004|Overall Study|Death|0|||
125283088|NCT00075946|450662541|FG000|Overall Study|Withdrawal by Subject|23|||
125283089|NCT00075946|450662542|FG001|Overall Study|Withdrawal by Subject|58|||
125283090|NCT00075946|450662543|FG002|Overall Study|Withdrawal by Subject|4|||
125283091|NCT00075946|450662544|FG003|Overall Study|Withdrawal by Subject|9|||
125283092|NCT00075946|450662545|FG004|Overall Study|Withdrawal by Subject|0|||
125283093|NCT00075946|450662541|FG000|Overall Study|Alternative therapy|16|||
125283094|NCT00075946|450662542|FG001|Overall Study|Alternative therapy|2|||
125283095|NCT00075946|450662543|FG002|Overall Study|Alternative therapy|5|||
125283096|NCT00075946|450662544|FG003|Overall Study|Alternative therapy|0|||
125283097|NCT00075946|450662545|FG004|Overall Study|Alternative therapy|0|||
125283098|NCT00075946|450662541|FG000|Overall Study|Other complicating disease|7|||
125283099|NCT00075946|450662542|FG001|Overall Study|Other complicating disease|13|||
125283100|NCT00075946|450662543|FG002|Overall Study|Other complicating disease|1|||
125283101|NCT00075946|450662544|FG003|Overall Study|Other complicating disease|4|||
125283102|NCT00075946|450662545|FG004|Overall Study|Other complicating disease|0|||
125283103|NCT00075946|450662541|FG000|Overall Study|No response to retreatment|23|||
125283104|NCT00075946|450662542|FG001|Overall Study|No response to retreatment|0|||
125283105|NCT00075946|450662543|FG002|Overall Study|No response to retreatment|2|||
125283106|NCT00075946|450662544|FG003|Overall Study|No response to retreatment|0|||
125283107|NCT00075946|450662545|FG004|Overall Study|No response to retreatment|0|||
125283108|NCT00075946|450662541|FG000|Overall Study|Time to progression less than 6 months|15|||
125283109|NCT00075946|450662542|FG001|Overall Study|Time to progression less than 6 months|30|||
125283110|NCT00075946|450662543|FG002|Overall Study|Time to progression less than 6 months|8|||
125283111|NCT00075946|450662544|FG003|Overall Study|Time to progression less than 6 months|3|||
125283112|NCT00075946|450662545|FG004|Overall Study|Time to progression less than 6 months|0|||
125283113|NCT00075946|450662541|FG000|Overall Study|Other|57|||
125283114|NCT00075946|450662542|FG001|Overall Study|Other|32|||
125283115|NCT00075946|450662543|FG002|Overall Study|Other|3|||
125283116|NCT00075946|450662544|FG003|Overall Study|Other|11|||
125283117|NCT00075946|450662545|FG004|Overall Study|Other|0|||
125283118|NCT00889603|450662548|FG000|Overall Study|Adverse Event|7|||
125283119|NCT00889603|450662548|FG000|Overall Study|Death|3|||
124782038|NCT02923921|448832740|FG001|Overall Study|Lost to Follow-up|0|||
125283120|NCT00889603|450662548|FG000|Overall Study|Lost to Follow-up|19|||
125283121|NCT00889603|450662548|FG000|Overall Study|No longer willing to participant in stud|4|||
125283122|NCT00889603|450662548|FG000|Overall Study|Other|4|||
125283123|NCT01229254|450662549|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
125283124|NCT01229254|450662550|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
125283125|NCT01229254|450662551|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
125283126|NCT01229254|450662549|FG000|Overall Study|Adverse Event|4|||
125283127|NCT01229254|450662550|FG001|Overall Study|Adverse Event|5|||
124782039|NCT02923921|448832739|FG000|Overall Study|Withdrawal by Subject|6|||
124782040|NCT02923921|448832740|FG001|Overall Study|Withdrawal by Subject|13|||
124782041|NCT02923921|448832739|FG000|Overall Study|Unknown, Not Collected|7|||
124782042|NCT02923921|448832740|FG001|Overall Study|Unknown, Not Collected|6|||
124782043|NCT00479687|448832741|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
124782044|NCT00479687|448832742|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
124782045|NCT00479687|448832743|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
124782046|NCT00479687|448832741|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
124782047|NCT00479687|448832742|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
124782048|NCT00479687|448832743|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
124782049|NCT00479687|448832741|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
124782050|NCT00479687|448832742|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
124782051|NCT00479687|448832743|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
124782052|NCT00479687|448832741|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
124782053|NCT00479687|448832742|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
124782054|NCT00479687|448832743|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
124782055|NCT00479687|448832741|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
124782056|NCT00479687|448832742|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
124782057|NCT00479687|448832743|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
124782058|NCT00479687|448832741|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
124782059|NCT00479687|448832742|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
124782060|NCT00479687|448832743|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
124782061|NCT00479687|448832741|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
124782062|NCT00479687|448832742|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
124782063|NCT00479687|448832743|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
124782064|NCT00479687|448832741|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
124782065|NCT00479687|448832742|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
124782066|NCT00479687|448832743|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
124782067|NCT00479687|448832741|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
124782068|NCT00479687|448832742|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
124782069|NCT00479687|448832743|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
124782070|NCT01474239|448832744|FG000|Overall Study|Disease Progression|37|||
124782071|NCT01474239|448832745|FG001|Overall Study|Disease Progression|25|||
124782072|NCT01474239|448832744|FG000|Overall Study|Adverse Event|12|||
124782073|NCT01474239|448832745|FG001|Overall Study|Adverse Event|3|||
124782074|NCT01474239|448832744|FG000|Overall Study|Withdrawal by Subject|1|||
124782075|NCT01474239|448832745|FG001|Overall Study|Withdrawal by Subject|2|||
124782076|NCT01474239|448832744|FG000|Overall Study|Death|1|||
124782077|NCT01474239|448832745|FG001|Overall Study|Death|1|||
124782078|NCT01474239|448832744|FG000|Overall Study|Clinical Disease Progression|7|||
124782079|NCT01474239|448832745|FG001|Overall Study|Clinical Disease Progression|1|||
124782080|NCT01474239|448832744|FG000|Overall Study|Withdrawal for Economic Reason|1|||
124782081|NCT01474239|448832745|FG001|Overall Study|Withdrawal for Economic Reason|0|||
124782082|NCT02175199|448832748|FG000|Overall Study|Withdrawal by Subject|1|||
124782083|NCT02175199|448832749|FG001|Overall Study|Withdrawal by Subject|5|||
124782084|NCT02175199|448832748|FG000|Overall Study|Randomized in Error|1|||
124782085|NCT02175199|448832749|FG001|Overall Study|Randomized in Error|0|||
124782086|NCT02175199|448832748|FG000|Overall Study|Sponsor Decision|1|||
124782087|NCT02175199|448832749|FG001|Overall Study|Sponsor Decision|0|||
124782088|NCT03983317|448832754|FG000|Overall Study|Physician Decision|5|||
124782089|NCT01349049|448832755|FG000|Overall Study|Disease progression|3|||
124782090|NCT01349049|448832756|FG001|Overall Study|Disease progression|5|||
124782091|NCT01349049|448832757|FG002|Overall Study|Disease progression|3|||
124782092|NCT01349049|448832758|FG003|Overall Study|Disease progression|2|||
124782093|NCT01349049|448832759|FG004|Overall Study|Disease progression|2|||
124782094|NCT01349049|448832760|FG005|Overall Study|Disease progression|2|||
124782095|NCT01349049|448832761|FG006|Overall Study|Disease progression|3|||
124782096|NCT01349049|448832762|FG007|Overall Study|Disease progression|2|||
124782097|NCT01349049|448832763|FG008|Overall Study|Disease progression|33|||
124782098|NCT01349049|448832755|FG000|Overall Study|Adverse Event|0|||
124782099|NCT01349049|448832756|FG001|Overall Study|Adverse Event|1|||
124782100|NCT01349049|448832757|FG002|Overall Study|Adverse Event|0|||
124782101|NCT01349049|448832758|FG003|Overall Study|Adverse Event|0|||
124782102|NCT01349049|448832759|FG004|Overall Study|Adverse Event|0|||
124782103|NCT01349049|448832760|FG005|Overall Study|Adverse Event|3|||
124782104|NCT01349049|448832761|FG006|Overall Study|Adverse Event|1|||
124782105|NCT01349049|448832762|FG007|Overall Study|Adverse Event|0|||
124782106|NCT01349049|448832763|FG008|Overall Study|Adverse Event|4|||
124782107|NCT01349049|448832755|FG000|Overall Study|Physician Decision|0|||
124782108|NCT01349049|448832756|FG001|Overall Study|Physician Decision|1|||
124782109|NCT01349049|448832757|FG002|Overall Study|Physician Decision|0|||
124782110|NCT01349049|448832758|FG003|Overall Study|Physician Decision|0|||
124782111|NCT01349049|448832759|FG004|Overall Study|Physician Decision|0|||
125283128|NCT01229254|450662551|FG002|Overall Study|Adverse Event|3|||
124782112|NCT01349049|448832760|FG005|Overall Study|Physician Decision|0|||
125283129|NCT01229254|450662549|FG000|Overall Study|Lost to Follow-up|3|||
125283130|NCT01229254|450662550|FG001|Overall Study|Lost to Follow-up|0|||
125283131|NCT01229254|450662551|FG002|Overall Study|Lost to Follow-up|1|||
125283132|NCT01229254|450662549|FG000|Overall Study|Physician Decision|0|||
125283133|NCT01229254|450662550|FG001|Overall Study|Physician Decision|3|||
125283134|NCT01229254|450662551|FG002|Overall Study|Physician Decision|0|||
125283135|NCT01229254|450662549|FG000|Overall Study|Protocol Violation|4|||
125283136|NCT01229254|450662550|FG001|Overall Study|Protocol Violation|6|||
125283137|NCT01229254|450662551|FG002|Overall Study|Protocol Violation|5|||
125283138|NCT01229254|450662549|FG000|Overall Study|Withdrawal by Subject|1|||
125283139|NCT01229254|450662550|FG001|Overall Study|Withdrawal by Subject|0|||
125283140|NCT01229254|450662551|FG002|Overall Study|Withdrawal by Subject|1|||
125283141|NCT01229254|450662549|FG000|Overall Study|Non-compliance with Study Drug|0|||
125283142|NCT01229254|450662550|FG001|Overall Study|Non-compliance with Study Drug|1|||
125283143|NCT01229254|450662551|FG002|Overall Study|Non-compliance with Study Drug|1|||
125283144|NCT02231892|450662552|FG000|Overall Study|Lost to Follow-up|1|||
125283145|NCT02231892|450662553|FG001|Overall Study|Lost to Follow-up|0|||
125283146|NCT02231892|450662554|FG002|Overall Study|Lost to Follow-up|3|||
125283147|NCT02231892|450662552|FG000|Overall Study|Withdrawal by Subject|4|||
125283148|NCT02231892|450662553|FG001|Overall Study|Withdrawal by Subject|3|||
125283149|NCT02231892|450662554|FG002|Overall Study|Withdrawal by Subject|15|||
125283150|NCT02231892|450662552|FG000|Overall Study|Physician Decision|0|||
125283151|NCT02231892|450662553|FG001|Overall Study|Physician Decision|2|||
125283152|NCT02231892|450662554|FG002|Overall Study|Physician Decision|4|||
125283153|NCT02231892|450662552|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
125283154|NCT02231892|450662553|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
125283155|NCT02231892|450662554|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
125283156|NCT02231892|450662552|FG000|Overall Study|Participant motor threshold was >83%|0|||
125283157|NCT02231892|450662553|FG001|Overall Study|Participant motor threshold was >83%|0|||
125283158|NCT02231892|450662554|FG002|Overall Study|Participant motor threshold was >83%|9|||
125283159|NCT02231892|450662552|FG000|Overall Study|Could not find motor threshold|2|||
125283160|NCT02231892|450662553|FG001|Overall Study|Could not find motor threshold|0|||
125283161|NCT02231892|450662554|FG002|Overall Study|Could not find motor threshold|1|||
125283162|NCT02231892|450662552|FG000|Overall Study|Could not find reliable motor hotspot|0|||
125283163|NCT02231892|450662553|FG001|Overall Study|Could not find reliable motor hotspot|0|||
124782113|NCT01349049|448832761|FG006|Overall Study|Physician Decision|0|||
124782114|NCT01349049|448832762|FG007|Overall Study|Physician Decision|0|||
124782115|NCT01349049|448832763|FG008|Overall Study|Physician Decision|2|||
124782116|NCT01349049|448832755|FG000|Overall Study|Protocol Violation|0|||
124782117|NCT01349049|448832756|FG001|Overall Study|Protocol Violation|0|||
124782118|NCT01349049|448832757|FG002|Overall Study|Protocol Violation|0|||
124782119|NCT01349049|448832758|FG003|Overall Study|Protocol Violation|0|||
124782120|NCT01349049|448832759|FG004|Overall Study|Protocol Violation|0|||
124782121|NCT01349049|448832760|FG005|Overall Study|Protocol Violation|0|||
124782122|NCT01349049|448832761|FG006|Overall Study|Protocol Violation|0|||
124782123|NCT01349049|448832762|FG007|Overall Study|Protocol Violation|0|||
124782124|NCT01349049|448832763|FG008|Overall Study|Protocol Violation|1|||
124782125|NCT01349049|448832755|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
125283164|NCT02231892|450662554|FG002|Overall Study|Could not find reliable motor hotspot|1|||
125283165|NCT01694121|450662557|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
125283166|NCT01694121|450662558|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
125283167|NCT02680041|450662559|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
125283168|NCT02680041|450662559|FG000|Overall Study|Lost to Follow-up|2|||
125283169|NCT00521599|450662560|FG000|Overall Study|Adverse Event|5|||
125283170|NCT00521599|450662561|FG001|Overall Study|Adverse Event|7|||
125283171|NCT00521599|450662562|FG002|Overall Study|Adverse Event|6|||
125283172|NCT00521599|450662560|FG000|Overall Study|Treatment Failure|8|||
125283173|NCT00521599|450662561|FG001|Overall Study|Treatment Failure|9|||
125283174|NCT00521599|450662562|FG002|Overall Study|Treatment Failure|22|||
125283175|NCT00521599|450662560|FG000|Overall Study|Lost to Follow-up|2|||
125283176|NCT00521599|450662561|FG001|Overall Study|Lost to Follow-up|1|||
125283177|NCT00521599|450662562|FG002|Overall Study|Lost to Follow-up|2|||
125283178|NCT00521599|450662560|FG000|Overall Study|Withdrawal by Subject|3|||
125283179|NCT00521599|450662561|FG001|Overall Study|Withdrawal by Subject|5|||
125283180|NCT00521599|450662562|FG002|Overall Study|Withdrawal by Subject|1|||
125283181|NCT00521599|450662560|FG000|Overall Study|Withdrawal by subject treatment related|3|||
125283182|NCT00521599|450662561|FG001|Overall Study|Withdrawal by subject treatment related|1|||
125283183|NCT00521599|450662562|FG002|Overall Study|Withdrawal by subject treatment related|2|||
125283184|NCT00521599|450662560|FG000|Overall Study|Protocol Violation|2|||
125283185|NCT00521599|450662561|FG001|Overall Study|Protocol Violation|4|||
125283186|NCT00521599|450662562|FG002|Overall Study|Protocol Violation|2|||
125283187|NCT00521599|450662560|FG000|Overall Study|Did not meet protocol eligibility|2|||
125283188|NCT00521599|450662561|FG001|Overall Study|Did not meet protocol eligibility|2|||
125283189|NCT00521599|450662562|FG002|Overall Study|Did not meet protocol eligibility|1|||
125283190|NCT02186652|450662563|FG000|Overall Study|Lost to Follow-up|2|||
125283191|NCT02186652|450662564|FG001|Overall Study|Lost to Follow-up|0|||
125283192|NCT00744978|450662565|FG000|Period 1|Lost to Follow-up|1|||
125283193|NCT00744978|450662566|FG001|Period 1|Lost to Follow-up|0|||
125283194|NCT00744978|450662565|FG000|Period 1|Withdrawal by Subject|0|||
125283195|NCT00744978|450662566|FG001|Period 1|Withdrawal by Subject|2|||
125283196|NCT00744978|450662565|FG000|Period 1|Other|0|||
125283197|NCT00744978|450662566|FG001|Period 1|Other|2|||
125283198|NCT00744978|450662565|FG000|Period 1|Adverse Event|4|||
125283199|NCT00744978|450662566|FG001|Period 1|Adverse Event|0|||
125283200|NCT00744978|450662565|FG000|Period 1|Randomized but not Treated|1|||
125283201|NCT00744978|450662566|FG001|Period 1|Randomized but not Treated|1|||
125283202|NCT00744978|450662565|FG000|Period 2|Adverse Event|0|||
125283203|NCT00744978|450662566|FG001|Period 2|Adverse Event|1|||
125283204|NCT00866047|450662570|FG000|Treatment Period|Progressive disease|13|||
125283205|NCT00866047|450662570|FG000|Treatment Period|Adverse Event|16|||
125283206|NCT00866047|450662570|FG000|Treatment Period|Physician Decision|14|||
125283207|NCT00866047|450662570|FG000|Treatment Period|Withdrawal by Subject|5|||
125283208|NCT00866047|450662570|FG000|Follow-up Period|Lost to Follow-up|5|||
125283209|NCT02928029|450662571|FG000|Overall Study|Withdrawal by Subject|0|||
125283210|NCT02928029|450662572|FG001|Overall Study|Withdrawal by Subject|1|||
125283211|NCT02928029|450662571|FG000|Overall Study|Radiological progression|1|||
124782126|NCT01349049|448832756|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
124782127|NCT01349049|448832757|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
125283212|NCT02928029|450662572|FG001|Overall Study|Radiological progression|0|||
124782128|NCT01349049|448832758|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
124782129|NCT01349049|448832759|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
124782130|NCT01349049|448832760|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
124782131|NCT01349049|448832761|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
124782132|NCT01349049|448832762|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
125283213|NCT02928029|450662571|FG000|Overall Study|Clinical progression|1|||
125283214|NCT02928029|450662572|FG001|Overall Study|Clinical progression|2|||
125283215|NCT02928029|450662571|FG000|Overall Study|AE not related to clinical progression|1|||
125283216|NCT02928029|450662572|FG001|Overall Study|AE not related to clinical progression|1|||
125283217|NCT00515294|450662573|FG000|Overall Study|Lost to Follow-up|3|||
125283218|NCT00515294|450662574|FG001|Overall Study|Lost to Follow-up|2|||
125283219|NCT00515294|450662575|FG002|Overall Study|Lost to Follow-up|3|||
125283220|NCT00515294|450662576|FG003|Overall Study|Lost to Follow-up|1|||
125283221|NCT00515294|450662573|FG000|Overall Study|Driver simulator problems|1|||
125283222|NCT00515294|450662574|FG001|Overall Study|Driver simulator problems|1|||
125283223|NCT00515294|450662575|FG002|Overall Study|Driver simulator problems|1|||
125283224|NCT00515294|450662576|FG003|Overall Study|Driver simulator problems|3|||
125283225|NCT00515294|450662573|FG000|Overall Study|Caffeine amount inaccurate|5|||
125283226|NCT00515294|450662574|FG001|Overall Study|Caffeine amount inaccurate|0|||
125283227|NCT00515294|450662575|FG002|Overall Study|Caffeine amount inaccurate|7|||
125283228|NCT00515294|450662576|FG003|Overall Study|Caffeine amount inaccurate|0|||
125283229|NCT02778555|450662577|FG000|Overall Study|Withdrawal by Subject|55|||
125283230|NCT02778555|450662578|FG001|Overall Study|Withdrawal by Subject|32|||
125283231|NCT02778555|450662579|FG002|Overall Study|Withdrawal by Subject|107|||
125283232|NCT04659174|450662584|FG000|Overall Study|Sponsor decision to discontinue study|0|||
125283233|NCT04659174|450662585|FG001|Overall Study|Sponsor decision to discontinue study|2|||
125283234|NCT04659174|450662584|FG000|Overall Study|Lost to Follow-up|9|||
125283235|NCT04659174|450662585|FG001|Overall Study|Lost to Follow-up|11|||
125283236|NCT04659174|450662584|FG000|Overall Study|Adverse Event|8|||
125283237|NCT04659174|450662585|FG001|Overall Study|Adverse Event|5|||
125283238|NCT04659174|450662584|FG000|Overall Study|Withdrawal by Subject|17|||
125283239|NCT04659174|450662585|FG001|Overall Study|Withdrawal by Subject|33|||
125283240|NCT04659174|450662584|FG000|Overall Study|Progressive disease|0|||
125283241|NCT04659174|450662585|FG001|Overall Study|Progressive disease|2|||
125283242|NCT04659174|450662584|FG000|Overall Study|Other reasons|0|||
125283243|NCT04659174|450662585|FG001|Overall Study|Other reasons|2|||
125283244|NCT04659174|450662584|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
125283245|NCT04659174|450662585|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
125283246|NCT04659174|450662584|FG000|Overall Study|Alcohol or illegal drug use|0|||
125283247|NCT04659174|450662585|FG001|Overall Study|Alcohol or illegal drug use|3|||
125283248|NCT04659174|450662584|FG000|Overall Study|Violation of entry criteria|1|||
125283249|NCT04659174|450662585|FG001|Overall Study|Violation of entry criteria|0|||
125283250|NCT04659174|450662584|FG000|Overall Study|Death|0|||
125283251|NCT04659174|450662585|FG001|Overall Study|Death|1|||
125283252|NCT01639339|450662590|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
125283253|NCT01639339|450662591|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
125283254|NCT01639339|450662590|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
125283255|NCT01639339|450662591|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
125283256|NCT01639339|450662590|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
125283257|NCT01639339|450662591|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
125283258|NCT01639339|450662590|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
125283259|NCT01639339|450662591|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
125283260|NCT01639339|450662590|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
125283261|NCT01639339|450662591|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
125283262|NCT01639339|450662590|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
125283263|NCT01639339|450662591|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
125283264|NCT01639339|450662590|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
125283265|NCT01639339|450662591|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
125283266|NCT01639339|450662590|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
125283267|NCT01639339|450662591|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
125283268|NCT01639339|450662590|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
125283269|NCT01639339|450662591|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
125283270|NCT01639339|450662590|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
125283271|NCT01639339|450662591|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
125283272|NCT03022097|450662592|FG000|Overall Study|Adverse Event|3|||
125283273|NCT03022097|450662593|FG001|Overall Study|Adverse Event|4|||
125283274|NCT03022097|450662594|FG002|Overall Study|Adverse Event|1|||
125283275|NCT03022097|450662595|FG003|Overall Study|Adverse Event|3|||
125283276|NCT03022097|450662592|FG000|Overall Study|Progressive Disease|2|||
125283277|NCT03022097|450662593|FG001|Overall Study|Progressive Disease|0|||
125283278|NCT03022097|450662594|FG002|Overall Study|Progressive Disease|5|||
125283279|NCT03022097|450662595|FG003|Overall Study|Progressive Disease|2|||
125283280|NCT03022097|450662592|FG000|Overall Study|Lack of Efficacy|0|||
125283281|NCT03022097|450662593|FG001|Overall Study|Lack of Efficacy|0|||
125283282|NCT03022097|450662594|FG002|Overall Study|Lack of Efficacy|3|||
125283283|NCT03022097|450662595|FG003|Overall Study|Lack of Efficacy|3|||
125283284|NCT03022097|450662592|FG000|Overall Study|Protocol Violation|1|||
125283285|NCT03022097|450662593|FG001|Overall Study|Protocol Violation|0|||
125283286|NCT03022097|450662594|FG002|Overall Study|Protocol Violation|1|||
125283287|NCT03022097|450662595|FG003|Overall Study|Protocol Violation|0|||
125283288|NCT03022097|450662592|FG000|Overall Study|Withdrawal by Subject|11|||
125283289|NCT03022097|450662593|FG001|Overall Study|Withdrawal by Subject|13|||
125283290|NCT03022097|450662594|FG002|Overall Study|Withdrawal by Subject|15|||
125283291|NCT03022097|450662595|FG003|Overall Study|Withdrawal by Subject|21|||
125283292|NCT03022097|450662592|FG000|Overall Study|Lost to Follow-up|0|||
125283293|NCT03022097|450662593|FG001|Overall Study|Lost to Follow-up|0|||
125283294|NCT03022097|450662594|FG002|Overall Study|Lost to Follow-up|1|||
125283295|NCT03022097|450662595|FG003|Overall Study|Lost to Follow-up|1|||
125283296|NCT03022097|450662592|FG000|Overall Study|Other|4|||
125283297|NCT03022097|450662593|FG001|Overall Study|Other|1|||
125283298|NCT03022097|450662594|FG002|Overall Study|Other|6|||
125283299|NCT03022097|450662595|FG003|Overall Study|Other|4|||
125283300|NCT03022097|450662592|FG000|Overall Study|Due to COVID-19 pandemic|0|||
125283301|NCT03022097|450662593|FG001|Overall Study|Due to COVID-19 pandemic|1|||
125283302|NCT03022097|450662594|FG002|Overall Study|Due to COVID-19 pandemic|0|||
125283303|NCT03022097|450662595|FG003|Overall Study|Due to COVID-19 pandemic|0|||
125283304|NCT01451931|450662598|FG000|Overall Study|Lost to Follow-up|17|||
125283305|NCT01451931|450662599|FG001|Overall Study|Lost to Follow-up|36|||
125283306|NCT01451931|450662600|FG002|Overall Study|Lost to Follow-up|21|||
125283307|NCT01451931|450662598|FG000|Overall Study|Withdrawal by Subject|16|||
125283308|NCT01451931|450662599|FG001|Overall Study|Withdrawal by Subject|22|||
125283309|NCT01451931|450662600|FG002|Overall Study|Withdrawal by Subject|22|||
125283310|NCT00503581|450662601|FG000|Overall Study|Study closed|3|||
125283311|NCT00503581|450662602|FG001|Overall Study|Study closed|4|||
125283312|NCT00503581|450662603|FG002|Overall Study|Study closed|2|||
125283313|NCT04470908|450662604|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
125283314|NCT06107803|450662610|FG000|Overall Study|Adverse Event|1|||
125283315|NCT06107803|450662610|FG000|Overall Study|Withdrawal by Subject|2|||
125283316|NCT06107803|450662610|FG000|Overall Study|Protocol Violation|1|||
125283317|NCT02378298|450662612|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
125283318|NCT02378298|450662613|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
125283319|NCT02378298|450662614|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
125283320|NCT02378298|450662612|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
125283321|NCT02378298|450662613|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
125283322|NCT02378298|450662614|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
125283323|NCT02378298|450662612|FG000|Surveillance (19-68 Weeks)|Death|1|||
125283324|NCT02378298|450662613|FG001|Surveillance (19-68 Weeks)|Death|0|||
125283325|NCT02378298|450662614|FG002|Surveillance (19-68 Weeks)|Death|0|||
125283326|NCT04730635|450662615|FG000|Overall Study|Lost to Follow-up|1|||
125283327|NCT04730635|450662616|FG001|Overall Study|Lost to Follow-up|0|||
125283328|NCT04730635|450662615|FG000|Overall Study|Withdrawal by Subject|0|||
125283329|NCT04730635|450662616|FG001|Overall Study|Withdrawal by Subject|1|||
125283330|NCT04934800|450662617|FG000|Overall Study|Other|1|||
125283331|NCT04934800|450662617|FG000|Overall Study|Withdrawal by Subject|5|||
125283332|NCT04934800|450662617|FG000|Overall Study|Lack of Efficacy|1|||
125283333|NCT04934800|450662617|FG000|Overall Study|Adverse Event|9|||
125283334|NCT04934800|450662617|FG000|Overall Study|Lost to Follow-up|5|||
125283335|NCT04934800|450662617|FG000|Overall Study|Enrolled but not treated|1|||
125283336|NCT02118766|450662620|FG000|Overall Study|Adverse Event|7|||
125283337|NCT02118766|450662621|FG001|Overall Study|Adverse Event|2|||
125283338|NCT02118766|450662620|FG000|Overall Study|Withdrawal by Subject|3|||
125283339|NCT02118766|450662621|FG001|Overall Study|Withdrawal by Subject|6|||
125283340|NCT02118766|450662620|FG000|Overall Study|Lost to Follow-up|5|||
125283341|NCT02118766|450662621|FG001|Overall Study|Lost to Follow-up|4|||
125283342|NCT02118766|450662620|FG000|Overall Study|Withdrawal by parent/guardian|12|||
125283343|NCT02118766|450662621|FG001|Overall Study|Withdrawal by parent/guardian|18|||
125283344|NCT02118766|450662620|FG000|Overall Study|Other|3|||
125283345|NCT02118766|450662621|FG001|Overall Study|Other|1|||
125283346|NCT03219034|450662623|FG000|Overall Study|Lost to Follow-up|9|||
125283347|NCT03219034|450662624|FG001|Overall Study|Lost to Follow-up|13|||
125283348|NCT03219034|450662623|FG000|Overall Study|Additional dental work needed|1|||
125283349|NCT03219034|450662624|FG001|Overall Study|Additional dental work needed|0|||
125283350|NCT03219034|450662623|FG000|Overall Study|UPPP Surgery|1|||
125283351|NCT03219034|450662624|FG001|Overall Study|UPPP Surgery|0|||
125283352|NCT03219034|450662623|FG000|Overall Study|Dental sensitivity|0|||
125283353|NCT03219034|450662624|FG001|Overall Study|Dental sensitivity|1|||
125283354|NCT03219034|450662623|FG000|Overall Study|Death in family|0|||
125283355|NCT03219034|450662624|FG001|Overall Study|Death in family|1|||
125283356|NCT02438683|450662625|FG000|Overall Study|Adverse Event|1|||
125283357|NCT02438683|450662626|FG001|Overall Study|Adverse Event|0|||
125283358|NCT02438683|450662627|FG002|Overall Study|Adverse Event|0|||
125283359|NCT02438683|450662628|FG003|Overall Study|Adverse Event|0|||
125283360|NCT02438683|450662629|FG004|Overall Study|Adverse Event|0|||
125283361|NCT02438683|450662630|FG005|Overall Study|Adverse Event|0|||
125283362|NCT04669262|450662633|FG000|Overall Study|Withdrawal by Subject|0|||
125283363|NCT04669262|450662634|FG001|Overall Study|Withdrawal by Subject|0|||
125283364|NCT04669262|450662635|FG002|Overall Study|Withdrawal by Subject|0|||
125283365|NCT04669262|450662636|FG003|Overall Study|Withdrawal by Subject|1|||
125283366|NCT04669262|450662633|FG000|Overall Study|Randomized but Not Treated|0|||
125283367|NCT04669262|450662634|FG001|Overall Study|Randomized but Not Treated|1|||
125283368|NCT04669262|450662635|FG002|Overall Study|Randomized but Not Treated|0|||
125283369|NCT04669262|450662636|FG003|Overall Study|Randomized but Not Treated|0|||
125283370|NCT01638013|450662637|FG000|Overall Study|Adverse Event|36|||
125283371|NCT01638013|450662638|FG001|Overall Study|Adverse Event|29|||
125283372|NCT01638013|450662639|FG002|Overall Study|Adverse Event|48|||
125283373|NCT01638013|450662637|FG000|Overall Study|Lack of Efficacy|39|||
125283374|NCT01638013|450662638|FG001|Overall Study|Lack of Efficacy|11|||
125283375|NCT01638013|450662639|FG002|Overall Study|Lack of Efficacy|14|||
125283376|NCT01638013|450662637|FG000|Overall Study|Protocol Violation|10|||
125283377|NCT01638013|450662638|FG001|Overall Study|Protocol Violation|7|||
125283378|NCT01638013|450662639|FG002|Overall Study|Protocol Violation|11|||
125283379|NCT01638013|450662637|FG000|Overall Study|Met discontinuation criteria|4|||
125283380|NCT01638013|450662638|FG001|Overall Study|Met discontinuation criteria|0|||
125283381|NCT01638013|450662639|FG002|Overall Study|Met discontinuation criteria|7|||
125283382|NCT01638013|450662637|FG000|Overall Study|Subject Lost to Follow up|1|||
125283383|NCT01638013|450662638|FG001|Overall Study|Subject Lost to Follow up|0|||
125283384|NCT01638013|450662639|FG002|Overall Study|Subject Lost to Follow up|1|||
125283385|NCT01638013|450662637|FG000|Overall Study|Miscellaneous|25|||
125283386|NCT01638013|450662638|FG001|Overall Study|Miscellaneous|19|||
125283387|NCT01638013|450662639|FG002|Overall Study|Miscellaneous|23|||
125283388|NCT01638013|450662637|FG000|Overall Study|Withdrawal of Consent|16|||
125283389|NCT01638013|450662638|FG001|Overall Study|Withdrawal of Consent|12|||
125283390|NCT01638013|450662639|FG002|Overall Study|Withdrawal of Consent|16|||
125283391|NCT01638013|450662637|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
125283392|NCT01638013|450662638|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
125283393|NCT01638013|450662639|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
125283394|NCT01846299|450662640|FG000|Overall Study|Physician Decision|4|||
125283395|NCT01846299|450662641|FG001|Overall Study|Physician Decision|2|||
125283396|NCT01846299|450662640|FG000|Overall Study|Protocol deviation|1|||
125283397|NCT01846299|450662641|FG001|Overall Study|Protocol deviation|0|||
125283398|NCT01846299|450662640|FG000|Overall Study|Death|1|||
125283399|NCT01846299|450662641|FG001|Overall Study|Death|2|||
125283400|NCT01846299|450662640|FG000|Overall Study|Lost to Follow-up|3|||
125283401|NCT01846299|450662641|FG001|Overall Study|Lost to Follow-up|0|||
125283402|NCT01846299|450662640|FG000|Overall Study|Withdrawal by Subject|1|||
125283403|NCT01846299|450662641|FG001|Overall Study|Withdrawal by Subject|6|||
125283404|NCT01846299|450662640|FG000|Overall Study|Adverse Event|2|||
125283405|NCT01846299|450662641|FG001|Overall Study|Adverse Event|0|||
125303128|NCT03100058|450736664|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303129|NCT03100058|450736665|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303130|NCT03100058|450736666|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303131|NCT03100058|450736667|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303132|NCT03100058|450736668|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303133|NCT03100058|450736669|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303134|NCT03100058|450736670|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303135|NCT03100058|450736671|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303136|NCT03100058|450736672|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303137|NCT03100058|450736673|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303138|NCT03100058|450736661|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303139|NCT03100058|450736662|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303140|NCT03100058|450736663|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303141|NCT03100058|450736664|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303142|NCT03100058|450736665|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303143|NCT03100058|450736666|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303144|NCT03100058|450736667|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
125303145|NCT03100058|450736668|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303146|NCT03100058|450736669|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303147|NCT03100058|450736670|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303148|NCT03100058|450736671|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303149|NCT03100058|450736672|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303150|NCT03100058|450736673|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303151|NCT03100058|450736661|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
125303152|NCT03100058|450736662|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
125303153|NCT03100058|450736663|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
125303154|NCT03100058|450736664|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
125303155|NCT03100058|450736665|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
125303156|NCT03100058|450736666|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
125303157|NCT03100058|450736667|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
125303158|NCT03100058|450736668|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
125303159|NCT03100058|450736669|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
125303160|NCT03100058|450736670|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
125303161|NCT03100058|450736671|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
125303162|NCT03100058|450736672|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
125303163|NCT03100058|450736673|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
125303164|NCT03100058|450736661|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125303165|NCT03100058|450736662|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125303166|NCT03100058|450736663|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125303167|NCT03100058|450736664|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125303168|NCT03100058|450736665|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125303169|NCT03100058|450736666|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125303170|NCT03100058|450736667|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125303171|NCT03100058|450736668|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125303172|NCT03100058|450736669|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125303173|NCT03100058|450736670|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125303174|NCT03100058|450736671|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
125303175|NCT03100058|450736672|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
125283406|NCT00496483|450664840|FG000|Overall Study|Not dosed|9|||
125283407|NCT00496483|450664840|FG000|Overall Study|Adverse Event|2|||
125283408|NCT00496483|450664840|FG000|Overall Study|Lack of Efficacy|1|||
125283409|NCT03095027|450664843|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
125283410|NCT03095027|450664844|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
125283411|NCT04021524|450664845|FG000|Overall Study|Change in surgical intervention|0|||
125283412|NCT04021524|450664846|FG001|Overall Study|Change in surgical intervention|1|||
125283413|NCT05275010|450664847|FG000|Overall Study|Reason Not Specified|4|||
125283414|NCT05275010|450664848|FG001|Overall Study|Reason Not Specified|1|||
125283415|NCT05275010|450664847|FG000|Overall Study|Withdrawal by Subject|1|||
125283416|NCT05275010|450664848|FG001|Overall Study|Withdrawal by Subject|0|||
125283417|NCT05275010|450664847|FG000|Overall Study|Lost to Follow-up|0|||
125283418|NCT05275010|450664848|FG001|Overall Study|Lost to Follow-up|1|||
125283419|NCT00730041|450664849|FG000|Overall Study|Lost to Follow-up|0|||
125283420|NCT00730041|450664850|FG001|Overall Study|Lost to Follow-up|2|||
125283421|NCT05526781|450664851|FG000|Overall Study|Lost to Follow-up|1|||
125283422|NCT04085458|450664852|FG000|Overall Study|Other|1|||
125283423|NCT04085458|450664852|FG000|Overall Study|Withdrawal by Subject|2|||
125283424|NCT04085458|450664852|FG000|Overall Study|Adverse Event|2|||
125283425|NCT03632993|450664853|FG000|Overall Study|Withdrawal by Subject|1|||
125283426|NCT03632993|450664854|FG001|Overall Study|Withdrawal by Subject|0|||
125283427|NCT03632993|450664855|FG002|Overall Study|Withdrawal by Subject|0|||
125283428|NCT03632993|450664856|FG003|Overall Study|Withdrawal by Subject|0|||
125283429|NCT03632993|450664857|FG004|Overall Study|Withdrawal by Subject|0|||
125283430|NCT03632993|450664858|FG005|Overall Study|Withdrawal by Subject|0|||
125283431|NCT03632993|450664859|FG006|Overall Study|Withdrawal by Subject|0|||
125283432|NCT03632993|450664860|FG007|Overall Study|Withdrawal by Subject|0|||
125283433|NCT03632993|450664861|FG008|Overall Study|Withdrawal by Subject|0|||
125283434|NCT03632993|450664862|FG009|Overall Study|Withdrawal by Subject|1|||
125283435|NCT03632993|450664853|FG000|Overall Study|Protocol Non-compliance|0|||
125283436|NCT03632993|450664854|FG001|Overall Study|Protocol Non-compliance|1|||
125283437|NCT03632993|450664855|FG002|Overall Study|Protocol Non-compliance|0|||
125283438|NCT03632993|450664856|FG003|Overall Study|Protocol Non-compliance|0|||
125283439|NCT03632993|450664857|FG004|Overall Study|Protocol Non-compliance|0|||
125283440|NCT03632993|450664858|FG005|Overall Study|Protocol Non-compliance|0|||
125283441|NCT03632993|450664859|FG006|Overall Study|Protocol Non-compliance|0|||
125283442|NCT03632993|450664860|FG007|Overall Study|Protocol Non-compliance|0|||
125283443|NCT03632993|450664861|FG008|Overall Study|Protocol Non-compliance|0|||
125283444|NCT03632993|450664862|FG009|Overall Study|Protocol Non-compliance|0|||
125283445|NCT03632993|450664853|FG000|Overall Study|Lost to Follow-up|0|||
125283446|NCT03632993|450664854|FG001|Overall Study|Lost to Follow-up|0|||
125283447|NCT03632993|450664855|FG002|Overall Study|Lost to Follow-up|0|||
125283448|NCT03632993|450664856|FG003|Overall Study|Lost to Follow-up|0|||
125283449|NCT03632993|450664857|FG004|Overall Study|Lost to Follow-up|0|||
125283450|NCT03632993|450664858|FG005|Overall Study|Lost to Follow-up|1|||
125283451|NCT03632993|450664859|FG006|Overall Study|Lost to Follow-up|0|||
125283452|NCT03632993|450664860|FG007|Overall Study|Lost to Follow-up|1|||
125283453|NCT03632993|450664861|FG008|Overall Study|Lost to Follow-up|0|||
125283454|NCT03632993|450664862|FG009|Overall Study|Lost to Follow-up|0|||
125283455|NCT03632993|450664853|FG000|Overall Study|Adverse Event|0|||
125283456|NCT03632993|450664854|FG001|Overall Study|Adverse Event|0|||
125283457|NCT03632993|450664855|FG002|Overall Study|Adverse Event|0|||
125283458|NCT03632993|450664856|FG003|Overall Study|Adverse Event|0|||
125283459|NCT03632993|450664857|FG004|Overall Study|Adverse Event|0|||
125283460|NCT03632993|450664858|FG005|Overall Study|Adverse Event|1|||
125283461|NCT03632993|450664859|FG006|Overall Study|Adverse Event|0|||
125283462|NCT03632993|450664860|FG007|Overall Study|Adverse Event|1|||
125283463|NCT03632993|450664861|FG008|Overall Study|Adverse Event|0|||
125283464|NCT03632993|450664862|FG009|Overall Study|Adverse Event|0|||
125283465|NCT02743949|450664863|FG000|Overall Study|Adverse Event|0|||
125283466|NCT02743949|450664864|FG001|Overall Study|Adverse Event|0|||
125283467|NCT02743949|450664865|FG002|Overall Study|Adverse Event|2|||
125283468|NCT02743949|450664863|FG000|Overall Study|Significant Protocol Deviation|2|||
125283469|NCT02743949|450664864|FG001|Overall Study|Significant Protocol Deviation|0|||
125283470|NCT02743949|450664865|FG002|Overall Study|Significant Protocol Deviation|1|||
125283471|NCT02743949|450664863|FG000|Overall Study|Voluntary Withdrawal|2|||
125283472|NCT02743949|450664864|FG001|Overall Study|Voluntary Withdrawal|1|||
125283473|NCT02743949|450664865|FG002|Overall Study|Voluntary Withdrawal|0|||
125283474|NCT03327220|450664866|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
125283475|NCT03327220|450664867|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
125283476|NCT03327220|450664866|FG000|Overall Study|Investigator Decision|2|||
125283477|NCT03327220|450664867|FG001|Overall Study|Investigator Decision|0|||
125283478|NCT03327220|450664866|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
125283479|NCT03327220|450664867|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
125283480|NCT03327220|450664866|FG000|Overall Study|Fungal infection|1|||
125283481|NCT03327220|450664867|FG001|Overall Study|Fungal infection|0|||
125283482|NCT03327220|450664866|FG000|Overall Study|Discharged to Rehabilitation|0|||
125283483|NCT03327220|450664867|FG001|Overall Study|Discharged to Rehabilitation|1|||
125283484|NCT03327220|450664866|FG000|Overall Study|Missing|1|||
125283485|NCT03327220|450664867|FG001|Overall Study|Missing|0|||
125283486|NCT00523705|450664870|FG000|Overall Study|No time for study.|0|||
125283487|NCT00523705|450664871|FG001|Overall Study|No time for study.|1|||
125283488|NCT00368836|450664872|FG000|Phase II|Screen Failure|1|||
125283489|NCT00368836|450664872|FG000|Phase II|Withdrawal by Subject|1|||
125283490|NCT00368836|450664872|FG000|Phase II|unable to collect blood and/or breath|17|||
125283491|NCT00368836|450664872|FG000|Phase II|Protocol Violation|2|||
125283492|NCT02442310|450664873|FG000|Overall Study|Adverse Event|2|||
125283493|NCT02442310|450664873|FG000|Overall Study|Withdrawal by Subject|1|||
125283494|NCT04154345|450664876|FG000|Overall Study|Covid-19 pandemic|4|||
125283495|NCT03622112|450664889|FG000|Overall Study|Withdrawal by Subject|6|||
125283496|NCT03622112|450664890|FG001|Overall Study|Withdrawal by Subject|2|||
125283497|NCT03622112|450664891|FG002|Overall Study|Withdrawal by Subject|4|||
125283498|NCT03622112|450664892|FG003|Overall Study|Withdrawal by Subject|2|||
125283499|NCT03622112|450664893|FG004|Overall Study|Withdrawal by Subject|1|||
125283500|NCT03622112|450664894|FG005|Overall Study|Withdrawal by Subject|2|||
125283501|NCT03622112|450664895|FG006|Overall Study|Withdrawal by Subject|2|||
125283502|NCT03622112|450664889|FG000|Overall Study|Death|0|||
125283503|NCT03622112|450664890|FG001|Overall Study|Death|0|||
125283504|NCT03622112|450664891|FG002|Overall Study|Death|0|||
125283505|NCT03622112|450664892|FG003|Overall Study|Death|1|||
125283506|NCT03622112|450664893|FG004|Overall Study|Death|0|||
125283507|NCT03622112|450664894|FG005|Overall Study|Death|0|||
125283508|NCT03622112|450664895|FG006|Overall Study|Death|0|||
125283509|NCT03622112|450664889|FG000|Overall Study|Lost to Follow-up|1|||
125283510|NCT03622112|450664890|FG001|Overall Study|Lost to Follow-up|1|||
125283511|NCT03622112|450664891|FG002|Overall Study|Lost to Follow-up|0|||
125283512|NCT03622112|450664892|FG003|Overall Study|Lost to Follow-up|0|||
125283513|NCT03622112|450664893|FG004|Overall Study|Lost to Follow-up|0|||
125283514|NCT03622112|450664894|FG005|Overall Study|Lost to Follow-up|0|||
125283515|NCT03622112|450664895|FG006|Overall Study|Lost to Follow-up|0|||
125283516|NCT03622112|450664889|FG000|Overall Study|Study-specific withdrawal criteria|10|||
125283517|NCT03622112|450664890|FG001|Overall Study|Study-specific withdrawal criteria|8|||
125283518|NCT03622112|450664891|FG002|Overall Study|Study-specific withdrawal criteria|7|||
125283519|NCT03622112|450664892|FG003|Overall Study|Study-specific withdrawal criteria|6|||
125283520|NCT03622112|450664893|FG004|Overall Study|Study-specific withdrawal criteria|4|||
125283521|NCT03622112|450664894|FG005|Overall Study|Study-specific withdrawal criteria|18|||
125283522|NCT03622112|450664895|FG006|Overall Study|Study-specific withdrawal criteria|4|||
125283523|NCT03622112|450664889|FG000|Overall Study|Protocol Violation|2|||
125283524|NCT03622112|450664890|FG001|Overall Study|Protocol Violation|0|||
125283525|NCT03622112|450664891|FG002|Overall Study|Protocol Violation|1|||
125283526|NCT03622112|450664892|FG003|Overall Study|Protocol Violation|1|||
125283527|NCT03622112|450664893|FG004|Overall Study|Protocol Violation|0|||
125283528|NCT03622112|450664894|FG005|Overall Study|Protocol Violation|0|||
125283529|NCT03622112|450664895|FG006|Overall Study|Protocol Violation|0|||
125283530|NCT03622112|450664889|FG000|Overall Study|Adverse Event|6|||
125283531|NCT03622112|450664890|FG001|Overall Study|Adverse Event|8|||
125283532|NCT03622112|450664891|FG002|Overall Study|Adverse Event|4|||
125283533|NCT03622112|450664892|FG003|Overall Study|Adverse Event|11|||
125283534|NCT03622112|450664893|FG004|Overall Study|Adverse Event|4|||
125283535|NCT03622112|450664894|FG005|Overall Study|Adverse Event|20|||
125283536|NCT03622112|450664895|FG006|Overall Study|Adverse Event|2|||
125283537|NCT03622112|450664889|FG000|Overall Study|Reason not specified|0|||
125283538|NCT03622112|450664890|FG001|Overall Study|Reason not specified|1|||
125283539|NCT03622112|450664891|FG002|Overall Study|Reason not specified|0|||
125283540|NCT03622112|450664892|FG003|Overall Study|Reason not specified|1|||
125283541|NCT03622112|450664893|FG004|Overall Study|Reason not specified|1|||
125283542|NCT03622112|450664894|FG005|Overall Study|Reason not specified|2|||
125283543|NCT03622112|450664895|FG006|Overall Study|Reason not specified|1|||
125283544|NCT03773133|450664896|FG000|Overall Study|Screen Failure|8|||
125283545|NCT01610713|450664897|FG000|Overall Study|Adverse Event|3|||
125283546|NCT01610713|450664898|FG001|Overall Study|Adverse Event|0|||
125283547|NCT01610713|450664897|FG000|Overall Study|Lack of Efficacy|1|||
125283548|NCT01610713|450664898|FG001|Overall Study|Lack of Efficacy|0|||
125283549|NCT01610713|450664897|FG000|Overall Study|low mood and poor motivation|1|||
125283550|NCT01610713|450664898|FG001|Overall Study|low mood and poor motivation|0|||
125283551|NCT01610713|450664897|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
125283552|NCT01610713|450664898|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
125283553|NCT01610713|450664897|FG000|Overall Study|Lost to Follow-up|0|||
125283554|NCT01610713|450664898|FG001|Overall Study|Lost to Follow-up|1|||
125283555|NCT03943550|450664902|FG000|Overall Study|Adverse Event|0|||
125283556|NCT03943550|450664903|FG001|Overall Study|Adverse Event|0|||
125283557|NCT03943550|450664904|FG002|Overall Study|Adverse Event|1|||
125283558|NCT03943550|450664902|FG000|Overall Study|Lost to Follow-up|0|||
125283559|NCT03943550|450664903|FG001|Overall Study|Lost to Follow-up|0|||
125283560|NCT03943550|450664904|FG002|Overall Study|Lost to Follow-up|1|||
125283561|NCT03943550|450664902|FG000|Overall Study|Progressive Disease|0|||
125283562|NCT03943550|450664903|FG001|Overall Study|Progressive Disease|0|||
125283563|NCT03943550|450664904|FG002|Overall Study|Progressive Disease|2|||
125283564|NCT03943550|450664902|FG000|Overall Study|Participant Moved Out of the Country|0|||
125283565|NCT03943550|450664903|FG001|Overall Study|Participant Moved Out of the Country|1|||
125283566|NCT03943550|450664904|FG002|Overall Study|Participant Moved Out of the Country|0|||
125283567|NCT03359785|450664905|FG000|Overall Study|Protocol Violation|0|||
125283568|NCT03359785|450664906|FG001|Overall Study|Protocol Violation|1|||
125283569|NCT03359785|450664907|FG002|Overall Study|Protocol Violation|0|||
125283570|NCT03359785|450664908|FG003|Overall Study|Protocol Violation|0|||
125283571|NCT03359785|450664905|FG000|Overall Study|Early study termination due to study pause|0|||
125283572|NCT03359785|450664906|FG001|Overall Study|Early study termination due to study pause|0|||
125283573|NCT03359785|450664907|FG002|Overall Study|Early study termination due to study pause|2|||
125283574|NCT03359785|450664908|FG003|Overall Study|Early study termination due to study pause|0|||
125283575|NCT03359785|450664905|FG000|Overall Study|Withdrawal by Subject|2|||
125283576|NCT03359785|450664906|FG001|Overall Study|Withdrawal by Subject|2|||
125283577|NCT03359785|450664907|FG002|Overall Study|Withdrawal by Subject|0|||
125283578|NCT03359785|450664908|FG003|Overall Study|Withdrawal by Subject|0|||
125283579|NCT03650803|450664912|FG000|Overall Study|Lost to Follow-up|6|||
125283580|NCT02901054|450664916|FG000|Overall Study|Physician Decision|1|||
125283581|NCT02901054|450664916|FG000|Overall Study|Withdrawal by Subject|3|||
125283582|NCT01534260|450664918|FG000|Overall Study|Adverse Event|1|||
125283583|NCT01534260|450664919|FG001|Overall Study|Adverse Event|8|||
125283584|NCT01534260|450664918|FG000|Overall Study|Death|2|||
125283585|NCT01534260|450664919|FG001|Overall Study|Death|0|||
125283586|NCT01534260|450664918|FG000|Overall Study|Lack of Efficacy|1|||
125283587|NCT01534260|450664919|FG001|Overall Study|Lack of Efficacy|1|||
125283588|NCT01534260|450664918|FG000|Overall Study|Withdrawal by Subject|1|||
125283589|NCT01534260|450664919|FG001|Overall Study|Withdrawal by Subject|3|||
125283590|NCT01534260|450664918|FG000|Overall Study|Disease Progression|8|||
125283591|NCT01534260|450664919|FG001|Overall Study|Disease Progression|6|||
125283592|NCT01534260|450664918|FG000|Overall Study|Physician Decision|3|||
125283593|NCT01534260|450664919|FG001|Overall Study|Physician Decision|1|||
125283594|NCT01534260|450664918|FG000|Overall Study|No treatment, per protocol|0|||
125283595|NCT01534260|450664919|FG001|Overall Study|No treatment, per protocol|1|||
125283596|NCT01818258|450664922|FG000|Overall Study|Death|3|||
125283597|NCT01818258|450664923|FG001|Overall Study|Death|0|||
125283598|NCT01818258|450664922|FG000|Overall Study|Withdrawal by Subject|0|||
125283599|NCT01818258|450664923|FG001|Overall Study|Withdrawal by Subject|1|||
125283600|NCT01818258|450664922|FG000|Overall Study|Lost to Follow-up|0|||
125283601|NCT01818258|450664923|FG001|Overall Study|Lost to Follow-up|1|||
125283602|NCT01818258|450664922|FG000|Overall Study|Unable to Travel to Clinic|0|||
125283603|NCT01818258|450664923|FG001|Overall Study|Unable to Travel to Clinic|1|||
125283604|NCT02649218|450664928|FG000|Overall Study|Adverse Event|8|||
125283605|NCT02649218|450664928|FG000|Overall Study|Lack of Efficacy|8|||
125283606|NCT02649218|450664928|FG000|Overall Study|Pregnancy|3|||
125283607|NCT02649218|450664928|FG000|Overall Study|Protocol Violation|3|||
125283608|NCT02649218|450664928|FG000|Overall Study|Physician Decision|1|||
125283609|NCT02649218|450664928|FG000|Overall Study|Withdrawal by Subject|2|||
125283610|NCT05145322|450664932|FG000|Overall Study|Lost to Follow-up|4|||
125283611|NCT05145322|450664933|FG001|Overall Study|Lost to Follow-up|5|||
125283612|NCT01349322|450664934|FG000|Overall Study|Protocol Violation|45|||
125283613|NCT01349322|450664935|FG001|Overall Study|Protocol Violation|47|||
125283614|NCT04376684|450664940|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
125283615|NCT04376684|450664941|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
125283616|NCT04376684|450664942|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
125283617|NCT04376684|450664943|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
125283618|NCT04376684|450664940|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
125283619|NCT04376684|450664941|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
125283620|NCT04376684|450664942|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
125283621|NCT04376684|450664943|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
125283622|NCT04376684|450664940|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
125283623|NCT04376684|450664941|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
125283624|NCT04376684|450664942|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
125283625|NCT04376684|450664943|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
125283626|NCT04376684|450664940|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
125283627|NCT04376684|450664941|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
125283628|NCT04376684|450664942|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
125283629|NCT04376684|450664943|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
125283630|NCT04376684|450664940|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
125283631|NCT04376684|450664941|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
125283632|NCT04376684|450664942|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
125283633|NCT04376684|450664943|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
125283634|NCT04376684|450664940|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
125283635|NCT04376684|450664941|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
125283636|NCT04376684|450664942|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
125283637|NCT04376684|450664943|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
125283638|NCT04376684|450664940|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
125283639|NCT04376684|450664941|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
125283640|NCT04376684|450664942|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
125283641|NCT04376684|450664943|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
125283642|NCT03099174|450664947|FG000|Overall Study|Withdrawal by Subject|0|||
125283643|NCT03099174|450664948|FG001|Overall Study|Withdrawal by Subject|0|||
125283644|NCT03099174|450664949|FG002|Overall Study|Withdrawal by Subject|1|||
125283645|NCT03099174|450664950|FG003|Overall Study|Withdrawal by Subject|0|||
125283646|NCT03099174|450664951|FG004|Overall Study|Withdrawal by Subject|2|||
125283647|NCT03099174|450664952|FG005|Overall Study|Withdrawal by Subject|2|||
125283648|NCT03099174|450664953|FG006|Overall Study|Withdrawal by Subject|1|||
125283649|NCT03099174|450664954|FG007|Overall Study|Withdrawal by Subject|4|||
125283650|NCT03099174|450664947|FG000|Overall Study|Adverse Event|0|||
125283651|NCT03099174|450664948|FG001|Overall Study|Adverse Event|1|||
125283652|NCT03099174|450664949|FG002|Overall Study|Adverse Event|1|||
125283653|NCT03099174|450664950|FG003|Overall Study|Adverse Event|2|||
125283654|NCT03099174|450664951|FG004|Overall Study|Adverse Event|5|||
125283655|NCT03099174|450664952|FG005|Overall Study|Adverse Event|3|||
125283656|NCT03099174|450664953|FG006|Overall Study|Adverse Event|6|||
125283657|NCT03099174|450664954|FG007|Overall Study|Adverse Event|4|||
125283658|NCT03099174|450664947|FG000|Overall Study|Other than listed|6|||
125283659|NCT03099174|450664948|FG001|Overall Study|Other than listed|6|||
125283660|NCT03099174|450664949|FG002|Overall Study|Other than listed|5|||
125283661|NCT03099174|450664950|FG003|Overall Study|Other than listed|6|||
125283662|NCT03099174|450664951|FG004|Overall Study|Other than listed|19|||
125283663|NCT03099174|450664952|FG005|Overall Study|Other than listed|10|||
125283664|NCT03099174|450664953|FG006|Overall Study|Other than listed|26|||
125283665|NCT03099174|450664954|FG007|Overall Study|Other than listed|23|||
125283666|NCT04173260|450664955|FG000|Overall Study|Early termination|4|||
125283667|NCT02308163|450664956|FG000|Overall Study|Not fulfill eligible criteria|1|||
125283668|NCT02308163|450664957|FG001|Overall Study|Not fulfill eligible criteria|2|||
125283669|NCT02308163|450664958|FG002|Overall Study|Not fulfill eligible criteria|0|||
125283670|NCT02308163|450664959|FG003|Overall Study|Not fulfill eligible criteria|1|||
125283671|NCT02308163|450664960|FG004|Overall Study|Not fulfill eligible criteria|1|||
125283672|NCT02308163|450664956|FG000|Overall Study|Adverse Event|9|||
125283673|NCT02308163|450664957|FG001|Overall Study|Adverse Event|5|||
125283674|NCT02308163|450664958|FG002|Overall Study|Adverse Event|2|||
125283675|NCT02308163|450664959|FG003|Overall Study|Adverse Event|2|||
125283676|NCT02308163|450664960|FG004|Overall Study|Adverse Event|11|||
125283677|NCT02308163|450664956|FG000|Overall Study|Lack of Efficacy|11|||
125283678|NCT02308163|450664957|FG001|Overall Study|Lack of Efficacy|3|||
125283679|NCT02308163|450664958|FG002|Overall Study|Lack of Efficacy|8|||
125283680|NCT02308163|450664959|FG003|Overall Study|Lack of Efficacy|4|||
125283681|NCT02308163|450664960|FG004|Overall Study|Lack of Efficacy|6|||
125283682|NCT02308163|450664956|FG000|Overall Study|Withdrawal of consent|2|||
125283683|NCT02308163|450664957|FG001|Overall Study|Withdrawal of consent|3|||
125283684|NCT02308163|450664958|FG002|Overall Study|Withdrawal of consent|0|||
125283685|NCT02308163|450664959|FG003|Overall Study|Withdrawal of consent|2|||
125283686|NCT02308163|450664960|FG004|Overall Study|Withdrawal of consent|6|||
125283687|NCT02308163|450664956|FG000|Overall Study|Protocol Violation|3|||
125283688|NCT02308163|450664957|FG001|Overall Study|Protocol Violation|3|||
125283689|NCT02308163|450664958|FG002|Overall Study|Protocol Violation|3|||
125283690|NCT02308163|450664959|FG003|Overall Study|Protocol Violation|2|||
125283691|NCT02308163|450664960|FG004|Overall Study|Protocol Violation|5|||
125283692|NCT02308163|450664956|FG000|Overall Study|Lab data met discontinuation criteria|3|||
125283693|NCT02308163|450664957|FG001|Overall Study|Lab data met discontinuation criteria|0|||
125283694|NCT02308163|450664958|FG002|Overall Study|Lab data met discontinuation criteria|0|||
125283695|NCT02308163|450664959|FG003|Overall Study|Lab data met discontinuation criteria|2|||
125283696|NCT02308163|450664960|FG004|Overall Study|Lab data met discontinuation criteria|0|||
125283697|NCT02308163|450664956|FG000|Overall Study|Miscellaneous|2|||
125283698|NCT02308163|450664957|FG001|Overall Study|Miscellaneous|2|||
125283699|NCT02308163|450664958|FG002|Overall Study|Miscellaneous|1|||
125283700|NCT02308163|450664959|FG003|Overall Study|Miscellaneous|0|||
125283701|NCT02308163|450664960|FG004|Overall Study|Miscellaneous|5|||
125283702|NCT03941964|450664963|FG000|Overall Study|Adverse Event|1|||
125283703|NCT03941964|450664964|FG001|Overall Study|Adverse Event|8|||
125283704|NCT03941964|450664963|FG000|Overall Study|Progressive disease|7|||
125283705|NCT03941964|450664964|FG001|Overall Study|Progressive disease|3|||
125283706|NCT03941964|450664963|FG000|Overall Study|Lack of Efficacy|0|||
125283707|NCT03941964|450664964|FG001|Overall Study|Lack of Efficacy|1|||
125283708|NCT03941964|450664963|FG000|Overall Study|Death|3|||
125283709|NCT03941964|450664964|FG001|Overall Study|Death|1|||
125283710|NCT03941964|450664963|FG000|Overall Study|Withdrew consent|1|||
125283711|NCT03941964|450664964|FG001|Overall Study|Withdrew consent|3|||
125283712|NCT03941964|450664963|FG000|Overall Study|Physician Decision|9|||
125283713|NCT03941964|450664964|FG001|Overall Study|Physician Decision|2|||
125283714|NCT03941964|450664963|FG000|Overall Study|Other, not specified|2|||
125283715|NCT03941964|450664964|FG001|Overall Study|Other, not specified|1|||
125283716|NCT02136680|450664969|FG000|Overall Study|No Longer Interested|1|||
125283717|NCT02136680|450664970|FG001|Overall Study|No Longer Interested|1|||
125283718|NCT02136680|450664969|FG000|Overall Study|No longer receiving care at clinic|3|||
125283719|NCT02136680|450664970|FG001|Overall Study|No longer receiving care at clinic|5|||
125283720|NCT02136680|450664969|FG000|Overall Study|Moved away|5|||
125283721|NCT02136680|450664970|FG001|Overall Study|Moved away|4|||
125283722|NCT02136680|450664969|FG000|Overall Study|Unable to schedule|17|||
125283723|NCT02136680|450664970|FG001|Overall Study|Unable to schedule|16|||
125283724|NCT02136680|450664969|FG000|Overall Study|Study ended before interview due|6|||
125283725|NCT02136680|450664970|FG001|Overall Study|Study ended before interview due|3|||
125283726|NCT05151445|450664971|FG000|Overall Study|Withdrawal by Subject|3|||
125283727|NCT02298179|450664972|FG000|Overall Study|Lost to Follow-up|0|||
125283728|NCT02298179|450664973|FG001|Overall Study|Lost to Follow-up|0|||
125283729|NCT02298179|450664974|FG002|Overall Study|Lost to Follow-up|1|||
125283730|NCT02298179|450664975|FG003|Overall Study|Lost to Follow-up|0|||
125283731|NCT02298179|450664976|FG004|Overall Study|Lost to Follow-up|0|||
125283732|NCT02298179|450664977|FG005|Overall Study|Lost to Follow-up|0|||
125283733|NCT02298179|450664978|FG006|Overall Study|Lost to Follow-up|0|||
125283734|NCT02298179|450664979|FG007|Overall Study|Lost to Follow-up|1|||
125283735|NCT02298179|450664980|FG008|Overall Study|Lost to Follow-up|0|||
125283736|NCT02298179|450664981|FG009|Overall Study|Lost to Follow-up|0|||
125283737|NCT02298179|450664982|FG010|Overall Study|Lost to Follow-up|0|||
125283738|NCT02298179|450664983|FG011|Overall Study|Lost to Follow-up|0|||
125283739|NCT03559517|450664986|FG000|Overall Study|Withdrawal by Subject|1|||
125283740|NCT03559517|450664987|FG001|Overall Study|Withdrawal by Subject|0|||
125283741|NCT03559517|450664988|FG002|Overall Study|Withdrawal by Subject|0|||
125283742|NCT01457014|450664989|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
125283743|NCT01457014|450664990|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
125283744|NCT01457014|450664991|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
125283745|NCT01457014|450664992|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
125283746|NCT01457014|450664989|FG000|First Night|Withdrawal by Subject|3|||
125283747|NCT01457014|450664990|FG001|First Night|Withdrawal by Subject|0|||
125283748|NCT01457014|450664991|FG002|First Night|Withdrawal by Subject|0|||
125283749|NCT01457014|450664992|FG003|First Night|Withdrawal by Subject|0|||
125283750|NCT01357161|450664993|FG000|Part 1 (Open Label Run-in)|Death|5|||
125283751|NCT01357161|450664994|FG001|Part 1 (Open Label Run-in)|Death|0|||
125283752|NCT01357161|450664995|FG002|Part 1 (Open Label Run-in)|Death|0|||
125283753|NCT01357161|450664993|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
125283754|NCT01357161|450664994|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
125283755|NCT01357161|450664995|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
125283756|NCT01357161|450664993|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
125283757|NCT01357161|450664994|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
125283758|NCT01357161|450664995|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
125283759|NCT01357161|450664993|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
125283760|NCT01357161|450664994|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
125283761|NCT01357161|450664995|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
125283762|NCT01357161|450664993|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
125283763|NCT01357161|450664994|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
125283764|NCT01357161|450664995|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
125283765|NCT01357161|450664993|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
125283766|NCT01357161|450664994|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
125283767|NCT01357161|450664995|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
125283768|NCT01357161|450664993|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
125283769|NCT01357161|450664994|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
125283770|NCT01357161|450664995|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
125283771|NCT01357161|450664993|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
125283772|NCT01357161|450664994|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
125283773|NCT01357161|450664995|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
125283774|NCT01357161|450664993|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
125283775|NCT01357161|450664994|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
125283776|NCT01357161|450664995|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
125283777|NCT01357161|450664993|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
125283778|NCT01357161|450664994|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
124782133|NCT01349049|448832763|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
125283779|NCT01357161|450664995|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
125283780|NCT01357161|450664993|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
125283781|NCT01357161|450664994|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
125283782|NCT01357161|450664995|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
125283783|NCT02825420|450664997|FG000|Overall Study|Death|30|||
125283784|NCT02825420|450664998|FG001|Overall Study|Death|12|||
125283785|NCT02825420|450664997|FG000|Overall Study|Progressive disease|6|||
125283786|NCT02825420|450664998|FG001|Overall Study|Progressive disease|1|||
124782134|NCT01349049|448832755|FG000|Overall Study|Other|0|||
125283787|NCT02825420|450664997|FG000|Overall Study|Lost to Follow-up|2|||
125283788|NCT02825420|450664998|FG001|Overall Study|Lost to Follow-up|2|||
125283789|NCT02825420|450664997|FG000|Overall Study|Withdrawal by Subject|1|||
125283790|NCT02825420|450664998|FG001|Overall Study|Withdrawal by Subject|1|||
125283791|NCT02825420|450664997|FG000|Overall Study|Protocol amendment not signed|1|||
125283792|NCT02825420|450664998|FG001|Overall Study|Protocol amendment not signed|1|||
125283793|NCT02825420|450664997|FG000|Overall Study|Physician Decision|1|||
125283794|NCT02825420|450664998|FG001|Overall Study|Physician Decision|0|||
125283795|NCT02825420|450664997|FG000|Overall Study|Did not receive PLD|2|||
125283796|NCT02825420|450664998|FG001|Overall Study|Did not receive PLD|0|||
125283797|NCT04027049|450664999|FG000|Overall Study|Withdrawn by family|1|||
125283798|NCT04027049|450665000|FG001|Overall Study|Withdrawn by family|0|||
125283799|NCT04027049|450664999|FG000|Overall Study|Participant safety|1|||
125283800|NCT04027049|450665000|FG001|Overall Study|Participant safety|0|||
125283801|NCT01730339|450666444|FG000|Overall Study|Withdrawal by Subject|3|||
125283802|NCT01730339|450666445|FG001|Overall Study|Withdrawal by Subject|2|||
125283803|NCT01730339|450666444|FG000|Overall Study|Lost to Follow-up|1|||
125283804|NCT01730339|450666445|FG001|Overall Study|Lost to Follow-up|1|||
125283805|NCT01730339|450666444|FG000|Overall Study|Un-specified|1|||
125283806|NCT01730339|450666445|FG001|Overall Study|Un-specified|0|||
125283807|NCT01145352|450666446|FG000|Overall Study|Found to have been registered twice|6|||
125283808|NCT01145352|450666446|FG000|Overall Study|Treated before marketing approval|4|||
125283809|NCT01145352|450666446|FG000|Overall Study|Syringe formulation was used|1|||
125283810|NCT04143217|450666447|FG000|Overall Study|Withdrawal by Subject|42|||
125283811|NCT04143217|450666447|FG000|Overall Study|Adverse Event|29|||
125283812|NCT04143217|450666447|FG000|Overall Study|Lost to Follow-up|29|||
125283813|NCT04143217|450666447|FG000|Overall Study|Lack of Efficacy|15|||
125283814|NCT04143217|450666447|FG000|Overall Study|Physician Decision|1|||
125283815|NCT04143217|450666447|FG000|Overall Study|Non-Compliance With Study Drug|6|||
125283816|NCT04143217|450666447|FG000|Overall Study|Other, Multiple Categories|11|||
125283817|NCT02264665|450666448|FG000|Overall Study|Other|0|||
125283818|NCT02264665|450666449|FG001|Overall Study|Other|0|||
125283819|NCT02264665|450666450|FG002|Overall Study|Other|3|||
125283820|NCT02264665|450666451|FG003|Overall Study|Other|0|||
125283821|NCT02264665|450666452|FG004|Overall Study|Other|0|||
125283822|NCT02264665|450666453|FG005|Overall Study|Other|0|||
125283823|NCT02264665|450666454|FG006|Overall Study|Other|0|||
125283824|NCT02264665|450666448|FG000|Overall Study|Death|9|||
125283825|NCT02264665|450666449|FG001|Overall Study|Death|8|||
125283826|NCT02264665|450666450|FG002|Overall Study|Death|13|||
125283827|NCT02264665|450666451|FG003|Overall Study|Death|5|||
125283828|NCT02264665|450666452|FG004|Overall Study|Death|0|||
125283829|NCT02264665|450666453|FG005|Overall Study|Death|0|||
125283830|NCT02264665|450666454|FG006|Overall Study|Death|1|||
125283831|NCT02264665|450666448|FG000|Overall Study|Lost to Follow-up|1|||
125283832|NCT02264665|450666449|FG001|Overall Study|Lost to Follow-up|0|||
125283833|NCT02264665|450666450|FG002|Overall Study|Lost to Follow-up|2|||
125283834|NCT02264665|450666451|FG003|Overall Study|Lost to Follow-up|1|||
125283835|NCT02264665|450666452|FG004|Overall Study|Lost to Follow-up|0|||
125283836|NCT02264665|450666453|FG005|Overall Study|Lost to Follow-up|0|||
125283837|NCT02264665|450666454|FG006|Overall Study|Lost to Follow-up|0|||
125283838|NCT02264665|450666448|FG000|Overall Study|Participant decision|0|||
125283839|NCT02264665|450666449|FG001|Overall Study|Participant decision|0|||
125283840|NCT02264665|450666450|FG002|Overall Study|Participant decision|0|||
125283841|NCT02264665|450666451|FG003|Overall Study|Participant decision|1|||
125283842|NCT02264665|450666452|FG004|Overall Study|Participant decision|0|||
125283843|NCT02264665|450666453|FG005|Overall Study|Participant decision|0|||
125283844|NCT02264665|450666454|FG006|Overall Study|Participant decision|0|||
125283845|NCT02264665|450666448|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
125283846|NCT02264665|450666449|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
125283847|NCT02264665|450666450|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
125283848|NCT02264665|450666451|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
125283849|NCT02264665|450666452|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
125283850|NCT02264665|450666453|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
125283851|NCT02264665|450666454|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
125283852|NCT02264665|450666448|FG000|Overall Study|Data Missing|0|||
125283853|NCT02264665|450666449|FG001|Overall Study|Data Missing|0|||
125283854|NCT02264665|450666450|FG002|Overall Study|Data Missing|1|||
125283855|NCT02264665|450666451|FG003|Overall Study|Data Missing|0|||
125283856|NCT02264665|450666452|FG004|Overall Study|Data Missing|0|||
125283857|NCT02264665|450666453|FG005|Overall Study|Data Missing|0|||
125283858|NCT02264665|450666454|FG006|Overall Study|Data Missing|0|||
125283859|NCT01962987|450666455|FG000|Overall Study|Adverse Event|4|||
125283860|NCT01962987|450666456|FG001|Overall Study|Adverse Event|4|||
125283861|NCT01962987|450666457|FG002|Overall Study|Adverse Event|0|||
125283862|NCT01962987|450666455|FG000|Overall Study|Lost to Follow-up|0|||
125283863|NCT01962987|450666456|FG001|Overall Study|Lost to Follow-up|0|||
125283864|NCT01962987|450666457|FG002|Overall Study|Lost to Follow-up|1|||
125283865|NCT01962987|450666455|FG000|Overall Study|Non compliance with dosing requirements|4|||
125283866|NCT01962987|450666456|FG001|Overall Study|Non compliance with dosing requirements|2|||
125283867|NCT01962987|450666457|FG002|Overall Study|Non compliance with dosing requirements|0|||
125283868|NCT01962987|450666455|FG000|Overall Study|Miscellaneous|1|||
125283869|NCT01962987|450666456|FG001|Overall Study|Miscellaneous|9|||
125283870|NCT01962987|450666457|FG002|Overall Study|Miscellaneous|2|||
125283871|NCT01962987|450666455|FG000|Overall Study|Restricted medication|5|||
125283872|NCT01962987|450666456|FG001|Overall Study|Restricted medication|1|||
125283873|NCT01962987|450666457|FG002|Overall Study|Restricted medication|1|||
125283874|NCT01962987|450666455|FG000|Overall Study|Serious Adverse Event|1|||
125283875|NCT01962987|450666456|FG001|Overall Study|Serious Adverse Event|0|||
125283876|NCT01962987|450666457|FG002|Overall Study|Serious Adverse Event|0|||
125283877|NCT01962987|450666455|FG000|Overall Study|Withdrawal by Subject|11|||
125283878|NCT01962987|450666456|FG001|Overall Study|Withdrawal by Subject|10|||
125283879|NCT01962987|450666457|FG002|Overall Study|Withdrawal by Subject|6|||
125283880|NCT01962987|450666455|FG000|Overall Study|Randomized in Error|4|||
125283881|NCT01962987|450666456|FG001|Overall Study|Randomized in Error|2|||
125283882|NCT01962987|450666457|FG002|Overall Study|Randomized in Error|2|||
125283883|NCT02688088|450666466|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
125283884|NCT02688088|450666467|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
125283885|NCT02688088|450666468|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
125283886|NCT02688088|450666469|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
125283887|NCT02688088|450666470|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
125283888|NCT02688088|450666466|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
125283889|NCT02688088|450666467|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
125283890|NCT02688088|450666468|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
125283891|NCT02688088|450666469|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
125283892|NCT02688088|450666470|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
125283893|NCT02688088|450666466|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
125283894|NCT02688088|450666467|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
125283895|NCT02688088|450666468|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
125283896|NCT02688088|450666469|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
125283897|NCT02688088|450666470|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
125283898|NCT02688088|450666466|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
125283899|NCT02688088|450666467|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
125283900|NCT02688088|450666468|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
125283901|NCT02688088|450666469|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
125283902|NCT02688088|450666470|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
125283903|NCT02688088|450666466|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
125283904|NCT02688088|450666467|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
125283905|NCT02688088|450666468|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
125283906|NCT02688088|450666469|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
125283907|NCT02688088|450666470|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
125283908|NCT02688088|450666466|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
125283909|NCT02688088|450666467|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
125283910|NCT02688088|450666468|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
125283911|NCT02688088|450666469|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
125283912|NCT02688088|450666470|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
125283913|NCT02688088|450666466|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
125283914|NCT02688088|450666467|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
125283915|NCT02688088|450666468|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
125283916|NCT02688088|450666469|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
125283917|NCT02688088|450666470|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
125283918|NCT02688088|450666466|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
125283919|NCT02688088|450666467|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
125283920|NCT02688088|450666468|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
125283921|NCT02688088|450666469|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
125283922|NCT02688088|450666470|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
124782135|NCT01349049|448832756|FG001|Overall Study|Other|0|||
124782136|NCT01349049|448832757|FG002|Overall Study|Other|0|||
125283923|NCT02688088|450666466|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
125283924|NCT02688088|450666467|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
125283925|NCT02688088|450666468|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
125283926|NCT02688088|450666469|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
125283927|NCT02688088|450666470|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
125283928|NCT01921218|450666473|FG000|Overall Study|Death|2|||
125283929|NCT01921218|450666474|FG001|Overall Study|Death|1|||
125283930|NCT01921218|450666473|FG000|Overall Study|Withdrawal by Subject|0|||
125283931|NCT01921218|450666474|FG001|Overall Study|Withdrawal by Subject|2|||
125283932|NCT01921218|450666473|FG000|Overall Study|Kidney transplant|1|||
125283933|NCT01921218|450666474|FG001|Overall Study|Kidney transplant|1|||
125283934|NCT02449889|450666475|FG000|Overall Study|Adverse Event|1|||
125283935|NCT02449889|450666476|FG001|Overall Study|Adverse Event|2|||
125283936|NCT02449889|450666477|FG002|Overall Study|Adverse Event|0|||
125283937|NCT02449889|450666475|FG000|Overall Study|Protocol Violation|0|||
125283938|NCT02449889|450666476|FG001|Overall Study|Protocol Violation|4|||
125283939|NCT02449889|450666477|FG002|Overall Study|Protocol Violation|1|||
125283940|NCT00090142|450666479|FG000|Treatment Period I|Lost to Follow-up|1|||
125283941|NCT00090142|450666480|FG001|Treatment Period I|Lost to Follow-up|2|||
125283942|NCT00090142|450666479|FG000|Treatment Period I|Protocol Violation|2|||
125283943|NCT00090142|450666480|FG001|Treatment Period I|Protocol Violation|0|||
125283944|NCT00090142|450666479|FG000|Treatment Period I|Withdrawal by Subject|2|||
125283945|NCT00090142|450666480|FG001|Treatment Period I|Withdrawal by Subject|0|||
125283946|NCT00090142|450666479|FG000|Treatment Period I|Other|0|||
125283947|NCT00090142|450666480|FG001|Treatment Period I|Other|1|||
125283948|NCT00090142|450666479|FG000|Treatment Period II|Other|1|||
125283949|NCT00090142|450666480|FG001|Treatment Period II|Other|0|||
125283950|NCT00688324|450666481|FG000|Overall Study|Withdrawal by Subject|2|||
125283951|NCT00688324|450666481|FG000|Overall Study|Physician Decision|5|||
125283952|NCT00688324|450666481|FG000|Overall Study|Lost to Follow-up|1|||
125283953|NCT00006046|450666482|FG000|Overall Study|Adverse Event|3|||
125283954|NCT00006046|450666483|FG001|Overall Study|Adverse Event|0|||
125283955|NCT00006046|450666484|FG002|Overall Study|Adverse Event|0|||
125283956|NCT00006046|450666485|FG003|Overall Study|Adverse Event|0|||
125283957|NCT00006046|450666486|FG004|Overall Study|Adverse Event|0|||
125283958|NCT00006046|450666482|FG000|Overall Study|Disease Progression|2|||
125283959|NCT00006046|450666483|FG001|Overall Study|Disease Progression|0|||
125283960|NCT00006046|450666484|FG002|Overall Study|Disease Progression|0|||
125283961|NCT00006046|450666485|FG003|Overall Study|Disease Progression|0|||
125283962|NCT00006046|450666486|FG004|Overall Study|Disease Progression|0|||
125283963|NCT03176472|450666487|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
125283964|NCT03176472|450666488|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
125283965|NCT03176472|450666487|FG000|Double Blind Treatment Period|Adverse Event|0|||
125283966|NCT03176472|450666488|FG001|Double Blind Treatment Period|Adverse Event|5|||
125283967|NCT03176472|450666487|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
125283968|NCT03176472|450666488|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
125283969|NCT03176472|450666487|FG000|Double Blind Treatment Period|Physician Decision|0|||
125283970|NCT03176472|450666488|FG001|Double Blind Treatment Period|Physician Decision|1|||
125283971|NCT03176472|450666487|FG000|Double Blind Treatment Period|Protocol Violation|1|||
125283972|NCT03176472|450666488|FG001|Double Blind Treatment Period|Protocol Violation|0|||
125283973|NCT03176472|450666487|FG000|Double Blind Treatment Period|Not Provided|1|||
125283974|NCT03176472|450666488|FG001|Double Blind Treatment Period|Not Provided|0|||
125283975|NCT03176472|450666487|FG000|Open Label Extension|Withdrawal by Subject|3|||
125283976|NCT03176472|450666488|FG001|Open Label Extension|Withdrawal by Subject|4|||
125283977|NCT03176472|450666487|FG000|Open Label Extension|Adverse Event|2|||
125283978|NCT03176472|450666488|FG001|Open Label Extension|Adverse Event|4|||
125283979|NCT03176472|450666487|FG000|Open Label Extension|Lost to Follow-up|1|||
125283980|NCT03176472|450666488|FG001|Open Label Extension|Lost to Follow-up|2|||
125283981|NCT03176472|450666487|FG000|Open Label Extension|Protocol Violation|0|||
125283982|NCT03176472|450666488|FG001|Open Label Extension|Protocol Violation|1|||
125283983|NCT03176472|450666487|FG000|Open Label Extension|Not Provided|2|||
125283984|NCT03176472|450666488|FG001|Open Label Extension|Not Provided|1|||
125283985|NCT00596154|450666489|FG000|Overall Study|Not Evaluable|2|||
125283986|NCT00642369|450666490|FG000|Overall Study|Adverse Event|2|||
125283987|NCT00642369|450666491|FG001|Overall Study|Adverse Event|3|||
125283988|NCT00642369|450666490|FG000|Overall Study|Withdrawal by Subject|1|||
125283989|NCT00642369|450666491|FG001|Overall Study|Withdrawal by Subject|0|||
125283990|NCT00642369|450666490|FG000|Overall Study|misdiagnosis|0|||
125283991|NCT00642369|450666491|FG001|Overall Study|misdiagnosis|1|||
125283992|NCT00642369|450666490|FG000|Overall Study|Lack of Efficacy|2|||
125283993|NCT00642369|450666491|FG001|Overall Study|Lack of Efficacy|2|||
125283994|NCT00585546|450666498|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
125283995|NCT00585546|450666498|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
125283996|NCT03077438|450666499|FG000|Overall Study|Protocol Violation|3|||
125283997|NCT03077438|450666500|FG001|Overall Study|Protocol Violation|5|||
125283998|NCT03077438|450666499|FG000|Overall Study|Withdrawal by Subject|3|||
125283999|NCT03077438|450666500|FG001|Overall Study|Withdrawal by Subject|6|||
125284000|NCT03077438|450666499|FG000|Overall Study|Lost to Follow-up|6|||
125284001|NCT03077438|450666500|FG001|Overall Study|Lost to Follow-up|3|||
125284002|NCT01190475|450666501|FG000|Overall Study|Withdrawal by Subject|0|||
125284003|NCT01190475|450666502|FG001|Overall Study|Withdrawal by Subject|0|||
125284004|NCT01190475|450666503|FG002|Overall Study|Withdrawal by Subject|1|||
125284005|NCT01535599|450666504|FG000|Overall Study|Adverse Event|6|||
125284006|NCT01535599|450666505|FG001|Overall Study|Adverse Event|15|||
125284007|NCT01535599|450666504|FG000|Overall Study|Lost to Follow-up|3|||
125284008|NCT01535599|450666505|FG001|Overall Study|Lost to Follow-up|4|||
125284009|NCT01535599|450666504|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
125284010|NCT01535599|450666505|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
125284011|NCT01535599|450666504|FG000|Overall Study|Treatment Failure|33|||
125284012|NCT01535599|450666505|FG001|Overall Study|Treatment Failure|66|||
125284013|NCT01535599|450666504|FG000|Overall Study|BL Culture + for Group A Strep|0|||
125284014|NCT01535599|450666505|FG001|Overall Study|BL Culture + for Group A Strep|1|||
125284015|NCT01535599|450666504|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
125284016|NCT01535599|450666505|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
125284017|NCT01535599|450666504|FG000|Overall Study|Randomized in Error|2|||
125284018|NCT01535599|450666505|FG001|Overall Study|Randomized in Error|4|||
125284019|NCT01535599|450666504|FG000|Overall Study|Did not use product|1|||
125284020|NCT01535599|450666505|FG001|Overall Study|Did not use product|0|||
125284021|NCT01535599|450666504|FG000|Overall Study|Other|1|||
125284022|NCT01535599|450666505|FG001|Overall Study|Other|0|||
125284023|NCT01535599|450666504|FG000|Overall Study|Stopped medication|0|||
125284024|NCT01535599|450666505|FG001|Overall Study|Stopped medication|1|||
125284025|NCT01535599|450666504|FG000|Overall Study|Noncompliance|0|||
125284026|NCT01535599|450666505|FG001|Overall Study|Noncompliance|1|||
125284027|NCT01165320|450666506|FG000|Overall Study|Clinical adverse experience|2|||
125284028|NCT01165320|450666507|FG001|Overall Study|Clinical adverse experience|1|||
125284029|NCT01165320|450666508|FG002|Overall Study|Clinical adverse experience|0|||
125284030|NCT01165320|450666506|FG000|Overall Study|Laboratory adverse experience|1|||
125284031|NCT01165320|450666507|FG001|Overall Study|Laboratory adverse experience|0|||
125284032|NCT01165320|450666508|FG002|Overall Study|Laboratory adverse experience|0|||
125284033|NCT01165320|450666506|FG000|Overall Study|Lack of Efficacy|0|||
125284034|NCT01165320|450666507|FG001|Overall Study|Lack of Efficacy|2|||
125284035|NCT01165320|450666508|FG002|Overall Study|Lack of Efficacy|0|||
125284036|NCT01165320|450666506|FG000|Overall Study|Reason unknown|0|||
125284037|NCT01165320|450666507|FG001|Overall Study|Reason unknown|1|||
125284038|NCT01165320|450666508|FG002|Overall Study|Reason unknown|0|||
125284039|NCT00385944|450666512|FG000|1st Maintenance Dose Period|Physician Decision|1|||
125284040|NCT00385944|450666513|FG001|1st Maintenance Dose Period|Physician Decision|0|||
125284041|NCT00385944|450666514|FG002|1st Maintenance Dose Period|Physician Decision|0|||
125284042|NCT00385944|450666512|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
125284043|NCT00385944|450666513|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
125284044|NCT00385944|450666514|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
125284045|NCT00385944|450666512|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
125284046|NCT00385944|450666513|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
125284047|NCT00385944|450666514|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
125284048|NCT00385944|450666512|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
125284049|NCT00385944|450666513|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
125284050|NCT00385944|450666514|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
125284051|NCT00590824|450666515|FG000|Overall Study|Disease could not be resected|0|||
125284052|NCT00590824|450666516|FG001|Overall Study|Disease could not be resected|2|||
125284053|NCT00590824|450666517|FG002|Overall Study|Disease could not be resected|1|||
125284054|NCT00590824|450666518|FG003|Overall Study|Disease could not be resected|0|||
125284055|NCT00590824|450666515|FG000|Overall Study|Adverse Event|0|||
125284056|NCT00590824|450666516|FG001|Overall Study|Adverse Event|0|||
125284057|NCT00590824|450666517|FG002|Overall Study|Adverse Event|0|||
125284058|NCT00590824|450666518|FG003|Overall Study|Adverse Event|1|||
125284059|NCT00791479|450666524|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
125284060|NCT00791479|450666525|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
125284061|NCT00791479|450666526|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
125284062|NCT00791479|450666527|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
125284063|NCT00791479|450666528|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
125284064|NCT00791479|450666529|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
125284065|NCT00791479|450666524|FG000|Overall Study|Adverse Event|0|||
125284066|NCT00791479|450666525|FG001|Overall Study|Adverse Event|1|||
125284067|NCT00791479|450666526|FG002|Overall Study|Adverse Event|0|||
125284068|NCT00791479|450666527|FG003|Overall Study|Adverse Event|2|||
125284069|NCT00791479|450666528|FG004|Overall Study|Adverse Event|0|||
125284070|NCT00791479|450666529|FG005|Overall Study|Adverse Event|1|||
125284071|NCT00791479|450666524|FG000|Overall Study|Lost to Follow-up|0|||
125284072|NCT00791479|450666525|FG001|Overall Study|Lost to Follow-up|1|||
125284073|NCT00791479|450666526|FG002|Overall Study|Lost to Follow-up|0|||
125284074|NCT00791479|450666527|FG003|Overall Study|Lost to Follow-up|0|||
125284075|NCT00791479|450666528|FG004|Overall Study|Lost to Follow-up|0|||
125284076|NCT00791479|450666529|FG005|Overall Study|Lost to Follow-up|1|||
125284077|NCT00791479|450666524|FG000|Overall Study|Protocol Violation|2|||
125284078|NCT00791479|450666525|FG001|Overall Study|Protocol Violation|1|||
125284079|NCT00791479|450666526|FG002|Overall Study|Protocol Violation|0|||
125284080|NCT00791479|450666527|FG003|Overall Study|Protocol Violation|1|||
125284081|NCT00791479|450666528|FG004|Overall Study|Protocol Violation|0|||
125284082|NCT00791479|450666529|FG005|Overall Study|Protocol Violation|0|||
125284083|NCT00791479|450666524|FG000|Overall Study|Withdrawal by Subject|0|||
125284084|NCT00791479|450666525|FG001|Overall Study|Withdrawal by Subject|0|||
125284085|NCT00791479|450666526|FG002|Overall Study|Withdrawal by Subject|0|||
125284086|NCT00791479|450666527|FG003|Overall Study|Withdrawal by Subject|1|||
125284087|NCT00791479|450666528|FG004|Overall Study|Withdrawal by Subject|0|||
125284088|NCT00791479|450666529|FG005|Overall Study|Withdrawal by Subject|1|||
125284089|NCT01778049|450666530|FG000|Open Label Treatment Period|Adverse Event|5|||
125284090|NCT01778049|450666531|FG001|Open Label Treatment Period|Adverse Event|15|||
125284091|NCT01778049|450666532|FG002|Open Label Treatment Period|Adverse Event|0|||
125284092|NCT01778049|450666533|FG003|Open Label Treatment Period|Adverse Event|0|||
125284093|NCT01778049|450666534|FG004|Open Label Treatment Period|Adverse Event|0|||
125284094|NCT01778049|450666535|FG005|Open Label Treatment Period|Adverse Event|0|||
125284095|NCT01778049|450666530|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
125284096|NCT01778049|450666531|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
125284097|NCT01778049|450666532|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
125284098|NCT01778049|450666533|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
125284099|NCT01778049|450666534|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
125284100|NCT01778049|450666535|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
125284101|NCT01778049|450666530|FG000|Open Label Treatment Period|Protocol Violation|5|||
125284102|NCT01778049|450666531|FG001|Open Label Treatment Period|Protocol Violation|5|||
125284103|NCT01778049|450666532|FG002|Open Label Treatment Period|Protocol Violation|0|||
125284104|NCT01778049|450666533|FG003|Open Label Treatment Period|Protocol Violation|0|||
125284105|NCT01778049|450666534|FG004|Open Label Treatment Period|Protocol Violation|0|||
125284106|NCT01778049|450666535|FG005|Open Label Treatment Period|Protocol Violation|0|||
125284107|NCT01778049|450666530|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
125284108|NCT01778049|450666531|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
125284109|NCT01778049|450666532|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
125284110|NCT01778049|450666533|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
125284111|NCT01778049|450666534|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
125284112|NCT01778049|450666535|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
125284113|NCT01778049|450666530|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
125284114|NCT01778049|450666531|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
125284115|NCT01778049|450666532|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
125284116|NCT01778049|450666533|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
125284117|NCT01778049|450666534|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
125284118|NCT01778049|450666535|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
125284119|NCT01778049|450666530|FG000|Open Label Treatment Period|Not treated|2|||
125284120|NCT01778049|450666531|FG001|Open Label Treatment Period|Not treated|1|||
125284121|NCT01778049|450666532|FG002|Open Label Treatment Period|Not treated|0|||
125284122|NCT01778049|450666533|FG003|Open Label Treatment Period|Not treated|0|||
125284123|NCT01778049|450666534|FG004|Open Label Treatment Period|Not treated|0|||
125284124|NCT01778049|450666535|FG005|Open Label Treatment Period|Not treated|0|||
125284125|NCT01778049|450666530|FG000|Open Label Treatment Period|Other reason not defined above|77|||
125284126|NCT01778049|450666531|FG001|Open Label Treatment Period|Other reason not defined above|94|||
125284127|NCT01778049|450666532|FG002|Open Label Treatment Period|Other reason not defined above|0|||
125284128|NCT01778049|450666533|FG003|Open Label Treatment Period|Other reason not defined above|0|||
125284129|NCT01778049|450666534|FG004|Open Label Treatment Period|Other reason not defined above|0|||
125284130|NCT01778049|450666535|FG005|Open Label Treatment Period|Other reason not defined above|0|||
125284131|NCT01778049|450666530|FG000|Double Blind Treatment Period|Adverse Event|0|||
125284132|NCT01778049|450666531|FG001|Double Blind Treatment Period|Adverse Event|0|||
125284133|NCT01778049|450666532|FG002|Double Blind Treatment Period|Adverse Event|4|||
125284134|NCT01778049|450666533|FG003|Double Blind Treatment Period|Adverse Event|5|||
125284135|NCT01778049|450666534|FG004|Double Blind Treatment Period|Adverse Event|3|||
125284136|NCT01778049|450666535|FG005|Double Blind Treatment Period|Adverse Event|2|||
125284137|NCT01778049|450666530|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
125284138|NCT01778049|450666531|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
125284139|NCT01778049|450666532|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
125284140|NCT01778049|450666533|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
125284141|NCT01778049|450666534|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
125284142|NCT01778049|450666535|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
125284143|NCT01778049|450666530|FG000|Double Blind Treatment Period|Protocol Violation|0|||
125284144|NCT01778049|450666531|FG001|Double Blind Treatment Period|Protocol Violation|0|||
125284145|NCT01778049|450666532|FG002|Double Blind Treatment Period|Protocol Violation|2|||
124782137|NCT01349049|448832758|FG003|Overall Study|Other|0|||
124782138|NCT01349049|448832759|FG004|Overall Study|Other|0|||
124782139|NCT01349049|448832760|FG005|Overall Study|Other|1|||
124782140|NCT01349049|448832761|FG006|Overall Study|Other|0|||
124782141|NCT01349049|448832762|FG007|Overall Study|Other|0|||
124782142|NCT01349049|448832763|FG008|Overall Study|Other|4|||
124782143|NCT01349049|448832755|FG000|Overall Study|Death|0|||
124782144|NCT01349049|448832756|FG001|Overall Study|Death|0|||
124782145|NCT01349049|448832757|FG002|Overall Study|Death|0|||
124782146|NCT01349049|448832758|FG003|Overall Study|Death|0|||
124782147|NCT01349049|448832759|FG004|Overall Study|Death|0|||
124782148|NCT01349049|448832760|FG005|Overall Study|Death|0|||
124782149|NCT01349049|448832761|FG006|Overall Study|Death|0|||
124782150|NCT01349049|448832762|FG007|Overall Study|Death|1|||
124782151|NCT01349049|448832763|FG008|Overall Study|Death|5|||
124782152|NCT01349049|448832755|FG000|Overall Study|Non-compliance|0|||
124782153|NCT01349049|448832756|FG001|Overall Study|Non-compliance|0|||
124782154|NCT01349049|448832757|FG002|Overall Study|Non-compliance|0|||
124782155|NCT01349049|448832758|FG003|Overall Study|Non-compliance|1|||
124782156|NCT01349049|448832759|FG004|Overall Study|Non-compliance|0|||
124782157|NCT01349049|448832760|FG005|Overall Study|Non-compliance|0|||
124782158|NCT01349049|448832761|FG006|Overall Study|Non-compliance|0|||
124782159|NCT01349049|448832762|FG007|Overall Study|Non-compliance|0|||
124782160|NCT01349049|448832763|FG008|Overall Study|Non-compliance|0|||
124782161|NCT01349049|448832755|FG000|Overall Study|Withdrawal by Subject|0|||
124782162|NCT01349049|448832756|FG001|Overall Study|Withdrawal by Subject|0|||
125284146|NCT01778049|450666533|FG003|Double Blind Treatment Period|Protocol Violation|0|||
125284147|NCT01778049|450666534|FG004|Double Blind Treatment Period|Protocol Violation|0|||
125284148|NCT01778049|450666535|FG005|Double Blind Treatment Period|Protocol Violation|0|||
124782163|NCT01349049|448832757|FG002|Overall Study|Withdrawal by Subject|0|||
124782164|NCT01349049|448832758|FG003|Overall Study|Withdrawal by Subject|0|||
124782165|NCT01349049|448832759|FG004|Overall Study|Withdrawal by Subject|0|||
124782166|NCT01349049|448832760|FG005|Overall Study|Withdrawal by Subject|0|||
124782167|NCT01349049|448832761|FG006|Overall Study|Withdrawal by Subject|0|||
124782168|NCT01349049|448832762|FG007|Overall Study|Withdrawal by Subject|0|||
124782169|NCT01349049|448832763|FG008|Overall Study|Withdrawal by Subject|6|||
124782170|NCT02810444|448832768|FG000|Overall Study|Screen Failures|14|||
124782171|NCT02810444|448832768|FG000|Overall Study|Withdrawal by Subject|4|||
125284149|NCT01778049|450666530|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
124782172|NCT02810444|448832768|FG000|Overall Study|Adverse Event|3|||
125284150|NCT01778049|450666531|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
125284151|NCT01778049|450666532|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
125284152|NCT01778049|450666533|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
125284153|NCT01778049|450666534|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
125284154|NCT01778049|450666535|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
125284155|NCT01778049|450666530|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
125284156|NCT01778049|450666531|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
125284157|NCT01778049|450666532|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
125284158|NCT01778049|450666533|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
125284159|NCT01778049|450666534|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
125284160|NCT01778049|450666535|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
125284161|NCT01778049|450666530|FG000|Double Blind Treatment Period|Not treated|0|||
125284162|NCT01778049|450666531|FG001|Double Blind Treatment Period|Not treated|0|||
125284163|NCT01778049|450666532|FG002|Double Blind Treatment Period|Not treated|0|||
125284164|NCT01778049|450666533|FG003|Double Blind Treatment Period|Not treated|2|||
125284165|NCT01778049|450666534|FG004|Double Blind Treatment Period|Not treated|2|||
125284166|NCT01778049|450666535|FG005|Double Blind Treatment Period|Not treated|0|||
125284167|NCT01778049|450666530|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
125284168|NCT01778049|450666531|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
125284169|NCT01778049|450666532|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
125284170|NCT01778049|450666533|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
125284171|NCT01778049|450666534|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
125284172|NCT01778049|450666535|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
125284173|NCT03770728|450666536|FG000|Overall Study|Adverse Event|1|||
125284174|NCT03770728|450666537|FG001|Overall Study|Adverse Event|0|||
125284175|NCT03770728|450666538|FG002|Overall Study|Adverse Event|1|||
125284176|NCT03770728|450666539|FG003|Overall Study|Adverse Event|0|||
125284177|NCT03770728|450666536|FG000|Overall Study|Poor compliance to protocol|0|||
125284178|NCT03770728|450666537|FG001|Overall Study|Poor compliance to protocol|0|||
125284179|NCT03770728|450666538|FG002|Overall Study|Poor compliance to protocol|1|||
125284180|NCT03770728|450666539|FG003|Overall Study|Poor compliance to protocol|0|||
125284181|NCT03770728|450666536|FG000|Overall Study|Withdrawal by Subject|13|||
125284182|NCT03770728|450666537|FG001|Overall Study|Withdrawal by Subject|8|||
125284183|NCT03770728|450666538|FG002|Overall Study|Withdrawal by Subject|9|||
125284184|NCT03770728|450666539|FG003|Overall Study|Withdrawal by Subject|13|||
125284185|NCT03770728|450666536|FG000|Overall Study|Other than specified|24|||
125284186|NCT03770728|450666537|FG001|Overall Study|Other than specified|23|||
125284187|NCT03770728|450666538|FG002|Overall Study|Other than specified|21|||
125284188|NCT03770728|450666539|FG003|Overall Study|Other than specified|22|||
125284189|NCT00503776|450666540|FG000|Overall Study|Withdrawal by Subject|1|||
125284190|NCT00503776|450666541|FG001|Overall Study|Withdrawal by Subject|0|||
125284191|NCT00503776|450666542|FG002|Overall Study|Withdrawal by Subject|1|||
125284192|NCT00503776|450666543|FG003|Overall Study|Withdrawal by Subject|1|||
125284193|NCT00503776|450666540|FG000|Overall Study|Physician Decision|0|||
125284194|NCT00503776|450666541|FG001|Overall Study|Physician Decision|0|||
125284195|NCT00503776|450666542|FG002|Overall Study|Physician Decision|1|||
125284196|NCT00503776|450666543|FG003|Overall Study|Physician Decision|1|||
125284197|NCT02379988|450666544|FG000|Overall Study|Not eligible|1|||
125284198|NCT00107315|450666545|FG000|Overall Study|Disease Progression|9|||
125284199|NCT00107315|450666545|FG000|Overall Study|Adverse Event|4|||
124782173|NCT02881567|448832774|FG000|Overall Study|Adverse Event|1|||
124782174|NCT02881567|448832774|FG000|Overall Study|Lost to Follow-up|3|||
125284200|NCT00107315|450666545|FG000|Overall Study|Withdrawal by Subject|2|||
125284201|NCT02509039|450666548|FG000|Overall Study|Adverse Event|0|||
125284202|NCT02509039|450666549|FG001|Overall Study|Adverse Event|1|||
125284203|NCT02509039|450666550|FG002|Overall Study|Adverse Event|1|||
125284204|NCT02509039|450666551|FG003|Overall Study|Adverse Event|1|||
125284205|NCT02509039|450666548|FG000|Overall Study|Withdrawal by Subject|0|||
125284206|NCT02509039|450666549|FG001|Overall Study|Withdrawal by Subject|0|||
125284207|NCT02509039|450666550|FG002|Overall Study|Withdrawal by Subject|1|||
125284208|NCT02509039|450666551|FG003|Overall Study|Withdrawal by Subject|0|||
125284209|NCT02509039|450666548|FG000|Overall Study|Progressive disease|2|||
125284210|NCT02509039|450666549|FG001|Overall Study|Progressive disease|2|||
125284211|NCT02509039|450666550|FG002|Overall Study|Progressive disease|1|||
125284212|NCT02509039|450666551|FG003|Overall Study|Progressive disease|5|||
125284213|NCT02509039|450666548|FG000|Overall Study|Study terminated by Sponsor|1|||
125284214|NCT02509039|450666549|FG001|Overall Study|Study terminated by Sponsor|0|||
125284215|NCT02509039|450666550|FG002|Overall Study|Study terminated by Sponsor|0|||
125284216|NCT02509039|450666551|FG003|Overall Study|Study terminated by Sponsor|0|||
125284217|NCT05427539|450666556|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
125284218|NCT05427539|450666557|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
125284219|NCT05427539|450666556|FG000|Period 1|Withdrawal by Subject|1|||
125284220|NCT05427539|450666557|FG001|Period 1|Withdrawal by Subject|0|||
125284221|NCT01895543|450666558|FG000|Overall Study|Withdrawal by Subject|43|||
125284222|NCT01895543|450666558|FG000|Overall Study|Lost to Follow-up|25|||
125284223|NCT01895543|450666558|FG000|Overall Study|Adverse Event|28|||
125284224|NCT01895543|450666558|FG000|Overall Study|Subject's substantial non-compliance|6|||
125284225|NCT01895543|450666558|FG000|Overall Study|Protocol Violation|1|||
125284226|NCT01895543|450666558|FG000|Overall Study|Physician Decision|2|||
125284227|NCT01895543|450666558|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
125284228|NCT00543296|450666559|FG000|Overall Study|Physician Decision|7|||
125284229|NCT00934947|450666560|FG000|Overall Study|Adverse Event|0|||
125284230|NCT00934947|450666561|FG001|Overall Study|Adverse Event|2|||
125284231|NCT03276026|450666564|FG000|Overall Study|Protocol Violation|1|||
125284232|NCT03276026|450666565|FG001|Overall Study|Protocol Violation|0|||
125284233|NCT04049266|450666566|FG000|Overall Study|Adverse Event|16|||
125284234|NCT04049266|450666567|FG001|Overall Study|Adverse Event|9|||
125284235|NCT04049266|450666566|FG000|Overall Study|Non-compliance with study drug|0|||
125284236|NCT04049266|450666567|FG001|Overall Study|Non-compliance with study drug|3|||
125284237|NCT04049266|450666566|FG000|Overall Study|Withdrawal by Subject|6|||
125284238|NCT04049266|450666567|FG001|Overall Study|Withdrawal by Subject|10|||
125284239|NCT04049266|450666566|FG000|Overall Study|Lost to Follow-up|2|||
125284240|NCT04049266|450666567|FG001|Overall Study|Lost to Follow-up|2|||
125284241|NCT04049266|450666566|FG000|Overall Study|Progressive disease|11|||
125284242|NCT04049266|450666567|FG001|Overall Study|Progressive disease|2|||
125284243|NCT04049266|450666566|FG000|Overall Study|Physician Decision|1|||
125284244|NCT04049266|450666567|FG001|Overall Study|Physician Decision|0|||
125284245|NCT04049266|450666566|FG000|Overall Study|Patient moved out of state|1|||
125284246|NCT04049266|450666567|FG001|Overall Study|Patient moved out of state|0|||
125284247|NCT01703208|450666568|FG000|Overall Study|Death|61|||
125284248|NCT01703208|450666569|FG001|Overall Study|Death|48|||
125284249|NCT01703208|450666568|FG000|Overall Study|Lack of Efficacy|1|||
125284250|NCT01703208|450666569|FG001|Overall Study|Lack of Efficacy|2|||
125284251|NCT01703208|450666568|FG000|Overall Study|Lost to Follow-up|68|||
125284252|NCT01703208|450666569|FG001|Overall Study|Lost to Follow-up|62|||
125284253|NCT01703208|450666568|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125284254|NCT01703208|450666569|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125284255|NCT01703208|450666568|FG000|Overall Study|Excluded Medication|1|||
125284256|NCT01703208|450666569|FG001|Overall Study|Excluded Medication|2|||
125284257|NCT01703208|450666568|FG000|Overall Study|Site Discontinued Study Participation|23|||
125284258|NCT01703208|450666569|FG001|Overall Study|Site Discontinued Study Participation|27|||
125284259|NCT01703208|450666568|FG000|Overall Study|Physician Decision|11|||
125284260|NCT01703208|450666569|FG001|Overall Study|Physician Decision|13|||
125284261|NCT01703208|450666568|FG000|Overall Study|Progressive disease|2|||
125284262|NCT01703208|450666569|FG001|Overall Study|Progressive disease|2|||
125284263|NCT01703208|450666568|FG000|Overall Study|Protocol Violation|1|||
125284264|NCT01703208|450666569|FG001|Overall Study|Protocol Violation|1|||
125284265|NCT01703208|450666568|FG000|Overall Study|Study Terminated by Sponsor|1710|||
125284266|NCT01703208|450666569|FG001|Overall Study|Study Terminated by Sponsor|1716|||
125284267|NCT01703208|450666568|FG000|Overall Study|Withdrawal by Subject|205|||
125284268|NCT01703208|450666569|FG001|Overall Study|Withdrawal by Subject|209|||
125284269|NCT01703208|450666568|FG000|Overall Study|Adverse Event|14|||
125284270|NCT01703208|450666569|FG001|Overall Study|Adverse Event|19|||
125284271|NCT01703208|450666568|FG000|Overall Study|Technical Problems|0|||
125284272|NCT01703208|450666569|FG001|Overall Study|Technical Problems|1|||
125284273|NCT01703208|450666568|FG000|Overall Study|Protocol Deviation|2|||
125284274|NCT01703208|450666569|FG001|Overall Study|Protocol Deviation|0|||
125284275|NCT02099344|450666570|FG000|Overall Study|Physician Decision|1|||
125284276|NCT02099344|450666571|FG001|Overall Study|Physician Decision|0|||
125284277|NCT05593913|450666578|FG000|Overall Study|Insufficient image quality|39|||
125284278|NCT02979093|450666581|FG000|First Scan Session|Scanning data problems|1|||
125284279|NCT02979093|450666582|FG001|First Scan Session|Scanning data problems|2|||
125284280|NCT02979093|450666583|FG002|First Scan Session|Scanning data problems|2|||
125284281|NCT02979093|450666584|FG003|First Scan Session|Scanning data problems|0|||
125284282|NCT02979093|450666581|FG000|Second Scan Session|Scanning data problems|3|||
125284283|NCT02979093|450666582|FG001|Second Scan Session|Scanning data problems|0|||
125284284|NCT02979093|450666583|FG002|Second Scan Session|Scanning data problems|1|||
125284285|NCT02979093|450666584|FG003|Second Scan Session|Scanning data problems|3|||
125284286|NCT01096368|450666585|FG000|Overall Study|Death|0|||
125284287|NCT01096368|450666586|FG001|Overall Study|Death|1|||
125284288|NCT01096368|450666587|FG002|Overall Study|Death|0|||
125284289|NCT01096368|450666588|FG003|Overall Study|Death|0|||
125284290|NCT01096368|450666589|FG004|Overall Study|Death|0|||
125284291|NCT01096368|450666585|FG000|Overall Study|Physician Decision|0|||
125284292|NCT01096368|450666586|FG001|Overall Study|Physician Decision|13|||
125284293|NCT01096368|450666587|FG002|Overall Study|Physician Decision|2|||
125284294|NCT01096368|450666588|FG003|Overall Study|Physician Decision|4|||
125284295|NCT01096368|450666589|FG004|Overall Study|Physician Decision|6|||
125284296|NCT01096368|450666585|FG000|Overall Study|Withdrawal by Subject|0|||
125284297|NCT01096368|450666586|FG001|Overall Study|Withdrawal by Subject|52|||
125284298|NCT01096368|450666587|FG002|Overall Study|Withdrawal by Subject|0|||
125284299|NCT01096368|450666588|FG003|Overall Study|Withdrawal by Subject|10|||
125284300|NCT01096368|450666589|FG004|Overall Study|Withdrawal by Subject|14|||
125284301|NCT01096368|450666585|FG000|Overall Study|Ineligible|0|||
125284302|NCT01096368|450666586|FG001|Overall Study|Ineligible|3|||
125284303|NCT01096368|450666587|FG002|Overall Study|Ineligible|2|||
125284304|NCT01096368|450666588|FG003|Overall Study|Ineligible|0|||
125284305|NCT01096368|450666589|FG004|Overall Study|Ineligible|25|||
125284306|NCT01096368|450666585|FG000|Overall Study|Did not start treatment|0|||
125284307|NCT01096368|450666586|FG001|Overall Study|Did not start treatment|4|||
125284308|NCT01096368|450666587|FG002|Overall Study|Did not start treatment|4|||
125284309|NCT01096368|450666588|FG003|Overall Study|Did not start treatment|0|||
125284310|NCT01096368|450666589|FG004|Overall Study|Did not start treatment|0|||
125284311|NCT01096368|450666585|FG000|Overall Study|Progressive disease|0|||
125284312|NCT01096368|450666586|FG001|Overall Study|Progressive disease|6|||
125284313|NCT01096368|450666587|FG002|Overall Study|Progressive disease|0|||
125284314|NCT01096368|450666588|FG003|Overall Study|Progressive disease|10|||
125284315|NCT01096368|450666589|FG004|Overall Study|Progressive disease|3|||
125284316|NCT01096368|450666585|FG000|Overall Study|Other|0|||
125284317|NCT01096368|450666586|FG001|Overall Study|Other|0|||
125284318|NCT01096368|450666587|FG002|Overall Study|Other|1|||
125284319|NCT01096368|450666588|FG003|Overall Study|Other|0|||
125284320|NCT01096368|450666589|FG004|Overall Study|Other|0|||
125284321|NCT01096368|450666585|FG000|Overall Study|Treated with institutional review|0|||
125284322|NCT01096368|450666586|FG001|Overall Study|Treated with institutional review|0|||
125284323|NCT01096368|450666587|FG002|Overall Study|Treated with institutional review|0|||
125284324|NCT01096368|450666588|FG003|Overall Study|Treated with institutional review|0|||
125284325|NCT01096368|450666589|FG004|Overall Study|Treated with institutional review|1|||
125284326|NCT03070223|450666590|FG000|Overall Study|Lost to Follow-up|34|||
125284327|NCT03070223|450666591|FG001|Overall Study|Lost to Follow-up|27|||
125284328|NCT03070223|450666590|FG000|Overall Study|Withdrawal by Subject|12|||
125284329|NCT03070223|450666591|FG001|Overall Study|Withdrawal by Subject|22|||
125284330|NCT03070223|450666590|FG000|Overall Study|Protocol Violation|0|||
125284331|NCT03070223|450666591|FG001|Overall Study|Protocol Violation|1|||
125284332|NCT02684058|450666595|FG000|Treatment Period|Progressive disease|4|||
125284333|NCT02684058|450666596|FG001|Treatment Period|Progressive disease|10|||
125284334|NCT02684058|450666597|FG002|Treatment Period|Progressive disease|19|||
125284335|NCT02684058|450666595|FG000|Treatment Period|Adverse Event|3|||
125284336|NCT02684058|450666596|FG001|Treatment Period|Adverse Event|8|||
125284337|NCT02684058|450666597|FG002|Treatment Period|Adverse Event|1|||
125284338|NCT02684058|450666595|FG000|Treatment Period|Physician Decision|5|||
125284339|NCT02684058|450666596|FG001|Treatment Period|Physician Decision|1|||
125284340|NCT02684058|450666597|FG002|Treatment Period|Physician Decision|2|||
124782175|NCT02881567|448832774|FG000|Overall Study|Consent withdrawn|1|||
124782176|NCT02881567|448832774|FG000|Overall Study|Investigator decision|1|||
124782177|NCT02881567|448832774|FG000|Overall Study|Study terminated by sponsor|9|||
124782178|NCT02881567|448832774|FG000|Overall Study|Reason not Specified|3|||
124782179|NCT02078960|448832778|FG000|Treatment Period|Other|0|||
124782180|NCT02078960|448832779|FG001|Treatment Period|Other|0|||
124782181|NCT02078960|448832780|FG002|Treatment Period|Other|1|||
125284341|NCT02684058|450666595|FG000|Treatment Period|New therapy for study indication|1|||
125284342|NCT02684058|450666596|FG001|Treatment Period|New therapy for study indication|0|||
125284343|NCT02684058|450666597|FG002|Treatment Period|New therapy for study indication|0|||
125284344|NCT02684058|450666595|FG000|Treatment Period|Protocol deviation|0|||
125284345|NCT02684058|450666596|FG001|Treatment Period|Protocol deviation|1|||
125284346|NCT02684058|450666597|FG002|Treatment Period|Protocol deviation|0|||
125284347|NCT02684058|450666595|FG000|Treatment Period|Subject/guardian decision|4|||
125284348|NCT02684058|450666596|FG001|Treatment Period|Subject/guardian decision|3|||
125284349|NCT02684058|450666597|FG002|Treatment Period|Subject/guardian decision|0|||
125284350|NCT02684058|450666595|FG000|Treatment Period|Death|0|||
125284351|NCT02684058|450666596|FG001|Treatment Period|Death|0|||
125284352|NCT02684058|450666597|FG002|Treatment Period|Death|2|||
125284353|NCT02684058|450666595|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
125284354|NCT02684058|450666596|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
125284355|NCT02684058|450666597|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
125284356|NCT02684058|450666595|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
125284357|NCT02684058|450666596|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
125284358|NCT02684058|450666597|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
125284359|NCT02684058|450666595|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
125284360|NCT02684058|450666596|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
125284361|NCT02684058|450666597|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
125284362|NCT02684058|450666595|FG000|Post-treatment Efficacy Follow-up|Death|0|||
125284363|NCT02684058|450666596|FG001|Post-treatment Efficacy Follow-up|Death|0|||
125284364|NCT02684058|450666597|FG002|Post-treatment Efficacy Follow-up|Death|3|||
125284365|NCT02684058|450666595|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
125284366|NCT02684058|450666596|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
125284367|NCT02684058|450666597|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
125284368|NCT02684058|450666595|FG000|Post-treatment Survival Follow-up|Death|0|||
125284369|NCT02684058|450666596|FG001|Post-treatment Survival Follow-up|Death|0|||
125284370|NCT02684058|450666597|FG002|Post-treatment Survival Follow-up|Death|7|||
125284371|NCT02684058|450666595|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
125284372|NCT02684058|450666596|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
125284373|NCT02684058|450666597|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
125284374|NCT02684058|450666595|FG000|Crossover Treatment Period|Progressive disease|0|||
125284375|NCT02684058|450666596|FG001|Crossover Treatment Period|Progressive disease|1|||
125284376|NCT02684058|450666597|FG002|Crossover Treatment Period|Progressive disease|0|||
125284377|NCT00443053|450666601|FG000|Overall Study|Adverse Event|2|||
125284378|NCT00443053|450666602|FG001|Overall Study|Adverse Event|1|||
125284379|NCT00443053|450666601|FG000|Overall Study|Withdrawal by Subject|9|||
125284380|NCT00443053|450666602|FG001|Overall Study|Withdrawal by Subject|18|||
125284381|NCT00443053|450666601|FG000|Overall Study|Lost to Follow-up|4|||
125284382|NCT00443053|450666602|FG001|Overall Study|Lost to Follow-up|5|||
125284383|NCT00443053|450666601|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
125284384|NCT00443053|450666602|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
125284385|NCT00443053|450666601|FG000|Overall Study|Noncompliance|2|||
125284386|NCT00443053|450666602|FG001|Overall Study|Noncompliance|1|||
125284387|NCT00443053|450666601|FG000|Overall Study|Other|3|||
125284388|NCT00443053|450666602|FG001|Overall Study|Other|4|||
125284389|NCT00443053|450666601|FG000|Overall Study|Physician Decision|0|||
125284390|NCT00443053|450666602|FG001|Overall Study|Physician Decision|4|||
125284391|NCT00350272|450666603|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
125284392|NCT00350272|450666604|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
125284393|NCT00350272|450666603|FG000|Blinded 12-Week Treatment|Death|1|||
125284394|NCT00350272|450666604|FG001|Blinded 12-Week Treatment|Death|0|||
125284395|NCT00350272|450666603|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
125284396|NCT00350272|450666604|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
125284397|NCT00350272|450666603|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
125284398|NCT00350272|450666604|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
125284399|NCT00350272|450666603|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
125284400|NCT00350272|450666604|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
125284401|NCT00350272|450666603|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
125284402|NCT00350272|450666604|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
125284403|NCT00350272|450666603|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
125284404|NCT00350272|450666604|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
125284405|NCT00350272|450666603|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
125284406|NCT00350272|450666604|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
125284407|NCT00350272|450666603|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
125284408|NCT00350272|450666604|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
125284409|NCT00350272|450666603|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
125284410|NCT00350272|450666604|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
125284411|NCT00350272|450666603|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
125284412|NCT00350272|450666604|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
125284413|NCT02226198|450667812|FG000|Lead-in Phase|Protocol Violation|1|||
125284414|NCT02226198|450667813|FG001|Lead-in Phase|Protocol Violation|0|||
125284415|NCT02226198|450667814|FG002|Lead-in Phase|Protocol Violation|0|||
125284416|NCT02226198|450667812|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
125284417|NCT02226198|450667813|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
125284418|NCT02226198|450667814|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
125284419|NCT01288612|450667816|FG000|Overall Study|Unable to contact|11|||
125284420|NCT01288612|450667817|FG001|Overall Study|Unable to contact|16|||
125284421|NCT01288612|450667818|FG002|Overall Study|Unable to contact|20|||
125284422|NCT01288612|450667816|FG000|Overall Study|Declined|78|||
125284423|NCT01288612|450667817|FG001|Overall Study|Declined|63|||
125284424|NCT01288612|450667818|FG002|Overall Study|Declined|62|||
125284425|NCT01288612|450667816|FG000|Overall Study|Unable to intubate|0|||
125284426|NCT01288612|450667817|FG001|Overall Study|Unable to intubate|3|||
125284427|NCT01288612|450667818|FG002|Overall Study|Unable to intubate|0|||
125284428|NCT00871923|450667819|FG000|Overall Study|Death|1|||
125284429|NCT00871923|450667819|FG000|Overall Study|Withdrawal by Subject|1|||
125284430|NCT05599451|450667820|FG000|Overall Study|Not randomized|11|||
125284431|NCT05599451|450667821|FG001|Overall Study|Not randomized|0|||
125284432|NCT05599451|450667822|FG002|Overall Study|Not randomized|0|||
125284433|NCT05599451|450667823|FG003|Overall Study|Not randomized|0|||
125284434|NCT05599451|450667824|FG004|Overall Study|Not randomized|0|||
125284435|NCT05599451|450667820|FG000|Overall Study|Physician Decision|0|||
125284436|NCT05599451|450667821|FG001|Overall Study|Physician Decision|0|||
125284437|NCT05599451|450667822|FG002|Overall Study|Physician Decision|0|||
125284438|NCT05599451|450667823|FG003|Overall Study|Physician Decision|1|||
125284439|NCT05599451|450667824|FG004|Overall Study|Physician Decision|0|||
125284440|NCT00789581|450667827|FG000|AC Therapy|Adverse Event|2|||
125284441|NCT00789581|450667828|FG001|AC Therapy|Adverse Event|3|||
125284442|NCT00789581|450667827|FG000|AC Therapy|Withdrawal by Subject|4|||
125284443|NCT00789581|450667828|FG001|AC Therapy|Withdrawal by Subject|7|||
125284444|NCT00789581|450667827|FG000|AC Therapy|Disease recurrence|3|||
125284445|NCT00789581|450667828|FG001|AC Therapy|Disease recurrence|1|||
125284446|NCT00789581|450667827|FG000|AC Therapy|Intercurrent Illness|1|||
125284447|NCT00789581|450667828|FG001|AC Therapy|Intercurrent Illness|0|||
125284448|NCT00789581|450667827|FG000|AC Therapy|Never Treated|1|||
125284449|NCT00789581|450667828|FG001|AC Therapy|Never Treated|4|||
125284450|NCT00789581|450667827|FG000|AC Therapy|Other|0|||
125284451|NCT00789581|450667828|FG001|AC Therapy|Other|2|||
125284452|NCT00789581|450667827|FG000|Adjuvant Therapy|Never treated|2|||
125284453|NCT00789581|450667828|FG001|Adjuvant Therapy|Never treated|2|||
125284454|NCT00789581|450667827|FG000|Adjuvant Therapy|Adverse Event|20|||
125284455|NCT00789581|450667828|FG001|Adjuvant Therapy|Adverse Event|44|||
125284456|NCT00789581|450667827|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
125284457|NCT00789581|450667828|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
125284458|NCT00789581|450667827|FG000|Adjuvant Therapy|Disease recurrence|2|||
125284459|NCT00789581|450667828|FG001|Adjuvant Therapy|Disease recurrence|1|||
125284460|NCT00789581|450667827|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
125284461|NCT00789581|450667828|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
125284462|NCT00789581|450667827|FG000|Adjuvant Therapy|Protocol Violation|1|||
125284463|NCT00789581|450667828|FG001|Adjuvant Therapy|Protocol Violation|1|||
125284464|NCT00789581|450667827|FG000|Adjuvant Therapy|Other|0|||
125284465|NCT00789581|450667828|FG001|Adjuvant Therapy|Other|1|||
125284466|NCT01468207|450667829|FG000|Treatment Period 1|Adverse Event|1|||
125284467|NCT01468207|450667830|FG001|Treatment Period 1|Adverse Event|0|||
125284468|NCT01468207|450667831|FG002|Treatment Period 1|Adverse Event|0|||
125284469|NCT01468207|450667832|FG003|Treatment Period 1|Adverse Event|0|||
125284470|NCT01468207|450667833|FG004|Treatment Period 1|Adverse Event|0|||
125284471|NCT01468207|450667834|FG005|Treatment Period 1|Adverse Event|0|||
125284472|NCT01468207|450667829|FG000|Treatment Period 1|Protocol Violation|1|||
125284473|NCT01468207|450667830|FG001|Treatment Period 1|Protocol Violation|1|||
125284474|NCT01468207|450667831|FG002|Treatment Period 1|Protocol Violation|0|||
125284475|NCT01468207|450667832|FG003|Treatment Period 1|Protocol Violation|0|||
125284476|NCT01468207|450667833|FG004|Treatment Period 1|Protocol Violation|0|||
125284477|NCT01468207|450667834|FG005|Treatment Period 1|Protocol Violation|0|||
125284478|NCT01468207|450667829|FG000|Treatment Period 1|Withdrawal by Subject|5|||
125284479|NCT01468207|450667830|FG001|Treatment Period 1|Withdrawal by Subject|4|||
125284480|NCT01468207|450667831|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125284481|NCT01468207|450667832|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125284482|NCT01468207|450667833|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125284483|NCT01468207|450667834|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125284484|NCT01468207|450667829|FG000|Treatment Period 1|Lost to Follow-up|2|||
125284485|NCT01468207|450667830|FG001|Treatment Period 1|Lost to Follow-up|1|||
125284486|NCT01468207|450667831|FG002|Treatment Period 1|Lost to Follow-up|0|||
125284487|NCT01468207|450667832|FG003|Treatment Period 1|Lost to Follow-up|0|||
125284488|NCT01468207|450667833|FG004|Treatment Period 1|Lost to Follow-up|0|||
124782182|NCT02078960|448832778|FG000|Treatment Period|Lack of Efficacy|0|||
124782183|NCT02078960|448832779|FG001|Treatment Period|Lack of Efficacy|1|||
125284489|NCT01468207|450667834|FG005|Treatment Period 1|Lost to Follow-up|0|||
125284490|NCT01468207|450667829|FG000|Treatment Period 1|Other|0|||
125284491|NCT01468207|450667830|FG001|Treatment Period 1|Other|2|||
125284492|NCT01468207|450667831|FG002|Treatment Period 1|Other|0|||
125284493|NCT01468207|450667832|FG003|Treatment Period 1|Other|0|||
125284494|NCT01468207|450667833|FG004|Treatment Period 1|Other|0|||
125284495|NCT01468207|450667834|FG005|Treatment Period 1|Other|0|||
125284496|NCT01468207|450667829|FG000|Treatment Period 2|Adverse Event|0|||
125284497|NCT01468207|450667830|FG001|Treatment Period 2|Adverse Event|0|||
125284498|NCT01468207|450667831|FG002|Treatment Period 2|Adverse Event|6|||
125284499|NCT01468207|450667832|FG003|Treatment Period 2|Adverse Event|1|||
125284500|NCT01468207|450667833|FG004|Treatment Period 2|Adverse Event|2|||
125284501|NCT01468207|450667834|FG005|Treatment Period 2|Adverse Event|1|||
125284502|NCT01468207|450667829|FG000|Treatment Period 2|Lack of Efficacy|0|||
125284503|NCT01468207|450667830|FG001|Treatment Period 2|Lack of Efficacy|0|||
125284504|NCT01468207|450667831|FG002|Treatment Period 2|Lack of Efficacy|1|||
125284505|NCT01468207|450667832|FG003|Treatment Period 2|Lack of Efficacy|1|||
125284506|NCT01468207|450667833|FG004|Treatment Period 2|Lack of Efficacy|0|||
125284507|NCT01468207|450667834|FG005|Treatment Period 2|Lack of Efficacy|2|||
125284508|NCT01468207|450667829|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125284509|NCT01468207|450667830|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125284510|NCT01468207|450667831|FG002|Treatment Period 2|Withdrawal by Subject|5|||
125284511|NCT01468207|450667832|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125284512|NCT01468207|450667833|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125284513|NCT01468207|450667834|FG005|Treatment Period 2|Withdrawal by Subject|2|||
125284514|NCT01468207|450667829|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
125284515|NCT01468207|450667830|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
125284516|NCT01468207|450667831|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
125284517|NCT01468207|450667832|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
125284518|NCT01468207|450667833|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
125284519|NCT01468207|450667834|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
125284520|NCT01468207|450667829|FG000|Treatment Period 2|Lost to Follow-up|0|||
125284521|NCT01468207|450667830|FG001|Treatment Period 2|Lost to Follow-up|0|||
125284522|NCT01468207|450667831|FG002|Treatment Period 2|Lost to Follow-up|5|||
125284523|NCT01468207|450667832|FG003|Treatment Period 2|Lost to Follow-up|1|||
125284524|NCT01468207|450667833|FG004|Treatment Period 2|Lost to Follow-up|0|||
125284525|NCT01468207|450667834|FG005|Treatment Period 2|Lost to Follow-up|0|||
125284526|NCT01468207|450667829|FG000|Treatment Period 2|Other|0|||
125284527|NCT01468207|450667830|FG001|Treatment Period 2|Other|0|||
125284528|NCT01468207|450667831|FG002|Treatment Period 2|Other|5|||
125284529|NCT01468207|450667832|FG003|Treatment Period 2|Other|1|||
125284530|NCT01468207|450667833|FG004|Treatment Period 2|Other|1|||
125284531|NCT01468207|450667834|FG005|Treatment Period 2|Other|2|||
125284532|NCT01328041|450667837|FG000|Overall Study|Adverse Event|7|||
125284533|NCT01328041|450667837|FG000|Overall Study|Lack of Efficacy|27|||
125284534|NCT01328041|450667837|FG000|Overall Study|Protocol Violation|7|||
125284535|NCT01328041|450667837|FG000|Overall Study|Lost to Follow-up|7|||
125284536|NCT01328041|450667837|FG000|Overall Study|Physician Decision|2|||
125284537|NCT01328041|450667837|FG000|Overall Study|Withdrawal by Subject|7|||
125284538|NCT00908115|450667838|FG000|Overall Study|Other|14|||
124782184|NCT02078960|448832780|FG002|Treatment Period|Lack of Efficacy|0|||
125284539|NCT01728077|450667839|FG000|Overall Study|Lack of Efficacy|3|||
125284540|NCT01728077|450667840|FG001|Overall Study|Lack of Efficacy|1|||
125284541|NCT01728077|450667839|FG000|Overall Study|Lost to Follow-up|1|||
125284542|NCT01728077|450667840|FG001|Overall Study|Lost to Follow-up|0|||
125284543|NCT01728077|450667839|FG000|Overall Study|Subject choice|2|||
125284544|NCT01728077|450667840|FG001|Overall Study|Subject choice|3|||
125284545|NCT01728077|450667839|FG000|Overall Study|Death|0|||
125284546|NCT01728077|450667840|FG001|Overall Study|Death|1|||
124782185|NCT02078960|448832778|FG000|Treatment Period|Disease progression - accelerated phase|0|||
124782186|NCT02078960|448832779|FG001|Treatment Period|Disease progression - accelerated phase|1|||
124782187|NCT02078960|448832780|FG002|Treatment Period|Disease progression - accelerated phase|0|||
124782188|NCT02078960|448832778|FG000|Treatment Period|Disease progression - blast phase|1|||
124782189|NCT02078960|448832779|FG001|Treatment Period|Disease progression - blast phase|0|||
124782190|NCT02078960|448832780|FG002|Treatment Period|Disease progression - blast phase|0|||
124782191|NCT02078960|448832778|FG000|Treatment Period|Withdrawal by Subject|0|||
124782192|NCT02078960|448832779|FG001|Treatment Period|Withdrawal by Subject|1|||
124782193|NCT02078960|448832780|FG002|Treatment Period|Withdrawal by Subject|1|||
124782194|NCT02078960|448832778|FG000|Treatment Period|Adverse Event|1|||
124782195|NCT02078960|448832779|FG001|Treatment Period|Adverse Event|0|||
124782196|NCT02078960|448832780|FG002|Treatment Period|Adverse Event|0|||
124782197|NCT02078960|448832778|FG000|Treatment Period|Death|0|||
124782198|NCT02078960|448832779|FG001|Treatment Period|Death|0|||
124782199|NCT02078960|448832780|FG002|Treatment Period|Death|1|||
124782200|NCT02078960|448832778|FG000|Follow-up Period|Death|2|||
124782201|NCT02078960|448832779|FG001|Follow-up Period|Death|0|||
124782202|NCT02078960|448832780|FG002|Follow-up Period|Death|0|||
124782203|NCT02078960|448832778|FG000|Follow-up Period|Lost to Follow-up|0|||
124782204|NCT02078960|448832779|FG001|Follow-up Period|Lost to Follow-up|1|||
124782205|NCT02078960|448832780|FG002|Follow-up Period|Lost to Follow-up|0|||
124782206|NCT00975689|448832786|FG000|Overall Study|Adverse Event|0|||
124782207|NCT00975689|448832787|FG001|Overall Study|Adverse Event|3|||
124782208|NCT00975689|448832786|FG000|Overall Study|Withdrawal by Subject|1|||
124782209|NCT00975689|448832787|FG001|Overall Study|Withdrawal by Subject|0|||
124782210|NCT00975689|448832786|FG000|Overall Study|Physician Decision|1|||
124782211|NCT00975689|448832787|FG001|Overall Study|Physician Decision|0|||
124782212|NCT04335136|448832788|FG000|Overall Study|Death|8|||
124782213|NCT04335136|448832789|FG001|Overall Study|Death|4|||
124782214|NCT04335136|448832788|FG000|Overall Study|Lost to Follow-up|2|||
124782215|NCT04335136|448832789|FG001|Overall Study|Lost to Follow-up|0|||
124782216|NCT04335136|448832788|FG000|Overall Study|Protocol Violation|1|||
124782217|NCT04335136|448832789|FG001|Overall Study|Protocol Violation|0|||
124782218|NCT04335136|448832788|FG000|Overall Study|Withdrawal by Subject|1|||
124782219|NCT04335136|448832789|FG001|Overall Study|Withdrawal by Subject|1|||
124782220|NCT04335136|448832788|FG000|Overall Study|Health-threatening condition|0|||
124782221|NCT04335136|448832789|FG001|Overall Study|Health-threatening condition|1|||
124782222|NCT04335136|448832788|FG000|Overall Study|Adverse Event|0|||
124782223|NCT04335136|448832789|FG001|Overall Study|Adverse Event|1|||
124782224|NCT04335136|448832788|FG000|Overall Study|Erroneously randomized|2|||
124782225|NCT04335136|448832789|FG001|Overall Study|Erroneously randomized|0|||
124782226|NCT01305577|448832793|FG000|Overall Study|Adverse Event|2|||
124782227|NCT01305577|448832794|FG001|Overall Study|Adverse Event|2|||
124782228|NCT01305577|448832795|FG002|Overall Study|Adverse Event|1|||
124782229|NCT01305577|448832793|FG000|Overall Study|Withdrawal by Subject|7|||
124782230|NCT01305577|448832794|FG001|Overall Study|Withdrawal by Subject|5|||
124782231|NCT01305577|448832795|FG002|Overall Study|Withdrawal by Subject|6|||
124782232|NCT01305577|448832793|FG000|Overall Study|Lost to Follow-up|4|||
124782233|NCT01305577|448832794|FG001|Overall Study|Lost to Follow-up|3|||
124782234|NCT01305577|448832795|FG002|Overall Study|Lost to Follow-up|2|||
124782235|NCT01305577|448832793|FG000|Overall Study|Protocol Deviation|0|||
124782236|NCT01305577|448832794|FG001|Overall Study|Protocol Deviation|1|||
124782237|NCT01305577|448832795|FG002|Overall Study|Protocol Deviation|1|||
125284547|NCT01728077|450667839|FG000|Overall Study|Patient moving|1|||
124782238|NCT00796978|448832796|FG000|Overall Study|Cardiac adverse event|5|||
124782239|NCT00796978|448832796|FG000|Overall Study|Adverse Event|4|||
124782240|NCT00796978|448832796|FG000|Overall Study|Withdrawal by Subject|3|||
124782241|NCT02364336|448832797|FG000|Overall Study|Adverse Event|0|||
124782242|NCT02364336|448832798|FG001|Overall Study|Adverse Event|1|||
124782243|NCT05246514|448832799|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
124782244|NCT05246514|448832799|FG000|Overall Study|Withdrawal by Subject|1|||
124782245|NCT05246514|448832799|FG000|Overall Study|Death|13|||
124782246|NCT02910986|448832800|FG000|Overall Study|non-Latina|14|||
124782247|NCT02910986|448832801|FG001|Overall Study|non-Latina|13|||
124782248|NCT02910986|448832802|FG002|Overall Study|non-Latina|12|||
125284548|NCT01728077|450667840|FG001|Overall Study|Patient moving|0|||
125284549|NCT01728077|450667839|FG000|Overall Study|Non compliance|1|||
125284550|NCT01728077|450667840|FG001|Overall Study|Non compliance|0|||
125284551|NCT00347438|450667844|FG000|Overall Study|Withdrawal by Subject|1|||
125284552|NCT00347438|450667844|FG000|Overall Study|Physician Decision|1|||
125284553|NCT00322023|450667845|FG000|Overall Study|various|0|||
125284554|NCT00322023|450667846|FG001|Overall Study|various|2|||
125284555|NCT00322023|450667847|FG002|Overall Study|various|6|||
125284556|NCT00693017|450667848|FG000|Overall Study|Sponsor Decision|2|||
125284557|NCT00693017|450667849|FG001|Overall Study|Sponsor Decision|1|||
125284558|NCT00693017|450667848|FG000|Overall Study|Death|0|||
125284559|NCT00693017|450667849|FG001|Overall Study|Death|1|||
125284560|NCT01082874|450667850|FG000|Overall Study|Lost to Follow-up|10|||
124782249|NCT02910986|448832800|FG000|Overall Study|Failure to return T! survey|72|||
125284561|NCT01082874|450667851|FG001|Overall Study|Lost to Follow-up|10|||
125284562|NCT01082874|450667852|FG002|Overall Study|Lost to Follow-up|6|||
125284563|NCT01082874|450667853|FG003|Overall Study|Lost to Follow-up|10|||
125284564|NCT01082874|450667850|FG000|Overall Study|Withdrawal by Subject|1|||
125284565|NCT01082874|450667851|FG001|Overall Study|Withdrawal by Subject|2|||
124782250|NCT02910986|448832801|FG001|Overall Study|Failure to return T! survey|84|||
125284566|NCT01082874|450667852|FG002|Overall Study|Withdrawal by Subject|5|||
125284567|NCT01082874|450667853|FG003|Overall Study|Withdrawal by Subject|3|||
125284568|NCT01685801|450667871|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
125284569|NCT01685801|450667872|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
125284570|NCT01685801|450667873|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
125284571|NCT01685801|450667874|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
125284572|NCT01685801|450667871|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
125284573|NCT01685801|450667872|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
125284574|NCT01685801|450667873|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
125284575|NCT01685801|450667874|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
125284576|NCT00113399|450667875|FG000|Overall Study|Death|1|||
125284577|NCT00113399|450667876|FG001|Overall Study|Death|1|||
125284578|NCT00113399|450667875|FG000|Overall Study|Withdrawal by Subject|1|||
125284579|NCT00113399|450667876|FG001|Overall Study|Withdrawal by Subject|2|||
125284580|NCT00113399|450667875|FG000|Overall Study|Complete Response|0|||
125284581|NCT00113399|450667876|FG001|Overall Study|Complete Response|1|||
125284582|NCT00113399|450667875|FG000|Overall Study|Other|0|||
125284583|NCT00113399|450667876|FG001|Overall Study|Other|1|||
125284584|NCT00396136|450667877|FG000|Overall Study|Death|43|||
125284585|NCT00396136|450667877|FG000|Overall Study|Withdrawal by Subject|59|||
125284586|NCT00396136|450667877|FG000|Overall Study|Lost to Follow-up|15|||
125284587|NCT00396136|450667877|FG000|Overall Study|Study device explanted|8|||
125284588|NCT04686084|450667879|FG000|Overall Study|Lost to Follow-up|1|||
125284589|NCT01779856|450667880|FG000|Overall Study|Withdrawal by Subject|15|||
125284590|NCT01779856|450667880|FG000|Overall Study|Death|3|||
125284591|NCT01779856|450667880|FG000|Overall Study|Physician Decision|1|||
125284592|NCT01779856|450667880|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
125284593|NCT01779856|450667880|FG000|Overall Study|Delays in scheduling implant|1|||
125284594|NCT01779856|450667880|FG000|Overall Study|Subject ineligible for Implant|2|||
125284595|NCT03350256|450667882|FG000|Overall Study|Inclusion/exclusion violation|4|||
125284596|NCT03350256|450667882|FG000|Overall Study|Recommended for other therapies|2|||
125284597|NCT03350256|450667882|FG000|Overall Study|Protocol Violation|3|||
125284598|NCT03350256|450667882|FG000|Overall Study|Non compliance|2|||
125284599|NCT03350256|450667882|FG000|Overall Study|Denial by insurance|1|||
125284600|NCT03350256|450667882|FG000|Overall Study|Adverse Event|2|||
125284601|NCT03350256|450667882|FG000|Overall Study|Trial failure|12|||
125284602|NCT03350256|450667882|FG000|Overall Study|Did not proceed to permanent implant|3|||
125284603|NCT03350256|450667882|FG000|Overall Study|Withdrawal by Subject|3|||
125284604|NCT03350256|450667882|FG000|Overall Study|Subject moving out of state|1|||
125284605|NCT03350256|450667882|FG000|Overall Study|Lost to Follow-up|1|||
125284606|NCT03350256|450667882|FG000|Overall Study|Lack of Efficacy|2|||
125284607|NCT04043234|450667885|FG000|Overall Study|Lost to Follow-up|1|||
125284608|NCT04043234|450667885|FG000|Overall Study|Withdrawal by Subject|1|||
125284609|NCT01155466|450667886|FG000|Overall Study|Adverse Event|13|||
125284610|NCT01155466|450667887|FG001|Overall Study|Adverse Event|15|||
125284611|NCT01155466|450667888|FG002|Overall Study|Adverse Event|6|||
125284612|NCT01155466|450667889|FG003|Overall Study|Adverse Event|17|||
125284613|NCT01155466|450667890|FG004|Overall Study|Adverse Event|18|||
125284614|NCT01155466|450667886|FG000|Overall Study|Lost to Follow-up|0|||
125284615|NCT01155466|450667887|FG001|Overall Study|Lost to Follow-up|0|||
125284616|NCT01155466|450667888|FG002|Overall Study|Lost to Follow-up|0|||
125284617|NCT01155466|450667889|FG003|Overall Study|Lost to Follow-up|0|||
125284618|NCT01155466|450667890|FG004|Overall Study|Lost to Follow-up|2|||
125284619|NCT01155466|450667886|FG000|Overall Study|Withdrawal by Subject|7|||
125284620|NCT01155466|450667887|FG001|Overall Study|Withdrawal by Subject|5|||
125284621|NCT01155466|450667888|FG002|Overall Study|Withdrawal by Subject|9|||
125284622|NCT01155466|450667889|FG003|Overall Study|Withdrawal by Subject|4|||
125284623|NCT01155466|450667890|FG004|Overall Study|Withdrawal by Subject|4|||
125284624|NCT01155466|450667886|FG000|Overall Study|Protocol Violation|0|||
125284625|NCT01155466|450667887|FG001|Overall Study|Protocol Violation|0|||
125284626|NCT01155466|450667888|FG002|Overall Study|Protocol Violation|2|||
125284627|NCT01155466|450667889|FG003|Overall Study|Protocol Violation|0|||
125284628|NCT01155466|450667890|FG004|Overall Study|Protocol Violation|1|||
125284629|NCT01155466|450667886|FG000|Overall Study|Administrative|0|||
125284630|NCT01155466|450667887|FG001|Overall Study|Administrative|3|||
125284631|NCT01155466|450667888|FG002|Overall Study|Administrative|0|||
125284632|NCT01155466|450667889|FG003|Overall Study|Administrative|0|||
125284633|NCT01155466|450667890|FG004|Overall Study|Administrative|0|||
125284634|NCT01155466|450667886|FG000|Overall Study|Randomized not treated|2|||
125284635|NCT01155466|450667887|FG001|Overall Study|Randomized not treated|2|||
125284636|NCT01155466|450667888|FG002|Overall Study|Randomized not treated|3|||
125284637|NCT01155466|450667889|FG003|Overall Study|Randomized not treated|0|||
125284638|NCT01155466|450667890|FG004|Overall Study|Randomized not treated|2|||
125284639|NCT02210689|450667891|FG000|Overall Study|Withdrawal by Subject|7|||
125284640|NCT02210689|450667892|FG001|Overall Study|Withdrawal by Subject|4|||
125284641|NCT02210689|450667893|FG002|Overall Study|Withdrawal by Subject|2|||
125284642|NCT02210689|450667891|FG000|Overall Study|Adverse Event|0|||
125284643|NCT02210689|450667892|FG001|Overall Study|Adverse Event|1|||
125284644|NCT02210689|450667893|FG002|Overall Study|Adverse Event|0|||
125284645|NCT02210689|450667891|FG000|Overall Study|Protocol Violation|1|||
125284646|NCT02210689|450667892|FG001|Overall Study|Protocol Violation|0|||
125284647|NCT02210689|450667893|FG002|Overall Study|Protocol Violation|0|||
125284648|NCT02210689|450667891|FG000|Overall Study|Lost to Follow-up|11|||
125284649|NCT02210689|450667892|FG001|Overall Study|Lost to Follow-up|9|||
125284650|NCT02210689|450667893|FG002|Overall Study|Lost to Follow-up|5|||
125284651|NCT02210689|450667891|FG000|Overall Study|Pregnancy|0|||
125284652|NCT02210689|450667892|FG001|Overall Study|Pregnancy|1|||
125284653|NCT02210689|450667893|FG002|Overall Study|Pregnancy|0|||
125284654|NCT02210689|450667891|FG000|Overall Study|Lack of Efficacy|0|||
125284655|NCT02210689|450667892|FG001|Overall Study|Lack of Efficacy|1|||
125284656|NCT02210689|450667893|FG002|Overall Study|Lack of Efficacy|5|||
125284657|NCT02210689|450667891|FG000|Overall Study|Prohibited medication|2|||
125284658|NCT02210689|450667892|FG001|Overall Study|Prohibited medication|8|||
125284659|NCT02210689|450667893|FG002|Overall Study|Prohibited medication|1|||
125284660|NCT02210689|450667891|FG000|Overall Study|Negative Nugent score at baseline|6|||
125284661|NCT02210689|450667892|FG001|Overall Study|Negative Nugent score at baseline|2|||
125284662|NCT02210689|450667893|FG002|Overall Study|Negative Nugent score at baseline|2|||
125284663|NCT02210689|450667891|FG000|Overall Study|Other|25|||
125284664|NCT02210689|450667892|FG001|Overall Study|Other|21|||
125284665|NCT02210689|450667893|FG002|Overall Study|Other|8|||
125284666|NCT00223977|450667900|FG000|Overall Study|Adverse Event|7|||
125284667|NCT00223977|450667901|FG001|Overall Study|Adverse Event|10|||
125284668|NCT00223977|450667902|FG002|Overall Study|Adverse Event|0|||
125284669|NCT00223977|450667900|FG000|Overall Study|Protocol Violation|0|||
125284670|NCT00223977|450667901|FG001|Overall Study|Protocol Violation|0|||
125284671|NCT00223977|450667902|FG002|Overall Study|Protocol Violation|1|||
125284672|NCT00223977|450667900|FG000|Overall Study|Withdrawal by Subject|1|||
125284673|NCT00223977|450667901|FG001|Overall Study|Withdrawal by Subject|1|||
125284674|NCT00223977|450667902|FG002|Overall Study|Withdrawal by Subject|2|||
125284675|NCT00223977|450667900|FG000|Overall Study|Other|1|||
125284676|NCT00223977|450667901|FG001|Overall Study|Other|0|||
125284677|NCT00223977|450667902|FG002|Overall Study|Other|0|||
125284678|NCT03136497|450667903|FG000|Overall Study|Screen Failure|1|||
125284679|NCT03136497|450667904|FG001|Overall Study|Screen Failure|0|||
125284680|NCT03136497|450667905|FG002|Overall Study|Screen Failure|0|||
125284681|NCT00557310|450667908|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
125284682|NCT00557310|450667908|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
125284683|NCT00557310|450667908|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
125284684|NCT00557310|450667908|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
125284685|NCT00557310|450667908|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
125284686|NCT00557310|450667908|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
125284687|NCT00367744|450667911|FG000|Overall Study|Lost to Follow-up|4|||
125284688|NCT00367744|450667912|FG001|Overall Study|Lost to Follow-up|5|||
125284689|NCT01271712|450667915|FG000|Double Blind Treatment|Death|2|||
125284690|NCT01271712|450667916|FG001|Double Blind Treatment|Death|0|||
125284691|NCT01271712|450667915|FG000|Double Blind Treatment|Lack of Efficacy|1|||
125284692|NCT01271712|450667916|FG001|Double Blind Treatment|Lack of Efficacy|0|||
125284693|NCT01271712|450667915|FG000|Double Blind Treatment|Adverse Event|9|||
125284694|NCT01271712|450667916|FG001|Double Blind Treatment|Adverse Event|4|||
125284695|NCT01271712|450667915|FG000|Double Blind Treatment|Progressive disease|23|||
125284696|NCT01271712|450667916|FG001|Double Blind Treatment|Progressive disease|3|||
125284697|NCT01271712|450667915|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
125284698|NCT01271712|450667916|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
125284699|NCT01271712|450667915|FG000|Double Blind Treatment|Non compliance with study drug|2|||
125284700|NCT01271712|450667916|FG001|Double Blind Treatment|Non compliance with study drug|0|||
125284701|NCT01271712|450667915|FG000|Double Blind Treatment|receive no study drug|1|||
125284702|NCT01271712|450667916|FG001|Double Blind Treatment|receive no study drug|0|||
125284703|NCT01271712|450667915|FG000|Open Label Treatment|Death|6|||
125284704|NCT01271712|450667916|FG001|Open Label Treatment|Death|5|||
125284705|NCT01271712|450667915|FG000|Open Label Treatment|Withdrawal by Subject|6|||
125284706|NCT01271712|450667916|FG001|Open Label Treatment|Withdrawal by Subject|11|||
125284707|NCT01271712|450667915|FG000|Open Label Treatment|Physician Decision|2|||
125284708|NCT01271712|450667916|FG001|Open Label Treatment|Physician Decision|0|||
125284709|NCT01271712|450667915|FG000|Open Label Treatment|Adverse Event|14|||
125284710|NCT01271712|450667916|FG001|Open Label Treatment|Adverse Event|8|||
125284711|NCT01271712|450667915|FG000|Open Label Treatment|Progressive disease|59|||
125284712|NCT01271712|450667916|FG001|Open Label Treatment|Progressive disease|32|||
125284713|NCT01271712|450667915|FG000|Open Label Treatment|transferred to rollover study|1|||
125284714|NCT01271712|450667916|FG001|Open Label Treatment|transferred to rollover study|0|||
125284715|NCT01271712|450667915|FG000|Open Label Treatment|Non-compliance with study drug|1|||
125284716|NCT01271712|450667916|FG001|Open Label Treatment|Non-compliance with study drug|0|||
125284717|NCT01271712|450667915|FG000|Open Label Treatment|Protocol Violation|0|||
125284718|NCT01271712|450667916|FG001|Open Label Treatment|Protocol Violation|1|||
125284719|NCT01271712|450667915|FG000|Open Label Treatment|Switching to other therapy|2|||
125284720|NCT01271712|450667916|FG001|Open Label Treatment|Switching to other therapy|1|||
125284721|NCT01271712|450667915|FG000|Safety Follow-up|Death|11|||
125284722|NCT01271712|450667916|FG001|Safety Follow-up|Death|7|||
125284723|NCT01271712|450667915|FG000|Safety Follow-up|Withdrawal by Subject|4|||
125284724|NCT01271712|450667916|FG001|Safety Follow-up|Withdrawal by Subject|2|||
125284725|NCT01271712|450667915|FG000|Safety Follow-up|Protocol Violation|1|||
125284726|NCT01271712|450667916|FG001|Safety Follow-up|Protocol Violation|1|||
125284727|NCT01271712|450667915|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
125284728|NCT01271712|450667916|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
125284729|NCT01271712|450667915|FG000|Safety Follow-up|No follow-up|1|||
125284730|NCT01271712|450667916|FG001|Safety Follow-up|No follow-up|1|||
125284731|NCT01271712|450667915|FG000|Safety Follow-up|Progressive disease|1|||
125284732|NCT01271712|450667916|FG001|Safety Follow-up|Progressive disease|0|||
125284733|NCT01271712|450667915|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
125284734|NCT01271712|450667916|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
125284735|NCT00096226|450667919|FG000|Overall Study|Ineligible|2|||
125284736|NCT00096226|450667919|FG000|Overall Study|Protocol treatment not started|1|||
125284737|NCT01666119|450667920|FG000|Overall Study|Adverse Event|6|||
125284738|NCT01666119|450667920|FG000|Overall Study|Withdrawal by Subject|16|||
125284739|NCT01666119|450667920|FG000|Overall Study|Lost to Follow-up|7|||
125284740|NCT01666119|450667920|FG000|Overall Study|non compliance with study medication, pa|18|||
125284741|NCT01666119|450667920|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
125284742|NCT05479097|450667926|FG000|Overall Study|Withdrawal by Subject|2|||
125284743|NCT04003207|450667929|FG000|Overall Study|Protocol Violation|1|||
125284744|NCT03894969|450667932|FG000|Overall Study|Adverse Event|0|||
125284745|NCT03894969|450667933|FG001|Overall Study|Adverse Event|2|||
125284746|NCT03894969|450667934|FG002|Overall Study|Adverse Event|0|||
125284747|NCT03894969|450667935|FG003|Overall Study|Adverse Event|1|||
125284748|NCT03894969|450667936|FG004|Overall Study|Adverse Event|2|||
125284749|NCT03894969|450667932|FG000|Overall Study|Lost to Follow-up|3|||
125284750|NCT03894969|450667933|FG001|Overall Study|Lost to Follow-up|1|||
125284751|NCT03894969|450667934|FG002|Overall Study|Lost to Follow-up|1|||
125284752|NCT03894969|450667935|FG003|Overall Study|Lost to Follow-up|0|||
125284753|NCT03894969|450667936|FG004|Overall Study|Lost to Follow-up|0|||
125284754|NCT03894969|450667932|FG000|Overall Study|Withdrawal by Subject|2|||
125284755|NCT03894969|450667933|FG001|Overall Study|Withdrawal by Subject|1|||
125284756|NCT03894969|450667934|FG002|Overall Study|Withdrawal by Subject|3|||
125284757|NCT03894969|450667935|FG003|Overall Study|Withdrawal by Subject|4|||
125284758|NCT03894969|450667936|FG004|Overall Study|Withdrawal by Subject|8|||
125284759|NCT03894969|450667932|FG000|Overall Study|Other|0|||
125284760|NCT03894969|450667933|FG001|Overall Study|Other|0|||
125284761|NCT03894969|450667934|FG002|Overall Study|Other|0|||
125284762|NCT03894969|450667935|FG003|Overall Study|Other|0|||
125284763|NCT03894969|450667936|FG004|Overall Study|Other|3|||
125284764|NCT03894969|450667932|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
125284765|NCT03894969|450667933|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
125284766|NCT03894969|450667934|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
125284767|NCT03894969|450667935|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
125284768|NCT03894969|450667936|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
125284769|NCT03894969|450667932|FG000|Overall Study|Solicited Adverse Event|0|||
125284770|NCT03894969|450667933|FG001|Overall Study|Solicited Adverse Event|1|||
125284771|NCT03894969|450667934|FG002|Overall Study|Solicited Adverse Event|0|||
125284772|NCT03894969|450667935|FG003|Overall Study|Solicited Adverse Event|0|||
125284773|NCT03894969|450667936|FG004|Overall Study|Solicited Adverse Event|0|||
125284774|NCT00468676|450667938|FG000|Overall Study|Lost to Follow-up|14|||
125284775|NCT00468676|450667939|FG001|Overall Study|Lost to Follow-up|11|||
125284776|NCT00468676|450667938|FG000|Overall Study|Death|2|||
125284777|NCT00468676|450667939|FG001|Overall Study|Death|1|||
125284778|NCT00118846|450667945|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
125284779|NCT00118846|450667946|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
125284780|NCT00118846|450667945|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
125284781|NCT00118846|450667946|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
125284782|NCT00118846|450667945|FG000|Overall Study|Physician Decision|1|||
125284783|NCT00118846|450667946|FG001|Overall Study|Physician Decision|0|||
125284784|NCT00118846|450667945|FG000|Overall Study|Medical condition|2|||
125284785|NCT00118846|450667946|FG001|Overall Study|Medical condition|2|||
125284786|NCT00118846|450667945|FG000|Overall Study|Lost to Follow-up|0|||
125284787|NCT00118846|450667946|FG001|Overall Study|Lost to Follow-up|2|||
125284788|NCT00118846|450667945|FG000|Overall Study|Personal reason|4|||
125284789|NCT00118846|450667946|FG001|Overall Study|Personal reason|5|||
125284790|NCT01574157|450667947|FG000|Overall Study|Withdrawal by Subject|4|||
125284791|NCT01574157|450667948|FG001|Overall Study|Withdrawal by Subject|5|||
125284792|NCT01574157|450667947|FG000|Overall Study|Lost to Follow-up|0|||
125284793|NCT01574157|450667948|FG001|Overall Study|Lost to Follow-up|3|||
125284794|NCT00721578|450667949|FG000|Overall Study|Death|1|||
125284795|NCT00721578|450667950|FG001|Overall Study|Death|1|||
125284796|NCT00721578|450667949|FG000|Overall Study|Withdrawal by Subject|1|||
125284797|NCT00721578|450667950|FG001|Overall Study|Withdrawal by Subject|1|||
125284798|NCT01330628|450667952|FG000|Overall Study|Death|2|||
125284799|NCT01330628|450667953|FG001|Overall Study|Death|3|||
125284800|NCT01330628|450667952|FG000|Overall Study|Lost to Follow-up|5|||
125284801|NCT01330628|450667953|FG001|Overall Study|Lost to Follow-up|6|||
125284802|NCT01330628|450667952|FG000|Overall Study|Adverse Event|44|||
125284803|NCT01330628|450667953|FG001|Overall Study|Adverse Event|25|||
125284804|NCT01330628|450667952|FG000|Overall Study|Withdrawn|18|||
125284805|NCT01330628|450667953|FG001|Overall Study|Withdrawn|6|||
125284806|NCT01330628|450667952|FG000|Overall Study|Didn't receive study treatment|1|||
125284807|NCT01330628|450667953|FG001|Overall Study|Didn't receive study treatment|0|||
125284808|NCT02910401|450667954|FG000|Overall Study|Study closure Study closure|0|||
125284809|NCT02910401|450667955|FG001|Overall Study|Study closure Study closure|0|||
125284810|NCT02910401|450667956|FG002|Overall Study|Study closure Study closure|2|||
125284811|NCT02910401|450667954|FG000|Overall Study|Physician Decision|1|||
125284812|NCT02910401|450667955|FG001|Overall Study|Physician Decision|0|||
125284813|NCT02910401|450667956|FG002|Overall Study|Physician Decision|0|||
125284814|NCT03222973|450667965|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
125284815|NCT03222973|450667966|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
125284816|NCT03222973|450667967|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
125284817|NCT03222973|450667968|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
125284818|NCT03222973|450667965|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
125284819|NCT03222973|450667966|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
125284820|NCT03222973|450667967|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
125284821|NCT03222973|450667968|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
125284822|NCT03222973|450667965|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
125284823|NCT03222973|450667966|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
125284824|NCT03222973|450667967|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
125284825|NCT03222973|450667968|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
125284826|NCT03222973|450667965|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
125284827|NCT03222973|450667966|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
125284828|NCT03222973|450667967|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
125284829|NCT03222973|450667968|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
125284830|NCT03222973|450667965|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
125284831|NCT03222973|450667966|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
125284832|NCT03222973|450667967|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
125284833|NCT03222973|450667968|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
125284834|NCT03222973|450667965|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
125284835|NCT03222973|450667966|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
125284836|NCT03222973|450667967|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
125284837|NCT03222973|450667968|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
125284838|NCT03222973|450667965|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
125284839|NCT03222973|450667966|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
125284840|NCT03222973|450667967|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
125284841|NCT03222973|450667968|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
125284842|NCT03222973|450667965|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
125284843|NCT03222973|450667966|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
125284844|NCT03222973|450667967|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
124782251|NCT02910986|448832802|FG002|Overall Study|Failure to return T! survey|72|||
124782252|NCT02910986|448832800|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
125284845|NCT03222973|450667968|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
125284846|NCT03222973|450667965|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
125284847|NCT03222973|450667966|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
125284848|NCT03222973|450667967|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
125284849|NCT03222973|450667968|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
125284850|NCT03222973|450667965|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
125284851|NCT03222973|450667966|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
124782253|NCT02910986|448832801|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
124782254|NCT02910986|448832802|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
125284852|NCT03222973|450667967|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
125284853|NCT03222973|450667968|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
125284854|NCT03222973|450667965|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
125284855|NCT03222973|450667966|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
125284856|NCT03222973|450667967|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
125284857|NCT03222973|450667968|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
125284858|NCT03222973|450667965|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
125284859|NCT03222973|450667966|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
125284860|NCT03222973|450667967|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
125284861|NCT03222973|450667968|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
125284862|NCT02080481|450667969|FG000|Overall Study|Never received a block.|1|||
125284863|NCT02080481|450667970|FG001|Overall Study|Never received a block.|0|||
125284864|NCT01440517|450669935|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
125284865|NCT02723006|450669940|FG000|Overall Study|Withdrawal by Subject|0|||
125284866|NCT02723006|450669941|FG001|Overall Study|Withdrawal by Subject|1|||
125284867|NCT02723006|450669942|FG002|Overall Study|Withdrawal by Subject|1|||
125284868|NCT02723006|450669940|FG000|Overall Study|Study Terminated by Sponsor|1|||
125284869|NCT02723006|450669941|FG001|Overall Study|Study Terminated by Sponsor|6|||
125284870|NCT02723006|450669942|FG002|Overall Study|Study Terminated by Sponsor|6|||
125284871|NCT00983515|450669943|FG000|Ritonavir Alone|liver panel out of range|6|||
125284872|NCT00983515|450669943|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
125284873|NCT01967823|450669946|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
125284874|NCT00316693|450669947|FG000|Overall Study|Adverse Event|6|||
125284875|NCT00316693|450669948|FG001|Overall Study|Adverse Event|1|||
125284876|NCT00316693|450669947|FG000|Overall Study|Protocol Violation|1|||
125284877|NCT00316693|450669948|FG001|Overall Study|Protocol Violation|0|||
125284878|NCT00316693|450669947|FG000|Overall Study|Withdrawal by Subject|6|||
125284879|NCT00316693|450669948|FG001|Overall Study|Withdrawal by Subject|6|||
125284880|NCT00316693|450669947|FG000|Overall Study|Lost to Follow-up|26|||
125284881|NCT00316693|450669948|FG001|Overall Study|Lost to Follow-up|34|||
125284882|NCT00316693|450669947|FG000|Overall Study|Other|38|||
125284883|NCT00316693|450669948|FG001|Overall Study|Other|44|||
125284884|NCT00539513|450669949|FG000|Overall Study|Withdrawal by Subject|2|||
125284885|NCT00539513|450669950|FG001|Overall Study|Withdrawal by Subject|1|||
125284886|NCT00539513|450669949|FG000|Overall Study|Lost to Follow-up|0|||
125284887|NCT00539513|450669950|FG001|Overall Study|Lost to Follow-up|1|||
125284888|NCT03002818|450669951|FG000|Overall Study|Decision of the investigator|1|||
125284889|NCT00711113|450669955|FG000|Overall Study|Lost to Follow-up|9|||
125284890|NCT00711113|450669955|FG000|Overall Study|Implant lost|2|||
125284891|NCT01606787|450669962|FG000|Overall Study|Withdrawal by Subject|4|||
125284892|NCT01606787|450669963|FG001|Overall Study|Withdrawal by Subject|5|||
125284893|NCT01606787|450669962|FG000|Overall Study|Surgery canceled|0|||
125284894|NCT01606787|450669963|FG001|Overall Study|Surgery canceled|2|||
125284895|NCT00413894|450669964|FG000|Overall Study|Withdrawal by Subject|10|||
125284896|NCT00413894|450669964|FG000|Overall Study|Administrative Reasons|1|||
125284897|NCT00413894|450669964|FG000|Overall Study|Hb <10 grams/deciliter|12|||
125284898|NCT00413894|450669964|FG000|Overall Study|Adverse Event|28|||
125284899|NCT00413894|450669964|FG000|Overall Study|Protocol Violation|11|||
125284900|NCT00413894|450669964|FG000|Overall Study|Other|18|||
125284901|NCT04225676|450669965|FG000|Overall Study|Physician Decision|1|||
125284902|NCT04225676|450669965|FG000|Overall Study|Lack of Efficacy|1|||
125284903|NCT04225676|450669965|FG000|Overall Study|Study terminated by sponsor|3|||
125284904|NCT03245736|450669966|FG000|Overall Study|Adverse Event|1|||
125284905|NCT03245736|450669966|FG000|Overall Study|Progressive Disease|4|||
125284906|NCT01942161|450669967|FG000|Overall Study|Adverse Event|1|||
125284907|NCT01942161|450669968|FG001|Overall Study|Adverse Event|2|||
125284908|NCT01942161|450669969|FG002|Overall Study|Adverse Event|5|||
125284909|NCT01942161|450669967|FG000|Overall Study|Physician Decision|3|||
125284910|NCT01942161|450669968|FG001|Overall Study|Physician Decision|1|||
125284911|NCT01942161|450669969|FG002|Overall Study|Physician Decision|0|||
125284912|NCT01942161|450669967|FG000|Overall Study|Protocol Violation|1|||
125284913|NCT01942161|450669968|FG001|Overall Study|Protocol Violation|0|||
125284914|NCT01942161|450669969|FG002|Overall Study|Protocol Violation|0|||
125284915|NCT01942161|450669967|FG000|Overall Study|Withdrawal by Subject|3|||
125284916|NCT01942161|450669968|FG001|Overall Study|Withdrawal by Subject|3|||
125284917|NCT01942161|450669969|FG002|Overall Study|Withdrawal by Subject|1|||
125284918|NCT05289271|450669972|FG000|Overall Study|Mistakenly allocated, untreated|1|||
125284919|NCT05289271|450669973|FG001|Overall Study|Mistakenly allocated, untreated|0|||
125284920|NCT01257568|450669974|FG000|Overall Study|Lost to Follow-up|2|||
125284921|NCT01257568|450669974|FG000|Overall Study|Withdrawal by Subject|6|||
125284922|NCT01257568|450669974|FG000|Overall Study|Terminated|1|||
125284923|NCT01257568|450669974|FG000|Overall Study|Component Revision|24|||
125284924|NCT03392883|450669977|FG000|Overall Study|Lost to Follow-up|122|||
125284925|NCT03392883|450669978|FG001|Overall Study|Lost to Follow-up|13|||
125284926|NCT03392883|450669979|FG002|Overall Study|Lost to Follow-up|9|||
125284927|NCT03392883|450669977|FG000|Overall Study|Death|4|||
125284928|NCT03392883|450669978|FG001|Overall Study|Death|0|||
125284929|NCT03392883|450669979|FG002|Overall Study|Death|0|||
125284930|NCT03392883|450669977|FG000|Overall Study|Lack of Efficacy|29|||
125284931|NCT03392883|450669978|FG001|Overall Study|Lack of Efficacy|0|||
125284932|NCT03392883|450669979|FG002|Overall Study|Lack of Efficacy|0|||
125284933|NCT03392883|450669977|FG000|Overall Study|Withdrawal by Subject|180|||
125284934|NCT03392883|450669978|FG001|Overall Study|Withdrawal by Subject|0|||
125284935|NCT03392883|450669979|FG002|Overall Study|Withdrawal by Subject|0|||
125284936|NCT03392883|450669977|FG000|Overall Study|Adverse Event|1|||
125284937|NCT03392883|450669978|FG001|Overall Study|Adverse Event|0|||
125284938|NCT03392883|450669979|FG002|Overall Study|Adverse Event|0|||
125284939|NCT00132691|450669980|FG000|Overall Study|Lost to Follow-up|5|||
125284940|NCT00132691|450669981|FG001|Overall Study|Lost to Follow-up|8|||
125284941|NCT00132691|450669980|FG000|Overall Study|Missed 2-year visit|4|||
125284942|NCT00132691|450669981|FG001|Overall Study|Missed 2-year visit|4|||
125284943|NCT00132691|450669980|FG000|Overall Study|Death|2|||
125284944|NCT00132691|450669981|FG001|Overall Study|Death|0|||
125284945|NCT01739933|450669991|FG000|Overall Study|Death|89|||
125284946|NCT01739933|450669992|FG001|Overall Study|Death|86|||
125284947|NCT01739933|450669991|FG000|Overall Study|Withdrawal by Subject|10|||
125284948|NCT01739933|450669992|FG001|Overall Study|Withdrawal by Subject|8|||
125284949|NCT01739933|450669991|FG000|Overall Study|Lost to Follow-up|3|||
125284950|NCT01739933|450669992|FG001|Overall Study|Lost to Follow-up|10|||
125284951|NCT01739933|450669991|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
125284952|NCT01739933|450669992|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
125284953|NCT04098367|450669993|FG000|Overall Study|Adverse Event|0|||
125284954|NCT04098367|450669994|FG001|Overall Study|Adverse Event|0|||
125284955|NCT04098367|450669995|FG002|Overall Study|Adverse Event|1|||
125284956|NCT04098367|450669993|FG000|Overall Study|Lost to Follow-up|1|||
125284957|NCT04098367|450669994|FG001|Overall Study|Lost to Follow-up|5|||
125284958|NCT04098367|450669995|FG002|Overall Study|Lost to Follow-up|2|||
125284959|NCT04098367|450669993|FG000|Overall Study|Withdrawal by Subject|0|||
125284960|NCT04098367|450669994|FG001|Overall Study|Withdrawal by Subject|0|||
125284961|NCT04098367|450669995|FG002|Overall Study|Withdrawal by Subject|1|||
125284962|NCT04098367|450669993|FG000|Overall Study|Sick . Could not attend visit|1|||
125284963|NCT04098367|450669994|FG001|Overall Study|Sick . Could not attend visit|0|||
125284964|NCT04098367|450669995|FG002|Overall Study|Sick . Could not attend visit|0|||
125284965|NCT01231321|450670001|FG000|Overall Study|Adverse Event|3|||
125284966|NCT01231321|450670001|FG000|Overall Study|Lack of Efficacy|2|||
125284967|NCT00354107|450670004|FG000|Overall Study|Adverse Event|2|||
125284968|NCT00354107|450670004|FG000|Overall Study|Physician Decision|2|||
125284969|NCT00354107|450670004|FG000|Overall Study|Withdrawal by Subject|1|||
125284970|NCT03575065|450670007|FG000|Overall Study|Death|31|||
125284971|NCT03575065|450670008|FG001|Overall Study|Death|12|||
125284972|NCT03575065|450670007|FG000|Overall Study|Sponsor's Decision|28|||
125284973|NCT03575065|450670008|FG001|Overall Study|Sponsor's Decision|13|||
125284974|NCT03575065|450670007|FG000|Overall Study|Withdrawal by Subject|2|||
125284975|NCT03575065|450670008|FG001|Overall Study|Withdrawal by Subject|1|||
125284976|NCT03575065|450670007|FG000|Overall Study|Lost to Follow-up|1|||
125284977|NCT03575065|450670008|FG001|Overall Study|Lost to Follow-up|0|||
125284978|NCT03960580|450670009|FG000|Overall Study|Adverse Event|2|||
125284979|NCT03960580|450670010|FG001|Overall Study|Adverse Event|1|||
125284980|NCT03960580|450670011|FG002|Overall Study|Adverse Event|1|||
125284981|NCT03960580|450670009|FG000|Overall Study|Lost to Follow-up|1|||
125284982|NCT03960580|450670010|FG001|Overall Study|Lost to Follow-up|0|||
125284983|NCT03960580|450670011|FG002|Overall Study|Lost to Follow-up|0|||
125284984|NCT03960580|450670009|FG000|Overall Study|Lack of Efficacy|2|||
125284985|NCT03960580|450670010|FG001|Overall Study|Lack of Efficacy|1|||
125284986|NCT03960580|450670011|FG002|Overall Study|Lack of Efficacy|0|||
125284987|NCT03960580|450670009|FG000|Overall Study|Protocol Violation|0|||
125284988|NCT03960580|450670010|FG001|Overall Study|Protocol Violation|0|||
125284989|NCT03960580|450670011|FG002|Overall Study|Protocol Violation|1|||
125284990|NCT03960580|450670009|FG000|Overall Study|Withdrawal by Subject|1|||
125284991|NCT03960580|450670010|FG001|Overall Study|Withdrawal by Subject|1|||
125284992|NCT03960580|450670011|FG002|Overall Study|Withdrawal by Subject|1|||
125284993|NCT03960580|450670009|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
125284994|NCT03960580|450670010|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
125284995|NCT03960580|450670011|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
125284996|NCT02359045|450670014|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
125284997|NCT02359045|450670015|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
125284998|NCT02359045|450670014|FG000|Overall Study|Lost to Follow-up|1|||
125284999|NCT02359045|450670015|FG001|Overall Study|Lost to Follow-up|1|||
125285000|NCT02359045|450670014|FG000|Overall Study|Adverse Event|0|||
125285001|NCT02359045|450670015|FG001|Overall Study|Adverse Event|1|||
125285002|NCT00541866|450670016|FG000|Overall Study|Adverse Event|3|||
125285003|NCT00541866|450670017|FG001|Overall Study|Adverse Event|0|||
125285004|NCT00541866|450670018|FG002|Overall Study|Adverse Event|0|||
125285005|NCT00541866|450670019|FG003|Overall Study|Adverse Event|0|||
125285006|NCT00541866|450670020|FG004|Overall Study|Adverse Event|0|||
125285007|NCT00541866|450670016|FG000|Overall Study|Death|1|||
125285008|NCT00541866|450670017|FG001|Overall Study|Death|0|||
125285009|NCT00541866|450670018|FG002|Overall Study|Death|0|||
125285010|NCT00541866|450670019|FG003|Overall Study|Death|0|||
125285011|NCT00541866|450670020|FG004|Overall Study|Death|0|||
125285012|NCT00541866|450670016|FG000|Overall Study|Lack of Efficacy|19|||
125285013|NCT00541866|450670017|FG001|Overall Study|Lack of Efficacy|15|||
125285014|NCT00541866|450670018|FG002|Overall Study|Lack of Efficacy|10|||
125285015|NCT00541866|450670019|FG003|Overall Study|Lack of Efficacy|12|||
125285016|NCT00541866|450670020|FG004|Overall Study|Lack of Efficacy|14|||
125285017|NCT00541866|450670016|FG000|Overall Study|Not Reported or Other|11|||
125285018|NCT00541866|450670017|FG001|Overall Study|Not Reported or Other|3|||
125285019|NCT00541866|450670018|FG002|Overall Study|Not Reported or Other|3|||
125285020|NCT00541866|450670019|FG003|Overall Study|Not Reported or Other|3|||
125285021|NCT00541866|450670020|FG004|Overall Study|Not Reported or Other|1|||
125285022|NCT00541866|450670016|FG000|Overall Study|Physician Decision|0|||
125285023|NCT00541866|450670017|FG001|Overall Study|Physician Decision|0|||
124782255|NCT02910986|448832800|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
125285024|NCT00541866|450670018|FG002|Overall Study|Physician Decision|2|||
125285025|NCT00541866|450670019|FG003|Overall Study|Physician Decision|1|||
125285026|NCT00541866|450670020|FG004|Overall Study|Physician Decision|0|||
125285027|NCT01327053|450670025|FG000|Overall Study|Adverse Event|23|||
125285028|NCT01327053|450670026|FG001|Overall Study|Adverse Event|57|||
125285029|NCT01327053|450670025|FG000|Overall Study|Patient/guardian decision|11|||
125285030|NCT01327053|450670026|FG001|Overall Study|Patient/guardian decision|35|||
125285031|NCT01327053|450670025|FG000|Overall Study|Physician Decision|10|||
125285032|NCT01327053|450670026|FG001|Overall Study|Physician Decision|14|||
125285033|NCT01327053|450670025|FG000|Overall Study|Death|1|||
125285034|NCT01327053|450670026|FG001|Overall Study|Death|5|||
125285035|NCT01327053|450670025|FG000|Overall Study|Lost to Follow-up|2|||
125285036|NCT01327053|450670026|FG001|Overall Study|Lost to Follow-up|4|||
125285037|NCT01327053|450670025|FG000|Overall Study|Non-compliance with study treatment|0|||
125285038|NCT01327053|450670026|FG001|Overall Study|Non-compliance with study treatment|5|||
125285039|NCT01327053|450670025|FG000|Overall Study|Study terminated by Sponsor|1|||
125285040|NCT01327053|450670026|FG001|Overall Study|Study terminated by Sponsor|3|||
125285041|NCT01327053|450670025|FG000|Overall Study|Progressive disease|31|||
125285042|NCT01327053|450670026|FG001|Overall Study|Progressive disease|26|||
125285043|NCT01327053|450670025|FG000|Overall Study|Protocol Violation|0|||
125285044|NCT01327053|450670026|FG001|Overall Study|Protocol Violation|1|||
125285045|NCT01327053|450670025|FG000|Overall Study|Untreated|0|||
125285046|NCT01327053|450670026|FG001|Overall Study|Untreated|1|||
125285047|NCT00957944|450670027|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
125285048|NCT00957944|450670028|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
125285049|NCT00522418|450670029|FG000|Overall Study|Local IRB Consent Violation|5|||
125285050|NCT00522418|450670030|FG001|Overall Study|Local IRB Consent Violation|5|||
125285051|NCT00522418|450670029|FG000|Overall Study|Early Study Termination|46|||
125285052|NCT00522418|450670030|FG001|Overall Study|Early Study Termination|47|||
125285053|NCT00522418|450670029|FG000|Overall Study|Noncompliance|2|||
125285054|NCT00522418|450670030|FG001|Overall Study|Noncompliance|2|||
125285055|NCT00522418|450670029|FG000|Overall Study|Reason Not Specified|3|||
125285056|NCT00522418|450670030|FG001|Overall Study|Reason Not Specified|1|||
125285057|NCT00522418|450670029|FG000|Overall Study|Consent Withdraw|1|||
125285058|NCT00522418|450670030|FG001|Overall Study|Consent Withdraw|2|||
125285059|NCT00522418|450670029|FG000|Overall Study|Lack of Efficacy|0|||
125285060|NCT00522418|450670030|FG001|Overall Study|Lack of Efficacy|1|||
125285061|NCT01482169|450670031|FG000|Overall Study|Physician Decision|2|||
125285062|NCT01944098|450670032|FG000|Overall Study|Physician Decision|1|||
125285063|NCT01944098|450670033|FG001|Overall Study|Physician Decision|0|||
125285064|NCT00951080|450670034|FG000|Overall Study|Adverse Event|3|||
125285065|NCT00951080|450670035|FG001|Overall Study|Adverse Event|3|||
125285066|NCT00951080|450670034|FG000|Overall Study|Lost to Follow-up|0|||
125285067|NCT00951080|450670035|FG001|Overall Study|Lost to Follow-up|1|||
125285068|NCT00951080|450670034|FG000|Overall Study|Physician Decision|4|||
125285069|NCT00951080|450670035|FG001|Overall Study|Physician Decision|1|||
125285070|NCT00951080|450670034|FG000|Overall Study|Other|19|||
125285071|NCT00951080|450670035|FG001|Overall Study|Other|22|||
125285072|NCT01939002|450670039|FG000|Overall Study|Adverse Event|13|||
125285073|NCT01939002|450670040|FG001|Overall Study|Adverse Event|13|||
125285074|NCT01939002|450670039|FG000|Overall Study|Withdrawal by Subject|5|||
125285075|NCT01939002|450670040|FG001|Overall Study|Withdrawal by Subject|3|||
125285076|NCT01939002|450670039|FG000|Overall Study|Other|1|||
125285077|NCT01939002|450670040|FG001|Overall Study|Other|2|||
125285078|NCT03300024|450670043|FG000|Overall Study|Physician Decision|4|||
125285079|NCT03300024|450670044|FG001|Overall Study|Physician Decision|6|||
125285080|NCT00570037|450670047|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
125285081|NCT00570037|450670048|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
125285082|NCT00433160|450670049|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
125285083|NCT00433160|450670050|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
125285084|NCT00433160|450670049|FG000|52-Week Double-Blind (DB) Period|Death|0|||
125285085|NCT00433160|450670050|FG001|52-Week Double-Blind (DB) Period|Death|0|||
125285086|NCT00433160|450670049|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
125285087|NCT00433160|450670050|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
125285088|NCT00433160|450670049|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
125285089|NCT00433160|450670050|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
125285090|NCT00433160|450670049|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
125285091|NCT00433160|450670050|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
125285092|NCT00433160|450670049|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
125285093|NCT00433160|450670050|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
125285094|NCT00433160|450670049|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
125285095|NCT00433160|450670050|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
125285096|NCT00433160|450670049|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
125285097|NCT00433160|450670050|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
125285098|NCT00433160|450670049|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
125285099|NCT00433160|450670050|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
125285100|NCT00433160|450670049|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
125285101|NCT00433160|450670050|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
125285102|NCT00433160|450670049|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
125285103|NCT00433160|450670050|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
125285104|NCT00433160|450670049|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
125285105|NCT00433160|450670050|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
125285106|NCT00433160|450670049|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
125285107|NCT00433160|450670050|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
125285108|NCT00433160|450670049|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
125285109|NCT00433160|450670050|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
125285110|NCT00433160|450670049|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
125285111|NCT00433160|450670050|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
125285112|NCT00433160|450670049|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
125285113|NCT00433160|450670050|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
125285114|NCT03372460|450670052|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
125285115|NCT03372460|450670053|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
125285116|NCT02499900|450670054|FG000|Core Study Period|Other|1|||
125285117|NCT02499900|450670055|FG001|Core Study Period|Other|4|||
124782256|NCT02910986|448832801|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
124782257|NCT02910986|448832802|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
124782258|NCT01068600|448832803|FG000|Overall Study|Withdrawal by Subject|5|||
125285118|NCT02499900|450670054|FG000|Core Study Period|Lost to Follow-up|1|||
124782259|NCT01068600|448832804|FG001|Overall Study|Withdrawal by Subject|6|||
124782260|NCT01068600|448832803|FG000|Overall Study|Adverse Event|3|||
125285119|NCT02499900|450670055|FG001|Core Study Period|Lost to Follow-up|2|||
125285120|NCT02499900|450670054|FG000|Core Study Period|Per sponsor request|0|||
125285121|NCT02499900|450670055|FG001|Core Study Period|Per sponsor request|1|||
125285122|NCT02499900|450670054|FG000|Core Study Period|Pregnancy|1|||
125285123|NCT02499900|450670055|FG001|Core Study Period|Pregnancy|0|||
125285124|NCT02499900|450670054|FG000|Core Study Period|Protocol Violation|3|||
125285125|NCT02499900|450670055|FG001|Core Study Period|Protocol Violation|0|||
125285126|NCT02499900|450670054|FG000|Core Study Period|Withdrawal by Subject|11|||
125285127|NCT02499900|450670055|FG001|Core Study Period|Withdrawal by Subject|10|||
125285128|NCT02499900|450670054|FG000|Core Study Period|Adverse Event|18|||
125285129|NCT02499900|450670055|FG001|Core Study Period|Adverse Event|14|||
125285130|NCT02499900|450670054|FG000|Core Study Period|Death|0|||
125285131|NCT02499900|450670055|FG001|Core Study Period|Death|1|||
125285132|NCT02499900|450670054|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
125285133|NCT02499900|450670055|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
125285134|NCT02499900|450670054|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
125285135|NCT02499900|450670055|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
125285136|NCT02499900|450670054|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
125285137|NCT02499900|450670055|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
125285138|NCT02499900|450670054|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
125285139|NCT02499900|450670055|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
125285140|NCT02499900|450670054|FG000|Extension Study Period|Adverse Event|2|||
125285141|NCT02499900|450670055|FG001|Extension Study Period|Adverse Event|4|||
125285142|NCT02499900|450670054|FG000|Extension Study Period|Withdrawal by Subject|5|||
125285143|NCT02499900|450670055|FG001|Extension Study Period|Withdrawal by Subject|2|||
125285144|NCT02499900|450670054|FG000|Extension Study Period|Physician Decision|2|||
125285145|NCT02499900|450670055|FG001|Extension Study Period|Physician Decision|5|||
125285146|NCT02499900|450670054|FG000|Extension Study Period|Pregnancy|1|||
125285147|NCT02499900|450670055|FG001|Extension Study Period|Pregnancy|2|||
125285148|NCT02499900|450670054|FG000|Extension Study Period|Lost to Follow-up|2|||
125285149|NCT02499900|450670055|FG001|Extension Study Period|Lost to Follow-up|5|||
125285150|NCT02499900|450670054|FG000|Extension Study Period|Other|0|||
125285151|NCT02499900|450670055|FG001|Extension Study Period|Other|2|||
125285152|NCT01170065|450670058|FG000|Overall Study|Adverse Event|17|||
125285153|NCT01170065|450670059|FG001|Overall Study|Adverse Event|50|||
125285154|NCT01170065|450670060|FG002|Overall Study|Adverse Event|10|||
125285155|NCT01170065|450670058|FG000|Overall Study|Lost to Follow-up|1|||
125285156|NCT01170065|450670059|FG001|Overall Study|Lost to Follow-up|4|||
125285157|NCT01170065|450670060|FG002|Overall Study|Lost to Follow-up|1|||
125285158|NCT01170065|450670058|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
125285159|NCT01170065|450670059|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
125285160|NCT01170065|450670060|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
125285161|NCT01170065|450670058|FG000|Overall Study|Reason other than specified|3|||
125285162|NCT01170065|450670059|FG001|Overall Study|Reason other than specified|8|||
125285163|NCT01170065|450670060|FG002|Overall Study|Reason other than specified|3|||
125285164|NCT01170065|450670058|FG000|Overall Study|Ongoing after planned observation time|5|||
125285165|NCT01170065|450670059|FG001|Overall Study|Ongoing after planned observation time|26|||
125285166|NCT01170065|450670060|FG002|Overall Study|Ongoing after planned observation time|10|||
125285167|NCT04258995|450672589|FG000|Overall Study|Lost to Follow-up|1|||
125285168|NCT04258995|450672590|FG001|Overall Study|Lost to Follow-up|1|||
125285169|NCT00642174|450672600|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
125285170|NCT00642174|450672601|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
125285171|NCT00896363|450672602|FG000|Overall Study|Adverse Event|3|||
125285172|NCT00896363|450672603|FG001|Overall Study|Adverse Event|4|||
125285173|NCT00896363|450672604|FG002|Overall Study|Adverse Event|2|||
125285174|NCT00896363|450672602|FG000|Overall Study|Lack of Efficacy|0|||
125285175|NCT00896363|450672603|FG001|Overall Study|Lack of Efficacy|2|||
125285176|NCT00896363|450672604|FG002|Overall Study|Lack of Efficacy|1|||
125285177|NCT00896363|450672602|FG000|Overall Study|Withdrawal by Subject|3|||
125285178|NCT00896363|450672603|FG001|Overall Study|Withdrawal by Subject|5|||
125285179|NCT00896363|450672604|FG002|Overall Study|Withdrawal by Subject|5|||
125285180|NCT02982018|450672605|FG000|Overall Study|Incorrect Lens Dispensed|1|||
125285181|NCT02982018|450672606|FG001|Overall Study|Incorrect Lens Dispensed|0|||
125285182|NCT02982018|450672605|FG000|Overall Study|Protocol Violation|1|||
125285183|NCT02982018|450672606|FG001|Overall Study|Protocol Violation|1|||
125285184|NCT02982018|450672605|FG000|Overall Study|Adverse Event|1|||
125285185|NCT02982018|450672606|FG001|Overall Study|Adverse Event|1|||
125285186|NCT02982018|450672605|FG000|Overall Study|Lens Discomfort|2|||
125285187|NCT02982018|450672606|FG001|Overall Study|Lens Discomfort|0|||
125285188|NCT02982018|450672605|FG000|Overall Study|Withdrawal by Subject|0|||
125285189|NCT02982018|450672606|FG001|Overall Study|Withdrawal by Subject|1|||
125285190|NCT03334851|450672609|FG000|Overall Study|Other|0|||
125285191|NCT03334851|450672610|FG001|Overall Study|Other|0|||
125285192|NCT03334851|450672611|FG002|Overall Study|Other|0|||
125285193|NCT03334851|450672612|FG003|Overall Study|Other|0|||
125285194|NCT03334851|450672613|FG004|Overall Study|Other|0|||
125285195|NCT03334851|450672614|FG005|Overall Study|Other|0|||
125285196|NCT03334851|450672615|FG006|Overall Study|Other|0|||
125285197|NCT03334851|450672616|FG007|Overall Study|Other|1|||
125285198|NCT03334851|450672617|FG008|Overall Study|Other|0|||
125285199|NCT03334851|450672618|FG009|Overall Study|Other|0|||
125285200|NCT03334851|450672619|FG010|Overall Study|Other|0|||
125285201|NCT03334851|450672620|FG011|Overall Study|Other|0|||
125285202|NCT03334851|450672621|FG012|Overall Study|Other|0|||
125285203|NCT03334851|450672609|FG000|Overall Study|Adverse Event|0|||
125285204|NCT03334851|450672610|FG001|Overall Study|Adverse Event|0|||
125285205|NCT03334851|450672611|FG002|Overall Study|Adverse Event|0|||
125285206|NCT03334851|450672612|FG003|Overall Study|Adverse Event|0|||
125285207|NCT03334851|450672613|FG004|Overall Study|Adverse Event|0|||
125285208|NCT03334851|450672614|FG005|Overall Study|Adverse Event|0|||
125285209|NCT03334851|450672615|FG006|Overall Study|Adverse Event|0|||
125285210|NCT03334851|450672616|FG007|Overall Study|Adverse Event|1|||
125285211|NCT03334851|450672617|FG008|Overall Study|Adverse Event|0|||
125285212|NCT03334851|450672618|FG009|Overall Study|Adverse Event|0|||
125285213|NCT03334851|450672619|FG010|Overall Study|Adverse Event|0|||
125285214|NCT03334851|450672620|FG011|Overall Study|Adverse Event|0|||
125285215|NCT03334851|450672621|FG012|Overall Study|Adverse Event|0|||
125285216|NCT03334851|450672609|FG000|Overall Study|Withdrawal by Subject|0|||
125285217|NCT03334851|450672610|FG001|Overall Study|Withdrawal by Subject|0|||
125285218|NCT03334851|450672611|FG002|Overall Study|Withdrawal by Subject|0|||
125285219|NCT03334851|450672612|FG003|Overall Study|Withdrawal by Subject|0|||
125285220|NCT03334851|450672613|FG004|Overall Study|Withdrawal by Subject|0|||
125285221|NCT03334851|450672614|FG005|Overall Study|Withdrawal by Subject|0|||
125285222|NCT03334851|450672615|FG006|Overall Study|Withdrawal by Subject|0|||
125285223|NCT03334851|450672616|FG007|Overall Study|Withdrawal by Subject|0|||
125285224|NCT03334851|450672617|FG008|Overall Study|Withdrawal by Subject|0|||
125285225|NCT03334851|450672618|FG009|Overall Study|Withdrawal by Subject|0|||
125285226|NCT03334851|450672619|FG010|Overall Study|Withdrawal by Subject|1|||
125285227|NCT03334851|450672620|FG011|Overall Study|Withdrawal by Subject|0|||
125285228|NCT03334851|450672621|FG012|Overall Study|Withdrawal by Subject|1|||
125285229|NCT03334851|450672609|FG000|Overall Study|Lost to Follow-up|0|||
125285230|NCT03334851|450672610|FG001|Overall Study|Lost to Follow-up|0|||
125285231|NCT03334851|450672611|FG002|Overall Study|Lost to Follow-up|0|||
125285232|NCT03334851|450672612|FG003|Overall Study|Lost to Follow-up|0|||
125285233|NCT03334851|450672613|FG004|Overall Study|Lost to Follow-up|0|||
125285234|NCT03334851|450672614|FG005|Overall Study|Lost to Follow-up|0|||
125285235|NCT03334851|450672615|FG006|Overall Study|Lost to Follow-up|0|||
125285236|NCT03334851|450672616|FG007|Overall Study|Lost to Follow-up|0|||
125285237|NCT03334851|450672617|FG008|Overall Study|Lost to Follow-up|0|||
125285238|NCT03334851|450672618|FG009|Overall Study|Lost to Follow-up|0|||
125285239|NCT03334851|450672619|FG010|Overall Study|Lost to Follow-up|2|||
125285240|NCT03334851|450672620|FG011|Overall Study|Lost to Follow-up|1|||
125285241|NCT03334851|450672621|FG012|Overall Study|Lost to Follow-up|0|||
125285242|NCT01691885|450672622|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
125285243|NCT01691885|450672623|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
125285244|NCT01691885|450672622|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
125285245|NCT01691885|450672623|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
125285246|NCT03555981|450672624|FG000|Overall Study|Lost to Follow-up|0|||
125285247|NCT03555981|450672625|FG001|Overall Study|Lost to Follow-up|2|||
125285248|NCT02754141|450672629|FG000|Overall Study|Disease progression|11|||
125285249|NCT02754141|450672630|FG001|Overall Study|Disease progression|7|||
125285250|NCT02754141|450672631|FG002|Overall Study|Disease progression|8|||
125285251|NCT02754141|450672632|FG003|Overall Study|Disease progression|5|||
125285252|NCT02754141|450672633|FG004|Overall Study|Disease progression|7|||
125285253|NCT02754141|450672634|FG005|Overall Study|Disease progression|7|||
125285254|NCT02754141|450672635|FG006|Overall Study|Disease progression|7|||
125285255|NCT02754141|450672636|FG007|Overall Study|Disease progression|6|||
125285256|NCT02754141|450672637|FG008|Overall Study|Disease progression|11|||
125285257|NCT02754141|450672638|FG009|Overall Study|Disease progression|16|||
125285258|NCT02754141|450672639|FG010|Overall Study|Disease progression|18|||
125285259|NCT02754141|450672640|FG011|Overall Study|Disease progression|13|||
125285260|NCT02754141|450672641|FG012|Overall Study|Disease progression|10|||
125285261|NCT02754141|450672642|FG013|Overall Study|Disease progression|12|||
125285262|NCT02754141|450672643|FG014|Overall Study|Disease progression|12|||
125285263|NCT02754141|450672644|FG015|Overall Study|Disease progression|14|||
125285264|NCT02754141|450672645|FG016|Overall Study|Disease progression|0|||
125285265|NCT02754141|450672646|FG017|Overall Study|Disease progression|1|||
125285266|NCT02754141|450672629|FG000|Overall Study|Study drug toxicity|1|||
125285267|NCT02754141|450672630|FG001|Overall Study|Study drug toxicity|1|||
125285268|NCT02754141|450672631|FG002|Overall Study|Study drug toxicity|0|||
125285269|NCT02754141|450672632|FG003|Overall Study|Study drug toxicity|0|||
125285270|NCT02754141|450672633|FG004|Overall Study|Study drug toxicity|0|||
125285271|NCT02754141|450672634|FG005|Overall Study|Study drug toxicity|0|||
125285272|NCT02754141|450672635|FG006|Overall Study|Study drug toxicity|0|||
125285273|NCT02754141|450672636|FG007|Overall Study|Study drug toxicity|0|||
125285274|NCT02754141|450672637|FG008|Overall Study|Study drug toxicity|0|||
125285275|NCT02754141|450672638|FG009|Overall Study|Study drug toxicity|0|||
125285276|NCT02754141|450672639|FG010|Overall Study|Study drug toxicity|2|||
125285277|NCT02754141|450672640|FG011|Overall Study|Study drug toxicity|1|||
125285278|NCT02754141|450672641|FG012|Overall Study|Study drug toxicity|1|||
125285279|NCT02754141|450672642|FG013|Overall Study|Study drug toxicity|0|||
125285280|NCT02754141|450672643|FG014|Overall Study|Study drug toxicity|0|||
125285281|NCT02754141|450672644|FG015|Overall Study|Study drug toxicity|0|||
125285282|NCT02754141|450672645|FG016|Overall Study|Study drug toxicity|0|||
125285283|NCT02754141|450672646|FG017|Overall Study|Study drug toxicity|0|||
125285284|NCT02754141|450672629|FG000|Overall Study|AE unrelated to study drug|1|||
125285285|NCT02754141|450672630|FG001|Overall Study|AE unrelated to study drug|1|||
125285286|NCT02754141|450672631|FG002|Overall Study|AE unrelated to study drug|0|||
125285287|NCT02754141|450672632|FG003|Overall Study|AE unrelated to study drug|1|||
125285288|NCT02754141|450672633|FG004|Overall Study|AE unrelated to study drug|3|||
125285289|NCT02754141|450672634|FG005|Overall Study|AE unrelated to study drug|2|||
125285290|NCT02754141|450672635|FG006|Overall Study|AE unrelated to study drug|1|||
125285291|NCT02754141|450672636|FG007|Overall Study|AE unrelated to study drug|0|||
125285292|NCT02754141|450672637|FG008|Overall Study|AE unrelated to study drug|0|||
125285293|NCT02754141|450672638|FG009|Overall Study|AE unrelated to study drug|0|||
125285294|NCT02754141|450672639|FG010|Overall Study|AE unrelated to study drug|0|||
125285295|NCT02754141|450672640|FG011|Overall Study|AE unrelated to study drug|0|||
125285296|NCT02754141|450672641|FG012|Overall Study|AE unrelated to study drug|0|||
125285297|NCT02754141|450672642|FG013|Overall Study|AE unrelated to study drug|0|||
125285298|NCT02754141|450672643|FG014|Overall Study|AE unrelated to study drug|0|||
125285299|NCT02754141|450672644|FG015|Overall Study|AE unrelated to study drug|0|||
125285300|NCT02754141|450672645|FG016|Overall Study|AE unrelated to study drug|0|||
125285301|NCT02754141|450672646|FG017|Overall Study|AE unrelated to study drug|0|||
125285302|NCT02754141|450672629|FG000|Overall Study|Request to discontinue|0|||
125285303|NCT02754141|450672630|FG001|Overall Study|Request to discontinue|0|||
125285304|NCT02754141|450672631|FG002|Overall Study|Request to discontinue|0|||
125285305|NCT02754141|450672632|FG003|Overall Study|Request to discontinue|0|||
125285306|NCT02754141|450672633|FG004|Overall Study|Request to discontinue|0|||
125285307|NCT02754141|450672634|FG005|Overall Study|Request to discontinue|0|||
125285308|NCT02754141|450672635|FG006|Overall Study|Request to discontinue|0|||
125285309|NCT02754141|450672636|FG007|Overall Study|Request to discontinue|0|||
125285310|NCT02754141|450672637|FG008|Overall Study|Request to discontinue|1|||
125285311|NCT02754141|450672638|FG009|Overall Study|Request to discontinue|0|||
125285312|NCT02754141|450672639|FG010|Overall Study|Request to discontinue|0|||
125285313|NCT02754141|450672640|FG011|Overall Study|Request to discontinue|0|||
125285314|NCT02754141|450672641|FG012|Overall Study|Request to discontinue|0|||
125285315|NCT02754141|450672642|FG013|Overall Study|Request to discontinue|1|||
125285316|NCT02754141|450672643|FG014|Overall Study|Request to discontinue|1|||
125285317|NCT02754141|450672644|FG015|Overall Study|Request to discontinue|0|||
125285318|NCT02754141|450672645|FG016|Overall Study|Request to discontinue|0|||
125285319|NCT02754141|450672646|FG017|Overall Study|Request to discontinue|0|||
125285320|NCT02754141|450672629|FG000|Overall Study|Withdrew consent|0|||
125285321|NCT02754141|450672630|FG001|Overall Study|Withdrew consent|0|||
125285322|NCT02754141|450672631|FG002|Overall Study|Withdrew consent|0|||
125285323|NCT02754141|450672632|FG003|Overall Study|Withdrew consent|0|||
125285324|NCT02754141|450672633|FG004|Overall Study|Withdrew consent|0|||
125285325|NCT02754141|450672634|FG005|Overall Study|Withdrew consent|0|||
125285326|NCT02754141|450672635|FG006|Overall Study|Withdrew consent|0|||
125285327|NCT02754141|450672636|FG007|Overall Study|Withdrew consent|0|||
125285328|NCT02754141|450672637|FG008|Overall Study|Withdrew consent|0|||
125285329|NCT02754141|450672638|FG009|Overall Study|Withdrew consent|1|||
125285330|NCT02754141|450672639|FG010|Overall Study|Withdrew consent|0|||
125285331|NCT02754141|450672640|FG011|Overall Study|Withdrew consent|0|||
125285332|NCT02754141|450672641|FG012|Overall Study|Withdrew consent|0|||
125285333|NCT02754141|450672642|FG013|Overall Study|Withdrew consent|0|||
125285334|NCT02754141|450672643|FG014|Overall Study|Withdrew consent|0|||
125285335|NCT02754141|450672644|FG015|Overall Study|Withdrew consent|0|||
125285336|NCT02754141|450672645|FG016|Overall Study|Withdrew consent|0|||
125285337|NCT02754141|450672646|FG017|Overall Study|Withdrew consent|0|||
125285338|NCT02754141|450672629|FG000|Overall Study|Maximum clinical benefit|0|||
125285339|NCT02754141|450672630|FG001|Overall Study|Maximum clinical benefit|0|||
125285340|NCT02754141|450672631|FG002|Overall Study|Maximum clinical benefit|0|||
125285341|NCT02754141|450672632|FG003|Overall Study|Maximum clinical benefit|1|||
125285342|NCT02754141|450672633|FG004|Overall Study|Maximum clinical benefit|0|||
125285343|NCT02754141|450672634|FG005|Overall Study|Maximum clinical benefit|0|||
125285344|NCT02754141|450672635|FG006|Overall Study|Maximum clinical benefit|0|||
125285345|NCT02754141|450672636|FG007|Overall Study|Maximum clinical benefit|0|||
125285346|NCT02754141|450672637|FG008|Overall Study|Maximum clinical benefit|0|||
125285347|NCT02754141|450672638|FG009|Overall Study|Maximum clinical benefit|0|||
124782261|NCT01068600|448832804|FG001|Overall Study|Adverse Event|3|||
125285348|NCT02754141|450672639|FG010|Overall Study|Maximum clinical benefit|0|||
125285349|NCT02754141|450672640|FG011|Overall Study|Maximum clinical benefit|0|||
125285350|NCT02754141|450672641|FG012|Overall Study|Maximum clinical benefit|0|||
124782262|NCT01068600|448832803|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124782263|NCT01068600|448832804|FG001|Overall Study|Abnormal laboratory value(s)|0|||
124782264|NCT01068600|448832803|FG000|Overall Study|Lost to Follow-up|1|||
124782265|NCT01068600|448832804|FG001|Overall Study|Lost to Follow-up|2|||
124782266|NCT01068600|448832803|FG000|Overall Study|Protocol deviation|1|||
124782267|NCT01068600|448832804|FG001|Overall Study|Protocol deviation|1|||
124782268|NCT01068600|448832803|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124782269|NCT01068600|448832804|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
124782270|NCT01068600|448832803|FG000|Overall Study|Administrative problems|0|||
125285351|NCT02754141|450672642|FG013|Overall Study|Maximum clinical benefit|0|||
125285352|NCT02754141|450672643|FG014|Overall Study|Maximum clinical benefit|0|||
124782271|NCT01068600|448832804|FG001|Overall Study|Administrative problems|1|||
125285353|NCT02754141|450672644|FG015|Overall Study|Maximum clinical benefit|0|||
124782272|NCT01727024|448832805|FG000|Period 1|Lost to Follow-up|1|||
125285354|NCT02754141|450672645|FG016|Overall Study|Maximum clinical benefit|0|||
124782273|NCT01727024|448832806|FG001|Period 1|Lost to Follow-up|1|||
125285355|NCT02754141|450672646|FG017|Overall Study|Maximum clinical benefit|0|||
124782274|NCT01727024|448832805|FG000|Period 1|Withdrawal by Subject|2|||
125285356|NCT02754141|450672629|FG000|Overall Study|No longer meets study criteria|0|||
124782275|NCT01727024|448832806|FG001|Period 1|Withdrawal by Subject|3|||
124782276|NCT02167139|448832807|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
125285357|NCT02754141|450672630|FG001|Overall Study|No longer meets study criteria|0|||
125285358|NCT02754141|450672631|FG002|Overall Study|No longer meets study criteria|0|||
125285359|NCT02754141|450672632|FG003|Overall Study|No longer meets study criteria|1|||
125285360|NCT02754141|450672633|FG004|Overall Study|No longer meets study criteria|0|||
125285361|NCT02754141|450672634|FG005|Overall Study|No longer meets study criteria|0|||
125285362|NCT02754141|450672635|FG006|Overall Study|No longer meets study criteria|0|||
125285363|NCT02754141|450672636|FG007|Overall Study|No longer meets study criteria|0|||
125285364|NCT02754141|450672637|FG008|Overall Study|No longer meets study criteria|0|||
125285365|NCT02754141|450672638|FG009|Overall Study|No longer meets study criteria|0|||
125285366|NCT02754141|450672639|FG010|Overall Study|No longer meets study criteria|0|||
125285367|NCT02754141|450672640|FG011|Overall Study|No longer meets study criteria|0|||
125285368|NCT02754141|450672641|FG012|Overall Study|No longer meets study criteria|0|||
125285369|NCT02754141|450672642|FG013|Overall Study|No longer meets study criteria|0|||
125285370|NCT02754141|450672643|FG014|Overall Study|No longer meets study criteria|0|||
125285371|NCT02754141|450672644|FG015|Overall Study|No longer meets study criteria|0|||
125285372|NCT02754141|450672645|FG016|Overall Study|No longer meets study criteria|0|||
125285373|NCT02754141|450672646|FG017|Overall Study|No longer meets study criteria|0|||
125285374|NCT02754141|450672629|FG000|Overall Study|Other reasons|0|||
125285375|NCT02754141|450672630|FG001|Overall Study|Other reasons|0|||
124782277|NCT02167139|448832808|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
125285376|NCT02754141|450672631|FG002|Overall Study|Other reasons|0|||
124782278|NCT02167139|448832809|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
124782279|NCT02167139|448832810|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
124782280|NCT02167139|448832807|FG000|Randomised, Double-blind|Adverse Event|2|||
124782281|NCT02167139|448832808|FG001|Randomised, Double-blind|Adverse Event|9|||
124782282|NCT02167139|448832809|FG002|Randomised, Double-blind|Adverse Event|0|||
124782283|NCT02167139|448832810|FG003|Randomised, Double-blind|Adverse Event|0|||
124782284|NCT02167139|448832807|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
124782285|NCT02167139|448832808|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
124782286|NCT02167139|448832809|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
124782287|NCT02167139|448832810|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
124782288|NCT02167139|448832807|FG000|Randomised, Double-blind|Other|3|||
124782289|NCT02167139|448832808|FG001|Randomised, Double-blind|Other|0|||
124782290|NCT02167139|448832809|FG002|Randomised, Double-blind|Other|0|||
124782291|NCT02167139|448832810|FG003|Randomised, Double-blind|Other|0|||
124782292|NCT02167139|448832807|FG000|Transition-extension|Adverse Event|2|||
124782293|NCT02167139|448832808|FG001|Transition-extension|Adverse Event|0|||
124782294|NCT02167139|448832809|FG002|Transition-extension|Adverse Event|2|||
124782295|NCT02167139|448832810|FG003|Transition-extension|Adverse Event|3|||
124782296|NCT02167139|448832807|FG000|Transition-extension|Withdrawal by Subject|2|||
124782297|NCT02167139|448832808|FG001|Transition-extension|Withdrawal by Subject|0|||
124782298|NCT02167139|448832809|FG002|Transition-extension|Withdrawal by Subject|4|||
124782299|NCT02167139|448832810|FG003|Transition-extension|Withdrawal by Subject|1|||
124782300|NCT02167139|448832807|FG000|Transition-extension|Lack of Efficacy|0|||
124782301|NCT02167139|448832808|FG001|Transition-extension|Lack of Efficacy|0|||
124782302|NCT02167139|448832809|FG002|Transition-extension|Lack of Efficacy|1|||
124782303|NCT02167139|448832810|FG003|Transition-extension|Lack of Efficacy|1|||
124782304|NCT02167139|448832807|FG000|Transition-extension|Other|1|||
124782305|NCT02167139|448832808|FG001|Transition-extension|Other|0|||
124782306|NCT02167139|448832809|FG002|Transition-extension|Other|1|||
124782307|NCT02167139|448832810|FG003|Transition-extension|Other|0|||
124782308|NCT02167139|448832807|FG000|Transition-extension|Lost to Follow-up|1|||
124782309|NCT02167139|448832808|FG001|Transition-extension|Lost to Follow-up|0|||
124782310|NCT02167139|448832809|FG002|Transition-extension|Lost to Follow-up|0|||
124782311|NCT02167139|448832810|FG003|Transition-extension|Lost to Follow-up|0|||
124782312|NCT00329797|448832811|FG000|Overall Study|Protocol Violation|1|||
124782313|NCT00329797|448832812|FG001|Overall Study|Protocol Violation|0|||
124782314|NCT00329797|448832811|FG000|Overall Study|Withdrawal by Subject|6|||
124782315|NCT00329797|448832812|FG001|Overall Study|Withdrawal by Subject|6|||
124782316|NCT00104520|448832813|FG000|Overall Study|Unrelated adverse event|34|||
124782317|NCT00104520|448832814|FG001|Overall Study|Unrelated adverse event|47|||
124782318|NCT00104520|448832813|FG000|Overall Study|Study drug intolerance|0|||
124782319|NCT00104520|448832814|FG001|Overall Study|Study drug intolerance|1|||
124782320|NCT00104520|448832813|FG000|Overall Study|Related adverse event|13|||
124782321|NCT00104520|448832814|FG001|Overall Study|Related adverse event|15|||
124782322|NCT00104520|448832813|FG000|Overall Study|Lost to Follow-up|1|||
124782323|NCT00104520|448832814|FG001|Overall Study|Lost to Follow-up|0|||
124782324|NCT00104520|448832813|FG000|Overall Study|Noncompliance|0|||
124782325|NCT00104520|448832814|FG001|Overall Study|Noncompliance|2|||
124782326|NCT00104520|448832813|FG000|Overall Study|Personal/administrative|1|||
124782327|NCT00104520|448832814|FG001|Overall Study|Personal/administrative|1|||
124782328|NCT00104520|448832813|FG000|Overall Study|Other|1|||
124782329|NCT00104520|448832814|FG001|Overall Study|Other|5|||
125285377|NCT02754141|450672632|FG003|Overall Study|Other reasons|0|||
125285378|NCT02754141|450672633|FG004|Overall Study|Other reasons|0|||
124782330|NCT01026324|448832816|FG000|Follow up/Survival|Withdrawal by Subject|1|||
124782331|NCT01026324|448832817|FG001|Follow up/Survival|Withdrawal by Subject|0|||
124782332|NCT01026324|448832818|FG002|Follow up/Survival|Withdrawal by Subject|0|||
124782333|NCT05188053|448832819|FG000|Overall Study|Lost to Follow-up|23|||
124782334|NCT05188053|448832820|FG001|Overall Study|Lost to Follow-up|30|||
124782335|NCT05188053|448832819|FG000|Overall Study|Protocol Violation|16|||
124782336|NCT05188053|448832820|FG001|Overall Study|Protocol Violation|16|||
124782337|NCT05188053|448832819|FG000|Overall Study|Physician Decision|3|||
124782338|NCT05188053|448832820|FG001|Overall Study|Physician Decision|0|||
124782339|NCT05188053|448832819|FG000|Overall Study|Withdrawal by Subject|0|||
124782340|NCT05188053|448832820|FG001|Overall Study|Withdrawal by Subject|1|||
124782341|NCT02447302|448832824|FG000|Overall Study|Physician Decision|1|||
124782342|NCT02447302|448832825|FG001|Overall Study|Physician Decision|0|||
124782343|NCT02447302|448832826|FG002|Overall Study|Physician Decision|0|||
124782344|NCT02447302|448832824|FG000|Overall Study|Adverse Event|4|||
124782345|NCT02447302|448832825|FG001|Overall Study|Adverse Event|3|||
124782346|NCT02447302|448832826|FG002|Overall Study|Adverse Event|0|||
124782347|NCT02447302|448832824|FG000|Overall Study|Withdrawal by Subject|0|||
124782348|NCT02447302|448832825|FG001|Overall Study|Withdrawal by Subject|1|||
124782349|NCT02447302|448832826|FG002|Overall Study|Withdrawal by Subject|5|||
124782350|NCT02447302|448832824|FG000|Overall Study|Sponsor Decision|0|||
124782351|NCT02447302|448832825|FG001|Overall Study|Sponsor Decision|0|||
124782352|NCT02447302|448832826|FG002|Overall Study|Sponsor Decision|1|||
124782353|NCT01456897|448832831|FG000|Overall Study|Adverse Event|19|||
124782354|NCT01456897|448832832|FG001|Overall Study|Adverse Event|22|||
124782355|NCT01456897|448832831|FG000|Overall Study|Protocol Violation|3|||
124782356|NCT01456897|448832832|FG001|Overall Study|Protocol Violation|4|||
124782357|NCT01456897|448832831|FG000|Overall Study|Physician Decision|5|||
124782358|NCT01456897|448832832|FG001|Overall Study|Physician Decision|3|||
124782359|NCT01456897|448832831|FG000|Overall Study|Withdrawal by Subject|44|||
124782360|NCT01456897|448832832|FG001|Overall Study|Withdrawal by Subject|17|||
124782361|NCT01456897|448832831|FG000|Overall Study|Lack of Efficacy|4|||
124782362|NCT01456897|448832832|FG001|Overall Study|Lack of Efficacy|11|||
124782363|NCT01396070|448832839|FG000|Overall Study|Withdrawal by Subject|2|||
124782364|NCT01396070|448832839|FG000|Overall Study|Death|2|||
124782365|NCT01396070|448832839|FG000|Overall Study|Adverse Event|8|||
124782366|NCT01396070|448832839|FG000|Overall Study|Physician Decision|3|||
124782367|NCT01396070|448832839|FG000|Overall Study|Lack of Efficacy|4|||
124782368|NCT01561313|448832840|FG000|Overall Study|Withdrawal by Subject|1|||
124782369|NCT01561313|448832841|FG001|Overall Study|Withdrawal by Subject|0|||
124782370|NCT01561313|448832840|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
124782371|NCT01561313|448832841|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
124782372|NCT04254913|448832842|FG000|Overall Study|Adverse Event|1|||
124782373|NCT02695420|448832843|FG000|Overall Study|Death|0|||
124782374|NCT02695420|448832844|FG001|Overall Study|Death|1|||
124782375|NCT02695420|448832845|FG002|Overall Study|Death|0|||
124782376|NCT02695420|448832846|FG003|Overall Study|Death|0|||
124782377|NCT04535453|448832847|FG000|Overall Study|Death|0|||
124782378|NCT04535453|448832848|FG001|Overall Study|Death|1|||
124782379|NCT04535453|448832849|FG002|Overall Study|Death|0|||
124782380|NCT04535453|448832850|FG003|Overall Study|Death|0|||
124782381|NCT04535453|448832851|FG004|Overall Study|Death|0|||
124782382|NCT04535453|448832852|FG005|Overall Study|Death|0|||
124782383|NCT04535453|448832853|FG006|Overall Study|Death|0|||
124782384|NCT04535453|448832854|FG007|Overall Study|Death|0|||
124782385|NCT04535453|448832855|FG008|Overall Study|Death|0|||
124782386|NCT04535453|448832856|FG009|Overall Study|Death|0|||
124782387|NCT04535453|448832857|FG010|Overall Study|Death|0|||
124782388|NCT04535453|448832858|FG011|Overall Study|Death|0|||
124782389|NCT04535453|448832847|FG000|Overall Study|Lost to Follow-up|1|||
124782390|NCT04535453|448832848|FG001|Overall Study|Lost to Follow-up|1|||
124782391|NCT04535453|448832849|FG002|Overall Study|Lost to Follow-up|1|||
124782392|NCT04535453|448832850|FG003|Overall Study|Lost to Follow-up|0|||
124782393|NCT04535453|448832851|FG004|Overall Study|Lost to Follow-up|3|||
124782394|NCT04535453|448832852|FG005|Overall Study|Lost to Follow-up|1|||
124782395|NCT04535453|448832853|FG006|Overall Study|Lost to Follow-up|0|||
124782396|NCT04535453|448832854|FG007|Overall Study|Lost to Follow-up|0|||
124782397|NCT04535453|448832855|FG008|Overall Study|Lost to Follow-up|1|||
124782398|NCT04535453|448832856|FG009|Overall Study|Lost to Follow-up|1|||
124782399|NCT04535453|448832857|FG010|Overall Study|Lost to Follow-up|0|||
124782400|NCT04535453|448832858|FG011|Overall Study|Lost to Follow-up|0|||
124782401|NCT04535453|448832847|FG000|Overall Study|Physician Decision|0|||
124782402|NCT04535453|448832848|FG001|Overall Study|Physician Decision|0|||
124782403|NCT04535453|448832849|FG002|Overall Study|Physician Decision|0|||
124782404|NCT04535453|448832850|FG003|Overall Study|Physician Decision|1|||
124782405|NCT04535453|448832851|FG004|Overall Study|Physician Decision|0|||
124782406|NCT04535453|448832852|FG005|Overall Study|Physician Decision|0|||
124782407|NCT04535453|448832853|FG006|Overall Study|Physician Decision|0|||
124782408|NCT04535453|448832854|FG007|Overall Study|Physician Decision|0|||
124782409|NCT04535453|448832855|FG008|Overall Study|Physician Decision|0|||
124782410|NCT04535453|448832856|FG009|Overall Study|Physician Decision|0|||
124782411|NCT04535453|448832857|FG010|Overall Study|Physician Decision|0|||
124782412|NCT04535453|448832858|FG011|Overall Study|Physician Decision|0|||
125285379|NCT02754141|450672634|FG005|Overall Study|Other reasons|0|||
125285380|NCT02754141|450672635|FG006|Overall Study|Other reasons|0|||
125285381|NCT02754141|450672636|FG007|Overall Study|Other reasons|1|||
125285382|NCT02754141|450672637|FG008|Overall Study|Other reasons|0|||
125285383|NCT02754141|450672638|FG009|Overall Study|Other reasons|0|||
125285384|NCT02754141|450672639|FG010|Overall Study|Other reasons|0|||
125285385|NCT02754141|450672640|FG011|Overall Study|Other reasons|0|||
125285386|NCT02754141|450672641|FG012|Overall Study|Other reasons|2|||
125285387|NCT02754141|450672642|FG013|Overall Study|Other reasons|0|||
125285388|NCT02754141|450672643|FG014|Overall Study|Other reasons|0|||
125285389|NCT02754141|450672644|FG015|Overall Study|Other reasons|0|||
125285390|NCT02754141|450672645|FG016|Overall Study|Other reasons|0|||
125285391|NCT02754141|450672646|FG017|Overall Study|Other reasons|0|||
125285392|NCT02754141|450672629|FG000|Overall Study|Completed treatment as per protocol|0|||
125285393|NCT02754141|450672630|FG001|Overall Study|Completed treatment as per protocol|1|||
125285394|NCT02754141|450672631|FG002|Overall Study|Completed treatment as per protocol|0|||
125285395|NCT02754141|450672632|FG003|Overall Study|Completed treatment as per protocol|0|||
125285396|NCT02754141|450672633|FG004|Overall Study|Completed treatment as per protocol|0|||
125285397|NCT02754141|450672634|FG005|Overall Study|Completed treatment as per protocol|0|||
125285398|NCT02754141|450672635|FG006|Overall Study|Completed treatment as per protocol|0|||
125285399|NCT02754141|450672636|FG007|Overall Study|Completed treatment as per protocol|0|||
125285400|NCT02754141|450672637|FG008|Overall Study|Completed treatment as per protocol|0|||
125285401|NCT02754141|450672638|FG009|Overall Study|Completed treatment as per protocol|0|||
125285402|NCT02754141|450672639|FG010|Overall Study|Completed treatment as per protocol|0|||
125285403|NCT02754141|450672640|FG011|Overall Study|Completed treatment as per protocol|0|||
125285404|NCT02754141|450672641|FG012|Overall Study|Completed treatment as per protocol|1|||
125285405|NCT02754141|450672642|FG013|Overall Study|Completed treatment as per protocol|0|||
125285406|NCT02754141|450672643|FG014|Overall Study|Completed treatment as per protocol|0|||
125285407|NCT02754141|450672644|FG015|Overall Study|Completed treatment as per protocol|0|||
125285408|NCT02754141|450672645|FG016|Overall Study|Completed treatment as per protocol|0|||
125285409|NCT02754141|450672646|FG017|Overall Study|Completed treatment as per protocol|0|||
125285410|NCT02754141|450672629|FG000|Overall Study|Not completing monotherapy|0|||
125285411|NCT02754141|450672630|FG001|Overall Study|Not completing monotherapy|0|||
125285412|NCT02754141|450672631|FG002|Overall Study|Not completing monotherapy|0|||
125285413|NCT02754141|450672632|FG003|Overall Study|Not completing monotherapy|0|||
125285414|NCT02754141|450672633|FG004|Overall Study|Not completing monotherapy|0|||
125285415|NCT02754141|450672634|FG005|Overall Study|Not completing monotherapy|0|||
125285416|NCT02754141|450672635|FG006|Overall Study|Not completing monotherapy|0|||
125285417|NCT02754141|450672636|FG007|Overall Study|Not completing monotherapy|0|||
125285418|NCT02754141|450672637|FG008|Overall Study|Not completing monotherapy|0|||
125285419|NCT02754141|450672638|FG009|Overall Study|Not completing monotherapy|0|||
125285420|NCT02754141|450672639|FG010|Overall Study|Not completing monotherapy|0|||
125285421|NCT02754141|450672640|FG011|Overall Study|Not completing monotherapy|0|||
125285422|NCT02754141|450672641|FG012|Overall Study|Not completing monotherapy|0|||
125285423|NCT02754141|450672642|FG013|Overall Study|Not completing monotherapy|1|||
125285424|NCT02754141|450672643|FG014|Overall Study|Not completing monotherapy|0|||
125285425|NCT02754141|450672644|FG015|Overall Study|Not completing monotherapy|0|||
125285426|NCT02754141|450672645|FG016|Overall Study|Not completing monotherapy|0|||
125285427|NCT02754141|450672646|FG017|Overall Study|Not completing monotherapy|0|||
125285428|NCT03361189|450672647|FG000|Overall Study|Received heart transplant|1|||
125285429|NCT03361189|450672648|FG001|Overall Study|Received heart transplant|0|||
125285430|NCT03361189|450672647|FG000|Overall Study|Pacemake replacement|0|||
125285431|NCT03361189|450672648|FG001|Overall Study|Pacemake replacement|1|||
125285432|NCT03344549|450672653|FG000|Overall Study|Withdrawal by Subject|3|||
125285433|NCT03344549|450672654|FG001|Overall Study|Withdrawal by Subject|2|||
125285434|NCT03344549|450672653|FG000|Overall Study|Dialysis|2|||
125285435|NCT03344549|450672654|FG001|Overall Study|Dialysis|0|||
125285436|NCT03344549|450672653|FG000|Overall Study|Cancer|1|||
125285437|NCT03344549|450672654|FG001|Overall Study|Cancer|0|||
125285438|NCT03344549|450672653|FG000|Overall Study|Lack of electronic device|1|||
125285439|NCT03344549|450672654|FG001|Overall Study|Lack of electronic device|0|||
125285440|NCT03344549|450672653|FG000|Overall Study|Transportation difficulty|0|||
125285441|NCT03344549|450672654|FG001|Overall Study|Transportation difficulty|13|||
125285442|NCT02323126|450672655|FG000|Overall Study|Patient / guardian decision|0|||
125285443|NCT02323126|450672656|FG001|Overall Study|Patient / guardian decision|1|||
125285444|NCT02323126|450672657|FG002|Overall Study|Patient / guardian decision|2|||
125285445|NCT02323126|450672655|FG000|Overall Study|Progressive disease|14|||
125285446|NCT02323126|450672656|FG001|Overall Study|Progressive disease|8|||
125285447|NCT02323126|450672657|FG002|Overall Study|Progressive disease|14|||
125285448|NCT02323126|450672655|FG000|Overall Study|Physician Decision|0|||
125285449|NCT02323126|450672656|FG001|Overall Study|Physician Decision|1|||
125285450|NCT02323126|450672657|FG002|Overall Study|Physician Decision|3|||
125285451|NCT02323126|450672655|FG000|Overall Study|Death|1|||
125285452|NCT02323126|450672656|FG001|Overall Study|Death|1|||
125285453|NCT02323126|450672657|FG002|Overall Study|Death|4|||
125285454|NCT02323126|450672655|FG000|Overall Study|Adverse Event|3|||
125285455|NCT02323126|450672656|FG001|Overall Study|Adverse Event|5|||
124782413|NCT04535453|448832847|FG000|Overall Study|Withdrawal by Subject|3|||
124782414|NCT04535453|448832848|FG001|Overall Study|Withdrawal by Subject|6|||
124782415|NCT04535453|448832849|FG002|Overall Study|Withdrawal by Subject|3|||
124782416|NCT04535453|448832850|FG003|Overall Study|Withdrawal by Subject|3|||
124782417|NCT04535453|448832851|FG004|Overall Study|Withdrawal by Subject|2|||
124782418|NCT04535453|448832852|FG005|Overall Study|Withdrawal by Subject|1|||
124782419|NCT04535453|448832853|FG006|Overall Study|Withdrawal by Subject|1|||
124782420|NCT04535453|448832854|FG007|Overall Study|Withdrawal by Subject|1|||
124782421|NCT04535453|448832855|FG008|Overall Study|Withdrawal by Subject|1|||
124782422|NCT04535453|448832856|FG009|Overall Study|Withdrawal by Subject|1|||
124782423|NCT04535453|448832857|FG010|Overall Study|Withdrawal by Subject|0|||
124782424|NCT04535453|448832858|FG011|Overall Study|Withdrawal by Subject|1|||
124782425|NCT04535453|448832847|FG000|Overall Study|Other|0|||
124782426|NCT04535453|448832848|FG001|Overall Study|Other|0|||
124782427|NCT04535453|448832849|FG002|Overall Study|Other|1|||
124782428|NCT04535453|448832850|FG003|Overall Study|Other|0|||
124782429|NCT04535453|448832851|FG004|Overall Study|Other|1|||
124782430|NCT04535453|448832852|FG005|Overall Study|Other|0|||
124782431|NCT04535453|448832853|FG006|Overall Study|Other|1|||
124782432|NCT04535453|448832854|FG007|Overall Study|Other|1|||
124782433|NCT04535453|448832855|FG008|Overall Study|Other|1|||
124782434|NCT04535453|448832856|FG009|Overall Study|Other|0|||
125285456|NCT02323126|450672657|FG002|Overall Study|Adverse Event|7|||
125285457|NCT03333252|450672658|FG000|Overall Study|Adverse Event|10|||
124782435|NCT04535453|448832857|FG010|Overall Study|Other|0|||
124782436|NCT04535453|448832858|FG011|Overall Study|Other|0|||
124782437|NCT00916929|448832859|FG000|Overall Study|Lost to Follow-up|1|||
124782438|NCT00916929|448832860|FG001|Overall Study|Lost to Follow-up|3|||
125285458|NCT03333252|450672659|FG001|Overall Study|Adverse Event|6|||
125285459|NCT03333252|450672660|FG002|Overall Study|Adverse Event|5|||
125285460|NCT03333252|450672661|FG003|Overall Study|Adverse Event|2|||
125285461|NCT03333252|450672658|FG000|Overall Study|Death|1|||
124782439|NCT00916929|448832859|FG000|Overall Study|Death|5|||
124782440|NCT00916929|448832860|FG001|Overall Study|Death|10|||
124782441|NCT00916929|448832859|FG000|Overall Study|Withdrawal by Subject|1|||
125285462|NCT03333252|450672659|FG001|Overall Study|Death|3|||
125285463|NCT03333252|450672660|FG002|Overall Study|Death|0|||
125285464|NCT03333252|450672661|FG003|Overall Study|Death|0|||
125285465|NCT03333252|450672658|FG000|Overall Study|Lack of Efficacy|8|||
125285466|NCT03333252|450672659|FG001|Overall Study|Lack of Efficacy|4|||
125285467|NCT03333252|450672660|FG002|Overall Study|Lack of Efficacy|0|||
125285468|NCT03333252|450672661|FG003|Overall Study|Lack of Efficacy|7|||
125285469|NCT03333252|450672658|FG000|Overall Study|Lost to Follow-up|0|||
125285470|NCT03333252|450672659|FG001|Overall Study|Lost to Follow-up|5|||
125285471|NCT03333252|450672660|FG002|Overall Study|Lost to Follow-up|9|||
125285472|NCT03333252|450672661|FG003|Overall Study|Lost to Follow-up|3|||
125285473|NCT03333252|450672658|FG000|Overall Study|Withdrawal by Subject|14|||
125285474|NCT03333252|450672659|FG001|Overall Study|Withdrawal by Subject|24|||
125285475|NCT03333252|450672660|FG002|Overall Study|Withdrawal by Subject|11|||
125285476|NCT03333252|450672661|FG003|Overall Study|Withdrawal by Subject|17|||
125285477|NCT00666588|450672665|FG000|Overall Study|ineligible|2|||
125285478|NCT00666588|450672666|FG001|Overall Study|ineligible|0|||
125285479|NCT00666588|450672667|FG002|Overall Study|ineligible|0|||
125285480|NCT00666588|450672668|FG003|Overall Study|ineligible|2|||
125285481|NCT00666588|450672665|FG000|Overall Study|inevaluable|2|||
125285482|NCT00666588|450672666|FG001|Overall Study|inevaluable|0|||
125285483|NCT00666588|450672667|FG002|Overall Study|inevaluable|0|||
125285484|NCT00666588|450672668|FG003|Overall Study|inevaluable|0|||
125285485|NCT02075047|450672669|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
125285486|NCT02075047|450672670|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
125285487|NCT02075047|450672669|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
125285488|NCT02075047|450672670|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
125285489|NCT02075047|450672669|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
125285490|NCT02075047|450672670|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
125285491|NCT02075047|450672669|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
125285492|NCT02075047|450672670|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
125285493|NCT02075047|450672669|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
125285494|NCT02075047|450672670|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
125285495|NCT02075047|450672669|FG000|Treatment Phase (4 Weeks)|Other|1|||
125285496|NCT02075047|450672670|FG001|Treatment Phase (4 Weeks)|Other|1|||
125285497|NCT02075047|450672669|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
125285498|NCT02075047|450672670|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
125285499|NCT02075047|450672669|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
125285500|NCT02075047|450672670|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
125285501|NCT02075047|450672669|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
125285502|NCT02075047|450672670|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
125285503|NCT02075047|450672669|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
125285504|NCT02075047|450672670|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
125285505|NCT02075047|450672669|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
125285506|NCT02075047|450672670|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
125285507|NCT02075047|450672669|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
125285508|NCT02075047|450672670|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
125285509|NCT02075047|450672669|FG000|Follow up Phase (5 Weeks)|Other|1|||
125285510|NCT02075047|450672670|FG001|Follow up Phase (5 Weeks)|Other|2|||
125285511|NCT02075047|450672669|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
125285512|NCT02075047|450672670|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
125285513|NCT04195438|450672678|FG000|Overall Study|Withdrawal by Subject|1|||
125285514|NCT03447314|450672684|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
125285515|NCT03447314|450672685|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
125285516|NCT03447314|450672686|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
125285517|NCT03447314|450672687|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
125285518|NCT03447314|450672688|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
125285519|NCT03447314|450672689|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
125285520|NCT03447314|450672690|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
125285521|NCT03447314|450672691|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
125285522|NCT03447314|450672692|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
125285523|NCT03447314|450672693|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
125285524|NCT03447314|450672694|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
125285525|NCT03447314|450672695|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
125285526|NCT03447314|450672696|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
125285527|NCT03447314|450672697|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
125285528|NCT03447314|450672698|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
124782442|NCT00916929|448832860|FG001|Overall Study|Withdrawal by Subject|5|||
124782443|NCT00916929|448832859|FG000|Overall Study|Left ventricular epicardial lead|1|||
125285529|NCT03447314|450672699|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
125285530|NCT03447314|450672700|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
125285531|NCT03447314|450672701|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
125285532|NCT03447314|450672684|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
125285533|NCT03447314|450672685|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285534|NCT03447314|450672686|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
125285535|NCT03447314|450672687|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285536|NCT03447314|450672688|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285537|NCT03447314|450672689|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
125285538|NCT03447314|450672690|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
125285539|NCT03447314|450672691|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285540|NCT03447314|450672692|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285541|NCT03447314|450672693|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285542|NCT03447314|450672694|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285543|NCT03447314|450672695|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285544|NCT03447314|450672696|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285545|NCT03447314|450672697|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285546|NCT03447314|450672698|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285547|NCT03447314|450672699|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285548|NCT03447314|450672700|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285549|NCT03447314|450672701|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285550|NCT03447314|450672684|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285551|NCT03447314|450672685|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285552|NCT03447314|450672686|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
125285553|NCT03447314|450672687|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285554|NCT03447314|450672688|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285555|NCT03447314|450672689|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285556|NCT03447314|450672690|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285557|NCT03447314|450672691|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285558|NCT03447314|450672692|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285559|NCT03447314|450672693|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285560|NCT03447314|450672694|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285561|NCT03447314|450672695|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285562|NCT03447314|450672696|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285563|NCT03447314|450672697|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285564|NCT03447314|450672698|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285565|NCT03447314|450672699|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285566|NCT03447314|450672700|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285567|NCT03447314|450672701|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285568|NCT03447314|450672684|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285569|NCT03447314|450672685|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285570|NCT03447314|450672686|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
125285571|NCT03447314|450672687|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285572|NCT03447314|450672688|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285573|NCT03447314|450672689|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285574|NCT03447314|450672690|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285575|NCT03447314|450672691|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285576|NCT03447314|450672692|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285577|NCT03447314|450672693|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285578|NCT03447314|450672694|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285579|NCT03447314|450672695|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285580|NCT03447314|450672696|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285581|NCT03447314|450672697|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285582|NCT03447314|450672698|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285583|NCT03447314|450672699|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285584|NCT03447314|450672700|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285585|NCT03447314|450672701|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285586|NCT03447314|450672684|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285587|NCT03447314|450672685|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285588|NCT03447314|450672686|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285589|NCT03447314|450672687|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
124782444|NCT00916929|448832860|FG001|Overall Study|Left ventricular epicardial lead|2|||
124782445|NCT00916929|448832859|FG000|Overall Study|Transferred to hospice care|1|||
124782446|NCT00916929|448832860|FG001|Overall Study|Transferred to hospice care|1|||
124782447|NCT00916929|448832859|FG000|Overall Study|System explant|1|||
124782448|NCT00916929|448832860|FG001|Overall Study|System explant|0|||
124782449|NCT00916929|448832859|FG000|Overall Study|Moved to another state|0|||
124782450|NCT00916929|448832860|FG001|Overall Study|Moved to another state|1|||
124782451|NCT00916929|448832859|FG000|Overall Study|Device unable to process impedance data|0|||
124782452|NCT00916929|448832860|FG001|Overall Study|Device unable to process impedance data|7|||
124782453|NCT02929407|448832861|FG000|Overall Study|Adverse Event|1|||
124782454|NCT02442804|448832865|FG000|Overall Study|Withdrawal by Subject|0|||
124782455|NCT02442804|448832866|FG001|Overall Study|Withdrawal by Subject|1|||
124782456|NCT02442804|448832865|FG000|Overall Study|Adverse Event|1|||
124782457|NCT02442804|448832866|FG001|Overall Study|Adverse Event|0|||
124782458|NCT02036853|448832867|FG000|Overall Study|Adverse Event|0|||
124782459|NCT02036853|448832868|FG001|Overall Study|Adverse Event|2|||
124782460|NCT02036853|448832867|FG000|Overall Study|Lack of Efficacy|0|||
124782461|NCT02036853|448832868|FG001|Overall Study|Lack of Efficacy|2|||
124782462|NCT02036853|448832867|FG000|Overall Study|Physician Decision|0|||
124782463|NCT02036853|448832868|FG001|Overall Study|Physician Decision|1|||
124782464|NCT02036853|448832867|FG000|Overall Study|Withdrawal by Subject|0|||
124782465|NCT02036853|448832868|FG001|Overall Study|Withdrawal by Subject|1|||
124782466|NCT01742286|448832869|FG000|Escalation Phase|Administrative problems|1|||
124782467|NCT01742286|448832870|FG001|Escalation Phase|Administrative problems|1|||
124782468|NCT01742286|448832871|FG002|Escalation Phase|Administrative problems|0|||
124782469|NCT01742286|448832872|FG003|Escalation Phase|Administrative problems|0|||
124782470|NCT01742286|448832873|FG004|Escalation Phase|Administrative problems|0|||
124782471|NCT01742286|448832874|FG005|Escalation Phase|Administrative problems|0|||
124782472|NCT01742286|448832875|FG006|Escalation Phase|Administrative problems|2|||
124782473|NCT01742286|448832869|FG000|Escalation Phase|Adverse Event|0|||
124782474|NCT01742286|448832870|FG001|Escalation Phase|Adverse Event|1|||
124782475|NCT01742286|448832871|FG002|Escalation Phase|Adverse Event|2|||
124782476|NCT01742286|448832872|FG003|Escalation Phase|Adverse Event|0|||
124782477|NCT01742286|448832873|FG004|Escalation Phase|Adverse Event|0|||
124782478|NCT01742286|448832874|FG005|Escalation Phase|Adverse Event|1|||
124782479|NCT01742286|448832875|FG006|Escalation Phase|Adverse Event|0|||
124782480|NCT01742286|448832869|FG000|Escalation Phase|Disease progression|3|||
124782481|NCT01742286|448832870|FG001|Escalation Phase|Disease progression|7|||
124782482|NCT01742286|448832871|FG002|Escalation Phase|Disease progression|4|||
124782483|NCT01742286|448832872|FG003|Escalation Phase|Disease progression|1|||
124782484|NCT01742286|448832873|FG004|Escalation Phase|Disease progression|4|||
124782485|NCT01742286|448832874|FG005|Escalation Phase|Disease progression|3|||
124782486|NCT01742286|448832875|FG006|Escalation Phase|Disease progression|2|||
124782487|NCT01742286|448832869|FG000|Escalation Phase|Death|0|||
124782488|NCT01742286|448832870|FG001|Escalation Phase|Death|0|||
124782489|NCT01742286|448832871|FG002|Escalation Phase|Death|0|||
124782490|NCT01742286|448832872|FG003|Escalation Phase|Death|0|||
124782491|NCT01742286|448832873|FG004|Escalation Phase|Death|0|||
124782492|NCT01742286|448832874|FG005|Escalation Phase|Death|1|||
124782493|NCT01742286|448832875|FG006|Escalation Phase|Death|0|||
124782494|NCT01742286|448832869|FG000|Escalation Phase|Physician Decision|0|||
124782495|NCT01742286|448832870|FG001|Escalation Phase|Physician Decision|3|||
124782496|NCT01742286|448832871|FG002|Escalation Phase|Physician Decision|0|||
124782497|NCT01742286|448832872|FG003|Escalation Phase|Physician Decision|1|||
125285590|NCT03447314|450672688|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285591|NCT03447314|450672689|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285592|NCT03447314|450672690|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285593|NCT03447314|450672691|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285594|NCT03447314|450672692|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285595|NCT03447314|450672693|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285596|NCT03447314|450672694|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
125285597|NCT03447314|450672695|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285598|NCT03447314|450672696|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285599|NCT03447314|450672697|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285600|NCT03447314|450672698|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285601|NCT03447314|450672699|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285602|NCT03447314|450672700|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
124782498|NCT01742286|448832873|FG004|Escalation Phase|Physician Decision|0|||
124782499|NCT01742286|448832874|FG005|Escalation Phase|Physician Decision|0|||
124782500|NCT01742286|448832875|FG006|Escalation Phase|Physician Decision|2|||
124782501|NCT01742286|448832869|FG000|Escalation Phase|Subject/guardian decision|1|||
124782502|NCT01742286|448832870|FG001|Escalation Phase|Subject/guardian decision|0|||
125285603|NCT03447314|450672701|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285604|NCT03447314|450672684|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285605|NCT03447314|450672685|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285606|NCT03447314|450672686|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285607|NCT03447314|450672687|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
125285608|NCT03447314|450672688|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285609|NCT03447314|450672689|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
125285610|NCT03447314|450672690|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285611|NCT03447314|450672691|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285612|NCT03447314|450672692|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285613|NCT03447314|450672693|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285614|NCT03447314|450672694|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285615|NCT03447314|450672695|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285616|NCT03447314|450672696|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285617|NCT03447314|450672697|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285618|NCT03447314|450672698|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285619|NCT03447314|450672699|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285620|NCT03447314|450672700|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285621|NCT03447314|450672701|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285622|NCT04600076|450672704|FG000|Overall Study|Lost to Follow-up|3|||
125285623|NCT03006458|450672705|FG000|First Intervention|Unsatisfied Vision|0|||
125285624|NCT03006458|450672706|FG001|First Intervention|Unsatisfied Vision|3|||
125285625|NCT00457821|450672707|FG000|Part 2|Withdrawal by Subject|0|||
125285626|NCT00457821|450672708|FG001|Part 2|Withdrawal by Subject|0|||
125285627|NCT00457821|450672709|FG002|Part 2|Withdrawal by Subject|0|||
125285628|NCT00457821|450672710|FG003|Part 2|Withdrawal by Subject|0|||
125285629|NCT00457821|450672711|FG004|Part 2|Withdrawal by Subject|0|||
125285630|NCT00457821|450672712|FG005|Part 2|Withdrawal by Subject|0|||
125285631|NCT00457821|450672713|FG006|Part 2|Withdrawal by Subject|0|||
125285632|NCT00457821|450672714|FG007|Part 2|Withdrawal by Subject|1|||
125285633|NCT00578877|450672717|FG000|Overall Study|Lost to Follow-up|8|||
125285634|NCT00578877|450672718|FG001|Overall Study|Lost to Follow-up|10|||
125285635|NCT00578877|450672717|FG000|Overall Study|early discontinue|61|||
125285636|NCT00578877|450672718|FG001|Overall Study|early discontinue|101|||
125285637|NCT00578877|450672717|FG000|Overall Study|did not provide follow-up data|12|||
125285638|NCT00578877|450672718|FG001|Overall Study|did not provide follow-up data|17|||
125285639|NCT02437409|450672723|FG000|Overall Study|Withdrawal by Subject|3|||
125285640|NCT02437409|450672723|FG000|Overall Study|Screening failure|12|||
125285641|NCT01632241|450672724|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
125285642|NCT01632241|450672725|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
125285643|NCT01632241|450672724|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
125285644|NCT01632241|450672725|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
125285645|NCT01632241|450672724|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
125285646|NCT01632241|450672725|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
125285647|NCT01632241|450672724|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
125285648|NCT01632241|450672725|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
125285649|NCT01632241|450672724|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
125285650|NCT01632241|450672725|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
125285651|NCT01632241|450672724|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
125285652|NCT01632241|450672725|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
125285653|NCT01632241|450672724|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
125285654|NCT01632241|450672725|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
125285655|NCT01632241|450672724|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
125285656|NCT01632241|450672725|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
125285657|NCT01632241|450672724|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
125285658|NCT01632241|450672725|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
125285659|NCT01632241|450672724|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
125285660|NCT01632241|450672725|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
125285661|NCT01632241|450672724|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
125285662|NCT01632241|450672725|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
125285663|NCT01632241|450672724|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
125285664|NCT01632241|450672725|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
125285665|NCT01632241|450672724|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
125285666|NCT01632241|450672725|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
125285667|NCT01632241|450672724|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
125285668|NCT01632241|450672725|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
125285669|NCT05032690|450672734|FG000|Period 1|Adverse Event|0|||
125285670|NCT05032690|450672735|FG001|Period 1|Adverse Event|1|||
125285671|NCT05032690|450672736|FG002|Period 1|Adverse Event|0|||
124782503|NCT01742286|448832871|FG002|Escalation Phase|Subject/guardian decision|0|||
125285672|NCT05032690|450672737|FG003|Period 1|Adverse Event|0|||
125285673|NCT05032690|450672734|FG000|Period 1|Withdrawal by Subject|1|||
125285674|NCT05032690|450672735|FG001|Period 1|Withdrawal by Subject|0|||
125285675|NCT05032690|450672736|FG002|Period 1|Withdrawal by Subject|0|||
125285676|NCT05032690|450672737|FG003|Period 1|Withdrawal by Subject|0|||
125285677|NCT05032690|450672734|FG000|Period 1|No longer meets eligibility criteria|0|||
125285678|NCT05032690|450672735|FG001|Period 1|No longer meets eligibility criteria|1|||
125285679|NCT05032690|450672736|FG002|Period 1|No longer meets eligibility criteria|0|||
125285680|NCT05032690|450672737|FG003|Period 1|No longer meets eligibility criteria|0|||
125285681|NCT05032690|450672734|FG000|Period 2|Adverse Event|1|||
125285682|NCT05032690|450672735|FG001|Period 2|Adverse Event|0|||
125285683|NCT05032690|450672736|FG002|Period 2|Adverse Event|0|||
125285684|NCT05032690|450672737|FG003|Period 2|Adverse Event|0|||
125285685|NCT05032690|450672734|FG000|Period 2|Withdrawal by Subject|0|||
125285686|NCT05032690|450672735|FG001|Period 2|Withdrawal by Subject|1|||
125285687|NCT05032690|450672736|FG002|Period 2|Withdrawal by Subject|0|||
125285688|NCT05032690|450672737|FG003|Period 2|Withdrawal by Subject|0|||
125285689|NCT05032690|450672734|FG000|Period 2|No longer meets eligibility criteria|0|||
125285690|NCT05032690|450672735|FG001|Period 2|No longer meets eligibility criteria|1|||
125285691|NCT05032690|450672736|FG002|Period 2|No longer meets eligibility criteria|0|||
125285692|NCT05032690|450672737|FG003|Period 2|No longer meets eligibility criteria|0|||
125285693|NCT05032690|450672734|FG000|Period 3|Adverse Event|0|||
125285694|NCT05032690|450672735|FG001|Period 3|Adverse Event|1|||
125285695|NCT05032690|450672736|FG002|Period 3|Adverse Event|0|||
125285696|NCT05032690|450672737|FG003|Period 3|Adverse Event|0|||
125285697|NCT00737568|450672740|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
125285698|NCT00737568|450672741|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
125285699|NCT00737568|450672740|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
125285700|NCT00737568|450672741|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
125285701|NCT00737568|450672740|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
125285702|NCT00737568|450672741|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
125285703|NCT00737568|450672740|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
125285704|NCT00737568|450672741|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
124782504|NCT01742286|448832872|FG003|Escalation Phase|Subject/guardian decision|0|||
125285705|NCT00737568|450672740|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
125285706|NCT00737568|450672741|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
125285707|NCT00737568|450672740|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
125285708|NCT00737568|450672741|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
124782505|NCT01742286|448832873|FG004|Escalation Phase|Subject/guardian decision|0|||
124782506|NCT01742286|448832874|FG005|Escalation Phase|Subject/guardian decision|0|||
124782507|NCT01742286|448832875|FG006|Escalation Phase|Subject/guardian decision|0|||
124782508|NCT01742286|448832869|FG000|Expansion Phase|Administrative problems|0|||
124782509|NCT01742286|448832870|FG001|Expansion Phase|Administrative problems|0|||
124782510|NCT01742286|448832871|FG002|Expansion Phase|Administrative problems|0|||
124782511|NCT01742286|448832872|FG003|Expansion Phase|Administrative problems|0|||
124782512|NCT01742286|448832873|FG004|Expansion Phase|Administrative problems|0|||
124782513|NCT01742286|448832874|FG005|Expansion Phase|Administrative problems|0|||
124782514|NCT01742286|448832875|FG006|Expansion Phase|Administrative problems|5|||
124782515|NCT01742286|448832869|FG000|Expansion Phase|Physician Decision|0|||
124782516|NCT01742286|448832870|FG001|Expansion Phase|Physician Decision|0|||
124782517|NCT01742286|448832871|FG002|Expansion Phase|Physician Decision|4|||
124782518|NCT01742286|448832872|FG003|Expansion Phase|Physician Decision|0|||
124782519|NCT01742286|448832873|FG004|Expansion Phase|Physician Decision|0|||
124782520|NCT01742286|448832874|FG005|Expansion Phase|Physician Decision|0|||
124782521|NCT01742286|448832875|FG006|Expansion Phase|Physician Decision|9|||
124782522|NCT01742286|448832869|FG000|Expansion Phase|Adverse Event|0|||
124782523|NCT01742286|448832870|FG001|Expansion Phase|Adverse Event|0|||
124782524|NCT01742286|448832871|FG002|Expansion Phase|Adverse Event|0|||
124782525|NCT01742286|448832872|FG003|Expansion Phase|Adverse Event|0|||
124782526|NCT01742286|448832873|FG004|Expansion Phase|Adverse Event|0|||
124782527|NCT01742286|448832874|FG005|Expansion Phase|Adverse Event|0|||
124782528|NCT01742286|448832875|FG006|Expansion Phase|Adverse Event|6|||
124782529|NCT01742286|448832869|FG000|Expansion Phase|Disease progression|0|||
124782530|NCT01742286|448832870|FG001|Expansion Phase|Disease progression|0|||
124782531|NCT01742286|448832871|FG002|Expansion Phase|Disease progression|3|||
124782532|NCT01742286|448832872|FG003|Expansion Phase|Disease progression|0|||
124782533|NCT01742286|448832873|FG004|Expansion Phase|Disease progression|0|||
124782534|NCT01742286|448832874|FG005|Expansion Phase|Disease progression|0|||
124782535|NCT01742286|448832875|FG006|Expansion Phase|Disease progression|15|||
124782536|NCT01742286|448832869|FG000|Expansion Phase|Withdrawal by Subject|0|||
124782537|NCT01742286|448832870|FG001|Expansion Phase|Withdrawal by Subject|0|||
124782538|NCT01742286|448832871|FG002|Expansion Phase|Withdrawal by Subject|0|||
124782539|NCT01742286|448832872|FG003|Expansion Phase|Withdrawal by Subject|0|||
124782540|NCT01742286|448832873|FG004|Expansion Phase|Withdrawal by Subject|0|||
124782541|NCT01742286|448832874|FG005|Expansion Phase|Withdrawal by Subject|0|||
124782542|NCT01742286|448832875|FG006|Expansion Phase|Withdrawal by Subject|1|||
124782543|NCT02633020|448832876|FG000|Overall Study|Adverse Event|1|||
124782544|NCT02633020|448832877|FG001|Overall Study|Adverse Event|0|||
124782545|NCT01136785|448832878|FG000|Overall Study|Protocol Violation|2|||
124782546|NCT01136785|448832879|FG001|Overall Study|Protocol Violation|1|||
124782547|NCT02954172|448832882|FG000|Overall Study|Protocol Violation|3|||
124782548|NCT02954172|448832883|FG001|Overall Study|Protocol Violation|0|||
124782549|NCT02954172|448832882|FG000|Overall Study|allergic reaction|2|||
124782550|NCT02954172|448832883|FG001|Overall Study|allergic reaction|1|||
124782551|NCT02954172|448832882|FG000|Overall Study|non-measurable lesions at baseline|1|||
124782552|NCT02954172|448832883|FG001|Overall Study|non-measurable lesions at baseline|2|||
124782553|NCT00853567|448832884|FG000|Overall Study|Study prematurely terminated|71|||
124782554|NCT03818035|448832885|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
124782555|NCT03818035|448832886|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
124782556|NCT03818035|448832887|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
124782557|NCT03818035|448832888|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
124782558|NCT03818035|448832885|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
124782559|NCT03818035|448832886|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
124782560|NCT03818035|448832887|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
125285709|NCT00737568|450672740|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
125285710|NCT00737568|450672741|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
125285711|NCT00737568|450672740|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
125285712|NCT00737568|450672741|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
125285713|NCT00737568|450672740|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
124782561|NCT03818035|448832888|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
124782562|NCT03818035|448832885|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
124782563|NCT03818035|448832886|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
124782564|NCT03818035|448832887|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
124782565|NCT03818035|448832888|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
124782566|NCT03818035|448832885|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
124782567|NCT03818035|448832886|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
124782568|NCT03818035|448832887|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
124782569|NCT03818035|448832888|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
124782570|NCT03818035|448832885|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
125285714|NCT00737568|450672741|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
125285715|NCT00855933|450672742|FG000|Overall Study|Withdrawal by Subject|0|||
125285716|NCT00855933|450672743|FG001|Overall Study|Withdrawal by Subject|1|||
124782571|NCT03818035|448832886|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
124782572|NCT03818035|448832887|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
124782573|NCT03818035|448832888|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
124782574|NCT03818035|448832885|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
124782575|NCT03818035|448832886|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
124782576|NCT03818035|448832887|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
125285717|NCT01960998|450672744|FG000|Overall Study|Lost to Follow-up|3|||
125285718|NCT01960998|450672745|FG001|Overall Study|Lost to Follow-up|7|||
125285719|NCT01960998|450672744|FG000|Overall Study|Death|0|||
125285720|NCT01960998|450672745|FG001|Overall Study|Death|1|||
125285721|NCT01960998|450672744|FG000|Overall Study|Withdrawal by Subject|8|||
125285722|NCT01960998|450672745|FG001|Overall Study|Withdrawal by Subject|2|||
125285723|NCT01960998|450672744|FG000|Overall Study|lost computer access|0|||
125285724|NCT01960998|450672745|FG001|Overall Study|lost computer access|1|||
125285725|NCT00759356|450672746|FG000|Overall Study|Adverse Event|0|||
125285726|NCT00759356|450672747|FG001|Overall Study|Adverse Event|1|||
125285727|NCT00759356|450672746|FG000|Overall Study|Withdrawal by Subject|0|||
125285728|NCT00759356|450672747|FG001|Overall Study|Withdrawal by Subject|2|||
125285729|NCT00759356|450672746|FG000|Overall Study|Subject was unable to return|1|||
125285730|NCT00759356|450672747|FG001|Overall Study|Subject was unable to return|0|||
125285731|NCT01713283|450672748|FG000|Overall Study|Lack of Efficacy|10|||
125285732|NCT01713283|450672749|FG001|Overall Study|Lack of Efficacy|2|||
125285733|NCT01713283|450672748|FG000|Overall Study|Lost to Follow-up|1|||
125285734|NCT01713283|450672749|FG001|Overall Study|Lost to Follow-up|1|||
125285735|NCT02403635|450672750|FG000|Overall Study|Not eligible|9|||
125285736|NCT00835640|450672756|FG000|Second Intervention|Protocol Violation|1|||
125285737|NCT00835640|450672757|FG001|Second Intervention|Protocol Violation|0|||
125285738|NCT01904149|450672758|FG000|Overall Study|Adverse Event|3|||
125285739|NCT01904149|450672759|FG001|Overall Study|Adverse Event|4|||
125285740|NCT01904149|450672760|FG002|Overall Study|Adverse Event|0|||
125285741|NCT01904149|450672761|FG003|Overall Study|Adverse Event|1|||
125285742|NCT01904149|450672762|FG004|Overall Study|Adverse Event|1|||
125285743|NCT01904149|450672763|FG005|Overall Study|Adverse Event|2|||
125285744|NCT01904149|450672758|FG000|Overall Study|Lack of Efficacy|0|||
125285745|NCT01904149|450672759|FG001|Overall Study|Lack of Efficacy|3|||
125285746|NCT01904149|450672760|FG002|Overall Study|Lack of Efficacy|1|||
125285747|NCT01904149|450672761|FG003|Overall Study|Lack of Efficacy|3|||
125285748|NCT01904149|450672762|FG004|Overall Study|Lack of Efficacy|3|||
125285749|NCT01904149|450672763|FG005|Overall Study|Lack of Efficacy|1|||
125285750|NCT01904149|450672758|FG000|Overall Study|Withdrawal by Subject|1|||
125285751|NCT01904149|450672759|FG001|Overall Study|Withdrawal by Subject|3|||
125285752|NCT01904149|450672760|FG002|Overall Study|Withdrawal by Subject|1|||
125285753|NCT01904149|450672761|FG003|Overall Study|Withdrawal by Subject|0|||
125285754|NCT01904149|450672762|FG004|Overall Study|Withdrawal by Subject|1|||
125285755|NCT01904149|450672763|FG005|Overall Study|Withdrawal by Subject|0|||
125285756|NCT01904149|450672758|FG000|Overall Study|Protocol Violation|0|||
125285757|NCT01904149|450672759|FG001|Overall Study|Protocol Violation|1|||
125285758|NCT01904149|450672760|FG002|Overall Study|Protocol Violation|0|||
125285759|NCT01904149|450672761|FG003|Overall Study|Protocol Violation|0|||
125285760|NCT01904149|450672762|FG004|Overall Study|Protocol Violation|0|||
125285761|NCT01904149|450672763|FG005|Overall Study|Protocol Violation|0|||
125285762|NCT01904149|450672758|FG000|Overall Study|non compliance with study drug|1|||
125285763|NCT01904149|450672759|FG001|Overall Study|non compliance with study drug|0|||
125285764|NCT01904149|450672760|FG002|Overall Study|non compliance with study drug|0|||
125285765|NCT01904149|450672761|FG003|Overall Study|non compliance with study drug|0|||
125285766|NCT01904149|450672762|FG004|Overall Study|non compliance with study drug|0|||
125285767|NCT01904149|450672763|FG005|Overall Study|non compliance with study drug|0|||
125285768|NCT00068250|450672764|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
125285769|NCT00068250|450672765|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
125285770|NCT00068250|450672766|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
125285771|NCT00068250|450672767|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
125285772|NCT00812006|450672768|FG000|Overall Study|Lost to Follow-up|0|||
125285773|NCT00812006|450672769|FG001|Overall Study|Lost to Follow-up|0|||
125285774|NCT00812006|450672770|FG002|Overall Study|Lost to Follow-up|2|||
125285775|NCT00812006|450672768|FG000|Overall Study|Physician Decision|0|||
125285776|NCT00812006|450672769|FG001|Overall Study|Physician Decision|0|||
125285777|NCT00812006|450672770|FG002|Overall Study|Physician Decision|1|||
125285778|NCT00812006|450672768|FG000|Overall Study|Withdrawal by Subject|2|||
125285779|NCT00812006|450672769|FG001|Overall Study|Withdrawal by Subject|1|||
125285780|NCT00812006|450672770|FG002|Overall Study|Withdrawal by Subject|1|||
125285781|NCT00812006|450672768|FG000|Overall Study|Lack of Qualifying Event|4|||
125285782|NCT00812006|450672769|FG001|Overall Study|Lack of Qualifying Event|2|||
125285783|NCT00812006|450672770|FG002|Overall Study|Lack of Qualifying Event|2|||
125285784|NCT00235391|450672771|FG000|Overall Study|Adverse Event|4|||
125285785|NCT00235391|450672772|FG001|Overall Study|Adverse Event|5|||
125285786|NCT00235391|450672773|FG002|Overall Study|Adverse Event|10|||
125285787|NCT00235391|450672774|FG003|Overall Study|Adverse Event|72|||
125285788|NCT00235391|450672775|FG004|Overall Study|Adverse Event|5|||
125285789|NCT00235391|450672776|FG005|Overall Study|Adverse Event|2|||
125285790|NCT00235391|450672771|FG000|Overall Study|Abnormal laboratory value(s)|3|||
125285791|NCT00235391|450672772|FG001|Overall Study|Abnormal laboratory value(s)|5|||
125285792|NCT00235391|450672773|FG002|Overall Study|Abnormal laboratory value(s)|4|||
125285793|NCT00235391|450672774|FG003|Overall Study|Abnormal laboratory value(s)|27|||
124782577|NCT03818035|448832888|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
124782578|NCT03818035|448832885|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
124782579|NCT03818035|448832886|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
124782580|NCT03818035|448832887|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
124782581|NCT03818035|448832888|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
124782582|NCT03818035|448832885|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
125285794|NCT00235391|450672775|FG004|Overall Study|Abnormal laboratory value(s)|1|||
125285795|NCT00235391|450672776|FG005|Overall Study|Abnormal laboratory value(s)|2|||
125285796|NCT00235391|450672771|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125285797|NCT00235391|450672772|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125285798|NCT00235391|450672773|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
125285799|NCT00235391|450672774|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
125285800|NCT00235391|450672775|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
125285801|NCT00235391|450672776|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
125285802|NCT00235391|450672771|FG000|Overall Study|Condition no longer requires treatment|3|||
125285803|NCT00235391|450672772|FG001|Overall Study|Condition no longer requires treatment|0|||
125285804|NCT00235391|450672773|FG002|Overall Study|Condition no longer requires treatment|0|||
125285805|NCT00235391|450672774|FG003|Overall Study|Condition no longer requires treatment|11|||
125285806|NCT00235391|450672775|FG004|Overall Study|Condition no longer requires treatment|1|||
125285807|NCT00235391|450672776|FG005|Overall Study|Condition no longer requires treatment|0|||
125285808|NCT00235391|450672771|FG000|Overall Study|Protocol deviation|0|||
124782583|NCT03818035|448832886|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
124782584|NCT03818035|448832887|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
124782585|NCT03818035|448832888|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
124782586|NCT03818035|448832885|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
124782587|NCT03818035|448832886|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
124782588|NCT03818035|448832887|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
124782589|NCT03818035|448832888|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
124782590|NCT03818035|448832885|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
124782591|NCT03818035|448832886|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
124782592|NCT03818035|448832887|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
124782593|NCT03818035|448832888|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
124782594|NCT03818035|448832885|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
124782595|NCT03818035|448832886|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
124782596|NCT03818035|448832887|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
124782597|NCT03818035|448832888|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
124782598|NCT03818035|448832885|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
124782599|NCT03818035|448832886|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
124782600|NCT03818035|448832887|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
124782601|NCT03818035|448832888|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
124782602|NCT03818035|448832885|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
124782603|NCT03818035|448832886|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
124782604|NCT03818035|448832887|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
124782605|NCT03818035|448832888|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
124782606|NCT03818035|448832885|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
124782607|NCT03818035|448832886|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
124782608|NCT03818035|448832887|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
124782609|NCT03818035|448832888|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
124782610|NCT03818035|448832885|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
124782611|NCT03818035|448832886|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
124782612|NCT03818035|448832887|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
124782613|NCT03818035|448832888|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
124782614|NCT03374202|448832891|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
124782615|NCT03374202|448832892|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
124782616|NCT03374202|448832893|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
124782617|NCT03374202|448832891|FG000|Five Year Long Term Follow Up|Death|0|||
124782618|NCT03374202|448832892|FG001|Five Year Long Term Follow Up|Death|1|||
124782619|NCT03374202|448832893|FG002|Five Year Long Term Follow Up|Death|0|||
124782620|NCT01395524|448834236|FG000|Overall Study|Non-compliance with study schedule|1|||
124782621|NCT01395524|448834237|FG001|Overall Study|Non-compliance with study schedule|0|||
124782622|NCT01395524|448834238|FG002|Overall Study|Non-compliance with study schedule|1|||
124782623|NCT01395524|448834236|FG000|Overall Study|Lost to Follow-up|3|||
124782624|NCT01395524|448834237|FG001|Overall Study|Lost to Follow-up|1|||
124782625|NCT01395524|448834238|FG002|Overall Study|Lost to Follow-up|1|||
124782626|NCT01395524|448834236|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
124782627|NCT01395524|448834237|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
124782628|NCT01395524|448834238|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
124782629|NCT01395524|448834236|FG000|Overall Study|Severe noncompliance with protocol|1|||
124782630|NCT01395524|448834237|FG001|Overall Study|Severe noncompliance with protocol|0|||
124782631|NCT01395524|448834238|FG002|Overall Study|Severe noncompliance with protocol|0|||
124782632|NCT01395524|448834236|FG000|Overall Study|Adverse Event|4|||
124782633|NCT01395524|448834237|FG001|Overall Study|Adverse Event|4|||
124782634|NCT01395524|448834238|FG002|Overall Study|Adverse Event|3|||
124782635|NCT01395524|448834236|FG000|Overall Study|Death|1|||
124782636|NCT01395524|448834237|FG001|Overall Study|Death|0|||
124782637|NCT01395524|448834238|FG002|Overall Study|Death|0|||
124782638|NCT01395524|448834236|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
124782639|NCT01395524|448834237|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
124782640|NCT01395524|448834238|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
124782641|NCT01395524|448834236|FG000|Overall Study|Withdrawal by Subject|4|||
124782642|NCT01395524|448834237|FG001|Overall Study|Withdrawal by Subject|8|||
124782643|NCT01395524|448834238|FG002|Overall Study|Withdrawal by Subject|8|||
124782644|NCT01395524|448834236|FG000|Overall Study|Did not receive treatment|1|||
124782645|NCT01395524|448834237|FG001|Overall Study|Did not receive treatment|1|||
124782646|NCT01395524|448834238|FG002|Overall Study|Did not receive treatment|3|||
124782647|NCT01395524|448834236|FG000|Overall Study|Subject had spinal surgery|0|||
124782648|NCT01395524|448834237|FG001|Overall Study|Subject had spinal surgery|0|||
124782649|NCT01395524|448834238|FG002|Overall Study|Subject had spinal surgery|1|||
124782650|NCT01657461|448834239|FG000|Overall Study|Death|9|||
124782651|NCT01657461|448834240|FG001|Overall Study|Death|12|||
124782652|NCT01657461|448834239|FG000|Overall Study|Lost to Follow-up|0|||
124782653|NCT01657461|448834240|FG001|Overall Study|Lost to Follow-up|3|||
124782654|NCT01657461|448834239|FG000|Overall Study|Physician Decision|0|||
124782655|NCT01657461|448834240|FG001|Overall Study|Physician Decision|2|||
124782656|NCT01657461|448834239|FG000|Overall Study|Withdrawal by Subject|1|||
124782657|NCT01657461|448834240|FG001|Overall Study|Withdrawal by Subject|3|||
124782658|NCT00295880|448834249|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
124782659|NCT00295880|448834249|FG000|Overall Study|Unit randomization did not occur|1|||
124782660|NCT00843284|448834250|FG000|Overall Study|Adverse Event|39|||
124782661|NCT00843284|448834250|FG000|Overall Study|Lack of Efficacy|5|||
124782662|NCT00843284|448834250|FG000|Overall Study|Lost to Follow-up|11|||
125285809|NCT00235391|450672772|FG001|Overall Study|Protocol deviation|0|||
125285810|NCT00235391|450672773|FG002|Overall Study|Protocol deviation|1|||
125285811|NCT00235391|450672774|FG003|Overall Study|Protocol deviation|11|||
125285812|NCT00235391|450672775|FG004|Overall Study|Protocol deviation|0|||
125285813|NCT00235391|450672776|FG005|Overall Study|Protocol deviation|0|||
125285814|NCT00235391|450672771|FG000|Overall Study|Withdrawal by Subject|2|||
125285815|NCT00235391|450672772|FG001|Overall Study|Withdrawal by Subject|3|||
125285816|NCT00235391|450672773|FG002|Overall Study|Withdrawal by Subject|3|||
125285817|NCT00235391|450672774|FG003|Overall Study|Withdrawal by Subject|61|||
125285818|NCT00235391|450672775|FG004|Overall Study|Withdrawal by Subject|5|||
125285819|NCT00235391|450672776|FG005|Overall Study|Withdrawal by Subject|0|||
125285820|NCT00235391|450672771|FG000|Overall Study|Lost to Follow-up|0|||
125285821|NCT00235391|450672772|FG001|Overall Study|Lost to Follow-up|3|||
125285822|NCT00235391|450672773|FG002|Overall Study|Lost to Follow-up|3|||
125285823|NCT00235391|450672774|FG003|Overall Study|Lost to Follow-up|16|||
125285824|NCT00235391|450672775|FG004|Overall Study|Lost to Follow-up|0|||
125285825|NCT00235391|450672776|FG005|Overall Study|Lost to Follow-up|0|||
125285826|NCT00235391|450672771|FG000|Overall Study|Administrative problems|0|||
125285827|NCT00235391|450672772|FG001|Overall Study|Administrative problems|0|||
125285828|NCT00235391|450672773|FG002|Overall Study|Administrative problems|0|||
125285829|NCT00235391|450672774|FG003|Overall Study|Administrative problems|1|||
125285830|NCT00235391|450672775|FG004|Overall Study|Administrative problems|0|||
125285831|NCT00235391|450672776|FG005|Overall Study|Administrative problems|0|||
125285832|NCT00235391|450672771|FG000|Overall Study|Death|0|||
125285833|NCT00235391|450672772|FG001|Overall Study|Death|0|||
125285834|NCT00235391|450672773|FG002|Overall Study|Death|1|||
125285835|NCT00235391|450672774|FG003|Overall Study|Death|4|||
125285836|NCT00235391|450672775|FG004|Overall Study|Death|0|||
125285837|NCT00235391|450672776|FG005|Overall Study|Death|0|||
125285838|NCT03349645|450672777|FG000|Overall Study|Sponsor Terminated Study|75|||
125285839|NCT03349645|450672777|FG000|Overall Study|Withdrawal by Subject|4|||
125285840|NCT03349645|450672777|FG000|Overall Study|Protocol Violation|1|||
125285841|NCT03349645|450672777|FG000|Overall Study|Other|2|||
125285842|NCT00580034|450672783|FG000|Overall Study|Toxicity|10|||
125285843|NCT00580034|450672784|FG001|Overall Study|Toxicity|0|||
125285844|NCT00098748|450672787|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
125285845|NCT00098748|450672788|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
125285846|NCT00098748|450672789|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
125285847|NCT00098748|450672787|FG000|Received Study Treatment|Death|2|||
125285848|NCT00098748|450672788|FG001|Received Study Treatment|Death|1|||
125285849|NCT00098748|450672789|FG002|Received Study Treatment|Death|2|||
125285850|NCT00098748|450672787|FG000|Received Study Treatment|Adverse Event|1|||
125285851|NCT00098748|450672788|FG001|Received Study Treatment|Adverse Event|2|||
125285852|NCT00098748|450672789|FG002|Received Study Treatment|Adverse Event|5|||
125285853|NCT00098748|450672787|FG000|Received Study Treatment|Lack of Efficacy|40|||
125285854|NCT00098748|450672788|FG001|Received Study Treatment|Lack of Efficacy|27|||
125285855|NCT00098748|450672789|FG002|Received Study Treatment|Lack of Efficacy|27|||
125285856|NCT00098748|450672787|FG000|Received Study Treatment|Other|2|||
125285857|NCT00098748|450672788|FG001|Received Study Treatment|Other|2|||
125285858|NCT00098748|450672789|FG002|Received Study Treatment|Other|6|||
125285859|NCT00098748|450672787|FG000|Received Study Treatment|Subject defaulted|3|||
125285860|NCT00098748|450672788|FG001|Received Study Treatment|Subject defaulted|4|||
125285861|NCT00098748|450672789|FG002|Received Study Treatment|Subject defaulted|4|||
125285862|NCT00098748|450672787|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
125285863|NCT00098748|450672788|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
125285864|NCT00098748|450672789|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
125285865|NCT00098748|450672787|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
125285866|NCT00098748|450672788|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
125285867|NCT00098748|450672789|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
125285868|NCT00098748|450672787|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
125285869|NCT00098748|450672788|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
125285870|NCT00098748|450672789|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
125285871|NCT00098748|450672787|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
125285872|NCT00098748|450672788|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
125285873|NCT00098748|450672789|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
125285874|NCT00098748|450672787|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
125285875|NCT00098748|450672788|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
125285876|NCT00098748|450672789|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
125285877|NCT02439450|450672793|FG000|Overall Study|Adverse Event|4|||
125285878|NCT02439450|450672794|FG001|Overall Study|Adverse Event|1|||
125285879|NCT02439450|450672795|FG002|Overall Study|Adverse Event|0|||
125285880|NCT02439450|450672796|FG003|Overall Study|Adverse Event|0|||
125285881|NCT02439450|450672793|FG000|Overall Study|Withdrawal by Subject|1|||
125285882|NCT02439450|450672794|FG001|Overall Study|Withdrawal by Subject|2|||
125285883|NCT02439450|450672795|FG002|Overall Study|Withdrawal by Subject|0|||
124782663|NCT00843284|448834250|FG000|Overall Study|Other|10|||
124782664|NCT00843284|448834250|FG000|Overall Study|Withdrawal by Subject|4|||
124782665|NCT00843284|448834250|FG000|Overall Study|Death|3|||
124782666|NCT01761162|448834257|FG000|Overall Study|Withdrawal by Subject|3|||
124782667|NCT02160899|448834266|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
124782668|NCT02160899|448834267|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
124782669|NCT02160899|448834268|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
125285884|NCT02439450|450672796|FG003|Overall Study|Withdrawal by Subject|0|||
125285885|NCT02439450|450672793|FG000|Overall Study|Death|3|||
125285886|NCT02439450|450672794|FG001|Overall Study|Death|0|||
124782670|NCT02160899|448834269|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
125285887|NCT02439450|450672795|FG002|Overall Study|Death|0|||
125285888|NCT02439450|450672796|FG003|Overall Study|Death|1|||
124782671|NCT02160899|448834270|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
124782672|NCT02160899|448834271|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
124782673|NCT00798759|448834272|FG000|Overall Study|Adverse Event|3|||
124782674|NCT00798759|448834273|FG001|Overall Study|Adverse Event|3|||
124782675|NCT00798759|448834272|FG000|Overall Study|Lost to Follow-up|1|||
124782676|NCT00798759|448834273|FG001|Overall Study|Lost to Follow-up|1|||
124782677|NCT00798759|448834272|FG000|Overall Study|Protocol Violation|4|||
124782678|NCT00798759|448834273|FG001|Overall Study|Protocol Violation|8|||
124782679|NCT00798759|448834272|FG000|Overall Study|Other|0|||
124782680|NCT00798759|448834273|FG001|Overall Study|Other|1|||
124782681|NCT01754727|448834274|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
124782682|NCT04518995|448834277|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
124782683|NCT04518995|448834278|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
124782684|NCT04518995|448834279|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
124782685|NCT04518995|448834277|FG000|Overall Study|Lack of Efficacy|2|||
124782686|NCT04518995|448834278|FG001|Overall Study|Lack of Efficacy|1|||
124782687|NCT04518995|448834279|FG002|Overall Study|Lack of Efficacy|0|||
124782688|NCT04518995|448834277|FG000|Overall Study|Non-compliance With Study Drug|0|||
124782689|NCT04518995|448834278|FG001|Overall Study|Non-compliance With Study Drug|3|||
124782690|NCT04518995|448834279|FG002|Overall Study|Non-compliance With Study Drug|2|||
124782691|NCT04518995|448834277|FG000|Overall Study|Pregnancy|0|||
124782692|NCT04518995|448834278|FG001|Overall Study|Pregnancy|0|||
124782693|NCT04518995|448834279|FG002|Overall Study|Pregnancy|1|||
124782694|NCT04518995|448834277|FG000|Overall Study|Protocol Violation|2|||
124782695|NCT04518995|448834278|FG001|Overall Study|Protocol Violation|0|||
124782696|NCT04518995|448834279|FG002|Overall Study|Protocol Violation|1|||
124782697|NCT04518995|448834277|FG000|Overall Study|Reason not Specified|4|||
124782698|NCT04518995|448834278|FG001|Overall Study|Reason not Specified|11|||
124782699|NCT04518995|448834279|FG002|Overall Study|Reason not Specified|2|||
124782700|NCT04518995|448834277|FG000|Overall Study|Lost to Follow-up|1|||
124782701|NCT04518995|448834278|FG001|Overall Study|Lost to Follow-up|10|||
124782702|NCT04518995|448834279|FG002|Overall Study|Lost to Follow-up|6|||
124782703|NCT02891070|448834281|FG000|Overall Study|Adverse Event|1|||
124782704|NCT02891070|448834282|FG001|Overall Study|Adverse Event|0|||
124782705|NCT02891070|448834281|FG000|Overall Study|Physician Decision|0|||
124782706|NCT02891070|448834282|FG001|Overall Study|Physician Decision|1|||
124782707|NCT02891070|448834281|FG000|Overall Study|Lost to Follow-up|4|||
124782708|NCT02891070|448834282|FG001|Overall Study|Lost to Follow-up|4|||
124782709|NCT02891070|448834281|FG000|Overall Study|Other|1|||
124782710|NCT02891070|448834282|FG001|Overall Study|Other|0|||
124782711|NCT02891070|448834281|FG000|Overall Study|Protocol Violation|0|||
124782712|NCT02891070|448834282|FG001|Overall Study|Protocol Violation|1|||
124782713|NCT02891070|448834281|FG000|Overall Study|Withdrawal by Subject|1|||
124782714|NCT02891070|448834282|FG001|Overall Study|Withdrawal by Subject|2|||
124782715|NCT02891070|448834281|FG000|Overall Study|Death|3|||
124782716|NCT02891070|448834282|FG001|Overall Study|Death|0|||
124782717|NCT04491604|448834283|FG000|Overall Study|Withdrawal by Subject|3|||
124782718|NCT02934503|448834284|FG000|Overall Study|progression of disease|3|||
124782719|NCT02934503|448834284|FG000|Overall Study|Withdrawal by Subject|1|||
124782720|NCT04248491|448834285|FG000|Overall Study|Lost to Follow-up|1|||
124782721|NCT04248491|448834286|FG001|Overall Study|Lost to Follow-up|0|||
124782722|NCT02597478|448834287|FG000|Overall Study|Withdrawal by Subject|2|||
124782723|NCT02597478|448834288|FG001|Overall Study|Withdrawal by Subject|0|||
124782724|NCT02597478|448834287|FG000|Overall Study|Change of opioid dose|1|||
124782725|NCT02597478|448834288|FG001|Overall Study|Change of opioid dose|0|||
124782726|NCT02597478|448834287|FG000|Overall Study|Insufficient exertional dyspnea|0|||
124782727|NCT02597478|448834288|FG001|Overall Study|Insufficient exertional dyspnea|1|||
124782728|NCT01536067|448834289|FG000|Overall Study|Disease Progression|1|||
125285889|NCT02439450|450672793|FG000|Overall Study|Progressive Disease|18|||
125285890|NCT02439450|450672794|FG001|Overall Study|Progressive Disease|41|||
124782729|NCT01652469|448834290|FG000|Overall Study|Withdrawal by Subject|1|||
124782730|NCT01652469|448834291|FG001|Overall Study|Withdrawal by Subject|4|||
124782731|NCT01652469|448834290|FG000|Overall Study|Lost to Follow-up|0|||
124782732|NCT01652469|448834291|FG001|Overall Study|Lost to Follow-up|2|||
124782733|NCT01402102|448834292|FG000|Overall Study|Protocol Violation|1|||
124782734|NCT01402102|448834293|FG001|Overall Study|Protocol Violation|0|||
124782735|NCT01402102|448834292|FG000|Overall Study|Insufficiency of compliance|1|||
124782736|NCT01402102|448834293|FG001|Overall Study|Insufficiency of compliance|1|||
124782737|NCT01402102|448834292|FG000|Overall Study|Withdrawal by Subject|0|||
124782738|NCT01402102|448834293|FG001|Overall Study|Withdrawal by Subject|2|||
124782739|NCT00905645|448834295|FG000|Overall Study|Death (not device related)|10|||
124782740|NCT00905645|448834296|FG001|Overall Study|Death (not device related)|4|||
124782741|NCT00905645|448834297|FG002|Overall Study|Death (not device related)|15|||
124782742|NCT00905645|448834298|FG003|Overall Study|Death (not device related)|8|||
124782743|NCT00905645|448834295|FG000|Overall Study|Explantation of study device(s)|78|||
124782744|NCT00905645|448834296|FG001|Overall Study|Explantation of study device(s)|47|||
124782745|NCT00905645|448834297|FG002|Overall Study|Explantation of study device(s)|28|||
125285891|NCT02439450|450672795|FG002|Overall Study|Progressive Disease|2|||
125285892|NCT02439450|450672796|FG003|Overall Study|Progressive Disease|3|||
125285893|NCT01081301|450672799|FG000|Overall Study|Bereaved|3|||
125285894|NCT01081301|450672799|FG000|Overall Study|Too busy|5|||
125285895|NCT01081301|450672799|FG000|Overall Study|Patient too ill|2|||
125285896|NCT01081301|450672799|FG000|Overall Study|Lost to Follow-up|4|||
125285897|NCT03551665|450672802|FG000|Overall Study|Lost to Follow-up|11|||
125285898|NCT03551665|450672803|FG001|Overall Study|Lost to Follow-up|2|||
125285899|NCT00428220|450674397|FG000|Overall Study|Participant died|8|||
125285900|NCT00428220|450674397|FG000|Overall Study|Global deterioration of health status|7|||
125285901|NCT00428220|450674397|FG000|Overall Study|Lost to Follow-up|4|||
125285902|NCT00428220|450674397|FG000|Overall Study|Objective progression or relapse|123|||
125285903|NCT00428220|450674397|FG000|Overall Study|Participant refused continued treatment|7|||
125285904|NCT00428220|450674397|FG000|Overall Study|Adverse Event|51|||
125285905|NCT00428220|450674397|FG000|Overall Study|Other|23|||
125285906|NCT03283098|450674402|FG000|Overall Study|Withdrawal by Subject|0|||
125285907|NCT03283098|450674403|FG001|Overall Study|Withdrawal by Subject|1|||
125285908|NCT03356977|450674406|FG000|Overall Study|Lost to Follow-up|3|||
125285909|NCT03356977|450674406|FG000|Overall Study|Withdrawal by parent/guardian|2|||
125285910|NCT00445939|450674410|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
125285911|NCT00445939|450674411|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
125285912|NCT00445939|450674412|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
125285913|NCT00445939|450674413|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
125285914|NCT00445939|450674410|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
125285915|NCT00445939|450674411|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
125285916|NCT00445939|450674412|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
125285917|NCT00445939|450674413|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
125285918|NCT00798317|450674415|FG000|Overall Study|Physician Decision|0|||
125285919|NCT00798317|450674416|FG001|Overall Study|Physician Decision|1|||
125285920|NCT00798317|450674415|FG000|Overall Study|Withdrawal by Subject|5|||
125285921|NCT00798317|450674416|FG001|Overall Study|Withdrawal by Subject|4|||
125285922|NCT00798317|450674415|FG000|Overall Study|Lost to Follow-up|2|||
125285923|NCT00798317|450674416|FG001|Overall Study|Lost to Follow-up|2|||
125285924|NCT00798317|450674415|FG000|Overall Study|Adverse Event|2|||
125285925|NCT00798317|450674416|FG001|Overall Study|Adverse Event|0|||
125285926|NCT00798317|450674415|FG000|Overall Study|Death|1|||
125285927|NCT00798317|450674416|FG001|Overall Study|Death|0|||
125285928|NCT00378599|450674420|FG000|Overall Study|Adverse Event|38|||
125285929|NCT00378599|450674420|FG000|Overall Study|Protocol Violation|2|||
125285930|NCT00378599|450674420|FG000|Overall Study|Treatment failure|7|||
125285931|NCT00378599|450674420|FG000|Overall Study|Withdrawal by Subject|5|||
125285932|NCT00416715|450674421|FG000|Overall Study|Not evaluable for joint aches|7|||
125285933|NCT00416715|450674421|FG000|Overall Study|Vitamin D levels not evaluable|8|||
125285934|NCT03812185|450674425|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
125285935|NCT02576535|450674440|FG000|Overall Study|Withdrawal by Subject|2|||
125285936|NCT02545517|450674441|FG000|Overall Study|Death|2|||
125285937|NCT02545517|450674442|FG001|Overall Study|Death|2|||
125285938|NCT02545517|450674443|FG002|Overall Study|Death|1|||
125285939|NCT02545517|450674441|FG000|Overall Study|Lost to Follow-up|14|||
125285940|NCT02545517|450674442|FG001|Overall Study|Lost to Follow-up|13|||
125285941|NCT02545517|450674443|FG002|Overall Study|Lost to Follow-up|17|||
125285942|NCT02545517|450674441|FG000|Overall Study|Protocol Violation|0|||
125285943|NCT02545517|450674442|FG001|Overall Study|Protocol Violation|1|||
125285944|NCT02545517|450674443|FG002|Overall Study|Protocol Violation|1|||
125285945|NCT02545517|450674441|FG000|Overall Study|Withdrawal by Subject|5|||
125285946|NCT02545517|450674442|FG001|Overall Study|Withdrawal by Subject|8|||
125285947|NCT02545517|450674443|FG002|Overall Study|Withdrawal by Subject|9|||
125285948|NCT02545517|450674441|FG000|Overall Study|Administrative reason|5|||
125285949|NCT02545517|450674442|FG001|Overall Study|Administrative reason|6|||
125285950|NCT02545517|450674443|FG002|Overall Study|Administrative reason|10|||
125285951|NCT02545517|450674441|FG000|Overall Study|Other|2|||
125285952|NCT02545517|450674442|FG001|Overall Study|Other|4|||
125285953|NCT02545517|450674443|FG002|Overall Study|Other|3|||
125285954|NCT01529515|450674446|FG000|TRANSITION PHASE|Adverse Event|16|||
125285955|NCT01529515|450674447|FG001|TRANSITION PHASE|Adverse Event|0|||
125285956|NCT01529515|450674448|FG002|TRANSITION PHASE|Adverse Event|0|||
125285957|NCT01529515|450674449|FG003|TRANSITION PHASE|Adverse Event|0|||
125285958|NCT01529515|450674446|FG000|TRANSITION PHASE|Death|1|||
125285959|NCT01529515|450674447|FG001|TRANSITION PHASE|Death|0|||
125285960|NCT01529515|450674448|FG002|TRANSITION PHASE|Death|0|||
125285961|NCT01529515|450674449|FG003|TRANSITION PHASE|Death|0|||
125285962|NCT01529515|450674446|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
125285963|NCT01529515|450674447|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
125285964|NCT01529515|450674448|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
125285965|NCT01529515|450674449|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
125285966|NCT01529515|450674446|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
125285967|NCT01529515|450674447|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
124782746|NCT00905645|448834298|FG003|Overall Study|Explantation of study device(s)|21|||
124782747|NCT00905645|448834295|FG000|Overall Study|Subject Request|41|||
124782748|NCT00905645|448834296|FG001|Overall Study|Subject Request|17|||
124782749|NCT00905645|448834297|FG002|Overall Study|Subject Request|13|||
124782750|NCT00905645|448834298|FG003|Overall Study|Subject Request|11|||
124782751|NCT00905645|448834295|FG000|Overall Study|Lost to Follow-up|299|||
124782752|NCT00905645|448834296|FG001|Overall Study|Lost to Follow-up|103|||
124782753|NCT00905645|448834297|FG002|Overall Study|Lost to Follow-up|51|||
124782754|NCT00905645|448834298|FG003|Overall Study|Lost to Follow-up|12|||
124782755|NCT01731938|448834299|FG000|Preliminary Part I|Withdrawal by Subject|2|||
124782756|NCT01731938|448834300|FG001|Preliminary Part I|Withdrawal by Subject|2|||
124782757|NCT01731938|448834299|FG000|Preliminary Part I|Physician Decision|1|||
124782758|NCT01731938|448834300|FG001|Preliminary Part I|Physician Decision|0|||
124782759|NCT01731938|448834299|FG000|Preliminary Part I|Lost to Follow-up|0|||
124782760|NCT01731938|448834300|FG001|Preliminary Part I|Lost to Follow-up|3|||
124782761|NCT01731938|448834299|FG000|Preliminary Part I|Missed Week 6 visit|0|||
124782762|NCT01731938|448834300|FG001|Preliminary Part I|Missed Week 6 visit|3|||
124782763|NCT01731938|448834299|FG000|Primary Part II|Withdrawal by Subject|5|||
124782764|NCT01731938|448834300|FG001|Primary Part II|Withdrawal by Subject|4|||
124782765|NCT01731938|448834299|FG000|Primary Part II|Lost to Follow-up|4|||
124782766|NCT01731938|448834300|FG001|Primary Part II|Lost to Follow-up|5|||
124782767|NCT01731938|448834299|FG000|Primary Part II|Death|2|||
124782768|NCT01731938|448834300|FG001|Primary Part II|Death|1|||
124782769|NCT01731938|448834299|FG000|Primary Part II|Missed Week 6 visit|2|||
124782770|NCT01731938|448834300|FG001|Primary Part II|Missed Week 6 visit|3|||
124782771|NCT04931888|448834301|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
124782772|NCT04931888|448834302|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
124782773|NCT04931888|448834303|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
124782774|NCT04931888|448834304|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
124782775|NCT04538144|448834305|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
124782776|NCT04538144|448834306|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
124782777|NCT04538144|448834307|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
124782778|NCT04538144|448834308|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
124782779|NCT02350478|448834309|FG000|Overall Study|Lost to Follow-up|5|||
124782780|NCT02350478|448834310|FG001|Overall Study|Lost to Follow-up|1|||
124782781|NCT00771953|448834311|FG000|Overall Study|Adverse Event|5|||
124782782|NCT00771953|448834312|FG001|Overall Study|Adverse Event|3|||
124782783|NCT00771953|448834311|FG000|Overall Study|Death|2|||
124782784|NCT00771953|448834312|FG001|Overall Study|Death|2|||
124782785|NCT00771953|448834311|FG000|Overall Study|Progression before active Tx|1|||
124782786|NCT00771953|448834312|FG001|Overall Study|Progression before active Tx|2|||
124782787|NCT00771953|448834311|FG000|Overall Study|Sponsor decision|1|||
124782788|NCT00771953|448834312|FG001|Overall Study|Sponsor decision|0|||
124782789|NCT00771953|448834311|FG000|Overall Study|Other complicating disease|1|||
124782790|NCT00771953|448834312|FG001|Overall Study|Other complicating disease|0|||
124782791|NCT00771953|448834311|FG000|Overall Study|Withdrawal by Subject|0|||
124782792|NCT00771953|448834312|FG001|Overall Study|Withdrawal by Subject|3|||
124782793|NCT02722304|448834317|FG000|Overall Study|Study Terminated by Sponsor|1|||
124782794|NCT02722304|448834318|FG001|Overall Study|Study Terminated by Sponsor|0|||
124782795|NCT02722304|448834319|FG002|Overall Study|Study Terminated by Sponsor|2|||
124782796|NCT02722304|448834320|FG003|Overall Study|Study Terminated by Sponsor|1|||
124782797|NCT02722304|448834321|FG004|Overall Study|Study Terminated by Sponsor|1|||
124782798|NCT02722304|448834317|FG000|Overall Study|Other|0|||
124782799|NCT02722304|448834318|FG001|Overall Study|Other|0|||
124782800|NCT02722304|448834319|FG002|Overall Study|Other|0|||
124782801|NCT02722304|448834320|FG003|Overall Study|Other|1|||
124782802|NCT02722304|448834321|FG004|Overall Study|Other|1|||
124782803|NCT02644109|448834322|FG000|Overall Study|Adverse Event|0|||
124782804|NCT02644109|448834323|FG001|Overall Study|Adverse Event|4|||
124782805|NCT01519869|448834326|FG000|Overall Study|Lost to Follow-up|1|||
124782806|NCT03023813|448834327|FG000|Overall Study|Lost to Follow-up|1|||
124782807|NCT03023813|448834328|FG001|Overall Study|Lost to Follow-up|2|||
124782808|NCT03023813|448834329|FG002|Overall Study|Lost to Follow-up|0|||
124782809|NCT02433080|448834331|FG000|Overall Study|Lost to Follow-up|1|||
124782810|NCT02433080|448834332|FG001|Overall Study|Lost to Follow-up|2|||
124782811|NCT02433080|448834331|FG000|Overall Study|Withdrawal by Subject|0|||
124782812|NCT02433080|448834332|FG001|Overall Study|Withdrawal by Subject|2|||
124782813|NCT04530136|448834333|FG000|Overall Study|Lost to Follow-up|2|||
124782814|NCT04530136|448834334|FG001|Overall Study|Lost to Follow-up|3|||
124782815|NCT04530136|448834333|FG000|Overall Study|Withdrawal by Subject|1|||
124782816|NCT04530136|448834334|FG001|Overall Study|Withdrawal by Subject|0|||
124782817|NCT04530136|448834333|FG000|Overall Study|Death|0|||
124782818|NCT04530136|448834334|FG001|Overall Study|Death|1|||
124782819|NCT01309282|448834335|FG000|Overall Study|Lost to Follow-up|1|||
124782820|NCT01387542|448834336|FG000|Overall Study|Adverse Event|3|||
124782821|NCT01387542|448834336|FG000|Overall Study|Withdrawal by Subject|1|||
124782822|NCT01387542|448834336|FG000|Overall Study|Changed diagnosis|1|||
124782823|NCT01387542|448834336|FG000|Overall Study|Insufficient response|1|||
124782824|NCT01387542|448834336|FG000|Overall Study|Non-compliant|1|||
124782825|NCT01387542|448834336|FG000|Overall Study|Lost to Follow-up|1|||
124782826|NCT01010867|448834339|FG000|Overall Study|< 50% adherence to probiotic|1|||
124782827|NCT00884741|448834340|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
124782828|NCT00884741|448834341|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
124782829|NCT00884741|448834342|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
124782830|NCT00884741|448834343|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
124782831|NCT00884741|448834340|FG000|Step 1 Registration: Tissue Screening|Death|3|||
124782832|NCT00884741|448834341|FG001|Step 1 Registration: Tissue Screening|Death|0|||
124782833|NCT00884741|448834342|FG002|Step 1 Registration: Tissue Screening|Death|0|||
124782834|NCT00884741|448834343|FG003|Step 1 Registration: Tissue Screening|Death|0|||
124782835|NCT00884741|448834340|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
124782836|NCT00884741|448834341|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
124782837|NCT00884741|448834342|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
124782838|NCT00884741|448834343|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
124782839|NCT00884741|448834340|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
125285968|NCT01529515|450674448|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
125285969|NCT01529515|450674449|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
124782840|NCT00884741|448834341|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
124782841|NCT00884741|448834342|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
124782842|NCT00884741|448834343|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
124782843|NCT00884741|448834340|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
124782844|NCT00884741|448834341|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
124782845|NCT00884741|448834342|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
124782846|NCT00884741|448834343|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
124782847|NCT00884741|448834340|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
124782848|NCT00884741|448834341|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
124782849|NCT00884741|448834342|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
124782850|NCT00884741|448834343|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
124782851|NCT00884741|448834340|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
124782852|NCT00884741|448834341|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
124782853|NCT00884741|448834342|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
124782854|NCT00884741|448834343|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
124782855|NCT00884741|448834340|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
124782856|NCT00884741|448834341|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
124782857|NCT00884741|448834342|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
124782858|NCT00884741|448834343|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
124782859|NCT00884741|448834340|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
124782860|NCT00884741|448834341|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
124782861|NCT00884741|448834342|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
124782862|NCT00884741|448834343|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
124782863|NCT00884741|448834340|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
124782864|NCT00884741|448834341|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
124782865|NCT00884741|448834342|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
124782866|NCT00884741|448834343|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
124782867|NCT00884741|448834340|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
124782868|NCT00884741|448834341|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
124782869|NCT00884741|448834342|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
124782870|NCT00884741|448834343|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
124782871|NCT00884741|448834340|FG000|Randomization|Protocol Violation|0|||
124782872|NCT00884741|448834341|FG001|Randomization|Protocol Violation|0|||
124782873|NCT00884741|448834342|FG002|Randomization|Protocol Violation|8|||
124782874|NCT00884741|448834343|FG003|Randomization|Protocol Violation|8|||
124782875|NCT01233232|448834344|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
124782876|NCT01233232|448834345|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
124782877|NCT01233232|448834346|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
124782878|NCT02762370|448834347|FG000|Overall Study|Protocol Violation|1|||
124782879|NCT02762370|448834348|FG001|Overall Study|Protocol Violation|0|||
124782880|NCT00101452|448834353|FG000|Overall Study|Adverse Event|2|||
124782881|NCT00101452|448834354|FG001|Overall Study|Adverse Event|0|||
124782882|NCT00101452|448834355|FG002|Overall Study|Adverse Event|1|||
124782883|NCT00101452|448834353|FG000|Overall Study|Lost to Follow-up|13|||
124782884|NCT00101452|448834354|FG001|Overall Study|Lost to Follow-up|8|||
124782885|NCT00101452|448834355|FG002|Overall Study|Lost to Follow-up|14|||
124782886|NCT00101452|448834353|FG000|Overall Study|Withdrawal by Subject|10|||
124782887|NCT00101452|448834354|FG001|Overall Study|Withdrawal by Subject|14|||
124782888|NCT00101452|448834355|FG002|Overall Study|Withdrawal by Subject|9|||
124782889|NCT00101452|448834353|FG000|Overall Study|Baseline Fail|2|||
124782890|NCT00101452|448834354|FG001|Overall Study|Baseline Fail|1|||
124782891|NCT00101452|448834355|FG002|Overall Study|Baseline Fail|2|||
124782892|NCT00101452|448834353|FG000|Overall Study|Physician Decision|0|||
125285970|NCT01529515|450674446|FG000|TRANSITION PHASE|Protocol Violation|4|||
125285971|NCT01529515|450674447|FG001|TRANSITION PHASE|Protocol Violation|0|||
125285972|NCT01529515|450674448|FG002|TRANSITION PHASE|Protocol Violation|0|||
125285973|NCT01529515|450674449|FG003|TRANSITION PHASE|Protocol Violation|0|||
125285974|NCT01529515|450674446|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
125285975|NCT01529515|450674447|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
125285976|NCT01529515|450674448|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
125285977|NCT01529515|450674449|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
125285978|NCT01529515|450674446|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
125285979|NCT01529515|450674447|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
125285980|NCT01529515|450674448|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
125285981|NCT01529515|450674449|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
125285982|NCT01529515|450674446|FG000|TRANSITION PHASE|Other|9|||
125285983|NCT01529515|450674447|FG001|TRANSITION PHASE|Other|0|||
125285984|NCT01529515|450674448|FG002|TRANSITION PHASE|Other|0|||
125285985|NCT01529515|450674449|FG003|TRANSITION PHASE|Other|0|||
125285986|NCT01529515|450674446|FG000|MAINTENANCE PHASE|Adverse Event|0|||
125285987|NCT01529515|450674447|FG001|MAINTENANCE PHASE|Adverse Event|10|||
125285988|NCT01529515|450674448|FG002|MAINTENANCE PHASE|Adverse Event|0|||
125285989|NCT01529515|450674449|FG003|MAINTENANCE PHASE|Adverse Event|0|||
125285990|NCT01529515|450674446|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
125285991|NCT01529515|450674447|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
125285992|NCT01529515|450674448|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
125285993|NCT01529515|450674449|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
125285994|NCT01529515|450674446|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
125285995|NCT01529515|450674447|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
125285996|NCT01529515|450674448|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
125285997|NCT01529515|450674449|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
125285998|NCT01529515|450674446|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
125285999|NCT01529515|450674447|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
125286000|NCT01529515|450674448|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
125286001|NCT01529515|450674449|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
125286002|NCT01529515|450674446|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
125286003|NCT01529515|450674447|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
125286004|NCT01529515|450674448|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
125286005|NCT01529515|450674449|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
125286006|NCT01529515|450674446|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
125286007|NCT01529515|450674447|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
125286008|NCT01529515|450674448|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
125286009|NCT01529515|450674449|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
125286010|NCT01529515|450674446|FG000|MAINTENANCE PHASE|Other|0|||
125286011|NCT01529515|450674447|FG001|MAINTENANCE PHASE|Other|10|||
125286012|NCT01529515|450674448|FG002|MAINTENANCE PHASE|Other|0|||
125286013|NCT01529515|450674449|FG003|MAINTENANCE PHASE|Other|0|||
125286014|NCT01529515|450674446|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
125286015|NCT01529515|450674447|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
125286016|NCT01529515|450674448|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
125286017|NCT01529515|450674449|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
125286018|NCT01529515|450674446|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
125286019|NCT01529515|450674447|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
125286020|NCT01529515|450674448|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
125286021|NCT01529515|450674449|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
125286022|NCT01529515|450674446|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
125286023|NCT01529515|450674447|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
125286024|NCT01529515|450674448|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
125286025|NCT01529515|450674449|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
125286026|NCT01529515|450674446|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
125286027|NCT01529515|450674447|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
125286028|NCT01529515|450674448|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
125286029|NCT01529515|450674449|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
125286030|NCT01529515|450674446|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
125286031|NCT01529515|450674447|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
125286032|NCT01529515|450674448|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
125286033|NCT01529515|450674449|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
125286034|NCT01529515|450674446|FG000|DOUBLE BLIND PHASE|Other|0|||
125286035|NCT01529515|450674447|FG001|DOUBLE BLIND PHASE|Other|0|||
125286036|NCT01529515|450674448|FG002|DOUBLE BLIND PHASE|Other|9|||
125286037|NCT01529515|450674449|FG003|DOUBLE BLIND PHASE|Other|2|||
125286038|NCT03920293|450674451|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
125286039|NCT03920293|450674452|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
125286040|NCT03920293|450674451|FG000|Randomized-Controlled Period|Physician Decision|1|||
125286041|NCT03920293|450674452|FG001|Randomized-Controlled Period|Physician Decision|2|||
125286042|NCT03920293|450674451|FG000|Randomized-Controlled Period|Adverse Event|0|||
125286043|NCT03920293|450674452|FG001|Randomized-Controlled Period|Adverse Event|2|||
125286044|NCT03920293|450674451|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
125286045|NCT03920293|450674452|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
125286046|NCT03920293|450674451|FG000|Randomized-Controlled Period|Death|2|||
125286047|NCT03920293|450674452|FG001|Randomized-Controlled Period|Death|0|||
125286048|NCT03920293|450674451|FG000|Randomized-Controlled Period|Protocol Violation|1|||
125286049|NCT03920293|450674452|FG001|Randomized-Controlled Period|Protocol Violation|0|||
125286050|NCT03920293|450674451|FG000|Randomized-Controlled Period|Noncompliance|1|||
125286051|NCT03920293|450674452|FG001|Randomized-Controlled Period|Noncompliance|0|||
125286052|NCT03920293|450674451|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
125286053|NCT03920293|450674452|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
125286054|NCT03920293|450674451|FG000|Open- Label Extension Period|Death|3|||
125286055|NCT03920293|450674452|FG001|Open- Label Extension Period|Death|3|||
125286056|NCT03920293|450674451|FG000|Open- Label Extension Period|Physician Decision|5|||
125286057|NCT03920293|450674452|FG001|Open- Label Extension Period|Physician Decision|3|||
125286058|NCT03920293|450674451|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
125286059|NCT03920293|450674452|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
125286060|NCT01069861|450674453|FG000|Overall Study|Death|1|||
125286061|NCT01069861|450674453|FG000|Overall Study|Adverse Event|1|||
125286062|NCT01069861|450674453|FG000|Overall Study|Did not meet entrance criteria|1|||
125286063|NCT03272828|450674455|FG000|Overall Study|Lost to Follow-up|7|||
125286064|NCT03272828|450674456|FG001|Overall Study|Lost to Follow-up|7|||
125286065|NCT03272828|450674455|FG000|Overall Study|Withdrawal by Subject|2|||
125286066|NCT03272828|450674456|FG001|Overall Study|Withdrawal by Subject|0|||
125286067|NCT03272828|450674455|FG000|Overall Study|Deceased|1|||
125286068|NCT03272828|450674456|FG001|Overall Study|Deceased|1|||
125286069|NCT03272828|450674455|FG000|Overall Study|Failed implant|1|||
125286070|NCT03272828|450674456|FG001|Overall Study|Failed implant|2|||
125286071|NCT00996281|450674458|FG000|Overall Study|Adverse Event|75|||
125286072|NCT00996281|450674459|FG001|Overall Study|Adverse Event|37|||
125286073|NCT00996281|450674458|FG000|Overall Study|Major Protocol Deviation|6|||
125286074|NCT00996281|450674459|FG001|Overall Study|Major Protocol Deviation|7|||
125286075|NCT00996281|450674458|FG000|Overall Study|Lost to Follow-up|14|||
125286076|NCT00996281|450674459|FG001|Overall Study|Lost to Follow-up|16|||
125286077|NCT00996281|450674458|FG000|Overall Study|Withdrawal by Subject|31|||
125286078|NCT00996281|450674459|FG001|Overall Study|Withdrawal by Subject|20|||
125286079|NCT00996281|450674458|FG000|Overall Study|Lack of Efficacy|0|||
125286080|NCT00996281|450674459|FG001|Overall Study|Lack of Efficacy|2|||
125286081|NCT00996281|450674458|FG000|Overall Study|Other|5|||
125286082|NCT00996281|450674459|FG001|Overall Study|Other|7|||
125286083|NCT01920568|450674462|FG000|Overall Study|Adverse Event|27|||
125286084|NCT01920568|450674463|FG001|Overall Study|Adverse Event|8|||
125286085|NCT01920568|450674462|FG000|Overall Study|Protocol Violation|5|||
125286086|NCT01920568|450674463|FG001|Overall Study|Protocol Violation|3|||
125286087|NCT01920568|450674462|FG000|Overall Study|Lost to Follow-up|2|||
125286088|NCT01920568|450674463|FG001|Overall Study|Lost to Follow-up|2|||
125286089|NCT01920568|450674462|FG000|Overall Study|Physician Decision|13|||
125286090|NCT01920568|450674463|FG001|Overall Study|Physician Decision|4|||
125286091|NCT01920568|450674462|FG000|Overall Study|Withdrawal by Subject|79|||
125286092|NCT01920568|450674463|FG001|Overall Study|Withdrawal by Subject|55|||
125286093|NCT01920568|450674462|FG000|Overall Study|Death due to disease progression|25|||
125286094|NCT01920568|450674463|FG001|Overall Study|Death due to disease progression|12|||
125286095|NCT02891681|450674467|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
125286096|NCT02891681|450674468|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
125286097|NCT02891681|450674469|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
125286098|NCT02891681|450674467|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
125286099|NCT02891681|450674468|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
125286100|NCT02891681|450674469|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
125286101|NCT02891681|450674467|FG000|Overall Study|Taken off study after first imaging appointment|1|||
125286102|NCT02891681|450674468|FG001|Overall Study|Taken off study after first imaging appointment|0|||
125286103|NCT02891681|450674469|FG002|Overall Study|Taken off study after first imaging appointment|0|||
125286104|NCT00856206|450674471|FG000|Overall Study|Protocol Violation|6|||
125286105|NCT00856206|450674472|FG001|Overall Study|Protocol Violation|18|||
125286106|NCT00856206|450674471|FG000|Overall Study|Adverse Event|10|||
125286107|NCT00856206|450674472|FG001|Overall Study|Adverse Event|46|||
125286108|NCT00856206|450674471|FG000|Overall Study|Lack of Efficacy|1|||
125286109|NCT00856206|450674472|FG001|Overall Study|Lack of Efficacy|2|||
125286110|NCT00856206|450674471|FG000|Overall Study|Withdrawal by Subject|15|||
124782893|NCT00101452|448834354|FG001|Overall Study|Physician Decision|3|||
124782894|NCT00101452|448834355|FG002|Overall Study|Physician Decision|2|||
124782895|NCT00101452|448834353|FG000|Overall Study|Protocol Violation|2|||
125286111|NCT00856206|450674472|FG001|Overall Study|Withdrawal by Subject|36|||
125286112|NCT00856206|450674471|FG000|Overall Study|Lost to Follow-up|13|||
125286113|NCT00856206|450674472|FG001|Overall Study|Lost to Follow-up|39|||
125286114|NCT00856206|450674471|FG000|Overall Study|Death|2|||
125286115|NCT00856206|450674472|FG001|Overall Study|Death|2|||
125286116|NCT00856206|450674471|FG000|Overall Study|Decision by the Sponsor|4|||
125286117|NCT00856206|450674472|FG001|Overall Study|Decision by the Sponsor|8|||
125286118|NCT00856206|450674471|FG000|Overall Study|Other than specified above|3|||
125286119|NCT00856206|450674472|FG001|Overall Study|Other than specified above|10|||
125286120|NCT04584346|450674473|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
125286121|NCT04584346|450674474|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
125286122|NCT02780856|450674481|FG000|Overall Study|Lost to Follow-up|1|||
125286123|NCT03640052|450674482|FG000|Overall Study|Lost to Follow-up|0|||
125286124|NCT03640052|450674483|FG001|Overall Study|Lost to Follow-up|1|||
125286125|NCT03640052|450674484|FG002|Overall Study|Lost to Follow-up|0|||
125286126|NCT03640052|450674485|FG003|Overall Study|Lost to Follow-up|0|||
125286127|NCT03640052|450674486|FG004|Overall Study|Lost to Follow-up|0|||
125286128|NCT04422561|450674487|FG000|Overall Study|Lost to Follow-up|25|||
125286129|NCT04422561|450674488|FG001|Overall Study|Lost to Follow-up|11|||
125286130|NCT04239222|450674491|FG000|Baseline|Withdrawal by Subject|0|||
125286131|NCT04239222|450674492|FG001|Baseline|Withdrawal by Subject|0|||
125286132|NCT04239222|450674493|FG002|Baseline|Withdrawal by Subject|1|||
125286133|NCT04239222|450674494|FG003|Baseline|Withdrawal by Subject|1|||
125286134|NCT04239222|450674491|FG000|First Foot Assignment|Withdrawal by Subject|0|||
125286135|NCT04239222|450674492|FG001|First Foot Assignment|Withdrawal by Subject|0|||
125286136|NCT04239222|450674493|FG002|First Foot Assignment|Withdrawal by Subject|1|||
125286137|NCT04239222|450674494|FG003|First Foot Assignment|Withdrawal by Subject|0|||
125286138|NCT04239222|450674491|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
125286139|NCT04239222|450674492|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
125286140|NCT04239222|450674493|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
125286141|NCT04239222|450674494|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
125286142|NCT01468233|450674499|FG000|Treatment Period 1|Adverse Event|5|||
125286143|NCT01468233|450674500|FG001|Treatment Period 1|Adverse Event|3|||
125286144|NCT01468233|450674501|FG002|Treatment Period 1|Adverse Event|0|||
125286145|NCT01468233|450674502|FG003|Treatment Period 1|Adverse Event|0|||
125286146|NCT01468233|450674503|FG004|Treatment Period 1|Adverse Event|0|||
125286147|NCT01468233|450674504|FG005|Treatment Period 1|Adverse Event|0|||
125286148|NCT01468233|450674499|FG000|Treatment Period 1|Withdrawal by Subject|3|||
125286149|NCT01468233|450674500|FG001|Treatment Period 1|Withdrawal by Subject|4|||
125286150|NCT01468233|450674501|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125286151|NCT01468233|450674502|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125286152|NCT01468233|450674503|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125286153|NCT01468233|450674504|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125286154|NCT01468233|450674499|FG000|Treatment Period 1|Lost to Follow-up|3|||
125286155|NCT01468233|450674500|FG001|Treatment Period 1|Lost to Follow-up|0|||
125286156|NCT01468233|450674501|FG002|Treatment Period 1|Lost to Follow-up|0|||
125286157|NCT01468233|450674502|FG003|Treatment Period 1|Lost to Follow-up|0|||
125286158|NCT01468233|450674503|FG004|Treatment Period 1|Lost to Follow-up|0|||
125286159|NCT01468233|450674504|FG005|Treatment Period 1|Lost to Follow-up|0|||
125286160|NCT01468233|450674499|FG000|Treatment Period 1|Other|1|||
125286161|NCT01468233|450674500|FG001|Treatment Period 1|Other|1|||
125286162|NCT01468233|450674501|FG002|Treatment Period 1|Other|0|||
125286163|NCT01468233|450674502|FG003|Treatment Period 1|Other|0|||
125286164|NCT01468233|450674503|FG004|Treatment Period 1|Other|0|||
125286165|NCT01468233|450674504|FG005|Treatment Period 1|Other|0|||
125286166|NCT01468233|450674499|FG000|Treatment Period 2|Adverse Event|0|||
125286167|NCT01468233|450674500|FG001|Treatment Period 2|Adverse Event|0|||
125286168|NCT01468233|450674501|FG002|Treatment Period 2|Adverse Event|3|||
125286169|NCT01468233|450674502|FG003|Treatment Period 2|Adverse Event|0|||
125286170|NCT01468233|450674503|FG004|Treatment Period 2|Adverse Event|2|||
125286171|NCT01468233|450674504|FG005|Treatment Period 2|Adverse Event|1|||
125286172|NCT01468233|450674499|FG000|Treatment Period 2|Lack of Efficacy|0|||
125286173|NCT01468233|450674500|FG001|Treatment Period 2|Lack of Efficacy|0|||
125286174|NCT01468233|450674501|FG002|Treatment Period 2|Lack of Efficacy|9|||
124782896|NCT00101452|448834354|FG001|Overall Study|Protocol Violation|1|||
125286175|NCT01468233|450674502|FG003|Treatment Period 2|Lack of Efficacy|2|||
125286176|NCT01468233|450674503|FG004|Treatment Period 2|Lack of Efficacy|0|||
125286177|NCT01468233|450674504|FG005|Treatment Period 2|Lack of Efficacy|1|||
125286178|NCT01468233|450674499|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125286179|NCT01468233|450674500|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125286180|NCT01468233|450674501|FG002|Treatment Period 2|Withdrawal by Subject|9|||
125286181|NCT01468233|450674502|FG003|Treatment Period 2|Withdrawal by Subject|1|||
125286182|NCT01468233|450674503|FG004|Treatment Period 2|Withdrawal by Subject|1|||
125286183|NCT01468233|450674504|FG005|Treatment Period 2|Withdrawal by Subject|1|||
125286184|NCT01468233|450674499|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
125286185|NCT01468233|450674500|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
125286186|NCT01468233|450674501|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
125286187|NCT01468233|450674502|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
125286188|NCT01468233|450674503|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
125286189|NCT01468233|450674504|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
125286190|NCT01468233|450674499|FG000|Treatment Period 2|Lost to Follow-up|0|||
125286191|NCT01468233|450674500|FG001|Treatment Period 2|Lost to Follow-up|0|||
125286192|NCT01468233|450674501|FG002|Treatment Period 2|Lost to Follow-up|3|||
125286193|NCT01468233|450674502|FG003|Treatment Period 2|Lost to Follow-up|0|||
125286194|NCT01468233|450674503|FG004|Treatment Period 2|Lost to Follow-up|2|||
125286195|NCT01468233|450674504|FG005|Treatment Period 2|Lost to Follow-up|0|||
125286196|NCT01468233|450674499|FG000|Treatment Period 2|Other|0|||
125286197|NCT01468233|450674500|FG001|Treatment Period 2|Other|0|||
125286198|NCT01468233|450674501|FG002|Treatment Period 2|Other|3|||
125286199|NCT01468233|450674502|FG003|Treatment Period 2|Other|0|||
125286200|NCT01468233|450674503|FG004|Treatment Period 2|Other|1|||
125286201|NCT01468233|450674504|FG005|Treatment Period 2|Other|0|||
125286202|NCT00790647|450674512|FG000|Overall Study|Adverse Event|1|||
125286203|NCT04926831|450674514|FG000|Overall Study|Withdrawal by Subject|2|||
125286204|NCT04926831|450674514|FG000|Overall Study|Adverse Event|2|||
125286205|NCT02701777|450674515|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
125286206|NCT02701777|450674516|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
125286207|NCT02701777|450674517|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
125286208|NCT02701777|450674518|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
125286209|NCT02701777|450674515|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
125286210|NCT02701777|450674516|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
125286211|NCT02701777|450674517|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
125286212|NCT02701777|450674518|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
125286213|NCT03549871|450674521|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
125286214|NCT03549871|450674522|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
125286215|NCT03549871|450674521|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
125286216|NCT03549871|450674522|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
125286217|NCT03549871|450674521|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
125286218|NCT03549871|450674522|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
125286219|NCT03549871|450674521|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
125286220|NCT03549871|450674522|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
125286221|NCT03549871|450674521|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
125286222|NCT03549871|450674522|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
125286223|NCT03549871|450674521|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
125286224|NCT03549871|450674522|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
125286225|NCT03549871|450674521|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
125286226|NCT03549871|450674522|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
125286227|NCT03549871|450674521|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
125286228|NCT03549871|450674522|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
125286229|NCT03549871|450674521|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
125286230|NCT03549871|450674522|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
125286231|NCT03549871|450674521|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
125286232|NCT03549871|450674522|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
125286233|NCT03549871|450674521|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
125286234|NCT03549871|450674522|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
125286235|NCT01133626|450674524|FG000|Overall Study|Adverse Event|0|||
125286236|NCT01133626|450674525|FG001|Overall Study|Adverse Event|1|||
125286237|NCT01133626|450674526|FG002|Overall Study|Adverse Event|0|||
125286238|NCT01133626|450674524|FG000|Overall Study|Withdrawal by Subject|1|||
125286239|NCT01133626|450674525|FG001|Overall Study|Withdrawal by Subject|2|||
125286240|NCT01133626|450674526|FG002|Overall Study|Withdrawal by Subject|2|||
125286241|NCT01133626|450674524|FG000|Overall Study|Other|0|||
125286242|NCT01133626|450674525|FG001|Overall Study|Other|2|||
125286243|NCT01133626|450674526|FG002|Overall Study|Other|0|||
125286244|NCT03298984|450674529|FG000|Overall Study|Physician Decision|1|||
125286245|NCT03298984|450674530|FG001|Overall Study|Physician Decision|0|||
125286246|NCT03298984|450674531|FG002|Overall Study|Physician Decision|0|||
125286247|NCT03298984|450674532|FG003|Overall Study|Physician Decision|6|||
125286248|NCT03298984|450674529|FG000|Overall Study|Lack of Efficacy|0|||
125286249|NCT03298984|450674530|FG001|Overall Study|Lack of Efficacy|1|||
125286250|NCT03298984|450674531|FG002|Overall Study|Lack of Efficacy|1|||
125286251|NCT03298984|450674532|FG003|Overall Study|Lack of Efficacy|4|||
125286252|NCT03298984|450674529|FG000|Overall Study|Relapsed disease (following remission)|0|||
125286253|NCT03298984|450674530|FG001|Overall Study|Relapsed disease (following remission)|0|||
125286254|NCT03298984|450674531|FG002|Overall Study|Relapsed disease (following remission)|1|||
125286255|NCT03298984|450674532|FG003|Overall Study|Relapsed disease (following remission)|1|||
125286256|NCT03298984|450674529|FG000|Overall Study|Adverse Event|0|||
125286257|NCT03298984|450674530|FG001|Overall Study|Adverse Event|0|||
125286258|NCT03298984|450674531|FG002|Overall Study|Adverse Event|0|||
125286259|NCT03298984|450674532|FG003|Overall Study|Adverse Event|1|||
125286260|NCT03298984|450674529|FG000|Overall Study|Death|0|||
125286261|NCT03298984|450674530|FG001|Overall Study|Death|0|||
125286262|NCT03298984|450674531|FG002|Overall Study|Death|0|||
125286263|NCT03298984|450674532|FG003|Overall Study|Death|2|||
125286264|NCT03298984|450674529|FG000|Overall Study|Insurance Company Decision|0|||
125286265|NCT03298984|450674530|FG001|Overall Study|Insurance Company Decision|0|||
125286266|NCT03298984|450674531|FG002|Overall Study|Insurance Company Decision|0|||
125286267|NCT03298984|450674532|FG003|Overall Study|Insurance Company Decision|1|||
125286268|NCT02851407|450674533|FG000|Overall Study|Withdrawal by parent/guardian|2|||
125286269|NCT02851407|450674534|FG001|Overall Study|Withdrawal by parent/guardian|7|||
125286270|NCT02851407|450674533|FG000|Overall Study|Protocol deviation|0|||
125286271|NCT02851407|450674534|FG001|Overall Study|Protocol deviation|1|||
125286272|NCT02851407|450674533|FG000|Overall Study|Transferred to another hospital to continue|1|||
125286273|NCT02851407|450674534|FG001|Overall Study|Transferred to another hospital to continue|0|||
125286274|NCT02851407|450674533|FG000|Overall Study|Other Death|30|||
125286275|NCT02851407|450674534|FG001|Overall Study|Other Death|20|||
125286276|NCT02851407|450674533|FG000|Overall Study|Adverse event, serious fatal|6|||
125286277|NCT02851407|450674534|FG001|Overall Study|Adverse event, serious fatal|8|||
125286278|NCT02851407|450674533|FG000|Overall Study|Consent withdrawn by participant|5|||
125286279|NCT02851407|450674534|FG001|Overall Study|Consent withdrawn by participant|3|||
125286280|NCT02851407|450674533|FG000|Overall Study|Screen failure|2|||
125286281|NCT02851407|450674534|FG001|Overall Study|Screen failure|1|||
125286282|NCT02851407|450674533|FG000|Overall Study|Disease relapse|9|||
125286283|NCT02851407|450674534|FG001|Overall Study|Disease relapse|6|||
125286284|NCT02851407|450674533|FG000|Overall Study|Physician Decision|7|||
125286285|NCT02851407|450674534|FG001|Overall Study|Physician Decision|6|||
125286286|NCT02851407|450674533|FG000|Overall Study|Transferred to hospital closer to home|0|||
125286287|NCT02851407|450674534|FG001|Overall Study|Transferred to hospital closer to home|1|||
125286288|NCT02851407|450674533|FG000|Overall Study|Enrolled in an investigational study|0|||
125286289|NCT02851407|450674534|FG001|Overall Study|Enrolled in an investigational study|1|||
125286290|NCT02851407|450674533|FG000|Overall Study|Early recovery|1|||
125286291|NCT02851407|450674534|FG001|Overall Study|Early recovery|0|||
125286292|NCT02851407|450674533|FG000|Overall Study|Adverse event, non-fatal|7|||
125286293|NCT02851407|450674534|FG001|Overall Study|Adverse event, non-fatal|5|||
125286294|NCT02851407|450674533|FG000|Overall Study|Lost to Follow-up|0|||
125286295|NCT02851407|450674534|FG001|Overall Study|Lost to Follow-up|2|||
125286296|NCT00294645|450674535|FG000|Overall Study|Death|10|||
125286297|NCT00294645|450674536|FG001|Overall Study|Death|18|||
125286298|NCT00294645|450674535|FG000|Overall Study|Lost to Follow-up|1|||
125286299|NCT00294645|450674536|FG001|Overall Study|Lost to Follow-up|10|||
125286300|NCT00294645|450674535|FG000|Overall Study|Withdrawal by Subject|18|||
125286301|NCT00294645|450674536|FG001|Overall Study|Withdrawal by Subject|34|||
125286302|NCT00294645|450674535|FG000|Overall Study|Physician Decision|15|||
125286303|NCT00294645|450674536|FG001|Overall Study|Physician Decision|20|||
125286304|NCT00294645|450674535|FG000|Overall Study|Other|4|||
125286305|NCT00294645|450674536|FG001|Overall Study|Other|10|||
125286306|NCT00075725|450674537|FG000|Overall Study|Adverse Event|6|||
125286307|NCT00075725|450674538|FG001|Overall Study|Adverse Event|6|||
125286308|NCT00075725|450674539|FG002|Overall Study|Adverse Event|20|||
125286309|NCT00075725|450674540|FG003|Overall Study|Adverse Event|8|||
125286310|NCT00075725|450674541|FG004|Overall Study|Adverse Event|4|||
125286311|NCT00075725|450674542|FG005|Overall Study|Adverse Event|38|||
125286312|NCT00075725|450674543|FG006|Overall Study|Adverse Event|3|||
125286313|NCT00075725|450674544|FG007|Overall Study|Adverse Event|51|||
125286314|NCT00075725|450674545|FG008|Overall Study|Adverse Event|15|||
125286315|NCT00075725|450674546|FG009|Overall Study|Adverse Event|4|||
125286316|NCT00075725|450674547|FG010|Overall Study|Adverse Event|2|||
125286317|NCT00075725|450674548|FG011|Overall Study|Adverse Event|2|||
125286318|NCT00075725|450674537|FG000|Overall Study|Death|3|||
125286319|NCT00075725|450674538|FG001|Overall Study|Death|5|||
125286320|NCT00075725|450674539|FG002|Overall Study|Death|10|||
125286321|NCT00075725|450674540|FG003|Overall Study|Death|2|||
125286322|NCT00075725|450674541|FG004|Overall Study|Death|3|||
125286323|NCT00075725|450674542|FG005|Overall Study|Death|25|||
125286324|NCT00075725|450674543|FG006|Overall Study|Death|4|||
125286325|NCT00075725|450674544|FG007|Overall Study|Death|22|||
125286326|NCT00075725|450674545|FG008|Overall Study|Death|14|||
125286327|NCT00075725|450674546|FG009|Overall Study|Death|4|||
125286328|NCT00075725|450674547|FG010|Overall Study|Death|3|||
125286329|NCT00075725|450674548|FG011|Overall Study|Death|0|||
125286330|NCT00075725|450674537|FG000|Overall Study|Lost to Follow-up|1|||
125286331|NCT00075725|450674538|FG001|Overall Study|Lost to Follow-up|1|||
125286332|NCT00075725|450674539|FG002|Overall Study|Lost to Follow-up|4|||
125286333|NCT00075725|450674540|FG003|Overall Study|Lost to Follow-up|1|||
125286334|NCT00075725|450674541|FG004|Overall Study|Lost to Follow-up|0|||
125286335|NCT00075725|450674542|FG005|Overall Study|Lost to Follow-up|13|||
125286336|NCT00075725|450674543|FG006|Overall Study|Lost to Follow-up|2|||
125286337|NCT00075725|450674544|FG007|Overall Study|Lost to Follow-up|4|||
125286338|NCT00075725|450674545|FG008|Overall Study|Lost to Follow-up|1|||
125286339|NCT00075725|450674546|FG009|Overall Study|Lost to Follow-up|0|||
125286340|NCT00075725|450674547|FG010|Overall Study|Lost to Follow-up|0|||
125286341|NCT00075725|450674548|FG011|Overall Study|Lost to Follow-up|0|||
125286342|NCT00075725|450674537|FG000|Overall Study|Physician Decision|2|||
125286343|NCT00075725|450674538|FG001|Overall Study|Physician Decision|6|||
125286344|NCT00075725|450674539|FG002|Overall Study|Physician Decision|5|||
125286345|NCT00075725|450674540|FG003|Overall Study|Physician Decision|8|||
125286346|NCT00075725|450674541|FG004|Overall Study|Physician Decision|4|||
125286347|NCT00075725|450674542|FG005|Overall Study|Physician Decision|19|||
125286348|NCT00075725|450674543|FG006|Overall Study|Physician Decision|3|||
125286349|NCT00075725|450674544|FG007|Overall Study|Physician Decision|17|||
125286350|NCT00075725|450674545|FG008|Overall Study|Physician Decision|5|||
125286351|NCT00075725|450674546|FG009|Overall Study|Physician Decision|0|||
125286352|NCT00075725|450674547|FG010|Overall Study|Physician Decision|1|||
125286353|NCT00075725|450674548|FG011|Overall Study|Physician Decision|0|||
125286354|NCT00075725|450674537|FG000|Overall Study|Pregnancy|0|||
125286355|NCT00075725|450674538|FG001|Overall Study|Pregnancy|0|||
125286356|NCT00075725|450674539|FG002|Overall Study|Pregnancy|0|||
125286357|NCT00075725|450674540|FG003|Overall Study|Pregnancy|0|||
125286358|NCT00075725|450674541|FG004|Overall Study|Pregnancy|0|||
125286359|NCT00075725|450674542|FG005|Overall Study|Pregnancy|1|||
125286360|NCT00075725|450674543|FG006|Overall Study|Pregnancy|0|||
125286361|NCT00075725|450674544|FG007|Overall Study|Pregnancy|1|||
125286362|NCT00075725|450674545|FG008|Overall Study|Pregnancy|0|||
125286363|NCT00075725|450674546|FG009|Overall Study|Pregnancy|0|||
125286364|NCT00075725|450674547|FG010|Overall Study|Pregnancy|0|||
125286365|NCT00075725|450674548|FG011|Overall Study|Pregnancy|0|||
125286366|NCT00075725|450674537|FG000|Overall Study|Protocol Violation|1|||
125286367|NCT00075725|450674538|FG001|Overall Study|Protocol Violation|1|||
125286368|NCT00075725|450674539|FG002|Overall Study|Protocol Violation|0|||
124782897|NCT00101452|448834355|FG002|Overall Study|Protocol Violation|3|||
124782898|NCT00101452|448834353|FG000|Overall Study|Other|15|||
124782899|NCT00101452|448834354|FG001|Overall Study|Other|16|||
125286369|NCT00075725|450674540|FG003|Overall Study|Protocol Violation|3|||
124782900|NCT00101452|448834355|FG002|Overall Study|Other|12|||
124782901|NCT00499590|448834356|FG000|Overall Study|Study Terminated|112|||
124782902|NCT00499590|448834357|FG001|Overall Study|Study Terminated|112|||
124782903|NCT00499590|448834358|FG002|Overall Study|Study Terminated|112|||
124782904|NCT00499590|448834356|FG000|Overall Study|Not treated|1|||
124782905|NCT00499590|448834357|FG001|Overall Study|Not treated|0|||
124782906|NCT00499590|448834358|FG002|Overall Study|Not treated|1|||
124782907|NCT05661851|448834359|FG000|Overall Study|Protocol Violation|1|||
124782908|NCT05661851|448834360|FG001|Overall Study|Protocol Violation|1|||
124782909|NCT05661851|448834359|FG000|Overall Study|Covid-19 Related|3|||
124782910|NCT05661851|448834360|FG001|Overall Study|Covid-19 Related|4|||
124782911|NCT05661851|448834359|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
124782912|NCT05661851|448834360|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
125286370|NCT00075725|450674541|FG004|Overall Study|Protocol Violation|3|||
125286371|NCT00075725|450674542|FG005|Overall Study|Protocol Violation|2|||
125286372|NCT00075725|450674543|FG006|Overall Study|Protocol Violation|1|||
125286373|NCT00075725|450674544|FG007|Overall Study|Protocol Violation|2|||
125286374|NCT00075725|450674545|FG008|Overall Study|Protocol Violation|3|||
125286375|NCT00075725|450674546|FG009|Overall Study|Protocol Violation|0|||
125286376|NCT00075725|450674547|FG010|Overall Study|Protocol Violation|0|||
125286377|NCT00075725|450674548|FG011|Overall Study|Protocol Violation|1|||
125286378|NCT00075725|450674537|FG000|Overall Study|Withdrawal by Subject|12|||
125286379|NCT00075725|450674538|FG001|Overall Study|Withdrawal by Subject|3|||
125286380|NCT00075725|450674539|FG002|Overall Study|Withdrawal by Subject|6|||
125286381|NCT00075725|450674540|FG003|Overall Study|Withdrawal by Subject|10|||
125286382|NCT00075725|450674541|FG004|Overall Study|Withdrawal by Subject|6|||
125286383|NCT00075725|450674542|FG005|Overall Study|Withdrawal by Subject|27|||
125286384|NCT00075725|450674543|FG006|Overall Study|Withdrawal by Subject|7|||
125286385|NCT00075725|450674544|FG007|Overall Study|Withdrawal by Subject|31|||
125286386|NCT00075725|450674545|FG008|Overall Study|Withdrawal by Subject|10|||
125286387|NCT00075725|450674546|FG009|Overall Study|Withdrawal by Subject|2|||
125286388|NCT00075725|450674547|FG010|Overall Study|Withdrawal by Subject|0|||
125286389|NCT00075725|450674548|FG011|Overall Study|Withdrawal by Subject|0|||
125286390|NCT00075725|450674537|FG000|Overall Study|Disease Progression, all other reasons|17|||
125286391|NCT00075725|450674538|FG001|Overall Study|Disease Progression, all other reasons|5|||
125286392|NCT00075725|450674539|FG002|Overall Study|Disease Progression, all other reasons|33|||
125286393|NCT00075725|450674540|FG003|Overall Study|Disease Progression, all other reasons|6|||
125286394|NCT00075725|450674541|FG004|Overall Study|Disease Progression, all other reasons|21|||
125286395|NCT00075725|450674542|FG005|Overall Study|Disease Progression, all other reasons|59|||
125286396|NCT00075725|450674543|FG006|Overall Study|Disease Progression, all other reasons|20|||
125286397|NCT00075725|450674544|FG007|Overall Study|Disease Progression, all other reasons|46|||
125286398|NCT00075725|450674545|FG008|Overall Study|Disease Progression, all other reasons|21|||
125286399|NCT00075725|450674546|FG009|Overall Study|Disease Progression, all other reasons|4|||
125286400|NCT00075725|450674547|FG010|Overall Study|Disease Progression, all other reasons|0|||
125286401|NCT00075725|450674548|FG011|Overall Study|Disease Progression, all other reasons|5|||
125286402|NCT00075725|450674537|FG000|Overall Study|Patient off treatment|0|||
125286403|NCT00075725|450674538|FG001|Overall Study|Patient off treatment|0|||
125286404|NCT00075725|450674539|FG002|Overall Study|Patient off treatment|1|||
125286405|NCT00075725|450674540|FG003|Overall Study|Patient off treatment|2|||
125286406|NCT00075725|450674541|FG004|Overall Study|Patient off treatment|1|||
125286407|NCT00075725|450674542|FG005|Overall Study|Patient off treatment|0|||
125286408|NCT00075725|450674543|FG006|Overall Study|Patient off treatment|0|||
125286409|NCT00075725|450674544|FG007|Overall Study|Patient off treatment|2|||
125286410|NCT00075725|450674545|FG008|Overall Study|Patient off treatment|1|||
125286411|NCT00075725|450674546|FG009|Overall Study|Patient off treatment|0|||
125286412|NCT00075725|450674547|FG010|Overall Study|Patient off treatment|0|||
125286413|NCT00075725|450674548|FG011|Overall Study|Patient off treatment|0|||
125286414|NCT00075725|450674537|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
125286415|NCT00075725|450674538|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
125286416|NCT00075725|450674539|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
125286417|NCT00075725|450674540|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
125286418|NCT00075725|450674541|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
125286419|NCT00075725|450674542|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
125286420|NCT00075725|450674543|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
125286421|NCT00075725|450674544|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
125286422|NCT00075725|450674545|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
125286423|NCT00075725|450674546|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
125286424|NCT00075725|450674547|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
125286425|NCT00075725|450674548|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
125286426|NCT00075725|450674537|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
125286427|NCT00075725|450674538|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
125286428|NCT00075725|450674539|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
125286429|NCT00075725|450674540|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
125286430|NCT00075725|450674541|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
125286431|NCT00075725|450674542|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
125286432|NCT00075725|450674543|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
125286433|NCT00075725|450674544|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
125286434|NCT00075725|450674545|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
125286435|NCT00075725|450674546|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
125286436|NCT00075725|450674547|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
125286437|NCT00075725|450674548|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
125286438|NCT00075725|450674537|FG000|Overall Study|Pt non compliant with therapy|2|||
124819524|NCT03902574|448965743|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
125286439|NCT00075725|450674538|FG001|Overall Study|Pt non compliant with therapy|1|||
125286440|NCT00075725|450674539|FG002|Overall Study|Pt non compliant with therapy|1|||
125286441|NCT00075725|450674540|FG003|Overall Study|Pt non compliant with therapy|0|||
125286442|NCT00075725|450674541|FG004|Overall Study|Pt non compliant with therapy|2|||
125286443|NCT00075725|450674542|FG005|Overall Study|Pt non compliant with therapy|14|||
125286444|NCT00075725|450674543|FG006|Overall Study|Pt non compliant with therapy|2|||
125286445|NCT00075725|450674544|FG007|Overall Study|Pt non compliant with therapy|5|||
125286446|NCT00075725|450674545|FG008|Overall Study|Pt non compliant with therapy|3|||
125286447|NCT00075725|450674546|FG009|Overall Study|Pt non compliant with therapy|0|||
125286448|NCT00075725|450674547|FG010|Overall Study|Pt non compliant with therapy|0|||
125286449|NCT00075725|450674548|FG011|Overall Study|Pt non compliant with therapy|0|||
125286450|NCT00075725|450674537|FG000|Overall Study|Pt age out of range for treatment|0|||
125286451|NCT00075725|450674538|FG001|Overall Study|Pt age out of range for treatment|1|||
125286452|NCT00075725|450674539|FG002|Overall Study|Pt age out of range for treatment|0|||
125286453|NCT00075725|450674540|FG003|Overall Study|Pt age out of range for treatment|0|||
125286454|NCT00075725|450674541|FG004|Overall Study|Pt age out of range for treatment|0|||
125286455|NCT00075725|450674542|FG005|Overall Study|Pt age out of range for treatment|1|||
125286456|NCT00075725|450674543|FG006|Overall Study|Pt age out of range for treatment|0|||
125286457|NCT00075725|450674544|FG007|Overall Study|Pt age out of range for treatment|1|||
125286458|NCT00075725|450674545|FG008|Overall Study|Pt age out of range for treatment|0|||
125286459|NCT00075725|450674546|FG009|Overall Study|Pt age out of range for treatment|0|||
125286460|NCT00075725|450674547|FG010|Overall Study|Pt age out of range for treatment|0|||
125286461|NCT00075725|450674548|FG011|Overall Study|Pt age out of range for treatment|0|||
125286462|NCT00075725|450674537|FG000|Overall Study|Insurance issues|0|||
125286463|NCT00075725|450674538|FG001|Overall Study|Insurance issues|1|||
125286464|NCT00075725|450674539|FG002|Overall Study|Insurance issues|0|||
125286465|NCT00075725|450674540|FG003|Overall Study|Insurance issues|1|||
125286466|NCT00075725|450674541|FG004|Overall Study|Insurance issues|1|||
125286467|NCT00075725|450674542|FG005|Overall Study|Insurance issues|1|||
125286468|NCT00075725|450674543|FG006|Overall Study|Insurance issues|0|||
125286469|NCT00075725|450674544|FG007|Overall Study|Insurance issues|1|||
125286470|NCT00075725|450674545|FG008|Overall Study|Insurance issues|0|||
125286471|NCT00075725|450674546|FG009|Overall Study|Insurance issues|0|||
125286472|NCT00075725|450674547|FG010|Overall Study|Insurance issues|0|||
125286473|NCT00075725|450674548|FG011|Overall Study|Insurance issues|0|||
125286474|NCT00075725|450674537|FG000|Overall Study|MRD positive after extended ind|0|||
125286475|NCT00075725|450674538|FG001|Overall Study|MRD positive after extended ind|1|||
125286476|NCT00075725|450674539|FG002|Overall Study|MRD positive after extended ind|1|||
125286477|NCT00075725|450674540|FG003|Overall Study|MRD positive after extended ind|0|||
125286478|NCT00075725|450674541|FG004|Overall Study|MRD positive after extended ind|1|||
125286479|NCT00075725|450674542|FG005|Overall Study|MRD positive after extended ind|2|||
125286480|NCT00075725|450674543|FG006|Overall Study|MRD positive after extended ind|0|||
125286481|NCT00075725|450674544|FG007|Overall Study|MRD positive after extended ind|1|||
125286482|NCT00075725|450674545|FG008|Overall Study|MRD positive after extended ind|0|||
125286483|NCT00075725|450674546|FG009|Overall Study|MRD positive after extended ind|0|||
125286484|NCT00075725|450674547|FG010|Overall Study|MRD positive after extended ind|0|||
125286485|NCT00075725|450674548|FG011|Overall Study|MRD positive after extended ind|0|||
125286486|NCT00075725|450674537|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
125286487|NCT00075725|450674538|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
125286488|NCT00075725|450674539|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
125286489|NCT00075725|450674540|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
125286490|NCT00075725|450674541|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
125286491|NCT00075725|450674542|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
125286492|NCT00075725|450674543|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
125286493|NCT00075725|450674544|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
125286494|NCT00075725|450674545|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
125286495|NCT00075725|450674546|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
125286496|NCT00075725|450674547|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
125286497|NCT00075725|450674548|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
125286498|NCT00075725|450674537|FG000|Overall Study|Inevaluable|1|||
125286499|NCT00075725|450674538|FG001|Overall Study|Inevaluable|1|||
125286500|NCT00075725|450674539|FG002|Overall Study|Inevaluable|4|||
125286501|NCT00075725|450674540|FG003|Overall Study|Inevaluable|2|||
125286502|NCT00075725|450674541|FG004|Overall Study|Inevaluable|2|||
125286503|NCT00075725|450674542|FG005|Overall Study|Inevaluable|9|||
125286504|NCT00075725|450674543|FG006|Overall Study|Inevaluable|1|||
125286505|NCT00075725|450674544|FG007|Overall Study|Inevaluable|11|||
125286506|NCT00075725|450674545|FG008|Overall Study|Inevaluable|2|||
125286507|NCT00075725|450674546|FG009|Overall Study|Inevaluable|0|||
125286508|NCT00075725|450674547|FG010|Overall Study|Inevaluable|1|||
125286509|NCT00075725|450674548|FG011|Overall Study|Inevaluable|0|||
125286510|NCT00075725|450674537|FG000|Overall Study|Other|4|||
125286511|NCT00075725|450674538|FG001|Overall Study|Other|2|||
125286512|NCT00075725|450674539|FG002|Overall Study|Other|1|||
124782913|NCT05661851|448834359|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
124782914|NCT05661851|448834360|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
124782915|NCT01014910|448834361|FG000|Overall Study|Withdrawal by Subject|0|||
124782916|NCT01014910|448834362|FG001|Overall Study|Withdrawal by Subject|2|||
124782917|NCT00612807|448834363|FG000|Overall Study|Withdrawal by Subject|2|||
124782918|NCT00612807|448834364|FG001|Overall Study|Withdrawal by Subject|0|||
124782919|NCT02252939|448834365|FG000|Overall Study|Lost to Follow-up|3|||
124782920|NCT00870584|448834369|FG000|Overall Study|Adverse Event|3|||
124782921|NCT00870584|448834370|FG001|Overall Study|Adverse Event|3|||
124782922|NCT00870584|448834369|FG000|Overall Study|Withdrawal by Subject|6|||
124782923|NCT00870584|448834370|FG001|Overall Study|Withdrawal by Subject|7|||
124782924|NCT00870584|448834369|FG000|Overall Study|Lost to Follow-up|5|||
124782925|NCT00870584|448834370|FG001|Overall Study|Lost to Follow-up|1|||
124782926|NCT00870584|448834369|FG000|Overall Study|Protocol Deviation|2|||
124782927|NCT00870584|448834370|FG001|Overall Study|Protocol Deviation|2|||
125286513|NCT00075725|450674540|FG003|Overall Study|Other|1|||
125286514|NCT00075725|450674541|FG004|Overall Study|Other|1|||
124782928|NCT01497366|448834371|FG000|Overall Study|Virologic failure|2|||
125286515|NCT00075725|450674542|FG005|Overall Study|Other|4|||
125286516|NCT00075725|450674543|FG006|Overall Study|Other|2|||
125286517|NCT00075725|450674544|FG007|Overall Study|Other|9|||
125286518|NCT00075725|450674545|FG008|Overall Study|Other|2|||
125286519|NCT00075725|450674546|FG009|Overall Study|Other|1|||
125286520|NCT00075725|450674547|FG010|Overall Study|Other|0|||
125286521|NCT00075725|450674548|FG011|Overall Study|Other|3|||
125286522|NCT00075725|450674537|FG000|Overall Study|Pt trying to find a BM donor|0|||
125286523|NCT00075725|450674538|FG001|Overall Study|Pt trying to find a BM donor|1|||
125286524|NCT00075725|450674539|FG002|Overall Study|Pt trying to find a BM donor|0|||
125286525|NCT00075725|450674540|FG003|Overall Study|Pt trying to find a BM donor|0|||
125286526|NCT00075725|450674541|FG004|Overall Study|Pt trying to find a BM donor|0|||
125286527|NCT00075725|450674542|FG005|Overall Study|Pt trying to find a BM donor|0|||
125286528|NCT00075725|450674543|FG006|Overall Study|Pt trying to find a BM donor|0|||
125286529|NCT00075725|450674544|FG007|Overall Study|Pt trying to find a BM donor|0|||
125286530|NCT00075725|450674545|FG008|Overall Study|Pt trying to find a BM donor|0|||
125286531|NCT00075725|450674546|FG009|Overall Study|Pt trying to find a BM donor|0|||
125286532|NCT00075725|450674547|FG010|Overall Study|Pt trying to find a BM donor|0|||
125286533|NCT00075725|450674548|FG011|Overall Study|Pt trying to find a BM donor|0|||
125286534|NCT00075725|450674537|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
125286535|NCT00075725|450674538|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
125286536|NCT00075725|450674539|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
125286537|NCT00075725|450674540|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
125286538|NCT00075725|450674541|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
125286539|NCT00075725|450674542|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
125286540|NCT00075725|450674543|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
125286541|NCT00075725|450674544|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
125286542|NCT00075725|450674545|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
125286543|NCT00075725|450674546|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
125286544|NCT00075725|450674547|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
125286545|NCT00075725|450674548|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
125286546|NCT00075725|450674537|FG000|Overall Study|Unsuccessful institutional transfer|0|||
125286547|NCT00075725|450674538|FG001|Overall Study|Unsuccessful institutional transfer|0|||
125286548|NCT00075725|450674539|FG002|Overall Study|Unsuccessful institutional transfer|2|||
125286549|NCT00075725|450674540|FG003|Overall Study|Unsuccessful institutional transfer|0|||
125286550|NCT00075725|450674541|FG004|Overall Study|Unsuccessful institutional transfer|0|||
125286551|NCT00075725|450674542|FG005|Overall Study|Unsuccessful institutional transfer|0|||
125286552|NCT00075725|450674543|FG006|Overall Study|Unsuccessful institutional transfer|0|||
125286553|NCT00075725|450674544|FG007|Overall Study|Unsuccessful institutional transfer|0|||
125286554|NCT00075725|450674545|FG008|Overall Study|Unsuccessful institutional transfer|0|||
125286555|NCT00075725|450674546|FG009|Overall Study|Unsuccessful institutional transfer|1|||
125286556|NCT00075725|450674547|FG010|Overall Study|Unsuccessful institutional transfer|0|||
125286557|NCT00075725|450674548|FG011|Overall Study|Unsuccessful institutional transfer|0|||
125286558|NCT00075725|450674537|FG000|Overall Study|specimen(s) not submitted|0|||
125286559|NCT00075725|450674538|FG001|Overall Study|specimen(s) not submitted|0|||
125286560|NCT00075725|450674539|FG002|Overall Study|specimen(s) not submitted|2|||
125286561|NCT00075725|450674540|FG003|Overall Study|specimen(s) not submitted|0|||
125286562|NCT00075725|450674541|FG004|Overall Study|specimen(s) not submitted|0|||
125286563|NCT00075725|450674542|FG005|Overall Study|specimen(s) not submitted|0|||
125286564|NCT00075725|450674543|FG006|Overall Study|specimen(s) not submitted|0|||
125286565|NCT00075725|450674544|FG007|Overall Study|specimen(s) not submitted|0|||
125286566|NCT00075725|450674545|FG008|Overall Study|specimen(s) not submitted|0|||
125286567|NCT00075725|450674546|FG009|Overall Study|specimen(s) not submitted|0|||
125286568|NCT00075725|450674547|FG010|Overall Study|specimen(s) not submitted|0|||
125286569|NCT00075725|450674548|FG011|Overall Study|specimen(s) not submitted|0|||
125286570|NCT00075725|450674537|FG000|Overall Study|Pt went to transplant|0|||
125286571|NCT00075725|450674538|FG001|Overall Study|Pt went to transplant|0|||
125286572|NCT00075725|450674539|FG002|Overall Study|Pt went to transplant|0|||
125286573|NCT00075725|450674540|FG003|Overall Study|Pt went to transplant|1|||
125286574|NCT00075725|450674541|FG004|Overall Study|Pt went to transplant|0|||
125286575|NCT00075725|450674542|FG005|Overall Study|Pt went to transplant|1|||
125286576|NCT00075725|450674543|FG006|Overall Study|Pt went to transplant|0|||
125286577|NCT00075725|450674544|FG007|Overall Study|Pt went to transplant|0|||
125286578|NCT00075725|450674545|FG008|Overall Study|Pt went to transplant|0|||
125286579|NCT00075725|450674546|FG009|Overall Study|Pt went to transplant|0|||
125286580|NCT00075725|450674547|FG010|Overall Study|Pt went to transplant|0|||
125286581|NCT00075725|450674548|FG011|Overall Study|Pt went to transplant|0|||
125286582|NCT00075725|450674537|FG000|Overall Study|Pt received additional steroids|0|||
125286583|NCT00075725|450674538|FG001|Overall Study|Pt received additional steroids|0|||
125286584|NCT00075725|450674539|FG002|Overall Study|Pt received additional steroids|0|||
125286585|NCT00075725|450674540|FG003|Overall Study|Pt received additional steroids|1|||
125286586|NCT00075725|450674541|FG004|Overall Study|Pt received additional steroids|0|||
125286587|NCT00075725|450674542|FG005|Overall Study|Pt received additional steroids|0|||
125286588|NCT00075725|450674543|FG006|Overall Study|Pt received additional steroids|0|||
125286589|NCT00075725|450674544|FG007|Overall Study|Pt received additional steroids|0|||
125286590|NCT00075725|450674545|FG008|Overall Study|Pt received additional steroids|0|||
125286591|NCT00075725|450674546|FG009|Overall Study|Pt received additional steroids|0|||
125286592|NCT00075725|450674547|FG010|Overall Study|Pt received additional steroids|0|||
125286593|NCT00075725|450674548|FG011|Overall Study|Pt received additional steroids|0|||
125286594|NCT00075725|450674537|FG000|Overall Study|Pt relocated|0|||
125286595|NCT00075725|450674538|FG001|Overall Study|Pt relocated|0|||
125286596|NCT00075725|450674539|FG002|Overall Study|Pt relocated|0|||
125286597|NCT00075725|450674540|FG003|Overall Study|Pt relocated|2|||
125286598|NCT00075725|450674541|FG004|Overall Study|Pt relocated|0|||
125286599|NCT00075725|450674542|FG005|Overall Study|Pt relocated|1|||
125286600|NCT00075725|450674543|FG006|Overall Study|Pt relocated|1|||
125286601|NCT00075725|450674544|FG007|Overall Study|Pt relocated|2|||
125286602|NCT00075725|450674545|FG008|Overall Study|Pt relocated|1|||
125286603|NCT00075725|450674546|FG009|Overall Study|Pt relocated|0|||
125286604|NCT00075725|450674547|FG010|Overall Study|Pt relocated|0|||
125286605|NCT00075725|450674548|FG011|Overall Study|Pt relocated|0|||
125286606|NCT00075725|450674537|FG000|Overall Study|Institution Terminated|0|||
125286607|NCT00075725|450674538|FG001|Overall Study|Institution Terminated|0|||
125286608|NCT00075725|450674539|FG002|Overall Study|Institution Terminated|0|||
125286609|NCT00075725|450674540|FG003|Overall Study|Institution Terminated|0|||
125286610|NCT00075725|450674541|FG004|Overall Study|Institution Terminated|1|||
125286611|NCT00075725|450674542|FG005|Overall Study|Institution Terminated|0|||
125286612|NCT00075725|450674543|FG006|Overall Study|Institution Terminated|0|||
125286613|NCT00075725|450674544|FG007|Overall Study|Institution Terminated|3|||
125286614|NCT00075725|450674545|FG008|Overall Study|Institution Terminated|0|||
125286615|NCT00075725|450674546|FG009|Overall Study|Institution Terminated|0|||
125286616|NCT00075725|450674547|FG010|Overall Study|Institution Terminated|0|||
125286617|NCT00075725|450674548|FG011|Overall Study|Institution Terminated|0|||
125286618|NCT00075725|450674537|FG000|Overall Study|Study Closure|1|||
125286619|NCT00075725|450674538|FG001|Overall Study|Study Closure|0|||
125286620|NCT00075725|450674539|FG002|Overall Study|Study Closure|0|||
125286621|NCT00075725|450674540|FG003|Overall Study|Study Closure|0|||
125286622|NCT00075725|450674541|FG004|Overall Study|Study Closure|1|||
125286623|NCT00075725|450674542|FG005|Overall Study|Study Closure|3|||
125286624|NCT00075725|450674543|FG006|Overall Study|Study Closure|0|||
125286625|NCT00075725|450674544|FG007|Overall Study|Study Closure|1|||
125286626|NCT00075725|450674545|FG008|Overall Study|Study Closure|0|||
125286627|NCT00075725|450674546|FG009|Overall Study|Study Closure|0|||
125286628|NCT00075725|450674547|FG010|Overall Study|Study Closure|0|||
125286629|NCT00075725|450674548|FG011|Overall Study|Study Closure|0|||
125286630|NCT00075725|450674537|FG000|Overall Study|Other complications|0|||
125286631|NCT00075725|450674538|FG001|Overall Study|Other complications|0|||
125286632|NCT00075725|450674539|FG002|Overall Study|Other complications|0|||
125286633|NCT00075725|450674540|FG003|Overall Study|Other complications|0|||
125286634|NCT00075725|450674541|FG004|Overall Study|Other complications|0|||
125286635|NCT00075725|450674542|FG005|Overall Study|Other complications|1|||
125286636|NCT00075725|450674543|FG006|Overall Study|Other complications|0|||
125286637|NCT00075725|450674544|FG007|Overall Study|Other complications|0|||
125286638|NCT00075725|450674545|FG008|Overall Study|Other complications|0|||
125286639|NCT00075725|450674546|FG009|Overall Study|Other complications|0|||
125286640|NCT00075725|450674547|FG010|Overall Study|Other complications|0|||
125286641|NCT00075725|450674548|FG011|Overall Study|Other complications|0|||
125286642|NCT00075725|450674537|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
125286643|NCT00075725|450674538|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
125286644|NCT00075725|450674539|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
125286645|NCT00075725|450674540|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
125286646|NCT00075725|450674541|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
125286647|NCT00075725|450674542|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
125286648|NCT00075725|450674543|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
125286649|NCT00075725|450674544|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
125286650|NCT00075725|450674545|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
125286651|NCT00075725|450674546|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
125286652|NCT00075725|450674547|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
125286653|NCT00075725|450674548|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
125286654|NCT00075725|450674537|FG000|Overall Study|Pt incarcerated|0|||
124782929|NCT01497366|448834372|FG001|Overall Study|Virologic failure|50|||
124782930|NCT01497366|448834371|FG000|Overall Study|Lost to Follow-up|11|||
124782931|NCT01497366|448834372|FG001|Overall Study|Lost to Follow-up|10|||
124782932|NCT01497366|448834371|FG000|Overall Study|Withdrawal by Subject|6|||
124782933|NCT01497366|448834372|FG001|Overall Study|Withdrawal by Subject|6|||
124782934|NCT01497366|448834371|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
124782935|NCT01497366|448834372|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
124782936|NCT01497366|448834371|FG000|Overall Study|Other|5|||
124782937|NCT01497366|448834372|FG001|Overall Study|Other|0|||
124782938|NCT01497366|448834371|FG000|Overall Study|Death|1|||
124782939|NCT01497366|448834372|FG001|Overall Study|Death|1|||
124782940|NCT01497366|448834371|FG000|Overall Study|Randomized but not treated|7|||
124782941|NCT01497366|448834372|FG001|Overall Study|Randomized but not treated|21|||
124782942|NCT02745080|448834386|FG000|Overall Study|Adverse Event|13|||
124782943|NCT02745080|448834387|FG001|Overall Study|Adverse Event|21|||
124782944|NCT02745080|448834386|FG000|Overall Study|Lack of Efficacy|11|||
124782945|NCT02745080|448834387|FG001|Overall Study|Lack of Efficacy|23|||
124782946|NCT02745080|448834386|FG000|Overall Study|Lost to Follow-up|3|||
124782947|NCT02745080|448834387|FG001|Overall Study|Lost to Follow-up|3|||
124782948|NCT02745080|448834386|FG000|Overall Study|Physician Decision|3|||
124782949|NCT02745080|448834387|FG001|Overall Study|Physician Decision|0|||
124782950|NCT02745080|448834386|FG000|Overall Study|Protocol Violation|3|||
124782951|NCT02745080|448834387|FG001|Overall Study|Protocol Violation|1|||
124782952|NCT02745080|448834386|FG000|Overall Study|Withdrawal by Subject|22|||
124782953|NCT02745080|448834387|FG001|Overall Study|Withdrawal by Subject|41|||
124782954|NCT01821560|448834388|FG000|Overall Study|Lost to Follow-up|5|||
124782955|NCT01821560|448834389|FG001|Overall Study|Lost to Follow-up|5|||
124782956|NCT01821560|448834388|FG000|Overall Study|Withdrawal by Subject|1|||
124782957|NCT01821560|448834389|FG001|Overall Study|Withdrawal by Subject|1|||
124782958|NCT01821560|448834388|FG000|Overall Study|Protocol Violation|0|||
124782959|NCT01821560|448834389|FG001|Overall Study|Protocol Violation|1|||
124782960|NCT01338298|448834392|FG000|Overall Study|Withdrawal by Subject|1|||
124782961|NCT01338298|448834393|FG001|Overall Study|Withdrawal by Subject|1|||
124782962|NCT01338298|448834392|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
124782963|NCT01338298|448834393|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
124782964|NCT01338298|448834392|FG000|Overall Study|Administrative error|0|||
124782965|NCT01338298|448834393|FG001|Overall Study|Administrative error|1|||
124782966|NCT01338298|448834392|FG000|Overall Study|Positive symptom worsening|1|||
125286655|NCT00075725|450674538|FG001|Overall Study|Pt incarcerated|0|||
125286656|NCT00075725|450674539|FG002|Overall Study|Pt incarcerated|0|||
125286657|NCT00075725|450674540|FG003|Overall Study|Pt incarcerated|0|||
125286658|NCT00075725|450674541|FG004|Overall Study|Pt incarcerated|0|||
125286659|NCT00075725|450674542|FG005|Overall Study|Pt incarcerated|0|||
125286660|NCT00075725|450674543|FG006|Overall Study|Pt incarcerated|0|||
125286661|NCT00075725|450674544|FG007|Overall Study|Pt incarcerated|1|||
125286662|NCT00075725|450674545|FG008|Overall Study|Pt incarcerated|0|||
125286663|NCT00075725|450674546|FG009|Overall Study|Pt incarcerated|0|||
125286664|NCT00075725|450674547|FG010|Overall Study|Pt incarcerated|0|||
125286665|NCT00075725|450674548|FG011|Overall Study|Pt incarcerated|0|||
125286666|NCT01444027|450674551|FG000|Overall Study|Withdrawal by Subject|4|||
125286667|NCT01444027|450674552|FG001|Overall Study|Withdrawal by Subject|10|||
125286668|NCT01444027|450674553|FG002|Overall Study|Withdrawal by Subject|24|||
125286669|NCT01444027|450674551|FG000|Overall Study|Lost to Follow-up|26|||
125286670|NCT01444027|450674552|FG001|Overall Study|Lost to Follow-up|20|||
125286671|NCT01444027|450674553|FG002|Overall Study|Lost to Follow-up|14|||
125286672|NCT00737711|450674555|FG000|Overall Study|Adverse Event|2|||
125286673|NCT00737711|450674555|FG000|Overall Study|Death|8|||
125286674|NCT00737711|450674555|FG000|Overall Study|Failure to return|4|||
125286675|NCT00737711|450674555|FG000|Overall Study|Protocol Violation|1|||
125286676|NCT00737711|450674555|FG000|Overall Study|Withdrawal by Subject|5|||
125286677|NCT00737711|450674555|FG000|Overall Study|Blood transfusion|6|||
125286678|NCT00737711|450674555|FG000|Overall Study|Other|5|||
125286679|NCT00840060|450676415|FG000|Overall Study|Withdrawal by Subject|1|||
125286680|NCT00840060|450676416|FG001|Overall Study|Withdrawal by Subject|0|||
125286681|NCT00840060|450676415|FG000|Overall Study|Change in emotional/behavioral status|0|||
124782967|NCT01338298|448834393|FG001|Overall Study|Positive symptom worsening|0|||
124782968|NCT01338298|448834392|FG000|Overall Study|Depressive symptoms and nausea|1|||
124782969|NCT01338298|448834393|FG001|Overall Study|Depressive symptoms and nausea|0|||
124782970|NCT01338298|448834392|FG000|Overall Study|Non-adherence|1|||
124782971|NCT01338298|448834393|FG001|Overall Study|Non-adherence|0|||
125286682|NCT00840060|450676416|FG001|Overall Study|Change in emotional/behavioral status|1|||
125286683|NCT01263015|450676417|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
125286684|NCT01263015|450676418|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
125286685|NCT01263015|450676417|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
125286686|NCT01263015|450676418|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
125286687|NCT01263015|450676417|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
125286688|NCT01263015|450676418|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
124782972|NCT05601544|448834394|FG000|Phase 2 Period 1|Adverse Event|0|||
124782973|NCT05601544|448834395|FG001|Phase 2 Period 1|Adverse Event|1|||
124782974|NCT05601544|448834396|FG002|Phase 2 Period 1|Adverse Event|0|||
124782975|NCT05601544|448834397|FG003|Phase 2 Period 1|Adverse Event|0|||
124782976|NCT05601544|448834398|FG004|Phase 2 Period 1|Adverse Event|0|||
124782977|NCT05601544|448834399|FG005|Phase 2 Period 1|Adverse Event|0|||
124782978|NCT01256294|448835817|FG000|Overall Study|Adverse Event|1|||
124782979|NCT01256294|448835818|FG001|Overall Study|Adverse Event|0|||
124782980|NCT01256294|448835817|FG000|Overall Study|Withdrawal by Subject|1|||
124782981|NCT01256294|448835818|FG001|Overall Study|Withdrawal by Subject|1|||
124782982|NCT01256294|448835817|FG000|Overall Study|Protocol deviation|2|||
124782983|NCT01256294|448835818|FG001|Overall Study|Protocol deviation|1|||
124782984|NCT04681352|448835819|FG000|Overall Study|Lost to Follow-up|2|||
124782985|NCT04681352|448835819|FG000|Overall Study|Withdrawal by Subject|22|||
124782986|NCT01643772|448835821|FG000|Overall Study|Protocol Violation|0|||
124782987|NCT01643772|448835822|FG001|Overall Study|Protocol Violation|0|||
124782988|NCT01643772|448835823|FG002|Overall Study|Protocol Violation|0|||
124782989|NCT01643772|448835824|FG003|Overall Study|Protocol Violation|1|||
124782990|NCT01643772|448835821|FG000|Overall Study|Adverse Event|0|||
124782991|NCT01643772|448835822|FG001|Overall Study|Adverse Event|0|||
124782992|NCT01643772|448835823|FG002|Overall Study|Adverse Event|0|||
124782993|NCT01643772|448835824|FG003|Overall Study|Adverse Event|1|||
124782994|NCT02338882|448835825|FG000|Overall Study|Death|1|||
124782995|NCT02338882|448835826|FG001|Overall Study|Death|0|||
124782996|NCT02338882|448835825|FG000|Overall Study|Lost to Follow-up|6|||
124782997|NCT02338882|448835826|FG001|Overall Study|Lost to Follow-up|3|||
124782998|NCT04838977|448835829|FG000|Overall Study|Lost to Follow-up|2|||
124782999|NCT04838977|448835830|FG001|Overall Study|Lost to Follow-up|3|||
124783000|NCT04838977|448835829|FG000|Overall Study|Withdrawal by Subject|1|||
124783001|NCT04838977|448835830|FG001|Overall Study|Withdrawal by Subject|1|||
124783002|NCT02314637|448835833|FG000|Overall Study|Adverse Event|4|||
124783003|NCT02314637|448835834|FG001|Overall Study|Adverse Event|8|||
124783004|NCT02314637|448835833|FG000|Overall Study|Lack of Efficacy|1|||
124783005|NCT02314637|448835834|FG001|Overall Study|Lack of Efficacy|0|||
124783006|NCT02314637|448835833|FG000|Overall Study|Physician Decision|5|||
124783007|NCT02314637|448835834|FG001|Overall Study|Physician Decision|2|||
124783008|NCT02314637|448835833|FG000|Overall Study|Withdrawal by Subject|5|||
124783009|NCT02314637|448835834|FG001|Overall Study|Withdrawal by Subject|4|||
124783010|NCT02314637|448835833|FG000|Overall Study|Other Reason|1|||
124783011|NCT02314637|448835834|FG001|Overall Study|Other Reason|0|||
124783012|NCT00724867|448835837|FG000|Overall Study|Adverse Event|25|||
124783013|NCT00724867|448835837|FG000|Overall Study|Lack of Efficacy|14|||
124783014|NCT00724867|448835837|FG000|Overall Study|Lost to Follow-up|12|||
124783015|NCT00724867|448835837|FG000|Overall Study|Non-compliance with study drug|6|||
124783016|NCT00724867|448835837|FG000|Overall Study|Physician Decision|17|||
124783017|NCT00724867|448835837|FG000|Overall Study|Protocol Violation|1|||
124783018|NCT00724867|448835837|FG000|Overall Study|Withdrawal by Subject|31|||
124783019|NCT00724867|448835837|FG000|Overall Study|Sponsor decision to end study|14|||
124783020|NCT00724867|448835837|FG000|Overall Study|Subject incarcerated|1|||
124783021|NCT00724867|448835837|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
124783022|NCT00724867|448835837|FG000|Overall Study|Subject moved out of state|1|||
124783023|NCT00724867|448835837|FG000|Overall Study|Elected to exit due to site closure|2|||
124783024|NCT00373113|448835838|FG000|Overall Study|Death|1|||
124783025|NCT00373113|448835839|FG001|Overall Study|Death|7|||
124783026|NCT00373113|448835838|FG000|Overall Study|Adverse Event|38|||
124783027|NCT00373113|448835839|FG001|Overall Study|Adverse Event|24|||
124783028|NCT00373113|448835838|FG000|Overall Study|Study terminated by sponsor|9|||
124783029|NCT00373113|448835839|FG001|Overall Study|Study terminated by sponsor|1|||
124783030|NCT00373113|448835838|FG000|Overall Study|Global deterioration of health status|10|||
124783031|NCT00373113|448835839|FG001|Overall Study|Global deterioration of health status|7|||
124783032|NCT00373113|448835838|FG000|Overall Study|Lost to Follow-up|1|||
124783033|NCT00373113|448835839|FG001|Overall Study|Lost to Follow-up|3|||
124783034|NCT00373113|448835838|FG000|Overall Study|Objective progression or relapse|150|||
124783035|NCT00373113|448835839|FG001|Overall Study|Objective progression or relapse|169|||
124783036|NCT00373113|448835838|FG000|Overall Study|Other|14|||
124783037|NCT00373113|448835839|FG001|Overall Study|Other|17|||
124783038|NCT00373113|448835838|FG000|Overall Study|Protocol Violation|5|||
124783039|NCT00373113|448835839|FG001|Overall Study|Protocol Violation|1|||
124783040|NCT00373113|448835838|FG000|Overall Study|Withdrawal by Subject|10|||
124783041|NCT00373113|448835839|FG001|Overall Study|Withdrawal by Subject|15|||
124783042|NCT03120351|448835848|FG000|Overall Study|Physician Decision|1|||
124783043|NCT03120351|448835849|FG001|Overall Study|Physician Decision|1|||
124783044|NCT01256190|448835850|FG000|Overall Study|Lost to Follow-up|2|||
124783045|NCT01256190|448835851|FG001|Overall Study|Lost to Follow-up|0|||
125286689|NCT01263015|450676417|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
124783046|NCT02834793|448835852|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
124783047|NCT02834793|448835853|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
124783048|NCT02834793|448835854|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
124783049|NCT02834793|448835855|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
124783050|NCT02834793|448835852|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
124783051|NCT02834793|448835853|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
125286690|NCT01263015|450676418|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
125286691|NCT01263015|450676417|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
125286692|NCT01263015|450676418|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
125286693|NCT01263015|450676417|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
125286694|NCT01263015|450676418|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
125286695|NCT01263015|450676417|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
125286696|NCT01263015|450676418|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
125286697|NCT01263015|450676417|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
125286698|NCT01263015|450676418|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
125286699|NCT01263015|450676417|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
125286700|NCT01263015|450676418|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
125286701|NCT01263015|450676417|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
125286702|NCT01263015|450676418|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
125286703|NCT01263015|450676417|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
125286704|NCT01263015|450676418|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
125286705|NCT01263015|450676417|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
125286706|NCT01263015|450676418|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
125286707|NCT00303446|450676420|FG000|Overall Study|Withdrawal by Subject|2|||
125286708|NCT00303446|450676421|FG001|Overall Study|Withdrawal by Subject|2|||
125286709|NCT00303446|450676420|FG000|Overall Study|Death|0|||
125286710|NCT00303446|450676421|FG001|Overall Study|Death|1|||
125286711|NCT00303446|450676420|FG000|Overall Study|Physician Decision|0|||
125286712|NCT00303446|450676421|FG001|Overall Study|Physician Decision|1|||
125286713|NCT02251717|450676422|FG000|Overall Study|Adverse Event|0|||
125286714|NCT02251717|450676423|FG001|Overall Study|Adverse Event|1|||
125286715|NCT02251717|450676422|FG000|Overall Study|Withdrew Consent|1|||
125286716|NCT02251717|450676423|FG001|Overall Study|Withdrew Consent|0|||
125286717|NCT00489736|450676424|FG000|Overall Study|Lack of Efficacy|53|||
125286718|NCT00489736|450676425|FG001|Overall Study|Lack of Efficacy|14|||
125286719|NCT00489736|450676424|FG000|Overall Study|Adverse Event|32|||
125286720|NCT00489736|450676425|FG001|Overall Study|Adverse Event|45|||
125286721|NCT00489736|450676424|FG000|Overall Study|Poor compliance|6|||
125286722|NCT00489736|450676425|FG001|Overall Study|Poor compliance|2|||
125286723|NCT00489736|450676424|FG000|Overall Study|Not coded/ Not pre-specified|5|||
125286724|NCT00489736|450676425|FG001|Overall Study|Not coded/ Not pre-specified|8|||
125286725|NCT04035564|450676426|FG000|Overall Study|Protocol Violation|1|||
125286726|NCT04035564|450676427|FG001|Overall Study|Protocol Violation|2|||
125286727|NCT04035564|450676426|FG000|Overall Study|No laboratory available|2|||
125286728|NCT04035564|450676427|FG001|Overall Study|No laboratory available|2|||
125286729|NCT04035564|450676426|FG000|Overall Study|Guardian declined consent|1|||
125286730|NCT04035564|450676427|FG001|Overall Study|Guardian declined consent|2|||
125286731|NCT03505788|450676428|FG000|Overall Study|Lost to Follow-up|2|||
125286732|NCT03505788|450676429|FG001|Overall Study|Lost to Follow-up|1|||
125286733|NCT03505788|450676428|FG000|Overall Study|Withdrawal by Subject|1|||
125286734|NCT03505788|450676429|FG001|Overall Study|Withdrawal by Subject|3|||
125286735|NCT03505788|450676428|FG000|Overall Study|Physician Decision|0|||
125286736|NCT03505788|450676429|FG001|Overall Study|Physician Decision|1|||
125286737|NCT02324205|450676430|FG000|Overall Study|Withdrawal by Subject|37|||
125286738|NCT01774097|450676431|FG000|Overall Study|Withdrawal by Subject|1|||
125286739|NCT01774097|450676432|FG001|Overall Study|Withdrawal by Subject|1|||
125286740|NCT01774097|450676431|FG000|Overall Study|Adverse Event|1|||
125286741|NCT01774097|450676432|FG001|Overall Study|Adverse Event|1|||
125286742|NCT03664674|450676434|FG000|Overall Study|Adverse Event|1|||
125286743|NCT03664674|450676435|FG001|Overall Study|Adverse Event|1|||
125286744|NCT03664674|450676434|FG000|Overall Study|Physician Decision|0|||
125286745|NCT03664674|450676435|FG001|Overall Study|Physician Decision|1|||
125286746|NCT03664674|450676434|FG000|Overall Study|Withdrawal by Subject|2|||
125286747|NCT03664674|450676435|FG001|Overall Study|Withdrawal by Subject|0|||
125286748|NCT02174523|450676437|FG000|Overall Study|Withdrawal by Subject|1|||
125286749|NCT02174523|450676438|FG001|Overall Study|Withdrawal by Subject|0|||
125286750|NCT00794365|450676439|FG000|Overall Study|Lost to Follow-up|38|||
125286751|NCT00794365|450676439|FG000|Overall Study|Other|17|||
125286752|NCT00794365|450676439|FG000|Overall Study|Poor Compliance|11|||
125286753|NCT00794365|450676439|FG000|Overall Study|Adverse Event|10|||
125286754|NCT00794365|450676439|FG000|Overall Study|Lack of Efficacy|3|||
125286755|NCT00937404|450676440|FG000|Overall Study|Protocol Violation|1|||
125286756|NCT00937404|450676440|FG000|Overall Study|Withdrawal by Subject|1|||
125286757|NCT00230282|450676442|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
125286758|NCT00230282|450676442|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
125286759|NCT00230282|450676442|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
125286760|NCT00230282|450676442|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
125286761|NCT00090233|450676445|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
124783052|NCT02834793|448835854|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
125286762|NCT00090233|450676446|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
125286763|NCT00090233|450676445|FG000|Overall Study|Adverse Event|214|||
125286764|NCT00090233|450676446|FG001|Overall Study|Adverse Event|198|||
125286765|NCT00090233|450676445|FG000|Overall Study|Lost to Follow-up|68|||
125286766|NCT00090233|450676446|FG001|Overall Study|Lost to Follow-up|95|||
125286767|NCT00090233|450676445|FG000|Overall Study|Protocol Violation|960|||
125286768|NCT00090233|450676446|FG001|Overall Study|Protocol Violation|1022|||
124783053|NCT02834793|448835855|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
124783054|NCT02834793|448835852|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
124783055|NCT02834793|448835853|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
125286769|NCT00090233|450676445|FG000|Overall Study|Withdrawal by Subject|182|||
125286770|NCT00090233|450676446|FG001|Overall Study|Withdrawal by Subject|211|||
125286771|NCT00090233|450676445|FG000|Overall Study|Moved|203|||
124783056|NCT02834793|448835854|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
124783057|NCT02834793|448835855|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
124783058|NCT02834793|448835852|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
124783059|NCT02834793|448835853|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
124783060|NCT02834793|448835854|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
124783061|NCT02834793|448835855|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
124783062|NCT02834793|448835852|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
124783063|NCT02834793|448835853|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
124783064|NCT02834793|448835854|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
124783065|NCT02834793|448835855|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
124783066|NCT02834793|448835852|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
124783067|NCT02834793|448835853|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
124783068|NCT02834793|448835854|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
124783069|NCT02834793|448835855|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
124783070|NCT02834793|448835852|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
124783071|NCT02834793|448835853|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
124783072|NCT02834793|448835854|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
124783073|NCT02834793|448835855|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
124783074|NCT02834793|448835852|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
124783075|NCT02834793|448835853|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
124783076|NCT02834793|448835854|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
124783077|NCT02834793|448835855|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
125286772|NCT00090233|450676446|FG001|Overall Study|Moved|189|||
124783078|NCT02834793|448835852|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
125286773|NCT00090233|450676445|FG000|Overall Study|Other|1211|||
125286774|NCT00090233|450676446|FG001|Overall Study|Other|1160|||
125286775|NCT00090233|450676445|FG000|Overall Study|Data not available at data cut-off point|1552|||
124783079|NCT02834793|448835853|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
124783080|NCT02834793|448835854|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
125286776|NCT00090233|450676446|FG001|Overall Study|Data not available at data cut-off point|1563|||
125286777|NCT04863248|450676447|FG000|Overall Study|Sponsor Terminated|4|||
125286778|NCT04863248|450676448|FG001|Overall Study|Sponsor Terminated|1|||
125286779|NCT04863248|450676447|FG000|Overall Study|Death|0|||
125286780|NCT04863248|450676448|FG001|Overall Study|Death|1|||
125286781|NCT04863248|450676447|FG000|Overall Study|Withdrawal by Subject|0|||
125286782|NCT04863248|450676448|FG001|Overall Study|Withdrawal by Subject|1|||
125286783|NCT01691105|450676449|FG000|1 Month Follow-up|Lost to Follow-up|41|||
125286784|NCT01691105|450676450|FG001|1 Month Follow-up|Lost to Follow-up|38|||
125286785|NCT01691105|450676449|FG000|1 Month Follow-up|Death|2|||
125286786|NCT01691105|450676450|FG001|1 Month Follow-up|Death|3|||
125286787|NCT01691105|450676449|FG000|6 Month Follow-up|Lost to Follow-up|39|||
125286788|NCT01691105|450676450|FG001|6 Month Follow-up|Lost to Follow-up|58|||
125286789|NCT01691105|450676449|FG000|6 Month Follow-up|Death|13|||
125286790|NCT01691105|450676450|FG001|6 Month Follow-up|Death|13|||
125286791|NCT01691105|450676449|FG000|12 Month Follow-up|Lost to Follow-up|50|||
125286792|NCT01691105|450676450|FG001|12 Month Follow-up|Lost to Follow-up|71|||
125286793|NCT01691105|450676449|FG000|12 Month Follow-up|Death|22|||
125286794|NCT01691105|450676450|FG001|12 Month Follow-up|Death|30|||
125286795|NCT01691105|450676449|FG000|12 Month Biochemical Verification|Death|22|||
125286796|NCT01691105|450676450|FG001|12 Month Biochemical Verification|Death|30|||
125286797|NCT01691105|450676449|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
125286798|NCT01691105|450676450|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
125286799|NCT01691105|450676449|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
125286800|NCT01691105|450676450|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
125286801|NCT03263923|450676451|FG000|Overall Study|Withdrawal by Subject|10|||
125286802|NCT03263923|450676452|FG001|Overall Study|Withdrawal by Subject|8|||
125286803|NCT03263923|450676451|FG000|Overall Study|Lost to Follow-up|15|||
125286804|NCT03263923|450676452|FG001|Overall Study|Lost to Follow-up|13|||
125286805|NCT03362931|450676453|FG000|Overall Study|Adverse Event|1|||
125286806|NCT03362931|450676453|FG000|Overall Study|Death|2|||
125286807|NCT02927925|450676462|FG000|Overall Study|Death|16|||
125286808|NCT02927925|450676462|FG000|Overall Study|Physician Decision|1|||
125286809|NCT02927925|450676462|FG000|Overall Study|Withdrawal by Subject|11|||
125286810|NCT02927925|450676462|FG000|Overall Study|Other|3|||
125286811|NCT02927925|450676462|FG000|Overall Study|Disease progression at clinical cutoff|1|||
125286812|NCT02229214|450676463|FG000|Overall Study|Adverse Event|2|||
125286813|NCT02229214|450676464|FG001|Overall Study|Adverse Event|0|||
125286814|NCT02229214|450676463|FG000|Overall Study|Withdrawal by Subject|4|||
125286815|NCT02229214|450676464|FG001|Overall Study|Withdrawal by Subject|0|||
125286816|NCT00969761|450676471|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
125286817|NCT00969761|450676472|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
125286818|NCT00969761|450676473|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
125286819|NCT00969761|450676474|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
125286820|NCT00969761|450676475|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
125286821|NCT00969761|450676476|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
125286822|NCT00969761|450676477|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
125286823|NCT00969761|450676478|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
125286824|NCT00969761|450676479|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
125286825|NCT00969761|450676480|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
125286826|NCT00969761|450676481|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
125286827|NCT00969761|450676482|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
125286828|NCT00969761|450676471|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286829|NCT00969761|450676472|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286830|NCT00969761|450676473|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
125286831|NCT00969761|450676474|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286832|NCT00969761|450676475|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286833|NCT00969761|450676476|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286834|NCT00969761|450676477|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286835|NCT00969761|450676478|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286836|NCT00969761|450676479|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286837|NCT00969761|450676480|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286838|NCT00969761|450676481|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286839|NCT00969761|450676482|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286840|NCT00969761|450676471|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286841|NCT00969761|450676472|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286842|NCT00969761|450676473|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
125286843|NCT00969761|450676474|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286844|NCT00969761|450676475|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286845|NCT00969761|450676476|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286846|NCT00969761|450676477|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286847|NCT00969761|450676478|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286848|NCT00969761|450676479|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286849|NCT00969761|450676480|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286850|NCT00969761|450676481|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286851|NCT00969761|450676482|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286852|NCT00969761|450676471|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
125286853|NCT00969761|450676472|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
124783081|NCT02834793|448835855|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
124783082|NCT02834793|448835852|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
125286854|NCT00969761|450676473|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
125286855|NCT00969761|450676474|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
125286856|NCT00969761|450676475|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
125286857|NCT00969761|450676476|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
124783083|NCT02834793|448835853|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
124783084|NCT02834793|448835854|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
124783085|NCT02834793|448835855|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
124783086|NCT02834793|448835852|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
124783087|NCT02834793|448835853|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
124783088|NCT02834793|448835854|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
124783089|NCT02834793|448835855|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
124783090|NCT02834793|448835852|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
124783091|NCT02834793|448835853|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
124783092|NCT02834793|448835854|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
124783093|NCT02834793|448835855|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
124783094|NCT02834793|448835852|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
124783095|NCT02834793|448835853|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
124783096|NCT02834793|448835854|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
124783097|NCT02834793|448835855|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
124783098|NCT02834793|448835852|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
124783099|NCT02834793|448835853|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
124783100|NCT02834793|448835854|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
124783101|NCT02834793|448835855|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
124783102|NCT02834793|448835852|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
124783103|NCT02834793|448835853|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
124783104|NCT02834793|448835854|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
124783105|NCT02834793|448835855|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
124783106|NCT01049009|448835856|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
124783107|NCT01049009|448835857|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
124783108|NCT01049009|448835856|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124783109|NCT01049009|448835857|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
124783110|NCT01049009|448835856|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
124783111|NCT01049009|448835857|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
124783112|NCT01049009|448835856|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
124783113|NCT01049009|448835857|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
124783114|NCT02423902|448835858|FG000|Overall Study|Disease progression|1|||
124783115|NCT02423902|448835859|FG001|Overall Study|Disease progression|4|||
124783116|NCT00622440|448835872|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
124783117|NCT00622440|448835873|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
124783118|NCT00622440|448835872|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
124783119|NCT00622440|448835873|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
124783120|NCT00622440|448835872|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
124783121|NCT00622440|448835873|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
124783122|NCT00622440|448835872|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
124783123|NCT00622440|448835873|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
124783124|NCT04195893|448835882|FG000|Second Intervention|Withdrawal by Subject|1|||
124783125|NCT04195893|448835883|FG001|Second Intervention|Withdrawal by Subject|0|||
124783126|NCT01802073|448835886|FG000|Overall Study|Lost to Follow-up|0|||
124783127|NCT01802073|448835887|FG001|Overall Study|Lost to Follow-up|1|||
124783128|NCT01802073|448835886|FG000|Overall Study|Non-compliant|4|||
124783129|NCT01802073|448835887|FG001|Overall Study|Non-compliant|2|||
124783130|NCT01802073|448835886|FG000|Overall Study|Withdrawal by Subject|1|||
124783131|NCT01802073|448835887|FG001|Overall Study|Withdrawal by Subject|1|||
124783132|NCT01802073|448835886|FG000|Overall Study|Physician Decision|0|||
124783133|NCT01802073|448835887|FG001|Overall Study|Physician Decision|7|||
124783134|NCT02123472|448835891|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
124783135|NCT02123472|448835892|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
124783136|NCT00918736|448835893|FG000|Overall Study|Withdrawal by Subject|4|||
124783137|NCT01474018|448835894|FG000|Overall Study|Lost to Follow-up|0|||
124783138|NCT01474018|448835895|FG001|Overall Study|Lost to Follow-up|1|||
124783139|NCT01474018|448835894|FG000|Overall Study|Withdrawal by Subject|0|||
124783140|NCT01474018|448835895|FG001|Overall Study|Withdrawal by Subject|2|||
124783141|NCT01137604|448835896|FG000|Overall Study|Adverse Event|3|||
124783142|NCT01137604|448835897|FG001|Overall Study|Adverse Event|6|||
124783143|NCT01137604|448835898|FG002|Overall Study|Adverse Event|9|||
124783144|NCT01137604|448835899|FG003|Overall Study|Adverse Event|9|||
124783145|NCT01137604|448835896|FG000|Overall Study|Participant Choice|0|||
124783146|NCT01137604|448835897|FG001|Overall Study|Participant Choice|2|||
124783147|NCT01137604|448835898|FG002|Overall Study|Participant Choice|2|||
124783148|NCT01137604|448835899|FG003|Overall Study|Participant Choice|0|||
124783149|NCT01137604|448835896|FG000|Overall Study|Withdrawal of consent|0|||
124783150|NCT01137604|448835897|FG001|Overall Study|Withdrawal of consent|0|||
124783151|NCT01137604|448835898|FG002|Overall Study|Withdrawal of consent|0|||
124783152|NCT01137604|448835899|FG003|Overall Study|Withdrawal of consent|2|||
124783153|NCT01137604|448835896|FG000|Overall Study|Clinical progression/deterioration|1|||
124783154|NCT01137604|448835897|FG001|Overall Study|Clinical progression/deterioration|2|||
124783155|NCT01137604|448835898|FG002|Overall Study|Clinical progression/deterioration|2|||
124783156|NCT01137604|448835899|FG003|Overall Study|Clinical progression/deterioration|0|||
124783157|NCT01297491|448835900|FG000|Overall Study|Adverse Event|11|||
124783158|NCT01297491|448835901|FG001|Overall Study|Adverse Event|6|||
124783159|NCT01297491|448835900|FG000|Overall Study|Physician Decision|3|||
124783160|NCT01297491|448835901|FG001|Overall Study|Physician Decision|2|||
124783161|NCT01297491|448835900|FG000|Overall Study|Progressive disease|11|||
124783162|NCT01297491|448835901|FG001|Overall Study|Progressive disease|20|||
124783163|NCT01297491|448835900|FG000|Overall Study|Patient/Guardian decision|3|||
124783164|NCT01297491|448835901|FG001|Overall Study|Patient/Guardian decision|4|||
124783165|NCT01297491|448835900|FG000|Overall Study|Death|2|||
124783166|NCT01297491|448835901|FG001|Overall Study|Death|1|||
124783167|NCT02511106|448835902|FG000|Overall Study|Lost to Follow-up|6|||
124783168|NCT02511106|448835903|FG001|Overall Study|Lost to Follow-up|4|||
124783169|NCT02511106|448835902|FG000|Overall Study|Withdrawal by Subject|24|||
124783170|NCT02511106|448835903|FG001|Overall Study|Withdrawal by Subject|21|||
124783171|NCT02511106|448835902|FG000|Overall Study|Death|42|||
124783172|NCT02511106|448835903|FG001|Overall Study|Death|82|||
124783173|NCT02511106|448835902|FG000|Overall Study|Ongoing study at data cut-off|3|||
124783174|NCT02511106|448835903|FG001|Overall Study|Ongoing study at data cut-off|2|||
124783175|NCT02511106|448835902|FG000|Overall Study|Without specified reason|3|||
124783176|NCT02511106|448835903|FG001|Overall Study|Without specified reason|0|||
124783177|NCT00344487|448835907|FG000|Overall Study|immunologic failure|1|||
124783178|NCT03679754|448835910|FG000|Overall Study|Investigator request|1|||
124783179|NCT01262820|448835911|FG000|Overall Study|Adverse Event|5|||
124783180|NCT01262820|448835911|FG000|Overall Study|Lack of Efficacy|9|||
124783181|NCT01262820|448835911|FG000|Overall Study|Drug held for 21+ days|1|||
124783182|NCT00711477|448835912|FG000|Overall Study|Adverse Event|3|||
124783183|NCT00711477|448835913|FG001|Overall Study|Adverse Event|1|||
124783184|NCT00711477|448835912|FG000|Overall Study|Lost to Follow-up|0|||
124783185|NCT00711477|448835913|FG001|Overall Study|Lost to Follow-up|1|||
124783186|NCT00711477|448835912|FG000|Overall Study|Noncompliance|0|||
124783187|NCT00711477|448835913|FG001|Overall Study|Noncompliance|1|||
124783188|NCT00145977|448835919|FG000|Overall Study|Lack of Efficacy|0|||
124783189|NCT00145977|448835920|FG001|Overall Study|Lack of Efficacy|4|||
124783190|NCT00145977|448835919|FG000|Overall Study|Lost to Follow-up|1|||
124783191|NCT00145977|448835920|FG001|Overall Study|Lost to Follow-up|0|||
125286858|NCT00969761|450676477|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
125286859|NCT00969761|450676478|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
125286860|NCT00969761|450676479|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
125286861|NCT00969761|450676480|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
125286862|NCT00969761|450676481|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
125286863|NCT00969761|450676482|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
125286864|NCT00969761|450676471|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
125286865|NCT00969761|450676472|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
125286866|NCT00969761|450676473|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
125286867|NCT00969761|450676474|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
125286868|NCT00969761|450676475|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
125286869|NCT00969761|450676476|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
125286870|NCT00969761|450676477|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
125286871|NCT00969761|450676478|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
125286872|NCT00969761|450676479|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
125286873|NCT00969761|450676480|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
124783192|NCT00145977|448835919|FG000|Overall Study|Withdrawal by Subject|1|||
124783193|NCT00145977|448835920|FG001|Overall Study|Withdrawal by Subject|0|||
124783194|NCT00782834|448835927|FG000|Treatment Phase|fibrous tumor not GIST|1|||
124783195|NCT02055118|448835928|FG000|Overall Study|Withdrawal by Subject|0|||
124783196|NCT02055118|448835929|FG001|Overall Study|Withdrawal by Subject|2|||
125286874|NCT00969761|450676481|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
125286875|NCT00969761|450676482|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
125286876|NCT00969761|450676471|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
125286877|NCT00969761|450676472|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
125286878|NCT00969761|450676473|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
125286879|NCT00969761|450676474|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
125286880|NCT00969761|450676475|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
125286881|NCT00969761|450676476|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
125286882|NCT00969761|450676477|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
125286883|NCT00969761|450676478|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
125286884|NCT00969761|450676479|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
125286885|NCT00969761|450676480|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
125286886|NCT00969761|450676481|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
125286887|NCT00969761|450676482|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
125286888|NCT03305081|450676485|FG000|Overall Study|Lost to Follow-up|10|||
125286889|NCT03305081|450676486|FG001|Overall Study|Lost to Follow-up|15|||
125286890|NCT01571284|450676493|FG000|Overall Study|Participant's decision|84|||
125286891|NCT01571284|450676493|FG000|Overall Study|Lost to Follow-up|3|||
125286892|NCT01571284|450676493|FG000|Overall Study|Enrolled but not treated|2|||
125286893|NCT01571284|450676493|FG000|Overall Study|Other than specified above|80|||
125286894|NCT04065074|450676494|FG000|Overall Study|Adverse Event|1|||
125286895|NCT04065074|450676494|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
125286896|NCT00871117|450676495|FG000|Overall Study|Lost to Follow-up|5|||
125286897|NCT00871117|450676496|FG001|Overall Study|Lost to Follow-up|6|||
125286898|NCT00871117|450676495|FG000|Overall Study|Other|0|||
125286899|NCT00871117|450676496|FG001|Overall Study|Other|4|||
125286900|NCT03385265|450676500|FG000|Overall Study|Withdrawal by Subject|5|||
125286901|NCT03385265|450676501|FG001|Overall Study|Withdrawal by Subject|2|||
125286902|NCT03385265|450676502|FG002|Overall Study|Withdrawal by Subject|5|||
125286903|NCT03385265|450676503|FG003|Overall Study|Withdrawal by Subject|2|||
125286904|NCT01560637|450676504|FG000|Overall Study|Adverse Event|63|||
125286905|NCT01560637|450676504|FG000|Overall Study|Death|69|||
125286906|NCT01560637|450676504|FG000|Overall Study|Lost to Follow-up|8|||
125286907|NCT01560637|450676504|FG000|Overall Study|Protocol Violation|8|||
125286908|NCT01560637|450676504|FG000|Overall Study|Withdrawal by Subject|24|||
125286909|NCT01560637|450676504|FG000|Overall Study|Progressive Disease|20|||
125286910|NCT01560637|450676504|FG000|Overall Study|Other Reason Not Specified|6|||
125286911|NCT02323204|450676505|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
125286912|NCT02323204|450676506|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
125286913|NCT02323204|450676507|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
125286914|NCT02323204|450676508|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
125286915|NCT02323204|450676505|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
125286916|NCT02323204|450676506|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
125286917|NCT02323204|450676507|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
125286918|NCT02323204|450676508|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
125286919|NCT02323204|450676505|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
125286920|NCT02323204|450676506|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
125286921|NCT02323204|450676507|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
125286922|NCT02323204|450676508|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
125286923|NCT02323204|450676505|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
125286924|NCT02323204|450676506|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
125286925|NCT02323204|450676507|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
125286926|NCT02323204|450676508|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
125286927|NCT02323204|450676505|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
125286928|NCT02323204|450676506|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
125286929|NCT02323204|450676507|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
125286930|NCT02323204|450676508|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
125286931|NCT02323204|450676505|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
125286932|NCT02323204|450676506|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
125286933|NCT02323204|450676507|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
125286934|NCT02323204|450676508|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
125286935|NCT02323204|450676505|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
125286936|NCT02323204|450676506|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
125286937|NCT02323204|450676507|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
125286938|NCT02323204|450676508|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
125286939|NCT02323204|450676505|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
125286940|NCT02323204|450676506|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
125286941|NCT02323204|450676507|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
125286942|NCT02323204|450676508|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
125286943|NCT02323204|450676505|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
125286944|NCT02323204|450676506|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
125286945|NCT02323204|450676507|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
125286946|NCT02323204|450676508|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
125286947|NCT03831880|450676514|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
125286948|NCT03831880|450676515|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
125286949|NCT03831880|450676514|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
125286950|NCT03831880|450676515|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
125286951|NCT01852825|450676516|FG000|Overall Study|Withdrawal by Subject|2|||
125286952|NCT01852825|450676517|FG001|Overall Study|Withdrawal by Subject|0|||
125286953|NCT01852825|450676518|FG002|Overall Study|Withdrawal by Subject|0|||
125286954|NCT00724854|450676520|FG000|Overall Study|Lack of Efficacy|187|||
125286955|NCT00724854|450676521|FG001|Overall Study|Lack of Efficacy|13|||
125286956|NCT00724854|450676520|FG000|Overall Study|Lost to Follow-up|87|||
125286957|NCT00724854|450676521|FG001|Overall Study|Lost to Follow-up|10|||
125286958|NCT00724854|450676520|FG000|Overall Study|Adverse Event|62|||
125286959|NCT00724854|450676521|FG001|Overall Study|Adverse Event|4|||
125286960|NCT00724854|450676520|FG000|Overall Study|Other|42|||
125286961|NCT00724854|450676521|FG001|Overall Study|Other|3|||
125286962|NCT00724854|450676520|FG000|Overall Study|Death|11|||
125286963|NCT00724854|450676521|FG001|Overall Study|Death|0|||
125286964|NCT00724854|450676520|FG000|Overall Study|Change of treatment|7|||
125286965|NCT00724854|450676521|FG001|Overall Study|Change of treatment|0|||
125286966|NCT00724854|450676520|FG000|Overall Study|Withdrawal by Subject|5|||
125286967|NCT00724854|450676521|FG001|Overall Study|Withdrawal by Subject|0|||
125286968|NCT00724854|450676520|FG000|Overall Study|Adverse event + lack of efficacy|2|||
125286969|NCT00724854|450676521|FG001|Overall Study|Adverse event + lack of efficacy|1|||
125286970|NCT01095653|450676522|FG000|Overall Study|Lack of Efficacy|3|||
125286971|NCT01095653|450676523|FG001|Overall Study|Lack of Efficacy|0|||
125286972|NCT01095653|450676524|FG002|Overall Study|Lack of Efficacy|0|||
125286973|NCT01095653|450676522|FG000|Overall Study|Adverse Event|1|||
125286974|NCT01095653|450676523|FG001|Overall Study|Adverse Event|4|||
125286975|NCT01095653|450676524|FG002|Overall Study|Adverse Event|4|||
125286976|NCT01095653|450676522|FG000|Overall Study|Lost to Follow-up|1|||
125286977|NCT01095653|450676523|FG001|Overall Study|Lost to Follow-up|0|||
125286978|NCT01095653|450676524|FG002|Overall Study|Lost to Follow-up|4|||
125286979|NCT01095653|450676522|FG000|Overall Study|Withdrawal by Subject|4|||
125286980|NCT01095653|450676523|FG001|Overall Study|Withdrawal by Subject|5|||
125286981|NCT01095653|450676524|FG002|Overall Study|Withdrawal by Subject|3|||
125286982|NCT01095653|450676522|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
125286983|NCT01095653|450676523|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
125286984|NCT01095653|450676524|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
125286985|NCT00171925|450676525|FG000|Overall Study|Adverse Event|10|||
125286986|NCT00171925|450676526|FG001|Overall Study|Adverse Event|6|||
125286987|NCT00171925|450676525|FG000|Overall Study|Protocol Violation|1|||
125286988|NCT00171925|450676526|FG001|Overall Study|Protocol Violation|1|||
125286989|NCT00171925|450676525|FG000|Overall Study|Withdrawal by Subject|6|||
125286990|NCT00171925|450676526|FG001|Overall Study|Withdrawal by Subject|9|||
125286991|NCT00171925|450676525|FG000|Overall Study|Lost to Follow-up|2|||
125286992|NCT00171925|450676526|FG001|Overall Study|Lost to Follow-up|2|||
125286993|NCT00171925|450676525|FG000|Overall Study|Administrative problems|10|||
125286994|NCT00171925|450676526|FG001|Overall Study|Administrative problems|11|||
125286995|NCT00171925|450676525|FG000|Overall Study|Death|1|||
125286996|NCT00171925|450676526|FG001|Overall Study|Death|2|||
125286997|NCT02692040|450676527|FG000|Overall Study|Protocol Violation|0|||
125286998|NCT02692040|450676528|FG001|Overall Study|Protocol Violation|0|||
125286999|NCT02692040|450676529|FG002|Overall Study|Protocol Violation|0|||
125287000|NCT02692040|450676530|FG003|Overall Study|Protocol Violation|0|||
125287001|NCT02692040|450676531|FG004|Overall Study|Protocol Violation|0|||
125287002|NCT02692040|450676532|FG005|Overall Study|Protocol Violation|0|||
125287003|NCT02692040|450676533|FG006|Overall Study|Protocol Violation|0|||
125287004|NCT02692040|450676534|FG007|Overall Study|Protocol Violation|0|||
125287005|NCT02692040|450676535|FG008|Overall Study|Protocol Violation|0|||
125287006|NCT02692040|450676536|FG009|Overall Study|Protocol Violation|0|||
125287007|NCT02692040|450676537|FG010|Overall Study|Protocol Violation|0|||
125287008|NCT02692040|450676538|FG011|Overall Study|Protocol Violation|0|||
125287009|NCT02692040|450676539|FG012|Overall Study|Protocol Violation|1|||
125287010|NCT02692040|450676540|FG013|Overall Study|Protocol Violation|0|||
125287011|NCT02692040|450676541|FG014|Overall Study|Protocol Violation|0|||
125287012|NCT02692040|450676542|FG015|Overall Study|Protocol Violation|0|||
125287013|NCT02692040|450676543|FG016|Overall Study|Protocol Violation|0|||
125287014|NCT02692040|450676527|FG000|Overall Study|Adverse Event|0|||
125287015|NCT02692040|450676528|FG001|Overall Study|Adverse Event|0|||
125287016|NCT02692040|450676529|FG002|Overall Study|Adverse Event|0|||
125287017|NCT02692040|450676530|FG003|Overall Study|Adverse Event|0|||
125287018|NCT02692040|450676531|FG004|Overall Study|Adverse Event|0|||
125287019|NCT02692040|450676532|FG005|Overall Study|Adverse Event|0|||
125287020|NCT02692040|450676533|FG006|Overall Study|Adverse Event|0|||
125287021|NCT02692040|450676534|FG007|Overall Study|Adverse Event|0|||
125287022|NCT02692040|450676535|FG008|Overall Study|Adverse Event|0|||
125287023|NCT02692040|450676536|FG009|Overall Study|Adverse Event|0|||
125287024|NCT02692040|450676537|FG010|Overall Study|Adverse Event|0|||
125287025|NCT02692040|450676538|FG011|Overall Study|Adverse Event|0|||
125287026|NCT02692040|450676539|FG012|Overall Study|Adverse Event|0|||
125287027|NCT02692040|450676540|FG013|Overall Study|Adverse Event|3|||
125287028|NCT02692040|450676541|FG014|Overall Study|Adverse Event|1|||
125287029|NCT02692040|450676542|FG015|Overall Study|Adverse Event|1|||
125287030|NCT02692040|450676543|FG016|Overall Study|Adverse Event|0|||
125287031|NCT02752958|450676544|FG000|Overall Study|Adverse Event|3|||
125287032|NCT02752958|450676544|FG000|Overall Study|Lost to Follow-up|1|||
125287033|NCT02752958|450676544|FG000|Overall Study|Protocol Violation|1|||
125287034|NCT02752958|450676544|FG000|Overall Study|Withdrawal by Subject|2|||
125287035|NCT02752958|450676544|FG000|Overall Study|Other (Reason not specified)|2|||
125287036|NCT00853125|450676545|FG000|Overall Study|Study participant's donor was CMV +|1|||
125287037|NCT03746600|450676551|FG000|Overall Study|Withdrawal by Subject|3|||
125287038|NCT03746600|450676552|FG001|Overall Study|Withdrawal by Subject|3|||
125287039|NCT03746600|450676551|FG000|Overall Study|dismissed from study|1|||
125287040|NCT03746600|450676552|FG001|Overall Study|dismissed from study|0|||
125287041|NCT03746600|450676551|FG000|Overall Study|Lost to Follow-up|1|||
125287042|NCT03746600|450676552|FG001|Overall Study|Lost to Follow-up|0|||
125287043|NCT03023826|450676553|FG000|Period 1|Withdrawal by Subject|0|||
125287044|NCT03023826|450676554|FG001|Period 1|Withdrawal by Subject|0|||
125287045|NCT03023826|450676555|FG002|Period 1|Withdrawal by Subject|0|||
125287046|NCT03023826|450676556|FG003|Period 1|Withdrawal by Subject|0|||
125287047|NCT03023826|450676557|FG004|Period 1|Withdrawal by Subject|1|||
125287048|NCT03023826|450676558|FG005|Period 1|Withdrawal by Subject|0|||
125287049|NCT00977938|450676559|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
125287050|NCT00977938|450676560|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
125287051|NCT00977938|450676561|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
125287052|NCT00977938|450676562|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
125287053|NCT00977938|450676559|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
125287054|NCT00977938|450676560|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
125287055|NCT00977938|450676561|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
125287056|NCT00977938|450676562|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
125287057|NCT00977938|450676559|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
125287058|NCT00977938|450676560|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
125287059|NCT00977938|450676561|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
125287060|NCT00977938|450676562|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
125287061|NCT00977938|450676559|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
125287062|NCT00977938|450676560|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
125287063|NCT00977938|450676561|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
125287064|NCT00977938|450676562|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
125287065|NCT00977938|450676559|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
125287066|NCT00977938|450676560|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
125287067|NCT00977938|450676561|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
125287068|NCT00977938|450676562|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
125287069|NCT00977938|450676559|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
125287070|NCT00977938|450676560|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
125287071|NCT00977938|450676561|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
125287072|NCT00977938|450676562|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
125287073|NCT02142283|450676565|FG000|Overall Study|Death|20|||
125287074|NCT02142283|450676566|FG001|Overall Study|Death|18|||
125287075|NCT02142283|450676565|FG000|Overall Study|Withdrawal by Subject|1|||
125287076|NCT02142283|450676566|FG001|Overall Study|Withdrawal by Subject|3|||
125287077|NCT00717522|450676567|FG000|Overall Study|Disease Progression|5|||
125287078|NCT00717522|450676567|FG000|Overall Study|Adverse Event|1|||
125287079|NCT00717522|450676567|FG000|Overall Study|Death|1|||
125287080|NCT02981407|450676572|FG000|Overall Study|Withdrawal by Subject|2|||
125287081|NCT02981407|450676573|FG001|Overall Study|Withdrawal by Subject|0|||
125287082|NCT00355342|450676576|FG000|Overall Study|Adverse Event|13|||
125287083|NCT00355342|450676577|FG001|Overall Study|Adverse Event|15|||
125287084|NCT00355342|450676576|FG000|Overall Study|Lost to Follow-up|4|||
125287085|NCT00355342|450676577|FG001|Overall Study|Lost to Follow-up|2|||
125287086|NCT00355342|450676576|FG000|Overall Study|Withdrawal by Subject|14|||
125287087|NCT00355342|450676577|FG001|Overall Study|Withdrawal by Subject|11|||
125287088|NCT00355342|450676576|FG000|Overall Study|Sponsor terminated study|2|||
125287089|NCT00355342|450676577|FG001|Overall Study|Sponsor terminated study|2|||
125287090|NCT00355342|450676576|FG000|Overall Study|Overcompliant-PI discretion|1|||
125287091|NCT00355342|450676577|FG001|Overall Study|Overcompliant-PI discretion|0|||
125287092|NCT00355342|450676576|FG000|Overall Study|Use of prohibited medication|1|||
125287093|NCT00355342|450676577|FG001|Overall Study|Use of prohibited medication|0|||
125287094|NCT00355342|450676576|FG000|Overall Study|COPD exacerbation|1|||
125287095|NCT00355342|450676577|FG001|Overall Study|COPD exacerbation|1|||
125287096|NCT00355342|450676576|FG000|Overall Study|Dispensed wrong study drug kit|1|||
125287097|NCT00355342|450676577|FG001|Overall Study|Dispensed wrong study drug kit|0|||
125287098|NCT00355342|450676576|FG000|Overall Study|Non-compliance with Dexa scans|1|||
125287099|NCT00355342|450676577|FG001|Overall Study|Non-compliance with Dexa scans|0|||
125287100|NCT00355342|450676576|FG000|Overall Study|Withdrawal by participant and physician|1|||
125287101|NCT00355342|450676577|FG001|Overall Study|Withdrawal by participant and physician|0|||
125287102|NCT00355342|450676576|FG000|Overall Study|Participant relocated|0|||
125287103|NCT00355342|450676577|FG001|Overall Study|Participant relocated|1|||
125287104|NCT00355342|450676576|FG000|Overall Study|Participant discontinued study drug|0|||
125287105|NCT00355342|450676577|FG001|Overall Study|Participant discontinued study drug|1|||
125287106|NCT00355342|450676576|FG000|Overall Study|Study management|0|||
125287107|NCT00355342|450676577|FG001|Overall Study|Study management|1|||
125287108|NCT00355342|450676576|FG000|Overall Study|Protocol Violation|0|||
125287109|NCT00355342|450676577|FG001|Overall Study|Protocol Violation|1|||
125287110|NCT00355342|450676576|FG000|Overall Study|Use of protocol excluded medication|0|||
125287111|NCT00355342|450676577|FG001|Overall Study|Use of protocol excluded medication|1|||
125287112|NCT01416441|450676578|FG000|Overall Study|Lost to Follow-up|5|||
125287113|NCT01416441|450676578|FG000|Overall Study|Adverse Event|6|||
125287114|NCT01416441|450676578|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
125287115|NCT01416441|450676578|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
124783197|NCT02055118|448835930|FG002|Overall Study|Withdrawal by Subject|0|||
125287116|NCT01416441|450676578|FG000|Overall Study|Investigator Withdrew Subject|2|||
125287117|NCT01416441|450676578|FG000|Overall Study|Subject Withdrew Consent|12|||
125287118|NCT01416441|450676578|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
125287119|NCT02653495|450676583|FG000|Overall Study|Lost to Follow-up|2|||
125287120|NCT02653495|450676584|FG001|Overall Study|Lost to Follow-up|0|||
125287121|NCT02653495|450676583|FG000|Overall Study|Screening Failure|10|||
124783198|NCT02281383|448835931|FG000|Overall Study|Progressive Disease|1|||
125287122|NCT02653495|450676584|FG001|Overall Study|Screening Failure|0|||
125287123|NCT00953680|450676585|FG000|Period 1|Withdrawal by Subject|0|||
124783199|NCT02281383|448835931|FG000|Overall Study|Withdrawal by Subject|6|||
124783200|NCT02281383|448835931|FG000|Overall Study|Protocol Violation|2|||
124783201|NCT02281383|448835931|FG000|Overall Study|Death|1|||
124783202|NCT02281383|448835931|FG000|Overall Study|Adverse Event|2|||
124783203|NCT01215097|448835932|FG000|Overall Study|Adverse Event|1|||
124783204|NCT01215097|448835933|FG001|Overall Study|Adverse Event|3|||
124783205|NCT01215097|448835932|FG000|Overall Study|Protocol Violation|0|||
124783206|NCT01215097|448835933|FG001|Overall Study|Protocol Violation|2|||
124783207|NCT01215097|448835932|FG000|Overall Study|Lost to Follow-up|2|||
124783208|NCT01215097|448835933|FG001|Overall Study|Lost to Follow-up|0|||
124783209|NCT01215097|448835932|FG000|Overall Study|Withdrawal by Subject|6|||
124783210|NCT01215097|448835933|FG001|Overall Study|Withdrawal by Subject|3|||
124783211|NCT01215097|448835932|FG000|Overall Study|Lack of Efficacy|0|||
124783212|NCT01215097|448835933|FG001|Overall Study|Lack of Efficacy|3|||
124783213|NCT01215097|448835932|FG000|Overall Study|patient's refusal to come|2|||
124783214|NCT01215097|448835933|FG001|Overall Study|patient's refusal to come|2|||
124783215|NCT01215097|448835932|FG000|Overall Study|patient's private reason|1|||
124783216|NCT01215097|448835933|FG001|Overall Study|patient's private reason|1|||
124783217|NCT02560025|448835936|FG000|Overall Study|Ineligible after consent/ registration|3|||
124783218|NCT02703337|448835937|FG000|Period One (Part A)|Withdrawal by Subject|0|||
124783219|NCT02703337|448835938|FG001|Period One (Part A)|Withdrawal by Subject|0|||
124783220|NCT02703337|448835939|FG002|Period One (Part A)|Withdrawal by Subject|0|||
124783221|NCT02703337|448835940|FG003|Period One (Part A)|Withdrawal by Subject|0|||
124783222|NCT02703337|448835941|FG004|Period One (Part A)|Withdrawal by Subject|1|||
124783223|NCT02703337|448835942|FG005|Period One (Part A)|Withdrawal by Subject|0|||
124783224|NCT02703337|448835943|FG006|Period One (Part A)|Withdrawal by Subject|0|||
124783225|NCT02703337|448835944|FG007|Period One (Part A)|Withdrawal by Subject|0|||
124783226|NCT00282308|448835945|FG000|Treatment Period|Lost to Follow-up|1|||
124783227|NCT00282308|448835946|FG001|Treatment Period|Lost to Follow-up|0|||
124783228|NCT00282308|448835947|FG002|Treatment Period|Lost to Follow-up|0|||
124783229|NCT00282308|448835945|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
125287124|NCT00953680|450676586|FG001|Period 1|Withdrawal by Subject|1|||
125287125|NCT01360398|450676587|FG000|Overall Study|Withdrawal by Subject|14|||
125287126|NCT01360398|450676587|FG000|Overall Study|Other|7|||
125287127|NCT01360398|450676587|FG000|Overall Study|Migrated/moved from study area|1|||
125287128|NCT00624780|450676591|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
125287129|NCT00624780|450676592|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
125287130|NCT00624780|450676593|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
125287131|NCT00624780|450676594|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
125287132|NCT00624780|450676595|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
125287133|NCT00624780|450676596|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
125287134|NCT00624780|450676591|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
125287135|NCT00624780|450676592|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
125287136|NCT00624780|450676593|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
125287137|NCT00624780|450676594|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
125287138|NCT00624780|450676595|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
125287139|NCT00624780|450676596|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
125287140|NCT00624780|450676591|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
125287141|NCT00624780|450676592|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
125287142|NCT00624780|450676593|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
125287143|NCT00624780|450676594|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
125287144|NCT00624780|450676595|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
125287145|NCT00624780|450676596|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
125287146|NCT00624780|450676591|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
125287147|NCT00624780|450676592|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
125287148|NCT00624780|450676593|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
125287149|NCT00624780|450676594|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
125287150|NCT00624780|450676595|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
125287151|NCT00624780|450676596|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
125287152|NCT00624780|450676591|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
125287153|NCT00624780|450676592|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
125287154|NCT00624780|450676593|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
124783230|NCT00282308|448835946|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
125287155|NCT00624780|450676594|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
124783231|NCT00282308|448835947|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
124783232|NCT00282308|448835945|FG000|Treatment Period|Adverse Event|0|||
124783233|NCT00282308|448835946|FG001|Treatment Period|Adverse Event|2|||
124783234|NCT00282308|448835947|FG002|Treatment Period|Adverse Event|0|||
124783235|NCT00282308|448835945|FG000|Treatment Period|Not Treated with Study Drug|1|||
125287156|NCT00624780|450676595|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
125287157|NCT00624780|450676596|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
125287158|NCT00624780|450676591|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
125287159|NCT00624780|450676592|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
125287160|NCT00624780|450676593|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
125287161|NCT00624780|450676594|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
125287162|NCT00624780|450676595|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
125287163|NCT00624780|450676596|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
125287164|NCT00624780|450676591|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
125287165|NCT00624780|450676592|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
125287166|NCT00624780|450676593|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
125287167|NCT00624780|450676594|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
125287168|NCT00624780|450676595|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
125287169|NCT00624780|450676596|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
125287170|NCT00624780|450676591|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
125287171|NCT00624780|450676592|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
125287172|NCT00624780|450676593|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
125287173|NCT00624780|450676594|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
125287174|NCT00624780|450676595|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
125287175|NCT00624780|450676596|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
125287176|NCT00624780|450676591|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
125287177|NCT00624780|450676592|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
125287178|NCT00624780|450676593|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
125287179|NCT00624780|450676594|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
125287180|NCT00624780|450676595|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
125287181|NCT00624780|450676596|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
125287182|NCT00624780|450676591|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
125287183|NCT00624780|450676592|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
125287184|NCT00624780|450676593|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
125287185|NCT00624780|450676594|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
125287186|NCT00624780|450676595|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
125287187|NCT00624780|450676596|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
125287188|NCT00624780|450676591|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
125287189|NCT00624780|450676592|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
125287190|NCT00624780|450676593|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
125287191|NCT00624780|450676594|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
125287192|NCT00624780|450676595|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
125287193|NCT00624780|450676596|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
125287194|NCT00624780|450676591|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
125287195|NCT00624780|450676592|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
125287196|NCT00624780|450676593|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
125287197|NCT00624780|450676594|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
125287198|NCT00624780|450676595|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
125287199|NCT00624780|450676596|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
125287200|NCT00624780|450676591|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
125287201|NCT00624780|450676592|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
125287202|NCT00624780|450676593|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
125287203|NCT00624780|450676594|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
125287204|NCT00624780|450676595|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
125287205|NCT00624780|450676596|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
125287206|NCT00624780|450676591|FG000|Follow-up (Week 26)|Death|0|||
125287207|NCT00624780|450676592|FG001|Follow-up (Week 26)|Death|0|||
125287208|NCT00624780|450676593|FG002|Follow-up (Week 26)|Death|1|||
125287209|NCT00624780|450676594|FG003|Follow-up (Week 26)|Death|0|||
125287210|NCT00624780|450676595|FG004|Follow-up (Week 26)|Death|0|||
125287211|NCT00624780|450676596|FG005|Follow-up (Week 26)|Death|0|||
125287212|NCT00624780|450676591|FG000|Follow-up (Week 26)|Adverse Event|0|||
125287213|NCT00624780|450676592|FG001|Follow-up (Week 26)|Adverse Event|0|||
125287214|NCT00624780|450676593|FG002|Follow-up (Week 26)|Adverse Event|0|||
125287215|NCT00624780|450676594|FG003|Follow-up (Week 26)|Adverse Event|0|||
125287216|NCT00624780|450676595|FG004|Follow-up (Week 26)|Adverse Event|1|||
125287217|NCT00624780|450676596|FG005|Follow-up (Week 26)|Adverse Event|0|||
125287218|NCT00624780|450676591|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
125287219|NCT00624780|450676592|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
125287220|NCT00624780|450676593|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
125287221|NCT00624780|450676594|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
125287222|NCT00624780|450676595|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
125287223|NCT00624780|450676596|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
125287224|NCT00624780|450676591|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
125287225|NCT00624780|450676592|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
125287226|NCT00624780|450676593|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
125287227|NCT00624780|450676594|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
125287228|NCT00624780|450676595|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
125287229|NCT00624780|450676596|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
125287230|NCT00624780|450676591|FG000|Follow-up (Week 26)|Other|1|||
125287231|NCT00624780|450676592|FG001|Follow-up (Week 26)|Other|1|||
125287232|NCT00624780|450676593|FG002|Follow-up (Week 26)|Other|0|||
125287233|NCT00624780|450676594|FG003|Follow-up (Week 26)|Other|0|||
125287234|NCT00624780|450676595|FG004|Follow-up (Week 26)|Other|0|||
125287235|NCT00624780|450676596|FG005|Follow-up (Week 26)|Other|0|||
125287236|NCT01514240|450678612|FG000|Overall Study|Adverse Event|4|||
125287237|NCT01514240|450678613|FG001|Overall Study|Adverse Event|4|||
125287238|NCT01514240|450678612|FG000|Overall Study|Subject Decision|2|||
125287239|NCT01514240|450678613|FG001|Overall Study|Subject Decision|7|||
125287240|NCT00549900|450678615|FG000|Overall Study|Adverse Event|1|||
125287241|NCT01007123|450678620|FG000|Overall Study|Adverse Event|3|||
125287242|NCT01007123|450678621|FG001|Overall Study|Adverse Event|4|||
125287243|NCT01007123|450678622|FG002|Overall Study|Adverse Event|7|||
125287244|NCT01007123|450678623|FG003|Overall Study|Adverse Event|1|||
125287245|NCT01007123|450678620|FG000|Overall Study|Lack of Efficacy|1|||
125287246|NCT01007123|450678621|FG001|Overall Study|Lack of Efficacy|0|||
125287247|NCT01007123|450678622|FG002|Overall Study|Lack of Efficacy|1|||
125287248|NCT01007123|450678623|FG003|Overall Study|Lack of Efficacy|4|||
125287249|NCT01007123|450678620|FG000|Overall Study|Protocol Violation|1|||
125287250|NCT01007123|450678621|FG001|Overall Study|Protocol Violation|1|||
125287251|NCT01007123|450678622|FG002|Overall Study|Protocol Violation|2|||
125287252|NCT01007123|450678623|FG003|Overall Study|Protocol Violation|1|||
125287253|NCT01007123|450678620|FG000|Overall Study|Withdrawal by Subject|1|||
125287254|NCT01007123|450678621|FG001|Overall Study|Withdrawal by Subject|0|||
125287255|NCT01007123|450678622|FG002|Overall Study|Withdrawal by Subject|1|||
125287256|NCT01007123|450678623|FG003|Overall Study|Withdrawal by Subject|0|||
125287257|NCT01007123|450678620|FG000|Overall Study|Lost to Follow-up|0|||
125287258|NCT01007123|450678621|FG001|Overall Study|Lost to Follow-up|1|||
125287259|NCT01007123|450678622|FG002|Overall Study|Lost to Follow-up|0|||
125287260|NCT01007123|450678623|FG003|Overall Study|Lost to Follow-up|0|||
125287261|NCT00149994|450678624|FG000|Overall Study|Administrative problems:|1|||
125287262|NCT00149994|450678625|FG001|Overall Study|Administrative problems:|0|||
125287263|NCT00149994|450678624|FG000|Overall Study|Protocol Violation|0|||
125287264|NCT00149994|450678625|FG001|Overall Study|Protocol Violation|1|||
125287265|NCT00613925|450678628|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
125287266|NCT00613925|450678629|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
125287267|NCT00252694|450678632|FG000|Overall Study|Withdrawal by Subject|83|||
125287268|NCT00252694|450678633|FG001|Overall Study|Withdrawal by Subject|91|||
125287269|NCT00252694|450678632|FG000|Overall Study|Death|36|||
125287270|NCT00252694|450678633|FG001|Overall Study|Death|34|||
125287271|NCT00252694|450678632|FG000|Overall Study|Mostly Lost to Follow Up|8|||
125287272|NCT00252694|450678633|FG001|Overall Study|Mostly Lost to Follow Up|13|||
125287273|NCT00252694|450678632|FG000|Overall Study|Patient Moving|17|||
125287274|NCT00252694|450678633|FG001|Overall Study|Patient Moving|16|||
125287275|NCT01342965|450678634|FG000|Overall Study|Death|58|||
125287276|NCT01342965|450678635|FG001|Overall Study|Death|57|||
125287277|NCT01342965|450678634|FG000|Overall Study|Lost to Follow-up|5|||
125287278|NCT01342965|450678635|FG001|Overall Study|Lost to Follow-up|3|||
125287279|NCT01342965|450678634|FG000|Overall Study|Other Reasons- Unspecified|44|||
125287280|NCT01342965|450678635|FG001|Overall Study|Other Reasons- Unspecified|38|||
125287281|NCT01342965|450678634|FG000|Overall Study|Withdrawal by Subject|2|||
125287282|NCT01342965|450678635|FG001|Overall Study|Withdrawal by Subject|9|||
125287283|NCT03538444|450678646|FG000|Overall Study|opioid withdrawal|1|||
125287284|NCT03538444|450678647|FG001|Overall Study|opioid withdrawal|0|||
125287285|NCT04644237|450678659|FG000|Overall Study|Death|3|||
125287286|NCT04644237|450678660|FG001|Overall Study|Death|2|||
125287287|NCT04644237|450678659|FG000|Overall Study|Adverse Event|15|||
125287288|NCT04644237|450678660|FG001|Overall Study|Adverse Event|12|||
125287289|NCT04644237|450678659|FG000|Overall Study|Progressive Disease|47|||
125287290|NCT04644237|450678660|FG001|Overall Study|Progressive Disease|19|||
125287291|NCT04644237|450678659|FG000|Overall Study|Clinical Progression|4|||
125287292|NCT04644237|450678660|FG001|Overall Study|Clinical Progression|1|||
125287293|NCT04644237|450678659|FG000|Overall Study|Withdrawal by Subject|1|||
125287294|NCT04644237|450678660|FG001|Overall Study|Withdrawal by Subject|2|||
125287295|NCT04644237|450678659|FG000|Overall Study|Physician Decision|3|||
125287296|NCT04644237|450678660|FG001|Overall Study|Physician Decision|0|||
125287297|NCT04644237|450678659|FG000|Overall Study|Other|1|||
125287298|NCT04644237|450678660|FG001|Overall Study|Other|0|||
125287299|NCT04644237|450678659|FG000|Overall Study|Randomized but not Treated|1|||
125287300|NCT04644237|450678660|FG001|Overall Study|Randomized but not Treated|0|||
125287301|NCT01779869|450678661|FG000|Overall Study|Physician Decision|2|||
125287302|NCT02233738|450678663|FG000|Overall Study|Lost to Follow-up|5|||
125287303|NCT02233738|450678664|FG001|Overall Study|Lost to Follow-up|12|||
125287304|NCT02233738|450678663|FG000|Overall Study|Death|0|||
125287305|NCT02233738|450678664|FG001|Overall Study|Death|1|||
125287306|NCT02233738|450678663|FG000|Overall Study|Withdrawal by Subject|0|||
125287307|NCT02233738|450678664|FG001|Overall Study|Withdrawal by Subject|1|||
125287308|NCT02233738|450678663|FG000|Overall Study|Did not return after Baseline|3|||
125287309|NCT02233738|450678664|FG001|Overall Study|Did not return after Baseline|2|||
125287310|NCT00096174|450678665|FG000|Overall Study|Lack of Efficacy|9|||
125287311|NCT00096174|450678665|FG000|Overall Study|Adverse Event|15|||
125287312|NCT00096174|450678665|FG000|Overall Study|Death|6|||
125287313|NCT00096174|450678665|FG000|Overall Study|Withdrawal by Subject|15|||
125287314|NCT00096174|450678665|FG000|Overall Study|Not started protocol therapy|3|||
125287315|NCT00096174|450678665|FG000|Overall Study|Ineligible|6|||
125287316|NCT00096174|450678665|FG000|Overall Study|other reason|8|||
125287317|NCT00027378|450678669|FG000|Overall Study|Physician Decision|0|||
125287318|NCT00027378|450678670|FG001|Overall Study|Physician Decision|3|||
125287319|NCT05605691|450678671|FG000|Overall Study|Lost to Follow-up|1|||
125287320|NCT03199053|450678674|FG000|ST Period|Withdrawal by Subject|2|||
125287321|NCT03199053|450678675|FG001|ST Period|Withdrawal by Subject|4|||
125287322|NCT03199053|450678676|FG002|ST Period|Withdrawal by Subject|6|||
125287323|NCT03199053|450678674|FG000|ST Period|Withdrawal by parent/guardian|1|||
125287324|NCT03199053|450678675|FG001|ST Period|Withdrawal by parent/guardian|1|||
125287325|NCT03199053|450678676|FG002|ST Period|Withdrawal by parent/guardian|1|||
125287326|NCT03199053|450678674|FG000|ST Period|Lost to Follow-up|2|||
125287327|NCT03199053|450678675|FG001|ST Period|Lost to Follow-up|0|||
125287328|NCT03199053|450678676|FG002|ST Period|Lost to Follow-up|1|||
125287329|NCT03199053|450678674|FG000|LT Period|Withdrawal by Subject|1|||
125287330|NCT03199053|450678675|FG001|LT Period|Withdrawal by Subject|3|||
125287331|NCT03199053|450678676|FG002|LT Period|Withdrawal by Subject|3|||
125287332|NCT03199053|450678674|FG000|LT Period|Withdrawal by parent/guardian|0|||
125287333|NCT03199053|450678675|FG001|LT Period|Withdrawal by parent/guardian|0|||
125287334|NCT03199053|450678676|FG002|LT Period|Withdrawal by parent/guardian|1|||
125287335|NCT03199053|450678674|FG000|LT Period|Lost to Follow-up|0|||
125287336|NCT03199053|450678675|FG001|LT Period|Lost to Follow-up|1|||
125287337|NCT03199053|450678676|FG002|LT Period|Lost to Follow-up|1|||
125287338|NCT03199053|450678674|FG000|LT Period|Miscellaneous|0|||
125287339|NCT03199053|450678675|FG001|LT Period|Miscellaneous|0|||
125287340|NCT03199053|450678676|FG002|LT Period|Miscellaneous|2|||
125287341|NCT03199053|450678674|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
125287342|NCT03199053|450678675|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
125287343|NCT03199053|450678676|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
125287344|NCT03199053|450678674|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
125287345|NCT03199053|450678675|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
125287346|NCT03199053|450678676|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
125287347|NCT03199053|450678674|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
125287348|NCT03199053|450678675|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
125287349|NCT03199053|450678676|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
125287350|NCT03199053|450678674|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
125287351|NCT03199053|450678675|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
125287352|NCT03199053|450678676|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
125287353|NCT01824823|450678679|FG000|Overall Study|Lack of Efficacy|1|||
125287354|NCT01824823|450678680|FG001|Overall Study|Lack of Efficacy|1|||
125287355|NCT01824823|450678679|FG000|Overall Study|Off-treatment reason not submitted|1|||
125287356|NCT01824823|450678680|FG001|Overall Study|Off-treatment reason not submitted|0|||
125287357|NCT02098369|450678681|FG000|Overall Study|Withdrawal by Subject|1|||
125287358|NCT02098369|450678682|FG001|Overall Study|Withdrawal by Subject|5|||
125287359|NCT02098369|450678683|FG002|Overall Study|Withdrawal by Subject|0|||
125287360|NCT02098369|450678681|FG000|Overall Study|Lost to Follow-up|5|||
125287361|NCT02098369|450678682|FG001|Overall Study|Lost to Follow-up|1|||
125287362|NCT02098369|450678683|FG002|Overall Study|Lost to Follow-up|3|||
125287363|NCT02098369|450678681|FG000|Overall Study|Death|1|||
125287364|NCT02098369|450678682|FG001|Overall Study|Death|1|||
125287365|NCT02098369|450678683|FG002|Overall Study|Death|1|||
125287366|NCT02098369|450678681|FG000|Overall Study|Other|0|||
125287367|NCT02098369|450678682|FG001|Overall Study|Other|2|||
125287368|NCT02098369|450678683|FG002|Overall Study|Other|1|||
125287369|NCT00246025|450678684|FG000|Overall Study|Adverse Event|7|||
125287370|NCT00246025|450678685|FG001|Overall Study|Adverse Event|9|||
125287371|NCT00246025|450678686|FG002|Overall Study|Adverse Event|9|||
125287372|NCT00246025|450678687|FG003|Overall Study|Adverse Event|10|||
125287373|NCT00246025|450678684|FG000|Overall Study|Withdrawal by Subject|3|||
125287374|NCT00246025|450678685|FG001|Overall Study|Withdrawal by Subject|0|||
125287375|NCT00246025|450678686|FG002|Overall Study|Withdrawal by Subject|1|||
125287376|NCT00246025|450678687|FG003|Overall Study|Withdrawal by Subject|2|||
125287377|NCT00246025|450678684|FG000|Overall Study|unsuitable medical history was found|0|||
125287378|NCT00246025|450678685|FG001|Overall Study|unsuitable medical history was found|0|||
125287379|NCT00246025|450678686|FG002|Overall Study|unsuitable medical history was found|0|||
125287380|NCT00246025|450678687|FG003|Overall Study|unsuitable medical history was found|1|||
125287381|NCT03444766|450678692|FG000|Overall Study|Other Reasons|2|||
125287382|NCT03444766|450678692|FG000|Overall Study|Participant Withdrew Consent|5|||
125287383|NCT03444766|450678692|FG000|Overall Study|Lost to Follow-up|2|||
125287384|NCT03444766|450678692|FG000|Overall Study|Death|2|||
125287385|NCT03444766|450678692|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
125287386|NCT03444766|450678692|FG000|Overall Study|Disease Progression|49|||
125287387|NCT02460783|450678696|FG000|Overall Study|Withdrawal by Subject|1|||
125287388|NCT02460783|450678697|FG001|Overall Study|Withdrawal by Subject|3|||
125287389|NCT02460783|450678696|FG000|Overall Study|Lost to Follow-up|1|||
125287390|NCT02460783|450678697|FG001|Overall Study|Lost to Follow-up|1|||
125287391|NCT01646645|450678698|FG000|Overall Study|No Treated|1|||
125287392|NCT01646645|450678698|FG000|Overall Study|Inevaluable Donor|29|||
125287393|NCT02374814|450678707|FG000|Overall Study|Lost to Follow-up|1|||
125287394|NCT02374814|450678708|FG001|Overall Study|Lost to Follow-up|1|||
125287395|NCT02374814|450678709|FG002|Overall Study|Lost to Follow-up|0|||
125287396|NCT02374814|450678710|FG003|Overall Study|Lost to Follow-up|1|||
125287397|NCT02374814|450678711|FG004|Overall Study|Lost to Follow-up|0|||
125287398|NCT02374814|450678712|FG005|Overall Study|Lost to Follow-up|0|||
125287399|NCT02374814|450678707|FG000|Overall Study|Withdrawal by Subject|0|||
125287400|NCT02374814|450678708|FG001|Overall Study|Withdrawal by Subject|0|||
125287401|NCT02374814|450678709|FG002|Overall Study|Withdrawal by Subject|1|||
125287402|NCT02374814|450678710|FG003|Overall Study|Withdrawal by Subject|1|||
125287403|NCT02374814|450678711|FG004|Overall Study|Withdrawal by Subject|0|||
125287404|NCT02374814|450678712|FG005|Overall Study|Withdrawal by Subject|0|||
125287405|NCT00884039|450678713|FG000|Overall Study|Withdrawal by Subject|0|||
125287406|NCT00884039|450678714|FG001|Overall Study|Withdrawal by Subject|1|||
125287407|NCT00884039|450678713|FG000|Overall Study|Lack of Efficacy|2|||
125287408|NCT00884039|450678714|FG001|Overall Study|Lack of Efficacy|0|||
125287409|NCT00072293|450678715|FG000|Overall Study|Lost to Follow-up|1|||
125287410|NCT00072293|450678716|FG001|Overall Study|Lost to Follow-up|1|||
125287411|NCT00072293|450678715|FG000|Overall Study|Withdrawal by Subject|0|||
125287412|NCT00072293|450678716|FG001|Overall Study|Withdrawal by Subject|1|||
125287413|NCT04209114|450678717|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
125287414|NCT04209114|450678718|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
125287415|NCT04209114|450678719|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
125287416|NCT04209114|450678717|FG000|Pre-Treatment Phase|Other reasons|0|||
125287417|NCT04209114|450678718|FG001|Pre-Treatment Phase|Other reasons|0|||
125287418|NCT04209114|450678719|FG002|Pre-Treatment Phase|Other reasons|1|||
125287419|NCT04209114|450678717|FG000|Pre-Treatment Phase|Death|0|||
125287420|NCT04209114|450678718|FG001|Pre-Treatment Phase|Death|0|||
125287421|NCT04209114|450678719|FG002|Pre-Treatment Phase|Death|1|||
125287422|NCT04209114|450678717|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
125287423|NCT04209114|450678718|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
125287424|NCT04209114|450678719|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
125287425|NCT04209114|450678717|FG000|Treatment Phase|Other reasons|5|||
125287426|NCT04209114|450678718|FG001|Treatment Phase|Other reasons|3|||
125287427|NCT04209114|450678719|FG002|Treatment Phase|Other reasons|0|||
125287428|NCT04209114|450678717|FG000|Treatment Phase|Lost to Follow-up|1|||
125287429|NCT04209114|450678718|FG001|Treatment Phase|Lost to Follow-up|0|||
125287430|NCT04209114|450678719|FG002|Treatment Phase|Lost to Follow-up|0|||
125287431|NCT04209114|450678717|FG000|Treatment Phase|Participant withdrew consent|1|||
125287432|NCT04209114|450678718|FG001|Treatment Phase|Participant withdrew consent|0|||
125287433|NCT04209114|450678719|FG002|Treatment Phase|Participant withdrew consent|0|||
125287434|NCT04209114|450678717|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
125287435|NCT04209114|450678718|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
125287436|NCT04209114|450678719|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
125287437|NCT04209114|450678717|FG000|Treatment Phase|Death|4|||
125287438|NCT04209114|450678718|FG001|Treatment Phase|Death|1|||
125287439|NCT04209114|450678719|FG002|Treatment Phase|Death|0|||
124783236|NCT00282308|448835946|FG001|Treatment Period|Not Treated with Study Drug|0|||
125287440|NCT04209114|450678717|FG000|Treatment Phase|Study drug toxicity|4|||
125287441|NCT04209114|450678718|FG001|Treatment Phase|Study drug toxicity|6|||
125287442|NCT04209114|450678719|FG002|Treatment Phase|Study drug toxicity|0|||
125287443|NCT04209114|450678717|FG000|Treatment Phase|Disease progression|6|||
124783237|NCT00282308|448835947|FG002|Treatment Period|Not Treated with Study Drug|0|||
124783238|NCT00282308|448835945|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
125287444|NCT04209114|450678718|FG001|Treatment Phase|Disease progression|9|||
125287445|NCT04209114|450678719|FG002|Treatment Phase|Disease progression|0|||
125287446|NCT00624819|450678722|FG000|Follow-up Period: Year 4|Parents decision|0|||
125287447|NCT00624819|450678723|FG001|Follow-up Period: Year 4|Parents decision|0|||
125287448|NCT00624819|450678724|FG002|Follow-up Period: Year 4|Parents decision|1|||
124783239|NCT00282308|448835946|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
124783240|NCT00282308|448835947|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
124783241|NCT00282308|448835945|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
124783242|NCT00282308|448835946|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
124783243|NCT00282308|448835947|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
124783244|NCT00282308|448835945|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
124783245|NCT00282308|448835946|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
124783246|NCT00282308|448835947|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
124783247|NCT00282308|448835945|FG000|Safety Follow-up Period|Adverse Event|0|||
124783248|NCT00282308|448835946|FG001|Safety Follow-up Period|Adverse Event|0|||
124783249|NCT00282308|448835947|FG002|Safety Follow-up Period|Adverse Event|1|||
124783250|NCT00282308|448835945|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
124783251|NCT00282308|448835946|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
124783252|NCT00282308|448835947|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
124783253|NCT00282308|448835945|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
124783254|NCT00282308|448835946|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
124783255|NCT00282308|448835947|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
124783256|NCT00282308|448835945|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
124783257|NCT00282308|448835946|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
124783258|NCT00282308|448835947|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
124783259|NCT01001325|448835950|FG000|Overall Study|Lost to Follow-up|16|||
124783260|NCT01001325|448835951|FG001|Overall Study|Lost to Follow-up|10|||
124783261|NCT01001325|448835950|FG000|Overall Study|Protocol Violation|2|||
124783262|NCT01001325|448835951|FG001|Overall Study|Protocol Violation|0|||
124783263|NCT01584440|448835952|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
124783264|NCT01584440|448835953|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
124783265|NCT01584440|448835954|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
124783266|NCT01584440|448835955|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
124783267|NCT01584440|448835956|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
124783268|NCT01584440|448835952|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
124783269|NCT01584440|448835953|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
124783270|NCT01584440|448835954|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
124783271|NCT01584440|448835955|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
124783272|NCT01584440|448835956|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
124783273|NCT01584440|448835952|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
124783274|NCT01584440|448835953|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
124783275|NCT01584440|448835954|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
124783276|NCT01584440|448835955|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
124783277|NCT01584440|448835956|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
124783278|NCT01584440|448835952|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
124783279|NCT01584440|448835953|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
124783280|NCT01584440|448835954|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
125287449|NCT00624819|450678725|FG003|Follow-up Period: Year 4|Parents decision|0|||
125287450|NCT00624819|450678722|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
125287451|NCT00624819|450678723|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
125287452|NCT00624819|450678724|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
125287453|NCT00624819|450678725|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
125287454|NCT02826421|450678730|FG000|Overall Study|Adverse Event|1|||
125287455|NCT02826421|450678731|FG001|Overall Study|Adverse Event|0|||
125287456|NCT02826421|450678732|FG002|Overall Study|Adverse Event|0|||
125287457|NCT02826421|450678733|FG003|Overall Study|Adverse Event|1|||
125287458|NCT02826421|450678730|FG000|Overall Study|Withdrawal by Subject|1|||
125287459|NCT02826421|450678731|FG001|Overall Study|Withdrawal by Subject|3|||
125287460|NCT02826421|450678732|FG002|Overall Study|Withdrawal by Subject|1|||
125287461|NCT02826421|450678733|FG003|Overall Study|Withdrawal by Subject|1|||
125287462|NCT02826421|450678730|FG000|Overall Study|Reason not given|1|||
125287463|NCT02826421|450678731|FG001|Overall Study|Reason not given|0|||
125287464|NCT02826421|450678732|FG002|Overall Study|Reason not given|1|||
125287465|NCT02826421|450678733|FG003|Overall Study|Reason not given|0|||
125287466|NCT02210221|450678736|FG000|Overall Study|Lack of Efficacy|7|||
125287467|NCT02210221|450678736|FG000|Overall Study|Withdrawal by Subject|43|||
125287468|NCT02141490|450678737|FG000|Overall Study|Screening failures|4|||
125287469|NCT02141490|450678738|FG001|Overall Study|Screening failures|0|||
125287470|NCT02141490|450678739|FG002|Overall Study|Screening failures|0|||
125287471|NCT00434759|450678740|FG000|Overall Study|Lack of Efficacy|5|||
125287472|NCT00434759|450678741|FG001|Overall Study|Lack of Efficacy|4|||
125287473|NCT00434759|450678740|FG000|Overall Study|Withdrawal by Subject|17|||
124783281|NCT01584440|448835955|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
124783282|NCT01584440|448835956|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
124783283|NCT01584440|448835952|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
124783284|NCT01584440|448835953|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
125287474|NCT00434759|450678741|FG001|Overall Study|Withdrawal by Subject|1|||
125287475|NCT00434759|450678740|FG000|Overall Study|family affairs|2|||
125287476|NCT00434759|450678741|FG001|Overall Study|family affairs|0|||
125287477|NCT02436408|450678743|FG000|Overall Study|Death|1|||
125287478|NCT01300819|450678744|FG000|Overall Study|Adverse Event|9|||
125287479|NCT01300819|450678745|FG001|Overall Study|Adverse Event|27|||
125287480|NCT01300819|450678744|FG000|Overall Study|Lack of Efficacy|2|||
125287481|NCT01300819|450678745|FG001|Overall Study|Lack of Efficacy|1|||
125287482|NCT01300819|450678744|FG000|Overall Study|Withdrawal by Subject|10|||
125287483|NCT01300819|450678745|FG001|Overall Study|Withdrawal by Subject|12|||
125287484|NCT01300819|450678744|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
125287485|NCT01300819|450678745|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
125287486|NCT01300819|450678744|FG000|Overall Study|Refusal to down titrate study drug|0|||
125287487|NCT01300819|450678745|FG001|Overall Study|Refusal to down titrate study drug|1|||
125287488|NCT01300819|450678744|FG000|Overall Study|Administrative reason|0|||
125287489|NCT01300819|450678745|FG001|Overall Study|Administrative reason|1|||
125287490|NCT01300819|450678744|FG000|Overall Study|Safety follow up not done by mistake|0|||
125287491|NCT01300819|450678745|FG001|Overall Study|Safety follow up not done by mistake|1|||
125287492|NCT01300819|450678744|FG000|Overall Study|Follow up call was not done|1|||
125287493|NCT01300819|450678745|FG001|Overall Study|Follow up call was not done|0|||
125287494|NCT02649855|450678746|FG000|Overall Study|Refused further treatment|2|||
125287495|NCT02649855|450678747|FG001|Overall Study|Refused further treatment|1|||
125287496|NCT02649855|450678748|FG002|Overall Study|Refused further treatment|1|||
125287497|NCT02649855|450678746|FG000|Overall Study|Withdrew consent|0|||
125287498|NCT02649855|450678747|FG001|Overall Study|Withdrew consent|1|||
125287499|NCT02649855|450678748|FG002|Overall Study|Withdrew consent|0|||
125287500|NCT02649855|450678746|FG000|Overall Study|Switched to alternative treatment|0|||
125287501|NCT02649855|450678747|FG001|Overall Study|Switched to alternative treatment|1|||
125287502|NCT02649855|450678748|FG002|Overall Study|Switched to alternative treatment|1|||
125287503|NCT02649855|450678746|FG000|Overall Study|Principal investigator discretion|0|||
125287504|NCT02649855|450678747|FG001|Overall Study|Principal investigator discretion|1|||
125287505|NCT02649855|450678748|FG002|Overall Study|Principal investigator discretion|1|||
125287506|NCT02649855|450678746|FG000|Overall Study|No treatment, per protocol|1|||
125287507|NCT02649855|450678747|FG001|Overall Study|No treatment, per protocol|0|||
125287508|NCT02649855|450678748|FG002|Overall Study|No treatment, per protocol|0|||
125287509|NCT02649855|450678746|FG000|Overall Study|Initiate new treatment|1|||
125287510|NCT02649855|450678747|FG001|Overall Study|Initiate new treatment|0|||
125287511|NCT02649855|450678748|FG002|Overall Study|Initiate new treatment|0|||
125287512|NCT01319721|450678752|FG000|Overall Study|Lost to Follow-up|1|||
125287513|NCT01319721|450678753|FG001|Overall Study|Lost to Follow-up|6|||
125287514|NCT00461305|450678754|FG000|Treatment|Adverse Event|26|||
125287515|NCT00461305|450678755|FG001|Treatment|Adverse Event|3|||
125287516|NCT00461305|450678754|FG000|Treatment|Lost to Follow-up|4|||
125287517|NCT00461305|450678755|FG001|Treatment|Lost to Follow-up|2|||
125287518|NCT00461305|450678754|FG000|Treatment|Protocol Violation|13|||
125287519|NCT00461305|450678755|FG001|Treatment|Protocol Violation|2|||
125287520|NCT00461305|450678754|FG000|Treatment|Withdrawal by Subject|48|||
125287521|NCT00461305|450678755|FG001|Treatment|Withdrawal by Subject|2|||
125287522|NCT00461305|450678754|FG000|Treatment|Never dispensed|5|||
125287523|NCT00461305|450678755|FG001|Treatment|Never dispensed|0|||
125287524|NCT00461305|450678754|FG000|Treatment|Study drug not taken|1|||
125287525|NCT00461305|450678755|FG001|Treatment|Study drug not taken|0|||
125287526|NCT00461305|450678754|FG000|Treatment|Partially missing diary|2|||
125287527|NCT00461305|450678755|FG001|Treatment|Partially missing diary|0|||
125287528|NCT00461305|450678754|FG000|Treatment|Other (missing drug etc)|2|||
125287529|NCT00461305|450678755|FG001|Treatment|Other (missing drug etc)|0|||
125287530|NCT00461305|450678754|FG000|Continued Treatment|Adverse Event|26|||
125287531|NCT00461305|450678755|FG001|Continued Treatment|Adverse Event|0|||
125287532|NCT00461305|450678754|FG000|Continued Treatment|Lost to Follow-up|4|||
125287533|NCT00461305|450678755|FG001|Continued Treatment|Lost to Follow-up|0|||
125287534|NCT00461305|450678754|FG000|Continued Treatment|Protocol Violation|13|||
125287535|NCT00461305|450678755|FG001|Continued Treatment|Protocol Violation|0|||
125287536|NCT00461305|450678754|FG000|Continued Treatment|Withdrawal by Subject|48|||
125287537|NCT00461305|450678755|FG001|Continued Treatment|Withdrawal by Subject|0|||
125287538|NCT00461305|450678754|FG000|Continued Treatment|Partially missing diary|2|||
125287539|NCT00461305|450678755|FG001|Continued Treatment|Partially missing diary|0|||
125287540|NCT00461305|450678754|FG000|Continued Treatment|Other (missing drug etc)|2|||
125287541|NCT00461305|450678755|FG001|Continued Treatment|Other (missing drug etc)|0|||
125287542|NCT01103063|450681336|FG000|Overall Study|Adverse Event|3|||
125287543|NCT01103063|450681337|FG001|Overall Study|Adverse Event|1|||
125287544|NCT01103063|450681336|FG000|Overall Study|Lost to Follow-up|68|||
125287545|NCT01103063|450681337|FG001|Overall Study|Lost to Follow-up|51|||
125287546|NCT01103063|450681336|FG000|Overall Study|Withdrawal by Subject|60|||
125287547|NCT01103063|450681337|FG001|Overall Study|Withdrawal by Subject|15|||
125287548|NCT01103063|450681336|FG000|Overall Study|Other|16|||
125287549|NCT01103063|450681337|FG001|Overall Study|Other|11|||
125287550|NCT01103063|450681336|FG000|Overall Study|Protocol Violation|1|||
125287551|NCT01103063|450681337|FG001|Overall Study|Protocol Violation|0|||
125287552|NCT01103063|450681336|FG000|Overall Study|Study terminated by Sponsor|326|||
125287553|NCT01103063|450681337|FG001|Overall Study|Study terminated by Sponsor|342|||
125287554|NCT01103063|450681336|FG000|Overall Study|Death|3|||
125287555|NCT01103063|450681337|FG001|Overall Study|Death|1|||
125287556|NCT01187446|450681340|FG000|Overall Study|Patient started non-protocol therapy|0|||
125287557|NCT01187446|450681341|FG001|Overall Study|Patient started non-protocol therapy|1|||
125287558|NCT00496197|450681342|FG000|Overall Study|Discontinued study due to death|43|||
125287559|NCT00496197|450681342|FG000|Overall Study|Adverse Event|13|||
125287560|NCT00496197|450681342|FG000|Overall Study|Does not meet entrance criteria|5|||
125287561|NCT00496197|450681342|FG000|Overall Study|Insufficient clinical response|3|||
125287562|NCT00496197|450681342|FG000|Overall Study|Insufficient bacteriological response|10|||
125287563|NCT00496197|450681342|FG000|Overall Study|Lost to Follow-up|11|||
125287564|NCT00496197|450681342|FG000|Overall Study|Withdrawal by Subject|11|||
125287565|NCT00496197|450681342|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
125287566|NCT00496197|450681342|FG000|Overall Study|Other|14|||
125287567|NCT00496197|450681342|FG000|Overall Study|Protocol Violation|8|||
125287568|NCT01344538|450681343|FG000|Overall Study|Adverse Event|1|||
125287569|NCT01344538|450681344|FG001|Overall Study|Adverse Event|1|||
125287570|NCT01344538|450681343|FG000|Overall Study|Lost to Follow-up|1|||
125287571|NCT01344538|450681344|FG001|Overall Study|Lost to Follow-up|0|||
125287572|NCT01655381|450681345|FG000|Overall Study|Investigator Decision|1|||
125287573|NCT01655381|450681345|FG000|Overall Study|Moved to Another City|1|||
125287574|NCT01655381|450681345|FG000|Overall Study|Insufficient Treatment Response|1|||
125287575|NCT00320255|450681346|FG000|Overall Study|Lack of Efficacy|1|||
125287576|NCT00320255|450681347|FG001|Overall Study|Lack of Efficacy|0|||
125287577|NCT00320255|450681348|FG002|Overall Study|Lack of Efficacy|0|||
125287578|NCT00320255|450681349|FG003|Overall Study|Lack of Efficacy|0|||
125287579|NCT00320255|450681350|FG004|Overall Study|Lack of Efficacy|0|||
125287580|NCT00320255|450681351|FG005|Overall Study|Lack of Efficacy|0|||
125287581|NCT00320255|450681346|FG000|Overall Study|Adverse Event|5|||
125287582|NCT00320255|450681347|FG001|Overall Study|Adverse Event|2|||
125287583|NCT00320255|450681348|FG002|Overall Study|Adverse Event|3|||
125287584|NCT00320255|450681349|FG003|Overall Study|Adverse Event|2|||
125287585|NCT00320255|450681350|FG004|Overall Study|Adverse Event|0|||
125287586|NCT00320255|450681351|FG005|Overall Study|Adverse Event|0|||
125287587|NCT00320255|450681346|FG000|Overall Study|Withdrawal by Subject|1|||
125287588|NCT00320255|450681347|FG001|Overall Study|Withdrawal by Subject|2|||
125287589|NCT00320255|450681348|FG002|Overall Study|Withdrawal by Subject|2|||
125287590|NCT00320255|450681349|FG003|Overall Study|Withdrawal by Subject|4|||
125287591|NCT00320255|450681350|FG004|Overall Study|Withdrawal by Subject|0|||
125287592|NCT00320255|450681351|FG005|Overall Study|Withdrawal by Subject|0|||
125287593|NCT00320255|450681346|FG000|Overall Study|Poor compliance/noncompliance|1|||
125287594|NCT00320255|450681347|FG001|Overall Study|Poor compliance/noncompliance|1|||
125287595|NCT00320255|450681348|FG002|Overall Study|Poor compliance/noncompliance|0|||
125287596|NCT00320255|450681349|FG003|Overall Study|Poor compliance/noncompliance|1|||
125287597|NCT00320255|450681350|FG004|Overall Study|Poor compliance/noncompliance|0|||
125287598|NCT00320255|450681351|FG005|Overall Study|Poor compliance/noncompliance|0|||
125287599|NCT00320255|450681346|FG000|Overall Study|No longer meets study criteria|0|||
125287600|NCT00320255|450681347|FG001|Overall Study|No longer meets study criteria|0|||
125287601|NCT00320255|450681348|FG002|Overall Study|No longer meets study criteria|0|||
125287602|NCT00320255|450681349|FG003|Overall Study|No longer meets study criteria|1|||
125287603|NCT00320255|450681350|FG004|Overall Study|No longer meets study criteria|0|||
125287604|NCT00320255|450681351|FG005|Overall Study|No longer meets study criteria|0|||
125287605|NCT00320255|450681346|FG000|Overall Study|Other|3|||
125287606|NCT00320255|450681347|FG001|Overall Study|Other|2|||
125287607|NCT00320255|450681348|FG002|Overall Study|Other|1|||
125287608|NCT00320255|450681349|FG003|Overall Study|Other|0|||
125287609|NCT00320255|450681350|FG004|Overall Study|Other|0|||
125287610|NCT00320255|450681351|FG005|Overall Study|Other|0|||
125287611|NCT04979897|450681353|FG000|Overall Study|Death|1|||
125287612|NCT04979897|450681354|FG001|Overall Study|Death|8|||
125287613|NCT04979897|450681353|FG000|Overall Study|Lost to Follow-up|111|||
125287614|NCT04979897|450681354|FG001|Overall Study|Lost to Follow-up|56|||
125287615|NCT04979897|450681353|FG000|Overall Study|Withdrawal by Subject|7|||
125287616|NCT04979897|450681354|FG001|Overall Study|Withdrawal by Subject|2|||
125287617|NCT03405935|450681355|FG000|Overall Study|Adverse Event|3|||
125287618|NCT03405935|450681355|FG000|Overall Study|Death|2|||
125287619|NCT03405935|450681355|FG000|Overall Study|Withdrawal by Subject|1|||
125287620|NCT03405935|450681355|FG000|Overall Study|Lost to Follow-up|2|||
125287621|NCT02781792|450681362|FG000|Overall Study|Adverse Event|1|||
125287622|NCT02781792|450681363|FG001|Overall Study|Adverse Event|2|||
125287623|NCT02781792|450681362|FG000|Overall Study|Withdrawal by Subject|3|||
125287624|NCT02781792|450681363|FG001|Overall Study|Withdrawal by Subject|1|||
125287625|NCT02781792|450681362|FG000|Overall Study|Lack of Efficacy|1|||
125287626|NCT02781792|450681363|FG001|Overall Study|Lack of Efficacy|1|||
125287627|NCT02781792|450681362|FG000|Overall Study|Hospice|0|||
125287628|NCT02781792|450681363|FG001|Overall Study|Hospice|1|||
125287629|NCT01703117|450681364|FG000|Overall Study|Adverse Event|4|||
125287630|NCT01703117|450681365|FG001|Overall Study|Adverse Event|3|||
125287631|NCT01703117|450681364|FG000|Overall Study|Withdrawal by Subject|0|||
125287632|NCT01703117|450681365|FG001|Overall Study|Withdrawal by Subject|1|||
125287633|NCT00683917|450681366|FG000|Overall Study|Study prematurely terminated|10|||
125287634|NCT01170598|450681371|FG000|Overall Study|Withdrawal by Subject|1|||
125287635|NCT01170598|450681371|FG000|Overall Study|Death|3|||
125287636|NCT01170598|450681371|FG000|Overall Study|Lost to Follow-up|1|||
125287637|NCT01170598|450681371|FG000|Overall Study|Refused|1|||
125287638|NCT02119156|450681372|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
125287639|NCT02119156|450681373|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
125287640|NCT02119156|450681374|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
125287641|NCT02119156|450681372|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
125287642|NCT02119156|450681373|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
125287643|NCT02119156|450681374|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
125287644|NCT02119156|450681372|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
125287645|NCT02119156|450681373|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
125287646|NCT02119156|450681374|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
125287647|NCT02119156|450681372|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
125287648|NCT02119156|450681373|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
125287649|NCT02119156|450681374|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
125287650|NCT02119156|450681372|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
125287651|NCT02119156|450681373|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
125287652|NCT02119156|450681374|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
125287653|NCT02685748|450681377|FG000|Overall Study|Withdrawal by Subject|3|||
125287654|NCT02685748|450681378|FG001|Overall Study|Withdrawal by Subject|2|||
125287655|NCT02536300|450681382|FG000|Overall Study|Investigator's Discretion|17|||
125287656|NCT02536300|450681383|FG001|Overall Study|Investigator's Discretion|11|||
125287657|NCT02536300|450681384|FG002|Overall Study|Investigator's Discretion|2|||
125287658|NCT02536300|450681382|FG000|Overall Study|Progressive Disease|11|||
125287659|NCT02536300|450681383|FG001|Overall Study|Progressive Disease|7|||
125287660|NCT02536300|450681384|FG002|Overall Study|Progressive Disease|6|||
125287661|NCT02536300|450681382|FG000|Overall Study|Study Terminated by Sponsor|6|||
125287662|NCT02536300|450681383|FG001|Overall Study|Study Terminated by Sponsor|4|||
125287663|NCT02536300|450681384|FG002|Overall Study|Study Terminated by Sponsor|7|||
125287664|NCT02536300|450681382|FG000|Overall Study|Death|7|||
125287665|NCT02536300|450681383|FG001|Overall Study|Death|0|||
125287666|NCT02536300|450681384|FG002|Overall Study|Death|5|||
125287667|NCT02536300|450681382|FG000|Overall Study|Withdrew Consent|4|||
125287668|NCT02536300|450681383|FG001|Overall Study|Withdrew Consent|2|||
125287669|NCT02536300|450681384|FG002|Overall Study|Withdrew Consent|0|||
125287670|NCT02536300|450681382|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
125287671|NCT02536300|450681383|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
124783285|NCT01584440|448835954|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
124783286|NCT01584440|448835955|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
124783287|NCT01584440|448835956|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
124783288|NCT01584440|448835952|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
124783289|NCT01584440|448835953|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
124783290|NCT01584440|448835954|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
124783291|NCT01584440|448835955|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
124783292|NCT01584440|448835956|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
124783293|NCT01584440|448835952|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
124783294|NCT01584440|448835953|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
124783295|NCT01584440|448835954|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
124783296|NCT01584440|448835955|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
124783297|NCT01584440|448835956|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
124783298|NCT01584440|448835952|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
124783299|NCT01584440|448835953|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
124783300|NCT01584440|448835954|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
124783301|NCT01584440|448835955|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
124783302|NCT01584440|448835956|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
124783303|NCT01584440|448835952|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
124783304|NCT01584440|448835953|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
124783305|NCT01584440|448835954|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
124783306|NCT01584440|448835955|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
124783307|NCT01584440|448835956|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
124783308|NCT00531427|448835957|FG000|Overall Study|Withdrawal by Subject|7|||
124783309|NCT00531427|448835958|FG001|Overall Study|Withdrawal by Subject|13|||
124783310|NCT00531427|448835957|FG000|Overall Study|Adverse Event|44|||
124783311|NCT00531427|448835958|FG001|Overall Study|Adverse Event|30|||
124783312|NCT00531427|448835957|FG000|Overall Study|Lost to Follow-up|4|||
124783313|NCT00531427|448835958|FG001|Overall Study|Lost to Follow-up|3|||
124783314|NCT00531427|448835957|FG000|Overall Study|Lack of Efficacy|14|||
124783315|NCT00531427|448835958|FG001|Overall Study|Lack of Efficacy|39|||
124783316|NCT00531427|448835957|FG000|Overall Study|Administrative|4|||
124783317|NCT00531427|448835958|FG001|Overall Study|Administrative|9|||
124783318|NCT02626624|448835973|FG000|Overall Study|Adverse Event|1|||
124783319|NCT02626624|448835973|FG000|Overall Study|Lost to Follow-up|3|||
124783320|NCT02626624|448835973|FG000|Overall Study|Protocol Violation|4|||
124783321|NCT02626624|448835973|FG000|Overall Study|Death|2|||
124783322|NCT00122980|448838080|FG000|Overall Study|Death|0|||
124783323|NCT00122980|448838081|FG001|Overall Study|Death|1|||
124783324|NCT00122980|448838080|FG000|Overall Study|Physician Decision|2|||
124783325|NCT00122980|448838081|FG001|Overall Study|Physician Decision|0|||
124783326|NCT00122980|448838080|FG000|Overall Study|Protocol Violation|5|||
124783327|NCT00122980|448838081|FG001|Overall Study|Protocol Violation|1|||
124783328|NCT00122980|448838080|FG000|Overall Study|Withdrawal by Subject|2|||
124783329|NCT00122980|448838081|FG001|Overall Study|Withdrawal by Subject|3|||
124783330|NCT00122980|448838080|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
124783331|NCT00122980|448838081|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
124783332|NCT00122980|448838080|FG000|Overall Study|Study termination|27|||
124783333|NCT00122980|448838081|FG001|Overall Study|Study termination|35|||
124783334|NCT01124864|448838082|FG000|Overall Study|Follow up phase competed as per protocol|18|||
124783335|NCT01124864|448838083|FG001|Overall Study|Follow up phase competed as per protocol|22|||
124783336|NCT01124864|448838084|FG002|Overall Study|Follow up phase competed as per protocol|24|||
124783337|NCT01124864|448838085|FG003|Overall Study|Follow up phase competed as per protocol|18|||
125287672|NCT02536300|450681384|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
125287673|NCT02536300|450681382|FG000|Overall Study|Enrolled but Never Treated|0|||
124783338|NCT01124864|448838086|FG004|Overall Study|Follow up phase competed as per protocol|26|||
124783339|NCT01124864|448838087|FG005|Overall Study|Follow up phase competed as per protocol|2|||
125287674|NCT02536300|450681383|FG001|Overall Study|Enrolled but Never Treated|0|||
125287675|NCT02536300|450681384|FG002|Overall Study|Enrolled but Never Treated|1|||
124783340|NCT01124864|448838082|FG000|Overall Study|Death|6|||
124783341|NCT01124864|448838083|FG001|Overall Study|Death|9|||
124783342|NCT01124864|448838084|FG002|Overall Study|Death|6|||
125287676|NCT02536300|450681382|FG000|Overall Study|Non-compliance With Study Drug|1|||
124783343|NCT01124864|448838085|FG003|Overall Study|Death|2|||
124783344|NCT01124864|448838086|FG004|Overall Study|Death|1|||
125287677|NCT02536300|450681383|FG001|Overall Study|Non-compliance With Study Drug|0|||
125287678|NCT02536300|450681384|FG002|Overall Study|Non-compliance With Study Drug|0|||
125287679|NCT02536300|450681382|FG000|Overall Study|Protocol Violation|0|||
125287680|NCT02536300|450681383|FG001|Overall Study|Protocol Violation|1|||
125287681|NCT02536300|450681384|FG002|Overall Study|Protocol Violation|0|||
125287682|NCT04706273|450681385|FG000|Overall Study|Withdrawal by Subject|27|||
125287683|NCT04706273|450681385|FG000|Overall Study|Physician Decision|1|||
125287684|NCT04706273|450681385|FG000|Overall Study|Lost to Follow-up|42|||
125287685|NCT04706273|450681385|FG000|Overall Study|Death|85|||
125287686|NCT04706273|450681385|FG000|Overall Study|Amputation that removes study device|2|||
125287687|NCT04706273|450681385|FG000|Overall Study|Surgical bypass|3|||
125287688|NCT04706273|450681385|FG000|Overall Study|Changing hospital|23|||
125287689|NCT04706273|450681385|FG000|Overall Study|Unable to attend hospital|2|||
125287690|NCT01080768|450681388|FG000|Overall Study|Protocol Deviation|2|||
125287691|NCT01080768|450681389|FG001|Overall Study|Protocol Deviation|1|||
125287692|NCT00931723|450681394|FG000|Overall Study|Withdrawal by Subject|11|||
125287693|NCT00931723|450681395|FG001|Overall Study|Withdrawal by Subject|13|||
125287694|NCT00931723|450681394|FG000|Overall Study|Adverse Event|6|||
125287695|NCT00931723|450681395|FG001|Overall Study|Adverse Event|13|||
125287696|NCT00931723|450681394|FG000|Overall Study|Lithium found in blood|0|||
125287697|NCT00931723|450681395|FG001|Overall Study|Lithium found in blood|1|||
125287698|NCT00931723|450681394|FG000|Overall Study|Condition under investigation worsened|1|||
125287699|NCT00931723|450681395|FG001|Overall Study|Condition under investigation worsened|2|||
125287700|NCT00931723|450681394|FG000|Overall Study|Lost to Follow-up|1|||
125287701|NCT00931723|450681395|FG001|Overall Study|Lost to Follow-up|2|||
125287702|NCT00931723|450681394|FG000|Overall Study|Study-specific discontinuation criteria|1|||
125287703|NCT00931723|450681395|FG001|Overall Study|Study-specific discontinuation criteria|1|||
125287704|NCT00931723|450681394|FG000|Overall Study|Severe non-compliance to protocol|2|||
125287705|NCT00931723|450681395|FG001|Overall Study|Severe non-compliance to protocol|0|||
125287706|NCT00931723|450681394|FG000|Overall Study|Safety reasons|0|||
125287707|NCT00931723|450681395|FG001|Overall Study|Safety reasons|1|||
125287708|NCT00931723|450681394|FG000|Overall Study|Took prohibited concomitant medication|0|||
125287709|NCT00931723|450681395|FG001|Overall Study|Took prohibited concomitant medication|1|||
125287710|NCT00931723|450681394|FG000|Overall Study|Lack or insufficient theraputic response|2|||
125287711|NCT00931723|450681395|FG001|Overall Study|Lack or insufficient theraputic response|5|||
125287712|NCT00931723|450681394|FG000|Overall Study|Sponsor decision|1|||
125287713|NCT00931723|450681395|FG001|Overall Study|Sponsor decision|0|||
125287714|NCT00931723|450681394|FG000|Overall Study|Late hospital discharge|1|||
125287715|NCT00931723|450681395|FG001|Overall Study|Late hospital discharge|0|||
125287716|NCT03054350|450681398|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
125287717|NCT03054350|450681399|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
125287718|NCT03054350|450681400|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
124783345|NCT01124864|448838087|FG005|Overall Study|Death|0|||
124783346|NCT01124864|448838082|FG000|Overall Study|Withdrawal by Subject|2|||
124783347|NCT01124864|448838083|FG001|Overall Study|Withdrawal by Subject|3|||
124783348|NCT01124864|448838084|FG002|Overall Study|Withdrawal by Subject|4|||
124783349|NCT01124864|448838085|FG003|Overall Study|Withdrawal by Subject|0|||
124783350|NCT01124864|448838086|FG004|Overall Study|Withdrawal by Subject|2|||
124783351|NCT01124864|448838087|FG005|Overall Study|Withdrawal by Subject|1|||
124783352|NCT01124864|448838082|FG000|Overall Study|Lost to Follow-up|1|||
124783353|NCT01124864|448838083|FG001|Overall Study|Lost to Follow-up|1|||
124783354|NCT01124864|448838084|FG002|Overall Study|Lost to Follow-up|0|||
124783355|NCT01124864|448838085|FG003|Overall Study|Lost to Follow-up|1|||
125287719|NCT03054350|450681401|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
125287720|NCT03054350|450681402|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
125287721|NCT03054350|450681403|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
125287722|NCT03054350|450681398|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
125287723|NCT03054350|450681399|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
125287724|NCT03054350|450681400|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
125287725|NCT03054350|450681401|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
124783356|NCT01124864|448838086|FG004|Overall Study|Lost to Follow-up|0|||
124783357|NCT01124864|448838087|FG005|Overall Study|Lost to Follow-up|0|||
124783358|NCT01124864|448838082|FG000|Overall Study|Protocol Violation|1|||
124783359|NCT01124864|448838083|FG001|Overall Study|Protocol Violation|0|||
125287726|NCT03054350|450681402|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
125287727|NCT03054350|450681403|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
125287728|NCT03054350|450681398|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
125287729|NCT03054350|450681399|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
124783360|NCT01124864|448838084|FG002|Overall Study|Protocol Violation|0|||
125287730|NCT03054350|450681400|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
125287731|NCT03054350|450681401|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
125287732|NCT03054350|450681402|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
125287733|NCT03054350|450681403|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
125287734|NCT03054350|450681398|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
125287735|NCT03054350|450681399|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
125287736|NCT03054350|450681400|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
125287737|NCT03054350|450681401|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
125287738|NCT03054350|450681402|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
125287739|NCT03054350|450681403|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
125287740|NCT01133405|450681404|FG000|Period 1|Withdrawal by Subject|0|||
125287741|NCT01133405|450681405|FG001|Period 1|Withdrawal by Subject|1|||
125287742|NCT01133405|450681406|FG002|Period 1|Withdrawal by Subject|0|||
125287743|NCT01133405|450681407|FG003|Period 1|Withdrawal by Subject|1|||
125287744|NCT01133405|450681408|FG004|Period 1|Withdrawal by Subject|0|||
125287745|NCT01133405|450681409|FG005|Period 1|Withdrawal by Subject|1|||
125287746|NCT01133405|450681410|FG006|Period 1|Withdrawal by Subject|0|||
125287747|NCT01133405|450681411|FG007|Period 1|Withdrawal by Subject|0|||
125287748|NCT01133405|450681412|FG008|Period 1|Withdrawal by Subject|0|||
125287749|NCT01133405|450681413|FG009|Period 1|Withdrawal by Subject|0|||
125287750|NCT01133405|450681404|FG000|Period 1|Physician Decision|0|||
125287751|NCT01133405|450681405|FG001|Period 1|Physician Decision|0|||
125287752|NCT01133405|450681406|FG002|Period 1|Physician Decision|0|||
125287753|NCT01133405|450681407|FG003|Period 1|Physician Decision|1|||
125287754|NCT01133405|450681408|FG004|Period 1|Physician Decision|0|||
125287755|NCT01133405|450681409|FG005|Period 1|Physician Decision|0|||
125287756|NCT01133405|450681410|FG006|Period 1|Physician Decision|0|||
125287757|NCT01133405|450681411|FG007|Period 1|Physician Decision|0|||
125287758|NCT01133405|450681412|FG008|Period 1|Physician Decision|0|||
125287759|NCT01133405|450681413|FG009|Period 1|Physician Decision|0|||
125287760|NCT01133405|450681404|FG000|Period 1|Discontinued after randomization|1|||
125287761|NCT01133405|450681405|FG001|Period 1|Discontinued after randomization|0|||
125287762|NCT01133405|450681406|FG002|Period 1|Discontinued after randomization|0|||
125287763|NCT01133405|450681407|FG003|Period 1|Discontinued after randomization|0|||
125287764|NCT01133405|450681408|FG004|Period 1|Discontinued after randomization|0|||
125287765|NCT01133405|450681409|FG005|Period 1|Discontinued after randomization|0|||
125287766|NCT01133405|450681410|FG006|Period 1|Discontinued after randomization|1|||
125287767|NCT01133405|450681411|FG007|Period 1|Discontinued after randomization|0|||
125287768|NCT01133405|450681412|FG008|Period 1|Discontinued after randomization|0|||
125287769|NCT01133405|450681413|FG009|Period 1|Discontinued after randomization|0|||
125287770|NCT01133405|450681404|FG000|Period 1|Received drug only in period 2|0|||
125287771|NCT01133405|450681405|FG001|Period 1|Received drug only in period 2|1|||
125287772|NCT01133405|450681406|FG002|Period 1|Received drug only in period 2|0|||
125287773|NCT01133405|450681407|FG003|Period 1|Received drug only in period 2|2|||
125287774|NCT01133405|450681408|FG004|Period 1|Received drug only in period 2|0|||
125287775|NCT01133405|450681409|FG005|Period 1|Received drug only in period 2|1|||
125287776|NCT01133405|450681410|FG006|Period 1|Received drug only in period 2|0|||
125287777|NCT01133405|450681411|FG007|Period 1|Received drug only in period 2|0|||
125287778|NCT01133405|450681412|FG008|Period 1|Received drug only in period 2|0|||
125287779|NCT01133405|450681413|FG009|Period 1|Received drug only in period 2|0|||
125287780|NCT01133405|450681404|FG000|Period 1|Received drug only in period 3|0|||
125287781|NCT01133405|450681405|FG001|Period 1|Received drug only in period 3|1|||
125287782|NCT01133405|450681406|FG002|Period 1|Received drug only in period 3|1|||
125287783|NCT01133405|450681407|FG003|Period 1|Received drug only in period 3|0|||
125287784|NCT01133405|450681408|FG004|Period 1|Received drug only in period 3|0|||
125287785|NCT01133405|450681409|FG005|Period 1|Received drug only in period 3|0|||
125287786|NCT01133405|450681410|FG006|Period 1|Received drug only in period 3|0|||
125287787|NCT01133405|450681411|FG007|Period 1|Received drug only in period 3|0|||
125287788|NCT01133405|450681412|FG008|Period 1|Received drug only in period 3|0|||
125287789|NCT01133405|450681413|FG009|Period 1|Received drug only in period 3|0|||
125287790|NCT01133405|450681404|FG000|Period 2|Adverse Event|0|||
125287791|NCT01133405|450681405|FG001|Period 2|Adverse Event|0|||
125287792|NCT01133405|450681406|FG002|Period 2|Adverse Event|1|||
125287793|NCT01133405|450681407|FG003|Period 2|Adverse Event|0|||
125287794|NCT01133405|450681408|FG004|Period 2|Adverse Event|0|||
125287795|NCT01133405|450681409|FG005|Period 2|Adverse Event|0|||
124783361|NCT01124864|448838085|FG003|Overall Study|Protocol Violation|0|||
124783362|NCT01124864|448838086|FG004|Overall Study|Protocol Violation|1|||
125287796|NCT01133405|450681410|FG006|Period 2|Adverse Event|0|||
125287797|NCT01133405|450681411|FG007|Period 2|Adverse Event|0|||
125287798|NCT01133405|450681412|FG008|Period 2|Adverse Event|0|||
125287799|NCT01133405|450681413|FG009|Period 2|Adverse Event|0|||
125287800|NCT01133405|450681404|FG000|Period 2|Withdrawal by Subject|0|||
125287801|NCT01133405|450681405|FG001|Period 2|Withdrawal by Subject|0|||
125287802|NCT01133405|450681406|FG002|Period 2|Withdrawal by Subject|0|||
125287803|NCT01133405|450681407|FG003|Period 2|Withdrawal by Subject|1|||
125287804|NCT01133405|450681408|FG004|Period 2|Withdrawal by Subject|0|||
125287805|NCT01133405|450681409|FG005|Period 2|Withdrawal by Subject|1|||
125287806|NCT01133405|450681410|FG006|Period 2|Withdrawal by Subject|0|||
125287807|NCT01133405|450681411|FG007|Period 2|Withdrawal by Subject|0|||
125287808|NCT01133405|450681412|FG008|Period 2|Withdrawal by Subject|0|||
125287809|NCT01133405|450681413|FG009|Period 2|Withdrawal by Subject|0|||
125287810|NCT01133405|450681404|FG000|Period 2|Entry Criteria Not Met|0|||
125287811|NCT01133405|450681405|FG001|Period 2|Entry Criteria Not Met|1|||
125287812|NCT01133405|450681406|FG002|Period 2|Entry Criteria Not Met|0|||
125287813|NCT01133405|450681407|FG003|Period 2|Entry Criteria Not Met|0|||
125287814|NCT01133405|450681408|FG004|Period 2|Entry Criteria Not Met|0|||
125287815|NCT01133405|450681409|FG005|Period 2|Entry Criteria Not Met|0|||
125287816|NCT01133405|450681410|FG006|Period 2|Entry Criteria Not Met|0|||
125287817|NCT01133405|450681411|FG007|Period 2|Entry Criteria Not Met|0|||
125287818|NCT01133405|450681412|FG008|Period 2|Entry Criteria Not Met|0|||
125287819|NCT01133405|450681413|FG009|Period 2|Entry Criteria Not Met|0|||
125287820|NCT01133405|450681404|FG000|Period 2|Physician Decision|0|||
125287821|NCT01133405|450681405|FG001|Period 2|Physician Decision|0|||
125287822|NCT01133405|450681406|FG002|Period 2|Physician Decision|0|||
125287823|NCT01133405|450681407|FG003|Period 2|Physician Decision|0|||
125287824|NCT01133405|450681408|FG004|Period 2|Physician Decision|0|||
125287825|NCT01133405|450681409|FG005|Period 2|Physician Decision|1|||
125287826|NCT01133405|450681410|FG006|Period 2|Physician Decision|0|||
125287827|NCT01133405|450681411|FG007|Period 2|Physician Decision|0|||
125287828|NCT01133405|450681412|FG008|Period 2|Physician Decision|0|||
125287829|NCT01133405|450681413|FG009|Period 2|Physician Decision|0|||
125287830|NCT01238835|450681416|FG000|Overall Study|Death|124|||
125287831|NCT01238835|450681416|FG000|Overall Study|Withdrawal by Subject|9|||
125287832|NCT01238835|450681416|FG000|Overall Study|Lost to Follow-up|1|||
125287833|NCT01238835|450681416|FG000|Overall Study|Site early discontinuation|2|||
125287834|NCT01774253|450681417|FG000|Overall Study|Lack of Efficacy|4|||
125287835|NCT01774253|450681417|FG000|Overall Study|Physician Decision|2|||
125287836|NCT01774253|450681417|FG000|Overall Study|Withdrawal by Subject|2|||
125287837|NCT01774253|450681417|FG000|Overall Study|Death|1|||
125287838|NCT00772369|450681418|FG000|Overall Study|Did not return record release form|1|||
125287839|NCT00554619|450681419|FG000|Overall Study|Adverse Event|1|||
125287840|NCT00554619|450681419|FG000|Overall Study|Physician Decision|1|||
125287841|NCT00554619|450681419|FG000|Overall Study|Liver Function Test Abnormality|1|||
125287842|NCT02240368|450681423|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
125287843|NCT02240368|450681424|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
125287844|NCT02240368|450681425|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
125287845|NCT02240368|450681423|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
125287846|NCT02240368|450681424|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
125287847|NCT02240368|450681425|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
125287848|NCT00907803|450681426|FG000|Overall Study|Withdrawal of consent - long commute|1|||
125287849|NCT00907803|450681427|FG001|Overall Study|Withdrawal of consent - long commute|0|||
125287850|NCT00907803|450681428|FG002|Overall Study|Withdrawal of consent - long commute|0|||
125287851|NCT00907803|450681426|FG000|Overall Study|Adverse Event|2|||
125287852|NCT00907803|450681427|FG001|Overall Study|Adverse Event|0|||
125287853|NCT00907803|450681428|FG002|Overall Study|Adverse Event|0|||
125287854|NCT00907803|450681426|FG000|Overall Study|Withdrawal by Subject|0|||
125287855|NCT00907803|450681427|FG001|Overall Study|Withdrawal by Subject|1|||
125287856|NCT00907803|450681428|FG002|Overall Study|Withdrawal by Subject|0|||
125287857|NCT00907803|450681426|FG000|Overall Study|Lost to Follow-up|0|||
125287858|NCT00907803|450681427|FG001|Overall Study|Lost to Follow-up|1|||
125287859|NCT00907803|450681428|FG002|Overall Study|Lost to Follow-up|0|||
125287860|NCT00907803|450681426|FG000|Overall Study|Protocol Violation|0|||
125287861|NCT00907803|450681427|FG001|Overall Study|Protocol Violation|1|||
125287862|NCT00907803|450681428|FG002|Overall Study|Protocol Violation|0|||
125287863|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Death|1|||
125287864|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Death|1|||
125287865|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Death|0|||
125287866|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Death|0|||
125287867|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Death|1|||
125287868|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Death|0|||
125287869|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Death|0|||
125287870|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Death|0|||
125287871|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Death|0|||
125287872|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Death|0|||
125287873|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
125287874|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
125287875|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
125287876|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
125287877|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
125287878|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
125287879|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
125287880|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
125287881|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
125287882|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
125287883|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
125287884|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
125287885|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
125287886|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
125287887|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
125287888|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
125287889|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
125287890|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
125287891|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
125287892|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
125287893|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
125287894|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
125287895|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
125287896|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
125287897|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
125287898|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
125287899|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
125287900|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
125287901|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
125287902|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
125287903|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
125287904|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
125287905|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
125287906|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
125287907|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
125287908|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
125287909|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
125287910|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
125287911|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
125287912|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
125287913|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
125287914|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
125287915|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
125287916|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
125287917|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
125287918|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
125287919|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
125287920|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
125287921|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
125287922|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
125287923|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
125287924|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
125287925|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
125287926|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
125287927|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
125287928|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
125287929|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
125287930|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
125287931|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
125287932|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
125287933|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
125287934|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
125287935|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
125287936|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125287937|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
125287938|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125287939|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125287940|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125287941|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125287942|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125287943|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
125287944|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
125287945|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
125287946|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
125287947|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
125287948|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
125287949|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
125287950|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
125287951|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
125287952|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
125287953|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
125287954|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
125287955|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125287956|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
125287957|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
125287958|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125287959|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125287960|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125287961|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125287962|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125287963|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
125287964|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
125287965|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
125287966|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
125287967|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
125287968|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
125287969|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
125287970|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
125287971|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
125287972|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
125287973|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
125287974|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
125287975|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
125287976|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
125287977|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
125287978|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
125287979|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
125287980|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
125287981|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
125287982|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
125287983|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125287984|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125287985|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125287986|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
125287987|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
125287988|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125287989|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125287990|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125287991|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125287992|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125287993|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
125287994|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125287995|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
125287996|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
125287997|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
125287998|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125287999|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288000|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288001|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288002|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288003|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
125288004|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
125288005|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
125288006|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
125288007|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
125288008|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
125288009|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
125288010|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
125288011|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
125288012|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
125288013|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288014|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288015|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288016|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288017|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
125288018|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288019|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288020|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288021|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288022|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288023|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
125288024|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
125288025|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
125288026|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
125288027|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
125288028|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
125288029|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
125288030|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
125288031|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
125288032|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
125288033|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
125288034|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
125288035|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
125288036|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
125288037|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
125288038|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
125288039|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
125288040|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
125288041|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
125288042|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
125288043|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
125288044|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
125288045|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
125288046|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
125288047|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
125288048|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
125288049|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
125288050|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
125288051|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
125288052|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
125288053|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Other|5|||
125288054|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Other|1|||
125288055|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Other|0|||
125288056|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Other|3|||
125288057|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Other|0|||
125288058|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Other|0|||
125288059|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Other|0|||
125288060|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Other|0|||
125288061|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Other|0|||
125288062|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Other|0|||
125288063|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
125288064|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
125288065|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
125288066|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
125288067|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
125288068|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
125288069|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
125288070|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
125288071|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
125288072|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
125288073|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Death|0|||
125288074|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Death|0|||
125288075|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Death|0|||
125288076|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Death|0|||
125288077|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Death|0|||
125288078|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Death|1|||
125288079|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Death|0|||
125288080|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Death|1|||
125288081|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Death|1|||
125288082|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Death|1|||
125288083|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
125288084|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
125288085|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
125288086|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
125288087|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
125288088|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
125288089|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
125288090|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
125288091|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
125288092|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
125288093|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
125288094|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
125288095|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
125288096|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
125288097|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
125288098|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
125288099|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
125288100|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
125288101|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
125288102|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
125288103|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
125288104|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
125288105|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
125288106|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
125288107|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
125288108|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
125288109|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
125288110|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
125288111|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
125288112|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
125288113|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125288114|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125288115|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125288116|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125288117|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125288118|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
125288119|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125288120|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
125288121|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
125288122|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
125288123|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125288124|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125288125|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125288126|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125288127|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125288128|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
125288129|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125288130|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
125288131|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
125288132|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125288133|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
125288134|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
125288135|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
125288136|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
125288137|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
125288138|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
125288139|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
125288140|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
125288141|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
125288142|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
125288143|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125288144|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125288145|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125288146|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125288147|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125288148|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125288149|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125288150|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125288151|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
125288152|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
125288153|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288154|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288155|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288156|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288157|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288158|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288159|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288160|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
125288161|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288162|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288163|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
125288164|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
125288165|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
125288166|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
125288167|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
125288168|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
125288169|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
125288170|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
125288171|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
125288172|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
125288173|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288174|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288175|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288176|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288177|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288178|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288179|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288180|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
125288181|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
125288182|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288183|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
125288184|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
125288185|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
125288186|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
125288187|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
125288188|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
125288189|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
125288190|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
125288191|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
125288192|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
125288193|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
125288194|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
125288195|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
125288196|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
125288197|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
125288198|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
125288199|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
125288200|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
125288201|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
125288202|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
125288203|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
125288204|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
125288205|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
125288206|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
125288207|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
125288208|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
125288209|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
125288210|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
125288211|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
125288212|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
125288213|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
125288214|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
125288215|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
125288216|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
125288217|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
125288218|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
125288219|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
125288220|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
125288221|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
125288222|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
125288223|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Other|0|||
125288224|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Other|0|||
125288225|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Other|0|||
125288226|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Other|0|||
125288227|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Other|0|||
125288228|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Other|0|||
125288229|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Other|0|||
125288230|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Other|1|||
125288231|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Other|0|||
125288232|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Other|0|||
125288233|NCT03510468|450681439|FG000|Overall Study|Lost to Follow-up|1|||
125288234|NCT03510468|450681439|FG000|Overall Study|Adverse Event|5|||
125288235|NCT03510468|450681439|FG000|Overall Study|Physician Decision|1|||
125288236|NCT03510468|450681439|FG000|Overall Study|non-compliant with treatment|2|||
125288237|NCT03510468|450681439|FG000|Overall Study|Missed visit|1|||
125288238|NCT04612842|450681440|FG000|Overall Study|Lost to Follow-up|20|||
125288239|NCT04612842|450681441|FG001|Overall Study|Lost to Follow-up|11|||
125288240|NCT04612842|450681440|FG000|Overall Study|Withdrawal by Subject|26|||
125288241|NCT04612842|450681441|FG001|Overall Study|Withdrawal by Subject|15|||
125288242|NCT04612842|450681440|FG000|Overall Study|Death|2|||
125288243|NCT04612842|450681441|FG001|Overall Study|Death|2|||
125288244|NCT05426031|450681442|FG000|Overall Study|Circulatory Arrest|3|||
125288245|NCT05426031|450681443|FG001|Overall Study|Circulatory Arrest|2|||
125288246|NCT02419131|450681444|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
125288247|NCT02419131|450681445|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
125288248|NCT02419131|450681446|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
125288249|NCT02419131|450681444|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
125288250|NCT02419131|450681445|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
125288251|NCT02419131|450681446|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
125288252|NCT04677660|450681447|FG000|Overall Study|Lost to Follow-up|0|||
125288253|NCT04677660|450681448|FG001|Overall Study|Lost to Follow-up|2|||
125288254|NCT04677660|450681447|FG000|Overall Study|Withdrawal by Subject|0|||
125288255|NCT04677660|450681448|FG001|Overall Study|Withdrawal by Subject|1|||
125288256|NCT04677660|450681447|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
125288257|NCT04677660|450681448|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
125288258|NCT00089986|450681449|FG000|Overall Study|Adverse Event|6|||
125288259|NCT00089986|450681450|FG001|Overall Study|Adverse Event|9|||
125288260|NCT00089986|450681451|FG002|Overall Study|Adverse Event|6|||
125288261|NCT00089986|450681449|FG000|Overall Study|Lost to Follow-up|3|||
125288262|NCT00089986|450681450|FG001|Overall Study|Lost to Follow-up|1|||
125288263|NCT00089986|450681451|FG002|Overall Study|Lost to Follow-up|1|||
125288264|NCT00089986|450681449|FG000|Overall Study|Protocol Violation|0|||
125288265|NCT00089986|450681450|FG001|Overall Study|Protocol Violation|1|||
124783363|NCT01124864|448838087|FG005|Overall Study|Protocol Violation|0|||
125288266|NCT00089986|450681451|FG002|Overall Study|Protocol Violation|0|||
124783364|NCT01243242|448838088|FG000|Overall Study|Adverse Event|1|||
125288267|NCT00089986|450681449|FG000|Overall Study|Patient transferred to another hospital|2|||
125288268|NCT00089986|450681450|FG001|Overall Study|Patient transferred to another hospital|1|||
125288269|NCT00089986|450681451|FG002|Overall Study|Patient transferred to another hospital|0|||
125288270|NCT00089986|450681449|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
125288271|NCT00089986|450681450|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
125288272|NCT00089986|450681451|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
125288273|NCT00089986|450681449|FG000|Overall Study|Hemohlobin stopping rule|0|||
125288274|NCT00089986|450681450|FG001|Overall Study|Hemohlobin stopping rule|1|||
125288275|NCT00089986|450681451|FG002|Overall Study|Hemohlobin stopping rule|0|||
125288276|NCT00089986|450681449|FG000|Overall Study|Investigator decision to withdrew|0|||
125288277|NCT00089986|450681450|FG001|Overall Study|Investigator decision to withdrew|1|||
125288278|NCT00089986|450681451|FG002|Overall Study|Investigator decision to withdrew|0|||
125288279|NCT00089986|450681449|FG000|Overall Study|Enrollment in another study|0|||
125288280|NCT00089986|450681450|FG001|Overall Study|Enrollment in another study|1|||
125288281|NCT00089986|450681451|FG002|Overall Study|Enrollment in another study|0|||
125288282|NCT00089986|450681449|FG000|Overall Study|Family decision|0|||
125288283|NCT00089986|450681450|FG001|Overall Study|Family decision|1|||
125288284|NCT00089986|450681451|FG002|Overall Study|Family decision|0|||
125288285|NCT00089986|450681449|FG000|Overall Study|Do not resuscitate (DNR)|0|||
125288286|NCT00089986|450681450|FG001|Overall Study|Do not resuscitate (DNR)|0|||
125288287|NCT00089986|450681451|FG002|Overall Study|Do not resuscitate (DNR)|1|||
125288288|NCT00089986|450681449|FG000|Overall Study|Withdrawal by Subject|3|||
125288289|NCT00089986|450681450|FG001|Overall Study|Withdrawal by Subject|6|||
125288290|NCT00089986|450681451|FG002|Overall Study|Withdrawal by Subject|2|||
125288291|NCT02334683|450681454|FG000|First 12 Week Period|Lost to Follow-up|1|||
125288292|NCT02334683|450681455|FG001|First 12 Week Period|Lost to Follow-up|0|||
125288293|NCT02334683|450681454|FG000|Second 12 Week Period|Adverse Event|0|||
125288294|NCT02334683|450681455|FG001|Second 12 Week Period|Adverse Event|1|||
125288295|NCT00916058|450681456|FG000|Phase 1|Screen Failure|0|||
125288296|NCT00916058|450681457|FG001|Phase 1|Screen Failure|0|||
125288297|NCT00916058|450681458|FG002|Phase 1|Screen Failure|0|||
125288298|NCT00916058|450681459|FG003|Phase 1|Screen Failure|0|||
125288299|NCT00916058|450681460|FG004|Phase 1|Screen Failure|0|||
125288300|NCT00916058|450681461|FG005|Phase 1|Screen Failure|1|||
125288301|NCT00916058|450681462|FG006|Phase 1|Screen Failure|0|||
125288302|NCT00916058|450681456|FG000|Phase 2|Screen Failure|0|||
125288303|NCT00916058|450681457|FG001|Phase 2|Screen Failure|0|||
125288304|NCT00916058|450681458|FG002|Phase 2|Screen Failure|0|||
125288305|NCT00916058|450681459|FG003|Phase 2|Screen Failure|0|||
125288306|NCT00916058|450681460|FG004|Phase 2|Screen Failure|0|||
125288307|NCT00916058|450681461|FG005|Phase 2|Screen Failure|0|||
125288308|NCT00916058|450681462|FG006|Phase 2|Screen Failure|3|||
125288309|NCT02437305|450681463|FG000|Overall Study|Lost to Follow-up|18|||
125288310|NCT02437305|450681464|FG001|Overall Study|Lost to Follow-up|12|||
125288311|NCT01071200|450681483|FG000|Overall Study|Lack of ovarian response|1|||
125288312|NCT01071200|450681484|FG001|Overall Study|Lack of ovarian response|1|||
125288313|NCT01071200|450681483|FG000|Overall Study|No fertilization|4|||
125288314|NCT01071200|450681484|FG001|Overall Study|No fertilization|0|||
125288315|NCT01071200|450681483|FG000|Overall Study|No oocytes retrieved|1|||
125288316|NCT01071200|450681484|FG001|Overall Study|No oocytes retrieved|1|||
125288317|NCT01071200|450681483|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
125288318|NCT01071200|450681484|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
125288319|NCT01071200|450681483|FG000|Overall Study|No viable embryos|0|||
125288320|NCT01071200|450681484|FG001|Overall Study|No viable embryos|1|||
125288321|NCT04465877|450681488|FG000|Overall Study|Noncompliant with study requirements|0|||
125288322|NCT04465877|450681489|FG001|Overall Study|Noncompliant with study requirements|0|||
125288323|NCT04465877|450681490|FG002|Overall Study|Noncompliant with study requirements|1|||
125288324|NCT04465877|450681491|FG003|Overall Study|Noncompliant with study requirements|0|||
125288325|NCT03762616|450681492|FG000|Overall Study|Protocol Violation|2|||
125288326|NCT04962230|450681493|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
125288327|NCT04962230|450681493|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
125288328|NCT03576755|450681494|FG000|Overall Study|Withdrawal by Subject|1|||
125288329|NCT03576755|450681495|FG001|Overall Study|Withdrawal by Subject|0|||
125288330|NCT03576755|450681496|FG002|Overall Study|Withdrawal by Subject|0|||
125288331|NCT03576755|450681497|FG003|Overall Study|Withdrawal by Subject|0|||
125288332|NCT03958656|450681500|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
125288333|NCT03958656|450681501|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
125288334|NCT03958656|450681502|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
125288335|NCT03958656|450681503|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
125288336|NCT03958656|450681500|FG000|Overall Study|No longer meets eligibility criteria|0|||
125288337|NCT03958656|450681501|FG001|Overall Study|No longer meets eligibility criteria|0|||
125288338|NCT03958656|450681502|FG002|Overall Study|No longer meets eligibility criteria|1|||
125288339|NCT03958656|450681503|FG003|Overall Study|No longer meets eligibility criteria|0|||
125288340|NCT03958656|450681500|FG000|Overall Study|Started anti-cancer treatment|0|||
125288341|NCT03958656|450681501|FG001|Overall Study|Started anti-cancer treatment|0|||
125288342|NCT03958656|450681502|FG002|Overall Study|Started anti-cancer treatment|1|||
125288343|NCT03958656|450681503|FG003|Overall Study|Started anti-cancer treatment|0|||
125288344|NCT01767493|450681504|FG000|Overall Study|screen failures|3|||
125288345|NCT01598753|450681505|FG000|Overall Study|Adverse Event|1|||
125288346|NCT01598753|450681506|FG001|Overall Study|Adverse Event|9|||
125288347|NCT01598753|450681507|FG002|Overall Study|Adverse Event|1|||
125288348|NCT01598753|450681508|FG003|Overall Study|Adverse Event|7|||
125288349|NCT01598753|450681505|FG000|Overall Study|Lost to Follow-up|4|||
125288350|NCT01598753|450681506|FG001|Overall Study|Lost to Follow-up|3|||
125288351|NCT01598753|450681507|FG002|Overall Study|Lost to Follow-up|7|||
125288352|NCT01598753|450681508|FG003|Overall Study|Lost to Follow-up|5|||
125288353|NCT01598753|450681505|FG000|Overall Study|Physician Decision|0|||
125288354|NCT01598753|450681506|FG001|Overall Study|Physician Decision|1|||
125288355|NCT01598753|450681507|FG002|Overall Study|Physician Decision|0|||
125288356|NCT01598753|450681508|FG003|Overall Study|Physician Decision|2|||
125288357|NCT01598753|450681505|FG000|Overall Study|Withdrawal by Subject|7|||
125288358|NCT01598753|450681506|FG001|Overall Study|Withdrawal by Subject|2|||
125288359|NCT01598753|450681507|FG002|Overall Study|Withdrawal by Subject|0|||
125288360|NCT01598753|450681508|FG003|Overall Study|Withdrawal by Subject|1|||
125288361|NCT03158012|450681509|FG000|Overall Study|Withdrawal by Subject|0|||
125288362|NCT03158012|450681510|FG001|Overall Study|Withdrawal by Subject|1|||
125288363|NCT04346108|450681511|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
125288364|NCT04346108|450681512|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
125288365|NCT04346108|450681513|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
125288366|NCT04346108|450681511|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
125288367|NCT04346108|450681512|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
125288368|NCT04346108|450681513|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
125288369|NCT02788201|450681514|FG000|Overall Study|Death|1|||
125288370|NCT02788201|450681515|FG001|Overall Study|Death|1|||
125288371|NCT02788201|450681516|FG002|Overall Study|Death|1|||
125288372|NCT02788201|450681517|FG003|Overall Study|Death|1|||
125288373|NCT02788201|450681518|FG004|Overall Study|Death|0|||
125288374|NCT02788201|450681519|FG005|Overall Study|Death|1|||
125288375|NCT02788201|450681514|FG000|Overall Study|Ineligible|0|||
125288376|NCT02788201|450681515|FG001|Overall Study|Ineligible|0|||
125288377|NCT02788201|450681516|FG002|Overall Study|Ineligible|0|||
125288378|NCT02788201|450681517|FG003|Overall Study|Ineligible|0|||
125288379|NCT02788201|450681518|FG004|Overall Study|Ineligible|0|||
125288380|NCT02788201|450681519|FG005|Overall Study|Ineligible|1|||
125288381|NCT02788201|450681514|FG000|Overall Study|Withdrawal by Subject|0|||
125288382|NCT02788201|450681515|FG001|Overall Study|Withdrawal by Subject|0|||
125288383|NCT02788201|450681516|FG002|Overall Study|Withdrawal by Subject|0|||
125288384|NCT02788201|450681517|FG003|Overall Study|Withdrawal by Subject|0|||
125288385|NCT02788201|450681518|FG004|Overall Study|Withdrawal by Subject|0|||
125288386|NCT02788201|450681519|FG005|Overall Study|Withdrawal by Subject|1|||
125288387|NCT02446418|450681524|FG000|Overall Study|Adverse Event|4|||
125288388|NCT02446418|450681525|FG001|Overall Study|Adverse Event|8|||
125288389|NCT02446418|450681524|FG000|Overall Study|Physician Decision|5|||
125288390|NCT02446418|450681525|FG001|Overall Study|Physician Decision|1|||
125288391|NCT02446418|450681524|FG000|Overall Study|Withdrawal by Subject|3|||
125288392|NCT02446418|450681525|FG001|Overall Study|Withdrawal by Subject|3|||
125288393|NCT02446418|450681524|FG000|Overall Study|Lost to Follow-up|2|||
125288394|NCT02446418|450681525|FG001|Overall Study|Lost to Follow-up|2|||
125288395|NCT02446418|450681524|FG000|Overall Study|Protocol Violation|1|||
125288396|NCT02446418|450681525|FG001|Overall Study|Protocol Violation|2|||
125288397|NCT02446418|450681524|FG000|Overall Study|Lack of Efficacy|2|||
125288398|NCT02446418|450681525|FG001|Overall Study|Lack of Efficacy|0|||
125288399|NCT02446418|450681524|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
125288400|NCT02446418|450681525|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
125288401|NCT04508751|450681526|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
125288402|NCT04508751|450681527|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
125288403|NCT04508751|450681528|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
125288404|NCT02014480|450681529|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
125288405|NCT02014480|450681530|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
125288406|NCT02014480|450681531|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
125288407|NCT02014480|450681532|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
125288408|NCT02014480|450681533|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
125288409|NCT02014480|450681534|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
125288410|NCT02014480|450681529|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125288411|NCT02014480|450681530|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
124783365|NCT01243242|448838089|FG001|Overall Study|Adverse Event|1|||
125288412|NCT02014480|450681531|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125288413|NCT02014480|450681532|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
124783366|NCT01243242|448838088|FG000|Overall Study|Withdrawal by Subject|1|||
125288414|NCT02014480|450681533|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
125288415|NCT02014480|450681534|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124783367|NCT01243242|448838089|FG001|Overall Study|Withdrawal by Subject|1|||
125288416|NCT02014480|450681529|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
125288417|NCT02014480|450681530|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
125288418|NCT02014480|450681531|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
125288419|NCT02014480|450681532|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
125288420|NCT02014480|450681533|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
125288421|NCT02014480|450681534|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
125288422|NCT02014480|450681529|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
125288423|NCT02014480|450681530|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
125288424|NCT02014480|450681531|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
125288425|NCT02014480|450681532|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
125288426|NCT02014480|450681533|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125288427|NCT02014480|450681534|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125288428|NCT02014480|450681529|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
125288429|NCT02014480|450681530|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
125288430|NCT02014480|450681531|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
125288431|NCT02014480|450681532|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
125288432|NCT02014480|450681533|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
125288433|NCT02014480|450681534|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
125288434|NCT02014480|450681529|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
125288435|NCT02014480|450681530|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
125288436|NCT02014480|450681531|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
125288437|NCT02014480|450681532|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
125288438|NCT02014480|450681533|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
125288439|NCT02014480|450681534|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
125288440|NCT02014480|450681529|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125288441|NCT02014480|450681530|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125288442|NCT02014480|450681531|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125288443|NCT02014480|450681532|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125288444|NCT02014480|450681533|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125288445|NCT02014480|450681534|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
125288446|NCT01865812|450681537|FG000|Primary Treatment Phase|Adverse Event|2|||
125288447|NCT01865812|450681538|FG001|Primary Treatment Phase|Adverse Event|0|||
125288448|NCT01865812|450681537|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
125288449|NCT01865812|450681538|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
125288450|NCT01865812|450681537|FG000|Long-term Safety Extension Phase|Pruritus|0|||
125288451|NCT01865812|450681538|FG001|Long-term Safety Extension Phase|Pruritus|3|||
125288452|NCT01865812|450681537|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
125288453|NCT01865812|450681538|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
125288454|NCT01865812|450681537|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
125288455|NCT01865812|450681538|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
125288456|NCT01338610|450681539|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
125288457|NCT01338610|450681540|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
125288458|NCT01338610|450681541|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
125288459|NCT01338610|450681539|FG000|Overall Study|Protocol Violation|1|||
125288460|NCT01338610|450681540|FG001|Overall Study|Protocol Violation|0|||
125288461|NCT01338610|450681541|FG002|Overall Study|Protocol Violation|1|||
125288462|NCT01338610|450681539|FG000|Overall Study|Adverse Event|3|||
124783368|NCT01243242|448838088|FG000|Overall Study|Physician Decision|0|||
124783369|NCT01243242|448838089|FG001|Overall Study|Physician Decision|1|||
124783370|NCT01243242|448838088|FG000|Overall Study|sponsor decision|0|||
124783371|NCT01243242|448838089|FG001|Overall Study|sponsor decision|1|||
124783372|NCT01243242|448838088|FG000|Overall Study|non compliance|1|||
124783373|NCT01243242|448838089|FG001|Overall Study|non compliance|0|||
124783374|NCT00724711|448838090|FG000|Overall Study|Adverse Event|7|||
124783375|NCT00724711|448838091|FG001|Overall Study|Adverse Event|3|||
124783376|NCT00724711|448838090|FG000|Overall Study|Pregnancy|0|||
124783377|NCT00724711|448838091|FG001|Overall Study|Pregnancy|1|||
124783378|NCT00724711|448838090|FG000|Overall Study|Lack of Efficacy|0|||
124783379|NCT00724711|448838091|FG001|Overall Study|Lack of Efficacy|1|||
124783380|NCT00724711|448838090|FG000|Overall Study|Physician Decision|0|||
124783381|NCT00724711|448838091|FG001|Overall Study|Physician Decision|3|||
124783382|NCT00724711|448838090|FG000|Overall Study|Withdrawal by Subject|5|||
124783383|NCT00724711|448838091|FG001|Overall Study|Withdrawal by Subject|4|||
124783384|NCT00724711|448838090|FG000|Overall Study|Lost to Follow-up|4|||
124783385|NCT00724711|448838091|FG001|Overall Study|Lost to Follow-up|5|||
124783386|NCT00724711|448838090|FG000|Overall Study|Protocol Violation|1|||
124783387|NCT00724711|448838091|FG001|Overall Study|Protocol Violation|0|||
124783388|NCT01945710|448838092|FG000|Overall Study|Progressive Disease|5|||
124783389|NCT01945710|448838093|FG001|Overall Study|Progressive Disease|4|||
124783390|NCT01945710|448838094|FG002|Overall Study|Progressive Disease|3|||
124783391|NCT01945710|448838095|FG003|Overall Study|Progressive Disease|2|||
124783392|NCT01945710|448838096|FG004|Overall Study|Progressive Disease|7|||
125288463|NCT01338610|450681540|FG001|Overall Study|Adverse Event|0|||
125288464|NCT01338610|450681541|FG002|Overall Study|Adverse Event|0|||
125288465|NCT01414205|450681542|FG000|Overall Study|Death|5|||
125288466|NCT01414205|450681543|FG001|Overall Study|Death|1|||
125288467|NCT01414205|450681542|FG000|Overall Study|Lost to Follow-up|1|||
125288468|NCT01414205|450681543|FG001|Overall Study|Lost to Follow-up|4|||
125288469|NCT01414205|450681542|FG000|Overall Study|Physician Decision|0|||
125288470|NCT01414205|450681543|FG001|Overall Study|Physician Decision|1|||
125288471|NCT01414205|450681542|FG000|Overall Study|Randomized but not Treated|1|||
125288472|NCT01414205|450681543|FG001|Overall Study|Randomized but not Treated|1|||
125288473|NCT02046226|450681546|FG000|Overall Study|Lost to Follow-up|7|||
125288474|NCT01166373|450681549|FG000|Overall Study|Lost to Follow-up|3|||
125288475|NCT01166373|450681550|FG001|Overall Study|Lost to Follow-up|2|||
125288476|NCT01166373|450681551|FG002|Overall Study|Lost to Follow-up|2|||
125288477|NCT01166373|450681552|FG003|Overall Study|Lost to Follow-up|2|||
125288478|NCT01166373|450681549|FG000|Overall Study|Withdrawal by Subject|1|||
125288479|NCT01166373|450681550|FG001|Overall Study|Withdrawal by Subject|2|||
125288480|NCT01166373|450681551|FG002|Overall Study|Withdrawal by Subject|2|||
125288481|NCT01166373|450681552|FG003|Overall Study|Withdrawal by Subject|3|||
125288482|NCT01166373|450681549|FG000|Overall Study|Physician Decision|1|||
125288483|NCT01166373|450681550|FG001|Overall Study|Physician Decision|0|||
125288484|NCT01166373|450681551|FG002|Overall Study|Physician Decision|0|||
125288485|NCT01166373|450681552|FG003|Overall Study|Physician Decision|0|||
125288486|NCT01819129|450681553|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
125288487|NCT01819129|450681554|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
125288488|NCT01819129|450681553|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
125288489|NCT01819129|450681554|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
125288490|NCT01819129|450681553|FG000|Overall Study|Other, Subject moved out of the country|0|||
125288491|NCT01819129|450681554|FG001|Overall Study|Other, Subject moved out of the country|1|||
125288492|NCT01819129|450681553|FG000|Overall Study|Withdrawal by Subject|15|||
125288493|NCT01819129|450681554|FG001|Overall Study|Withdrawal by Subject|15|||
125288494|NCT01819129|450681553|FG000|Overall Study|Lost to Follow-up|5|||
125288495|NCT01819129|450681554|FG001|Overall Study|Lost to Follow-up|2|||
125288496|NCT01819129|450681553|FG000|Overall Study|Lack of Efficacy|0|||
125288497|NCT01819129|450681554|FG001|Overall Study|Lack of Efficacy|1|||
125288498|NCT01819129|450681553|FG000|Overall Study|Adverse Event|1|||
125288499|NCT01819129|450681554|FG001|Overall Study|Adverse Event|4|||
125288500|NCT01819129|450681553|FG000|Overall Study|Death|1|||
125288501|NCT01819129|450681554|FG001|Overall Study|Death|1|||
125288502|NCT01819129|450681553|FG000|Overall Study|Withdrawal Criteria|20|||
125288503|NCT01819129|450681554|FG001|Overall Study|Withdrawal Criteria|15|||
125288504|NCT02836873|450681555|FG000|Overall Study|Protocol Violation|0|||
125288505|NCT02836873|450681556|FG001|Overall Study|Protocol Violation|1|||
125288506|NCT02836873|450681555|FG000|Overall Study|Adverse Event|1|||
125288507|NCT02836873|450681556|FG001|Overall Study|Adverse Event|4|||
125288508|NCT02836873|450681555|FG000|Overall Study|Withdrawal by Subject|2|||
125288509|NCT02836873|450681556|FG001|Overall Study|Withdrawal by Subject|2|||
125288510|NCT02836873|450681555|FG000|Overall Study|Lost to Follow-up|1|||
125288511|NCT02836873|450681556|FG001|Overall Study|Lost to Follow-up|3|||
125288512|NCT02836873|450681555|FG000|Overall Study|Physician Decision|0|||
125288513|NCT02836873|450681556|FG001|Overall Study|Physician Decision|1|||
125288514|NCT02836873|450681555|FG000|Overall Study|Other|1|||
125288515|NCT02836873|450681556|FG001|Overall Study|Other|0|||
125288516|NCT02914548|450681559|FG000|Overall Study|Adverse Event|15|||
125288517|NCT02914548|450681560|FG001|Overall Study|Adverse Event|7|||
125288518|NCT02914548|450681561|FG002|Overall Study|Adverse Event|15|||
125288519|NCT02914548|450681559|FG000|Overall Study|Physician Decision|2|||
125288520|NCT02914548|450681560|FG001|Overall Study|Physician Decision|2|||
125288521|NCT02914548|450681561|FG002|Overall Study|Physician Decision|0|||
125288522|NCT02914548|450681559|FG000|Overall Study|Protocol Violation|1|||
125288523|NCT02914548|450681560|FG001|Overall Study|Protocol Violation|0|||
125288524|NCT02914548|450681561|FG002|Overall Study|Protocol Violation|0|||
125288525|NCT02914548|450681559|FG000|Overall Study|Withdrawal by Subject|3|||
125288526|NCT02914548|450681560|FG001|Overall Study|Withdrawal by Subject|4|||
125288527|NCT02914548|450681561|FG002|Overall Study|Withdrawal by Subject|4|||
125288528|NCT02914548|450681559|FG000|Overall Study|>40% of body surface area|0|||
125288529|NCT02914548|450681560|FG001|Overall Study|>40% of body surface area|1|||
125288530|NCT02914548|450681561|FG002|Overall Study|>40% of body surface area|1|||
125288531|NCT02214225|450681564|FG000|Overall Study|Lost to Follow-up|46|||
125288532|NCT02214225|450681565|FG001|Overall Study|Lost to Follow-up|18|||
125288533|NCT02214225|450681566|FG002|Overall Study|Lost to Follow-up|18|||
125288534|NCT02214225|450681564|FG000|Overall Study|Withdrawal by Subject|2|||
125288535|NCT02214225|450681565|FG001|Overall Study|Withdrawal by Subject|0|||
125288536|NCT02214225|450681566|FG002|Overall Study|Withdrawal by Subject|2|||
125288537|NCT02214225|450681564|FG000|Overall Study|Death|5|||
125288538|NCT02214225|450681565|FG001|Overall Study|Death|0|||
125288539|NCT02214225|450681566|FG002|Overall Study|Death|1|||
125288540|NCT02214225|450681564|FG000|Overall Study|randomized in error, not vaccinated|2|||
125288541|NCT02214225|450681565|FG001|Overall Study|randomized in error, not vaccinated|1|||
125288542|NCT02214225|450681566|FG002|Overall Study|randomized in error, not vaccinated|1|||
125288543|NCT02182440|450681569|FG000|Overall Study|Adverse Event|0|||
125288544|NCT02182440|450681570|FG001|Overall Study|Adverse Event|1|||
125288545|NCT02182440|450681571|FG002|Overall Study|Adverse Event|0|||
125288546|NCT02182440|450681572|FG003|Overall Study|Adverse Event|0|||
125288547|NCT02182440|450681569|FG000|Overall Study|Death|31|||
125288548|NCT02182440|450681570|FG001|Overall Study|Death|8|||
125288549|NCT02182440|450681571|FG002|Overall Study|Death|5|||
125288550|NCT02182440|450681572|FG003|Overall Study|Death|16|||
125288551|NCT02182440|450681569|FG000|Overall Study|Protocol Violation|0|||
125288552|NCT02182440|450681570|FG001|Overall Study|Protocol Violation|1|||
125288553|NCT02182440|450681571|FG002|Overall Study|Protocol Violation|0|||
125288554|NCT02182440|450681572|FG003|Overall Study|Protocol Violation|0|||
125288555|NCT02182440|450681569|FG000|Overall Study|Physician Decision|1|||
125288556|NCT02182440|450681570|FG001|Overall Study|Physician Decision|0|||
125288557|NCT02182440|450681571|FG002|Overall Study|Physician Decision|0|||
125288558|NCT02182440|450681572|FG003|Overall Study|Physician Decision|0|||
125288559|NCT02182440|450681569|FG000|Overall Study|Withdrawal by Subject|1|||
125288560|NCT02182440|450681570|FG001|Overall Study|Withdrawal by Subject|1|||
125288561|NCT02182440|450681571|FG002|Overall Study|Withdrawal by Subject|3|||
125288562|NCT02182440|450681572|FG003|Overall Study|Withdrawal by Subject|4|||
125288563|NCT02182440|450681569|FG000|Overall Study|different, e.g adm other hospital|12|||
125288564|NCT02182440|450681570|FG001|Overall Study|different, e.g adm other hospital|3|||
125288565|NCT02182440|450681571|FG002|Overall Study|different, e.g adm other hospital|3|||
125288566|NCT02182440|450681572|FG003|Overall Study|different, e.g adm other hospital|10|||
125288567|NCT01166958|450681573|FG000|Overall Study|Withdrawal by Subject|1|||
125288568|NCT01166958|450681574|FG001|Overall Study|Withdrawal by Subject|0|||
125288569|NCT00405964|450681577|FG000|Overall Study|Treatment Failure|17|||
125288570|NCT00405964|450681578|FG001|Overall Study|Treatment Failure|45|||
125288571|NCT00405964|450681577|FG000|Overall Study|Adverse Event|7|||
125288572|NCT00405964|450681578|FG001|Overall Study|Adverse Event|16|||
125288573|NCT00405964|450681577|FG000|Overall Study|Lost to Follow-up|5|||
125288574|NCT00405964|450681578|FG001|Overall Study|Lost to Follow-up|5|||
125288575|NCT00405964|450681577|FG000|Overall Study|Withdrawal by Subject|19|||
125288576|NCT00405964|450681578|FG001|Overall Study|Withdrawal by Subject|23|||
125288577|NCT00405964|450681577|FG000|Overall Study|Protocol Violation|11|||
125288578|NCT00405964|450681578|FG001|Overall Study|Protocol Violation|6|||
125288579|NCT01253265|450681583|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
125288580|NCT01253265|450681584|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
125288581|NCT01253265|450681585|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
125288582|NCT01253265|450681586|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
125288583|NCT01253265|450681587|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
125288584|NCT01253265|450681583|FG000|Overall Study|Withdrawal by Subject|0|||
125288585|NCT01253265|450681584|FG001|Overall Study|Withdrawal by Subject|0|||
125288586|NCT01253265|450681585|FG002|Overall Study|Withdrawal by Subject|0|||
125288587|NCT01253265|450681586|FG003|Overall Study|Withdrawal by Subject|0|||
125288588|NCT01253265|450681587|FG004|Overall Study|Withdrawal by Subject|1|||
125288589|NCT03271047|450681591|FG000|Phase 1b: Dose Finding Period|Death|8|||
125288590|NCT03271047|450681592|FG001|Phase 1b: Dose Finding Period|Death|8|||
125288591|NCT03271047|450681593|FG002|Phase 1b: Dose Finding Period|Death|0|||
125288592|NCT03271047|450681594|FG003|Phase 1b: Dose Finding Period|Death|0|||
125288593|NCT03271047|450681591|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
125288594|NCT03271047|450681592|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
125288595|NCT03271047|450681593|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
125288596|NCT03271047|450681594|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
125288597|NCT03271047|450681591|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
125288598|NCT03271047|450681592|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
125288599|NCT03271047|450681593|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
125288600|NCT03271047|450681594|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
125288601|NCT03271047|450681591|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
125288602|NCT03271047|450681592|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
125288603|NCT03271047|450681593|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
125288604|NCT03271047|450681594|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
125288605|NCT03271047|450681591|FG000|Randomized Phase 2 Period|Other|0|||
125288606|NCT03271047|450681592|FG001|Randomized Phase 2 Period|Other|0|||
125288607|NCT03271047|450681593|FG002|Randomized Phase 2 Period|Other|0|||
125288608|NCT03271047|450681594|FG003|Randomized Phase 2 Period|Other|1|||
125288609|NCT03271047|450681591|FG000|Randomized Phase 2 Period|Death|0|||
125288610|NCT03271047|450681592|FG001|Randomized Phase 2 Period|Death|0|||
125288611|NCT03271047|450681593|FG002|Randomized Phase 2 Period|Death|20|||
125288612|NCT03271047|450681594|FG003|Randomized Phase 2 Period|Death|21|||
125288613|NCT03271047|450681591|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
125288614|NCT03271047|450681592|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
125288615|NCT03271047|450681593|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
125288616|NCT03271047|450681594|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
125288617|NCT03271047|450681591|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
125288618|NCT03271047|450681592|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
125288619|NCT03271047|450681593|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
125288620|NCT03271047|450681594|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
125288621|NCT03271047|450681591|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
125288622|NCT03271047|450681592|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
125288623|NCT03271047|450681593|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
125288624|NCT03271047|450681594|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
125288625|NCT00495521|450681595|FG000|Overall Study|Physician Decision|0|||
125288626|NCT00495521|450681596|FG001|Overall Study|Physician Decision|1|||
125288627|NCT00823212|450683443|FG000|Overall Study|Death|8|||
125288628|NCT00823212|450683444|FG001|Overall Study|Death|10|||
125288629|NCT00823212|450683443|FG000|Overall Study|Withdrawal by Subject|6|||
125288630|NCT00823212|450683444|FG001|Overall Study|Withdrawal by Subject|1|||
125288631|NCT00823212|450683443|FG000|Overall Study|Incarcerated|0|||
125288632|NCT00823212|450683444|FG001|Overall Study|Incarcerated|1|||
125288633|NCT00823212|450683443|FG000|Overall Study|Missed 12-month visit|21|||
125288634|NCT00823212|450683444|FG001|Overall Study|Missed 12-month visit|21|||
125288635|NCT02509052|450683447|FG000|Overall Study|Non compliance|0|||
125288636|NCT02509052|450683448|FG001|Overall Study|Non compliance|0|||
125288637|NCT02509052|450683449|FG002|Overall Study|Non compliance|1|||
125288638|NCT02585830|450683450|FG000|Overall Study|Withdrawal by Subject|3|||
125288639|NCT01323270|450683456|FG000|Overall Study|Withdrawal by Subject|19|||
125288640|NCT01323270|450683457|FG001|Overall Study|Withdrawal by Subject|10|||
125288641|NCT01323270|450683456|FG000|Overall Study|Protocol Violation|9|||
125288642|NCT01323270|450683457|FG001|Overall Study|Protocol Violation|7|||
125288643|NCT01323270|450683456|FG000|Overall Study|Lost to Follow-up|4|||
125288644|NCT01323270|450683457|FG001|Overall Study|Lost to Follow-up|6|||
125288645|NCT01323270|450683456|FG000|Overall Study|Adverse Event|8|||
125288646|NCT01323270|450683457|FG001|Overall Study|Adverse Event|0|||
125288647|NCT01323270|450683456|FG000|Overall Study|Other|0|||
125288648|NCT01323270|450683457|FG001|Overall Study|Other|3|||
125288649|NCT01323270|450683456|FG000|Overall Study|Physician Decision|0|||
125288650|NCT01323270|450683457|FG001|Overall Study|Physician Decision|2|||
125288651|NCT01323270|450683456|FG000|Overall Study|Not eligible|1|||
125288652|NCT01323270|450683457|FG001|Overall Study|Not eligible|1|||
125288653|NCT01323270|450683456|FG000|Overall Study|Death|1|||
125288654|NCT01323270|450683457|FG001|Overall Study|Death|0|||
125288655|NCT01323270|450683456|FG000|Overall Study|Randomized, but not vaccinated|1|||
125288656|NCT01323270|450683457|FG001|Overall Study|Randomized, but not vaccinated|0|||
125288657|NCT03761394|450683461|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
125288658|NCT03761394|450683462|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
125288659|NCT03761394|450683463|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
125288660|NCT03761394|450683464|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
125288661|NCT03761394|450683461|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
125288662|NCT03761394|450683462|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
125288663|NCT03761394|450683463|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
125288664|NCT03761394|450683464|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
125288665|NCT03761394|450683461|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
125288666|NCT03761394|450683462|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
125288667|NCT03761394|450683463|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
125288668|NCT03761394|450683464|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
125288669|NCT03761394|450683461|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
125288670|NCT03761394|450683462|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
125288671|NCT03761394|450683463|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
125288672|NCT03761394|450683464|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
125288673|NCT01643850|450683473|FG000|Overall Study|Withdrawal by Subject|0|||
125288674|NCT01643850|450683474|FG001|Overall Study|Withdrawal by Subject|0|||
125288675|NCT01643850|450683475|FG002|Overall Study|Withdrawal by Subject|0|||
125288676|NCT01643850|450683476|FG003|Overall Study|Withdrawal by Subject|0|||
125288677|NCT01643850|450683477|FG004|Overall Study|Withdrawal by Subject|1|||
125288678|NCT01643850|450683478|FG005|Overall Study|Withdrawal by Subject|0|||
125288679|NCT01643850|450683479|FG006|Overall Study|Withdrawal by Subject|0|||
125288680|NCT01643850|450683480|FG007|Overall Study|Withdrawal by Subject|0|||
125288681|NCT01643850|450683481|FG008|Overall Study|Withdrawal by Subject|0|||
125288682|NCT01643850|450683473|FG000|Overall Study|Lost to Follow-up|0|||
125288683|NCT01643850|450683474|FG001|Overall Study|Lost to Follow-up|0|||
125288684|NCT01643850|450683475|FG002|Overall Study|Lost to Follow-up|0|||
125288685|NCT01643850|450683476|FG003|Overall Study|Lost to Follow-up|0|||
125288686|NCT01643850|450683477|FG004|Overall Study|Lost to Follow-up|0|||
125288687|NCT01643850|450683478|FG005|Overall Study|Lost to Follow-up|0|||
125288688|NCT01643850|450683479|FG006|Overall Study|Lost to Follow-up|1|||
125288689|NCT01643850|450683480|FG007|Overall Study|Lost to Follow-up|0|||
125288690|NCT01643850|450683481|FG008|Overall Study|Lost to Follow-up|1|||
125288691|NCT01643850|450683473|FG000|Overall Study|Adverse Event|0|||
125288692|NCT01643850|450683474|FG001|Overall Study|Adverse Event|0|||
125288693|NCT01643850|450683475|FG002|Overall Study|Adverse Event|0|||
125288694|NCT01643850|450683476|FG003|Overall Study|Adverse Event|0|||
125288695|NCT01643850|450683477|FG004|Overall Study|Adverse Event|1|||
125288696|NCT01643850|450683478|FG005|Overall Study|Adverse Event|0|||
125288697|NCT01643850|450683479|FG006|Overall Study|Adverse Event|0|||
125288698|NCT01643850|450683480|FG007|Overall Study|Adverse Event|0|||
125288699|NCT01643850|450683481|FG008|Overall Study|Adverse Event|0|||
125288700|NCT01643850|450683473|FG000|Overall Study|Administrative Problems|0|||
125288701|NCT01643850|450683474|FG001|Overall Study|Administrative Problems|0|||
125288702|NCT01643850|450683475|FG002|Overall Study|Administrative Problems|1|||
125288703|NCT01643850|450683476|FG003|Overall Study|Administrative Problems|0|||
125288704|NCT01643850|450683477|FG004|Overall Study|Administrative Problems|1|||
125288705|NCT01643850|450683478|FG005|Overall Study|Administrative Problems|0|||
125288706|NCT01643850|450683479|FG006|Overall Study|Administrative Problems|0|||
125288707|NCT01643850|450683480|FG007|Overall Study|Administrative Problems|0|||
125288708|NCT01643850|450683481|FG008|Overall Study|Administrative Problems|0|||
125288709|NCT03242772|450683483|FG000|Overall Study|Lost to Follow-up|2|||
125288710|NCT03242772|450683484|FG001|Overall Study|Lost to Follow-up|0|||
125288711|NCT03242772|450683483|FG000|Overall Study|Physician Decision|0|||
125288712|NCT03242772|450683484|FG001|Overall Study|Physician Decision|1|||
125288713|NCT03242772|450683483|FG000|Overall Study|Withdrawal by Subject|1|||
125288714|NCT03242772|450683484|FG001|Overall Study|Withdrawal by Subject|0|||
125288715|NCT02434354|450683491|FG000|Overall Study|screen fail|3|||
125288716|NCT00413920|450683492|FG000|Overall Study|Adverse Event|9|||
125288717|NCT00413920|450683493|FG001|Overall Study|Adverse Event|11|||
125288718|NCT00413920|450683492|FG000|Overall Study|Lack of Efficacy|11|||
125288719|NCT00413920|450683493|FG001|Overall Study|Lack of Efficacy|9|||
125288720|NCT00413920|450683492|FG000|Overall Study|Death|3|||
125288721|NCT00413920|450683493|FG001|Overall Study|Death|5|||
125288722|NCT00413920|450683492|FG000|Overall Study|Graft Loss|5|||
125288723|NCT00413920|450683493|FG001|Overall Study|Graft Loss|3|||
125288724|NCT03730961|450683494|FG000|Overall Study|Adverse Event|0|||
125288725|NCT03730961|450683495|FG001|Overall Study|Adverse Event|1|||
125288726|NCT01185964|450683499|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
125288727|NCT01185964|450683500|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
125288728|NCT01185964|450683501|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
125288729|NCT01185964|450683502|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
125288730|NCT01185964|450683499|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
125288731|NCT01185964|450683500|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
125288732|NCT01185964|450683501|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
125288733|NCT01185964|450683502|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
125288734|NCT01185964|450683499|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
125288735|NCT01185964|450683500|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
125288736|NCT01185964|450683501|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
125288737|NCT01185964|450683502|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
125288738|NCT01185964|450683499|FG000|Phase 1b and Phase 2|Adverse Event|1|||
125288739|NCT01185964|450683500|FG001|Phase 1b and Phase 2|Adverse Event|0|||
125288740|NCT01185964|450683501|FG002|Phase 1b and Phase 2|Adverse Event|2|||
125288741|NCT01185964|450683502|FG003|Phase 1b and Phase 2|Adverse Event|0|||
125288742|NCT01185964|450683499|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
125288743|NCT01185964|450683500|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
125288744|NCT01185964|450683501|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
125288745|NCT01185964|450683502|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
125288746|NCT01185964|450683499|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
125288747|NCT01185964|450683500|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
125288748|NCT01185964|450683501|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
125288749|NCT01185964|450683502|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
125288750|NCT01185964|450683499|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
125288751|NCT01185964|450683500|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
124783393|NCT01945710|448838097|FG005|Overall Study|Progressive Disease|3|||
124783394|NCT01945710|448838098|FG006|Overall Study|Progressive Disease|19|||
124783395|NCT01945710|448838092|FG000|Overall Study|Adverse Event|0|||
124783396|NCT01945710|448838093|FG001|Overall Study|Adverse Event|1|||
124783397|NCT01945710|448838094|FG002|Overall Study|Adverse Event|0|||
125288752|NCT01185964|450683501|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
125288753|NCT01185964|450683502|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
125288754|NCT01185964|450683499|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
125288755|NCT01185964|450683500|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
125288756|NCT01185964|450683501|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
125288757|NCT01185964|450683502|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
125288758|NCT01920893|450683503|FG000|Overall Study|Adverse Event|5|||
125288759|NCT01920893|450683504|FG001|Overall Study|Adverse Event|2|||
125288760|NCT01920893|450683503|FG000|Overall Study|Lack of Efficacy|2|||
125288761|NCT01920893|450683504|FG001|Overall Study|Lack of Efficacy|0|||
125288762|NCT03440918|450683508|FG000|Overall Study|Protocol Violation|0|||
125288763|NCT03440918|450683509|FG001|Overall Study|Protocol Violation|16|||
125288764|NCT03754582|450683525|FG000|Treatment Phase|Adverse Event|0|||
125288765|NCT03754582|450683526|FG001|Treatment Phase|Adverse Event|1|||
125288766|NCT03754582|450683527|FG002|Treatment Phase|Adverse Event|0|||
125288767|NCT03754582|450683525|FG000|Follow-up Phase|Other|0|||
125288768|NCT03754582|450683526|FG001|Follow-up Phase|Other|0|||
125288769|NCT03754582|450683527|FG002|Follow-up Phase|Other|1|||
125288770|NCT02680574|450683528|FG000|Overall Study|Death|137|||
125288771|NCT02680574|450683529|FG001|Overall Study|Death|137|||
125288772|NCT02680574|450683528|FG000|Overall Study|Withdrawal by Subject|17|||
125288773|NCT02680574|450683529|FG001|Overall Study|Withdrawal by Subject|9|||
125288774|NCT02680574|450683528|FG000|Overall Study|Lost to Follow-up|4|||
125288775|NCT02680574|450683529|FG001|Overall Study|Lost to Follow-up|6|||
125288776|NCT02847858|450683530|FG000|Overall Study|Lost to Follow-up|401|||
125288777|NCT02847858|450683531|FG001|Overall Study|Lost to Follow-up|269|||
125288778|NCT00066469|450683533|FG000|Overall Study|Death|3|||
125288779|NCT00066469|450683533|FG000|Overall Study|Lack of Efficacy|9|||
125288780|NCT00066469|450683533|FG000|Overall Study|Lost to Follow-up|1|||
125288781|NCT00066469|450683533|FG000|Overall Study|Physician Decision|1|||
125288782|NCT00066469|450683533|FG000|Overall Study|Withdrawal by Subject|1|||
125288783|NCT00066469|450683533|FG000|Overall Study|ineligible|1|||
125288784|NCT00711802|450683534|FG000|Overall Study|Not treated (no further detail)|2|||
125288785|NCT00711802|450683535|FG001|Overall Study|Not treated (no further detail)|1|||
125288786|NCT00711802|450683536|FG002|Overall Study|Not treated (no further detail)|2|||
125288787|NCT00711802|450683537|FG003|Overall Study|Not treated (no further detail)|0|||
125288788|NCT00711802|450683538|FG004|Overall Study|Not treated (no further detail)|2|||
125288789|NCT00711802|450683539|FG005|Overall Study|Not treated (no further detail)|0|||
125288790|NCT00711802|450683540|FG006|Overall Study|Not treated (no further detail)|0|||
125288791|NCT00711802|450683541|FG007|Overall Study|Not treated (no further detail)|0|||
125288792|NCT00711802|450683534|FG000|Overall Study|Adverse Event|0|||
125288793|NCT00711802|450683535|FG001|Overall Study|Adverse Event|0|||
125288794|NCT00711802|450683536|FG002|Overall Study|Adverse Event|0|||
125288795|NCT00711802|450683537|FG003|Overall Study|Adverse Event|0|||
125288796|NCT00711802|450683538|FG004|Overall Study|Adverse Event|1|||
125288797|NCT00711802|450683539|FG005|Overall Study|Adverse Event|1|||
125288798|NCT00711802|450683540|FG006|Overall Study|Adverse Event|0|||
125288799|NCT00711802|450683541|FG007|Overall Study|Adverse Event|0|||
125288800|NCT00711802|450683534|FG000|Overall Study|Microbiological failure|0|||
125288801|NCT00711802|450683535|FG001|Overall Study|Microbiological failure|1|||
125288802|NCT00711802|450683536|FG002|Overall Study|Microbiological failure|0|||
125288803|NCT00711802|450683537|FG003|Overall Study|Microbiological failure|0|||
125288804|NCT00711802|450683538|FG004|Overall Study|Microbiological failure|0|||
125288805|NCT00711802|450683539|FG005|Overall Study|Microbiological failure|1|||
125288806|NCT00711802|450683540|FG006|Overall Study|Microbiological failure|0|||
125288807|NCT00711802|450683541|FG007|Overall Study|Microbiological failure|0|||
125288808|NCT00711802|450683534|FG000|Overall Study|Protocol Violation|0|||
125288809|NCT00711802|450683535|FG001|Overall Study|Protocol Violation|0|||
125288810|NCT00711802|450683536|FG002|Overall Study|Protocol Violation|0|||
125288811|NCT00711802|450683537|FG003|Overall Study|Protocol Violation|1|||
125288812|NCT00711802|450683538|FG004|Overall Study|Protocol Violation|0|||
125288813|NCT00711802|450683539|FG005|Overall Study|Protocol Violation|0|||
125288814|NCT00711802|450683540|FG006|Overall Study|Protocol Violation|0|||
125288815|NCT00711802|450683541|FG007|Overall Study|Protocol Violation|0|||
125288816|NCT00711802|450683534|FG000|Overall Study|Physician Decision|0|||
125288817|NCT00711802|450683535|FG001|Overall Study|Physician Decision|2|||
125288818|NCT00711802|450683536|FG002|Overall Study|Physician Decision|0|||
125288819|NCT00711802|450683537|FG003|Overall Study|Physician Decision|0|||
125288820|NCT00711802|450683538|FG004|Overall Study|Physician Decision|0|||
125288821|NCT00711802|450683539|FG005|Overall Study|Physician Decision|0|||
125288822|NCT00711802|450683540|FG006|Overall Study|Physician Decision|0|||
125288823|NCT00711802|450683541|FG007|Overall Study|Physician Decision|0|||
125288824|NCT00711802|450683534|FG000|Overall Study|Withdrawal by Subject|0|||
125288825|NCT00711802|450683535|FG001|Overall Study|Withdrawal by Subject|1|||
125288826|NCT00711802|450683536|FG002|Overall Study|Withdrawal by Subject|0|||
125288827|NCT00711802|450683537|FG003|Overall Study|Withdrawal by Subject|1|||
125288828|NCT00711802|450683538|FG004|Overall Study|Withdrawal by Subject|0|||
125288829|NCT00711802|450683539|FG005|Overall Study|Withdrawal by Subject|0|||
125288830|NCT00711802|450683540|FG006|Overall Study|Withdrawal by Subject|0|||
125288831|NCT00711802|450683541|FG007|Overall Study|Withdrawal by Subject|0|||
125288832|NCT00711802|450683534|FG000|Overall Study|Lost to Follow-up|0|||
125288833|NCT00711802|450683535|FG001|Overall Study|Lost to Follow-up|0|||
125288834|NCT00711802|450683536|FG002|Overall Study|Lost to Follow-up|3|||
125288835|NCT00711802|450683537|FG003|Overall Study|Lost to Follow-up|1|||
125288836|NCT00711802|450683538|FG004|Overall Study|Lost to Follow-up|10|||
125288837|NCT00711802|450683539|FG005|Overall Study|Lost to Follow-up|6|||
125288838|NCT00711802|450683540|FG006|Overall Study|Lost to Follow-up|4|||
125288839|NCT00711802|450683541|FG007|Overall Study|Lost to Follow-up|2|||
125288840|NCT00711802|450683534|FG000|Overall Study|Reason not reported|0|||
125288841|NCT00711802|450683535|FG001|Overall Study|Reason not reported|1|||
125288842|NCT00711802|450683536|FG002|Overall Study|Reason not reported|1|||
125288843|NCT00711802|450683537|FG003|Overall Study|Reason not reported|0|||
125288844|NCT00711802|450683538|FG004|Overall Study|Reason not reported|1|||
125288845|NCT00711802|450683539|FG005|Overall Study|Reason not reported|0|||
125288846|NCT00711802|450683540|FG006|Overall Study|Reason not reported|1|||
125288847|NCT00711802|450683541|FG007|Overall Study|Reason not reported|0|||
125288848|NCT02305849|450683543|FG000|Overall Study|Adverse Event|10|||
125288849|NCT02305849|450683544|FG001|Overall Study|Adverse Event|12|||
125288850|NCT02305849|450683545|FG002|Overall Study|Adverse Event|7|||
125288851|NCT02305849|450683546|FG003|Overall Study|Adverse Event|3|||
125288852|NCT02305849|450683543|FG000|Overall Study|Lack of Efficacy|10|||
125288853|NCT02305849|450683544|FG001|Overall Study|Lack of Efficacy|6|||
125288854|NCT02305849|450683545|FG002|Overall Study|Lack of Efficacy|3|||
125288855|NCT02305849|450683546|FG003|Overall Study|Lack of Efficacy|9|||
125288856|NCT02305849|450683543|FG000|Overall Study|Withdrawal by Subject|2|||
125288857|NCT02305849|450683544|FG001|Overall Study|Withdrawal by Subject|2|||
125288858|NCT02305849|450683545|FG002|Overall Study|Withdrawal by Subject|1|||
125288859|NCT02305849|450683546|FG003|Overall Study|Withdrawal by Subject|4|||
125288860|NCT02305849|450683543|FG000|Overall Study|Lost to Follow-up|0|||
125288861|NCT02305849|450683544|FG001|Overall Study|Lost to Follow-up|2|||
125288862|NCT02305849|450683545|FG002|Overall Study|Lost to Follow-up|0|||
125288863|NCT02305849|450683546|FG003|Overall Study|Lost to Follow-up|0|||
125288864|NCT02305849|450683543|FG000|Overall Study|Protocol Violation|3|||
125288865|NCT02305849|450683544|FG001|Overall Study|Protocol Violation|2|||
125288866|NCT02305849|450683545|FG002|Overall Study|Protocol Violation|1|||
125288867|NCT02305849|450683546|FG003|Overall Study|Protocol Violation|1|||
125288868|NCT02305849|450683543|FG000|Overall Study|Lab data met discontinuation criteria|0|||
125288869|NCT02305849|450683544|FG001|Overall Study|Lab data met discontinuation criteria|1|||
125288870|NCT02305849|450683545|FG002|Overall Study|Lab data met discontinuation criteria|2|||
125288871|NCT02305849|450683546|FG003|Overall Study|Lab data met discontinuation criteria|1|||
125288872|NCT02305849|450683543|FG000|Overall Study|Miscellaneous|1|||
125288873|NCT02305849|450683544|FG001|Overall Study|Miscellaneous|2|||
125288874|NCT02305849|450683545|FG002|Overall Study|Miscellaneous|4|||
125288875|NCT02305849|450683546|FG003|Overall Study|Miscellaneous|1|||
125288876|NCT02305849|450683543|FG000|Overall Study|Not fulfill eligibility criteria|1|||
125288877|NCT02305849|450683544|FG001|Overall Study|Not fulfill eligibility criteria|1|||
125288878|NCT02305849|450683545|FG002|Overall Study|Not fulfill eligibility criteria|0|||
125288879|NCT02305849|450683546|FG003|Overall Study|Not fulfill eligibility criteria|0|||
125288880|NCT02410824|450683551|FG000|First Intervention (One Week)|Headache|0|||
125288881|NCT02410824|450683552|FG001|First Intervention (One Week)|Headache|1|||
125288882|NCT00392808|450683553|FG000|Overall Study|Lost to Follow-up|3|||
125288883|NCT00392808|450683554|FG001|Overall Study|Lost to Follow-up|2|||
125288884|NCT00392808|450683555|FG002|Overall Study|Lost to Follow-up|1|||
125288885|NCT00392808|450683556|FG003|Overall Study|Lost to Follow-up|2|||
125288886|NCT00392808|450683553|FG000|Overall Study|Unable to withdraw blood|3|||
125288887|NCT00392808|450683554|FG001|Overall Study|Unable to withdraw blood|1|||
125288888|NCT00392808|450683555|FG002|Overall Study|Unable to withdraw blood|1|||
125288889|NCT00392808|450683556|FG003|Overall Study|Unable to withdraw blood|2|||
125288890|NCT02782325|450683557|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
125288891|NCT02782325|450683558|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
125288892|NCT02782325|450683559|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
125288893|NCT02782325|450683557|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
125288894|NCT02782325|450683558|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
125288895|NCT02782325|450683559|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
125288896|NCT02818036|450683560|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
125288897|NCT02818036|450683561|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
125288898|NCT02818036|450683560|FG000|Overall Study|Withdrawal by Subject|1|||
125288899|NCT02818036|450683561|FG001|Overall Study|Withdrawal by Subject|0|||
125288900|NCT01038713|450683564|FG000|Overall Study|Patient to hospice|1|||
125288901|NCT01038713|450683565|FG001|Overall Study|Patient to hospice|1|||
125288902|NCT01038713|450683566|FG002|Overall Study|Patient to hospice|1|||
125288903|NCT01038713|450683564|FG000|Overall Study|Lost to Follow-up|3|||
125288904|NCT01038713|450683565|FG001|Overall Study|Lost to Follow-up|0|||
125288905|NCT01038713|450683566|FG002|Overall Study|Lost to Follow-up|0|||
125288906|NCT01038713|450683564|FG000|Overall Study|Neuroendocrine Tumor|0|||
125288907|NCT01038713|450683565|FG001|Overall Study|Neuroendocrine Tumor|1|||
124783398|NCT01945710|448838095|FG003|Overall Study|Adverse Event|0|||
124783399|NCT01945710|448838096|FG004|Overall Study|Adverse Event|0|||
125288908|NCT01038713|450683566|FG002|Overall Study|Neuroendocrine Tumor|0|||
125288909|NCT01038713|450683564|FG000|Overall Study|died from PEP|0|||
125288910|NCT01038713|450683565|FG001|Overall Study|died from PEP|1|||
125288911|NCT01038713|450683566|FG002|Overall Study|died from PEP|0|||
125288912|NCT01038713|450683564|FG000|Overall Study|Autoimmune Pancreatitis|1|||
124783400|NCT01945710|448838097|FG005|Overall Study|Adverse Event|0|||
124783401|NCT01945710|448838098|FG006|Overall Study|Adverse Event|0|||
124783402|NCT01945710|448838092|FG000|Overall Study|Other|2|||
124783403|NCT01945710|448838093|FG001|Overall Study|Other|0|||
124783404|NCT01945710|448838094|FG002|Overall Study|Other|3|||
124783405|NCT01945710|448838095|FG003|Overall Study|Other|1|||
124783406|NCT01945710|448838096|FG004|Overall Study|Other|1|||
124783407|NCT01945710|448838097|FG005|Overall Study|Other|0|||
124783408|NCT01945710|448838098|FG006|Overall Study|Other|4|||
124783409|NCT01945710|448838092|FG000|Overall Study|Withdrawal by Subject|0|||
124783410|NCT01945710|448838093|FG001|Overall Study|Withdrawal by Subject|1|||
124783411|NCT01945710|448838094|FG002|Overall Study|Withdrawal by Subject|1|||
124783412|NCT01945710|448838095|FG003|Overall Study|Withdrawal by Subject|0|||
124783413|NCT01945710|448838096|FG004|Overall Study|Withdrawal by Subject|1|||
124783414|NCT01945710|448838097|FG005|Overall Study|Withdrawal by Subject|0|||
124783415|NCT01945710|448838098|FG006|Overall Study|Withdrawal by Subject|0|||
124783416|NCT00375609|448838099|FG000|Overall Study|Did not receive treatment|1|||
124783417|NCT00375609|448838100|FG001|Overall Study|Did not receive treatment|0|||
124783418|NCT00375609|448838101|FG002|Overall Study|Did not receive treatment|0|||
124783419|NCT00375609|448838099|FG000|Overall Study|Adverse Event|0|||
124783420|NCT00375609|448838100|FG001|Overall Study|Adverse Event|3|||
124783421|NCT00375609|448838101|FG002|Overall Study|Adverse Event|0|||
124783422|NCT00375609|448838099|FG000|Overall Study|Lost to Follow-up|1|||
124783423|NCT00375609|448838100|FG001|Overall Study|Lost to Follow-up|0|||
124783424|NCT00375609|448838101|FG002|Overall Study|Lost to Follow-up|0|||
124783425|NCT00375609|448838099|FG000|Overall Study|Physician Decision|0|||
124783426|NCT00375609|448838100|FG001|Overall Study|Physician Decision|0|||
124783427|NCT00375609|448838101|FG002|Overall Study|Physician Decision|1|||
124783428|NCT00375609|448838099|FG000|Overall Study|Withdrawal by Subject|1|||
124783429|NCT00375609|448838100|FG001|Overall Study|Withdrawal by Subject|4|||
124783430|NCT00375609|448838101|FG002|Overall Study|Withdrawal by Subject|0|||
124783431|NCT00375609|448838099|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
124783432|NCT00375609|448838100|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
124783433|NCT00375609|448838101|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
124783434|NCT01368562|448838102|FG000|Overall Study|Adverse Event|1|||
124783435|NCT01368562|448838102|FG000|Overall Study|Disease progression|1|||
124783436|NCT01368562|448838102|FG000|Overall Study|Lost to Follow-up|1|||
124783437|NCT01368562|448838102|FG000|Overall Study|Death|6|||
124783438|NCT01368562|448838102|FG000|Overall Study|Unresponsive to treatment|5|||
124783439|NCT01368562|448838102|FG000|Overall Study|Other|3|||
124783440|NCT01368562|448838102|FG000|Overall Study|Other than specified|2|||
124783441|NCT00669409|448838105|FG000|Part 2|Withdrawal by Subject|0|||
124783442|NCT00669409|448838106|FG001|Part 2|Withdrawal by Subject|0|||
124783443|NCT00669409|448838107|FG002|Part 2|Withdrawal by Subject|0|||
124783444|NCT00669409|448838108|FG003|Part 2|Withdrawal by Subject|0|||
124783445|NCT00669409|448838109|FG004|Part 2|Withdrawal by Subject|0|||
124783446|NCT00669409|448838110|FG005|Part 2|Withdrawal by Subject|0|||
124783447|NCT00669409|448838111|FG006|Part 2|Withdrawal by Subject|0|||
124783448|NCT00669409|448838112|FG007|Part 2|Withdrawal by Subject|0|||
124783449|NCT00669409|448838113|FG008|Part 2|Withdrawal by Subject|0|||
124783450|NCT00669409|448838114|FG009|Part 2|Withdrawal by Subject|1|||
124783451|NCT00669409|448838115|FG010|Part 2|Withdrawal by Subject|0|||
124783452|NCT03583385|448838120|FG000|Treatment Period 1|Withdrawal by Subject|1|||
124783453|NCT03583385|448838121|FG001|Treatment Period 1|Withdrawal by Subject|1|||
124783454|NCT03583385|448838120|FG000|Treatment Period 2|Adverse Event|1|||
124783455|NCT03583385|448838121|FG001|Treatment Period 2|Adverse Event|0|||
124783456|NCT00095940|448838122|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
124783457|NCT00095940|448838123|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
124783458|NCT00095940|448838124|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
124783459|NCT00095940|448838125|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
124783460|NCT00095940|448838126|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
124783461|NCT00095940|448838127|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
124783462|NCT00095940|448838128|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
124783463|NCT00095940|448838129|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
124783464|NCT00095940|448838130|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
124783465|NCT00095940|448838122|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
124783466|NCT00095940|448838123|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
124783467|NCT00095940|448838124|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
124783468|NCT00095940|448838125|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
124783469|NCT00095940|448838126|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
124783470|NCT00095940|448838127|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
124783471|NCT00095940|448838128|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
124783472|NCT00095940|448838129|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
124783473|NCT00095940|448838130|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
124783474|NCT00095940|448838122|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
125288913|NCT01038713|450683565|FG001|Overall Study|Autoimmune Pancreatitis|0|||
125288914|NCT01038713|450683566|FG002|Overall Study|Autoimmune Pancreatitis|0|||
125288915|NCT01154283|450683567|FG000|0-6 Weeks|Withdrawal by Subject|7|||
125288916|NCT01154283|450683568|FG001|0-6 Weeks|Withdrawal by Subject|2|||
125288917|NCT01154283|450683567|FG000|0-6 Weeks|Death|0|||
125288918|NCT01154283|450683568|FG001|0-6 Weeks|Death|1|||
125288919|NCT01154283|450683567|FG000|7-12 Weeks|Death|1|||
125288920|NCT01154283|450683568|FG001|7-12 Weeks|Death|0|||
125288921|NCT01154283|450683567|FG000|7-12 Weeks|Withdrawal by Subject|0|||
125288922|NCT01154283|450683568|FG001|7-12 Weeks|Withdrawal by Subject|1|||
125288923|NCT03777917|450683569|FG000|Overall Study|Withdrawal by Subject|1|||
125288924|NCT03777917|450683570|FG001|Overall Study|Withdrawal by Subject|0|||
125288925|NCT03777917|450683569|FG000|Overall Study|Physician Decision|1|||
125288926|NCT03777917|450683570|FG001|Overall Study|Physician Decision|0|||
125288927|NCT03777917|450683569|FG000|Overall Study|Lost to Follow-up|6|||
125288928|NCT03777917|450683570|FG001|Overall Study|Lost to Follow-up|2|||
125288929|NCT03777917|450683569|FG000|Overall Study|Other|1|||
125288930|NCT03777917|450683570|FG001|Overall Study|Other|0|||
125288931|NCT00042432|450683571|FG000|Overall Study|Adverse Event|4|||
125288932|NCT00042432|450683572|FG001|Overall Study|Adverse Event|1|||
125288933|NCT00042432|450683571|FG000|Overall Study|Withdrawal by Subject|1|||
125288934|NCT00042432|450683572|FG001|Overall Study|Withdrawal by Subject|3|||
125288935|NCT00042432|450683571|FG000|Overall Study|Death|0|||
125288936|NCT00042432|450683572|FG001|Overall Study|Death|2|||
125288937|NCT00042432|450683571|FG000|Overall Study|Ineligibility determined|1|||
125288938|NCT00042432|450683572|FG001|Overall Study|Ineligibility determined|0|||
125288939|NCT00042432|450683571|FG000|Overall Study|Initiation of maintenance dialysis|1|||
125288940|NCT00042432|450683572|FG001|Overall Study|Initiation of maintenance dialysis|1|||
125288941|NCT00042432|450683571|FG000|Overall Study|Other|2|||
125288942|NCT00042432|450683572|FG001|Overall Study|Other|0|||
125288943|NCT01853072|450683573|FG000|Overall Study|Adverse event prior to treatment|0|||
125288944|NCT01853072|450683574|FG001|Overall Study|Adverse event prior to treatment|1|||
125288945|NCT01853072|450683573|FG000|Overall Study|Adverse Event|0|||
125288946|NCT01853072|450683574|FG001|Overall Study|Adverse Event|3|||
125288947|NCT01853072|450683573|FG000|Overall Study|Death|1|||
125288948|NCT01853072|450683574|FG001|Overall Study|Death|4|||
125288949|NCT01853072|450683573|FG000|Overall Study|Lost to Follow-up|0|||
125288950|NCT01853072|450683574|FG001|Overall Study|Lost to Follow-up|3|||
125288951|NCT01853072|450683573|FG000|Overall Study|Non-compliance with study drug|0|||
125288952|NCT01853072|450683574|FG001|Overall Study|Non-compliance with study drug|1|||
125288953|NCT01853072|450683573|FG000|Overall Study|Physician Decision|1|||
125288954|NCT01853072|450683574|FG001|Overall Study|Physician Decision|1|||
125288955|NCT01853072|450683573|FG000|Overall Study|Withdrawal by Subject|1|||
125288956|NCT01853072|450683574|FG001|Overall Study|Withdrawal by Subject|2|||
125288957|NCT01853072|450683573|FG000|Overall Study|Reason not specified|9|||
125288958|NCT01853072|450683574|FG001|Overall Study|Reason not specified|6|||
125288959|NCT01816906|450683575|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
125288960|NCT01816906|450683576|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
125288961|NCT01816906|450683575|FG000|Six Months|Lost to Follow-up|14|||
125288962|NCT01816906|450683576|FG001|Six Months|Lost to Follow-up|16|||
125288963|NCT01816906|450683575|FG000|12 Months|Adverse Event|2|||
125288964|NCT01816906|450683576|FG001|12 Months|Adverse Event|2|||
125288965|NCT01816906|450683575|FG000|12 Months|Death|0|||
125288966|NCT01816906|450683576|FG001|12 Months|Death|2|||
125288967|NCT01816906|450683575|FG000|12 Months|Lost to Follow-up|2|||
125288968|NCT01816906|450683576|FG001|12 Months|Lost to Follow-up|1|||
125288969|NCT00746733|450683577|FG000|Second Intervention|Adverse Event|1|||
125288970|NCT00746733|450683578|FG001|Second Intervention|Adverse Event|0|||
125288971|NCT00746733|450683577|FG000|Third Intervention|Withdrawal by Subject|1|||
125288972|NCT00746733|450683578|FG001|Third Intervention|Withdrawal by Subject|1|||
125288973|NCT01527383|450683579|FG000|Overall Study|Adverse Event|5|||
125288974|NCT01527383|450683580|FG001|Overall Study|Adverse Event|0|||
125288975|NCT01527383|450683579|FG000|Overall Study|Lost to Follow-up|3|||
125288976|NCT01527383|450683580|FG001|Overall Study|Lost to Follow-up|0|||
125288977|NCT01527383|450683579|FG000|Overall Study|Physician Decision|2|||
125288978|NCT01527383|450683580|FG001|Overall Study|Physician Decision|0|||
125288979|NCT01527383|450683579|FG000|Overall Study|Pregnancy|1|||
125288980|NCT01527383|450683580|FG001|Overall Study|Pregnancy|0|||
125288981|NCT01527383|450683579|FG000|Overall Study|Protocol Violation|1|||
125288982|NCT01527383|450683580|FG001|Overall Study|Protocol Violation|0|||
125288983|NCT01527383|450683579|FG000|Overall Study|Screen failure|1|||
125288984|NCT01527383|450683580|FG001|Overall Study|Screen failure|0|||
125288985|NCT01527383|450683579|FG000|Overall Study|Participant moved|0|||
125288986|NCT01527383|450683580|FG001|Overall Study|Participant moved|1|||
125288987|NCT01527383|450683579|FG000|Overall Study|Withdrawal by Subject|2|||
125288988|NCT01527383|450683580|FG001|Overall Study|Withdrawal by Subject|3|||
125288989|NCT03412604|450683581|FG000|Overall Study|Withdrawal by Subject|1|||
125288990|NCT01287221|450683583|FG000|Overall Study|Lack of Perceived Benefit|1|||
125288991|NCT01287221|450683584|FG001|Overall Study|Lack of Perceived Benefit|1|||
125288992|NCT01287221|450683583|FG000|Overall Study|Adverse Event|3|||
124783475|NCT00095940|448838123|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
124783476|NCT00095940|448838124|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
124783477|NCT00095940|448838125|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
124783478|NCT00095940|448838126|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
124783479|NCT00095940|448838127|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
124783480|NCT00095940|448838128|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
124783481|NCT00095940|448838129|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
124783482|NCT00095940|448838130|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
124783483|NCT03539549|448838132|FG000|Overall Study|Adverse Event|12|||
124783484|NCT03539549|448838132|FG000|Overall Study|Lost to Follow-up|1|||
124783485|NCT03539549|448838132|FG000|Overall Study|Death|2|||
124783486|NCT03539549|448838132|FG000|Overall Study|Progressive Disease|1|||
124783487|NCT03539549|448838132|FG000|Overall Study|Reason not Specified|1|||
124783488|NCT02864862|448838133|FG000|Overall Study|Lost to Follow-up|1|||
124783489|NCT02864862|448838134|FG001|Overall Study|Lost to Follow-up|0|||
124783490|NCT02864862|448838135|FG002|Overall Study|Lost to Follow-up|1|||
124783491|NCT02864862|448838133|FG000|Overall Study|Protocol Violation|0|||
124783492|NCT02864862|448838134|FG001|Overall Study|Protocol Violation|0|||
124783493|NCT02864862|448838135|FG002|Overall Study|Protocol Violation|1|||
124783494|NCT04693234|448838139|FG000|Overall Study|Death|79|||
124783495|NCT04693234|448838140|FG001|Overall Study|Death|19|||
124783496|NCT04693234|448838139|FG000|Overall Study|Sponsor Ended Study|47|||
124783497|NCT04693234|448838140|FG001|Overall Study|Sponsor Ended Study|18|||
124783498|NCT04693234|448838139|FG000|Overall Study|Withdrawal by Subject|10|||
124783499|NCT04693234|448838140|FG001|Overall Study|Withdrawal by Subject|2|||
124783500|NCT04693234|448838139|FG000|Overall Study|Lost to Follow-up|2|||
124783501|NCT04693234|448838140|FG001|Overall Study|Lost to Follow-up|1|||
124783502|NCT04643158|448838141|FG000|Overall Study|Study terminated by sponsor|0|||
124783503|NCT04643158|448838142|FG001|Overall Study|Study terminated by sponsor|0|||
124783504|NCT04643158|448838143|FG002|Overall Study|Study terminated by sponsor|1|||
124783505|NCT04643158|448838144|FG003|Overall Study|Study terminated by sponsor|0|||
124783506|NCT04643158|448838145|FG004|Overall Study|Study terminated by sponsor|0|||
124783507|NCT04643158|448838146|FG005|Overall Study|Study terminated by sponsor|1|||
124783508|NCT04643158|448838147|FG006|Overall Study|Study terminated by sponsor|0|||
124783509|NCT04643158|448838141|FG000|Overall Study|Global/country situation|0|||
124783510|NCT04643158|448838142|FG001|Overall Study|Global/country situation|0|||
124783511|NCT04643158|448838143|FG002|Overall Study|Global/country situation|1|||
124783512|NCT04643158|448838144|FG003|Overall Study|Global/country situation|0|||
124783513|NCT04643158|448838145|FG004|Overall Study|Global/country situation|0|||
124783514|NCT04643158|448838146|FG005|Overall Study|Global/country situation|0|||
125288993|NCT01287221|450683584|FG001|Overall Study|Adverse Event|3|||
125288994|NCT01287221|450683583|FG000|Overall Study|Withdrawal by Subject|0|||
125288995|NCT01287221|450683584|FG001|Overall Study|Withdrawal by Subject|1|||
125288996|NCT00930969|450683585|FG000|Overall Study|Death|5|||
125288997|NCT00930969|450683585|FG000|Overall Study|Lost to Follow-up|1|||
125288998|NCT00930969|450683585|FG000|Overall Study|Physician Decision|13|||
125288999|NCT00930969|450683585|FG000|Overall Study|Withdrawal by Subject|19|||
125289000|NCT00657150|450683586|FG000|Overall Study|Adverse Event|19|||
125289001|NCT00657150|450683587|FG001|Overall Study|Adverse Event|10|||
125289002|NCT00657150|450683586|FG000|Overall Study|Non-compliant with protocol|5|||
125289003|NCT00657150|450683587|FG001|Overall Study|Non-compliant with protocol|9|||
125289004|NCT00657150|450683586|FG000|Overall Study|Lost to Follow-up|2|||
125289005|NCT00657150|450683587|FG001|Overall Study|Lost to Follow-up|0|||
125289006|NCT00657150|450683586|FG000|Overall Study|Withdrawal by Subject|51|||
125289007|NCT00657150|450683587|FG001|Overall Study|Withdrawal by Subject|36|||
125289008|NCT00657150|450683586|FG000|Overall Study|Other|38|||
125289009|NCT00657150|450683587|FG001|Overall Study|Other|38|||
125289010|NCT00657150|450683586|FG000|Treatment|Adverse Event|60|||
125289011|NCT00657150|450683587|FG001|Treatment|Adverse Event|53|||
125289012|NCT00657150|450683586|FG000|Treatment|Non-compliant with protocol|10|||
125289013|NCT00657150|450683587|FG001|Treatment|Non-compliant with protocol|9|||
125289014|NCT00657150|450683586|FG000|Treatment|Lost to Follow-up|1|||
125289015|NCT00657150|450683587|FG001|Treatment|Lost to Follow-up|0|||
125289016|NCT00657150|450683586|FG000|Treatment|Withdrawal by Subject|23|||
125289017|NCT00657150|450683587|FG001|Treatment|Withdrawal by Subject|20|||
125289018|NCT00657150|450683586|FG000|Treatment|Other|13|||
125289019|NCT00657150|450683587|FG001|Treatment|Other|15|||
125289020|NCT02966795|450683588|FG000|Overall Study|Patient Left the Country|0|||
125289021|NCT02966795|450683589|FG001|Overall Study|Patient Left the Country|1|||
124783515|NCT04643158|448838147|FG006|Overall Study|Global/country situation|0|||
124783516|NCT04643158|448838141|FG000|Overall Study|Withdrawal by Subject|0|||
124783517|NCT04643158|448838142|FG001|Overall Study|Withdrawal by Subject|0|||
124783518|NCT04643158|448838143|FG002|Overall Study|Withdrawal by Subject|0|||
125289022|NCT00787137|450683605|FG000|Overall Study|Study Termination|0|||
124783519|NCT04643158|448838144|FG003|Overall Study|Withdrawal by Subject|0|||
124783520|NCT04643158|448838145|FG004|Overall Study|Withdrawal by Subject|0|||
125289023|NCT00787137|450683606|FG001|Overall Study|Study Termination|0|||
125289024|NCT00787137|450683607|FG002|Overall Study|Study Termination|1|||
125289025|NCT00787930|450683613|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
125289026|NCT02395055|450683614|FG000|Overall Study|Withdrawal by Subject|7|||
125289027|NCT02395055|450683615|FG001|Overall Study|Withdrawal by Subject|3|||
125289028|NCT01896271|450683616|FG000|Overall Study|Physician Decision|10|||
125289029|NCT01367704|450683622|FG000|Overall Study|Lost to Follow-up|47|||
125289030|NCT01367704|450683623|FG001|Overall Study|Lost to Follow-up|161|||
125289031|NCT00526110|450683624|FG000|Overall Study|Adverse Event|2|||
125289032|NCT00526110|450683625|FG001|Overall Study|Adverse Event|9|||
125289033|NCT00526110|450683624|FG000|Overall Study|Disease Progression|0|||
125289034|NCT00526110|450683625|FG001|Overall Study|Disease Progression|19|||
125289035|NCT00526110|450683624|FG000|Overall Study|Maximal Response|0|||
125289036|NCT00526110|450683625|FG001|Overall Study|Maximal Response|6|||
125289037|NCT00526110|450683624|FG000|Overall Study|Withdrawal by Subject|0|||
125289038|NCT00526110|450683625|FG001|Overall Study|Withdrawal by Subject|2|||
125289039|NCT00526110|450683624|FG000|Overall Study|Poor Tolerance|0|||
125289040|NCT00526110|450683625|FG001|Overall Study|Poor Tolerance|5|||
125289041|NCT02193087|450683626|FG000|Overall Study|Adverse Event|2|||
125289042|NCT02193087|450683627|FG001|Overall Study|Adverse Event|0|||
125289043|NCT02193087|450683628|FG002|Overall Study|Adverse Event|0|||
125289044|NCT02193087|450683629|FG003|Overall Study|Adverse Event|11|||
125289045|NCT02193087|450683626|FG000|Overall Study|Lost to Follow-up|14|||
125289046|NCT02193087|450683627|FG001|Overall Study|Lost to Follow-up|6|||
125289047|NCT02193087|450683628|FG002|Overall Study|Lost to Follow-up|4|||
125289048|NCT02193087|450683629|FG003|Overall Study|Lost to Follow-up|37|||
125289049|NCT02193087|450683626|FG000|Overall Study|Protocol Violation|2|||
125289050|NCT02193087|450683627|FG001|Overall Study|Protocol Violation|0|||
125289051|NCT02193087|450683628|FG002|Overall Study|Protocol Violation|1|||
125289052|NCT02193087|450683629|FG003|Overall Study|Protocol Violation|2|||
125289053|NCT02193087|450683626|FG000|Overall Study|Withdrawal by Subject|10|||
125289054|NCT02193087|450683627|FG001|Overall Study|Withdrawal by Subject|3|||
125289055|NCT02193087|450683628|FG002|Overall Study|Withdrawal by Subject|1|||
125289056|NCT02193087|450683629|FG003|Overall Study|Withdrawal by Subject|19|||
125289057|NCT02193087|450683626|FG000|Overall Study|Other Reason Not Specified|7|||
125289058|NCT02193087|450683627|FG001|Overall Study|Other Reason Not Specified|2|||
125289059|NCT02193087|450683628|FG002|Overall Study|Other Reason Not Specified|1|||
125289060|NCT02193087|450683629|FG003|Overall Study|Other Reason Not Specified|9|||
125289061|NCT02193087|450683626|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
125289062|NCT02193087|450683627|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
125289063|NCT02193087|450683628|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
125289064|NCT02193087|450683629|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
125289065|NCT04096820|450683630|FG000|Overall Study|Did not return for intervention|2|||
125289066|NCT04096820|450683630|FG000|Overall Study|Death|1|||
125289067|NCT04030247|450685563|FG000|Overall Study|Withdrawal by Subject|4|||
125289068|NCT04030247|450685563|FG000|Overall Study|Lost to Follow-up|13|||
125289069|NCT00509093|450685564|FG000|Overall Study|Adverse Event|10|||
125289070|NCT00509093|450685564|FG000|Overall Study|Disease Progression|9|||
125289071|NCT00509093|450685564|FG000|Overall Study|Transformed into MDS|1|||
125289072|NCT00509093|450685564|FG000|Overall Study|Withdrawal by Subject|3|||
125289073|NCT00509093|450685564|FG000|Overall Study|Physician Decision|1|||
125289074|NCT04431713|450685565|FG000|Overall Study|Withdrawal by Subject|2|||
125289075|NCT04431713|450685566|FG001|Overall Study|Withdrawal by Subject|0|||
125289076|NCT04431713|450685565|FG000|Overall Study|Death|2|||
125289077|NCT04431713|450685566|FG001|Overall Study|Death|2|||
125289078|NCT03383783|450685569|FG000|Overall Study|Withdrawal by Subject|2|||
125289087|NCT01224821|450685575|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
125289088|NCT01224821|450685575|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
125289089|NCT01224821|450685575|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
125289090|NCT01224821|450685575|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
125289091|NCT01224821|450685575|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
125289092|NCT01224821|450685575|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
125289093|NCT01224821|450685575|FG000|Long-Term Follow-Up|Death|2|||
125289094|NCT01224821|450685575|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
125289095|NCT01340937|450685576|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
125289096|NCT01340937|450685577|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
125289097|NCT01340937|450685578|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
125289098|NCT01340937|450685579|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
125289099|NCT01340937|450685576|FG000|Period 1: Infant Series|Adverse Event|0|||
125289100|NCT01340937|450685577|FG001|Period 1: Infant Series|Adverse Event|1|||
125289101|NCT01340937|450685578|FG002|Period 1: Infant Series|Adverse Event|4|||
125289102|NCT01340937|450685579|FG003|Period 1: Infant Series|Adverse Event|0|||
125289103|NCT01340937|450685576|FG000|Period 1: Infant Series|Death|2|||
125289104|NCT01340937|450685577|FG001|Period 1: Infant Series|Death|0|||
125289105|NCT01340937|450685578|FG002|Period 1: Infant Series|Death|2|||
125289106|NCT01340937|450685579|FG003|Period 1: Infant Series|Death|0|||
125289107|NCT01340937|450685576|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
125289108|NCT01340937|450685577|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
125289109|NCT01340937|450685578|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
125289110|NCT01340937|450685579|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
125289111|NCT01340937|450685576|FG000|Period 1: Infant Series|Physician Decision|2|||
125289112|NCT01340937|450685577|FG001|Period 1: Infant Series|Physician Decision|3|||
125289113|NCT01340937|450685578|FG002|Period 1: Infant Series|Physician Decision|1|||
125289114|NCT01340937|450685579|FG003|Period 1: Infant Series|Physician Decision|0|||
125289115|NCT01340937|450685576|FG000|Period 1: Infant Series|Protocol Violation|1|||
125289116|NCT01340937|450685577|FG001|Period 1: Infant Series|Protocol Violation|4|||
125289117|NCT01340937|450685578|FG002|Period 1: Infant Series|Protocol Violation|4|||
125289118|NCT01340937|450685579|FG003|Period 1: Infant Series|Protocol Violation|3|||
125289119|NCT01340937|450685576|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
125289120|NCT01340937|450685577|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
125289121|NCT01340937|450685578|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
125289122|NCT01340937|450685579|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
125289123|NCT01340937|450685576|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
125289124|NCT01340937|450685577|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
125289125|NCT01340937|450685578|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
125289126|NCT01340937|450685579|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
125289127|NCT01340937|450685576|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
125289128|NCT01340937|450685577|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
125289129|NCT01340937|450685578|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
125289130|NCT01340937|450685579|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
125289131|NCT01340937|450685576|FG000|Period 2: Interim Period|Adverse Event|1|||
125289132|NCT01340937|450685577|FG001|Period 2: Interim Period|Adverse Event|0|||
125289133|NCT01340937|450685578|FG002|Period 2: Interim Period|Adverse Event|1|||
125289134|NCT01340937|450685579|FG003|Period 2: Interim Period|Adverse Event|0|||
125289135|NCT01340937|450685576|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
125289136|NCT01340937|450685577|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
125289137|NCT01340937|450685578|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
125289138|NCT01340937|450685579|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
125289139|NCT01340937|450685576|FG000|Period 2: Interim Period|Physician Decision|0|||
125289140|NCT01340937|450685577|FG001|Period 2: Interim Period|Physician Decision|1|||
125289141|NCT01340937|450685578|FG002|Period 2: Interim Period|Physician Decision|1|||
125289142|NCT01340937|450685579|FG003|Period 2: Interim Period|Physician Decision|0|||
125289143|NCT01340937|450685576|FG000|Period 2: Interim Period|Protocol Violation|5|||
125289144|NCT01340937|450685577|FG001|Period 2: Interim Period|Protocol Violation|3|||
125289145|NCT01340937|450685578|FG002|Period 2: Interim Period|Protocol Violation|6|||
125289146|NCT01340937|450685579|FG003|Period 2: Interim Period|Protocol Violation|3|||
125289147|NCT01340937|450685576|FG000|Period 2: Interim Period|Technical problems|4|||
125289148|NCT01340937|450685577|FG001|Period 2: Interim Period|Technical problems|4|||
125289149|NCT01340937|450685578|FG002|Period 2: Interim Period|Technical problems|6|||
125289150|NCT01340937|450685579|FG003|Period 2: Interim Period|Technical problems|3|||
125289151|NCT01340937|450685576|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
125289152|NCT01340937|450685577|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
125289153|NCT01340937|450685578|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
125289154|NCT01340937|450685579|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
125289155|NCT01340937|450685576|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
125289156|NCT01340937|450685577|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
125289157|NCT01340937|450685578|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
125289158|NCT01340937|450685579|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
125289159|NCT01340937|450685576|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
125289160|NCT01340937|450685577|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
125289161|NCT01340937|450685578|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
125289162|NCT01340937|450685579|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
125289163|NCT01340937|450685576|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
125289164|NCT01340937|450685577|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
125289165|NCT01340937|450685578|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
125289166|NCT01340937|450685579|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
125289167|NCT02469415|450685583|FG000|Overall Study|Withdrawal by Subject|1|||
124783521|NCT04643158|448838146|FG005|Overall Study|Withdrawal by Subject|1|||
125289168|NCT02469415|450685583|FG000|Overall Study|Investigational agent placed on hold|2|||
124783522|NCT04643158|448838147|FG006|Overall Study|Withdrawal by Subject|0|||
125289169|NCT00350623|450685586|FG000|Overall Study|Lost to Follow-up|8|||
125289170|NCT00350623|450685587|FG001|Overall Study|Lost to Follow-up|3|||
125289171|NCT00350623|450685588|FG002|Overall Study|Lost to Follow-up|4|||
125289172|NCT00350623|450685586|FG000|Overall Study|Withdrawal by Subject|0|||
125289173|NCT00350623|450685587|FG001|Overall Study|Withdrawal by Subject|1|||
125289174|NCT00350623|450685588|FG002|Overall Study|Withdrawal by Subject|1|||
125289175|NCT00350623|450685586|FG000|Overall Study|patient traveling outside the country|0|||
125289176|NCT00350623|450685587|FG001|Overall Study|patient traveling outside the country|0|||
125289177|NCT00350623|450685588|FG002|Overall Study|patient traveling outside the country|1|||
125289178|NCT00623545|450685589|FG000|Overall Study|Adverse Event|6|||
125289179|NCT00623545|450685589|FG000|Overall Study|Withdrawal by Subject|4|||
125289180|NCT04126564|450685590|FG000|Overall Study|Withdrawal by Subject|0|||
125289181|NCT04126564|450685591|FG001|Overall Study|Withdrawal by Subject|2|||
125289182|NCT04126564|450685590|FG000|Overall Study|Lost to Follow-up|0|||
125289183|NCT04126564|450685591|FG001|Overall Study|Lost to Follow-up|1|||
125289184|NCT03500172|450685592|FG000|Period 1: Baseline Randomization|Death|0|||
125289185|NCT03500172|450685593|FG001|Period 1: Baseline Randomization|Death|0|||
125289186|NCT03500172|450685594|FG002|Period 1: Baseline Randomization|Death|0|||
125289187|NCT03500172|450685595|FG003|Period 1: Baseline Randomization|Death|0|||
125289188|NCT03500172|450685596|FG004|Period 1: Baseline Randomization|Death|0|||
125289189|NCT03500172|450685597|FG005|Period 1: Baseline Randomization|Death|0|||
125289190|NCT03500172|450685598|FG006|Period 1: Baseline Randomization|Death|0|||
125289191|NCT03500172|450685599|FG007|Period 1: Baseline Randomization|Death|0|||
125289192|NCT03500172|450685600|FG008|Period 1: Baseline Randomization|Death|0|||
125289193|NCT03500172|450685601|FG009|Period 1: Baseline Randomization|Death|2|||
125289194|NCT03500172|450685602|FG010|Period 1: Baseline Randomization|Death|0|||
125289195|NCT03500172|450685592|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
125289196|NCT03500172|450685593|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
125289197|NCT03500172|450685594|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
125289198|NCT03500172|450685595|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
125289199|NCT03500172|450685596|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
125289200|NCT03500172|450685597|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
125289201|NCT03500172|450685598|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
125289202|NCT03500172|450685599|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
125289203|NCT03500172|450685600|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
125289204|NCT03500172|450685601|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
125289205|NCT03500172|450685602|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
125289206|NCT03500172|450685592|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
125289207|NCT03500172|450685593|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
125289208|NCT03500172|450685594|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
125289209|NCT03500172|450685595|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
125289210|NCT03500172|450685596|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
125289211|NCT03500172|450685597|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
125289212|NCT03500172|450685598|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
125289213|NCT03500172|450685599|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
125289214|NCT03500172|450685600|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
125289215|NCT03500172|450685601|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
125289216|NCT03500172|450685602|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
125289217|NCT03500172|450685592|FG000|Period 2: Re-Randomization|Death|0|||
125289218|NCT03500172|450685593|FG001|Period 2: Re-Randomization|Death|0|||
125289219|NCT03500172|450685594|FG002|Period 2: Re-Randomization|Death|0|||
125289220|NCT03500172|450685595|FG003|Period 2: Re-Randomization|Death|4|||
125289221|NCT03500172|450685596|FG004|Period 2: Re-Randomization|Death|2|||
125289222|NCT03500172|450685597|FG005|Period 2: Re-Randomization|Death|0|||
125289223|NCT03500172|450685598|FG006|Period 2: Re-Randomization|Death|5|||
125289224|NCT03500172|450685599|FG007|Period 2: Re-Randomization|Death|2|||
125289225|NCT03500172|450685600|FG008|Period 2: Re-Randomization|Death|0|||
125289226|NCT03500172|450685601|FG009|Period 2: Re-Randomization|Death|0|||
125289227|NCT03500172|450685602|FG010|Period 2: Re-Randomization|Death|0|||
125289228|NCT01974752|450685609|FG000|Overall Study|Death|33|||
125289229|NCT01974752|450685610|FG001|Overall Study|Death|11|||
125289230|NCT01974752|450685609|FG000|Overall Study|Lost to Follow-up|2|||
125289231|NCT01974752|450685610|FG001|Overall Study|Lost to Follow-up|0|||
125289232|NCT01974752|450685609|FG000|Overall Study|Withdrawal by Subject|2|||
125289233|NCT01974752|450685610|FG001|Overall Study|Withdrawal by Subject|3|||
125289234|NCT01974752|450685609|FG000|Overall Study|Other Eligibility Criteria|0|||
125289235|NCT01974752|450685610|FG001|Overall Study|Other Eligibility Criteria|1|||
125289236|NCT02435680|450685617|FG000|Overall Study|Physician Decision|3|||
125289237|NCT02435680|450685618|FG001|Overall Study|Physician Decision|0|||
125289238|NCT02435680|450685619|FG002|Overall Study|Physician Decision|0|||
124783523|NCT04540198|448838148|FG000|Overall Study|Lost to Follow-up|25|||
124783524|NCT04540198|448838149|FG001|Overall Study|Lost to Follow-up|23|||
125289239|NCT02435680|450685617|FG000|Overall Study|subject / guardian decision|0|||
125289240|NCT02435680|450685618|FG001|Overall Study|subject / guardian decision|3|||
124783525|NCT04540198|448838148|FG000|Overall Study|Withdrawal by Subject|15|||
125289241|NCT02435680|450685619|FG002|Overall Study|subject / guardian decision|2|||
125289242|NCT02435680|450685617|FG000|Overall Study|Adverse Event|8|||
125289243|NCT02435680|450685618|FG001|Overall Study|Adverse Event|3|||
125289244|NCT02435680|450685619|FG002|Overall Study|Adverse Event|2|||
125289245|NCT02435680|450685617|FG000|Overall Study|progressive disease|10|||
125289246|NCT02435680|450685618|FG001|Overall Study|progressive disease|7|||
125289247|NCT02435680|450685619|FG002|Overall Study|progressive disease|11|||
125289248|NCT02435680|450685617|FG000|Overall Study|not treated|0|||
125289249|NCT02435680|450685618|FG001|Overall Study|not treated|0|||
125289250|NCT02435680|450685619|FG002|Overall Study|not treated|1|||
125289251|NCT00445848|450685620|FG000|Overall Study|Adverse Event|14|||
125289252|NCT00445848|450685620|FG000|Overall Study|Withdrawal by Subject|4|||
125289253|NCT00445848|450685620|FG000|Overall Study|Progression|62|||
125289254|NCT00445848|450685620|FG000|Overall Study|Other-Not protocol specified|5|||
125289255|NCT00330928|450685621|FG000|Overall Study|Lost to Follow-up|6|||
125289256|NCT00330928|450685621|FG000|Overall Study|Physician Decision|9|||
125289257|NCT00330928|450685621|FG000|Overall Study|Death|1|||
125289258|NCT00330928|450685621|FG000|Overall Study|IVUS could not be performed.|1|||
125289259|NCT03028480|450685622|FG000|Overall Study|No revisit after the first prescription date|2|||
125289260|NCT03028480|450685622|FG000|Overall Study|Did not use the drug|1|||
125289261|NCT03028480|450685622|FG000|Overall Study|Violation of the enrollment deadline|10|||
125289262|NCT03028480|450685622|FG000|Overall Study|Case report forms were not collected|21|||
125289263|NCT02279719|450685625|FG000|Overall Study|Patients randomized but never treated|0|||
125289264|NCT02279719|450685626|FG001|Overall Study|Patients randomized but never treated|0|||
125289265|NCT02279719|450685627|FG002|Overall Study|Patients randomized but never treated|0|||
125289266|NCT02279719|450685628|FG003|Overall Study|Patients randomized but never treated|0|||
125289267|NCT02279719|450685629|FG004|Overall Study|Patients randomized but never treated|3|||
125289268|NCT02279719|450685630|FG005|Overall Study|Patients randomized but never treated|0|||
125289269|NCT02279719|450685631|FG006|Overall Study|Patients randomized but never treated|3|||
125289270|NCT03541187|450685632|FG000|Overall Study|Lost to Follow-up|2|||
125289271|NCT03541187|450685633|FG001|Overall Study|Lost to Follow-up|6|||
125289272|NCT03541187|450685632|FG000|Overall Study|Pregnancy|0|||
125289273|NCT03541187|450685633|FG001|Overall Study|Pregnancy|1|||
125289274|NCT03541187|450685632|FG000|Overall Study|Withdrawal by Subject|6|||
125289275|NCT03541187|450685633|FG001|Overall Study|Withdrawal by Subject|2|||
125289276|NCT03541187|450685632|FG000|Overall Study|Moved out of town|1|||
125289277|NCT03541187|450685633|FG001|Overall Study|Moved out of town|0|||
125289278|NCT03541187|450685632|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
125289279|NCT03541187|450685633|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
125289280|NCT03541187|450685632|FG000|Overall Study|Did not meet randomization criteria|1|||
125289281|NCT03541187|450685633|FG001|Overall Study|Did not meet randomization criteria|1|||
125289282|NCT03541187|450685632|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
125289283|NCT03541187|450685633|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
125289284|NCT03541187|450685632|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
125289285|NCT03541187|450685633|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
125289286|NCT01369680|450685639|FG000|Overall Study|Lost to Follow-up|0|||
125289287|NCT01369680|450685640|FG001|Overall Study|Lost to Follow-up|0|||
125289288|NCT01369680|450685641|FG002|Overall Study|Lost to Follow-up|1|||
125289289|NCT01369680|450685642|FG003|Overall Study|Lost to Follow-up|2|||
125289290|NCT01062841|450685646|FG000|Overall Study|Indwelling Device Removed|41|||
125289291|NCT01062841|450685647|FG001|Overall Study|Indwelling Device Removed|48|||
125289292|NCT01062841|450685646|FG000|Overall Study|Death|3|||
125289293|NCT01062841|450685647|FG001|Overall Study|Death|5|||
125289294|NCT01062841|450685646|FG000|Overall Study|Withdrawal by Subject|2|||
125289295|NCT01062841|450685647|FG001|Overall Study|Withdrawal by Subject|0|||
125289296|NCT01062841|450685646|FG000|Overall Study|Withdrawal by Study|3|||
125289297|NCT01062841|450685647|FG001|Overall Study|Withdrawal by Study|0|||
125289298|NCT01218100|450685648|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
125289299|NCT01218100|450685649|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
125289300|NCT01218100|450685650|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
125289301|NCT01218100|450685651|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
125289302|NCT01218100|450685648|FG000|Overall Study|Adverse Event|4|||
125289303|NCT01218100|450685649|FG001|Overall Study|Adverse Event|6|||
125289304|NCT01218100|450685650|FG002|Overall Study|Adverse Event|6|||
125289305|NCT01218100|450685651|FG003|Overall Study|Adverse Event|7|||
125289306|NCT01218100|450685648|FG000|Overall Study|Lack of Efficacy|9|||
125289307|NCT01218100|450685649|FG001|Overall Study|Lack of Efficacy|6|||
125289308|NCT01218100|450685650|FG002|Overall Study|Lack of Efficacy|5|||
125289309|NCT01218100|450685651|FG003|Overall Study|Lack of Efficacy|12|||
125289310|NCT01218100|450685648|FG000|Overall Study|Protocol Violation|0|||
125289311|NCT01218100|450685649|FG001|Overall Study|Protocol Violation|0|||
125289312|NCT01218100|450685650|FG002|Overall Study|Protocol Violation|1|||
125289313|NCT01218100|450685651|FG003|Overall Study|Protocol Violation|1|||
125289314|NCT01218100|450685648|FG000|Overall Study|Withdrawal by Subject|5|||
125289315|NCT01218100|450685649|FG001|Overall Study|Withdrawal by Subject|2|||
125289316|NCT01218100|450685650|FG002|Overall Study|Withdrawal by Subject|6|||
125289317|NCT01218100|450685651|FG003|Overall Study|Withdrawal by Subject|7|||
125289318|NCT01218100|450685648|FG000|Overall Study|Lost to Follow-up|3|||
125289319|NCT01218100|450685649|FG001|Overall Study|Lost to Follow-up|8|||
125289320|NCT01218100|450685650|FG002|Overall Study|Lost to Follow-up|2|||
125289321|NCT01218100|450685651|FG003|Overall Study|Lost to Follow-up|1|||
125289322|NCT01218100|450685648|FG000|Overall Study|Other Reason|2|||
125289323|NCT01218100|450685649|FG001|Overall Study|Other Reason|2|||
125289324|NCT01218100|450685650|FG002|Overall Study|Other Reason|6|||
125289325|NCT01218100|450685651|FG003|Overall Study|Other Reason|4|||
125289326|NCT01118520|450685652|FG000|Overall Study|AAA repair|9|||
125289327|NCT01118520|450685653|FG001|Overall Study|AAA repair|7|||
125289328|NCT01118520|450685654|FG002|Overall Study|AAA repair|9|||
125289329|NCT01118520|450685652|FG000|Overall Study|Adverse Event|3|||
125289330|NCT01118520|450685653|FG001|Overall Study|Adverse Event|3|||
125289331|NCT01118520|450685654|FG002|Overall Study|Adverse Event|3|||
125289332|NCT01118520|450685652|FG000|Overall Study|Withdrawal by Subject|8|||
125289333|NCT01118520|450685653|FG001|Overall Study|Withdrawal by Subject|13|||
125289334|NCT01118520|450685654|FG002|Overall Study|Withdrawal by Subject|8|||
125289335|NCT01089023|450685660|FG000|Overall Study|Lost to Follow-up|3|||
125289336|NCT01089023|450685660|FG000|Overall Study|Adverse Event|1|||
125289337|NCT01089023|450685660|FG000|Overall Study|Withdrawal by Subject|1|||
125289338|NCT01089023|450685660|FG000|Overall Study|Protocol Violation|1|||
125289339|NCT01089023|450685660|FG000|Overall Study|Lack of Efficacy|1|||
125289340|NCT03220581|450685662|FG000|Overall Study|Withdrawal by Subject|0|||
125289341|NCT03220581|450685663|FG001|Overall Study|Withdrawal by Subject|1|||
125289342|NCT03220581|450685662|FG000|Overall Study|Lost to Follow-up|3|||
125289343|NCT03220581|450685663|FG001|Overall Study|Lost to Follow-up|6|||
125289344|NCT01396265|450685664|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
125289345|NCT02275117|450685666|FG000|Overall Study|Adverse Event|0|||
125289346|NCT02275117|450685667|FG001|Overall Study|Adverse Event|0|||
125289347|NCT02275117|450685668|FG002|Overall Study|Adverse Event|0|||
125289348|NCT02275117|450685669|FG003|Overall Study|Adverse Event|0|||
125289349|NCT02275117|450685670|FG004|Overall Study|Adverse Event|1|||
125289350|NCT02275117|450685666|FG000|Overall Study|Lack of Efficacy|6|||
125289351|NCT02275117|450685667|FG001|Overall Study|Lack of Efficacy|7|||
125289352|NCT02275117|450685668|FG002|Overall Study|Lack of Efficacy|5|||
125289353|NCT02275117|450685669|FG003|Overall Study|Lack of Efficacy|2|||
125289354|NCT02275117|450685670|FG004|Overall Study|Lack of Efficacy|10|||
125289355|NCT02275117|450685666|FG000|Overall Study|Lost to Follow-up|11|||
125289356|NCT02275117|450685667|FG001|Overall Study|Lost to Follow-up|16|||
125289357|NCT02275117|450685668|FG002|Overall Study|Lost to Follow-up|15|||
125289358|NCT02275117|450685669|FG003|Overall Study|Lost to Follow-up|16|||
125289359|NCT02275117|450685670|FG004|Overall Study|Lost to Follow-up|8|||
125289360|NCT02275117|450685666|FG000|Overall Study|Physician Decision|0|||
125289361|NCT02275117|450685667|FG001|Overall Study|Physician Decision|1|||
125289362|NCT02275117|450685668|FG002|Overall Study|Physician Decision|1|||
125289363|NCT02275117|450685669|FG003|Overall Study|Physician Decision|0|||
125289364|NCT02275117|450685670|FG004|Overall Study|Physician Decision|1|||
125289365|NCT02275117|450685666|FG000|Overall Study|Protocol Violation|1|||
125289366|NCT02275117|450685667|FG001|Overall Study|Protocol Violation|0|||
125289367|NCT02275117|450685668|FG002|Overall Study|Protocol Violation|1|||
125289368|NCT02275117|450685669|FG003|Overall Study|Protocol Violation|1|||
125289369|NCT02275117|450685670|FG004|Overall Study|Protocol Violation|0|||
125289370|NCT02275117|450685666|FG000|Overall Study|Withdrawal by Subject|6|||
125289371|NCT02275117|450685667|FG001|Overall Study|Withdrawal by Subject|4|||
125289372|NCT02275117|450685668|FG002|Overall Study|Withdrawal by Subject|7|||
125289373|NCT02275117|450685669|FG003|Overall Study|Withdrawal by Subject|3|||
125289374|NCT02275117|450685670|FG004|Overall Study|Withdrawal by Subject|3|||
125289375|NCT02275117|450685666|FG000|Overall Study|Terminated by Sponsor|4|||
125289376|NCT02275117|450685667|FG001|Overall Study|Terminated by Sponsor|4|||
125289377|NCT02275117|450685668|FG002|Overall Study|Terminated by Sponsor|4|||
124783526|NCT04540198|448838149|FG001|Overall Study|Withdrawal by Subject|9|||
124783527|NCT04540198|448838148|FG000|Overall Study|Discontinued|1|||
125289378|NCT02275117|450685669|FG003|Overall Study|Terminated by Sponsor|6|||
125289379|NCT02275117|450685670|FG004|Overall Study|Terminated by Sponsor|4|||
125289380|NCT02275117|450685666|FG000|Overall Study|Worsening of Study Indication|0|||
125289381|NCT02275117|450685667|FG001|Overall Study|Worsening of Study Indication|1|||
125289382|NCT02275117|450685668|FG002|Overall Study|Worsening of Study Indication|2|||
125289383|NCT02275117|450685669|FG003|Overall Study|Worsening of Study Indication|0|||
125289384|NCT02275117|450685670|FG004|Overall Study|Worsening of Study Indication|0|||
125289385|NCT02275117|450685666|FG000|Overall Study|Study Burden|5|||
125289386|NCT02275117|450685667|FG001|Overall Study|Study Burden|4|||
125289387|NCT02275117|450685668|FG002|Overall Study|Study Burden|7|||
125289388|NCT02275117|450685669|FG003|Overall Study|Study Burden|5|||
125289389|NCT02275117|450685670|FG004|Overall Study|Study Burden|7|||
125289390|NCT02275117|450685666|FG000|Overall Study|Other|1|||
125289391|NCT02275117|450685667|FG001|Overall Study|Other|0|||
125289392|NCT02275117|450685668|FG002|Overall Study|Other|0|||
125289393|NCT02275117|450685669|FG003|Overall Study|Other|0|||
125289394|NCT02275117|450685670|FG004|Overall Study|Other|2|||
125289395|NCT03421743|450685674|FG000|Overall Study|Lack of Efficacy|1|||
125289396|NCT03421743|450685675|FG001|Overall Study|Lack of Efficacy|0|||
125289397|NCT03421743|450685674|FG000|Overall Study|Adverse Event|2|||
125289398|NCT03421743|450685675|FG001|Overall Study|Adverse Event|1|||
125289399|NCT03421743|450685674|FG000|Overall Study|Withdrawal by Subject|0|||
125289400|NCT03421743|450685675|FG001|Overall Study|Withdrawal by Subject|1|||
125289401|NCT00681564|450685677|FG000|Overall Study|Lost to Follow-up|6|||
125289402|NCT00681564|450685678|FG001|Overall Study|Lost to Follow-up|6|||
125289403|NCT00681564|450685677|FG000|Overall Study|Withdrawal by Subject|0|||
125289404|NCT00681564|450685678|FG001|Overall Study|Withdrawal by Subject|1|||
125289405|NCT00681564|450685677|FG000|Overall Study|Death|0|||
125289406|NCT00681564|450685678|FG001|Overall Study|Death|1|||
125289407|NCT01009346|450685683|FG000|Overall Study|Adverse Event|4|||
125289408|NCT00541099|450685687|FG000|Overall Study|Ineligible|3|||
125289409|NCT00432744|450685688|FG000|Months 0-6|Withdrawal by Subject|4|||
125289410|NCT00432744|450685689|FG001|Months 0-6|Withdrawal by Subject|4|||
125289411|NCT00432744|450685688|FG000|Months 0-6|Too disabled to score|1|||
125289412|NCT00432744|450685689|FG001|Months 0-6|Too disabled to score|0|||
125289413|NCT00432744|450685688|FG000|Months 7 - 12|Withdrawal by Subject|1|||
125289414|NCT00432744|450685689|FG001|Months 7 - 12|Withdrawal by Subject|0|||
125289415|NCT00432744|450685688|FG000|Months 7 - 12|Too disabled to score|0|||
125289416|NCT00432744|450685689|FG001|Months 7 - 12|Too disabled to score|1|||
125289417|NCT02759315|450685693|FG000|Overall Study|Adverse Event|0|||
125289418|NCT02759315|450685694|FG001|Overall Study|Adverse Event|0|||
125289419|NCT02759315|450685695|FG002|Overall Study|Adverse Event|0|||
125289420|NCT02759315|450685696|FG003|Overall Study|Adverse Event|1|||
125289421|NCT02759315|450685697|FG004|Overall Study|Adverse Event|0|||
125289422|NCT02759315|450685693|FG000|Overall Study|Death|0|||
125289423|NCT02759315|450685694|FG001|Overall Study|Death|0|||
125289424|NCT02759315|450685695|FG002|Overall Study|Death|1|||
125289425|NCT02759315|450685696|FG003|Overall Study|Death|0|||
125289426|NCT02759315|450685697|FG004|Overall Study|Death|0|||
125289427|NCT02759315|450685693|FG000|Overall Study|Lost to Follow-up|2|||
125289428|NCT02759315|450685694|FG001|Overall Study|Lost to Follow-up|0|||
125289429|NCT02759315|450685695|FG002|Overall Study|Lost to Follow-up|4|||
125289430|NCT02759315|450685696|FG003|Overall Study|Lost to Follow-up|0|||
125289431|NCT02759315|450685697|FG004|Overall Study|Lost to Follow-up|0|||
125289432|NCT02759315|450685693|FG000|Overall Study|Protocol Violation|0|||
125289433|NCT02759315|450685694|FG001|Overall Study|Protocol Violation|1|||
125289434|NCT02759315|450685695|FG002|Overall Study|Protocol Violation|0|||
125289435|NCT02759315|450685696|FG003|Overall Study|Protocol Violation|0|||
125289436|NCT02759315|450685697|FG004|Overall Study|Protocol Violation|0|||
125289437|NCT02759315|450685693|FG000|Overall Study|Study terminated prior to completion|2|||
125289438|NCT02759315|450685694|FG001|Overall Study|Study terminated prior to completion|0|||
125289439|NCT02759315|450685695|FG002|Overall Study|Study terminated prior to completion|5|||
125289440|NCT02759315|450685696|FG003|Overall Study|Study terminated prior to completion|0|||
125289441|NCT02759315|450685697|FG004|Overall Study|Study terminated prior to completion|1|||
125289442|NCT02761694|450685698|FG000|Overall Study|Lack of Efficacy|0|||
125289443|NCT02761694|450685699|FG001|Overall Study|Lack of Efficacy|0|||
125289444|NCT02761694|450685700|FG002|Overall Study|Lack of Efficacy|0|||
125289445|NCT02761694|450685701|FG003|Overall Study|Lack of Efficacy|0|||
125289446|NCT02761694|450685702|FG004|Overall Study|Lack of Efficacy|0|||
125289447|NCT02761694|450685703|FG005|Overall Study|Lack of Efficacy|0|||
125289448|NCT02761694|450685704|FG006|Overall Study|Lack of Efficacy|6|||
125289449|NCT02761694|450685705|FG007|Overall Study|Lack of Efficacy|0|||
125289450|NCT02761694|450685706|FG008|Overall Study|Lack of Efficacy|0|||
125289451|NCT02761694|450685707|FG009|Overall Study|Lack of Efficacy|1|||
125289452|NCT02761694|450685708|FG010|Overall Study|Lack of Efficacy|1|||
125289453|NCT02761694|450685709|FG011|Overall Study|Lack of Efficacy|4|||
125289454|NCT02761694|450685698|FG000|Overall Study|Death|0|||
125289455|NCT02761694|450685699|FG001|Overall Study|Death|0|||
125289456|NCT02761694|450685700|FG002|Overall Study|Death|0|||
124783528|NCT04540198|448838149|FG001|Overall Study|Discontinued|0|||
124783529|NCT02888119|448838150|FG000|Overall Study|Lost to Follow-up|5|||
125289457|NCT02761694|450685701|FG003|Overall Study|Death|0|||
124783530|NCT02888119|448838151|FG001|Overall Study|Lost to Follow-up|4|||
124783531|NCT02888119|448838152|FG002|Overall Study|Lost to Follow-up|0|||
124783532|NCT05573386|448838153|FG000|Overall Study|Withdrawal by Subject|3|||
125289458|NCT02761694|450685702|FG004|Overall Study|Death|0|||
125289459|NCT02761694|450685703|FG005|Overall Study|Death|0|||
124783533|NCT05573386|448838154|FG001|Overall Study|Withdrawal by Subject|2|||
125289460|NCT02761694|450685704|FG006|Overall Study|Death|2|||
125289461|NCT02761694|450685705|FG007|Overall Study|Death|0|||
125289462|NCT02761694|450685706|FG008|Overall Study|Death|2|||
125289463|NCT02761694|450685707|FG009|Overall Study|Death|2|||
125289464|NCT02761694|450685708|FG010|Overall Study|Death|1|||
125289465|NCT02761694|450685709|FG011|Overall Study|Death|0|||
125289466|NCT02761694|450685698|FG000|Overall Study|Physician Decision|0|||
125289467|NCT02761694|450685699|FG001|Overall Study|Physician Decision|0|||
125289468|NCT02761694|450685700|FG002|Overall Study|Physician Decision|0|||
125289469|NCT02761694|450685701|FG003|Overall Study|Physician Decision|0|||
125289470|NCT02761694|450685702|FG004|Overall Study|Physician Decision|0|||
125289471|NCT02761694|450685703|FG005|Overall Study|Physician Decision|0|||
125289472|NCT02761694|450685704|FG006|Overall Study|Physician Decision|1|||
125289473|NCT02761694|450685705|FG007|Overall Study|Physician Decision|0|||
125289474|NCT02761694|450685706|FG008|Overall Study|Physician Decision|0|||
125289475|NCT02761694|450685707|FG009|Overall Study|Physician Decision|0|||
125289476|NCT02761694|450685708|FG010|Overall Study|Physician Decision|0|||
125289477|NCT02761694|450685709|FG011|Overall Study|Physician Decision|0|||
125289478|NCT02761694|450685698|FG000|Overall Study|Withdrawal by Subject|0|||
125289479|NCT02761694|450685699|FG001|Overall Study|Withdrawal by Subject|0|||
125289480|NCT02761694|450685700|FG002|Overall Study|Withdrawal by Subject|0|||
125289481|NCT02761694|450685701|FG003|Overall Study|Withdrawal by Subject|1|||
125289482|NCT02761694|450685702|FG004|Overall Study|Withdrawal by Subject|0|||
125289483|NCT02761694|450685703|FG005|Overall Study|Withdrawal by Subject|0|||
125289484|NCT02761694|450685704|FG006|Overall Study|Withdrawal by Subject|4|||
125289485|NCT02761694|450685705|FG007|Overall Study|Withdrawal by Subject|0|||
125289486|NCT02761694|450685706|FG008|Overall Study|Withdrawal by Subject|2|||
125289487|NCT02761694|450685707|FG009|Overall Study|Withdrawal by Subject|1|||
125289488|NCT02761694|450685708|FG010|Overall Study|Withdrawal by Subject|0|||
125289489|NCT02761694|450685709|FG011|Overall Study|Withdrawal by Subject|0|||
125289490|NCT02761694|450685698|FG000|Overall Study|Lost to Follow-up|0|||
125289491|NCT02761694|450685699|FG001|Overall Study|Lost to Follow-up|0|||
125289492|NCT02761694|450685700|FG002|Overall Study|Lost to Follow-up|0|||
125289493|NCT02761694|450685701|FG003|Overall Study|Lost to Follow-up|0|||
125289494|NCT02761694|450685702|FG004|Overall Study|Lost to Follow-up|0|||
125289495|NCT02761694|450685703|FG005|Overall Study|Lost to Follow-up|0|||
125289496|NCT02761694|450685704|FG006|Overall Study|Lost to Follow-up|1|||
125289497|NCT02761694|450685705|FG007|Overall Study|Lost to Follow-up|0|||
125289498|NCT02761694|450685706|FG008|Overall Study|Lost to Follow-up|0|||
125289499|NCT02761694|450685707|FG009|Overall Study|Lost to Follow-up|0|||
125289500|NCT02761694|450685708|FG010|Overall Study|Lost to Follow-up|0|||
125289501|NCT02761694|450685709|FG011|Overall Study|Lost to Follow-up|1|||
125289502|NCT02761694|450685698|FG000|Overall Study|Adverse Event|0|||
125289503|NCT02761694|450685699|FG001|Overall Study|Adverse Event|0|||
125289504|NCT02761694|450685700|FG002|Overall Study|Adverse Event|0|||
125289505|NCT02761694|450685701|FG003|Overall Study|Adverse Event|0|||
125289506|NCT02761694|450685702|FG004|Overall Study|Adverse Event|0|||
125289507|NCT02761694|450685703|FG005|Overall Study|Adverse Event|0|||
125289508|NCT02761694|450685704|FG006|Overall Study|Adverse Event|1|||
125289509|NCT02761694|450685705|FG007|Overall Study|Adverse Event|0|||
125289510|NCT02761694|450685706|FG008|Overall Study|Adverse Event|1|||
125289511|NCT02761694|450685707|FG009|Overall Study|Adverse Event|0|||
125289512|NCT02761694|450685708|FG010|Overall Study|Adverse Event|0|||
125289513|NCT02761694|450685709|FG011|Overall Study|Adverse Event|1|||
125289514|NCT02761694|450685698|FG000|Overall Study|Other|4|||
125289515|NCT02761694|450685699|FG001|Overall Study|Other|4|||
125289516|NCT02761694|450685700|FG002|Overall Study|Other|1|||
125289517|NCT02761694|450685701|FG003|Overall Study|Other|2|||
125289518|NCT02761694|450685702|FG004|Overall Study|Other|3|||
125289519|NCT02761694|450685703|FG005|Overall Study|Other|3|||
125289520|NCT02761694|450685704|FG006|Overall Study|Other|18|||
125289521|NCT02761694|450685705|FG007|Overall Study|Other|8|||
125289522|NCT02761694|450685706|FG008|Overall Study|Other|0|||
125289523|NCT02761694|450685707|FG009|Overall Study|Other|1|||
125289524|NCT02761694|450685708|FG010|Overall Study|Other|1|||
125289525|NCT02761694|450685709|FG011|Overall Study|Other|0|||
125289526|NCT03464422|450685713|FG000|Overall Study|Lost to Follow-up|2|||
125289527|NCT03464422|450685713|FG000|Overall Study|Withdrawal by Subject|2|||
125289528|NCT01628367|450685719|FG000|Overall Study|Adverse Event|1|||
125289529|NCT01628367|450685720|FG001|Overall Study|Adverse Event|0|||
125289530|NCT02513823|450685723|FG000|Overall Study|Lost to Follow-up|4|||
125289531|NCT02513823|450685723|FG000|Overall Study|Physician Decision|1|||
125289532|NCT03353922|450685724|FG000|Overall Study|Withdrawal by Subject|1|||
125289533|NCT03353922|450685725|FG001|Overall Study|Withdrawal by Subject|0|||
125289534|NCT03353922|450685726|FG002|Overall Study|Withdrawal by Subject|1|||
125289535|NCT03353922|450685727|FG003|Overall Study|Withdrawal by Subject|1|||
125289536|NCT03353922|450685728|FG004|Overall Study|Withdrawal by Subject|0|||
125289537|NCT03353922|450685729|FG005|Overall Study|Withdrawal by Subject|0|||
125289538|NCT03353922|450685724|FG000|Overall Study|Adverse Event|0|||
125289539|NCT03353922|450685725|FG001|Overall Study|Adverse Event|1|||
125289540|NCT03353922|450685726|FG002|Overall Study|Adverse Event|0|||
125289541|NCT03353922|450685727|FG003|Overall Study|Adverse Event|0|||
125289542|NCT03353922|450685728|FG004|Overall Study|Adverse Event|0|||
125289543|NCT03353922|450685729|FG005|Overall Study|Adverse Event|0|||
125289544|NCT00740714|450685730|FG000|Overall Study|Withdrawal by Subject|17|||
125289545|NCT00740714|450685731|FG001|Overall Study|Withdrawal by Subject|19|||
125289546|NCT00740714|450685732|FG002|Overall Study|Withdrawal by Subject|29|||
124783534|NCT03646123|448838155|FG000|Overall Study|Withdrawal by Subject|2|||
124783535|NCT03646123|448838156|FG001|Overall Study|Withdrawal by Subject|2|||
124783536|NCT03646123|448838157|FG002|Overall Study|Withdrawal by Subject|3|||
125289547|NCT03688555|450685733|FG000|Treatment Period|Adverse Event|0|||
125289548|NCT03688555|450685734|FG001|Treatment Period|Adverse Event|0|||
125289549|NCT03688555|450685735|FG002|Treatment Period|Adverse Event|1|||
125289550|NCT00886119|450685741|FG000|Period 1|Did not meet inclusion criteria|1|||
125289551|NCT00886119|450685742|FG001|Period 1|Did not meet inclusion criteria|0|||
125289552|NCT02743780|450685743|FG000|Part 3 (7 Days)|Adverse Event|0|||
125289553|NCT02743780|450685744|FG001|Part 3 (7 Days)|Adverse Event|0|||
125289554|NCT02743780|450685745|FG002|Part 3 (7 Days)|Adverse Event|1|||
125289555|NCT02743780|450685746|FG003|Part 3 (7 Days)|Adverse Event|0|||
125289556|NCT02743780|450685747|FG004|Part 3 (7 Days)|Adverse Event|0|||
125289557|NCT01294462|450685748|FG000|Overall Study|Lost to Follow-up|1|||
125289558|NCT01294462|450685749|FG001|Overall Study|Lost to Follow-up|0|||
125289559|NCT01294462|450685748|FG000|Overall Study|Withdrawal by Subject|65|||
125289560|NCT01294462|450685749|FG001|Overall Study|Withdrawal by Subject|63|||
125289561|NCT01140568|450685750|FG000|Overall Study|disease progression|31|||
125289562|NCT01140568|450685750|FG000|Overall Study|Withdrawal by Subject|1|||
125289563|NCT01140568|450685750|FG000|Overall Study|Screen Fail|4|||
125289564|NCT01400243|450685752|FG000|Overall Study|Protocol Violation|8|||
125289565|NCT01400243|450685753|FG001|Overall Study|Protocol Violation|11|||
125289566|NCT02279498|450685754|FG000|Overall Study|Adverse Event|3|||
125289567|NCT02279498|450685755|FG001|Overall Study|Adverse Event|0|||
125289568|NCT02279498|450685754|FG000|Overall Study|Lack of Efficacy|4|||
125289569|NCT02279498|450685755|FG001|Overall Study|Lack of Efficacy|0|||
125289570|NCT02279498|450685754|FG000|Overall Study|Lost to Follow-up|0|||
125289571|NCT02279498|450685755|FG001|Overall Study|Lost to Follow-up|1|||
125289572|NCT02279498|450685754|FG000|Overall Study|Withdrawal by Subject|9|||
125289573|NCT02279498|450685755|FG001|Overall Study|Withdrawal by Subject|2|||
125289574|NCT02279498|450685754|FG000|Overall Study|Undefined|2|||
125289575|NCT02279498|450685755|FG001|Overall Study|Undefined|1|||
125289576|NCT01048866|450685756|FG000|Overall Study|Adverse Event|1|||
125289577|NCT01048866|450685757|FG001|Overall Study|Adverse Event|0|||
125289578|NCT01048866|450685756|FG000|Overall Study|Protocol Violation|1|||
125289579|NCT01048866|450685757|FG001|Overall Study|Protocol Violation|0|||
125289580|NCT01048866|450685756|FG000|Overall Study|Physician Decision|1|||
125289581|NCT01048866|450685757|FG001|Overall Study|Physician Decision|0|||
125289582|NCT01048866|450685756|FG000|Overall Study|Withdrawal by Subject|0|||
125289583|NCT01048866|450685757|FG001|Overall Study|Withdrawal by Subject|2|||
125289584|NCT01048866|450685756|FG000|Overall Study|Lost to Follow-up|0|||
125289585|NCT01048866|450685757|FG001|Overall Study|Lost to Follow-up|2|||
125289586|NCT01048866|450685756|FG000|Overall Study|Other|1|||
125289587|NCT01048866|450685757|FG001|Overall Study|Other|1|||
125289588|NCT05320393|450687653|FG000|Overall Study|Withdrawal by Subject|1|||
125289589|NCT05320393|450687654|FG001|Overall Study|Withdrawal by Subject|0|||
125289590|NCT05320393|450687655|FG002|Overall Study|Withdrawal by Subject|2|||
125289591|NCT05320393|450687653|FG000|Overall Study|Lost to Follow-up|1|||
125289592|NCT05320393|450687654|FG001|Overall Study|Lost to Follow-up|2|||
125289593|NCT05320393|450687655|FG002|Overall Study|Lost to Follow-up|1|||
125289594|NCT05320393|450687653|FG000|Overall Study|Moved; too much driving|0|||
125289595|NCT05320393|450687654|FG001|Overall Study|Moved; too much driving|0|||
125289596|NCT05320393|450687655|FG002|Overall Study|Moved; too much driving|2|||
125289597|NCT05320393|450687653|FG000|Overall Study|Did not receive treatment|0|||
125289598|NCT05320393|450687654|FG001|Overall Study|Did not receive treatment|0|||
125289599|NCT05320393|450687655|FG002|Overall Study|Did not receive treatment|1|||
125289600|NCT03187834|450687659|FG000|Overall Study|Lost to Follow-up|0|||
125289601|NCT03187834|450687660|FG001|Overall Study|Lost to Follow-up|1|||
125289602|NCT03187834|450687661|FG002|Overall Study|Lost to Follow-up|2|||
125289603|NCT03187834|450687662|FG003|Overall Study|Lost to Follow-up|2|||
125289604|NCT03187834|450687659|FG000|Overall Study|Had invalid anthropometric measurements|5|||
125289605|NCT03187834|450687660|FG001|Overall Study|Had invalid anthropometric measurements|3|||
125289606|NCT03187834|450687661|FG002|Overall Study|Had invalid anthropometric measurements|4|||
125289607|NCT03187834|450687662|FG003|Overall Study|Had invalid anthropometric measurements|2|||
125289608|NCT03559699|450687663|FG000|Overall Study|Withdrawal by Subject|6|||
125289609|NCT03559699|450687663|FG000|Overall Study|Lost to Follow-up|1|||
125289610|NCT05438602|450687670|FG000|Treatment (15 Days)|Adverse Event|2|||
125289611|NCT05438602|450687671|FG001|Treatment (15 Days)|Adverse Event|1|||
125289612|NCT05438602|450687672|FG002|Treatment (15 Days)|Adverse Event|3|||
125289613|NCT05438602|450687670|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
125289614|NCT05438602|450687671|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
125289615|NCT05438602|450687672|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
125289616|NCT05438602|450687670|FG000|Treatment (15 Days)|Other|0|||
125289617|NCT05438602|450687671|FG001|Treatment (15 Days)|Other|0|||
125289618|NCT05438602|450687672|FG002|Treatment (15 Days)|Other|1|||
125289619|NCT05438602|450687670|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
125289620|NCT05438602|450687671|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
125289621|NCT05438602|450687672|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
125289622|NCT05438602|450687670|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
125289623|NCT05438602|450687671|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
125289624|NCT05438602|450687672|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
125289625|NCT05438602|450687670|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
125289626|NCT05438602|450687671|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
125289627|NCT05438602|450687672|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
125289628|NCT05438602|450687670|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
125289629|NCT05438602|450687671|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
125289630|NCT05438602|450687672|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
125289631|NCT05438602|450687670|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
125289632|NCT05438602|450687671|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
125289633|NCT05438602|450687672|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
125289634|NCT05438602|450687670|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
125289635|NCT05438602|450687671|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
125289636|NCT05438602|450687672|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
125289637|NCT05438602|450687670|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
125289638|NCT05438602|450687671|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
125289639|NCT05438602|450687672|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
125289640|NCT01930890|450687673|FG000|Overall Study|Study Termination|14|||
125289641|NCT01930890|450687674|FG001|Overall Study|Study Termination|28|||
125289642|NCT01930890|450687675|FG002|Overall Study|Study Termination|13|||
125289643|NCT01930890|450687676|FG003|Overall Study|Study Termination|25|||
125289644|NCT01930890|450687673|FG000|Overall Study|Death|0|||
125289645|NCT01930890|450687674|FG001|Overall Study|Death|0|||
125289646|NCT01930890|450687675|FG002|Overall Study|Death|0|||
125289647|NCT01930890|450687676|FG003|Overall Study|Death|1|||
125289648|NCT01930890|450687673|FG000|Overall Study|Investigator Decision|0|||
125289649|NCT01930890|450687674|FG001|Overall Study|Investigator Decision|1|||
125289650|NCT01930890|450687675|FG002|Overall Study|Investigator Decision|0|||
125289651|NCT01930890|450687676|FG003|Overall Study|Investigator Decision|0|||
125289652|NCT01930890|450687673|FG000|Overall Study|Consent Withdrawn|0|||
125289653|NCT01930890|450687674|FG001|Overall Study|Consent Withdrawn|3|||
125289654|NCT01930890|450687675|FG002|Overall Study|Consent Withdrawn|0|||
125289655|NCT01930890|450687676|FG003|Overall Study|Consent Withdrawn|1|||
125289656|NCT01930890|450687673|FG000|Overall Study|Adverse Event|0|||
125289657|NCT01930890|450687674|FG001|Overall Study|Adverse Event|1|||
125289658|NCT01930890|450687675|FG002|Overall Study|Adverse Event|0|||
125289659|NCT01930890|450687676|FG003|Overall Study|Adverse Event|0|||
125289660|NCT02091284|450687677|FG000|Overall Study|Withdrawal by Subject|2|||
125289661|NCT02091284|450687678|FG001|Overall Study|Withdrawal by Subject|1|||
125289662|NCT02091284|450687677|FG000|Overall Study|unreliable data|1|||
125289663|NCT02091284|450687678|FG001|Overall Study|unreliable data|0|||
125289664|NCT01278407|450687679|FG000|Confirmatory Phase|Adverse Event|5|||
125289665|NCT01278407|450687680|FG001|Confirmatory Phase|Adverse Event|10|||
125289666|NCT01278407|450687681|FG002|Confirmatory Phase|Adverse Event|1|||
125289667|NCT01278407|450687682|FG003|Confirmatory Phase|Adverse Event|0|||
125289668|NCT01278407|450687683|FG004|Confirmatory Phase|Adverse Event|0|||
125289669|NCT01278407|450687679|FG000|Confirmatory Phase|Participant's Choice|3|||
125289670|NCT01278407|450687680|FG001|Confirmatory Phase|Participant's Choice|5|||
125289671|NCT01278407|450687681|FG002|Confirmatory Phase|Participant's Choice|3|||
125289672|NCT01278407|450687682|FG003|Confirmatory Phase|Participant's Choice|0|||
125289673|NCT01278407|450687683|FG004|Confirmatory Phase|Participant's Choice|0|||
125289674|NCT01278407|450687679|FG000|Confirmatory Phase|Other|1|||
125289675|NCT01278407|450687680|FG001|Confirmatory Phase|Other|1|||
125289676|NCT01278407|450687681|FG002|Confirmatory Phase|Other|2|||
125289677|NCT01278407|450687682|FG003|Confirmatory Phase|Other|0|||
125289678|NCT01278407|450687683|FG004|Confirmatory Phase|Other|0|||
125289679|NCT01278407|450687679|FG000|Extension Phase|Adverse Event|0|||
125289680|NCT01278407|450687680|FG001|Extension Phase|Adverse Event|0|||
125289681|NCT01278407|450687681|FG002|Extension Phase|Adverse Event|0|||
125289682|NCT01278407|450687682|FG003|Extension Phase|Adverse Event|7|||
125289683|NCT01278407|450687683|FG004|Extension Phase|Adverse Event|16|||
125289684|NCT01278407|450687679|FG000|Extension Phase|Participant's Choice|0|||
125289685|NCT01278407|450687680|FG001|Extension Phase|Participant's Choice|0|||
125289686|NCT01278407|450687681|FG002|Extension Phase|Participant's Choice|0|||
124783537|NCT03646123|448838155|FG000|Overall Study|Study termination by sponsor|0|||
125289687|NCT01278407|450687682|FG003|Extension Phase|Participant's Choice|4|||
125289688|NCT01278407|450687683|FG004|Extension Phase|Participant's Choice|11|||
125289689|NCT01278407|450687679|FG000|Extension Phase|Other|0|||
124783538|NCT03646123|448838156|FG001|Overall Study|Study termination by sponsor|45|||
125289690|NCT01278407|450687680|FG001|Extension Phase|Other|0|||
125289691|NCT01278407|450687681|FG002|Extension Phase|Other|0|||
125289692|NCT01278407|450687682|FG003|Extension Phase|Other|1|||
125289693|NCT01278407|450687683|FG004|Extension Phase|Other|3|||
125289694|NCT02534935|450687684|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
125289695|NCT02534935|450687685|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
125289696|NCT02534935|450687686|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
125289697|NCT02534935|450687684|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
125289698|NCT02534935|450687685|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
125289699|NCT02534935|450687686|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
125289700|NCT02534935|450687684|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
125289701|NCT02534935|450687685|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
125289702|NCT02534935|450687686|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
125289703|NCT02534935|450687684|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
125289704|NCT02534935|450687685|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
125289705|NCT02534935|450687686|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
125289706|NCT02534935|450687684|FG000|Stage 1: 24 Months|Adverse Event|0|||
125289707|NCT02534935|450687685|FG001|Stage 1: 24 Months|Adverse Event|2|||
125289708|NCT02534935|450687686|FG002|Stage 1: 24 Months|Adverse Event|0|||
125289709|NCT02534935|450687684|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
125289710|NCT02534935|450687685|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
125289711|NCT02534935|450687686|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
125289712|NCT02534935|450687684|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
125289713|NCT02534935|450687685|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
125289714|NCT02534935|450687686|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
125289715|NCT01460719|450687687|FG000|Overall Study|Adverse Event|1|||
125289716|NCT01460719|450687687|FG000|Overall Study|Withdrawal by Subject|1|||
125289717|NCT00076336|450687690|FG000|Overall Study|Death|13|||
125289718|NCT00076336|450687691|FG001|Overall Study|Death|17|||
125289719|NCT00076336|450687690|FG000|Overall Study|Adverse Event|4|||
125289720|NCT00076336|450687691|FG001|Overall Study|Adverse Event|4|||
125289721|NCT00076336|450687690|FG000|Overall Study|Lost to Follow-up|4|||
125289722|NCT00076336|450687691|FG001|Overall Study|Lost to Follow-up|4|||
125289723|NCT00076336|450687690|FG000|Overall Study|Non-Compliance|2|||
125289724|NCT00076336|450687691|FG001|Overall Study|Non-Compliance|0|||
125289725|NCT00076336|450687690|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
125289726|NCT00076336|450687691|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
125289727|NCT00076336|450687690|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
125289728|NCT00076336|450687691|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
125289729|NCT00076336|450687690|FG000|Overall Study|Liver Transplantation|3|||
125289730|NCT00076336|450687691|FG001|Overall Study|Liver Transplantation|3|||
125289731|NCT00076336|450687690|FG000|Overall Study|Virologic Breakthrough|14|||
125289732|NCT00076336|450687691|FG001|Overall Study|Virologic Breakthrough|16|||
125289733|NCT00076336|450687690|FG000|Overall Study|Treatment failure|4|||
125289734|NCT00076336|450687691|FG001|Overall Study|Treatment failure|5|||
125289735|NCT02838901|450687692|FG000|Overall Study|Withdrawal by Subject|1|||
125289736|NCT02838901|450687693|FG001|Overall Study|Withdrawal by Subject|1|||
125289737|NCT02838901|450687692|FG000|Overall Study|Lost to Follow-up|1|||
125289738|NCT02838901|450687693|FG001|Overall Study|Lost to Follow-up|1|||
125289739|NCT02285114|450687694|FG000|Main Phase|Investigator's Discretion|0|||
125289740|NCT02285114|450687695|FG001|Main Phase|Investigator's Discretion|2|||
125289741|NCT02285114|450687696|FG002|Main Phase|Investigator's Discretion|0|||
125289742|NCT02285114|450687697|FG003|Main Phase|Investigator's Discretion|0|||
125289743|NCT02285114|450687698|FG004|Main Phase|Investigator's Discretion|0|||
125289744|NCT02285114|450687699|FG005|Main Phase|Investigator's Discretion|0|||
125289745|NCT02285114|450687694|FG000|Main Phase|Enrolled but Never Treated|1|||
125289746|NCT02285114|450687695|FG001|Main Phase|Enrolled but Never Treated|0|||
125289747|NCT02285114|450687696|FG002|Main Phase|Enrolled but Never Treated|0|||
125289748|NCT02285114|450687697|FG003|Main Phase|Enrolled but Never Treated|0|||
125289749|NCT02285114|450687698|FG004|Main Phase|Enrolled but Never Treated|0|||
125289750|NCT02285114|450687699|FG005|Main Phase|Enrolled but Never Treated|0|||
125289751|NCT02285114|450687694|FG000|Main Phase|Withdrew Consent|0|||
124783539|NCT03646123|448838157|FG002|Overall Study|Study termination by sponsor|139|||
124783540|NCT03646123|448838155|FG000|Overall Study|Lost to Follow-up|4|||
124783541|NCT03646123|448838156|FG001|Overall Study|Lost to Follow-up|10|||
124783542|NCT03646123|448838157|FG002|Overall Study|Lost to Follow-up|10|||
124783543|NCT03646123|448838155|FG000|Overall Study|Death|2|||
124783544|NCT03646123|448838156|FG001|Overall Study|Death|1|||
124783545|NCT03646123|448838157|FG002|Overall Study|Death|1|||
124783546|NCT03646123|448838155|FG000|Overall Study|Other|2|||
125289752|NCT02285114|450687695|FG001|Main Phase|Withdrew Consent|0|||
125289753|NCT02285114|450687696|FG002|Main Phase|Withdrew Consent|1|||
125289754|NCT02285114|450687697|FG003|Main Phase|Withdrew Consent|0|||
125289755|NCT02285114|450687698|FG004|Main Phase|Withdrew Consent|0|||
125289756|NCT02285114|450687699|FG005|Main Phase|Withdrew Consent|0|||
125289757|NCT02285114|450687694|FG000|Extension Phase|Investigator's Discretion|0|||
125289758|NCT02285114|450687695|FG001|Extension Phase|Investigator's Discretion|0|||
125289759|NCT02285114|450687696|FG002|Extension Phase|Investigator's Discretion|0|||
125289760|NCT02285114|450687697|FG003|Extension Phase|Investigator's Discretion|14|||
125289761|NCT02285114|450687698|FG004|Extension Phase|Investigator's Discretion|1|||
125289762|NCT02285114|450687699|FG005|Extension Phase|Investigator's Discretion|0|||
125289763|NCT02285114|450687694|FG000|Extension Phase|Lost to Follow-up|0|||
125289764|NCT02285114|450687695|FG001|Extension Phase|Lost to Follow-up|0|||
125289765|NCT02285114|450687696|FG002|Extension Phase|Lost to Follow-up|0|||
125289766|NCT02285114|450687697|FG003|Extension Phase|Lost to Follow-up|1|||
125289767|NCT02285114|450687698|FG004|Extension Phase|Lost to Follow-up|1|||
125289768|NCT02285114|450687699|FG005|Extension Phase|Lost to Follow-up|0|||
125289769|NCT02285114|450687694|FG000|Extension Phase|Non-compliance with Study Drug|0|||
125289770|NCT02285114|450687695|FG001|Extension Phase|Non-compliance with Study Drug|0|||
125289771|NCT02285114|450687696|FG002|Extension Phase|Non-compliance with Study Drug|0|||
125289772|NCT02285114|450687697|FG003|Extension Phase|Non-compliance with Study Drug|2|||
125289773|NCT02285114|450687698|FG004|Extension Phase|Non-compliance with Study Drug|0|||
125289774|NCT02285114|450687699|FG005|Extension Phase|Non-compliance with Study Drug|0|||
125289775|NCT02285114|450687694|FG000|Extension Phase|Pregnancy|0|||
125289776|NCT02285114|450687695|FG001|Extension Phase|Pregnancy|0|||
125289777|NCT02285114|450687696|FG002|Extension Phase|Pregnancy|0|||
125289778|NCT02285114|450687697|FG003|Extension Phase|Pregnancy|1|||
125289779|NCT02285114|450687698|FG004|Extension Phase|Pregnancy|0|||
125289780|NCT02285114|450687699|FG005|Extension Phase|Pregnancy|0|||
125289781|NCT01156389|450687705|FG000|Overall Study|Elevated liver enzymes|4|||
125289782|NCT01156389|450687706|FG001|Overall Study|Elevated liver enzymes|0|||
125289783|NCT01156389|450687705|FG000|Overall Study|Vomiting|0|||
125289784|NCT01156389|450687706|FG001|Overall Study|Vomiting|1|||
125289785|NCT00869050|450687711|FG000|Overall Study|Screen Failure|3|||
125289786|NCT00585221|450687714|FG000|Overall Study|Protocol Violation|8|||
125289787|NCT03276052|450687716|FG000|Overall Study|Withdrawal by Subject|5|||
125289788|NCT03276052|450687716|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
125289789|NCT01145053|450687717|FG000|Overall Study|Adverse Event|22|||
125289790|NCT01145053|450687717|FG000|Overall Study|Lost to Follow-up|28|||
125289791|NCT01145053|450687717|FG000|Overall Study|Withdrawal by Subject|25|||
125289792|NCT01145053|450687717|FG000|Overall Study|Other|18|||
125289793|NCT01994863|450687718|FG000|Period 1|Adverse Event|4|||
125289794|NCT01994863|450687719|FG001|Period 1|Adverse Event|0|||
125289795|NCT01994863|450687718|FG000|Period 1|Withdrawal by Subject|1|||
125289796|NCT01994863|450687719|FG001|Period 1|Withdrawal by Subject|0|||
125289797|NCT01994863|450687718|FG000|Period 1|Trial stopped by sponsor|1|||
125289798|NCT01994863|450687719|FG001|Period 1|Trial stopped by sponsor|3|||
125289799|NCT01994863|450687718|FG000|Period 1|Lack of Efficacy|1|||
125289800|NCT01994863|450687719|FG001|Period 1|Lack of Efficacy|0|||
125289801|NCT01994863|450687718|FG000|Period 2|Adverse Event|0|||
125289802|NCT01994863|450687719|FG001|Period 2|Adverse Event|1|||
125289803|NCT01994863|450687718|FG000|Period 2|Lack of Efficacy|0|||
125289804|NCT01994863|450687719|FG001|Period 2|Lack of Efficacy|2|||
125289805|NCT01994863|450687718|FG000|Period 2|Withdrawal by Subject|1|||
125289806|NCT01994863|450687719|FG001|Period 2|Withdrawal by Subject|1|||
125289807|NCT03060512|450687720|FG000|Overall Study|Adverse Event|4|||
125289808|NCT03060512|450687721|FG001|Overall Study|Adverse Event|6|||
125289809|NCT03060512|450687720|FG000|Overall Study|Lost to Follow-up|1|||
125289810|NCT03060512|450687721|FG001|Overall Study|Lost to Follow-up|1|||
125289811|NCT03060512|450687720|FG000|Overall Study|Withdrawal by Subject|1|||
125289812|NCT03060512|450687721|FG001|Overall Study|Withdrawal by Subject|0|||
125289813|NCT03060512|450687720|FG000|Overall Study|Non-compliance with study medication|1|||
125289814|NCT03060512|450687721|FG001|Overall Study|Non-compliance with study medication|2|||
125289815|NCT03946124|450687722|FG000|Overall Study|Withdrawal by Subject|19|||
125289816|NCT00919867|450687724|FG000|First Intervention|Withdrawal by Subject|0|||
125289817|NCT00919867|450687725|FG001|First Intervention|Withdrawal by Subject|0|||
125289818|NCT00919867|450687726|FG002|First Intervention|Withdrawal by Subject|1|||
125289819|NCT00919867|450687727|FG003|First Intervention|Withdrawal by Subject|0|||
125289820|NCT00919867|450687728|FG004|First Intervention|Withdrawal by Subject|0|||
125289821|NCT00919867|450687729|FG005|First Intervention|Withdrawal by Subject|0|||
125289822|NCT00919867|450687724|FG000|First Intervention|Physician Decision|0|||
125289823|NCT00919867|450687725|FG001|First Intervention|Physician Decision|0|||
125289824|NCT00919867|450687726|FG002|First Intervention|Physician Decision|0|||
125289825|NCT00919867|450687727|FG003|First Intervention|Physician Decision|0|||
125289826|NCT00919867|450687728|FG004|First Intervention|Physician Decision|0|||
125289827|NCT00919867|450687729|FG005|First Intervention|Physician Decision|1|||
125289828|NCT02498067|450687735|FG000|Overall Study|Lost to Follow-up|22|||
125289829|NCT02498067|450687735|FG000|Overall Study|Did not meet inclusion criteria|11|||
125289830|NCT00747344|450687736|FG000|Controlled Period|Adverse Event|3|||
124783547|NCT03646123|448838156|FG001|Overall Study|Other|0|||
124783548|NCT03646123|448838157|FG002|Overall Study|Other|2|||
125289831|NCT00747344|450687737|FG001|Controlled Period|Adverse Event|0|||
125289832|NCT00747344|450687738|FG002|Controlled Period|Adverse Event|0|||
125289833|NCT00747344|450687739|FG003|Controlled Period|Adverse Event|0|||
125289834|NCT00747344|450687736|FG000|Controlled Period|Lack of Efficacy|2|||
124783549|NCT03462511|448838163|FG000|Overall Study|Withdrawal by Subject|2|||
125289835|NCT00747344|450687737|FG001|Controlled Period|Lack of Efficacy|1|||
125289836|NCT00747344|450687738|FG002|Controlled Period|Lack of Efficacy|0|||
125289837|NCT00747344|450687739|FG003|Controlled Period|Lack of Efficacy|0|||
125289838|NCT00747344|450687736|FG000|Controlled Period|Other|0|||
125289839|NCT00747344|450687737|FG001|Controlled Period|Other|3|||
125289840|NCT00747344|450687738|FG002|Controlled Period|Other|0|||
125289841|NCT00747344|450687739|FG003|Controlled Period|Other|0|||
125289842|NCT00747344|450687736|FG000|After Controlled Period|Adverse Event|0|||
125289843|NCT00747344|450687737|FG001|After Controlled Period|Adverse Event|0|||
125289844|NCT00747344|450687738|FG002|After Controlled Period|Adverse Event|0|||
125289845|NCT00747344|450687739|FG003|After Controlled Period|Adverse Event|1|||
125289846|NCT01484834|450687740|FG000|Overall Study|Lost to Follow-up|5|||
125289847|NCT01484834|450687741|FG001|Overall Study|Lost to Follow-up|8|||
125289848|NCT01484834|450687742|FG002|Overall Study|Lost to Follow-up|1|||
125289849|NCT01484834|450687743|FG003|Overall Study|Lost to Follow-up|4|||
125289850|NCT00765882|450687744|FG000|Overall Study|Adverse Event|10|||
125289851|NCT00765882|450687745|FG001|Overall Study|Adverse Event|21|||
125289852|NCT00765882|450687746|FG002|Overall Study|Adverse Event|20|||
125289853|NCT00765882|450687744|FG000|Overall Study|Lack of Efficacy|4|||
125289854|NCT00765882|450687745|FG001|Overall Study|Lack of Efficacy|0|||
125289855|NCT00765882|450687746|FG002|Overall Study|Lack of Efficacy|1|||
125289856|NCT00765882|450687744|FG000|Overall Study|Protocol Violation|4|||
125289857|NCT00765882|450687745|FG001|Overall Study|Protocol Violation|3|||
125289858|NCT00765882|450687746|FG002|Overall Study|Protocol Violation|1|||
125289859|NCT00765882|450687744|FG000|Overall Study|Withdrawal by Subject|2|||
125289860|NCT00765882|450687745|FG001|Overall Study|Withdrawal by Subject|6|||
125289861|NCT00765882|450687746|FG002|Overall Study|Withdrawal by Subject|6|||
125289862|NCT00765882|450687744|FG000|Overall Study|Lost to Follow-up|1|||
125289863|NCT00765882|450687745|FG001|Overall Study|Lost to Follow-up|9|||
125289864|NCT00765882|450687746|FG002|Overall Study|Lost to Follow-up|6|||
125289865|NCT00765882|450687744|FG000|Overall Study|Other Reason|3|||
125289866|NCT00765882|450687745|FG001|Overall Study|Other Reason|1|||
125289867|NCT00765882|450687746|FG002|Overall Study|Other Reason|2|||
125289868|NCT02231762|450687750|FG000|Combination Phase|Adverse Event|10|||
125289869|NCT02231762|450687751|FG001|Combination Phase|Adverse Event|0|||
125289870|NCT02231762|450687752|FG002|Combination Phase|Adverse Event|0|||
125289871|NCT02231762|450687753|FG003|Combination Phase|Adverse Event|0|||
125289872|NCT02231762|450687750|FG000|Combination Phase|Withdrawal by Subject|2|||
125289873|NCT02231762|450687751|FG001|Combination Phase|Withdrawal by Subject|0|||
125289874|NCT02231762|450687752|FG002|Combination Phase|Withdrawal by Subject|0|||
125289875|NCT02231762|450687753|FG003|Combination Phase|Withdrawal by Subject|0|||
125289876|NCT02231762|450687750|FG000|Combination Phase|Disease Progression|6|||
125289877|NCT02231762|450687751|FG001|Combination Phase|Disease Progression|0|||
125289878|NCT02231762|450687752|FG002|Combination Phase|Disease Progression|0|||
125289879|NCT02231762|450687753|FG003|Combination Phase|Disease Progression|0|||
125289880|NCT02231762|450687750|FG000|Combination Phase|Did not meet inclusion criteria|1|||
125289881|NCT02231762|450687751|FG001|Combination Phase|Did not meet inclusion criteria|0|||
125289882|NCT02231762|450687752|FG002|Combination Phase|Did not meet inclusion criteria|0|||
125289883|NCT02231762|450687753|FG003|Combination Phase|Did not meet inclusion criteria|0|||
125289884|NCT02231762|450687750|FG000|Combination Phase|Protocol Violation|1|||
125289885|NCT02231762|450687751|FG001|Combination Phase|Protocol Violation|0|||
125289886|NCT02231762|450687752|FG002|Combination Phase|Protocol Violation|0|||
125289887|NCT02231762|450687753|FG003|Combination Phase|Protocol Violation|0|||
124783550|NCT03462511|448838164|FG001|Overall Study|Withdrawal by Subject|3|||
124783551|NCT02925416|448838165|FG000|Overall Study|Adverse Event|2|||
124783552|NCT02925416|448838166|FG001|Overall Study|Adverse Event|0|||
124783553|NCT03595228|448838167|FG000|Overall Study|Death|2|||
124783554|NCT03595228|448838167|FG000|Overall Study|Lack of Efficacy|13|||
124783555|NCT03595228|448838167|FG000|Overall Study|Withdrawal by Subject|3|||
124783556|NCT03595228|448838167|FG000|Overall Study|Withdrawal by Sponsor|1|||
124783557|NCT00200356|448838168|FG000|Overall Study|Lack of Efficacy|3|||
124783558|NCT00200356|448838169|FG001|Overall Study|Lack of Efficacy|3|||
124783559|NCT00200356|448838168|FG000|Overall Study|Protocol Violation|4|||
124783560|NCT00200356|448838169|FG001|Overall Study|Protocol Violation|4|||
124783561|NCT00200356|448838168|FG000|Overall Study|Nontreatment|1|||
124783562|NCT00200356|448838169|FG001|Overall Study|Nontreatment|0|||
124783563|NCT00435045|448838171|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
124783564|NCT00435045|448838172|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
124783565|NCT00435045|448838171|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
124783566|NCT00435045|448838172|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
124783567|NCT00435045|448838171|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
125289888|NCT02231762|450687750|FG000|Maintenance Phase|Disease progression|0|||
125289889|NCT02231762|450687751|FG001|Maintenance Phase|Disease progression|3|||
125289890|NCT02231762|450687752|FG002|Maintenance Phase|Disease progression|4|||
125289891|NCT02231762|450687753|FG003|Maintenance Phase|Disease progression|3|||
125289892|NCT02231762|450687750|FG000|Maintenance Phase|Adverse Event|0|||
125289893|NCT02231762|450687751|FG001|Maintenance Phase|Adverse Event|0|||
125289894|NCT02231762|450687752|FG002|Maintenance Phase|Adverse Event|1|||
125289895|NCT02231762|450687753|FG003|Maintenance Phase|Adverse Event|2|||
124783568|NCT00435045|448838172|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
125289896|NCT01799239|450687758|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
125289897|NCT01799239|450687759|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
125289898|NCT01799239|450687758|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
125289899|NCT01799239|450687759|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
125289900|NCT01799239|450687758|FG000|Period 1 (7 Days)|Protocol Violation|0|||
125289901|NCT01799239|450687759|FG001|Period 1 (7 Days)|Protocol Violation|1|||
125289902|NCT01799239|450687758|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
125289903|NCT01799239|450687759|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
125289904|NCT01799239|450687758|FG000|Period 2 (7 Days)|Protocol Violation|1|||
125289905|NCT01799239|450687759|FG001|Period 2 (7 Days)|Protocol Violation|0|||
125289906|NCT02594098|450687760|FG000|Overall Study|Lack of Efficacy|17|||
125289907|NCT02594098|450687761|FG001|Overall Study|Lack of Efficacy|6|||
125289908|NCT02594098|450687760|FG000|Overall Study|Withdrawal by Subject|1|||
125289909|NCT02594098|450687761|FG001|Overall Study|Withdrawal by Subject|3|||
125289910|NCT02594098|450687760|FG000|Overall Study|Terminated participation|6|||
125289911|NCT02594098|450687761|FG001|Overall Study|Terminated participation|2|||
125289912|NCT02594098|450687760|FG000|Overall Study|Seek alternative treatment|2|||
125289913|NCT02594098|450687761|FG001|Overall Study|Seek alternative treatment|1|||
125289914|NCT02594098|450687760|FG000|Overall Study|Other|0|||
125289915|NCT02594098|450687761|FG001|Overall Study|Other|1|||
125289916|NCT00033540|450687762|FG000|Overall Study|Adverse Event|14|||
125289917|NCT00033540|450687762|FG000|Overall Study|Death|1|||
125289918|NCT00033540|450687762|FG000|Overall Study|Progression|26|||
125289919|NCT00033540|450687762|FG000|Overall Study|Withdrawal by Subject|6|||
125289920|NCT00033540|450687762|FG000|Overall Study|Other|5|||
125289921|NCT00033540|450687762|FG000|Overall Study|Ineligible|3|||
125289922|NCT00033540|450687762|FG000|Overall Study|Never received treatment|2|||
125289923|NCT03366103|450687763|FG000|Overall Study|Disease Progression|3|||
125289924|NCT03366103|450687764|FG001|Overall Study|Disease Progression|1|||
125289925|NCT03366103|450687765|FG002|Overall Study|Disease Progression|0|||
125289926|NCT03366103|450687763|FG000|Overall Study|Adverse Event|0|||
125289927|NCT03366103|450687764|FG001|Overall Study|Adverse Event|1|||
125289928|NCT03366103|450687765|FG002|Overall Study|Adverse Event|0|||
125289929|NCT01036529|450687766|FG000|Overall Study|Adverse Event|0|||
125289930|NCT01036529|450687767|FG001|Overall Study|Adverse Event|1|||
125289931|NCT01036529|450687766|FG000|Overall Study|Lost to Follow-up|0|||
125289932|NCT01036529|450687767|FG001|Overall Study|Lost to Follow-up|1|||
125289933|NCT01036529|450687766|FG000|Overall Study|Physician Decision|1|||
125289934|NCT01036529|450687767|FG001|Overall Study|Physician Decision|0|||
125289935|NCT01036529|450687766|FG000|Overall Study|Withdrawal by Subject|1|||
125289936|NCT01036529|450687767|FG001|Overall Study|Withdrawal by Subject|1|||
125289937|NCT01036529|450687766|FG000|Overall Study|Sponsor study termination|11|||
125289938|NCT01036529|450687767|FG001|Overall Study|Sponsor study termination|12|||
125289939|NCT01945775|450687768|FG000|Overall Study|Death|214|||
125289940|NCT01945775|450687769|FG001|Overall Study|Death|98|||
125289941|NCT01945775|450687768|FG000|Overall Study|Lost to Follow-up|12|||
125289942|NCT01945775|450687769|FG001|Overall Study|Lost to Follow-up|7|||
125289943|NCT01945775|450687768|FG000|Overall Study|Withdrawal by Subject|11|||
125289944|NCT01945775|450687769|FG001|Overall Study|Withdrawal by Subject|21|||
125289945|NCT01945775|450687768|FG000|Overall Study|Other|50|||
125289946|NCT01945775|450687769|FG001|Overall Study|Other|18|||
125289947|NCT02876328|450687770|FG000|Overall Study|Death|2|||
125289948|NCT02876328|450687771|FG001|Overall Study|Death|1|||
125289949|NCT02876328|450687772|FG002|Overall Study|Death|3|||
125289950|NCT02876328|450687773|FG003|Overall Study|Death|0|||
125289951|NCT02876328|450687774|FG004|Overall Study|Death|0|||
125289952|NCT02876328|450687775|FG005|Overall Study|Death|0|||
125289953|NCT02876328|450687776|FG006|Overall Study|Death|1|||
125289954|NCT02876328|450687777|FG007|Overall Study|Death|3|||
125289955|NCT02876328|450687778|FG008|Overall Study|Death|0|||
125289956|NCT02876328|450687779|FG009|Overall Study|Death|1|||
125289957|NCT02876328|450687780|FG010|Overall Study|Death|1|||
125289958|NCT02876328|450687781|FG011|Overall Study|Death|0|||
125289959|NCT02876328|450687782|FG012|Overall Study|Death|0|||
125289960|NCT02876328|450687783|FG013|Overall Study|Death|0|||
125289961|NCT02876328|450687784|FG014|Overall Study|Death|0|||
125289962|NCT02876328|450687785|FG015|Overall Study|Death|0|||
125289963|NCT02876328|450687786|FG016|Overall Study|Death|1|||
125289964|NCT02876328|450687787|FG017|Overall Study|Death|1|||
125289965|NCT02876328|450687788|FG018|Overall Study|Death|0|||
125289966|NCT02876328|450687789|FG019|Overall Study|Death|0|||
125289967|NCT02876328|450687790|FG020|Overall Study|Death|0|||
125289968|NCT02876328|450687791|FG021|Overall Study|Death|1|||
125289969|NCT02876328|450687792|FG022|Overall Study|Death|0|||
125289970|NCT02876328|450687793|FG023|Overall Study|Death|0|||
125289971|NCT02876328|450687770|FG000|Overall Study|Withdrawal by Subject|0|||
125289972|NCT02876328|450687771|FG001|Overall Study|Withdrawal by Subject|2|||
125289973|NCT02876328|450687772|FG002|Overall Study|Withdrawal by Subject|3|||
125289974|NCT02876328|450687773|FG003|Overall Study|Withdrawal by Subject|3|||
125289975|NCT02876328|450687774|FG004|Overall Study|Withdrawal by Subject|0|||
125289976|NCT02876328|450687775|FG005|Overall Study|Withdrawal by Subject|1|||
125289977|NCT02876328|450687776|FG006|Overall Study|Withdrawal by Subject|0|||
125289978|NCT02876328|450687777|FG007|Overall Study|Withdrawal by Subject|1|||
125289979|NCT02876328|450687778|FG008|Overall Study|Withdrawal by Subject|1|||
125289980|NCT02876328|450687779|FG009|Overall Study|Withdrawal by Subject|2|||
125289981|NCT02876328|450687780|FG010|Overall Study|Withdrawal by Subject|0|||
125289982|NCT02876328|450687781|FG011|Overall Study|Withdrawal by Subject|0|||
125289983|NCT02876328|450687782|FG012|Overall Study|Withdrawal by Subject|0|||
125289984|NCT02876328|450687783|FG013|Overall Study|Withdrawal by Subject|0|||
125289985|NCT02876328|450687784|FG014|Overall Study|Withdrawal by Subject|0|||
125289986|NCT02876328|450687785|FG015|Overall Study|Withdrawal by Subject|0|||
125289987|NCT02876328|450687786|FG016|Overall Study|Withdrawal by Subject|1|||
125289988|NCT02876328|450687787|FG017|Overall Study|Withdrawal by Subject|3|||
125289989|NCT02876328|450687788|FG018|Overall Study|Withdrawal by Subject|0|||
125289990|NCT02876328|450687789|FG019|Overall Study|Withdrawal by Subject|0|||
125289991|NCT02876328|450687790|FG020|Overall Study|Withdrawal by Subject|1|||
125289992|NCT02876328|450687791|FG021|Overall Study|Withdrawal by Subject|0|||
125289993|NCT02876328|450687792|FG022|Overall Study|Withdrawal by Subject|0|||
125289994|NCT02876328|450687793|FG023|Overall Study|Withdrawal by Subject|0|||
125289995|NCT02876328|450687770|FG000|Overall Study|Missed 12 Month Visit|15|||
125289996|NCT02876328|450687771|FG001|Overall Study|Missed 12 Month Visit|10|||
125289997|NCT02876328|450687772|FG002|Overall Study|Missed 12 Month Visit|11|||
125289998|NCT02876328|450687773|FG003|Overall Study|Missed 12 Month Visit|6|||
125289999|NCT02876328|450687774|FG004|Overall Study|Missed 12 Month Visit|10|||
125290000|NCT02876328|450687775|FG005|Overall Study|Missed 12 Month Visit|14|||
125290001|NCT02876328|450687776|FG006|Overall Study|Missed 12 Month Visit|3|||
125290002|NCT02876328|450687777|FG007|Overall Study|Missed 12 Month Visit|8|||
125290003|NCT02876328|450687778|FG008|Overall Study|Missed 12 Month Visit|9|||
125290004|NCT02876328|450687779|FG009|Overall Study|Missed 12 Month Visit|5|||
125290005|NCT02876328|450687780|FG010|Overall Study|Missed 12 Month Visit|4|||
125290006|NCT02876328|450687781|FG011|Overall Study|Missed 12 Month Visit|1|||
125290007|NCT02876328|450687782|FG012|Overall Study|Missed 12 Month Visit|5|||
125290008|NCT02876328|450687783|FG013|Overall Study|Missed 12 Month Visit|4|||
125290009|NCT02876328|450687784|FG014|Overall Study|Missed 12 Month Visit|4|||
125290010|NCT02876328|450687785|FG015|Overall Study|Missed 12 Month Visit|4|||
125290011|NCT02876328|450687786|FG016|Overall Study|Missed 12 Month Visit|3|||
125290012|NCT02876328|450687787|FG017|Overall Study|Missed 12 Month Visit|6|||
125290013|NCT02876328|450687788|FG018|Overall Study|Missed 12 Month Visit|2|||
125290014|NCT02876328|450687789|FG019|Overall Study|Missed 12 Month Visit|2|||
125290015|NCT02876328|450687790|FG020|Overall Study|Missed 12 Month Visit|11|||
125290016|NCT02876328|450687791|FG021|Overall Study|Missed 12 Month Visit|7|||
125290017|NCT02876328|450687792|FG022|Overall Study|Missed 12 Month Visit|1|||
125290018|NCT02876328|450687793|FG023|Overall Study|Missed 12 Month Visit|0|||
125290019|NCT03515941|450687795|FG000|Overall Study|Adverse Event|1|||
125290020|NCT03515941|450687796|FG001|Overall Study|Adverse Event|0|||
125290021|NCT00334282|450687799|FG000|Overall Study|Lost to Follow-up|11|||
125290022|NCT00334282|450687800|FG001|Overall Study|Lost to Follow-up|5|||
125290023|NCT00334282|450687799|FG000|Overall Study|Withdrawal by Subject|17|||
125290024|NCT00334282|450687800|FG001|Overall Study|Withdrawal by Subject|3|||
125290025|NCT00334282|450687799|FG000|Overall Study|Death|194|||
125290026|NCT00334282|450687800|FG001|Overall Study|Death|100|||
125290027|NCT00468845|450687801|FG000|Overall Study|Adverse Event|9|||
125290028|NCT00468845|450687802|FG001|Overall Study|Adverse Event|14|||
125290029|NCT00468845|450687803|FG002|Overall Study|Adverse Event|11|||
125290030|NCT00468845|450687801|FG000|Overall Study|Lost to Follow-up|2|||
125290031|NCT00468845|450687802|FG001|Overall Study|Lost to Follow-up|1|||
125290032|NCT00468845|450687803|FG002|Overall Study|Lost to Follow-up|2|||
125290033|NCT00468845|450687801|FG000|Overall Study|Other|4|||
125290034|NCT00468845|450687802|FG001|Overall Study|Other|9|||
125290035|NCT00468845|450687803|FG002|Overall Study|Other|5|||
125290036|NCT00468845|450687801|FG000|Overall Study|No longer willing to participate|5|||
125290037|NCT00468845|450687802|FG001|Overall Study|No longer willing to participate|6|||
125290038|NCT00468845|450687803|FG002|Overall Study|No longer willing to participate|10|||
125290039|NCT00468845|450687801|FG000|Overall Study|Randomized, not treated|1|||
125290040|NCT00468845|450687802|FG001|Overall Study|Randomized, not treated|4|||
125290041|NCT00468845|450687803|FG002|Overall Study|Randomized, not treated|2|||
125290042|NCT04342689|450687816|FG000|Overall Study|Withdrawal by Subject|32|||
125290043|NCT04342689|450687817|FG001|Overall Study|Withdrawal by Subject|33|||
125290044|NCT04342689|450687816|FG000|Overall Study|Lost to Follow-up|10|||
125290045|NCT04342689|450687817|FG001|Overall Study|Lost to Follow-up|12|||
125290046|NCT01460407|450687818|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
125290047|NCT01460407|450687819|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
125290048|NCT00844805|450687824|FG000|Treatment Phase|Adverse Event|5|||
125290049|NCT00844805|450687825|FG001|Treatment Phase|Adverse Event|1|||
125290050|NCT00844805|450687826|FG002|Treatment Phase|Adverse Event|0|||
125290051|NCT00844805|450687827|FG003|Treatment Phase|Adverse Event|0|||
125290052|NCT00844805|450687824|FG000|Treatment Phase|Withdrawal by Subject|3|||
125290053|NCT00844805|450687825|FG001|Treatment Phase|Withdrawal by Subject|4|||
125290054|NCT00844805|450687826|FG002|Treatment Phase|Withdrawal by Subject|0|||
125290055|NCT00844805|450687827|FG003|Treatment Phase|Withdrawal by Subject|0|||
125290056|NCT00844805|450687824|FG000|Treatment Phase|Noncompliance With Protocol|1|||
125290057|NCT00844805|450687825|FG001|Treatment Phase|Noncompliance With Protocol|0|||
125290058|NCT00844805|450687826|FG002|Treatment Phase|Noncompliance With Protocol|0|||
125290059|NCT00844805|450687827|FG003|Treatment Phase|Noncompliance With Protocol|0|||
125290060|NCT00844805|450687824|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
125290061|NCT00844805|450687825|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
125290062|NCT00844805|450687826|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
125290063|NCT00844805|450687827|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
125290064|NCT00844805|450687824|FG000|Follow-Up Phase|Adverse Event|0|||
125290065|NCT00844805|450687825|FG001|Follow-Up Phase|Adverse Event|0|||
125290066|NCT00844805|450687826|FG002|Follow-Up Phase|Adverse Event|1|||
125290067|NCT00844805|450687827|FG003|Follow-Up Phase|Adverse Event|0|||
125290068|NCT00844805|450687824|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
125290069|NCT00844805|450687825|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
125290070|NCT00844805|450687826|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
125290071|NCT00844805|450687827|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
125290072|NCT00844805|450687824|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
125290073|NCT00844805|450687825|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
125290074|NCT00844805|450687826|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
125290075|NCT00844805|450687827|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
125290076|NCT00844805|450687824|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
125290077|NCT00844805|450687825|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
125290078|NCT00844805|450687826|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
125290079|NCT00844805|450687827|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
125290080|NCT00844805|450687824|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
125290081|NCT00844805|450687825|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
125290082|NCT00844805|450687826|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
125290083|NCT00844805|450687827|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
125290084|NCT03618628|450687831|FG000|Overall Study|Death|1|||
125290085|NCT03618628|450687831|FG000|Overall Study|Lost to Follow-up|1|||
125290086|NCT01741532|450687833|FG000|Overall Study|Adverse Event|4|||
125290087|NCT01741532|450687834|FG001|Overall Study|Adverse Event|0|||
125290088|NCT01741532|450687833|FG000|Overall Study|Withdrawal by Subject|1|||
125290089|NCT01741532|450687834|FG001|Overall Study|Withdrawal by Subject|1|||
125290090|NCT01741532|450687833|FG000|Overall Study|Protocol Violation|0|||
125290091|NCT01741532|450687834|FG001|Overall Study|Protocol Violation|1|||
125290092|NCT01741532|450687833|FG000|Overall Study|Worsening of the disease|3|||
125290093|NCT01741532|450687834|FG001|Overall Study|Worsening of the disease|1|||
125290094|NCT01741532|450687833|FG000|Overall Study|Sponsor decision|1|||
125290095|NCT01741532|450687834|FG001|Overall Study|Sponsor decision|0|||
125290096|NCT01741532|450687833|FG000|Overall Study|Medical event|1|||
125290097|NCT01741532|450687834|FG001|Overall Study|Medical event|0|||
125290098|NCT00475865|450687835|FG000|Overall Study|Adverse Event|0|||
125290099|NCT00475865|450687836|FG001|Overall Study|Adverse Event|3|||
125290100|NCT00475865|450687837|FG002|Overall Study|Adverse Event|4|||
125290101|NCT00475865|450687835|FG000|Overall Study|Lack of Efficacy|1|||
125290102|NCT00475865|450687836|FG001|Overall Study|Lack of Efficacy|0|||
125290103|NCT00475865|450687837|FG002|Overall Study|Lack of Efficacy|0|||
125290104|NCT00475865|450687835|FG000|Overall Study|Progressive disease|0|||
125290105|NCT00475865|450687836|FG001|Overall Study|Progressive disease|1|||
125290106|NCT00475865|450687837|FG002|Overall Study|Progressive disease|2|||
125290107|NCT00475865|450687835|FG000|Overall Study|Participant did not wish to continue|1|||
125290108|NCT00475865|450687836|FG001|Overall Study|Participant did not wish to continue|0|||
125290109|NCT00475865|450687837|FG002|Overall Study|Participant did not wish to continue|0|||
125290110|NCT00475865|450687835|FG000|Overall Study|Other than above|0|||
125290111|NCT00475865|450687836|FG001|Overall Study|Other than above|1|||
125290112|NCT00475865|450687837|FG002|Overall Study|Other than above|0|||
125290113|NCT01453946|450687840|FG000|Overall Study|Did not receive drug for the taper phase|1|||
125290114|NCT01453946|450687840|FG000|Overall Study|Protocol Violation|2|||
125290115|NCT01453946|450687840|FG000|Overall Study|Lack of Efficacy|3|||
125290116|NCT01453946|450687840|FG000|Overall Study|Adverse Event|3|||
125290117|NCT03158272|450687843|FG000|Overall Study|Disease progression|3|||
125290118|NCT03158272|450687844|FG001|Overall Study|Disease progression|3|||
125290119|NCT03158272|450687845|FG002|Overall Study|Disease progression|4|||
125290120|NCT03158272|450687846|FG003|Overall Study|Disease progression|6|||
125290121|NCT03158272|450687843|FG000|Overall Study|Death|0|||
125290122|NCT03158272|450687844|FG001|Overall Study|Death|0|||
125290123|NCT03158272|450687845|FG002|Overall Study|Death|1|||
125290124|NCT03158272|450687846|FG003|Overall Study|Death|0|||
125290125|NCT03158272|450687843|FG000|Overall Study|Other reasons|0|||
125290126|NCT03158272|450687844|FG001|Overall Study|Other reasons|0|||
125290127|NCT03158272|450687845|FG002|Overall Study|Other reasons|1|||
125290128|NCT03158272|450687846|FG003|Overall Study|Other reasons|0|||
125290129|NCT03158272|450687843|FG000|Overall Study|Adverse event unrelated to the drug|0|||
125290130|NCT03158272|450687844|FG001|Overall Study|Adverse event unrelated to the drug|1|||
125290131|NCT03158272|450687845|FG002|Overall Study|Adverse event unrelated to the drug|0|||
125290132|NCT03158272|450687846|FG003|Overall Study|Adverse event unrelated to the drug|0|||
125290133|NCT01822535|450687847|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
125290134|NCT01822535|450687848|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
125290135|NCT01822535|450687847|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
125290136|NCT01822535|450687848|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
125290137|NCT01822535|450687847|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
125290138|NCT01822535|450687848|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
125290139|NCT02278614|450687851|FG000|Overall Study|Withdrawal by Subject|3|||
125290140|NCT02278614|450687852|FG001|Overall Study|Withdrawal by Subject|5|||
125290141|NCT02278614|450687851|FG000|Overall Study|Adverse Event|1|||
125290142|NCT02278614|450687852|FG001|Overall Study|Adverse Event|0|||
125290143|NCT02278614|450687851|FG000|Overall Study|left eye was not eligible|1|||
125290144|NCT02278614|450687852|FG001|Overall Study|left eye was not eligible|0|||
125290145|NCT03582813|450687855|FG000|Overall Study|Lost to Follow-up|18|||
125290146|NCT03582813|450687856|FG001|Overall Study|Lost to Follow-up|21|||
125290147|NCT03582813|450687855|FG000|Overall Study|Withdrawal by Subject|1|||
125290148|NCT03582813|450687856|FG001|Overall Study|Withdrawal by Subject|0|||
125290149|NCT02366767|450687859|FG000|Overall Study|left for home after 1 day at camp|1|||
125290150|NCT02366767|450687860|FG001|Overall Study|left for home after 1 day at camp|0|||
125290151|NCT02558400|450687863|FG000|Overall Study|Adverse Event|47|||
125290152|NCT02558400|450687864|FG001|Overall Study|Adverse Event|53|||
125290153|NCT02558400|450687865|FG002|Overall Study|Adverse Event|4|||
125290154|NCT02558400|450687863|FG000|Overall Study|Withdrawal by Subject|13|||
125290155|NCT02558400|450687864|FG001|Overall Study|Withdrawal by Subject|9|||
125290156|NCT02558400|450687865|FG002|Overall Study|Withdrawal by Subject|8|||
125290157|NCT02558400|450687863|FG000|Overall Study|Non-Compliant|0|||
125290158|NCT02558400|450687864|FG001|Overall Study|Non-Compliant|1|||
125290159|NCT02558400|450687865|FG002|Overall Study|Non-Compliant|3|||
125290160|NCT02558400|450687863|FG000|Overall Study|Lost to Follow-up|5|||
125290161|NCT02558400|450687864|FG001|Overall Study|Lost to Follow-up|5|||
125290162|NCT02558400|450687865|FG002|Overall Study|Lost to Follow-up|4|||
124783569|NCT00435045|448838171|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
124783570|NCT00435045|448838172|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
124783571|NCT00435045|448838171|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
124783572|NCT00435045|448838172|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
124783573|NCT00435045|448838171|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
124783574|NCT00435045|448838172|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
124783575|NCT00435045|448838171|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
124783576|NCT00435045|448838172|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
124783577|NCT00435045|448838171|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
124783578|NCT00435045|448838172|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
124783579|NCT00435045|448838171|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
124783580|NCT00435045|448838172|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
124783581|NCT00435045|448838171|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
124783582|NCT00435045|448838172|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
124783583|NCT00435045|448838171|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
124783584|NCT00435045|448838172|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
124783585|NCT00312195|448838173|FG000|Overall Study|Adverse Event|4|||
124783586|NCT00312195|448838174|FG001|Overall Study|Adverse Event|6|||
124783587|NCT00312195|448838173|FG000|Overall Study|Lost to Follow-up|1|||
124783588|NCT00312195|448838174|FG001|Overall Study|Lost to Follow-up|0|||
124783589|NCT00312195|448838173|FG000|Overall Study|Protocol Violation|1|||
124783590|NCT00312195|448838174|FG001|Overall Study|Protocol Violation|0|||
124783591|NCT01015638|448838177|FG000|Overall Study|Withdrawal by Subject|1|||
124783592|NCT01015638|448838178|FG001|Overall Study|Withdrawal by Subject|0|||
124783593|NCT01703754|448838182|FG000|Overall Study|Clinically significant disease progression|2|||
124783594|NCT01703754|448838183|FG001|Overall Study|Clinically significant disease progression|2|||
124783595|NCT01703754|448838184|FG002|Overall Study|Clinically significant disease progression|1|||
124783596|NCT01703754|448838182|FG000|Overall Study|Adverse Event|1|||
124783597|NCT01703754|448838183|FG001|Overall Study|Adverse Event|1|||
124783598|NCT01703754|448838184|FG002|Overall Study|Adverse Event|0|||
124783599|NCT01703754|448838182|FG000|Overall Study|Withdrawal by Subject|2|||
124783600|NCT01703754|448838183|FG001|Overall Study|Withdrawal by Subject|0|||
124783601|NCT01703754|448838184|FG002|Overall Study|Withdrawal by Subject|0|||
124783602|NCT00964171|448838187|FG000|Overall Study|Death|5|||
124783603|NCT02872935|448838193|FG000|Overall Study|Other|0|||
124783604|NCT02872935|448838194|FG001|Overall Study|Other|1|||
124783605|NCT02792829|448838195|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
124783606|NCT02792829|448838196|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
124783607|NCT02792829|448838197|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
125290163|NCT02558400|450687863|FG000|Overall Study|Lack of Efficacy|0|||
125290164|NCT02558400|450687864|FG001|Overall Study|Lack of Efficacy|13|||
125290165|NCT02558400|450687865|FG002|Overall Study|Lack of Efficacy|1|||
125290166|NCT02558400|450687863|FG000|Overall Study|Disallowed Concurrent Medication|6|||
125290167|NCT02558400|450687864|FG001|Overall Study|Disallowed Concurrent Medication|7|||
125290168|NCT02558400|450687865|FG002|Overall Study|Disallowed Concurrent Medication|5|||
125290169|NCT02558400|450687863|FG000|Overall Study|Physician Decision|2|||
125290170|NCT02558400|450687864|FG001|Overall Study|Physician Decision|2|||
125290171|NCT02558400|450687865|FG002|Overall Study|Physician Decision|0|||
125290172|NCT02558400|450687863|FG000|Overall Study|Protocol Violation|6|||
125290173|NCT02558400|450687864|FG001|Overall Study|Protocol Violation|3|||
125290174|NCT02558400|450687865|FG002|Overall Study|Protocol Violation|8|||
125290175|NCT02558400|450687863|FG000|Overall Study|Death|0|||
125290176|NCT02558400|450687864|FG001|Overall Study|Death|1|||
125290177|NCT02558400|450687865|FG002|Overall Study|Death|0|||
125290178|NCT02558400|450687863|FG000|Overall Study|Ineligible for the study|0|||
125290179|NCT02558400|450687864|FG001|Overall Study|Ineligible for the study|2|||
125290180|NCT02558400|450687865|FG002|Overall Study|Ineligible for the study|0|||
125290181|NCT02230683|450687866|FG000|Overall Study|Adverse Event|1|||
125290182|NCT00260065|450687867|FG000|Overall Study|Progressive Disease|22|||
125290183|NCT00260065|450687867|FG000|Overall Study|Adverse Event|17|||
125290184|NCT00260065|450687867|FG000|Overall Study|Death|13|||
125290185|NCT00260065|450687867|FG000|Overall Study|Withdrawal by Subject|13|||
125290186|NCT00260065|450687867|FG000|Overall Study|Physician Decision|19|||
125290187|NCT00260065|450687867|FG000|Overall Study|Not otherwise specified|8|||
125290188|NCT00260065|450687867|FG000|Overall Study|Medication Noncompliance|1|||
125290189|NCT04068519|450687868|FG000|Dose Verification|Death|15|||
125290190|NCT04068519|450687868|FG000|Dose Verification|Withdrawal by Subject|1|||
125290191|NCT04068519|450687868|FG000|Pharmacokinetic Sub-study|Death|35|||
125290192|NCT04068519|450687868|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
125290193|NCT04068519|450687868|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
125290194|NCT04068519|450687868|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
125290195|NCT04068519|450687868|FG000|Indication Expansion|Death|152|||
125290196|NCT04068519|450687868|FG000|Indication Expansion|Withdrawal by Subject|10|||
125290197|NCT04068519|450687868|FG000|Indication Expansion|Lost to Follow-up|7|||
125290198|NCT00758589|450689731|FG000|Overall Study|Adverse Event|3|||
125290199|NCT00758589|450689732|FG001|Overall Study|Adverse Event|2|||
125290200|NCT00758589|450689733|FG002|Overall Study|Adverse Event|5|||
125290201|NCT00758589|450689734|FG003|Overall Study|Adverse Event|4|||
125290202|NCT00758589|450689731|FG000|Overall Study|Withdrawal by Subject|0|||
125290203|NCT00758589|450689732|FG001|Overall Study|Withdrawal by Subject|1|||
125290204|NCT00758589|450689733|FG002|Overall Study|Withdrawal by Subject|1|||
125290205|NCT00758589|450689734|FG003|Overall Study|Withdrawal by Subject|1|||
125290206|NCT00758589|450689731|FG000|Overall Study|Palm stopped to work|0|||
125290207|NCT00758589|450689732|FG001|Overall Study|Palm stopped to work|0|||
125290208|NCT00758589|450689733|FG002|Overall Study|Palm stopped to work|0|||
125290209|NCT00758589|450689734|FG003|Overall Study|Palm stopped to work|1|||
125290210|NCT04599166|450689735|FG000|Overall Study|Technological failure connecting to study app|80|||
125290211|NCT01777542|450689736|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
125290212|NCT01777542|450689737|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
125290213|NCT00953524|450689738|FG000|Overall Study|Adverse Event|2|||
125290214|NCT00953524|450689739|FG001|Overall Study|Adverse Event|0|||
125290215|NCT00953524|450689740|FG002|Overall Study|Adverse Event|1|||
125290216|NCT00953524|450689741|FG003|Overall Study|Adverse Event|2|||
125290217|NCT00953524|450689738|FG000|Overall Study|Protocol Violation|18|||
125290218|NCT00953524|450689739|FG001|Overall Study|Protocol Violation|10|||
125290219|NCT00953524|450689740|FG002|Overall Study|Protocol Violation|11|||
125290220|NCT00953524|450689741|FG003|Overall Study|Protocol Violation|6|||
125290221|NCT00953524|450689738|FG000|Overall Study|Lost to Follow-up|0|||
124783608|NCT02792829|448838198|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
124783609|NCT02792829|448838199|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
124783610|NCT02792829|448838200|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
124783611|NCT02792829|448838201|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
124783612|NCT02792829|448838202|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
124783613|NCT02792829|448838195|FG000|Treatment Period 2|Adverse Event|0|||
124783614|NCT02792829|448838196|FG001|Treatment Period 2|Adverse Event|0|||
124783615|NCT02792829|448838197|FG002|Treatment Period 2|Adverse Event|0|||
124783616|NCT02792829|448838198|FG003|Treatment Period 2|Adverse Event|0|||
124783617|NCT02792829|448838199|FG004|Treatment Period 2|Adverse Event|1|||
124783618|NCT02792829|448838200|FG005|Treatment Period 2|Adverse Event|0|||
125290222|NCT00953524|450689739|FG001|Overall Study|Lost to Follow-up|1|||
125290223|NCT00953524|450689740|FG002|Overall Study|Lost to Follow-up|1|||
125290224|NCT00953524|450689741|FG003|Overall Study|Lost to Follow-up|0|||
125290225|NCT00953524|450689738|FG000|Overall Study|Withdrawal by Subject|2|||
125290226|NCT00953524|450689739|FG001|Overall Study|Withdrawal by Subject|4|||
125290227|NCT00953524|450689740|FG002|Overall Study|Withdrawal by Subject|1|||
125290228|NCT00953524|450689741|FG003|Overall Study|Withdrawal by Subject|0|||
125290229|NCT03554772|450689748|FG000|Overall Study|Lost to Follow-up|0|||
125290230|NCT03554772|450689749|FG001|Overall Study|Lost to Follow-up|0|||
125290231|NCT03554772|450689750|FG002|Overall Study|Lost to Follow-up|0|||
125290232|NCT03554772|450689751|FG003|Overall Study|Lost to Follow-up|2|||
125290233|NCT05136898|450689752|FG000|Overall Study|Adverse Event|2|||
125290234|NCT03784846|450689753|FG000|Pre-COVID Study|Lost to Follow-up|3|||
125290235|NCT03784846|450689754|FG001|Pre-COVID Study|Lost to Follow-up|3|||
125290236|NCT03784846|450689755|FG002|Pre-COVID Study|Lost to Follow-up|2|||
125290237|NCT03784846|450689753|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
125290238|NCT03784846|450689754|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
125290239|NCT03784846|450689755|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
125290240|NCT03784846|450689753|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
125290241|NCT03784846|450689754|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
125290242|NCT03784846|450689755|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
125290243|NCT03784846|450689753|FG000|Post-COVID Study|Lost to Follow-up|3|||
125290244|NCT03784846|450689754|FG001|Post-COVID Study|Lost to Follow-up|5|||
125290245|NCT03784846|450689755|FG002|Post-COVID Study|Lost to Follow-up|1|||
125290246|NCT03784846|450689753|FG000|Post-COVID Study|Withdrawal by Subject|1|||
125290247|NCT03784846|450689754|FG001|Post-COVID Study|Withdrawal by Subject|2|||
125290248|NCT03784846|450689755|FG002|Post-COVID Study|Withdrawal by Subject|0|||
125290249|NCT00867087|450689756|FG000|Overall Study|Other|1|||
125290250|NCT00867087|450689756|FG000|Overall Study|Withdrawal by Subject|4|||
125290251|NCT00867087|450689756|FG000|Overall Study|Death|37|||
125290252|NCT02088073|450689758|FG000|Acute Phase|Withdrawal by Subject|5|||
125290253|NCT02088073|450689759|FG001|Acute Phase|Withdrawal by Subject|0|||
125290254|NCT02088073|450689760|FG002|Acute Phase|Withdrawal by Subject|0|||
125290255|NCT02088073|450689761|FG003|Acute Phase|Withdrawal by Subject|0|||
125290256|NCT02088073|450689762|FG004|Acute Phase|Withdrawal by Subject|0|||
125290257|NCT02088073|450689758|FG000|Acute Phase|Hyperkalemia|2|||
125290258|NCT02088073|450689759|FG001|Acute Phase|Hyperkalemia|0|||
125290259|NCT02088073|450689760|FG002|Acute Phase|Hyperkalemia|0|||
125290260|NCT02088073|450689761|FG003|Acute Phase|Hyperkalemia|0|||
125290261|NCT02088073|450689762|FG004|Acute Phase|Hyperkalemia|0|||
125290262|NCT02088073|450689758|FG000|Maintanance Phase|Withdrawal by Subject|0|||
125290263|NCT02088073|450689759|FG001|Maintanance Phase|Withdrawal by Subject|2|||
125290264|NCT02088073|450689760|FG002|Maintanance Phase|Withdrawal by Subject|0|||
125290265|NCT02088073|450689761|FG003|Maintanance Phase|Withdrawal by Subject|0|||
125290266|NCT02088073|450689762|FG004|Maintanance Phase|Withdrawal by Subject|0|||
125290267|NCT02088073|450689758|FG000|Maintanance Phase|Adverse Event|0|||
125290268|NCT02088073|450689759|FG001|Maintanance Phase|Adverse Event|0|||
125290269|NCT02088073|450689760|FG002|Maintanance Phase|Adverse Event|3|||
125290270|NCT02088073|450689761|FG003|Maintanance Phase|Adverse Event|0|||
125290271|NCT02088073|450689762|FG004|Maintanance Phase|Adverse Event|1|||
125290272|NCT02088073|450689758|FG000|Maintanance Phase|Physician Decision|0|||
125290273|NCT02088073|450689759|FG001|Maintanance Phase|Physician Decision|0|||
125290274|NCT02088073|450689760|FG002|Maintanance Phase|Physician Decision|0|||
125290275|NCT02088073|450689761|FG003|Maintanance Phase|Physician Decision|0|||
125290276|NCT02088073|450689762|FG004|Maintanance Phase|Physician Decision|1|||
125290277|NCT02088073|450689758|FG000|Maintanance Phase|Sponsor's decision|0|||
125290278|NCT02088073|450689759|FG001|Maintanance Phase|Sponsor's decision|2|||
125290279|NCT02088073|450689760|FG002|Maintanance Phase|Sponsor's decision|0|||
125290280|NCT02088073|450689761|FG003|Maintanance Phase|Sponsor's decision|2|||
125290281|NCT02088073|450689762|FG004|Maintanance Phase|Sponsor's decision|1|||
125290282|NCT02088073|450689758|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
125290283|NCT02088073|450689759|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
125290284|NCT02088073|450689760|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
125290285|NCT02088073|450689761|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
125290286|NCT02088073|450689762|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
125290287|NCT02088073|450689758|FG000|Maintanance Phase|Miscellaneous|0|||
125290288|NCT02088073|450689759|FG001|Maintanance Phase|Miscellaneous|2|||
125290289|NCT02088073|450689760|FG002|Maintanance Phase|Miscellaneous|1|||
125290290|NCT02088073|450689761|FG003|Maintanance Phase|Miscellaneous|2|||
125290291|NCT02088073|450689762|FG004|Maintanance Phase|Miscellaneous|1|||
125290292|NCT02088073|450689758|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
125290293|NCT02088073|450689759|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
125290294|NCT02088073|450689760|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
125290295|NCT02088073|450689761|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
125290296|NCT02088073|450689762|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
125290297|NCT02088073|450689758|FG000|Maintanance Phase|Subject compliance|0|||
125290298|NCT02088073|450689759|FG001|Maintanance Phase|Subject compliance|1|||
125290299|NCT02088073|450689760|FG002|Maintanance Phase|Subject compliance|0|||
125290300|NCT02088073|450689761|FG003|Maintanance Phase|Subject compliance|0|||
125290301|NCT02088073|450689762|FG004|Maintanance Phase|Subject compliance|0|||
125290302|NCT00241631|450689763|FG000|Run in (2 Weeks)|Physician Decision|3|||
125290303|NCT00241631|450689764|FG001|Run in (2 Weeks)|Physician Decision|3|||
125290304|NCT00241631|450689763|FG000|Phase 1 (4 Weeks)|sore throat|1|||
125290305|NCT00241631|450689764|FG001|Phase 1 (4 Weeks)|sore throat|0|||
125290306|NCT00241631|450689763|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
125290307|NCT00241631|450689764|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
125290308|NCT00241631|450689763|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
124783619|NCT02792829|448838201|FG006|Treatment Period 2|Adverse Event|1|||
124783620|NCT02792829|448838202|FG007|Treatment Period 2|Adverse Event|1|||
124783621|NCT02792829|448838195|FG000|Treatment Period 2|Use of proscribed medications|0|||
124783622|NCT02792829|448838196|FG001|Treatment Period 2|Use of proscribed medications|0|||
124783623|NCT02792829|448838197|FG002|Treatment Period 2|Use of proscribed medications|0|||
124783624|NCT02792829|448838198|FG003|Treatment Period 2|Use of proscribed medications|0|||
124783625|NCT02792829|448838199|FG004|Treatment Period 2|Use of proscribed medications|0|||
124783626|NCT02792829|448838200|FG005|Treatment Period 2|Use of proscribed medications|0|||
124783627|NCT02792829|448838201|FG006|Treatment Period 2|Use of proscribed medications|0|||
124783628|NCT02792829|448838202|FG007|Treatment Period 2|Use of proscribed medications|1|||
124783629|NCT02873429|448838203|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
124783630|NCT02873429|448838204|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
124783631|NCT02873429|448838203|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
124783632|NCT02873429|448838204|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
124783633|NCT02873429|448838203|FG000|16 Weeks|Lost to Follow-up|3|||
124783634|NCT02873429|448838204|FG001|16 Weeks|Lost to Follow-up|0|||
124783635|NCT04270370|448838205|FG000|Overall Study|Lost to Follow-up|1|||
124783636|NCT04270370|448838206|FG001|Overall Study|Lost to Follow-up|0|||
124783637|NCT04270370|448838207|FG002|Overall Study|Lost to Follow-up|0|||
124783638|NCT04270370|448838208|FG003|Overall Study|Lost to Follow-up|0|||
124783639|NCT04270370|448838209|FG004|Overall Study|Lost to Follow-up|0|||
125290309|NCT00241631|450689764|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
125290310|NCT00241631|450689763|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
125290311|NCT00241631|450689764|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
125290312|NCT03883113|450689765|FG000|Overall Study|Physician Decision|4|||
125290313|NCT03883113|450689766|FG001|Overall Study|Physician Decision|2|||
125290314|NCT03883113|450689765|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
125290315|NCT03883113|450689766|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
125290316|NCT03883113|450689765|FG000|Overall Study|Pregnancy|1|||
125290317|NCT03883113|450689766|FG001|Overall Study|Pregnancy|0|||
125290318|NCT03883113|450689765|FG000|Overall Study|Adverse Event|0|||
125290319|NCT03883113|450689766|FG001|Overall Study|Adverse Event|1|||
125290320|NCT03883113|450689765|FG000|Overall Study|Withdrawal by Subject|1|||
125290321|NCT03883113|450689766|FG001|Overall Study|Withdrawal by Subject|2|||
125290322|NCT03883113|450689765|FG000|Overall Study|Lost to Follow-up|1|||
125290323|NCT03883113|450689766|FG001|Overall Study|Lost to Follow-up|0|||
125290324|NCT01457950|450689774|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
125290325|NCT01457950|450689775|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
125290326|NCT01457950|450689776|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
125290327|NCT01457950|450689777|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
125290328|NCT01457950|450689774|FG000|Double-Blind Phase|Protocol Violation|2|||
125290329|NCT01457950|450689775|FG001|Double-Blind Phase|Protocol Violation|1|||
125290330|NCT01457950|450689776|FG002|Double-Blind Phase|Protocol Violation|0|||
125290331|NCT01457950|450689777|FG003|Double-Blind Phase|Protocol Violation|0|||
125290332|NCT01457950|450689774|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
125290333|NCT01457950|450689775|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
125290334|NCT01457950|450689776|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
125290335|NCT01457950|450689777|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
125290336|NCT01457950|450689774|FG000|Open-Label Phase|Adverse Event|0|||
125290337|NCT01457950|450689775|FG001|Open-Label Phase|Adverse Event|0|||
125290338|NCT01457950|450689776|FG002|Open-Label Phase|Adverse Event|0|||
125290339|NCT01457950|450689777|FG003|Open-Label Phase|Adverse Event|1|||
125290340|NCT01457950|450689774|FG000|Open-Label Phase|Protocol Violation|0|||
125290341|NCT01457950|450689775|FG001|Open-Label Phase|Protocol Violation|0|||
125290342|NCT01457950|450689776|FG002|Open-Label Phase|Protocol Violation|0|||
125290343|NCT01457950|450689777|FG003|Open-Label Phase|Protocol Violation|1|||
125290344|NCT01457950|450689774|FG000|Open-Label Phase|Withdrawal by Subject|0|||
125290345|NCT01457950|450689775|FG001|Open-Label Phase|Withdrawal by Subject|0|||
125290346|NCT01457950|450689776|FG002|Open-Label Phase|Withdrawal by Subject|2|||
125290347|NCT01457950|450689777|FG003|Open-Label Phase|Withdrawal by Subject|0|||
125290348|NCT00435162|450689778|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
124783640|NCT04270370|448838210|FG005|Overall Study|Lost to Follow-up|0|||
124783641|NCT04270370|448838211|FG006|Overall Study|Lost to Follow-up|0|||
124783642|NCT04270370|448838212|FG007|Overall Study|Lost to Follow-up|0|||
124783643|NCT04270370|448838213|FG008|Overall Study|Lost to Follow-up|1|||
124783644|NCT04270370|448838214|FG009|Overall Study|Lost to Follow-up|0|||
125290349|NCT00435162|450689779|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
125290350|NCT00435162|450689780|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
124783645|NCT04270370|448838215|FG010|Overall Study|Lost to Follow-up|0|||
124783646|NCT04270370|448838216|FG011|Overall Study|Lost to Follow-up|0|||
124783647|NCT00530504|448838219|FG000|Overall Study|Death|54|||
124783648|NCT00530504|448838219|FG000|Overall Study|Lost to Follow-up|26|||
125290351|NCT00435162|450689781|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
125290352|NCT00435162|450689782|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
125290353|NCT00435162|450689783|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
125290354|NCT01765426|450689786|FG000|Overall Study|Lost to Follow-up|0|||
125290355|NCT01765426|450689787|FG001|Overall Study|Lost to Follow-up|1|||
124783649|NCT00530504|448838219|FG000|Overall Study|Withdrawal by Subject|39|||
124783650|NCT00530504|448838219|FG000|Overall Study|Exited study due to other reasons|33|||
124783651|NCT02872285|448838222|FG000|Overall Study|Withdrawal by Subject|2|||
124783652|NCT02872285|448838223|FG001|Overall Study|Withdrawal by Subject|0|||
124783653|NCT02872285|448838222|FG000|Overall Study|Lost to Follow-up|2|||
124783654|NCT02872285|448838223|FG001|Overall Study|Lost to Follow-up|2|||
124783655|NCT02872285|448838222|FG000|Overall Study|Discontinued due to back surgery|1|||
124783656|NCT02872285|448838223|FG001|Overall Study|Discontinued due to back surgery|0|||
124783657|NCT05477108|448838224|FG000|Overall Study|Participants randomized, not treated|1|||
124783658|NCT05477108|448838225|FG001|Overall Study|Participants randomized, not treated|1|||
124783659|NCT05477108|448838226|FG002|Overall Study|Participants randomized, not treated|1|||
124783660|NCT05477108|448838224|FG000|Overall Study|Physician Decision|0|||
124783661|NCT05477108|448838225|FG001|Overall Study|Physician Decision|0|||
124783662|NCT05477108|448838226|FG002|Overall Study|Physician Decision|1|||
124783663|NCT05477108|448838224|FG000|Overall Study|withdrawn from study|0|||
124783664|NCT05477108|448838225|FG001|Overall Study|withdrawn from study|0|||
124783665|NCT05477108|448838226|FG002|Overall Study|withdrawn from study|1|||
124783666|NCT02660983|448838227|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
124783667|NCT02660983|448838228|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
124783668|NCT02660983|448838227|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
124783669|NCT02660983|448838228|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
124783670|NCT02660983|448838227|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
124783671|NCT02660983|448838228|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
124783672|NCT02660983|448838227|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
124783673|NCT02660983|448838228|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
124783674|NCT02660983|448838227|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
124783675|NCT02660983|448838228|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
124783676|NCT02660983|448838227|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
124783677|NCT02660983|448838228|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
124783678|NCT02660983|448838227|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
124783679|NCT02660983|448838228|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
124783680|NCT04303195|448838233|FG000|Overall Study|Adverse Event|1|||
124783681|NCT04303195|448838234|FG001|Overall Study|Adverse Event|3|||
124783682|NCT04303195|448838235|FG002|Overall Study|Adverse Event|7|||
124783683|NCT04303195|448838236|FG003|Overall Study|Adverse Event|0|||
124783684|NCT04303195|448838233|FG000|Overall Study|Lost to Follow-up|1|||
124783685|NCT04303195|448838234|FG001|Overall Study|Lost to Follow-up|0|||
124783686|NCT04303195|448838235|FG002|Overall Study|Lost to Follow-up|1|||
124783687|NCT04303195|448838236|FG003|Overall Study|Lost to Follow-up|4|||
124783688|NCT04303195|448838233|FG000|Overall Study|Withdrawal by Subject|3|||
124783689|NCT04303195|448838234|FG001|Overall Study|Withdrawal by Subject|1|||
124783690|NCT04303195|448838235|FG002|Overall Study|Withdrawal by Subject|1|||
124783691|NCT04303195|448838236|FG003|Overall Study|Withdrawal by Subject|1|||
124783692|NCT04303195|448838233|FG000|Overall Study|No study drug administered or protocol deviation|0|||
124783693|NCT04303195|448838234|FG001|Overall Study|No study drug administered or protocol deviation|2|||
124783694|NCT04303195|448838235|FG002|Overall Study|No study drug administered or protocol deviation|0|||
124783695|NCT04303195|448838236|FG003|Overall Study|No study drug administered or protocol deviation|2|||
124783696|NCT01065454|448838237|FG000|Treatment|Adverse Event|7|||
124783697|NCT01065454|448838238|FG001|Treatment|Adverse Event|4|||
124783698|NCT01065454|448838239|FG002|Treatment|Adverse Event|3|||
124783699|NCT01065454|448838240|FG003|Treatment|Adverse Event|6|||
124783700|NCT01065454|448838237|FG000|Treatment|Death|1|||
124783701|NCT01065454|448838238|FG001|Treatment|Death|0|||
124783702|NCT01065454|448838239|FG002|Treatment|Death|0|||
124783703|NCT01065454|448838240|FG003|Treatment|Death|0|||
124783704|NCT01065454|448838237|FG000|Treatment|Non-compliance|1|||
124783705|NCT01065454|448838238|FG001|Treatment|Non-compliance|0|||
124783706|NCT01065454|448838239|FG002|Treatment|Non-compliance|0|||
124783707|NCT01065454|448838240|FG003|Treatment|Non-compliance|1|||
124783708|NCT01065454|448838237|FG000|Treatment|Protocol Decision|0|||
124783709|NCT01065454|448838238|FG001|Treatment|Protocol Decision|0|||
124783710|NCT01065454|448838239|FG002|Treatment|Protocol Decision|3|||
124783711|NCT01065454|448838240|FG003|Treatment|Protocol Decision|2|||
124783712|NCT01065454|448838237|FG000|Treatment|Protocol Violation|1|||
125290356|NCT01765426|450689788|FG002|Overall Study|Lost to Follow-up|0|||
125290357|NCT01765426|450689789|FG003|Overall Study|Lost to Follow-up|0|||
124783713|NCT01065454|448838238|FG001|Treatment|Protocol Violation|0|||
124783714|NCT01065454|448838239|FG002|Treatment|Protocol Violation|1|||
124783715|NCT01065454|448838240|FG003|Treatment|Protocol Violation|0|||
124783716|NCT01065454|448838237|FG000|Treatment|Withdrawal by Subject|3|||
124783717|NCT01065454|448838238|FG001|Treatment|Withdrawal by Subject|1|||
124783718|NCT01065454|448838239|FG002|Treatment|Withdrawal by Subject|2|||
124783719|NCT01065454|448838240|FG003|Treatment|Withdrawal by Subject|3|||
124783720|NCT01065454|448838237|FG000|Follow up|Adverse Event|1|||
124783721|NCT01065454|448838238|FG001|Follow up|Adverse Event|0|||
124783722|NCT01065454|448838239|FG002|Follow up|Adverse Event|0|||
124783723|NCT01065454|448838240|FG003|Follow up|Adverse Event|1|||
124783724|NCT01065454|448838237|FG000|Follow up|Death|0|||
124783725|NCT01065454|448838238|FG001|Follow up|Death|1|||
124783726|NCT01065454|448838239|FG002|Follow up|Death|1|||
124783727|NCT01065454|448838240|FG003|Follow up|Death|0|||
124783728|NCT01065454|448838237|FG000|Follow up|Lost to Follow-up|0|||
124783729|NCT01065454|448838238|FG001|Follow up|Lost to Follow-up|0|||
124783730|NCT01065454|448838239|FG002|Follow up|Lost to Follow-up|0|||
124783731|NCT01065454|448838240|FG003|Follow up|Lost to Follow-up|1|||
124783732|NCT01065454|448838237|FG000|Follow up|Progressive disease|0|||
124783733|NCT01065454|448838238|FG001|Follow up|Progressive disease|0|||
124783734|NCT01065454|448838239|FG002|Follow up|Progressive disease|0|||
124783735|NCT01065454|448838240|FG003|Follow up|Progressive disease|1|||
124783736|NCT01065454|448838237|FG000|Follow up|Withdrawal by Subject|1|||
124783737|NCT01065454|448838238|FG001|Follow up|Withdrawal by Subject|1|||
124783738|NCT01065454|448838239|FG002|Follow up|Withdrawal by Subject|1|||
124783739|NCT01065454|448838240|FG003|Follow up|Withdrawal by Subject|0|||
124783740|NCT01065454|448838237|FG000|Follow up|study ongoing|37|||
124783741|NCT01065454|448838238|FG001|Follow up|study ongoing|22|||
124783742|NCT01065454|448838239|FG002|Follow up|study ongoing|15|||
124783743|NCT01065454|448838240|FG003|Follow up|study ongoing|41|||
124783744|NCT01601652|448838241|FG000|Overall Study|Death|1|||
124783745|NCT05688670|448838242|FG000|Overall Study|Change in surgery plan|1|||
124783746|NCT05688670|448838243|FG001|Overall Study|Change in surgery plan|4|||
124783747|NCT05688670|448838242|FG000|Overall Study|Inability to extubate|1|||
124783748|NCT05688670|448838243|FG001|Overall Study|Inability to extubate|2|||
124783749|NCT05688670|448838242|FG000|Overall Study|Day of surgery cancellation|0|||
124783750|NCT05688670|448838243|FG001|Overall Study|Day of surgery cancellation|1|||
124783751|NCT05688670|448838242|FG000|Overall Study|Reintubated on PCICU arrival|0|||
124783752|NCT05688670|448838243|FG001|Overall Study|Reintubated on PCICU arrival|1|||
124783753|NCT03425253|448838244|FG000|Overall Study|Adverse Event|2|||
124783754|NCT03425253|448838244|FG000|Overall Study|Lost to Follow-up|3|||
124783755|NCT03425253|448838244|FG000|Overall Study|Withdrew Consent|6|||
124783756|NCT03425253|448838244|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
124783757|NCT05009979|448838245|FG000|Overall Study|Withdrawal by Subject|1|||
124783758|NCT03844945|448839931|FG000|Overall Study|Adverse Event|1|||
124783759|NCT03844945|448839932|FG001|Overall Study|Adverse Event|1|||
124783760|NCT03844945|448839933|FG002|Overall Study|Adverse Event|4|||
124783761|NCT03844945|448839934|FG003|Overall Study|Adverse Event|0|||
124783762|NCT03844945|448839931|FG000|Overall Study|Withdrawal by Subject|0|||
124783763|NCT03844945|448839932|FG001|Overall Study|Withdrawal by Subject|0|||
124783764|NCT03844945|448839933|FG002|Overall Study|Withdrawal by Subject|1|||
124783765|NCT03844945|448839934|FG003|Overall Study|Withdrawal by Subject|0|||
124783766|NCT03844945|448839931|FG000|Overall Study|Lack of Efficacy|0|||
124783767|NCT03844945|448839932|FG001|Overall Study|Lack of Efficacy|0|||
124783768|NCT03844945|448839933|FG002|Overall Study|Lack of Efficacy|0|||
124783769|NCT03844945|448839934|FG003|Overall Study|Lack of Efficacy|1|||
124783770|NCT04129151|448839941|FG000|Overall Study|Adverse Event|1|||
124783771|NCT04129151|448839941|FG000|Overall Study|Disease Progression|7|||
125290358|NCT01510184|450689790|FG000|Overall Study|Sponsor discretion|28|||
125290359|NCT01510184|450689791|FG001|Overall Study|Sponsor discretion|28|||
125290360|NCT01510184|450689790|FG000|Overall Study|Death|1|||
125290361|NCT01510184|450689791|FG001|Overall Study|Death|2|||
125290362|NCT01510184|450689790|FG000|Overall Study|Withdrawal by Subject|1|||
125290363|NCT01510184|450689791|FG001|Overall Study|Withdrawal by Subject|4|||
125290364|NCT01510184|450689790|FG000|Overall Study|Other|0|||
125290365|NCT01510184|450689791|FG001|Overall Study|Other|1|||
125290366|NCT00694096|450689800|FG000|Overall Study|Withdrawal by Subject|5|||
125290367|NCT03351114|450689804|FG000|Overall Study|Withdrawal by Subject|1|||
125290368|NCT01665430|450689805|FG000|Overall Study|Adverse Event|1|||
125290369|NCT01665430|450689805|FG000|Overall Study|Withdrawal by Subject|6|||
125290370|NCT01665430|450689805|FG000|Overall Study|Other Unspecified|2|||
124783772|NCT04129151|448839941|FG000|Overall Study|Study closure|1|||
124783773|NCT02051933|448839942|FG000|Overall Study|Physician Decision|0|||
124783774|NCT02051933|448839943|FG001|Overall Study|Physician Decision|1|||
124783775|NCT00588861|448839947|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
124783776|NCT00588861|448839948|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
124783777|NCT00588861|448839947|FG000|6 Months|Patients did not return for follow-up|98|||
124783778|NCT00588861|448839948|FG001|6 Months|Patients did not return for follow-up|73|||
124783779|NCT00588861|448839947|FG000|1 Year|Patients did not return for follow-up|89|||
124783780|NCT00588861|448839948|FG001|1 Year|Patients did not return for follow-up|82|||
124783781|NCT00588861|448839947|FG000|2 Years|Patients did not return for follow-up|92|||
125290371|NCT02310230|450689806|FG000|Overall Study|Physician Decision|1|||
125290372|NCT02310230|450689807|FG001|Overall Study|Physician Decision|3|||
125290373|NCT02310230|450689806|FG000|Overall Study|monitor baseline taken after induction|2|||
125290374|NCT02310230|450689807|FG001|Overall Study|monitor baseline taken after induction|7|||
124783782|NCT00588861|448839948|FG001|2 Years|Patients did not return for follow-up|87|||
124783783|NCT00588861|448839947|FG000|4 Years|Patients did not return for follow-up|91|||
125290375|NCT02310230|450689806|FG000|Overall Study|Poor signal quality|5|||
125290376|NCT02310230|450689807|FG001|Overall Study|Poor signal quality|8|||
125290377|NCT02310230|450689806|FG000|Overall Study|Case cancelled|1|||
125290378|NCT02310230|450689807|FG001|Overall Study|Case cancelled|0|||
125290379|NCT01371643|450689808|FG000|Overall Study|Withdrawal by Subject|3|||
125290380|NCT01371643|450689809|FG001|Overall Study|Withdrawal by Subject|0|||
125290381|NCT03249935|450689810|FG000|Overall Study|Discharged from facility early|36|||
125290382|NCT03249935|450689810|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
125290383|NCT03249935|450689810|FG000|Overall Study|Protocol Violation|5|||
125290384|NCT01669421|450689815|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
125290385|NCT01669421|450689815|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
125290386|NCT01561755|450689820|FG000|Overall Study|Lost to Follow-up|0|||
125290387|NCT01561755|450689821|FG001|Overall Study|Lost to Follow-up|1|||
125290388|NCT01286987|450689824|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
125290389|NCT01286987|450689825|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
125290390|NCT01286987|450689826|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
125290391|NCT01286987|450689827|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
125290392|NCT01286987|450689828|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
125290393|NCT01286987|450689829|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
125290394|NCT01286987|450689830|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
125290395|NCT01286987|450689831|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
125290396|NCT01286987|450689832|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
125290397|NCT01286987|450689833|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
125290398|NCT01286987|450689834|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
125290399|NCT01286987|450689835|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
125290400|NCT01286987|450689836|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
125290401|NCT01286987|450689837|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
125290402|NCT01286987|450689838|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
125290403|NCT01286987|450689824|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
125290404|NCT01286987|450689825|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
125290405|NCT01286987|450689826|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
125290406|NCT01286987|450689827|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
125290407|NCT01286987|450689828|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
125290408|NCT01286987|450689829|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
125290409|NCT01286987|450689830|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
125290410|NCT01286987|450689831|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
125290411|NCT01286987|450689832|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
125290412|NCT01286987|450689833|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
125290413|NCT01286987|450689834|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
125290414|NCT01286987|450689835|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
125290415|NCT01286987|450689836|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
125290416|NCT01286987|450689837|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
125290417|NCT01286987|450689838|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
125290418|NCT01286987|450689824|FG000|Part 1: Dose Escalation|Physician Decision|0|||
125290419|NCT01286987|450689825|FG001|Part 1: Dose Escalation|Physician Decision|0|||
125290420|NCT01286987|450689826|FG002|Part 1: Dose Escalation|Physician Decision|0|||
125290421|NCT01286987|450689827|FG003|Part 1: Dose Escalation|Physician Decision|0|||
125290422|NCT01286987|450689828|FG004|Part 1: Dose Escalation|Physician Decision|1|||
125290423|NCT01286987|450689829|FG005|Part 1: Dose Escalation|Physician Decision|0|||
125290424|NCT01286987|450689830|FG006|Part 1: Dose Escalation|Physician Decision|0|||
125290425|NCT01286987|450689831|FG007|Part 1: Dose Escalation|Physician Decision|0|||
125290426|NCT01286987|450689832|FG008|Part 1: Dose Escalation|Physician Decision|0|||
125290427|NCT01286987|450689833|FG009|Part 1: Dose Escalation|Physician Decision|0|||
125290428|NCT01286987|450689834|FG010|Part 1: Dose Escalation|Physician Decision|0|||
125290429|NCT01286987|450689835|FG011|Part 1: Dose Escalation|Physician Decision|0|||
125290430|NCT01286987|450689836|FG012|Part 1: Dose Escalation|Physician Decision|0|||
124783784|NCT00588861|448839948|FG001|4 Years|Patients did not return for follow-up|103|||
124783785|NCT00588861|448839947|FG000|6 Years|Patients did not return for follow-up|104|||
124783786|NCT00588861|448839948|FG001|6 Years|Patients did not return for follow-up|109|||
124783787|NCT00588861|448839947|FG000|8 Years|Patients did not return for follow-up|105|||
124783788|NCT00588861|448839948|FG001|8 Years|Patients did not return for follow-up|114|||
124783789|NCT00588861|448839947|FG000|10 Years|Incomplete due to study termination|107|||
125290431|NCT01286987|450689837|FG013|Part 1: Dose Escalation|Physician Decision|0|||
125290432|NCT01286987|450689838|FG014|Part 1: Dose Escalation|Physician Decision|0|||
125290433|NCT01286987|450689824|FG000|Part 2: Dose Expansion|Death|0|||
125290434|NCT01286987|450689825|FG001|Part 2: Dose Expansion|Death|0|||
125290435|NCT01286987|450689826|FG002|Part 2: Dose Expansion|Death|0|||
125290436|NCT01286987|450689827|FG003|Part 2: Dose Expansion|Death|0|||
125290437|NCT01286987|450689828|FG004|Part 2: Dose Expansion|Death|0|||
125290438|NCT01286987|450689829|FG005|Part 2: Dose Expansion|Death|0|||
125290439|NCT01286987|450689830|FG006|Part 2: Dose Expansion|Death|0|||
125290440|NCT01286987|450689831|FG007|Part 2: Dose Expansion|Death|0|||
125290441|NCT01286987|450689832|FG008|Part 2: Dose Expansion|Death|0|||
125290442|NCT01286987|450689833|FG009|Part 2: Dose Expansion|Death|0|||
125290443|NCT01286987|450689834|FG010|Part 2: Dose Expansion|Death|0|||
125290444|NCT01286987|450689835|FG011|Part 2: Dose Expansion|Death|0|||
125290445|NCT01286987|450689836|FG012|Part 2: Dose Expansion|Death|1|||
125290446|NCT01286987|450689837|FG013|Part 2: Dose Expansion|Death|1|||
125290447|NCT01286987|450689838|FG014|Part 2: Dose Expansion|Death|0|||
125290448|NCT01286987|450689824|FG000|Part 2: Dose Expansion|Physician Decision|0|||
125290449|NCT01286987|450689825|FG001|Part 2: Dose Expansion|Physician Decision|0|||
125290450|NCT01286987|450689826|FG002|Part 2: Dose Expansion|Physician Decision|0|||
125290451|NCT01286987|450689827|FG003|Part 2: Dose Expansion|Physician Decision|0|||
125290452|NCT01286987|450689828|FG004|Part 2: Dose Expansion|Physician Decision|0|||
125290453|NCT01286987|450689829|FG005|Part 2: Dose Expansion|Physician Decision|0|||
125290454|NCT01286987|450689830|FG006|Part 2: Dose Expansion|Physician Decision|0|||
125290455|NCT01286987|450689831|FG007|Part 2: Dose Expansion|Physician Decision|0|||
125290456|NCT01286987|450689832|FG008|Part 2: Dose Expansion|Physician Decision|0|||
125290457|NCT01286987|450689833|FG009|Part 2: Dose Expansion|Physician Decision|0|||
125290458|NCT01286987|450689834|FG010|Part 2: Dose Expansion|Physician Decision|1|||
125290459|NCT01286987|450689835|FG011|Part 2: Dose Expansion|Physician Decision|1|||
125290460|NCT01286987|450689836|FG012|Part 2: Dose Expansion|Physician Decision|0|||
125290461|NCT01286987|450689837|FG013|Part 2: Dose Expansion|Physician Decision|1|||
125290462|NCT01286987|450689838|FG014|Part 2: Dose Expansion|Physician Decision|0|||
125290463|NCT01286987|450689824|FG000|Part 2: Dose Expansion|Other|0|||
125290464|NCT01286987|450689825|FG001|Part 2: Dose Expansion|Other|0|||
125290465|NCT01286987|450689826|FG002|Part 2: Dose Expansion|Other|0|||
125290466|NCT01286987|450689827|FG003|Part 2: Dose Expansion|Other|0|||
125290467|NCT01286987|450689828|FG004|Part 2: Dose Expansion|Other|0|||
125290468|NCT01286987|450689829|FG005|Part 2: Dose Expansion|Other|0|||
125290469|NCT01286987|450689830|FG006|Part 2: Dose Expansion|Other|0|||
125290470|NCT01286987|450689831|FG007|Part 2: Dose Expansion|Other|0|||
125290471|NCT01286987|450689832|FG008|Part 2: Dose Expansion|Other|0|||
125290472|NCT01286987|450689833|FG009|Part 2: Dose Expansion|Other|0|||
125290473|NCT01286987|450689834|FG010|Part 2: Dose Expansion|Other|0|||
125290474|NCT01286987|450689835|FG011|Part 2: Dose Expansion|Other|0|||
125290475|NCT01286987|450689836|FG012|Part 2: Dose Expansion|Other|0|||
125290476|NCT01286987|450689837|FG013|Part 2: Dose Expansion|Other|1|||
125290477|NCT01286987|450689838|FG014|Part 2: Dose Expansion|Other|0|||
125290478|NCT01286987|450689824|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
125290479|NCT01286987|450689825|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
125290480|NCT01286987|450689826|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
125290481|NCT01286987|450689827|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
125290482|NCT01286987|450689828|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
125290483|NCT01286987|450689829|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
125290484|NCT01286987|450689830|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
125290485|NCT01286987|450689831|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
125290486|NCT01286987|450689832|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
125290487|NCT01286987|450689833|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
125290488|NCT01286987|450689834|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
125290489|NCT01286987|450689835|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
125290490|NCT01286987|450689836|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
125290491|NCT01286987|450689837|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
125290492|NCT01286987|450689838|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
125290493|NCT01286987|450689824|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
125290494|NCT01286987|450689825|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
125290495|NCT01286987|450689826|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
125290496|NCT01286987|450689827|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
125290497|NCT01286987|450689828|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
125290498|NCT01286987|450689829|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
125290499|NCT01286987|450689830|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
125290500|NCT01286987|450689831|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
125290501|NCT01286987|450689832|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
125290502|NCT01286987|450689833|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
125290503|NCT01286987|450689834|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
125290504|NCT01286987|450689835|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
125290505|NCT01286987|450689836|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
125290506|NCT01286987|450689837|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
125290507|NCT01286987|450689838|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
125290508|NCT01286987|450689824|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290509|NCT01286987|450689825|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290510|NCT01286987|450689826|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290511|NCT01286987|450689827|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290512|NCT01286987|450689828|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290513|NCT01286987|450689829|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290514|NCT01286987|450689830|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124783790|NCT00588861|448839948|FG001|10 Years|Incomplete due to study termination|114|||
124783791|NCT02730195|448839949|FG000|Overall Study|Withdrawal by Subject|1|||
124783792|NCT00265148|448839950|FG000|Overall Study|Adverse Event|2|||
124783793|NCT00265148|448839951|FG001|Overall Study|Adverse Event|2|||
124783794|NCT00265148|448839950|FG000|Overall Study|Lack of Efficacy|0|||
124783795|NCT00265148|448839951|FG001|Overall Study|Lack of Efficacy|2|||
124783796|NCT00265148|448839950|FG000|Overall Study|Protocol Violation|3|||
124783797|NCT00265148|448839951|FG001|Overall Study|Protocol Violation|2|||
124783798|NCT00265148|448839950|FG000|Overall Study|Lost to Follow-up|0|||
124783799|NCT00265148|448839951|FG001|Overall Study|Lost to Follow-up|1|||
124783800|NCT00265148|448839950|FG000|Overall Study|Withdrawal by Subject|2|||
124783801|NCT00265148|448839951|FG001|Overall Study|Withdrawal by Subject|1|||
124783802|NCT00265148|448839950|FG000|Overall Study|Physician Decision|1|||
124783803|NCT00265148|448839951|FG001|Overall Study|Physician Decision|0|||
124783804|NCT00265148|448839950|FG000|Overall Study|Increasing frailty|0|||
124783805|NCT00265148|448839951|FG001|Overall Study|Increasing frailty|1|||
124783806|NCT00265148|448839950|FG000|Overall Study|Subject chose to change of the dose|1|||
124783807|NCT00265148|448839951|FG001|Overall Study|Subject chose to change of the dose|0|||
124783808|NCT00942994|448839956|FG000|Overall Study|Adverse Event|7|||
124783809|NCT00942994|448839957|FG001|Overall Study|Adverse Event|4|||
124783810|NCT00942994|448839956|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124783811|NCT00942994|448839957|FG001|Overall Study|Abnormal laboratory value(s)|0|||
124783812|NCT00942994|448839956|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124783813|NCT00942994|448839957|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
124783814|NCT00942994|448839956|FG000|Overall Study|Patient withdrew consent|5|||
124783815|NCT00942994|448839957|FG001|Overall Study|Patient withdrew consent|8|||
124783816|NCT00942994|448839956|FG000|Overall Study|Lost to Follow-up|1|||
124783817|NCT00942994|448839957|FG001|Overall Study|Lost to Follow-up|4|||
124783818|NCT00942994|448839956|FG000|Overall Study|Protocol deviation|1|||
124783819|NCT00942994|448839957|FG001|Overall Study|Protocol deviation|2|||
124783820|NCT01874340|448839960|FG000|Overall Study|Study terminated by Sponsor|6|||
124783821|NCT01874340|448839961|FG001|Overall Study|Study terminated by Sponsor|8|||
124783822|NCT01874340|448839962|FG002|Overall Study|Study terminated by Sponsor|8|||
124783823|NCT01874340|448839963|FG003|Overall Study|Study terminated by Sponsor|4|||
124783824|NCT01874340|448839960|FG000|Overall Study|Withdrawal by Subject|0|||
124783825|NCT01874340|448839961|FG001|Overall Study|Withdrawal by Subject|0|||
124783826|NCT01874340|448839962|FG002|Overall Study|Withdrawal by Subject|0|||
124783827|NCT01874340|448839963|FG003|Overall Study|Withdrawal by Subject|1|||
124783828|NCT01311024|448839971|FG000|Overall Study|Protocol Violation|35|||
124783829|NCT01311024|448839972|FG001|Overall Study|Protocol Violation|22|||
124783830|NCT01523275|448839975|FG000|Overall Study|Lost to Follow-up|1|||
124783831|NCT01523275|448839976|FG001|Overall Study|Lost to Follow-up|2|||
124783832|NCT01523275|448839975|FG000|Overall Study|Withdrawal by Subject|1|||
124783833|NCT01523275|448839976|FG001|Overall Study|Withdrawal by Subject|0|||
124783834|NCT01206322|448839977|FG000|Overall Study|Adverse Event|0|||
124783835|NCT01206322|448839978|FG001|Overall Study|Adverse Event|0|||
124783836|NCT01206322|448839979|FG002|Overall Study|Adverse Event|0|||
124783837|NCT01206322|448839980|FG003|Overall Study|Adverse Event|1|||
124783838|NCT00689117|448839981|FG000|Overall Study|Adverse Event|6|||
124783839|NCT00689117|448839982|FG001|Overall Study|Adverse Event|0|||
125198415|NCT02829723|450348071|FG003|Overall Study|Subject/guardian decision|1|||
125198416|NCT02829723|450348072|FG004|Overall Study|Subject/guardian decision|0|||
124783840|NCT00689117|448839983|FG002|Overall Study|Adverse Event|5|||
124783841|NCT00689117|448839984|FG003|Overall Study|Adverse Event|0|||
125198417|NCT02829723|450348073|FG005|Overall Study|Subject/guardian decision|0|||
125198418|NCT02829723|450348074|FG006|Overall Study|Subject/guardian decision|0|||
125198419|NCT02829723|450348075|FG007|Overall Study|Subject/guardian decision|1|||
124783842|NCT00689117|448839981|FG000|Overall Study|Lost to Follow-up|26|||
124783843|NCT00689117|448839982|FG001|Overall Study|Lost to Follow-up|19|||
124783844|NCT00689117|448839983|FG002|Overall Study|Lost to Follow-up|17|||
124783845|NCT00689117|448839984|FG003|Overall Study|Lost to Follow-up|11|||
124783846|NCT00689117|448839981|FG000|Overall Study|Lack of Efficacy|1|||
124783847|NCT00689117|448839982|FG001|Overall Study|Lack of Efficacy|2|||
124783848|NCT00689117|448839983|FG002|Overall Study|Lack of Efficacy|2|||
125198420|NCT02829723|450348076|FG008|Overall Study|Subject/guardian decision|0|||
125198421|NCT02829723|450348077|FG009|Overall Study|Subject/guardian decision|0|||
125198422|NCT02829723|450348078|FG010|Overall Study|Subject/guardian decision|0|||
125198423|NCT02829723|450348079|FG011|Overall Study|Subject/guardian decision|0|||
125198424|NCT02829723|450348080|FG012|Overall Study|Subject/guardian decision|0|||
125198425|NCT02829723|450348081|FG013|Overall Study|Subject/guardian decision|0|||
125198426|NCT02829723|450348082|FG014|Overall Study|Subject/guardian decision|1|||
125198427|NCT02829723|450348083|FG015|Overall Study|Subject/guardian decision|0|||
125198428|NCT02829723|450348084|FG016|Overall Study|Subject/guardian decision|1|||
125198429|NCT02829723|450348085|FG017|Overall Study|Subject/guardian decision|0|||
125198430|NCT02829723|450348086|FG018|Overall Study|Subject/guardian decision|1|||
125198431|NCT02829723|450348087|FG019|Overall Study|Subject/guardian decision|0|||
125198432|NCT02829723|450348088|FG020|Overall Study|Subject/guardian decision|1|||
124783849|NCT00689117|448839984|FG003|Overall Study|Lack of Efficacy|2|||
124783850|NCT00689117|448839981|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
124783851|NCT00689117|448839982|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
124783852|NCT00689117|448839983|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
124783853|NCT00689117|448839984|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
124783854|NCT00689117|448839981|FG000|Overall Study|Withdrawal by Subject|19|||
124783855|NCT00689117|448839982|FG001|Overall Study|Withdrawal by Subject|18|||
124783856|NCT00689117|448839983|FG002|Overall Study|Withdrawal by Subject|26|||
124783857|NCT00689117|448839984|FG003|Overall Study|Withdrawal by Subject|13|||
124783858|NCT00689117|448839981|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
124783859|NCT00689117|448839982|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
124783860|NCT00689117|448839983|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
124783861|NCT00689117|448839984|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
124783862|NCT00689117|448839981|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
124783863|NCT00689117|448839982|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
124783864|NCT00689117|448839983|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124783865|NCT00689117|448839984|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124783866|NCT00689117|448839981|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
124783867|NCT00689117|448839982|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
124783868|NCT00689117|448839983|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
124783869|NCT00689117|448839984|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
124783870|NCT00689117|448839981|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
124783871|NCT00689117|448839982|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
124783872|NCT00689117|448839983|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
124783873|NCT00689117|448839984|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
124783874|NCT00689117|448839981|FG000|Overall Study|Use of Prohibitive Medication|2|||
124783875|NCT00689117|448839982|FG001|Overall Study|Use of Prohibitive Medication|1|||
125198433|NCT02829723|450348089|FG021|Overall Study|Subject/guardian decision|0|||
125198434|NCT02829723|450348090|FG022|Overall Study|Subject/guardian decision|0|||
125198435|NCT02829723|450348091|FG023|Overall Study|Subject/guardian decision|1|||
125198436|NCT02829723|450348092|FG024|Overall Study|Subject/guardian decision|0|||
125198437|NCT02829723|450348093|FG025|Overall Study|Subject/guardian decision|1|||
125198438|NCT02829723|450348094|FG026|Overall Study|Subject/guardian decision|1|||
125198439|NCT02829723|450348068|FG000|Overall Study|Study terminated by sponsor|0|||
125198440|NCT02829723|450348069|FG001|Overall Study|Study terminated by sponsor|0|||
125198441|NCT02829723|450348070|FG002|Overall Study|Study terminated by sponsor|0|||
125198442|NCT02829723|450348071|FG003|Overall Study|Study terminated by sponsor|0|||
125198443|NCT02829723|450348072|FG004|Overall Study|Study terminated by sponsor|0|||
125198444|NCT02829723|450348073|FG005|Overall Study|Study terminated by sponsor|0|||
125198445|NCT02829723|450348074|FG006|Overall Study|Study terminated by sponsor|0|||
125198446|NCT02829723|450348075|FG007|Overall Study|Study terminated by sponsor|0|||
125198447|NCT02829723|450348076|FG008|Overall Study|Study terminated by sponsor|0|||
125198448|NCT02829723|450348077|FG009|Overall Study|Study terminated by sponsor|0|||
125198449|NCT02829723|450348078|FG010|Overall Study|Study terminated by sponsor|0|||
125198450|NCT02829723|450348079|FG011|Overall Study|Study terminated by sponsor|0|||
125198451|NCT02829723|450348080|FG012|Overall Study|Study terminated by sponsor|0|||
125198452|NCT02829723|450348081|FG013|Overall Study|Study terminated by sponsor|0|||
125198453|NCT02829723|450348082|FG014|Overall Study|Study terminated by sponsor|0|||
125198454|NCT02829723|450348083|FG015|Overall Study|Study terminated by sponsor|0|||
125198455|NCT02829723|450348084|FG016|Overall Study|Study terminated by sponsor|0|||
125198456|NCT02829723|450348085|FG017|Overall Study|Study terminated by sponsor|0|||
125198457|NCT02829723|450348086|FG018|Overall Study|Study terminated by sponsor|0|||
125198458|NCT02829723|450348087|FG019|Overall Study|Study terminated by sponsor|0|||
125198459|NCT02829723|450348088|FG020|Overall Study|Study terminated by sponsor|0|||
125198460|NCT02829723|450348089|FG021|Overall Study|Study terminated by sponsor|1|||
125198461|NCT02829723|450348090|FG022|Overall Study|Study terminated by sponsor|0|||
125198462|NCT02829723|450348091|FG023|Overall Study|Study terminated by sponsor|0|||
125198463|NCT02829723|450348092|FG024|Overall Study|Study terminated by sponsor|0|||
125198464|NCT02829723|450348093|FG025|Overall Study|Study terminated by sponsor|0|||
124783876|NCT00689117|448839983|FG002|Overall Study|Use of Prohibitive Medication|3|||
125198465|NCT02829723|450348094|FG026|Overall Study|Study terminated by sponsor|0|||
125198466|NCT02989649|450348095|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
125198467|NCT02989649|450348095|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
125198468|NCT02989649|450348095|FG000|Overall Study|Lost For Observation During Study|3|||
125198469|NCT02989649|450348095|FG000|Overall Study|Reason Not Specified|13|||
125198470|NCT00330343|450348096|FG000|Overall Study|Lost to Follow-up|5|||
124783877|NCT00689117|448839984|FG003|Overall Study|Use of Prohibitive Medication|0|||
124783878|NCT00689117|448839981|FG000|Overall Study|Pregnancy|0|||
124783879|NCT00689117|448839982|FG001|Overall Study|Pregnancy|2|||
125198471|NCT00281632|450348097|FG000|Overall Study|Adverse Event|7|||
125198472|NCT00281632|450348097|FG000|Overall Study|Withdrawal by Subject|2|||
125198473|NCT00281632|450348097|FG000|Overall Study|Disease Progression|22|||
125198474|NCT00281632|450348097|FG000|Overall Study|Death|1|||
125198475|NCT00281632|450348097|FG000|Overall Study|Physician Decision|1|||
125198476|NCT00281632|450348097|FG000|Overall Study|Ongoing|3|||
125198477|NCT03614078|450348098|FG000|Overall Study|Withdrawal by Subject|2|||
125198478|NCT03614078|450348099|FG001|Overall Study|Withdrawal by Subject|2|||
125198479|NCT03614078|450348100|FG002|Overall Study|Withdrawal by Subject|3|||
125198480|NCT03614078|450348098|FG000|Overall Study|Participant Did Not Return for Visit|0|||
125198481|NCT03614078|450348099|FG001|Overall Study|Participant Did Not Return for Visit|1|||
125198482|NCT03614078|450348100|FG002|Overall Study|Participant Did Not Return for Visit|0|||
125198483|NCT03614078|450348098|FG000|Overall Study|High Neutrophils|0|||
125198484|NCT03614078|450348099|FG001|Overall Study|High Neutrophils|0|||
125198485|NCT03614078|450348100|FG002|Overall Study|High Neutrophils|2|||
125198486|NCT03614078|450348098|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
125198487|NCT03614078|450348099|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
125198488|NCT03614078|450348100|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
125198489|NCT03614078|450348098|FG000|Overall Study|Exacerbation of Psoriasis|0|||
125198490|NCT03614078|450348099|FG001|Overall Study|Exacerbation of Psoriasis|1|||
125198491|NCT03614078|450348100|FG002|Overall Study|Exacerbation of Psoriasis|0|||
125198492|NCT03614078|450348098|FG000|Overall Study|Adverse Event|0|||
125198493|NCT03614078|450348099|FG001|Overall Study|Adverse Event|2|||
125198494|NCT03614078|450348100|FG002|Overall Study|Adverse Event|0|||
125198495|NCT03614078|450348098|FG000|Overall Study|Dizziness and Rash|0|||
125198496|NCT03614078|450348099|FG001|Overall Study|Dizziness and Rash|1|||
125198497|NCT03614078|450348100|FG002|Overall Study|Dizziness and Rash|0|||
125198498|NCT02691936|450348102|FG000|Overall Study|Withdrawal by Subject|2|||
125198499|NCT02691936|450348103|FG001|Overall Study|Withdrawal by Subject|5|||
125198500|NCT03382834|450348105|FG000|Step 1|Lost to Follow-up|0|||
125198501|NCT03382834|450348106|FG001|Step 1|Lost to Follow-up|1|||
125198502|NCT03382834|450348105|FG000|Step 2|Death|1|||
125198503|NCT03382834|450348106|FG001|Step 2|Death|0|||
125198504|NCT03382834|450348105|FG000|Step 2|Lost to Follow-up|2|||
125198505|NCT03382834|450348106|FG001|Step 2|Lost to Follow-up|2|||
125198506|NCT03382834|450348105|FG000|Step 2|Site Terminated by Sponsor|1|||
125198507|NCT03382834|450348106|FG001|Step 2|Site Terminated by Sponsor|0|||
125198508|NCT02387957|450348107|FG000|Overall Study|The study was discontinued|21|||
125198509|NCT02387957|450348108|FG001|Overall Study|The study was discontinued|21|||
125198510|NCT02387957|450348109|FG002|Overall Study|The study was discontinued|20|||
125198511|NCT00977314|450348116|FG000|Overall Study|Withdrawal by Subject|1|||
125198512|NCT00977314|450348117|FG001|Overall Study|Withdrawal by Subject|0|||
125198513|NCT00977314|450348116|FG000|Overall Study|Physician Decision|1|||
125198514|NCT00977314|450348117|FG001|Overall Study|Physician Decision|0|||
125198515|NCT01343277|450348121|FG000|Overall Study|Other|3|||
125198516|NCT01343277|450348122|FG001|Overall Study|Other|3|||
125198517|NCT01343277|450348121|FG000|Overall Study|Withdrawal by Subject|18|||
125198518|NCT01343277|450348122|FG001|Overall Study|Withdrawal by Subject|13|||
125198519|NCT01343277|450348121|FG000|Overall Study|Physician Decision|1|||
125290515|NCT01286987|450689831|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290516|NCT01286987|450689832|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290517|NCT01286987|450689833|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290518|NCT01286987|450689834|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
125290519|NCT01286987|450689835|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290520|NCT01286987|450689836|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290521|NCT01286987|450689837|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290522|NCT01286987|450689838|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290523|NCT04662073|450689839|FG000|Overall Study|Withdrawal by Subject|1|||
125290524|NCT04662073|450689840|FG001|Overall Study|Withdrawal by Subject|0|||
125290525|NCT01479595|450689847|FG000|Overall Study|Protocol deviation|0|||
125290526|NCT01479595|450689848|FG001|Overall Study|Protocol deviation|1|||
125290527|NCT01479595|450689847|FG000|Overall Study|Adverse Event|2|||
125290528|NCT01479595|450689848|FG001|Overall Study|Adverse Event|1|||
125290529|NCT02255565|450689850|FG000|Overall Study|Withdrawal by Subject|0|||
125290530|NCT02255565|450689851|FG001|Overall Study|Withdrawal by Subject|1|||
125290531|NCT02255565|450689852|FG002|Overall Study|Withdrawal by Subject|0|||
125290532|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
125290533|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
125290534|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
125290535|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
125290536|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
125290537|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
125290538|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
125290539|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
125290540|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
125290541|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
125290542|NCT03906656|450689856|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
125290543|NCT03906656|450689857|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
125198520|NCT01343277|450348122|FG001|Overall Study|Physician Decision|2|||
125290544|NCT03906656|450689856|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
125290545|NCT03906656|450689857|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
125290546|NCT03906656|450689856|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
125290547|NCT03906656|450689857|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
125290548|NCT03906656|450689856|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
125290549|NCT03906656|450689857|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
125290550|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
125290551|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
125290552|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
125290553|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
125290554|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
125290555|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
125290556|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
125290557|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
125290558|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
125290559|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
125290560|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
125290561|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
125290562|NCT03906656|450689856|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
125290563|NCT03906656|450689857|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
125290564|NCT03906656|450689856|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
125290565|NCT03906656|450689857|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
125290566|NCT03906656|450689856|FG000|Home Use 2 (3 Months)|Death|2|||
125290567|NCT03906656|450689857|FG001|Home Use 2 (3 Months)|Death|0|||
125290568|NCT03906656|450689856|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
125290569|NCT03906656|450689857|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
125290570|NCT03906656|450689856|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
125290571|NCT03906656|450689857|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
125290572|NCT00343915|450689858|FG000|Primary Study|Withdrawal by Subject|1|||
125290573|NCT00343915|450689859|FG001|Primary Study|Withdrawal by Subject|0|||
125290574|NCT00343915|450689858|FG000|Primary Study|Lost to Follow-up|2|||
125290575|NCT00343915|450689859|FG001|Primary Study|Lost to Follow-up|3|||
125290576|NCT00343915|450689858|FG000|Primary Study|Other|1|||
125290577|NCT00343915|450689859|FG001|Primary Study|Other|0|||
125290578|NCT00882908|450689860|FG000|Overall Study|Adverse Event|0|||
125290579|NCT00882908|450689861|FG001|Overall Study|Adverse Event|0|||
125290580|NCT00882908|450689862|FG002|Overall Study|Adverse Event|1|||
125290581|NCT00882908|450689863|FG003|Overall Study|Adverse Event|0|||
125290582|NCT00882908|450689864|FG004|Overall Study|Adverse Event|1|||
125290583|NCT00882908|450689860|FG000|Overall Study|Lost to Follow-up|3|||
125290584|NCT00882908|450689861|FG001|Overall Study|Lost to Follow-up|5|||
125290585|NCT00882908|450689862|FG002|Overall Study|Lost to Follow-up|3|||
125290586|NCT00882908|450689863|FG003|Overall Study|Lost to Follow-up|1|||
125290587|NCT00882908|450689864|FG004|Overall Study|Lost to Follow-up|2|||
125290588|NCT00882908|450689860|FG000|Overall Study|Protocol Violation|0|||
125290589|NCT00882908|450689861|FG001|Overall Study|Protocol Violation|1|||
125290590|NCT00882908|450689862|FG002|Overall Study|Protocol Violation|0|||
125290591|NCT00882908|450689863|FG003|Overall Study|Protocol Violation|0|||
125290592|NCT00882908|450689864|FG004|Overall Study|Protocol Violation|0|||
125290593|NCT00882908|450689860|FG000|Overall Study|Withdrawal by Subject|0|||
125290594|NCT00882908|450689861|FG001|Overall Study|Withdrawal by Subject|0|||
125290595|NCT00882908|450689862|FG002|Overall Study|Withdrawal by Subject|3|||
125290596|NCT00882908|450689863|FG003|Overall Study|Withdrawal by Subject|5|||
125290597|NCT00882908|450689864|FG004|Overall Study|Withdrawal by Subject|2|||
125290598|NCT00882908|450689860|FG000|Overall Study|Subject reached a virologic endpoint|0|||
125290599|NCT00882908|450689861|FG001|Overall Study|Subject reached a virologic endpoint|0|||
125290600|NCT00882908|450689862|FG002|Overall Study|Subject reached a virologic endpoint|0|||
125290601|NCT00882908|450689863|FG003|Overall Study|Subject reached a virologic endpoint|0|||
124783880|NCT00689117|448839983|FG002|Overall Study|Pregnancy|0|||
124783881|NCT00689117|448839984|FG003|Overall Study|Pregnancy|2|||
125290602|NCT00882908|450689864|FG004|Overall Study|Subject reached a virologic endpoint|1|||
125290603|NCT00882908|450689860|FG000|Overall Study|Study terminated in error|0|||
125290604|NCT00882908|450689861|FG001|Overall Study|Study terminated in error|0|||
125290605|NCT00882908|450689862|FG002|Overall Study|Study terminated in error|0|||
125198521|NCT01343277|450348121|FG000|Overall Study|Death|10|||
125198522|NCT01343277|450348122|FG001|Overall Study|Death|1|||
125198523|NCT01343277|450348121|FG000|Overall Study|Adverse Event|67|||
125198524|NCT01343277|450348122|FG001|Overall Study|Adverse Event|13|||
125198525|NCT01343277|450348121|FG000|Overall Study|Disease progression|270|||
125198526|NCT01343277|450348122|FG001|Overall Study|Disease progression|138|||
125198527|NCT01343277|450348121|FG000|Overall Study|Randomized not treated|6|||
125198528|NCT01343277|450348122|FG001|Overall Study|Randomized not treated|21|||
125198529|NCT01343277|450348121|FG000|Overall Study|Treatment ongoing|8|||
125198530|NCT01343277|450348122|FG001|Overall Study|Treatment ongoing|2|||
125198531|NCT01343277|450348121|FG000|Overall Study|Subsequent anticancer therapy|1|||
125198532|NCT01343277|450348122|FG001|Overall Study|Subsequent anticancer therapy|0|||
125198533|NCT01582178|450348130|FG000|Overall Study|Physician Decision|6|||
125198534|NCT01582178|450348131|FG001|Overall Study|Physician Decision|5|||
125198535|NCT03852628|450348132|FG000|Overall Study|Lost to Follow-up|7|||
125198536|NCT03852628|450348133|FG001|Overall Study|Lost to Follow-up|6|||
125198537|NCT03852628|450348132|FG000|Overall Study|Lack of Efficacy|6|||
125198538|NCT03852628|450348133|FG001|Overall Study|Lack of Efficacy|6|||
125198539|NCT02964208|450348134|FG000|Overall Study|Death|103|||
125198540|NCT02964208|450348134|FG000|Overall Study|Withdrawal by Subject|6|||
125198541|NCT02964208|450348134|FG000|Overall Study|Lost to Follow-up|6|||
125198542|NCT02964208|450348134|FG000|Overall Study|Unsuccessful Procedure|5|||
125198543|NCT02964208|450348134|FG000|Overall Study|Device Explant|1|||
125198544|NCT02964208|450348134|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
125198545|NCT00556933|450348138|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
125198546|NCT00556933|450348139|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
125198547|NCT00556933|450348140|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
125198548|NCT00556933|450348141|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
125198549|NCT00556933|450348138|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
125198550|NCT00556933|450348139|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
125198551|NCT00556933|450348140|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
125198552|NCT00556933|450348141|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
125198553|NCT00556933|450348138|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
125198554|NCT00556933|450348139|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
125198555|NCT00556933|450348140|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
125198556|NCT00556933|450348141|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
125198557|NCT00556933|450348138|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
125198558|NCT00556933|450348139|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
125198559|NCT00556933|450348140|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
125198560|NCT00556933|450348141|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
125198561|NCT00556933|450348138|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
125198562|NCT00556933|450348139|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
125290606|NCT00882908|450689863|FG003|Overall Study|Study terminated in error|1|||
125290607|NCT00882908|450689864|FG004|Overall Study|Study terminated in error|0|||
125290608|NCT05291936|450689865|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
125290609|NCT05291936|450689866|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
125290610|NCT05291936|450689865|FG000|Period 1|Withdrew Consent during study|1|||
125290611|NCT05291936|450689866|FG001|Period 1|Withdrew Consent during study|0|||
125290612|NCT05291936|450689865|FG000|Period 2|Adverse Event|0|||
125290613|NCT05291936|450689866|FG001|Period 2|Adverse Event|1|||
125290614|NCT05291936|450689865|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
125290615|NCT05291936|450689866|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
125290616|NCT02370095|450689867|FG000|Overall Study|Withdrawal by Subject|0|||
125290617|NCT02370095|450689868|FG001|Overall Study|Withdrawal by Subject|1|||
125290618|NCT01667562|450689872|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
125290619|NCT01667562|450689873|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
125290620|NCT01667562|450689872|FG000|Erlotinib Phase|Lost to Follow-up|0|||
125290621|NCT01667562|450689873|FG001|Erlotinib Phase|Lost to Follow-up|1|||
125290622|NCT01667562|450689872|FG000|Erlotinib Phase|Adverse Event|0|||
125290623|NCT01667562|450689873|FG001|Erlotinib Phase|Adverse Event|1|||
125290624|NCT01667562|450689872|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
125290625|NCT01667562|450689873|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
125290626|NCT02130986|450689874|FG000|Overall Study|Withdrawal by Subject|4|||
125290627|NCT02130986|450689875|FG001|Overall Study|Withdrawal by Subject|4|||
125290628|NCT02130986|450689874|FG000|Overall Study|Lost to Follow-up|151|||
125290629|NCT02130986|450689875|FG001|Overall Study|Lost to Follow-up|160|||
125290630|NCT01129882|450689876|FG000|Overall Study|Adverse Event|39|||
125290631|NCT01129882|450689876|FG000|Overall Study|Death|6|||
125198563|NCT00556933|450348140|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
125198564|NCT00556933|450348141|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
125198565|NCT00556933|450348138|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
125198566|NCT00556933|450348139|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
125198567|NCT00556933|450348140|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
125198568|NCT00556933|450348141|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
125198569|NCT00556933|450348138|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
125198570|NCT00556933|450348139|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
125198571|NCT00556933|450348140|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
125198572|NCT00556933|450348141|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
125198573|NCT00556933|450348138|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
125198574|NCT00556933|450348139|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
125198575|NCT00556933|450348140|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
125290632|NCT01129882|450689876|FG000|Overall Study|Lack of Efficacy|5|||
125290633|NCT01129882|450689876|FG000|Overall Study|Lost to Follow-up|13|||
125290634|NCT01129882|450689876|FG000|Overall Study|Physician Decision|27|||
125290635|NCT01129882|450689876|FG000|Overall Study|Protocol Deviation|3|||
125290636|NCT01129882|450689876|FG000|Overall Study|Withdrawal Criteria Met|19|||
125290637|NCT01129882|450689876|FG000|Overall Study|Trial Termination by Sponsor|6|||
125290638|NCT01129882|450689876|FG000|Overall Study|Withdrawal by Subject|160|||
125290639|NCT00993499|450689880|FG000|Run-in Period (8 Days)|Adverse Event|0|||
125290640|NCT00993499|450689881|FG001|Run-in Period (8 Days)|Adverse Event|1|||
125290641|NCT00993499|450689882|FG002|Run-in Period (8 Days)|Adverse Event|0|||
125290642|NCT00993499|450689883|FG003|Run-in Period (8 Days)|Adverse Event|0|||
125290643|NCT00993499|450689884|FG004|Run-in Period (8 Days)|Adverse Event|0|||
125290644|NCT00993499|450689885|FG005|Run-in Period (8 Days)|Adverse Event|0|||
125290645|NCT00993499|450689880|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
125290646|NCT00993499|450689881|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
125290647|NCT00993499|450689882|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
125290648|NCT00993499|450689883|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
125290649|NCT00993499|450689884|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
125290650|NCT00993499|450689885|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
125290651|NCT00993499|450689880|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
125290652|NCT00993499|450689881|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
125290653|NCT00993499|450689882|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
125290654|NCT00993499|450689883|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
125290655|NCT00993499|450689884|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
125290656|NCT00993499|450689885|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
125290657|NCT00993499|450689880|FG000|Run-in Period (8 Days)|Progressive disease|0|||
125290658|NCT00993499|450689881|FG001|Run-in Period (8 Days)|Progressive disease|1|||
125290659|NCT00993499|450689882|FG002|Run-in Period (8 Days)|Progressive disease|1|||
125290660|NCT00993499|450689883|FG003|Run-in Period (8 Days)|Progressive disease|0|||
125290661|NCT00993499|450689884|FG004|Run-in Period (8 Days)|Progressive disease|0|||
125290662|NCT00993499|450689885|FG005|Run-in Period (8 Days)|Progressive disease|0|||
125290663|NCT00993499|450689880|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
125290664|NCT00993499|450689881|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
125290665|NCT00993499|450689882|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
125290666|NCT00993499|450689883|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
125290667|NCT00993499|450689884|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
125290668|NCT00993499|450689885|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
125290669|NCT00993499|450689880|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
125290670|NCT00993499|450689881|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
125290671|NCT00993499|450689882|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
125290672|NCT00993499|450689883|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
125290673|NCT00993499|450689884|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
125198576|NCT00556933|450348141|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
125198577|NCT00556933|450348138|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
125198578|NCT00556933|450348139|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
125198579|NCT00556933|450348140|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
125198580|NCT00556933|450348141|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
125198581|NCT00556933|450348138|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
125198582|NCT00556933|450348139|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
125198583|NCT00556933|450348140|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
125198584|NCT00556933|450348141|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
125198585|NCT00556933|450348138|FG000|CNI Withdrawal vs. Minimization|Death|0|||
125198586|NCT00556933|450348139|FG001|CNI Withdrawal vs. Minimization|Death|0|||
125198587|NCT00556933|450348140|FG002|CNI Withdrawal vs. Minimization|Death|0|||
125198588|NCT00556933|450348141|FG003|CNI Withdrawal vs. Minimization|Death|1|||
125198589|NCT01743560|450348142|FG000|Overall Study|Disease progression|26|||
125198590|NCT01743560|450348142|FG000|Overall Study|Adverse Event|8|||
125198591|NCT01743560|450348142|FG000|Overall Study|Death|3|||
125198592|NCT01743560|450348142|FG000|Overall Study|Withdrawal by Subject|2|||
125198593|NCT01743560|450348142|FG000|Overall Study|Protocol Violation|1|||
125198594|NCT01743560|450348142|FG000|Overall Study|>1 dose of study drug|3|||
125198595|NCT02640677|450348147|FG000|Overall Study|Lost to Follow-up|1|||
125198596|NCT02640677|450348147|FG000|Overall Study|Withdrawal by Subject|1|||
125198597|NCT04553471|450348148|FG000|Overall Study|Did not start treatment on protocol|3|||
125198598|NCT04553471|450348148|FG000|Overall Study|Death|1|||
125198599|NCT00940823|450348149|FG000|Overall Study|Death|8|||
125198600|NCT00940823|450348150|FG001|Overall Study|Death|12|||
125198601|NCT00940823|450348149|FG000|Overall Study|Lost to Follow-up|27|||
125198602|NCT00940823|450348150|FG001|Overall Study|Lost to Follow-up|20|||
125290674|NCT00993499|450689885|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
125290675|NCT00993499|450689880|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
125290676|NCT00993499|450689881|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
125290677|NCT00993499|450689882|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
125290678|NCT00993499|450689883|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
125290679|NCT00993499|450689884|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
125290680|NCT00993499|450689885|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
125290681|NCT00993499|450689880|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
125290682|NCT00993499|450689881|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
125290683|NCT00993499|450689882|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
125290684|NCT00993499|450689883|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
125290685|NCT00993499|450689884|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
125290686|NCT00993499|450689885|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
125290687|NCT00993499|450689880|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
125290688|NCT00993499|450689881|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
125290689|NCT00993499|450689882|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
125290690|NCT00993499|450689883|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
125290691|NCT00993499|450689884|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
125290692|NCT00993499|450689885|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
125290693|NCT00993499|450689880|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
125290694|NCT00993499|450689881|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
125290695|NCT00993499|450689882|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
125290696|NCT00993499|450689883|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
125290697|NCT00993499|450689884|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
125290698|NCT00993499|450689885|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
125290699|NCT00993499|450689880|FG000|Discontinued After Starting Course 3|DLT|1|||
125290700|NCT00993499|450689881|FG001|Discontinued After Starting Course 3|DLT|0|||
125290701|NCT00993499|450689882|FG002|Discontinued After Starting Course 3|DLT|2|||
125290702|NCT00993499|450689883|FG003|Discontinued After Starting Course 3|DLT|1|||
125290703|NCT00993499|450689884|FG004|Discontinued After Starting Course 3|DLT|0|||
125290704|NCT00993499|450689885|FG005|Discontinued After Starting Course 3|DLT|0|||
125290705|NCT00993499|450689880|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
125290706|NCT00993499|450689881|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
125290707|NCT00993499|450689882|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
125290708|NCT00993499|450689883|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
125290709|NCT00993499|450689884|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
125290710|NCT00993499|450689885|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
125290711|NCT01352741|450689886|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
125290712|NCT01352741|450689887|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
125290713|NCT01352741|450689886|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
125290714|NCT01352741|450689887|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
125290715|NCT01352741|450689886|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
125290716|NCT01352741|450689887|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
125290717|NCT01352741|450689886|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
125290718|NCT01352741|450689887|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
125290719|NCT01352741|450689886|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
125290720|NCT01352741|450689887|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
125290721|NCT01352741|450689886|FG000|Open-label Tapentadol Titration Period|Other|4|||
125290722|NCT01352741|450689887|FG001|Open-label Tapentadol Titration Period|Other|0|||
125290723|NCT01352741|450689886|FG000|Double-blind Comparative Period|Protocol Violation|2|||
125290724|NCT01352741|450689887|FG001|Double-blind Comparative Period|Protocol Violation|0|||
125290725|NCT01352741|450689886|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
125290726|NCT01352741|450689887|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
125290727|NCT01352741|450689886|FG000|Double-blind Comparative Period|Adverse Event|16|||
125290728|NCT01352741|450689887|FG001|Double-blind Comparative Period|Adverse Event|17|||
125290729|NCT01352741|450689886|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
125290730|NCT01352741|450689887|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
125290731|NCT01352741|450689886|FG000|Double-blind Comparative Period|Death|0|||
125290732|NCT01352741|450689887|FG001|Double-blind Comparative Period|Death|1|||
125290733|NCT01352741|450689886|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
125290734|NCT01352741|450689887|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
125290735|NCT01352741|450689886|FG000|Double-blind Comparative Period|Other|1|||
125290736|NCT01352741|450689887|FG001|Double-blind Comparative Period|Other|2|||
125290737|NCT01352741|450689886|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
125290738|NCT01352741|450689887|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
125290739|NCT01352741|450689886|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
125290740|NCT01352741|450689887|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
125290741|NCT01352741|450689886|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
125290742|NCT01352741|450689887|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
125290743|NCT01352741|450689886|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
125290744|NCT01352741|450689887|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
125290745|NCT04070326|450689888|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
125290746|NCT04070326|450689889|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
125290747|NCT00645528|450689890|FG000|Overall Study|Did not show up for Visit 2|7|||
125290748|NCT01498185|450689893|FG000|Overall Study|Adverse Event|0|||
125290749|NCT01498185|450689894|FG001|Overall Study|Adverse Event|0|||
125290750|NCT01498185|450689895|FG002|Overall Study|Adverse Event|0|||
125290751|NCT01498185|450689896|FG003|Overall Study|Adverse Event|1|||
125290752|NCT01498185|450689897|FG004|Overall Study|Adverse Event|0|||
125290753|NCT01498185|450689893|FG000|Overall Study|Withdrawal by Subject|1|||
125290754|NCT01498185|450689894|FG001|Overall Study|Withdrawal by Subject|1|||
125290755|NCT01498185|450689895|FG002|Overall Study|Withdrawal by Subject|0|||
125290756|NCT01498185|450689896|FG003|Overall Study|Withdrawal by Subject|2|||
125290757|NCT01498185|450689897|FG004|Overall Study|Withdrawal by Subject|1|||
125290758|NCT01498185|450689893|FG000|Overall Study|No longer met criteria, etc|0|||
125290759|NCT01498185|450689894|FG001|Overall Study|No longer met criteria, etc|0|||
125290760|NCT01498185|450689895|FG002|Overall Study|No longer met criteria, etc|0|||
125290761|NCT01498185|450689896|FG003|Overall Study|No longer met criteria, etc|0|||
125290762|NCT01498185|450689897|FG004|Overall Study|No longer met criteria, etc|2|||
125290763|NCT00946322|450689898|FG000|Pre-treatment|participant failure to follow up|1|||
125290764|NCT00946322|450689898|FG000|Post-treatment|participant failure to follow up|2|||
125290765|NCT02153346|450689899|FG000|Overall Study|Lost to Follow-up|11|||
125290766|NCT00846040|450689900|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
125290767|NCT00846040|450689901|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
125290768|NCT00846040|450689902|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
125290769|NCT00846040|450689900|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
125290770|NCT00846040|450689901|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
125290771|NCT00846040|450689902|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
125290772|NCT02725593|450689904|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
125290773|NCT02725593|450689905|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
125290774|NCT02725593|450689904|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
125290775|NCT02725593|450689905|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
125290776|NCT02725593|450689904|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
125290777|NCT02725593|450689905|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
125290778|NCT02725593|450689904|FG000|Long Term Extension|Withdrawal by Subject|1|||
125290779|NCT02725593|450689905|FG001|Long Term Extension|Withdrawal by Subject|3|||
125290780|NCT03959982|450691258|FG000|Overall Study|Withdrawal by Subject|1|||
125290781|NCT03959982|450691259|FG001|Overall Study|Withdrawal by Subject|0|||
125290782|NCT03959982|450691258|FG000|Overall Study|Physician Decision|2|||
125290783|NCT03959982|450691259|FG001|Overall Study|Physician Decision|0|||
125290784|NCT03959982|450691258|FG000|Overall Study|Lost to Follow-up|1|||
125290785|NCT03959982|450691259|FG001|Overall Study|Lost to Follow-up|0|||
125290786|NCT05275582|450691262|FG000|Overall Study|Lost to Follow-up|1|||
125290787|NCT05275582|450691263|FG001|Overall Study|Lost to Follow-up|0|||
125290788|NCT05275582|450691262|FG000|Overall Study|Withdrawal by Subject|0|||
125290789|NCT05275582|450691263|FG001|Overall Study|Withdrawal by Subject|2|||
125290790|NCT05275582|450691262|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
125290791|NCT05275582|450691263|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
125290792|NCT05275582|450691262|FG000|Overall Study|Death|1|||
125290793|NCT05275582|450691263|FG001|Overall Study|Death|0|||
125290794|NCT05275582|450691262|FG000|Overall Study|Protocol Violation|1|||
125290795|NCT05275582|450691263|FG001|Overall Study|Protocol Violation|0|||
125290796|NCT04411420|450691264|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
125290797|NCT04411420|450691265|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
125290798|NCT04411420|450691264|FG000|Survey Subset|Lost to Follow-up|134|||
125290799|NCT04411420|450691265|FG001|Survey Subset|Lost to Follow-up|120|||
125290800|NCT00524589|450691272|FG000|Overall Study|Withdrawal by Subject|2|||
125290801|NCT00524589|450691272|FG000|Overall Study|Disease Progression|16|||
125290802|NCT01030874|450691276|FG000|Overall Study|Withdrawal by Subject|1|||
125290803|NCT01030874|450691277|FG001|Overall Study|Withdrawal by Subject|0|||
125290804|NCT01030874|450691276|FG000|Overall Study|Discharged in first 2 weeks|17|||
125290805|NCT01030874|450691277|FG001|Overall Study|Discharged in first 2 weeks|16|||
125290806|NCT04639219|450691280|FG000|Overall Study|Withdrawal by Subject|8|||
125290807|NCT04639219|450691280|FG000|Overall Study|Lost to Follow-up|6|||
125290808|NCT04639219|450691280|FG000|Overall Study|Death|55|||
125290809|NCT01998893|450691283|FG000|Overall Study|Adverse Event|2|||
125290810|NCT01998893|450691283|FG000|Overall Study|Death|1|||
125290811|NCT01998893|450691283|FG000|Overall Study|Lost to Follow-up|8|||
125290812|NCT01998893|450691283|FG000|Overall Study|Physician Decision|2|||
125290813|NCT01998893|450691283|FG000|Overall Study|Protocol Violation|2|||
125290814|NCT01998893|450691283|FG000|Overall Study|Withdrawal by Subject|1|||
125290815|NCT01998893|450691283|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
125290816|NCT02046174|450691284|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
125290817|NCT02046174|450691285|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
125290818|NCT02118597|450691286|FG000|Overall Study|Sponsor terminated the study|14|||
125290819|NCT02118597|450691286|FG000|Overall Study|Serious Adverse Event|1|||
125290820|NCT02118597|450691286|FG000|Overall Study|Investigator's decision|1|||
125290821|NCT01891344|450691287|FG000|Overall Study|Ongoing|6|||
125290822|NCT01891344|450691288|FG001|Overall Study|Ongoing|2|||
125290823|NCT01891344|450691289|FG002|Overall Study|Ongoing|0|||
125290824|NCT01891344|450691290|FG003|Overall Study|Ongoing|1|||
125290825|NCT01891344|450691291|FG004|Overall Study|Ongoing|4|||
125290826|NCT01891344|450691292|FG005|Overall Study|Ongoing|1|||
125290827|NCT01891344|450691293|FG006|Overall Study|Ongoing|0|||
125290828|NCT01891344|450691294|FG007|Overall Study|Ongoing|0|||
125290829|NCT02969590|450691295|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
125290830|NCT02969590|450691296|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
125290831|NCT02969590|450691297|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
125290832|NCT03294135|450691298|FG000|Overall Study|Serious Adverse Event|1|||
125290833|NCT03294135|450691299|FG001|Overall Study|Serious Adverse Event|0|||
125290834|NCT03294135|450691300|FG002|Overall Study|Serious Adverse Event|0|||
125290835|NCT03294135|450691298|FG000|Overall Study|Lost to Follow-up|1|||
125290836|NCT03294135|450691299|FG001|Overall Study|Lost to Follow-up|0|||
125290837|NCT03294135|450691300|FG002|Overall Study|Lost to Follow-up|1|||
125290838|NCT03294135|450691298|FG000|Overall Study|Withdrawal by Subject|0|||
125290839|NCT03294135|450691299|FG001|Overall Study|Withdrawal by Subject|0|||
125290840|NCT03294135|450691300|FG002|Overall Study|Withdrawal by Subject|1|||
125290841|NCT03294135|450691298|FG000|Overall Study|Other|2|||
125290842|NCT03294135|450691299|FG001|Overall Study|Other|0|||
125290843|NCT03294135|450691300|FG002|Overall Study|Other|0|||
125290844|NCT00186537|450691301|FG000|Overall Study|Withdrawal by Subject|4|||
125290845|NCT00186537|450691302|FG001|Overall Study|Withdrawal by Subject|0|||
125290846|NCT00186537|450691303|FG002|Overall Study|Withdrawal by Subject|3|||
125290847|NCT00186537|450691301|FG000|Overall Study|ALT > 1.5 x ULN|3|||
125290848|NCT00186537|450691302|FG001|Overall Study|ALT > 1.5 x ULN|0|||
125290849|NCT00186537|450691303|FG002|Overall Study|ALT > 1.5 x ULN|0|||
125290850|NCT02590562|450691304|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
125290851|NCT02763254|450691305|FG000|Overall Study|Adverse Event|1|||
125290852|NCT03684304|450691306|FG000|Overall Study|Lost to Follow-up|19|||
125290853|NCT03684304|450691307|FG001|Overall Study|Lost to Follow-up|17|||
125290854|NCT00054691|450691308|FG000|Overall Study|Unmeasurable Disease|2|||
125290855|NCT00054691|450691308|FG000|Overall Study|Noncompliant|1|||
125290856|NCT03593681|450691311|FG000|Overall Study|Inadequate sample collected|12|||
125290857|NCT03593681|450691311|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
125290858|NCT03593681|450691311|FG000|Overall Study|Protocol Violation|3|||
125290859|NCT03593681|450691311|FG000|Overall Study|Withdrawal by Subject|3|||
125290860|NCT03593681|450691311|FG000|Overall Study|Procedure not attempted|3|||
125290861|NCT03593681|450691311|FG000|Overall Study|Adverse Event|2|||
125290862|NCT03593681|450691311|FG000|Overall Study|Physician Decision|1|||
125290863|NCT03987932|450691315|FG000|Overall Study|Lost to Follow-up|2|||
125290864|NCT03987932|450691316|FG001|Overall Study|Lost to Follow-up|1|||
125290865|NCT03987932|450691317|FG002|Overall Study|Lost to Follow-up|1|||
125290866|NCT03987932|450691315|FG000|Overall Study|Non-study related elective surgery|0|||
125290867|NCT03987932|450691316|FG001|Overall Study|Non-study related elective surgery|0|||
125290868|NCT03987932|450691317|FG002|Overall Study|Non-study related elective surgery|1|||
125290869|NCT02813668|450691320|FG000|Overall Study|Death|4|||
125290870|NCT02813668|450691320|FG000|Overall Study|Lost to Follow-up|509|||
125290871|NCT02813668|450691320|FG000|Overall Study|Withdrawal by Subject|148|||
125290872|NCT02813668|450691320|FG000|Overall Study|No longer at worksite|85|||
125290873|NCT02813668|450691320|FG000|Overall Study|Medical reasons not related to the study|4|||
125290874|NCT02961790|450691321|FG000|Overall Study|Canceled|4|||
125290875|NCT02961790|450691322|FG001|Overall Study|Canceled|5|||
125290876|NCT02961790|450691323|FG002|Overall Study|Canceled|1|||
124783882|NCT00689117|448839981|FG000|Overall Study|Incarceration|2|||
125290877|NCT02961790|450691324|FG003|Overall Study|Canceled|4|||
125290878|NCT02961790|450691321|FG000|Overall Study|without baseline data|4|||
125290879|NCT02961790|450691322|FG001|Overall Study|without baseline data|0|||
125290880|NCT02961790|450691323|FG002|Overall Study|without baseline data|1|||
125290881|NCT02961790|450691324|FG003|Overall Study|without baseline data|0|||
125290882|NCT02961790|450691321|FG000|Overall Study|without post baseline data|7|||
125290883|NCT02961790|450691322|FG001|Overall Study|without post baseline data|6|||
125290884|NCT02961790|450691323|FG002|Overall Study|without post baseline data|4|||
125290885|NCT02961790|450691324|FG003|Overall Study|without post baseline data|1|||
125290886|NCT02078102|450691329|FG000|Overall Study|Adverse Event|1|||
125290887|NCT02078102|450691330|FG001|Overall Study|Adverse Event|0|||
125290888|NCT02078102|450691329|FG000|Overall Study|Withdrawal by Subject|1|||
125290889|NCT02078102|450691330|FG001|Overall Study|Withdrawal by Subject|0|||
125290890|NCT02078102|450691329|FG000|Overall Study|Physician Decision|0|||
125290891|NCT02078102|450691330|FG001|Overall Study|Physician Decision|1|||
125290892|NCT00598078|450691333|FG000|Period 2 (Day 2)|Adverse Event|1|||
125290893|NCT00598078|450691334|FG001|Period 2 (Day 2)|Adverse Event|0|||
125290894|NCT02185014|450691335|FG000|Overall Study|Adverse Event|18|||
125290895|NCT02185014|450691335|FG000|Overall Study|Withdrew Consent|8|||
125290896|NCT02185014|450691335|FG000|Overall Study|Lost to Follow-up|4|||
125290897|NCT02185014|450691335|FG000|Overall Study|Lack of Efficacy|14|||
125290898|NCT02185014|450691335|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
125290899|NCT02185014|450691335|FG000|Overall Study|Subject Noncompliance|1|||
125290900|NCT02185014|450691335|FG000|Overall Study|Other|4|||
125290901|NCT02387164|450691338|FG000|Overall Study|Lost to Follow-up|2|||
125290902|NCT02387164|450691339|FG001|Overall Study|Lost to Follow-up|0|||
125290903|NCT02387164|450691338|FG000|Overall Study|Diagnosed|1|||
125290904|NCT02387164|450691339|FG001|Overall Study|Diagnosed|2|||
125290905|NCT02370641|450691340|FG000|Overall Study|dropped study|4|||
125290906|NCT02370641|450691341|FG001|Overall Study|dropped study|2|||
125290907|NCT02133664|450691342|FG000|Overall Study|Lost to Follow-up|2|||
125290908|NCT02133664|450691343|FG001|Overall Study|Lost to Follow-up|1|||
125290909|NCT02133664|450691342|FG000|Overall Study|Adverse Event|3|||
125290910|NCT02133664|450691343|FG001|Overall Study|Adverse Event|6|||
125290911|NCT02120365|450691350|FG000|Overall Study|Withdrawal by Subject|0|||
125290912|NCT02120365|450691351|FG001|Overall Study|Withdrawal by Subject|0|||
125290913|NCT02120365|450691352|FG002|Overall Study|Withdrawal by Subject|2|||
125290914|NCT02120365|450691353|FG003|Overall Study|Withdrawal by Subject|4|||
125290915|NCT02120365|450691354|FG004|Overall Study|Withdrawal by Subject|0|||
125290916|NCT02120365|450691355|FG005|Overall Study|Withdrawal by Subject|2|||
125290917|NCT01719003|450691358|FG000|Overall Study|Non compliant with protocol|1|||
125290918|NCT01719003|450691359|FG001|Overall Study|Non compliant with protocol|1|||
125290919|NCT01719003|450691360|FG002|Overall Study|Non compliant with protocol|0|||
125290920|NCT01719003|450691361|FG003|Overall Study|Non compliant with protocol|1|||
125290921|NCT01719003|450691362|FG004|Overall Study|Non compliant with protocol|2|||
125290922|NCT01719003|450691363|FG005|Overall Study|Non compliant with protocol|1|||
125290923|NCT01719003|450691364|FG006|Overall Study|Non compliant with protocol|2|||
125290924|NCT01719003|450691365|FG007|Overall Study|Non compliant with protocol|3|||
125290925|NCT01719003|450691366|FG008|Overall Study|Non compliant with protocol|0|||
125290926|NCT01719003|450691358|FG000|Overall Study|Adverse Event|6|||
125290927|NCT01719003|450691359|FG001|Overall Study|Adverse Event|5|||
125290928|NCT01719003|450691360|FG002|Overall Study|Adverse Event|4|||
125290929|NCT01719003|450691361|FG003|Overall Study|Adverse Event|3|||
125290930|NCT01719003|450691362|FG004|Overall Study|Adverse Event|4|||
125290931|NCT01719003|450691363|FG005|Overall Study|Adverse Event|3|||
125290932|NCT01719003|450691364|FG006|Overall Study|Adverse Event|6|||
125290933|NCT01719003|450691365|FG007|Overall Study|Adverse Event|5|||
125290934|NCT01719003|450691366|FG008|Overall Study|Adverse Event|0|||
125290935|NCT01719003|450691358|FG000|Overall Study|Lost to Follow-up|0|||
125290936|NCT01719003|450691359|FG001|Overall Study|Lost to Follow-up|6|||
125290937|NCT01719003|450691360|FG002|Overall Study|Lost to Follow-up|7|||
125290938|NCT01719003|450691361|FG003|Overall Study|Lost to Follow-up|2|||
125290939|NCT01719003|450691362|FG004|Overall Study|Lost to Follow-up|3|||
125290940|NCT01719003|450691363|FG005|Overall Study|Lost to Follow-up|4|||
125290941|NCT01719003|450691364|FG006|Overall Study|Lost to Follow-up|3|||
125290942|NCT01719003|450691365|FG007|Overall Study|Lost to Follow-up|2|||
125290943|NCT01719003|450691366|FG008|Overall Study|Lost to Follow-up|2|||
125290944|NCT01719003|450691358|FG000|Overall Study|Refusal to continue, not due to AE|2|||
125290945|NCT01719003|450691359|FG001|Overall Study|Refusal to continue, not due to AE|5|||
125290946|NCT01719003|450691360|FG002|Overall Study|Refusal to continue, not due to AE|4|||
125290947|NCT01719003|450691361|FG003|Overall Study|Refusal to continue, not due to AE|4|||
125290948|NCT01719003|450691362|FG004|Overall Study|Refusal to continue, not due to AE|4|||
125290949|NCT01719003|450691363|FG005|Overall Study|Refusal to continue, not due to AE|3|||
125290950|NCT01719003|450691364|FG006|Overall Study|Refusal to continue, not due to AE|8|||
125290951|NCT01719003|450691365|FG007|Overall Study|Refusal to continue, not due to AE|7|||
125290952|NCT01719003|450691366|FG008|Overall Study|Refusal to continue, not due to AE|1|||
124783883|NCT00689117|448839982|FG001|Overall Study|Incarceration|0|||
124783884|NCT00689117|448839983|FG002|Overall Study|Incarceration|0|||
125290953|NCT01719003|450691358|FG000|Overall Study|Reason other than those specified|0|||
125290954|NCT01719003|450691359|FG001|Overall Study|Reason other than those specified|0|||
125290955|NCT01719003|450691360|FG002|Overall Study|Reason other than those specified|2|||
124783885|NCT00689117|448839984|FG003|Overall Study|Incarceration|0|||
124783886|NCT00689117|448839981|FG000|Overall Study|Fear of Birth Defects|0|||
125290956|NCT01719003|450691361|FG003|Overall Study|Reason other than those specified|3|||
125290957|NCT01719003|450691362|FG004|Overall Study|Reason other than those specified|4|||
125290958|NCT01719003|450691363|FG005|Overall Study|Reason other than those specified|1|||
125290959|NCT01719003|450691364|FG006|Overall Study|Reason other than those specified|0|||
125290960|NCT01719003|450691365|FG007|Overall Study|Reason other than those specified|3|||
125290961|NCT01719003|450691366|FG008|Overall Study|Reason other than those specified|1|||
125290962|NCT01719003|450691358|FG000|Overall Study|Lack of Efficacy|0|||
125290963|NCT01719003|450691359|FG001|Overall Study|Lack of Efficacy|0|||
125290964|NCT01719003|450691360|FG002|Overall Study|Lack of Efficacy|0|||
125290965|NCT01719003|450691361|FG003|Overall Study|Lack of Efficacy|0|||
125290966|NCT01719003|450691362|FG004|Overall Study|Lack of Efficacy|0|||
125290967|NCT01719003|450691363|FG005|Overall Study|Lack of Efficacy|0|||
125290968|NCT01719003|450691364|FG006|Overall Study|Lack of Efficacy|1|||
125290969|NCT01719003|450691365|FG007|Overall Study|Lack of Efficacy|0|||
125290970|NCT01719003|450691366|FG008|Overall Study|Lack of Efficacy|0|||
125290971|NCT00581828|450691367|FG000|Overall Study|Protocol Violation|1|||
125290972|NCT01406015|450691373|FG000|Overall Study|Withdrawal by Subject|3|||
125290973|NCT01406015|450691374|FG001|Overall Study|Withdrawal by Subject|3|||
125290974|NCT00394901|450691375|FG000|Baseline Phase|Protocol Violation|0|||
125290975|NCT00394901|450691376|FG001|Baseline Phase|Protocol Violation|0|||
125290976|NCT00394901|450691377|FG002|Baseline Phase|Protocol Violation|1|||
125290977|NCT00394901|450691378|FG003|Baseline Phase|Protocol Violation|0|||
125290978|NCT00394901|450691375|FG000|Double-blind Phase|Adverse Event|5|||
125290979|NCT00394901|450691376|FG001|Double-blind Phase|Adverse Event|7|||
125290980|NCT00394901|450691377|FG002|Double-blind Phase|Adverse Event|16|||
125290981|NCT00394901|450691378|FG003|Double-blind Phase|Adverse Event|20|||
125290982|NCT00394901|450691375|FG000|Double-blind Phase|Lack of Efficacy|6|||
125290983|NCT00394901|450691376|FG001|Double-blind Phase|Lack of Efficacy|4|||
124783887|NCT00689117|448839982|FG001|Overall Study|Fear of Birth Defects|0|||
124783888|NCT00689117|448839983|FG002|Overall Study|Fear of Birth Defects|1|||
124783889|NCT00689117|448839984|FG003|Overall Study|Fear of Birth Defects|0|||
124783890|NCT00689117|448839981|FG000|Overall Study|Transportation|1|||
124783891|NCT00689117|448839982|FG001|Overall Study|Transportation|0|||
124783892|NCT00689117|448839983|FG002|Overall Study|Transportation|0|||
124783893|NCT00689117|448839984|FG003|Overall Study|Transportation|0|||
124783894|NCT00689117|448839981|FG000|Overall Study|Patient Withdrew from Study|0|||
124783895|NCT00689117|448839982|FG001|Overall Study|Patient Withdrew from Study|0|||
124783896|NCT00689117|448839983|FG002|Overall Study|Patient Withdrew from Study|0|||
124783897|NCT00689117|448839984|FG003|Overall Study|Patient Withdrew from Study|1|||
124783898|NCT00689117|448839981|FG000|Overall Study|Personal Reason|0|||
124783899|NCT00689117|448839982|FG001|Overall Study|Personal Reason|1|||
124783900|NCT00689117|448839983|FG002|Overall Study|Personal Reason|0|||
124783901|NCT00689117|448839984|FG003|Overall Study|Personal Reason|0|||
124783902|NCT00689117|448839981|FG000|Overall Study|Dispensing Error|0|||
124783903|NCT00689117|448839982|FG001|Overall Study|Dispensing Error|1|||
124783904|NCT00689117|448839983|FG002|Overall Study|Dispensing Error|0|||
124783905|NCT00689117|448839984|FG003|Overall Study|Dispensing Error|0|||
124783906|NCT01086358|448839987|FG000|First Intervention|Lost to Follow-up|9|||
124783907|NCT01086358|448839988|FG001|First Intervention|Lost to Follow-up|4|||
124783908|NCT01086358|448839987|FG000|First Intervention|Withdrawal by Subject|0|||
124783909|NCT01086358|448839988|FG001|First Intervention|Withdrawal by Subject|1|||
124783910|NCT01086358|448839987|FG000|Second Intervention|Lost to Follow-up|4|||
124783911|NCT01086358|448839988|FG001|Second Intervention|Lost to Follow-up|4|||
124783912|NCT03206788|448839991|FG000|Overall Study|Withdrawal by Subject|0|||
124783913|NCT03206788|448839992|FG001|Overall Study|Withdrawal by Subject|1|||
124783914|NCT03206788|448839991|FG000|Overall Study|Adverse Event|0|||
124783915|NCT03206788|448839992|FG001|Overall Study|Adverse Event|1|||
124783916|NCT03206788|448839991|FG000|Overall Study|Physician Decision|0|||
124783917|NCT03206788|448839992|FG001|Overall Study|Physician Decision|1|||
124783918|NCT02471612|448839993|FG000|Overall Study|Lost to Follow-up|2|||
124783919|NCT03899805|448839994|FG000|Overall Study|Physician Decision|3|||
124783920|NCT03899805|448839995|FG001|Overall Study|Physician Decision|0|||
124783921|NCT03899805|448839996|FG002|Overall Study|Physician Decision|2|||
125290984|NCT00394901|450691377|FG002|Double-blind Phase|Lack of Efficacy|1|||
125290985|NCT00394901|450691378|FG003|Double-blind Phase|Lack of Efficacy|3|||
125290986|NCT00394901|450691375|FG000|Double-blind Phase|Withdrawal by Subject|2|||
125290987|NCT00394901|450691376|FG001|Double-blind Phase|Withdrawal by Subject|0|||
125290988|NCT00394901|450691377|FG002|Double-blind Phase|Withdrawal by Subject|0|||
125290989|NCT00394901|450691378|FG003|Double-blind Phase|Withdrawal by Subject|0|||
125290990|NCT00394901|450691375|FG000|Double-blind Phase|Lost to Follow-up|0|||
125290991|NCT00394901|450691376|FG001|Double-blind Phase|Lost to Follow-up|0|||
125290992|NCT00394901|450691377|FG002|Double-blind Phase|Lost to Follow-up|0|||
125290993|NCT00394901|450691378|FG003|Double-blind Phase|Lost to Follow-up|1|||
125290994|NCT00394901|450691375|FG000|Double-blind Phase|Protocol Violation|0|||
125290995|NCT00394901|450691376|FG001|Double-blind Phase|Protocol Violation|0|||
125290996|NCT00394901|450691377|FG002|Double-blind Phase|Protocol Violation|0|||
125290997|NCT00394901|450691378|FG003|Double-blind Phase|Protocol Violation|1|||
125290998|NCT00394901|450691375|FG000|Double-blind Phase|Death|1|||
124783922|NCT03899805|448839994|FG000|Overall Study|Withdrawal by Subject|1|||
124783923|NCT03899805|448839995|FG001|Overall Study|Withdrawal by Subject|0|||
124783924|NCT03899805|448839996|FG002|Overall Study|Withdrawal by Subject|2|||
124783925|NCT03899805|448839994|FG000|Overall Study|Progressive Disease|10|||
125290999|NCT00394901|450691376|FG001|Double-blind Phase|Death|0|||
125291000|NCT00394901|450691377|FG002|Double-blind Phase|Death|0|||
125291001|NCT00394901|450691378|FG003|Double-blind Phase|Death|0|||
125291002|NCT00394901|450691375|FG000|Double-blind Phase|Subject's Personal Reason|1|||
125291003|NCT00394901|450691376|FG001|Double-blind Phase|Subject's Personal Reason|0|||
125291004|NCT00394901|450691377|FG002|Double-blind Phase|Subject's Personal Reason|0|||
125291005|NCT00394901|450691378|FG003|Double-blind Phase|Subject's Personal Reason|1|||
125291006|NCT00394901|450691375|FG000|Double-blind Phase|Lack of Compliance|0|||
125291007|NCT00394901|450691376|FG001|Double-blind Phase|Lack of Compliance|3|||
125291008|NCT00394901|450691377|FG002|Double-blind Phase|Lack of Compliance|0|||
125291009|NCT00394901|450691378|FG003|Double-blind Phase|Lack of Compliance|0|||
125291010|NCT00394901|450691375|FG000|Double-blind Phase|Entry into another study was found|0|||
125291011|NCT00394901|450691376|FG001|Double-blind Phase|Entry into another study was found|0|||
125291012|NCT00394901|450691377|FG002|Double-blind Phase|Entry into another study was found|1|||
125291013|NCT00394901|450691378|FG003|Double-blind Phase|Entry into another study was found|0|||
125291014|NCT00394901|450691375|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
125291015|NCT00394901|450691376|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
125291016|NCT00394901|450691377|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
125291017|NCT00394901|450691378|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
125291018|NCT01886690|450691379|FG000|Overall Study|Protocol Violation|0|||
125291019|NCT01886690|450691380|FG001|Overall Study|Protocol Violation|1|||
125291020|NCT01886690|450691379|FG000|Overall Study|Personal Reasons|0|||
125291021|NCT01886690|450691380|FG001|Overall Study|Personal Reasons|1|||
125291022|NCT02360293|450691381|FG000|Overall Study|Lost to Follow-up|73|||
125291023|NCT02360293|450691382|FG001|Overall Study|Lost to Follow-up|95|||
125291024|NCT02360293|450691381|FG000|Overall Study|Withdrawal by Subject|2|||
125291025|NCT02360293|450691382|FG001|Overall Study|Withdrawal by Subject|1|||
125291026|NCT02360293|450691381|FG000|Overall Study|Excluded|1|||
125291027|NCT02360293|450691382|FG001|Overall Study|Excluded|0|||
124783926|NCT03899805|448839995|FG001|Overall Study|Progressive Disease|18|||
124783927|NCT03899805|448839996|FG002|Overall Study|Progressive Disease|12|||
124783928|NCT03899805|448839994|FG000|Overall Study|Adverse Event|3|||
124783929|NCT03899805|448839995|FG001|Overall Study|Adverse Event|1|||
124783930|NCT03899805|448839996|FG002|Overall Study|Adverse Event|0|||
124783931|NCT03899805|448839994|FG000|Overall Study|Death|2|||
124783932|NCT03899805|448839995|FG001|Overall Study|Death|0|||
124783933|NCT03899805|448839996|FG002|Overall Study|Death|0|||
124783934|NCT03899805|448839994|FG000|Overall Study|Came off for surgery|0|||
124783935|NCT03899805|448839995|FG001|Overall Study|Came off for surgery|0|||
124783936|NCT03899805|448839996|FG002|Overall Study|Came off for surgery|1|||
124783937|NCT03317405|448839997|FG000|Overall Study|Withdrawal by Subject|1|||
124783938|NCT03317405|448839998|FG001|Overall Study|Withdrawal by Subject|0|||
124783939|NCT03317405|448839999|FG002|Overall Study|Withdrawal by Subject|0|||
124783940|NCT03317405|448839997|FG000|Overall Study|Physician Decision|0|||
124783941|NCT03317405|448839998|FG001|Overall Study|Physician Decision|0|||
124783942|NCT03317405|448839999|FG002|Overall Study|Physician Decision|1|||
124783943|NCT03317405|448839997|FG000|Overall Study|Surgery Rescheduled|0|||
124783944|NCT03317405|448839998|FG001|Overall Study|Surgery Rescheduled|1|||
124783945|NCT03317405|448839999|FG002|Overall Study|Surgery Rescheduled|0|||
124783946|NCT01018810|448840002|FG000|Overall Study|Withdrawal by Subject|0|||
124783947|NCT01018810|448840003|FG001|Overall Study|Withdrawal by Subject|1|||
124783948|NCT01018810|448840004|FG002|Overall Study|Withdrawal by Subject|0|||
124783949|NCT01018810|448840005|FG003|Overall Study|Withdrawal by Subject|0|||
124783950|NCT01018810|448840006|FG004|Overall Study|Withdrawal by Subject|0|||
124783951|NCT01018810|448840002|FG000|Overall Study|Sponsor Decision|2|||
124783952|NCT01018810|448840003|FG001|Overall Study|Sponsor Decision|0|||
124783953|NCT01018810|448840004|FG002|Overall Study|Sponsor Decision|1|||
124783954|NCT01018810|448840005|FG003|Overall Study|Sponsor Decision|1|||
124783955|NCT01018810|448840006|FG004|Overall Study|Sponsor Decision|1|||
125291028|NCT04316741|450691383|FG000|Baseline Enrollment|Lost to Follow-up|1|||
125291029|NCT04316741|450691384|FG001|Baseline Enrollment|Lost to Follow-up|1|||
124783956|NCT01640314|448840007|FG000|Overall Study|Protocol Violation|0|||
124783957|NCT01640314|448840008|FG001|Overall Study|Protocol Violation|1|||
124783958|NCT04450381|448840009|FG000|Overall Study|Protocol Violation|4|||
124783959|NCT04450381|448840009|FG000|Overall Study|Wrong device setting|2|||
124783960|NCT01989208|448840010|FG000|200 mg (7 Days)|Protocol Violation|0|||
124783961|NCT01989208|448840011|FG001|200 mg (7 Days)|Protocol Violation|1|||
124783962|NCT04973436|448840012|FG000|Overall Study|Lost to Follow-up|3|||
124783963|NCT04973436|448840012|FG000|Overall Study|Withdrawal by Subject|1|||
124783964|NCT04973436|448840012|FG000|Overall Study|Death|2|||
124783965|NCT00566696|448840013|FG000|Overall Study|Met Exclusion Criteria|2|||
125291030|NCT04316741|450691383|FG000|Immediate Post-Test|Lost to Follow-up|5|||
125291031|NCT04316741|450691384|FG001|Immediate Post-Test|Lost to Follow-up|1|||
125291032|NCT04316741|450691383|FG000|1-month Post-test|Lost to Follow-up|7|||
125291033|NCT04316741|450691384|FG001|1-month Post-test|Lost to Follow-up|2|||
125291034|NCT04316741|450691383|FG000|3-month Follow-up|Lost to Follow-up|10|||
125291035|NCT04316741|450691384|FG001|3-month Follow-up|Lost to Follow-up|2|||
125291036|NCT01510145|450691385|FG000|Overall Study|Adverse Event|6|||
125291037|NCT01510145|450691385|FG000|Overall Study|Lost to Follow-up|5|||
125291038|NCT01510145|450691385|FG000|Overall Study|Withdrawal by Subject|6|||
125291039|NCT01510145|450691385|FG000|Overall Study|Relative reported subject withdrew|1|||
125291040|NCT02312219|450691386|FG000|Overall Study|Withdrawal by Subject|1|||
125291041|NCT02312219|450691387|FG001|Overall Study|Withdrawal by Subject|2|||
125291042|NCT02312219|450691386|FG000|Overall Study|could not schedule imaging in time|0|||
125291043|NCT02312219|450691387|FG001|Overall Study|could not schedule imaging in time|2|||
125291044|NCT02312219|450691386|FG000|Overall Study|Other|0|||
125291045|NCT02312219|450691387|FG001|Overall Study|Other|1|||
125291046|NCT02312219|450691386|FG000|Overall Study|Not randomized. Ineligible|0|||
125291047|NCT02312219|450691387|FG001|Overall Study|Not randomized. Ineligible|1|||
125291048|NCT01827332|450691389|FG000|Overall Study|Lost to Follow-up|2|||
125291049|NCT01827332|450691390|FG001|Overall Study|Lost to Follow-up|1|||
125291050|NCT00546260|450691391|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
125291051|NCT00546260|450691392|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
125291052|NCT03654885|450693209|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
125291053|NCT03654885|450693210|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
125291054|NCT03654885|450693209|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
125291055|NCT03654885|450693210|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
125291056|NCT03654885|450693209|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
125291057|NCT03654885|450693210|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
125291058|NCT03654885|450693209|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
125291059|NCT03654885|450693210|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
125291060|NCT03654885|450693209|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
125291061|NCT03654885|450693210|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
125291062|NCT03654885|450693209|FG000|Overall Study|Adverse Event in Study Eye|3|||
125291063|NCT03654885|450693210|FG001|Overall Study|Adverse Event in Study Eye|0|||
125291064|NCT03654885|450693209|FG000|Overall Study|Consent Withdrawn|1|||
125291065|NCT03654885|450693210|FG001|Overall Study|Consent Withdrawn|0|||
125291066|NCT03654885|450693209|FG000|Overall Study|Death|3|||
125291067|NCT03654885|450693210|FG001|Overall Study|Death|1|||
125291068|NCT03654885|450693209|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
125291069|NCT03654885|450693210|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
125291070|NCT03654885|450693209|FG000|Overall Study|Lost to Follow-up|3|||
125291071|NCT03654885|450693210|FG001|Overall Study|Lost to Follow-up|3|||
125291072|NCT00289198|450693229|FG000|Overall Study|Adverse Event|0|||
125291073|NCT00289198|450693230|FG001|Overall Study|Adverse Event|2|||
125291074|NCT00289198|450693229|FG000|Overall Study|Protocol Violation|2|||
125291075|NCT00289198|450693230|FG001|Overall Study|Protocol Violation|1|||
125291076|NCT00289198|450693229|FG000|Overall Study|Withdrawal by Subject|4|||
125291077|NCT00289198|450693230|FG001|Overall Study|Withdrawal by Subject|1|||
125291078|NCT00289198|450693229|FG000|Overall Study|Lack of Efficacy|2|||
125291079|NCT00289198|450693230|FG001|Overall Study|Lack of Efficacy|0|||
125291080|NCT00289198|450693229|FG000|Overall Study|Other: Low compliance|0|||
125291081|NCT00289198|450693230|FG001|Overall Study|Other: Low compliance|1|||
125291082|NCT00289198|450693229|FG000|Overall Study|Other: Physician's decision|0|||
125291083|NCT00289198|450693230|FG001|Overall Study|Other: Physician's decision|1|||
125291084|NCT00289198|450693229|FG000|Overall Study|Other: Unable to attend on schedule|2|||
125291085|NCT00289198|450693230|FG001|Overall Study|Other: Unable to attend on schedule|1|||
125291086|NCT00289198|450693229|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
125291087|NCT00289198|450693230|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
125291088|NCT00289198|450693229|FG000|Overall Study|Other: Impossible to come on visit|0|||
125291089|NCT00289198|450693230|FG001|Overall Study|Other: Impossible to come on visit|1|||
125291090|NCT01176565|450693231|FG000|Overall Study|Lost to Follow-up|12|||
125291091|NCT01176565|450693232|FG001|Overall Study|Lost to Follow-up|16|||
125291092|NCT01176565|450693231|FG000|Overall Study|Withdrawal by Subject|7|||
125291093|NCT01176565|450693232|FG001|Overall Study|Withdrawal by Subject|1|||
125291094|NCT01176565|450693231|FG000|Overall Study|Not Analyzed (any other reason)|1|||
125291095|NCT01176565|450693232|FG001|Overall Study|Not Analyzed (any other reason)|2|||
124783966|NCT00566696|448840013|FG000|Overall Study|Muromonab not available|1|||
125291096|NCT01062061|450693235|FG000|Overall Study|Enrolled more than once|2|||
125291097|NCT01062061|450693235|FG000|Overall Study|Investigated before study start|13|||
125291098|NCT01062061|450693235|FG000|Overall Study|Outside chief indications|10|||
125291099|NCT01062061|450693235|FG000|Overall Study|Failed to meet inclusion criteria|2|||
125291100|NCT01143051|450693242|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
125291101|NCT01143051|450693243|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
125291102|NCT01143051|450693244|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
125291103|NCT01143051|450693245|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
125291104|NCT01143051|450693246|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
125291105|NCT01143051|450693247|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
125291106|NCT01143051|450693242|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
125291107|NCT01143051|450693243|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
125291108|NCT01143051|450693244|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
125291109|NCT01143051|450693245|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
125291110|NCT01143051|450693246|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
125291111|NCT01143051|450693247|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
125291112|NCT01605227|450693248|FG000|Overall Study|Did not receive study treatment|2|||
125291113|NCT01605227|450693249|FG001|Overall Study|Did not receive study treatment|3|||
125291114|NCT01605227|450693248|FG000|Overall Study|Adverse Event|228|||
125291115|NCT01605227|450693249|FG001|Overall Study|Adverse Event|42|||
125291116|NCT01605227|450693248|FG000|Overall Study|Progressive Disease|132|||
125291117|NCT01605227|450693249|FG001|Overall Study|Progressive Disease|128|||
125291118|NCT01605227|450693248|FG000|Overall Study|Clinical Deterioration|227|||
125291119|NCT01605227|450693249|FG001|Overall Study|Clinical Deterioration|133|||
125291120|NCT01605227|450693248|FG000|Overall Study|Lost to Follow-up|1|||
125291121|NCT01605227|450693249|FG001|Overall Study|Lost to Follow-up|0|||
125291122|NCT01605227|450693248|FG000|Overall Study|Protocol Violation|1|||
125291123|NCT01605227|450693249|FG001|Overall Study|Protocol Violation|0|||
125291124|NCT01605227|450693248|FG000|Overall Study|Physician Decision|9|||
125291125|NCT01605227|450693249|FG001|Overall Study|Physician Decision|7|||
125291126|NCT01605227|450693248|FG000|Overall Study|Withdrawal by Subject|18|||
125291127|NCT01605227|450693249|FG001|Overall Study|Withdrawal by Subject|14|||
125291128|NCT01605227|450693248|FG000|Overall Study|Sponsor Decision|2|||
125291129|NCT01605227|450693249|FG001|Overall Study|Sponsor Decision|0|||
125291130|NCT01605227|450693248|FG000|Overall Study|Started New Therapy|1|||
125291131|NCT01605227|450693249|FG001|Overall Study|Started New Therapy|0|||
125291132|NCT01605227|450693248|FG000|Overall Study|Subject Decision|0|||
125291133|NCT01605227|450693249|FG001|Overall Study|Subject Decision|1|||
125291134|NCT01605227|450693248|FG000|Overall Study|Dose Held >6 weeks|0|||
125291135|NCT01605227|450693249|FG001|Overall Study|Dose Held >6 weeks|1|||
125291136|NCT03093974|450693252|FG000|Overall Study|Withdrawal by Subject|32|||
125291137|NCT03093974|450693253|FG001|Overall Study|Withdrawal by Subject|27|||
125291138|NCT03093974|450693252|FG000|Overall Study|Adverse Event|17|||
125291139|NCT03093974|450693253|FG001|Overall Study|Adverse Event|24|||
125291140|NCT03093974|450693252|FG000|Overall Study|Death|0|||
125291141|NCT03093974|450693253|FG001|Overall Study|Death|1|||
125291142|NCT03093974|450693252|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125291143|NCT03093974|450693253|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125291144|NCT03093974|450693252|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
125291145|NCT03093974|450693253|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
125291146|NCT03093974|450693252|FG000|Overall Study|Lost to Follow-up|0|||
125291147|NCT03093974|450693253|FG001|Overall Study|Lost to Follow-up|1|||
125291148|NCT03093974|450693252|FG000|Overall Study|Other|1|||
125291149|NCT03093974|450693253|FG001|Overall Study|Other|2|||
125291150|NCT01866423|450693255|FG000|Overall Study|Lack of Efficacy|3|||
125291151|NCT01866423|450693255|FG000|Overall Study|Sponsor Decision|1|||
125291152|NCT01813721|450693256|FG000|Overall Study|Ineligibility determined|63|||
125291153|NCT01813721|450693256|FG000|Overall Study|Withdrawal by Subject|1|||
125291154|NCT00810901|450693257|FG000|Overall Study|Lost to Follow-up|88|||
125291155|NCT00810901|450693258|FG001|Overall Study|Lost to Follow-up|58|||
125291156|NCT01133275|450693259|FG000|Overall Study|Withdrawal by Subject|1|||
125291157|NCT01133275|450693259|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
125291158|NCT00900146|450693260|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
124783967|NCT00566696|448840013|FG000|Overall Study|Health Status Change|1|||
124783968|NCT00566696|448840013|FG000|Overall Study|Physician Decision|1|||
125291159|NCT00900146|450693261|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
125291160|NCT00900146|450693262|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
125291161|NCT00900146|450693263|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
125291162|NCT00900146|450693264|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
125291163|NCT00900146|450693260|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
125291164|NCT00900146|450693261|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
125291165|NCT00900146|450693262|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
125291166|NCT00900146|450693263|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
125291167|NCT00900146|450693264|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
125291168|NCT00900146|450693260|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
125291169|NCT00900146|450693261|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
125291170|NCT00900146|450693262|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
125291171|NCT00900146|450693263|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
125291172|NCT00900146|450693264|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
125291173|NCT00900146|450693260|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
125291174|NCT00900146|450693261|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
125291175|NCT00900146|450693262|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
125291176|NCT00900146|450693263|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
125291177|NCT00900146|450693264|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
125291178|NCT00900146|450693260|FG000|Intermediate: Period III|Lost to Follow-up|2|||
125291179|NCT00900146|450693261|FG001|Intermediate: Period III|Lost to Follow-up|0|||
125291180|NCT00900146|450693262|FG002|Intermediate: Period III|Lost to Follow-up|0|||
125291181|NCT00900146|450693263|FG003|Intermediate: Period III|Lost to Follow-up|0|||
125291182|NCT00900146|450693264|FG004|Intermediate: Period III|Lost to Follow-up|1|||
125291183|NCT00900146|450693260|FG000|Intermediate: Period III|Administrative problems|85|||
125291184|NCT00900146|450693261|FG001|Intermediate: Period III|Administrative problems|92|||
125291185|NCT00900146|450693262|FG002|Intermediate: Period III|Administrative problems|84|||
125291186|NCT00900146|450693263|FG003|Intermediate: Period III|Administrative problems|90|||
125291187|NCT00900146|450693264|FG004|Intermediate: Period III|Administrative problems|163|||
125291188|NCT00700102|450693265|FG000|Overall Study|Died|394|||
125291189|NCT00700102|450693266|FG001|Overall Study|Died|385|||
125291190|NCT00700102|450693265|FG000|Overall Study|Lost to Follow-up|8|||
125291191|NCT00700102|450693266|FG001|Overall Study|Lost to Follow-up|10|||
125291192|NCT02525939|450693271|FG000|Overall Study|Lost to Follow-up|27|||
125291193|NCT02525939|450693272|FG001|Overall Study|Lost to Follow-up|24|||
125291194|NCT02525939|450693271|FG000|Overall Study|Physician Decision|0|||
125291195|NCT02525939|450693272|FG001|Overall Study|Physician Decision|1|||
125291196|NCT02525939|450693271|FG000|Overall Study|Withdrawal by Subject|24|||
125291197|NCT02525939|450693272|FG001|Overall Study|Withdrawal by Subject|39|||
125291198|NCT02525939|450693271|FG000|Overall Study|Death|180|||
125291199|NCT02525939|450693272|FG001|Overall Study|Death|179|||
125291200|NCT01028716|450693273|FG000|Overall Study|Physician Decision|1|||
125291201|NCT05590000|450693274|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
125291202|NCT00536874|450693275|FG000|Overall Study|Adverse Event|1|||
125291203|NCT00536874|450693275|FG000|Overall Study|Death|2|||
125291204|NCT00536874|450693275|FG000|Overall Study|Withdrawal by Subject|1|||
125291205|NCT00762996|450693276|FG000|Period One|Protocol Violation|0|||
125291206|NCT00762996|450693277|FG001|Period One|Protocol Violation|0|||
125291207|NCT00762996|450693278|FG002|Period One|Protocol Violation|1|||
125291208|NCT00762996|450693279|FG003|Period One|Protocol Violation|0|||
125291209|NCT00762996|450693276|FG000|Period One|ineligible|0|||
125291210|NCT00762996|450693277|FG001|Period One|ineligible|0|||
125291211|NCT00762996|450693278|FG002|Period One|ineligible|1|||
125291212|NCT00762996|450693279|FG003|Period One|ineligible|1|||
125291213|NCT00762996|450693276|FG000|Period One|Adverse Event|0|||
125291214|NCT00762996|450693277|FG001|Period One|Adverse Event|0|||
125291215|NCT00762996|450693278|FG002|Period One|Adverse Event|1|||
125291216|NCT00762996|450693279|FG003|Period One|Adverse Event|0|||
125291217|NCT00762996|450693276|FG000|Period One|Withdrawal by Subject|0|||
125291218|NCT00762996|450693277|FG001|Period One|Withdrawal by Subject|0|||
125291219|NCT00762996|450693278|FG002|Period One|Withdrawal by Subject|1|||
125291220|NCT00762996|450693279|FG003|Period One|Withdrawal by Subject|0|||
125291221|NCT02689076|450693281|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
125291222|NCT02689076|450693282|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
125291223|NCT02689076|450693283|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
125291224|NCT02689076|450693281|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
125291225|NCT02689076|450693282|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
125291226|NCT02689076|450693283|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
125291227|NCT02689076|450693281|FG000|Overall Study|Did not have an HIE match|2|||
125291228|NCT02689076|450693282|FG001|Overall Study|Did not have an HIE match|0|||
125291229|NCT02689076|450693283|FG002|Overall Study|Did not have an HIE match|0|||
125291230|NCT02689076|450693281|FG000|Overall Study|Death during non-VA encounter|2|||
125291231|NCT02689076|450693282|FG001|Overall Study|Death during non-VA encounter|5|||
125291232|NCT02689076|450693283|FG002|Overall Study|Death during non-VA encounter|0|||
125291233|NCT02689076|450693281|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
125291234|NCT02689076|450693282|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
125291235|NCT02689076|450693283|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
125291236|NCT02689076|450693281|FG000|Overall Study|Participant no longer active in VA system|1|||
125291237|NCT02689076|450693282|FG001|Overall Study|Participant no longer active in VA system|0|||
125291238|NCT02689076|450693283|FG002|Overall Study|Participant no longer active in VA system|0|||
125291239|NCT02689076|450693281|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
125291240|NCT02689076|450693282|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
125291241|NCT02689076|450693283|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
125291242|NCT01143896|450693285|FG000|Overall Study|Did not complete Baseline Interview|5|||
125291243|NCT01143896|450693286|FG001|Overall Study|Did not complete Baseline Interview|4|||
125291244|NCT01143896|450693285|FG000|Overall Study|Lost to Follow-up|18|||
125291245|NCT01143896|450693286|FG001|Overall Study|Lost to Follow-up|13|||
125291246|NCT01143896|450693285|FG000|Overall Study|Withdrawal by Subject|13|||
125291247|NCT01143896|450693286|FG001|Overall Study|Withdrawal by Subject|5|||
125291248|NCT01143896|450693285|FG000|Overall Study|Death|6|||
125291249|NCT01143896|450693286|FG001|Overall Study|Death|3|||
125291250|NCT02084238|450693287|FG000|Overall Study|Lost to Follow-up|2|||
125291251|NCT00320372|450693288|FG000|Overall Study|Physician Decision|4|||
125291252|NCT00320372|450693289|FG001|Overall Study|Physician Decision|7|||
124783969|NCT00566696|448840013|FG000|Overall Study|Non-Patient Donors|37|||
125291253|NCT00320372|450693288|FG000|Overall Study|Death|7|||
125291254|NCT00320372|450693289|FG001|Overall Study|Death|8|||
125291255|NCT00320372|450693288|FG000|Overall Study|Withdrawal by Subject|55|||
125291256|NCT00320372|450693289|FG001|Overall Study|Withdrawal by Subject|37|||
125291257|NCT00320372|450693288|FG000|Overall Study|Non-Compliance|40|||
125291258|NCT00320372|450693289|FG001|Overall Study|Non-Compliance|39|||
125291259|NCT00320372|450693288|FG000|Overall Study|Did not Meet (I/E)|3|||
125291260|NCT00320372|450693289|FG001|Overall Study|Did not Meet (I/E)|1|||
125291261|NCT00320372|450693288|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
125291262|NCT00320372|450693289|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
125291263|NCT00849875|450693290|FG000|Overall Study|Death|28|||
125291264|NCT00849875|450693290|FG000|Overall Study|Ongoing (unknown completion status)|11|||
125291265|NCT00849875|450693290|FG000|Overall Study|Others|6|||
125291266|NCT00849875|450693290|FG000|Overall Study|Lost to Follow-up|2|||
125291267|NCT00086502|450693291|FG000|Overall Study|Adverse Event|11|||
125291268|NCT00086502|450693292|FG001|Overall Study|Adverse Event|2|||
125291269|NCT00086502|450693291|FG000|Overall Study|Lack of Efficacy|0|||
125291270|NCT00086502|450693292|FG001|Overall Study|Lack of Efficacy|2|||
125291271|NCT00086502|450693291|FG000|Overall Study|Lost to Follow-up|3|||
125291272|NCT00086502|450693292|FG001|Overall Study|Lost to Follow-up|1|||
125291273|NCT00086502|450693291|FG000|Overall Study|Physician Decision|1|||
125291274|NCT00086502|450693292|FG001|Overall Study|Physician Decision|1|||
125291275|NCT00086502|450693291|FG000|Overall Study|Pregnancy|0|||
125291276|NCT00086502|450693292|FG001|Overall Study|Pregnancy|1|||
125291277|NCT00086502|450693291|FG000|Overall Study|Protocol Violation|3|||
125291278|NCT00086502|450693292|FG001|Overall Study|Protocol Violation|3|||
125291279|NCT00086502|450693291|FG000|Overall Study|Withdrawal by Subject|5|||
125291280|NCT00086502|450693292|FG001|Overall Study|Withdrawal by Subject|6|||
125291281|NCT00086502|450693291|FG000|Overall Study|Patient Moved|1|||
125291282|NCT00086502|450693292|FG001|Overall Study|Patient Moved|1|||
125291283|NCT00086502|450693291|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
125291284|NCT00086502|450693292|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
125291285|NCT00086502|450693291|FG000|Overall Study|Patient Accidentally Unblinded|1|||
125291286|NCT00086502|450693292|FG001|Overall Study|Patient Accidentally Unblinded|0|||
125291287|NCT01304329|450693293|FG000|Third Intervention (3 Days)|Adverse Event|0|||
125291288|NCT01304329|450693294|FG001|Third Intervention (3 Days)|Adverse Event|1|||
125291289|NCT01304329|450693295|FG002|Third Intervention (3 Days)|Adverse Event|0|||
125291290|NCT01304329|450693296|FG003|Third Intervention (3 Days)|Adverse Event|0|||
125291291|NCT01304329|450693297|FG004|Third Intervention (3 Days)|Adverse Event|0|||
125291292|NCT01304329|450693298|FG005|Third Intervention (3 Days)|Adverse Event|0|||
125291293|NCT02068118|450693306|FG000|18-month Comparative Study Period|Death|90|||
125291294|NCT02068118|450693307|FG001|18-month Comparative Study Period|Death|97|||
125291295|NCT02068118|450693306|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
125291296|NCT02068118|450693307|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
125291297|NCT02068118|450693306|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
125291298|NCT02068118|450693307|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
125291299|NCT02068118|450693306|FG000|18-month Comparative Study Period|Heart transplant|9|||
125291300|NCT02068118|450693307|FG001|18-month Comparative Study Period|Heart transplant|15|||
125291301|NCT02068118|450693306|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
125291302|NCT02068118|450693307|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
125291303|NCT02068118|450693306|FG000|18-month Comparative Study Period|Hemiplegia|0|||
125291304|NCT02068118|450693307|FG001|18-month Comparative Study Period|Hemiplegia|1|||
125291305|NCT02068118|450693306|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
125291306|NCT02068118|450693307|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
125291307|NCT02068118|450693306|FG000|18-month Comparative Study Period|Move|0|||
125291308|NCT02068118|450693307|FG001|18-month Comparative Study Period|Move|1|||
125291309|NCT02068118|450693306|FG000|18-month Comparative Study Period|Hearing loss|0|||
125291310|NCT02068118|450693307|FG001|18-month Comparative Study Period|Hearing loss|1|||
125291311|NCT02068118|450693306|FG000|Extension Period|Death|0|||
125291312|NCT02068118|450693307|FG001|Extension Period|Death|2|||
125291313|NCT02068118|450693306|FG000|Extension Period|Withdrawal by Subject|1|||
125291314|NCT02068118|450693307|FG001|Extension Period|Withdrawal by Subject|0|||
125291315|NCT02068118|450693306|FG000|Extension Period|Heart transplant|1|||
125291316|NCT02068118|450693307|FG001|Extension Period|Heart transplant|0|||
125291317|NCT02068118|450693306|FG000|Extension Period|Wrong device use|0|||
125291318|NCT02068118|450693307|FG001|Extension Period|Wrong device use|1|||
125291319|NCT00283868|450693308|FG000|Overall Study|Lost to Follow-up|7|||
125291320|NCT00283868|450693309|FG001|Overall Study|Lost to Follow-up|8|||
125291321|NCT01515475|450693310|FG000|Overall Study|Lost to Follow-up|20|||
125291322|NCT01515475|450693311|FG001|Overall Study|Lost to Follow-up|15|||
125291323|NCT01515475|450693312|FG002|Overall Study|Lost to Follow-up|12|||
125291324|NCT01515475|450693313|FG003|Overall Study|Lost to Follow-up|12|||
125291325|NCT01420627|450693314|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
125291326|NCT00837876|450693315|FG000|Overall Study|Death|2|||
125291327|NCT00837876|450693315|FG000|Overall Study|Adverse Event|7|||
125291328|NCT00837876|450693315|FG000|Overall Study|Physician Decision|1|||
125291329|NCT00837876|450693315|FG000|Overall Study|Withdrawal by Subject|3|||
125291330|NCT00837876|450693315|FG000|Overall Study|disease progression|24|||
125291331|NCT01996592|450693320|FG000|Overall Study|no response to text/no diary entry|32|||
125291332|NCT01996592|450693320|FG000|Overall Study|change in surgical date|4|||
125291333|NCT01996592|450693320|FG000|Overall Study|Withdrawal by Subject|5|||
125291334|NCT01996592|450693320|FG000|Overall Study|change in mode of delivery|4|||
125291335|NCT02075632|450693323|FG000|Overall Study|Adverse Event|1|||
125291336|NCT02075632|450693324|FG001|Overall Study|Adverse Event|1|||
125291337|NCT02075632|450693323|FG000|Overall Study|Lost to Follow-up|0|||
125291338|NCT02075632|450693324|FG001|Overall Study|Lost to Follow-up|3|||
125291339|NCT02075632|450693323|FG000|Overall Study|Withdrawal by Subject|0|||
125291340|NCT02075632|450693324|FG001|Overall Study|Withdrawal by Subject|1|||
125291341|NCT05028517|450693325|FG000|Overall Study|Lost to Follow-up|13|||
125291342|NCT05028517|450693326|FG001|Overall Study|Lost to Follow-up|20|||
125291343|NCT05028517|450693327|FG002|Overall Study|Lost to Follow-up|12|||
125291344|NCT05028517|450693325|FG000|Overall Study|Withdrawal by Subject|0|||
125291345|NCT05028517|450693326|FG001|Overall Study|Withdrawal by Subject|0|||
125291346|NCT05028517|450693327|FG002|Overall Study|Withdrawal by Subject|1|||
125291347|NCT02256267|450693328|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
125291348|NCT02256267|450693328|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
125291349|NCT00259298|450693336|FG000|Overall Study|Withdrawal by Subject|1|||
125291350|NCT00259298|450693336|FG000|Overall Study|Physician Decision|2|||
125291351|NCT01969500|450693342|FG000|Overall Study|Death|0|||
125291352|NCT01969500|450693343|FG001|Overall Study|Death|1|||
125291353|NCT01969500|450693342|FG000|Overall Study|extended hospitalization|1|||
125291354|NCT01969500|450693343|FG001|Overall Study|extended hospitalization|1|||
125291355|NCT00613080|450693344|FG000|Overall Study|Ineligible / no protocol treatment|11|||
125291356|NCT03757130|450693345|FG000|Overall Study|Lost to Follow-up|0|||
125291357|NCT03757130|450693346|FG001|Overall Study|Lost to Follow-up|0|||
125291358|NCT03757130|450693347|FG002|Overall Study|Lost to Follow-up|0|||
125291359|NCT03757130|450693348|FG003|Overall Study|Lost to Follow-up|1|||
125291360|NCT03757130|450693349|FG004|Overall Study|Lost to Follow-up|0|||
125291361|NCT03757130|450693350|FG005|Overall Study|Lost to Follow-up|0|||
125291362|NCT03757130|450693351|FG006|Overall Study|Lost to Follow-up|0|||
125291363|NCT03757130|450693352|FG007|Overall Study|Lost to Follow-up|1|||
125291364|NCT03757130|450693345|FG000|Overall Study|Withdrawal by Subject|0|||
125291365|NCT03757130|450693346|FG001|Overall Study|Withdrawal by Subject|0|||
125291366|NCT03757130|450693347|FG002|Overall Study|Withdrawal by Subject|0|||
125291367|NCT03757130|450693348|FG003|Overall Study|Withdrawal by Subject|0|||
125291368|NCT03757130|450693349|FG004|Overall Study|Withdrawal by Subject|0|||
125291369|NCT03757130|450693350|FG005|Overall Study|Withdrawal by Subject|0|||
125291370|NCT03757130|450693351|FG006|Overall Study|Withdrawal by Subject|1|||
125291371|NCT03757130|450693352|FG007|Overall Study|Withdrawal by Subject|0|||
125291372|NCT02226549|450693353|FG000|Overall Study|Randomized but Never Treated|1|||
125291373|NCT02226549|450693354|FG001|Overall Study|Randomized but Never Treated|0|||
125291374|NCT02226549|450693353|FG000|Overall Study|Lost to Follow-up|0|||
125291375|NCT02226549|450693354|FG001|Overall Study|Lost to Follow-up|1|||
125291376|NCT02726880|450693355|FG000|Overall Study|Withdrawal by Subject|2|||
125291377|NCT02726880|450693356|FG001|Overall Study|Withdrawal by Subject|0|||
125291378|NCT02726880|450693355|FG000|Overall Study|Lost to Follow-up|1|||
125291379|NCT02726880|450693356|FG001|Overall Study|Lost to Follow-up|3|||
125291380|NCT01269385|450693357|FG000|Overall Study|Adverse Event|1|||
125291381|NCT01269385|450693358|FG001|Overall Study|Adverse Event|1|||
125291382|NCT01269385|450693359|FG002|Overall Study|Adverse Event|0|||
125291383|NCT01269385|450693360|FG003|Overall Study|Adverse Event|0|||
125291384|NCT03553498|450693361|FG000|Overall Study|Missing primary outcome|1|||
125291385|NCT03553498|450693362|FG001|Overall Study|Missing primary outcome|2|||
125291386|NCT04941807|450693363|FG000|Overall Study|Lost to Follow-up|1|||
125291387|NCT04941807|450693364|FG001|Overall Study|Lost to Follow-up|1|||
125291388|NCT02741570|450693365|FG000|Pre-Treatment Period|Other reasons|0|||
125291389|NCT02741570|450693366|FG001|Pre-Treatment Period|Other reasons|3|||
125291390|NCT02741570|450693365|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
125291391|NCT02741570|450693366|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
125291392|NCT02741570|450693365|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
125291393|NCT02741570|450693366|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
125291394|NCT02741570|450693365|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
125291395|NCT02741570|450693366|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
125291396|NCT02741570|450693365|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
125291397|NCT02741570|450693366|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
125291398|NCT02741570|450693365|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
125291399|NCT02741570|450693366|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
125291400|NCT02741570|450693365|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
125291401|NCT02741570|450693366|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
125291402|NCT02741570|450693365|FG000|Pre-Treatment Period|Death|0|||
124783970|NCT06338462|448840014|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
124783971|NCT00452361|448840017|FG000|Overall Study|Adverse Event|8|||
124783972|NCT00452361|448840018|FG001|Overall Study|Adverse Event|0|||
124783973|NCT00452361|448840017|FG000|Overall Study|Withdrawal by Subject|0|||
124783974|NCT00452361|448840018|FG001|Overall Study|Withdrawal by Subject|1|||
124783975|NCT00452361|448840017|FG000|Overall Study|Premature termination|13|||
124783976|NCT00452361|448840018|FG001|Overall Study|Premature termination|9|||
124783977|NCT03116152|448840021|FG000|Overall Study|Disease Progression|49|||
124783978|NCT03116152|448840022|FG001|Overall Study|Disease Progression|47|||
124783979|NCT03116152|448840021|FG000|Overall Study|Death|5|||
124783980|NCT03116152|448840022|FG001|Overall Study|Death|2|||
124783981|NCT03116152|448840021|FG000|Overall Study|Adverse Event|21|||
124783982|NCT03116152|448840022|FG001|Overall Study|Adverse Event|7|||
124783983|NCT03116152|448840021|FG000|Overall Study|Protocol Violation|2|||
124783984|NCT03116152|448840022|FG001|Overall Study|Protocol Violation|2|||
124783985|NCT03116152|448840021|FG000|Overall Study|Withdrawal by Subject|0|||
124783986|NCT03116152|448840022|FG001|Overall Study|Withdrawal by Subject|1|||
124783987|NCT03116152|448840021|FG000|Overall Study|Physician Decision|3|||
124783988|NCT03116152|448840022|FG001|Overall Study|Physician Decision|2|||
124783989|NCT03116152|448840021|FG000|Overall Study|other|11|||
124783990|NCT03116152|448840022|FG001|Overall Study|other|34|||
124783991|NCT03179605|448840023|FG000|Overall Study|Withdrawal by Subject|1|||
124783992|NCT00910299|448840024|FG000|Overall Study|Withdrawal by Subject|16|||
124783993|NCT00910299|448840025|FG001|Overall Study|Withdrawal by Subject|13|||
124783994|NCT00910299|448840024|FG000|Overall Study|Sponsor Decision|58|||
124783995|NCT00910299|448840025|FG001|Overall Study|Sponsor Decision|60|||
124783996|NCT00910299|448840024|FG000|Overall Study|Didn't receive any study drug|2|||
124783997|NCT00910299|448840025|FG001|Overall Study|Didn't receive any study drug|1|||
124783998|NCT00635999|448840026|FG000|Overall Study|Withdrawal by Subject|4|||
124783999|NCT00635999|448840027|FG001|Overall Study|Withdrawal by Subject|2|||
124784000|NCT00635999|448840028|FG002|Overall Study|Withdrawal by Subject|1|||
124784001|NCT00228553|448840033|FG000|Overall Study|Adverse Event|112|||
124784002|NCT00228553|448840033|FG000|Overall Study|Lack of Efficacy|34|||
124784003|NCT00228553|448840033|FG000|Overall Study|Lost to Follow-up|67|||
124784004|NCT00228553|448840033|FG000|Overall Study|Physician Decision|48|||
124784005|NCT00228553|448840033|FG000|Overall Study|Protocol Violation|6|||
124784006|NCT00228553|448840033|FG000|Overall Study|Withdrawal by Subject|115|||
124784007|NCT00228553|448840033|FG000|Overall Study|Pregnancy|2|||
124784008|NCT00228553|448840033|FG000|Overall Study|Miscellaneous|46|||
124784009|NCT01536392|448840034|FG000|Overall Study|Adverse Event|2|||
124784010|NCT01536392|448840035|FG001|Overall Study|Adverse Event|2|||
124784011|NCT01536392|448840034|FG000|Overall Study|Physician Decision|2|||
124784012|NCT01536392|448840035|FG001|Overall Study|Physician Decision|3|||
124784013|NCT01536392|448840034|FG000|Overall Study|Withdrawal by Subject|3|||
124784014|NCT01536392|448840035|FG001|Overall Study|Withdrawal by Subject|6|||
124784015|NCT01536392|448840034|FG000|Overall Study|Non Compliance|3|||
124784016|NCT01536392|448840035|FG001|Overall Study|Non Compliance|4|||
124784017|NCT01536392|448840034|FG000|Overall Study|Completed therapy early|3|||
124784018|NCT01536392|448840035|FG001|Overall Study|Completed therapy early|0|||
124784019|NCT02259088|448840037|FG000|Overall Study|Adverse Event|6|||
124784020|NCT02259088|448840038|FG001|Overall Study|Adverse Event|4|||
124784021|NCT02259088|448840037|FG000|Overall Study|Lost to Follow-up|2|||
124784022|NCT02259088|448840038|FG001|Overall Study|Lost to Follow-up|0|||
124784023|NCT02259088|448840037|FG000|Overall Study|Death|2|||
124784024|NCT02259088|448840038|FG001|Overall Study|Death|0|||
124784025|NCT02259088|448840037|FG000|Overall Study|Physician Decision|5|||
124784026|NCT02259088|448840038|FG001|Overall Study|Physician Decision|2|||
124784027|NCT02259088|448840037|FG000|Overall Study|Protocol deviation|5|||
124784028|NCT02259088|448840038|FG001|Overall Study|Protocol deviation|0|||
124784029|NCT02259088|448840037|FG000|Overall Study|Subject/guardian decision|8|||
124784030|NCT02259088|448840038|FG001|Overall Study|Subject/guardian decision|8|||
124784031|NCT01033448|448840040|FG000|Overall Study|Withdrawal by Subject|4|||
124784032|NCT01033448|448840040|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
124784033|NCT01033448|448840040|FG000|Overall Study|Lost to Follow-up|3|||
124784034|NCT01033448|448840040|FG000|Overall Study|Withdrew due to other reasons|3|||
124784035|NCT01033448|448840040|FG000|Overall Study|Unknown disposition|1|||
125291403|NCT02741570|450693366|FG001|Pre-Treatment Period|Death|1|||
125291404|NCT02741570|450693365|FG000|Pre-Treatment Period|Disease progression|0|||
124784036|NCT01818752|448840041|FG000|Overall Study|Adverse Event|64|||
124784037|NCT01818752|448840042|FG001|Overall Study|Adverse Event|74|||
124784038|NCT01818752|448840041|FG000|Overall Study|Death|14|||
124784039|NCT01818752|448840042|FG001|Overall Study|Death|18|||
124784040|NCT01818752|448840041|FG000|Overall Study|Non-compliance|16|||
124784041|NCT01818752|448840042|FG001|Overall Study|Non-compliance|20|||
124784042|NCT01818752|448840041|FG000|Overall Study|Withdrawal by Subject|15|||
124784043|NCT01818752|448840042|FG001|Overall Study|Withdrawal by Subject|14|||
124784044|NCT01818752|448840041|FG000|Overall Study|Physician Decision|9|||
124784045|NCT01818752|448840042|FG001|Overall Study|Physician Decision|8|||
124784046|NCT01818752|448840041|FG000|Overall Study|Disease Progression|54|||
125291405|NCT02741570|450693366|FG001|Pre-Treatment Period|Disease progression|1|||
125291406|NCT02741570|450693365|FG000|Treatment Period|Other reasons|47|||
125291407|NCT02741570|450693366|FG001|Treatment Period|Other reasons|12|||
125291408|NCT02741570|450693365|FG000|Treatment Period|Poor/non-compliance|0|||
125291409|NCT02741570|450693366|FG001|Treatment Period|Poor/non-compliance|2|||
125291410|NCT02741570|450693365|FG000|Treatment Period|Maximum clinical benefit|4|||
125291411|NCT02741570|450693366|FG001|Treatment Period|Maximum clinical benefit|6|||
125291412|NCT02741570|450693365|FG000|Treatment Period|Lost to Follow-up|1|||
125291413|NCT02741570|450693366|FG001|Treatment Period|Lost to Follow-up|3|||
125291414|NCT02741570|450693365|FG000|Treatment Period|Participant withdrew consent|9|||
125291415|NCT02741570|450693366|FG001|Treatment Period|Participant withdrew consent|13|||
125291416|NCT02741570|450693365|FG000|Treatment Period|Participant request to discontinue treatment|8|||
125291417|NCT02741570|450693366|FG001|Treatment Period|Participant request to discontinue treatment|23|||
125291418|NCT02741570|450693365|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
125291419|NCT02741570|450693366|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
125291420|NCT02741570|450693365|FG000|Treatment Period|Death|9|||
125291421|NCT02741570|450693366|FG001|Treatment Period|Death|7|||
125291422|NCT02741570|450693365|FG000|Treatment Period|Study drug toxicity|55|||
125291423|NCT02741570|450693366|FG001|Treatment Period|Study drug toxicity|47|||
125291424|NCT02741570|450693365|FG000|Treatment Period|Disease progression|294|||
125291425|NCT02741570|450693366|FG001|Treatment Period|Disease progression|301|||
125291426|NCT02741570|450693365|FG000|Treatment Period|Administrative reason by sponsor|0|||
125291427|NCT02741570|450693366|FG001|Treatment Period|Administrative reason by sponsor|1|||
125291428|NCT01100567|450693367|FG000|Overall Study|Withdrawal by Subject|5|||
125291429|NCT01100567|450693368|FG001|Overall Study|Withdrawal by Subject|8|||
125291430|NCT01100567|450693367|FG000|Overall Study|Early Hospital Discharge|6|||
125291431|NCT01100567|450693368|FG001|Overall Study|Early Hospital Discharge|4|||
125291432|NCT01100567|450693367|FG000|Overall Study|Lost to Follow-up|1|||
125291433|NCT01100567|450693368|FG001|Overall Study|Lost to Follow-up|2|||
125291434|NCT01100567|450693367|FG000|Overall Study|Physician Decision|0|||
125291435|NCT01100567|450693368|FG001|Overall Study|Physician Decision|1|||
125291436|NCT01100567|450693367|FG000|Overall Study|Deemed ineligible after consent|0|||
125291437|NCT01100567|450693368|FG001|Overall Study|Deemed ineligible after consent|1|||
125291438|NCT03697993|450693380|FG000|Overall Study|Became Ineligible after Enrollment|1|||
125291439|NCT03697993|450693381|FG001|Overall Study|Became Ineligible after Enrollment|3|||
125291440|NCT03697993|450693380|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
125291441|NCT03697993|450693381|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
125291442|NCT03697993|450693380|FG000|Overall Study|Lost to Follow-up|3|||
125291443|NCT03697993|450693381|FG001|Overall Study|Lost to Follow-up|0|||
125291444|NCT03697993|450693380|FG000|Overall Study|Physician Decision|4|||
125291445|NCT03697993|450693381|FG001|Overall Study|Physician Decision|0|||
125291446|NCT03697993|450693380|FG000|Overall Study|Initial Urine Culture Negative|0|||
125291447|NCT03697993|450693381|FG001|Overall Study|Initial Urine Culture Negative|1|||
125291448|NCT03759041|450693382|FG000|Overall Study|Withdrawal by Subject|4|||
125291449|NCT03759041|450693383|FG001|Overall Study|Withdrawal by Subject|10|||
125291450|NCT03759041|450693384|FG002|Overall Study|Withdrawal by Subject|10|||
125291451|NCT03759041|450693382|FG000|Overall Study|Adverse Event|1|||
125291452|NCT03759041|450693383|FG001|Overall Study|Adverse Event|3|||
125291453|NCT03759041|450693384|FG002|Overall Study|Adverse Event|4|||
125291454|NCT03759041|450693382|FG000|Overall Study|Lack of Efficacy|0|||
125291455|NCT03759041|450693383|FG001|Overall Study|Lack of Efficacy|0|||
125291456|NCT03759041|450693384|FG002|Overall Study|Lack of Efficacy|1|||
125291457|NCT03759041|450693382|FG000|Overall Study|Study Terminated by Sponsor|15|||
125291458|NCT03759041|450693383|FG001|Overall Study|Study Terminated by Sponsor|16|||
125291459|NCT03759041|450693384|FG002|Overall Study|Study Terminated by Sponsor|10|||
125291460|NCT03759041|450693382|FG000|Overall Study|Other reason for discontinuation|0|||
125291461|NCT03759041|450693383|FG001|Overall Study|Other reason for discontinuation|2|||
125291462|NCT03759041|450693384|FG002|Overall Study|Other reason for discontinuation|1|||
125291463|NCT03759041|450693382|FG000|Overall Study|Lost to Follow-up|7|||
125291464|NCT03759041|450693383|FG001|Overall Study|Lost to Follow-up|2|||
125291465|NCT03759041|450693384|FG002|Overall Study|Lost to Follow-up|2|||
125291466|NCT03759041|450693382|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
125291467|NCT03759041|450693383|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
125291468|NCT03759041|450693384|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
125291469|NCT04384107|450693385|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
125291470|NCT04384107|450693386|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
125291471|NCT04384107|450693385|FG000|Overall Study|Lost to Follow-up|1|||
125291472|NCT04384107|450693386|FG001|Overall Study|Lost to Follow-up|0|||
125291473|NCT00276614|450693387|FG000|Overall Study|Progression of disease under study|3|||
125291474|NCT01522404|450693390|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
125291475|NCT01522404|450693391|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
125291476|NCT01522404|450693390|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
125291477|NCT01522404|450693391|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
124784047|NCT01818752|448840042|FG001|Overall Study|Disease Progression|48|||
124784048|NCT01818752|448840041|FG000|Overall Study|Other|7|||
124784049|NCT01818752|448840042|FG001|Overall Study|Other|8|||
124784050|NCT01818752|448840041|FG000|Overall Study|Continuing Treatment|1|||
124784051|NCT01818752|448840042|FG001|Overall Study|Continuing Treatment|4|||
124784052|NCT01818752|448840041|FG000|Overall Study|Randomized but not Dosed|7|||
124784053|NCT01818752|448840042|FG001|Overall Study|Randomized but not Dosed|4|||
124784054|NCT01324141|448840043|FG000|Overall Study|Declined to participate before treatment started|1|||
124784055|NCT01324141|448840043|FG000|Overall Study|Disease progression on study|1|||
124784056|NCT01165216|448840049|FG000|Overall Study|Adverse Event|6|||
124784057|NCT01165216|448840050|FG001|Overall Study|Adverse Event|3|||
124784058|NCT01165216|448840049|FG000|Overall Study|Withdrawal by Subject|1|||
124784059|NCT01165216|448840050|FG001|Overall Study|Withdrawal by Subject|1|||
124784060|NCT01165216|448840049|FG000|Overall Study|Disease progression|1|||
124784061|NCT01165216|448840050|FG001|Overall Study|Disease progression|3|||
125291478|NCT01522404|450693390|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
125291479|NCT01522404|450693391|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
125291480|NCT02698371|450693392|FG000|All Participants Flow|Lost to Follow-up|3|||
125291481|NCT02698371|450693392|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
125291482|NCT02698371|450693392|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
125291483|NCT02698371|450693392|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
125291484|NCT02698371|450693392|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
125291485|NCT02698371|450693392|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
125291486|NCT02698371|450693392|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
125291487|NCT03734029|450693393|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
125291488|NCT03734029|450693394|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
125291489|NCT03734029|450693393|FG000|Overall Study|Adverse Event|60|||
125291490|NCT03734029|450693394|FG001|Overall Study|Adverse Event|14|||
124784078|NCT06457204|448840060|FG000|Washout|Adverse Event|0|||
124784079|NCT06457204|448840061|FG001|Washout|Adverse Event|2|||
124784080|NCT01808092|448840062|FG000|Overall Study|Death|39|||
124784081|NCT01808092|448840063|FG001|Overall Study|Death|29|||
124784082|NCT01808092|448840062|FG000|Overall Study|Lost to Follow-up|3|||
124784083|NCT01808092|448840063|FG001|Overall Study|Lost to Follow-up|7|||
124784084|NCT01808092|448840062|FG000|Overall Study|Withdrawal by Subject|9|||
124784085|NCT01808092|448840063|FG001|Overall Study|Withdrawal by Subject|4|||
124784086|NCT01808092|448840062|FG000|Overall Study|Other Eligibility criteria|3|||
124784087|NCT01808092|448840063|FG001|Overall Study|Other Eligibility criteria|5|||
124784088|NCT01097005|448840064|FG000|Overall Study|Case Report Form not collected|18|||
124784089|NCT01097005|448840064|FG000|Overall Study|Subjects cannot visit the hospital|1|||
124784090|NCT01097005|448840064|FG000|Overall Study|Poor medication compliance|1|||
124784091|NCT01097005|448840064|FG000|Overall Study|No examination data available|244|||
124784092|NCT01097005|448840064|FG000|Overall Study|Deviation from exclusion criteria|37|||
124784093|NCT01097005|448840064|FG000|Overall Study|Adverse Event|14|||
124784094|NCT01097005|448840064|FG000|Overall Study|Discontinuance by complication|50|||
124784095|NCT05289037|448840069|FG000|Overall Study|Withdrawal by Subject|7|||
124784096|NCT05289037|448840070|FG001|Overall Study|Withdrawal by Subject|0|||
124784097|NCT05289037|448840071|FG002|Overall Study|Withdrawal by Subject|3|||
124784098|NCT05289037|448840072|FG003|Overall Study|Withdrawal by Subject|3|||
124784099|NCT05289037|448840073|FG004|Overall Study|Withdrawal by Subject|1|||
124784100|NCT05289037|448840074|FG005|Overall Study|Withdrawal by Subject|5|||
124784101|NCT05289037|448840075|FG006|Overall Study|Withdrawal by Subject|2|||
124784102|NCT05289037|448840076|FG007|Overall Study|Withdrawal by Subject|1|||
124784103|NCT05289037|448840077|FG008|Overall Study|Withdrawal by Subject|2|||
124784104|NCT05289037|448840078|FG009|Overall Study|Withdrawal by Subject|2|||
124784105|NCT05289037|448840079|FG010|Overall Study|Withdrawal by Subject|1|||
124784106|NCT05289037|448840080|FG011|Overall Study|Withdrawal by Subject|0|||
124784107|NCT05289037|448840081|FG012|Overall Study|Withdrawal by Subject|1|||
124784108|NCT05289037|448840082|FG013|Overall Study|Withdrawal by Subject|2|||
124784109|NCT05289037|448840083|FG014|Overall Study|Withdrawal by Subject|0|||
124784110|NCT05289037|448840084|FG015|Overall Study|Withdrawal by Subject|3|||
124784111|NCT05289037|448840085|FG016|Overall Study|Withdrawal by Subject|3|||
124784112|NCT05289037|448840069|FG000|Overall Study|Lost to Follow-up|1|||
124784113|NCT05289037|448840070|FG001|Overall Study|Lost to Follow-up|4|||
124784114|NCT05289037|448840071|FG002|Overall Study|Lost to Follow-up|3|||
124784115|NCT05289037|448840072|FG003|Overall Study|Lost to Follow-up|3|||
124784116|NCT05289037|448840073|FG004|Overall Study|Lost to Follow-up|3|||
124784117|NCT05289037|448840074|FG005|Overall Study|Lost to Follow-up|2|||
124784118|NCT05289037|448840075|FG006|Overall Study|Lost to Follow-up|3|||
124784119|NCT05289037|448840076|FG007|Overall Study|Lost to Follow-up|2|||
124784120|NCT05289037|448840077|FG008|Overall Study|Lost to Follow-up|2|||
124784121|NCT05289037|448840078|FG009|Overall Study|Lost to Follow-up|1|||
124784122|NCT05289037|448840079|FG010|Overall Study|Lost to Follow-up|3|||
124784123|NCT05289037|448840080|FG011|Overall Study|Lost to Follow-up|4|||
124784124|NCT05289037|448840081|FG012|Overall Study|Lost to Follow-up|2|||
124784125|NCT05289037|448840082|FG013|Overall Study|Lost to Follow-up|7|||
125291491|NCT03734029|450693393|FG000|Overall Study|Withdrawal by Subject|12|||
125291492|NCT03734029|450693394|FG001|Overall Study|Withdrawal by Subject|11|||
125291493|NCT03734029|450693393|FG000|Overall Study|Clinical progression by investigator|10|||
125291494|NCT03734029|450693394|FG001|Overall Study|Clinical progression by investigator|8|||
125291495|NCT03734029|450693393|FG000|Overall Study|Death|5|||
125291496|NCT03734029|450693394|FG001|Overall Study|Death|2|||
125291497|NCT03734029|450693393|FG000|Overall Study|Physician Decision|4|||
125291498|NCT03734029|450693394|FG001|Overall Study|Physician Decision|3|||
125291499|NCT03734029|450693393|FG000|Overall Study|Other|2|||
125291500|NCT03734029|450693394|FG001|Overall Study|Other|0|||
125291501|NCT03734029|450693393|FG000|Overall Study|Lost to Follow-up|0|||
125291502|NCT03734029|450693394|FG001|Overall Study|Lost to Follow-up|1|||
125291503|NCT03734029|450693393|FG000|Overall Study|Randomized, but not treated|2|||
125291504|NCT03734029|450693394|FG001|Overall Study|Randomized, but not treated|12|||
125291505|NCT03081858|450694879|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
125291506|NCT03081858|450694880|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
125291507|NCT03081858|450694881|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
125291508|NCT03081858|450694882|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
125291509|NCT00262847|450694885|FG000|Overall Study|Disease Progression|309|||
125291510|NCT00262847|450694886|FG001|Overall Study|Disease Progression|274|||
125291511|NCT00262847|450694887|FG002|Overall Study|Disease Progression|195|||
125291512|NCT00262847|450694885|FG000|Overall Study|Patient Refusal|41|||
125291513|NCT00262847|450694886|FG001|Overall Study|Patient Refusal|52|||
125291514|NCT00262847|450694887|FG002|Overall Study|Patient Refusal|47|||
125291515|NCT00262847|450694885|FG000|Overall Study|Adverse Event|74|||
125291516|NCT00262847|450694886|FG001|Overall Study|Adverse Event|88|||
125291517|NCT00262847|450694887|FG002|Overall Study|Adverse Event|108|||
125291518|NCT00262847|450694885|FG000|Overall Study|Death|8|||
125291519|NCT00262847|450694886|FG001|Overall Study|Death|8|||
125291520|NCT00262847|450694887|FG002|Overall Study|Death|11|||
125291521|NCT00262847|450694885|FG000|Overall Study|Concomitant disease|3|||
125291522|NCT00262847|450694886|FG001|Overall Study|Concomitant disease|2|||
125291523|NCT00262847|450694887|FG002|Overall Study|Concomitant disease|4|||
125291524|NCT00262847|450694885|FG000|Overall Study|Other Reasons|79|||
125291525|NCT00262847|450694886|FG001|Overall Study|Other Reasons|88|||
125291526|NCT00262847|450694887|FG002|Overall Study|Other Reasons|27|||
125291527|NCT00262847|450694885|FG000|Overall Study|Did not receive study treatment|4|||
125291528|NCT00262847|450694886|FG001|Overall Study|Did not receive study treatment|1|||
125291529|NCT00262847|450694887|FG002|Overall Study|Did not receive study treatment|4|||
125291530|NCT03966885|450694888|FG000|Overall Study|Death|1|||
125291531|NCT03966885|450694889|FG001|Overall Study|Death|0|||
125291532|NCT03966885|450694888|FG000|Overall Study|Lost to Follow-up|1|||
125291533|NCT03966885|450694889|FG001|Overall Study|Lost to Follow-up|2|||
125291534|NCT03966885|450694888|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
125291535|NCT03966885|450694889|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
125291536|NCT03966885|450694888|FG000|Overall Study|Moved from study area.|0|||
125291537|NCT03966885|450694889|FG001|Overall Study|Moved from study area.|2|||
125291538|NCT03899064|450694904|FG000|Overall Study|Lost to Follow-up|1|||
125291539|NCT03899064|450694904|FG000|Overall Study|Protocol Violation|2|||
125291540|NCT03899064|450694904|FG000|Overall Study|Withdrawal by Subject|2|||
125291541|NCT03899064|450694904|FG000|Overall Study|Other|2|||
125291542|NCT00031460|450694907|FG000|Overall Study|Lost to Follow-up|0|||
125291543|NCT00031460|450694908|FG001|Overall Study|Lost to Follow-up|1|||
125291544|NCT00031460|450694907|FG000|Overall Study|Withdrawal by Subject|1|||
125291545|NCT00031460|450694908|FG001|Overall Study|Withdrawal by Subject|1|||
125291546|NCT00031460|450694907|FG000|Overall Study|Non-Compliant|1|||
125291547|NCT00031460|450694908|FG001|Overall Study|Non-Compliant|1|||
125291548|NCT00031460|450694907|FG000|Overall Study|Death|0|||
125291549|NCT00031460|450694908|FG001|Overall Study|Death|1|||
125291550|NCT00031460|450694907|FG000|Overall Study|Reactivation of Disease|5|||
125291551|NCT00031460|450694908|FG001|Overall Study|Reactivation of Disease|9|||
125291552|NCT00031460|450694907|FG000|Overall Study|Disruption of blinded drug supply|2|||
125291553|NCT00031460|450694908|FG001|Overall Study|Disruption of blinded drug supply|0|||
125291554|NCT00031460|450694907|FG000|Overall Study|Confirmed unevaluable|0|||
125291555|NCT00031460|450694908|FG001|Overall Study|Confirmed unevaluable|1|||
125291556|NCT02210832|450694909|FG000|Overall Study|Pregnancy termination .|3|||
125291557|NCT02210832|450694910|FG001|Overall Study|Pregnancy termination .|4|||
125291558|NCT02210832|450694911|FG002|Overall Study|Pregnancy termination .|1|||
125291559|NCT02210832|450694909|FG000|Overall Study|Lost to Follow-up|26|||
125291560|NCT02210832|450694910|FG001|Overall Study|Lost to Follow-up|32|||
125291561|NCT02210832|450694911|FG002|Overall Study|Lost to Follow-up|17|||
125291562|NCT02080260|450694916|FG000|Overall Study|Death|18|||
125291563|NCT02080260|450694916|FG000|Overall Study|Withdrawal by Subject|1|||
125291564|NCT00471887|450694919|FG000|Overall Study|Adverse Event|9|||
125291565|NCT03602885|450694920|FG000|Overall Study|Lost to Follow-up|3|||
125291566|NCT03602885|450694921|FG001|Overall Study|Lost to Follow-up|0|||
124784126|NCT05289037|448840083|FG014|Overall Study|Lost to Follow-up|4|||
124784127|NCT05289037|448840084|FG015|Overall Study|Lost to Follow-up|6|||
124784128|NCT05289037|448840085|FG016|Overall Study|Lost to Follow-up|4|||
124784129|NCT05289037|448840069|FG000|Overall Study|Death|0|||
124784130|NCT05289037|448840070|FG001|Overall Study|Death|0|||
124784131|NCT05289037|448840071|FG002|Overall Study|Death|0|||
124784132|NCT05289037|448840072|FG003|Overall Study|Death|0|||
124784133|NCT05289037|448840073|FG004|Overall Study|Death|0|||
124784134|NCT05289037|448840074|FG005|Overall Study|Death|1|||
124784135|NCT05289037|448840075|FG006|Overall Study|Death|0|||
124784136|NCT05289037|448840076|FG007|Overall Study|Death|0|||
124784137|NCT05289037|448840077|FG008|Overall Study|Death|0|||
124784138|NCT05289037|448840078|FG009|Overall Study|Death|0|||
124784139|NCT05289037|448840079|FG010|Overall Study|Death|0|||
124784140|NCT05289037|448840080|FG011|Overall Study|Death|0|||
124784141|NCT05289037|448840081|FG012|Overall Study|Death|0|||
124784142|NCT05289037|448840082|FG013|Overall Study|Death|0|||
124784143|NCT05289037|448840083|FG014|Overall Study|Death|1|||
124784144|NCT05289037|448840084|FG015|Overall Study|Death|0|||
124784145|NCT05289037|448840085|FG016|Overall Study|Death|0|||
124784146|NCT05289037|448840069|FG000|Overall Study|Did not receive vaccine|0|||
124784147|NCT05289037|448840070|FG001|Overall Study|Did not receive vaccine|3|||
124784148|NCT05289037|448840071|FG002|Overall Study|Did not receive vaccine|0|||
124784149|NCT05289037|448840072|FG003|Overall Study|Did not receive vaccine|0|||
124784150|NCT05289037|448840073|FG004|Overall Study|Did not receive vaccine|1|||
124784151|NCT05289037|448840074|FG005|Overall Study|Did not receive vaccine|1|||
124784152|NCT05289037|448840075|FG006|Overall Study|Did not receive vaccine|1|||
125291567|NCT00098722|450694922|FG000|Double Blind Phase|Adverse Event|7|||
125291568|NCT00098722|450694923|FG001|Double Blind Phase|Adverse Event|7|||
125291569|NCT00098722|450694924|FG002|Double Blind Phase|Adverse Event|3|||
125291570|NCT00098722|450694925|FG003|Double Blind Phase|Adverse Event|0|||
125291571|NCT00098722|450694926|FG004|Double Blind Phase|Adverse Event|0|||
125291572|NCT00098722|450694927|FG005|Double Blind Phase|Adverse Event|0|||
125291573|NCT00098722|450694928|FG006|Double Blind Phase|Adverse Event|0|||
125291574|NCT00098722|450694922|FG000|Double Blind Phase|Death|2|||
125291575|NCT00098722|450694923|FG001|Double Blind Phase|Death|5|||
125291576|NCT00098722|450694924|FG002|Double Blind Phase|Death|0|||
125291577|NCT00098722|450694925|FG003|Double Blind Phase|Death|0|||
125291578|NCT00098722|450694926|FG004|Double Blind Phase|Death|0|||
125291579|NCT00098722|450694927|FG005|Double Blind Phase|Death|0|||
125291580|NCT00098722|450694928|FG006|Double Blind Phase|Death|0|||
125291581|NCT00098722|450694922|FG000|Double Blind Phase|Lack of Efficacy|21|||
125291582|NCT00098722|450694923|FG001|Double Blind Phase|Lack of Efficacy|23|||
125291583|NCT00098722|450694924|FG002|Double Blind Phase|Lack of Efficacy|15|||
125291584|NCT00098722|450694925|FG003|Double Blind Phase|Lack of Efficacy|0|||
125291585|NCT00098722|450694926|FG004|Double Blind Phase|Lack of Efficacy|0|||
125291586|NCT00098722|450694927|FG005|Double Blind Phase|Lack of Efficacy|0|||
125291587|NCT00098722|450694928|FG006|Double Blind Phase|Lack of Efficacy|0|||
125291588|NCT00098722|450694922|FG000|Double Blind Phase|Participant defaulted|16|||
125291589|NCT00098722|450694923|FG001|Double Blind Phase|Participant defaulted|11|||
125291590|NCT00098722|450694924|FG002|Double Blind Phase|Participant defaulted|9|||
125291591|NCT00098722|450694925|FG003|Double Blind Phase|Participant defaulted|0|||
125291592|NCT00098722|450694926|FG004|Double Blind Phase|Participant defaulted|0|||
125291593|NCT00098722|450694927|FG005|Double Blind Phase|Participant defaulted|0|||
125291594|NCT00098722|450694928|FG006|Double Blind Phase|Participant defaulted|0|||
125291595|NCT00098722|450694922|FG000|Double Blind Phase|Pregnancy|1|||
125291596|NCT00098722|450694923|FG001|Double Blind Phase|Pregnancy|0|||
125291597|NCT00098722|450694924|FG002|Double Blind Phase|Pregnancy|0|||
125291598|NCT00098722|450694925|FG003|Double Blind Phase|Pregnancy|0|||
125291599|NCT00098722|450694926|FG004|Double Blind Phase|Pregnancy|0|||
125291600|NCT00098722|450694927|FG005|Double Blind Phase|Pregnancy|0|||
125291601|NCT00098722|450694928|FG006|Double Blind Phase|Pregnancy|0|||
125291602|NCT00098722|450694922|FG000|Double Blind Phase|Randomized, not treated|4|||
125291603|NCT00098722|450694923|FG001|Double Blind Phase|Randomized, not treated|3|||
125291604|NCT00098722|450694924|FG002|Double Blind Phase|Randomized, not treated|3|||
125291605|NCT00098722|450694925|FG003|Double Blind Phase|Randomized, not treated|0|||
125291606|NCT00098722|450694926|FG004|Double Blind Phase|Randomized, not treated|0|||
125291607|NCT00098722|450694927|FG005|Double Blind Phase|Randomized, not treated|0|||
125291608|NCT00098722|450694928|FG006|Double Blind Phase|Randomized, not treated|0|||
125291609|NCT00098722|450694922|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
125291610|NCT00098722|450694923|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
124784153|NCT05289037|448840076|FG007|Overall Study|Did not receive vaccine|0|||
125291611|NCT00098722|450694924|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
125291612|NCT00098722|450694925|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
125291613|NCT00098722|450694926|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
125291614|NCT00098722|450694927|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
124784154|NCT05289037|448840077|FG008|Overall Study|Did not receive vaccine|0|||
124784155|NCT05289037|448840078|FG009|Overall Study|Did not receive vaccine|0|||
124784156|NCT05289037|448840079|FG010|Overall Study|Did not receive vaccine|0|||
125291615|NCT00098722|450694928|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
125291616|NCT00098722|450694922|FG000|Double Blind Phase|Other|7|||
125291617|NCT00098722|450694923|FG001|Double Blind Phase|Other|8|||
125291618|NCT00098722|450694924|FG002|Double Blind Phase|Other|7|||
125291619|NCT00098722|450694925|FG003|Double Blind Phase|Other|0|||
125291620|NCT00098722|450694926|FG004|Double Blind Phase|Other|0|||
125291621|NCT00098722|450694927|FG005|Double Blind Phase|Other|0|||
125291622|NCT00098722|450694928|FG006|Double Blind Phase|Other|0|||
125291623|NCT00098722|450694922|FG000|Open Label Phase|Adverse Event|0|||
125291624|NCT00098722|450694923|FG001|Open Label Phase|Adverse Event|0|||
125291625|NCT00098722|450694924|FG002|Open Label Phase|Adverse Event|0|||
125291626|NCT00098722|450694925|FG003|Open Label Phase|Adverse Event|5|||
125291627|NCT00098722|450694926|FG004|Open Label Phase|Adverse Event|0|||
125291628|NCT00098722|450694927|FG005|Open Label Phase|Adverse Event|0|||
125291629|NCT00098722|450694928|FG006|Open Label Phase|Adverse Event|0|||
125291630|NCT00098722|450694922|FG000|Open Label Phase|Death|0|||
125291631|NCT00098722|450694923|FG001|Open Label Phase|Death|0|||
125291632|NCT00098722|450694924|FG002|Open Label Phase|Death|0|||
125291633|NCT00098722|450694925|FG003|Open Label Phase|Death|2|||
125291634|NCT00098722|450694926|FG004|Open Label Phase|Death|0|||
125291635|NCT00098722|450694927|FG005|Open Label Phase|Death|0|||
125291636|NCT00098722|450694928|FG006|Open Label Phase|Death|0|||
125291637|NCT00098722|450694922|FG000|Open Label Phase|Lack of Efficacy|0|||
125291638|NCT00098722|450694923|FG001|Open Label Phase|Lack of Efficacy|0|||
125291639|NCT00098722|450694924|FG002|Open Label Phase|Lack of Efficacy|0|||
125291640|NCT00098722|450694925|FG003|Open Label Phase|Lack of Efficacy|8|||
125291641|NCT00098722|450694926|FG004|Open Label Phase|Lack of Efficacy|0|||
125291642|NCT00098722|450694927|FG005|Open Label Phase|Lack of Efficacy|0|||
125291643|NCT00098722|450694928|FG006|Open Label Phase|Lack of Efficacy|0|||
125291644|NCT00098722|450694922|FG000|Open Label Phase|Pregnancy|0|||
125291645|NCT00098722|450694923|FG001|Open Label Phase|Pregnancy|0|||
125291646|NCT00098722|450694924|FG002|Open Label Phase|Pregnancy|0|||
125291647|NCT00098722|450694925|FG003|Open Label Phase|Pregnancy|1|||
125291648|NCT00098722|450694926|FG004|Open Label Phase|Pregnancy|0|||
125291649|NCT00098722|450694927|FG005|Open Label Phase|Pregnancy|0|||
125291650|NCT00098722|450694928|FG006|Open Label Phase|Pregnancy|0|||
125291651|NCT00098722|450694922|FG000|Open Label Phase|Participant defaulted|0|||
125291652|NCT00098722|450694923|FG001|Open Label Phase|Participant defaulted|0|||
125291653|NCT00098722|450694924|FG002|Open Label Phase|Participant defaulted|0|||
125291654|NCT00098722|450694925|FG003|Open Label Phase|Participant defaulted|18|||
125291655|NCT00098722|450694926|FG004|Open Label Phase|Participant defaulted|0|||
125291656|NCT00098722|450694927|FG005|Open Label Phase|Participant defaulted|0|||
125291657|NCT00098722|450694928|FG006|Open Label Phase|Participant defaulted|0|||
125291658|NCT00098722|450694922|FG000|Open Label Phase|Ongoing at cut-off date|0|||
125291659|NCT00098722|450694923|FG001|Open Label Phase|Ongoing at cut-off date|0|||
125291660|NCT00098722|450694924|FG002|Open Label Phase|Ongoing at cut-off date|0|||
125291661|NCT00098722|450694925|FG003|Open Label Phase|Ongoing at cut-off date|220|||
125291662|NCT00098722|450694926|FG004|Open Label Phase|Ongoing at cut-off date|50|||
125291663|NCT00098722|450694927|FG005|Open Label Phase|Ongoing at cut-off date|0|||
125291664|NCT00098722|450694928|FG006|Open Label Phase|Ongoing at cut-off date|0|||
125291665|NCT00098722|450694922|FG000|Open Label Phase|Other|0|||
125291666|NCT00098722|450694923|FG001|Open Label Phase|Other|0|||
125291667|NCT00098722|450694924|FG002|Open Label Phase|Other|0|||
125291668|NCT00098722|450694925|FG003|Open Label Phase|Other|18|||
125291669|NCT00098722|450694926|FG004|Open Label Phase|Other|0|||
125291670|NCT00098722|450694927|FG005|Open Label Phase|Other|0|||
125291671|NCT00098722|450694928|FG006|Open Label Phase|Other|0|||
125291672|NCT00098722|450694922|FG000|Observation Phase|Death|0|||
125291673|NCT00098722|450694923|FG001|Observation Phase|Death|0|||
125291674|NCT00098722|450694924|FG002|Observation Phase|Death|0|||
125291675|NCT00098722|450694925|FG003|Observation Phase|Death|0|||
125291676|NCT00098722|450694926|FG004|Observation Phase|Death|0|||
125291677|NCT00098722|450694927|FG005|Observation Phase|Death|5|||
125291678|NCT00098722|450694928|FG006|Observation Phase|Death|3|||
125291679|NCT00098722|450694922|FG000|Observation Phase|Lack of Efficacy|0|||
125291680|NCT00098722|450694923|FG001|Observation Phase|Lack of Efficacy|0|||
125291681|NCT00098722|450694924|FG002|Observation Phase|Lack of Efficacy|0|||
125291682|NCT00098722|450694925|FG003|Observation Phase|Lack of Efficacy|0|||
125291683|NCT00098722|450694926|FG004|Observation Phase|Lack of Efficacy|0|||
125291684|NCT00098722|450694927|FG005|Observation Phase|Lack of Efficacy|2|||
125291685|NCT00098722|450694928|FG006|Observation Phase|Lack of Efficacy|0|||
125291686|NCT00098722|450694922|FG000|Observation Phase|Participant defaulted|0|||
125291687|NCT00098722|450694923|FG001|Observation Phase|Participant defaulted|0|||
125291688|NCT00098722|450694924|FG002|Observation Phase|Participant defaulted|0|||
125291689|NCT00098722|450694925|FG003|Observation Phase|Participant defaulted|0|||
125291690|NCT00098722|450694926|FG004|Observation Phase|Participant defaulted|0|||
125291691|NCT00098722|450694927|FG005|Observation Phase|Participant defaulted|17|||
125291692|NCT00098722|450694928|FG006|Observation Phase|Participant defaulted|4|||
125291693|NCT00098722|450694922|FG000|Observation Phase|Other|0|||
125291694|NCT00098722|450694923|FG001|Observation Phase|Other|0|||
125291695|NCT00098722|450694924|FG002|Observation Phase|Other|0|||
125291696|NCT00098722|450694925|FG003|Observation Phase|Other|0|||
125291697|NCT00098722|450694926|FG004|Observation Phase|Other|0|||
125291698|NCT00098722|450694927|FG005|Observation Phase|Other|21|||
125291699|NCT00098722|450694928|FG006|Observation Phase|Other|10|||
125291700|NCT02351349|450694929|FG000|Overall Study|Withdrawal by Subject|2|||
125291701|NCT02351349|450694930|FG001|Overall Study|Withdrawal by Subject|3|||
125291702|NCT00440310|450694931|FG000|Overall Study|Lost to Follow-up|4|||
125291703|NCT00440310|450694932|FG001|Overall Study|Lost to Follow-up|5|||
125291704|NCT00440310|450694931|FG000|Overall Study|Protocol Violation|0|||
125291705|NCT00440310|450694932|FG001|Overall Study|Protocol Violation|1|||
125291706|NCT00440310|450694931|FG000|Overall Study|Withdrawal by Subject|15|||
125291707|NCT00440310|450694932|FG001|Overall Study|Withdrawal by Subject|14|||
125291708|NCT00440310|450694931|FG000|Overall Study|No Reply at EOS|7|||
125291709|NCT00440310|450694932|FG001|Overall Study|No Reply at EOS|7|||
125291710|NCT00440310|450694931|FG000|Overall Study|Other|1|||
125291711|NCT00440310|450694932|FG001|Overall Study|Other|0|||
125291712|NCT00440310|450694931|FG000|Overall Study|Status Unknown|1|||
125291713|NCT00440310|450694932|FG001|Overall Study|Status Unknown|3|||
125291714|NCT01610596|450694939|FG000|Overall Study|Lost to Follow-up|0|||
125291715|NCT01610596|450694940|FG001|Overall Study|Lost to Follow-up|1|||
125291716|NCT01519674|450694941|FG000|Overall Study|Adverse Event|3|||
125291717|NCT01519674|450694942|FG001|Overall Study|Adverse Event|3|||
125291718|NCT01519674|450694943|FG002|Overall Study|Adverse Event|0|||
125291719|NCT01519674|450694941|FG000|Overall Study|Lack of Efficacy|1|||
125291720|NCT01519674|450694942|FG001|Overall Study|Lack of Efficacy|1|||
125291721|NCT01519674|450694943|FG002|Overall Study|Lack of Efficacy|1|||
125291722|NCT01519674|450694941|FG000|Overall Study|Protocol Violation|0|||
125291723|NCT01519674|450694942|FG001|Overall Study|Protocol Violation|3|||
125291724|NCT01519674|450694943|FG002|Overall Study|Protocol Violation|1|||
125291725|NCT01519674|450694941|FG000|Overall Study|Withdrawal Criteria|7|||
125291726|NCT01519674|450694942|FG001|Overall Study|Withdrawal Criteria|2|||
125291727|NCT01519674|450694943|FG002|Overall Study|Withdrawal Criteria|7|||
125291728|NCT01519674|450694941|FG000|Overall Study|Unsclassified|10|||
125291729|NCT01519674|450694942|FG001|Overall Study|Unsclassified|4|||
125291730|NCT01519674|450694943|FG002|Overall Study|Unsclassified|3|||
125291731|NCT00799591|450694944|FG000|Overall Study|De-escalation of doses|20|||
125291732|NCT00799591|450694944|FG000|Overall Study|Death|14|||
125291733|NCT00799591|450694944|FG000|Overall Study|Technical failure|12|||
125291734|NCT00799591|450694944|FG000|Overall Study|Resistant germ|11|||
125291735|NCT00799591|450694944|FG000|Overall Study|New infection|4|||
125291736|NCT00799591|450694944|FG000|Overall Study|Resistance germ and technical failure|2|||
125291737|NCT00799591|450694944|FG000|Overall Study|Persistance of fever undetermined origin|1|||
125291738|NCT00799591|450694944|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
125291739|NCT00799591|450694944|FG000|Overall Study|Infectious origin not probable|1|||
125291740|NCT03106415|450694947|FG000|Phase 1|Withdrawal by Subject|1|||
125291741|NCT03106415|450694948|FG001|Phase 1|Withdrawal by Subject|0|||
125291742|NCT03106415|450694949|FG002|Phase 1|Withdrawal by Subject|0|||
125291743|NCT03106415|450694947|FG000|Phase 1|Adverse Event|1|||
125291744|NCT03106415|450694948|FG001|Phase 1|Adverse Event|1|||
125291745|NCT03106415|450694949|FG002|Phase 1|Adverse Event|0|||
125291746|NCT03106415|450694947|FG000|Phase 1|Protocol Violation|0|||
125291747|NCT03106415|450694948|FG001|Phase 1|Protocol Violation|1|||
125291748|NCT03106415|450694949|FG002|Phase 1|Protocol Violation|0|||
125291749|NCT00293709|450694950|FG000|Overall Study|Other|47|||
125291750|NCT02785458|450694951|FG000|1 Month|Withdrawal by Subject|2|||
125291751|NCT02785458|450694952|FG001|1 Month|Withdrawal by Subject|1|||
125291752|NCT02785458|450694951|FG000|1 Month|Lost to Follow-up|38|||
125291753|NCT02785458|450694952|FG001|1 Month|Lost to Follow-up|31|||
125291754|NCT02785458|450694951|FG000|1 Month|Deemed Ineligible|1|||
125291755|NCT02785458|450694952|FG001|1 Month|Deemed Ineligible|0|||
125291756|NCT02785458|450694951|FG000|1 Month|Completed Evaluation by Baseline|42|||
125291757|NCT02785458|450694952|FG001|1 Month|Completed Evaluation by Baseline|39|||
125291758|NCT02785458|450694951|FG000|1 Month|Partial Interview|0|||
125291759|NCT02785458|450694952|FG001|1 Month|Partial Interview|4|||
125291760|NCT02785458|450694951|FG000|3 Months|Withdrawal by Subject|3|||
125291761|NCT02785458|450694952|FG001|3 Months|Withdrawal by Subject|1|||
125291762|NCT02785458|450694951|FG000|3 Months|Lost to Follow-up|25|||
125291763|NCT02785458|450694952|FG001|3 Months|Lost to Follow-up|21|||
125291764|NCT02785458|450694951|FG000|3 Months|Completed Evaluation at 1 Month|100|||
125291765|NCT02785458|450694952|FG001|3 Months|Completed Evaluation at 1 Month|89|||
125291766|NCT01804582|450694953|FG000|Overall Study|Lost to Follow-up|47|||
125291767|NCT01804582|450694954|FG001|Overall Study|Lost to Follow-up|56|||
125291768|NCT01804582|450694953|FG000|Overall Study|Physician Decision|2|||
125291769|NCT01804582|450694954|FG001|Overall Study|Physician Decision|0|||
125291770|NCT00520013|450694955|FG000|Overall Study|Withdrawal by Subject|0|||
125291771|NCT00520013|450694956|FG001|Overall Study|Withdrawal by Subject|0|||
125291772|NCT00520013|450694957|FG002|Overall Study|Withdrawal by Subject|1|||
125291773|NCT00520013|450694955|FG000|Overall Study|Adverse Event|2|||
125291774|NCT00520013|450694956|FG001|Overall Study|Adverse Event|10|||
125291775|NCT00520013|450694957|FG002|Overall Study|Adverse Event|7|||
125291776|NCT00520013|450694955|FG000|Overall Study|Progressive Disease|7|||
125291777|NCT00520013|450694956|FG001|Overall Study|Progressive Disease|3|||
125291778|NCT00520013|450694957|FG002|Overall Study|Progressive Disease|0|||
125291779|NCT00520013|450694955|FG000|Overall Study|Clinical Progression|3|||
125291780|NCT00520013|450694956|FG001|Overall Study|Clinical Progression|1|||
125291781|NCT00520013|450694957|FG002|Overall Study|Clinical Progression|0|||
125291782|NCT00520013|450694955|FG000|Overall Study|Death|0|||
125291783|NCT00520013|450694956|FG001|Overall Study|Death|1|||
125291784|NCT00520013|450694957|FG002|Overall Study|Death|0|||
125291785|NCT00520013|450694955|FG000|Overall Study|Physician Decision|0|||
125291786|NCT00520013|450694956|FG001|Overall Study|Physician Decision|0|||
125291787|NCT00520013|450694957|FG002|Overall Study|Physician Decision|3|||
125291788|NCT02677844|450694958|FG000|Period 3|Withdrawal by Subject|0|||
125291789|NCT02677844|450694959|FG001|Period 3|Withdrawal by Subject|0|||
125291790|NCT02677844|450694960|FG002|Period 3|Withdrawal by Subject|0|||
125291791|NCT02677844|450694961|FG003|Period 3|Withdrawal by Subject|1|||
125291792|NCT02677844|450694962|FG004|Period 3|Withdrawal by Subject|0|||
125291793|NCT02677844|450694963|FG005|Period 3|Withdrawal by Subject|0|||
125291794|NCT02677844|450694964|FG006|Period 3|Withdrawal by Subject|0|||
125291795|NCT01697462|450694965|FG000|Overall Study|Disease Progression|1|||
125291796|NCT01697462|450694965|FG000|Overall Study|Adverse Event|6|||
125291797|NCT01697462|450694965|FG000|Overall Study|Lost to Follow-up|21|||
125291798|NCT01697462|450694965|FG000|Overall Study|Withdrawal by Subject|12|||
125291799|NCT01697462|450694965|FG000|Overall Study|Investigator Decision|21|||
125291800|NCT01697462|450694965|FG000|Overall Study|Death|1|||
125291801|NCT01697462|450694965|FG000|Overall Study|Other|10|||
125291802|NCT01697462|450694965|FG000|Overall Study|Missing|5|||
125291803|NCT03630302|450694966|FG000|Surgery|hardware issue prevented LFP recordings|1|||
125291804|NCT03630302|450694966|FG000|3 Month Visit|Adverse Event|2|||
125291805|NCT03630302|450694966|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
125291806|NCT01135914|450694969|FG000|Overall Study|Withdrawal by Subject|1|||
125291807|NCT01135914|450694970|FG001|Overall Study|Withdrawal by Subject|3|||
125291808|NCT01135914|450694971|FG002|Overall Study|Withdrawal by Subject|6|||
125291809|NCT01135914|450694969|FG000|Overall Study|Lost to Follow-up|1|||
125291810|NCT01135914|450694970|FG001|Overall Study|Lost to Follow-up|0|||
125291811|NCT01135914|450694971|FG002|Overall Study|Lost to Follow-up|1|||
125291812|NCT01135914|450694969|FG000|Overall Study|Protocol Violation|0|||
125291813|NCT01135914|450694970|FG001|Overall Study|Protocol Violation|0|||
125291814|NCT01135914|450694971|FG002|Overall Study|Protocol Violation|3|||
125291815|NCT01135914|450694969|FG000|Overall Study|Lack of Efficacy|2|||
125291816|NCT01135914|450694970|FG001|Overall Study|Lack of Efficacy|1|||
125291817|NCT01135914|450694971|FG002|Overall Study|Lack of Efficacy|10|||
125291818|NCT01135914|450694969|FG000|Overall Study|Adverse Event|0|||
125291819|NCT01135914|450694970|FG001|Overall Study|Adverse Event|1|||
125291820|NCT01135914|450694971|FG002|Overall Study|Adverse Event|2|||
125291821|NCT03532932|450694972|FG000|Overall Study|Protocol Deviation|33|||
125291822|NCT03532932|450694973|FG001|Overall Study|Protocol Deviation|31|||
125291823|NCT03532932|450694972|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
125291824|NCT03532932|450694973|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
125291825|NCT03532932|450694972|FG000|Overall Study|Withdrawal by Subject|2|||
125291826|NCT03532932|450694973|FG001|Overall Study|Withdrawal by Subject|0|||
125291827|NCT03532932|450694972|FG000|Overall Study|Lost to Follow-up|15|||
125291828|NCT03532932|450694973|FG001|Overall Study|Lost to Follow-up|9|||
125291829|NCT03532932|450694972|FG000|Overall Study|Adverse Event|4|||
125291830|NCT03532932|450694973|FG001|Overall Study|Adverse Event|3|||
125291831|NCT03532932|450694972|FG000|Overall Study|Death|0|||
125291832|NCT03532932|450694973|FG001|Overall Study|Death|2|||
125291833|NCT03532932|450694972|FG000|Overall Study|Other|11|||
125291834|NCT03532932|450694973|FG001|Overall Study|Other|16|||
125291835|NCT02699450|450694974|FG000|Overall Study|Death|2|||
125291836|NCT02699450|450694975|FG001|Overall Study|Death|1|||
125291837|NCT02699450|450694976|FG002|Overall Study|Death|2|||
125291838|NCT02699450|450694974|FG000|Overall Study|Met Criteria for Study Exit|0|||
125291839|NCT02699450|450694975|FG001|Overall Study|Met Criteria for Study Exit|0|||
125291840|NCT02699450|450694976|FG002|Overall Study|Met Criteria for Study Exit|1|||
125291841|NCT02699450|450694974|FG000|Overall Study|Protocol Violation|4|||
125291842|NCT02699450|450694975|FG001|Overall Study|Protocol Violation|3|||
125291843|NCT02699450|450694976|FG002|Overall Study|Protocol Violation|5|||
125291844|NCT02699450|450694974|FG000|Overall Study|Lost to Follow-up|3|||
125291845|NCT02699450|450694975|FG001|Overall Study|Lost to Follow-up|0|||
125291846|NCT02699450|450694976|FG002|Overall Study|Lost to Follow-up|5|||
125291847|NCT02699450|450694974|FG000|Overall Study|Physician Decision|2|||
125291848|NCT02699450|450694975|FG001|Overall Study|Physician Decision|0|||
125291849|NCT02699450|450694976|FG002|Overall Study|Physician Decision|0|||
125291850|NCT02699450|450694974|FG000|Overall Study|Withdrawal by Subject|3|||
125291851|NCT02699450|450694975|FG001|Overall Study|Withdrawal by Subject|1|||
125291852|NCT02699450|450694976|FG002|Overall Study|Withdrawal by Subject|2|||
125291853|NCT02699450|450694974|FG000|Overall Study|Adverse Event|1|||
125291854|NCT02699450|450694975|FG001|Overall Study|Adverse Event|0|||
125291855|NCT02699450|450694976|FG002|Overall Study|Adverse Event|0|||
125291856|NCT01344629|450694977|FG000|Crossover Period 2|Withdrawal by Subject|0|||
125291857|NCT01344629|450694978|FG001|Crossover Period 2|Withdrawal by Subject|1|||
125291858|NCT00693472|450694980|FG000|Part 1|Adverse Event|1|||
125291859|NCT00693472|450694981|FG001|Part 1|Adverse Event|1|||
125291860|NCT00693472|450694982|FG002|Part 1|Adverse Event|0|||
125291861|NCT00693472|450694983|FG003|Part 1|Adverse Event|0|||
125291862|NCT00693472|450694980|FG000|Part 1|Lost to Follow-up|0|||
125291863|NCT00693472|450694981|FG001|Part 1|Lost to Follow-up|1|||
125291864|NCT00693472|450694982|FG002|Part 1|Lost to Follow-up|0|||
125291865|NCT00693472|450694983|FG003|Part 1|Lost to Follow-up|0|||
125291866|NCT00693472|450694980|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
125291867|NCT00693472|450694981|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
125291868|NCT00693472|450694982|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
125291869|NCT00693472|450694983|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
125291870|NCT00693472|450694980|FG000|Part 2|Adverse Event|0|||
125291871|NCT00693472|450694981|FG001|Part 2|Adverse Event|0|||
125291872|NCT00693472|450694982|FG002|Part 2|Adverse Event|1|||
125291873|NCT00693472|450694983|FG003|Part 2|Adverse Event|0|||
125291874|NCT00693472|450694980|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
125291875|NCT00693472|450694981|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
125291876|NCT00693472|450694982|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
125291877|NCT00693472|450694983|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
125291878|NCT04063787|450694986|FG000|Overall Study|Inadequate Doppler data|4|||
125291879|NCT04063787|450694986|FG000|Overall Study|Lost to Follow-up|2|||
125291880|NCT04063787|450694986|FG000|Overall Study|Death|3|||
125291881|NCT05545644|450694987|FG000|Overall Study|Lost to Follow-up|4|||
125291882|NCT05545644|450694988|FG001|Overall Study|Lost to Follow-up|3|||
125291883|NCT00453973|450694991|FG000|Overall Study|Adverse Event|4|||
125291884|NCT00453973|450694992|FG001|Overall Study|Adverse Event|9|||
125291885|NCT00453973|450694991|FG000|Overall Study|Withdrawal by Subject|7|||
125291886|NCT00453973|450694992|FG001|Overall Study|Withdrawal by Subject|6|||
125291887|NCT00453973|450694991|FG000|Overall Study|PI Decision|0|||
125291888|NCT00453973|450694992|FG001|Overall Study|PI Decision|2|||
125291889|NCT00453973|450694991|FG000|Overall Study|Relocation|1|||
125291890|NCT00453973|450694992|FG001|Overall Study|Relocation|0|||
125291891|NCT00453973|450694991|FG000|Overall Study|Renal transplant|1|||
125291892|NCT00453973|450694992|FG001|Overall Study|Renal transplant|1|||
125291893|NCT00453973|450694991|FG000|Overall Study|Site closed by sponsor|3|||
125291894|NCT00453973|450694992|FG001|Overall Study|Site closed by sponsor|0|||
125291895|NCT00453973|450694991|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
125291896|NCT00453973|450694992|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
125291897|NCT00276094|450694993|FG000|Overall Study|Adverse Event|15|||
125291898|NCT00276094|450694994|FG001|Overall Study|Adverse Event|13|||
125291899|NCT00276094|450694995|FG002|Overall Study|Adverse Event|11|||
125291900|NCT00276094|450694993|FG000|Overall Study|Withdrawal by Subject|14|||
125291901|NCT00276094|450694994|FG001|Overall Study|Withdrawal by Subject|14|||
125291902|NCT00276094|450694995|FG002|Overall Study|Withdrawal by Subject|12|||
125291903|NCT00276094|450694993|FG000|Overall Study|Protocol Violation|16|||
125291904|NCT00276094|450694994|FG001|Overall Study|Protocol Violation|7|||
125291905|NCT00276094|450694995|FG002|Overall Study|Protocol Violation|10|||
125291906|NCT00276094|450694993|FG000|Overall Study|Lost to Follow-up|8|||
125291907|NCT00276094|450694994|FG001|Overall Study|Lost to Follow-up|6|||
125291908|NCT00276094|450694995|FG002|Overall Study|Lost to Follow-up|4|||
124784157|NCT05289037|448840080|FG011|Overall Study|Did not receive vaccine|0|||
124784158|NCT05289037|448840081|FG012|Overall Study|Did not receive vaccine|0|||
124784159|NCT05289037|448840082|FG013|Overall Study|Did not receive vaccine|0|||
125291909|NCT00276094|450694993|FG000|Overall Study|Other-Subject moved out of country|1|||
124784160|NCT05289037|448840083|FG014|Overall Study|Did not receive vaccine|1|||
124784161|NCT05289037|448840084|FG015|Overall Study|Did not receive vaccine|0|||
124784162|NCT05289037|448840085|FG016|Overall Study|Did not receive vaccine|0|||
125291910|NCT00276094|450694994|FG001|Overall Study|Other-Subject moved out of country|0|||
125291911|NCT00276094|450694995|FG002|Overall Study|Other-Subject moved out of country|0|||
125291912|NCT00276094|450694993|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
125291913|NCT00276094|450694994|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
125291914|NCT00276094|450694995|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
125291915|NCT00276094|450694993|FG000|Overall Study|Other-Lack of efficacy|1|||
125291916|NCT00276094|450694994|FG001|Overall Study|Other-Lack of efficacy|0|||
124784163|NCT05289037|448840069|FG000|Overall Study|Unable to make last visit|0|||
125291917|NCT00276094|450694995|FG002|Overall Study|Other-Lack of efficacy|0|||
125291918|NCT00276094|450694993|FG000|Overall Study|Other-Refused follow-up visit|1|||
125291919|NCT00276094|450694994|FG001|Overall Study|Other-Refused follow-up visit|0|||
125291920|NCT00276094|450694995|FG002|Overall Study|Other-Refused follow-up visit|0|||
125291921|NCT00276094|450694993|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
125291922|NCT00276094|450694994|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
125291923|NCT00276094|450694995|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
125291924|NCT00276094|450694993|FG000|Overall Study|Other-Relocation|0|||
125291925|NCT00276094|450694994|FG001|Overall Study|Other-Relocation|1|||
125291926|NCT00276094|450694995|FG002|Overall Study|Other-Relocation|0|||
125291927|NCT00276094|450694993|FG000|Overall Study|Other-Study medication lost|0|||
125291928|NCT00276094|450694994|FG001|Overall Study|Other-Study medication lost|0|||
125291929|NCT00276094|450694995|FG002|Overall Study|Other-Study medication lost|1|||
125291930|NCT01873729|450694998|FG000|Overall Study|Withdrawal by Subject|1|||
125291931|NCT02463032|450694999|FG000|Overall Study|Lack of Efficacy|61|||
125291932|NCT02463032|450695000|FG001|Overall Study|Lack of Efficacy|50|||
125291933|NCT02463032|450694999|FG000|Overall Study|Death|8|||
125291934|NCT02463032|450695000|FG001|Overall Study|Death|8|||
125291935|NCT02463032|450694999|FG000|Overall Study|Adverse Event|2|||
125291936|NCT02463032|450695000|FG001|Overall Study|Adverse Event|6|||
125291937|NCT00160199|450695004|FG000|Overall Study|Adverse Event|5|||
125291938|NCT00160199|450695005|FG001|Overall Study|Adverse Event|14|||
125291939|NCT00160199|450695004|FG000|Overall Study|Lack of Efficacy|0|||
125291940|NCT00160199|450695005|FG001|Overall Study|Lack of Efficacy|1|||
125291941|NCT00160199|450695004|FG000|Overall Study|Lost to Follow-up|7|||
125291942|NCT00160199|450695005|FG001|Overall Study|Lost to Follow-up|7|||
125291943|NCT00160199|450695004|FG000|Overall Study|Withdrawal by Subject|4|||
125291944|NCT00160199|450695005|FG001|Overall Study|Withdrawal by Subject|6|||
125291945|NCT00160199|450695004|FG000|Overall Study|Administrative|0|||
125291946|NCT00160199|450695005|FG001|Overall Study|Administrative|1|||
125291947|NCT00160199|450695004|FG000|Overall Study|Protocol Violation|8|||
125291948|NCT00160199|450695005|FG001|Overall Study|Protocol Violation|8|||
125291949|NCT03352453|450695006|FG000|Overall Study|Miscellaneous Reasons|1|||
125291950|NCT03352453|450695007|FG001|Overall Study|Miscellaneous Reasons|2|||
125291951|NCT03352453|450695006|FG000|Overall Study|Lack of Efficacy|1|||
125291952|NCT03352453|450695007|FG001|Overall Study|Lack of Efficacy|0|||
125291953|NCT03352453|450695006|FG000|Overall Study|Withdrawal by Subject|8|||
125291954|NCT03352453|450695007|FG001|Overall Study|Withdrawal by Subject|14|||
125291955|NCT03352453|450695006|FG000|Overall Study|Study Terminated by Sponsor|2|||
125291956|NCT03352453|450695007|FG001|Overall Study|Study Terminated by Sponsor|1|||
125291957|NCT03352453|450695006|FG000|Overall Study|Protocol Deviation|1|||
125291958|NCT03352453|450695007|FG001|Overall Study|Protocol Deviation|0|||
125291959|NCT03352453|450695006|FG000|Overall Study|Lost to Follow-up|7|||
125291960|NCT03352453|450695007|FG001|Overall Study|Lost to Follow-up|6|||
125291961|NCT03352453|450695006|FG000|Overall Study|Adverse Event|2|||
125291962|NCT03352453|450695007|FG001|Overall Study|Adverse Event|9|||
125291963|NCT01241760|450695010|FG000|Overall Study|Adverse Event|1|||
125291964|NCT01241760|450695011|FG001|Overall Study|Adverse Event|0|||
125291965|NCT01241760|450695010|FG000|Overall Study|Lost to Follow-up|18|||
125291966|NCT01241760|450695011|FG001|Overall Study|Lost to Follow-up|22|||
125291967|NCT01241760|450695010|FG000|Overall Study|Withdrawal by Subject|13|||
125291968|NCT01241760|450695011|FG001|Overall Study|Withdrawal by Subject|13|||
125291969|NCT01241760|450695010|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
125291970|NCT01241760|450695011|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
125291971|NCT01241760|450695010|FG000|Overall Study|Other|1|||
125291972|NCT01241760|450695011|FG001|Overall Study|Other|1|||
125291973|NCT03689244|450695012|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
125291974|NCT03689244|450695013|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
125291975|NCT03689244|450695014|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
125291976|NCT03689244|450695015|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
125291977|NCT03689244|450695012|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
125291978|NCT03689244|450695013|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
125291979|NCT03689244|450695014|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
125291980|NCT03689244|450695015|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
125291981|NCT03689244|450695012|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
125291982|NCT03689244|450695013|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
125291983|NCT03689244|450695014|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
125291984|NCT03689244|450695015|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
125291985|NCT03689244|450695012|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
125291986|NCT03689244|450695013|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
125291987|NCT03689244|450695014|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
125291988|NCT03689244|450695015|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
125291989|NCT03689244|450695012|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
125291990|NCT03689244|450695013|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
125291991|NCT03689244|450695014|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
125291992|NCT03689244|450695015|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
125291993|NCT03689244|450695012|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
125291994|NCT03689244|450695013|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
125291995|NCT03689244|450695014|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
125291996|NCT03689244|450695015|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
125291997|NCT03689244|450695012|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
125291998|NCT03689244|450695013|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
125291999|NCT03689244|450695014|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
125292000|NCT03689244|450695015|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
125292001|NCT03689244|450695012|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
125292002|NCT03689244|450695013|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
125292003|NCT03689244|450695014|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
125292004|NCT03689244|450695015|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
125292005|NCT01565564|450695016|FG000|Overall Study|Lost to Follow-up|5|||
125292006|NCT01565564|450695017|FG001|Overall Study|Lost to Follow-up|1|||
125292007|NCT01591863|450695019|FG000|Overall Study|Adverse Event|3|||
125292008|NCT01591863|450695019|FG000|Overall Study|Withdrawal by Subject|1|||
125292009|NCT01591863|450695019|FG000|Overall Study|recurrence|9|||
125292010|NCT01591863|450695019|FG000|Overall Study|Lack of Efficacy|1|||
125292011|NCT00969436|450695020|FG000|Overall Study|Protocol Violation|1|||
125292012|NCT00969436|450695021|FG001|Overall Study|Protocol Violation|3|||
125292013|NCT00969436|450695022|FG002|Overall Study|Protocol Violation|0|||
125292014|NCT00969436|450695020|FG000|Overall Study|Migrated/moved from study area|12|||
125292015|NCT00969436|450695021|FG001|Overall Study|Migrated/moved from study area|10|||
125292016|NCT00969436|450695022|FG002|Overall Study|Migrated/moved from study area|2|||
125292017|NCT00969436|450695020|FG000|Overall Study|Father - serious health problem|0|||
125292018|NCT00969436|450695021|FG001|Overall Study|Father - serious health problem|0|||
125292019|NCT00969436|450695022|FG002|Overall Study|Father - serious health problem|1|||
125292020|NCT00969436|450695020|FG000|Overall Study|Parents personal problem|0|||
125292021|NCT00969436|450695021|FG001|Overall Study|Parents personal problem|0|||
125292022|NCT00969436|450695022|FG002|Overall Study|Parents personal problem|1|||
124784164|NCT05289037|448840070|FG001|Overall Study|Unable to make last visit|0|||
124784165|NCT05289037|448840071|FG002|Overall Study|Unable to make last visit|1|||
124784166|NCT05289037|448840072|FG003|Overall Study|Unable to make last visit|0|||
124784167|NCT05289037|448840073|FG004|Overall Study|Unable to make last visit|0|||
124784168|NCT05289037|448840074|FG005|Overall Study|Unable to make last visit|0|||
124784169|NCT05289037|448840075|FG006|Overall Study|Unable to make last visit|0|||
124784170|NCT05289037|448840076|FG007|Overall Study|Unable to make last visit|0|||
124784171|NCT05289037|448840077|FG008|Overall Study|Unable to make last visit|0|||
124784172|NCT05289037|448840078|FG009|Overall Study|Unable to make last visit|0|||
124784173|NCT05289037|448840079|FG010|Overall Study|Unable to make last visit|0|||
124784174|NCT05289037|448840080|FG011|Overall Study|Unable to make last visit|0|||
124784175|NCT05289037|448840081|FG012|Overall Study|Unable to make last visit|0|||
124784176|NCT05289037|448840082|FG013|Overall Study|Unable to make last visit|0|||
124784177|NCT05289037|448840083|FG014|Overall Study|Unable to make last visit|0|||
124784178|NCT05289037|448840084|FG015|Overall Study|Unable to make last visit|0|||
124784179|NCT05289037|448840085|FG016|Overall Study|Unable to make last visit|0|||
124784180|NCT05289037|448840069|FG000|Overall Study|Protocol deviation|0|||
124784181|NCT05289037|448840070|FG001|Overall Study|Protocol deviation|0|||
124784182|NCT05289037|448840071|FG002|Overall Study|Protocol deviation|0|||
124784183|NCT05289037|448840072|FG003|Overall Study|Protocol deviation|0|||
124784184|NCT05289037|448840073|FG004|Overall Study|Protocol deviation|0|||
124784185|NCT05289037|448840074|FG005|Overall Study|Protocol deviation|0|||
124784186|NCT05289037|448840075|FG006|Overall Study|Protocol deviation|0|||
124784187|NCT05289037|448840076|FG007|Overall Study|Protocol deviation|0|||
124784188|NCT05289037|448840077|FG008|Overall Study|Protocol deviation|0|||
124784189|NCT05289037|448840078|FG009|Overall Study|Protocol deviation|0|||
124784190|NCT05289037|448840079|FG010|Overall Study|Protocol deviation|0|||
124784191|NCT05289037|448840080|FG011|Overall Study|Protocol deviation|0|||
124784192|NCT05289037|448840081|FG012|Overall Study|Protocol deviation|0|||
124784193|NCT05289037|448840082|FG013|Overall Study|Protocol deviation|0|||
124784194|NCT05289037|448840083|FG014|Overall Study|Protocol deviation|0|||
124784195|NCT05289037|448840084|FG015|Overall Study|Protocol deviation|1|||
124784196|NCT05289037|448840085|FG016|Overall Study|Protocol deviation|0|||
124784197|NCT05141448|448840086|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
124784198|NCT05141448|448840087|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
124784199|NCT05141448|448840088|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
124784200|NCT05141448|448840089|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
124784201|NCT05141448|448840090|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
124784202|NCT05141448|448840091|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
124784203|NCT05141448|448840086|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
124784204|NCT05141448|448840087|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
124784205|NCT05141448|448840088|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
124784206|NCT05141448|448840089|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
124784207|NCT05141448|448840090|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
124784208|NCT05141448|448840091|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
124784209|NCT05141448|448840086|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
124784210|NCT05141448|448840087|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
124784211|NCT05141448|448840088|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
124784212|NCT05141448|448840089|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
124784213|NCT05141448|448840090|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
124784214|NCT05141448|448840091|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
124784215|NCT05141448|448840086|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
124784216|NCT05141448|448840087|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
124784217|NCT05141448|448840088|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
124784218|NCT05141448|448840089|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
124784219|NCT05141448|448840090|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
124784220|NCT05141448|448840091|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
124784221|NCT05141448|448840086|FG000|Period 2|COVID-19 Related|0|||
124784222|NCT05141448|448840087|FG001|Period 2|COVID-19 Related|0|||
124784223|NCT05141448|448840088|FG002|Period 2|COVID-19 Related|0|||
124784224|NCT05141448|448840089|FG003|Period 2|COVID-19 Related|1|||
124784225|NCT05141448|448840090|FG004|Period 2|COVID-19 Related|0|||
124784226|NCT05141448|448840091|FG005|Period 2|COVID-19 Related|1|||
124784227|NCT05141448|448840086|FG000|3|Covid-19 related|2|||
124784228|NCT05141448|448840087|FG001|3|Covid-19 related|0|||
124784229|NCT05141448|448840088|FG002|3|Covid-19 related|0|||
124784230|NCT05141448|448840089|FG003|3|Covid-19 related|0|||
124784231|NCT05141448|448840090|FG004|3|Covid-19 related|0|||
124784232|NCT05141448|448840091|FG005|3|Covid-19 related|1|||
124784233|NCT05141448|448840086|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
124784234|NCT05141448|448840087|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
124784235|NCT05141448|448840088|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
124784236|NCT05141448|448840089|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
124784237|NCT05141448|448840090|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
124784238|NCT05141448|448840091|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
124819525|NCT03902574|448965744|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
124819526|NCT05147350|448965747|FG000|Overall Study|Death|2|||
124819527|NCT05147350|448965748|FG001|Overall Study|Death|3|||
124819528|NCT05147350|448965749|FG002|Overall Study|Death|3|||
124819529|NCT05147350|448965750|FG003|Overall Study|Death|2|||
124819530|NCT05147350|448965751|FG004|Overall Study|Death|2|||
124819531|NCT05147350|448965752|FG005|Overall Study|Death|1|||
124819532|NCT05147350|448965753|FG006|Overall Study|Death|1|||
124819533|NCT05147350|448965754|FG007|Overall Study|Death|3|||
125292023|NCT00969436|450695020|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
125292024|NCT00969436|450695021|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
125292025|NCT00969436|450695022|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
125292026|NCT00969436|450695020|FG000|Overall Study|Withdrawal by Subject|3|||
125292027|NCT00969436|450695021|FG001|Overall Study|Withdrawal by Subject|0|||
125292028|NCT00969436|450695022|FG002|Overall Study|Withdrawal by Subject|2|||
125292029|NCT00969436|450695020|FG000|Overall Study|Lost to Follow-up|8|||
125292030|NCT00969436|450695021|FG001|Overall Study|Lost to Follow-up|8|||
125292031|NCT00969436|450695022|FG002|Overall Study|Lost to Follow-up|5|||
125292032|NCT00459537|450695033|FG000|Overall Study|Adverse Event|1|||
125292033|NCT00459537|450695034|FG001|Overall Study|Adverse Event|6|||
125292034|NCT00459537|450695033|FG000|Overall Study|Lack of Efficacy|10|||
125292035|NCT00459537|450695034|FG001|Overall Study|Lack of Efficacy|11|||
125292036|NCT00459537|450695033|FG000|Overall Study|Withdrawal by Subject|20|||
125292037|NCT00459537|450695034|FG001|Overall Study|Withdrawal by Subject|26|||
125292038|NCT00459537|450695033|FG000|Overall Study|Lost to Follow-up|27|||
125292039|NCT00459537|450695034|FG001|Overall Study|Lost to Follow-up|30|||
125292040|NCT00459537|450695033|FG000|Overall Study|Administrative problems|3|||
125292041|NCT00459537|450695034|FG001|Overall Study|Administrative problems|0|||
125292042|NCT00459537|450695033|FG000|Overall Study|Protocol Violation|4|||
125292043|NCT00459537|450695034|FG001|Overall Study|Protocol Violation|3|||
125292044|NCT00459537|450695033|FG000|Overall Study|Missing|1|||
125292045|NCT00459537|450695034|FG001|Overall Study|Missing|0|||
125292046|NCT03159104|450695035|FG000|Overall Study|Violation of inclusion criteria|1|||
125292047|NCT03159104|450695036|FG001|Overall Study|Violation of inclusion criteria|2|||
124819534|NCT05147350|448965747|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
124819535|NCT05147350|448965748|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
125292048|NCT00456599|450695037|FG000|Overall Study|Non-compliance|1|||
125292049|NCT00456599|450695037|FG000|Overall Study|Withdrawal by Subject|2|||
125292050|NCT01999218|450695038|FG000|Overall Study|Hyperglycemia|18|||
124819536|NCT05147350|448965749|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
124819537|NCT05147350|448965750|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
124819538|NCT05147350|448965751|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
125292051|NCT01999218|450695039|FG001|Overall Study|Hyperglycemia|17|||
125292052|NCT01999218|450695040|FG002|Overall Study|Hyperglycemia|17|||
125292053|NCT01999218|450695038|FG000|Overall Study|Lack of Efficacy|1|||
125292054|NCT01999218|450695039|FG001|Overall Study|Lack of Efficacy|0|||
125292055|NCT01999218|450695040|FG002|Overall Study|Lack of Efficacy|1|||
124784239|NCT01217307|448841413|FG000|Overall Study|Withdrawal by Subject|0|||
124784240|NCT01217307|448841414|FG001|Overall Study|Withdrawal by Subject|1|||
124784241|NCT01868542|448841415|FG000|Overall Study|Protocol Violation|0|||
124784242|NCT01868542|448841416|FG001|Overall Study|Protocol Violation|1|||
124784243|NCT01868542|448841415|FG000|Overall Study|Unclassified|0|||
124784244|NCT01868542|448841416|FG001|Overall Study|Unclassified|1|||
124784245|NCT02248675|448841417|FG000|Overall Study|Lost to Follow-up|3|||
124784246|NCT02248675|448841418|FG001|Overall Study|Lost to Follow-up|1|||
124784247|NCT00813943|448841426|FG000|Overall Study|Ongoing at cut-off date|5|||
124784248|NCT00813943|448841427|FG001|Overall Study|Ongoing at cut-off date|5|||
124784249|NCT00813943|448841428|FG002|Overall Study|Ongoing at cut-off date|3|||
124784250|NCT02551991|448841429|FG000|Overall Study|Death|5|||
124784251|NCT02551991|448841430|FG001|Overall Study|Death|7|||
124784252|NCT02551991|448841431|FG002|Overall Study|Death|8|||
124784253|NCT02551991|448841432|FG003|Overall Study|Death|7|||
124784254|NCT02551991|448841433|FG004|Overall Study|Death|17|||
124784255|NCT02551991|448841429|FG000|Overall Study|Withdrawal by Subject|1|||
124784256|NCT02551991|448841430|FG001|Overall Study|Withdrawal by Subject|0|||
124784257|NCT02551991|448841431|FG002|Overall Study|Withdrawal by Subject|0|||
124784258|NCT02551991|448841432|FG003|Overall Study|Withdrawal by Subject|0|||
124784259|NCT02551991|448841433|FG004|Overall Study|Withdrawal by Subject|2|||
124784260|NCT02551991|448841429|FG000|Overall Study|Lost to Follow-up|0|||
124784261|NCT02551991|448841430|FG001|Overall Study|Lost to Follow-up|0|||
124784262|NCT02551991|448841431|FG002|Overall Study|Lost to Follow-up|1|||
124784263|NCT02551991|448841432|FG003|Overall Study|Lost to Follow-up|0|||
124784264|NCT02551991|448841433|FG004|Overall Study|Lost to Follow-up|0|||
124784265|NCT02551991|448841429|FG000|Overall Study|Sponsor Decision|1|||
124784266|NCT02551991|448841430|FG001|Overall Study|Sponsor Decision|0|||
124784267|NCT02551991|448841431|FG002|Overall Study|Sponsor Decision|1|||
124784268|NCT02551991|448841432|FG003|Overall Study|Sponsor Decision|0|||
124784269|NCT02551991|448841433|FG004|Overall Study|Sponsor Decision|5|||
124784270|NCT02551991|448841429|FG000|Overall Study|Other|0|||
124784271|NCT02551991|448841430|FG001|Overall Study|Other|0|||
124784272|NCT02551991|448841431|FG002|Overall Study|Other|0|||
124784273|NCT02551991|448841432|FG003|Overall Study|Other|0|||
124784274|NCT02551991|448841433|FG004|Overall Study|Other|1|||
124784275|NCT00984620|448841434|FG000|Overall Study|Adverse Event|5|||
124784276|NCT00984620|448841435|FG001|Overall Study|Adverse Event|5|||
124784277|NCT00984620|448841434|FG000|Overall Study|Lost to Follow-up|1|||
124784278|NCT00984620|448841435|FG001|Overall Study|Lost to Follow-up|1|||
124784279|NCT00984620|448841434|FG000|Overall Study|Withdrawal by Subject|0|||
124784280|NCT00984620|448841435|FG001|Overall Study|Withdrawal by Subject|2|||
124784281|NCT00984620|448841434|FG000|Overall Study|reason other than listed above|0|||
124784282|NCT00984620|448841435|FG001|Overall Study|reason other than listed above|4|||
124784283|NCT02424578|448841437|FG000|Overall Study|Withdrawal by Subject|0|||
124784284|NCT02424578|448841438|FG001|Overall Study|Withdrawal by Subject|1|||
124784285|NCT00470834|448841441|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
124784286|NCT00470834|448841442|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
124784287|NCT00470834|448841441|FG000|Treatment Period (18 Months)|Adverse Event|7|||
124784288|NCT00470834|448841442|FG001|Treatment Period (18 Months)|Adverse Event|6|||
124784289|NCT00470834|448841441|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
124784290|NCT00470834|448841442|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
124784291|NCT00470834|448841441|FG000|Treatment Period (18 Months)|Physician Decision|4|||
124784292|NCT00470834|448841442|FG001|Treatment Period (18 Months)|Physician Decision|4|||
124784293|NCT00470834|448841441|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
124784294|NCT00470834|448841442|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
125292056|NCT01999218|450695038|FG000|Overall Study|Lost to Follow-up|22|||
125292057|NCT01999218|450695039|FG001|Overall Study|Lost to Follow-up|17|||
124784295|NCT00470834|448841441|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
124784296|NCT00470834|448841442|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
124784297|NCT00470834|448841441|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
124784298|NCT00470834|448841442|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
124784299|NCT00470834|448841441|FG000|Treatment Period (18 Months)|Non-compliance|1|||
124784300|NCT00470834|448841442|FG001|Treatment Period (18 Months)|Non-compliance|0|||
124784301|NCT00470834|448841441|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
124784302|NCT00470834|448841442|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
124784303|NCT00470834|448841441|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
124784304|NCT00470834|448841442|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
124784305|NCT00470834|448841441|FG000|Extension Period (24 Months)|Adverse Event|3|||
124784306|NCT00470834|448841442|FG001|Extension Period (24 Months)|Adverse Event|4|||
124784307|NCT00470834|448841441|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
124784308|NCT00470834|448841442|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
124784309|NCT00470834|448841441|FG000|Extension Period (24 Months)|Physician Decision|4|||
124784310|NCT00470834|448841442|FG001|Extension Period (24 Months)|Physician Decision|3|||
124784311|NCT00470834|448841441|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
124784312|NCT00470834|448841442|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
124784313|NCT00470834|448841441|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
124784314|NCT00470834|448841442|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
124784315|NCT00470834|448841441|FG000|Extension Period (24 Months)|Non-compliance|0|||
124784316|NCT00470834|448841442|FG001|Extension Period (24 Months)|Non-compliance|1|||
124784317|NCT00470834|448841441|FG000|Extension Period (24 Months)|Disease Progression|0|||
124784318|NCT00470834|448841442|FG001|Extension Period (24 Months)|Disease Progression|1|||
124784319|NCT04975438|448841446|FG000|Overall Study|Lost to Follow-up|1|||
124784320|NCT04975438|448841447|FG001|Overall Study|Lost to Follow-up|0|||
124784321|NCT04975438|448841448|FG002|Overall Study|Lost to Follow-up|1|||
124784322|NCT04975438|448841449|FG003|Overall Study|Lost to Follow-up|0|||
124784323|NCT04975438|448841446|FG000|Overall Study|Withdrawal by Subject|1|||
124784324|NCT04975438|448841447|FG001|Overall Study|Withdrawal by Subject|0|||
124784325|NCT04975438|448841448|FG002|Overall Study|Withdrawal by Subject|0|||
124784326|NCT04975438|448841449|FG003|Overall Study|Withdrawal by Subject|0|||
124784327|NCT01276054|448841454|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
124784328|NCT01276054|448841455|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
124784329|NCT02640508|448841456|FG000|Overall Study|Death|19|||
124784330|NCT02640508|448841456|FG000|Overall Study|Withdrawal by Subject|8|||
124784331|NCT02640508|448841456|FG000|Overall Study|Physician Decision|1|||
124784332|NCT02640508|448841456|FG000|Overall Study|Lost to Follow-up|1|||
124784333|NCT05405257|448841460|FG000|Overall Study|Withdrawal by Subject|1|||
124784334|NCT00776919|448841461|FG000|Overall Study|Withdrawal by Subject|16|||
124784335|NCT00776919|448841462|FG001|Overall Study|Withdrawal by Subject|14|||
124784336|NCT00776919|448841463|FG002|Overall Study|Withdrawal by Subject|15|||
124784337|NCT00776919|448841464|FG003|Overall Study|Withdrawal by Subject|26|||
124784338|NCT00776919|448841461|FG000|Overall Study|Lost to Follow-up|8|||
124784339|NCT00776919|448841462|FG001|Overall Study|Lost to Follow-up|12|||
124784340|NCT00776919|448841463|FG002|Overall Study|Lost to Follow-up|11|||
124784341|NCT00776919|448841464|FG003|Overall Study|Lost to Follow-up|8|||
124784342|NCT00776919|448841461|FG000|Overall Study|Adverse Event|1|||
124784343|NCT00776919|448841462|FG001|Overall Study|Adverse Event|0|||
124784344|NCT00776919|448841463|FG002|Overall Study|Adverse Event|2|||
124784345|NCT00776919|448841464|FG003|Overall Study|Adverse Event|2|||
124784346|NCT00776919|448841461|FG000|Overall Study|Protocol Violation|1|||
124784347|NCT00776919|448841462|FG001|Overall Study|Protocol Violation|2|||
124784348|NCT00776919|448841463|FG002|Overall Study|Protocol Violation|0|||
124784349|NCT00776919|448841464|FG003|Overall Study|Protocol Violation|1|||
124784350|NCT00776919|448841461|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
124784351|NCT00776919|448841462|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
124784352|NCT00776919|448841463|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
124784353|NCT00776919|448841464|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
124784354|NCT00275340|448841465|FG000|Overall Study|Lost to Follow-up|2|||
124784355|NCT00275340|448841466|FG001|Overall Study|Lost to Follow-up|4|||
124784356|NCT02379637|448841470|FG000|Overall Study|Protocol Violation|0|||
124784357|NCT02379637|448841471|FG001|Overall Study|Protocol Violation|1|||
124784358|NCT02379637|448841470|FG000|Overall Study|Adverse Event|1|||
124784359|NCT02379637|448841471|FG001|Overall Study|Adverse Event|0|||
124784360|NCT02379637|448841470|FG000|Overall Study|Withdrawal by Subject|1|||
124784361|NCT02379637|448841471|FG001|Overall Study|Withdrawal by Subject|0|||
124784362|NCT00862641|448841472|FG000|Overall Study|Randomized, but drug not received|1|||
124784363|NCT00862641|448841473|FG001|Overall Study|Randomized, but drug not received|4|||
124784364|NCT00862641|448841474|FG002|Overall Study|Randomized, but drug not received|1|||
124784365|NCT00862641|448841475|FG003|Overall Study|Randomized, but drug not received|4|||
124784366|NCT02365480|448841476|FG000|Overall Study|Withdrawal by Subject|2|||
124784367|NCT02365480|448841477|FG001|Overall Study|Withdrawal by Subject|0|||
124784368|NCT03091348|448841478|FG000|Overall Study|Lost to Follow-up|2|||
124784369|NCT03091348|448841479|FG001|Overall Study|Lost to Follow-up|1|||
124784370|NCT02791763|448841480|FG000|Overall Study|Protocol Violation|0|||
124784371|NCT02791763|448841481|FG001|Overall Study|Protocol Violation|0|||
124784372|NCT02791763|448841482|FG002|Overall Study|Protocol Violation|1|||
124784373|NCT02791763|448841480|FG000|Overall Study|Withdrawal by Subject|5|||
124784374|NCT02791763|448841481|FG001|Overall Study|Withdrawal by Subject|1|||
124784375|NCT02791763|448841482|FG002|Overall Study|Withdrawal by Subject|0|||
124784376|NCT02791763|448841480|FG000|Overall Study|Physician Decision|0|||
124784377|NCT02791763|448841481|FG001|Overall Study|Physician Decision|1|||
125292058|NCT01999218|450695040|FG002|Overall Study|Lost to Follow-up|18|||
125292059|NCT01999218|450695038|FG000|Overall Study|Non-Compliance With Study Drug|6|||
125292060|NCT01999218|450695039|FG001|Overall Study|Non-Compliance With Study Drug|4|||
125292061|NCT01999218|450695040|FG002|Overall Study|Non-Compliance With Study Drug|1|||
125292062|NCT01999218|450695038|FG000|Overall Study|Physician Decision|1|||
125292063|NCT01999218|450695039|FG001|Overall Study|Physician Decision|4|||
125292064|NCT01999218|450695040|FG002|Overall Study|Physician Decision|6|||
125292065|NCT01999218|450695038|FG000|Overall Study|Protocol Violation|4|||
125292066|NCT01999218|450695039|FG001|Overall Study|Protocol Violation|5|||
125292067|NCT01999218|450695040|FG002|Overall Study|Protocol Violation|4|||
125292068|NCT01999218|450695038|FG000|Overall Study|Screen failure|0|||
125292069|NCT01999218|450695039|FG001|Overall Study|Screen failure|1|||
125292070|NCT01999218|450695040|FG002|Overall Study|Screen failure|0|||
125292071|NCT01999218|450695038|FG000|Overall Study|Study Terminated By Sponsor|7|||
125292072|NCT01999218|450695039|FG001|Overall Study|Study Terminated By Sponsor|5|||
125292073|NCT01999218|450695040|FG002|Overall Study|Study Terminated By Sponsor|12|||
125292074|NCT01999218|450695038|FG000|Overall Study|Participant moves|2|||
125292075|NCT01999218|450695039|FG001|Overall Study|Participant moves|5|||
125292076|NCT01999218|450695040|FG002|Overall Study|Participant moves|3|||
125292077|NCT01999218|450695038|FG000|Overall Study|Withdrawal by Subject|28|||
125292078|NCT01999218|450695039|FG001|Overall Study|Withdrawal by Subject|29|||
125292079|NCT01999218|450695040|FG002|Overall Study|Withdrawal by Subject|34|||
125292080|NCT01999218|450695038|FG000|Overall Study|Creatinine/eGFR|0|||
125292081|NCT01999218|450695039|FG001|Overall Study|Creatinine/eGFR|0|||
125292082|NCT01999218|450695040|FG002|Overall Study|Creatinine/eGFR|1|||
125292083|NCT01999218|450695038|FG000|Overall Study|Death|7|||
124784378|NCT02791763|448841482|FG002|Overall Study|Physician Decision|0|||
124784379|NCT02791763|448841480|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
124784380|NCT02791763|448841481|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
124784381|NCT02791763|448841482|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
124784382|NCT02791763|448841480|FG000|Overall Study|Cancer event|1|||
124784383|NCT02791763|448841481|FG001|Overall Study|Cancer event|3|||
124784384|NCT02791763|448841482|FG002|Overall Study|Cancer event|0|||
124784385|NCT02791763|448841480|FG000|Overall Study|Participant had renal transplant|3|||
124784386|NCT02791763|448841481|FG001|Overall Study|Participant had renal transplant|0|||
124784387|NCT02791763|448841482|FG002|Overall Study|Participant had renal transplant|0|||
124784388|NCT02791763|448841480|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
124784389|NCT02791763|448841481|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
124784390|NCT02791763|448841482|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
124784391|NCT02791763|448841480|FG000|Overall Study|Adverse Event|12|||
124784392|NCT02791763|448841481|FG001|Overall Study|Adverse Event|13|||
124784393|NCT02791763|448841482|FG002|Overall Study|Adverse Event|7|||
124784394|NCT04534686|448841483|FG000|Baseline Measurement|Lost to Follow-up|4|||
124784395|NCT04534686|448841484|FG001|Baseline Measurement|Lost to Follow-up|6|||
124784396|NCT04534686|448841483|FG000|Baseline Measurement|Withdrawal by Subject|3|||
124784397|NCT04534686|448841484|FG001|Baseline Measurement|Withdrawal by Subject|1|||
124784398|NCT04534686|448841483|FG000|Intervention|Withdrawal by Subject|2|||
124784399|NCT04534686|448841484|FG001|Intervention|Withdrawal by Subject|2|||
124784400|NCT00706342|448841485|FG000|Overall Study|Adverse Event|3|||
124784401|NCT00706342|448841485|FG000|Overall Study|Not responding to treatment|2|||
124784402|NCT00706342|448841485|FG000|Overall Study|Withdrawn due to failure to respond|1|||
124784403|NCT00706342|448841485|FG000|Overall Study|Death|1|||
124784404|NCT00706342|448841485|FG000|Overall Study|Withdrew from the study on his own.|1|||
124784405|NCT00706342|448841485|FG000|Overall Study|Investigator discretion|2|||
124784406|NCT00706342|448841485|FG000|Overall Study|Non-responder Week 12|1|||
124784407|NCT00706342|448841485|FG000|Overall Study|Ongoing|6|||
124784408|NCT00706342|448841485|FG000|Overall Study|WIthdrawal of consent|1|||
124784409|NCT01419197|448841490|FG000|Overall Study|Death|247|||
124784410|NCT01419197|448841491|FG001|Overall Study|Death|122|||
124784411|NCT01419197|448841490|FG000|Overall Study|Physician Decision|4|||
124784412|NCT01419197|448841491|FG001|Overall Study|Physician Decision|4|||
124784413|NCT01419197|448841490|FG000|Overall Study|Non-compliance|3|||
124784414|NCT01419197|448841491|FG001|Overall Study|Non-compliance|1|||
124784415|NCT01419197|448841490|FG000|Overall Study|Withdrawal by Subject|33|||
124784416|NCT01419197|448841491|FG001|Overall Study|Withdrawal by Subject|32|||
124784417|NCT01419197|448841490|FG000|Overall Study|Study Completed by Sponsor|103|||
124784418|NCT01419197|448841491|FG001|Overall Study|Study Completed by Sponsor|34|||
124784419|NCT01419197|448841490|FG000|Overall Study|Reason Not Specified|0|||
125292084|NCT01999218|450695039|FG001|Overall Study|Death|1|||
124784420|NCT01419197|448841491|FG001|Overall Study|Reason Not Specified|1|||
124784421|NCT01419197|448841490|FG000|Overall Study|Lost to Follow-up|14|||
124784422|NCT01419197|448841491|FG001|Overall Study|Lost to Follow-up|4|||
124784423|NCT02410343|448841492|FG000|Core Period (24 Weeks)|Adverse Event|1|||
124784424|NCT02410343|448841493|FG001|Core Period (24 Weeks)|Adverse Event|0|||
124784425|NCT02410343|448841492|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
124784426|NCT02410343|448841493|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
124784427|NCT02410343|448841492|FG000|Extension Period (12 Months)|Adverse Event|1|||
124784428|NCT02410343|448841493|FG001|Extension Period (12 Months)|Adverse Event|0|||
124784429|NCT02410343|448841492|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
124784430|NCT02410343|448841493|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
124784431|NCT02878798|448841498|FG000|Overall Study|Withdrawal by Subject|5|||
124784432|NCT02878798|448841499|FG001|Overall Study|Withdrawal by Subject|4|||
124784433|NCT02878798|448841498|FG000|Overall Study|Lost to Follow-up|2|||
124784434|NCT02878798|448841499|FG001|Overall Study|Lost to Follow-up|2|||
124784435|NCT02878798|448841498|FG000|Overall Study|Protocol Violation|0|||
124784436|NCT02878798|448841499|FG001|Overall Study|Protocol Violation|1|||
124784437|NCT00246740|448841500|FG000|Initial Enrollment|Death|1|||
124784438|NCT00246740|448841501|FG001|Initial Enrollment|Death|0|||
124784439|NCT00246740|448841500|FG000|Initial Enrollment|Additional surgery scheduled|0|||
124784440|NCT00246740|448841501|FG001|Initial Enrollment|Additional surgery scheduled|2|||
124784441|NCT00246740|448841500|FG000|Initial Enrollment|Surgery schedule change|4|||
124784442|NCT00246740|448841501|FG001|Initial Enrollment|Surgery schedule change|4|||
124784443|NCT00246740|448841500|FG000|Initial Enrollment|Other|1|||
124784444|NCT00246740|448841501|FG001|Initial Enrollment|Other|2|||
124784445|NCT01510769|448841502|FG000|Overall Study|Adverse Event|7|||
124784446|NCT01510769|448841503|FG001|Overall Study|Adverse Event|6|||
124784447|NCT01510769|448841504|FG002|Overall Study|Adverse Event|4|||
124784448|NCT01510769|448841502|FG000|Overall Study|Gout Flare|0|||
124784449|NCT01510769|448841503|FG001|Overall Study|Gout Flare|3|||
124784450|NCT01510769|448841504|FG002|Overall Study|Gout Flare|1|||
124784451|NCT01510769|448841502|FG000|Overall Study|Protocol Violation|11|||
124784452|NCT01510769|448841503|FG001|Overall Study|Protocol Violation|10|||
124784453|NCT01510769|448841504|FG002|Overall Study|Protocol Violation|9|||
124784454|NCT01510769|448841502|FG000|Overall Study|Lost to Follow-up|5|||
124784455|NCT01510769|448841503|FG001|Overall Study|Lost to Follow-up|1|||
124784456|NCT01510769|448841504|FG002|Overall Study|Lost to Follow-up|5|||
124784457|NCT01510769|448841502|FG000|Overall Study|Withdrawal by Subject|3|||
124784458|NCT01510769|448841503|FG001|Overall Study|Withdrawal by Subject|4|||
124784459|NCT01510769|448841504|FG002|Overall Study|Withdrawal by Subject|3|||
124784460|NCT01510769|448841502|FG000|Overall Study|Death|1|||
124784461|NCT01510769|448841503|FG001|Overall Study|Death|1|||
124784462|NCT01510769|448841504|FG002|Overall Study|Death|0|||
124784463|NCT00335764|448841505|FG000|Overall Study|wrong histology|1|||
124784464|NCT00335764|448841506|FG001|Overall Study|wrong histology|0|||
124784465|NCT00335764|448841507|FG002|Overall Study|wrong histology|0|||
124784466|NCT00335764|448841508|FG003|Overall Study|wrong histology|0|||
124784467|NCT00335764|448841509|FG004|Overall Study|wrong histology|1|||
124784468|NCT02466659|448841512|FG000|Overall Study|Lost to Follow-up|5|||
124784469|NCT02466659|448841513|FG001|Overall Study|Lost to Follow-up|2|||
124784470|NCT00929643|448841514|FG000|Overall Study|Protocol Violation|2|||
124784471|NCT00934440|448841517|FG000|Overall Study|Lost to Follow-up|1|||
124784472|NCT00744042|448841518|FG000|Overall Study|Withdrawal by Subject|1|||
124784473|NCT00750152|448841519|FG000|Overall Study|Adverse Event|2|||
124784474|NCT00750152|448841520|FG001|Overall Study|Adverse Event|1|||
124784475|NCT00750152|448841519|FG000|Overall Study|Lost to Follow-up|8|||
124784476|NCT00750152|448841520|FG001|Overall Study|Lost to Follow-up|13|||
124784477|NCT00750152|448841519|FG000|Overall Study|Withdrawal by Subject|3|||
124784478|NCT00750152|448841520|FG001|Overall Study|Withdrawal by Subject|3|||
124784479|NCT00750152|448841519|FG000|Overall Study|Physician Decision|1|||
124784480|NCT00750152|448841520|FG001|Overall Study|Physician Decision|1|||
124784481|NCT00750152|448841519|FG000|Overall Study|Non-compliance|0|||
124784482|NCT00750152|448841520|FG001|Overall Study|Non-compliance|1|||
124784483|NCT00750152|448841519|FG000|Overall Study|Termination by sponsor|1|||
124784484|NCT00750152|448841520|FG001|Overall Study|Termination by sponsor|0|||
124784485|NCT00750152|448841519|FG000|Overall Study|Other|7|||
124784486|NCT00750152|448841520|FG001|Overall Study|Other|8|||
124784487|NCT04629066|448841523|FG000|Overall Study|Lost to Follow-up|3|||
124784488|NCT04629066|448841524|FG001|Overall Study|Lost to Follow-up|2|||
124784489|NCT01028300|448841525|FG000|Overall Study|Study Terminated|4|||
124784490|NCT01214395|448841528|FG000|Overall Study|All patients had infection|5|||
124784491|NCT00715910|448841532|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
124784492|NCT00715910|448841533|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
124784493|NCT00715910|448841534|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
124784494|NCT00715910|448841535|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
124784495|NCT00715910|448841536|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
124784496|NCT00715910|448841537|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
124784497|NCT00715910|448841532|FG000|Booster and ESFU Phase|Other|0|||
124784498|NCT00715910|448841533|FG001|Booster and ESFU Phase|Other|0|||
124784499|NCT00715910|448841534|FG002|Booster and ESFU Phase|Other|0|||
124784500|NCT00715910|448841535|FG003|Booster and ESFU Phase|Other|5|||
124784501|NCT00715910|448841536|FG004|Booster and ESFU Phase|Other|1|||
124784502|NCT00715910|448841537|FG005|Booster and ESFU Phase|Other|0|||
124784503|NCT02034409|448841538|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
124784504|NCT02034409|448841539|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
124784505|NCT02034409|448841538|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
124784506|NCT02034409|448841539|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
124784507|NCT02034409|448841538|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
124784508|NCT02034409|448841539|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
124784509|NCT02034409|448841538|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
124784510|NCT02034409|448841539|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
124784511|NCT02034409|448841538|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
124784512|NCT02034409|448841539|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
124784513|NCT02034409|448841538|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
124784514|NCT02034409|448841539|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
124784515|NCT05092360|448841540|FG000|Overall Study|Withdrawal by Subject|21|||
124784516|NCT05092360|448841541|FG001|Overall Study|Withdrawal by Subject|4|||
124784517|NCT05092360|448841542|FG002|Overall Study|Withdrawal by Subject|9|||
124784518|NCT05092360|448841543|FG003|Overall Study|Withdrawal by Subject|26|||
124784519|NCT05092360|448841540|FG000|Overall Study|Death|97|||
124784520|NCT05092360|448841541|FG001|Overall Study|Death|14|||
124784521|NCT05092360|448841542|FG002|Overall Study|Death|31|||
124784522|NCT05092360|448841543|FG003|Overall Study|Death|101|||
124784523|NCT05092360|448841540|FG000|Overall Study|Lost to Follow-up|1|||
124784524|NCT05092360|448841541|FG001|Overall Study|Lost to Follow-up|2|||
124784525|NCT05092360|448841542|FG002|Overall Study|Lost to Follow-up|2|||
124784526|NCT05092360|448841543|FG003|Overall Study|Lost to Follow-up|2|||
124784527|NCT05092360|448841540|FG000|Overall Study|Study terminated by sponsor|65|||
124784528|NCT05092360|448841541|FG001|Overall Study|Study terminated by sponsor|7|||
124784529|NCT05092360|448841542|FG002|Overall Study|Study terminated by sponsor|13|||
124784530|NCT05092360|448841543|FG003|Overall Study|Study terminated by sponsor|61|||
124784531|NCT03952039|448841546|FG000|Overall Study|Adverse Event|22|||
124784532|NCT03952039|448841547|FG001|Overall Study|Adverse Event|8|||
124784533|NCT03952039|448841546|FG000|Overall Study|Withdrawal by Participant|17|||
124784534|NCT03952039|448841547|FG001|Overall Study|Withdrawal by Participant|12|||
124784535|NCT03952039|448841546|FG000|Overall Study|Death|13|||
124784536|NCT03952039|448841547|FG001|Overall Study|Death|6|||
124784537|NCT03952039|448841546|FG000|Overall Study|Lack of Efficacy|12|||
124784538|NCT03952039|448841547|FG001|Overall Study|Lack of Efficacy|2|||
124784539|NCT03952039|448841546|FG000|Overall Study|Physician Decision|9|||
124784540|NCT03952039|448841547|FG001|Overall Study|Physician Decision|3|||
124784541|NCT03952039|448841546|FG000|Overall Study|Progressive Disease|6|||
124784542|NCT03952039|448841547|FG001|Overall Study|Progressive Disease|4|||
124784543|NCT03952039|448841546|FG000|Overall Study|Other Reasons|12|||
124784544|NCT03952039|448841547|FG001|Overall Study|Other Reasons|4|||
124784545|NCT04614324|448841553|FG000|Overall Study|Lost to Follow-up|3|||
124784546|NCT04614324|448841553|FG000|Overall Study|Physician Decision|1|||
124784547|NCT04614324|448841553|FG000|Overall Study|Withdrawal by Subject|2|||
124784548|NCT04614324|448841553|FG000|Overall Study|Remaining in Follow up|123|||
124784549|NCT04627285|448841554|FG000|Overall Study|Adverse Event|0|||
124784550|NCT04627285|448841555|FG001|Overall Study|Adverse Event|2|||
124784551|NCT04627285|448841554|FG000|Overall Study|Lost to Follow-up|1|||
124784552|NCT04627285|448841555|FG001|Overall Study|Lost to Follow-up|0|||
124784553|NCT04627285|448841554|FG000|Overall Study|Withdrawal by Subject|1|||
124784554|NCT04627285|448841555|FG001|Overall Study|Withdrawal by Subject|1|||
124784555|NCT04627285|448841554|FG000|Overall Study|Sponsor decision|5|||
125292085|NCT01999218|450695040|FG002|Overall Study|Death|2|||
125292086|NCT01999218|450695038|FG000|Overall Study|Excluded Medication|1|||
124784556|NCT04627285|448841555|FG001|Overall Study|Sponsor decision|0|||
124784557|NCT04627285|448841554|FG000|Overall Study|Participant left country; aunt informed the site|0|||
124784558|NCT04627285|448841555|FG001|Overall Study|Participant left country; aunt informed the site|1|||
124784559|NCT04473235|448843613|FG000|Overall Study|Lost to Follow-up|6|||
124784560|NCT04473235|448843614|FG001|Overall Study|Lost to Follow-up|5|||
124784561|NCT04473235|448843613|FG000|Overall Study|Declined continuation|2|||
124784562|NCT04473235|448843614|FG001|Overall Study|Declined continuation|0|||
124784563|NCT04473235|448843613|FG000|Overall Study|Physician Decision|1|||
124784564|NCT04473235|448843614|FG001|Overall Study|Physician Decision|1|||
124784565|NCT04473235|448843613|FG000|Overall Study|Protocol Violation|10|||
124784566|NCT04473235|448843614|FG001|Overall Study|Protocol Violation|6|||
124784567|NCT01754402|448843615|FG000|Overall Study|Death|0|||
124784568|NCT01754402|448843616|FG001|Overall Study|Death|0|||
124784569|NCT01754402|448843617|FG002|Overall Study|Death|1|||
124784570|NCT01754402|448843615|FG000|Overall Study|Adverse Event|2|||
124784571|NCT01754402|448843616|FG001|Overall Study|Adverse Event|2|||
125292087|NCT01999218|450695039|FG001|Overall Study|Excluded Medication|1|||
125292088|NCT01999218|450695040|FG002|Overall Study|Excluded Medication|2|||
125292089|NCT01999218|450695038|FG000|Overall Study|Adverse Event|9|||
125292090|NCT01999218|450695039|FG001|Overall Study|Adverse Event|7|||
125292091|NCT01999218|450695040|FG002|Overall Study|Adverse Event|7|||
125292092|NCT01999218|450695038|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
125292093|NCT01999218|450695039|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
125292094|NCT01999218|450695040|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
125292095|NCT00664326|450696496|FG000|Overall Study|Adverse Event|14|||
125292096|NCT00664326|450696496|FG000|Overall Study|Noncompliance with study medication|3|||
125292097|NCT00664326|450696496|FG000|Overall Study|Withdrawal by Subject|1|||
125292098|NCT00664326|450696496|FG000|Overall Study|Physician Decision|1|||
125292099|NCT00664326|450696496|FG000|Overall Study|Other Reasons|3|||
125292100|NCT00664326|450696496|FG000|Overall Study|Death|2|||
125292101|NCT00664326|450696496|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
125292102|NCT00387647|450696497|FG000|Overall Study|Death|18|||
125292103|NCT02032407|450696498|FG000|Overall Study|Lost to Follow-up|2|||
125292104|NCT02032407|450696498|FG000|Overall Study|Pregnancy|1|||
125292105|NCT02032407|450696498|FG000|Overall Study|Other Miscellaneous Reasons|2|||
125292106|NCT02191605|450696499|FG000|Overall Study|Lost to Follow-up|9|||
125292107|NCT02191605|450696500|FG001|Overall Study|Lost to Follow-up|4|||
125292108|NCT02191605|450696501|FG002|Overall Study|Lost to Follow-up|7|||
125292109|NCT02191605|450696502|FG003|Overall Study|Lost to Follow-up|3|||
125292110|NCT02191605|450696503|FG004|Overall Study|Lost to Follow-up|4|||
125292111|NCT01309269|450696506|FG000|Overall Study|Adverse Event|56|||
125292112|NCT01309269|450696506|FG000|Overall Study|Withdrawal by Subject|25|||
125292113|NCT01309269|450696506|FG000|Overall Study|Lack of Acceptance|15|||
125292114|NCT01309269|450696506|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
125292115|NCT01309269|450696506|FG000|Overall Study|Kidney Transplant|25|||
125292116|NCT01309269|450696506|FG000|Overall Study|Administrative Problems|141|||
125292117|NCT01309269|450696506|FG000|Overall Study|Other|256|||
125292118|NCT01309269|450696506|FG000|Overall Study|Other|1|||
125292119|NCT01309269|450696506|FG000|Overall Study|Study Completion Data Not Recorded|95|||
125292120|NCT01309269|450696506|FG000|Overall Study|Enrolled but not Treated|107|||
125292121|NCT03647267|450696510|FG000|Overall Study|Lost to Follow-up|1|||
125292122|NCT03647267|450696511|FG001|Overall Study|Lost to Follow-up|0|||
125292123|NCT01350115|450696512|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
125292124|NCT01350115|450696513|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
125292125|NCT01350115|450696512|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
125292126|NCT01350115|450696513|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
125292127|NCT01350115|450696512|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
125292128|NCT01350115|450696513|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
125292129|NCT05079477|450696514|FG000|Overall Study|Lost to Follow-up|2|||
125292130|NCT05079477|450696515|FG001|Overall Study|Lost to Follow-up|0|||
125292131|NCT05079477|450696514|FG000|Overall Study|Withdrawal by Subject|1|||
125292132|NCT05079477|450696515|FG001|Overall Study|Withdrawal by Subject|0|||
125292133|NCT05079477|450696514|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
125292134|NCT05079477|450696515|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
125292135|NCT05079477|450696514|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
125292136|NCT05079477|450696515|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
125292137|NCT05013424|450696518|FG000|Overall Study|Lost to Follow-up|1|||
125292138|NCT05013424|450696519|FG001|Overall Study|Lost to Follow-up|1|||
125292139|NCT05013424|450696520|FG002|Overall Study|Lost to Follow-up|1|||
125292140|NCT05013424|450696518|FG000|Overall Study|Withdrawal by Subject|0|||
125292141|NCT05013424|450696519|FG001|Overall Study|Withdrawal by Subject|1|||
125292142|NCT05013424|450696520|FG002|Overall Study|Withdrawal by Subject|0|||
125292143|NCT00240110|450696521|FG000|Overall Study|Lost to Follow-up|6|||
125292144|NCT00240110|450696522|FG001|Overall Study|Lost to Follow-up|7|||
125292145|NCT02654236|450696526|FG000|Overall Study|Withdrawal by Subject|0|||
125292146|NCT02654236|450696527|FG001|Overall Study|Withdrawal by Subject|0|||
125292147|NCT02654236|450696528|FG002|Overall Study|Withdrawal by Subject|2|||
125292148|NCT03204890|450696529|FG000|Overall Study|Withdrawal by Subject|1|||
125292149|NCT01549873|450696530|FG000|Overall Study|Physician Decision|0|||
125292150|NCT01549873|450696531|FG001|Overall Study|Physician Decision|1|||
125292151|NCT03769311|450696532|FG000|Overall Study|Withdrawal by Subject|1|||
125292152|NCT01596335|450696533|FG000|Overall Study|exacerbation of primary disease|5|||
125292153|NCT01596335|450696534|FG001|Overall Study|exacerbation of primary disease|9|||
125292154|NCT03627065|450696535|FG000|Overall Study|Study Terminated by sponsor|1|||
125292155|NCT03627065|450696535|FG000|Overall Study|Withdrawal by Subject|2|||
125292156|NCT04524455|450696537|FG000|Overall Study|Death|3|||
125292157|NCT04524455|450696538|FG001|Overall Study|Death|3|||
125292158|NCT04524455|450696537|FG000|Overall Study|Decision by Sponsor|0|||
125292159|NCT04524455|450696538|FG001|Overall Study|Decision by Sponsor|2|||
125292160|NCT04524455|450696537|FG000|Overall Study|Withdrawal of Consent From Study|1|||
125292161|NCT04524455|450696538|FG001|Overall Study|Withdrawal of Consent From Study|0|||
124784572|NCT01754402|448843617|FG002|Overall Study|Adverse Event|1|||
124784573|NCT01754402|448843615|FG000|Overall Study|Withdrawal by Subject|0|||
124784574|NCT01754402|448843616|FG001|Overall Study|Withdrawal by Subject|0|||
124784575|NCT01754402|448843617|FG002|Overall Study|Withdrawal by Subject|1|||
124784576|NCT01754402|448843615|FG000|Overall Study|Lack of Efficacy|0|||
124784577|NCT01754402|448843616|FG001|Overall Study|Lack of Efficacy|0|||
124784578|NCT01754402|448843617|FG002|Overall Study|Lack of Efficacy|1|||
124784579|NCT01282463|448843618|FG000|Overall Study|Lost to Follow-up|1|||
124784580|NCT01282463|448843619|FG001|Overall Study|Lost to Follow-up|0|||
124784581|NCT01282463|448843620|FG002|Overall Study|Lost to Follow-up|0|||
124784582|NCT01282463|448843618|FG000|Overall Study|Withdrawal by Subject|6|||
124784583|NCT01282463|448843619|FG001|Overall Study|Withdrawal by Subject|2|||
124784584|NCT01282463|448843620|FG002|Overall Study|Withdrawal by Subject|3|||
124784585|NCT01282463|448843618|FG000|Overall Study|"Never Treated Death"|0|||
124784586|NCT01282463|448843619|FG001|Overall Study|"Never Treated Death"|1|||
124784587|NCT01282463|448843620|FG002|Overall Study|"Never Treated Death"|0|||
124784588|NCT01282463|448843618|FG000|Overall Study|"Never Treated PD"|0|||
124784589|NCT01282463|448843619|FG001|Overall Study|"Never Treated PD"|1|||
124784590|NCT01282463|448843620|FG002|Overall Study|"Never Treated PD"|0|||
124784591|NCT01282463|448843618|FG000|Overall Study|Protocol Violation|0|||
124784592|NCT01282463|448843619|FG001|Overall Study|Protocol Violation|0|||
124784593|NCT01282463|448843620|FG002|Overall Study|Protocol Violation|1|||
124784594|NCT01282463|448843618|FG000|Overall Study|Physician Decision|1|||
124784595|NCT01282463|448843619|FG001|Overall Study|Physician Decision|0|||
124784596|NCT01282463|448843620|FG002|Overall Study|Physician Decision|0|||
124784597|NCT01221285|448843623|FG000|Overall Study|Withdrawal by Subject|1|||
124784598|NCT01239992|448843625|FG000|Overall Study|Withdrawal by Subject|2|||
124784599|NCT00220779|448843631|FG000|Overall Study|Adverse Event|1|||
124784600|NCT00220779|448843632|FG001|Overall Study|Adverse Event|0|||
124784601|NCT00220779|448843633|FG002|Overall Study|Adverse Event|0|||
124784602|NCT00220779|448843631|FG000|Overall Study|Withdrawal by Subject|1|||
124784603|NCT00220779|448843632|FG001|Overall Study|Withdrawal by Subject|4|||
124784604|NCT00220779|448843633|FG002|Overall Study|Withdrawal by Subject|1|||
124784605|NCT00220779|448843631|FG000|Overall Study|Non-compliance|1|||
124784606|NCT00220779|448843632|FG001|Overall Study|Non-compliance|0|||
124784607|NCT00220779|448843633|FG002|Overall Study|Non-compliance|0|||
124784608|NCT00220779|448843631|FG000|Overall Study|Too time consuming|1|||
124784609|NCT00220779|448843632|FG001|Overall Study|Too time consuming|0|||
124784610|NCT00220779|448843633|FG002|Overall Study|Too time consuming|0|||
124784611|NCT00220779|448843631|FG000|Overall Study|Pregnancy|0|||
124784612|NCT00220779|448843632|FG001|Overall Study|Pregnancy|0|||
124784613|NCT00220779|448843633|FG002|Overall Study|Pregnancy|2|||
124784614|NCT00220779|448843631|FG000|Overall Study|Lack of Efficacy|3|||
124784615|NCT00220779|448843632|FG001|Overall Study|Lack of Efficacy|0|||
124784616|NCT00220779|448843633|FG002|Overall Study|Lack of Efficacy|1|||
124784617|NCT03390101|448843634|FG000|Weeks 0-12|Withdrawal by Subject|0|||
124784618|NCT03390101|448843635|FG001|Weeks 0-12|Withdrawal by Subject|1|||
124784619|NCT03390101|448843636|FG002|Weeks 0-12|Withdrawal by Subject|1|||
124784620|NCT03390101|448843634|FG000|Weeks 0-12|Lost to Follow-up|0|||
124784621|NCT03390101|448843635|FG001|Weeks 0-12|Lost to Follow-up|1|||
124784622|NCT03390101|448843636|FG002|Weeks 0-12|Lost to Follow-up|0|||
124784623|NCT03390101|448843634|FG000|Weeks 12-54|Withdrawal by Subject|0|||
124784624|NCT03390101|448843635|FG001|Weeks 12-54|Withdrawal by Subject|3|||
124784625|NCT03390101|448843636|FG002|Weeks 12-54|Withdrawal by Subject|1|||
124784626|NCT03390101|448843634|FG000|Weeks 12-54|Pregnancy|1|||
124784627|NCT03390101|448843635|FG001|Weeks 12-54|Pregnancy|0|||
124784628|NCT03390101|448843636|FG002|Weeks 12-54|Pregnancy|0|||
124784629|NCT03390101|448843634|FG000|Weeks 12-54|Adverse Event|2|||
124784630|NCT03390101|448843635|FG001|Weeks 12-54|Adverse Event|1|||
124784631|NCT03390101|448843636|FG002|Weeks 12-54|Adverse Event|1|||
124784632|NCT00281658|448843637|FG000|Randomized Phase|Adverse Event|0|||
124784633|NCT00281658|448843638|FG001|Randomized Phase|Adverse Event|2|||
124784634|NCT00281658|448843639|FG002|Randomized Phase|Adverse Event|0|||
124784635|NCT00281658|448843640|FG003|Randomized Phase|Adverse Event|0|||
124784636|NCT00281658|448843637|FG000|Randomized Phase|Lost to Follow-up|34|||
124784637|NCT00281658|448843638|FG001|Randomized Phase|Lost to Follow-up|27|||
124784638|NCT00281658|448843639|FG002|Randomized Phase|Lost to Follow-up|0|||
124784639|NCT00281658|448843640|FG003|Randomized Phase|Lost to Follow-up|0|||
124784640|NCT00281658|448843637|FG000|Randomized Phase|Withdrawal by Subject|8|||
124784641|NCT00281658|448843638|FG001|Randomized Phase|Withdrawal by Subject|7|||
124784642|NCT00281658|448843639|FG002|Randomized Phase|Withdrawal by Subject|0|||
124784643|NCT00281658|448843640|FG003|Randomized Phase|Withdrawal by Subject|0|||
124784644|NCT00281658|448843637|FG000|Randomized Phase|Study closed/terminated|1|||
124784645|NCT00281658|448843638|FG001|Randomized Phase|Study closed/terminated|1|||
124784646|NCT00281658|448843639|FG002|Randomized Phase|Study closed/terminated|0|||
124784647|NCT00281658|448843640|FG003|Randomized Phase|Study closed/terminated|0|||
124784648|NCT00281658|448843637|FG000|Randomized Phase|Disease progression|36|||
124784649|NCT00281658|448843638|FG001|Randomized Phase|Disease progression|27|||
124784650|NCT00281658|448843639|FG002|Randomized Phase|Disease progression|0|||
124784651|NCT00281658|448843640|FG003|Randomized Phase|Disease progression|0|||
124784652|NCT00281658|448843637|FG000|Randomized Phase|Physician Decision|1|||
124784653|NCT00281658|448843638|FG001|Randomized Phase|Physician Decision|1|||
124784654|NCT00281658|448843639|FG002|Randomized Phase|Physician Decision|0|||
124784655|NCT00281658|448843640|FG003|Randomized Phase|Physician Decision|0|||
124784656|NCT00281658|448843637|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
124784657|NCT00281658|448843638|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
124784658|NCT00281658|448843639|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
124784659|NCT00281658|448843640|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
124784660|NCT00281658|448843637|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
124784661|NCT00281658|448843638|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
124784662|NCT00281658|448843639|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
124784663|NCT00281658|448843640|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
124784664|NCT00281658|448843637|FG000|Randomized Phase|Treatment ongoing|1|||
124784665|NCT00281658|448843638|FG001|Randomized Phase|Treatment ongoing|0|||
124784666|NCT00281658|448843639|FG002|Randomized Phase|Treatment ongoing|0|||
124784667|NCT00281658|448843640|FG003|Randomized Phase|Treatment ongoing|0|||
124784668|NCT00281658|448843637|FG000|Open Label Phase|Adverse Event|0|||
124784669|NCT00281658|448843638|FG001|Open Label Phase|Adverse Event|0|||
124784670|NCT00281658|448843639|FG002|Open Label Phase|Adverse Event|1|||
124784671|NCT00281658|448843640|FG003|Open Label Phase|Adverse Event|0|||
124784672|NCT00281658|448843637|FG000|Open Label Phase|Lost to Follow-up|0|||
124784673|NCT00281658|448843638|FG001|Open Label Phase|Lost to Follow-up|0|||
124784674|NCT00281658|448843639|FG002|Open Label Phase|Lost to Follow-up|16|||
124784675|NCT00281658|448843640|FG003|Open Label Phase|Lost to Follow-up|2|||
124784676|NCT00281658|448843637|FG000|Open Label Phase|Withdrawal by Subject|0|||
124784677|NCT00281658|448843638|FG001|Open Label Phase|Withdrawal by Subject|0|||
124784678|NCT00281658|448843639|FG002|Open Label Phase|Withdrawal by Subject|3|||
124784679|NCT00281658|448843640|FG003|Open Label Phase|Withdrawal by Subject|2|||
124784680|NCT00281658|448843637|FG000|Open Label Phase|Disease progression|0|||
124784681|NCT00281658|448843638|FG001|Open Label Phase|Disease progression|0|||
124784682|NCT00281658|448843639|FG002|Open Label Phase|Disease progression|18|||
124784683|NCT00281658|448843640|FG003|Open Label Phase|Disease progression|0|||
124784684|NCT00281658|448843637|FG000|Open Label Phase|Physician Decision|0|||
124784685|NCT00281658|448843638|FG001|Open Label Phase|Physician Decision|0|||
124784686|NCT00281658|448843639|FG002|Open Label Phase|Physician Decision|1|||
124784687|NCT00281658|448843640|FG003|Open Label Phase|Physician Decision|0|||
124784688|NCT00281658|448843637|FG000|Open Label Phase|Relocation of patient|0|||
124784689|NCT00281658|448843638|FG001|Open Label Phase|Relocation of patient|0|||
124784690|NCT00281658|448843639|FG002|Open Label Phase|Relocation of patient|1|||
124784691|NCT00281658|448843640|FG003|Open Label Phase|Relocation of patient|0|||
124784692|NCT00281658|448843637|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
124784693|NCT00281658|448843638|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
124784694|NCT00281658|448843639|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
124784695|NCT00281658|448843640|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
124784696|NCT01343693|448843641|FG000|Overall Study|Lost to Follow-up|9|||
124784697|NCT02704143|448843642|FG000|Overall Study|disease progression|10|||
124784698|NCT01235598|448843643|FG000|Overall Study|Adverse Event|0|||
124784699|NCT01235598|448843644|FG001|Overall Study|Adverse Event|3|||
124784700|NCT01235598|448843643|FG000|Overall Study|Lack of Efficacy|0|||
124784701|NCT01235598|448843644|FG001|Overall Study|Lack of Efficacy|1|||
124784702|NCT01235598|448843643|FG000|Overall Study|Withdrawal by Subject|1|||
124784703|NCT01235598|448843644|FG001|Overall Study|Withdrawal by Subject|0|||
124784704|NCT02151773|448843645|FG000|Overall Study|Protocol Deviation|64|||
124784705|NCT00395343|448843646|FG000|Overall Study|Adverse Event|13|||
124784706|NCT00395343|448843647|FG001|Overall Study|Adverse Event|5|||
124784707|NCT00395343|448843646|FG000|Overall Study|Lack of Efficacy|0|||
124784708|NCT00395343|448843647|FG001|Overall Study|Lack of Efficacy|1|||
124784709|NCT00395343|448843646|FG000|Overall Study|Lost to Follow-up|4|||
125292162|NCT04524455|450696537|FG000|Overall Study|Lost to Follow-up|0|||
125292163|NCT04524455|450696538|FG001|Overall Study|Lost to Follow-up|1|||
125292164|NCT01688739|450696541|FG000|Overall Study|Administrative Decision|1|||
125292165|NCT01688739|450696542|FG001|Overall Study|Administrative Decision|0|||
125292166|NCT01688739|450696543|FG002|Overall Study|Administrative Decision|0|||
125292167|NCT01688739|450696544|FG003|Overall Study|Administrative Decision|0|||
125292168|NCT01688739|450696545|FG004|Overall Study|Administrative Decision|0|||
125292169|NCT01688739|450696546|FG005|Overall Study|Administrative Decision|0|||
125292170|NCT01688739|450696547|FG006|Overall Study|Administrative Decision|0|||
124784710|NCT00395343|448843647|FG001|Overall Study|Lost to Follow-up|4|||
124784711|NCT00395343|448843646|FG000|Overall Study|Physician Decision|2|||
124784712|NCT00395343|448843647|FG001|Overall Study|Physician Decision|4|||
124784713|NCT00395343|448843646|FG000|Overall Study|Protocol Violation|6|||
124784714|NCT00395343|448843647|FG001|Overall Study|Protocol Violation|8|||
124784715|NCT00395343|448843646|FG000|Overall Study|Withdrawal by Subject|11|||
124784716|NCT00395343|448843647|FG001|Overall Study|Withdrawal by Subject|12|||
125292171|NCT01688739|450696548|FG007|Overall Study|Administrative Decision|0|||
125292172|NCT01688739|450696549|FG008|Overall Study|Administrative Decision|0|||
125292173|NCT01688739|450696550|FG009|Overall Study|Administrative Decision|0|||
125292174|NCT00996801|450696551|FG000|Overall Study|Adverse Event|6|||
125292175|NCT00996801|450696552|FG001|Overall Study|Adverse Event|4|||
125292176|NCT00996801|450696553|FG002|Overall Study|Adverse Event|12|||
125292177|NCT00996801|450696554|FG003|Overall Study|Adverse Event|17|||
125292178|NCT00996801|450696555|FG004|Overall Study|Adverse Event|31|||
125292179|NCT00996801|450696556|FG005|Overall Study|Adverse Event|3|||
125292180|NCT00996801|450696551|FG000|Overall Study|Lack of Efficacy|3|||
125292181|NCT00996801|450696552|FG001|Overall Study|Lack of Efficacy|0|||
124784717|NCT00395343|448843646|FG000|Overall Study|Other|5|||
124784718|NCT00395343|448843647|FG001|Overall Study|Other|2|||
124784719|NCT01463007|448843649|FG000|Overall Study|Physician Decision|1|||
124784720|NCT00387790|448843650|FG000|Overall Study|Adverse Event|5|||
124784721|NCT00387790|448843650|FG000|Overall Study|Lack of Efficacy|2|||
124784722|NCT00387790|448843650|FG000|Overall Study|Physician Decision|2|||
124784723|NCT00387790|448843650|FG000|Overall Study|Withdrawal by Subject|3|||
124784724|NCT00387790|448843650|FG000|Overall Study|Ineligible for study|2|||
124784725|NCT00444678|448843651|FG000|Overall Study|Toxicity|11|||
124784726|NCT00444678|448843651|FG000|Overall Study|Disease Progression|12|||
124784727|NCT00444678|448843651|FG000|Overall Study|Death|3|||
124784728|NCT00444678|448843651|FG000|Overall Study|Physician Decision|3|||
124784729|NCT00444678|448843651|FG000|Overall Study|Withdrawal by Subject|2|||
124784730|NCT02779556|448843654|FG000|Baseline|Partial baseline interview completed|1|||
124784731|NCT02779556|448843655|FG001|Baseline|Partial baseline interview completed|0|||
124784732|NCT02779556|448843654|FG000|3 Months|Lost to Follow-up|40|||
124784733|NCT02779556|448843655|FG001|3 Months|Lost to Follow-up|29|||
124784734|NCT02779556|448843654|FG000|3 Months|Missed 3 month clinic visit|27|||
124784735|NCT02779556|448843655|FG001|3 Months|Missed 3 month clinic visit|19|||
124784736|NCT02779556|448843654|FG000|6 Month|Lost to Follow-up|33|||
124784737|NCT02779556|448843655|FG001|6 Month|Lost to Follow-up|39|||
124784738|NCT02779556|448843654|FG000|6 Month HbA1c|No value collected during window|69|||
124784739|NCT02779556|448843655|FG001|6 Month HbA1c|No value collected during window|50|||
124784740|NCT02779556|448843654|FG000|12 Month HbA1c|No value collected during window|138|||
124784741|NCT02779556|448843655|FG001|12 Month HbA1c|No value collected during window|102|||
124784742|NCT03110770|448843659|FG000|Overall Study|Death|1|||
124784743|NCT03110770|448843660|FG001|Overall Study|Death|0|||
124784744|NCT03110770|448843661|FG002|Overall Study|Death|0|||
124784745|NCT03110770|448843662|FG003|Overall Study|Death|1|||
124784746|NCT03110770|448843663|FG004|Overall Study|Death|0|||
124784747|NCT03110770|448843659|FG000|Overall Study|Enrolled but did not receive product|0|||
124784748|NCT03110770|448843660|FG001|Overall Study|Enrolled but did not receive product|0|||
124784749|NCT03110770|448843661|FG002|Overall Study|Enrolled but did not receive product|0|||
124784750|NCT03110770|448843662|FG003|Overall Study|Enrolled but did not receive product|8|||
124784751|NCT03110770|448843663|FG004|Overall Study|Enrolled but did not receive product|7|||
124784752|NCT03110770|448843659|FG000|Overall Study|Lost to Follow-up|0|||
124784753|NCT03110770|448843660|FG001|Overall Study|Lost to Follow-up|0|||
124784754|NCT03110770|448843661|FG002|Overall Study|Lost to Follow-up|0|||
124784755|NCT03110770|448843662|FG003|Overall Study|Lost to Follow-up|53|||
124784756|NCT03110770|448843663|FG004|Overall Study|Lost to Follow-up|45|||
124784757|NCT03110770|448843659|FG000|Overall Study|Investigator Decision|0|||
124784758|NCT03110770|448843660|FG001|Overall Study|Investigator Decision|0|||
124784759|NCT03110770|448843661|FG002|Overall Study|Investigator Decision|0|||
124784760|NCT03110770|448843662|FG003|Overall Study|Investigator Decision|5|||
124784761|NCT03110770|448843663|FG004|Overall Study|Investigator Decision|3|||
124784762|NCT03110770|448843659|FG000|Overall Study|Withdrawal by Subject|0|||
124784763|NCT03110770|448843660|FG001|Overall Study|Withdrawal by Subject|0|||
124784764|NCT03110770|448843661|FG002|Overall Study|Withdrawal by Subject|0|||
124784765|NCT03110770|448843662|FG003|Overall Study|Withdrawal by Subject|24|||
124784766|NCT03110770|448843663|FG004|Overall Study|Withdrawal by Subject|24|||
124784767|NCT03110770|448843659|FG000|Overall Study|Moved from area|5|||
124784768|NCT03110770|448843660|FG001|Overall Study|Moved from area|0|||
124784769|NCT03110770|448843661|FG002|Overall Study|Moved from area|2|||
124784770|NCT03110770|448843662|FG003|Overall Study|Moved from area|42|||
124784771|NCT03110770|448843663|FG004|Overall Study|Moved from area|43|||
124784772|NCT03110770|448843659|FG000|Overall Study|Illness/Injury unrelated to product|0|||
124784773|NCT03110770|448843660|FG001|Overall Study|Illness/Injury unrelated to product|0|||
124784774|NCT03110770|448843661|FG002|Overall Study|Illness/Injury unrelated to product|0|||
124784775|NCT03110770|448843662|FG003|Overall Study|Illness/Injury unrelated to product|0|||
125292182|NCT00996801|450696553|FG002|Overall Study|Lack of Efficacy|1|||
125292183|NCT00996801|450696554|FG003|Overall Study|Lack of Efficacy|3|||
125292184|NCT00996801|450696555|FG004|Overall Study|Lack of Efficacy|0|||
125292185|NCT00996801|450696556|FG005|Overall Study|Lack of Efficacy|1|||
124784776|NCT03110770|448843663|FG004|Overall Study|Illness/Injury unrelated to product|1|||
124784777|NCT02082340|448843671|FG000|Overall Study|Lost to Follow-up|1|||
125292186|NCT00996801|450696551|FG000|Overall Study|Lost to Follow-up|0|||
125292187|NCT00996801|450696552|FG001|Overall Study|Lost to Follow-up|0|||
125292188|NCT00996801|450696553|FG002|Overall Study|Lost to Follow-up|0|||
124784778|NCT02082340|448843672|FG001|Overall Study|Lost to Follow-up|1|||
124784779|NCT01625260|448843673|FG000|Overall Study|Adverse Event|3|||
124784780|NCT01625260|448843674|FG001|Overall Study|Adverse Event|0|||
124784781|NCT01625260|448843673|FG000|Overall Study|Study Terminated by Investigator|2|||
124784782|NCT01625260|448843674|FG001|Overall Study|Study Terminated by Investigator|0|||
124784783|NCT01625260|448843673|FG000|Overall Study|Disease Progression|2|||
124784784|NCT01625260|448843674|FG001|Overall Study|Disease Progression|0|||
124784785|NCT01625260|448843673|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
124784786|NCT01625260|448843674|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
124784787|NCT02937584|448843675|FG000|Period 1|Adverse Event|1|||
124784788|NCT02937584|448843676|FG001|Period 1|Adverse Event|2|||
124784789|NCT02937584|448843675|FG000|Washout|Adverse Event|0|||
124784790|NCT02937584|448843676|FG001|Washout|Adverse Event|1|||
124784791|NCT00635219|448843677|FG000|Overall Study|Adverse Event|12|||
124784792|NCT00635219|448843678|FG001|Overall Study|Adverse Event|10|||
124784793|NCT00635219|448843679|FG002|Overall Study|Adverse Event|18|||
124784794|NCT00635219|448843680|FG003|Overall Study|Adverse Event|15|||
124784795|NCT00635219|448843681|FG004|Overall Study|Adverse Event|19|||
124784796|NCT00635219|448843677|FG000|Overall Study|Lack of Efficacy|5|||
124784797|NCT00635219|448843678|FG001|Overall Study|Lack of Efficacy|6|||
124784798|NCT00635219|448843679|FG002|Overall Study|Lack of Efficacy|3|||
124784799|NCT00635219|448843680|FG003|Overall Study|Lack of Efficacy|4|||
124784800|NCT00635219|448843681|FG004|Overall Study|Lack of Efficacy|6|||
124784801|NCT00635219|448843677|FG000|Overall Study|Non-compliance With Study Product|0|||
124784802|NCT00635219|448843678|FG001|Overall Study|Non-compliance With Study Product|0|||
124784803|NCT00635219|448843679|FG002|Overall Study|Non-compliance With Study Product|0|||
124784804|NCT00635219|448843680|FG003|Overall Study|Non-compliance With Study Product|2|||
124784805|NCT00635219|448843681|FG004|Overall Study|Non-compliance With Study Product|1|||
124784806|NCT00635219|448843677|FG000|Overall Study|Protocol Violation|0|||
124784807|NCT00635219|448843678|FG001|Overall Study|Protocol Violation|2|||
124784808|NCT00635219|448843679|FG002|Overall Study|Protocol Violation|3|||
124784809|NCT00635219|448843680|FG003|Overall Study|Protocol Violation|2|||
124784810|NCT00635219|448843681|FG004|Overall Study|Protocol Violation|4|||
124784811|NCT00635219|448843677|FG000|Overall Study|Withdrawal of Consent|8|||
124784812|NCT00635219|448843678|FG001|Overall Study|Withdrawal of Consent|6|||
124784813|NCT00635219|448843679|FG002|Overall Study|Withdrawal of Consent|8|||
124784814|NCT00635219|448843680|FG003|Overall Study|Withdrawal of Consent|11|||
124784815|NCT00635219|448843681|FG004|Overall Study|Withdrawal of Consent|8|||
124784816|NCT00635219|448843677|FG000|Overall Study|Lost to Follow-up|0|||
124784817|NCT00635219|448843678|FG001|Overall Study|Lost to Follow-up|0|||
124784818|NCT00635219|448843679|FG002|Overall Study|Lost to Follow-up|2|||
124784819|NCT00635219|448843680|FG003|Overall Study|Lost to Follow-up|0|||
124784820|NCT00635219|448843681|FG004|Overall Study|Lost to Follow-up|3|||
124784821|NCT00635219|448843677|FG000|Overall Study|Administrative or Other Reasons|0|||
124784822|NCT00635219|448843678|FG001|Overall Study|Administrative or Other Reasons|1|||
124784823|NCT00635219|448843679|FG002|Overall Study|Administrative or Other Reasons|1|||
124784824|NCT00635219|448843680|FG003|Overall Study|Administrative or Other Reasons|0|||
124784825|NCT00635219|448843681|FG004|Overall Study|Administrative or Other Reasons|1|||
124784826|NCT01598129|448843690|FG000|Overall Study|Disease progression|6|||
124784827|NCT01598129|448843690|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
124784828|NCT01598129|448843690|FG000|Overall Study|Withdrawal by Subject|1|||
124784829|NCT00591318|448843691|FG000|Overall Study|Lack of Efficacy|2|||
124784830|NCT00591318|448843692|FG001|Overall Study|Lack of Efficacy|0|||
124784831|NCT00591318|448843691|FG000|Overall Study|Adverse Event|2|||
124784832|NCT00591318|448843692|FG001|Overall Study|Adverse Event|0|||
124784833|NCT04074161|448843695|FG000|Overall Study|Withdrawal by Subject|2|||
124784834|NCT04074161|448843696|FG001|Overall Study|Withdrawal by Subject|4|||
124784835|NCT04074161|448843697|FG002|Overall Study|Withdrawal by Subject|1|||
124784836|NCT04074161|448843695|FG000|Overall Study|Lost to Follow-up|4|||
124784837|NCT04074161|448843696|FG001|Overall Study|Lost to Follow-up|5|||
124784838|NCT04074161|448843697|FG002|Overall Study|Lost to Follow-up|3|||
124784839|NCT03890666|448843702|FG000|Overall Study|Withdrawal by Subject|0|||
124784840|NCT03890666|448843703|FG001|Overall Study|Withdrawal by Subject|1|||
124784841|NCT03890666|448843702|FG000|Overall Study|Protocol deviation|1|||
124784842|NCT03890666|448843703|FG001|Overall Study|Protocol deviation|4|||
124784843|NCT03890666|448843702|FG000|Overall Study|Lost to Follow-up|2|||
124784844|NCT03890666|448843703|FG001|Overall Study|Lost to Follow-up|5|||
124784845|NCT03890666|448843702|FG000|Overall Study|Other than specified|1|||
124784846|NCT03890666|448843703|FG001|Overall Study|Other than specified|8|||
124784847|NCT01639729|448843704|FG000|Overall Study|Withdrawal by Subject|1|||
124784848|NCT01639729|448843705|FG001|Overall Study|Withdrawal by Subject|0|||
124784849|NCT01639729|448843706|FG002|Overall Study|Withdrawal by Subject|1|||
124784850|NCT01639729|448843707|FG003|Overall Study|Withdrawal by Subject|1|||
124784851|NCT01639729|448843708|FG004|Overall Study|Withdrawal by Subject|0|||
124784852|NCT01639729|448843709|FG005|Overall Study|Withdrawal by Subject|0|||
124784853|NCT03052426|448843710|FG000|Overall Study|Withdrawal by Subject|0|||
124784854|NCT03052426|448843711|FG001|Overall Study|Withdrawal by Subject|1|||
124784855|NCT03052426|448843712|FG002|Overall Study|Withdrawal by Subject|0|||
124784856|NCT03052426|448843710|FG000|Overall Study|Lost to Follow-up|2|||
124784857|NCT03052426|448843711|FG001|Overall Study|Lost to Follow-up|0|||
124784858|NCT03052426|448843712|FG002|Overall Study|Lost to Follow-up|1|||
124784859|NCT03083990|448843715|FG000|Overall Study|Adverse Event|1|||
124784860|NCT03083990|448843716|FG001|Overall Study|Adverse Event|0|||
124784861|NCT03672097|448843717|FG000|Period 1|Withdrawal by Subject|2|||
124784862|NCT03672097|448843717|FG000|Period 1|Adverse Event|1|||
124784863|NCT03672097|448843717|FG000|Period 1|Did not receive treatment|1|||
124784864|NCT03672097|448843717|FG000|Period 2|Withdrawal by Subject|3|||
124784865|NCT03672097|448843717|FG000|Period 2|Other|1|||
124784866|NCT01781299|448843718|FG000|Overall Study|Withdrawal by Subject|0|||
124784867|NCT01781299|448843719|FG001|Overall Study|Withdrawal by Subject|1|||
124784868|NCT00146848|448843720|FG000|Pre-randomization|Death|19|||
124784869|NCT00146848|448843721|FG001|Pre-randomization|Death|0|||
124784870|NCT00146848|448843722|FG002|Pre-randomization|Death|0|||
124784871|NCT00146848|448843720|FG000|Pre-randomization|Lost to Follow-up|70|||
124784872|NCT00146848|448843721|FG001|Pre-randomization|Lost to Follow-up|0|||
124784873|NCT00146848|448843722|FG002|Pre-randomization|Lost to Follow-up|0|||
124784874|NCT00146848|448843720|FG000|Pre-randomization|Physician Decision|8|||
124784875|NCT00146848|448843721|FG001|Pre-randomization|Physician Decision|0|||
124784876|NCT00146848|448843722|FG002|Pre-randomization|Physician Decision|0|||
124784877|NCT00146848|448843720|FG000|Pre-randomization|Protocol Violation|172|||
124784878|NCT00146848|448843721|FG001|Pre-randomization|Protocol Violation|0|||
124784879|NCT00146848|448843722|FG002|Pre-randomization|Protocol Violation|0|||
124784880|NCT00146848|448843720|FG000|Pre-randomization|Withdrawal by Subject|40|||
124784881|NCT00146848|448843721|FG001|Pre-randomization|Withdrawal by Subject|0|||
124784882|NCT00146848|448843722|FG002|Pre-randomization|Withdrawal by Subject|0|||
124784883|NCT00146848|448843720|FG000|Post-randomization|Lost to Follow-up|12|||
124784884|NCT00146848|448843721|FG001|Post-randomization|Lost to Follow-up|15|||
124784885|NCT00146848|448843722|FG002|Post-randomization|Lost to Follow-up|12|||
124784886|NCT00146848|448843720|FG000|Post-randomization|Withdrawn|26|||
124784887|NCT00146848|448843721|FG001|Post-randomization|Withdrawn|32|||
124784888|NCT00146848|448843722|FG002|Post-randomization|Withdrawn|27|||
124784889|NCT01798849|448843723|FG000|Overall Study|Physician Decision|0|||
124784890|NCT01798849|448843724|FG001|Overall Study|Physician Decision|0|||
124784891|NCT01798849|448843725|FG002|Overall Study|Physician Decision|1|||
124784892|NCT02636361|448843726|FG000|Period 4|Physician Decision|0|||
124784893|NCT02636361|448843727|FG001|Period 4|Physician Decision|0|||
124784894|NCT02636361|448843728|FG002|Period 4|Physician Decision|0|||
124784895|NCT02636361|448843729|FG003|Period 4|Physician Decision|1|||
124784896|NCT02636361|448843730|FG004|Period 4|Physician Decision|0|||
124784897|NCT02032238|448843731|FG000|Overall Study|Lost to Follow-up|2|||
124784898|NCT02032238|448843732|FG001|Overall Study|Lost to Follow-up|0|||
124784899|NCT03158285|448843737|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
124784900|NCT03158285|448843738|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
124784901|NCT03158285|448843739|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
124784902|NCT03158285|448843737|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
124784903|NCT03158285|448843738|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
124784904|NCT03158285|448843739|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
124784905|NCT03158285|448843737|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
124784906|NCT03158285|448843738|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
124784907|NCT03158285|448843739|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
124784908|NCT03158285|448843737|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
124784909|NCT03158285|448843738|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
124784910|NCT03158285|448843739|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
124784911|NCT03158285|448843737|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
124784912|NCT03158285|448843738|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
124784913|NCT03158285|448843739|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
124784914|NCT03158285|448843737|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
124784915|NCT03158285|448843738|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
124784916|NCT03158285|448843739|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
124784917|NCT03158285|448843737|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
124784918|NCT03158285|448843738|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
124784919|NCT03158285|448843739|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
124784920|NCT03158285|448843737|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
124784921|NCT03158285|448843738|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
124784922|NCT03158285|448843739|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
124784923|NCT03158285|448843737|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
124784924|NCT03158285|448843738|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
124784925|NCT03158285|448843739|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
124784926|NCT03158285|448843737|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
124784927|NCT03158285|448843738|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
124784928|NCT03158285|448843739|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
124784929|NCT03158285|448843737|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
124784930|NCT03158285|448843738|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
124784931|NCT03158285|448843739|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
124784932|NCT03158285|448843737|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
124784933|NCT03158285|448843738|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
124784934|NCT03158285|448843739|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
124784935|NCT03158285|448843737|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
124784936|NCT03158285|448843738|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
124784937|NCT03158285|448843739|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
124784938|NCT03158285|448843737|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
124784939|NCT03158285|448843738|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
124784940|NCT03158285|448843739|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
124784941|NCT03158285|448843737|FG000|Active Treatment Period: Week 52-100|Death|1|||
124784942|NCT03158285|448843738|FG001|Active Treatment Period: Week 52-100|Death|0|||
124784943|NCT03158285|448843739|FG002|Active Treatment Period: Week 52-100|Death|0|||
124784944|NCT03158285|448843737|FG000|Active Treatment Period: Week 52-100|Other|4|||
124784945|NCT03158285|448843738|FG001|Active Treatment Period: Week 52-100|Other|1|||
124784946|NCT03158285|448843739|FG002|Active Treatment Period: Week 52-100|Other|0|||
124784947|NCT02228980|448843740|FG000|Overall Study|Adverse Event|14|||
124784948|NCT02228980|448843741|FG001|Overall Study|Adverse Event|0|||
124784949|NCT02228980|448843742|FG002|Overall Study|Adverse Event|0|||
124784950|NCT02228980|448843743|FG003|Overall Study|Adverse Event|0|||
124784951|NCT02228980|448843740|FG000|Overall Study|Protocol Violation|7|||
124784952|NCT02228980|448843741|FG001|Overall Study|Protocol Violation|0|||
124784953|NCT02228980|448843742|FG002|Overall Study|Protocol Violation|0|||
124784954|NCT02228980|448843743|FG003|Overall Study|Protocol Violation|0|||
124784955|NCT02228980|448843740|FG000|Overall Study|Withdrawal by Subject|3|||
124784956|NCT02228980|448843741|FG001|Overall Study|Withdrawal by Subject|3|||
124784957|NCT02228980|448843742|FG002|Overall Study|Withdrawal by Subject|2|||
124784958|NCT02228980|448843743|FG003|Overall Study|Withdrawal by Subject|3|||
124784959|NCT01642615|448843744|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
124784960|NCT01642615|448843745|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
124784961|NCT01642615|448843746|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
124784962|NCT01642615|448843744|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
124784963|NCT01642615|448843745|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
124784964|NCT01642615|448843746|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
124784965|NCT01642615|448843744|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
124784966|NCT01642615|448843745|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
124784967|NCT01642615|448843746|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
124784968|NCT01642615|448843744|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
124784969|NCT01642615|448843745|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
124784970|NCT01642615|448843746|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
124784971|NCT01642615|448843744|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
124784972|NCT01642615|448843745|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
124784973|NCT01642615|448843746|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
124784974|NCT01642615|448843744|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
124784975|NCT01642615|448843745|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
124784976|NCT01642615|448843746|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
124784977|NCT01642615|448843744|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
124784978|NCT01642615|448843745|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
124784979|NCT01642615|448843746|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
124784980|NCT01642615|448843744|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
124784981|NCT01642615|448843745|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
124784982|NCT01642615|448843746|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
124784983|NCT01642615|448843744|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
124784984|NCT01642615|448843745|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
124784985|NCT01642615|448843746|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
124784986|NCT01699867|448843747|FG000|Overall Study|Screening Failure|3|||
124784987|NCT04002908|448843750|FG000|Overall Study|Death|41|||
124784988|NCT04002908|448843751|FG001|Overall Study|Death|0|||
124784989|NCT04002908|448843752|FG002|Overall Study|Death|0|||
124784990|NCT04002908|448843753|FG003|Overall Study|Death|0|||
124784991|NCT04002908|448843750|FG000|Overall Study|Withdrawal by Subject|112|||
124784992|NCT04002908|448843751|FG001|Overall Study|Withdrawal by Subject|0|||
124784993|NCT04002908|448843752|FG002|Overall Study|Withdrawal by Subject|0|||
124784994|NCT04002908|448843753|FG003|Overall Study|Withdrawal by Subject|0|||
124784995|NCT04002908|448843750|FG000|Overall Study|Lost to Follow-up|72|||
124784996|NCT04002908|448843751|FG001|Overall Study|Lost to Follow-up|0|||
124784997|NCT04002908|448843752|FG002|Overall Study|Lost to Follow-up|0|||
124784998|NCT04002908|448843753|FG003|Overall Study|Lost to Follow-up|0|||
124784999|NCT04002908|448843750|FG000|Overall Study|Infant died, so mother withdrawn|34|||
124785000|NCT04002908|448843751|FG001|Overall Study|Infant died, so mother withdrawn|0|||
124785001|NCT04002908|448843752|FG002|Overall Study|Infant died, so mother withdrawn|0|||
124785002|NCT04002908|448843753|FG003|Overall Study|Infant died, so mother withdrawn|0|||
124785003|NCT00006289|448843756|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
124785004|NCT00006289|448843757|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
124785005|NCT00006289|448843756|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
124785006|NCT00006289|448843757|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
124785007|NCT04359901|448843767|FG000|Overall Study|Withdrawal by Subject|0|||
124785008|NCT04359901|448843768|FG001|Overall Study|Withdrawal by Subject|1|||
124785009|NCT04359901|448843767|FG000|Overall Study|Death|6|||
124785010|NCT04359901|448843768|FG001|Overall Study|Death|2|||
124785011|NCT03703297|448843771|FG000|Overall Study|Death|115|||
124785012|NCT03703297|448843772|FG001|Overall Study|Death|0|||
124785013|NCT03703297|448843773|FG002|Overall Study|Death|144|||
124785014|NCT03703297|448843771|FG000|Overall Study|Withdrawal by Subject|9|||
124785015|NCT03703297|448843772|FG001|Overall Study|Withdrawal by Subject|0|||
124785016|NCT03703297|448843773|FG002|Overall Study|Withdrawal by Subject|11|||
124785017|NCT03703297|448843771|FG000|Overall Study|Ongoing at the time of DCO|140|||
124785018|NCT03703297|448843772|FG001|Overall Study|Ongoing at the time of DCO|200|||
124785019|NCT03703297|448843773|FG002|Overall Study|Ongoing at the time of DCO|111|||
124785020|NCT01888432|448845134|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
124785021|NCT01888432|448845135|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
124785022|NCT01888432|448845134|FG000|12-month Analysis (FAS)|Physician Decision|1|||
124785023|NCT01888432|448845135|FG001|12-month Analysis (FAS)|Physician Decision|1|||
124785024|NCT01888432|448845134|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
124785025|NCT01888432|448845135|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
124785026|NCT01888432|448845134|FG000|12-month Analysis (FAS)|Death|4|||
124785027|NCT01888432|448845135|FG001|12-month Analysis (FAS)|Death|3|||
124785028|NCT01888432|448845134|FG000|24-month Analysis (FAS)|Graft loss|0|||
124785029|NCT01888432|448845135|FG001|24-month Analysis (FAS)|Graft loss|1|||
124785030|NCT01888432|448845134|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
124785031|NCT01888432|448845135|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
124785032|NCT01888432|448845134|FG000|24-month Analysis (FAS)|Physician Decision|2|||
124785033|NCT01888432|448845135|FG001|24-month Analysis (FAS)|Physician Decision|4|||
124785034|NCT01888432|448845134|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
124785035|NCT01888432|448845135|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
124785036|NCT01888432|448845134|FG000|24-month Analysis (FAS)|Death|8|||
124785037|NCT01888432|448845135|FG001|24-month Analysis (FAS)|Death|4|||
124785038|NCT01888432|448845134|FG000|36-month Analysis (Extension)|Death|1|||
124785039|NCT01888432|448845135|FG001|36-month Analysis (Extension)|Death|0|||
124785040|NCT00130247|448845138|FG000|Overall Study|Pregnancy|1|||
124785041|NCT00130247|448845139|FG001|Overall Study|Pregnancy|0|||
124785042|NCT00130247|448845138|FG000|Overall Study|Post-randomization exclusion|1|||
124785043|NCT00130247|448845139|FG001|Overall Study|Post-randomization exclusion|2|||
124785044|NCT00130247|448845138|FG000|Overall Study|Not compliant with DOT|0|||
124785045|NCT00130247|448845139|FG001|Overall Study|Not compliant with DOT|2|||
124785046|NCT02848729|448845140|FG000|Overall Study|Withdrawal by Subject|1|||
124785047|NCT02848729|448845141|FG001|Overall Study|Withdrawal by Subject|0|||
124785048|NCT02848729|448845140|FG000|Overall Study|Emesis|15|||
124785049|NCT02848729|448845141|FG001|Overall Study|Emesis|11|||
124785050|NCT01904773|448845142|FG000|Screen|Screen failure|3|||
124785051|NCT01904773|448845143|FG001|Screen|Screen failure|0|||
124785052|NCT01904773|448845144|FG002|Screen|Screen failure|0|||
124785053|NCT01904773|448845145|FG003|Screen|Screen failure|0|||
124785054|NCT01904773|448845146|FG004|Screen|Screen failure|0|||
124785055|NCT01904773|448845147|FG005|Screen|Screen failure|0|||
124785056|NCT01904773|448845148|FG006|Screen|Screen failure|0|||
124785057|NCT01904773|448845149|FG007|Screen|Screen failure|0|||
124785058|NCT01904773|448845150|FG008|Screen|Screen failure|0|||
124785059|NCT01904773|448845142|FG000|Screen|Withdrawal by Subject|1|||
124785060|NCT01904773|448845143|FG001|Screen|Withdrawal by Subject|0|||
124785061|NCT01904773|448845144|FG002|Screen|Withdrawal by Subject|0|||
124785062|NCT01904773|448845145|FG003|Screen|Withdrawal by Subject|0|||
124785063|NCT01904773|448845146|FG004|Screen|Withdrawal by Subject|0|||
124785064|NCT01904773|448845147|FG005|Screen|Withdrawal by Subject|0|||
124785065|NCT01904773|448845148|FG006|Screen|Withdrawal by Subject|0|||
124785066|NCT01904773|448845149|FG007|Screen|Withdrawal by Subject|0|||
124785067|NCT01904773|448845150|FG008|Screen|Withdrawal by Subject|0|||
125292189|NCT00996801|450696554|FG003|Overall Study|Lost to Follow-up|3|||
124785068|NCT01904773|448845142|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
124785069|NCT01904773|448845143|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
124785070|NCT01904773|448845144|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
124785071|NCT01904773|448845145|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
124785072|NCT01904773|448845146|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
125292190|NCT00996801|450696555|FG004|Overall Study|Lost to Follow-up|3|||
124785073|NCT01904773|448845147|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
124785074|NCT01904773|448845148|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
124785075|NCT01904773|448845149|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
124785076|NCT01904773|448845150|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
124785077|NCT01904773|448845142|FG000|First Intervention|Adverse Event|0|||
124785078|NCT01904773|448845143|FG001|First Intervention|Adverse Event|0|||
124785079|NCT01904773|448845144|FG002|First Intervention|Adverse Event|0|||
124785080|NCT01904773|448845145|FG003|First Intervention|Adverse Event|0|||
124785081|NCT01904773|448845146|FG004|First Intervention|Adverse Event|0|||
124785082|NCT01904773|448845147|FG005|First Intervention|Adverse Event|0|||
124785083|NCT01904773|448845148|FG006|First Intervention|Adverse Event|1|||
124785084|NCT01904773|448845149|FG007|First Intervention|Adverse Event|0|||
124785085|NCT01904773|448845150|FG008|First Intervention|Adverse Event|0|||
124785086|NCT01904773|448845142|FG000|Placebo Washout First Intervention|Condition worsened|0|||
124785087|NCT01904773|448845143|FG001|Placebo Washout First Intervention|Condition worsened|1|||
124785088|NCT01904773|448845144|FG002|Placebo Washout First Intervention|Condition worsened|0|||
124785089|NCT01904773|448845145|FG003|Placebo Washout First Intervention|Condition worsened|0|||
124785090|NCT01904773|448845146|FG004|Placebo Washout First Intervention|Condition worsened|0|||
124785091|NCT01904773|448845147|FG005|Placebo Washout First Intervention|Condition worsened|0|||
124785092|NCT01904773|448845148|FG006|Placebo Washout First Intervention|Condition worsened|0|||
124785093|NCT01904773|448845149|FG007|Placebo Washout First Intervention|Condition worsened|0|||
124785094|NCT01904773|448845150|FG008|Placebo Washout First Intervention|Condition worsened|0|||
124785095|NCT01904773|448845142|FG000|Fifth Intervention|Adverse Event|0|||
124785096|NCT01904773|448845143|FG001|Fifth Intervention|Adverse Event|0|||
124785097|NCT01904773|448845144|FG002|Fifth Intervention|Adverse Event|0|||
124785098|NCT01904773|448845145|FG003|Fifth Intervention|Adverse Event|0|||
124785099|NCT01904773|448845146|FG004|Fifth Intervention|Adverse Event|0|||
124785100|NCT01904773|448845147|FG005|Fifth Intervention|Adverse Event|0|||
124785101|NCT01904773|448845148|FG006|Fifth Intervention|Adverse Event|0|||
124785102|NCT01904773|448845149|FG007|Fifth Intervention|Adverse Event|1|||
124785103|NCT01904773|448845150|FG008|Fifth Intervention|Adverse Event|0|||
124785104|NCT01904773|448845142|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
124785105|NCT01904773|448845143|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
124785106|NCT01904773|448845144|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
124785107|NCT01904773|448845145|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
124785108|NCT01904773|448845146|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
124785109|NCT01904773|448845147|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
124785110|NCT01904773|448845148|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
124785111|NCT01904773|448845149|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
124785112|NCT01904773|448845150|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
124785113|NCT00791076|448845151|FG000|Overall Study|Study was terminated,PI left institution|8|||
124785114|NCT00606905|448845154|FG000|Overall Study|No Pregnancy|9|||
124785115|NCT00606905|448845155|FG001|Overall Study|No Pregnancy|6|||
124785116|NCT00606905|448845154|FG000|Overall Study|Non-Index Pregnancy|1|||
124785117|NCT00606905|448845155|FG001|Overall Study|Non-Index Pregnancy|4|||
124785118|NCT00606905|448845154|FG000|Overall Study|Withdrew|5|||
124785119|NCT00606905|448845155|FG001|Overall Study|Withdrew|5|||
124785120|NCT03700684|448845156|FG000|Overall Study|COVID-19|0|||
124785121|NCT03700684|448845157|FG001|Overall Study|COVID-19|0|||
124785122|NCT03700684|448845158|FG002|Overall Study|COVID-19|2|||
124785123|NCT03319745|448845159|FG000|Overall Study|Death|1|||
124785124|NCT03319745|448845159|FG000|Overall Study|Toxicity Precluding Surgery|1|||
124785125|NCT00870103|448845160|FG000|Overall Study|Physician Decision|2|||
124785126|NCT00870103|448845160|FG000|Overall Study|Lost to Follow-up|2|||
124785127|NCT03255629|448845161|FG000|Overall Study|Adverse Event|1|||
124785128|NCT03255629|448845162|FG001|Overall Study|Adverse Event|0|||
124785129|NCT03255629|448845161|FG000|Overall Study|did not experience hypoglycemia|2|||
124785130|NCT03255629|448845162|FG001|Overall Study|did not experience hypoglycemia|1|||
124785131|NCT00859638|448845163|FG000|Overall Study|Lost to Follow-up|6|||
124785132|NCT00859638|448845164|FG001|Overall Study|Lost to Follow-up|1|||
124785133|NCT00859638|448845163|FG000|Overall Study|Withdrawal by Subject|3|||
124785134|NCT00859638|448845164|FG001|Overall Study|Withdrawal by Subject|2|||
124785135|NCT00859638|448845163|FG000|Overall Study|Ill health|1|||
124785136|NCT00859638|448845164|FG001|Overall Study|Ill health|1|||
124785137|NCT02969408|448845166|FG000|Overall Study|Adverse Event|2|||
124785138|NCT02969408|448845166|FG000|Overall Study|Withdrawal by Subject|8|||
124785139|NCT02969408|448845166|FG000|Overall Study|Lost to Follow-up|4|||
124785140|NCT02969408|448845166|FG000|Overall Study|Protocol Violation|1|||
124785141|NCT02969408|448845166|FG000|Overall Study|Other than specified|1|||
124785142|NCT01767142|448845167|FG000|Overall Study|Lost to Follow-up|3|||
124785143|NCT04075734|448845170|FG000|Overall Study|Lost to Follow-up|1|||
124785144|NCT04075734|448845171|FG001|Overall Study|Lost to Follow-up|1|||
124785145|NCT04075734|448845172|FG002|Overall Study|Lost to Follow-up|0|||
124785146|NCT04075734|448845170|FG000|Overall Study|Withdrawal by Subject|3|||
124785147|NCT04075734|448845171|FG001|Overall Study|Withdrawal by Subject|0|||
124785148|NCT04075734|448845172|FG002|Overall Study|Withdrawal by Subject|0|||
124785149|NCT01776307|448845175|FG000|Overall Study|Not dosed|0|||
124785150|NCT01776307|448845176|FG001|Overall Study|Not dosed|0|||
124785151|NCT01776307|448845177|FG002|Overall Study|Not dosed|1|||
124785152|NCT03615040|448845178|FG000|Overall Study|Withdrawal by Subject|2|||
124785153|NCT03615040|448845179|FG001|Overall Study|Withdrawal by Subject|1|||
124785154|NCT03615040|448845178|FG000|Overall Study|Physician Decision|2|||
124785155|NCT03615040|448845179|FG001|Overall Study|Physician Decision|2|||
124785156|NCT03615040|448845178|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
124785157|NCT03615040|448845179|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
124785158|NCT03615040|448845178|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
124785159|NCT03615040|448845179|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
124785160|NCT03615040|448845178|FG000|Overall Study|Death|0|||
124785161|NCT03615040|448845179|FG001|Overall Study|Death|2|||
124785162|NCT05194579|448845184|FG000|Overall Study|Lost to Follow-up|2|||
124785163|NCT05194579|448845185|FG001|Overall Study|Lost to Follow-up|3|||
124785164|NCT05194579|448845184|FG000|Overall Study|Withdrawal by Subject|3|||
124785165|NCT05194579|448845185|FG001|Overall Study|Withdrawal by Subject|4|||
124785166|NCT05194579|448845184|FG000|Overall Study|Refused further study procedures|0|||
124785167|NCT05194579|448845185|FG001|Overall Study|Refused further study procedures|1|||
124785168|NCT05194579|448845184|FG000|Overall Study|Protocol deviation|1|||
124785169|NCT05194579|448845185|FG001|Overall Study|Protocol deviation|0|||
124785170|NCT04145219|448845186|FG000|Overall Study|Adverse Event|18|||
124785171|NCT04145219|448845187|FG001|Overall Study|Adverse Event|6|||
124785172|NCT04145219|448845186|FG000|Overall Study|Lost to Follow-up|2|||
124785173|NCT04145219|448845187|FG001|Overall Study|Lost to Follow-up|3|||
124785174|NCT04145219|448845186|FG000|Overall Study|Physician Decision|0|||
124785175|NCT04145219|448845187|FG001|Overall Study|Physician Decision|2|||
124785176|NCT04145219|448845186|FG000|Overall Study|Withdrawal by Subject|12|||
124785177|NCT04145219|448845187|FG001|Overall Study|Withdrawal by Subject|8|||
124785178|NCT04145219|448845186|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
124785179|NCT04145219|448845187|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
124785180|NCT01788215|448845193|FG000|Overall Study|Withdrawal by Subject|0|||
124785181|NCT01788215|448845194|FG001|Overall Study|Withdrawal by Subject|1|||
124785182|NCT01788215|448845193|FG000|Overall Study|Lost to Follow-up|2|||
124785183|NCT01788215|448845194|FG001|Overall Study|Lost to Follow-up|0|||
124785184|NCT01950013|448845195|FG000|Overall Study|Withdrawal by Subject|0|||
124785185|NCT01950013|448845196|FG001|Overall Study|Withdrawal by Subject|2|||
124785186|NCT01950013|448845197|FG002|Overall Study|Withdrawal by Subject|0|||
124785187|NCT00612105|448845206|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
124785188|NCT00612105|448845207|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
124785189|NCT00612105|448845206|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
124785190|NCT00612105|448845207|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
124785191|NCT00612105|448845206|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
124785192|NCT00612105|448845207|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
124785193|NCT00612105|448845206|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
124785194|NCT00612105|448845207|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
124785195|NCT00612105|448845206|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
124785196|NCT00612105|448845207|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
124785197|NCT00612105|448845206|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
124785198|NCT00612105|448845207|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
124785199|NCT00612105|448845206|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
124785200|NCT00612105|448845207|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
124785201|NCT00612105|448845206|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
124785202|NCT00612105|448845207|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
124785203|NCT00612105|448845206|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
124785204|NCT00612105|448845207|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
124785205|NCT00612105|448845206|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
124785206|NCT00612105|448845207|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
124785207|NCT00612105|448845206|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
124785208|NCT00612105|448845207|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
124785209|NCT00612105|448845206|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
124785210|NCT00612105|448845207|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
124785211|NCT00271505|448845209|FG000|Overall Study|Screen Failure|3|||
124785212|NCT00271505|448845209|FG000|Overall Study|Adverse Event|1|||
125292191|NCT00996801|450696556|FG005|Overall Study|Lost to Follow-up|2|||
125292192|NCT00996801|450696551|FG000|Overall Study|Physician Decision|0|||
124785213|NCT00271505|448845209|FG000|Overall Study|Death|1|||
124785214|NCT04556383|448845210|FG000|PCP|Lack of Efficacy|28|||
124785215|NCT04556383|448845211|FG001|PCP|Lack of Efficacy|23|||
124785216|NCT04556383|448845212|FG002|PCP|Lack of Efficacy|23|||
124785217|NCT04556383|448845213|FG003|PCP|Lack of Efficacy|0|||
124785218|NCT04556383|448845210|FG000|PCP|Study terminated by sponsor|15|||
124785219|NCT04556383|448845211|FG001|PCP|Study terminated by sponsor|13|||
124785220|NCT04556383|448845212|FG002|PCP|Study terminated by sponsor|16|||
124785221|NCT04556383|448845213|FG003|PCP|Study terminated by sponsor|0|||
124785222|NCT04556383|448845210|FG000|PCP|Withdrawal by Subject|8|||
124785223|NCT04556383|448845211|FG001|PCP|Withdrawal by Subject|6|||
124785224|NCT04556383|448845212|FG002|PCP|Withdrawal by Subject|6|||
124785225|NCT04556383|448845213|FG003|PCP|Withdrawal by Subject|0|||
124785226|NCT04556383|448845210|FG000|PCP|Adverse Event|1|||
124785227|NCT04556383|448845211|FG001|PCP|Adverse Event|7|||
124785228|NCT04556383|448845212|FG002|PCP|Adverse Event|7|||
124785229|NCT04556383|448845213|FG003|PCP|Adverse Event|0|||
124785230|NCT04556383|448845210|FG000|PCP|Other, Not Specified|1|||
124785231|NCT04556383|448845211|FG001|PCP|Other, Not Specified|2|||
124785232|NCT04556383|448845212|FG002|PCP|Other, Not Specified|1|||
124785233|NCT04556383|448845213|FG003|PCP|Other, Not Specified|0|||
124785234|NCT04556383|448845210|FG000|PCP|Protocol Violation|1|||
124785235|NCT04556383|448845211|FG001|PCP|Protocol Violation|0|||
124785236|NCT04556383|448845212|FG002|PCP|Protocol Violation|1|||
124785237|NCT04556383|448845213|FG003|PCP|Protocol Violation|0|||
124785238|NCT04556383|448845210|FG000|PCP|Lost to Follow-up|1|||
124785239|NCT04556383|448845211|FG001|PCP|Lost to Follow-up|0|||
124785240|NCT04556383|448845212|FG002|PCP|Lost to Follow-up|0|||
124785241|NCT04556383|448845213|FG003|PCP|Lost to Follow-up|0|||
124785242|NCT04556383|448845210|FG000|PCP|Physician Decision|0|||
124785243|NCT04556383|448845211|FG001|PCP|Physician Decision|1|||
124785244|NCT04556383|448845212|FG002|PCP|Physician Decision|0|||
124785245|NCT04556383|448845213|FG003|PCP|Physician Decision|0|||
124785246|NCT04556383|448845210|FG000|PCP|Site terminated by sponsor|0|||
124785247|NCT04556383|448845211|FG001|PCP|Site terminated by sponsor|1|||
124785248|NCT04556383|448845212|FG002|PCP|Site terminated by sponsor|0|||
124785249|NCT04556383|448845213|FG003|PCP|Site terminated by sponsor|0|||
124785250|NCT04556383|448845210|FG000|OLE|Study terminated by sponsor|0|||
124785251|NCT04556383|448845211|FG001|OLE|Study terminated by sponsor|0|||
124785252|NCT04556383|448845212|FG002|OLE|Study terminated by sponsor|0|||
124785253|NCT04556383|448845213|FG003|OLE|Study terminated by sponsor|68|||
124785254|NCT04556383|448845210|FG000|OLE|Withdrawal by Subject|0|||
124785255|NCT04556383|448845211|FG001|OLE|Withdrawal by Subject|0|||
124785256|NCT04556383|448845212|FG002|OLE|Withdrawal by Subject|0|||
124785257|NCT04556383|448845213|FG003|OLE|Withdrawal by Subject|10|||
124785258|NCT04556383|448845210|FG000|OLE|Lack of Efficacy|0|||
124785259|NCT04556383|448845211|FG001|OLE|Lack of Efficacy|0|||
124785260|NCT04556383|448845212|FG002|OLE|Lack of Efficacy|0|||
124785261|NCT04556383|448845213|FG003|OLE|Lack of Efficacy|7|||
124785262|NCT04556383|448845210|FG000|OLE|Adverse Event|0|||
124785263|NCT04556383|448845211|FG001|OLE|Adverse Event|0|||
124785264|NCT04556383|448845212|FG002|OLE|Adverse Event|0|||
124785265|NCT04556383|448845213|FG003|OLE|Adverse Event|2|||
124785266|NCT04556383|448845210|FG000|OLE|Other, Not Specified|0|||
124785267|NCT04556383|448845211|FG001|OLE|Other, Not Specified|0|||
124785268|NCT04556383|448845212|FG002|OLE|Other, Not Specified|0|||
124785269|NCT04556383|448845213|FG003|OLE|Other, Not Specified|2|||
124785270|NCT04556383|448845210|FG000|OLE|Death|0|||
124785271|NCT04556383|448845211|FG001|OLE|Death|0|||
124785272|NCT04556383|448845212|FG002|OLE|Death|0|||
124785273|NCT04556383|448845213|FG003|OLE|Death|1|||
124785274|NCT04556383|448845210|FG000|OLE|Lost to Follow-up|0|||
124785275|NCT04556383|448845211|FG001|OLE|Lost to Follow-up|0|||
124785276|NCT04556383|448845212|FG002|OLE|Lost to Follow-up|0|||
124785277|NCT04556383|448845213|FG003|OLE|Lost to Follow-up|1|||
124785278|NCT00119678|448845214|FG000|Double-blind Treatment Period|Death|1|||
124785279|NCT00119678|448845215|FG001|Double-blind Treatment Period|Death|0|||
124785280|NCT00119678|448845214|FG000|Double-blind Treatment Period|Adverse Event|7|||
124785281|NCT00119678|448845215|FG001|Double-blind Treatment Period|Adverse Event|1|||
124785282|NCT00119678|448845214|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
124785283|NCT00119678|448845215|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
124785284|NCT00119678|448845214|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
124785285|NCT00119678|448845215|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
124785286|NCT00119678|448845214|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
124785287|NCT00119678|448845215|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
124785288|NCT00119678|448845214|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
124785289|NCT00119678|448845215|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
124785290|NCT00119678|448845214|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
124785291|NCT00119678|448845215|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
124785292|NCT00119678|448845214|FG000|Double-blind Treatment Period|Pregnancy|0|||
124785293|NCT00119678|448845215|FG001|Double-blind Treatment Period|Pregnancy|2|||
124785294|NCT00119678|448845214|FG000|Double-blind Treatment Period|Not treated|1|||
124785295|NCT00119678|448845215|FG001|Double-blind Treatment Period|Not treated|2|||
124785296|NCT00119678|448845214|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
124785297|NCT00119678|448845215|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
124785298|NCT00119678|448845214|FG000|Open-label Treatment Period|Death|1|||
124785299|NCT00119678|448845215|FG001|Open-label Treatment Period|Death|0|||
124785300|NCT00119678|448845214|FG000|Open-label Treatment Period|Adverse Event|3|||
124785301|NCT00119678|448845215|FG001|Open-label Treatment Period|Adverse Event|0|||
124785302|NCT00119678|448845214|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
124785303|NCT00119678|448845215|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
124785304|NCT00119678|448845214|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
124785305|NCT00119678|448845215|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
124785306|NCT00119678|448845214|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
124785307|NCT00119678|448845215|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
124785308|NCT00119678|448845214|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
124785309|NCT00119678|448845215|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
124785310|NCT00119678|448845214|FG000|Open-label Treatment Period|Pregnancy|1|||
124785311|NCT00119678|448845215|FG001|Open-label Treatment Period|Pregnancy|0|||
124785312|NCT00119678|448845214|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
124785313|NCT00119678|448845215|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
124785314|NCT02720042|448845223|FG000|Overall Study|Death|3|||
124785315|NCT02720042|448845223|FG000|Overall Study|Lost to Follow-up|4|||
124785316|NCT02720042|448845223|FG000|Overall Study|Withdrawal by Subject|1|||
124785317|NCT02720042|448845223|FG000|Overall Study|Physician Decision|3|||
124785318|NCT02720042|448845223|FG000|Overall Study|Phasix Mesh explanted|1|||
124785319|NCT02720042|448845223|FG000|Overall Study|unable due to non-study-related illness|3|||
124785320|NCT01761240|448845224|FG000|Overall Study|Progressive disease:radiology assessment|3|||
124785321|NCT01761240|448845225|FG001|Overall Study|Progressive disease:radiology assessment|3|||
124785322|NCT01761240|448845226|FG002|Overall Study|Progressive disease:radiology assessment|0|||
124785323|NCT01761240|448845227|FG003|Overall Study|Progressive disease:radiology assessment|0|||
124785324|NCT01761240|448845228|FG004|Overall Study|Progressive disease:radiology assessment|0|||
124785325|NCT01761240|448845224|FG000|Overall Study|Progressive disease:clinical assessment|0|||
124785326|NCT01761240|448845225|FG001|Overall Study|Progressive disease:clinical assessment|0|||
124785327|NCT01761240|448845226|FG002|Overall Study|Progressive disease:clinical assessment|3|||
124785328|NCT01761240|448845227|FG003|Overall Study|Progressive disease:clinical assessment|1|||
124785329|NCT01761240|448845228|FG004|Overall Study|Progressive disease:clinical assessment|0|||
124785330|NCT01761240|448845224|FG000|Overall Study|Withdrawal by Subject|0|||
124785331|NCT01761240|448845225|FG001|Overall Study|Withdrawal by Subject|0|||
124785332|NCT01761240|448845226|FG002|Overall Study|Withdrawal by Subject|0|||
124785333|NCT01761240|448845227|FG003|Overall Study|Withdrawal by Subject|3|||
124785334|NCT01761240|448845228|FG004|Overall Study|Withdrawal by Subject|1|||
124785335|NCT01761240|448845224|FG000|Overall Study|Adverse Event|0|||
124785336|NCT01761240|448845225|FG001|Overall Study|Adverse Event|0|||
124785337|NCT01761240|448845226|FG002|Overall Study|Adverse Event|0|||
124785338|NCT01761240|448845227|FG003|Overall Study|Adverse Event|1|||
124785339|NCT01761240|448845228|FG004|Overall Study|Adverse Event|6|||
124785340|NCT01761240|448845224|FG000|Overall Study|Death|0|||
124785341|NCT01761240|448845225|FG001|Overall Study|Death|1|||
124785342|NCT01761240|448845226|FG002|Overall Study|Death|1|||
124785343|NCT01761240|448845227|FG003|Overall Study|Death|2|||
124785344|NCT01761240|448845228|FG004|Overall Study|Death|1|||
124785345|NCT01761240|448845224|FG000|Overall Study|Non-compliance|0|||
124785346|NCT01761240|448845225|FG001|Overall Study|Non-compliance|0|||
124785347|NCT01761240|448845226|FG002|Overall Study|Non-compliance|1|||
124785348|NCT01761240|448845227|FG003|Overall Study|Non-compliance|0|||
124785349|NCT01761240|448845228|FG004|Overall Study|Non-compliance|0|||
124785350|NCT00509145|448845231|FG000|Overall Study|Death|0|||
124785351|NCT00509145|448845232|FG001|Overall Study|Death|2|||
124785352|NCT00509145|448845231|FG000|Overall Study|Adverse Event|42|||
124785353|NCT00509145|448845232|FG001|Overall Study|Adverse Event|28|||
124785354|NCT00509145|448845231|FG000|Overall Study|Withdrawal by Subject|32|||
124785355|NCT00509145|448845232|FG001|Overall Study|Withdrawal by Subject|38|||
124785356|NCT00509145|448845231|FG000|Overall Study|Physician Decision|11|||
124785357|NCT00509145|448845232|FG001|Overall Study|Physician Decision|14|||
124785358|NCT00509145|448845231|FG000|Overall Study|Protocol Violation|1|||
124785359|NCT00509145|448845232|FG001|Overall Study|Protocol Violation|6|||
124785360|NCT00509145|448845231|FG000|Overall Study|Pregnancy|3|||
124785361|NCT00509145|448845232|FG001|Overall Study|Pregnancy|8|||
124785362|NCT00509145|448845231|FG000|Overall Study|Lost to Follow-up|6|||
124785363|NCT00509145|448845232|FG001|Overall Study|Lost to Follow-up|5|||
124785364|NCT00509145|448845231|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
124785365|NCT00509145|448845232|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
124785366|NCT00509145|448845231|FG000|Overall Study|Other|6|||
124785367|NCT00509145|448845232|FG001|Overall Study|Other|6|||
124785368|NCT01994889|448845233|FG000|Overall Study|Adverse Event|5|||
124785369|NCT01994889|448845234|FG001|Overall Study|Adverse Event|12|||
124785370|NCT01994889|448845235|FG002|Overall Study|Adverse Event|11|||
124785371|NCT01994889|448845233|FG000|Overall Study|Cardiac Device Implantation|0|||
124785372|NCT01994889|448845234|FG001|Overall Study|Cardiac Device Implantation|2|||
124785373|NCT01994889|448845235|FG002|Overall Study|Cardiac Device Implantation|0|||
124785374|NCT01994889|448845233|FG000|Overall Study|Organ Transplantation|1|||
124785375|NCT01994889|448845234|FG001|Overall Study|Organ Transplantation|5|||
124785376|NCT01994889|448845235|FG002|Overall Study|Organ Transplantation|5|||
124785377|NCT01994889|448845233|FG000|Overall Study|No longer willing to participate|8|||
124785378|NCT01994889|448845234|FG001|Overall Study|No longer willing to participate|17|||
124785379|NCT01994889|448845235|FG002|Overall Study|No longer willing to participate|37|||
124785380|NCT01994889|448845233|FG000|Overall Study|Lost to Follow-up|0|||
124785381|NCT01994889|448845234|FG001|Overall Study|Lost to Follow-up|1|||
124785382|NCT01994889|448845235|FG002|Overall Study|Lost to Follow-up|0|||
124785383|NCT01994889|448845233|FG000|Overall Study|Protocol Violation|0|||
124785384|NCT01994889|448845234|FG001|Overall Study|Protocol Violation|1|||
124785385|NCT01994889|448845235|FG002|Overall Study|Protocol Violation|1|||
124785386|NCT01994889|448845233|FG000|Overall Study|Death|14|||
124785387|NCT01994889|448845234|FG001|Overall Study|Death|25|||
124785388|NCT01994889|448845235|FG002|Overall Study|Death|38|||
124785389|NCT02969655|448845237|FG000|Overall Study|Withdrawal by Subject|3|||
124785390|NCT02969655|448845238|FG001|Overall Study|Withdrawal by Subject|2|||
124785391|NCT02969655|448845237|FG000|Overall Study|Physician Decision|4|||
124785392|NCT02969655|448845238|FG001|Overall Study|Physician Decision|3|||
124785393|NCT02969655|448845237|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
124785394|NCT02969655|448845238|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
124785395|NCT02969655|448845237|FG000|Overall Study|Adverse Event|10|||
124785396|NCT02969655|448845238|FG001|Overall Study|Adverse Event|8|||
124785397|NCT02674204|448845239|FG000|Overall Study|Adverse Event|1|||
124785398|NCT02674204|448845240|FG001|Overall Study|Adverse Event|0|||
124785399|NCT01516034|448845244|FG000|Overall Study|Physician Decision|1|||
124785400|NCT01516034|448845244|FG000|Overall Study|Lack of Efficacy|7|||
124785401|NCT03060551|448845245|FG000|Overall Study|Withdrawal by Subject|1|||
124785402|NCT03060551|448845245|FG000|Overall Study|Adverse Event|1|||
124785403|NCT01525225|448845250|FG000|Enrollment|No longer met study criteria|1|||
124785404|NCT01525225|448845250|FG000|Enrollment|Other|1|||
124785405|NCT00363545|448845251|FG000|Overall Study|Serious Adverse Event|0|||
124785406|NCT00363545|448845252|FG001|Overall Study|Serious Adverse Event|1|||
124785407|NCT00363545|448845251|FG000|Overall Study|Withdrawal by Subject|12|||
124785408|NCT00363545|448845252|FG001|Overall Study|Withdrawal by Subject|15|||
124785409|NCT00363545|448845251|FG000|Overall Study|Migrated/moved from study area|3|||
124785410|NCT00363545|448845252|FG001|Overall Study|Migrated/moved from study area|6|||
124785411|NCT00363545|448845251|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
124785412|NCT00363545|448845252|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
124785413|NCT00363545|448845251|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
124785414|NCT00363545|448845252|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
124785415|NCT00363545|448845251|FG000|Overall Study|Others|1|||
124785416|NCT00363545|448845252|FG001|Overall Study|Others|0|||
124785417|NCT01379508|448845253|FG000|Treatment to Week 104|Adverse Event|2|||
124785418|NCT01379508|448845254|FG001|Treatment to Week 104|Adverse Event|0|||
124785419|NCT01379508|448845255|FG002|Treatment to Week 104|Adverse Event|5|||
124785420|NCT01379508|448845256|FG003|Treatment to Week 104|Adverse Event|0|||
124785421|NCT01379508|448845253|FG000|Treatment to Week 104|Abnormal lab value|1|||
124785422|NCT01379508|448845254|FG001|Treatment to Week 104|Abnormal lab value|0|||
124785423|NCT01379508|448845255|FG002|Treatment to Week 104|Abnormal lab value|0|||
124785424|NCT01379508|448845256|FG003|Treatment to Week 104|Abnormal lab value|0|||
124785425|NCT01379508|448845253|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
124785426|NCT01379508|448845254|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
124785427|NCT01379508|448845255|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
124785428|NCT01379508|448845256|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
124785429|NCT01379508|448845253|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
124785430|NCT01379508|448845254|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
124785431|NCT01379508|448845255|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
124785432|NCT01379508|448845256|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
124785433|NCT01379508|448845253|FG000|Treatment to Week 104|Lost to Follow-up|5|||
124785434|NCT01379508|448845254|FG001|Treatment to Week 104|Lost to Follow-up|0|||
124785435|NCT01379508|448845255|FG002|Treatment to Week 104|Lost to Follow-up|3|||
124785436|NCT01379508|448845256|FG003|Treatment to Week 104|Lost to Follow-up|0|||
124785437|NCT01379508|448845253|FG000|Treatment to Week 104|Administrative problems|3|||
124785438|NCT01379508|448845254|FG001|Treatment to Week 104|Administrative problems|1|||
124785439|NCT01379508|448845255|FG002|Treatment to Week 104|Administrative problems|0|||
124785440|NCT01379508|448845256|FG003|Treatment to Week 104|Administrative problems|0|||
124785441|NCT01379508|448845253|FG000|Treatment to Week 104|Protocol Violation|1|||
124785442|NCT01379508|448845254|FG001|Treatment to Week 104|Protocol Violation|1|||
124785443|NCT01379508|448845255|FG002|Treatment to Week 104|Protocol Violation|1|||
124785444|NCT01379508|448845256|FG003|Treatment to Week 104|Protocol Violation|0|||
124785445|NCT01379508|448845253|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
124785446|NCT01379508|448845254|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
124785447|NCT01379508|448845255|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
124785448|NCT01379508|448845256|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
124785449|NCT01379508|448845253|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
124785450|NCT01379508|448845254|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
124785451|NCT01379508|448845255|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
124785452|NCT01379508|448845256|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
124785453|NCT01379508|448845253|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
124785454|NCT01379508|448845254|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
124785455|NCT01379508|448845255|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
124785456|NCT01379508|448845256|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
124785457|NCT01379508|448845253|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
124785458|NCT01379508|448845254|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
124785459|NCT01379508|448845255|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
124785460|NCT01379508|448845256|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
124785461|NCT01457352|448845257|FG000|Period 1|Adverse Event|2|||
124785462|NCT01457352|448845258|FG001|Period 1|Adverse Event|0|||
124785463|NCT01457352|448845257|FG000|Period 1|Withdrawal by Subject|2|||
124785464|NCT01457352|448845258|FG001|Period 1|Withdrawal by Subject|0|||
124785465|NCT01457352|448845257|FG000|Period 1|Physician Decision|2|||
124785466|NCT01457352|448845258|FG001|Period 1|Physician Decision|0|||
124785467|NCT01457352|448845257|FG000|Period 1|MS related disease progression|1|||
124785468|NCT01457352|448845258|FG001|Period 1|MS related disease progression|0|||
124785469|NCT01457352|448845257|FG000|Period 1|Withdrawn|1|||
124785470|NCT01457352|448845258|FG001|Period 1|Withdrawn|0|||
124785471|NCT01457352|448845257|FG000|Period 1|withdrew per sponsor|1|||
124785472|NCT01457352|448845258|FG001|Period 1|withdrew per sponsor|0|||
124785473|NCT01457352|448845257|FG000|Period 1|Protocol Violation|4|||
124785474|NCT01457352|448845258|FG001|Period 1|Protocol Violation|0|||
124785475|NCT01457352|448845257|FG000|Period 1|Did not meet eligibility criteria|3|||
124785476|NCT01457352|448845258|FG001|Period 1|Did not meet eligibility criteria|0|||
124785477|NCT01457352|448845257|FG000|Period 2|Withdrawal by Subject|23|||
124785478|NCT01457352|448845258|FG001|Period 2|Withdrawal by Subject|0|||
124785479|NCT01457352|448845257|FG000|Period 2|Adverse Event|22|||
124785480|NCT01457352|448845258|FG001|Period 2|Adverse Event|0|||
124785481|NCT01457352|448845257|FG000|Period 2|no analysis|10|||
124785482|NCT01457352|448845258|FG001|Period 2|no analysis|0|||
124785483|NCT01457352|448845257|FG000|Period 2|Lack of Efficacy|8|||
124785484|NCT01457352|448845258|FG001|Period 2|Lack of Efficacy|0|||
124785485|NCT01457352|448845257|FG000|Period 2|Protocol Violation|4|||
124785486|NCT01457352|448845258|FG001|Period 2|Protocol Violation|0|||
124785487|NCT01457352|448845257|FG000|Period 2|Sponsor's withdrawal|7|||
124785488|NCT01457352|448845258|FG001|Period 2|Sponsor's withdrawal|0|||
124785489|NCT01457352|448845257|FG000|Period 2|Lost to Follow-up|1|||
124785490|NCT01457352|448845258|FG001|Period 2|Lost to Follow-up|0|||
124785491|NCT01457352|448845257|FG000|Period 2|dose change|1|||
124785492|NCT01457352|448845258|FG001|Period 2|dose change|0|||
124785493|NCT01457352|448845257|FG000|Period 2|Physician Decision|1|||
124785494|NCT01457352|448845258|FG001|Period 2|Physician Decision|0|||
124785495|NCT01457352|448845257|FG000|Period 2|Did not meet eligibility criteria|3|||
124785496|NCT01457352|448845258|FG001|Period 2|Did not meet eligibility criteria|0|||
124785497|NCT01457352|448845257|FG000|Period 3|Adverse Event|1|||
124785498|NCT01457352|448845258|FG001|Period 3|Adverse Event|1|||
124785499|NCT01457352|448845257|FG000|Period 3|Withdrawal by Subject|0|||
124785500|NCT01457352|448845258|FG001|Period 3|Withdrawal by Subject|2|||
124785501|NCT01457352|448845257|FG000|Period 3|incorrect treatment|0|||
124785502|NCT01457352|448845258|FG001|Period 3|incorrect treatment|1|||
124785503|NCT01457352|448845257|FG000|Period 3|Sponsor's withdrawal|0|||
124785504|NCT01457352|448845258|FG001|Period 3|Sponsor's withdrawal|1|||
124785505|NCT02537015|448845259|FG000|Overall Study|Adverse Event|3|||
124785506|NCT02537015|448845259|FG000|Overall Study|Withdrawal by Subject|2|||
124785507|NCT02537015|448845259|FG000|Overall Study|Other Miscellaneous Reasons|1|||
124785508|NCT04174365|448845260|FG000|Overall Study|Lost to Follow-up|1|||
124785509|NCT04174365|448845261|FG001|Overall Study|Lost to Follow-up|2|||
125292193|NCT00996801|450696552|FG001|Overall Study|Physician Decision|0|||
125292194|NCT00996801|450696553|FG002|Overall Study|Physician Decision|0|||
125292195|NCT00996801|450696554|FG003|Overall Study|Physician Decision|1|||
124785510|NCT04174365|448845260|FG000|Overall Study|Adverse Event|2|||
124785511|NCT04174365|448845261|FG001|Overall Study|Adverse Event|1|||
124785512|NCT04174365|448845260|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
124785513|NCT04174365|448845261|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
124785514|NCT04174365|448845260|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
124785515|NCT04174365|448845261|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
124785516|NCT04174365|448845260|FG000|Overall Study|Protocol Deviation|1|||
124785517|NCT04174365|448845261|FG001|Overall Study|Protocol Deviation|0|||
124785518|NCT04174365|448845260|FG000|Overall Study|Lack of Efficacy|0|||
124785519|NCT04174365|448845261|FG001|Overall Study|Lack of Efficacy|2|||
124785520|NCT04174365|448845260|FG000|Overall Study|Disease Relapse|1|||
124785521|NCT04174365|448845261|FG001|Overall Study|Disease Relapse|0|||
124785522|NCT04174365|448845260|FG000|Overall Study|Reason Not Specified|0|||
125292196|NCT00996801|450696555|FG004|Overall Study|Physician Decision|0|||
124785523|NCT04174365|448845261|FG001|Overall Study|Reason Not Specified|1|||
124785524|NCT02156271|448847889|FG000|Overall Study|Physician Decision|4|||
124785525|NCT02156271|448847890|FG001|Overall Study|Physician Decision|3|||
124785526|NCT00109590|448847891|FG000|Overall Study|Lost to Follow-up|1|||
124785527|NCT00109590|448847892|FG001|Overall Study|Lost to Follow-up|0|||
124785528|NCT00109590|448847893|FG002|Overall Study|Lost to Follow-up|1|||
124785529|NCT00109590|448847891|FG000|Overall Study|Never Started Treatment|1|||
124785530|NCT00109590|448847892|FG001|Overall Study|Never Started Treatment|2|||
124785531|NCT00109590|448847893|FG002|Overall Study|Never Started Treatment|3|||
124785532|NCT00409331|448847897|FG000|Overall Study|Physician Decision|1|||
124785533|NCT01511055|448847902|FG000|Overall Study|Withdrawal by Subject|6|||
124785534|NCT04590248|448847904|FG000|Overall Study|Lost to Follow-up|1|||
124785535|NCT04590248|448847904|FG000|Overall Study|Withdrawal by Subject|16|||
124785536|NCT04590248|448847904|FG000|Overall Study|Other|2|||
124785537|NCT02052414|448847907|FG000|Overall Study|Adverse Event|12|||
124785538|NCT02052414|448847907|FG000|Overall Study|Lack of Efficacy|2|||
124785539|NCT02052414|448847907|FG000|Overall Study|Withdrawal by Subject|3|||
124785540|NCT03263702|448847911|FG000|Overall Study|Lost to Follow-up|2|||
124785541|NCT03263702|448847912|FG001|Overall Study|Lost to Follow-up|2|||
124785542|NCT03263702|448847911|FG000|Overall Study|Withdrawal by Subject|1|||
124785543|NCT03263702|448847912|FG001|Overall Study|Withdrawal by Subject|2|||
124785544|NCT02527200|448847913|FG000|Overall Study|Withdrawal by Subject|3|||
124785545|NCT02527200|448847914|FG001|Overall Study|Withdrawal by Subject|2|||
124785546|NCT02527200|448847915|FG002|Overall Study|Withdrawal by Subject|1|||
124785547|NCT02527200|448847916|FG003|Overall Study|Withdrawal by Subject|0|||
124785548|NCT02527200|448847913|FG000|Overall Study|Unclassified|0|||
124785549|NCT02527200|448847914|FG001|Overall Study|Unclassified|1|||
124785550|NCT02527200|448847915|FG002|Overall Study|Unclassified|0|||
124785551|NCT02527200|448847916|FG003|Overall Study|Unclassified|0|||
124785552|NCT02527200|448847913|FG000|Overall Study|Lost to Follow-up|0|||
124785553|NCT02527200|448847914|FG001|Overall Study|Lost to Follow-up|0|||
124785554|NCT02527200|448847915|FG002|Overall Study|Lost to Follow-up|1|||
124785555|NCT02527200|448847916|FG003|Overall Study|Lost to Follow-up|0|||
124785556|NCT00966875|448847918|FG000|Part A|Adverse Event|2|||
124785557|NCT00966875|448847919|FG001|Part A|Adverse Event|1|||
124785558|NCT00966875|448847920|FG002|Part A|Adverse Event|0|||
124785559|NCT00966875|448847921|FG003|Part A|Adverse Event|1|||
124785560|NCT00966875|448847922|FG004|Part A|Adverse Event|0|||
124785561|NCT00966875|448847923|FG005|Part A|Adverse Event|1|||
124785562|NCT00966875|448847924|FG006|Part A|Adverse Event|0|||
124785563|NCT00966875|448847925|FG007|Part A|Adverse Event|3|||
124785564|NCT00966875|448847926|FG008|Part A|Adverse Event|3|||
124785565|NCT00966875|448847918|FG000|Part A|Entry Criteria|0|||
124785566|NCT00966875|448847919|FG001|Part A|Entry Criteria|0|||
124785567|NCT00966875|448847920|FG002|Part A|Entry Criteria|0|||
124785568|NCT00966875|448847921|FG003|Part A|Entry Criteria|0|||
124785569|NCT00966875|448847922|FG004|Part A|Entry Criteria|0|||
124785570|NCT00966875|448847923|FG005|Part A|Entry Criteria|2|||
124785571|NCT00966875|448847924|FG006|Part A|Entry Criteria|0|||
124785572|NCT00966875|448847925|FG007|Part A|Entry Criteria|0|||
124785573|NCT00966875|448847926|FG008|Part A|Entry Criteria|0|||
124785574|NCT00966875|448847918|FG000|Part A|Lack of Efficacy|0|||
124785575|NCT00966875|448847919|FG001|Part A|Lack of Efficacy|1|||
124785576|NCT00966875|448847920|FG002|Part A|Lack of Efficacy|0|||
124785577|NCT00966875|448847921|FG003|Part A|Lack of Efficacy|0|||
124785578|NCT00966875|448847922|FG004|Part A|Lack of Efficacy|0|||
124785579|NCT00966875|448847923|FG005|Part A|Lack of Efficacy|0|||
124785580|NCT00966875|448847924|FG006|Part A|Lack of Efficacy|4|||
124785581|NCT00966875|448847925|FG007|Part A|Lack of Efficacy|0|||
124785582|NCT00966875|448847926|FG008|Part A|Lack of Efficacy|0|||
124785583|NCT00966875|448847918|FG000|Part A|Lost to Follow-up|2|||
124785584|NCT00966875|448847919|FG001|Part A|Lost to Follow-up|0|||
124785585|NCT00966875|448847920|FG002|Part A|Lost to Follow-up|0|||
124785586|NCT00966875|448847921|FG003|Part A|Lost to Follow-up|0|||
124785587|NCT00966875|448847922|FG004|Part A|Lost to Follow-up|0|||
124785588|NCT00966875|448847923|FG005|Part A|Lost to Follow-up|1|||
124785589|NCT00966875|448847924|FG006|Part A|Lost to Follow-up|0|||
124785590|NCT00966875|448847925|FG007|Part A|Lost to Follow-up|0|||
124785591|NCT00966875|448847926|FG008|Part A|Lost to Follow-up|0|||
124785592|NCT00966875|448847918|FG000|Part A|Parent/Caregiver Decision|0|||
124785593|NCT00966875|448847919|FG001|Part A|Parent/Caregiver Decision|0|||
124785594|NCT00966875|448847920|FG002|Part A|Parent/Caregiver Decision|0|||
124785595|NCT00966875|448847921|FG003|Part A|Parent/Caregiver Decision|1|||
124785596|NCT00966875|448847922|FG004|Part A|Parent/Caregiver Decision|0|||
124785597|NCT00966875|448847923|FG005|Part A|Parent/Caregiver Decision|0|||
124785598|NCT00966875|448847924|FG006|Part A|Parent/Caregiver Decision|0|||
124785599|NCT00966875|448847925|FG007|Part A|Parent/Caregiver Decision|0|||
124785600|NCT00966875|448847926|FG008|Part A|Parent/Caregiver Decision|0|||
124785601|NCT00966875|448847918|FG000|Part A|Physician Decision|0|||
124785602|NCT00966875|448847919|FG001|Part A|Physician Decision|0|||
124785603|NCT00966875|448847920|FG002|Part A|Physician Decision|0|||
124785604|NCT00966875|448847921|FG003|Part A|Physician Decision|0|||
124785605|NCT00966875|448847922|FG004|Part A|Physician Decision|1|||
124785606|NCT00966875|448847923|FG005|Part A|Physician Decision|0|||
124785607|NCT00966875|448847924|FG006|Part A|Physician Decision|1|||
124785608|NCT00966875|448847925|FG007|Part A|Physician Decision|0|||
124785609|NCT00966875|448847926|FG008|Part A|Physician Decision|2|||
124785610|NCT00966875|448847918|FG000|Part A|Sponsor Decision|0|||
124785611|NCT00966875|448847919|FG001|Part A|Sponsor Decision|0|||
124785612|NCT00966875|448847920|FG002|Part A|Sponsor Decision|1|||
124785613|NCT00966875|448847921|FG003|Part A|Sponsor Decision|0|||
124785614|NCT00966875|448847922|FG004|Part A|Sponsor Decision|1|||
124785615|NCT00966875|448847923|FG005|Part A|Sponsor Decision|0|||
124785616|NCT00966875|448847924|FG006|Part A|Sponsor Decision|0|||
124785617|NCT00966875|448847925|FG007|Part A|Sponsor Decision|2|||
124785618|NCT00966875|448847926|FG008|Part A|Sponsor Decision|1|||
124785619|NCT00966875|448847918|FG000|Part A|Withdrawal by Subject|2|||
124785620|NCT00966875|448847919|FG001|Part A|Withdrawal by Subject|2|||
124785621|NCT00966875|448847920|FG002|Part A|Withdrawal by Subject|1|||
124785622|NCT00966875|448847921|FG003|Part A|Withdrawal by Subject|1|||
124785623|NCT00966875|448847922|FG004|Part A|Withdrawal by Subject|3|||
124785624|NCT00966875|448847923|FG005|Part A|Withdrawal by Subject|0|||
124785625|NCT00966875|448847924|FG006|Part A|Withdrawal by Subject|5|||
124785626|NCT00966875|448847925|FG007|Part A|Withdrawal by Subject|1|||
124785627|NCT00966875|448847926|FG008|Part A|Withdrawal by Subject|1|||
124785628|NCT00966875|448847918|FG000|Part A|Protocol Violation|0|||
124785629|NCT00966875|448847919|FG001|Part A|Protocol Violation|0|||
124785630|NCT00966875|448847920|FG002|Part A|Protocol Violation|0|||
124785631|NCT00966875|448847921|FG003|Part A|Protocol Violation|0|||
124785632|NCT00966875|448847922|FG004|Part A|Protocol Violation|0|||
124785633|NCT00966875|448847923|FG005|Part A|Protocol Violation|0|||
124785634|NCT00966875|448847924|FG006|Part A|Protocol Violation|2|||
124785635|NCT00966875|448847925|FG007|Part A|Protocol Violation|1|||
124785636|NCT00966875|448847926|FG008|Part A|Protocol Violation|1|||
124785637|NCT00966875|448847918|FG000|Part B|Adverse Event|0|||
124785638|NCT00966875|448847919|FG001|Part B|Adverse Event|1|||
124785639|NCT00966875|448847920|FG002|Part B|Adverse Event|1|||
124785640|NCT00966875|448847921|FG003|Part B|Adverse Event|0|||
124785641|NCT00966875|448847922|FG004|Part B|Adverse Event|1|||
124785642|NCT00966875|448847923|FG005|Part B|Adverse Event|0|||
124785643|NCT00966875|448847924|FG006|Part B|Adverse Event|5|||
124785644|NCT00966875|448847925|FG007|Part B|Adverse Event|2|||
124785645|NCT00966875|448847926|FG008|Part B|Adverse Event|2|||
124785646|NCT00966875|448847918|FG000|Part B|Death|0|||
124785647|NCT00966875|448847919|FG001|Part B|Death|0|||
124785648|NCT00966875|448847920|FG002|Part B|Death|1|||
124785649|NCT00966875|448847921|FG003|Part B|Death|0|||
124785650|NCT00966875|448847922|FG004|Part B|Death|0|||
124785651|NCT00966875|448847923|FG005|Part B|Death|0|||
124785652|NCT00966875|448847924|FG006|Part B|Death|0|||
124785653|NCT00966875|448847925|FG007|Part B|Death|1|||
124785654|NCT00966875|448847926|FG008|Part B|Death|0|||
124785655|NCT00966875|448847918|FG000|Part B|Lack of Efficacy|2|||
124785656|NCT00966875|448847919|FG001|Part B|Lack of Efficacy|1|||
124785657|NCT00966875|448847920|FG002|Part B|Lack of Efficacy|1|||
124785658|NCT00966875|448847921|FG003|Part B|Lack of Efficacy|1|||
124785659|NCT00966875|448847922|FG004|Part B|Lack of Efficacy|2|||
124785660|NCT00966875|448847923|FG005|Part B|Lack of Efficacy|3|||
124785661|NCT00966875|448847924|FG006|Part B|Lack of Efficacy|12|||
124785662|NCT00966875|448847925|FG007|Part B|Lack of Efficacy|9|||
124785663|NCT00966875|448847926|FG008|Part B|Lack of Efficacy|6|||
124785664|NCT00966875|448847918|FG000|Part B|Lost to Follow-up|0|||
124785665|NCT00966875|448847919|FG001|Part B|Lost to Follow-up|0|||
124785666|NCT00966875|448847920|FG002|Part B|Lost to Follow-up|0|||
124785667|NCT00966875|448847921|FG003|Part B|Lost to Follow-up|1|||
124785668|NCT00966875|448847922|FG004|Part B|Lost to Follow-up|0|||
124785669|NCT00966875|448847923|FG005|Part B|Lost to Follow-up|0|||
124785670|NCT00966875|448847924|FG006|Part B|Lost to Follow-up|0|||
124785671|NCT00966875|448847925|FG007|Part B|Lost to Follow-up|0|||
124785672|NCT00966875|448847926|FG008|Part B|Lost to Follow-up|1|||
124785673|NCT00966875|448847918|FG000|Part B|Physician Decision|0|||
124785674|NCT00966875|448847919|FG001|Part B|Physician Decision|0|||
124785675|NCT00966875|448847920|FG002|Part B|Physician Decision|1|||
124785676|NCT00966875|448847921|FG003|Part B|Physician Decision|0|||
124785677|NCT00966875|448847922|FG004|Part B|Physician Decision|2|||
124785678|NCT00966875|448847923|FG005|Part B|Physician Decision|1|||
124785679|NCT00966875|448847924|FG006|Part B|Physician Decision|0|||
124785680|NCT00966875|448847925|FG007|Part B|Physician Decision|0|||
124785681|NCT00966875|448847926|FG008|Part B|Physician Decision|2|||
125292197|NCT00996801|450696556|FG005|Overall Study|Physician Decision|0|||
124785682|NCT00966875|448847918|FG000|Part B|Sponsor Decision|1|||
124785683|NCT00966875|448847919|FG001|Part B|Sponsor Decision|0|||
124785684|NCT00966875|448847920|FG002|Part B|Sponsor Decision|0|||
124785685|NCT00966875|448847921|FG003|Part B|Sponsor Decision|0|||
124785686|NCT00966875|448847922|FG004|Part B|Sponsor Decision|0|||
124785687|NCT00966875|448847923|FG005|Part B|Sponsor Decision|1|||
124785688|NCT00966875|448847924|FG006|Part B|Sponsor Decision|0|||
124785689|NCT00966875|448847925|FG007|Part B|Sponsor Decision|2|||
124785690|NCT00966875|448847926|FG008|Part B|Sponsor Decision|1|||
124785691|NCT00966875|448847918|FG000|Part B|Withdrawal by Subject|2|||
124785692|NCT00966875|448847919|FG001|Part B|Withdrawal by Subject|1|||
124785693|NCT00966875|448847920|FG002|Part B|Withdrawal by Subject|2|||
124785694|NCT00966875|448847921|FG003|Part B|Withdrawal by Subject|1|||
124785695|NCT00966875|448847922|FG004|Part B|Withdrawal by Subject|2|||
124785696|NCT00966875|448847923|FG005|Part B|Withdrawal by Subject|1|||
124785697|NCT00966875|448847924|FG006|Part B|Withdrawal by Subject|4|||
124785698|NCT00966875|448847925|FG007|Part B|Withdrawal by Subject|5|||
124785699|NCT00966875|448847926|FG008|Part B|Withdrawal by Subject|5|||
124785700|NCT00966875|448847918|FG000|Part B|Entry Criteria|0|||
124785701|NCT00966875|448847919|FG001|Part B|Entry Criteria|0|||
124785702|NCT00966875|448847920|FG002|Part B|Entry Criteria|0|||
124785703|NCT00966875|448847921|FG003|Part B|Entry Criteria|0|||
124785704|NCT00966875|448847922|FG004|Part B|Entry Criteria|0|||
124785705|NCT00966875|448847923|FG005|Part B|Entry Criteria|0|||
124785706|NCT00966875|448847924|FG006|Part B|Entry Criteria|1|||
124785707|NCT00966875|448847925|FG007|Part B|Entry Criteria|0|||
124785708|NCT00966875|448847926|FG008|Part B|Entry Criteria|1|||
124785709|NCT04657666|448847929|FG000|Period 1|Withdrawal of participant consent|2|||
124785710|NCT04657666|448847930|FG001|Period 1|Withdrawal of participant consent|1|||
124785711|NCT04657666|448847929|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
124785712|NCT04657666|448847930|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
124785713|NCT04657666|448847929|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
124785714|NCT04657666|448847930|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
124785715|NCT04657666|448847929|FG000|Period 2|Other|2|||
124785716|NCT04657666|448847930|FG001|Period 2|Other|0|||
124785717|NCT04657666|448847929|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
124785718|NCT04657666|448847930|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
124785719|NCT02386189|448847931|FG000|Overall Study|Lost to Follow-up|2|||
124785720|NCT02386189|448847932|FG001|Overall Study|Lost to Follow-up|3|||
124785721|NCT02386189|448847931|FG000|Overall Study|Withdrawal by Subject|1|||
124785722|NCT02386189|448847932|FG001|Overall Study|Withdrawal by Subject|0|||
124785723|NCT02386189|448847931|FG000|Overall Study|Death|1|||
124785724|NCT02386189|448847932|FG001|Overall Study|Death|0|||
124785725|NCT01659554|448847938|FG000|Overall Study|Study Termination|4|||
124785726|NCT01022398|448847941|FG000|Overall Study|Study terminated|2|||
124785727|NCT01022398|448847942|FG001|Overall Study|Study terminated|2|||
124785728|NCT01317550|448847943|FG000|Overall Study|Withdrawal by Subject|1|||
124785729|NCT01317550|448847944|FG001|Overall Study|Withdrawal by Subject|0|||
124785730|NCT01317550|448847945|FG002|Overall Study|Withdrawal by Subject|0|||
124785731|NCT01317550|448847946|FG003|Overall Study|Withdrawal by Subject|0|||
124785732|NCT01317550|448847943|FG000|Overall Study|Lack of compliance study med|1|||
124785733|NCT01317550|448847944|FG001|Overall Study|Lack of compliance study med|0|||
124785734|NCT01317550|448847945|FG002|Overall Study|Lack of compliance study med|0|||
124785735|NCT01317550|448847946|FG003|Overall Study|Lack of compliance study med|0|||
124785736|NCT03179202|448847947|FG000|Overall Study|Screen Failure|67|||
124785737|NCT03179202|448847947|FG000|Overall Study|Subject Lost to Follow Up|12|||
124785738|NCT03179202|448847947|FG000|Overall Study|Withdrawal by Subject|7|||
124785739|NCT03179202|448847947|FG000|Overall Study|Adverse Event|3|||
124785740|NCT03179202|448847947|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
124785741|NCT03179202|448847947|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
124785742|NCT01120782|448847948|FG000|Overall Study|Test article shipping error|11|||
124785743|NCT00640224|448847952|FG000|Overall Study|Lost to Follow-up|5|||
124785744|NCT00640224|448847953|FG001|Overall Study|Lost to Follow-up|2|||
124785745|NCT00640224|448847954|FG002|Overall Study|Lost to Follow-up|0|||
124785746|NCT00640224|448847955|FG003|Overall Study|Lost to Follow-up|0|||
124785747|NCT00640224|448847952|FG000|Overall Study|Withdrawal by Subject|1|||
124785748|NCT00640224|448847953|FG001|Overall Study|Withdrawal by Subject|0|||
124785749|NCT00640224|448847954|FG002|Overall Study|Withdrawal by Subject|0|||
124785750|NCT00640224|448847955|FG003|Overall Study|Withdrawal by Subject|0|||
124785751|NCT00640224|448847952|FG000|Overall Study|Headaches|0|||
124785752|NCT00640224|448847953|FG001|Overall Study|Headaches|1|||
124785753|NCT00640224|448847954|FG002|Overall Study|Headaches|0|||
124785754|NCT00640224|448847955|FG003|Overall Study|Headaches|0|||
124785755|NCT04224688|448847959|FG000|Overall Study|Withdrawal by Subject|1|||
124785756|NCT04224688|448847960|FG001|Overall Study|Withdrawal by Subject|3|||
124785757|NCT04224688|448847959|FG000|Overall Study|Lack of Efficacy|1|||
124785758|NCT04224688|448847960|FG001|Overall Study|Lack of Efficacy|1|||
124785759|NCT04224688|448847959|FG000|Overall Study|Adverse event, not fatal|0|||
124785760|NCT04224688|448847960|FG001|Overall Study|Adverse event, not fatal|2|||
124785761|NCT04224688|448847959|FG000|Overall Study|COVID-19|0|||
124785762|NCT04224688|448847960|FG001|Overall Study|COVID-19|1|||
124785763|NCT01024309|448847966|FG000|Overall Study|Physician Decision|4|||
124785764|NCT01024309|448847967|FG001|Overall Study|Physician Decision|0|||
124785765|NCT01024309|448847966|FG000|Overall Study|Withdrawal by Subject|4|||
124785766|NCT01024309|448847967|FG001|Overall Study|Withdrawal by Subject|4|||
124785767|NCT03232333|448847973|FG000|Overall Study|Infection or Osteomyelitis|9|||
124785768|NCT03232333|448847973|FG000|Overall Study|Lost to Follow-up|4|||
124785769|NCT03232333|448847973|FG000|Overall Study|Withdrawal by Subject|2|||
124785770|NCT00653432|448847977|FG000|Overall Study|Adverse Event|4|||
124785771|NCT00653432|448847978|FG001|Overall Study|Adverse Event|1|||
125292198|NCT00996801|450696551|FG000|Overall Study|Progressive Disease|0|||
124785772|NCT00653432|448847977|FG000|Overall Study|Withdrawal by Subject|4|||
124785773|NCT00653432|448847978|FG001|Overall Study|Withdrawal by Subject|5|||
124785774|NCT00653432|448847977|FG000|Overall Study|Lost to Follow-up|7|||
124785775|NCT00653432|448847978|FG001|Overall Study|Lost to Follow-up|6|||
124785776|NCT00653432|448847977|FG000|Overall Study|Use/Need of Con Therapy|2|||
124785777|NCT00653432|448847978|FG001|Overall Study|Use/Need of Con Therapy|1|||
124785778|NCT00653432|448847977|FG000|Overall Study|Other - Reason Not Provided|5|||
124785779|NCT00653432|448847978|FG001|Overall Study|Other - Reason Not Provided|3|||
124785780|NCT00567255|448847979|FG000|Overall Study|Adverse Event|241|||
124785781|NCT00567255|448847980|FG001|Overall Study|Adverse Event|68|||
124785782|NCT00567255|448847979|FG000|Overall Study|Lost to Follow-up|77|||
124785783|NCT00567255|448847980|FG001|Overall Study|Lost to Follow-up|48|||
124785784|NCT00567255|448847979|FG000|Overall Study|Withdrawal by Subject|75|||
124785785|NCT00567255|448847980|FG001|Overall Study|Withdrawal by Subject|56|||
124785786|NCT00567255|448847979|FG000|Overall Study|Lack of Efficacy|19|||
124785787|NCT00567255|448847980|FG001|Overall Study|Lack of Efficacy|33|||
124785788|NCT00567255|448847979|FG000|Overall Study|Protocol Violation|20|||
124785789|NCT00567255|448847980|FG001|Overall Study|Protocol Violation|8|||
124785790|NCT00567255|448847979|FG000|Overall Study|Pregnancy|6|||
124785791|NCT00567255|448847980|FG001|Overall Study|Pregnancy|0|||
124785792|NCT00567255|448847979|FG000|Overall Study|Drug noncompliance,moved,other|25|||
124785793|NCT00567255|448847980|FG001|Overall Study|Drug noncompliance,moved,other|15|||
124785794|NCT01290796|448847985|FG000|Overall Study|Lost to Follow-up|21|||
124785795|NCT01290796|448847985|FG000|Overall Study|Withdrawal by Subject|4|||
124785796|NCT01290796|448847985|FG000|Overall Study|Physician Decision|2|||
124785797|NCT01290796|448847985|FG000|Overall Study|Secondary Surgical Intervention|2|||
124785798|NCT01290796|448847985|FG000|Overall Study|Withdrawal by Sponsor|1|||
124785799|NCT02343549|448847986|FG000|Overall Study|Death|11|||
124785800|NCT02343549|448847986|FG000|Overall Study|Withdrawal by Subject|2|||
124785801|NCT03087617|448847987|FG000|Overall Study|Lost to Follow-up|32|||
124785802|NCT03087617|448847988|FG001|Overall Study|Lost to Follow-up|30|||
124785803|NCT03087617|448847989|FG002|Overall Study|Lost to Follow-up|30|||
124785804|NCT03087617|448847990|FG003|Overall Study|Lost to Follow-up|39|||
124785805|NCT01090323|448847992|FG000|Overall Study|Adverse Event|12|||
124785806|NCT01090323|448847993|FG001|Overall Study|Adverse Event|2|||
124785807|NCT01090323|448847992|FG000|Overall Study|Abnormal Lab Values|3|||
124785808|NCT01090323|448847993|FG001|Overall Study|Abnormal Lab Values|1|||
124785809|NCT01090323|448847992|FG000|Overall Study|Abnormal Test Procedure Results|2|||
124785810|NCT01090323|448847993|FG001|Overall Study|Abnormal Test Procedure Results|0|||
124785811|NCT01090323|448847992|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
124785812|NCT01090323|448847993|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124785813|NCT01090323|448847992|FG000|Overall Study|Condition no longer requires drug|5|||
124785814|NCT01090323|448847993|FG001|Overall Study|Condition no longer requires drug|4|||
124785815|NCT01090323|448847992|FG000|Overall Study|Protocol Violation|2|||
124785816|NCT01090323|448847993|FG001|Overall Study|Protocol Violation|1|||
124785817|NCT01090323|448847992|FG000|Overall Study|Withdrew consent|33|||
124785818|NCT01090323|448847993|FG001|Overall Study|Withdrew consent|11|||
124785819|NCT01090323|448847992|FG000|Overall Study|Lost to Follow-up|11|||
124785820|NCT01090323|448847993|FG001|Overall Study|Lost to Follow-up|6|||
124785821|NCT01090323|448847992|FG000|Overall Study|Administrative problems|6|||
124785822|NCT01090323|448847993|FG001|Overall Study|Administrative problems|4|||
124785823|NCT01090323|448847992|FG000|Overall Study|Death|1|||
124785824|NCT01090323|448847993|FG001|Overall Study|Death|2|||
124785825|NCT01090323|448847992|FG000|Overall Study|Stopped end of core|7|||
124785826|NCT01090323|448847993|FG001|Overall Study|Stopped end of core|0|||
124785827|NCT01090323|448847992|FG000|Overall Study|Stopped end of extension 1#|3|||
124785828|NCT01090323|448847993|FG001|Overall Study|Stopped end of extension 1#|1|||
124785829|NCT01864005|448847994|FG000|Overall Study|Protocol Violation|0|||
124785830|NCT01864005|448847995|FG001|Overall Study|Protocol Violation|1|||
124785831|NCT01864005|448847994|FG000|Overall Study|Withdrawal by Subject|0|||
124785832|NCT01864005|448847995|FG001|Overall Study|Withdrawal by Subject|1|||
124785833|NCT01864005|448847994|FG000|Overall Study|Incorrect enrolment|1|||
124785834|NCT01864005|448847995|FG001|Overall Study|Incorrect enrolment|0|||
124785835|NCT01864005|448847994|FG000|Overall Study|Disease need|1|||
124785836|NCT01864005|448847995|FG001|Overall Study|Disease need|1|||
124785837|NCT01864005|448847994|FG000|Overall Study|Need GP IIb/IIIa|1|||
124785838|NCT01864005|448847995|FG001|Overall Study|Need GP IIb/IIIa|3|||
124785839|NCT00763698|448847996|FG000|Overall Study|Unsuccessful Implant|5|||
124785840|NCT00763698|448847996|FG000|Overall Study|Death|4|||
124785841|NCT00763698|448847996|FG000|Overall Study|Withdrawal by Subject|1|||
124785842|NCT02059291|448847997|FG000|Epoch 2|Lack of Efficacy|0|||
124785843|NCT02059291|448847998|FG001|Epoch 2|Lack of Efficacy|0|||
124785844|NCT02059291|448847999|FG002|Epoch 2|Lack of Efficacy|0|||
124785845|NCT02059291|448848000|FG003|Epoch 2|Lack of Efficacy|1|||
124785846|NCT02059291|448848001|FG004|Epoch 2|Lack of Efficacy|0|||
124785847|NCT02059291|448848002|FG005|Epoch 2|Lack of Efficacy|1|||
124785848|NCT02059291|448848003|FG006|Epoch 2|Lack of Efficacy|0|||
124785849|NCT02059291|448848004|FG007|Epoch 2|Lack of Efficacy|0|||
124785850|NCT02059291|448848005|FG008|Epoch 2|Lack of Efficacy|0|||
124785851|NCT02059291|448848006|FG009|Epoch 2|Lack of Efficacy|0|||
124785852|NCT02059291|448848007|FG010|Epoch 2|Lack of Efficacy|0|||
124785853|NCT02059291|448848008|FG011|Epoch 2|Lack of Efficacy|0|||
124785854|NCT02059291|448848009|FG012|Epoch 2|Lack of Efficacy|0|||
124785855|NCT02059291|448848010|FG013|Epoch 2|Lack of Efficacy|0|||
124785856|NCT02059291|448848011|FG014|Epoch 2|Lack of Efficacy|0|||
124785857|NCT02059291|448848012|FG015|Epoch 2|Lack of Efficacy|0|||
124785858|NCT02059291|448848013|FG016|Epoch 2|Lack of Efficacy|0|||
124785859|NCT02059291|448848014|FG017|Epoch 2|Lack of Efficacy|0|||
124785860|NCT02059291|448848015|FG018|Epoch 2|Lack of Efficacy|0|||
124785861|NCT02059291|448848016|FG019|Epoch 2|Lack of Efficacy|0|||
124785862|NCT02059291|448848017|FG020|Epoch 2|Lack of Efficacy|0|||
124785863|NCT02059291|448848018|FG021|Epoch 2|Lack of Efficacy|0|||
124785864|NCT02059291|448848019|FG022|Epoch 2|Lack of Efficacy|0|||
124785865|NCT02059291|448848020|FG023|Epoch 2|Lack of Efficacy|0|||
124785866|NCT02059291|448848021|FG024|Epoch 2|Lack of Efficacy|0|||
124785867|NCT02059291|448847997|FG000|Epoch 2|Adverse Event|0|||
124785868|NCT02059291|448847998|FG001|Epoch 2|Adverse Event|0|||
124785869|NCT02059291|448847999|FG002|Epoch 2|Adverse Event|1|||
124785870|NCT02059291|448848000|FG003|Epoch 2|Adverse Event|1|||
124785871|NCT02059291|448848001|FG004|Epoch 2|Adverse Event|0|||
124785872|NCT02059291|448848002|FG005|Epoch 2|Adverse Event|0|||
124785873|NCT02059291|448848003|FG006|Epoch 2|Adverse Event|0|||
124785874|NCT02059291|448848004|FG007|Epoch 2|Adverse Event|1|||
124785875|NCT02059291|448848005|FG008|Epoch 2|Adverse Event|1|||
124785876|NCT02059291|448848006|FG009|Epoch 2|Adverse Event|0|||
124785877|NCT02059291|448848007|FG010|Epoch 2|Adverse Event|0|||
124785878|NCT02059291|448848008|FG011|Epoch 2|Adverse Event|0|||
124785879|NCT02059291|448848009|FG012|Epoch 2|Adverse Event|0|||
124785880|NCT02059291|448848010|FG013|Epoch 2|Adverse Event|0|||
124785881|NCT02059291|448848011|FG014|Epoch 2|Adverse Event|0|||
124785882|NCT02059291|448848012|FG015|Epoch 2|Adverse Event|0|||
124785883|NCT02059291|448848013|FG016|Epoch 2|Adverse Event|0|||
124785884|NCT02059291|448848014|FG017|Epoch 2|Adverse Event|0|||
124785885|NCT02059291|448848015|FG018|Epoch 2|Adverse Event|0|||
124785886|NCT02059291|448848016|FG019|Epoch 2|Adverse Event|0|||
124785887|NCT02059291|448848017|FG020|Epoch 2|Adverse Event|0|||
124785888|NCT02059291|448848018|FG021|Epoch 2|Adverse Event|0|||
124785889|NCT02059291|448848019|FG022|Epoch 2|Adverse Event|0|||
124785890|NCT02059291|448848020|FG023|Epoch 2|Adverse Event|0|||
124785891|NCT02059291|448848021|FG024|Epoch 2|Adverse Event|0|||
124785892|NCT02059291|448847997|FG000|Epoch 2|Withdrawal by Subject|0|||
124785893|NCT02059291|448847998|FG001|Epoch 2|Withdrawal by Subject|1|||
124785894|NCT02059291|448847999|FG002|Epoch 2|Withdrawal by Subject|0|||
124785895|NCT02059291|448848000|FG003|Epoch 2|Withdrawal by Subject|0|||
124785896|NCT02059291|448848001|FG004|Epoch 2|Withdrawal by Subject|0|||
124785897|NCT02059291|448848002|FG005|Epoch 2|Withdrawal by Subject|1|||
124785898|NCT02059291|448848003|FG006|Epoch 2|Withdrawal by Subject|0|||
124785899|NCT02059291|448848004|FG007|Epoch 2|Withdrawal by Subject|0|||
124785900|NCT02059291|448848005|FG008|Epoch 2|Withdrawal by Subject|1|||
124785901|NCT02059291|448848006|FG009|Epoch 2|Withdrawal by Subject|0|||
124785902|NCT02059291|448848007|FG010|Epoch 2|Withdrawal by Subject|0|||
124785903|NCT02059291|448848008|FG011|Epoch 2|Withdrawal by Subject|0|||
124785904|NCT02059291|448848009|FG012|Epoch 2|Withdrawal by Subject|0|||
124785905|NCT02059291|448848010|FG013|Epoch 2|Withdrawal by Subject|0|||
124785906|NCT02059291|448848011|FG014|Epoch 2|Withdrawal by Subject|0|||
124785907|NCT02059291|448848012|FG015|Epoch 2|Withdrawal by Subject|0|||
124785908|NCT02059291|448848013|FG016|Epoch 2|Withdrawal by Subject|0|||
124785909|NCT02059291|448848014|FG017|Epoch 2|Withdrawal by Subject|0|||
124785910|NCT02059291|448848015|FG018|Epoch 2|Withdrawal by Subject|0|||
124785911|NCT02059291|448848016|FG019|Epoch 2|Withdrawal by Subject|0|||
124785912|NCT02059291|448848017|FG020|Epoch 2|Withdrawal by Subject|0|||
124785913|NCT02059291|448848018|FG021|Epoch 2|Withdrawal by Subject|0|||
124785914|NCT02059291|448848019|FG022|Epoch 2|Withdrawal by Subject|0|||
124785915|NCT02059291|448848020|FG023|Epoch 2|Withdrawal by Subject|0|||
124785916|NCT02059291|448848021|FG024|Epoch 2|Withdrawal by Subject|0|||
124785917|NCT02059291|448847997|FG000|Epoch 3|Physician Decision|0|||
124785918|NCT02059291|448847998|FG001|Epoch 3|Physician Decision|0|||
124785919|NCT02059291|448847999|FG002|Epoch 3|Physician Decision|0|||
124785920|NCT02059291|448848000|FG003|Epoch 3|Physician Decision|0|||
124785921|NCT02059291|448848001|FG004|Epoch 3|Physician Decision|0|||
124785922|NCT02059291|448848002|FG005|Epoch 3|Physician Decision|0|||
124785923|NCT02059291|448848003|FG006|Epoch 3|Physician Decision|0|||
124785924|NCT02059291|448848004|FG007|Epoch 3|Physician Decision|0|||
124785925|NCT02059291|448848005|FG008|Epoch 3|Physician Decision|0|||
124785926|NCT02059291|448848006|FG009|Epoch 3|Physician Decision|0|||
124785927|NCT02059291|448848007|FG010|Epoch 3|Physician Decision|0|||
124785928|NCT02059291|448848008|FG011|Epoch 3|Physician Decision|0|||
124785929|NCT02059291|448848009|FG012|Epoch 3|Physician Decision|0|||
124785930|NCT02059291|448848010|FG013|Epoch 3|Physician Decision|1|||
124785931|NCT02059291|448848011|FG014|Epoch 3|Physician Decision|0|||
124785932|NCT02059291|448848012|FG015|Epoch 3|Physician Decision|1|||
124785933|NCT02059291|448848013|FG016|Epoch 3|Physician Decision|0|||
124785934|NCT02059291|448848014|FG017|Epoch 3|Physician Decision|0|||
124785935|NCT02059291|448848015|FG018|Epoch 3|Physician Decision|0|||
124785936|NCT02059291|448848016|FG019|Epoch 3|Physician Decision|0|||
124785937|NCT02059291|448848017|FG020|Epoch 3|Physician Decision|0|||
124785938|NCT02059291|448848018|FG021|Epoch 3|Physician Decision|0|||
124785939|NCT02059291|448848019|FG022|Epoch 3|Physician Decision|0|||
124785940|NCT02059291|448848020|FG023|Epoch 3|Physician Decision|0|||
124785941|NCT02059291|448848021|FG024|Epoch 3|Physician Decision|0|||
124785942|NCT02059291|448847997|FG000|Epoch 3|Adverse Event|0|||
124785943|NCT02059291|448847998|FG001|Epoch 3|Adverse Event|0|||
124785944|NCT02059291|448847999|FG002|Epoch 3|Adverse Event|0|||
124785945|NCT02059291|448848000|FG003|Epoch 3|Adverse Event|0|||
124785946|NCT02059291|448848001|FG004|Epoch 3|Adverse Event|0|||
124785947|NCT02059291|448848002|FG005|Epoch 3|Adverse Event|0|||
124785948|NCT02059291|448848003|FG006|Epoch 3|Adverse Event|0|||
124785949|NCT02059291|448848004|FG007|Epoch 3|Adverse Event|0|||
124785950|NCT02059291|448848005|FG008|Epoch 3|Adverse Event|0|||
124785951|NCT02059291|448848006|FG009|Epoch 3|Adverse Event|0|||
124785952|NCT02059291|448848007|FG010|Epoch 3|Adverse Event|0|||
124785953|NCT02059291|448848008|FG011|Epoch 3|Adverse Event|0|||
124785954|NCT02059291|448848009|FG012|Epoch 3|Adverse Event|0|||
124785955|NCT02059291|448848010|FG013|Epoch 3|Adverse Event|0|||
124785956|NCT02059291|448848011|FG014|Epoch 3|Adverse Event|0|||
124785957|NCT02059291|448848012|FG015|Epoch 3|Adverse Event|1|||
124785958|NCT02059291|448848013|FG016|Epoch 3|Adverse Event|0|||
124785959|NCT02059291|448848014|FG017|Epoch 3|Adverse Event|0|||
124785960|NCT02059291|448848015|FG018|Epoch 3|Adverse Event|0|||
124785961|NCT02059291|448848016|FG019|Epoch 3|Adverse Event|0|||
124785962|NCT02059291|448848017|FG020|Epoch 3|Adverse Event|0|||
124785963|NCT02059291|448848018|FG021|Epoch 3|Adverse Event|0|||
124785964|NCT02059291|448848019|FG022|Epoch 3|Adverse Event|0|||
124785965|NCT02059291|448848020|FG023|Epoch 3|Adverse Event|0|||
124785966|NCT02059291|448848021|FG024|Epoch 3|Adverse Event|0|||
124785967|NCT02059291|448847997|FG000|Epoch 3|Lack of Efficacy|0|||
124785968|NCT02059291|448847998|FG001|Epoch 3|Lack of Efficacy|0|||
124785969|NCT02059291|448847999|FG002|Epoch 3|Lack of Efficacy|0|||
124785970|NCT02059291|448848000|FG003|Epoch 3|Lack of Efficacy|0|||
124785971|NCT02059291|448848001|FG004|Epoch 3|Lack of Efficacy|0|||
124785972|NCT02059291|448848002|FG005|Epoch 3|Lack of Efficacy|0|||
124785973|NCT02059291|448848003|FG006|Epoch 3|Lack of Efficacy|0|||
124785974|NCT02059291|448848004|FG007|Epoch 3|Lack of Efficacy|0|||
124785975|NCT02059291|448848005|FG008|Epoch 3|Lack of Efficacy|0|||
124785976|NCT02059291|448848006|FG009|Epoch 3|Lack of Efficacy|0|||
124785977|NCT02059291|448848007|FG010|Epoch 3|Lack of Efficacy|0|||
124785978|NCT02059291|448848008|FG011|Epoch 3|Lack of Efficacy|0|||
124785979|NCT02059291|448848009|FG012|Epoch 3|Lack of Efficacy|0|||
124785980|NCT02059291|448848010|FG013|Epoch 3|Lack of Efficacy|0|||
124785981|NCT02059291|448848011|FG014|Epoch 3|Lack of Efficacy|0|||
124785982|NCT02059291|448848012|FG015|Epoch 3|Lack of Efficacy|3|||
124785983|NCT02059291|448848013|FG016|Epoch 3|Lack of Efficacy|0|||
124785984|NCT02059291|448848014|FG017|Epoch 3|Lack of Efficacy|0|||
124785985|NCT02059291|448848015|FG018|Epoch 3|Lack of Efficacy|0|||
124785986|NCT02059291|448848016|FG019|Epoch 3|Lack of Efficacy|0|||
124785987|NCT02059291|448848017|FG020|Epoch 3|Lack of Efficacy|0|||
124785988|NCT02059291|448848018|FG021|Epoch 3|Lack of Efficacy|0|||
124785989|NCT02059291|448848019|FG022|Epoch 3|Lack of Efficacy|0|||
124785990|NCT02059291|448848020|FG023|Epoch 3|Lack of Efficacy|0|||
124785991|NCT02059291|448848021|FG024|Epoch 3|Lack of Efficacy|0|||
124785992|NCT02059291|448847997|FG000|Epoch 3|Withdrawal by Subject|0|||
124785993|NCT02059291|448847998|FG001|Epoch 3|Withdrawal by Subject|0|||
125292199|NCT00996801|450696552|FG001|Overall Study|Progressive Disease|1|||
124785994|NCT02059291|448847999|FG002|Epoch 3|Withdrawal by Subject|0|||
124785995|NCT02059291|448848000|FG003|Epoch 3|Withdrawal by Subject|0|||
124785996|NCT02059291|448848001|FG004|Epoch 3|Withdrawal by Subject|0|||
124785997|NCT02059291|448848002|FG005|Epoch 3|Withdrawal by Subject|0|||
125292200|NCT00996801|450696553|FG002|Overall Study|Progressive Disease|0|||
124785998|NCT02059291|448848003|FG006|Epoch 3|Withdrawal by Subject|0|||
124785999|NCT02059291|448848004|FG007|Epoch 3|Withdrawal by Subject|0|||
124786000|NCT02059291|448848005|FG008|Epoch 3|Withdrawal by Subject|0|||
124786001|NCT02059291|448848006|FG009|Epoch 3|Withdrawal by Subject|0|||
124786002|NCT02059291|448848007|FG010|Epoch 3|Withdrawal by Subject|0|||
124786003|NCT02059291|448848008|FG011|Epoch 3|Withdrawal by Subject|0|||
124786004|NCT02059291|448848009|FG012|Epoch 3|Withdrawal by Subject|0|||
124786005|NCT02059291|448848010|FG013|Epoch 3|Withdrawal by Subject|0|||
124786006|NCT02059291|448848011|FG014|Epoch 3|Withdrawal by Subject|0|||
124786007|NCT02059291|448848012|FG015|Epoch 3|Withdrawal by Subject|1|||
124786008|NCT02059291|448848013|FG016|Epoch 3|Withdrawal by Subject|0|||
124786009|NCT02059291|448848014|FG017|Epoch 3|Withdrawal by Subject|0|||
124786010|NCT02059291|448848015|FG018|Epoch 3|Withdrawal by Subject|0|||
124786011|NCT02059291|448848016|FG019|Epoch 3|Withdrawal by Subject|0|||
124786012|NCT02059291|448848017|FG020|Epoch 3|Withdrawal by Subject|0|||
124786013|NCT02059291|448848018|FG021|Epoch 3|Withdrawal by Subject|0|||
124786014|NCT02059291|448848019|FG022|Epoch 3|Withdrawal by Subject|0|||
124786015|NCT02059291|448848020|FG023|Epoch 3|Withdrawal by Subject|0|||
124786016|NCT02059291|448848021|FG024|Epoch 3|Withdrawal by Subject|0|||
124786017|NCT02059291|448847997|FG000|Epoch 4|Adverse Event|0|||
124786018|NCT02059291|448847998|FG001|Epoch 4|Adverse Event|0|||
124786019|NCT02059291|448847999|FG002|Epoch 4|Adverse Event|0|||
124786020|NCT02059291|448848000|FG003|Epoch 4|Adverse Event|0|||
124786021|NCT02059291|448848001|FG004|Epoch 4|Adverse Event|0|||
124786022|NCT02059291|448848002|FG005|Epoch 4|Adverse Event|0|||
124786023|NCT02059291|448848003|FG006|Epoch 4|Adverse Event|0|||
124786024|NCT02059291|448848004|FG007|Epoch 4|Adverse Event|0|||
124786025|NCT02059291|448848005|FG008|Epoch 4|Adverse Event|0|||
124786026|NCT02059291|448848006|FG009|Epoch 4|Adverse Event|0|||
124786027|NCT02059291|448848007|FG010|Epoch 4|Adverse Event|0|||
124786028|NCT02059291|448848008|FG011|Epoch 4|Adverse Event|0|||
124786029|NCT02059291|448848009|FG012|Epoch 4|Adverse Event|0|||
124786030|NCT02059291|448848010|FG013|Epoch 4|Adverse Event|0|||
124786031|NCT02059291|448848011|FG014|Epoch 4|Adverse Event|0|||
124786032|NCT02059291|448848012|FG015|Epoch 4|Adverse Event|0|||
124786033|NCT02059291|448848013|FG016|Epoch 4|Adverse Event|1|||
124786034|NCT02059291|448848014|FG017|Epoch 4|Adverse Event|0|||
124786035|NCT02059291|448848015|FG018|Epoch 4|Adverse Event|0|||
124786036|NCT02059291|448848016|FG019|Epoch 4|Adverse Event|0|||
124786037|NCT02059291|448848017|FG020|Epoch 4|Adverse Event|0|||
124786038|NCT02059291|448848018|FG021|Epoch 4|Adverse Event|0|||
124786039|NCT02059291|448848019|FG022|Epoch 4|Adverse Event|1|||
124786040|NCT02059291|448848020|FG023|Epoch 4|Adverse Event|0|||
124786041|NCT02059291|448848021|FG024|Epoch 4|Adverse Event|0|||
124786042|NCT02059291|448847997|FG000|Epoch 4|Pregnancy|0|||
124786043|NCT02059291|448847998|FG001|Epoch 4|Pregnancy|0|||
124786044|NCT02059291|448847999|FG002|Epoch 4|Pregnancy|0|||
124786045|NCT02059291|448848000|FG003|Epoch 4|Pregnancy|0|||
124786046|NCT02059291|448848001|FG004|Epoch 4|Pregnancy|0|||
124786047|NCT02059291|448848002|FG005|Epoch 4|Pregnancy|0|||
124786048|NCT02059291|448848003|FG006|Epoch 4|Pregnancy|0|||
124786049|NCT02059291|448848004|FG007|Epoch 4|Pregnancy|0|||
124786050|NCT02059291|448848005|FG008|Epoch 4|Pregnancy|0|||
124786051|NCT02059291|448848006|FG009|Epoch 4|Pregnancy|0|||
124786052|NCT02059291|448848007|FG010|Epoch 4|Pregnancy|0|||
124786053|NCT02059291|448848008|FG011|Epoch 4|Pregnancy|0|||
124786054|NCT02059291|448848009|FG012|Epoch 4|Pregnancy|0|||
124786055|NCT02059291|448848010|FG013|Epoch 4|Pregnancy|0|||
124786056|NCT02059291|448848011|FG014|Epoch 4|Pregnancy|0|||
124786057|NCT02059291|448848012|FG015|Epoch 4|Pregnancy|0|||
124786058|NCT02059291|448848013|FG016|Epoch 4|Pregnancy|1|||
124786059|NCT02059291|448848014|FG017|Epoch 4|Pregnancy|0|||
124786060|NCT02059291|448848015|FG018|Epoch 4|Pregnancy|0|||
124786061|NCT02059291|448848016|FG019|Epoch 4|Pregnancy|0|||
124786062|NCT02059291|448848017|FG020|Epoch 4|Pregnancy|0|||
124786063|NCT02059291|448848018|FG021|Epoch 4|Pregnancy|0|||
124786064|NCT02059291|448848019|FG022|Epoch 4|Pregnancy|0|||
124786065|NCT02059291|448848020|FG023|Epoch 4|Pregnancy|0|||
124786066|NCT02059291|448848021|FG024|Epoch 4|Pregnancy|0|||
124786067|NCT02059291|448847997|FG000|Epoch 4|Withdrawal by Subject|0|||
124786068|NCT02059291|448847998|FG001|Epoch 4|Withdrawal by Subject|0|||
124786069|NCT02059291|448847999|FG002|Epoch 4|Withdrawal by Subject|0|||
124786070|NCT02059291|448848000|FG003|Epoch 4|Withdrawal by Subject|0|||
124786071|NCT02059291|448848001|FG004|Epoch 4|Withdrawal by Subject|0|||
124786072|NCT02059291|448848002|FG005|Epoch 4|Withdrawal by Subject|0|||
124786073|NCT02059291|448848003|FG006|Epoch 4|Withdrawal by Subject|0|||
124786074|NCT02059291|448848004|FG007|Epoch 4|Withdrawal by Subject|0|||
124786075|NCT02059291|448848005|FG008|Epoch 4|Withdrawal by Subject|0|||
124786076|NCT02059291|448848006|FG009|Epoch 4|Withdrawal by Subject|0|||
124786077|NCT02059291|448848007|FG010|Epoch 4|Withdrawal by Subject|0|||
124786078|NCT02059291|448848008|FG011|Epoch 4|Withdrawal by Subject|0|||
124786079|NCT02059291|448848009|FG012|Epoch 4|Withdrawal by Subject|0|||
124786080|NCT02059291|448848010|FG013|Epoch 4|Withdrawal by Subject|0|||
124786081|NCT02059291|448848011|FG014|Epoch 4|Withdrawal by Subject|0|||
124786082|NCT02059291|448848012|FG015|Epoch 4|Withdrawal by Subject|0|||
124786083|NCT02059291|448848013|FG016|Epoch 4|Withdrawal by Subject|0|||
124786084|NCT02059291|448848014|FG017|Epoch 4|Withdrawal by Subject|0|||
124786085|NCT02059291|448848015|FG018|Epoch 4|Withdrawal by Subject|0|||
124786086|NCT02059291|448848016|FG019|Epoch 4|Withdrawal by Subject|0|||
124786087|NCT02059291|448848017|FG020|Epoch 4|Withdrawal by Subject|1|||
124786088|NCT02059291|448848018|FG021|Epoch 4|Withdrawal by Subject|0|||
124786089|NCT02059291|448848019|FG022|Epoch 4|Withdrawal by Subject|0|||
124786090|NCT02059291|448848020|FG023|Epoch 4|Withdrawal by Subject|0|||
124786091|NCT02059291|448848021|FG024|Epoch 4|Withdrawal by Subject|0|||
124786092|NCT02059291|448847997|FG000|Epoch 4|Lack of Efficacy|0|||
124786093|NCT02059291|448847998|FG001|Epoch 4|Lack of Efficacy|0|||
124786094|NCT02059291|448847999|FG002|Epoch 4|Lack of Efficacy|0|||
124786095|NCT02059291|448848000|FG003|Epoch 4|Lack of Efficacy|0|||
124786096|NCT02059291|448848001|FG004|Epoch 4|Lack of Efficacy|0|||
124786097|NCT02059291|448848002|FG005|Epoch 4|Lack of Efficacy|0|||
124786098|NCT02059291|448848003|FG006|Epoch 4|Lack of Efficacy|0|||
124786099|NCT02059291|448848004|FG007|Epoch 4|Lack of Efficacy|0|||
124786100|NCT02059291|448848005|FG008|Epoch 4|Lack of Efficacy|0|||
124786101|NCT02059291|448848006|FG009|Epoch 4|Lack of Efficacy|0|||
124786102|NCT02059291|448848007|FG010|Epoch 4|Lack of Efficacy|0|||
124786103|NCT02059291|448848008|FG011|Epoch 4|Lack of Efficacy|0|||
124786104|NCT02059291|448848009|FG012|Epoch 4|Lack of Efficacy|0|||
124786105|NCT02059291|448848010|FG013|Epoch 4|Lack of Efficacy|0|||
124786106|NCT02059291|448848011|FG014|Epoch 4|Lack of Efficacy|0|||
124786107|NCT02059291|448848012|FG015|Epoch 4|Lack of Efficacy|0|||
124786108|NCT02059291|448848013|FG016|Epoch 4|Lack of Efficacy|0|||
124786109|NCT02059291|448848014|FG017|Epoch 4|Lack of Efficacy|0|||
124786110|NCT02059291|448848015|FG018|Epoch 4|Lack of Efficacy|0|||
124786111|NCT02059291|448848016|FG019|Epoch 4|Lack of Efficacy|0|||
124786112|NCT02059291|448848017|FG020|Epoch 4|Lack of Efficacy|0|||
124786113|NCT02059291|448848018|FG021|Epoch 4|Lack of Efficacy|0|||
124786114|NCT02059291|448848019|FG022|Epoch 4|Lack of Efficacy|0|||
124786115|NCT02059291|448848020|FG023|Epoch 4|Lack of Efficacy|1|||
124786116|NCT02059291|448848021|FG024|Epoch 4|Lack of Efficacy|0|||
124786117|NCT01433289|448848022|FG000|Overall Study|Pregnancy|0|||
124786118|NCT01433289|448848023|FG001|Overall Study|Pregnancy|1|||
124786119|NCT01433289|448848024|FG002|Overall Study|Pregnancy|0|||
124786120|NCT01433289|448848025|FG003|Overall Study|Pregnancy|0|||
124786121|NCT03241368|448848026|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
124786122|NCT03241368|448848026|FG000|Overall Study|Lost to Follow-up|1|||
124786123|NCT03241368|448848026|FG000|Overall Study|Physician Decision|6|||
124786124|NCT03241368|448848026|FG000|Overall Study|Withdrawal by Subject|6|||
124786125|NCT03241368|448848026|FG000|Overall Study|Protocol Violation|1|||
124786126|NCT00080899|448848029|FG000|Overall Study|Adverse Event|1|||
124786127|NCT00787267|448848031|FG000|Overall Study|Screen failure/Ineligible|10|||
124786128|NCT00787267|448848031|FG000|Overall Study|No Reason Provided|1|||
124786129|NCT00787267|448848031|FG000|Overall Study|Withdrawal by Subject|1|||
124786130|NCT04343235|448848032|FG000|Overall Study|Lost to Follow-up|3|||
124786131|NCT04343235|448848033|FG001|Overall Study|Lost to Follow-up|2|||
124786132|NCT00865280|448848034|FG000|Overall Study|Withdrawal by Subject|4|||
124786133|NCT00865280|448848035|FG001|Overall Study|Withdrawal by Subject|1|||
124786134|NCT00865280|448848034|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
124786135|NCT00865280|448848035|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
124786136|NCT00865280|448848034|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
124786137|NCT00865280|448848035|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
124786138|NCT00865280|448848034|FG000|Overall Study|Exclusion Condition|1|||
124786139|NCT00865280|448848035|FG001|Overall Study|Exclusion Condition|0|||
124786140|NCT00865280|448848034|FG000|Overall Study|Adverse Event|0|||
124786141|NCT00865280|448848035|FG001|Overall Study|Adverse Event|1|||
124786142|NCT01616693|448848036|FG000|Evaluated for Safety|Physician Decision|1|||
124786143|NCT01616693|448848037|FG001|Evaluated for Safety|Physician Decision|0|||
124786144|NCT01616693|448848038|FG002|Evaluated for Safety|Physician Decision|1|||
124786145|NCT01616693|448848039|FG003|Evaluated for Safety|Physician Decision|0|||
124786146|NCT01616693|448848036|FG000|Received Both Vaccines|Adverse Event|2|||
124786147|NCT01616693|448848037|FG001|Received Both Vaccines|Adverse Event|0|||
124786148|NCT01616693|448848038|FG002|Received Both Vaccines|Adverse Event|0|||
124786149|NCT01616693|448848039|FG003|Received Both Vaccines|Adverse Event|0|||
124786150|NCT01616693|448848036|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
124786151|NCT01616693|448848037|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
124786152|NCT01616693|448848038|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
124786153|NCT01616693|448848039|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
124786154|NCT01616693|448848036|FG000|Received Both Vaccines|Lost to Follow-up|4|||
124786155|NCT01616693|448848037|FG001|Received Both Vaccines|Lost to Follow-up|3|||
124786156|NCT01616693|448848038|FG002|Received Both Vaccines|Lost to Follow-up|4|||
124786157|NCT01616693|448848039|FG003|Received Both Vaccines|Lost to Follow-up|4|||
124786158|NCT01616693|448848036|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
124786159|NCT01616693|448848037|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
124786160|NCT01616693|448848038|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
124786161|NCT01616693|448848039|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
124786162|NCT00653939|448848040|FG000|Overall Study|Adverse Event|1|||
124786163|NCT00653939|448848041|FG001|Overall Study|Adverse Event|3|||
124786164|NCT00653939|448848040|FG000|Overall Study|Withdrawal by Subject|3|||
124786165|NCT00653939|448848041|FG001|Overall Study|Withdrawal by Subject|3|||
124786166|NCT00653939|448848040|FG000|Overall Study|Physician Decision|4|||
124786167|NCT00653939|448848041|FG001|Overall Study|Physician Decision|0|||
124786168|NCT00653939|448848040|FG000|Overall Study|Disease Progression|2|||
124786169|NCT00653939|448848041|FG001|Overall Study|Disease Progression|3|||
124786170|NCT00653939|448848040|FG000|Overall Study|Other|2|||
124786171|NCT00653939|448848041|FG001|Overall Study|Other|6|||
124786172|NCT01105767|448848042|FG000|Overall Study|Lost to Follow-up|1160|||
124786173|NCT01105767|448848043|FG001|Overall Study|Lost to Follow-up|1614|||
124786174|NCT01105767|448848044|FG002|Overall Study|Lost to Follow-up|1184|||
124786175|NCT00743106|448848045|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
124786176|NCT00743106|448848046|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
124786177|NCT02874144|448848051|FG000|Overall Study|Lost to Follow-up|3|||
124786178|NCT02874144|448848052|FG001|Overall Study|Lost to Follow-up|5|||
124786179|NCT00486811|448848053|FG000|Overall Study|Adverse Event|28|||
124786180|NCT00486811|448848054|FG001|Overall Study|Adverse Event|60|||
124786181|NCT00486811|448848055|FG002|Overall Study|Adverse Event|135|||
124786182|NCT00486811|448848053|FG000|Overall Study|Lack of Efficacy|34|||
124786183|NCT00486811|448848054|FG001|Overall Study|Lack of Efficacy|14|||
124786184|NCT00486811|448848055|FG002|Overall Study|Lack of Efficacy|7|||
124786185|NCT00486811|448848053|FG000|Overall Study|Lost to Follow-up|4|||
124786186|NCT00486811|448848054|FG001|Overall Study|Lost to Follow-up|6|||
124786187|NCT00486811|448848055|FG002|Overall Study|Lost to Follow-up|4|||
124786188|NCT00486811|448848053|FG000|Overall Study|Withdrawal by Subject|33|||
124786189|NCT00486811|448848054|FG001|Overall Study|Withdrawal by Subject|44|||
124786190|NCT00486811|448848055|FG002|Overall Study|Withdrawal by Subject|58|||
124786191|NCT00486811|448848053|FG000|Overall Study|Study drug non-compliant|5|||
124786192|NCT00486811|448848054|FG001|Overall Study|Study drug non-compliant|6|||
124786193|NCT00486811|448848055|FG002|Overall Study|Study drug non-compliant|3|||
124786194|NCT00486811|448848053|FG000|Overall Study|All other|18|||
124786195|NCT00486811|448848054|FG001|Overall Study|All other|11|||
124786196|NCT00486811|448848055|FG002|Overall Study|All other|7|||
124786197|NCT03753789|448848058|FG000|Overall Study|Withdrawal by Subject|2|||
124786198|NCT01711216|448848065|FG000|Overall Study|Adverse Event|4|||
124786199|NCT01711216|448848065|FG000|Overall Study|Pregnancy|56|||
124786200|NCT01711216|448848065|FG000|Overall Study|Withdrawal by Subject|6|||
124786201|NCT01711216|448848065|FG000|Overall Study|Lost to Follow-up|46|||
124786202|NCT01711216|448848065|FG000|Overall Study|variety of other minor reasons|83|||
124786203|NCT01711216|448848065|FG000|Overall Study|no reason specified|22|||
124786204|NCT00946153|448848067|FG000|Phase 2|Adverse Event|0|||
124786205|NCT00946153|448848068|FG001|Phase 2|Adverse Event|0|||
124786206|NCT00946153|448848069|FG002|Phase 2|Adverse Event|0|||
124786207|NCT00946153|448848070|FG003|Phase 2|Adverse Event|0|||
124786208|NCT00946153|448848071|FG004|Phase 2|Adverse Event|6|||
124786209|NCT00946153|448848067|FG000|Phase 2|Need more reduction of dose|0|||
124786210|NCT00946153|448848068|FG001|Phase 2|Need more reduction of dose|0|||
124786211|NCT00946153|448848069|FG002|Phase 2|Need more reduction of dose|0|||
124786212|NCT00946153|448848070|FG003|Phase 2|Need more reduction of dose|0|||
124786213|NCT00946153|448848071|FG004|Phase 2|Need more reduction of dose|2|||
124786214|NCT00946153|448848067|FG000|Phase 2|Physician Decision|0|||
124786215|NCT00946153|448848068|FG001|Phase 2|Physician Decision|0|||
124786216|NCT00946153|448848069|FG002|Phase 2|Physician Decision|0|||
124786217|NCT00946153|448848070|FG003|Phase 2|Physician Decision|0|||
124786218|NCT00946153|448848071|FG004|Phase 2|Physician Decision|1|||
124786219|NCT00946153|448848067|FG000|Phase 2|14 days washout for recovery due to AE|0|||
124786220|NCT00946153|448848068|FG001|Phase 2|14 days washout for recovery due to AE|0|||
124786221|NCT00946153|448848069|FG002|Phase 2|14 days washout for recovery due to AE|0|||
124786222|NCT00946153|448848070|FG003|Phase 2|14 days washout for recovery due to AE|0|||
124786223|NCT00946153|448848071|FG004|Phase 2|14 days washout for recovery due to AE|4|||
124786224|NCT01030666|448848072|FG000|Overall Study|Lost to Follow-up|3|||
124786225|NCT01030666|448848073|FG001|Overall Study|Lost to Follow-up|2|||
124786226|NCT03698591|448848075|FG000|Overall Study|Withdrawal by Subject|2|||
124786227|NCT03698591|448848076|FG001|Overall Study|Withdrawal by Subject|2|||
124786228|NCT03698591|448848075|FG000|Overall Study|Failed drug screen|1|||
124786229|NCT03698591|448848076|FG001|Overall Study|Failed drug screen|1|||
124786230|NCT03698591|448848075|FG000|Overall Study|Failed health screen|0|||
124786231|NCT03698591|448848076|FG001|Overall Study|Failed health screen|1|||
124786232|NCT03698591|448848075|FG000|Overall Study|Ineligible for financial compensation|1|||
124786233|NCT03698591|448848076|FG001|Overall Study|Ineligible for financial compensation|0|||
124786234|NCT03698591|448848075|FG000|Overall Study|Equipment Error|1|||
124786235|NCT03698591|448848076|FG001|Overall Study|Equipment Error|0|||
124786236|NCT03698591|448848075|FG000|Overall Study|Could not establish TMS dosage|0|||
124786237|NCT03698591|448848076|FG001|Overall Study|Could not establish TMS dosage|1|||
124786238|NCT00831493|448848080|FG000|Overall Study|Intractable nausea and vomiting|1|||
124786239|NCT00557856|448848087|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
124786240|NCT00557856|448848088|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
124786241|NCT00557856|448848089|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
124786242|NCT00557856|448848090|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
124786243|NCT00557856|448848091|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
124786244|NCT00557856|448848092|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
124786245|NCT00557856|448848093|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
124786246|NCT00557856|448848094|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
124786247|NCT00557856|448848095|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
124786248|NCT00557856|448848087|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
124786249|NCT00557856|448848088|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
124786250|NCT00557856|448848089|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
124786251|NCT00557856|448848090|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
124786252|NCT00557856|448848091|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
124786253|NCT00557856|448848092|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
124786254|NCT00557856|448848093|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
124786255|NCT00557856|448848094|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
124786256|NCT00557856|448848095|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
125292201|NCT00996801|450696554|FG003|Overall Study|Progressive Disease|0|||
124786257|NCT00557856|448848087|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
124786258|NCT00557856|448848088|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
124786259|NCT00557856|448848089|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
124786260|NCT00557856|448848090|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
124786261|NCT00557856|448848091|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
124786262|NCT00557856|448848092|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
124786263|NCT00557856|448848093|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
124786264|NCT00557856|448848094|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
124786265|NCT00557856|448848095|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
124786266|NCT00557856|448848087|FG000|Part 1: Dose Escalation Phase|Other|0|||
124786267|NCT00557856|448848088|FG001|Part 1: Dose Escalation Phase|Other|0|||
124786268|NCT00557856|448848089|FG002|Part 1: Dose Escalation Phase|Other|1|||
124786269|NCT00557856|448848090|FG003|Part 1: Dose Escalation Phase|Other|1|||
124786270|NCT00557856|448848091|FG004|Part 1: Dose Escalation Phase|Other|0|||
124786271|NCT00557856|448848092|FG005|Part 1: Dose Escalation Phase|Other|0|||
124786272|NCT00557856|448848093|FG006|Part 1: Dose Escalation Phase|Other|0|||
124786273|NCT00557856|448848094|FG007|Part 1: Dose Escalation Phase|Other|1|||
124786274|NCT00557856|448848095|FG008|Part 1: Dose Escalation Phase|Other|0|||
124786275|NCT00557856|448848087|FG000|Part 1: Dose Escalation Phase|Death|0|||
124786276|NCT00557856|448848088|FG001|Part 1: Dose Escalation Phase|Death|0|||
124786277|NCT00557856|448848089|FG002|Part 1: Dose Escalation Phase|Death|0|||
124786278|NCT00557856|448848090|FG003|Part 1: Dose Escalation Phase|Death|0|||
124786279|NCT00557856|448848091|FG004|Part 1: Dose Escalation Phase|Death|0|||
124786280|NCT00557856|448848092|FG005|Part 1: Dose Escalation Phase|Death|1|||
124786281|NCT00557856|448848093|FG006|Part 1: Dose Escalation Phase|Death|0|||
124786282|NCT00557856|448848094|FG007|Part 1: Dose Escalation Phase|Death|0|||
124786283|NCT00557856|448848095|FG008|Part 1: Dose Escalation Phase|Death|0|||
124786284|NCT00557856|448848087|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
124786285|NCT00557856|448848088|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
124786286|NCT00557856|448848089|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
124786287|NCT00557856|448848090|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
124786288|NCT00557856|448848091|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
124786289|NCT00557856|448848092|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
124786290|NCT00557856|448848093|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
124786291|NCT00557856|448848094|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
124786292|NCT00557856|448848095|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
124786293|NCT00557856|448848087|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
124786294|NCT00557856|448848088|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
124786295|NCT00557856|448848089|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
124786296|NCT00557856|448848090|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
124786297|NCT00557856|448848091|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
124786298|NCT00557856|448848092|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
124786299|NCT00557856|448848093|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
124786300|NCT00557856|448848094|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
124786301|NCT00557856|448848095|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
124786302|NCT00557856|448848087|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
124786303|NCT00557856|448848088|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
124786304|NCT00557856|448848089|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
124786305|NCT00557856|448848090|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
124786306|NCT00557856|448848091|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
124786307|NCT00557856|448848092|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
124786308|NCT00557856|448848093|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
124786309|NCT00557856|448848094|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
124786310|NCT00557856|448848095|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
124786311|NCT00557856|448848087|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
124786312|NCT00557856|448848088|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
124786313|NCT00557856|448848089|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
124786314|NCT00557856|448848090|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
124786315|NCT00557856|448848091|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
124786316|NCT00557856|448848092|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
124786317|NCT00557856|448848093|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
124786318|NCT00557856|448848094|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
124786319|NCT00557856|448848095|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
124786320|NCT00557856|448848087|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
124786321|NCT00557856|448848088|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
124786322|NCT00557856|448848089|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
124786323|NCT00557856|448848090|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
124786324|NCT00557856|448848091|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
124786325|NCT00557856|448848092|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
124786326|NCT00557856|448848093|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
124786327|NCT00557856|448848094|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
124786328|NCT00557856|448848095|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
124786329|NCT00557856|448848087|FG000|Part 2: Exploratory Phase|Other|0|||
124786330|NCT00557856|448848088|FG001|Part 2: Exploratory Phase|Other|0|||
124786331|NCT00557856|448848089|FG002|Part 2: Exploratory Phase|Other|0|||
124786332|NCT00557856|448848090|FG003|Part 2: Exploratory Phase|Other|0|||
124786333|NCT00557856|448848091|FG004|Part 2: Exploratory Phase|Other|0|||
124786334|NCT00557856|448848092|FG005|Part 2: Exploratory Phase|Other|0|||
124786335|NCT00557856|448848093|FG006|Part 2: Exploratory Phase|Other|0|||
124786336|NCT00557856|448848094|FG007|Part 2: Exploratory Phase|Other|0|||
124786337|NCT00557856|448848095|FG008|Part 2: Exploratory Phase|Other|1|||
124786338|NCT00557856|448848087|FG000|Part 2: Exploratory Phase|Death|0|||
124786339|NCT00557856|448848088|FG001|Part 2: Exploratory Phase|Death|0|||
124786340|NCT00557856|448848089|FG002|Part 2: Exploratory Phase|Death|0|||
124786341|NCT00557856|448848090|FG003|Part 2: Exploratory Phase|Death|0|||
124786342|NCT00557856|448848091|FG004|Part 2: Exploratory Phase|Death|0|||
124786343|NCT00557856|448848092|FG005|Part 2: Exploratory Phase|Death|0|||
124786344|NCT00557856|448848093|FG006|Part 2: Exploratory Phase|Death|0|||
124786345|NCT00557856|448848094|FG007|Part 2: Exploratory Phase|Death|0|||
124786346|NCT00557856|448848095|FG008|Part 2: Exploratory Phase|Death|2|||
124786347|NCT00557856|448848087|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
124786348|NCT00557856|448848088|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
124786349|NCT00557856|448848089|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
124786350|NCT00557856|448848090|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
124786351|NCT00557856|448848091|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
124786352|NCT00557856|448848092|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
124786353|NCT00557856|448848093|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
124786354|NCT00557856|448848094|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
124786355|NCT00557856|448848095|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
124786356|NCT01675167|448848096|FG000|Open-label Titration Phase|Adverse Event|81|||
124786357|NCT01675167|448848097|FG001|Open-label Titration Phase|Adverse Event|0|||
124786358|NCT01675167|448848098|FG002|Open-label Titration Phase|Adverse Event|0|||
124786359|NCT01675167|448848096|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
124786360|NCT01675167|448848097|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
124786361|NCT01675167|448848098|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
124786362|NCT01675167|448848096|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
124786363|NCT01675167|448848097|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
124786364|NCT01675167|448848098|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
124786365|NCT01675167|448848096|FG000|Open-label Titration Phase|Protocol Violation|43|||
124786366|NCT01675167|448848097|FG001|Open-label Titration Phase|Protocol Violation|0|||
124786367|NCT01675167|448848098|FG002|Open-label Titration Phase|Protocol Violation|0|||
124786368|NCT01675167|448848096|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
124786369|NCT01675167|448848097|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
124786370|NCT01675167|448848098|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
124786371|NCT01675167|448848096|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
124786372|NCT01675167|448848097|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
124786373|NCT01675167|448848098|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
124786374|NCT01675167|448848096|FG000|Open-label Titration Phase|Other|55|||
124786375|NCT01675167|448848097|FG001|Open-label Titration Phase|Other|0|||
124786376|NCT01675167|448848098|FG002|Open-label Titration Phase|Other|0|||
124786377|NCT01675167|448848096|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
124786378|NCT01675167|448848097|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
124786379|NCT01675167|448848098|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
124786380|NCT01675167|448848096|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
124786381|NCT01675167|448848097|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
124786382|NCT01675167|448848098|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
124786383|NCT01675167|448848096|FG000|Double-blind Treatment Phase|Adverse Event|0|||
124786384|NCT01675167|448848097|FG001|Double-blind Treatment Phase|Adverse Event|5|||
124786385|NCT01675167|448848098|FG002|Double-blind Treatment Phase|Adverse Event|13|||
124786386|NCT01675167|448848096|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
124786387|NCT01675167|448848097|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
124786388|NCT01675167|448848098|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
124786389|NCT01675167|448848096|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
124786390|NCT01675167|448848097|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
124786391|NCT01675167|448848098|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
124786392|NCT01675167|448848096|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
124786393|NCT01675167|448848097|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
124786394|NCT01675167|448848098|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
124786395|NCT01675167|448848096|FG000|Double-blind Treatment Phase|Other|0|||
124786396|NCT01675167|448848097|FG001|Double-blind Treatment Phase|Other|7|||
124786397|NCT01675167|448848098|FG002|Double-blind Treatment Phase|Other|5|||
124786398|NCT01925131|448850166|FG000|Overall Study|Death|0|||
124786399|NCT01925131|448850167|FG001|Overall Study|Death|0|||
124786400|NCT01925131|448850168|FG002|Overall Study|Death|1|||
124786401|NCT01925131|448850169|FG003|Overall Study|Death|0|||
124786402|NCT01925131|448850170|FG004|Overall Study|Death|0|||
124786403|NCT01925131|448850171|FG005|Overall Study|Death|0|||
124786404|NCT01925131|448850166|FG000|Overall Study|Progression/Relapse|1|||
124786405|NCT01925131|448850167|FG001|Overall Study|Progression/Relapse|1|||
124786406|NCT01925131|448850168|FG002|Overall Study|Progression/Relapse|4|||
124786407|NCT01925131|448850169|FG003|Overall Study|Progression/Relapse|0|||
124786408|NCT01925131|448850170|FG004|Overall Study|Progression/Relapse|0|||
124786409|NCT01925131|448850171|FG005|Overall Study|Progression/Relapse|1|||
124786410|NCT01925131|448850166|FG000|Overall Study|Patient Refusal|1|||
124786411|NCT01925131|448850167|FG001|Overall Study|Patient Refusal|0|||
124786412|NCT01925131|448850168|FG002|Overall Study|Patient Refusal|0|||
124786413|NCT01925131|448850169|FG003|Overall Study|Patient Refusal|0|||
124786414|NCT01925131|448850170|FG004|Overall Study|Patient Refusal|0|||
124786415|NCT01925131|448850171|FG005|Overall Study|Patient Refusal|0|||
124786416|NCT01925131|448850166|FG000|Overall Study|Adverse Event|0|||
124786417|NCT01925131|448850167|FG001|Overall Study|Adverse Event|0|||
124786418|NCT01925131|448850168|FG002|Overall Study|Adverse Event|2|||
124786419|NCT01925131|448850169|FG003|Overall Study|Adverse Event|0|||
124786420|NCT01925131|448850170|FG004|Overall Study|Adverse Event|1|||
124786421|NCT01925131|448850171|FG005|Overall Study|Adverse Event|3|||
124786422|NCT01925131|448850166|FG000|Overall Study|Other - Not Protocol Specified|3|||
124786423|NCT01925131|448850167|FG001|Overall Study|Other - Not Protocol Specified|1|||
124786424|NCT01925131|448850168|FG002|Overall Study|Other - Not Protocol Specified|2|||
124786425|NCT01925131|448850169|FG003|Overall Study|Other - Not Protocol Specified|5|||
124786426|NCT01925131|448850170|FG004|Overall Study|Other - Not Protocol Specified|10|||
124786427|NCT01925131|448850171|FG005|Overall Study|Other - Not Protocol Specified|6|||
124786428|NCT01696929|448850175|FG000|Overall Study|Physician Decision|1|||
124786429|NCT01794338|448850176|FG000|Overall Study|Death|2|||
124786430|NCT01794338|448850177|FG001|Overall Study|Death|0|||
124786431|NCT01794338|448850176|FG000|Overall Study|Lost to Follow-up|6|||
124786432|NCT01794338|448850177|FG001|Overall Study|Lost to Follow-up|9|||
124786433|NCT02522624|448850178|FG000|Overall Study|Technical failure|1|||
124786434|NCT02522624|448850179|FG001|Overall Study|Technical failure|0|||
124786435|NCT02123251|448850180|FG000|Overall Study|Death|1|||
124786436|NCT02123251|448850181|FG001|Overall Study|Death|1|||
124786437|NCT02123251|448850180|FG000|Overall Study|Withdrawal by Subject|0|||
124786438|NCT02123251|448850181|FG001|Overall Study|Withdrawal by Subject|3|||
124786439|NCT02123251|448850180|FG000|Overall Study|Lost Medicaid eligibility|29|||
124786440|NCT02123251|448850181|FG001|Overall Study|Lost Medicaid eligibility|22|||
124786441|NCT02123251|448850180|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
124786442|NCT02123251|448850181|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
124786443|NCT02617485|448850196|FG000|Treatment and Observation Period|Adverse Event|9|||
124786444|NCT02617485|448850197|FG001|Treatment and Observation Period|Adverse Event|1|||
124786445|NCT02617485|448850196|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
124786446|NCT02617485|448850197|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
124786447|NCT02617485|448850196|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
124786448|NCT02617485|448850197|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
124786449|NCT02617485|448850196|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
124786450|NCT02617485|448850197|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
124786451|NCT02617485|448850196|FG000|Treatment and Observation Period|Physician Decision|0|||
124786452|NCT02617485|448850197|FG001|Treatment and Observation Period|Physician Decision|1|||
124786453|NCT02617485|448850196|FG000|Follow-up Period|Adverse Event|1|||
124786454|NCT02617485|448850197|FG001|Follow-up Period|Adverse Event|0|||
124786455|NCT02617485|448850196|FG000|Follow-up Period|Withdrawal by Subject|1|||
124786456|NCT02617485|448850197|FG001|Follow-up Period|Withdrawal by Subject|0|||
124786457|NCT02617485|448850196|FG000|Follow-up Period|Disease progression|2|||
124786458|NCT02617485|448850197|FG001|Follow-up Period|Disease progression|1|||
124786459|NCT02617485|448850196|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
124786460|NCT02617485|448850197|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
124786461|NCT02617485|448850196|FG000|Follow-up Period|Patient needed radiotherapy|9|||
124786462|NCT02617485|448850197|FG001|Follow-up Period|Patient needed radiotherapy|5|||
124786463|NCT02617485|448850196|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
124786464|NCT02617485|448850197|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
124786465|NCT00617669|448850199|FG000|Overall Study|Withdrawal by Subject|71|||
124786466|NCT00617669|448850200|FG001|Overall Study|Withdrawal by Subject|77|||
124786467|NCT00617669|448850199|FG000|Overall Study|Lost to Follow-up|3|||
124786468|NCT00617669|448850200|FG001|Overall Study|Lost to Follow-up|2|||
124786469|NCT00617669|448850199|FG000|Overall Study|Adverse Event|87|||
124786470|NCT00617669|448850200|FG001|Overall Study|Adverse Event|76|||
124786471|NCT00617669|448850199|FG000|Overall Study|Protocol Violation|2|||
124786472|NCT00617669|448850200|FG001|Overall Study|Protocol Violation|3|||
124786473|NCT00617669|448850199|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
124786474|NCT00617669|448850200|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
124786475|NCT00617669|448850199|FG000|Overall Study|Patients randomized but not treated|2|||
124786476|NCT00617669|448850200|FG001|Overall Study|Patients randomized but not treated|3|||
124786477|NCT03680742|448850201|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
124786478|NCT02894502|448850204|FG000|Baseline|Withdrawal by Subject|24|||
124786479|NCT02894502|448850205|FG001|Baseline|Withdrawal by Subject|31|||
124786480|NCT02894502|448850206|FG002|Baseline|Withdrawal by Subject|36|||
124786481|NCT02894502|448850204|FG000|Baseline|Death|3|||
124786482|NCT02894502|448850205|FG001|Baseline|Death|1|||
124786483|NCT02894502|448850206|FG002|Baseline|Death|9|||
124786484|NCT02894502|448850204|FG000|First Follow up|Withdrawal by Subject|32|||
124786485|NCT02894502|448850205|FG001|First Follow up|Withdrawal by Subject|29|||
124786486|NCT02894502|448850206|FG002|First Follow up|Withdrawal by Subject|37|||
124786487|NCT02894502|448850204|FG000|First Follow up|Death|2|||
124786488|NCT02894502|448850205|FG001|First Follow up|Death|2|||
124786489|NCT02894502|448850206|FG002|First Follow up|Death|3|||
124786490|NCT02894502|448850204|FG000|Second Follow up|Withdrawal by Subject|13|||
124786491|NCT02894502|448850205|FG001|Second Follow up|Withdrawal by Subject|15|||
124786492|NCT02894502|448850206|FG002|Second Follow up|Withdrawal by Subject|13|||
124786493|NCT02894502|448850204|FG000|Second Follow up|Death|2|||
124786494|NCT02894502|448850205|FG001|Second Follow up|Death|3|||
124786495|NCT02894502|448850206|FG002|Second Follow up|Death|1|||
124786496|NCT02894502|448850204|FG000|Third Follow up|Withdrawal by Subject|5|||
124786497|NCT02894502|448850205|FG001|Third Follow up|Withdrawal by Subject|6|||
124786498|NCT02894502|448850206|FG002|Third Follow up|Withdrawal by Subject|3|||
124786499|NCT02894502|448850204|FG000|Third Follow up|Death|1|||
124786500|NCT02894502|448850205|FG001|Third Follow up|Death|1|||
124786501|NCT02894502|448850206|FG002|Third Follow up|Death|0|||
124786502|NCT04605991|448850207|FG000|Overall Study|Adverse Event|5|||
124786503|NCT04605991|448850207|FG000|Overall Study|Lack of Efficacy|1|||
124786504|NCT04605991|448850207|FG000|Overall Study|Lost to Follow-up|8|||
124786505|NCT04605991|448850207|FG000|Overall Study|Physician Decision|4|||
124786506|NCT04605991|448850207|FG000|Overall Study|Withdrawal by Subject|14|||
124786507|NCT04605991|448850207|FG000|Overall Study|Non-compliance with study|1|||
124786508|NCT01410357|448850208|FG000|Overall Study|Death|2|||
124786509|NCT01410357|448850209|FG001|Overall Study|Death|1|||
124786510|NCT01410357|448850208|FG000|Overall Study|Withdrawal by Subject|1|||
124786511|NCT01410357|448850209|FG001|Overall Study|Withdrawal by Subject|2|||
124786512|NCT01410357|448850208|FG000|Overall Study|Lost to Follow-up|23|||
124786513|NCT01410357|448850209|FG001|Overall Study|Lost to Follow-up|21|||
124786514|NCT00615901|448850210|FG000|Overall Study|Withdrawal by Subject|2|||
124786515|NCT00615901|448850210|FG000|Overall Study|Adverse Event|7|||
124786516|NCT03598114|448850211|FG000|Overall Study|Staff turnover/left the program|3|||
124786517|NCT03598114|448850212|FG001|Overall Study|Staff turnover/left the program|39|||
124786518|NCT01589653|448850213|FG000|Overall Study|Protocol Violation|3|||
124786519|NCT01589653|448850214|FG001|Overall Study|Protocol Violation|1|||
124786520|NCT01589653|448850213|FG000|Overall Study|Withdrawal criteria|4|||
124786521|NCT01589653|448850214|FG001|Overall Study|Withdrawal criteria|7|||
124786522|NCT01589653|448850213|FG000|Overall Study|Unclassified|0|||
124786523|NCT01589653|448850214|FG001|Overall Study|Unclassified|3|||
124786524|NCT00361634|448850216|FG000|Overall Study|Lost to Follow-up|1|||
124786525|NCT00361634|448850216|FG000|Overall Study|Withdrawal by Subject|1|||
124786526|NCT00833417|448850217|FG000|Overall Study|Adverse Event|5|||
124786527|NCT00833417|448850218|FG001|Overall Study|Adverse Event|16|||
124786528|NCT00833417|448850217|FG000|Overall Study|Death|1|||
124786529|NCT00833417|448850218|FG001|Overall Study|Death|3|||
124786530|NCT00833417|448850217|FG000|Overall Study|Lost to Follow-up|1|||
124786531|NCT00833417|448850218|FG001|Overall Study|Lost to Follow-up|2|||
124786532|NCT00833417|448850217|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
124786533|NCT00833417|448850218|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
124786534|NCT00833417|448850217|FG000|Overall Study|Patient Decision to Withdraw|4|||
124786535|NCT00833417|448850218|FG001|Overall Study|Patient Decision to Withdraw|23|||
124786536|NCT00833417|448850217|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
124786537|NCT00833417|448850218|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
124786538|NCT00833417|448850217|FG000|Overall Study|Disease Progression|18|||
124786539|NCT00833417|448850218|FG001|Overall Study|Disease Progression|17|||
124786540|NCT00833417|448850217|FG000|Overall Study|Reason Not Specified|0|||
124786541|NCT00833417|448850218|FG001|Overall Study|Reason Not Specified|1|||
124786542|NCT03330002|448850219|FG000|Overall Study|Lost to Follow-up|15|||
124786543|NCT03330002|448850219|FG000|Overall Study|Death|7|||
124786544|NCT01883453|448850220|FG000|Overall Study|No episode of common cold|25|||
124786545|NCT01883453|448850221|FG001|Overall Study|No episode of common cold|23|||
124786546|NCT00505076|448850222|FG000|Overall Study|Adverse Event|1|||
124786547|NCT00505076|448850223|FG001|Overall Study|Adverse Event|0|||
124786548|NCT00505076|448850224|FG002|Overall Study|Adverse Event|1|||
124786549|NCT00505076|448850222|FG000|Overall Study|Protocol Violation|2|||
124786550|NCT00505076|448850223|FG001|Overall Study|Protocol Violation|1|||
124786551|NCT00505076|448850224|FG002|Overall Study|Protocol Violation|2|||
124786552|NCT00505076|448850222|FG000|Overall Study|Withdrawal by Subject|0|||
124786553|NCT00505076|448850223|FG001|Overall Study|Withdrawal by Subject|1|||
124786554|NCT00505076|448850224|FG002|Overall Study|Withdrawal by Subject|2|||
124786555|NCT00647270|448850225|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
124786556|NCT00647270|448850226|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
124786557|NCT00647270|448850227|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
124786558|NCT00647270|448850225|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
124786559|NCT00647270|448850226|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
124786560|NCT00647270|448850227|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
124786561|NCT00647270|448850225|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
124786562|NCT00647270|448850226|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
124786563|NCT00647270|448850227|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
124786564|NCT00647270|448850225|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
124786565|NCT00647270|448850226|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
124786566|NCT00647270|448850227|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
124786567|NCT00647270|448850225|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
124786568|NCT00647270|448850226|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
124786569|NCT00647270|448850227|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
124786570|NCT00647270|448850225|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
124786571|NCT00647270|448850226|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
124786572|NCT00647270|448850227|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
124786573|NCT00647270|448850225|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
124786574|NCT00647270|448850226|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
124786575|NCT00647270|448850227|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
124786576|NCT03337490|448850228|FG000|Overall Study|Withdrawal by Subject|1|||
124786577|NCT03337490|448850229|FG001|Overall Study|Withdrawal by Subject|0|||
124786578|NCT03337490|448850230|FG002|Overall Study|Withdrawal by Subject|0|||
124786579|NCT03337490|448850228|FG000|Overall Study|Lack of Efficacy|10|||
124786580|NCT03337490|448850229|FG001|Overall Study|Lack of Efficacy|12|||
124786581|NCT03337490|448850230|FG002|Overall Study|Lack of Efficacy|35|||
124786582|NCT03337490|448850228|FG000|Overall Study|Physician Decision|0|||
124786583|NCT03337490|448850229|FG001|Overall Study|Physician Decision|1|||
124786584|NCT03337490|448850230|FG002|Overall Study|Physician Decision|0|||
124786585|NCT03337490|448850228|FG000|Overall Study|Lost to Follow-up|0|||
124786586|NCT03337490|448850229|FG001|Overall Study|Lost to Follow-up|1|||
124786587|NCT03337490|448850230|FG002|Overall Study|Lost to Follow-up|0|||
124786588|NCT02745145|448850231|FG000|Overall Study|Adverse Event|1|||
124786589|NCT02745145|448850232|FG001|Overall Study|Adverse Event|0|||
124786590|NCT02745145|448850233|FG002|Overall Study|Adverse Event|0|||
124786591|NCT02745145|448850231|FG000|Overall Study|Death|0|||
124786592|NCT02745145|448850232|FG001|Overall Study|Death|1|||
124786593|NCT02745145|448850233|FG002|Overall Study|Death|0|||
124786594|NCT02745145|448850231|FG000|Overall Study|Progressive disease|0|||
124786595|NCT02745145|448850232|FG001|Overall Study|Progressive disease|0|||
124786596|NCT02745145|448850233|FG002|Overall Study|Progressive disease|1|||
124786597|NCT02745145|448850231|FG000|Overall Study|Withdrew consent|1|||
124786598|NCT02745145|448850232|FG001|Overall Study|Withdrew consent|1|||
124786599|NCT02745145|448850233|FG002|Overall Study|Withdrew consent|1|||
124786600|NCT02745145|448850231|FG000|Overall Study|Study Termination|8|||
124786601|NCT02745145|448850232|FG001|Overall Study|Study Termination|3|||
124786602|NCT02745145|448850233|FG002|Overall Study|Study Termination|7|||
124786603|NCT00388583|448850234|FG000|Overall Study|Protocol Violation|1|||
124786604|NCT00388583|448850235|FG001|Overall Study|Protocol Violation|0|||
124786605|NCT00388583|448850234|FG000|Overall Study|Withdrawal by Subject|3|||
124786606|NCT00388583|448850235|FG001|Overall Study|Withdrawal by Subject|3|||
124786607|NCT00388583|448850234|FG000|Overall Study|Serious Adverse Event|2|||
124786608|NCT00388583|448850235|FG001|Overall Study|Serious Adverse Event|0|||
124786609|NCT00388583|448850234|FG000|Overall Study|Did not receive vaccine|0|||
124786610|NCT00388583|448850235|FG001|Overall Study|Did not receive vaccine|1|||
124786611|NCT02709538|448850240|FG000|Overall Study|Adverse Event|13|||
124786612|NCT02709538|448850241|FG001|Overall Study|Adverse Event|2|||
124786613|NCT02709538|448850242|FG002|Overall Study|Adverse Event|3|||
124786614|NCT02709538|448850240|FG000|Overall Study|Lack of Efficacy|1|||
124786615|NCT02709538|448850241|FG001|Overall Study|Lack of Efficacy|0|||
124786616|NCT02709538|448850242|FG002|Overall Study|Lack of Efficacy|0|||
124786617|NCT02709538|448850240|FG000|Overall Study|Lost to Follow-up|24|||
124786618|NCT02709538|448850241|FG001|Overall Study|Lost to Follow-up|8|||
124786619|NCT02709538|448850242|FG002|Overall Study|Lost to Follow-up|4|||
124786620|NCT02709538|448850240|FG000|Overall Study|Physician Decision|1|||
124786621|NCT02709538|448850241|FG001|Overall Study|Physician Decision|0|||
124786622|NCT02709538|448850242|FG002|Overall Study|Physician Decision|0|||
124786623|NCT02709538|448850240|FG000|Overall Study|Withdrawal by Subject|40|||
124786624|NCT02709538|448850241|FG001|Overall Study|Withdrawal by Subject|7|||
124786625|NCT02709538|448850242|FG002|Overall Study|Withdrawal by Subject|4|||
124786626|NCT02709538|448850240|FG000|Overall Study|Non-compliance with study procedures|5|||
124786627|NCT02709538|448850241|FG001|Overall Study|Non-compliance with study procedures|0|||
124786628|NCT02709538|448850242|FG002|Overall Study|Non-compliance with study procedures|0|||
124786629|NCT02709538|448850240|FG000|Overall Study|Non-compliance with study drug|2|||
124786630|NCT02709538|448850241|FG001|Overall Study|Non-compliance with study drug|0|||
124786631|NCT02709538|448850242|FG002|Overall Study|Non-compliance with study drug|0|||
124786632|NCT02709538|448850240|FG000|Overall Study|Protocol deviation|10|||
124786633|NCT02709538|448850241|FG001|Overall Study|Protocol deviation|4|||
124786634|NCT02709538|448850242|FG002|Overall Study|Protocol deviation|4|||
124786635|NCT02709538|448850240|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
124786636|NCT02709538|448850241|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
124786637|NCT02709538|448850242|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
124786638|NCT02709538|448850240|FG000|Overall Study|Other|16|||
124786639|NCT02709538|448850241|FG001|Overall Study|Other|7|||
124786640|NCT02709538|448850242|FG002|Overall Study|Other|5|||
124786641|NCT00835211|448850243|FG000|First Intervention|Withdrawal by Subject|0|||
124786642|NCT00835211|448850244|FG001|First Intervention|Withdrawal by Subject|1|||
124786643|NCT00835211|448850243|FG000|Washout: 7 Days|Adverse Event|2|||
124786644|NCT00835211|448850244|FG001|Washout: 7 Days|Adverse Event|1|||
124786645|NCT00835211|448850243|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
124786646|NCT00835211|448850244|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
124786647|NCT02160041|448850245|FG000|Overall Study|Adverse Event|11|||
124786648|NCT02160041|448850245|FG000|Overall Study|Death|2|||
124786649|NCT02160041|448850245|FG000|Overall Study|disease progression|57|||
124786650|NCT02160041|448850245|FG000|Overall Study|Protocol Violation|1|||
124786651|NCT02160041|448850245|FG000|Overall Study|non-compliance with study|1|||
124786652|NCT02160041|448850245|FG000|Overall Study|Physician Decision|3|||
124786653|NCT02160041|448850245|FG000|Overall Study|Withdrawal by Subject|8|||
124786654|NCT02160041|448850245|FG000|Overall Study|study terminated by by sponsor|1|||
124786655|NCT01403948|448850246|FG000|Overall Study|Progressive disease|0|||
124786656|NCT01403948|448850247|FG001|Overall Study|Progressive disease|2|||
124786657|NCT01403948|448850248|FG002|Overall Study|Progressive disease|2|||
124786658|NCT01403948|448850249|FG003|Overall Study|Progressive disease|4|||
124786659|NCT01403948|448850250|FG004|Overall Study|Progressive disease|2|||
124786660|NCT01403948|448850251|FG005|Overall Study|Progressive disease|6|||
124786661|NCT01403948|448850252|FG006|Overall Study|Progressive disease|2|||
124786662|NCT01403948|448850253|FG007|Overall Study|Progressive disease|4|||
124786663|NCT01403948|448850254|FG008|Overall Study|Progressive disease|5|||
124786664|NCT01403948|448850255|FG009|Overall Study|Progressive disease|5|||
124786665|NCT01403948|448850246|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
124786666|NCT01403948|448850247|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
124786667|NCT01403948|448850248|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
124786668|NCT01403948|448850249|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
124786669|NCT01403948|448850250|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
124786670|NCT01403948|448850251|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
124786671|NCT01403948|448850252|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
124786672|NCT01403948|448850253|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
124786673|NCT01403948|448850254|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
124786674|NCT01403948|448850255|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
124786675|NCT01403948|448850246|FG000|Overall Study|Lost to Follow-up|0|||
124786676|NCT01403948|448850247|FG001|Overall Study|Lost to Follow-up|0|||
124786677|NCT01403948|448850248|FG002|Overall Study|Lost to Follow-up|0|||
124786678|NCT01403948|448850249|FG003|Overall Study|Lost to Follow-up|0|||
124786679|NCT01403948|448850250|FG004|Overall Study|Lost to Follow-up|0|||
124786680|NCT01403948|448850251|FG005|Overall Study|Lost to Follow-up|0|||
124786681|NCT01403948|448850252|FG006|Overall Study|Lost to Follow-up|0|||
124786682|NCT01403948|448850253|FG007|Overall Study|Lost to Follow-up|0|||
124786683|NCT01403948|448850254|FG008|Overall Study|Lost to Follow-up|0|||
124786684|NCT01403948|448850255|FG009|Overall Study|Lost to Follow-up|1|||
124786685|NCT01403948|448850246|FG000|Overall Study|Refused cont. medication|0|||
124786686|NCT01403948|448850247|FG001|Overall Study|Refused cont. medication|0|||
124786687|NCT01403948|448850248|FG002|Overall Study|Refused cont. medication|0|||
124786688|NCT01403948|448850249|FG003|Overall Study|Refused cont. medication|0|||
124786689|NCT01403948|448850250|FG004|Overall Study|Refused cont. medication|1|||
124786690|NCT01403948|448850251|FG005|Overall Study|Refused cont. medication|0|||
124786691|NCT01403948|448850252|FG006|Overall Study|Refused cont. medication|0|||
124786692|NCT01403948|448850253|FG007|Overall Study|Refused cont. medication|0|||
124786693|NCT01403948|448850254|FG008|Overall Study|Refused cont. medication|0|||
124786694|NCT01403948|448850255|FG009|Overall Study|Refused cont. medication|1|||
124786695|NCT01403948|448850246|FG000|Overall Study|other than above|1|||
124786696|NCT01403948|448850247|FG001|Overall Study|other than above|2|||
124786697|NCT01403948|448850248|FG002|Overall Study|other than above|1|||
124786698|NCT01403948|448850249|FG003|Overall Study|other than above|0|||
124786699|NCT01403948|448850250|FG004|Overall Study|other than above|1|||
124786700|NCT01403948|448850251|FG005|Overall Study|other than above|1|||
124786701|NCT01403948|448850252|FG006|Overall Study|other than above|2|||
124786702|NCT01403948|448850253|FG007|Overall Study|other than above|0|||
124786703|NCT01403948|448850254|FG008|Overall Study|other than above|0|||
124786704|NCT01403948|448850255|FG009|Overall Study|other than above|0|||
124786705|NCT05498701|448850256|FG000|Period 3|Adverse Event|1|||
124786706|NCT05498701|448850257|FG001|Period 3|Adverse Event|0|||
124786707|NCT00006409|448850261|FG000|Baseline|Protocol Violation|48|||
124786708|NCT00006409|448850262|FG001|Baseline|Protocol Violation|70|||
124786709|NCT00006409|448850263|FG002|Baseline|Protocol Violation|0|||
124786710|NCT00006409|448850264|FG003|Baseline|Protocol Violation|0|||
124786711|NCT00006409|448850265|FG004|Baseline|Protocol Violation|0|||
124786712|NCT00006409|448850266|FG005|Baseline|Protocol Violation|0|||
124786713|NCT00006409|448850261|FG000|Post-2 Year Intervention|Protocol Violation|0|||
124786714|NCT00006409|448850262|FG001|Post-2 Year Intervention|Protocol Violation|0|||
124786715|NCT00006409|448850263|FG002|Post-2 Year Intervention|Protocol Violation|251|||
124786716|NCT00006409|448850264|FG003|Post-2 Year Intervention|Protocol Violation|168|||
124786717|NCT00006409|448850265|FG004|Post-2 Year Intervention|Protocol Violation|0|||
124786718|NCT00006409|448850266|FG005|Post-2 Year Intervention|Protocol Violation|0|||
124786719|NCT00006409|448850261|FG000|Post-3 Year Intervention|Protocol Violation|0|||
124786720|NCT00006409|448850262|FG001|Post-3 Year Intervention|Protocol Violation|0|||
124786721|NCT00006409|448850263|FG002|Post-3 Year Intervention|Protocol Violation|0|||
124786722|NCT00006409|448850264|FG003|Post-3 Year Intervention|Protocol Violation|0|||
124786723|NCT00006409|448850265|FG004|Post-3 Year Intervention|Protocol Violation|62|||
124786724|NCT00006409|448850266|FG005|Post-3 Year Intervention|Protocol Violation|62|||
124786725|NCT00638183|448850267|FG000|Overall Study|Adverse Event|23|||
124786726|NCT00638183|448850267|FG000|Overall Study|Lack of Efficacy|14|||
124786727|NCT00638183|448850267|FG000|Overall Study|Physician Decision|9|||
124786728|NCT00638183|448850267|FG000|Overall Study|Lost to Follow-up|46|||
124786729|NCT00638183|448850267|FG000|Overall Study|Other reason not defined above|27|||
124786730|NCT01763996|448850270|FG000|Treatment Period 2|Adverse Event|0|||
124786731|NCT01763996|448850271|FG001|Treatment Period 2|Adverse Event|1|||
124786732|NCT03704636|448850275|FG000|Overall Study|Inadequate Venous Flow|3|||
124786733|NCT00539188|448850278|FG000|Overall Study|Withdrawal by Subject|1|||
124786734|NCT00539188|448850279|FG001|Overall Study|Withdrawal by Subject|0|||
124786735|NCT00539188|448850278|FG000|Overall Study|Lost to Follow-up|2|||
124786736|NCT00539188|448850279|FG001|Overall Study|Lost to Follow-up|1|||
124786737|NCT01546623|448850280|FG000|Overall Study|Adverse Event|2|||
124786738|NCT01546623|448850281|FG001|Overall Study|Adverse Event|3|||
124786739|NCT01546623|448850280|FG000|Overall Study|Major Protocol Deviation|1|||
124786740|NCT01546623|448850281|FG001|Overall Study|Major Protocol Deviation|1|||
124786741|NCT01546623|448850280|FG000|Overall Study|High Prostate specific antigen|2|||
124786742|NCT01546623|448850281|FG001|Overall Study|High Prostate specific antigen|1|||
124786743|NCT01546623|448850280|FG000|Overall Study|Did Not Receive Study Drug|1|||
124786744|NCT01546623|448850281|FG001|Overall Study|Did Not Receive Study Drug|1|||
124786745|NCT01134705|448850282|FG000|Overall Study|Adverse Event|1|||
124786746|NCT01134705|448850283|FG001|Overall Study|Adverse Event|7|||
124786747|NCT01134705|448850282|FG000|Overall Study|Withdrawal by Subject|6|||
124786748|NCT01134705|448850283|FG001|Overall Study|Withdrawal by Subject|6|||
124786749|NCT01134705|448850282|FG000|Overall Study|Pregnancy|1|||
124786750|NCT01134705|448850283|FG001|Overall Study|Pregnancy|0|||
124786751|NCT01134705|448850282|FG000|Overall Study|Lost to Follow-up|5|||
124786752|NCT01134705|448850283|FG001|Overall Study|Lost to Follow-up|2|||
124786753|NCT01134705|448850282|FG000|Overall Study|Protocol Violation|1|||
124786754|NCT01134705|448850283|FG001|Overall Study|Protocol Violation|1|||
124786755|NCT01134705|448850282|FG000|Overall Study|Other|1|||
124786756|NCT01134705|448850283|FG001|Overall Study|Other|6|||
124786757|NCT04784442|448850284|FG000|Overall Study|Adverse Event|1|||
124786758|NCT04784442|448850285|FG001|Overall Study|Adverse Event|0|||
124786759|NCT04784442|448850286|FG002|Overall Study|Adverse Event|2|||
124786760|NCT04784442|448850287|FG003|Overall Study|Adverse Event|1|||
124786761|NCT04784442|448850284|FG000|Overall Study|Protocol Violation|1|||
124786762|NCT04784442|448850285|FG001|Overall Study|Protocol Violation|0|||
124786763|NCT04784442|448850286|FG002|Overall Study|Protocol Violation|0|||
124786764|NCT04784442|448850287|FG003|Overall Study|Protocol Violation|0|||
124786765|NCT04784442|448850284|FG000|Overall Study|Non-compliance with study drug|1|||
124786766|NCT04784442|448850285|FG001|Overall Study|Non-compliance with study drug|0|||
124786767|NCT04784442|448850286|FG002|Overall Study|Non-compliance with study drug|0|||
124786768|NCT04784442|448850287|FG003|Overall Study|Non-compliance with study drug|0|||
124786769|NCT01590758|448850290|FG000|Overall Study|Withdrawal by Subject|0|||
124786770|NCT01590758|448850291|FG001|Overall Study|Withdrawal by Subject|3|||
124786771|NCT01590758|448850290|FG000|Overall Study|Physician Decision|1|||
124786772|NCT01590758|448850291|FG001|Overall Study|Physician Decision|2|||
124786773|NCT01590758|448850290|FG000|Overall Study|Lost to Follow-up|4|||
124786774|NCT01590758|448850291|FG001|Overall Study|Lost to Follow-up|2|||
124786775|NCT01578850|448850292|FG000|Period 1|Insufficient Clinical Response|1|||
124786776|NCT01578850|448850293|FG001|Period 1|Insufficient Clinical Response|0|||
124786777|NCT01578850|448850294|FG002|Period 1|Insufficient Clinical Response|0|||
124786778|NCT01578850|448850292|FG000|Period 1|Adverse Event|11|||
124786779|NCT01578850|448850293|FG001|Period 1|Adverse Event|0|||
124786780|NCT01578850|448850294|FG002|Period 1|Adverse Event|0|||
124786781|NCT01578850|448850292|FG000|Period 1|Death|1|||
124786782|NCT01578850|448850293|FG001|Period 1|Death|0|||
124786783|NCT01578850|448850294|FG002|Period 1|Death|0|||
124786784|NCT01578850|448850292|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
124786785|NCT01578850|448850293|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
124786786|NCT01578850|448850294|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
124786787|NCT01578850|448850292|FG000|Period 1|Withdrawal by Subject|9|||
124786788|NCT01578850|448850293|FG001|Period 1|Withdrawal by Subject|0|||
124786789|NCT01578850|448850294|FG002|Period 1|Withdrawal by Subject|0|||
124786790|NCT01578850|448850292|FG000|Period 1|Study Terminated by Sponsor|3|||
124786791|NCT01578850|448850293|FG001|Period 1|Study Terminated by Sponsor|0|||
124786792|NCT01578850|448850294|FG002|Period 1|Study Terminated by Sponsor|0|||
124786793|NCT01578850|448850292|FG000|Period 2|Insufficient Clinical Response|0|||
124786794|NCT01578850|448850293|FG001|Period 2|Insufficient Clinical Response|1|||
124786795|NCT01578850|448850294|FG002|Period 2|Insufficient Clinical Response|0|||
124786796|NCT01578850|448850292|FG000|Period 2|Adverse Event|0|||
124786797|NCT01578850|448850293|FG001|Period 2|Adverse Event|3|||
124786798|NCT01578850|448850294|FG002|Period 2|Adverse Event|6|||
124786799|NCT01578850|448850292|FG000|Period 2|Lost to Follow-up|0|||
124786800|NCT01578850|448850293|FG001|Period 2|Lost to Follow-up|1|||
124786801|NCT01578850|448850294|FG002|Period 2|Lost to Follow-up|2|||
124786802|NCT01578850|448850292|FG000|Period 2|Withdrawal by Subject|0|||
124786803|NCT01578850|448850293|FG001|Period 2|Withdrawal by Subject|2|||
124786804|NCT01578850|448850294|FG002|Period 2|Withdrawal by Subject|2|||
124786805|NCT01578850|448850292|FG000|Period 2|Study Terminated by Sponsor|0|||
124786806|NCT01578850|448850293|FG001|Period 2|Study Terminated by Sponsor|5|||
124786807|NCT01578850|448850294|FG002|Period 2|Study Terminated by Sponsor|4|||
124786808|NCT01578850|448850292|FG000|Period 2|Unspecified Reasons|0|||
124786809|NCT01578850|448850293|FG001|Period 2|Unspecified Reasons|1|||
124786810|NCT01578850|448850294|FG002|Period 2|Unspecified Reasons|0|||
124786811|NCT02756806|448850295|FG000|Overall Study|Study terminated early|5|||
124786812|NCT02717832|448850296|FG000|Overall Study|Inability to place IV|3|||
124786813|NCT02929498|448850297|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
124786814|NCT02929498|448850298|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
124786815|NCT02929498|448850299|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
124786816|NCT02929498|448850297|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
124786817|NCT02929498|448850298|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
124786818|NCT02929498|448850299|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
124786819|NCT02744040|448850300|FG000|Overall Study|Withdrawal by Subject|3|||
124786820|NCT02744040|448850301|FG001|Overall Study|Withdrawal by Subject|2|||
124786821|NCT02744040|448850302|FG002|Overall Study|Withdrawal by Subject|2|||
124786822|NCT02744040|448850300|FG000|Overall Study|Physician Decision|0|||
124786823|NCT02744040|448850301|FG001|Overall Study|Physician Decision|8|||
124786824|NCT02744040|448850302|FG002|Overall Study|Physician Decision|13|||
124786825|NCT02744040|448850300|FG000|Overall Study|Lost to Follow-up|3|||
124786826|NCT02744040|448850301|FG001|Overall Study|Lost to Follow-up|1|||
124786827|NCT02744040|448850302|FG002|Overall Study|Lost to Follow-up|7|||
124786828|NCT00096356|448850303|FG000|Overall Study|Adverse Event|11|||
124786829|NCT00096356|448850304|FG001|Overall Study|Adverse Event|9|||
124786830|NCT00096356|448850303|FG000|Overall Study|Physician Decision|5|||
124786831|NCT00096356|448850304|FG001|Overall Study|Physician Decision|3|||
124786832|NCT00096356|448850303|FG000|Overall Study|Withdrawal by Subject|17|||
124786833|NCT00096356|448850304|FG001|Overall Study|Withdrawal by Subject|23|||
124786834|NCT00096356|448850303|FG000|Overall Study|Lack of Efficacy|1|||
124786835|NCT00096356|448850304|FG001|Overall Study|Lack of Efficacy|0|||
124786836|NCT00096356|448850303|FG000|Overall Study|multiple reasons|10|||
124786837|NCT00096356|448850304|FG001|Overall Study|multiple reasons|18|||
124786838|NCT01008423|448850305|FG000|Overall Study|Adverse Event|13|||
124786839|NCT01008423|448850306|FG001|Overall Study|Adverse Event|6|||
124786840|NCT01008423|448850305|FG000|Overall Study|Withdrawal by Subject|4|||
124786841|NCT01008423|448850306|FG001|Overall Study|Withdrawal by Subject|7|||
124786842|NCT01008423|448850305|FG000|Overall Study|Lost to Follow-up|0|||
124786843|NCT01008423|448850306|FG001|Overall Study|Lost to Follow-up|2|||
124786844|NCT01008423|448850305|FG000|Overall Study|Low Cortisol|0|||
124786845|NCT01008423|448850306|FG001|Overall Study|Low Cortisol|1|||
124786846|NCT01008423|448850305|FG000|Overall Study|Lack of Efficacy|0|||
124786847|NCT01008423|448850306|FG001|Overall Study|Lack of Efficacy|5|||
124786848|NCT01008423|448850305|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
124786849|NCT01008423|448850306|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
124786850|NCT01008423|448850305|FG000|Overall Study|Personal Conflict|1|||
124786851|NCT01008423|448850306|FG001|Overall Study|Personal Conflict|0|||
124786852|NCT01008423|448850305|FG000|Overall Study|Other|0|||
124786853|NCT01008423|448850306|FG001|Overall Study|Other|1|||
124786854|NCT03288142|448850308|FG000|Overall Study|Lost to Follow-up|22|||
124786855|NCT03288142|448850309|FG001|Overall Study|Lost to Follow-up|15|||
124786856|NCT00934843|448850310|FG000|Overall Study|Protocol Violation|0|||
124786857|NCT00934843|448850311|FG001|Overall Study|Protocol Violation|1|||
124786858|NCT01144299|448850314|FG000|Overall Study|Lost to Follow-up|1|||
124786859|NCT01144299|448850315|FG001|Overall Study|Lost to Follow-up|0|||
124786860|NCT01144299|448850314|FG000|Overall Study|Withdrawal by Subject|1|||
124786861|NCT01144299|448850315|FG001|Overall Study|Withdrawal by Subject|0|||
124786862|NCT03976648|448850324|FG000|Overall Study|Adverse Event|0|||
124786863|NCT03976648|448850325|FG001|Overall Study|Adverse Event|2|||
124786864|NCT03976648|448850324|FG000|Overall Study|Study terminated by sponsor|21|||
124786865|NCT03976648|448850325|FG001|Overall Study|Study terminated by sponsor|8|||
124786866|NCT00243841|448850326|FG000|Overall Study|Physician Decision|0|||
124786867|NCT00243841|448850327|FG001|Overall Study|Physician Decision|0|||
124786868|NCT00243841|448850328|FG002|Overall Study|Physician Decision|1|||
124786869|NCT00243841|448850329|FG003|Overall Study|Physician Decision|0|||
124786870|NCT00243841|448850330|FG004|Overall Study|Physician Decision|0|||
124786871|NCT00243841|448850331|FG005|Overall Study|Physician Decision|2|||
124786872|NCT00881868|448850332|FG000|Overall Study|Adverse Event|0|||
124786873|NCT00881868|448850333|FG001|Overall Study|Adverse Event|1|||
124786874|NCT00881868|448850332|FG000|Overall Study|Lost to Follow-up|2|||
124786875|NCT00881868|448850333|FG001|Overall Study|Lost to Follow-up|1|||
124786876|NCT00881868|448850332|FG000|Overall Study|Physician Decision|4|||
124786877|NCT00881868|448850333|FG001|Overall Study|Physician Decision|0|||
124786878|NCT00881868|448850332|FG000|Overall Study|Protocol Violation|2|||
124786879|NCT00881868|448850333|FG001|Overall Study|Protocol Violation|0|||
124786880|NCT01981551|448850334|FG000|Overall Study|Refused further treatment|8|||
124786881|NCT01981551|448850334|FG000|Overall Study|Adverse Event|1|||
124786882|NCT03255083|448850335|FG000|Overall Study|Clinical progression|1|||
124786883|NCT03255083|448850336|FG001|Overall Study|Clinical progression|0|||
124786884|NCT03255083|448850337|FG002|Overall Study|Clinical progression|0|||
124786885|NCT03255083|448850338|FG003|Overall Study|Clinical progression|0|||
124786886|NCT03255083|448850335|FG000|Overall Study|Adverse Event|0|||
124786887|NCT03255083|448850336|FG001|Overall Study|Adverse Event|1|||
124786888|NCT03255083|448850337|FG002|Overall Study|Adverse Event|0|||
124786889|NCT03255083|448850338|FG003|Overall Study|Adverse Event|0|||
124786890|NCT03255083|448850335|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
124786891|NCT03255083|448850336|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
124786892|NCT03255083|448850337|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
124786893|NCT03255083|448850338|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
124786894|NCT03255083|448850335|FG000|Overall Study|Withdrawal by Subject|1|||
124786895|NCT03255083|448850336|FG001|Overall Study|Withdrawal by Subject|1|||
124786896|NCT03255083|448850337|FG002|Overall Study|Withdrawal by Subject|1|||
124786897|NCT03255083|448850338|FG003|Overall Study|Withdrawal by Subject|0|||
124786898|NCT01182844|448850339|FG000|Overall Study|Withdrawal by Subject|0|||
124786899|NCT01182844|448850340|FG001|Overall Study|Withdrawal by Subject|2|||
124786900|NCT00960570|448850341|FG000|21 Day Washout Period|Adverse Event|1|||
124786901|NCT00960570|448850341|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
124786902|NCT00960570|448850341|FG000|1 Day Period Between Dosing|Adverse Event|2|||
124786903|NCT00960570|448850341|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
124786904|NCT01451437|448850342|FG000|Overall Study|Adverse Event|0|||
124786905|NCT01451437|448850343|FG001|Overall Study|Adverse Event|0|||
124786906|NCT01451437|448850344|FG002|Overall Study|Adverse Event|0|||
124786907|NCT01451437|448850345|FG003|Overall Study|Adverse Event|0|||
124786908|NCT01451437|448850346|FG004|Overall Study|Adverse Event|0|||
124786909|NCT01451437|448850347|FG005|Overall Study|Adverse Event|1|||
124786910|NCT01451437|448850348|FG006|Overall Study|Adverse Event|1|||
124786911|NCT01451437|448850349|FG007|Overall Study|Adverse Event|2|||
124786912|NCT01451437|448850350|FG008|Overall Study|Adverse Event|1|||
124786913|NCT01451437|448850342|FG000|Overall Study|Physician Decision|1|||
124786914|NCT01451437|448850343|FG001|Overall Study|Physician Decision|1|||
124786915|NCT01451437|448850344|FG002|Overall Study|Physician Decision|2|||
124786916|NCT01451437|448850345|FG003|Overall Study|Physician Decision|0|||
124786917|NCT01451437|448850346|FG004|Overall Study|Physician Decision|0|||
124786918|NCT01451437|448850347|FG005|Overall Study|Physician Decision|0|||
124786919|NCT01451437|448850348|FG006|Overall Study|Physician Decision|0|||
124786920|NCT01451437|448850349|FG007|Overall Study|Physician Decision|0|||
124786921|NCT01451437|448850350|FG008|Overall Study|Physician Decision|0|||
124786922|NCT01451437|448850342|FG000|Overall Study|Disease Progression|0|||
124786923|NCT01451437|448850343|FG001|Overall Study|Disease Progression|0|||
124786924|NCT01451437|448850344|FG002|Overall Study|Disease Progression|1|||
124786925|NCT01451437|448850345|FG003|Overall Study|Disease Progression|1|||
124786926|NCT01451437|448850346|FG004|Overall Study|Disease Progression|3|||
124786927|NCT01451437|448850347|FG005|Overall Study|Disease Progression|2|||
124786928|NCT01451437|448850348|FG006|Overall Study|Disease Progression|3|||
124786929|NCT01451437|448850349|FG007|Overall Study|Disease Progression|1|||
124786930|NCT01451437|448850350|FG008|Overall Study|Disease Progression|3|||
124786931|NCT01451437|448850342|FG000|Overall Study|Protocol Violation|0|||
124786932|NCT01451437|448850343|FG001|Overall Study|Protocol Violation|0|||
124786933|NCT01451437|448850344|FG002|Overall Study|Protocol Violation|0|||
124786934|NCT01451437|448850345|FG003|Overall Study|Protocol Violation|0|||
124786935|NCT01451437|448850346|FG004|Overall Study|Protocol Violation|0|||
124786936|NCT01451437|448850347|FG005|Overall Study|Protocol Violation|0|||
124786937|NCT01451437|448850348|FG006|Overall Study|Protocol Violation|1|||
124786938|NCT01451437|448850349|FG007|Overall Study|Protocol Violation|0|||
124786939|NCT01451437|448850350|FG008|Overall Study|Protocol Violation|0|||
124786940|NCT01451437|448850342|FG000|Overall Study|Withdrawal by Subject|0|||
124786941|NCT01451437|448850343|FG001|Overall Study|Withdrawal by Subject|0|||
124786942|NCT01451437|448850344|FG002|Overall Study|Withdrawal by Subject|0|||
124786943|NCT01451437|448850345|FG003|Overall Study|Withdrawal by Subject|0|||
124786944|NCT01451437|448850346|FG004|Overall Study|Withdrawal by Subject|1|||
124786945|NCT01451437|448850347|FG005|Overall Study|Withdrawal by Subject|0|||
124786946|NCT01451437|448850348|FG006|Overall Study|Withdrawal by Subject|1|||
124786947|NCT01451437|448850349|FG007|Overall Study|Withdrawal by Subject|0|||
124786948|NCT01451437|448850350|FG008|Overall Study|Withdrawal by Subject|0|||
124786949|NCT03254108|448852334|FG000|Overall Study|Adverse Event|0|||
124786950|NCT03254108|448852335|FG001|Overall Study|Adverse Event|2|||
124786951|NCT03254108|448852336|FG002|Overall Study|Adverse Event|0|||
124786952|NCT03254108|448852337|FG003|Overall Study|Adverse Event|1|||
124786953|NCT03254108|448852338|FG004|Overall Study|Adverse Event|1|||
124786954|NCT03254108|448852334|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
124786955|NCT03254108|448852335|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
124786956|NCT03254108|448852336|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
124786957|NCT03254108|448852337|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
124786958|NCT03254108|448852338|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
124786959|NCT00490529|448852340|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
124786960|NCT00490529|448852340|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
124786961|NCT00490529|448852340|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
124786962|NCT00490529|448852340|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
124786963|NCT00490529|448852340|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
124786964|NCT00490529|448852340|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
124786965|NCT03254459|448852341|FG000|Overall Study|Adverse Event|7|||
124786966|NCT03254459|448852342|FG001|Overall Study|Adverse Event|20|||
124786967|NCT03254459|448852341|FG000|Overall Study|Withdrawal by Subject Consent|3|||
124786968|NCT03254459|448852342|FG001|Overall Study|Withdrawal by Subject Consent|1|||
124786969|NCT03254459|448852341|FG000|Overall Study|Lost to Follow-up|0|||
124786970|NCT03254459|448852342|FG001|Overall Study|Lost to Follow-up|1|||
124786971|NCT03254459|448852341|FG000|Overall Study|Miscellaneous|0|||
124786972|NCT03254459|448852342|FG001|Overall Study|Miscellaneous|1|||
124786973|NCT00727441|448852343|FG000|Overall Study|Disease Progression|11|||
124786974|NCT00727441|448852344|FG001|Overall Study|Disease Progression|14|||
124786975|NCT00727441|448852345|FG002|Overall Study|Disease Progression|17|||
124786976|NCT00727441|448852343|FG000|Overall Study|Eligibility|7|||
124786977|NCT00727441|448852344|FG001|Overall Study|Eligibility|5|||
124786978|NCT00727441|448852345|FG002|Overall Study|Eligibility|7|||
124786979|NCT00727441|448852343|FG000|Overall Study|Death|0|||
124786980|NCT00727441|448852344|FG001|Overall Study|Death|1|||
124786981|NCT00727441|448852345|FG002|Overall Study|Death|1|||
124786982|NCT00727441|448852343|FG000|Overall Study|Physician Decision|0|||
124786983|NCT00727441|448852344|FG001|Overall Study|Physician Decision|1|||
124786984|NCT00727441|448852345|FG002|Overall Study|Physician Decision|0|||
124786985|NCT00727441|448852343|FG000|Overall Study|Withdrawal by Subject|0|||
124786986|NCT00727441|448852344|FG001|Overall Study|Withdrawal by Subject|1|||
124786987|NCT00727441|448852345|FG002|Overall Study|Withdrawal by Subject|0|||
124786988|NCT00535288|448852346|FG000|Overall Study|Adverse Event|20|||
124786989|NCT00535288|448852347|FG001|Overall Study|Adverse Event|19|||
124786990|NCT00535288|448852348|FG002|Overall Study|Adverse Event|25|||
124786991|NCT00535288|448852349|FG003|Overall Study|Adverse Event|20|||
124786992|NCT00535288|448852350|FG004|Overall Study|Adverse Event|30|||
124786993|NCT00535288|448852346|FG000|Overall Study|Lost to Follow-up|0|||
124786994|NCT00535288|448852347|FG001|Overall Study|Lost to Follow-up|3|||
124786995|NCT00535288|448852348|FG002|Overall Study|Lost to Follow-up|0|||
124786996|NCT00535288|448852349|FG003|Overall Study|Lost to Follow-up|0|||
124786997|NCT00535288|448852350|FG004|Overall Study|Lost to Follow-up|0|||
124786998|NCT00535288|448852346|FG000|Overall Study|Lack of Efficacy|26|||
124786999|NCT00535288|448852347|FG001|Overall Study|Lack of Efficacy|3|||
124787000|NCT00535288|448852348|FG002|Overall Study|Lack of Efficacy|4|||
124787001|NCT00535288|448852349|FG003|Overall Study|Lack of Efficacy|4|||
124787002|NCT00535288|448852350|FG004|Overall Study|Lack of Efficacy|7|||
124787003|NCT00535288|448852346|FG000|Overall Study|Unwilling to cooperate|6|||
124787004|NCT00535288|448852347|FG001|Overall Study|Unwilling to cooperate|6|||
124787005|NCT00535288|448852348|FG002|Overall Study|Unwilling to cooperate|3|||
124787006|NCT00535288|448852349|FG003|Overall Study|Unwilling to cooperate|3|||
124787007|NCT00535288|448852350|FG004|Overall Study|Unwilling to cooperate|4|||
124787008|NCT00535288|448852346|FG000|Overall Study|Other|2|||
124787009|NCT00535288|448852347|FG001|Overall Study|Other|1|||
124787010|NCT00535288|448852348|FG002|Overall Study|Other|1|||
124787011|NCT00535288|448852349|FG003|Overall Study|Other|2|||
124787012|NCT00535288|448852350|FG004|Overall Study|Other|1|||
124787013|NCT00745849|448852351|FG000|First Intervention|Withdrawal by Subject|0|||
124787014|NCT00745849|448852352|FG001|First Intervention|Withdrawal by Subject|1|||
124787015|NCT00745849|448852351|FG000|First Intervention|Lost to Follow-up|1|||
124787016|NCT00745849|448852352|FG001|First Intervention|Lost to Follow-up|1|||
124787017|NCT00745849|448852351|FG000|Second Intervention|Lost to Follow-up|2|||
124787018|NCT00745849|448852352|FG001|Second Intervention|Lost to Follow-up|1|||
124787019|NCT01129583|448852353|FG000|Overall Study|Death|1|||
124787020|NCT01129583|448852354|FG001|Overall Study|Death|0|||
124787021|NCT01129583|448852353|FG000|Overall Study|Lost to Follow-up|1|||
124787022|NCT01129583|448852354|FG001|Overall Study|Lost to Follow-up|1|||
124787023|NCT01129583|448852353|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
124787024|NCT01129583|448852354|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
124787025|NCT02600871|448852355|FG000|Overall Study|Lost to Follow-up|13|||
124787026|NCT02600871|448852356|FG001|Overall Study|Lost to Follow-up|10|||
124787027|NCT00830869|448852359|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
124787028|NCT00830869|448852360|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
124787029|NCT00830869|448852361|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
124787030|NCT00830869|448852362|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
124787031|NCT00830869|448852363|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
124787032|NCT00830869|448852364|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
124787033|NCT00830869|448852365|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
124787034|NCT00830869|448852366|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
124787035|NCT00830869|448852367|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
124787036|NCT00830869|448852368|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
124787037|NCT00830869|448852369|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
124787038|NCT00830869|448852370|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
124787039|NCT00830869|448852359|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
124787040|NCT00830869|448852360|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
124787041|NCT00830869|448852361|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
124787042|NCT00830869|448852362|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
124787043|NCT00830869|448852363|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
124787044|NCT00830869|448852364|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
124787045|NCT00830869|448852365|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
124787046|NCT00830869|448852366|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
124787047|NCT00830869|448852367|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
124787048|NCT00830869|448852368|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
124787049|NCT00830869|448852369|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
124787050|NCT00830869|448852370|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
124787051|NCT00830869|448852359|FG000|Period 1: Part 1|Adverse Event|0|||
124787052|NCT00830869|448852360|FG001|Period 1: Part 1|Adverse Event|0|||
124787053|NCT00830869|448852361|FG002|Period 1: Part 1|Adverse Event|0|||
124787054|NCT00830869|448852362|FG003|Period 1: Part 1|Adverse Event|0|||
124787055|NCT00830869|448852363|FG004|Period 1: Part 1|Adverse Event|0|||
124787056|NCT00830869|448852364|FG005|Period 1: Part 1|Adverse Event|1|||
124787057|NCT00830869|448852365|FG006|Period 1: Part 1|Adverse Event|1|||
124787058|NCT00830869|448852366|FG007|Period 1: Part 1|Adverse Event|0|||
124787059|NCT00830869|448852367|FG008|Period 1: Part 1|Adverse Event|0|||
124787060|NCT00830869|448852368|FG009|Period 1: Part 1|Adverse Event|0|||
124787061|NCT00830869|448852369|FG010|Period 1: Part 1|Adverse Event|0|||
124787062|NCT00830869|448852370|FG011|Period 1: Part 1|Adverse Event|0|||
124787063|NCT00830869|448852359|FG000|Period 1: Part 1|Progressive disease|1|||
124787064|NCT00830869|448852360|FG001|Period 1: Part 1|Progressive disease|0|||
124787065|NCT00830869|448852361|FG002|Period 1: Part 1|Progressive disease|1|||
124787066|NCT00830869|448852362|FG003|Period 1: Part 1|Progressive disease|6|||
124787067|NCT00830869|448852363|FG004|Period 1: Part 1|Progressive disease|4|||
124787068|NCT00830869|448852364|FG005|Period 1: Part 1|Progressive disease|4|||
124787069|NCT00830869|448852365|FG006|Period 1: Part 1|Progressive disease|1|||
124787070|NCT00830869|448852366|FG007|Period 1: Part 1|Progressive disease|0|||
124787071|NCT00830869|448852367|FG008|Period 1: Part 1|Progressive disease|0|||
124787072|NCT00830869|448852368|FG009|Period 1: Part 1|Progressive disease|0|||
124787073|NCT00830869|448852369|FG010|Period 1: Part 1|Progressive disease|0|||
124787074|NCT00830869|448852370|FG011|Period 1: Part 1|Progressive disease|0|||
124787075|NCT00830869|448852359|FG000|Period 2: Part 2|Protocol Violation|0|||
124787076|NCT00830869|448852360|FG001|Period 2: Part 2|Protocol Violation|0|||
124787077|NCT00830869|448852361|FG002|Period 2: Part 2|Protocol Violation|0|||
124787078|NCT00830869|448852362|FG003|Period 2: Part 2|Protocol Violation|0|||
124787079|NCT00830869|448852363|FG004|Period 2: Part 2|Protocol Violation|0|||
124787080|NCT00830869|448852364|FG005|Period 2: Part 2|Protocol Violation|0|||
124787081|NCT00830869|448852365|FG006|Period 2: Part 2|Protocol Violation|0|||
124787082|NCT00830869|448852366|FG007|Period 2: Part 2|Protocol Violation|1|||
124787083|NCT00830869|448852367|FG008|Period 2: Part 2|Protocol Violation|0|||
124787084|NCT00830869|448852368|FG009|Period 2: Part 2|Protocol Violation|1|||
124787085|NCT00830869|448852369|FG010|Period 2: Part 2|Protocol Violation|0|||
124787086|NCT00830869|448852370|FG011|Period 2: Part 2|Protocol Violation|0|||
124787087|NCT00830869|448852359|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
124787088|NCT00830869|448852360|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
124787089|NCT00830869|448852361|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
124787090|NCT00830869|448852362|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
124787091|NCT00830869|448852363|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
124787092|NCT00830869|448852364|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
124787093|NCT00830869|448852365|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
124787094|NCT00830869|448852366|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
124787095|NCT00830869|448852367|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
124787096|NCT00830869|448852368|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
124787097|NCT00830869|448852369|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
124787098|NCT00830869|448852370|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
124787099|NCT00830869|448852359|FG000|Period 2: Part 2|Adverse Event|0|||
124787100|NCT00830869|448852360|FG001|Period 2: Part 2|Adverse Event|0|||
124787101|NCT00830869|448852361|FG002|Period 2: Part 2|Adverse Event|0|||
124787102|NCT00830869|448852362|FG003|Period 2: Part 2|Adverse Event|0|||
124787103|NCT00830869|448852363|FG004|Period 2: Part 2|Adverse Event|0|||
124787104|NCT00830869|448852364|FG005|Period 2: Part 2|Adverse Event|0|||
124787105|NCT00830869|448852365|FG006|Period 2: Part 2|Adverse Event|0|||
124787106|NCT00830869|448852366|FG007|Period 2: Part 2|Adverse Event|4|||
124787107|NCT00830869|448852367|FG008|Period 2: Part 2|Adverse Event|3|||
124787108|NCT00830869|448852368|FG009|Period 2: Part 2|Adverse Event|2|||
124787109|NCT00830869|448852369|FG010|Period 2: Part 2|Adverse Event|2|||
124787110|NCT00830869|448852370|FG011|Period 2: Part 2|Adverse Event|0|||
124787111|NCT00830869|448852359|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
124787112|NCT00830869|448852360|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
124787113|NCT00830869|448852361|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
124787114|NCT00830869|448852362|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
124787115|NCT00830869|448852363|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
124787116|NCT00830869|448852364|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
124787117|NCT00830869|448852365|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
124787118|NCT00830869|448852366|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
124787119|NCT00830869|448852367|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
124787120|NCT00830869|448852368|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
124787121|NCT00830869|448852369|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
124787122|NCT00830869|448852370|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
124787123|NCT00830869|448852359|FG000|Period 2: Part 2|Progressive disease|0|||
124787124|NCT00830869|448852360|FG001|Period 2: Part 2|Progressive disease|0|||
124787125|NCT00830869|448852361|FG002|Period 2: Part 2|Progressive disease|0|||
124787126|NCT00830869|448852362|FG003|Period 2: Part 2|Progressive disease|0|||
124787127|NCT00830869|448852363|FG004|Period 2: Part 2|Progressive disease|0|||
124787128|NCT00830869|448852364|FG005|Period 2: Part 2|Progressive disease|0|||
124787129|NCT00830869|448852365|FG006|Period 2: Part 2|Progressive disease|0|||
124787130|NCT00830869|448852366|FG007|Period 2: Part 2|Progressive disease|14|||
124787131|NCT00830869|448852367|FG008|Period 2: Part 2|Progressive disease|11|||
124787132|NCT00830869|448852368|FG009|Period 2: Part 2|Progressive disease|12|||
125292202|NCT00996801|450696555|FG004|Overall Study|Progressive Disease|0|||
125292203|NCT00996801|450696556|FG005|Overall Study|Progressive Disease|0|||
124787133|NCT00830869|448852369|FG010|Period 2: Part 2|Progressive disease|8|||
124787134|NCT00830869|448852370|FG011|Period 2: Part 2|Progressive disease|15|||
124787135|NCT00830869|448852359|FG000|Period 2: Part 2|Other|0|||
124787136|NCT00830869|448852360|FG001|Period 2: Part 2|Other|0|||
124787137|NCT00830869|448852361|FG002|Period 2: Part 2|Other|0|||
124787138|NCT00830869|448852362|FG003|Period 2: Part 2|Other|0|||
124787139|NCT00830869|448852363|FG004|Period 2: Part 2|Other|0|||
124787140|NCT00830869|448852364|FG005|Period 2: Part 2|Other|0|||
124787141|NCT00830869|448852365|FG006|Period 2: Part 2|Other|0|||
124787142|NCT00830869|448852366|FG007|Period 2: Part 2|Other|0|||
124787143|NCT00830869|448852367|FG008|Period 2: Part 2|Other|0|||
124787144|NCT00830869|448852368|FG009|Period 2: Part 2|Other|1|||
124787145|NCT00830869|448852369|FG010|Period 2: Part 2|Other|0|||
124787146|NCT00830869|448852370|FG011|Period 2: Part 2|Other|0|||
124787147|NCT03745820|448852371|FG000|Overall Study|Adverse Event|0|||
124787148|NCT03745820|448852372|FG001|Overall Study|Adverse Event|3|||
124787149|NCT03745820|448852373|FG002|Overall Study|Adverse Event|2|||
124787150|NCT03745820|448852371|FG000|Overall Study|Non-Compliance with Study Drug|4|||
124787151|NCT03745820|448852372|FG001|Overall Study|Non-Compliance with Study Drug|3|||
124787152|NCT03745820|448852373|FG002|Overall Study|Non-Compliance with Study Drug|0|||
124787153|NCT03745820|448852371|FG000|Overall Study|Withdrawal by Subject|4|||
124787154|NCT03745820|448852372|FG001|Overall Study|Withdrawal by Subject|4|||
125292204|NCT00996801|450696551|FG000|Overall Study|Protocol Violation|3|||
124787155|NCT03745820|448852373|FG002|Overall Study|Withdrawal by Subject|4|||
124787156|NCT03745820|448852371|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
124787157|NCT03745820|448852372|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
124787158|NCT03745820|448852373|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
124787159|NCT03745820|448852371|FG000|Overall Study|Lost to Follow-up|2|||
124787160|NCT03745820|448852372|FG001|Overall Study|Lost to Follow-up|0|||
124787161|NCT03745820|448852373|FG002|Overall Study|Lost to Follow-up|3|||
125292205|NCT00996801|450696552|FG001|Overall Study|Protocol Violation|4|||
124787162|NCT03745820|448852371|FG000|Overall Study|Reason not Specified|2|||
124787163|NCT03745820|448852372|FG001|Overall Study|Reason not Specified|4|||
124787164|NCT03745820|448852373|FG002|Overall Study|Reason not Specified|1|||
124787165|NCT00668733|448852377|FG000|Overall Study|Lost to Follow-up|2|||
124787166|NCT00668733|448852378|FG001|Overall Study|Lost to Follow-up|3|||
124787167|NCT00668733|448852377|FG000|Overall Study|Withdrawal by Subject|0|||
124787168|NCT00668733|448852378|FG001|Overall Study|Withdrawal by Subject|4|||
124787169|NCT00945906|448852382|FG000|Overall Study|Withdrawal by Subject|1|||
124787170|NCT00945906|448852382|FG000|Overall Study|Did not want to return for last visit|2|||
124787171|NCT00945906|448852382|FG000|Overall Study|Unable to return for last visit|2|||
124787172|NCT00945906|448852382|FG000|Overall Study|Moved to another country|2|||
124787173|NCT00797966|448852383|FG000|Phase A|Lost to Follow-up|0|||
124787174|NCT00797966|448852384|FG001|Phase A|Lost to Follow-up|0|||
124787175|NCT00797966|448852385|FG002|Phase A|Lost to Follow-up|0|||
124787176|NCT00797966|448852386|FG003|Phase A|Lost to Follow-up|0|||
124787177|NCT00797966|448852387|FG004|Phase A|Lost to Follow-up|33|||
124787178|NCT00797966|448852388|FG005|Phase A|Lost to Follow-up|0|||
124787179|NCT00797966|448852383|FG000|Phase A|Adverse Event|0|||
124787180|NCT00797966|448852384|FG001|Phase A|Adverse Event|0|||
124787181|NCT00797966|448852385|FG002|Phase A|Adverse Event|0|||
124787182|NCT00797966|448852386|FG003|Phase A|Adverse Event|0|||
124787183|NCT00797966|448852387|FG004|Phase A|Adverse Event|46|||
124787184|NCT00797966|448852388|FG005|Phase A|Adverse Event|0|||
124787185|NCT00797966|448852383|FG000|Phase A|Met withdrawal criteria|0|||
124787186|NCT00797966|448852384|FG001|Phase A|Met withdrawal criteria|0|||
124787187|NCT00797966|448852385|FG002|Phase A|Met withdrawal criteria|0|||
124787188|NCT00797966|448852386|FG003|Phase A|Met withdrawal criteria|0|||
124787189|NCT00797966|448852387|FG004|Phase A|Met withdrawal criteria|4|||
124787190|NCT00797966|448852388|FG005|Phase A|Met withdrawal criteria|0|||
124787191|NCT00797966|448852383|FG000|Phase A|Physician Decision|0|||
124787192|NCT00797966|448852384|FG001|Phase A|Physician Decision|0|||
124787193|NCT00797966|448852385|FG002|Phase A|Physician Decision|0|||
124787194|NCT00797966|448852386|FG003|Phase A|Physician Decision|0|||
124787195|NCT00797966|448852387|FG004|Phase A|Physician Decision|13|||
124787196|NCT00797966|448852388|FG005|Phase A|Physician Decision|0|||
124787197|NCT00797966|448852383|FG000|Phase A|Withdrawal by Subject|0|||
124787198|NCT00797966|448852384|FG001|Phase A|Withdrawal by Subject|0|||
124787199|NCT00797966|448852385|FG002|Phase A|Withdrawal by Subject|0|||
124787200|NCT00797966|448852386|FG003|Phase A|Withdrawal by Subject|0|||
124787201|NCT00797966|448852387|FG004|Phase A|Withdrawal by Subject|33|||
124787202|NCT00797966|448852388|FG005|Phase A|Withdrawal by Subject|0|||
124787203|NCT00797966|448852383|FG000|Phase A|Protocol deviation|0|||
124787204|NCT00797966|448852384|FG001|Phase A|Protocol deviation|0|||
124787205|NCT00797966|448852385|FG002|Phase A|Protocol deviation|0|||
124787206|NCT00797966|448852386|FG003|Phase A|Protocol deviation|0|||
124787207|NCT00797966|448852387|FG004|Phase A|Protocol deviation|56|||
124787208|NCT00797966|448852388|FG005|Phase A|Protocol deviation|0|||
124787209|NCT00797966|448852383|FG000|Phase B|Lost to Follow-up|0|||
124787210|NCT00797966|448852384|FG001|Phase B|Lost to Follow-up|1|||
124787211|NCT00797966|448852385|FG002|Phase B|Lost to Follow-up|3|||
124787212|NCT00797966|448852386|FG003|Phase B|Lost to Follow-up|0|||
124787213|NCT00797966|448852387|FG004|Phase B|Lost to Follow-up|0|||
124787214|NCT00797966|448852388|FG005|Phase B|Lost to Follow-up|0|||
124787215|NCT00797966|448852383|FG000|Phase B|Adverse Event|2|||
124787216|NCT00797966|448852384|FG001|Phase B|Adverse Event|1|||
124787217|NCT00797966|448852385|FG002|Phase B|Adverse Event|3|||
124787218|NCT00797966|448852386|FG003|Phase B|Adverse Event|1|||
124787219|NCT00797966|448852387|FG004|Phase B|Adverse Event|0|||
124787220|NCT00797966|448852388|FG005|Phase B|Adverse Event|0|||
124787221|NCT00797966|448852383|FG000|Phase B|Met Withdrawal Criteria|3|||
124787222|NCT00797966|448852384|FG001|Phase B|Met Withdrawal Criteria|3|||
124787223|NCT00797966|448852385|FG002|Phase B|Met Withdrawal Criteria|6|||
124787224|NCT00797966|448852386|FG003|Phase B|Met Withdrawal Criteria|1|||
124787225|NCT00797966|448852387|FG004|Phase B|Met Withdrawal Criteria|0|||
124787226|NCT00797966|448852388|FG005|Phase B|Met Withdrawal Criteria|0|||
124787227|NCT00797966|448852383|FG000|Phase B|Physician Decision|1|||
124787228|NCT00797966|448852384|FG001|Phase B|Physician Decision|0|||
124787229|NCT00797966|448852385|FG002|Phase B|Physician Decision|3|||
124787230|NCT00797966|448852386|FG003|Phase B|Physician Decision|1|||
124787231|NCT00797966|448852387|FG004|Phase B|Physician Decision|0|||
124787232|NCT00797966|448852388|FG005|Phase B|Physician Decision|0|||
124787233|NCT00797966|448852383|FG000|Phase B|Withdrawal by Subject|1|||
124787234|NCT00797966|448852384|FG001|Phase B|Withdrawal by Subject|4|||
124787235|NCT00797966|448852385|FG002|Phase B|Withdrawal by Subject|3|||
124787236|NCT00797966|448852386|FG003|Phase B|Withdrawal by Subject|3|||
124787237|NCT00797966|448852387|FG004|Phase B|Withdrawal by Subject|0|||
124787238|NCT00797966|448852388|FG005|Phase B|Withdrawal by Subject|0|||
124787239|NCT00797966|448852383|FG000|Phase B|Protocol Deviation|4|||
124787240|NCT00797966|448852384|FG001|Phase B|Protocol Deviation|8|||
124787241|NCT00797966|448852385|FG002|Phase B|Protocol Deviation|2|||
124787242|NCT00797966|448852386|FG003|Phase B|Protocol Deviation|6|||
124787243|NCT00797966|448852387|FG004|Phase B|Protocol Deviation|0|||
124787244|NCT00797966|448852388|FG005|Phase B|Protocol Deviation|0|||
124787245|NCT00797966|448852383|FG000|Phase B|Lack of Efficacy|0|||
124787246|NCT00797966|448852384|FG001|Phase B|Lack of Efficacy|1|||
124787247|NCT00797966|448852385|FG002|Phase B|Lack of Efficacy|1|||
124787248|NCT00797966|448852386|FG003|Phase B|Lack of Efficacy|4|||
124787249|NCT00797966|448852387|FG004|Phase B|Lack of Efficacy|0|||
124787250|NCT00797966|448852388|FG005|Phase B|Lack of Efficacy|0|||
124787251|NCT00797966|448852383|FG000|Phase A+|Lost to Follow-up|0|||
124787252|NCT00797966|448852384|FG001|Phase A+|Lost to Follow-up|0|||
124787253|NCT00797966|448852385|FG002|Phase A+|Lost to Follow-up|0|||
124787254|NCT00797966|448852386|FG003|Phase A+|Lost to Follow-up|0|||
124787255|NCT00797966|448852387|FG004|Phase A+|Lost to Follow-up|0|||
124787256|NCT00797966|448852388|FG005|Phase A+|Lost to Follow-up|9|||
124787257|NCT00797966|448852383|FG000|Phase A+|Met withdrawal criteria|0|||
124787258|NCT00797966|448852384|FG001|Phase A+|Met withdrawal criteria|0|||
124787259|NCT00797966|448852385|FG002|Phase A+|Met withdrawal criteria|0|||
124787260|NCT00797966|448852386|FG003|Phase A+|Met withdrawal criteria|0|||
124787261|NCT00797966|448852387|FG004|Phase A+|Met withdrawal criteria|0|||
124787262|NCT00797966|448852388|FG005|Phase A+|Met withdrawal criteria|5|||
124787263|NCT00797966|448852383|FG000|Phase A+|Withdrawal by Subject|0|||
124787264|NCT00797966|448852384|FG001|Phase A+|Withdrawal by Subject|0|||
124787265|NCT00797966|448852385|FG002|Phase A+|Withdrawal by Subject|0|||
124787266|NCT00797966|448852386|FG003|Phase A+|Withdrawal by Subject|0|||
124787267|NCT00797966|448852387|FG004|Phase A+|Withdrawal by Subject|0|||
124787268|NCT00797966|448852388|FG005|Phase A+|Withdrawal by Subject|6|||
124787269|NCT00797966|448852383|FG000|Phase A+|Adverse Event|0|||
124787270|NCT00797966|448852384|FG001|Phase A+|Adverse Event|0|||
124787271|NCT00797966|448852385|FG002|Phase A+|Adverse Event|0|||
124787272|NCT00797966|448852386|FG003|Phase A+|Adverse Event|0|||
124787273|NCT00797966|448852387|FG004|Phase A+|Adverse Event|0|||
124787274|NCT00797966|448852388|FG005|Phase A+|Adverse Event|4|||
124787275|NCT00797966|448852383|FG000|Phase A+|Protocol deviation|0|||
124787276|NCT00797966|448852384|FG001|Phase A+|Protocol deviation|0|||
124787277|NCT00797966|448852385|FG002|Phase A+|Protocol deviation|0|||
124787278|NCT00797966|448852386|FG003|Phase A+|Protocol deviation|0|||
124787279|NCT00797966|448852387|FG004|Phase A+|Protocol deviation|0|||
124787280|NCT00797966|448852388|FG005|Phase A+|Protocol deviation|4|||
124787281|NCT03859973|448852389|FG000|Overall Study|Other reason than listed|3|||
124787282|NCT03859973|448852390|FG001|Overall Study|Other reason than listed|2|||
124787283|NCT03859973|448852389|FG000|Overall Study|COVID-19 related, not due to AE|3|||
124787284|NCT03859973|448852390|FG001|Overall Study|COVID-19 related, not due to AE|4|||
124787285|NCT03859973|448852389|FG000|Overall Study|Withdrawal by Subject|8|||
124787286|NCT03859973|448852390|FG001|Overall Study|Withdrawal by Subject|9|||
124787287|NCT03859973|448852389|FG000|Overall Study|Lost to Follow-up|2|||
124787288|NCT03859973|448852390|FG001|Overall Study|Lost to Follow-up|3|||
124787289|NCT03859973|448852389|FG000|Overall Study|Protocol Violation|1|||
124787290|NCT03859973|448852390|FG001|Overall Study|Protocol Violation|3|||
124787291|NCT03859973|448852389|FG000|Overall Study|Adverse Event|3|||
124787292|NCT03859973|448852390|FG001|Overall Study|Adverse Event|5|||
124787293|NCT01478048|448852391|FG000|Overall Study|Disease Progression|52|||
124787294|NCT01478048|448852392|FG001|Overall Study|Disease Progression|35|||
124787295|NCT01478048|448852391|FG000|Overall Study|study drug toxicity|11|||
124787296|NCT01478048|448852392|FG001|Overall Study|study drug toxicity|14|||
124787297|NCT01478048|448852391|FG000|Overall Study|Adverse Event|2|||
124787298|NCT01478048|448852392|FG001|Overall Study|Adverse Event|11|||
124787299|NCT01478048|448852391|FG000|Overall Study|subject request to discontinue treatment|3|||
124787300|NCT01478048|448852392|FG001|Overall Study|subject request to discontinue treatment|5|||
124787301|NCT01478048|448852391|FG000|Overall Study|Withdrawal by Subject|2|||
124787302|NCT01478048|448852392|FG001|Overall Study|Withdrawal by Subject|5|||
124787303|NCT01478048|448852391|FG000|Overall Study|non-specified|6|||
124787304|NCT01478048|448852392|FG001|Overall Study|non-specified|4|||
124787305|NCT01478048|448852391|FG000|Overall Study|poor/non-compliance|0|||
124787306|NCT01478048|448852392|FG001|Overall Study|poor/non-compliance|1|||
124787307|NCT01478048|448852391|FG000|Overall Study|no longer meets study criteria|1|||
124787308|NCT01478048|448852392|FG001|Overall Study|no longer meets study criteria|0|||
124787309|NCT03032380|448852401|FG000|Overall Study|Adverse Event|0|||
124787310|NCT03032380|448852402|FG001|Overall Study|Adverse Event|1|||
124787311|NCT03032380|448852401|FG000|Overall Study|Lack of Efficacy|1|||
124787312|NCT03032380|448852402|FG001|Overall Study|Lack of Efficacy|0|||
124787313|NCT03032380|448852401|FG000|Overall Study|Withdrawal by Subject|2|||
124787314|NCT03032380|448852402|FG001|Overall Study|Withdrawal by Subject|3|||
124787315|NCT03032380|448852401|FG000|Overall Study|Recovery|0|||
124787316|NCT03032380|448852402|FG001|Overall Study|Recovery|1|||
124787317|NCT03032380|448852401|FG000|Overall Study|Death|39|||
124787318|NCT03032380|448852402|FG001|Overall Study|Death|34|||
124787319|NCT03032380|448852401|FG000|Overall Study|Other - Miscellaneous|0|||
124787320|NCT03032380|448852402|FG001|Overall Study|Other - Miscellaneous|1|||
124787321|NCT01561898|448852403|FG000|Overall Study|Withdrawal by Subject|0|||
124787322|NCT01561898|448852404|FG001|Overall Study|Withdrawal by Subject|8|||
124787323|NCT01561898|448852405|FG002|Overall Study|Withdrawal by Subject|12|||
124787324|NCT01561898|448852406|FG003|Overall Study|Withdrawal by Subject|5|||
124787325|NCT01561898|448852403|FG000|Overall Study|Lack of Efficacy|0|||
124787326|NCT01561898|448852404|FG001|Overall Study|Lack of Efficacy|8|||
124787327|NCT01561898|448852405|FG002|Overall Study|Lack of Efficacy|10|||
124787328|NCT01561898|448852406|FG003|Overall Study|Lack of Efficacy|5|||
124787329|NCT01561898|448852403|FG000|Overall Study|Worsening of complications|0|||
124787330|NCT01561898|448852404|FG001|Overall Study|Worsening of complications|1|||
124787331|NCT01561898|448852405|FG002|Overall Study|Worsening of complications|0|||
124787332|NCT01561898|448852406|FG003|Overall Study|Worsening of complications|0|||
124787333|NCT01561898|448852403|FG000|Overall Study|Lost to Follow-up|0|||
124787334|NCT01561898|448852404|FG001|Overall Study|Lost to Follow-up|0|||
124787335|NCT01561898|448852405|FG002|Overall Study|Lost to Follow-up|1|||
124787336|NCT01561898|448852406|FG003|Overall Study|Lost to Follow-up|0|||
124787337|NCT01561898|448852403|FG000|Overall Study|Adverse Event|1|||
124787338|NCT01561898|448852404|FG001|Overall Study|Adverse Event|19|||
124787339|NCT01561898|448852405|FG002|Overall Study|Adverse Event|14|||
124787340|NCT01561898|448852406|FG003|Overall Study|Adverse Event|9|||
124787341|NCT01561898|448852403|FG000|Overall Study|Physician Decision|1|||
124787342|NCT01561898|448852404|FG001|Overall Study|Physician Decision|5|||
124787343|NCT01561898|448852405|FG002|Overall Study|Physician Decision|7|||
124787344|NCT01561898|448852406|FG003|Overall Study|Physician Decision|1|||
124787345|NCT00294762|448852407|FG000|Overall Study|Did not receive study treatment|3|||
124787346|NCT00294762|448852408|FG001|Overall Study|Did not receive study treatment|3|||
124787347|NCT02238080|448852409|FG000|Overall Study|Death|13|||
124787348|NCT02238080|448852409|FG000|Overall Study|Treatment interrupted|6|||
124787349|NCT02238080|448852409|FG000|Overall Study|Withdrawal by Subject|2|||
124787350|NCT02238080|448852409|FG000|Overall Study|Other|4|||
124787351|NCT01738646|448852410|FG000|Overall Study|Still Receiving Treatment|2|||
124787352|NCT04093024|448852413|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
124787353|NCT04093024|448852414|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
124787354|NCT04093024|448852413|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
124787355|NCT04093024|448852414|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
124787356|NCT04093024|448852413|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
124787357|NCT04093024|448852414|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
124787358|NCT04093024|448852413|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
124787359|NCT04093024|448852414|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
124787360|NCT00233454|448852417|FG000|Overall Study|Death|6|||
124787361|NCT00796445|448852418|FG000|Overall Study|Protocol Violation|5|||
124787362|NCT00796445|448852419|FG001|Overall Study|Protocol Violation|3|||
124787363|NCT00796445|448852418|FG000|Overall Study|Adverse event, serious fatal|10|||
124787364|NCT00796445|448852419|FG001|Overall Study|Adverse event, serious fatal|5|||
124787365|NCT00796445|448852418|FG000|Overall Study|Adverse event, non-fatal|4|||
124787366|NCT00796445|448852419|FG001|Overall Study|Adverse event, non-fatal|0|||
124787367|NCT00796445|448852418|FG000|Overall Study|Disease progression/recurrence|537|||
124787368|NCT00796445|448852419|FG001|Overall Study|Disease progression/recurrence|268|||
124787369|NCT00796445|448852418|FG000|Overall Study|Other|10|||
124787370|NCT00796445|448852419|FG001|Overall Study|Other|7|||
124787371|NCT00796445|448852418|FG000|Overall Study|Withdrawal by Subject|18|||
124787372|NCT00796445|448852419|FG001|Overall Study|Withdrawal by Subject|9|||
124787373|NCT00796445|448852418|FG000|Overall Study|Invalid Informed Consent Form|1|||
124787374|NCT00796445|448852419|FG001|Overall Study|Invalid Informed Consent Form|0|||
124787375|NCT02366091|448852420|FG000|Overall Study|Withdrawal by Subject|3|||
124787376|NCT02366091|448852421|FG001|Overall Study|Withdrawal by Subject|7|||
124787377|NCT02366091|448852422|FG002|Overall Study|Withdrawal by Subject|3|||
124787378|NCT02366091|448852423|FG003|Overall Study|Withdrawal by Subject|1|||
124787379|NCT00322621|448852424|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
124787380|NCT00322621|448852425|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
124787381|NCT00322621|448852426|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
124787382|NCT00322621|448852424|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
124787383|NCT00322621|448852425|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
124787384|NCT00322621|448852426|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
124787385|NCT00322621|448852424|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
124787386|NCT00322621|448852425|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
124787387|NCT00322621|448852426|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
124787388|NCT00322621|448852424|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
124787389|NCT00322621|448852425|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
124787390|NCT00322621|448852426|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
124787391|NCT00322621|448852424|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
124787392|NCT00322621|448852425|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
124787393|NCT00322621|448852426|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
124787394|NCT00322621|448852424|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
124787395|NCT00322621|448852425|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
124787396|NCT00322621|448852426|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
124787397|NCT00322621|448852424|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
124787398|NCT00322621|448852425|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
124787399|NCT00322621|448852426|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
124787400|NCT00322621|448852424|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
124787401|NCT00322621|448852425|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
124787402|NCT00322621|448852426|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
124787403|NCT00322621|448852424|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
124787404|NCT00322621|448852425|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
124787405|NCT00322621|448852426|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
124787406|NCT00322621|448852424|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
124787407|NCT00322621|448852425|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
124787408|NCT00322621|448852426|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
124787409|NCT00322621|448852424|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
124787410|NCT00322621|448852425|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
124787411|NCT00322621|448852426|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
124787412|NCT01743001|448852427|FG000|Overall Study|Physician Decision|1|||
124787413|NCT01743001|448852428|FG001|Overall Study|Physician Decision|0|||
124787414|NCT01743001|448852427|FG000|Overall Study|Pregnancy|1|||
124787415|NCT01743001|448852428|FG001|Overall Study|Pregnancy|0|||
124787416|NCT01743001|448852427|FG000|Overall Study|Death|1|||
124787417|NCT01743001|448852428|FG001|Overall Study|Death|0|||
124787418|NCT01565343|448852429|FG000|Overall Study|Administrative decision/technical issues|1|||
124787419|NCT01565343|448852430|FG001|Overall Study|Administrative decision/technical issues|0|||
124787420|NCT01565343|448852431|FG002|Overall Study|Administrative decision/technical issues|0|||
124787421|NCT01853839|448852433|FG000|Overall Study|Violated inclusion criteria|2|||
124787422|NCT01853839|448852433|FG000|Overall Study|Not meet ITT population definition|58|||
124787423|NCT01853839|448852433|FG000|Overall Study|End of treatment visit too early|33|||
124787424|NCT01853839|448852433|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
124787425|NCT02350764|448852434|FG000|Overall Study|Adverse Event|4|||
124787426|NCT02350764|448852434|FG000|Overall Study|Death|3|||
124787427|NCT02350764|448852434|FG000|Overall Study|Physician Decision|2|||
124787428|NCT02350764|448852434|FG000|Overall Study|Withdrawal by Subject|2|||
124787429|NCT03531632|448852435|FG000|Overall Study|Adverse Event|0|||
124787430|NCT03531632|448852436|FG001|Overall Study|Adverse Event|0|||
124787431|NCT03531632|448852437|FG002|Overall Study|Adverse Event|1|||
124787432|NCT03531632|448852435|FG000|Overall Study|Death|4|||
124787433|NCT03531632|448852436|FG001|Overall Study|Death|0|||
124787434|NCT03531632|448852437|FG002|Overall Study|Death|14|||
124787435|NCT03531632|448852435|FG000|Overall Study|Study Terminated|1|||
124787436|NCT03531632|448852436|FG001|Overall Study|Study Terminated|3|||
124787437|NCT03531632|448852437|FG002|Overall Study|Study Terminated|11|||
124787438|NCT00600119|448852438|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
124787439|NCT00600119|448852439|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
124787440|NCT00600119|448852440|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
124787441|NCT00600119|448852441|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
124787442|NCT00600119|448852442|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
124787443|NCT00600119|448852443|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
124787444|NCT00600119|448852438|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
124787445|NCT00600119|448852439|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
124787446|NCT00600119|448852440|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
124787447|NCT00600119|448852441|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
124787448|NCT00600119|448852442|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
124787449|NCT00600119|448852443|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
124787450|NCT00600119|448852438|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
124787451|NCT00600119|448852439|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
124787452|NCT00600119|448852440|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
124787453|NCT00600119|448852441|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
124787454|NCT00600119|448852442|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
124787455|NCT00600119|448852443|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
124787456|NCT00600119|448852438|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
124787457|NCT00600119|448852439|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
124787458|NCT00600119|448852440|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
124787459|NCT00600119|448852441|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
124787460|NCT00600119|448852442|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
124787461|NCT00600119|448852443|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
124787462|NCT00600119|448852438|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
124787463|NCT00600119|448852439|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
124787464|NCT00600119|448852440|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
124787465|NCT00600119|448852441|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
124787466|NCT00600119|448852442|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
124787467|NCT00600119|448852443|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
124787468|NCT00600119|448852438|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
124787469|NCT00600119|448852439|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
124787470|NCT00600119|448852440|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
124787471|NCT00600119|448852441|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
124787472|NCT00600119|448852442|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
125292206|NCT00996801|450696553|FG002|Overall Study|Protocol Violation|1|||
124787473|NCT00600119|448852443|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
124787474|NCT00600119|448852438|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
124787475|NCT00600119|448852439|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
124787476|NCT00600119|448852440|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
124787477|NCT00600119|448852441|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
124787478|NCT00600119|448852442|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
124787479|NCT00600119|448852443|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
124787480|NCT00600119|448852438|FG000|Double-blind Treatment Period|Other|0|||
124787481|NCT00600119|448852439|FG001|Double-blind Treatment Period|Other|0|||
124787482|NCT00600119|448852440|FG002|Double-blind Treatment Period|Other|0|||
124787483|NCT00600119|448852441|FG003|Double-blind Treatment Period|Other|0|||
124787484|NCT00600119|448852442|FG004|Double-blind Treatment Period|Other|2|||
124787485|NCT00600119|448852443|FG005|Double-blind Treatment Period|Other|1|||
124787486|NCT00600119|448852438|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
124787487|NCT00600119|448852439|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
124787488|NCT00600119|448852440|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
124787489|NCT00600119|448852441|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
124787490|NCT00600119|448852442|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
124787491|NCT00600119|448852443|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
124787492|NCT00600119|448852438|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
124787493|NCT00600119|448852439|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
124787494|NCT00600119|448852440|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
124787495|NCT00600119|448852441|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
124787496|NCT00600119|448852442|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
124787497|NCT00600119|448852443|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
124787498|NCT00600119|448852438|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
124787499|NCT00600119|448852439|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
124787500|NCT00600119|448852440|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
124787501|NCT00600119|448852441|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
124787502|NCT00600119|448852442|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
124787503|NCT00600119|448852443|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
124787504|NCT00600119|448852438|FG000|Double-blind Treatment Period|Physician Decision|2|||
124787505|NCT00600119|448852439|FG001|Double-blind Treatment Period|Physician Decision|0|||
124787506|NCT00600119|448852440|FG002|Double-blind Treatment Period|Physician Decision|0|||
124787507|NCT00600119|448852441|FG003|Double-blind Treatment Period|Physician Decision|0|||
124787508|NCT00600119|448852442|FG004|Double-blind Treatment Period|Physician Decision|0|||
124787509|NCT00600119|448852443|FG005|Double-blind Treatment Period|Physician Decision|0|||
124787510|NCT00600119|448852438|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
124787511|NCT00600119|448852439|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
124787512|NCT00600119|448852440|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
124787513|NCT00600119|448852441|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
124787514|NCT00600119|448852442|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
124787515|NCT00600119|448852443|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
124787516|NCT00600119|448852438|FG000|Double-blind Treatment Period|Adverse Event|1|||
124787517|NCT00600119|448852439|FG001|Double-blind Treatment Period|Adverse Event|1|||
124787518|NCT00600119|448852440|FG002|Double-blind Treatment Period|Adverse Event|0|||
124787519|NCT00600119|448852441|FG003|Double-blind Treatment Period|Adverse Event|1|||
124787520|NCT00600119|448852442|FG004|Double-blind Treatment Period|Adverse Event|2|||
124787521|NCT00600119|448852443|FG005|Double-blind Treatment Period|Adverse Event|10|||
124787522|NCT00600119|448852438|FG000|Follow-up Period|Adverse Event|0|||
124787523|NCT00600119|448852439|FG001|Follow-up Period|Adverse Event|0|||
124787524|NCT00600119|448852440|FG002|Follow-up Period|Adverse Event|0|||
124787525|NCT00600119|448852441|FG003|Follow-up Period|Adverse Event|0|||
124787526|NCT00600119|448852442|FG004|Follow-up Period|Adverse Event|0|||
124787527|NCT00600119|448852443|FG005|Follow-up Period|Adverse Event|1|||
124787528|NCT00600119|448852438|FG000|Follow-up Period|Other|1|||
124787529|NCT00600119|448852439|FG001|Follow-up Period|Other|0|||
124787530|NCT00600119|448852440|FG002|Follow-up Period|Other|0|||
124787531|NCT00600119|448852441|FG003|Follow-up Period|Other|0|||
124787532|NCT00600119|448852442|FG004|Follow-up Period|Other|0|||
124787533|NCT00600119|448852443|FG005|Follow-up Period|Other|0|||
124787534|NCT00729469|448852444|FG000|Overall Study|Adverse Event|14|||
124787535|NCT00729469|448852445|FG001|Overall Study|Adverse Event|25|||
124787536|NCT00729469|448852444|FG000|Overall Study|Lost to Follow-up|9|||
124787537|NCT00729469|448852445|FG001|Overall Study|Lost to Follow-up|9|||
124787538|NCT00729469|448852444|FG000|Overall Study|Protocol Violation|2|||
124787539|NCT00729469|448852445|FG001|Overall Study|Protocol Violation|1|||
124787540|NCT00729469|448852444|FG000|Overall Study|Withdrawal by Subject|19|||
124787541|NCT00729469|448852445|FG001|Overall Study|Withdrawal by Subject|8|||
124787542|NCT00729469|448852444|FG000|Overall Study|Other-Not mentioned|9|||
124787543|NCT00729469|448852445|FG001|Overall Study|Other-Not mentioned|4|||
124787544|NCT01270802|448852448|FG000|Overall Study|Withdrawal by Subject|1|||
124787545|NCT01270802|448852449|FG001|Overall Study|Withdrawal by Subject|0|||
124787546|NCT01270802|448852448|FG000|Overall Study|Adverse Event|1|||
124787547|NCT01270802|448852449|FG001|Overall Study|Adverse Event|0|||
124787548|NCT01270802|448852448|FG000|Overall Study|Lost to Follow-up|0|||
124787549|NCT01270802|448852449|FG001|Overall Study|Lost to Follow-up|1|||
124787550|NCT04620798|448852452|FG000|Overall Study|Lost to Follow-up|126|||
124787551|NCT04620798|448852453|FG001|Overall Study|Lost to Follow-up|138|||
124787552|NCT01960907|448852456|FG000|Overall Study|Death|4|||
124787553|NCT01960907|448852457|FG001|Overall Study|Death|3|||
124787554|NCT01960907|448852456|FG000|Overall Study|Withdrawal by Subject|32|||
124787555|NCT01960907|448852457|FG001|Overall Study|Withdrawal by Subject|42|||
124787556|NCT00439738|448852463|FG000|Overall Study|Withdrawal by Subject|16|||
124787557|NCT00439738|448852464|FG001|Overall Study|Withdrawal by Subject|13|||
124787558|NCT00439738|448852463|FG000|Overall Study|Adverse Event|6|||
124787559|NCT00439738|448852464|FG001|Overall Study|Adverse Event|4|||
124787560|NCT00439738|448852463|FG000|Overall Study|Lost to Follow-up|5|||
124787561|NCT00439738|448852464|FG001|Overall Study|Lost to Follow-up|6|||
124787562|NCT00439738|448852463|FG000|Overall Study|Protocol Violation|6|||
124787563|NCT00439738|448852464|FG001|Overall Study|Protocol Violation|3|||
124787564|NCT00439738|448852463|FG000|Overall Study|Lack of Efficacy|2|||
124787565|NCT00439738|448852464|FG001|Overall Study|Lack of Efficacy|2|||
124787566|NCT00439738|448852463|FG000|Overall Study|Abnormal Lab Values|1|||
124787567|NCT00439738|448852464|FG001|Overall Study|Abnormal Lab Values|0|||
124787568|NCT00402740|448852468|FG000|Overall Study|Withdrawal by Subject|18|||
124787569|NCT00402740|448852468|FG000|Overall Study|Death|50|||
124787570|NCT00402740|448852468|FG000|Overall Study|Lost to Follow-up|6|||
124787571|NCT00402740|448852468|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
124787572|NCT00402740|448852468|FG000|Overall Study|Subject disposition unknown.|1|||
124787573|NCT01185353|448852470|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
124787574|NCT01185353|448852471|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
124787575|NCT01185353|448852472|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
124787576|NCT01185353|448852473|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
124787577|NCT01185353|448852474|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
124787578|NCT01185353|448852475|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
124787579|NCT01185353|448852476|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
124787580|NCT01185353|448852477|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
124787581|NCT01185353|448852478|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
124787582|NCT01185353|448852479|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
124787583|NCT01185353|448852470|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
124787584|NCT01185353|448852471|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
124787585|NCT01185353|448852472|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
124787586|NCT01185353|448852473|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
124787587|NCT01185353|448852474|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
124787588|NCT01185353|448852475|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
124787589|NCT01185353|448852476|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
124787590|NCT01185353|448852477|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
124787591|NCT01185353|448852478|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
124787592|NCT01185353|448852479|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
124787593|NCT01185353|448852470|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
124787594|NCT01185353|448852471|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
124787595|NCT01185353|448852472|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
124787596|NCT01185353|448852473|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
124787597|NCT01185353|448852474|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
124787598|NCT01185353|448852475|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
124787599|NCT01185353|448852476|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
124787600|NCT01185353|448852477|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
124787601|NCT01185353|448852478|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
124787602|NCT01185353|448852479|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
124787603|NCT01185353|448852470|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
124787604|NCT01185353|448852471|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
124787605|NCT01185353|448852472|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
124787606|NCT01185353|448852473|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
124787607|NCT01185353|448852474|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
124787608|NCT01185353|448852475|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
124787609|NCT01185353|448852476|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
124787610|NCT01185353|448852477|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
124787611|NCT01185353|448852478|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
124787612|NCT01185353|448852479|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
124787613|NCT01185353|448852470|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
124787614|NCT01185353|448852471|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
124787615|NCT01185353|448852472|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
124787616|NCT01185353|448852473|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
124787617|NCT01185353|448852474|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
124787618|NCT01185353|448852475|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
124787619|NCT01185353|448852476|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
124787620|NCT01185353|448852477|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
124787621|NCT01185353|448852478|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
124787622|NCT01185353|448852479|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
124787623|NCT01185353|448852470|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
124787624|NCT01185353|448852471|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
124787625|NCT01185353|448852472|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
124787626|NCT01185353|448852473|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
124787627|NCT01185353|448852474|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
124787628|NCT01185353|448852475|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
124787629|NCT01185353|448852476|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
124787630|NCT01185353|448852477|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
124787631|NCT01185353|448852478|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
124787632|NCT01185353|448852479|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
124787633|NCT01185353|448852470|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
124787634|NCT01185353|448852471|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
124787635|NCT01185353|448852472|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
124787636|NCT01185353|448852473|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
124787637|NCT01185353|448852474|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
124787638|NCT01185353|448852475|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
124787639|NCT01185353|448852476|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
124787640|NCT01185353|448852477|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
124787641|NCT01185353|448852478|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
124787642|NCT01185353|448852479|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
124787643|NCT01185353|448852470|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
124787644|NCT01185353|448852471|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
124787645|NCT01185353|448852472|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
124787646|NCT01185353|448852473|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
124787647|NCT01185353|448852474|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
124787648|NCT01185353|448852475|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
124787649|NCT01185353|448852476|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
124787650|NCT01185353|448852477|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
124787651|NCT01185353|448852478|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
124787652|NCT01185353|448852479|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
124787653|NCT01185353|448852470|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
124787654|NCT01185353|448852471|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
124787655|NCT01185353|448852472|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
124787656|NCT01185353|448852473|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
124787657|NCT01185353|448852474|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
124787658|NCT01185353|448852475|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
124787659|NCT01185353|448852476|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
124787660|NCT01185353|448852477|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
124787661|NCT01185353|448852478|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
124787662|NCT01185353|448852479|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
124787663|NCT01185353|448852470|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
124787664|NCT01185353|448852471|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
124787665|NCT01185353|448852472|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
124787666|NCT01185353|448852473|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
124787667|NCT01185353|448852474|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
124787668|NCT01185353|448852475|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
124787669|NCT01185353|448852476|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
124787670|NCT01185353|448852477|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
124787671|NCT01185353|448852478|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
124787672|NCT01185353|448852479|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
124787673|NCT01185353|448852470|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
124787674|NCT01185353|448852471|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
124787675|NCT01185353|448852472|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
124787676|NCT01185353|448852473|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
124787677|NCT01185353|448852474|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
124787678|NCT01185353|448852475|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
124787679|NCT01185353|448852476|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
124787680|NCT01185353|448852477|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
124787681|NCT01185353|448852478|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
124787682|NCT01185353|448852479|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
124787683|NCT01185353|448852470|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
124787684|NCT01185353|448852471|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
124787685|NCT01185353|448852472|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
124787686|NCT01185353|448852473|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
124787687|NCT01185353|448852474|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
124787688|NCT01185353|448852475|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
124787689|NCT01185353|448852476|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
124787690|NCT01185353|448852477|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
124787691|NCT01185353|448852478|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
124787692|NCT01185353|448852479|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
124787693|NCT01185353|448852470|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
124787694|NCT01185353|448852471|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
124787695|NCT01185353|448852472|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
124787696|NCT01185353|448852473|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
124787697|NCT01185353|448852474|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
124787698|NCT01185353|448852475|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
124787699|NCT01185353|448852476|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
124787700|NCT01185353|448852477|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
124787701|NCT01185353|448852478|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
124787702|NCT01185353|448852479|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
124787703|NCT01185353|448852470|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
124787704|NCT01185353|448852471|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
124787705|NCT01185353|448852472|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
124787706|NCT01185353|448852473|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
124787707|NCT01185353|448852474|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
124787708|NCT01185353|448852475|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
124787709|NCT01185353|448852476|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
124787710|NCT01185353|448852477|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
124787711|NCT01185353|448852478|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
124787712|NCT01185353|448852479|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
124787713|NCT01185353|448852470|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
124787714|NCT01185353|448852471|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
124787715|NCT01185353|448852472|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
124787716|NCT01185353|448852473|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
124787717|NCT01185353|448852474|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
124787718|NCT01185353|448852475|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
124787719|NCT01185353|448852476|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
124787720|NCT01185353|448852477|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
124787721|NCT01185353|448852478|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
124787722|NCT01185353|448852479|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
124787723|NCT01185353|448852470|FG000|Part C (Weeks 24 Through 76)|Death|0|||
124787724|NCT01185353|448852471|FG001|Part C (Weeks 24 Through 76)|Death|0|||
124787725|NCT01185353|448852472|FG002|Part C (Weeks 24 Through 76)|Death|0|||
124787726|NCT01185353|448852473|FG003|Part C (Weeks 24 Through 76)|Death|0|||
124787727|NCT01185353|448852474|FG004|Part C (Weeks 24 Through 76)|Death|0|||
124787728|NCT01185353|448852475|FG005|Part C (Weeks 24 Through 76)|Death|0|||
124787729|NCT01185353|448852476|FG006|Part C (Weeks 24 Through 76)|Death|0|||
124787730|NCT01185353|448852477|FG007|Part C (Weeks 24 Through 76)|Death|0|||
124787731|NCT01185353|448852478|FG008|Part C (Weeks 24 Through 76)|Death|0|||
124787732|NCT01185353|448852479|FG009|Part C (Weeks 24 Through 76)|Death|1|||
124787733|NCT01185353|448852470|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
124787734|NCT01185353|448852471|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
124787735|NCT01185353|448852472|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
124787736|NCT01185353|448852473|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
124787737|NCT01185353|448852474|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
124787738|NCT01185353|448852475|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
124787739|NCT01185353|448852476|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
124787740|NCT01185353|448852477|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
124787741|NCT01185353|448852478|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
124787742|NCT01185353|448852479|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
124787743|NCT01185353|448852470|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
124787744|NCT01185353|448852471|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
124787745|NCT01185353|448852472|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
124787746|NCT01185353|448852473|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
124787747|NCT01185353|448852474|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
124787748|NCT01185353|448852475|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
124787749|NCT01185353|448852476|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
124787750|NCT01185353|448852477|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
124787751|NCT01185353|448852478|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
124787752|NCT01185353|448852479|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
124787753|NCT01185353|448852470|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
124787754|NCT01185353|448852471|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
124787755|NCT01185353|448852472|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
125292207|NCT00996801|450696554|FG003|Overall Study|Protocol Violation|2|||
125292208|NCT00996801|450696555|FG004|Overall Study|Protocol Violation|3|||
124787756|NCT01185353|448852473|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
124787757|NCT01185353|448852474|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
125292209|NCT00996801|450696556|FG005|Overall Study|Protocol Violation|4|||
125292210|NCT00996801|450696551|FG000|Overall Study|Study Terminated by Sponsor|0|||
125292211|NCT00996801|450696552|FG001|Overall Study|Study Terminated by Sponsor|1|||
125292212|NCT00996801|450696553|FG002|Overall Study|Study Terminated by Sponsor|0|||
125292213|NCT00996801|450696554|FG003|Overall Study|Study Terminated by Sponsor|0|||
125292214|NCT00996801|450696555|FG004|Overall Study|Study Terminated by Sponsor|46|||
125292215|NCT00996801|450696556|FG005|Overall Study|Study Terminated by Sponsor|0|||
125292216|NCT00996801|450696551|FG000|Overall Study|Withdrawal by Subject|8|||
125292217|NCT00996801|450696552|FG001|Overall Study|Withdrawal by Subject|6|||
125292218|NCT00996801|450696553|FG002|Overall Study|Withdrawal by Subject|9|||
125292219|NCT00996801|450696554|FG003|Overall Study|Withdrawal by Subject|5|||
125292220|NCT00996801|450696555|FG004|Overall Study|Withdrawal by Subject|5|||
125292221|NCT00996801|450696556|FG005|Overall Study|Withdrawal by Subject|9|||
125292222|NCT02804750|450696557|FG000|Period 1|Adverse Event|0|||
125292223|NCT02804750|450696558|FG001|Period 1|Adverse Event|2|||
125292224|NCT02804750|450696557|FG000|Period 1|Withdrawal by Subject|0|||
125292225|NCT02804750|450696558|FG001|Period 1|Withdrawal by Subject|1|||
125292226|NCT02804750|450696557|FG000|Period 2|Adverse Event|1|||
125292227|NCT02804750|450696558|FG001|Period 2|Adverse Event|0|||
125292228|NCT02804750|450696557|FG000|Period 3|Adverse Event|0|||
125292229|NCT02804750|450696558|FG001|Period 3|Adverse Event|2|||
125292230|NCT02804750|450696557|FG000|Period 4|Adverse Event|0|||
125292231|NCT02804750|450696558|FG001|Period 4|Adverse Event|5|||
125292232|NCT02559414|450696559|FG000|Overall Study|Lost to Follow-up|0|||
125292233|NCT02559414|450696560|FG001|Overall Study|Lost to Follow-up|1|||
125292234|NCT02559414|450696561|FG002|Overall Study|Lost to Follow-up|0|||
125292235|NCT02559414|450696559|FG000|Overall Study|Withdrawal by Subject|1|||
125292236|NCT02559414|450696560|FG001|Overall Study|Withdrawal by Subject|0|||
125292237|NCT02559414|450696561|FG002|Overall Study|Withdrawal by Subject|1|||
124787758|NCT01185353|448852475|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
124787759|NCT01185353|448852476|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
124787760|NCT01185353|448852477|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
124787761|NCT01185353|448852478|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
124787762|NCT01185353|448852479|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
124787763|NCT01185353|448852470|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
124787764|NCT01185353|448852471|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
124787765|NCT01185353|448852472|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
124787766|NCT01185353|448852473|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
124787767|NCT01185353|448852474|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
124787768|NCT01185353|448852475|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
124787769|NCT01185353|448852476|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
124787770|NCT01185353|448852477|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
124787771|NCT01185353|448852478|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
124787772|NCT01185353|448852479|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
124787773|NCT01185353|448852470|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
124787774|NCT01185353|448852471|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
124787775|NCT01185353|448852472|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
124787776|NCT01185353|448852473|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
124787777|NCT01185353|448852474|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
124787778|NCT01185353|448852475|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
124787779|NCT01185353|448852476|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
124787780|NCT01185353|448852477|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
124787781|NCT01185353|448852478|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
124787782|NCT01185353|448852479|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
124787783|NCT01185353|448852470|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
124787784|NCT01185353|448852471|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
124787785|NCT01185353|448852472|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
124787786|NCT01185353|448852473|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
124787787|NCT01185353|448852474|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
124787788|NCT01185353|448852475|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
125292238|NCT02559414|450696559|FG000|Overall Study|Other|0|||
125292239|NCT02559414|450696560|FG001|Overall Study|Other|1|||
125292240|NCT02559414|450696561|FG002|Overall Study|Other|1|||
125292241|NCT03369431|450696562|FG000|Overall Study|Lost to Follow-up|1|||
125292242|NCT03369431|450696563|FG001|Overall Study|Lost to Follow-up|3|||
125292243|NCT03369431|450696562|FG000|Overall Study|Withdrawal by Subject|2|||
125292244|NCT03369431|450696563|FG001|Overall Study|Withdrawal by Subject|3|||
125292245|NCT03369431|450696562|FG000|Overall Study|Protocol Violation|1|||
125292246|NCT03369431|450696563|FG001|Overall Study|Protocol Violation|1|||
125292247|NCT00046930|450696568|FG000|Overall Study|Ineligible|12|||
125292248|NCT00046930|450696569|FG001|Overall Study|Ineligible|4|||
125292249|NCT01113580|450696570|FG000|Overall Study|Protocol Violation|1|||
125292250|NCT01113580|450696571|FG001|Overall Study|Protocol Violation|0|||
124787789|NCT01185353|448852476|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
124787790|NCT01185353|448852477|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
124787791|NCT01185353|448852478|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
124787792|NCT01185353|448852479|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
124787793|NCT02270944|448852480|FG000|Overall Study|Lost to Follow-up|9|||
124787794|NCT02270944|448852481|FG001|Overall Study|Lost to Follow-up|4|||
124787795|NCT02270944|448852480|FG000|Overall Study|Withdrawal by Subject|2|||
124787796|NCT02270944|448852481|FG001|Overall Study|Withdrawal by Subject|1|||
124787797|NCT00095147|448852482|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
124787798|NCT00095147|448852483|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
124787799|NCT00095147|448852484|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
124787800|NCT00095147|448852485|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
124787801|NCT00095147|448852486|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
124787802|NCT00095147|448852482|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
124787803|NCT00095147|448852483|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
124787804|NCT00095147|448852484|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
124787805|NCT00095147|448852485|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
124787806|NCT00095147|448852486|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
124787807|NCT00095147|448852482|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
124787808|NCT00095147|448852483|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
124787809|NCT00095147|448852484|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
124787810|NCT00095147|448852485|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
124787811|NCT00095147|448852486|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
124787812|NCT00095147|448852482|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
124787813|NCT00095147|448852483|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
124787814|NCT00095147|448852484|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
124787815|NCT00095147|448852485|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
124787816|NCT00095147|448852486|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
124787817|NCT00095147|448852482|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
124787818|NCT00095147|448852483|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
124787819|NCT00095147|448852484|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
124787820|NCT00095147|448852485|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
124787821|NCT00095147|448852486|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
124787822|NCT00095147|448852482|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
124787823|NCT00095147|448852483|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
124787824|NCT00095147|448852484|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
124787825|NCT00095147|448852485|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
124787826|NCT00095147|448852486|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
124787827|NCT00095147|448852482|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
124787828|NCT00095147|448852483|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
124787829|NCT00095147|448852484|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
124787830|NCT00095147|448852485|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
124787831|NCT00095147|448852486|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
124787832|NCT00095147|448852482|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
124787833|NCT00095147|448852483|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
124787834|NCT00095147|448852484|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
124787835|NCT00095147|448852485|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
124787836|NCT00095147|448852486|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
124787837|NCT00095147|448852482|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
124787838|NCT00095147|448852483|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
124787839|NCT00095147|448852484|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
124787840|NCT00095147|448852485|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
124787841|NCT00095147|448852486|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
124787842|NCT00095147|448852482|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
124787843|NCT00095147|448852483|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
124787844|NCT00095147|448852484|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
124787845|NCT00095147|448852485|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
124787846|NCT00095147|448852486|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
124787847|NCT00095147|448852482|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
124787848|NCT00095147|448852483|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
124787849|NCT00095147|448852484|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
124787850|NCT00095147|448852485|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
124787851|NCT00095147|448852486|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
124787852|NCT00095147|448852482|FG000|Long-term Extension Period|Death|0|||
124787853|NCT00095147|448852483|FG001|Long-term Extension Period|Death|0|||
124787854|NCT00095147|448852484|FG002|Long-term Extension Period|Death|0|||
124787855|NCT00095147|448852485|FG003|Long-term Extension Period|Death|0|||
124787856|NCT00095147|448852486|FG004|Long-term Extension Period|Death|3|||
124787857|NCT00095147|448852482|FG000|Long-term Extension Period|Adverse Event|0|||
124787858|NCT00095147|448852483|FG001|Long-term Extension Period|Adverse Event|0|||
124787859|NCT00095147|448852484|FG002|Long-term Extension Period|Adverse Event|0|||
124787860|NCT00095147|448852485|FG003|Long-term Extension Period|Adverse Event|0|||
124787861|NCT00095147|448852486|FG004|Long-term Extension Period|Adverse Event|11|||
124787862|NCT00095147|448852482|FG000|Long-term Extension Period|Lack of Efficacy|0|||
124787863|NCT00095147|448852483|FG001|Long-term Extension Period|Lack of Efficacy|0|||
124787864|NCT00095147|448852484|FG002|Long-term Extension Period|Lack of Efficacy|0|||
124787865|NCT00095147|448852485|FG003|Long-term Extension Period|Lack of Efficacy|0|||
124787866|NCT00095147|448852486|FG004|Long-term Extension Period|Lack of Efficacy|9|||
124787867|NCT00095147|448852482|FG000|Long-term Extension Period|Lost to Follow-up|0|||
124787868|NCT00095147|448852483|FG001|Long-term Extension Period|Lost to Follow-up|0|||
124787869|NCT00095147|448852484|FG002|Long-term Extension Period|Lost to Follow-up|0|||
124787870|NCT00095147|448852485|FG003|Long-term Extension Period|Lost to Follow-up|0|||
124787871|NCT00095147|448852486|FG004|Long-term Extension Period|Lost to Follow-up|6|||
124787872|NCT00095147|448852482|FG000|Long-term Extension Period|Withdrawal of consent|0|||
124787873|NCT00095147|448852483|FG001|Long-term Extension Period|Withdrawal of consent|0|||
124787874|NCT00095147|448852484|FG002|Long-term Extension Period|Withdrawal of consent|0|||
124787875|NCT00095147|448852485|FG003|Long-term Extension Period|Withdrawal of consent|0|||
124787876|NCT00095147|448852486|FG004|Long-term Extension Period|Withdrawal of consent|12|||
124787877|NCT00095147|448852482|FG000|Long-term Extension Period|Pregnancy|0|||
124787878|NCT00095147|448852483|FG001|Long-term Extension Period|Pregnancy|0|||
124787879|NCT00095147|448852484|FG002|Long-term Extension Period|Pregnancy|0|||
124787880|NCT00095147|448852485|FG003|Long-term Extension Period|Pregnancy|0|||
124787881|NCT00095147|448852486|FG004|Long-term Extension Period|Pregnancy|1|||
124787882|NCT00095147|448852482|FG000|Long-term Extension Period|No longer meets study criteria|0|||
124787883|NCT00095147|448852483|FG001|Long-term Extension Period|No longer meets study criteria|0|||
124787884|NCT00095147|448852484|FG002|Long-term Extension Period|No longer meets study criteria|0|||
124787885|NCT00095147|448852485|FG003|Long-term Extension Period|No longer meets study criteria|0|||
124787886|NCT00095147|448852486|FG004|Long-term Extension Period|No longer meets study criteria|1|||
124787887|NCT00095147|448852482|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
124787888|NCT00095147|448852483|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
124787889|NCT00095147|448852484|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
124787890|NCT00095147|448852485|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
124787891|NCT00095147|448852486|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
124787892|NCT00095147|448852482|FG000|Long-term Extension Period|Leaving country|0|||
124787893|NCT00095147|448852483|FG001|Long-term Extension Period|Leaving country|0|||
124787894|NCT00095147|448852484|FG002|Long-term Extension Period|Leaving country|0|||
124787895|NCT00095147|448852485|FG003|Long-term Extension Period|Leaving country|0|||
124787896|NCT00095147|448852486|FG004|Long-term Extension Period|Leaving country|1|||
124787897|NCT01375075|448852489|FG000|Overall Study|Adverse Event|0|||
124787898|NCT01375075|448852490|FG001|Overall Study|Adverse Event|0|||
124787899|NCT01375075|448852491|FG002|Overall Study|Adverse Event|3|||
124787900|NCT01375075|448852492|FG003|Overall Study|Adverse Event|1|||
124787901|NCT01375075|448852493|FG004|Overall Study|Adverse Event|0|||
124787902|NCT01375075|448852494|FG005|Overall Study|Adverse Event|1|||
124787903|NCT01375075|448852489|FG000|Overall Study|Entry Criterion Not Met|1|||
124787904|NCT01375075|448852490|FG001|Overall Study|Entry Criterion Not Met|0|||
124787905|NCT01375075|448852491|FG002|Overall Study|Entry Criterion Not Met|0|||
124787906|NCT01375075|448852492|FG003|Overall Study|Entry Criterion Not Met|0|||
124787907|NCT01375075|448852493|FG004|Overall Study|Entry Criterion Not Met|0|||
124787908|NCT01375075|448852494|FG005|Overall Study|Entry Criterion Not Met|1|||
124787909|NCT01375075|448852489|FG000|Overall Study|Withdrawal by Subject|0|||
124787910|NCT01375075|448852490|FG001|Overall Study|Withdrawal by Subject|1|||
124787911|NCT01375075|448852491|FG002|Overall Study|Withdrawal by Subject|0|||
124787912|NCT01375075|448852492|FG003|Overall Study|Withdrawal by Subject|0|||
124787913|NCT01375075|448852493|FG004|Overall Study|Withdrawal by Subject|0|||
124787914|NCT01375075|448852494|FG005|Overall Study|Withdrawal by Subject|1|||
124787915|NCT01011309|448852495|FG000|Overall Study|Adverse Event|2|||
124787916|NCT01011309|448852496|FG001|Overall Study|Adverse Event|1|||
124787917|NCT01011309|448852497|FG002|Overall Study|Adverse Event|2|||
124787918|NCT01011309|448852495|FG000|Overall Study|Lack of Efficacy|0|||
124787919|NCT01011309|448852496|FG001|Overall Study|Lack of Efficacy|1|||
124787920|NCT01011309|448852497|FG002|Overall Study|Lack of Efficacy|0|||
124787921|NCT01011309|448852495|FG000|Overall Study|Protocol Violation|0|||
124787922|NCT01011309|448852496|FG001|Overall Study|Protocol Violation|1|||
124787923|NCT01011309|448852497|FG002|Overall Study|Protocol Violation|3|||
124787924|NCT03472547|448852506|FG000|Overall Study|Withdrawal by Subject|30|||
124787925|NCT04236141|448854209|FG000|Overall Study|Death|18|||
124787926|NCT04236141|448854210|FG001|Overall Study|Death|10|||
124787927|NCT04236141|448854209|FG000|Overall Study|Withdrawal by Participant|1|||
124787928|NCT04236141|448854210|FG001|Overall Study|Withdrawal by Participant|0|||
124787929|NCT04236141|448854209|FG000|Overall Study|Reason not Specified|1|||
124787930|NCT04236141|448854210|FG001|Overall Study|Reason not Specified|0|||
124787931|NCT04236141|448854209|FG000|Overall Study|Study terminated by Sponsor|8|||
124787932|NCT04236141|448854210|FG001|Overall Study|Study terminated by Sponsor|4|||
124787933|NCT01948193|448854211|FG000|Overall Study|Serious event|2|||
124787934|NCT01948193|448854211|FG000|Overall Study|Lost to Follow-up|7|||
124787935|NCT00507728|448854220|FG000|Randomization to Month 3|Lost to Follow-up|15|||
124787936|NCT00507728|448854221|FG001|Randomization to Month 3|Lost to Follow-up|14|||
124787937|NCT00507728|448854222|FG002|Randomization to Month 3|Lost to Follow-up|20|||
124787938|NCT00507728|448854220|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
124787939|NCT00507728|448854221|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
124787940|NCT00507728|448854222|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
124787941|NCT01964755|448854223|FG000|Overall Study|Death|2|||
124787942|NCT01332799|448854227|FG000|Overall Study|Insufficient funding|10|||
124787943|NCT01332799|448854228|FG001|Overall Study|Insufficient funding|10|||
124787944|NCT01909791|448854229|FG000|Overall Study|Death|9|||
124787945|NCT01909791|448854230|FG001|Overall Study|Death|8|||
124787946|NCT01909791|448854231|FG002|Overall Study|Death|4|||
124787947|NCT01909791|448854229|FG000|Overall Study|Withdrawal by Subject|5|||
124787948|NCT01909791|448854230|FG001|Overall Study|Withdrawal by Subject|9|||
124787949|NCT01909791|448854231|FG002|Overall Study|Withdrawal by Subject|13|||
124787950|NCT01909791|448854229|FG000|Overall Study|Lost to Follow-up|5|||
124787951|NCT01909791|448854230|FG001|Overall Study|Lost to Follow-up|11|||
124787952|NCT01909791|448854231|FG002|Overall Study|Lost to Follow-up|10|||
124787953|NCT01909791|448854229|FG000|Overall Study|Missed Visit|2|||
124787954|NCT01909791|448854230|FG001|Overall Study|Missed Visit|0|||
124787955|NCT01909791|448854231|FG002|Overall Study|Missed Visit|1|||
124787956|NCT02168387|448854234|FG000|Overall Study|Planned exubation|6|||
124787957|NCT02168387|448854235|FG001|Overall Study|Planned exubation|3|||
124787958|NCT02168387|448854234|FG000|Overall Study|Death|1|||
124787959|NCT02168387|448854235|FG001|Overall Study|Death|0|||
124787960|NCT03467152|448854236|FG000|Overall Study|Adverse Event|4|||
124787961|NCT03467152|448854237|FG001|Overall Study|Adverse Event|5|||
124787962|NCT03467152|448854238|FG002|Overall Study|Adverse Event|0|||
124787963|NCT03467152|448854236|FG000|Overall Study|Subject Choice|1|||
124787964|NCT03467152|448854237|FG001|Overall Study|Subject Choice|3|||
124787965|NCT03467152|448854238|FG002|Overall Study|Subject Choice|0|||
124787966|NCT03467152|448854236|FG000|Overall Study|Lost to Follow-up|1|||
124787967|NCT03467152|448854237|FG001|Overall Study|Lost to Follow-up|0|||
124787968|NCT03467152|448854238|FG002|Overall Study|Lost to Follow-up|0|||
124787969|NCT03467152|448854236|FG000|Overall Study|Withdrawal by Subject|4|||
124787970|NCT03467152|448854237|FG001|Overall Study|Withdrawal by Subject|2|||
124787971|NCT03467152|448854238|FG002|Overall Study|Withdrawal by Subject|0|||
124787972|NCT03467152|448854236|FG000|Overall Study|Others|3|||
124787973|NCT03467152|448854237|FG001|Overall Study|Others|0|||
124787974|NCT03467152|448854238|FG002|Overall Study|Others|0|||
124787975|NCT03467152|448854236|FG000|Overall Study|Not treated|3|||
124787976|NCT03467152|448854237|FG001|Overall Study|Not treated|1|||
124787977|NCT03467152|448854238|FG002|Overall Study|Not treated|6|||
124787978|NCT01236547|448854239|FG000|Overall Study|Protocol Violation|0|||
124787979|NCT01236547|448854240|FG001|Overall Study|Protocol Violation|1|||
124787980|NCT01236547|448854241|FG002|Overall Study|Protocol Violation|1|||
124787981|NCT01236547|448854242|FG003|Overall Study|Protocol Violation|6|||
124787982|NCT01236547|448854243|FG004|Overall Study|Protocol Violation|12|||
124787983|NCT04250077|448854244|FG000|Overall Study|Withdrawal by Subject|0|||
124787984|NCT04250077|448854245|FG001|Overall Study|Withdrawal by Subject|1|||
124787985|NCT04250077|448854246|FG002|Overall Study|Withdrawal by Subject|0|||
124787986|NCT04250077|448854244|FG000|Overall Study|Lost to Follow-up|2|||
124787987|NCT04250077|448854245|FG001|Overall Study|Lost to Follow-up|3|||
124787988|NCT04250077|448854246|FG002|Overall Study|Lost to Follow-up|0|||
124787989|NCT00910624|448854247|FG000|Treatment Phase|Adverse Event|2|||
124787990|NCT00910624|448854248|FG001|Treatment Phase|Adverse Event|6|||
124787991|NCT00910624|448854249|FG002|Treatment Phase|Adverse Event|6|||
124787992|NCT00910624|448854250|FG003|Treatment Phase|Adverse Event|0|||
124787993|NCT00910624|448854247|FG000|Treatment Phase|Treatment Failure|23|||
124787994|NCT00910624|448854248|FG001|Treatment Phase|Treatment Failure|10|||
124787995|NCT00910624|448854249|FG002|Treatment Phase|Treatment Failure|0|||
124787996|NCT00910624|448854250|FG003|Treatment Phase|Treatment Failure|0|||
124787997|NCT00910624|448854247|FG000|Treatment Phase|Lost to Follow-up|0|||
124787998|NCT00910624|448854248|FG001|Treatment Phase|Lost to Follow-up|0|||
124787999|NCT00910624|448854249|FG002|Treatment Phase|Lost to Follow-up|1|||
124788000|NCT00910624|448854250|FG003|Treatment Phase|Lost to Follow-up|0|||
124788001|NCT00910624|448854247|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
124788002|NCT00910624|448854248|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
124788003|NCT00910624|448854249|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
124788004|NCT00910624|448854250|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
124788005|NCT00910624|448854247|FG000|Treatment Phase|Withdrawal by Subject|2|||
124788006|NCT00910624|448854248|FG001|Treatment Phase|Withdrawal by Subject|1|||
124788007|NCT00910624|448854249|FG002|Treatment Phase|Withdrawal by Subject|0|||
124788008|NCT00910624|448854250|FG003|Treatment Phase|Withdrawal by Subject|0|||
124788009|NCT00910624|448854247|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
124788010|NCT00910624|448854248|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
124788011|NCT00910624|448854249|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
124788012|NCT00910624|448854250|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
124788013|NCT00910624|448854247|FG000|Follow-Up Phase|Adverse Event|0|||
124788014|NCT00910624|448854248|FG001|Follow-Up Phase|Adverse Event|0|||
124788015|NCT00910624|448854249|FG002|Follow-Up Phase|Adverse Event|1|||
124788016|NCT00910624|448854250|FG003|Follow-Up Phase|Adverse Event|0|||
124788017|NCT00910624|448854247|FG000|Follow-Up Phase|Lost to Follow-up|3|||
124788018|NCT00910624|448854248|FG001|Follow-Up Phase|Lost to Follow-up|1|||
124788019|NCT00910624|448854249|FG002|Follow-Up Phase|Lost to Follow-up|2|||
124788020|NCT00910624|448854250|FG003|Follow-Up Phase|Lost to Follow-up|0|||
124788021|NCT00910624|448854247|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
124788022|NCT00910624|448854248|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
124788023|NCT00910624|448854249|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
124788024|NCT00910624|448854250|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
124788025|NCT00910624|448854247|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
124788026|NCT00910624|448854248|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
124788027|NCT00910624|448854249|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
124788028|NCT00910624|448854250|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
124788029|NCT00910624|448854247|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
124788030|NCT00910624|448854248|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
124788031|NCT00910624|448854249|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
124788032|NCT00910624|448854250|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
124788033|NCT00910624|448854247|FG000|Follow-Up Phase|Administrative|0|||
124788034|NCT00910624|448854248|FG001|Follow-Up Phase|Administrative|1|||
124788035|NCT00910624|448854249|FG002|Follow-Up Phase|Administrative|1|||
124788036|NCT00910624|448854250|FG003|Follow-Up Phase|Administrative|0|||
124788037|NCT04140227|448854251|FG000|Overall Study|Withdrawal by Subject|26|||
124788038|NCT04140227|448854251|FG000|Overall Study|Lost to Follow-up|8|||
124788039|NCT04140227|448854251|FG000|Overall Study|Adverse Event|8|||
124788040|NCT04140227|448854251|FG000|Overall Study|Death|1|||
124788041|NCT04140227|448854251|FG000|Overall Study|Other|3|||
124788042|NCT04140227|448854251|FG000|Overall Study|Protocol Violation|2|||
124788043|NCT01713933|448854252|FG000|Overall Study|Lost to Follow-up|2|||
124788044|NCT01713933|448854252|FG000|Overall Study|Withdrawal by Subject|3|||
124788045|NCT01713933|448854252|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
124788046|NCT00412373|448854253|FG000|Overall Study|Adverse Event|8|||
124788047|NCT00412373|448854254|FG001|Overall Study|Adverse Event|13|||
124788048|NCT00412373|448854253|FG000|Overall Study|Lack of Efficacy|16|||
124788049|NCT00412373|448854254|FG001|Overall Study|Lack of Efficacy|22|||
124788050|NCT00412373|448854253|FG000|Overall Study|Lost to Follow-up|7|||
124788051|NCT00412373|448854254|FG001|Overall Study|Lost to Follow-up|13|||
124788052|NCT00412373|448854253|FG000|Overall Study|Withdrawal by Subject|8|||
124788053|NCT00412373|448854254|FG001|Overall Study|Withdrawal by Subject|27|||
124788054|NCT00412373|448854253|FG000|Overall Study|Other|2|||
124788055|NCT00412373|448854254|FG001|Overall Study|Other|2|||
124788056|NCT04022733|448854258|FG000|Overall Study|conversion to open surgery|3|||
124788057|NCT04022733|448854259|FG001|Overall Study|conversion to open surgery|2|||
124788058|NCT04022733|448854258|FG000|Overall Study|bradycardia|0|||
124788059|NCT04022733|448854259|FG001|Overall Study|bradycardia|1|||
124788060|NCT02855541|448854261|FG000|Overall Study|Change in health status|2|||
124788061|NCT02855541|448854261|FG000|Overall Study|Withdrawal by Subject|2|||
124788062|NCT00422513|448854262|FG000|Overall Study|Lack of Efficacy|4|||
124788063|NCT00422513|448854263|FG001|Overall Study|Lack of Efficacy|5|||
124788064|NCT00422513|448854262|FG000|Overall Study|Protocol Violation|23|||
124788065|NCT00422513|448854263|FG001|Overall Study|Protocol Violation|7|||
124788066|NCT00422513|448854262|FG000|Overall Study|Refused Treatment|4|||
124788067|NCT00422513|448854263|FG001|Overall Study|Refused Treatment|2|||
124788068|NCT00422513|448854262|FG000|Overall Study|Withdrawal by Subject|2|||
124788069|NCT00422513|448854263|FG001|Overall Study|Withdrawal by Subject|1|||
124788070|NCT00422513|448854262|FG000|Overall Study|early termination of the study|67|||
124788071|NCT00422513|448854263|FG001|Overall Study|early termination of the study|80|||
124788072|NCT00422513|448854262|FG000|Overall Study|Adverse Event|4|||
124788073|NCT00422513|448854263|FG001|Overall Study|Adverse Event|4|||
124788074|NCT00422513|448854262|FG000|Overall Study|Death|3|||
124788075|NCT00422513|448854263|FG001|Overall Study|Death|7|||
124788076|NCT03135119|448854264|FG000|Overall Study|Lost to Follow-up|2|||
124788077|NCT03135119|448854265|FG001|Overall Study|Lost to Follow-up|0|||
124788078|NCT03135119|448854264|FG000|Overall Study|Physician Decision|1|||
124788079|NCT03135119|448854265|FG001|Overall Study|Physician Decision|1|||
124788080|NCT03135119|448854264|FG000|Overall Study|COVID-19 Shutdown|2|||
124788081|NCT03135119|448854265|FG001|Overall Study|COVID-19 Shutdown|2|||
124788082|NCT01541397|448854266|FG000|Overall Study|Study ended prior to data collection|4|||
124788083|NCT01541397|448854267|FG001|Overall Study|Study ended prior to data collection|2|||
124788084|NCT02267317|448854268|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
124788085|NCT02267317|448854269|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
124788086|NCT02267317|448854270|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
124788087|NCT02267317|448854271|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
124788088|NCT02267317|448854272|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
124788089|NCT02267317|448854273|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
124788090|NCT02267317|448854268|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
124788091|NCT02267317|448854269|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
124788092|NCT02267317|448854270|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
124788093|NCT02267317|448854271|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
124788094|NCT02267317|448854272|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
124788095|NCT02267317|448854273|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
124788096|NCT01689532|448854276|FG000|Overall Study|Adverse Event|9|||
124788097|NCT01689532|448854277|FG001|Overall Study|Adverse Event|5|||
124788098|NCT01689532|448854276|FG000|Overall Study|Lack of Efficacy|2|||
124788099|NCT01689532|448854277|FG001|Overall Study|Lack of Efficacy|2|||
124788100|NCT01689532|448854276|FG000|Overall Study|Withdrawal by Subject|1|||
124788101|NCT01689532|448854277|FG001|Overall Study|Withdrawal by Subject|2|||
124788102|NCT01689532|448854276|FG000|Overall Study|Physician Decision|2|||
124788103|NCT01689532|448854277|FG001|Overall Study|Physician Decision|0|||
124788104|NCT01363349|448854278|FG000|Overall Study|Adverse Event|6|||
124788105|NCT01363349|448854279|FG001|Overall Study|Adverse Event|7|||
124788106|NCT01363349|448854278|FG000|Overall Study|Lack of Efficacy|3|||
124788107|NCT01363349|448854279|FG001|Overall Study|Lack of Efficacy|10|||
124788108|NCT01363349|448854278|FG000|Overall Study|Non compliance/Protocol deviations|2|||
124788109|NCT01363349|448854279|FG001|Overall Study|Non compliance/Protocol deviations|2|||
124788110|NCT01363349|448854278|FG000|Overall Study|Withdrawal by Subject|14|||
124788111|NCT01363349|448854279|FG001|Overall Study|Withdrawal by Subject|6|||
124788112|NCT01363349|448854278|FG000|Overall Study|Lost to Follow-up|5|||
124788113|NCT01363349|448854279|FG001|Overall Study|Lost to Follow-up|6|||
124788114|NCT01363349|448854278|FG000|Overall Study|Not reported|36|||
124788115|NCT01363349|448854279|FG001|Overall Study|Not reported|37|||
124788116|NCT01363349|448854278|FG000|Overall Study|missing|1|||
124788117|NCT01363349|448854279|FG001|Overall Study|missing|2|||
124788118|NCT02208063|448854280|FG000|Overall Study|Death|3|||
124788119|NCT02208063|448854281|FG001|Overall Study|Death|5|||
124788120|NCT02208063|448854280|FG000|Overall Study|Not Specified in report|3|||
124788121|NCT02208063|448854281|FG001|Overall Study|Not Specified in report|4|||
124788122|NCT02208063|448854280|FG000|Overall Study|Withdrawal by Subject|5|||
124788123|NCT02208063|448854281|FG001|Overall Study|Withdrawal by Subject|2|||
124788124|NCT02208063|448854280|FG000|Overall Study|Lost to Follow-up|1|||
124788125|NCT02208063|448854281|FG001|Overall Study|Lost to Follow-up|0|||
124788126|NCT00913458|448854282|FG000|Phase 1|Non-Responder|54|||
124788127|NCT00913458|448854283|FG001|Phase 1|Non-Responder|0|||
124788128|NCT00913458|448854284|FG002|Phase 1|Non-Responder|0|||
124788129|NCT00913458|448854285|FG003|Phase 1|Non-Responder|0|||
124788130|NCT00913458|448854286|FG004|Phase 1|Non-Responder|0|||
124788131|NCT00913458|448854287|FG005|Phase 1|Non-Responder|0|||
124788132|NCT00913458|448854288|FG006|Phase 1|Non-Responder|0|||
124788133|NCT00913458|448854282|FG000|Phase 1|Subject Request|17|||
124788134|NCT00913458|448854283|FG001|Phase 1|Subject Request|0|||
124788135|NCT00913458|448854284|FG002|Phase 1|Subject Request|0|||
124788136|NCT00913458|448854285|FG003|Phase 1|Subject Request|0|||
124788137|NCT00913458|448854286|FG004|Phase 1|Subject Request|0|||
124788138|NCT00913458|448854287|FG005|Phase 1|Subject Request|0|||
124788139|NCT00913458|448854288|FG006|Phase 1|Subject Request|0|||
124788140|NCT00913458|448854282|FG000|Phase 1|Adverse Event|20|||
124788141|NCT00913458|448854283|FG001|Phase 1|Adverse Event|0|||
124788142|NCT00913458|448854284|FG002|Phase 1|Adverse Event|0|||
124788143|NCT00913458|448854285|FG003|Phase 1|Adverse Event|0|||
124788144|NCT00913458|448854286|FG004|Phase 1|Adverse Event|0|||
124788145|NCT00913458|448854287|FG005|Phase 1|Adverse Event|0|||
124788146|NCT00913458|448854288|FG006|Phase 1|Adverse Event|0|||
124788147|NCT00913458|448854282|FG000|Phase 1|Lost to Follow-up|2|||
124788148|NCT00913458|448854283|FG001|Phase 1|Lost to Follow-up|0|||
124788149|NCT00913458|448854284|FG002|Phase 1|Lost to Follow-up|0|||
124788150|NCT00913458|448854285|FG003|Phase 1|Lost to Follow-up|0|||
124788151|NCT00913458|448854286|FG004|Phase 1|Lost to Follow-up|0|||
124788152|NCT00913458|448854287|FG005|Phase 1|Lost to Follow-up|0|||
124788153|NCT00913458|448854288|FG006|Phase 1|Lost to Follow-up|0|||
124788154|NCT00913458|448854282|FG000|Phase 1|Protocol Violation|10|||
124788155|NCT00913458|448854283|FG001|Phase 1|Protocol Violation|0|||
124788156|NCT00913458|448854284|FG002|Phase 1|Protocol Violation|0|||
124788157|NCT00913458|448854285|FG003|Phase 1|Protocol Violation|0|||
124788158|NCT00913458|448854286|FG004|Phase 1|Protocol Violation|0|||
124788159|NCT00913458|448854287|FG005|Phase 1|Protocol Violation|0|||
124788160|NCT00913458|448854288|FG006|Phase 1|Protocol Violation|0|||
124788161|NCT00913458|448854282|FG000|Phase 1|Sponsor|2|||
124788162|NCT00913458|448854283|FG001|Phase 1|Sponsor|0|||
124788163|NCT00913458|448854284|FG002|Phase 1|Sponsor|0|||
124788164|NCT00913458|448854285|FG003|Phase 1|Sponsor|0|||
124788165|NCT00913458|448854286|FG004|Phase 1|Sponsor|0|||
124788166|NCT00913458|448854287|FG005|Phase 1|Sponsor|0|||
124788167|NCT00913458|448854288|FG006|Phase 1|Sponsor|0|||
124788168|NCT00913458|448854282|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
124788169|NCT00913458|448854283|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
124788170|NCT00913458|448854284|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
124788171|NCT00913458|448854285|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
124788172|NCT00913458|448854286|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
124788173|NCT00913458|448854287|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
124788174|NCT00913458|448854288|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
124788175|NCT00913458|448854282|FG000|Phase 2|Non-Responder|0|||
124788176|NCT00913458|448854283|FG001|Phase 2|Non-Responder|5|||
124788177|NCT00913458|448854284|FG002|Phase 2|Non-Responder|7|||
124788178|NCT00913458|448854285|FG003|Phase 2|Non-Responder|12|||
124788179|NCT00913458|448854286|FG004|Phase 2|Non-Responder|0|||
124788180|NCT00913458|448854287|FG005|Phase 2|Non-Responder|0|||
124788181|NCT00913458|448854288|FG006|Phase 2|Non-Responder|0|||
124788182|NCT00913458|448854282|FG000|Phase 2|Subject Request|0|||
124788183|NCT00913458|448854283|FG001|Phase 2|Subject Request|0|||
124788184|NCT00913458|448854284|FG002|Phase 2|Subject Request|1|||
124788185|NCT00913458|448854285|FG003|Phase 2|Subject Request|2|||
124788186|NCT00913458|448854286|FG004|Phase 2|Subject Request|0|||
124788187|NCT00913458|448854287|FG005|Phase 2|Subject Request|0|||
124788188|NCT00913458|448854288|FG006|Phase 2|Subject Request|0|||
124788189|NCT00913458|448854282|FG000|Phase 2|Adverse Event|0|||
124788190|NCT00913458|448854283|FG001|Phase 2|Adverse Event|3|||
124788191|NCT00913458|448854284|FG002|Phase 2|Adverse Event|0|||
124788192|NCT00913458|448854285|FG003|Phase 2|Adverse Event|1|||
124788193|NCT00913458|448854286|FG004|Phase 2|Adverse Event|0|||
124788194|NCT00913458|448854287|FG005|Phase 2|Adverse Event|0|||
124788195|NCT00913458|448854288|FG006|Phase 2|Adverse Event|0|||
124788196|NCT00913458|448854282|FG000|Phase 2|Lost to Follow-up|0|||
124788197|NCT00913458|448854283|FG001|Phase 2|Lost to Follow-up|0|||
124788198|NCT00913458|448854284|FG002|Phase 2|Lost to Follow-up|0|||
124788199|NCT00913458|448854285|FG003|Phase 2|Lost to Follow-up|1|||
124788200|NCT00913458|448854286|FG004|Phase 2|Lost to Follow-up|0|||
124788201|NCT00913458|448854287|FG005|Phase 2|Lost to Follow-up|0|||
124788202|NCT00913458|448854288|FG006|Phase 2|Lost to Follow-up|0|||
124788203|NCT00913458|448854282|FG000|Phase 2|Protocol Violation|0|||
124788204|NCT00913458|448854283|FG001|Phase 2|Protocol Violation|2|||
124788205|NCT00913458|448854284|FG002|Phase 2|Protocol Violation|0|||
124788206|NCT00913458|448854285|FG003|Phase 2|Protocol Violation|0|||
124788207|NCT00913458|448854286|FG004|Phase 2|Protocol Violation|0|||
124788208|NCT00913458|448854287|FG005|Phase 2|Protocol Violation|0|||
124788209|NCT00913458|448854288|FG006|Phase 2|Protocol Violation|0|||
124788210|NCT00913458|448854282|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
124788211|NCT00913458|448854283|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
124788212|NCT00913458|448854284|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
124788213|NCT00913458|448854285|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
124788214|NCT00913458|448854286|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
124788215|NCT00913458|448854287|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
124788216|NCT00913458|448854288|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
124788217|NCT00913458|448854282|FG000|Phase 3|Adverse Event|0|||
124788218|NCT00913458|448854283|FG001|Phase 3|Adverse Event|0|||
124788219|NCT00913458|448854284|FG002|Phase 3|Adverse Event|0|||
124788220|NCT00913458|448854285|FG003|Phase 3|Adverse Event|0|||
124788221|NCT00913458|448854286|FG004|Phase 3|Adverse Event|5|||
124788222|NCT00913458|448854287|FG005|Phase 3|Adverse Event|4|||
124788223|NCT00913458|448854288|FG006|Phase 3|Adverse Event|1|||
124788224|NCT00913458|448854282|FG000|Phase 3|Lost to Follow-up|0|||
124788225|NCT00913458|448854283|FG001|Phase 3|Lost to Follow-up|0|||
124788226|NCT00913458|448854284|FG002|Phase 3|Lost to Follow-up|0|||
124788227|NCT00913458|448854285|FG003|Phase 3|Lost to Follow-up|0|||
124788228|NCT00913458|448854286|FG004|Phase 3|Lost to Follow-up|2|||
124788229|NCT00913458|448854287|FG005|Phase 3|Lost to Follow-up|0|||
124788230|NCT00913458|448854288|FG006|Phase 3|Lost to Follow-up|0|||
124788231|NCT00913458|448854282|FG000|Phase 3|Non-Responder|0|||
124788232|NCT00913458|448854283|FG001|Phase 3|Non-Responder|0|||
124788233|NCT00913458|448854284|FG002|Phase 3|Non-Responder|0|||
124788234|NCT00913458|448854285|FG003|Phase 3|Non-Responder|0|||
124788235|NCT00913458|448854286|FG004|Phase 3|Non-Responder|0|||
124788236|NCT00913458|448854287|FG005|Phase 3|Non-Responder|1|||
124788237|NCT00913458|448854288|FG006|Phase 3|Non-Responder|3|||
124788238|NCT00913458|448854282|FG000|Phase 3|Withdrawal by Subject|0|||
124788239|NCT00913458|448854283|FG001|Phase 3|Withdrawal by Subject|0|||
124788240|NCT00913458|448854284|FG002|Phase 3|Withdrawal by Subject|0|||
124788241|NCT00913458|448854285|FG003|Phase 3|Withdrawal by Subject|0|||
124788242|NCT00913458|448854286|FG004|Phase 3|Withdrawal by Subject|1|||
124788243|NCT00913458|448854287|FG005|Phase 3|Withdrawal by Subject|2|||
124788244|NCT00913458|448854288|FG006|Phase 3|Withdrawal by Subject|0|||
124788245|NCT00913458|448854282|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
124788246|NCT00913458|448854283|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
124788247|NCT00913458|448854284|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
124788248|NCT00913458|448854285|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
124788249|NCT00913458|448854286|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
124788250|NCT00913458|448854287|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
124788251|NCT00913458|448854288|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
124788252|NCT02279407|448854289|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
124788253|NCT02279407|448854290|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
124788254|NCT02279407|448854291|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
124788255|NCT02279407|448854292|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
124788256|NCT02279407|448854289|FG000|Overall Study|Withdrawal by Subject|1|||
124788257|NCT02279407|448854290|FG001|Overall Study|Withdrawal by Subject|0|||
124788258|NCT02279407|448854291|FG002|Overall Study|Withdrawal by Subject|1|||
124788259|NCT02279407|448854292|FG003|Overall Study|Withdrawal by Subject|1|||
124788260|NCT02279407|448854289|FG000|Overall Study|Adverse Event|1|||
124788261|NCT02279407|448854290|FG001|Overall Study|Adverse Event|1|||
124788262|NCT02279407|448854291|FG002|Overall Study|Adverse Event|2|||
124788263|NCT02279407|448854292|FG003|Overall Study|Adverse Event|0|||
124788264|NCT01155011|448854297|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
124788265|NCT01155011|448854298|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
124788266|NCT01155011|448854297|FG000|Baseline to 6 Months|investigator decision, moved|4|||
124788267|NCT01155011|448854298|FG001|Baseline to 6 Months|investigator decision, moved|5|||
124788268|NCT01155011|448854297|FG000|Baseline to 6 Months|Death|0|||
124788269|NCT01155011|448854298|FG001|Baseline to 6 Months|Death|1|||
124788270|NCT01155011|448854297|FG000|6 to 12 Months|Withdrawal by Subject|8|||
124788271|NCT01155011|448854298|FG001|6 to 12 Months|Withdrawal by Subject|5|||
124788272|NCT01155011|448854297|FG000|6 to 12 Months|Death|1|||
124788273|NCT01155011|448854298|FG001|6 to 12 Months|Death|5|||
124788274|NCT00422084|448854299|FG000|Overall Study|Adverse Event|21|||
124788275|NCT00422084|448854300|FG001|Overall Study|Adverse Event|7|||
124788276|NCT00422084|448854299|FG000|Overall Study|Withdrawal by Subject|12|||
124788277|NCT00422084|448854300|FG001|Overall Study|Withdrawal by Subject|9|||
124788278|NCT00422084|448854299|FG000|Overall Study|Lost to Follow-up|14|||
124788279|NCT00422084|448854300|FG001|Overall Study|Lost to Follow-up|9|||
124788280|NCT00422084|448854299|FG000|Overall Study|Protocol Violation|4|||
124788281|NCT00422084|448854300|FG001|Overall Study|Protocol Violation|1|||
124788282|NCT00422084|448854299|FG000|Overall Study|Lack of Efficacy|40|||
124788283|NCT00422084|448854300|FG001|Overall Study|Lack of Efficacy|42|||
124788284|NCT00422084|448854299|FG000|Overall Study|P. vivax infection|3|||
124788285|NCT00422084|448854300|FG001|Overall Study|P. vivax infection|6|||
124788286|NCT00422084|448854299|FG000|Overall Study|Cyesis|1|||
124788287|NCT00422084|448854300|FG001|Overall Study|Cyesis|0|||
124788288|NCT00422084|448854299|FG000|Overall Study|Withdrawn from study accidentally|1|||
124788289|NCT00422084|448854300|FG001|Overall Study|Withdrawn from study accidentally|0|||
124788290|NCT00422084|448854299|FG000|Overall Study|Non-compliance|1|||
124788291|NCT00422084|448854300|FG001|Overall Study|Non-compliance|0|||
124788292|NCT00422084|448854299|FG000|Overall Study|Re-location|0|||
124788293|NCT00422084|448854300|FG001|Overall Study|Re-location|1|||
124788294|NCT00422084|448854299|FG000|Overall Study|Not defined|1|||
124788295|NCT00422084|448854300|FG001|Overall Study|Not defined|1|||
124788296|NCT03774823|448854303|FG000|Overall Study|Withdrawal by Subject|1|||
124788297|NCT03774823|448854304|FG001|Overall Study|Withdrawal by Subject|1|||
124788298|NCT00958438|448854305|FG000|Overall Study|Protocol Violation|3|||
124788299|NCT00958438|448854306|FG001|Overall Study|Protocol Violation|2|||
124788300|NCT00958438|448854307|FG002|Overall Study|Protocol Violation|2|||
124788301|NCT00958438|448854305|FG000|Overall Study|Withdrawal by Subject|4|||
124788302|NCT00958438|448854306|FG001|Overall Study|Withdrawal by Subject|2|||
124788303|NCT00958438|448854307|FG002|Overall Study|Withdrawal by Subject|1|||
124788304|NCT00958438|448854305|FG000|Overall Study|Adverse Event|0|||
124788305|NCT00958438|448854306|FG001|Overall Study|Adverse Event|3|||
124788306|NCT00958438|448854307|FG002|Overall Study|Adverse Event|0|||
124788307|NCT00958438|448854305|FG000|Overall Study|Physician Decision|1|||
124788308|NCT00958438|448854306|FG001|Overall Study|Physician Decision|0|||
124788309|NCT00958438|448854307|FG002|Overall Study|Physician Decision|1|||
124788310|NCT00958438|448854305|FG000|Overall Study|Other than specified above|2|||
124788311|NCT00958438|448854306|FG001|Overall Study|Other than specified above|3|||
124788312|NCT00958438|448854307|FG002|Overall Study|Other than specified above|2|||
124788313|NCT00759564|448854308|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
124788314|NCT00759564|448854309|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
124788315|NCT00759564|448854310|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
124788316|NCT00759564|448854311|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
124788317|NCT00759564|448854312|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
124788318|NCT02788279|448854314|FG000|Overall Study|Death|62|||
124788319|NCT02788279|448854315|FG001|Overall Study|Death|136|||
124788320|NCT02788279|448854316|FG002|Overall Study|Death|72|||
124788321|NCT02788279|448854314|FG000|Overall Study|Withdrawal by Subject|10|||
124788322|NCT02788279|448854315|FG001|Overall Study|Withdrawal by Subject|15|||
124788323|NCT02788279|448854316|FG002|Overall Study|Withdrawal by Subject|5|||
124788324|NCT02788279|448854314|FG000|Overall Study|Lost to Follow-up|0|||
124788325|NCT02788279|448854315|FG001|Overall Study|Lost to Follow-up|3|||
124788326|NCT02788279|448854316|FG002|Overall Study|Lost to Follow-up|2|||
124788327|NCT02788279|448854314|FG000|Overall Study|Sponsor decision|18|||
124788328|NCT02788279|448854315|FG001|Overall Study|Sponsor decision|29|||
124788329|NCT02788279|448854316|FG002|Overall Study|Sponsor decision|11|||
124788330|NCT00329849|448854317|FG000|Overall Study|Withdrawal by Subject|6|||
124788331|NCT00329849|448854318|FG001|Overall Study|Withdrawal by Subject|4|||
124788332|NCT03996369|448854319|FG000|Overall Study|Protocol deviation|1|||
124788333|NCT03996369|448854320|FG001|Overall Study|Protocol deviation|1|||
124788334|NCT03996369|448854319|FG000|Overall Study|Physician Decision|4|||
124788335|NCT03996369|448854320|FG001|Overall Study|Physician Decision|2|||
124788336|NCT03996369|448854319|FG000|Overall Study|Participant decision|0|||
124788337|NCT03996369|448854320|FG001|Overall Study|Participant decision|1|||
124788338|NCT03996369|448854319|FG000|Overall Study|Lack of Efficacy|4|||
124788339|NCT03996369|448854320|FG001|Overall Study|Lack of Efficacy|0|||
124788340|NCT03996369|448854319|FG000|Overall Study|Adverse Event|9|||
124788341|NCT03996369|448854320|FG001|Overall Study|Adverse Event|0|||
124788342|NCT03996369|448854319|FG000|Overall Study|Withdrawal by Subject|6|||
124788343|NCT03996369|448854320|FG001|Overall Study|Withdrawal by Subject|8|||
124788344|NCT03996369|448854319|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
124788345|NCT03996369|448854320|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
124788346|NCT03996369|448854319|FG000|Overall Study|Lost to Follow-up|0|||
124788347|NCT03996369|448854320|FG001|Overall Study|Lost to Follow-up|1|||
124788348|NCT02238067|448854321|FG000|Overall Study|Not completed survey at Month 6|45|||
124788349|NCT01566214|448854323|FG000|Overall Study|Lost to Follow-up|3|||
124788350|NCT01566214|448854324|FG001|Overall Study|Lost to Follow-up|0|||
124788351|NCT00832624|448854328|FG000|Overall Study|Study Terminated|10|||
124788352|NCT02395172|448854329|FG000|Overall Study|Participants randomized but not treated|3|||
124788353|NCT02395172|448854330|FG001|Overall Study|Participants randomized but not treated|31|||
124788354|NCT00717236|448854331|FG000|Double-Blind Period|Adverse Event|33|||
124788355|NCT00717236|448854332|FG001|Double-Blind Period|Adverse Event|6|||
124788356|NCT00717236|448854331|FG000|Double-Blind Period|Lack of Efficacy|6|||
124788357|NCT00717236|448854332|FG001|Double-Blind Period|Lack of Efficacy|6|||
124788358|NCT00717236|448854331|FG000|Double-Blind Period|Lost to Follow-up|3|||
124788359|NCT00717236|448854332|FG001|Double-Blind Period|Lost to Follow-up|5|||
124788360|NCT00717236|448854331|FG000|Double-Blind Period|Withdrawal by Subject|10|||
124788361|NCT00717236|448854332|FG001|Double-Blind Period|Withdrawal by Subject|2|||
124788362|NCT00717236|448854331|FG000|Double-Blind Period|Loss of efficacy|3|||
124788363|NCT00717236|448854332|FG001|Double-Blind Period|Loss of efficacy|0|||
124788364|NCT00717236|448854331|FG000|Double-Blind Period|Other: Death|1|||
124788365|NCT00717236|448854332|FG001|Double-Blind Period|Other: Death|0|||
124788366|NCT00717236|448854331|FG000|Double-Blind Period|Other: Pregnancy|1|||
124788367|NCT00717236|448854332|FG001|Double-Blind Period|Other: Pregnancy|0|||
124788368|NCT00717236|448854331|FG000|Double-Blind Period|Other: Protocol Violation|2|||
124788369|NCT00717236|448854332|FG001|Double-Blind Period|Other: Protocol Violation|0|||
124788370|NCT00717236|448854331|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
124788371|NCT00717236|448854332|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
124788372|NCT00717236|448854331|FG000|Double-Blind Period|Other: Site withdrew|2|||
124788373|NCT00717236|448854332|FG001|Double-Blind Period|Other: Site withdrew|0|||
124788374|NCT00717236|448854331|FG000|Double-Blind Period|Other: Screening failure|1|||
124788375|NCT00717236|448854332|FG001|Double-Blind Period|Other: Screening failure|0|||
124788376|NCT00717236|448854331|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
124788377|NCT00717236|448854332|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
124788378|NCT00717236|448854331|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
124788379|NCT00717236|448854332|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
124788380|NCT00717236|448854331|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
124788381|NCT00717236|448854332|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
124788382|NCT00717236|448854331|FG000|Double-Blind Period|Other: History of cancer|1|||
124788383|NCT00717236|448854332|FG001|Double-Blind Period|Other: History of cancer|0|||
124788384|NCT00717236|448854331|FG000|Double-Blind Period|Other: Sponsor request|1|||
124788385|NCT00717236|448854332|FG001|Double-Blind Period|Other: Sponsor request|0|||
124788386|NCT00717236|448854331|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
124788387|NCT00717236|448854332|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
124788388|NCT00717236|448854331|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
124788389|NCT00717236|448854332|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
124788390|NCT00717236|448854331|FG000|Double-Blind Period|Other: Subject moved|1|||
124788391|NCT00717236|448854332|FG001|Double-Blind Period|Other: Subject moved|1|||
124788392|NCT00717236|448854331|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
124788393|NCT00717236|448854332|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
124788394|NCT00717236|448854331|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
124788395|NCT00717236|448854332|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
124788396|NCT00717236|448854331|FG000|Double-Blind Period|Other: Transportation problems|0|||
124788397|NCT00717236|448854332|FG001|Double-Blind Period|Other: Transportation problems|1|||
124788398|NCT00717236|448854331|FG000|Double-Blind Period|Other: Investigator Decision|0|||
124788399|NCT00717236|448854332|FG001|Double-Blind Period|Other: Investigator Decision|1|||
124788400|NCT00717236|448854331|FG000|Open-Label Period|Adverse Event|29|||
124788401|NCT00717236|448854332|FG001|Open-Label Period|Adverse Event|4|||
124788402|NCT00717236|448854331|FG000|Open-Label Period|Lack of Efficacy|30|||
124788403|NCT00717236|448854332|FG001|Open-Label Period|Lack of Efficacy|8|||
124788404|NCT00717236|448854331|FG000|Open-Label Period|Lost to Follow-up|28|||
124788405|NCT00717236|448854332|FG001|Open-Label Period|Lost to Follow-up|4|||
124788406|NCT00717236|448854331|FG000|Open-Label Period|Withdrawal by Subject|20|||
124788407|NCT00717236|448854332|FG001|Open-Label Period|Withdrawal by Subject|2|||
124788408|NCT00717236|448854331|FG000|Open-Label Period|Loss of Efficacy|6|||
124788409|NCT00717236|448854332|FG001|Open-Label Period|Loss of Efficacy|1|||
124788410|NCT00717236|448854331|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
124788411|NCT00717236|448854332|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
124788412|NCT00717236|448854331|FG000|Open-Label Period|Other: Lack of Compliance|1|||
124788413|NCT00717236|448854332|FG001|Open-Label Period|Other: Lack of Compliance|1|||
124788414|NCT00717236|448854331|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
124788415|NCT00717236|448854332|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
124788416|NCT00717236|448854331|FG000|Open-Label Period|Other: Moved|1|||
124788417|NCT00717236|448854332|FG001|Open-Label Period|Other: Moved|0|||
124788418|NCT00717236|448854331|FG000|Open-Label Period|Other: Investigator Decision|1|||
124788419|NCT00717236|448854332|FG001|Open-Label Period|Other: Investigator Decision|0|||
124788420|NCT00717236|448854331|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
124788421|NCT00717236|448854332|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
124788422|NCT00717236|448854331|FG000|Open-Label Period|Other: Sponsor Request|3|||
124788423|NCT00717236|448854332|FG001|Open-Label Period|Other: Sponsor Request|0|||
124788424|NCT00717236|448854331|FG000|Open-Label Period|Other: Cataract Surgery|1|||
124788425|NCT00717236|448854332|FG001|Open-Label Period|Other: Cataract Surgery|0|||
124788426|NCT00717236|448854331|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
124788427|NCT00717236|448854332|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
124788428|NCT00717236|448854331|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
124788429|NCT00717236|448854332|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
124788430|NCT00717236|448854331|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
124788431|NCT00717236|448854332|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
124788432|NCT00475982|448854333|FG000|Overall Study|surgery rescheduled|7|||
124788433|NCT00475982|448854334|FG001|Overall Study|surgery rescheduled|3|||
124788434|NCT00783198|448854339|FG000|Overall Study|Adverse Event|15|||
124788435|NCT00783198|448854340|FG001|Overall Study|Adverse Event|19|||
124788436|NCT00783198|448854341|FG002|Overall Study|Adverse Event|3|||
124788437|NCT00783198|448854339|FG000|Overall Study|Lost to Follow-up|11|||
124788438|NCT00783198|448854340|FG001|Overall Study|Lost to Follow-up|1|||
124788439|NCT00783198|448854341|FG002|Overall Study|Lost to Follow-up|7|||
124788440|NCT00783198|448854339|FG000|Overall Study|Withdrawal by Subject|22|||
124788441|NCT00783198|448854340|FG001|Overall Study|Withdrawal by Subject|14|||
124788442|NCT00783198|448854341|FG002|Overall Study|Withdrawal by Subject|20|||
124788443|NCT00783198|448854339|FG000|Overall Study|Noncompliance with protocol|7|||
124788444|NCT00783198|448854340|FG001|Overall Study|Noncompliance with protocol|7|||
124788445|NCT00783198|448854341|FG002|Overall Study|Noncompliance with protocol|10|||
124788446|NCT00783198|448854339|FG000|Overall Study|Did not meet protocol eligibility|0|||
124788447|NCT00783198|448854340|FG001|Overall Study|Did not meet protocol eligibility|1|||
124788448|NCT00783198|448854341|FG002|Overall Study|Did not meet protocol eligibility|0|||
124788449|NCT00783198|448854339|FG000|Overall Study|Administrative|2|||
124788450|NCT00783198|448854340|FG001|Overall Study|Administrative|1|||
124788451|NCT00783198|448854341|FG002|Overall Study|Administrative|2|||
124788452|NCT00946985|448854342|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
124788453|NCT00946985|448854342|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
124788454|NCT00946985|448854342|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
124788455|NCT00946985|448854342|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
124788456|NCT00946985|448854342|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
124788457|NCT00946985|448854342|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
124788458|NCT00946985|448854342|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
124788459|NCT00946985|448854342|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
124788460|NCT00946985|448854342|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
124788461|NCT04345367|448854343|FG000|Overall Study|Other|3|||
124788462|NCT04345367|448854344|FG001|Overall Study|Other|4|||
124788463|NCT04345367|448854343|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
124788464|NCT04345367|448854344|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
124788465|NCT04345367|448854343|FG000|Overall Study|Withdrawal by Subject|11|||
124788466|NCT04345367|448854344|FG001|Overall Study|Withdrawal by Subject|11|||
124788467|NCT04345367|448854343|FG000|Overall Study|Protocol Violation|4|||
124788468|NCT04345367|448854344|FG001|Overall Study|Protocol Violation|3|||
124788469|NCT04345367|448854343|FG000|Overall Study|Lost to Follow-up|2|||
125292251|NCT02317809|450696576|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
125292252|NCT02317809|450696577|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
124788470|NCT04345367|448854344|FG001|Overall Study|Lost to Follow-up|4|||
124788471|NCT04345367|448854343|FG000|Overall Study|Lack of Efficacy|2|||
124788472|NCT04345367|448854344|FG001|Overall Study|Lack of Efficacy|0|||
124788473|NCT04345367|448854343|FG000|Overall Study|Death|2|||
124788474|NCT04345367|448854344|FG001|Overall Study|Death|0|||
124788475|NCT04345367|448854343|FG000|Overall Study|Adverse Event|10|||
124788476|NCT04345367|448854344|FG001|Overall Study|Adverse Event|9|||
124788477|NCT00852371|448854345|FG000|Overall Study|Lost to Follow-up|2|||
124788478|NCT00852371|448854346|FG001|Overall Study|Lost to Follow-up|3|||
124788479|NCT00852371|448854347|FG002|Overall Study|Lost to Follow-up|4|||
124788480|NCT00852371|448854348|FG003|Overall Study|Lost to Follow-up|2|||
124788481|NCT00796523|448854349|FG000|Overall Study|Lost to Follow-up|9|||
124788482|NCT00796523|448854350|FG001|Overall Study|Lost to Follow-up|7|||
124788483|NCT04525885|448854351|FG000|Overall Study|Screen Failure|1|||
124788484|NCT04525885|448854352|FG001|Overall Study|Screen Failure|0|||
124788485|NCT04525885|448854353|FG002|Overall Study|Screen Failure|0|||
124788486|NCT04525885|448854351|FG000|Overall Study|Withdrawal by Subject|14|||
124788487|NCT04525885|448854352|FG001|Overall Study|Withdrawal by Subject|6|||
124788488|NCT04525885|448854353|FG002|Overall Study|Withdrawal by Subject|20|||
124788489|NCT04525885|448854351|FG000|Overall Study|Physician Decision|1|||
124788490|NCT04525885|448854352|FG001|Overall Study|Physician Decision|0|||
124788491|NCT04525885|448854353|FG002|Overall Study|Physician Decision|1|||
124788492|NCT00978757|448854362|FG000|Overall Study|Physician Decision|1|||
124788493|NCT00978757|448854363|FG001|Overall Study|Physician Decision|3|||
124788494|NCT01700387|448854364|FG000|Overall Study|Withdrawal by Subject|1|||
124788495|NCT01700387|448854365|FG001|Overall Study|Withdrawal by Subject|2|||
124788496|NCT01700387|448854364|FG000|Overall Study|Adverse Event|1|||
124788497|NCT01700387|448854365|FG001|Overall Study|Adverse Event|1|||
124788498|NCT01700387|448854364|FG000|Overall Study|Lost to Follow-up|2|||
124788499|NCT01700387|448854365|FG001|Overall Study|Lost to Follow-up|1|||
124788500|NCT01031836|448855840|FG000|Stage I|Adverse Event|1|||
124788501|NCT01031836|448855841|FG001|Stage I|Adverse Event|1|||
124788502|NCT01031836|448855842|FG002|Stage I|Adverse Event|0|||
124788503|NCT01031836|448855843|FG003|Stage I|Adverse Event|0|||
125292253|NCT02317809|450696576|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
125292254|NCT02317809|450696577|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
125292255|NCT04912895|450696581|FG000|Overall Study|Unable to provide specimen|2|||
125292256|NCT04912895|450696582|FG001|Overall Study|Unable to provide specimen|0|||
125292257|NCT04912895|450696583|FG002|Overall Study|Unable to provide specimen|0|||
125292258|NCT03458702|450696584|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
125292259|NCT03458702|450696585|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
125292260|NCT03458702|450696584|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
125292261|NCT03458702|450696585|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
125292262|NCT01390779|450696586|FG000|Overall Study|Physician Decision|1|||
125292263|NCT00545532|450696587|FG000|Overall Study|Withdrawal by Subject|1|||
125292264|NCT00545532|450696588|FG001|Overall Study|Withdrawal by Subject|3|||
125292265|NCT00545532|450696587|FG000|Overall Study|Lost to Follow-up|5|||
125292266|NCT00545532|450696588|FG001|Overall Study|Lost to Follow-up|6|||
125292267|NCT00545532|450696587|FG000|Overall Study|Death|0|||
125292268|NCT00545532|450696588|FG001|Overall Study|Death|1|||
125292269|NCT01149486|450696591|FG000|First Intervention|Adverse Event|0|||
125292270|NCT01149486|450696592|FG001|First Intervention|Adverse Event|1|||
125292271|NCT00931801|450696601|FG000|Overall Study|Adverse Event|0|||
125292272|NCT00931801|450696602|FG001|Overall Study|Adverse Event|0|||
125292273|NCT00931801|450696603|FG002|Overall Study|Adverse Event|1|||
124788504|NCT01031836|448855844|FG004|Stage I|Adverse Event|0|||
124788505|NCT01031836|448855845|FG005|Stage I|Adverse Event|0|||
124788506|NCT01031836|448855840|FG000|Stage I|Other|0|||
124788507|NCT01031836|448855841|FG001|Stage I|Other|1|||
124788508|NCT01031836|448855842|FG002|Stage I|Other|0|||
124788509|NCT01031836|448855843|FG003|Stage I|Other|0|||
125292274|NCT00931801|450696601|FG000|Overall Study|Lost to Follow-up|0|||
125292275|NCT00931801|450696602|FG001|Overall Study|Lost to Follow-up|1|||
124788510|NCT01031836|448855844|FG004|Stage I|Other|0|||
124788511|NCT01031836|448855845|FG005|Stage I|Other|1|||
124788512|NCT01031836|448855840|FG000|Stage II|Adverse Event|0|||
124788513|NCT01031836|448855841|FG001|Stage II|Adverse Event|0|||
124788514|NCT01031836|448855842|FG002|Stage II|Adverse Event|2|||
124788515|NCT01031836|448855843|FG003|Stage II|Adverse Event|2|||
124788516|NCT01031836|448855844|FG004|Stage II|Adverse Event|1|||
124788517|NCT01031836|448855845|FG005|Stage II|Adverse Event|1|||
124788518|NCT01031836|448855840|FG000|Stage II|Other|2|||
124788519|NCT01031836|448855841|FG001|Stage II|Other|0|||
124788520|NCT01031836|448855842|FG002|Stage II|Other|0|||
124788521|NCT01031836|448855843|FG003|Stage II|Other|1|||
124788522|NCT01031836|448855844|FG004|Stage II|Other|1|||
124788523|NCT01031836|448855845|FG005|Stage II|Other|0|||
125292276|NCT00931801|450696603|FG002|Overall Study|Lost to Follow-up|0|||
125292277|NCT00931801|450696601|FG000|Overall Study|Withdrawal by Subject|1|||
125292278|NCT00931801|450696602|FG001|Overall Study|Withdrawal by Subject|0|||
125292279|NCT00931801|450696603|FG002|Overall Study|Withdrawal by Subject|0|||
125292280|NCT00931801|450696601|FG000|Overall Study|Confirmed Virologic Failure|0|||
125292281|NCT00931801|450696602|FG001|Overall Study|Confirmed Virologic Failure|0|||
125292282|NCT00931801|450696603|FG002|Overall Study|Confirmed Virologic Failure|3|||
125292283|NCT01635764|450696605|FG000|Overall Study|Adverse Event|46|||
125292284|NCT01635764|450696605|FG000|Overall Study|Lack of Efficacy|76|||
125292285|NCT01635764|450696605|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
125292286|NCT01635764|450696605|FG000|Overall Study|Protocol Deviation|1|||
125292287|NCT01635764|450696605|FG000|Overall Study|Withdrew Consent|67|||
125292288|NCT01635764|450696605|FG000|Overall Study|Lost to Follow-up|53|||
125292289|NCT01635764|450696605|FG000|Overall Study|Other|28|||
125292290|NCT01174004|450696606|FG000|Overall Study|Adverse Event|2|||
125292291|NCT01174004|450696607|FG001|Overall Study|Adverse Event|10|||
125292292|NCT01174004|450696606|FG000|Overall Study|Withdrawal by Subject|2|||
125292293|NCT01174004|450696607|FG001|Overall Study|Withdrawal by Subject|3|||
125292294|NCT01174004|450696606|FG000|Overall Study|At Discretion of Sponsor|2|||
125292295|NCT01174004|450696607|FG001|Overall Study|At Discretion of Sponsor|2|||
125292296|NCT01174004|450696606|FG000|Overall Study|Protocol Violation|0|||
125292297|NCT01174004|450696607|FG001|Overall Study|Protocol Violation|1|||
125292298|NCT01174004|450696606|FG000|Overall Study|Physician Decision|1|||
125292299|NCT01174004|450696607|FG001|Overall Study|Physician Decision|0|||
125292300|NCT00933244|450696608|FG000|Overall Study|Withdrawal by Subject|5|||
125292301|NCT00933244|450696609|FG001|Overall Study|Withdrawal by Subject|1|||
125292302|NCT00933244|450696610|FG002|Overall Study|Withdrawal by Subject|3|||
125292303|NCT04375397|450696617|FG000|Overall Study|Death|1|||
124788524|NCT03137069|448855846|FG000|Overall Study|Withdrawal by Subject|1|||
124788525|NCT03137069|448855847|FG001|Overall Study|Withdrawal by Subject|2|||
124788526|NCT03137069|448855848|FG002|Overall Study|Withdrawal by Subject|2|||
124788527|NCT03137069|448855849|FG003|Overall Study|Withdrawal by Subject|2|||
124788528|NCT03137069|448855850|FG004|Overall Study|Withdrawal by Subject|0|||
124788529|NCT03137069|448855851|FG005|Overall Study|Withdrawal by Subject|0|||
124788530|NCT03137069|448855846|FG000|Overall Study|Adverse Event|0|||
124788531|NCT03137069|448855847|FG001|Overall Study|Adverse Event|3|||
124788532|NCT03137069|448855848|FG002|Overall Study|Adverse Event|1|||
124788533|NCT03137069|448855849|FG003|Overall Study|Adverse Event|1|||
125292304|NCT04375397|450696618|FG001|Overall Study|Death|1|||
125292305|NCT04375397|450696617|FG000|Overall Study|Withdrew consent|2|||
125292306|NCT04375397|450696618|FG001|Overall Study|Withdrew consent|0|||
125292307|NCT04375397|450696617|FG000|Overall Study|Lost to Follow-up|6|||
125292308|NCT04375397|450696618|FG001|Overall Study|Lost to Follow-up|4|||
125292309|NCT04375397|450696617|FG000|Overall Study|Other, not specified|0|||
125292310|NCT04375397|450696618|FG001|Overall Study|Other, not specified|1|||
124788534|NCT03137069|448855850|FG004|Overall Study|Adverse Event|0|||
124788535|NCT03137069|448855851|FG005|Overall Study|Adverse Event|1|||
125292311|NCT00610441|450696620|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
125292312|NCT00610441|450696621|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
125292313|NCT00610441|450696622|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
125292314|NCT00610441|450696623|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
125292315|NCT00610441|450696620|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
125292316|NCT00610441|450696621|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
125292317|NCT00610441|450696622|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
125292318|NCT00610441|450696623|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
125292319|NCT00610441|450696620|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
125292320|NCT00610441|450696621|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
125292321|NCT00610441|450696622|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
125292322|NCT00610441|450696623|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
125292323|NCT00610441|450696620|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
125292324|NCT00610441|450696621|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
125292325|NCT00610441|450696622|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
125292326|NCT00610441|450696623|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
124788536|NCT03137069|448855846|FG000|Overall Study|Protocol Violation|0|||
125292327|NCT00610441|450696620|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
125292328|NCT00610441|450696621|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
125292329|NCT00610441|450696622|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
125292330|NCT00610441|450696623|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
125292331|NCT00610441|450696620|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
125292332|NCT00610441|450696621|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
125292333|NCT00610441|450696622|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
125292334|NCT00610441|450696623|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
125292335|NCT00610441|450696620|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
125292336|NCT00610441|450696621|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
125292337|NCT00610441|450696622|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
125292338|NCT00610441|450696623|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
125292339|NCT00610441|450696620|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
124788537|NCT03137069|448855847|FG001|Overall Study|Protocol Violation|1|||
124788538|NCT03137069|448855848|FG002|Overall Study|Protocol Violation|0|||
124788539|NCT03137069|448855849|FG003|Overall Study|Protocol Violation|1|||
125292340|NCT00610441|450696621|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
125292341|NCT00610441|450696622|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
125292342|NCT00610441|450696623|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
125292343|NCT00610441|450696620|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
125292344|NCT00610441|450696621|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
125292345|NCT00610441|450696622|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
125292346|NCT00610441|450696623|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
125292347|NCT03002623|450696628|FG000|Overall Study|Lost to Follow-up|1|||
125292348|NCT03002623|450696629|FG001|Overall Study|Lost to Follow-up|0|||
125292349|NCT03002623|450696628|FG000|Overall Study|Physician Decision|1|||
125292350|NCT03002623|450696629|FG001|Overall Study|Physician Decision|1|||
125292351|NCT02639338|450696630|FG000|Overall Study|Lost to Follow-up|2|||
125292352|NCT02639338|450696631|FG001|Overall Study|Lost to Follow-up|2|||
125292353|NCT02639338|450696630|FG000|Overall Study|Withdrew Consent|1|||
125292354|NCT02639338|450696631|FG001|Overall Study|Withdrew Consent|2|||
125292355|NCT02639338|450696630|FG000|Overall Study|Death|1|||
125292356|NCT02639338|450696631|FG001|Overall Study|Death|0|||
125292357|NCT02639338|450696630|FG000|Overall Study|Randomized but Not Treated|0|||
125292358|NCT02639338|450696631|FG001|Overall Study|Randomized but Not Treated|1|||
125292359|NCT00493636|450696632|FG000|Overall Study|Withdrawal by Subject|1|||
125292360|NCT00493636|450696633|FG001|Overall Study|Withdrawal by Subject|0|||
125292361|NCT00493636|450696632|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
125292362|NCT00493636|450696633|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
125292363|NCT00493636|450696632|FG000|Overall Study|Mis-randomization|1|||
125292364|NCT00493636|450696633|FG001|Overall Study|Mis-randomization|1|||
125292365|NCT01066780|450696640|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
125292366|NCT01066780|450696641|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
125292367|NCT03131596|450698660|FG000|Overall Study|Protocol Violation|3|||
125292368|NCT03131596|450698661|FG001|Overall Study|Protocol Violation|3|||
125292369|NCT03131596|450698660|FG000|Overall Study|Lost to Follow-up|3|||
125292370|NCT03131596|450698661|FG001|Overall Study|Lost to Follow-up|0|||
125292371|NCT00734071|450698664|FG000|Overall Study|Adverse Event|4|||
125292372|NCT00734071|450698665|FG001|Overall Study|Adverse Event|3|||
125292373|NCT00734071|450698664|FG000|Overall Study|Lack of Efficacy|3|||
125292374|NCT00734071|450698665|FG001|Overall Study|Lack of Efficacy|1|||
125292375|NCT00734071|450698664|FG000|Overall Study|Noncompliance|2|||
125292376|NCT00734071|450698665|FG001|Overall Study|Noncompliance|2|||
125292377|NCT00734071|450698664|FG000|Overall Study|Protocol Deviations|3|||
125292378|NCT00734071|450698665|FG001|Overall Study|Protocol Deviations|4|||
125292379|NCT00734071|450698664|FG000|Overall Study|Voluntary Withdrawal|9|||
125292380|NCT00734071|450698665|FG001|Overall Study|Voluntary Withdrawal|7|||
125292381|NCT00734071|450698664|FG000|Overall Study|Lost to Follow-up|16|||
125292382|NCT00734071|450698665|FG001|Overall Study|Lost to Follow-up|8|||
125292383|NCT00734071|450698664|FG000|Overall Study|Other|1|||
125292384|NCT00734071|450698665|FG001|Overall Study|Other|2|||
125292385|NCT00151372|450698666|FG000|Overall Study|Death|12|||
125292386|NCT00151372|450698667|FG001|Overall Study|Death|11|||
125292387|NCT00151372|450698666|FG000|Overall Study|Lost to Follow-up|5|||
125292388|NCT00151372|450698667|FG001|Overall Study|Lost to Follow-up|5|||
125292389|NCT00151372|450698666|FG000|Overall Study|Too sick medically to continue|5|||
125292390|NCT00151372|450698667|FG001|Overall Study|Too sick medically to continue|6|||
125292391|NCT00151372|450698666|FG000|Overall Study|Withdrawal by Subject|7|||
125292392|NCT00151372|450698667|FG001|Overall Study|Withdrawal by Subject|7|||
125292393|NCT00541346|450698669|FG000|Follow-up|Adverse Event|1|||
125292394|NCT04732949|450698670|FG000|Overall Study|Withdrawal by Subject|23|||
125292395|NCT04732949|450698671|FG001|Overall Study|Withdrawal by Subject|27|||
125292396|NCT04732949|450698670|FG000|Overall Study|Protocol Violation|0|||
125292397|NCT04732949|450698671|FG001|Overall Study|Protocol Violation|1|||
125292398|NCT04732949|450698670|FG000|Overall Study|Non-compliance|0|||
125292399|NCT04732949|450698671|FG001|Overall Study|Non-compliance|2|||
125292400|NCT04732949|450698670|FG000|Overall Study|Physician Decision|2|||
124788540|NCT03137069|448855850|FG004|Overall Study|Protocol Violation|1|||
124788541|NCT03137069|448855851|FG005|Overall Study|Protocol Violation|1|||
125292401|NCT04732949|450698671|FG001|Overall Study|Physician Decision|1|||
125292402|NCT04732949|450698670|FG000|Overall Study|Serious adverse event (Fatal)|16|||
125292403|NCT04732949|450698671|FG001|Overall Study|Serious adverse event (Fatal)|18|||
125292404|NCT04732949|450698670|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
125292405|NCT04732949|450698671|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
125292406|NCT04732949|450698670|FG000|Overall Study|Non-serious adverse event|1|||
125292407|NCT04732949|450698671|FG001|Overall Study|Non-serious adverse event|3|||
125292408|NCT04732949|450698670|FG000|Overall Study|Lost to Follow-up|26|||
125292409|NCT04732949|450698671|FG001|Overall Study|Lost to Follow-up|27|||
125292410|NCT04732949|450698670|FG000|Overall Study|Other|6|||
125292411|NCT04732949|450698671|FG001|Overall Study|Other|3|||
125292412|NCT00583791|450698674|FG000|Overall Study|Other|67|||
124788542|NCT03137069|448855846|FG000|Overall Study|Physician Decision|0|||
125292413|NCT00583791|450698674|FG000|Overall Study|Death|6|||
125292414|NCT03323736|450698675|FG000|Overall Study|Screen Failure|14|||
125292415|NCT03323736|450698676|FG001|Overall Study|Screen Failure|9|||
125292416|NCT03323736|450698677|FG002|Overall Study|Screen Failure|1|||
125292417|NCT03323736|450698675|FG000|Overall Study|Withdrawal Before Treatment|3|||
125292418|NCT03323736|450698676|FG001|Overall Study|Withdrawal Before Treatment|1|||
125292419|NCT03323736|450698677|FG002|Overall Study|Withdrawal Before Treatment|1|||
125292420|NCT03323736|450698675|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
125292421|NCT03323736|450698676|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
125292422|NCT03323736|450698677|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
125292423|NCT03710876|450698678|FG000|Overall Study|Death|0|||
125292424|NCT03710876|450698679|FG001|Overall Study|Death|2|||
125292425|NCT03710876|450698678|FG000|Overall Study|Withdrawal by Subject|0|||
125292426|NCT03710876|450698679|FG001|Overall Study|Withdrawal by Subject|2|||
125292427|NCT02853435|450698680|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
125292428|NCT02853435|450698681|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
125292429|NCT02853435|450698682|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
125292430|NCT02853435|450698683|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
125292431|NCT02853435|450698684|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
125292432|NCT02853435|450698685|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
125292433|NCT03747120|450698688|FG000|Overall Study|treatment related toxicity|3|||
125292434|NCT03747120|450698689|FG001|Overall Study|treatment related toxicity|0|||
125292435|NCT03747120|450698690|FG002|Overall Study|treatment related toxicity|0|||
125292436|NCT03747120|450698688|FG000|Overall Study|Withdrawal by Subject|0|||
125292437|NCT03747120|450698689|FG001|Overall Study|Withdrawal by Subject|1|||
125292438|NCT03747120|450698690|FG002|Overall Study|Withdrawal by Subject|2|||
125292439|NCT04191499|450698699|FG000|Overall Study|Adverse Event|1|||
125292440|NCT04191499|450698700|FG001|Overall Study|Adverse Event|0|||
125292441|NCT04191499|450698699|FG000|Overall Study|Death|42|||
125292442|NCT04191499|450698700|FG001|Overall Study|Death|55|||
125292443|NCT04191499|450698699|FG000|Overall Study|Lost to Follow-up|4|||
125292444|NCT04191499|450698700|FG001|Overall Study|Lost to Follow-up|1|||
125292445|NCT04191499|450698699|FG000|Overall Study|Physician Decision|1|||
125292446|NCT04191499|450698700|FG001|Overall Study|Physician Decision|0|||
125292447|NCT04191499|450698699|FG000|Overall Study|Progressive Disease|1|||
125292448|NCT04191499|450698700|FG001|Overall Study|Progressive Disease|0|||
125292449|NCT04191499|450698699|FG000|Overall Study|Symptomatic Deterioration|1|||
125292450|NCT04191499|450698700|FG001|Overall Study|Symptomatic Deterioration|0|||
125292451|NCT04191499|450698699|FG000|Overall Study|Withdrawal by Subject|7|||
125292452|NCT04191499|450698700|FG001|Overall Study|Withdrawal by Subject|11|||
125292453|NCT04191499|450698699|FG000|Overall Study|Ongoing in the study|104|||
125292454|NCT04191499|450698700|FG001|Overall Study|Ongoing in the study|97|||
125292455|NCT01266317|450698701|FG000|Overall Study|Withdrawal by Subject|2|||
125292456|NCT00490776|450698702|FG000|Overall Study|Withdrawal by Subject|1|||
125292457|NCT00490776|450698702|FG000|Overall Study|Administrative Problems|1|||
125292458|NCT00490776|450698702|FG000|Overall Study|Death|1|||
125292459|NCT00490776|450698702|FG000|Overall Study|New Cancer Therapy|1|||
125292460|NCT00490776|450698702|FG000|Overall Study|Disease Progression|5|||
125292461|NCT04271475|450698714|FG000|DB Period: Day 1 up to EODBT|Death|1|||
125292462|NCT04271475|450698715|FG001|DB Period: Day 1 up to EODBT|Death|0|||
125292463|NCT04271475|450698716|FG002|DB Period: Day 1 up to EODBT|Death|0|||
125292464|NCT04271475|450698717|FG003|DB Period: Day 1 up to EODBT|Death|0|||
125292465|NCT04271475|450698714|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
125292466|NCT04271475|450698715|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
125292467|NCT04271475|450698716|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
125292468|NCT04271475|450698717|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
125292469|NCT04271475|450698714|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
125292470|NCT04271475|450698715|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
125292471|NCT04271475|450698716|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
125292472|NCT04271475|450698717|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
125292473|NCT04271475|450698714|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
125292474|NCT04271475|450698715|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
125292475|NCT04271475|450698716|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
124788543|NCT03137069|448855847|FG001|Overall Study|Physician Decision|0|||
124788544|NCT03137069|448855848|FG002|Overall Study|Physician Decision|0|||
125292476|NCT04271475|450698717|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
125292477|NCT04271475|450698714|FG000|DB Period: Day 1 up to EODBT|Other|8|||
125292478|NCT04271475|450698715|FG001|DB Period: Day 1 up to EODBT|Other|5|||
125292479|NCT04271475|450698716|FG002|DB Period: Day 1 up to EODBT|Other|0|||
125292480|NCT04271475|450698717|FG003|DB Period: Day 1 up to EODBT|Other|0|||
125292481|NCT04271475|450698714|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
125292482|NCT04271475|450698715|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
125292483|NCT04271475|450698716|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
125292484|NCT04271475|450698717|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
125292485|NCT04271475|450698714|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
125292486|NCT04271475|450698715|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
125292487|NCT04271475|450698716|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
125292488|NCT04271475|450698717|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
125292489|NCT00159913|450698719|FG000|Overall Study|Adverse Event|1|||
125292490|NCT00159913|450698720|FG001|Overall Study|Adverse Event|0|||
125292491|NCT00159913|450698721|FG002|Overall Study|Adverse Event|1|||
125292492|NCT00159913|450698722|FG003|Overall Study|Adverse Event|0|||
125292493|NCT00159913|450698719|FG000|Overall Study|Withdrawal by Subject|0|||
125292494|NCT00159913|450698720|FG001|Overall Study|Withdrawal by Subject|0|||
125292495|NCT00159913|450698721|FG002|Overall Study|Withdrawal by Subject|0|||
125292496|NCT00159913|450698722|FG003|Overall Study|Withdrawal by Subject|1|||
125292497|NCT00159913|450698719|FG000|Overall Study|Lost to Follow-up|0|||
125292498|NCT00159913|450698720|FG001|Overall Study|Lost to Follow-up|0|||
125292499|NCT00159913|450698721|FG002|Overall Study|Lost to Follow-up|0|||
125292500|NCT00159913|450698722|FG003|Overall Study|Lost to Follow-up|1|||
125292501|NCT00159913|450698719|FG000|Overall Study|Protocol Violation|1|||
125292502|NCT00159913|450698720|FG001|Overall Study|Protocol Violation|0|||
125292503|NCT00159913|450698721|FG002|Overall Study|Protocol Violation|1|||
125292504|NCT00159913|450698722|FG003|Overall Study|Protocol Violation|0|||
125292505|NCT00824005|450698723|FG000|Overall Study|Death|0|||
125292506|NCT00824005|450698724|FG001|Overall Study|Death|1|||
125292507|NCT00824005|450698723|FG000|Overall Study|Lost to Follow-up|0|||
125292508|NCT00824005|450698724|FG001|Overall Study|Lost to Follow-up|1|||
125292509|NCT01874275|450698725|FG000|Overall Study|Lost to Follow-up|1|||
125292510|NCT01874275|450698726|FG001|Overall Study|Lost to Follow-up|0|||
125292511|NCT00168103|450698729|FG000|Overall Study|Withdrawal by Subject|1|||
125292512|NCT00168103|450698730|FG001|Overall Study|Withdrawal by Subject|2|||
125292513|NCT00168103|450698731|FG002|Overall Study|Withdrawal by Subject|1|||
125292514|NCT00168103|450698732|FG003|Overall Study|Withdrawal by Subject|0|||
125292515|NCT00168103|450698729|FG000|Overall Study|Lost to Follow-up|1|||
125292516|NCT00168103|450698730|FG001|Overall Study|Lost to Follow-up|3|||
125292517|NCT00168103|450698731|FG002|Overall Study|Lost to Follow-up|0|||
125292518|NCT00168103|450698732|FG003|Overall Study|Lost to Follow-up|0|||
125292519|NCT00989235|450698733|FG000|Overall Study|Death|0|||
125292520|NCT00989235|450698734|FG001|Overall Study|Death|1|||
125292521|NCT00989235|450698733|FG000|Overall Study|Adverse Event|0|||
125292522|NCT00989235|450698734|FG001|Overall Study|Adverse Event|1|||
125292523|NCT00989235|450698733|FG000|Overall Study|Lack of Efficacy|1|||
125292524|NCT00989235|450698734|FG001|Overall Study|Lack of Efficacy|0|||
125292525|NCT00989235|450698733|FG000|Overall Study|Withdrawal of Consent|1|||
125292526|NCT00989235|450698734|FG001|Overall Study|Withdrawal of Consent|1|||
125292527|NCT00989235|450698733|FG000|Overall Study|Desire to Become Pregnant|1|||
125292528|NCT00989235|450698734|FG001|Overall Study|Desire to Become Pregnant|0|||
125292529|NCT00989235|450698733|FG000|Overall Study|Randomized by Mistake|0|||
125292530|NCT00989235|450698734|FG001|Overall Study|Randomized by Mistake|2|||
125292531|NCT00989235|450698733|FG000|Overall Study|Lost to Follow-up|0|||
125292532|NCT00989235|450698734|FG001|Overall Study|Lost to Follow-up|1|||
125292533|NCT02266875|450698735|FG000|Overall Study|Withdrawal by Subject|9|||
125292534|NCT02266875|450698736|FG001|Overall Study|Withdrawal by Subject|0|||
125292535|NCT02266875|450698735|FG000|Overall Study|Lost to Follow-up|2|||
125292536|NCT02266875|450698736|FG001|Overall Study|Lost to Follow-up|0|||
125292537|NCT00875056|450698739|FG000|Overall Study|Adverse Event|6|||
125292538|NCT00875056|450698740|FG001|Overall Study|Adverse Event|1|||
125292539|NCT00875056|450698741|FG002|Overall Study|Adverse Event|2|||
125292540|NCT00875056|450698739|FG000|Overall Study|Progressive Disease|14|||
125292541|NCT00875056|450698740|FG001|Overall Study|Progressive Disease|8|||
125292542|NCT00875056|450698741|FG002|Overall Study|Progressive Disease|3|||
125292543|NCT00875056|450698739|FG000|Overall Study|Withdrawal by Subject|3|||
125292544|NCT00875056|450698740|FG001|Overall Study|Withdrawal by Subject|0|||
125292545|NCT00875056|450698741|FG002|Overall Study|Withdrawal by Subject|1|||
125292546|NCT01318070|450698742|FG000|Overall Study|Adverse Event|1|||
125292547|NCT01318070|450698743|FG001|Overall Study|Adverse Event|1|||
125292548|NCT01318070|450698744|FG002|Overall Study|Adverse Event|5|||
125292549|NCT01318070|450698742|FG000|Overall Study|Withdrawal by Subject|0|||
125292550|NCT01318070|450698743|FG001|Overall Study|Withdrawal by Subject|1|||
125292551|NCT01318070|450698744|FG002|Overall Study|Withdrawal by Subject|1|||
125292552|NCT01318070|450698742|FG000|Overall Study|Lack of Efficacy|0|||
125292553|NCT01318070|450698743|FG001|Overall Study|Lack of Efficacy|0|||
125292554|NCT01318070|450698744|FG002|Overall Study|Lack of Efficacy|1|||
125292555|NCT01318070|450698742|FG000|Overall Study|Principal Investigator Discretion|1|||
125292556|NCT01318070|450698743|FG001|Overall Study|Principal Investigator Discretion|0|||
125292557|NCT01318070|450698744|FG002|Overall Study|Principal Investigator Discretion|0|||
125292558|NCT02956850|450698745|FG000|Overall Study|Withdrawal by Subject|0|||
125292559|NCT02956850|450698746|FG001|Overall Study|Withdrawal by Subject|0|||
125292560|NCT02956850|450698747|FG002|Overall Study|Withdrawal by Subject|0|||
125292561|NCT02956850|450698748|FG003|Overall Study|Withdrawal by Subject|0|||
125292562|NCT02956850|450698749|FG004|Overall Study|Withdrawal by Subject|0|||
125292563|NCT02956850|450698750|FG005|Overall Study|Withdrawal by Subject|0|||
125292564|NCT02956850|450698751|FG006|Overall Study|Withdrawal by Subject|0|||
125292565|NCT02956850|450698752|FG007|Overall Study|Withdrawal by Subject|0|||
125292566|NCT02956850|450698753|FG008|Overall Study|Withdrawal by Subject|0|||
125292567|NCT02956850|450698754|FG009|Overall Study|Withdrawal by Subject|0|||
125292568|NCT02956850|450698755|FG010|Overall Study|Withdrawal by Subject|0|||
125292569|NCT02956850|450698756|FG011|Overall Study|Withdrawal by Subject|0|||
125292570|NCT02956850|450698757|FG012|Overall Study|Withdrawal by Subject|0|||
125292571|NCT02956850|450698758|FG013|Overall Study|Withdrawal by Subject|0|||
125292572|NCT02956850|450698759|FG014|Overall Study|Withdrawal by Subject|0|||
125292573|NCT02956850|450698760|FG015|Overall Study|Withdrawal by Subject|0|||
125292574|NCT02956850|450698761|FG016|Overall Study|Withdrawal by Subject|0|||
125292575|NCT02956850|450698762|FG017|Overall Study|Withdrawal by Subject|1|||
125292576|NCT00391391|450698763|FG000|Overall Study|Adverse Event|0|||
125292577|NCT00391391|450698764|FG001|Overall Study|Adverse Event|0|||
125292578|NCT00391391|450698765|FG002|Overall Study|Adverse Event|0|||
125292579|NCT00391391|450698766|FG003|Overall Study|Adverse Event|1|||
125292580|NCT00391391|450698763|FG000|Overall Study|Lost to Follow-up|1|||
125292581|NCT00391391|450698764|FG001|Overall Study|Lost to Follow-up|3|||
125292582|NCT00391391|450698765|FG002|Overall Study|Lost to Follow-up|7|||
125292583|NCT00391391|450698766|FG003|Overall Study|Lost to Follow-up|4|||
125292584|NCT00391391|450698763|FG000|Overall Study|Protocol Violation|2|||
125292585|NCT00391391|450698764|FG001|Overall Study|Protocol Violation|3|||
125292586|NCT00391391|450698765|FG002|Overall Study|Protocol Violation|6|||
125292587|NCT00391391|450698766|FG003|Overall Study|Protocol Violation|7|||
125292588|NCT00391391|450698763|FG000|Overall Study|Withdrawal by Subject|6|||
125292589|NCT00391391|450698764|FG001|Overall Study|Withdrawal by Subject|4|||
125292590|NCT00391391|450698765|FG002|Overall Study|Withdrawal by Subject|10|||
125292591|NCT00391391|450698766|FG003|Overall Study|Withdrawal by Subject|7|||
125292592|NCT01920152|450698769|FG000|Overall Study|Withdrawal by Subject|1|||
125292593|NCT01920152|450698770|FG001|Overall Study|Withdrawal by Subject|2|||
125292594|NCT01995552|450698773|FG000|Overall Study|Protocol Violation|1|||
125292595|NCT01995552|450698773|FG000|Overall Study|Lack of Efficacy|15|||
125292596|NCT01995552|450698773|FG000|Overall Study|Death|1|||
125292597|NCT00353873|450698774|FG000|Overall Study|Protocol Violation|1|||
125292598|NCT00353873|450698775|FG001|Overall Study|Protocol Violation|2|||
125292599|NCT00353873|450698774|FG000|Overall Study|Exacerbation|1|||
125292600|NCT00353873|450698775|FG001|Overall Study|Exacerbation|0|||
125292601|NCT00353873|450698774|FG000|Overall Study|Adverse Event|1|||
125292602|NCT00353873|450698775|FG001|Overall Study|Adverse Event|0|||
125292603|NCT00353873|450698774|FG000|Overall Study|Physician Decision|2|||
125292604|NCT00353873|450698775|FG001|Overall Study|Physician Decision|0|||
125292605|NCT00353873|450698774|FG000|Overall Study|Withdrawal by Subject|1|||
125292606|NCT00353873|450698775|FG001|Overall Study|Withdrawal by Subject|1|||
125292607|NCT00870194|450698778|FG000|Overall Study|Adverse Event|10|||
125292608|NCT00870194|450698779|FG001|Overall Study|Adverse Event|5|||
125292609|NCT00870194|450698778|FG000|Overall Study|Lack of Efficacy|0|||
125292610|NCT00870194|450698779|FG001|Overall Study|Lack of Efficacy|1|||
125292611|NCT00870194|450698778|FG000|Overall Study|Lost to Follow-up|2|||
125292612|NCT00870194|450698779|FG001|Overall Study|Lost to Follow-up|0|||
125292613|NCT00870194|450698778|FG000|Overall Study|Physician Decision|3|||
125292614|NCT00870194|450698779|FG001|Overall Study|Physician Decision|1|||
125292615|NCT00870194|450698778|FG000|Overall Study|Protocol Violation|3|||
125292616|NCT00870194|450698779|FG001|Overall Study|Protocol Violation|3|||
125292617|NCT00870194|450698778|FG000|Overall Study|Entry Criteria Not Met|1|||
125292618|NCT00870194|450698779|FG001|Overall Study|Entry Criteria Not Met|2|||
125292619|NCT00870194|450698778|FG000|Overall Study|Subject Decision|7|||
125292620|NCT00870194|450698779|FG001|Overall Study|Subject Decision|2|||
124788545|NCT03137069|448855849|FG003|Overall Study|Physician Decision|1|||
124788546|NCT03137069|448855850|FG004|Overall Study|Physician Decision|0|||
124788547|NCT03137069|448855851|FG005|Overall Study|Physician Decision|0|||
124788548|NCT03137069|448855846|FG000|Overall Study|Study Terminated by Sponsor|0|||
125292621|NCT02717130|450698780|FG000|Overall Study|Withdrawal by Subject|1|||
125292622|NCT02717130|450698780|FG000|Overall Study|Adverse Event|1|||
125292623|NCT02717130|450698780|FG000|Overall Study|Physician Decision|1|||
125292624|NCT02717130|450698780|FG000|Overall Study|Study Closure|4|||
125292625|NCT00554099|450698781|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
125292626|NCT00554099|450698782|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
124788549|NCT03137069|448855847|FG001|Overall Study|Study Terminated by Sponsor|0|||
125292627|NCT00554099|450698783|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
125292628|NCT00554099|450698781|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
125292629|NCT00554099|450698782|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
125292630|NCT00554099|450698783|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
125292631|NCT00554099|450698781|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
125292632|NCT00554099|450698782|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
125292633|NCT00554099|450698783|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
125292634|NCT00554099|450698781|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
125292635|NCT00554099|450698782|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
125292636|NCT00554099|450698783|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
125292637|NCT00554099|450698781|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
125292638|NCT00554099|450698782|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
125292639|NCT00554099|450698783|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
125292640|NCT00554099|450698781|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
125292641|NCT00554099|450698782|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
125292642|NCT00554099|450698783|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
125292643|NCT00554099|450698781|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
125292644|NCT00554099|450698782|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
125292645|NCT00554099|450698783|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
125292646|NCT00554099|450698781|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
125292647|NCT00554099|450698782|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
125292648|NCT00554099|450698783|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
125292649|NCT00554099|450698781|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
125292650|NCT00554099|450698782|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
125292651|NCT00554099|450698783|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
125292652|NCT01443130|450698784|FG000|Overall Study|Lost to Follow-up|44|||
125292653|NCT01443130|450698785|FG001|Overall Study|Lost to Follow-up|42|||
125292654|NCT01443130|450698786|FG002|Overall Study|Lost to Follow-up|50|||
125292655|NCT01443130|450698787|FG003|Overall Study|Lost to Follow-up|23|||
125292656|NCT01443130|450698788|FG004|Overall Study|Lost to Follow-up|25|||
125292657|NCT01443130|450698789|FG005|Overall Study|Lost to Follow-up|21|||
125292658|NCT01443130|450698784|FG000|Overall Study|Death|0|||
125292659|NCT01443130|450698785|FG001|Overall Study|Death|1|||
125292660|NCT01443130|450698786|FG002|Overall Study|Death|0|||
125292661|NCT01443130|450698787|FG003|Overall Study|Death|7|||
125292662|NCT01443130|450698788|FG004|Overall Study|Death|10|||
125292663|NCT01443130|450698789|FG005|Overall Study|Death|8|||
125292664|NCT01443130|450698784|FG000|Overall Study|Adverse Event|2|||
125292665|NCT01443130|450698785|FG001|Overall Study|Adverse Event|1|||
125292666|NCT01443130|450698786|FG002|Overall Study|Adverse Event|1|||
125292667|NCT01443130|450698787|FG003|Overall Study|Adverse Event|0|||
125292668|NCT01443130|450698788|FG004|Overall Study|Adverse Event|0|||
125292669|NCT01443130|450698789|FG005|Overall Study|Adverse Event|0|||
125292670|NCT01443130|450698784|FG000|Overall Study|Protocol Violation|2|||
125292671|NCT01443130|450698785|FG001|Overall Study|Protocol Violation|1|||
125292672|NCT01443130|450698786|FG002|Overall Study|Protocol Violation|3|||
125292673|NCT01443130|450698787|FG003|Overall Study|Protocol Violation|2|||
125292674|NCT01443130|450698788|FG004|Overall Study|Protocol Violation|2|||
125292675|NCT01443130|450698789|FG005|Overall Study|Protocol Violation|3|||
125292676|NCT01443130|450698784|FG000|Overall Study|Withdrawal by Subject|15|||
125292677|NCT01443130|450698785|FG001|Overall Study|Withdrawal by Subject|14|||
125292678|NCT01443130|450698786|FG002|Overall Study|Withdrawal by Subject|12|||
125292679|NCT01443130|450698787|FG003|Overall Study|Withdrawal by Subject|7|||
125292680|NCT01443130|450698788|FG004|Overall Study|Withdrawal by Subject|7|||
125292681|NCT01443130|450698789|FG005|Overall Study|Withdrawal by Subject|2|||
125292682|NCT01443130|450698784|FG000|Overall Study|Death of Subject's Infant|5|||
125292683|NCT01443130|450698785|FG001|Overall Study|Death of Subject's Infant|10|||
125292684|NCT01443130|450698786|FG002|Overall Study|Death of Subject's Infant|11|||
125292685|NCT01443130|450698787|FG003|Overall Study|Death of Subject's Infant|0|||
125292686|NCT01443130|450698788|FG004|Overall Study|Death of Subject's Infant|0|||
125292687|NCT01443130|450698789|FG005|Overall Study|Death of Subject's Infant|0|||
125292688|NCT01011933|450698792|FG000|Overall Study|Wrong cell type|1|||
124788550|NCT03137069|448855848|FG002|Overall Study|Study Terminated by Sponsor|0|||
124788551|NCT03137069|448855849|FG003|Overall Study|Study Terminated by Sponsor|0|||
124788552|NCT03137069|448855850|FG004|Overall Study|Study Terminated by Sponsor|1|||
125292689|NCT01011933|450698792|FG000|Overall Study|Improper pre-protocol Rx|1|||
125292690|NCT01011933|450698792|FG000|Overall Study|Inadequate pathology|1|||
125292691|NCT01011933|450698792|FG000|Overall Study|Never treated|1|||
125292692|NCT03461406|450698795|FG000|Overall Study|Death|1|||
125292693|NCT03461406|450698796|FG001|Overall Study|Death|2|||
125292694|NCT03461406|450698795|FG000|Overall Study|Consent Withdrawn by Participant|0|||
125292695|NCT03461406|450698796|FG001|Overall Study|Consent Withdrawn by Participant|1|||
125292696|NCT03461406|450698795|FG000|Overall Study|Screen Failure|3|||
125292697|NCT03461406|450698796|FG001|Overall Study|Screen Failure|1|||
125292698|NCT03461406|450698795|FG000|Overall Study|Reason not Specified|1|||
125292699|NCT03461406|450698796|FG001|Overall Study|Reason not Specified|3|||
125292700|NCT03461406|450698795|FG000|Overall Study|Lost to Follow-up|3|||
124788553|NCT03137069|448855851|FG005|Overall Study|Study Terminated by Sponsor|0|||
125292701|NCT03461406|450698796|FG001|Overall Study|Lost to Follow-up|0|||
125292702|NCT01439074|450698797|FG000|Overall Study|Lost to Follow-up|3|||
125292703|NCT01439074|450698798|FG001|Overall Study|Lost to Follow-up|4|||
125292704|NCT01439074|450698797|FG000|Overall Study|Subject shedding|1|||
125292705|NCT01439074|450698798|FG001|Overall Study|Subject shedding|0|||
125292706|NCT01439074|450698797|FG000|Overall Study|Withdrawal by Subject|1|||
125292707|NCT01439074|450698798|FG001|Overall Study|Withdrawal by Subject|5|||
125292708|NCT01439074|450698797|FG000|Overall Study|Other|4|||
124788554|NCT03137069|448855846|FG000|Overall Study|Data Entry Error|0|||
124788555|NCT03137069|448855847|FG001|Overall Study|Data Entry Error|0|||
124788556|NCT03137069|448855848|FG002|Overall Study|Data Entry Error|0|||
124788557|NCT03137069|448855849|FG003|Overall Study|Data Entry Error|1|||
124788558|NCT03137069|448855850|FG004|Overall Study|Data Entry Error|0|||
124788559|NCT03137069|448855851|FG005|Overall Study|Data Entry Error|0|||
124788560|NCT02043899|448855853|FG000|Overall Study|Adverse Event|3|||
124788561|NCT02043899|448855853|FG000|Overall Study|Physician Decision|1|||
124788562|NCT02043899|448855853|FG000|Overall Study|Withdrawal by Subject|2|||
124788563|NCT02043899|448855853|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
124788564|NCT02043899|448855853|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
124788565|NCT02043899|448855853|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
124788566|NCT02043899|448855853|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
124788567|NCT02043899|448855853|FG000|Overall Study|Treatment delayed|1|||
124788568|NCT01954927|448855854|FG000|Overall Study|Withdrawal by Subject|3|||
124788569|NCT01954927|448855855|FG001|Overall Study|Withdrawal by Subject|1|||
124788570|NCT03320824|448855856|FG000|Overall Study|Withdrawal by Subject|8|||
125292709|NCT01439074|450698798|FG001|Overall Study|Other|4|||
125292710|NCT02012686|450698799|FG000|Overall Study|muscle contraction|0|||
125292711|NCT02012686|450698800|FG001|Overall Study|muscle contraction|1|||
125292712|NCT02012686|450698799|FG000|Overall Study|electrocardiography monitoring noise|0|||
125292713|NCT02012686|450698800|FG001|Overall Study|electrocardiography monitoring noise|1|||
125292714|NCT00612508|450698801|FG000|Overall Study|Withdrawal by Subject|3|||
125292715|NCT00612508|450698802|FG001|Overall Study|Withdrawal by Subject|4|||
125292716|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
125292717|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
125292718|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
125292719|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
125292720|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
125292721|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
125292722|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
125292723|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
125292724|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
125292725|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
125292726|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
125292727|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
125292728|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
125292729|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
125292730|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
125292731|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
125292732|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
125292733|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
125292734|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
125292735|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
125292736|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
125292737|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
125292738|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
125292739|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
125292740|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
125292741|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
125292742|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
125292743|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
125292744|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
125292745|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
125292746|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
125292747|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
125292748|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
125292749|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
125292750|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
125292751|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
125292752|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
125292753|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
125292754|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
125292755|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
125292756|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
125292757|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
125292758|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
125292759|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
125292760|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
125292761|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
125292762|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
125292763|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
125292764|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
125292765|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
125292766|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
125292767|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
125292768|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
125292769|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
125292770|NCT02008357|450698803|FG000|Open-label Extension Period|Adverse Event|8|||
125292771|NCT02008357|450698804|FG001|Open-label Extension Period|Adverse Event|7|||
125292772|NCT02008357|450698803|FG000|Open-label Extension Period|Death|7|||
125292773|NCT02008357|450698804|FG001|Open-label Extension Period|Death|4|||
125292774|NCT02008357|450698803|FG000|Open-label Extension Period|Lack of Efficacy|9|||
125292775|NCT02008357|450698804|FG001|Open-label Extension Period|Lack of Efficacy|5|||
125292776|NCT02008357|450698803|FG000|Open-label Extension Period|Lost to Follow-up|2|||
125292777|NCT02008357|450698804|FG001|Open-label Extension Period|Lost to Follow-up|2|||
125292778|NCT02008357|450698803|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
125292779|NCT02008357|450698804|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
125292780|NCT02008357|450698803|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
125292781|NCT02008357|450698804|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
125292782|NCT02008357|450698803|FG000|Open-label Extension Period|Safety Risk|2|||
125292783|NCT02008357|450698804|FG001|Open-label Extension Period|Safety Risk|1|||
125292784|NCT02008357|450698803|FG000|Open-label Extension Period|Non-Compliance|0|||
125292785|NCT02008357|450698804|FG001|Open-label Extension Period|Non-Compliance|1|||
125292786|NCT02008357|450698803|FG000|Open-label Extension Period|Investigator Recommendation|0|||
125292787|NCT02008357|450698804|FG001|Open-label Extension Period|Investigator Recommendation|1|||
125292788|NCT02008357|450698803|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
125292789|NCT02008357|450698804|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
125292790|NCT02008357|450698803|FG000|Open-label Extension Period|Coordinating Center Request|2|||
125292791|NCT02008357|450698804|FG001|Open-label Extension Period|Coordinating Center Request|4|||
125292792|NCT02008357|450698803|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
125292793|NCT02008357|450698804|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
125292794|NCT02008357|450698803|FG000|Open-label Extension Period|Study Ended|20|||
125292795|NCT02008357|450698804|FG001|Open-label Extension Period|Study Ended|25|||
125292796|NCT02008357|450698803|FG000|Open-label Extension Period|Personal Reasons|0|||
125292797|NCT02008357|450698804|FG001|Open-label Extension Period|Personal Reasons|1|||
125292798|NCT02008357|450698803|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
125292799|NCT02008357|450698804|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
125292800|NCT02008357|450698803|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
125292801|NCT02008357|450698804|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
125292802|NCT02008357|450698803|FG000|Open-label Extension Period|Other|2|||
125292803|NCT02008357|450698804|FG001|Open-label Extension Period|Other|0|||
125292804|NCT00787202|450698805|FG000|Overall Study|Adverse Event|3|||
125292805|NCT00787202|450698806|FG001|Overall Study|Adverse Event|2|||
125292806|NCT00787202|450698807|FG002|Overall Study|Adverse Event|0|||
125292807|NCT00787202|450698808|FG003|Overall Study|Adverse Event|0|||
125292808|NCT00787202|450698809|FG004|Overall Study|Adverse Event|2|||
125292809|NCT00787202|450698805|FG000|Overall Study|Lack of Efficacy|5|||
125292810|NCT00787202|450698806|FG001|Overall Study|Lack of Efficacy|6|||
124788571|NCT03320824|448855857|FG001|Overall Study|Withdrawal by Subject|1|||
124788572|NCT03320824|448855856|FG000|Overall Study|Lost to Follow-up|10|||
125292811|NCT00787202|450698807|FG002|Overall Study|Lack of Efficacy|5|||
125292812|NCT00787202|450698808|FG003|Overall Study|Lack of Efficacy|2|||
125292813|NCT00787202|450698809|FG004|Overall Study|Lack of Efficacy|1|||
125292814|NCT00787202|450698805|FG000|Overall Study|Lost to Follow-up|1|||
125292815|NCT00787202|450698806|FG001|Overall Study|Lost to Follow-up|0|||
125292816|NCT00787202|450698807|FG002|Overall Study|Lost to Follow-up|0|||
125292817|NCT00787202|450698808|FG003|Overall Study|Lost to Follow-up|0|||
125292818|NCT00787202|450698809|FG004|Overall Study|Lost to Follow-up|0|||
125292819|NCT00787202|450698805|FG000|Overall Study|Withdrawal by Subject|2|||
125292820|NCT00787202|450698806|FG001|Overall Study|Withdrawal by Subject|2|||
125292821|NCT00787202|450698807|FG002|Overall Study|Withdrawal by Subject|2|||
125292822|NCT00787202|450698808|FG003|Overall Study|Withdrawal by Subject|0|||
125292823|NCT00787202|450698809|FG004|Overall Study|Withdrawal by Subject|0|||
125292824|NCT00787202|450698805|FG000|Overall Study|Protocol Violation|2|||
125292825|NCT00787202|450698806|FG001|Overall Study|Protocol Violation|1|||
125292826|NCT00787202|450698807|FG002|Overall Study|Protocol Violation|0|||
125292827|NCT00787202|450698808|FG003|Overall Study|Protocol Violation|0|||
125292828|NCT00787202|450698809|FG004|Overall Study|Protocol Violation|1|||
125292829|NCT00787202|450698805|FG000|Overall Study|Randomized, not treated|1|||
125292830|NCT00787202|450698806|FG001|Overall Study|Randomized, not treated|0|||
125292831|NCT00787202|450698807|FG002|Overall Study|Randomized, not treated|0|||
125292832|NCT00787202|450698808|FG003|Overall Study|Randomized, not treated|0|||
125292833|NCT00787202|450698809|FG004|Overall Study|Randomized, not treated|0|||
125292834|NCT01442064|450698810|FG000|Overall Study|Adverse Event|2|||
125292835|NCT01442064|450698811|FG001|Overall Study|Adverse Event|2|||
125292836|NCT01442064|450698812|FG002|Overall Study|Adverse Event|2|||
125292837|NCT01442064|450698813|FG003|Overall Study|Adverse Event|1|||
125292838|NCT01442064|450698814|FG004|Overall Study|Adverse Event|2|||
125292839|NCT01442064|450698815|FG005|Overall Study|Adverse Event|0|||
125292840|NCT01442064|450698810|FG000|Overall Study|Death|0|||
125292841|NCT01442064|450698811|FG001|Overall Study|Death|1|||
125292842|NCT01442064|450698812|FG002|Overall Study|Death|3|||
125292843|NCT01442064|450698813|FG003|Overall Study|Death|3|||
125292844|NCT01442064|450698814|FG004|Overall Study|Death|1|||
125292845|NCT01442064|450698815|FG005|Overall Study|Death|3|||
125292846|NCT01442064|450698810|FG000|Overall Study|Lost to Follow-up|5|||
125292847|NCT01442064|450698811|FG001|Overall Study|Lost to Follow-up|5|||
125292848|NCT01442064|450698812|FG002|Overall Study|Lost to Follow-up|1|||
125292849|NCT01442064|450698813|FG003|Overall Study|Lost to Follow-up|1|||
125292850|NCT01442064|450698814|FG004|Overall Study|Lost to Follow-up|3|||
125292851|NCT01442064|450698815|FG005|Overall Study|Lost to Follow-up|3|||
125292852|NCT01442064|450698810|FG000|Overall Study|Physician Decision|1|||
125292853|NCT01442064|450698811|FG001|Overall Study|Physician Decision|1|||
125292854|NCT01442064|450698812|FG002|Overall Study|Physician Decision|2|||
125292855|NCT01442064|450698813|FG003|Overall Study|Physician Decision|3|||
125292856|NCT01442064|450698814|FG004|Overall Study|Physician Decision|3|||
125292857|NCT01442064|450698815|FG005|Overall Study|Physician Decision|1|||
125292858|NCT01442064|450698810|FG000|Overall Study|Withdrawal by Subject|6|||
125292859|NCT01442064|450698811|FG001|Overall Study|Withdrawal by Subject|3|||
125292860|NCT01442064|450698812|FG002|Overall Study|Withdrawal by Subject|2|||
125292861|NCT01442064|450698813|FG003|Overall Study|Withdrawal by Subject|2|||
125292862|NCT01442064|450698814|FG004|Overall Study|Withdrawal by Subject|2|||
125292863|NCT01442064|450698815|FG005|Overall Study|Withdrawal by Subject|1|||
125292864|NCT01442064|450698810|FG000|Overall Study|Sponsor decision|82|||
125292865|NCT01442064|450698811|FG001|Overall Study|Sponsor decision|88|||
125292866|NCT01442064|450698812|FG002|Overall Study|Sponsor decision|92|||
125292867|NCT01442064|450698813|FG003|Overall Study|Sponsor decision|88|||
125292868|NCT01442064|450698814|FG004|Overall Study|Sponsor decision|95|||
125292869|NCT01442064|450698815|FG005|Overall Study|Sponsor decision|87|||
125292870|NCT01442064|450698810|FG000|Overall Study|Subject non-compliance|0|||
125292871|NCT01442064|450698811|FG001|Overall Study|Subject non-compliance|0|||
125292872|NCT01442064|450698812|FG002|Overall Study|Subject non-compliance|0|||
125292873|NCT01442064|450698813|FG003|Overall Study|Subject non-compliance|0|||
125292874|NCT01442064|450698814|FG004|Overall Study|Subject non-compliance|0|||
125292875|NCT01442064|450698815|FG005|Overall Study|Subject non-compliance|2|||
125292876|NCT01442064|450698810|FG000|Overall Study|Condition mandated other intervention|1|||
125292877|NCT01442064|450698811|FG001|Overall Study|Condition mandated other intervention|1|||
125292878|NCT01442064|450698812|FG002|Overall Study|Condition mandated other intervention|2|||
125292879|NCT01442064|450698813|FG003|Overall Study|Condition mandated other intervention|0|||
125292880|NCT01442064|450698814|FG004|Overall Study|Condition mandated other intervention|0|||
125292881|NCT01442064|450698815|FG005|Overall Study|Condition mandated other intervention|2|||
125292882|NCT00966719|450698816|FG000|Overall Study|Lost to Follow-up|6|||
125292883|NCT00966719|450698817|FG001|Overall Study|Lost to Follow-up|11|||
124788573|NCT03320824|448855857|FG001|Overall Study|Lost to Follow-up|1|||
125292884|NCT01703065|450698818|FG000|Overall Study|Lack of Efficacy|1|||
125292885|NCT01703065|450698819|FG001|Overall Study|Lack of Efficacy|0|||
125292886|NCT02635347|450698820|FG000|Overall Study|Failed screening|20|||
124788574|NCT03320824|448855856|FG000|Overall Study|moved out of state|0|||
125292887|NCT02635347|450698821|FG001|Overall Study|Failed screening|7|||
125292888|NCT00514020|450698823|FG000|Overall Study|Adverse Event|6|||
125292889|NCT00514020|450698823|FG000|Overall Study|Withdrawal by Subject|3|||
125292890|NCT00514020|450698823|FG000|Overall Study|Physician Decision|1|||
125292891|NCT00514020|450698823|FG000|Overall Study|disease progression|9|||
125292892|NCT00514020|450698823|FG000|Overall Study|other complicating disease|2|||
125292893|NCT00514020|450698823|FG000|Overall Study|patient went to radiation treatment|1|||
125292894|NCT00514020|450698823|FG000|Overall Study|"patients moved to the no tx group"|6|||
124788575|NCT03320824|448855857|FG001|Overall Study|moved out of state|1|||
125292895|NCT01688921|450698824|FG000|Overall Study|Lost to Follow-up|7|||
125292896|NCT01688921|450698825|FG001|Overall Study|Lost to Follow-up|13|||
125292897|NCT01688921|450698824|FG000|Overall Study|Physician Decision|6|||
125292898|NCT01688921|450698825|FG001|Overall Study|Physician Decision|1|||
125292899|NCT01688921|450698824|FG000|Overall Study|Protocol Violation|0|||
125292900|NCT01688921|450698825|FG001|Overall Study|Protocol Violation|1|||
125292901|NCT01688921|450698824|FG000|Overall Study|informed consent|3|||
125292902|NCT01688921|450698825|FG001|Overall Study|informed consent|0|||
125292903|NCT03089944|450698826|FG000|Overall Study|Lost to Follow-up|8|||
125292904|NCT03089944|450698826|FG000|Overall Study|Withdrew Consent|2|||
125292905|NCT03089944|450698826|FG000|Overall Study|Adverse Event|1|||
125292906|NCT03089944|450698826|FG000|Overall Study|Other|1|||
125292907|NCT01636713|450698831|FG000|Overall Study|Adverse Event|16|||
125292908|NCT01636713|450698832|FG001|Overall Study|Adverse Event|16|||
125292909|NCT01636713|450698833|FG002|Overall Study|Adverse Event|7|||
125292910|NCT01636713|450698831|FG000|Overall Study|Lack of Efficacy|6|||
125292911|NCT01636713|450698832|FG001|Overall Study|Lack of Efficacy|6|||
125292912|NCT01636713|450698833|FG002|Overall Study|Lack of Efficacy|2|||
125292913|NCT01636713|450698831|FG000|Overall Study|Protocol Violation|3|||
125292914|NCT01636713|450698832|FG001|Overall Study|Protocol Violation|0|||
125292915|NCT01636713|450698833|FG002|Overall Study|Protocol Violation|1|||
125292916|NCT01636713|450698831|FG000|Overall Study|Lost to Follow-up|0|||
125292917|NCT01636713|450698832|FG001|Overall Study|Lost to Follow-up|0|||
125292918|NCT01636713|450698833|FG002|Overall Study|Lost to Follow-up|1|||
125292919|NCT01636713|450698831|FG000|Overall Study|Withdrawal by Subject|5|||
125292920|NCT01636713|450698832|FG001|Overall Study|Withdrawal by Subject|4|||
125292921|NCT01636713|450698833|FG002|Overall Study|Withdrawal by Subject|8|||
125292922|NCT01636713|450698831|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
125292923|NCT01636713|450698832|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
125292924|NCT01636713|450698833|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
125292925|NCT03780959|450698834|FG000|Part 1|Adverse Event|1|||
125292926|NCT03780959|450698835|FG001|Part 1|Adverse Event|0|||
125292927|NCT03780959|450698836|FG002|Part 1|Adverse Event|0|||
125292928|NCT03780959|450698834|FG000|Part 1|Withdrawal by Subject|1|||
125292929|NCT03780959|450698835|FG001|Part 1|Withdrawal by Subject|0|||
125292930|NCT03780959|450698836|FG002|Part 1|Withdrawal by Subject|0|||
125292931|NCT03780959|450698834|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
125292932|NCT03780959|450698835|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
125292933|NCT03780959|450698836|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
125292934|NCT03780959|450698834|FG000|Part 1|Response Status|2|||
125292935|NCT03780959|450698835|FG001|Part 1|Response Status|0|||
125292936|NCT03780959|450698836|FG002|Part 1|Response Status|0|||
125292937|NCT03780959|450698834|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
125292938|NCT03780959|450698835|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
125292939|NCT03780959|450698836|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
125292940|NCT03780959|450698834|FG000|Part 2|Response Status|0|||
125292941|NCT03780959|450698835|FG001|Part 2|Response Status|18|||
125292942|NCT03780959|450698836|FG002|Part 2|Response Status|6|||
125292943|NCT00831701|450698837|FG000|Overall Study|Withdrawal by Subject|2|||
125292944|NCT00831701|450698838|FG001|Overall Study|Withdrawal by Subject|0|||
125292945|NCT00831701|450698837|FG000|Overall Study|Stone expulsion before first medication|2|||
125292946|NCT00831701|450698838|FG001|Overall Study|Stone expulsion before first medication|2|||
125292947|NCT00831701|450698837|FG000|Overall Study|Lost to Follow-up|1|||
125292948|NCT00831701|450698838|FG001|Overall Study|Lost to Follow-up|3|||
125292949|NCT00940485|450700175|FG000|Overall Study|HBeAb positive at Baseline|3|||
125292950|NCT00940485|450700176|FG001|Overall Study|HBeAb positive at Baseline|2|||
125292951|NCT00940485|450700175|FG000|Overall Study|Lost to Follow-up|2|||
125292952|NCT00940485|450700176|FG001|Overall Study|Lost to Follow-up|3|||
125292953|NCT00940485|450700175|FG000|Overall Study|Adverse Event|8|||
125292954|NCT00940485|450700176|FG001|Overall Study|Adverse Event|0|||
125292955|NCT00940485|450700175|FG000|Overall Study|Withdrawal by Subject|1|||
125292956|NCT00940485|450700176|FG001|Overall Study|Withdrawal by Subject|1|||
125292957|NCT00940485|450700175|FG000|Overall Study|Others|1|||
125292958|NCT00940485|450700176|FG001|Overall Study|Others|1|||
125292959|NCT03921554|450700180|FG000|Overall Study|Adverse Event|2|||
125292960|NCT03921554|450700180|FG000|Overall Study|Withdrawal by Subject|1|||
125292961|NCT03921554|450700180|FG000|Overall Study|Death|3|||
125292962|NCT03283150|450700187|FG000|Overall Study|Withdrawal by Subject|6|||
125292963|NCT03283150|450700188|FG001|Overall Study|Withdrawal by Subject|0|||
125292964|NCT03283150|450700189|FG002|Overall Study|Withdrawal by Subject|0|||
125292965|NCT01299571|450700192|FG000|Overall Study|Protocol Violation|107|||
125292966|NCT00864851|450700193|FG000|Overall Study|Withdrawal by Subject|0|||
125292967|NCT00864851|450700194|FG001|Overall Study|Withdrawal by Subject|1|||
125292968|NCT00864851|450700195|FG002|Overall Study|Withdrawal by Subject|0|||
125292969|NCT00864851|450700193|FG000|Overall Study|Physician Decision|1|||
125292970|NCT00864851|450700194|FG001|Overall Study|Physician Decision|0|||
125292971|NCT00864851|450700195|FG002|Overall Study|Physician Decision|0|||
125292972|NCT00864851|450700193|FG000|Overall Study|Death|1|||
125292973|NCT00864851|450700194|FG001|Overall Study|Death|0|||
125292974|NCT00864851|450700195|FG002|Overall Study|Death|0|||
125292975|NCT00864851|450700193|FG000|Overall Study|Patient uncooperative|1|||
125292976|NCT00864851|450700194|FG001|Overall Study|Patient uncooperative|0|||
125292977|NCT00864851|450700195|FG002|Overall Study|Patient uncooperative|0|||
125292978|NCT01842581|450700199|FG000|Overall Study|Adverse Event|6|||
125292979|NCT01842581|450700200|FG001|Overall Study|Adverse Event|4|||
125292980|NCT01842581|450700199|FG000|Overall Study|HE breakthrough|26|||
125292981|NCT01842581|450700200|FG001|Overall Study|HE breakthrough|13|||
125292982|NCT01842581|450700199|FG000|Overall Study|Liver transplant|2|||
125292983|NCT01842581|450700200|FG001|Overall Study|Liver transplant|0|||
125292984|NCT01842581|450700199|FG000|Overall Study|Lost to Follow-up|2|||
125292985|NCT01842581|450700200|FG001|Overall Study|Lost to Follow-up|5|||
125292986|NCT01842581|450700199|FG000|Overall Study|Withdrawal by Subject|5|||
125292987|NCT01842581|450700200|FG001|Overall Study|Withdrawal by Subject|7|||
125292988|NCT01842581|450700199|FG000|Overall Study|Other than specified|3|||
125292989|NCT01842581|450700200|FG001|Overall Study|Other than specified|1|||
125292990|NCT01287195|450700203|FG000|Overall Study|Withdrawal by Subject|2|||
125292991|NCT02006069|450700206|FG000|Overall Study|MPP other programming|239|||
125292992|NCT02006069|450700207|FG001|Overall Study|MPP other programming|0|||
125292993|NCT02006069|450700206|FG000|Overall Study|RV only pacing|0|||
125292994|NCT02006069|450700207|FG001|Overall Study|RV only pacing|3|||
125292995|NCT00106691|450700208|FG000|Overall Study|Adverse Event|60|||
125292996|NCT00106691|450700209|FG001|Overall Study|Adverse Event|64|||
125292997|NCT00106691|450700208|FG000|Overall Study|Lost to Follow-up|23|||
125292998|NCT00106691|450700209|FG001|Overall Study|Lost to Follow-up|18|||
125292999|NCT00106691|450700208|FG000|Overall Study|Physician Decision|18|||
125293000|NCT00106691|450700209|FG001|Overall Study|Physician Decision|21|||
125293001|NCT00106691|450700208|FG000|Overall Study|Protocol Violation|13|||
125293002|NCT00106691|450700209|FG001|Overall Study|Protocol Violation|18|||
124788576|NCT03320824|448855856|FG000|Overall Study|could not complete final visit|0|||
124788577|NCT03320824|448855857|FG001|Overall Study|could not complete final visit|1|||
124788578|NCT00955305|448855858|FG000|Overall Study|Disease progression|39|||
124788579|NCT00955305|448855859|FG001|Overall Study|Disease progression|41|||
124788580|NCT00955305|448855858|FG000|Overall Study|Adverse Event|22|||
124788581|NCT00955305|448855859|FG001|Overall Study|Adverse Event|22|||
125293003|NCT00106691|450700208|FG000|Overall Study|Withdrawal by Subject|75|||
125293004|NCT00106691|450700209|FG001|Overall Study|Withdrawal by Subject|70|||
125293005|NCT00106691|450700208|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
125293006|NCT00106691|450700209|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
125293007|NCT00106691|450700208|FG000|Overall Study|QTc>480|3|||
125293008|NCT00106691|450700209|FG001|Overall Study|QTc>480|1|||
125293009|NCT00106691|450700208|FG000|Overall Study|mililtary deployment|2|||
125293010|NCT00106691|450700209|FG001|Overall Study|mililtary deployment|0|||
125293011|NCT00106691|450700208|FG000|Overall Study|Study Site Closing/PI Moved|1|||
125293012|NCT00106691|450700209|FG001|Overall Study|Study Site Closing/PI Moved|2|||
125293013|NCT00106691|450700208|FG000|Overall Study|Cardiologist recommendation|1|||
125293014|NCT00106691|450700209|FG001|Overall Study|Cardiologist recommendation|0|||
125293015|NCT00106691|450700208|FG000|Overall Study|Pt. moved to another state|1|||
125293016|NCT00106691|450700209|FG001|Overall Study|Pt. moved to another state|0|||
125293017|NCT00106691|450700208|FG000|Overall Study|Taking exclusionary avodart|1|||
125293018|NCT00106691|450700209|FG001|Overall Study|Taking exclusionary avodart|0|||
125293019|NCT00106691|450700208|FG000|Overall Study|Not able to discontinue plavix|0|||
125293020|NCT00106691|450700209|FG001|Overall Study|Not able to discontinue plavix|1|||
125293021|NCT00530920|450700210|FG000|Overall Study|Randomized but not treated|0|||
125293022|NCT00530920|450700211|FG001|Overall Study|Randomized but not treated|2|||
125293023|NCT00530920|450700212|FG002|Overall Study|Randomized but not treated|0|||
125293024|NCT00530920|450700210|FG000|Overall Study|Adverse Event|0|||
125293025|NCT00530920|450700211|FG001|Overall Study|Adverse Event|0|||
125293026|NCT00530920|450700212|FG002|Overall Study|Adverse Event|3|||
125293027|NCT00530920|450700210|FG000|Overall Study|Withdrawal by Subject|0|||
124788582|NCT00955305|448855858|FG000|Overall Study|Death|2|||
124788583|NCT00955305|448855859|FG001|Overall Study|Death|1|||
124788584|NCT00955305|448855858|FG000|Overall Study|Withdrawal by Subject|5|||
124788585|NCT00955305|448855859|FG001|Overall Study|Withdrawal by Subject|4|||
125293028|NCT00530920|450700211|FG001|Overall Study|Withdrawal by Subject|0|||
125293029|NCT00530920|450700212|FG002|Overall Study|Withdrawal by Subject|1|||
125293030|NCT04957758|450700214|FG000|Overall Study|Adverse Event|1|||
125293031|NCT04957758|450700215|FG001|Overall Study|Adverse Event|0|||
125293032|NCT04957758|450700214|FG000|Overall Study|Lost to Follow-up|0|||
125293033|NCT04957758|450700215|FG001|Overall Study|Lost to Follow-up|2|||
125293034|NCT04957758|450700214|FG000|Overall Study|Withdrawal by Subject|4|||
125293035|NCT04957758|450700215|FG001|Overall Study|Withdrawal by Subject|2|||
125293036|NCT04957758|450700214|FG000|Overall Study|Protocol Violation|0|||
125293037|NCT04957758|450700215|FG001|Overall Study|Protocol Violation|1|||
125293038|NCT00707746|450700216|FG000|Treatment Period|Adverse Event|2|||
125293039|NCT00707746|450700217|FG001|Treatment Period|Adverse Event|4|||
125293040|NCT00707746|450700216|FG000|Treatment Period|Ineligibility|0|||
124788586|NCT00955305|448855858|FG000|Overall Study|Alternative therapy|4|||
124788587|NCT00955305|448855859|FG001|Overall Study|Alternative therapy|0|||
125293041|NCT00707746|450700217|FG001|Treatment Period|Ineligibility|1|||
124788588|NCT00955305|448855858|FG000|Overall Study|Other complicating disease|2|||
124788589|NCT00955305|448855859|FG001|Overall Study|Other complicating disease|4|||
124788590|NCT00955305|448855858|FG000|Overall Study|Physician Decision|1|||
124788591|NCT00955305|448855859|FG001|Overall Study|Physician Decision|0|||
124788592|NCT00955305|448855858|FG000|Overall Study|Continued presence of residual disease|0|||
124788593|NCT00955305|448855859|FG001|Overall Study|Continued presence of residual disease|1|||
124788594|NCT00955305|448855858|FG000|Overall Study|Functional decline|2|||
124788595|NCT00955305|448855859|FG001|Overall Study|Functional decline|0|||
124788596|NCT00955305|448855858|FG000|Overall Study|Maximum response achieved|0|||
124788597|NCT00955305|448855859|FG001|Overall Study|Maximum response achieved|1|||
124788598|NCT00955305|448855858|FG000|Overall Study|Lost to Follow-up|0|||
124788599|NCT00955305|448855859|FG001|Overall Study|Lost to Follow-up|1|||
124788600|NCT00955305|448855858|FG000|Overall Study|No off-treatment reason submitted|1|||
124788601|NCT00955305|448855859|FG001|Overall Study|No off-treatment reason submitted|0|||
124788602|NCT00955305|448855858|FG000|Overall Study|Never started protocol treatment|5|||
124788603|NCT00955305|448855859|FG001|Overall Study|Never started protocol treatment|5|||
124788604|NCT00955305|448855858|FG000|Overall Study|Ineligible|5|||
124788605|NCT00955305|448855859|FG001|Overall Study|Ineligible|7|||
124788606|NCT03387111|448855860|FG000|Overall Study|Progressive Disease|3|||
124788607|NCT03387111|448855860|FG000|Overall Study|Other|1|||
124788608|NCT01325337|448855870|FG000|Overall Study|Adverse Event|0|||
124788609|NCT01325337|448855871|FG001|Overall Study|Adverse Event|2|||
124788610|NCT01325337|448855872|FG002|Overall Study|Adverse Event|2|||
124788611|NCT01325337|448855873|FG003|Overall Study|Adverse Event|1|||
124788612|NCT01325337|448855874|FG004|Overall Study|Adverse Event|2|||
125293042|NCT02322190|450700218|FG000|Overall Study|Death on study|1|||
125293043|NCT02322190|450700219|FG001|Overall Study|Death on study|0|||
125293044|NCT01685983|450700224|FG000|Overall Study|Adverse Event|7|||
125293045|NCT01685983|450700224|FG000|Overall Study|Death|1|||
125293046|NCT01685983|450700224|FG000|Overall Study|Withdrawal by Subject|19|||
125293047|NCT01685983|450700224|FG000|Overall Study|Protocol Violation|2|||
125293048|NCT01685983|450700224|FG000|Overall Study|Physician Decision|13|||
125293049|NCT01685983|450700224|FG000|Overall Study|Other|7|||
125293050|NCT01685983|450700224|FG000|Overall Study|Progressive Disease|32|||
125293051|NCT01685983|450700224|FG000|Overall Study|Noncompliance with Study Drug|1|||
125293052|NCT00685373|450700225|FG000|Overall Study|Adverse Event|3|||
125293053|NCT00685373|450700225|FG000|Overall Study|Withdrawal by Subject|5|||
125293054|NCT00685373|450700225|FG000|Overall Study|Lack of Efficacy|3|||
124788613|NCT01325337|448855870|FG000|Overall Study|Lost to Follow-up|2|||
124788614|NCT01325337|448855871|FG001|Overall Study|Lost to Follow-up|2|||
124788615|NCT01325337|448855872|FG002|Overall Study|Lost to Follow-up|2|||
124788616|NCT01325337|448855873|FG003|Overall Study|Lost to Follow-up|1|||
124788617|NCT01325337|448855874|FG004|Overall Study|Lost to Follow-up|2|||
124788618|NCT01325337|448855870|FG000|Overall Study|Personal Reasons|2|||
124788619|NCT01325337|448855871|FG001|Overall Study|Personal Reasons|5|||
124788620|NCT01325337|448855872|FG002|Overall Study|Personal Reasons|4|||
124788621|NCT01325337|448855873|FG003|Overall Study|Personal Reasons|8|||
124788622|NCT01325337|448855874|FG004|Overall Study|Personal Reasons|3|||
124788623|NCT01325337|448855870|FG000|Overall Study|Withdrawal by Subject|1|||
124788624|NCT01325337|448855871|FG001|Overall Study|Withdrawal by Subject|0|||
124788625|NCT01325337|448855872|FG002|Overall Study|Withdrawal by Subject|1|||
124788626|NCT01325337|448855873|FG003|Overall Study|Withdrawal by Subject|0|||
124788627|NCT01325337|448855874|FG004|Overall Study|Withdrawal by Subject|1|||
124788628|NCT00362180|448855875|FG000|Treated Period|Withdrawal by Subject|1|||
124788629|NCT00362180|448855876|FG001|Treated Period|Withdrawal by Subject|0|||
124788630|NCT00362180|448855877|FG002|Treated Period|Withdrawal by Subject|0|||
124788631|NCT00362180|448855878|FG003|Treated Period|Withdrawal by Subject|0|||
124788632|NCT00362180|448855879|FG004|Treated Period|Withdrawal by Subject|0|||
124788633|NCT00362180|448855880|FG005|Treated Period|Withdrawal by Subject|0|||
124788634|NCT00362180|448855881|FG006|Treated Period|Withdrawal by Subject|0|||
124788635|NCT00362180|448855882|FG007|Treated Period|Withdrawal by Subject|0|||
124788636|NCT00362180|448855883|FG008|Treated Period|Withdrawal by Subject|0|||
124788637|NCT00362180|448855875|FG000|Treated Period|Adverse Event|0|||
124788638|NCT00362180|448855876|FG001|Treated Period|Adverse Event|0|||
125293055|NCT00685373|450700225|FG000|Overall Study|Condition no longer requires study drug|1|||
124788639|NCT00362180|448855877|FG002|Treated Period|Adverse Event|0|||
124788640|NCT00362180|448855878|FG003|Treated Period|Adverse Event|0|||
124788641|NCT00362180|448855879|FG004|Treated Period|Adverse Event|0|||
124788642|NCT00362180|448855880|FG005|Treated Period|Adverse Event|1|||
124788643|NCT00362180|448855881|FG006|Treated Period|Adverse Event|0|||
124788644|NCT00362180|448855882|FG007|Treated Period|Adverse Event|1|||
124788645|NCT00362180|448855883|FG008|Treated Period|Adverse Event|0|||
125293056|NCT00685373|450700225|FG000|Overall Study|Lost to Follow-up|2|||
125293057|NCT00685373|450700225|FG000|Overall Study|Protocol Violation|1|||
125293058|NCT02642965|450700226|FG000|Overall Study|Lack of Efficacy|4|||
125293059|NCT02642965|450700226|FG000|Overall Study|Physician Decision|9|||
124788646|NCT02434471|448855893|FG000|Overall Study|Physician Decision|9|||
125293060|NCT01167907|450700227|FG000|Overall Study|Protocol Violation|1|||
124788647|NCT00369629|448855894|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
124788648|NCT00369629|448855895|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
124788649|NCT00369629|448855896|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
124788650|NCT00369629|448855897|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
124788651|NCT00369629|448855894|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
124788652|NCT00369629|448855895|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
124788653|NCT00369629|448855896|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
125293061|NCT01167907|450700228|FG001|Overall Study|Protocol Violation|0|||
125293062|NCT01167907|450700227|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
125293063|NCT01167907|450700228|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
125293064|NCT00857948|450700229|FG000|Overall Study|Withdrawal by Subject|2|||
125293065|NCT00857948|450700230|FG001|Overall Study|Withdrawal by Subject|0|||
125293066|NCT00857948|450700231|FG002|Overall Study|Withdrawal by Subject|0|||
125293067|NCT00857948|450700232|FG003|Overall Study|Withdrawal by Subject|0|||
125293068|NCT00857948|450700229|FG000|Overall Study|Protocol Violation|1|||
125293069|NCT00857948|450700230|FG001|Overall Study|Protocol Violation|0|||
125293070|NCT00857948|450700231|FG002|Overall Study|Protocol Violation|1|||
125293071|NCT00857948|450700232|FG003|Overall Study|Protocol Violation|0|||
125293072|NCT03077698|450700235|FG000|Progestin Monotherapy|Stable Disease|8|||
125293073|NCT03077698|450700236|FG001|Progestin Monotherapy|Stable Disease|0|||
125293074|NCT03077698|450700235|FG000|Progestin Monotherapy|Adverse Event|1|||
125293075|NCT03077698|450700236|FG001|Progestin Monotherapy|Adverse Event|0|||
125293076|NCT03077698|450700235|FG000|Progestin Monotherapy|Death|1|||
125293077|NCT03077698|450700236|FG001|Progestin Monotherapy|Death|0|||
125293078|NCT03077698|450700235|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
125293079|NCT03077698|450700236|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
125293080|NCT03077698|450700235|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
125293081|NCT03077698|450700236|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
125293082|NCT03077698|450700235|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
125293083|NCT03077698|450700236|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
125293084|NCT03077698|450700235|FG000|Safety Follow Up|Withdrawal by Subject|2|||
125293085|NCT03077698|450700236|FG001|Safety Follow Up|Withdrawal by Subject|1|||
125293086|NCT03077698|450700235|FG000|Safety Follow Up|Transfer of care to hospice|1|||
125293087|NCT03077698|450700236|FG001|Safety Follow Up|Transfer of care to hospice|0|||
125293088|NCT00973102|450700239|FG000|Overall Study|Protocol Violation|1|||
125293089|NCT00973102|450700240|FG001|Overall Study|Protocol Violation|0|||
125293090|NCT00973102|450700239|FG000|Overall Study|Prisoner|0|||
125293091|NCT00973102|450700240|FG001|Overall Study|Prisoner|1|||
125293092|NCT03099148|450700243|FG000|Wash-out|scheduling conflict|0|||
125293093|NCT03099148|450700244|FG001|Wash-out|scheduling conflict|1|||
125293094|NCT03099148|450700245|FG002|Wash-out|scheduling conflict|0|||
125293095|NCT03099148|450700246|FG003|Wash-out|scheduling conflict|0|||
125293096|NCT03099148|450700243|FG000|Wash-out|Adverse Event|0|||
125293097|NCT03099148|450700244|FG001|Wash-out|Adverse Event|1|||
125293098|NCT03099148|450700245|FG002|Wash-out|Adverse Event|0|||
125293099|NCT03099148|450700246|FG003|Wash-out|Adverse Event|0|||
125293100|NCT01439126|450700247|FG000|Overall Study|Adverse Event|2|||
125293101|NCT01439126|450700248|FG001|Overall Study|Adverse Event|0|||
125293102|NCT01439126|450700247|FG000|Overall Study|Withdrawal by Subject|5|||
125293103|NCT01439126|450700248|FG001|Overall Study|Withdrawal by Subject|21|||
125293104|NCT01439126|450700247|FG000|Overall Study|Protocol Violation|6|||
125293105|NCT01439126|450700248|FG001|Overall Study|Protocol Violation|4|||
125293106|NCT01439126|450700247|FG000|Overall Study|Lost to Follow-up|6|||
125293107|NCT01439126|450700248|FG001|Overall Study|Lost to Follow-up|3|||
125293108|NCT01439126|450700247|FG000|Overall Study|Other-Use of prohibited treatment|0|||
125293109|NCT01439126|450700248|FG001|Overall Study|Other-Use of prohibited treatment|2|||
125293110|NCT01439126|450700247|FG000|Overall Study|Other-Miscellaneous|12|||
125293111|NCT01439126|450700248|FG001|Overall Study|Other-Miscellaneous|12|||
125293112|NCT01710527|450700249|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
125293113|NCT01710527|450700250|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
125293114|NCT02124772|450700251|FG000|Overall Study|Lack of Efficacy|2|||
125293115|NCT02124772|450700252|FG001|Overall Study|Lack of Efficacy|0|||
125293116|NCT02124772|450700253|FG002|Overall Study|Lack of Efficacy|0|||
125293117|NCT02124772|450700254|FG003|Overall Study|Lack of Efficacy|1|||
125293118|NCT02124772|450700255|FG004|Overall Study|Lack of Efficacy|2|||
125293119|NCT02124772|450700256|FG005|Overall Study|Lack of Efficacy|3|||
125293120|NCT02124772|450700257|FG006|Overall Study|Lack of Efficacy|0|||
125293121|NCT02124772|450700258|FG007|Overall Study|Lack of Efficacy|2|||
125293122|NCT02124772|450700259|FG008|Overall Study|Lack of Efficacy|0|||
125293123|NCT02124772|450700260|FG009|Overall Study|Lack of Efficacy|1|||
125293124|NCT02124772|450700261|FG010|Overall Study|Lack of Efficacy|0|||
125293125|NCT02124772|450700262|FG011|Overall Study|Lack of Efficacy|0|||
125293126|NCT02124772|450700263|FG012|Overall Study|Lack of Efficacy|1|||
125293127|NCT02124772|450700251|FG000|Overall Study|Adverse Event|1|||
125293128|NCT02124772|450700252|FG001|Overall Study|Adverse Event|4|||
125293129|NCT02124772|450700253|FG002|Overall Study|Adverse Event|1|||
125293130|NCT02124772|450700254|FG003|Overall Study|Adverse Event|5|||
125293131|NCT02124772|450700255|FG004|Overall Study|Adverse Event|2|||
125293132|NCT02124772|450700256|FG005|Overall Study|Adverse Event|1|||
125293133|NCT02124772|450700257|FG006|Overall Study|Adverse Event|1|||
125293134|NCT02124772|450700258|FG007|Overall Study|Adverse Event|5|||
125293135|NCT02124772|450700259|FG008|Overall Study|Adverse Event|0|||
125293136|NCT02124772|450700260|FG009|Overall Study|Adverse Event|3|||
125293137|NCT02124772|450700261|FG010|Overall Study|Adverse Event|1|||
125293138|NCT02124772|450700262|FG011|Overall Study|Adverse Event|3|||
125293139|NCT02124772|450700263|FG012|Overall Study|Adverse Event|1|||
125293140|NCT02124772|450700251|FG000|Overall Study|Withdrawal consent|0|||
125293141|NCT02124772|450700252|FG001|Overall Study|Withdrawal consent|1|||
125293142|NCT02124772|450700253|FG002|Overall Study|Withdrawal consent|1|||
125293143|NCT02124772|450700254|FG003|Overall Study|Withdrawal consent|1|||
125293144|NCT02124772|450700255|FG004|Overall Study|Withdrawal consent|0|||
125293145|NCT02124772|450700256|FG005|Overall Study|Withdrawal consent|1|||
125293146|NCT02124772|450700257|FG006|Overall Study|Withdrawal consent|1|||
125293147|NCT02124772|450700258|FG007|Overall Study|Withdrawal consent|0|||
125293148|NCT02124772|450700259|FG008|Overall Study|Withdrawal consent|0|||
125293149|NCT02124772|450700260|FG009|Overall Study|Withdrawal consent|1|||
125293150|NCT02124772|450700261|FG010|Overall Study|Withdrawal consent|0|||
125293151|NCT02124772|450700262|FG011|Overall Study|Withdrawal consent|1|||
125293152|NCT02124772|450700263|FG012|Overall Study|Withdrawal consent|0|||
125293153|NCT02124772|450700251|FG000|Overall Study|Investigator discretion|0|||
125293154|NCT02124772|450700252|FG001|Overall Study|Investigator discretion|2|||
125293155|NCT02124772|450700253|FG002|Overall Study|Investigator discretion|2|||
125293156|NCT02124772|450700254|FG003|Overall Study|Investigator discretion|1|||
125293157|NCT02124772|450700255|FG004|Overall Study|Investigator discretion|1|||
125293158|NCT02124772|450700256|FG005|Overall Study|Investigator discretion|0|||
125293159|NCT02124772|450700257|FG006|Overall Study|Investigator discretion|1|||
125293160|NCT02124772|450700258|FG007|Overall Study|Investigator discretion|0|||
125293161|NCT02124772|450700259|FG008|Overall Study|Investigator discretion|0|||
125293162|NCT02124772|450700260|FG009|Overall Study|Investigator discretion|1|||
125293163|NCT02124772|450700261|FG010|Overall Study|Investigator discretion|0|||
125293164|NCT02124772|450700262|FG011|Overall Study|Investigator discretion|1|||
125293165|NCT02124772|450700263|FG012|Overall Study|Investigator discretion|0|||
125293166|NCT02124772|450700251|FG000|Overall Study|Progressive disease|0|||
125293167|NCT02124772|450700252|FG001|Overall Study|Progressive disease|0|||
125293168|NCT02124772|450700253|FG002|Overall Study|Progressive disease|0|||
125293169|NCT02124772|450700254|FG003|Overall Study|Progressive disease|0|||
125293170|NCT02124772|450700255|FG004|Overall Study|Progressive disease|0|||
125293171|NCT02124772|450700256|FG005|Overall Study|Progressive disease|0|||
125293172|NCT02124772|450700257|FG006|Overall Study|Progressive disease|1|||
125293173|NCT02124772|450700258|FG007|Overall Study|Progressive disease|1|||
125293174|NCT02124772|450700259|FG008|Overall Study|Progressive disease|0|||
125293175|NCT02124772|450700260|FG009|Overall Study|Progressive disease|0|||
125293176|NCT02124772|450700261|FG010|Overall Study|Progressive disease|0|||
125293177|NCT02124772|450700262|FG011|Overall Study|Progressive disease|0|||
125293178|NCT02124772|450700263|FG012|Overall Study|Progressive disease|0|||
125293179|NCT02124772|450700251|FG000|Overall Study|Other|0|||
125293180|NCT02124772|450700252|FG001|Overall Study|Other|7|||
125293181|NCT02124772|450700253|FG002|Overall Study|Other|2|||
125293182|NCT02124772|450700254|FG003|Overall Study|Other|5|||
125293183|NCT02124772|450700255|FG004|Overall Study|Other|4|||
125293184|NCT02124772|450700256|FG005|Overall Study|Other|3|||
125293185|NCT02124772|450700257|FG006|Overall Study|Other|4|||
125293186|NCT02124772|450700258|FG007|Overall Study|Other|1|||
125293187|NCT02124772|450700259|FG008|Overall Study|Other|1|||
125293188|NCT02124772|450700260|FG009|Overall Study|Other|1|||
125293189|NCT02124772|450700261|FG010|Overall Study|Other|1|||
125293190|NCT02124772|450700262|FG011|Overall Study|Other|1|||
125293191|NCT02124772|450700263|FG012|Overall Study|Other|0|||
125293192|NCT01617447|450700264|FG000|Overall Study|Adverse Event|0|||
125293193|NCT01617447|450700265|FG001|Overall Study|Adverse Event|1|||
125293194|NCT01617447|450700264|FG000|Overall Study|Physician Decision|0|||
125293195|NCT01617447|450700265|FG001|Overall Study|Physician Decision|2|||
125293196|NCT02713529|450700267|FG000|Overall Study|Withdrawal by Subject|3|||
125293197|NCT02713529|450700268|FG001|Overall Study|Withdrawal by Subject|1|||
125293198|NCT02713529|450700269|FG002|Overall Study|Withdrawal by Subject|4|||
125293199|NCT02713529|450700270|FG003|Overall Study|Withdrawal by Subject|2|||
125293200|NCT02713529|450700271|FG004|Overall Study|Withdrawal by Subject|0|||
124788654|NCT00369629|448855897|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
125293201|NCT02713529|450700272|FG005|Overall Study|Withdrawal by Subject|1|||
125293202|NCT02713529|450700273|FG006|Overall Study|Withdrawal by Subject|1|||
125293203|NCT02713529|450700267|FG000|Overall Study|Lost to Follow-up|1|||
125293204|NCT02713529|450700268|FG001|Overall Study|Lost to Follow-up|0|||
125293205|NCT02713529|450700269|FG002|Overall Study|Lost to Follow-up|1|||
125293206|NCT02713529|450700270|FG003|Overall Study|Lost to Follow-up|0|||
125293207|NCT02713529|450700271|FG004|Overall Study|Lost to Follow-up|0|||
125293208|NCT02713529|450700272|FG005|Overall Study|Lost to Follow-up|0|||
124788655|NCT00369629|448855894|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
124788656|NCT00369629|448855895|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
124788657|NCT00369629|448855896|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
125293209|NCT02713529|450700273|FG006|Overall Study|Lost to Follow-up|0|||
125293210|NCT02713529|450700267|FG000|Overall Study|Death|3|||
125293211|NCT02713529|450700268|FG001|Overall Study|Death|3|||
125293212|NCT02713529|450700269|FG002|Overall Study|Death|26|||
125293213|NCT02713529|450700270|FG003|Overall Study|Death|27|||
125293214|NCT02713529|450700271|FG004|Overall Study|Death|3|||
125293215|NCT02713529|450700272|FG005|Overall Study|Death|13|||
125293216|NCT02713529|450700273|FG006|Overall Study|Death|3|||
125293217|NCT00780273|450700274|FG000|Overall Study|Death|1|||
125293218|NCT00780273|450700274|FG000|Overall Study|Lost to Follow-up|1|||
125293219|NCT02358044|450700277|FG000|Overall Study|Adverse Event|0|||
125293220|NCT02358044|450700278|FG001|Overall Study|Adverse Event|1|||
125293221|NCT02358044|450700277|FG000|Overall Study|Lost to Follow-up|2|||
125293222|NCT02358044|450700278|FG001|Overall Study|Lost to Follow-up|1|||
125293223|NCT02358044|450700277|FG000|Overall Study|Physician Decision|0|||
125293224|NCT02358044|450700278|FG001|Overall Study|Physician Decision|1|||
125293225|NCT02358044|450700277|FG000|Overall Study|Withdrawal by Subject|0|||
125293226|NCT02358044|450700278|FG001|Overall Study|Withdrawal by Subject|4|||
125293227|NCT01739803|450700279|FG000|Overall Study|Lost to Follow-up|9|||
125293228|NCT01739803|450700280|FG001|Overall Study|Lost to Follow-up|6|||
125293229|NCT02525094|450700288|FG000|Overall Study|Lost to Follow-up|2|||
125293230|NCT02525094|450700289|FG001|Overall Study|Lost to Follow-up|1|||
125293231|NCT02525094|450700288|FG000|Overall Study|Withdrawal by Subject|5|||
125293232|NCT02525094|450700289|FG001|Overall Study|Withdrawal by Subject|6|||
125293233|NCT02525094|450700288|FG000|Overall Study|Not Treated|1|||
125293234|NCT02525094|450700289|FG001|Overall Study|Not Treated|1|||
125293235|NCT02242981|450700291|FG000|Overall Study|Withdrawal by Subject|1|||
125293236|NCT02210091|450700292|FG000|Overall Study|Physician Decision|0|||
125293237|NCT02210091|450700293|FG001|Overall Study|Physician Decision|1|||
125293238|NCT02210091|450700292|FG000|Overall Study|Withdrawal by Sponsor|0|||
125293239|NCT02210091|450700293|FG001|Overall Study|Withdrawal by Sponsor|1|||
125293240|NCT02290938|450700294|FG000|Overall Study|Lost to Follow-up|14|||
125293241|NCT02290938|450700295|FG001|Overall Study|Lost to Follow-up|43|||
125293242|NCT01831817|450700296|FG000|Overall Study|Lost to Follow-up|1|||
125293243|NCT01831817|450700297|FG001|Overall Study|Lost to Follow-up|0|||
125293244|NCT01831817|450700298|FG002|Overall Study|Lost to Follow-up|0|||
125293245|NCT01831817|450700299|FG003|Overall Study|Lost to Follow-up|0|||
125293246|NCT01831817|450700296|FG000|Overall Study|Withdrawl of Consent|3|||
125293247|NCT01831817|450700297|FG001|Overall Study|Withdrawl of Consent|0|||
125293248|NCT01831817|450700298|FG002|Overall Study|Withdrawl of Consent|0|||
125293249|NCT01831817|450700299|FG003|Overall Study|Withdrawl of Consent|0|||
125293250|NCT05065190|450702012|FG000|Overall Study|Other than listed|2|||
125293251|NCT05065190|450702013|FG001|Overall Study|Other than listed|12|||
125293252|NCT05065190|450702012|FG000|Overall Study|Lack of Efficacy|4|||
125293253|NCT05065190|450702013|FG001|Overall Study|Lack of Efficacy|0|||
125293254|NCT05065190|450702012|FG000|Overall Study|Adverse Event|1|||
125293255|NCT05065190|450702013|FG001|Overall Study|Adverse Event|10|||
125293256|NCT04938037|450702014|FG000|Overall Study|Lost to Follow-up|4|||
125293257|NCT04938037|450702015|FG001|Overall Study|Lost to Follow-up|3|||
125293258|NCT03320330|450702018|FG000|Overall Study|Lack of Efficacy|5|||
125293259|NCT03320330|450702019|FG001|Overall Study|Lack of Efficacy|5|||
125293260|NCT03320330|450702020|FG002|Overall Study|Lack of Efficacy|14|||
125293261|NCT03320330|450702018|FG000|Overall Study|Physician Decision|1|||
125293262|NCT03320330|450702019|FG001|Overall Study|Physician Decision|0|||
125293263|NCT03320330|450702020|FG002|Overall Study|Physician Decision|0|||
125293264|NCT00203021|450702021|FG000|Overall Study|Death|4|||
125293265|NCT00203021|450702022|FG001|Overall Study|Death|1|||
125293266|NCT00203021|450702021|FG000|Overall Study|Adverse Event|10|||
125293267|NCT00203021|450702022|FG001|Overall Study|Adverse Event|5|||
125293268|NCT00203021|450702021|FG000|Overall Study|Withdrawal by Subject|45|||
125293269|NCT00203021|450702022|FG001|Overall Study|Withdrawal by Subject|48|||
125293270|NCT00203021|450702021|FG000|Overall Study|Lost to Follow-up|9|||
125293271|NCT00203021|450702022|FG001|Overall Study|Lost to Follow-up|7|||
125293272|NCT00203021|450702021|FG000|Overall Study|Other than specified|11|||
125293273|NCT00203021|450702022|FG001|Overall Study|Other than specified|16|||
125293274|NCT02936284|450702026|FG000|Overall Study|Withdrawal by Subject|3|||
125293275|NCT02936284|450702027|FG001|Overall Study|Withdrawal by Subject|1|||
125293276|NCT02936284|450702026|FG000|Overall Study|Lost to Follow-up|7|||
125293277|NCT02936284|450702027|FG001|Overall Study|Lost to Follow-up|8|||
125293278|NCT04284813|450702028|FG000|Overall Study|Withdrawal by Subject|1|||
125293279|NCT01146652|450702033|FG000|Overall Study|Adverse Event|506|||
125293280|NCT01146652|450702034|FG001|Overall Study|Adverse Event|15|||
125293281|NCT01146652|450702033|FG000|Overall Study|Lack of Efficacy|91|||
125293282|NCT01146652|450702034|FG001|Overall Study|Lack of Efficacy|7|||
124788658|NCT00369629|448855897|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
124788659|NCT00369629|448855894|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
125293283|NCT01146652|450702033|FG000|Overall Study|Poor compliance to protocol|38|||
125293284|NCT01146652|450702034|FG001|Overall Study|Poor compliance to protocol|1|||
125293285|NCT01146652|450702033|FG000|Overall Study|Other unspecified reasons|314|||
125293286|NCT01146652|450702034|FG001|Overall Study|Other unspecified reasons|22|||
125293287|NCT01146652|450702033|FG000|Overall Study|Enrolled but not treated|2|||
125293288|NCT01146652|450702034|FG001|Overall Study|Enrolled but not treated|0|||
125293289|NCT01300351|450702038|FG000|Overall Study|Did not receive treatment|2|||
125293290|NCT01300351|450702039|FG001|Overall Study|Did not receive treatment|0|||
125293291|NCT01300351|450702038|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
125293292|NCT01300351|450702039|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
125293293|NCT01300351|450702038|FG000|Overall Study|Lost to Follow-up|0|||
125293294|NCT01300351|450702039|FG001|Overall Study|Lost to Follow-up|1|||
125293295|NCT01300351|450702038|FG000|Overall Study|Adverse Event|0|||
124788660|NCT00369629|448855895|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
125293296|NCT01300351|450702039|FG001|Overall Study|Adverse Event|4|||
125293297|NCT01300351|450702038|FG000|Overall Study|Withdrawal by Subject|7|||
125293298|NCT01300351|450702039|FG001|Overall Study|Withdrawal by Subject|10|||
125293299|NCT00431951|450702040|FG000|Overall Study|Inability to follow study procedures|1|||
125293300|NCT00431951|450702041|FG001|Overall Study|Inability to follow study procedures|0|||
125293301|NCT00431951|450702042|FG002|Overall Study|Inability to follow study procedures|1|||
125293302|NCT00431951|450702043|FG003|Overall Study|Inability to follow study procedures|2|||
125293303|NCT00431951|450702040|FG000|Overall Study|Lost to Follow-up|0|||
125293304|NCT00431951|450702041|FG001|Overall Study|Lost to Follow-up|1|||
125293305|NCT00431951|450702042|FG002|Overall Study|Lost to Follow-up|0|||
125293306|NCT00431951|450702043|FG003|Overall Study|Lost to Follow-up|0|||
125293307|NCT00431951|450702040|FG000|Overall Study|Withdrawal by Subject|0|||
125293308|NCT00431951|450702041|FG001|Overall Study|Withdrawal by Subject|1|||
125293309|NCT00431951|450702042|FG002|Overall Study|Withdrawal by Subject|0|||
125293310|NCT00431951|450702043|FG003|Overall Study|Withdrawal by Subject|0|||
125293311|NCT00431951|450702040|FG000|Overall Study|Adverse Event|0|||
125293312|NCT00431951|450702041|FG001|Overall Study|Adverse Event|0|||
125293313|NCT00431951|450702042|FG002|Overall Study|Adverse Event|1|||
125293314|NCT00431951|450702043|FG003|Overall Study|Adverse Event|0|||
125293315|NCT00673881|450702046|FG000|Overall Study|Withdrawal by Subject|1|||
125293316|NCT00096018|450702047|FG000|Overall Study|Became Ineligible (not treated)|0|||
125293317|NCT00096018|450702048|FG001|Overall Study|Became Ineligible (not treated)|3|||
125293318|NCT00096018|450702047|FG000|Overall Study|Miscellaneous (not treated)|0|||
125293319|NCT00096018|450702048|FG001|Overall Study|Miscellaneous (not treated)|2|||
125293320|NCT00096018|450702047|FG000|Overall Study|Adverse Event|0|||
125293321|NCT00096018|450702048|FG001|Overall Study|Adverse Event|5|||
125293322|NCT00096018|450702047|FG000|Overall Study|Death|0|||
125293323|NCT00096018|450702048|FG001|Overall Study|Death|1|||
125293324|NCT00096018|450702047|FG000|Overall Study|Withdrawal by Subject|0|||
125293325|NCT00096018|450702048|FG001|Overall Study|Withdrawal by Subject|2|||
125293326|NCT00096018|450702047|FG000|Overall Study|Miscellaneous|2|||
125293327|NCT00096018|450702048|FG001|Overall Study|Miscellaneous|1|||
125293328|NCT00689793|450702049|FG000|Overall Study|Lost to Follow-up|4|||
125293329|NCT00689793|450702050|FG001|Overall Study|Lost to Follow-up|5|||
125293330|NCT01100528|450702051|FG000|Overall Study|Death|1|||
125293331|NCT01100528|450702051|FG000|Overall Study|Withdrawal by Subject|2|||
125293332|NCT03968159|450702052|FG000|Overall Study|Adverse Event|4|||
125293333|NCT03968159|450702053|FG001|Overall Study|Adverse Event|4|||
125293334|NCT03968159|450702052|FG000|Overall Study|Lost to Follow-up|1|||
125293335|NCT03968159|450702053|FG001|Overall Study|Lost to Follow-up|1|||
125293336|NCT03968159|450702052|FG000|Overall Study|Use of prohibited medication|0|||
125293337|NCT03968159|450702053|FG001|Overall Study|Use of prohibited medication|1|||
125293338|NCT03968159|450702052|FG000|Overall Study|Protocol Violation|2|||
125293339|NCT03968159|450702053|FG001|Overall Study|Protocol Violation|2|||
125293340|NCT03968159|450702052|FG000|Overall Study|Withdrawal by Subject|4|||
125293341|NCT03968159|450702053|FG001|Overall Study|Withdrawal by Subject|6|||
125293342|NCT03968159|450702052|FG000|Overall Study|Lack of Efficacy|0|||
125293343|NCT03968159|450702053|FG001|Overall Study|Lack of Efficacy|1|||
125293344|NCT03968159|450702052|FG000|Overall Study|Not further specified|2|||
125293345|NCT03968159|450702053|FG001|Overall Study|Not further specified|0|||
125293346|NCT02827500|450702061|FG000|Overall Study|Death|7|||
125293347|NCT02827500|450702062|FG001|Overall Study|Death|3|||
125293348|NCT02827500|450702061|FG000|Overall Study|Lost to Follow-up|1|||
125293349|NCT02827500|450702062|FG001|Overall Study|Lost to Follow-up|1|||
125293350|NCT02827500|450702061|FG000|Overall Study|Withdrawal by Subject|3|||
125293351|NCT02827500|450702062|FG001|Overall Study|Withdrawal by Subject|1|||
125293352|NCT02827500|450702061|FG000|Overall Study|Missing primary endpoint data|3|||
125293353|NCT02827500|450702062|FG001|Overall Study|Missing primary endpoint data|1|||
125293354|NCT02827500|450702061|FG000|Overall Study|Other|5|||
125293355|NCT02827500|450702062|FG001|Overall Study|Other|1|||
125293356|NCT02308488|450702065|FG000|Overall Study|Withdrawal by Subject|2|||
125293357|NCT01541917|450702066|FG000|Overall Study|Lost to Follow-up|2|||
125293358|NCT01541917|450702067|FG001|Overall Study|Lost to Follow-up|2|||
125293359|NCT01541917|450702066|FG000|Overall Study|Withdrawal by Subject|13|||
125293360|NCT01541917|450702067|FG001|Overall Study|Withdrawal by Subject|7|||
125293361|NCT00094107|450702072|FG000|Overall Study|Lack of Efficacy|23|||
125293362|NCT00094107|450702072|FG000|Overall Study|Death|5|||
125293363|NCT00094107|450702072|FG000|Overall Study|Adverse Event|3|||
125293364|NCT00094107|450702072|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
125293365|NCT00525824|450702073|FG000|Overall Study|Adverse Event|7|||
125293366|NCT00525824|450702074|FG001|Overall Study|Adverse Event|11|||
125293367|NCT00525824|450702075|FG002|Overall Study|Adverse Event|6|||
125293368|NCT00525824|450702076|FG003|Overall Study|Adverse Event|7|||
125293369|NCT00525824|450702073|FG000|Overall Study|Withdrawal by Subject|5|||
125293370|NCT00525824|450702074|FG001|Overall Study|Withdrawal by Subject|9|||
125293371|NCT00525824|450702075|FG002|Overall Study|Withdrawal by Subject|3|||
125293372|NCT00525824|450702076|FG003|Overall Study|Withdrawal by Subject|4|||
125293373|NCT00525824|450702073|FG000|Overall Study|Lost to Follow-up|4|||
125293374|NCT00525824|450702074|FG001|Overall Study|Lost to Follow-up|2|||
125293375|NCT00525824|450702075|FG002|Overall Study|Lost to Follow-up|4|||
125293376|NCT00525824|450702076|FG003|Overall Study|Lost to Follow-up|0|||
125293377|NCT00525824|450702073|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
125293378|NCT00525824|450702074|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
125293379|NCT00525824|450702075|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
125293380|NCT00525824|450702076|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
125293381|NCT00525824|450702073|FG000|Overall Study|Severe non-compliance|0|||
125293382|NCT00525824|450702074|FG001|Overall Study|Severe non-compliance|1|||
125293383|NCT00525824|450702075|FG002|Overall Study|Severe non-compliance|1|||
125293384|NCT00525824|450702076|FG003|Overall Study|Severe non-compliance|1|||
125293385|NCT00525824|450702073|FG000|Overall Study|Safety reasons|1|||
125293386|NCT00525824|450702074|FG001|Overall Study|Safety reasons|0|||
125293387|NCT00525824|450702075|FG002|Overall Study|Safety reasons|1|||
125293388|NCT00525824|450702076|FG003|Overall Study|Safety reasons|0|||
125293389|NCT00525824|450702073|FG000|Overall Study|Other|1|||
125293390|NCT00525824|450702074|FG001|Overall Study|Other|3|||
125293391|NCT00525824|450702075|FG002|Overall Study|Other|3|||
125293392|NCT00525824|450702076|FG003|Overall Study|Other|1|||
125293393|NCT01378429|450702080|FG000|Overall Study|Noncompliance with study drug|1|||
125293394|NCT01378429|450702081|FG001|Overall Study|Noncompliance with study drug|0|||
125293395|NCT01490294|450702084|FG000|Overall Study|Prematurely discontinuation|4|||
125293396|NCT01490294|450702085|FG001|Overall Study|Prematurely discontinuation|0|||
125293397|NCT01490294|450702086|FG002|Overall Study|Prematurely discontinuation|1|||
125293398|NCT01490294|450702087|FG003|Overall Study|Prematurely discontinuation|1|||
125293399|NCT01490294|450702084|FG000|Overall Study|Adverse Event|1|||
125293400|NCT01490294|450702085|FG001|Overall Study|Adverse Event|0|||
125293401|NCT01490294|450702086|FG002|Overall Study|Adverse Event|0|||
125293402|NCT01490294|450702087|FG003|Overall Study|Adverse Event|0|||
125293403|NCT01751776|450702088|FG000|Overall Study|Adverse Event|0|||
125293404|NCT01751776|450702089|FG001|Overall Study|Adverse Event|0|||
125293405|NCT01751776|450702090|FG002|Overall Study|Adverse Event|0|||
125293406|NCT01751776|450702091|FG003|Overall Study|Adverse Event|0|||
125293407|NCT01751776|450702092|FG004|Overall Study|Adverse Event|0|||
125293408|NCT01751776|450702093|FG005|Overall Study|Adverse Event|0|||
125293409|NCT01751776|450702094|FG006|Overall Study|Adverse Event|4|||
124788661|NCT00369629|448855896|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
124788662|NCT00369629|448855897|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
124788663|NCT00369629|448855894|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
124788664|NCT00369629|448855895|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
125293410|NCT01751776|450702095|FG007|Overall Study|Adverse Event|2|||
125293411|NCT01751776|450702088|FG000|Overall Study|Consent withdrawn|0|||
125293412|NCT01751776|450702089|FG001|Overall Study|Consent withdrawn|0|||
125293413|NCT01751776|450702090|FG002|Overall Study|Consent withdrawn|0|||
125293414|NCT01751776|450702091|FG003|Overall Study|Consent withdrawn|0|||
125293415|NCT01751776|450702092|FG004|Overall Study|Consent withdrawn|0|||
125293416|NCT01751776|450702093|FG005|Overall Study|Consent withdrawn|0|||
125293417|NCT01751776|450702094|FG006|Overall Study|Consent withdrawn|0|||
125293418|NCT01751776|450702095|FG007|Overall Study|Consent withdrawn|1|||
125293419|NCT01751776|450702088|FG000|Overall Study|Other reason not specified above|0|||
125293420|NCT01751776|450702089|FG001|Overall Study|Other reason not specified above|0|||
125293421|NCT01751776|450702090|FG002|Overall Study|Other reason not specified above|0|||
125293422|NCT01751776|450702091|FG003|Overall Study|Other reason not specified above|0|||
125293423|NCT01751776|450702092|FG004|Overall Study|Other reason not specified above|0|||
125293424|NCT01751776|450702093|FG005|Overall Study|Other reason not specified above|0|||
124788665|NCT00369629|448855896|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
125293425|NCT01751776|450702094|FG006|Overall Study|Other reason not specified above|0|||
125293426|NCT01751776|450702095|FG007|Overall Study|Other reason not specified above|1|||
125293427|NCT05219669|450702096|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
125293428|NCT05219669|450702097|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
125293429|NCT05219669|450702098|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
125293430|NCT05219669|450702099|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
125293431|NCT05219669|450702100|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
125293432|NCT05219669|450702101|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
125293433|NCT02404649|450702106|FG000|Overall Study|Adverse Event|1|||
125293434|NCT02404649|450702107|FG001|Overall Study|Adverse Event|2|||
125293435|NCT00330668|450702111|FG000|BID Dosing Period|Adverse Event|1|||
124788666|NCT00369629|448855897|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
124788667|NCT00369629|448855894|FG000|Completed 4 More Cycles|Progressive disease|2|||
124788668|NCT00369629|448855895|FG001|Completed 4 More Cycles|Progressive disease|1|||
124788669|NCT00369629|448855896|FG002|Completed 4 More Cycles|Progressive disease|2|||
124788670|NCT00369629|448855897|FG003|Completed 4 More Cycles|Progressive disease|0|||
125293436|NCT00330668|450702111|FG000|BID Dosing Period|Lost to Follow-up|7|||
125293437|NCT00330668|450702111|FG000|BID Dosing Period|Non-Compliance|5|||
125293438|NCT00330668|450702111|FG000|BID Dosing Period|Withdrawal by Subject|19|||
125293439|NCT00330668|450702111|FG000|BID Dosing Period|Sponsor's decision|1|||
124788671|NCT00369629|448855894|FG000|Follow up for 1 Year|Death|2|||
124788672|NCT00369629|448855895|FG001|Follow up for 1 Year|Death|1|||
125293440|NCT00330668|450702111|FG000|BID Dosing Period|Other|3|||
125293441|NCT00330668|450702111|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
125293442|NCT00330668|450702111|FG000|QD Dosing Period|Other|1|||
125293443|NCT00330668|450702111|FG000|QD Dosing Period|Withdrawal by Subject|1|||
125293444|NCT00330668|450702111|FG000|QD Dosing Period|Lost to Follow-up|2|||
125293445|NCT01839656|450702112|FG000|Overall Study|Withdrawal by Subject|1|||
125293446|NCT01839656|450702113|FG001|Overall Study|Withdrawal by Subject|1|||
125293447|NCT01839656|450702112|FG000|Overall Study|Adverse event, serious fatal|1|||
125293448|NCT01839656|450702113|FG001|Overall Study|Adverse event, serious fatal|4|||
125293449|NCT01839656|450702112|FG000|Overall Study|Early study closure|0|||
125293450|NCT01839656|450702113|FG001|Overall Study|Early study closure|11|||
125293451|NCT01839656|450702112|FG000|Overall Study|Adverse Event|1|||
125293452|NCT01839656|450702113|FG001|Overall Study|Adverse Event|0|||
125293453|NCT01595581|450702114|FG000|Overall Study|Withdrawal by Subject|1|||
125293454|NCT01595581|450702115|FG001|Overall Study|Withdrawal by Subject|0|||
125293455|NCT02621073|450702116|FG000|Overall Study|Lost to Follow-up|0|||
125293456|NCT02621073|450702117|FG001|Overall Study|Lost to Follow-up|1|||
125293457|NCT02621073|450702116|FG000|Overall Study|Physician Decision|3|||
125293458|NCT02621073|450702117|FG001|Overall Study|Physician Decision|2|||
125293459|NCT01440881|450702127|FG000|Overall Study|Death|0|||
125293460|NCT01440881|450702128|FG001|Overall Study|Death|1|||
125293461|NCT03474081|450702129|FG000|Overall Study|Adverse Event|6|||
125293462|NCT03474081|450702130|FG001|Overall Study|Adverse Event|3|||
125293463|NCT03474081|450702129|FG000|Overall Study|Lost to Follow-up|2|||
125293464|NCT03474081|450702130|FG001|Overall Study|Lost to Follow-up|1|||
125293465|NCT03474081|450702129|FG000|Overall Study|Physician Decision|3|||
125293466|NCT03474081|450702130|FG001|Overall Study|Physician Decision|2|||
125293467|NCT03474081|450702129|FG000|Overall Study|Withdrawal by Subject|5|||
125293468|NCT03474081|450702130|FG001|Overall Study|Withdrawal by Subject|7|||
125293469|NCT03474081|450702129|FG000|Overall Study|Investigator site closed|1|||
125293470|NCT03474081|450702130|FG001|Overall Study|Investigator site closed|0|||
125293471|NCT02920957|450702137|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
125293472|NCT02920957|450702138|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
125293473|NCT02920957|450702137|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
125293474|NCT02920957|450702138|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
125293475|NCT02920957|450702137|FG000|First Intervention : 1 Month|Adverse Event|1|||
125293476|NCT02920957|450702138|FG001|First Intervention : 1 Month|Adverse Event|0|||
125293477|NCT02920957|450702137|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
125293478|NCT02920957|450702138|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
125293479|NCT02644356|450702140|FG000|Overall Study|Withdrawal by Subject|2|||
125293480|NCT02739321|450702147|FG000|Overall Study|Lack of Efficacy|1|||
125293481|NCT02739321|450702148|FG001|Overall Study|Lack of Efficacy|1|||
125293482|NCT02739321|450702147|FG000|Overall Study|Lost to Follow-up|1|||
125293483|NCT02739321|450702148|FG001|Overall Study|Lost to Follow-up|1|||
125293484|NCT02739321|450702147|FG000|Overall Study|Withdrawal by Subject|1|||
125293485|NCT02739321|450702148|FG001|Overall Study|Withdrawal by Subject|2|||
125293486|NCT01711866|450702149|FG000|Overall Study|Noncompliant|3|||
125293487|NCT01711866|450702149|FG000|Overall Study|Withdrawal by Subject|3|||
125293488|NCT01711866|450702149|FG000|Overall Study|Adverse Event|2|||
125293489|NCT01345682|450702150|FG000|Overall Study|Progressive disease per RECIST|226|||
125293490|NCT01345682|450702151|FG001|Overall Study|Progressive disease per RECIST|93|||
125293491|NCT01345682|450702150|FG000|Overall Study|Worsening of underlying cancer disease|23|||
125293492|NCT01345682|450702151|FG001|Overall Study|Worsening of underlying cancer disease|12|||
125293493|NCT01345682|450702150|FG000|Overall Study|Adverse Event|51|||
125293494|NCT01345682|450702151|FG001|Overall Study|Adverse Event|41|||
125293495|NCT01345682|450702150|FG000|Overall Study|Non-compliance with protocol|0|||
125293496|NCT01345682|450702151|FG001|Overall Study|Non-compliance with protocol|1|||
125293497|NCT01345682|450702150|FG000|Overall Study|Lost to Follow-up|0|||
125293498|NCT01345682|450702151|FG001|Overall Study|Lost to Follow-up|1|||
125293499|NCT01345682|450702150|FG000|Overall Study|Refused to continue trial medication|16|||
125293500|NCT01345682|450702151|FG001|Overall Study|Refused to continue trial medication|9|||
125293501|NCT01345682|450702150|FG000|Overall Study|Not treated|2|||
125293502|NCT01345682|450702151|FG001|Overall Study|Not treated|1|||
125293503|NCT01345682|450702150|FG000|Overall Study|Reason other than those specified above|4|||
125293504|NCT01345682|450702151|FG001|Overall Study|Reason other than those specified above|3|||
125293505|NCT00897390|450702154|FG000|Overall Study|Adverse Event|2|||
125293506|NCT00897390|450702154|FG000|Overall Study|No Longer Met Study Criteria|1|||
125293507|NCT00897390|450702154|FG000|Overall Study|Personal Reasons|1|||
125293508|NCT00897390|450702154|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
125293509|NCT00958217|450702158|FG000|Overall Study|Death|2|||
125293510|NCT00958217|450702159|FG001|Overall Study|Death|1|||
125293511|NCT00958217|450702158|FG000|Overall Study|Withdrawal by Subject|4|||
125293512|NCT00958217|450702159|FG001|Overall Study|Withdrawal by Subject|3|||
125293513|NCT00958217|450702158|FG000|Overall Study|Lost to Follow-up|17|||
125293514|NCT00958217|450702159|FG001|Overall Study|Lost to Follow-up|19|||
125293515|NCT00958217|450702158|FG000|Overall Study|Moved out of area|1|||
125293516|NCT00958217|450702159|FG001|Overall Study|Moved out of area|1|||
125293517|NCT00958217|450702158|FG000|Overall Study|Inpatient hospitalization|0|||
125293518|NCT00958217|450702159|FG001|Overall Study|Inpatient hospitalization|1|||
125293519|NCT01075984|450702162|FG000|Treatment Phase|Adverse Event|0|||
125293520|NCT01075984|450702163|FG001|Treatment Phase|Adverse Event|1|||
125293521|NCT01075984|450702164|FG002|Treatment Phase|Adverse Event|3|||
125293522|NCT01075984|450702165|FG003|Treatment Phase|Adverse Event|7|||
125293523|NCT01075984|450702166|FG004|Treatment Phase|Adverse Event|35|||
125293524|NCT01075984|450702162|FG000|Treatment Phase|Protocol Violation|0|||
125293525|NCT01075984|450702163|FG001|Treatment Phase|Protocol Violation|0|||
125293526|NCT01075984|450702164|FG002|Treatment Phase|Protocol Violation|1|||
125293527|NCT01075984|450702165|FG003|Treatment Phase|Protocol Violation|0|||
125293528|NCT01075984|450702166|FG004|Treatment Phase|Protocol Violation|3|||
125293529|NCT01075984|450702162|FG000|Treatment Phase|Withdrawal by Subject|0|||
125293530|NCT01075984|450702163|FG001|Treatment Phase|Withdrawal by Subject|0|||
125293531|NCT01075984|450702164|FG002|Treatment Phase|Withdrawal by Subject|2|||
125293532|NCT01075984|450702165|FG003|Treatment Phase|Withdrawal by Subject|0|||
125293533|NCT01075984|450702166|FG004|Treatment Phase|Withdrawal by Subject|15|||
125293534|NCT01075984|450702162|FG000|Treatment Phase|Treatment Failure|0|||
125293535|NCT01075984|450702163|FG001|Treatment Phase|Treatment Failure|0|||
125293536|NCT01075984|450702164|FG002|Treatment Phase|Treatment Failure|1|||
125293537|NCT01075984|450702165|FG003|Treatment Phase|Treatment Failure|0|||
125293538|NCT01075984|450702166|FG004|Treatment Phase|Treatment Failure|5|||
125293539|NCT01075984|450702162|FG000|Treatment Phase|Progression of disease|0|||
125293540|NCT01075984|450702163|FG001|Treatment Phase|Progression of disease|0|||
125293541|NCT01075984|450702164|FG002|Treatment Phase|Progression of disease|0|||
125293542|NCT01075984|450702165|FG003|Treatment Phase|Progression of disease|0|||
125293543|NCT01075984|450702166|FG004|Treatment Phase|Progression of disease|2|||
125293544|NCT01075984|450702162|FG000|Follow-up Phase|Protocol Violation|0|||
125293545|NCT01075984|450702163|FG001|Follow-up Phase|Protocol Violation|0|||
125293546|NCT01075984|450702164|FG002|Follow-up Phase|Protocol Violation|1|||
124788673|NCT00369629|448855896|FG002|Follow up for 1 Year|Death|1|||
124788674|NCT00369629|448855897|FG003|Follow up for 1 Year|Death|0|||
124788675|NCT00369629|448855894|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
124788676|NCT00369629|448855895|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
124788677|NCT00369629|448855896|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
124788678|NCT00369629|448855897|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
124788679|NCT00369629|448855894|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
124788680|NCT00369629|448855895|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
124788681|NCT00369629|448855896|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
124788682|NCT00369629|448855897|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
124788683|NCT00874939|448855898|FG000|Overall Study|Study terminated|4|||
124788684|NCT01250496|448855901|FG000|Overall Study|Study terminated|124|||
124788685|NCT01250496|448855902|FG001|Overall Study|Study terminated|124|||
124788686|NCT00883688|448855905|FG000|Overall Study|Ineligible|2|||
124788687|NCT01104376|448855911|FG000|Overall Study|Withdrawal by Subject|15|||
124788688|NCT01104376|448855911|FG000|Overall Study|Consented but excluded after labs|13|||
124788689|NCT03085914|448855919|FG000|Overall Study|Death|6|||
124788690|NCT03085914|448855920|FG001|Overall Study|Death|6|||
124788691|NCT03085914|448855921|FG002|Overall Study|Death|4|||
124788692|NCT03085914|448855922|FG003|Overall Study|Death|1|||
125293547|NCT01075984|450702165|FG003|Follow-up Phase|Protocol Violation|0|||
125293548|NCT01075984|450702166|FG004|Follow-up Phase|Protocol Violation|3|||
125293549|NCT01075984|450702162|FG000|Follow-up Phase|Adverse Event|0|||
125293550|NCT01075984|450702163|FG001|Follow-up Phase|Adverse Event|0|||
125293551|NCT01075984|450702164|FG002|Follow-up Phase|Adverse Event|0|||
125293552|NCT01075984|450702165|FG003|Follow-up Phase|Adverse Event|2|||
125293553|NCT01075984|450702166|FG004|Follow-up Phase|Adverse Event|27|||
125293554|NCT01075984|450702162|FG000|Follow-up Phase|Administrative|0|||
125293555|NCT01075984|450702163|FG001|Follow-up Phase|Administrative|0|||
125293556|NCT01075984|450702164|FG002|Follow-up Phase|Administrative|0|||
124788693|NCT03085914|448855923|FG004|Overall Study|Death|5|||
124788694|NCT03085914|448855924|FG005|Overall Study|Death|2|||
125293557|NCT01075984|450702165|FG003|Follow-up Phase|Administrative|0|||
125293558|NCT01075984|450702166|FG004|Follow-up Phase|Administrative|1|||
125293559|NCT01075984|450702162|FG000|Follow-up Phase|Withdrawal by Subject|0|||
125293560|NCT01075984|450702163|FG001|Follow-up Phase|Withdrawal by Subject|0|||
125293561|NCT01075984|450702164|FG002|Follow-up Phase|Withdrawal by Subject|0|||
125293562|NCT01075984|450702165|FG003|Follow-up Phase|Withdrawal by Subject|0|||
125293563|NCT01075984|450702166|FG004|Follow-up Phase|Withdrawal by Subject|10|||
124788695|NCT03085914|448855925|FG006|Overall Study|Death|2|||
124788696|NCT03085914|448855919|FG000|Overall Study|Withdrawal by Subject|1|||
124788697|NCT03085914|448855920|FG001|Overall Study|Withdrawal by Subject|1|||
124788698|NCT03085914|448855921|FG002|Overall Study|Withdrawal by Subject|2|||
124788699|NCT03085914|448855922|FG003|Overall Study|Withdrawal by Subject|2|||
125293564|NCT01075984|450702162|FG000|Follow-up Phase|Progression of disease|0|||
125293565|NCT01075984|450702163|FG001|Follow-up Phase|Progression of disease|0|||
125293566|NCT01075984|450702164|FG002|Follow-up Phase|Progression of disease|0|||
125293567|NCT01075984|450702165|FG003|Follow-up Phase|Progression of disease|0|||
124788700|NCT03085914|448855923|FG004|Overall Study|Withdrawal by Subject|2|||
124788701|NCT03085914|448855924|FG005|Overall Study|Withdrawal by Subject|0|||
125293568|NCT01075984|450702166|FG004|Follow-up Phase|Progression of disease|2|||
125293569|NCT01075984|450702162|FG000|Follow-up Phase|Treatment failure|0|||
124788702|NCT03085914|448855925|FG006|Overall Study|Withdrawal by Subject|1|||
124788703|NCT03085914|448855919|FG000|Overall Study|Lost to Follow-up|0|||
125293570|NCT01075984|450702163|FG001|Follow-up Phase|Treatment failure|0|||
125293571|NCT01075984|450702164|FG002|Follow-up Phase|Treatment failure|0|||
125293572|NCT01075984|450702165|FG003|Follow-up Phase|Treatment failure|0|||
125293573|NCT01075984|450702166|FG004|Follow-up Phase|Treatment failure|4|||
125293574|NCT02198235|450702168|FG000|Overall Study|Lost to Follow-up|3|||
125293575|NCT02198235|450702169|FG001|Overall Study|Lost to Follow-up|2|||
125293576|NCT02198235|450702170|FG002|Overall Study|Lost to Follow-up|2|||
125293577|NCT02440789|450702174|FG000|Overall Study|Withdrawal by Subject|3|||
125293578|NCT02440789|450702174|FG000|Overall Study|Not willing to adhere to reqs|1|||
125293579|NCT04573881|450702176|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
125293580|NCT02564978|450702179|FG000|Overall Study|Adverse Event|8|||
125293581|NCT02564978|450702179|FG000|Overall Study|Death|1|||
125293582|NCT02564978|450702179|FG000|Overall Study|Lost to Follow-up|1|||
125293583|NCT02564978|450702179|FG000|Overall Study|Withdrawal by Subject|15|||
125293584|NCT02564978|450702179|FG000|Overall Study|Early Study Closure|2|||
125293585|NCT02564978|450702179|FG000|Overall Study|Other Reason|5|||
125293586|NCT03684694|450702180|FG000|Phase 1|Withdrawal by Subject|1|||
125293587|NCT03684694|450702181|FG001|Phase 1|Withdrawal by Subject|0|||
125293588|NCT03684694|450702182|FG002|Phase 1|Withdrawal by Subject|0|||
125293589|NCT03684694|450702183|FG003|Phase 1|Withdrawal by Subject|0|||
125293590|NCT03684694|450702184|FG004|Phase 1|Withdrawal by Subject|0|||
125293591|NCT03684694|450702185|FG005|Phase 1|Withdrawal by Subject|0|||
125293592|NCT03684694|450702180|FG000|Phase 1|Investigator/Sponsor Decision|12|||
125293593|NCT03684694|450702181|FG001|Phase 1|Investigator/Sponsor Decision|2|||
125293594|NCT03684694|450702182|FG002|Phase 1|Investigator/Sponsor Decision|1|||
125293595|NCT03684694|450702183|FG003|Phase 1|Investigator/Sponsor Decision|0|||
125293596|NCT03684694|450702184|FG004|Phase 1|Investigator/Sponsor Decision|0|||
125293597|NCT03684694|450702185|FG005|Phase 1|Investigator/Sponsor Decision|0|||
125293598|NCT03684694|450702180|FG000|Phase 1|Death|24|||
125293599|NCT03684694|450702181|FG001|Phase 1|Death|0|||
125293600|NCT03684694|450702182|FG002|Phase 1|Death|3|||
125293601|NCT03684694|450702183|FG003|Phase 1|Death|0|||
125293602|NCT03684694|450702184|FG004|Phase 1|Death|0|||
125293603|NCT03684694|450702185|FG005|Phase 1|Death|0|||
125293604|NCT03684694|450702180|FG000|Phase 1|Lost to Follow-up|0|||
125293605|NCT03684694|450702181|FG001|Phase 1|Lost to Follow-up|0|||
125293606|NCT03684694|450702182|FG002|Phase 1|Lost to Follow-up|1|||
125293607|NCT03684694|450702183|FG003|Phase 1|Lost to Follow-up|0|||
125293608|NCT03684694|450702184|FG004|Phase 1|Lost to Follow-up|0|||
125293609|NCT03684694|450702185|FG005|Phase 1|Lost to Follow-up|0|||
125293610|NCT03684694|450702180|FG000|Phase 1|Miscellaneous|0|||
125293611|NCT03684694|450702181|FG001|Phase 1|Miscellaneous|1|||
125293612|NCT03684694|450702182|FG002|Phase 1|Miscellaneous|0|||
125293613|NCT03684694|450702183|FG003|Phase 1|Miscellaneous|0|||
125293614|NCT03684694|450702184|FG004|Phase 1|Miscellaneous|0|||
125293615|NCT03684694|450702185|FG005|Phase 1|Miscellaneous|0|||
125293616|NCT03684694|450702180|FG000|Phase 2|Withdrawal by Subject|0|||
125293617|NCT03684694|450702181|FG001|Phase 2|Withdrawal by Subject|0|||
125293618|NCT03684694|450702182|FG002|Phase 2|Withdrawal by Subject|0|||
125293619|NCT03684694|450702183|FG003|Phase 2|Withdrawal by Subject|0|||
124788704|NCT03085914|448855920|FG001|Overall Study|Lost to Follow-up|0|||
124788705|NCT03085914|448855921|FG002|Overall Study|Lost to Follow-up|1|||
124788706|NCT03085914|448855922|FG003|Overall Study|Lost to Follow-up|0|||
124788707|NCT03085914|448855923|FG004|Overall Study|Lost to Follow-up|0|||
124788708|NCT03085914|448855924|FG005|Overall Study|Lost to Follow-up|1|||
124788709|NCT03085914|448855925|FG006|Overall Study|Lost to Follow-up|1|||
124788710|NCT03085914|448855919|FG000|Overall Study|Reason was not specified,|2|||
124788711|NCT03085914|448855920|FG001|Overall Study|Reason was not specified,|2|||
124788712|NCT03085914|448855921|FG002|Overall Study|Reason was not specified,|2|||
124788713|NCT03085914|448855922|FG003|Overall Study|Reason was not specified,|3|||
124788714|NCT03085914|448855923|FG004|Overall Study|Reason was not specified,|3|||
125293620|NCT03684694|450702184|FG004|Phase 2|Withdrawal by Subject|0|||
125293621|NCT03684694|450702185|FG005|Phase 2|Withdrawal by Subject|1|||
125293622|NCT03684694|450702180|FG000|Phase 2|Investigator/Sponsor Decision|0|||
125293623|NCT03684694|450702181|FG001|Phase 2|Investigator/Sponsor Decision|0|||
125293624|NCT03684694|450702182|FG002|Phase 2|Investigator/Sponsor Decision|0|||
125293625|NCT03684694|450702183|FG003|Phase 2|Investigator/Sponsor Decision|17|||
125293626|NCT03684694|450702184|FG004|Phase 2|Investigator/Sponsor Decision|16|||
125293627|NCT03684694|450702185|FG005|Phase 2|Investigator/Sponsor Decision|6|||
125293628|NCT03684694|450702180|FG000|Phase 2|Death|0|||
124788715|NCT03085914|448855924|FG005|Overall Study|Reason was not specified,|3|||
124788716|NCT03085914|448855925|FG006|Overall Study|Reason was not specified,|6|||
125293629|NCT03684694|450702181|FG001|Phase 2|Death|0|||
125293630|NCT03684694|450702182|FG002|Phase 2|Death|0|||
125293631|NCT03684694|450702183|FG003|Phase 2|Death|28|||
124788717|NCT03085914|448855919|FG000|Overall Study|Progressive Disease|0|||
125293632|NCT03684694|450702184|FG004|Phase 2|Death|14|||
125293633|NCT03684694|450702185|FG005|Phase 2|Death|3|||
125293634|NCT03684694|450702180|FG000|Phase 2|Lost to Follow-up|0|||
125293635|NCT03684694|450702181|FG001|Phase 2|Lost to Follow-up|0|||
125293636|NCT03684694|450702182|FG002|Phase 2|Lost to Follow-up|0|||
125293637|NCT03684694|450702183|FG003|Phase 2|Lost to Follow-up|1|||
125293638|NCT03684694|450702184|FG004|Phase 2|Lost to Follow-up|0|||
125293639|NCT03684694|450702185|FG005|Phase 2|Lost to Follow-up|0|||
125293640|NCT03684694|450702180|FG000|Phase 2|Miscellaneous|0|||
124788718|NCT03085914|448855920|FG001|Overall Study|Progressive Disease|0|||
124788719|NCT03085914|448855921|FG002|Overall Study|Progressive Disease|2|||
124788720|NCT03085914|448855922|FG003|Overall Study|Progressive Disease|2|||
124788721|NCT03085914|448855923|FG004|Overall Study|Progressive Disease|1|||
124788722|NCT03085914|448855924|FG005|Overall Study|Progressive Disease|1|||
124788723|NCT03085914|448855925|FG006|Overall Study|Progressive Disease|1|||
124788724|NCT03085914|448855919|FG000|Overall Study|Study Terminated by the Sponsor|0|||
124788725|NCT03085914|448855920|FG001|Overall Study|Study Terminated by the Sponsor|0|||
124788726|NCT03085914|448855921|FG002|Overall Study|Study Terminated by the Sponsor|0|||
124788727|NCT03085914|448855922|FG003|Overall Study|Study Terminated by the Sponsor|1|||
124788728|NCT03085914|448855923|FG004|Overall Study|Study Terminated by the Sponsor|2|||
124788729|NCT03085914|448855924|FG005|Overall Study|Study Terminated by the Sponsor|1|||
124788730|NCT03085914|448855925|FG006|Overall Study|Study Terminated by the Sponsor|0|||
124788731|NCT04644315|448855926|FG000|Overall Study|Subject withdrawal of consent|1|||
124788732|NCT05315908|448855927|FG000|Overall Study|Lost to Follow-up|4477|||
124788733|NCT05315908|448855928|FG001|Overall Study|Lost to Follow-up|4606|||
124788734|NCT01445548|448855929|FG000|Overall Study|Adverse Event|1|||
124788735|NCT03642132|448855931|FG000|Chemotherapy Period|Adverse Event|1|||
124788736|NCT03642132|448855932|FG001|Chemotherapy Period|Adverse Event|1|||
124788737|NCT03642132|448855933|FG002|Chemotherapy Period|Adverse Event|0|||
124788738|NCT03642132|448855931|FG000|Chemotherapy Period|Physician's decision|4|||
124788739|NCT03642132|448855932|FG001|Chemotherapy Period|Physician's decision|1|||
124788740|NCT03642132|448855933|FG002|Chemotherapy Period|Physician's decision|0|||
124788741|NCT03642132|448855931|FG000|Chemotherapy Period|Progressive disease|0|||
124788742|NCT03642132|448855932|FG001|Chemotherapy Period|Progressive disease|0|||
124788743|NCT03642132|448855933|FG002|Chemotherapy Period|Progressive disease|1|||
124788744|NCT03642132|448855931|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
124788745|NCT03642132|448855932|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
124788746|NCT03642132|448855933|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
124788747|NCT03642132|448855931|FG000|Chemotherapy Period|Other|1|||
124788748|NCT03642132|448855932|FG001|Chemotherapy Period|Other|0|||
124788749|NCT03642132|448855933|FG002|Chemotherapy Period|Other|2|||
125293641|NCT03684694|450702181|FG001|Phase 2|Miscellaneous|0|||
125293642|NCT03684694|450702182|FG002|Phase 2|Miscellaneous|0|||
125293643|NCT03684694|450702183|FG003|Phase 2|Miscellaneous|3|||
125293644|NCT03684694|450702184|FG004|Phase 2|Miscellaneous|0|||
125293645|NCT03684694|450702185|FG005|Phase 2|Miscellaneous|0|||
125293646|NCT01825941|450703702|FG000|Overall Study|Lost to Follow-up|4|||
125293647|NCT01825941|450703703|FG001|Overall Study|Lost to Follow-up|1|||
125293648|NCT00528996|450703704|FG000|Overall Study|Other reasons than listing|6|||
125293649|NCT00528996|450703705|FG001|Overall Study|Other reasons than listing|7|||
125293650|NCT00528996|450703706|FG002|Overall Study|Other reasons than listing|14|||
125293651|NCT00528996|450703707|FG003|Overall Study|Other reasons than listing|11|||
125293652|NCT00528996|450703708|FG004|Overall Study|Other reasons than listing|5|||
125293653|NCT00528996|450703704|FG000|Overall Study|Refused continue medication|16|||
125293654|NCT00528996|450703705|FG001|Overall Study|Refused continue medication|0|||
125293655|NCT00528996|450703706|FG002|Overall Study|Refused continue medication|3|||
125293656|NCT00528996|450703707|FG003|Overall Study|Refused continue medication|3|||
125293657|NCT00528996|450703708|FG004|Overall Study|Refused continue medication|6|||
125293658|NCT00528996|450703704|FG000|Overall Study|Lost to Follow-up|2|||
125293659|NCT00528996|450703705|FG001|Overall Study|Lost to Follow-up|0|||
125293660|NCT00528996|450703706|FG002|Overall Study|Lost to Follow-up|4|||
125293661|NCT00528996|450703707|FG003|Overall Study|Lost to Follow-up|1|||
125293662|NCT00528996|450703708|FG004|Overall Study|Lost to Follow-up|3|||
125293663|NCT00528996|450703704|FG000|Overall Study|Protocol Violation|1|||
125293664|NCT00528996|450703705|FG001|Overall Study|Protocol Violation|2|||
125293665|NCT00528996|450703706|FG002|Overall Study|Protocol Violation|3|||
125293666|NCT00528996|450703707|FG003|Overall Study|Protocol Violation|3|||
125293667|NCT00528996|450703708|FG004|Overall Study|Protocol Violation|2|||
124788750|NCT03642132|448855931|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
124788751|NCT03642132|448855932|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
124788752|NCT03642132|448855933|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
125293668|NCT00528996|450703704|FG000|Overall Study|Lack of Efficacy|7|||
125293669|NCT00528996|450703705|FG001|Overall Study|Lack of Efficacy|2|||
125293670|NCT00528996|450703706|FG002|Overall Study|Lack of Efficacy|1|||
125293671|NCT00528996|450703707|FG003|Overall Study|Lack of Efficacy|3|||
125293672|NCT00528996|450703708|FG004|Overall Study|Lack of Efficacy|3|||
125293673|NCT00528996|450703704|FG000|Overall Study|Adverse Event|32|||
125293674|NCT00528996|450703705|FG001|Overall Study|Adverse Event|13|||
124788753|NCT03642132|448855931|FG000|Maintenance Period|Adverse Event|1|||
124788754|NCT03642132|448855932|FG001|Maintenance Period|Adverse Event|2|||
125293675|NCT00528996|450703706|FG002|Overall Study|Adverse Event|18|||
124788755|NCT03642132|448855933|FG002|Maintenance Period|Adverse Event|0|||
124788756|NCT03642132|448855931|FG000|Maintenance Period|Non-compliance with study drug|0|||
124788757|NCT03642132|448855932|FG001|Maintenance Period|Non-compliance with study drug|0|||
125293676|NCT00528996|450703707|FG003|Overall Study|Adverse Event|29|||
125293677|NCT00528996|450703708|FG004|Overall Study|Adverse Event|18|||
125293678|NCT05565937|450703715|FG000|Overall Study|Adverse Event|0|||
125293679|NCT05565937|450703716|FG001|Overall Study|Adverse Event|1|||
125293680|NCT05565937|450703715|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
125293681|NCT05565937|450703716|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
125293682|NCT05565937|450703715|FG000|Overall Study|Lost to Follow-up|2|||
125293683|NCT05565937|450703716|FG001|Overall Study|Lost to Follow-up|0|||
125293684|NCT05565937|450703715|FG000|Overall Study|Pregnancy|0|||
125293685|NCT05565937|450703716|FG001|Overall Study|Pregnancy|2|||
125293686|NCT05565937|450703715|FG000|Overall Study|Anisometropia|0|||
125293687|NCT05565937|450703716|FG001|Overall Study|Anisometropia|1|||
125293688|NCT01022424|450703717|FG000|Overall Study|Adverse Event|1|||
125293689|NCT01022424|450703717|FG000|Overall Study|Physician Decision|1|||
125293690|NCT01022424|450703717|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
125293691|NCT01806064|450703722|FG000|Overall Study|Randomized Not Enrolled|0|||
125293692|NCT01806064|450703723|FG001|Overall Study|Randomized Not Enrolled|0|||
125293693|NCT01806064|450703724|FG002|Overall Study|Randomized Not Enrolled|0|||
125293694|NCT01806064|450703725|FG003|Overall Study|Randomized Not Enrolled|1|||
125293695|NCT01806064|450703726|FG004|Overall Study|Randomized Not Enrolled|2|||
125293696|NCT05160766|450703731|FG000|Overall Study|Adverse Event|0|||
125293697|NCT05160766|450703732|FG001|Overall Study|Adverse Event|1|||
125293698|NCT05160766|450703733|FG002|Overall Study|Adverse Event|0|||
125293699|NCT05160766|450703734|FG003|Overall Study|Adverse Event|0|||
125293700|NCT05160766|450703731|FG000|Overall Study|COVID-19 infection|0|||
125293701|NCT05160766|450703732|FG001|Overall Study|COVID-19 infection|1|||
125293702|NCT05160766|450703733|FG002|Overall Study|COVID-19 infection|0|||
125293703|NCT05160766|450703734|FG003|Overall Study|COVID-19 infection|0|||
125293704|NCT05160766|450703731|FG000|Overall Study|travel time|1|||
125293705|NCT05160766|450703732|FG001|Overall Study|travel time|0|||
124788758|NCT03642132|448855933|FG002|Maintenance Period|Non-compliance with study drug|1|||
124788759|NCT03642132|448855931|FG000|Maintenance Period|Physician's decision|2|||
124788760|NCT03642132|448855932|FG001|Maintenance Period|Physician's decision|2|||
124788761|NCT03642132|448855933|FG002|Maintenance Period|Physician's decision|2|||
124788762|NCT03642132|448855931|FG000|Maintenance Period|Progressive disease|9|||
124788763|NCT03642132|448855932|FG001|Maintenance Period|Progressive disease|3|||
124788764|NCT03642132|448855933|FG002|Maintenance Period|Progressive disease|6|||
124788765|NCT03642132|448855931|FG000|Maintenance Period|Other|0|||
124788766|NCT03642132|448855932|FG001|Maintenance Period|Other|0|||
124788767|NCT03642132|448855933|FG002|Maintenance Period|Other|3|||
124788768|NCT03642132|448855931|FG000|Maintenance Period|Withdrawal by Subject|1|||
124788769|NCT03642132|448855932|FG001|Maintenance Period|Withdrawal by Subject|1|||
124788770|NCT03642132|448855933|FG002|Maintenance Period|Withdrawal by Subject|2|||
125293706|NCT05160766|450703733|FG002|Overall Study|travel time|0|||
125293707|NCT05160766|450703734|FG003|Overall Study|travel time|1|||
125293708|NCT05160766|450703731|FG000|Overall Study|Withdrawal by Subject|3|||
125293709|NCT05160766|450703732|FG001|Overall Study|Withdrawal by Subject|5|||
125293710|NCT05160766|450703733|FG002|Overall Study|Withdrawal by Subject|4|||
125293711|NCT05160766|450703734|FG003|Overall Study|Withdrawal by Subject|2|||
125293712|NCT05160766|450703731|FG000|Overall Study|Death|0|||
125293713|NCT05160766|450703732|FG001|Overall Study|Death|0|||
125293714|NCT05160766|450703733|FG002|Overall Study|Death|2|||
125293715|NCT05160766|450703734|FG003|Overall Study|Death|5|||
125293716|NCT05160766|450703731|FG000|Overall Study|Lost to Follow-up|0|||
125293717|NCT05160766|450703732|FG001|Overall Study|Lost to Follow-up|0|||
125293718|NCT05160766|450703733|FG002|Overall Study|Lost to Follow-up|1|||
125293719|NCT05160766|450703734|FG003|Overall Study|Lost to Follow-up|2|||
125293720|NCT05160766|450703731|FG000|Overall Study|No show|0|||
125293721|NCT05160766|450703732|FG001|Overall Study|No show|0|||
125293722|NCT05160766|450703733|FG002|Overall Study|No show|1|||
125293723|NCT05160766|450703734|FG003|Overall Study|No show|1|||
124788771|NCT03642132|448855931|FG000|Follow-up Period|Other|0|||
125293724|NCT05160766|450703731|FG000|Overall Study|Physician Decision|0|||
125293725|NCT05160766|450703732|FG001|Overall Study|Physician Decision|0|||
125293726|NCT05160766|450703733|FG002|Overall Study|Physician Decision|0|||
125293727|NCT05160766|450703734|FG003|Overall Study|Physician Decision|1|||
125293728|NCT05160766|450703731|FG000|Overall Study|Protocol Violation|0|||
125293729|NCT05160766|450703732|FG001|Overall Study|Protocol Violation|0|||
125293730|NCT05160766|450703733|FG002|Overall Study|Protocol Violation|1|||
125293731|NCT05160766|450703734|FG003|Overall Study|Protocol Violation|0|||
125293732|NCT01282294|450703735|FG000|Overall Study|Lost to Follow-up|14|||
125293733|NCT01282294|450703735|FG000|Overall Study|Screening failure|1|||
125293734|NCT01282294|450703735|FG000|Overall Study|Adverse Event|1|||
124788772|NCT03642132|448855932|FG001|Follow-up Period|Other|0|||
125293735|NCT01282294|450703735|FG000|Overall Study|Patient non-compliance|2|||
125293736|NCT01282294|450703735|FG000|Overall Study|Physician Decision|1|||
125293737|NCT00004445|450703737|FG000|Overall Study|Physician Decision|2|||
124788773|NCT03642132|448855933|FG002|Follow-up Period|Other|1|||
124788774|NCT03642132|448855931|FG000|Follow-up Period|Withdrawal by Subject|1|||
125293738|NCT00004445|450703737|FG000|Overall Study|Withdrawal by Subject|1|||
125293739|NCT04692077|450703738|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
125293740|NCT02753127|450703745|FG000|Overall Study|Lost to Follow-up|13|||
125293741|NCT02753127|450703746|FG001|Overall Study|Lost to Follow-up|11|||
125293742|NCT02753127|450703745|FG000|Overall Study|Withdrawal by Subject|37|||
125293743|NCT02753127|450703746|FG001|Overall Study|Withdrawal by Subject|47|||
125293744|NCT02753127|450703745|FG000|Overall Study|Other|3|||
125293745|NCT02753127|450703746|FG001|Overall Study|Other|8|||
125293746|NCT02753127|450703745|FG000|Overall Study|Hospice|0|||
125293747|NCT02753127|450703746|FG001|Overall Study|Hospice|2|||
125293748|NCT03826342|450703747|FG000|Overall Study|Withdrawal by Subject|8|||
125293749|NCT03826342|450703748|FG001|Overall Study|Withdrawal by Subject|1|||
125293750|NCT03826342|450703747|FG000|Overall Study|Lost to Follow-up|7|||
125293751|NCT03826342|450703748|FG001|Overall Study|Lost to Follow-up|7|||
125293752|NCT03826342|450703747|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
125293753|NCT03826342|450703748|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
125293754|NCT01657760|450703751|FG000|Overall Study|Withdrawal by Subject|0|||
125293755|NCT01657760|450703752|FG001|Overall Study|Withdrawal by Subject|0|||
125293756|NCT01657760|450703753|FG002|Overall Study|Withdrawal by Subject|0|||
125293757|NCT01657760|450703754|FG003|Overall Study|Withdrawal by Subject|1|||
125293758|NCT01657760|450703751|FG000|Overall Study|Physician Decision|1|||
125293759|NCT01657760|450703752|FG001|Overall Study|Physician Decision|1|||
125293760|NCT01657760|450703753|FG002|Overall Study|Physician Decision|1|||
125293761|NCT01657760|450703754|FG003|Overall Study|Physician Decision|2|||
125293762|NCT06250738|450703762|FG000|Overall Study|Lost to Follow-up|1|||
125293763|NCT01818284|450703766|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
125293764|NCT01818284|450703767|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
125293765|NCT01818284|450703766|FG000|Overall Study|Death|0|||
125293766|NCT01818284|450703767|FG001|Overall Study|Death|2|||
125293767|NCT03681678|450703768|FG000|Overall Study|Lost to Follow-up|20|||
125293768|NCT01068249|450703769|FG000|Overall Study|Death|1|||
125293769|NCT01068249|450703769|FG000|Overall Study|Withdrawal by Subject|3|||
125293770|NCT04030962|450703771|FG000|Stage 2|Adverse Event|0|||
125293771|NCT04030962|450703772|FG001|Stage 2|Adverse Event|0|||
125293772|NCT04030962|450703773|FG002|Stage 2|Adverse Event|0|||
125293773|NCT04030962|450703774|FG003|Stage 2|Adverse Event|0|||
125293774|NCT04030962|450703775|FG004|Stage 2|Adverse Event|0|||
125293775|NCT04030962|450703776|FG005|Stage 2|Adverse Event|0|||
125293776|NCT04030962|450703777|FG006|Stage 2|Adverse Event|0|||
125293777|NCT04030962|450703778|FG007|Stage 2|Adverse Event|0|||
125293778|NCT04030962|450703779|FG008|Stage 2|Adverse Event|1|||
125293779|NCT04030962|450703780|FG009|Stage 2|Adverse Event|0|||
125293780|NCT04030962|450703781|FG010|Stage 2|Adverse Event|1|||
125293781|NCT04030962|450703782|FG011|Stage 2|Adverse Event|1|||
125293782|NCT04030962|450703783|FG012|Stage 2|Adverse Event|1|||
125293783|NCT04030962|450703771|FG000|Stage 2|Withdrawal by Subject|0|||
125293784|NCT04030962|450703772|FG001|Stage 2|Withdrawal by Subject|0|||
125293785|NCT04030962|450703773|FG002|Stage 2|Withdrawal by Subject|0|||
125293786|NCT04030962|450703774|FG003|Stage 2|Withdrawal by Subject|0|||
125293787|NCT04030962|450703775|FG004|Stage 2|Withdrawal by Subject|0|||
125293788|NCT04030962|450703776|FG005|Stage 2|Withdrawal by Subject|0|||
125293789|NCT04030962|450703777|FG006|Stage 2|Withdrawal by Subject|0|||
125293790|NCT04030962|450703778|FG007|Stage 2|Withdrawal by Subject|0|||
125293791|NCT04030962|450703779|FG008|Stage 2|Withdrawal by Subject|1|||
125293792|NCT04030962|450703780|FG009|Stage 2|Withdrawal by Subject|0|||
125293793|NCT04030962|450703781|FG010|Stage 2|Withdrawal by Subject|0|||
125293794|NCT04030962|450703782|FG011|Stage 2|Withdrawal by Subject|2|||
125293795|NCT04030962|450703783|FG012|Stage 2|Withdrawal by Subject|1|||
125293796|NCT04030962|450703771|FG000|Stage 2|Lost to Follow-up|0|||
125293797|NCT04030962|450703772|FG001|Stage 2|Lost to Follow-up|0|||
125293798|NCT04030962|450703773|FG002|Stage 2|Lost to Follow-up|0|||
125293799|NCT04030962|450703774|FG003|Stage 2|Lost to Follow-up|0|||
125293800|NCT04030962|450703775|FG004|Stage 2|Lost to Follow-up|0|||
125293801|NCT04030962|450703776|FG005|Stage 2|Lost to Follow-up|0|||
125293802|NCT04030962|450703777|FG006|Stage 2|Lost to Follow-up|0|||
125293803|NCT04030962|450703778|FG007|Stage 2|Lost to Follow-up|0|||
125293804|NCT04030962|450703779|FG008|Stage 2|Lost to Follow-up|1|||
125293805|NCT04030962|450703780|FG009|Stage 2|Lost to Follow-up|0|||
125293806|NCT04030962|450703781|FG010|Stage 2|Lost to Follow-up|0|||
125293807|NCT04030962|450703782|FG011|Stage 2|Lost to Follow-up|0|||
125293808|NCT04030962|450703783|FG012|Stage 2|Lost to Follow-up|0|||
125293809|NCT04030962|450703771|FG000|Stage 2|Technical Problems|0|||
125293810|NCT04030962|450703772|FG001|Stage 2|Technical Problems|0|||
125293811|NCT04030962|450703773|FG002|Stage 2|Technical Problems|0|||
125293812|NCT04030962|450703774|FG003|Stage 2|Technical Problems|0|||
125293813|NCT04030962|450703775|FG004|Stage 2|Technical Problems|0|||
125293814|NCT04030962|450703776|FG005|Stage 2|Technical Problems|0|||
125293815|NCT04030962|450703777|FG006|Stage 2|Technical Problems|0|||
125293816|NCT04030962|450703778|FG007|Stage 2|Technical Problems|0|||
125293817|NCT04030962|450703779|FG008|Stage 2|Technical Problems|0|||
125293818|NCT04030962|450703780|FG009|Stage 2|Technical Problems|0|||
125293819|NCT04030962|450703781|FG010|Stage 2|Technical Problems|0|||
125293820|NCT04030962|450703782|FG011|Stage 2|Technical Problems|1|||
125293821|NCT04030962|450703783|FG012|Stage 2|Technical Problems|0|||
125293822|NCT05288166|450703784|FG000|Overall Study|Adverse Event|1|||
125293823|NCT05288166|450703785|FG001|Overall Study|Adverse Event|0|||
125293824|NCT05288166|450703784|FG000|Overall Study|Lost to Follow-up|2|||
125293825|NCT05288166|450703785|FG001|Overall Study|Lost to Follow-up|0|||
125293826|NCT05288166|450703784|FG000|Overall Study|Physician Decision|0|||
125293827|NCT05288166|450703785|FG001|Overall Study|Physician Decision|2|||
125293828|NCT05288166|450703784|FG000|Overall Study|Screen Failure|1|||
125293829|NCT05288166|450703785|FG001|Overall Study|Screen Failure|1|||
125293830|NCT05288166|450703784|FG000|Overall Study|Withdrawal by Subject|4|||
125293831|NCT05288166|450703785|FG001|Overall Study|Withdrawal by Subject|2|||
125293832|NCT05288166|450703784|FG000|Overall Study|On Study Treatment|408|||
125293833|NCT05288166|450703785|FG001|Overall Study|On Study Treatment|418|||
125293834|NCT01114360|450703786|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
125293835|NCT01114360|450703787|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
125293836|NCT03007745|450703788|FG000|Overall Study|Sleep test negative for OSA|53|||
125293837|NCT03007745|450703789|FG001|Overall Study|Sleep test negative for OSA|49|||
125293838|NCT03007745|450703788|FG000|Overall Study|Physician Decision|6|||
125293839|NCT03007745|450703789|FG001|Overall Study|Physician Decision|9|||
125293840|NCT03007745|450703788|FG000|Overall Study|Withdrawal by Subject|38|||
125293841|NCT03007745|450703789|FG001|Overall Study|Withdrawal by Subject|16|||
125293842|NCT03007745|450703788|FG000|Overall Study|Lost to Follow-up|19|||
125293843|NCT03007745|450703789|FG001|Overall Study|Lost to Follow-up|25|||
125293844|NCT03007745|450703788|FG000|Overall Study|Unable to login to website|17|||
125293845|NCT03007745|450703789|FG001|Overall Study|Unable to login to website|4|||
125293846|NCT01146288|450703791|FG000|First Intervention(1 Day)|Adverse Event|0|||
125293847|NCT01146288|450703792|FG001|First Intervention(1 Day)|Adverse Event|1|||
125293848|NCT00385723|450703793|FG000|Overall Study|Lost to Follow-up|1|||
125293849|NCT00385723|450703794|FG001|Overall Study|Lost to Follow-up|1|||
125293850|NCT00385723|450703795|FG002|Overall Study|Lost to Follow-up|0|||
125293851|NCT00385723|450703793|FG000|Overall Study|Withdrawal by Subject|1|||
125293852|NCT00385723|450703794|FG001|Overall Study|Withdrawal by Subject|0|||
125293853|NCT00385723|450703795|FG002|Overall Study|Withdrawal by Subject|2|||
125293854|NCT03455829|450703796|FG000|Overall Study|Death|2|||
125293855|NCT03455829|450703797|FG001|Overall Study|Death|3|||
125293856|NCT03455829|450703798|FG002|Overall Study|Death|2|||
125293857|NCT03455829|450703799|FG003|Overall Study|Death|4|||
125293858|NCT03455829|450703800|FG004|Overall Study|Death|2|||
125293859|NCT03455829|450703796|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
125293860|NCT03455829|450703797|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
125293861|NCT03455829|450703798|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
125293862|NCT03455829|450703799|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
125293863|NCT03455829|450703800|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
125293864|NCT03455829|450703796|FG000|Overall Study|Disease progression|0|||
125293865|NCT03455829|450703797|FG001|Overall Study|Disease progression|0|||
125293866|NCT03455829|450703798|FG002|Overall Study|Disease progression|0|||
125293867|NCT03455829|450703799|FG003|Overall Study|Disease progression|1|||
125293868|NCT03455829|450703800|FG004|Overall Study|Disease progression|1|||
125293869|NCT05824936|450703802|FG000|Overall Study|Lost to Follow-up|1|||
125293870|NCT03689712|450703803|FG000|Overall Study|Adverse Event|1|||
125293871|NCT03689712|450703804|FG001|Overall Study|Adverse Event|0|||
125293872|NCT03689712|450703803|FG000|Overall Study|Death|20|||
125293873|NCT03689712|450703804|FG001|Overall Study|Death|10|||
125293874|NCT03689712|450703803|FG000|Overall Study|Lost to Follow-up|6|||
125293875|NCT03689712|450703804|FG001|Overall Study|Lost to Follow-up|6|||
125293876|NCT03689712|450703803|FG000|Overall Study|Other|1|||
125293877|NCT03689712|450703804|FG001|Overall Study|Other|0|||
125293878|NCT03689712|450703803|FG000|Overall Study|Patient Non-Compliance|0|||
125293879|NCT03689712|450703804|FG001|Overall Study|Patient Non-Compliance|1|||
125293880|NCT03689712|450703803|FG000|Overall Study|Withdrawal by Subject|20|||
125293881|NCT03689712|450703804|FG001|Overall Study|Withdrawal by Subject|4|||
125293882|NCT03689712|450703803|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
125293883|NCT03689712|450703804|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
125293884|NCT03689712|450703803|FG000|Overall Study|Randomized but not Treated|13|||
125293885|NCT03689712|450703804|FG001|Overall Study|Randomized but not Treated|7|||
125293886|NCT03689712|450703803|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
125293887|NCT03689712|450703804|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
124788775|NCT03642132|448855932|FG001|Follow-up Period|Withdrawal by Subject|2|||
124788776|NCT03642132|448855933|FG002|Follow-up Period|Withdrawal by Subject|0|||
124788777|NCT03642132|448855931|FG000|Follow-up Period|Study terminated by sponsor|1|||
125293888|NCT01533922|450703808|FG000|Overall Study|Adverse Event|5|||
125293889|NCT01533922|450703809|FG001|Overall Study|Adverse Event|8|||
124788778|NCT03642132|448855932|FG001|Follow-up Period|Study terminated by sponsor|0|||
125293890|NCT01533922|450703810|FG002|Overall Study|Adverse Event|6|||
125293891|NCT01533922|450703811|FG003|Overall Study|Adverse Event|3|||
125293892|NCT01533922|450703812|FG004|Overall Study|Adverse Event|4|||
125293893|NCT01533922|450703808|FG000|Overall Study|Lack of Efficacy|0|||
125293894|NCT01533922|450703809|FG001|Overall Study|Lack of Efficacy|0|||
125293895|NCT01533922|450703810|FG002|Overall Study|Lack of Efficacy|1|||
125293896|NCT01533922|450703811|FG003|Overall Study|Lack of Efficacy|0|||
125293897|NCT01533922|450703812|FG004|Overall Study|Lack of Efficacy|0|||
125293898|NCT01533922|450703808|FG000|Overall Study|Protocol Violation|0|||
125293899|NCT01533922|450703809|FG001|Overall Study|Protocol Violation|3|||
125293900|NCT01533922|450703810|FG002|Overall Study|Protocol Violation|0|||
125293901|NCT01533922|450703811|FG003|Overall Study|Protocol Violation|0|||
125293902|NCT01533922|450703812|FG004|Overall Study|Protocol Violation|1|||
125293903|NCT01533922|450703808|FG000|Overall Study|Withdrawal by Subject|3|||
125293904|NCT01533922|450703809|FG001|Overall Study|Withdrawal by Subject|1|||
125293905|NCT01533922|450703810|FG002|Overall Study|Withdrawal by Subject|2|||
125293906|NCT01533922|450703811|FG003|Overall Study|Withdrawal by Subject|2|||
125293907|NCT01533922|450703812|FG004|Overall Study|Withdrawal by Subject|1|||
125293908|NCT01533922|450703808|FG000|Overall Study|Other reason not defined above|2|||
125293909|NCT01533922|450703809|FG001|Overall Study|Other reason not defined above|0|||
125293910|NCT01533922|450703810|FG002|Overall Study|Other reason not defined above|1|||
125293911|NCT01533922|450703811|FG003|Overall Study|Other reason not defined above|0|||
125293912|NCT01533922|450703812|FG004|Overall Study|Other reason not defined above|0|||
125293913|NCT02634606|450703813|FG000|Overall Study|unable to obtain the drug at start|13|||
125293914|NCT00286221|450703814|FG000|Overall Study|Protocol Violation|2|||
125293915|NCT00286221|450703815|FG001|Overall Study|Protocol Violation|1|||
125293916|NCT00286221|450703816|FG002|Overall Study|Protocol Violation|6|||
125293917|NCT00286221|450703817|FG003|Overall Study|Protocol Violation|4|||
125293918|NCT00286221|450703814|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
125293919|NCT00286221|450703815|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
125293920|NCT00286221|450703816|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
125293921|NCT00286221|450703817|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
125293922|NCT00286221|450703814|FG000|Overall Study|Inability to trigger PCA|2|||
125293923|NCT00286221|450703815|FG001|Overall Study|Inability to trigger PCA|0|||
125293924|NCT00286221|450703816|FG002|Overall Study|Inability to trigger PCA|0|||
125293925|NCT00286221|450703817|FG003|Overall Study|Inability to trigger PCA|0|||
125293926|NCT00286221|450703814|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
125293927|NCT00286221|450703815|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
125293928|NCT00286221|450703816|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
125293929|NCT00286221|450703817|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
125293930|NCT02276547|450703819|FG000|Overall Study|Death|2|||
125293931|NCT02276547|450703819|FG000|Overall Study|Explant|2|||
125293932|NCT01754194|450703820|FG000|Overall Study|Lost to Follow-up|39|||
125293933|NCT01754194|450703821|FG001|Overall Study|Lost to Follow-up|14|||
125293934|NCT01754194|450703820|FG000|Overall Study|Withdrawal by Subject|4|||
125293935|NCT01754194|450703821|FG001|Overall Study|Withdrawal by Subject|5|||
125293936|NCT01754194|450703820|FG000|Overall Study|Other|9|||
125293937|NCT01754194|450703821|FG001|Overall Study|Other|8|||
125293938|NCT03344640|450703823|FG000|Overall Study|Adverse Event|1|||
125293939|NCT03344640|450703824|FG001|Overall Study|Adverse Event|0|||
125293940|NCT03344640|450703823|FG000|Overall Study|Physician Decision|1|||
125293941|NCT03344640|450703824|FG001|Overall Study|Physician Decision|1|||
125293942|NCT03344640|450703823|FG000|Overall Study|Withdrawal by Subject|1|||
125293943|NCT03344640|450703824|FG001|Overall Study|Withdrawal by Subject|2|||
125293944|NCT03344640|450703823|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
125293945|NCT03344640|450703824|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
125293946|NCT00815191|450703828|FG000|Overall Study|Protocol Violation|1|||
125293947|NCT00815191|450703829|FG001|Overall Study|Protocol Violation|1|||
125293948|NCT02576860|450703830|FG000|Overall Study|Adverse Event|6|||
125293949|NCT02576860|450703831|FG001|Overall Study|Adverse Event|6|||
125293950|NCT02576860|450703830|FG000|Overall Study|Lost to Follow-up|5|||
125293951|NCT02576860|450703831|FG001|Overall Study|Lost to Follow-up|7|||
125293952|NCT02576860|450703830|FG000|Overall Study|Physician Decision|0|||
125293953|NCT02576860|450703831|FG001|Overall Study|Physician Decision|1|||
125293954|NCT02576860|450703830|FG000|Overall Study|Protocol Violation|0|||
125293955|NCT02576860|450703831|FG001|Overall Study|Protocol Violation|2|||
125293956|NCT02576860|450703830|FG000|Overall Study|Withdrawal by Subject|13|||
125293957|NCT02576860|450703831|FG001|Overall Study|Withdrawal by Subject|8|||
125293958|NCT02576860|450703830|FG000|Overall Study|Disallowed medication|1|||
125293959|NCT02576860|450703831|FG001|Overall Study|Disallowed medication|0|||
125293960|NCT02356887|450703862|FG000|Overall Study|poor compliance|2|||
125293961|NCT00199888|450703863|FG000|Overall Study|Lost to Follow-up|1|||
125293962|NCT02544373|450703869|FG000|Overall Study|Lost to Follow-up|5|||
125293963|NCT02544373|450703870|FG001|Overall Study|Lost to Follow-up|3|||
125293964|NCT02544373|450703869|FG000|Overall Study|Withdrawal by Subject|8|||
125293965|NCT02544373|450703870|FG001|Overall Study|Withdrawal by Subject|2|||
125293966|NCT03172130|450705159|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
125293967|NCT03172130|450705160|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
125293968|NCT02783170|450705162|FG000|Overall Study|Randomized but not Vaccinated|1|||
125293969|NCT02783170|450705163|FG001|Overall Study|Randomized but not Vaccinated|0|||
125293970|NCT02943915|450705164|FG000|Overall Study|Withdrawal by Subject|2|||
125293971|NCT02943915|450705165|FG001|Overall Study|Withdrawal by Subject|1|||
125293972|NCT02943915|450705166|FG002|Overall Study|Withdrawal by Subject|0|||
125293973|NCT02943915|450705167|FG003|Overall Study|Withdrawal by Subject|0|||
125293974|NCT02943915|450705164|FG000|Overall Study|Lost to Follow-up|3|||
125293975|NCT02943915|450705165|FG001|Overall Study|Lost to Follow-up|1|||
125293976|NCT02943915|450705166|FG002|Overall Study|Lost to Follow-up|0|||
125293977|NCT02943915|450705167|FG003|Overall Study|Lost to Follow-up|0|||
125293978|NCT02943915|450705164|FG000|Overall Study|excluded|0|||
124788779|NCT03642132|448855933|FG002|Follow-up Period|Study terminated by sponsor|1|||
124788780|NCT03642132|448855931|FG000|Follow-up Period|Lack of Efficacy|1|||
124788781|NCT03642132|448855932|FG001|Follow-up Period|Lack of Efficacy|0|||
124788782|NCT03642132|448855933|FG002|Follow-up Period|Lack of Efficacy|0|||
124788783|NCT03642132|448855931|FG000|Follow-up Period|Death|1|||
124788784|NCT03642132|448855932|FG001|Follow-up Period|Death|0|||
124788785|NCT03642132|448855933|FG002|Follow-up Period|Death|2|||
124788786|NCT03642132|448855931|FG000|Follow-up Period|Adverse Event|1|||
124788787|NCT03642132|448855932|FG001|Follow-up Period|Adverse Event|0|||
125293979|NCT02943915|450705165|FG001|Overall Study|excluded|1|||
125293980|NCT02943915|450705166|FG002|Overall Study|excluded|0|||
125293981|NCT02943915|450705167|FG003|Overall Study|excluded|0|||
125293982|NCT05601102|450705168|FG000|Overall Study|Death|1|||
125293983|NCT05601102|450705169|FG001|Overall Study|Death|2|||
125293984|NCT05601102|450705168|FG000|Overall Study|Withdrawal by Subject|1|||
125293985|NCT05601102|450705169|FG001|Overall Study|Withdrawal by Subject|1|||
125293986|NCT05601102|450705168|FG000|Overall Study|Lost to Follow-up|0|||
125293987|NCT05601102|450705169|FG001|Overall Study|Lost to Follow-up|2|||
125293988|NCT02981524|450705171|FG000|Overall Study|Progressive Disease|14|||
125293989|NCT02981524|450705171|FG000|Overall Study|Death (unrelated)|1|||
125293990|NCT02981524|450705171|FG000|Overall Study|Treatment Related Toxicity|1|||
125293991|NCT02981524|450705171|FG000|Overall Study|Withdrawal by Subject|1|||
125293992|NCT00483041|450705172|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
125293993|NCT00483041|450705173|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
125293994|NCT00413010|450705176|FG000|Overall Study|Adverse Event|8|||
125293995|NCT00413010|450705177|FG001|Overall Study|Adverse Event|4|||
125293996|NCT00413010|450705176|FG000|Overall Study|Laboratory abnormality|0|||
125293997|NCT00413010|450705177|FG001|Overall Study|Laboratory abnormality|2|||
125293998|NCT00413010|450705176|FG000|Overall Study|Lack of Efficacy|0|||
125293999|NCT00413010|450705177|FG001|Overall Study|Lack of Efficacy|3|||
125294000|NCT00413010|450705176|FG000|Overall Study|Lost to Follow-up|3|||
125294001|NCT00413010|450705177|FG001|Overall Study|Lost to Follow-up|0|||
125294002|NCT00413010|450705176|FG000|Overall Study|Withdrawal by Subject|7|||
125294003|NCT00413010|450705177|FG001|Overall Study|Withdrawal by Subject|2|||
125294004|NCT00413010|450705176|FG000|Overall Study|Due to termination of the study|54|||
125294005|NCT00413010|450705177|FG001|Overall Study|Due to termination of the study|52|||
125294006|NCT00708734|450705180|FG000|Overall Study|scheduling conflict|2|||
125294007|NCT00708734|450705180|FG000|Overall Study|moved|1|||
125294008|NCT00708734|450705180|FG000|Overall Study|leg injury|1|||
125294009|NCT00708734|450705180|FG000|Overall Study|knee replacement|1|||
125294010|NCT00708734|450705180|FG000|Overall Study|vertigo|1|||
125294011|NCT00708734|450705180|FG000|Overall Study|leg fracture|1|||
125294012|NCT00895661|450705182|FG000|Overall Study|Death|1|||
125294013|NCT00895661|450705182|FG000|Overall Study|reason unknown|2|||
125294014|NCT00907296|450705183|FG000|Overall Study|Ineligibility Determined|1|||
125294015|NCT00907296|450705184|FG001|Overall Study|Ineligibility Determined|0|||
125294016|NCT00907296|450705185|FG002|Overall Study|Ineligibility Determined|0|||
125294017|NCT00907296|450705186|FG003|Overall Study|Ineligibility Determined|1|||
125294018|NCT00907296|450705187|FG004|Overall Study|Ineligibility Determined|0|||
125294019|NCT00907296|450705188|FG005|Overall Study|Ineligibility Determined|0|||
124788788|NCT03642132|448855933|FG002|Follow-up Period|Adverse Event|0|||
124788789|NCT04493892|448855944|FG000|Overall Study|Withdrawal by Subject|15|||
124788790|NCT01128621|448855945|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
124788791|NCT01128621|448855946|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
125294020|NCT00907296|450705189|FG006|Overall Study|Ineligibility Determined|0|||
125294021|NCT00907296|450705190|FG007|Overall Study|Ineligibility Determined|1|||
125294022|NCT00907296|450705191|FG008|Overall Study|Ineligibility Determined|0|||
125294023|NCT00907296|450705192|FG009|Overall Study|Ineligibility Determined|0|||
125294024|NCT00907296|450705183|FG000|Overall Study|Protocol Deviation|0|||
125294025|NCT00907296|450705184|FG001|Overall Study|Protocol Deviation|1|||
124788792|NCT03595618|448855947|FG000|Overall Study|Adverse Event|16|||
125294026|NCT00907296|450705185|FG002|Overall Study|Protocol Deviation|0|||
125294027|NCT00907296|450705186|FG003|Overall Study|Protocol Deviation|0|||
125294028|NCT00907296|450705187|FG004|Overall Study|Protocol Deviation|0|||
125294029|NCT00907296|450705188|FG005|Overall Study|Protocol Deviation|0|||
125294030|NCT00907296|450705189|FG006|Overall Study|Protocol Deviation|0|||
124788793|NCT03595618|448855948|FG001|Overall Study|Adverse Event|17|||
124788794|NCT03595618|448855949|FG002|Overall Study|Adverse Event|20|||
125294031|NCT00907296|450705190|FG007|Overall Study|Protocol Deviation|0|||
125294032|NCT00907296|450705191|FG008|Overall Study|Protocol Deviation|0|||
125294033|NCT00907296|450705192|FG009|Overall Study|Protocol Deviation|0|||
125294034|NCT00907296|450705183|FG000|Overall Study|Noncompliance|1|||
125294035|NCT00907296|450705184|FG001|Overall Study|Noncompliance|1|||
125294036|NCT00907296|450705185|FG002|Overall Study|Noncompliance|1|||
125294037|NCT00907296|450705186|FG003|Overall Study|Noncompliance|0|||
125294038|NCT00907296|450705187|FG004|Overall Study|Noncompliance|0|||
125294039|NCT00907296|450705188|FG005|Overall Study|Noncompliance|1|||
125294040|NCT00907296|450705189|FG006|Overall Study|Noncompliance|0|||
125294041|NCT00907296|450705190|FG007|Overall Study|Noncompliance|2|||
125294042|NCT00907296|450705191|FG008|Overall Study|Noncompliance|0|||
125294043|NCT00907296|450705192|FG009|Overall Study|Noncompliance|0|||
125294044|NCT00907296|450705183|FG000|Overall Study|Adverse Event|2|||
125294045|NCT00907296|450705184|FG001|Overall Study|Adverse Event|0|||
125294046|NCT00907296|450705185|FG002|Overall Study|Adverse Event|0|||
125294047|NCT00907296|450705186|FG003|Overall Study|Adverse Event|0|||
125294048|NCT00907296|450705187|FG004|Overall Study|Adverse Event|0|||
125294049|NCT00907296|450705188|FG005|Overall Study|Adverse Event|0|||
125294050|NCT00907296|450705189|FG006|Overall Study|Adverse Event|1|||
125294051|NCT00907296|450705190|FG007|Overall Study|Adverse Event|0|||
125294052|NCT00907296|450705191|FG008|Overall Study|Adverse Event|0|||
125294053|NCT00907296|450705192|FG009|Overall Study|Adverse Event|1|||
125294054|NCT00907296|450705183|FG000|Overall Study|Withdrawal by Subject|7|||
125294055|NCT00907296|450705184|FG001|Overall Study|Withdrawal by Subject|2|||
125294056|NCT00907296|450705185|FG002|Overall Study|Withdrawal by Subject|1|||
125294057|NCT00907296|450705186|FG003|Overall Study|Withdrawal by Subject|1|||
125294058|NCT00907296|450705187|FG004|Overall Study|Withdrawal by Subject|1|||
125294059|NCT00907296|450705188|FG005|Overall Study|Withdrawal by Subject|5|||
125294060|NCT00907296|450705189|FG006|Overall Study|Withdrawal by Subject|3|||
125294061|NCT00907296|450705190|FG007|Overall Study|Withdrawal by Subject|2|||
125294062|NCT00907296|450705191|FG008|Overall Study|Withdrawal by Subject|4|||
125294063|NCT00907296|450705192|FG009|Overall Study|Withdrawal by Subject|2|||
125294064|NCT00907296|450705183|FG000|Overall Study|Lost to Follow-up|9|||
125294065|NCT00907296|450705184|FG001|Overall Study|Lost to Follow-up|1|||
125294066|NCT00907296|450705185|FG002|Overall Study|Lost to Follow-up|0|||
125294067|NCT00907296|450705186|FG003|Overall Study|Lost to Follow-up|2|||
125294068|NCT00907296|450705187|FG004|Overall Study|Lost to Follow-up|0|||
125294069|NCT00907296|450705188|FG005|Overall Study|Lost to Follow-up|3|||
125294070|NCT00907296|450705189|FG006|Overall Study|Lost to Follow-up|2|||
125294071|NCT00907296|450705190|FG007|Overall Study|Lost to Follow-up|2|||
125294072|NCT00907296|450705191|FG008|Overall Study|Lost to Follow-up|0|||
125294073|NCT00907296|450705192|FG009|Overall Study|Lost to Follow-up|4|||
125294074|NCT02066129|450705193|FG000|Overall Study|Lost to Follow-up|13|||
125294075|NCT02066129|450705194|FG001|Overall Study|Lost to Follow-up|12|||
125294076|NCT02066129|450705193|FG000|Overall Study|Withdrawal by Subject|7|||
125294077|NCT02066129|450705194|FG001|Overall Study|Withdrawal by Subject|10|||
125294078|NCT02066129|450705193|FG000|Overall Study|Lack of Efficacy|8|||
125294079|NCT02066129|450705194|FG001|Overall Study|Lack of Efficacy|10|||
125294080|NCT02066129|450705193|FG000|Overall Study|Physician Decision|1|||
125294081|NCT02066129|450705194|FG001|Overall Study|Physician Decision|1|||
125294082|NCT00357656|450705195|FG000|Overall Study|Other, No surgery performed|0|||
125294083|NCT00357656|450705196|FG001|Overall Study|Other, No surgery performed|3|||
125294084|NCT02573246|450705197|FG000|Overall Study|Lost to Follow-up|2|||
125294085|NCT02573246|450705198|FG001|Overall Study|Lost to Follow-up|0|||
125294086|NCT02573246|450705199|FG002|Overall Study|Lost to Follow-up|0|||
125294087|NCT02573246|450705200|FG003|Overall Study|Lost to Follow-up|0|||
125294088|NCT02573246|450705201|FG004|Overall Study|Lost to Follow-up|1|||
125294089|NCT02573246|450705197|FG000|Overall Study|Withdrawal by Subject|0|||
125294090|NCT02573246|450705198|FG001|Overall Study|Withdrawal by Subject|0|||
125294091|NCT02573246|450705199|FG002|Overall Study|Withdrawal by Subject|0|||
125294092|NCT02573246|450705200|FG003|Overall Study|Withdrawal by Subject|0|||
125294093|NCT02573246|450705201|FG004|Overall Study|Withdrawal by Subject|1|||
125294094|NCT02573246|450705197|FG000|Overall Study|Physician Decision|1|||
125294095|NCT02573246|450705198|FG001|Overall Study|Physician Decision|1|||
125294096|NCT02573246|450705199|FG002|Overall Study|Physician Decision|3|||
125294097|NCT02573246|450705200|FG003|Overall Study|Physician Decision|2|||
125294098|NCT02573246|450705201|FG004|Overall Study|Physician Decision|2|||
125294099|NCT01219933|450705202|FG000|Overall Study|Adverse Event|8|||
125294100|NCT01219933|450705202|FG000|Overall Study|No LDA reached|5|||
125294101|NCT01219933|450705202|FG000|Overall Study|No LDA maintained|7|||
125294102|NCT01219933|450705202|FG000|Overall Study|Lost to Follow-up|3|||
125294103|NCT01219933|450705202|FG000|Overall Study|GC free|1|||
124788795|NCT03595618|448855950|FG003|Overall Study|Adverse Event|8|||
124788796|NCT03595618|448855947|FG000|Overall Study|Withdrawal by Subject|12|||
124788797|NCT03595618|448855948|FG001|Overall Study|Withdrawal by Subject|14|||
125294104|NCT01219933|450705202|FG000|Overall Study|Withdrawal by Subject|5|||
125294105|NCT01219933|450705202|FG000|Overall Study|Protocol Violation|8|||
125294106|NCT01219933|450705202|FG000|Overall Study|Lack of Efficacy|1|||
125294107|NCT01902888|450705203|FG000|Overall Study|Study Terminated|3|||
125294108|NCT00316888|450705204|FG000|Overall Study|Adverse Event|4|||
125294109|NCT00316888|450705205|FG001|Overall Study|Adverse Event|5|||
125294110|NCT00316888|450705204|FG000|Overall Study|Withdrawal by Subject|2|||
125294111|NCT00316888|450705205|FG001|Overall Study|Withdrawal by Subject|2|||
125294112|NCT00316888|450705204|FG000|Overall Study|Not start protocol therapy|0|||
125294113|NCT00316888|450705205|FG001|Overall Study|Not start protocol therapy|1|||
125294114|NCT03149003|450705206|FG000|Overall Study|Randomized but not treated|0|||
125294115|NCT03149003|450705207|FG001|Overall Study|Randomized but not treated|1|||
125294116|NCT03149003|450705208|FG002|Overall Study|Randomized but not treated|18|||
125294117|NCT04135859|450705209|FG000|Overall Study|Withdrawal by Subject|1|||
125294118|NCT04135859|450705210|FG001|Overall Study|Withdrawal by Subject|0|||
125294119|NCT04135859|450705209|FG000|Overall Study|Withdrawal due to screening failure|1|||
124788798|NCT03595618|448855949|FG002|Overall Study|Withdrawal by Subject|14|||
124788799|NCT03595618|448855950|FG003|Overall Study|Withdrawal by Subject|10|||
124788800|NCT03595618|448855947|FG000|Overall Study|Lost to Follow-up|6|||
124788801|NCT03595618|448855948|FG001|Overall Study|Lost to Follow-up|4|||
124788802|NCT03595618|448855949|FG002|Overall Study|Lost to Follow-up|5|||
124788803|NCT03595618|448855950|FG003|Overall Study|Lost to Follow-up|6|||
124788804|NCT03595618|448855947|FG000|Overall Study|Protocol Violation|2|||
124788805|NCT03595618|448855948|FG001|Overall Study|Protocol Violation|0|||
124788806|NCT03595618|448855949|FG002|Overall Study|Protocol Violation|6|||
124788807|NCT03595618|448855950|FG003|Overall Study|Protocol Violation|2|||
124788808|NCT03595618|448855947|FG000|Overall Study|Physician Decision|0|||
124788809|NCT03595618|448855948|FG001|Overall Study|Physician Decision|0|||
124788810|NCT03595618|448855949|FG002|Overall Study|Physician Decision|1|||
124788811|NCT03595618|448855950|FG003|Overall Study|Physician Decision|2|||
124788812|NCT03595618|448855947|FG000|Overall Study|Miscellaneous|7|||
124788813|NCT03595618|448855948|FG001|Overall Study|Miscellaneous|5|||
124788814|NCT03595618|448855949|FG002|Overall Study|Miscellaneous|10|||
124788815|NCT03595618|448855950|FG003|Overall Study|Miscellaneous|6|||
124788816|NCT01253811|448855951|FG000|Overall Study|Withdrawal criteria|1|||
124788817|NCT01782469|448855954|FG000|Overall Study|Lost to Follow-up|1|||
124788818|NCT00357760|448855961|FG000|Overall Study|Disease progression|44|||
124788819|NCT00357760|448855962|FG001|Overall Study|Disease progression|17|||
124788820|NCT00357760|448855961|FG000|Overall Study|Adverse Event|10|||
124788821|NCT00357760|448855962|FG001|Overall Study|Adverse Event|7|||
124788822|NCT00357760|448855961|FG000|Overall Study|Death|0|||
124788823|NCT00357760|448855962|FG001|Overall Study|Death|3|||
124788824|NCT00357760|448855961|FG000|Overall Study|Alternative therapy|1|||
124788825|NCT00357760|448855962|FG001|Overall Study|Alternative therapy|0|||
124788826|NCT00357760|448855961|FG000|Overall Study|Withdrawal by Subject|0|||
124788827|NCT00357760|448855962|FG001|Overall Study|Withdrawal by Subject|2|||
124788828|NCT00357760|448855961|FG000|Overall Study|Never started treatment|2|||
124788829|NCT00357760|448855962|FG001|Overall Study|Never started treatment|1|||
124788830|NCT00357760|448855961|FG000|Overall Study|Ineligible|0|||
124788831|NCT00357760|448855962|FG001|Overall Study|Ineligible|2|||
124788832|NCT00357760|448855961|FG000|Overall Study|Physician Decision|2|||
124788833|NCT00357760|448855962|FG001|Overall Study|Physician Decision|1|||
124788834|NCT00357760|448855961|FG000|Overall Study|Protocol Violation|0|||
124788835|NCT00357760|448855962|FG001|Overall Study|Protocol Violation|1|||
124788836|NCT00357760|448855961|FG000|Overall Study|To receive hospice care|0|||
124788837|NCT00357760|448855962|FG001|Overall Study|To receive hospice care|1|||
124788838|NCT04136444|448855963|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
124788839|NCT04136444|448855964|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
124788840|NCT02184572|448855970|FG000|Overall Study|Lost to Follow-up|29|||
124788841|NCT02184572|448855971|FG001|Overall Study|Lost to Follow-up|21|||
124788842|NCT02184572|448855970|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
124788843|NCT02184572|448855971|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
124788844|NCT02184572|448855970|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
124788845|NCT02184572|448855971|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
124788846|NCT02184572|448855970|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
124788847|NCT02184572|448855971|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
124788848|NCT02184572|448855970|FG000|Overall Study|Traveling Outside The Country|1|||
124788849|NCT02184572|448855971|FG001|Overall Study|Traveling Outside The Country|0|||
124788850|NCT02184572|448855970|FG000|Overall Study|Withdrawal by Subject|14|||
124788851|NCT02184572|448855971|FG001|Overall Study|Withdrawal by Subject|9|||
125294120|NCT04135859|450705210|FG001|Overall Study|Withdrawal due to screening failure|2|||
124788852|NCT03726996|448855972|FG000|Overall Study|Parent's decision|2|||
124788853|NCT03726996|448855972|FG000|Overall Study|Study early termination|2|||
124788854|NCT01328444|448855973|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
124788855|NCT01328444|448855974|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
124788856|NCT01328444|448855975|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
124788857|NCT01328444|448855976|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
125294121|NCT04135859|450705209|FG000|Overall Study|Did not complete stress test|3|||
124788858|NCT01328444|448855977|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
124788859|NCT01328444|448855978|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
124788860|NCT01328444|448855973|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
124788861|NCT01328444|448855974|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
124788862|NCT01328444|448855975|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
124788863|NCT01328444|448855976|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
124788864|NCT01328444|448855977|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
124788865|NCT01328444|448855978|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
124788866|NCT01328444|448855973|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
124788867|NCT01328444|448855974|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
124788868|NCT01328444|448855975|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
124788869|NCT01328444|448855976|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
124788870|NCT01328444|448855977|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
124788871|NCT01328444|448855978|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
124788872|NCT01328444|448855973|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
124788873|NCT01328444|448855974|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
124788874|NCT01328444|448855975|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
124788875|NCT01328444|448855976|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
124788876|NCT01328444|448855977|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
124788877|NCT01328444|448855978|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
124788878|NCT01328444|448855973|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
124788879|NCT01328444|448855974|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124788880|NCT01328444|448855975|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124788881|NCT01328444|448855976|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
124788882|NCT01328444|448855977|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124788883|NCT01328444|448855978|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
124788884|NCT01328444|448855973|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
124788885|NCT01328444|448855974|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
124788886|NCT01328444|448855975|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
124788887|NCT01328444|448855976|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
124788888|NCT01328444|448855977|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
124788889|NCT01328444|448855978|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
124788890|NCT01328444|448855973|FG000|Washout Period (14 Days)|Adverse Event|1|||
124788891|NCT01328444|448855974|FG001|Washout Period (14 Days)|Adverse Event|1|||
124788892|NCT01328444|448855975|FG002|Washout Period (14 Days)|Adverse Event|0|||
124788893|NCT01328444|448855976|FG003|Washout Period (14 Days)|Adverse Event|1|||
124788894|NCT01328444|448855977|FG004|Washout Period (14 Days)|Adverse Event|1|||
124788895|NCT01328444|448855978|FG005|Washout Period (14 Days)|Adverse Event|2|||
124788896|NCT01328444|448855973|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
124788897|NCT01328444|448855974|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
124788898|NCT01328444|448855975|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
124788899|NCT01328444|448855976|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
124788900|NCT01328444|448855977|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
124788901|NCT01328444|448855978|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
124788902|NCT01328444|448855973|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
124788903|NCT01328444|448855974|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
124788904|NCT01328444|448855975|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
124788905|NCT01328444|448855976|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
124788906|NCT01328444|448855977|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
124788907|NCT01328444|448855978|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
124788908|NCT01328444|448855973|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
124788909|NCT01328444|448855974|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
124788910|NCT01328444|448855975|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
124788911|NCT01328444|448855976|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
124788912|NCT01328444|448855977|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
124788913|NCT01328444|448855978|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
124788914|NCT01328444|448855973|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
124788915|NCT01328444|448855974|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
124788916|NCT01328444|448855975|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
124788917|NCT01328444|448855976|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
124788918|NCT01328444|448855977|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
124788919|NCT01328444|448855978|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
124788920|NCT01328444|448855973|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
124788921|NCT01328444|448855974|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
124788922|NCT01328444|448855975|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
124788923|NCT01328444|448855976|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
124788924|NCT01328444|448855977|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
124788925|NCT01328444|448855978|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
124788926|NCT01328444|448855973|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
124788927|NCT01328444|448855974|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
124788928|NCT01328444|448855975|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
125294122|NCT04135859|450705210|FG001|Overall Study|Did not complete stress test|3|||
125294123|NCT04135859|450705209|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
124788929|NCT01328444|448855976|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
124788930|NCT01328444|448855977|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
124788931|NCT01328444|448855978|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
124788932|NCT01328444|448855973|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
124788933|NCT01328444|448855974|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
124788934|NCT01328444|448855975|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
124788935|NCT01328444|448855976|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
124788936|NCT01328444|448855977|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
124788937|NCT01328444|448855978|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
124788938|NCT01328444|448855973|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124788939|NCT01328444|448855974|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124788940|NCT01328444|448855975|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124788941|NCT01328444|448855976|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124788942|NCT01328444|448855977|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
124788943|NCT01328444|448855978|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
124788944|NCT03180619|448855979|FG000|Overall Study|Withdrew Consent|5|||
124788945|NCT03180619|448855980|FG001|Overall Study|Withdrew Consent|0|||
124788946|NCT03180619|448855981|FG002|Overall Study|Withdrew Consent|2|||
124788947|NCT03180619|448855979|FG000|Overall Study|Death|2|||
124788948|NCT03180619|448855980|FG001|Overall Study|Death|1|||
124788949|NCT03180619|448855981|FG002|Overall Study|Death|2|||
124788950|NCT03180619|448855979|FG000|Overall Study|Adverse Event|2|||
124788951|NCT03180619|448855980|FG001|Overall Study|Adverse Event|0|||
124788952|NCT03180619|448855981|FG002|Overall Study|Adverse Event|1|||
124788953|NCT03180619|448855979|FG000|Overall Study|Investigator's discretion|2|||
124788954|NCT03180619|448855980|FG001|Overall Study|Investigator's discretion|0|||
124788955|NCT03180619|448855981|FG002|Overall Study|Investigator's discretion|1|||
124788956|NCT02743611|448855982|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
124788957|NCT02743611|448855983|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
124788958|NCT02743611|448855984|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
124788959|NCT02743611|448855985|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
124788960|NCT00561977|448855986|FG000|Overall Study|Withdrawal by Subject|0|||
124788961|NCT00561977|448855987|FG001|Overall Study|Withdrawal by Subject|2|||
124788962|NCT00561977|448855988|FG002|Overall Study|Withdrawal by Subject|1|||
124788963|NCT00561977|448855986|FG000|Overall Study|Pregnancy|0|||
124788964|NCT00561977|448855987|FG001|Overall Study|Pregnancy|1|||
124788965|NCT00561977|448855988|FG002|Overall Study|Pregnancy|1|||
124788966|NCT00781885|448855989|FG000|Overall Study|Physician Decision|1|||
124788967|NCT01755026|448855990|FG000|Overall Study|Adverse Event|1|||
124788968|NCT01755026|448855991|FG001|Overall Study|Adverse Event|0|||
124788969|NCT01755026|448855990|FG000|Overall Study|Withdrawal by Subject|1|||
124788970|NCT01755026|448855991|FG001|Overall Study|Withdrawal by Subject|1|||
124788971|NCT00392379|448855992|FG000|Overall Study|Withdrawal by Subject|17|||
124788972|NCT00392379|448855993|FG001|Overall Study|Withdrawal by Subject|28|||
124788973|NCT00392379|448855992|FG000|Overall Study|Lost to Follow-up|4|||
124788974|NCT00392379|448855993|FG001|Overall Study|Lost to Follow-up|9|||
124788975|NCT00392379|448855992|FG000|Overall Study|Adverse Event|1|||
124788976|NCT00392379|448855993|FG001|Overall Study|Adverse Event|1|||
124788977|NCT03041129|448855994|FG000|Overall Study|Withdrawal by Subject|2|||
124788978|NCT03041129|448855995|FG001|Overall Study|Withdrawal by Subject|0|||
124788979|NCT03041129|448855996|FG002|Overall Study|Withdrawal by Subject|0|||
124788980|NCT03041129|448855997|FG003|Overall Study|Withdrawal by Subject|0|||
124788981|NCT03678870|448855998|FG000|Overall Study|prescribed non- protocol medications|10|||
124788982|NCT03678870|448855999|FG001|Overall Study|prescribed non- protocol medications|6|||
124788983|NCT03678870|448855998|FG000|Overall Study|Lost to Follow-up|3|||
124788984|NCT03678870|448855999|FG001|Overall Study|Lost to Follow-up|2|||
124788985|NCT03104816|448856000|FG000|Overall Study|Lack of Efficacy|0|||
124788986|NCT03104816|448856001|FG001|Overall Study|Lack of Efficacy|2|||
124788987|NCT03104816|448856002|FG002|Overall Study|Lack of Efficacy|0|||
124788988|NCT03104816|448856000|FG000|Overall Study|Protocol Violation|2|||
124788989|NCT03104816|448856001|FG001|Overall Study|Protocol Violation|0|||
124788990|NCT03104816|448856002|FG002|Overall Study|Protocol Violation|2|||
124788991|NCT01159431|448856004|FG000|Overall Study|Adverse Event|1|||
124788992|NCT01159431|448856005|FG001|Overall Study|Adverse Event|2|||
124788993|NCT01159431|448856004|FG000|Overall Study|non-compliance|1|||
124788994|NCT01159431|448856005|FG001|Overall Study|non-compliance|1|||
124788995|NCT01159431|448856004|FG000|Overall Study|Lack of Efficacy|0|||
124788996|NCT01159431|448856005|FG001|Overall Study|Lack of Efficacy|3|||
124788997|NCT03645434|448856008|FG000|Period 1|Adverse Event|0|||
124788998|NCT03645434|448856009|FG001|Period 1|Adverse Event|0|||
124788999|NCT03645434|448856010|FG002|Period 1|Adverse Event|0|||
124789000|NCT03645434|448856011|FG003|Period 1|Adverse Event|1|||
124789001|NCT03645434|448856012|FG004|Period 1|Adverse Event|0|||
124789002|NCT03645434|448856013|FG005|Period 1|Adverse Event|0|||
124789003|NCT03645434|448856008|FG000|Period 1|COPD exacerbation|0|||
124789004|NCT03645434|448856009|FG001|Period 1|COPD exacerbation|0|||
124789005|NCT03645434|448856010|FG002|Period 1|COPD exacerbation|0|||
124789006|NCT03645434|448856011|FG003|Period 1|COPD exacerbation|0|||
124789007|NCT03645434|448856012|FG004|Period 1|COPD exacerbation|1|||
124789008|NCT03645434|448856013|FG005|Period 1|COPD exacerbation|0|||
124789009|NCT03658876|448857847|FG000|Overall Study|Protocol Violation|3|||
124789010|NCT03658876|448857848|FG001|Overall Study|Protocol Violation|2|||
124789011|NCT03658876|448857847|FG000|Overall Study|Withdrawal by Subject|2|||
124789012|NCT03658876|448857848|FG001|Overall Study|Withdrawal by Subject|0|||
124789013|NCT03658876|448857847|FG000|Overall Study|Death|0|||
124789014|NCT03658876|448857848|FG001|Overall Study|Death|1|||
124789015|NCT03658876|448857847|FG000|Overall Study|Intercurrent illness|6|||
124789016|NCT03658876|448857848|FG001|Overall Study|Intercurrent illness|4|||
124789017|NCT03658876|448857847|FG000|Overall Study|Transplantation/other operation|1|||
124789018|NCT03658876|448857848|FG001|Overall Study|Transplantation/other operation|5|||
124789019|NCT01330017|448857849|FG000|Overall Study|Adverse Event|0|||
124789020|NCT01330017|448857850|FG001|Overall Study|Adverse Event|1|||
124789021|NCT01330017|448857851|FG002|Overall Study|Adverse Event|1|||
124789022|NCT01330017|448857852|FG003|Overall Study|Adverse Event|4|||
124789023|NCT01330017|448857853|FG004|Overall Study|Adverse Event|0|||
124789024|NCT01330017|448857849|FG000|Overall Study|Withdrawal by Subject|0|||
124789025|NCT01330017|448857850|FG001|Overall Study|Withdrawal by Subject|0|||
124789026|NCT01330017|448857851|FG002|Overall Study|Withdrawal by Subject|1|||
124789027|NCT01330017|448857852|FG003|Overall Study|Withdrawal by Subject|0|||
124789028|NCT01330017|448857853|FG004|Overall Study|Withdrawal by Subject|1|||
124789029|NCT01330017|448857849|FG000|Overall Study|Lost to Follow-up|0|||
124789030|NCT01330017|448857850|FG001|Overall Study|Lost to Follow-up|0|||
124789031|NCT01330017|448857851|FG002|Overall Study|Lost to Follow-up|1|||
124789032|NCT01330017|448857852|FG003|Overall Study|Lost to Follow-up|0|||
124789033|NCT01330017|448857853|FG004|Overall Study|Lost to Follow-up|0|||
124789034|NCT01330017|448857849|FG000|Overall Study|Protocol Violation|0|||
124789035|NCT01330017|448857850|FG001|Overall Study|Protocol Violation|0|||
124789036|NCT01330017|448857851|FG002|Overall Study|Protocol Violation|0|||
124789037|NCT01330017|448857852|FG003|Overall Study|Protocol Violation|1|||
124789038|NCT01330017|448857853|FG004|Overall Study|Protocol Violation|0|||
124789039|NCT01330017|448857849|FG000|Overall Study|Unknown Reason|5|||
124789040|NCT01330017|448857850|FG001|Overall Study|Unknown Reason|3|||
124789041|NCT01330017|448857851|FG002|Overall Study|Unknown Reason|5|||
124789042|NCT01330017|448857852|FG003|Overall Study|Unknown Reason|7|||
124789043|NCT01330017|448857853|FG004|Overall Study|Unknown Reason|2|||
124789044|NCT01106092|448857854|FG000|Overall Study|Withdrawal by Subject|0|||
124789045|NCT01106092|448857855|FG001|Overall Study|Withdrawal by Subject|0|||
124789046|NCT01106092|448857856|FG002|Overall Study|Withdrawal by Subject|0|||
124789047|NCT01106092|448857857|FG003|Overall Study|Withdrawal by Subject|1|||
124789048|NCT00843778|448857858|FG000|Overall Study|Adverse Event|15|||
124789049|NCT00843778|448857858|FG000|Overall Study|Lack of Efficacy|14|||
124789050|NCT00843778|448857858|FG000|Overall Study|Loss of efficacy|2|||
124789051|NCT00843778|448857858|FG000|Overall Study|Withdrawal by Subject|4|||
124789052|NCT03338959|448857863|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
124789053|NCT03338959|448857863|FG000|Overall Study|Physician Decision|1|||
124789054|NCT03328182|448857866|FG000|Overall Study|Withdrawal by Subject|1|||
124789055|NCT03328182|448857866|FG000|Overall Study|Protocol Violation|2|||
124789056|NCT03328182|448857866|FG000|Overall Study|No Product Evaluated|1|||
124789057|NCT01347580|448857870|FG000|Overall Study|Withdrawal by Subject|13|||
124789058|NCT01347580|448857871|FG001|Overall Study|Withdrawal by Subject|23|||
124789059|NCT01347580|448857870|FG000|Overall Study|Death|30|||
124789060|NCT01347580|448857871|FG001|Overall Study|Death|19|||
124789061|NCT01347580|448857870|FG000|Overall Study|Protocol Violation|10|||
124789062|NCT01347580|448857871|FG001|Overall Study|Protocol Violation|7|||
124789063|NCT01347580|448857870|FG000|Overall Study|Lost to Follow-up|3|||
124789064|NCT01347580|448857871|FG001|Overall Study|Lost to Follow-up|1|||
124789065|NCT01347580|448857870|FG000|Overall Study|Had other reason|9|||
124789066|NCT01347580|448857871|FG001|Overall Study|Had other reason|6|||
124789067|NCT02870933|448857872|FG000|Overall Study|Death|2|||
124789068|NCT02870933|448857873|FG001|Overall Study|Death|1|||
124789069|NCT02870933|448857872|FG000|Overall Study|Withdrawal by Subject|0|||
124789070|NCT02870933|448857873|FG001|Overall Study|Withdrawal by Subject|1|||
124789071|NCT00003590|448857874|FG000|Overall Study|Ineligible Patient|1|||
124789072|NCT00003590|448857874|FG000|Overall Study|Adverse Event|7|||
124789073|NCT00003590|448857874|FG000|Overall Study|Withdrawal by Subject|1|||
124789074|NCT00003590|448857874|FG000|Overall Study|Lack of Efficacy|11|||
124789075|NCT00003590|448857874|FG000|Overall Study|Death|1|||
124789076|NCT00003590|448857874|FG000|Overall Study|Physician Decision|1|||
124789077|NCT01425463|448857875|FG000|Overall Study|Adverse Event|5|||
124789078|NCT01425463|448857876|FG001|Overall Study|Adverse Event|7|||
124789079|NCT01425463|448857875|FG000|Overall Study|Lack of Efficacy|1|||
124789080|NCT01425463|448857876|FG001|Overall Study|Lack of Efficacy|1|||
124789081|NCT01425463|448857875|FG000|Overall Study|Protocol Violation|2|||
124789082|NCT01425463|448857876|FG001|Overall Study|Protocol Violation|2|||
124789083|NCT01425463|448857875|FG000|Overall Study|Lost to Follow-up|5|||
124789084|NCT01425463|448857876|FG001|Overall Study|Lost to Follow-up|2|||
124789085|NCT01425463|448857875|FG000|Overall Study|Withdrawal by Subject|7|||
124789086|NCT01425463|448857876|FG001|Overall Study|Withdrawal by Subject|5|||
124789087|NCT01425463|448857875|FG000|Overall Study|Unknown Reason|4|||
124789088|NCT01425463|448857876|FG001|Overall Study|Unknown Reason|7|||
124789089|NCT01009840|448857877|FG000|Overall Study|Lost to Follow-up|1|||
124789090|NCT01009840|448857877|FG000|Overall Study|Adverse Event|4|||
124789091|NCT01009840|448857877|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
124789092|NCT01009840|448857877|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
124789093|NCT01009840|448857877|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
124789094|NCT01958489|448857888|FG000|Period 2|Adverse Event|0|||
124789095|NCT01958489|448857889|FG001|Period 2|Adverse Event|1|||
124789096|NCT00917644|448857890|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
124789097|NCT00917644|448857891|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
124789098|NCT00917644|448857890|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
124789099|NCT00917644|448857891|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
124789100|NCT00917644|448857890|FG000|Period 2: Second Intervention|family emergency|1|||
124789101|NCT00917644|448857891|FG001|Period 2: Second Intervention|family emergency|0|||
124789102|NCT02338232|448857892|FG000|Overall Study|Screen Failure|3|||
124789103|NCT02338232|448857892|FG000|Overall Study|Withdrawal by Subject|6|||
124789104|NCT02338232|448857892|FG000|Overall Study|Adverse Event|2|||
124789105|NCT02500056|448857893|FG000|Overall Study|Lost to Follow-up|3|||
124789106|NCT02500056|448857894|FG001|Overall Study|Lost to Follow-up|7|||
124789107|NCT02500056|448857893|FG000|Overall Study|Recurrence|1|||
124789108|NCT02500056|448857894|FG001|Overall Study|Recurrence|0|||
124789109|NCT02500056|448857893|FG000|Overall Study|Death|3|||
124789110|NCT02500056|448857894|FG001|Overall Study|Death|1|||
124789111|NCT00864916|448857895|FG000|Overall Study|Lost to Follow-up|4|||
124789112|NCT00864916|448857896|FG001|Overall Study|Lost to Follow-up|4|||
124789113|NCT00864916|448857895|FG000|Overall Study|Protocol Violation|1|||
124789114|NCT00864916|448857896|FG001|Overall Study|Protocol Violation|0|||
124789115|NCT00864916|448857895|FG000|Overall Study|Withdrawal by Subject|1|||
124789116|NCT00864916|448857896|FG001|Overall Study|Withdrawal by Subject|0|||
124789117|NCT01087736|448857899|FG000|Overall Study|Lost to Follow-up|1|||
124789118|NCT01087736|448857900|FG001|Overall Study|Lost to Follow-up|0|||
124789119|NCT01087736|448857899|FG000|Overall Study|Death|0|||
124789120|NCT01087736|448857900|FG001|Overall Study|Death|1|||
124789121|NCT01087736|448857899|FG000|Overall Study|Withdrawal by Subject|0|||
124789122|NCT01087736|448857900|FG001|Overall Study|Withdrawal by Subject|1|||
124789123|NCT02122783|448857909|FG000|Overall Study|Adverse Event|0|||
124789124|NCT02122783|448857910|FG001|Overall Study|Adverse Event|1|||
124789125|NCT01579812|448857913|FG000|Overall Study|Ineligible after treatment start|40|||
124789126|NCT01579812|448857913|FG000|Overall Study|Patient choice|3|||
124789127|NCT01579812|448857913|FG000|Overall Study|Noncompliance|3|||
124789128|NCT01579812|448857913|FG000|Overall Study|Withdrawal by Subject|6|||
124789129|NCT01101308|448857914|FG000|Period 1|Adverse Event|2|||
124789130|NCT01101308|448857915|FG001|Period 1|Adverse Event|1|||
124789131|NCT01101308|448857914|FG000|Period 1|Positive for cotinine|1|||
124789132|NCT01101308|448857915|FG001|Period 1|Positive for cotinine|0|||
124789133|NCT04905498|448857920|FG000|Overall Study|Lost to Follow-up|0|||
124789134|NCT04905498|448857921|FG001|Overall Study|Lost to Follow-up|2|||
124789135|NCT04905498|448857920|FG000|Overall Study|COVID lockdown|1|||
124789136|NCT04905498|448857921|FG001|Overall Study|COVID lockdown|0|||
124789137|NCT00869778|448857924|FG000|Overall Study|Adverse Event|2|||
124789138|NCT00869778|448857925|FG001|Overall Study|Adverse Event|0|||
124789139|NCT00869778|448857926|FG002|Overall Study|Adverse Event|0|||
124789140|NCT00869778|448857924|FG000|Overall Study|Withdrawal by Subject|3|||
124789141|NCT00869778|448857925|FG001|Overall Study|Withdrawal by Subject|4|||
124789142|NCT00869778|448857926|FG002|Overall Study|Withdrawal by Subject|5|||
124789143|NCT00869778|448857924|FG000|Overall Study|Pregnancy|1|||
124789144|NCT00869778|448857925|FG001|Overall Study|Pregnancy|0|||
124789145|NCT00869778|448857926|FG002|Overall Study|Pregnancy|0|||
124789146|NCT00869778|448857924|FG000|Overall Study|Protocol Violation|5|||
124789147|NCT00869778|448857925|FG001|Overall Study|Protocol Violation|3|||
124789148|NCT00869778|448857926|FG002|Overall Study|Protocol Violation|5|||
124789149|NCT00869778|448857924|FG000|Overall Study|Unblinding|1|||
124789150|NCT00869778|448857925|FG001|Overall Study|Unblinding|0|||
124789151|NCT00869778|448857926|FG002|Overall Study|Unblinding|0|||
124789152|NCT03339297|448857927|FG000|Overall Study|Relapse of Hematologic Disease|1|||
124789153|NCT03339297|448857928|FG001|Overall Study|Relapse of Hematologic Disease|0|||
124789154|NCT03339297|448857927|FG000|Overall Study|Death|10|||
124789155|NCT03339297|448857928|FG001|Overall Study|Death|7|||
124789156|NCT03339297|448857927|FG000|Overall Study|Hepatic Candidosis|1|||
124789157|NCT03339297|448857928|FG001|Overall Study|Hepatic Candidosis|0|||
124789158|NCT03339297|448857927|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
124789159|NCT03339297|448857928|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
124789160|NCT03339297|448857927|FG000|Overall Study|Consent Withdrawn by Participant|3|||
124789161|NCT03339297|448857928|FG001|Overall Study|Consent Withdrawn by Participant|3|||
124789162|NCT03339297|448857927|FG000|Overall Study|Disease Relapse|2|||
124789163|NCT03339297|448857928|FG001|Overall Study|Disease Relapse|0|||
124789164|NCT03339297|448857927|FG000|Overall Study|Physician Decision|1|||
124789165|NCT03339297|448857928|FG001|Overall Study|Physician Decision|1|||
124789166|NCT03339297|448857927|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
124789167|NCT03339297|448857928|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
124789168|NCT03339297|448857927|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
124789169|NCT03339297|448857928|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
124789170|NCT03339297|448857927|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
124789171|NCT03339297|448857928|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
124789172|NCT03339297|448857927|FG000|Overall Study|Adverse Event, Non-fatal|1|||
124789173|NCT03339297|448857928|FG001|Overall Study|Adverse Event, Non-fatal|0|||
124789174|NCT03339297|448857927|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
124789175|NCT03339297|448857928|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
124789176|NCT03339297|448857927|FG000|Overall Study|Patient Was Not Eligible|1|||
124789177|NCT03339297|448857928|FG001|Overall Study|Patient Was Not Eligible|0|||
124789178|NCT03051620|448857929|FG000|Overall Study|Lost to Follow-up|6|||
124789179|NCT03051620|448857929|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
124789180|NCT00393510|448857930|FG000|Overall Study|Physician Decision|3|||
124789181|NCT00393510|448857931|FG001|Overall Study|Physician Decision|9|||
124789182|NCT03077087|448857932|FG000|Overall Study|Physician Decision|2|||
124789183|NCT02112045|448857935|FG000|Overall Study|Withdrawal by Subject|1|||
124789184|NCT02112045|448857936|FG001|Overall Study|Withdrawal by Subject|0|||
124789185|NCT00977080|448857938|FG000|Overall Study|Adverse Event|2|||
124789186|NCT00977080|448857939|FG001|Overall Study|Adverse Event|7|||
124789187|NCT00977080|448857940|FG002|Overall Study|Adverse Event|7|||
124789188|NCT00977080|448857941|FG003|Overall Study|Adverse Event|7|||
124789189|NCT00977080|448857938|FG000|Overall Study|Withdrawal by Subject|1|||
124789190|NCT00977080|448857939|FG001|Overall Study|Withdrawal by Subject|5|||
124789191|NCT00977080|448857940|FG002|Overall Study|Withdrawal by Subject|1|||
124789192|NCT00977080|448857941|FG003|Overall Study|Withdrawal by Subject|5|||
124789193|NCT00977080|448857938|FG000|Overall Study|Protocol Violation|7|||
124789194|NCT00977080|448857939|FG001|Overall Study|Protocol Violation|3|||
124789195|NCT00977080|448857940|FG002|Overall Study|Protocol Violation|4|||
124789196|NCT00977080|448857941|FG003|Overall Study|Protocol Violation|3|||
124789197|NCT00977080|448857938|FG000|Overall Study|Noncompliance|0|||
124789198|NCT00977080|448857939|FG001|Overall Study|Noncompliance|2|||
124789199|NCT00977080|448857940|FG002|Overall Study|Noncompliance|1|||
124789200|NCT00977080|448857941|FG003|Overall Study|Noncompliance|0|||
124789201|NCT00977080|448857938|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
124789202|NCT00977080|448857939|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
124789203|NCT00977080|448857940|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
124789204|NCT00977080|448857941|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
124789205|NCT00977080|448857938|FG000|Overall Study|Required kidney transplantation|1|||
124789206|NCT00977080|448857939|FG001|Overall Study|Required kidney transplantation|3|||
124789207|NCT00977080|448857940|FG002|Overall Study|Required kidney transplantation|3|||
124789208|NCT00977080|448857941|FG003|Overall Study|Required kidney transplantation|1|||
124789209|NCT00977080|448857938|FG000|Overall Study|Travel for family reasons|1|||
124789210|NCT00977080|448857939|FG001|Overall Study|Travel for family reasons|0|||
124789211|NCT00977080|448857940|FG002|Overall Study|Travel for family reasons|0|||
124789212|NCT00977080|448857941|FG003|Overall Study|Travel for family reasons|0|||
124789213|NCT00441116|448857944|FG000|Overall Study|Adverse Event|1|||
124789214|NCT00441116|448857945|FG001|Overall Study|Adverse Event|1|||
124789215|NCT00441116|448857944|FG000|Overall Study|Withdrawal by Subject|1|||
124789216|NCT00441116|448857945|FG001|Overall Study|Withdrawal by Subject|0|||
124789217|NCT00441116|448857944|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
124789218|NCT00441116|448857945|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
124789219|NCT00796991|448857957|FG000|Overall Study|Adverse Event|0|||
124789220|NCT00796991|448857958|FG001|Overall Study|Adverse Event|0|||
124789221|NCT00796991|448857959|FG002|Overall Study|Adverse Event|1|||
124789222|NCT00796991|448857957|FG000|Overall Study|Death|2|||
124789223|NCT00796991|448857958|FG001|Overall Study|Death|0|||
124789224|NCT00796991|448857959|FG002|Overall Study|Death|0|||
125294124|NCT04135859|450705210|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
124789225|NCT00796991|448857957|FG000|Overall Study|Disease Progression|10|||
124789226|NCT00796991|448857958|FG001|Overall Study|Disease Progression|9|||
125294125|NCT01814670|450705213|FG000|Overall Study|Protocol Violation|12|||
125294126|NCT01565941|450705214|FG000|Overall Study|Withdrawn by parent/guardian|3|||
124789227|NCT00796991|448857959|FG002|Overall Study|Disease Progression|7|||
124789228|NCT00796991|448857957|FG000|Overall Study|Study Drug Toxicity|3|||
124789229|NCT00796991|448857958|FG001|Overall Study|Study Drug Toxicity|3|||
124789230|NCT00796991|448857959|FG002|Overall Study|Study Drug Toxicity|5|||
124789231|NCT00796991|448857957|FG000|Overall Study|Withdrawal by Subject|0|||
124789232|NCT00796991|448857958|FG001|Overall Study|Withdrawal by Subject|0|||
124789233|NCT00796991|448857959|FG002|Overall Study|Withdrawal by Subject|1|||
124789234|NCT01765218|448857960|FG000|Overall Study|Protocol Violation|1|||
124789235|NCT01765218|448857961|FG001|Overall Study|Protocol Violation|2|||
124789236|NCT03148691|448857962|FG000|Overall Study|Protocol Violation|1|||
124789237|NCT03148691|448857963|FG001|Overall Study|Protocol Violation|2|||
124789238|NCT03148691|448857964|FG002|Overall Study|Protocol Violation|7|||
124789239|NCT03148691|448857962|FG000|Overall Study|Lost to Follow-up|0|||
124789240|NCT03148691|448857963|FG001|Overall Study|Lost to Follow-up|0|||
124789241|NCT03148691|448857964|FG002|Overall Study|Lost to Follow-up|1|||
124789242|NCT03148691|448857962|FG000|Overall Study|Other|1|||
124789243|NCT03148691|448857963|FG001|Overall Study|Other|0|||
124789244|NCT03148691|448857964|FG002|Overall Study|Other|0|||
124789245|NCT03148691|448857962|FG000|Overall Study|Withdrawal by Subject|1|||
124789246|NCT03148691|448857963|FG001|Overall Study|Withdrawal by Subject|0|||
124789247|NCT03148691|448857964|FG002|Overall Study|Withdrawal by Subject|0|||
124789248|NCT00171834|448857965|FG000|Overall Study|Adverse Event|2|||
124789249|NCT00171834|448857966|FG001|Overall Study|Adverse Event|1|||
124789250|NCT00171834|448857967|FG002|Overall Study|Adverse Event|3|||
124789251|NCT00171834|448857968|FG003|Overall Study|Adverse Event|2|||
124789252|NCT00171834|448857969|FG004|Overall Study|Adverse Event|2|||
124789253|NCT00171834|448857970|FG005|Overall Study|Adverse Event|15|||
124789254|NCT00171834|448857971|FG006|Overall Study|Adverse Event|1|||
124789255|NCT00171834|448857965|FG000|Overall Study|Withdrawal by Subject|0|||
124789256|NCT00171834|448857966|FG001|Overall Study|Withdrawal by Subject|2|||
124789257|NCT00171834|448857967|FG002|Overall Study|Withdrawal by Subject|0|||
124789258|NCT00171834|448857968|FG003|Overall Study|Withdrawal by Subject|1|||
124789259|NCT00171834|448857969|FG004|Overall Study|Withdrawal by Subject|1|||
124789260|NCT00171834|448857970|FG005|Overall Study|Withdrawal by Subject|1|||
124789261|NCT00171834|448857971|FG006|Overall Study|Withdrawal by Subject|0|||
124789262|NCT00171834|448857965|FG000|Overall Study|Death from study indication|0|||
124789263|NCT00171834|448857966|FG001|Overall Study|Death from study indication|1|||
124789264|NCT00171834|448857967|FG002|Overall Study|Death from study indication|0|||
124789265|NCT00171834|448857968|FG003|Overall Study|Death from study indication|0|||
124789266|NCT00171834|448857969|FG004|Overall Study|Death from study indication|1|||
124789267|NCT00171834|448857970|FG005|Overall Study|Death from study indication|0|||
124789268|NCT00171834|448857971|FG006|Overall Study|Death from study indication|0|||
124789269|NCT00171834|448857965|FG000|Overall Study|Disease Progression|4|||
124789270|NCT00171834|448857966|FG001|Overall Study|Disease Progression|8|||
124789271|NCT00171834|448857967|FG002|Overall Study|Disease Progression|8|||
124789272|NCT00171834|448857968|FG003|Overall Study|Disease Progression|9|||
124789273|NCT00171834|448857969|FG004|Overall Study|Disease Progression|2|||
124789274|NCT00171834|448857970|FG005|Overall Study|Disease Progression|18|||
124789275|NCT00171834|448857971|FG006|Overall Study|Disease Progression|3|||
124789276|NCT00171834|448857965|FG000|Overall Study|Treatment Duration Completed|0|||
124789277|NCT00171834|448857966|FG001|Overall Study|Treatment Duration Completed|0|||
124789278|NCT00171834|448857967|FG002|Overall Study|Treatment Duration Completed|1|||
124789279|NCT00171834|448857968|FG003|Overall Study|Treatment Duration Completed|0|||
124789280|NCT00171834|448857969|FG004|Overall Study|Treatment Duration Completed|2|||
124789281|NCT00171834|448857970|FG005|Overall Study|Treatment Duration Completed|1|||
124789282|NCT00171834|448857971|FG006|Overall Study|Treatment Duration Completed|0|||
124789283|NCT02365233|448857981|FG000|Overall Study|IRB withheld the data|1|||
124789284|NCT02365233|448857982|FG001|Overall Study|IRB withheld the data|2|||
124789285|NCT02365233|448857983|FG002|Overall Study|IRB withheld the data|2|||
124789286|NCT01978938|448857984|FG000|Overall Study|Lost to Follow-up|12|||
124789287|NCT01978938|448857985|FG001|Overall Study|Lost to Follow-up|6|||
124789288|NCT01978938|448857984|FG000|Overall Study|Withdrawal by Subject|8|||
124789289|NCT01978938|448857985|FG001|Overall Study|Withdrawal by Subject|4|||
124789290|NCT01978938|448857984|FG000|Overall Study|Adverse Event, non-fatal|2|||
124789291|NCT01978938|448857985|FG001|Overall Study|Adverse Event, non-fatal|1|||
124789292|NCT01978938|448857984|FG000|Overall Study|Participant noncompliance|1|||
124789293|NCT01978938|448857985|FG001|Overall Study|Participant noncompliance|1|||
124789294|NCT01978938|448857984|FG000|Overall Study|Did not meet inclusion criteria|0|||
124789295|NCT01978938|448857985|FG001|Overall Study|Did not meet inclusion criteria|1|||
124789296|NCT01978938|448857984|FG000|Overall Study|Previously scheduled procedure|0|||
124789297|NCT01978938|448857985|FG001|Overall Study|Previously scheduled procedure|1|||
124789298|NCT02342418|448857986|FG000|Overall Study|Adverse Event|0|||
124789299|NCT02342418|448857987|FG001|Overall Study|Adverse Event|1|||
124789300|NCT04255394|448857988|FG000|Overall Study|Death|35|||
124789301|NCT04255394|448857989|FG001|Overall Study|Death|25|||
124789302|NCT04255394|448857988|FG000|Overall Study|Device removed|2|||
124789303|NCT04255394|448857989|FG001|Overall Study|Device removed|10|||
124789304|NCT04255394|448857988|FG000|Overall Study|Withdrawal by Subject|9|||
124789305|NCT04255394|448857989|FG001|Overall Study|Withdrawal by Subject|8|||
124789306|NCT04255394|448857988|FG000|Overall Study|Screen Failure/Not treated|12|||
124789307|NCT04255394|448857989|FG001|Overall Study|Screen Failure/Not treated|8|||
124789308|NCT04255394|448857988|FG000|Overall Study|Lost to Follow-up|123|||
124789309|NCT04255394|448857989|FG001|Overall Study|Lost to Follow-up|265|||
124789310|NCT04255394|448857988|FG000|Overall Study|Adverse Event|1|||
124789311|NCT04255394|448857989|FG001|Overall Study|Adverse Event|3|||
124789312|NCT02285062|448857995|FG000|Pre-Treatment Period|Protocol Violation|0|||
124789313|NCT02285062|448857996|FG001|Pre-Treatment Period|Protocol Violation|2|||
124789314|NCT02285062|448857995|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
124789315|NCT02285062|448857996|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
124789316|NCT00821509|448857997|FG000|Overall Study|Withdrawal by Subject|12|||
124789317|NCT00821509|448857998|FG001|Overall Study|Withdrawal by Subject|11|||
124789318|NCT00821509|448857999|FG002|Overall Study|Withdrawal by Subject|34|||
124789319|NCT01227629|448858001|FG000|Overall Study|Adverse Event|2|||
124789320|NCT01227629|448858002|FG001|Overall Study|Adverse Event|2|||
124789321|NCT01227629|448858003|FG002|Overall Study|Adverse Event|1|||
124789322|NCT01227629|448858004|FG003|Overall Study|Adverse Event|6|||
124789323|NCT01227629|448858005|FG004|Overall Study|Adverse Event|1|||
124789324|NCT01227629|448858006|FG005|Overall Study|Adverse Event|1|||
124789325|NCT01227629|448858007|FG006|Overall Study|Adverse Event|6|||
124789326|NCT01227629|448858008|FG007|Overall Study|Adverse Event|6|||
124789327|NCT01227629|448858009|FG008|Overall Study|Adverse Event|4|||
124789328|NCT01227629|448858010|FG009|Overall Study|Adverse Event|0|||
124789329|NCT01227629|448858001|FG000|Overall Study|Protocol Violation|0|||
124789330|NCT01227629|448858002|FG001|Overall Study|Protocol Violation|0|||
124789331|NCT01227629|448858003|FG002|Overall Study|Protocol Violation|0|||
124789332|NCT01227629|448858004|FG003|Overall Study|Protocol Violation|1|||
124789333|NCT01227629|448858005|FG004|Overall Study|Protocol Violation|0|||
124789334|NCT01227629|448858006|FG005|Overall Study|Protocol Violation|0|||
124789335|NCT01227629|448858007|FG006|Overall Study|Protocol Violation|0|||
124789336|NCT01227629|448858008|FG007|Overall Study|Protocol Violation|0|||
124789337|NCT01227629|448858009|FG008|Overall Study|Protocol Violation|0|||
124789338|NCT01227629|448858010|FG009|Overall Study|Protocol Violation|0|||
124789339|NCT01227629|448858001|FG000|Overall Study|Lost to Follow-up|0|||
124789340|NCT01227629|448858002|FG001|Overall Study|Lost to Follow-up|0|||
124789341|NCT01227629|448858003|FG002|Overall Study|Lost to Follow-up|0|||
124789342|NCT01227629|448858004|FG003|Overall Study|Lost to Follow-up|0|||
124789343|NCT01227629|448858005|FG004|Overall Study|Lost to Follow-up|1|||
124789344|NCT01227629|448858006|FG005|Overall Study|Lost to Follow-up|0|||
124789345|NCT01227629|448858007|FG006|Overall Study|Lost to Follow-up|0|||
124789346|NCT01227629|448858008|FG007|Overall Study|Lost to Follow-up|0|||
124789347|NCT01227629|448858009|FG008|Overall Study|Lost to Follow-up|0|||
124789348|NCT01227629|448858010|FG009|Overall Study|Lost to Follow-up|0|||
124789349|NCT01227629|448858001|FG000|Overall Study|Withdrawal by Subject|0|||
124789350|NCT01227629|448858002|FG001|Overall Study|Withdrawal by Subject|0|||
124789351|NCT01227629|448858003|FG002|Overall Study|Withdrawal by Subject|0|||
124789352|NCT01227629|448858004|FG003|Overall Study|Withdrawal by Subject|0|||
124789353|NCT01227629|448858005|FG004|Overall Study|Withdrawal by Subject|0|||
124789354|NCT01227629|448858006|FG005|Overall Study|Withdrawal by Subject|0|||
124789355|NCT01227629|448858007|FG006|Overall Study|Withdrawal by Subject|2|||
124789356|NCT01227629|448858008|FG007|Overall Study|Withdrawal by Subject|0|||
124789357|NCT01227629|448858009|FG008|Overall Study|Withdrawal by Subject|0|||
124789358|NCT01227629|448858010|FG009|Overall Study|Withdrawal by Subject|1|||
124789359|NCT01227629|448858001|FG000|Overall Study|Other|0|||
124789360|NCT01227629|448858002|FG001|Overall Study|Other|0|||
124789361|NCT01227629|448858003|FG002|Overall Study|Other|0|||
124789362|NCT01227629|448858004|FG003|Overall Study|Other|1|||
124789363|NCT01227629|448858005|FG004|Overall Study|Other|0|||
124789364|NCT01227629|448858006|FG005|Overall Study|Other|0|||
124789365|NCT01227629|448858007|FG006|Overall Study|Other|0|||
124789366|NCT01227629|448858008|FG007|Overall Study|Other|0|||
124789367|NCT01227629|448858009|FG008|Overall Study|Other|2|||
124789368|NCT01227629|448858010|FG009|Overall Study|Other|1|||
124789369|NCT00534599|448858016|FG000|Overall Study|Adverse Event|25|||
124789370|NCT00534599|448858017|FG001|Overall Study|Adverse Event|4|||
124789371|NCT00534599|448858016|FG000|Overall Study|Incorrect enrollment|2|||
124789372|NCT00534599|448858017|FG001|Overall Study|Incorrect enrollment|1|||
124789373|NCT00534599|448858016|FG000|Overall Study|Mis-randomization|2|||
124789374|NCT00534599|448858017|FG001|Overall Study|Mis-randomization|2|||
124789375|NCT00534599|448858016|FG000|Overall Study|Developed study-specific d/c criteria|5|||
124789376|NCT00534599|448858017|FG001|Overall Study|Developed study-specific d/c criteria|0|||
124789377|NCT00534599|448858016|FG000|Overall Study|Lack of Efficacy|0|||
124789378|NCT00534599|448858017|FG001|Overall Study|Lack of Efficacy|1|||
124789379|NCT00534599|448858016|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
124789380|NCT00534599|448858017|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
124789381|NCT00534599|448858016|FG000|Overall Study|Protocol Violation|1|||
124789382|NCT00534599|448858017|FG001|Overall Study|Protocol Violation|3|||
124789383|NCT00534599|448858016|FG000|Overall Study|Lost to Follow-up|11|||
124789384|NCT00534599|448858017|FG001|Overall Study|Lost to Follow-up|14|||
124789385|NCT00534599|448858016|FG000|Overall Study|Withdrawal by Subject|4|||
124789386|NCT00534599|448858017|FG001|Overall Study|Withdrawal by Subject|6|||
124789387|NCT00534599|448858016|FG000|Overall Study|Other|7|||
124789388|NCT00534599|448858017|FG001|Overall Study|Other|0|||
124789389|NCT03865316|448859970|FG000|Overall Study|Procedure Cancelled|4|||
124789390|NCT03865316|448859970|FG000|Overall Study|Equipment failure|4|||
124789391|NCT02616146|448859971|FG000|Overall Study|Adverse Event|64|||
124789392|NCT02616146|448859972|FG001|Overall Study|Adverse Event|24|||
124789393|NCT02616146|448859971|FG000|Overall Study|Lost to Follow-up|23|||
124789394|NCT02616146|448859972|FG001|Overall Study|Lost to Follow-up|13|||
124789395|NCT02616146|448859971|FG000|Overall Study|Non-compliance with study protocol|2|||
124789396|NCT02616146|448859972|FG001|Overall Study|Non-compliance with study protocol|0|||
124789397|NCT02616146|448859971|FG000|Overall Study|Non-compliance with study drug|4|||
124789398|NCT02616146|448859972|FG001|Overall Study|Non-compliance with study drug|2|||
124789399|NCT02616146|448859971|FG000|Overall Study|Pregnancy|2|||
124789400|NCT02616146|448859972|FG001|Overall Study|Pregnancy|2|||
124789401|NCT02616146|448859971|FG000|Overall Study|Pregnancy wish|3|||
124789402|NCT02616146|448859972|FG001|Overall Study|Pregnancy wish|0|||
124789403|NCT02616146|448859971|FG000|Overall Study|Protocol Violation|6|||
124789404|NCT02616146|448859972|FG001|Overall Study|Protocol Violation|3|||
124789405|NCT02616146|448859971|FG000|Overall Study|Study terminated by sponsor|1372|||
124789406|NCT02616146|448859972|FG001|Overall Study|Study terminated by sponsor|432|||
124789407|NCT02616146|448859971|FG000|Overall Study|Participant moved|4|||
124789408|NCT02616146|448859972|FG001|Overall Study|Participant moved|3|||
124789409|NCT02616146|448859971|FG000|Overall Study|Withdrawal by Subject|30|||
124789410|NCT02616146|448859972|FG001|Overall Study|Withdrawal by Subject|24|||
124789411|NCT02616146|448859971|FG000|Overall Study|Physician Decision|2|||
124789412|NCT02616146|448859972|FG001|Overall Study|Physician Decision|1|||
124789413|NCT00336856|448859973|FG000|Overall Study|Withdrawal by Subject|3|||
124789414|NCT00336856|448859973|FG000|Overall Study|Found ineligible at time of analysis|1|||
124789415|NCT01604278|448859974|FG000|Overall Study|Lack of Efficacy|0|||
124789416|NCT01604278|448859975|FG001|Overall Study|Lack of Efficacy|1|||
124789417|NCT01604278|448859974|FG000|Overall Study|Lost to Follow-up|1|||
124789418|NCT01604278|448859975|FG001|Overall Study|Lost to Follow-up|0|||
124789419|NCT01604278|448859974|FG000|Overall Study|Administrative problems|2|||
124789420|NCT01604278|448859975|FG001|Overall Study|Administrative problems|1|||
124789421|NCT01604278|448859974|FG000|Overall Study|Withdrawal by Subject|3|||
124789422|NCT01604278|448859975|FG001|Overall Study|Withdrawal by Subject|3|||
124789423|NCT01604278|448859974|FG000|Overall Study|Adverse Event|3|||
124789424|NCT01604278|448859975|FG001|Overall Study|Adverse Event|5|||
124789425|NCT01604278|448859974|FG000|Overall Study|Protocol Deviation|5|||
124789426|NCT01604278|448859975|FG001|Overall Study|Protocol Deviation|3|||
124789427|NCT02184455|448859976|FG000|Overall Study|Lost to Follow-up|1|||
124789428|NCT01012219|448859977|FG000|Period 1|Withdrawal by Subject|1|||
124789429|NCT01012219|448859977|FG000|Period 2|Withdrawal by Subject|1|||
124789430|NCT01444092|448859988|FG000|Overall Study|Adverse Event|8|||
124789431|NCT01444092|448859988|FG000|Overall Study|Protocol Violation|1|||
124789432|NCT01444092|448859988|FG000|Overall Study|Withdrawal by Subject|1|||
124789433|NCT01444092|448859988|FG000|Overall Study|Other Eligibility criteria|7|||
124789434|NCT01328366|448859989|FG000|Overall Study|Death|1|||
124789435|NCT01328366|448859989|FG000|Overall Study|Withdrawal by Subject|2|||
124789436|NCT01328366|448859989|FG000|Overall Study|Lost to Follow-up|7|||
124789437|NCT01122264|448859993|FG000|Overall Study|Adverse Event|6|||
124789438|NCT01122264|448859994|FG001|Overall Study|Adverse Event|5|||
124789439|NCT01122264|448859995|FG002|Overall Study|Adverse Event|7|||
124789440|NCT01122264|448859993|FG000|Overall Study|Death|1|||
124789441|NCT01122264|448859994|FG001|Overall Study|Death|0|||
124789442|NCT01122264|448859995|FG002|Overall Study|Death|0|||
124789443|NCT01122264|448859993|FG000|Overall Study|Lost to Follow-up|5|||
124789444|NCT01122264|448859994|FG001|Overall Study|Lost to Follow-up|9|||
124789445|NCT01122264|448859995|FG002|Overall Study|Lost to Follow-up|13|||
124789446|NCT01122264|448859993|FG000|Overall Study|Entry Criteria Not Met|1|||
124789447|NCT01122264|448859994|FG001|Overall Study|Entry Criteria Not Met|0|||
124789448|NCT01122264|448859995|FG002|Overall Study|Entry Criteria Not Met|0|||
124789449|NCT01122264|448859993|FG000|Overall Study|Protocol Violation|7|||
124789450|NCT01122264|448859994|FG001|Overall Study|Protocol Violation|7|||
124789451|NCT01122264|448859995|FG002|Overall Study|Protocol Violation|9|||
124789452|NCT01122264|448859993|FG000|Overall Study|Withdrawal by Subject|6|||
124789453|NCT01122264|448859994|FG001|Overall Study|Withdrawal by Subject|6|||
124789454|NCT01122264|448859995|FG002|Overall Study|Withdrawal by Subject|16|||
124789455|NCT01122264|448859993|FG000|Overall Study|Physician Decision|3|||
124789456|NCT01122264|448859994|FG001|Overall Study|Physician Decision|1|||
124789457|NCT01122264|448859995|FG002|Overall Study|Physician Decision|1|||
124789458|NCT01122264|448859993|FG000|Overall Study|Lack of Efficacy|3|||
124789459|NCT01122264|448859994|FG001|Overall Study|Lack of Efficacy|1|||
124789460|NCT01122264|448859995|FG002|Overall Study|Lack of Efficacy|1|||
124789461|NCT03005873|448859996|FG000|Overall Study|Prohibited medication use post radnomization|1|||
124789462|NCT03005873|448859997|FG001|Overall Study|Prohibited medication use post radnomization|1|||
124789463|NCT03005873|448859998|FG002|Overall Study|Prohibited medication use post radnomization|1|||
124789464|NCT03005873|448859996|FG000|Overall Study|Withdrew consent|0|||
124789465|NCT03005873|448859997|FG001|Overall Study|Withdrew consent|1|||
124789466|NCT03005873|448859998|FG002|Overall Study|Withdrew consent|2|||
124789467|NCT03005873|448859996|FG000|Overall Study|Lost to Follow-up|0|||
124789468|NCT03005873|448859997|FG001|Overall Study|Lost to Follow-up|1|||
124789469|NCT03005873|448859998|FG002|Overall Study|Lost to Follow-up|0|||
124789470|NCT03005873|448859996|FG000|Overall Study|Ineligible post randomization|0|||
124789471|NCT03005873|448859997|FG001|Overall Study|Ineligible post randomization|0|||
124789472|NCT03005873|448859998|FG002|Overall Study|Ineligible post randomization|1|||
124789473|NCT04585009|448859999|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
124789474|NCT04585009|448860000|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789475|NCT04585009|448860001|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789476|NCT04585009|448860002|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789477|NCT04585009|448860003|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789478|NCT04585009|448860004|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789479|NCT04585009|448860005|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789480|NCT04585009|448860006|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789481|NCT04585009|448860007|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789482|NCT04585009|448860008|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789483|NCT04585009|448860009|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789484|NCT04585009|448860010|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789485|NCT04585009|448859999|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
124789486|NCT04585009|448860000|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789487|NCT04585009|448860001|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789488|NCT04585009|448860002|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789489|NCT04585009|448860003|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789490|NCT04585009|448860004|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789491|NCT04585009|448860005|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789492|NCT04585009|448860006|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789493|NCT04585009|448860007|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789494|NCT04585009|448860008|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789495|NCT04585009|448860009|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789496|NCT04585009|448860010|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789497|NCT04585009|448859999|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789498|NCT04585009|448860000|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789499|NCT04585009|448860001|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789500|NCT04585009|448860002|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789501|NCT04585009|448860003|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789502|NCT04585009|448860004|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789503|NCT04585009|448860005|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789504|NCT04585009|448860006|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
124789505|NCT04585009|448860007|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789506|NCT04585009|448860008|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789507|NCT04585009|448860009|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789508|NCT04585009|448860010|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789509|NCT04585009|448859999|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789510|NCT04585009|448860000|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789511|NCT04585009|448860001|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789512|NCT04585009|448860002|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789513|NCT04585009|448860003|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
124789514|NCT04585009|448860004|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789515|NCT04585009|448860005|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789516|NCT04585009|448860006|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789517|NCT04585009|448860007|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789518|NCT04585009|448860008|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789519|NCT04585009|448860009|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789520|NCT04585009|448860010|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789521|NCT04585009|448859999|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789522|NCT04585009|448860000|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789523|NCT04585009|448860001|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789524|NCT04585009|448860002|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789525|NCT04585009|448860003|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789526|NCT04585009|448860004|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789527|NCT04585009|448860005|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789528|NCT04585009|448860006|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789529|NCT04585009|448860007|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789530|NCT04585009|448860008|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
124789531|NCT04585009|448860009|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789532|NCT04585009|448860010|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789533|NCT04585009|448859999|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789534|NCT04585009|448860000|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789535|NCT04585009|448860001|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789536|NCT04585009|448860002|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789537|NCT04585009|448860003|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789538|NCT04585009|448860004|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789539|NCT04585009|448860005|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789540|NCT04585009|448860006|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789541|NCT04585009|448860007|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789542|NCT04585009|448860008|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789543|NCT04585009|448860009|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789544|NCT04585009|448860010|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
124789545|NCT00097981|448860019|FG000|Overall Study|Adverse Event|31|||
124789546|NCT00097981|448860020|FG001|Overall Study|Adverse Event|44|||
124789547|NCT00097981|448860019|FG000|Overall Study|Withdrawal by Subject|10|||
124789548|NCT00097981|448860020|FG001|Overall Study|Withdrawal by Subject|8|||
124789549|NCT00097981|448860019|FG000|Overall Study|Protocol Violation|1|||
124789550|NCT00097981|448860020|FG001|Overall Study|Protocol Violation|1|||
124789551|NCT00097981|448860019|FG000|Overall Study|Death|2|||
124789552|NCT00097981|448860020|FG001|Overall Study|Death|4|||
124789553|NCT00097981|448860019|FG000|Overall Study|Physician Decision|7|||
124789554|NCT00097981|448860020|FG001|Overall Study|Physician Decision|1|||
124789555|NCT00097981|448860019|FG000|Overall Study|Disease Progression|8|||
124789556|NCT00097981|448860020|FG001|Overall Study|Disease Progression|2|||
124789557|NCT00097981|448860019|FG000|Overall Study|Transplant planned|28|||
124789558|NCT00097981|448860020|FG001|Overall Study|Transplant planned|27|||
124789559|NCT00097981|448860019|FG000|Overall Study|Other|19|||
124789560|NCT00097981|448860020|FG001|Overall Study|Other|13|||
124789561|NCT00895011|448860022|FG000|Overall Study|Withdrawal by Subject|14|||
124789562|NCT00895011|448860023|FG001|Overall Study|Withdrawal by Subject|7|||
124789563|NCT00895011|448860024|FG002|Overall Study|Withdrawal by Subject|2|||
124789564|NCT00895011|448860022|FG000|Overall Study|Lost to Follow-up|5|||
124789565|NCT00895011|448860023|FG001|Overall Study|Lost to Follow-up|4|||
124789566|NCT00895011|448860024|FG002|Overall Study|Lost to Follow-up|1|||
124789567|NCT00895011|448860022|FG000|Overall Study|Protocol Violation|3|||
124789568|NCT00895011|448860023|FG001|Overall Study|Protocol Violation|1|||
124789569|NCT00895011|448860024|FG002|Overall Study|Protocol Violation|3|||
124789570|NCT00895011|448860022|FG000|Overall Study|Adverse Event|1|||
124789571|NCT00895011|448860023|FG001|Overall Study|Adverse Event|2|||
124789572|NCT00895011|448860024|FG002|Overall Study|Adverse Event|2|||
124789573|NCT00895011|448860022|FG000|Overall Study|schedule conflict|1|||
124789574|NCT00895011|448860023|FG001|Overall Study|schedule conflict|0|||
124789575|NCT00895011|448860024|FG002|Overall Study|schedule conflict|0|||
124789576|NCT02230527|448860026|FG000|Overall Study|Withdrawal by Subject|1|||
124789577|NCT02230527|448860027|FG001|Overall Study|Withdrawal by Subject|1|||
124789578|NCT02230527|448860026|FG000|Overall Study|Death|1|||
124789579|NCT02230527|448860027|FG001|Overall Study|Death|0|||
124789580|NCT02230527|448860026|FG000|Overall Study|Lost to Follow-up|2|||
124789581|NCT02230527|448860027|FG001|Overall Study|Lost to Follow-up|1|||
124789582|NCT02230527|448860026|FG000|Overall Study|Other|1|||
124789583|NCT02230527|448860027|FG001|Overall Study|Other|0|||
124789584|NCT04461600|448860029|FG000|Overall Study|Death|6|||
124789585|NCT04461600|448860030|FG001|Overall Study|Death|5|||
124789586|NCT04461600|448860029|FG000|Overall Study|Withdrawal by Subject|0|||
124789587|NCT04461600|448860030|FG001|Overall Study|Withdrawal by Subject|1|||
124789588|NCT01242813|448860031|FG000|Overall Study|Lost to Follow-up|2|||
124789589|NCT01369329|448860034|FG000|Overall Study|Withdrawal by Subject|8|||
124789590|NCT01369329|448860035|FG001|Overall Study|Withdrawal by Subject|6|||
124789591|NCT01369329|448860036|FG002|Overall Study|Withdrawal by Subject|10|||
124789592|NCT01369329|448860034|FG000|Overall Study|Lost to Follow-up|2|||
124789593|NCT01369329|448860035|FG001|Overall Study|Lost to Follow-up|2|||
124789594|NCT01369329|448860036|FG002|Overall Study|Lost to Follow-up|2|||
124789595|NCT01369329|448860034|FG000|Overall Study|Other|2|||
124789596|NCT01369329|448860035|FG001|Overall Study|Other|3|||
124789597|NCT01369329|448860036|FG002|Overall Study|Other|2|||
124789598|NCT01252667|448860037|FG000|Overall Study|Transplant aborted post-conditioning|0|||
124789599|NCT01252667|448860038|FG001|Overall Study|Transplant aborted post-conditioning|0|||
124789600|NCT01252667|448860039|FG002|Overall Study|Transplant aborted post-conditioning|0|||
124789601|NCT01252667|448860040|FG003|Overall Study|Transplant aborted post-conditioning|0|||
124789602|NCT01252667|448860041|FG004|Overall Study|Transplant aborted post-conditioning|0|||
124789603|NCT01252667|448860042|FG005|Overall Study|Transplant aborted post-conditioning|1|||
124789604|NCT01836276|448860043|FG000|Overall Study|Lost to Follow-up|28|||
124789605|NCT01836276|448860044|FG001|Overall Study|Lost to Follow-up|51|||
124789606|NCT00331552|448860047|FG000|Period 3: Phase II|Neurological Symptoms|1|||
124789607|NCT00331552|448860048|FG001|Period 3: Phase II|Neurological Symptoms|0|||
124789608|NCT00331552|448860047|FG000|Period 3: Phase II|Severe Nausea|1|||
124789609|NCT00331552|448860048|FG001|Period 3: Phase II|Severe Nausea|0|||
124789610|NCT02577887|448860050|FG000|Overall Study|Death|93|||
124789611|NCT02577887|448860050|FG000|Overall Study|Protocol Violation|125|||
124789612|NCT02577887|448860050|FG000|Overall Study|Withdrawal by Subject|80|||
124789613|NCT03560518|448860051|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
124789614|NCT03560518|448860052|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
124789615|NCT03560518|448860053|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
124789616|NCT03560518|448860051|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
124789617|NCT03560518|448860052|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
124789618|NCT03560518|448860053|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
124789619|NCT03560518|448860051|FG000|Double Blind Treatment Period|Protocol Violation|1|||
124789620|NCT03560518|448860052|FG001|Double Blind Treatment Period|Protocol Violation|2|||
124789621|NCT03560518|448860053|FG002|Double Blind Treatment Period|Protocol Violation|0|||
124789622|NCT03560518|448860051|FG000|Double Blind Treatment Period|Pregnancy|0|||
124789623|NCT03560518|448860052|FG001|Double Blind Treatment Period|Pregnancy|2|||
124789624|NCT03560518|448860053|FG002|Double Blind Treatment Period|Pregnancy|0|||
124789625|NCT03560518|448860051|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
124789626|NCT03560518|448860052|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
124789627|NCT03560518|448860053|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
124789628|NCT03560518|448860051|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
124789629|NCT03560518|448860052|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
124789630|NCT03560518|448860053|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
124789631|NCT03560518|448860051|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
124789632|NCT03560518|448860052|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
124789633|NCT03560518|448860053|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
124789634|NCT03560518|448860051|FG000|Double Blind Treatment Period|Adverse Event|0|||
124789635|NCT03560518|448860052|FG001|Double Blind Treatment Period|Adverse Event|3|||
124789636|NCT03560518|448860053|FG002|Double Blind Treatment Period|Adverse Event|1|||
124789637|NCT02984943|448860055|FG000|Overall Study|Withdrawal by Subject|3|||
124789638|NCT02984943|448860055|FG000|Overall Study|Physician Decision|1|||
124789639|NCT01133990|448860056|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
124789640|NCT01133990|448860057|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
124789641|NCT01133990|448860058|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
124789642|NCT01133990|448860059|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
124789643|NCT01133990|448860060|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
124789644|NCT01133990|448860061|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
124789645|NCT01133990|448860056|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
124789646|NCT01133990|448860057|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
124789647|NCT01133990|448860058|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
124789648|NCT01133990|448860059|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
124789649|NCT01133990|448860060|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
124789650|NCT01133990|448860061|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
124789651|NCT01133990|448860056|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
124789652|NCT01133990|448860057|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
124789653|NCT01133990|448860058|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
124789654|NCT01133990|448860059|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
124789655|NCT01133990|448860060|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
124789656|NCT01133990|448860061|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
124789657|NCT01133990|448860056|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
124789658|NCT01133990|448860057|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
124789659|NCT01133990|448860058|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
124789660|NCT01133990|448860059|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
124789661|NCT01133990|448860060|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
124789662|NCT01133990|448860061|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
124789663|NCT05277337|448860062|FG000|Overall Study|Lost to Follow-up|2|||
124789664|NCT05277337|448860063|FG001|Overall Study|Lost to Follow-up|0|||
124789665|NCT05277337|448860062|FG000|Overall Study|Withdrawal by Subject|1|||
124789666|NCT05277337|448860063|FG001|Overall Study|Withdrawal by Subject|0|||
124789667|NCT02282345|448860065|FG000|Overall Study|Progression|0|||
124789668|NCT02282345|448860066|FG001|Overall Study|Progression|1|||
124789669|NCT01185301|448860067|FG000|Overall Study|Adverse Event|3|||
124789670|NCT01185301|448860068|FG001|Overall Study|Adverse Event|0|||
124789671|NCT01185301|448860069|FG002|Overall Study|Adverse Event|2|||
124789672|NCT01185301|448860070|FG003|Overall Study|Adverse Event|3|||
124789673|NCT01185301|448860067|FG000|Overall Study|Withdrawal by Subject|7|||
124789674|NCT01185301|448860068|FG001|Overall Study|Withdrawal by Subject|5|||
124789675|NCT01185301|448860069|FG002|Overall Study|Withdrawal by Subject|2|||
124789676|NCT01185301|448860070|FG003|Overall Study|Withdrawal by Subject|3|||
124789677|NCT01185301|448860067|FG000|Overall Study|Lost to Follow-up|2|||
124789678|NCT01185301|448860068|FG001|Overall Study|Lost to Follow-up|0|||
124789679|NCT01185301|448860069|FG002|Overall Study|Lost to Follow-up|0|||
124789680|NCT01185301|448860070|FG003|Overall Study|Lost to Follow-up|1|||
124789681|NCT01185301|448860067|FG000|Overall Study|Other Reason|3|||
124789682|NCT01185301|448860068|FG001|Overall Study|Other Reason|2|||
124789683|NCT01185301|448860069|FG002|Overall Study|Other Reason|2|||
124789684|NCT01185301|448860070|FG003|Overall Study|Other Reason|2|||
124789685|NCT02683746|448860071|FG000|Overall Study|Adverse Event|3|||
124789686|NCT02683746|448860072|FG001|Overall Study|Adverse Event|2|||
124789687|NCT02683746|448860071|FG000|Overall Study|Lost to Follow-up|5|||
124789688|NCT02683746|448860072|FG001|Overall Study|Lost to Follow-up|6|||
124789689|NCT02683746|448860071|FG000|Overall Study|Withdrawal by Subject|6|||
124789690|NCT02683746|448860072|FG001|Overall Study|Withdrawal by Subject|5|||
124789691|NCT02683746|448860071|FG000|Overall Study|Physician Decision|2|||
124789692|NCT02683746|448860072|FG001|Overall Study|Physician Decision|1|||
124789693|NCT04987944|448860073|FG000|Overall Study|Adverse Event|0|||
124789694|NCT04987944|448860074|FG001|Overall Study|Adverse Event|1|||
124789695|NCT04987944|448860073|FG000|Overall Study|Withdrawal by Subject|0|||
124789696|NCT04987944|448860074|FG001|Overall Study|Withdrawal by Subject|1|||
124789697|NCT02353143|448860079|FG000|Overall Study|Withdrawal by Subject|1|||
124789698|NCT02353143|448860080|FG001|Overall Study|Withdrawal by Subject|0|||
124789699|NCT02353143|448860081|FG002|Overall Study|Withdrawal by Subject|0|||
124789700|NCT02353143|448860082|FG003|Overall Study|Withdrawal by Subject|0|||
124789701|NCT02353143|448860083|FG004|Overall Study|Withdrawal by Subject|1|||
124789702|NCT02353143|448860084|FG005|Overall Study|Withdrawal by Subject|0|||
124789703|NCT02353143|448860085|FG006|Overall Study|Withdrawal by Subject|0|||
124789704|NCT02353143|448860086|FG007|Overall Study|Withdrawal by Subject|1|||
124789705|NCT02353143|448860087|FG008|Overall Study|Withdrawal by Subject|1|||
124789706|NCT02353143|448860079|FG000|Overall Study|Lack of Efficacy|2|||
124789707|NCT02353143|448860080|FG001|Overall Study|Lack of Efficacy|1|||
124789708|NCT02353143|448860081|FG002|Overall Study|Lack of Efficacy|2|||
124789709|NCT02353143|448860082|FG003|Overall Study|Lack of Efficacy|4|||
124789710|NCT02353143|448860083|FG004|Overall Study|Lack of Efficacy|13|||
124789711|NCT02353143|448860084|FG005|Overall Study|Lack of Efficacy|2|||
124789712|NCT02353143|448860085|FG006|Overall Study|Lack of Efficacy|2|||
124789713|NCT02353143|448860086|FG007|Overall Study|Lack of Efficacy|2|||
124789714|NCT02353143|448860087|FG008|Overall Study|Lack of Efficacy|1|||
124789715|NCT02353143|448860079|FG000|Overall Study|reason not specified|1|||
124789716|NCT02353143|448860080|FG001|Overall Study|reason not specified|2|||
124789717|NCT02353143|448860081|FG002|Overall Study|reason not specified|0|||
124789718|NCT02353143|448860082|FG003|Overall Study|reason not specified|0|||
124789719|NCT02353143|448860083|FG004|Overall Study|reason not specified|6|||
124789720|NCT02353143|448860084|FG005|Overall Study|reason not specified|1|||
124789721|NCT02353143|448860085|FG006|Overall Study|reason not specified|0|||
124789722|NCT02353143|448860086|FG007|Overall Study|reason not specified|3|||
125294127|NCT01565941|450705215|FG001|Overall Study|Withdrawn by parent/guardian|2|||
125294128|NCT01565941|450705214|FG000|Overall Study|Randomized; did not receive intevention|8|||
125294129|NCT01565941|450705215|FG001|Overall Study|Randomized; did not receive intevention|2|||
125294130|NCT04047420|450705216|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
125294131|NCT04047420|450705216|FG000|Washout Period|Refused Participation|2|||
125294132|NCT03242018|450705217|FG000|Overall Study|Adverse Event|7|||
125294133|NCT03242018|450705218|FG001|Overall Study|Adverse Event|7|||
125294134|NCT03242018|450705219|FG002|Overall Study|Adverse Event|6|||
125294135|NCT03242018|450705217|FG000|Overall Study|Lost to Follow-up|2|||
125294136|NCT03242018|450705218|FG001|Overall Study|Lost to Follow-up|2|||
125294137|NCT03242018|450705219|FG002|Overall Study|Lost to Follow-up|2|||
125294138|NCT03242018|450705217|FG000|Overall Study|At the Participant's Own Request|5|||
125294139|NCT03242018|450705218|FG001|Overall Study|At the Participant's Own Request|1|||
125294140|NCT03242018|450705219|FG002|Overall Study|At the Participant's Own Request|4|||
125294141|NCT03242018|450705217|FG000|Overall Study|Reason Not Specified|3|||
125294142|NCT03242018|450705218|FG001|Overall Study|Reason Not Specified|4|||
125294143|NCT03242018|450705219|FG002|Overall Study|Reason Not Specified|1|||
125294144|NCT03242018|450705217|FG000|Overall Study|Study Terminated by Sponsor|1|||
125294145|NCT03242018|450705218|FG001|Overall Study|Study Terminated by Sponsor|0|||
125294146|NCT03242018|450705219|FG002|Overall Study|Study Terminated by Sponsor|1|||
125294147|NCT03262116|450705220|FG000|Overall Study|Physician Decision|0|||
125294148|NCT03262116|450705221|FG001|Overall Study|Physician Decision|2|||
125294149|NCT03262116|450705222|FG002|Overall Study|Physician Decision|1|||
125294150|NCT03262116|450705223|FG003|Overall Study|Physician Decision|1|||
124789723|NCT02353143|448860087|FG008|Overall Study|reason not specified|1|||
124789724|NCT02353143|448860079|FG000|Overall Study|Physician Decision|0|||
124789725|NCT02353143|448860080|FG001|Overall Study|Physician Decision|4|||
124789726|NCT02353143|448860081|FG002|Overall Study|Physician Decision|2|||
124789727|NCT02353143|448860082|FG003|Overall Study|Physician Decision|3|||
124789728|NCT02353143|448860083|FG004|Overall Study|Physician Decision|4|||
124789729|NCT02353143|448860084|FG005|Overall Study|Physician Decision|0|||
124789730|NCT02353143|448860085|FG006|Overall Study|Physician Decision|1|||
124789731|NCT02353143|448860086|FG007|Overall Study|Physician Decision|2|||
124789732|NCT02353143|448860087|FG008|Overall Study|Physician Decision|0|||
124789733|NCT02353143|448860079|FG000|Overall Study|Adverse Event|0|||
124789734|NCT02353143|448860080|FG001|Overall Study|Adverse Event|0|||
124789735|NCT02353143|448860081|FG002|Overall Study|Adverse Event|1|||
124789736|NCT02353143|448860082|FG003|Overall Study|Adverse Event|0|||
124789737|NCT02353143|448860083|FG004|Overall Study|Adverse Event|1|||
124789738|NCT02353143|448860084|FG005|Overall Study|Adverse Event|1|||
124789739|NCT02353143|448860085|FG006|Overall Study|Adverse Event|0|||
124789740|NCT02353143|448860086|FG007|Overall Study|Adverse Event|0|||
124789741|NCT02353143|448860087|FG008|Overall Study|Adverse Event|0|||
124789742|NCT02353143|448860079|FG000|Overall Study|patient receiving other treatment for AML|0|||
124789743|NCT02353143|448860080|FG001|Overall Study|patient receiving other treatment for AML|0|||
124789744|NCT02353143|448860081|FG002|Overall Study|patient receiving other treatment for AML|1|||
124789745|NCT02353143|448860082|FG003|Overall Study|patient receiving other treatment for AML|0|||
124789746|NCT02353143|448860083|FG004|Overall Study|patient receiving other treatment for AML|0|||
124789747|NCT02353143|448860084|FG005|Overall Study|patient receiving other treatment for AML|0|||
124789748|NCT02353143|448860085|FG006|Overall Study|patient receiving other treatment for AML|0|||
124789749|NCT02353143|448860086|FG007|Overall Study|patient receiving other treatment for AML|0|||
124789750|NCT02353143|448860087|FG008|Overall Study|patient receiving other treatment for AML|0|||
124789751|NCT02353143|448860079|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
124789752|NCT02353143|448860080|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
124789753|NCT02353143|448860081|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
124789754|NCT02353143|448860082|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
124789755|NCT02353143|448860083|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
124789756|NCT02353143|448860084|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
124789757|NCT02353143|448860085|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
124789758|NCT02353143|448860086|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
124789759|NCT02353143|448860087|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
124789760|NCT02946931|448860090|FG000|Overall Study|Did not require collection of CRFs|588|||
124789761|NCT02946931|448860090|FG000|Overall Study|Other than listed|37|||
124789762|NCT02946931|448860090|FG000|Overall Study|Discharge from hospital|118|||
124789763|NCT02946931|448860090|FG000|Overall Study|Adverse Event|81|||
124789764|NCT02946931|448860090|FG000|Overall Study|CRFs not valid|1|||
124789765|NCT02946931|448860090|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
124789766|NCT02213133|448860091|FG000|Overall Study|Participant discontinued study therapy|2|||
124789767|NCT02213133|448860092|FG001|Overall Study|Participant discontinued study therapy|0|||
124789768|NCT02213133|448860093|FG002|Overall Study|Participant discontinued study therapy|0|||
124789769|NCT02213133|448860091|FG000|Overall Study|Participant withdrew informed consent|2|||
124789770|NCT02213133|448860092|FG001|Overall Study|Participant withdrew informed consent|1|||
124789771|NCT02213133|448860093|FG002|Overall Study|Participant withdrew informed consent|2|||
124789772|NCT02213133|448860091|FG000|Overall Study|Disease progression|11|||
124789773|NCT02213133|448860092|FG001|Overall Study|Disease progression|2|||
124789774|NCT02213133|448860093|FG002|Overall Study|Disease progression|0|||
124789775|NCT02213133|448860091|FG000|Overall Study|Adverse Event (AE)|1|||
124789776|NCT02213133|448860092|FG001|Overall Study|Adverse Event (AE)|0|||
124789777|NCT02213133|448860093|FG002|Overall Study|Adverse Event (AE)|0|||
124789778|NCT02213133|448860091|FG000|Overall Study|Death|16|||
124789779|NCT02213133|448860092|FG001|Overall Study|Death|2|||
124789780|NCT02213133|448860093|FG002|Overall Study|Death|1|||
124789781|NCT02213133|448860091|FG000|Overall Study|Other|5|||
124789782|NCT02213133|448860092|FG001|Overall Study|Other|0|||
124789783|NCT02213133|448860093|FG002|Overall Study|Other|0|||
124789784|NCT04740905|448860102|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
124789785|NCT04740905|448860103|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
124789786|NCT04740905|448860102|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
124789787|NCT04740905|448860103|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
124789788|NCT04740905|448860102|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
124789789|NCT04740905|448860103|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
124789790|NCT04740905|448860102|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
124789791|NCT04740905|448860103|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
124789792|NCT04740905|448860102|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
124789793|NCT04740905|448860103|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
124789794|NCT04740905|448860102|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
124789795|NCT04740905|448860103|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
124789796|NCT04740905|448860102|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
124789797|NCT04740905|448860103|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
124789798|NCT04740905|448860102|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
124789799|NCT04740905|448860103|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
124789800|NCT04740905|448860102|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
124789801|NCT04740905|448860103|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
124789802|NCT04740905|448860102|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
124789803|NCT04740905|448860103|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
124789804|NCT04740905|448860102|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
124789805|NCT04740905|448860103|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
124789806|NCT04740905|448860102|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
124789807|NCT04740905|448860103|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
124789808|NCT04740905|448860102|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
124789809|NCT04740905|448860103|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
124789810|NCT04740905|448860102|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
124789811|NCT04740905|448860103|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
124789812|NCT02412488|448860108|FG000|Overall Study|Lost to Follow-up|10|||
124789813|NCT02412488|448860108|FG000|Overall Study|Withdrawal by Subject|5|||
124789814|NCT02412488|448860108|FG000|Overall Study|Physician Decision|1|||
124789815|NCT02412488|448860108|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
124789816|NCT02412488|448860108|FG000|Overall Study|Reveal LINQ explant|1|||
124789817|NCT01989468|448860109|FG000|Overall Study|Adverse Event|10|||
124789818|NCT01989468|448860110|FG001|Overall Study|Adverse Event|15|||
124789819|NCT01989468|448860111|FG002|Overall Study|Adverse Event|4|||
124789820|NCT01989468|448860112|FG003|Overall Study|Adverse Event|5|||
124789821|NCT01989468|448860113|FG004|Overall Study|Adverse Event|4|||
124789822|NCT01989468|448860109|FG000|Overall Study|Lack of Efficacy|11|||
124789823|NCT01989468|448860110|FG001|Overall Study|Lack of Efficacy|11|||
124789824|NCT01989468|448860111|FG002|Overall Study|Lack of Efficacy|7|||
124789825|NCT01989468|448860112|FG003|Overall Study|Lack of Efficacy|4|||
124789826|NCT01989468|448860113|FG004|Overall Study|Lack of Efficacy|2|||
124789827|NCT01989468|448860109|FG000|Overall Study|Lost to Follow-up|5|||
124789828|NCT01989468|448860110|FG001|Overall Study|Lost to Follow-up|2|||
124789829|NCT01989468|448860111|FG002|Overall Study|Lost to Follow-up|0|||
124789830|NCT01989468|448860112|FG003|Overall Study|Lost to Follow-up|1|||
124789831|NCT01989468|448860113|FG004|Overall Study|Lost to Follow-up|1|||
124789832|NCT01989468|448860109|FG000|Overall Study|Physician Decision|4|||
124789833|NCT01989468|448860110|FG001|Overall Study|Physician Decision|1|||
124789834|NCT01989468|448860111|FG002|Overall Study|Physician Decision|0|||
124789835|NCT01989468|448860112|FG003|Overall Study|Physician Decision|1|||
124789836|NCT01989468|448860113|FG004|Overall Study|Physician Decision|0|||
124789837|NCT01989468|448860109|FG000|Overall Study|Pregnancy|0|||
124789838|NCT01989468|448860110|FG001|Overall Study|Pregnancy|1|||
124789839|NCT01989468|448860111|FG002|Overall Study|Pregnancy|0|||
124789840|NCT01989468|448860112|FG003|Overall Study|Pregnancy|0|||
124789841|NCT01989468|448860113|FG004|Overall Study|Pregnancy|0|||
124789842|NCT01989468|448860109|FG000|Overall Study|Technical Problems|3|||
124789843|NCT01989468|448860110|FG001|Overall Study|Technical Problems|1|||
124789844|NCT01989468|448860111|FG002|Overall Study|Technical Problems|3|||
124789845|NCT01989468|448860112|FG003|Overall Study|Technical Problems|1|||
124789846|NCT01989468|448860113|FG004|Overall Study|Technical Problems|0|||
124789847|NCT01989468|448860109|FG000|Overall Study|Subject Guardian Decision|11|||
124789848|NCT01989468|448860110|FG001|Overall Study|Subject Guardian Decision|6|||
124789849|NCT01989468|448860111|FG002|Overall Study|Subject Guardian Decision|4|||
124789850|NCT01989468|448860112|FG003|Overall Study|Subject Guardian Decision|4|||
124789851|NCT01989468|448860113|FG004|Overall Study|Subject Guardian Decision|1|||
124789852|NCT01989468|448860109|FG000|Overall Study|Death|3|||
124789853|NCT01989468|448860110|FG001|Overall Study|Death|0|||
124789854|NCT01989468|448860111|FG002|Overall Study|Death|1|||
124789855|NCT01989468|448860112|FG003|Overall Study|Death|0|||
124789856|NCT01989468|448860113|FG004|Overall Study|Death|0|||
124789857|NCT03222492|448860116|FG000|Overall Study|Withdrawal by Subject|0|||
124789858|NCT03222492|448860117|FG001|Overall Study|Withdrawal by Subject|0|||
124789859|NCT03222492|448860118|FG002|Overall Study|Withdrawal by Subject|1|||
124789860|NCT03222492|448860119|FG003|Overall Study|Withdrawal by Subject|0|||
124789861|NCT03222492|448860116|FG000|Overall Study|COVID-19 related|0|||
124789862|NCT03222492|448860117|FG001|Overall Study|COVID-19 related|0|||
124789863|NCT03222492|448860118|FG002|Overall Study|COVID-19 related|1|||
124789864|NCT03222492|448860119|FG003|Overall Study|COVID-19 related|0|||
124789865|NCT01224782|448860125|FG000|Overall Study|Lost to Follow-up|177|||
124789866|NCT01224782|448860125|FG000|Overall Study|Withdrawal by Subject|16|||
124789867|NCT01224782|448860125|FG000|Overall Study|Death|14|||
124789868|NCT01224782|448860125|FG000|Overall Study|Improvement|13|||
124789869|NCT01224782|448860125|FG000|Overall Study|Adverse Event|12|||
124789870|NCT01224782|448860125|FG000|Overall Study|Adverse Reaction|11|||
124789871|NCT01224782|448860125|FG000|Overall Study|Noncompliance|10|||
124789872|NCT01224782|448860125|FG000|Overall Study|Other|4|||
124789873|NCT01224782|448860125|FG000|Overall Study|Start of Dialysis|3|||
124789874|NCT01224782|448860125|FG000|Overall Study|Change of Treatment|1|||
124789875|NCT01224782|448860125|FG000|Overall Study|Financial Reasons|1|||
124789876|NCT01224782|448860125|FG000|Overall Study|Deterioration|1|||
124789877|NCT01224782|448860125|FG000|Overall Study|Transplantation|1|||
124789878|NCT00065429|448860128|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
124789879|NCT00065429|448860129|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
124789880|NCT00065429|448860130|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
124789881|NCT00065429|448860131|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
124789882|NCT00065429|448860132|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
124789883|NCT00065429|448860133|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
124789884|NCT00065429|448860134|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
124789885|NCT00065429|448860128|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
124789886|NCT00065429|448860129|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
124789887|NCT00065429|448860130|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
124789888|NCT00065429|448860131|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
124789889|NCT00065429|448860132|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
124789890|NCT00065429|448860133|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
124789891|NCT00065429|448860134|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
124789892|NCT00065429|448860128|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
124789893|NCT00065429|448860129|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
124789894|NCT00065429|448860130|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
124789895|NCT00065429|448860131|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
124789896|NCT00065429|448860132|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
124789897|NCT00065429|448860133|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
124789898|NCT00065429|448860134|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
124789899|NCT00065429|448860128|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
124789900|NCT00065429|448860129|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
124789901|NCT00065429|448860130|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
124789902|NCT00065429|448860131|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
124789903|NCT00065429|448860132|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
124789904|NCT00065429|448860133|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
124789905|NCT00065429|448860134|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
124789906|NCT00065429|448860128|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
124789907|NCT00065429|448860129|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
124789908|NCT00065429|448860130|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
124789909|NCT00065429|448860131|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
124789910|NCT00065429|448860132|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
124789911|NCT00065429|448860133|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
124789912|NCT00065429|448860134|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
124789913|NCT00065429|448860128|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
124789914|NCT00065429|448860129|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
124789915|NCT00065429|448860130|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
124789916|NCT00065429|448860131|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
124789917|NCT00065429|448860132|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
124789918|NCT00065429|448860133|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
124789919|NCT00065429|448860134|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
124789920|NCT00065429|448860128|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
124789921|NCT00065429|448860129|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
124789922|NCT00065429|448860130|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
124789923|NCT00065429|448860131|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
125294151|NCT03262116|450705224|FG004|Overall Study|Physician Decision|1|||
125294152|NCT03262116|450705225|FG005|Overall Study|Physician Decision|2|||
125294153|NCT02365285|450705226|FG000|Overall Study|Physician Decision|0|||
125294154|NCT02365285|450705227|FG001|Overall Study|Physician Decision|1|||
125294155|NCT02365285|450705228|FG002|Overall Study|Physician Decision|1|||
125294156|NCT02365285|450705229|FG003|Overall Study|Physician Decision|0|||
125294157|NCT02365285|450705226|FG000|Overall Study|Adverse Event|0|||
125294158|NCT02365285|450705227|FG001|Overall Study|Adverse Event|0|||
125294159|NCT02365285|450705228|FG002|Overall Study|Adverse Event|0|||
125294160|NCT02365285|450705229|FG003|Overall Study|Adverse Event|2|||
125294161|NCT02636946|450705232|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
125294162|NCT02636946|450705233|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
125294163|NCT02636946|450705232|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
125294164|NCT02636946|450705233|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
125294165|NCT02636946|450705232|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
125294166|NCT02636946|450705233|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
125294167|NCT02636946|450705232|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
125294168|NCT02636946|450705233|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
125294169|NCT02636946|450705232|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
124789924|NCT00065429|448860132|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
124789925|NCT00065429|448860133|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
124789926|NCT00065429|448860134|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
124789927|NCT02015221|448860137|FG000|Overall Study|Withdrawal by Subject|8|||
124789928|NCT02015221|448860138|FG001|Overall Study|Withdrawal by Subject|6|||
125294170|NCT02636946|450705233|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
125294171|NCT02636946|450705232|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
125294172|NCT02636946|450705233|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
124789929|NCT02015221|448860137|FG000|Overall Study|Lost to Follow-up|1|||
124789930|NCT02015221|448860138|FG001|Overall Study|Lost to Follow-up|0|||
124789931|NCT00995566|448860139|FG000|Overall Study|Adverse Event|2|||
124789932|NCT00995566|448860139|FG000|Overall Study|Early study termination|52|||
125294173|NCT00121641|450705236|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
125294174|NCT00121641|450705237|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
125294175|NCT00121641|450705238|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
125294176|NCT00121641|450705239|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
125294177|NCT00121641|450705240|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
125294178|NCT00121641|450705236|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
125294179|NCT00121641|450705237|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
125294180|NCT00121641|450705238|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
125294181|NCT00121641|450705239|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
125294182|NCT00121641|450705240|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
125294183|NCT00121641|450705236|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
125294184|NCT00121641|450705237|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
125294185|NCT00121641|450705238|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
125294186|NCT00121641|450705239|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
125294187|NCT00121641|450705240|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
125294188|NCT00121641|450705236|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
125294189|NCT00121641|450705237|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
125294190|NCT00121641|450705238|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
125294191|NCT00121641|450705239|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
125294192|NCT00121641|450705240|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
125294193|NCT00121641|450705236|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
125294194|NCT00121641|450705237|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
125294195|NCT00121641|450705238|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
125294196|NCT00121641|450705239|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
125294197|NCT00121641|450705240|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
125294198|NCT00121641|450705236|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
125294199|NCT00121641|450705237|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
125294200|NCT00121641|450705238|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
125294201|NCT00121641|450705239|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
125294202|NCT00121641|450705240|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
125294203|NCT00121641|450705236|FG000|24-week Short-term Treatment Period|Other Reason|1|||
125294204|NCT00121641|450705237|FG001|24-week Short-term Treatment Period|Other Reason|0|||
125294205|NCT00121641|450705238|FG002|24-week Short-term Treatment Period|Other Reason|0|||
125294206|NCT00121641|450705239|FG003|24-week Short-term Treatment Period|Other Reason|0|||
125294207|NCT00121641|450705240|FG004|24-week Short-term Treatment Period|Other Reason|0|||
125294208|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
125294209|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
125294210|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
125294211|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
125294212|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
125294213|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
125294214|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
125294215|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
125294216|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
125294217|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
125294218|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
125294219|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
125294220|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
125294221|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
125294222|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
125294223|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
125294224|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
125294225|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
125294226|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
125294227|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
125294228|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
125294229|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
125294230|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
125294231|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
125294232|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
125294233|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
124789933|NCT01576159|448860140|FG000|Overall Study|Withdrawal by Subject|0|||
125294234|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
125294235|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
125303176|NCT03100058|450736673|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125294236|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
125294237|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
125294238|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
125294239|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
125294240|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
125294241|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
125294242|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
125294243|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
125294244|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
125294245|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
125294246|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
125294247|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
125294248|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Death|0|||
125294249|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Death|0|||
125294250|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Death|0|||
125294251|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Death|1|||
125294252|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Death|0|||
125294253|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Missing|0|||
125294254|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Missing|0|||
125294255|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Missing|1|||
125294256|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Missing|0|||
125294257|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Missing|0|||
125294258|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
125294259|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
125294260|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
125294261|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
125294262|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
125294263|NCT01792518|450705241|FG000|Overall Study|Adverse Event|3|||
125294264|NCT01792518|450705242|FG001|Overall Study|Adverse Event|4|||
125294265|NCT01792518|450705241|FG000|Overall Study|Protocol Violation|0|||
125294266|NCT01792518|450705242|FG001|Overall Study|Protocol Violation|1|||
125294267|NCT01792518|450705241|FG000|Overall Study|Lost to Follow-up|3|||
125294268|NCT01792518|450705242|FG001|Overall Study|Lost to Follow-up|1|||
125294269|NCT01792518|450705241|FG000|Overall Study|Withdrawal by Subject|2|||
125294270|NCT01792518|450705242|FG001|Overall Study|Withdrawal by Subject|0|||
125294271|NCT01792518|450705241|FG000|Overall Study|Other Reason|0|||
125294272|NCT01792518|450705242|FG001|Overall Study|Other Reason|1|||
125294273|NCT00249613|450705246|FG000|12 Month Follow-up|Death|1|||
125294274|NCT00249613|450705247|FG001|12 Month Follow-up|Death|1|||
125294275|NCT00249613|450705246|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
125294276|NCT00249613|450705247|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
125294277|NCT00249613|450705246|FG000|12 Month Follow-up|Lost to Follow-up|10|||
125294278|NCT00249613|450705247|FG001|12 Month Follow-up|Lost to Follow-up|8|||
125294279|NCT00806442|450705257|FG000|Overall Study|Lost to Follow-up|3|||
125294280|NCT00806442|450705258|FG001|Overall Study|Lost to Follow-up|2|||
125294281|NCT00806442|450705257|FG000|Overall Study|Withdrawal by Subject|1|||
125294282|NCT00806442|450705258|FG001|Overall Study|Withdrawal by Subject|5|||
125294283|NCT00654004|450705266|FG000|Overall Study|Lost to Follow-up|1|||
125294284|NCT00654004|450705267|FG001|Overall Study|Lost to Follow-up|0|||
125294285|NCT01264770|450705268|FG000|Overall Study|Not reported|0|||
125294286|NCT01264770|450705269|FG001|Overall Study|Not reported|0|||
125294287|NCT01264770|450705270|FG002|Overall Study|Not reported|1|||
125294288|NCT01264770|450705271|FG003|Overall Study|Not reported|0|||
125294289|NCT01264770|450705272|FG004|Overall Study|Not reported|0|||
125294290|NCT01264770|450705273|FG005|Overall Study|Not reported|0|||
125294291|NCT01264770|450705268|FG000|Overall Study|e.g., change in circumstances|8|||
125294292|NCT01264770|450705269|FG001|Overall Study|e.g., change in circumstances|3|||
125294293|NCT01264770|450705270|FG002|Overall Study|e.g., change in circumstances|3|||
125294294|NCT01264770|450705271|FG003|Overall Study|e.g., change in circumstances|3|||
125294295|NCT01264770|450705272|FG004|Overall Study|e.g., change in circumstances|4|||
125294296|NCT01264770|450705273|FG005|Overall Study|e.g., change in circumstances|4|||
125294297|NCT01264770|450705268|FG000|Overall Study|Severe non-compliance to protocol|0|||
125294298|NCT01264770|450705269|FG001|Overall Study|Severe non-compliance to protocol|0|||
125294299|NCT01264770|450705270|FG002|Overall Study|Severe non-compliance to protocol|1|||
125294300|NCT01264770|450705271|FG003|Overall Study|Severe non-compliance to protocol|1|||
125294301|NCT01264770|450705272|FG004|Overall Study|Severe non-compliance to protocol|0|||
125294302|NCT01264770|450705273|FG005|Overall Study|Severe non-compliance to protocol|0|||
125294303|NCT01264770|450705268|FG000|Overall Study|Lack of therapeutic response|1|||
125294304|NCT01264770|450705269|FG001|Overall Study|Lack of therapeutic response|0|||
125294305|NCT01264770|450705270|FG002|Overall Study|Lack of therapeutic response|2|||
125294306|NCT01264770|450705271|FG003|Overall Study|Lack of therapeutic response|1|||
125294307|NCT01264770|450705272|FG004|Overall Study|Lack of therapeutic response|1|||
125294308|NCT01264770|450705273|FG005|Overall Study|Lack of therapeutic response|0|||
125294309|NCT01264770|450705268|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
125294310|NCT01264770|450705269|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
125294311|NCT01264770|450705270|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
125294312|NCT01264770|450705271|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
125294313|NCT01264770|450705272|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
125294314|NCT01264770|450705273|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
125294315|NCT01264770|450705268|FG000|Overall Study|Lost to Follow-up|0|||
125294316|NCT01264770|450705269|FG001|Overall Study|Lost to Follow-up|0|||
125294317|NCT01264770|450705270|FG002|Overall Study|Lost to Follow-up|1|||
125294318|NCT01264770|450705271|FG003|Overall Study|Lost to Follow-up|1|||
125294319|NCT01264770|450705272|FG004|Overall Study|Lost to Follow-up|0|||
125294320|NCT01264770|450705273|FG005|Overall Study|Lost to Follow-up|0|||
125294321|NCT01264770|450705268|FG000|Overall Study|Adverse Event|7|||
125294322|NCT01264770|450705269|FG001|Overall Study|Adverse Event|7|||
125294323|NCT01264770|450705270|FG002|Overall Study|Adverse Event|8|||
125294324|NCT01264770|450705271|FG003|Overall Study|Adverse Event|0|||
125294325|NCT01264770|450705272|FG004|Overall Study|Adverse Event|2|||
125294326|NCT01264770|450705273|FG005|Overall Study|Adverse Event|1|||
125294327|NCT00424190|450705275|FG000|Overall Study|Withdrew consent|3|||
125294328|NCT00424190|450705276|FG001|Overall Study|Withdrew consent|4|||
125294329|NCT00424190|450705275|FG000|Overall Study|Death|3|||
125294330|NCT00424190|450705276|FG001|Overall Study|Death|0|||
125294331|NCT00424190|450705275|FG000|Overall Study|Noncompliance|1|||
125294332|NCT00424190|450705276|FG001|Overall Study|Noncompliance|2|||
125294333|NCT00424190|450705275|FG000|Overall Study|Request of sponsor or investigator|0|||
125294334|NCT00424190|450705276|FG001|Overall Study|Request of sponsor or investigator|2|||
125294335|NCT00424190|450705275|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
125294336|NCT00424190|450705276|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
125294337|NCT00424190|450705275|FG000|Overall Study|Other|15|||
125294338|NCT00424190|450705276|FG001|Overall Study|Other|21|||
125294339|NCT00351273|450705277|FG000|Overall Study|Lost to Follow-up|1|||
125294340|NCT00351273|450705278|FG001|Overall Study|Lost to Follow-up|2|||
125294341|NCT00351273|450705279|FG002|Overall Study|Lost to Follow-up|5|||
125294342|NCT01672866|450705280|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
125294343|NCT01672866|450705281|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
125294344|NCT01672866|450705282|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
125294345|NCT01672866|450705280|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
125294346|NCT01672866|450705281|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
125294347|NCT01672866|450705282|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
125294348|NCT01672866|450705280|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
125294349|NCT01672866|450705281|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
125294350|NCT01672866|450705282|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
125294351|NCT01672866|450705280|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
125294352|NCT01672866|450705281|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
125294353|NCT01672866|450705282|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
125294354|NCT01672866|450705280|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
125294355|NCT01672866|450705281|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
125294356|NCT01672866|450705282|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
125294357|NCT01672866|450705280|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
125294358|NCT01672866|450705281|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
125294359|NCT01672866|450705282|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
125294360|NCT01672866|450705280|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
125294361|NCT01672866|450705281|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
125294362|NCT01672866|450705282|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
125294363|NCT01672866|450705280|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
125294364|NCT01672866|450705281|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
125294365|NCT01672866|450705282|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
125294366|NCT01672866|450705280|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
125294367|NCT01672866|450705281|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
124789934|NCT01576159|448860141|FG001|Overall Study|Withdrawal by Subject|1|||
124789935|NCT01576159|448860142|FG002|Overall Study|Withdrawal by Subject|0|||
124789936|NCT01576159|448860143|FG003|Overall Study|Withdrawal by Subject|0|||
124789937|NCT01576159|448860140|FG000|Overall Study|Physician Decision|0|||
124789938|NCT01576159|448860141|FG001|Overall Study|Physician Decision|0|||
124789939|NCT01576159|448860142|FG002|Overall Study|Physician Decision|1|||
124789940|NCT01576159|448860143|FG003|Overall Study|Physician Decision|0|||
124789941|NCT01576159|448860140|FG000|Overall Study|Lost to Follow-up|0|||
125294368|NCT01672866|450705282|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
124789942|NCT01576159|448860141|FG001|Overall Study|Lost to Follow-up|0|||
124789943|NCT01576159|448860142|FG002|Overall Study|Lost to Follow-up|0|||
125294369|NCT01672866|450705280|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
125294370|NCT01672866|450705281|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
125294371|NCT01672866|450705282|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
125294372|NCT01672866|450705280|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
125294373|NCT01672866|450705281|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
125294374|NCT01672866|450705282|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
125294375|NCT01672866|450705280|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
125294376|NCT01672866|450705281|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
125294377|NCT01672866|450705282|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
125294378|NCT01672866|450705280|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
125294379|NCT01672866|450705281|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
125294380|NCT01672866|450705282|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
125294381|NCT02241187|450705283|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
125294382|NCT00160654|450705286|FG000|Overall Study|Adverse Event|14|||
125294383|NCT00160654|450705286|FG000|Overall Study|Lack of Efficacy|4|||
125294384|NCT00160654|450705286|FG000|Overall Study|Lost to Follow-up|2|||
125294385|NCT00160654|450705286|FG000|Overall Study|Intake of expired drug|7|||
125294386|NCT00160654|450705286|FG000|Overall Study|Psychological trauma|1|||
125294387|NCT00160654|450705286|FG000|Overall Study|Sponsor decision|1|||
125294388|NCT00160654|450705286|FG000|Overall Study|Patient met exclusion criteria|1|||
125294389|NCT00160654|450705286|FG000|Overall Study|Patient decision|1|||
125294390|NCT00160654|450705286|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
125294391|NCT00160654|450705286|FG000|Overall Study|Met exclusion criteria|1|||
125294392|NCT02383433|450705289|FG000|Overall Study|Disease progression|2|||
125294393|NCT02535416|450705290|FG000|Overall Study|Family bereavement overseas|1|||
125294394|NCT02535416|450705291|FG001|Overall Study|Family bereavement overseas|0|||
125294395|NCT02535416|450705292|FG002|Overall Study|Family bereavement overseas|0|||
125294396|NCT02535416|450705293|FG003|Overall Study|Family bereavement overseas|0|||
125294397|NCT02535416|450705294|FG004|Overall Study|Family bereavement overseas|0|||
125294398|NCT02535416|450705295|FG005|Overall Study|Family bereavement overseas|0|||
125294399|NCT02535416|450705296|FG006|Overall Study|Family bereavement overseas|0|||
125294400|NCT02535416|450705297|FG007|Overall Study|Family bereavement overseas|0|||
125294401|NCT02535416|450705298|FG008|Overall Study|Family bereavement overseas|0|||
125294402|NCT02831933|450706477|FG000|Overall Study|Physician Decision|11|||
125294403|NCT04544683|450706479|FG000|Overall Study|Lost to Follow-up|2|||
125294404|NCT04544683|450706479|FG000|Overall Study|Underwent cervical spine surgery|6|||
125294405|NCT01073930|450706480|FG000|Overall Study|Withdrawal by Subject|3|||
125294406|NCT01073930|450706481|FG001|Overall Study|Withdrawal by Subject|2|||
125294407|NCT01073930|450706480|FG000|Overall Study|Lost to Follow-up|0|||
125294408|NCT01073930|450706481|FG001|Overall Study|Lost to Follow-up|1|||
125294409|NCT01073930|450706480|FG000|Overall Study|Adverse Event|0|||
125294410|NCT01073930|450706481|FG001|Overall Study|Adverse Event|1|||
125294411|NCT01073930|450706480|FG000|Overall Study|Noncompliance with study drug|0|||
125294412|NCT01073930|450706481|FG001|Overall Study|Noncompliance with study drug|1|||
125294413|NCT01073930|450706480|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
125294414|NCT01073930|450706481|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
125294415|NCT02081599|450706482|FG000|Period 1：Double-blind Period|Adverse Event|3|||
125294416|NCT02081599|450706483|FG001|Period 1：Double-blind Period|Adverse Event|0|||
125294417|NCT02081599|450706482|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
125294418|NCT02081599|450706483|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
125294419|NCT02081599|450706482|FG000|Period 1：Double-blind Period|Physician Decision|1|||
125294420|NCT02081599|450706483|FG001|Period 1：Double-blind Period|Physician Decision|0|||
125294421|NCT02081599|450706482|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
125294422|NCT02081599|450706483|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
124789944|NCT01576159|448860143|FG003|Overall Study|Lost to Follow-up|1|||
124789945|NCT01576159|448860140|FG000|Overall Study|Protocol Violation|1|||
124789946|NCT01576159|448860141|FG001|Overall Study|Protocol Violation|0|||
124789947|NCT01576159|448860142|FG002|Overall Study|Protocol Violation|0|||
124789948|NCT01576159|448860143|FG003|Overall Study|Protocol Violation|0|||
124789949|NCT01181986|448860146|FG000|Phase 1|Lost to Follow-up|0|||
124789950|NCT01181986|448860147|FG001|Phase 1|Lost to Follow-up|1|||
124789951|NCT01181986|448860148|FG002|Phase 1|Lost to Follow-up|1|||
124789952|NCT01181986|448860146|FG000|Phase 1|Adverse Event|0|||
125294423|NCT02081599|450706482|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
125294424|NCT02081599|450706483|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
125294425|NCT02081599|450706482|FG000|Period 1：Double-blind Period|stopping criteria|1|||
125294426|NCT02081599|450706483|FG001|Period 1：Double-blind Period|stopping criteria|0|||
125294427|NCT02081599|450706482|FG000|Period 2：Open-label Period|Adverse Event|1|||
124789953|NCT01181986|448860147|FG001|Phase 1|Adverse Event|0|||
124789954|NCT01181986|448860148|FG002|Phase 1|Adverse Event|1|||
124789955|NCT01181986|448860146|FG000|Phase 1|Protocol Violation|1|||
124789956|NCT01181986|448860147|FG001|Phase 1|Protocol Violation|0|||
125294428|NCT02081599|450706483|FG001|Period 2：Open-label Period|Adverse Event|0|||
125294429|NCT02081599|450706482|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
124789957|NCT01181986|448860148|FG002|Phase 1|Protocol Violation|0|||
124789958|NCT01181986|448860146|FG000|Phase 2|Adverse Event|0|||
124789959|NCT01181986|448860147|FG001|Phase 2|Adverse Event|3|||
124789960|NCT01181986|448860148|FG002|Phase 2|Adverse Event|0|||
124789961|NCT01181986|448860146|FG000|Phase 2|Medical condition|0|||
124789962|NCT01181986|448860147|FG001|Phase 2|Medical condition|1|||
124789963|NCT01181986|448860148|FG002|Phase 2|Medical condition|0|||
124789964|NCT03720652|448860149|FG000|Overall Study|Withdrawal by Subject|2|||
124789965|NCT03720652|448860150|FG001|Overall Study|Withdrawal by Subject|7|||
124789966|NCT03720652|448860149|FG000|Overall Study|Lost to Follow-up|0|||
124789967|NCT03720652|448860150|FG001|Overall Study|Lost to Follow-up|4|||
124789968|NCT03073733|448860151|FG000|Overall Study|Lost to Follow-up|1|||
124789969|NCT03073733|448860152|FG001|Overall Study|Lost to Follow-up|0|||
124789970|NCT03073733|448860153|FG002|Overall Study|Lost to Follow-up|0|||
124789971|NCT03073733|448860151|FG000|Overall Study|Physician Decision|0|||
124789972|NCT03073733|448860152|FG001|Overall Study|Physician Decision|1|||
124789973|NCT03073733|448860153|FG002|Overall Study|Physician Decision|0|||
124789974|NCT03073733|448860151|FG000|Overall Study|Withdrawal by Subject|0|||
124789975|NCT03073733|448860152|FG001|Overall Study|Withdrawal by Subject|0|||
124789976|NCT03073733|448860153|FG002|Overall Study|Withdrawal by Subject|1|||
124789977|NCT01454778|448860154|FG000|Overall Study|Lost to Follow-up|2|||
124789978|NCT01454778|448860154|FG000|Overall Study|Death|1|||
124789979|NCT00835731|448860155|FG000|Overall Study|Withdrawal by Subject|1|||
124789980|NCT00835731|448860156|FG001|Overall Study|Withdrawal by Subject|0|||
124789981|NCT00835731|448860155|FG000|Overall Study|Physician Decision|1|||
124789982|NCT00835731|448860156|FG001|Overall Study|Physician Decision|1|||
124789983|NCT00348881|448860157|FG000|Overall Study|Lost to Follow-up|12|||
124789984|NCT00348881|448860158|FG001|Overall Study|Lost to Follow-up|6|||
124789985|NCT00348881|448860157|FG000|Overall Study|Withdrawal by Subject|3|||
125294430|NCT02081599|450706483|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
124789986|NCT00348881|448860158|FG001|Overall Study|Withdrawal by Subject|4|||
124789987|NCT00348881|448860157|FG000|Overall Study|Adverse Event|2|||
125294431|NCT02081599|450706482|FG000|Period 2：Open-label Period|Physician Decision|1|||
125294432|NCT02081599|450706483|FG001|Period 2：Open-label Period|Physician Decision|0|||
125294433|NCT02081599|450706482|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
125294434|NCT02081599|450706483|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
124789988|NCT00348881|448860158|FG001|Overall Study|Adverse Event|0|||
124789989|NCT00348881|448860157|FG000|Overall Study|Serious Adverse Event|0|||
124789990|NCT00348881|448860158|FG001|Overall Study|Serious Adverse Event|2|||
124789991|NCT01221272|448862017|FG000|Period 1|Adverse Event|2|||
124789992|NCT01221272|448862018|FG001|Period 1|Adverse Event|0|||
124789993|NCT01221272|448862017|FG000|Period 1|Consent Withdrawal|0|||
124789994|NCT01221272|448862018|FG001|Period 1|Consent Withdrawal|1|||
124789995|NCT01221272|448862017|FG000|Period 1|Significant Dosing Noncompliance|0|||
124789996|NCT01221272|448862018|FG001|Period 1|Significant Dosing Noncompliance|1|||
124789997|NCT01221272|448862017|FG000|Period 2|Adverse Event|0|||
124789998|NCT01221272|448862018|FG001|Period 2|Adverse Event|2|||
125294435|NCT01266590|450706484|FG000|Overall Study|Adverse Event|3|||
125294436|NCT01266590|450706484|FG000|Overall Study|Lost to Follow-up|1|||
125294437|NCT01266590|450706484|FG000|Overall Study|Withdrawal by Subject|1|||
125294438|NCT01266590|450706484|FG000|Overall Study|Physician Decision|1|||
125294439|NCT00720343|450706487|FG000|Overall Study|Lost to Follow-up|1|||
125294440|NCT00720343|450706488|FG001|Overall Study|Lost to Follow-up|0|||
125294441|NCT00720343|450706487|FG000|Overall Study|Protocol Violation|0|||
125294442|NCT00720343|450706488|FG001|Overall Study|Protocol Violation|2|||
125294443|NCT02008773|450706489|FG000|Overall Study|Adverse Event|3|||
125294444|NCT02008773|450706490|FG001|Overall Study|Adverse Event|3|||
125294445|NCT02008773|450706491|FG002|Overall Study|Adverse Event|1|||
125294446|NCT02008773|450706492|FG003|Overall Study|Adverse Event|2|||
125294447|NCT02008773|450706489|FG000|Overall Study|Medication Non-compliance|2|||
125294448|NCT02008773|450706490|FG001|Overall Study|Medication Non-compliance|1|||
124789999|NCT04839562|448862019|FG000|Overall Study|Withdrawal by Subject|0|||
124790000|NCT04839562|448862020|FG001|Overall Study|Withdrawal by Subject|1|||
124790001|NCT04839562|448862019|FG000|Overall Study|Physician Decision|0|||
124790002|NCT04839562|448862020|FG001|Overall Study|Physician Decision|1|||
124790003|NCT01246466|448862021|FG000|Overall Study|Death|1|||
124790004|NCT01246466|448862021|FG000|Overall Study|Withdrawal by Subject|1|||
124790005|NCT00877773|448862022|FG000|Overall Study|Disease Progression|44|||
124790006|NCT00003472|448862027|FG000|Overall Study|Not evaluable|3|||
124790007|NCT01350544|448862028|FG000|Overall Study|Administrative Withdrawal|0|||
124790008|NCT01350544|448862029|FG001|Overall Study|Administrative Withdrawal|1|||
124790009|NCT01350544|448862028|FG000|Overall Study|Death|1|||
124790010|NCT01350544|448862029|FG001|Overall Study|Death|2|||
124790011|NCT01350544|448862028|FG000|Overall Study|Moved out of LA County|2|||
124790012|NCT01350544|448862029|FG001|Overall Study|Moved out of LA County|2|||
124790013|NCT01350544|448862028|FG000|Overall Study|Medical Issues|1|||
125294449|NCT02008773|450706491|FG002|Overall Study|Medication Non-compliance|3|||
125294450|NCT02008773|450706492|FG003|Overall Study|Medication Non-compliance|2|||
125294451|NCT02008773|450706489|FG000|Overall Study|Withdrawal by Subject|8|||
124790014|NCT01350544|448862029|FG001|Overall Study|Medical Issues|1|||
124790015|NCT01350544|448862028|FG000|Overall Study|Withdrawal by Subject|0|||
124790016|NCT01350544|448862029|FG001|Overall Study|Withdrawal by Subject|1|||
124790017|NCT01350544|448862028|FG000|Overall Study|Incarceration|1|||
124790018|NCT01350544|448862029|FG001|Overall Study|Incarceration|0|||
124790019|NCT01350544|448862028|FG000|Overall Study|Lost to Follow-up|18|||
124790020|NCT01350544|448862029|FG001|Overall Study|Lost to Follow-up|15|||
124790021|NCT00538785|448862030|FG000|Overall Study|Death|9|||
124790022|NCT00538785|448862031|FG001|Overall Study|Death|10|||
124790023|NCT00538785|448862030|FG000|Overall Study|Withdrawal of consent|9|||
124790024|NCT00538785|448862031|FG001|Overall Study|Withdrawal of consent|7|||
124790025|NCT00538785|448862030|FG000|Overall Study|Lost to Follow-up|1|||
124790026|NCT00538785|448862031|FG001|Overall Study|Lost to Follow-up|0|||
124790027|NCT01002820|448862032|FG000|Overall Study|Adverse Event|1|||
124790028|NCT01002820|448862032|FG000|Overall Study|Withdrawal by Subject|2|||
124790029|NCT01002820|448862032|FG000|Overall Study|Lack of Efficacy|1|||
124790030|NCT01673347|448862033|FG000|Overall Study|failure of allograft|7|||
124790031|NCT03086967|448862034|FG000|Overall Study|Screen Failure|2|||
124790032|NCT03086967|448862035|FG001|Overall Study|Screen Failure|2|||
124790033|NCT02661178|448862040|FG000|Part 1|Protocol Violation|1|||
124790034|NCT02661178|448862041|FG001|Part 1|Protocol Violation|0|||
124790035|NCT02661178|448862042|FG002|Part 1|Protocol Violation|0|||
124790036|NCT02661178|448862043|FG003|Part 1|Protocol Violation|0|||
124790037|NCT02661178|448862044|FG004|Part 1|Protocol Violation|0|||
124790038|NCT02661178|448862045|FG005|Part 1|Protocol Violation|0|||
124790039|NCT02661178|448862046|FG006|Part 1|Protocol Violation|0|||
124790040|NCT02661178|448862047|FG007|Part 1|Protocol Violation|0|||
124790041|NCT02661178|448862048|FG008|Part 1|Protocol Violation|0|||
124790042|NCT02661178|448862049|FG009|Part 1|Protocol Violation|0|||
124790043|NCT02661178|448862050|FG010|Part 1|Protocol Violation|0|||
124790044|NCT02661178|448862051|FG011|Part 1|Protocol Violation|0|||
124790045|NCT02661178|448862052|FG012|Part 1|Protocol Violation|0|||
124790046|NCT02661178|448862053|FG013|Part 1|Protocol Violation|0|||
124790047|NCT02661178|448862054|FG014|Part 1|Protocol Violation|0|||
124790048|NCT00775203|448862057|FG000|Overall Study|Adverse Event|25|||
124790049|NCT00775203|448862058|FG001|Overall Study|Adverse Event|6|||
124790050|NCT00775203|448862057|FG000|Overall Study|Lack of Efficacy|8|||
124790051|NCT00775203|448862058|FG001|Overall Study|Lack of Efficacy|9|||
124790052|NCT00775203|448862057|FG000|Overall Study|Withdrawal by Subject|11|||
124790053|NCT00775203|448862058|FG001|Overall Study|Withdrawal by Subject|9|||
124790054|NCT00775203|448862057|FG000|Overall Study|Lost to Follow-up|11|||
124790055|NCT00775203|448862058|FG001|Overall Study|Lost to Follow-up|15|||
124790056|NCT00775203|448862057|FG000|Overall Study|Administrative reason|2|||
124790057|NCT00775203|448862058|FG001|Overall Study|Administrative reason|0|||
124790058|NCT00775203|448862057|FG000|Overall Study|Noncompliance|4|||
124790059|NCT00775203|448862058|FG001|Overall Study|Noncompliance|2|||
124790060|NCT00775203|448862057|FG000|Overall Study|Protocol Violation|0|||
124790061|NCT00775203|448862058|FG001|Overall Study|Protocol Violation|1|||
124790062|NCT00775203|448862057|FG000|Overall Study|Entered other study|1|||
124790063|NCT00775203|448862058|FG001|Overall Study|Entered other study|0|||
124790064|NCT00775203|448862057|FG000|Overall Study|Physician Decision|0|||
124790065|NCT00775203|448862058|FG001|Overall Study|Physician Decision|1|||
124790066|NCT00704522|448862059|FG000|Overall Study|Lack of Efficacy|65|||
124790067|NCT00704522|448862060|FG001|Overall Study|Lack of Efficacy|17|||
124790068|NCT00704522|448862059|FG000|Overall Study|Failure to appear again at hospital|56|||
124790069|NCT00704522|448862060|FG001|Overall Study|Failure to appear again at hospital|10|||
124790070|NCT00704522|448862059|FG000|Overall Study|Withdrawal by Subject|17|||
124790071|NCT00704522|448862060|FG001|Overall Study|Withdrawal by Subject|8|||
124790072|NCT00704522|448862059|FG000|Overall Study|Adverse Event|9|||
124790073|NCT00704522|448862060|FG001|Overall Study|Adverse Event|1|||
124790074|NCT00704522|448862059|FG000|Overall Study|Undefined causes|9|||
124790075|NCT00704522|448862060|FG001|Overall Study|Undefined causes|7|||
124790076|NCT00704522|448862059|FG000|Overall Study|No information on therapy end|27|||
124790077|NCT00704522|448862060|FG001|Overall Study|No information on therapy end|2|||
124790078|NCT01525901|448862065|FG000|Period 2: 12 Weeks|Adverse Event|0|||
124790079|NCT01525901|448862066|FG001|Period 2: 12 Weeks|Adverse Event|1|||
124790080|NCT01525901|448862067|FG002|Period 2: 12 Weeks|Adverse Event|0|||
124790081|NCT01525901|448862068|FG003|Period 2: 12 Weeks|Adverse Event|0|||
124790082|NCT02486627|448862073|FG000|Overall Study|Death|1|||
124790083|NCT02486627|448862074|FG001|Overall Study|Death|0|||
124790084|NCT02486627|448862073|FG000|Overall Study|Other Unspecified|0|||
124790085|NCT02486627|448862074|FG001|Overall Study|Other Unspecified|2|||
124790086|NCT02486627|448862073|FG000|Overall Study|Consent Withdrawn by Participant|4|||
124790087|NCT02486627|448862074|FG001|Overall Study|Consent Withdrawn by Participant|3|||
124790088|NCT02486627|448862073|FG000|Overall Study|Significant Participant Noncompliance|1|||
124790089|NCT02486627|448862074|FG001|Overall Study|Significant Participant Noncompliance|1|||
124790090|NCT02486627|448862073|FG000|Overall Study|Lost to Follow-up|1|||
124790091|NCT02486627|448862074|FG001|Overall Study|Lost to Follow-up|3|||
124790092|NCT01073462|448862075|FG000|Overall Study|Death|14|||
124790093|NCT01073462|448862075|FG000|Overall Study|Kidney transplant|10|||
124790094|NCT01073462|448862075|FG000|Overall Study|Low parathyroid hormone levels|8|||
124790095|NCT01073462|448862075|FG000|Overall Study|Serious adverse event|2|||
124790096|NCT01073462|448862075|FG000|Overall Study|Lost to Follow-up|7|||
124790097|NCT03554486|448862079|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
124790098|NCT03554486|448862080|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
124790099|NCT03554486|448862081|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
124790100|NCT03554486|448862079|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
124790101|NCT03554486|448862080|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
124790102|NCT03554486|448862081|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
124790103|NCT03554486|448862079|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
124790104|NCT03554486|448862080|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
124790105|NCT03554486|448862081|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
124790106|NCT01509053|448862082|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
124790107|NCT01509053|448862082|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
124790108|NCT01509053|448862082|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
124790109|NCT01509053|448862082|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
124790110|NCT01509053|448862082|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
124790111|NCT01509053|448862082|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
124790112|NCT01738477|448862084|FG000|Overall Study|Lost to Follow-up|1|||
124790113|NCT01738477|448862085|FG001|Overall Study|Lost to Follow-up|4|||
124790114|NCT01915303|448862086|FG000|Core Phase|Adverse Event|7|||
124790115|NCT01915303|448862086|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
124790116|NCT01915303|448862086|FG000|Core Phase|Death|2|||
124790117|NCT01915303|448862086|FG000|Core Phase|Protocol Violation|2|||
124790118|NCT01915303|448862086|FG000|Core Phase|Abnormal lab value|1|||
124790119|NCT01915303|448862086|FG000|Core Phase|Withdrawal by Subject|1|||
124790120|NCT01915303|448862086|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
124790121|NCT01915303|448862086|FG000|Extension Phase|Withdrawal by Subject|4|||
124790122|NCT01915303|448862086|FG000|Extension Phase|Adverse Event|3|||
124790123|NCT01915303|448862086|FG000|Extension Phase|Death|1|||
124790124|NCT01915303|448862086|FG000|Extension Phase|Protocol Violation|1|||
124790125|NCT02925338|448862087|FG000|Overall Study|Death|0|||
125294452|NCT02008773|450706490|FG001|Overall Study|Withdrawal by Subject|4|||
125294453|NCT02008773|450706491|FG002|Overall Study|Withdrawal by Subject|7|||
125294454|NCT02008773|450706492|FG003|Overall Study|Withdrawal by Subject|6|||
125294455|NCT02008773|450706489|FG000|Overall Study|Lost to Follow-up|0|||
125294456|NCT02008773|450706490|FG001|Overall Study|Lost to Follow-up|1|||
125294457|NCT02008773|450706491|FG002|Overall Study|Lost to Follow-up|3|||
125294458|NCT02008773|450706492|FG003|Overall Study|Lost to Follow-up|2|||
125294459|NCT02198794|450706493|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
125294460|NCT02198794|450706494|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
125294461|NCT02198794|450706495|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
125294462|NCT02198794|450706496|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
125294463|NCT02198794|450706493|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
125294464|NCT02198794|450706494|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
125294465|NCT02198794|450706495|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
125294466|NCT02198794|450706496|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
125294467|NCT02198794|450706493|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
125294468|NCT02198794|450706494|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
125294469|NCT02198794|450706495|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
125294470|NCT02198794|450706496|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
125294471|NCT02198794|450706493|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
125294472|NCT02198794|450706494|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
125294473|NCT02198794|450706495|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
125294474|NCT02198794|450706496|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
125294475|NCT02198794|450706493|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
125294476|NCT02198794|450706494|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
125294477|NCT02198794|450706495|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
125294478|NCT02198794|450706496|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
125294479|NCT02198794|450706493|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
125294480|NCT02198794|450706494|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
125294481|NCT02198794|450706495|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
125294482|NCT02198794|450706496|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
125294483|NCT02198794|450706493|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
125294484|NCT02198794|450706494|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
125294485|NCT02198794|450706495|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
124790126|NCT02925338|448862088|FG001|Overall Study|Death|2|||
124790127|NCT02925338|448862089|FG002|Overall Study|Death|1|||
124790128|NCT02925338|448862090|FG003|Overall Study|Death|0|||
124790129|NCT02925338|448862091|FG004|Overall Study|Death|0|||
124790130|NCT02925338|448862087|FG000|Overall Study|Lost to Follow-up|30|||
124790131|NCT02925338|448862088|FG001|Overall Study|Lost to Follow-up|10|||
124790132|NCT02925338|448862089|FG002|Overall Study|Lost to Follow-up|1|||
124790133|NCT02925338|448862090|FG003|Overall Study|Lost to Follow-up|16|||
124790134|NCT02925338|448862091|FG004|Overall Study|Lost to Follow-up|3|||
124790135|NCT02925338|448862087|FG000|Overall Study|Withdrawal by Subject|3|||
124790136|NCT02925338|448862088|FG001|Overall Study|Withdrawal by Subject|0|||
124790137|NCT02925338|448862089|FG002|Overall Study|Withdrawal by Subject|3|||
124790138|NCT02925338|448862090|FG003|Overall Study|Withdrawal by Subject|2|||
124790139|NCT02925338|448862091|FG004|Overall Study|Withdrawal by Subject|2|||
124790140|NCT02925338|448862087|FG000|Overall Study|Missing|38|||
124790141|NCT02925338|448862088|FG001|Overall Study|Missing|27|||
124790142|NCT02925338|448862089|FG002|Overall Study|Missing|0|||
124790143|NCT02925338|448862090|FG003|Overall Study|Missing|3|||
124790144|NCT02925338|448862091|FG004|Overall Study|Missing|2|||
124790145|NCT02925338|448862087|FG000|Overall Study|Participant's Decision|11|||
124790146|NCT02925338|448862088|FG001|Overall Study|Participant's Decision|7|||
124790147|NCT02925338|448862089|FG002|Overall Study|Participant's Decision|3|||
124790148|NCT02925338|448862090|FG003|Overall Study|Participant's Decision|8|||
124790149|NCT02925338|448862091|FG004|Overall Study|Participant's Decision|1|||
124790150|NCT02925338|448862087|FG000|Overall Study|Treatment Discontinuation|144|||
124790151|NCT02925338|448862088|FG001|Overall Study|Treatment Discontinuation|65|||
124790152|NCT02925338|448862089|FG002|Overall Study|Treatment Discontinuation|56|||
125294486|NCT02198794|450706496|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
125294487|NCT02198794|450706493|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
125294488|NCT02198794|450706494|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
125294489|NCT02198794|450706495|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
125294490|NCT02198794|450706496|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
125294491|NCT02198794|450706493|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
125294492|NCT02198794|450706494|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
125294493|NCT02198794|450706495|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
125294494|NCT02198794|450706496|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
124790153|NCT02925338|448862090|FG003|Overall Study|Treatment Discontinuation|131|||
124790154|NCT02925338|448862091|FG004|Overall Study|Treatment Discontinuation|22|||
124790155|NCT02509117|448862092|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
124790156|NCT02509117|448862093|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
124790157|NCT02509117|448862094|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
124790158|NCT02509117|448862095|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
124790159|NCT02509117|448862096|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
124790160|NCT02509117|448862097|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
124790161|NCT02509117|448862098|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
124790162|NCT02509117|448862099|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
124790163|NCT02509117|448862100|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
124790164|NCT02509117|448862101|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
124790165|NCT02509117|448862092|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
124790166|NCT02509117|448862093|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
124790167|NCT02509117|448862094|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
124790168|NCT02509117|448862095|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
124790169|NCT02509117|448862096|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
124790170|NCT02509117|448862097|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
124790171|NCT02509117|448862098|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
124790172|NCT02509117|448862099|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
124790173|NCT02509117|448862100|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
124790174|NCT02509117|448862101|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
124790175|NCT02509117|448862092|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
124790176|NCT02509117|448862093|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
124790177|NCT02509117|448862094|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
124790178|NCT02509117|448862095|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
124790179|NCT02509117|448862096|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
124790180|NCT02509117|448862097|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
125294495|NCT02198794|450706493|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
125294496|NCT02198794|450706494|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
124790181|NCT02509117|448862098|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
124790182|NCT02509117|448862099|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
124790183|NCT02509117|448862100|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
124790184|NCT02509117|448862101|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
124790185|NCT00548184|448862104|FG000|Overall Study|Adverse Event|3|||
124790186|NCT00548184|448862104|FG000|Overall Study|took other drug|1|||
124790187|NCT00548184|448862104|FG000|Overall Study|Found Her2 negative|1|||
125294497|NCT02198794|450706495|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
125294498|NCT02198794|450706496|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
125294499|NCT02198794|450706493|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
125294500|NCT02198794|450706494|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
125294501|NCT02198794|450706495|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
125294502|NCT02198794|450706496|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
125294503|NCT02198794|450706493|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
125294504|NCT02198794|450706494|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
125294505|NCT02198794|450706495|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
125294506|NCT02198794|450706496|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
125294507|NCT02198794|450706493|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
125294508|NCT02198794|450706494|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
125294509|NCT02198794|450706495|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
125294510|NCT02198794|450706496|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
125294511|NCT02198794|450706493|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
125294512|NCT02198794|450706494|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
125294513|NCT02198794|450706495|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
125294514|NCT02198794|450706496|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
125294515|NCT02198794|450706493|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
124790188|NCT00636363|448862105|FG000|Overall Study|Conjunctivitis|0|||
124790189|NCT00636363|448862106|FG001|Overall Study|Conjunctivitis|0|||
124790190|NCT00636363|448862107|FG002|Overall Study|Conjunctivitis|1|||
124790191|NCT00636363|448862105|FG000|Overall Study|Adverse Event|0|||
124790192|NCT00636363|448862106|FG001|Overall Study|Adverse Event|0|||
124790193|NCT00636363|448862107|FG002|Overall Study|Adverse Event|1|||
124790194|NCT00636363|448862105|FG000|Overall Study|Positive slit lamp finding|0|||
124790195|NCT00636363|448862106|FG001|Overall Study|Positive slit lamp finding|2|||
124790196|NCT00636363|448862107|FG002|Overall Study|Positive slit lamp finding|1|||
124790197|NCT00636363|448862105|FG000|Overall Study|Study related symptoms/complaints|8|||
124790198|NCT00636363|448862106|FG001|Overall Study|Study related symptoms/complaints|7|||
124790199|NCT00636363|448862107|FG002|Overall Study|Study related symptoms/complaints|4|||
124790200|NCT00636363|448862105|FG000|Overall Study|Met ineligibility criteria|0|||
124790201|NCT00636363|448862106|FG001|Overall Study|Met ineligibility criteria|0|||
124790202|NCT00636363|448862107|FG002|Overall Study|Met ineligibility criteria|3|||
124790203|NCT00636363|448862105|FG000|Overall Study|Missed > 1 visit|0|||
124790204|NCT00636363|448862106|FG001|Overall Study|Missed > 1 visit|1|||
124790205|NCT00636363|448862107|FG002|Overall Study|Missed > 1 visit|3|||
124790206|NCT00636363|448862105|FG000|Overall Study|Lack of motivation|1|||
124790207|NCT00636363|448862106|FG001|Overall Study|Lack of motivation|0|||
124790208|NCT00636363|448862107|FG002|Overall Study|Lack of motivation|1|||
124790209|NCT00636363|448862105|FG000|Overall Study|Protocol Violation|0|||
124790210|NCT00636363|448862106|FG001|Overall Study|Protocol Violation|3|||
124790211|NCT00636363|448862107|FG002|Overall Study|Protocol Violation|0|||
124790212|NCT00636363|448862105|FG000|Overall Study|Lost to Follow-up|3|||
124790213|NCT00636363|448862106|FG001|Overall Study|Lost to Follow-up|4|||
124790214|NCT00636363|448862107|FG002|Overall Study|Lost to Follow-up|2|||
124790215|NCT00636363|448862105|FG000|Overall Study|Withdrawal by Subject|1|||
124790216|NCT00636363|448862106|FG001|Overall Study|Withdrawal by Subject|3|||
124790217|NCT00636363|448862107|FG002|Overall Study|Withdrawal by Subject|2|||
124790218|NCT00280748|448862109|FG000|Overall Study|Decline in performance|3|||
124790219|NCT00280748|448862109|FG000|Overall Study|Extra-cranial disease progression|1|||
124790220|NCT00029146|448862110|FG000|Overall Study|Lost to Follow-up|2|||
124790221|NCT00029146|448862111|FG001|Overall Study|Lost to Follow-up|1|||
124790222|NCT03567343|448862113|FG000|Overall Study|Lost to Follow-up|2|||
124790223|NCT03567343|448862114|FG001|Overall Study|Lost to Follow-up|1|||
124790224|NCT03567343|448862113|FG000|Overall Study|No longer eligible|2|||
124790225|NCT03567343|448862114|FG001|Overall Study|No longer eligible|1|||
124790226|NCT03567343|448862113|FG000|Overall Study|Adverse Event|1|||
124790227|NCT03567343|448862114|FG001|Overall Study|Adverse Event|0|||
124790228|NCT03567343|448862113|FG000|Overall Study|Protocol Violation|1|||
124790229|NCT03567343|448862114|FG001|Overall Study|Protocol Violation|1|||
124790230|NCT03007888|448862118|FG000|First Intervention (14 Days)|Adverse Event|1|||
124790231|NCT03007888|448862119|FG001|First Intervention (14 Days)|Adverse Event|0|||
124790232|NCT01806662|448862120|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
124790233|NCT01806662|448862121|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
124790234|NCT01806662|448862120|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
124790235|NCT01806662|448862121|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
124790236|NCT01806662|448862120|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
124790237|NCT01806662|448862121|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
124790238|NCT01806662|448862120|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
124790239|NCT01806662|448862121|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
124790240|NCT00043550|448862124|FG000|Overall Study|Withdrawal by Subject|22|||
124790241|NCT00043550|448862125|FG001|Overall Study|Withdrawal by Subject|12|||
124790242|NCT00043550|448862126|FG002|Overall Study|Withdrawal by Subject|20|||
124790243|NCT00827931|448862130|FG000|Overall Study|Death|3|||
124790244|NCT00827931|448862131|FG001|Overall Study|Death|5|||
124790245|NCT00827931|448862130|FG000|Overall Study|Adverse Event|1|||
124790246|NCT00827931|448862131|FG001|Overall Study|Adverse Event|0|||
124790247|NCT00827931|448862130|FG000|Overall Study|Lost to Follow-up|1|||
124790248|NCT00827931|448862131|FG001|Overall Study|Lost to Follow-up|0|||
124790249|NCT00827931|448862130|FG000|Overall Study|Withdrawal by Subject|0|||
124790250|NCT00827931|448862131|FG001|Overall Study|Withdrawal by Subject|1|||
125294516|NCT02198794|450706494|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
125294517|NCT02198794|450706495|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
125294518|NCT02198794|450706496|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
125294519|NCT00701805|450706497|FG000|Overall Study|Withdrawal by Subject|3|||
125294520|NCT00701805|450706498|FG001|Overall Study|Withdrawal by Subject|1|||
125294521|NCT00701805|450706499|FG002|Overall Study|Withdrawal by Subject|4|||
125294522|NCT00701805|450706500|FG003|Overall Study|Withdrawal by Subject|3|||
125294523|NCT00701805|450706497|FG000|Overall Study|Adverse Event|0|||
125294524|NCT00701805|450706498|FG001|Overall Study|Adverse Event|1|||
125294525|NCT00701805|450706499|FG002|Overall Study|Adverse Event|1|||
125294526|NCT00701805|450706500|FG003|Overall Study|Adverse Event|0|||
125294527|NCT00701805|450706497|FG000|Overall Study|Missed 7 consecutive doses|0|||
125294528|NCT00701805|450706498|FG001|Overall Study|Missed 7 consecutive doses|1|||
125294529|NCT00701805|450706499|FG002|Overall Study|Missed 7 consecutive doses|0|||
125294530|NCT00701805|450706500|FG003|Overall Study|Missed 7 consecutive doses|0|||
125294531|NCT00701805|450706497|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
125294532|NCT00701805|450706498|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
125294533|NCT00701805|450706499|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
125294534|NCT00701805|450706500|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
125294535|NCT00701805|450706497|FG000|Overall Study|Physician decision, change of therapy|0|||
125294536|NCT00701805|450706498|FG001|Overall Study|Physician decision, change of therapy|0|||
125294537|NCT00701805|450706499|FG002|Overall Study|Physician decision, change of therapy|0|||
125294538|NCT00701805|450706500|FG003|Overall Study|Physician decision, change of therapy|1|||
125294539|NCT00701805|450706497|FG000|Overall Study|Difficult to travel to dialysis site|0|||
125294540|NCT00701805|450706498|FG001|Overall Study|Difficult to travel to dialysis site|0|||
125294541|NCT00701805|450706499|FG002|Overall Study|Difficult to travel to dialysis site|1|||
125294542|NCT00701805|450706500|FG003|Overall Study|Difficult to travel to dialysis site|0|||
125294543|NCT00701805|450706497|FG000|Overall Study|Resumption criteria were not met|0|||
125294544|NCT00701805|450706498|FG001|Overall Study|Resumption criteria were not met|1|||
125294545|NCT00701805|450706499|FG002|Overall Study|Resumption criteria were not met|0|||
125294546|NCT00701805|450706500|FG003|Overall Study|Resumption criteria were not met|0|||
125294547|NCT02252965|450706504|FG000|Overall Study|Adverse Event|9|||
125294548|NCT02252965|450706505|FG001|Overall Study|Adverse Event|14|||
125294549|NCT02252965|450706504|FG000|Overall Study|Lost to Follow-up|16|||
125294550|NCT02252965|450706505|FG001|Overall Study|Lost to Follow-up|8|||
125294551|NCT02252965|450706504|FG000|Overall Study|Protocol Violation|4|||
125294552|NCT02252965|450706505|FG001|Overall Study|Protocol Violation|5|||
125294553|NCT02252965|450706504|FG000|Overall Study|Lack of Efficacy|0|||
125294554|NCT02252965|450706505|FG001|Overall Study|Lack of Efficacy|2|||
125294555|NCT02252965|450706504|FG000|Overall Study|Withdrawal by Subject|7|||
125294556|NCT02252965|450706505|FG001|Overall Study|Withdrawal by Subject|9|||
125294557|NCT02252965|450706504|FG000|Overall Study|Other|4|||
125294558|NCT02252965|450706505|FG001|Overall Study|Other|5|||
125294559|NCT04435600|450706513|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125294560|NCT04435600|450706514|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125294561|NCT04435600|450706515|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
125294562|NCT04435600|450706516|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125294563|NCT04435600|450706517|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125294564|NCT04435600|450706518|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125294565|NCT04435600|450706519|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125294566|NCT04435600|450706520|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125294567|NCT04435600|450706521|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125294568|NCT04435600|450706522|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125294569|NCT04435600|450706513|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
125294570|NCT04435600|450706514|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
124790251|NCT00827931|448862130|FG000|Overall Study|Other|1|||
124790252|NCT00827931|448862131|FG001|Overall Study|Other|0|||
124790253|NCT01917656|448862135|FG000|Overall Study|Adverse Event|11|||
125294571|NCT04435600|450706515|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
125294572|NCT04435600|450706516|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
125294573|NCT04435600|450706517|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
124790254|NCT01917656|448862136|FG001|Overall Study|Adverse Event|0|||
124790255|NCT01917656|448862135|FG000|Overall Study|Withdrawal criteria|8|||
124790256|NCT01917656|448862136|FG001|Overall Study|Withdrawal criteria|14|||
125294574|NCT04435600|450706518|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
125294575|NCT04435600|450706519|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
125294576|NCT04435600|450706520|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
125294577|NCT04435600|450706521|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
125294578|NCT04435600|450706522|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
125294579|NCT04435600|450706513|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
125294580|NCT04435600|450706514|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
125294581|NCT04435600|450706515|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
125294582|NCT04435600|450706516|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
125294583|NCT04435600|450706517|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
125294584|NCT04435600|450706518|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
125294585|NCT04435600|450706519|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
125294586|NCT04435600|450706520|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
125294587|NCT04435600|450706521|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
125294588|NCT04435600|450706522|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
125294589|NCT04435600|450706513|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
125294590|NCT04435600|450706514|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
125294591|NCT04435600|450706515|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
125294592|NCT04435600|450706516|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
125294593|NCT04435600|450706517|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
125294594|NCT04435600|450706518|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
125294595|NCT04435600|450706519|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
125294596|NCT04435600|450706520|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
125294597|NCT04435600|450706521|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
125294598|NCT04435600|450706522|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
124790257|NCT01917656|448862135|FG000|Overall Study|Unclassified|0|||
124790258|NCT01917656|448862136|FG001|Overall Study|Unclassified|3|||
124790259|NCT01917656|448862135|FG000|Overall Study|Withdrawal by Subject|4|||
124790260|NCT01917656|448862136|FG001|Overall Study|Withdrawal by Subject|3|||
125294599|NCT02797184|450706525|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
125294600|NCT02797184|450706526|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
125294601|NCT05149313|450706527|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
125294602|NCT05149313|450706528|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
125294603|NCT05149313|450706529|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
125294604|NCT05149313|450706530|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
125294605|NCT05149313|450706527|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
125294606|NCT05149313|450706528|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
125294607|NCT05149313|450706529|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
125294608|NCT05149313|450706530|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
125294609|NCT05149313|450706527|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
125294610|NCT05149313|450706528|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
125294611|NCT05149313|450706529|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
125294612|NCT05149313|450706530|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
125294613|NCT05149313|450706527|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
125294614|NCT05149313|450706528|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
125294615|NCT05149313|450706529|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
125294616|NCT05149313|450706530|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
125294617|NCT05149313|450706527|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
125294618|NCT05149313|450706528|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
124790261|NCT01917656|448862135|FG000|Overall Study|Lost to Follow-up|3|||
124790262|NCT01917656|448862136|FG001|Overall Study|Lost to Follow-up|4|||
124790263|NCT02081859|448862137|FG000|Overall Study|No fertilization|2|||
124790264|NCT02081859|448862138|FG001|Overall Study|No fertilization|2|||
124790265|NCT02081859|448862137|FG000|Overall Study|No sperm|1|||
124790266|NCT02081859|448862138|FG001|Overall Study|No sperm|0|||
124790267|NCT02081859|448862137|FG000|Overall Study|Unanticipated freeze all cycle|2|||
124790268|NCT02081859|448862138|FG001|Overall Study|Unanticipated freeze all cycle|6|||
124790269|NCT02081859|448862137|FG000|Overall Study|< 4 embryos|27|||
124790270|NCT02081859|448862138|FG001|Overall Study|< 4 embryos|23|||
124790271|NCT02081859|448862137|FG000|Overall Study|Other reasons|2|||
124790272|NCT02081859|448862138|FG001|Overall Study|Other reasons|0|||
124790273|NCT01870076|448862139|FG000|Overall Study|Withdrawal by Subject|1|||
124790274|NCT01870076|448862140|FG001|Overall Study|Withdrawal by Subject|0|||
124790275|NCT01870076|448862141|FG002|Overall Study|Withdrawal by Subject|1|||
124790276|NCT01870076|448862142|FG003|Overall Study|Withdrawal by Subject|0|||
124790277|NCT00492063|448862143|FG000|Overall Study|Death|0|||
124790278|NCT00492063|448862144|FG001|Overall Study|Death|0|||
124790279|NCT00492063|448862145|FG002|Overall Study|Death|1|||
124790280|NCT00492063|448862146|FG003|Overall Study|Death|2|||
124790281|NCT00492063|448862143|FG000|Overall Study|Withdrawal by Subject|4|||
124790282|NCT00492063|448862144|FG001|Overall Study|Withdrawal by Subject|3|||
124790283|NCT00492063|448862145|FG002|Overall Study|Withdrawal by Subject|5|||
124790284|NCT00492063|448862146|FG003|Overall Study|Withdrawal by Subject|4|||
124790285|NCT00492063|448862143|FG000|Overall Study|Lost to Follow-up|6|||
124790286|NCT00492063|448862144|FG001|Overall Study|Lost to Follow-up|11|||
124790287|NCT00492063|448862145|FG002|Overall Study|Lost to Follow-up|5|||
124790288|NCT00492063|448862146|FG003|Overall Study|Lost to Follow-up|3|||
124790289|NCT00492063|448862143|FG000|Overall Study|Protocol Violation|0|||
124790290|NCT00492063|448862144|FG001|Overall Study|Protocol Violation|0|||
124790291|NCT00492063|448862145|FG002|Overall Study|Protocol Violation|0|||
124790292|NCT00492063|448862146|FG003|Overall Study|Protocol Violation|1|||
124790293|NCT00510653|448862157|FG000|Overall Study|Withdrawal by Subject|8|||
124790294|NCT00510653|448862157|FG000|Overall Study|Monetary|3|||
124790295|NCT02312687|448862159|FG000|Overall Study|Other, Not Specified|1|||
124790296|NCT00217464|448862162|FG000|Overall Study|Progression|15|||
124790297|NCT00217464|448862162|FG000|Overall Study|Other|2|||
124790298|NCT00169442|448862163|FG000|Overall Study|Withdrawal by Subject|0|||
124790299|NCT00169442|448862164|FG001|Overall Study|Withdrawal by Subject|0|||
124790300|NCT00169442|448862165|FG002|Overall Study|Withdrawal by Subject|1|||
124790301|NCT00169442|448862166|FG003|Overall Study|Withdrawal by Subject|0|||
124790302|NCT00169442|448862167|FG004|Overall Study|Withdrawal by Subject|0|||
124790303|NCT00169442|448862168|FG005|Overall Study|Withdrawal by Subject|0|||
124790304|NCT00169442|448862163|FG000|Overall Study|Migrated/moved from study area|0|||
124790305|NCT00169442|448862164|FG001|Overall Study|Migrated/moved from study area|0|||
124790306|NCT00169442|448862165|FG002|Overall Study|Migrated/moved from study area|0|||
124790307|NCT00169442|448862166|FG003|Overall Study|Migrated/moved from study area|0|||
124790308|NCT00169442|448862167|FG004|Overall Study|Migrated/moved from study area|0|||
124790309|NCT00169442|448862168|FG005|Overall Study|Migrated/moved from study area|2|||
124790310|NCT00169442|448862163|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
124790311|NCT00169442|448862164|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
124790312|NCT00169442|448862165|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
124790313|NCT00169442|448862166|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
124790314|NCT00169442|448862167|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
124790315|NCT00169442|448862168|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
124790316|NCT00169442|448862163|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
124790317|NCT00169442|448862164|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
124790318|NCT00169442|448862165|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
124790319|NCT00169442|448862166|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
124790320|NCT00169442|448862167|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
124790321|NCT00169442|448862168|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
124790322|NCT01426789|448862169|FG000|Part 1|Protocol deviation|0|||
124790323|NCT01426789|448862170|FG001|Part 1|Protocol deviation|1|||
124790324|NCT01426789|448862171|FG002|Part 1|Protocol deviation|0|||
124790325|NCT01426789|448862172|FG003|Part 1|Protocol deviation|0|||
124790326|NCT01426789|448862173|FG004|Part 1|Protocol deviation|0|||
124790327|NCT01426789|448862174|FG005|Part 1|Protocol deviation|0|||
124790328|NCT01426789|448862169|FG000|Part 1|Lost to Follow-up|1|||
124790329|NCT01426789|448862170|FG001|Part 1|Lost to Follow-up|2|||
124790330|NCT01426789|448862171|FG002|Part 1|Lost to Follow-up|0|||
124790331|NCT01426789|448862172|FG003|Part 1|Lost to Follow-up|0|||
124790332|NCT01426789|448862173|FG004|Part 1|Lost to Follow-up|0|||
124790333|NCT01426789|448862174|FG005|Part 1|Lost to Follow-up|0|||
124790334|NCT01426789|448862169|FG000|Part 1|Lack of Efficacy|2|||
125294619|NCT05149313|450706529|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
124790335|NCT01426789|448862170|FG001|Part 1|Lack of Efficacy|1|||
124790336|NCT01426789|448862171|FG002|Part 1|Lack of Efficacy|0|||
124790337|NCT01426789|448862172|FG003|Part 1|Lack of Efficacy|0|||
124790338|NCT01426789|448862173|FG004|Part 1|Lack of Efficacy|0|||
124790339|NCT01426789|448862174|FG005|Part 1|Lack of Efficacy|0|||
124790340|NCT01426789|448862169|FG000|Part 1|Adverse Event|3|||
124790341|NCT01426789|448862170|FG001|Part 1|Adverse Event|0|||
124790342|NCT01426789|448862171|FG002|Part 1|Adverse Event|0|||
124790343|NCT01426789|448862172|FG003|Part 1|Adverse Event|0|||
124790344|NCT01426789|448862173|FG004|Part 1|Adverse Event|0|||
124790345|NCT01426789|448862174|FG005|Part 1|Adverse Event|0|||
124790346|NCT01426789|448862169|FG000|Part 2|Protocol deviation|0|||
125294620|NCT05149313|450706530|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
125294621|NCT05149313|450706527|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
124790347|NCT01426789|448862170|FG001|Part 2|Protocol deviation|0|||
124790348|NCT01426789|448862171|FG002|Part 2|Protocol deviation|1|||
124790349|NCT01426789|448862172|FG003|Part 2|Protocol deviation|0|||
124790350|NCT01426789|448862173|FG004|Part 2|Protocol deviation|0|||
124790351|NCT01426789|448862174|FG005|Part 2|Protocol deviation|0|||
124790352|NCT01426789|448862169|FG000|Part 2|Death|0|||
124790353|NCT01426789|448862170|FG001|Part 2|Death|0|||
124790354|NCT01426789|448862171|FG002|Part 2|Death|1|||
124790355|NCT01426789|448862172|FG003|Part 2|Death|0|||
124790356|NCT01426789|448862173|FG004|Part 2|Death|1|||
124790357|NCT01426789|448862174|FG005|Part 2|Death|0|||
124790358|NCT01426789|448862169|FG000|Part 2|Administrative problems|0|||
125294622|NCT05149313|450706528|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
125294623|NCT05149313|450706529|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
125294624|NCT05149313|450706530|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
125294625|NCT05149313|450706527|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
125294626|NCT05149313|450706528|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
125294627|NCT05149313|450706529|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
125294628|NCT05149313|450706530|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
125294629|NCT05149313|450706527|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125294630|NCT05149313|450706528|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125294631|NCT05149313|450706529|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
125294632|NCT05149313|450706530|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
124790359|NCT01426789|448862170|FG001|Part 2|Administrative problems|0|||
124790360|NCT01426789|448862171|FG002|Part 2|Administrative problems|2|||
124790361|NCT01426789|448862172|FG003|Part 2|Administrative problems|0|||
124790362|NCT01426789|448862173|FG004|Part 2|Administrative problems|1|||
124790363|NCT01426789|448862174|FG005|Part 2|Administrative problems|0|||
124790364|NCT01426789|448862169|FG000|Part 2|Lost to Follow-up|0|||
124790365|NCT01426789|448862170|FG001|Part 2|Lost to Follow-up|0|||
124790366|NCT01426789|448862171|FG002|Part 2|Lost to Follow-up|4|||
124790367|NCT01426789|448862172|FG003|Part 2|Lost to Follow-up|0|||
124790368|NCT01426789|448862173|FG004|Part 2|Lost to Follow-up|1|||
124790369|NCT01426789|448862174|FG005|Part 2|Lost to Follow-up|0|||
125294633|NCT05149313|450706527|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
125294634|NCT05149313|450706528|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
125294635|NCT05149313|450706529|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
125294636|NCT05149313|450706530|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
125294637|NCT05149313|450706527|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125294638|NCT05149313|450706528|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125294639|NCT05149313|450706529|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
125294640|NCT05149313|450706530|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125294641|NCT05149313|450706527|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
125294642|NCT05149313|450706528|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
125294643|NCT05149313|450706529|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
125294644|NCT05149313|450706530|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
125294645|NCT03199391|450706535|FG000|Overall Study|Death|1|||
125294646|NCT03199391|450706535|FG000|Overall Study|Lost to Follow-up|3|||
125294647|NCT03199391|450706535|FG000|Overall Study|Adverse Event|2|||
125294648|NCT03199391|450706535|FG000|Overall Study|Withdrawal by Subject|10|||
125294649|NCT04736628|450706536|FG000|Overall Study|Not treated|0|||
125294650|NCT04736628|450706537|FG001|Overall Study|Not treated|0|||
125294651|NCT04736628|450706538|FG002|Overall Study|Not treated|0|||
125294652|NCT04736628|450706539|FG003|Overall Study|Not treated|2|||
125294653|NCT04736628|450706536|FG000|Overall Study|Other reason than listed|1|||
125294654|NCT04736628|450706537|FG001|Overall Study|Other reason than listed|2|||
125294655|NCT04736628|450706538|FG002|Overall Study|Other reason than listed|2|||
125294656|NCT04736628|450706539|FG003|Overall Study|Other reason than listed|3|||
125294657|NCT04736628|450706536|FG000|Overall Study|Protocol deviation|0|||
125294658|NCT04736628|450706537|FG001|Overall Study|Protocol deviation|0|||
125294659|NCT04736628|450706538|FG002|Overall Study|Protocol deviation|0|||
125294660|NCT04736628|450706539|FG003|Overall Study|Protocol deviation|1|||
125294661|NCT04736628|450706536|FG000|Overall Study|Burden of study procedures|1|||
125294662|NCT04736628|450706537|FG001|Overall Study|Burden of study procedures|0|||
125294663|NCT04736628|450706538|FG002|Overall Study|Burden of study procedures|0|||
125294664|NCT04736628|450706539|FG003|Overall Study|Burden of study procedures|1|||
125294665|NCT04736628|450706536|FG000|Overall Study|Change of residence|0|||
124790370|NCT01426789|448862169|FG000|Part 2|Withdrawal by Subject|0|||
124790371|NCT01426789|448862170|FG001|Part 2|Withdrawal by Subject|0|||
124790372|NCT01426789|448862171|FG002|Part 2|Withdrawal by Subject|0|||
125294666|NCT04736628|450706537|FG001|Overall Study|Change of residence|1|||
125294667|NCT04736628|450706538|FG002|Overall Study|Change of residence|0|||
125294668|NCT04736628|450706539|FG003|Overall Study|Change of residence|0|||
125294669|NCT04736628|450706536|FG000|Overall Study|Perceived lack of efficacy|1|||
125294670|NCT04736628|450706537|FG001|Overall Study|Perceived lack of efficacy|0|||
124790373|NCT01426789|448862172|FG003|Part 2|Withdrawal by Subject|1|||
125294671|NCT04736628|450706538|FG002|Overall Study|Perceived lack of efficacy|0|||
125294672|NCT04736628|450706539|FG003|Overall Study|Perceived lack of efficacy|1|||
125294673|NCT04736628|450706536|FG000|Overall Study|Adverse Event|3|||
125294674|NCT04736628|450706537|FG001|Overall Study|Adverse Event|2|||
125294675|NCT04736628|450706538|FG002|Overall Study|Adverse Event|4|||
124790374|NCT01426789|448862173|FG004|Part 2|Withdrawal by Subject|2|||
124790375|NCT01426789|448862174|FG005|Part 2|Withdrawal by Subject|0|||
124790376|NCT01426789|448862169|FG000|Part 2|Lack of Efficacy|0|||
124790377|NCT01426789|448862170|FG001|Part 2|Lack of Efficacy|0|||
125294676|NCT04736628|450706539|FG003|Overall Study|Adverse Event|3|||
125294677|NCT02046070|450706549|FG000|Overall Study|Progressive Disease|18|||
125294678|NCT02046070|450706550|FG001|Overall Study|Progressive Disease|11|||
125294679|NCT02046070|450706551|FG002|Overall Study|Progressive Disease|40|||
125294680|NCT02046070|450706549|FG000|Overall Study|Adverse Event|8|||
125294681|NCT02046070|450706550|FG001|Overall Study|Adverse Event|10|||
125294682|NCT02046070|450706551|FG002|Overall Study|Adverse Event|17|||
125294683|NCT02046070|450706549|FG000|Overall Study|Withdrawal by Subject|1|||
125294684|NCT02046070|450706550|FG001|Overall Study|Withdrawal by Subject|2|||
125294685|NCT02046070|450706551|FG002|Overall Study|Withdrawal by Subject|6|||
125294686|NCT02046070|450706549|FG000|Overall Study|Study Terminated by Sponsor|1|||
125294687|NCT02046070|450706550|FG001|Overall Study|Study Terminated by Sponsor|1|||
125294688|NCT02046070|450706551|FG002|Overall Study|Study Terminated by Sponsor|1|||
125294689|NCT02046070|450706549|FG000|Overall Study|Reason not Specified|4|||
125294690|NCT02046070|450706550|FG001|Overall Study|Reason not Specified|4|||
125294691|NCT02046070|450706551|FG002|Overall Study|Reason not Specified|6|||
125294692|NCT04619004|450706552|FG000|Overall Study|Death|114|||
125294693|NCT04619004|450706553|FG001|Overall Study|Death|28|||
125294694|NCT04619004|450706552|FG000|Overall Study|Lost to Follow-up|1|||
125294695|NCT04619004|450706553|FG001|Overall Study|Lost to Follow-up|1|||
125294696|NCT04619004|450706552|FG000|Overall Study|Withdrawal by Subject|24|||
125294697|NCT04619004|450706553|FG001|Overall Study|Withdrawal by Subject|7|||
125294698|NCT04619004|450706552|FG000|Overall Study|Other - Not specified|0|||
125294699|NCT04619004|450706553|FG001|Overall Study|Other - Not specified|1|||
125294700|NCT02258529|450706557|FG000|Overall Study|Study Terminated by Sponsor|9|||
125294701|NCT02258529|450706557|FG000|Overall Study|Adverse Event|1|||
125294702|NCT05432167|450706563|FG000|Overall Study|Adverse Event|0|||
125294703|NCT05432167|450706564|FG001|Overall Study|Adverse Event|2|||
125294704|NCT05432167|450706565|FG002|Overall Study|Adverse Event|1|||
125294705|NCT05432167|450706563|FG000|Overall Study|Lost to Follow-up|3|||
124790378|NCT01426789|448862171|FG002|Part 2|Lack of Efficacy|5|||
124790379|NCT01426789|448862172|FG003|Part 2|Lack of Efficacy|0|||
124790380|NCT01426789|448862173|FG004|Part 2|Lack of Efficacy|2|||
124790381|NCT01426789|448862174|FG005|Part 2|Lack of Efficacy|0|||
124790382|NCT01426789|448862169|FG000|Part 2|Adverse Event|0|||
124790383|NCT01426789|448862170|FG001|Part 2|Adverse Event|0|||
124790384|NCT01426789|448862171|FG002|Part 2|Adverse Event|2|||
124790385|NCT01426789|448862172|FG003|Part 2|Adverse Event|0|||
124790386|NCT01426789|448862173|FG004|Part 2|Adverse Event|1|||
124790387|NCT01426789|448862174|FG005|Part 2|Adverse Event|0|||
124790388|NCT00311584|448862177|FG000|Overall Study|Death|1|||
124790389|NCT00311584|448862178|FG001|Overall Study|Death|0|||
124790390|NCT00311584|448862177|FG000|Overall Study|Lack of Efficacy|12|||
124790391|NCT00311584|448862178|FG001|Overall Study|Lack of Efficacy|15|||
124790392|NCT00311584|448862177|FG000|Overall Study|Physician Decision|4|||
124790393|NCT00311584|448862178|FG001|Overall Study|Physician Decision|5|||
124790394|NCT00311584|448862177|FG000|Overall Study|Withdrawal by Subject|1|||
124790395|NCT00311584|448862178|FG001|Overall Study|Withdrawal by Subject|1|||
124790396|NCT00311584|448862177|FG000|Overall Study|ineligible|2|||
124790397|NCT00311584|448862178|FG001|Overall Study|ineligible|2|||
124790398|NCT00167778|448862183|FG000|Overall Study|Withdrawal by Subject|1|||
124790399|NCT02654717|448862184|FG000|Overall Study|Adverse Event|2|||
124790400|NCT02654717|448862185|FG001|Overall Study|Adverse Event|2|||
124790401|NCT02654717|448862184|FG000|Overall Study|Protocol Violation|1|||
124790402|NCT02654717|448862185|FG001|Overall Study|Protocol Violation|2|||
124790403|NCT02654717|448862184|FG000|Overall Study|Withdrawal by Subject|0|||
124790404|NCT02654717|448862185|FG001|Overall Study|Withdrawal by Subject|1|||
124790405|NCT02654717|448862184|FG000|Overall Study|Non-permitted medication|3|||
124790406|NCT02654717|448862185|FG001|Overall Study|Non-permitted medication|0|||
124790407|NCT05395091|448863664|FG000|Baseline to Month 12|Adverse Event|7|||
124790408|NCT05395091|448863665|FG001|Baseline to Month 12|Adverse Event|2|||
124790409|NCT05395091|448863666|FG002|Baseline to Month 12|Adverse Event|0|||
125294706|NCT05432167|450706564|FG001|Overall Study|Lost to Follow-up|3|||
125294707|NCT05432167|450706565|FG002|Overall Study|Lost to Follow-up|2|||
125294708|NCT05432167|450706563|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
125294709|NCT05432167|450706564|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
125294710|NCT05432167|450706565|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
124790410|NCT05395091|448863664|FG000|Baseline to Month 12|Death|3|||
124790411|NCT05395091|448863665|FG001|Baseline to Month 12|Death|1|||
124790412|NCT05395091|448863666|FG002|Baseline to Month 12|Death|0|||
125294711|NCT05432167|450706563|FG000|Overall Study|Physician Decision|1|||
124790413|NCT05395091|448863664|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
124790414|NCT05395091|448863665|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
124790415|NCT05395091|448863666|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
124790416|NCT05395091|448863664|FG000|Baseline to Month 12|Protocol Violation|2|||
124790417|NCT05395091|448863665|FG001|Baseline to Month 12|Protocol Violation|3|||
124790418|NCT05395091|448863666|FG002|Baseline to Month 12|Protocol Violation|0|||
124790419|NCT05395091|448863664|FG000|Baseline to Month 12|Physician Decision|1|||
124790420|NCT05395091|448863665|FG001|Baseline to Month 12|Physician Decision|0|||
124790421|NCT05395091|448863666|FG002|Baseline to Month 12|Physician Decision|0|||
124790422|NCT05395091|448863664|FG000|Month 12 to Month 18|Death|1|||
124790423|NCT05395091|448863665|FG001|Month 12 to Month 18|Death|0|||
124790424|NCT05395091|448863666|FG002|Month 12 to Month 18|Death|0|||
124790425|NCT05395091|448863664|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
124790426|NCT05395091|448863665|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
124790427|NCT05395091|448863666|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
124790428|NCT05395091|448863664|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
124790429|NCT05395091|448863665|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
124790430|NCT05395091|448863666|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
124790431|NCT05395091|448863664|FG000|Month 12 to Month 18|Other reasons|0|||
124790432|NCT05395091|448863665|FG001|Month 12 to Month 18|Other reasons|0|||
124790433|NCT05395091|448863666|FG002|Month 12 to Month 18|Other reasons|1|||
124790434|NCT00313781|448863669|FG000|Before Crossover|Death|22|||
124790435|NCT00313781|448863670|FG001|Before Crossover|Death|8|||
125294712|NCT05432167|450706564|FG001|Overall Study|Physician Decision|0|||
125294713|NCT05432167|450706565|FG002|Overall Study|Physician Decision|0|||
125294714|NCT05432167|450706563|FG000|Overall Study|Withdrawal by Subject|7|||
125294715|NCT05432167|450706564|FG001|Overall Study|Withdrawal by Subject|4|||
125294716|NCT05432167|450706565|FG002|Overall Study|Withdrawal by Subject|11|||
125294717|NCT05432167|450706563|FG000|Overall Study|Other|0|||
125294718|NCT05432167|450706564|FG001|Overall Study|Other|0|||
125294719|NCT05432167|450706565|FG002|Overall Study|Other|1|||
125294720|NCT01267175|450706566|FG000|Overall Study|Withdrawal by Subject|1|||
125294721|NCT01267175|450706566|FG000|Overall Study|Lost to Follow-up|1|||
125294722|NCT02553538|450706571|FG000|Overall Study|Could Not Reach by Telephone|133|||
125294723|NCT02553538|450706572|FG001|Overall Study|Could Not Reach by Telephone|0|||
125294724|NCT02553538|450706571|FG000|Overall Study|Died or Left Network|54|||
125294725|NCT02553538|450706572|FG001|Overall Study|Died or Left Network|56|||
125294726|NCT04094584|450706573|FG000|Overall Study|No interest in study|88|||
125294727|NCT04094584|450706573|FG000|Overall Study|Unwilling to undergo screening tests|36|||
125294728|NCT04094584|450706573|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
125294729|NCT04094584|450706573|FG000|Overall Study|Opioid use|7|||
125294730|NCT04094584|450706573|FG000|Overall Study|Need for major surgery in study period|4|||
125294731|NCT04094584|450706573|FG000|Overall Study|eligible but declined enrollment|4|||
125294732|NCT04094584|450706573|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
125294733|NCT04094584|450706573|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
125294734|NCT04094584|450706573|FG000|Overall Study|Lost to Follow-up|3|||
125294735|NCT04094584|450706573|FG000|Overall Study|Withdrawal by Subject|2|||
125294736|NCT02690649|450706574|FG000|Overall Study|Withdrawal by Subject|1|||
125294737|NCT02690649|450706575|FG001|Overall Study|Withdrawal by Subject|1|||
125294738|NCT02690649|450706574|FG000|Overall Study|Protocol Violation|0|||
125294739|NCT02690649|450706575|FG001|Overall Study|Protocol Violation|3|||
125294740|NCT00791557|450706576|FG000|Overall Study|Adverse Event|1|||
125294741|NCT02616393|450706582|FG000|Overall Study|Death|5|||
125294742|NCT02616393|450706583|FG001|Overall Study|Death|12|||
125294743|NCT02616393|450706584|FG002|Overall Study|Death|1|||
125294744|NCT02616393|450706582|FG000|Overall Study|Termination by Sponsor|4|||
125294745|NCT02616393|450706583|FG001|Overall Study|Termination by Sponsor|5|||
125294746|NCT02616393|450706584|FG002|Overall Study|Termination by Sponsor|2|||
125294747|NCT02616393|450706582|FG000|Overall Study|Other|3|||
124790436|NCT00313781|448863671|FG002|Before Crossover|Death|0|||
124790437|NCT00313781|448863669|FG000|Before Crossover|Lost to Follow-up|0|||
124790438|NCT00313781|448863670|FG001|Before Crossover|Lost to Follow-up|3|||
124790439|NCT00313781|448863671|FG002|Before Crossover|Lost to Follow-up|0|||
124790440|NCT00313781|448863669|FG000|Before Crossover|Withdrawal by Subject|3|||
124790441|NCT00313781|448863670|FG001|Before Crossover|Withdrawal by Subject|1|||
124790442|NCT00313781|448863671|FG002|Before Crossover|Withdrawal by Subject|0|||
124790443|NCT00313781|448863669|FG000|Before Crossover|Other|45|||
124790444|NCT00313781|448863670|FG001|Before Crossover|Other|30|||
124790445|NCT00313781|448863671|FG002|Before Crossover|Other|0|||
125294748|NCT02616393|450706583|FG001|Overall Study|Other|0|||
125294749|NCT02616393|450706584|FG002|Overall Study|Other|0|||
125294750|NCT02616393|450706582|FG000|Overall Study|Withdrawal by Subject|1|||
125294751|NCT02616393|450706583|FG001|Overall Study|Withdrawal by Subject|1|||
125294752|NCT02616393|450706584|FG002|Overall Study|Withdrawal by Subject|0|||
124790446|NCT00313781|448863669|FG000|Before Crossover|Crossover|0|||
124790447|NCT00313781|448863670|FG001|Before Crossover|Crossover|37|||
125294753|NCT02616393|450706582|FG000|Overall Study|Lost to Follow-up|0|||
125294754|NCT02616393|450706583|FG001|Overall Study|Lost to Follow-up|2|||
125294755|NCT02616393|450706584|FG002|Overall Study|Lost to Follow-up|0|||
125294756|NCT02900170|450706588|FG000|Overall Study|Lost to Follow-up|8|||
125294757|NCT01600053|450706589|FG000|Overall Study|Adverse Event|2|||
125294758|NCT01600053|450706589|FG000|Overall Study|trial will not meet the interim endpoint|9|||
125294759|NCT02855944|450706590|FG000|Period 1: Treatment|Ongoing|14|||
125294760|NCT02855944|450706591|FG001|Period 1: Treatment|Ongoing|0|||
125294761|NCT02855944|450706590|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
125294762|NCT02855944|450706591|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
125294763|NCT02855944|450706590|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
124790448|NCT00313781|448863671|FG002|Before Crossover|Crossover|0|||
124790449|NCT00313781|448863669|FG000|Before Crossover|Randomized, not treated|5|||
124790450|NCT00313781|448863670|FG001|Before Crossover|Randomized, not treated|0|||
124790451|NCT00313781|448863671|FG002|Before Crossover|Randomized, not treated|0|||
124790452|NCT00313781|448863669|FG000|After Crossover|Death|0|||
124790453|NCT00313781|448863670|FG001|After Crossover|Death|0|||
124790454|NCT00313781|448863671|FG002|After Crossover|Death|6|||
124790455|NCT00313781|448863669|FG000|After Crossover|Withdrawal by Subject|0|||
124790456|NCT00313781|448863670|FG001|After Crossover|Withdrawal by Subject|0|||
124790457|NCT00313781|448863671|FG002|After Crossover|Withdrawal by Subject|3|||
125294764|NCT02855944|450706591|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
125294765|NCT01475162|450706598|FG000|Overall Study|Physician Decision|1|||
125294766|NCT01475162|450706598|FG000|Overall Study|Death|10|||
125294767|NCT01475162|450706598|FG000|Overall Study|Study closed for safety|3|||
125294768|NCT00490022|450706599|FG000|Overall Study|Adverse Event|0|||
125294769|NCT00490022|450706600|FG001|Overall Study|Adverse Event|2|||
125294770|NCT00490022|450706599|FG000|Overall Study|Withdrawal by Subject|1|||
125294771|NCT00490022|450706600|FG001|Overall Study|Withdrawal by Subject|0|||
125294772|NCT00490022|450706599|FG000|Overall Study|Subject failed to disclose concommitant|0|||
125294773|NCT00490022|450706600|FG001|Overall Study|Subject failed to disclose concommitant|1|||
125294774|NCT02608450|450706601|FG000|Overall Study|Lost to Follow-up|39|||
125294775|NCT02608450|450706602|FG001|Overall Study|Lost to Follow-up|32|||
125294776|NCT02608450|450706601|FG000|Overall Study|Withdrawal by Subject|21|||
125294777|NCT02608450|450706602|FG001|Overall Study|Withdrawal by Subject|15|||
125294778|NCT02608450|450706601|FG000|Overall Study|Adverse Event|3|||
125294779|NCT02608450|450706602|FG001|Overall Study|Adverse Event|6|||
125294780|NCT02608450|450706601|FG000|Overall Study|Withdrawal by parent|2|||
125294781|NCT02608450|450706602|FG001|Overall Study|Withdrawal by parent|3|||
125294782|NCT02608450|450706601|FG000|Overall Study|Lack of Efficacy|0|||
125294783|NCT02608450|450706602|FG001|Overall Study|Lack of Efficacy|3|||
125294784|NCT02608450|450706601|FG000|Overall Study|Noncompliance with study drug|0|||
125294785|NCT02608450|450706602|FG001|Overall Study|Noncompliance with study drug|2|||
125294786|NCT02608450|450706601|FG000|Overall Study|Physician Decision|0|||
125294787|NCT02608450|450706602|FG001|Overall Study|Physician Decision|1|||
125294788|NCT02608450|450706601|FG000|Overall Study|Pregnancy|0|||
125294789|NCT02608450|450706602|FG001|Overall Study|Pregnancy|1|||
125294790|NCT02608450|450706601|FG000|Overall Study|Progressive disease|1|||
125294791|NCT02608450|450706602|FG001|Overall Study|Progressive disease|0|||
125294792|NCT02608450|450706601|FG000|Overall Study|Multiple reasons|0|||
125294793|NCT02608450|450706602|FG001|Overall Study|Multiple reasons|2|||
125294794|NCT01283542|450706603|FG000|Main Phase|Acute or progressive vision loss|1|||
125294795|NCT01283542|450706603|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
125294796|NCT01283542|450706603|FG000|Main Phase|abnormal laboratory values|5|||
125294797|NCT01283542|450706603|FG000|Extension Phase|Physician Decision|1|||
125294798|NCT01283542|450706603|FG000|Extension Phase|Adverse Event|1|||
125294799|NCT01283542|450706603|FG000|Extension Phase|Administrative problems|1|||
125294800|NCT03443427|450706605|FG000|Overall Study|Adverse Event|2|||
125294801|NCT03443427|450706606|FG001|Overall Study|Adverse Event|3|||
125294802|NCT03443427|450706605|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
125294803|NCT03443427|450706606|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
125294804|NCT03443427|450706605|FG000|Overall Study|Other|4|||
125294805|NCT03443427|450706606|FG001|Overall Study|Other|6|||
125294806|NCT00477269|450706607|FG000|Core Study|Adverse Event|6|||
125294807|NCT00477269|450706608|FG001|Core Study|Adverse Event|4|||
125294808|NCT00477269|450706609|FG002|Core Study|Adverse Event|0|||
125294809|NCT00477269|450706607|FG000|Core Study|Death|3|||
125294810|NCT00477269|450706608|FG001|Core Study|Death|3|||
125294811|NCT00477269|450706609|FG002|Core Study|Death|0|||
125294812|NCT00477269|450706607|FG000|Core Study|Withdrawn Consent|0|||
124790458|NCT00313781|448863669|FG000|After Crossover|Other|0|||
124790459|NCT00313781|448863670|FG001|After Crossover|Other|0|||
125294813|NCT00477269|450706608|FG001|Core Study|Withdrawn Consent|1|||
125294814|NCT00477269|450706609|FG002|Core Study|Withdrawn Consent|0|||
125294815|NCT00477269|450706607|FG000|Open Label Extension|Adverse Event|0|||
125294816|NCT00477269|450706608|FG001|Open Label Extension|Adverse Event|0|||
125294817|NCT00477269|450706609|FG002|Open Label Extension|Adverse Event|4|||
125294818|NCT00477269|450706607|FG000|Open Label Extension|Abnormal laboratory values|0|||
124790460|NCT00313781|448863671|FG002|After Crossover|Other|18|||
125294819|NCT00477269|450706608|FG001|Open Label Extension|Abnormal laboratory values|0|||
125294820|NCT00477269|450706609|FG002|Open Label Extension|Abnormal laboratory values|1|||
125294821|NCT00477269|450706607|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
125294822|NCT00477269|450706608|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
125294823|NCT00477269|450706609|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
125294824|NCT00477269|450706607|FG000|Open Label Extension|Adminiatrative problems|0|||
125294825|NCT00477269|450706608|FG001|Open Label Extension|Adminiatrative problems|0|||
125294826|NCT00477269|450706609|FG002|Open Label Extension|Adminiatrative problems|2|||
124790461|NCT01433250|448863672|FG000|Overall Study|Protocol Violation|0|||
124790462|NCT01433250|448863673|FG001|Overall Study|Protocol Violation|1|||
124790463|NCT01433250|448863672|FG000|Overall Study|Withdrawal by Subject|3|||
124790464|NCT01433250|448863673|FG001|Overall Study|Withdrawal by Subject|2|||
124790465|NCT00834080|448863674|FG000|Overall Study|Adverse Event|7|||
124790466|NCT00834080|448863674|FG000|Overall Study|Lost to Follow-up|7|||
125294827|NCT00477269|450706607|FG000|Open Label Extension|Death|0|||
125294828|NCT00477269|450706608|FG001|Open Label Extension|Death|0|||
125294829|NCT00477269|450706609|FG002|Open Label Extension|Death|4|||
125294830|NCT03263780|450706610|FG000|Overall Study|Withdrawal by Subject|3|||
125294831|NCT03263780|450706610|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
125294832|NCT03938324|450707756|FG000|Overall Study|Lost to Follow-up|42|||
125294833|NCT03938324|450707757|FG001|Overall Study|Lost to Follow-up|21|||
125294834|NCT03938324|450707756|FG000|Overall Study|Withdrawal by Subject|6|||
125294835|NCT03938324|450707757|FG001|Overall Study|Withdrawal by Subject|1|||
125294836|NCT02769962|450707758|FG000|Overall Study|Physician Decision|0|||
125294837|NCT02769962|450707759|FG001|Overall Study|Physician Decision|0|||
125294838|NCT02769962|450707760|FG002|Overall Study|Physician Decision|0|||
125294839|NCT02769962|450707761|FG003|Overall Study|Physician Decision|0|||
125294840|NCT02769962|450707762|FG004|Overall Study|Physician Decision|0|||
125294841|NCT02769962|450707763|FG005|Overall Study|Physician Decision|1|||
125294842|NCT02769962|450707764|FG006|Overall Study|Physician Decision|0|||
125294843|NCT02769962|450707765|FG007|Overall Study|Physician Decision|1|||
125294844|NCT02769962|450707758|FG000|Overall Study|Refused further treatment|0|||
125294845|NCT02769962|450707759|FG001|Overall Study|Refused further treatment|0|||
125294846|NCT02769962|450707760|FG002|Overall Study|Refused further treatment|0|||
125294847|NCT02769962|450707761|FG003|Overall Study|Refused further treatment|0|||
125294848|NCT02769962|450707762|FG004|Overall Study|Refused further treatment|0|||
125294849|NCT02769962|450707763|FG005|Overall Study|Refused further treatment|1|||
125294850|NCT02769962|450707764|FG006|Overall Study|Refused further treatment|1|||
125294851|NCT02769962|450707765|FG007|Overall Study|Refused further treatment|0|||
125294852|NCT00837759|450707766|FG000|Overall Study|Protocol Violation|3|||
125294853|NCT00837759|450707766|FG000|Overall Study|Lost to Follow-up|1|||
125294854|NCT05063539|450707767|FG000|Overall Study|Adverse Event|1|||
125294855|NCT05063539|450707768|FG001|Overall Study|Adverse Event|2|||
125294856|NCT05063539|450707769|FG002|Overall Study|Adverse Event|1|||
125294857|NCT05063539|450707767|FG000|Overall Study|Death|0|||
125294858|NCT05063539|450707768|FG001|Overall Study|Death|1|||
125294859|NCT05063539|450707769|FG002|Overall Study|Death|1|||
125294860|NCT05063539|450707767|FG000|Overall Study|Lost to Follow-up|0|||
125294861|NCT05063539|450707768|FG001|Overall Study|Lost to Follow-up|1|||
125294862|NCT05063539|450707769|FG002|Overall Study|Lost to Follow-up|0|||
125294863|NCT05063539|450707767|FG000|Overall Study|Physician Decision|4|||
125294864|NCT05063539|450707768|FG001|Overall Study|Physician Decision|3|||
125294865|NCT05063539|450707769|FG002|Overall Study|Physician Decision|1|||
125294866|NCT05063539|450707767|FG000|Overall Study|Progressive Disease|0|||
125294867|NCT05063539|450707768|FG001|Overall Study|Progressive Disease|2|||
125294868|NCT05063539|450707769|FG002|Overall Study|Progressive Disease|0|||
125294869|NCT05063539|450707767|FG000|Overall Study|Withdrawal by Subject|17|||
125294870|NCT05063539|450707768|FG001|Overall Study|Withdrawal by Subject|26|||
125294871|NCT05063539|450707769|FG002|Overall Study|Withdrawal by Subject|14|||
125294872|NCT05063539|450707767|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
125294873|NCT05063539|450707768|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
125294874|NCT05063539|450707769|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
125294875|NCT05063539|450707767|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
124790467|NCT00834080|448863674|FG000|Overall Study|Withdrawal by Subject|5|||
124790468|NCT00834080|448863674|FG000|Overall Study|Other - Pregnancy|1|||
124790469|NCT00834080|448863674|FG000|Overall Study|Other - False positive tests of the UDS|1|||
124790470|NCT00834080|448863674|FG000|Overall Study|Physician Decision|1|||
124790471|NCT00834080|448863674|FG000|Overall Study|Subject Relocated|1|||
124790472|NCT02431260|448863675|FG000|Overall Study|Subject Decision|0|||
124790473|NCT02431260|448863676|FG001|Overall Study|Subject Decision|1|||
124790474|NCT02431260|448863677|FG002|Overall Study|Subject Decision|1|||
124790475|NCT02431260|448863678|FG003|Overall Study|Subject Decision|0|||
125294876|NCT05063539|450707768|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
125294877|NCT05063539|450707769|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
125294878|NCT05063539|450707767|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
124790476|NCT02431260|448863679|FG004|Overall Study|Subject Decision|0|||
125294879|NCT05063539|450707768|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
125294880|NCT05063539|450707769|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
125294881|NCT05063539|450707767|FG000|Overall Study|Discontinued due to Common Close Design|0|||
125294882|NCT05063539|450707768|FG001|Overall Study|Discontinued due to Common Close Design|1|||
125294883|NCT05063539|450707769|FG002|Overall Study|Discontinued due to Common Close Design|0|||
125294884|NCT05063539|450707767|FG000|Overall Study|Participant not co-operative|0|||
125294885|NCT05063539|450707768|FG001|Overall Study|Participant not co-operative|1|||
125294886|NCT05063539|450707769|FG002|Overall Study|Participant not co-operative|0|||
125294887|NCT05063539|450707767|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
125294888|NCT05063539|450707768|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
125294889|NCT05063539|450707769|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
125294890|NCT05063539|450707767|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
125294891|NCT05063539|450707768|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
125294892|NCT05063539|450707769|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
125294893|NCT04256512|450707770|FG000|Overall Study|Withdrawal by Subject|1|||
125294894|NCT00680368|450707776|FG000|Overall Study|not supervised, not eligible|15|||
125294895|NCT00443781|450707781|FG000|Overall Study|Lost to Follow-up|10|||
125294896|NCT00443781|450707781|FG000|Overall Study|Physician Decision|2|||
125294897|NCT00443781|450707781|FG000|Overall Study|Protocol Violation|1|||
125294898|NCT00443781|450707781|FG000|Overall Study|Withdrawal by Subject|6|||
125294899|NCT00443781|450707781|FG000|Overall Study|Unable to comply with study follow up|2|||
125294900|NCT00443781|450707781|FG000|Overall Study|Investigator terminated participation|1|||
124790477|NCT02431260|448863680|FG005|Overall Study|Subject Decision|0|||
124790478|NCT02431260|448863681|FG006|Overall Study|Subject Decision|0|||
124790479|NCT02431260|448863682|FG007|Overall Study|Subject Decision|0|||
124790480|NCT02431260|448863683|FG008|Overall Study|Subject Decision|1|||
125294901|NCT00443781|450707781|FG000|Overall Study|Insurance not covered|2|||
125294902|NCT00443781|450707781|FG000|Overall Study|PD/FAD not done|1|||
125294903|NCT00582738|450707782|FG000|Overall Study|Administrative Problems|7|||
125294904|NCT00582738|450707783|FG001|Overall Study|Administrative Problems|8|||
125294905|NCT00582738|450707782|FG000|Overall Study|Adverse Event|0|||
125294906|NCT00582738|450707783|FG001|Overall Study|Adverse Event|5|||
125294907|NCT00582738|450707782|FG000|Overall Study|Graft Lost|0|||
125294908|NCT00582738|450707783|FG001|Overall Study|Graft Lost|1|||
124790481|NCT02431260|448863684|FG009|Overall Study|Subject Decision|1|||
124790482|NCT02431260|448863685|FG010|Overall Study|Subject Decision|0|||
124790483|NCT02431260|448863686|FG011|Overall Study|Subject Decision|1|||
124790484|NCT02431260|448863687|FG012|Overall Study|Subject Decision|0|||
124790485|NCT02431260|448863688|FG013|Overall Study|Subject Decision|0|||
124790486|NCT02431260|448863675|FG000|Overall Study|Death|4|||
124790487|NCT02431260|448863676|FG001|Overall Study|Death|4|||
124790488|NCT02431260|448863677|FG002|Overall Study|Death|3|||
124790489|NCT02431260|448863678|FG003|Overall Study|Death|4|||
124790490|NCT02431260|448863679|FG004|Overall Study|Death|2|||
124790491|NCT02431260|448863680|FG005|Overall Study|Death|2|||
124790492|NCT02431260|448863681|FG006|Overall Study|Death|3|||
124790493|NCT02431260|448863682|FG007|Overall Study|Death|1|||
124790494|NCT02431260|448863683|FG008|Overall Study|Death|6|||
124790495|NCT02431260|448863684|FG009|Overall Study|Death|6|||
124790496|NCT02431260|448863685|FG010|Overall Study|Death|3|||
125294909|NCT00582738|450707782|FG000|Overall Study|Other|1|||
125294910|NCT00582738|450707783|FG001|Overall Study|Other|0|||
125294911|NCT00582738|450707782|FG000|Overall Study|Protocol Violation|1|||
125294912|NCT00582738|450707783|FG001|Overall Study|Protocol Violation|1|||
124790497|NCT02431260|448863686|FG011|Overall Study|Death|2|||
124790498|NCT02431260|448863687|FG012|Overall Study|Death|5|||
125294913|NCT00582738|450707782|FG000|Overall Study|Withdrawal by Subject|0|||
125294914|NCT00582738|450707783|FG001|Overall Study|Withdrawal by Subject|3|||
125294915|NCT02758301|450707784|FG000|Overall Study|Death|12|||
125294916|NCT02758301|450707785|FG001|Overall Study|Death|0|||
125294917|NCT02758301|450707784|FG000|Overall Study|Physician Decision|10|||
125294918|NCT02758301|450707785|FG001|Overall Study|Physician Decision|1|||
125294919|NCT02758301|450707784|FG000|Overall Study|Withdrawal by Subject|5|||
125294920|NCT02758301|450707785|FG001|Overall Study|Withdrawal by Subject|6|||
124790499|NCT02431260|448863688|FG013|Overall Study|Death|1|||
124790500|NCT02431260|448863675|FG000|Overall Study|Lost to Follow-up|0|||
124790501|NCT02431260|448863676|FG001|Overall Study|Lost to Follow-up|0|||
124790502|NCT02431260|448863677|FG002|Overall Study|Lost to Follow-up|0|||
124790503|NCT02431260|448863678|FG003|Overall Study|Lost to Follow-up|0|||
124790504|NCT02431260|448863679|FG004|Overall Study|Lost to Follow-up|0|||
124790505|NCT02431260|448863680|FG005|Overall Study|Lost to Follow-up|1|||
124790506|NCT02431260|448863681|FG006|Overall Study|Lost to Follow-up|0|||
124790507|NCT02431260|448863682|FG007|Overall Study|Lost to Follow-up|0|||
124790508|NCT02431260|448863683|FG008|Overall Study|Lost to Follow-up|0|||
125294921|NCT02758301|450707784|FG000|Overall Study|Lost to Follow-up|7|||
125294922|NCT02758301|450707785|FG001|Overall Study|Lost to Follow-up|0|||
125294923|NCT02758301|450707784|FG000|Overall Study|Protocol Violation|0|||
125294924|NCT02758301|450707785|FG001|Overall Study|Protocol Violation|1|||
125294925|NCT00364533|450707786|FG000|Overall Study|Adverse Event|8|||
125294926|NCT00364533|450707787|FG001|Overall Study|Adverse Event|7|||
125294927|NCT00364533|450707788|FG002|Overall Study|Adverse Event|15|||
125294928|NCT00364533|450707789|FG003|Overall Study|Adverse Event|5|||
125294929|NCT00364533|450707790|FG004|Overall Study|Adverse Event|2|||
125294930|NCT00364533|450707786|FG000|Overall Study|Withdrawal by Subject|4|||
125294931|NCT00364533|450707787|FG001|Overall Study|Withdrawal by Subject|8|||
125294932|NCT00364533|450707788|FG002|Overall Study|Withdrawal by Subject|6|||
125294933|NCT00364533|450707789|FG003|Overall Study|Withdrawal by Subject|6|||
125294934|NCT00364533|450707790|FG004|Overall Study|Withdrawal by Subject|6|||
125294935|NCT00364533|450707786|FG000|Overall Study|Lack of Efficacy|22|||
125294936|NCT00364533|450707787|FG001|Overall Study|Lack of Efficacy|22|||
125294937|NCT00364533|450707788|FG002|Overall Study|Lack of Efficacy|21|||
125294938|NCT00364533|450707789|FG003|Overall Study|Lack of Efficacy|17|||
125294939|NCT00364533|450707790|FG004|Overall Study|Lack of Efficacy|42|||
125294940|NCT00364533|450707786|FG000|Overall Study|Subject discharged from hospital|4|||
125294941|NCT00364533|450707787|FG001|Overall Study|Subject discharged from hospital|1|||
125294942|NCT00364533|450707788|FG002|Overall Study|Subject discharged from hospital|2|||
125294943|NCT00364533|450707789|FG003|Overall Study|Subject discharged from hospital|3|||
125294944|NCT00364533|450707790|FG004|Overall Study|Subject discharged from hospital|1|||
125294945|NCT00364533|450707786|FG000|Overall Study|Variations in drug compliance|2|||
125294946|NCT00364533|450707787|FG001|Overall Study|Variations in drug compliance|1|||
125294947|NCT00364533|450707788|FG002|Overall Study|Variations in drug compliance|1|||
125294948|NCT00364533|450707789|FG003|Overall Study|Variations in drug compliance|0|||
125294949|NCT00364533|450707790|FG004|Overall Study|Variations in drug compliance|0|||
125294950|NCT00364533|450707786|FG000|Overall Study|Non-compliance|1|||
125294951|NCT00364533|450707787|FG001|Overall Study|Non-compliance|0|||
125294952|NCT00364533|450707788|FG002|Overall Study|Non-compliance|0|||
125294953|NCT00364533|450707789|FG003|Overall Study|Non-compliance|0|||
125294954|NCT00364533|450707790|FG004|Overall Study|Non-compliance|0|||
125294955|NCT00364533|450707786|FG000|Overall Study|Protocol Violation|1|||
125294956|NCT00364533|450707787|FG001|Overall Study|Protocol Violation|1|||
125294957|NCT00364533|450707788|FG002|Overall Study|Protocol Violation|0|||
125294958|NCT00364533|450707789|FG003|Overall Study|Protocol Violation|0|||
125294959|NCT00364533|450707790|FG004|Overall Study|Protocol Violation|0|||
125294960|NCT00652899|450707791|FG000|Overall Study|Death|1|||
125294961|NCT00652899|450707791|FG000|Overall Study|Treating physician decision|1|||
125294962|NCT00551291|450707792|FG000|Overall Study|Physician Decision|1|||
125294963|NCT01943552|450707793|FG000|Overall Study|Adverse Event|3|||
125294964|NCT01943552|450707794|FG001|Overall Study|Adverse Event|2|||
125294965|NCT01943552|450707793|FG000|Overall Study|Withdrawal by Subject|6|||
125294966|NCT01943552|450707794|FG001|Overall Study|Withdrawal by Subject|6|||
125294967|NCT01943552|450707793|FG000|Overall Study|Other Reasons|16|||
125294968|NCT01943552|450707794|FG001|Overall Study|Other Reasons|17|||
125294969|NCT05059977|450707797|FG000|Overall Study|Withdrawal by Subject|0|||
125294970|NCT05059977|450707798|FG001|Overall Study|Withdrawal by Subject|0|||
125294971|NCT05059977|450707799|FG002|Overall Study|Withdrawal by Subject|1|||
125294972|NCT00576472|450707802|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294973|NCT00576472|450707803|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294974|NCT00576472|450707804|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294975|NCT00576472|450707805|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
125294976|NCT00576472|450707806|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294977|NCT00576472|450707807|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294978|NCT00576472|450707808|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294979|NCT00576472|450707809|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294980|NCT00576472|450707810|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294981|NCT00576472|450707811|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294982|NCT00576472|450707812|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294983|NCT00576472|450707813|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294984|NCT00576472|450707814|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294985|NCT00576472|450707815|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294986|NCT00576472|450707816|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294987|NCT00576472|450707802|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
125294988|NCT00576472|450707803|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
125294989|NCT00576472|450707804|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
125294990|NCT00576472|450707805|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
125294991|NCT00576472|450707806|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
125294992|NCT00576472|450707807|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
124790509|NCT02431260|448863684|FG009|Overall Study|Lost to Follow-up|0|||
125294993|NCT00576472|450707808|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
125294994|NCT00576472|450707809|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
125294995|NCT00576472|450707810|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
125294996|NCT00576472|450707811|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
125294997|NCT00576472|450707812|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
125294998|NCT00576472|450707813|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
125294999|NCT00576472|450707814|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
125295000|NCT00576472|450707815|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
125295001|NCT00576472|450707816|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
125295002|NCT00576472|450707802|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295003|NCT00576472|450707803|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295004|NCT00576472|450707804|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295005|NCT00576472|450707805|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
124790510|NCT02431260|448863685|FG010|Overall Study|Lost to Follow-up|0|||
124790511|NCT02431260|448863686|FG011|Overall Study|Lost to Follow-up|0|||
125295006|NCT00576472|450707806|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295007|NCT00576472|450707807|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295008|NCT00576472|450707808|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295009|NCT00576472|450707809|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295010|NCT00576472|450707810|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295011|NCT00576472|450707811|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295012|NCT00576472|450707812|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295013|NCT00576472|450707813|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295014|NCT00576472|450707814|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295015|NCT00576472|450707815|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295016|NCT00576472|450707816|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295017|NCT00576472|450707802|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
125295018|NCT00576472|450707803|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
125295019|NCT00576472|450707804|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
125295020|NCT00576472|450707805|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
125295021|NCT00576472|450707806|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
125295022|NCT00576472|450707807|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
125295023|NCT00576472|450707808|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
125295024|NCT00576472|450707809|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
125295025|NCT00576472|450707810|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
125295026|NCT00576472|450707811|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
125295027|NCT00576472|450707812|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
125295028|NCT00576472|450707813|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
125295029|NCT00576472|450707814|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
125295030|NCT00576472|450707815|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
125295031|NCT00576472|450707816|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
125295032|NCT00576472|450707802|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295033|NCT00576472|450707803|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295034|NCT00576472|450707804|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295035|NCT00576472|450707805|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
125295036|NCT00576472|450707806|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295037|NCT00576472|450707807|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295038|NCT00576472|450707808|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295039|NCT00576472|450707809|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295040|NCT00576472|450707810|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295041|NCT00576472|450707811|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295042|NCT00576472|450707812|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295043|NCT00576472|450707813|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295044|NCT00576472|450707814|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
124790512|NCT02431260|448863687|FG012|Overall Study|Lost to Follow-up|0|||
125295045|NCT00576472|450707815|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
124790513|NCT02431260|448863688|FG013|Overall Study|Lost to Follow-up|0|||
124790514|NCT02431260|448863675|FG000|Overall Study|Study Terminated by the Sponsor|0|||
124790515|NCT02431260|448863676|FG001|Overall Study|Study Terminated by the Sponsor|0|||
125295046|NCT00576472|450707816|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
124790516|NCT02431260|448863677|FG002|Overall Study|Study Terminated by the Sponsor|2|||
124790517|NCT02431260|448863678|FG003|Overall Study|Study Terminated by the Sponsor|1|||
124790518|NCT02431260|448863679|FG004|Overall Study|Study Terminated by the Sponsor|1|||
124790519|NCT02431260|448863680|FG005|Overall Study|Study Terminated by the Sponsor|0|||
124790520|NCT02431260|448863681|FG006|Overall Study|Study Terminated by the Sponsor|1|||
124790521|NCT02431260|448863682|FG007|Overall Study|Study Terminated by the Sponsor|2|||
125295047|NCT00576472|450707802|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295048|NCT00576472|450707803|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295049|NCT00576472|450707804|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295050|NCT00576472|450707805|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295051|NCT00576472|450707806|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295052|NCT00576472|450707807|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295053|NCT00576472|450707808|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
125295054|NCT00576472|450707809|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295055|NCT00576472|450707810|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295056|NCT00576472|450707811|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295057|NCT00576472|450707812|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295058|NCT00576472|450707813|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295059|NCT00576472|450707814|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295060|NCT00576472|450707815|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295061|NCT00576472|450707816|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295062|NCT00576472|450707802|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
125295063|NCT00576472|450707803|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
125295064|NCT00576472|450707804|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
125295065|NCT00576472|450707805|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
125295066|NCT00576472|450707806|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
125295067|NCT00576472|450707807|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
125295068|NCT00576472|450707808|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
125295069|NCT00576472|450707809|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
125295070|NCT00576472|450707810|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
125295071|NCT00576472|450707811|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
125295072|NCT00576472|450707812|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
125295073|NCT00576472|450707813|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
125295074|NCT00576472|450707814|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
125295075|NCT00576472|450707815|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
125295076|NCT00576472|450707816|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
125295077|NCT00576472|450707802|FG000|MPH Cross Over Phase|Physician Decision|0|||
125295078|NCT00576472|450707803|FG001|MPH Cross Over Phase|Physician Decision|0|||
125295079|NCT00576472|450707804|FG002|MPH Cross Over Phase|Physician Decision|0|||
125295080|NCT00576472|450707805|FG003|MPH Cross Over Phase|Physician Decision|0|||
125295081|NCT00576472|450707806|FG004|MPH Cross Over Phase|Physician Decision|0|||
125295082|NCT00576472|450707807|FG005|MPH Cross Over Phase|Physician Decision|0|||
125295083|NCT00576472|450707808|FG006|MPH Cross Over Phase|Physician Decision|4|||
125295084|NCT00576472|450707809|FG007|MPH Cross Over Phase|Physician Decision|0|||
125295085|NCT00576472|450707810|FG008|MPH Cross Over Phase|Physician Decision|0|||
125295086|NCT00576472|450707811|FG009|MPH Cross Over Phase|Physician Decision|0|||
125295087|NCT00576472|450707812|FG010|MPH Cross Over Phase|Physician Decision|0|||
125295088|NCT00576472|450707813|FG011|MPH Cross Over Phase|Physician Decision|0|||
125295089|NCT00576472|450707814|FG012|MPH Cross Over Phase|Physician Decision|0|||
125295090|NCT00576472|450707815|FG013|MPH Cross Over Phase|Physician Decision|0|||
125295091|NCT00576472|450707816|FG014|MPH Cross Over Phase|Physician Decision|0|||
125295092|NCT00576472|450707802|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295093|NCT00576472|450707803|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295094|NCT00576472|450707804|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295095|NCT00576472|450707805|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295096|NCT00576472|450707806|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295097|NCT00576472|450707807|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295098|NCT00576472|450707808|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295099|NCT00576472|450707809|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295100|NCT00576472|450707810|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
125295101|NCT00576472|450707811|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295102|NCT00576472|450707812|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
125295103|NCT00576472|450707813|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
125295104|NCT00576472|450707814|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295105|NCT00576472|450707815|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295106|NCT00576472|450707816|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295107|NCT00576472|450707802|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295108|NCT00576472|450707803|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295109|NCT00576472|450707804|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295110|NCT00576472|450707805|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295111|NCT00576472|450707806|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295112|NCT00576472|450707807|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295113|NCT00576472|450707808|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295114|NCT00576472|450707809|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295115|NCT00576472|450707810|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295116|NCT00576472|450707811|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295117|NCT00576472|450707812|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295118|NCT00576472|450707813|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295119|NCT00576472|450707814|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295120|NCT00576472|450707815|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
125295121|NCT00576472|450707816|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295122|NCT00576472|450707802|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
125295123|NCT00576472|450707803|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
125295124|NCT00576472|450707804|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
125295125|NCT00576472|450707805|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
125295126|NCT00576472|450707806|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
125295127|NCT00576472|450707807|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
125295128|NCT00576472|450707808|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
125295129|NCT00576472|450707809|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
125295130|NCT00576472|450707810|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
125295131|NCT00576472|450707811|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
125295132|NCT00576472|450707812|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
125295133|NCT00576472|450707813|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
125295134|NCT00576472|450707814|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
125295135|NCT00576472|450707815|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
125295136|NCT00576472|450707816|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
125295137|NCT00576472|450707802|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
125295138|NCT00576472|450707803|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
125295139|NCT00576472|450707804|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
125295140|NCT00576472|450707805|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
125295141|NCT00576472|450707806|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
125295142|NCT00576472|450707807|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
125295143|NCT00576472|450707808|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
125295144|NCT00576472|450707809|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
125295145|NCT00576472|450707810|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
125295146|NCT00576472|450707811|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
125295147|NCT00576472|450707812|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
125295148|NCT00576472|450707813|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
125295149|NCT00576472|450707814|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
125295150|NCT00576472|450707815|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
125295151|NCT00576472|450707816|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
125295152|NCT00576472|450707802|FG000|MPH Home Maintenance Phase|Side effects|0|||
125295153|NCT00576472|450707803|FG001|MPH Home Maintenance Phase|Side effects|0|||
125295154|NCT00576472|450707804|FG002|MPH Home Maintenance Phase|Side effects|0|||
125295155|NCT00576472|450707805|FG003|MPH Home Maintenance Phase|Side effects|0|||
125295156|NCT00576472|450707806|FG004|MPH Home Maintenance Phase|Side effects|0|||
125295157|NCT00576472|450707807|FG005|MPH Home Maintenance Phase|Side effects|0|||
125295158|NCT00576472|450707808|FG006|MPH Home Maintenance Phase|Side effects|0|||
125295159|NCT00576472|450707809|FG007|MPH Home Maintenance Phase|Side effects|0|||
125295160|NCT00576472|450707810|FG008|MPH Home Maintenance Phase|Side effects|0|||
125295161|NCT00576472|450707811|FG009|MPH Home Maintenance Phase|Side effects|0|||
125295162|NCT00576472|450707812|FG010|MPH Home Maintenance Phase|Side effects|0|||
125295163|NCT00576472|450707813|FG011|MPH Home Maintenance Phase|Side effects|0|||
125295164|NCT00576472|450707814|FG012|MPH Home Maintenance Phase|Side effects|0|||
125295165|NCT00576472|450707815|FG013|MPH Home Maintenance Phase|Side effects|0|||
125295166|NCT00576472|450707816|FG014|MPH Home Maintenance Phase|Side effects|8|||
125295167|NCT00576472|450707802|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125295168|NCT00576472|450707803|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125295169|NCT00576472|450707804|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125295170|NCT00576472|450707805|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125295171|NCT00576472|450707806|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125295172|NCT00576472|450707807|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125295173|NCT00576472|450707808|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
124790522|NCT02431260|448863683|FG008|Overall Study|Study Terminated by the Sponsor|1|||
124790523|NCT02431260|448863684|FG009|Overall Study|Study Terminated by the Sponsor|1|||
124790524|NCT02431260|448863685|FG010|Overall Study|Study Terminated by the Sponsor|1|||
124790525|NCT02431260|448863686|FG011|Overall Study|Study Terminated by the Sponsor|0|||
124790526|NCT02431260|448863687|FG012|Overall Study|Study Terminated by the Sponsor|4|||
124790527|NCT02431260|448863688|FG013|Overall Study|Study Terminated by the Sponsor|0|||
124790528|NCT02431260|448863675|FG000|Overall Study|Physician Decision|0|||
124790529|NCT02431260|448863676|FG001|Overall Study|Physician Decision|0|||
124790530|NCT02431260|448863677|FG002|Overall Study|Physician Decision|0|||
124790531|NCT02431260|448863678|FG003|Overall Study|Physician Decision|0|||
124790532|NCT02431260|448863679|FG004|Overall Study|Physician Decision|0|||
125295174|NCT00576472|450707809|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125295175|NCT00576472|450707810|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
124790533|NCT02431260|448863680|FG005|Overall Study|Physician Decision|1|||
124790534|NCT02431260|448863681|FG006|Overall Study|Physician Decision|0|||
124790535|NCT02431260|448863682|FG007|Overall Study|Physician Decision|0|||
124790536|NCT02431260|448863683|FG008|Overall Study|Physician Decision|0|||
124790537|NCT02431260|448863684|FG009|Overall Study|Physician Decision|0|||
125295176|NCT00576472|450707811|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
124790538|NCT02431260|448863685|FG010|Overall Study|Physician Decision|0|||
124790539|NCT02431260|448863686|FG011|Overall Study|Physician Decision|0|||
124790540|NCT02431260|448863687|FG012|Overall Study|Physician Decision|0|||
124790541|NCT02431260|448863688|FG013|Overall Study|Physician Decision|0|||
124790542|NCT02431260|448863675|FG000|Overall Study|Other Unspecified|0|||
124790543|NCT02431260|448863676|FG001|Overall Study|Other Unspecified|0|||
124790544|NCT02431260|448863677|FG002|Overall Study|Other Unspecified|0|||
124790545|NCT02431260|448863678|FG003|Overall Study|Other Unspecified|0|||
124790546|NCT02431260|448863679|FG004|Overall Study|Other Unspecified|0|||
124790547|NCT02431260|448863680|FG005|Overall Study|Other Unspecified|0|||
124790548|NCT02431260|448863681|FG006|Overall Study|Other Unspecified|0|||
124790549|NCT02431260|448863682|FG007|Overall Study|Other Unspecified|0|||
124790550|NCT02431260|448863683|FG008|Overall Study|Other Unspecified|0|||
124790551|NCT02431260|448863684|FG009|Overall Study|Other Unspecified|0|||
124790552|NCT02431260|448863685|FG010|Overall Study|Other Unspecified|0|||
124790553|NCT02431260|448863686|FG011|Overall Study|Other Unspecified|1|||
124790554|NCT02431260|448863687|FG012|Overall Study|Other Unspecified|1|||
124790555|NCT02431260|448863688|FG013|Overall Study|Other Unspecified|0|||
124790556|NCT00321646|448863689|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
124790557|NCT00321646|448863689|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
124790558|NCT00321646|448863689|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
124790559|NCT02576145|448863692|FG000|Overall Study|Adverse Event|1|||
124790560|NCT02576145|448863693|FG001|Overall Study|Adverse Event|0|||
124790561|NCT02576145|448863692|FG000|Overall Study|Withdrawal by Subject|1|||
124790562|NCT02576145|448863693|FG001|Overall Study|Withdrawal by Subject|0|||
124790563|NCT02576145|448863692|FG000|Overall Study|Acute rejection|1|||
124790564|NCT02576145|448863693|FG001|Overall Study|Acute rejection|0|||
124790565|NCT02576145|448863692|FG000|Overall Study|Tetanus Titers Decreased|0|||
124790566|NCT02576145|448863693|FG001|Overall Study|Tetanus Titers Decreased|1|||
124790567|NCT02660138|448863694|FG000|Overall Study|Adverse Event|0|||
124790568|NCT02660138|448863695|FG001|Overall Study|Adverse Event|3|||
124790569|NCT02660138|448863696|FG002|Overall Study|Adverse Event|2|||
124790570|NCT02660138|448863694|FG000|Overall Study|Lack of Efficacy|1|||
124790571|NCT02660138|448863695|FG001|Overall Study|Lack of Efficacy|2|||
124790572|NCT02660138|448863696|FG002|Overall Study|Lack of Efficacy|1|||
124790573|NCT02660138|448863694|FG000|Overall Study|Withdrawal by Subject|7|||
124790574|NCT02660138|448863695|FG001|Overall Study|Withdrawal by Subject|6|||
124790575|NCT02660138|448863696|FG002|Overall Study|Withdrawal by Subject|6|||
124790576|NCT02660138|448863694|FG000|Overall Study|Lost to Follow-up|4|||
124790577|NCT02660138|448863695|FG001|Overall Study|Lost to Follow-up|4|||
124790578|NCT02660138|448863696|FG002|Overall Study|Lost to Follow-up|1|||
124790579|NCT02660138|448863694|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
124790580|NCT02660138|448863695|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
124790581|NCT02660138|448863696|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
124790582|NCT02660138|448863694|FG000|Overall Study|Other|1|||
124790583|NCT02660138|448863695|FG001|Overall Study|Other|1|||
124790584|NCT02660138|448863696|FG002|Overall Study|Other|0|||
124790585|NCT02660138|448863694|FG000|Overall Study|Not treated|0|||
124790586|NCT02660138|448863695|FG001|Overall Study|Not treated|1|||
124790587|NCT02660138|448863696|FG002|Overall Study|Not treated|0|||
124790588|NCT00308581|448863697|FG000|Induction Phase|Adverse Event|0|||
124790589|NCT00308581|448863698|FG001|Induction Phase|Adverse Event|0|||
124790590|NCT00308581|448863699|FG002|Induction Phase|Adverse Event|37|||
124790591|NCT00308581|448863697|FG000|Induction Phase|Lack of Efficacy|0|||
124790592|NCT00308581|448863698|FG001|Induction Phase|Lack of Efficacy|0|||
124790593|NCT00308581|448863699|FG002|Induction Phase|Lack of Efficacy|121|||
124790594|NCT00308581|448863697|FG000|Induction Phase|Withdrawal by Subject|0|||
124790595|NCT00308581|448863698|FG001|Induction Phase|Withdrawal by Subject|0|||
124790596|NCT00308581|448863699|FG002|Induction Phase|Withdrawal by Subject|5|||
124790597|NCT00308581|448863697|FG000|Induction Phase|Unknown reason|0|||
124790598|NCT00308581|448863698|FG001|Induction Phase|Unknown reason|0|||
124790599|NCT00308581|448863699|FG002|Induction Phase|Unknown reason|3|||
124790600|NCT00308581|448863697|FG000|Randomized Maintenance Phase|Adverse Event|10|||
124790601|NCT00308581|448863698|FG001|Randomized Maintenance Phase|Adverse Event|17|||
124790602|NCT00308581|448863699|FG002|Randomized Maintenance Phase|Adverse Event|0|||
124790603|NCT00308581|448863697|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
124790604|NCT00308581|448863698|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
124790605|NCT00308581|448863699|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
124790606|NCT00308581|448863697|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
124790607|NCT00308581|448863698|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
124790608|NCT00308581|448863699|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
124790609|NCT00308581|448863697|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
124790610|NCT00308581|448863698|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
124790611|NCT00308581|448863699|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
124790612|NCT00308581|448863697|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
124790613|NCT00308581|448863698|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
124790614|NCT00308581|448863699|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
124790615|NCT00308581|448863697|FG000|Randomized Maintenance Phase|Unknown reason|3|||
124790616|NCT00308581|448863698|FG001|Randomized Maintenance Phase|Unknown reason|0|||
124790617|NCT00308581|448863699|FG002|Randomized Maintenance Phase|Unknown reason|0|||
124790618|NCT01087788|448863701|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
124790619|NCT01087788|448863702|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
124790620|NCT01087788|448863703|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
124790621|NCT01087788|448863701|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
124790622|NCT01087788|448863702|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
124790623|NCT01087788|448863703|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
124790624|NCT01087788|448863701|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
124790625|NCT01087788|448863702|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
124790626|NCT01087788|448863703|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
124790627|NCT01087788|448863701|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
124790628|NCT01087788|448863702|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
124790629|NCT01087788|448863703|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
124790630|NCT01087788|448863701|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
124790631|NCT01087788|448863702|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
124790632|NCT01087788|448863703|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
124790633|NCT01087788|448863701|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
124790634|NCT01087788|448863702|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
124790635|NCT01087788|448863703|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
124790636|NCT01087788|448863701|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
124790637|NCT01087788|448863702|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
124790638|NCT01087788|448863703|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
124790639|NCT01087788|448863701|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
124790640|NCT01087788|448863702|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
124790641|NCT01087788|448863703|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
124790642|NCT01087788|448863701|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
124790643|NCT01087788|448863702|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
124790644|NCT01087788|448863703|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
124790645|NCT01087788|448863701|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
124790646|NCT01087788|448863702|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
124790647|NCT01087788|448863703|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
124790648|NCT01087788|448863701|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
124790649|NCT01087788|448863702|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
124790650|NCT01087788|448863703|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
124790651|NCT01087788|448863701|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
124790652|NCT01087788|448863702|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
124790653|NCT01087788|448863703|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
124790654|NCT01087788|448863701|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
124790655|NCT01087788|448863702|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
124790656|NCT01087788|448863703|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
124790657|NCT01087788|448863701|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
124790658|NCT01087788|448863702|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
124790659|NCT01087788|448863703|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
124790660|NCT01087788|448863701|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
124790661|NCT01087788|448863702|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
124790662|NCT01087788|448863703|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
124790663|NCT01087788|448863701|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
124790664|NCT01087788|448863702|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
124790665|NCT01087788|448863703|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
124790666|NCT01087788|448863701|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
124790667|NCT01087788|448863702|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
124790668|NCT01087788|448863703|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
124790669|NCT01087788|448863701|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
124790670|NCT01087788|448863702|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
124790671|NCT01087788|448863703|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
124790672|NCT01087788|448863701|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
124790673|NCT01087788|448863702|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
124790674|NCT01087788|448863703|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
124790675|NCT01087788|448863701|FG000|24-weeks Dose-blind Period|Patient moved|0|||
124790676|NCT01087788|448863702|FG001|24-weeks Dose-blind Period|Patient moved|0|||
124790677|NCT01087788|448863703|FG002|24-weeks Dose-blind Period|Patient moved|1|||
124790678|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
124790679|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
124790680|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
124790681|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
125295177|NCT00576472|450707812|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
124790682|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
124790683|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
124790684|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
124790685|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
124790686|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
124790687|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
124790688|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
124790689|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
124790690|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
124790691|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
124790692|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
124790693|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
124790694|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
124790695|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
124790696|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
124790697|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
124790698|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
124790699|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
124790700|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
124790701|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
124790702|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
124790703|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
124790704|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
124790705|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
124790706|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
124790707|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
124790708|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
124790709|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
124790710|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
124790711|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
124790712|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
124790713|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
124790714|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
124790715|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
124790716|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
124790717|NCT00534313|448863707|FG000|Short-term Period|Adverse Event|1|||
124790718|NCT00534313|448863708|FG001|Short-term Period|Adverse Event|2|||
124790719|NCT00534313|448863709|FG002|Short-term Period|Adverse Event|1|||
124790720|NCT00534313|448863710|FG003|Short-term Period|Adverse Event|3|||
124790721|NCT00534313|448863707|FG000|Short-term Period|Lack of Efficacy|3|||
124790722|NCT00534313|448863708|FG001|Short-term Period|Lack of Efficacy|4|||
124790723|NCT00534313|448863709|FG002|Short-term Period|Lack of Efficacy|0|||
124790724|NCT00534313|448863710|FG003|Short-term Period|Lack of Efficacy|3|||
124790725|NCT00534313|448863707|FG000|Short-term Period|Participant not meeting study criteria|0|||
124790726|NCT00534313|448863708|FG001|Short-term Period|Participant not meeting study criteria|0|||
124790727|NCT00534313|448863709|FG002|Short-term Period|Participant not meeting study criteria|0|||
124790728|NCT00534313|448863710|FG003|Short-term Period|Participant not meeting study criteria|1|||
124790729|NCT00534313|448863707|FG000|Short-term Period|Participant withdrew consent|2|||
124790730|NCT00534313|448863708|FG001|Short-term Period|Participant withdrew consent|0|||
124790731|NCT00534313|448863709|FG002|Short-term Period|Participant withdrew consent|0|||
124790732|NCT00534313|448863710|FG003|Short-term Period|Participant withdrew consent|2|||
124790733|NCT00534313|448863707|FG000|Short-term Period|Pregnancy|0|||
124790734|NCT00534313|448863708|FG001|Short-term Period|Pregnancy|0|||
124790735|NCT00534313|448863709|FG002|Short-term Period|Pregnancy|1|||
124790736|NCT00534313|448863710|FG003|Short-term Period|Pregnancy|0|||
124790737|NCT00534313|448863707|FG000|Long-term Period|Adverse Event|2|||
124790738|NCT00534313|448863708|FG001|Long-term Period|Adverse Event|1|||
124790739|NCT00534313|448863709|FG002|Long-term Period|Adverse Event|0|||
124790740|NCT00534313|448863710|FG003|Long-term Period|Adverse Event|1|||
124790741|NCT00534313|448863707|FG000|Long-term Period|Lack of Efficacy|14|||
124790742|NCT00534313|448863708|FG001|Long-term Period|Lack of Efficacy|10|||
124790743|NCT00534313|448863709|FG002|Long-term Period|Lack of Efficacy|14|||
124790744|NCT00534313|448863710|FG003|Long-term Period|Lack of Efficacy|12|||
124790745|NCT00534313|448863707|FG000|Long-term Period|Lost to Follow-up|1|||
124790746|NCT00534313|448863708|FG001|Long-term Period|Lost to Follow-up|2|||
124790747|NCT00534313|448863709|FG002|Long-term Period|Lost to Follow-up|0|||
124790748|NCT00534313|448863710|FG003|Long-term Period|Lost to Follow-up|0|||
124790749|NCT00534313|448863707|FG000|Long-term Period|Withdrawal by Subject|2|||
124790750|NCT00534313|448863708|FG001|Long-term Period|Withdrawal by Subject|2|||
124790751|NCT00534313|448863709|FG002|Long-term Period|Withdrawal by Subject|0|||
124790752|NCT00534313|448863710|FG003|Long-term Period|Withdrawal by Subject|0|||
124790753|NCT00534313|448863707|FG000|Long-term Period|No longer meets study criteria|0|||
124790754|NCT00534313|448863708|FG001|Long-term Period|No longer meets study criteria|1|||
124790755|NCT00534313|448863709|FG002|Long-term Period|No longer meets study criteria|0|||
124790756|NCT00534313|448863710|FG003|Long-term Period|No longer meets study criteria|0|||
124790757|NCT00534313|448863707|FG000|Long-term Period|Poor compliance/noncompliance|0|||
124790758|NCT00534313|448863708|FG001|Long-term Period|Poor compliance/noncompliance|1|||
124790759|NCT00534313|448863709|FG002|Long-term Period|Poor compliance/noncompliance|1|||
124790760|NCT00534313|448863710|FG003|Long-term Period|Poor compliance/noncompliance|0|||
124790761|NCT00534313|448863707|FG000|Long-term Period|Administrative reason by sponsor|17|||
124790762|NCT00534313|448863708|FG001|Long-term Period|Administrative reason by sponsor|15|||
124790763|NCT00534313|448863709|FG002|Long-term Period|Administrative reason by sponsor|26|||
124790764|NCT00534313|448863710|FG003|Long-term Period|Administrative reason by sponsor|18|||
124790765|NCT00534313|448863707|FG000|Long-term Period|Other|1|||
124790766|NCT00534313|448863708|FG001|Long-term Period|Other|2|||
124790767|NCT00534313|448863709|FG002|Long-term Period|Other|2|||
124790768|NCT00534313|448863710|FG003|Long-term Period|Other|2|||
124790769|NCT03709576|448863716|FG000|Overall Study|progression prior to enrollment|1|||
124790770|NCT01947855|448863717|FG000|Overall Study|Withdrawal by Subject|1|||
124790771|NCT01947855|448863718|FG001|Overall Study|Withdrawal by Subject|0|||
124790772|NCT01947855|448863719|FG002|Overall Study|Withdrawal by Subject|0|||
124790773|NCT00436501|448863721|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
124790774|NCT00436501|448863722|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
124790775|NCT00436501|448863721|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
124790776|NCT00436501|448863722|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
124790777|NCT03011892|448863729|FG000|Double Blind (DB) Period|Adverse Event|0|||
124790778|NCT03011892|448863730|FG001|Double Blind (DB) Period|Adverse Event|1|||
124790779|NCT03011892|448863731|FG002|Double Blind (DB) Period|Adverse Event|1|||
124790780|NCT03011892|448863732|FG003|Double Blind (DB) Period|Adverse Event|0|||
124790781|NCT03011892|448863733|FG004|Double Blind (DB) Period|Adverse Event|0|||
124790782|NCT03011892|448863734|FG005|Double Blind (DB) Period|Adverse Event|0|||
124790783|NCT03011892|448863735|FG006|Double Blind (DB) Period|Adverse Event|0|||
124790784|NCT03011892|448863736|FG007|Double Blind (DB) Period|Adverse Event|0|||
124790785|NCT03011892|448863737|FG008|Double Blind (DB) Period|Adverse Event|0|||
124790786|NCT03011892|448863738|FG009|Double Blind (DB) Period|Adverse Event|0|||
124790787|NCT03011892|448863739|FG010|Double Blind (DB) Period|Adverse Event|0|||
124790788|NCT03011892|448863740|FG011|Double Blind (DB) Period|Adverse Event|0|||
124790789|NCT03011892|448863729|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
124790790|NCT03011892|448863730|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
124790791|NCT03011892|448863731|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
124790792|NCT03011892|448863732|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
124790793|NCT03011892|448863733|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
124790794|NCT03011892|448863734|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
124790795|NCT03011892|448863735|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
124790796|NCT03011892|448863736|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
124790797|NCT03011892|448863737|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
124790798|NCT03011892|448863738|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
124790799|NCT03011892|448863739|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
124790800|NCT03011892|448863740|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
124790801|NCT03011892|448863729|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
124790802|NCT03011892|448863730|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
124790803|NCT03011892|448863731|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
124790804|NCT03011892|448863732|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
124790805|NCT03011892|448863733|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
124790806|NCT03011892|448863734|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
124790807|NCT03011892|448863735|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
124790808|NCT03011892|448863736|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
124790809|NCT03011892|448863737|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
124790810|NCT03011892|448863738|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
124790811|NCT03011892|448863739|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
124790812|NCT03011892|448863740|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
124790813|NCT03011892|448863729|FG000|Double Blind (DB) Period|Other|1|||
124790814|NCT03011892|448863730|FG001|Double Blind (DB) Period|Other|1|||
124790815|NCT03011892|448863731|FG002|Double Blind (DB) Period|Other|1|||
124790816|NCT03011892|448863732|FG003|Double Blind (DB) Period|Other|0|||
124790817|NCT03011892|448863733|FG004|Double Blind (DB) Period|Other|1|||
124790818|NCT03011892|448863734|FG005|Double Blind (DB) Period|Other|0|||
124790819|NCT03011892|448863735|FG006|Double Blind (DB) Period|Other|0|||
124790820|NCT03011892|448863736|FG007|Double Blind (DB) Period|Other|0|||
124790821|NCT03011892|448863737|FG008|Double Blind (DB) Period|Other|0|||
124790822|NCT03011892|448863738|FG009|Double Blind (DB) Period|Other|0|||
124790823|NCT03011892|448863739|FG010|Double Blind (DB) Period|Other|0|||
124790824|NCT03011892|448863740|FG011|Double Blind (DB) Period|Other|0|||
124790825|NCT03011892|448863729|FG000|Double Blind (DB) Period|Physician Decision|1|||
124790826|NCT03011892|448863730|FG001|Double Blind (DB) Period|Physician Decision|0|||
124790827|NCT03011892|448863731|FG002|Double Blind (DB) Period|Physician Decision|1|||
124790828|NCT03011892|448863732|FG003|Double Blind (DB) Period|Physician Decision|0|||
124790829|NCT03011892|448863733|FG004|Double Blind (DB) Period|Physician Decision|0|||
124790830|NCT03011892|448863734|FG005|Double Blind (DB) Period|Physician Decision|0|||
124790831|NCT03011892|448863735|FG006|Double Blind (DB) Period|Physician Decision|0|||
124790832|NCT03011892|448863736|FG007|Double Blind (DB) Period|Physician Decision|0|||
124790833|NCT03011892|448863737|FG008|Double Blind (DB) Period|Physician Decision|0|||
124790834|NCT03011892|448863738|FG009|Double Blind (DB) Period|Physician Decision|0|||
124790835|NCT03011892|448863739|FG010|Double Blind (DB) Period|Physician Decision|0|||
124790836|NCT03011892|448863740|FG011|Double Blind (DB) Period|Physician Decision|0|||
124790837|NCT03011892|448863729|FG000|Double Blind (DB) Period|Pregnancy|0|||
124790838|NCT03011892|448863730|FG001|Double Blind (DB) Period|Pregnancy|0|||
124790839|NCT03011892|448863731|FG002|Double Blind (DB) Period|Pregnancy|0|||
124790840|NCT03011892|448863732|FG003|Double Blind (DB) Period|Pregnancy|0|||
124790841|NCT03011892|448863733|FG004|Double Blind (DB) Period|Pregnancy|1|||
124790842|NCT03011892|448863734|FG005|Double Blind (DB) Period|Pregnancy|0|||
124790843|NCT03011892|448863735|FG006|Double Blind (DB) Period|Pregnancy|0|||
124790844|NCT03011892|448863736|FG007|Double Blind (DB) Period|Pregnancy|0|||
124790845|NCT03011892|448863737|FG008|Double Blind (DB) Period|Pregnancy|0|||
124790846|NCT03011892|448863738|FG009|Double Blind (DB) Period|Pregnancy|0|||
124790847|NCT03011892|448863739|FG010|Double Blind (DB) Period|Pregnancy|0|||
124790848|NCT03011892|448863740|FG011|Double Blind (DB) Period|Pregnancy|0|||
124790849|NCT03011892|448863729|FG000|Double Blind (DB) Period|Protocol Violation|1|||
124790850|NCT03011892|448863730|FG001|Double Blind (DB) Period|Protocol Violation|0|||
124790851|NCT03011892|448863731|FG002|Double Blind (DB) Period|Protocol Violation|0|||
124790852|NCT03011892|448863732|FG003|Double Blind (DB) Period|Protocol Violation|0|||
124790853|NCT03011892|448863733|FG004|Double Blind (DB) Period|Protocol Violation|0|||
124790854|NCT03011892|448863734|FG005|Double Blind (DB) Period|Protocol Violation|0|||
124790855|NCT03011892|448863735|FG006|Double Blind (DB) Period|Protocol Violation|0|||
124790856|NCT03011892|448863736|FG007|Double Blind (DB) Period|Protocol Violation|0|||
124790857|NCT03011892|448863737|FG008|Double Blind (DB) Period|Protocol Violation|0|||
124790858|NCT03011892|448863738|FG009|Double Blind (DB) Period|Protocol Violation|0|||
124790859|NCT03011892|448863739|FG010|Double Blind (DB) Period|Protocol Violation|0|||
124790860|NCT03011892|448863740|FG011|Double Blind (DB) Period|Protocol Violation|0|||
124790861|NCT03011892|448863729|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
124790862|NCT03011892|448863730|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
124790863|NCT03011892|448863731|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
124790864|NCT03011892|448863732|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
124790865|NCT03011892|448863733|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
124790866|NCT03011892|448863734|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
124790867|NCT03011892|448863735|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
124790868|NCT03011892|448863736|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
124790869|NCT03011892|448863737|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
124790870|NCT03011892|448863738|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
124790871|NCT03011892|448863739|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
124790872|NCT03011892|448863740|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
124790873|NCT03011892|448863729|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
124790874|NCT03011892|448863730|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
124790875|NCT03011892|448863731|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
124790876|NCT03011892|448863732|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
124790877|NCT03011892|448863733|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
124790878|NCT03011892|448863734|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
124790879|NCT03011892|448863735|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
124790880|NCT03011892|448863736|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
124790881|NCT03011892|448863737|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
124790882|NCT03011892|448863738|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
124790883|NCT03011892|448863739|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
124790884|NCT03011892|448863740|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
124790885|NCT03011892|448863729|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
124790886|NCT03011892|448863730|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
124790887|NCT03011892|448863731|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
124790888|NCT03011892|448863732|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
124790889|NCT03011892|448863733|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
124790890|NCT03011892|448863734|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
124790891|NCT03011892|448863735|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
124790892|NCT03011892|448863736|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
124790893|NCT03011892|448863737|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
124790894|NCT03011892|448863738|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
124790895|NCT03011892|448863739|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
124790896|NCT03011892|448863740|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
124790897|NCT03011892|448863729|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
124790898|NCT03011892|448863730|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
124790899|NCT03011892|448863731|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
124790900|NCT03011892|448863732|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
124790901|NCT03011892|448863733|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
124790902|NCT03011892|448863734|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
124790903|NCT03011892|448863735|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
124790904|NCT03011892|448863736|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
124790905|NCT03011892|448863737|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
124790906|NCT03011892|448863738|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
124790907|NCT03011892|448863739|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
124790908|NCT03011892|448863740|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
124790909|NCT03011892|448863729|FG000|Open Label (OL) Period|Reason not specified|0|||
124790910|NCT03011892|448863730|FG001|Open Label (OL) Period|Reason not specified|0|||
124790911|NCT03011892|448863731|FG002|Open Label (OL) Period|Reason not specified|0|||
124790912|NCT03011892|448863732|FG003|Open Label (OL) Period|Reason not specified|0|||
124790913|NCT03011892|448863733|FG004|Open Label (OL) Period|Reason not specified|0|||
124790914|NCT03011892|448863734|FG005|Open Label (OL) Period|Reason not specified|0|||
124790915|NCT03011892|448863735|FG006|Open Label (OL) Period|Reason not specified|0|||
124790916|NCT03011892|448863736|FG007|Open Label (OL) Period|Reason not specified|1|||
124790917|NCT03011892|448863737|FG008|Open Label (OL) Period|Reason not specified|0|||
124790918|NCT03011892|448863738|FG009|Open Label (OL) Period|Reason not specified|0|||
124790919|NCT03011892|448863739|FG010|Open Label (OL) Period|Reason not specified|0|||
124790920|NCT03011892|448863740|FG011|Open Label (OL) Period|Reason not specified|0|||
124790921|NCT02282293|448863741|FG000|Overall Study|Lost to Follow-up|2|||
124790922|NCT02282293|448863742|FG001|Overall Study|Lost to Follow-up|2|||
124790923|NCT02282293|448863741|FG000|Overall Study|Unable to comply with study procedures|1|||
124790924|NCT02282293|448863742|FG001|Overall Study|Unable to comply with study procedures|0|||
124790925|NCT02282293|448863741|FG000|Overall Study|Moved out of study area|0|||
124790926|NCT02282293|448863742|FG001|Overall Study|Moved out of study area|1|||
124790927|NCT01924429|448863754|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
124790928|NCT01924429|448863755|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
124790929|NCT00384111|448863756|FG000|Overall Study|Disease Progression|3|||
124790930|NCT00384111|448863756|FG000|Overall Study|Adverse Event|1|||
124790931|NCT00384111|448863756|FG000|Overall Study|Investigator Decision|3|||
124790932|NCT00384111|448863756|FG000|Overall Study|Study Terminated by the Sponsor|19|||
124790933|NCT00807573|448863757|FG000|Overall Study|Withdrawal by Subject|1|||
124790934|NCT00807573|448863757|FG000|Overall Study|Adverse Event|1|||
124790935|NCT01089361|448863758|FG000|Overall Study|Death|1|||
124790936|NCT01089361|448863759|FG001|Overall Study|Death|0|||
124790937|NCT03612856|448863760|FG000|Pre-dose Period|Physician Decision|0|||
124790938|NCT03612856|448863761|FG001|Pre-dose Period|Physician Decision|1|||
124790939|NCT03612856|448863762|FG002|Pre-dose Period|Physician Decision|1|||
124790940|NCT03612856|448863760|FG000|Pre-dose Period|Withdrawal by Subject|0|||
124790941|NCT03612856|448863761|FG001|Pre-dose Period|Withdrawal by Subject|1|||
124790942|NCT03612856|448863762|FG002|Pre-dose Period|Withdrawal by Subject|0|||
124790943|NCT04463069|448863763|FG000|Overall Study|Withdrawal by Subject|2|||
124790944|NCT04463069|448863764|FG001|Overall Study|Withdrawal by Subject|10|||
124790945|NCT04463069|448863763|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
124790946|NCT04463069|448863764|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
124790947|NCT01155167|448863767|FG000|Overall Study|Insufficient ultrasound data|2|||
124790948|NCT01155167|448863768|FG001|Overall Study|Insufficient ultrasound data|0|||
124790949|NCT01155167|448863767|FG000|Overall Study|Access site changed to femoral artery|1|||
124790950|NCT01155167|448863768|FG001|Overall Study|Access site changed to femoral artery|0|||
124790951|NCT02880956|448863774|FG000|Overall Study|Adverse Event|3|||
124790952|NCT02880956|448863775|FG001|Overall Study|Adverse Event|6|||
124790953|NCT02880956|448863776|FG002|Overall Study|Adverse Event|5|||
124790954|NCT02880956|448863777|FG003|Overall Study|Adverse Event|4|||
124790955|NCT02880956|448863774|FG000|Overall Study|Withdrawal by Subject|9|||
124790956|NCT02880956|448863775|FG001|Overall Study|Withdrawal by Subject|4|||
124790957|NCT02880956|448863776|FG002|Overall Study|Withdrawal by Subject|6|||
124790958|NCT02880956|448863777|FG003|Overall Study|Withdrawal by Subject|11|||
124790959|NCT02880956|448863774|FG000|Overall Study|Lost to Follow-up|0|||
124790960|NCT02880956|448863775|FG001|Overall Study|Lost to Follow-up|1|||
124790961|NCT02880956|448863776|FG002|Overall Study|Lost to Follow-up|0|||
124790962|NCT02880956|448863777|FG003|Overall Study|Lost to Follow-up|0|||
124790963|NCT02880956|448863774|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
124790964|NCT02880956|448863775|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
124790965|NCT02880956|448863776|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
124790966|NCT02880956|448863777|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
124790967|NCT02880956|448863774|FG000|Overall Study|Other, Not Specified|4|||
124790968|NCT02880956|448863775|FG001|Overall Study|Other, Not Specified|2|||
124790969|NCT02880956|448863776|FG002|Overall Study|Other, Not Specified|0|||
124790970|NCT02880956|448863777|FG003|Overall Study|Other, Not Specified|3|||
124790971|NCT00853970|448863778|FG000|Overall Study|Withdrawal by Subject|2|||
124790972|NCT00853970|448863779|FG001|Overall Study|Withdrawal by Subject|1|||
124790973|NCT00853970|448863778|FG000|Overall Study|Cancelled surgery|4|||
124790974|NCT00853970|448863779|FG001|Overall Study|Cancelled surgery|2|||
124790975|NCT00576420|448865751|FG000|Overall Study|Death|0|||
124790976|NCT00576420|448865752|FG001|Overall Study|Death|0|||
124790977|NCT00576420|448865753|FG002|Overall Study|Death|1|||
124790978|NCT01771809|448865758|FG000|Overall Study|Adverse Event|4|||
124790979|NCT01771809|448865759|FG001|Overall Study|Adverse Event|12|||
124790980|NCT01771809|448865758|FG000|Overall Study|Protocol Violation|0|||
124790981|NCT01771809|448865759|FG001|Overall Study|Protocol Violation|1|||
124790982|NCT01771809|448865758|FG000|Overall Study|Withdrawal by Subject|34|||
124790983|NCT01771809|448865759|FG001|Overall Study|Withdrawal by Subject|42|||
124790984|NCT01771809|448865758|FG000|Overall Study|Lost to Follow-up|1|||
124790985|NCT01771809|448865759|FG001|Overall Study|Lost to Follow-up|3|||
124790986|NCT01771809|448865758|FG000|Overall Study|Other (Insufficient clinical response)|22|||
124790987|NCT01771809|448865759|FG001|Overall Study|Other (Insufficient clinical response)|20|||
124790988|NCT01771809|448865758|FG000|Overall Study|Death|1|||
124790989|NCT01771809|448865759|FG001|Overall Study|Death|0|||
124790990|NCT01771809|448865758|FG000|Overall Study|Other (other)|9|||
124790991|NCT01771809|448865759|FG001|Overall Study|Other (other)|5|||
124790992|NCT02656680|448865760|FG000|Overall Study|Lost to Follow-up|0|||
124790993|NCT02656680|448865761|FG001|Overall Study|Lost to Follow-up|1|||
124790994|NCT02656680|448865762|FG002|Overall Study|Lost to Follow-up|7|||
124790995|NCT01142089|448865768|FG000|Overall Study|Physician Decision|1|||
124790996|NCT01142089|448865769|FG001|Overall Study|Physician Decision|0|||
124790997|NCT01142089|448865768|FG000|Overall Study|Withdrawal by Subject|1|||
124790998|NCT01142089|448865769|FG001|Overall Study|Withdrawal by Subject|2|||
124790999|NCT01142089|448865768|FG000|Overall Study|Use of prohibited medications|0|||
124791000|NCT01142089|448865769|FG001|Overall Study|Use of prohibited medications|1|||
124791001|NCT01142089|448865768|FG000|Overall Study|Noncompliance with study procedures|2|||
125295178|NCT00576472|450707813|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125295179|NCT00576472|450707814|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125295180|NCT00576472|450707815|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125295181|NCT00576472|450707816|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
125295182|NCT00576472|450707802|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
125295183|NCT00576472|450707803|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
125295184|NCT00576472|450707804|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
125295185|NCT00576472|450707805|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
125295186|NCT00576472|450707806|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
125295187|NCT00576472|450707807|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
125295188|NCT00576472|450707808|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
125295189|NCT00576472|450707809|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
125295190|NCT00576472|450707810|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
125295191|NCT00576472|450707811|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
125295192|NCT00576472|450707812|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
125295193|NCT00576472|450707813|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
125295194|NCT00576472|450707814|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
125295195|NCT00576472|450707815|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
125295196|NCT00576472|450707816|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
125295197|NCT00576472|450707802|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295198|NCT00576472|450707803|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295199|NCT00576472|450707804|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295200|NCT00576472|450707805|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295201|NCT00576472|450707806|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295202|NCT00576472|450707807|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295203|NCT00576472|450707808|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295204|NCT00576472|450707809|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295205|NCT00576472|450707810|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295206|NCT00576472|450707811|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295207|NCT00576472|450707812|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295208|NCT00576472|450707813|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
124791002|NCT01142089|448865769|FG001|Overall Study|Noncompliance with study procedures|1|||
124791003|NCT01142089|448865768|FG000|Overall Study|Patient required rescue medication|8|||
124791004|NCT01142089|448865769|FG001|Overall Study|Patient required rescue medication|17|||
124791005|NCT02907892|448865772|FG000|Overall Study|Lost to Follow-up|27|||
124791006|NCT02907892|448865773|FG001|Overall Study|Lost to Follow-up|40|||
124791007|NCT01974765|448865774|FG000|Overall Study|Withdrawal by Subject|1|||
125295209|NCT00576472|450707814|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295210|NCT00576472|450707815|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295211|NCT00576472|450707816|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
125295212|NCT01504204|450707827|FG000|Overall Study|Lost to Follow-up|1|||
124791008|NCT01974765|448865774|FG000|Overall Study|Death|1|||
124791009|NCT01974765|448865774|FG000|Overall Study|Adverse Event|2|||
124791010|NCT00528970|448865775|FG000|Overall Study|Adverse Event|6|||
124791011|NCT00528970|448865776|FG001|Overall Study|Adverse Event|8|||
124791012|NCT00528970|448865777|FG002|Overall Study|Adverse Event|5|||
124791013|NCT00528970|448865775|FG000|Overall Study|Lost to Follow-up|0|||
124791014|NCT00528970|448865776|FG001|Overall Study|Lost to Follow-up|0|||
124791015|NCT00528970|448865777|FG002|Overall Study|Lost to Follow-up|1|||
124791016|NCT00528970|448865775|FG000|Overall Study|Other than specified|2|||
124791017|NCT00528970|448865776|FG001|Overall Study|Other than specified|3|||
124791018|NCT00528970|448865777|FG002|Overall Study|Other than specified|3|||
124791019|NCT00528970|448865775|FG000|Overall Study|Protocol Violation|2|||
124791020|NCT00528970|448865776|FG001|Overall Study|Protocol Violation|1|||
124791021|NCT00528970|448865777|FG002|Overall Study|Protocol Violation|4|||
124791022|NCT00528970|448865775|FG000|Overall Study|Lack of Efficacy|0|||
124791023|NCT00528970|448865776|FG001|Overall Study|Lack of Efficacy|0|||
124791024|NCT00528970|448865777|FG002|Overall Study|Lack of Efficacy|1|||
124791025|NCT00528970|448865775|FG000|Overall Study|Withdrawal by Subject|4|||
124791026|NCT00528970|448865776|FG001|Overall Study|Withdrawal by Subject|3|||
124791027|NCT00528970|448865777|FG002|Overall Study|Withdrawal by Subject|5|||
124791028|NCT00528970|448865775|FG000|Overall Study|Randomized but not treated|0|||
124791029|NCT00528970|448865776|FG001|Overall Study|Randomized but not treated|0|||
124791030|NCT00528970|448865777|FG002|Overall Study|Randomized but not treated|1|||
124791031|NCT03860935|448865778|FG000|Overall Study|Withdrawal of Consent|15|||
124791032|NCT03860935|448865779|FG001|Overall Study|Withdrawal of Consent|6|||
125295213|NCT01504204|450707828|FG001|Overall Study|Lost to Follow-up|1|||
125295214|NCT00903331|450707829|FG000|Overall Study|Death|4|||
124791033|NCT03860935|448865778|FG000|Overall Study|Death|75|||
124791034|NCT03860935|448865779|FG001|Overall Study|Death|51|||
124791035|NCT01430754|448865780|FG000|Run-In Phase|Circadian Period Ineligible|24|||
124791036|NCT01430754|448865781|FG001|Run-In Phase|Circadian Period Ineligible|0|||
124791037|NCT01430754|448865780|FG000|Run-In Phase|Protocol Violation|6|||
124791038|NCT01430754|448865781|FG001|Run-In Phase|Protocol Violation|0|||
124791039|NCT01430754|448865780|FG000|Run-In Phase|Adverse Event|2|||
124791040|NCT01430754|448865781|FG001|Run-In Phase|Adverse Event|0|||
124791041|NCT01430754|448865780|FG000|Run-In Phase|Other|2|||
124791042|NCT01430754|448865781|FG001|Run-In Phase|Other|0|||
124791043|NCT01430754|448865780|FG000|Run-In Phase|Withdrawal by Subject|2|||
124791044|NCT01430754|448865781|FG001|Run-In Phase|Withdrawal by Subject|0|||
124791045|NCT01430754|448865780|FG000|Run-In Phase|Lost to Follow-up|1|||
124791046|NCT01430754|448865781|FG001|Run-In Phase|Lost to Follow-up|0|||
124791047|NCT00701662|448865785|FG000|Overall Study|Lack of Efficacy|1|||
124791048|NCT00635024|448865786|FG000|Overall Study|Adverse Event|1|||
124791049|NCT01105065|448865787|FG000|Overall Study|Adverse Event|5|||
124791050|NCT01105065|448865787|FG000|Overall Study|Technical Problems|1|||
124791051|NCT01038869|448865790|FG000|Overall Study|Withdrawal by Subject|1|||
124791052|NCT01038869|448865790|FG000|Overall Study|Lost to Follow-up|6|||
124791053|NCT04575597|448865791|FG000|Overall Study|Death|0|||
124791054|NCT04575597|448865792|FG001|Overall Study|Death|0|||
124791055|NCT04575597|448865793|FG002|Overall Study|Death|0|||
124791056|NCT04575597|448865794|FG003|Overall Study|Death|1|||
124791057|NCT04575597|448865795|FG004|Overall Study|Death|3|||
124791058|NCT04575597|448865796|FG005|Overall Study|Death|14|||
124791059|NCT04575597|448865791|FG000|Overall Study|Lost to Follow-up|2|||
124791060|NCT04575597|448865792|FG001|Overall Study|Lost to Follow-up|1|||
124791061|NCT04575597|448865793|FG002|Overall Study|Lost to Follow-up|1|||
124791062|NCT04575597|448865794|FG003|Overall Study|Lost to Follow-up|2|||
124791063|NCT04575597|448865795|FG004|Overall Study|Lost to Follow-up|10|||
124791064|NCT04575597|448865796|FG005|Overall Study|Lost to Follow-up|8|||
124791065|NCT04575597|448865791|FG000|Overall Study|Withdrawal by Subject|2|||
124791066|NCT04575597|448865792|FG001|Overall Study|Withdrawal by Subject|2|||
124791067|NCT04575597|448865793|FG002|Overall Study|Withdrawal by Subject|4|||
124791068|NCT04575597|448865794|FG003|Overall Study|Withdrawal by Subject|2|||
124791069|NCT04575597|448865795|FG004|Overall Study|Withdrawal by Subject|25|||
124791070|NCT04575597|448865796|FG005|Overall Study|Withdrawal by Subject|28|||
124791071|NCT04575597|448865791|FG000|Overall Study|Not Recorded|0|||
125295215|NCT00903331|450707830|FG001|Overall Study|Death|8|||
124791072|NCT04575597|448865792|FG001|Overall Study|Not Recorded|0|||
124791073|NCT04575597|448865793|FG002|Overall Study|Not Recorded|0|||
124791074|NCT04575597|448865794|FG003|Overall Study|Not Recorded|0|||
125295216|NCT00903331|450707829|FG000|Overall Study|Withdrawal of consent|1|||
124791075|NCT04575597|448865795|FG004|Overall Study|Not Recorded|0|||
124791076|NCT04575597|448865796|FG005|Overall Study|Not Recorded|2|||
124791077|NCT04575597|448865791|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124791078|NCT04575597|448865792|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124791079|NCT04575597|448865793|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124791080|NCT04575597|448865794|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124791081|NCT04575597|448865795|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
124791082|NCT04575597|448865796|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
124791083|NCT03316911|448865801|FG000|Overall Study|Lost to Follow-up|33|||
124791084|NCT03316911|448865802|FG001|Overall Study|Lost to Follow-up|29|||
124791085|NCT01119937|448865803|FG000|Overall Study|Adverse Event|11|||
124791086|NCT01119937|448865804|FG001|Overall Study|Adverse Event|5|||
124791087|NCT01119937|448865803|FG000|Overall Study|Protocol deviation|3|||
124791088|NCT01119937|448865804|FG001|Overall Study|Protocol deviation|1|||
124791089|NCT01119937|448865803|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
124791090|NCT01119937|448865804|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124791091|NCT01119937|448865803|FG000|Overall Study|Withdrawal by Subject|2|||
124791092|NCT01119937|448865804|FG001|Overall Study|Withdrawal by Subject|1|||
124791093|NCT02536404|448865809|FG000|Overall Study|Adverse Event|5|||
124791094|NCT02536404|448865810|FG001|Overall Study|Adverse Event|0|||
124791095|NCT02536404|448865809|FG000|Overall Study|Withdrawal by Subject|4|||
124791096|NCT02536404|448865810|FG001|Overall Study|Withdrawal by Subject|1|||
124791097|NCT02536404|448865809|FG000|Overall Study|Physician Decision|10|||
124791098|NCT02536404|448865810|FG001|Overall Study|Physician Decision|0|||
124791099|NCT02536404|448865809|FG000|Overall Study|Sponsor decision|1|||
124791100|NCT02536404|448865810|FG001|Overall Study|Sponsor decision|0|||
124791101|NCT00770146|448865811|FG000|Treatment Period|Withdrawal by Subject|6|||
124791102|NCT00770146|448865812|FG001|Treatment Period|Withdrawal by Subject|13|||
124791103|NCT00770146|448865811|FG000|Treatment Period|Adverse Event|2|||
124791104|NCT00770146|448865812|FG001|Treatment Period|Adverse Event|26|||
124791105|NCT00770146|448865811|FG000|Treatment Period|Other|1|||
124791106|NCT00770146|448865812|FG001|Treatment Period|Other|5|||
124791107|NCT00770146|448865811|FG000|Treatment Period|Protocol non-compliance|0|||
124791108|NCT00770146|448865812|FG001|Treatment Period|Protocol non-compliance|1|||
124791109|NCT00770146|448865811|FG000|Follow-up Period|Withdrawal by Subject|7|||
124791110|NCT00770146|448865812|FG001|Follow-up Period|Withdrawal by Subject|13|||
124791111|NCT00770146|448865811|FG000|Follow-up Period|Adverse Event|0|||
124791112|NCT00770146|448865812|FG001|Follow-up Period|Adverse Event|2|||
124791113|NCT00770146|448865811|FG000|Follow-up Period|Other|4|||
124791114|NCT00770146|448865812|FG001|Follow-up Period|Other|5|||
124791115|NCT00816023|448865814|FG000|Overall Study|Lost to Follow-up|1|||
124791116|NCT00816023|448865815|FG001|Overall Study|Lost to Follow-up|1|||
124791117|NCT00816023|448865816|FG002|Overall Study|Lost to Follow-up|0|||
124791118|NCT00816023|448865817|FG003|Overall Study|Lost to Follow-up|0|||
124791119|NCT00816023|448865814|FG000|Overall Study|Withdrawal by Subject|1|||
124791120|NCT00816023|448865815|FG001|Overall Study|Withdrawal by Subject|0|||
124791121|NCT00816023|448865816|FG002|Overall Study|Withdrawal by Subject|0|||
124791122|NCT00816023|448865817|FG003|Overall Study|Withdrawal by Subject|0|||
124791123|NCT00816023|448865814|FG000|Overall Study|Physician Decision|0|||
124791124|NCT00816023|448865815|FG001|Overall Study|Physician Decision|0|||
124791125|NCT00816023|448865816|FG002|Overall Study|Physician Decision|1|||
124791126|NCT00816023|448865817|FG003|Overall Study|Physician Decision|0|||
124791127|NCT00816023|448865814|FG000|Overall Study|assessments complete prior to window|1|||
124791128|NCT00816023|448865815|FG001|Overall Study|assessments complete prior to window|1|||
124791129|NCT00816023|448865816|FG002|Overall Study|assessments complete prior to window|2|||
124791130|NCT00816023|448865817|FG003|Overall Study|assessments complete prior to window|1|||
124791131|NCT00816023|448865814|FG000|Overall Study|Randomized Not Treated|6|||
124791132|NCT00816023|448865815|FG001|Overall Study|Randomized Not Treated|4|||
124791133|NCT00816023|448865816|FG002|Overall Study|Randomized Not Treated|6|||
124791134|NCT00816023|448865817|FG003|Overall Study|Randomized Not Treated|11|||
124791135|NCT05027971|448865818|FG000|Overall Study|Physician Decision|7|||
124791136|NCT05027971|448865819|FG001|Overall Study|Physician Decision|3|||
124791137|NCT05027971|448865818|FG000|Overall Study|Lost to Follow-up|1|||
124791138|NCT05027971|448865819|FG001|Overall Study|Lost to Follow-up|1|||
124791139|NCT05027971|448865818|FG000|Overall Study|Withdrawal by Subject|0|||
124791140|NCT05027971|448865819|FG001|Overall Study|Withdrawal by Subject|2|||
124791141|NCT05027971|448865818|FG000|Overall Study|Non-study fiber used.|0|||
124791142|NCT05027971|448865819|FG001|Overall Study|Non-study fiber used.|1|||
124791143|NCT05027971|448865818|FG000|Overall Study|Protocol Violation|0|||
124791144|NCT05027971|448865819|FG001|Overall Study|Protocol Violation|2|||
124791145|NCT01238588|448865824|FG000|Overall Study|Withdrawal by Subject|1|||
124791146|NCT01238588|448865824|FG000|Overall Study|Physician Decision|2|||
124791147|NCT01903252|448865829|FG000|Double-Blind Induction|Adverse Event|20|||
124791148|NCT01903252|448865830|FG001|Double-Blind Induction|Adverse Event|18|||
124791149|NCT01903252|448865831|FG002|Double-Blind Induction|Adverse Event|0|||
124791150|NCT01903252|448865832|FG003|Double-Blind Induction|Adverse Event|0|||
124791151|NCT01903252|448865833|FG004|Double-Blind Induction|Adverse Event|0|||
124791152|NCT01903252|448865834|FG005|Double-Blind Induction|Adverse Event|0|||
124791153|NCT01903252|448865829|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
124791154|NCT01903252|448865830|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
124791155|NCT01903252|448865831|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
124791156|NCT01903252|448865832|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
124791157|NCT01903252|448865833|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
124791158|NCT01903252|448865834|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
124791159|NCT01903252|448865829|FG000|Double-Blind Induction|Physician Decision|2|||
124791160|NCT01903252|448865830|FG001|Double-Blind Induction|Physician Decision|3|||
124791161|NCT01903252|448865831|FG002|Double-Blind Induction|Physician Decision|0|||
124791162|NCT01903252|448865832|FG003|Double-Blind Induction|Physician Decision|0|||
124791163|NCT01903252|448865833|FG004|Double-Blind Induction|Physician Decision|0|||
124791164|NCT01903252|448865834|FG005|Double-Blind Induction|Physician Decision|0|||
124791165|NCT01903252|448865829|FG000|Double-Blind Induction|non-compliance,|7|||
124791166|NCT01903252|448865830|FG001|Double-Blind Induction|non-compliance,|7|||
124791167|NCT01903252|448865831|FG002|Double-Blind Induction|non-compliance,|0|||
124791168|NCT01903252|448865832|FG003|Double-Blind Induction|non-compliance,|0|||
124791169|NCT01903252|448865833|FG004|Double-Blind Induction|non-compliance,|0|||
124791170|NCT01903252|448865834|FG005|Double-Blind Induction|non-compliance,|0|||
124791171|NCT01903252|448865829|FG000|Extended Induction, Open-Label|Adverse Event|0|||
124791172|NCT01903252|448865830|FG001|Extended Induction, Open-Label|Adverse Event|0|||
124791173|NCT01903252|448865831|FG002|Extended Induction, Open-Label|Adverse Event|17|||
124791174|NCT01903252|448865832|FG003|Extended Induction, Open-Label|Adverse Event|0|||
124791175|NCT01903252|448865833|FG004|Extended Induction, Open-Label|Adverse Event|0|||
124791176|NCT01903252|448865834|FG005|Extended Induction, Open-Label|Adverse Event|0|||
124791177|NCT01903252|448865829|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
124791178|NCT01903252|448865830|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
124791179|NCT01903252|448865831|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
124791180|NCT01903252|448865832|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
124791181|NCT01903252|448865833|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
124791182|NCT01903252|448865834|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
124791183|NCT01903252|448865829|FG000|Extended Induction, Open-Label|Physician Decision|0|||
124791184|NCT01903252|448865830|FG001|Extended Induction, Open-Label|Physician Decision|0|||
124791185|NCT01903252|448865831|FG002|Extended Induction, Open-Label|Physician Decision|1|||
124791186|NCT01903252|448865832|FG003|Extended Induction, Open-Label|Physician Decision|0|||
124791187|NCT01903252|448865833|FG004|Extended Induction, Open-Label|Physician Decision|0|||
124791188|NCT01903252|448865834|FG005|Extended Induction, Open-Label|Physician Decision|0|||
124791189|NCT01903252|448865829|FG000|Maintenance, Open-Label|Adverse Event|0|||
124791190|NCT01903252|448865830|FG001|Maintenance, Open-Label|Adverse Event|0|||
124791191|NCT01903252|448865831|FG002|Maintenance, Open-Label|Adverse Event|0|||
124791192|NCT01903252|448865832|FG003|Maintenance, Open-Label|Adverse Event|3|||
124791193|NCT01903252|448865833|FG004|Maintenance, Open-Label|Adverse Event|9|||
124791194|NCT01903252|448865834|FG005|Maintenance, Open-Label|Adverse Event|14|||
124791195|NCT01903252|448865829|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
124791196|NCT01903252|448865830|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
124791197|NCT01903252|448865831|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
124791198|NCT01903252|448865832|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
124791199|NCT01903252|448865833|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
124791200|NCT01903252|448865834|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
124791201|NCT01903252|448865829|FG000|Maintenance, Open-Label|Other|0|||
124791202|NCT01903252|448865830|FG001|Maintenance, Open-Label|Other|0|||
124791203|NCT01903252|448865831|FG002|Maintenance, Open-Label|Other|0|||
124791204|NCT01903252|448865832|FG003|Maintenance, Open-Label|Other|2|||
124791205|NCT01903252|448865833|FG004|Maintenance, Open-Label|Other|6|||
124791206|NCT01903252|448865834|FG005|Maintenance, Open-Label|Other|2|||
124791207|NCT02437110|448865835|FG000|Screening|Lost to Follow-up|3|||
124791208|NCT02437110|448865835|FG000|Screening|Physician Decision|1|||
124791209|NCT02437110|448865835|FG000|ART|Adverse Event|3|||
124791210|NCT02437110|448865835|FG000|ART|Protocol Violation|3|||
124791211|NCT02437110|448865835|FG000|ART|Withdrawal by Subject|4|||
124791212|NCT02437110|448865835|FG000|ART|Lost to follow-up prior to start of intervention|1|||
124791213|NCT02437110|448865835|FG000|ART|Physician decision prior to start of intervention|2|||
124791214|NCT02437110|448865835|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
124791215|NCT02437110|448865835|FG000|Post-ART|Lost to Follow-up|3|||
124791216|NCT02437110|448865835|FG000|Post-ART|Protocol Violation|4|||
124791217|NCT02437110|448865835|FG000|Post-ART|Withdrawal by Subject|3|||
124791218|NCT03836001|448865838|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
124791219|NCT03836001|448865839|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
124791220|NCT03836001|448865840|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
124791221|NCT03836001|448865838|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
124791222|NCT03836001|448865839|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
124791223|NCT03836001|448865840|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
124791224|NCT03836001|448865838|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
124791225|NCT03836001|448865839|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
124791226|NCT03836001|448865840|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
124791227|NCT03836001|448865838|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
124791228|NCT03836001|448865839|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
124791229|NCT03836001|448865840|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
124791230|NCT01381562|448865841|FG000|Overall Study|Adverse Event|0|||
124791231|NCT01381562|448865842|FG001|Overall Study|Adverse Event|1|||
124791232|NCT01381562|448865843|FG002|Overall Study|Adverse Event|0|||
124791233|NCT01642732|448865848|FG000|Overall Study|Withdrawal by Subject|1|||
124791234|NCT00899353|448865851|FG000|Overall Study|Adverse Event|2|||
124791235|NCT00899353|448865851|FG000|Overall Study|Lost to Follow-up|1|||
124791236|NCT00899353|448865851|FG000|Overall Study|Withdrawal by Subject|2|||
124791237|NCT02730793|448865857|FG000|Overall Study|Physician Decision|0|||
124791238|NCT02730793|448865858|FG001|Overall Study|Physician Decision|1|||
124791239|NCT02730793|448865857|FG000|Overall Study|Withdrawal by Subject|0|||
124791240|NCT02730793|448865858|FG001|Overall Study|Withdrawal by Subject|1|||
124791241|NCT01284491|448865859|FG000|Overall Study|Study termination|13|||
124791242|NCT02694757|448865862|FG000|Overall Study|Lack of Efficacy|3|||
124791243|NCT02650921|448865863|FG000|Overall Study|Withdrawal by Subject|4|||
124791244|NCT02650921|448865863|FG000|Overall Study|Lost to Follow-up|2|||
124791245|NCT02650921|448865863|FG000|Overall Study|Adverse Event|1|||
124791246|NCT02650921|448865863|FG000|Overall Study|Due to Medical Condition|1|||
124791247|NCT00783302|448865864|FG000|Overall Study|Lost to Follow-up|17|||
124791248|NCT00783302|448865864|FG000|Overall Study|Technical Problems|11|||
124791249|NCT00783302|448865864|FG000|Overall Study|Protocol Violation|3|||
124791250|NCT00783302|448865864|FG000|Overall Study|Physician Decision|1|||
124791251|NCT00783302|448865864|FG000|Overall Study|Withdrawal by Subject|3|||
124791252|NCT04604132|448865865|FG000|Overall Study|Adverse Event|2|||
124791253|NCT04604132|448865866|FG001|Overall Study|Adverse Event|0|||
124791254|NCT04604132|448865867|FG002|Overall Study|Adverse Event|0|||
124791255|NCT04604132|448865868|FG003|Overall Study|Adverse Event|1|||
124791256|NCT04604132|448865869|FG004|Overall Study|Adverse Event|2|||
124791257|NCT04604132|448865865|FG000|Overall Study|Study terminated by sponsor|0|||
124791258|NCT04604132|448865866|FG001|Overall Study|Study terminated by sponsor|0|||
124791259|NCT04604132|448865867|FG002|Overall Study|Study terminated by sponsor|0|||
124791260|NCT04604132|448865868|FG003|Overall Study|Study terminated by sponsor|0|||
124791261|NCT04604132|448865869|FG004|Overall Study|Study terminated by sponsor|1|||
124791262|NCT04604132|448865865|FG000|Overall Study|Progressive disease: Clinical progression|0|||
124791263|NCT04604132|448865866|FG001|Overall Study|Progressive disease: Clinical progression|0|||
124791264|NCT04604132|448865867|FG002|Overall Study|Progressive disease: Clinical progression|1|||
124791265|NCT04604132|448865868|FG003|Overall Study|Progressive disease: Clinical progression|0|||
124791266|NCT04604132|448865869|FG004|Overall Study|Progressive disease: Clinical progression|0|||
124791267|NCT04604132|448865865|FG000|Overall Study|Progressive disease: Radiological progression|8|||
124791268|NCT04604132|448865866|FG001|Overall Study|Progressive disease: Radiological progression|7|||
124791269|NCT04604132|448865867|FG002|Overall Study|Progressive disease: Radiological progression|10|||
124791270|NCT04604132|448865868|FG003|Overall Study|Progressive disease: Radiological progression|4|||
124791271|NCT04604132|448865869|FG004|Overall Study|Progressive disease: Radiological progression|3|||
124791272|NCT04604132|448865865|FG000|Overall Study|Death|3|||
124791273|NCT04604132|448865866|FG001|Overall Study|Death|1|||
124791274|NCT04604132|448865867|FG002|Overall Study|Death|2|||
124791275|NCT04604132|448865868|FG003|Overall Study|Death|1|||
124791276|NCT04604132|448865869|FG004|Overall Study|Death|0|||
124791277|NCT00952380|448865870|FG000|Overall Study|Other|0|||
124791278|NCT00952380|448865871|FG001|Overall Study|Other|0|||
124791279|NCT00952380|448865872|FG002|Overall Study|Other|0|||
124791280|NCT00952380|448865873|FG003|Overall Study|Other|0|||
124791281|NCT00952380|448865874|FG004|Overall Study|Other|1|||
124791282|NCT00952380|448865870|FG000|Overall Study|Withdrawal by Subject|0|||
124791283|NCT00952380|448865871|FG001|Overall Study|Withdrawal by Subject|0|||
124791284|NCT00952380|448865872|FG002|Overall Study|Withdrawal by Subject|1|||
124791285|NCT00952380|448865873|FG003|Overall Study|Withdrawal by Subject|0|||
124791286|NCT00952380|448865874|FG004|Overall Study|Withdrawal by Subject|2|||
124791287|NCT00952380|448865870|FG000|Overall Study|Adverse Event|0|||
124791288|NCT00952380|448865871|FG001|Overall Study|Adverse Event|1|||
124791289|NCT00952380|448865872|FG002|Overall Study|Adverse Event|0|||
124791290|NCT00952380|448865873|FG003|Overall Study|Adverse Event|0|||
124791291|NCT00952380|448865874|FG004|Overall Study|Adverse Event|3|||
124791292|NCT00952380|448865870|FG000|Overall Study|Physician Decision|0|||
124791293|NCT00952380|448865871|FG001|Overall Study|Physician Decision|0|||
125295217|NCT00903331|450707830|FG001|Overall Study|Withdrawal of consent|8|||
124791294|NCT00952380|448865872|FG002|Overall Study|Physician Decision|1|||
124791295|NCT00952380|448865873|FG003|Overall Study|Physician Decision|2|||
124791296|NCT00952380|448865874|FG004|Overall Study|Physician Decision|0|||
124791297|NCT00952380|448865870|FG000|Overall Study|Non-compliant to protocol|0|||
124791298|NCT00952380|448865871|FG001|Overall Study|Non-compliant to protocol|0|||
125295218|NCT00903331|450707829|FG000|Overall Study|Lung transplant|0|||
124791299|NCT00952380|448865872|FG002|Overall Study|Non-compliant to protocol|0|||
124791300|NCT00952380|448865873|FG003|Overall Study|Non-compliant to protocol|1|||
124791301|NCT00952380|448865874|FG004|Overall Study|Non-compliant to protocol|0|||
124791302|NCT03400956|448865875|FG000|Treatment Period 1|Adverse Event|0|||
125295219|NCT00903331|450707830|FG001|Overall Study|Lung transplant|2|||
124791303|NCT03400956|448865876|FG001|Treatment Period 1|Adverse Event|1|||
124791304|NCT03400956|448865877|FG002|Treatment Period 1|Adverse Event|0|||
124791305|NCT03400956|448865875|FG000|Treatment Period 1|Lost to Follow-up|0|||
124791306|NCT03400956|448865876|FG001|Treatment Period 1|Lost to Follow-up|0|||
124791307|NCT03400956|448865877|FG002|Treatment Period 1|Lost to Follow-up|1|||
124791308|NCT03400956|448865875|FG000|Treatment Period 1|Protocol Violation|0|||
124791309|NCT03400956|448865876|FG001|Treatment Period 1|Protocol Violation|2|||
124791310|NCT03400956|448865877|FG002|Treatment Period 1|Protocol Violation|0|||
124791311|NCT03400956|448865875|FG000|Treatment Period 1|Study terminated by sponsor|3|||
124791312|NCT03400956|448865876|FG001|Treatment Period 1|Study terminated by sponsor|1|||
124791313|NCT03400956|448865877|FG002|Treatment Period 1|Study terminated by sponsor|1|||
124791314|NCT03400956|448865875|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124791315|NCT03400956|448865876|FG001|Treatment Period 1|Withdrawal by Subject|2|||
124791316|NCT03400956|448865877|FG002|Treatment Period 1|Withdrawal by Subject|4|||
124791317|NCT03400956|448865875|FG000|Treatment Period 1|Other|1|||
124791318|NCT03400956|448865876|FG001|Treatment Period 1|Other|2|||
124791319|NCT03400956|448865877|FG002|Treatment Period 1|Other|3|||
124791320|NCT03400956|448865875|FG000|Post-treatment Period 1|Adverse Event|0|||
124791321|NCT03400956|448865876|FG001|Post-treatment Period 1|Adverse Event|0|||
124791322|NCT03400956|448865877|FG002|Post-treatment Period 1|Adverse Event|1|||
124791323|NCT03400956|448865875|FG000|Post-treatment Period 1|Physician Decision|2|||
124791324|NCT03400956|448865876|FG001|Post-treatment Period 1|Physician Decision|3|||
124791325|NCT03400956|448865877|FG002|Post-treatment Period 1|Physician Decision|0|||
124791326|NCT03400956|448865875|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
124791327|NCT03400956|448865876|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
124791328|NCT03400956|448865877|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
124791329|NCT03400956|448865875|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
124791330|NCT03400956|448865876|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
124791331|NCT03400956|448865877|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
124791332|NCT03400956|448865875|FG000|Post-treatment Period 1|Other|4|||
124791333|NCT03400956|448865876|FG001|Post-treatment Period 1|Other|3|||
124791334|NCT03400956|448865877|FG002|Post-treatment Period 1|Other|4|||
124791335|NCT03400956|448865875|FG000|Treatment Period 2|Adverse Event|2|||
124791336|NCT03400956|448865876|FG001|Treatment Period 2|Adverse Event|1|||
124791337|NCT03400956|448865877|FG002|Treatment Period 2|Adverse Event|1|||
124791338|NCT03400956|448865875|FG000|Treatment Period 2|Lost to Follow-up|1|||
124791339|NCT03400956|448865876|FG001|Treatment Period 2|Lost to Follow-up|1|||
124791340|NCT03400956|448865877|FG002|Treatment Period 2|Lost to Follow-up|0|||
124791341|NCT03400956|448865875|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124791342|NCT03400956|448865876|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124791343|NCT03400956|448865877|FG002|Treatment Period 2|Withdrawal by Subject|3|||
124791344|NCT03400956|448865875|FG000|Treatment Period 2|Other|1|||
124791345|NCT03400956|448865876|FG001|Treatment Period 2|Other|1|||
124791346|NCT03400956|448865877|FG002|Treatment Period 2|Other|0|||
124791347|NCT03400956|448865875|FG000|Follow-up Period|Withdrawal by Subject|0|||
124791348|NCT03400956|448865876|FG001|Follow-up Period|Withdrawal by Subject|0|||
124791349|NCT03400956|448865877|FG002|Follow-up Period|Withdrawal by Subject|1|||
124791350|NCT03400956|448865875|FG000|Follow-up Period|Other|0|||
124791351|NCT03400956|448865876|FG001|Follow-up Period|Other|0|||
124791352|NCT03400956|448865877|FG002|Follow-up Period|Other|1|||
124791353|NCT00160667|448865878|FG000|Overall Study|Adverse Event|3|||
124791354|NCT00160667|448865879|FG001|Overall Study|Adverse Event|1|||
124791355|NCT00160667|448865880|FG002|Overall Study|Adverse Event|4|||
124791356|NCT00160667|448865878|FG000|Overall Study|Withdrawal by Subject|2|||
124791357|NCT00160667|448865879|FG001|Overall Study|Withdrawal by Subject|0|||
124791358|NCT00160667|448865880|FG002|Overall Study|Withdrawal by Subject|1|||
124791359|NCT00160667|448865878|FG000|Overall Study|Lack of Efficacy|0|||
124791360|NCT00160667|448865879|FG001|Overall Study|Lack of Efficacy|1|||
124791361|NCT00160667|448865880|FG002|Overall Study|Lack of Efficacy|0|||
124791362|NCT00160667|448865878|FG000|Overall Study|Protocol Violation|0|||
124791363|NCT00160667|448865879|FG001|Overall Study|Protocol Violation|1|||
124791364|NCT00160667|448865880|FG002|Overall Study|Protocol Violation|0|||
124791365|NCT00160667|448865878|FG000|Overall Study|Patient decision|0|||
124791366|NCT00160667|448865879|FG001|Overall Study|Patient decision|0|||
124791367|NCT00160667|448865880|FG002|Overall Study|Patient decision|1|||
124791368|NCT00927940|448865881|FG000|Overall Study|Death|1|||
124791369|NCT03044574|448865885|FG000|Overall Study|Lost to Follow-up|37|||
124791370|NCT03044574|448865886|FG001|Overall Study|Lost to Follow-up|45|||
124791371|NCT00890045|448865887|FG000|Overall Study|Death|0|||
124791372|NCT00890045|448865888|FG001|Overall Study|Death|1|||
124791373|NCT00890045|448865887|FG000|Overall Study|Did not receive HeRO Graft|0|||
124791374|NCT00890045|448865888|FG001|Overall Study|Did not receive HeRO Graft|2|||
124791375|NCT00890045|448865887|FG000|Overall Study|Lost to Follow-up|5|||
124791376|NCT00890045|448865888|FG001|Overall Study|Lost to Follow-up|7|||
124791377|NCT00483756|448865893|FG000|Overall Study|Death|2|||
124791378|NCT00483756|448865894|FG001|Overall Study|Death|0|||
124791379|NCT00483756|448865895|FG002|Overall Study|Death|1|||
124791380|NCT00483756|448865893|FG000|Overall Study|Adverse Event|19|||
124791381|NCT00483756|448865894|FG001|Overall Study|Adverse Event|38|||
124791382|NCT00483756|448865895|FG002|Overall Study|Adverse Event|40|||
124791383|NCT00483756|448865893|FG000|Overall Study|Lack of Efficacy|1|||
124791384|NCT00483756|448865894|FG001|Overall Study|Lack of Efficacy|0|||
124791385|NCT00483756|448865895|FG002|Overall Study|Lack of Efficacy|0|||
124791386|NCT00483756|448865893|FG000|Overall Study|Lost to Follow-up|3|||
124791387|NCT00483756|448865894|FG001|Overall Study|Lost to Follow-up|1|||
124791388|NCT00483756|448865895|FG002|Overall Study|Lost to Follow-up|0|||
124791389|NCT00483756|448865893|FG000|Overall Study|Withdrawal by Subject|5|||
124791390|NCT00483756|448865894|FG001|Overall Study|Withdrawal by Subject|3|||
124791391|NCT00483756|448865895|FG002|Overall Study|Withdrawal by Subject|4|||
124791392|NCT00483756|448865893|FG000|Overall Study|Other|2|||
124791393|NCT00483756|448865894|FG001|Overall Study|Other|4|||
124791394|NCT00483756|448865895|FG002|Overall Study|Other|3|||
124791395|NCT00483756|448865893|FG000|Overall Study|Randomized, Not Treated|1|||
124791396|NCT00483756|448865894|FG001|Overall Study|Randomized, Not Treated|4|||
124791397|NCT00483756|448865895|FG002|Overall Study|Randomized, Not Treated|4|||
124791398|NCT00906971|448865896|FG000|Overall Study|Withdrawal by Subject|8|||
124791399|NCT00906971|448865897|FG001|Overall Study|Withdrawal by Subject|2|||
124791400|NCT00906971|448865896|FG000|Overall Study|Lost to Follow-up|0|||
124791401|NCT00906971|448865897|FG001|Overall Study|Lost to Follow-up|1|||
124791402|NCT04054947|448865898|FG000|Overall Study|Withdrawal by Subject|1|||
124791403|NCT04054947|448865899|FG001|Overall Study|Withdrawal by Subject|0|||
124791404|NCT04054947|448865898|FG000|Overall Study|Lost to Follow-up|2|||
124791405|NCT04054947|448865899|FG001|Overall Study|Lost to Follow-up|5|||
124791406|NCT01606878|448865900|FG000|Overall Study|Adverse Event|1|||
124791407|NCT01606878|448865901|FG001|Overall Study|Adverse Event|1|||
124791408|NCT01606878|448865902|FG002|Overall Study|Adverse Event|0|||
124791409|NCT01606878|448865903|FG003|Overall Study|Adverse Event|0|||
124791410|NCT01606878|448865904|FG004|Overall Study|Adverse Event|0|||
124791411|NCT01606878|448865905|FG005|Overall Study|Adverse Event|0|||
124791412|NCT01606878|448865906|FG006|Overall Study|Adverse Event|1|||
124791413|NCT01606878|448865907|FG007|Overall Study|Adverse Event|0|||
124791414|NCT01606878|448865908|FG008|Overall Study|Adverse Event|1|||
124791415|NCT01606878|448865909|FG009|Overall Study|Adverse Event|3|||
124791416|NCT01606878|448865910|FG010|Overall Study|Adverse Event|0|||
124791417|NCT01606878|448865900|FG000|Overall Study|Lack of Efficacy|1|||
124791418|NCT01606878|448865901|FG001|Overall Study|Lack of Efficacy|1|||
124791419|NCT01606878|448865902|FG002|Overall Study|Lack of Efficacy|1|||
124791420|NCT01606878|448865903|FG003|Overall Study|Lack of Efficacy|2|||
124791421|NCT01606878|448865904|FG004|Overall Study|Lack of Efficacy|1|||
124791422|NCT01606878|448865905|FG005|Overall Study|Lack of Efficacy|2|||
124791423|NCT01606878|448865906|FG006|Overall Study|Lack of Efficacy|1|||
124791424|NCT01606878|448865907|FG007|Overall Study|Lack of Efficacy|2|||
124791425|NCT01606878|448865908|FG008|Overall Study|Lack of Efficacy|2|||
124791426|NCT01606878|448865909|FG009|Overall Study|Lack of Efficacy|0|||
124791427|NCT01606878|448865910|FG010|Overall Study|Lack of Efficacy|1|||
124791428|NCT01606878|448865900|FG000|Overall Study|Physician Decision|1|||
124791429|NCT01606878|448865901|FG001|Overall Study|Physician Decision|0|||
124791430|NCT01606878|448865902|FG002|Overall Study|Physician Decision|2|||
124791431|NCT01606878|448865903|FG003|Overall Study|Physician Decision|1|||
124791432|NCT01606878|448865904|FG004|Overall Study|Physician Decision|1|||
124791433|NCT01606878|448865905|FG005|Overall Study|Physician Decision|1|||
124791434|NCT01606878|448865906|FG006|Overall Study|Physician Decision|2|||
124791435|NCT01606878|448865907|FG007|Overall Study|Physician Decision|0|||
124791436|NCT01606878|448865908|FG008|Overall Study|Physician Decision|1|||
124791437|NCT01606878|448865909|FG009|Overall Study|Physician Decision|0|||
124791438|NCT01606878|448865910|FG010|Overall Study|Physician Decision|0|||
124791439|NCT01606878|448865900|FG000|Overall Study|Withdrawal by Subject|3|||
124791440|NCT01606878|448865901|FG001|Overall Study|Withdrawal by Subject|2|||
124791441|NCT01606878|448865902|FG002|Overall Study|Withdrawal by Subject|2|||
124791442|NCT01606878|448865903|FG003|Overall Study|Withdrawal by Subject|0|||
124791443|NCT01606878|448865904|FG004|Overall Study|Withdrawal by Subject|1|||
124791444|NCT01606878|448865905|FG005|Overall Study|Withdrawal by Subject|1|||
124791445|NCT01606878|448865906|FG006|Overall Study|Withdrawal by Subject|2|||
124791446|NCT01606878|448865907|FG007|Overall Study|Withdrawal by Subject|1|||
124791447|NCT01606878|448865908|FG008|Overall Study|Withdrawal by Subject|2|||
124791448|NCT01606878|448865909|FG009|Overall Study|Withdrawal by Subject|0|||
124791449|NCT01606878|448865910|FG010|Overall Study|Withdrawal by Subject|2|||
124791450|NCT03473548|448865911|FG000|Overall Study|Did not attempt HST testing|3|||
124791451|NCT03473548|448865912|FG001|Overall Study|Did not attempt HST testing|0|||
124791452|NCT00129311|448865913|FG000|Overall Study|Withdrawal by Subject|12|||
124791453|NCT00129311|448865914|FG001|Overall Study|Withdrawal by Subject|19|||
124791454|NCT01340872|448867415|FG000|Double-blind Phase|Adverse Event|6|||
124791455|NCT01340872|448867416|FG001|Double-blind Phase|Adverse Event|4|||
124791456|NCT01340872|448867417|FG002|Double-blind Phase|Adverse Event|0|||
124791457|NCT01340872|448867418|FG003|Double-blind Phase|Adverse Event|0|||
124791458|NCT01340872|448867415|FG000|Double-blind Phase|Withdrawal by Subject|3|||
124791459|NCT01340872|448867416|FG001|Double-blind Phase|Withdrawal by Subject|5|||
124791460|NCT01340872|448867417|FG002|Double-blind Phase|Withdrawal by Subject|0|||
124791461|NCT01340872|448867418|FG003|Double-blind Phase|Withdrawal by Subject|0|||
124791462|NCT01340872|448867415|FG000|Double-blind Phase|Lost to Follow-up|0|||
124791463|NCT01340872|448867416|FG001|Double-blind Phase|Lost to Follow-up|1|||
124791464|NCT01340872|448867417|FG002|Double-blind Phase|Lost to Follow-up|0|||
124791465|NCT01340872|448867418|FG003|Double-blind Phase|Lost to Follow-up|0|||
124791466|NCT01340872|448867415|FG000|Double-blind Phase|Protocol Violation|0|||
124791467|NCT01340872|448867416|FG001|Double-blind Phase|Protocol Violation|1|||
124791468|NCT01340872|448867417|FG002|Double-blind Phase|Protocol Violation|0|||
124791469|NCT01340872|448867418|FG003|Double-blind Phase|Protocol Violation|0|||
124791470|NCT01340872|448867415|FG000|Open-label Phase|Physician Decision|0|||
124791471|NCT01340872|448867416|FG001|Open-label Phase|Physician Decision|0|||
124791472|NCT01340872|448867417|FG002|Open-label Phase|Physician Decision|2|||
124791473|NCT01340872|448867418|FG003|Open-label Phase|Physician Decision|1|||
124791474|NCT01340872|448867415|FG000|Open-label Phase|Pregnancy|0|||
124791475|NCT01340872|448867416|FG001|Open-label Phase|Pregnancy|0|||
124791476|NCT01340872|448867417|FG002|Open-label Phase|Pregnancy|1|||
124791477|NCT01340872|448867418|FG003|Open-label Phase|Pregnancy|0|||
124791478|NCT01340872|448867415|FG000|Open-label Phase|Adverse Event|0|||
124791479|NCT01340872|448867416|FG001|Open-label Phase|Adverse Event|0|||
124791480|NCT01340872|448867417|FG002|Open-label Phase|Adverse Event|8|||
124791481|NCT01340872|448867418|FG003|Open-label Phase|Adverse Event|4|||
124791482|NCT01340872|448867415|FG000|Open-label Phase|Withdrawal by Subject|0|||
124791483|NCT01340872|448867416|FG001|Open-label Phase|Withdrawal by Subject|0|||
124791484|NCT01340872|448867417|FG002|Open-label Phase|Withdrawal by Subject|1|||
124791485|NCT01340872|448867418|FG003|Open-label Phase|Withdrawal by Subject|6|||
124791486|NCT01340872|448867415|FG000|Open-label Phase|Worsening of IBD|0|||
124791487|NCT01340872|448867416|FG001|Open-label Phase|Worsening of IBD|0|||
124791488|NCT01340872|448867417|FG002|Open-label Phase|Worsening of IBD|1|||
124791489|NCT01340872|448867418|FG003|Open-label Phase|Worsening of IBD|0|||
124791490|NCT03603509|448867419|FG000|Overall Study|Lost to Follow-up|3|||
124791491|NCT03603509|448867420|FG001|Overall Study|Lost to Follow-up|4|||
124791492|NCT01258998|448867423|FG000|Overall Study|Ineligible|1|||
124791493|NCT01143389|448867426|FG000|Overall Study|Lost to Follow-up|26|||
124791494|NCT01143389|448867427|FG001|Overall Study|Lost to Follow-up|25|||
124791495|NCT04966910|448867428|FG000|Baseline|Participant did not complete measure|0|||
124791496|NCT04966910|448867429|FG001|Baseline|Participant did not complete measure|0|||
124791497|NCT04966910|448867430|FG002|Baseline|Participant did not complete measure|1|||
124791498|NCT04966910|448867431|FG003|Baseline|Participant did not complete measure|0|||
124791499|NCT04966910|448867428|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
124791500|NCT04966910|448867429|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
124791501|NCT04966910|448867430|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
124791502|NCT04966910|448867431|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
124791503|NCT04966910|448867428|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
124791504|NCT04966910|448867429|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
124791505|NCT04966910|448867430|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
124791506|NCT04966910|448867431|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
124791507|NCT04966910|448867428|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
124791508|NCT04966910|448867429|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
124791509|NCT04966910|448867430|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
124791510|NCT04966910|448867431|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
124791511|NCT02276027|448867433|FG000|Overall Study|Death|1|||
124791512|NCT02276027|448867434|FG001|Overall Study|Death|0|||
124791513|NCT02276027|448867435|FG002|Overall Study|Death|0|||
124791514|NCT02276027|448867436|FG003|Overall Study|Death|2|||
124791515|NCT02276027|448867433|FG000|Overall Study|Physician Decision|0|||
124791516|NCT02276027|448867434|FG001|Overall Study|Physician Decision|0|||
124791517|NCT02276027|448867435|FG002|Overall Study|Physician Decision|0|||
124791518|NCT02276027|448867436|FG003|Overall Study|Physician Decision|1|||
124791519|NCT02276027|448867433|FG000|Overall Study|Progressive disease|1|||
124791520|NCT02276027|448867434|FG001|Overall Study|Progressive disease|13|||
124791521|NCT02276027|448867435|FG002|Overall Study|Progressive disease|12|||
124791522|NCT02276027|448867436|FG003|Overall Study|Progressive disease|14|||
124791523|NCT02276027|448867433|FG000|Overall Study|Subject/guardian decision|0|||
124791524|NCT02276027|448867434|FG001|Overall Study|Subject/guardian decision|1|||
124791525|NCT02276027|448867435|FG002|Overall Study|Subject/guardian decision|0|||
124791526|NCT02276027|448867436|FG003|Overall Study|Subject/guardian decision|3|||
124791527|NCT02276027|448867433|FG000|Overall Study|Adverse Event|0|||
124791528|NCT02276027|448867434|FG001|Overall Study|Adverse Event|2|||
124791529|NCT02276027|448867435|FG002|Overall Study|Adverse Event|8|||
124791530|NCT02276027|448867436|FG003|Overall Study|Adverse Event|2|||
124791531|NCT03224598|448867437|FG000|Overall Study|Lost to Follow-up|0|||
124791532|NCT03224598|448867438|FG001|Overall Study|Lost to Follow-up|2|||
124791533|NCT03224598|448867439|FG002|Overall Study|Lost to Follow-up|0|||
124791534|NCT03224598|448867437|FG000|Overall Study|Other|0|||
124791535|NCT03224598|448867438|FG001|Overall Study|Other|1|||
124791536|NCT03224598|448867439|FG002|Overall Study|Other|0|||
124791537|NCT01527357|448867449|FG000|Overall Study|Death|8|||
124791538|NCT01527357|448867450|FG001|Overall Study|Death|2|||
124791539|NCT01527357|448867449|FG000|Overall Study|Lost to Follow-up|6|||
124791540|NCT01527357|448867450|FG001|Overall Study|Lost to Follow-up|4|||
124791541|NCT01527357|448867449|FG000|Overall Study|Withdrew Consent|1|||
124791542|NCT01527357|448867450|FG001|Overall Study|Withdrew Consent|1|||
124791543|NCT01527357|448867449|FG000|Overall Study|Non-compliance|0|||
124791544|NCT01527357|448867450|FG001|Overall Study|Non-compliance|1|||
124791545|NCT01527357|448867449|FG000|Overall Study|No Day 29 Visit|0|||
124791546|NCT01527357|448867450|FG001|Overall Study|No Day 29 Visit|1|||
124791547|NCT01527357|448867449|FG000|Overall Study|Did Not Receive Treatment|2|||
124791548|NCT01527357|448867450|FG001|Overall Study|Did Not Receive Treatment|0|||
124791549|NCT02446171|448867451|FG000|Overall Study|Withdrawal by Subject|0|||
124791550|NCT02446171|448867452|FG001|Overall Study|Withdrawal by Subject|0|||
124791551|NCT02446171|448867453|FG002|Overall Study|Withdrawal by Subject|2|||
124791552|NCT02446171|448867454|FG003|Overall Study|Withdrawal by Subject|0|||
124791553|NCT04531462|448867455|FG000|Overall Study|Withdrawal by Subject|3|||
124791554|NCT04531462|448867456|FG001|Overall Study|Withdrawal by Subject|1|||
124791555|NCT04531462|448867455|FG000|Overall Study|Adverse Event|3|||
124791556|NCT04531462|448867456|FG001|Overall Study|Adverse Event|3|||
124791557|NCT00504582|448867457|FG000|Overall Study|Lost to Follow-up|1|||
124791558|NCT00504582|448867458|FG001|Overall Study|Lost to Follow-up|0|||
124791559|NCT00504582|448867459|FG002|Overall Study|Lost to Follow-up|0|||
124791560|NCT02292784|448867462|FG000|Overall Study|Lost to Follow-up|1|||
124791561|NCT02292784|448867463|FG001|Overall Study|Lost to Follow-up|17|||
124791562|NCT02292784|448867464|FG002|Overall Study|Lost to Follow-up|18|||
124791563|NCT02292784|448867462|FG000|Overall Study|Withdrawal by Subject|0|||
124791564|NCT02292784|448867463|FG001|Overall Study|Withdrawal by Subject|3|||
124791565|NCT02292784|448867464|FG002|Overall Study|Withdrawal by Subject|3|||
124791566|NCT00348933|448867465|FG000|Overall Study|Withdrawal by Subject|10|||
124791567|NCT00348933|448867465|FG000|Overall Study|Lost to Follow-up|6|||
124791568|NCT00348933|448867465|FG000|Overall Study|Protocol Violation|2|||
124791569|NCT00348933|448867465|FG000|Overall Study|Adverse Event|7|||
124791570|NCT01264081|448867466|FG000|Participants Screened|Screening failures|30|||
124791571|NCT01264081|448867466|FG000|Started Treatment|Withdrawal by Subject|1|||
124791572|NCT01264081|448867466|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
124791573|NCT01489111|448867467|FG000|Overall Study|Withdrawal criterion|1|||
124791574|NCT00134784|448867468|FG000|Overall Study|Withdrawal by Subject|2|||
124791575|NCT00134784|448867469|FG001|Overall Study|Withdrawal by Subject|2|||
124791576|NCT00134784|448867470|FG002|Overall Study|Withdrawal by Subject|2|||
124791577|NCT00134784|448867471|FG003|Overall Study|Withdrawal by Subject|1|||
124791578|NCT00730028|448867476|FG000|Overall Study|Adverse Event|23|||
124791579|NCT00730028|448867477|FG001|Overall Study|Adverse Event|26|||
124791580|NCT00730028|448867478|FG002|Overall Study|Adverse Event|16|||
124791581|NCT00730028|448867479|FG003|Overall Study|Adverse Event|20|||
124791582|NCT00730028|448867480|FG004|Overall Study|Adverse Event|43|||
124791583|NCT00730028|448867476|FG000|Overall Study|Lost to Follow-up|13|||
124791584|NCT00730028|448867477|FG001|Overall Study|Lost to Follow-up|26|||
124791585|NCT00730028|448867478|FG002|Overall Study|Lost to Follow-up|22|||
124791586|NCT00730028|448867479|FG003|Overall Study|Lost to Follow-up|26|||
124791587|NCT00730028|448867480|FG004|Overall Study|Lost to Follow-up|25|||
124791588|NCT00730028|448867476|FG000|Overall Study|Protocol Violation|6|||
124791589|NCT00730028|448867477|FG001|Overall Study|Protocol Violation|1|||
124791590|NCT00730028|448867478|FG002|Overall Study|Protocol Violation|1|||
124791591|NCT00730028|448867479|FG003|Overall Study|Protocol Violation|2|||
124791592|NCT00730028|448867480|FG004|Overall Study|Protocol Violation|0|||
124791593|NCT00730028|448867476|FG000|Overall Study|Withdrawal by Subject|9|||
124791594|NCT00730028|448867477|FG001|Overall Study|Withdrawal by Subject|5|||
124791595|NCT00730028|448867478|FG002|Overall Study|Withdrawal by Subject|4|||
124791596|NCT00730028|448867479|FG003|Overall Study|Withdrawal by Subject|5|||
124791597|NCT00730028|448867480|FG004|Overall Study|Withdrawal by Subject|9|||
124791598|NCT00730028|448867476|FG000|Overall Study|Physician Decision|3|||
124791599|NCT00730028|448867477|FG001|Overall Study|Physician Decision|3|||
124791600|NCT00730028|448867478|FG002|Overall Study|Physician Decision|2|||
124791601|NCT00730028|448867479|FG003|Overall Study|Physician Decision|3|||
124791602|NCT00730028|448867480|FG004|Overall Study|Physician Decision|2|||
124791603|NCT00730028|448867476|FG000|Overall Study|Treatment Failure|5|||
125295220|NCT02723175|450707831|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
125295221|NCT02723175|450707832|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
125295222|NCT02723175|450707831|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
124791604|NCT00730028|448867477|FG001|Overall Study|Treatment Failure|5|||
124791605|NCT00730028|448867478|FG002|Overall Study|Treatment Failure|0|||
124791606|NCT00730028|448867479|FG003|Overall Study|Treatment Failure|0|||
124791607|NCT00730028|448867480|FG004|Overall Study|Treatment Failure|1|||
124791608|NCT00730028|448867476|FG000|Overall Study|Randomization Error|1|||
124791609|NCT00730028|448867477|FG001|Overall Study|Randomization Error|0|||
124791610|NCT00730028|448867478|FG002|Overall Study|Randomization Error|0|||
124791611|NCT00730028|448867479|FG003|Overall Study|Randomization Error|0|||
124791612|NCT00730028|448867480|FG004|Overall Study|Randomization Error|2|||
124791613|NCT03811093|448867481|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
124791614|NCT03811093|448867482|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
124791615|NCT03811093|448867481|FG000|Overall Study|Unable to measure body fat percentage|2|||
124791616|NCT03811093|448867482|FG001|Overall Study|Unable to measure body fat percentage|0|||
124791617|NCT00464490|448867483|FG000|Overall Study|Physician Decision|11|||
124791618|NCT00464490|448867484|FG001|Overall Study|Physician Decision|11|||
124791619|NCT03188042|448867485|FG000|Overall Study|Withdrawal by Subject|1|||
124791620|NCT03188042|448867486|FG001|Overall Study|Withdrawal by Subject|1|||
124791621|NCT03565367|448867490|FG000|Overall Study|No scan due to technical issues|4|||
124791622|NCT03565367|448867491|FG001|Overall Study|No scan due to technical issues|0|||
124791623|NCT01227824|448867494|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
124791624|NCT01227824|448867495|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
124791625|NCT01227824|448867496|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
124791626|NCT01227824|448867494|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
124791627|NCT01227824|448867495|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
124791628|NCT01227824|448867496|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
124791629|NCT01227824|448867494|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
124791630|NCT01227824|448867495|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
124791631|NCT01227824|448867496|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
124791632|NCT01227824|448867494|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
124791633|NCT01227824|448867495|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
124791634|NCT01227824|448867496|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
124791635|NCT01227824|448867494|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
124791636|NCT01227824|448867495|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
124791637|NCT01227824|448867496|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
124791638|NCT01227824|448867494|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
124791639|NCT01227824|448867495|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
124791640|NCT01227824|448867496|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
124791641|NCT01227824|448867494|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
124791642|NCT01227824|448867495|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
124791643|NCT01227824|448867496|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
124791644|NCT01227824|448867494|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
124791645|NCT01227824|448867495|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
124791646|NCT01227824|448867496|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
124791647|NCT01227824|448867494|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
124791648|NCT01227824|448867495|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
124791649|NCT01227824|448867496|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
124791650|NCT01227824|448867494|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
124791651|NCT01227824|448867495|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
124791652|NCT01227824|448867496|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
124791653|NCT01227824|448867494|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
124791654|NCT01227824|448867495|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
124791655|NCT01227824|448867496|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
124791656|NCT01227824|448867494|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
124791657|NCT01227824|448867495|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
124791658|NCT01227824|448867496|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
124791659|NCT01227824|448867494|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
124791660|NCT01227824|448867495|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
124791661|NCT01227824|448867496|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
124791662|NCT01227824|448867494|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
124791663|NCT01227824|448867495|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
124791664|NCT01227824|448867496|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
124791665|NCT01227824|448867494|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
124791666|NCT01227824|448867495|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
124791667|NCT01227824|448867496|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
124791668|NCT02395302|448867499|FG000|Overall Study|Screen Failure|3|||
124791669|NCT02395302|448867499|FG000|Overall Study|Run In Failure|7|||
124791670|NCT02395302|448867499|FG000|Overall Study|Withdrawal by Subject|2|||
124791671|NCT02395302|448867499|FG000|Overall Study|Physician Decision|2|||
124791672|NCT01306929|448867500|FG000|Overall Study|Withdrawal by Subject|23|||
124791673|NCT01306929|448867500|FG000|Overall Study|Adverse Event|21|||
124791674|NCT01306929|448867500|FG000|Overall Study|Physician Decision|13|||
124791675|NCT01306929|448867500|FG000|Overall Study|Death|8|||
124791676|NCT01306929|448867500|FG000|Overall Study|Withdrawal by parent/guardian|5|||
124791677|NCT01306929|448867500|FG000|Overall Study|Protocol Violation|3|||
124791678|NCT01306929|448867500|FG000|Overall Study|Non-compliance with study drug|2|||
124791679|NCT01306929|448867500|FG000|Overall Study|Lost to Follow-up|2|||
124791680|NCT01306929|448867500|FG000|Overall Study|Various|17|||
124791681|NCT00710762|448867503|FG000|Overall Study|Progressive disease|27|||
124791682|NCT00710762|448867504|FG001|Overall Study|Progressive disease|30|||
124791683|NCT00710762|448867503|FG000|Overall Study|Adverse Event other disease worsening|2|||
124791684|NCT00710762|448867504|FG001|Overall Study|Adverse Event other disease worsening|1|||
124791685|NCT00710762|448867503|FG000|Overall Study|Other Adverse Event|7|||
124791686|NCT00710762|448867504|FG001|Overall Study|Other Adverse Event|7|||
124791687|NCT00710762|448867503|FG000|Overall Study|Lost to Follow-up|1|||
124791688|NCT00710762|448867504|FG001|Overall Study|Lost to Follow-up|0|||
124791689|NCT00710762|448867503|FG000|Overall Study|Reason other than listed above|2|||
124791690|NCT00710762|448867504|FG001|Overall Study|Reason other than listed above|2|||
124791691|NCT00495040|448867505|FG000|Overall Study|Withdrawal by Subject|3|||
124791692|NCT01892384|448867509|FG000|Overall Study|Withdrawal by Subject|1|||
124791693|NCT01892384|448867510|FG001|Overall Study|Withdrawal by Subject|1|||
124791694|NCT01892384|448867511|FG002|Overall Study|Withdrawal by Subject|0|||
124791695|NCT01892384|448867512|FG003|Overall Study|Withdrawal by Subject|0|||
124791696|NCT00592774|448867513|FG000|Overall Study|Adverse Event|5|||
124791697|NCT00592774|448867514|FG001|Overall Study|Adverse Event|19|||
124791698|NCT00592774|448867515|FG002|Overall Study|Adverse Event|2|||
124791699|NCT00592774|448867516|FG003|Overall Study|Adverse Event|14|||
124791700|NCT00592774|448867517|FG004|Overall Study|Adverse Event|8|||
124791701|NCT00592774|448867513|FG000|Overall Study|Protocol Violation|0|||
124791702|NCT00592774|448867514|FG001|Overall Study|Protocol Violation|1|||
124791703|NCT00592774|448867515|FG002|Overall Study|Protocol Violation|0|||
124791704|NCT00592774|448867516|FG003|Overall Study|Protocol Violation|0|||
124791705|NCT00592774|448867517|FG004|Overall Study|Protocol Violation|1|||
124791706|NCT00592774|448867513|FG000|Overall Study|Withdrawal by Subject|3|||
124791707|NCT00592774|448867514|FG001|Overall Study|Withdrawal by Subject|7|||
124791708|NCT00592774|448867515|FG002|Overall Study|Withdrawal by Subject|0|||
124791709|NCT00592774|448867516|FG003|Overall Study|Withdrawal by Subject|0|||
124791710|NCT00592774|448867517|FG004|Overall Study|Withdrawal by Subject|0|||
124791711|NCT00592774|448867513|FG000|Overall Study|Lack of Efficacy|3|||
124791712|NCT00592774|448867514|FG001|Overall Study|Lack of Efficacy|3|||
124791713|NCT00592774|448867515|FG002|Overall Study|Lack of Efficacy|0|||
124791714|NCT00592774|448867516|FG003|Overall Study|Lack of Efficacy|0|||
124791715|NCT00592774|448867517|FG004|Overall Study|Lack of Efficacy|2|||
124791716|NCT00592774|448867513|FG000|Overall Study|Physician Decision|0|||
124791717|NCT00592774|448867514|FG001|Overall Study|Physician Decision|1|||
124791718|NCT00592774|448867515|FG002|Overall Study|Physician Decision|1|||
124791719|NCT00592774|448867516|FG003|Overall Study|Physician Decision|0|||
124791720|NCT00592774|448867517|FG004|Overall Study|Physician Decision|1|||
124791721|NCT00592774|448867513|FG000|Overall Study|Other|0|||
124791722|NCT00592774|448867514|FG001|Overall Study|Other|1|||
124791723|NCT00592774|448867515|FG002|Overall Study|Other|1|||
124791724|NCT00592774|448867516|FG003|Overall Study|Other|0|||
124791725|NCT00592774|448867517|FG004|Overall Study|Other|2|||
124791726|NCT01700439|448867518|FG000|Overall Study|Lost to Follow-up|47|||
124791727|NCT01700439|448867518|FG000|Overall Study|Withdrawal by Subject|183|||
124791728|NCT01700439|448867518|FG000|Overall Study|Death|186|||
124791729|NCT00621621|448867523|FG000|Overall Study|Subjects were exited at EP study|30|||
124791730|NCT00621621|448867524|FG001|Overall Study|Subjects were exited at EP study|0|||
124791731|NCT00608569|448867530|FG000|Overall Study|Death|4|||
124791732|NCT00608569|448867531|FG001|Overall Study|Death|3|||
124791733|NCT00608569|448867530|FG000|Overall Study|Lost to Follow-up|4|||
124791734|NCT00608569|448867531|FG001|Overall Study|Lost to Follow-up|5|||
124791735|NCT00608569|448867530|FG000|Overall Study|Withdrawal by Subject|1|||
124791736|NCT00608569|448867531|FG001|Overall Study|Withdrawal by Subject|0|||
124791737|NCT00608569|448867530|FG000|Overall Study|Adverse Event|1|||
124791738|NCT00608569|448867531|FG001|Overall Study|Adverse Event|0|||
124791739|NCT00608569|448867530|FG000|Overall Study|Unable to adhere with study requirements|0|||
124791740|NCT00608569|448867531|FG001|Overall Study|Unable to adhere with study requirements|1|||
124791741|NCT00053898|448867538|FG000|Overall Study|No follow-up data from any source|9|||
124791742|NCT00053898|448867539|FG001|Overall Study|No follow-up data from any source|12|||
124791743|NCT00053898|448867538|FG000|Overall Study|Follow-up from telephone contact only|5|||
124791744|NCT00053898|448867539|FG001|Overall Study|Follow-up from telephone contact only|1|||
124791745|NCT00545129|448867542|FG000|Overall Study|Lack of Efficacy|2|||
124791746|NCT00545129|448867543|FG001|Overall Study|Lack of Efficacy|5|||
124791747|NCT00545129|448867542|FG000|Overall Study|Death|2|||
124791748|NCT00545129|448867543|FG001|Overall Study|Death|1|||
124791749|NCT00545129|448867542|FG000|Overall Study|Adverse Event|1|||
124791750|NCT00545129|448867543|FG001|Overall Study|Adverse Event|1|||
124791751|NCT00545129|448867542|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
124791752|NCT00545129|448867543|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
124791753|NCT00545129|448867542|FG000|Overall Study|Other|3|||
124791754|NCT00545129|448867543|FG001|Overall Study|Other|3|||
124791755|NCT01894568|448867544|FG000|Overall Study|Adverse Event|2|||
124791756|NCT01894568|448867545|FG001|Overall Study|Adverse Event|3|||
124791757|NCT01894568|448867544|FG000|Overall Study|Protocol required discontinuation|2|||
124791758|NCT01894568|448867545|FG001|Overall Study|Protocol required discontinuation|1|||
124791759|NCT01894568|448867544|FG000|Overall Study|Withdrawal by Subject|5|||
124791760|NCT01894568|448867545|FG001|Overall Study|Withdrawal by Subject|5|||
124791761|NCT01894568|448867544|FG000|Overall Study|Physician Decision|1|||
124791762|NCT01894568|448867545|FG001|Overall Study|Physician Decision|0|||
124791763|NCT01894568|448867544|FG000|Overall Study|Lost to Follow-up|0|||
124791764|NCT01894568|448867545|FG001|Overall Study|Lost to Follow-up|1|||
124791765|NCT01514370|448867547|FG000|Overall Study|Protocol Violation|2|||
124791766|NCT01514370|448867548|FG001|Overall Study|Protocol Violation|3|||
124791767|NCT01514370|448867547|FG000|Overall Study|Lost to Follow-up|0|||
124791768|NCT01514370|448867548|FG001|Overall Study|Lost to Follow-up|2|||
124791769|NCT01514370|448867547|FG000|Overall Study|Withdrawal by Subject|2|||
124791770|NCT01514370|448867548|FG001|Overall Study|Withdrawal by Subject|1|||
124791771|NCT01514370|448867547|FG000|Overall Study|Adverse Event|1|||
124791772|NCT01514370|448867548|FG001|Overall Study|Adverse Event|3|||
124791773|NCT01514370|448867547|FG000|Overall Study|Other|6|||
124791774|NCT01514370|448867548|FG001|Overall Study|Other|7|||
124791775|NCT01551420|448867549|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
124791776|NCT01551420|448867550|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
124791777|NCT01551420|448867549|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
124791778|NCT01551420|448867550|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
124791779|NCT01551420|448867549|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
124791780|NCT01551420|448867550|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
124791781|NCT01551420|448867549|FG000|Screened for Part B Eligibility|Declined participation|8|||
124791782|NCT01551420|448867550|FG001|Screened for Part B Eligibility|Declined participation|1|||
124791783|NCT01551420|448867549|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
124791784|NCT01551420|448867550|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
124791785|NCT01551420|448867549|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
124791786|NCT01551420|448867550|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
124791787|NCT01551420|448867549|FG000|Home Use (Part B)|Withdrawal by staff|0|||
124791788|NCT01551420|448867550|FG001|Home Use (Part B)|Withdrawal by staff|1|||
124791789|NCT03353740|448867552|FG000|Overall Study|Images for these participants not viable|52|||
124791790|NCT02232880|448867553|FG000|Overall Study|study stopped prior to randomization|1|||
124791791|NCT02545543|448867554|FG000|Overall Study|Lost to Follow-up|67|||
124791792|NCT02545543|448867555|FG001|Overall Study|Lost to Follow-up|25|||
124791793|NCT02545543|448867554|FG000|Overall Study|Physician Decision|3|||
124791794|NCT02545543|448867555|FG001|Overall Study|Physician Decision|0|||
124791795|NCT02545543|448867554|FG000|Overall Study|Withdrawal by Subject|9|||
124791796|NCT02545543|448867555|FG001|Overall Study|Withdrawal by Subject|8|||
124791797|NCT02545543|448867554|FG000|Overall Study|Noncomplaince|1|||
124791798|NCT02545543|448867555|FG001|Overall Study|Noncomplaince|0|||
124791799|NCT02545543|448867554|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
124791800|NCT02545543|448867555|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
124791801|NCT01395784|448867556|FG000|Overall Study|Lost to Follow-up|7|||
124791802|NCT01395784|448867556|FG000|Overall Study|Withdrawal by Subject|3|||
124791803|NCT01395784|448867556|FG000|Overall Study|Physician Decision|5|||
124791804|NCT04268823|448867557|FG000|Overall Study|Adverse Event|1|||
124791805|NCT04268823|448867558|FG001|Overall Study|Adverse Event|0|||
124791806|NCT04268823|448867557|FG000|Overall Study|Participant Decision|1|||
124791807|NCT04268823|448867558|FG001|Overall Study|Participant Decision|0|||
124791808|NCT02055365|448869474|FG000|Overall Study|Prematurely Withdrawn|1|||
124791809|NCT02882152|448869475|FG000|Overall Study|Lost to Follow-up|1|||
124791810|NCT02882152|448869476|FG001|Overall Study|Lost to Follow-up|0|||
124791811|NCT01343823|448869479|FG000|Overall Study|Study Terminated|1|||
124791812|NCT01343823|448869480|FG001|Overall Study|Study Terminated|0|||
124791813|NCT01343823|448869481|FG002|Overall Study|Study Terminated|0|||
124791814|NCT01343823|448869482|FG003|Overall Study|Study Terminated|1|||
124791815|NCT01343823|448869479|FG000|Overall Study|Withdrawal by Subject|1|||
124791816|NCT01343823|448869480|FG001|Overall Study|Withdrawal by Subject|0|||
124791817|NCT01343823|448869481|FG002|Overall Study|Withdrawal by Subject|0|||
124791818|NCT01343823|448869482|FG003|Overall Study|Withdrawal by Subject|0|||
124791819|NCT00923364|448869483|FG000|Overall Study|Death|3|||
124791820|NCT00923364|448869484|FG001|Overall Study|Death|0|||
124791821|NCT00923364|448869483|FG000|Overall Study|Did not go to transplant|1|||
124791822|NCT00923364|448869484|FG001|Overall Study|Did not go to transplant|0|||
124791823|NCT01752036|448869485|FG000|Overall Study|Death|2|||
124791824|NCT04352127|448869486|FG000|Overall Study|Unable to obtain readings|4|||
124791825|NCT04352127|448869487|FG001|Overall Study|Unable to obtain readings|1|||
124791826|NCT01437995|448869488|FG000|Overall Study|Lost to Follow-up|11|||
124791827|NCT01437995|448869489|FG001|Overall Study|Lost to Follow-up|18|||
124791828|NCT01437995|448869490|FG002|Overall Study|Lost to Follow-up|20|||
124791829|NCT05338671|448869491|FG000|Overall Study|Lost to Follow-up|2|||
124791830|NCT05338671|448869492|FG001|Overall Study|Lost to Follow-up|2|||
124791831|NCT05338671|448869491|FG000|Overall Study|Root canal completed in a single visit|1|||
124791832|NCT05338671|448869492|FG001|Overall Study|Root canal completed in a single visit|0|||
124791833|NCT04456673|448869493|FG000|Overall Study|Adverse Event|7|||
124791834|NCT04456673|448869494|FG001|Overall Study|Adverse Event|14|||
124791835|NCT04456673|448869493|FG000|Overall Study|Poor compliance to protocol|1|||
124791836|NCT04456673|448869494|FG001|Overall Study|Poor compliance to protocol|0|||
124791837|NCT04456673|448869493|FG000|Overall Study|Withdrawal by Subject|31|||
124791838|NCT04456673|448869494|FG001|Overall Study|Withdrawal by Subject|23|||
124791839|NCT04456673|448869493|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
124791840|NCT04456673|448869494|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
124791841|NCT04391049|448869495|FG000|Overall Study|Protocol Violation|1|||
124791842|NCT03874429|448869496|FG000|Overall Study|Adverse Event|2|||
124791843|NCT03874429|448869497|FG001|Overall Study|Adverse Event|2|||
124791844|NCT03874429|448869496|FG000|Overall Study|Lack of Efficacy|0|||
124791845|NCT03874429|448869497|FG001|Overall Study|Lack of Efficacy|1|||
124791846|NCT03874429|448869496|FG000|Overall Study|Covid-19 pandemic|4|||
124791847|NCT03874429|448869497|FG001|Overall Study|Covid-19 pandemic|2|||
124791848|NCT02160002|448869498|FG000|Overall Study|Withdrawal by Subject|2|||
124791849|NCT02160002|448869499|FG001|Overall Study|Withdrawal by Subject|1|||
124791850|NCT00246571|448869500|FG000|Overall Study|Adverse Event|7|||
124791851|NCT00246571|448869501|FG001|Overall Study|Adverse Event|0|||
124791852|NCT00246571|448869500|FG000|Overall Study|Protocol Violation|0|||
124791853|NCT00246571|448869501|FG001|Overall Study|Protocol Violation|1|||
124791854|NCT00246571|448869500|FG000|Overall Study|Withdrawal by Subject|2|||
124791855|NCT00246571|448869501|FG001|Overall Study|Withdrawal by Subject|3|||
124791856|NCT00246571|448869500|FG000|Overall Study|Lack of Efficacy|84|||
124791857|NCT00246571|448869501|FG001|Overall Study|Lack of Efficacy|21|||
124791858|NCT00246571|448869500|FG000|Overall Study|Death|17|||
124791859|NCT00246571|448869501|FG001|Overall Study|Death|3|||
124791860|NCT00246571|448869500|FG000|Overall Study|Sponsor|0|||
124791861|NCT00246571|448869501|FG001|Overall Study|Sponsor|1|||
124791862|NCT00246571|448869500|FG000|Overall Study|Did not meet entrance criteria|2|||
124791863|NCT00246571|448869501|FG001|Overall Study|Did not meet entrance criteria|1|||
124791864|NCT00246571|448869500|FG000|Overall Study|Laboratory abnormalities|1|||
124791865|NCT00246571|448869501|FG001|Overall Study|Laboratory abnormalities|0|||
124791866|NCT00246571|448869500|FG000|Overall Study|Crossover participants|0|||
124791867|NCT00246571|448869501|FG001|Overall Study|Crossover participants|74|||
124791868|NCT04896229|448869502|FG000|Overall Study|Lost to Follow-up|113|||
124791869|NCT04896229|448869503|FG001|Overall Study|Lost to Follow-up|113|||
124791870|NCT00159822|448869506|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
124791871|NCT00159822|448869506|FG000|Voriconazole Treatment Period|Adverse Event|9|||
124791872|NCT00159822|448869506|FG000|Voriconazole Treatment Period|Death|4|||
124791873|NCT00159822|448869506|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
124791874|NCT00159822|448869506|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
124791875|NCT00159822|448869506|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
124791876|NCT00159822|448869506|FG000|Post-treatment Follow-up Period|Death|1|||
124791877|NCT00159822|448869506|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
124791878|NCT00159822|448869506|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
124791879|NCT00713310|448869507|FG000|Overall Study|Adverse Event|5|||
124791880|NCT00713310|448869508|FG001|Overall Study|Adverse Event|2|||
124791881|NCT00713310|448869507|FG000|Overall Study|Lack of Efficacy|0|||
124791882|NCT00713310|448869508|FG001|Overall Study|Lack of Efficacy|2|||
124791883|NCT00713310|448869507|FG000|Overall Study|Withdrawal by Subject|0|||
124791884|NCT00713310|448869508|FG001|Overall Study|Withdrawal by Subject|2|||
124791885|NCT00275821|448869510|FG000|Overall Study|Adverse Event|4|||
124791886|NCT00275821|448869511|FG001|Overall Study|Adverse Event|12|||
124791887|NCT00275821|448869512|FG002|Overall Study|Adverse Event|5|||
124791888|NCT00275821|448869510|FG000|Overall Study|Administrative problems|3|||
124791889|NCT00275821|448869511|FG001|Overall Study|Administrative problems|4|||
124791890|NCT00275821|448869512|FG002|Overall Study|Administrative problems|4|||
124791891|NCT00275821|448869510|FG000|Overall Study|Withdrawal by Subject|0|||
124791892|NCT00275821|448869511|FG001|Overall Study|Withdrawal by Subject|2|||
124791893|NCT00275821|448869512|FG002|Overall Study|Withdrawal by Subject|1|||
124791894|NCT00275821|448869510|FG000|Overall Study|Lost to Follow-up|0|||
125295223|NCT02723175|450707832|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
125295224|NCT00257660|450707835|FG000|Overall Study|Lack of Efficacy|5|||
125295225|NCT00257660|450707836|FG001|Overall Study|Lack of Efficacy|23|||
125295226|NCT00257660|450707835|FG000|Overall Study|Withdrawal by Subject|2|||
125295227|NCT00257660|450707836|FG001|Overall Study|Withdrawal by Subject|0|||
125295228|NCT00257660|450707835|FG000|Overall Study|Lost to Follow-up|1|||
124791895|NCT00275821|448869511|FG001|Overall Study|Lost to Follow-up|1|||
124791896|NCT00275821|448869512|FG002|Overall Study|Lost to Follow-up|1|||
124791897|NCT00275821|448869510|FG000|Overall Study|Death|0|||
124791898|NCT00275821|448869511|FG001|Overall Study|Death|2|||
124791899|NCT00275821|448869512|FG002|Overall Study|Death|1|||
124791900|NCT00275821|448869510|FG000|Overall Study|Lack of Efficacy|2|||
124791901|NCT00275821|448869511|FG001|Overall Study|Lack of Efficacy|1|||
124791902|NCT00275821|448869512|FG002|Overall Study|Lack of Efficacy|0|||
124791903|NCT00275821|448869510|FG000|Overall Study|Protocol Violation|5|||
124791904|NCT00275821|448869511|FG001|Overall Study|Protocol Violation|1|||
124791905|NCT00275821|448869512|FG002|Overall Study|Protocol Violation|0|||
124791906|NCT00329901|448869513|FG000|Overall Study|Withdrawal by Subject|4|||
125295229|NCT00257660|450707836|FG001|Overall Study|Lost to Follow-up|0|||
124791907|NCT00329901|448869514|FG001|Overall Study|Withdrawal by Subject|3|||
124791908|NCT00329901|448869515|FG002|Overall Study|Withdrawal by Subject|2|||
124791909|NCT00329901|448869513|FG000|Overall Study|Lost to Follow-up|2|||
124791910|NCT00329901|448869514|FG001|Overall Study|Lost to Follow-up|0|||
124791911|NCT00329901|448869515|FG002|Overall Study|Lost to Follow-up|1|||
124791912|NCT00329901|448869513|FG000|Overall Study|Protocol Violation|1|||
124791913|NCT00329901|448869514|FG001|Overall Study|Protocol Violation|0|||
124791914|NCT00329901|448869515|FG002|Overall Study|Protocol Violation|1|||
124791915|NCT00329901|448869513|FG000|Overall Study|Unable to classify|2|||
124791916|NCT00329901|448869514|FG001|Overall Study|Unable to classify|2|||
124791917|NCT00329901|448869515|FG002|Overall Study|Unable to classify|0|||
124791918|NCT00992589|448869516|FG000|Open-Label Phase|Adverse Event|4|||
124791919|NCT00992589|448869517|FG001|Open-Label Phase|Adverse Event|0|||
124791920|NCT00992589|448869518|FG002|Open-Label Phase|Adverse Event|0|||
124791921|NCT00992589|448869519|FG003|Open-Label Phase|Adverse Event|0|||
124791922|NCT00992589|448869516|FG000|Open-Label Phase|Withdrawal by Subject|20|||
124791923|NCT00992589|448869517|FG001|Open-Label Phase|Withdrawal by Subject|0|||
124791924|NCT00992589|448869518|FG002|Open-Label Phase|Withdrawal by Subject|0|||
124791925|NCT00992589|448869519|FG003|Open-Label Phase|Withdrawal by Subject|0|||
124791926|NCT00992589|448869516|FG000|Open-Label Phase|Lost to Follow-up|1|||
124791927|NCT00992589|448869517|FG001|Open-Label Phase|Lost to Follow-up|0|||
124791928|NCT00992589|448869518|FG002|Open-Label Phase|Lost to Follow-up|0|||
124791929|NCT00992589|448869519|FG003|Open-Label Phase|Lost to Follow-up|0|||
124791930|NCT00992589|448869516|FG000|Open-Label Phase|Protocol Violation|3|||
124791931|NCT00992589|448869517|FG001|Open-Label Phase|Protocol Violation|0|||
124791932|NCT00992589|448869518|FG002|Open-Label Phase|Protocol Violation|0|||
124791933|NCT00992589|448869519|FG003|Open-Label Phase|Protocol Violation|0|||
124791934|NCT00992589|448869516|FG000|Open-Label Phase|Physician Decision|4|||
124791935|NCT00992589|448869517|FG001|Open-Label Phase|Physician Decision|0|||
124791936|NCT00992589|448869518|FG002|Open-Label Phase|Physician Decision|0|||
124791937|NCT00992589|448869519|FG003|Open-Label Phase|Physician Decision|0|||
124791938|NCT00992589|448869516|FG000|Open-Label Phase|Other|45|||
124791939|NCT00992589|448869517|FG001|Open-Label Phase|Other|0|||
124791940|NCT00992589|448869518|FG002|Open-Label Phase|Other|0|||
124791941|NCT00992589|448869519|FG003|Open-Label Phase|Other|0|||
124791942|NCT00992589|448869516|FG000|Double-Blind Phase|Adverse Event|0|||
124791943|NCT00992589|448869517|FG001|Double-Blind Phase|Adverse Event|6|||
124791944|NCT00992589|448869518|FG002|Double-Blind Phase|Adverse Event|2|||
124791945|NCT00992589|448869519|FG003|Double-Blind Phase|Adverse Event|3|||
124791946|NCT00992589|448869516|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
124791947|NCT00992589|448869517|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
124791948|NCT00992589|448869518|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
124791949|NCT00992589|448869519|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
124791950|NCT00992589|448869516|FG000|Double-Blind Phase|Lost to Follow-up|0|||
124791951|NCT00992589|448869517|FG001|Double-Blind Phase|Lost to Follow-up|0|||
124791952|NCT00992589|448869518|FG002|Double-Blind Phase|Lost to Follow-up|0|||
124791953|NCT00992589|448869519|FG003|Double-Blind Phase|Lost to Follow-up|2|||
124791954|NCT00992589|448869516|FG000|Double-Blind Phase|Other|0|||
124791955|NCT00992589|448869517|FG001|Double-Blind Phase|Other|1|||
124791956|NCT00992589|448869518|FG002|Double-Blind Phase|Other|6|||
124791957|NCT00992589|448869519|FG003|Double-Blind Phase|Other|3|||
124791958|NCT01215916|448869520|FG000|Overall Study|Progressive Disease|0|||
124791959|NCT01215916|448869521|FG001|Overall Study|Progressive Disease|2|||
124791960|NCT01215916|448869522|FG002|Overall Study|Progressive Disease|1|||
124791961|NCT01215916|448869523|FG003|Overall Study|Progressive Disease|2|||
124791962|NCT01215916|448869524|FG004|Overall Study|Progressive Disease|5|||
124791963|NCT01215916|448869525|FG005|Overall Study|Progressive Disease|4|||
124791964|NCT01215916|448869526|FG006|Overall Study|Progressive Disease|5|||
125295230|NCT00257660|450707835|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
125295231|NCT00257660|450707836|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
125295232|NCT00257660|450707835|FG000|Overall Study|No longer wanted to do blood draws|1|||
124791965|NCT01215916|448869527|FG007|Overall Study|Progressive Disease|3|||
124791966|NCT01215916|448869528|FG008|Overall Study|Progressive Disease|1|||
124791967|NCT01215916|448869520|FG000|Overall Study|Adverse Event|1|||
124791968|NCT01215916|448869521|FG001|Overall Study|Adverse Event|1|||
124791969|NCT01215916|448869522|FG002|Overall Study|Adverse Event|0|||
124791970|NCT01215916|448869523|FG003|Overall Study|Adverse Event|1|||
124791971|NCT01215916|448869524|FG004|Overall Study|Adverse Event|0|||
124791972|NCT01215916|448869525|FG005|Overall Study|Adverse Event|0|||
124791973|NCT01215916|448869526|FG006|Overall Study|Adverse Event|3|||
124791974|NCT01215916|448869527|FG007|Overall Study|Adverse Event|0|||
124791975|NCT01215916|448869528|FG008|Overall Study|Adverse Event|0|||
124791976|NCT01215916|448869520|FG000|Overall Study|Withdrawal by Subject|0|||
124791977|NCT01215916|448869521|FG001|Overall Study|Withdrawal by Subject|1|||
124791978|NCT01215916|448869522|FG002|Overall Study|Withdrawal by Subject|1|||
124791979|NCT01215916|448869523|FG003|Overall Study|Withdrawal by Subject|2|||
124791980|NCT01215916|448869524|FG004|Overall Study|Withdrawal by Subject|0|||
124791981|NCT01215916|448869525|FG005|Overall Study|Withdrawal by Subject|0|||
125295233|NCT00257660|450707836|FG001|Overall Study|No longer wanted to do blood draws|0|||
124791982|NCT01215916|448869526|FG006|Overall Study|Withdrawal by Subject|1|||
124791983|NCT01215916|448869527|FG007|Overall Study|Withdrawal by Subject|0|||
124791984|NCT01215916|448869528|FG008|Overall Study|Withdrawal by Subject|0|||
124791985|NCT01215916|448869520|FG000|Overall Study|Death|0|||
124791986|NCT01215916|448869521|FG001|Overall Study|Death|1|||
124791987|NCT01215916|448869522|FG002|Overall Study|Death|0|||
124791988|NCT01215916|448869523|FG003|Overall Study|Death|0|||
124791989|NCT01215916|448869524|FG004|Overall Study|Death|1|||
124791990|NCT01215916|448869525|FG005|Overall Study|Death|0|||
124791991|NCT01215916|448869526|FG006|Overall Study|Death|0|||
124791992|NCT01215916|448869527|FG007|Overall Study|Death|0|||
124791993|NCT01215916|448869528|FG008|Overall Study|Death|1|||
124791994|NCT01215916|448869520|FG000|Overall Study|Physician Decision|0|||
124791995|NCT01215916|448869521|FG001|Overall Study|Physician Decision|0|||
124791996|NCT01215916|448869522|FG002|Overall Study|Physician Decision|1|||
124791997|NCT01215916|448869523|FG003|Overall Study|Physician Decision|1|||
124791998|NCT01215916|448869524|FG004|Overall Study|Physician Decision|0|||
124791999|NCT01215916|448869525|FG005|Overall Study|Physician Decision|0|||
124792000|NCT01215916|448869526|FG006|Overall Study|Physician Decision|0|||
124792001|NCT01215916|448869527|FG007|Overall Study|Physician Decision|0|||
124792002|NCT01215916|448869528|FG008|Overall Study|Physician Decision|0|||
124792003|NCT02142387|448869529|FG000|Overall Study|<19 years old|49|||
124792004|NCT02142387|448869530|FG001|Overall Study|<19 years old|326|||
124792005|NCT02142387|448869529|FG000|Overall Study|non-cardiac etiology|504|||
124792006|NCT02142387|448869530|FG001|Overall Study|non-cardiac etiology|3431|||
124792007|NCT02142387|448869529|FG000|Overall Study|CPR not performed|74|||
124792008|NCT02142387|448869530|FG001|Overall Study|CPR not performed|473|||
124792009|NCT02142387|448869529|FG000|Overall Study|witnessed by paramedic|139|||
124792010|NCT02142387|448869530|FG001|Overall Study|witnessed by paramedic|917|||
124792011|NCT02142387|448869529|FG000|Overall Study|incomplete data|1|||
124792012|NCT02142387|448869530|FG001|Overall Study|incomplete data|9|||
124792013|NCT02142387|448869529|FG000|Overall Study|occurred not at home|298|||
124792014|NCT02142387|448869530|FG001|Overall Study|occurred not at home|2474|||
124792015|NCT05028361|448869531|FG000|Overall Study|Withdrawal by Subject|1|||
124792016|NCT05028361|448869532|FG001|Overall Study|Withdrawal by Subject|0|||
124792017|NCT00779259|448869537|FG000|Quinine Alone|Adverse Event|2|||
124792018|NCT02047318|448869541|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
124792019|NCT02047318|448869541|FG000|Core Study Period|Adverse Event|1|||
124792020|NCT02047318|448869541|FG000|Core Study Period|Withdrawal by caregiver|3|||
124792021|NCT02047318|448869541|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
124792022|NCT02296138|448869542|FG000|Overall Study|Adverse Event|348|||
124792023|NCT02296138|448869543|FG001|Overall Study|Adverse Event|259|||
124792024|NCT02296138|448869542|FG000|Overall Study|Lack of Efficacy|59|||
124792025|NCT02296138|448869543|FG001|Overall Study|Lack of Efficacy|37|||
124792026|NCT02296138|448869542|FG000|Overall Study|Protocol Violation|35|||
124792027|NCT02296138|448869543|FG001|Overall Study|Protocol Violation|36|||
124792028|NCT02296138|448869542|FG000|Overall Study|Lost to Follow-up|9|||
124792029|NCT02296138|448869543|FG001|Overall Study|Lost to Follow-up|12|||
124792030|NCT02296138|448869542|FG000|Overall Study|Withdrawal by Subject|184|||
124792031|NCT02296138|448869543|FG001|Overall Study|Withdrawal by Subject|131|||
124792032|NCT02296138|448869542|FG000|Overall Study|Not Treated|1|||
124792033|NCT02296138|448869543|FG001|Overall Study|Not Treated|1|||
124792034|NCT02296138|448869542|FG000|Overall Study|Patients with data irregularities|10|||
124792035|NCT02296138|448869543|FG001|Overall Study|Patients with data irregularities|11|||
124792036|NCT02296138|448869542|FG000|Overall Study|Other than specified|15|||
124792037|NCT02296138|448869543|FG001|Overall Study|Other than specified|13|||
124792038|NCT00711516|448869544|FG000|Overall Study|Adverse Event|1|||
124792039|NCT00711516|448869545|FG001|Overall Study|Adverse Event|1|||
124792040|NCT00711516|448869544|FG000|Overall Study|Withdrawal by Subject|0|||
124792041|NCT00711516|448869545|FG001|Overall Study|Withdrawal by Subject|1|||
124792042|NCT00711516|448869544|FG000|Overall Study|Protocol Violation|0|||
124792043|NCT00711516|448869545|FG001|Overall Study|Protocol Violation|1|||
124792044|NCT01029405|448869549|FG000|Overall Study|Withdrawal by Subject|0|||
124792045|NCT01029405|448869550|FG001|Overall Study|Withdrawal by Subject|1|||
124792046|NCT01029405|448869551|FG002|Overall Study|Withdrawal by Subject|2|||
124792047|NCT01029405|448869552|FG003|Overall Study|Withdrawal by Subject|0|||
124792048|NCT01029405|448869549|FG000|Overall Study|Protocol Violation|0|||
124792049|NCT01029405|448869550|FG001|Overall Study|Protocol Violation|0|||
124792050|NCT01029405|448869551|FG002|Overall Study|Protocol Violation|0|||
124792051|NCT01029405|448869552|FG003|Overall Study|Protocol Violation|1|||
124792052|NCT01029405|448869549|FG000|Overall Study|Adverse Event|0|||
124792053|NCT01029405|448869550|FG001|Overall Study|Adverse Event|0|||
124792054|NCT01029405|448869551|FG002|Overall Study|Adverse Event|1|||
124792055|NCT01029405|448869552|FG003|Overall Study|Adverse Event|1|||
124792056|NCT01029405|448869549|FG000|Overall Study|Lost to Follow-up|2|||
124792057|NCT01029405|448869550|FG001|Overall Study|Lost to Follow-up|1|||
124792058|NCT01029405|448869551|FG002|Overall Study|Lost to Follow-up|1|||
124792059|NCT01029405|448869552|FG003|Overall Study|Lost to Follow-up|2|||
124792060|NCT01029405|448869549|FG000|Overall Study|Other|0|||
124792061|NCT01029405|448869550|FG001|Overall Study|Other|1|||
124792062|NCT01029405|448869551|FG002|Overall Study|Other|0|||
124792063|NCT01029405|448869552|FG003|Overall Study|Other|1|||
124792064|NCT00409175|448869553|FG000|Overall Study|Adverse Event|4|||
124792065|NCT00409175|448869554|FG001|Overall Study|Adverse Event|3|||
124792066|NCT00409175|448869553|FG000|Overall Study|Withdrawal by Subject|1|||
124792067|NCT00409175|448869554|FG001|Overall Study|Withdrawal by Subject|2|||
124792068|NCT00409175|448869553|FG000|Overall Study|Negative genotype|0|||
124792069|NCT00409175|448869554|FG001|Overall Study|Negative genotype|1|||
124792070|NCT00409175|448869553|FG000|Overall Study|Liver transplantation|13|||
124792071|NCT00409175|448869554|FG001|Overall Study|Liver transplantation|13|||
124792072|NCT02108262|448869557|FG000|Overall Study|Non-compliance|0|||
124792073|NCT02108262|448869558|FG001|Overall Study|Non-compliance|2|||
124792074|NCT02108262|448869559|FG002|Overall Study|Non-compliance|1|||
124792075|NCT02108262|448869560|FG003|Overall Study|Non-compliance|1|||
124792076|NCT02108262|448869557|FG000|Overall Study|Randomized by error/screen failure|0|||
124792077|NCT02108262|448869558|FG001|Overall Study|Randomized by error/screen failure|0|||
124792078|NCT02108262|448869559|FG002|Overall Study|Randomized by error/screen failure|1|||
124792079|NCT02108262|448869560|FG003|Overall Study|Randomized by error/screen failure|0|||
124792080|NCT02108262|448869557|FG000|Overall Study|Distance to center|0|||
124792081|NCT02108262|448869558|FG001|Overall Study|Distance to center|1|||
124792082|NCT02108262|448869559|FG002|Overall Study|Distance to center|1|||
124792083|NCT02108262|448869560|FG003|Overall Study|Distance to center|0|||
124792084|NCT02108262|448869557|FG000|Overall Study|Adverse Event|0|||
124792085|NCT02108262|448869558|FG001|Overall Study|Adverse Event|11|||
124792086|NCT02108262|448869559|FG002|Overall Study|Adverse Event|6|||
124792087|NCT02108262|448869560|FG003|Overall Study|Adverse Event|12|||
124792088|NCT02108262|448869557|FG000|Overall Study|Death|0|||
124792089|NCT02108262|448869558|FG001|Overall Study|Death|2|||
124792090|NCT02108262|448869559|FG002|Overall Study|Death|2|||
124792091|NCT02108262|448869560|FG003|Overall Study|Death|1|||
124792092|NCT02108262|448869557|FG000|Overall Study|Lost to Follow-up|0|||
124792093|NCT02108262|448869558|FG001|Overall Study|Lost to Follow-up|0|||
124792094|NCT02108262|448869559|FG002|Overall Study|Lost to Follow-up|1|||
124792095|NCT02108262|448869560|FG003|Overall Study|Lost to Follow-up|0|||
124792096|NCT02108262|448869557|FG000|Overall Study|Physician Decision|0|||
124792097|NCT02108262|448869558|FG001|Overall Study|Physician Decision|0|||
124792098|NCT02108262|448869559|FG002|Overall Study|Physician Decision|2|||
124792099|NCT02108262|448869560|FG003|Overall Study|Physician Decision|0|||
124792100|NCT02108262|448869557|FG000|Overall Study|Withdrawal by Subject|0|||
124792101|NCT02108262|448869558|FG001|Overall Study|Withdrawal by Subject|7|||
124792102|NCT02108262|448869559|FG002|Overall Study|Withdrawal by Subject|3|||
124792103|NCT02108262|448869560|FG003|Overall Study|Withdrawal by Subject|4|||
124792104|NCT02108262|448869557|FG000|Overall Study|Due to key hepatic values|0|||
124792105|NCT02108262|448869558|FG001|Overall Study|Due to key hepatic values|1|||
124792106|NCT02108262|448869559|FG002|Overall Study|Due to key hepatic values|0|||
124792107|NCT02108262|448869560|FG003|Overall Study|Due to key hepatic values|0|||
124792108|NCT02108262|448869557|FG000|Overall Study|Unable to contact patient|0|||
124792109|NCT02108262|448869558|FG001|Overall Study|Unable to contact patient|3|||
124792110|NCT02108262|448869559|FG002|Overall Study|Unable to contact patient|1|||
124792111|NCT02108262|448869560|FG003|Overall Study|Unable to contact patient|2|||
124792112|NCT02108262|448869557|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
124792113|NCT02108262|448869558|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
124792114|NCT02108262|448869559|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
124792115|NCT02108262|448869560|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
124792116|NCT02108262|448869557|FG000|Overall Study|Patient did not want another infusion|0|||
124792117|NCT02108262|448869558|FG001|Overall Study|Patient did not want another infusion|3|||
124792118|NCT02108262|448869559|FG002|Overall Study|Patient did not want another infusion|3|||
124792119|NCT02108262|448869560|FG003|Overall Study|Patient did not want another infusion|2|||
124792120|NCT02108262|448869557|FG000|Overall Study|Vacation|0|||
124792121|NCT02108262|448869558|FG001|Overall Study|Vacation|1|||
124792122|NCT02108262|448869559|FG002|Overall Study|Vacation|0|||
124792123|NCT02108262|448869560|FG003|Overall Study|Vacation|0|||
124792124|NCT02108262|448869557|FG000|Overall Study|Patient decision|0|||
124792125|NCT02108262|448869558|FG001|Overall Study|Patient decision|7|||
124792126|NCT02108262|448869559|FG002|Overall Study|Patient decision|9|||
124792127|NCT02108262|448869560|FG003|Overall Study|Patient decision|14|||
124792128|NCT02108262|448869557|FG000|Overall Study|Missed IV due to pharmacy error|0|||
124792129|NCT02108262|448869558|FG001|Overall Study|Missed IV due to pharmacy error|0|||
124792130|NCT02108262|448869559|FG002|Overall Study|Missed IV due to pharmacy error|1|||
124792131|NCT02108262|448869560|FG003|Overall Study|Missed IV due to pharmacy error|0|||
124792132|NCT00761150|448869561|FG000|Open-label Period|Adverse Event|36|||
124792133|NCT00761150|448869562|FG001|Open-label Period|Adverse Event|0|||
124792134|NCT00761150|448869563|FG002|Open-label Period|Adverse Event|0|||
124792135|NCT00761150|448869561|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
124792136|NCT00761150|448869562|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
124792137|NCT00761150|448869563|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
124792138|NCT00761150|448869561|FG000|Open-label Period|Lost to Follow-up|7|||
124792139|NCT00761150|448869562|FG001|Open-label Period|Lost to Follow-up|0|||
124792140|NCT00761150|448869563|FG002|Open-label Period|Lost to Follow-up|0|||
124792141|NCT00761150|448869561|FG000|Open-label Period|Lack of Efficacy|4|||
124792142|NCT00761150|448869562|FG001|Open-label Period|Lack of Efficacy|0|||
124792143|NCT00761150|448869563|FG002|Open-label Period|Lack of Efficacy|0|||
124792144|NCT00761150|448869561|FG000|Open-label Period|Withdrawal by Subject|5|||
124792145|NCT00761150|448869562|FG001|Open-label Period|Withdrawal by Subject|0|||
124792146|NCT00761150|448869563|FG002|Open-label Period|Withdrawal by Subject|0|||
124792147|NCT00761150|448869561|FG000|Open-label Period|Noncompliance|2|||
124792148|NCT00761150|448869562|FG001|Open-label Period|Noncompliance|0|||
124792149|NCT00761150|448869563|FG002|Open-label Period|Noncompliance|0|||
124792150|NCT00761150|448869561|FG000|Open-label Period|Other|5|||
124792151|NCT00761150|448869562|FG001|Open-label Period|Other|0|||
124792152|NCT00761150|448869563|FG002|Open-label Period|Other|0|||
124792153|NCT00761150|448869561|FG000|Double-blind Period|Lack of Efficacy|0|||
124792154|NCT00761150|448869562|FG001|Double-blind Period|Lack of Efficacy|2|||
124792155|NCT00761150|448869563|FG002|Double-blind Period|Lack of Efficacy|19|||
124792156|NCT00761150|448869561|FG000|Double-blind Period|Adverse Event|0|||
124792157|NCT00761150|448869562|FG001|Double-blind Period|Adverse Event|3|||
124792158|NCT00761150|448869563|FG002|Double-blind Period|Adverse Event|3|||
124792159|NCT00761150|448869561|FG000|Double-blind Period|Withdrawal by Subject|0|||
124792160|NCT00761150|448869562|FG001|Double-blind Period|Withdrawal by Subject|3|||
124792161|NCT00761150|448869563|FG002|Double-blind Period|Withdrawal by Subject|2|||
124792162|NCT00761150|448869561|FG000|Double-blind Period|Lost to Follow-up|0|||
124792163|NCT00761150|448869562|FG001|Double-blind Period|Lost to Follow-up|2|||
124792164|NCT00761150|448869563|FG002|Double-blind Period|Lost to Follow-up|1|||
124792165|NCT00761150|448869561|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
124792166|NCT00761150|448869562|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
124792167|NCT00761150|448869563|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
124792168|NCT00761150|448869561|FG000|Double-blind Period|Noncompliance|0|||
124792169|NCT00761150|448869562|FG001|Double-blind Period|Noncompliance|1|||
124792170|NCT00761150|448869563|FG002|Double-blind Period|Noncompliance|0|||
124792171|NCT00761150|448869561|FG000|Double-blind Period|Other|0|||
124792172|NCT00761150|448869562|FG001|Double-blind Period|Other|3|||
124792173|NCT00761150|448869563|FG002|Double-blind Period|Other|3|||
124792174|NCT05463198|448869564|FG000|Overall Study|Withdrawal by Subject|19|||
124792175|NCT05463198|448869564|FG000|Overall Study|Procedure Notes Missing|18|||
124792176|NCT01860846|448869565|FG000|Overall Study|Lost to Follow-up|33|||
124792177|NCT00466687|448869568|FG000|Overall Study|Adverse Event|1|||
124792178|NCT00466687|448869568|FG000|Overall Study|Other complicating illness|3|||
124792179|NCT00466687|448869568|FG000|Overall Study|Withdrawal by Subject|1|||
124792180|NCT00466687|448869568|FG000|Overall Study|Disease progression|29|||
124792181|NCT01925989|448869569|FG000|Period 1|Sponsor Decision|1|||
124792182|NCT01925989|448869570|FG001|Period 1|Sponsor Decision|1|||
124792183|NCT01925989|448869571|FG002|Period 1|Sponsor Decision|0|||
124792184|NCT01925989|448869569|FG000|Period 1|Withdrawal by Subject|0|||
124792185|NCT01925989|448869570|FG001|Period 1|Withdrawal by Subject|1|||
124792186|NCT01925989|448869571|FG002|Period 1|Withdrawal by Subject|0|||
124792187|NCT00868517|448869576|FG000|Overall Study|Withdrawal by Subject|3|||
124792188|NCT00868517|448869577|FG001|Overall Study|Withdrawal by Subject|3|||
124792189|NCT00868517|448869578|FG002|Overall Study|Withdrawal by Subject|2|||
124792190|NCT00868517|448869576|FG000|Overall Study|Protocol Violation|1|||
124792191|NCT00868517|448869577|FG001|Overall Study|Protocol Violation|1|||
124792192|NCT00868517|448869578|FG002|Overall Study|Protocol Violation|0|||
124792193|NCT00420641|448869581|FG000|Overall Study|Adverse Event|3|||
124792194|NCT00420641|448869582|FG001|Overall Study|Adverse Event|25|||
124792195|NCT00420641|448869583|FG002|Overall Study|Adverse Event|10|||
124792196|NCT00420641|448869581|FG000|Overall Study|Lost to Follow-up|2|||
124792197|NCT00420641|448869582|FG001|Overall Study|Lost to Follow-up|4|||
125295234|NCT04109976|450707837|FG000|Overall Study|Withdrawal by Subject|1|||
124792198|NCT00420641|448869583|FG002|Overall Study|Lost to Follow-up|2|||
124792199|NCT00420641|448869581|FG000|Overall Study|Protocol Violation|8|||
124792200|NCT00420641|448869582|FG001|Overall Study|Protocol Violation|8|||
124792201|NCT00420641|448869583|FG002|Overall Study|Protocol Violation|7|||
124792202|NCT00420641|448869581|FG000|Overall Study|Withdrawal by Subject|15|||
124792203|NCT00420641|448869582|FG001|Overall Study|Withdrawal by Subject|21|||
124792204|NCT00420641|448869583|FG002|Overall Study|Withdrawal by Subject|14|||
124792205|NCT00420641|448869581|FG000|Overall Study|Lack of Efficacy|6|||
124792206|NCT00420641|448869582|FG001|Overall Study|Lack of Efficacy|5|||
124792207|NCT00420641|448869583|FG002|Overall Study|Lack of Efficacy|4|||
124792208|NCT00420641|448869581|FG000|Overall Study|Non-compliance|7|||
124792209|NCT00420641|448869582|FG001|Overall Study|Non-compliance|5|||
124792210|NCT00420641|448869583|FG002|Overall Study|Non-compliance|4|||
124792211|NCT00420641|448869581|FG000|Overall Study|Other|4|||
124792212|NCT00420641|448869582|FG001|Overall Study|Other|4|||
124792213|NCT00420641|448869583|FG002|Overall Study|Other|3|||
124792214|NCT03459690|448869585|FG000|Overall Study|Lost to Follow-up|0|||
124792215|NCT03459690|448869586|FG001|Overall Study|Lost to Follow-up|1|||
124792216|NCT03459690|448869585|FG000|Overall Study|Withdrawal by Subject|1|||
124792217|NCT03459690|448869586|FG001|Overall Study|Withdrawal by Subject|1|||
124792218|NCT02586506|448869587|FG000|Overall Study|Protocol Violation|6|||
124792219|NCT02586506|448869587|FG000|Overall Study|Lost to Follow-up|1|||
124792220|NCT02586506|448869587|FG000|Overall Study|Other Reason|2|||
124792221|NCT02815280|448869593|FG000|Double-Blind Phase|Adverse Event|1|||
124792222|NCT02815280|448869594|FG001|Double-Blind Phase|Adverse Event|1|||
124792223|NCT02815280|448869593|FG000|Double-Blind Phase|Lost to Follow-up|10|||
124792224|NCT02815280|448869594|FG001|Double-Blind Phase|Lost to Follow-up|9|||
124792225|NCT02815280|448869593|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
124792226|NCT02815280|448869594|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
124792227|NCT02815280|448869593|FG000|Double-Blind Phase|Protocol Violation|2|||
124792228|NCT02815280|448869594|FG001|Double-Blind Phase|Protocol Violation|2|||
124792229|NCT02815280|448869593|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
124792230|NCT02815280|448869594|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
124792231|NCT02815280|448869593|FG000|Open-Label Phase|Adverse Event|2|||
124792232|NCT02815280|448869594|FG001|Open-Label Phase|Adverse Event|3|||
124792233|NCT02815280|448869593|FG000|Open-Label Phase|Lost to Follow-up|18|||
124792234|NCT02815280|448869594|FG001|Open-Label Phase|Lost to Follow-up|9|||
124792235|NCT02815280|448869593|FG000|Open-Label Phase|Withdrawal by Subject|33|||
124792236|NCT02815280|448869594|FG001|Open-Label Phase|Withdrawal by Subject|18|||
124792237|NCT02815280|448869593|FG000|Open-Label Phase|Protocol Violation|3|||
124792238|NCT02815280|448869594|FG001|Open-Label Phase|Protocol Violation|0|||
124792239|NCT02815280|448869593|FG000|Open-Label Phase|Administrative|26|||
124792240|NCT02815280|448869594|FG001|Open-Label Phase|Administrative|12|||
124792241|NCT02815280|448869593|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
124792242|NCT02815280|448869594|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
124792243|NCT01534182|448869609|FG000|Overall Study|Administrative problems|1|||
124792244|NCT01534182|448869610|FG001|Overall Study|Administrative problems|0|||
124792245|NCT01534182|448869609|FG000|Overall Study|Withdrawal by Subject|4|||
124792246|NCT01534182|448869610|FG001|Overall Study|Withdrawal by Subject|7|||
124792247|NCT01534182|448869609|FG000|Overall Study|Adverse Event|7|||
124792248|NCT01534182|448869610|FG001|Overall Study|Adverse Event|3|||
124792249|NCT01944839|448869611|FG000|Overall Study|Physician Decision|2|||
124792250|NCT01944839|448869612|FG001|Overall Study|Physician Decision|2|||
124792251|NCT01944839|448869611|FG000|Overall Study|Protocol Violation|0|||
124792252|NCT01944839|448869612|FG001|Overall Study|Protocol Violation|1|||
124792253|NCT01944839|448869611|FG000|Overall Study|Adverse Event|10|||
124792254|NCT01944839|448869612|FG001|Overall Study|Adverse Event|5|||
124792255|NCT01944839|448869611|FG000|Overall Study|Withdrawal by Subject|9|||
124792256|NCT01944839|448869612|FG001|Overall Study|Withdrawal by Subject|17|||
124792257|NCT01944839|448869611|FG000|Overall Study|Lost to Follow-up|1|||
124792258|NCT01944839|448869612|FG001|Overall Study|Lost to Follow-up|0|||
124792259|NCT01944839|448869611|FG000|Overall Study|Subject non-compliance|0|||
124792260|NCT01944839|448869612|FG001|Overall Study|Subject non-compliance|3|||
124792261|NCT05093790|448869616|FG000|Overall Study|Failure to meet continuation criteria|0|||
124792262|NCT05093790|448869617|FG001|Overall Study|Failure to meet continuation criteria|0|||
124792263|NCT05093790|448869618|FG002|Overall Study|Failure to meet continuation criteria|1|||
124792264|NCT05093790|448869619|FG003|Overall Study|Failure to meet continuation criteria|0|||
124792265|NCT05093790|448869616|FG000|Overall Study|Adverse Event|1|||
124792266|NCT05093790|448869617|FG001|Overall Study|Adverse Event|0|||
124792267|NCT05093790|448869618|FG002|Overall Study|Adverse Event|0|||
124792268|NCT05093790|448869619|FG003|Overall Study|Adverse Event|0|||
124792269|NCT00924170|448869620|FG000|Overall Study|Refused further treatment|0|||
124792270|NCT00924170|448869621|FG001|Overall Study|Refused further treatment|1|||
124792271|NCT00924170|448869620|FG000|Overall Study|Physician Decision|0|||
124792272|NCT00924170|448869621|FG001|Overall Study|Physician Decision|1|||
124792273|NCT00924170|448869620|FG000|Overall Study|Progressive disease|3|||
124792274|NCT00924170|448869621|FG001|Overall Study|Progressive disease|6|||
124792275|NCT00924170|448869620|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
124792276|NCT00924170|448869621|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
124792277|NCT00924170|448869620|FG000|Overall Study|Death|1|||
124792278|NCT00924170|448869621|FG001|Overall Study|Death|0|||
124792279|NCT04449029|448869624|FG000|Overall Study|Adverse Event|0|||
124792280|NCT04449029|448869625|FG001|Overall Study|Adverse Event|1|||
124792281|NCT04449029|448869626|FG002|Overall Study|Adverse Event|1|||
124792282|NCT04449029|448869627|FG003|Overall Study|Adverse Event|0|||
124792283|NCT04449029|448869628|FG004|Overall Study|Adverse Event|1|||
124792284|NCT04449029|448869629|FG005|Overall Study|Adverse Event|0|||
124792285|NCT04449029|448869630|FG006|Overall Study|Adverse Event|1|||
124792286|NCT04449029|448869631|FG007|Overall Study|Adverse Event|0|||
124792287|NCT04449029|448869624|FG000|Overall Study|Lost to Follow-up|0|||
124792288|NCT04449029|448869625|FG001|Overall Study|Lost to Follow-up|1|||
124792289|NCT04449029|448869626|FG002|Overall Study|Lost to Follow-up|0|||
124792290|NCT04449029|448869627|FG003|Overall Study|Lost to Follow-up|0|||
124792291|NCT04449029|448869628|FG004|Overall Study|Lost to Follow-up|0|||
124792292|NCT04449029|448869629|FG005|Overall Study|Lost to Follow-up|0|||
124792293|NCT04449029|448869630|FG006|Overall Study|Lost to Follow-up|0|||
124792294|NCT04449029|448869631|FG007|Overall Study|Lost to Follow-up|0|||
124792295|NCT04449029|448869624|FG000|Overall Study|Protocol Violation|0|||
124792296|NCT04449029|448869625|FG001|Overall Study|Protocol Violation|1|||
124792297|NCT04449029|448869626|FG002|Overall Study|Protocol Violation|0|||
124792298|NCT04449029|448869627|FG003|Overall Study|Protocol Violation|0|||
124792299|NCT04449029|448869628|FG004|Overall Study|Protocol Violation|0|||
124792300|NCT04449029|448869629|FG005|Overall Study|Protocol Violation|0|||
124792301|NCT04449029|448869630|FG006|Overall Study|Protocol Violation|0|||
124792302|NCT04449029|448869631|FG007|Overall Study|Protocol Violation|0|||
124792303|NCT04449029|448869624|FG000|Overall Study|Physician Decision|0|||
124792304|NCT04449029|448869625|FG001|Overall Study|Physician Decision|0|||
124792305|NCT04449029|448869626|FG002|Overall Study|Physician Decision|0|||
124792306|NCT04449029|448869627|FG003|Overall Study|Physician Decision|0|||
124792307|NCT04449029|448869628|FG004|Overall Study|Physician Decision|0|||
124792308|NCT04449029|448869629|FG005|Overall Study|Physician Decision|1|||
124792309|NCT04449029|448869630|FG006|Overall Study|Physician Decision|0|||
124792310|NCT04449029|448869631|FG007|Overall Study|Physician Decision|0|||
124792311|NCT04449029|448869624|FG000|Overall Study|Withdrawal by Subject|3|||
124792312|NCT04449029|448869625|FG001|Overall Study|Withdrawal by Subject|0|||
124792313|NCT04449029|448869626|FG002|Overall Study|Withdrawal by Subject|1|||
124792314|NCT04449029|448869627|FG003|Overall Study|Withdrawal by Subject|1|||
124792315|NCT04449029|448869628|FG004|Overall Study|Withdrawal by Subject|5|||
124792316|NCT04449029|448869629|FG005|Overall Study|Withdrawal by Subject|1|||
124792317|NCT04449029|448869630|FG006|Overall Study|Withdrawal by Subject|4|||
124792318|NCT04449029|448869631|FG007|Overall Study|Withdrawal by Subject|0|||
124792319|NCT02025556|448869633|FG000|Overall Study|Adverse Event|0|||
124792320|NCT02025556|448869634|FG001|Overall Study|Adverse Event|4|||
124792321|NCT02025556|448869635|FG002|Overall Study|Adverse Event|2|||
124792322|NCT02025556|448869633|FG000|Overall Study|Lack of Efficacy|2|||
124792323|NCT02025556|448869634|FG001|Overall Study|Lack of Efficacy|1|||
124792324|NCT02025556|448869635|FG002|Overall Study|Lack of Efficacy|0|||
124792325|NCT02025556|448869633|FG000|Overall Study|Protocol Violation|2|||
124792326|NCT02025556|448869634|FG001|Overall Study|Protocol Violation|1|||
124792327|NCT02025556|448869635|FG002|Overall Study|Protocol Violation|0|||
124792328|NCT02025556|448869633|FG000|Overall Study|Withdrawal by Subject|0|||
124792329|NCT02025556|448869634|FG001|Overall Study|Withdrawal by Subject|3|||
124792330|NCT02025556|448869635|FG002|Overall Study|Withdrawal by Subject|6|||
124792331|NCT02025556|448869633|FG000|Overall Study|Lost to Follow-up|2|||
124792332|NCT02025556|448869634|FG001|Overall Study|Lost to Follow-up|4|||
124792333|NCT02025556|448869635|FG002|Overall Study|Lost to Follow-up|0|||
124792334|NCT02025556|448869633|FG000|Overall Study|Reason not reported|0|||
124792335|NCT02025556|448869634|FG001|Overall Study|Reason not reported|0|||
124792336|NCT02025556|448869635|FG002|Overall Study|Reason not reported|1|||
124792337|NCT00627445|448869637|FG000|Overall Study|Adverse Event|3|||
124792338|NCT00627445|448869638|FG001|Overall Study|Adverse Event|3|||
124792339|NCT00627445|448869637|FG000|Overall Study|Lack of Efficacy|0|||
124792340|NCT00627445|448869638|FG001|Overall Study|Lack of Efficacy|1|||
124792341|NCT00627445|448869637|FG000|Overall Study|Other|6|||
124792342|NCT00627445|448869638|FG001|Overall Study|Other|8|||
124792343|NCT04098224|448869639|FG000|Overall Study|Adverse Event|1|||
124792344|NCT04098224|448869640|FG001|Overall Study|Adverse Event|0|||
124792345|NCT04098224|448869639|FG000|Overall Study|Physician Decision|1|||
124792346|NCT04098224|448869640|FG001|Overall Study|Physician Decision|0|||
124792347|NCT04098224|448869639|FG000|Overall Study|Patient not required enteral feeding|1|||
124792348|NCT04098224|448869640|FG001|Overall Study|Patient not required enteral feeding|0|||
124792349|NCT04098224|448869639|FG000|Overall Study|Patient failure nasogastric tube|1|||
124792350|NCT04098224|448869640|FG001|Overall Study|Patient failure nasogastric tube|0|||
124792351|NCT04098224|448869639|FG000|Overall Study|Patient early extubation|1|||
124792352|NCT04098224|448869640|FG001|Overall Study|Patient early extubation|3|||
124792353|NCT02217527|448869641|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
124792354|NCT02217527|448869642|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
124792355|NCT02217527|448869641|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
124792356|NCT02217527|448869642|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
124792357|NCT01203852|448869643|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
124792358|NCT01203852|448869643|FG000|Washout 2 Weeks|Physician Decision|46|||
124792359|NCT00247611|448869647|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
124792360|NCT00247611|448869648|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
124792361|NCT00247611|448869647|FG000|Baselined|Completed baseline only|9|||
124792362|NCT00247611|448869648|FG001|Baselined|Completed baseline only|8|||
124792363|NCT01587898|448869649|FG000|Overall Study|Adverse Event|1|||
124792364|NCT01587898|448869650|FG001|Overall Study|Adverse Event|1|||
124792365|NCT01587898|448869651|FG002|Overall Study|Adverse Event|0|||
124792366|NCT01587898|448869652|FG003|Overall Study|Adverse Event|0|||
124792367|NCT01587898|448869649|FG000|Overall Study|Protocol Violation|0|||
124792368|NCT01587898|448869650|FG001|Overall Study|Protocol Violation|2|||
124792369|NCT01587898|448869651|FG002|Overall Study|Protocol Violation|1|||
124792370|NCT01587898|448869652|FG003|Overall Study|Protocol Violation|1|||
124792371|NCT01587898|448869649|FG000|Overall Study|Lost to Follow-up|0|||
124792372|NCT01587898|448869650|FG001|Overall Study|Lost to Follow-up|0|||
124792373|NCT01587898|448869651|FG002|Overall Study|Lost to Follow-up|0|||
124792374|NCT01587898|448869652|FG003|Overall Study|Lost to Follow-up|1|||
124792375|NCT01587898|448869649|FG000|Overall Study|Withdrawal by Subject|2|||
124792376|NCT01587898|448869650|FG001|Overall Study|Withdrawal by Subject|1|||
124792377|NCT01587898|448869651|FG002|Overall Study|Withdrawal by Subject|0|||
124792378|NCT01587898|448869652|FG003|Overall Study|Withdrawal by Subject|0|||
124792379|NCT01587898|448869649|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
124792380|NCT01587898|448869650|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
124792381|NCT01587898|448869651|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
124792382|NCT01587898|448869652|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
124792383|NCT00502203|448869653|FG000|Overall Study|Inevaluable|1|||
124792384|NCT01829243|448869656|FG000|First Intervention|Screen Failure|4|||
124792385|NCT01829243|448869657|FG001|First Intervention|Screen Failure|2|||
124792386|NCT02829944|448869661|FG000|Overall Study|Physician Decision|0|||
124792387|NCT02829944|448869662|FG001|Overall Study|Physician Decision|1|||
124792388|NCT02829944|448869661|FG000|Overall Study|Screen Failure|2|||
124792389|NCT02829944|448869662|FG001|Overall Study|Screen Failure|2|||
124792390|NCT02829944|448869661|FG000|Overall Study|Inadequate Neuraxial Block|1|||
124792391|NCT02829944|448869662|FG001|Overall Study|Inadequate Neuraxial Block|1|||
124792392|NCT02829944|448869661|FG000|Overall Study|Withdrawal by Subject|2|||
124792393|NCT02829944|448869662|FG001|Overall Study|Withdrawal by Subject|1|||
124792394|NCT02829944|448869661|FG000|Overall Study|Catheter Displacement|1|||
124792395|NCT02829944|448869662|FG001|Overall Study|Catheter Displacement|0|||
124792396|NCT02829944|448869661|FG000|Overall Study|Catheter broke|0|||
124792397|NCT02829944|448869662|FG001|Overall Study|Catheter broke|1|||
124792398|NCT02829944|448869661|FG000|Overall Study|Staff unavailable|0|||
124792399|NCT02829944|448869662|FG001|Overall Study|Staff unavailable|1|||
124792400|NCT00336583|448871306|FG000|Overall Study|Lost to Follow-up|1|||
124792401|NCT00336583|448871306|FG000|Overall Study|Death|1|||
124792402|NCT03039621|448871307|FG000|Overall Study|Violation of inclusion criteria|3|||
124792403|NCT03039621|448871308|FG001|Overall Study|Violation of inclusion criteria|2|||
124792404|NCT03039621|448871307|FG000|Overall Study|Non-compliance with protocol requirement|4|||
124792405|NCT03039621|448871308|FG001|Overall Study|Non-compliance with protocol requirement|5|||
124792406|NCT03039621|448871307|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
124792407|NCT03039621|448871308|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
124792408|NCT03039621|448871307|FG000|Overall Study|Violation of non-inclusion criteria|1|||
124792409|NCT03039621|448871308|FG001|Overall Study|Violation of non-inclusion criteria|2|||
124792410|NCT00814333|448871311|FG000|Enrollment|Lost to Follow-up|1|||
124792411|NCT00814333|448871312|FG001|Enrollment|Lost to Follow-up|0|||
124792412|NCT02927067|448871313|FG000|Overall Study|Withdrawn Consent|20|||
124792413|NCT02927067|448871314|FG001|Overall Study|Withdrawn Consent|12|||
124792414|NCT02927067|448871313|FG000|Overall Study|Death|18|||
124792415|NCT02927067|448871314|FG001|Overall Study|Death|31|||
124792416|NCT02927067|448871313|FG000|Overall Study|Adverse Event|13|||
124792417|NCT02927067|448871314|FG001|Overall Study|Adverse Event|10|||
124792418|NCT02927067|448871313|FG000|Overall Study|Noncompliance|5|||
124792419|NCT02927067|448871314|FG001|Overall Study|Noncompliance|2|||
124792420|NCT02927067|448871313|FG000|Overall Study|Reason not Specified|4|||
124792421|NCT02927067|448871314|FG001|Overall Study|Reason not Specified|6|||
124792422|NCT02716896|448871315|FG000|Overall Study|Physician Decision|0|||
124792423|NCT02716896|448871316|FG001|Overall Study|Physician Decision|1|||
124792424|NCT01727700|448871317|FG000|Overall Study|Adverse Event|0|||
124792425|NCT01727700|448871318|FG001|Overall Study|Adverse Event|7|||
124792426|NCT01727700|448871319|FG002|Overall Study|Adverse Event|1|||
124792427|NCT01727700|448871317|FG000|Overall Study|Particpant withdrew consent|0|||
124792428|NCT01727700|448871318|FG001|Overall Study|Particpant withdrew consent|3|||
124792429|NCT01727700|448871319|FG002|Overall Study|Particpant withdrew consent|1|||
124792430|NCT01727700|448871317|FG000|Overall Study|Protocol Violation|2|||
124792431|NCT01727700|448871318|FG001|Overall Study|Protocol Violation|0|||
124792432|NCT01727700|448871319|FG002|Overall Study|Protocol Violation|0|||
124792433|NCT02519855|448871320|FG000|Overall Study|Adverse Event|0|||
124792434|NCT02519855|448871321|FG001|Overall Study|Adverse Event|1|||
124792435|NCT02519855|448871320|FG000|Overall Study|Lost to Follow-up|3|||
124792436|NCT02519855|448871321|FG001|Overall Study|Lost to Follow-up|3|||
124792437|NCT00003830|448871335|FG000|Overall Study|No follow up data|3|||
124792438|NCT00003830|448871336|FG001|Overall Study|No follow up data|0|||
124792439|NCT00003830|448871335|FG000|Overall Study|Sentinel node positive patients|829|||
124792440|NCT00003830|448871336|FG001|Overall Study|Sentinel node positive patients|793|||
124792441|NCT00603590|448871340|FG000|Overall Study|Did not attend study clinic|39|||
124792442|NCT00603590|448871341|FG001|Overall Study|Did not attend study clinic|30|||
124792443|NCT00603590|448871340|FG000|Overall Study|Refused blood test|5|||
124792444|NCT00603590|448871341|FG001|Overall Study|Refused blood test|1|||
124792445|NCT00603590|448871340|FG000|Overall Study|Patient discontinued study drug|22|||
124792446|NCT00603590|448871341|FG001|Overall Study|Patient discontinued study drug|15|||
124792447|NCT00603590|448871340|FG000|Overall Study|Adverse Event|2|||
124792448|NCT00603590|448871341|FG001|Overall Study|Adverse Event|0|||
124792449|NCT00603590|448871340|FG000|Overall Study|Lost to Follow-up|8|||
124792450|NCT00603590|448871341|FG001|Overall Study|Lost to Follow-up|4|||
124792451|NCT00603590|448871340|FG000|Overall Study|Cardiovascular event|0|||
124792452|NCT00603590|448871341|FG001|Overall Study|Cardiovascular event|1|||
124792453|NCT03699475|448871347|FG000|Overall Study|Death|1|||
124792454|NCT00137839|448871348|FG000|Overall Study|Adverse Event|7|||
124792455|NCT00137839|448871348|FG000|Overall Study|Physician Decision|7|||
124792456|NCT00137839|448871348|FG000|Overall Study|Death|8|||
124792457|NCT00137839|448871348|FG000|Overall Study|Disease Progression|60|||
124792458|NCT00137839|448871348|FG000|Overall Study|Not Start Treatment|1|||
124792459|NCT00137839|448871348|FG000|Overall Study|Prolonged Treatment Delay|1|||
124792460|NCT03739242|448871355|FG000|Overall Study|Withdrawal by Subject|1|||
124792461|NCT03739242|448871356|FG001|Overall Study|Withdrawal by Subject|1|||
124792462|NCT03739242|448871355|FG000|Overall Study|Protocol Violation|0|||
124792463|NCT03739242|448871356|FG001|Overall Study|Protocol Violation|1|||
124792464|NCT02446743|448871357|FG000|Overall Study|Withdrawal by Subject|1|||
124792465|NCT02446743|448871358|FG001|Overall Study|Withdrawal by Subject|1|||
124792466|NCT02446743|448871357|FG000|Overall Study|Lost to Follow-up|1|||
124792467|NCT02446743|448871358|FG001|Overall Study|Lost to Follow-up|0|||
124792468|NCT02446743|448871357|FG000|Overall Study|Adverse Event|1|||
124792469|NCT02446743|448871358|FG001|Overall Study|Adverse Event|1|||
124792470|NCT02446743|448871357|FG000|Overall Study|Other|2|||
124792471|NCT02446743|448871358|FG001|Overall Study|Other|3|||
124792472|NCT03718299|448871359|FG000|Overall Study|Adverse Event|1|||
124792473|NCT03718299|448871359|FG000|Overall Study|Withdrawal by Subject|6|||
124792474|NCT03718299|448871359|FG000|Overall Study|Physician Decision|2|||
124792475|NCT03718299|448871359|FG000|Overall Study|Lost to Follow-up|1|||
124792476|NCT01475071|448871364|FG000|Overall Study|Physician Decision|1|||
124792477|NCT01475071|448871364|FG000|Overall Study|Withdrawal by Subject|6|||
124792478|NCT01475071|448871364|FG000|Overall Study|Lost to Follow-up|1|||
124792479|NCT01011478|448871365|FG000|Overall Study|No follow up data|12|||
124792480|NCT01011478|448871366|FG001|Overall Study|No follow up data|7|||
124792481|NCT02158364|448871371|FG000|Overall Study|Case report forms uncollected|10|||
124792482|NCT02158364|448871371|FG000|Overall Study|Protocol Deviation|50|||
124792483|NCT02514473|448871372|FG000|Overall Study|Adverse Event|0|||
124792484|NCT02514473|448871373|FG001|Overall Study|Adverse Event|2|||
124792485|NCT02514473|448871372|FG000|Overall Study|Withdrawal by Subject|2|||
124792486|NCT02514473|448871373|FG001|Overall Study|Withdrawal by Subject|1|||
124792487|NCT02514473|448871372|FG000|Overall Study|Lost to Follow-up|0|||
124792488|NCT02514473|448871373|FG001|Overall Study|Lost to Follow-up|1|||
124792489|NCT02514473|448871372|FG000|Overall Study|Other|1|||
124792490|NCT02514473|448871373|FG001|Overall Study|Other|1|||
124792491|NCT00674154|448871376|FG000|Overall Study|Withdrawal by Subject|3|||
124792492|NCT00674154|448871377|FG001|Overall Study|Withdrawal by Subject|1|||
124792493|NCT00674154|448871376|FG000|Overall Study|Did not want parathyroidectomy|0|||
124792494|NCT00674154|448871377|FG001|Overall Study|Did not want parathyroidectomy|2|||
124792495|NCT01107379|448871378|FG000|Overall Study|Withdrawal by Subject|18|||
124792496|NCT01107379|448871378|FG000|Overall Study|Lost to Follow-up|3|||
124792497|NCT04559529|448871379|FG000|First Intervention (1 Day)|Adverse Event|0|||
124792498|NCT04559529|448871380|FG001|First Intervention (1 Day)|Adverse Event|0|||
124792499|NCT04559529|448871381|FG002|First Intervention (1 Day)|Adverse Event|0|||
124792500|NCT04559529|448871382|FG003|First Intervention (1 Day)|Adverse Event|1|||
124792501|NCT04559529|448871379|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
124792502|NCT04559529|448871380|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
124792503|NCT04559529|448871381|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
125295235|NCT04109976|450707838|FG001|Overall Study|Withdrawal by Subject|0|||
125295236|NCT02449018|450707839|FG000|Overall Study|Abnormal laboratory value|0|||
125295237|NCT02449018|450707840|FG001|Overall Study|Abnormal laboratory value|1|||
125295238|NCT02449018|450707839|FG000|Overall Study|Administrative problems|1|||
125295239|NCT02449018|450707840|FG001|Overall Study|Administrative problems|0|||
125295240|NCT02449018|450707839|FG000|Overall Study|Adverse Event|5|||
125295241|NCT02449018|450707840|FG001|Overall Study|Adverse Event|1|||
125295242|NCT02449018|450707839|FG000|Overall Study|Protocol deviation|4|||
125295243|NCT02449018|450707840|FG001|Overall Study|Protocol deviation|0|||
125295244|NCT02449018|450707839|FG000|Overall Study|Patient decision|2|||
124792504|NCT04559529|448871382|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
124792505|NCT04559529|448871379|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
124792506|NCT04559529|448871380|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
124792507|NCT04559529|448871381|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
124792508|NCT04559529|448871382|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
124792509|NCT00609362|448871383|FG000|Overall Study|Withdrawal by Subject|2|||
124792510|NCT00609362|448871384|FG001|Overall Study|Withdrawal by Subject|1|||
124792511|NCT00609362|448871383|FG000|Overall Study|Adverse Event|1|||
124792512|NCT00609362|448871384|FG001|Overall Study|Adverse Event|0|||
125295245|NCT02449018|450707840|FG001|Overall Study|Patient decision|0|||
125295246|NCT03831945|450707841|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
125295247|NCT03831945|450707842|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
125295248|NCT03831945|450707841|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
125295249|NCT03831945|450707842|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
125295250|NCT03831945|450707841|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
125295251|NCT03831945|450707842|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
125295252|NCT03426631|450707843|FG000|Overall Study|Lost to Follow-up|0|||
125295253|NCT03426631|450707844|FG001|Overall Study|Lost to Follow-up|1|||
125295254|NCT03691779|450707850|FG000|Part B (24 Weeks)|Adverse Event|0|||
125295255|NCT03691779|450707851|FG001|Part B (24 Weeks)|Adverse Event|1|||
125295256|NCT03691779|450707850|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
125295257|NCT03691779|450707851|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
125295258|NCT00267150|450707852|FG000|Overall Study|Adverse Event|1|||
125295259|NCT00521222|450707854|FG000|Overall Study|Lost to Follow-up|0|||
125295260|NCT00521222|450707855|FG001|Overall Study|Lost to Follow-up|0|||
125295261|NCT00521222|450707856|FG002|Overall Study|Lost to Follow-up|1|||
125295262|NCT00521222|450707857|FG003|Overall Study|Lost to Follow-up|1|||
124792513|NCT01009281|448871385|FG000|Overall Study|Administrative problems|7|||
124792514|NCT00548405|448871386|FG000|Overall Study|Adverse Event|6|||
124792515|NCT00548405|448871387|FG001|Overall Study|Adverse Event|2|||
124792516|NCT00548405|448871388|FG002|Overall Study|Adverse Event|0|||
124792517|NCT00548405|448871386|FG000|Overall Study|Lack of Efficacy|6|||
124792518|NCT00548405|448871387|FG001|Overall Study|Lack of Efficacy|0|||
124792519|NCT00548405|448871388|FG002|Overall Study|Lack of Efficacy|0|||
124792520|NCT00548405|448871386|FG000|Overall Study|Physician Decision|3|||
124792521|NCT00548405|448871387|FG001|Overall Study|Physician Decision|4|||
124792522|NCT00548405|448871388|FG002|Overall Study|Physician Decision|1|||
124792523|NCT00548405|448871386|FG000|Overall Study|Pregnancy|1|||
124792524|NCT00548405|448871387|FG001|Overall Study|Pregnancy|0|||
124792525|NCT00548405|448871388|FG002|Overall Study|Pregnancy|0|||
124792526|NCT00548405|448871386|FG000|Overall Study|Protocol Violation|1|||
124792527|NCT00548405|448871387|FG001|Overall Study|Protocol Violation|0|||
124792528|NCT00548405|448871388|FG002|Overall Study|Protocol Violation|0|||
124792529|NCT00548405|448871386|FG000|Overall Study|Withdrawal by Subject|36|||
124792530|NCT00548405|448871387|FG001|Overall Study|Withdrawal by Subject|12|||
124792531|NCT00548405|448871388|FG002|Overall Study|Withdrawal by Subject|5|||
124792532|NCT00548405|448871386|FG000|Overall Study|Lost to Follow-up|1|||
124792533|NCT00548405|448871387|FG001|Overall Study|Lost to Follow-up|1|||
124792534|NCT00548405|448871388|FG002|Overall Study|Lost to Follow-up|2|||
124792535|NCT00548405|448871386|FG000|Overall Study|Death|0|||
124792536|NCT00548405|448871387|FG001|Overall Study|Death|1|||
124792537|NCT00548405|448871388|FG002|Overall Study|Death|1|||
124792538|NCT00548405|448871386|FG000|Overall Study|Sponsor decision|1|||
124792539|NCT00548405|448871387|FG001|Overall Study|Sponsor decision|0|||
124792540|NCT00548405|448871388|FG002|Overall Study|Sponsor decision|0|||
124792541|NCT00548405|448871386|FG000|Overall Study|Randomized but not treated|1|||
124792542|NCT00548405|448871387|FG001|Overall Study|Randomized but not treated|0|||
124792543|NCT00548405|448871388|FG002|Overall Study|Randomized but not treated|0|||
124792544|NCT02582684|448871389|FG000|Overall Study|Unable to contact subject/parent|4|||
124792545|NCT02582684|448871389|FG000|Overall Study|Subject not able to get to clinic|10|||
124792546|NCT02582684|448871389|FG000|Overall Study|Subject withdrew consent|1|||
124792547|NCT02582684|448871389|FG000|Overall Study|Found to be ineligible after enrollment|2|||
124792548|NCT00899392|448871399|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
124792549|NCT00899392|448871400|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
124792550|NCT01261780|448871407|FG000|Overall Study|Withdrawal by Subject|1|||
124792551|NCT01261780|448871408|FG001|Overall Study|Withdrawal by Subject|0|||
124792552|NCT01261780|448871407|FG000|Overall Study|Event not related to subject|1|||
124792553|NCT01261780|448871408|FG001|Overall Study|Event not related to subject|2|||
124792554|NCT01239732|448871409|FG000|Overall Study|Termination of study per protocol|667|||
124792555|NCT01239732|448871409|FG000|Overall Study|Death|226|||
124792556|NCT01239732|448871409|FG000|Overall Study|Withdrawal by Subject|87|||
124792557|NCT01239732|448871409|FG000|Overall Study|Adverse Event|6|||
124792558|NCT01239732|448871409|FG000|Overall Study|Protocol Violation|3|||
124792559|NCT01239732|448871409|FG000|Overall Study|Participant non compliance|5|||
124792560|NCT01239732|448871409|FG000|Overall Study|Study termination by sponsor|2|||
125295263|NCT00521222|450707854|FG000|Overall Study|Withdrawal by Subject|0|||
124792561|NCT01239732|448871409|FG000|Overall Study|Investigator's decision|4|||
124792562|NCT01239732|448871409|FG000|Overall Study|Treatment failure|2|||
124792563|NCT01239732|448871409|FG000|Overall Study|Other|19|||
124792564|NCT00732940|448871410|FG000|Overall Study|Withdrawal by Subject|1|||
124792565|NCT00732940|448871411|FG001|Overall Study|Withdrawal by Subject|2|||
124792566|NCT00732940|448871410|FG000|Overall Study|Adverse Event|0|||
124792567|NCT00732940|448871411|FG001|Overall Study|Adverse Event|1|||
124792568|NCT00732940|448871410|FG000|Overall Study|Lost to Follow-up|1|||
124792569|NCT00732940|448871411|FG001|Overall Study|Lost to Follow-up|0|||
124792570|NCT02241889|448871412|FG000|Overall Study|device issues|0|||
124792571|NCT02241889|448871413|FG001|Overall Study|device issues|0|||
124792572|NCT02241889|448871414|FG002|Overall Study|device issues|1|||
124792573|NCT02241889|448871415|FG003|Overall Study|device issues|0|||
124792574|NCT02241889|448871416|FG004|Overall Study|device issues|0|||
124792575|NCT02241889|448871417|FG005|Overall Study|device issues|0|||
124792576|NCT02241889|448871412|FG000|Overall Study|Withdrawal by Subject|0|||
124792577|NCT02241889|448871413|FG001|Overall Study|Withdrawal by Subject|0|||
124792578|NCT02241889|448871414|FG002|Overall Study|Withdrawal by Subject|0|||
124792579|NCT02241889|448871415|FG003|Overall Study|Withdrawal by Subject|0|||
124792580|NCT02241889|448871416|FG004|Overall Study|Withdrawal by Subject|0|||
124792581|NCT02241889|448871417|FG005|Overall Study|Withdrawal by Subject|1|||
124792582|NCT00266877|448871420|FG000|Overall Study|Death|1|||
124792583|NCT00266877|448871421|FG001|Overall Study|Death|1|||
124792584|NCT00266877|448871422|FG002|Overall Study|Death|1|||
124792585|NCT00266877|448871420|FG000|Overall Study|Adverse Event|6|||
124792586|NCT00266877|448871421|FG001|Overall Study|Adverse Event|4|||
124792587|NCT00266877|448871422|FG002|Overall Study|Adverse Event|1|||
124792588|NCT00266877|448871420|FG000|Overall Study|Physician Decision|2|||
124792589|NCT00266877|448871421|FG001|Overall Study|Physician Decision|1|||
124792590|NCT00266877|448871422|FG002|Overall Study|Physician Decision|1|||
124792591|NCT00266877|448871420|FG000|Overall Study|Withdrawal by Subject|3|||
124792592|NCT00266877|448871421|FG001|Overall Study|Withdrawal by Subject|1|||
124792593|NCT00266877|448871422|FG002|Overall Study|Withdrawal by Subject|1|||
124792594|NCT00266877|448871420|FG000|Overall Study|Disease Progression|72|||
124792595|NCT00266877|448871421|FG001|Overall Study|Disease Progression|37|||
124792596|NCT00266877|448871422|FG002|Overall Study|Disease Progression|23|||
124792597|NCT00266877|448871420|FG000|Overall Study|Symptomatic Deterioration|6|||
124792598|NCT00266877|448871421|FG001|Overall Study|Symptomatic Deterioration|3|||
124792599|NCT00266877|448871422|FG002|Overall Study|Symptomatic Deterioration|1|||
124792600|NCT00266877|448871420|FG000|Overall Study|Hospitalization|1|||
124792601|NCT00266877|448871421|FG001|Overall Study|Hospitalization|0|||
124792602|NCT00266877|448871422|FG002|Overall Study|Hospitalization|0|||
124792603|NCT00266877|448871420|FG000|Overall Study|Concomitant Radiotherapy|0|||
124792604|NCT00266877|448871421|FG001|Overall Study|Concomitant Radiotherapy|1|||
124792605|NCT00266877|448871422|FG002|Overall Study|Concomitant Radiotherapy|0|||
124792606|NCT01077375|448871428|FG000|Overall Study|Adverse Event|2|||
124792607|NCT01077375|448871429|FG001|Overall Study|Adverse Event|15|||
124792608|NCT01077375|448871428|FG000|Overall Study|Lack of Efficacy|6|||
124792609|NCT01077375|448871429|FG001|Overall Study|Lack of Efficacy|8|||
124792610|NCT01077375|448871428|FG000|Overall Study|Withdrawal by Subject|0|||
124792611|NCT01077375|448871429|FG001|Overall Study|Withdrawal by Subject|6|||
124792612|NCT01077375|448871428|FG000|Overall Study|Lost to Follow-up|2|||
124792613|NCT01077375|448871429|FG001|Overall Study|Lost to Follow-up|5|||
124792614|NCT01077375|448871428|FG000|Overall Study|Other Reason|0|||
124792615|NCT01077375|448871429|FG001|Overall Study|Other Reason|1|||
124792616|NCT03985878|448871435|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
124792617|NCT03985878|448871435|FG000|Overall Study|Study Terminated by Sponsor|12|||
124792618|NCT03985878|448871435|FG000|Overall Study|Withdrawal by Subject|1|||
124792619|NCT00278915|448871439|FG000|Overall Study|Disease progression|1|||
124792620|NCT02520089|448871440|FG000|Overall Study|Lost to Follow-up|3|||
124792621|NCT02520089|448871441|FG001|Overall Study|Lost to Follow-up|4|||
124792622|NCT00002931|448872689|FG000|Overall Study|rapidly progressing disease during|2|||
124792623|NCT00910247|448872691|FG000|Overall Study|Adverse Event|15|||
124792624|NCT00910247|448872691|FG000|Overall Study|Death|2|||
124792625|NCT00910247|448872691|FG000|Overall Study|Lost to Follow-up|10|||
124792626|NCT00910247|448872691|FG000|Overall Study|Physician Decision|3|||
124792627|NCT00910247|448872691|FG000|Overall Study|Protocol Violation|10|||
124792628|NCT00910247|448872691|FG000|Overall Study|Withdrawal by Subject|25|||
124792629|NCT00910247|448872691|FG000|Overall Study|Not collected|4|||
124792630|NCT01879579|448872692|FG000|Overall Study|Phone incompatible with texting platform|3|||
124792631|NCT01879579|448872693|FG001|Overall Study|Phone incompatible with texting platform|0|||
124792632|NCT01879579|448872692|FG000|Overall Study|Did not enroll in texting platform|1|||
124792633|NCT01879579|448872693|FG001|Overall Study|Did not enroll in texting platform|0|||
124792634|NCT01879579|448872692|FG000|Overall Study|Did not initiate insulin treatment|1|||
124792635|NCT01879579|448872693|FG001|Overall Study|Did not initiate insulin treatment|0|||
124792636|NCT01879579|448872692|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
124792637|NCT01879579|448872693|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
124792638|NCT01879579|448872692|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
124792639|NCT01879579|448872693|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
124792640|NCT01757691|448872697|FG000|Overall Study|Administrative problems|2|||
124792641|NCT01757691|448872698|FG001|Overall Study|Administrative problems|0|||
124792642|NCT02919969|448872705|FG000|Overall Study|Lack of Efficacy|22|||
124792643|NCT02919969|448872705|FG000|Overall Study|Death|4|||
124792644|NCT02919969|448872705|FG000|Overall Study|Physician Decision|3|||
124792645|NCT02919969|448872705|FG000|Overall Study|Withdrawal by Subject|2|||
124792646|NCT01842633|448872706|FG000|Overall Study|Screen Failure|1|||
124792647|NCT01842633|448872707|FG001|Overall Study|Screen Failure|0|||
124792648|NCT01842633|448872708|FG002|Overall Study|Screen Failure|0|||
124792649|NCT01842633|448872706|FG000|Overall Study|Adverse Event|1|||
124792650|NCT01842633|448872707|FG001|Overall Study|Adverse Event|1|||
124792651|NCT01842633|448872708|FG002|Overall Study|Adverse Event|0|||
124792652|NCT01842633|448872706|FG000|Overall Study|Withdrawal by Subject|0|||
124792653|NCT01842633|448872707|FG001|Overall Study|Withdrawal by Subject|1|||
124792654|NCT01842633|448872708|FG002|Overall Study|Withdrawal by Subject|0|||
124792655|NCT01842633|448872706|FG000|Overall Study|Technical issues|1|||
124792656|NCT01842633|448872707|FG001|Overall Study|Technical issues|0|||
124792657|NCT01842633|448872708|FG002|Overall Study|Technical issues|0|||
124792658|NCT05347147|448872709|FG000|Overall Study|Lost to Follow-up|0|||
124792659|NCT05347147|448872710|FG001|Overall Study|Lost to Follow-up|1|||
124792660|NCT05347147|448872709|FG000|Overall Study|Sponsor request|3|||
124792661|NCT05347147|448872710|FG001|Overall Study|Sponsor request|3|||
124792662|NCT05347147|448872709|FG000|Overall Study|Study termination|2|||
124792663|NCT05347147|448872710|FG001|Overall Study|Study termination|1|||
124792664|NCT00718081|448872713|FG000|Overall Study|Adverse Event|0|||
124792665|NCT00718081|448872714|FG001|Overall Study|Adverse Event|1|||
124792666|NCT00718081|448872715|FG002|Overall Study|Adverse Event|0|||
124792667|NCT00718081|448872713|FG000|Overall Study|Lack of Efficacy|7|||
124792668|NCT00718081|448872714|FG001|Overall Study|Lack of Efficacy|3|||
124792669|NCT00718081|448872715|FG002|Overall Study|Lack of Efficacy|21|||
124792670|NCT01397825|448872716|FG000|Overall Study|Progressive Disease|10|||
124792671|NCT01397825|448872717|FG001|Overall Study|Progressive Disease|3|||
124792672|NCT01397825|448872718|FG002|Overall Study|Progressive Disease|11|||
124792673|NCT01397825|448872719|FG003|Overall Study|Progressive Disease|1|||
124792674|NCT01397825|448872720|FG004|Overall Study|Progressive Disease|0|||
124792675|NCT01397825|448872716|FG000|Overall Study|Symptomatic Deterioration|2|||
124792676|NCT01397825|448872717|FG001|Overall Study|Symptomatic Deterioration|0|||
124792677|NCT01397825|448872718|FG002|Overall Study|Symptomatic Deterioration|4|||
124792678|NCT01397825|448872719|FG003|Overall Study|Symptomatic Deterioration|0|||
124792679|NCT01397825|448872720|FG004|Overall Study|Symptomatic Deterioration|0|||
124792680|NCT01397825|448872716|FG000|Overall Study|Adverse Event|0|||
124792681|NCT01397825|448872717|FG001|Overall Study|Adverse Event|1|||
124792682|NCT01397825|448872718|FG002|Overall Study|Adverse Event|5|||
124792683|NCT01397825|448872719|FG003|Overall Study|Adverse Event|1|||
124792684|NCT01397825|448872720|FG004|Overall Study|Adverse Event|0|||
124792685|NCT01397825|448872716|FG000|Overall Study|Withdrawal by Subject|1|||
124792686|NCT01397825|448872717|FG001|Overall Study|Withdrawal by Subject|0|||
124792687|NCT01397825|448872718|FG002|Overall Study|Withdrawal by Subject|5|||
124792688|NCT01397825|448872719|FG003|Overall Study|Withdrawal by Subject|1|||
124792689|NCT01397825|448872720|FG004|Overall Study|Withdrawal by Subject|0|||
124792690|NCT01931670|448872722|FG000|Treatment Period|Exclusionary Medication Received|1|||
124792691|NCT01931670|448872723|FG001|Treatment Period|Exclusionary Medication Received|1|||
124792692|NCT01931670|448872724|FG002|Treatment Period|Exclusionary Medication Received|1|||
124792693|NCT01931670|448872722|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
124792694|NCT01931670|448872723|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
124792695|NCT01931670|448872724|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
124792696|NCT01931670|448872722|FG000|Treatment Period|Subject Noncompliant|4|||
124792697|NCT01931670|448872723|FG001|Treatment Period|Subject Noncompliant|9|||
124792698|NCT01931670|448872724|FG002|Treatment Period|Subject Noncompliant|5|||
124792699|NCT01931670|448872722|FG000|Treatment Period|Adverse Event|19|||
124792700|NCT01931670|448872723|FG001|Treatment Period|Adverse Event|8|||
124792701|NCT01931670|448872724|FG002|Treatment Period|Adverse Event|21|||
124792702|NCT01931670|448872722|FG000|Treatment Period|Lack of Efficacy|11|||
124792703|NCT01931670|448872723|FG001|Treatment Period|Lack of Efficacy|2|||
124792704|NCT01931670|448872724|FG002|Treatment Period|Lack of Efficacy|2|||
124792705|NCT01931670|448872722|FG000|Treatment Period|Pregnancy|7|||
124792706|NCT01931670|448872723|FG001|Treatment Period|Pregnancy|2|||
124792707|NCT01931670|448872724|FG002|Treatment Period|Pregnancy|0|||
124792708|NCT01931670|448872722|FG000|Treatment Period|Other|8|||
124792709|NCT01931670|448872723|FG001|Treatment Period|Other|7|||
124792710|NCT01931670|448872724|FG002|Treatment Period|Other|2|||
124792711|NCT01931670|448872722|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
124792712|NCT01931670|448872723|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
124792713|NCT01931670|448872724|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
124792714|NCT01931670|448872722|FG000|Treatment Period|Lost to Follow-up|19|||
124792715|NCT01931670|448872723|FG001|Treatment Period|Lost to Follow-up|5|||
124792716|NCT01931670|448872724|FG002|Treatment Period|Lost to Follow-up|7|||
124792717|NCT01931670|448872722|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
124792718|NCT01931670|448872723|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
124792719|NCT01931670|448872724|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
124792720|NCT01931670|448872722|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
124792721|NCT01931670|448872723|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
124792722|NCT01931670|448872724|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
124792723|NCT01931670|448872722|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
124792724|NCT01931670|448872723|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
124792725|NCT01931670|448872724|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
124792726|NCT01931670|448872722|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
124792727|NCT01931670|448872723|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
124792728|NCT01931670|448872724|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
124792729|NCT01931670|448872722|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
124792730|NCT01931670|448872723|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
124792731|NCT01931670|448872724|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
124792732|NCT01931670|448872722|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
124792733|NCT01931670|448872723|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
124792734|NCT01931670|448872724|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
124792735|NCT00976508|448872730|FG000|Overall Study|Death|7|||
124792736|NCT00976508|448872731|FG001|Overall Study|Death|1|||
124792737|NCT00976508|448872730|FG000|Overall Study|Lost to Follow-up|1|||
124792738|NCT00976508|448872731|FG001|Overall Study|Lost to Follow-up|0|||
124792739|NCT00976508|448872730|FG000|Overall Study|Withdrawal by Subject|1|||
124792740|NCT00976508|448872731|FG001|Overall Study|Withdrawal by Subject|0|||
124792741|NCT00976508|448872730|FG000|Overall Study|Disease Progression|4|||
124792742|NCT00976508|448872731|FG001|Overall Study|Disease Progression|4|||
124792743|NCT00976508|448872730|FG000|Overall Study|Subject Enrolled in Hospice|1|||
124792744|NCT00976508|448872731|FG001|Overall Study|Subject Enrolled in Hospice|0|||
124792745|NCT00976508|448872730|FG000|Overall Study|Terminated by the Sponsor|0|||
124792746|NCT00976508|448872731|FG001|Overall Study|Terminated by the Sponsor|1|||
124792747|NCT01205581|448872733|FG000|Overall Study|Withdrawal by Subject|1|||
124792748|NCT01205581|448872734|FG001|Overall Study|Withdrawal by Subject|0|||
124792749|NCT01205581|448872735|FG002|Overall Study|Withdrawal by Subject|0|||
124792750|NCT01205581|448872736|FG003|Overall Study|Withdrawal by Subject|0|||
124792751|NCT01205581|448872737|FG004|Overall Study|Withdrawal by Subject|0|||
124792752|NCT01205581|448872738|FG005|Overall Study|Withdrawal by Subject|0|||
124792753|NCT00978432|448872740|FG000|Overall Study|Withdrawal by Subject|0|||
124792754|NCT00978432|448872741|FG001|Overall Study|Withdrawal by Subject|0|||
124792755|NCT00978432|448872742|FG002|Overall Study|Withdrawal by Subject|1|||
124792756|NCT00978432|448872740|FG000|Overall Study|Lack of Efficacy|1|||
124792757|NCT00978432|448872741|FG001|Overall Study|Lack of Efficacy|1|||
124792758|NCT00978432|448872742|FG002|Overall Study|Lack of Efficacy|3|||
124792759|NCT00978432|448872740|FG000|Overall Study|Adverse Event|2|||
124792760|NCT00978432|448872741|FG001|Overall Study|Adverse Event|0|||
124792761|NCT00978432|448872742|FG002|Overall Study|Adverse Event|1|||
124792762|NCT04418661|448872743|FG000|Overall Study|Adverse Event|0|||
124792763|NCT04418661|448872744|FG001|Overall Study|Adverse Event|1|||
124792764|NCT04418661|448872745|FG002|Overall Study|Adverse Event|5|||
124792765|NCT04418661|448872746|FG003|Overall Study|Adverse Event|3|||
124792766|NCT04418661|448872747|FG004|Overall Study|Adverse Event|0|||
124792767|NCT04418661|448872748|FG005|Overall Study|Adverse Event|2|||
124792768|NCT04418661|448872743|FG000|Overall Study|Progressive disease|4|||
124792769|NCT04418661|448872744|FG001|Overall Study|Progressive disease|11|||
124792770|NCT04418661|448872745|FG002|Overall Study|Progressive disease|6|||
124792771|NCT04418661|448872746|FG003|Overall Study|Progressive disease|11|||
124792772|NCT04418661|448872747|FG004|Overall Study|Progressive disease|1|||
124792773|NCT04418661|448872748|FG005|Overall Study|Progressive disease|12|||
124792774|NCT04418661|448872743|FG000|Overall Study|Withdrawal by Subject|0|||
124792775|NCT04418661|448872744|FG001|Overall Study|Withdrawal by Subject|1|||
124792776|NCT04418661|448872745|FG002|Overall Study|Withdrawal by Subject|0|||
124792777|NCT04418661|448872746|FG003|Overall Study|Withdrawal by Subject|1|||
124792778|NCT04418661|448872747|FG004|Overall Study|Withdrawal by Subject|0|||
124792779|NCT04418661|448872748|FG005|Overall Study|Withdrawal by Subject|0|||
124792780|NCT04418661|448872743|FG000|Overall Study|Other|0|||
124792781|NCT04418661|448872744|FG001|Overall Study|Other|0|||
124792782|NCT04418661|448872745|FG002|Overall Study|Other|1|||
124792783|NCT04418661|448872746|FG003|Overall Study|Other|3|||
124792784|NCT04418661|448872747|FG004|Overall Study|Other|0|||
124792785|NCT04418661|448872748|FG005|Overall Study|Other|1|||
124792786|NCT00045942|448872751|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
124792787|NCT00045942|448872752|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
124792788|NCT00045942|448872753|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
124792789|NCT00045942|448872754|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
124792790|NCT00045942|448872755|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
124792791|NCT00045942|448872756|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
124792792|NCT00045942|448872757|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
124792793|NCT00045942|448872758|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
124792794|NCT00045942|448872759|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
124792795|NCT00045942|448872751|FG000|PKC412A2104 (Core)|Adverse Event|5|||
124792796|NCT00045942|448872752|FG001|PKC412A2104 (Core)|Adverse Event|0|||
124792797|NCT00045942|448872753|FG002|PKC412A2104 (Core)|Adverse Event|0|||
124792798|NCT00045942|448872754|FG003|PKC412A2104 (Core)|Adverse Event|0|||
124792799|NCT00045942|448872755|FG004|PKC412A2104 (Core)|Adverse Event|0|||
124792800|NCT00045942|448872756|FG005|PKC412A2104 (Core)|Adverse Event|0|||
124792801|NCT00045942|448872757|FG006|PKC412A2104 (Core)|Adverse Event|0|||
124792802|NCT00045942|448872758|FG007|PKC412A2104 (Core)|Adverse Event|0|||
124792803|NCT00045942|448872759|FG008|PKC412A2104 (Core)|Adverse Event|0|||
124792804|NCT00045942|448872751|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
124792805|NCT00045942|448872752|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
124792806|NCT00045942|448872753|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
124792807|NCT00045942|448872754|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
124792808|NCT00045942|448872755|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
124792809|NCT00045942|448872756|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
124792810|NCT00045942|448872757|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
124792811|NCT00045942|448872758|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
124792812|NCT00045942|448872759|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
124792813|NCT00045942|448872751|FG000|PKC412A2104 (Core)|Death|1|||
124792814|NCT00045942|448872752|FG001|PKC412A2104 (Core)|Death|0|||
124792815|NCT00045942|448872753|FG002|PKC412A2104 (Core)|Death|0|||
124792816|NCT00045942|448872754|FG003|PKC412A2104 (Core)|Death|0|||
124792817|NCT00045942|448872755|FG004|PKC412A2104 (Core)|Death|0|||
124792818|NCT00045942|448872756|FG005|PKC412A2104 (Core)|Death|0|||
124792819|NCT00045942|448872757|FG006|PKC412A2104 (Core)|Death|0|||
124792820|NCT00045942|448872758|FG007|PKC412A2104 (Core)|Death|0|||
124792821|NCT00045942|448872759|FG008|PKC412A2104 (Core)|Death|0|||
124792822|NCT00045942|448872751|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
124792823|NCT00045942|448872752|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
124792824|NCT00045942|448872753|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
124792825|NCT00045942|448872754|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
124792826|NCT00045942|448872755|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
124792827|NCT00045942|448872756|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
124792828|NCT00045942|448872757|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
124792829|NCT00045942|448872758|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
124792830|NCT00045942|448872759|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
124792831|NCT00045942|448872751|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
124792832|NCT00045942|448872752|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
124792833|NCT00045942|448872753|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
124792834|NCT00045942|448872754|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
124792835|NCT00045942|448872755|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
124792836|NCT00045942|448872756|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
124792837|NCT00045942|448872757|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
124792838|NCT00045942|448872758|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
124792839|NCT00045942|448872759|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
124792840|NCT00045942|448872751|FG000|PKC412A2104E1|Lack of Efficacy|0|||
124792841|NCT00045942|448872752|FG001|PKC412A2104E1|Lack of Efficacy|11|||
124792842|NCT00045942|448872753|FG002|PKC412A2104E1|Lack of Efficacy|11|||
124792843|NCT00045942|448872754|FG003|PKC412A2104E1|Lack of Efficacy|23|||
124792844|NCT00045942|448872755|FG004|PKC412A2104E1|Lack of Efficacy|17|||
124792845|NCT00045942|448872756|FG005|PKC412A2104E1|Lack of Efficacy|0|||
124792846|NCT00045942|448872757|FG006|PKC412A2104E1|Lack of Efficacy|0|||
124792847|NCT00045942|448872758|FG007|PKC412A2104E1|Lack of Efficacy|0|||
124792848|NCT00045942|448872759|FG008|PKC412A2104E1|Lack of Efficacy|0|||
124792849|NCT00045942|448872751|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
124792850|NCT00045942|448872752|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
124792851|NCT00045942|448872753|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
124792852|NCT00045942|448872754|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
124792853|NCT00045942|448872755|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
124792854|NCT00045942|448872756|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
124792855|NCT00045942|448872757|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
124792856|NCT00045942|448872758|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
124792857|NCT00045942|448872759|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
124792858|NCT00045942|448872751|FG000|PKC412A2104E1|Adverse Event|0|||
124792859|NCT00045942|448872752|FG001|PKC412A2104E1|Adverse Event|1|||
124792860|NCT00045942|448872753|FG002|PKC412A2104E1|Adverse Event|1|||
124792861|NCT00045942|448872754|FG003|PKC412A2104E1|Adverse Event|3|||
124792862|NCT00045942|448872755|FG004|PKC412A2104E1|Adverse Event|6|||
124792863|NCT00045942|448872756|FG005|PKC412A2104E1|Adverse Event|0|||
124792864|NCT00045942|448872757|FG006|PKC412A2104E1|Adverse Event|0|||
124792865|NCT00045942|448872758|FG007|PKC412A2104E1|Adverse Event|0|||
124792866|NCT00045942|448872759|FG008|PKC412A2104E1|Adverse Event|0|||
124792867|NCT00045942|448872751|FG000|PKC412A2104E1|Death|0|||
124792868|NCT00045942|448872752|FG001|PKC412A2104E1|Death|4|||
124792869|NCT00045942|448872753|FG002|PKC412A2104E1|Death|1|||
124792870|NCT00045942|448872754|FG003|PKC412A2104E1|Death|1|||
124792871|NCT00045942|448872755|FG004|PKC412A2104E1|Death|1|||
124792872|NCT00045942|448872756|FG005|PKC412A2104E1|Death|0|||
124792873|NCT00045942|448872757|FG006|PKC412A2104E1|Death|0|||
124792874|NCT00045942|448872758|FG007|PKC412A2104E1|Death|0|||
124792875|NCT00045942|448872759|FG008|PKC412A2104E1|Death|0|||
124792876|NCT00045942|448872751|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
124792877|NCT00045942|448872752|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
124792878|NCT00045942|448872753|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
124792879|NCT00045942|448872754|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
124792880|NCT00045942|448872755|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
124792881|NCT00045942|448872756|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
124792882|NCT00045942|448872757|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
124792883|NCT00045942|448872758|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
124792884|NCT00045942|448872759|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
124792885|NCT00045942|448872751|FG000|PKC412A2104E2|Lost to Follow-up|0|||
124792886|NCT00045942|448872752|FG001|PKC412A2104E2|Lost to Follow-up|0|||
124792887|NCT00045942|448872753|FG002|PKC412A2104E2|Lost to Follow-up|0|||
124792888|NCT00045942|448872754|FG003|PKC412A2104E2|Lost to Follow-up|0|||
124792889|NCT00045942|448872755|FG004|PKC412A2104E2|Lost to Follow-up|0|||
124792890|NCT00045942|448872756|FG005|PKC412A2104E2|Lost to Follow-up|0|||
124792891|NCT00045942|448872757|FG006|PKC412A2104E2|Lost to Follow-up|0|||
124792892|NCT00045942|448872758|FG007|PKC412A2104E2|Lost to Follow-up|3|||
124792893|NCT00045942|448872759|FG008|PKC412A2104E2|Lost to Follow-up|0|||
124792894|NCT00045942|448872751|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
124792895|NCT00045942|448872752|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
124792896|NCT00045942|448872753|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
124792897|NCT00045942|448872754|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
124792898|NCT00045942|448872755|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
124792899|NCT00045942|448872756|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
124792900|NCT00045942|448872757|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
124792901|NCT00045942|448872758|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
124792902|NCT00045942|448872759|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
124792903|NCT00045942|448872751|FG000|PKC412A2104E2|Lack of Efficacy|0|||
124792904|NCT00045942|448872752|FG001|PKC412A2104E2|Lack of Efficacy|0|||
124792905|NCT00045942|448872753|FG002|PKC412A2104E2|Lack of Efficacy|0|||
124792906|NCT00045942|448872754|FG003|PKC412A2104E2|Lack of Efficacy|0|||
124792907|NCT00045942|448872755|FG004|PKC412A2104E2|Lack of Efficacy|0|||
124792908|NCT00045942|448872756|FG005|PKC412A2104E2|Lack of Efficacy|3|||
124792909|NCT00045942|448872757|FG006|PKC412A2104E2|Lack of Efficacy|2|||
124792910|NCT00045942|448872758|FG007|PKC412A2104E2|Lack of Efficacy|2|||
124792911|NCT00045942|448872759|FG008|PKC412A2104E2|Lack of Efficacy|6|||
124792912|NCT00045942|448872751|FG000|PKC412A2104E2|Adverse Event|0|||
124792913|NCT00045942|448872752|FG001|PKC412A2104E2|Adverse Event|0|||
124792914|NCT00045942|448872753|FG002|PKC412A2104E2|Adverse Event|0|||
124792915|NCT00045942|448872754|FG003|PKC412A2104E2|Adverse Event|0|||
124792916|NCT00045942|448872755|FG004|PKC412A2104E2|Adverse Event|0|||
124792917|NCT00045942|448872756|FG005|PKC412A2104E2|Adverse Event|4|||
124792918|NCT00045942|448872757|FG006|PKC412A2104E2|Adverse Event|3|||
124792919|NCT00045942|448872758|FG007|PKC412A2104E2|Adverse Event|1|||
124792920|NCT00045942|448872759|FG008|PKC412A2104E2|Adverse Event|0|||
124792921|NCT00045942|448872751|FG000|PKC412A2104E2|Death|0|||
124792922|NCT00045942|448872752|FG001|PKC412A2104E2|Death|0|||
124792923|NCT00045942|448872753|FG002|PKC412A2104E2|Death|0|||
124792924|NCT00045942|448872754|FG003|PKC412A2104E2|Death|0|||
124792925|NCT00045942|448872755|FG004|PKC412A2104E2|Death|0|||
124792926|NCT00045942|448872756|FG005|PKC412A2104E2|Death|1|||
124792927|NCT00045942|448872757|FG006|PKC412A2104E2|Death|2|||
124792928|NCT00045942|448872758|FG007|PKC412A2104E2|Death|0|||
124792929|NCT00045942|448872759|FG008|PKC412A2104E2|Death|0|||
124792930|NCT02095132|448872760|FG000|Overall Study|Adverse Event|0|||
124792931|NCT02095132|448872761|FG001|Overall Study|Adverse Event|0|||
124792932|NCT02095132|448872762|FG002|Overall Study|Adverse Event|0|||
124792933|NCT02095132|448872763|FG003|Overall Study|Adverse Event|0|||
124792934|NCT02095132|448872764|FG004|Overall Study|Adverse Event|1|||
124792935|NCT02095132|448872765|FG005|Overall Study|Adverse Event|0|||
124792936|NCT02095132|448872766|FG006|Overall Study|Adverse Event|1|||
124792937|NCT02095132|448872767|FG007|Overall Study|Adverse Event|0|||
124792938|NCT02095132|448872768|FG008|Overall Study|Adverse Event|0|||
125295264|NCT00521222|450707855|FG001|Overall Study|Withdrawal by Subject|0|||
124792939|NCT02095132|448872760|FG000|Overall Study|Death|0|||
125295265|NCT00521222|450707856|FG002|Overall Study|Withdrawal by Subject|2|||
125295266|NCT00521222|450707857|FG003|Overall Study|Withdrawal by Subject|0|||
124792940|NCT02095132|448872761|FG001|Overall Study|Death|0|||
124792941|NCT02095132|448872762|FG002|Overall Study|Death|0|||
124792942|NCT02095132|448872763|FG003|Overall Study|Death|0|||
124792943|NCT02095132|448872764|FG004|Overall Study|Death|0|||
124792944|NCT02095132|448872765|FG005|Overall Study|Death|0|||
124792945|NCT02095132|448872766|FG006|Overall Study|Death|1|||
124792946|NCT02095132|448872767|FG007|Overall Study|Death|0|||
124792947|NCT02095132|448872768|FG008|Overall Study|Death|0|||
124792948|NCT02095132|448872760|FG000|Overall Study|Lack of Efficacy|3|||
124792949|NCT02095132|448872761|FG001|Overall Study|Lack of Efficacy|5|||
124792950|NCT02095132|448872762|FG002|Overall Study|Lack of Efficacy|2|||
124792951|NCT02095132|448872763|FG003|Overall Study|Lack of Efficacy|8|||
124792952|NCT02095132|448872764|FG004|Overall Study|Lack of Efficacy|3|||
124792953|NCT02095132|448872765|FG005|Overall Study|Lack of Efficacy|6|||
124792954|NCT02095132|448872766|FG006|Overall Study|Lack of Efficacy|10|||
124792955|NCT02095132|448872767|FG007|Overall Study|Lack of Efficacy|9|||
124792956|NCT02095132|448872768|FG008|Overall Study|Lack of Efficacy|8|||
124792957|NCT02095132|448872760|FG000|Overall Study|Physician Decision|1|||
124792958|NCT02095132|448872761|FG001|Overall Study|Physician Decision|0|||
124792959|NCT02095132|448872762|FG002|Overall Study|Physician Decision|0|||
124792960|NCT02095132|448872763|FG003|Overall Study|Physician Decision|0|||
124792961|NCT02095132|448872764|FG004|Overall Study|Physician Decision|0|||
124792962|NCT02095132|448872765|FG005|Overall Study|Physician Decision|0|||
124792963|NCT02095132|448872766|FG006|Overall Study|Physician Decision|1|||
124792964|NCT02095132|448872767|FG007|Overall Study|Physician Decision|0|||
124792965|NCT02095132|448872768|FG008|Overall Study|Physician Decision|2|||
125295267|NCT00521222|450707854|FG000|Overall Study|Physician Decision|0|||
125295268|NCT00521222|450707855|FG001|Overall Study|Physician Decision|1|||
125295269|NCT00521222|450707856|FG002|Overall Study|Physician Decision|0|||
125295270|NCT00521222|450707857|FG003|Overall Study|Physician Decision|1|||
125295271|NCT03332160|450707860|FG000|Overall Study|Withdrawal by Subject|1|||
125295272|NCT03332160|450707861|FG001|Overall Study|Withdrawal by Subject|1|||
125295273|NCT03332160|450707860|FG000|Overall Study|Adverse Event|0|||
125295274|NCT03332160|450707861|FG001|Overall Study|Adverse Event|1|||
124792966|NCT02095132|448872760|FG000|Overall Study|Withdrawal by Subject|0|||
124792967|NCT02095132|448872761|FG001|Overall Study|Withdrawal by Subject|0|||
124792968|NCT02095132|448872762|FG002|Overall Study|Withdrawal by Subject|2|||
124792969|NCT02095132|448872763|FG003|Overall Study|Withdrawal by Subject|2|||
124792970|NCT02095132|448872764|FG004|Overall Study|Withdrawal by Subject|3|||
124792971|NCT02095132|448872765|FG005|Overall Study|Withdrawal by Subject|0|||
124792972|NCT02095132|448872766|FG006|Overall Study|Withdrawal by Subject|5|||
124792973|NCT02095132|448872767|FG007|Overall Study|Withdrawal by Subject|0|||
124792974|NCT02095132|448872768|FG008|Overall Study|Withdrawal by Subject|0|||
124792975|NCT01895361|448872772|FG000|Overall Study|Adverse Event|1|||
124792976|NCT01895361|448872773|FG001|Overall Study|Adverse Event|1|||
124792977|NCT01895361|448872774|FG002|Overall Study|Adverse Event|3|||
124792978|NCT01895361|448872772|FG000|Overall Study|Death|2|||
124792979|NCT01895361|448872773|FG001|Overall Study|Death|1|||
124792980|NCT01895361|448872774|FG002|Overall Study|Death|2|||
124792981|NCT01895361|448872772|FG000|Overall Study|Lost to Follow-up|4|||
124792982|NCT01895361|448872773|FG001|Overall Study|Lost to Follow-up|4|||
124792983|NCT01895361|448872774|FG002|Overall Study|Lost to Follow-up|6|||
124792984|NCT01895361|448872772|FG000|Overall Study|Non-compliance with study|1|||
124792985|NCT01895361|448872773|FG001|Overall Study|Non-compliance with study|3|||
124792986|NCT01895361|448872774|FG002|Overall Study|Non-compliance with study|1|||
124792987|NCT01895361|448872772|FG000|Overall Study|Physician Decision|2|||
124792988|NCT01895361|448872773|FG001|Overall Study|Physician Decision|2|||
124792989|NCT01895361|448872774|FG002|Overall Study|Physician Decision|2|||
124792990|NCT01895361|448872772|FG000|Overall Study|Withdrawal by Subject|7|||
124792991|NCT01895361|448872773|FG001|Overall Study|Withdrawal by Subject|6|||
124792992|NCT01895361|448872774|FG002|Overall Study|Withdrawal by Subject|6|||
124792993|NCT01895361|448872772|FG000|Overall Study|Lack of Efficacy|0|||
124792994|NCT01895361|448872773|FG001|Overall Study|Lack of Efficacy|1|||
124792995|NCT01895361|448872774|FG002|Overall Study|Lack of Efficacy|0|||
124792996|NCT01895361|448872772|FG000|Overall Study|Reasons different from categories above|7|||
124792997|NCT01895361|448872773|FG001|Overall Study|Reasons different from categories above|3|||
124792998|NCT01895361|448872774|FG002|Overall Study|Reasons different from categories above|4|||
124792999|NCT00761748|448872778|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
124793000|NCT00761748|448872779|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
124793001|NCT00761748|448872778|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
124793002|NCT00761748|448872779|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
124793003|NCT01209832|448872780|FG000|Period 1|Sponsor Decision and was not dosed|1|||
124793004|NCT01209832|448872780|FG000|Period 2|Sponsor Decision|1|||
124793005|NCT01268579|448872781|FG000|Overall Study|Adverse Event|1|||
124793006|NCT01268579|448872781|FG000|Overall Study|Withdrawal by Subject|2|||
124793007|NCT02692651|448872782|FG000|Study Treatment|Death|7|||
124793008|NCT02692651|448872783|FG001|Study Treatment|Death|3|||
124793009|NCT02692651|448872782|FG000|Study Treatment|comfort care|1|||
124793010|NCT02692651|448872783|FG001|Study Treatment|comfort care|1|||
125295275|NCT03332160|450707860|FG000|Overall Study|Developed Exclusion Criteria|0|||
125295276|NCT03332160|450707861|FG001|Overall Study|Developed Exclusion Criteria|1|||
125295277|NCT03332160|450707860|FG000|Overall Study|Non-adherence to treatment|0|||
125295278|NCT03332160|450707861|FG001|Overall Study|Non-adherence to treatment|2|||
124793011|NCT02692651|448872782|FG000|Study Treatment|Protocol violation per treating team preference|8|||
124793012|NCT02692651|448872783|FG001|Study Treatment|Protocol violation per treating team preference|6|||
124793013|NCT02692651|448872782|FG000|Post Study Treatment Follow-up|Death|4|||
124793014|NCT02692651|448872783|FG001|Post Study Treatment Follow-up|Death|4|||
124793015|NCT02480712|448872784|FG000|Overall Study|Enrolled but Never Treated|1|||
125295279|NCT01561963|450707862|FG000|Overall Study|Adverse Event|1|||
124793016|NCT02480712|448872784|FG000|Overall Study|Lost to Follow-up|5|||
124793017|NCT02480712|448872784|FG000|Overall Study|Withdrew Consent|3|||
125295280|NCT04208087|450707865|FG000|Overall Study|Adverse Event|1|||
124793018|NCT02480712|448872784|FG000|Overall Study|Death|1|||
124793019|NCT02480712|448872784|FG000|Overall Study|Lack of Efficacy|1|||
124793020|NCT02239120|448872785|FG000|Overall Study|Death|56|||
124793021|NCT02239120|448872786|FG001|Overall Study|Death|58|||
124793022|NCT02239120|448872785|FG000|Overall Study|Lost to Follow-up|19|||
124793023|NCT02239120|448872786|FG001|Overall Study|Lost to Follow-up|14|||
124793024|NCT01878149|448872791|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
124793025|NCT01878149|448872792|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
124793026|NCT02048241|448872793|FG000|Overall Study|Withdrawal by Subject|0|||
124793027|NCT02048241|448872794|FG001|Overall Study|Withdrawal by Subject|1|||
124793028|NCT00402233|448872795|FG000|Overall Study|Adverse Event|1|||
124793029|NCT00402233|448872796|FG001|Overall Study|Adverse Event|7|||
124793030|NCT00402233|448872797|FG002|Overall Study|Adverse Event|9|||
124793031|NCT00402233|448872798|FG003|Overall Study|Adverse Event|9|||
124793032|NCT00402233|448872795|FG000|Overall Study|Protocol Violation|0|||
124793033|NCT00402233|448872796|FG001|Overall Study|Protocol Violation|1|||
124793034|NCT00402233|448872797|FG002|Overall Study|Protocol Violation|0|||
124793035|NCT00402233|448872798|FG003|Overall Study|Protocol Violation|0|||
124793036|NCT00402233|448872795|FG000|Overall Study|Withdrawal by Subject|2|||
124793037|NCT00402233|448872796|FG001|Overall Study|Withdrawal by Subject|1|||
124793038|NCT00402233|448872797|FG002|Overall Study|Withdrawal by Subject|2|||
124793039|NCT00402233|448872798|FG003|Overall Study|Withdrawal by Subject|2|||
124793040|NCT00402233|448872795|FG000|Overall Study|Worsening of disease under study|2|||
124793041|NCT00402233|448872796|FG001|Overall Study|Worsening of disease under study|0|||
124793042|NCT00402233|448872797|FG002|Overall Study|Worsening of disease under study|0|||
124793043|NCT00402233|448872798|FG003|Overall Study|Worsening of disease under study|0|||
124793044|NCT00402233|448872795|FG000|Overall Study|Worsening of other pre-existing disease|0|||
124793045|NCT00402233|448872796|FG001|Overall Study|Worsening of other pre-existing disease|1|||
124793046|NCT00402233|448872797|FG002|Overall Study|Worsening of other pre-existing disease|0|||
124793047|NCT00402233|448872798|FG003|Overall Study|Worsening of other pre-existing disease|0|||
124793048|NCT04658940|448872802|FG000|Overall Study|Withdrawal by Subject|1|||
124793049|NCT03579602|448872803|FG000|Overall Study|Subject unable to receive study drug|0|||
124793050|NCT03579602|448872804|FG001|Overall Study|Subject unable to receive study drug|2|||
124793051|NCT03579602|448872803|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
124793052|NCT03579602|448872804|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
124793053|NCT02518464|448872805|FG000|Overall Study|Adverse Event|2|||
124793054|NCT01120067|448872808|FG000|Overall Study|Lost to Follow-up|3|||
124793055|NCT01120067|448872809|FG001|Overall Study|Lost to Follow-up|1|||
124793056|NCT01120067|448872808|FG000|Overall Study|fail to engage >3 sessions|2|||
124793057|NCT01120067|448872809|FG001|Overall Study|fail to engage >3 sessions|0|||
124793058|NCT00604214|448872829|FG000|Baseline to Day 28|Death|223|||
124793059|NCT00604214|448872830|FG001|Baseline to Day 28|Death|202|||
124793060|NCT00604214|448872829|FG000|Baseline to Day 28|Lost to Follow-up|2|||
124793061|NCT00604214|448872830|FG001|Baseline to Day 28|Lost to Follow-up|4|||
124793062|NCT00604214|448872829|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
124793063|NCT00604214|448872830|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
124793064|NCT00604214|448872829|FG000|Day 29 to Day 90|Death|64|||
124793065|NCT00604214|448872830|FG001|Day 29 to Day 90|Death|67|||
124793066|NCT00604214|448872829|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
124793067|NCT00604214|448872830|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
124793068|NCT00604214|448872829|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
124793069|NCT00604214|448872830|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
124793070|NCT00604214|448872829|FG000|Day 91 to Day 180|Death|19|||
124793071|NCT00604214|448872830|FG001|Day 91 to Day 180|Death|23|||
124793072|NCT00604214|448872829|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
124793073|NCT00604214|448872830|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
124793074|NCT00604214|448872829|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
124793075|NCT00604214|448872830|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
124793076|NCT00686998|448872831|FG000|Overall Study|Adverse Event|3|||
124793077|NCT00686998|448872832|FG001|Overall Study|Adverse Event|2|||
124793078|NCT00686998|448872833|FG002|Overall Study|Adverse Event|1|||
124793079|NCT00686998|448872831|FG000|Overall Study|Withdrawal by Subject|2|||
124793080|NCT00686998|448872832|FG001|Overall Study|Withdrawal by Subject|1|||
124793081|NCT00686998|448872833|FG002|Overall Study|Withdrawal by Subject|2|||
124793082|NCT00686998|448872831|FG000|Overall Study|Lack of Efficacy|7|||
124793083|NCT00686998|448872832|FG001|Overall Study|Lack of Efficacy|5|||
124793084|NCT00686998|448872833|FG002|Overall Study|Lack of Efficacy|0|||
124793085|NCT00686998|448872831|FG000|Overall Study|Other|0|||
124793086|NCT00686998|448872832|FG001|Overall Study|Other|0|||
125295281|NCT04208087|450707866|FG001|Overall Study|Adverse Event|0|||
124793087|NCT00686998|448872833|FG002|Overall Study|Other|1|||
124793088|NCT00686998|448872831|FG000|Overall Study|Safety Reasons|1|||
125295282|NCT04208087|450707867|FG002|Overall Study|Adverse Event|0|||
125295283|NCT04208087|450707868|FG003|Overall Study|Adverse Event|0|||
124793089|NCT00686998|448872832|FG001|Overall Study|Safety Reasons|0|||
124793090|NCT00686998|448872833|FG002|Overall Study|Safety Reasons|0|||
124793091|NCT00130442|448874152|FG000|Overall Study|Withdrawal by Subject|0|||
124793092|NCT00130442|448874153|FG001|Overall Study|Withdrawal by Subject|1|||
124793093|NCT00130442|448874152|FG000|Overall Study|did not meet criteria|1|||
124793094|NCT00130442|448874153|FG001|Overall Study|did not meet criteria|1|||
124793095|NCT02233946|448874154|FG000|Baseline|Withdrawal by Subject|2|||
124793096|NCT02233946|448874155|FG001|Baseline|Withdrawal by Subject|0|||
124793097|NCT02233946|448874154|FG000|3-months Follow-up|Lost to Follow-up|53|||
124793098|NCT02233946|448874155|FG001|3-months Follow-up|Lost to Follow-up|29|||
124793099|NCT02233946|448874154|FG000|6-months Follow-up|Lost to Follow-up|21|||
124793100|NCT02233946|448874155|FG001|6-months Follow-up|Lost to Follow-up|2|||
124793101|NCT02233946|448874154|FG000|9-month Follow-up|Lost to Follow-up|20|||
124793102|NCT02233946|448874155|FG001|9-month Follow-up|Lost to Follow-up|11|||
124793103|NCT02233946|448874154|FG000|12-month Follow-up|Lost to Follow-up|28|||
124793104|NCT02233946|448874155|FG001|12-month Follow-up|Lost to Follow-up|11|||
124793105|NCT02054481|448874156|FG000|Overall Study|Adverse Event|1|||
124793106|NCT02054481|448874157|FG001|Overall Study|Adverse Event|1|||
124793107|NCT02054481|448874158|FG002|Overall Study|Adverse Event|0|||
124793108|NCT02054481|448874159|FG003|Overall Study|Adverse Event|1|||
124793109|NCT02054481|448874156|FG000|Overall Study|Lost to Follow-up|1|||
124793110|NCT02054481|448874157|FG001|Overall Study|Lost to Follow-up|0|||
124793111|NCT02054481|448874158|FG002|Overall Study|Lost to Follow-up|0|||
124793112|NCT02054481|448874159|FG003|Overall Study|Lost to Follow-up|0|||
124793113|NCT02054481|448874156|FG000|Overall Study|Other reason|2|||
124793114|NCT02054481|448874157|FG001|Overall Study|Other reason|1|||
124793115|NCT02054481|448874158|FG002|Overall Study|Other reason|2|||
124793116|NCT02054481|448874159|FG003|Overall Study|Other reason|0|||
124793117|NCT02320903|448874160|FG000|Overall Study|Withdrawal by Subject|0|||
124793118|NCT02320903|448874161|FG001|Overall Study|Withdrawal by Subject|9|||
124793119|NCT02320903|448874162|FG002|Overall Study|Withdrawal by Subject|9|||
124793120|NCT02320903|448874160|FG000|Overall Study|Exited therapy; no longer eligible|8|||
124793121|NCT02320903|448874161|FG001|Overall Study|Exited therapy; no longer eligible|2|||
124793122|NCT02320903|448874162|FG002|Overall Study|Exited therapy; no longer eligible|2|||
124793123|NCT02320903|448874160|FG000|Overall Study|Lost to Follow-up|0|||
124793124|NCT02320903|448874161|FG001|Overall Study|Lost to Follow-up|5|||
124793125|NCT02320903|448874162|FG002|Overall Study|Lost to Follow-up|5|||
124793126|NCT00773383|448874163|FG000|Overall Study|Adverse Event|4|||
124793127|NCT00773383|448874163|FG000|Overall Study|Death|1|||
124793128|NCT00773383|448874163|FG000|Overall Study|Progression of Disease|23|||
124793129|NCT00773383|448874163|FG000|Overall Study|Other|2|||
124793130|NCT00773383|448874163|FG000|Overall Study|No study dose received|1|||
124793131|NCT03384693|448874164|FG000|Overall Study|Adverse Event|3|||
124793132|NCT03621475|448874167|FG000|Overall Study|No longer required restraints at initiation|0|||
124793133|NCT03621475|448874168|FG001|Overall Study|No longer required restraints at initiation|1|||
124793134|NCT01095094|448874170|FG000|Overall Study|Withdrawal by Subject|1|||
124793135|NCT01095094|448874170|FG000|Overall Study|Death|1|||
124793136|NCT01095094|448874170|FG000|Overall Study|Physician Decision|1|||
124793137|NCT02093351|448874171|FG000|Part A|Adverse Event|0|||
124793138|NCT02093351|448874172|FG001|Part A|Adverse Event|1|||
124793139|NCT02093351|448874173|FG002|Part A|Adverse Event|1|||
124793140|NCT02093351|448874174|FG003|Part A|Adverse Event|0|||
124793141|NCT02093351|448874171|FG000|Part A|Condition under investigation worsened|2|||
124793142|NCT02093351|448874172|FG001|Part A|Condition under investigation worsened|0|||
124793143|NCT02093351|448874173|FG002|Part A|Condition under investigation worsened|2|||
124793144|NCT02093351|448874174|FG003|Part A|Condition under investigation worsened|0|||
124793145|NCT02093351|448874171|FG000|Part A|Death|0|||
124793146|NCT02093351|448874172|FG001|Part A|Death|1|||
124793147|NCT02093351|448874173|FG002|Part A|Death|0|||
124793148|NCT02093351|448874174|FG003|Part A|Death|0|||
124793149|NCT02093351|448874171|FG000|Part B|Patient decision|0|||
124793150|NCT02093351|448874172|FG001|Part B|Patient decision|0|||
124793151|NCT02093351|448874173|FG002|Part B|Patient decision|0|||
124793152|NCT02093351|448874174|FG003|Part B|Patient decision|3|||
124793153|NCT02093351|448874171|FG000|Part B|Disease progression|0|||
124793154|NCT02093351|448874172|FG001|Part B|Disease progression|0|||
125295284|NCT04208087|450707869|FG004|Overall Study|Adverse Event|0|||
125295285|NCT04208087|450707865|FG000|Overall Study|Withdrawal by Subject|0|||
125295286|NCT04208087|450707866|FG001|Overall Study|Withdrawal by Subject|0|||
125295287|NCT04208087|450707867|FG002|Overall Study|Withdrawal by Subject|1|||
125295288|NCT04208087|450707868|FG003|Overall Study|Withdrawal by Subject|0|||
125295289|NCT04208087|450707869|FG004|Overall Study|Withdrawal by Subject|0|||
125295290|NCT04208087|450707865|FG000|Overall Study|Other|0|||
124793155|NCT02093351|448874173|FG002|Part B|Disease progression|0|||
124793156|NCT02093351|448874174|FG003|Part B|Disease progression|4|||
124793157|NCT02093351|448874171|FG000|Part B|Complete response|0|||
124793158|NCT02093351|448874172|FG001|Part B|Complete response|0|||
124793159|NCT02093351|448874173|FG002|Part B|Complete response|0|||
124793160|NCT02093351|448874174|FG003|Part B|Complete response|1|||
124793161|NCT02093351|448874171|FG000|Part B|Adverse event + disease progression|0|||
124793162|NCT02093351|448874172|FG001|Part B|Adverse event + disease progression|0|||
124793163|NCT02093351|448874173|FG002|Part B|Adverse event + disease progression|0|||
124793164|NCT02093351|448874174|FG003|Part B|Adverse event + disease progression|1|||
124793165|NCT02093351|448874171|FG000|Part B|Lack of therapeutic response|0|||
124793166|NCT02093351|448874172|FG001|Part B|Lack of therapeutic response|0|||
124793167|NCT02093351|448874173|FG002|Part B|Lack of therapeutic response|0|||
124793168|NCT02093351|448874174|FG003|Part B|Lack of therapeutic response|12|||
124793169|NCT02093351|448874171|FG000|Part B|Condition under investigation worsened|0|||
124793170|NCT02093351|448874172|FG001|Part B|Condition under investigation worsened|0|||
124793171|NCT02093351|448874173|FG002|Part B|Condition under investigation worsened|0|||
124793172|NCT02093351|448874174|FG003|Part B|Condition under investigation worsened|39|||
124793173|NCT02093351|448874171|FG000|Part B|Adverse Event|0|||
124793174|NCT02093351|448874172|FG001|Part B|Adverse Event|0|||
124793175|NCT02093351|448874173|FG002|Part B|Adverse Event|0|||
124793176|NCT02093351|448874174|FG003|Part B|Adverse Event|2|||
124793177|NCT02093351|448874171|FG000|Part B|Death|0|||
124793178|NCT02093351|448874172|FG001|Part B|Death|0|||
124793179|NCT02093351|448874173|FG002|Part B|Death|0|||
124793180|NCT02093351|448874174|FG003|Part B|Death|1|||
124793181|NCT01099709|448874175|FG000|Period 1|Withdrawal by Subject|0|||
124793182|NCT01099709|448874176|FG001|Period 1|Withdrawal by Subject|1|||
124793183|NCT01099709|448874175|FG000|Period 1|Positive cotinine test|0|||
124793184|NCT01099709|448874176|FG001|Period 1|Positive cotinine test|1|||
124793185|NCT01099709|448874175|FG000|Period 1|Adverse Event|1|||
124793186|NCT01099709|448874176|FG001|Period 1|Adverse Event|0|||
124793187|NCT01122394|448874184|FG000|Overall Study|Withdrawal by Subject|1|||
124793188|NCT01122394|448874185|FG001|Overall Study|Withdrawal by Subject|1|||
124793189|NCT01122394|448874184|FG000|Overall Study|Lost to Follow-up|2|||
124793190|NCT01122394|448874185|FG001|Overall Study|Lost to Follow-up|2|||
124793191|NCT01122394|448874184|FG000|Overall Study|Adverse Event|0|||
124793192|NCT01122394|448874185|FG001|Overall Study|Adverse Event|1|||
124793193|NCT00039871|448874186|FG000|Overall Study|Adverse Event|165|||
124793194|NCT00039871|448874186|FG000|Overall Study|Lost to Follow-up|18|||
124793195|NCT00039871|448874186|FG000|Overall Study|Protocol Violation|24|||
124793196|NCT00039871|448874186|FG000|Overall Study|Withdrawal by Subject|97|||
124793197|NCT00039871|448874186|FG000|Overall Study|Did not meet eligibility criteria|11|||
124793198|NCT00039871|448874186|FG000|Overall Study|Administrative|1|||
124793199|NCT00039871|448874186|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
124793200|NCT00039871|448874186|FG000|Overall Study|Never entered follow-up|7|||
124793201|NCT00815516|448874189|FG000|Overall Study|Death|3|||
124793202|NCT00815516|448874190|FG001|Overall Study|Death|1|||
124793203|NCT00815516|448874189|FG000|Overall Study|Physician Decision|1|||
124793204|NCT00815516|448874190|FG001|Overall Study|Physician Decision|0|||
124793205|NCT01736657|448874191|FG000|Overall Study|insufficient vascular access|1|||
124793206|NCT01992159|448874204|FG000|Overall Study|Withdrawal by Subject|4|||
124793207|NCT01992159|448874205|FG001|Overall Study|Withdrawal by Subject|7|||
124793208|NCT01992159|448874206|FG002|Overall Study|Withdrawal by Subject|0|||
124793209|NCT01992159|448874207|FG003|Overall Study|Withdrawal by Subject|3|||
124793210|NCT01992159|448874204|FG000|Overall Study|Adverse Event|0|||
124793211|NCT01992159|448874205|FG001|Overall Study|Adverse Event|1|||
124793212|NCT01992159|448874206|FG002|Overall Study|Adverse Event|0|||
124793213|NCT01992159|448874207|FG003|Overall Study|Adverse Event|1|||
124793214|NCT01992159|448874204|FG000|Overall Study|Death|0|||
124793215|NCT01992159|448874205|FG001|Overall Study|Death|0|||
124793216|NCT01992159|448874206|FG002|Overall Study|Death|1|||
124793217|NCT01992159|448874207|FG003|Overall Study|Death|0|||
124793218|NCT03023046|448874210|FG000|Overall Study|Withdrawal by Subject|1|||
124793219|NCT02278471|448874211|FG000|Overall Study|Lost to Follow-up|6|||
124793220|NCT02278471|448874212|FG001|Overall Study|Lost to Follow-up|15|||
124793221|NCT02278471|448874211|FG000|Overall Study|Death|2|||
124793222|NCT02278471|448874212|FG001|Overall Study|Death|2|||
124793223|NCT02278471|448874211|FG000|Overall Study|Withdrawal by Subject|0|||
124793224|NCT02278471|448874212|FG001|Overall Study|Withdrawal by Subject|3|||
124793225|NCT00640835|448874213|FG000|Overall Study|Adverse Event|5|||
124793226|NCT00640835|448874214|FG001|Overall Study|Adverse Event|3|||
124793227|NCT00640835|448874213|FG000|Overall Study|Withdrawal by Subject|12|||
124793228|NCT00640835|448874214|FG001|Overall Study|Withdrawal by Subject|14|||
124793229|NCT00640835|448874213|FG000|Overall Study|Physician Decision|10|||
124793230|NCT00640835|448874214|FG001|Overall Study|Physician Decision|14|||
124793231|NCT00640835|448874213|FG000|Overall Study|Sponsor's Decision|11|||
124793232|NCT00640835|448874214|FG001|Overall Study|Sponsor's Decision|7|||
124793233|NCT00640835|448874213|FG000|Overall Study|Protocol Violation|2|||
124793234|NCT00640835|448874214|FG001|Overall Study|Protocol Violation|2|||
124793235|NCT00640835|448874213|FG000|Overall Study|Lost to Follow-up|17|||
124793236|NCT00640835|448874214|FG001|Overall Study|Lost to Follow-up|13|||
124793237|NCT00640835|448874213|FG000|Overall Study|Other Reason|19|||
124793238|NCT00640835|448874214|FG001|Overall Study|Other Reason|4|||
124793239|NCT01741012|448874215|FG000|Overall Study|Lost to Follow-up|1|||
124793240|NCT01741012|448874215|FG000|Overall Study|Withdrawal by Subject|2|||
124793241|NCT03468543|448874216|FG000|Overall Study|Protocol stopping rules met|3|||
124793242|NCT04618770|448874219|FG000|Overall Study|Censored from Analysis|12|||
124793243|NCT04618770|448874219|FG000|Overall Study|Early Termination|25|||
124793244|NCT04393298|448874220|FG000|Overall Study|Adverse Event|0|||
124793245|NCT04393298|448874221|FG001|Overall Study|Adverse Event|0|||
124793246|NCT04393298|448874222|FG002|Overall Study|Adverse Event|0|||
124793247|NCT04393298|448874223|FG003|Overall Study|Adverse Event|0|||
124793248|NCT04393298|448874224|FG004|Overall Study|Adverse Event|1|||
124793249|NCT04393298|448874225|FG005|Overall Study|Adverse Event|0|||
124793250|NCT04393298|448874226|FG006|Overall Study|Adverse Event|0|||
124793251|NCT04393298|448874227|FG007|Overall Study|Adverse Event|0|||
124793252|NCT04393298|448874228|FG008|Overall Study|Adverse Event|2|||
124793253|NCT04393298|448874229|FG009|Overall Study|Adverse Event|0|||
124793254|NCT04393298|448874230|FG010|Overall Study|Adverse Event|0|||
124793255|NCT04393298|448874231|FG011|Overall Study|Adverse Event|0|||
124793256|NCT04393298|448874232|FG012|Overall Study|Adverse Event|1|||
124793257|NCT04393298|448874233|FG013|Overall Study|Adverse Event|1|||
124793258|NCT04393298|448874234|FG014|Overall Study|Adverse Event|0|||
124793259|NCT04393298|448874220|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793260|NCT04393298|448874221|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793261|NCT04393298|448874222|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
124793262|NCT04393298|448874223|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793263|NCT04393298|448874224|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793264|NCT04393298|448874225|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793265|NCT04393298|448874226|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793266|NCT04393298|448874227|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793267|NCT04393298|448874228|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793268|NCT04393298|448874229|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793269|NCT04393298|448874230|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793270|NCT04393298|448874231|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793271|NCT04393298|448874232|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793272|NCT04393298|448874233|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793273|NCT04393298|448874234|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
124793274|NCT04393298|448874220|FG000|Overall Study|Lack of Efficacy|0|||
124793275|NCT04393298|448874221|FG001|Overall Study|Lack of Efficacy|0|||
124793276|NCT04393298|448874222|FG002|Overall Study|Lack of Efficacy|0|||
124793277|NCT04393298|448874223|FG003|Overall Study|Lack of Efficacy|0|||
124793278|NCT04393298|448874224|FG004|Overall Study|Lack of Efficacy|0|||
124793279|NCT04393298|448874225|FG005|Overall Study|Lack of Efficacy|0|||
124793280|NCT04393298|448874226|FG006|Overall Study|Lack of Efficacy|0|||
124793281|NCT04393298|448874227|FG007|Overall Study|Lack of Efficacy|0|||
124793282|NCT04393298|448874228|FG008|Overall Study|Lack of Efficacy|0|||
124793283|NCT04393298|448874229|FG009|Overall Study|Lack of Efficacy|0|||
124793284|NCT04393298|448874230|FG010|Overall Study|Lack of Efficacy|0|||
124793285|NCT04393298|448874231|FG011|Overall Study|Lack of Efficacy|0|||
124793286|NCT04393298|448874232|FG012|Overall Study|Lack of Efficacy|0|||
124793287|NCT04393298|448874233|FG013|Overall Study|Lack of Efficacy|0|||
124793288|NCT04393298|448874234|FG014|Overall Study|Lack of Efficacy|1|||
124793289|NCT04393298|448874220|FG000|Overall Study|Progression|1|||
124793290|NCT04393298|448874221|FG001|Overall Study|Progression|0|||
124793291|NCT04393298|448874222|FG002|Overall Study|Progression|0|||
124793292|NCT04393298|448874223|FG003|Overall Study|Progression|0|||
124793293|NCT04393298|448874224|FG004|Overall Study|Progression|0|||
124793294|NCT04393298|448874225|FG005|Overall Study|Progression|0|||
124793295|NCT04393298|448874226|FG006|Overall Study|Progression|0|||
124793296|NCT04393298|448874227|FG007|Overall Study|Progression|0|||
124793297|NCT04393298|448874228|FG008|Overall Study|Progression|0|||
124793298|NCT04393298|448874229|FG009|Overall Study|Progression|0|||
124793299|NCT04393298|448874230|FG010|Overall Study|Progression|1|||
124793300|NCT04393298|448874231|FG011|Overall Study|Progression|1|||
124793301|NCT04393298|448874232|FG012|Overall Study|Progression|0|||
124793302|NCT04393298|448874233|FG013|Overall Study|Progression|0|||
124793303|NCT04393298|448874234|FG014|Overall Study|Progression|0|||
124793304|NCT04393298|448874220|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
124793305|NCT04393298|448874221|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
125295291|NCT04208087|450707866|FG001|Overall Study|Other|0|||
125295292|NCT04208087|450707867|FG002|Overall Study|Other|0|||
125295293|NCT04208087|450707868|FG003|Overall Study|Other|0|||
124793306|NCT04393298|448874222|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793307|NCT04393298|448874223|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793308|NCT04393298|448874224|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793309|NCT04393298|448874225|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793310|NCT04393298|448874226|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793311|NCT04393298|448874227|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793312|NCT04393298|448874228|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793313|NCT04393298|448874229|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793314|NCT04393298|448874230|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
125295294|NCT04208087|450707869|FG004|Overall Study|Other|1|||
125295295|NCT01977690|450707870|FG000|Overall Study|Withdrawal by Subject|0|||
124793315|NCT04393298|448874231|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793316|NCT04393298|448874232|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793317|NCT04393298|448874233|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793318|NCT04393298|448874234|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793319|NCT04393298|448874220|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793320|NCT04393298|448874221|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
124793321|NCT04393298|448874222|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793322|NCT04393298|448874223|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793323|NCT04393298|448874224|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793324|NCT04393298|448874225|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793325|NCT04393298|448874226|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793326|NCT04393298|448874227|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793327|NCT04393298|448874228|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793328|NCT04393298|448874229|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793329|NCT04393298|448874230|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793330|NCT04393298|448874231|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793331|NCT04393298|448874232|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793332|NCT04393298|448874233|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793333|NCT04393298|448874234|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793334|NCT04393298|448874220|FG000|Overall Study|Clinical Progression|0|||
124793335|NCT04393298|448874221|FG001|Overall Study|Clinical Progression|2|||
124793336|NCT04393298|448874222|FG002|Overall Study|Clinical Progression|0|||
124793337|NCT04393298|448874223|FG003|Overall Study|Clinical Progression|0|||
124793338|NCT04393298|448874224|FG004|Overall Study|Clinical Progression|0|||
124793339|NCT04393298|448874225|FG005|Overall Study|Clinical Progression|0|||
124793340|NCT04393298|448874226|FG006|Overall Study|Clinical Progression|0|||
124793341|NCT04393298|448874227|FG007|Overall Study|Clinical Progression|0|||
124793342|NCT04393298|448874228|FG008|Overall Study|Clinical Progression|0|||
124793343|NCT04393298|448874229|FG009|Overall Study|Clinical Progression|0|||
124793344|NCT04393298|448874230|FG010|Overall Study|Clinical Progression|0|||
124793345|NCT04393298|448874231|FG011|Overall Study|Clinical Progression|0|||
124793346|NCT04393298|448874232|FG012|Overall Study|Clinical Progression|0|||
124793347|NCT04393298|448874233|FG013|Overall Study|Clinical Progression|0|||
124793348|NCT04393298|448874234|FG014|Overall Study|Clinical Progression|0|||
124793349|NCT04393298|448874220|FG000|Overall Study|Disease Progression|0|||
124793350|NCT04393298|448874221|FG001|Overall Study|Disease Progression|1|||
124793351|NCT04393298|448874222|FG002|Overall Study|Disease Progression|0|||
124793352|NCT04393298|448874223|FG003|Overall Study|Disease Progression|0|||
124793353|NCT04393298|448874224|FG004|Overall Study|Disease Progression|0|||
124793354|NCT04393298|448874225|FG005|Overall Study|Disease Progression|3|||
124793355|NCT04393298|448874226|FG006|Overall Study|Disease Progression|2|||
124793356|NCT04393298|448874227|FG007|Overall Study|Disease Progression|1|||
124793357|NCT04393298|448874228|FG008|Overall Study|Disease Progression|2|||
124793358|NCT04393298|448874229|FG009|Overall Study|Disease Progression|1|||
124793359|NCT04393298|448874230|FG010|Overall Study|Disease Progression|0|||
124793360|NCT04393298|448874231|FG011|Overall Study|Disease Progression|3|||
124793361|NCT04393298|448874232|FG012|Overall Study|Disease Progression|0|||
124793362|NCT04393298|448874233|FG013|Overall Study|Disease Progression|0|||
124793363|NCT04393298|448874234|FG014|Overall Study|Disease Progression|1|||
124793364|NCT04393298|448874220|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793365|NCT04393298|448874221|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793366|NCT04393298|448874222|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
124793367|NCT04393298|448874223|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793368|NCT04393298|448874224|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793369|NCT04393298|448874225|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793370|NCT04393298|448874226|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793371|NCT04393298|448874227|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793372|NCT04393298|448874228|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793373|NCT04393298|448874229|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793374|NCT04393298|448874230|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793375|NCT04393298|448874231|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793376|NCT04393298|448874232|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793377|NCT04393298|448874233|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793378|NCT04393298|448874234|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793379|NCT04393298|448874220|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793380|NCT04393298|448874221|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793381|NCT04393298|448874222|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
124793382|NCT04393298|448874223|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793383|NCT04393298|448874224|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793384|NCT04393298|448874225|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793385|NCT04393298|448874226|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793386|NCT04393298|448874227|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793387|NCT04393298|448874228|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793388|NCT04393298|448874229|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793389|NCT04393298|448874230|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793390|NCT04393298|448874231|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793391|NCT04393298|448874232|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793392|NCT04393298|448874233|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793393|NCT04393298|448874234|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793394|NCT04393298|448874220|FG000|Overall Study|Progressive Disease (PD)|0|||
124793395|NCT04393298|448874221|FG001|Overall Study|Progressive Disease (PD)|0|||
124793396|NCT04393298|448874222|FG002|Overall Study|Progressive Disease (PD)|0|||
124793397|NCT04393298|448874223|FG003|Overall Study|Progressive Disease (PD)|3|||
124793398|NCT04393298|448874224|FG004|Overall Study|Progressive Disease (PD)|0|||
124793399|NCT04393298|448874225|FG005|Overall Study|Progressive Disease (PD)|0|||
124793400|NCT04393298|448874226|FG006|Overall Study|Progressive Disease (PD)|0|||
124793401|NCT04393298|448874227|FG007|Overall Study|Progressive Disease (PD)|0|||
124793402|NCT04393298|448874228|FG008|Overall Study|Progressive Disease (PD)|0|||
124793403|NCT04393298|448874229|FG009|Overall Study|Progressive Disease (PD)|0|||
124793404|NCT04393298|448874230|FG010|Overall Study|Progressive Disease (PD)|0|||
124793405|NCT04393298|448874231|FG011|Overall Study|Progressive Disease (PD)|0|||
124793406|NCT04393298|448874232|FG012|Overall Study|Progressive Disease (PD)|0|||
124793407|NCT04393298|448874233|FG013|Overall Study|Progressive Disease (PD)|0|||
124793408|NCT04393298|448874234|FG014|Overall Study|Progressive Disease (PD)|0|||
124793409|NCT04393298|448874220|FG000|Overall Study|Started a New Cancer Treatment|0|||
124793410|NCT04393298|448874221|FG001|Overall Study|Started a New Cancer Treatment|0|||
124793411|NCT04393298|448874222|FG002|Overall Study|Started a New Cancer Treatment|0|||
124793412|NCT04393298|448874223|FG003|Overall Study|Started a New Cancer Treatment|0|||
124793413|NCT04393298|448874224|FG004|Overall Study|Started a New Cancer Treatment|1|||
124793414|NCT04393298|448874225|FG005|Overall Study|Started a New Cancer Treatment|0|||
124793415|NCT04393298|448874226|FG006|Overall Study|Started a New Cancer Treatment|0|||
125295296|NCT01977690|450707871|FG001|Overall Study|Withdrawal by Subject|4|||
125295297|NCT00952614|450707872|FG000|Overall Study|Death|3|||
125295298|NCT00952614|450707872|FG000|Overall Study|Lost to Follow-up|3|||
125295299|NCT00952614|450707872|FG000|Overall Study|other reason|1|||
125295300|NCT04023682|450707873|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
125295301|NCT00637572|450707875|FG000|Overall Study|Adverse Event|1|||
125295302|NCT00637572|450707876|FG001|Overall Study|Adverse Event|2|||
125295303|NCT00637572|450707875|FG000|Overall Study|Death|0|||
125295304|NCT00637572|450707876|FG001|Overall Study|Death|1|||
125295305|NCT00637572|450707875|FG000|Overall Study|Lost to Follow-up|0|||
125295306|NCT00637572|450707876|FG001|Overall Study|Lost to Follow-up|1|||
125295307|NCT00637572|450707875|FG000|Overall Study|Physician Decision|1|||
125295308|NCT00637572|450707876|FG001|Overall Study|Physician Decision|1|||
125295309|NCT00637572|450707875|FG000|Overall Study|Withdrawal by Subject|0|||
125295310|NCT00637572|450707876|FG001|Overall Study|Withdrawal by Subject|2|||
125295311|NCT00637572|450707875|FG000|Overall Study|Illicit Drug Use|1|||
125295312|NCT00637572|450707876|FG001|Overall Study|Illicit Drug Use|0|||
125295313|NCT04268745|450707884|FG000|Overall Study|Lost to Follow-up|2|||
125295314|NCT04268745|450707885|FG001|Overall Study|Lost to Follow-up|3|||
125295315|NCT04268745|450707884|FG000|Overall Study|Withdrawal by Subject|4|||
125295316|NCT04268745|450707885|FG001|Overall Study|Withdrawal by Subject|2|||
125295317|NCT04268745|450707884|FG000|Overall Study|Death in the family|1|||
125295318|NCT04268745|450707885|FG001|Overall Study|Death in the family|0|||
125295319|NCT00447122|450707887|FG000|Overall Study|worsening medical condition -came off|0|||
125295320|NCT00447122|450707888|FG001|Overall Study|worsening medical condition -came off|1|||
125295321|NCT00447122|450707889|FG002|Overall Study|worsening medical condition -came off|0|||
125295322|NCT00447122|450707890|FG003|Overall Study|worsening medical condition -came off|0|||
125295323|NCT02540291|450707891|FG000|Overall Study|Death|7|||
125295324|NCT02540291|450707892|FG001|Overall Study|Death|7|||
125295325|NCT02540291|450707893|FG002|Overall Study|Death|5|||
125295326|NCT02540291|450707894|FG003|Overall Study|Death|7|||
125295327|NCT02540291|450707891|FG000|Overall Study|Lost to Follow-up|0|||
125295328|NCT02540291|450707892|FG001|Overall Study|Lost to Follow-up|0|||
125295329|NCT02540291|450707893|FG002|Overall Study|Lost to Follow-up|1|||
124793416|NCT04393298|448874227|FG007|Overall Study|Started a New Cancer Treatment|0|||
124793417|NCT04393298|448874228|FG008|Overall Study|Started a New Cancer Treatment|0|||
124793418|NCT04393298|448874229|FG009|Overall Study|Started a New Cancer Treatment|0|||
125295330|NCT02540291|450707894|FG003|Overall Study|Lost to Follow-up|0|||
125295331|NCT02540291|450707891|FG000|Overall Study|Withdrawal Of Consent|0|||
125295332|NCT02540291|450707892|FG001|Overall Study|Withdrawal Of Consent|1|||
125295333|NCT02540291|450707893|FG002|Overall Study|Withdrawal Of Consent|0|||
125295334|NCT02540291|450707894|FG003|Overall Study|Withdrawal Of Consent|0|||
125295335|NCT02540291|450707891|FG000|Overall Study|Study Terminated By Sponsor|1|||
125295336|NCT02540291|450707892|FG001|Overall Study|Study Terminated By Sponsor|0|||
125295337|NCT02540291|450707893|FG002|Overall Study|Study Terminated By Sponsor|0|||
125295338|NCT02540291|450707894|FG003|Overall Study|Study Terminated By Sponsor|0|||
125295339|NCT02540291|450707891|FG000|Overall Study|Other|0|||
125295340|NCT02540291|450707892|FG001|Overall Study|Other|0|||
125295341|NCT02540291|450707893|FG002|Overall Study|Other|1|||
125295342|NCT02540291|450707894|FG003|Overall Study|Other|0|||
125295343|NCT01174173|450707899|FG000|Overall Study|drug-drug interaction|1|||
125295344|NCT01918332|450709418|FG000|Overall Study|Adverse Event|0|||
125295345|NCT01918332|450709419|FG001|Overall Study|Adverse Event|0|||
125295346|NCT01918332|450709420|FG002|Overall Study|Adverse Event|0|||
125295347|NCT01918332|450709421|FG003|Overall Study|Adverse Event|1|||
125295348|NCT01918332|450709418|FG000|Overall Study|Withdrawal by Subject|2|||
125295349|NCT01918332|450709419|FG001|Overall Study|Withdrawal by Subject|3|||
125295350|NCT01918332|450709420|FG002|Overall Study|Withdrawal by Subject|2|||
125295351|NCT01918332|450709421|FG003|Overall Study|Withdrawal by Subject|3|||
125295352|NCT01918332|450709418|FG000|Overall Study|Protocol Violation|6|||
125295353|NCT01918332|450709419|FG001|Overall Study|Protocol Violation|2|||
125295354|NCT01918332|450709420|FG002|Overall Study|Protocol Violation|6|||
125295355|NCT01918332|450709421|FG003|Overall Study|Protocol Violation|3|||
125295356|NCT01918332|450709418|FG000|Overall Study|lipid result by central lab did not meet|0|||
125295357|NCT01918332|450709419|FG001|Overall Study|lipid result by central lab did not meet|0|||
125295358|NCT01918332|450709420|FG002|Overall Study|lipid result by central lab did not meet|1|||
125295359|NCT01918332|450709421|FG003|Overall Study|lipid result by central lab did not meet|0|||
125295360|NCT02408523|450709422|FG000|Overall Study|Adverse Event|4|||
125295361|NCT02408523|450709423|FG001|Overall Study|Adverse Event|10|||
125295362|NCT02408523|450709422|FG000|Overall Study|Lack of Efficacy|0|||
125295363|NCT02408523|450709423|FG001|Overall Study|Lack of Efficacy|1|||
125295364|NCT02408523|450709422|FG000|Overall Study|Protocol Violation|1|||
125295365|NCT02408523|450709423|FG001|Overall Study|Protocol Violation|2|||
125295366|NCT02408523|450709422|FG000|Overall Study|Lost to Follow-up|2|||
125295367|NCT02408523|450709423|FG001|Overall Study|Lost to Follow-up|3|||
125295368|NCT02408523|450709422|FG000|Overall Study|Withdrawal by Subject|3|||
125295369|NCT02408523|450709423|FG001|Overall Study|Withdrawal by Subject|1|||
125295370|NCT02408523|450709422|FG000|Overall Study|Sponsor request|1|||
125295371|NCT02408523|450709423|FG001|Overall Study|Sponsor request|0|||
124793419|NCT04393298|448874230|FG010|Overall Study|Started a New Cancer Treatment|0|||
124793420|NCT04393298|448874231|FG011|Overall Study|Started a New Cancer Treatment|0|||
124793421|NCT04393298|448874232|FG012|Overall Study|Started a New Cancer Treatment|0|||
124793422|NCT04393298|448874233|FG013|Overall Study|Started a New Cancer Treatment|0|||
124793423|NCT04393298|448874234|FG014|Overall Study|Started a New Cancer Treatment|0|||
124793424|NCT04393298|448874220|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793425|NCT04393298|448874221|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793426|NCT04393298|448874222|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793427|NCT04393298|448874223|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793428|NCT04393298|448874224|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
124793429|NCT04393298|448874225|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793430|NCT04393298|448874226|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793431|NCT04393298|448874227|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793432|NCT04393298|448874228|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793433|NCT04393298|448874229|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793434|NCT04393298|448874230|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793435|NCT04393298|448874231|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793436|NCT04393298|448874232|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793437|NCT04393298|448874233|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793438|NCT04393298|448874234|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125295372|NCT02408523|450709422|FG000|Overall Study|Did not satisfy extension conditions|0|||
125295373|NCT02408523|450709423|FG001|Overall Study|Did not satisfy extension conditions|1|||
125295374|NCT01751139|450709424|FG000|Overall Study|Other|135|||
125295375|NCT01751139|450709424|FG000|Overall Study|Sponsor study termination|1609|||
125295376|NCT01751139|450709424|FG000|Overall Study|Lost to Follow-up|240|||
125295377|NCT01751139|450709424|FG000|Overall Study|Withdrawal by Subject|251|||
125295378|NCT01751139|450709424|FG000|Overall Study|Adverse Event|1|||
125295379|NCT01751139|450709424|FG000|Overall Study|Death|31|||
125295380|NCT01867086|450709425|FG000|Overall Study|Disease Progression|1|||
125295381|NCT04279613|450709426|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
125295382|NCT04279613|450709427|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
125295383|NCT04279613|450709428|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
125295384|NCT04279613|450709429|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
125295385|NCT04279613|450709430|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
125295386|NCT04279613|450709426|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
124793439|NCT04393298|448874220|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793440|NCT04393298|448874221|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793441|NCT04393298|448874222|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793442|NCT04393298|448874223|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793443|NCT04393298|448874224|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793444|NCT04393298|448874225|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
124793445|NCT04393298|448874226|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793446|NCT04393298|448874227|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793447|NCT04393298|448874228|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793448|NCT04393298|448874229|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793449|NCT04393298|448874230|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793450|NCT04393298|448874231|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793451|NCT04393298|448874232|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793452|NCT04393298|448874233|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793453|NCT04393298|448874234|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793454|NCT04393298|448874220|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793455|NCT04393298|448874221|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793456|NCT04393298|448874222|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793457|NCT04393298|448874223|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793458|NCT04393298|448874224|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793459|NCT04393298|448874225|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
124793460|NCT04393298|448874226|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793461|NCT04393298|448874227|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793462|NCT04393298|448874228|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793463|NCT04393298|448874229|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793464|NCT04393298|448874230|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793465|NCT04393298|448874231|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793466|NCT04393298|448874232|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793467|NCT04393298|448874233|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793468|NCT04393298|448874234|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
124793469|NCT04393298|448874220|FG000|Overall Study|Death|0|||
124793470|NCT04393298|448874221|FG001|Overall Study|Death|0|||
124793471|NCT04393298|448874222|FG002|Overall Study|Death|0|||
124793472|NCT04393298|448874223|FG003|Overall Study|Death|0|||
124793473|NCT04393298|448874224|FG004|Overall Study|Death|0|||
124793474|NCT04393298|448874225|FG005|Overall Study|Death|1|||
124793475|NCT04393298|448874226|FG006|Overall Study|Death|1|||
124793476|NCT04393298|448874227|FG007|Overall Study|Death|0|||
124793477|NCT04393298|448874228|FG008|Overall Study|Death|1|||
124793478|NCT04393298|448874229|FG009|Overall Study|Death|1|||
124793479|NCT04393298|448874230|FG010|Overall Study|Death|0|||
124793480|NCT04393298|448874231|FG011|Overall Study|Death|1|||
124793481|NCT04393298|448874232|FG012|Overall Study|Death|1|||
124793482|NCT04393298|448874233|FG013|Overall Study|Death|0|||
124793483|NCT04393298|448874234|FG014|Overall Study|Death|1|||
124793484|NCT04393298|448874220|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793485|NCT04393298|448874221|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793486|NCT04393298|448874222|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793487|NCT04393298|448874223|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793488|NCT04393298|448874224|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793489|NCT04393298|448874225|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
124793490|NCT04393298|448874226|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793491|NCT04393298|448874227|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793492|NCT04393298|448874228|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793493|NCT04393298|448874229|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793494|NCT04393298|448874230|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793495|NCT04393298|448874231|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793496|NCT04393298|448874232|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793497|NCT04393298|448874233|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125295387|NCT04279613|450709427|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
125295388|NCT04279613|450709428|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
124793498|NCT04393298|448874234|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793499|NCT04393298|448874220|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
124793500|NCT04393298|448874221|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
124793501|NCT04393298|448874222|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
125295389|NCT04279613|450709429|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
125295390|NCT04279613|450709430|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
125295391|NCT04279613|450709426|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
124793502|NCT04393298|448874223|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
124793503|NCT04393298|448874224|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
124793504|NCT04393298|448874225|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
124793505|NCT04393298|448874226|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
124793506|NCT04393298|448874227|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
124793507|NCT04393298|448874228|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
124793508|NCT04393298|448874229|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
124793509|NCT04393298|448874230|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
124793510|NCT04393298|448874231|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
124793511|NCT04393298|448874232|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
124793512|NCT04393298|448874233|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
124793513|NCT04393298|448874234|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
124793514|NCT04393298|448874220|FG000|Overall Study|Patient Passed Away|0|||
124793515|NCT04393298|448874221|FG001|Overall Study|Patient Passed Away|0|||
124793516|NCT04393298|448874222|FG002|Overall Study|Patient Passed Away|0|||
124793517|NCT04393298|448874223|FG003|Overall Study|Patient Passed Away|0|||
124793518|NCT04393298|448874224|FG004|Overall Study|Patient Passed Away|0|||
124793519|NCT04393298|448874225|FG005|Overall Study|Patient Passed Away|0|||
124793520|NCT04393298|448874226|FG006|Overall Study|Patient Passed Away|0|||
124793521|NCT04393298|448874227|FG007|Overall Study|Patient Passed Away|1|||
124793522|NCT04393298|448874228|FG008|Overall Study|Patient Passed Away|0|||
124793523|NCT04393298|448874229|FG009|Overall Study|Patient Passed Away|0|||
124793524|NCT04393298|448874230|FG010|Overall Study|Patient Passed Away|0|||
124793525|NCT04393298|448874231|FG011|Overall Study|Patient Passed Away|0|||
124793526|NCT04393298|448874232|FG012|Overall Study|Patient Passed Away|0|||
124793527|NCT04393298|448874233|FG013|Overall Study|Patient Passed Away|0|||
124793528|NCT04393298|448874234|FG014|Overall Study|Patient Passed Away|0|||
124793529|NCT04393298|448874220|FG000|Overall Study|Patient Deceased|0|||
124793530|NCT04393298|448874221|FG001|Overall Study|Patient Deceased|0|||
124793531|NCT04393298|448874222|FG002|Overall Study|Patient Deceased|0|||
124793532|NCT04393298|448874223|FG003|Overall Study|Patient Deceased|0|||
124793533|NCT04393298|448874224|FG004|Overall Study|Patient Deceased|0|||
124793534|NCT04393298|448874225|FG005|Overall Study|Patient Deceased|0|||
124793535|NCT04393298|448874226|FG006|Overall Study|Patient Deceased|0|||
124793536|NCT04393298|448874227|FG007|Overall Study|Patient Deceased|1|||
124793537|NCT04393298|448874228|FG008|Overall Study|Patient Deceased|0|||
124793538|NCT04393298|448874229|FG009|Overall Study|Patient Deceased|0|||
124793539|NCT04393298|448874230|FG010|Overall Study|Patient Deceased|0|||
124793540|NCT04393298|448874231|FG011|Overall Study|Patient Deceased|0|||
124793541|NCT04393298|448874232|FG012|Overall Study|Patient Deceased|0|||
124793542|NCT04393298|448874233|FG013|Overall Study|Patient Deceased|0|||
124793543|NCT04393298|448874234|FG014|Overall Study|Patient Deceased|0|||
124793544|NCT04393298|448874220|FG000|Overall Study|Patient Discharged to Hospice|0|||
124793545|NCT04393298|448874221|FG001|Overall Study|Patient Discharged to Hospice|0|||
124793546|NCT04393298|448874222|FG002|Overall Study|Patient Discharged to Hospice|0|||
124793547|NCT04393298|448874223|FG003|Overall Study|Patient Discharged to Hospice|0|||
124793548|NCT04393298|448874224|FG004|Overall Study|Patient Discharged to Hospice|0|||
124793549|NCT04393298|448874225|FG005|Overall Study|Patient Discharged to Hospice|0|||
124793550|NCT04393298|448874226|FG006|Overall Study|Patient Discharged to Hospice|0|||
124793551|NCT04393298|448874227|FG007|Overall Study|Patient Discharged to Hospice|0|||
124793552|NCT04393298|448874228|FG008|Overall Study|Patient Discharged to Hospice|1|||
124793553|NCT04393298|448874229|FG009|Overall Study|Patient Discharged to Hospice|0|||
124793554|NCT04393298|448874230|FG010|Overall Study|Patient Discharged to Hospice|0|||
124793555|NCT04393298|448874231|FG011|Overall Study|Patient Discharged to Hospice|0|||
124793556|NCT04393298|448874232|FG012|Overall Study|Patient Discharged to Hospice|0|||
124793557|NCT04393298|448874233|FG013|Overall Study|Patient Discharged to Hospice|0|||
124793558|NCT04393298|448874234|FG014|Overall Study|Patient Discharged to Hospice|0|||
124793559|NCT04393298|448874220|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793560|NCT04393298|448874221|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793561|NCT04393298|448874222|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793562|NCT04393298|448874223|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793563|NCT04393298|448874224|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125295392|NCT04279613|450709427|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
124793564|NCT04393298|448874225|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125295393|NCT04279613|450709428|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
124793565|NCT04393298|448874226|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793566|NCT04393298|448874227|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793567|NCT04393298|448874228|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793568|NCT04393298|448874229|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
124793569|NCT04393298|448874230|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793570|NCT04393298|448874231|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793571|NCT04393298|448874232|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793572|NCT04393298|448874233|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793573|NCT04393298|448874234|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793574|NCT04393298|448874220|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
124793575|NCT04393298|448874221|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
124793576|NCT04393298|448874222|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
124793577|NCT04393298|448874223|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
124793578|NCT04393298|448874224|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
124793579|NCT04393298|448874225|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
124793580|NCT04393298|448874226|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
124793581|NCT04393298|448874227|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
124793582|NCT04393298|448874228|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
124793583|NCT04393298|448874229|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
124793584|NCT04393298|448874230|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
124793585|NCT04393298|448874231|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
124793586|NCT04393298|448874232|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
124793587|NCT04393298|448874233|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
124793588|NCT04393298|448874234|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
124793589|NCT02311582|448874237|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
124793590|NCT02311582|448874238|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
124793591|NCT02311582|448874239|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
124793592|NCT02311582|448874240|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
124793593|NCT02311582|448874241|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
124793594|NCT04972630|448874243|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
124793595|NCT04972630|448874244|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
124793596|NCT04972630|448874245|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
124793597|NCT01129024|448874253|FG000|Overall Study|Physician Decision|5|||
124793598|NCT01129024|448874253|FG000|Overall Study|Study Terminated by Sponsor|8|||
124793599|NCT01129024|448874253|FG000|Overall Study|Withdrawal by Subject|2|||
124793600|NCT01129024|448874253|FG000|Overall Study|Lack of Efficacy|3|||
124793601|NCT01129024|448874253|FG000|Overall Study|Needed a Platelet Transfusion|1|||
124793602|NCT00686634|448874259|FG000|Overall Study|Protocol Violation|6|||
124793603|NCT00924781|448874262|FG000|Overall Study|Study terminated by sponsor|12|||
124793604|NCT00924781|448874263|FG001|Overall Study|Study terminated by sponsor|10|||
124793605|NCT01653132|448874264|FG000|First Intervention|Protocol Violation|1|||
124793606|NCT01653132|448874265|FG001|First Intervention|Protocol Violation|0|||
124793607|NCT03828370|448874266|FG000|3 Month Follow-up|Lost to Follow-up|4|||
124793608|NCT03828370|448874267|FG001|3 Month Follow-up|Lost to Follow-up|12|||
124793609|NCT03828370|448874266|FG000|9 Month Follow up|Lost to Follow-up|12|||
124793610|NCT03828370|448874267|FG001|9 Month Follow up|Lost to Follow-up|20|||
124793611|NCT02677324|448874268|FG000|Overall Study|Disease Progression|6|||
124793612|NCT02677324|448874268|FG000|Overall Study|Inability to Swallow pills|1|||
124793613|NCT02677324|448874268|FG000|Overall Study|Non-compliance|1|||
124793614|NCT02677324|448874268|FG000|Overall Study|Lack of Efficacy|1|||
124793615|NCT02677324|448874268|FG000|Overall Study|Medical insurance coverage|1|||
124793616|NCT02677324|448874268|FG000|Overall Study|Adverse Event|1|||
124793617|NCT02677324|448874268|FG000|Overall Study|IgM Myeloma diagnosis|1|||
124793618|NCT03312751|448874271|FG000|Overall Study|Death|7|||
124793619|NCT03312751|448874272|FG001|Overall Study|Death|9|||
124793620|NCT03312751|448874271|FG000|Overall Study|Study discontinuation due to other reason|0|||
124793621|NCT03312751|448874272|FG001|Overall Study|Study discontinuation due to other reason|1|||
124793622|NCT00475423|448874273|FG000|Overall Study|Protocol Violation|5|||
124793623|NCT00475423|448874273|FG000|Overall Study|Adverse Event|4|||
124793624|NCT00475423|448874273|FG000|Overall Study|Withdrawal by Subject|6|||
124793625|NCT00475423|448874273|FG000|Overall Study|Lack of Efficacy|8|||
124793626|NCT00475423|448874273|FG000|Overall Study|Death|1|||
124793627|NCT00475423|448874273|FG000|Overall Study|Reason not specified|1|||
124793628|NCT00475423|448874273|FG000|Overall Study|Lost to Follow-up|7|||
124793629|NCT00046891|448874274|FG000|Overall Study|Cancels|5|||
124793630|NCT00046891|448874275|FG001|Overall Study|Cancels|9|||
124793631|NCT00046891|448874274|FG000|Overall Study|Ineligible|1|||
124793632|NCT00046891|448874275|FG001|Overall Study|Ineligible|1|||
124793633|NCT00046891|448874274|FG000|Overall Study|Withdrawal by Subject|18|||
124793634|NCT00046891|448874275|FG001|Overall Study|Withdrawal by Subject|15|||
124793635|NCT00046891|448874274|FG000|Overall Study|Adverse Event|5|||
124793636|NCT00046891|448874275|FG001|Overall Study|Adverse Event|5|||
124793637|NCT02496676|448874276|FG000|Phase 1 - Period 1|Adverse Event|0|||
124793638|NCT02496676|448874277|FG001|Phase 1 - Period 1|Adverse Event|1|||
124793639|NCT02496676|448874276|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
124793640|NCT02496676|448874277|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
124793641|NCT01624870|448874278|FG000|Overall Study|Death|19|||
124793642|NCT01624870|448874278|FG000|Overall Study|Withdrawal by Subject|1|||
124793643|NCT01624870|448874278|FG000|Overall Study|CoreValve not implanted|6|||
124793644|NCT01624870|448874278|FG000|Overall Study|Lost to follow up|1|||
124793645|NCT04672252|448874282|FG000|Overall Study|Protocol Violation|1|||
124793646|NCT04672252|448874283|FG001|Overall Study|Protocol Violation|0|||
124793647|NCT04391569|448874284|FG000|Overall Study|Death|15|||
124793648|NCT04391569|448874285|FG001|Overall Study|Death|10|||
124793649|NCT04391569|448874284|FG000|Overall Study|Withdrawal by Subject|1|||
124793650|NCT04391569|448874285|FG001|Overall Study|Withdrawal by Subject|0|||
124793651|NCT04391569|448874284|FG000|Overall Study|Lost to Follow-up|3|||
124793652|NCT04391569|448874285|FG001|Overall Study|Lost to Follow-up|2|||
124793653|NCT04391569|448874284|FG000|Overall Study|Lack of Efficacy|0|||
124793654|NCT04391569|448874285|FG001|Overall Study|Lack of Efficacy|1|||
124793655|NCT04391569|448874284|FG000|Overall Study|Participant discharged to hospice facility|0|||
124793656|NCT04391569|448874285|FG001|Overall Study|Participant discharged to hospice facility|1|||
124793657|NCT04391569|448874284|FG000|Overall Study|Participant family decision|1|||
124793658|NCT04391569|448874285|FG001|Overall Study|Participant family decision|0|||
124793659|NCT04391569|448874284|FG000|Overall Study|Participant discharged prematurely|1|||
124793660|NCT04391569|448874285|FG001|Overall Study|Participant discharged prematurely|0|||
124793661|NCT01431638|448874286|FG000|Overall Study|Adverse Event|1|||
124793662|NCT01431638|448874287|FG001|Overall Study|Adverse Event|3|||
124793663|NCT01431638|448874288|FG002|Overall Study|Adverse Event|1|||
124793664|NCT01431638|448874286|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124793665|NCT01431638|448874287|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124793666|NCT01431638|448874288|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
124793667|NCT01431638|448874286|FG000|Overall Study|Participants condition no longer requires study drug|0|||
124793668|NCT01431638|448874287|FG001|Overall Study|Participants condition no longer requires study drug|1|||
124793669|NCT01431638|448874288|FG002|Overall Study|Participants condition no longer requires study drug|0|||
124793670|NCT01431638|448874286|FG000|Overall Study|Participant withdrew consent|14|||
124793671|NCT01431638|448874287|FG001|Overall Study|Participant withdrew consent|5|||
124793672|NCT01431638|448874288|FG002|Overall Study|Participant withdrew consent|8|||
124793673|NCT01431638|448874286|FG000|Overall Study|Lost to Follow-up|7|||
124793674|NCT01431638|448874287|FG001|Overall Study|Lost to Follow-up|9|||
124793675|NCT01431638|448874288|FG002|Overall Study|Lost to Follow-up|7|||
124793676|NCT01431638|448874286|FG000|Overall Study|Administrative problems|1|||
124793677|NCT01431638|448874287|FG001|Overall Study|Administrative problems|4|||
124793678|NCT01431638|448874288|FG002|Overall Study|Administrative problems|6|||
124793679|NCT01431638|448874286|FG000|Overall Study|Death|1|||
124793680|NCT01431638|448874287|FG001|Overall Study|Death|0|||
124793681|NCT01431638|448874288|FG002|Overall Study|Death|0|||
124793682|NCT01431638|448874286|FG000|Overall Study|Protocol deviation|1|||
124793683|NCT01431638|448874287|FG001|Overall Study|Protocol deviation|1|||
124793684|NCT01431638|448874288|FG002|Overall Study|Protocol deviation|4|||
124793685|NCT01431638|448874286|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
124793686|NCT01431638|448874287|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
124793687|NCT01431638|448874288|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
124793688|NCT00773838|448874289|FG000|Overall Study|Adverse Event|29|||
124793689|NCT00773838|448874289|FG000|Overall Study|Lost to Follow-up|1|||
124793690|NCT00773838|448874289|FG000|Overall Study|Physician Decision|8|||
124793691|NCT00773838|448874289|FG000|Overall Study|Progressive Disease|82|||
124793692|NCT00773838|448874289|FG000|Overall Study|Protocol Violation|2|||
124793693|NCT00773838|448874289|FG000|Overall Study|Withdrawal by Subject|21|||
124793694|NCT04085367|448875689|FG000|Overall Study|Adverse Event|1|||
124793695|NCT04085367|448875690|FG001|Overall Study|Adverse Event|1|||
124793696|NCT04085367|448875689|FG000|Overall Study|Withdrawal by Subject|13|||
124793697|NCT04085367|448875690|FG001|Overall Study|Withdrawal by Subject|4|||
124793698|NCT04085367|448875689|FG000|Overall Study|Lost to Follow-up|3|||
124793699|NCT04085367|448875690|FG001|Overall Study|Lost to Follow-up|1|||
124793700|NCT04085367|448875689|FG000|Overall Study|Other unspecified|2|||
124793701|NCT04085367|448875690|FG001|Overall Study|Other unspecified|1|||
124793702|NCT04085367|448875689|FG000|Overall Study|Status Unknown|1|||
124793703|NCT04085367|448875690|FG001|Overall Study|Status Unknown|1|||
124793704|NCT00470158|448875701|FG000|Overall Study|Death|0|||
125295394|NCT04279613|450709429|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
125295395|NCT04279613|450709430|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
125295396|NCT04279613|450709426|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
125295397|NCT04279613|450709427|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
124793705|NCT00470158|448875702|FG001|Overall Study|Death|0|||
124793706|NCT00470158|448875703|FG002|Overall Study|Death|0|||
124793707|NCT00470158|448875704|FG003|Overall Study|Death|0|||
124793708|NCT00470158|448875705|FG004|Overall Study|Death|2|||
124793709|NCT00470158|448875701|FG000|Overall Study|Lost to Follow-up|7|||
124793710|NCT00470158|448875702|FG001|Overall Study|Lost to Follow-up|8|||
124793711|NCT00470158|448875703|FG002|Overall Study|Lost to Follow-up|8|||
124793712|NCT00470158|448875704|FG003|Overall Study|Lost to Follow-up|5|||
124793713|NCT00470158|448875705|FG004|Overall Study|Lost to Follow-up|4|||
124793714|NCT00470158|448875701|FG000|Overall Study|Protocol Violation|1|||
124793715|NCT00470158|448875702|FG001|Overall Study|Protocol Violation|0|||
124793716|NCT00470158|448875703|FG002|Overall Study|Protocol Violation|0|||
124793717|NCT00470158|448875704|FG003|Overall Study|Protocol Violation|0|||
124793718|NCT00470158|448875705|FG004|Overall Study|Protocol Violation|0|||
124793719|NCT01249118|448875706|FG000|First Washout Period|Physician Decision|0|||
124793720|NCT01249118|448875707|FG001|First Washout Period|Physician Decision|1|||
124793721|NCT01249118|448875708|FG002|First Washout Period|Physician Decision|0|||
124793722|NCT00880685|448875709|FG000|Memantine 10mg|Lost to Follow-up|2|||
124793723|NCT00880685|448875709|FG000|Memantine 20mg|Withdrawal by Subject|1|||
124793724|NCT00997438|448875710|FG000|Overall Study|Blood draw difficulty|2|||
124793725|NCT00997438|448875711|FG001|Overall Study|Blood draw difficulty|0|||
124793726|NCT00997438|448875712|FG002|Overall Study|Blood draw difficulty|1|||
124793727|NCT00997438|448875710|FG000|Overall Study|Withdrawal by Subject|1|||
124793728|NCT00997438|448875711|FG001|Overall Study|Withdrawal by Subject|1|||
124793729|NCT00997438|448875712|FG002|Overall Study|Withdrawal by Subject|0|||
124793730|NCT00997438|448875710|FG000|Overall Study|Exclusion criteria at visit 1|2|||
124793731|NCT00997438|448875711|FG001|Overall Study|Exclusion criteria at visit 1|2|||
124793732|NCT00997438|448875712|FG002|Overall Study|Exclusion criteria at visit 1|3|||
124793733|NCT01236118|448875713|FG000|Overall Study|Adverse Event|2|||
124793734|NCT01236118|448875714|FG001|Overall Study|Adverse Event|0|||
124793735|NCT01236118|448875715|FG002|Overall Study|Adverse Event|2|||
124793736|NCT01236118|448875713|FG000|Overall Study|Physician Decision|0|||
124793737|NCT01236118|448875714|FG001|Overall Study|Physician Decision|1|||
124793738|NCT01236118|448875715|FG002|Overall Study|Physician Decision|0|||
124793739|NCT01236118|448875713|FG000|Overall Study|Withdrawal by Subject|0|||
124793740|NCT01236118|448875714|FG001|Overall Study|Withdrawal by Subject|0|||
124793741|NCT01236118|448875715|FG002|Overall Study|Withdrawal by Subject|1|||
124793742|NCT00095238|448875716|FG000|Overall Study|Lack of Efficacy|9|||
124793743|NCT00095238|448875717|FG001|Overall Study|Lack of Efficacy|9|||
124793744|NCT00095238|448875716|FG000|Overall Study|Adverse Event|331|||
124793745|NCT00095238|448875717|FG001|Overall Study|Adverse Event|287|||
124793746|NCT00095238|448875716|FG000|Overall Study|Subject Withdrew Consent|208|||
124793747|NCT00095238|448875717|FG001|Overall Study|Subject Withdrew Consent|223|||
124793748|NCT00095238|448875716|FG000|Overall Study|Death|154|||
124793749|NCT00095238|448875717|FG001|Overall Study|Death|170|||
124793750|NCT00095238|448875716|FG000|Overall Study|Lost to Follow-up|19|||
124793751|NCT00095238|448875717|FG001|Overall Study|Lost to Follow-up|24|||
124793752|NCT00095238|448875716|FG000|Overall Study|Noncompliance|44|||
124793753|NCT00095238|448875717|FG001|Overall Study|Noncompliance|45|||
124793754|NCT00095238|448875716|FG000|Overall Study|No longer met study criteria|4|||
124793755|NCT00095238|448875717|FG001|Overall Study|No longer met study criteria|5|||
124793756|NCT00095238|448875716|FG000|Overall Study|Study terminated by sponsor|0|||
124793757|NCT00095238|448875717|FG001|Overall Study|Study terminated by sponsor|1|||
124793758|NCT00095238|448875716|FG000|Overall Study|Missing|1|||
124793759|NCT00095238|448875717|FG001|Overall Study|Missing|0|||
124793760|NCT00095238|448875716|FG000|Overall Study|Other Reasons|87|||
124793761|NCT00095238|448875717|FG001|Overall Study|Other Reasons|88|||
124793762|NCT03505671|448875718|FG000|Overall Study|Withdrawal by Subject|2|||
124793763|NCT03505671|448875719|FG001|Overall Study|Withdrawal by Subject|1|||
124793764|NCT03505671|448875718|FG000|Overall Study|Lost to Follow-up|1|||
124793765|NCT03505671|448875719|FG001|Overall Study|Lost to Follow-up|0|||
124793766|NCT04535167|448875722|FG000|Treatment|Adverse Event|0|||
124793767|NCT04535167|448875723|FG001|Treatment|Adverse Event|0|||
124793768|NCT04535167|448875724|FG002|Treatment|Adverse Event|0|||
124793769|NCT04535167|448875725|FG003|Treatment|Adverse Event|0|||
124793770|NCT04535167|448875726|FG004|Treatment|Adverse Event|0|||
124793771|NCT04535167|448875727|FG005|Treatment|Adverse Event|0|||
124793772|NCT04535167|448875728|FG006|Treatment|Adverse Event|1|||
124793773|NCT04535167|448875722|FG000|Follow-Up|Death|0|||
124793774|NCT04535167|448875723|FG001|Follow-Up|Death|0|||
124793775|NCT04535167|448875724|FG002|Follow-Up|Death|0|||
124793776|NCT04535167|448875725|FG003|Follow-Up|Death|0|||
124793777|NCT04535167|448875726|FG004|Follow-Up|Death|0|||
124793778|NCT04535167|448875727|FG005|Follow-Up|Death|0|||
125295398|NCT04279613|450709428|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
124793779|NCT04535167|448875728|FG006|Follow-Up|Death|1|||
124793780|NCT04535167|448875722|FG000|Follow-Up|Lost to Follow-up|0|||
124793781|NCT04535167|448875723|FG001|Follow-Up|Lost to Follow-up|0|||
124793782|NCT04535167|448875724|FG002|Follow-Up|Lost to Follow-up|0|||
124793783|NCT04535167|448875725|FG003|Follow-Up|Lost to Follow-up|1|||
124793784|NCT04535167|448875726|FG004|Follow-Up|Lost to Follow-up|0|||
124793785|NCT04535167|448875727|FG005|Follow-Up|Lost to Follow-up|0|||
124793786|NCT04535167|448875728|FG006|Follow-Up|Lost to Follow-up|0|||
124793787|NCT02038829|448875729|FG000|Washout Period 1|Death|0|||
124793788|NCT02038829|448875730|FG001|Washout Period 1|Death|0|||
124793789|NCT02038829|448875731|FG002|Washout Period 1|Death|0|||
124793790|NCT02038829|448875732|FG003|Washout Period 1|Death|0|||
124793791|NCT02038829|448875733|FG004|Washout Period 1|Death|1|||
124793792|NCT02038829|448875734|FG005|Washout Period 1|Death|0|||
124793793|NCT02038829|448875735|FG006|Washout Period 1|Death|0|||
124793794|NCT02038829|448875736|FG007|Washout Period 1|Death|0|||
124793795|NCT02038829|448875737|FG008|Washout Period 1|Death|0|||
124793796|NCT02038829|448875738|FG009|Washout Period 1|Death|0|||
125295399|NCT04279613|450709429|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
124793797|NCT02038829|448875739|FG010|Washout Period 1|Death|0|||
124793798|NCT02038829|448875740|FG011|Washout Period 1|Death|0|||
124793799|NCT02038829|448875729|FG000|Treatment Period 2|Adverse Event|0|||
124793800|NCT02038829|448875730|FG001|Treatment Period 2|Adverse Event|0|||
124793801|NCT02038829|448875731|FG002|Treatment Period 2|Adverse Event|0|||
124793802|NCT02038829|448875732|FG003|Treatment Period 2|Adverse Event|0|||
124793803|NCT02038829|448875733|FG004|Treatment Period 2|Adverse Event|0|||
124793804|NCT02038829|448875734|FG005|Treatment Period 2|Adverse Event|0|||
124793805|NCT02038829|448875735|FG006|Treatment Period 2|Adverse Event|0|||
124793806|NCT02038829|448875736|FG007|Treatment Period 2|Adverse Event|0|||
124793807|NCT02038829|448875737|FG008|Treatment Period 2|Adverse Event|0|||
124793808|NCT02038829|448875738|FG009|Treatment Period 2|Adverse Event|0|||
124793809|NCT02038829|448875739|FG010|Treatment Period 2|Adverse Event|1|||
124793810|NCT02038829|448875740|FG011|Treatment Period 2|Adverse Event|0|||
124793811|NCT02038829|448875729|FG000|Treatment Period 2|Withdrawal by Subject|1|||
124793812|NCT02038829|448875730|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124793813|NCT02038829|448875731|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124793814|NCT02038829|448875732|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124793815|NCT02038829|448875733|FG004|Treatment Period 2|Withdrawal by Subject|0|||
124793816|NCT02038829|448875734|FG005|Treatment Period 2|Withdrawal by Subject|0|||
124793817|NCT02038829|448875735|FG006|Treatment Period 2|Withdrawal by Subject|0|||
124793818|NCT02038829|448875736|FG007|Treatment Period 2|Withdrawal by Subject|0|||
124793819|NCT02038829|448875737|FG008|Treatment Period 2|Withdrawal by Subject|0|||
124793820|NCT02038829|448875738|FG009|Treatment Period 2|Withdrawal by Subject|0|||
124793821|NCT02038829|448875739|FG010|Treatment Period 2|Withdrawal by Subject|0|||
124793822|NCT02038829|448875740|FG011|Treatment Period 2|Withdrawal by Subject|0|||
124793823|NCT02038829|448875729|FG000|Washout Period 2|Adverse Event|0|||
124793824|NCT02038829|448875730|FG001|Washout Period 2|Adverse Event|0|||
124793825|NCT02038829|448875731|FG002|Washout Period 2|Adverse Event|0|||
124793826|NCT02038829|448875732|FG003|Washout Period 2|Adverse Event|0|||
124793827|NCT02038829|448875733|FG004|Washout Period 2|Adverse Event|0|||
124793828|NCT02038829|448875734|FG005|Washout Period 2|Adverse Event|0|||
124793829|NCT02038829|448875735|FG006|Washout Period 2|Adverse Event|0|||
124793830|NCT02038829|448875736|FG007|Washout Period 2|Adverse Event|0|||
124793831|NCT02038829|448875737|FG008|Washout Period 2|Adverse Event|1|||
125295400|NCT04279613|450709430|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
125295401|NCT04279613|450709426|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
124793832|NCT02038829|448875738|FG009|Washout Period 2|Adverse Event|0|||
124793833|NCT02038829|448875739|FG010|Washout Period 2|Adverse Event|0|||
124793834|NCT02038829|448875740|FG011|Washout Period 2|Adverse Event|0|||
124793835|NCT02038829|448875729|FG000|Washout Period 2|Withdrawal by Subject|0|||
124793836|NCT02038829|448875730|FG001|Washout Period 2|Withdrawal by Subject|0|||
124793837|NCT02038829|448875731|FG002|Washout Period 2|Withdrawal by Subject|0|||
124793838|NCT02038829|448875732|FG003|Washout Period 2|Withdrawal by Subject|0|||
124793839|NCT02038829|448875733|FG004|Washout Period 2|Withdrawal by Subject|0|||
124793840|NCT02038829|448875734|FG005|Washout Period 2|Withdrawal by Subject|1|||
124793841|NCT02038829|448875735|FG006|Washout Period 2|Withdrawal by Subject|0|||
124793842|NCT02038829|448875736|FG007|Washout Period 2|Withdrawal by Subject|0|||
124793843|NCT02038829|448875737|FG008|Washout Period 2|Withdrawal by Subject|0|||
124793844|NCT02038829|448875738|FG009|Washout Period 2|Withdrawal by Subject|0|||
124793845|NCT02038829|448875739|FG010|Washout Period 2|Withdrawal by Subject|0|||
124793846|NCT02038829|448875740|FG011|Washout Period 2|Withdrawal by Subject|0|||
124793847|NCT02038829|448875729|FG000|Treatment Period 4|Adverse Event|0|||
124793848|NCT02038829|448875730|FG001|Treatment Period 4|Adverse Event|1|||
124793849|NCT02038829|448875731|FG002|Treatment Period 4|Adverse Event|0|||
124793850|NCT02038829|448875732|FG003|Treatment Period 4|Adverse Event|0|||
124793851|NCT02038829|448875733|FG004|Treatment Period 4|Adverse Event|0|||
124793852|NCT02038829|448875734|FG005|Treatment Period 4|Adverse Event|0|||
124793853|NCT02038829|448875735|FG006|Treatment Period 4|Adverse Event|0|||
124793854|NCT02038829|448875736|FG007|Treatment Period 4|Adverse Event|0|||
124793855|NCT02038829|448875737|FG008|Treatment Period 4|Adverse Event|0|||
124793856|NCT02038829|448875738|FG009|Treatment Period 4|Adverse Event|0|||
125295402|NCT04279613|450709427|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
125295403|NCT04279613|450709428|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
124793857|NCT02038829|448875739|FG010|Treatment Period 4|Adverse Event|0|||
124793858|NCT02038829|448875740|FG011|Treatment Period 4|Adverse Event|0|||
125295404|NCT04279613|450709429|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
125295405|NCT04279613|450709430|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
125295406|NCT04428151|450709431|FG000|Overall Study|Death|100|||
124793859|NCT02038829|448875729|FG000|Washout Period 4|Adverse Event|0|||
124793860|NCT02038829|448875730|FG001|Washout Period 4|Adverse Event|0|||
124793861|NCT02038829|448875731|FG002|Washout Period 4|Adverse Event|0|||
124793862|NCT02038829|448875732|FG003|Washout Period 4|Adverse Event|0|||
124793863|NCT02038829|448875733|FG004|Washout Period 4|Adverse Event|0|||
124793864|NCT02038829|448875734|FG005|Washout Period 4|Adverse Event|0|||
124793865|NCT02038829|448875735|FG006|Washout Period 4|Adverse Event|1|||
124793866|NCT02038829|448875736|FG007|Washout Period 4|Adverse Event|0|||
124793867|NCT02038829|448875737|FG008|Washout Period 4|Adverse Event|0|||
125295407|NCT04428151|450709432|FG001|Overall Study|Death|86|||
124793868|NCT02038829|448875738|FG009|Washout Period 4|Adverse Event|0|||
124793869|NCT02038829|448875739|FG010|Washout Period 4|Adverse Event|0|||
124793870|NCT02038829|448875740|FG011|Washout Period 4|Adverse Event|0|||
124793871|NCT02038829|448875729|FG000|Treatment Period 6|Adverse Event|0|||
124793872|NCT02038829|448875730|FG001|Treatment Period 6|Adverse Event|0|||
124793873|NCT02038829|448875731|FG002|Treatment Period 6|Adverse Event|1|||
124793874|NCT02038829|448875732|FG003|Treatment Period 6|Adverse Event|0|||
124793875|NCT02038829|448875733|FG004|Treatment Period 6|Adverse Event|0|||
124793876|NCT02038829|448875734|FG005|Treatment Period 6|Adverse Event|0|||
124793877|NCT02038829|448875735|FG006|Treatment Period 6|Adverse Event|0|||
124793878|NCT02038829|448875736|FG007|Treatment Period 6|Adverse Event|0|||
124793879|NCT02038829|448875737|FG008|Treatment Period 6|Adverse Event|0|||
124793880|NCT02038829|448875738|FG009|Treatment Period 6|Adverse Event|0|||
124793881|NCT02038829|448875739|FG010|Treatment Period 6|Adverse Event|0|||
124793882|NCT02038829|448875740|FG011|Treatment Period 6|Adverse Event|0|||
124793883|NCT00075270|448875741|FG000|Overall Study|Withdrawal by Subject|28|||
124793884|NCT00075270|448875742|FG001|Overall Study|Withdrawal by Subject|21|||
124793885|NCT00075270|448875741|FG000|Overall Study|Lost to Follow-up|25|||
124793886|NCT00075270|448875742|FG001|Overall Study|Lost to Follow-up|28|||
124793887|NCT00075270|448875741|FG000|Overall Study|Protocol Violation|0|||
124793888|NCT00075270|448875742|FG001|Overall Study|Protocol Violation|2|||
124793889|NCT00075270|448875741|FG000|Overall Study|Death|198|||
124793890|NCT00075270|448875742|FG001|Overall Study|Death|215|||
124793891|NCT00075270|448875741|FG000|Overall Study|Other/Unknown|9|||
124793892|NCT00075270|448875742|FG001|Overall Study|Other/Unknown|5|||
124793893|NCT00075270|448875741|FG000|Overall Study|Missing|26|||
124793894|NCT00075270|448875742|FG001|Overall Study|Missing|13|||
124793895|NCT04656275|448875744|FG000|Overall Study|Study terminated by sponsor|2|||
124793896|NCT04656275|448875745|FG001|Overall Study|Study terminated by sponsor|4|||
124793897|NCT02361580|448875747|FG000|Overall Study|Lost to Follow-up|6|||
124793898|NCT02361580|448875748|FG001|Overall Study|Lost to Follow-up|3|||
124793899|NCT03490981|448875749|FG000|Overall Study|Lost to Follow-up|1|||
124793900|NCT03490981|448875750|FG001|Overall Study|Lost to Follow-up|2|||
124793901|NCT00723203|448875759|FG000|Overall Study|Withdrawal by Subject|3|||
124793902|NCT00740051|448875760|FG000|Overall Study|Lack of Efficacy|2|||
124793903|NCT00740051|448875761|FG001|Overall Study|Lack of Efficacy|5|||
124793904|NCT00740051|448875760|FG000|Overall Study|Adverse Event|1|||
124793905|NCT00740051|448875761|FG001|Overall Study|Adverse Event|4|||
124793906|NCT00740051|448875760|FG000|Overall Study|Protocol Violation|2|||
124793907|NCT00740051|448875761|FG001|Overall Study|Protocol Violation|6|||
124793908|NCT00740051|448875760|FG000|Overall Study|Lost to Follow-up|3|||
124793909|NCT00740051|448875761|FG001|Overall Study|Lost to Follow-up|8|||
124793910|NCT00740051|448875760|FG000|Overall Study|Withdrawal by Subject|6|||
124793911|NCT00740051|448875761|FG001|Overall Study|Withdrawal by Subject|8|||
124793912|NCT00740051|448875760|FG000|Overall Study|Other reason (not specified)|4|||
124793913|NCT00740051|448875761|FG001|Overall Study|Other reason (not specified)|1|||
124793914|NCT00274924|448875762|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
124793915|NCT00274924|448875763|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
124793916|NCT00274924|448875764|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
124793917|NCT00274924|448875762|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
124793918|NCT00274924|448875763|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
125295408|NCT04428151|450709433|FG002|Overall Study|Death|57|||
125295409|NCT04428151|450709431|FG000|Overall Study|Lost to Follow-up|1|||
125295410|NCT04428151|450709432|FG001|Overall Study|Lost to Follow-up|1|||
124793919|NCT00274924|448875764|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
124793920|NCT00274924|448875762|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
124793921|NCT00274924|448875763|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
124793922|NCT00274924|448875764|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
124793923|NCT00274924|448875762|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
124793924|NCT00274924|448875763|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
124793925|NCT00274924|448875764|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
124793926|NCT00274924|448875762|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
124793927|NCT00274924|448875763|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
124793928|NCT00274924|448875764|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
124793929|NCT00274924|448875762|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
124793930|NCT00274924|448875763|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
124793931|NCT00274924|448875764|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
124793932|NCT00274924|448875762|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
124793933|NCT00274924|448875763|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
124793934|NCT00274924|448875764|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
124793935|NCT00274924|448875762|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
124793936|NCT00274924|448875763|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
124793937|NCT00274924|448875764|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
124793938|NCT00274924|448875762|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
124793939|NCT00274924|448875763|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
125295411|NCT04428151|450709433|FG002|Overall Study|Lost to Follow-up|0|||
124793940|NCT00274924|448875764|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
124793941|NCT00274924|448875762|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
124793942|NCT00274924|448875763|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
124793943|NCT00274924|448875764|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
124793944|NCT00274924|448875762|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
124793945|NCT00274924|448875763|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
124793946|NCT00274924|448875764|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
124793947|NCT00274924|448875762|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
124793948|NCT00274924|448875763|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
124793949|NCT00274924|448875764|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
124793950|NCT00274924|448875762|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
124793951|NCT00274924|448875763|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
124793952|NCT00274924|448875764|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
124793953|NCT01903525|448875766|FG000|Overall Study|Lost to Follow-up|5|||
124793954|NCT01903525|448875767|FG001|Overall Study|Lost to Follow-up|9|||
124793955|NCT01903525|448875766|FG000|Overall Study|Adverse Event|0|||
124793956|NCT01903525|448875767|FG001|Overall Study|Adverse Event|1|||
124793957|NCT04381988|448875768|FG000|Overall Study|The study was terminated|4|||
124793958|NCT04381988|448875769|FG001|Overall Study|The study was terminated|0|||
124793959|NCT03025035|448875770|FG000|Overall Study|Death|2|||
124793960|NCT03025035|448875770|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
124793961|NCT03562767|448875776|FG000|Overall Study|Physician Decision|2|||
124793962|NCT03562767|448875777|FG001|Overall Study|Physician Decision|0|||
124793963|NCT03562767|448875778|FG002|Overall Study|Physician Decision|0|||
124793964|NCT03562767|448875776|FG000|Overall Study|Logistic Reason|1|||
124793965|NCT03562767|448875777|FG001|Overall Study|Logistic Reason|3|||
124793966|NCT03562767|448875778|FG002|Overall Study|Logistic Reason|0|||
124793967|NCT01589770|448875781|FG000|Overall Study|EGFR <60ml/min|6|||
124793968|NCT01589770|448875782|FG001|Overall Study|EGFR <60ml/min|4|||
124793969|NCT01589770|448875781|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
124793970|NCT01589770|448875782|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
124793971|NCT00725842|448875783|FG000|Overall Study|Lost to Follow-up|19|||
124793972|NCT00725842|448875783|FG000|Overall Study|Death|1|||
124793973|NCT00725842|448875783|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
124793974|NCT00725842|448875783|FG000|Overall Study|Consent date prior to study start date|5|||
124793975|NCT00725842|448875783|FG000|Overall Study|Inclusion criterion not met|1|||
124793976|NCT00725842|448875783|FG000|Overall Study|No Visit 1 data|1|||
124793977|NCT01853618|448875786|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
124793978|NCT01853618|448875787|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
124793979|NCT01853618|448875788|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
124793980|NCT01853618|448875789|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
124793981|NCT01853618|448875790|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
124793982|NCT01853618|448875786|FG000|Overall Study|Progressive disease|1|||
124793983|NCT01853618|448875787|FG001|Overall Study|Progressive disease|1|||
124793984|NCT01853618|448875788|FG002|Overall Study|Progressive disease|1|||
124793985|NCT01853618|448875789|FG003|Overall Study|Progressive disease|1|||
124793986|NCT01853618|448875790|FG004|Overall Study|Progressive disease|2|||
124793987|NCT01853618|448875786|FG000|Overall Study|Physician Decision|0|||
124793988|NCT01853618|448875787|FG001|Overall Study|Physician Decision|1|||
124793989|NCT01853618|448875788|FG002|Overall Study|Physician Decision|1|||
124793990|NCT01853618|448875789|FG003|Overall Study|Physician Decision|0|||
124793991|NCT01853618|448875790|FG004|Overall Study|Physician Decision|0|||
124793992|NCT01853618|448875786|FG000|Overall Study|Refused further treatment|0|||
124793993|NCT01853618|448875787|FG001|Overall Study|Refused further treatment|0|||
124793994|NCT01853618|448875788|FG002|Overall Study|Refused further treatment|0|||
124793995|NCT01853618|448875789|FG003|Overall Study|Refused further treatment|0|||
124793996|NCT01853618|448875790|FG004|Overall Study|Refused further treatment|1|||
124793997|NCT01658813|448875791|FG000|Overall Study|Disease progression|3|||
125295412|NCT04428151|450709431|FG000|Overall Study|Withdrawal by Subject|2|||
125295413|NCT04428151|450709432|FG001|Overall Study|Withdrawal by Subject|2|||
125295414|NCT04428151|450709433|FG002|Overall Study|Withdrawal by Subject|3|||
125295415|NCT04428151|450709431|FG000|Overall Study|Participant Ongoing in Study|41|||
124794000|NCT00938886|448875794|FG000|Overall Study|Death|0|||
124794001|NCT00938886|448875795|FG001|Overall Study|Death|1|||
124794002|NCT00938886|448875794|FG000|Overall Study|Withdrawal by Subject|4|||
124794003|NCT00938886|448875795|FG001|Overall Study|Withdrawal by Subject|7|||
124794004|NCT00938886|448875794|FG000|Overall Study|Lost to Follow-up|3|||
124794005|NCT00938886|448875795|FG001|Overall Study|Lost to Follow-up|2|||
124794006|NCT01075191|448875796|FG000|Overall Study|Death|1|||
124794007|NCT01075191|448875796|FG000|Overall Study|Intensification|3|||
124794008|NCT01075191|448875796|FG000|Overall Study|Co-morbidities|1|||
124794009|NCT01075191|448875796|FG000|Overall Study|Adverse Event|4|||
124794010|NCT01075191|448875796|FG000|Overall Study|Noncompliance|3|||
124794011|NCT01075191|448875796|FG000|Overall Study|Therapy Break|3|||
124794012|NCT01075191|448875796|FG000|Overall Study|Patient's Wish|2|||
124794013|NCT01075191|448875796|FG000|Overall Study|Unknown Reasons|1|||
124794014|NCT02674854|448875797|FG000|Overall Study|Adverse Event|17|||
124794015|NCT02674854|448875798|FG001|Overall Study|Adverse Event|15|||
124794016|NCT02674854|448875799|FG002|Overall Study|Adverse Event|5|||
124794017|NCT02674854|448875797|FG000|Overall Study|Withdrawal by Subject|1|||
124794018|NCT02674854|448875798|FG001|Overall Study|Withdrawal by Subject|5|||
124794019|NCT02674854|448875799|FG002|Overall Study|Withdrawal by Subject|4|||
124794020|NCT02674854|448875797|FG000|Overall Study|No-compliant subject|1|||
124794021|NCT02674854|448875798|FG001|Overall Study|No-compliant subject|0|||
124794022|NCT02674854|448875799|FG002|Overall Study|No-compliant subject|1|||
124794023|NCT02674854|448875797|FG000|Overall Study|Lost to Follow-up|1|||
124794024|NCT02674854|448875798|FG001|Overall Study|Lost to Follow-up|0|||
124794025|NCT02674854|448875799|FG002|Overall Study|Lost to Follow-up|2|||
124794026|NCT02674854|448875797|FG000|Overall Study|Lack of Efficacy|0|||
124794027|NCT02674854|448875798|FG001|Overall Study|Lack of Efficacy|3|||
124794028|NCT02674854|448875799|FG002|Overall Study|Lack of Efficacy|0|||
124794029|NCT02674854|448875797|FG000|Overall Study|Disallowed Concurrent Medication|2|||
124794030|NCT02674854|448875798|FG001|Overall Study|Disallowed Concurrent Medication|2|||
124794031|NCT02674854|448875799|FG002|Overall Study|Disallowed Concurrent Medication|0|||
124794032|NCT02674854|448875797|FG000|Overall Study|Protocol Violation|1|||
124794033|NCT02674854|448875798|FG001|Overall Study|Protocol Violation|1|||
124794034|NCT02674854|448875799|FG002|Overall Study|Protocol Violation|2|||
124794035|NCT02674854|448875797|FG000|Overall Study|Death|0|||
124794036|NCT02674854|448875798|FG001|Overall Study|Death|1|||
124794037|NCT02674854|448875799|FG002|Overall Study|Death|0|||
124794038|NCT02674854|448875797|FG000|Overall Study|Subject missed V6.2|1|||
124794039|NCT02674854|448875798|FG001|Overall Study|Subject missed V6.2|0|||
124794040|NCT02674854|448875799|FG002|Overall Study|Subject missed V6.2|0|||
124794041|NCT00913692|448875800|FG000|Screening (4 Months)|Physician Decision|3|||
124794042|NCT00913692|448875800|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
124794043|NCT00913692|448875800|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
124794044|NCT04738318|448875801|FG000|Overall Study|Protocol Violation|1|||
124794045|NCT04738318|448875802|FG001|Overall Study|Protocol Violation|0|||
124794046|NCT01226121|448875803|FG000|Overall Study|Lost to Follow-up|2|||
124794047|NCT01226121|448875804|FG001|Overall Study|Lost to Follow-up|0|||
124794048|NCT01226121|448875805|FG002|Overall Study|Lost to Follow-up|1|||
124794049|NCT04231981|448875806|FG000|Overall Study|Adverse Event|1|||
124794050|NCT04231981|448875806|FG000|Overall Study|Death|16|||
124794051|NCT04231981|448875806|FG000|Overall Study|Lost to Follow-up|1|||
124794052|NCT02889562|448875807|FG000|Overall Study|Physician Decision|0|||
124794053|NCT02889562|448875808|FG001|Overall Study|Physician Decision|1|||
124794054|NCT02889562|448875807|FG000|Overall Study|Withdrawal by Subject|0|||
124794055|NCT02889562|448875808|FG001|Overall Study|Withdrawal by Subject|1|||
124794056|NCT01470989|448875811|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
124794057|NCT01470989|448875812|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
124794058|NCT01470989|448875811|FG000|Overall Study|Adverse Event|2|||
124794059|NCT01470989|448875812|FG001|Overall Study|Adverse Event|5|||
124794060|NCT01470989|448875811|FG000|Overall Study|Abnormal laboratory value|1|||
124794061|NCT01470989|448875812|FG001|Overall Study|Abnormal laboratory value|1|||
124794062|NCT01470989|448875811|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124794063|NCT01470989|448875812|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
124794064|NCT01470989|448875811|FG000|Overall Study|Withdrawal by Subject|19|||
124794065|NCT01470989|448875812|FG001|Overall Study|Withdrawal by Subject|17|||
124794066|NCT01470989|448875811|FG000|Overall Study|Lost to Follow-up|18|||
124794067|NCT01470989|448875812|FG001|Overall Study|Lost to Follow-up|13|||
124794068|NCT01470989|448875811|FG000|Overall Study|Administrative problems|2|||
124794069|NCT01470989|448875812|FG001|Overall Study|Administrative problems|4|||
124794070|NCT01470989|448875811|FG000|Overall Study|Death|2|||
124794071|NCT01470989|448875812|FG001|Overall Study|Death|2|||
124794072|NCT01470989|448875811|FG000|Overall Study|Protocol deviation|1|||
124794073|NCT01470989|448875812|FG001|Overall Study|Protocol deviation|2|||
124794074|NCT00969280|448875813|FG000|Overall Study|Protocol Violation|2|||
124794075|NCT00969280|448875814|FG001|Overall Study|Protocol Violation|1|||
124794076|NCT00969280|448875813|FG000|Overall Study|Withdrawal by Subject|0|||
124794077|NCT00969280|448875814|FG001|Overall Study|Withdrawal by Subject|1|||
124794078|NCT00969280|448875813|FG000|Overall Study|infection of influenza A(H1N1)|0|||
124794079|NCT00969280|448875814|FG001|Overall Study|infection of influenza A(H1N1)|1|||
124794080|NCT02119676|448875815|FG000|Overall Study|Adverse Event|9|||
124794081|NCT02119676|448875816|FG001|Overall Study|Adverse Event|17|||
124794082|NCT02119676|448875817|FG002|Overall Study|Adverse Event|10|||
124794083|NCT02119676|448875818|FG003|Overall Study|Adverse Event|10|||
124794084|NCT02119676|448875815|FG000|Overall Study|Disease progression|53|||
124794085|NCT02119676|448875816|FG001|Overall Study|Disease progression|55|||
124794086|NCT02119676|448875817|FG002|Overall Study|Disease progression|68|||
124794087|NCT02119676|448875818|FG003|Overall Study|Disease progression|73|||
124794088|NCT02119676|448875815|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
124794089|NCT02119676|448875816|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
124794090|NCT02119676|448875817|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
124794091|NCT02119676|448875818|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
124794092|NCT02119676|448875815|FG000|Overall Study|Physician Decision|4|||
124794093|NCT02119676|448875816|FG001|Overall Study|Physician Decision|2|||
124794094|NCT02119676|448875817|FG002|Overall Study|Physician Decision|3|||
124794095|NCT02119676|448875818|FG003|Overall Study|Physician Decision|2|||
124794096|NCT02119676|448875815|FG000|Overall Study|Death|9|||
124794097|NCT02119676|448875816|FG001|Overall Study|Death|3|||
124794098|NCT02119676|448875817|FG002|Overall Study|Death|2|||
124794099|NCT02119676|448875818|FG003|Overall Study|Death|1|||
124794100|NCT02119676|448875815|FG000|Overall Study|Noncompliance|0|||
124794101|NCT02119676|448875816|FG001|Overall Study|Noncompliance|1|||
124794102|NCT02119676|448875817|FG002|Overall Study|Noncompliance|0|||
124794103|NCT02119676|448875818|FG003|Overall Study|Noncompliance|0|||
124794104|NCT02119676|448875815|FG000|Overall Study|Lost to Follow-up|0|||
124794105|NCT02119676|448875816|FG001|Overall Study|Lost to Follow-up|0|||
124794106|NCT02119676|448875817|FG002|Overall Study|Lost to Follow-up|1|||
124794107|NCT02119676|448875818|FG003|Overall Study|Lost to Follow-up|0|||
124794108|NCT02119676|448875815|FG000|Overall Study|Protocol deviation|0|||
124794109|NCT02119676|448875816|FG001|Overall Study|Protocol deviation|0|||
124794110|NCT02119676|448875817|FG002|Overall Study|Protocol deviation|1|||
124794111|NCT02119676|448875818|FG003|Overall Study|Protocol deviation|0|||
124794112|NCT02119676|448875815|FG000|Overall Study|Other, unspecified|2|||
124794113|NCT02119676|448875816|FG001|Overall Study|Other, unspecified|1|||
124794114|NCT02119676|448875817|FG002|Overall Study|Other, unspecified|3|||
124794115|NCT02119676|448875818|FG003|Overall Study|Other, unspecified|4|||
124794116|NCT02119676|448875815|FG000|Overall Study|Did not receive study med|2|||
124794117|NCT02119676|448875816|FG001|Overall Study|Did not receive study med|2|||
124794118|NCT02119676|448875817|FG002|Overall Study|Did not receive study med|4|||
124794119|NCT02119676|448875818|FG003|Overall Study|Did not receive study med|5|||
124794120|NCT00570232|448875819|FG000|Overall Study|Adverse Event|10|||
124794121|NCT00570232|448875819|FG000|Overall Study|discontinued due to medical condition|3|||
124794122|NCT00570232|448875819|FG000|Overall Study|discontinued due to recurrence|8|||
124794123|NCT00570232|448875819|FG000|Overall Study|discontinued due to noncompliance|2|||
124794124|NCT01037088|448875822|FG000|Overall Study|Withdrawal by Subject|3|||
124794125|NCT02216812|448875823|FG000|Overall Study|Lost to Follow-up|10|||
124794126|NCT02216812|448875824|FG001|Overall Study|Lost to Follow-up|5|||
124794127|NCT01585584|448875825|FG000|Overall Study|Lack of Efficacy|1|||
124794128|NCT01585584|448875825|FG000|Overall Study|Withdrawal by Subject|1|||
124794129|NCT01585584|448875825|FG000|Overall Study|Physician Decision|2|||
124794130|NCT00527488|448875826|FG000|Overall Study|Withdrawn prior to dosing|0|||
124794131|NCT00527488|448875827|FG001|Overall Study|Withdrawn prior to dosing|1|||
124794132|NCT00527488|448875828|FG002|Overall Study|Withdrawn prior to dosing|1|||
124794133|NCT00527488|448875829|FG003|Overall Study|Withdrawn prior to dosing|0|||
124794134|NCT01958827|448875830|FG000|Overall Study|Adverse Event|3|||
124794135|NCT01958827|448875830|FG000|Overall Study|Lack of Efficacy|6|||
124794136|NCT01958827|448875830|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
124794137|NCT00266864|448875831|FG000|Overall Study|Lost to Follow-up|4|||
124794138|NCT00266864|448875832|FG001|Overall Study|Lost to Follow-up|1|||
124794139|NCT00266864|448875831|FG000|Overall Study|Withdrawal by Subject|1|||
124794140|NCT00266864|448875832|FG001|Overall Study|Withdrawal by Subject|1|||
124794141|NCT03036800|448875833|FG000|Overall Study|Protocol Violation|1|||
124794142|NCT03036800|448875834|FG001|Overall Study|Protocol Violation|0|||
124794143|NCT03036800|448875833|FG000|Overall Study|Non-compliance|1|||
124794144|NCT03036800|448875834|FG001|Overall Study|Non-compliance|0|||
124794145|NCT03036800|448875833|FG000|Overall Study|Lost to Follow-up|1|||
124794146|NCT03036800|448875834|FG001|Overall Study|Lost to Follow-up|0|||
124794147|NCT03036800|448875833|FG000|Overall Study|Death|1|||
125295416|NCT04428151|450709432|FG001|Overall Study|Participant Ongoing in Study|53|||
125295417|NCT04428151|450709433|FG002|Overall Study|Participant Ongoing in Study|28|||
124794148|NCT03036800|448875834|FG001|Overall Study|Death|0|||
124794149|NCT03036800|448875833|FG000|Overall Study|Tolerance|5|||
124794150|NCT03036800|448875834|FG001|Overall Study|Tolerance|0|||
124794151|NCT03036800|448875833|FG000|Overall Study|Unknown/no reason given|50|||
124794152|NCT03036800|448875834|FG001|Overall Study|Unknown/no reason given|39|||
124794153|NCT01077154|448875835|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
124794154|NCT01077154|448875836|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
124794155|NCT01077154|448875835|FG000|Overall Study|Withdrawal by Subject|369|||
124794156|NCT01077154|448875836|FG001|Overall Study|Withdrawal by Subject|385|||
124794157|NCT01077154|448875835|FG000|Overall Study|Death|215|||
124794158|NCT01077154|448875836|FG001|Overall Study|Death|214|||
124794159|NCT01077154|448875835|FG000|Overall Study|Lost to Follow-up|43|||
124794160|NCT01077154|448875836|FG001|Overall Study|Lost to Follow-up|35|||
124794161|NCT01077154|448875835|FG000|Overall Study|Noncompliance|22|||
124794162|NCT01077154|448875836|FG001|Overall Study|Noncompliance|20|||
124794163|NCT01077154|448875835|FG000|Overall Study|Disease Progression|18|||
124794164|NCT01077154|448875836|FG001|Overall Study|Disease Progression|20|||
124794165|NCT01077154|448875835|FG000|Overall Study|Ineligibility Determined|10|||
124794166|NCT01077154|448875836|FG001|Overall Study|Ineligibility Determined|14|||
124794167|NCT01077154|448875835|FG000|Overall Study|Other|14|||
124794168|NCT01077154|448875836|FG001|Overall Study|Other|11|||
124794169|NCT01077154|448875835|FG000|Overall Study|Adverse Event|9|||
124794170|NCT01077154|448875836|FG001|Overall Study|Adverse Event|9|||
124794171|NCT01077154|448875835|FG000|Overall Study|Administrative Decision|1|||
124794172|NCT01077154|448875836|FG001|Overall Study|Administrative Decision|6|||
124794173|NCT01077154|448875835|FG000|Overall Study|Protocol Deviation|1|||
124794174|NCT01077154|448875836|FG001|Overall Study|Protocol Deviation|0|||
124794175|NCT05985980|448875837|FG000|Overall Study|Withdrawal by Subject|1|||
124794176|NCT05985980|448875837|FG000|Overall Study|Withdrawal by Subject|1|||
124794177|NCT05985980|448875837|FG000|Overall Study|Withdrawal by Subject|1|||
124794178|NCT05985980|448875837|FG000|Overall Study|Withdrawal by Subject|1|||
124794179|NCT02207946|448875838|FG000|Overall Study|Lost to Follow-up|1|||
124794180|NCT02207946|448875839|FG001|Overall Study|Lost to Follow-up|0|||
124794181|NCT02207946|448875838|FG000|Overall Study|Adverse Event|0|||
124794182|NCT02207946|448875839|FG001|Overall Study|Adverse Event|1|||
124794183|NCT00811642|448875840|FG000|Overall Study|Adverse Event|3|||
124794184|NCT00811642|448875840|FG000|Overall Study|Protocol Violation|1|||
124794185|NCT00811642|448875840|FG000|Overall Study|Death|2|||
124794186|NCT00811642|448875840|FG000|Overall Study|Withdrawal by Subject|7|||
124794187|NCT00811642|448875840|FG000|Overall Study|Cumulative use of antifungal agent|2|||
124794188|NCT01163318|448875848|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
124794189|NCT01163318|448875848|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
124794190|NCT01163318|448875848|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
124794191|NCT01163318|448875848|FG000|Overall Study|Participants Without Case Report Form|7|||
124794192|NCT01163318|448875848|FG000|Overall Study|Multiple Reasons Per Participant|224|||
124794193|NCT01006603|448875850|FG000|Overall Study|Withdrawal by Subject|17|||
124794194|NCT01006603|448875851|FG001|Overall Study|Withdrawal by Subject|19|||
124794195|NCT01006603|448875850|FG000|Overall Study|Lost to Follow-up|0|||
124794196|NCT01006603|448875851|FG001|Overall Study|Lost to Follow-up|1|||
124794197|NCT01006603|448875850|FG000|Overall Study|Safety reason|1|||
124794198|NCT01006603|448875851|FG001|Overall Study|Safety reason|1|||
124794199|NCT01006603|448875850|FG000|Overall Study|Protocol Violation|1|||
124794200|NCT01006603|448875851|FG001|Overall Study|Protocol Violation|3|||
124794201|NCT01006603|448875850|FG000|Overall Study|Incorrect enrolment|0|||
124794202|NCT01006603|448875851|FG001|Overall Study|Incorrect enrolment|2|||
124794203|NCT01006603|448875850|FG000|Overall Study|Adverse Event|15|||
124794204|NCT01006603|448875851|FG001|Overall Study|Adverse Event|7|||
124794205|NCT01006603|448875850|FG000|Overall Study|Death|1|||
124794206|NCT01006603|448875851|FG001|Overall Study|Death|1|||
124794207|NCT01006603|448875850|FG000|Overall Study|Study specific discontinuation criteria|33|||
124794208|NCT01006603|448875851|FG001|Overall Study|Study specific discontinuation criteria|34|||
124794209|NCT01006603|448875850|FG000|Overall Study|Other|3|||
124794210|NCT01006603|448875851|FG001|Overall Study|Other|7|||
124794211|NCT00706849|448877193|FG000|Treatment Period|Adverse Event|0|||
124794212|NCT00706849|448877194|FG001|Treatment Period|Adverse Event|9|||
124794213|NCT00706849|448877193|FG000|Treatment Period|Other|0|||
124794214|NCT00706849|448877194|FG001|Treatment Period|Other|1|||
124794215|NCT00706849|448877193|FG000|Follow-up Period|Withdrawal by Subject|0|||
124794216|NCT00706849|448877194|FG001|Follow-up Period|Withdrawal by Subject|2|||
124794217|NCT00706849|448877193|FG000|Follow-up Period|Protocol non-compliance|0|||
124794218|NCT00706849|448877194|FG001|Follow-up Period|Protocol non-compliance|1|||
124794219|NCT01611454|448877195|FG000|Overall Study|Lack of Efficacy|18|||
124794220|NCT01611454|448877196|FG001|Overall Study|Lack of Efficacy|10|||
124794221|NCT03269552|448877198|FG000|Overall Study|Adverse Event|2|||
124794222|NCT00920907|448877199|FG000|Induction Period|Adverse Event|0|||
124794223|NCT00920907|448877200|FG001|Induction Period|Adverse Event|2|||
124794224|NCT00920907|448877199|FG000|Induction Period|Death|1|||
124794225|NCT00920907|448877200|FG001|Induction Period|Death|1|||
124794226|NCT00920907|448877199|FG000|Induction Period|Disease Progression|12|||
124794227|NCT00920907|448877200|FG001|Induction Period|Disease Progression|11|||
124794228|NCT00920907|448877199|FG000|Induction Period|Study Drug Toxicity|8|||
124794229|NCT00920907|448877200|FG001|Induction Period|Study Drug Toxicity|6|||
124794230|NCT00920907|448877199|FG000|Induction Period|No longer meets study criteria|0|||
124794231|NCT00920907|448877200|FG001|Induction Period|No longer meets study criteria|1|||
124794232|NCT00920907|448877199|FG000|Induction Period|Withdrawal by Subject|1|||
124794233|NCT00920907|448877200|FG001|Induction Period|Withdrawal by Subject|1|||
124794234|NCT00920907|448877199|FG000|Maintenance Period|Disease Progression|3|||
124794235|NCT00920907|448877200|FG001|Maintenance Period|Disease Progression|7|||
124794236|NCT00920907|448877199|FG000|Maintenance Period|Administrative (study closure)|7|||
124794237|NCT00920907|448877200|FG001|Maintenance Period|Administrative (study closure)|2|||
124794238|NCT00920907|448877199|FG000|Maintenance Period|Study Drug Toxicity|0|||
124794239|NCT00920907|448877200|FG001|Maintenance Period|Study Drug Toxicity|2|||
124794240|NCT00920907|448877199|FG000|Maintenance Period|Death|1|||
124794241|NCT00920907|448877200|FG001|Maintenance Period|Death|1|||
124794242|NCT00920907|448877199|FG000|Maintenance Period|Withdrawal by Subject|1|||
124794243|NCT00920907|448877200|FG001|Maintenance Period|Withdrawal by Subject|0|||
124794244|NCT00920907|448877199|FG000|Maintenance Period|Adverse Event|0|||
124794245|NCT00920907|448877200|FG001|Maintenance Period|Adverse Event|1|||
124794246|NCT02616601|448877201|FG000|Overall Study|Withdrawal by Subject|4|||
124794247|NCT02616601|448877202|FG001|Overall Study|Withdrawal by Subject|4|||
124794248|NCT02616601|448877203|FG002|Overall Study|Withdrawal by Subject|3|||
124794249|NCT02616601|448877201|FG000|Overall Study|Adverse Event|2|||
124794250|NCT02616601|448877202|FG001|Overall Study|Adverse Event|0|||
124794251|NCT02616601|448877203|FG002|Overall Study|Adverse Event|2|||
124794252|NCT02616601|448877201|FG000|Overall Study|Death|1|||
124794253|NCT02616601|448877202|FG001|Overall Study|Death|0|||
124794254|NCT02616601|448877203|FG002|Overall Study|Death|0|||
124794255|NCT02616601|448877201|FG000|Overall Study|Lost to Follow-up|1|||
124794256|NCT02616601|448877202|FG001|Overall Study|Lost to Follow-up|0|||
124794257|NCT02616601|448877203|FG002|Overall Study|Lost to Follow-up|1|||
124794258|NCT02616601|448877201|FG000|Overall Study|Non-Compliance with Test Article|1|||
124794259|NCT02616601|448877202|FG001|Overall Study|Non-Compliance with Test Article|0|||
124794260|NCT02616601|448877203|FG002|Overall Study|Non-Compliance with Test Article|1|||
124794261|NCT04389970|448877205|FG000|Overall Study|Lost to Follow-up|1|||
124794262|NCT04179890|448877206|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
124794263|NCT04179890|448877207|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
124794264|NCT04179890|448877206|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
124794265|NCT04179890|448877207|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
124794266|NCT04179890|448877206|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
124794267|NCT04179890|448877207|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
124794268|NCT04179890|448877206|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
124794269|NCT04179890|448877207|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
124794270|NCT04179890|448877206|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
124794271|NCT04179890|448877207|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
124794272|NCT04179890|448877206|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
124794273|NCT04179890|448877207|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
124794274|NCT04179890|448877206|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
124794275|NCT04179890|448877207|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
124794276|NCT04179890|448877206|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
124794277|NCT04179890|448877207|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
124794278|NCT04179890|448877206|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
124794279|NCT04179890|448877207|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
124794280|NCT02579928|448877208|FG000|Overall Study|Withdrawal by Subject|1|||
124794281|NCT02579928|448877209|FG001|Overall Study|Withdrawal by Subject|0|||
124794282|NCT03754972|448877212|FG000|Overall Study|Protocol Violation|25|||
124794283|NCT03422627|448877213|FG000|Overall Study|Protocol-specified Criteria|1|||
124794284|NCT03422627|448877214|FG001|Overall Study|Protocol-specified Criteria|1|||
124794285|NCT03422627|448877215|FG002|Overall Study|Protocol-specified Criteria|0|||
124794286|NCT03422627|448877216|FG003|Overall Study|Protocol-specified Criteria|0|||
124794287|NCT03422627|448877217|FG004|Overall Study|Protocol-specified Criteria|2|||
124794288|NCT03422627|448877213|FG000|Overall Study|Requirement for Alternative Therapy|1|||
124794289|NCT03422627|448877214|FG001|Overall Study|Requirement for Alternative Therapy|1|||
124794290|NCT03422627|448877215|FG002|Overall Study|Requirement for Alternative Therapy|2|||
124794291|NCT03422627|448877216|FG003|Overall Study|Requirement for Alternative Therapy|0|||
124794292|NCT03422627|448877217|FG004|Overall Study|Requirement for Alternative Therapy|0|||
124794293|NCT03422627|448877213|FG000|Overall Study|Disease Progression|1|||
124794294|NCT03422627|448877214|FG001|Overall Study|Disease Progression|0|||
124794295|NCT03422627|448877215|FG002|Overall Study|Disease Progression|1|||
124794296|NCT03422627|448877216|FG003|Overall Study|Disease Progression|2|||
124794297|NCT03422627|448877217|FG004|Overall Study|Disease Progression|0|||
124794298|NCT03422627|448877213|FG000|Overall Study|Adverse Event|2|||
124794299|NCT03422627|448877214|FG001|Overall Study|Adverse Event|1|||
124794300|NCT03422627|448877215|FG002|Overall Study|Adverse Event|0|||
124794301|NCT03422627|448877216|FG003|Overall Study|Adverse Event|0|||
124794302|NCT03422627|448877217|FG004|Overall Study|Adverse Event|2|||
124794303|NCT03422627|448877213|FG000|Overall Study|Ineligibility Determined|0|||
124794304|NCT03422627|448877214|FG001|Overall Study|Ineligibility Determined|1|||
124794305|NCT03422627|448877215|FG002|Overall Study|Ineligibility Determined|0|||
124794306|NCT03422627|448877216|FG003|Overall Study|Ineligibility Determined|0|||
124794307|NCT03422627|448877217|FG004|Overall Study|Ineligibility Determined|0|||
124794308|NCT03422627|448877213|FG000|Overall Study|Death|0|||
124794309|NCT03422627|448877214|FG001|Overall Study|Death|1|||
124794310|NCT03422627|448877215|FG002|Overall Study|Death|1|||
124794311|NCT03422627|448877216|FG003|Overall Study|Death|0|||
124794312|NCT03422627|448877217|FG004|Overall Study|Death|0|||
124794313|NCT03422627|448877213|FG000|Overall Study|Withdrawal by Subject|0|||
124794314|NCT03422627|448877214|FG001|Overall Study|Withdrawal by Subject|0|||
124794315|NCT03422627|448877215|FG002|Overall Study|Withdrawal by Subject|0|||
124794316|NCT03422627|448877216|FG003|Overall Study|Withdrawal by Subject|1|||
124794317|NCT03422627|448877217|FG004|Overall Study|Withdrawal by Subject|0|||
124794318|NCT00934648|448877220|FG000|Overall Study|Failure to return|8|||
124794319|NCT00934648|448877220|FG000|Overall Study|Withdrawal by Subject|1|||
124794320|NCT01993836|448877221|FG000|Overall Study|Surgery Cancelled|3|||
124794321|NCT01993836|448877222|FG001|Overall Study|Surgery Cancelled|0|||
124794322|NCT01993836|448877223|FG002|Overall Study|Surgery Cancelled|0|||
124794323|NCT01993836|448877221|FG000|Overall Study|Physician Decision|2|||
124794324|NCT01993836|448877222|FG001|Overall Study|Physician Decision|1|||
124794325|NCT01993836|448877223|FG002|Overall Study|Physician Decision|0|||
124794326|NCT01993836|448877221|FG000|Overall Study|Death|0|||
124794327|NCT01993836|448877222|FG001|Overall Study|Death|2|||
124794328|NCT01993836|448877223|FG002|Overall Study|Death|0|||
124794329|NCT01993836|448877221|FG000|Overall Study|Withdrawal by Subject|12|||
124794330|NCT01993836|448877222|FG001|Overall Study|Withdrawal by Subject|10|||
124794331|NCT01993836|448877223|FG002|Overall Study|Withdrawal by Subject|5|||
124794332|NCT02195687|448877225|FG000|Overall Study|Personal Reasons|1|||
124794333|NCT02195687|448877226|FG001|Overall Study|Personal Reasons|1|||
124794334|NCT02195687|448877225|FG000|Overall Study|Lost to Follow-up|4|||
124794335|NCT02195687|448877226|FG001|Overall Study|Lost to Follow-up|1|||
124794336|NCT04369924|448877227|FG000|Overall Study|Lost to Follow-up|302|||
124794337|NCT04369924|448877228|FG001|Overall Study|Lost to Follow-up|339|||
124794338|NCT00708201|448877229|FG000|Overall Study|Adverse Event|4|||
124794339|NCT00708201|448877230|FG001|Overall Study|Adverse Event|4|||
124794340|NCT00708201|448877229|FG000|Overall Study|Withdrawal by Subject|1|||
124794341|NCT00708201|448877230|FG001|Overall Study|Withdrawal by Subject|1|||
124794342|NCT00708201|448877229|FG000|Overall Study|Lost to Follow-up|2|||
124794343|NCT00708201|448877230|FG001|Overall Study|Lost to Follow-up|0|||
124794344|NCT00708201|448877229|FG000|Overall Study|Protocol Violation|0|||
124794345|NCT00708201|448877230|FG001|Overall Study|Protocol Violation|1|||
124794346|NCT00282464|448877231|FG000|Overall Study|Adverse Event|26|||
124794347|NCT00282464|448877232|FG001|Overall Study|Adverse Event|20|||
124794348|NCT00282464|448877231|FG000|Overall Study|Lack of Efficacy|8|||
124794349|NCT00282464|448877232|FG001|Overall Study|Lack of Efficacy|8|||
124794350|NCT00282464|448877231|FG000|Overall Study|Lost to Follow-up|10|||
124794351|NCT00282464|448877232|FG001|Overall Study|Lost to Follow-up|10|||
124794352|NCT00282464|448877231|FG000|Overall Study|Withdrawal by Subject|24|||
124794353|NCT00282464|448877232|FG001|Overall Study|Withdrawal by Subject|10|||
124794354|NCT00282464|448877231|FG000|Overall Study|laboratory abnormality|1|||
124794355|NCT00282464|448877232|FG001|Overall Study|laboratory abnormality|2|||
124794356|NCT00282464|448877231|FG000|Overall Study|Protocol Violation|0|||
124794357|NCT00282464|448877232|FG001|Overall Study|Protocol Violation|7|||
124794358|NCT00282464|448877231|FG000|Overall Study|Patient moved|1|||
124794359|NCT00282464|448877232|FG001|Overall Study|Patient moved|0|||
124794360|NCT00282464|448877231|FG000|Overall Study|patient non-compliant|3|||
124794361|NCT00282464|448877232|FG001|Overall Study|patient non-compliant|0|||
124794362|NCT00282464|448877231|FG000|Overall Study|patient no show|0|||
124794363|NCT00282464|448877232|FG001|Overall Study|patient no show|1|||
124794364|NCT00282464|448877231|FG000|Overall Study|patient incarcerated|0|||
124794365|NCT00282464|448877232|FG001|Overall Study|patient incarcerated|1|||
124794366|NCT00282464|448877231|FG000|Overall Study|family crisis|0|||
124794367|NCT00282464|448877232|FG001|Overall Study|family crisis|1|||
125295418|NCT02704689|450709434|FG000|Overall Study|Physician Decision|1|||
125295419|NCT02704689|450709434|FG000|Overall Study|Study device not implanted|2|||
125295420|NCT02212678|450709437|FG000|Overall Study|Adverse Event|1|||
125295421|NCT02337634|450709438|FG000|Overall Study|Protocol Violation|3|||
125295422|NCT02337634|450709439|FG001|Overall Study|Protocol Violation|1|||
124794368|NCT00282464|448877231|FG000|Overall Study|dispensed wrong kit|0|||
124794369|NCT00282464|448877232|FG001|Overall Study|dispensed wrong kit|1|||
124794370|NCT00282464|448877231|FG000|Overall Study|dropped due to missed visits|0|||
124794371|NCT00282464|448877232|FG001|Overall Study|dropped due to missed visits|1|||
124794372|NCT00812487|448877233|FG000|Overall Study|Lost to Follow-up|2|||
125295423|NCT02337634|450709438|FG000|Overall Study|Lost to Follow-up|1|||
125295424|NCT02337634|450709439|FG001|Overall Study|Lost to Follow-up|0|||
124794373|NCT00812487|448877234|FG001|Overall Study|Lost to Follow-up|0|||
124794374|NCT00812487|448877233|FG000|Overall Study|Withdrawal by Subject|3|||
124794375|NCT00812487|448877234|FG001|Overall Study|Withdrawal by Subject|2|||
124794376|NCT00812487|448877233|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
124794377|NCT00812487|448877234|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
124794378|NCT00812487|448877233|FG000|Overall Study|Protocol Violation|0|||
124794379|NCT00812487|448877234|FG001|Overall Study|Protocol Violation|1|||
125295425|NCT04068610|450709440|FG000|Overall Study|Death|4|||
125295426|NCT04068610|450709441|FG001|Overall Study|Death|8|||
124794380|NCT02360605|448877235|FG000|Overall Study|Withdrawal by Subject|4|||
124794381|NCT02360605|448877236|FG001|Overall Study|Withdrawal by Subject|9|||
124794382|NCT02360605|448877235|FG000|Overall Study|Lost to Follow-up|7|||
124794383|NCT02360605|448877236|FG001|Overall Study|Lost to Follow-up|8|||
124794384|NCT02360605|448877235|FG000|Overall Study|Death|0|||
124794385|NCT02360605|448877236|FG001|Overall Study|Death|1|||
124794386|NCT00290407|448877237|FG000|Overall Study|Physician Decision|2|||
124794387|NCT01117792|448877239|FG000|Overall Study|Death|1|||
124794388|NCT01117792|448877239|FG000|Overall Study|Adverse Event|3|||
124794389|NCT01721577|448877240|FG000|Overall Study|Lack of Efficacy|1|||
124794390|NCT01721577|448877241|FG001|Overall Study|Lack of Efficacy|0|||
124794391|NCT01721577|448877240|FG000|Overall Study|Death|1|||
124794392|NCT01721577|448877241|FG001|Overall Study|Death|0|||
124794393|NCT01721577|448877240|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
124794394|NCT01721577|448877241|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
124794395|NCT01721577|448877240|FG000|Overall Study|Adverse Event|0|||
124794396|NCT01721577|448877241|FG001|Overall Study|Adverse Event|2|||
124794397|NCT01055496|448877249|FG000|Overall Study|Withdrawal by Subject|2|||
124794398|NCT01055496|448877250|FG001|Overall Study|Withdrawal by Subject|4|||
124794399|NCT01055496|448877249|FG000|Overall Study|Death|13|||
124794400|NCT01055496|448877250|FG001|Overall Study|Death|23|||
124794401|NCT01055496|448877249|FG000|Overall Study|Lost to Follow-up|0|||
124794402|NCT01055496|448877250|FG001|Overall Study|Lost to Follow-up|2|||
124794403|NCT01055496|448877249|FG000|Overall Study|Other - Unspecified|0|||
124794404|NCT01055496|448877250|FG001|Overall Study|Other - Unspecified|1|||
124794405|NCT01673282|448877258|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
124794406|NCT01673282|448877259|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
124794407|NCT01673282|448877258|FG000|Overall Study|Lack of Efficacy|9|||
124794408|NCT01673282|448877259|FG001|Overall Study|Lack of Efficacy|2|||
124794409|NCT01673282|448877258|FG000|Overall Study|Lost to Follow-up|11|||
124794410|NCT01673282|448877259|FG001|Overall Study|Lost to Follow-up|10|||
124794411|NCT01673282|448877258|FG000|Overall Study|Withdrawal by Subject|3|||
124794412|NCT01673282|448877259|FG001|Overall Study|Withdrawal by Subject|3|||
124794413|NCT01673282|448877258|FG000|Overall Study|Other|1|||
124794414|NCT01673282|448877259|FG001|Overall Study|Other|6|||
124794415|NCT02106923|448877265|FG000|Overall Study|Protocol Violation|0|||
124794416|NCT02106923|448877266|FG001|Overall Study|Protocol Violation|0|||
124794417|NCT02106923|448877267|FG002|Overall Study|Protocol Violation|0|||
124794418|NCT02106923|448877268|FG003|Overall Study|Protocol Violation|0|||
124794419|NCT02106923|448877269|FG004|Overall Study|Protocol Violation|0|||
124794420|NCT02106923|448877270|FG005|Overall Study|Protocol Violation|1|||
124794421|NCT03485495|448877271|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
124794422|NCT03485495|448877272|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
124794423|NCT01323920|448877273|FG000|Overall Study|Death|5|||
124794424|NCT01323920|448877273|FG000|Overall Study|Withdrawal by Subject|1|||
124794425|NCT02915874|448877274|FG000|Overall Study|Lost to Follow-up|5|||
124794426|NCT02915874|448877275|FG001|Overall Study|Lost to Follow-up|4|||
124794427|NCT02915874|448877274|FG000|Overall Study|Withdrawal by Subject|1|||
124794428|NCT02915874|448877275|FG001|Overall Study|Withdrawal by Subject|1|||
124794429|NCT02915874|448877274|FG000|Overall Study|Started New Anxiety Medication|0|||
124794430|NCT02915874|448877275|FG001|Overall Study|Started New Anxiety Medication|1|||
125295427|NCT04068610|450709442|FG002|Overall Study|Death|13|||
125295428|NCT04068610|450709440|FG000|Overall Study|Lost to Follow-up|0|||
125295429|NCT04068610|450709441|FG001|Overall Study|Lost to Follow-up|2|||
125295430|NCT04068610|450709442|FG002|Overall Study|Lost to Follow-up|0|||
125295431|NCT04068610|450709440|FG000|Overall Study|Withdrawal by Subject|0|||
124794431|NCT01056380|448877277|FG000|Overall Study|Lost to Follow-up|2|||
124794432|NCT01056380|448877278|FG001|Overall Study|Lost to Follow-up|3|||
124794433|NCT03901456|448877279|FG000|Overall Study|Withdrawal by Subject|0|||
124794434|NCT03901456|448877280|FG001|Overall Study|Withdrawal by Subject|0|||
124794435|NCT03901456|448877281|FG002|Overall Study|Withdrawal by Subject|1|||
124794436|NCT03901456|448877279|FG000|Overall Study|Lost to Follow-up|0|||
124794437|NCT03901456|448877280|FG001|Overall Study|Lost to Follow-up|1|||
124794438|NCT03901456|448877281|FG002|Overall Study|Lost to Follow-up|0|||
124794439|NCT01715129|448877286|FG000|Overall Study|Adverse Event, fatal|1|||
124794440|NCT01715129|448877286|FG000|Overall Study|Lack of Efficacy|3|||
124794441|NCT01715129|448877286|FG000|Overall Study|Protocol Violation|1|||
125295432|NCT04068610|450709441|FG001|Overall Study|Withdrawal by Subject|4|||
125295433|NCT04068610|450709442|FG002|Overall Study|Withdrawal by Subject|2|||
125295434|NCT04068610|450709440|FG000|Overall Study|Other|3|||
124794442|NCT01715129|448877286|FG000|Overall Study|Consent Withdrawn|2|||
124794443|NCT01715129|448877286|FG000|Overall Study|Lost to Follow-up|1|||
124794444|NCT01715129|448877286|FG000|Overall Study|Other|1|||
124794445|NCT02068768|448877291|FG000|Overall Study|Lost to Follow-up|5|||
124794446|NCT02068768|448877291|FG000|Overall Study|Early Termination by Sponsor|2|||
124794447|NCT00555425|448877292|FG000|Overall Study|Missed Medication > 1 wk|34|||
124794448|NCT00555425|448877293|FG001|Overall Study|Missed Medication > 1 wk|15|||
125295435|NCT04068610|450709441|FG001|Overall Study|Other|12|||
125295436|NCT04068610|450709442|FG002|Overall Study|Other|11|||
124794449|NCT00555425|448877292|FG000|Overall Study|Missed 3 physician management visits|1|||
124794450|NCT00555425|448877293|FG001|Overall Study|Missed 3 physician management visits|0|||
124794451|NCT00555425|448877292|FG000|Overall Study|Met criteria for protective transfer|16|||
124794452|NCT00555425|448877293|FG001|Overall Study|Met criteria for protective transfer|3|||
124794453|NCT00555425|448877292|FG000|Overall Study|Became pregnant and transferred care|0|||
124794454|NCT00555425|448877293|FG001|Overall Study|Became pregnant and transferred care|1|||
124794455|NCT00400153|448877301|FG000|Overall Study|AE due to study disease worsening|14|||
124794456|NCT00400153|448877302|FG001|Overall Study|AE due to study disease worsening|19|||
124794457|NCT00400153|448877303|FG002|Overall Study|AE due to study disease worsening|20|||
124794458|NCT00400153|448877301|FG000|Overall Study|AE due to other disease worsening|2|||
124794459|NCT00400153|448877302|FG001|Overall Study|AE due to other disease worsening|1|||
124794460|NCT00400153|448877303|FG002|Overall Study|AE due to other disease worsening|0|||
124794461|NCT00400153|448877301|FG000|Overall Study|AE due to other condition|3|||
124794462|NCT00400153|448877302|FG001|Overall Study|AE due to other condition|14|||
124794463|NCT00400153|448877303|FG002|Overall Study|AE due to other condition|15|||
124794464|NCT00400153|448877301|FG000|Overall Study|Protocol Violation|7|||
124794465|NCT00400153|448877302|FG001|Overall Study|Protocol Violation|4|||
124794466|NCT00400153|448877303|FG002|Overall Study|Protocol Violation|9|||
124794467|NCT00400153|448877301|FG000|Overall Study|Lost to Follow-up|2|||
124794468|NCT00400153|448877302|FG001|Overall Study|Lost to Follow-up|1|||
124794469|NCT00400153|448877303|FG002|Overall Study|Lost to Follow-up|4|||
124794470|NCT00400153|448877301|FG000|Overall Study|Withdrawal by Subject|12|||
124794471|NCT00400153|448877302|FG001|Overall Study|Withdrawal by Subject|11|||
124794472|NCT00400153|448877303|FG002|Overall Study|Withdrawal by Subject|10|||
124794473|NCT00400153|448877301|FG000|Overall Study|Other reasons - not mentioned above|8|||
124794474|NCT00400153|448877302|FG001|Overall Study|Other reasons - not mentioned above|5|||
124794475|NCT00400153|448877303|FG002|Overall Study|Other reasons - not mentioned above|3|||
124794476|NCT01423604|448877304|FG000|Safety Run-In|Adverse Event|3|||
124794477|NCT01423604|448877305|FG001|Safety Run-In|Adverse Event|0|||
124794478|NCT01423604|448877304|FG000|Safety Run-In|Death|1|||
124794479|NCT01423604|448877305|FG001|Safety Run-In|Death|0|||
124794480|NCT01423604|448877304|FG000|Safety Run-In|Physician Decision|1|||
124794481|NCT01423604|448877305|FG001|Safety Run-In|Physician Decision|0|||
124794482|NCT01423604|448877304|FG000|Safety Run-In|Disease progression|3|||
124794483|NCT01423604|448877305|FG001|Safety Run-In|Disease progression|0|||
124794484|NCT01423604|448877304|FG000|Safety Run-In|Patient decision|1|||
124794485|NCT01423604|448877305|FG001|Safety Run-In|Patient decision|0|||
125295437|NCT02428205|450709443|FG000|Overall Study|Lack of Efficacy|1|||
125295438|NCT02428205|450709444|FG001|Overall Study|Lack of Efficacy|0|||
125295439|NCT02428205|450709443|FG000|Overall Study|Lost to Follow-up|1|||
125295440|NCT02428205|450709444|FG001|Overall Study|Lost to Follow-up|1|||
125295441|NCT02428205|450709443|FG000|Overall Study|Worse behavior|0|||
125295442|NCT02428205|450709444|FG001|Overall Study|Worse behavior|1|||
125295443|NCT00527319|450709445|FG000|Overall Study|Withdrawal by Subject|5|||
125295444|NCT00527319|450709446|FG001|Overall Study|Withdrawal by Subject|0|||
125295445|NCT00527319|450709447|FG002|Overall Study|Withdrawal by Subject|1|||
125295446|NCT00527319|450709445|FG000|Overall Study|Lost to Follow-up|1|||
125295447|NCT00527319|450709446|FG001|Overall Study|Lost to Follow-up|0|||
125295448|NCT00527319|450709447|FG002|Overall Study|Lost to Follow-up|0|||
125295449|NCT00527319|450709445|FG000|Overall Study|Death|0|||
125295450|NCT00527319|450709446|FG001|Overall Study|Death|3|||
125295451|NCT00527319|450709447|FG002|Overall Study|Death|1|||
125295452|NCT00527319|450709445|FG000|Overall Study|Intercurrent Medical Illness|0|||
125295453|NCT00527319|450709446|FG001|Overall Study|Intercurrent Medical Illness|1|||
125295454|NCT00527319|450709447|FG002|Overall Study|Intercurrent Medical Illness|3|||
125295455|NCT00527319|450709445|FG000|Overall Study|Adverse Event|0|||
125295456|NCT00527319|450709446|FG001|Overall Study|Adverse Event|0|||
125295457|NCT00527319|450709447|FG002|Overall Study|Adverse Event|1|||
124794486|NCT01423604|448877304|FG000|Randomized|Adverse Event|4|||
124794487|NCT01423604|448877305|FG001|Randomized|Adverse Event|10|||
125295458|NCT01646203|450709448|FG000|Overall Study|Adverse Event|2|||
125295459|NCT01646203|450709449|FG001|Overall Study|Adverse Event|0|||
125295460|NCT01646203|450709450|FG002|Overall Study|Adverse Event|1|||
125295461|NCT01646203|450709448|FG000|Overall Study|Withdrawal by Subject|0|||
125295462|NCT01646203|450709449|FG001|Overall Study|Withdrawal by Subject|1|||
125295463|NCT01646203|450709450|FG002|Overall Study|Withdrawal by Subject|0|||
125295464|NCT01646203|450709448|FG000|Overall Study|Physician's Decision|0|||
125295465|NCT01646203|450709449|FG001|Overall Study|Physician's Decision|1|||
124794488|NCT01423604|448877304|FG000|Randomized|Death|1|||
124794489|NCT01423604|448877305|FG001|Randomized|Death|0|||
124794490|NCT01423604|448877304|FG000|Randomized|Physician Decision|16|||
125295466|NCT01646203|450709450|FG002|Overall Study|Physician's Decision|0|||
124794491|NCT01423604|448877305|FG001|Randomized|Physician Decision|13|||
124794492|NCT01423604|448877304|FG000|Randomized|Other - unspecified|37|||
124794493|NCT01423604|448877305|FG001|Randomized|Other - unspecified|31|||
124794494|NCT01423604|448877304|FG000|Randomized|Patient decision|5|||
125295467|NCT02066415|450709451|FG000|Overall Study|Decision by Sponsor|5|||
125295468|NCT02066415|450709452|FG001|Overall Study|Decision by Sponsor|4|||
124794495|NCT01423604|448877305|FG001|Randomized|Patient decision|9|||
124794496|NCT00424255|448877306|FG000|Overall Study|Death|115|||
124794497|NCT00424255|448877307|FG001|Overall Study|Death|111|||
124794498|NCT00424255|448877306|FG000|Overall Study|Lost to Follow-up|26|||
124794499|NCT00424255|448877307|FG001|Overall Study|Lost to Follow-up|20|||
124794500|NCT00424255|448877306|FG000|Overall Study|Protocol Violation|0|||
124794501|NCT00424255|448877307|FG001|Overall Study|Protocol Violation|1|||
124794502|NCT00424255|448877306|FG000|Overall Study|Withdrawal by Subject|34|||
124794503|NCT00424255|448877307|FG001|Overall Study|Withdrawal by Subject|38|||
124794504|NCT00424255|448877306|FG000|Overall Study|Physician Decision|3|||
124794505|NCT00424255|448877307|FG001|Overall Study|Physician Decision|7|||
124794506|NCT00424255|448877306|FG000|Overall Study|Cognitive Disturbance|1|||
124794507|NCT00424255|448877307|FG001|Overall Study|Cognitive Disturbance|0|||
124794508|NCT00424255|448877306|FG000|Overall Study|Non-compliance by Participants|1|||
124794509|NCT00424255|448877307|FG001|Overall Study|Non-compliance by Participants|0|||
124794510|NCT00424255|448877306|FG000|Overall Study|Fatigue|1|||
124794511|NCT00424255|448877307|FG001|Overall Study|Fatigue|0|||
124794512|NCT00424255|448877306|FG000|Overall Study|Disease Progression|0|||
124794513|NCT00424255|448877307|FG001|Overall Study|Disease Progression|2|||
124794514|NCT00424255|448877306|FG000|Overall Study|Sponsor Terminated Study|161|||
124794515|NCT00424255|448877307|FG001|Overall Study|Sponsor Terminated Study|167|||
124794516|NCT02186301|448879140|FG000|Overall Study|Progressive Disease|7|||
124794517|NCT02186301|448879141|FG001|Overall Study|Progressive Disease|22|||
124794518|NCT02186301|448879142|FG002|Overall Study|Progressive Disease|27|||
124794519|NCT02186301|448879140|FG000|Overall Study|Adverse Event|5|||
124794520|NCT02186301|448879141|FG001|Overall Study|Adverse Event|5|||
124794521|NCT02186301|448879142|FG002|Overall Study|Adverse Event|5|||
124794522|NCT02186301|448879140|FG000|Overall Study|Death|1|||
124794523|NCT02186301|448879141|FG001|Overall Study|Death|0|||
124794524|NCT02186301|448879142|FG002|Overall Study|Death|0|||
124794525|NCT02186301|448879140|FG000|Overall Study|Withdrawal by Subject|5|||
124794526|NCT02186301|448879141|FG001|Overall Study|Withdrawal by Subject|1|||
124794527|NCT02186301|448879142|FG002|Overall Study|Withdrawal by Subject|3|||
124794528|NCT02186301|448879140|FG000|Overall Study|Physician Decision|1|||
124794529|NCT02186301|448879141|FG001|Overall Study|Physician Decision|0|||
124794530|NCT02186301|448879142|FG002|Overall Study|Physician Decision|1|||
124794531|NCT02186301|448879140|FG000|Overall Study|Study Terminated by Sponsor|1|||
124794532|NCT02186301|448879141|FG001|Overall Study|Study Terminated by Sponsor|0|||
124794533|NCT02186301|448879142|FG002|Overall Study|Study Terminated by Sponsor|11|||
124794534|NCT02186301|448879140|FG000|Overall Study|Protocol Deviation|0|||
124794535|NCT02186301|448879141|FG001|Overall Study|Protocol Deviation|2|||
124794536|NCT02186301|448879142|FG002|Overall Study|Protocol Deviation|0|||
124794537|NCT02186301|448879140|FG000|Overall Study|Missing|0|||
124794538|NCT02186301|448879141|FG001|Overall Study|Missing|0|||
124794539|NCT02186301|448879142|FG002|Overall Study|Missing|2|||
124794540|NCT02186301|448879140|FG000|Overall Study|Other|0|||
124794541|NCT02186301|448879141|FG001|Overall Study|Other|0|||
124794542|NCT02186301|448879142|FG002|Overall Study|Other|1|||
124794543|NCT00371761|448879143|FG000|Overall Study|Adverse Event|1|||
124794544|NCT00371761|448879144|FG001|Overall Study|Adverse Event|1|||
124794545|NCT00371761|448879143|FG000|Overall Study|Withdrawal by Subject|1|||
124794546|NCT00371761|448879144|FG001|Overall Study|Withdrawal by Subject|3|||
124794547|NCT00371761|448879143|FG000|Overall Study|Investigator Judgment|2|||
124794548|NCT00371761|448879144|FG001|Overall Study|Investigator Judgment|3|||
124794549|NCT00371761|448879143|FG000|Overall Study|Study termination|4|||
124794550|NCT00371761|448879144|FG001|Overall Study|Study termination|3|||
124794551|NCT03560739|448879145|FG000|Overall Study|Adverse Event|0|||
124794552|NCT03560739|448879146|FG001|Overall Study|Adverse Event|1|||
125295469|NCT02066415|450709453|FG002|Overall Study|Decision by Sponsor|2|||
125295470|NCT02066415|450709451|FG000|Overall Study|Withdrawal by Subject|9|||
125295471|NCT02066415|450709452|FG001|Overall Study|Withdrawal by Subject|1|||
125295472|NCT02066415|450709453|FG002|Overall Study|Withdrawal by Subject|4|||
124794553|NCT03560739|448879147|FG002|Overall Study|Adverse Event|0|||
124794554|NCT03560739|448879148|FG003|Overall Study|Adverse Event|0|||
124794555|NCT03361176|448879149|FG000|Overall Study|Lost to Follow-up|1|||
124794556|NCT03361176|448879150|FG001|Overall Study|Lost to Follow-up|2|||
124794557|NCT03361176|448879149|FG000|Overall Study|Adverse Event|0|||
124794558|NCT03361176|448879150|FG001|Overall Study|Adverse Event|2|||
124794559|NCT03361176|448879149|FG000|Overall Study|Withdrawal by Subject|0|||
124794560|NCT03361176|448879150|FG001|Overall Study|Withdrawal by Subject|1|||
124794561|NCT03123185|448879151|FG000|Overall Study|Withdrawal by Subject|0|||
124794562|NCT03123185|448879152|FG001|Overall Study|Withdrawal by Subject|0|||
124794563|NCT03123185|448879153|FG002|Overall Study|Withdrawal by Subject|0|||
124794564|NCT03123185|448879154|FG003|Overall Study|Withdrawal by Subject|0|||
124794565|NCT03123185|448879155|FG004|Overall Study|Withdrawal by Subject|0|||
124794566|NCT03123185|448879156|FG005|Overall Study|Withdrawal by Subject|0|||
124794567|NCT03123185|448879157|FG006|Overall Study|Withdrawal by Subject|0|||
124794568|NCT03123185|448879158|FG007|Overall Study|Withdrawal by Subject|0|||
124794569|NCT03123185|448879159|FG008|Overall Study|Withdrawal by Subject|0|||
124794570|NCT03123185|448879160|FG009|Overall Study|Withdrawal by Subject|0|||
124794571|NCT03123185|448879161|FG010|Overall Study|Withdrawal by Subject|0|||
124794572|NCT03123185|448879162|FG011|Overall Study|Withdrawal by Subject|0|||
124794573|NCT03123185|448879163|FG012|Overall Study|Withdrawal by Subject|1|||
124794574|NCT03123185|448879164|FG013|Overall Study|Withdrawal by Subject|0|||
124794575|NCT01083173|448879168|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
124794576|NCT01083173|448879169|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
124794577|NCT01083173|448879168|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
124794578|NCT01083173|448879169|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
124794579|NCT01083173|448879168|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
124794580|NCT01083173|448879169|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
124794581|NCT01083173|448879168|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
124794582|NCT01083173|448879169|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
124794583|NCT01083173|448879168|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
124794584|NCT01083173|448879169|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
124794585|NCT01083173|448879168|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
124794586|NCT01083173|448879169|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
124794587|NCT01083173|448879168|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
124794588|NCT01083173|448879169|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
124794589|NCT01083173|448879168|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
124794590|NCT01083173|448879169|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
124794591|NCT01083173|448879168|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
124794592|NCT01083173|448879169|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
124794593|NCT01083173|448879168|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
124794594|NCT01083173|448879169|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
124794595|NCT01083173|448879168|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
124794596|NCT01083173|448879169|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
124794597|NCT02554279|448879173|FG000|Overall Study|Adverse Event|2|||
124794598|NCT02554279|448879174|FG001|Overall Study|Adverse Event|5|||
124794599|NCT02554279|448879173|FG000|Overall Study|Lost to Follow-up|3|||
124794600|NCT02554279|448879174|FG001|Overall Study|Lost to Follow-up|2|||
124794601|NCT02554279|448879173|FG000|Overall Study|Withdrawal by Subject|6|||
124794602|NCT02554279|448879174|FG001|Overall Study|Withdrawal by Subject|4|||
124794603|NCT02554279|448879173|FG000|Overall Study|Protocol Violation|2|||
124794604|NCT02554279|448879174|FG001|Overall Study|Protocol Violation|1|||
124794605|NCT02554279|448879173|FG000|Overall Study|Other reason|19|||
124794606|NCT02554279|448879174|FG001|Overall Study|Other reason|6|||
124794607|NCT01933789|448879175|FG000|Overall Study|Death|0|||
124794608|NCT01933789|448879176|FG001|Overall Study|Death|0|||
124794609|NCT01933789|448879177|FG002|Overall Study|Death|0|||
124794610|NCT01933789|448879178|FG003|Overall Study|Death|0|||
124794611|NCT01933789|448879179|FG004|Overall Study|Death|21|||
124794612|NCT01933789|448879180|FG005|Overall Study|Death|32|||
124794613|NCT01933789|448879181|FG006|Overall Study|Death|0|||
124794614|NCT01933789|448879182|FG007|Overall Study|Death|0|||
124794615|NCT01933789|448879183|FG008|Overall Study|Death|0|||
124794616|NCT01933789|448879175|FG000|Overall Study|Lost to Follow-up|0|||
124794617|NCT01933789|448879176|FG001|Overall Study|Lost to Follow-up|0|||
124794618|NCT01933789|448879177|FG002|Overall Study|Lost to Follow-up|0|||
124794619|NCT01933789|448879178|FG003|Overall Study|Lost to Follow-up|1|||
124794620|NCT01933789|448879179|FG004|Overall Study|Lost to Follow-up|8|||
124794621|NCT01933789|448879180|FG005|Overall Study|Lost to Follow-up|9|||
124794622|NCT01933789|448879181|FG006|Overall Study|Lost to Follow-up|1|||
124794623|NCT01933789|448879182|FG007|Overall Study|Lost to Follow-up|4|||
124794624|NCT01933789|448879183|FG008|Overall Study|Lost to Follow-up|0|||
124794625|NCT01933789|448879175|FG000|Overall Study|Withdrawal by Subject|2|||
124794626|NCT01933789|448879176|FG001|Overall Study|Withdrawal by Subject|1|||
124794627|NCT01933789|448879177|FG002|Overall Study|Withdrawal by Subject|0|||
124794628|NCT01933789|448879178|FG003|Overall Study|Withdrawal by Subject|0|||
124794629|NCT01933789|448879179|FG004|Overall Study|Withdrawal by Subject|17|||
124794630|NCT01933789|448879180|FG005|Overall Study|Withdrawal by Subject|16|||
124794631|NCT01933789|448879181|FG006|Overall Study|Withdrawal by Subject|1|||
124794632|NCT01933789|448879182|FG007|Overall Study|Withdrawal by Subject|4|||
124794633|NCT01933789|448879183|FG008|Overall Study|Withdrawal by Subject|0|||
124794634|NCT01933789|448879175|FG000|Overall Study|Became Ineligible|4|||
124794635|NCT01933789|448879176|FG001|Overall Study|Became Ineligible|0|||
124794636|NCT01933789|448879177|FG002|Overall Study|Became Ineligible|0|||
124794637|NCT01933789|448879178|FG003|Overall Study|Became Ineligible|0|||
124794638|NCT01933789|448879179|FG004|Overall Study|Became Ineligible|13|||
124794639|NCT01933789|448879180|FG005|Overall Study|Became Ineligible|10|||
124794640|NCT01933789|448879181|FG006|Overall Study|Became Ineligible|13|||
124794641|NCT01933789|448879182|FG007|Overall Study|Became Ineligible|6|||
124794642|NCT01933789|448879183|FG008|Overall Study|Became Ineligible|0|||
124794643|NCT01966432|448879184|FG000|Overall Study|Lost to Follow-up|3|||
124794644|NCT01966432|448879185|FG001|Overall Study|Lost to Follow-up|2|||
124794645|NCT01966432|448879186|FG002|Overall Study|Lost to Follow-up|5|||
124794646|NCT01966432|448879184|FG000|Overall Study|Withdrawal by Subject|1|||
124794647|NCT01966432|448879185|FG001|Overall Study|Withdrawal by Subject|3|||
124794648|NCT01966432|448879186|FG002|Overall Study|Withdrawal by Subject|0|||
124794649|NCT01966432|448879184|FG000|Overall Study|Subject Incarcerated|0|||
124794650|NCT01966432|448879185|FG001|Overall Study|Subject Incarcerated|0|||
124794651|NCT01966432|448879186|FG002|Overall Study|Subject Incarcerated|1|||
124794652|NCT01966432|448879184|FG000|Overall Study|SBIRT program ended|1|||
124794653|NCT01966432|448879185|FG001|Overall Study|SBIRT program ended|8|||
124794654|NCT01966432|448879186|FG002|Overall Study|SBIRT program ended|20|||
124794655|NCT00930982|448879187|FG000|Overall Study|Adverse Event|19|||
124794656|NCT00930982|448879188|FG001|Overall Study|Adverse Event|23|||
124794657|NCT00930982|448879187|FG000|Overall Study|Protocol Violation|1|||
124794658|NCT00930982|448879188|FG001|Overall Study|Protocol Violation|5|||
124794659|NCT00930982|448879187|FG000|Overall Study|Withdrawal by Subject|1|||
124794660|NCT00930982|448879188|FG001|Overall Study|Withdrawal by Subject|1|||
124794661|NCT01609478|448879189|FG000|Overall Study|Adverse Event|3|||
124794662|NCT01609478|448879190|FG001|Overall Study|Adverse Event|1|||
124794663|NCT01609478|448879191|FG002|Overall Study|Adverse Event|5|||
124794664|NCT01609478|448879189|FG000|Overall Study|Protocol Deviation|0|||
124794665|NCT01609478|448879190|FG001|Overall Study|Protocol Deviation|1|||
124794666|NCT01609478|448879191|FG002|Overall Study|Protocol Deviation|1|||
124794667|NCT01609478|448879189|FG000|Overall Study|Non-Compliance with study treatment|1|||
124794668|NCT01609478|448879190|FG001|Overall Study|Non-Compliance with study treatment|0|||
124794669|NCT01609478|448879191|FG002|Overall Study|Non-Compliance with study treatment|0|||
124794670|NCT01609478|448879189|FG000|Overall Study|Physician Decision|1|||
124794671|NCT01609478|448879190|FG001|Overall Study|Physician Decision|0|||
124794672|NCT01609478|448879191|FG002|Overall Study|Physician Decision|1|||
124794673|NCT01609478|448879189|FG000|Overall Study|Withdrawal by Subject|2|||
124794674|NCT01609478|448879190|FG001|Overall Study|Withdrawal by Subject|0|||
124794675|NCT01609478|448879191|FG002|Overall Study|Withdrawal by Subject|2|||
124794676|NCT04966741|448879192|FG000|Overall Study|Lost to Follow-up|1|||
124794677|NCT04966741|448879193|FG001|Overall Study|Lost to Follow-up|0|||
124794678|NCT02953509|448879199|FG000|Overall Study|Death|1|||
124794679|NCT02953509|448879200|FG001|Overall Study|Death|3|||
124794680|NCT02953509|448879201|FG002|Overall Study|Death|3|||
124794681|NCT02953509|448879202|FG003|Overall Study|Death|4|||
124794682|NCT02953509|448879203|FG004|Overall Study|Death|12|||
124794683|NCT02953509|448879204|FG005|Overall Study|Death|3|||
124794684|NCT02953509|448879205|FG006|Overall Study|Death|25|||
124794685|NCT02953509|448879206|FG007|Overall Study|Death|10|||
124794686|NCT02953509|448879207|FG008|Overall Study|Death|21|||
124794687|NCT02953509|448879208|FG009|Overall Study|Death|20|||
124794688|NCT02953509|448879199|FG000|Overall Study|Reason Not Specified|0|||
124794689|NCT02953509|448879200|FG001|Overall Study|Reason Not Specified|2|||
124794690|NCT02953509|448879201|FG002|Overall Study|Reason Not Specified|8|||
124794691|NCT02953509|448879202|FG003|Overall Study|Reason Not Specified|2|||
124794692|NCT02953509|448879203|FG004|Overall Study|Reason Not Specified|11|||
124794693|NCT02953509|448879204|FG005|Overall Study|Reason Not Specified|4|||
124794694|NCT02953509|448879205|FG006|Overall Study|Reason Not Specified|12|||
124794695|NCT02953509|448879206|FG007|Overall Study|Reason Not Specified|2|||
124794696|NCT02953509|448879207|FG008|Overall Study|Reason Not Specified|7|||
124794697|NCT02953509|448879208|FG009|Overall Study|Reason Not Specified|2|||
124794698|NCT02953509|448879199|FG000|Overall Study|Consent Withdrawn|1|||
124794699|NCT02953509|448879200|FG001|Overall Study|Consent Withdrawn|1|||
124794700|NCT02953509|448879201|FG002|Overall Study|Consent Withdrawn|2|||
124794701|NCT02953509|448879202|FG003|Overall Study|Consent Withdrawn|1|||
124794702|NCT02953509|448879203|FG004|Overall Study|Consent Withdrawn|3|||
124794703|NCT02953509|448879204|FG005|Overall Study|Consent Withdrawn|0|||
124794704|NCT02953509|448879205|FG006|Overall Study|Consent Withdrawn|4|||
124794705|NCT02953509|448879206|FG007|Overall Study|Consent Withdrawn|1|||
124794706|NCT02953509|448879207|FG008|Overall Study|Consent Withdrawn|1|||
124794707|NCT02953509|448879208|FG009|Overall Study|Consent Withdrawn|4|||
124794708|NCT02953509|448879199|FG000|Overall Study|Lost to Follow-up|0|||
124794709|NCT02953509|448879200|FG001|Overall Study|Lost to Follow-up|0|||
124794710|NCT02953509|448879201|FG002|Overall Study|Lost to Follow-up|0|||
125295473|NCT02066415|450709451|FG000|Overall Study|Lost to Follow-up|7|||
124794711|NCT02953509|448879202|FG003|Overall Study|Lost to Follow-up|0|||
124794712|NCT02953509|448879203|FG004|Overall Study|Lost to Follow-up|0|||
124794713|NCT02953509|448879204|FG005|Overall Study|Lost to Follow-up|0|||
124794714|NCT02953509|448879205|FG006|Overall Study|Lost to Follow-up|1|||
124794715|NCT02953509|448879206|FG007|Overall Study|Lost to Follow-up|1|||
124794716|NCT02953509|448879207|FG008|Overall Study|Lost to Follow-up|1|||
124794717|NCT02953509|448879208|FG009|Overall Study|Lost to Follow-up|1|||
124794718|NCT02953509|448879199|FG000|Overall Study|Study terminated by sponsor|1|||
124794719|NCT02953509|448879200|FG001|Overall Study|Study terminated by sponsor|0|||
124794720|NCT02953509|448879201|FG002|Overall Study|Study terminated by sponsor|0|||
124794721|NCT02953509|448879202|FG003|Overall Study|Study terminated by sponsor|0|||
124794722|NCT02953509|448879203|FG004|Overall Study|Study terminated by sponsor|0|||
124794723|NCT02953509|448879204|FG005|Overall Study|Study terminated by sponsor|0|||
124794724|NCT02953509|448879205|FG006|Overall Study|Study terminated by sponsor|1|||
124794725|NCT02953509|448879206|FG007|Overall Study|Study terminated by sponsor|0|||
124794726|NCT02953509|448879207|FG008|Overall Study|Study terminated by sponsor|1|||
124794727|NCT02953509|448879208|FG009|Overall Study|Study terminated by sponsor|1|||
124794728|NCT00484185|448879209|FG000|Overall Study|Lost to Follow-up|44|||
124794729|NCT00484185|448879209|FG000|Overall Study|Other|20|||
124794730|NCT00484185|448879209|FG000|Overall Study|Randomized but not treated|5|||
124794731|NCT00484185|448879209|FG000|Overall Study|Death|2|||
124794732|NCT00459056|448879210|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
124794733|NCT00459056|448879211|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
124794734|NCT02522871|448879212|FG000|Overall Study|Protocol Violation|1|||
124794735|NCT02522871|448879213|FG001|Overall Study|Protocol Violation|4|||
124794736|NCT02522871|448879212|FG000|Overall Study|Treated without randomization|1|||
124794737|NCT02522871|448879213|FG001|Overall Study|Treated without randomization|0|||
124794738|NCT02522871|448879212|FG000|Overall Study|Death|9|||
124794739|NCT02522871|448879213|FG001|Overall Study|Death|9|||
124794740|NCT02522871|448879212|FG000|Overall Study|Died in operating room prior to transplant|0|||
124794741|NCT02522871|448879213|FG001|Overall Study|Died in operating room prior to transplant|1|||
124794742|NCT00509262|448879214|FG000|Overall Study|Adverse Event|16|||
124794743|NCT00509262|448879215|FG001|Overall Study|Adverse Event|18|||
124794744|NCT00509262|448879214|FG000|Overall Study|Other|2|||
124794745|NCT00509262|448879215|FG001|Overall Study|Other|2|||
124794746|NCT00509262|448879214|FG000|Overall Study|Lack of Efficacy|1|||
124794747|NCT00509262|448879215|FG001|Overall Study|Lack of Efficacy|0|||
124794748|NCT00509262|448879214|FG000|Overall Study|Lost to Follow-up|1|||
124794749|NCT00509262|448879215|FG001|Overall Study|Lost to Follow-up|6|||
124794750|NCT00509262|448879214|FG000|Overall Study|Physician Decision|1|||
124794751|NCT00509262|448879215|FG001|Overall Study|Physician Decision|3|||
124794752|NCT00509262|448879214|FG000|Overall Study|Protocol Violation|2|||
124794753|NCT00509262|448879215|FG001|Overall Study|Protocol Violation|2|||
124794754|NCT00509262|448879214|FG000|Overall Study|Withdrawal by Subject|24|||
124794755|NCT00509262|448879215|FG001|Overall Study|Withdrawal by Subject|11|||
124794756|NCT02793622|448879220|FG000|Overall Study|Lost to Follow-up|31|||
124794757|NCT02793622|448879221|FG001|Overall Study|Lost to Follow-up|19|||
124794758|NCT02793622|448879220|FG000|Overall Study|Withdrawal by Subject|21|||
124794759|NCT02793622|448879221|FG001|Overall Study|Withdrawal by Subject|17|||
124794760|NCT02793622|448879220|FG000|Overall Study|Adverse Event|0|||
124794761|NCT02793622|448879221|FG001|Overall Study|Adverse Event|1|||
124794762|NCT02793622|448879220|FG000|Overall Study|Protocol Violation|1|||
124794763|NCT02793622|448879221|FG001|Overall Study|Protocol Violation|5|||
124794764|NCT01146860|448879222|FG000|Overall Study|Withdrawal by Subject|0|||
124794765|NCT01146860|448879223|FG001|Overall Study|Withdrawal by Subject|1|||
124794766|NCT01092832|448879224|FG000|Overall Study|Other|1|||
124794767|NCT01092832|448879225|FG001|Overall Study|Other|0|||
124794768|NCT00393042|448879227|FG000|First Intervention|Withdrawal by Subject|1|||
124794769|NCT00393042|448879228|FG001|First Intervention|Withdrawal by Subject|2|||
124794770|NCT00393042|448879227|FG000|First Intervention|Lost to Follow-up|3|||
124794771|NCT00393042|448879228|FG001|First Intervention|Lost to Follow-up|3|||
124794772|NCT00393042|448879227|FG000|First Intervention|Protocol Violation|1|||
124794773|NCT00393042|448879228|FG001|First Intervention|Protocol Violation|0|||
124794774|NCT00393042|448879227|FG000|First Intervention|Adverse Event|0|||
124794775|NCT00393042|448879228|FG001|First Intervention|Adverse Event|1|||
124794776|NCT00393042|448879227|FG000|Second Intervetion|Adverse Event|0|||
124794777|NCT00393042|448879228|FG001|Second Intervetion|Adverse Event|3|||
124794778|NCT00393042|448879227|FG000|Second Intervetion|Withdrawal by Subject|0|||
124794779|NCT00393042|448879228|FG001|Second Intervetion|Withdrawal by Subject|2|||
124794780|NCT00393042|448879227|FG000|Second Intervetion|Lack of Efficacy|1|||
124794781|NCT00393042|448879228|FG001|Second Intervetion|Lack of Efficacy|0|||
124794782|NCT00393042|448879227|FG000|Second Intervetion|Lost to Follow-up|0|||
124794783|NCT00393042|448879228|FG001|Second Intervetion|Lost to Follow-up|2|||
124794784|NCT00393042|448879227|FG000|Second Intervetion|Protocol Violation|1|||
124794785|NCT00393042|448879228|FG001|Second Intervetion|Protocol Violation|1|||
124794786|NCT01150474|448879230|FG000|Overall Study|Withdrawal by Subject|5|||
124794787|NCT01150474|448879231|FG001|Overall Study|Withdrawal by Subject|2|||
124794788|NCT01150474|448879230|FG000|Overall Study|Cancer found|1|||
124794789|NCT01150474|448879231|FG001|Overall Study|Cancer found|0|||
124794790|NCT01150474|448879230|FG000|Overall Study|Multiple Studies|0|||
124794791|NCT01150474|448879231|FG001|Overall Study|Multiple Studies|1|||
124794792|NCT01150474|448879230|FG000|Overall Study|Rectotomy|1|||
124794793|NCT01150474|448879231|FG001|Overall Study|Rectotomy|0|||
124794794|NCT01150474|448879230|FG000|Overall Study|Drug did not arrive in time|1|||
124794795|NCT01150474|448879231|FG001|Overall Study|Drug did not arrive in time|0|||
124794796|NCT01150474|448879230|FG000|Overall Study|Drug not administered|1|||
124794797|NCT01150474|448879231|FG001|Overall Study|Drug not administered|0|||
124794798|NCT01150474|448879230|FG000|Overall Study|Surgery Changed|1|||
124794799|NCT01150474|448879231|FG001|Overall Study|Surgery Changed|0|||
124794800|NCT02290431|448879232|FG000|Overall Study|Adverse Event|20|||
124794801|NCT02290431|448879232|FG000|Overall Study|Progressive disease|4|||
124794802|NCT02290431|448879232|FG000|Overall Study|Study terminated by Sponsor|1|||
124794803|NCT02290431|448879232|FG000|Overall Study|Physician Decision|2|||
124794804|NCT00821327|448879235|FG000|Overall Study|Adverse Event|13|||
124794805|NCT00821327|448879235|FG000|Overall Study|Patient Request|1|||
124794806|NCT00821327|448879235|FG000|Overall Study|Investigator Request|2|||
124794807|NCT00821327|448879235|FG000|Overall Study|Sponsor Request|1|||
124794808|NCT00821327|448879235|FG000|Overall Study|Disease Progression|13|||
124794809|NCT00821327|448879235|FG000|Overall Study|Other/Unknown|5|||
124794810|NCT00459979|448879238|FG000|Overall Study|Withdrawal by Subject|1|||
124794811|NCT00459979|448879238|FG000|Overall Study|Protocol Violation|1|||
124794812|NCT01007253|448879245|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
124794813|NCT01007253|448879246|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
124794814|NCT01007253|448879247|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
124794815|NCT01007253|448879248|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
124794816|NCT00814801|448879249|FG000|Overall Study|Adverse Event|15|||
124794817|NCT00814801|448879250|FG001|Overall Study|Adverse Event|16|||
124794818|NCT00814801|448879251|FG002|Overall Study|Adverse Event|19|||
124794819|NCT00814801|448879249|FG000|Overall Study|Withdrawal by Subject|9|||
124794820|NCT00814801|448879250|FG001|Overall Study|Withdrawal by Subject|11|||
124794821|NCT00814801|448879251|FG002|Overall Study|Withdrawal by Subject|14|||
124794822|NCT00814801|448879249|FG000|Overall Study|Inappropriate as a subject|1|||
124794823|NCT00814801|448879250|FG001|Overall Study|Inappropriate as a subject|1|||
124794824|NCT00814801|448879251|FG002|Overall Study|Inappropriate as a subject|1|||
124794825|NCT00814801|448879249|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
124794826|NCT00814801|448879250|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
124794827|NCT00814801|448879251|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
124794828|NCT00814801|448879249|FG000|Overall Study|Missing or change of caregiver|6|||
124794829|NCT00814801|448879250|FG001|Overall Study|Missing or change of caregiver|2|||
124794830|NCT00814801|448879251|FG002|Overall Study|Missing or change of caregiver|4|||
124794831|NCT00814801|448879249|FG000|Overall Study|Non-compliance|0|||
124794832|NCT00814801|448879250|FG001|Overall Study|Non-compliance|1|||
124794833|NCT00814801|448879251|FG002|Overall Study|Non-compliance|1|||
124794834|NCT00814801|448879249|FG000|Overall Study|Other|2|||
124794835|NCT00814801|448879250|FG001|Overall Study|Other|6|||
124794836|NCT00814801|448879251|FG002|Overall Study|Other|4|||
124794837|NCT01163032|448879255|FG000|Randomization Phase|Withdrawal by Subject|2|||
124794838|NCT01163032|448879256|FG001|Randomization Phase|Withdrawal by Subject|3|||
124794839|NCT01163032|448879257|FG002|Randomization Phase|Withdrawal by Subject|0|||
124794840|NCT01163032|448879255|FG000|Randomization Phase|Adverse Event|3|||
124794841|NCT01163032|448879256|FG001|Randomization Phase|Adverse Event|3|||
124794842|NCT01163032|448879257|FG002|Randomization Phase|Adverse Event|0|||
124794843|NCT01163032|448879255|FG000|Randomization Phase|Protocol Violation|0|||
124794844|NCT01163032|448879256|FG001|Randomization Phase|Protocol Violation|1|||
124794845|NCT01163032|448879257|FG002|Randomization Phase|Protocol Violation|0|||
124794846|NCT01163032|448879255|FG000|Randomization Phase|Various*|5|||
124794847|NCT01163032|448879256|FG001|Randomization Phase|Various*|4|||
124794848|NCT01163032|448879257|FG002|Randomization Phase|Various*|0|||
124794849|NCT01163032|448879255|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
124794850|NCT01163032|448879256|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
124794851|NCT01163032|448879257|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
124794852|NCT01163032|448879255|FG000|Open Label Extension Phase|Adverse Event|0|||
124794853|NCT01163032|448879256|FG001|Open Label Extension Phase|Adverse Event|0|||
124794854|NCT01163032|448879257|FG002|Open Label Extension Phase|Adverse Event|3|||
124794855|NCT01163032|448879255|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
124794856|NCT01163032|448879256|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
124794857|NCT01163032|448879257|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
124794858|NCT01163032|448879255|FG000|Open Label Extension Phase|Protocol Violation|0|||
124794859|NCT01163032|448879256|FG001|Open Label Extension Phase|Protocol Violation|0|||
124794860|NCT01163032|448879257|FG002|Open Label Extension Phase|Protocol Violation|1|||
124794861|NCT01163032|448879255|FG000|Open Label Extension Phase|Study Termination|0|||
124794862|NCT01163032|448879256|FG001|Open Label Extension Phase|Study Termination|0|||
124794863|NCT01163032|448879257|FG002|Open Label Extension Phase|Study Termination|7|||
124794864|NCT01163032|448879255|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
124794865|NCT01163032|448879256|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
124794866|NCT01163032|448879257|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
125295474|NCT02066415|450709452|FG001|Overall Study|Lost to Follow-up|2|||
124794867|NCT02751931|448879258|FG000|Overall Study|Adverse Event|3|||
124794868|NCT02751931|448879259|FG001|Overall Study|Adverse Event|0|||
124794869|NCT02751931|448879258|FG000|Overall Study|Other: Miscelleneous|10|||
124794870|NCT02751931|448879259|FG001|Overall Study|Other: Miscelleneous|8|||
124794871|NCT02380690|448879260|FG000|Overall Study|Lost to Follow-up|14|||
124794872|NCT02380690|448879261|FG001|Overall Study|Lost to Follow-up|4|||
124794873|NCT02380690|448879260|FG000|Overall Study|Withdrawal by Subject|20|||
124794874|NCT02380690|448879261|FG001|Overall Study|Withdrawal by Subject|8|||
124794875|NCT00817479|448879265|FG000|Overall Study|Physician Decision|1|||
124794876|NCT00817479|448879266|FG001|Overall Study|Physician Decision|1|||
124794877|NCT04030026|448879268|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
124794878|NCT04030026|448879269|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
124794879|NCT04030026|448879268|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
124794880|NCT04030026|448879269|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
124794881|NCT04030026|448879268|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
124794882|NCT04030026|448879269|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
124794883|NCT04030026|448879268|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
124794884|NCT04030026|448879269|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
124794885|NCT04030026|448879268|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
124794886|NCT04030026|448879269|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
124794887|NCT04030026|448879268|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
124794888|NCT04030026|448879269|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
124794889|NCT04030026|448879268|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
124794890|NCT04030026|448879269|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
124794891|NCT00523367|448879270|FG000|Overall Study|19 screen failures|19|||
124794892|NCT00523367|448879270|FG000|Overall Study|4 Withdrawn by PI|4|||
124794893|NCT00282347|448879275|FG000|Treatment Period|Death|2|||
124794894|NCT00282347|448879276|FG001|Treatment Period|Death|0|||
124794895|NCT00282347|448879275|FG000|Treatment Period|Lost to Follow-up|2|||
124794896|NCT00282347|448879276|FG001|Treatment Period|Lost to Follow-up|5|||
124794897|NCT00282347|448879275|FG000|Treatment Period|Withdrawal by Subject|1|||
124794898|NCT00282347|448879276|FG001|Treatment Period|Withdrawal by Subject|3|||
124794899|NCT00282347|448879275|FG000|Treatment Period|Physician Decision|0|||
124794900|NCT00282347|448879276|FG001|Treatment Period|Physician Decision|1|||
124794901|NCT00282347|448879275|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
124794902|NCT00282347|448879276|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
124794903|NCT00282347|448879275|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
124794904|NCT00282347|448879276|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
124794905|NCT00282347|448879275|FG000|Safety Follow-up Period|Physician Decision|1|||
124794906|NCT00282347|448879276|FG001|Safety Follow-up Period|Physician Decision|1|||
124794907|NCT00282347|448879275|FG000|Safety Follow-up Period|Protocol Deviation|0|||
124794908|NCT00282347|448879276|FG001|Safety Follow-up Period|Protocol Deviation|2|||
124794909|NCT00282347|448879275|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
124794910|NCT00282347|448879276|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
124794911|NCT00282347|448879275|FG000|B Cell Follow-up Period|Physician Decision|1|||
124794912|NCT00282347|448879276|FG001|B Cell Follow-up Period|Physician Decision|0|||
124794913|NCT00282347|448879275|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
124794914|NCT00282347|448879276|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
124794915|NCT02361346|448879277|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
124794916|NCT02361346|448879278|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
124794917|NCT02361346|448879279|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
124794918|NCT02361346|448879280|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
124794919|NCT02361346|448879281|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
124794920|NCT02361346|448879282|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
124794921|NCT02361346|448879283|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
124794922|NCT02361346|448879284|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
124794923|NCT02361346|448879285|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
124794924|NCT02361346|448879277|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
124794925|NCT02361346|448879278|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
124794926|NCT02361346|448879279|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
124794927|NCT02361346|448879280|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
124794928|NCT02361346|448879281|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
124794929|NCT02361346|448879282|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
124794930|NCT02361346|448879283|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
124794931|NCT02361346|448879284|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
124794932|NCT02361346|448879285|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
124794933|NCT02361346|448879277|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
125295475|NCT02066415|450709453|FG002|Overall Study|Lost to Follow-up|2|||
124794934|NCT02361346|448879278|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
124794935|NCT02361346|448879279|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
125295476|NCT00430937|450709454|FG000|Overall Study|Adverse Event|3|||
124794936|NCT02361346|448879280|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
124794937|NCT02361346|448879281|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
124794938|NCT02361346|448879282|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
124794939|NCT02361346|448879283|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
124794940|NCT02361346|448879284|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
124794941|NCT02361346|448879285|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
124794942|NCT02361346|448879277|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
124794943|NCT02361346|448879278|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
124794944|NCT02361346|448879279|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
124794945|NCT02361346|448879280|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
124794946|NCT02361346|448879281|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
124794947|NCT02361346|448879282|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
124794948|NCT02361346|448879283|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
124794949|NCT02361346|448879284|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
124794950|NCT02361346|448879285|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
124794951|NCT02361346|448879277|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
124794952|NCT02361346|448879278|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
124794953|NCT02361346|448879279|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
124794954|NCT02361346|448879280|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
124794955|NCT02361346|448879281|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
124794956|NCT02361346|448879282|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
124794957|NCT02361346|448879283|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
124794958|NCT02361346|448879284|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
124794959|NCT02361346|448879285|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
124794960|NCT02361346|448879277|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
124794961|NCT02361346|448879278|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
124794962|NCT02361346|448879279|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
124794963|NCT02361346|448879280|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
124794964|NCT02361346|448879281|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
124794965|NCT02361346|448879282|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
124794966|NCT02361346|448879283|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
124794967|NCT02361346|448879284|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
124794968|NCT02361346|448879285|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
124794969|NCT00782795|448879286|FG000|Overall Study|Withdrawal by Subject|1|||
124794970|NCT00782795|448879287|FG001|Overall Study|Withdrawal by Subject|2|||
124794971|NCT04480424|448879288|FG000|Overall Study|Withdrawal by Subject|0|||
124794972|NCT04480424|448879289|FG001|Overall Study|Withdrawal by Subject|2|||
124794973|NCT04480424|448879288|FG000|Overall Study|Lost to Follow-up|3|||
124794974|NCT04480424|448879289|FG001|Overall Study|Lost to Follow-up|3|||
124794975|NCT04480424|448879288|FG000|Overall Study|Death|14|||
124794976|NCT04480424|448879289|FG001|Overall Study|Death|16|||
124794977|NCT04480424|448879288|FG000|Overall Study|Reason not Specified|5|||
124794978|NCT04480424|448879289|FG001|Overall Study|Reason not Specified|5|||
124794979|NCT02782923|448879290|FG000|Overall Study|Lost to Follow-up|15|||
124794980|NCT00993044|448879292|FG000|Irinotecan 50 mg|Physician Decision|1|||
124794981|NCT00734747|448879293|FG000|SRS Procedure|No staples placed|3|||
124794982|NCT00734747|448879293|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
124794983|NCT01275339|448880651|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
124794984|NCT01275339|448880652|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
124794985|NCT01275339|448880653|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
124794986|NCT01275339|448880654|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
124794987|NCT01275339|448880651|FG000|Overall Study|Withdrawal by Subject|0|||
124794988|NCT01275339|448880652|FG001|Overall Study|Withdrawal by Subject|0|||
124794989|NCT01275339|448880653|FG002|Overall Study|Withdrawal by Subject|1|||
124794990|NCT01275339|448880654|FG003|Overall Study|Withdrawal by Subject|0|||
124794991|NCT02469038|448880655|FG000|Overall Study|Physician Decision|4|||
124794992|NCT02469038|448880656|FG001|Overall Study|Physician Decision|5|||
124794993|NCT01850602|448880662|FG000|Overall Study|Adverse Event|7|||
124794994|NCT01850602|448880663|FG001|Overall Study|Adverse Event|10|||
124794995|NCT01850602|448880662|FG000|Overall Study|Physician Decision|2|||
124794996|NCT01850602|448880663|FG001|Overall Study|Physician Decision|1|||
124794997|NCT01850602|448880662|FG000|Overall Study|Withdrawal by Subject|2|||
124794998|NCT01850602|448880663|FG001|Overall Study|Withdrawal by Subject|4|||
124794999|NCT01850602|448880662|FG000|Overall Study|Decrease in serum calcium|2|||
124795000|NCT01850602|448880663|FG001|Overall Study|Decrease in serum calcium|3|||
124795001|NCT01850602|448880662|FG000|Overall Study|Increase in serum ferritin|1|||
124795002|NCT01850602|448880663|FG001|Overall Study|Increase in serum ferritin|0|||
124795003|NCT01857310|448880664|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
124795004|NCT01857310|448880665|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
124795005|NCT02497976|448880666|FG000|Overall Study|Withdrawal by Subject|2|||
124795006|NCT02497976|448880667|FG001|Overall Study|Withdrawal by Subject|0|||
124795007|NCT02497976|448880666|FG000|Overall Study|Moved out of area|0|||
124795008|NCT02497976|448880667|FG001|Overall Study|Moved out of area|1|||
124795009|NCT00584740|448880668|FG000|Overall Study|Adverse Event|1|||
124795010|NCT00584740|448880669|FG001|Overall Study|Adverse Event|1|||
124795011|NCT00584740|448880668|FG000|Overall Study|Lack of Efficacy|8|||
124795012|NCT00584740|448880669|FG001|Overall Study|Lack of Efficacy|2|||
124795013|NCT00584740|448880668|FG000|Overall Study|Withdrawal by Subject|3|||
124795014|NCT00584740|448880669|FG001|Overall Study|Withdrawal by Subject|2|||
124795015|NCT00584740|448880668|FG000|Overall Study|Lost to Follow-up|0|||
124795016|NCT00584740|448880669|FG001|Overall Study|Lost to Follow-up|1|||
124795017|NCT03915860|448880673|FG000|Overall Study|Adverse Event|3|||
124795018|NCT03915860|448880673|FG000|Overall Study|Withdrawal by Subject|6|||
124795019|NCT03915860|448880673|FG000|Overall Study|Lost to Follow-up|2|||
124795020|NCT03915860|448880673|FG000|Overall Study|Other than specified|3|||
124795021|NCT02195011|448880674|FG000|Overall Study|Adverse Event|4|||
124795022|NCT02195011|448880675|FG001|Overall Study|Adverse Event|0|||
124795023|NCT02195011|448880674|FG000|Overall Study|Progressive Disease|18|||
124795024|NCT02195011|448880675|FG001|Overall Study|Progressive Disease|1|||
124795025|NCT02195011|448880674|FG000|Overall Study|Withdrawal by Subject|3|||
124795026|NCT02195011|448880675|FG001|Overall Study|Withdrawal by Subject|0|||
124795027|NCT00768469|448880678|FG000|Overall Study|Adverse Event|0|||
124795028|NCT00768469|448880679|FG001|Overall Study|Adverse Event|2|||
124795029|NCT00768469|448880678|FG000|Overall Study|Disease Progression|3|||
124795030|NCT00768469|448880679|FG001|Overall Study|Disease Progression|4|||
124795031|NCT00768469|448880678|FG000|Overall Study|Withdrawal by Subject|0|||
124795032|NCT00768469|448880679|FG001|Overall Study|Withdrawal by Subject|1|||
124795033|NCT00722371|448880682|FG000|Overall Study|Adverse Event|6|||
124795034|NCT00722371|448880683|FG001|Overall Study|Adverse Event|13|||
124795035|NCT00722371|448880684|FG002|Overall Study|Adverse Event|9|||
124795036|NCT00722371|448880685|FG003|Overall Study|Adverse Event|10|||
124795037|NCT00722371|448880686|FG004|Overall Study|Adverse Event|6|||
124795038|NCT00722371|448880687|FG005|Overall Study|Adverse Event|8|||
124795039|NCT00722371|448880688|FG006|Overall Study|Adverse Event|4|||
124795040|NCT00722371|448880682|FG000|Overall Study|Contraindication|0|||
124795041|NCT00722371|448880683|FG001|Overall Study|Contraindication|0|||
124795042|NCT00722371|448880684|FG002|Overall Study|Contraindication|1|||
124795043|NCT00722371|448880685|FG003|Overall Study|Contraindication|0|||
124795044|NCT00722371|448880686|FG004|Overall Study|Contraindication|0|||
124795045|NCT00722371|448880687|FG005|Overall Study|Contraindication|0|||
124795046|NCT00722371|448880688|FG006|Overall Study|Contraindication|0|||
124795047|NCT00722371|448880682|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
124795048|NCT00722371|448880683|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
124795049|NCT00722371|448880684|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
124795050|NCT00722371|448880685|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
124795051|NCT00722371|448880686|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
124795052|NCT00722371|448880687|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
124795053|NCT00722371|448880688|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
124795054|NCT00722371|448880682|FG000|Overall Study|Excluded medication|0|||
124795055|NCT00722371|448880683|FG001|Overall Study|Excluded medication|1|||
124795056|NCT00722371|448880684|FG002|Overall Study|Excluded medication|1|||
124795057|NCT00722371|448880685|FG003|Overall Study|Excluded medication|0|||
124795058|NCT00722371|448880686|FG004|Overall Study|Excluded medication|0|||
124795059|NCT00722371|448880687|FG005|Overall Study|Excluded medication|0|||
124795060|NCT00722371|448880688|FG006|Overall Study|Excluded medication|1|||
124795061|NCT00722371|448880682|FG000|Overall Study|Hyperglycemia|2|||
124795062|NCT00722371|448880683|FG001|Overall Study|Hyperglycemia|6|||
124795063|NCT00722371|448880684|FG002|Overall Study|Hyperglycemia|4|||
124795064|NCT00722371|448880685|FG003|Overall Study|Hyperglycemia|2|||
124795065|NCT00722371|448880686|FG004|Overall Study|Hyperglycemia|5|||
124795066|NCT00722371|448880687|FG005|Overall Study|Hyperglycemia|1|||
124795067|NCT00722371|448880688|FG006|Overall Study|Hyperglycemia|1|||
124795068|NCT00722371|448880682|FG000|Overall Study|Hypoglycemia|1|||
124795069|NCT00722371|448880683|FG001|Overall Study|Hypoglycemia|0|||
124795070|NCT00722371|448880684|FG002|Overall Study|Hypoglycemia|0|||
124795071|NCT00722371|448880685|FG003|Overall Study|Hypoglycemia|0|||
124795072|NCT00722371|448880686|FG004|Overall Study|Hypoglycemia|0|||
124795073|NCT00722371|448880687|FG005|Overall Study|Hypoglycemia|0|||
124795074|NCT00722371|448880688|FG006|Overall Study|Hypoglycemia|0|||
124795075|NCT00722371|448880682|FG000|Overall Study|Lack of Efficacy|4|||
124795076|NCT00722371|448880683|FG001|Overall Study|Lack of Efficacy|6|||
124795077|NCT00722371|448880684|FG002|Overall Study|Lack of Efficacy|6|||
124795078|NCT00722371|448880685|FG003|Overall Study|Lack of Efficacy|6|||
124795079|NCT00722371|448880686|FG004|Overall Study|Lack of Efficacy|2|||
124795080|NCT00722371|448880687|FG005|Overall Study|Lack of Efficacy|3|||
124795081|NCT00722371|448880688|FG006|Overall Study|Lack of Efficacy|0|||
124795082|NCT00722371|448880682|FG000|Overall Study|Lost to Follow-up|11|||
124795083|NCT00722371|448880683|FG001|Overall Study|Lost to Follow-up|14|||
124795084|NCT00722371|448880684|FG002|Overall Study|Lost to Follow-up|21|||
124795085|NCT00722371|448880685|FG003|Overall Study|Lost to Follow-up|13|||
124795086|NCT00722371|448880686|FG004|Overall Study|Lost to Follow-up|8|||
124795087|NCT00722371|448880687|FG005|Overall Study|Lost to Follow-up|16|||
124795088|NCT00722371|448880688|FG006|Overall Study|Lost to Follow-up|13|||
124795089|NCT00722371|448880682|FG000|Overall Study|Physician Decision|5|||
124795090|NCT00722371|448880683|FG001|Overall Study|Physician Decision|2|||
124795091|NCT00722371|448880684|FG002|Overall Study|Physician Decision|2|||
124795092|NCT00722371|448880685|FG003|Overall Study|Physician Decision|5|||
124795093|NCT00722371|448880686|FG004|Overall Study|Physician Decision|2|||
124795094|NCT00722371|448880687|FG005|Overall Study|Physician Decision|3|||
124795095|NCT00722371|448880688|FG006|Overall Study|Physician Decision|4|||
124795096|NCT00722371|448880682|FG000|Overall Study|Pregnancy|1|||
124795097|NCT00722371|448880683|FG001|Overall Study|Pregnancy|1|||
124795098|NCT00722371|448880684|FG002|Overall Study|Pregnancy|0|||
124795099|NCT00722371|448880685|FG003|Overall Study|Pregnancy|0|||
124795100|NCT00722371|448880686|FG004|Overall Study|Pregnancy|0|||
124795101|NCT00722371|448880687|FG005|Overall Study|Pregnancy|1|||
124795102|NCT00722371|448880688|FG006|Overall Study|Pregnancy|0|||
124795103|NCT00722371|448880682|FG000|Overall Study|Protocol Violation|6|||
124795104|NCT00722371|448880683|FG001|Overall Study|Protocol Violation|1|||
124795105|NCT00722371|448880684|FG002|Overall Study|Protocol Violation|0|||
124795106|NCT00722371|448880685|FG003|Overall Study|Protocol Violation|1|||
124795107|NCT00722371|448880686|FG004|Overall Study|Protocol Violation|4|||
124795108|NCT00722371|448880687|FG005|Overall Study|Protocol Violation|2|||
124795109|NCT00722371|448880688|FG006|Overall Study|Protocol Violation|1|||
124795110|NCT00722371|448880682|FG000|Overall Study|Withdrawal by Subject|18|||
124795111|NCT00722371|448880683|FG001|Overall Study|Withdrawal by Subject|27|||
124795112|NCT00722371|448880684|FG002|Overall Study|Withdrawal by Subject|19|||
124795113|NCT00722371|448880685|FG003|Overall Study|Withdrawal by Subject|23|||
124795114|NCT00722371|448880686|FG004|Overall Study|Withdrawal by Subject|19|||
124795115|NCT00722371|448880687|FG005|Overall Study|Withdrawal by Subject|18|||
124795116|NCT00722371|448880688|FG006|Overall Study|Withdrawal by Subject|26|||
124795117|NCT02635646|448880689|FG000|Overall Study|Lost to Follow-up|24|||
124795118|NCT02635646|448880690|FG001|Overall Study|Lost to Follow-up|25|||
124795119|NCT02635646|448880689|FG000|Overall Study|Pregnancy|1|||
124795120|NCT02635646|448880690|FG001|Overall Study|Pregnancy|1|||
124795121|NCT03189381|448880691|FG000|Overall Study|Death|1|||
124795122|NCT03189381|448880692|FG001|Overall Study|Death|0|||
124795123|NCT03761797|448880693|FG000|Overall Study|Changing hospital|11|||
124795124|NCT03761797|448880693|FG000|Overall Study|Improvement/remission|6|||
125295477|NCT00430937|450709455|FG001|Overall Study|Adverse Event|8|||
125295478|NCT00430937|450709454|FG000|Overall Study|Death|0|||
125295479|NCT00430937|450709455|FG001|Overall Study|Death|1|||
125295480|NCT00430937|450709454|FG000|Overall Study|Lost to Follow-up|6|||
125295481|NCT00430937|450709455|FG001|Overall Study|Lost to Follow-up|6|||
125295482|NCT00430937|450709454|FG000|Overall Study|Withdrawal by Subject|5|||
125295483|NCT00430937|450709455|FG001|Overall Study|Withdrawal by Subject|2|||
125295484|NCT00430937|450709454|FG000|Overall Study|Protocol Violation|3|||
124795125|NCT03761797|448880693|FG000|Overall Study|Withdrawal by Subject|19|||
124795126|NCT03761797|448880693|FG000|Overall Study|Lost to Follow-up|33|||
124795127|NCT03761797|448880693|FG000|Overall Study|Adverse Event|37|||
124795128|NCT03761797|448880693|FG000|Overall Study|Case report form (CRF) not collected|5|||
124795129|NCT03761797|448880693|FG000|Overall Study|No patient visit after entry|13|||
124795130|NCT03761797|448880693|FG000|Overall Study|Switch to other diabetes medication|10|||
124795131|NCT03761797|448880693|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
124795132|NCT03761797|448880693|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
124795133|NCT03761797|448880693|FG000|Overall Study|Insufficient effectives|2|||
124795134|NCT03761797|448880693|FG000|Overall Study|Excessive alcohol intake|1|||
124795135|NCT00251004|448880694|FG000|Overall Study|Withdrawal by Subject|23|||
124795136|NCT00251004|448880695|FG001|Overall Study|Withdrawal by Subject|16|||
124795137|NCT00251004|448880696|FG002|Overall Study|Withdrawal by Subject|14|||
124795138|NCT00251004|448880694|FG000|Overall Study|Death|9|||
124795139|NCT00251004|448880695|FG001|Overall Study|Death|10|||
124795140|NCT00251004|448880696|FG002|Overall Study|Death|8|||
124795141|NCT00251004|448880694|FG000|Overall Study|Lost to Follow-up|1|||
124795142|NCT00251004|448880695|FG001|Overall Study|Lost to Follow-up|2|||
125295485|NCT00430937|450709455|FG001|Overall Study|Protocol Violation|2|||
125295486|NCT00430937|450709454|FG000|Overall Study|Lack of Efficacy|6|||
125295487|NCT00430937|450709455|FG001|Overall Study|Lack of Efficacy|5|||
125295488|NCT00430937|450709454|FG000|Overall Study|Inappropriate enrollment|2|||
125295489|NCT00430937|450709455|FG001|Overall Study|Inappropriate enrollment|1|||
125295490|NCT00430937|450709454|FG000|Overall Study|Administrative reasons|1|||
125295491|NCT00430937|450709455|FG001|Overall Study|Administrative reasons|0|||
125295492|NCT00430937|450709454|FG000|Overall Study|Protocol discontinuation criteria met|1|||
125295493|NCT00430937|450709455|FG001|Overall Study|Protocol discontinuation criteria met|2|||
125295494|NCT00430937|450709454|FG000|Overall Study|Unable to classify|0|||
125295495|NCT00430937|450709455|FG001|Overall Study|Unable to classify|1|||
124795143|NCT00251004|448880696|FG002|Overall Study|Lost to Follow-up|1|||
124795144|NCT00251004|448880694|FG000|Overall Study|Graft Loss|12|||
124795145|NCT00251004|448880695|FG001|Overall Study|Graft Loss|13|||
124795146|NCT00251004|448880696|FG002|Overall Study|Graft Loss|8|||
124795147|NCT00645788|448880697|FG000|Overall Study|Did not receive study drug|1|||
124795148|NCT00645788|448880698|FG001|Overall Study|Did not receive study drug|1|||
124795149|NCT00645788|448880699|FG002|Overall Study|Did not receive study drug|0|||
124795150|NCT00645788|448880700|FG003|Overall Study|Did not receive study drug|0|||
124795151|NCT00645788|448880697|FG000|Overall Study|Adverse Event|4|||
124795152|NCT00645788|448880698|FG001|Overall Study|Adverse Event|9|||
124795153|NCT00645788|448880699|FG002|Overall Study|Adverse Event|5|||
124795154|NCT00645788|448880700|FG003|Overall Study|Adverse Event|3|||
124795155|NCT00645788|448880697|FG000|Overall Study|Lost to Follow-up|1|||
124795156|NCT00645788|448880698|FG001|Overall Study|Lost to Follow-up|0|||
124795157|NCT00645788|448880699|FG002|Overall Study|Lost to Follow-up|0|||
124795158|NCT00645788|448880700|FG003|Overall Study|Lost to Follow-up|0|||
124795159|NCT00645788|448880697|FG000|Overall Study|Protocol Violation|1|||
124795160|NCT00645788|448880698|FG001|Overall Study|Protocol Violation|0|||
124795161|NCT00645788|448880699|FG002|Overall Study|Protocol Violation|2|||
124795162|NCT00645788|448880700|FG003|Overall Study|Protocol Violation|0|||
124795163|NCT00645788|448880697|FG000|Overall Study|Withdrawal by Subject|0|||
124795164|NCT00645788|448880698|FG001|Overall Study|Withdrawal by Subject|1|||
124795165|NCT00645788|448880699|FG002|Overall Study|Withdrawal by Subject|0|||
124795166|NCT00645788|448880700|FG003|Overall Study|Withdrawal by Subject|2|||
124795167|NCT00645788|448880697|FG000|Overall Study|Pulmonary exacerbation|13|||
124795168|NCT00645788|448880698|FG001|Overall Study|Pulmonary exacerbation|16|||
124795169|NCT00645788|448880699|FG002|Overall Study|Pulmonary exacerbation|11|||
124795170|NCT00645788|448880700|FG003|Overall Study|Pulmonary exacerbation|9|||
124795171|NCT03149848|448880701|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
124795172|NCT03149848|448880701|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
124795173|NCT01244490|448880702|FG000|Overall Study|Lack of Efficacy|14|||
124795174|NCT01244490|448880703|FG001|Overall Study|Lack of Efficacy|5|||
124795175|NCT01244490|448880704|FG002|Overall Study|Lack of Efficacy|5|||
124795176|NCT01244490|448880702|FG000|Overall Study|Withdrawal by Subject|4|||
124795177|NCT01244490|448880703|FG001|Overall Study|Withdrawal by Subject|4|||
124795178|NCT01244490|448880704|FG002|Overall Study|Withdrawal by Subject|9|||
124795179|NCT01244490|448880702|FG000|Overall Study|Adverse Event|1|||
124795180|NCT01244490|448880703|FG001|Overall Study|Adverse Event|9|||
124795181|NCT01244490|448880704|FG002|Overall Study|Adverse Event|5|||
124795182|NCT01244490|448880702|FG000|Overall Study|Lost to Follow-up|0|||
124795183|NCT01244490|448880703|FG001|Overall Study|Lost to Follow-up|6|||
124795184|NCT01244490|448880704|FG002|Overall Study|Lost to Follow-up|3|||
124795185|NCT01244490|448880702|FG000|Overall Study|Other|0|||
124795186|NCT01244490|448880703|FG001|Overall Study|Other|0|||
124795187|NCT01244490|448880704|FG002|Overall Study|Other|1|||
124795188|NCT00256282|448880712|FG000|Overall Study|Disease progression, relapse during acti|12|||
124795189|NCT00256282|448880712|FG000|Overall Study|Adverse Event|3|||
124795190|NCT00256282|448880712|FG000|Overall Study|Physician Decision|1|||
124795191|NCT00327470|448880715|FG000|Overall Study|Randomized, but not treated|0|||
124795192|NCT00327470|448880716|FG001|Overall Study|Randomized, but not treated|2|||
124795193|NCT00327470|448880715|FG000|Overall Study|Adverse Event|9|||
124795194|NCT00327470|448880716|FG001|Overall Study|Adverse Event|14|||
124795195|NCT00327470|448880715|FG000|Overall Study|Lack of Efficacy|7|||
124795196|NCT00327470|448880716|FG001|Overall Study|Lack of Efficacy|19|||
124795197|NCT00327470|448880715|FG000|Overall Study|Other|5|||
124795198|NCT00327470|448880716|FG001|Overall Study|Other|9|||
124795199|NCT00327470|448880715|FG000|Overall Study|Lost to Follow-up|1|||
124795200|NCT00327470|448880716|FG001|Overall Study|Lost to Follow-up|3|||
124795201|NCT00327470|448880715|FG000|Overall Study|Withdrawal by Subject|6|||
124795202|NCT00327470|448880716|FG001|Overall Study|Withdrawal by Subject|12|||
124795203|NCT00327470|448880715|FG000|Overall Study|Death|1|||
124795204|NCT00327470|448880716|FG001|Overall Study|Death|4|||
124795205|NCT02581943|448880719|FG000|Overall Study|Death|5|||
124795206|NCT02581943|448880720|FG001|Overall Study|Death|2|||
124795207|NCT02581943|448880719|FG000|Overall Study|Disease Progression|12|||
124795208|NCT02581943|448880720|FG001|Overall Study|Disease Progression|15|||
124795209|NCT02581943|448880719|FG000|Overall Study|Withdrawal by Subject|1|||
124795210|NCT02581943|448880720|FG001|Overall Study|Withdrawal by Subject|2|||
124795211|NCT03021564|448880721|FG000|Overall Study|Death|84|||
124795212|NCT03021564|448880722|FG001|Overall Study|Death|466|||
124795213|NCT03021564|448880721|FG000|Overall Study|Lost to Follow-up|0|||
124795214|NCT03021564|448880722|FG001|Overall Study|Lost to Follow-up|2|||
124795215|NCT00219544|448880723|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
125295496|NCT03242252|450709457|FG000|Overall Study|At the Participant's own Request|18|||
125295497|NCT03242252|450709458|FG001|Overall Study|At the Participant's own Request|10|||
125295498|NCT03242252|450709459|FG002|Overall Study|At the Participant's own Request|15|||
124795216|NCT00219544|448880724|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
124795217|NCT00219544|448880723|FG000|Single Blind Treatment Period|Adverse Event|9|||
124795218|NCT00219544|448880724|FG001|Single Blind Treatment Period|Adverse Event|0|||
124795219|NCT00219544|448880723|FG000|Single Blind Treatment Period|Protocol Violation|4|||
124795220|NCT00219544|448880724|FG001|Single Blind Treatment Period|Protocol Violation|0|||
124795221|NCT00219544|448880723|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
124795222|NCT00219544|448880724|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
124795223|NCT00219544|448880723|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
125295499|NCT03242252|450709457|FG000|Overall Study|Adverse Event|8|||
124795224|NCT00219544|448880724|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
124795225|NCT00219544|448880723|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
124795226|NCT00219544|448880724|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
124795227|NCT00745615|448880727|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
124795228|NCT00745615|448880728|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
124795229|NCT00745615|448880729|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
124795230|NCT00745615|448880730|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
124795231|NCT00745615|448880731|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
124795232|NCT00745615|448880732|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
124795233|NCT00745615|448880727|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
124795234|NCT00745615|448880728|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
124795235|NCT00745615|448880729|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
124795236|NCT00745615|448880730|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
124795237|NCT00745615|448880731|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
124795238|NCT00745615|448880732|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
124795239|NCT00745615|448880727|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
124795240|NCT00745615|448880728|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
124795241|NCT00745615|448880729|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
124795242|NCT00745615|448880730|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
124795243|NCT00745615|448880731|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
124795244|NCT00745615|448880732|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
124795245|NCT00745615|448880727|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
124795246|NCT00745615|448880728|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
124795247|NCT00745615|448880729|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
124795248|NCT00745615|448880730|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
124795249|NCT00745615|448880731|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
124795250|NCT00745615|448880732|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
124795251|NCT00745615|448880727|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
124795252|NCT00745615|448880728|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
124795253|NCT00745615|448880729|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
124795254|NCT00745615|448880730|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
124795255|NCT00745615|448880731|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
124795256|NCT00745615|448880732|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
124795257|NCT00745615|448880727|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
124795258|NCT00745615|448880728|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
124795259|NCT00745615|448880729|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
124795260|NCT00745615|448880730|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
124795261|NCT00745615|448880731|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
124795262|NCT00745615|448880732|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
124795263|NCT00745615|448880727|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
124795264|NCT00745615|448880728|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
124795265|NCT00745615|448880729|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
124795266|NCT00745615|448880730|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
124795267|NCT00745615|448880731|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
124795268|NCT00745615|448880732|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
124795269|NCT00745615|448880727|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
124795270|NCT00745615|448880728|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
124795271|NCT00745615|448880729|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
124795272|NCT00745615|448880730|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
124795273|NCT00745615|448880731|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
124795274|NCT00745615|448880732|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
124795275|NCT00745615|448880727|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
124795276|NCT00745615|448880728|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
124795277|NCT00745615|448880729|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
124795278|NCT00745615|448880730|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
124795279|NCT00745615|448880731|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
124795280|NCT00745615|448880732|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
124795281|NCT00745615|448880727|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
124795282|NCT00745615|448880728|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
124795283|NCT00745615|448880729|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
124795284|NCT00745615|448880730|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
124795285|NCT00745615|448880731|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
124795286|NCT00745615|448880732|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
124795287|NCT00745615|448880727|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
124795288|NCT00745615|448880728|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
124795289|NCT00745615|448880729|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
124795290|NCT00745615|448880730|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
124795291|NCT00745615|448880731|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
124795292|NCT00745615|448880732|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
124795293|NCT00745615|448880727|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
124795294|NCT00745615|448880728|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
124795295|NCT00745615|448880729|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
124795296|NCT00745615|448880730|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
124795297|NCT00745615|448880731|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
124795298|NCT00745615|448880732|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
124795299|NCT00745615|448880727|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
124795300|NCT00745615|448880728|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
124795301|NCT00745615|448880729|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
124795302|NCT00745615|448880730|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
124795303|NCT00745615|448880731|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
124795304|NCT00745615|448880732|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
124795305|NCT00745615|448880727|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
124795306|NCT00745615|448880728|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
124795307|NCT00745615|448880729|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
124795308|NCT00745615|448880730|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
124795309|NCT00745615|448880731|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
124795310|NCT00745615|448880732|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
124795311|NCT00586664|448880733|FG000|Overall Study|Withdrawal by Subject|3|||
124795312|NCT00586664|448880734|FG001|Overall Study|Withdrawal by Subject|7|||
124795313|NCT00586664|448880735|FG002|Overall Study|Withdrawal by Subject|1|||
124795314|NCT00586664|448880733|FG000|Overall Study|Exclusion criteria met|2|||
124795315|NCT00586664|448880734|FG001|Overall Study|Exclusion criteria met|0|||
124795316|NCT00586664|448880735|FG002|Overall Study|Exclusion criteria met|0|||
124795317|NCT00727532|448880737|FG000|Overall Study|Adverse Event|1|||
124795318|NCT00727532|448880737|FG000|Overall Study|Withdrawal by Subject|1|||
124795319|NCT00829933|448880738|FG000|Overall Study|Adverse Event|2|||
124795320|NCT00829933|448880739|FG001|Overall Study|Adverse Event|3|||
124795321|NCT00829933|448880740|FG002|Overall Study|Adverse Event|2|||
124795322|NCT00829933|448880741|FG003|Overall Study|Adverse Event|1|||
124795323|NCT00829933|448880738|FG000|Overall Study|Death|0|||
124795324|NCT00829933|448880739|FG001|Overall Study|Death|0|||
124795325|NCT00829933|448880740|FG002|Overall Study|Death|1|||
124795326|NCT00829933|448880741|FG003|Overall Study|Death|1|||
124795327|NCT00829933|448880738|FG000|Overall Study|Lack of Efficacy|0|||
124795328|NCT00829933|448880739|FG001|Overall Study|Lack of Efficacy|1|||
124795329|NCT00829933|448880740|FG002|Overall Study|Lack of Efficacy|0|||
124795330|NCT00829933|448880741|FG003|Overall Study|Lack of Efficacy|0|||
124795331|NCT00829933|448880738|FG000|Overall Study|Physician Decision|5|||
124795332|NCT00829933|448880739|FG001|Overall Study|Physician Decision|7|||
124795333|NCT00829933|448880740|FG002|Overall Study|Physician Decision|8|||
124795334|NCT00829933|448880741|FG003|Overall Study|Physician Decision|1|||
124795335|NCT00829933|448880738|FG000|Overall Study|Pregnancy|0|||
124795336|NCT00829933|448880739|FG001|Overall Study|Pregnancy|0|||
124795337|NCT00829933|448880740|FG002|Overall Study|Pregnancy|0|||
124795338|NCT00829933|448880741|FG003|Overall Study|Pregnancy|2|||
124795339|NCT00829933|448880738|FG000|Overall Study|Protocol Violation|2|||
124795340|NCT00829933|448880739|FG001|Overall Study|Protocol Violation|1|||
124795341|NCT00829933|448880740|FG002|Overall Study|Protocol Violation|0|||
124795342|NCT00829933|448880741|FG003|Overall Study|Protocol Violation|0|||
124795343|NCT00829933|448880738|FG000|Overall Study|withdrew before treatment started|5|||
124795344|NCT00829933|448880739|FG001|Overall Study|withdrew before treatment started|1|||
125295500|NCT03242252|450709458|FG001|Overall Study|Adverse Event|6|||
124795345|NCT00829933|448880740|FG002|Overall Study|withdrew before treatment started|2|||
124795346|NCT00829933|448880741|FG003|Overall Study|withdrew before treatment started|9|||
124795347|NCT01986933|448880746|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
124795348|NCT01986933|448880747|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
124795349|NCT01986933|448880748|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
124795350|NCT01986933|448880749|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
124795351|NCT01986933|448880750|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
125295501|NCT03242252|450709459|FG002|Overall Study|Adverse Event|9|||
125295502|NCT03242252|450709457|FG000|Overall Study|Poor Compliance to Protocol|0|||
125295503|NCT03242252|450709458|FG001|Overall Study|Poor Compliance to Protocol|2|||
125295504|NCT03242252|450709459|FG002|Overall Study|Poor Compliance to Protocol|3|||
124795352|NCT01986933|448880746|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
124795353|NCT01986933|448880747|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
125295505|NCT03242252|450709457|FG000|Overall Study|Study Terminated by Sponsor|1|||
125295506|NCT03242252|450709458|FG001|Overall Study|Study Terminated by Sponsor|0|||
124795354|NCT01986933|448880748|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
124795355|NCT01986933|448880749|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
124795356|NCT01986933|448880750|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
124795357|NCT01986933|448880746|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
124795358|NCT01986933|448880747|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
124795359|NCT01986933|448880748|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
125295507|NCT03242252|450709459|FG002|Overall Study|Study Terminated by Sponsor|0|||
124795360|NCT01986933|448880749|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
124795361|NCT01986933|448880750|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
124795362|NCT01986933|448880746|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
124795363|NCT01986933|448880747|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
124795364|NCT01986933|448880748|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
124795365|NCT01986933|448880749|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
124795366|NCT01986933|448880750|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
124795367|NCT01986933|448880746|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
124795368|NCT01986933|448880747|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
124795369|NCT01986933|448880748|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
124795370|NCT01986933|448880749|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
124795371|NCT01986933|448880750|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
124795372|NCT01986933|448880746|FG000|Active-to-active (Part B)|Adverse Event|0|||
124795373|NCT01986933|448880747|FG001|Active-to-active (Part B)|Adverse Event|2|||
124795374|NCT01986933|448880748|FG002|Active-to-active (Part B)|Adverse Event|0|||
124795375|NCT01986933|448880749|FG003|Active-to-active (Part B)|Adverse Event|1|||
124795376|NCT01986933|448880750|FG004|Active-to-active (Part B)|Adverse Event|3|||
124795377|NCT01986933|448880746|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
124795378|NCT01986933|448880747|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
124795379|NCT01986933|448880748|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
124795380|NCT01986933|448880749|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
124795381|NCT01986933|448880750|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
124795382|NCT01986933|448880746|FG000|Active-to-active (Part B)|Pregnancy|0|||
124795383|NCT01986933|448880747|FG001|Active-to-active (Part B)|Pregnancy|0|||
124795384|NCT01986933|448880748|FG002|Active-to-active (Part B)|Pregnancy|0|||
124795385|NCT01986933|448880749|FG003|Active-to-active (Part B)|Pregnancy|0|||
124795386|NCT01986933|448880750|FG004|Active-to-active (Part B)|Pregnancy|1|||
124795387|NCT01986933|448880746|FG000|Active-to-active (Part B)|Physician Decision|0|||
124795388|NCT01986933|448880747|FG001|Active-to-active (Part B)|Physician Decision|0|||
124795389|NCT01986933|448880748|FG002|Active-to-active (Part B)|Physician Decision|1|||
124795390|NCT01986933|448880749|FG003|Active-to-active (Part B)|Physician Decision|1|||
124795391|NCT01986933|448880750|FG004|Active-to-active (Part B)|Physician Decision|0|||
124795392|NCT01986933|448880746|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
124795393|NCT01986933|448880747|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
124795394|NCT01986933|448880748|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
124795395|NCT01986933|448880749|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
124795396|NCT01986933|448880750|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
124795397|NCT01986933|448880746|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
124795398|NCT01986933|448880747|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
124795399|NCT01986933|448880748|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
124795400|NCT01986933|448880749|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
124795401|NCT01986933|448880750|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
124795402|NCT01986933|448880746|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
124795403|NCT01986933|448880747|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
124795404|NCT01986933|448880748|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
124795405|NCT01986933|448880749|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
124795406|NCT01986933|448880750|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
124795407|NCT01986933|448880746|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
124795408|NCT01986933|448880747|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
124795409|NCT01986933|448880748|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
124795410|NCT01986933|448880749|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
124795411|NCT01986933|448880750|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
124795412|NCT01986933|448880746|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
124795413|NCT01986933|448880747|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
124795414|NCT01986933|448880748|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
124795415|NCT01986933|448880749|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
124795416|NCT01986933|448880750|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
124795417|NCT01986933|448880746|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
124795418|NCT01986933|448880747|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
124795419|NCT01986933|448880748|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
124795420|NCT01986933|448880749|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
124795421|NCT01986933|448880750|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
124795422|NCT01986933|448880746|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
124795423|NCT01986933|448880747|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
124795424|NCT01986933|448880748|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
124795425|NCT01986933|448880749|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
124795426|NCT01986933|448880750|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
124795427|NCT01986933|448880746|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
124795428|NCT01986933|448880747|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
124795429|NCT01986933|448880748|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
124795430|NCT01986933|448880749|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
124795431|NCT01986933|448880750|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
124795432|NCT03119701|448880751|FG000|6-day Dosing|Death|4|||
124795433|NCT03119701|448880752|FG001|6-day Dosing|Death|1|||
124795434|NCT03119701|448880751|FG000|6-day Dosing|Adverse Event|3|||
124795435|NCT03119701|448880752|FG001|6-day Dosing|Adverse Event|0|||
124795436|NCT03119701|448880751|FG000|6-day Dosing|Physician Decision|0|||
124795437|NCT03119701|448880752|FG001|6-day Dosing|Physician Decision|1|||
124795438|NCT03119701|448880751|FG000|6-day Dosing|Withdrawal by Subject|0|||
124795439|NCT03119701|448880752|FG001|6-day Dosing|Withdrawal by Subject|1|||
124795440|NCT03119701|448880751|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
124795441|NCT03119701|448880752|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
124795442|NCT00596362|448880753|FG000|Overall Study|Progressive Disease|1|||
124795443|NCT00356122|448880756|FG000|TREATMENT|Lack of Efficacy|26|||
124795444|NCT00356122|448880756|FG000|TREATMENT|Adverse Event|10|||
124795445|NCT00356122|448880756|FG000|TREATMENT|Subject's request|4|||
124795446|NCT00356122|448880756|FG000|TREATMENT|Other|4|||
124795447|NCT00356122|448880756|FG000|TREATMENT|Did not receive study medication|1|||
124795448|NCT00356122|448880756|FG000|FOLLOW-UP|Death|37|||
124795449|NCT00356122|448880756|FG000|FOLLOW-UP|Lost to Follow-up|2|||
124795450|NCT00356122|448880756|FG000|FOLLOW-UP|Other|2|||
124795451|NCT00491556|448880757|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
124795452|NCT00491556|448880758|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
124795453|NCT00491556|448880757|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
124795454|NCT00491556|448880758|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
124795455|NCT00491556|448880757|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
124795456|NCT00491556|448880758|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
124795457|NCT00491556|448880757|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
124795458|NCT00491556|448880758|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
124795459|NCT00491556|448880757|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
124795460|NCT00491556|448880758|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
124795461|NCT00491556|448880757|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
124795462|NCT00491556|448880758|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
124795463|NCT00491556|448880757|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
124795464|NCT00491556|448880758|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
124795465|NCT00491556|448880757|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
124795466|NCT00491556|448880758|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
124795467|NCT00491556|448880757|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
124795468|NCT00491556|448880758|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
124795469|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
124795470|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
124795471|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
124795472|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
124795473|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
124795474|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
124795475|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
124795476|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
124795477|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
124795478|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
124795479|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
124795480|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
124795481|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
124795482|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
124795483|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
124795484|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
124795485|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
124795486|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
124795487|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
124795488|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
124795489|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
124795490|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
124795491|NCT02418156|448880759|FG000|Overall Study|Lost to Follow-up|12|||
124795492|NCT02418156|448880759|FG000|Overall Study|Death|2|||
124795493|NCT02418156|448880759|FG000|Overall Study|Physician Decision|1|||
124795494|NCT02418156|448880759|FG000|Overall Study|Withdrawal by Subject|1|||
124795495|NCT02418156|448880759|FG000|Overall Study|Subject refused to return|1|||
124795496|NCT05772702|448880771|FG000|Overall Study|Adverse Event|1|||
124795497|NCT01909453|448880772|FG000|Overall Study|Ongoing|118|||
124795498|NCT01909453|448880773|FG001|Overall Study|Ongoing|103|||
124795499|NCT01909453|448880774|FG002|Overall Study|Ongoing|83|||
124795500|NCT01909453|448880775|FG003|Overall Study|Ongoing|164|||
124795501|NCT01909453|448880776|FG004|Overall Study|Ongoing|50|||
124795502|NCT01909453|448880772|FG000|Overall Study|Death|69|||
124795503|NCT01909453|448880773|FG001|Overall Study|Death|74|||
124795504|NCT01909453|448880774|FG002|Overall Study|Death|88|||
124795505|NCT01909453|448880775|FG003|Overall Study|Death|86|||
124795506|NCT01909453|448880776|FG004|Overall Study|Death|29|||
124795507|NCT01909453|448880772|FG000|Overall Study|Lost to Follow-up|3|||
124795508|NCT01909453|448880773|FG001|Overall Study|Lost to Follow-up|4|||
124795509|NCT01909453|448880774|FG002|Overall Study|Lost to Follow-up|4|||
124795510|NCT01909453|448880775|FG003|Overall Study|Lost to Follow-up|3|||
124795511|NCT01909453|448880776|FG004|Overall Study|Lost to Follow-up|3|||
124795512|NCT01909453|448880772|FG000|Overall Study|Withdrawal by Subject|2|||
124795513|NCT01909453|448880773|FG001|Overall Study|Withdrawal by Subject|13|||
124795514|NCT01909453|448880774|FG002|Overall Study|Withdrawal by Subject|16|||
124795515|NCT01909453|448880775|FG003|Overall Study|Withdrawal by Subject|5|||
124795516|NCT01909453|448880776|FG004|Overall Study|Withdrawal by Subject|4|||
124795517|NCT00884377|448882408|FG000|Overall Study|Withdrawal by Subject|1|||
124795518|NCT00884377|448882409|FG001|Overall Study|Withdrawal by Subject|0|||
124795519|NCT00884377|448882408|FG000|Overall Study|Could not confirm diagnosis|1|||
124795520|NCT00884377|448882409|FG001|Overall Study|Could not confirm diagnosis|0|||
124795521|NCT00884377|448882408|FG000|Overall Study|Physician Decision|0|||
124795522|NCT00884377|448882409|FG001|Overall Study|Physician Decision|1|||
124795523|NCT02003365|448882410|FG000|Overall Study|Lost to Follow-up|0|||
124795524|NCT02003365|448882411|FG001|Overall Study|Lost to Follow-up|0|||
124795525|NCT02003365|448882412|FG002|Overall Study|Lost to Follow-up|1|||
124795526|NCT00622739|448882413|FG000|Overall Study|Physician Decision|1|||
124795527|NCT00622739|448882414|FG001|Overall Study|Physician Decision|0|||
124795528|NCT00622739|448882413|FG000|Overall Study|Adverse Event|1|||
124795529|NCT00622739|448882414|FG001|Overall Study|Adverse Event|2|||
124795530|NCT00622739|448882413|FG000|Overall Study|Lack of Efficacy|0|||
124795531|NCT00622739|448882414|FG001|Overall Study|Lack of Efficacy|2|||
124795532|NCT00622739|448882413|FG000|Overall Study|Withdrawal by Subject|0|||
124795533|NCT00622739|448882414|FG001|Overall Study|Withdrawal by Subject|1|||
124795534|NCT00622739|448882413|FG000|Overall Study|Lost to Follow-up|0|||
124795535|NCT00622739|448882414|FG001|Overall Study|Lost to Follow-up|1|||
124795536|NCT03387150|448882423|FG000|Overall Study|Withdrawal by Subject|3|||
124795537|NCT03387150|448882424|FG001|Overall Study|Withdrawal by Subject|0|||
124795538|NCT03387150|448882425|FG002|Overall Study|Withdrawal by Subject|3|||
124795539|NCT03387150|448882426|FG003|Overall Study|Withdrawal by Subject|4|||
124795540|NCT03387150|448882427|FG004|Overall Study|Withdrawal by Subject|1|||
124795541|NCT03387150|448882428|FG005|Overall Study|Withdrawal by Subject|2|||
124795542|NCT03387150|448882429|FG006|Overall Study|Withdrawal by Subject|0|||
124795543|NCT03387150|448882423|FG000|Overall Study|Lost to Follow-up|3|||
124795544|NCT03387150|448882424|FG001|Overall Study|Lost to Follow-up|2|||
124795545|NCT03387150|448882425|FG002|Overall Study|Lost to Follow-up|2|||
124795546|NCT03387150|448882426|FG003|Overall Study|Lost to Follow-up|3|||
124795547|NCT03387150|448882427|FG004|Overall Study|Lost to Follow-up|3|||
124795548|NCT03387150|448882428|FG005|Overall Study|Lost to Follow-up|3|||
124795549|NCT03387150|448882429|FG006|Overall Study|Lost to Follow-up|0|||
124795550|NCT03387150|448882423|FG000|Overall Study|Participant unable to adhere to visit|0|||
124795551|NCT03387150|448882424|FG001|Overall Study|Participant unable to adhere to visit|1|||
124795552|NCT03387150|448882425|FG002|Overall Study|Participant unable to adhere to visit|0|||
124795553|NCT03387150|448882426|FG003|Overall Study|Participant unable to adhere to visit|0|||
124795554|NCT03387150|448882427|FG004|Overall Study|Participant unable to adhere to visit|2|||
124795555|NCT03387150|448882428|FG005|Overall Study|Participant unable to adhere to visit|2|||
124795556|NCT03387150|448882429|FG006|Overall Study|Participant unable to adhere to visit|0|||
124795557|NCT04617795|448882430|FG000|Main Study|Lost to Follow-up|1|||
124795558|NCT04617795|448882431|FG001|Main Study|Lost to Follow-up|0|||
124795559|NCT03442764|448882432|FG000|Overall Study|Adverse Event|1|||
124795560|NCT03442764|448882433|FG001|Overall Study|Adverse Event|0|||
124795561|NCT03442764|448882434|FG002|Overall Study|Adverse Event|0|||
124795562|NCT04850313|448882435|FG000|Overall Study|Withdrawal by Subject|0|||
124795563|NCT04850313|448882436|FG001|Overall Study|Withdrawal by Subject|1|||
124795564|NCT02395016|448882437|FG000|Overall Study|Adverse Event|4|||
124795565|NCT02395016|448882438|FG001|Overall Study|Adverse Event|3|||
124795566|NCT02395016|448882437|FG000|Overall Study|Withdrawal by Subject|9|||
124795567|NCT02395016|448882438|FG001|Overall Study|Withdrawal by Subject|6|||
124795568|NCT02395016|448882437|FG000|Overall Study|Protocol Violation|2|||
124795569|NCT02395016|448882438|FG001|Overall Study|Protocol Violation|3|||
124795570|NCT01547780|448882439|FG000|Baseline PET Scan|Physician Decision|1|||
124795571|NCT01547780|448882440|FG001|Baseline PET Scan|Physician Decision|0|||
124795572|NCT01547780|448882441|FG002|Baseline PET Scan|Physician Decision|1|||
124795573|NCT01547780|448882442|FG003|Baseline PET Scan|Physician Decision|0|||
124795574|NCT01547780|448882439|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
124795575|NCT01547780|448882440|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
124795576|NCT01547780|448882441|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
124795577|NCT01547780|448882442|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
124795578|NCT01288976|448882444|FG000|Overall Study|Withdrawal by Subject|58|||
124795579|NCT01288976|448882445|FG001|Overall Study|Withdrawal by Subject|12|||
124795580|NCT01288976|448882446|FG002|Overall Study|Withdrawal by Subject|9|||
124795581|NCT01288976|448882444|FG000|Overall Study|Death|98|||
124795582|NCT01288976|448882445|FG001|Overall Study|Death|6|||
124795583|NCT01288976|448882446|FG002|Overall Study|Death|4|||
124795584|NCT01288976|448882444|FG000|Overall Study|Data unavailable|22|||
124795585|NCT01288976|448882445|FG001|Overall Study|Data unavailable|9|||
124795586|NCT01288976|448882446|FG002|Overall Study|Data unavailable|7|||
124795587|NCT02478398|448882455|FG000|Overall Study|Adverse Event|20|||
124795588|NCT02478398|448882456|FG001|Overall Study|Adverse Event|5|||
124795589|NCT02478398|448882455|FG000|Overall Study|Lost to Follow-up|5|||
124795590|NCT02478398|448882456|FG001|Overall Study|Lost to Follow-up|4|||
124795591|NCT02478398|448882455|FG000|Overall Study|Non-Compliance With Study Drug|5|||
124795592|NCT02478398|448882456|FG001|Overall Study|Non-Compliance With Study Drug|1|||
124795593|NCT02478398|448882455|FG000|Overall Study|Protocol Violation|3|||
124795594|NCT02478398|448882456|FG001|Overall Study|Protocol Violation|1|||
124795595|NCT02478398|448882455|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
124795596|NCT02478398|448882456|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
124795597|NCT02478398|448882455|FG000|Overall Study|Withdrawal By Participant|10|||
124795598|NCT02478398|448882456|FG001|Overall Study|Withdrawal By Participant|4|||
124795599|NCT01362595|448882458|FG000|Overall Study|Screen failure|10|||
124795600|NCT01362595|448882458|FG000|Overall Study|Withdrawal by Subject|2|||
124795601|NCT00959374|448882459|FG000|Overall Study|Withdrawal by Subject|2|||
124795602|NCT00959374|448882459|FG000|Overall Study|Lost to Follow-up|14|||
124795603|NCT00959374|448882459|FG000|Overall Study|Death|1|||
124795604|NCT00959374|448882459|FG000|Overall Study|Protocol Violation|1|||
124795605|NCT00959374|448882459|FG000|Overall Study|Implant Removed/Not Replaced|4|||
124795606|NCT00959374|448882459|FG000|Overall Study|Physician Decision|1|||
124795607|NCT02448680|448882460|FG000|Overall Study|Physician Decision|1|||
124795608|NCT02448680|448882461|FG001|Overall Study|Physician Decision|1|||
124795609|NCT02448680|448882460|FG000|Overall Study|Withdrawal by Subject|0|||
124795610|NCT02448680|448882461|FG001|Overall Study|Withdrawal by Subject|2|||
124795611|NCT00636987|448882462|FG000|Overall Study|Death|44|||
124795612|NCT00636987|448882462|FG000|Overall Study|Explanted|13|||
124795613|NCT00636987|448882462|FG000|Overall Study|Lost to Follow-up|63|||
124795614|NCT00636987|448882462|FG000|Overall Study|5 year visit window not complete|69|||
124795615|NCT01251146|448882463|FG000|Overall Study|Lost to Follow-up|3|||
124795616|NCT01251146|448882464|FG001|Overall Study|Lost to Follow-up|10|||
124795617|NCT00737464|448882473|FG000|Overall Study|Adverse Event|1|||
124795618|NCT00737464|448882473|FG000|Overall Study|Death|6|||
124795619|NCT00737464|448882473|FG000|Overall Study|Other - Failure to Return|1|||
124795620|NCT00737464|448882473|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
124795621|NCT00737464|448882473|FG000|Overall Study|Other reasons|4|||
124795622|NCT03220438|448882476|FG000|Overall Study|Lost to Follow-up|0|||
124795623|NCT03220438|448882477|FG001|Overall Study|Lost to Follow-up|0|||
124795624|NCT03220438|448882478|FG002|Overall Study|Lost to Follow-up|1|||
124795625|NCT03220438|448882479|FG003|Overall Study|Lost to Follow-up|0|||
124795626|NCT01634178|448882482|FG000|Treatment Period 1|Adverse Event|0|||
124795627|NCT01634178|448882483|FG001|Treatment Period 1|Adverse Event|1|||
124795628|NCT01634178|448882482|FG000|Treatment Period 2|Adverse Event|1|||
124795629|NCT01634178|448882483|FG001|Treatment Period 2|Adverse Event|0|||
124795630|NCT00991952|448882498|FG000|Overall Study|Adverse Event|0|||
124795631|NCT00991952|448882499|FG001|Overall Study|Adverse Event|1|||
124795632|NCT02483533|448882501|FG000|Overall Study|Lack of Efficacy|50|||
124795633|NCT02483533|448882502|FG001|Overall Study|Lack of Efficacy|50|||
124795634|NCT03452527|448882503|FG000|Overall Study|Withdrawal by Subject|1|||
124795635|NCT03452527|448882504|FG001|Overall Study|Withdrawal by Subject|1|||
124795636|NCT03452527|448882503|FG000|Overall Study|Study Terminated|2|||
124795637|NCT03452527|448882504|FG001|Overall Study|Study Terminated|3|||
124795638|NCT00582816|448882505|FG000|Overall Study|Engraftment Failure|3|||
124795639|NCT00174291|448882516|FG000|Overall Study|Lost to Follow-up|1|||
124795640|NCT00174291|448882517|FG001|Overall Study|Lost to Follow-up|1|||
124795641|NCT00174291|448882516|FG000|Overall Study|Protocol Violation|0|||
124795642|NCT00174291|448882517|FG001|Overall Study|Protocol Violation|2|||
124795643|NCT00174291|448882516|FG000|Overall Study|Study terminated by sponsor|1|||
124795644|NCT00174291|448882517|FG001|Overall Study|Study terminated by sponsor|0|||
124795645|NCT00174291|448882516|FG000|Overall Study|Withdrawal by Subject|3|||
124795646|NCT00174291|448882517|FG001|Overall Study|Withdrawal by Subject|3|||
124795647|NCT03116347|448882520|FG000|Overall Study|Withdrawal by Subject|1|||
124795648|NCT03116347|448882521|FG001|Overall Study|Withdrawal by Subject|2|||
124795649|NCT03170232|448882522|FG000|Overall Study|Adverse Event|0|||
124795650|NCT03170232|448882523|FG001|Overall Study|Adverse Event|1|||
124795651|NCT03170232|448882522|FG000|Overall Study|Protocol Violation|0|||
124795652|NCT03170232|448882523|FG001|Overall Study|Protocol Violation|1|||
124795653|NCT03170232|448882522|FG000|Overall Study|Lack of Efficacy|0|||
124795654|NCT03170232|448882523|FG001|Overall Study|Lack of Efficacy|1|||
124795655|NCT03170232|448882522|FG000|Overall Study|Study closed/terminated|26|||
124795656|NCT03170232|448882523|FG001|Overall Study|Study closed/terminated|23|||
124795657|NCT03170232|448882522|FG000|Overall Study|Lost to Follow-up|1|||
124795658|NCT03170232|448882523|FG001|Overall Study|Lost to Follow-up|0|||
124795659|NCT03170232|448882522|FG000|Overall Study|Withdrawal by Subject|0|||
124795660|NCT03170232|448882523|FG001|Overall Study|Withdrawal by Subject|1|||
124795661|NCT00586326|448882524|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
124795662|NCT00586326|448882524|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
124795663|NCT00586326|448882524|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
124795664|NCT00586326|448882524|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
124795665|NCT00586326|448882524|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
124795666|NCT00586326|448882524|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
124795667|NCT00586326|448882524|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
124795668|NCT00586326|448882524|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
124795669|NCT00586326|448882524|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
124795670|NCT00586326|448882524|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
124795671|NCT00586326|448882524|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
124795672|NCT00586326|448882524|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
124795673|NCT00586326|448882524|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
124795674|NCT00586326|448882524|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
124795675|NCT00586326|448882524|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
124795676|NCT00586326|448882524|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
124795677|NCT00586326|448882524|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
124795678|NCT01439347|448882525|FG000|Overall Study|Death|10|||
124795679|NCT01439347|448882526|FG001|Overall Study|Death|9|||
124795680|NCT01439347|448882525|FG000|Overall Study|Withdrawal by Subject|0|||
124795681|NCT01439347|448882526|FG001|Overall Study|Withdrawal by Subject|1|||
124795682|NCT01439347|448882525|FG000|Overall Study|Physician Decision|1|||
124795683|NCT01439347|448882526|FG001|Overall Study|Physician Decision|0|||
124795684|NCT01439347|448882525|FG000|Overall Study|Sponsor Terminated Study|2|||
124795685|NCT01439347|448882526|FG001|Overall Study|Sponsor Terminated Study|3|||
124795686|NCT04068896|448882528|FG000|Overall Study|Adverse Event|2|||
124795687|NCT04068896|448882529|FG001|Overall Study|Adverse Event|0|||
124795688|NCT04068896|448882530|FG002|Overall Study|Adverse Event|1|||
124795689|NCT04068896|448882531|FG003|Overall Study|Adverse Event|0|||
124795690|NCT04068896|448882532|FG004|Overall Study|Adverse Event|0|||
124795691|NCT04068896|448882533|FG005|Overall Study|Adverse Event|0|||
124795692|NCT04068896|448882528|FG000|Overall Study|Death|3|||
124795693|NCT04068896|448882529|FG001|Overall Study|Death|1|||
124795694|NCT04068896|448882530|FG002|Overall Study|Death|3|||
124795695|NCT04068896|448882531|FG003|Overall Study|Death|19|||
124795696|NCT04068896|448882532|FG004|Overall Study|Death|17|||
124795697|NCT04068896|448882533|FG005|Overall Study|Death|0|||
124795698|NCT04068896|448882528|FG000|Overall Study|Physician Decision|0|||
124795699|NCT04068896|448882529|FG001|Overall Study|Physician Decision|0|||
124795700|NCT04068896|448882530|FG002|Overall Study|Physician Decision|0|||
124795701|NCT04068896|448882531|FG003|Overall Study|Physician Decision|1|||
124795702|NCT04068896|448882532|FG004|Overall Study|Physician Decision|0|||
124795703|NCT04068896|448882533|FG005|Overall Study|Physician Decision|0|||
124795704|NCT04068896|448882528|FG000|Overall Study|progressive disease|3|||
124795705|NCT04068896|448882529|FG001|Overall Study|progressive disease|5|||
124795706|NCT04068896|448882530|FG002|Overall Study|progressive disease|3|||
124795707|NCT04068896|448882531|FG003|Overall Study|progressive disease|2|||
124795708|NCT04068896|448882532|FG004|Overall Study|progressive disease|1|||
125295508|NCT03242252|450709457|FG000|Overall Study|Reason not Specified|4|||
125295509|NCT03242252|450709458|FG001|Overall Study|Reason not Specified|4|||
125295510|NCT03242252|450709459|FG002|Overall Study|Reason not Specified|1|||
125295511|NCT03242252|450709457|FG000|Overall Study|Lost to Follow-up|5|||
125295512|NCT03242252|450709458|FG001|Overall Study|Lost to Follow-up|1|||
125295513|NCT03242252|450709459|FG002|Overall Study|Lost to Follow-up|4|||
125295514|NCT01659255|450709460|FG000|Overall Study|Adverse Event|0|||
125295515|NCT01659255|450709461|FG001|Overall Study|Adverse Event|0|||
125295516|NCT01659255|450709462|FG002|Overall Study|Adverse Event|0|||
125295517|NCT01659255|450709463|FG003|Overall Study|Adverse Event|0|||
125295518|NCT01659255|450709464|FG004|Overall Study|Adverse Event|0|||
125295519|NCT01659255|450709465|FG005|Overall Study|Adverse Event|1|||
124795709|NCT04068896|448882533|FG005|Overall Study|progressive disease|2|||
124795710|NCT04068896|448882528|FG000|Overall Study|Study terminated by sponsor|0|||
125295520|NCT01659255|450709466|FG006|Overall Study|Adverse Event|1|||
125295521|NCT01659255|450709467|FG007|Overall Study|Adverse Event|0|||
125295522|NCT01659255|450709468|FG008|Overall Study|Adverse Event|0|||
125295523|NCT01659255|450709469|FG009|Overall Study|Adverse Event|1|||
124795711|NCT04068896|448882529|FG001|Overall Study|Study terminated by sponsor|0|||
124795712|NCT04068896|448882530|FG002|Overall Study|Study terminated by sponsor|1|||
125295524|NCT01659255|450709470|FG010|Overall Study|Adverse Event|0|||
125295525|NCT01659255|450709471|FG011|Overall Study|Adverse Event|1|||
125295526|NCT01659255|450709472|FG012|Overall Study|Adverse Event|0|||
125295527|NCT01659255|450709473|FG013|Overall Study|Adverse Event|2|||
124795713|NCT04068896|448882531|FG003|Overall Study|Study terminated by sponsor|2|||
125295528|NCT01659255|450709474|FG014|Overall Study|Adverse Event|0|||
125295529|NCT01659255|450709475|FG015|Overall Study|Adverse Event|1|||
125295530|NCT01659255|450709476|FG016|Overall Study|Adverse Event|0|||
125295531|NCT01659255|450709460|FG000|Overall Study|Death|0|||
125295532|NCT01659255|450709461|FG001|Overall Study|Death|1|||
125295533|NCT01659255|450709462|FG002|Overall Study|Death|0|||
125295534|NCT01659255|450709463|FG003|Overall Study|Death|0|||
125295535|NCT01659255|450709464|FG004|Overall Study|Death|0|||
125295536|NCT01659255|450709465|FG005|Overall Study|Death|0|||
125295537|NCT01659255|450709466|FG006|Overall Study|Death|0|||
125295538|NCT01659255|450709467|FG007|Overall Study|Death|1|||
125295539|NCT01659255|450709468|FG008|Overall Study|Death|1|||
125295540|NCT01659255|450709469|FG009|Overall Study|Death|0|||
125295541|NCT01659255|450709470|FG010|Overall Study|Death|0|||
124795714|NCT04068896|448882532|FG004|Overall Study|Study terminated by sponsor|1|||
124795715|NCT04068896|448882533|FG005|Overall Study|Study terminated by sponsor|4|||
124795716|NCT04068896|448882528|FG000|Overall Study|Protocol Violation|0|||
124795717|NCT04068896|448882529|FG001|Overall Study|Protocol Violation|0|||
124795718|NCT04068896|448882530|FG002|Overall Study|Protocol Violation|0|||
124795719|NCT04068896|448882531|FG003|Overall Study|Protocol Violation|1|||
124795720|NCT04068896|448882532|FG004|Overall Study|Protocol Violation|0|||
124795721|NCT04068896|448882533|FG005|Overall Study|Protocol Violation|0|||
124795722|NCT04068896|448882528|FG000|Overall Study|Withdrawal by Subject|0|||
124795723|NCT04068896|448882529|FG001|Overall Study|Withdrawal by Subject|3|||
124795724|NCT04068896|448882530|FG002|Overall Study|Withdrawal by Subject|0|||
124795725|NCT04068896|448882531|FG003|Overall Study|Withdrawal by Subject|2|||
124795726|NCT04068896|448882532|FG004|Overall Study|Withdrawal by Subject|1|||
124795727|NCT04068896|448882533|FG005|Overall Study|Withdrawal by Subject|0|||
125295542|NCT01659255|450709471|FG011|Overall Study|Death|0|||
124795728|NCT04068896|448882528|FG000|Overall Study|Symptomatic deterioration|2|||
124795729|NCT04068896|448882529|FG001|Overall Study|Symptomatic deterioration|0|||
124795730|NCT04068896|448882530|FG002|Overall Study|Symptomatic deterioration|0|||
124795731|NCT04068896|448882531|FG003|Overall Study|Symptomatic deterioration|0|||
124795732|NCT04068896|448882532|FG004|Overall Study|Symptomatic deterioration|0|||
124795733|NCT04068896|448882533|FG005|Overall Study|Symptomatic deterioration|0|||
124795734|NCT01101191|448882534|FG000|Period 1|Withdrawal by Subject|1|||
124795735|NCT01101191|448882535|FG001|Period 1|Withdrawal by Subject|0|||
124795736|NCT01101191|448882534|FG000|Period 1|Adverse Event|1|||
124795737|NCT01101191|448882535|FG001|Period 1|Adverse Event|2|||
124795738|NCT02009384|448882536|FG000|Overall Study|Death|2|||
124795739|NCT00718237|448882538|FG000|Overall Study|Adverse Event|1|||
124795740|NCT00718237|448882539|FG001|Overall Study|Adverse Event|3|||
124795741|NCT00718237|448882538|FG000|Overall Study|Lost to Follow-up|2|||
124795742|NCT00718237|448882539|FG001|Overall Study|Lost to Follow-up|2|||
124795743|NCT00718237|448882538|FG000|Overall Study|Physician Decision|1|||
124795744|NCT00718237|448882539|FG001|Overall Study|Physician Decision|0|||
124795745|NCT00718237|448882538|FG000|Overall Study|Withdrawal by Subject|9|||
124795746|NCT00718237|448882539|FG001|Overall Study|Withdrawal by Subject|10|||
124795747|NCT02694718|448882540|FG000|Overall Study|Death|1|||
124795748|NCT02694718|448882540|FG000|Overall Study|Withdrawal by Subject|1|||
124795749|NCT02925793|448882541|FG000|Overall Study|Adverse Event|3|||
124795750|NCT02925793|448882542|FG001|Overall Study|Adverse Event|3|||
124795751|NCT02925793|448882543|FG002|Overall Study|Adverse Event|6|||
124795752|NCT02925793|448882541|FG000|Overall Study|Withdrawal by Subject|16|||
124795753|NCT02925793|448882542|FG001|Overall Study|Withdrawal by Subject|15|||
124795754|NCT02925793|448882543|FG002|Overall Study|Withdrawal by Subject|13|||
124795755|NCT02925793|448882541|FG000|Overall Study|Investigator Discretion|0|||
124795756|NCT02925793|448882542|FG001|Overall Study|Investigator Discretion|1|||
124795757|NCT02925793|448882543|FG002|Overall Study|Investigator Discretion|1|||
124795758|NCT02925793|448882541|FG000|Overall Study|Lost to Follow-up|2|||
124795759|NCT02925793|448882542|FG001|Overall Study|Lost to Follow-up|3|||
124795760|NCT02925793|448882543|FG002|Overall Study|Lost to Follow-up|1|||
124795761|NCT02925793|448882541|FG000|Overall Study|Lack of Efficacy|2|||
124795762|NCT02925793|448882542|FG001|Overall Study|Lack of Efficacy|6|||
124795763|NCT02925793|448882543|FG002|Overall Study|Lack of Efficacy|4|||
124795764|NCT02925793|448882541|FG000|Overall Study|Other:|2|||
124795765|NCT02925793|448882542|FG001|Overall Study|Other:|1|||
124795766|NCT02925793|448882543|FG002|Overall Study|Other:|3|||
124795767|NCT00879879|448882544|FG000|Overall Study|Death|1|||
124795768|NCT00879879|448882544|FG000|Overall Study|Withdrawal by Subject|1|||
124795769|NCT00879879|448882544|FG000|Overall Study|Physician Decision|1|||
124795770|NCT00667446|448882546|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
124795771|NCT00667446|448882547|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
124795772|NCT00667446|448882546|FG000|Treatment Period (36 Months)|Other|2|||
124795773|NCT00667446|448882547|FG001|Treatment Period (36 Months)|Other|2|||
124795774|NCT00667446|448882546|FG000|Treatment Period (36 Months)|Personal reasons|2|||
125295543|NCT01659255|450709472|FG012|Overall Study|Death|1|||
125295544|NCT01659255|450709473|FG013|Overall Study|Death|1|||
125295545|NCT01659255|450709474|FG014|Overall Study|Death|2|||
125295546|NCT01659255|450709475|FG015|Overall Study|Death|1|||
125295547|NCT01659255|450709476|FG016|Overall Study|Death|0|||
124795775|NCT00667446|448882547|FG001|Treatment Period (36 Months)|Personal reasons|2|||
124795776|NCT00667446|448882546|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
124795777|NCT00667446|448882547|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
124795778|NCT00667446|448882546|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
124795779|NCT00667446|448882547|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
124795780|NCT00667446|448882546|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
124795781|NCT00667446|448882547|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
124795782|NCT00667446|448882546|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
124795783|NCT00667446|448882547|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
124795784|NCT00667446|448882546|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
124795785|NCT00667446|448882547|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
124795786|NCT00667446|448882546|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
124795787|NCT00667446|448882547|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
124795788|NCT01343901|448882548|FG000|Overall Study|Death|85|||
124795789|NCT01343901|448882548|FG000|Overall Study|Physician Decision|4|||
124795790|NCT01343901|448882548|FG000|Overall Study|Lost to Follow-up|12|||
124795791|NCT01343901|448882548|FG000|Overall Study|Management by another medical team|11|||
124795792|NCT01343901|448882548|FG000|Overall Study|Participant decision|1|||
124795793|NCT00769483|448882551|FG000|Overall Study|Withdrawal by Subject|0|||
124795794|NCT00769483|448882552|FG001|Overall Study|Withdrawal by Subject|1|||
124795795|NCT00769483|448882553|FG002|Overall Study|Withdrawal by Subject|0|||
124795796|NCT00769483|448882554|FG003|Overall Study|Withdrawal by Subject|0|||
124795797|NCT00769483|448882555|FG004|Overall Study|Withdrawal by Subject|1|||
124795798|NCT00769483|448882556|FG005|Overall Study|Withdrawal by Subject|0|||
124795799|NCT03455764|448882557|FG000|Overall Study|Adverse Event|1|||
124795800|NCT03455764|448882558|FG001|Overall Study|Adverse Event|0|||
124795801|NCT03455764|448882559|FG002|Overall Study|Adverse Event|0|||
124795802|NCT03455764|448882560|FG003|Overall Study|Adverse Event|0|||
124795803|NCT03455764|448882561|FG004|Overall Study|Adverse Event|0|||
124795804|NCT03455764|448882557|FG000|Overall Study|Disease Progression|4|||
124795805|NCT03455764|448882558|FG001|Overall Study|Disease Progression|0|||
124795806|NCT03455764|448882559|FG002|Overall Study|Disease Progression|0|||
124795807|NCT03455764|448882560|FG003|Overall Study|Disease Progression|0|||
124795808|NCT03455764|448882561|FG004|Overall Study|Disease Progression|0|||
124795809|NCT03455764|448882557|FG000|Overall Study|On Treatment|1|||
124795810|NCT03455764|448882558|FG001|Overall Study|On Treatment|0|||
124795811|NCT03455764|448882559|FG002|Overall Study|On Treatment|0|||
124795812|NCT03455764|448882560|FG003|Overall Study|On Treatment|0|||
124795813|NCT03455764|448882561|FG004|Overall Study|On Treatment|0|||
124795814|NCT05080660|448882562|FG000|Overall Study|Adverse Event|4|||
124795815|NCT05080660|448882563|FG001|Overall Study|Adverse Event|0|||
124795816|NCT05080660|448882562|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
124795817|NCT05080660|448882563|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
124795818|NCT05080660|448882562|FG000|Overall Study|Physician Decision|1|||
124795819|NCT05080660|448882563|FG001|Overall Study|Physician Decision|0|||
124795820|NCT05080660|448882562|FG000|Overall Study|Protocol Deviation|2|||
124795821|NCT05080660|448882563|FG001|Overall Study|Protocol Deviation|0|||
124795822|NCT05080660|448882562|FG000|Overall Study|Withdrawal by Subject|5|||
124795823|NCT05080660|448882563|FG001|Overall Study|Withdrawal by Subject|2|||
124795824|NCT04221230|448882573|FG000|Overall Study|Lost to Follow-up|12|||
124795825|NCT04221230|448882574|FG001|Overall Study|Lost to Follow-up|12|||
124795826|NCT04221230|448882573|FG000|Overall Study|Protocol Violation|2|||
124795827|NCT04221230|448882574|FG001|Overall Study|Protocol Violation|2|||
124795828|NCT04221230|448882573|FG000|Overall Study|Adverse Event|0|||
124795829|NCT04221230|448882574|FG001|Overall Study|Adverse Event|8|||
124795830|NCT04221230|448882573|FG000|Overall Study|Physician Decision|1|||
124795831|NCT04221230|448882574|FG001|Overall Study|Physician Decision|0|||
124795832|NCT04221230|448882573|FG000|Overall Study|Withdrawal by Subject|13|||
124795833|NCT04221230|448882574|FG001|Overall Study|Withdrawal by Subject|11|||
124795834|NCT04221230|448882573|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124795835|NCT04221230|448882574|FG001|Overall Study|Non-Compliance with Study Drug|1|||
124795836|NCT04221230|448882573|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124795837|NCT04221230|448882574|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
124795838|NCT04221230|448882573|FG000|Overall Study|Pregnancy|0|||
124795839|NCT04221230|448882574|FG001|Overall Study|Pregnancy|1|||
124795840|NCT04221230|448882573|FG000|Overall Study|Other|1|||
124795841|NCT04221230|448882574|FG001|Overall Study|Other|2|||
124795842|NCT01307020|448882577|FG000|Overall Study|Lost to Follow-up|0|||
124795843|NCT01307020|448882578|FG001|Overall Study|Lost to Follow-up|0|||
124795844|NCT01307020|448882579|FG002|Overall Study|Lost to Follow-up|1|||
124795845|NCT01307020|448882580|FG003|Overall Study|Lost to Follow-up|1|||
124795846|NCT01307020|448882581|FG004|Overall Study|Lost to Follow-up|0|||
124795847|NCT01307020|448882582|FG005|Overall Study|Lost to Follow-up|0|||
124795848|NCT01307020|448882583|FG006|Overall Study|Lost to Follow-up|1|||
124795849|NCT01307020|448882584|FG007|Overall Study|Lost to Follow-up|0|||
124795850|NCT01307020|448882585|FG008|Overall Study|Lost to Follow-up|0|||
124795851|NCT01307020|448882586|FG009|Overall Study|Lost to Follow-up|0|||
124795852|NCT01307020|448882577|FG000|Overall Study|Electronic data capture failure|0|||
124795853|NCT01307020|448882578|FG001|Overall Study|Electronic data capture failure|1|||
124795854|NCT01307020|448882579|FG002|Overall Study|Electronic data capture failure|0|||
124795855|NCT01307020|448882580|FG003|Overall Study|Electronic data capture failure|0|||
124795856|NCT01307020|448882581|FG004|Overall Study|Electronic data capture failure|0|||
124795857|NCT01307020|448882582|FG005|Overall Study|Electronic data capture failure|0|||
124795858|NCT01307020|448882583|FG006|Overall Study|Electronic data capture failure|0|||
124795859|NCT01307020|448882584|FG007|Overall Study|Electronic data capture failure|0|||
124795860|NCT01307020|448882585|FG008|Overall Study|Electronic data capture failure|0|||
124795861|NCT01307020|448882586|FG009|Overall Study|Electronic data capture failure|0|||
124795862|NCT02021656|448882587|FG000|Overall Study|Adverse Event|1|||
124795863|NCT02021656|448882587|FG000|Overall Study|Lack of Efficacy|2|||
124795864|NCT02021656|448882587|FG000|Overall Study|Lost to Follow-up|1|||
124795865|NCT02021656|448882587|FG000|Overall Study|Withdrew Consent|2|||
124795866|NCT03150485|448883842|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
124795867|NCT03150485|448883843|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
124795868|NCT03150485|448883844|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
124795869|NCT03150485|448883845|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
124795870|NCT03150485|448883846|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
124795871|NCT03150485|448883847|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
124795872|NCT01394718|448883848|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
124795873|NCT01394718|448883849|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
124795874|NCT00814879|448883850|FG000|By Week 24|Cancer Diagnosis|1|||
124795875|NCT00814879|448883851|FG001|By Week 24|Cancer Diagnosis|0|||
124795876|NCT00814879|448883850|FG000|By Week 24|Incarceration|0|||
124795877|NCT00814879|448883851|FG001|By Week 24|Incarceration|1|||
124795878|NCT00814879|448883850|FG000|By Week 48|Lost to Follow-up|2|||
124795879|NCT00814879|448883851|FG001|By Week 48|Lost to Follow-up|2|||
124795880|NCT00814879|448883850|FG000|By Week 48|Death|0|||
124795881|NCT00814879|448883851|FG001|By Week 48|Death|1|||
124795882|NCT01461057|448883852|FG000|Overall Study|Death|10|||
124795883|NCT01461057|448883853|FG001|Overall Study|Death|9|||
124795884|NCT01461057|448883852|FG000|Overall Study|Withdrawal by Subject|2|||
124795885|NCT01461057|448883853|FG001|Overall Study|Withdrawal by Subject|3|||
124795886|NCT01461057|448883852|FG000|Overall Study|Physician Decision|0|||
124795887|NCT01461057|448883853|FG001|Overall Study|Physician Decision|2|||
124795888|NCT01461057|448883852|FG000|Overall Study|Adverse Event|0|||
124795889|NCT01461057|448883853|FG001|Overall Study|Adverse Event|1|||
124795890|NCT01461057|448883852|FG000|Overall Study|Progression of Disease|1|||
124795891|NCT01461057|448883853|FG001|Overall Study|Progression of Disease|0|||
124795892|NCT01461057|448883852|FG000|Overall Study|Study Terminated by Sponsor|2|||
124795893|NCT01461057|448883853|FG001|Overall Study|Study Terminated by Sponsor|0|||
124795894|NCT01739400|448883854|FG000|Overall Study|Physician Decision|3|||
124795895|NCT01739400|448883855|FG001|Overall Study|Physician Decision|0|||
124795896|NCT01739400|448883854|FG000|Overall Study|Lost to Follow-up|2|||
124795897|NCT01739400|448883855|FG001|Overall Study|Lost to Follow-up|0|||
124795898|NCT01739400|448883854|FG000|Overall Study|Death|5|||
124795899|NCT01739400|448883855|FG001|Overall Study|Death|2|||
124795900|NCT01739400|448883854|FG000|Overall Study|Withdrawal by Subject|7|||
124795901|NCT01739400|448883855|FG001|Overall Study|Withdrawal by Subject|7|||
124795902|NCT03350984|448883856|FG000|Overall Study|Death|1|||
124795903|NCT03350984|448883857|FG001|Overall Study|Death|0|||
124795904|NCT03350984|448883856|FG000|Overall Study|Lost to Follow-up|5|||
124795905|NCT03350984|448883857|FG001|Overall Study|Lost to Follow-up|6|||
124795906|NCT03350984|448883856|FG000|Overall Study|Protocol Violation|1|||
124795907|NCT03350984|448883857|FG001|Overall Study|Protocol Violation|2|||
124795908|NCT03350984|448883856|FG000|Overall Study|Physician Decision|1|||
124795909|NCT03350984|448883857|FG001|Overall Study|Physician Decision|0|||
124795910|NCT00642473|448883858|FG000|Overall Study|Withdrawal by Subject|0|||
124795911|NCT00642473|448883859|FG001|Overall Study|Withdrawal by Subject|5|||
124795912|NCT00642473|448883858|FG000|Overall Study|Progression or death|2|||
124795913|NCT00642473|448883859|FG001|Overall Study|Progression or death|4|||
124795914|NCT00642473|448883858|FG000|Overall Study|Other|2|||
124795915|NCT00642473|448883859|FG001|Overall Study|Other|2|||
125295548|NCT01659255|450709460|FG000|Overall Study|Progressive Disease|2|||
124795916|NCT00478881|448883862|FG000|Overall Study|Adverse Event|31|||
124795917|NCT00478881|448883863|FG001|Overall Study|Adverse Event|12|||
124795918|NCT00478881|448883862|FG000|Overall Study|Lack of Efficacy|0|||
124795919|NCT00478881|448883863|FG001|Overall Study|Lack of Efficacy|3|||
124795920|NCT00478881|448883862|FG000|Overall Study|Lost to Follow-up|0|||
124795921|NCT00478881|448883863|FG001|Overall Study|Lost to Follow-up|1|||
124795922|NCT00478881|448883862|FG000|Overall Study|Protocol Violation|2|||
124795923|NCT00478881|448883863|FG001|Overall Study|Protocol Violation|2|||
124795924|NCT00478881|448883862|FG000|Overall Study|Withdrawal by Subject|6|||
124795925|NCT00478881|448883863|FG001|Overall Study|Withdrawal by Subject|2|||
124795926|NCT00478881|448883862|FG000|Overall Study|Non-Compliance with Study Medication|0|||
124795927|NCT00478881|448883863|FG001|Overall Study|Non-Compliance with Study Medication|2|||
124795928|NCT03410823|448883864|FG000|Overall Study|Death|1|||
124795929|NCT03410823|448883864|FG000|Overall Study|Withdrawal by Subject|2|||
124795930|NCT03410823|448883864|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
124795931|NCT05128929|448883866|FG000|Overall Study|Adverse Event|0|||
124795932|NCT05128929|448883867|FG001|Overall Study|Adverse Event|1|||
124795933|NCT02742246|448883868|FG000|Overall Study|Never initiated treatment|5|||
124795934|NCT02742246|448883869|FG001|Overall Study|Never initiated treatment|3|||
124795935|NCT02742246|448883870|FG002|Overall Study|Never initiated treatment|1|||
124795936|NCT02742246|448883868|FG000|Overall Study|dropped out during treatment|7|||
124795937|NCT02742246|448883869|FG001|Overall Study|dropped out during treatment|13|||
124795938|NCT02742246|448883870|FG002|Overall Study|dropped out during treatment|10|||
124795939|NCT02742246|448883868|FG000|Overall Study|Death|1|||
124795940|NCT02742246|448883869|FG001|Overall Study|Death|0|||
124795941|NCT02742246|448883870|FG002|Overall Study|Death|0|||
124795942|NCT03584373|448883872|FG000|Overall Study|Lost to Follow-up|7|||
124795943|NCT03584373|448883873|FG001|Overall Study|Lost to Follow-up|8|||
124795944|NCT01487577|448883874|FG000|Overall Study|Became ineligible after signing consent|1|||
124795945|NCT00662532|448883877|FG000|Overall Study|Adverse Event|0|||
124795946|NCT00662532|448883878|FG001|Overall Study|Adverse Event|1|||
124795947|NCT00662532|448883877|FG000|Overall Study|Lost to Follow-up|0|||
124795948|NCT00662532|448883878|FG001|Overall Study|Lost to Follow-up|1|||
124795949|NCT00367770|448883879|FG000|Overall Study|Adverse Event|1|||
124795950|NCT00367770|448883879|FG000|Overall Study|Withdrawal by Subject|1|||
124795951|NCT01155479|448883880|FG000|Part I|Adverse Event|13|||
124795952|NCT01155479|448883881|FG001|Part I|Adverse Event|8|||
124795953|NCT01155479|448883882|FG002|Part I|Adverse Event|18|||
124795954|NCT01155479|448883883|FG003|Part I|Adverse Event|7|||
124795955|NCT01155479|448883884|FG004|Part I|Adverse Event|6|||
124795956|NCT01155479|448883880|FG000|Part I|Administrative|2|||
124795957|NCT01155479|448883881|FG001|Part I|Administrative|2|||
124795958|NCT01155479|448883882|FG002|Part I|Administrative|2|||
124795959|NCT01155479|448883883|FG003|Part I|Administrative|0|||
124795960|NCT01155479|448883884|FG004|Part I|Administrative|0|||
124795961|NCT01155479|448883880|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
124795962|NCT01155479|448883881|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
124795963|NCT01155479|448883882|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
124795964|NCT01155479|448883883|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
124795965|NCT01155479|448883884|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
124795966|NCT01155479|448883880|FG000|Part I|Withdrawal by Subject|11|||
124795967|NCT01155479|448883881|FG001|Part I|Withdrawal by Subject|13|||
124795968|NCT01155479|448883882|FG002|Part I|Withdrawal by Subject|8|||
124795969|NCT01155479|448883883|FG003|Part I|Withdrawal by Subject|8|||
124795970|NCT01155479|448883884|FG004|Part I|Withdrawal by Subject|9|||
124795971|NCT01155479|448883880|FG000|Part I|Lost to Follow-up|0|||
124795972|NCT01155479|448883881|FG001|Part I|Lost to Follow-up|0|||
124795973|NCT01155479|448883882|FG002|Part I|Lost to Follow-up|1|||
124795974|NCT01155479|448883883|FG003|Part I|Lost to Follow-up|1|||
124795975|NCT01155479|448883884|FG004|Part I|Lost to Follow-up|0|||
124795976|NCT01155479|448883880|FG000|Part I|Treatment Failure|3|||
124795977|NCT01155479|448883881|FG001|Part I|Treatment Failure|0|||
124795978|NCT01155479|448883882|FG002|Part I|Treatment Failure|3|||
124795979|NCT01155479|448883883|FG003|Part I|Treatment Failure|1|||
124795980|NCT01155479|448883884|FG004|Part I|Treatment Failure|2|||
124795981|NCT01155479|448883880|FG000|Part I|Did Not Receive Treatment|4|||
124795982|NCT01155479|448883881|FG001|Part I|Did Not Receive Treatment|2|||
124795983|NCT01155479|448883882|FG002|Part I|Did Not Receive Treatment|2|||
124795984|NCT01155479|448883883|FG003|Part I|Did Not Receive Treatment|6|||
124795985|NCT01155479|448883884|FG004|Part I|Did Not Receive Treatment|1|||
124795986|NCT01155479|448883880|FG000|Part I|Non-Compliance with Protocol|2|||
124795987|NCT01155479|448883881|FG001|Part I|Non-Compliance with Protocol|1|||
124795988|NCT01155479|448883882|FG002|Part I|Non-Compliance with Protocol|3|||
124795989|NCT01155479|448883883|FG003|Part I|Non-Compliance with Protocol|3|||
124795990|NCT01155479|448883884|FG004|Part I|Non-Compliance with Protocol|2|||
124795991|NCT01155479|448883880|FG000|Part II|Adverse Event|7|||
124795992|NCT01155479|448883881|FG001|Part II|Adverse Event|6|||
124795993|NCT01155479|448883882|FG002|Part II|Adverse Event|8|||
124795994|NCT01155479|448883883|FG003|Part II|Adverse Event|3|||
124795995|NCT01155479|448883884|FG004|Part II|Adverse Event|4|||
124795996|NCT01155479|448883880|FG000|Part II|Administrative|43|||
124795997|NCT01155479|448883881|FG001|Part II|Administrative|49|||
124795998|NCT01155479|448883882|FG002|Part II|Administrative|36|||
124795999|NCT01155479|448883883|FG003|Part II|Administrative|38|||
124796000|NCT01155479|448883884|FG004|Part II|Administrative|46|||
124796001|NCT01155479|448883880|FG000|Part II|Withdrawal by Subject|8|||
124796002|NCT01155479|448883881|FG001|Part II|Withdrawal by Subject|4|||
124796003|NCT01155479|448883882|FG002|Part II|Withdrawal by Subject|12|||
124796004|NCT01155479|448883883|FG003|Part II|Withdrawal by Subject|7|||
124796005|NCT01155479|448883884|FG004|Part II|Withdrawal by Subject|3|||
124796006|NCT01155479|448883880|FG000|Part II|Lost to Follow-up|1|||
124796007|NCT01155479|448883881|FG001|Part II|Lost to Follow-up|0|||
124796008|NCT01155479|448883882|FG002|Part II|Lost to Follow-up|0|||
124796009|NCT01155479|448883883|FG003|Part II|Lost to Follow-up|0|||
124796010|NCT01155479|448883884|FG004|Part II|Lost to Follow-up|1|||
124796011|NCT01155479|448883880|FG000|Part II|Treatment Failure|0|||
124796012|NCT01155479|448883881|FG001|Part II|Treatment Failure|1|||
124796013|NCT01155479|448883882|FG002|Part II|Treatment Failure|2|||
124796014|NCT01155479|448883883|FG003|Part II|Treatment Failure|0|||
124796015|NCT01155479|448883884|FG004|Part II|Treatment Failure|1|||
124796016|NCT01155479|448883880|FG000|Part II|Non-Compliance with Protocol|0|||
124796017|NCT01155479|448883881|FG001|Part II|Non-Compliance with Protocol|1|||
124796018|NCT01155479|448883882|FG002|Part II|Non-Compliance with Protocol|0|||
124796019|NCT01155479|448883883|FG003|Part II|Non-Compliance with Protocol|2|||
124796020|NCT01155479|448883884|FG004|Part II|Non-Compliance with Protocol|0|||
124796021|NCT00998764|448883885|FG000|Overall Study|Lack of Efficacy|3|||
124796022|NCT00998764|448883886|FG001|Overall Study|Lack of Efficacy|6|||
124796023|NCT00998764|448883885|FG000|Overall Study|Adverse Event|17|||
124796024|NCT00998764|448883886|FG001|Overall Study|Adverse Event|12|||
124796025|NCT00998764|448883885|FG000|Overall Study|Withdrawal by Subject|19|||
124796026|NCT00998764|448883886|FG001|Overall Study|Withdrawal by Subject|25|||
124796027|NCT00998764|448883885|FG000|Overall Study|Physician Decision|3|||
124796028|NCT00998764|448883886|FG001|Overall Study|Physician Decision|3|||
124796029|NCT00998764|448883885|FG000|Overall Study|Death|3|||
124796030|NCT00998764|448883886|FG001|Overall Study|Death|1|||
124796031|NCT00998764|448883885|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
124796032|NCT00998764|448883886|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
124796033|NCT00998764|448883885|FG000|Overall Study|Protocol Violation|0|||
124796034|NCT00998764|448883886|FG001|Overall Study|Protocol Violation|1|||
124796035|NCT00998764|448883885|FG000|Overall Study|Failed to Return|1|||
124796036|NCT00998764|448883886|FG001|Overall Study|Failed to Return|1|||
124796037|NCT00998764|448883885|FG000|Overall Study|Lost to Follow-up|1|||
124796038|NCT00998764|448883886|FG001|Overall Study|Lost to Follow-up|1|||
124796039|NCT00998764|448883885|FG000|Overall Study|Loss of Caregiver|0|||
124796040|NCT00998764|448883886|FG001|Overall Study|Loss of Caregiver|3|||
124796041|NCT00998764|448883885|FG000|Overall Study|Other|4|||
124796042|NCT00998764|448883886|FG001|Overall Study|Other|4|||
124796043|NCT00998764|448883885|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
124796044|NCT00998764|448883886|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
124796045|NCT04761627|448883887|FG000|Run-in Period|Death|1|||
124796046|NCT04761627|448883888|FG001|Run-in Period|Death|0|||
124796047|NCT04761627|448883889|FG002|Run-in Period|Death|0|||
124796048|NCT04761627|448883887|FG000|Run-in Period|Required alternative therapy|2|||
124796049|NCT04761627|448883888|FG001|Run-in Period|Required alternative therapy|0|||
124796050|NCT04761627|448883889|FG002|Run-in Period|Required alternative therapy|0|||
124796051|NCT04761627|448883887|FG000|Run-in Period|Lost to Follow-up|2|||
124796052|NCT04761627|448883888|FG001|Run-in Period|Lost to Follow-up|0|||
124796053|NCT04761627|448883889|FG002|Run-in Period|Lost to Follow-up|0|||
124796054|NCT04761627|448883887|FG000|Run-in Period|Protocol Violation|3|||
124796055|NCT04761627|448883888|FG001|Run-in Period|Protocol Violation|0|||
124796056|NCT04761627|448883889|FG002|Run-in Period|Protocol Violation|0|||
124796057|NCT04761627|448883887|FG000|Run-in Period|Abnormal liver function|1|||
124796058|NCT04761627|448883888|FG001|Run-in Period|Abnormal liver function|0|||
124796059|NCT04761627|448883889|FG002|Run-in Period|Abnormal liver function|0|||
124796060|NCT04761627|448883887|FG000|Run-in Period|Adverse Event|6|||
124796061|NCT04761627|448883888|FG001|Run-in Period|Adverse Event|0|||
124796062|NCT04761627|448883889|FG002|Run-in Period|Adverse Event|0|||
124796063|NCT04761627|448883887|FG000|Run-in Period|Withdrawal by Subject|7|||
124796064|NCT04761627|448883888|FG001|Run-in Period|Withdrawal by Subject|0|||
124796065|NCT04761627|448883889|FG002|Run-in Period|Withdrawal by Subject|0|||
124796066|NCT04761627|448883887|FG000|Run-in Period|Did not meet PASI 50|15|||
124796067|NCT04761627|448883888|FG001|Run-in Period|Did not meet PASI 50|0|||
124796068|NCT04761627|448883889|FG002|Run-in Period|Did not meet PASI 50|0|||
124796069|NCT04761627|448883887|FG000|Run-in Period|Study site closure|2|||
124796070|NCT04761627|448883888|FG001|Run-in Period|Study site closure|0|||
124796071|NCT04761627|448883889|FG002|Run-in Period|Study site closure|0|||
124796072|NCT04761627|448883887|FG000|Run-in Period|Pregnancy|2|||
124796073|NCT04761627|448883888|FG001|Run-in Period|Pregnancy|0|||
124796074|NCT04761627|448883889|FG002|Run-in Period|Pregnancy|0|||
124796075|NCT04761627|448883887|FG000|Post-randomization Period|Military service|0|||
124796076|NCT04761627|448883888|FG001|Post-randomization Period|Military service|1|||
124796077|NCT04761627|448883889|FG002|Post-randomization Period|Military service|0|||
124796078|NCT04761627|448883887|FG000|Post-randomization Period|Adverse Event|0|||
124796079|NCT04761627|448883888|FG001|Post-randomization Period|Adverse Event|4|||
124796080|NCT04761627|448883889|FG002|Post-randomization Period|Adverse Event|2|||
124796081|NCT04761627|448883887|FG000|Post-randomization Period|Lost to Follow-up|0|||
124796082|NCT04761627|448883888|FG001|Post-randomization Period|Lost to Follow-up|6|||
124796083|NCT04761627|448883889|FG002|Post-randomization Period|Lost to Follow-up|6|||
124796084|NCT04761627|448883887|FG000|Post-randomization Period|Withdrawal by Subject|0|||
124796085|NCT04761627|448883888|FG001|Post-randomization Period|Withdrawal by Subject|7|||
124796086|NCT04761627|448883889|FG002|Post-randomization Period|Withdrawal by Subject|6|||
124796087|NCT04761627|448883887|FG000|Post-randomization Period|Pregnancy|0|||
124796088|NCT04761627|448883888|FG001|Post-randomization Period|Pregnancy|0|||
124796089|NCT04761627|448883889|FG002|Post-randomization Period|Pregnancy|1|||
124796090|NCT04761627|448883887|FG000|Post-randomization Period|Study site closure|0|||
124796091|NCT04761627|448883888|FG001|Post-randomization Period|Study site closure|0|||
124796092|NCT04761627|448883889|FG002|Post-randomization Period|Study site closure|1|||
124796093|NCT04761627|448883887|FG000|Post-randomization Period|Family planning|0|||
124796094|NCT04761627|448883888|FG001|Post-randomization Period|Family planning|1|||
124796095|NCT04761627|448883889|FG002|Post-randomization Period|Family planning|0|||
124796096|NCT01214174|448883890|FG000|Overall Study|Withdrawal by Subject|0|||
124796097|NCT01214174|448883891|FG001|Overall Study|Withdrawal by Subject|0|||
124796098|NCT01214174|448883892|FG002|Overall Study|Withdrawal by Subject|1|||
124796099|NCT03823378|448883895|FG000|Overall Study|Adverse Event|2|||
124796100|NCT03823378|448883896|FG001|Overall Study|Adverse Event|2|||
124796101|NCT03823378|448883897|FG002|Overall Study|Adverse Event|0|||
124796102|NCT03823378|448883898|FG003|Overall Study|Adverse Event|0|||
124796103|NCT03823378|448883899|FG004|Overall Study|Adverse Event|0|||
124796104|NCT03823378|448883900|FG005|Overall Study|Adverse Event|0|||
124796105|NCT03823378|448883895|FG000|Overall Study|Lost to Follow-up|0|||
124796106|NCT03823378|448883896|FG001|Overall Study|Lost to Follow-up|1|||
124796107|NCT03823378|448883897|FG002|Overall Study|Lost to Follow-up|0|||
124796108|NCT03823378|448883898|FG003|Overall Study|Lost to Follow-up|0|||
124796109|NCT03823378|448883899|FG004|Overall Study|Lost to Follow-up|1|||
124796110|NCT03823378|448883900|FG005|Overall Study|Lost to Follow-up|0|||
124796111|NCT03823378|448883895|FG000|Overall Study|Withdrawal by Subject|0|||
124796112|NCT03823378|448883896|FG001|Overall Study|Withdrawal by Subject|1|||
124796113|NCT03823378|448883897|FG002|Overall Study|Withdrawal by Subject|4|||
124796114|NCT03823378|448883898|FG003|Overall Study|Withdrawal by Subject|2|||
124796115|NCT03823378|448883899|FG004|Overall Study|Withdrawal by Subject|0|||
124796116|NCT03823378|448883900|FG005|Overall Study|Withdrawal by Subject|1|||
124796117|NCT03823378|448883895|FG000|Overall Study|Other, not specified|19|||
124796118|NCT03823378|448883896|FG001|Overall Study|Other, not specified|12|||
124796119|NCT03823378|448883897|FG002|Overall Study|Other, not specified|6|||
124796120|NCT03823378|448883898|FG003|Overall Study|Other, not specified|8|||
124796121|NCT03823378|448883899|FG004|Overall Study|Other, not specified|17|||
125295549|NCT01659255|450709461|FG001|Overall Study|Progressive Disease|0|||
125295550|NCT01659255|450709462|FG002|Overall Study|Progressive Disease|0|||
125295551|NCT01659255|450709463|FG003|Overall Study|Progressive Disease|0|||
125295552|NCT01659255|450709464|FG004|Overall Study|Progressive Disease|0|||
125295553|NCT01659255|450709465|FG005|Overall Study|Progressive Disease|0|||
124796122|NCT03823378|448883900|FG005|Overall Study|Other, not specified|7|||
124796123|NCT02093026|448883901|FG000|Overall Study|Adverse Event|26|||
124796124|NCT02093026|448883901|FG000|Overall Study|Death|10|||
124796125|NCT02093026|448883901|FG000|Overall Study|Other|157|||
124796126|NCT02376829|448883902|FG000|Overall Study|Withdrawal by Subject|27|||
124796127|NCT02376829|448883903|FG001|Overall Study|Withdrawal by Subject|44|||
124796128|NCT01255787|448883904|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
124796129|NCT01255787|448883905|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
124796130|NCT01255787|448883906|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
124796131|NCT01255787|448883907|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
124796132|NCT01255787|448883904|FG000|Overall Study|Major Protocol Deviation|1|||
124796133|NCT01255787|448883905|FG001|Overall Study|Major Protocol Deviation|1|||
124796134|NCT01255787|448883906|FG002|Overall Study|Major Protocol Deviation|0|||
124796135|NCT01255787|448883907|FG003|Overall Study|Major Protocol Deviation|4|||
124796136|NCT01255787|448883904|FG000|Overall Study|Lost to Follow-up|1|||
124796137|NCT01255787|448883905|FG001|Overall Study|Lost to Follow-up|2|||
124796138|NCT01255787|448883906|FG002|Overall Study|Lost to Follow-up|4|||
124796139|NCT01255787|448883907|FG003|Overall Study|Lost to Follow-up|2|||
124796140|NCT01255787|448883904|FG000|Overall Study|Withdrawal of Consent|3|||
124796141|NCT01255787|448883905|FG001|Overall Study|Withdrawal of Consent|9|||
124796142|NCT01255787|448883906|FG002|Overall Study|Withdrawal of Consent|3|||
124796143|NCT01255787|448883907|FG003|Overall Study|Withdrawal of Consent|4|||
124796144|NCT01255787|448883904|FG000|Overall Study|Pregnancy|0|||
124796145|NCT01255787|448883905|FG001|Overall Study|Pregnancy|0|||
124796146|NCT01255787|448883906|FG002|Overall Study|Pregnancy|0|||
124796147|NCT01255787|448883907|FG003|Overall Study|Pregnancy|1|||
124796148|NCT01255787|448883904|FG000|Overall Study|Lack of Efficacy|2|||
124796149|NCT01255787|448883905|FG001|Overall Study|Lack of Efficacy|2|||
124796150|NCT01255787|448883906|FG002|Overall Study|Lack of Efficacy|2|||
124796151|NCT01255787|448883907|FG003|Overall Study|Lack of Efficacy|2|||
125295554|NCT01659255|450709466|FG006|Overall Study|Progressive Disease|0|||
125295555|NCT01659255|450709467|FG007|Overall Study|Progressive Disease|1|||
125295556|NCT01659255|450709468|FG008|Overall Study|Progressive Disease|0|||
124796152|NCT01255787|448883904|FG000|Overall Study|Noncompliance with Study Drug|3|||
124796153|NCT01255787|448883905|FG001|Overall Study|Noncompliance with Study Drug|1|||
124796154|NCT01255787|448883906|FG002|Overall Study|Noncompliance with Study Drug|0|||
124796155|NCT01255787|448883907|FG003|Overall Study|Noncompliance with Study Drug|0|||
124796156|NCT00476047|448883908|FG000|Overall Study|Lost to Follow-up|1|||
124796157|NCT05153473|448883909|FG000|Overall Study|Death|46|||
124796158|NCT05153473|448883909|FG000|Overall Study|Lost to Follow-up|3|||
124796159|NCT02283177|448883910|FG000|Overall Study|Withdrawal by Subject|1|||
124796160|NCT02283177|448883911|FG001|Overall Study|Withdrawal by Subject|1|||
124796161|NCT02398227|448883912|FG000|Overall Study|Lost to Follow-up|21|||
124796162|NCT02398227|448883913|FG001|Overall Study|Lost to Follow-up|12|||
124796163|NCT02398227|448883912|FG000|Overall Study|Withdrawal by Subject|5|||
124796164|NCT02398227|448883913|FG001|Overall Study|Withdrawal by Subject|6|||
124796165|NCT02398227|448883912|FG000|Overall Study|Removed from treatment and dropped out|1|||
124796166|NCT02398227|448883913|FG001|Overall Study|Removed from treatment and dropped out|0|||
124796167|NCT01185834|448883914|FG000|Overall Study|Lost to Follow-up|2|||
124796168|NCT01185834|448883914|FG000|Overall Study|Discomfort|4|||
124796169|NCT01185834|448883914|FG000|Overall Study|Biomicroscopy|4|||
124796170|NCT01185834|448883914|FG000|Overall Study|Time/Job Conflict|2|||
124796171|NCT01185834|448883914|FG000|Overall Study|Early exit - Site error|2|||
124796172|NCT01975831|448883915|FG000|Overall Study|Adverse Event|1|||
124796173|NCT01975831|448883916|FG001|Overall Study|Adverse Event|2|||
124796174|NCT01975831|448883917|FG002|Overall Study|Adverse Event|2|||
124796175|NCT01975831|448883918|FG003|Overall Study|Adverse Event|0|||
124796176|NCT01975831|448883919|FG004|Overall Study|Adverse Event|1|||
124796177|NCT01975831|448883920|FG005|Overall Study|Adverse Event|1|||
124796178|NCT01975831|448883921|FG006|Overall Study|Adverse Event|3|||
124796179|NCT01975831|448883922|FG007|Overall Study|Adverse Event|4|||
124796180|NCT01975831|448883923|FG008|Overall Study|Adverse Event|1|||
124796181|NCT01975831|448883915|FG000|Overall Study|Death|1|||
124796182|NCT01975831|448883916|FG001|Overall Study|Death|1|||
124796183|NCT01975831|448883917|FG002|Overall Study|Death|0|||
124796184|NCT01975831|448883918|FG003|Overall Study|Death|0|||
124796185|NCT01975831|448883919|FG004|Overall Study|Death|1|||
124796186|NCT01975831|448883920|FG005|Overall Study|Death|0|||
124796187|NCT01975831|448883921|FG006|Overall Study|Death|1|||
124796188|NCT01975831|448883922|FG007|Overall Study|Death|0|||
124796189|NCT01975831|448883923|FG008|Overall Study|Death|0|||
124796190|NCT01975831|448883915|FG000|Overall Study|Progressive Disease|1|||
124796191|NCT01975831|448883916|FG001|Overall Study|Progressive Disease|3|||
124796192|NCT01975831|448883917|FG002|Overall Study|Progressive Disease|2|||
124796193|NCT01975831|448883918|FG003|Overall Study|Progressive Disease|4|||
124796194|NCT01975831|448883919|FG004|Overall Study|Progressive Disease|13|||
124796195|NCT01975831|448883920|FG005|Overall Study|Progressive Disease|9|||
124796196|NCT01975831|448883921|FG006|Overall Study|Progressive Disease|10|||
124796197|NCT01975831|448883922|FG007|Overall Study|Progressive Disease|8|||
124796198|NCT01975831|448883923|FG008|Overall Study|Progressive Disease|10|||
124796199|NCT01975831|448883915|FG000|Overall Study|Withdrawal by Subject|0|||
124796200|NCT01975831|448883916|FG001|Overall Study|Withdrawal by Subject|3|||
124796201|NCT01975831|448883917|FG002|Overall Study|Withdrawal by Subject|0|||
124796202|NCT01975831|448883918|FG003|Overall Study|Withdrawal by Subject|0|||
124796203|NCT01975831|448883919|FG004|Overall Study|Withdrawal by Subject|3|||
124796204|NCT01975831|448883920|FG005|Overall Study|Withdrawal by Subject|1|||
124796205|NCT01975831|448883921|FG006|Overall Study|Withdrawal by Subject|1|||
124796206|NCT01975831|448883922|FG007|Overall Study|Withdrawal by Subject|0|||
124796207|NCT01975831|448883923|FG008|Overall Study|Withdrawal by Subject|0|||
124796208|NCT01975831|448883915|FG000|Overall Study|Physician Decision|0|||
124796209|NCT01975831|448883916|FG001|Overall Study|Physician Decision|0|||
124796210|NCT01975831|448883917|FG002|Overall Study|Physician Decision|0|||
124796211|NCT01975831|448883918|FG003|Overall Study|Physician Decision|0|||
124796212|NCT01975831|448883919|FG004|Overall Study|Physician Decision|0|||
124796213|NCT01975831|448883920|FG005|Overall Study|Physician Decision|1|||
124796214|NCT01975831|448883921|FG006|Overall Study|Physician Decision|0|||
124796215|NCT01975831|448883922|FG007|Overall Study|Physician Decision|1|||
124796216|NCT01975831|448883923|FG008|Overall Study|Physician Decision|0|||
124796217|NCT01975831|448883915|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
124796218|NCT01975831|448883916|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
124796219|NCT01975831|448883917|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
124796220|NCT01975831|448883918|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
124796221|NCT01975831|448883919|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
124796222|NCT01975831|448883920|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
124796223|NCT01975831|448883921|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
124796224|NCT01975831|448883922|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
124796225|NCT01975831|448883923|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
124796226|NCT01975831|448883915|FG000|Overall Study|Entered Hospice|0|||
124796227|NCT01975831|448883916|FG001|Overall Study|Entered Hospice|0|||
124796228|NCT01975831|448883917|FG002|Overall Study|Entered Hospice|0|||
125295557|NCT01659255|450709469|FG009|Overall Study|Progressive Disease|2|||
124796229|NCT01975831|448883918|FG003|Overall Study|Entered Hospice|0|||
124796230|NCT01975831|448883919|FG004|Overall Study|Entered Hospice|0|||
124796231|NCT01975831|448883920|FG005|Overall Study|Entered Hospice|1|||
124796232|NCT01975831|448883921|FG006|Overall Study|Entered Hospice|0|||
124796233|NCT01975831|448883922|FG007|Overall Study|Entered Hospice|0|||
124796234|NCT01975831|448883923|FG008|Overall Study|Entered Hospice|0|||
124796235|NCT01975831|448883915|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
124796236|NCT01975831|448883916|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
124796237|NCT01975831|448883917|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
124796238|NCT01975831|448883918|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
124796239|NCT01975831|448883919|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
124796240|NCT01975831|448883920|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
124796241|NCT01975831|448883921|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
124796242|NCT01975831|448883922|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
124796243|NCT01975831|448883923|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
124796244|NCT00887744|448883924|FG000|Overall Study|Adverse Event|3|||
124796245|NCT00887744|448883924|FG000|Overall Study|Death|1|||
124796246|NCT00887744|448883924|FG000|Overall Study|Lost to Follow-up|3|||
124796247|NCT00887744|448883924|FG000|Overall Study|Withdrawal by Subject|18|||
124796248|NCT00887744|448883924|FG000|Overall Study|Various reasons|9|||
124796249|NCT03324581|448883928|FG000|Overall Study|Adverse Event|18|||
124796250|NCT03324581|448883929|FG001|Overall Study|Adverse Event|11|||
124796251|NCT03324581|448883930|FG002|Overall Study|Adverse Event|7|||
124796252|NCT03324581|448883928|FG000|Overall Study|Lack of Efficacy|0|||
124796253|NCT03324581|448883929|FG001|Overall Study|Lack of Efficacy|1|||
124796254|NCT03324581|448883930|FG002|Overall Study|Lack of Efficacy|0|||
124796255|NCT03324581|448883928|FG000|Overall Study|Lost to Follow-up|5|||
124796256|NCT03324581|448883929|FG001|Overall Study|Lost to Follow-up|3|||
124796257|NCT03324581|448883930|FG002|Overall Study|Lost to Follow-up|6|||
124796258|NCT03324581|448883928|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
124796259|NCT03324581|448883929|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
124796260|NCT03324581|448883930|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
124796261|NCT03324581|448883928|FG000|Overall Study|Physician Decision|0|||
124796262|NCT03324581|448883929|FG001|Overall Study|Physician Decision|1|||
124796263|NCT03324581|448883930|FG002|Overall Study|Physician Decision|2|||
124796264|NCT03324581|448883928|FG000|Overall Study|Protocol Deviation|8|||
124796265|NCT03324581|448883929|FG001|Overall Study|Protocol Deviation|9|||
124796266|NCT03324581|448883930|FG002|Overall Study|Protocol Deviation|4|||
124796267|NCT03324581|448883928|FG000|Overall Study|Withdrawal by Subject|6|||
124796268|NCT03324581|448883929|FG001|Overall Study|Withdrawal by Subject|8|||
124796269|NCT03324581|448883930|FG002|Overall Study|Withdrawal by Subject|6|||
124796270|NCT03324581|448883928|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
124796271|NCT03324581|448883929|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
124796272|NCT03324581|448883930|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
124796273|NCT02274038|448883931|FG000|Overall Study|Death|1|||
124796274|NCT03783702|448883932|FG000|Overall Study|Lost to Follow-up|6|||
124796275|NCT03783702|448883933|FG001|Overall Study|Lost to Follow-up|8|||
124796276|NCT03783702|448883932|FG000|Overall Study|Protocol Violation|1|||
124796277|NCT03783702|448883933|FG001|Overall Study|Protocol Violation|3|||
124796278|NCT04473482|448883934|FG000|Overall Study|Death|0|||
124796279|NCT04473482|448883935|FG001|Overall Study|Death|3|||
124796280|NCT04473482|448883934|FG000|Overall Study|Lost to Follow-up|9|||
124796281|NCT04473482|448883935|FG001|Overall Study|Lost to Follow-up|7|||
124796282|NCT04473482|448883934|FG000|Overall Study|Withdrawal by Subject|2|||
124796283|NCT04473482|448883935|FG001|Overall Study|Withdrawal by Subject|1|||
124796284|NCT00321893|448883937|FG000|Overall Study|Non-Compliance/Refusal|16|||
124796285|NCT00321893|448883938|FG001|Overall Study|Non-Compliance/Refusal|10|||
124796286|NCT00321893|448883937|FG000|Overall Study|Lost to Follow-up|2|||
124796287|NCT00321893|448883938|FG001|Overall Study|Lost to Follow-up|1|||
124796288|NCT00321893|448883937|FG000|Overall Study|Adverse Event|6|||
124796289|NCT00321893|448883938|FG001|Overall Study|Adverse Event|3|||
124796290|NCT01306877|448883939|FG000|Overall Study|Lost to Follow-up|3|||
124796291|NCT01306877|448883940|FG001|Overall Study|Lost to Follow-up|3|||
124796292|NCT01306877|448883939|FG000|Overall Study|Physician Decision|0|||
124796293|NCT01306877|448883940|FG001|Overall Study|Physician Decision|1|||
124796294|NCT00999921|448883945|FG000|Overall Study|Lost to Follow-up|10|||
124796295|NCT00999921|448883946|FG001|Overall Study|Lost to Follow-up|19|||
124796296|NCT00989573|448883950|FG000|Overall Study|Adverse Event|8|||
124796297|NCT00989573|448883951|FG001|Overall Study|Adverse Event|12|||
124796298|NCT00989573|448883952|FG002|Overall Study|Adverse Event|4|||
124796299|NCT00989573|448883950|FG000|Overall Study|Physician Decision|0|||
124796300|NCT00989573|448883951|FG001|Overall Study|Physician Decision|2|||
124796301|NCT00989573|448883952|FG002|Overall Study|Physician Decision|0|||
124796302|NCT00989573|448883950|FG000|Overall Study|Protocol Violation|1|||
124796303|NCT00989573|448883951|FG001|Overall Study|Protocol Violation|1|||
124796304|NCT00989573|448883952|FG002|Overall Study|Protocol Violation|1|||
124796305|NCT00989573|448883950|FG000|Overall Study|Withdrawal by Subject|4|||
124796306|NCT00989573|448883951|FG001|Overall Study|Withdrawal by Subject|7|||
124796307|NCT00989573|448883952|FG002|Overall Study|Withdrawal by Subject|3|||
124796308|NCT01076075|448883954|FG000|Overall Study|Adverse Event|3|||
124796309|NCT01076075|448883955|FG001|Overall Study|Adverse Event|9|||
124796310|NCT01076075|448883954|FG000|Overall Study|Lack of Efficacy|5|||
124796311|NCT01076075|448883955|FG001|Overall Study|Lack of Efficacy|4|||
124796312|NCT01076075|448883954|FG000|Overall Study|Lost to Follow-up|6|||
124796313|NCT01076075|448883955|FG001|Overall Study|Lost to Follow-up|5|||
124796314|NCT01076075|448883954|FG000|Overall Study|other|19|||
124796315|NCT01076075|448883955|FG001|Overall Study|other|9|||
124796316|NCT01076075|448883954|FG000|Overall Study|Protocol Violation|0|||
124796317|NCT01076075|448883955|FG001|Overall Study|Protocol Violation|1|||
124796318|NCT01076075|448883954|FG000|Overall Study|Withdrawal by Subject|8|||
124796319|NCT01076075|448883955|FG001|Overall Study|Withdrawal by Subject|19|||
124796320|NCT00995865|448883958|FG000|Overall Study|Protocol Violation|2|||
124796321|NCT00995865|448883959|FG001|Overall Study|Protocol Violation|0|||
124796322|NCT00995865|448883960|FG002|Overall Study|Protocol Violation|0|||
124796323|NCT00995865|448883958|FG000|Overall Study|Lost to Follow-up|0|||
124796324|NCT00995865|448883959|FG001|Overall Study|Lost to Follow-up|0|||
124796325|NCT00995865|448883960|FG002|Overall Study|Lost to Follow-up|1|||
124796326|NCT03687970|448883962|FG000|Overall Study|visit scheduling conflicts|2|||
124796327|NCT03687970|448883963|FG001|Overall Study|visit scheduling conflicts|0|||
124796328|NCT02359851|448883966|FG000|Overall Study|Death|1|||
124796329|NCT02359851|448883966|FG000|Overall Study|Disease progression|1|||
124796330|NCT01888003|448883967|FG000|Overall Study|Study Terminated|5|||
124796331|NCT01888003|448883968|FG001|Overall Study|Study Terminated|6|||
124796332|NCT01888003|448883969|FG002|Overall Study|Study Terminated|40|||
124796333|NCT00055471|448883970|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
124796334|NCT00055471|448883971|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
124796335|NCT00055471|448883972|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
124796336|NCT00055471|448883970|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
124796337|NCT00055471|448883971|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
124796338|NCT00055471|448883972|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
124796339|NCT00055471|448883970|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
124796340|NCT00055471|448883971|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
124796341|NCT00055471|448883972|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
124796342|NCT01854944|448883973|FG000|Overall Study|Withdrawal by Subject|0|||
124796343|NCT01854944|448883974|FG001|Overall Study|Withdrawal by Subject|0|||
124796344|NCT01854944|448883975|FG002|Overall Study|Withdrawal by Subject|1|||
124796345|NCT02101112|448883976|FG000|Overall Study|Adverse Event|0|||
124796346|NCT02101112|448883977|FG001|Overall Study|Adverse Event|0|||
124796347|NCT02101112|448883978|FG002|Overall Study|Adverse Event|1|||
124796348|NCT02101112|448883979|FG003|Overall Study|Adverse Event|0|||
124796349|NCT02101112|448883980|FG004|Overall Study|Adverse Event|0|||
124796350|NCT02101112|448883981|FG005|Overall Study|Adverse Event|0|||
124796351|NCT02101112|448883976|FG000|Overall Study|Withdrawal by Subject|0|||
124796352|NCT02101112|448883977|FG001|Overall Study|Withdrawal by Subject|0|||
124796353|NCT02101112|448883978|FG002|Overall Study|Withdrawal by Subject|0|||
124796354|NCT02101112|448883979|FG003|Overall Study|Withdrawal by Subject|0|||
124796355|NCT02101112|448883980|FG004|Overall Study|Withdrawal by Subject|1|||
124796356|NCT02101112|448883981|FG005|Overall Study|Withdrawal by Subject|0|||
124796357|NCT04340063|448883982|FG000|Overall Study|Withdrawal by Subject|1|||
124796358|NCT04340063|448883983|FG001|Overall Study|Withdrawal by Subject|2|||
124796359|NCT04340063|448883982|FG000|Overall Study|Lost to Follow-up|3|||
124796360|NCT04340063|448883983|FG001|Overall Study|Lost to Follow-up|1|||
124796361|NCT04340063|448883982|FG000|Overall Study|Protocol Violation|0|||
124796362|NCT04340063|448883983|FG001|Overall Study|Protocol Violation|1|||
124796363|NCT01857583|448883984|FG000|Overall Study|Adverse Event|0|||
124796364|NCT01857583|448883985|FG001|Overall Study|Adverse Event|0|||
124796365|NCT01857583|448883986|FG002|Overall Study|Adverse Event|1|||
124796366|NCT01857583|448883987|FG003|Overall Study|Adverse Event|1|||
124796367|NCT01857583|448883984|FG000|Overall Study|Death|0|||
124796368|NCT01857583|448883985|FG001|Overall Study|Death|1|||
124796369|NCT01857583|448883986|FG002|Overall Study|Death|1|||
124796370|NCT01857583|448883987|FG003|Overall Study|Death|0|||
124796371|NCT01857583|448883984|FG000|Overall Study|Physician Decision|0|||
124796372|NCT01857583|448883985|FG001|Overall Study|Physician Decision|0|||
124796373|NCT01857583|448883986|FG002|Overall Study|Physician Decision|0|||
124796374|NCT01857583|448883987|FG003|Overall Study|Physician Decision|1|||
124796375|NCT01857583|448883984|FG000|Overall Study|Withdrawal by Subject|1|||
124796376|NCT01857583|448883985|FG001|Overall Study|Withdrawal by Subject|0|||
124796377|NCT01857583|448883986|FG002|Overall Study|Withdrawal by Subject|1|||
124796378|NCT01857583|448883987|FG003|Overall Study|Withdrawal by Subject|2|||
124796379|NCT00458536|448883990|FG000|Overall Study|Disease progression prior to treatment|7|||
124796380|NCT00458536|448883990|FG000|Overall Study|Unable to make vaccine|3|||
124796381|NCT00458536|448883990|FG000|Overall Study|No measurable disease after surgery|2|||
124796382|NCT00458536|448883990|FG000|Overall Study|Did not have renal cell carcinoma|2|||
124796383|NCT00458536|448883990|FG000|Overall Study|Patient did not have surgery|1|||
124796384|NCT00458536|448883990|FG000|Overall Study|Ineligible due to toxicity|1|||
124796385|NCT00458536|448883990|FG000|Overall Study|Withdrawal by Subject|1|||
124796386|NCT00458536|448883990|FG000|Overall Study|Progressive disease during treatment|2|||
124796387|NCT00562627|448885807|FG000|Overall Study|Protocol Violation|1|||
124796388|NCT00562627|448885808|FG001|Overall Study|Protocol Violation|1|||
124796389|NCT00562627|448885809|FG002|Overall Study|Protocol Violation|1|||
124796390|NCT00625742|448885810|FG000|Overall Study|Disease Progression|2|||
124796391|NCT00625742|448885810|FG000|Overall Study|Withdrawal by Subject|1|||
124796392|NCT00625742|448885810|FG000|Overall Study|Adverse Event|4|||
124796393|NCT00625742|448885810|FG000|Overall Study|Lost to Follow-up|4|||
124796394|NCT00625742|448885810|FG000|Overall Study|Ineligible|1|||
124796395|NCT01709578|448885811|FG000|Overall Study|Rescued and entered in long term safety|63|||
124796396|NCT01709578|448885812|FG001|Overall Study|Rescued and entered in long term safety|25|||
124796397|NCT01709578|448885813|FG002|Overall Study|Rescued and entered in long term safety|26|||
124796398|NCT01709578|448885811|FG000|Overall Study|Adverse Event|9|||
124796399|NCT01709578|448885812|FG001|Overall Study|Adverse Event|18|||
124796400|NCT01709578|448885813|FG002|Overall Study|Adverse Event|17|||
124796401|NCT01709578|448885811|FG000|Overall Study|Lack of Efficacy|5|||
124796402|NCT01709578|448885812|FG001|Overall Study|Lack of Efficacy|4|||
124796403|NCT01709578|448885813|FG002|Overall Study|Lack of Efficacy|2|||
124796404|NCT01709578|448885811|FG000|Overall Study|Poor compliance to protocol|1|||
124796405|NCT01709578|448885812|FG001|Overall Study|Poor compliance to protocol|2|||
124796406|NCT01709578|448885813|FG002|Overall Study|Poor compliance to protocol|1|||
124796407|NCT01709578|448885811|FG000|Overall Study|Other, not related to safety or efficacy|2|||
124796408|NCT01709578|448885812|FG001|Overall Study|Other, not related to safety or efficacy|7|||
124796409|NCT01709578|448885813|FG002|Overall Study|Other, not related to safety or efficacy|5|||
124796410|NCT04050371|448885814|FG000|Overall Study|Withdrawal by Subject|1|||
124796411|NCT04050371|448885815|FG001|Overall Study|Withdrawal by Subject|0|||
124796412|NCT01314911|448885817|FG000|Overall Study|Lost to Follow-up|3|||
124796413|NCT01314911|448885818|FG001|Overall Study|Lost to Follow-up|2|||
124796414|NCT01314911|448885817|FG000|Overall Study|Withdrawal by Subject|1|||
124796415|NCT01314911|448885818|FG001|Overall Study|Withdrawal by Subject|3|||
124796416|NCT01314911|448885817|FG000|Overall Study|Received Non-randomized Study Drug|0|||
124796417|NCT01314911|448885818|FG001|Overall Study|Received Non-randomized Study Drug|1|||
124796418|NCT01314911|448885817|FG000|Overall Study|Never Started Treatment|1|||
124796419|NCT01314911|448885818|FG001|Overall Study|Never Started Treatment|0|||
124796420|NCT00588952|448885820|FG000|Overall Study|Adverse Event|0|||
124796421|NCT00588952|448885821|FG001|Overall Study|Adverse Event|2|||
124796422|NCT00588952|448885820|FG000|Overall Study|Withdrawal by Subject|3|||
124796423|NCT00588952|448885821|FG001|Overall Study|Withdrawal by Subject|5|||
124796424|NCT01277042|448885822|FG000|Overall Study|Adverse Event|4|||
124796425|NCT01277042|448885823|FG001|Overall Study|Adverse Event|3|||
124796426|NCT01277042|448885822|FG000|Overall Study|Lost to Follow-up|2|||
124796427|NCT01277042|448885823|FG001|Overall Study|Lost to Follow-up|2|||
124796428|NCT01277042|448885822|FG000|Overall Study|Withdrawal by Subject|2|||
124796429|NCT01277042|448885823|FG001|Overall Study|Withdrawal by Subject|0|||
124796430|NCT02284178|448885824|FG000|Overall Study|Met exclusion criteria|49|||
124796431|NCT02284178|448885825|FG001|Overall Study|Met exclusion criteria|54|||
124796432|NCT01483690|448885828|FG000|Overall Study|Adverse Event|1|||
124796433|NCT01483690|448885829|FG001|Overall Study|Adverse Event|2|||
124796434|NCT01483690|448885828|FG000|Overall Study|clinical deterioration|1|||
124796435|NCT01483690|448885829|FG001|Overall Study|clinical deterioration|0|||
124796436|NCT01483690|448885828|FG000|Overall Study|Physician Decision|0|||
124796437|NCT01483690|448885829|FG001|Overall Study|Physician Decision|2|||
124796438|NCT01483690|448885828|FG000|Overall Study|exclusionary procedure|0|||
124796439|NCT01483690|448885829|FG001|Overall Study|exclusionary procedure|1|||
124796440|NCT03569293|448885832|FG000|Overall Study|Adverse Event|4|||
124796441|NCT03569293|448885833|FG001|Overall Study|Adverse Event|1|||
124796442|NCT03569293|448885834|FG002|Overall Study|Adverse Event|5|||
124796443|NCT03569293|448885835|FG003|Overall Study|Adverse Event|1|||
124796444|NCT03569293|448885836|FG004|Overall Study|Adverse Event|0|||
124796445|NCT03569293|448885837|FG005|Overall Study|Adverse Event|0|||
124796446|NCT03569293|448885832|FG000|Overall Study|Withdrawal by Subject|16|||
124796447|NCT03569293|448885833|FG001|Overall Study|Withdrawal by Subject|2|||
124796448|NCT03569293|448885834|FG002|Overall Study|Withdrawal by Subject|4|||
124796449|NCT03569293|448885835|FG003|Overall Study|Withdrawal by Subject|1|||
124796450|NCT03569293|448885836|FG004|Overall Study|Withdrawal by Subject|0|||
124796451|NCT03569293|448885837|FG005|Overall Study|Withdrawal by Subject|0|||
124796452|NCT03569293|448885832|FG000|Overall Study|Lost to Follow-up|1|||
124796453|NCT03569293|448885833|FG001|Overall Study|Lost to Follow-up|3|||
124796454|NCT03569293|448885834|FG002|Overall Study|Lost to Follow-up|1|||
124796455|NCT03569293|448885835|FG003|Overall Study|Lost to Follow-up|1|||
124796456|NCT03569293|448885836|FG004|Overall Study|Lost to Follow-up|0|||
124796457|NCT03569293|448885837|FG005|Overall Study|Lost to Follow-up|0|||
124796458|NCT03569293|448885832|FG000|Overall Study|Other|8|||
124796459|NCT03569293|448885833|FG001|Overall Study|Other|2|||
124796460|NCT03569293|448885834|FG002|Overall Study|Other|1|||
124796461|NCT03569293|448885835|FG003|Overall Study|Other|1|||
124796462|NCT03569293|448885836|FG004|Overall Study|Other|0|||
124796463|NCT03569293|448885837|FG005|Overall Study|Other|0|||
124796464|NCT03569293|448885832|FG000|Overall Study|Ongoing at Time of Analysis|8|||
124796465|NCT03569293|448885833|FG001|Overall Study|Ongoing at Time of Analysis|1|||
124796466|NCT03569293|448885834|FG002|Overall Study|Ongoing at Time of Analysis|3|||
124796467|NCT03569293|448885835|FG003|Overall Study|Ongoing at Time of Analysis|0|||
124796468|NCT03569293|448885836|FG004|Overall Study|Ongoing at Time of Analysis|0|||
124796469|NCT03569293|448885837|FG005|Overall Study|Ongoing at Time of Analysis|0|||
124796470|NCT03553836|448885839|FG000|Overall Study|Ongoing in Study|460|||
124796471|NCT03553836|448885840|FG001|Overall Study|Ongoing in Study|459|||
124796472|NCT03553836|448885839|FG000|Overall Study|Withdrawal by Subject|9|||
124796473|NCT03553836|448885840|FG001|Overall Study|Withdrawal by Subject|10|||
124796474|NCT03553836|448885839|FG000|Overall Study|Lost to Follow-up|1|||
124796475|NCT03553836|448885840|FG001|Overall Study|Lost to Follow-up|3|||
124796476|NCT03553836|448885839|FG000|Overall Study|Death|17|||
124796477|NCT03553836|448885840|FG001|Overall Study|Death|17|||
124796478|NCT04062123|448885841|FG000|Overall Study|Withdrawal by Subject|0|||
124796479|NCT04062123|448885842|FG001|Overall Study|Withdrawal by Subject|1|||
124796480|NCT04062123|448885843|FG002|Overall Study|Withdrawal by Subject|0|||
124796481|NCT01041495|448885844|FG000|Overall Study|Withdrawal by Subject|2|||
124796482|NCT01041495|448885845|FG001|Overall Study|Withdrawal by Subject|5|||
124796483|NCT01041495|448885844|FG000|Overall Study|Adverse Event|2|||
124796484|NCT01041495|448885845|FG001|Overall Study|Adverse Event|1|||
124796485|NCT01041495|448885844|FG000|Overall Study|Lost to Follow-up|0|||
124796486|NCT01041495|448885845|FG001|Overall Study|Lost to Follow-up|1|||
124796487|NCT03780400|448885849|FG000|Overall Study|Lost to Follow-up|5|||
124796488|NCT03780400|448885849|FG000|Overall Study|Withdrawal by Subject|2|||
124796489|NCT01479985|448885850|FG000|Overall Study|Tablet malfunction, no data saved|1|||
124796490|NCT01479985|448885851|FG001|Overall Study|Tablet malfunction, no data saved|1|||
124796491|NCT01479985|448885850|FG000|Overall Study|No decisional conflict scale responses|0|||
124796492|NCT01479985|448885851|FG001|Overall Study|No decisional conflict scale responses|2|||
124796493|NCT01479985|448885850|FG000|Overall Study|No post-visit survey|5|||
124796494|NCT01479985|448885851|FG001|Overall Study|No post-visit survey|3|||
124796495|NCT01653782|448885852|FG000|Overall Study|Withdrawal by Subject|9|||
124796496|NCT01653782|448885853|FG001|Overall Study|Withdrawal by Subject|15|||
124796497|NCT01653782|448885854|FG002|Overall Study|Withdrawal by Subject|4|||
124796498|NCT01653782|448885852|FG000|Overall Study|Lost to Follow-up|7|||
124796499|NCT01653782|448885853|FG001|Overall Study|Lost to Follow-up|3|||
124796500|NCT01653782|448885854|FG002|Overall Study|Lost to Follow-up|2|||
124796501|NCT01142128|448885855|FG000|Overall Study|Physician Decision|1|||
124796502|NCT01142128|448885855|FG000|Overall Study|Lost to Follow-up|1|||
124796503|NCT01142128|448885855|FG000|Overall Study|Withdrawal by Subject|2|||
124796504|NCT00442468|448885856|FG000|Overall Study|Adverse Event|4|||
124796505|NCT00442468|448885856|FG000|Overall Study|Withdrawal by Subject|91|||
124796506|NCT00442468|448885856|FG000|Overall Study|Did not complete all study procedures|88|||
124796507|NCT05867342|448885859|FG000|Overall Study|Investigator Decision|3|||
124796508|NCT05867342|448885860|FG001|Overall Study|Investigator Decision|3|||
124796509|NCT00470184|448885861|FG000|Overall Study|Not Treated(became ineligible)|4|||
124796510|NCT00470184|448885861|FG000|Overall Study|Not treated (other)|1|||
124796511|NCT00470184|448885861|FG000|Overall Study|disease Progression|4|||
124796512|NCT00470184|448885861|FG000|Overall Study|Adverse Event|3|||
124796513|NCT00470184|448885861|FG000|Overall Study|Withdrawal by Subject|4|||
124796514|NCT00470184|448885861|FG000|Overall Study|other|5|||
124796515|NCT00470184|448885861|FG000|Overall Study|recurrence|1|||
124796516|NCT05442775|448885862|FG000|Overall Study|Trial terminated|61|||
124796517|NCT05442775|448885862|FG000|Overall Study|Lack of Efficacy|4|||
124796518|NCT05442775|448885862|FG000|Overall Study|Withdrawal by Subject|4|||
124796519|NCT05442775|448885862|FG000|Overall Study|Death|1|||
124796520|NCT05442775|448885862|FG000|Overall Study|Participant removed at Sponsor request|1|||
124796521|NCT00058539|448885864|FG000|Overall Study|Disease progression|24|||
124796522|NCT00058539|448885864|FG000|Overall Study|Adverse Event|3|||
124796523|NCT00058539|448885864|FG000|Overall Study|Withdrawal by Subject|5|||
124796524|NCT00058539|448885864|FG000|Overall Study|Physician Decision|9|||
124796525|NCT00058539|448885864|FG000|Overall Study|Death|1|||
124796526|NCT03190369|448885865|FG000|Overall Study|Poor compliance to protocol|0|||
124796527|NCT03190369|448885866|FG001|Overall Study|Poor compliance to protocol|1|||
124796528|NCT03190369|448885865|FG000|Overall Study|Withdraw before treatment|1|||
124796529|NCT03190369|448885866|FG001|Overall Study|Withdraw before treatment|5|||
124796530|NCT03190369|448885865|FG000|Overall Study|Randomized but not treated|0|||
124796531|NCT03190369|448885866|FG001|Overall Study|Randomized but not treated|2|||
124796532|NCT02963831|448885867|FG000|Overall Study|Progressive Disease|3|||
124796533|NCT02963831|448885868|FG001|Overall Study|Progressive Disease|3|||
124796534|NCT02963831|448885869|FG002|Overall Study|Progressive Disease|16|||
124796535|NCT02963831|448885870|FG003|Overall Study|Progressive Disease|27|||
124796536|NCT02963831|448885867|FG000|Overall Study|Withdrawal by Subject|1|||
124796537|NCT02963831|448885868|FG001|Overall Study|Withdrawal by Subject|0|||
124796538|NCT02963831|448885869|FG002|Overall Study|Withdrawal by Subject|2|||
124796539|NCT02963831|448885870|FG003|Overall Study|Withdrawal by Subject|4|||
124796540|NCT02963831|448885867|FG000|Overall Study|Adverse Event|0|||
124796541|NCT02963831|448885868|FG001|Overall Study|Adverse Event|1|||
124796542|NCT02963831|448885869|FG002|Overall Study|Adverse Event|1|||
124796543|NCT02963831|448885870|FG003|Overall Study|Adverse Event|2|||
124796544|NCT02963831|448885867|FG000|Overall Study|Death|0|||
124796545|NCT02963831|448885868|FG001|Overall Study|Death|0|||
124796546|NCT02963831|448885869|FG002|Overall Study|Death|0|||
124796547|NCT02963831|448885870|FG003|Overall Study|Death|2|||
124796548|NCT04543409|448885871|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
124796549|NCT04543409|448885872|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
124796550|NCT04543409|448885871|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
124796551|NCT04543409|448885872|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
124796552|NCT04543409|448885871|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
124796553|NCT04543409|448885872|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
124796554|NCT04543409|448885871|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
124796555|NCT04543409|448885872|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
124796556|NCT04543409|448885871|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
124796557|NCT04543409|448885872|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
124796558|NCT04543409|448885871|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
124796559|NCT04543409|448885872|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
124796560|NCT04543409|448885871|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
124796561|NCT04543409|448885872|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
124796562|NCT04543409|448885871|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
124796563|NCT04543409|448885872|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
124796564|NCT04543409|448885871|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
124796565|NCT04543409|448885872|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
124796566|NCT04543409|448885871|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
124796567|NCT04543409|448885872|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
124796568|NCT04543409|448885871|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
124796569|NCT04543409|448885872|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
124796570|NCT01923168|448885873|FG000|Overall Study|Protocol Violation|1|||
124796571|NCT01923168|448885874|FG001|Overall Study|Protocol Violation|1|||
124796572|NCT01923168|448885875|FG002|Overall Study|Protocol Violation|0|||
124796573|NCT01923168|448885873|FG000|Overall Study|Subject/guardian decision|14|||
124796574|NCT01923168|448885874|FG001|Overall Study|Subject/guardian decision|14|||
124796575|NCT01923168|448885875|FG002|Overall Study|Subject/guardian decision|4|||
124796576|NCT01923168|448885873|FG000|Overall Study|Adverse Event|12|||
124796577|NCT01923168|448885874|FG001|Overall Study|Adverse Event|12|||
124796578|NCT01923168|448885875|FG002|Overall Study|Adverse Event|0|||
124796579|NCT01923168|448885873|FG000|Overall Study|Physician Decision|6|||
124796580|NCT01923168|448885874|FG001|Overall Study|Physician Decision|9|||
124796581|NCT01923168|448885875|FG002|Overall Study|Physician Decision|5|||
124796582|NCT01923168|448885873|FG000|Overall Study|Progressive disease|4|||
124796583|NCT01923168|448885874|FG001|Overall Study|Progressive disease|3|||
124796584|NCT01923168|448885875|FG002|Overall Study|Progressive disease|7|||
124796585|NCT01923168|448885873|FG000|Overall Study|Death|0|||
124796586|NCT01923168|448885874|FG001|Overall Study|Death|0|||
124796587|NCT01923168|448885875|FG002|Overall Study|Death|1|||
124796588|NCT03418571|448885876|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
124796589|NCT03418571|448885877|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
124796590|NCT03882008|448885878|FG000|Overall Study|Withdrawal by Subject|1|||
124796591|NCT03882008|448885878|FG000|Overall Study|Lost to Follow-up|1|||
124796592|NCT04341662|448885879|FG000|Overall Study|Did not have source-verified blood loss data|423|||
124796593|NCT04341662|448885880|FG001|Overall Study|Did not have source-verified blood loss data|514|||
124796594|NCT03101267|448885881|FG000|Primary Study Period|Withdrawal by Subject|1|||
124796595|NCT03101267|448885882|FG001|Primary Study Period|Withdrawal by Subject|2|||
124796596|NCT03101267|448885883|FG002|Primary Study Period|Withdrawal by Subject|3|||
124796597|NCT03101267|448885881|FG000|Primary Study Period|Miscellaneous|2|||
124796598|NCT03101267|448885882|FG001|Primary Study Period|Miscellaneous|0|||
124796599|NCT03101267|448885883|FG002|Primary Study Period|Miscellaneous|0|||
124796600|NCT01222403|448885884|FG000|Overall Study|Inappropriate enrollment|0|||
124796601|NCT01222403|448885885|FG001|Overall Study|Inappropriate enrollment|2|||
124796602|NCT01262352|448885887|FG000|Period 1|Illness after randomization|1|||
124796603|NCT01262352|448885888|FG001|Period 1|Illness after randomization|0|||
124796604|NCT01262352|448885887|FG000|Washout|Adverse Event|1|||
124796605|NCT01262352|448885888|FG001|Washout|Adverse Event|1|||
124796606|NCT01262352|448885887|FG000|Washout|Extended Washout|0|||
124796607|NCT01262352|448885888|FG001|Washout|Extended Washout|1|||
124796608|NCT02045303|448885889|FG000|Overall Study|Protocol Violation|2|||
124796609|NCT02045303|448885890|FG001|Overall Study|Protocol Violation|1|||
124796610|NCT02045303|448885891|FG002|Overall Study|Protocol Violation|0|||
124796611|NCT02045303|448885889|FG000|Overall Study|Withdrawal by Subject|0|||
124796612|NCT02045303|448885890|FG001|Overall Study|Withdrawal by Subject|2|||
124796613|NCT02045303|448885891|FG002|Overall Study|Withdrawal by Subject|0|||
124796614|NCT01642407|448885892|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
124796615|NCT01642407|448885892|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
124796616|NCT01642407|448885892|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
124796617|NCT03533686|448885893|FG000|Overall Study|Withdrawal by Subject|1|||
124796618|NCT03533686|448885894|FG001|Overall Study|Withdrawal by Subject|0|||
124796619|NCT03533686|448885895|FG002|Overall Study|Withdrawal by Subject|0|||
124796620|NCT03533686|448885896|FG003|Overall Study|Withdrawal by Subject|3|||
124796621|NCT03533686|448885897|FG004|Overall Study|Withdrawal by Subject|5|||
124796622|NCT03533686|448885898|FG005|Overall Study|Withdrawal by Subject|1|||
124796623|NCT03533686|448885893|FG000|Overall Study|Lost to Follow-up|0|||
124796624|NCT03533686|448885894|FG001|Overall Study|Lost to Follow-up|1|||
124796625|NCT03533686|448885895|FG002|Overall Study|Lost to Follow-up|0|||
124796626|NCT03533686|448885896|FG003|Overall Study|Lost to Follow-up|0|||
124796627|NCT03533686|448885897|FG004|Overall Study|Lost to Follow-up|2|||
124796628|NCT03533686|448885898|FG005|Overall Study|Lost to Follow-up|0|||
124796629|NCT03533686|448885893|FG000|Overall Study|Screen Failure|0|||
124796630|NCT03533686|448885894|FG001|Overall Study|Screen Failure|0|||
124796631|NCT03533686|448885895|FG002|Overall Study|Screen Failure|0|||
124796632|NCT03533686|448885896|FG003|Overall Study|Screen Failure|2|||
124796633|NCT03533686|448885897|FG004|Overall Study|Screen Failure|0|||
124796634|NCT03533686|448885898|FG005|Overall Study|Screen Failure|0|||
124796635|NCT00245583|448885901|FG000|Overall Study|Lost to Follow-up|1|||
124796636|NCT00245583|448885902|FG001|Overall Study|Lost to Follow-up|5|||
124796637|NCT00245583|448885901|FG000|Overall Study|Adverse Event|2|||
124796638|NCT00245583|448885902|FG001|Overall Study|Adverse Event|1|||
124796639|NCT00245583|448885901|FG000|Overall Study|Lack of Efficacy|1|||
124796640|NCT00245583|448885902|FG001|Overall Study|Lack of Efficacy|0|||
124796641|NCT00245583|448885901|FG000|Overall Study|Withdrawal by Subject|2|||
124796642|NCT00245583|448885902|FG001|Overall Study|Withdrawal by Subject|3|||
124796643|NCT00829283|448885903|FG000|Overall Study|Lost to Follow-up|7|||
124796644|NCT00829283|448885904|FG001|Overall Study|Lost to Follow-up|25|||
124796645|NCT00591578|448885907|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
124796646|NCT00591578|448885908|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
124796647|NCT00591578|448885909|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
124796648|NCT00591578|448885907|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
124796649|NCT00591578|448885908|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
124796650|NCT00591578|448885909|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
124796651|NCT00591578|448885907|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
124796652|NCT00591578|448885908|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
124796653|NCT00591578|448885909|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
124796654|NCT00591578|448885907|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
124796655|NCT00591578|448885908|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
124796656|NCT00591578|448885909|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
124796657|NCT00591578|448885907|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
124796658|NCT00591578|448885908|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
124796659|NCT00591578|448885909|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
124796660|NCT00591578|448885907|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
124796661|NCT00591578|448885908|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
124796662|NCT00591578|448885909|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
124796663|NCT00591578|448885907|FG000|Double-Blind Treatment Phase|Other|4|||
124796664|NCT00591578|448885908|FG001|Double-Blind Treatment Phase|Other|9|||
124796665|NCT00591578|448885909|FG002|Double-Blind Treatment Phase|Other|4|||
124796666|NCT00591578|448885907|FG000|Open-Label Extension Phase|Adverse Event|3|||
124796667|NCT00591578|448885908|FG001|Open-Label Extension Phase|Adverse Event|5|||
124796668|NCT00591578|448885909|FG002|Open-Label Extension Phase|Adverse Event|0|||
124796669|NCT00591578|448885907|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
124796670|NCT00591578|448885908|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
124796671|NCT00591578|448885909|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
124796672|NCT00591578|448885907|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
124796673|NCT00591578|448885908|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
124796674|NCT00591578|448885909|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
124796675|NCT00591578|448885907|FG000|Open-Label Extension Phase|Other|1|||
124796676|NCT00591578|448885908|FG001|Open-Label Extension Phase|Other|0|||
124796677|NCT00591578|448885909|FG002|Open-Label Extension Phase|Other|0|||
124796678|NCT03945175|448885910|FG000|Overall Study|Did not meet inclusion criteria|31|||
124796679|NCT03945175|448885910|FG000|Overall Study|Withdrew consent|2|||
124796680|NCT03945175|448885910|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
124796681|NCT03945175|448885910|FG000|Overall Study|Early termination during Mydayis treatment|1|||
124796682|NCT00870233|448885911|FG000|Overall Study|Withdrawal by Subject|18|||
124796683|NCT00870233|448885911|FG000|Overall Study|Did not undergo laparotomy|3|||
124796684|NCT00870233|448885911|FG000|Overall Study|Incompatible internet browser|2|||
124796685|NCT00870233|448885911|FG000|Overall Study|Death|1|||
124796686|NCT00378079|448885912|FG000|Overall Study|Lost to Follow-up|6|||
124796687|NCT00378079|448885913|FG001|Overall Study|Lost to Follow-up|1|||
124796688|NCT00378079|448885914|FG002|Overall Study|Lost to Follow-up|0|||
124796689|NCT00006389|448885915|FG000|Overall Study|Adverse Event|1|||
124796690|NCT01445886|448885924|FG000|Overall Study|Lost to Follow-up|2|||
124796691|NCT01445886|448885924|FG000|Overall Study|Protocol Violation|3|||
124796692|NCT03500679|448885925|FG000|Overall Study|Lost to Follow-up|6|||
124796693|NCT03500679|448885926|FG001|Overall Study|Lost to Follow-up|3|||
124796694|NCT03500679|448885925|FG000|Overall Study|Withdrawal by Subject|3|||
124796695|NCT03500679|448885926|FG001|Overall Study|Withdrawal by Subject|0|||
124796696|NCT01962922|448885927|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
124796697|NCT01962922|448885928|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
124796698|NCT01962922|448885927|FG000|PK Portion Day 7|non-compliance|1|||
124796699|NCT01962922|448885928|FG001|PK Portion Day 7|non-compliance|0|||
124796700|NCT01962922|448885927|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
124796701|NCT01962922|448885928|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
124796702|NCT01962922|448885927|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
124796703|NCT01962922|448885928|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
124796704|NCT03224546|448885929|FG000|Overall Study|Lost to Follow-up|9|||
124796705|NCT03224546|448885930|FG001|Overall Study|Lost to Follow-up|8|||
124796706|NCT03224546|448885931|FG002|Overall Study|Lost to Follow-up|3|||
124796707|NCT03224546|448885929|FG000|Overall Study|Withdrawal by Subject|7|||
124796708|NCT03224546|448885930|FG001|Overall Study|Withdrawal by Subject|14|||
124796709|NCT03224546|448885931|FG002|Overall Study|Withdrawal by Subject|12|||
124796710|NCT02730208|448885932|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
124796711|NCT02730208|448885933|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
124796712|NCT00510952|448885939|FG000|Overall Study|Adverse Event|1|||
124796713|NCT00510952|448885940|FG001|Overall Study|Adverse Event|0|||
124796714|NCT00510952|448885939|FG000|Overall Study|Entry Criteria Not Met|3|||
124796715|NCT00510952|448885940|FG001|Overall Study|Entry Criteria Not Met|1|||
124796716|NCT00510952|448885939|FG000|Overall Study|Lost to Follow-up|5|||
124796717|NCT00510952|448885940|FG001|Overall Study|Lost to Follow-up|3|||
124796718|NCT00510952|448885939|FG000|Overall Study|Physician Decision|1|||
124796719|NCT00510952|448885940|FG001|Overall Study|Physician Decision|1|||
124796720|NCT00510952|448885939|FG000|Overall Study|Protocol Violation|7|||
124796721|NCT00510952|448885940|FG001|Overall Study|Protocol Violation|4|||
124796722|NCT00510952|448885939|FG000|Overall Study|Sponsor Decision|1|||
124796723|NCT00510952|448885940|FG001|Overall Study|Sponsor Decision|0|||
124796724|NCT00510952|448885939|FG000|Overall Study|Withdrawal by Subject|6|||
124796725|NCT00510952|448885940|FG001|Overall Study|Withdrawal by Subject|7|||
124796726|NCT00510952|448885939|FG000|Overall Study|Did Not Receive Study Drug|2|||
124796727|NCT00510952|448885940|FG001|Overall Study|Did Not Receive Study Drug|0|||
124796728|NCT02793128|448885945|FG000|Overall Study|Death|4|||
124796729|NCT02793128|448885945|FG000|Overall Study|Withdrawal by Subject|2|||
124796730|NCT02793128|448885945|FG000|Overall Study|Physician Decision|1|||
124796731|NCT02793128|448885945|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
124796732|NCT02793128|448885945|FG000|Overall Study|Patient elected nephroureterectomy|1|||
124796733|NCT03287635|448885949|FG000|Overall Study|Lost to Follow-up|5|||
124796734|NCT03287635|448885949|FG000|Overall Study|Withdrawal by Subject|1|||
124796735|NCT03287635|448885949|FG000|Overall Study|Physician Decision|1|||
124796736|NCT03670836|448885950|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
124796737|NCT03670836|448885951|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
124796738|NCT03670836|448885950|FG000|Per Protocol Population (PP)|Physician Decision|9|||
124796739|NCT03670836|448885951|FG001|Per Protocol Population (PP)|Physician Decision|10|||
124796740|NCT03670836|448885950|FG000|Per Protocol Population (PP)|Physician Decision|4|||
124796741|NCT03670836|448885951|FG001|Per Protocol Population (PP)|Physician Decision|6|||
124796742|NCT03670836|448885950|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
124796743|NCT03670836|448885951|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
124796744|NCT04285580|448887944|FG000|Overall Study|Protocol Violation|0|||
124796745|NCT04285580|448887945|FG001|Overall Study|Protocol Violation|1|||
124796746|NCT02582255|448887946|FG000|Overall Study|Protocol Violation|0|||
124796747|NCT02582255|448887947|FG001|Overall Study|Protocol Violation|3|||
124796748|NCT04854642|448887948|FG000|Overall Study|Adverse Event|1|||
124796749|NCT04854642|448887949|FG001|Overall Study|Adverse Event|2|||
124796750|NCT04854642|448887948|FG000|Overall Study|Withdrawal by Subject|0|||
124796751|NCT04854642|448887949|FG001|Overall Study|Withdrawal by Subject|1|||
124796752|NCT01107418|448887951|FG000|Overall Study|Disease Progression|45|||
124796753|NCT01107418|448887951|FG000|Overall Study|Adverse Event|3|||
124796754|NCT01107418|448887951|FG000|Overall Study|Withdrawal by Subject|1|||
124796755|NCT01107418|448887951|FG000|Overall Study|Study Closing|1|||
124796756|NCT01107418|448887951|FG000|Overall Study|Started Other Therapy|1|||
124796757|NCT01107418|448887951|FG000|Overall Study|Entered Extension Study|1|||
124796758|NCT00597701|448887952|FG000|Overall Study|Withdrawal by Subject|5|||
124796759|NCT00597701|448887953|FG001|Overall Study|Withdrawal by Subject|5|||
124796760|NCT00597701|448887952|FG000|Overall Study|Death|0|||
124796761|NCT00597701|448887953|FG001|Overall Study|Death|1|||
124796762|NCT00597701|448887952|FG000|Overall Study|Physician Decision|2|||
124796763|NCT00597701|448887953|FG001|Overall Study|Physician Decision|0|||
124796764|NCT00597701|448887952|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
124796765|NCT00597701|448887953|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
124796766|NCT00076024|448887956|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
124796767|NCT00076024|448887957|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
124796768|NCT00076024|448887958|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
124796769|NCT00076024|448887959|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
124796770|NCT00076024|448887956|FG000|Phase 1, Lead-in|Adverse Event|1|||
124796771|NCT00076024|448887957|FG001|Phase 1, Lead-in|Adverse Event|0|||
124796772|NCT00076024|448887958|FG002|Phase 1, Lead-in|Adverse Event|0|||
124796773|NCT00076024|448887959|FG003|Phase 1, Lead-in|Adverse Event|0|||
124796774|NCT00076024|448887956|FG000|Phase 1, Lead-in|Clinical progression|1|||
124796775|NCT00076024|448887957|FG001|Phase 1, Lead-in|Clinical progression|0|||
124796776|NCT00076024|448887958|FG002|Phase 1, Lead-in|Clinical progression|0|||
124796777|NCT00076024|448887959|FG003|Phase 1, Lead-in|Clinical progression|0|||
124796778|NCT00076024|448887956|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
124796779|NCT00076024|448887957|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
124796780|NCT00076024|448887958|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
124796781|NCT00076024|448887959|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
124796782|NCT00076024|448887956|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
124796783|NCT00076024|448887957|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
124796784|NCT00076024|448887958|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
124796785|NCT00076024|448887959|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
124796786|NCT00076024|448887956|FG000|Phase 2, Double-blind|Adverse Event|0|||
124796787|NCT00076024|448887957|FG001|Phase 2, Double-blind|Adverse Event|25|||
124796788|NCT00076024|448887958|FG002|Phase 2, Double-blind|Adverse Event|6|||
124796789|NCT00076024|448887959|FG003|Phase 2, Double-blind|Adverse Event|0|||
124796790|NCT00076024|448887956|FG000|Phase 2, Double-blind|Un-specified|0|||
124796791|NCT00076024|448887957|FG001|Phase 2, Double-blind|Un-specified|14|||
124796792|NCT00076024|448887958|FG002|Phase 2, Double-blind|Un-specified|6|||
124796793|NCT00076024|448887959|FG003|Phase 2, Double-blind|Un-specified|0|||
124796794|NCT00076024|448887956|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
124796795|NCT00076024|448887957|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
124796796|NCT00076024|448887958|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
124796797|NCT00076024|448887959|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
124796798|NCT00076024|448887956|FG000|Phase 2, Open-label|Adverse Event|0|||
124796799|NCT00076024|448887957|FG001|Phase 2, Open-label|Adverse Event|0|||
124796800|NCT00076024|448887958|FG002|Phase 2, Open-label|Adverse Event|0|||
124796801|NCT00076024|448887959|FG003|Phase 2, Open-label|Adverse Event|2|||
124796802|NCT00076024|448887956|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
124796803|NCT00076024|448887957|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
124796804|NCT00076024|448887958|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
124796805|NCT00076024|448887959|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
124796806|NCT00076024|448887956|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
124796807|NCT00076024|448887957|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
124796808|NCT00076024|448887958|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
124796809|NCT00076024|448887959|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
124796810|NCT00076024|448887956|FG000|Phase 2, Open-label|Other|0|||
124796811|NCT00076024|448887957|FG001|Phase 2, Open-label|Other|0|||
124796812|NCT00076024|448887958|FG002|Phase 2, Open-label|Other|0|||
124796813|NCT00076024|448887959|FG003|Phase 2, Open-label|Other|2|||
124796814|NCT01155219|448887963|FG000|Overall Study|Adverse Event|3|||
124796815|NCT01155219|448887964|FG001|Overall Study|Adverse Event|1|||
124796816|NCT01155219|448887963|FG000|Overall Study|non-medical reason|1|||
124796817|NCT01155219|448887964|FG001|Overall Study|non-medical reason|2|||
124796818|NCT00301821|448887966|FG000|Overall Study|Ineligible|25|||
124796819|NCT00301821|448887966|FG000|Overall Study|Cancel|1|||
124796820|NCT04078178|448887971|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
124796821|NCT04078178|448887972|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
124796822|NCT04078178|448887971|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
124796823|NCT04078178|448887972|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
124796824|NCT04078178|448887971|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
124796825|NCT04078178|448887972|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
124796826|NCT04078178|448887971|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
124796827|NCT04078178|448887972|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
124796828|NCT04078178|448887971|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
124796829|NCT04078178|448887972|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
124796830|NCT04006119|448887973|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
124796831|NCT04006119|448887973|FG000|End of Treatment Veledimex|Adverse Event|2|||
124796832|NCT04006119|448887973|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
124796833|NCT04006119|448887973|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
124796834|NCT04006119|448887973|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
124796835|NCT04006119|448887973|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
124796836|NCT00472459|448887974|FG000|Overall Study|Adverse Event|13|||
124796837|NCT00472459|448887975|FG001|Overall Study|Adverse Event|13|||
124796838|NCT00472459|448887974|FG000|Overall Study|Withdrawal by Subject|5|||
124796839|NCT00472459|448887975|FG001|Overall Study|Withdrawal by Subject|5|||
124796840|NCT00472459|448887974|FG000|Overall Study|Protocol Violation|3|||
124796841|NCT00472459|448887975|FG001|Overall Study|Protocol Violation|3|||
124796842|NCT00472459|448887974|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
124796843|NCT00472459|448887975|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
124796844|NCT00472459|448887974|FG000|Overall Study|Lost to Follow-up|1|||
124796845|NCT00472459|448887975|FG001|Overall Study|Lost to Follow-up|1|||
124796846|NCT03981822|448887980|FG000|Overall Study|Lost to Follow-up|0|||
124796847|NCT03981822|448887981|FG001|Overall Study|Lost to Follow-up|1|||
124796848|NCT03981822|448887982|FG002|Overall Study|Lost to Follow-up|1|||
124796849|NCT03981822|448887983|FG003|Overall Study|Lost to Follow-up|0|||
124796850|NCT03981822|448887984|FG004|Overall Study|Lost to Follow-up|6|||
124796851|NCT03981822|448887985|FG005|Overall Study|Lost to Follow-up|4|||
124796852|NCT03981822|448887986|FG006|Overall Study|Lost to Follow-up|4|||
124796853|NCT03981822|448887987|FG007|Overall Study|Lost to Follow-up|2|||
124796854|NCT03981822|448887980|FG000|Overall Study|Withdrawal by Subject|0|||
124796855|NCT03981822|448887981|FG001|Overall Study|Withdrawal by Subject|1|||
124796856|NCT03981822|448887982|FG002|Overall Study|Withdrawal by Subject|0|||
124796857|NCT03981822|448887983|FG003|Overall Study|Withdrawal by Subject|0|||
124796858|NCT03981822|448887984|FG004|Overall Study|Withdrawal by Subject|0|||
124796859|NCT03981822|448887985|FG005|Overall Study|Withdrawal by Subject|1|||
124796860|NCT03981822|448887986|FG006|Overall Study|Withdrawal by Subject|0|||
124796861|NCT03981822|448887987|FG007|Overall Study|Withdrawal by Subject|2|||
124796862|NCT03981822|448887980|FG000|Overall Study|COVID-19 Related|0|||
124796863|NCT03981822|448887981|FG001|Overall Study|COVID-19 Related|0|||
124796864|NCT03981822|448887982|FG002|Overall Study|COVID-19 Related|0|||
124796865|NCT03981822|448887983|FG003|Overall Study|COVID-19 Related|0|||
124796866|NCT03981822|448887984|FG004|Overall Study|COVID-19 Related|2|||
124796867|NCT03981822|448887985|FG005|Overall Study|COVID-19 Related|1|||
124796868|NCT03981822|448887986|FG006|Overall Study|COVID-19 Related|2|||
124796869|NCT03981822|448887987|FG007|Overall Study|COVID-19 Related|1|||
124796870|NCT06460493|448887988|FG000|Overall Study|Withdrawal by Subject|2|||
124796871|NCT03489551|448887991|FG000|Overall Study|Withdrawal by Subject|2|||
124796872|NCT02987660|448887994|FG000|Overall Study|Study terminated by sponsor|10|||
124796873|NCT02987660|448887995|FG001|Overall Study|Study terminated by sponsor|10|||
124796874|NCT00054717|448887996|FG000|Overall Study|Randomized but not treated|2|||
124796875|NCT00054717|448887997|FG001|Overall Study|Randomized but not treated|8|||
124796876|NCT00054717|448887996|FG000|Overall Study|Adverse Event|70|||
124796877|NCT00054717|448887997|FG001|Overall Study|Adverse Event|22|||
124796878|NCT00054717|448887996|FG000|Overall Study|Protocol Violation|18|||
124796879|NCT00054717|448887997|FG001|Overall Study|Protocol Violation|19|||
124796880|NCT00054717|448887996|FG000|Overall Study|Lost to Follow-up|23|||
124796881|NCT00054717|448887997|FG001|Overall Study|Lost to Follow-up|13|||
124796882|NCT00054717|448887996|FG000|Overall Study|Withdrawal by Subject|32|||
124796883|NCT00054717|448887997|FG001|Overall Study|Withdrawal by Subject|20|||
124796884|NCT00054717|448887996|FG000|Overall Study|Other reason not defined above|117|||
124796885|NCT00054717|448887997|FG001|Overall Study|Other reason not defined above|217|||
124796886|NCT03707184|448887998|FG000|Overall Study|Withdrawal by Subject|2|||
124796887|NCT04704154|448887999|FG000|Overall Study|Adverse Event|3|||
124796888|NCT04704154|448888000|FG001|Overall Study|Adverse Event|2|||
124796889|NCT04704154|448888001|FG002|Overall Study|Adverse Event|4|||
124796890|NCT04704154|448888002|FG003|Overall Study|Adverse Event|2|||
124796891|NCT04704154|448888003|FG004|Overall Study|Adverse Event|3|||
124796892|NCT04704154|448888004|FG005|Overall Study|Adverse Event|0|||
124796893|NCT04704154|448887999|FG000|Overall Study|Death|3|||
124796894|NCT04704154|448888000|FG001|Overall Study|Death|0|||
124796895|NCT04704154|448888001|FG002|Overall Study|Death|0|||
124796896|NCT04704154|448888002|FG003|Overall Study|Death|0|||
124796897|NCT04704154|448888003|FG004|Overall Study|Death|3|||
124796898|NCT04704154|448888004|FG005|Overall Study|Death|0|||
124796899|NCT04704154|448887999|FG000|Overall Study|Physician Decision|1|||
124796900|NCT04704154|448888000|FG001|Overall Study|Physician Decision|0|||
124796901|NCT04704154|448888001|FG002|Overall Study|Physician Decision|1|||
124796902|NCT04704154|448888002|FG003|Overall Study|Physician Decision|0|||
124796903|NCT04704154|448888003|FG004|Overall Study|Physician Decision|2|||
124796904|NCT04704154|448888004|FG005|Overall Study|Physician Decision|0|||
124796905|NCT04704154|448887999|FG000|Overall Study|Participant Decision|1|||
124796906|NCT04704154|448888000|FG001|Overall Study|Participant Decision|1|||
124796907|NCT04704154|448888001|FG002|Overall Study|Participant Decision|0|||
124796908|NCT04704154|448888002|FG003|Overall Study|Participant Decision|0|||
124796909|NCT04704154|448888003|FG004|Overall Study|Participant Decision|0|||
124796910|NCT04704154|448888004|FG005|Overall Study|Participant Decision|0|||
124796911|NCT04704154|448887999|FG000|Overall Study|Progressive Disease|19|||
124796912|NCT04704154|448888000|FG001|Overall Study|Progressive Disease|17|||
124796913|NCT04704154|448888001|FG002|Overall Study|Progressive Disease|20|||
124796914|NCT04704154|448888002|FG003|Overall Study|Progressive Disease|18|||
124796915|NCT04704154|448888003|FG004|Overall Study|Progressive Disease|36|||
124796916|NCT04704154|448888004|FG005|Overall Study|Progressive Disease|30|||
124796917|NCT04704154|448887999|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
124819539|NCT05147350|448965752|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
124796918|NCT04704154|448888000|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
124796919|NCT04704154|448888001|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
124796920|NCT04704154|448888002|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
124796921|NCT04704154|448888003|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
124796922|NCT04704154|448888004|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
124796923|NCT04704154|448887999|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
124796924|NCT04704154|448888000|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
124796925|NCT04704154|448888001|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
124796926|NCT04704154|448888002|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
124796927|NCT04704154|448888003|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
124796928|NCT04704154|448888004|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
124796929|NCT04251156|448888005|FG000|Overall Study|Lost to Follow-up|1|||
124796930|NCT04251156|448888006|FG001|Overall Study|Lost to Follow-up|1|||
124796931|NCT04251156|448888005|FG000|Overall Study|Withdrawal by Subject|4|||
124796932|NCT04251156|448888006|FG001|Overall Study|Withdrawal by Subject|4|||
124796933|NCT04209426|448888007|FG000|Overall Study|Lost to Follow-up|3|||
124796934|NCT04209426|448888008|FG001|Overall Study|Lost to Follow-up|2|||
124796935|NCT04423939|448888009|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
124796936|NCT04423939|448888010|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
124796937|NCT04423939|448888009|FG000|Overall Study|Death|3|||
124796938|NCT04423939|448888010|FG001|Overall Study|Death|0|||
124796939|NCT04423939|448888009|FG000|Overall Study|Withdrawal by Subject|3|||
124796940|NCT04423939|448888010|FG001|Overall Study|Withdrawal by Subject|0|||
124796941|NCT04423939|448888009|FG000|Overall Study|Caregiver to patient who died|0|||
124796942|NCT04423939|448888010|FG001|Overall Study|Caregiver to patient who died|3|||
124796943|NCT04423939|448888009|FG000|Overall Study|Caregiver to patient who withdrew|0|||
124796944|NCT04423939|448888010|FG001|Overall Study|Caregiver to patient who withdrew|3|||
124796945|NCT04626310|448888013|FG000|Overall Study|4-miss from treatment|6|||
124796946|NCT04626310|448888014|FG001|Overall Study|4-miss from treatment|5|||
124796947|NCT04626310|448888015|FG002|Overall Study|4-miss from treatment|5|||
124796948|NCT04626310|448888013|FG000|Overall Study|Withdrawal by Subject|1|||
124796949|NCT04626310|448888014|FG001|Overall Study|Withdrawal by Subject|0|||
124796950|NCT04626310|448888015|FG002|Overall Study|Withdrawal by Subject|3|||
124796951|NCT02278341|448888016|FG000|Overall Study|Randomized but never received study drug|1|||
124796952|NCT02278341|448888017|FG001|Overall Study|Randomized but never received study drug|1|||
124796953|NCT02278341|448888016|FG000|Overall Study|Adverse Event|3|||
124796954|NCT02278341|448888017|FG001|Overall Study|Adverse Event|0|||
124796955|NCT02278341|448888016|FG000|Overall Study|Death|68|||
124796956|NCT02278341|448888017|FG001|Overall Study|Death|56|||
124796957|NCT02278341|448888016|FG000|Overall Study|Withdrawal by Subject|30|||
124796958|NCT02278341|448888017|FG001|Overall Study|Withdrawal by Subject|19|||
124796959|NCT02278341|448888016|FG000|Overall Study|Lost to Follow-up|0|||
124796960|NCT02278341|448888017|FG001|Overall Study|Lost to Follow-up|1|||
124796961|NCT02278341|448888016|FG000|Overall Study|Physician Decision|1|||
124796962|NCT02278341|448888017|FG001|Overall Study|Physician Decision|1|||
124796963|NCT02278341|448888016|FG000|Overall Study|Miscellaneous|15|||
124796964|NCT02278341|448888017|FG001|Overall Study|Miscellaneous|14|||
124796965|NCT02604017|448888018|FG000|Overall Study|Withdrew Consent|0|||
124796966|NCT02604017|448888019|FG001|Overall Study|Withdrew Consent|2|||
124796967|NCT02604017|448888018|FG000|Overall Study|Lost to Follow-up|5|||
124796968|NCT02604017|448888019|FG001|Overall Study|Lost to Follow-up|6|||
124796969|NCT02604017|448888018|FG000|Overall Study|Other|1|||
124796970|NCT02604017|448888019|FG001|Overall Study|Other|0|||
124796971|NCT00740246|448888020|FG000|Overall Study|Received Blood Transfusion|0|||
124796972|NCT00740246|448888021|FG001|Overall Study|Received Blood Transfusion|1|||
124796973|NCT00740246|448888020|FG000|Overall Study|Adverse Event|1|||
124796974|NCT00740246|448888021|FG001|Overall Study|Adverse Event|2|||
124796975|NCT00740246|448888020|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
124796976|NCT00740246|448888021|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
124796977|NCT00740246|448888020|FG000|Overall Study|Lost to Follow-up|2|||
124796978|NCT00740246|448888021|FG001|Overall Study|Lost to Follow-up|2|||
124796979|NCT00740246|448888020|FG000|Overall Study|Withdrawal by Subject|4|||
124796980|NCT00740246|448888021|FG001|Overall Study|Withdrawal by Subject|3|||
124796981|NCT00740246|448888020|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
124796982|NCT00740246|448888021|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
124796983|NCT00740246|448888020|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
124796984|NCT00740246|448888021|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
124796985|NCT00740246|448888020|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
124796986|NCT00740246|448888021|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
124796987|NCT00740246|448888020|FG000|Overall Study|Unable To Comply With Study Visits|2|||
124796988|NCT00740246|448888021|FG001|Overall Study|Unable To Comply With Study Visits|0|||
124796989|NCT00740246|448888020|FG000|Overall Study|Unable to Access Vein|0|||
124796990|NCT00740246|448888021|FG001|Overall Study|Unable to Access Vein|2|||
124796991|NCT00740246|448888020|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
124796992|NCT00740246|448888021|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
124796993|NCT01606254|448888024|FG000|Overall Study|Withdrawal by Subject|1|||
124796994|NCT01606254|448888025|FG001|Overall Study|Withdrawal by Subject|3|||
124796995|NCT01606254|448888026|FG002|Overall Study|Withdrawal by Subject|0|||
124796996|NCT01606254|448888027|FG003|Overall Study|Withdrawal by Subject|2|||
124796997|NCT01606254|448888024|FG000|Overall Study|Adverse Event|1|||
124796998|NCT01606254|448888025|FG001|Overall Study|Adverse Event|1|||
124796999|NCT01606254|448888026|FG002|Overall Study|Adverse Event|0|||
124797000|NCT01606254|448888027|FG003|Overall Study|Adverse Event|1|||
124797001|NCT02011893|448888028|FG000|Enrollment to Randomization|Adverse Event|2|||
124797002|NCT02011893|448888029|FG001|Enrollment to Randomization|Adverse Event|0|||
124797003|NCT02011893|448888030|FG002|Enrollment to Randomization|Adverse Event|0|||
124797004|NCT02011893|448888028|FG000|Enrollment to Randomization|Physician Decision|10|||
124797005|NCT02011893|448888029|FG001|Enrollment to Randomization|Physician Decision|0|||
124797006|NCT02011893|448888030|FG002|Enrollment to Randomization|Physician Decision|0|||
124797007|NCT02011893|448888028|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
124797008|NCT02011893|448888029|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
124797009|NCT02011893|448888030|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
124797010|NCT02011893|448888028|FG000|Enrollment to Randomization|Screening Failure|29|||
124797011|NCT02011893|448888029|FG001|Enrollment to Randomization|Screening Failure|0|||
124797012|NCT02011893|448888030|FG002|Enrollment to Randomization|Screening Failure|0|||
124797013|NCT02011893|448888028|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
124797014|NCT02011893|448888029|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
124797015|NCT02011893|448888030|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
124797016|NCT02011893|448888028|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
124797017|NCT02011893|448888029|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
124797018|NCT02011893|448888030|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
124797019|NCT02011893|448888028|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
124797020|NCT02011893|448888029|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
124797021|NCT02011893|448888030|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
124797022|NCT02011893|448888028|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
124797023|NCT02011893|448888029|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
124797024|NCT02011893|448888030|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
124797025|NCT02011893|448888028|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
124797026|NCT02011893|448888029|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
124797027|NCT02011893|448888030|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
124797028|NCT03977454|448888031|FG000|Overall Study|immediate postoperative revision|2|||
124797029|NCT03977454|448888032|FG001|Overall Study|immediate postoperative revision|2|||
124797030|NCT01289782|448888033|FG000|Overall Study|Lost to Follow-up|14|||
124797031|NCT01289782|448888034|FG001|Overall Study|Lost to Follow-up|7|||
124797032|NCT01289782|448888033|FG000|Overall Study|Protocol Violation|1|||
124797033|NCT01289782|448888034|FG001|Overall Study|Protocol Violation|1|||
124797034|NCT01289782|448888033|FG000|Overall Study|Withdrawal by Subject|8|||
124797035|NCT01289782|448888034|FG001|Overall Study|Withdrawal by Subject|2|||
124797036|NCT01289782|448888033|FG000|Overall Study|Sponsor's Decision|1|||
124797037|NCT01289782|448888034|FG001|Overall Study|Sponsor's Decision|0|||
124797038|NCT01289782|448888033|FG000|Overall Study|Reason not specified|1|||
124797039|NCT01289782|448888034|FG001|Overall Study|Reason not specified|2|||
124797040|NCT01241240|448888035|FG000|Overall Study|Adverse Event|5|||
124797041|NCT01241240|448888036|FG001|Overall Study|Adverse Event|4|||
124797042|NCT01241240|448888035|FG000|Overall Study|Lost to Follow-up|2|||
124797043|NCT01241240|448888036|FG001|Overall Study|Lost to Follow-up|4|||
124797044|NCT01241240|448888035|FG000|Overall Study|Personal Reasons|1|||
124797045|NCT01241240|448888036|FG001|Overall Study|Personal Reasons|1|||
124797046|NCT04365257|448888040|FG000|Overall Study|Physician Decision|1|||
124797047|NCT04365257|448888041|FG001|Overall Study|Physician Decision|0|||
124797048|NCT04365257|448888040|FG000|Overall Study|Patient Noncompliance|1|||
124797049|NCT04365257|448888041|FG001|Overall Study|Patient Noncompliance|0|||
124797050|NCT04365257|448888040|FG000|Overall Study|Withdrawal by Subject|0|||
124797051|NCT04365257|448888041|FG001|Overall Study|Withdrawal by Subject|1|||
124797052|NCT00518973|448888042|FG000|Overall Study|Withdrawal by Subject|3|||
124797053|NCT00518973|448888043|FG001|Overall Study|Withdrawal by Subject|2|||
124797054|NCT01001299|448888046|FG000|Overall Study|Insufficient Therapeutic Response|20|||
124797055|NCT01001299|448888046|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
124797056|NCT01001299|448888046|FG000|Overall Study|Death|1|||
124797057|NCT01001299|448888046|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
124797058|NCT01001299|448888046|FG000|Overall Study|Withdrew Consent|1|||
124797059|NCT01565499|448888051|FG000|Overall Study|Physician Decision|1|||
124797060|NCT01565499|448888051|FG000|Overall Study|Adverse Event|5|||
124797061|NCT01565499|448888051|FG000|Overall Study|Withdrawal by Subject|2|||
124797062|NCT03519386|448888054|FG000|Overall Study|Withdrawal by Subject|4|||
124797063|NCT03519386|448888055|FG001|Overall Study|Withdrawal by Subject|1|||
124797064|NCT03519386|448888056|FG002|Overall Study|Withdrawal by Subject|2|||
124797065|NCT03519386|448888054|FG000|Overall Study|Physician Decision|1|||
124797066|NCT03519386|448888055|FG001|Overall Study|Physician Decision|1|||
124797067|NCT03519386|448888056|FG002|Overall Study|Physician Decision|1|||
124797068|NCT03519386|448888054|FG000|Overall Study|Lost to Follow-up|0|||
124797069|NCT03519386|448888055|FG001|Overall Study|Lost to Follow-up|1|||
124797070|NCT03519386|448888056|FG002|Overall Study|Lost to Follow-up|1|||
124797071|NCT03519386|448888054|FG000|Overall Study|Death|1|||
124797072|NCT03519386|448888055|FG001|Overall Study|Death|0|||
124797073|NCT03519386|448888056|FG002|Overall Study|Death|4|||
124797074|NCT03519386|448888054|FG000|Overall Study|Adverse Event|2|||
124797075|NCT03519386|448888055|FG001|Overall Study|Adverse Event|1|||
124797076|NCT03519386|448888056|FG002|Overall Study|Adverse Event|2|||
124797077|NCT03519386|448888054|FG000|Overall Study|Explanted|2|||
124797078|NCT03519386|448888055|FG001|Overall Study|Explanted|1|||
124797079|NCT03519386|448888056|FG002|Overall Study|Explanted|0|||
124797080|NCT03519386|448888054|FG000|Overall Study|Ongoing in study|190|||
124797081|NCT03519386|448888055|FG001|Overall Study|Ongoing in study|192|||
124797082|NCT03519386|448888056|FG002|Overall Study|Ongoing in study|183|||
124797083|NCT01582854|448888058|FG000|Overall Study|Death|8|||
124797084|NCT01582854|448888059|FG001|Overall Study|Death|5|||
124797085|NCT01582854|448888058|FG000|Overall Study|Adverse Event|2|||
124797086|NCT01582854|448888059|FG001|Overall Study|Adverse Event|3|||
124797087|NCT01582854|448888058|FG000|Overall Study|Withdrawal by Participant|8|||
124797088|NCT01582854|448888059|FG001|Overall Study|Withdrawal by Participant|11|||
124797089|NCT01582854|448888058|FG000|Overall Study|Lost to Follow-up|1|||
124797090|NCT01582854|448888059|FG001|Overall Study|Lost to Follow-up|2|||
124797091|NCT01582854|448888058|FG000|Overall Study|Physician Decision|0|||
124797092|NCT01582854|448888059|FG001|Overall Study|Physician Decision|1|||
124797093|NCT01582854|448888058|FG000|Overall Study|Recurrent Stroke|13|||
124797094|NCT01582854|448888059|FG001|Overall Study|Recurrent Stroke|8|||
124797095|NCT01582854|448888058|FG000|Overall Study|Disallowed Concomitant Medication|3|||
124797096|NCT01582854|448888059|FG001|Overall Study|Disallowed Concomitant Medication|2|||
124797097|NCT01582854|448888058|FG000|Overall Study|Carotid or Neurosurgery|0|||
124797098|NCT01582854|448888059|FG001|Overall Study|Carotid or Neurosurgery|1|||
124797099|NCT01582854|448888058|FG000|Overall Study|General Anaesthesia|0|||
124797100|NCT01582854|448888059|FG001|Overall Study|General Anaesthesia|1|||
124797101|NCT01582854|448888058|FG000|Overall Study|Other Miscellaneous Reason|1|||
124797102|NCT01582854|448888059|FG001|Overall Study|Other Miscellaneous Reason|0|||
124797103|NCT02652767|448888064|FG000|Overall Study|Death|2|||
124797104|NCT02652767|448888064|FG000|Overall Study|Lost to Follow-up|1|||
124797105|NCT02652767|448888064|FG000|Overall Study|Withdrawal by Subject|1|||
124797106|NCT01028378|448888065|FG000|Overall Study|Lost to Follow-up|12|||
124797107|NCT01028378|448888065|FG000|Overall Study|Withdrawal by Subject|1|||
124797108|NCT01028378|448888065|FG000|Overall Study|Adminstrative Reasons|4|||
124797109|NCT00107952|448888069|FG000|Overall Study|Death|75|||
124797110|NCT00107952|448888070|FG001|Overall Study|Death|61|||
124797111|NCT00107952|448888069|FG000|Overall Study|Lost to Follow-up|0|||
124797112|NCT00107952|448888070|FG001|Overall Study|Lost to Follow-up|3|||
124797113|NCT00107952|448888069|FG000|Overall Study|Withdrawal by Subject|9|||
124797114|NCT00107952|448888070|FG001|Overall Study|Withdrawal by Subject|6|||
124797115|NCT00107952|448888069|FG000|Overall Study|Other|2|||
124797116|NCT00107952|448888070|FG001|Overall Study|Other|5|||
124797117|NCT00107952|448888069|FG000|Overall Study|Never received study treatment|9|||
124797118|NCT00107952|448888070|FG001|Overall Study|Never received study treatment|6|||
124797119|NCT01401959|448888071|FG000|Enrolled|Withdrawal by Subject|1|||
124797120|NCT01401959|448888072|FG001|Enrolled|Withdrawal by Subject|0|||
124797121|NCT01401959|448888073|FG002|Enrolled|Withdrawal by Subject|0|||
124797122|NCT01401959|448888071|FG000|Treated|Disease Progression|2|||
124797123|NCT01401959|448888072|FG001|Treated|Disease Progression|2|||
124797124|NCT01401959|448888073|FG002|Treated|Disease Progression|1|||
124797125|NCT01401959|448888071|FG000|Treated|Adverse Event|4|||
124797126|NCT01401959|448888072|FG001|Treated|Adverse Event|3|||
124797127|NCT01401959|448888073|FG002|Treated|Adverse Event|2|||
125295558|NCT01659255|450709470|FG010|Overall Study|Progressive Disease|2|||
125295559|NCT01659255|450709471|FG011|Overall Study|Progressive Disease|3|||
125295560|NCT01659255|450709472|FG012|Overall Study|Progressive Disease|5|||
125295561|NCT01659255|450709473|FG013|Overall Study|Progressive Disease|13|||
124797128|NCT01401959|448888071|FG000|Treated|Withdrawal by Subject|1|||
124797129|NCT01401959|448888072|FG001|Treated|Withdrawal by Subject|2|||
124797130|NCT01401959|448888073|FG002|Treated|Withdrawal by Subject|2|||
124797131|NCT01401959|448888071|FG000|Treated|Protocol Violation|0|||
124797132|NCT01401959|448888072|FG001|Treated|Protocol Violation|1|||
124797133|NCT01401959|448888073|FG002|Treated|Protocol Violation|0|||
124797134|NCT03614975|448888080|FG000|Overall Study|Physician Decision|7|||
124797135|NCT03614975|448888081|FG001|Overall Study|Physician Decision|5|||
125295562|NCT01659255|450709474|FG014|Overall Study|Progressive Disease|6|||
124797136|NCT03614975|448888080|FG000|Overall Study|Withdrawal by Subject|2|||
124797137|NCT03614975|448888081|FG001|Overall Study|Withdrawal by Subject|2|||
124797138|NCT03614975|448888080|FG000|Overall Study|Specimens not in lab batch shipment|1|||
124797139|NCT03614975|448888081|FG001|Overall Study|Specimens not in lab batch shipment|1|||
124797140|NCT00450385|448888082|FG000|Overall Study|Death|3|||
124797141|NCT00450385|448888082|FG000|Overall Study|Protocol Violation|1|||
124797142|NCT00450385|448888082|FG000|Overall Study|Withdrawal by Subject|2|||
124797143|NCT00450385|448888082|FG000|Overall Study|Lack of Efficacy|2|||
124797144|NCT00450385|448888082|FG000|Overall Study|Adverse Event|1|||
124797145|NCT00450385|448888082|FG000|Overall Study|Physician Decision|1|||
124797146|NCT00450385|448888082|FG000|Overall Study|Other|3|||
124797147|NCT01569464|448888083|FG000|Overall Study|Adverse Event|4|||
124797148|NCT01569464|448888084|FG001|Overall Study|Adverse Event|0|||
124797149|NCT01569464|448888083|FG000|Overall Study|Lack of Efficacy|1|||
124797150|NCT01569464|448888084|FG001|Overall Study|Lack of Efficacy|0|||
124797151|NCT01569464|448888083|FG000|Overall Study|Protocol Violation|1|||
124797152|NCT01569464|448888084|FG001|Overall Study|Protocol Violation|0|||
124797153|NCT01569464|448888083|FG000|Overall Study|Lost to Follow-up|2|||
124797154|NCT01569464|448888084|FG001|Overall Study|Lost to Follow-up|3|||
124797155|NCT01569464|448888083|FG000|Overall Study|Withdrawal by Subject|1|||
124797156|NCT01569464|448888084|FG001|Overall Study|Withdrawal by Subject|1|||
124797157|NCT01569464|448888083|FG000|Overall Study|Other|1|||
124797158|NCT01569464|448888084|FG001|Overall Study|Other|1|||
124797159|NCT01390220|448888090|FG000|Test Dose Phase|Adverse Event|17|||
124797160|NCT01390220|448888091|FG001|Test Dose Phase|Adverse Event|0|||
124797161|NCT01390220|448888092|FG002|Test Dose Phase|Adverse Event|0|||
124797162|NCT01390220|448888090|FG000|Test Dose Phase|Withdrawal by Subject|8|||
124797163|NCT01390220|448888091|FG001|Test Dose Phase|Withdrawal by Subject|0|||
124797164|NCT01390220|448888092|FG002|Test Dose Phase|Withdrawal by Subject|0|||
124797165|NCT01390220|448888090|FG000|Test Dose Phase|Lost to Follow-up|2|||
124797166|NCT01390220|448888091|FG001|Test Dose Phase|Lost to Follow-up|0|||
124797167|NCT01390220|448888092|FG002|Test Dose Phase|Lost to Follow-up|0|||
124797168|NCT01390220|448888090|FG000|Test Dose Phase|Protocol Violation|8|||
124797169|NCT01390220|448888091|FG001|Test Dose Phase|Protocol Violation|0|||
124797170|NCT01390220|448888092|FG002|Test Dose Phase|Protocol Violation|0|||
124797171|NCT01390220|448888090|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
124797172|NCT01390220|448888091|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
124797173|NCT01390220|448888092|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
124797174|NCT01390220|448888090|FG000|Test Dose Phase|Study/Site closure|6|||
124797175|NCT01390220|448888091|FG001|Test Dose Phase|Study/Site closure|0|||
124797176|NCT01390220|448888092|FG002|Test Dose Phase|Study/Site closure|0|||
124797177|NCT01390220|448888090|FG000|Test Dose Phase|Caregiver no longer available|5|||
124797178|NCT01390220|448888091|FG001|Test Dose Phase|Caregiver no longer available|0|||
124797179|NCT01390220|448888092|FG002|Test Dose Phase|Caregiver no longer available|0|||
124797180|NCT01390220|448888090|FG000|Test Dose Phase|Noncompliance|2|||
124797181|NCT01390220|448888091|FG001|Test Dose Phase|Noncompliance|0|||
124797182|NCT01390220|448888092|FG002|Test Dose Phase|Noncompliance|0|||
124797183|NCT01390220|448888090|FG000|Test Dose Phase|Logistical|6|||
124797184|NCT01390220|448888091|FG001|Test Dose Phase|Logistical|0|||
124797185|NCT01390220|448888092|FG002|Test Dose Phase|Logistical|0|||
124797186|NCT01390220|448888090|FG000|Comparative Phase|Withdrawal by Subject|0|||
125295563|NCT01659255|450709475|FG015|Overall Study|Progressive Disease|2|||
125295564|NCT01659255|450709476|FG016|Overall Study|Progressive Disease|3|||
125295565|NCT01659255|450709460|FG000|Overall Study|Withdrew Consent|0|||
124797187|NCT01390220|448888091|FG001|Comparative Phase|Withdrawal by Subject|1|||
124797188|NCT01390220|448888092|FG002|Comparative Phase|Withdrawal by Subject|0|||
124797189|NCT03063203|448888093|FG000|Overall Study|Chose alternative therapy|3|||
124797190|NCT03063203|448888093|FG000|Overall Study|Death|2|||
124797191|NCT03063203|448888093|FG000|Overall Study|Disease progression|4|||
124797192|NCT03063203|448888093|FG000|Overall Study|Physician Decision|5|||
124797193|NCT04718103|448888094|FG000|Overall Study|Adverse Event|1|||
124797194|NCT04718103|448888095|FG001|Overall Study|Adverse Event|1|||
124797195|NCT04718103|448888094|FG000|Overall Study|Lack of Efficacy|4|||
124797196|NCT04718103|448888095|FG001|Overall Study|Lack of Efficacy|1|||
124797197|NCT04718103|448888094|FG000|Overall Study|Lost to Follow-up|2|||
124797198|NCT04718103|448888095|FG001|Overall Study|Lost to Follow-up|2|||
124797199|NCT04718103|448888094|FG000|Overall Study|Physician Decision|2|||
124797200|NCT04718103|448888095|FG001|Overall Study|Physician Decision|0|||
124797201|NCT04718103|448888094|FG000|Overall Study|Pregnancy|0|||
124797202|NCT04718103|448888095|FG001|Overall Study|Pregnancy|1|||
124797203|NCT04718103|448888094|FG000|Overall Study|Withdrawal by Subject|10|||
125295566|NCT01659255|450709461|FG001|Overall Study|Withdrew Consent|0|||
124797204|NCT04718103|448888095|FG001|Overall Study|Withdrawal by Subject|6|||
124797205|NCT04718103|448888094|FG000|Overall Study|Randomized, not treated|4|||
124797206|NCT04718103|448888095|FG001|Overall Study|Randomized, not treated|1|||
124797207|NCT04718103|448888094|FG000|Overall Study|GCP violations|7|||
124797208|NCT04718103|448888095|FG001|Overall Study|GCP violations|5|||
124797209|NCT00136604|448888096|FG000|Overall Study|Lost to Follow-up|1|||
124797210|NCT00136604|448888097|FG001|Overall Study|Lost to Follow-up|0|||
124797211|NCT00136604|448888098|FG002|Overall Study|Lost to Follow-up|0|||
124797212|NCT00136604|448888099|FG003|Overall Study|Lost to Follow-up|0|||
124797213|NCT00136604|448888100|FG004|Overall Study|Lost to Follow-up|1|||
124797214|NCT00136604|448888096|FG000|Overall Study|Migrated/moved from study area|0|||
124797215|NCT00136604|448888097|FG001|Overall Study|Migrated/moved from study area|1|||
124797216|NCT00136604|448888098|FG002|Overall Study|Migrated/moved from study area|0|||
124797217|NCT00136604|448888099|FG003|Overall Study|Migrated/moved from study area|0|||
124797218|NCT00136604|448888100|FG004|Overall Study|Migrated/moved from study area|0|||
124797219|NCT03631355|448888101|FG000|Overall Study|Lost to Follow-up|1|||
124797220|NCT03631355|448888102|FG001|Overall Study|Lost to Follow-up|2|||
124797221|NCT03640559|448888105|FG000|Overall Study|Physician Decision|1|||
124797222|NCT03640559|448888106|FG001|Overall Study|Physician Decision|1|||
124797223|NCT03640559|448888105|FG000|Overall Study|Withdrawal by Subject|1|||
124797224|NCT03640559|448888106|FG001|Overall Study|Withdrawal by Subject|0|||
124797225|NCT02125604|448888107|FG000|Overall Study|Other|4|||
124797226|NCT02125604|448888107|FG000|Overall Study|Investigator Decision|1|||
124797227|NCT02125604|448888107|FG000|Overall Study|Lost to Follow-up|2|||
124797228|NCT02125604|448888107|FG000|Overall Study|Consent Withdrawn|4|||
124797229|NCT02125604|448888107|FG000|Overall Study|Adverse Event|20|||
124797230|NCT01876810|448888110|FG000|Overall Study|Physician Decision|0|||
124797231|NCT01876810|448888111|FG001|Overall Study|Physician Decision|1|||
124797232|NCT00719264|448889733|FG000|Overall Study|Adverse Event|41|||
124797233|NCT00719264|448889734|FG001|Overall Study|Adverse Event|49|||
124797234|NCT00719264|448889733|FG000|Overall Study|Death|13|||
124797235|NCT00719264|448889734|FG001|Overall Study|Death|10|||
124797236|NCT00719264|448889733|FG000|Overall Study|Administrative Problems|6|||
124797237|NCT00719264|448889734|FG001|Overall Study|Administrative Problems|4|||
124797238|NCT00719264|448889733|FG000|Overall Study|Lost to Follow-up|1|||
124797239|NCT00719264|448889734|FG001|Overall Study|Lost to Follow-up|1|||
124797240|NCT00719264|448889733|FG000|Overall Study|Withdrawal by Subject|12|||
124797241|NCT00719264|448889734|FG001|Overall Study|Withdrawal by Subject|7|||
124797242|NCT00719264|448889733|FG000|Overall Study|Protocol Deviation|1|||
124797243|NCT00719264|448889734|FG001|Overall Study|Protocol Deviation|3|||
124797244|NCT00719264|448889733|FG000|Overall Study|New Cancer Therapy|4|||
124797245|NCT00719264|448889734|FG001|Overall Study|New Cancer Therapy|2|||
124797246|NCT00719264|448889733|FG000|Overall Study|Disease Progression|104|||
124797247|NCT00719264|448889734|FG001|Overall Study|Disease Progression|107|||
124797248|NCT03034200|448889735|FG000|Overall Study|Disease progression|8|||
124797249|NCT03034200|448889736|FG001|Overall Study|Disease progression|10|||
124797250|NCT03034200|448889737|FG002|Overall Study|Disease progression|4|||
124797251|NCT03034200|448889735|FG000|Overall Study|Physician Decision|2|||
124797252|NCT03034200|448889736|FG001|Overall Study|Physician Decision|0|||
124797253|NCT03034200|448889737|FG002|Overall Study|Physician Decision|3|||
124797254|NCT03034200|448889735|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
124797255|NCT03034200|448889736|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
124797256|NCT03034200|448889737|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
124797257|NCT03034200|448889735|FG000|Overall Study|Adjuvant Therapy|0|||
124797258|NCT03034200|448889736|FG001|Overall Study|Adjuvant Therapy|0|||
124797259|NCT03034200|448889737|FG002|Overall Study|Adjuvant Therapy|1|||
124797260|NCT05523323|448889738|FG000|Overall Study|Death|26|||
124797261|NCT05523323|448889739|FG001|Overall Study|Death|21|||
124797262|NCT05523323|448889738|FG000|Overall Study|Ongoing participants|35|||
124797263|NCT05523323|448889739|FG001|Overall Study|Ongoing participants|30|||
124797264|NCT03435640|448889740|FG000|Overall Study|Withdrawal by Subject|0|||
124797265|NCT03435640|448889741|FG001|Overall Study|Withdrawal by Subject|1|||
124797266|NCT03435640|448889742|FG002|Overall Study|Withdrawal by Subject|0|||
124797267|NCT03435640|448889743|FG003|Overall Study|Withdrawal by Subject|2|||
124797268|NCT03435640|448889744|FG004|Overall Study|Withdrawal by Subject|0|||
124797269|NCT03435640|448889745|FG005|Overall Study|Withdrawal by Subject|0|||
124797270|NCT03435640|448889746|FG006|Overall Study|Withdrawal by Subject|3|||
124797271|NCT03435640|448889747|FG007|Overall Study|Withdrawal by Subject|0|||
124797272|NCT03435640|448889748|FG008|Overall Study|Withdrawal by Subject|0|||
124797273|NCT03435640|448889749|FG009|Overall Study|Withdrawal by Subject|2|||
124797274|NCT03435640|448889750|FG010|Overall Study|Withdrawal by Subject|3|||
124797275|NCT03435640|448889740|FG000|Overall Study|Lost to Follow-up|0|||
124797276|NCT03435640|448889741|FG001|Overall Study|Lost to Follow-up|0|||
124797277|NCT03435640|448889742|FG002|Overall Study|Lost to Follow-up|1|||
124797278|NCT03435640|448889743|FG003|Overall Study|Lost to Follow-up|0|||
124797279|NCT03435640|448889744|FG004|Overall Study|Lost to Follow-up|0|||
124797280|NCT03435640|448889745|FG005|Overall Study|Lost to Follow-up|0|||
124797281|NCT03435640|448889746|FG006|Overall Study|Lost to Follow-up|0|||
124797282|NCT03435640|448889747|FG007|Overall Study|Lost to Follow-up|0|||
124797283|NCT03435640|448889748|FG008|Overall Study|Lost to Follow-up|0|||
124797284|NCT03435640|448889749|FG009|Overall Study|Lost to Follow-up|0|||
124797285|NCT03435640|448889750|FG010|Overall Study|Lost to Follow-up|0|||
124797286|NCT00920829|448889758|FG000|Allocation|No post randomization data|3|||
124797287|NCT00920829|448889759|FG001|Allocation|No post randomization data|1|||
124797288|NCT00920829|448889760|FG002|Allocation|No post randomization data|0|||
124797289|NCT00920829|448889761|FG003|Allocation|No post randomization data|2|||
124797290|NCT00920829|448889758|FG000|Available for Analysis|Withdrawal by Subject|6|||
124797291|NCT00920829|448889759|FG001|Available for Analysis|Withdrawal by Subject|6|||
124797292|NCT00920829|448889760|FG002|Available for Analysis|Withdrawal by Subject|6|||
124797293|NCT00920829|448889761|FG003|Available for Analysis|Withdrawal by Subject|10|||
124797294|NCT00920829|448889758|FG000|Available for Analysis|Required Medical Treatment|0|||
124797295|NCT00920829|448889759|FG001|Available for Analysis|Required Medical Treatment|1|||
124797296|NCT00920829|448889760|FG002|Available for Analysis|Required Medical Treatment|2|||
124797297|NCT00920829|448889761|FG003|Available for Analysis|Required Medical Treatment|0|||
124797298|NCT00920829|448889758|FG000|Available for Analysis|Adverse Event|1|||
124797299|NCT00920829|448889759|FG001|Available for Analysis|Adverse Event|2|||
124797300|NCT00920829|448889760|FG002|Available for Analysis|Adverse Event|1|||
124797301|NCT00920829|448889761|FG003|Available for Analysis|Adverse Event|0|||
124797302|NCT00920829|448889758|FG000|Available for Analysis|Death|1|||
124797303|NCT00920829|448889759|FG001|Available for Analysis|Death|0|||
124797304|NCT00920829|448889760|FG002|Available for Analysis|Death|0|||
124797305|NCT00920829|448889761|FG003|Available for Analysis|Death|0|||
124797306|NCT00920829|448889758|FG000|Available for Analysis|Protocol Violation|0|||
124797307|NCT00920829|448889759|FG001|Available for Analysis|Protocol Violation|0|||
124797308|NCT00920829|448889760|FG002|Available for Analysis|Protocol Violation|1|||
124797309|NCT00920829|448889761|FG003|Available for Analysis|Protocol Violation|0|||
124797310|NCT00920829|448889758|FG000|Available for Analysis|Required more treatment|0|||
124797311|NCT00920829|448889759|FG001|Available for Analysis|Required more treatment|2|||
124797312|NCT00920829|448889760|FG002|Available for Analysis|Required more treatment|0|||
124797313|NCT00920829|448889761|FG003|Available for Analysis|Required more treatment|1|||
124797314|NCT04533880|448889762|FG000|Overall Study|Lost to Follow-up|0|||
124797315|NCT04533880|448889763|FG001|Overall Study|Lost to Follow-up|1|||
124797316|NCT04533880|448889764|FG002|Overall Study|Lost to Follow-up|1|||
124797317|NCT01711879|448889769|FG000|Overall Study|Death|1|||
124797318|NCT01711879|448889770|FG001|Overall Study|Death|0|||
124797319|NCT02239224|448889773|FG000|Overall Study|Administrative|0|||
124797320|NCT02239224|448889774|FG001|Overall Study|Administrative|0|||
124797321|NCT02239224|448889775|FG002|Overall Study|Administrative|3|||
124797322|NCT02239224|448889776|FG003|Overall Study|Administrative|1|||
124797323|NCT03183778|448889779|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
124797324|NCT01466179|448889781|FG000|Overall Study|Ongoing in core study|2|||
124797325|NCT01466179|448889781|FG000|Overall Study|Physician Decision|46|||
124797326|NCT01466179|448889781|FG000|Overall Study|Progressive disease|43|||
124797327|NCT01466179|448889781|FG000|Overall Study|Adverse Event|32|||
124797328|NCT01466179|448889781|FG000|Overall Study|Disease relapse|23|||
124797329|NCT01466179|448889781|FG000|Overall Study|Lack of Efficacy|14|||
124797330|NCT01466179|448889781|FG000|Overall Study|Death|7|||
124797331|NCT01466179|448889781|FG000|Overall Study|Withdrawal by Subject|7|||
124797332|NCT01466179|448889781|FG000|Overall Study|Protocol Violation|2|||
124797333|NCT01466179|448889781|FG000|Overall Study|Other|3|||
124797334|NCT00749580|448889782|FG000|Overall Study|Lost to Follow-up|4|||
124797335|NCT00749580|448889783|FG001|Overall Study|Lost to Follow-up|8|||
124797336|NCT00749580|448889782|FG000|Overall Study|Adverse Event|0|||
124797337|NCT00749580|448889783|FG001|Overall Study|Adverse Event|1|||
124797338|NCT03868124|448889787|FG000|Overall Study|Withdrawal by Subject|4|||
124797339|NCT03868124|448889788|FG001|Overall Study|Withdrawal by Subject|0|||
124797340|NCT03868124|448889789|FG002|Overall Study|Withdrawal by Subject|1|||
124797341|NCT03868124|448889787|FG000|Overall Study|Physician Decision|1|||
124797342|NCT03868124|448889788|FG001|Overall Study|Physician Decision|0|||
124797343|NCT03868124|448889789|FG002|Overall Study|Physician Decision|1|||
124797344|NCT03868124|448889787|FG000|Overall Study|Lost to Follow-up|1|||
124797345|NCT03868124|448889788|FG001|Overall Study|Lost to Follow-up|1|||
124797346|NCT03868124|448889789|FG002|Overall Study|Lost to Follow-up|2|||
124797347|NCT03868124|448889787|FG000|Overall Study|Death|1|||
124797348|NCT03868124|448889788|FG001|Overall Study|Death|1|||
124797349|NCT03868124|448889789|FG002|Overall Study|Death|2|||
124797350|NCT03868124|448889787|FG000|Overall Study|Adverse Event|0|||
124797351|NCT03868124|448889788|FG001|Overall Study|Adverse Event|0|||
124797352|NCT03868124|448889789|FG002|Overall Study|Adverse Event|3|||
124797353|NCT03868124|448889787|FG000|Overall Study|Explanted|2|||
124797354|NCT03868124|448889788|FG001|Overall Study|Explanted|1|||
124797355|NCT03868124|448889789|FG002|Overall Study|Explanted|0|||
124797356|NCT03868124|448889787|FG000|Overall Study|Ongoing in study|176|||
124797357|NCT03868124|448889788|FG001|Overall Study|Ongoing in study|180|||
124797358|NCT03868124|448889789|FG002|Overall Study|Ongoing in study|183|||
124797359|NCT04565236|448889790|FG000|Overall Study|Patient/Guardian Decision|0|||
124797360|NCT04565236|448889791|FG001|Overall Study|Patient/Guardian Decision|0|||
124797361|NCT04565236|448889792|FG002|Overall Study|Patient/Guardian Decision|1|||
124797362|NCT04565236|448889793|FG003|Overall Study|Patient/Guardian Decision|0|||
124797363|NCT01117051|448889794|FG000|Overall Study|Withdrawal by Subject|5|||
124797364|NCT01117051|448889795|FG001|Overall Study|Withdrawal by Subject|3|||
124797365|NCT01117051|448889794|FG000|Overall Study|Adverse Event|4|||
124797366|NCT01117051|448889795|FG001|Overall Study|Adverse Event|3|||
124797367|NCT01117051|448889794|FG000|Overall Study|Lost to Follow-up|0|||
124797368|NCT01117051|448889795|FG001|Overall Study|Lost to Follow-up|1|||
124797369|NCT01117051|448889794|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
124797370|NCT01117051|448889795|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
124797371|NCT01117051|448889794|FG000|Overall Study|Sponsor's decision|3|||
124797372|NCT01117051|448889795|FG001|Overall Study|Sponsor's decision|1|||
124797373|NCT01117051|448889794|FG000|Overall Study|Surgical procedure|0|||
124797374|NCT01117051|448889795|FG001|Overall Study|Surgical procedure|1|||
124797375|NCT01117051|448889794|FG000|Overall Study|Randomized by mistake|0|||
124797376|NCT01117051|448889795|FG001|Overall Study|Randomized by mistake|1|||
124797377|NCT01117051|448889794|FG000|Overall Study|Convenience issue|1|||
124797378|NCT01117051|448889795|FG001|Overall Study|Convenience issue|0|||
124797379|NCT00206076|448889797|FG000|Overall Study|Physician Decision|2|||
124797380|NCT00206076|448889798|FG001|Overall Study|Physician Decision|0|||
124797381|NCT00206076|448889797|FG000|Overall Study|Withdrawal by Subject|1|||
124797382|NCT00206076|448889798|FG001|Overall Study|Withdrawal by Subject|1|||
124797383|NCT00366340|448889801|FG000|Infant Series|Protocol Violation|3|||
124797384|NCT00366340|448889802|FG001|Infant Series|Protocol Violation|4|||
124797385|NCT00366340|448889801|FG000|Infant Series|Withdrawal by Subject|3|||
124797386|NCT00366340|448889802|FG001|Infant Series|Withdrawal by Subject|3|||
124797387|NCT00366340|448889801|FG000|Infant Series|Adverse Event|0|||
124797388|NCT00366340|448889802|FG001|Infant Series|Adverse Event|2|||
124797389|NCT00366340|448889801|FG000|Infant Series|Lost to Follow-up|1|||
124797390|NCT00366340|448889802|FG001|Infant Series|Lost to Follow-up|1|||
124797391|NCT00366340|448889801|FG000|Infant Series|Failure to return|1|||
124797392|NCT00366340|448889802|FG001|Infant Series|Failure to return|0|||
124797393|NCT00366340|448889801|FG000|After the Infant Series|Parent/legal guardian request|1|||
124797394|NCT00366340|448889802|FG001|After the Infant Series|Parent/legal guardian request|1|||
124797395|NCT00366340|448889801|FG000|After the Infant Series|Failed to return|0|||
124797396|NCT00366340|448889802|FG001|After the Infant Series|Failed to return|1|||
124797397|NCT00366340|448889801|FG000|After the Infant Series|Protocol Violation|2|||
124797398|NCT00366340|448889802|FG001|After the Infant Series|Protocol Violation|2|||
124797399|NCT00366340|448889801|FG000|After the Infant Series|Adverse Event|0|||
124797400|NCT00366340|448889802|FG001|After the Infant Series|Adverse Event|1|||
124797401|NCT00366340|448889801|FG000|After the Infant Series|Lost to Follow-up|0|||
124797402|NCT00366340|448889802|FG001|After the Infant Series|Lost to Follow-up|1|||
124797403|NCT00366340|448889801|FG000|Toddler Dose|Failed to return|1|||
124797404|NCT00366340|448889802|FG001|Toddler Dose|Failed to return|0|||
124797405|NCT00366340|448889801|FG000|Toddler Dose|Parent/legal guardian request|0|||
124797406|NCT00366340|448889802|FG001|Toddler Dose|Parent/legal guardian request|1|||
124797407|NCT03355664|448889803|FG000|Overall Study|Adverse Event|1|||
124797408|NCT03355664|448889804|FG001|Overall Study|Adverse Event|2|||
124797409|NCT03355664|448889803|FG000|Overall Study|Lost to Follow-up|11|||
124797410|NCT03355664|448889804|FG001|Overall Study|Lost to Follow-up|7|||
124797411|NCT03355664|448889803|FG000|Overall Study|Protocol Violation|1|||
124797412|NCT03355664|448889804|FG001|Overall Study|Protocol Violation|2|||
124797413|NCT03355664|448889803|FG000|Overall Study|Withdrawal by Subject|2|||
124797414|NCT03355664|448889804|FG001|Overall Study|Withdrawal by Subject|1|||
124797415|NCT01315236|448889810|FG000|Double-blind Phase|Death|1|||
124797416|NCT01315236|448889811|FG001|Double-blind Phase|Death|0|||
125295567|NCT01659255|450709462|FG002|Overall Study|Withdrew Consent|0|||
124797417|NCT01315236|448889810|FG000|Double-blind Phase|Adverse Event|1|||
124797418|NCT01315236|448889811|FG001|Double-blind Phase|Adverse Event|0|||
124797419|NCT01315236|448889810|FG000|Double-blind Phase|Withdrawal of Consent|1|||
124797420|NCT01315236|448889811|FG001|Double-blind Phase|Withdrawal of Consent|0|||
124797421|NCT01315236|448889810|FG000|Double-blind Phase|Lost to Follow-up|1|||
124797422|NCT01315236|448889811|FG001|Double-blind Phase|Lost to Follow-up|0|||
124797423|NCT01315236|448889810|FG000|Open-label Phase|Death|1|||
124797424|NCT01315236|448889811|FG001|Open-label Phase|Death|0|||
124797425|NCT01315236|448889810|FG000|Open-label Phase|Adverse Event|0|||
124797426|NCT01315236|448889811|FG001|Open-label Phase|Adverse Event|1|||
124797427|NCT01315236|448889810|FG000|Open-label Phase|Other|0|||
124797428|NCT01315236|448889811|FG001|Open-label Phase|Other|1|||
124797429|NCT01315236|448889810|FG000|12-Month Follow-up Period|Death|0|||
124797430|NCT01315236|448889811|FG001|12-Month Follow-up Period|Death|1|||
124797431|NCT01315236|448889810|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
124797432|NCT01315236|448889811|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
124797433|NCT01751802|448889812|FG000|Overall Study|Adverse Event|4|||
124797434|NCT01751802|448889813|FG001|Overall Study|Adverse Event|2|||
124797435|NCT00589784|448889816|FG000|Overall Study|Withdrawal by Subject|0|||
124797436|NCT00589784|448889817|FG001|Overall Study|Withdrawal by Subject|6|||
124797437|NCT00589784|448889816|FG000|Overall Study|Patient inevaluable|1|||
124797438|NCT00589784|448889817|FG001|Overall Study|Patient inevaluable|0|||
124797439|NCT00589784|448889816|FG000|Overall Study|Adverse Event|0|||
124797440|NCT00589784|448889817|FG001|Overall Study|Adverse Event|4|||
124797441|NCT00521001|448889818|FG000|Overall Study|Ineligible|1|||
124797442|NCT02821910|448889820|FG000|Overall Study|Withdrawal by Subject|0|||
124797443|NCT02821910|448889821|FG001|Overall Study|Withdrawal by Subject|0|||
124797444|NCT02821910|448889822|FG002|Overall Study|Withdrawal by Subject|1|||
124797445|NCT02821910|448889823|FG003|Overall Study|Withdrawal by Subject|0|||
124797446|NCT02821910|448889824|FG004|Overall Study|Withdrawal by Subject|0|||
124797447|NCT02821910|448889825|FG005|Overall Study|Withdrawal by Subject|1|||
124797448|NCT02821910|448889820|FG000|Overall Study|Other than specified|1|||
124797449|NCT02821910|448889821|FG001|Overall Study|Other than specified|0|||
124797450|NCT02821910|448889822|FG002|Overall Study|Other than specified|1|||
124797451|NCT02821910|448889823|FG003|Overall Study|Other than specified|0|||
124797452|NCT02821910|448889824|FG004|Overall Study|Other than specified|0|||
124797453|NCT02821910|448889825|FG005|Overall Study|Other than specified|0|||
124797454|NCT00287079|448889826|FG000|Overall Study|Qualifying relapse|12|||
124797455|NCT00287079|448889827|FG001|Overall Study|Qualifying relapse|1|||
124797456|NCT00287079|448889826|FG000|Overall Study|Non-qualifying relapse|1|||
124797457|NCT00287079|448889827|FG001|Overall Study|Non-qualifying relapse|0|||
124797458|NCT00287079|448889826|FG000|Overall Study|Adverse Event|5|||
124797459|NCT00287079|448889827|FG001|Overall Study|Adverse Event|0|||
124797460|NCT00287079|448889826|FG000|Overall Study|Protocol Violation|1|||
124797461|NCT00287079|448889827|FG001|Overall Study|Protocol Violation|0|||
124797462|NCT00287079|448889826|FG000|Overall Study|Other|3|||
124797463|NCT00287079|448889827|FG001|Overall Study|Other|0|||
124797464|NCT01082640|448889830|FG000|Overall Study|Adverse Event|9|||
124797465|NCT01082640|448889831|FG001|Overall Study|Adverse Event|5|||
124797466|NCT01082640|448889832|FG002|Overall Study|Adverse Event|3|||
124797467|NCT01082640|448889830|FG000|Overall Study|Withdrawal by Subject|3|||
124797468|NCT01082640|448889831|FG001|Overall Study|Withdrawal by Subject|3|||
124797469|NCT01082640|448889832|FG002|Overall Study|Withdrawal by Subject|2|||
124797470|NCT01082640|448889830|FG000|Overall Study|Major protocol deviation|3|||
124797471|NCT01082640|448889831|FG001|Overall Study|Major protocol deviation|3|||
124797472|NCT01082640|448889832|FG002|Overall Study|Major protocol deviation|0|||
124797473|NCT01082640|448889830|FG000|Overall Study|Lost to Follow-up|0|||
124797474|NCT01082640|448889831|FG001|Overall Study|Lost to Follow-up|3|||
124797475|NCT01082640|448889832|FG002|Overall Study|Lost to Follow-up|0|||
124797476|NCT01082640|448889830|FG000|Overall Study|Other|2|||
124797477|NCT01082640|448889831|FG001|Overall Study|Other|1|||
124797478|NCT01082640|448889832|FG002|Overall Study|Other|3|||
124797479|NCT01282203|448889837|FG000|Overall Study|Adverse Event|1|||
124797480|NCT02129777|448889841|FG000|Double-Blind Period|Adverse Event|0|||
124797481|NCT02129777|448889842|FG001|Double-Blind Period|Adverse Event|0|||
124797482|NCT02129777|448889843|FG002|Double-Blind Period|Adverse Event|0|||
124797483|NCT02129777|448889844|FG003|Double-Blind Period|Adverse Event|0|||
124797484|NCT02129777|448889845|FG004|Double-Blind Period|Adverse Event|1|||
124797485|NCT02129777|448889846|FG005|Double-Blind Period|Adverse Event|0|||
124797486|NCT02129777|448889847|FG006|Double-Blind Period|Adverse Event|0|||
124797487|NCT02129777|448889841|FG000|Double-Blind Period|Lost to Follow-up|1|||
124797488|NCT02129777|448889842|FG001|Double-Blind Period|Lost to Follow-up|1|||
124797489|NCT02129777|448889843|FG002|Double-Blind Period|Lost to Follow-up|1|||
124797490|NCT02129777|448889844|FG003|Double-Blind Period|Lost to Follow-up|2|||
124797491|NCT02129777|448889845|FG004|Double-Blind Period|Lost to Follow-up|0|||
124797492|NCT02129777|448889846|FG005|Double-Blind Period|Lost to Follow-up|0|||
124797493|NCT02129777|448889847|FG006|Double-Blind Period|Lost to Follow-up|0|||
124797494|NCT02129777|448889841|FG000|Double-Blind Period|Withdrawal by Subject|2|||
124797495|NCT02129777|448889842|FG001|Double-Blind Period|Withdrawal by Subject|4|||
124797496|NCT02129777|448889843|FG002|Double-Blind Period|Withdrawal by Subject|3|||
124797497|NCT02129777|448889844|FG003|Double-Blind Period|Withdrawal by Subject|2|||
124797498|NCT02129777|448889845|FG004|Double-Blind Period|Withdrawal by Subject|3|||
124797499|NCT02129777|448889846|FG005|Double-Blind Period|Withdrawal by Subject|0|||
124797500|NCT02129777|448889847|FG006|Double-Blind Period|Withdrawal by Subject|0|||
124797501|NCT02129777|448889841|FG000|Double-Blind Period|Pregnancy|0|||
124797502|NCT02129777|448889842|FG001|Double-Blind Period|Pregnancy|0|||
124797503|NCT02129777|448889843|FG002|Double-Blind Period|Pregnancy|0|||
124797504|NCT02129777|448889844|FG003|Double-Blind Period|Pregnancy|0|||
124797505|NCT02129777|448889845|FG004|Double-Blind Period|Pregnancy|1|||
124797506|NCT02129777|448889846|FG005|Double-Blind Period|Pregnancy|0|||
124797507|NCT02129777|448889847|FG006|Double-Blind Period|Pregnancy|0|||
124797508|NCT02129777|448889841|FG000|Double-Blind Period|Lack of Efficacy|3|||
124797509|NCT02129777|448889842|FG001|Double-Blind Period|Lack of Efficacy|1|||
124797510|NCT02129777|448889843|FG002|Double-Blind Period|Lack of Efficacy|0|||
124797511|NCT02129777|448889844|FG003|Double-Blind Period|Lack of Efficacy|3|||
125295568|NCT01659255|450709463|FG003|Overall Study|Withdrew Consent|0|||
124797512|NCT02129777|448889845|FG004|Double-Blind Period|Lack of Efficacy|2|||
124797513|NCT02129777|448889846|FG005|Double-Blind Period|Lack of Efficacy|0|||
124797514|NCT02129777|448889847|FG006|Double-Blind Period|Lack of Efficacy|0|||
124797515|NCT02129777|448889841|FG000|Double-Blind Period|Other|1|||
124797516|NCT02129777|448889842|FG001|Double-Blind Period|Other|2|||
124797517|NCT02129777|448889843|FG002|Double-Blind Period|Other|0|||
124797518|NCT02129777|448889844|FG003|Double-Blind Period|Other|0|||
124797519|NCT02129777|448889845|FG004|Double-Blind Period|Other|0|||
124797520|NCT02129777|448889846|FG005|Double-Blind Period|Other|0|||
125295569|NCT01659255|450709464|FG004|Overall Study|Withdrew Consent|0|||
125295570|NCT01659255|450709465|FG005|Overall Study|Withdrew Consent|0|||
124797521|NCT02129777|448889847|FG006|Double-Blind Period|Other|0|||
124797522|NCT02129777|448889841|FG000|Open-Label Period|Lack of Efficacy|0|||
124797523|NCT02129777|448889842|FG001|Open-Label Period|Lack of Efficacy|0|||
124797524|NCT02129777|448889843|FG002|Open-Label Period|Lack of Efficacy|0|||
124797525|NCT02129777|448889844|FG003|Open-Label Period|Lack of Efficacy|0|||
124797526|NCT02129777|448889845|FG004|Open-Label Period|Lack of Efficacy|0|||
124797527|NCT02129777|448889846|FG005|Open-Label Period|Lack of Efficacy|0|||
124797528|NCT02129777|448889847|FG006|Open-Label Period|Lack of Efficacy|5|||
124797529|NCT02129777|448889841|FG000|Open-Label Period|Lost to Follow-up|0|||
124797530|NCT02129777|448889842|FG001|Open-Label Period|Lost to Follow-up|0|||
124797531|NCT02129777|448889843|FG002|Open-Label Period|Lost to Follow-up|0|||
124797532|NCT02129777|448889844|FG003|Open-Label Period|Lost to Follow-up|0|||
124797533|NCT02129777|448889845|FG004|Open-Label Period|Lost to Follow-up|0|||
124797534|NCT02129777|448889846|FG005|Open-Label Period|Lost to Follow-up|1|||
124797535|NCT02129777|448889847|FG006|Open-Label Period|Lost to Follow-up|1|||
124797536|NCT02129777|448889841|FG000|Open-Label Period|Withdrawal by Subject|0|||
124797537|NCT02129777|448889842|FG001|Open-Label Period|Withdrawal by Subject|0|||
124797538|NCT02129777|448889843|FG002|Open-Label Period|Withdrawal by Subject|0|||
124797539|NCT02129777|448889844|FG003|Open-Label Period|Withdrawal by Subject|0|||
124797540|NCT02129777|448889845|FG004|Open-Label Period|Withdrawal by Subject|0|||
124797541|NCT02129777|448889846|FG005|Open-Label Period|Withdrawal by Subject|1|||
124797542|NCT02129777|448889847|FG006|Open-Label Period|Withdrawal by Subject|3|||
124797543|NCT02129777|448889841|FG000|Open-Label Period|Study Termination|0|||
124797544|NCT02129777|448889842|FG001|Open-Label Period|Study Termination|0|||
124797545|NCT02129777|448889843|FG002|Open-Label Period|Study Termination|0|||
124797546|NCT02129777|448889844|FG003|Open-Label Period|Study Termination|0|||
124797547|NCT02129777|448889845|FG004|Open-Label Period|Study Termination|0|||
124797548|NCT02129777|448889846|FG005|Open-Label Period|Study Termination|10|||
124797549|NCT02129777|448889847|FG006|Open-Label Period|Study Termination|39|||
124797550|NCT00542451|448889851|FG000|Overall Study|Adverse Event|31|||
124797551|NCT00542451|448889851|FG000|Overall Study|Withdrawal by Subject|30|||
124797552|NCT00542451|448889851|FG000|Overall Study|Physician Decision|4|||
124797553|NCT00542451|448889851|FG000|Overall Study|Recurrent disease|1|||
124797554|NCT00542451|448889851|FG000|Overall Study|unknown reason|1|||
124797555|NCT00542451|448889851|FG000|Overall Study|Death|2|||
124797556|NCT00542451|448889851|FG000|Overall Study|Lost to Follow-up|10|||
124797557|NCT00064298|448889860|FG000|Overall Study|Withdrawal by Subject|2|||
124797558|NCT00064298|448889861|FG001|Overall Study|Withdrawal by Subject|1|||
124797559|NCT00064298|448889860|FG000|Overall Study|Lost to Follow-up|2|||
124797560|NCT00064298|448889861|FG001|Overall Study|Lost to Follow-up|2|||
124797561|NCT00064298|448889860|FG000|Overall Study|Death|0|||
124797562|NCT00064298|448889861|FG001|Overall Study|Death|1|||
124797563|NCT00064298|448889860|FG000|Overall Study|Disease Progression|2|||
124797564|NCT00064298|448889861|FG001|Overall Study|Disease Progression|1|||
124797565|NCT01856023|448889862|FG000|Overall Study|Death|1|||
124797566|NCT01856023|448889863|FG001|Overall Study|Death|2|||
124797567|NCT01856023|448889862|FG000|Overall Study|Adverse Event|2|||
124797568|NCT01856023|448889863|FG001|Overall Study|Adverse Event|1|||
124797569|NCT01856023|448889862|FG000|Overall Study|Lack of Efficacy|5|||
124797570|NCT01856023|448889863|FG001|Overall Study|Lack of Efficacy|5|||
124797571|NCT01856023|448889862|FG000|Overall Study|non compliance, study closure|1|||
124797572|NCT01856023|448889863|FG001|Overall Study|non compliance, study closure|3|||
124797573|NCT01856023|448889862|FG000|Overall Study|Withdrawal by Subject|1|||
124797574|NCT01856023|448889863|FG001|Overall Study|Withdrawal by Subject|1|||
124797575|NCT00322153|448889866|FG000|Overall Study|Adverse Event|21|||
124797576|NCT00322153|448889867|FG001|Overall Study|Adverse Event|34|||
124797577|NCT00322153|448889866|FG000|Overall Study|Protocol Violation|6|||
124797578|NCT00322153|448889867|FG001|Overall Study|Protocol Violation|14|||
124797579|NCT00322153|448889866|FG000|Overall Study|Withdrawal by Subject|18|||
124797580|NCT00322153|448889867|FG001|Overall Study|Withdrawal by Subject|10|||
124797581|NCT00322153|448889866|FG000|Overall Study|Lack of Efficacy|8|||
124797582|NCT00322153|448889867|FG001|Overall Study|Lack of Efficacy|3|||
124797583|NCT00322153|448889866|FG000|Overall Study|Lost to Follow-up|5|||
124797584|NCT00322153|448889867|FG001|Overall Study|Lost to Follow-up|4|||
124797585|NCT00322153|448889866|FG000|Overall Study|Withdrawn for other reasons|5|||
124797586|NCT00322153|448889867|FG001|Overall Study|Withdrawn for other reasons|4|||
124797587|NCT01309893|448889868|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
124797588|NCT01309893|448889869|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
125295571|NCT01659255|450709466|FG006|Overall Study|Withdrew Consent|0|||
125295572|NCT01659255|450709467|FG007|Overall Study|Withdrew Consent|0|||
125295573|NCT01659255|450709468|FG008|Overall Study|Withdrew Consent|0|||
125295574|NCT01659255|450709469|FG009|Overall Study|Withdrew Consent|0|||
125295575|NCT01659255|450709470|FG010|Overall Study|Withdrew Consent|1|||
124797589|NCT01309893|448889868|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
124797590|NCT01309893|448889869|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
125295576|NCT01659255|450709471|FG011|Overall Study|Withdrew Consent|0|||
125295577|NCT01659255|450709472|FG012|Overall Study|Withdrew Consent|0|||
125295578|NCT01659255|450709473|FG013|Overall Study|Withdrew Consent|1|||
125295579|NCT01659255|450709474|FG014|Overall Study|Withdrew Consent|0|||
125295580|NCT01659255|450709475|FG015|Overall Study|Withdrew Consent|0|||
125295581|NCT01659255|450709476|FG016|Overall Study|Withdrew Consent|0|||
125295582|NCT01659255|450709460|FG000|Overall Study|Investigator Decision|0|||
125295583|NCT01659255|450709461|FG001|Overall Study|Investigator Decision|0|||
125295584|NCT01659255|450709462|FG002|Overall Study|Investigator Decision|0|||
125295585|NCT01659255|450709463|FG003|Overall Study|Investigator Decision|0|||
125295586|NCT01659255|450709464|FG004|Overall Study|Investigator Decision|0|||
125295587|NCT01659255|450709465|FG005|Overall Study|Investigator Decision|0|||
125295588|NCT01659255|450709466|FG006|Overall Study|Investigator Decision|0|||
125295589|NCT01659255|450709467|FG007|Overall Study|Investigator Decision|0|||
125295590|NCT01659255|450709468|FG008|Overall Study|Investigator Decision|0|||
125295591|NCT01659255|450709469|FG009|Overall Study|Investigator Decision|0|||
125295592|NCT01659255|450709470|FG010|Overall Study|Investigator Decision|0|||
125295593|NCT01659255|450709471|FG011|Overall Study|Investigator Decision|0|||
125295594|NCT01659255|450709472|FG012|Overall Study|Investigator Decision|1|||
125295595|NCT01659255|450709473|FG013|Overall Study|Investigator Decision|1|||
125295596|NCT01659255|450709474|FG014|Overall Study|Investigator Decision|0|||
125295597|NCT01659255|450709475|FG015|Overall Study|Investigator Decision|0|||
125295598|NCT01659255|450709476|FG016|Overall Study|Investigator Decision|0|||
125295599|NCT01659255|450709460|FG000|Overall Study|Sponsor's Decision|0|||
125295600|NCT01659255|450709461|FG001|Overall Study|Sponsor's Decision|0|||
125295601|NCT01659255|450709462|FG002|Overall Study|Sponsor's Decision|0|||
125295602|NCT01659255|450709463|FG003|Overall Study|Sponsor's Decision|0|||
125295603|NCT01659255|450709464|FG004|Overall Study|Sponsor's Decision|0|||
125295604|NCT01659255|450709465|FG005|Overall Study|Sponsor's Decision|0|||
125295605|NCT01659255|450709466|FG006|Overall Study|Sponsor's Decision|1|||
125295606|NCT01659255|450709467|FG007|Overall Study|Sponsor's Decision|0|||
125295607|NCT01659255|450709468|FG008|Overall Study|Sponsor's Decision|0|||
125295608|NCT01659255|450709469|FG009|Overall Study|Sponsor's Decision|0|||
125295609|NCT01659255|450709470|FG010|Overall Study|Sponsor's Decision|0|||
125295610|NCT01659255|450709471|FG011|Overall Study|Sponsor's Decision|0|||
125295611|NCT01659255|450709472|FG012|Overall Study|Sponsor's Decision|0|||
125295612|NCT01659255|450709473|FG013|Overall Study|Sponsor's Decision|0|||
125295613|NCT01659255|450709474|FG014|Overall Study|Sponsor's Decision|0|||
125295614|NCT01659255|450709475|FG015|Overall Study|Sponsor's Decision|0|||
125295615|NCT01659255|450709476|FG016|Overall Study|Sponsor's Decision|0|||
125295616|NCT01659255|450709460|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295617|NCT01659255|450709461|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295618|NCT01659255|450709462|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295619|NCT01659255|450709463|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295620|NCT01659255|450709464|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295621|NCT01659255|450709465|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295622|NCT01659255|450709466|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295623|NCT01659255|450709467|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295624|NCT01659255|450709468|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295625|NCT01659255|450709469|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295626|NCT01659255|450709470|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295627|NCT01659255|450709471|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295628|NCT01659255|450709472|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295629|NCT01659255|450709473|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295630|NCT01659255|450709474|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295631|NCT01659255|450709475|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
125295632|NCT01659255|450709476|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
124797591|NCT02414139|448889870|FG000|Treatment Period|Adverse Event|11|||
124797592|NCT02414139|448889871|FG001|Treatment Period|Adverse Event|6|||
124797593|NCT02414139|448889872|FG002|Treatment Period|Adverse Event|8|||
124797594|NCT02414139|448889873|FG003|Treatment Period|Adverse Event|5|||
124797595|NCT02414139|448889874|FG004|Treatment Period|Adverse Event|14|||
124797596|NCT02414139|448889875|FG005|Treatment Period|Adverse Event|3|||
124797597|NCT02414139|448889876|FG006|Treatment Period|Adverse Event|6|||
124797598|NCT02414139|448889877|FG007|Treatment Period|Adverse Event|1|||
124797599|NCT02414139|448889878|FG008|Treatment Period|Adverse Event|6|||
124797600|NCT02414139|448889879|FG009|Treatment Period|Adverse Event|8|||
124797601|NCT02414139|448889870|FG000|Treatment Period|Death|0|||
124797602|NCT02414139|448889871|FG001|Treatment Period|Death|0|||
124797603|NCT02414139|448889872|FG002|Treatment Period|Death|1|||
124797604|NCT02414139|448889873|FG003|Treatment Period|Death|1|||
124797605|NCT02414139|448889874|FG004|Treatment Period|Death|0|||
124797606|NCT02414139|448889875|FG005|Treatment Period|Death|0|||
124797607|NCT02414139|448889876|FG006|Treatment Period|Death|0|||
124797608|NCT02414139|448889877|FG007|Treatment Period|Death|0|||
124797609|NCT02414139|448889878|FG008|Treatment Period|Death|0|||
124797610|NCT02414139|448889879|FG009|Treatment Period|Death|1|||
124797611|NCT02414139|448889870|FG000|Treatment Period|Physician Decision|5|||
124797612|NCT02414139|448889871|FG001|Treatment Period|Physician Decision|4|||
124797613|NCT02414139|448889872|FG002|Treatment Period|Physician Decision|6|||
124797614|NCT02414139|448889873|FG003|Treatment Period|Physician Decision|1|||
124797615|NCT02414139|448889874|FG004|Treatment Period|Physician Decision|4|||
124797616|NCT02414139|448889875|FG005|Treatment Period|Physician Decision|0|||
124797617|NCT02414139|448889876|FG006|Treatment Period|Physician Decision|2|||
124797618|NCT02414139|448889877|FG007|Treatment Period|Physician Decision|0|||
124797619|NCT02414139|448889878|FG008|Treatment Period|Physician Decision|1|||
124797620|NCT02414139|448889879|FG009|Treatment Period|Physician Decision|4|||
124797621|NCT02414139|448889870|FG000|Treatment Period|Progressive disease|48|||
124797622|NCT02414139|448889871|FG001|Treatment Period|Progressive disease|31|||
124797623|NCT02414139|448889872|FG002|Treatment Period|Progressive disease|37|||
124797624|NCT02414139|448889873|FG003|Treatment Period|Progressive disease|21|||
124797625|NCT02414139|448889874|FG004|Treatment Period|Progressive disease|43|||
124797626|NCT02414139|448889875|FG005|Treatment Period|Progressive disease|12|||
124797627|NCT02414139|448889876|FG006|Treatment Period|Progressive disease|16|||
124797628|NCT02414139|448889877|FG007|Treatment Period|Progressive disease|2|||
124797629|NCT02414139|448889878|FG008|Treatment Period|Progressive disease|20|||
124797630|NCT02414139|448889879|FG009|Treatment Period|Progressive disease|14|||
124797631|NCT02414139|448889870|FG000|Treatment Period|Protocol deviation|0|||
124797632|NCT02414139|448889871|FG001|Treatment Period|Protocol deviation|0|||
124797633|NCT02414139|448889872|FG002|Treatment Period|Protocol deviation|1|||
124797634|NCT02414139|448889873|FG003|Treatment Period|Protocol deviation|0|||
124797635|NCT02414139|448889874|FG004|Treatment Period|Protocol deviation|0|||
124797636|NCT02414139|448889875|FG005|Treatment Period|Protocol deviation|0|||
124797637|NCT02414139|448889876|FG006|Treatment Period|Protocol deviation|0|||
124797638|NCT02414139|448889877|FG007|Treatment Period|Protocol deviation|0|||
124797639|NCT02414139|448889878|FG008|Treatment Period|Protocol deviation|0|||
124797640|NCT02414139|448889879|FG009|Treatment Period|Protocol deviation|0|||
124797641|NCT02414139|448889870|FG000|Treatment Period|Subject/Guardian decision|5|||
124797642|NCT02414139|448889871|FG001|Treatment Period|Subject/Guardian decision|1|||
124797643|NCT02414139|448889872|FG002|Treatment Period|Subject/Guardian decision|1|||
124797644|NCT02414139|448889873|FG003|Treatment Period|Subject/Guardian decision|2|||
124797645|NCT02414139|448889874|FG004|Treatment Period|Subject/Guardian decision|5|||
124797646|NCT02414139|448889875|FG005|Treatment Period|Subject/Guardian decision|0|||
124797647|NCT02414139|448889876|FG006|Treatment Period|Subject/Guardian decision|2|||
124797648|NCT02414139|448889877|FG007|Treatment Period|Subject/Guardian decision|0|||
124797649|NCT02414139|448889878|FG008|Treatment Period|Subject/Guardian decision|1|||
124797650|NCT02414139|448889879|FG009|Treatment Period|Subject/Guardian decision|1|||
124797651|NCT02414139|448889870|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
124797652|NCT02414139|448889871|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
124797653|NCT02414139|448889872|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
124797654|NCT02414139|448889873|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
124797655|NCT02414139|448889874|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
124797656|NCT02414139|448889875|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
124797657|NCT02414139|448889876|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
124797658|NCT02414139|448889877|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
124797659|NCT02414139|448889878|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
124797660|NCT02414139|448889879|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
124797661|NCT02414139|448889870|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
124797662|NCT02414139|448889871|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
124797663|NCT02414139|448889872|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
124797664|NCT02414139|448889873|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
124797665|NCT02414139|448889874|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
124797666|NCT02414139|448889875|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
124797667|NCT02414139|448889876|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
124797668|NCT02414139|448889877|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
124797669|NCT02414139|448889878|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
124797670|NCT02414139|448889879|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
124797671|NCT02414139|448889870|FG000|Post-treatment Efficacy Follow-up|Death|0|||
124797672|NCT02414139|448889871|FG001|Post-treatment Efficacy Follow-up|Death|1|||
124797673|NCT02414139|448889872|FG002|Post-treatment Efficacy Follow-up|Death|0|||
124797674|NCT02414139|448889873|FG003|Post-treatment Efficacy Follow-up|Death|0|||
124797675|NCT02414139|448889874|FG004|Post-treatment Efficacy Follow-up|Death|1|||
124797676|NCT02414139|448889875|FG005|Post-treatment Efficacy Follow-up|Death|0|||
124797677|NCT02414139|448889876|FG006|Post-treatment Efficacy Follow-up|Death|0|||
124797678|NCT02414139|448889877|FG007|Post-treatment Efficacy Follow-up|Death|0|||
124797679|NCT02414139|448889878|FG008|Post-treatment Efficacy Follow-up|Death|0|||
124797680|NCT02414139|448889879|FG009|Post-treatment Efficacy Follow-up|Death|1|||
124797681|NCT02414139|448889870|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
124797682|NCT02414139|448889871|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
124797683|NCT02414139|448889872|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
124797684|NCT02414139|448889873|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
124797685|NCT02414139|448889874|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
124797686|NCT02414139|448889875|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
124797687|NCT02414139|448889876|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
124797688|NCT02414139|448889877|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
124797689|NCT02414139|448889878|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
124797690|NCT02414139|448889879|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
124797691|NCT02414139|448889870|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
124797692|NCT02414139|448889871|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
124797693|NCT02414139|448889872|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
124797694|NCT02414139|448889873|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
124797695|NCT02414139|448889874|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
124797696|NCT02414139|448889875|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
124797697|NCT02414139|448889876|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
124797698|NCT02414139|448889877|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
124797699|NCT02414139|448889878|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
124797700|NCT02414139|448889879|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
124797701|NCT02414139|448889870|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
124797702|NCT02414139|448889871|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
124797703|NCT02414139|448889872|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
124797704|NCT02414139|448889873|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
124797705|NCT02414139|448889874|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
124797706|NCT02414139|448889875|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
124797707|NCT02414139|448889876|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
124797708|NCT02414139|448889877|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
124797709|NCT02414139|448889878|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
124797710|NCT02414139|448889879|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
124797711|NCT02414139|448889870|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
124797712|NCT02414139|448889871|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
124797713|NCT02414139|448889872|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
124797714|NCT02414139|448889873|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
124797715|NCT02414139|448889874|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
124797716|NCT02414139|448889875|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
124797717|NCT02414139|448889876|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
124797718|NCT02414139|448889877|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
124797719|NCT02414139|448889878|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
124797720|NCT02414139|448889879|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
124797721|NCT02414139|448889870|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
124797722|NCT02414139|448889871|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
124797723|NCT02414139|448889872|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
124797724|NCT02414139|448889873|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
125295633|NCT01659255|450709460|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
125295634|NCT01659255|450709461|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
124797725|NCT02414139|448889874|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
124797726|NCT02414139|448889875|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
124797727|NCT02414139|448889876|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
124797728|NCT02414139|448889877|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
124797729|NCT02414139|448889878|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
124797730|NCT02414139|448889879|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
124797731|NCT02632838|448889880|FG000|Overall Study|Withdrawal by Subject|3|||
124797732|NCT02632838|448889881|FG001|Overall Study|Withdrawal by Subject|0|||
124797733|NCT02632838|448889880|FG000|Overall Study|Lost to Follow-up|0|||
124797734|NCT02632838|448889881|FG001|Overall Study|Lost to Follow-up|2|||
124797735|NCT02810340|448889882|FG000|Overall Study|Withdrawal by Subject|1|||
124797736|NCT02810340|448889883|FG001|Overall Study|Withdrawal by Subject|0|||
124797737|NCT02810340|448889884|FG002|Overall Study|Withdrawal by Subject|0|||
124797738|NCT02810340|448889882|FG000|Overall Study|Incarceration|0|||
124797739|NCT02810340|448889883|FG001|Overall Study|Incarceration|1|||
124797740|NCT02810340|448889884|FG002|Overall Study|Incarceration|0|||
124797741|NCT02810340|448889882|FG000|Overall Study|Lost to Follow-up|0|||
124797742|NCT02810340|448889883|FG001|Overall Study|Lost to Follow-up|0|||
124797743|NCT02810340|448889884|FG002|Overall Study|Lost to Follow-up|1|||
124797744|NCT01233687|448889890|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
124797745|NCT01233687|448889890|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
124797746|NCT01233687|448889890|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
124797747|NCT01484938|448889891|FG000|Overall Study|Adverse Event|2|||
124797748|NCT01484938|448889891|FG000|Overall Study|Lost to Follow-up|1|||
124797749|NCT01484938|448889891|FG000|Overall Study|Noncompliance|1|||
124797750|NCT02211638|448889892|FG000|Overall Study|Case Report Forms Uncollected|291|||
124797751|NCT02211638|448889892|FG000|Overall Study|Protocol Violation|692|||
124797752|NCT04571515|448889895|FG000|Overall Study|Physician Decision|0|||
124797753|NCT04571515|448889896|FG001|Overall Study|Physician Decision|0|||
124797754|NCT04571515|448889897|FG002|Overall Study|Physician Decision|0|||
124797755|NCT04571515|448889898|FG003|Overall Study|Physician Decision|0|||
124797756|NCT04571515|448889899|FG004|Overall Study|Physician Decision|1|||
124797757|NCT04571515|448889895|FG000|Overall Study|Withdrawal by Subject|0|||
124797758|NCT04571515|448889896|FG001|Overall Study|Withdrawal by Subject|0|||
124797759|NCT04571515|448889897|FG002|Overall Study|Withdrawal by Subject|0|||
124797760|NCT04571515|448889898|FG003|Overall Study|Withdrawal by Subject|0|||
124797761|NCT04571515|448889899|FG004|Overall Study|Withdrawal by Subject|1|||
124797762|NCT04571515|448889895|FG000|Overall Study|insufficient pain|1|||
124797763|NCT04571515|448889896|FG001|Overall Study|insufficient pain|0|||
124797764|NCT04571515|448889897|FG002|Overall Study|insufficient pain|0|||
124797765|NCT04571515|448889898|FG003|Overall Study|insufficient pain|0|||
124797766|NCT04571515|448889899|FG004|Overall Study|insufficient pain|1|||
124797767|NCT05140382|448889900|FG000|Overall Study|Death|3|||
125295635|NCT01659255|450709462|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
125295636|NCT01659255|450709463|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
125295637|NCT01659255|450709464|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
125295638|NCT01659255|450709465|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
125295639|NCT01659255|450709466|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
125295640|NCT01659255|450709467|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
125295641|NCT01659255|450709468|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
124797768|NCT05140382|448889901|FG001|Overall Study|Death|0|||
124797769|NCT05140382|448889902|FG002|Overall Study|Death|0|||
124797770|NCT05140382|448889900|FG000|Overall Study|Investigator decision|1|||
124797771|NCT05140382|448889901|FG001|Overall Study|Investigator decision|0|||
124797772|NCT05140382|448889902|FG002|Overall Study|Investigator decision|0|||
124797773|NCT05140382|448889900|FG000|Overall Study|Other|4|||
124797774|NCT05140382|448889901|FG001|Overall Study|Other|0|||
124797775|NCT05140382|448889902|FG002|Overall Study|Other|1|||
124797776|NCT05140382|448889900|FG000|Overall Study|Progressive disease|20|||
124797777|NCT05140382|448889901|FG001|Overall Study|Progressive disease|1|||
125295642|NCT01659255|450709469|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
125295643|NCT01659255|450709470|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
125295644|NCT01659255|450709471|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
125295645|NCT01659255|450709472|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
124797778|NCT05140382|448889902|FG002|Overall Study|Progressive disease|12|||
124797779|NCT05140382|448889900|FG000|Overall Study|Subjective disease progression|2|||
124797780|NCT05140382|448889901|FG001|Overall Study|Subjective disease progression|1|||
124797781|NCT05140382|448889902|FG002|Overall Study|Subjective disease progression|0|||
124797782|NCT05140382|448889900|FG000|Overall Study|Unknown at data cut-off|0|||
124797783|NCT05140382|448889901|FG001|Overall Study|Unknown at data cut-off|0|||
124797784|NCT05140382|448889902|FG002|Overall Study|Unknown at data cut-off|1|||
124797785|NCT05140382|448889900|FG000|Overall Study|Withdrawal by Subject|1|||
124797786|NCT05140382|448889901|FG001|Overall Study|Withdrawal by Subject|0|||
124797787|NCT05140382|448889902|FG002|Overall Study|Withdrawal by Subject|4|||
124797788|NCT05140382|448889900|FG000|Overall Study|Withdrawal of consent|0|||
124797789|NCT05140382|448889901|FG001|Overall Study|Withdrawal of consent|0|||
124797790|NCT05140382|448889902|FG002|Overall Study|Withdrawal of consent|1|||
124797791|NCT00323869|448889907|FG000|Overall Study|Death|1|||
124797792|NCT04902326|448891530|FG000|Overall Study|Withdrawal by Subject|1|||
124797793|NCT04902326|448891531|FG001|Overall Study|Withdrawal by Subject|3|||
124797794|NCT04902326|448891532|FG002|Overall Study|Withdrawal by Subject|0|||
124797795|NCT04902326|448891533|FG003|Overall Study|Withdrawal by Subject|1|||
124797796|NCT04902326|448891530|FG000|Overall Study|Lost to Follow-up|14|||
124797797|NCT04902326|448891531|FG001|Overall Study|Lost to Follow-up|14|||
124797798|NCT04902326|448891532|FG002|Overall Study|Lost to Follow-up|14|||
124797799|NCT04902326|448891533|FG003|Overall Study|Lost to Follow-up|6|||
124797800|NCT00427960|448891534|FG000|Overall Study|Adverse Event|2|||
124797801|NCT00427960|448891535|FG001|Overall Study|Adverse Event|0|||
124797802|NCT00427960|448891534|FG000|Overall Study|Withdrawal by Subject|0|||
124797803|NCT00427960|448891535|FG001|Overall Study|Withdrawal by Subject|3|||
124797804|NCT00427960|448891534|FG000|Overall Study|Other|0|||
124797805|NCT00427960|448891535|FG001|Overall Study|Other|1|||
124797806|NCT00423670|448891538|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
124797807|NCT00423670|448891539|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
124797808|NCT00423670|448891540|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
124797809|NCT00423670|448891541|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
124797810|NCT00423670|448891542|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
124797811|NCT00423670|448891543|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
124797812|NCT00423670|448891544|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
124797813|NCT00423670|448891545|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
124797814|NCT00423670|448891538|FG000|Treatment Period|Adverse Event|8|||
124797815|NCT00423670|448891539|FG001|Treatment Period|Adverse Event|12|||
124797816|NCT00423670|448891540|FG002|Treatment Period|Adverse Event|15|||
124797817|NCT00423670|448891541|FG003|Treatment Period|Adverse Event|20|||
124797818|NCT00423670|448891542|FG004|Treatment Period|Adverse Event|9|||
124797819|NCT00423670|448891543|FG005|Treatment Period|Adverse Event|4|||
124797820|NCT00423670|448891544|FG006|Treatment Period|Adverse Event|7|||
124797821|NCT00423670|448891545|FG007|Treatment Period|Adverse Event|2|||
124797822|NCT00423670|448891538|FG000|Treatment Period|Protocol-defined clinical event|0|||
124797823|NCT00423670|448891539|FG001|Treatment Period|Protocol-defined clinical event|7|||
124797824|NCT00423670|448891540|FG002|Treatment Period|Protocol-defined clinical event|4|||
124797825|NCT00423670|448891541|FG003|Treatment Period|Protocol-defined clinical event|12|||
124797826|NCT00423670|448891542|FG004|Treatment Period|Protocol-defined clinical event|5|||
124797827|NCT00423670|448891543|FG005|Treatment Period|Protocol-defined clinical event|4|||
124797828|NCT00423670|448891544|FG006|Treatment Period|Protocol-defined clinical event|16|||
124797829|NCT00423670|448891545|FG007|Treatment Period|Protocol-defined clinical event|15|||
124797830|NCT00423670|448891538|FG000|Treatment Period|Lost to Follow-up|2|||
124797831|NCT00423670|448891539|FG001|Treatment Period|Lost to Follow-up|1|||
124797832|NCT00423670|448891540|FG002|Treatment Period|Lost to Follow-up|3|||
124797833|NCT00423670|448891541|FG003|Treatment Period|Lost to Follow-up|1|||
124797834|NCT00423670|448891542|FG004|Treatment Period|Lost to Follow-up|6|||
124797835|NCT00423670|448891543|FG005|Treatment Period|Lost to Follow-up|0|||
124797836|NCT00423670|448891544|FG006|Treatment Period|Lost to Follow-up|3|||
124797837|NCT00423670|448891545|FG007|Treatment Period|Lost to Follow-up|1|||
124797838|NCT00423670|448891538|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
124797839|NCT00423670|448891539|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
124797840|NCT00423670|448891540|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
124797841|NCT00423670|448891541|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
124797842|NCT00423670|448891542|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
124797843|NCT00423670|448891543|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
124797844|NCT00423670|448891544|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
124797845|NCT00423670|448891545|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
124797846|NCT00423670|448891538|FG000|Treatment Period|Investigator decision|0|||
124797847|NCT00423670|448891539|FG001|Treatment Period|Investigator decision|0|||
124797848|NCT00423670|448891540|FG002|Treatment Period|Investigator decision|0|||
124797849|NCT00423670|448891541|FG003|Treatment Period|Investigator decision|0|||
124797850|NCT00423670|448891542|FG004|Treatment Period|Investigator decision|0|||
124797851|NCT00423670|448891543|FG005|Treatment Period|Investigator decision|0|||
124797852|NCT00423670|448891544|FG006|Treatment Period|Investigator decision|0|||
124797853|NCT00423670|448891545|FG007|Treatment Period|Investigator decision|1|||
124797854|NCT00423670|448891538|FG000|Treatment Period|Non-compliance with protocol|3|||
124797855|NCT00423670|448891539|FG001|Treatment Period|Non-compliance with protocol|1|||
124797856|NCT00423670|448891540|FG002|Treatment Period|Non-compliance with protocol|1|||
124797857|NCT00423670|448891541|FG003|Treatment Period|Non-compliance with protocol|3|||
124797858|NCT00423670|448891542|FG004|Treatment Period|Non-compliance with protocol|2|||
124797859|NCT00423670|448891543|FG005|Treatment Period|Non-compliance with protocol|0|||
124797860|NCT00423670|448891544|FG006|Treatment Period|Non-compliance with protocol|2|||
124797861|NCT00423670|448891545|FG007|Treatment Period|Non-compliance with protocol|2|||
124797862|NCT00423670|448891538|FG000|Follow-up Period|Lost to Follow-up|0|||
124797863|NCT00423670|448891539|FG001|Follow-up Period|Lost to Follow-up|12|||
124797864|NCT00423670|448891540|FG002|Follow-up Period|Lost to Follow-up|8|||
124797865|NCT00423670|448891541|FG003|Follow-up Period|Lost to Follow-up|3|||
124797866|NCT00423670|448891542|FG004|Follow-up Period|Lost to Follow-up|1|||
124797867|NCT00423670|448891543|FG005|Follow-up Period|Lost to Follow-up|0|||
124797868|NCT00423670|448891544|FG006|Follow-up Period|Lost to Follow-up|5|||
124797869|NCT00423670|448891545|FG007|Follow-up Period|Lost to Follow-up|0|||
124797870|NCT00423670|448891538|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
124797871|NCT00423670|448891539|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
124797872|NCT00423670|448891540|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
124797873|NCT00423670|448891541|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
124797874|NCT00423670|448891542|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
124797875|NCT00423670|448891543|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
124797876|NCT00423670|448891544|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
124797877|NCT00423670|448891545|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
124797878|NCT00423670|448891538|FG000|Follow-up Period|Non-compliance with protocol|2|||
124797879|NCT00423670|448891539|FG001|Follow-up Period|Non-compliance with protocol|0|||
124797880|NCT00423670|448891540|FG002|Follow-up Period|Non-compliance with protocol|1|||
124797881|NCT00423670|448891541|FG003|Follow-up Period|Non-compliance with protocol|1|||
124797882|NCT00423670|448891542|FG004|Follow-up Period|Non-compliance with protocol|0|||
124797883|NCT00423670|448891543|FG005|Follow-up Period|Non-compliance with protocol|0|||
124797884|NCT00423670|448891544|FG006|Follow-up Period|Non-compliance with protocol|3|||
124797885|NCT00423670|448891545|FG007|Follow-up Period|Non-compliance with protocol|2|||
124797886|NCT04163718|448891546|FG000|Overall Study|Study terminated|12|||
124797887|NCT01025154|448891547|FG000|Overall Study|Lost to Follow-up|1|||
124797888|NCT01025154|448891547|FG000|Overall Study|Withdrawal by Subject|1|||
124797889|NCT02942576|448891549|FG000|Overall Study|Adverse Event|28|||
124797890|NCT02942576|448891550|FG001|Overall Study|Adverse Event|6|||
124797891|NCT02942576|448891549|FG000|Overall Study|Withdrawal by Subject|7|||
124797892|NCT02942576|448891550|FG001|Overall Study|Withdrawal by Subject|5|||
124797893|NCT02942576|448891549|FG000|Overall Study|Physician Decision|1|||
124797894|NCT02942576|448891550|FG001|Overall Study|Physician Decision|4|||
124797895|NCT02942576|448891549|FG000|Overall Study|Other|10|||
125295646|NCT01659255|450709473|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
125295647|NCT01659255|450709474|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
125295648|NCT01659255|450709475|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
125295649|NCT01659255|450709476|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
124797896|NCT02942576|448891550|FG001|Overall Study|Other|8|||
124797897|NCT00938964|448891551|FG000|Overall Study|Death|3|||
124797898|NCT00938964|448891552|FG001|Overall Study|Death|3|||
124797899|NCT00938964|448891551|FG000|Overall Study|Lost to Follow-up|2|||
124797900|NCT00938964|448891552|FG001|Overall Study|Lost to Follow-up|3|||
124797901|NCT00938964|448891551|FG000|Overall Study|Withdrawal by Subject|22|||
124797902|NCT00938964|448891552|FG001|Overall Study|Withdrawal by Subject|18|||
124797903|NCT00938964|448891551|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
124797904|NCT00938964|448891552|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
124797905|NCT01858636|448891553|FG000|Overall Study|No Device Deployment Attempted|24|||
124797906|NCT01858636|448891553|FG000|Overall Study|Physician Decision|1|||
124797907|NCT01858636|448891553|FG000|Overall Study|Death|1|||
124797908|NCT01858636|448891553|FG000|Overall Study|Lost to Follow-up|1|||
124797909|NCT01858636|448891553|FG000|Overall Study|Withdrawal by Subject|1|||
124797910|NCT03523000|448891557|FG000|Overall Study|Withdrawal by Subject|3|||
124797911|NCT03523000|448891558|FG001|Overall Study|Withdrawal by Subject|0|||
124797912|NCT03523000|448891557|FG000|Overall Study|Unsuccessful trial|2|||
124797913|NCT03523000|448891558|FG001|Overall Study|Unsuccessful trial|0|||
124797914|NCT01227564|448891561|FG000|Overall Study|No Longer Willing to Participate|4|||
124797915|NCT01227564|448891562|FG001|Overall Study|No Longer Willing to Participate|2|||
124797916|NCT01227564|448891563|FG002|Overall Study|No Longer Willing to Participate|5|||
124797917|NCT01227564|448891561|FG000|Overall Study|Participant moved to another town|0|||
124797918|NCT01227564|448891562|FG001|Overall Study|Participant moved to another town|0|||
124797919|NCT01227564|448891563|FG002|Overall Study|Participant moved to another town|1|||
124797920|NCT02862600|448891575|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
124797921|NCT02862600|448891575|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
124797922|NCT02862600|448891575|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
124797923|NCT02862600|448891575|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
124797924|NCT00772070|448891592|FG000|Overall Study|Lost to Follow-up|0|||
124797925|NCT00772070|448891593|FG001|Overall Study|Lost to Follow-up|8|||
124797926|NCT00772070|448891592|FG000|Overall Study|Withdrawal by Subject|0|||
124797927|NCT00772070|448891593|FG001|Overall Study|Withdrawal by Subject|2|||
124797928|NCT00772070|448891592|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
125295650|NCT01116427|450709479|FG000|Core Phase|Adverse Event|0|||
125295651|NCT01116427|450709480|FG001|Core Phase|Adverse Event|1|||
125295652|NCT01116427|450709479|FG000|Core Phase|Lost to Follow-up|1|||
124797929|NCT00772070|448891593|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
124797930|NCT01309308|448891594|FG000|Overall Study|Lost to Follow-up|6|||
124797931|NCT01309308|448891595|FG001|Overall Study|Lost to Follow-up|4|||
124797932|NCT01017575|448891596|FG000|Overall Study|Lack of Efficacy|0|||
124797933|NCT01017575|448891597|FG001|Overall Study|Lack of Efficacy|1|||
124797934|NCT01017575|448891598|FG002|Overall Study|Lack of Efficacy|0|||
124797935|NCT01017575|448891599|FG003|Overall Study|Lack of Efficacy|1|||
124797936|NCT01017575|448891600|FG004|Overall Study|Lack of Efficacy|1|||
124797937|NCT01017575|448891596|FG000|Overall Study|Adverse Event|0|||
124797938|NCT01017575|448891597|FG001|Overall Study|Adverse Event|1|||
124797939|NCT01017575|448891598|FG002|Overall Study|Adverse Event|0|||
124797940|NCT01017575|448891599|FG003|Overall Study|Adverse Event|0|||
124797941|NCT01017575|448891600|FG004|Overall Study|Adverse Event|2|||
124797942|NCT01017575|448891596|FG000|Overall Study|Withdrawal by Subject|1|||
124797943|NCT01017575|448891597|FG001|Overall Study|Withdrawal by Subject|0|||
124797944|NCT01017575|448891598|FG002|Overall Study|Withdrawal by Subject|0|||
124797945|NCT01017575|448891599|FG003|Overall Study|Withdrawal by Subject|0|||
124797946|NCT01017575|448891600|FG004|Overall Study|Withdrawal by Subject|0|||
124797947|NCT01476644|448891601|FG000|Overall Study|Death|5|||
124797948|NCT01476644|448891601|FG000|Overall Study|moved to another state|2|||
124797949|NCT01476644|448891601|FG000|Overall Study|Lost to Follow-up|19|||
124797950|NCT01476644|448891601|FG000|Overall Study|Withdrawal by Subject|13|||
124797951|NCT00095628|448891602|FG000|Overall Study|Disease progression prior to treatment|1|||
124797952|NCT04271280|448891603|FG000|Overall Study|Lost to Follow-up|300|||
124797953|NCT04271280|448891603|FG000|Overall Study|Death|153|||
124797954|NCT04271280|448891603|FG000|Overall Study|Withdrawal of consent by patient|59|||
124797955|NCT04271280|448891603|FG000|Overall Study|Other|51|||
124797956|NCT04271280|448891603|FG000|Overall Study|No end of study information|42|||
124797957|NCT00495131|448891604|FG000|Overall Study|Adverse Event|6|||
124797958|NCT00495131|448891605|FG001|Overall Study|Adverse Event|2|||
124797959|NCT00495131|448891604|FG000|Overall Study|Lack of Efficacy|0|||
124797960|NCT00495131|448891605|FG001|Overall Study|Lack of Efficacy|2|||
124797961|NCT00495131|448891604|FG000|Overall Study|Lost to Follow-up|0|||
124797962|NCT00495131|448891605|FG001|Overall Study|Lost to Follow-up|2|||
124797963|NCT00495131|448891604|FG000|Overall Study|Withdrawal by Subject|1|||
124797964|NCT00495131|448891605|FG001|Overall Study|Withdrawal by Subject|0|||
124797965|NCT00744471|448891606|FG000|Overall Study|Randomized but not treated|1|||
124797966|NCT00744471|448891607|FG001|Overall Study|Randomized but not treated|1|||
124797967|NCT00744471|448891608|FG002|Overall Study|Randomized but not treated|4|||
124797968|NCT00744471|448891609|FG003|Overall Study|Randomized but not treated|0|||
124797969|NCT00744471|448891606|FG000|Overall Study|Death|0|||
124797970|NCT00744471|448891607|FG001|Overall Study|Death|0|||
124797971|NCT00744471|448891608|FG002|Overall Study|Death|0|||
124797972|NCT00744471|448891609|FG003|Overall Study|Death|1|||
124797973|NCT00744471|448891606|FG000|Overall Study|Adverse Event|6|||
124797974|NCT00744471|448891607|FG001|Overall Study|Adverse Event|7|||
124797975|NCT00744471|448891608|FG002|Overall Study|Adverse Event|5|||
124797976|NCT00744471|448891609|FG003|Overall Study|Adverse Event|9|||
124797977|NCT00744471|448891606|FG000|Overall Study|Withdrawal by Subject|9|||
124797978|NCT00744471|448891607|FG001|Overall Study|Withdrawal by Subject|9|||
124797979|NCT00744471|448891608|FG002|Overall Study|Withdrawal by Subject|15|||
124797980|NCT00744471|448891609|FG003|Overall Study|Withdrawal by Subject|12|||
124797981|NCT00744471|448891606|FG000|Overall Study|Protocol Violation|1|||
124797982|NCT00744471|448891607|FG001|Overall Study|Protocol Violation|4|||
124797983|NCT00744471|448891608|FG002|Overall Study|Protocol Violation|1|||
124797984|NCT00744471|448891609|FG003|Overall Study|Protocol Violation|2|||
124797985|NCT00744471|448891606|FG000|Overall Study|Entered extension study|41|||
124797986|NCT00744471|448891607|FG001|Overall Study|Entered extension study|84|||
124797987|NCT00744471|448891608|FG002|Overall Study|Entered extension study|100|||
124797988|NCT00744471|448891609|FG003|Overall Study|Entered extension study|91|||
124797989|NCT00744471|448891606|FG000|Overall Study|Other|2|||
124797990|NCT00744471|448891607|FG001|Overall Study|Other|3|||
124797991|NCT00744471|448891608|FG002|Overall Study|Other|6|||
124797992|NCT00744471|448891609|FG003|Overall Study|Other|2|||
124797993|NCT00744471|448891606|FG000|Overall Study|Lack of Efficacy|83|||
124797994|NCT00744471|448891607|FG001|Overall Study|Lack of Efficacy|37|||
124797995|NCT00744471|448891608|FG002|Overall Study|Lack of Efficacy|19|||
124797996|NCT00744471|448891609|FG003|Overall Study|Lack of Efficacy|31|||
124797997|NCT00744471|448891606|FG000|Overall Study|Lost to Follow-up|0|||
124797998|NCT00744471|448891607|FG001|Overall Study|Lost to Follow-up|0|||
124797999|NCT00744471|448891608|FG002|Overall Study|Lost to Follow-up|2|||
125295653|NCT01116427|450709480|FG001|Core Phase|Lost to Follow-up|0|||
124798000|NCT00744471|448891609|FG003|Overall Study|Lost to Follow-up|0|||
124798001|NCT04706416|448891614|FG000|Overall Study|Lost to Follow-up|2|||
124798002|NCT04706416|448891615|FG001|Overall Study|Lost to Follow-up|0|||
124798003|NCT01539317|448891619|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
124798004|NCT01539317|448891620|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
124798005|NCT00976573|448891627|FG000|Overall Study|Ineligible|0|||
124798006|NCT00976573|448891628|FG001|Overall Study|Ineligible|1|||
124798007|NCT00976573|448891627|FG000|Overall Study|Cancel prior to receiving treatment|4|||
124798008|NCT00976573|448891628|FG001|Overall Study|Cancel prior to receiving treatment|2|||
124798009|NCT02117427|448891629|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
124798010|NCT02117427|448891630|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
124798011|NCT02117427|448891631|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
124798012|NCT02117427|448891629|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
125295654|NCT01116427|450709479|FG000|Core Phase|Withdrawal by Subject|3|||
124798013|NCT02117427|448891630|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
124798014|NCT02117427|448891631|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
124798015|NCT02117427|448891629|FG000|Overall Study|Physician Decision|0|||
124798016|NCT02117427|448891630|FG001|Overall Study|Physician Decision|2|||
124798017|NCT02117427|448891631|FG002|Overall Study|Physician Decision|0|||
124798018|NCT02117427|448891629|FG000|Overall Study|No longer meets inclusion criteria|0|||
124798019|NCT02117427|448891630|FG001|Overall Study|No longer meets inclusion criteria|1|||
124798020|NCT02117427|448891631|FG002|Overall Study|No longer meets inclusion criteria|0|||
124798021|NCT02117427|448891629|FG000|Overall Study|Death|0|||
124798022|NCT02117427|448891630|FG001|Overall Study|Death|1|||
124798023|NCT02117427|448891631|FG002|Overall Study|Death|0|||
124798024|NCT00937391|448891640|FG000|Stage 2|Withdrawal by Subject|1|||
124798025|NCT01436162|448891651|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
124798026|NCT01436162|448891652|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
124798027|NCT01436162|448891653|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
124798028|NCT01436162|448891651|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
124798029|NCT01436162|448891652|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
124798030|NCT01436162|448891653|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
124798031|NCT01436162|448891651|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
124798032|NCT01436162|448891652|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
124798033|NCT01436162|448891653|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
124798034|NCT01436162|448891651|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
124798035|NCT01436162|448891652|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
124798036|NCT01436162|448891653|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
124798037|NCT01436162|448891651|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
124798038|NCT01436162|448891652|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
124798039|NCT01436162|448891653|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
124798040|NCT01436162|448891651|FG000|Single-blind Lead-in Phase|Other|107|||
124798041|NCT01436162|448891652|FG001|Single-blind Lead-in Phase|Other|0|||
124798042|NCT01436162|448891653|FG002|Single-blind Lead-in Phase|Other|0|||
124798043|NCT01436162|448891651|FG000|Randomized Phase|Adverse Event|1|||
124798044|NCT01436162|448891652|FG001|Randomized Phase|Adverse Event|5|||
124798045|NCT01436162|448891653|FG002|Randomized Phase|Adverse Event|6|||
124798046|NCT01436162|448891651|FG000|Randomized Phase|Protocol Violation|4|||
124798047|NCT01436162|448891652|FG001|Randomized Phase|Protocol Violation|4|||
124798048|NCT01436162|448891653|FG002|Randomized Phase|Protocol Violation|2|||
124798049|NCT01436162|448891651|FG000|Randomized Phase|Withdrawal by Subject|16|||
124798050|NCT01436162|448891652|FG001|Randomized Phase|Withdrawal by Subject|9|||
124798051|NCT01436162|448891653|FG002|Randomized Phase|Withdrawal by Subject|8|||
124798052|NCT01436162|448891651|FG000|Randomized Phase|Lost to Follow-up|17|||
124798053|NCT01436162|448891652|FG001|Randomized Phase|Lost to Follow-up|5|||
124798054|NCT01436162|448891653|FG002|Randomized Phase|Lost to Follow-up|4|||
124798055|NCT01436162|448891651|FG000|Randomized Phase|Lack of Efficacy|0|||
124798056|NCT01436162|448891652|FG001|Randomized Phase|Lack of Efficacy|1|||
124798057|NCT01436162|448891653|FG002|Randomized Phase|Lack of Efficacy|1|||
124798058|NCT01436162|448891651|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
124798059|NCT01436162|448891652|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
124798060|NCT01436162|448891653|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
124798061|NCT01436162|448891651|FG000|Randomized Phase|Other|2|||
124798062|NCT01436162|448891652|FG001|Randomized Phase|Other|5|||
124798063|NCT01436162|448891653|FG002|Randomized Phase|Other|4|||
124798064|NCT01931202|448891657|FG000|Overall Study|Withdrawal by Subject|0|||
124798065|NCT01931202|448891658|FG001|Overall Study|Withdrawal by Subject|0|||
124798066|NCT01931202|448891659|FG002|Overall Study|Withdrawal by Subject|2|||
124798067|NCT01931202|448891657|FG000|Overall Study|Lost to Follow-up|0|||
124798068|NCT01931202|448891658|FG001|Overall Study|Lost to Follow-up|5|||
124798069|NCT01931202|448891659|FG002|Overall Study|Lost to Follow-up|2|||
124798070|NCT04597918|448891662|FG000|Overall Study|Withdrawal by Subject|6|||
124798071|NCT04597918|448891662|FG000|Overall Study|Lost to Follow-up|3|||
124798072|NCT04597918|448891662|FG000|Overall Study|Death|1|||
124798073|NCT00395538|448891663|FG000|Overall Study|Did not re-consent to revised protocol|1|||
124798074|NCT00395538|448891664|FG001|Overall Study|Did not re-consent to revised protocol|10|||
124798075|NCT00395538|448891665|FG002|Overall Study|Did not re-consent to revised protocol|0|||
124798076|NCT00395538|448891663|FG000|Overall Study|FDA partial hold on PTH|0|||
125295655|NCT01116427|450709480|FG001|Core Phase|Withdrawal by Subject|0|||
124798077|NCT00395538|448891664|FG001|Overall Study|FDA partial hold on PTH|0|||
124798078|NCT00395538|448891665|FG002|Overall Study|FDA partial hold on PTH|11|||
124798079|NCT00395538|448891663|FG000|Overall Study|Failed screening|0|||
125295656|NCT01116427|450709479|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
124798080|NCT00395538|448891664|FG001|Overall Study|Failed screening|0|||
124798081|NCT00395538|448891665|FG002|Overall Study|Failed screening|4|||
124798082|NCT00395538|448891663|FG000|Overall Study|Switch to Natpara|0|||
124798083|NCT00395538|448891664|FG001|Overall Study|Switch to Natpara|0|||
124798084|NCT00395538|448891665|FG002|Overall Study|Switch to Natpara|3|||
125295657|NCT01116427|450709480|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
124798085|NCT00395538|448891663|FG000|Overall Study|Adverse Event|1|||
124798086|NCT00395538|448891664|FG001|Overall Study|Adverse Event|0|||
124798087|NCT00395538|448891665|FG002|Overall Study|Adverse Event|2|||
124798088|NCT00395538|448891663|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
124798089|NCT00395538|448891664|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
124798090|NCT00395538|448891665|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
124798091|NCT00395538|448891663|FG000|Overall Study|Non-compliance with study protocol|0|||
124798092|NCT00395538|448891664|FG001|Overall Study|Non-compliance with study protocol|1|||
124798093|NCT00395538|448891665|FG002|Overall Study|Non-compliance with study protocol|0|||
124798094|NCT00395538|448891663|FG000|Overall Study|PTH resistance|0|||
124798095|NCT00395538|448891664|FG001|Overall Study|PTH resistance|0|||
124798096|NCT00395538|448891665|FG002|Overall Study|PTH resistance|1|||
124798097|NCT00395538|448891663|FG000|Overall Study|Pregnancy|1|||
124798098|NCT00395538|448891664|FG001|Overall Study|Pregnancy|0|||
124798099|NCT00395538|448891665|FG002|Overall Study|Pregnancy|0|||
124798100|NCT00395538|448891663|FG000|Overall Study|Partial recovery of parathyroid function|0|||
124798101|NCT00395538|448891664|FG001|Overall Study|Partial recovery of parathyroid function|0|||
124798102|NCT00395538|448891665|FG002|Overall Study|Partial recovery of parathyroid function|1|||
124798103|NCT00395538|448891663|FG000|Overall Study|Participant elected to discontinue|0|||
124798104|NCT00395538|448891664|FG001|Overall Study|Participant elected to discontinue|0|||
124798105|NCT00395538|448891665|FG002|Overall Study|Participant elected to discontinue|1|||
124798106|NCT01074047|448891666|FG000|Treatment Phase|Adverse Event|89|||
124798107|NCT01074047|448891667|FG001|Treatment Phase|Adverse Event|66|||
124798108|NCT01074047|448891666|FG000|Treatment Phase|Disease Progression|16|||
124798109|NCT01074047|448891667|FG001|Treatment Phase|Disease Progression|21|||
124798110|NCT01074047|448891666|FG000|Treatment Phase|Withdrawal by Subject|27|||
124798111|NCT01074047|448891667|FG001|Treatment Phase|Withdrawal by Subject|48|||
124798112|NCT01074047|448891666|FG000|Treatment Phase|Death|53|||
124798113|NCT01074047|448891667|FG001|Treatment Phase|Death|58|||
124798114|NCT01074047|448891666|FG000|Treatment Phase|Lost to Follow-up|0|||
124798115|NCT01074047|448891667|FG001|Treatment Phase|Lost to Follow-up|1|||
124798116|NCT01074047|448891666|FG000|Treatment Phase|Protocol Violation|0|||
124798117|NCT01074047|448891667|FG001|Treatment Phase|Protocol Violation|1|||
124798118|NCT01074047|448891666|FG000|Treatment Phase|Miscellaneous|32|||
124798119|NCT01074047|448891667|FG001|Treatment Phase|Miscellaneous|39|||
124798120|NCT01074047|448891666|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
124798121|NCT01074047|448891667|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
124798122|NCT01074047|448891666|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
124798123|NCT01074047|448891667|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
124798124|NCT01074047|448891666|FG000|Survival Follow-Up Phase|Death|116|||
124798125|NCT01074047|448891667|FG001|Survival Follow-Up Phase|Death|124|||
124798126|NCT01074047|448891666|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
124798127|NCT01074047|448891667|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
124798128|NCT01074047|448891666|FG000|Extension Phase|Physician Decision|1|||
124798129|NCT01074047|448891667|FG001|Extension Phase|Physician Decision|0|||
124798130|NCT01074047|448891666|FG000|Extension Phase|Adverse Event|5|||
124798131|NCT01074047|448891667|FG001|Extension Phase|Adverse Event|0|||
124798132|NCT01074047|448891666|FG000|Extension Phase|Disease Progression|9|||
124798133|NCT01074047|448891667|FG001|Extension Phase|Disease Progression|0|||
124798134|NCT01074047|448891666|FG000|Extension Phase|Withdrawal by Subject|2|||
124798135|NCT01074047|448891667|FG001|Extension Phase|Withdrawal by Subject|0|||
124798136|NCT01074047|448891666|FG000|Extension Phase|Death|5|||
124798137|NCT01074047|448891667|FG001|Extension Phase|Death|0|||
124798138|NCT04041700|448891672|FG000|Overall Study|Pregnancy|1|||
124798139|NCT04041700|448891672|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
124798140|NCT02775903|448891673|FG000|Overall Study|Death|7|||
124798141|NCT02775903|448891674|FG001|Overall Study|Death|11|||
124798142|NCT02775903|448891675|FG002|Overall Study|Death|12|||
124798143|NCT02775903|448891676|FG003|Overall Study|Death|11|||
124798144|NCT02775903|448891673|FG000|Overall Study|Adverse Event|0|||
124798145|NCT02775903|448891674|FG001|Overall Study|Adverse Event|1|||
124798146|NCT02775903|448891675|FG002|Overall Study|Adverse Event|12|||
124798147|NCT02775903|448891676|FG003|Overall Study|Adverse Event|3|||
124798148|NCT02775903|448891673|FG000|Overall Study|Progressive disease|15|||
124798149|NCT02775903|448891674|FG001|Overall Study|Progressive disease|14|||
124798150|NCT02775903|448891675|FG002|Overall Study|Progressive disease|30|||
124798151|NCT02775903|448891676|FG003|Overall Study|Progressive disease|20|||
124798152|NCT02775903|448891673|FG000|Overall Study|Lack of Efficacy|2|||
124798153|NCT02775903|448891674|FG001|Overall Study|Lack of Efficacy|2|||
124798154|NCT02775903|448891675|FG002|Overall Study|Lack of Efficacy|2|||
124798155|NCT02775903|448891676|FG003|Overall Study|Lack of Efficacy|6|||
124798156|NCT02775903|448891673|FG000|Overall Study|Withdrawal by Subject|7|||
124798157|NCT02775903|448891674|FG001|Overall Study|Withdrawal by Subject|5|||
124798158|NCT02775903|448891675|FG002|Overall Study|Withdrawal by Subject|5|||
124798159|NCT02775903|448891676|FG003|Overall Study|Withdrawal by Subject|8|||
124798160|NCT02775903|448891673|FG000|Overall Study|Other reasons|7|||
124798161|NCT02775903|448891674|FG001|Overall Study|Other reasons|8|||
124798162|NCT02775903|448891675|FG002|Overall Study|Other reasons|2|||
124798163|NCT02775903|448891676|FG003|Overall Study|Other reasons|12|||
124798164|NCT01683019|448893284|FG000|Overall Study|Withdrawal by Subject|2|||
124798165|NCT01683019|448893285|FG001|Overall Study|Withdrawal by Subject|1|||
124798166|NCT01683019|448893286|FG002|Overall Study|Withdrawal by Subject|4|||
124798167|NCT00543855|448893287|FG000|Overall Study|Adverse Event|3|||
124798168|NCT00543855|448893288|FG001|Overall Study|Adverse Event|1|||
124798169|NCT00543855|448893289|FG002|Overall Study|Adverse Event|3|||
124798170|NCT00543855|448893290|FG003|Overall Study|Adverse Event|4|||
124798171|NCT00543855|448893287|FG000|Overall Study|Lost to Follow-up|0|||
124798172|NCT00543855|448893288|FG001|Overall Study|Lost to Follow-up|0|||
124798173|NCT00543855|448893289|FG002|Overall Study|Lost to Follow-up|1|||
124798174|NCT00543855|448893290|FG003|Overall Study|Lost to Follow-up|0|||
124798175|NCT00543855|448893287|FG000|Overall Study|Withdrawal by Subject|0|||
124798176|NCT00543855|448893288|FG001|Overall Study|Withdrawal by Subject|1|||
124798177|NCT00543855|448893289|FG002|Overall Study|Withdrawal by Subject|2|||
124798178|NCT00543855|448893290|FG003|Overall Study|Withdrawal by Subject|0|||
124798179|NCT00543855|448893287|FG000|Overall Study|Protocol Violation|1|||
124798180|NCT00543855|448893288|FG001|Overall Study|Protocol Violation|0|||
124798181|NCT00543855|448893289|FG002|Overall Study|Protocol Violation|0|||
124798182|NCT00543855|448893290|FG003|Overall Study|Protocol Violation|0|||
124798183|NCT04444895|448893292|FG000|Overall Study|Adverse Event|2|||
124798184|NCT04444895|448893292|FG000|Overall Study|Lost to Follow-up|2|||
124798185|NCT04444895|448893292|FG000|Overall Study|Withdrawal by Subject|5|||
124798186|NCT03954041|448893295|FG000|Overall Study|Lost to Follow-up|3|||
124798187|NCT03954041|448893296|FG001|Overall Study|Lost to Follow-up|3|||
124798188|NCT03954041|448893297|FG002|Overall Study|Lost to Follow-up|6|||
124798189|NCT03954041|448893295|FG000|Overall Study|Death|4|||
124798190|NCT03954041|448893296|FG001|Overall Study|Death|0|||
124798191|NCT03954041|448893297|FG002|Overall Study|Death|1|||
124798192|NCT03954041|448893295|FG000|Overall Study|Death by neurologic criteria|0|||
124798193|NCT03954041|448893296|FG001|Overall Study|Death by neurologic criteria|0|||
124798194|NCT03954041|448893297|FG002|Overall Study|Death by neurologic criteria|1|||
124798195|NCT03954041|448893295|FG000|Overall Study|Reason not specified|7|||
124798196|NCT03954041|448893296|FG001|Overall Study|Reason not specified|4|||
124798197|NCT03954041|448893297|FG002|Overall Study|Reason not specified|2|||
124798198|NCT03954041|448893295|FG000|Overall Study|Withdrew prior to dosing|4|||
124798199|NCT03954041|448893296|FG001|Overall Study|Withdrew prior to dosing|2|||
124798200|NCT03954041|448893297|FG002|Overall Study|Withdrew prior to dosing|0|||
124798201|NCT04177355|448893298|FG000|Overall Study|Lost to Follow-up|0|||
124798202|NCT04177355|448893299|FG001|Overall Study|Lost to Follow-up|2|||
124798203|NCT04177355|448893300|FG002|Overall Study|Lost to Follow-up|0|||
124798204|NCT04177355|448893301|FG003|Overall Study|Lost to Follow-up|1|||
124798205|NCT04177355|448893302|FG004|Overall Study|Lost to Follow-up|2|||
124798206|NCT04177355|448893303|FG005|Overall Study|Lost to Follow-up|0|||
124798207|NCT04177355|448893304|FG006|Overall Study|Lost to Follow-up|1|||
124798208|NCT04177355|448893305|FG007|Overall Study|Lost to Follow-up|0|||
124798209|NCT04177355|448893306|FG008|Overall Study|Lost to Follow-up|0|||
124798210|NCT04177355|448893307|FG009|Overall Study|Lost to Follow-up|0|||
124798211|NCT04177355|448893308|FG010|Overall Study|Lost to Follow-up|0|||
124798212|NCT04177355|448893298|FG000|Overall Study|Withdrawal by Subject|0|||
124798213|NCT04177355|448893299|FG001|Overall Study|Withdrawal by Subject|0|||
124798214|NCT04177355|448893300|FG002|Overall Study|Withdrawal by Subject|0|||
124798215|NCT04177355|448893301|FG003|Overall Study|Withdrawal by Subject|1|||
124798216|NCT04177355|448893302|FG004|Overall Study|Withdrawal by Subject|1|||
124798217|NCT04177355|448893303|FG005|Overall Study|Withdrawal by Subject|0|||
124798218|NCT04177355|448893304|FG006|Overall Study|Withdrawal by Subject|0|||
124798219|NCT04177355|448893305|FG007|Overall Study|Withdrawal by Subject|0|||
124798220|NCT04177355|448893306|FG008|Overall Study|Withdrawal by Subject|1|||
124798221|NCT04177355|448893307|FG009|Overall Study|Withdrawal by Subject|0|||
124798222|NCT04177355|448893308|FG010|Overall Study|Withdrawal by Subject|0|||
124798223|NCT00397943|448893309|FG000|Overall Study|Unspecified reasons|12|||
124798224|NCT00397943|448893310|FG001|Overall Study|Unspecified reasons|9|||
124798225|NCT00397943|448893311|FG002|Overall Study|Unspecified reasons|0|||
124798226|NCT00397943|448893312|FG003|Overall Study|Unspecified reasons|0|||
124798227|NCT00397943|448893313|FG004|Overall Study|Unspecified reasons|0|||
124798228|NCT05007717|448893314|FG000|Overall Study|Death|3|||
124798229|NCT05007717|448893315|FG001|Overall Study|Death|2|||
124798230|NCT02806973|448893317|FG000|Period 1|Withdrawal by Subject|0|||
124798231|NCT02806973|448893318|FG001|Period 1|Withdrawal by Subject|2|||
124798232|NCT02806973|448893319|FG002|Period 1|Withdrawal by Subject|1|||
124798233|NCT02806973|448893320|FG003|Period 1|Withdrawal by Subject|1|||
124798234|NCT02806973|448893317|FG000|Period 1|Adverse Event|0|||
124798235|NCT02806973|448893318|FG001|Period 1|Adverse Event|0|||
124798236|NCT02806973|448893319|FG002|Period 1|Adverse Event|0|||
124798237|NCT02806973|448893320|FG003|Period 1|Adverse Event|1|||
124798238|NCT02806973|448893317|FG000|Period 3|Withdrawal by Subject|0|||
124798239|NCT02806973|448893318|FG001|Period 3|Withdrawal by Subject|0|||
124798240|NCT02806973|448893319|FG002|Period 3|Withdrawal by Subject|0|||
124798241|NCT02806973|448893320|FG003|Period 3|Withdrawal by Subject|3|||
124798242|NCT02806973|448893317|FG000|Period 3|Adverse Event|0|||
124798243|NCT02806973|448893318|FG001|Period 3|Adverse Event|0|||
124798244|NCT02806973|448893319|FG002|Period 3|Adverse Event|1|||
124798245|NCT02806973|448893320|FG003|Period 3|Adverse Event|0|||
124798246|NCT03282565|448893326|FG000|Overall Study|COVID-19 Research Shutdown|0|||
124798247|NCT03282565|448893327|FG001|Overall Study|COVID-19 Research Shutdown|2|||
124798248|NCT03282565|448893328|FG002|Overall Study|COVID-19 Research Shutdown|2|||
124798249|NCT02131532|448893329|FG000|Overall Study|Withdrawal by Subject|1|||
124798250|NCT02131532|448893329|FG000|Overall Study|Physician Decision|1|||
124798251|NCT02131532|448893329|FG000|Overall Study|Other health conditions|2|||
124798252|NCT01466595|448893330|FG000|Overall Study|Withdrawal by Subject|0|||
124798253|NCT01466595|448893331|FG001|Overall Study|Withdrawal by Subject|1|||
124798254|NCT00450112|448893332|FG000|Overall Study|Other Treatment Required|5|||
124798255|NCT00450112|448893333|FG001|Overall Study|Other Treatment Required|1|||
124798256|NCT00450112|448893332|FG000|Overall Study|Withdrawal by Subject|4|||
124798257|NCT00450112|448893333|FG001|Overall Study|Withdrawal by Subject|1|||
124798258|NCT00450112|448893332|FG000|Overall Study|Lost to Follow-up|2|||
124798259|NCT00450112|448893333|FG001|Overall Study|Lost to Follow-up|1|||
124798260|NCT00450112|448893332|FG000|Overall Study|Others|2|||
124798261|NCT00450112|448893333|FG001|Overall Study|Others|3|||
124798262|NCT01264016|448893334|FG000|Overall Study|Withdrawal by Subject|1|||
124798263|NCT01264016|448893334|FG000|Overall Study|Felt faint at sight of blood|1|||
124798264|NCT02147184|448893335|FG000|Overall Study|Lost to Follow-up|28|||
124798265|NCT02147184|448893336|FG001|Overall Study|Lost to Follow-up|15|||
124798266|NCT02147184|448893335|FG000|Overall Study|Study Burden|11|||
124798267|NCT02147184|448893336|FG001|Overall Study|Study Burden|7|||
124798268|NCT02147184|448893335|FG000|Overall Study|Pregnancy|6|||
124798269|NCT02147184|448893336|FG001|Overall Study|Pregnancy|0|||
124798270|NCT02147184|448893335|FG000|Overall Study|Moved out of state|3|||
124798271|NCT02147184|448893336|FG001|Overall Study|Moved out of state|3|||
124798272|NCT02147184|448893335|FG000|Overall Study|Physician Decision|0|||
124798273|NCT02147184|448893336|FG001|Overall Study|Physician Decision|2|||
124798274|NCT02147184|448893335|FG000|Overall Study|Other|1|||
124798275|NCT02147184|448893336|FG001|Overall Study|Other|0|||
124798276|NCT02117414|448893337|FG000|Overall Study|Death|5|||
124798277|NCT02117414|448893338|FG001|Overall Study|Death|2|||
124798278|NCT02117414|448893337|FG000|Overall Study|Withdrawal by Subject|10|||
124798279|NCT02117414|448893338|FG001|Overall Study|Withdrawal by Subject|4|||
124798280|NCT00417482|448893339|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
124798281|NCT00417482|448893340|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
124798282|NCT00417482|448893341|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
124798283|NCT00417482|448893339|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
124798284|NCT00417482|448893340|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
124798285|NCT00417482|448893341|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
125295658|NCT01116427|450709479|FG000|Extension Phase|Adverse Event|1|||
125295659|NCT01116427|450709480|FG001|Extension Phase|Adverse Event|1|||
124798286|NCT00417482|448893339|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
124798287|NCT00417482|448893340|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
124798288|NCT00417482|448893341|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
124798289|NCT00417482|448893339|FG000|Phase B 1st 16 Weeks|Death|1|||
124798290|NCT00417482|448893340|FG001|Phase B 1st 16 Weeks|Death|0|||
124798291|NCT00417482|448893341|FG002|Phase B 1st 16 Weeks|Death|0|||
124798292|NCT00417482|448893339|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
124798293|NCT00417482|448893340|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
124798294|NCT00417482|448893341|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
124798295|NCT00417482|448893339|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
124798296|NCT00417482|448893340|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
124798297|NCT00417482|448893341|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
124798298|NCT00417482|448893339|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
124798299|NCT00417482|448893340|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
124798300|NCT00417482|448893341|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
124798301|NCT00417482|448893339|FG000|Phase B 2nd 16 Weeks|Death|1|||
125295660|NCT01116427|450709479|FG000|Extension Phase|Lost to Follow-up|2|||
125295661|NCT01116427|450709480|FG001|Extension Phase|Lost to Follow-up|0|||
125295662|NCT01116427|450709479|FG000|Extension Phase|Withdrawal by Subject|5|||
125295663|NCT01116427|450709480|FG001|Extension Phase|Withdrawal by Subject|1|||
124798302|NCT00417482|448893340|FG001|Phase B 2nd 16 Weeks|Death|1|||
125295664|NCT01116427|450709479|FG000|Extension Phase|Not using appropriate birth control|1|||
125295665|NCT01116427|450709480|FG001|Extension Phase|Not using appropriate birth control|0|||
125295666|NCT02989805|450709481|FG000|Overall Study|invalid consent|6|||
125295667|NCT02989805|450709482|FG001|Overall Study|invalid consent|4|||
125295668|NCT02211313|450709483|FG000|Overall Study|Treatment Failure|5|||
125295669|NCT02211313|450709484|FG001|Overall Study|Treatment Failure|2|||
124798303|NCT00417482|448893341|FG002|Phase B 2nd 16 Weeks|Death|0|||
124798304|NCT06400979|448893344|FG000|Overall Study|Lost to Follow-up|29|||
124798305|NCT06400979|448893344|FG000|Overall Study|Withdrawal by Subject|1|||
125295670|NCT02211313|450709483|FG000|Overall Study|No Follow up Questionnaires|1|||
124798306|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
124798307|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
124798308|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
124798309|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
124798310|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
124798311|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
124798312|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
124798313|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
124798314|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
124798315|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
124798316|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
124798317|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
124798318|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
124798319|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
124798320|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
124798321|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
124798322|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Program Termination|3|||
124798323|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Program Termination|0|||
124798324|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Program Termination|1|||
124798325|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Program Termination|1|||
124798326|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
124798327|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
124798328|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
124798329|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
124798330|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
124798331|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
124798332|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
124798333|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
124798334|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
124798335|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
124798336|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
124798337|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
124798338|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
124798339|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
124798340|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
124798341|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
124798342|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
124798343|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
124798344|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
124798345|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
124798346|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
124798347|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
124798348|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
124798349|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
124798350|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
124798351|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
124798352|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
124798353|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
124798354|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
124798355|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
124798356|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
124798357|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
124798358|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
124798359|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
124798360|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
124798361|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
124798362|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
124798363|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
124798364|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
124798365|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
124798366|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
124798367|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
124798368|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
124798369|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
124798370|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
124798371|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
124798372|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
125295671|NCT02211313|450709484|FG001|Overall Study|No Follow up Questionnaires|1|||
125295672|NCT02648217|450709487|FG000|Overall Study|Adverse Event|0|||
125295673|NCT02648217|450709488|FG001|Overall Study|Adverse Event|1|||
125295674|NCT02648217|450709487|FG000|Overall Study|Lost to Follow-up|1|||
125295675|NCT02648217|450709488|FG001|Overall Study|Lost to Follow-up|1|||
125295676|NCT02648217|450709487|FG000|Overall Study|Withdrawal by Subject|4|||
125295677|NCT02648217|450709488|FG001|Overall Study|Withdrawal by Subject|3|||
124798373|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
124798374|NCT03739840|448893345|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
124798375|NCT03739840|448893346|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
124798376|NCT03739840|448893347|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
124798377|NCT03739840|448893348|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
125295678|NCT02648217|450709487|FG000|Overall Study|Unclassified|5|||
125295679|NCT02648217|450709488|FG001|Overall Study|Unclassified|0|||
125295680|NCT03316950|450709489|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
125295681|NCT03316950|450709490|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
125295682|NCT03316950|450709491|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
125295683|NCT03316950|450709492|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
125295684|NCT03316950|450709489|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
125295685|NCT03316950|450709490|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
125295686|NCT03316950|450709491|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
125295687|NCT03316950|450709492|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
125295688|NCT03316950|450709489|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
125295689|NCT03316950|450709490|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
125295690|NCT03316950|450709491|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
125295691|NCT03316950|450709492|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
125295692|NCT02392403|450709493|FG000|Overall Study|Adverse Event|1|||
125295693|NCT02392403|450709493|FG000|Overall Study|Death|1|||
125295694|NCT02392403|450709493|FG000|Overall Study|Withdrawal by Subject|1|||
125295695|NCT02335424|450709497|FG000|Overall Study|Withdrawal by Subject|19|||
125295696|NCT02335424|450709497|FG000|Overall Study|Adverse Event|25|||
125295697|NCT02335424|450709497|FG000|Overall Study|Death|273|||
125295698|NCT02335424|450709497|FG000|Overall Study|Lost to Follow-up|3|||
125295699|NCT02335424|450709497|FG000|Overall Study|Physician Decision|13|||
125295700|NCT02335424|450709497|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
125295701|NCT02335424|450709497|FG000|Overall Study|Protocol Violation|1|||
124798378|NCT03739840|448893345|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
124798379|NCT03739840|448893346|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
124798380|NCT03739840|448893347|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
124798381|NCT03739840|448893348|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
124798382|NCT03739840|448893345|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
124798383|NCT03739840|448893346|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
124798384|NCT03739840|448893347|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
124798385|NCT03739840|448893348|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
124798386|NCT03739840|448893345|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
124798387|NCT03739840|448893346|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
124798388|NCT03739840|448893347|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
124798389|NCT03739840|448893348|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
124798390|NCT03739840|448893345|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
124798391|NCT03739840|448893346|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
124798392|NCT03739840|448893347|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
124798393|NCT03739840|448893348|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
124798394|NCT03739840|448893345|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
124798395|NCT03739840|448893346|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
124798396|NCT03739840|448893347|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
124798397|NCT03739840|448893348|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
125295702|NCT02335424|450709497|FG000|Overall Study|Screen failure|1|||
125295703|NCT02776033|450709500|FG000|Overall Study|Withdrawal by Subject|0|||
125295704|NCT02776033|450709501|FG001|Overall Study|Withdrawal by Subject|0|||
125295705|NCT02776033|450709502|FG002|Overall Study|Withdrawal by Subject|2|||
125295706|NCT02776033|450709500|FG000|Overall Study|Physician Decision|2|||
125295707|NCT02776033|450709501|FG001|Overall Study|Physician Decision|0|||
125295708|NCT02776033|450709502|FG002|Overall Study|Physician Decision|0|||
125295709|NCT02776033|450709500|FG000|Overall Study|Lost to Follow-up|1|||
125295710|NCT02776033|450709501|FG001|Overall Study|Lost to Follow-up|0|||
125295711|NCT02776033|450709502|FG002|Overall Study|Lost to Follow-up|0|||
125295712|NCT02776033|450709500|FG000|Overall Study|Adverse Event|1|||
125295713|NCT02776033|450709501|FG001|Overall Study|Adverse Event|2|||
125295714|NCT02776033|450709502|FG002|Overall Study|Adverse Event|0|||
125295715|NCT00657371|450709503|FG000|Overall Study|Poor bowel preparation|15|||
125295716|NCT00657371|450709503|FG000|Overall Study|Unable to intubate the cecum|5|||
125295717|NCT00657371|450709503|FG000|Overall Study|Protocol Violation|2|||
125295718|NCT00657371|450709503|FG000|Overall Study|Device- related reasons|13|||
124798398|NCT03739840|448893345|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
124798399|NCT03739840|448893346|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
124798400|NCT03739840|448893347|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
124798401|NCT03739840|448893348|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
124798402|NCT03739840|448893345|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
124798403|NCT03739840|448893346|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
124798404|NCT03739840|448893347|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
124798405|NCT03739840|448893348|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
124798406|NCT01058265|448893351|FG000|Overall Study|Lost to Follow-up|11|||
124798407|NCT01058265|448893352|FG001|Overall Study|Lost to Follow-up|12|||
124798408|NCT02962765|448893353|FG000|Overall Study|Protocol Violation|9|||
124798409|NCT02962765|448893353|FG000|Overall Study|Withdrawal by Subject|3|||
124798410|NCT02962765|448893353|FG000|Overall Study|Lost to Follow-up|1|||
124798411|NCT02962765|448893353|FG000|Overall Study|Death|1|||
124798412|NCT02962765|448893353|FG000|Overall Study|Limited access to study medication|3|||
124798413|NCT00750880|448893359|FG000|Overall Study|Adverse Event|76|||
124798414|NCT00750880|448893359|FG000|Overall Study|Death|4|||
124798415|NCT00750880|448893359|FG000|Overall Study|Lack of Efficacy|46|||
124798416|NCT00750880|448893359|FG000|Overall Study|Lost to Follow-up|10|||
124798417|NCT00750880|448893359|FG000|Overall Study|Protocol Violation|15|||
124798418|NCT00750880|448893359|FG000|Overall Study|Withdrawal by Subject|33|||
124798419|NCT00750880|448893359|FG000|Overall Study|Physician Decision|20|||
124798420|NCT00750880|448893359|FG000|Overall Study|Administrative|11|||
124798421|NCT00984568|448893360|FG000|Overall Study|Withdrawal by Subject|1|||
124798422|NCT00984568|448893361|FG001|Overall Study|Withdrawal by Subject|2|||
124798423|NCT00984568|448893360|FG000|Overall Study|Lack of Efficacy|2|||
124798424|NCT00984568|448893361|FG001|Overall Study|Lack of Efficacy|0|||
124798425|NCT00984568|448893360|FG000|Overall Study|Adverse Event|2|||
124798426|NCT00984568|448893361|FG001|Overall Study|Adverse Event|0|||
124798427|NCT00984568|448893360|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
124798428|NCT00984568|448893361|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
124798429|NCT00984568|448893360|FG000|Overall Study|Lost to Follow-up|0|||
124798430|NCT00984568|448893361|FG001|Overall Study|Lost to Follow-up|1|||
124798431|NCT00984568|448893360|FG000|Overall Study|Opportunistic Infection|1|||
124798432|NCT00984568|448893361|FG001|Overall Study|Opportunistic Infection|0|||
124798433|NCT00984568|448893360|FG000|Overall Study|Unknown Reason|1|||
124798434|NCT00984568|448893361|FG001|Overall Study|Unknown Reason|3|||
124798435|NCT02964507|448893362|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
124798436|NCT02964507|448893363|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
124798437|NCT02964507|448893364|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
124798438|NCT02964507|448893365|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
124798439|NCT02964507|448893366|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
124798440|NCT02964507|448893367|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
124798441|NCT02964507|448893368|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
124798442|NCT02964507|448893369|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
124798443|NCT02964507|448893362|FG000|Overall Study|Study terminated by Sponsor|9|||
124798444|NCT02964507|448893363|FG001|Overall Study|Study terminated by Sponsor|1|||
124798445|NCT02964507|448893364|FG002|Overall Study|Study terminated by Sponsor|9|||
124798446|NCT02964507|448893365|FG003|Overall Study|Study terminated by Sponsor|3|||
124798447|NCT02964507|448893366|FG004|Overall Study|Study terminated by Sponsor|3|||
124798448|NCT02964507|448893367|FG005|Overall Study|Study terminated by Sponsor|2|||
124798449|NCT02964507|448893368|FG006|Overall Study|Study terminated by Sponsor|0|||
124798450|NCT02964507|448893369|FG007|Overall Study|Study terminated by Sponsor|0|||
124798451|NCT02964507|448893362|FG000|Overall Study|Other|3|||
124798452|NCT02964507|448893363|FG001|Overall Study|Other|0|||
124798453|NCT02964507|448893364|FG002|Overall Study|Other|0|||
124798454|NCT02964507|448893365|FG003|Overall Study|Other|0|||
124798455|NCT02964507|448893366|FG004|Overall Study|Other|1|||
124798456|NCT02964507|448893367|FG005|Overall Study|Other|0|||
124798457|NCT02964507|448893368|FG006|Overall Study|Other|0|||
124798458|NCT02964507|448893369|FG007|Overall Study|Other|0|||
124798459|NCT02964507|448893362|FG000|Overall Study|Death|11|||
124798460|NCT02964507|448893363|FG001|Overall Study|Death|9|||
124798461|NCT02964507|448893364|FG002|Overall Study|Death|12|||
124798462|NCT02964507|448893365|FG003|Overall Study|Death|2|||
124798463|NCT02964507|448893366|FG004|Overall Study|Death|10|||
124798464|NCT02964507|448893367|FG005|Overall Study|Death|5|||
124798465|NCT02964507|448893368|FG006|Overall Study|Death|0|||
124798466|NCT02964507|448893369|FG007|Overall Study|Death|0|||
124798467|NCT02964507|448893362|FG000|Overall Study|Withdrawal by Subject|1|||
124798468|NCT02964507|448893363|FG001|Overall Study|Withdrawal by Subject|0|||
124798469|NCT02964507|448893364|FG002|Overall Study|Withdrawal by Subject|1|||
124798470|NCT02964507|448893365|FG003|Overall Study|Withdrawal by Subject|1|||
124798471|NCT02964507|448893366|FG004|Overall Study|Withdrawal by Subject|0|||
124798472|NCT02964507|448893367|FG005|Overall Study|Withdrawal by Subject|1|||
124798473|NCT02964507|448893368|FG006|Overall Study|Withdrawal by Subject|0|||
124798474|NCT02964507|448893369|FG007|Overall Study|Withdrawal by Subject|0|||
124798475|NCT02964507|448893362|FG000|Overall Study|Physician Decision|2|||
124798476|NCT02964507|448893363|FG001|Overall Study|Physician Decision|0|||
124798477|NCT02964507|448893364|FG002|Overall Study|Physician Decision|3|||
124798478|NCT02964507|448893365|FG003|Overall Study|Physician Decision|0|||
124798479|NCT02964507|448893366|FG004|Overall Study|Physician Decision|1|||
124798480|NCT02964507|448893367|FG005|Overall Study|Physician Decision|0|||
124798481|NCT02964507|448893368|FG006|Overall Study|Physician Decision|0|||
124798482|NCT02964507|448893369|FG007|Overall Study|Physician Decision|0|||
124798483|NCT03880461|448893373|FG000|Overall Study|Determined ineligible after enrollment|45|||
124798484|NCT03880461|448893374|FG001|Overall Study|Determined ineligible after enrollment|44|||
124798485|NCT03880461|448893373|FG000|Overall Study|No weight measurement after enrollment|24|||
124798486|NCT03880461|448893374|FG001|Overall Study|No weight measurement after enrollment|17|||
124798487|NCT04025710|448893377|FG000|Overall Study|Death|3|||
124798488|NCT04025710|448893377|FG000|Overall Study|Lost to Follow-up|5|||
124798489|NCT04025710|448893377|FG000|Overall Study|Withdrawal by Subject|1|||
124798490|NCT04025710|448893377|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
124798491|NCT04025710|448893377|FG000|Overall Study|Drop-out according to protocol|34|||
124798492|NCT02431247|448893378|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
124798493|NCT02431247|448893379|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
124798494|NCT02431247|448893380|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
124798495|NCT02431247|448893378|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
124798496|NCT02431247|448893379|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
124798497|NCT02431247|448893380|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
124798498|NCT02431247|448893378|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
124798499|NCT02431247|448893379|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
124798500|NCT02431247|448893380|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
124798501|NCT02431247|448893378|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
124798502|NCT02431247|448893379|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
124798503|NCT02431247|448893380|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
124798504|NCT02431247|448893378|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
124798505|NCT02431247|448893379|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
124798506|NCT02431247|448893380|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
124798507|NCT02431247|448893378|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
124798508|NCT02431247|448893379|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
124798509|NCT02431247|448893380|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
124798510|NCT02431247|448893378|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
124798511|NCT02431247|448893379|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
124798512|NCT02431247|448893380|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
124798513|NCT02431247|448893378|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
125295719|NCT00657371|450709503|FG000|Overall Study|Pre-existing medical condition|4|||
125295720|NCT02712424|450709504|FG000|Overall Study|Lost to Follow-up|34|||
125295721|NCT02712424|450709505|FG001|Overall Study|Lost to Follow-up|32|||
125295722|NCT02713867|450709511|FG000|Randomization|Other Reason|2|||
125295723|NCT02713867|450709512|FG001|Randomization|Other Reason|1|||
125295724|NCT02713867|450709511|FG000|Randomization|Participant Withdrew consent|0|||
125295725|NCT02713867|450709512|FG001|Randomization|Participant Withdrew consent|2|||
125295726|NCT02713867|450709511|FG000|Treatment Period|Other Reasons|22|||
125295727|NCT02713867|450709512|FG001|Treatment Period|Other Reasons|28|||
125295728|NCT02713867|450709511|FG000|Treatment Period|Administrative reason by sponsor|21|||
125295729|NCT02713867|450709512|FG001|Treatment Period|Administrative reason by sponsor|16|||
125295730|NCT02713867|450709511|FG000|Treatment Period|No longer meets study criteria|2|||
125295731|NCT02713867|450709512|FG001|Treatment Period|No longer meets study criteria|1|||
125295732|NCT02713867|450709511|FG000|Treatment Period|Poor/Non Compliance|1|||
125295733|NCT02713867|450709512|FG001|Treatment Period|Poor/Non Compliance|0|||
125295734|NCT02713867|450709511|FG000|Treatment Period|Maximum Clinical Benefit|5|||
125295735|NCT02713867|450709512|FG001|Treatment Period|Maximum Clinical Benefit|6|||
125295736|NCT02713867|450709511|FG000|Treatment Period|Withdrew consent|3|||
125295737|NCT02713867|450709512|FG001|Treatment Period|Withdrew consent|6|||
125295738|NCT02713867|450709511|FG000|Treatment Period|Requested to Discontinue|8|||
125295739|NCT02713867|450709512|FG001|Treatment Period|Requested to Discontinue|8|||
125295740|NCT02713867|450709511|FG000|Treatment Period|AE unrelated to Study Drug|11|||
125295741|NCT02713867|450709512|FG001|Treatment Period|AE unrelated to Study Drug|10|||
125295742|NCT02713867|450709511|FG000|Treatment Period|Death|7|||
125295743|NCT02713867|450709512|FG001|Treatment Period|Death|3|||
125295744|NCT02713867|450709511|FG000|Treatment Period|Study Drug Toxicity|16|||
125295745|NCT02713867|450709512|FG001|Treatment Period|Study Drug Toxicity|19|||
125295746|NCT02713867|450709511|FG000|Treatment Period|Disease Progression|82|||
125295747|NCT02713867|450709512|FG001|Treatment Period|Disease Progression|83|||
124798514|NCT02431247|448893379|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
124798515|NCT02431247|448893380|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
124798516|NCT02431247|448893378|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
124798517|NCT02431247|448893379|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
124798518|NCT02431247|448893380|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
124798519|NCT02431247|448893378|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
124798520|NCT02431247|448893379|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
124798521|NCT02431247|448893380|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
124798522|NCT02431247|448893378|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
124798523|NCT02431247|448893379|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
124798524|NCT02431247|448893380|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
124798525|NCT02431247|448893378|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
124798526|NCT02431247|448893379|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
125295748|NCT02715726|450709516|FG000|Overall Study|Adverse Event|2|||
125295749|NCT02715726|450709517|FG001|Overall Study|Adverse Event|6|||
125295750|NCT02715726|450709516|FG000|Overall Study|Protocol Violation|1|||
125295751|NCT02715726|450709517|FG001|Overall Study|Protocol Violation|0|||
125295752|NCT02715726|450709516|FG000|Overall Study|Death|2|||
125295753|NCT02715726|450709517|FG001|Overall Study|Death|1|||
125295754|NCT02715726|450709516|FG000|Overall Study|Participant moved|1|||
125295755|NCT02715726|450709517|FG001|Overall Study|Participant moved|3|||
125295756|NCT02715726|450709516|FG000|Overall Study|Other than specified above|11|||
125295757|NCT02715726|450709517|FG001|Overall Study|Other than specified above|15|||
125295758|NCT02715726|450709516|FG000|Overall Study|Randomized but not treated|1|||
125295759|NCT02715726|450709517|FG001|Overall Study|Randomized but not treated|2|||
125295760|NCT02445573|450709518|FG000|Overall Study|Withdrawal by Subject|1|||
125295761|NCT02445573|450709519|FG001|Overall Study|Withdrawal by Subject|1|||
124798527|NCT02431247|448893380|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
124798528|NCT02431247|448893378|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
124798529|NCT02431247|448893379|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
124798530|NCT02431247|448893380|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
124798531|NCT02431247|448893378|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
124798532|NCT02431247|448893379|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
124798533|NCT02431247|448893380|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
124798534|NCT01562873|448893381|FG000|Overall Study|Disease Progression per RECIST|10|||
124798535|NCT01562873|448893382|FG001|Overall Study|Disease Progression per RECIST|0|||
124798536|NCT01562873|448893381|FG000|Overall Study|Adverse Event|1|||
124798537|NCT01562873|448893382|FG001|Overall Study|Adverse Event|0|||
124798538|NCT01562873|448893381|FG000|Overall Study|Clinical Disease Progression|9|||
124798539|NCT01562873|448893382|FG001|Overall Study|Clinical Disease Progression|0|||
124798540|NCT01562873|448893381|FG000|Overall Study|Clinical PD and adverse event|1|||
124798541|NCT01562873|448893382|FG001|Overall Study|Clinical PD and adverse event|0|||
124798542|NCT01369485|448893383|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
124798543|NCT01369485|448893384|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
124798544|NCT01369485|448893383|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
124798545|NCT01369485|448893384|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
124798546|NCT01369485|448893383|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
124798547|NCT01369485|448893384|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
124798548|NCT01369485|448893383|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
124798549|NCT01369485|448893384|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
124798550|NCT01369485|448893383|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
124798551|NCT01369485|448893384|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
124798552|NCT01369485|448893383|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
124798553|NCT01369485|448893384|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
124798554|NCT01369485|448893383|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
124798555|NCT01369485|448893384|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
124798556|NCT01369485|448893383|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
124798557|NCT01369485|448893384|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
124798558|NCT01369485|448893383|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
124798559|NCT01369485|448893384|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
124798560|NCT01369485|448893383|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
124798561|NCT01369485|448893384|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
124798562|NCT00194675|448893395|FG000|Overall Study|Lost to Follow-up|1|||
125295762|NCT02445573|450709518|FG000|Overall Study|Lost to Follow-up|0|||
125295763|NCT02445573|450709519|FG001|Overall Study|Lost to Follow-up|1|||
125295764|NCT03230292|450709520|FG000|Overall Study|Adverse Event|1|||
125295765|NCT03230292|450709520|FG000|Overall Study|Protocol Violation|1|||
125295766|NCT03230292|450709520|FG000|Overall Study|Lost to Follow-up|1|||
125295767|NCT03230292|450709520|FG000|Overall Study|Withdrawal by Subject|3|||
125295768|NCT01639755|450709521|FG000|Overall Study|Study Ongoing|15|||
125295769|NCT01639755|450709521|FG000|Overall Study|Patient had device explantation|4|||
124798563|NCT00194675|448893396|FG001|Overall Study|Lost to Follow-up|1|||
124798564|NCT00194675|448893395|FG000|Overall Study|lack of interest|1|||
124798565|NCT00194675|448893396|FG001|Overall Study|lack of interest|1|||
124798566|NCT00194675|448893395|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
124798567|NCT00194675|448893396|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
124798568|NCT00194675|448893395|FG000|Overall Study|Protocol Violation|1|||
124798569|NCT00194675|448893396|FG001|Overall Study|Protocol Violation|0|||
124798570|NCT00194675|448893395|FG000|Overall Study|Death|1|||
124798571|NCT00194675|448893396|FG001|Overall Study|Death|0|||
124798572|NCT01285960|448893397|FG000|Overall Study|Withdrawal by Subject|2|||
124798573|NCT01285960|448893397|FG000|Overall Study|Lost to Follow-up|2|||
124798574|NCT01285960|448893397|FG000|Overall Study|2 subjects received less 10 sonications|2|||
124798575|NCT02280473|448893400|FG000|Overall Study|Adverse Event|1|||
124798576|NCT02280473|448893401|FG001|Overall Study|Adverse Event|1|||
124798577|NCT02280473|448893400|FG000|Overall Study|Lack of Efficacy|0|||
124798578|NCT02280473|448893401|FG001|Overall Study|Lack of Efficacy|1|||
124798579|NCT02280473|448893400|FG000|Overall Study|Lost to Follow-up|0|||
124798580|NCT02280473|448893401|FG001|Overall Study|Lost to Follow-up|1|||
124798581|NCT01484054|448893402|FG000|Period 1|Withdrawal by Subject|0|||
124798582|NCT01484054|448893403|FG001|Period 1|Withdrawal by Subject|1|||
124798583|NCT01610271|448893404|FG000|Overall Study|Surgery not complete|0|||
124798584|NCT01610271|448893405|FG001|Overall Study|Surgery not complete|1|||
124798585|NCT01610271|448893404|FG000|Overall Study|Prosthesis not implanted|2|||
124798586|NCT01610271|448893405|FG001|Overall Study|Prosthesis not implanted|3|||
124798587|NCT00364130|448893406|FG000|Intervention Period|Lost to Follow-up|4|||
124798588|NCT00364130|448893407|FG001|Intervention Period|Lost to Follow-up|3|||
124798589|NCT00364130|448893406|FG000|Intervention Period|Pregnancy|1|||
124798590|NCT00364130|448893407|FG001|Intervention Period|Pregnancy|0|||
124798591|NCT00364130|448893406|FG000|Intervention Period|Withdrawal by Subject|4|||
124798592|NCT00364130|448893407|FG001|Intervention Period|Withdrawal by Subject|5|||
124798593|NCT00364130|448893406|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
124798594|NCT00364130|448893407|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
124798595|NCT00410202|448893408|FG000|On-Treatment|Continuing treatment|69|||
124798596|NCT00410202|448893409|FG001|On-Treatment|Continuing treatment|71|||
124798597|NCT00410202|448893410|FG002|On-Treatment|Continuing treatment|66|||
124798598|NCT00410202|448893408|FG000|On-Treatment|Adverse Event|1|||
124798599|NCT00410202|448893409|FG001|On-Treatment|Adverse Event|3|||
124798600|NCT00410202|448893410|FG002|On-Treatment|Adverse Event|2|||
124798601|NCT00410202|448893408|FG000|On-Treatment|Death|1|||
124798602|NCT00410202|448893409|FG001|On-Treatment|Death|0|||
124798603|NCT00410202|448893410|FG002|On-Treatment|Death|0|||
124798604|NCT00410202|448893408|FG000|On-Treatment|Lost to Follow-up|1|||
124798605|NCT00410202|448893409|FG001|On-Treatment|Lost to Follow-up|0|||
124798606|NCT00410202|448893410|FG002|On-Treatment|Lost to Follow-up|1|||
124798607|NCT00410202|448893408|FG000|On-Treatment|Lack of Efficacy|1|||
124798608|NCT00410202|448893409|FG001|On-Treatment|Lack of Efficacy|4|||
124798609|NCT00410202|448893410|FG002|On-Treatment|Lack of Efficacy|0|||
124798610|NCT00410202|448893408|FG000|On-Treatment|Withdrawal by Subject|2|||
124798611|NCT00410202|448893409|FG001|On-Treatment|Withdrawal by Subject|1|||
124798612|NCT00410202|448893410|FG002|On-Treatment|Withdrawal by Subject|1|||
124798613|NCT00410202|448893408|FG000|On-Treatment|Other Reason|0|||
124798614|NCT00410202|448893409|FG001|On-Treatment|Other Reason|0|||
124798615|NCT00410202|448893410|FG002|On-Treatment|Other Reason|1|||
124798616|NCT00410202|448893408|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
124798617|NCT00410202|448893409|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
124798618|NCT00410202|448893410|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
124798619|NCT00410202|448893408|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
124798620|NCT00410202|448893409|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
124798621|NCT00410202|448893410|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
124798622|NCT00410202|448893408|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
124798623|NCT00410202|448893409|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
124798624|NCT00410202|448893410|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
124798625|NCT00144027|448893412|FG000|Overall Study|Lost to Follow-up|1|||
124798626|NCT00144027|448893413|FG001|Overall Study|Lost to Follow-up|3|||
124798627|NCT00144027|448893412|FG000|Overall Study|Withdrawal by Subject|2|||
124798628|NCT00144027|448893413|FG001|Overall Study|Withdrawal by Subject|2|||
124798629|NCT00144027|448893412|FG000|Overall Study|did not complete baseline assessment|0|||
124798630|NCT00144027|448893413|FG001|Overall Study|did not complete baseline assessment|6|||
125295770|NCT03995355|450709527|FG000|Overall Study|Adverse Event|1|||
124798631|NCT03194490|448893425|FG000|Overall Study|Lost to Follow-up|1|||
124798632|NCT03194490|448893426|FG001|Overall Study|Lost to Follow-up|3|||
124798633|NCT03194490|448893425|FG000|Overall Study|participant developed specific neck pain|1|||
124798634|NCT03194490|448893426|FG001|Overall Study|participant developed specific neck pain|0|||
124798635|NCT01758289|448893427|FG000|Overall Study|Premature Study Termination|44|||
124798636|NCT01758289|448893427|FG000|Overall Study|Adverse Event|9|||
125295771|NCT03995355|450709528|FG001|Overall Study|Adverse Event|0|||
124798637|NCT01574079|448893428|FG000|Overall Study|Physician Decision|0|||
124798638|NCT01574079|448893429|FG001|Overall Study|Physician Decision|2|||
124798639|NCT01574079|448893428|FG000|Overall Study|Lost to Follow-up|1|||
124798640|NCT01574079|448893429|FG001|Overall Study|Lost to Follow-up|0|||
124798641|NCT00285207|448893432|FG000|Overall Study|Lost to Follow-up|3|||
124798642|NCT00285207|448893433|FG001|Overall Study|Lost to Follow-up|2|||
124798643|NCT00285207|448893432|FG000|Overall Study|Withdrawal by Subject|5|||
124798644|NCT00285207|448893433|FG001|Overall Study|Withdrawal by Subject|2|||
124798645|NCT00285207|448893432|FG000|Overall Study|Pregnancy|1|||
124798646|NCT00285207|448893433|FG001|Overall Study|Pregnancy|1|||
124798647|NCT00285207|448893432|FG000|Overall Study|non-compliance|0|||
124798648|NCT00285207|448893433|FG001|Overall Study|non-compliance|1|||
124798649|NCT02294773|448895019|FG000|Overall Study|Withdrawal by Subject|0|||
124798650|NCT02294773|448895020|FG001|Overall Study|Withdrawal by Subject|2|||
124798651|NCT03052764|448895021|FG000|Double-Blind Treatment Period|Adverse Event|2|||
124798652|NCT03052764|448895022|FG001|Double-Blind Treatment Period|Adverse Event|0|||
124798653|NCT03052764|448895021|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
124798654|NCT03052764|448895022|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
124798655|NCT03052764|448895021|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
124798656|NCT03052764|448895022|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
124798657|NCT03052764|448895021|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
124798658|NCT03052764|448895022|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
124798659|NCT03052764|448895021|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
124798660|NCT03052764|448895022|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
124798661|NCT05828095|448895023|FG000|Overall Study|Lost to Follow-up|1|||
124798662|NCT05828095|448895024|FG001|Overall Study|Lost to Follow-up|0|||
124798663|NCT05828095|448895023|FG000|Overall Study|Reactogenicity symptom|0|||
124798664|NCT05828095|448895024|FG001|Overall Study|Reactogenicity symptom|1|||
124798665|NCT03206073|448895025|FG000|Overall Study|Participant Noncompliance|0|||
124798666|NCT03206073|448895026|FG001|Overall Study|Participant Noncompliance|1|||
124798667|NCT03206073|448895027|FG002|Overall Study|Participant Noncompliance|0|||
124798668|NCT03206073|448895028|FG003|Overall Study|Participant Noncompliance|0|||
124798669|NCT03206073|448895025|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
124798670|NCT03206073|448895026|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
124798671|NCT03206073|448895027|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
124798672|NCT03206073|448895028|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
124798673|NCT03206073|448895025|FG000|Overall Study|Death|0|||
124798674|NCT03206073|448895026|FG001|Overall Study|Death|0|||
124798675|NCT03206073|448895027|FG002|Overall Study|Death|1|||
124798676|NCT03206073|448895028|FG003|Overall Study|Death|0|||
124798677|NCT03206073|448895025|FG000|Overall Study|Taken off active treatment|0|||
124798678|NCT03206073|448895026|FG001|Overall Study|Taken off active treatment|0|||
124798679|NCT03206073|448895027|FG002|Overall Study|Taken off active treatment|3|||
124798680|NCT03206073|448895028|FG003|Overall Study|Taken off active treatment|0|||
124798681|NCT03332771|448895029|FG000|Overall Study|Adverse Event|6|||
124798682|NCT03332771|448895030|FG001|Overall Study|Adverse Event|4|||
124798683|NCT03332771|448895031|FG002|Overall Study|Adverse Event|1|||
124798684|NCT03332771|448895032|FG003|Overall Study|Adverse Event|3|||
124798685|NCT03332771|448895029|FG000|Overall Study|Poor Compliance to Protocol|0|||
124798686|NCT03332771|448895030|FG001|Overall Study|Poor Compliance to Protocol|1|||
124798687|NCT03332771|448895031|FG002|Overall Study|Poor Compliance to Protocol|0|||
124798688|NCT03332771|448895032|FG003|Overall Study|Poor Compliance to Protocol|1|||
124798689|NCT03332771|448895029|FG000|Overall Study|Lost to Follow-up|2|||
124798690|NCT03332771|448895030|FG001|Overall Study|Lost to Follow-up|2|||
124798691|NCT03332771|448895031|FG002|Overall Study|Lost to Follow-up|1|||
124798692|NCT03332771|448895032|FG003|Overall Study|Lost to Follow-up|2|||
124798693|NCT03332771|448895029|FG000|Overall Study|At the Participant's own request|20|||
124798694|NCT03332771|448895030|FG001|Overall Study|At the Participant's own request|26|||
124798695|NCT03332771|448895031|FG002|Overall Study|At the Participant's own request|14|||
124798696|NCT03332771|448895032|FG003|Overall Study|At the Participant's own request|23|||
124798697|NCT03332771|448895029|FG000|Overall Study|Reason Not Specified|6|||
124798698|NCT03332771|448895030|FG001|Overall Study|Reason Not Specified|18|||
124798699|NCT03332771|448895031|FG002|Overall Study|Reason Not Specified|16|||
124798700|NCT03332771|448895032|FG003|Overall Study|Reason Not Specified|19|||
124798701|NCT00096954|448895033|FG000|Overall Study|Adverse Event|3|||
124798702|NCT00096954|448895034|FG001|Overall Study|Adverse Event|1|||
124798703|NCT00096954|448895033|FG000|Overall Study|Withdrawal by Subject|9|||
124798704|NCT00096954|448895034|FG001|Overall Study|Withdrawal by Subject|8|||
124798705|NCT00096954|448895033|FG000|Overall Study|Physician Decision|1|||
124798706|NCT00096954|448895034|FG001|Overall Study|Physician Decision|1|||
124798707|NCT00096954|448895033|FG000|Overall Study|Sponsors Decision|1|||
124798708|NCT00096954|448895034|FG001|Overall Study|Sponsors Decision|1|||
124798709|NCT00096954|448895033|FG000|Overall Study|Pregnancy|1|||
124798710|NCT00096954|448895034|FG001|Overall Study|Pregnancy|1|||
124798711|NCT00096954|448895033|FG000|Overall Study|Initiation of immunotherapy|1|||
124798712|NCT00096954|448895034|FG001|Overall Study|Initiation of immunotherapy|0|||
124798713|NCT00096954|448895033|FG000|Overall Study|Non-compliance|0|||
124798714|NCT00096954|448895034|FG001|Overall Study|Non-compliance|3|||
124798715|NCT00096954|448895033|FG000|Overall Study|Lost to Follow-up|8|||
124798716|NCT00096954|448895034|FG001|Overall Study|Lost to Follow-up|5|||
124798717|NCT04478123|448895036|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
124798718|NCT04478123|448895036|FG000|Overall Study|NE|1|||
124798719|NCT03581786|448895039|FG000|Overall Study|Death|67|||
124798720|NCT03581786|448895040|FG001|Overall Study|Death|47|||
124798721|NCT03581786|448895039|FG000|Overall Study|Withdrawal by Subject|2|||
124798722|NCT03581786|448895040|FG001|Overall Study|Withdrawal by Subject|5|||
124798723|NCT03581786|448895039|FG000|Overall Study|Lost to Follow-up|7|||
124798724|NCT03581786|448895040|FG001|Overall Study|Lost to Follow-up|4|||
124798725|NCT03581786|448895039|FG000|Overall Study|reason other than specified above|0|||
124798726|NCT03581786|448895040|FG001|Overall Study|reason other than specified above|1|||
124798727|NCT01347307|448895043|FG000|Overall Study|Death|0|||
124798728|NCT01347307|448895044|FG001|Overall Study|Death|4|||
124798729|NCT01347307|448895043|FG000|Overall Study|Physician Decision|0|||
124798730|NCT01347307|448895044|FG001|Overall Study|Physician Decision|1|||
124798731|NCT04123665|448895049|FG000|Overall Study|Withdrawal by Subject|7|||
124798732|NCT04123665|448895050|FG001|Overall Study|Withdrawal by Subject|0|||
124798733|NCT04123665|448895049|FG000|Overall Study|Lost to Follow-up|1|||
124798734|NCT04123665|448895050|FG001|Overall Study|Lost to Follow-up|0|||
124798735|NCT02237911|448895051|FG000|Overall Study|Withdrawal by Subject|4|||
124798736|NCT02237911|448895052|FG001|Overall Study|Withdrawal by Subject|7|||
124798737|NCT02237911|448895053|FG002|Overall Study|Withdrawal by Subject|2|||
124798738|NCT02237911|448895051|FG000|Overall Study|Lost to Follow-up|3|||
124798739|NCT02237911|448895052|FG001|Overall Study|Lost to Follow-up|1|||
124798740|NCT02237911|448895053|FG002|Overall Study|Lost to Follow-up|1|||
124798741|NCT00053365|448895054|FG000|Overall Study|Incorrect cell type|1|||
124798742|NCT00053365|448895054|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
124798743|NCT00053365|448895054|FG000|Overall Study|Never treated|4|||
124798744|NCT00958789|448895059|FG000|Overall Study|Death|5|||
124798745|NCT00958789|448895059|FG000|Overall Study|Lost to Follow-up|14|||
124798746|NCT00958789|448895059|FG000|Overall Study|Withdrawal by Subject|17|||
124798747|NCT00958789|448895059|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
124798748|NCT00958789|448895059|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
124798749|NCT00958789|448895059|FG000|Overall Study|Subject terminated|2|||
124798750|NCT00958789|448895059|FG000|Overall Study|Revision|7|||
124798751|NCT00721123|448895060|FG000|Overall Study|Adverse Event|96|||
124798752|NCT00721123|448895060|FG000|Overall Study|Death|10|||
124798753|NCT00721123|448895060|FG000|Overall Study|Insufficient Therapeutic Response|21|||
124798754|NCT00721123|448895060|FG000|Overall Study|Protocol Violation|1|||
124798755|NCT00721123|448895060|FG000|Overall Study|Refused Treatment|41|||
124798756|NCT00721123|448895060|FG000|Overall Study|Failure to Return|9|||
124798757|NCT00721123|448895060|FG000|Overall Study|Withdrawal by Subject|5|||
124798758|NCT00433511|448895067|FG000|Step 1|Adverse Event|50|||
124798759|NCT00433511|448895068|FG001|Step 1|Adverse Event|157|||
124798760|NCT00433511|448895069|FG002|Step 1|Adverse Event|153|||
124798761|NCT00433511|448895067|FG000|Step 1|Withdrawal by Subject|45|||
124798762|NCT00433511|448895068|FG001|Step 1|Withdrawal by Subject|143|||
124798763|NCT00433511|448895069|FG002|Step 1|Withdrawal by Subject|154|||
124798764|NCT00433511|448895067|FG000|Step 1|Death|3|||
124798765|NCT00433511|448895068|FG001|Step 1|Death|1|||
124798766|NCT00433511|448895069|FG002|Step 1|Death|1|||
124798767|NCT00433511|448895067|FG000|Step 1|Physician Decision|1|||
124798768|NCT00433511|448895068|FG001|Step 1|Physician Decision|4|||
124798769|NCT00433511|448895069|FG002|Step 1|Physician Decision|3|||
124798770|NCT00433511|448895067|FG000|Step 1|Never started protocol therapy|28|||
124798771|NCT00433511|448895068|FG001|Step 1|Never started protocol therapy|64|||
124798772|NCT00433511|448895069|FG002|Step 1|Never started protocol therapy|66|||
124798773|NCT00433511|448895067|FG000|Step 1|Alternative therapy|2|||
125295772|NCT03995355|450709527|FG000|Overall Study|Withdrawal by Subject|1|||
124798774|NCT00433511|448895068|FG001|Step 1|Alternative therapy|1|||
124798775|NCT00433511|448895069|FG002|Step 1|Alternative therapy|3|||
124798776|NCT00433511|448895067|FG000|Step 1|Disease progression, relapse|5|||
124798777|NCT00433511|448895068|FG001|Step 1|Disease progression, relapse|3|||
124798778|NCT00433511|448895069|FG002|Step 1|Disease progression, relapse|3|||
124798779|NCT00433511|448895067|FG000|Step 1|Other complicating disease|2|||
124798780|NCT00433511|448895068|FG001|Step 1|Other complicating disease|6|||
124798781|NCT00433511|448895069|FG002|Step 1|Other complicating disease|3|||
124798782|NCT00433511|448895067|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
124798783|NCT00433511|448895068|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
124798784|NCT00433511|448895069|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
124798785|NCT00433511|448895067|FG000|Step 1|Suspected recurrence|0|||
124798786|NCT00433511|448895068|FG001|Step 1|Suspected recurrence|1|||
124798787|NCT00433511|448895069|FG002|Step 1|Suspected recurrence|0|||
124798788|NCT00433511|448895067|FG000|Step 1|Insurance/drug distribution issues|0|||
124798789|NCT00433511|448895068|FG001|Step 1|Insurance/drug distribution issues|1|||
124798790|NCT00433511|448895069|FG002|Step 1|Insurance/drug distribution issues|2|||
124798791|NCT00433511|448895067|FG000|Step 1|Patient moved|0|||
124798792|NCT00433511|448895068|FG001|Step 1|Patient moved|0|||
124798793|NCT00433511|448895069|FG002|Step 1|Patient moved|1|||
124798794|NCT00433511|448895067|FG000|Step 2 (Arm D)|Adverse Event|0|||
124798795|NCT00433511|448895068|FG001|Step 2 (Arm D)|Adverse Event|0|||
124798796|NCT00433511|448895069|FG002|Step 2 (Arm D)|Adverse Event|135|||
124798797|NCT00433511|448895067|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
124798798|NCT00433511|448895068|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
124798799|NCT00433511|448895069|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
124798800|NCT00433511|448895067|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
124798801|NCT00433511|448895068|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
124798802|NCT00433511|448895069|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
124798803|NCT00433511|448895067|FG000|Step 2 (Arm D)|Physician Decision|0|||
124798804|NCT00433511|448895068|FG001|Step 2 (Arm D)|Physician Decision|0|||
124798805|NCT00433511|448895069|FG002|Step 2 (Arm D)|Physician Decision|9|||
124798806|NCT00433511|448895067|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
124798807|NCT00433511|448895068|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
124798808|NCT00433511|448895069|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
124798809|NCT00433511|448895067|FG000|Step 2 (Arm D)|Other complicating disease|0|||
124798810|NCT00433511|448895068|FG001|Step 2 (Arm D)|Other complicating disease|0|||
124798811|NCT00433511|448895069|FG002|Step 2 (Arm D)|Other complicating disease|3|||
124798812|NCT00433511|448895067|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
124798813|NCT00433511|448895068|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
124798814|NCT00433511|448895069|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
124798815|NCT00433511|448895067|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
124798816|NCT00433511|448895068|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
124798817|NCT00433511|448895069|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
124798818|NCT00433511|448895067|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
124798819|NCT00433511|448895068|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
124798820|NCT00433511|448895069|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
124798821|NCT00433511|448895067|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
124798822|NCT00433511|448895068|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
124798823|NCT00433511|448895069|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
124798824|NCT03139604|448895070|FG000|Overall Study|Other|7|||
124798825|NCT03139604|448895071|FG001|Overall Study|Other|3|||
124798826|NCT03139604|448895070|FG000|Overall Study|Withdrawal by Subject|16|||
124798827|NCT03139604|448895071|FG001|Overall Study|Withdrawal by Subject|17|||
124798828|NCT03139604|448895070|FG000|Overall Study|Physician Decision|1|||
124798829|NCT03139604|448895071|FG001|Overall Study|Physician Decision|2|||
124798830|NCT03139604|448895070|FG000|Overall Study|Lost to Follow-up|3|||
124798831|NCT03139604|448895071|FG001|Overall Study|Lost to Follow-up|1|||
124798832|NCT03139604|448895070|FG000|Overall Study|Death|65|||
124798833|NCT03139604|448895071|FG001|Overall Study|Death|67|||
124798834|NCT03139604|448895070|FG000|Overall Study|Study Terminated by Sponsor|122|||
124798835|NCT03139604|448895071|FG001|Overall Study|Study Terminated by Sponsor|127|||
124798836|NCT03139604|448895070|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
124798837|NCT03139604|448895071|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
124798838|NCT04950608|448895072|FG000|Overall Study|Withdrawal by Subject|2|||
124798839|NCT04950608|448895072|FG000|Overall Study|Physician Decision|3|||
124798840|NCT02007512|448895076|FG000|Double Blind Treatment Period|Adverse Event|4|||
124798841|NCT02007512|448895077|FG001|Double Blind Treatment Period|Adverse Event|6|||
124798842|NCT02007512|448895078|FG002|Double Blind Treatment Period|Adverse Event|2|||
124798843|NCT02007512|448895079|FG003|Double Blind Treatment Period|Adverse Event|2|||
124798844|NCT02007512|448895076|FG000|Double Blind Treatment Period|Death|1|||
124798845|NCT02007512|448895077|FG001|Double Blind Treatment Period|Death|0|||
124798846|NCT02007512|448895078|FG002|Double Blind Treatment Period|Death|0|||
124798847|NCT02007512|448895079|FG003|Double Blind Treatment Period|Death|0|||
124798848|NCT02007512|448895076|FG000|Double Blind Treatment Period|Disease progression|51|||
124798849|NCT02007512|448895077|FG001|Double Blind Treatment Period|Disease progression|50|||
124798850|NCT02007512|448895078|FG002|Double Blind Treatment Period|Disease progression|57|||
124798851|NCT02007512|448895079|FG003|Double Blind Treatment Period|Disease progression|52|||
124798852|NCT02007512|448895076|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
124798853|NCT02007512|448895077|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
124798854|NCT02007512|448895078|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
124798855|NCT02007512|448895079|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
125295773|NCT03995355|450709528|FG001|Overall Study|Withdrawal by Subject|0|||
125295774|NCT03995355|450709527|FG000|Overall Study|Scheduling Issues|0|||
124798856|NCT02007512|448895076|FG000|Double Blind Treatment Period|Protocol Violation|1|||
124798857|NCT02007512|448895077|FG001|Double Blind Treatment Period|Protocol Violation|0|||
124798858|NCT02007512|448895078|FG002|Double Blind Treatment Period|Protocol Violation|0|||
124798859|NCT02007512|448895079|FG003|Double Blind Treatment Period|Protocol Violation|1|||
124798860|NCT02007512|448895076|FG000|Double Blind Treatment Period|Other|2|||
124798861|NCT02007512|448895077|FG001|Double Blind Treatment Period|Other|1|||
124798862|NCT02007512|448895078|FG002|Double Blind Treatment Period|Other|1|||
124798863|NCT02007512|448895079|FG003|Double Blind Treatment Period|Other|2|||
124798864|NCT02007512|448895076|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
124798865|NCT02007512|448895077|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
124798866|NCT02007512|448895078|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
124798867|NCT02007512|448895079|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
124798868|NCT02007512|448895076|FG000|Open Label Treatment Period|Adverse Event|1|||
124798869|NCT02007512|448895077|FG001|Open Label Treatment Period|Adverse Event|0|||
124798870|NCT02007512|448895078|FG002|Open Label Treatment Period|Adverse Event|0|||
124798871|NCT02007512|448895079|FG003|Open Label Treatment Period|Adverse Event|0|||
124798872|NCT02007512|448895076|FG000|Open Label Treatment Period|Other|1|||
124798873|NCT02007512|448895077|FG001|Open Label Treatment Period|Other|1|||
124798874|NCT02007512|448895078|FG002|Open Label Treatment Period|Other|0|||
124798875|NCT02007512|448895079|FG003|Open Label Treatment Period|Other|0|||
124798876|NCT02007512|448895076|FG000|Open Label Treatment Period|Disease progression|23|||
124798877|NCT02007512|448895077|FG001|Open Label Treatment Period|Disease progression|11|||
124798878|NCT02007512|448895078|FG002|Open Label Treatment Period|Disease progression|0|||
124798879|NCT02007512|448895079|FG003|Open Label Treatment Period|Disease progression|0|||
124798880|NCT00608543|448895082|FG000|Overall Study|Adverse Event|4|||
124798881|NCT03026088|448895084|FG000|Overall Study|Study termination|20|||
124798882|NCT01869725|448895086|FG000|Overall Study|ineligible after registration|1|||
124798883|NCT01869725|448895086|FG000|Overall Study|Death|1|||
124798884|NCT01869725|448895086|FG000|Overall Study|Lost to Follow-up|2|||
124798885|NCT01143207|448895087|FG000|Overall Study|Lost to Follow-up|2|||
124798886|NCT03416374|448895100|FG000|Between Treatment Period I and II|Other|0|||
124798887|NCT03416374|448895101|FG001|Between Treatment Period I and II|Other|9|||
124798888|NCT03416374|448895100|FG000|Treatment Period II|Lack of Efficacy|3|||
124798889|NCT03416374|448895101|FG001|Treatment Period II|Lack of Efficacy|11|||
124798890|NCT03416374|448895100|FG000|Treatment Period II|Adverse Event|1|||
124798891|NCT03416374|448895101|FG001|Treatment Period II|Adverse Event|4|||
124798892|NCT03416374|448895100|FG000|Treatment Period II|Death|0|||
124798893|NCT03416374|448895101|FG001|Treatment Period II|Death|1|||
124798894|NCT03416374|448895100|FG000|Treatment Period II|Other|0|||
124798895|NCT03416374|448895101|FG001|Treatment Period II|Other|2|||
124798896|NCT01052844|448895102|FG000|Overall Study|Adverse Event|0|||
124798897|NCT01052844|448895103|FG001|Overall Study|Adverse Event|1|||
124798898|NCT03463031|448895104|FG000|Overall Study|Withdrawal by Subject|4|||
124798899|NCT03463031|448895105|FG001|Overall Study|Withdrawal by Subject|2|||
124798900|NCT03463031|448895104|FG000|Overall Study|Investigator/Sponsor Decision|0|||
124798901|NCT03463031|448895105|FG001|Overall Study|Investigator/Sponsor Decision|1|||
124798902|NCT03463031|448895104|FG000|Overall Study|Lost to Follow-up|1|||
124798903|NCT03463031|448895105|FG001|Overall Study|Lost to Follow-up|1|||
124798904|NCT03463031|448895104|FG000|Overall Study|Adverse Event|4|||
124798905|NCT03463031|448895105|FG001|Overall Study|Adverse Event|1|||
124798906|NCT03463031|448895104|FG000|Overall Study|Use of prohibited medication by subject|1|||
124798907|NCT03463031|448895105|FG001|Overall Study|Use of prohibited medication by subject|0|||
124798908|NCT02537574|448895110|FG000|Overall Study|Adverse Event|1|||
124798909|NCT02537574|448895111|FG001|Overall Study|Adverse Event|3|||
124798910|NCT02537574|448895112|FG002|Overall Study|Adverse Event|2|||
124798911|NCT02537574|448895110|FG000|Overall Study|Lost to Follow-up|40|||
124798912|NCT02537574|448895111|FG001|Overall Study|Lost to Follow-up|51|||
124798913|NCT02537574|448895112|FG002|Overall Study|Lost to Follow-up|55|||
124798914|NCT02537574|448895110|FG000|Overall Study|Noncompliance with study drug|0|||
124798915|NCT02537574|448895111|FG001|Overall Study|Noncompliance with study drug|1|||
124798916|NCT02537574|448895112|FG002|Overall Study|Noncompliance with study drug|1|||
124798917|NCT02537574|448895110|FG000|Overall Study|Physician Decision|2|||
124798918|NCT02537574|448895111|FG001|Overall Study|Physician Decision|0|||
124798919|NCT02537574|448895112|FG002|Overall Study|Physician Decision|0|||
124798920|NCT02537574|448895110|FG000|Overall Study|Protocol Violation|4|||
124798921|NCT02537574|448895111|FG001|Overall Study|Protocol Violation|2|||
124798922|NCT02537574|448895112|FG002|Overall Study|Protocol Violation|3|||
124798923|NCT02537574|448895110|FG000|Overall Study|Withdrawal by Subject|37|||
124798924|NCT02537574|448895111|FG001|Overall Study|Withdrawal by Subject|27|||
124798925|NCT02537574|448895112|FG002|Overall Study|Withdrawal by Subject|29|||
124798926|NCT02537574|448895110|FG000|Overall Study|Lack of Efficacy|14|||
124798927|NCT02537574|448895111|FG001|Overall Study|Lack of Efficacy|16|||
124798928|NCT02537574|448895112|FG002|Overall Study|Lack of Efficacy|15|||
124798929|NCT02537574|448895110|FG000|Overall Study|Duplicate Patient|1|||
124798930|NCT02537574|448895111|FG001|Overall Study|Duplicate Patient|0|||
124798931|NCT02537574|448895112|FG002|Overall Study|Duplicate Patient|0|||
124798932|NCT02537574|448895110|FG000|Overall Study|Patient not Stable|0|||
124798933|NCT02537574|448895111|FG001|Overall Study|Patient not Stable|1|||
124798934|NCT02537574|448895112|FG002|Overall Study|Patient not Stable|0|||
124798935|NCT02537574|448895110|FG000|Overall Study|Incarceration|0|||
124798936|NCT02537574|448895111|FG001|Overall Study|Incarceration|1|||
124798937|NCT02537574|448895112|FG002|Overall Study|Incarceration|0|||
124798938|NCT02537574|448895110|FG000|Overall Study|Failed Naloxone Challenge|0|||
124798939|NCT02537574|448895111|FG001|Overall Study|Failed Naloxone Challenge|1|||
124798940|NCT02537574|448895112|FG002|Overall Study|Failed Naloxone Challenge|0|||
124798941|NCT02537574|448895110|FG000|Overall Study|Transportation Issues|0|||
124798942|NCT02537574|448895111|FG001|Overall Study|Transportation Issues|0|||
124798943|NCT02537574|448895112|FG002|Overall Study|Transportation Issues|1|||
124798944|NCT02537574|448895110|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
124798945|NCT02537574|448895111|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
124798946|NCT02537574|448895112|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
124798947|NCT02537574|448895110|FG000|Overall Study|Noncompliance with Protocol|0|||
124798948|NCT02537574|448895111|FG001|Overall Study|Noncompliance with Protocol|0|||
124798949|NCT02537574|448895112|FG002|Overall Study|Noncompliance with Protocol|1|||
124798950|NCT00048061|448895113|FG000|Overall Study|Adverse Event|41|||
124798951|NCT00048061|448895114|FG001|Overall Study|Adverse Event|32|||
124798952|NCT00048061|448895115|FG002|Overall Study|Adverse Event|44|||
124798953|NCT00048061|448895116|FG003|Overall Study|Adverse Event|37|||
124798954|NCT00048061|448895113|FG000|Overall Study|Lost to Follow-up|3|||
124798955|NCT00048061|448895114|FG001|Overall Study|Lost to Follow-up|2|||
124798956|NCT00048061|448895115|FG002|Overall Study|Lost to Follow-up|4|||
124798957|NCT00048061|448895116|FG003|Overall Study|Lost to Follow-up|5|||
124798958|NCT00048061|448895113|FG000|Overall Study|Withdrawal by Subject|20|||
124798959|NCT00048061|448895114|FG001|Overall Study|Withdrawal by Subject|29|||
124798960|NCT00048061|448895115|FG002|Overall Study|Withdrawal by Subject|29|||
124798961|NCT00048061|448895116|FG003|Overall Study|Withdrawal by Subject|32|||
124798962|NCT00048061|448895113|FG000|Overall Study|Did not follow-up|5|||
124798963|NCT00048061|448895114|FG001|Overall Study|Did not follow-up|5|||
124798964|NCT00048061|448895115|FG002|Overall Study|Did not follow-up|4|||
124798965|NCT00048061|448895116|FG003|Overall Study|Did not follow-up|5|||
124798966|NCT00048061|448895113|FG000|Overall Study|Early improvement|6|||
124798967|NCT00048061|448895114|FG001|Overall Study|Early improvement|5|||
124798968|NCT00048061|448895115|FG002|Overall Study|Early improvement|3|||
124798969|NCT00048061|448895116|FG003|Overall Study|Early improvement|0|||
124798970|NCT02675231|448895117|FG000|Overall Study|Withdrawal by Subject|2|||
124798971|NCT02675231|448895118|FG001|Overall Study|Withdrawal by Subject|4|||
124798972|NCT02675231|448895119|FG002|Overall Study|Withdrawal by Subject|2|||
124798973|NCT02675231|448895117|FG000|Overall Study|Lost to Follow-up|3|||
124798974|NCT02675231|448895118|FG001|Overall Study|Lost to Follow-up|4|||
124798975|NCT02675231|448895119|FG002|Overall Study|Lost to Follow-up|3|||
124798976|NCT02495233|448895120|FG000|Overall Study|Miscellaneous|0|||
124798977|NCT02495233|448895121|FG001|Overall Study|Miscellaneous|1|||
124798978|NCT02220998|448895123|FG000|Overall Study|Randomized but Never Treated|1|||
124798979|NCT02220998|448895124|FG001|Overall Study|Randomized but Never Treated|2|||
124798980|NCT02220998|448895123|FG000|Overall Study|Death|2|||
124798981|NCT02220998|448895124|FG001|Overall Study|Death|0|||
124798982|NCT02220998|448895123|FG000|Overall Study|Lack of Efficacy|0|||
124798983|NCT02220998|448895124|FG001|Overall Study|Lack of Efficacy|5|||
124798984|NCT02220998|448895123|FG000|Overall Study|Lost to Follow-up|4|||
124798985|NCT02220998|448895124|FG001|Overall Study|Lost to Follow-up|4|||
124798986|NCT02314143|448895125|FG000|Overall Study|Adverse Event|0|||
124798987|NCT02314143|448895126|FG001|Overall Study|Adverse Event|6|||
124798988|NCT02314143|448895127|FG002|Overall Study|Adverse Event|4|||
124798989|NCT02314143|448895125|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
124798990|NCT02314143|448895126|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
124798991|NCT02314143|448895127|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
124798992|NCT02314143|448895125|FG000|Overall Study|Physician Decision|2|||
124798993|NCT02314143|448895126|FG001|Overall Study|Physician Decision|1|||
124798994|NCT02314143|448895127|FG002|Overall Study|Physician Decision|0|||
124798995|NCT02314143|448895125|FG000|Overall Study|Withdrawal by Subject|1|||
124798996|NCT02314143|448895126|FG001|Overall Study|Withdrawal by Subject|0|||
124798997|NCT02314143|448895127|FG002|Overall Study|Withdrawal by Subject|1|||
124798998|NCT00873860|448895129|FG000|Overall Study|Lost to Follow-up|1|||
124798999|NCT00873860|448895130|FG001|Overall Study|Lost to Follow-up|0|||
124799000|NCT00873860|448895131|FG002|Overall Study|Lost to Follow-up|0|||
124799001|NCT00873860|448895132|FG003|Overall Study|Lost to Follow-up|1|||
124799002|NCT00873860|448895129|FG000|Overall Study|Withdrawal by Subject|1|||
124799003|NCT00873860|448895130|FG001|Overall Study|Withdrawal by Subject|0|||
124799004|NCT00873860|448895131|FG002|Overall Study|Withdrawal by Subject|2|||
124799005|NCT00873860|448895132|FG003|Overall Study|Withdrawal by Subject|0|||
124799006|NCT00873860|448895129|FG000|Overall Study|Death|1|||
124799007|NCT00873860|448895130|FG001|Overall Study|Death|0|||
124799008|NCT00873860|448895131|FG002|Overall Study|Death|0|||
124799009|NCT00873860|448895132|FG003|Overall Study|Death|0|||
124799010|NCT00873860|448895129|FG000|Overall Study|Other|1|||
124799011|NCT00873860|448895130|FG001|Overall Study|Other|0|||
124799012|NCT00873860|448895131|FG002|Overall Study|Other|1|||
124799013|NCT00873860|448895132|FG003|Overall Study|Other|0|||
124799014|NCT02140775|448895134|FG000|Overall Study|Withdrawal by Subject|30|||
124799015|NCT02140775|448895135|FG001|Overall Study|Withdrawal by Subject|7|||
124799016|NCT04650854|448895138|FG000|Overall Study|Adverse Event|1|||
124799017|NCT04650854|448895139|FG001|Overall Study|Adverse Event|12|||
124799018|NCT04650854|448895140|FG002|Overall Study|Adverse Event|14|||
124799019|NCT04650854|448895138|FG000|Overall Study|Lack of Efficacy|1|||
124799020|NCT04650854|448895139|FG001|Overall Study|Lack of Efficacy|3|||
124799021|NCT04650854|448895140|FG002|Overall Study|Lack of Efficacy|6|||
124799022|NCT04650854|448895138|FG000|Overall Study|Lost to Follow-up|1|||
125295775|NCT03995355|450709528|FG001|Overall Study|Scheduling Issues|1|||
125295776|NCT00710385|450709536|FG000|Overall Study|Did not qualify|1|||
125295777|NCT00710385|450709536|FG000|Overall Study|Withdrawal by Subject|1|||
125295778|NCT00710385|450709536|FG000|Overall Study|Undisclosed back pain|1|||
125295779|NCT00710385|450709536|FG000|Overall Study|Physician Decision|1|||
125295780|NCT00710385|450709536|FG000|Overall Study|Undisclosed excessive methadone use|1|||
125295781|NCT01459913|450709543|FG000|Overall Study|Adverse Event|0|||
125295782|NCT01459913|450709544|FG001|Overall Study|Adverse Event|0|||
125295783|NCT01459913|450709545|FG002|Overall Study|Adverse Event|0|||
125295784|NCT01459913|450709546|FG003|Overall Study|Adverse Event|3|||
125295785|NCT01459913|450709543|FG000|Overall Study|Withdrawal by Subject|4|||
125295786|NCT01459913|450709544|FG001|Overall Study|Withdrawal by Subject|0|||
125295787|NCT01459913|450709545|FG002|Overall Study|Withdrawal by Subject|0|||
124799023|NCT04650854|448895139|FG001|Overall Study|Lost to Follow-up|1|||
124799024|NCT04650854|448895140|FG002|Overall Study|Lost to Follow-up|0|||
124799025|NCT04650854|448895138|FG000|Overall Study|Withdrawal by Subject|2|||
124799026|NCT04650854|448895139|FG001|Overall Study|Withdrawal by Subject|17|||
124799027|NCT04650854|448895140|FG002|Overall Study|Withdrawal by Subject|9|||
124799028|NCT04650854|448895138|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
124799029|NCT04650854|448895139|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
124799030|NCT04650854|448895140|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
124799031|NCT04650854|448895138|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
124799032|NCT04650854|448895139|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
124799033|NCT04650854|448895140|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
124799034|NCT04650854|448895138|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
124799035|NCT04650854|448895139|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
124799036|NCT04650854|448895140|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
124799037|NCT04650854|448895138|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
124799038|NCT04650854|448895139|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
124799039|NCT04650854|448895140|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
124799040|NCT04650854|448895138|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
124799041|NCT04650854|448895139|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
124799042|NCT04650854|448895140|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
124799043|NCT04650854|448895138|FG000|Overall Study|Use of Rescue Medication|0|||
124799044|NCT04650854|448895139|FG001|Overall Study|Use of Rescue Medication|0|||
124799045|NCT04650854|448895140|FG002|Overall Study|Use of Rescue Medication|1|||
124799046|NCT04650854|448895138|FG000|Overall Study|Last Treatment Per Sponsor|0|||
124799047|NCT04650854|448895139|FG001|Overall Study|Last Treatment Per Sponsor|0|||
124799048|NCT04650854|448895140|FG002|Overall Study|Last Treatment Per Sponsor|2|||
124799049|NCT04650854|448895138|FG000|Overall Study|Rescue Medication|0|||
125295788|NCT01459913|450709546|FG003|Overall Study|Withdrawal by Subject|5|||
125295789|NCT01459913|450709543|FG000|Overall Study|Lost to Follow-up|7|||
125295790|NCT01459913|450709544|FG001|Overall Study|Lost to Follow-up|4|||
125295791|NCT01459913|450709545|FG002|Overall Study|Lost to Follow-up|1|||
125295792|NCT01459913|450709546|FG003|Overall Study|Lost to Follow-up|8|||
125295793|NCT01459913|450709543|FG000|Overall Study|Death|0|||
125295794|NCT01459913|450709544|FG001|Overall Study|Death|0|||
125295795|NCT01459913|450709545|FG002|Overall Study|Death|0|||
125295796|NCT01459913|450709546|FG003|Overall Study|Death|1|||
125295797|NCT01459913|450709543|FG000|Overall Study|Non- Compliance|0|||
125295798|NCT01459913|450709544|FG001|Overall Study|Non- Compliance|0|||
125295799|NCT01459913|450709545|FG002|Overall Study|Non- Compliance|0|||
125295800|NCT01459913|450709546|FG003|Overall Study|Non- Compliance|3|||
125295801|NCT01459913|450709543|FG000|Overall Study|Physician Decision|0|||
125295802|NCT01459913|450709544|FG001|Overall Study|Physician Decision|1|||
125295803|NCT01459913|450709545|FG002|Overall Study|Physician Decision|0|||
125295804|NCT01459913|450709546|FG003|Overall Study|Physician Decision|0|||
125295805|NCT01459913|450709543|FG000|Overall Study|Study Terminated by Sponsor|30|||
125295806|NCT01459913|450709544|FG001|Overall Study|Study Terminated by Sponsor|15|||
125295807|NCT01459913|450709545|FG002|Overall Study|Study Terminated by Sponsor|9|||
125295808|NCT01459913|450709546|FG003|Overall Study|Study Terminated by Sponsor|11|||
125295809|NCT01459913|450709543|FG000|Overall Study|Other|0|||
125295810|NCT01459913|450709544|FG001|Overall Study|Other|0|||
125295811|NCT01459913|450709545|FG002|Overall Study|Other|3|||
125295812|NCT01459913|450709546|FG003|Overall Study|Other|1|||
125295813|NCT01459913|450709543|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
125295814|NCT01459913|450709544|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
125295815|NCT01459913|450709545|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
125295816|NCT01459913|450709546|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
125295817|NCT01064687|450709549|FG000|Overall Study|Adverse Event|9|||
125295818|NCT01064687|450709550|FG001|Overall Study|Adverse Event|4|||
125295819|NCT01064687|450709551|FG002|Overall Study|Adverse Event|10|||
125295820|NCT01064687|450709552|FG003|Overall Study|Adverse Event|3|||
125295821|NCT01064687|450709549|FG000|Overall Study|Death|1|||
125295822|NCT01064687|450709550|FG001|Overall Study|Death|1|||
125295823|NCT01064687|450709551|FG002|Overall Study|Death|0|||
125295824|NCT01064687|450709552|FG003|Overall Study|Death|0|||
125295825|NCT01064687|450709549|FG000|Overall Study|Entry Criteria Not Met|3|||
125295826|NCT01064687|450709550|FG001|Overall Study|Entry Criteria Not Met|0|||
125295827|NCT01064687|450709551|FG002|Overall Study|Entry Criteria Not Met|0|||
125295828|NCT01064687|450709552|FG003|Overall Study|Entry Criteria Not Met|0|||
125295829|NCT01064687|450709549|FG000|Overall Study|Lack of Efficacy|1|||
125295830|NCT01064687|450709550|FG001|Overall Study|Lack of Efficacy|0|||
125295831|NCT01064687|450709551|FG002|Overall Study|Lack of Efficacy|2|||
125295832|NCT01064687|450709552|FG003|Overall Study|Lack of Efficacy|3|||
124799050|NCT04650854|448895139|FG001|Overall Study|Rescue Medication|0|||
124799051|NCT04650854|448895140|FG002|Overall Study|Rescue Medication|1|||
124799052|NCT04650854|448895138|FG000|Overall Study|Participant Want to Start a Family|0|||
124799053|NCT04650854|448895139|FG001|Overall Study|Participant Want to Start a Family|0|||
124799054|NCT04650854|448895140|FG002|Overall Study|Participant Want to Start a Family|1|||
124799055|NCT04650854|448895138|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
124799056|NCT04650854|448895139|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
124799057|NCT04650854|448895140|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
124799058|NCT04650854|448895138|FG000|Overall Study|Participant Screened For MG0020|0|||
124799059|NCT04650854|448895139|FG001|Overall Study|Participant Screened For MG0020|2|||
124799060|NCT04650854|448895140|FG002|Overall Study|Participant Screened For MG0020|3|||
124799061|NCT04650854|448895138|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
124799062|NCT04650854|448895139|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
124799063|NCT04650854|448895140|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
124799064|NCT04650854|448895138|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
124799065|NCT04650854|448895139|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
124799066|NCT04650854|448895140|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
124799067|NCT04650854|448895138|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
124799068|NCT04650854|448895139|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
124799069|NCT04650854|448895140|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
124799070|NCT04650854|448895138|FG000|Overall Study|End Of Study|0|||
124799071|NCT04650854|448895139|FG001|Overall Study|End Of Study|2|||
124799072|NCT04650854|448895140|FG002|Overall Study|End Of Study|1|||
124799073|NCT04650854|448895138|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
124799074|NCT04650854|448895139|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
124799075|NCT04650854|448895140|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
124799076|NCT04650854|448895138|FG000|Overall Study|Participant Received Rescue Medication|0|||
124799077|NCT04650854|448895139|FG001|Overall Study|Participant Received Rescue Medication|1|||
124799078|NCT04650854|448895140|FG002|Overall Study|Participant Received Rescue Medication|0|||
124799079|NCT04650854|448895138|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
124799080|NCT04650854|448895139|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
124799081|NCT04650854|448895140|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
124799082|NCT04650854|448895138|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
124799083|NCT04650854|448895139|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
124799084|NCT04650854|448895140|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
124799085|NCT04650854|448895138|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
124799086|NCT04650854|448895139|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
124799087|NCT04650854|448895140|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
124799088|NCT04650854|448895138|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
124799089|NCT04650854|448895139|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
124799090|NCT04650854|448895140|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
124799091|NCT04650854|448895138|FG000|Overall Study|Enrollment Cup|0|||
124799092|NCT04650854|448895139|FG001|Overall Study|Enrollment Cup|0|||
124799093|NCT04650854|448895140|FG002|Overall Study|Enrollment Cup|1|||
124799094|NCT00704808|448895141|FG000|Overall Study|Discontinued prior to starting treatment|14|||
124799095|NCT00704808|448895141|FG000|Overall Study|Death|7|||
124799096|NCT00704808|448895141|FG000|Overall Study|Tumor progression|80|||
125295833|NCT01064687|450709549|FG000|Overall Study|Lost to Follow-up|7|||
125295834|NCT01064687|450709550|FG001|Overall Study|Lost to Follow-up|10|||
125295835|NCT01064687|450709551|FG002|Overall Study|Lost to Follow-up|13|||
125295836|NCT01064687|450709552|FG003|Overall Study|Lost to Follow-up|5|||
125295837|NCT01064687|450709549|FG000|Overall Study|Physician Decision|2|||
125295838|NCT01064687|450709550|FG001|Overall Study|Physician Decision|2|||
125295839|NCT01064687|450709551|FG002|Overall Study|Physician Decision|0|||
125295840|NCT01064687|450709552|FG003|Overall Study|Physician Decision|0|||
125295841|NCT01064687|450709549|FG000|Overall Study|Protocol Violation|1|||
125295842|NCT01064687|450709550|FG001|Overall Study|Protocol Violation|1|||
125295843|NCT01064687|450709551|FG002|Overall Study|Protocol Violation|0|||
125295844|NCT01064687|450709552|FG003|Overall Study|Protocol Violation|1|||
125295845|NCT01064687|450709549|FG000|Overall Study|Sponsor Decision|0|||
125295846|NCT01064687|450709550|FG001|Overall Study|Sponsor Decision|0|||
125295847|NCT01064687|450709551|FG002|Overall Study|Sponsor Decision|3|||
125295848|NCT01064687|450709552|FG003|Overall Study|Sponsor Decision|0|||
125295849|NCT01064687|450709549|FG000|Overall Study|Withdrawal by Subject|9|||
125295850|NCT01064687|450709550|FG001|Overall Study|Withdrawal by Subject|7|||
125295851|NCT01064687|450709551|FG002|Overall Study|Withdrawal by Subject|12|||
125295852|NCT01064687|450709552|FG003|Overall Study|Withdrawal by Subject|5|||
125295853|NCT01064687|450709549|FG000|Overall Study|Treatment Noncompliance|1|||
125295854|NCT01064687|450709550|FG001|Overall Study|Treatment Noncompliance|1|||
125295855|NCT01064687|450709551|FG002|Overall Study|Treatment Noncompliance|1|||
125295856|NCT01064687|450709552|FG003|Overall Study|Treatment Noncompliance|0|||
125295857|NCT02299076|450709553|FG000|Overall Study|Fraudulent Entries|20|||
125295858|NCT02299076|450709554|FG001|Overall Study|Fraudulent Entries|14|||
125295859|NCT01969721|450709555|FG000|Overall Study|Adverse Event|3|||
125295860|NCT01969721|450709556|FG001|Overall Study|Adverse Event|8|||
125295861|NCT01969721|450709557|FG002|Overall Study|Adverse Event|3|||
125295862|NCT01969721|450709558|FG003|Overall Study|Adverse Event|2|||
125295863|NCT01969721|450709555|FG000|Overall Study|Lack of Efficacy|0|||
125295864|NCT01969721|450709556|FG001|Overall Study|Lack of Efficacy|0|||
125295865|NCT01969721|450709557|FG002|Overall Study|Lack of Efficacy|1|||
125295866|NCT01969721|450709558|FG003|Overall Study|Lack of Efficacy|0|||
125295867|NCT01969721|450709555|FG000|Overall Study|Non compliant with protocol|1|||
125295868|NCT01969721|450709556|FG001|Overall Study|Non compliant with protocol|1|||
125295869|NCT01969721|450709557|FG002|Overall Study|Non compliant with protocol|0|||
125295870|NCT01969721|450709558|FG003|Overall Study|Non compliant with protocol|2|||
125295871|NCT01969721|450709555|FG000|Overall Study|Other not defined above|0|||
125295872|NCT01969721|450709556|FG001|Overall Study|Other not defined above|2|||
125295873|NCT01969721|450709557|FG002|Overall Study|Other not defined above|0|||
125295874|NCT01969721|450709558|FG003|Overall Study|Other not defined above|0|||
125295875|NCT01969721|450709555|FG000|Overall Study|Discontinued during washout periods.|0|||
125295876|NCT01969721|450709556|FG001|Overall Study|Discontinued during washout periods.|1|||
125295877|NCT01969721|450709557|FG002|Overall Study|Discontinued during washout periods.|1|||
125295878|NCT01969721|450709558|FG003|Overall Study|Discontinued during washout periods.|2|||
125295879|NCT01012323|450709559|FG000|Overall Study|Investigator Judgment|1|||
125295880|NCT02117349|450709560|FG000|Overall Study|Withdrawal by Subject|1|||
125295881|NCT02117349|450709561|FG001|Overall Study|Withdrawal by Subject|0|||
125295882|NCT02117349|450709560|FG000|Overall Study|Lost to Follow-up|1|||
125295883|NCT02117349|450709561|FG001|Overall Study|Lost to Follow-up|1|||
125295884|NCT02117349|450709560|FG000|Overall Study|Death|1|||
125295885|NCT02117349|450709561|FG001|Overall Study|Death|0|||
125295886|NCT00495755|450709562|FG000|Overall Study|Adverse Event|3|||
125295887|NCT02265796|450709563|FG000|Overall Study|Death|1|||
125295888|NCT02265796|450709564|FG001|Overall Study|Death|0|||
125295889|NCT02265796|450709563|FG000|Overall Study|started on excluded medication|1|||
125295890|NCT02265796|450709564|FG001|Overall Study|started on excluded medication|0|||
125295891|NCT02265796|450709563|FG000|Overall Study|Withdrawal by Subject|1|||
125295892|NCT02265796|450709564|FG001|Overall Study|Withdrawal by Subject|1|||
125295893|NCT02477553|450709565|FG000|Overall Study|Screening up-to-date|12|||
125295894|NCT02477553|450709566|FG001|Overall Study|Screening up-to-date|13|||
125295895|NCT02477553|450709565|FG000|Overall Study|No MD visit|1|||
125295896|NCT02477553|450709566|FG001|Overall Study|No MD visit|1|||
124799097|NCT00704808|448895141|FG000|Overall Study|Patient's decision|11|||
124799098|NCT00704808|448895141|FG000|Overall Study|Early therapy discontinuation|16|||
124799099|NCT00704808|448895141|FG000|Overall Study|Adverse Event|1|||
124799100|NCT00704808|448895141|FG000|Overall Study|Lost to Follow-up|1|||
124799101|NCT00704808|448895141|FG000|Overall Study|Treatment change|1|||
124799102|NCT01280955|448895145|FG000|Overall Study|Death|2|||
124799103|NCT01280955|448895145|FG000|Overall Study|Withdrawal by Subject|1|||
124799104|NCT04223232|448895146|FG000|Overall Study|Withdrawal by Subject|1|||
124799105|NCT05281601|448895147|FG000|Overall Study|Physician Decision|2|||
124799106|NCT05281601|448895148|FG001|Overall Study|Physician Decision|0|||
124799107|NCT05281601|448895147|FG000|Overall Study|Lost to Follow-up|2|||
124799108|NCT05281601|448895148|FG001|Overall Study|Lost to Follow-up|0|||
125295897|NCT02477553|450709565|FG000|Overall Study|Workup consistent w/CRC|1|||
125295898|NCT02477553|450709566|FG001|Overall Study|Workup consistent w/CRC|1|||
125295899|NCT02477553|450709565|FG000|Overall Study|Technical issues with intervention|2|||
124799109|NCT05281601|448895147|FG000|Overall Study|Death|1|||
125295900|NCT02477553|450709566|FG001|Overall Study|Technical issues with intervention|0|||
125295901|NCT02477553|450709565|FG000|Overall Study|Elevated risk for CRC|2|||
125295902|NCT02477553|450709566|FG001|Overall Study|Elevated risk for CRC|2|||
125295903|NCT02477553|450709565|FG000|Overall Study|MD advised against screening|1|||
124799110|NCT05281601|448895148|FG001|Overall Study|Death|0|||
124799111|NCT05281601|448895147|FG000|Overall Study|Withdrawal by parent/guardian|2|||
124799112|NCT05281601|448895148|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124799113|NCT03172910|448896612|FG000|Overall Study|Adverse Event|0|||
124799114|NCT03172910|448896613|FG001|Overall Study|Adverse Event|0|||
124799115|NCT03172910|448896614|FG002|Overall Study|Adverse Event|0|||
125295904|NCT02477553|450709566|FG001|Overall Study|MD advised against screening|3|||
125295905|NCT02477553|450709565|FG000|Overall Study|patient deceased|1|||
125295906|NCT02477553|450709566|FG001|Overall Study|patient deceased|0|||
125295907|NCT02963701|450709567|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
125295908|NCT02963701|450709568|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
125295909|NCT00896649|450709571|FG000|Overall Study|Physician Decision|1|||
125295910|NCT00896649|450709571|FG000|Overall Study|Pregnancy|1|||
125295911|NCT00896649|450709571|FG000|Overall Study|missing documentation|1|||
125295912|NCT00896649|450709571|FG000|Overall Study|technical difficulties|2|||
125295913|NCT03652675|450709572|FG000|Overall Study|Lost to Follow-up|4|||
125295914|NCT03652675|450709573|FG001|Overall Study|Lost to Follow-up|4|||
125295915|NCT03442296|450709574|FG000|3 Month Follow-up|Death|3|||
125295916|NCT03442296|450709575|FG001|3 Month Follow-up|Death|1|||
125295917|NCT03442296|450709574|FG000|3 Month Follow-up|Lost to Follow-up|1|||
124799116|NCT03172910|448896615|FG003|Overall Study|Adverse Event|0|||
124799117|NCT03172910|448896616|FG004|Overall Study|Adverse Event|1|||
124799118|NCT01659658|448896617|FG000|Overall Study|Withdrawal by Patient|18|||
124799119|NCT01659658|448896618|FG001|Overall Study|Withdrawal by Patient|4|||
124799120|NCT01659658|448896619|FG002|Overall Study|Withdrawal by Patient|2|||
124799121|NCT01659658|448896620|FG003|Overall Study|Withdrawal by Patient|0|||
124799122|NCT01659658|448896621|FG004|Overall Study|Withdrawal by Patient|11|||
124799123|NCT01659658|448896617|FG000|Overall Study|Study Terminated by Sponsor|9|||
124799124|NCT01659658|448896618|FG001|Overall Study|Study Terminated by Sponsor|7|||
124799125|NCT01659658|448896619|FG002|Overall Study|Study Terminated by Sponsor|0|||
124799126|NCT01659658|448896620|FG003|Overall Study|Study Terminated by Sponsor|1|||
124799127|NCT01659658|448896621|FG004|Overall Study|Study Terminated by Sponsor|4|||
124799128|NCT01659658|448896617|FG000|Overall Study|Reason not Specified|61|||
124799129|NCT01659658|448896618|FG001|Overall Study|Reason not Specified|15|||
124799130|NCT01659658|448896619|FG002|Overall Study|Reason not Specified|8|||
124799131|NCT01659658|448896620|FG003|Overall Study|Reason not Specified|1|||
124799132|NCT01659658|448896621|FG004|Overall Study|Reason not Specified|34|||
124799133|NCT01659658|448896617|FG000|Overall Study|Lost to Follow-up|2|||
124799134|NCT01659658|448896618|FG001|Overall Study|Lost to Follow-up|0|||
124799135|NCT01659658|448896619|FG002|Overall Study|Lost to Follow-up|0|||
124799136|NCT01659658|448896620|FG003|Overall Study|Lost to Follow-up|0|||
124799137|NCT01659658|448896621|FG004|Overall Study|Lost to Follow-up|0|||
124799138|NCT01442038|448896624|FG000|Overall Study|Death|35|||
124799139|NCT01442038|448896625|FG001|Overall Study|Death|29|||
124799140|NCT01442038|448896624|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
124799141|NCT01442038|448896625|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
124799142|NCT01442038|448896624|FG000|Overall Study|Participant Withdrew Consent|137|||
124799143|NCT01442038|448896625|FG001|Overall Study|Participant Withdrew Consent|102|||
124799144|NCT01442038|448896624|FG000|Overall Study|Lost to Follow-up|37|||
124799145|NCT01442038|448896625|FG001|Overall Study|Lost to Follow-up|51|||
124799146|NCT01442038|448896624|FG000|Overall Study|Adverse Event|26|||
124799147|NCT01442038|448896625|FG001|Overall Study|Adverse Event|15|||
124799148|NCT01442038|448896624|FG000|Overall Study|Protocol Deviation|9|||
124799149|NCT01442038|448896625|FG001|Overall Study|Protocol Deviation|20|||
124799150|NCT01442038|448896624|FG000|Overall Study|Investigator's Discretion|13|||
124799151|NCT01442038|448896625|FG001|Overall Study|Investigator's Discretion|16|||
124799152|NCT01442038|448896624|FG000|Overall Study|Study Terminated By Sponsor|2|||
124799153|NCT01442038|448896625|FG001|Overall Study|Study Terminated By Sponsor|3|||
124799154|NCT00089284|448896626|FG000|Overall Study|Adverse event before starting treatment|0|||
124799155|NCT00089284|448896627|FG001|Overall Study|Adverse event before starting treatment|0|||
124799156|NCT00089284|448896628|FG002|Overall Study|Adverse event before starting treatment|0|||
124799157|NCT00089284|448896629|FG003|Overall Study|Adverse event before starting treatment|0|||
124799158|NCT00089284|448896630|FG004|Overall Study|Adverse event before starting treatment|0|||
124799159|NCT00089284|448896631|FG005|Overall Study|Adverse event before starting treatment|0|||
124799160|NCT00089284|448896632|FG006|Overall Study|Adverse event before starting treatment|1|||
124799161|NCT02428608|448896633|FG000|Overall Study|Pregnancy|2|||
124799162|NCT02428608|448896633|FG000|Overall Study|Lost to Follow-up|37|||
124799163|NCT02428608|448896633|FG000|Overall Study|Withdrawal by Subject|2|||
124799164|NCT02428608|448896633|FG000|Overall Study|scheduling conflicts|15|||
125295918|NCT03442296|450709575|FG001|3 Month Follow-up|Lost to Follow-up|1|||
125295919|NCT03442296|450709574|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
124799165|NCT02428608|448896633|FG000|Overall Study|moved away|10|||
124799166|NCT02428608|448896633|FG000|Overall Study|Death|1|||
124799167|NCT02428608|448896633|FG000|Overall Study|various|16|||
124799168|NCT03646643|448896634|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
125295920|NCT03442296|450709575|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
125295921|NCT03442296|450709574|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
125295922|NCT03442296|450709575|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
124799169|NCT03646643|448896635|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
124799170|NCT03646643|448896634|FG000|Overall Study|Lost to Follow-up|0|||
124799171|NCT03646643|448896635|FG001|Overall Study|Lost to Follow-up|1|||
124799172|NCT04521777|448896636|FG000|Overall Study|Death|2|||
124799173|NCT04521777|448896636|FG000|Overall Study|Withdrawal by Subject|2|||
124799174|NCT00900601|448896637|FG000|Overall Study|Physician Decision|1|||
124799175|NCT00214500|448896639|FG000|Treatment Period|Adverse Event|1|||
124799176|NCT00214500|448896639|FG000|Extension Period|Withdrawal by Subject|2|||
124799177|NCT00147251|448896640|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
124799178|NCT00147251|448896641|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
124799179|NCT01629706|448896642|FG000|Phase 1 PureVision|Screen Failure|4|||
124799180|NCT01629706|448896642|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
124799181|NCT01629706|448896642|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
124799182|NCT01629706|448896642|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
124799183|NCT01629706|448896642|FG000|Phase 2 Habitual|Screen Failure|6|||
124799184|NCT01629706|448896642|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
124799185|NCT01629706|448896642|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
124799186|NCT01629706|448896642|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
124799187|NCT01629706|448896642|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
124799188|NCT02663687|448896644|FG000|Overall Study|Adverse Event|1|||
124799189|NCT02663687|448896645|FG001|Overall Study|Adverse Event|0|||
124799190|NCT02663687|448896646|FG002|Overall Study|Adverse Event|0|||
124799191|NCT02663687|448896647|FG003|Overall Study|Adverse Event|0|||
124799192|NCT02663687|448896648|FG004|Overall Study|Adverse Event|0|||
124799193|NCT02663687|448896644|FG000|Overall Study|Other|1|||
124799194|NCT02663687|448896645|FG001|Overall Study|Other|0|||
124799195|NCT02663687|448896646|FG002|Overall Study|Other|1|||
124799196|NCT02663687|448896647|FG003|Overall Study|Other|0|||
124799197|NCT02663687|448896648|FG004|Overall Study|Other|0|||
124799198|NCT03595774|448896649|FG000|Overall Study|Adverse Event|1|||
124799199|NCT03595774|448896650|FG001|Overall Study|Adverse Event|0|||
124799200|NCT03595774|448896651|FG002|Overall Study|Adverse Event|1|||
124799201|NCT03595774|448896652|FG003|Overall Study|Adverse Event|0|||
124799202|NCT03595774|448896649|FG000|Overall Study|screen failure|0|||
124799203|NCT03595774|448896650|FG001|Overall Study|screen failure|1|||
124799204|NCT03595774|448896651|FG002|Overall Study|screen failure|0|||
124799205|NCT03595774|448896652|FG003|Overall Study|screen failure|1|||
124799206|NCT01151098|448896653|FG000|Overall Study|Adverse Event|82|||
124799207|NCT01151098|448896653|FG000|Overall Study|Lost to Follow-up|6|||
124799208|NCT01151098|448896653|FG000|Overall Study|Lack of Efficacy|15|||
124799209|NCT01151098|448896653|FG000|Overall Study|Protocol Violation|1|||
124799210|NCT01151098|448896653|FG000|Overall Study|Miscellaneous|13|||
124799211|NCT00116168|448896660|FG000|Overall Study|Lost to Follow-up|6|||
124799212|NCT00116168|448896661|FG001|Overall Study|Lost to Follow-up|5|||
124799213|NCT00116168|448896662|FG002|Overall Study|Lost to Follow-up|0|||
124799214|NCT00116168|448896663|FG003|Overall Study|Lost to Follow-up|0|||
124799215|NCT02788474|448896664|FG000|Double Blind Treatment Period|Not treated|1|||
124799216|NCT02788474|448896665|FG001|Double Blind Treatment Period|Not treated|0|||
124799217|NCT02788474|448896664|FG000|Double Blind Treatment Period|Patient's refusal|3|||
124799218|NCT02788474|448896665|FG001|Double Blind Treatment Period|Patient's refusal|0|||
124799219|NCT02788474|448896664|FG000|Double Blind Treatment Period|Adverse Event|6|||
124799220|NCT02788474|448896665|FG001|Double Blind Treatment Period|Adverse Event|4|||
124799221|NCT02788474|448896664|FG000|Open Label Treatment Period|Adverse Event|29|||
124799222|NCT02788474|448896665|FG001|Open Label Treatment Period|Adverse Event|9|||
124799223|NCT02788474|448896664|FG000|Open Label Treatment Period|Other than reason specified|1|||
124799224|NCT02788474|448896665|FG001|Open Label Treatment Period|Other than reason specified|0|||
124799225|NCT02788474|448896664|FG000|Open Label Treatment Period|Patient's refusal|1|||
124799226|NCT02788474|448896665|FG001|Open Label Treatment Period|Patient's refusal|3|||
124799227|NCT02788474|448896664|FG000|Open Label Treatment Period|Non-compliance|1|||
124799228|NCT02788474|448896665|FG001|Open Label Treatment Period|Non-compliance|0|||
124799229|NCT00117286|448896667|FG000|Overall Study|Adverse Event|12|||
124799230|NCT00117286|448896668|FG001|Overall Study|Adverse Event|6|||
124799231|NCT00117286|448896667|FG000|Overall Study|Lost to Follow-up|2|||
124799232|NCT00117286|448896668|FG001|Overall Study|Lost to Follow-up|0|||
124799233|NCT00117286|448896667|FG000|Overall Study|Protocol Violation|3|||
124799234|NCT00117286|448896668|FG001|Overall Study|Protocol Violation|3|||
124799235|NCT00117286|448896667|FG000|Overall Study|Withdrawal by Subject|6|||
124799236|NCT00117286|448896668|FG001|Overall Study|Withdrawal by Subject|2|||
124799237|NCT00117286|448896667|FG000|Overall Study|Physician Decision|3|||
124799238|NCT00117286|448896668|FG001|Overall Study|Physician Decision|7|||
124799239|NCT00117286|448896667|FG000|Overall Study|Lack of Efficacy|2|||
124799240|NCT00117286|448896668|FG001|Overall Study|Lack of Efficacy|1|||
124799241|NCT00117286|448896667|FG000|Overall Study|Research site closing|0|||
124799242|NCT00117286|448896668|FG001|Overall Study|Research site closing|2|||
124799243|NCT03555435|448896669|FG000|Overall Study|Lost to Follow-up|17|||
124799244|NCT03555435|448896670|FG001|Overall Study|Lost to Follow-up|19|||
124799245|NCT03555435|448896671|FG002|Overall Study|Lost to Follow-up|8|||
124799246|NCT01272661|448896675|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
124799247|NCT01272661|448896676|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
124799248|NCT01272661|448896677|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
124799249|NCT02869438|448896678|FG000|Overall Study|Lost to Follow-up|1|||
124799250|NCT02869438|448896679|FG001|Overall Study|Lost to Follow-up|0|||
124799251|NCT02869438|448896678|FG000|Overall Study|Adverse Event|1|||
124799252|NCT02869438|448896679|FG001|Overall Study|Adverse Event|0|||
124799253|NCT02869438|448896678|FG000|Overall Study|Withdrawal by Subject|1|||
124799254|NCT02869438|448896679|FG001|Overall Study|Withdrawal by Subject|2|||
124799255|NCT02169284|448896685|FG000|Overall Study|Physician Decision|0|||
124799256|NCT02169284|448896686|FG001|Overall Study|Physician Decision|1|||
124799257|NCT04505540|448896687|FG000|Baseline|Protocol Violation|10|||
124799258|NCT04505540|448896687|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
124799259|NCT04505540|448896687|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
124799260|NCT04505540|448896687|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
124799261|NCT04505540|448896687|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
124799262|NCT04505540|448896687|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
124799263|NCT04505540|448896687|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
124799264|NCT04505540|448896687|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
124799265|NCT04505540|448896687|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
124799266|NCT04505540|448896687|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
124799267|NCT04505540|448896687|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
124799268|NCT04505540|448896687|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
124799269|NCT04505540|448896687|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
124799270|NCT03583073|448896688|FG000|Overall Study|Lost to Follow-up|8|||
124799271|NCT03583073|448896689|FG001|Overall Study|Lost to Follow-up|12|||
124799272|NCT01367119|448896690|FG000|Overall Study|Adverse Event|1|||
124799273|NCT01367119|448896691|FG001|Overall Study|Adverse Event|0|||
124799274|NCT01367119|448896690|FG000|Overall Study|Withdrawal by Subject|1|||
124799275|NCT01367119|448896691|FG001|Overall Study|Withdrawal by Subject|1|||
124799276|NCT05342532|448896692|FG000|Overall Study|Adverse Event|5|||
124799277|NCT05342532|448896693|FG001|Overall Study|Adverse Event|20|||
124799278|NCT05342532|448896692|FG000|Overall Study|Lost to Follow-up|10|||
124799279|NCT05342532|448896693|FG001|Overall Study|Lost to Follow-up|15|||
124799280|NCT02057393|448896696|FG000|Overall Study|Withdrawal by Subject|1|||
124799281|NCT02057393|448896696|FG000|Overall Study|Patient did not meet criteria|1|||
124799282|NCT03180684|448896697|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
124799283|NCT03180684|448896698|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
124799284|NCT03180684|448896697|FG000|Overall Study|Physician Decision|1|||
124799285|NCT03180684|448896698|FG001|Overall Study|Physician Decision|0|||
124799286|NCT03180684|448896697|FG000|Overall Study|Lost to Follow-up|1|||
124799287|NCT03180684|448896698|FG001|Overall Study|Lost to Follow-up|0|||
124799288|NCT03180684|448896697|FG000|Overall Study|Progressive Disease|1|||
124799289|NCT03180684|448896698|FG001|Overall Study|Progressive Disease|0|||
124799290|NCT01115803|448896699|FG000|Overall Study|Withdrawal by Subject|0|||
124799291|NCT01115803|448896700|FG001|Overall Study|Withdrawal by Subject|0|||
124799292|NCT01115803|448896701|FG002|Overall Study|Withdrawal by Subject|0|||
124799293|NCT01115803|448896702|FG003|Overall Study|Withdrawal by Subject|0|||
124799294|NCT01115803|448896703|FG004|Overall Study|Withdrawal by Subject|0|||
124799295|NCT01115803|448896704|FG005|Overall Study|Withdrawal by Subject|0|||
124799296|NCT01115803|448896705|FG006|Overall Study|Withdrawal by Subject|1|||
124799297|NCT01115803|448896699|FG000|Overall Study|Lost to Follow-up|0|||
124799298|NCT01115803|448896700|FG001|Overall Study|Lost to Follow-up|0|||
124799299|NCT01115803|448896701|FG002|Overall Study|Lost to Follow-up|1|||
124799300|NCT01115803|448896702|FG003|Overall Study|Lost to Follow-up|0|||
124799301|NCT01115803|448896703|FG004|Overall Study|Lost to Follow-up|0|||
124799302|NCT01115803|448896704|FG005|Overall Study|Lost to Follow-up|0|||
124799303|NCT01115803|448896705|FG006|Overall Study|Lost to Follow-up|0|||
124799304|NCT01115803|448896699|FG000|Overall Study|Progressive Disease during Cycle1|0|||
124799305|NCT01115803|448896700|FG001|Overall Study|Progressive Disease during Cycle1|0|||
124799306|NCT01115803|448896701|FG002|Overall Study|Progressive Disease during Cycle1|0|||
124799307|NCT01115803|448896702|FG003|Overall Study|Progressive Disease during Cycle1|0|||
124799308|NCT01115803|448896703|FG004|Overall Study|Progressive Disease during Cycle1|0|||
124799309|NCT01115803|448896704|FG005|Overall Study|Progressive Disease during Cycle1|0|||
124799310|NCT01115803|448896705|FG006|Overall Study|Progressive Disease during Cycle1|1|||
124799311|NCT03475875|448896706|FG000|Period 1|Lost to Follow-up|1|||
124799312|NCT03475875|448896707|FG001|Period 1|Lost to Follow-up|0|||
124799313|NCT03475875|448896706|FG000|Period 1|Adverse Event|2|||
124799314|NCT03475875|448896707|FG001|Period 1|Adverse Event|1|||
124799315|NCT03475875|448896706|FG000|Period 2|Adverse Event|3|||
124799316|NCT03475875|448896707|FG001|Period 2|Adverse Event|0|||
124799317|NCT03475875|448896706|FG000|Period 2|Protocol Violation|0|||
124799318|NCT03475875|448896707|FG001|Period 2|Protocol Violation|1|||
124799319|NCT02017171|448896708|FG000|Overall Study|Death|10|||
124799320|NCT02017171|448896709|FG001|Overall Study|Death|4|||
124799321|NCT02017171|448896708|FG000|Overall Study|Withdrawal by Subject|23|||
124799322|NCT02017171|448896709|FG001|Overall Study|Withdrawal by Subject|17|||
124799323|NCT02017171|448896708|FG000|Overall Study|Lost to Follow-up|21|||
124799324|NCT02017171|448896709|FG001|Overall Study|Lost to Follow-up|20|||
124799325|NCT02017171|448896708|FG000|Overall Study|ESKD|6|||
124799326|NCT02017171|448896709|FG001|Overall Study|ESKD|2|||
124799327|NCT02017171|448896708|FG000|Overall Study|Miscellaneous|2|||
124799328|NCT02017171|448896709|FG001|Overall Study|Miscellaneous|3|||
124799329|NCT03091777|448896711|FG000|Overall Study|Pregnancy|2|||
124799330|NCT03091777|448896712|FG001|Overall Study|Pregnancy|1|||
124799331|NCT03091777|448896713|FG002|Overall Study|Pregnancy|0|||
124799332|NCT03091777|448896711|FG000|Overall Study|Adverse Event|2|||
124799333|NCT03091777|448896712|FG001|Overall Study|Adverse Event|1|||
124799334|NCT03091777|448896713|FG002|Overall Study|Adverse Event|4|||
124799335|NCT03091777|448896711|FG000|Overall Study|Withdrawal by Subject|4|||
124799336|NCT03091777|448896712|FG001|Overall Study|Withdrawal by Subject|2|||
124799337|NCT03091777|448896713|FG002|Overall Study|Withdrawal by Subject|6|||
124799338|NCT03091777|448896711|FG000|Overall Study|Protocol Violation|2|||
124799339|NCT03091777|448896712|FG001|Overall Study|Protocol Violation|1|||
124799340|NCT03091777|448896713|FG002|Overall Study|Protocol Violation|1|||
124799341|NCT03091777|448896711|FG000|Overall Study|Lost to Follow-up|12|||
124799342|NCT03091777|448896712|FG001|Overall Study|Lost to Follow-up|14|||
124799343|NCT03091777|448896713|FG002|Overall Study|Lost to Follow-up|7|||
124799344|NCT03091777|448896711|FG000|Overall Study|Lack of Efficacy|0|||
124799345|NCT03091777|448896712|FG001|Overall Study|Lack of Efficacy|0|||
124799346|NCT03091777|448896713|FG002|Overall Study|Lack of Efficacy|5|||
124799347|NCT03091777|448896711|FG000|Overall Study|Noncompliance with study drug|2|||
124799348|NCT03091777|448896712|FG001|Overall Study|Noncompliance with study drug|3|||
124799349|NCT03091777|448896713|FG002|Overall Study|Noncompliance with study drug|1|||
124799350|NCT03091777|448896711|FG000|Overall Study|Physician Decision|1|||
124799351|NCT03091777|448896712|FG001|Overall Study|Physician Decision|0|||
124799352|NCT03091777|448896713|FG002|Overall Study|Physician Decision|1|||
124799353|NCT03091777|448896711|FG000|Overall Study|Abnormal Laboratory Value|7|||
124799354|NCT03091777|448896712|FG001|Overall Study|Abnormal Laboratory Value|11|||
124799355|NCT03091777|448896713|FG002|Overall Study|Abnormal Laboratory Value|12|||
124799356|NCT02536833|448896714|FG000|Overall Study|Discontinued Before Treatment|0|||
124799357|NCT02536833|448896715|FG001|Overall Study|Discontinued Before Treatment|0|||
124799358|NCT02536833|448896716|FG002|Overall Study|Discontinued Before Treatment|1|||
124799359|NCT02536833|448896717|FG003|Overall Study|Discontinued Before Treatment|2|||
124799360|NCT02536833|448896714|FG000|Overall Study|Adverse Event|1|||
124799361|NCT02536833|448896715|FG001|Overall Study|Adverse Event|3|||
124799362|NCT02536833|448896716|FG002|Overall Study|Adverse Event|4|||
124799363|NCT02536833|448896717|FG003|Overall Study|Adverse Event|1|||
124799364|NCT02536833|448896714|FG000|Overall Study|Lost to Follow-up|2|||
124799365|NCT02536833|448896715|FG001|Overall Study|Lost to Follow-up|1|||
124799366|NCT02536833|448896716|FG002|Overall Study|Lost to Follow-up|2|||
124799367|NCT02536833|448896717|FG003|Overall Study|Lost to Follow-up|2|||
124799368|NCT02536833|448896714|FG000|Overall Study|Physician Decision|0|||
124799369|NCT02536833|448896715|FG001|Overall Study|Physician Decision|0|||
124799370|NCT02536833|448896716|FG002|Overall Study|Physician Decision|0|||
124799371|NCT02536833|448896717|FG003|Overall Study|Physician Decision|1|||
124799372|NCT02536833|448896714|FG000|Overall Study|Site Terminated by Sponsor|2|||
124799373|NCT02536833|448896715|FG001|Overall Study|Site Terminated by Sponsor|2|||
124799374|NCT02536833|448896716|FG002|Overall Study|Site Terminated by Sponsor|2|||
124799375|NCT02536833|448896717|FG003|Overall Study|Site Terminated by Sponsor|2|||
124799376|NCT02536833|448896714|FG000|Overall Study|Subject Non-Compliance|0|||
124799377|NCT02536833|448896715|FG001|Overall Study|Subject Non-Compliance|1|||
124799378|NCT02536833|448896716|FG002|Overall Study|Subject Non-Compliance|1|||
124799379|NCT02536833|448896717|FG003|Overall Study|Subject Non-Compliance|0|||
124799380|NCT02536833|448896714|FG000|Overall Study|Withdrawal by Subject|4|||
124799381|NCT02536833|448896715|FG001|Overall Study|Withdrawal by Subject|3|||
124799382|NCT02536833|448896716|FG002|Overall Study|Withdrawal by Subject|5|||
124799383|NCT02536833|448896717|FG003|Overall Study|Withdrawal by Subject|11|||
124799384|NCT02764190|448896719|FG000|Overall Study|Lost to Follow-up|17|||
124799385|NCT02764190|448896720|FG001|Overall Study|Lost to Follow-up|13|||
124799386|NCT01172275|448896721|FG000|Overall Study|Lost to Follow-up|1|||
124799387|NCT01172275|448896722|FG001|Overall Study|Lost to Follow-up|0|||
124799388|NCT01172275|448896721|FG000|Overall Study|Protocol Violation|1|||
124799389|NCT01172275|448896722|FG001|Overall Study|Protocol Violation|0|||
125295923|NCT03442296|450709574|FG000|12 Month Follow-up|Incomplete measurement|1|||
125295924|NCT03442296|450709575|FG001|12 Month Follow-up|Incomplete measurement|1|||
124799390|NCT05308290|448896727|FG000|Overall Study|Death|1|||
124799391|NCT05308290|448896728|FG001|Overall Study|Death|0|||
124799392|NCT05308290|448896727|FG000|Overall Study|Lost to Follow-up|2|||
124799393|NCT05308290|448896728|FG001|Overall Study|Lost to Follow-up|1|||
124799394|NCT05308290|448896727|FG000|Overall Study|still in study followup|0|||
124799395|NCT05308290|448896728|FG001|Overall Study|still in study followup|1|||
124799396|NCT04437368|448896729|FG000|Overall Study|Death|3|||
124799397|NCT04437368|448896730|FG001|Overall Study|Death|0|||
124799398|NCT04437368|448896731|FG002|Overall Study|Death|2|||
124799399|NCT04437368|448896729|FG000|Overall Study|Study terminated by sponsor|16|||
124799400|NCT04437368|448896730|FG001|Overall Study|Study terminated by sponsor|1|||
124799401|NCT04437368|448896731|FG002|Overall Study|Study terminated by sponsor|25|||
124799402|NCT04437368|448896729|FG000|Overall Study|Withdrawal by Subject|4|||
124799403|NCT04437368|448896730|FG001|Overall Study|Withdrawal by Subject|0|||
124799404|NCT04437368|448896731|FG002|Overall Study|Withdrawal by Subject|3|||
124799405|NCT04437368|448896729|FG000|Overall Study|Sponsor instructions|23|||
124799406|NCT04437368|448896730|FG001|Overall Study|Sponsor instructions|0|||
124799407|NCT04437368|448896731|FG002|Overall Study|Sponsor instructions|0|||
124799408|NCT01982331|448896732|FG000|Received Vaccination 2|Adverse Event|1|||
124799409|NCT01982331|448896733|FG001|Received Vaccination 2|Adverse Event|2|||
124799410|NCT01982331|448896732|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
124799411|NCT01982331|448896733|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
124799412|NCT01982331|448896732|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
124799413|NCT01982331|448896733|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
124799414|NCT02393690|448896743|FG000|Overall Study|Ineligible|0|||
125295925|NCT00707954|450711402|FG000|Overall Study|Physician Decision|0|||
124799415|NCT02393690|448896744|FG001|Overall Study|Ineligible|1|||
124799416|NCT00586846|448896745|FG000|Overall Study|Physician Decision|1|||
124799417|NCT00586846|448896745|FG000|Overall Study|Death|1|||
124799418|NCT00586846|448896745|FG000|Overall Study|Evaluable for Toxicity Only|4|||
124799419|NCT01674634|448896746|FG000|Overall Study|Withdrawal by Subject|3|||
124799420|NCT01674634|448896746|FG000|Overall Study|Lost to Follow-up|3|||
124799421|NCT02059005|448896747|FG000|Overall Study|Death|1|||
124799422|NCT02059005|448896748|FG001|Overall Study|Death|3|||
124799423|NCT02059005|448896747|FG000|Overall Study|Lost to Follow-up|19|||
124799424|NCT02059005|448896748|FG001|Overall Study|Lost to Follow-up|19|||
124799425|NCT02059005|448896747|FG000|Overall Study|Incarceration|0|||
124799426|NCT02059005|448896748|FG001|Overall Study|Incarceration|1|||
124799427|NCT02059005|448896747|FG000|Overall Study|Inpatient|0|||
124799428|NCT02059005|448896748|FG001|Overall Study|Inpatient|1|||
124799429|NCT02142803|448896749|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
124799430|NCT02142803|448896750|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
124799431|NCT02142803|448896751|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
124799432|NCT02142803|448896752|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
124799433|NCT02718300|448896758|FG000|Overall Study|Death|4|||
124799434|NCT02718300|448896759|FG001|Overall Study|Death|5|||
124799435|NCT02718300|448896760|FG002|Overall Study|Death|17|||
124799436|NCT02718300|448896758|FG000|Overall Study|Lost to Follow-up|1|||
124799437|NCT02718300|448896759|FG001|Overall Study|Lost to Follow-up|0|||
124799438|NCT02718300|448896760|FG002|Overall Study|Lost to Follow-up|2|||
124799439|NCT02718300|448896758|FG000|Overall Study|Physician Decision|1|||
124799440|NCT02718300|448896759|FG001|Overall Study|Physician Decision|0|||
124799441|NCT02718300|448896760|FG002|Overall Study|Physician Decision|2|||
124799442|NCT02718300|448896758|FG000|Overall Study|Study Terminated by Sponsor|6|||
124799443|NCT02718300|448896759|FG001|Overall Study|Study Terminated by Sponsor|3|||
124799444|NCT02718300|448896760|FG002|Overall Study|Study Terminated by Sponsor|4|||
124799445|NCT02718300|448896758|FG000|Overall Study|Withdrawal by Subject|0|||
124799446|NCT02718300|448896759|FG001|Overall Study|Withdrawal by Subject|4|||
124799447|NCT02718300|448896760|FG002|Overall Study|Withdrawal by Subject|3|||
124799448|NCT02718300|448896758|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
124799449|NCT02718300|448896759|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
124799450|NCT02718300|448896760|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
124799451|NCT03120624|448896761|FG000|Overall Study|Withdrawal by Subject|0|||
124799452|NCT03120624|448896762|FG001|Overall Study|Withdrawal by Subject|1|||
124799453|NCT03120624|448896763|FG002|Overall Study|Withdrawal by Subject|0|||
124799454|NCT03120624|448896764|FG003|Overall Study|Withdrawal by Subject|0|||
124799455|NCT03120624|448896765|FG004|Overall Study|Withdrawal by Subject|0|||
124799456|NCT03120624|448896766|FG005|Overall Study|Withdrawal by Subject|0|||
124799457|NCT03120624|448896767|FG006|Overall Study|Withdrawal by Subject|0|||
124799458|NCT03120624|448896768|FG007|Overall Study|Withdrawal by Subject|0|||
124799459|NCT05063318|448896769|FG000|Overall Study|Progressive disease|2|||
124799460|NCT05063318|448896770|FG001|Overall Study|Progressive disease|0|||
124799461|NCT05063318|448896771|FG002|Overall Study|Progressive disease|3|||
124799462|NCT05063318|448896769|FG000|Overall Study|Compassionate use|1|||
124799463|NCT05063318|448896770|FG001|Overall Study|Compassionate use|3|||
124799464|NCT05063318|448896771|FG002|Overall Study|Compassionate use|3|||
124799465|NCT05063318|448896769|FG000|Overall Study|Adverse Event|0|||
124799466|NCT05063318|448896770|FG001|Overall Study|Adverse Event|1|||
125295926|NCT00707954|450711403|FG001|Overall Study|Physician Decision|0|||
124799467|NCT05063318|448896771|FG002|Overall Study|Adverse Event|0|||
124799468|NCT05063318|448896769|FG000|Overall Study|Withdrawal by Subject|0|||
124799469|NCT05063318|448896770|FG001|Overall Study|Withdrawal by Subject|1|||
125295927|NCT00707954|450711404|FG002|Overall Study|Physician Decision|0|||
124799470|NCT05063318|448896771|FG002|Overall Study|Withdrawal by Subject|0|||
124799471|NCT01927341|448898627|FG000|Phase 1b|Lost to Follow-up|1|||
124799472|NCT01927341|448898628|FG001|Phase 1b|Lost to Follow-up|0|||
124799473|NCT01927341|448898629|FG002|Phase 1b|Lost to Follow-up|0|||
124799474|NCT01927341|448898630|FG003|Phase 1b|Lost to Follow-up|0|||
124799475|NCT01927341|448898631|FG004|Phase 1b|Lost to Follow-up|0|||
124799476|NCT01927341|448898627|FG000|Phase 1b|Death|2|||
124799477|NCT01927341|448898628|FG001|Phase 1b|Death|0|||
124799478|NCT01927341|448898629|FG002|Phase 1b|Death|0|||
124799479|NCT01927341|448898630|FG003|Phase 1b|Death|0|||
124799480|NCT01927341|448898631|FG004|Phase 1b|Death|0|||
124799481|NCT01927341|448898627|FG000|Phase 1b|Follow-up completed|7|||
124799482|NCT01927341|448898628|FG001|Phase 1b|Follow-up completed|0|||
124799483|NCT01927341|448898629|FG002|Phase 1b|Follow-up completed|0|||
124799484|NCT01927341|448898630|FG003|Phase 1b|Follow-up completed|0|||
124799485|NCT01927341|448898631|FG004|Phase 1b|Follow-up completed|0|||
124799486|NCT01927341|448898627|FG000|Phase 2|Lost to Follow-up|0|||
124799487|NCT01927341|448898628|FG001|Phase 2|Lost to Follow-up|1|||
124799488|NCT01927341|448898629|FG002|Phase 2|Lost to Follow-up|0|||
124799489|NCT01927341|448898630|FG003|Phase 2|Lost to Follow-up|0|||
124799490|NCT01927341|448898631|FG004|Phase 2|Lost to Follow-up|0|||
124799491|NCT01927341|448898627|FG000|Phase 2|Participant withdrew consent|0|||
124799492|NCT01927341|448898628|FG001|Phase 2|Participant withdrew consent|2|||
124799493|NCT01927341|448898629|FG002|Phase 2|Participant withdrew consent|1|||
124799494|NCT01927341|448898630|FG003|Phase 2|Participant withdrew consent|2|||
124799495|NCT01927341|448898631|FG004|Phase 2|Participant withdrew consent|3|||
124799496|NCT01927341|448898627|FG000|Phase 2|Death|0|||
124799497|NCT01927341|448898628|FG001|Phase 2|Death|4|||
124799498|NCT01927341|448898629|FG002|Phase 2|Death|0|||
124799499|NCT01927341|448898630|FG003|Phase 2|Death|3|||
124799500|NCT01927341|448898631|FG004|Phase 2|Death|2|||
124799501|NCT01927341|448898627|FG000|Phase 2|New cancer therapy|0|||
124799502|NCT01927341|448898628|FG001|Phase 2|New cancer therapy|1|||
124799503|NCT01927341|448898629|FG002|Phase 2|New cancer therapy|0|||
124799504|NCT01927341|448898630|FG003|Phase 2|New cancer therapy|4|||
124799505|NCT01927341|448898631|FG004|Phase 2|New cancer therapy|1|||
124799506|NCT01927341|448898627|FG000|Phase 2|Disease progression|0|||
124799507|NCT01927341|448898628|FG001|Phase 2|Disease progression|1|||
124799508|NCT01927341|448898629|FG002|Phase 2|Disease progression|1|||
124799509|NCT01927341|448898630|FG003|Phase 2|Disease progression|1|||
124799510|NCT01927341|448898631|FG004|Phase 2|Disease progression|0|||
124799511|NCT01927341|448898627|FG000|Phase 2|Follow-up completed|0|||
124799512|NCT01927341|448898628|FG001|Phase 2|Follow-up completed|6|||
124799513|NCT01927341|448898629|FG002|Phase 2|Follow-up completed|3|||
124799514|NCT01927341|448898630|FG003|Phase 2|Follow-up completed|5|||
124799515|NCT01927341|448898631|FG004|Phase 2|Follow-up completed|2|||
124799516|NCT00451451|448898640|FG000|Overall Study|Adverse Event|11|||
124799517|NCT00451451|448898641|FG001|Overall Study|Adverse Event|21|||
124799518|NCT00451451|448898642|FG002|Overall Study|Adverse Event|26|||
124799519|NCT00451451|448898643|FG003|Overall Study|Adverse Event|10|||
124799520|NCT00451451|448898640|FG000|Overall Study|Lost to Follow-up|11|||
124799521|NCT00451451|448898641|FG001|Overall Study|Lost to Follow-up|9|||
124799522|NCT00451451|448898642|FG002|Overall Study|Lost to Follow-up|8|||
124799523|NCT00451451|448898643|FG003|Overall Study|Lost to Follow-up|11|||
124799524|NCT00451451|448898640|FG000|Overall Study|Consent Withdrawn|14|||
124799525|NCT00451451|448898641|FG001|Overall Study|Consent Withdrawn|9|||
124799526|NCT00451451|448898642|FG002|Overall Study|Consent Withdrawn|17|||
124799527|NCT00451451|448898643|FG003|Overall Study|Consent Withdrawn|17|||
124799528|NCT00451451|448898640|FG000|Overall Study|Investigator Decision|6|||
124799529|NCT00451451|448898641|FG001|Overall Study|Investigator Decision|2|||
124799530|NCT00451451|448898642|FG002|Overall Study|Investigator Decision|1|||
124799531|NCT00451451|448898643|FG003|Overall Study|Investigator Decision|2|||
124799532|NCT00451451|448898640|FG000|Overall Study|Subject Non-Compliance|8|||
124799533|NCT00451451|448898641|FG001|Overall Study|Subject Non-Compliance|4|||
124799534|NCT00451451|448898642|FG002|Overall Study|Subject Non-Compliance|3|||
124799535|NCT00451451|448898643|FG003|Overall Study|Subject Non-Compliance|3|||
124799536|NCT00451451|448898640|FG000|Overall Study|Death|1|||
124799537|NCT00451451|448898641|FG001|Overall Study|Death|0|||
124799538|NCT00451451|448898642|FG002|Overall Study|Death|0|||
124799539|NCT00451451|448898643|FG003|Overall Study|Death|1|||
124799540|NCT00451451|448898640|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
124799541|NCT00451451|448898641|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
124799542|NCT00451451|448898642|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
124799543|NCT00451451|448898643|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
124799544|NCT00084838|448898644|FG000|Overall Study|Death|1|||
124799545|NCT00084838|448898644|FG000|Overall Study|Adverse Event|2|||
124799546|NCT00084838|448898644|FG000|Overall Study|Withdrawal by Subject|1|||
124799547|NCT00084838|448898644|FG000|Overall Study|Progressive Disease|4|||
124799548|NCT00084838|448898644|FG000|Overall Study|Pt Non-Compliance|1|||
124799549|NCT00084838|448898644|FG000|Overall Study|Ineligible|4|||
124799550|NCT00122278|448898645|FG000|Overall Study|Lost to Follow-up|2|||
124799551|NCT00122278|448898646|FG001|Overall Study|Lost to Follow-up|0|||
124799552|NCT01865084|448898647|FG000|Double Blind Period (DB)|Adverse Event|2|||
124799553|NCT01865084|448898648|FG001|Double Blind Period (DB)|Adverse Event|2|||
124799554|NCT01865084|448898649|FG002|Double Blind Period (DB)|Adverse Event|1|||
124799555|NCT01865084|448898647|FG000|Double Blind Period (DB)|Protocol Violation|0|||
124799556|NCT01865084|448898648|FG001|Double Blind Period (DB)|Protocol Violation|0|||
124799557|NCT01865084|448898649|FG002|Double Blind Period (DB)|Protocol Violation|1|||
124799558|NCT01865084|448898647|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
124799559|NCT01865084|448898648|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
124799560|NCT01865084|448898649|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
124799561|NCT01865084|448898647|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
124799562|NCT01865084|448898648|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
124799563|NCT01865084|448898649|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
124799564|NCT01865084|448898647|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
124799565|NCT01865084|448898648|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
124799566|NCT01865084|448898649|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
124799567|NCT01865084|448898647|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
124799568|NCT01865084|448898648|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
124799569|NCT01865084|448898649|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
124799570|NCT01865084|448898647|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
124799571|NCT01865084|448898648|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
124799572|NCT01865084|448898649|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
124799573|NCT01865084|448898647|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
124799574|NCT01865084|448898648|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
124799575|NCT01865084|448898649|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
124799576|NCT01865084|448898647|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
124799577|NCT01865084|448898648|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
124799578|NCT01865084|448898649|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
124799579|NCT01994590|448898650|FG000|Overall Study|Adverse Event|1|||
124799580|NCT01994590|448898650|FG000|Overall Study|Trial Terminated|1|||
124799581|NCT03607422|448898651|FG000|Overall Study|Adverse Event|7|||
124799582|NCT03607422|448898652|FG001|Overall Study|Adverse Event|3|||
124799583|NCT03607422|448898653|FG002|Overall Study|Adverse Event|2|||
124799584|NCT03607422|448898654|FG003|Overall Study|Adverse Event|0|||
124799585|NCT03607422|448898655|FG004|Overall Study|Adverse Event|2|||
124799586|NCT03607422|448898656|FG005|Overall Study|Adverse Event|0|||
124799587|NCT03607422|448898651|FG000|Overall Study|Withdrawal by Subject|11|||
124799588|NCT03607422|448898652|FG001|Overall Study|Withdrawal by Subject|3|||
124799589|NCT03607422|448898653|FG002|Overall Study|Withdrawal by Subject|6|||
124799590|NCT03607422|448898654|FG003|Overall Study|Withdrawal by Subject|2|||
124799591|NCT03607422|448898655|FG004|Overall Study|Withdrawal by Subject|0|||
124799592|NCT03607422|448898656|FG005|Overall Study|Withdrawal by Subject|0|||
124799593|NCT03607422|448898651|FG000|Overall Study|Lost to Follow-up|0|||
124799594|NCT03607422|448898652|FG001|Overall Study|Lost to Follow-up|0|||
124799595|NCT03607422|448898653|FG002|Overall Study|Lost to Follow-up|1|||
124799596|NCT03607422|448898654|FG003|Overall Study|Lost to Follow-up|0|||
124799597|NCT03607422|448898655|FG004|Overall Study|Lost to Follow-up|0|||
124799598|NCT03607422|448898656|FG005|Overall Study|Lost to Follow-up|0|||
124799599|NCT03607422|448898651|FG000|Overall Study|Other|12|||
124799600|NCT03607422|448898652|FG001|Overall Study|Other|4|||
124799601|NCT03607422|448898653|FG002|Overall Study|Other|1|||
124799602|NCT03607422|448898654|FG003|Overall Study|Other|2|||
124799603|NCT03607422|448898655|FG004|Overall Study|Other|0|||
124799604|NCT03607422|448898656|FG005|Overall Study|Other|2|||
124799605|NCT03607422|448898651|FG000|Overall Study|Ongoing at Time of Analysis|8|||
124799606|NCT03607422|448898652|FG001|Overall Study|Ongoing at Time of Analysis|0|||
124799607|NCT03607422|448898653|FG002|Overall Study|Ongoing at Time of Analysis|2|||
124799608|NCT03607422|448898654|FG003|Overall Study|Ongoing at Time of Analysis|1|||
124799609|NCT03607422|448898655|FG004|Overall Study|Ongoing at Time of Analysis|1|||
124799610|NCT03607422|448898656|FG005|Overall Study|Ongoing at Time of Analysis|1|||
124799611|NCT03693170|448898657|FG000|Overall Study|Disease Progression|48|||
124799612|NCT03693170|448898657|FG000|Overall Study|Adverse Event|16|||
124799613|NCT03693170|448898657|FG000|Overall Study|Physician Decision|6|||
124799614|NCT03693170|448898657|FG000|Overall Study|Protocol Violation|2|||
124799615|NCT03693170|448898657|FG000|Overall Study|Death|1|||
124799616|NCT03693170|448898657|FG000|Overall Study|Non compliance with study drug|1|||
124799617|NCT03693170|448898657|FG000|Overall Study|Withdrawal by Subject|1|||
124799618|NCT03875118|448898658|FG000|Overall Study|Withdrawal by Subject|4|||
124799619|NCT03875118|448898659|FG001|Overall Study|Withdrawal by Subject|4|||
124799620|NCT03228420|448898669|FG000|Overall Study|Lost to Follow-up|5|||
124799621|NCT03228420|448898670|FG001|Overall Study|Lost to Follow-up|3|||
124799622|NCT03228420|448898669|FG000|Overall Study|Withdrawal by Subject|10|||
124799623|NCT03228420|448898670|FG001|Overall Study|Withdrawal by Subject|0|||
124799624|NCT03228420|448898669|FG000|Overall Study|Adverse Event|5|||
124799625|NCT03228420|448898670|FG001|Overall Study|Adverse Event|2|||
124799626|NCT01298531|448898671|FG000|Overall Study|Lack of Efficacy|0|||
124799627|NCT01298531|448898672|FG001|Overall Study|Lack of Efficacy|1|||
124799628|NCT01298531|448898671|FG000|Overall Study|Lost to Follow-up|2|||
124799629|NCT01298531|448898672|FG001|Overall Study|Lost to Follow-up|0|||
124799630|NCT01298531|448898671|FG000|Overall Study|Protocol Violation|1|||
124799631|NCT01298531|448898672|FG001|Overall Study|Protocol Violation|1|||
124799632|NCT01298531|448898671|FG000|Overall Study|Adverse Event|4|||
124799633|NCT01298531|448898672|FG001|Overall Study|Adverse Event|3|||
124799634|NCT01298531|448898671|FG000|Overall Study|Does not meet entrance criteria|0|||
124799635|NCT01298531|448898672|FG001|Overall Study|Does not meet entrance criteria|1|||
124799636|NCT01298531|448898671|FG000|Overall Study|Other|2|||
124799637|NCT01298531|448898672|FG001|Overall Study|Other|1|||
124799638|NCT01933217|448898675|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
124799639|NCT01933217|448898676|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
124799640|NCT01933217|448898675|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
124799641|NCT01933217|448898676|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
124799642|NCT03923738|448898679|FG000|Period 1|Adverse Event|1|||
124799643|NCT03923738|448898679|FG000|Period 1|Withdrawal by Subject|1|||
124799644|NCT03583164|448898681|FG000|Overall Study|Death in Main Phase|35|||
124799645|NCT03583164|448898681|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
124799646|NCT03583164|448898681|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
124799647|NCT03583164|448898681|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
124799648|NCT03583164|448898681|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
124799649|NCT03583164|448898681|FG000|Overall Study|Physician decision in Main Phase|1|||
124799650|NCT03583164|448898681|FG000|Overall Study|Physician decision in Extended Phase|2|||
124799651|NCT03583164|448898681|FG000|Overall Study|Death in Extended Phase|13|||
124799652|NCT03583164|448898681|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
124799653|NCT03583164|448898681|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
124799654|NCT03583164|448898681|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
124799655|NCT03583164|448898681|FG000|Overall Study|Treatment failure in Main Phase|2|||
124799656|NCT03583164|448898681|FG000|Overall Study|Treatment failure in Extended Phase|4|||
124799657|NCT03583164|448898681|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
124799658|NCT03583164|448898681|FG000|Overall Study|Other not specified reason in Main Phase|2|||
124799659|NCT00735254|448898682|FG000|Overall Study|Protocol Violation|1|||
124799660|NCT00735254|448898683|FG001|Overall Study|Protocol Violation|1|||
124799661|NCT00735254|448898684|FG002|Overall Study|Protocol Violation|1|||
124799662|NCT00735254|448898685|FG003|Overall Study|Protocol Violation|0|||
124799663|NCT00057954|448898689|FG000|Overall Study|Death|1|||
124799664|NCT00057954|448898689|FG000|Overall Study|Disease progression|1|||
124799665|NCT00559754|448898690|FG000|Overall Study|Disease progression|1|||
124799666|NCT00559754|448898690|FG000|Overall Study|Adverse Event|5|||
124799667|NCT00559754|448898690|FG000|Overall Study|Protocol Violation|1|||
124799668|NCT00559754|448898690|FG000|Overall Study|Investigator criteria|2|||
124799669|NCT00559754|448898690|FG000|Overall Study|Withdrawal by Subject|2|||
124799670|NCT01251744|448898691|FG000|Overall Study|Lost to Follow-up|1|||
124799671|NCT01251744|448898692|FG001|Overall Study|Lost to Follow-up|0|||
124799672|NCT01068652|448898697|FG000|Overall Study|Adverse Event|4|||
124799673|NCT01068652|448898698|FG001|Overall Study|Adverse Event|0|||
124799674|NCT01068652|448898697|FG000|Overall Study|Lack of Efficacy|0|||
124799675|NCT01068652|448898698|FG001|Overall Study|Lack of Efficacy|2|||
124799676|NCT01068652|448898697|FG000|Overall Study|Lost to Follow-up|2|||
124799677|NCT01068652|448898698|FG001|Overall Study|Lost to Follow-up|1|||
124799678|NCT01068652|448898697|FG000|Overall Study|Protocol Violation|3|||
124799679|NCT01068652|448898698|FG001|Overall Study|Protocol Violation|6|||
124799680|NCT01068652|448898697|FG000|Overall Study|Withdrawal criteria|1|||
124799681|NCT01068652|448898698|FG001|Overall Study|Withdrawal criteria|2|||
124799682|NCT01068652|448898697|FG000|Overall Study|Patient was not eligible|1|||
124799683|NCT01068652|448898698|FG001|Overall Study|Patient was not eligible|0|||
124799684|NCT01068652|448898697|FG000|Overall Study|Unclassified|7|||
124799685|NCT01068652|448898698|FG001|Overall Study|Unclassified|4|||
124799686|NCT00751621|448898699|FG000|Overall Study|Adverse Event|1|||
124799687|NCT00751621|448898699|FG000|Overall Study|Withdrawal by Subject|1|||
124799688|NCT00751621|448898699|FG000|Overall Study|Subject moved to another country|1|||
124799689|NCT00751621|448898699|FG000|Overall Study|Poor adherence to asthma treatment|1|||
124799690|NCT03343067|448898700|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
124799691|NCT03343067|448898701|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
124799692|NCT03343067|448898702|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
124799693|NCT01323946|448898703|FG000|Overall Study|Lost to Follow-up|0|||
124799694|NCT01323946|448898704|FG001|Overall Study|Lost to Follow-up|1|||
124799695|NCT01323946|448898705|FG002|Overall Study|Lost to Follow-up|0|||
124799696|NCT01323946|448898703|FG000|Overall Study|Parents refused the last blood draw|1|||
124799697|NCT01323946|448898704|FG001|Overall Study|Parents refused the last blood draw|0|||
124799698|NCT01323946|448898705|FG002|Overall Study|Parents refused the last blood draw|0|||
124799699|NCT01323946|448898703|FG000|Overall Study|Withdrawal by Subject|2|||
124799700|NCT01323946|448898704|FG001|Overall Study|Withdrawal by Subject|2|||
124799701|NCT01323946|448898705|FG002|Overall Study|Withdrawal by Subject|0|||
124799702|NCT01243671|448898706|FG000|Overall Study|Adverse Event|3|||
124799703|NCT01243671|448898706|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
124799704|NCT01243671|448898706|FG000|Overall Study|Other|1|||
124799705|NCT00573248|448898707|FG000|Overall Study|scheduling conflicts|15|||
124799706|NCT00573248|448898708|FG001|Overall Study|scheduling conflicts|11|||
124799707|NCT01013649|448898711|FG000|First Step|Withdrawal by Subject|36|||
124799708|NCT01013649|448898712|FG001|First Step|Withdrawal by Subject|19|||
124799709|NCT01013649|448898713|FG002|First Step|Withdrawal by Subject|0|||
124799710|NCT01013649|448898714|FG003|First Step|Withdrawal by Subject|0|||
124799711|NCT01013649|448898711|FG000|First Step|Progression|58|||
124799712|NCT01013649|448898712|FG001|First Step|Progression|23|||
124799713|NCT01013649|448898713|FG002|First Step|Progression|0|||
124799714|NCT01013649|448898714|FG003|First Step|Progression|0|||
124799715|NCT01013649|448898711|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
124799716|NCT01013649|448898712|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
124799717|NCT01013649|448898713|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
124799718|NCT01013649|448898714|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
124799719|NCT01013649|448898711|FG000|First Step|Death|3|||
124799720|NCT01013649|448898712|FG001|First Step|Death|4|||
124799721|NCT01013649|448898713|FG002|First Step|Death|0|||
124799722|NCT01013649|448898714|FG003|First Step|Death|0|||
125295928|NCT00707954|450711405|FG003|Overall Study|Physician Decision|0|||
125295929|NCT00707954|450711406|FG004|Overall Study|Physician Decision|1|||
124799723|NCT01013649|448898711|FG000|First Step|Adverse Event|9|||
124799724|NCT01013649|448898712|FG001|First Step|Adverse Event|5|||
124799725|NCT01013649|448898713|FG002|First Step|Adverse Event|0|||
124799726|NCT01013649|448898714|FG003|First Step|Adverse Event|0|||
124799727|NCT01013649|448898711|FG000|First Step|Other|4|||
124799728|NCT01013649|448898712|FG001|First Step|Other|6|||
124799729|NCT01013649|448898713|FG002|First Step|Other|0|||
124799730|NCT01013649|448898714|FG003|First Step|Other|0|||
124799731|NCT05323656|448898717|FG000|Overall Study|Still On-Treatment|6|||
125295930|NCT01306656|450711407|FG000|Overall Study|Lost to Follow-up|1|||
125295931|NCT01306656|450711408|FG001|Overall Study|Lost to Follow-up|0|||
125295932|NCT01286077|450711409|FG000|Overall Study|Adverse Event|2|||
125295933|NCT01286077|450711410|FG001|Overall Study|Adverse Event|0|||
125295934|NCT01286077|450711409|FG000|Overall Study|Death|1|||
125295935|NCT01286077|450711410|FG001|Overall Study|Death|0|||
125295936|NCT01286077|450711409|FG000|Overall Study|Protocol Violation|1|||
125295937|NCT01286077|450711410|FG001|Overall Study|Protocol Violation|1|||
125295938|NCT01286077|450711409|FG000|Overall Study|Withdrawal by Subject|0|||
125295939|NCT01286077|450711410|FG001|Overall Study|Withdrawal by Subject|2|||
125295940|NCT01286077|450711409|FG000|Overall Study|Intercurrent illness|1|||
125295941|NCT01286077|450711410|FG001|Overall Study|Intercurrent illness|0|||
125295942|NCT01286077|450711409|FG000|Overall Study|Non-compliance|1|||
125295943|NCT01286077|450711410|FG001|Overall Study|Non-compliance|0|||
125295944|NCT01286077|450711409|FG000|Overall Study|The subject starts with alternative MMY|0|||
125295945|NCT01286077|450711410|FG001|Overall Study|The subject starts with alternative MMY|3|||
125295946|NCT01286077|450711409|FG000|Overall Study|Patient's decision to stop treatment|3|||
125295947|NCT01286077|450711410|FG001|Overall Study|Patient's decision to stop treatment|0|||
125295948|NCT01286077|450711409|FG000|Overall Study|Progression of disease|0|||
124799732|NCT05323656|448898718|FG001|Overall Study|Still On-Treatment|6|||
124799733|NCT05323656|448898717|FG000|Overall Study|Progressive Disease|15|||
124799734|NCT05323656|448898718|FG001|Overall Study|Progressive Disease|14|||
124799735|NCT05323656|448898717|FG000|Overall Study|Adverse Event|2|||
124799736|NCT05323656|448898718|FG001|Overall Study|Adverse Event|3|||
124799737|NCT05323656|448898717|FG000|Overall Study|Death|1|||
124799738|NCT05323656|448898718|FG001|Overall Study|Death|2|||
124799739|NCT05323656|448898717|FG000|Overall Study|Withdrawal by Subject|1|||
124799740|NCT05323656|448898718|FG001|Overall Study|Withdrawal by Subject|0|||
124799741|NCT05323656|448898717|FG000|Overall Study|Clinical disease progression|0|||
124799742|NCT05323656|448898718|FG001|Overall Study|Clinical disease progression|1|||
125295949|NCT01286077|450711410|FG001|Overall Study|Progression of disease|1|||
125295950|NCT01286077|450711409|FG000|Overall Study|refill medication not received in time|1|||
125295951|NCT01286077|450711410|FG001|Overall Study|refill medication not received in time|0|||
125295952|NCT01571232|450711411|FG000|Overall Study|Lost to Follow-up|0|||
125295953|NCT01571232|450711412|FG001|Overall Study|Lost to Follow-up|1|||
125295954|NCT01571232|450711411|FG000|Overall Study|Withdrawal by Subject|1|||
125295955|NCT01571232|450711412|FG001|Overall Study|Withdrawal by Subject|0|||
125295956|NCT03517969|450711414|FG000|Overall Study|Never started protocol treatment|3|||
124799743|NCT05323656|448898717|FG000|Overall Study|Patient and Investigator decision|1|||
124799744|NCT05323656|448898718|FG001|Overall Study|Patient and Investigator decision|0|||
124799745|NCT05323656|448898717|FG000|Overall Study|Physician Decision|0|||
124799746|NCT05323656|448898718|FG001|Overall Study|Physician Decision|1|||
124799747|NCT03370289|448898721|FG000|Overall Study|Screen Failure|1|||
124799748|NCT03370289|448898721|FG000|Overall Study|Sample Size Sufficient|4|||
124799749|NCT03309046|448898722|FG000|Overall Study|Withdrawal by Subject|4|||
124799750|NCT03309046|448898723|FG001|Overall Study|Withdrawal by Subject|17|||
125295957|NCT03517969|450711415|FG001|Overall Study|Never started protocol treatment|5|||
125295958|NCT03517969|450711414|FG000|Overall Study|Disease progression|11|||
124799751|NCT03963401|448898728|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
124799752|NCT03963401|448898729|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
124799753|NCT03963401|448898730|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
124799754|NCT03963401|448898731|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
124799755|NCT03963401|448898732|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
124799756|NCT03963401|448898733|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
124799757|NCT03963401|448898728|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
124799758|NCT03963401|448898729|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
124799759|NCT03963401|448898730|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
124799760|NCT03963401|448898731|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
124799761|NCT03963401|448898732|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
124799762|NCT03963401|448898733|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
124799763|NCT03963401|448898728|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
124799764|NCT03963401|448898729|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
124799765|NCT03963401|448898730|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
124799766|NCT03963401|448898731|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
124799767|NCT03963401|448898732|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
124799768|NCT03963401|448898733|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
124799769|NCT03963401|448898728|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
124799770|NCT03963401|448898729|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
124799771|NCT03963401|448898730|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
124799772|NCT03963401|448898731|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
124799773|NCT03963401|448898732|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
124799774|NCT03963401|448898733|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
124799775|NCT03963401|448898728|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
124799776|NCT03963401|448898729|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
124799777|NCT03963401|448898730|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
124799778|NCT03963401|448898731|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
124799779|NCT03963401|448898732|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
124799780|NCT03963401|448898733|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
124799781|NCT03963401|448898728|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
124799782|NCT03963401|448898729|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
124799783|NCT03963401|448898730|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
124799784|NCT03963401|448898731|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
124799785|NCT03963401|448898732|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
124799786|NCT03963401|448898733|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
124799787|NCT03963401|448898728|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
124799788|NCT03963401|448898729|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
124799789|NCT03963401|448898730|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
124799790|NCT03963401|448898731|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
124799791|NCT03963401|448898732|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
124799792|NCT03963401|448898733|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
124799793|NCT03963401|448898728|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
124799794|NCT03963401|448898729|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
124799795|NCT03963401|448898730|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
124799796|NCT03963401|448898731|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
124799797|NCT03963401|448898732|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
124799798|NCT03963401|448898733|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
124799799|NCT03963401|448898728|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
124799800|NCT03963401|448898729|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
124799801|NCT03963401|448898730|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
124799802|NCT03963401|448898731|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
124799803|NCT03963401|448898732|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
124799804|NCT03963401|448898733|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
124799805|NCT03963401|448898728|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
124799806|NCT03963401|448898729|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
124799807|NCT03963401|448898730|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
124799808|NCT03963401|448898731|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
125295959|NCT03517969|450711415|FG001|Overall Study|Disease progression|16|||
125295960|NCT03517969|450711414|FG000|Overall Study|PSA progression|8|||
125295961|NCT03517969|450711415|FG001|Overall Study|PSA progression|1|||
125295962|NCT03517969|450711414|FG000|Overall Study|Clinical progression|4|||
125295963|NCT03517969|450711415|FG001|Overall Study|Clinical progression|2|||
125295964|NCT03517969|450711414|FG000|Overall Study|Adverse Event|5|||
125295965|NCT03517969|450711415|FG001|Overall Study|Adverse Event|4|||
125295966|NCT03517969|450711414|FG000|Overall Study|Intercurrent illness|1|||
124799809|NCT03963401|448898732|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
124799810|NCT03963401|448898733|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
124799811|NCT03963401|448898728|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
124799812|NCT03963401|448898729|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
124799813|NCT03963401|448898730|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
124799814|NCT03963401|448898731|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
124799815|NCT03963401|448898732|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
124799816|NCT03963401|448898733|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
124799817|NCT01721070|448898736|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
124799818|NCT02204007|448898737|FG000|Overall Study|Surgery Canceled|1|||
124799819|NCT02204007|448898738|FG001|Overall Study|Surgery Canceled|1|||
124799820|NCT00910988|448898739|FG000|Overall Study|Lost to Follow-up|2|||
124799821|NCT00910988|448898740|FG001|Overall Study|Lost to Follow-up|4|||
124799822|NCT00910988|448898741|FG002|Overall Study|Lost to Follow-up|3|||
124799823|NCT00910988|448898742|FG003|Overall Study|Lost to Follow-up|0|||
124799824|NCT03004443|448898743|FG000|Overall Study|Pregnancy|0|||
124799825|NCT03004443|448898744|FG001|Overall Study|Pregnancy|1|||
124799826|NCT00828854|448898745|FG000|Overall Study|Disease Progression|17|||
124799827|NCT00828854|448898745|FG000|Overall Study|Adverse Event|9|||
124799828|NCT00828854|448898745|FG000|Overall Study|Reason not Specified|1|||
124799829|NCT03911843|448898746|FG000|Overall Study|Adverse Event|2|||
124799830|NCT03911843|448898747|FG001|Overall Study|Adverse Event|0|||
124799831|NCT03911843|448898746|FG000|Overall Study|Protocol Violation|2|||
124799832|NCT03911843|448898747|FG001|Overall Study|Protocol Violation|0|||
124799833|NCT03911843|448898746|FG000|Overall Study|Lost to Follow-up|0|||
124799834|NCT03911843|448898747|FG001|Overall Study|Lost to Follow-up|1|||
124799835|NCT01907100|448898748|FG000|Overall Study|PD based on modified RECIST criteria|31|||
124799836|NCT01907100|448898749|FG001|Overall Study|PD based on modified RECIST criteria|32|||
124799837|NCT01907100|448898750|FG002|Overall Study|PD based on modified RECIST criteria|95|||
124799838|NCT01907100|448898751|FG003|Overall Study|PD based on modified RECIST criteria|92|||
124799839|NCT01907100|448898748|FG000|Overall Study|Withdrawal by Subject|2|||
124799840|NCT01907100|448898749|FG001|Overall Study|Withdrawal by Subject|5|||
124799841|NCT01907100|448898750|FG002|Overall Study|Withdrawal by Subject|10|||
124799842|NCT01907100|448898751|FG003|Overall Study|Withdrawal by Subject|13|||
124799843|NCT01907100|448898748|FG000|Overall Study|Protocol Violation|0|||
124799844|NCT01907100|448898749|FG001|Overall Study|Protocol Violation|0|||
124799845|NCT01907100|448898750|FG002|Overall Study|Protocol Violation|1|||
124799846|NCT01907100|448898751|FG003|Overall Study|Protocol Violation|1|||
124799847|NCT01907100|448898748|FG000|Overall Study|Lost to Follow-up|0|||
124799848|NCT01907100|448898749|FG001|Overall Study|Lost to Follow-up|0|||
124799849|NCT01907100|448898750|FG002|Overall Study|Lost to Follow-up|0|||
124799850|NCT01907100|448898751|FG003|Overall Study|Lost to Follow-up|1|||
124799851|NCT01907100|448898748|FG000|Overall Study|Not treated|2|||
124799852|NCT01907100|448898749|FG001|Overall Study|Not treated|0|||
124799853|NCT01907100|448898750|FG002|Overall Study|Not treated|1|||
124799854|NCT01907100|448898751|FG003|Overall Study|Not treated|2|||
124799855|NCT01907100|448898748|FG000|Overall Study|Other than reasons specified|1|||
124799856|NCT01907100|448898749|FG001|Overall Study|Other than reasons specified|0|||
124799857|NCT01907100|448898750|FG002|Overall Study|Other than reasons specified|10|||
124799858|NCT01907100|448898751|FG003|Overall Study|Other than reasons specified|6|||
124799859|NCT01907100|448898748|FG000|Overall Study|Adverse event (AE)|6|||
124799860|NCT01907100|448898749|FG001|Overall Study|Adverse event (AE)|3|||
124799861|NCT01907100|448898750|FG002|Overall Study|Adverse event (AE)|22|||
124799862|NCT01907100|448898751|FG003|Overall Study|Adverse event (AE)|23|||
124799863|NCT01907100|448898748|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
124799864|NCT01907100|448898749|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
124799865|NCT01907100|448898750|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
124799866|NCT01907100|448898751|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
124799867|NCT03635788|448898752|FG000|Step 1|Death|1|||
124799868|NCT03635788|448898753|FG001|Step 1|Death|0|||
124799869|NCT03635788|448898754|FG002|Step 1|Death|0|||
124799870|NCT03635788|448898752|FG000|Step 1|Lost to Follow-up|31|||
124799871|NCT03635788|448898753|FG001|Step 1|Lost to Follow-up|0|||
124799872|NCT03635788|448898754|FG002|Step 1|Lost to Follow-up|0|||
124799873|NCT03635788|448898752|FG000|Step 1|Pregnancy|1|||
124799874|NCT03635788|448898753|FG001|Step 1|Pregnancy|0|||
124799875|NCT03635788|448898754|FG002|Step 1|Pregnancy|0|||
124799876|NCT03635788|448898752|FG000|Step 1|Protocol Violation|8|||
124799877|NCT03635788|448898753|FG001|Step 1|Protocol Violation|0|||
124799878|NCT03635788|448898754|FG002|Step 1|Protocol Violation|0|||
124799879|NCT03635788|448898752|FG000|Step 1|Withdrawal by Subject|13|||
124799880|NCT03635788|448898753|FG001|Step 1|Withdrawal by Subject|0|||
124799881|NCT03635788|448898754|FG002|Step 1|Withdrawal by Subject|0|||
125295967|NCT03517969|450711415|FG001|Overall Study|Intercurrent illness|2|||
124799882|NCT03635788|448898752|FG000|Step 1|Other reasons|12|||
124799883|NCT03635788|448898753|FG001|Step 1|Other reasons|0|||
124799884|NCT03635788|448898754|FG002|Step 1|Other reasons|0|||
124799885|NCT03635788|448898752|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
124799886|NCT03635788|448898753|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
124799887|NCT03635788|448898754|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
124799888|NCT03635788|448898752|FG000|Step 2|Lost to Follow-up|0|||
124799889|NCT03635788|448898753|FG001|Step 2|Lost to Follow-up|8|||
124799890|NCT03635788|448898754|FG002|Step 2|Lost to Follow-up|15|||
124799891|NCT03635788|448898752|FG000|Step 2|Withdrawal by Subject|0|||
124799892|NCT03635788|448898753|FG001|Step 2|Withdrawal by Subject|6|||
124799893|NCT03635788|448898754|FG002|Step 2|Withdrawal by Subject|6|||
124799894|NCT03635788|448898752|FG000|Step 2|Death|0|||
124799895|NCT03635788|448898753|FG001|Step 2|Death|2|||
124799896|NCT03635788|448898754|FG002|Step 2|Death|0|||
124799897|NCT03635788|448898752|FG000|Step 2|Incarceration|0|||
124799898|NCT03635788|448898753|FG001|Step 2|Incarceration|2|||
124799899|NCT03635788|448898754|FG002|Step 2|Incarceration|0|||
124799900|NCT03635788|448898752|FG000|Step 2|Non-Compliance With Study Requirements|0|||
124799901|NCT03635788|448898753|FG001|Step 2|Non-Compliance With Study Requirements|1|||
124799902|NCT03635788|448898754|FG002|Step 2|Non-Compliance With Study Requirements|1|||
124799903|NCT03635788|448898752|FG000|Step 2|Confounding Medical Condition|0|||
124799904|NCT03635788|448898753|FG001|Step 2|Confounding Medical Condition|0|||
124799905|NCT03635788|448898754|FG002|Step 2|Confounding Medical Condition|1|||
124799906|NCT03635788|448898752|FG000|Step 2|Out Of State With No Plan To Return|0|||
124799907|NCT03635788|448898753|FG001|Step 2|Out Of State With No Plan To Return|1|||
124799908|NCT03635788|448898754|FG002|Step 2|Out Of State With No Plan To Return|0|||
124799909|NCT03635788|448898752|FG000|Step 2|Switched To Injectables|0|||
124799910|NCT03635788|448898753|FG001|Step 2|Switched To Injectables|0|||
124799911|NCT03635788|448898754|FG002|Step 2|Switched To Injectables|1|||
124799912|NCT03635788|448898752|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
124799913|NCT03635788|448898753|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
124799914|NCT03635788|448898754|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
124799915|NCT04382755|448898755|FG000|Overall Study|Withdrawal by Subject|1|||
124799916|NCT04382755|448898756|FG001|Overall Study|Withdrawal by Subject|0|||
124799917|NCT04382755|448898755|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
124799918|NCT04382755|448898756|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
124799919|NCT04382755|448898755|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
124799920|NCT04382755|448898756|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
124799921|NCT01397201|448900382|FG000|Overall Study|Not treated|0|||
124799922|NCT01397201|448900383|FG001|Overall Study|Not treated|0|||
124799923|NCT01397201|448900384|FG002|Overall Study|Not treated|1|||
124799924|NCT01397201|448900385|FG003|Overall Study|Not treated|0|||
124799925|NCT01397201|448900386|FG004|Overall Study|Not treated|0|||
124799926|NCT01397201|448900382|FG000|Overall Study|Not yet defined|3|||
124799927|NCT01397201|448900383|FG001|Overall Study|Not yet defined|6|||
124799928|NCT01397201|448900384|FG002|Overall Study|Not yet defined|5|||
124799929|NCT01397201|448900385|FG003|Overall Study|Not yet defined|5|||
124799930|NCT01397201|448900386|FG004|Overall Study|Not yet defined|4|||
124799931|NCT01397201|448900382|FG000|Overall Study|Adverse Event|2|||
124799932|NCT01397201|448900383|FG001|Overall Study|Adverse Event|0|||
124799933|NCT01397201|448900384|FG002|Overall Study|Adverse Event|0|||
124799934|NCT01397201|448900385|FG003|Overall Study|Adverse Event|0|||
124799935|NCT01397201|448900386|FG004|Overall Study|Adverse Event|0|||
124799936|NCT00215683|448900387|FG000|Overall Study|Adverse Event|15|||
124799937|NCT00215683|448900388|FG001|Overall Study|Adverse Event|16|||
124799938|NCT00215683|448900389|FG002|Overall Study|Adverse Event|15|||
124799939|NCT00215683|448900387|FG000|Overall Study|Lack of Efficacy|5|||
124799940|NCT00215683|448900388|FG001|Overall Study|Lack of Efficacy|1|||
124799941|NCT00215683|448900389|FG002|Overall Study|Lack of Efficacy|2|||
124799942|NCT00215683|448900387|FG000|Overall Study|Lost to Follow-up|0|||
124799943|NCT00215683|448900388|FG001|Overall Study|Lost to Follow-up|2|||
124799944|NCT00215683|448900389|FG002|Overall Study|Lost to Follow-up|1|||
124799945|NCT00215683|448900387|FG000|Overall Study|Withdrawal by Subject|9|||
124799946|NCT00215683|448900388|FG001|Overall Study|Withdrawal by Subject|4|||
124799947|NCT00215683|448900389|FG002|Overall Study|Withdrawal by Subject|13|||
124799948|NCT00215683|448900387|FG000|Overall Study|Physician Decision|0|||
124799949|NCT00215683|448900388|FG001|Overall Study|Physician Decision|0|||
124799950|NCT00215683|448900389|FG002|Overall Study|Physician Decision|1|||
124799951|NCT00215683|448900387|FG000|Overall Study|Difficult to attend visits|0|||
124799952|NCT00215683|448900388|FG001|Overall Study|Difficult to attend visits|1|||
124799953|NCT00215683|448900389|FG002|Overall Study|Difficult to attend visits|0|||
124799954|NCT00215683|448900387|FG000|Overall Study|No study drug available|0|||
124799955|NCT00215683|448900388|FG001|Overall Study|No study drug available|1|||
124799956|NCT00215683|448900389|FG002|Overall Study|No study drug available|0|||
124799957|NCT00215683|448900387|FG000|Overall Study|Intermittent therapy required|0|||
124799958|NCT00215683|448900388|FG001|Overall Study|Intermittent therapy required|1|||
124799959|NCT00215683|448900389|FG002|Overall Study|Intermittent therapy required|0|||
124799960|NCT01083485|448900390|FG000|Overall Study|Adverse Event|0|||
124799961|NCT01083485|448900391|FG001|Overall Study|Adverse Event|1|||
124799962|NCT01083485|448900390|FG000|Overall Study|Protocol Violation|1|||
124799963|NCT01083485|448900391|FG001|Overall Study|Protocol Violation|0|||
124799964|NCT01083485|448900390|FG000|Overall Study|Withdrawal by Subject|5|||
124799965|NCT01083485|448900391|FG001|Overall Study|Withdrawal by Subject|2|||
124799966|NCT01083485|448900390|FG000|Overall Study|Other|1|||
124799967|NCT01083485|448900391|FG001|Overall Study|Other|0|||
124799968|NCT04493333|448900392|FG000|Overall Study|Withdrawal by Subject|1|||
124799969|NCT04493333|448900393|FG001|Overall Study|Withdrawal by Subject|1|||
124799970|NCT04493333|448900392|FG000|Overall Study|Ineligible|0|||
124799971|NCT04493333|448900393|FG001|Overall Study|Ineligible|1|||
124799972|NCT04493333|448900392|FG000|Overall Study|Noncompliance|2|||
124799973|NCT04493333|448900393|FG001|Overall Study|Noncompliance|1|||
124799974|NCT02247531|448900394|FG000|Overall Study|Adverse Event|3|||
124799975|NCT02247531|448900395|FG001|Overall Study|Adverse Event|4|||
124799976|NCT02247531|448900396|FG002|Overall Study|Adverse Event|9|||
124799977|NCT02247531|448900394|FG000|Overall Study|Death|8|||
124799978|NCT02247531|448900395|FG001|Overall Study|Death|9|||
124799979|NCT02247531|448900396|FG002|Overall Study|Death|5|||
124799980|NCT02247531|448900394|FG000|Overall Study|Lost to Follow-up|1|||
124799981|NCT02247531|448900395|FG001|Overall Study|Lost to Follow-up|8|||
124799982|NCT02247531|448900396|FG002|Overall Study|Lost to Follow-up|3|||
124799983|NCT02247531|448900394|FG000|Overall Study|Non-compliance|2|||
124799984|NCT02247531|448900395|FG001|Overall Study|Non-compliance|2|||
124799985|NCT02247531|448900396|FG002|Overall Study|Non-compliance|0|||
124799986|NCT02247531|448900394|FG000|Overall Study|Withdrawal by Subject|26|||
124799987|NCT02247531|448900395|FG001|Overall Study|Withdrawal by Subject|31|||
124799988|NCT02247531|448900396|FG002|Overall Study|Withdrawal by Subject|25|||
124799989|NCT02247531|448900394|FG000|Overall Study|Study Terminated by Sponsor|64|||
124799990|NCT02247531|448900395|FG001|Overall Study|Study Terminated by Sponsor|66|||
124799991|NCT02247531|448900396|FG002|Overall Study|Study Terminated by Sponsor|62|||
124799992|NCT02247531|448900394|FG000|Overall Study|Physician Decision|0|||
125295968|NCT03517969|450711414|FG000|Overall Study|Death|1|||
125295969|NCT03517969|450711415|FG001|Overall Study|Death|1|||
125295970|NCT03517969|450711414|FG000|Overall Study|Withdrawal by Subject|1|||
125295971|NCT03517969|450711415|FG001|Overall Study|Withdrawal by Subject|2|||
125295972|NCT03517969|450711414|FG000|Overall Study|Physician Decision|1|||
125295973|NCT03517969|450711415|FG001|Overall Study|Physician Decision|1|||
125295974|NCT03517969|450711414|FG000|Overall Study|No clinical benefit|1|||
125295975|NCT03517969|450711415|FG001|Overall Study|No clinical benefit|0|||
125295976|NCT03517969|450711414|FG000|Overall Study|Delayed treatment for dental treatment|1|||
125295977|NCT03517969|450711415|FG001|Overall Study|Delayed treatment for dental treatment|0|||
125295978|NCT03517969|450711414|FG000|Overall Study|Difficult to maintain appointment|0|||
125295979|NCT03517969|450711415|FG001|Overall Study|Difficult to maintain appointment|1|||
125295980|NCT03517969|450711414|FG000|Overall Study|Protocol Violation|0|||
125295981|NCT03517969|450711415|FG001|Overall Study|Protocol Violation|1|||
125295982|NCT03344172|450711422|FG000|Overall Study|Received <1 dose of treatment|1|||
125295983|NCT03344172|450711423|FG001|Overall Study|Received <1 dose of treatment|0|||
125295984|NCT03779503|450711424|FG000|First Intervention|Adverse Event|0|||
125295985|NCT03779503|450711425|FG001|First Intervention|Adverse Event|1|||
125295986|NCT03779503|450711424|FG000|First Intervention|Withdrawal by Subject|1|||
125295987|NCT03779503|450711425|FG001|First Intervention|Withdrawal by Subject|0|||
125295988|NCT01177969|450711426|FG000|Overall Study|Protocol Violation|2|||
125295989|NCT01177969|450711427|FG001|Overall Study|Protocol Violation|1|||
125295990|NCT01177969|450711426|FG000|Overall Study|Withdrawal by Subject|1|||
125295991|NCT01177969|450711427|FG001|Overall Study|Withdrawal by Subject|2|||
125295992|NCT03629912|450711428|FG000|Overall Study|Lost to Follow-up|19|||
125295993|NCT03629912|450711429|FG001|Overall Study|Lost to Follow-up|7|||
125295994|NCT03629912|450711430|FG002|Overall Study|Lost to Follow-up|5|||
125295995|NCT03629912|450711431|FG003|Overall Study|Lost to Follow-up|1|||
125295996|NCT03629912|450711428|FG000|Overall Study|Withdrawal by Subject|6|||
125295997|NCT03629912|450711429|FG001|Overall Study|Withdrawal by Subject|0|||
125295998|NCT03629912|450711430|FG002|Overall Study|Withdrawal by Subject|1|||
125295999|NCT03629912|450711431|FG003|Overall Study|Withdrawal by Subject|2|||
125296000|NCT03629912|450711428|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
125296001|NCT03629912|450711429|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
124799993|NCT02247531|448900395|FG001|Overall Study|Physician Decision|2|||
124799994|NCT02247531|448900396|FG002|Overall Study|Physician Decision|2|||
124799995|NCT02247531|448900394|FG000|Overall Study|Unspecified Reason|2|||
124799996|NCT02247531|448900395|FG001|Overall Study|Unspecified Reason|3|||
124799997|NCT02247531|448900396|FG002|Overall Study|Unspecified Reason|4|||
124799998|NCT03468985|448900397|FG000|Overall Study|Adverse Event|0|||
124799999|NCT03468985|448900398|FG001|Overall Study|Adverse Event|2|||
125296002|NCT03629912|450711430|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
125296003|NCT03629912|450711431|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
125296004|NCT03629912|450711428|FG000|Overall Study|Death|1|||
125296005|NCT03629912|450711429|FG001|Overall Study|Death|0|||
125296006|NCT03629912|450711430|FG002|Overall Study|Death|0|||
125296007|NCT03629912|450711431|FG003|Overall Study|Death|0|||
125296008|NCT00687609|450711432|FG000|Overall Study|Physician Decision|1|||
125296009|NCT00687609|450711432|FG000|Overall Study|Withdrawal by Subject|2|||
125296010|NCT00908037|450711433|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
125296011|NCT00908037|450711434|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
125296012|NCT00908037|450711435|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
125296013|NCT00908037|450711436|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
125296014|NCT00908037|450711437|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
125296015|NCT00908037|450711438|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
125296016|NCT00908037|450711439|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
125296017|NCT00908037|450711440|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
125296018|NCT00908037|450711441|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
125296019|NCT00908037|450711442|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
125296020|NCT00908037|450711443|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
125296021|NCT00908037|450711444|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
125296022|NCT00908037|450711433|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
125296023|NCT00908037|450711434|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
125296024|NCT00908037|450711435|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
125296025|NCT00908037|450711436|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
125296026|NCT00908037|450711437|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
125296027|NCT00908037|450711438|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
125296028|NCT00908037|450711439|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
125296029|NCT00908037|450711440|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
125296030|NCT00908037|450711441|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
125296031|NCT00908037|450711442|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
125296032|NCT00908037|450711443|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
125296033|NCT00908037|450711444|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
125296034|NCT00908037|450711433|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
125296035|NCT00908037|450711434|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
125296036|NCT00908037|450711435|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
125296037|NCT00908037|450711436|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
125296038|NCT00908037|450711437|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
125296039|NCT00908037|450711438|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
125296040|NCT00908037|450711439|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
125296041|NCT00908037|450711440|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
125296042|NCT00908037|450711441|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
125296043|NCT00908037|450711442|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
125296044|NCT00908037|450711443|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
125296045|NCT00908037|450711444|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
125296046|NCT00908037|450711433|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296047|NCT00908037|450711434|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296048|NCT00908037|450711435|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296049|NCT00908037|450711436|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296050|NCT00908037|450711437|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296051|NCT00908037|450711438|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296052|NCT00908037|450711439|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296053|NCT00908037|450711440|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296054|NCT00908037|450711441|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296055|NCT00908037|450711442|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296056|NCT00908037|450711443|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296057|NCT00908037|450711444|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
125296058|NCT00908037|450711433|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
125296059|NCT00908037|450711434|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
125296060|NCT00908037|450711435|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
125296061|NCT00908037|450711436|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
125296062|NCT00908037|450711437|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
125296063|NCT00908037|450711438|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
125296064|NCT00908037|450711439|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
125296065|NCT00908037|450711440|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
125296066|NCT00908037|450711441|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
125296067|NCT00908037|450711442|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
125296068|NCT00908037|450711443|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
125296069|NCT00908037|450711444|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
124800000|NCT03468985|448900399|FG002|Overall Study|Adverse Event|0|||
125296070|NCT00908037|450711433|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296071|NCT00908037|450711434|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296072|NCT00908037|450711435|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296073|NCT00908037|450711436|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296074|NCT00908037|450711437|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296075|NCT00908037|450711438|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296076|NCT00908037|450711439|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296077|NCT00908037|450711440|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296078|NCT00908037|450711441|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296079|NCT00908037|450711442|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
125296080|NCT00908037|450711443|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296081|NCT00908037|450711444|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296082|NCT00908037|450711433|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296083|NCT00908037|450711434|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296084|NCT00908037|450711435|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296085|NCT00908037|450711436|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296086|NCT00908037|450711437|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296087|NCT00908037|450711438|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296088|NCT00908037|450711439|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296089|NCT00908037|450711440|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296090|NCT00908037|450711441|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296091|NCT00908037|450711442|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296092|NCT00908037|450711443|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
125296093|NCT00908037|450711444|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296094|NCT00908037|450711433|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
125296095|NCT00908037|450711434|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
125296096|NCT00908037|450711435|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
125296097|NCT00908037|450711436|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
125296098|NCT00908037|450711437|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
125296099|NCT00908037|450711438|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
125296100|NCT00908037|450711439|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
125296101|NCT00908037|450711440|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
125296102|NCT00908037|450711441|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
124800001|NCT03468985|448900400|FG003|Overall Study|Adverse Event|0|||
124800002|NCT03468985|448900397|FG000|Overall Study|Withdrawal by Subject|0|||
124800003|NCT03468985|448900398|FG001|Overall Study|Withdrawal by Subject|0|||
124800004|NCT03468985|448900399|FG002|Overall Study|Withdrawal by Subject|0|||
124800005|NCT03468985|448900400|FG003|Overall Study|Withdrawal by Subject|1|||
124800006|NCT04131556|448900401|FG000|Overall Study|Adverse Event|1|||
124800007|NCT04131556|448900401|FG000|Overall Study|Withdrawal by Subject|1|||
124800008|NCT04060862|448900404|FG000|Overall Study|Symptomatic Deterioration|1|||
124800009|NCT04060862|448900404|FG000|Overall Study|Un-specified|6|||
124800010|NCT04060862|448900404|FG000|Overall Study|Progressive disease|12|||
124800011|NCT04060862|448900404|FG000|Overall Study|Physician Decision|1|||
124800012|NCT04629508|448900405|FG000|Overall Study|Adverse Event|1|||
124800013|NCT04629508|448900405|FG000|Overall Study|Death|2|||
124800014|NCT04629508|448900405|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
124800015|NCT00760214|448900413|FG000|Overall Study|Adverse Event|8|||
124800016|NCT00760214|448900414|FG001|Overall Study|Adverse Event|9|||
124800017|NCT00760214|448900415|FG002|Overall Study|Adverse Event|12|||
124800018|NCT00760214|448900413|FG000|Overall Study|Protocol Violation|3|||
124800019|NCT00760214|448900414|FG001|Overall Study|Protocol Violation|0|||
124800020|NCT00760214|448900415|FG002|Overall Study|Protocol Violation|3|||
124800021|NCT00760214|448900413|FG000|Overall Study|Lost to Follow-up|0|||
124800022|NCT00760214|448900414|FG001|Overall Study|Lost to Follow-up|0|||
124800023|NCT00760214|448900415|FG002|Overall Study|Lost to Follow-up|1|||
124800024|NCT00760214|448900413|FG000|Overall Study|Withdrawal by Subject|12|||
124800025|NCT00760214|448900414|FG001|Overall Study|Withdrawal by Subject|14|||
124800026|NCT00760214|448900415|FG002|Overall Study|Withdrawal by Subject|13|||
124800027|NCT00760214|448900413|FG000|Overall Study|Lack of Efficacy|3|||
124800028|NCT00760214|448900414|FG001|Overall Study|Lack of Efficacy|2|||
124800029|NCT00760214|448900415|FG002|Overall Study|Lack of Efficacy|4|||
124800030|NCT00760214|448900413|FG000|Overall Study|Pregnancy|0|||
124800031|NCT00760214|448900414|FG001|Overall Study|Pregnancy|0|||
124800032|NCT00760214|448900415|FG002|Overall Study|Pregnancy|1|||
125296103|NCT00908037|450711442|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
124800033|NCT00760214|448900413|FG000|Overall Study|Physician Decision|1|||
124800034|NCT00760214|448900414|FG001|Overall Study|Physician Decision|1|||
124800035|NCT00760214|448900415|FG002|Overall Study|Physician Decision|1|||
124800036|NCT00760214|448900413|FG000|Overall Study|Other|3|||
124800037|NCT00760214|448900414|FG001|Overall Study|Other|4|||
124800038|NCT00760214|448900415|FG002|Overall Study|Other|6|||
124800039|NCT03960554|448900419|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
124800040|NCT03960554|448900420|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
124800041|NCT02545075|448900421|FG000|Randomization|Lost to Follow-up|0|||
124800042|NCT02545075|448900422|FG001|Randomization|Lost to Follow-up|1|||
124800043|NCT02545075|448900421|FG000|Randomization|Withdrawal by Subject|0|||
124800044|NCT02545075|448900422|FG001|Randomization|Withdrawal by Subject|6|||
124800045|NCT02545075|448900421|FG000|Treatment|Disease progression|71|||
124800046|NCT02545075|448900422|FG001|Treatment|Disease progression|32|||
124800047|NCT02545075|448900421|FG000|Treatment|Participant dicontinued study treatment|7|||
124800048|NCT02545075|448900422|FG001|Treatment|Participant dicontinued study treatment|9|||
124800049|NCT02545075|448900421|FG000|Treatment|Withdrawal by Subject|1|||
124800050|NCT02545075|448900422|FG001|Treatment|Withdrawal by Subject|0|||
124800051|NCT02545075|448900421|FG000|Treatment|Adverse event not related to study drug|1|||
124800052|NCT02545075|448900422|FG001|Treatment|Adverse event not related to study drug|0|||
124800053|NCT02545075|448900421|FG000|Treatment|Death|1|||
124800054|NCT02545075|448900422|FG001|Treatment|Death|0|||
124800055|NCT02545075|448900421|FG000|Treatment|Participant drug toxicity|1|||
124800056|NCT02545075|448900422|FG001|Treatment|Participant drug toxicity|0|||
124800057|NCT02545075|448900421|FG000|Treatment|Completed treatment|40|||
124800058|NCT02545075|448900422|FG001|Treatment|Completed treatment|12|||
124800059|NCT01810432|448900423|FG000|Washout|Protocol Violation|0|||
124800060|NCT01810432|448900424|FG001|Washout|Protocol Violation|1|||
124800061|NCT01810432|448900423|FG000|Washout|Adverse Event|1|||
124800062|NCT01810432|448900424|FG001|Washout|Adverse Event|0|||
124800063|NCT01810432|448900423|FG000|Period 2|Withdrawal by Subject|2|||
124800064|NCT01810432|448900424|FG001|Period 2|Withdrawal by Subject|1|||
124800065|NCT01810432|448900423|FG000|Period 2|Physician Decision|1|||
124800066|NCT01810432|448900424|FG001|Period 2|Physician Decision|0|||
124800067|NCT01810432|448900423|FG000|Period 2|Lost to Follow-up|1|||
124800068|NCT01810432|448900424|FG001|Period 2|Lost to Follow-up|1|||
124800069|NCT00736879|448900425|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
124800070|NCT00736879|448900426|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
124800071|NCT00736879|448900427|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
124800072|NCT00736879|448900428|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
124800073|NCT00736879|448900425|FG000|Double Blind Treatment Period|Adverse Event|0|||
124800074|NCT00736879|448900426|FG001|Double Blind Treatment Period|Adverse Event|1|||
124800075|NCT00736879|448900427|FG002|Double Blind Treatment Period|Adverse Event|1|||
124800076|NCT00736879|448900428|FG003|Double Blind Treatment Period|Adverse Event|0|||
124800077|NCT00736879|448900425|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
124800078|NCT00736879|448900426|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
124800079|NCT00736879|448900427|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
125296104|NCT00908037|450711443|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
125296105|NCT00908037|450711444|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
125296106|NCT00908037|450711433|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296107|NCT00908037|450711434|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296108|NCT00908037|450711435|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296109|NCT00908037|450711436|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296110|NCT00908037|450711437|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296111|NCT00908037|450711438|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296112|NCT00908037|450711439|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296113|NCT00908037|450711440|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296114|NCT00908037|450711441|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296115|NCT00908037|450711442|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296116|NCT00908037|450711443|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
125296117|NCT00908037|450711444|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296118|NCT00869401|450711446|FG000|Overall Study|Withdrawal by Subject|0|||
125296119|NCT00869401|450711447|FG001|Overall Study|Withdrawal by Subject|0|||
125296120|NCT00869401|450711448|FG002|Overall Study|Withdrawal by Subject|0|||
125296121|NCT00869401|450711449|FG003|Overall Study|Withdrawal by Subject|5|||
125296122|NCT00869401|450711450|FG004|Overall Study|Withdrawal by Subject|3|||
125296123|NCT01147900|450711451|FG000|At Year 10|Lost to Follow-up|0|||
125296124|NCT01147900|450711452|FG001|At Year 10|Lost to Follow-up|1|||
124800080|NCT00736879|448900428|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
124800081|NCT00736879|448900425|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
124800082|NCT00736879|448900426|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
124800083|NCT00736879|448900427|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
124800084|NCT00736879|448900428|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
124800085|NCT00736879|448900425|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
125296125|NCT01147900|450711453|FG002|At Year 10|Lost to Follow-up|0|||
125296126|NCT00581360|450711456|FG000|Overall Study|Withdrawal by Subject|1|||
125296127|NCT04405245|450711457|FG000|Overall Study|Adverse Event|0|||
125296128|NCT04405245|450711458|FG001|Overall Study|Adverse Event|1|||
125296129|NCT04405245|450711459|FG002|Overall Study|Adverse Event|0|||
124800086|NCT00736879|448900426|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
124800087|NCT00736879|448900427|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
124800088|NCT00736879|448900428|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
124800089|NCT00736879|448900425|FG000|Double Blind Treatment Period|No longer met criteria|0|||
124800090|NCT00736879|448900426|FG001|Double Blind Treatment Period|No longer met criteria|1|||
124800091|NCT00736879|448900427|FG002|Double Blind Treatment Period|No longer met criteria|0|||
124800092|NCT00736879|448900428|FG003|Double Blind Treatment Period|No longer met criteria|0|||
124800093|NCT00736879|448900425|FG000|Double Blind Treatment Period|non-specified|0|||
124800094|NCT00736879|448900426|FG001|Double Blind Treatment Period|non-specified|1|||
124800095|NCT00736879|448900427|FG002|Double Blind Treatment Period|non-specified|0|||
124800096|NCT00736879|448900428|FG003|Double Blind Treatment Period|non-specified|0|||
124800097|NCT00736879|448900425|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
124800098|NCT00736879|448900426|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
124800099|NCT00736879|448900427|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
124800100|NCT00736879|448900428|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
124800101|NCT00736879|448900425|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
124800102|NCT00736879|448900426|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
124800103|NCT00736879|448900427|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
124800104|NCT00736879|448900428|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
124800105|NCT02360111|448900431|FG000|Overall Study|Death|2|||
125296130|NCT02391961|450711460|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
124800107|NCT02310321|448900435|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
124800108|NCT02310321|448900436|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
124800109|NCT02310321|448900437|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
124800110|NCT02310321|448900435|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
124800111|NCT02310321|448900436|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
124800112|NCT02310321|448900437|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
124800113|NCT02310321|448900435|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
124800114|NCT02310321|448900436|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
124800115|NCT02310321|448900437|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
124800116|NCT02310321|448900435|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
124800117|NCT02310321|448900436|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
124800118|NCT02310321|448900437|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
124800119|NCT02310321|448900435|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
124800120|NCT02310321|448900436|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
124800121|NCT02310321|448900437|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
124800122|NCT02310321|448900435|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
124800123|NCT02310321|448900436|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
124800124|NCT02310321|448900437|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
124800125|NCT02310321|448900435|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
124800126|NCT02310321|448900436|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
124800127|NCT02310321|448900437|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
124800128|NCT02310321|448900435|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
124800129|NCT02310321|448900436|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
124800130|NCT02310321|448900437|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
124800131|NCT02310321|448900435|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
124800132|NCT02310321|448900436|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
124800133|NCT02310321|448900437|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
124800134|NCT02310321|448900435|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
124800135|NCT02310321|448900436|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
124800136|NCT02310321|448900437|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
125296131|NCT02391961|450711461|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
125296132|NCT02391961|450711460|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
125296133|NCT02391961|450711461|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
125296134|NCT02391961|450711460|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
125296135|NCT02391961|450711461|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
125296136|NCT00491608|450711465|FG000|Overall Study|Death|2|||
124800137|NCT02310321|448900435|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
124800138|NCT02310321|448900436|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
124800139|NCT02310321|448900437|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
124800140|NCT02310321|448900435|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
124800141|NCT02310321|448900436|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
124800142|NCT02310321|448900437|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
124800143|NCT02310321|448900435|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
124800144|NCT02310321|448900436|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
124800145|NCT02310321|448900437|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
124800146|NCT02310321|448900435|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
124800147|NCT02310321|448900436|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
124800148|NCT02310321|448900437|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
124800149|NCT02310321|448900435|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
124800150|NCT02310321|448900436|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
124800151|NCT02310321|448900437|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
124800152|NCT02310321|448900435|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
124800153|NCT02310321|448900436|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
124800154|NCT02310321|448900437|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
124800155|NCT02310321|448900435|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
124800156|NCT02310321|448900436|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
124800157|NCT02310321|448900437|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
124800158|NCT02310321|448900435|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
124800159|NCT02310321|448900436|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
124800160|NCT02310321|448900437|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
124800161|NCT02310321|448900435|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
124800162|NCT02310321|448900436|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
124800163|NCT02310321|448900437|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
124800164|NCT02310321|448900435|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
124800165|NCT02310321|448900436|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
125296137|NCT00491608|450711465|FG000|Overall Study|Withdrawal by Subject|1|||
125296138|NCT00025155|450711466|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
125296139|NCT00025155|450711466|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
125296140|NCT00413374|450711467|FG000|Overall Study|Ineligible due to screening criteria.|3|||
125296141|NCT00413374|450711468|FG001|Overall Study|Ineligible due to screening criteria.|0|||
125296142|NCT00413374|450711467|FG000|Overall Study|Adverse Event|1|||
125296143|NCT00413374|450711468|FG001|Overall Study|Adverse Event|0|||
125296144|NCT00413374|450711467|FG000|Overall Study|Lost to Follow-up|1|||
125296145|NCT00413374|450711468|FG001|Overall Study|Lost to Follow-up|0|||
124800166|NCT02310321|448900437|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
124800167|NCT02310321|448900435|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
124800168|NCT02310321|448900436|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
124800169|NCT02310321|448900437|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
124800170|NCT02310321|448900435|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
124800171|NCT02310321|448900436|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
124800172|NCT02310321|448900437|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
124800173|NCT02310321|448900435|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
124800174|NCT02310321|448900436|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
124800175|NCT02310321|448900437|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
125296146|NCT00413374|450711467|FG000|Overall Study|Surgery|1|||
125296147|NCT00413374|450711468|FG001|Overall Study|Surgery|0|||
125296148|NCT00552760|450711469|FG000|Overall Study|Adverse Event|3|||
125296149|NCT00552760|450711470|FG001|Overall Study|Adverse Event|5|||
125296150|NCT00552760|450711469|FG000|Overall Study|Relapsed- Depressed Event|10|||
125296151|NCT00552760|450711470|FG001|Overall Study|Relapsed- Depressed Event|16|||
125296152|NCT00552760|450711469|FG000|Overall Study|Relapse- Manic Event|3|||
125296153|NCT00552760|450711470|FG001|Overall Study|Relapse- Manic Event|3|||
125296154|NCT00552760|450711469|FG000|Overall Study|Relapsed- Mixed Event|3|||
125296155|NCT00552760|450711470|FG001|Overall Study|Relapsed- Mixed Event|5|||
125296156|NCT00552760|450711469|FG000|Overall Study|Protocol Violation|0|||
125296157|NCT00552760|450711470|FG001|Overall Study|Protocol Violation|1|||
125296158|NCT00552760|450711469|FG000|Overall Study|Lost to Follow-up|1|||
124800176|NCT01698905|448900438|FG000|Overall Study|Adverse Event|4|||
124800177|NCT01698905|448900438|FG000|Overall Study|Physician Decision|2|||
124800178|NCT01698905|448900438|FG000|Overall Study|Pregnancy|1|||
124800179|NCT01698905|448900438|FG000|Overall Study|Protocol Violation|1|||
124800180|NCT01698905|448900438|FG000|Overall Study|Subject/guardian decision|2|||
124800181|NCT01698905|448900438|FG000|Overall Study|Death|1|||
124800182|NCT02325791|448900441|FG000|Overall Study|Adverse Event|0|||
124800183|NCT02325791|448900442|FG001|Overall Study|Adverse Event|1|||
124800184|NCT02325791|448900443|FG002|Overall Study|Adverse Event|1|||
124800185|NCT02325791|448900444|FG003|Overall Study|Adverse Event|0|||
125296159|NCT00552760|450711470|FG001|Overall Study|Lost to Follow-up|1|||
125296160|NCT00552760|450711469|FG000|Overall Study|Non-compliance|1|||
125296161|NCT00552760|450711470|FG001|Overall Study|Non-compliance|1|||
125296162|NCT00552760|450711469|FG000|Overall Study|Medical Condition|1|||
125296163|NCT00552760|450711470|FG001|Overall Study|Medical Condition|1|||
124800186|NCT02325791|448900441|FG000|Overall Study|Death|0|||
124800187|NCT02325791|448900442|FG001|Overall Study|Death|3|||
124800188|NCT02325791|448900443|FG002|Overall Study|Death|0|||
124800189|NCT02325791|448900444|FG003|Overall Study|Death|1|||
124800190|NCT02325791|448900441|FG000|Overall Study|Lost to Follow-up|0|||
124800191|NCT02325791|448900442|FG001|Overall Study|Lost to Follow-up|15|||
124800192|NCT02325791|448900443|FG002|Overall Study|Lost to Follow-up|14|||
124800193|NCT02325791|448900444|FG003|Overall Study|Lost to Follow-up|9|||
124800194|NCT02325791|448900441|FG000|Overall Study|Physician Decision|0|||
124800195|NCT02325791|448900442|FG001|Overall Study|Physician Decision|1|||
124800196|NCT02325791|448900443|FG002|Overall Study|Physician Decision|1|||
124800197|NCT02325791|448900444|FG003|Overall Study|Physician Decision|0|||
124800198|NCT02325791|448900441|FG000|Overall Study|Protocol Violation|0|||
124800199|NCT02325791|448900442|FG001|Overall Study|Protocol Violation|0|||
125296164|NCT00552760|450711469|FG000|Overall Study|Withdrawal by Subject|3|||
125296165|NCT00552760|450711470|FG001|Overall Study|Withdrawal by Subject|0|||
125296166|NCT00552760|450711469|FG000|Overall Study|Medication Change|1|||
125296167|NCT00552760|450711470|FG001|Overall Study|Medication Change|0|||
125296168|NCT00924404|450711474|FG000|Overall Study|Lost to Follow-up|6|||
125296169|NCT00924404|450711475|FG001|Overall Study|Lost to Follow-up|4|||
125296170|NCT02613169|450711476|FG000|Overall Study|Withdrawal by Subject|4|||
125296171|NCT02613169|450711477|FG001|Overall Study|Withdrawal by Subject|1|||
125296172|NCT02613169|450711476|FG000|Overall Study|Lost to Follow-up|0|||
125296173|NCT02613169|450711477|FG001|Overall Study|Lost to Follow-up|5|||
125296174|NCT02613169|450711476|FG000|Overall Study|HIV|0|||
125296175|NCT02613169|450711477|FG001|Overall Study|HIV|2|||
125296176|NCT02613169|450711476|FG000|Overall Study|No TB infection endpoint|14|||
125296177|NCT02613169|450711477|FG001|Overall Study|No TB infection endpoint|9|||
125296178|NCT00343382|450711478|FG000|Overall Study|Adverse Event|2|||
125296179|NCT00343382|450711479|FG001|Overall Study|Adverse Event|10|||
125296180|NCT00343382|450711480|FG002|Overall Study|Adverse Event|7|||
125296181|NCT00343382|450711478|FG000|Overall Study|Withdrawal by Subject|1|||
125296182|NCT00343382|450711479|FG001|Overall Study|Withdrawal by Subject|2|||
125296183|NCT00343382|450711480|FG002|Overall Study|Withdrawal by Subject|6|||
125296184|NCT00343382|450711478|FG000|Overall Study|Other Reason Not Specified|1|||
125296185|NCT00343382|450711479|FG001|Overall Study|Other Reason Not Specified|2|||
125296186|NCT00343382|450711480|FG002|Overall Study|Other Reason Not Specified|4|||
125296187|NCT02976103|450711481|FG000|Overall Study|Withdrawal by Subject|1|||
125296188|NCT02976103|450711482|FG001|Overall Study|Withdrawal by Subject|0|||
125296189|NCT02976103|450711481|FG000|Overall Study|Lost to Follow-up|12|||
125296190|NCT02976103|450711482|FG001|Overall Study|Lost to Follow-up|8|||
125296191|NCT01985360|450711483|FG000|Overall Study|Withdrawal by Subject|4|||
125296192|NCT01985360|450711484|FG001|Overall Study|Withdrawal by Subject|0|||
125296193|NCT01985360|450711483|FG000|Overall Study|Lost to Follow-up|5|||
125296194|NCT01985360|450711484|FG001|Overall Study|Lost to Follow-up|3|||
125296195|NCT02914561|450711485|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
125296196|NCT02914561|450711486|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
125296197|NCT02914561|450711487|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
125296198|NCT02914561|450711488|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
125296199|NCT02914561|450711489|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
125296200|NCT02914561|450711490|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
125296201|NCT02914561|450711491|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
125296202|NCT02914561|450711492|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
125296203|NCT02914561|450711493|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
125296204|NCT02914561|450711494|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
125296205|NCT02914561|450711495|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
125296206|NCT02914561|450711485|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
125296207|NCT02914561|450711486|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
125296208|NCT02914561|450711487|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
125296209|NCT02914561|450711488|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
125296210|NCT02914561|450711489|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
125296211|NCT02914561|450711490|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
124800200|NCT02325791|448900443|FG002|Overall Study|Protocol Violation|1|||
124800201|NCT02325791|448900444|FG003|Overall Study|Protocol Violation|0|||
125296212|NCT02914561|450711491|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
125296213|NCT02914561|450711492|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
125296214|NCT02914561|450711493|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
125296215|NCT02914561|450711494|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
125296216|NCT02914561|450711495|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
125296217|NCT02914561|450711485|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
125296218|NCT02914561|450711486|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
124800202|NCT02325791|448900441|FG000|Overall Study|Withdrawal by Subject|0|||
124800203|NCT02325791|448900442|FG001|Overall Study|Withdrawal by Subject|5|||
124800204|NCT02325791|448900443|FG002|Overall Study|Withdrawal by Subject|8|||
124800205|NCT02325791|448900444|FG003|Overall Study|Withdrawal by Subject|16|||
125296219|NCT02914561|450711487|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
125296220|NCT02914561|450711488|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
125296221|NCT02914561|450711489|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
125296222|NCT02914561|450711490|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
125296223|NCT02914561|450711491|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
125296224|NCT02914561|450711492|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
125296225|NCT02914561|450711493|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
124800206|NCT03953183|448900445|FG000|Overall Study|Physician Decision|0|||
124800207|NCT03953183|448900446|FG001|Overall Study|Physician Decision|1|||
124800208|NCT03953183|448900445|FG000|Overall Study|Withdrawal by Subject|0|||
124800209|NCT03953183|448900446|FG001|Overall Study|Withdrawal by Subject|1|||
124800210|NCT01465191|448900447|FG000|Overall Study|Protocol Violation|6|||
124800211|NCT01465191|448900448|FG001|Overall Study|Protocol Violation|3|||
124800212|NCT01465191|448900449|FG002|Overall Study|Protocol Violation|3|||
124800213|NCT01465191|448900447|FG000|Overall Study|Lost to Follow-up|3|||
124800214|NCT01465191|448900448|FG001|Overall Study|Lost to Follow-up|6|||
124800215|NCT01465191|448900449|FG002|Overall Study|Lost to Follow-up|4|||
124800216|NCT02273739|448900450|FG000|Overall Study|Progression of Disease|3|||
124800217|NCT02273739|448900451|FG001|Overall Study|Progression of Disease|4|||
125296226|NCT02914561|450711494|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
124800218|NCT02273739|448900452|FG002|Overall Study|Progression of Disease|5|||
124800219|NCT02273739|448900453|FG003|Overall Study|Progression of Disease|2|||
124800220|NCT02273739|448900450|FG000|Overall Study|Death|0|||
124800221|NCT02273739|448900451|FG001|Overall Study|Death|0|||
124800222|NCT02273739|448900452|FG002|Overall Study|Death|0|||
124800223|NCT02273739|448900453|FG003|Overall Study|Death|2|||
124800224|NCT02273739|448900450|FG000|Overall Study|Adverse Event|0|||
124800225|NCT02273739|448900451|FG001|Overall Study|Adverse Event|0|||
124800226|NCT02273739|448900452|FG002|Overall Study|Adverse Event|0|||
124800227|NCT02273739|448900453|FG003|Overall Study|Adverse Event|1|||
124800228|NCT02273739|448900450|FG000|Overall Study|Withdrawal by Subject|0|||
124800229|NCT02273739|448900451|FG001|Overall Study|Withdrawal by Subject|0|||
124800230|NCT02273739|448900452|FG002|Overall Study|Withdrawal by Subject|2|||
124800231|NCT02273739|448900453|FG003|Overall Study|Withdrawal by Subject|1|||
124800232|NCT02273739|448900450|FG000|Overall Study|Physician Decision|0|||
124800233|NCT02273739|448900451|FG001|Overall Study|Physician Decision|0|||
124800234|NCT02273739|448900452|FG002|Overall Study|Physician Decision|0|||
124800235|NCT02273739|448900453|FG003|Overall Study|Physician Decision|1|||
125296227|NCT02914561|450711495|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
125296228|NCT02914561|450711485|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
125296229|NCT02914561|450711486|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
125296230|NCT02914561|450711487|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
125296231|NCT02914561|450711488|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
125296232|NCT02914561|450711489|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
125296233|NCT02914561|450711490|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
125296234|NCT02914561|450711491|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
125296235|NCT02914561|450711492|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
125296236|NCT02914561|450711493|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
125296237|NCT02914561|450711494|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
125296238|NCT02914561|450711495|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
125296239|NCT02914561|450711485|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
125296240|NCT02914561|450711486|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
125296241|NCT02914561|450711487|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
125296242|NCT02914561|450711488|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
125296243|NCT02914561|450711489|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
125296244|NCT02914561|450711490|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
125296245|NCT02914561|450711491|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
125296246|NCT02914561|450711492|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
125296247|NCT02914561|450711493|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
125296248|NCT02914561|450711494|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
125296249|NCT02914561|450711495|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
125296250|NCT02914561|450711485|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
125296251|NCT02914561|450711486|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
124800236|NCT04795622|448900454|FG000|Overall Study|Adverse Event|1|||
125296252|NCT02914561|450711487|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
124800237|NCT04795622|448900455|FG001|Overall Study|Adverse Event|0|||
124800238|NCT04795622|448900454|FG000|Overall Study|Withdrawal by Subject|3|||
124800239|NCT04795622|448900455|FG001|Overall Study|Withdrawal by Subject|3|||
124800240|NCT04795622|448900454|FG000|Overall Study|Protocol Violation|0|||
124800241|NCT04795622|448900455|FG001|Overall Study|Protocol Violation|2|||
124800242|NCT04795622|448900454|FG000|Overall Study|Lost to Follow-up|2|||
125296253|NCT02914561|450711488|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
125296254|NCT02914561|450711489|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
124800243|NCT04795622|448900455|FG001|Overall Study|Lost to Follow-up|3|||
124800244|NCT04795622|448900454|FG000|Overall Study|Other|7|||
124800245|NCT04795622|448900455|FG001|Overall Study|Other|8|||
124800246|NCT00089674|448900456|FG000|Overall Study|Physician Decision|4|||
124800247|NCT00089674|448900457|FG001|Overall Study|Physician Decision|2|||
124800248|NCT00089674|448900456|FG000|Overall Study|Adverse Event|23|||
124800249|NCT00089674|448900457|FG001|Overall Study|Adverse Event|29|||
125296255|NCT02914561|450711490|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
125296256|NCT02914561|450711491|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
125296257|NCT02914561|450711492|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
125296258|NCT02914561|450711493|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
124800250|NCT00089674|448900456|FG000|Overall Study|Withdrawal by Subject|143|||
124800251|NCT00089674|448900457|FG001|Overall Study|Withdrawal by Subject|127|||
124800252|NCT00089674|448900456|FG000|Overall Study|Death|43|||
124800253|NCT00089674|448900457|FG001|Overall Study|Death|43|||
124800254|NCT00089674|448900456|FG000|Overall Study|Disease progression|21|||
124800255|NCT00089674|448900457|FG001|Overall Study|Disease progression|23|||
124800256|NCT00089674|448900456|FG000|Overall Study|Ineligibility determined|8|||
124800257|NCT00089674|448900457|FG001|Overall Study|Ineligibility determined|10|||
124800258|NCT00089674|448900456|FG000|Overall Study|Lost to Follow-up|21|||
124800259|NCT00089674|448900457|FG001|Overall Study|Lost to Follow-up|17|||
124800260|NCT00089674|448900456|FG000|Overall Study|Noncompliance|7|||
124800261|NCT00089674|448900457|FG001|Overall Study|Noncompliance|3|||
124800262|NCT00089674|448900456|FG000|Overall Study|Other|5|||
124800263|NCT00089674|448900457|FG001|Overall Study|Other|9|||
124800264|NCT00089674|448900456|FG000|Overall Study|Requirement for alternative therapy|14|||
124800265|NCT00089674|448900457|FG001|Overall Study|Requirement for alternative therapy|4|||
124800266|NCT02961218|448900458|FG000|Overall Study|Lost to Follow-up|0|||
124800267|NCT02961218|448900459|FG001|Overall Study|Lost to Follow-up|2|||
124800268|NCT02961218|448900458|FG000|Overall Study|Physician Decision|0|||
124800269|NCT02961218|448900459|FG001|Overall Study|Physician Decision|2|||
124800270|NCT02961218|448900458|FG000|Overall Study|Subject/Guardian Decision|3|||
124800271|NCT02961218|448900459|FG001|Overall Study|Subject/Guardian Decision|1|||
124800272|NCT00591266|448900460|FG000|Overall Study|Adverse Event|2|||
124800273|NCT00591266|448900461|FG001|Overall Study|Adverse Event|2|||
124800274|NCT00591266|448900462|FG002|Overall Study|Adverse Event|3|||
124800275|NCT00591266|448900460|FG000|Overall Study|Lost to Follow-up|0|||
124800276|NCT00591266|448900461|FG001|Overall Study|Lost to Follow-up|1|||
124800277|NCT00591266|448900462|FG002|Overall Study|Lost to Follow-up|0|||
124800278|NCT00591266|448900460|FG000|Overall Study|Protocol Violation|0|||
124800279|NCT00591266|448900461|FG001|Overall Study|Protocol Violation|0|||
124800280|NCT00591266|448900462|FG002|Overall Study|Protocol Violation|1|||
124800281|NCT00591266|448900460|FG000|Overall Study|Withdrawal by Subject|6|||
124800282|NCT00591266|448900461|FG001|Overall Study|Withdrawal by Subject|2|||
124800283|NCT00591266|448900462|FG002|Overall Study|Withdrawal by Subject|5|||
124800284|NCT00591266|448900460|FG000|Overall Study|Lack of Efficacy|0|||
124800285|NCT00591266|448900461|FG001|Overall Study|Lack of Efficacy|2|||
124800286|NCT00591266|448900462|FG002|Overall Study|Lack of Efficacy|0|||
124800287|NCT00591266|448900460|FG000|Overall Study|Other|1|||
124800288|NCT00591266|448900461|FG001|Overall Study|Other|4|||
124800289|NCT00591266|448900462|FG002|Overall Study|Other|5|||
124800290|NCT03488927|448900463|FG000|Overall Study|Withdrawal by Subject|44|||
124800291|NCT03488927|448900464|FG001|Overall Study|Withdrawal by Subject|118|||
124800292|NCT03488927|448900465|FG002|Overall Study|Withdrawal by Subject|217|||
124800293|NCT00901927|448900466|FG000|Overall Study|Lack of Efficacy|1|||
124800294|NCT00901927|448900466|FG000|Overall Study|Protocol Violation|3|||
124800295|NCT00901927|448900466|FG000|Overall Study|Withdrawal by Subject|2|||
124800296|NCT02676466|448900469|FG000|Overall Study|Death|0|||
124800297|NCT02676466|448900470|FG001|Overall Study|Death|2|||
124800298|NCT02676466|448900471|FG002|Overall Study|Death|1|||
124800299|NCT02676466|448900472|FG003|Overall Study|Death|0|||
124800300|NCT02676466|448900473|FG004|Overall Study|Death|0|||
125296259|NCT02914561|450711494|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
124800301|NCT02676466|448900474|FG005|Overall Study|Death|0|||
124800302|NCT02676466|448900475|FG006|Overall Study|Death|0|||
124800303|NCT02676466|448900476|FG007|Overall Study|Death|0|||
124800304|NCT02676466|448900469|FG000|Overall Study|Withdrawal by Subject|4|||
124800305|NCT02676466|448900470|FG001|Overall Study|Withdrawal by Subject|3|||
124800306|NCT02676466|448900471|FG002|Overall Study|Withdrawal by Subject|1|||
124800307|NCT02676466|448900472|FG003|Overall Study|Withdrawal by Subject|0|||
124800308|NCT02676466|448900473|FG004|Overall Study|Withdrawal by Subject|3|||
124800309|NCT02676466|448900474|FG005|Overall Study|Withdrawal by Subject|1|||
124800310|NCT02676466|448900475|FG006|Overall Study|Withdrawal by Subject|1|||
124800311|NCT02676466|448900476|FG007|Overall Study|Withdrawal by Subject|1|||
124800312|NCT01178073|448900478|FG000|Overall Study|Adverse Event|34|||
124800313|NCT01178073|448900479|FG001|Overall Study|Adverse Event|27|||
124800314|NCT01178073|448900480|FG002|Overall Study|Adverse Event|24|||
124800315|NCT01178073|448900478|FG000|Overall Study|Protocol Violation|1|||
124800316|NCT01178073|448900479|FG001|Overall Study|Protocol Violation|1|||
124800317|NCT01178073|448900480|FG002|Overall Study|Protocol Violation|1|||
124800318|NCT01178073|448900478|FG000|Overall Study|Lost to Follow-up|2|||
124800319|NCT01178073|448900479|FG001|Overall Study|Lost to Follow-up|0|||
124800320|NCT01178073|448900480|FG002|Overall Study|Lost to Follow-up|3|||
124800321|NCT01178073|448900478|FG000|Overall Study|Physician Decision|14|||
124800322|NCT01178073|448900479|FG001|Overall Study|Physician Decision|10|||
124800323|NCT01178073|448900480|FG002|Overall Study|Physician Decision|10|||
124800324|NCT01178073|448900478|FG000|Overall Study|Withdrawal by Subject|10|||
124800325|NCT01178073|448900479|FG001|Overall Study|Withdrawal by Subject|6|||
124800326|NCT01178073|448900480|FG002|Overall Study|Withdrawal by Subject|8|||
124800327|NCT01178073|448900478|FG000|Overall Study|Missing Completion Status|1|||
124800328|NCT01178073|448900479|FG001|Overall Study|Missing Completion Status|0|||
124800329|NCT01178073|448900480|FG002|Overall Study|Missing Completion Status|0|||
124800330|NCT03497676|448900483|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
124800331|NCT03497676|448900484|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
124800332|NCT03497676|448900485|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
124800333|NCT03497676|448900486|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
124800334|NCT03497676|448900483|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
124800335|NCT03497676|448900484|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
124800336|NCT03497676|448900485|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
124800337|NCT03497676|448900486|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
124800338|NCT03497676|448900483|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
124800339|NCT03497676|448900484|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
124800340|NCT03497676|448900485|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
124800341|NCT03497676|448900486|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
124800342|NCT03497676|448900483|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
124800343|NCT03497676|448900484|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
124800344|NCT03497676|448900485|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
124800345|NCT03497676|448900486|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
124800346|NCT03497676|448900483|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
124800347|NCT03497676|448900484|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
124800348|NCT03497676|448900485|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
124800349|NCT03497676|448900486|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
124800350|NCT03497676|448900483|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
124800351|NCT03497676|448900484|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
124800352|NCT03497676|448900485|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
124800353|NCT03497676|448900486|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
124800354|NCT03497676|448900483|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
124800355|NCT03497676|448900484|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
124800356|NCT03497676|448900485|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
124800357|NCT03497676|448900486|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
124800358|NCT03497676|448900483|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
124800359|NCT03497676|448900484|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
124800360|NCT03497676|448900485|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
124800361|NCT03497676|448900486|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
124800362|NCT01226043|448900496|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
124800363|NCT01226043|448900497|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
124800364|NCT01226043|448900498|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
124800365|NCT01226043|448900499|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
124800366|NCT01226043|448900496|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
124800367|NCT01226043|448900497|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
124800368|NCT01226043|448900498|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
124800369|NCT01226043|448900499|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
124800370|NCT01226043|448900496|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
124800371|NCT01226043|448900497|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
124800372|NCT01226043|448900498|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
124800373|NCT01226043|448900499|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
124800374|NCT01226043|448900496|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
124800375|NCT01226043|448900497|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
124800376|NCT01226043|448900498|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
124800377|NCT01226043|448900499|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
124800378|NCT01226043|448900496|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
124800379|NCT01226043|448900497|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
124800380|NCT01226043|448900498|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
124800381|NCT01226043|448900499|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
124800382|NCT01226043|448900496|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
124800383|NCT01226043|448900497|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
124800384|NCT01226043|448900498|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
124800385|NCT01226043|448900499|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
124800386|NCT01226043|448900496|FG000|6-week Re-randomization Phase|Adverse Event|0|||
124800387|NCT01226043|448900497|FG001|6-week Re-randomization Phase|Adverse Event|0|||
124800388|NCT01226043|448900498|FG002|6-week Re-randomization Phase|Adverse Event|1|||
124800389|NCT01226043|448900499|FG003|6-week Re-randomization Phase|Adverse Event|1|||
124800390|NCT01226043|448900496|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
124800391|NCT01226043|448900497|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
124800392|NCT01226043|448900498|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
124800393|NCT01226043|448900499|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
124800394|NCT01226043|448900496|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
124800395|NCT01226043|448900497|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
124800396|NCT01226043|448900498|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
124800397|NCT01226043|448900499|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
124800398|NCT01226043|448900496|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
124800399|NCT01226043|448900497|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
124800400|NCT01226043|448900498|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
124800401|NCT01226043|448900499|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
124800402|NCT01226043|448900496|FG000|6-week Re-randomization Phase|Physician Decision|0|||
124800403|NCT01226043|448900497|FG001|6-week Re-randomization Phase|Physician Decision|0|||
124800404|NCT01226043|448900498|FG002|6-week Re-randomization Phase|Physician Decision|3|||
124800405|NCT01226043|448900499|FG003|6-week Re-randomization Phase|Physician Decision|2|||
124800406|NCT01226043|448900496|FG000|6-week Re-randomization Phase|completed in error|0|||
124800407|NCT01226043|448900497|FG001|6-week Re-randomization Phase|completed in error|0|||
124800408|NCT01226043|448900498|FG002|6-week Re-randomization Phase|completed in error|0|||
124800409|NCT01226043|448900499|FG003|6-week Re-randomization Phase|completed in error|1|||
124800410|NCT01226043|448900496|FG000|30-week Observational Phase|Adverse Event|0|||
124800411|NCT01226043|448900497|FG001|30-week Observational Phase|Adverse Event|0|||
124800412|NCT01226043|448900498|FG002|30-week Observational Phase|Adverse Event|1|||
124800413|NCT01226043|448900499|FG003|30-week Observational Phase|Adverse Event|1|||
124800414|NCT01226043|448900496|FG000|30-week Observational Phase|Protocol Violation|0|||
124800415|NCT01226043|448900497|FG001|30-week Observational Phase|Protocol Violation|0|||
124800416|NCT01226043|448900498|FG002|30-week Observational Phase|Protocol Violation|0|||
124800417|NCT01226043|448900499|FG003|30-week Observational Phase|Protocol Violation|1|||
124800418|NCT01226043|448900496|FG000|30-week Observational Phase|Lost to Follow-up|0|||
124800419|NCT01226043|448900497|FG001|30-week Observational Phase|Lost to Follow-up|0|||
124800420|NCT01226043|448900498|FG002|30-week Observational Phase|Lost to Follow-up|2|||
124800421|NCT01226043|448900499|FG003|30-week Observational Phase|Lost to Follow-up|2|||
124800422|NCT01226043|448900496|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
124800423|NCT01226043|448900497|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
124800424|NCT01226043|448900498|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
124800425|NCT01226043|448900499|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
124800426|NCT01226043|448900496|FG000|30-week Observational Phase|Physician Decision|0|||
124800427|NCT01226043|448900497|FG001|30-week Observational Phase|Physician Decision|0|||
124800428|NCT01226043|448900498|FG002|30-week Observational Phase|Physician Decision|2|||
124800429|NCT01226043|448900499|FG003|30-week Observational Phase|Physician Decision|2|||
124800430|NCT00191646|448900501|FG000|Overall Study|Toxicity|26|||
124800431|NCT00191646|448900502|FG001|Overall Study|Toxicity|37|||
124800432|NCT00191646|448900501|FG000|Overall Study|Disease Progression|5|||
124800433|NCT00191646|448900502|FG001|Overall Study|Disease Progression|6|||
124800434|NCT00191646|448900501|FG000|Overall Study|Physician Decision|20|||
124800435|NCT00191646|448900502|FG001|Overall Study|Physician Decision|11|||
124800436|NCT00191646|448900501|FG000|Overall Study|Withdrawal by Subject|58|||
124800437|NCT00191646|448900502|FG001|Overall Study|Withdrawal by Subject|39|||
124800438|NCT00191646|448900501|FG000|Overall Study|Protocol Violation|5|||
124800439|NCT00191646|448900502|FG001|Overall Study|Protocol Violation|7|||
124800440|NCT00191646|448900501|FG000|Overall Study|Death|6|||
124800441|NCT00191646|448900502|FG001|Overall Study|Death|8|||
124800442|NCT00191646|448900501|FG000|Overall Study|Other|33|||
124800443|NCT00191646|448900502|FG001|Overall Study|Other|34|||
124800444|NCT00191646|448900501|FG000|Overall Study|Missing Data|18|||
124800445|NCT00191646|448900502|FG001|Overall Study|Missing Data|11|||
124800446|NCT05211284|448900507|FG000|Overall Study|Study Terminated|3|||
124800447|NCT05211284|448900508|FG001|Overall Study|Study Terminated|1|||
124800448|NCT00739596|448900509|FG000|Overall Study|Adverse Event|12|||
124800449|NCT00739596|448900510|FG001|Overall Study|Adverse Event|6|||
124800450|NCT00739596|448900509|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
124800451|NCT00739596|448900510|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124800452|NCT00739596|448900509|FG000|Overall Study|Patient Withdrew Consent|8|||
124800453|NCT00739596|448900510|FG001|Overall Study|Patient Withdrew Consent|8|||
124800454|NCT00739596|448900509|FG000|Overall Study|Lost to Follow-up|0|||
124800455|NCT00739596|448900510|FG001|Overall Study|Lost to Follow-up|2|||
124800456|NCT00739596|448900509|FG000|Overall Study|Protocol Deviation|1|||
124800457|NCT00739596|448900510|FG001|Overall Study|Protocol Deviation|1|||
124800458|NCT00908011|448900515|FG000|Overall Study|Withdrawal by Subject|2|||
124800459|NCT00908011|448900516|FG001|Overall Study|Withdrawal by Subject|2|||
124800460|NCT02567552|448900517|FG000|Overall Study|Adverse Event|0|||
124800461|NCT02567552|448900518|FG001|Overall Study|Adverse Event|1|||
124800462|NCT04669535|448900522|FG000|Overall Study|Death|1|||
124800463|NCT04669535|448900523|FG001|Overall Study|Death|1|||
124800464|NCT04669535|448900524|FG002|Overall Study|Death|0|||
124800465|NCT04669535|448900525|FG003|Overall Study|Death|0|||
124800466|NCT02452697|448900526|FG000|Overall Study|Physician Decision|4|||
124800467|NCT02452697|448900527|FG001|Overall Study|Physician Decision|4|||
124800468|NCT02452697|448900528|FG002|Overall Study|Physician Decision|3|||
124800469|NCT02452697|448900529|FG003|Overall Study|Physician Decision|2|||
124800470|NCT02452697|448900526|FG000|Overall Study|Withdrawal by Subject|1|||
124800471|NCT02452697|448900527|FG001|Overall Study|Withdrawal by Subject|0|||
124800472|NCT02452697|448900528|FG002|Overall Study|Withdrawal by Subject|0|||
124800473|NCT02452697|448900529|FG003|Overall Study|Withdrawal by Subject|0|||
124800474|NCT02452697|448900526|FG000|Overall Study|still in follow-up|2|||
124800475|NCT02452697|448900527|FG001|Overall Study|still in follow-up|2|||
124800476|NCT02452697|448900528|FG002|Overall Study|still in follow-up|1|||
124800477|NCT02452697|448900529|FG003|Overall Study|still in follow-up|3|||
124800478|NCT03552965|448900531|FG000|Overall Study|Death|1|||
124800479|NCT03552965|448900532|FG001|Overall Study|Death|1|||
124800480|NCT03552965|448900531|FG000|Overall Study|Lost to Follow-up|1|||
124800481|NCT03552965|448900532|FG001|Overall Study|Lost to Follow-up|1|||
124800482|NCT03552965|448900531|FG000|Overall Study|Physician Decision|1|||
124800483|NCT03552965|448900532|FG001|Overall Study|Physician Decision|1|||
124800484|NCT03552965|448900531|FG000|Overall Study|Withdrawal by Subject|0|||
124800485|NCT03552965|448900532|FG001|Overall Study|Withdrawal by Subject|2|||
124800486|NCT03552965|448900531|FG000|Overall Study|Continuation not in patient best interest|1|||
124800487|NCT03552965|448900532|FG001|Overall Study|Continuation not in patient best interest|0|||
124800488|NCT03552965|448900531|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
124800489|NCT03552965|448900532|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
124800490|NCT02477696|448900533|FG000|Overall Study|Death|89|||
124800491|NCT02477696|448900534|FG001|Overall Study|Death|106|||
124800492|NCT02477696|448900533|FG000|Overall Study|Lost to Follow-up|7|||
124800493|NCT02477696|448900534|FG001|Overall Study|Lost to Follow-up|5|||
124800494|NCT02477696|448900533|FG000|Overall Study|Withdrawal by Subject|37|||
124800495|NCT02477696|448900534|FG001|Overall Study|Withdrawal by Subject|34|||
124800496|NCT02477696|448900533|FG000|Overall Study|Physician Decision|7|||
124800497|NCT02477696|448900534|FG001|Overall Study|Physician Decision|9|||
124800498|NCT02477696|448900533|FG000|Overall Study|Study terminated by sponsor|103|||
124800499|NCT02477696|448900534|FG001|Overall Study|Study terminated by sponsor|99|||
124800500|NCT02477696|448900533|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
124800501|NCT02477696|448900534|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
124800502|NCT02477696|448900533|FG000|Overall Study|Missing/Unknown|2|||
124800503|NCT02477696|448900534|FG001|Overall Study|Missing/Unknown|0|||
124800504|NCT05419908|448900536|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
124800505|NCT05419908|448900537|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
124800506|NCT05419908|448900536|FG000|Overall Study|Serious Adverse Event|0|||
124800507|NCT05419908|448900537|FG001|Overall Study|Serious Adverse Event|2|||
124800508|NCT05419908|448900536|FG000|Overall Study|Withdrawal by Subject|2|||
124800509|NCT05419908|448900537|FG001|Overall Study|Withdrawal by Subject|0|||
125296260|NCT02914561|450711495|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
125296261|NCT02914561|450711485|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
125296262|NCT02914561|450711486|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
125296263|NCT02914561|450711487|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
125296264|NCT02914561|450711488|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
125296265|NCT02914561|450711489|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
125296266|NCT02914561|450711490|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
125296267|NCT02914561|450711491|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
125296268|NCT02914561|450711492|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
125296269|NCT02914561|450711493|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
124800510|NCT05419908|448900536|FG000|Overall Study|Miscellaneous|1|||
124800511|NCT05419908|448900537|FG001|Overall Study|Miscellaneous|1|||
124800512|NCT00085709|448901719|FG000|Overall Study|Adverse Event|8|||
124800513|NCT00085709|448901720|FG001|Overall Study|Adverse Event|0|||
124800514|NCT00085709|448901719|FG000|Overall Study|Death|8|||
124800515|NCT00085709|448901720|FG001|Overall Study|Death|2|||
124800516|NCT00085709|448901719|FG000|Overall Study|Refusal unrelated to adverse events|1|||
124800517|NCT00085709|448901720|FG001|Overall Study|Refusal unrelated to adverse events|2|||
124800518|NCT00085709|448901719|FG000|Overall Study|Progression|3|||
125296270|NCT02914561|450711494|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
125296271|NCT02914561|450711495|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
125296272|NCT02914561|450711485|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
125296273|NCT02914561|450711486|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
125296274|NCT02914561|450711487|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
125296275|NCT02914561|450711488|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
125296276|NCT02914561|450711489|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
125296277|NCT02914561|450711490|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
125296278|NCT02914561|450711491|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
125296279|NCT02914561|450711492|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
125296280|NCT02914561|450711493|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
125296281|NCT02914561|450711494|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
125296282|NCT02914561|450711495|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
125296283|NCT02914561|450711485|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
125296284|NCT02914561|450711486|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
125296285|NCT02914561|450711487|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
125296286|NCT02914561|450711488|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
125296287|NCT02914561|450711489|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
125296288|NCT02914561|450711490|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
125296289|NCT02914561|450711491|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
125296290|NCT02914561|450711492|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
125296291|NCT02914561|450711493|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
125296292|NCT02914561|450711494|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
125296293|NCT02914561|450711495|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
125296294|NCT02914561|450711485|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
125296295|NCT02914561|450711486|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
125296296|NCT02914561|450711487|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
125296297|NCT02914561|450711488|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
125296298|NCT02914561|450711489|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
125296299|NCT02914561|450711490|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
125296300|NCT02914561|450711491|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
125296301|NCT02914561|450711492|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
125296302|NCT02914561|450711493|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
125296303|NCT02914561|450711494|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
125296304|NCT02914561|450711495|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
125296305|NCT02914561|450711485|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
125296306|NCT02914561|450711486|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
125296307|NCT02914561|450711487|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
125296308|NCT02914561|450711488|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
125296309|NCT02914561|450711489|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
125296310|NCT02914561|450711490|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
125296311|NCT02914561|450711491|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
125296312|NCT02914561|450711492|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
125296313|NCT02914561|450711493|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
125296314|NCT02914561|450711494|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
125296315|NCT02914561|450711495|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
125296316|NCT02914561|450711485|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
125296317|NCT02914561|450711486|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
125296318|NCT02914561|450711487|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
125296319|NCT02914561|450711488|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
125296320|NCT02914561|450711489|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
125296321|NCT02914561|450711490|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
125296322|NCT02914561|450711491|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
125296323|NCT02914561|450711492|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
125296324|NCT02914561|450711493|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
125296325|NCT02914561|450711494|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
125296326|NCT02914561|450711495|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
125296327|NCT02914561|450711485|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
125296328|NCT02914561|450711486|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
125296329|NCT02914561|450711487|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
125296330|NCT02914561|450711488|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
125296331|NCT02914561|450711489|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
124800519|NCT00085709|448901720|FG001|Overall Study|Progression|4|||
124800520|NCT00085709|448901719|FG000|Overall Study|Not protocol specified|12|||
125296332|NCT02914561|450711490|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
125296333|NCT02914561|450711491|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
125296334|NCT02914561|450711492|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
125296335|NCT02914561|450711493|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
125296336|NCT02914561|450711494|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
125296337|NCT02914561|450711495|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
125296338|NCT02914561|450711485|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
125296339|NCT02914561|450711486|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
125296340|NCT02914561|450711487|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
125296341|NCT02914561|450711488|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
125296342|NCT02914561|450711489|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
125296343|NCT02914561|450711490|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
125296344|NCT02914561|450711491|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
125296345|NCT02914561|450711492|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
125296346|NCT02914561|450711493|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
125296347|NCT02914561|450711494|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
125296348|NCT02914561|450711495|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
125296349|NCT02914561|450711485|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
125296350|NCT02914561|450711486|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
125296351|NCT02914561|450711487|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
125296352|NCT02914561|450711488|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
125296353|NCT02914561|450711489|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
125296354|NCT02914561|450711490|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
125296355|NCT02914561|450711491|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
125296356|NCT02914561|450711492|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
125296357|NCT02914561|450711493|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
125296358|NCT02914561|450711494|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
125296359|NCT02914561|450711495|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
125296360|NCT02914561|450711485|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
125296361|NCT02914561|450711486|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
125296362|NCT02914561|450711487|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
125296363|NCT02914561|450711488|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
125296364|NCT02914561|450711489|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
125296365|NCT02914561|450711490|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
125296366|NCT02914561|450711491|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
125296367|NCT02914561|450711492|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
125296368|NCT02914561|450711493|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
125296369|NCT02914561|450711494|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
125296370|NCT02914561|450711495|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
125296371|NCT02914561|450711485|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
125296372|NCT02914561|450711486|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
125296373|NCT02914561|450711487|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
125296374|NCT02914561|450711488|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
125296375|NCT02914561|450711489|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
125296376|NCT02914561|450711490|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
125296377|NCT02914561|450711491|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
125296378|NCT02914561|450711492|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
125296379|NCT02914561|450711493|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
125296380|NCT02914561|450711494|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
125296381|NCT02914561|450711495|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
125296382|NCT01455220|450711498|FG000|Overall Study|screen fail|30|||
125296383|NCT04881747|450711499|FG000|Period 2 Washout|Adverse Event|1|||
125296384|NCT04881747|450711500|FG001|Period 2 Washout|Adverse Event|0|||
125296385|NCT04881747|450711501|FG002|Period 2 Washout|Adverse Event|0|||
125296386|NCT04881747|450711502|FG003|Period 2 Washout|Adverse Event|0|||
125296387|NCT04881747|450711503|FG004|Period 2 Washout|Adverse Event|1|||
125296388|NCT04881747|450711504|FG005|Period 2 Washout|Adverse Event|0|||
125296389|NCT04881747|450711499|FG000|Period 2 Washout|Withdrawal by Subject|1|||
125296390|NCT04881747|450711500|FG001|Period 2 Washout|Withdrawal by Subject|0|||
125296391|NCT04881747|450711501|FG002|Period 2 Washout|Withdrawal by Subject|0|||
125296392|NCT04881747|450711502|FG003|Period 2 Washout|Withdrawal by Subject|1|||
125296393|NCT04881747|450711503|FG004|Period 2 Washout|Withdrawal by Subject|0|||
125296394|NCT04881747|450711504|FG005|Period 2 Washout|Withdrawal by Subject|0|||
125296395|NCT04598269|450711505|FG000|Overall Study|Adverse Event|0|||
125296396|NCT04598269|450711506|FG001|Overall Study|Adverse Event|3|||
125296397|NCT04598269|450711505|FG000|Overall Study|Withdrawal by Subject|1|||
125296398|NCT04598269|450711506|FG001|Overall Study|Withdrawal by Subject|4|||
125296399|NCT04598269|450711505|FG000|Overall Study|Lost to Follow-up|1|||
125296400|NCT04598269|450711506|FG001|Overall Study|Lost to Follow-up|0|||
125296401|NCT04598269|450711505|FG000|Overall Study|Not Treated|2|||
125296402|NCT04598269|450711506|FG001|Overall Study|Not Treated|0|||
125296403|NCT03869333|450711511|FG000|Overall Study|Lost to Follow-up|1|||
125296404|NCT03869333|450711512|FG001|Overall Study|Lost to Follow-up|0|||
125296405|NCT03869333|450711513|FG002|Overall Study|Lost to Follow-up|0|||
125296406|NCT03869333|450711514|FG003|Overall Study|Lost to Follow-up|0|||
125296407|NCT03869333|450711511|FG000|Overall Study|Pregnancy|1|||
125296408|NCT03869333|450711512|FG001|Overall Study|Pregnancy|0|||
125296409|NCT03869333|450711513|FG002|Overall Study|Pregnancy|0|||
125296410|NCT03869333|450711514|FG003|Overall Study|Pregnancy|0|||
125296411|NCT03869333|450711511|FG000|Overall Study|Physician Decision|0|||
125296412|NCT03869333|450711512|FG001|Overall Study|Physician Decision|1|||
125296413|NCT03869333|450711513|FG002|Overall Study|Physician Decision|0|||
125296414|NCT03869333|450711514|FG003|Overall Study|Physician Decision|0|||
125296415|NCT02598128|450711515|FG000|Period A: Days -7 to -1|Adverse Event|1|||
125296416|NCT02598128|450711516|FG001|Period A: Days -7 to -1|Adverse Event|0|||
125296417|NCT02598128|450711517|FG002|Period A: Days -7 to -1|Adverse Event|0|||
125296418|NCT02598128|450711518|FG003|Period A: Days -7 to -1|Adverse Event|0|||
125296419|NCT03134183|450711521|FG000|Overall Study|Withdrawal by Subject|1|||
125296420|NCT03134183|450711522|FG001|Overall Study|Withdrawal by Subject|1|||
125296421|NCT00845065|450711523|FG000|Overall Study|Adverse Event|3|||
125296422|NCT00845065|450711524|FG001|Overall Study|Adverse Event|23|||
125296423|NCT00845065|450711523|FG000|Overall Study|Lack of Efficacy|43|||
125296424|NCT00845065|450711524|FG001|Overall Study|Lack of Efficacy|21|||
125296425|NCT00845065|450711523|FG000|Overall Study|Non-Medical Reasons|1|||
125296426|NCT00845065|450711524|FG001|Overall Study|Non-Medical Reasons|11|||
125296427|NCT00162266|450711525|FG000|Double-Blind Period|Adverse Event|5|||
125296428|NCT00162266|450711526|FG001|Double-Blind Period|Adverse Event|9|||
125296429|NCT00162266|450711527|FG002|Double-Blind Period|Adverse Event|11|||
125296430|NCT00162266|450711528|FG003|Double-Blind Period|Adverse Event|0|||
125296431|NCT00162266|450711525|FG000|Double-Blind Period|Death|0|||
125296432|NCT00162266|450711526|FG001|Double-Blind Period|Death|1|||
125296433|NCT00162266|450711527|FG002|Double-Blind Period|Death|0|||
125296434|NCT00162266|450711528|FG003|Double-Blind Period|Death|0|||
125296435|NCT00162266|450711525|FG000|Double-Blind Period|Lost to Follow-up|1|||
125296436|NCT00162266|450711526|FG001|Double-Blind Period|Lost to Follow-up|2|||
125296437|NCT00162266|450711527|FG002|Double-Blind Period|Lost to Follow-up|0|||
125296438|NCT00162266|450711528|FG003|Double-Blind Period|Lost to Follow-up|0|||
125296439|NCT00162266|450711525|FG000|Double-Blind Period|Other Reason|1|||
125296440|NCT00162266|450711526|FG001|Double-Blind Period|Other Reason|0|||
125296441|NCT00162266|450711527|FG002|Double-Blind Period|Other Reason|1|||
125296442|NCT00162266|450711528|FG003|Double-Blind Period|Other Reason|0|||
125296443|NCT00162266|450711525|FG000|Double-Blind Period|Lack of Efficacy|13|||
125296444|NCT00162266|450711526|FG001|Double-Blind Period|Lack of Efficacy|17|||
125296445|NCT00162266|450711527|FG002|Double-Blind Period|Lack of Efficacy|30|||
125296446|NCT00162266|450711528|FG003|Double-Blind Period|Lack of Efficacy|0|||
125296447|NCT00162266|450711525|FG000|Double-Blind Period|Withdrawal by Subject|5|||
125296448|NCT00162266|450711526|FG001|Double-Blind Period|Withdrawal by Subject|2|||
125296449|NCT00162266|450711527|FG002|Double-Blind Period|Withdrawal by Subject|6|||
125296450|NCT00162266|450711528|FG003|Double-Blind Period|Withdrawal by Subject|0|||
125296451|NCT00162266|450711525|FG000|Open-Label Period|Death|0|||
125296452|NCT00162266|450711526|FG001|Open-Label Period|Death|0|||
125296453|NCT00162266|450711527|FG002|Open-Label Period|Death|0|||
125296454|NCT00162266|450711528|FG003|Open-Label Period|Death|7|||
125296455|NCT00162266|450711525|FG000|Open-Label Period|Adverse Event|0|||
125296456|NCT00162266|450711526|FG001|Open-Label Period|Adverse Event|0|||
125296457|NCT00162266|450711527|FG002|Open-Label Period|Adverse Event|0|||
125296458|NCT00162266|450711528|FG003|Open-Label Period|Adverse Event|46|||
125296459|NCT00162266|450711525|FG000|Open-Label Period|Lack of Efficacy|0|||
125296460|NCT00162266|450711526|FG001|Open-Label Period|Lack of Efficacy|0|||
125296461|NCT00162266|450711527|FG002|Open-Label Period|Lack of Efficacy|0|||
125296462|NCT00162266|450711528|FG003|Open-Label Period|Lack of Efficacy|26|||
125296463|NCT00162266|450711525|FG000|Open-Label Period|Lost to Follow-up|0|||
125296464|NCT00162266|450711526|FG001|Open-Label Period|Lost to Follow-up|0|||
124800521|NCT00085709|448901720|FG001|Overall Study|Not protocol specified|22|||
125296465|NCT00162266|450711527|FG002|Open-Label Period|Lost to Follow-up|0|||
125296466|NCT00162266|450711528|FG003|Open-Label Period|Lost to Follow-up|3|||
125296467|NCT00162266|450711525|FG000|Open-Label Period|Withdrawal by Subject|0|||
125296468|NCT00162266|450711526|FG001|Open-Label Period|Withdrawal by Subject|0|||
125296469|NCT00162266|450711527|FG002|Open-Label Period|Withdrawal by Subject|0|||
125296470|NCT00162266|450711528|FG003|Open-Label Period|Withdrawal by Subject|31|||
125296471|NCT00162266|450711525|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
125296472|NCT00162266|450711526|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
125296473|NCT00162266|450711527|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
125296474|NCT00162266|450711528|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
125296475|NCT00162266|450711525|FG000|Open-Label Period|Other Reasons|0|||
125296476|NCT00162266|450711526|FG001|Open-Label Period|Other Reasons|0|||
125296477|NCT00162266|450711527|FG002|Open-Label Period|Other Reasons|0|||
125296478|NCT00162266|450711528|FG003|Open-Label Period|Other Reasons|15|||
125296479|NCT01198509|450711529|FG000|Overall Study|Withdrawal by Subject|1|||
125296480|NCT01198509|450711530|FG001|Overall Study|Withdrawal by Subject|0|||
125296481|NCT01198509|450711531|FG002|Overall Study|Withdrawal by Subject|0|||
125296482|NCT01198509|450711532|FG003|Overall Study|Withdrawal by Subject|0|||
125296483|NCT01198509|450711533|FG004|Overall Study|Withdrawal by Subject|0|||
125296484|NCT01198509|450711534|FG005|Overall Study|Withdrawal by Subject|0|||
125296485|NCT00499746|450711535|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
125296486|NCT00499746|450711535|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
125296487|NCT00499746|450711535|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
125296488|NCT00499746|450711535|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
125296489|NCT03480009|450711538|FG000|Overall Study|Lost to Follow-up|4|||
125296490|NCT03480009|450711539|FG001|Overall Study|Lost to Follow-up|5|||
125296491|NCT03480009|450711540|FG002|Overall Study|Lost to Follow-up|4|||
125296492|NCT03480009|450711541|FG003|Overall Study|Lost to Follow-up|0|||
125296493|NCT01638559|450711543|FG000|Overall Study|Lost to Follow-up|1|||
125296494|NCT01638559|450711543|FG000|Overall Study|Withdrawal by Subject|1|||
125296495|NCT01638559|450711543|FG000|Overall Study|Subject declined to travel for biopsy|1|||
125296496|NCT00483002|450711546|FG000|Overall Study|Adverse Event|68|||
125296497|NCT00483002|450711546|FG000|Overall Study|Lack of Efficacy|555|||
125296498|NCT00483002|450711546|FG000|Overall Study|Lost to Follow-up|962|||
125296499|NCT00483002|450711546|FG000|Overall Study|Other|2|||
125296500|NCT00483002|450711546|FG000|Overall Study|Other|967|||
125296501|NCT00772109|450711547|FG000|Overall Study|Serious adverse event|1|||
125296502|NCT00772109|450711548|FG001|Overall Study|Serious adverse event|0|||
125296503|NCT00772109|450711549|FG002|Overall Study|Serious adverse event|1|||
125296504|NCT00772109|450711550|FG003|Overall Study|Serious adverse event|0|||
125296505|NCT00772109|450711547|FG000|Overall Study|Protocol Violation|5|||
125296506|NCT00772109|450711548|FG001|Overall Study|Protocol Violation|8|||
125296507|NCT00772109|450711549|FG002|Overall Study|Protocol Violation|7|||
125296508|NCT00772109|450711550|FG003|Overall Study|Protocol Violation|6|||
125296509|NCT00772109|450711547|FG000|Overall Study|Lost to Follow-up|7|||
125296510|NCT00772109|450711548|FG001|Overall Study|Lost to Follow-up|3|||
125296511|NCT00772109|450711549|FG002|Overall Study|Lost to Follow-up|5|||
125296512|NCT00772109|450711550|FG003|Overall Study|Lost to Follow-up|9|||
125296513|NCT00772109|450711547|FG000|Overall Study|Withdrawal by Subject|8|||
125296514|NCT00772109|450711548|FG001|Overall Study|Withdrawal by Subject|8|||
125296515|NCT00772109|450711549|FG002|Overall Study|Withdrawal by Subject|6|||
125296516|NCT00772109|450711550|FG003|Overall Study|Withdrawal by Subject|16|||
125296517|NCT01624090|450711551|FG000|Overall Study|DLT, taken off therapy|0|||
125296518|NCT01624090|450711552|FG001|Overall Study|DLT, taken off therapy|1|||
125296519|NCT01624090|450711553|FG002|Overall Study|DLT, taken off therapy|0|||
125296520|NCT01624090|450711554|FG003|Overall Study|DLT, taken off therapy|0|||
125296521|NCT01624090|450711551|FG000|Overall Study|Withdrew prior to treatment|0|||
125296522|NCT01624090|450711552|FG001|Overall Study|Withdrew prior to treatment|1|||
125296523|NCT01624090|450711553|FG002|Overall Study|Withdrew prior to treatment|0|||
125296524|NCT01624090|450711554|FG003|Overall Study|Withdrew prior to treatment|0|||
125296525|NCT01624090|450711551|FG000|Overall Study|Died on study|0|||
125296526|NCT01624090|450711552|FG001|Overall Study|Died on study|0|||
125296527|NCT01624090|450711553|FG002|Overall Study|Died on study|2|||
125296528|NCT01624090|450711554|FG003|Overall Study|Died on study|0|||
125296529|NCT01624090|450711551|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
125296530|NCT01624090|450711552|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
125296531|NCT01624090|450711553|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
125296532|NCT01624090|450711554|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
125296533|NCT01624090|450711551|FG000|Overall Study|Dose escalated|0|||
125296534|NCT01624090|450711552|FG001|Overall Study|Dose escalated|0|||
125296535|NCT01624090|450711553|FG002|Overall Study|Dose escalated|3|||
125296536|NCT01624090|450711554|FG003|Overall Study|Dose escalated|0|||
125296537|NCT00752726|450711555|FG000|Overall Study|Lost to Follow-up|2|||
125296538|NCT00752726|450711556|FG001|Overall Study|Lost to Follow-up|1|||
125296539|NCT00752726|450711555|FG000|Overall Study|Adverse Event|3|||
125296540|NCT00752726|450711556|FG001|Overall Study|Adverse Event|0|||
125296541|NCT00752726|450711555|FG000|Overall Study|Withdrawal by Subject|5|||
125296542|NCT00752726|450711556|FG001|Overall Study|Withdrawal by Subject|10|||
125296543|NCT00752726|450711555|FG000|Overall Study|Other Reason|1|||
125296544|NCT00752726|450711556|FG001|Overall Study|Other Reason|2|||
125296545|NCT01403116|450711557|FG000|Overall Study|Adverse Event|7|||
125296546|NCT01403116|450711558|FG001|Overall Study|Adverse Event|4|||
125296547|NCT01403116|450711557|FG000|Overall Study|Lost to Follow-up|7|||
125296548|NCT01403116|450711558|FG001|Overall Study|Lost to Follow-up|5|||
125296549|NCT01403116|450711557|FG000|Overall Study|Withdrawal by Subject|12|||
125296550|NCT01403116|450711558|FG001|Overall Study|Withdrawal by Subject|15|||
125296551|NCT01403116|450711557|FG000|Overall Study|Non-compliance of study drug|3|||
125296552|NCT01403116|450711558|FG001|Overall Study|Non-compliance of study drug|0|||
125296553|NCT01403116|450711557|FG000|Overall Study|Protocol Violation|0|||
125296554|NCT01403116|450711558|FG001|Overall Study|Protocol Violation|1|||
125296555|NCT01403116|450711557|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
125296556|NCT01403116|450711558|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
125296557|NCT01403116|450711557|FG000|Overall Study|Hct >54%|2|||
125296558|NCT01403116|450711558|FG001|Overall Study|Hct >54%|0|||
125296559|NCT01403116|450711557|FG000|Overall Study|unable to keep appointments|0|||
125296560|NCT01403116|450711558|FG001|Overall Study|unable to keep appointments|2|||
125296561|NCT01895309|450711559|FG000|Overall Study|Adverse Event|13|||
125296562|NCT01895309|450711560|FG001|Overall Study|Adverse Event|17|||
125296563|NCT01895309|450711559|FG000|Overall Study|Protocol Violation|1|||
125296564|NCT01895309|450711560|FG001|Overall Study|Protocol Violation|0|||
125296565|NCT01895309|450711559|FG000|Overall Study|Lack of Efficacy|1|||
125296566|NCT01895309|450711560|FG001|Overall Study|Lack of Efficacy|3|||
125296567|NCT01895309|450711559|FG000|Overall Study|Lost to Follow-up|1|||
125296568|NCT01895309|450711560|FG001|Overall Study|Lost to Follow-up|3|||
125296569|NCT01895309|450711559|FG000|Overall Study|Physician Decision|15|||
125296570|NCT01895309|450711560|FG001|Overall Study|Physician Decision|10|||
125296571|NCT01895309|450711559|FG000|Overall Study|Withdrawal by Subject|9|||
125296572|NCT01895309|450711560|FG001|Overall Study|Withdrawal by Subject|18|||
125296573|NCT00042666|450711561|FG000|Overall Study|Adverse Event|2|||
125296574|NCT00042666|450711561|FG000|Overall Study|Death|4|||
125296575|NCT00042666|450711561|FG000|Overall Study|Protocol Violation|1|||
125296576|NCT00042666|450711561|FG000|Overall Study|Participant/Physician Perception|1|||
125296577|NCT00042666|450711561|FG000|Overall Study|Progressive Disease|41|||
125296578|NCT00042666|450711561|FG000|Overall Study|Other|1|||
125296579|NCT00042666|450711561|FG000|Overall Study|Other|4|||
125296580|NCT04232215|450711562|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
125296581|NCT04232215|450711563|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
125296582|NCT04046250|450711579|FG000|Overall Study|Death|0|||
125296583|NCT04046250|450711580|FG001|Overall Study|Death|1|||
125296584|NCT04046250|450711579|FG000|Overall Study|Withdrawal by Subject|3|||
125296585|NCT04046250|450711580|FG001|Overall Study|Withdrawal by Subject|3|||
125296586|NCT04576897|450711585|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
125296587|NCT00527332|450711586|FG000|Overall Study|Protocol Violation|4|||
125296588|NCT00527332|450711587|FG001|Overall Study|Protocol Violation|8|||
125296589|NCT00527332|450711586|FG000|Overall Study|Withdrew consent|5|||
125296590|NCT00527332|450711587|FG001|Overall Study|Withdrew consent|1|||
125296591|NCT02666105|450711588|FG000|Overall Study|Death|1|||
125296592|NCT01078168|450711589|FG000|Overall Study|Physician Decision|0|||
125296593|NCT01078168|450711590|FG001|Overall Study|Physician Decision|1|||
125296594|NCT01264419|450711592|FG000|Overall Study|Lost to Follow-up|3|||
125296595|NCT00358436|450713824|FG000|Overall Study|Adverse Event|29|||
125296596|NCT00358436|450713825|FG001|Overall Study|Adverse Event|13|||
125296597|NCT00358436|450713824|FG000|Overall Study|Lack of Efficacy|34|||
125296598|NCT00358436|450713825|FG001|Overall Study|Lack of Efficacy|36|||
125296599|NCT00358436|450713824|FG000|Overall Study|Lost to Follow-up|11|||
125296600|NCT00358436|450713825|FG001|Overall Study|Lost to Follow-up|6|||
125296601|NCT00358436|450713824|FG000|Overall Study|Protocol Violation|8|||
125296602|NCT00358436|450713825|FG001|Overall Study|Protocol Violation|3|||
125296603|NCT00358436|450713824|FG000|Overall Study|Withdrawal by Subject|40|||
125296604|NCT00358436|450713825|FG001|Overall Study|Withdrawal by Subject|17|||
125296605|NCT00358436|450713824|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
125296606|NCT00358436|450713825|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
125296607|NCT00358436|450713824|FG000|Overall Study|COPD exacerbation|22|||
125296608|NCT00358436|450713825|FG001|Overall Study|COPD exacerbation|10|||
125296609|NCT00358436|450713824|FG000|Overall Study|Other|6|||
125296610|NCT00358436|450713825|FG001|Overall Study|Other|1|||
125296611|NCT02905006|450713827|FG000|Overall Study|Adverse Event|1|||
125296612|NCT02905006|450713828|FG001|Overall Study|Adverse Event|1|||
125296613|NCT02905006|450713829|FG002|Overall Study|Adverse Event|1|||
125296614|NCT02905006|450713830|FG003|Overall Study|Adverse Event|1|||
125296615|NCT02905006|450713831|FG004|Overall Study|Adverse Event|0|||
125296616|NCT02905006|450713832|FG005|Overall Study|Adverse Event|1|||
125296617|NCT02905006|450713827|FG000|Overall Study|Lack of Efficacy|1|||
125296618|NCT02905006|450713828|FG001|Overall Study|Lack of Efficacy|0|||
125296619|NCT02905006|450713829|FG002|Overall Study|Lack of Efficacy|0|||
125296620|NCT02905006|450713830|FG003|Overall Study|Lack of Efficacy|0|||
125296621|NCT02905006|450713831|FG004|Overall Study|Lack of Efficacy|0|||
125296622|NCT02905006|450713832|FG005|Overall Study|Lack of Efficacy|0|||
125296623|NCT02905006|450713827|FG000|Overall Study|Protocol Violation|2|||
125296624|NCT02905006|450713828|FG001|Overall Study|Protocol Violation|0|||
125296625|NCT02905006|450713829|FG002|Overall Study|Protocol Violation|0|||
124800522|NCT00085709|448901719|FG000|Overall Study|Not eligible|19|||
125296626|NCT02905006|450713830|FG003|Overall Study|Protocol Violation|0|||
125296627|NCT02905006|450713831|FG004|Overall Study|Protocol Violation|0|||
125296628|NCT02905006|450713832|FG005|Overall Study|Protocol Violation|0|||
125296629|NCT02905006|450713827|FG000|Overall Study|Lost to Follow-up|0|||
125296630|NCT02905006|450713828|FG001|Overall Study|Lost to Follow-up|0|||
125296631|NCT02905006|450713829|FG002|Overall Study|Lost to Follow-up|0|||
125296632|NCT02905006|450713830|FG003|Overall Study|Lost to Follow-up|1|||
125296633|NCT02905006|450713831|FG004|Overall Study|Lost to Follow-up|1|||
124800523|NCT00085709|448901720|FG001|Overall Study|Not eligible|19|||
124800524|NCT00085709|448901719|FG000|Overall Study|Withdrawal by Subject|2|||
124800525|NCT00085709|448901720|FG001|Overall Study|Withdrawal by Subject|1|||
124800526|NCT00293215|448901721|FG000|Overall Study|Progressive disease|3|||
124800527|NCT00293215|448901722|FG001|Overall Study|Progressive disease|1|||
124800528|NCT00293215|448901721|FG000|Overall Study|Adverse Event|2|||
124800529|NCT00293215|448901722|FG001|Overall Study|Adverse Event|2|||
124800530|NCT01229371|448901725|FG000|Overall Study|Withdrawal by Subject|0|||
124800531|NCT01229371|448901726|FG001|Overall Study|Withdrawal by Subject|1|||
124800532|NCT01229371|448901727|FG002|Overall Study|Withdrawal by Subject|0|||
124800533|NCT01229371|448901728|FG003|Overall Study|Withdrawal by Subject|0|||
124800534|NCT04622735|448901729|FG000|Overall Study|Lost to Follow-up|1|||
124800535|NCT04622735|448901730|FG001|Overall Study|Lost to Follow-up|2|||
124800536|NCT04622735|448901731|FG002|Overall Study|Lost to Follow-up|1|||
124800537|NCT04622735|448901729|FG000|Overall Study|Adverse Event|0|||
124800538|NCT04622735|448901730|FG001|Overall Study|Adverse Event|0|||
124800539|NCT04622735|448901731|FG002|Overall Study|Adverse Event|1|||
124800540|NCT04622735|448901729|FG000|Overall Study|Protocol Violation|1|||
124800541|NCT04622735|448901730|FG001|Overall Study|Protocol Violation|0|||
124800542|NCT04622735|448901731|FG002|Overall Study|Protocol Violation|0|||
124800543|NCT05314478|448901732|FG000|Overall Study|Physician Decision|1|||
124800544|NCT02923427|448901733|FG000|Overall Study|convert to laparatomy|2|||
124800545|NCT02923427|448901734|FG001|Overall Study|convert to laparatomy|2|||
124800546|NCT02923427|448901733|FG000|Overall Study|destaturation|1|||
124800547|NCT02923427|448901734|FG001|Overall Study|destaturation|0|||
124800548|NCT02923427|448901733|FG000|Overall Study|can not replace LMA|1|||
124800549|NCT02923427|448901734|FG001|Overall Study|can not replace LMA|0|||
124800550|NCT01325623|448901735|FG000|Overall Study|Withdrawal by Subject|3|||
124800551|NCT01229397|448901736|FG000|Overall Study|Withdrawal by Subject|3|||
124800552|NCT01229397|448901737|FG001|Overall Study|Withdrawal by Subject|3|||
124800553|NCT01229397|448901736|FG000|Overall Study|Lost to Follow-up|7|||
124800554|NCT01229397|448901737|FG001|Overall Study|Lost to Follow-up|6|||
124800555|NCT01229397|448901736|FG000|Overall Study|Migrated/moved from study area|1|||
124800556|NCT01229397|448901737|FG001|Overall Study|Migrated/moved from study area|0|||
124800557|NCT02694523|448901738|FG000|Part A|Adverse Event|7|||
124800558|NCT02694523|448901739|FG001|Part A|Adverse Event|3|||
124800559|NCT02694523|448901740|FG002|Part A|Adverse Event|0|||
124800560|NCT02694523|448901741|FG003|Part A|Adverse Event|0|||
124800561|NCT02694523|448901742|FG004|Part A|Adverse Event|0|||
124800562|NCT02694523|448901743|FG005|Part A|Adverse Event|0|||
124800563|NCT02694523|448901744|FG006|Part A|Adverse Event|0|||
124800564|NCT02694523|448901738|FG000|Part A|Protocol Violation|1|||
124800565|NCT02694523|448901739|FG001|Part A|Protocol Violation|0|||
124800566|NCT02694523|448901740|FG002|Part A|Protocol Violation|0|||
124800567|NCT02694523|448901741|FG003|Part A|Protocol Violation|0|||
124800568|NCT02694523|448901742|FG004|Part A|Protocol Violation|0|||
124800569|NCT02694523|448901743|FG005|Part A|Protocol Violation|0|||
124800570|NCT02694523|448901744|FG006|Part A|Protocol Violation|0|||
124800571|NCT02694523|448901738|FG000|Part A|Lost to Follow-up|1|||
124800572|NCT02694523|448901739|FG001|Part A|Lost to Follow-up|2|||
124800573|NCT02694523|448901740|FG002|Part A|Lost to Follow-up|0|||
124800574|NCT02694523|448901741|FG003|Part A|Lost to Follow-up|0|||
124800575|NCT02694523|448901742|FG004|Part A|Lost to Follow-up|0|||
124800576|NCT02694523|448901743|FG005|Part A|Lost to Follow-up|0|||
124800577|NCT02694523|448901744|FG006|Part A|Lost to Follow-up|0|||
124800578|NCT02694523|448901738|FG000|Part A|Withdrawal by Subject|3|||
124800579|NCT02694523|448901739|FG001|Part A|Withdrawal by Subject|1|||
124800580|NCT02694523|448901740|FG002|Part A|Withdrawal by Subject|0|||
124800581|NCT02694523|448901741|FG003|Part A|Withdrawal by Subject|0|||
124800582|NCT02694523|448901742|FG004|Part A|Withdrawal by Subject|0|||
124800583|NCT02694523|448901743|FG005|Part A|Withdrawal by Subject|0|||
125296634|NCT02905006|450713832|FG005|Overall Study|Lost to Follow-up|0|||
124800584|NCT02694523|448901744|FG006|Part A|Withdrawal by Subject|0|||
124800585|NCT02694523|448901738|FG000|Part A|Other|1|||
124800586|NCT02694523|448901739|FG001|Part A|Other|1|||
124800587|NCT02694523|448901740|FG002|Part A|Other|0|||
124800588|NCT02694523|448901741|FG003|Part A|Other|0|||
124800589|NCT02694523|448901742|FG004|Part A|Other|0|||
124800590|NCT02694523|448901743|FG005|Part A|Other|0|||
124800591|NCT02694523|448901744|FG006|Part A|Other|0|||
124800592|NCT02694523|448901738|FG000|Part B|Adverse Event|0|||
124800593|NCT02694523|448901739|FG001|Part B|Adverse Event|0|||
124800594|NCT02694523|448901740|FG002|Part B|Adverse Event|7|||
124800595|NCT02694523|448901741|FG003|Part B|Adverse Event|1|||
124800596|NCT02694523|448901742|FG004|Part B|Adverse Event|1|||
124800597|NCT02694523|448901743|FG005|Part B|Adverse Event|2|||
124800598|NCT02694523|448901744|FG006|Part B|Adverse Event|0|||
125296635|NCT02905006|450713827|FG000|Overall Study|Withdrawal by Subject|0|||
124800599|NCT02694523|448901738|FG000|Part B|Protocol Violation|0|||
124800600|NCT02694523|448901739|FG001|Part B|Protocol Violation|0|||
124800601|NCT02694523|448901740|FG002|Part B|Protocol Violation|1|||
124800602|NCT02694523|448901741|FG003|Part B|Protocol Violation|0|||
124800603|NCT02694523|448901742|FG004|Part B|Protocol Violation|0|||
124800604|NCT02694523|448901743|FG005|Part B|Protocol Violation|0|||
124800605|NCT02694523|448901744|FG006|Part B|Protocol Violation|0|||
124800606|NCT02694523|448901738|FG000|Part B|Lost to Follow-up|0|||
124800607|NCT02694523|448901739|FG001|Part B|Lost to Follow-up|0|||
124800608|NCT02694523|448901740|FG002|Part B|Lost to Follow-up|2|||
124800609|NCT02694523|448901741|FG003|Part B|Lost to Follow-up|3|||
124800610|NCT02694523|448901742|FG004|Part B|Lost to Follow-up|2|||
124800611|NCT02694523|448901743|FG005|Part B|Lost to Follow-up|0|||
124800612|NCT02694523|448901744|FG006|Part B|Lost to Follow-up|1|||
124800613|NCT02694523|448901738|FG000|Part B|Withdrawal by Subject|0|||
124800614|NCT02694523|448901739|FG001|Part B|Withdrawal by Subject|0|||
124800615|NCT02694523|448901740|FG002|Part B|Withdrawal by Subject|9|||
124800616|NCT02694523|448901741|FG003|Part B|Withdrawal by Subject|0|||
125296636|NCT02905006|450713828|FG001|Overall Study|Withdrawal by Subject|0|||
125296637|NCT02905006|450713829|FG002|Overall Study|Withdrawal by Subject|1|||
125296638|NCT02905006|450713830|FG003|Overall Study|Withdrawal by Subject|1|||
125296639|NCT02905006|450713831|FG004|Overall Study|Withdrawal by Subject|0|||
125296640|NCT02905006|450713832|FG005|Overall Study|Withdrawal by Subject|1|||
125296641|NCT02905006|450713827|FG000|Overall Study|Screening exclusion criteria met|1|||
125296642|NCT02905006|450713828|FG001|Overall Study|Screening exclusion criteria met|0|||
125296643|NCT02905006|450713829|FG002|Overall Study|Screening exclusion criteria met|0|||
125296644|NCT02905006|450713830|FG003|Overall Study|Screening exclusion criteria met|0|||
124800617|NCT02694523|448901742|FG004|Part B|Withdrawal by Subject|1|||
124800618|NCT02694523|448901743|FG005|Part B|Withdrawal by Subject|3|||
124800619|NCT02694523|448901744|FG006|Part B|Withdrawal by Subject|0|||
124800620|NCT02694523|448901738|FG000|Part B|Other|0|||
124800621|NCT02694523|448901739|FG001|Part B|Other|0|||
124800622|NCT02694523|448901740|FG002|Part B|Other|1|||
124800623|NCT02694523|448901741|FG003|Part B|Other|0|||
124800624|NCT02694523|448901742|FG004|Part B|Other|0|||
124800625|NCT02694523|448901743|FG005|Part B|Other|0|||
124800626|NCT02694523|448901744|FG006|Part B|Other|1|||
124800627|NCT05896748|448901745|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
124800628|NCT05896748|448901745|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
124800629|NCT05896748|448901745|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
124800630|NCT05896748|448901745|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
124800631|NCT05896748|448901745|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
124800632|NCT00764504|448901746|FG000|Overall Study|Death|12|||
124800633|NCT00764504|448901747|FG001|Overall Study|Death|6|||
124800634|NCT00764504|448901748|FG002|Overall Study|Death|13|||
124800635|NCT00764504|448901746|FG000|Overall Study|Revision of Device|12|||
124800636|NCT00764504|448901747|FG001|Overall Study|Revision of Device|23|||
124800637|NCT00764504|448901748|FG002|Overall Study|Revision of Device|14|||
124800638|NCT00764504|448901746|FG000|Overall Study|Physician Decision|1|||
124800639|NCT00764504|448901747|FG001|Overall Study|Physician Decision|0|||
124800640|NCT00764504|448901748|FG002|Overall Study|Physician Decision|0|||
124800641|NCT00764504|448901746|FG000|Overall Study|Withdrawal by Subject|1|||
124800642|NCT00764504|448901747|FG001|Overall Study|Withdrawal by Subject|7|||
124800643|NCT00764504|448901748|FG002|Overall Study|Withdrawal by Subject|4|||
124800644|NCT00764504|448901746|FG000|Overall Study|Lost to Follow-up|40|||
124800645|NCT00764504|448901747|FG001|Overall Study|Lost to Follow-up|34|||
124800646|NCT00764504|448901748|FG002|Overall Study|Lost to Follow-up|72|||
124800647|NCT01298193|448901749|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
124800648|NCT01298193|448901749|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
124800649|NCT01298193|448901749|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
124800650|NCT01298193|448901749|FG000|Efficacy Phase (Second Cycle)|Death|1|||
124800651|NCT04010539|448901750|FG000|Overall Study|Withdrawal by Subject|4|||
124800652|NCT04010539|448901751|FG001|Overall Study|Withdrawal by Subject|1|||
124800653|NCT04010539|448901750|FG000|Overall Study|Physician Decision|0|||
124800654|NCT04010539|448901751|FG001|Overall Study|Physician Decision|2|||
124800655|NCT04010539|448901750|FG000|Overall Study|Lost to Follow-up|10|||
124800656|NCT04010539|448901751|FG001|Overall Study|Lost to Follow-up|14|||
124800657|NCT04010539|448901750|FG000|Overall Study|Adverse Event|3|||
124800658|NCT04010539|448901751|FG001|Overall Study|Adverse Event|0|||
125296645|NCT02905006|450713831|FG004|Overall Study|Screening exclusion criteria met|0|||
124800659|NCT04010539|448901750|FG000|Overall Study|Participant Did Not Receive IP|0|||
124800660|NCT04010539|448901751|FG001|Overall Study|Participant Did Not Receive IP|1|||
124800661|NCT04010539|448901750|FG000|Overall Study|Protocol Deviation|0|||
124800662|NCT04010539|448901751|FG001|Overall Study|Protocol Deviation|1|||
124800663|NCT04010539|448901750|FG000|Overall Study|Randomized in Error/ Mistake|2|||
124800664|NCT04010539|448901751|FG001|Overall Study|Randomized in Error/ Mistake|0|||
124800665|NCT04010539|448901750|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
124800666|NCT04010539|448901751|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
124800667|NCT00249288|448901752|FG000|Overall Study|Lost to Follow-up|3|||
124800668|NCT00249288|448901753|FG001|Overall Study|Lost to Follow-up|3|||
124800669|NCT00249288|448901752|FG000|Overall Study|Withdrawal by Subject|2|||
124800670|NCT00249288|448901753|FG001|Overall Study|Withdrawal by Subject|2|||
124800671|NCT03059446|448901754|FG000|Overall Study|Adverse Event|11|||
125296646|NCT02905006|450713832|FG005|Overall Study|Screening exclusion criteria met|0|||
124800672|NCT03059446|448901754|FG000|Overall Study|Withdrawal of Consent|16|||
124800673|NCT03059446|448901754|FG000|Overall Study|Lost to Follow-up|3|||
124800674|NCT03059446|448901754|FG000|Overall Study|Protocol Violation|1|||
124800675|NCT03059446|448901754|FG000|Overall Study|Study Terminated by Sponsor|131|||
124800676|NCT03059446|448901754|FG000|Overall Study|Reason not Specified|5|||
124800677|NCT05298306|448901761|FG000|Overall Study|Physician Decision|0|||
124800678|NCT05298306|448901762|FG001|Overall Study|Physician Decision|0|||
124800679|NCT05298306|448901763|FG002|Overall Study|Physician Decision|0|||
124800680|NCT05298306|448901764|FG003|Overall Study|Physician Decision|1|||
124800681|NCT05298306|448901765|FG004|Overall Study|Physician Decision|0|||
125296647|NCT02905006|450713827|FG000|Overall Study|Lab withdrawal criterion met|0|||
125296648|NCT02905006|450713828|FG001|Overall Study|Lab withdrawal criterion met|1|||
125296649|NCT02905006|450713829|FG002|Overall Study|Lab withdrawal criterion met|2|||
125296650|NCT02905006|450713830|FG003|Overall Study|Lab withdrawal criterion met|2|||
125296651|NCT02905006|450713831|FG004|Overall Study|Lab withdrawal criterion met|2|||
125296652|NCT02905006|450713832|FG005|Overall Study|Lab withdrawal criterion met|1|||
125296653|NCT02905006|450713827|FG000|Overall Study|Positive for Tuberculosis|0|||
125296654|NCT02905006|450713828|FG001|Overall Study|Positive for Tuberculosis|1|||
125296655|NCT02905006|450713829|FG002|Overall Study|Positive for Tuberculosis|0|||
125296656|NCT02905006|450713830|FG003|Overall Study|Positive for Tuberculosis|0|||
125296657|NCT02905006|450713831|FG004|Overall Study|Positive for Tuberculosis|0|||
125296658|NCT02905006|450713832|FG005|Overall Study|Positive for Tuberculosis|0|||
125296659|NCT02905006|450713827|FG000|Overall Study|Subject positive for Hep B|0|||
125296660|NCT02905006|450713828|FG001|Overall Study|Subject positive for Hep B|0|||
125296661|NCT02905006|450713829|FG002|Overall Study|Subject positive for Hep B|1|||
125296662|NCT02905006|450713830|FG003|Overall Study|Subject positive for Hep B|0|||
125296663|NCT02905006|450713831|FG004|Overall Study|Subject positive for Hep B|0|||
125296664|NCT02905006|450713832|FG005|Overall Study|Subject positive for Hep B|0|||
125296665|NCT02905006|450713827|FG000|Overall Study|Patient moved abroad|0|||
125296666|NCT02905006|450713828|FG001|Overall Study|Patient moved abroad|0|||
125296667|NCT02905006|450713829|FG002|Overall Study|Patient moved abroad|0|||
125296668|NCT02905006|450713830|FG003|Overall Study|Patient moved abroad|1|||
125296669|NCT02905006|450713831|FG004|Overall Study|Patient moved abroad|0|||
125296670|NCT02905006|450713832|FG005|Overall Study|Patient moved abroad|0|||
125296671|NCT02905006|450713827|FG000|Overall Study|Patient randomized by mistake|0|||
125296672|NCT02905006|450713828|FG001|Overall Study|Patient randomized by mistake|0|||
125296673|NCT02905006|450713829|FG002|Overall Study|Patient randomized by mistake|0|||
125296674|NCT02905006|450713830|FG003|Overall Study|Patient randomized by mistake|0|||
125296675|NCT02905006|450713831|FG004|Overall Study|Patient randomized by mistake|0|||
125296676|NCT02905006|450713832|FG005|Overall Study|Patient randomized by mistake|1|||
125296677|NCT04201093|450713837|FG000|Overall Study|Adverse Event|6|||
125296678|NCT04201093|450713838|FG001|Overall Study|Adverse Event|29|||
125296679|NCT04201093|450713839|FG002|Overall Study|Adverse Event|35|||
125296680|NCT04201093|450713837|FG000|Overall Study|Death|2|||
125296681|NCT04201093|450713838|FG001|Overall Study|Death|1|||
125296682|NCT04201093|450713839|FG002|Overall Study|Death|0|||
125296683|NCT04201093|450713837|FG000|Overall Study|Lack of Efficacy|5|||
125296684|NCT04201093|450713838|FG001|Overall Study|Lack of Efficacy|1|||
125296685|NCT04201093|450713839|FG002|Overall Study|Lack of Efficacy|2|||
124800682|NCT05298306|448901766|FG005|Overall Study|Physician Decision|0|||
124800683|NCT03538431|448901770|FG000|Overall Study|Physician Decision|0|||
124800684|NCT03538431|448901771|FG001|Overall Study|Physician Decision|1|||
124800685|NCT03538431|448901770|FG000|Overall Study|Withdrawal by Subject|1|||
124800686|NCT03538431|448901771|FG001|Overall Study|Withdrawal by Subject|0|||
124800687|NCT00620464|448901772|FG000|Overall Study|Adverse Event|15|||
124800688|NCT00620464|448901773|FG001|Overall Study|Adverse Event|17|||
124800689|NCT00620464|448901772|FG000|Overall Study|Lost to Follow-up|1|||
124800690|NCT00620464|448901773|FG001|Overall Study|Lost to Follow-up|1|||
124800691|NCT00620464|448901772|FG000|Overall Study|Planning Pregnancy|1|||
124800692|NCT00620464|448901773|FG001|Overall Study|Planning Pregnancy|4|||
124800693|NCT00620464|448901772|FG000|Overall Study|Personal|2|||
124800694|NCT00620464|448901773|FG001|Overall Study|Personal|2|||
124800695|NCT00620464|448901772|FG000|Overall Study|Used prohibited medication|1|||
124800696|NCT00620464|448901773|FG001|Overall Study|Used prohibited medication|0|||
124800697|NCT00986479|448901776|FG000|Period 1|Improved mood|1|||
124800698|NCT00986479|448901777|FG001|Period 1|Improved mood|0|||
124800699|NCT00986479|448901776|FG000|Period 1|Administrative reasons|1|||
124800700|NCT00986479|448901777|FG001|Period 1|Administrative reasons|0|||
124800701|NCT00771316|448901782|FG000|Overall Study|Adverse Event|0|||
124800702|NCT00771316|448901783|FG001|Overall Study|Adverse Event|1|||
124800703|NCT00771316|448901782|FG000|Overall Study|Patient withdrew consent|1|||
125296686|NCT04201093|450713837|FG000|Overall Study|Lost to Follow-up|0|||
125296687|NCT04201093|450713838|FG001|Overall Study|Lost to Follow-up|0|||
125296688|NCT04201093|450713839|FG002|Overall Study|Lost to Follow-up|1|||
125296689|NCT04201093|450713837|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
125296690|NCT04201093|450713838|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
125296691|NCT04201093|450713839|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
124800704|NCT00771316|448901783|FG001|Overall Study|Patient withdrew consent|0|||
124800705|NCT00771316|448901782|FG000|Overall Study|Discontinued due to early termination|1|||
124800706|NCT00771316|448901783|FG001|Overall Study|Discontinued due to early termination|0|||
124800707|NCT02027376|448901784|FG000|Overall Study|Death|1|||
124800708|NCT02027376|448901785|FG001|Overall Study|Death|0|||
124800709|NCT02027376|448901786|FG002|Overall Study|Death|0|||
124800710|NCT00880165|448901795|FG000|Overall Study|Withdrawal by Subject|27|||
124800711|NCT00880165|448901796|FG001|Overall Study|Withdrawal by Subject|23|||
124800712|NCT00880165|448901795|FG000|Overall Study|Not diagnosed with OSA|14|||
124800713|NCT00880165|448901796|FG001|Overall Study|Not diagnosed with OSA|8|||
124800714|NCT00880165|448901795|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
124800715|NCT00880165|448901796|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
124800716|NCT00880165|448901795|FG000|Overall Study|Lost to follow|9|||
124800717|NCT00880165|448901796|FG001|Overall Study|Lost to follow|15|||
124800718|NCT00667602|448901797|FG000|Overall Study|Withdrawal by Subject|4|||
124800719|NCT00667602|448901798|FG001|Overall Study|Withdrawal by Subject|9|||
124800720|NCT00667602|448901799|FG002|Overall Study|Withdrawal by Subject|10|||
124800721|NCT00667602|448901797|FG000|Overall Study|Lost to Follow-up|4|||
124800722|NCT00667602|448901798|FG001|Overall Study|Lost to Follow-up|5|||
124800723|NCT00667602|448901799|FG002|Overall Study|Lost to Follow-up|6|||
124800724|NCT00667602|448901797|FG000|Overall Study|Administrative reason|0|||
124800725|NCT00667602|448901798|FG001|Overall Study|Administrative reason|0|||
124800726|NCT00667602|448901799|FG002|Overall Study|Administrative reason|2|||
124800727|NCT00667602|448901797|FG000|Overall Study|Protocol Violation|0|||
124800728|NCT00667602|448901798|FG001|Overall Study|Protocol Violation|1|||
124800729|NCT00667602|448901799|FG002|Overall Study|Protocol Violation|0|||
124800730|NCT00644228|448901804|FG000|Randomization & Eligibility|Ineligible|31|||
124800731|NCT00644228|448901805|FG001|Randomization & Eligibility|Ineligible|21|||
124800732|NCT00644228|448901804|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
124800733|NCT00644228|448901805|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
124800734|NCT00644228|448901804|FG000|Randomization & Eligibility|Invalid Consent|0|||
124800735|NCT00644228|448901805|FG001|Randomization & Eligibility|Invalid Consent|1|||
124800736|NCT00644228|448901804|FG000|Induction Therapy|Adverse Event|22|||
124800737|NCT00644228|448901805|FG001|Induction Therapy|Adverse Event|55|||
124800738|NCT00644228|448901804|FG000|Induction Therapy|Withdrawal by Subject|10|||
124800739|NCT00644228|448901805|FG001|Induction Therapy|Withdrawal by Subject|3|||
124800740|NCT00644228|448901804|FG000|Induction Therapy|Progression/Relapse|24|||
124800741|NCT00644228|448901805|FG001|Induction Therapy|Progression/Relapse|12|||
124800742|NCT00644228|448901804|FG000|Induction Therapy|Death|3|||
124800743|NCT00644228|448901805|FG001|Induction Therapy|Death|7|||
124800744|NCT00644228|448901804|FG000|Induction Therapy|Not Protocol-Specified|24|||
124800745|NCT00644228|448901805|FG001|Induction Therapy|Not Protocol-Specified|28|||
124800746|NCT00644228|448901804|FG000|Maintenance|Adverse Event|27|||
124800747|NCT00644228|448901805|FG001|Maintenance|Adverse Event|31|||
124800748|NCT00644228|448901804|FG000|Maintenance|Withdrawal by Subject|6|||
124800749|NCT00644228|448901805|FG001|Maintenance|Withdrawal by Subject|4|||
124800750|NCT00644228|448901804|FG000|Maintenance|Progression/Relapse|67|||
124800751|NCT00644228|448901805|FG001|Maintenance|Progression/Relapse|42|||
124800752|NCT00644228|448901804|FG000|Maintenance|Death|3|||
124800753|NCT00644228|448901805|FG001|Maintenance|Death|3|||
124800754|NCT00644228|448901804|FG000|Maintenance|Not Protocol-Specified|14|||
124800755|NCT00644228|448901805|FG001|Maintenance|Not Protocol-Specified|15|||
124800756|NCT00644228|448901804|FG000|Maintenance|On Treatment|26|||
124800757|NCT00644228|448901805|FG001|Maintenance|On Treatment|40|||
124800758|NCT00760084|448901806|FG000|Overall Study|Physician Decision|5|||
124800759|NCT00760084|448901806|FG000|Overall Study|Withdrawal by Subject|2|||
124800760|NCT00760084|448901806|FG000|Overall Study|Progressive Disease|3|||
124800761|NCT00973349|448901807|FG000|Overall Study|Adverse Event|0|||
124800762|NCT00973349|448901808|FG001|Overall Study|Adverse Event|0|||
124800763|NCT00973349|448901809|FG002|Overall Study|Adverse Event|0|||
124800764|NCT00973349|448901810|FG003|Overall Study|Adverse Event|0|||
124800765|NCT00973349|448901811|FG004|Overall Study|Adverse Event|1|||
124800766|NCT00973349|448901812|FG005|Overall Study|Adverse Event|0|||
125296692|NCT04201093|450713837|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
125296693|NCT04201093|450713838|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
124800767|NCT00973349|448901813|FG006|Overall Study|Adverse Event|0|||
124800768|NCT00973349|448901814|FG007|Overall Study|Adverse Event|0|||
124800769|NCT00973349|448901815|FG008|Overall Study|Adverse Event|1|||
124800770|NCT00973349|448901816|FG009|Overall Study|Adverse Event|0|||
124800771|NCT00973349|448901817|FG010|Overall Study|Adverse Event|0|||
124800772|NCT00973349|448901818|FG011|Overall Study|Adverse Event|0|||
124800773|NCT00973349|448901819|FG012|Overall Study|Adverse Event|0|||
124800774|NCT00973349|448901820|FG013|Overall Study|Adverse Event|0|||
124800775|NCT00973349|448901821|FG014|Overall Study|Adverse Event|1|||
124800776|NCT00973349|448901822|FG015|Overall Study|Adverse Event|0|||
124800777|NCT00973349|448901807|FG000|Overall Study|Withdrawal by Subject|1|||
124800778|NCT00973349|448901808|FG001|Overall Study|Withdrawal by Subject|2|||
124800779|NCT00973349|448901809|FG002|Overall Study|Withdrawal by Subject|2|||
124800780|NCT00973349|448901810|FG003|Overall Study|Withdrawal by Subject|3|||
124800781|NCT00973349|448901811|FG004|Overall Study|Withdrawal by Subject|2|||
125296694|NCT04201093|450713839|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
125296695|NCT04201093|450713837|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
125296696|NCT04201093|450713838|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
125296697|NCT04201093|450713839|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
125296698|NCT04201093|450713837|FG000|Overall Study|Physician Decision|1|||
125296699|NCT04201093|450713838|FG001|Overall Study|Physician Decision|0|||
125296700|NCT04201093|450713839|FG002|Overall Study|Physician Decision|0|||
124800782|NCT00973349|448901812|FG005|Overall Study|Withdrawal by Subject|0|||
124800783|NCT00973349|448901813|FG006|Overall Study|Withdrawal by Subject|2|||
124800784|NCT00973349|448901814|FG007|Overall Study|Withdrawal by Subject|2|||
124800785|NCT00973349|448901815|FG008|Overall Study|Withdrawal by Subject|0|||
124800786|NCT00973349|448901816|FG009|Overall Study|Withdrawal by Subject|2|||
124800787|NCT00973349|448901817|FG010|Overall Study|Withdrawal by Subject|0|||
124800788|NCT00973349|448901818|FG011|Overall Study|Withdrawal by Subject|1|||
124800789|NCT00973349|448901819|FG012|Overall Study|Withdrawal by Subject|0|||
124800790|NCT00973349|448901820|FG013|Overall Study|Withdrawal by Subject|0|||
124800791|NCT00973349|448901821|FG014|Overall Study|Withdrawal by Subject|0|||
124800792|NCT00973349|448901822|FG015|Overall Study|Withdrawal by Subject|0|||
125296701|NCT04201093|450713837|FG000|Overall Study|Protocol Deviation|1|||
125296702|NCT04201093|450713838|FG001|Overall Study|Protocol Deviation|0|||
125296703|NCT04201093|450713839|FG002|Overall Study|Protocol Deviation|0|||
125296704|NCT04201093|450713837|FG000|Overall Study|Site Terminated by Sponsor|5|||
125296705|NCT04201093|450713838|FG001|Overall Study|Site Terminated by Sponsor|3|||
125296706|NCT04201093|450713839|FG002|Overall Study|Site Terminated by Sponsor|1|||
125296707|NCT04201093|450713837|FG000|Overall Study|Withdrawal by Subject|7|||
125296708|NCT04201093|450713838|FG001|Overall Study|Withdrawal by Subject|8|||
125296709|NCT04201093|450713839|FG002|Overall Study|Withdrawal by Subject|15|||
125296710|NCT04201093|450713837|FG000|Overall Study|Other|0|||
125296711|NCT04201093|450713838|FG001|Overall Study|Other|1|||
125296712|NCT04201093|450713839|FG002|Overall Study|Other|2|||
125296713|NCT00881504|450713840|FG000|Overall Study|Withdrawal by Subject|1|||
125296714|NCT00007020|450713841|FG000|Overall Study|Death|16|||
125296715|NCT00007020|450713841|FG000|Overall Study|Lost to Follow-up|13|||
125296716|NCT00007020|450713841|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
125296717|NCT00007020|450713841|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
125296718|NCT00007020|450713841|FG000|Overall Study|Pt cared for by outside physician|4|||
125296719|NCT00007020|450713841|FG000|Overall Study|No evidence of treatment|6|||
125296720|NCT01276223|450713842|FG000|Overall Study|Adverse Event|7|||
125296721|NCT01276223|450713843|FG001|Overall Study|Adverse Event|4|||
125296722|NCT01276223|450713844|FG002|Overall Study|Adverse Event|1|||
125296723|NCT01276223|450713842|FG000|Overall Study|Lost to Follow-up|0|||
125296724|NCT01276223|450713843|FG001|Overall Study|Lost to Follow-up|0|||
125296725|NCT01276223|450713844|FG002|Overall Study|Lost to Follow-up|1|||
125296726|NCT01276223|450713842|FG000|Overall Study|Other|0|||
125296727|NCT01276223|450713843|FG001|Overall Study|Other|0|||
125296728|NCT01276223|450713844|FG002|Overall Study|Other|1|||
125296729|NCT01276223|450713842|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
125296730|NCT01276223|450713843|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
125296731|NCT01276223|450713844|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
125296732|NCT01276223|450713842|FG000|Overall Study|Protocol Violation|1|||
125296733|NCT01276223|450713843|FG001|Overall Study|Protocol Violation|0|||
125296734|NCT01276223|450713844|FG002|Overall Study|Protocol Violation|0|||
125296735|NCT02455076|450713846|FG000|Inpatient|Withdrawal by Subject|1|||
125296736|NCT02455076|450713847|FG001|Inpatient|Withdrawal by Subject|0|||
125296737|NCT02455076|450713848|FG002|Inpatient|Withdrawal by Subject|0|||
125296738|NCT02455076|450713849|FG003|Inpatient|Withdrawal by Subject|0|||
125296739|NCT02455076|450713850|FG004|Inpatient|Withdrawal by Subject|0|||
125296740|NCT02455076|450713846|FG000|Inpatient|Discharged <24 h after admission|0|||
125296741|NCT02455076|450713847|FG001|Inpatient|Discharged <24 h after admission|1|||
125296742|NCT02455076|450713848|FG002|Inpatient|Discharged <24 h after admission|0|||
125296743|NCT02455076|450713849|FG003|Inpatient|Discharged <24 h after admission|0|||
125296744|NCT02455076|450713850|FG004|Inpatient|Discharged <24 h after admission|0|||
125296745|NCT02455076|450713846|FG000|Inpatient|Adverse Event|3|||
125296746|NCT02455076|450713847|FG001|Inpatient|Adverse Event|0|||
125296747|NCT02455076|450713848|FG002|Inpatient|Adverse Event|0|||
125296748|NCT02455076|450713849|FG003|Inpatient|Adverse Event|0|||
125296749|NCT02455076|450713850|FG004|Inpatient|Adverse Event|0|||
125296750|NCT02455076|450713846|FG000|Outpatient|Adverse Event|0|||
125296751|NCT02455076|450713847|FG001|Outpatient|Adverse Event|0|||
125296752|NCT02455076|450713848|FG002|Outpatient|Adverse Event|0|||
125296753|NCT02455076|450713849|FG003|Outpatient|Adverse Event|5|||
125296754|NCT02455076|450713850|FG004|Outpatient|Adverse Event|0|||
125296755|NCT02455076|450713846|FG000|Outpatient|Lost to Follow-up|0|||
125296756|NCT02455076|450713847|FG001|Outpatient|Lost to Follow-up|0|||
125296757|NCT02455076|450713848|FG002|Outpatient|Lost to Follow-up|0|||
124800793|NCT00973349|448901807|FG000|Overall Study|Lost to Follow-up|3|||
124800794|NCT00973349|448901808|FG001|Overall Study|Lost to Follow-up|1|||
124800795|NCT00973349|448901809|FG002|Overall Study|Lost to Follow-up|2|||
124800796|NCT00973349|448901810|FG003|Overall Study|Lost to Follow-up|2|||
125296758|NCT02455076|450713849|FG003|Outpatient|Lost to Follow-up|1|||
125296759|NCT02455076|450713850|FG004|Outpatient|Lost to Follow-up|12|||
125296760|NCT04051827|450713851|FG000|Overall Study|Death|1|||
124800797|NCT00973349|448901811|FG004|Overall Study|Lost to Follow-up|1|||
125296761|NCT04051827|450713851|FG000|Overall Study|Withdrawal by Subject|4|||
125296762|NCT04051827|450713851|FG000|Overall Study|Progressive disease|16|||
125296763|NCT04051827|450713851|FG000|Overall Study|Physician Decision|1|||
125296764|NCT04051827|450713851|FG000|Overall Study|Other|4|||
125296765|NCT03743064|450713856|FG000|Overall Study|Adverse Event|7|||
125296766|NCT03743064|450713857|FG001|Overall Study|Adverse Event|9|||
125296767|NCT03743064|450713856|FG000|Overall Study|Death|25|||
125296768|NCT03743064|450713857|FG001|Overall Study|Death|28|||
125296769|NCT03743064|450713856|FG000|Overall Study|Lost to Follow-up|3|||
125296770|NCT03743064|450713857|FG001|Overall Study|Lost to Follow-up|6|||
125296771|NCT03743064|450713856|FG000|Overall Study|Withdrawal by Subject|28|||
125296772|NCT03743064|450713857|FG001|Overall Study|Withdrawal by Subject|25|||
125296773|NCT03743064|450713856|FG000|Overall Study|Physician Decision|2|||
125296774|NCT03743064|450713857|FG001|Overall Study|Physician Decision|4|||
125296775|NCT03743064|450713856|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
125296776|NCT03743064|450713857|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
125296777|NCT02771626|450713860|FG000|Overall Study|Adverse Event|1|||
125296778|NCT02771626|450713861|FG001|Overall Study|Adverse Event|5|||
125296779|NCT02771626|450713862|FG002|Overall Study|Adverse Event|3|||
125296780|NCT02771626|450713863|FG003|Overall Study|Adverse Event|0|||
125296781|NCT02771626|450713864|FG004|Overall Study|Adverse Event|1|||
125296782|NCT02771626|450713865|FG005|Overall Study|Adverse Event|1|||
125296783|NCT02771626|450713860|FG000|Overall Study|Radiologic Disease Progression|6|||
125296784|NCT02771626|450713861|FG001|Overall Study|Radiologic Disease Progression|13|||
125296785|NCT02771626|450713862|FG002|Overall Study|Radiologic Disease Progression|10|||
125296786|NCT02771626|450713863|FG003|Overall Study|Radiologic Disease Progression|7|||
125296787|NCT02771626|450713864|FG004|Overall Study|Radiologic Disease Progression|28|||
125296788|NCT02771626|450713865|FG005|Overall Study|Radiologic Disease Progression|15|||
125296789|NCT02771626|450713860|FG000|Overall Study|Symptomatic Deterioration|0|||
125296790|NCT02771626|450713861|FG001|Overall Study|Symptomatic Deterioration|4|||
125296791|NCT02771626|450713862|FG002|Overall Study|Symptomatic Deterioration|2|||
125296792|NCT02771626|450713863|FG003|Overall Study|Symptomatic Deterioration|0|||
125296793|NCT02771626|450713864|FG004|Overall Study|Symptomatic Deterioration|5|||
125296794|NCT02771626|450713865|FG005|Overall Study|Symptomatic Deterioration|2|||
125296795|NCT02771626|450713860|FG000|Overall Study|Participant Request|0|||
125296796|NCT02771626|450713861|FG001|Overall Study|Participant Request|1|||
125296797|NCT02771626|450713862|FG002|Overall Study|Participant Request|0|||
125296798|NCT02771626|450713863|FG003|Overall Study|Participant Request|2|||
125296799|NCT02771626|450713864|FG004|Overall Study|Participant Request|0|||
125296800|NCT02771626|450713865|FG005|Overall Study|Participant Request|1|||
125296801|NCT02771626|450713860|FG000|Overall Study|Investigator Decision|0|||
125296802|NCT02771626|450713861|FG001|Overall Study|Investigator Decision|1|||
125296803|NCT02771626|450713862|FG002|Overall Study|Investigator Decision|0|||
125296804|NCT02771626|450713863|FG003|Overall Study|Investigator Decision|0|||
125296805|NCT02771626|450713864|FG004|Overall Study|Investigator Decision|1|||
125296806|NCT02771626|450713865|FG005|Overall Study|Investigator Decision|0|||
125296807|NCT02771626|450713860|FG000|Overall Study|Study Termination by Sponsor|0|||
125296808|NCT02771626|450713861|FG001|Overall Study|Study Termination by Sponsor|2|||
125296809|NCT02771626|450713862|FG002|Overall Study|Study Termination by Sponsor|1|||
125296810|NCT02771626|450713863|FG003|Overall Study|Study Termination by Sponsor|0|||
125296811|NCT02771626|450713864|FG004|Overall Study|Study Termination by Sponsor|1|||
125296812|NCT02771626|450713865|FG005|Overall Study|Study Termination by Sponsor|0|||
125296813|NCT02771626|450713860|FG000|Overall Study|Informed Consent Withdrawn|0|||
125296814|NCT02771626|450713861|FG001|Overall Study|Informed Consent Withdrawn|0|||
125296815|NCT02771626|450713862|FG002|Overall Study|Informed Consent Withdrawn|1|||
125296816|NCT02771626|450713863|FG003|Overall Study|Informed Consent Withdrawn|0|||
125296817|NCT02771626|450713864|FG004|Overall Study|Informed Consent Withdrawn|1|||
125296818|NCT02771626|450713865|FG005|Overall Study|Informed Consent Withdrawn|1|||
125296819|NCT02771626|450713860|FG000|Overall Study|Other, Not Specified|1|||
125296820|NCT02771626|450713861|FG001|Overall Study|Other, Not Specified|0|||
125296821|NCT02771626|450713862|FG002|Overall Study|Other, Not Specified|0|||
125296822|NCT02771626|450713863|FG003|Overall Study|Other, Not Specified|0|||
125296823|NCT02771626|450713864|FG004|Overall Study|Other, Not Specified|0|||
125296824|NCT02771626|450713865|FG005|Overall Study|Other, Not Specified|1|||
125296825|NCT00635089|450713867|FG000|Overall Study|Adverse Event|7|||
125296826|NCT00635089|450713867|FG000|Overall Study|Lack of Efficacy|28|||
125296827|NCT00635089|450713867|FG000|Overall Study|Protocol Deviation|4|||
125296828|NCT00635089|450713867|FG000|Overall Study|Lost to Follow-up|8|||
125296829|NCT00635089|450713867|FG000|Overall Study|Other|31|||
125296830|NCT00444067|450713868|FG000|Overall Study|Lost to Follow-up|0|||
125296831|NCT00444067|450713869|FG001|Overall Study|Lost to Follow-up|1|||
125296832|NCT01300455|450713870|FG000|Washout|Withdrawal by Subject|1|||
125296833|NCT01300455|450713871|FG001|Washout|Withdrawal by Subject|0|||
125296834|NCT02528357|450713872|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296835|NCT02528357|450713873|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
125296836|NCT02528357|450713874|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296837|NCT02528357|450713875|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296838|NCT02528357|450713876|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296839|NCT02528357|450713877|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296840|NCT02528357|450713878|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296841|NCT02528357|450713879|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296842|NCT02528357|450713880|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296843|NCT02528357|450713881|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296844|NCT02528357|450713882|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296845|NCT02528357|450713883|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296846|NCT02528357|450713884|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296847|NCT02528357|450713885|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296848|NCT02528357|450713886|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296849|NCT02528357|450713887|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296850|NCT02528357|450713888|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296851|NCT02528357|450713889|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296852|NCT02528357|450713890|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296853|NCT02528357|450713872|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296854|NCT02528357|450713873|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296855|NCT02528357|450713874|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296856|NCT02528357|450713875|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
125296857|NCT02528357|450713876|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296858|NCT02528357|450713877|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
125296859|NCT02528357|450713878|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296860|NCT02528357|450713879|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
125296861|NCT02528357|450713880|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296862|NCT02528357|450713881|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296863|NCT02528357|450713882|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296864|NCT02528357|450713883|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296865|NCT02528357|450713884|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296866|NCT02528357|450713885|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296867|NCT02528357|450713886|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296868|NCT02528357|450713887|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296869|NCT02528357|450713888|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296870|NCT02528357|450713889|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296871|NCT02528357|450713890|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296872|NCT02528357|450713872|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296873|NCT02528357|450713873|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296874|NCT02528357|450713874|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
125296875|NCT02528357|450713875|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296876|NCT02528357|450713876|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
125296877|NCT02528357|450713877|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296878|NCT02528357|450713878|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
125296879|NCT02528357|450713879|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
125296880|NCT02528357|450713880|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296881|NCT02528357|450713881|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296882|NCT02528357|450713882|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296883|NCT02528357|450713883|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296884|NCT02528357|450713884|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296885|NCT02528357|450713885|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296886|NCT02528357|450713886|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296887|NCT02528357|450713887|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296888|NCT02528357|450713888|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296889|NCT02528357|450713889|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296890|NCT02528357|450713890|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296891|NCT02528357|450713872|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296892|NCT02528357|450713873|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296893|NCT02528357|450713874|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296894|NCT02528357|450713875|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296895|NCT02528357|450713876|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
125296896|NCT02528357|450713877|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296897|NCT02528357|450713878|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125303177|NCT03100058|450736661|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
125296898|NCT02528357|450713879|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296899|NCT02528357|450713880|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296900|NCT02528357|450713881|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296901|NCT02528357|450713882|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296902|NCT02528357|450713883|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296903|NCT02528357|450713884|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296904|NCT02528357|450713885|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296905|NCT02528357|450713886|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296906|NCT02528357|450713887|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296907|NCT02528357|450713888|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296908|NCT02528357|450713889|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296909|NCT02528357|450713890|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296910|NCT02528357|450713872|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296911|NCT02528357|450713873|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296912|NCT02528357|450713874|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296913|NCT02528357|450713875|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296914|NCT02528357|450713876|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296915|NCT02528357|450713877|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296916|NCT02528357|450713878|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296917|NCT02528357|450713879|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296918|NCT02528357|450713880|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296919|NCT02528357|450713881|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296920|NCT02528357|450713882|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296921|NCT02528357|450713883|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296922|NCT02528357|450713884|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296923|NCT02528357|450713885|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
125296924|NCT02528357|450713886|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
125296925|NCT02528357|450713887|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296926|NCT02528357|450713888|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296927|NCT02528357|450713889|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296928|NCT02528357|450713890|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296929|NCT02528357|450713872|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296930|NCT02528357|450713873|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296931|NCT02528357|450713874|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296932|NCT02528357|450713875|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296933|NCT02528357|450713876|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296934|NCT02528357|450713877|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296935|NCT02528357|450713878|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296936|NCT02528357|450713879|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296937|NCT02528357|450713880|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296938|NCT02528357|450713881|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296939|NCT02528357|450713882|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296940|NCT02528357|450713883|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296941|NCT02528357|450713884|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296942|NCT02528357|450713885|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
125296943|NCT02528357|450713886|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296944|NCT02528357|450713887|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296945|NCT02528357|450713888|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296946|NCT02528357|450713889|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296947|NCT02528357|450713890|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296948|NCT02528357|450713872|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296949|NCT02528357|450713873|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296950|NCT02528357|450713874|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296951|NCT02528357|450713875|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296952|NCT02528357|450713876|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296953|NCT02528357|450713877|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296954|NCT02528357|450713878|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296955|NCT02528357|450713879|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296956|NCT02528357|450713880|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296957|NCT02528357|450713881|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296958|NCT02528357|450713882|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
125296959|NCT02528357|450713883|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296960|NCT02528357|450713884|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
125296961|NCT02528357|450713885|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
125296962|NCT02528357|450713886|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
125296963|NCT02528357|450713887|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296964|NCT02528357|450713888|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296965|NCT02528357|450713889|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296966|NCT02528357|450713890|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296967|NCT02528357|450713872|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296968|NCT02528357|450713873|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296969|NCT02528357|450713874|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296970|NCT02528357|450713875|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296971|NCT02528357|450713876|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296972|NCT02528357|450713877|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296973|NCT02528357|450713878|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296974|NCT02528357|450713879|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296975|NCT02528357|450713880|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
125296976|NCT02528357|450713881|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
125296977|NCT02528357|450713882|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296978|NCT02528357|450713883|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
125296979|NCT02528357|450713884|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
125296980|NCT02528357|450713885|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
125296981|NCT02528357|450713886|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
125296982|NCT02528357|450713887|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296983|NCT02528357|450713888|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296984|NCT02528357|450713889|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296985|NCT02528357|450713890|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296986|NCT02528357|450713872|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296987|NCT02528357|450713873|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296988|NCT02528357|450713874|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296989|NCT02528357|450713875|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296990|NCT02528357|450713876|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296991|NCT02528357|450713877|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296992|NCT02528357|450713878|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296993|NCT02528357|450713879|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296994|NCT02528357|450713880|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296995|NCT02528357|450713881|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296996|NCT02528357|450713882|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296997|NCT02528357|450713883|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296998|NCT02528357|450713884|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296999|NCT02528357|450713885|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125297000|NCT02528357|450713886|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125297001|NCT02528357|450713887|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125297002|NCT02528357|450713888|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
125297003|NCT02528357|450713889|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125297004|NCT02528357|450713890|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125297005|NCT02528357|450713872|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297006|NCT02528357|450713873|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297007|NCT02528357|450713874|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297008|NCT02528357|450713875|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297009|NCT02528357|450713876|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297010|NCT02528357|450713877|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297011|NCT02528357|450713878|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297012|NCT02528357|450713879|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297013|NCT02528357|450713880|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297014|NCT02528357|450713881|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297015|NCT02528357|450713882|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297016|NCT02528357|450713883|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297017|NCT02528357|450713884|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297018|NCT02528357|450713885|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297019|NCT02528357|450713886|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297020|NCT02528357|450713887|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297021|NCT02528357|450713888|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
125297022|NCT02528357|450713889|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
125297023|NCT02528357|450713890|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
125297024|NCT02438813|450713896|FG000|Overall Study|Patient Decision|59|||
125297025|NCT02438813|450713896|FG000|Overall Study|Patient Lost to Follow-Up|137|||
125297026|NCT02438813|450713896|FG000|Overall Study|Study Ended by Sponsor|80|||
125297027|NCT02438813|450713896|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
125297028|NCT01927055|450713897|FG000|Open-label|Adverse Event|6|||
125297029|NCT01927055|450713898|FG001|Open-label|Adverse Event|0|||
125297030|NCT01927055|450713899|FG002|Open-label|Adverse Event|0|||
125297031|NCT01927055|450713897|FG000|Open-label|Withdrawal by Subject|1|||
125297032|NCT01927055|450713898|FG001|Open-label|Withdrawal by Subject|0|||
125297033|NCT01927055|450713899|FG002|Open-label|Withdrawal by Subject|0|||
125297034|NCT01927055|450713897|FG000|Open-label|Study Stopped|4|||
125297035|NCT01927055|450713898|FG001|Open-label|Study Stopped|0|||
125297036|NCT01927055|450713899|FG002|Open-label|Study Stopped|0|||
125297037|NCT01927055|450713897|FG000|Open-label|Supine Hypertension|4|||
125297038|NCT01927055|450713898|FG001|Open-label|Supine Hypertension|0|||
125297039|NCT01927055|450713899|FG002|Open-label|Supine Hypertension|0|||
125297040|NCT01927055|450713897|FG000|Open-label|Difficulty attending study visits|1|||
125297041|NCT01927055|450713898|FG001|Open-label|Difficulty attending study visits|0|||
125297042|NCT01927055|450713899|FG002|Open-label|Difficulty attending study visits|0|||
125297043|NCT01927055|450713897|FG000|Double-Blind|Adverse Event|0|||
125297044|NCT01927055|450713898|FG001|Double-Blind|Adverse Event|1|||
125297045|NCT01927055|450713899|FG002|Double-Blind|Adverse Event|1|||
125297046|NCT01927055|450713897|FG000|Double-Blind|Protocol Violation|0|||
125297047|NCT01927055|450713898|FG001|Double-Blind|Protocol Violation|0|||
125297048|NCT01927055|450713899|FG002|Double-Blind|Protocol Violation|1|||
125297049|NCT01927055|450713897|FG000|Double-Blind|Withdrawal by Subject|0|||
125297050|NCT01927055|450713898|FG001|Double-Blind|Withdrawal by Subject|2|||
125297051|NCT01927055|450713899|FG002|Double-Blind|Withdrawal by Subject|3|||
125297052|NCT01927055|450713897|FG000|Double-Blind|Study Stopped|0|||
125297053|NCT01927055|450713898|FG001|Double-Blind|Study Stopped|7|||
125297054|NCT01927055|450713899|FG002|Double-Blind|Study Stopped|7|||
125297055|NCT01927055|450713897|FG000|Double-Blind|Supine Hypertension|0|||
125297056|NCT01927055|450713898|FG001|Double-Blind|Supine Hypertension|0|||
125297057|NCT01927055|450713899|FG002|Double-Blind|Supine Hypertension|1|||
125297058|NCT01927055|450713897|FG000|Double-Blind|Extended Vacation|0|||
125297059|NCT01927055|450713898|FG001|Double-Blind|Extended Vacation|1|||
125297060|NCT01927055|450713899|FG002|Double-Blind|Extended Vacation|0|||
125297061|NCT00619489|450713902|FG000|Overall Study|Adverse Event|0|||
125297062|NCT00619489|450713903|FG001|Overall Study|Adverse Event|7|||
125297063|NCT00619489|450713902|FG000|Overall Study|Withdrawal by Subject|1|||
125297064|NCT00619489|450713903|FG001|Overall Study|Withdrawal by Subject|1|||
125297065|NCT00619489|450713902|FG000|Overall Study|Lack of Efficacy|0|||
125297066|NCT00619489|450713903|FG001|Overall Study|Lack of Efficacy|11|||
125297067|NCT00619489|450713902|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
125297068|NCT00619489|450713903|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
125297069|NCT02966015|450713904|FG000|Inclusion Visit|did not answer questionnaire|8|||
125297070|NCT02966015|450713905|FG001|Inclusion Visit|did not answer questionnaire|3|||
125297071|NCT01183468|450713914|FG000|Overall Study|Lost to Follow-up|2|||
125297072|NCT01183468|450713915|FG001|Overall Study|Lost to Follow-up|1|||
125297073|NCT01183468|450713916|FG002|Overall Study|Lost to Follow-up|0|||
125297074|NCT01183468|450713917|FG003|Overall Study|Lost to Follow-up|0|||
125297075|NCT01183468|450713914|FG000|Overall Study|Physician Decision|1|||
125297076|NCT01183468|450713915|FG001|Overall Study|Physician Decision|0|||
125297077|NCT01183468|450713916|FG002|Overall Study|Physician Decision|0|||
125297078|NCT01183468|450713917|FG003|Overall Study|Physician Decision|0|||
125297079|NCT01183468|450713914|FG000|Overall Study|Withdrawal by Subject|0|||
125297080|NCT01183468|450713915|FG001|Overall Study|Withdrawal by Subject|1|||
125297081|NCT01183468|450713916|FG002|Overall Study|Withdrawal by Subject|0|||
125297082|NCT01183468|450713917|FG003|Overall Study|Withdrawal by Subject|0|||
125297083|NCT02228096|450713926|FG000|Overall Study|Study terminated by Sponsor|24|||
125297084|NCT02228096|450713926|FG000|Overall Study|Lack of Efficacy|18|||
125297085|NCT02228096|450713926|FG000|Overall Study|Death|12|||
125297086|NCT02228096|450713926|FG000|Overall Study|Physician Decision|3|||
125297087|NCT02228096|450713926|FG000|Overall Study|Subject/guardian decision|2|||
125297088|NCT02228096|450713926|FG000|Overall Study|New therapy for study indication|1|||
125297089|NCT02228096|450713926|FG000|Overall Study|Enrolled, not infused|11|||
125297090|NCT00558272|450713927|FG000|Overall Study|Adverse Event|10|||
125297091|NCT00558272|450713928|FG001|Overall Study|Adverse Event|0|||
125297092|NCT00558272|450713927|FG000|Overall Study|Death|1|||
125297093|NCT00558272|450713928|FG001|Overall Study|Death|0|||
125297094|NCT00558272|450713927|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
125297095|NCT00558272|450713928|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
125297096|NCT00558272|450713927|FG000|Overall Study|AZ study team decision|0|||
125297097|NCT00558272|450713928|FG001|Overall Study|AZ study team decision|1|||
125297098|NCT00558272|450713927|FG000|Overall Study|Incorrectly enrolled|1|||
125297099|NCT00558272|450713928|FG001|Overall Study|Incorrectly enrolled|0|||
125297100|NCT00558272|450713927|FG000|Overall Study|Withdrawal by Subject|0|||
125297101|NCT00558272|450713928|FG001|Overall Study|Withdrawal by Subject|1|||
125297102|NCT00454649|450713929|FG000|Overall Study|Lack of Efficacy|2|||
125297103|NCT00454649|450713930|FG001|Overall Study|Lack of Efficacy|2|||
125297104|NCT00454649|450713931|FG002|Overall Study|Lack of Efficacy|10|||
125297105|NCT00454649|450713932|FG003|Overall Study|Lack of Efficacy|3|||
125297106|NCT00454649|450713933|FG004|Overall Study|Lack of Efficacy|0|||
125297107|NCT00454649|450713934|FG005|Overall Study|Lack of Efficacy|4|||
125297108|NCT00454649|450713935|FG006|Overall Study|Lack of Efficacy|5|||
125297109|NCT00454649|450713936|FG007|Overall Study|Lack of Efficacy|13|||
125297110|NCT00454649|450713937|FG008|Overall Study|Lack of Efficacy|10|||
125297111|NCT00454649|450713938|FG009|Overall Study|Lack of Efficacy|2|||
125297112|NCT00454649|450713929|FG000|Overall Study|Adverse Event|0|||
125297113|NCT00454649|450713930|FG001|Overall Study|Adverse Event|1|||
125297114|NCT00454649|450713931|FG002|Overall Study|Adverse Event|3|||
125297115|NCT00454649|450713932|FG003|Overall Study|Adverse Event|0|||
125297116|NCT00454649|450713933|FG004|Overall Study|Adverse Event|1|||
125297117|NCT00454649|450713934|FG005|Overall Study|Adverse Event|2|||
125297118|NCT00454649|450713935|FG006|Overall Study|Adverse Event|3|||
125297119|NCT00454649|450713936|FG007|Overall Study|Adverse Event|4|||
125297120|NCT00454649|450713937|FG008|Overall Study|Adverse Event|6|||
125297121|NCT00454649|450713938|FG009|Overall Study|Adverse Event|2|||
125297122|NCT00454649|450713929|FG000|Overall Study|Lost to Follow-up|0|||
125297123|NCT00454649|450713930|FG001|Overall Study|Lost to Follow-up|0|||
125297124|NCT00454649|450713931|FG002|Overall Study|Lost to Follow-up|1|||
125297125|NCT00454649|450713932|FG003|Overall Study|Lost to Follow-up|0|||
125297126|NCT00454649|450713933|FG004|Overall Study|Lost to Follow-up|0|||
125297127|NCT00454649|450713934|FG005|Overall Study|Lost to Follow-up|0|||
125297128|NCT00454649|450713935|FG006|Overall Study|Lost to Follow-up|1|||
125297129|NCT00454649|450713936|FG007|Overall Study|Lost to Follow-up|0|||
125297130|NCT00454649|450713937|FG008|Overall Study|Lost to Follow-up|0|||
125297131|NCT00454649|450713938|FG009|Overall Study|Lost to Follow-up|0|||
125297132|NCT00454649|450713929|FG000|Overall Study|Other|1|||
125297133|NCT00454649|450713930|FG001|Overall Study|Other|1|||
125297134|NCT00454649|450713931|FG002|Overall Study|Other|5|||
125297135|NCT00454649|450713932|FG003|Overall Study|Other|3|||
125297136|NCT00454649|450713933|FG004|Overall Study|Other|0|||
125297137|NCT00454649|450713934|FG005|Overall Study|Other|0|||
125297138|NCT00454649|450713935|FG006|Overall Study|Other|0|||
125297139|NCT00454649|450713936|FG007|Overall Study|Other|0|||
125297140|NCT00454649|450713937|FG008|Overall Study|Other|3|||
125297141|NCT00454649|450713938|FG009|Overall Study|Other|1|||
125297142|NCT00454649|450713929|FG000|Overall Study|Withdrawal by Subject|0|||
125297143|NCT00454649|450713930|FG001|Overall Study|Withdrawal by Subject|0|||
125297144|NCT00454649|450713931|FG002|Overall Study|Withdrawal by Subject|0|||
125297145|NCT00454649|450713932|FG003|Overall Study|Withdrawal by Subject|0|||
125297146|NCT00454649|450713933|FG004|Overall Study|Withdrawal by Subject|0|||
125297147|NCT00454649|450713934|FG005|Overall Study|Withdrawal by Subject|1|||
125297148|NCT00454649|450713935|FG006|Overall Study|Withdrawal by Subject|0|||
125297149|NCT00454649|450713936|FG007|Overall Study|Withdrawal by Subject|2|||
125297150|NCT00454649|450713937|FG008|Overall Study|Withdrawal by Subject|1|||
125297151|NCT00454649|450713938|FG009|Overall Study|Withdrawal by Subject|0|||
125297152|NCT02745535|450713939|FG000|Overall Study|Death|1|||
125297153|NCT02745535|450713939|FG000|Overall Study|Adverse Event|3|||
125297154|NCT02745535|450713939|FG000|Overall Study|Lost to Follow-up|2|||
125297155|NCT01789606|450713940|FG000|Overall Study|Participant not Purchased the Product|0|||
125297156|NCT01789606|450713941|FG001|Overall Study|Participant not Purchased the Product|20|||
125297157|NCT01789606|450713940|FG000|Overall Study|Withdrawal by Subject|0|||
125297158|NCT01789606|450713941|FG001|Overall Study|Withdrawal by Subject|1|||
125297159|NCT01789606|450713940|FG000|Overall Study|Ineligible|6|||
125297160|NCT01789606|450713941|FG001|Overall Study|Ineligible|2|||
125297161|NCT01789606|450713940|FG000|Overall Study|Administrative Reasons|17|||
125297162|NCT01789606|450713941|FG001|Overall Study|Administrative Reasons|6|||
125297163|NCT01789606|450713940|FG000|Overall Study|No Study Medication Taken|0|||
125297164|NCT01789606|450713941|FG001|Overall Study|No Study Medication Taken|1|||
125297165|NCT01789606|450713940|FG000|Overall Study|Protocol Violation|0|||
125297166|NCT01789606|450713941|FG001|Overall Study|Protocol Violation|55|||
125297167|NCT01789606|450713940|FG000|Overall Study|Adverse Event|0|||
125297168|NCT01789606|450713941|FG001|Overall Study|Adverse Event|3|||
125297169|NCT01789606|450713940|FG000|Overall Study|Lost to Follow-up|0|||
125297170|NCT01789606|450713941|FG001|Overall Study|Lost to Follow-up|14|||
125297171|NCT01789606|450713940|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
125297172|NCT01789606|450713941|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
125297173|NCT01291277|450713942|FG000|Overall Study|Death|2|||
125297174|NCT01291277|450713943|FG001|Overall Study|Death|2|||
125297175|NCT01291277|450713942|FG000|Overall Study|Lost to Follow-up|3|||
125297176|NCT01291277|450713943|FG001|Overall Study|Lost to Follow-up|1|||
125297177|NCT00849108|450713944|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
125297178|NCT00849108|450713945|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
125297179|NCT00849108|450713944|FG000|Cohort 2 Efficacy|Adverse Event|0|||
125297180|NCT00849108|450713945|FG001|Cohort 2 Efficacy|Adverse Event|1|||
125297181|NCT00849108|450713944|FG000|Cohort 2 Efficacy|Other|0|||
125297182|NCT00849108|450713945|FG001|Cohort 2 Efficacy|Other|9|||
125297183|NCT01563172|450713949|FG000|Overall Study|Adverse Event|5|||
124800798|NCT00973349|448901812|FG005|Overall Study|Lost to Follow-up|3|||
124800799|NCT00973349|448901813|FG006|Overall Study|Lost to Follow-up|0|||
124800800|NCT00973349|448901814|FG007|Overall Study|Lost to Follow-up|1|||
124800801|NCT00973349|448901815|FG008|Overall Study|Lost to Follow-up|2|||
124800802|NCT00973349|448901816|FG009|Overall Study|Lost to Follow-up|1|||
124800803|NCT00973349|448901817|FG010|Overall Study|Lost to Follow-up|0|||
124800804|NCT00973349|448901818|FG011|Overall Study|Lost to Follow-up|1|||
124800805|NCT00973349|448901819|FG012|Overall Study|Lost to Follow-up|0|||
124800806|NCT00973349|448901820|FG013|Overall Study|Lost to Follow-up|0|||
124800807|NCT00973349|448901821|FG014|Overall Study|Lost to Follow-up|0|||
124800808|NCT00973349|448901822|FG015|Overall Study|Lost to Follow-up|1|||
124800809|NCT00973349|448901807|FG000|Overall Study|Inappropriate enrolment|0|||
124800810|NCT00973349|448901808|FG001|Overall Study|Inappropriate enrolment|0|||
124800811|NCT00973349|448901809|FG002|Overall Study|Inappropriate enrolment|1|||
124800812|NCT00973349|448901810|FG003|Overall Study|Inappropriate enrolment|0|||
124800813|NCT00973349|448901811|FG004|Overall Study|Inappropriate enrolment|0|||
124800814|NCT00973349|448901812|FG005|Overall Study|Inappropriate enrolment|0|||
124800815|NCT00973349|448901813|FG006|Overall Study|Inappropriate enrolment|0|||
124800816|NCT00973349|448901814|FG007|Overall Study|Inappropriate enrolment|0|||
124800817|NCT00973349|448901815|FG008|Overall Study|Inappropriate enrolment|0|||
124800818|NCT00973349|448901816|FG009|Overall Study|Inappropriate enrolment|2|||
124800819|NCT00973349|448901817|FG010|Overall Study|Inappropriate enrolment|0|||
124800820|NCT00973349|448901818|FG011|Overall Study|Inappropriate enrolment|0|||
124800821|NCT00973349|448901819|FG012|Overall Study|Inappropriate enrolment|1|||
124800822|NCT00973349|448901820|FG013|Overall Study|Inappropriate enrolment|0|||
124800823|NCT00973349|448901821|FG014|Overall Study|Inappropriate enrolment|1|||
124800824|NCT00973349|448901822|FG015|Overall Study|Inappropriate enrolment|1|||
124800825|NCT00973349|448901807|FG000|Overall Study|Protocol Violation|0|||
124800826|NCT00973349|448901808|FG001|Overall Study|Protocol Violation|0|||
124800827|NCT00973349|448901809|FG002|Overall Study|Protocol Violation|0|||
124800828|NCT00973349|448901810|FG003|Overall Study|Protocol Violation|0|||
124800829|NCT00973349|448901811|FG004|Overall Study|Protocol Violation|0|||
124800830|NCT00973349|448901812|FG005|Overall Study|Protocol Violation|0|||
124800831|NCT00973349|448901813|FG006|Overall Study|Protocol Violation|0|||
124800832|NCT00973349|448901814|FG007|Overall Study|Protocol Violation|0|||
124800833|NCT00973349|448901815|FG008|Overall Study|Protocol Violation|1|||
124800834|NCT00973349|448901816|FG009|Overall Study|Protocol Violation|0|||
124800835|NCT00973349|448901817|FG010|Overall Study|Protocol Violation|0|||
124800836|NCT00973349|448901818|FG011|Overall Study|Protocol Violation|0|||
124800837|NCT00973349|448901819|FG012|Overall Study|Protocol Violation|0|||
125297184|NCT01563172|450713949|FG000|Overall Study|Lost to Follow-up|2|||
124800838|NCT00973349|448901820|FG013|Overall Study|Protocol Violation|0|||
124800839|NCT00973349|448901821|FG014|Overall Study|Protocol Violation|0|||
124800840|NCT00973349|448901822|FG015|Overall Study|Protocol Violation|0|||
124800841|NCT00973349|448901807|FG000|Overall Study|Unable to classify|0|||
124800842|NCT00973349|448901808|FG001|Overall Study|Unable to classify|0|||
124800843|NCT00973349|448901809|FG002|Overall Study|Unable to classify|0|||
124800844|NCT00973349|448901810|FG003|Overall Study|Unable to classify|0|||
124800845|NCT00973349|448901811|FG004|Overall Study|Unable to classify|1|||
124800846|NCT00973349|448901812|FG005|Overall Study|Unable to classify|1|||
124800847|NCT00973349|448901813|FG006|Overall Study|Unable to classify|0|||
125297185|NCT01563172|450713949|FG000|Overall Study|Other (Protocol deviation)|5|||
125297186|NCT01563172|450713949|FG000|Overall Study|Other (Not specified)|1|||
125297187|NCT01105377|450713950|FG000|Overall Study|Withdrawal by Subject|0|||
125297188|NCT01105377|450713951|FG001|Overall Study|Withdrawal by Subject|1|||
124800848|NCT00973349|448901814|FG007|Overall Study|Unable to classify|0|||
124800849|NCT00973349|448901815|FG008|Overall Study|Unable to classify|0|||
124800850|NCT00973349|448901816|FG009|Overall Study|Unable to classify|1|||
124800851|NCT00973349|448901817|FG010|Overall Study|Unable to classify|0|||
124800852|NCT00973349|448901818|FG011|Overall Study|Unable to classify|0|||
124800853|NCT00973349|448901819|FG012|Overall Study|Unable to classify|0|||
124800854|NCT00973349|448901820|FG013|Overall Study|Unable to classify|0|||
124800855|NCT00973349|448901821|FG014|Overall Study|Unable to classify|0|||
124800856|NCT00973349|448901822|FG015|Overall Study|Unable to classify|0|||
124800857|NCT03187756|448901823|FG000|Overall Study|Termination of study|4|||
124800858|NCT02301988|448901824|FG000|Overall Study|Withdrawal by Subject|2|||
124800859|NCT02301988|448901825|FG001|Overall Study|Withdrawal by Subject|1|||
124800860|NCT02301988|448901824|FG000|Overall Study|Physician Decision|2|||
124800861|NCT02301988|448901825|FG001|Overall Study|Physician Decision|2|||
124800862|NCT02301988|448901824|FG000|Overall Study|Unknown Reason|1|||
124800863|NCT02301988|448901825|FG001|Overall Study|Unknown Reason|3|||
124800864|NCT02301988|448901824|FG000|Overall Study|Lack of Efficacy|3|||
124800865|NCT02301988|448901825|FG001|Overall Study|Lack of Efficacy|2|||
124800866|NCT02301988|448901824|FG000|Overall Study|Death|1|||
124800867|NCT02301988|448901825|FG001|Overall Study|Death|0|||
124800868|NCT02301988|448901824|FG000|Overall Study|Adverse Event|1|||
124800869|NCT02301988|448901825|FG001|Overall Study|Adverse Event|1|||
124800870|NCT04755283|448901826|FG000|Overall Study|Withdrawal by Subject|14|||
124800871|NCT04755283|448901827|FG001|Overall Study|Withdrawal by Subject|3|||
124800872|NCT04755283|448901828|FG002|Overall Study|Withdrawal by Subject|6|||
124800873|NCT04755283|448901826|FG000|Overall Study|Lost to Follow-up|0|||
124800874|NCT04755283|448901827|FG001|Overall Study|Lost to Follow-up|0|||
124800875|NCT04755283|448901828|FG002|Overall Study|Lost to Follow-up|1|||
124800876|NCT04755283|448901826|FG000|Overall Study|Death|31|||
124800877|NCT04755283|448901827|FG001|Overall Study|Death|36|||
124800878|NCT04755283|448901828|FG002|Overall Study|Death|34|||
124800879|NCT02750943|448901829|FG000|Overall Study|Lost to Follow-up|1|||
124800880|NCT02750943|448901830|FG001|Overall Study|Lost to Follow-up|2|||
124800881|NCT02750943|448901829|FG000|Overall Study|Withdrawal by Subject|5|||
124800882|NCT02750943|448901830|FG001|Overall Study|Withdrawal by Subject|7|||
124800883|NCT00171054|448901831|FG000|Overall Study|Protocol Violation|1|||
124800884|NCT00171054|448901832|FG001|Overall Study|Protocol Violation|2|||
124800885|NCT00171054|448901831|FG000|Overall Study|Patient withdrew consent|1|||
124800886|NCT00171054|448901832|FG001|Overall Study|Patient withdrew consent|0|||
124800887|NCT00171054|448901831|FG000|Overall Study|Lost to Follow-up|0|||
124800888|NCT00171054|448901832|FG001|Overall Study|Lost to Follow-up|1|||
124800889|NCT00171054|448901831|FG000|Overall Study|Adverse Event|8|||
124800890|NCT00171054|448901832|FG001|Overall Study|Adverse Event|8|||
124800891|NCT00171054|448901831|FG000|Overall Study|Condition no longer required study drug|0|||
124800892|NCT00171054|448901832|FG001|Overall Study|Condition no longer required study drug|1|||
124800893|NCT05098938|448901836|FG000|Overall Study|Adverse Event|4|||
124800894|NCT05098938|448901837|FG001|Overall Study|Adverse Event|3|||
124800895|NCT05098938|448901836|FG000|Overall Study|inclusion/exclusion criteria change|11|||
124800896|NCT05098938|448901837|FG001|Overall Study|inclusion/exclusion criteria change|5|||
124800897|NCT05098938|448901836|FG000|Overall Study|lack of compliance|26|||
124800898|NCT05098938|448901837|FG001|Overall Study|lack of compliance|19|||
124800899|NCT05098938|448901836|FG000|Overall Study|Lost to Follow-up|37|||
124800900|NCT05098938|448901837|FG001|Overall Study|Lost to Follow-up|40|||
124800901|NCT05098938|448901836|FG000|Overall Study|Lost in treatment period|17|||
124800902|NCT05098938|448901837|FG001|Overall Study|Lost in treatment period|13|||
124800903|NCT05098938|448901836|FG000|Overall Study|Met an exclusion criterion|0|||
124800904|NCT05098938|448901837|FG001|Overall Study|Met an exclusion criterion|3|||
124800905|NCT05098938|448901836|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
124800906|NCT05098938|448901837|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
124800907|NCT05098938|448901836|FG000|Overall Study|Physician Decision|25|||
124800908|NCT05098938|448901837|FG001|Overall Study|Physician Decision|32|||
124800909|NCT05098938|448901836|FG000|Overall Study|Run in failure in treatment phase|1|||
124800910|NCT05098938|448901837|FG001|Overall Study|Run in failure in treatment phase|1|||
124800911|NCT05098938|448901836|FG000|Overall Study|Withdrawal by Subject|0|||
124800912|NCT05098938|448901837|FG001|Overall Study|Withdrawal by Subject|3|||
124800913|NCT05098938|448901836|FG000|Overall Study|Run-in Failure in early study|505|||
124800914|NCT05098938|448901837|FG001|Overall Study|Run-in Failure in early study|514|||
124800915|NCT05098938|448901836|FG000|Overall Study|IMP delivery missed|1|||
124800916|NCT05098938|448901837|FG001|Overall Study|IMP delivery missed|5|||
124800917|NCT05098938|448901836|FG000|Overall Study|6 months visit was missed|2|||
124800918|NCT05098938|448901837|FG001|Overall Study|6 months visit was missed|0|||
124800919|NCT05098938|448901836|FG000|Overall Study|fit for use was not completed within window|3|||
124800920|NCT05098938|448901837|FG001|Overall Study|fit for use was not completed within window|0|||
124800921|NCT05098938|448901836|FG000|Overall Study|V2 visit was not completed within window|0|||
124800922|NCT05098938|448901837|FG001|Overall Study|V2 visit was not completed within window|1|||
124800923|NCT05098938|448901836|FG000|Overall Study|exclusionary medication use|1|||
124800924|NCT05098938|448901837|FG001|Overall Study|exclusionary medication use|2|||
124800925|NCT05098938|448901836|FG000|Overall Study|change in medication|1|||
124800926|NCT05098938|448901837|FG001|Overall Study|change in medication|0|||
124800927|NCT05098938|448901836|FG000|Overall Study|treatment failure|2|||
124800928|NCT05098938|448901837|FG001|Overall Study|treatment failure|1|||
124800929|NCT01828320|448901838|FG000|Overall Study|Lost to Follow-up|1|||
124800930|NCT01828320|448901839|FG001|Overall Study|Lost to Follow-up|3|||
124800931|NCT01828320|448901838|FG000|Overall Study|Withdrawal by Subject|7|||
124800932|NCT01828320|448901839|FG001|Overall Study|Withdrawal by Subject|2|||
124800933|NCT02160782|448902867|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
124800934|NCT02160782|448902868|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
124800935|NCT02160782|448902869|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
124800936|NCT02160782|448902870|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
124800937|NCT02160782|448902871|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
124800938|NCT02160782|448902867|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
124800939|NCT02160782|448902868|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
124800940|NCT02160782|448902869|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
124800941|NCT02160782|448902870|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
124800942|NCT02160782|448902871|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
124800943|NCT02160782|448902867|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
124800944|NCT02160782|448902868|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
124800945|NCT02160782|448902869|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
124800946|NCT02160782|448902870|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
124800947|NCT02160782|448902871|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
124800948|NCT02160782|448902867|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
124800949|NCT02160782|448902868|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
124800950|NCT02160782|448902869|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
124800951|NCT02160782|448902870|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
124800952|NCT02160782|448902871|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
124800953|NCT02160782|448902867|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
124800954|NCT02160782|448902868|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
124800955|NCT02160782|448902869|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
124800956|NCT02160782|448902870|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
124800957|NCT02160782|448902871|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
124800958|NCT02160782|448902867|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
124800959|NCT02160782|448902868|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
124800960|NCT02160782|448902869|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
124800961|NCT02160782|448902870|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
124800962|NCT02160782|448902871|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
124800963|NCT02160782|448902867|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
124800964|NCT02160782|448902868|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
124800965|NCT02160782|448902869|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
124800966|NCT02160782|448902870|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
124800967|NCT02160782|448902871|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
124800968|NCT00401531|448902876|FG000|Overall Study|Adverse Event|2|||
124800969|NCT00401531|448902877|FG001|Overall Study|Adverse Event|0|||
124800970|NCT00401531|448902876|FG000|Overall Study|Protocol Violation|3|||
124800971|NCT00401531|448902877|FG001|Overall Study|Protocol Violation|7|||
124800972|NCT00401531|448902876|FG000|Overall Study|Lost to Follow-up|1|||
124800973|NCT00401531|448902877|FG001|Overall Study|Lost to Follow-up|1|||
124800974|NCT00401531|448902876|FG000|Overall Study|Withdrawal by Subject|3|||
124800975|NCT00401531|448902877|FG001|Overall Study|Withdrawal by Subject|2|||
124800976|NCT01801072|448902878|FG000|Overall Study|Lost to Follow-up|17|||
124800977|NCT01801072|448902879|FG001|Overall Study|Lost to Follow-up|14|||
124800978|NCT01801072|448902878|FG000|Overall Study|Physician Decision|2|||
124800979|NCT01801072|448902879|FG001|Overall Study|Physician Decision|3|||
124800980|NCT01801072|448902878|FG000|Overall Study|Withdrawal by Subject|1|||
124800981|NCT01801072|448902879|FG001|Overall Study|Withdrawal by Subject|0|||
124800982|NCT01801072|448902878|FG000|Overall Study|Protocol Violation|2|||
124800983|NCT01801072|448902879|FG001|Overall Study|Protocol Violation|0|||
124800984|NCT01801072|448902878|FG000|Overall Study|Death|7|||
124800985|NCT01801072|448902879|FG001|Overall Study|Death|8|||
124800986|NCT03906461|448902880|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
124800987|NCT03906461|448902880|FG000|Completed 12-month Follow-up|Missed Visit|6|||
124800988|NCT00510874|448902881|FG000|Overall Study|Withdrawal by Subject|1|||
124800989|NCT00510874|448902882|FG001|Overall Study|Withdrawal by Subject|1|||
124800990|NCT00510874|448902883|FG002|Overall Study|Withdrawal by Subject|0|||
124800991|NCT00510874|448902884|FG003|Overall Study|Withdrawal by Subject|0|||
124800992|NCT00510874|448902885|FG004|Overall Study|Withdrawal by Subject|3|||
124800993|NCT00510874|448902886|FG005|Overall Study|Withdrawal by Subject|0|||
124800994|NCT00510874|448902887|FG006|Overall Study|Withdrawal by Subject|0|||
124800995|NCT00510874|448902881|FG000|Overall Study|Lost to Follow-up|2|||
124800996|NCT00510874|448902882|FG001|Overall Study|Lost to Follow-up|3|||
124800997|NCT00510874|448902883|FG002|Overall Study|Lost to Follow-up|1|||
124800998|NCT00510874|448902884|FG003|Overall Study|Lost to Follow-up|3|||
124800999|NCT00510874|448902885|FG004|Overall Study|Lost to Follow-up|4|||
124801000|NCT00510874|448902886|FG005|Overall Study|Lost to Follow-up|0|||
124801001|NCT00510874|448902887|FG006|Overall Study|Lost to Follow-up|1|||
124801002|NCT02423109|448902890|FG000|Lens 1|Adverse Event|1|||
124801003|NCT02423109|448902891|FG001|Lens 1|Adverse Event|0|||
124801004|NCT03956056|448902892|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
124801005|NCT03956056|448902892|FG000|Overall Study|Lack of Efficacy|1|||
124801006|NCT03403374|448902893|FG000|Overall Study|Lost to Follow-up|1|||
124801007|NCT00950911|448902894|FG000|Overall Study|Adverse Event|0|||
124801008|NCT00950911|448902895|FG001|Overall Study|Adverse Event|2|||
124801009|NCT00950911|448902894|FG000|Overall Study|Death|4|||
124801010|NCT00950911|448902895|FG001|Overall Study|Death|6|||
124801011|NCT00950911|448902894|FG000|Overall Study|Disease progression|2|||
124801012|NCT00950911|448902895|FG001|Overall Study|Disease progression|2|||
124801013|NCT00950911|448902894|FG000|Overall Study|Consent withdrawn|1|||
124801014|NCT00950911|448902895|FG001|Overall Study|Consent withdrawn|3|||
124801015|NCT00950911|448902894|FG000|Overall Study|Administrative decision|3|||
124801016|NCT00950911|448902895|FG001|Overall Study|Administrative decision|1|||
124801017|NCT00950911|448902894|FG000|Overall Study|Ineligibility determined|1|||
124801018|NCT00950911|448902895|FG001|Overall Study|Ineligibility determined|0|||
124801019|NCT00950911|448902894|FG000|Overall Study|Noncompliance|1|||
124801020|NCT00950911|448902895|FG001|Overall Study|Noncompliance|0|||
124801021|NCT00950911|448902894|FG000|Overall Study|Poor performance status|0|||
124801022|NCT00950911|448902895|FG001|Overall Study|Poor performance status|1|||
124801023|NCT02476422|448902898|FG000|Overall Study|Subject/guardian decision|0|||
124801024|NCT02476422|448902899|FG001|Overall Study|Subject/guardian decision|1|||
124801025|NCT01134315|448902904|FG000|Overall Study|Adverse Event|1|||
124801026|NCT01134315|448902905|FG001|Overall Study|Adverse Event|2|||
124801027|NCT01134315|448902904|FG000|Overall Study|Other Reason|8|||
124801028|NCT01134315|448902905|FG001|Overall Study|Other Reason|17|||
124801029|NCT02180165|448902908|FG000|Overall Study|Not Treated|0|||
124801030|NCT02180165|448902909|FG001|Overall Study|Not Treated|0|||
124801031|NCT02180165|448902910|FG002|Overall Study|Not Treated|1|||
124801032|NCT02180165|448902911|FG003|Overall Study|Not Treated|0|||
124801033|NCT02180165|448902908|FG000|Overall Study|Adverse Event|7|||
124801034|NCT02180165|448902909|FG001|Overall Study|Adverse Event|0|||
124801035|NCT02180165|448902910|FG002|Overall Study|Adverse Event|18|||
124801036|NCT02180165|448902911|FG003|Overall Study|Adverse Event|3|||
124801037|NCT02180165|448902908|FG000|Overall Study|Lack of Efficacy|0|||
124801038|NCT02180165|448902909|FG001|Overall Study|Lack of Efficacy|1|||
124801039|NCT02180165|448902910|FG002|Overall Study|Lack of Efficacy|3|||
124801040|NCT02180165|448902911|FG003|Overall Study|Lack of Efficacy|2|||
124801041|NCT02180165|448902908|FG000|Overall Study|Physician Decision|1|||
124801042|NCT02180165|448902909|FG001|Overall Study|Physician Decision|0|||
124801043|NCT02180165|448902910|FG002|Overall Study|Physician Decision|5|||
124801044|NCT02180165|448902911|FG003|Overall Study|Physician Decision|0|||
124801045|NCT02180165|448902908|FG000|Overall Study|Withdrawal by Subject|3|||
124801046|NCT02180165|448902909|FG001|Overall Study|Withdrawal by Subject|0|||
124801047|NCT02180165|448902910|FG002|Overall Study|Withdrawal by Subject|2|||
124801048|NCT02180165|448902911|FG003|Overall Study|Withdrawal by Subject|1|||
124801049|NCT03875768|448902912|FG000|Overall Study|Lost to Follow-up|16|||
124801050|NCT03875768|448902913|FG001|Overall Study|Lost to Follow-up|13|||
124801051|NCT03875768|448902912|FG000|Overall Study|Withdrawal by Subject|10|||
124801052|NCT03875768|448902913|FG001|Overall Study|Withdrawal by Subject|21|||
124801053|NCT03875768|448902912|FG000|Overall Study|Did not complete assessment|21|||
125297189|NCT02014584|450713958|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
124801054|NCT03875768|448902913|FG001|Overall Study|Did not complete assessment|12|||
124801055|NCT03875768|448902912|FG000|Overall Study|Became ineligible|1|||
124801056|NCT03875768|448902913|FG001|Overall Study|Became ineligible|0|||
124801057|NCT00737438|448902914|FG000|Overall Study|Withdrawal by Subject|2|||
124801058|NCT00737438|448902914|FG000|Overall Study|Patient ineligible|1|||
124801059|NCT02791594|448902915|FG000|Overall Study|Physician Decision|2|||
124801060|NCT04950166|448902918|FG000|Overall Study|Withdrawal by Subject|1|||
124801061|NCT00857415|448902919|FG000|Overall Study|Image acquisition failure|2|||
124801062|NCT00857415|448902920|FG001|Overall Study|Image acquisition failure|0|||
124801063|NCT00857415|448902919|FG000|Overall Study|Invalid image or not imaged|3|||
124801064|NCT00857415|448902920|FG001|Overall Study|Invalid image or not imaged|0|||
124801065|NCT00857415|448902919|FG000|Overall Study|Subject still living at end of study|110|||
124801066|NCT00857415|448902920|FG001|Overall Study|Subject still living at end of study|0|||
124801067|NCT00857415|448902919|FG000|Overall Study|Deceased with no autopsy|2|||
124801068|NCT00857415|448902920|FG001|Overall Study|Deceased with no autopsy|0|||
124801069|NCT04508140|448902923|FG000|Overall Study|Adverse Event|2|||
124801070|NCT04508140|448902924|FG001|Overall Study|Adverse Event|2|||
124801071|NCT04508140|448902923|FG000|Overall Study|Withdrawal by Subject|0|||
124801072|NCT04508140|448902924|FG001|Overall Study|Withdrawal by Subject|2|||
124801073|NCT04508140|448902923|FG000|Overall Study|progressive disease|9|||
124801074|NCT04508140|448902924|FG001|Overall Study|progressive disease|3|||
124801075|NCT01130103|448902925|FG000|Randomized Treatment|Adverse Event|1|||
124801076|NCT01130103|448902926|FG001|Randomized Treatment|Adverse Event|1|||
124801077|NCT01130103|448902925|FG000|Randomized Treatment|Lost to Follow-up|1|||
124801078|NCT01130103|448902926|FG001|Randomized Treatment|Lost to Follow-up|0|||
124801079|NCT01130103|448902925|FG000|Randomized Treatment|Protocol Violation|3|||
124801080|NCT01130103|448902926|FG001|Randomized Treatment|Protocol Violation|2|||
124801081|NCT01130103|448902925|FG000|Randomized Treatment|Withdrawal by Subject|1|||
124801082|NCT01130103|448902926|FG001|Randomized Treatment|Withdrawal by Subject|2|||
124801083|NCT01130103|448902925|FG000|Maintenance Treatment|Lack of Efficacy|0|||
124801084|NCT01130103|448902926|FG001|Maintenance Treatment|Lack of Efficacy|1|||
124801085|NCT01130103|448902925|FG000|Maintenance Treatment|Lost to Follow-up|1|||
124801086|NCT01130103|448902926|FG001|Maintenance Treatment|Lost to Follow-up|1|||
124801087|NCT01130103|448902925|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
124801088|NCT01130103|448902926|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
124801089|NCT01199731|448902927|FG000|Overall Study|Adverse Event|0|||
124801090|NCT01199731|448902928|FG001|Overall Study|Adverse Event|1|||
124801091|NCT01199731|448902929|FG002|Overall Study|Adverse Event|0|||
124801092|NCT01199731|448902927|FG000|Overall Study|Study closed/terminated|7|||
124801093|NCT01199731|448902928|FG001|Overall Study|Study closed/terminated|9|||
124801094|NCT01199731|448902929|FG002|Overall Study|Study closed/terminated|7|||
124801095|NCT01199731|448902927|FG000|Overall Study|Lost to Follow-up|0|||
124801096|NCT01199731|448902928|FG001|Overall Study|Lost to Follow-up|0|||
124801097|NCT01199731|448902929|FG002|Overall Study|Lost to Follow-up|2|||
124801098|NCT01199731|448902927|FG000|Overall Study|Physician Decision|0|||
124801099|NCT01199731|448902928|FG001|Overall Study|Physician Decision|1|||
124801100|NCT01199731|448902929|FG002|Overall Study|Physician Decision|1|||
124801101|NCT01199731|448902927|FG000|Overall Study|Withdrawal by Subject|2|||
124801102|NCT01199731|448902928|FG001|Overall Study|Withdrawal by Subject|0|||
124801103|NCT01199731|448902929|FG002|Overall Study|Withdrawal by Subject|0|||
124801104|NCT02992132|448902930|FG000|Overall Study|Adverse Event|4|||
124801105|NCT02992132|448902931|FG001|Overall Study|Adverse Event|1|||
124801106|NCT02992132|448902932|FG002|Overall Study|Adverse Event|3|||
124801107|NCT02992132|448902930|FG000|Overall Study|Lack of Efficacy|2|||
124801108|NCT02992132|448902931|FG001|Overall Study|Lack of Efficacy|0|||
124801109|NCT02992132|448902932|FG002|Overall Study|Lack of Efficacy|0|||
124801110|NCT02992132|448902930|FG000|Overall Study|Non-compliance with study drug|2|||
124801111|NCT02992132|448902931|FG001|Overall Study|Non-compliance with study drug|0|||
124801112|NCT02992132|448902932|FG002|Overall Study|Non-compliance with study drug|0|||
124801113|NCT02992132|448902930|FG000|Overall Study|Progressive disease|1|||
124801114|NCT02992132|448902931|FG001|Overall Study|Progressive disease|0|||
124801115|NCT02992132|448902932|FG002|Overall Study|Progressive disease|0|||
124801116|NCT02992132|448902930|FG000|Overall Study|Protocol Violation|2|||
124801117|NCT02992132|448902931|FG001|Overall Study|Protocol Violation|2|||
124801118|NCT02992132|448902932|FG002|Overall Study|Protocol Violation|0|||
124801119|NCT02992132|448902930|FG000|Overall Study|Caregiver withdrew consent|2|||
124801120|NCT02992132|448902931|FG001|Overall Study|Caregiver withdrew consent|3|||
124801121|NCT02992132|448902932|FG002|Overall Study|Caregiver withdrew consent|2|||
124801122|NCT02992132|448902930|FG000|Overall Study|Withdrawal by Subject|0|||
124801123|NCT02992132|448902931|FG001|Overall Study|Withdrawal by Subject|2|||
124801124|NCT02992132|448902932|FG002|Overall Study|Withdrawal by Subject|1|||
124801125|NCT02992132|448902930|FG000|Overall Study|Physician Decision|0|||
124801126|NCT02992132|448902931|FG001|Overall Study|Physician Decision|0|||
124801127|NCT02992132|448902932|FG002|Overall Study|Physician Decision|1|||
124801128|NCT00381381|448902938|FG000|Overall Study|Adverse Event|3|||
124801129|NCT00381381|448902938|FG000|Overall Study|Lost to Follow-up|52|||
124801130|NCT00381381|448902938|FG000|Overall Study|Withdrawal by Subject|9|||
124801131|NCT01437878|448902943|FG000|Overall Study|Withdrawal by Subject|1|||
124801132|NCT01437878|448902944|FG001|Overall Study|Withdrawal by Subject|0|||
124801133|NCT01070043|448902945|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
124801134|NCT01070043|448902946|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
124801135|NCT01070043|448902947|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
124801136|NCT01070043|448902945|FG000|Double-Blind Treatment|Adverse Event|0|||
124801137|NCT01070043|448902946|FG001|Double-Blind Treatment|Adverse Event|0|||
124801138|NCT01070043|448902947|FG002|Double-Blind Treatment|Adverse Event|2|||
125297190|NCT02014584|450713959|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
124801139|NCT00473746|448902949|FG000|Period 1 (Phase 1)|Adverse Event|1|||
124801140|NCT00473746|448902950|FG001|Period 1 (Phase 1)|Adverse Event|0|||
124801141|NCT00473746|448902951|FG002|Period 1 (Phase 1)|Adverse Event|0|||
124801142|NCT00473746|448902952|FG003|Period 1 (Phase 1)|Adverse Event|0|||
124801143|NCT00473746|448902953|FG004|Period 1 (Phase 1)|Adverse Event|0|||
124801144|NCT00473746|448902949|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
124801145|NCT00473746|448902950|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
125297191|NCT02014584|450713960|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
124801146|NCT00473746|448902951|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
125297192|NCT02014584|450713961|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
125297193|NCT02014584|450713962|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
125297194|NCT02014584|450713963|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
124801147|NCT00473746|448902952|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
124801148|NCT00473746|448902953|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
124801149|NCT00473746|448902949|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
124801150|NCT00473746|448902950|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
124801151|NCT00473746|448902951|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
124801152|NCT00473746|448902952|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
124801153|NCT00473746|448902953|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
124801154|NCT00473746|448902949|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
124801155|NCT00473746|448902950|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
124801156|NCT00473746|448902951|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
124801157|NCT00473746|448902952|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
124801158|NCT00473746|448902953|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
124801159|NCT00473746|448902949|FG000|Period 1 (Phase 1)|Reason not specified|0|||
124801160|NCT00473746|448902950|FG001|Period 1 (Phase 1)|Reason not specified|1|||
124801161|NCT00473746|448902951|FG002|Period 1 (Phase 1)|Reason not specified|0|||
124801162|NCT00473746|448902952|FG003|Period 1 (Phase 1)|Reason not specified|0|||
124801163|NCT00473746|448902953|FG004|Period 1 (Phase 1)|Reason not specified|0|||
124801164|NCT00473746|448902949|FG000|Period 2 (Phase 2)|Adverse Event|0|||
124801165|NCT00473746|448902950|FG001|Period 2 (Phase 2)|Adverse Event|0|||
124801166|NCT00473746|448902951|FG002|Period 2 (Phase 2)|Adverse Event|0|||
124801167|NCT00473746|448902952|FG003|Period 2 (Phase 2)|Adverse Event|0|||
124801168|NCT00473746|448902953|FG004|Period 2 (Phase 2)|Adverse Event|3|||
124801169|NCT00473746|448902949|FG000|Period 2 (Phase 2)|Death|0|||
124801170|NCT00473746|448902950|FG001|Period 2 (Phase 2)|Death|0|||
124801171|NCT00473746|448902951|FG002|Period 2 (Phase 2)|Death|0|||
124801172|NCT00473746|448902952|FG003|Period 2 (Phase 2)|Death|0|||
124801173|NCT00473746|448902953|FG004|Period 2 (Phase 2)|Death|1|||
124801174|NCT00473746|448902949|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
124801175|NCT00473746|448902950|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
124801176|NCT00473746|448902951|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
124801177|NCT00473746|448902952|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
124801178|NCT00473746|448902953|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
124801179|NCT00473746|448902949|FG000|Period 2 (Phase 2)|Reason not specified|0|||
124801180|NCT00473746|448902950|FG001|Period 2 (Phase 2)|Reason not specified|0|||
124801181|NCT00473746|448902951|FG002|Period 2 (Phase 2)|Reason not specified|0|||
124801182|NCT00473746|448902952|FG003|Period 2 (Phase 2)|Reason not specified|0|||
124801183|NCT00473746|448902953|FG004|Period 2 (Phase 2)|Reason not specified|3|||
124801184|NCT00667420|448902957|FG000|Overall Study|Adverse Event|2|||
124801185|NCT00667420|448902957|FG000|Overall Study|Lack of Efficacy|5|||
124801186|NCT00667420|448902957|FG000|Overall Study|Physician Decision|1|||
124801187|NCT00667420|448902957|FG000|Overall Study|Withdrawal by Subject|2|||
124801188|NCT01528215|448902958|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
124801189|NCT01528215|448902959|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
124801190|NCT01528215|448902958|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
124801191|NCT01528215|448902959|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
124801192|NCT01528215|448902958|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
124801193|NCT01528215|448902959|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
124801194|NCT01528215|448902958|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
124801195|NCT01528215|448902959|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
124801196|NCT01462227|448902960|FG000|Second Assignment|Lost to Follow-up|1|||
124801197|NCT01462227|448902961|FG001|Second Assignment|Lost to Follow-up|0|||
124801198|NCT01462227|448902962|FG002|Second Assignment|Lost to Follow-up|0|||
125297195|NCT02014584|450713958|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
125297196|NCT02014584|450713959|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
125297197|NCT02014584|450713960|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
124801199|NCT01462227|448902963|FG003|Second Assignment|Lost to Follow-up|0|||
124801200|NCT01462227|448902960|FG000|Second Assignment|Protocol Violation|0|||
125297198|NCT02014584|450713961|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
125297199|NCT02014584|450713962|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
125297200|NCT02014584|450713963|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
125297201|NCT02014584|450713958|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
125297202|NCT02014584|450713959|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
125297203|NCT02014584|450713960|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
124801201|NCT01462227|448902961|FG001|Second Assignment|Protocol Violation|1|||
124801202|NCT01462227|448902962|FG002|Second Assignment|Protocol Violation|1|||
124801203|NCT01462227|448902963|FG003|Second Assignment|Protocol Violation|0|||
124801204|NCT00586066|448902966|FG000|Overall Study|Lost to Follow-up|6|||
125297204|NCT02014584|450713961|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
125297205|NCT02014584|450713962|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
124801205|NCT00586066|448902967|FG001|Overall Study|Lost to Follow-up|3|||
124801206|NCT00586066|448902966|FG000|Overall Study|Lack of Efficacy|5|||
124801207|NCT00586066|448902967|FG001|Overall Study|Lack of Efficacy|3|||
124801208|NCT00586066|448902966|FG000|Overall Study|Adverse Event|2|||
124801209|NCT00586066|448902967|FG001|Overall Study|Adverse Event|2|||
124801210|NCT00586066|448902966|FG000|Overall Study|Physician Decision|1|||
124801211|NCT00586066|448902967|FG001|Overall Study|Physician Decision|0|||
124801212|NCT00586066|448902966|FG000|Overall Study|Withdrawal of consent|4|||
124801213|NCT00586066|448902967|FG001|Overall Study|Withdrawal of consent|2|||
124801214|NCT00467610|448902968|FG000|Overall Study|Withdrawal by Subject|1|||
124801215|NCT01369615|448902969|FG000|Overall Study|Withdrawal by Subject|0|||
124801216|NCT01369615|448902970|FG001|Overall Study|Withdrawal by Subject|1|||
124801217|NCT01369615|448902969|FG000|Overall Study|Lost to Follow-up|0|||
124801218|NCT01369615|448902970|FG001|Overall Study|Lost to Follow-up|1|||
124801219|NCT04263454|448902971|FG000|Overall Study|Adverse Event|0|||
124801220|NCT04263454|448902972|FG001|Overall Study|Adverse Event|2|||
124801221|NCT04263454|448902971|FG000|Overall Study|Physician Decision|3|||
124801222|NCT04263454|448902972|FG001|Overall Study|Physician Decision|5|||
124801223|NCT04263454|448902971|FG000|Overall Study|Poor Data Quality|0|||
124801224|NCT04263454|448902972|FG001|Overall Study|Poor Data Quality|1|||
124801225|NCT03911154|448902973|FG000|Overall Study|Withdrawal by Subject|1|||
124801226|NCT02035475|448902974|FG000|Overall Study|Withdrawal by Subject|4|||
124801227|NCT02035475|448902974|FG000|Overall Study|Physician Decision|1|||
124801228|NCT02035475|448902974|FG000|Overall Study|Equipment Error|1|||
124801229|NCT01231347|448902975|FG000|Overall Study|Full Consent withdrawn|19|||
124801230|NCT01231347|448902976|FG001|Overall Study|Full Consent withdrawn|19|||
124801231|NCT01231347|448902977|FG002|Overall Study|Full Consent withdrawn|11|||
124801232|NCT01231347|448902975|FG000|Overall Study|Lost to Follow-up|4|||
124801233|NCT01231347|448902976|FG001|Overall Study|Lost to Follow-up|2|||
124801234|NCT01231347|448902977|FG002|Overall Study|Lost to Follow-up|2|||
124801235|NCT01231347|448902975|FG000|Overall Study|Death|202|||
124801236|NCT01231347|448902976|FG001|Overall Study|Death|210|||
124801237|NCT01231347|448902977|FG002|Overall Study|Death|101|||
124801238|NCT01231347|448902975|FG000|Overall Study|other event|7|||
124801239|NCT01231347|448902976|FG001|Overall Study|other event|9|||
124801240|NCT01231347|448902977|FG002|Overall Study|other event|3|||
124801241|NCT02322021|448902978|FG000|Core Phase|Adverse Event|1|||
125297206|NCT02014584|450713963|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
124801242|NCT02322021|448902979|FG001|Core Phase|Adverse Event|3|||
124801243|NCT02322021|448902980|FG002|Core Phase|Adverse Event|4|||
124801244|NCT02322021|448902981|FG003|Core Phase|Adverse Event|2|||
124801245|NCT02322021|448902982|FG004|Core Phase|Adverse Event|0|||
124801246|NCT02322021|448902978|FG000|Core Phase|Participant Choice|4|||
124801247|NCT02322021|448902979|FG001|Core Phase|Participant Choice|5|||
124801248|NCT02322021|448902980|FG002|Core Phase|Participant Choice|4|||
124801249|NCT02322021|448902981|FG003|Core Phase|Participant Choice|2|||
124801250|NCT02322021|448902982|FG004|Core Phase|Participant Choice|0|||
124801251|NCT02322021|448902978|FG000|Core Phase|Lost to Follow-up|0|||
124801252|NCT02322021|448902979|FG001|Core Phase|Lost to Follow-up|0|||
124801253|NCT02322021|448902980|FG002|Core Phase|Lost to Follow-up|0|||
124801254|NCT02322021|448902981|FG003|Core Phase|Lost to Follow-up|1|||
124801255|NCT02322021|448902982|FG004|Core Phase|Lost to Follow-up|0|||
124801256|NCT02322021|448902978|FG000|Core Phase|Other|0|||
124801257|NCT02322021|448902979|FG001|Core Phase|Other|0|||
124801258|NCT02322021|448902980|FG002|Core Phase|Other|1|||
125297207|NCT02014584|450713958|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
125297208|NCT02014584|450713959|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
125297209|NCT02014584|450713960|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
125297210|NCT02014584|450713961|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
125297211|NCT02014584|450713962|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
125297212|NCT02014584|450713963|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
125297213|NCT02014584|450713958|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
125297214|NCT02014584|450713959|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
125297215|NCT02014584|450713960|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
124801259|NCT02322021|448902981|FG003|Core Phase|Other|0|||
124801260|NCT02322021|448902982|FG004|Core Phase|Other|0|||
124801261|NCT02322021|448902978|FG000|Extension Phase|Adverse Event|0|||
124801262|NCT02322021|448902979|FG001|Extension Phase|Adverse Event|0|||
124801263|NCT02322021|448902980|FG002|Extension Phase|Adverse Event|0|||
124801264|NCT02322021|448902981|FG003|Extension Phase|Adverse Event|0|||
124801265|NCT02322021|448902982|FG004|Extension Phase|Adverse Event|3|||
124801266|NCT02322021|448902978|FG000|Extension Phase|Participant Choice|0|||
124801267|NCT02322021|448902979|FG001|Extension Phase|Participant Choice|0|||
124801268|NCT02322021|448902980|FG002|Extension Phase|Participant Choice|0|||
124801269|NCT02322021|448902981|FG003|Extension Phase|Participant Choice|0|||
124801270|NCT02322021|448902982|FG004|Extension Phase|Participant Choice|6|||
124801271|NCT02322021|448902978|FG000|Extension Phase|Other|0|||
124801272|NCT02322021|448902979|FG001|Extension Phase|Other|0|||
124801273|NCT02322021|448902980|FG002|Extension Phase|Other|0|||
124801274|NCT02322021|448902981|FG003|Extension Phase|Other|0|||
124801275|NCT02322021|448902982|FG004|Extension Phase|Other|3|||
124801276|NCT02322021|448902978|FG000|Extension Phase|Lost to Follow-up|0|||
124801277|NCT02322021|448902979|FG001|Extension Phase|Lost to Follow-up|0|||
124801278|NCT02322021|448902980|FG002|Extension Phase|Lost to Follow-up|0|||
124801279|NCT02322021|448902981|FG003|Extension Phase|Lost to Follow-up|0|||
124801280|NCT02322021|448902982|FG004|Extension Phase|Lost to Follow-up|1|||
124801281|NCT02322021|448902978|FG000|Extension Phase|Study terminated by sponsor|0|||
124801282|NCT02322021|448902979|FG001|Extension Phase|Study terminated by sponsor|0|||
124801283|NCT02322021|448902980|FG002|Extension Phase|Study terminated by sponsor|0|||
124801284|NCT02322021|448902981|FG003|Extension Phase|Study terminated by sponsor|0|||
124801285|NCT02322021|448902982|FG004|Extension Phase|Study terminated by sponsor|28|||
124801286|NCT02047227|448902983|FG000|Overall Study|Adverse Event|2|||
124801287|NCT02047227|448902984|FG001|Overall Study|Adverse Event|4|||
124801288|NCT02047227|448902983|FG000|Overall Study|Lost to Follow-up|0|||
124801289|NCT02047227|448902984|FG001|Overall Study|Lost to Follow-up|3|||
124801290|NCT02047227|448902983|FG000|Overall Study|Protocol Violation|1|||
124801291|NCT02047227|448902984|FG001|Overall Study|Protocol Violation|0|||
124801292|NCT02047227|448902983|FG000|Overall Study|Spontaneous pregnancy|1|||
124801293|NCT02047227|448902984|FG001|Overall Study|Spontaneous pregnancy|0|||
124801294|NCT02047227|448902983|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
124801295|NCT02047227|448902984|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
124801296|NCT02047227|448902983|FG000|Overall Study|No oocytes retrieved|21|||
124801297|NCT02047227|448902984|FG001|Overall Study|No oocytes retrieved|20|||
124801298|NCT02047227|448902983|FG000|Overall Study|No fertilization|61|||
124801299|NCT02047227|448902984|FG001|Overall Study|No fertilization|51|||
124801300|NCT02047227|448902983|FG000|Overall Study|Intention to freeze all embryos|1|||
124801301|NCT02047227|448902984|FG001|Overall Study|Intention to freeze all embryos|0|||
124801302|NCT02047227|448902983|FG000|Overall Study|All embryos discarded|12|||
124801303|NCT02047227|448902984|FG001|Overall Study|All embryos discarded|11|||
124801304|NCT02047227|448902983|FG000|Overall Study|Other|10|||
124801305|NCT02047227|448902984|FG001|Overall Study|Other|9|||
124801306|NCT00492050|448902990|FG000|Overall Study|Adverse Event|1|||
124801307|NCT00492050|448902990|FG000|Overall Study|Lack of Efficacy|1|||
124801308|NCT00492050|448902990|FG000|Overall Study|Withdrawal by Subject|3|||
124801309|NCT00492050|448902990|FG000|Overall Study|Unable to collect SCT|2|||
124801310|NCT00492050|448902990|FG000|Overall Study|Progressive Disease|2|||
124801311|NCT01104701|448904356|FG000|Overall Study|Withdrawal by Subject|0|||
124801312|NCT01104701|448904357|FG001|Overall Study|Withdrawal by Subject|1|||
124801313|NCT01104701|448904358|FG002|Overall Study|Withdrawal by Subject|2|||
124801314|NCT01104701|448904359|FG003|Overall Study|Withdrawal by Subject|1|||
124801315|NCT01104701|448904356|FG000|Overall Study|Adverse Event|0|||
124801316|NCT01104701|448904357|FG001|Overall Study|Adverse Event|0|||
124801317|NCT01104701|448904358|FG002|Overall Study|Adverse Event|0|||
124801318|NCT01104701|448904359|FG003|Overall Study|Adverse Event|1|||
124801319|NCT01104701|448904356|FG000|Overall Study|Physician Decision|0|||
125297216|NCT02014584|450713961|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
125297217|NCT02014584|450713962|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
125297218|NCT02014584|450713963|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
125297219|NCT01555125|450713964|FG000|Induction Period|Lost to Follow-up|0|||
125297220|NCT01555125|450713965|FG001|Induction Period|Lost to Follow-up|2|||
125297221|NCT01555125|450713966|FG002|Induction Period|Lost to Follow-up|0|||
125297222|NCT01555125|450713967|FG003|Induction Period|Lost to Follow-up|0|||
125297223|NCT01555125|450713968|FG004|Induction Period|Lost to Follow-up|0|||
124801320|NCT01104701|448904357|FG001|Overall Study|Physician Decision|2|||
124801321|NCT01104701|448904358|FG002|Overall Study|Physician Decision|0|||
124801322|NCT01104701|448904359|FG003|Overall Study|Physician Decision|0|||
124801323|NCT03437512|448904360|FG000|Randomized|Withdrawal by Subject|0|||
124801324|NCT03437512|448904361|FG001|Randomized|Withdrawal by Subject|2|||
124801325|NCT03437512|448904360|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
124801326|NCT03437512|448904361|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
124801327|NCT00674973|448904362|FG000|Overall Study|Insufficient Therapeutic Response|77|||
124801328|NCT00674973|448904363|FG001|Overall Study|Insufficient Therapeutic Response|72|||
124801329|NCT00674973|448904362|FG000|Overall Study|Refused Treatment|1|||
124801330|NCT00674973|448904363|FG001|Overall Study|Refused Treatment|5|||
124801331|NCT00674973|448904362|FG000|Overall Study|Failure to Return|1|||
124801332|NCT00674973|448904363|FG001|Overall Study|Failure to Return|0|||
124801333|NCT00674973|448904362|FG000|Overall Study|Adverse Event|2|||
124801334|NCT00674973|448904363|FG001|Overall Study|Adverse Event|9|||
125297224|NCT01555125|450713964|FG000|Induction Period|Adverse Event|0|||
125297225|NCT01555125|450713965|FG001|Induction Period|Adverse Event|1|||
124801335|NCT00674973|448904362|FG000|Overall Study|Death|19|||
124801336|NCT00674973|448904363|FG001|Overall Study|Death|15|||
124801337|NCT00674973|448904362|FG000|Overall Study|Protocol Violation|0|||
124801338|NCT00674973|448904363|FG001|Overall Study|Protocol Violation|1|||
124801339|NCT01002482|448904366|FG000|Overall Study|Withdrawal by Subject|14|||
124801340|NCT01002482|448904367|FG001|Overall Study|Withdrawal by Subject|21|||
124801341|NCT01002482|448904366|FG000|Overall Study|Included twice|1|||
124801342|NCT01002482|448904367|FG001|Overall Study|Included twice|0|||
124801343|NCT05108922|448904371|FG000|Overall Study|Adverse Event|2|||
124801344|NCT05108922|448904372|FG001|Overall Study|Adverse Event|3|||
124801345|NCT05108922|448904371|FG000|Overall Study|Lost to Follow-up|2|||
124801346|NCT05108922|448904372|FG001|Overall Study|Lost to Follow-up|1|||
124801347|NCT05108922|448904371|FG000|Overall Study|Inadvertent enrollment|0|||
124801348|NCT05108922|448904372|FG001|Overall Study|Inadvertent enrollment|1|||
124801349|NCT05108922|448904371|FG000|Overall Study|Physician Decision|2|||
124801350|NCT05108922|448904372|FG001|Overall Study|Physician Decision|3|||
124801351|NCT05108922|448904371|FG000|Overall Study|Protocol deviation|1|||
124801352|NCT05108922|448904372|FG001|Overall Study|Protocol deviation|0|||
124801353|NCT05108922|448904371|FG000|Overall Study|Screen failure|1|||
124801354|NCT05108922|448904372|FG001|Overall Study|Screen failure|0|||
124801355|NCT05108922|448904371|FG000|Overall Study|Withdrawal by Subject|11|||
124801356|NCT05108922|448904372|FG001|Overall Study|Withdrawal by Subject|8|||
124801357|NCT05036369|448904373|FG000|Overall Study|Run In non compliance|1|||
124801358|NCT05036369|448904374|FG001|Overall Study|Run In non compliance|2|||
124801359|NCT05036369|448904373|FG000|Overall Study|Change in eligibility criteria|0|||
124801360|NCT05036369|448904374|FG001|Overall Study|Change in eligibility criteria|1|||
124801361|NCT00426231|448904377|FG000|Overall Study|Withdrawal by Subject|9|||
124801362|NCT00426231|448904378|FG001|Overall Study|Withdrawal by Subject|12|||
124801363|NCT01795638|448904379|FG000|Overall Study|Death|0|||
124801364|NCT01795638|448904380|FG001|Overall Study|Death|3|||
124801365|NCT01795638|448904379|FG000|Overall Study|transferred to quaternary hospital|2|||
124801366|NCT01795638|448904380|FG001|Overall Study|transferred to quaternary hospital|3|||
124801367|NCT01795638|448904379|FG000|Overall Study|Protocol Violation|3|||
124801368|NCT01795638|448904380|FG001|Overall Study|Protocol Violation|0|||
124801369|NCT01795638|448904379|FG000|Overall Study|discharged from hospital|7|||
124801370|NCT01795638|448904380|FG001|Overall Study|discharged from hospital|5|||
124801371|NCT01795638|448904379|FG000|Overall Study|Withdrawal by Subject|1|||
124801372|NCT01795638|448904380|FG001|Overall Study|Withdrawal by Subject|0|||
124801373|NCT03061097|448904381|FG000|Overall Study|Withdrawal by Subject|0|||
124801374|NCT03061097|448904382|FG001|Overall Study|Withdrawal by Subject|3|||
124801375|NCT03911713|448904383|FG000|Overall Study|Lost to Follow-up|0|||
124801376|NCT03911713|448904384|FG001|Overall Study|Lost to Follow-up|2|||
124801377|NCT03911713|448904385|FG002|Overall Study|Lost to Follow-up|0|||
124801378|NCT03911713|448904386|FG003|Overall Study|Lost to Follow-up|0|||
124801379|NCT03911713|448904387|FG004|Overall Study|Lost to Follow-up|0|||
125297226|NCT01555125|450713966|FG002|Induction Period|Adverse Event|0|||
125297227|NCT01555125|450713967|FG003|Induction Period|Adverse Event|0|||
125297228|NCT01555125|450713968|FG004|Induction Period|Adverse Event|1|||
125297229|NCT01555125|450713964|FG000|Induction Period|Subject / guardian decision|0|||
124801380|NCT03911713|448904383|FG000|Overall Study|Other|0|||
124801381|NCT03911713|448904384|FG001|Overall Study|Other|0|||
124801382|NCT03911713|448904385|FG002|Overall Study|Other|0|||
125297230|NCT01555125|450713965|FG001|Induction Period|Subject / guardian decision|0|||
125297231|NCT01555125|450713966|FG002|Induction Period|Subject / guardian decision|0|||
125297232|NCT01555125|450713967|FG003|Induction Period|Subject / guardian decision|0|||
125297233|NCT01555125|450713968|FG004|Induction Period|Subject / guardian decision|2|||
124801383|NCT03911713|448904386|FG003|Overall Study|Other|1|||
124801384|NCT03911713|448904387|FG004|Overall Study|Other|0|||
124801385|NCT03911713|448904383|FG000|Overall Study|Randomized, Never Dosed|1|||
124801386|NCT03911713|448904384|FG001|Overall Study|Randomized, Never Dosed|0|||
124801387|NCT03911713|448904385|FG002|Overall Study|Randomized, Never Dosed|0|||
124801388|NCT03911713|448904386|FG003|Overall Study|Randomized, Never Dosed|1|||
124801389|NCT03911713|448904387|FG004|Overall Study|Randomized, Never Dosed|0|||
124801390|NCT02437513|448904388|FG000|Overall Study|Withdrawal by Subject|2|||
124801391|NCT01845818|448904389|FG000|Overall Study|Withdrawal by Subject|0|||
124801392|NCT01845818|448904390|FG001|Overall Study|Withdrawal by Subject|1|||
124801393|NCT01845818|448904389|FG000|Overall Study|Lost to Follow-up|7|||
124801394|NCT01845818|448904390|FG001|Overall Study|Lost to Follow-up|5|||
124801395|NCT01845818|448904389|FG000|Overall Study|Administrative Reasons|3|||
124801396|NCT01845818|448904390|FG001|Overall Study|Administrative Reasons|1|||
124801397|NCT01845818|448904389|FG000|Overall Study|Serious Adverse Event|1|||
124801398|NCT01845818|448904390|FG001|Overall Study|Serious Adverse Event|1|||
124801399|NCT01845818|448904389|FG000|Overall Study|Other|25|||
124801400|NCT01845818|448904390|FG001|Overall Study|Other|8|||
124801401|NCT01845818|448904389|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
124801402|NCT01845818|448904390|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
124801403|NCT01845818|448904389|FG000|Overall Study|No Follow-Up Data Available|4|||
124801404|NCT01845818|448904390|FG001|Overall Study|No Follow-Up Data Available|1|||
124801405|NCT00422097|448904391|FG000|Dose Level 2|Still on treatment|0|||
124801406|NCT00422097|448904392|FG001|Dose Level 2|Still on treatment|1|||
124801407|NCT00422097|448904393|FG002|Dose Level 2|Still on treatment|0|||
125297234|NCT01555125|450713964|FG000|Induction Period|Death|1|||
125297235|NCT01555125|450713965|FG001|Induction Period|Death|0|||
124801408|NCT00422097|448904394|FG003|Dose Level 2|Still on treatment|0|||
124801409|NCT00422097|448904395|FG004|Dose Level 2|Still on treatment|0|||
124801410|NCT00422097|448904396|FG005|Dose Level 2|Still on treatment|0|||
125297236|NCT01555125|450713966|FG002|Induction Period|Death|0|||
125297237|NCT01555125|450713967|FG003|Induction Period|Death|0|||
125297238|NCT01555125|450713968|FG004|Induction Period|Death|0|||
125297239|NCT01555125|450713964|FG000|Maintenance Period|Adverse Event|1|||
125297240|NCT01555125|450713965|FG001|Maintenance Period|Adverse Event|1|||
125297241|NCT01555125|450713966|FG002|Maintenance Period|Adverse Event|0|||
125297242|NCT01555125|450713967|FG003|Maintenance Period|Adverse Event|0|||
125297243|NCT01555125|450713968|FG004|Maintenance Period|Adverse Event|0|||
125297244|NCT01555125|450713964|FG000|Maintenance Period|Subject / guardian decision|1|||
125297245|NCT01555125|450713965|FG001|Maintenance Period|Subject / guardian decision|2|||
125297246|NCT01555125|450713966|FG002|Maintenance Period|Subject / guardian decision|0|||
124801411|NCT00422097|448904397|FG006|Dose Level 2|Still on treatment|0|||
124801412|NCT00422097|448904398|FG007|Dose Level 2|Still on treatment|0|||
124801413|NCT02360995|448904399|FG000|Overall Study|Lost to Follow-up|2|||
124801414|NCT02360995|448904400|FG001|Overall Study|Lost to Follow-up|0|||
124801415|NCT02360995|448904401|FG002|Overall Study|Lost to Follow-up|2|||
124801416|NCT02360995|448904399|FG000|Overall Study|Withdrawal by Subject|0|||
124801417|NCT02360995|448904400|FG001|Overall Study|Withdrawal by Subject|1|||
124801418|NCT02360995|448904401|FG002|Overall Study|Withdrawal by Subject|0|||
124801419|NCT02395666|448904402|FG000|Overall Study|Physician Decision|3|||
124801420|NCT02395666|448904403|FG001|Overall Study|Physician Decision|0|||
124801421|NCT02395666|448904402|FG000|Overall Study|Lost to Follow-up|1|||
124801422|NCT02395666|448904403|FG001|Overall Study|Lost to Follow-up|0|||
124801423|NCT02395666|448904402|FG000|Overall Study|Withdrawal by Subject|2|||
124801424|NCT02395666|448904403|FG001|Overall Study|Withdrawal by Subject|1|||
124801425|NCT02611960|448904404|FG000|Overall Study|Adverse Event|7|||
124801426|NCT02611960|448904405|FG001|Overall Study|Adverse Event|8|||
124801427|NCT02611960|448904404|FG000|Overall Study|Death|98|||
124801428|NCT02611960|448904405|FG001|Overall Study|Death|92|||
124801429|NCT02611960|448904404|FG000|Overall Study|Withdrawal by Subject|1|||
124801430|NCT02611960|448904405|FG001|Overall Study|Withdrawal by Subject|5|||
124801431|NCT02611960|448904404|FG000|Overall Study|Sponsor Decision|11|||
124801432|NCT02611960|448904405|FG001|Overall Study|Sponsor Decision|11|||
124801433|NCT01409434|448904417|FG000|Overall Study|Protocol Violation|4|||
124801434|NCT05061966|448904418|FG000|Overall Study|Lost to Follow-up|13|||
124801435|NCT05061966|448904419|FG001|Overall Study|Lost to Follow-up|13|||
124801436|NCT02213042|448904420|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
124801437|NCT02213042|448904421|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
124801438|NCT02213042|448904422|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
124801439|NCT02213042|448904420|FG000|Overall Study|Adverse Event|2|||
124801440|NCT02213042|448904421|FG001|Overall Study|Adverse Event|1|||
124801441|NCT02213042|448904422|FG002|Overall Study|Adverse Event|0|||
124801442|NCT02213042|448904420|FG000|Overall Study|Withdrawal by Subject|0|||
124801443|NCT02213042|448904421|FG001|Overall Study|Withdrawal by Subject|1|||
124801444|NCT02213042|448904422|FG002|Overall Study|Withdrawal by Subject|1|||
124801445|NCT02213042|448904420|FG000|Overall Study|Protocol Violation|1|||
124801446|NCT02213042|448904421|FG001|Overall Study|Protocol Violation|0|||
124801447|NCT02213042|448904422|FG002|Overall Study|Protocol Violation|0|||
124801448|NCT02213042|448904420|FG000|Overall Study|Investigator discretion|0|||
124801449|NCT02213042|448904421|FG001|Overall Study|Investigator discretion|0|||
124801450|NCT02213042|448904422|FG002|Overall Study|Investigator discretion|1|||
124801451|NCT00777205|448904429|FG000|Overall Study|Lost to Follow-up|25|||
124801452|NCT00777205|448904430|FG001|Overall Study|Lost to Follow-up|9|||
124801453|NCT00777205|448904429|FG000|Overall Study|Withdrawal by Subject|6|||
124801454|NCT00777205|448904430|FG001|Overall Study|Withdrawal by Subject|4|||
124801455|NCT00777205|448904429|FG000|Overall Study|Death|0|||
124801456|NCT00777205|448904430|FG001|Overall Study|Death|2|||
124801457|NCT00777205|448904429|FG000|Overall Study|Protocol Violation|0|||
125297247|NCT01555125|450713967|FG003|Maintenance Period|Subject / guardian decision|0|||
125297248|NCT01555125|450713968|FG004|Maintenance Period|Subject / guardian decision|0|||
125297249|NCT01555125|450713964|FG000|Maintenance Period|Lost to Follow-up|2|||
125297250|NCT01555125|450713965|FG001|Maintenance Period|Lost to Follow-up|0|||
124801458|NCT00777205|448904430|FG001|Overall Study|Protocol Violation|56|||
124801459|NCT03053271|448904433|FG000|Overall Study|Did not meet randomization criteria|3|||
124801460|NCT03053271|448904433|FG000|Overall Study|Withdrawal by Subject|1|||
124801461|NCT04137224|448904435|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
124801462|NCT04137224|448904436|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
124801463|NCT04137224|448904435|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
124801464|NCT04137224|448904436|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
124801465|NCT04137224|448904435|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
124801466|NCT04137224|448904436|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
124801467|NCT01225887|448904437|FG000|Overall Study|Ineligible:required test not done|2|||
125297251|NCT01555125|450713966|FG002|Maintenance Period|Lost to Follow-up|0|||
125297252|NCT01555125|450713967|FG003|Maintenance Period|Lost to Follow-up|1|||
125297253|NCT01555125|450713968|FG004|Maintenance Period|Lost to Follow-up|0|||
125297254|NCT01555125|450713964|FG000|Maintenance Period|Lack of Efficacy|6|||
125297255|NCT01555125|450713965|FG001|Maintenance Period|Lack of Efficacy|1|||
125297256|NCT01555125|450713966|FG002|Maintenance Period|Lack of Efficacy|3|||
124801468|NCT01225887|448904437|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
124801469|NCT01225887|448904437|FG000|Overall Study|Ineligible:inadequate pathology|2|||
124801470|NCT01669928|448904438|FG000|First Intervention|Withdrawal by Subject|3|||
124801471|NCT01669928|448904439|FG001|First Intervention|Withdrawal by Subject|5|||
124801472|NCT00925990|448904443|FG000|Overall Study|Adverse Event|1|||
124801473|NCT00925990|448904444|FG001|Overall Study|Adverse Event|3|||
124801474|NCT00925990|448904443|FG000|Overall Study|Withdrawal by Subject|2|||
124801475|NCT00925990|448904444|FG001|Overall Study|Withdrawal by Subject|2|||
124801476|NCT00925990|448904443|FG000|Overall Study|Lost to Follow-up|1|||
124801477|NCT00925990|448904444|FG001|Overall Study|Lost to Follow-up|3|||
124801478|NCT00925990|448904443|FG000|Overall Study|Physician Decision|1|||
124801479|NCT00925990|448904444|FG001|Overall Study|Physician Decision|1|||
125297257|NCT01555125|450713967|FG003|Maintenance Period|Lack of Efficacy|0|||
125297258|NCT01555125|450713968|FG004|Maintenance Period|Lack of Efficacy|0|||
125297259|NCT01555125|450713964|FG000|Maintenance Period|Physician Decision|0|||
125297260|NCT01555125|450713965|FG001|Maintenance Period|Physician Decision|0|||
125297261|NCT01555125|450713966|FG002|Maintenance Period|Physician Decision|1|||
125297262|NCT01555125|450713967|FG003|Maintenance Period|Physician Decision|0|||
124801480|NCT00925990|448904443|FG000|Overall Study|moved out of state, missed medication|0|||
124801481|NCT00925990|448904444|FG001|Overall Study|moved out of state, missed medication|2|||
124801482|NCT00679055|448904445|FG000|Overall Study|Adverse Event|0|||
124801483|NCT00679055|448904446|FG001|Overall Study|Adverse Event|1|||
125297263|NCT01555125|450713968|FG004|Maintenance Period|Physician Decision|0|||
125297264|NCT01555125|450713964|FG000|Maintenance Period|Death|0|||
125297265|NCT01555125|450713965|FG001|Maintenance Period|Death|0|||
125297266|NCT01555125|450713966|FG002|Maintenance Period|Death|0|||
125297267|NCT01555125|450713967|FG003|Maintenance Period|Death|1|||
124801484|NCT00679055|448904445|FG000|Overall Study|Other|0|||
124801485|NCT00679055|448904446|FG001|Overall Study|Other|3|||
124801486|NCT00679055|448904445|FG000|Overall Study|Study Terminated|2|||
124801487|NCT00679055|448904446|FG001|Overall Study|Study Terminated|1|||
124801488|NCT01822678|448904453|FG000|Overall Study|Withdrawal by Subject|5|||
124801489|NCT01822678|448904454|FG001|Overall Study|Withdrawal by Subject|4|||
124801490|NCT01822678|448904455|FG002|Overall Study|Withdrawal by Subject|4|||
124801491|NCT01822678|448904453|FG000|Overall Study|Adverse Event|4|||
124801492|NCT01822678|448904454|FG001|Overall Study|Adverse Event|3|||
124801493|NCT01822678|448904455|FG002|Overall Study|Adverse Event|1|||
124801494|NCT01822678|448904453|FG000|Overall Study|Lack of Efficacy|3|||
124801495|NCT01822678|448904454|FG001|Overall Study|Lack of Efficacy|6|||
124801496|NCT01822678|448904455|FG002|Overall Study|Lack of Efficacy|5|||
124801497|NCT01822678|448904453|FG000|Overall Study|Lost to Follow-up|0|||
124801498|NCT01822678|448904454|FG001|Overall Study|Lost to Follow-up|2|||
124801499|NCT01822678|448904455|FG002|Overall Study|Lost to Follow-up|1|||
124801500|NCT00943124|448904459|FG000|Period 1|Withdrawal by Subject|1|||
124801501|NCT00943124|448904460|FG001|Period 1|Withdrawal by Subject|1|||
124801502|NCT00943124|448904459|FG000|Period 1|Did Not Follow Study Procedures|1|||
124801503|NCT00943124|448904460|FG001|Period 1|Did Not Follow Study Procedures|0|||
124801504|NCT00943124|448904459|FG000|Period 1|Personal Reasons|0|||
124801505|NCT00943124|448904460|FG001|Period 1|Personal Reasons|1|||
124801506|NCT01916967|448904463|FG000|Overall Study|Adverse Event|0|||
124801507|NCT01916967|448904464|FG001|Overall Study|Adverse Event|0|||
124801508|NCT01916967|448904465|FG002|Overall Study|Adverse Event|2|||
124801509|NCT01916967|448904463|FG000|Overall Study|Lack of Efficacy|0|||
124801510|NCT01916967|448904464|FG001|Overall Study|Lack of Efficacy|0|||
124801511|NCT01916967|448904465|FG002|Overall Study|Lack of Efficacy|6|||
124801512|NCT01916967|448904463|FG000|Overall Study|Physician Decision|0|||
125297268|NCT01555125|450713968|FG004|Maintenance Period|Death|0|||
125297269|NCT01555125|450713964|FG000|Extension|Adverse Event|1|||
125297270|NCT01555125|450713965|FG001|Extension|Adverse Event|2|||
125297271|NCT01555125|450713966|FG002|Extension|Adverse Event|1|||
125297272|NCT01555125|450713967|FG003|Extension|Adverse Event|1|||
125297273|NCT01555125|450713968|FG004|Extension|Adverse Event|0|||
124801513|NCT01916967|448904464|FG001|Overall Study|Physician Decision|0|||
124801514|NCT01916967|448904465|FG002|Overall Study|Physician Decision|1|||
124801515|NCT01916967|448904463|FG000|Overall Study|Protocol Violation|0|||
124801516|NCT01916967|448904464|FG001|Overall Study|Protocol Violation|1|||
124801517|NCT01916967|448904465|FG002|Overall Study|Protocol Violation|0|||
124801518|NCT01912963|448904466|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
124801519|NCT01912963|448904467|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
124801520|NCT01912963|448904468|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
124801521|NCT01912963|448904466|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
124801522|NCT01912963|448904467|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
124801523|NCT01912963|448904468|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
124801524|NCT01912963|448904466|FG000|Overall Study|Adverse Event|0|||
124801525|NCT01912963|448904467|FG001|Overall Study|Adverse Event|1|||
124801526|NCT01912963|448904468|FG002|Overall Study|Adverse Event|1|||
124801527|NCT01912963|448904466|FG000|Overall Study|Withdrawal by Subject|0|||
124801528|NCT01912963|448904467|FG001|Overall Study|Withdrawal by Subject|1|||
124801529|NCT01912963|448904468|FG002|Overall Study|Withdrawal by Subject|0|||
124801530|NCT01912963|448904466|FG000|Overall Study|Sought treatment locally|0|||
124801531|NCT01912963|448904467|FG001|Overall Study|Sought treatment locally|1|||
124801532|NCT01912963|448904468|FG002|Overall Study|Sought treatment locally|0|||
124801533|NCT01702571|448904471|FG000|Overall Study|Death|1067|||
124801534|NCT01702571|448904472|FG001|Overall Study|Death|76|||
124801535|NCT01702571|448904471|FG000|Overall Study|Lost to Follow-up|144|||
124801536|NCT01702571|448904472|FG001|Overall Study|Lost to Follow-up|10|||
124801537|NCT01702571|448904471|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
125297274|NCT01555125|450713964|FG000|Extension|Protocol deviation|1|||
125297275|NCT01555125|450713965|FG001|Extension|Protocol deviation|0|||
125297276|NCT01555125|450713966|FG002|Extension|Protocol deviation|0|||
125297277|NCT01555125|450713967|FG003|Extension|Protocol deviation|0|||
125297278|NCT01555125|450713968|FG004|Extension|Protocol deviation|0|||
125297279|NCT01555125|450713964|FG000|Extension|Lack of Efficacy|7|||
125297280|NCT01555125|450713965|FG001|Extension|Lack of Efficacy|6|||
125297281|NCT01555125|450713966|FG002|Extension|Lack of Efficacy|3|||
125297282|NCT01555125|450713967|FG003|Extension|Lack of Efficacy|0|||
125297283|NCT01555125|450713968|FG004|Extension|Lack of Efficacy|0|||
124801538|NCT01702571|448904472|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
124801539|NCT01702571|448904471|FG000|Overall Study|Investigator Decision|5|||
124801540|NCT01702571|448904472|FG001|Overall Study|Investigator Decision|0|||
124801541|NCT01702571|448904471|FG000|Overall Study|Not Classifiable|1|||
124801542|NCT01702571|448904472|FG001|Overall Study|Not Classifiable|0|||
124801543|NCT01702571|448904471|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
124801544|NCT01702571|448904472|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
124801545|NCT01702571|448904471|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
124801546|NCT01702571|448904472|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
124801547|NCT01702571|448904471|FG000|Overall Study|Progressive Disease|3|||
124801548|NCT01702571|448904472|FG001|Overall Study|Progressive Disease|0|||
124801549|NCT01702571|448904471|FG000|Overall Study|Protocol Violation|2|||
124801550|NCT01702571|448904472|FG001|Overall Study|Protocol Violation|0|||
124801551|NCT01702571|448904471|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
124801552|NCT01702571|448904472|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
124801553|NCT01702571|448904471|FG000|Overall Study|Termination By Sponsor|4|||
124801554|NCT01702571|448904472|FG001|Overall Study|Termination By Sponsor|0|||
124801555|NCT01702571|448904471|FG000|Overall Study|Withdrawal by Subject|177|||
124801556|NCT01702571|448904472|FG001|Overall Study|Withdrawal by Subject|29|||
124801557|NCT01977937|448904479|FG000|Overall Study|Withdrawal by Subject|2|||
124801558|NCT01977937|448904480|FG001|Overall Study|Withdrawal by Subject|1|||
124801559|NCT01977937|448904479|FG000|Overall Study|Adverse Event|1|||
124801560|NCT01977937|448904480|FG001|Overall Study|Adverse Event|0|||
124801561|NCT01977937|448904479|FG000|Overall Study|Physician Decision|0|||
124801562|NCT01977937|448904480|FG001|Overall Study|Physician Decision|1|||
124801563|NCT00915356|448904481|FG000|Overall Study|Withdrawal by Subject|1|||
124801564|NCT00915356|448904482|FG001|Overall Study|Withdrawal by Subject|0|||
124801565|NCT00915356|448904483|FG002|Overall Study|Withdrawal by Subject|0|||
124801566|NCT00915356|448904484|FG003|Overall Study|Withdrawal by Subject|0|||
124801567|NCT00915356|448904485|FG004|Overall Study|Withdrawal by Subject|0|||
124801568|NCT02001181|448904491|FG000|Overall Study|Adverse Event|0|||
124801569|NCT02001181|448904492|FG001|Overall Study|Adverse Event|2|||
124801570|NCT02001181|448904491|FG000|Overall Study|Lost to Follow-up|1|||
124801571|NCT02001181|448904492|FG001|Overall Study|Lost to Follow-up|0|||
124801572|NCT02001181|448904491|FG000|Overall Study|Withdrawal by Subject|0|||
124801573|NCT02001181|448904492|FG001|Overall Study|Withdrawal by Subject|1|||
124801574|NCT00292318|448904493|FG000|Overall Study|Study terminated by officials|2|||
124801575|NCT00292318|448904494|FG001|Overall Study|Study terminated by officials|1|||
124801576|NCT01278160|448904495|FG000|Overall Study|Adverse Event|1|||
124801577|NCT01278160|448904496|FG001|Overall Study|Adverse Event|1|||
124801578|NCT01278160|448904495|FG000|Overall Study|Lost to Follow-up|0|||
124801579|NCT01278160|448904496|FG001|Overall Study|Lost to Follow-up|1|||
124801580|NCT01278160|448904495|FG000|Overall Study|Withdrawal by Subject|3|||
124801581|NCT01278160|448904496|FG001|Overall Study|Withdrawal by Subject|2|||
124801582|NCT01278160|448904495|FG000|Overall Study|Unclassified|1|||
125297284|NCT01555125|450713964|FG000|Extension|Lost to Follow-up|2|||
125297285|NCT01555125|450713965|FG001|Extension|Lost to Follow-up|1|||
125297286|NCT01555125|450713966|FG002|Extension|Lost to Follow-up|2|||
125297287|NCT01555125|450713967|FG003|Extension|Lost to Follow-up|0|||
125297288|NCT01555125|450713968|FG004|Extension|Lost to Follow-up|0|||
125297289|NCT01555125|450713964|FG000|Extension|Study terminated by sponsor|32|||
125297290|NCT01555125|450713965|FG001|Extension|Study terminated by sponsor|33|||
125297291|NCT01555125|450713966|FG002|Extension|Study terminated by sponsor|16|||
125297292|NCT01555125|450713967|FG003|Extension|Study terminated by sponsor|20|||
125297293|NCT01555125|450713968|FG004|Extension|Study terminated by sponsor|0|||
125297294|NCT01555125|450713964|FG000|Extension|Subject/guardian decision|1|||
125297295|NCT01555125|450713965|FG001|Extension|Subject/guardian decision|9|||
125297296|NCT01555125|450713966|FG002|Extension|Subject/guardian decision|1|||
125297297|NCT01555125|450713967|FG003|Extension|Subject/guardian decision|0|||
125297298|NCT01555125|450713968|FG004|Extension|Subject/guardian decision|0|||
125297299|NCT01555125|450713964|FG000|Extension|Technical Problems|1|||
125297300|NCT01555125|450713965|FG001|Extension|Technical Problems|0|||
125297301|NCT01555125|450713966|FG002|Extension|Technical Problems|0|||
125297302|NCT01555125|450713967|FG003|Extension|Technical Problems|1|||
124801583|NCT01278160|448904496|FG001|Overall Study|Unclassified|2|||
124801584|NCT02819518|448904497|FG000|Overall Study|Death|9|||
124801585|NCT02819518|448904498|FG001|Overall Study|Death|12|||
124801586|NCT02819518|448904499|FG002|Overall Study|Death|9|||
124801587|NCT02819518|448904500|FG003|Overall Study|Death|475|||
124801588|NCT02819518|448904501|FG004|Overall Study|Death|244|||
124801589|NCT02819518|448904497|FG000|Overall Study|Withdrawal by Subject|0|||
124801590|NCT02819518|448904498|FG001|Overall Study|Withdrawal by Subject|0|||
124801591|NCT02819518|448904499|FG002|Overall Study|Withdrawal by Subject|0|||
124801592|NCT02819518|448904500|FG003|Overall Study|Withdrawal by Subject|25|||
125297303|NCT01555125|450713968|FG004|Extension|Technical Problems|0|||
125297304|NCT01555125|450713964|FG000|Follow-Up Period|Lost to Follow-up|1|||
125297305|NCT01555125|450713965|FG001|Follow-Up Period|Lost to Follow-up|0|||
124801593|NCT02819518|448904501|FG004|Overall Study|Withdrawal by Subject|8|||
124801594|NCT02819518|448904497|FG000|Overall Study|Lost to Follow-up|0|||
124801595|NCT02819518|448904498|FG001|Overall Study|Lost to Follow-up|0|||
124801596|NCT02819518|448904499|FG002|Overall Study|Lost to Follow-up|0|||
124801597|NCT02819518|448904500|FG003|Overall Study|Lost to Follow-up|0|||
124801598|NCT02819518|448904501|FG004|Overall Study|Lost to Follow-up|1|||
124801599|NCT02819518|448904497|FG000|Overall Study|Sponsor Decision|1|||
124801600|NCT02819518|448904498|FG001|Overall Study|Sponsor Decision|1|||
124801601|NCT02819518|448904499|FG002|Overall Study|Sponsor Decision|0|||
124801602|NCT02819518|448904500|FG003|Overall Study|Sponsor Decision|34|||
124801603|NCT02819518|448904501|FG004|Overall Study|Sponsor Decision|17|||
124801604|NCT02819518|448904497|FG000|Overall Study|Transferred to extension study|1|||
124801605|NCT02819518|448904498|FG001|Overall Study|Transferred to extension study|1|||
124801606|NCT02819518|448904499|FG002|Overall Study|Transferred to extension study|1|||
124801607|NCT02819518|448904500|FG003|Overall Study|Transferred to extension study|32|||
124801608|NCT02819518|448904501|FG004|Overall Study|Transferred to extension study|11|||
124801609|NCT01505647|448904502|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
124801610|NCT01505647|448904503|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
124801611|NCT01505647|448904502|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
124801612|NCT01505647|448904503|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
124801613|NCT01505647|448904502|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
124801614|NCT01505647|448904503|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
124801615|NCT01505647|448904502|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
124801616|NCT01505647|448904503|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
124801617|NCT01505647|448904502|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
124801618|NCT01505647|448904503|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
124801619|NCT03112590|448904504|FG000|Overall Study|Adverse Event|0|||
124801620|NCT03112590|448904505|FG001|Overall Study|Adverse Event|1|||
124801621|NCT03112590|448904506|FG002|Overall Study|Adverse Event|0|||
124801622|NCT00843726|448904507|FG000|Overall Study|Death|1|||
124801623|NCT00843726|448904508|FG001|Overall Study|Death|0|||
124801624|NCT00843726|448904507|FG000|Overall Study|Withdrawal by Subject|0|||
124801625|NCT00843726|448904508|FG001|Overall Study|Withdrawal by Subject|1|||
124801626|NCT00406718|448904509|FG000|Overall Study|Withdrawal by Subject|2|||
124801627|NCT00406718|448904510|FG001|Overall Study|Withdrawal by Subject|9|||
124801628|NCT00406718|448904511|FG002|Overall Study|Withdrawal by Subject|4|||
124801629|NCT00406718|448904509|FG000|Overall Study|Lost to Follow-up|2|||
124801630|NCT00406718|448904510|FG001|Overall Study|Lost to Follow-up|5|||
124801631|NCT00406718|448904511|FG002|Overall Study|Lost to Follow-up|4|||
124801632|NCT02898116|448904519|FG000|Overall Study|Adverse Event|1|||
124801633|NCT02898116|448904519|FG000|Overall Study|Progressive disease|1|||
124801634|NCT05597020|448904522|FG000|Washout|Forbidden medication|2|||
124801635|NCT05597020|448904523|FG001|Washout|Forbidden medication|0|||
124801636|NCT05597020|448904522|FG000|Treatment Period II|Advice from primary care physician|1|||
124801637|NCT05597020|448904523|FG001|Treatment Period II|Advice from primary care physician|0|||
124801638|NCT05597020|448904522|FG000|Treatment Period II|Subject lost investigational product|1|||
124801639|NCT05597020|448904523|FG001|Treatment Period II|Subject lost investigational product|0|||
124801640|NCT05597020|448904522|FG000|Treatment Period II|Private reasons|0|||
124801641|NCT05597020|448904523|FG001|Treatment Period II|Private reasons|1|||
124801642|NCT05169567|448904524|FG000|Overall Study|On study treatment|116|||
124801643|NCT05169567|448904525|FG001|Overall Study|On study treatment|128|||
124801644|NCT05169567|448904524|FG000|Overall Study|Lost to Follow-up|1|||
124801645|NCT05169567|448904525|FG001|Overall Study|Lost to Follow-up|0|||
124801646|NCT05169567|448904524|FG000|Overall Study|Withdrawal by Subject|25|||
124801647|NCT05169567|448904525|FG001|Overall Study|Withdrawal by Subject|21|||
124801648|NCT01015131|448904526|FG000|Overall Study|Physician Decision|1|||
124801649|NCT01015131|448904526|FG000|Overall Study|Protocol Violation|1|||
124801650|NCT01015131|448904526|FG000|Overall Study|Withdrawal by Subject|2|||
124801651|NCT01015131|448904526|FG000|Overall Study|Other Protocol Specified Criteria|4|||
124801652|NCT05430022|448904527|FG000|Overall Study|Withdrawal by Subject|4|||
124801653|NCT05430022|448904528|FG001|Overall Study|Withdrawal by Subject|4|||
124801654|NCT02445391|448904537|FG000|Overall Study|No active protocol treatment|3|||
124801655|NCT02445391|448904538|FG001|Overall Study|No active protocol treatment|0|||
125297306|NCT01555125|450713966|FG002|Follow-Up Period|Lost to Follow-up|0|||
124801656|NCT02445391|448904539|FG002|Overall Study|No active protocol treatment|0|||
124801657|NCT02445391|448904537|FG000|Overall Study|Adverse Event|0|||
124801658|NCT02445391|448904538|FG001|Overall Study|Adverse Event|21|||
124801659|NCT02445391|448904539|FG002|Overall Study|Adverse Event|12|||
124801660|NCT02445391|448904537|FG000|Overall Study|Alternative therapy|0|||
124801661|NCT02445391|448904538|FG001|Overall Study|Alternative therapy|0|||
124801662|NCT02445391|448904539|FG002|Overall Study|Alternative therapy|1|||
124801663|NCT02445391|448904537|FG000|Overall Study|Disease progression|0|||
124801664|NCT02445391|448904538|FG001|Overall Study|Disease progression|7|||
124801665|NCT02445391|448904539|FG002|Overall Study|Disease progression|22|||
125297307|NCT01555125|450713967|FG003|Follow-Up Period|Lost to Follow-up|0|||
124801666|NCT02445391|448904537|FG000|Overall Study|Complicating disease|0|||
124801667|NCT02445391|448904538|FG001|Overall Study|Complicating disease|2|||
124801668|NCT02445391|448904539|FG002|Overall Study|Complicating disease|1|||
124801669|NCT02445391|448904537|FG000|Overall Study|Withdrawal by Subject|0|||
124801670|NCT02445391|448904538|FG001|Overall Study|Withdrawal by Subject|4|||
124801671|NCT02445391|448904539|FG002|Overall Study|Withdrawal by Subject|9|||
124801672|NCT02445391|448904537|FG000|Overall Study|Financial issue|0|||
124801673|NCT02445391|448904538|FG001|Overall Study|Financial issue|0|||
124801674|NCT02445391|448904539|FG002|Overall Study|Financial issue|2|||
124801675|NCT02445391|448904537|FG000|Overall Study|Still on treatment|0|||
124801676|NCT02445391|448904538|FG001|Overall Study|Still on treatment|7|||
125297308|NCT01555125|450713968|FG004|Follow-Up Period|Lost to Follow-up|0|||
125297309|NCT01555125|450713964|FG000|Follow-Up Period|Subject / guardian decision|3|||
125297310|NCT01555125|450713965|FG001|Follow-Up Period|Subject / guardian decision|1|||
125297311|NCT01555125|450713966|FG002|Follow-Up Period|Subject / guardian decision|1|||
124801677|NCT02445391|448904539|FG002|Overall Study|Still on treatment|16|||
124801678|NCT02445391|448904537|FG000|Overall Study|Not start protocol therapy|0|||
124801679|NCT02445391|448904538|FG001|Overall Study|Not start protocol therapy|12|||
124801680|NCT02445391|448904539|FG002|Overall Study|Not start protocol therapy|9|||
124801681|NCT00891462|448906088|FG000|Overall Study|Withdrawal by Subject|9|||
124801682|NCT00891462|448906089|FG001|Overall Study|Withdrawal by Subject|6|||
124801683|NCT00891462|448906090|FG002|Overall Study|Withdrawal by Subject|7|||
124801684|NCT00891462|448906088|FG000|Overall Study|Adverse Event|7|||
124801685|NCT00891462|448906089|FG001|Overall Study|Adverse Event|8|||
124801686|NCT00891462|448906090|FG002|Overall Study|Adverse Event|7|||
124801687|NCT00891462|448906088|FG000|Overall Study|Lack of Efficacy|10|||
124801688|NCT00891462|448906089|FG001|Overall Study|Lack of Efficacy|5|||
124801689|NCT00891462|448906090|FG002|Overall Study|Lack of Efficacy|1|||
124801690|NCT00891462|448906088|FG000|Overall Study|COPD exacerbation|7|||
124801691|NCT00891462|448906089|FG001|Overall Study|COPD exacerbation|4|||
124801692|NCT00891462|448906090|FG002|Overall Study|COPD exacerbation|1|||
124801693|NCT00891462|448906088|FG000|Overall Study|Other Reason|2|||
124801694|NCT00891462|448906089|FG001|Overall Study|Other Reason|5|||
124801695|NCT00891462|448906090|FG002|Overall Study|Other Reason|3|||
124801696|NCT00891462|448906088|FG000|Overall Study|Protocol Violation|2|||
124801697|NCT00891462|448906089|FG001|Overall Study|Protocol Violation|1|||
124801698|NCT00891462|448906090|FG002|Overall Study|Protocol Violation|3|||
124801699|NCT00891462|448906088|FG000|Overall Study|Inclusion/exclusion criteria|0|||
124801700|NCT00891462|448906089|FG001|Overall Study|Inclusion/exclusion criteria|2|||
124801701|NCT00891462|448906090|FG002|Overall Study|Inclusion/exclusion criteria|2|||
124801702|NCT00891462|448906088|FG000|Overall Study|Lost to Follow-up|0|||
124801703|NCT00891462|448906089|FG001|Overall Study|Lost to Follow-up|2|||
124801704|NCT00891462|448906090|FG002|Overall Study|Lost to Follow-up|0|||
124801705|NCT00423722|448906094|FG000|Overall Study|Death|4|||
124801706|NCT00423722|448906095|FG001|Overall Study|Death|4|||
124801707|NCT00423722|448906094|FG000|Overall Study|Declined to participate|2|||
124801708|NCT00423722|448906095|FG001|Overall Study|Declined to participate|3|||
124801709|NCT00423722|448906094|FG000|Overall Study|Unable to complete questionnaires|4|||
125297312|NCT01555125|450713967|FG003|Follow-Up Period|Subject / guardian decision|1|||
125297313|NCT01555125|450713968|FG004|Follow-Up Period|Subject / guardian decision|0|||
125297314|NCT02651220|450713969|FG000|Overall Study|Adverse Event|1|||
125297315|NCT02651220|450713970|FG001|Overall Study|Adverse Event|5|||
125297316|NCT02651220|450713971|FG002|Overall Study|Adverse Event|1|||
125297317|NCT02651220|450713969|FG000|Overall Study|Lost to Follow-up|8|||
125297318|NCT02651220|450713970|FG001|Overall Study|Lost to Follow-up|14|||
125297319|NCT02651220|450713971|FG002|Overall Study|Lost to Follow-up|14|||
125297320|NCT02651220|450713969|FG000|Overall Study|Non-Compliance with Study Drug|4|||
125297321|NCT02651220|450713970|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125297322|NCT02651220|450713971|FG002|Overall Study|Non-Compliance with Study Drug|1|||
125297323|NCT02651220|450713969|FG000|Overall Study|Pregnancy|1|||
125297324|NCT02651220|450713970|FG001|Overall Study|Pregnancy|0|||
125297325|NCT02651220|450713971|FG002|Overall Study|Pregnancy|1|||
125297326|NCT02651220|450713969|FG000|Overall Study|Protocol Violation|0|||
125297327|NCT02651220|450713970|FG001|Overall Study|Protocol Violation|0|||
125297328|NCT02651220|450713971|FG002|Overall Study|Protocol Violation|1|||
125297329|NCT02651220|450713969|FG000|Overall Study|Withdrawal by Subject|5|||
125297330|NCT02651220|450713970|FG001|Overall Study|Withdrawal by Subject|6|||
125297331|NCT02651220|450713971|FG002|Overall Study|Withdrawal by Subject|8|||
125297332|NCT02651220|450713969|FG000|Overall Study|Miscellaneous|4|||
125297333|NCT02651220|450713970|FG001|Overall Study|Miscellaneous|1|||
125297334|NCT02651220|450713971|FG002|Overall Study|Miscellaneous|2|||
125297335|NCT02651220|450713969|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125297336|NCT02651220|450713970|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
124801710|NCT00423722|448906095|FG001|Overall Study|Unable to complete questionnaires|4|||
124801711|NCT00423722|448906094|FG000|Overall Study|Withdrawal by Subject|4|||
124801712|NCT00423722|448906095|FG001|Overall Study|Withdrawal by Subject|2|||
124801713|NCT00518687|448906097|FG000|Overall Study|Adverse Event|201|||
124801714|NCT00518687|448906098|FG001|Overall Study|Adverse Event|177|||
125297337|NCT02651220|450713971|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
125297338|NCT00279812|450713976|FG000|Overall Study|Protocol Violation|1|||
125297339|NCT00279812|450713977|FG001|Overall Study|Protocol Violation|1|||
125297340|NCT00279812|450713978|FG002|Overall Study|Protocol Violation|0|||
125297341|NCT00279812|450713979|FG003|Overall Study|Protocol Violation|0|||
125297342|NCT00279812|450713980|FG004|Overall Study|Protocol Violation|1|||
125297343|NCT00279812|450713981|FG005|Overall Study|Protocol Violation|0|||
125297344|NCT00279812|450713976|FG000|Overall Study|Withdrawal by Subject|0|||
125297345|NCT00279812|450713977|FG001|Overall Study|Withdrawal by Subject|4|||
125297346|NCT00279812|450713978|FG002|Overall Study|Withdrawal by Subject|2|||
125297347|NCT00279812|450713979|FG003|Overall Study|Withdrawal by Subject|0|||
125297348|NCT00279812|450713980|FG004|Overall Study|Withdrawal by Subject|0|||
125297349|NCT00279812|450713981|FG005|Overall Study|Withdrawal by Subject|0|||
125297350|NCT00279812|450713976|FG000|Overall Study|Adverse Event|0|||
125297351|NCT00279812|450713977|FG001|Overall Study|Adverse Event|1|||
125297352|NCT00279812|450713978|FG002|Overall Study|Adverse Event|1|||
125297353|NCT00279812|450713979|FG003|Overall Study|Adverse Event|0|||
125297354|NCT00279812|450713980|FG004|Overall Study|Adverse Event|2|||
125297355|NCT00279812|450713981|FG005|Overall Study|Adverse Event|1|||
125297356|NCT01274429|450713982|FG000|Overall Study|Study closed do to lack of funding|5|||
125297357|NCT01879072|450713990|FG000|Overall Study|Withdrawal by Subject|121|||
125297358|NCT01879072|450713990|FG000|Overall Study|Not Transplanted|30|||
125297359|NCT05327361|450713991|FG000|Overall Study|Lost to Follow-up|4|||
125297360|NCT01439373|450714001|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
125297361|NCT01439373|450714002|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
125297362|NCT01439373|450714001|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
125297363|NCT01439373|450714002|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
125297364|NCT03281304|450714003|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
125297365|NCT03281304|450714004|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
125297366|NCT03281304|450714003|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
125297367|NCT03281304|450714004|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
125297368|NCT03281304|450714003|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
125297369|NCT03281304|450714004|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
125297370|NCT03281304|450714003|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
125297371|NCT03281304|450714004|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
125297372|NCT03281304|450714003|FG000|Treatment Phase (up to 42 Months)|Death|0|||
125297373|NCT03281304|450714004|FG001|Treatment Phase (up to 42 Months)|Death|1|||
125297374|NCT03281304|450714003|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
125297375|NCT03281304|450714004|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
125297376|NCT03281304|450714003|FG000|Treatment Phase (up to 42 Months)|Other|0|||
125297377|NCT03281304|450714004|FG001|Treatment Phase (up to 42 Months)|Other|2|||
124801715|NCT00518687|448906097|FG000|Overall Study|Lost to Follow-up|144|||
124801716|NCT00518687|448906098|FG001|Overall Study|Lost to Follow-up|155|||
124801717|NCT00518687|448906097|FG000|Overall Study|Physician Decision|42|||
124801718|NCT00518687|448906098|FG001|Overall Study|Physician Decision|48|||
124801719|NCT00518687|448906097|FG000|Overall Study|Progressive disease|2|||
124801720|NCT00518687|448906098|FG001|Overall Study|Progressive disease|2|||
124801721|NCT00518687|448906097|FG000|Overall Study|Protocol Violation|8|||
124801722|NCT00518687|448906098|FG001|Overall Study|Protocol Violation|10|||
124801723|NCT00518687|448906097|FG000|Overall Study|Study terminated by sponsor|930|||
124801724|NCT00518687|448906098|FG001|Overall Study|Study terminated by sponsor|918|||
124801725|NCT00518687|448906097|FG000|Overall Study|Withdrawal by Subject|110|||
124801726|NCT00518687|448906098|FG001|Overall Study|Withdrawal by Subject|110|||
124801727|NCT01846104|448906099|FG000|Overall Study|Withdrawal by Subject|1|||
124801728|NCT02095223|448906100|FG000|Overall Study|Withdrawal by Subject|1|||
124801729|NCT02095223|448906101|FG001|Overall Study|Withdrawal by Subject|0|||
124801730|NCT01397162|448906102|FG000|Overall Study|Adverse Event|4|||
124801731|NCT01397162|448906103|FG001|Overall Study|Adverse Event|0|||
124801732|NCT01397162|448906104|FG002|Overall Study|Adverse Event|0|||
124801733|NCT01397162|448906105|FG003|Overall Study|Adverse Event|0|||
124801734|NCT01397162|448906106|FG004|Overall Study|Adverse Event|0|||
124801735|NCT01397162|448906102|FG000|Overall Study|Not yet defined|3|||
124801736|NCT01397162|448906103|FG001|Overall Study|Not yet defined|4|||
124801737|NCT01397162|448906104|FG002|Overall Study|Not yet defined|3|||
124801738|NCT01397162|448906105|FG003|Overall Study|Not yet defined|5|||
124801739|NCT01397162|448906106|FG004|Overall Study|Not yet defined|3|||
124801740|NCT02339285|448906107|FG000|Overall Study|Withdrawal by Subject|0|||
124801741|NCT02339285|448906108|FG001|Overall Study|Withdrawal by Subject|1|||
124801742|NCT02339285|448906109|FG002|Overall Study|Withdrawal by Subject|1|||
124801743|NCT02339285|448906107|FG000|Overall Study|Lost to Follow-up|1|||
124801744|NCT02339285|448906108|FG001|Overall Study|Lost to Follow-up|1|||
124801745|NCT02339285|448906109|FG002|Overall Study|Lost to Follow-up|1|||
124801746|NCT02339285|448906107|FG000|Overall Study|Protocol Deviation|0|||
124801747|NCT02339285|448906108|FG001|Overall Study|Protocol Deviation|1|||
124801748|NCT02339285|448906109|FG002|Overall Study|Protocol Deviation|0|||
124801749|NCT00282412|448906112|FG000|Overall Study|Death|2|||
124801750|NCT00697073|448906113|FG000|Overall Study|Withdrawal by Subject|2|||
124801751|NCT00697073|448906113|FG000|Overall Study|Pregnancy|1|||
124801752|NCT00697073|448906113|FG000|Overall Study|non compliance and other|6|||
124801753|NCT00736957|448906118|FG000|Overall Study|Adverse Event|43|||
124801754|NCT00736957|448906118|FG000|Overall Study|Withdrawal by Subject|49|||
124801755|NCT00736957|448906118|FG000|Overall Study|violation of eligibility criteria|2|||
124801756|NCT00736957|448906118|FG000|Overall Study|did not attend hospital appointments|1|||
124801757|NCT00736957|448906118|FG000|Overall Study|not eligible for Treatment Period I|22|||
124801758|NCT00736957|448906118|FG000|Overall Study|Physician Decision|5|||
124801759|NCT02231918|448906120|FG000|Overall Study|Withdrawal by Subject|0|||
124801760|NCT02231918|448906121|FG001|Overall Study|Withdrawal by Subject|1|||
124801761|NCT02231918|448906122|FG002|Overall Study|Withdrawal by Subject|0|||
124801762|NCT02231918|448906120|FG000|Overall Study|Adverse Event|0|||
124801763|NCT02231918|448906121|FG001|Overall Study|Adverse Event|0|||
124801764|NCT02231918|448906122|FG002|Overall Study|Adverse Event|1|||
124801765|NCT00331864|448906123|FG000|Overall Study|Adverse Event|30|||
124801766|NCT00331864|448906124|FG001|Overall Study|Adverse Event|1|||
124801767|NCT00331864|448906123|FG000|Overall Study|Lack of Efficacy|4|||
124801768|NCT00331864|448906124|FG001|Overall Study|Lack of Efficacy|0|||
124801769|NCT00331864|448906123|FG000|Overall Study|Protocol Violation|3|||
124801770|NCT00331864|448906124|FG001|Overall Study|Protocol Violation|0|||
124801771|NCT00331864|448906123|FG000|Overall Study|Withdrawal by Subject|10|||
124801772|NCT00331864|448906124|FG001|Overall Study|Withdrawal by Subject|0|||
124801773|NCT00331864|448906123|FG000|Overall Study|Lost to Follow-up|4|||
124801774|NCT00331864|448906124|FG001|Overall Study|Lost to Follow-up|3|||
124801775|NCT00331864|448906123|FG000|Overall Study|Administrative Problems|1|||
124801776|NCT00331864|448906124|FG001|Overall Study|Administrative Problems|0|||
124801777|NCT00331864|448906123|FG000|Overall Study|Death|6|||
124801778|NCT00331864|448906124|FG001|Overall Study|Death|0|||
124801779|NCT01092507|448906125|FG000|Overall Study|Withdrawal by Subject|2|||
124801780|NCT01092507|448906126|FG001|Overall Study|Withdrawal by Subject|0|||
124801781|NCT04073368|448906129|FG000|Overall Study|Adverse Event|2|||
124801782|NCT04073368|448906130|FG001|Overall Study|Adverse Event|0|||
124801783|NCT04073368|448906131|FG002|Overall Study|Adverse Event|1|||
124801784|NCT04073368|448906132|FG003|Overall Study|Adverse Event|1|||
124801785|NCT04073368|448906129|FG000|Overall Study|Withdrawal by Subject|2|||
124801786|NCT04073368|448906130|FG001|Overall Study|Withdrawal by Subject|2|||
124801787|NCT04073368|448906131|FG002|Overall Study|Withdrawal by Subject|1|||
124801788|NCT04073368|448906132|FG003|Overall Study|Withdrawal by Subject|1|||
124801789|NCT04073368|448906129|FG000|Overall Study|Lost to Follow-up|1|||
124801790|NCT04073368|448906130|FG001|Overall Study|Lost to Follow-up|1|||
124801791|NCT04073368|448906131|FG002|Overall Study|Lost to Follow-up|1|||
124801792|NCT04073368|448906132|FG003|Overall Study|Lost to Follow-up|0|||
124801793|NCT04073368|448906129|FG000|Overall Study|Protocol Violation|0|||
124801794|NCT04073368|448906130|FG001|Overall Study|Protocol Violation|1|||
124801795|NCT04073368|448906131|FG002|Overall Study|Protocol Violation|0|||
124801796|NCT04073368|448906132|FG003|Overall Study|Protocol Violation|0|||
124801797|NCT04073368|448906129|FG000|Overall Study|Subject noncompliance|7|||
124801798|NCT04073368|448906130|FG001|Overall Study|Subject noncompliance|4|||
124801799|NCT04073368|448906131|FG002|Overall Study|Subject noncompliance|0|||
124801800|NCT04073368|448906132|FG003|Overall Study|Subject noncompliance|0|||
124801801|NCT00145600|448906133|FG000|Overall Study|Death|1|||
124801802|NCT00145600|448906134|FG001|Overall Study|Death|2|||
124801803|NCT00145600|448906135|FG002|Overall Study|Death|2|||
124801804|NCT00145600|448906136|FG003|Overall Study|Death|6|||
124801805|NCT00145600|448906133|FG000|Overall Study|Ineligible|3|||
124801806|NCT00145600|448906134|FG001|Overall Study|Ineligible|0|||
124801807|NCT00145600|448906135|FG002|Overall Study|Ineligible|1|||
124801808|NCT00145600|448906136|FG003|Overall Study|Ineligible|5|||
124801809|NCT00145600|448906133|FG000|Overall Study|Lost to Follow-up|2|||
124801810|NCT00145600|448906134|FG001|Overall Study|Lost to Follow-up|6|||
124801811|NCT00145600|448906135|FG002|Overall Study|Lost to Follow-up|2|||
124801812|NCT00145600|448906136|FG003|Overall Study|Lost to Follow-up|4|||
124801813|NCT00145600|448906133|FG000|Overall Study|Noncompliance|1|||
124801814|NCT00145600|448906134|FG001|Overall Study|Noncompliance|0|||
124801815|NCT00145600|448906135|FG002|Overall Study|Noncompliance|0|||
124801816|NCT00145600|448906136|FG003|Overall Study|Noncompliance|0|||
124801817|NCT00145600|448906133|FG000|Overall Study|Withdrawal by Subject|1|||
124801818|NCT00145600|448906134|FG001|Overall Study|Withdrawal by Subject|2|||
124801819|NCT00145600|448906135|FG002|Overall Study|Withdrawal by Subject|0|||
124801820|NCT00145600|448906136|FG003|Overall Study|Withdrawal by Subject|1|||
125297378|NCT03281304|450714003|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
125297379|NCT03281304|450714004|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
125297380|NCT00626405|450714005|FG000|Overall Study|Deemed Ineligible|1|||
125297381|NCT00626405|450714006|FG001|Overall Study|Deemed Ineligible|0|||
125297382|NCT00626405|450714005|FG000|Overall Study|Withdrawal by Subject|0|||
125297383|NCT00626405|450714006|FG001|Overall Study|Withdrawal by Subject|1|||
125297384|NCT03834220|450714007|FG000|Overall Study|Adverse Event|1|||
125297385|NCT03834220|450714008|FG001|Overall Study|Adverse Event|0|||
125297386|NCT03834220|450714009|FG002|Overall Study|Adverse Event|0|||
125297387|NCT03834220|450714007|FG000|Overall Study|Death|8|||
124801821|NCT01539642|448906142|FG000|Overall Study|Lack of Efficacy|20|||
124801822|NCT01539642|448906143|FG001|Overall Study|Lack of Efficacy|18|||
124801823|NCT01539642|448906142|FG000|Overall Study|Patient ready for early discharge|8|||
124801824|NCT01539642|448906143|FG001|Overall Study|Patient ready for early discharge|7|||
124801825|NCT01539642|448906142|FG000|Overall Study|Adverse Event|6|||
124801826|NCT01539642|448906143|FG001|Overall Study|Adverse Event|4|||
124801827|NCT01539642|448906142|FG000|Overall Study|Withdrawal by Subject|2|||
124801828|NCT01539642|448906143|FG001|Overall Study|Withdrawal by Subject|2|||
124801829|NCT00761579|448906144|FG000|Overall Study|Adverse Event|10|||
124801830|NCT00761579|448906144|FG000|Overall Study|Death|2|||
124801831|NCT00761579|448906144|FG000|Overall Study|Lack of Efficacy|21|||
124801832|NCT00761579|448906144|FG000|Overall Study|Lost to Follow-up|16|||
125297388|NCT03834220|450714008|FG001|Overall Study|Death|1|||
125297389|NCT03834220|450714009|FG002|Overall Study|Death|17|||
125297390|NCT03834220|450714007|FG000|Overall Study|Reason not Specified|9|||
125297391|NCT03834220|450714008|FG001|Overall Study|Reason not Specified|0|||
125297392|NCT03834220|450714009|FG002|Overall Study|Reason not Specified|6|||
125297393|NCT03834220|450714007|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
125297394|NCT03834220|450714008|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
125297395|NCT03834220|450714009|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
125297396|NCT03834220|450714007|FG000|Overall Study|Withdrawal of Consent|2|||
125297397|NCT03834220|450714008|FG001|Overall Study|Withdrawal of Consent|2|||
125297398|NCT03834220|450714009|FG002|Overall Study|Withdrawal of Consent|2|||
125297399|NCT02593318|450714010|FG000|Overall Study|Withdrawal by Subject|1|||
125297400|NCT02593318|450714011|FG001|Overall Study|Withdrawal by Subject|1|||
125297401|NCT02720692|450715595|FG000|Overall Study|Withdrawal by Subject|3|||
125297402|NCT02720692|450715596|FG001|Overall Study|Withdrawal by Subject|0|||
125297403|NCT02720692|450715595|FG000|Overall Study|Physician Decision|1|||
125297404|NCT02720692|450715596|FG001|Overall Study|Physician Decision|0|||
125297405|NCT02720692|450715595|FG000|Overall Study|Lost to Follow-up|8|||
125297406|NCT02720692|450715596|FG001|Overall Study|Lost to Follow-up|3|||
125297407|NCT02720692|450715595|FG000|Overall Study|Subject unable to return for visit|1|||
125297408|NCT02720692|450715596|FG001|Overall Study|Subject unable to return for visit|0|||
125297409|NCT05011513|450715597|FG000|Overall Study|Death|0|||
125297410|NCT05011513|450715598|FG001|Overall Study|Death|1|||
125297411|NCT05011513|450715597|FG000|Overall Study|Lost to Follow-up|4|||
124801833|NCT00761579|448906144|FG000|Overall Study|Pregnancy|1|||
124801834|NCT00761579|448906144|FG000|Overall Study|Withdrawal by Subject|34|||
124801835|NCT00761579|448906144|FG000|Overall Study|Lack of compliance|2|||
124801836|NCT00761579|448906144|FG000|Overall Study|Protocol deviation|1|||
124801837|NCT00761579|448906144|FG000|Overall Study|Drug overdose|1|||
124801838|NCT00761579|448906144|FG000|Overall Study|Aggravation of depression|1|||
125297412|NCT05011513|450715598|FG001|Overall Study|Lost to Follow-up|0|||
125297413|NCT05011513|450715597|FG000|Overall Study|Withdrawal by Subject|18|||
125297414|NCT05011513|450715598|FG001|Overall Study|Withdrawal by Subject|17|||
125297415|NCT05011513|450715597|FG000|Overall Study|Other|4|||
125297416|NCT05011513|450715598|FG001|Overall Study|Other|2|||
125297417|NCT03878758|450715599|FG000|Overall Study|Withdrawal by Subject|1|||
125297418|NCT03878758|450715599|FG000|Overall Study|Protocol defined|2|||
125297419|NCT03878758|450715599|FG000|Overall Study|Improper consent documentation|1|||
125297420|NCT02315560|450715600|FG000|Overall Study|noncompliance by subjects|3|||
125297421|NCT02100969|450715602|FG000|Overall Study|Did not pass screening phase|1|||
125297422|NCT01629953|450715603|FG000|Overall Study|Death|3|||
125297423|NCT01629953|450715604|FG001|Overall Study|Death|1|||
125297424|NCT01629953|450715603|FG000|Overall Study|Lost to Follow-up|10|||
125297425|NCT01629953|450715604|FG001|Overall Study|Lost to Follow-up|14|||
125297426|NCT06359080|450715605|FG000|Overall Study|Withdrawal by Subject|3|||
125297427|NCT00306527|450715608|FG000|Overall Study|Lost to Follow-up|3|||
125297428|NCT00306527|450715609|FG001|Overall Study|Lost to Follow-up|4|||
125297429|NCT00306527|450715610|FG002|Overall Study|Lost to Follow-up|3|||
125297430|NCT00306527|450715611|FG003|Overall Study|Lost to Follow-up|0|||
125297431|NCT00306527|450715608|FG000|Overall Study|Withdrawal by Subject|2|||
125297432|NCT00306527|450715609|FG001|Overall Study|Withdrawal by Subject|3|||
125297433|NCT00306527|450715610|FG002|Overall Study|Withdrawal by Subject|0|||
125297434|NCT00306527|450715611|FG003|Overall Study|Withdrawal by Subject|3|||
125297435|NCT00306527|450715608|FG000|Overall Study|Adverse Event|0|||
125297436|NCT00306527|450715609|FG001|Overall Study|Adverse Event|0|||
125297437|NCT00306527|450715610|FG002|Overall Study|Adverse Event|1|||
125297438|NCT00306527|450715611|FG003|Overall Study|Adverse Event|1|||
125297439|NCT00306527|450715608|FG000|Overall Study|Death|1|||
125297440|NCT00306527|450715609|FG001|Overall Study|Death|0|||
125297441|NCT00306527|450715610|FG002|Overall Study|Death|1|||
125297442|NCT00306527|450715611|FG003|Overall Study|Death|2|||
125297443|NCT04037254|450715612|FG000|Overall Study|Protocol Violation|1|||
125297444|NCT04037254|450715613|FG001|Overall Study|Protocol Violation|0|||
125297445|NCT04037254|450715614|FG002|Overall Study|Protocol Violation|0|||
125297446|NCT04037254|450715615|FG003|Overall Study|Protocol Violation|0|||
125297447|NCT04037254|450715616|FG004|Overall Study|Protocol Violation|0|||
125297448|NCT04037254|450715612|FG000|Overall Study|Withdrawal by Subject|0|||
125297449|NCT04037254|450715613|FG001|Overall Study|Withdrawal by Subject|0|||
125297450|NCT04037254|450715614|FG002|Overall Study|Withdrawal by Subject|1|||
125297451|NCT04037254|450715615|FG003|Overall Study|Withdrawal by Subject|0|||
125297452|NCT04037254|450715616|FG004|Overall Study|Withdrawal by Subject|0|||
125297453|NCT04037254|450715612|FG000|Overall Study|Delayed or incomplete treatment|0|||
125297454|NCT04037254|450715613|FG001|Overall Study|Delayed or incomplete treatment|2|||
125297455|NCT04037254|450715614|FG002|Overall Study|Delayed or incomplete treatment|1|||
125297456|NCT04037254|450715615|FG003|Overall Study|Delayed or incomplete treatment|0|||
124801839|NCT00761579|448906144|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
124801840|NCT00761579|448906144|FG000|Overall Study|Lost survey form|1|||
124801841|NCT00761579|448906144|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
125297457|NCT04037254|450715616|FG004|Overall Study|Delayed or incomplete treatment|0|||
125297458|NCT01023672|450715617|FG000|Overall Study|Worsening disease|2|||
125297459|NCT01023672|450715617|FG000|Overall Study|Death|1|||
125297460|NCT02504580|450715618|FG000|Overall Study|Other|1|||
125297461|NCT02504580|450715619|FG001|Overall Study|Other|0|||
125297462|NCT02504580|450715620|FG002|Overall Study|Other|0|||
125297463|NCT02504580|450715621|FG003|Overall Study|Other|2|||
125297464|NCT02504580|450715622|FG004|Overall Study|Other|1|||
125297465|NCT02504580|450715623|FG005|Overall Study|Other|1|||
125297466|NCT02504580|450715624|FG006|Overall Study|Other|1|||
125297467|NCT02504580|450715625|FG007|Overall Study|Other|2|||
125297468|NCT02504580|450715626|FG008|Overall Study|Other|0|||
125297469|NCT02504580|450715627|FG009|Overall Study|Other|0|||
125297470|NCT02504580|450715628|FG010|Overall Study|Other|0|||
125297471|NCT02504580|450715629|FG011|Overall Study|Other|2|||
125297472|NCT02504580|450715618|FG000|Overall Study|Subject refusal to continue|0|||
125297473|NCT02504580|450715619|FG001|Overall Study|Subject refusal to continue|1|||
125297474|NCT02504580|450715620|FG002|Overall Study|Subject refusal to continue|0|||
125297475|NCT02504580|450715621|FG003|Overall Study|Subject refusal to continue|0|||
125297476|NCT02504580|450715622|FG004|Overall Study|Subject refusal to continue|0|||
125297477|NCT02504580|450715623|FG005|Overall Study|Subject refusal to continue|0|||
125297478|NCT02504580|450715624|FG006|Overall Study|Subject refusal to continue|0|||
125297479|NCT02504580|450715625|FG007|Overall Study|Subject refusal to continue|0|||
125297480|NCT02504580|450715626|FG008|Overall Study|Subject refusal to continue|0|||
125297481|NCT02504580|450715627|FG009|Overall Study|Subject refusal to continue|0|||
124801842|NCT03611010|448906145|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
124801843|NCT03611010|448906146|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
124801844|NCT03611010|448906147|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
124801845|NCT03611010|448906148|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
124801846|NCT00598702|448906149|FG000|Overall Study|Other|0|||
124801847|NCT00598702|448906150|FG001|Overall Study|Other|2|||
124801848|NCT00598702|448906151|FG002|Overall Study|Other|0|||
124801849|NCT00598702|448906152|FG003|Overall Study|Other|0|||
124801850|NCT00598702|448906153|FG004|Overall Study|Other|0|||
124801851|NCT00598702|448906154|FG005|Overall Study|Other|1|||
124801852|NCT00598702|448906155|FG006|Overall Study|Other|0|||
124801853|NCT00598702|448906156|FG007|Overall Study|Other|0|||
124801854|NCT00598702|448906149|FG000|Overall Study|Early discharge from hospital|0|||
124801855|NCT00598702|448906150|FG001|Overall Study|Early discharge from hospital|0|||
124801856|NCT00598702|448906151|FG002|Overall Study|Early discharge from hospital|2|||
124801857|NCT00598702|448906152|FG003|Overall Study|Early discharge from hospital|5|||
124801858|NCT00598702|448906153|FG004|Overall Study|Early discharge from hospital|0|||
124801859|NCT00598702|448906154|FG005|Overall Study|Early discharge from hospital|10|||
124801860|NCT00598702|448906155|FG006|Overall Study|Early discharge from hospital|1|||
124801861|NCT00598702|448906156|FG007|Overall Study|Early discharge from hospital|0|||
124801862|NCT00598702|448906149|FG000|Overall Study|Adverse Event|0|||
124801863|NCT00598702|448906150|FG001|Overall Study|Adverse Event|0|||
124801864|NCT00598702|448906151|FG002|Overall Study|Adverse Event|0|||
124801865|NCT00598702|448906152|FG003|Overall Study|Adverse Event|1|||
124801866|NCT00598702|448906153|FG004|Overall Study|Adverse Event|0|||
124801867|NCT00598702|448906154|FG005|Overall Study|Adverse Event|0|||
124801868|NCT00598702|448906155|FG006|Overall Study|Adverse Event|0|||
124801869|NCT00598702|448906156|FG007|Overall Study|Adverse Event|0|||
124801870|NCT00598702|448906149|FG000|Overall Study|Withdrawal by Subject|0|||
124801871|NCT00598702|448906150|FG001|Overall Study|Withdrawal by Subject|0|||
124801872|NCT00598702|448906151|FG002|Overall Study|Withdrawal by Subject|0|||
124801873|NCT00598702|448906152|FG003|Overall Study|Withdrawal by Subject|1|||
124801874|NCT00598702|448906153|FG004|Overall Study|Withdrawal by Subject|1|||
124801875|NCT00598702|448906154|FG005|Overall Study|Withdrawal by Subject|0|||
124801876|NCT00598702|448906155|FG006|Overall Study|Withdrawal by Subject|0|||
124801877|NCT00598702|448906156|FG007|Overall Study|Withdrawal by Subject|0|||
124801878|NCT00598702|448906149|FG000|Overall Study|Physician Decision|0|||
124801879|NCT00598702|448906150|FG001|Overall Study|Physician Decision|0|||
124801880|NCT00598702|448906151|FG002|Overall Study|Physician Decision|0|||
124801881|NCT00598702|448906152|FG003|Overall Study|Physician Decision|0|||
124801882|NCT00598702|448906153|FG004|Overall Study|Physician Decision|1|||
124801883|NCT00598702|448906154|FG005|Overall Study|Physician Decision|0|||
124801884|NCT00598702|448906155|FG006|Overall Study|Physician Decision|0|||
124801885|NCT00598702|448906156|FG007|Overall Study|Physician Decision|0|||
124801886|NCT00598702|448906149|FG000|Overall Study|Dose limiting toxicity|0|||
124801887|NCT00598702|448906150|FG001|Overall Study|Dose limiting toxicity|0|||
124801888|NCT00598702|448906151|FG002|Overall Study|Dose limiting toxicity|0|||
124801889|NCT00598702|448906152|FG003|Overall Study|Dose limiting toxicity|1|||
124801890|NCT00598702|448906153|FG004|Overall Study|Dose limiting toxicity|1|||
124801891|NCT00598702|448906154|FG005|Overall Study|Dose limiting toxicity|1|||
124801892|NCT00598702|448906155|FG006|Overall Study|Dose limiting toxicity|0|||
124801893|NCT00598702|448906156|FG007|Overall Study|Dose limiting toxicity|0|||
124801894|NCT02600351|448906157|FG000|Overall Study|Lack of Efficacy|3|||
124801895|NCT02600351|448906158|FG001|Overall Study|Lack of Efficacy|0|||
124801896|NCT02600351|448906159|FG002|Overall Study|Lack of Efficacy|5|||
124801897|NCT02600351|448906160|FG003|Overall Study|Lack of Efficacy|2|||
124801898|NCT02600351|448906157|FG000|Overall Study|Lost to Follow-up|1|||
124801899|NCT02600351|448906158|FG001|Overall Study|Lost to Follow-up|0|||
124801900|NCT02600351|448906159|FG002|Overall Study|Lost to Follow-up|0|||
124801901|NCT02600351|448906160|FG003|Overall Study|Lost to Follow-up|0|||
124801902|NCT02600351|448906157|FG000|Overall Study|Randomized but Not Treated|1|||
124801903|NCT02600351|448906158|FG001|Overall Study|Randomized but Not Treated|0|||
124801904|NCT02600351|448906159|FG002|Overall Study|Randomized but Not Treated|1|||
124801905|NCT02600351|448906160|FG003|Overall Study|Randomized but Not Treated|3|||
125297482|NCT02504580|450715628|FG010|Overall Study|Subject refusal to continue|0|||
124801906|NCT04087213|448906163|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
124801907|NCT04087213|448906163|FG000|In-Facility Introduction|Adverse Event|1|||
124801908|NCT04087213|448906163|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
124801909|NCT04087213|448906163|FG000|Assisted Evaluable Period|Personal reasons|3|||
124801910|NCT04087213|448906163|FG000|Transition Period B|Renal Transplantation|1|||
124801911|NCT01859143|448906164|FG000|Overall Study|Lost to Follow-up|2|||
124801912|NCT01859143|448906165|FG001|Overall Study|Lost to Follow-up|0|||
124801913|NCT02413372|448906169|FG000|Treatment|Lost to Follow-up|0|||
124801914|NCT02413372|448906170|FG001|Treatment|Lost to Follow-up|2|||
124801915|NCT02413372|448906171|FG002|Treatment|Lost to Follow-up|1|||
124801916|NCT02413372|448906169|FG000|Treatment|Withdrawal by Subject|1|||
124801917|NCT02413372|448906170|FG001|Treatment|Withdrawal by Subject|0|||
124801918|NCT02413372|448906171|FG002|Treatment|Withdrawal by Subject|0|||
125297483|NCT02504580|450715629|FG011|Overall Study|Subject refusal to continue|0|||
125297484|NCT00448747|450715630|FG000|Overall Study|collapsed veins|1|||
125297485|NCT00448747|450715631|FG001|Overall Study|collapsed veins|0|||
125297486|NCT02429791|450715634|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
125297487|NCT02429791|450715635|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
125297488|NCT02429791|450715634|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
125297489|NCT02429791|450715635|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
125297490|NCT02429791|450715634|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
125297491|NCT02429791|450715635|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
125297492|NCT02429791|450715634|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
124801919|NCT02413372|448906169|FG000|Follow-up|Lost to Follow-up|1|||
124801920|NCT02413372|448906170|FG001|Follow-up|Lost to Follow-up|1|||
124801921|NCT02413372|448906171|FG002|Follow-up|Lost to Follow-up|0|||
124801922|NCT02413372|448906169|FG000|Follow-up|Subject Withdrew Consent|1|||
124801923|NCT02413372|448906170|FG001|Follow-up|Subject Withdrew Consent|0|||
124801924|NCT02413372|448906171|FG002|Follow-up|Subject Withdrew Consent|1|||
124801925|NCT02413372|448906169|FG000|Follow-up|Subject unable to return for visit|0|||
124801926|NCT02413372|448906170|FG001|Follow-up|Subject unable to return for visit|0|||
124801927|NCT02413372|448906171|FG002|Follow-up|Subject unable to return for visit|1|||
124801928|NCT02556203|448906178|FG000|Overall Study|Withdrawal by Subject|21|||
124801929|NCT02556203|448906179|FG001|Overall Study|Withdrawal by Subject|21|||
124801930|NCT02556203|448906178|FG000|Overall Study|Lost to Follow-up|5|||
124801931|NCT02556203|448906179|FG001|Overall Study|Lost to Follow-up|5|||
124801932|NCT02556203|448906178|FG000|Overall Study|Adverse Event|1|||
124801933|NCT02556203|448906179|FG001|Overall Study|Adverse Event|0|||
124801934|NCT04587271|448906180|FG000|Overall Study|Lost to Follow-up|2|||
124801935|NCT04587271|448906181|FG001|Overall Study|Lost to Follow-up|2|||
124801936|NCT04587271|448906182|FG002|Overall Study|Lost to Follow-up|0|||
124801937|NCT04587271|448906183|FG003|Overall Study|Lost to Follow-up|2|||
124801938|NCT04587271|448906184|FG004|Overall Study|Lost to Follow-up|2|||
124801939|NCT04587271|448906185|FG005|Overall Study|Lost to Follow-up|0|||
124801940|NCT04587271|448906180|FG000|Overall Study|Caregiver brought child to visits|0|||
124801941|NCT04587271|448906181|FG001|Overall Study|Caregiver brought child to visits|0|||
124801942|NCT04587271|448906182|FG002|Overall Study|Caregiver brought child to visits|0|||
124801943|NCT04587271|448906183|FG003|Overall Study|Caregiver brought child to visits|1|||
124801944|NCT04587271|448906184|FG004|Overall Study|Caregiver brought child to visits|0|||
124801945|NCT04587271|448906185|FG005|Overall Study|Caregiver brought child to visits|0|||
124801946|NCT02943460|448906189|FG000|Blinded Study Phase|Adverse Event|3|||
124801947|NCT02943460|448906190|FG001|Blinded Study Phase|Adverse Event|0|||
124801948|NCT02943460|448906191|FG002|Blinded Study Phase|Adverse Event|0|||
124801949|NCT02943460|448906189|FG000|Blinded Study Phase|Withdrew Consent|0|||
124801950|NCT02943460|448906190|FG001|Blinded Study Phase|Withdrew Consent|1|||
124801951|NCT02943460|448906191|FG002|Blinded Study Phase|Withdrew Consent|0|||
124801952|NCT02943460|448906189|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
124801953|NCT02943460|448906190|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
124801954|NCT02943460|448906191|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
124801955|NCT02943460|448906189|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
124801956|NCT02943460|448906190|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
124801957|NCT02943460|448906191|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
124801958|NCT02943460|448906189|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
124801959|NCT02943460|448906190|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
124801960|NCT02943460|448906191|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
124801961|NCT01925274|448906192|FG000|Overall Study|Death|1|||
124801962|NCT01925274|448906193|FG001|Overall Study|Death|0|||
124801963|NCT01925274|448906194|FG002|Overall Study|Death|0|||
124801964|NCT01925274|448906192|FG000|Overall Study|Lost to Follow-up|0|||
124801965|NCT01925274|448906193|FG001|Overall Study|Lost to Follow-up|1|||
124801966|NCT01925274|448906194|FG002|Overall Study|Lost to Follow-up|0|||
124801967|NCT01925274|448906192|FG000|Overall Study|Withdrawal by Subject|1|||
125297493|NCT02429791|450715635|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
125297494|NCT02429791|450715634|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
125297495|NCT02429791|450715635|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
124801968|NCT01925274|448906193|FG001|Overall Study|Withdrawal by Subject|2|||
124801969|NCT01925274|448906194|FG002|Overall Study|Withdrawal by Subject|0|||
124801970|NCT01925274|448906192|FG000|Overall Study|Study terminated by sponsor|4|||
124801971|NCT01925274|448906193|FG001|Overall Study|Study terminated by sponsor|0|||
124801972|NCT01925274|448906194|FG002|Overall Study|Study terminated by sponsor|0|||
124801973|NCT01925274|448906192|FG000|Overall Study|Protocol amendment|1|||
124801974|NCT01925274|448906193|FG001|Overall Study|Protocol amendment|3|||
124801975|NCT01925274|448906194|FG002|Overall Study|Protocol amendment|6|||
124801976|NCT01031381|448906197|FG000|Overall Study|Physician Decision|3|||
124801977|NCT01031381|448906197|FG000|Overall Study|Withdrawal by Subject|6|||
124801978|NCT00723398|448906198|FG000|Overall Study|Withdrawal by Subject|2|||
124801979|NCT00723398|448906199|FG001|Overall Study|Withdrawal by Subject|6|||
124801980|NCT00723398|448906200|FG002|Overall Study|Withdrawal by Subject|4|||
124801981|NCT00723398|448906201|FG003|Overall Study|Withdrawal by Subject|4|||
124801982|NCT00723398|448906202|FG004|Overall Study|Withdrawal by Subject|4|||
124801983|NCT00723398|448906198|FG000|Overall Study|Protocol Violation|2|||
124801984|NCT00723398|448906199|FG001|Overall Study|Protocol Violation|1|||
124801985|NCT00723398|448906200|FG002|Overall Study|Protocol Violation|5|||
124801986|NCT00723398|448906201|FG003|Overall Study|Protocol Violation|0|||
124801987|NCT00723398|448906202|FG004|Overall Study|Protocol Violation|0|||
124801988|NCT00723398|448906198|FG000|Overall Study|Physician Decision|2|||
124801989|NCT00723398|448906199|FG001|Overall Study|Physician Decision|2|||
124801990|NCT00723398|448906200|FG002|Overall Study|Physician Decision|5|||
124801991|NCT00723398|448906201|FG003|Overall Study|Physician Decision|0|||
124801992|NCT00723398|448906202|FG004|Overall Study|Physician Decision|1|||
124801993|NCT00723398|448906198|FG000|Overall Study|Adverse Event|0|||
124801994|NCT00723398|448906199|FG001|Overall Study|Adverse Event|5|||
124801995|NCT00723398|448906200|FG002|Overall Study|Adverse Event|3|||
124801996|NCT00723398|448906201|FG003|Overall Study|Adverse Event|1|||
124801997|NCT00723398|448906202|FG004|Overall Study|Adverse Event|4|||
124801998|NCT00723398|448906198|FG000|Overall Study|Lost to Follow-up|0|||
124801999|NCT00723398|448906199|FG001|Overall Study|Lost to Follow-up|1|||
124802000|NCT00723398|448906200|FG002|Overall Study|Lost to Follow-up|0|||
124802001|NCT00723398|448906201|FG003|Overall Study|Lost to Follow-up|0|||
124802002|NCT00723398|448906202|FG004|Overall Study|Lost to Follow-up|0|||
124802003|NCT00580970|448906205|FG000|Pre-treatment|Non-compliance|1|||
124802004|NCT00580970|448906205|FG000|Treatment (Lovastatin)|Non-compliance|6|||
124802005|NCT00580970|448906205|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
124802006|NCT00580970|448906205|FG000|Treatment (Lovastatin)|Physician Decision|4|||
124802007|NCT00580970|448906205|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
124802008|NCT00580970|448906205|FG000|Treatment (Lovastatin)|Death|1|||
124802009|NCT01008150|448906206|FG000|Overall Study|did not receive study drug|1|||
124802010|NCT01008150|448906207|FG001|Overall Study|did not receive study drug|1|||
124802011|NCT01008150|448906208|FG002|Overall Study|did not receive study drug|1|||
124802012|NCT01008150|448906209|FG003|Overall Study|did not receive study drug|0|||
124802013|NCT01400815|448906210|FG000|Overall Study|Adverse Event|3|||
124802014|NCT01400815|448906211|FG001|Overall Study|Adverse Event|0|||
124802015|NCT01400815|448906210|FG000|Overall Study|Death|0|||
124802016|NCT01400815|448906211|FG001|Overall Study|Death|1|||
124802017|NCT01400815|448906210|FG000|Overall Study|Lost to Follow-up|18|||
124802018|NCT01400815|448906211|FG001|Overall Study|Lost to Follow-up|11|||
124802019|NCT01400815|448906210|FG000|Overall Study|Protocol Violation|0|||
124802020|NCT01400815|448906211|FG001|Overall Study|Protocol Violation|1|||
124802021|NCT01400815|448906210|FG000|Overall Study|Physician Decision|1|||
124802022|NCT01400815|448906211|FG001|Overall Study|Physician Decision|0|||
124802023|NCT01400815|448906210|FG000|Overall Study|Withdrawal by Subject|15|||
124802024|NCT01400815|448906211|FG001|Overall Study|Withdrawal by Subject|8|||
124802025|NCT01400815|448906210|FG000|Overall Study|Subject in jail|1|||
124802026|NCT01400815|448906211|FG001|Overall Study|Subject in jail|0|||
124802027|NCT00568685|448906222|FG000|Overall Study|Adverse Event|2|||
124802028|NCT00568685|448906223|FG001|Overall Study|Adverse Event|3|||
124802029|NCT00568685|448906224|FG002|Overall Study|Adverse Event|3|||
124802030|NCT00568685|448906222|FG000|Overall Study|Withdrawal by Subject|7|||
124802031|NCT00568685|448906223|FG001|Overall Study|Withdrawal by Subject|2|||
124802032|NCT00568685|448906224|FG002|Overall Study|Withdrawal by Subject|2|||
124802033|NCT00568685|448906222|FG000|Overall Study|Protocol Violation|1|||
124802034|NCT00568685|448906223|FG001|Overall Study|Protocol Violation|0|||
124802035|NCT00568685|448906224|FG002|Overall Study|Protocol Violation|0|||
124802036|NCT01147172|448906225|FG000|Overall Study|Withdrawal by Subject|2|||
124802037|NCT01147172|448906225|FG000|Overall Study|Lost to Follow-up|2|||
124802038|NCT02787551|448906226|FG000|Core Period: 26 Weeks|Adverse Event|10|||
124802039|NCT02787551|448906227|FG001|Core Period: 26 Weeks|Adverse Event|0|||
124802040|NCT02787551|448906226|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
124802041|NCT02787551|448906227|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
124802042|NCT02787551|448906226|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
124802043|NCT02787551|448906227|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
124802044|NCT02787551|448906226|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
124802045|NCT02787551|448906227|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
124802046|NCT02787551|448906226|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
124802047|NCT02787551|448906227|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
124802048|NCT02787551|448906226|FG000|Core Period: 26 Weeks|Other than specified|3|||
124802049|NCT02787551|448906227|FG001|Core Period: 26 Weeks|Other than specified|1|||
124802050|NCT02787551|448906226|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
124802051|NCT02787551|448906227|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
124802052|NCT02787551|448906226|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
124802053|NCT02787551|448906227|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
124802054|NCT02787551|448906226|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
124802055|NCT02787551|448906227|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
124802056|NCT01638819|448906228|FG000|Overall Study|Lost to Follow-up|1|||
124802057|NCT01638819|448906229|FG001|Overall Study|Lost to Follow-up|0|||
124802058|NCT00237185|448906230|FG000|Core|Adverse Event|3|||
124802059|NCT00237185|448906231|FG001|Core|Adverse Event|4|||
124802060|NCT00237185|448906230|FG000|Core|Abnormal laboratory value|0|||
124802061|NCT00237185|448906231|FG001|Core|Abnormal laboratory value|4|||
124802062|NCT00237185|448906230|FG000|Core|Abnormal test procedure results|1|||
124802063|NCT00237185|448906231|FG001|Core|Abnormal test procedure results|0|||
124802064|NCT00237185|448906230|FG000|Core|Lack of Efficacy|30|||
124802065|NCT00237185|448906231|FG001|Core|Lack of Efficacy|23|||
124802066|NCT00237185|448906230|FG000|Core|Protocol Violation|1|||
124802067|NCT00237185|448906231|FG001|Core|Protocol Violation|1|||
124802068|NCT00237185|448906230|FG000|Core|Withdrawal by Subject|4|||
124802069|NCT00237185|448906231|FG001|Core|Withdrawal by Subject|4|||
124802070|NCT00237185|448906230|FG000|Core|Administrative problems|0|||
124802071|NCT00237185|448906231|FG001|Core|Administrative problems|1|||
124802072|NCT00237185|448906230|FG000|Core|Death|4|||
124802073|NCT00237185|448906231|FG001|Core|Death|0|||
124802074|NCT00237185|448906230|FG000|Core|Determined ineligible post randomization|1|||
124802075|NCT00237185|448906231|FG001|Core|Determined ineligible post randomization|0|||
124802076|NCT00237185|448906230|FG000|Extension|Adverse Event|1|||
124802077|NCT00237185|448906231|FG001|Extension|Adverse Event|0|||
124802078|NCT00237185|448906230|FG000|Extension|Abnormal laboratory value|0|||
124802079|NCT00237185|448906231|FG001|Extension|Abnormal laboratory value|1|||
124802080|NCT00237185|448906230|FG000|Extension|Lack of Efficacy|9|||
124802081|NCT00237185|448906231|FG001|Extension|Lack of Efficacy|14|||
124802082|NCT00237185|448906230|FG000|Extension|Condition no longer required study drug|0|||
124802083|NCT00237185|448906231|FG001|Extension|Condition no longer required study drug|1|||
124802084|NCT00237185|448906230|FG000|Extension|Withdrawal by Subject|3|||
124802085|NCT00237185|448906231|FG001|Extension|Withdrawal by Subject|2|||
124802086|NCT00237185|448906230|FG000|Extension|Lost to Follow-up|1|||
124802087|NCT00237185|448906231|FG001|Extension|Lost to Follow-up|0|||
124802088|NCT00237185|448906230|FG000|Extension|Administrative problems|1|||
124802089|NCT00237185|448906231|FG001|Extension|Administrative problems|0|||
124802090|NCT00237185|448906230|FG000|Extension|Death|1|||
124802091|NCT00237185|448906231|FG001|Extension|Death|1|||
124802092|NCT05069259|448906232|FG000|Overall Study|Withdrawal by Subject|1|||
124802093|NCT05069259|448906232|FG000|Overall Study|Sponsor decision|1|||
124802094|NCT03148275|448906233|FG000|Overall Study|Death|6|||
124802095|NCT03148275|448906233|FG000|Overall Study|Adverse Event|3|||
124802096|NCT03148275|448906233|FG000|Overall Study|Liver transplant|2|||
124802097|NCT03148275|448906233|FG000|Overall Study|Patient decision|5|||
124802098|NCT03148275|448906233|FG000|Overall Study|transition to commercial drug|1|||
124802099|NCT03148275|448906233|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
124802100|NCT03803683|448906234|FG000|Overall Study|Lost to Follow-up|41|||
124802101|NCT03803683|448906235|FG001|Overall Study|Lost to Follow-up|18|||
124802102|NCT03803683|448906236|FG002|Overall Study|Lost to Follow-up|12|||
124802103|NCT03803683|448906234|FG000|Overall Study|Withdrawal by Subject|9|||
124802104|NCT03803683|448906235|FG001|Overall Study|Withdrawal by Subject|1|||
124802105|NCT03803683|448906236|FG002|Overall Study|Withdrawal by Subject|4|||
124802106|NCT01897714|448907582|FG000|Phase I (Dose Escalation)|Disease progression|3|||
124802107|NCT01897714|448907583|FG001|Phase I (Dose Escalation)|Disease progression|5|||
124802108|NCT01897714|448907584|FG002|Phase I (Dose Escalation)|Disease progression|1|||
124802109|NCT01897714|448907585|FG003|Phase I (Dose Escalation)|Disease progression|3|||
124802110|NCT01897714|448907586|FG004|Phase I (Dose Escalation)|Disease progression|0|||
124802111|NCT01897714|448907587|FG005|Phase I (Dose Escalation)|Disease progression|0|||
124802112|NCT01897714|448907582|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
124802113|NCT01897714|448907583|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
124802114|NCT01897714|448907584|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
124802115|NCT01897714|448907585|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
124802116|NCT01897714|448907586|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
124802117|NCT01897714|448907587|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
124802118|NCT01897714|448907582|FG000|Phase I (Dose Escalation)|Other|0|||
124802119|NCT01897714|448907583|FG001|Phase I (Dose Escalation)|Other|1|||
124802120|NCT01897714|448907584|FG002|Phase I (Dose Escalation)|Other|0|||
125297496|NCT02429791|450715634|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
125297497|NCT02429791|450715635|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
124802121|NCT01897714|448907585|FG003|Phase I (Dose Escalation)|Other|0|||
124802122|NCT01897714|448907586|FG004|Phase I (Dose Escalation)|Other|0|||
124802123|NCT01897714|448907587|FG005|Phase I (Dose Escalation)|Other|0|||
124802124|NCT01897714|448907582|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
124802125|NCT01897714|448907583|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
124802126|NCT01897714|448907584|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
124802127|NCT01897714|448907585|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
124802128|NCT01897714|448907586|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
125297498|NCT02429791|450715634|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
125297499|NCT02429791|450715635|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
125297500|NCT02429791|450715634|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
125297501|NCT02429791|450715635|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
125297502|NCT02429791|450715634|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
125297503|NCT02429791|450715635|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
125297504|NCT02429791|450715634|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
125297505|NCT02429791|450715635|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
125297506|NCT02429791|450715634|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
125297507|NCT02429791|450715635|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
125297508|NCT02429791|450715634|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
125297509|NCT02429791|450715635|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
125297510|NCT02429791|450715634|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
125297511|NCT02429791|450715635|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
125297512|NCT02429791|450715634|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
125297513|NCT02429791|450715635|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
125297514|NCT02429791|450715634|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
125297515|NCT02429791|450715635|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
125297516|NCT02429791|450715634|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
125297517|NCT02429791|450715635|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
125297518|NCT02429791|450715634|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
125297519|NCT02429791|450715635|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
125297520|NCT02429791|450715634|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
125297521|NCT02429791|450715635|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
125297522|NCT02166463|450715636|FG000|Overall Study|Lost to Follow-up|0|||
125297523|NCT02166463|450715637|FG001|Overall Study|Lost to Follow-up|1|||
125297524|NCT02166463|450715636|FG000|Overall Study|Physician Decision|10|||
125297525|NCT02166463|450715637|FG001|Overall Study|Physician Decision|10|||
125297526|NCT02166463|450715636|FG000|Overall Study|Ineligible|11|||
125297527|NCT02166463|450715637|FG001|Overall Study|Ineligible|2|||
125297528|NCT02166463|450715636|FG000|Overall Study|Progressive Disease|9|||
125297529|NCT02166463|450715637|FG001|Overall Study|Progressive Disease|6|||
125297530|NCT02166463|450715636|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
125297531|NCT02166463|450715637|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
125297532|NCT02166463|450715636|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
125297533|NCT02166463|450715637|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
125297534|NCT02166463|450715636|FG000|Overall Study|Refusal of further protocol therapy|5|||
125297535|NCT02166463|450715637|FG001|Overall Study|Refusal of further protocol therapy|6|||
125297536|NCT05856227|450715638|FG000|Overall Study|Adverse Event|0|||
125297537|NCT05856227|450715639|FG001|Overall Study|Adverse Event|1|||
125297538|NCT05856227|450715638|FG000|Overall Study|Due to Investigator absence|1|||
125297539|NCT05856227|450715639|FG001|Overall Study|Due to Investigator absence|0|||
125297540|NCT05856227|450715638|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
125297541|NCT05856227|450715639|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
125297542|NCT00771615|450715640|FG000|Overall Study|Withdrawal by Subject|0|||
125297543|NCT00771615|450715641|FG001|Overall Study|Withdrawal by Subject|1|||
125297544|NCT00771615|450715642|FG002|Overall Study|Withdrawal by Subject|0|||
125297545|NCT00771615|450715643|FG003|Overall Study|Withdrawal by Subject|0|||
125297546|NCT00771615|450715644|FG004|Overall Study|Withdrawal by Subject|0|||
125297547|NCT00771615|450715645|FG005|Overall Study|Withdrawal by Subject|0|||
125297548|NCT00771615|450715646|FG006|Overall Study|Withdrawal by Subject|0|||
125297549|NCT00771615|450715647|FG007|Overall Study|Withdrawal by Subject|1|||
125297550|NCT00771615|450715648|FG008|Overall Study|Withdrawal by Subject|0|||
125297551|NCT00771615|450715640|FG000|Overall Study|Lost to Follow-up|1|||
125297552|NCT00771615|450715641|FG001|Overall Study|Lost to Follow-up|1|||
125297553|NCT00771615|450715642|FG002|Overall Study|Lost to Follow-up|1|||
125297554|NCT00771615|450715643|FG003|Overall Study|Lost to Follow-up|1|||
125297555|NCT00771615|450715644|FG004|Overall Study|Lost to Follow-up|0|||
125297556|NCT00771615|450715645|FG005|Overall Study|Lost to Follow-up|1|||
124802129|NCT01897714|448907587|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
124802130|NCT01897714|448907582|FG000|Phase II (MTD)|Lost to Follow-up|0|||
124802131|NCT01897714|448907583|FG001|Phase II (MTD)|Lost to Follow-up|0|||
124802132|NCT01897714|448907584|FG002|Phase II (MTD)|Lost to Follow-up|0|||
124802133|NCT01897714|448907585|FG003|Phase II (MTD)|Lost to Follow-up|0|||
124802134|NCT01897714|448907586|FG004|Phase II (MTD)|Lost to Follow-up|1|||
124802135|NCT01897714|448907587|FG005|Phase II (MTD)|Lost to Follow-up|0|||
124802136|NCT01897714|448907582|FG000|Phase II (MTD)|Death|0|||
124802137|NCT01897714|448907583|FG001|Phase II (MTD)|Death|0|||
124802138|NCT01897714|448907584|FG002|Phase II (MTD)|Death|0|||
124802139|NCT01897714|448907585|FG003|Phase II (MTD)|Death|0|||
124802140|NCT01897714|448907586|FG004|Phase II (MTD)|Death|25|||
124802141|NCT01897714|448907587|FG005|Phase II (MTD)|Death|10|||
124802142|NCT01897714|448907582|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
124802143|NCT01897714|448907583|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
124802144|NCT01897714|448907584|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
124802145|NCT01897714|448907585|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
125297557|NCT00771615|450715646|FG006|Overall Study|Lost to Follow-up|1|||
125297558|NCT00771615|450715647|FG007|Overall Study|Lost to Follow-up|0|||
125297559|NCT00771615|450715648|FG008|Overall Study|Lost to Follow-up|0|||
125297560|NCT02478164|450715649|FG000|Overall Study|Lack of Efficacy|13|||
125297561|NCT02478164|450715649|FG000|Overall Study|Adverse Event|1|||
125297562|NCT02478164|450715649|FG000|Overall Study|Withdrawal by Subject|1|||
125297563|NCT04588389|450715650|FG000|Overall Study|Issues with anesthesia during surgery|2|||
125297564|NCT04588389|450715651|FG001|Overall Study|Issues with anesthesia during surgery|0|||
125297565|NCT04588389|450715652|FG002|Overall Study|Issues with anesthesia during surgery|0|||
125297566|NCT05147662|450715665|FG000|Overall Study|Withdrawal by parent/guardian|3|||
125297567|NCT05147662|450715665|FG000|Overall Study|Assigned to treatment but never treated|1|||
125297568|NCT04676867|450715666|FG000|Overall Study|Screen failure|0|||
125297569|NCT04676867|450715667|FG001|Overall Study|Screen failure|0|||
125297570|NCT04676867|450715668|FG002|Overall Study|Screen failure|6|||
125297571|NCT04676867|450715669|FG003|Overall Study|Screen failure|2|||
125297572|NCT04676867|450715666|FG000|Overall Study|Death|0|||
125297573|NCT04676867|450715667|FG001|Overall Study|Death|0|||
125297574|NCT04676867|450715668|FG002|Overall Study|Death|1|||
125297575|NCT04676867|450715669|FG003|Overall Study|Death|0|||
125297576|NCT04676867|450715666|FG000|Overall Study|Withdrawal by Subject|2|||
125297577|NCT04676867|450715667|FG001|Overall Study|Withdrawal by Subject|2|||
125297578|NCT04676867|450715668|FG002|Overall Study|Withdrawal by Subject|4|||
125297579|NCT04676867|450715669|FG003|Overall Study|Withdrawal by Subject|4|||
125297580|NCT04676867|450715666|FG000|Overall Study|Lost to Follow-up|1|||
125297581|NCT04676867|450715667|FG001|Overall Study|Lost to Follow-up|0|||
125297582|NCT04676867|450715668|FG002|Overall Study|Lost to Follow-up|0|||
125297583|NCT04676867|450715669|FG003|Overall Study|Lost to Follow-up|0|||
125297584|NCT00549770|450715670|FG000|Overall Study|Protocol deviation|1|||
125297585|NCT00549770|450715671|FG001|Overall Study|Protocol deviation|1|||
125297586|NCT00549770|450715672|FG002|Overall Study|Protocol deviation|1|||
125297587|NCT00549770|450715673|FG003|Overall Study|Protocol deviation|2|||
125297588|NCT00549770|450715674|FG004|Overall Study|Protocol deviation|2|||
125297589|NCT00549770|450715675|FG005|Overall Study|Protocol deviation|2|||
125297590|NCT00549770|450715676|FG006|Overall Study|Protocol deviation|1|||
125297591|NCT00549770|450715677|FG007|Overall Study|Protocol deviation|2|||
125297592|NCT00549770|450715670|FG000|Overall Study|Administrative problems|0|||
125297593|NCT00549770|450715671|FG001|Overall Study|Administrative problems|1|||
125297594|NCT00549770|450715672|FG002|Overall Study|Administrative problems|0|||
125297595|NCT00549770|450715673|FG003|Overall Study|Administrative problems|0|||
125297596|NCT00549770|450715674|FG004|Overall Study|Administrative problems|0|||
125297597|NCT00549770|450715675|FG005|Overall Study|Administrative problems|0|||
125297598|NCT00549770|450715676|FG006|Overall Study|Administrative problems|0|||
125297599|NCT00549770|450715677|FG007|Overall Study|Administrative problems|1|||
125297600|NCT00549770|450715670|FG000|Overall Study|Lost to Follow-up|0|||
125297601|NCT00549770|450715671|FG001|Overall Study|Lost to Follow-up|0|||
125297602|NCT00549770|450715672|FG002|Overall Study|Lost to Follow-up|2|||
125297603|NCT00549770|450715673|FG003|Overall Study|Lost to Follow-up|2|||
125297604|NCT00549770|450715674|FG004|Overall Study|Lost to Follow-up|3|||
125297605|NCT00549770|450715675|FG005|Overall Study|Lost to Follow-up|2|||
125297606|NCT00549770|450715676|FG006|Overall Study|Lost to Follow-up|0|||
125297607|NCT00549770|450715677|FG007|Overall Study|Lost to Follow-up|0|||
125297608|NCT00549770|450715670|FG000|Overall Study|Withdrawal by Subject|4|||
124802146|NCT01897714|448907586|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
124802147|NCT01897714|448907587|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
124802148|NCT01897714|448907582|FG000|Phase II (MTD)|Other|0|||
124802149|NCT01897714|448907583|FG001|Phase II (MTD)|Other|0|||
124802150|NCT01897714|448907584|FG002|Phase II (MTD)|Other|0|||
124802151|NCT01897714|448907585|FG003|Phase II (MTD)|Other|0|||
124802152|NCT01897714|448907586|FG004|Phase II (MTD)|Other|3|||
124802153|NCT01897714|448907587|FG005|Phase II (MTD)|Other|0|||
124802154|NCT00851630|448907595|FG000|Overall Study|Death|2|||
124802155|NCT00851630|448907596|FG001|Overall Study|Death|1|||
124802156|NCT00851630|448907595|FG000|Overall Study|Clinical failure|0|||
125297609|NCT00549770|450715671|FG001|Overall Study|Withdrawal by Subject|6|||
125297610|NCT00549770|450715672|FG002|Overall Study|Withdrawal by Subject|4|||
125297611|NCT00549770|450715673|FG003|Overall Study|Withdrawal by Subject|5|||
125297612|NCT00549770|450715674|FG004|Overall Study|Withdrawal by Subject|6|||
125297613|NCT00549770|450715675|FG005|Overall Study|Withdrawal by Subject|6|||
125297614|NCT00549770|450715676|FG006|Overall Study|Withdrawal by Subject|4|||
125297615|NCT00549770|450715677|FG007|Overall Study|Withdrawal by Subject|9|||
125297616|NCT00549770|450715670|FG000|Overall Study|Lack of Efficacy|1|||
125297617|NCT00549770|450715671|FG001|Overall Study|Lack of Efficacy|0|||
124802157|NCT00851630|448907596|FG001|Overall Study|Clinical failure|1|||
124802158|NCT02349061|448907597|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
124802159|NCT02349061|448907598|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
124802160|NCT02349061|448907599|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
124802161|NCT02349061|448907597|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
124802162|NCT02349061|448907598|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
124802163|NCT02349061|448907599|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
125297618|NCT00549770|450715672|FG002|Overall Study|Lack of Efficacy|2|||
125297619|NCT00549770|450715673|FG003|Overall Study|Lack of Efficacy|3|||
125297620|NCT00549770|450715674|FG004|Overall Study|Lack of Efficacy|5|||
125297621|NCT00549770|450715675|FG005|Overall Study|Lack of Efficacy|1|||
125297622|NCT00549770|450715676|FG006|Overall Study|Lack of Efficacy|3|||
125297623|NCT00549770|450715677|FG007|Overall Study|Lack of Efficacy|8|||
125297624|NCT00549770|450715670|FG000|Overall Study|Abnormal test procedure results|0|||
125297625|NCT00549770|450715671|FG001|Overall Study|Abnormal test procedure results|0|||
125297626|NCT00549770|450715672|FG002|Overall Study|Abnormal test procedure results|0|||
125297627|NCT00549770|450715673|FG003|Overall Study|Abnormal test procedure results|2|||
125297628|NCT00549770|450715674|FG004|Overall Study|Abnormal test procedure results|0|||
125297629|NCT00549770|450715675|FG005|Overall Study|Abnormal test procedure results|1|||
125297630|NCT00549770|450715676|FG006|Overall Study|Abnormal test procedure results|1|||
125297631|NCT00549770|450715677|FG007|Overall Study|Abnormal test procedure results|1|||
125297632|NCT00549770|450715670|FG000|Overall Study|Abnormal laboratory values|0|||
125297633|NCT00549770|450715671|FG001|Overall Study|Abnormal laboratory values|0|||
125297634|NCT00549770|450715672|FG002|Overall Study|Abnormal laboratory values|0|||
125297635|NCT00549770|450715673|FG003|Overall Study|Abnormal laboratory values|0|||
125297636|NCT00549770|450715674|FG004|Overall Study|Abnormal laboratory values|0|||
125297637|NCT00549770|450715675|FG005|Overall Study|Abnormal laboratory values|1|||
125297638|NCT00549770|450715676|FG006|Overall Study|Abnormal laboratory values|0|||
125297639|NCT00549770|450715677|FG007|Overall Study|Abnormal laboratory values|0|||
124802164|NCT02349061|448907597|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
124802165|NCT02349061|448907598|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
124802166|NCT02349061|448907599|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
124802167|NCT02349061|448907597|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
124802168|NCT02349061|448907598|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
125297640|NCT00549770|450715670|FG000|Overall Study|Adverse Event|1|||
125297641|NCT00549770|450715671|FG001|Overall Study|Adverse Event|3|||
125297642|NCT00549770|450715672|FG002|Overall Study|Adverse Event|1|||
125297643|NCT00549770|450715673|FG003|Overall Study|Adverse Event|2|||
125297644|NCT00549770|450715674|FG004|Overall Study|Adverse Event|1|||
125297645|NCT00549770|450715675|FG005|Overall Study|Adverse Event|0|||
124802169|NCT02349061|448907599|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
124802170|NCT02349061|448907597|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
124802171|NCT02349061|448907598|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
124802172|NCT02349061|448907599|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
124802173|NCT02349061|448907597|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
124802174|NCT02349061|448907598|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
124802175|NCT02349061|448907599|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
124802176|NCT02349061|448907597|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
124802177|NCT02349061|448907598|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
124802178|NCT02349061|448907599|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
124802179|NCT02349061|448907597|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
124802180|NCT02349061|448907598|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
124802181|NCT02349061|448907599|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
124802182|NCT02349061|448907597|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
125297646|NCT00549770|450715676|FG006|Overall Study|Adverse Event|5|||
125297647|NCT00549770|450715677|FG007|Overall Study|Adverse Event|4|||
125297648|NCT01079936|450715678|FG000|Phase I: MTD|First Remission Status|2|||
125297649|NCT01079936|450715679|FG001|Phase I: MTD|First Remission Status|0|||
125297650|NCT01079936|450715680|FG002|Phase I: MTD|First Remission Status|0|||
125297651|NCT01079936|450715681|FG003|Phase I: MTD|First Remission Status|0|||
125297652|NCT01079936|450715682|FG004|Phase I: MTD|First Remission Status|0|||
125297653|NCT01079936|450715678|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
125297654|NCT01079936|450715679|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
125297655|NCT01079936|450715680|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
125297656|NCT01079936|450715681|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
125297657|NCT01079936|450715682|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
124802183|NCT02349061|448907598|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
124802184|NCT02349061|448907599|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
125297658|NCT01079936|450715678|FG000|Phase II|Adverse Event|0|||
125297659|NCT01079936|450715679|FG001|Phase II|Adverse Event|0|||
125297660|NCT01079936|450715680|FG002|Phase II|Adverse Event|1|||
125297661|NCT01079936|450715681|FG003|Phase II|Adverse Event|0|||
125297662|NCT01079936|450715682|FG004|Phase II|Adverse Event|0|||
125297663|NCT01079936|450715678|FG000|Phase II|Insurance Issue|0|||
125297664|NCT01079936|450715679|FG001|Phase II|Insurance Issue|0|||
125297665|NCT01079936|450715680|FG002|Phase II|Insurance Issue|0|||
125297666|NCT01079936|450715681|FG003|Phase II|Insurance Issue|0|||
125297667|NCT01079936|450715682|FG004|Phase II|Insurance Issue|1|||
125297668|NCT00548717|450715683|FG000|Overall Study|Death|5|||
125297669|NCT00548717|450715684|FG001|Overall Study|Death|2|||
125297670|NCT00548717|450715683|FG000|Overall Study|Relapse|3|||
125297671|NCT00548717|450715684|FG001|Overall Study|Relapse|0|||
125297672|NCT00548717|450715683|FG000|Overall Study|Alternative treatment for GVHD|1|||
125297673|NCT00548717|450715684|FG001|Overall Study|Alternative treatment for GVHD|0|||
125297674|NCT01302054|450715685|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
125297675|NCT01302054|450715686|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
125297676|NCT01302054|450715687|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
125297677|NCT01302054|450715685|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
125297678|NCT01302054|450715686|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
125297679|NCT01302054|450715687|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
125297680|NCT01302054|450715685|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
125297681|NCT01302054|450715686|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
125297682|NCT01302054|450715687|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
125297683|NCT01302054|450715685|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
125297684|NCT01302054|450715686|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
125297685|NCT01302054|450715687|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
125297686|NCT01302054|450715685|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
125297687|NCT01302054|450715686|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
125297688|NCT01302054|450715687|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
125297689|NCT01302054|450715685|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
125297690|NCT01302054|450715686|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
125297691|NCT01302054|450715687|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
125297692|NCT01302054|450715685|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
125297693|NCT01302054|450715686|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
125297694|NCT01302054|450715687|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
125297695|NCT01302054|450715685|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
125297696|NCT01302054|450715686|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
125297697|NCT01302054|450715687|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
125297698|NCT01302054|450715685|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
125297699|NCT01302054|450715686|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
125297700|NCT01302054|450715687|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
125297701|NCT01302054|450715685|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125297702|NCT01302054|450715686|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
125297703|NCT01302054|450715687|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
125297704|NCT01302054|450715685|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
125297705|NCT01302054|450715686|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
125297706|NCT01302054|450715687|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
125297707|NCT01302054|450715685|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
125297708|NCT01302054|450715686|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
125297709|NCT01302054|450715687|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
125297710|NCT01302054|450715685|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
125297711|NCT01302054|450715686|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
125297712|NCT01302054|450715687|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
125297713|NCT01302054|450715685|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
125297714|NCT01302054|450715686|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
125297715|NCT01302054|450715687|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
125297716|NCT01302054|450715685|FG000|Double-Blind Treatment Phase|Other|0|||
125297717|NCT01302054|450715686|FG001|Double-Blind Treatment Phase|Other|4|||
125297718|NCT01302054|450715687|FG002|Double-Blind Treatment Phase|Other|9|||
125297719|NCT00847015|450715688|FG000|Overall Study|Withdrawal by Subject|1|||
125297720|NCT00847015|450715688|FG000|Overall Study|declined any surgery|1|||
125297721|NCT00847015|450715688|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
125297722|NCT02809053|450715689|FG000|Overall Study|Death|0|||
125297723|NCT02809053|450715690|FG001|Overall Study|Death|1|||
125297724|NCT02809053|450715689|FG000|Overall Study|Lost to Follow-up|3|||
125297725|NCT02809053|450715690|FG001|Overall Study|Lost to Follow-up|1|||
125297726|NCT02809053|450715689|FG000|Overall Study|Withdrawal by Subject|2|||
125297727|NCT02809053|450715690|FG001|Overall Study|Withdrawal by Subject|3|||
125297728|NCT02809053|450715689|FG000|Overall Study|Disease Progression|2|||
125297729|NCT02809053|450715690|FG001|Overall Study|Disease Progression|1|||
125297730|NCT02565810|450715693|FG000|Overall Study|Withdrawal by Subject|1|||
125297731|NCT01732913|450715700|FG000|Overall Study|Study Terminated by Sponsor|105|||
125297732|NCT01732913|450715701|FG001|Overall Study|Study Terminated by Sponsor|55|||
125297733|NCT01732913|450715700|FG000|Overall Study|Withdrawal by Subject|27|||
125297734|NCT01732913|450715701|FG001|Overall Study|Withdrawal by Subject|4|||
125297735|NCT01732913|450715700|FG000|Overall Study|Physician Decision|14|||
125297736|NCT01732913|450715701|FG001|Overall Study|Physician Decision|7|||
125297737|NCT01732913|450715700|FG000|Overall Study|Other|7|||
125297738|NCT01732913|450715701|FG001|Overall Study|Other|1|||
125297739|NCT01732913|450715700|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
125297740|NCT01732913|450715701|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
125297741|NCT02925741|450715702|FG000|Overall Study|Withdrawal by Subject|11|||
125297742|NCT02925741|450715703|FG001|Overall Study|Withdrawal by Subject|0|||
125297743|NCT05086510|450715704|FG000|Overall Study|Lost to Follow-up|0|||
125297744|NCT05086510|450715705|FG001|Overall Study|Lost to Follow-up|2|||
125297745|NCT05086510|450715704|FG000|Overall Study|Death|0|||
125297746|NCT05086510|450715705|FG001|Overall Study|Death|2|||
125297747|NCT03022981|450715706|FG000|Overall Study|Adverse Event|0|||
125297748|NCT03022981|450715707|FG001|Overall Study|Adverse Event|1|||
125297749|NCT03022981|450715708|FG002|Overall Study|Adverse Event|0|||
125297750|NCT03022981|450715706|FG000|Overall Study|Investigator's Discretion|0|||
125297751|NCT03022981|450715707|FG001|Overall Study|Investigator's Discretion|1|||
125297752|NCT03022981|450715708|FG002|Overall Study|Investigator's Discretion|2|||
125297753|NCT03022981|450715706|FG000|Overall Study|Lost to Follow-up|6|||
125297754|NCT03022981|450715707|FG001|Overall Study|Lost to Follow-up|2|||
125297755|NCT03022981|450715708|FG002|Overall Study|Lost to Follow-up|1|||
125297756|NCT03022981|450715706|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125297757|NCT03022981|450715707|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125297758|NCT03022981|450715708|FG002|Overall Study|Non-Compliance With Study Drug|2|||
125297759|NCT03022981|450715706|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
125297760|NCT03022981|450715707|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
125297761|NCT03022981|450715708|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
125297762|NCT00295932|450715709|FG000|Overall Study|Not Treated|0|||
125297763|NCT00295932|450715710|FG001|Overall Study|Not Treated|0|||
125297764|NCT00295932|450715711|FG002|Overall Study|Not Treated|0|||
125297765|NCT00295932|450715712|FG003|Overall Study|Not Treated|0|||
125297766|NCT00295932|450715713|FG004|Overall Study|Not Treated|0|||
125297767|NCT00295932|450715714|FG005|Overall Study|Not Treated|0|||
125297768|NCT00295932|450715715|FG006|Overall Study|Not Treated|0|||
125297769|NCT00295932|450715716|FG007|Overall Study|Not Treated|0|||
125297770|NCT00295932|450715717|FG008|Overall Study|Not Treated|0|||
125297771|NCT00295932|450715718|FG009|Overall Study|Not Treated|0|||
125297772|NCT00295932|450715719|FG010|Overall Study|Not Treated|1|||
125297773|NCT04891107|450715720|FG000|Overall Study|Physician Decision|1|||
125297774|NCT04891107|450715720|FG000|Overall Study|Withdrawal by Subject|1|||
125297775|NCT04891107|450715720|FG000|Overall Study|Screen failure after consent|1|||
125297776|NCT01571453|450715721|FG000|Overall Study|Adverse Event|14|||
125297777|NCT01571453|450715722|FG001|Overall Study|Adverse Event|32|||
125297778|NCT01571453|450715721|FG000|Overall Study|Lack of Efficacy|8|||
125297779|NCT01571453|450715722|FG001|Overall Study|Lack of Efficacy|3|||
125297780|NCT01571453|450715721|FG000|Overall Study|Non-compliance|2|||
125297781|NCT01571453|450715722|FG001|Overall Study|Non-compliance|4|||
125297782|NCT01571453|450715721|FG000|Overall Study|Protocol Violation|1|||
125297783|NCT01571453|450715722|FG001|Overall Study|Protocol Violation|5|||
125297784|NCT01571453|450715721|FG000|Overall Study|Withdrawal of consent|5|||
125297785|NCT01571453|450715722|FG001|Overall Study|Withdrawal of consent|13|||
125297786|NCT01571453|450715721|FG000|Overall Study|Lost to Follow-up|4|||
125297787|NCT01571453|450715722|FG001|Overall Study|Lost to Follow-up|2|||
125297788|NCT01571453|450715721|FG000|Overall Study|Administrative or other reason(s)|4|||
125297789|NCT01571453|450715722|FG001|Overall Study|Administrative or other reason(s)|3|||
125297790|NCT00084487|450715729|FG000|Overall Study|Death|1|||
125297791|NCT03040986|450715731|FG000|Overall Study|Hospice|1|||
125297792|NCT03040986|450715732|FG001|Overall Study|Hospice|0|||
125297793|NCT03040986|450715731|FG000|Overall Study|Adverse Event|2|||
124802185|NCT02349061|448907597|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
124802186|NCT02349061|448907598|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
124802187|NCT02349061|448907599|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
124802188|NCT02349061|448907597|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
124802189|NCT02349061|448907598|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
125297794|NCT03040986|450715732|FG001|Overall Study|Adverse Event|1|||
125297795|NCT03040986|450715731|FG000|Overall Study|Disease progression on study|3|||
124802190|NCT02349061|448907599|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
125297796|NCT03040986|450715732|FG001|Overall Study|Disease progression on study|1|||
125297797|NCT02273960|450715733|FG000|Short Term Period|Lost to Follow-up|1|||
125297798|NCT02273960|450715734|FG001|Short Term Period|Lost to Follow-up|0|||
125297799|NCT02273960|450715735|FG002|Short Term Period|Lost to Follow-up|0|||
125297800|NCT02273960|450715736|FG003|Short Term Period|Lost to Follow-up|0|||
125297801|NCT02273960|450715733|FG000|Short Term Period|Lack of Efficacy|0|||
125297802|NCT02273960|450715734|FG001|Short Term Period|Lack of Efficacy|0|||
125297803|NCT02273960|450715735|FG002|Short Term Period|Lack of Efficacy|0|||
125297804|NCT02273960|450715736|FG003|Short Term Period|Lack of Efficacy|1|||
125297805|NCT02273960|450715733|FG000|Short Term Period|ST complete, not entering LTE|4|||
125297806|NCT02273960|450715734|FG001|Short Term Period|ST complete, not entering LTE|6|||
125297807|NCT02273960|450715735|FG002|Short Term Period|ST complete, not entering LTE|4|||
125297808|NCT02273960|450715736|FG003|Short Term Period|ST complete, not entering LTE|5|||
124802191|NCT02349061|448907597|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
124802192|NCT02349061|448907598|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
124802193|NCT02349061|448907599|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
124802194|NCT02349061|448907597|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
124802195|NCT02349061|448907598|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
124802196|NCT02349061|448907599|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
124802197|NCT00398411|448907600|FG000|Overall Study|Death|0|||
124802198|NCT00398411|448907601|FG001|Overall Study|Death|1|||
124802199|NCT00537238|448907602|FG000|Overall Study|Death|1|||
124802200|NCT00537238|448907603|FG001|Overall Study|Death|2|||
124802201|NCT00537238|448907602|FG000|Overall Study|Adverse Event|31|||
124802202|NCT00537238|448907603|FG001|Overall Study|Adverse Event|22|||
124802203|NCT00537238|448907602|FG000|Overall Study|Lack of Efficacy|20|||
124802204|NCT00537238|448907603|FG001|Overall Study|Lack of Efficacy|21|||
124802205|NCT00537238|448907602|FG000|Overall Study|Lost to Follow-up|12|||
124802206|NCT00537238|448907603|FG001|Overall Study|Lost to Follow-up|8|||
124802207|NCT00537238|448907602|FG000|Overall Study|Withdrawal by Subject|51|||
124802208|NCT00537238|448907603|FG001|Overall Study|Withdrawal by Subject|47|||
124802209|NCT00537238|448907602|FG000|Overall Study|Protocol Violation|15|||
124802210|NCT00537238|448907603|FG001|Overall Study|Protocol Violation|19|||
124802211|NCT00537238|448907602|FG000|Overall Study|Does not meet entrance criteria|0|||
124802212|NCT00537238|448907603|FG001|Overall Study|Does not meet entrance criteria|2|||
124802213|NCT00537238|448907602|FG000|Overall Study|Other|44|||
124802214|NCT00537238|448907603|FG001|Overall Study|Other|52|||
124802215|NCT03347188|448907604|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
124802216|NCT03347188|448907605|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
124802217|NCT03347188|448907604|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
124802218|NCT03347188|448907605|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
124802219|NCT03347188|448907604|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
124802220|NCT03347188|448907605|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
124802221|NCT03347188|448907604|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
124802222|NCT03347188|448907605|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
124802223|NCT03347188|448907604|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
124802224|NCT03347188|448907605|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
124802225|NCT03347188|448907604|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
124802226|NCT03347188|448907605|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
124802227|NCT03347188|448907604|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
124802228|NCT03347188|448907605|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
124802229|NCT03347188|448907604|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
124802230|NCT03347188|448907605|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
124802231|NCT01193660|448907606|FG000|Overall Study|Withdrawal by Subject|2|||
124802232|NCT01193660|448907607|FG001|Overall Study|Withdrawal by Subject|3|||
124802233|NCT01193660|448907608|FG002|Overall Study|Withdrawal by Subject|1|||
124802234|NCT01193660|448907606|FG000|Overall Study|Death|1|||
124802235|NCT01193660|448907607|FG001|Overall Study|Death|0|||
124802236|NCT01193660|448907608|FG002|Overall Study|Death|0|||
124802237|NCT01193660|448907606|FG000|Overall Study|Physician Decision|1|||
124802238|NCT01193660|448907607|FG001|Overall Study|Physician Decision|0|||
124802239|NCT01193660|448907608|FG002|Overall Study|Physician Decision|1|||
124802240|NCT02572388|448907609|FG000|Overall Study|Withdrawal by Subject|1|||
124802241|NCT02572388|448907610|FG001|Overall Study|Withdrawal by Subject|1|||
124802242|NCT02572388|448907611|FG002|Overall Study|Withdrawal by Subject|2|||
124802243|NCT02572388|448907612|FG003|Overall Study|Withdrawal by Subject|2|||
124802244|NCT00810108|448907615|FG000|Overall Study|Withdrawal by Subject|1|||
124802245|NCT00810108|448907616|FG001|Overall Study|Withdrawal by Subject|0|||
124802246|NCT01051466|448907617|FG000|Overall Study|Adverse Event|1|||
124802247|NCT01051466|448907618|FG001|Overall Study|Adverse Event|0|||
124802248|NCT01051466|448907617|FG000|Overall Study|Lost to Follow-up|1|||
124802249|NCT01051466|448907618|FG001|Overall Study|Lost to Follow-up|1|||
124802250|NCT01051466|448907617|FG000|Overall Study|Withdrawal by Subject|5|||
124802251|NCT01051466|448907618|FG001|Overall Study|Withdrawal by Subject|1|||
124802252|NCT01051466|448907617|FG000|Overall Study|Entry Criteria Not Met|0|||
124802253|NCT01051466|448907618|FG001|Overall Study|Entry Criteria Not Met|3|||
124802254|NCT01051466|448907617|FG000|Overall Study|Physician Decision|1|||
124802255|NCT01051466|448907618|FG001|Overall Study|Physician Decision|0|||
124802256|NCT01676727|448907625|FG000|Overall Study|Death|18|||
124802257|NCT01676727|448907625|FG000|Overall Study|Withdrawal by Subject|6|||
124802258|NCT01676727|448907625|FG000|Overall Study|Screening failure|5|||
124802259|NCT01676727|448907625|FG000|Overall Study|Not willing to attend 1-year visit|2|||
124802260|NCT01676727|448907625|FG000|Overall Study|Valve explanted|1|||
124802261|NCT01578330|448907626|FG000|Overall Study|Adverse Event|2|||
125297809|NCT02273960|450715733|FG000|Long Term Extension|Death|0|||
124802262|NCT01578330|448907626|FG000|Overall Study|Protocol Violation|5|||
124802263|NCT01086423|448907627|FG000|Overall Study|Protocol Violation|0|||
124802264|NCT01086423|448907628|FG001|Overall Study|Protocol Violation|0|||
124802265|NCT01086423|448907629|FG002|Overall Study|Protocol Violation|1|||
124802266|NCT01086423|448907627|FG000|Overall Study|Migrated/moved from study area|2|||
124802267|NCT01086423|448907628|FG001|Overall Study|Migrated/moved from study area|0|||
124802268|NCT01086423|448907629|FG002|Overall Study|Migrated/moved from study area|4|||
124802269|NCT01086423|448907627|FG000|Overall Study|Adverse event, fatal|1|||
124802270|NCT01086423|448907628|FG001|Overall Study|Adverse event, fatal|1|||
124802271|NCT01086423|448907629|FG002|Overall Study|Adverse event, fatal|0|||
124802272|NCT01086423|448907627|FG000|Overall Study|Adverse event, non-fatal|2|||
124802273|NCT01086423|448907628|FG001|Overall Study|Adverse event, non-fatal|1|||
124802274|NCT01086423|448907629|FG002|Overall Study|Adverse event, non-fatal|0|||
124802275|NCT01086423|448907627|FG000|Overall Study|Withdrawal by Subject|5|||
124802276|NCT01086423|448907628|FG001|Overall Study|Withdrawal by Subject|1|||
124802277|NCT01086423|448907629|FG002|Overall Study|Withdrawal by Subject|3|||
124802278|NCT01086423|448907627|FG000|Overall Study|Lost to Follow-up|0|||
124802279|NCT01086423|448907628|FG001|Overall Study|Lost to Follow-up|0|||
124802280|NCT01086423|448907629|FG002|Overall Study|Lost to Follow-up|1|||
124802281|NCT03114488|448907630|FG000|Time Period 2|Withdrawal by Subject|1|||
124802282|NCT03114488|448907631|FG001|Time Period 2|Withdrawal by Subject|3|||
124802283|NCT00566501|448907632|FG000|Overall Study|Adverse Event|68|||
124802284|NCT00566501|448907633|FG001|Overall Study|Adverse Event|59|||
124802285|NCT00566501|448907632|FG000|Overall Study|Medication Non-compliance|5|||
124802286|NCT00566501|448907633|FG001|Overall Study|Medication Non-compliance|0|||
124802287|NCT00566501|448907632|FG000|Overall Study|Protocol Violation|2|||
124802288|NCT00566501|448907633|FG001|Overall Study|Protocol Violation|2|||
124802289|NCT00566501|448907632|FG000|Overall Study|Request of Investigator or Sponsor|6|||
124802290|NCT00566501|448907633|FG001|Overall Study|Request of Investigator or Sponsor|7|||
124802291|NCT00566501|448907632|FG000|Overall Study|Withdrawal by Subject|33|||
124802292|NCT00566501|448907633|FG001|Overall Study|Withdrawal by Subject|30|||
124802293|NCT00566501|448907632|FG000|Overall Study|Lack of Efficacy|8|||
124802294|NCT00566501|448907633|FG001|Overall Study|Lack of Efficacy|3|||
124802295|NCT00566501|448907632|FG000|Overall Study|Other|25|||
124802296|NCT00566501|448907633|FG001|Overall Study|Other|21|||
124802297|NCT01368432|448907638|FG000|Overall Study|Lost to Follow-up|0|||
124802298|NCT01368432|448907639|FG001|Overall Study|Lost to Follow-up|1|||
124802299|NCT00437320|448907641|FG000|Overall Study|Participant request|2|||
124802300|NCT00437320|448907642|FG001|Overall Study|Participant request|1|||
124802301|NCT00437320|448907643|FG002|Overall Study|Participant request|4|||
124802302|NCT01938573|448907644|FG000|Overall Study|Lack of Efficacy|1|||
124802303|NCT01938573|448907645|FG001|Overall Study|Lack of Efficacy|0|||
124802304|NCT01938573|448907644|FG000|Overall Study|Operation at other hospital|1|||
124802305|NCT01938573|448907645|FG001|Overall Study|Operation at other hospital|0|||
124802306|NCT03845543|448907653|FG000|Overall Study|Death|25|||
124802307|NCT03845543|448907653|FG000|Overall Study|Withdrawal by Subject|2|||
124802308|NCT03845543|448907653|FG000|Overall Study|Lost to Follow-up|12|||
124802309|NCT03845543|448907653|FG000|Overall Study|Adverse Event|17|||
124802310|NCT02456103|448907654|FG000|Overall Study|Study Closure|207|||
124802311|NCT02456103|448907654|FG000|Overall Study|Physician Decision|1|||
124802312|NCT02456103|448907654|FG000|Overall Study|Required prohibited medications|5|||
124802313|NCT02456103|448907654|FG000|Overall Study|Protocol Violation|1|||
124802314|NCT02456103|448907654|FG000|Overall Study|Adverse Event|5|||
124802315|NCT02456103|448907654|FG000|Overall Study|Abnormal Laboratory Value|2|||
124802316|NCT02456103|448907654|FG000|Overall Study|Lost to Follow-up|1|||
124802317|NCT02456103|448907654|FG000|Overall Study|Withdrawal by Subject|24|||
124802318|NCT02448810|448907656|FG000|Overall Study|Adverse Event|0|||
124802319|NCT02448810|448907657|FG001|Overall Study|Adverse Event|0|||
124802320|NCT02448810|448907658|FG002|Overall Study|Adverse Event|1|||
124802321|NCT02448810|448907659|FG003|Overall Study|Adverse Event|0|||
124802322|NCT02448810|448907660|FG004|Overall Study|Adverse Event|0|||
124802323|NCT02448810|448907661|FG005|Overall Study|Adverse Event|0|||
124802324|NCT02448810|448907662|FG006|Overall Study|Adverse Event|0|||
124802325|NCT02448810|448907663|FG007|Overall Study|Adverse Event|0|||
125297810|NCT02273960|450715734|FG001|Long Term Extension|Death|0|||
125297811|NCT02273960|450715735|FG002|Long Term Extension|Death|0|||
124802326|NCT02448810|448907656|FG000|Overall Study|Withdrawal by Subject|0|||
124802327|NCT02448810|448907657|FG001|Overall Study|Withdrawal by Subject|0|||
124802328|NCT02448810|448907658|FG002|Overall Study|Withdrawal by Subject|1|||
124802329|NCT02448810|448907659|FG003|Overall Study|Withdrawal by Subject|0|||
124802330|NCT02448810|448907660|FG004|Overall Study|Withdrawal by Subject|3|||
124802331|NCT02448810|448907661|FG005|Overall Study|Withdrawal by Subject|5|||
124802332|NCT02448810|448907662|FG006|Overall Study|Withdrawal by Subject|0|||
124802333|NCT02448810|448907663|FG007|Overall Study|Withdrawal by Subject|2|||
124802334|NCT02448810|448907656|FG000|Overall Study|Other (study terminated by sponsor)|0|||
124802335|NCT02448810|448907657|FG001|Overall Study|Other (study terminated by sponsor)|0|||
124802336|NCT02448810|448907658|FG002|Overall Study|Other (study terminated by sponsor)|0|||
124802337|NCT02448810|448907659|FG003|Overall Study|Other (study terminated by sponsor)|0|||
124802338|NCT02448810|448907660|FG004|Overall Study|Other (study terminated by sponsor)|4|||
124802339|NCT02448810|448907661|FG005|Overall Study|Other (study terminated by sponsor)|2|||
124802340|NCT02448810|448907662|FG006|Overall Study|Other (study terminated by sponsor)|2|||
124802341|NCT02448810|448907663|FG007|Overall Study|Other (study terminated by sponsor)|1|||
124802342|NCT02448810|448907656|FG000|Overall Study|Death|1|||
124802343|NCT02448810|448907657|FG001|Overall Study|Death|0|||
124802344|NCT02448810|448907658|FG002|Overall Study|Death|1|||
124802345|NCT02448810|448907659|FG003|Overall Study|Death|0|||
124802346|NCT02448810|448907660|FG004|Overall Study|Death|1|||
124802347|NCT02448810|448907661|FG005|Overall Study|Death|0|||
124802348|NCT02448810|448907662|FG006|Overall Study|Death|0|||
124802349|NCT02448810|448907663|FG007|Overall Study|Death|0|||
124802350|NCT02448810|448907656|FG000|Overall Study|Other (Progressive disease)|2|||
125297812|NCT02273960|450715736|FG003|Long Term Extension|Death|1|||
125297813|NCT04033068|450715737|FG000|Overall Study|Withdrawal by Subject|0|||
125297814|NCT04033068|450715738|FG001|Overall Study|Withdrawal by Subject|0|||
125297815|NCT04033068|450715739|FG002|Overall Study|Withdrawal by Subject|1|||
125297816|NCT04033068|450715740|FG003|Overall Study|Withdrawal by Subject|0|||
125297817|NCT04033068|450715737|FG000|Overall Study|Lost to Follow-up|0|||
125297818|NCT04033068|450715738|FG001|Overall Study|Lost to Follow-up|1|||
125297819|NCT04033068|450715739|FG002|Overall Study|Lost to Follow-up|0|||
125297820|NCT04033068|450715740|FG003|Overall Study|Lost to Follow-up|0|||
125297821|NCT04033068|450715737|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
125297822|NCT04033068|450715738|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
125297823|NCT04033068|450715739|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
124802351|NCT02448810|448907657|FG001|Overall Study|Other (Progressive disease)|2|||
124802352|NCT02448810|448907658|FG002|Overall Study|Other (Progressive disease)|0|||
124802353|NCT02448810|448907659|FG003|Overall Study|Other (Progressive disease)|3|||
124802354|NCT02448810|448907660|FG004|Overall Study|Other (Progressive disease)|23|||
124802355|NCT02448810|448907661|FG005|Overall Study|Other (Progressive disease)|9|||
124802356|NCT02448810|448907662|FG006|Overall Study|Other (Progressive disease)|14|||
124802357|NCT02448810|448907663|FG007|Overall Study|Other (Progressive disease)|5|||
124802358|NCT02448810|448907656|FG000|Overall Study|Lost to Follow-up|0|||
124802359|NCT02448810|448907657|FG001|Overall Study|Lost to Follow-up|1|||
124802360|NCT02448810|448907658|FG002|Overall Study|Lost to Follow-up|0|||
124802361|NCT02448810|448907659|FG003|Overall Study|Lost to Follow-up|0|||
124802362|NCT02448810|448907660|FG004|Overall Study|Lost to Follow-up|0|||
124802363|NCT02448810|448907661|FG005|Overall Study|Lost to Follow-up|0|||
124802364|NCT02448810|448907662|FG006|Overall Study|Lost to Follow-up|0|||
124802365|NCT02448810|448907663|FG007|Overall Study|Lost to Follow-up|0|||
124802366|NCT02448810|448907656|FG000|Overall Study|Other (unspecified)|0|||
124802367|NCT02448810|448907657|FG001|Overall Study|Other (unspecified)|0|||
124802368|NCT02448810|448907658|FG002|Overall Study|Other (unspecified)|0|||
124802369|NCT02448810|448907659|FG003|Overall Study|Other (unspecified)|0|||
124802370|NCT02448810|448907660|FG004|Overall Study|Other (unspecified)|0|||
124802371|NCT02448810|448907661|FG005|Overall Study|Other (unspecified)|0|||
124802372|NCT02448810|448907662|FG006|Overall Study|Other (unspecified)|2|||
124802373|NCT02448810|448907663|FG007|Overall Study|Other (unspecified)|0|||
124802374|NCT00470847|448907668|FG000|Overall Study|Pt still receiving treatment|1|||
124802375|NCT03139279|448907676|FG000|Overall Study|Physician Decision|2|||
124802376|NCT03139279|448907677|FG001|Overall Study|Physician Decision|0|||
124802377|NCT03139279|448907676|FG000|Overall Study|Protocol Violation|5|||
124802378|NCT03139279|448907677|FG001|Overall Study|Protocol Violation|4|||
124802379|NCT03139279|448907676|FG000|Overall Study|Withdrawal by Subject|0|||
124802380|NCT03139279|448907677|FG001|Overall Study|Withdrawal by Subject|2|||
124802381|NCT01090973|448907678|FG000|Overall Study|Disease progression|1|||
124802382|NCT01626495|448907681|FG000|Overall Study|Adverse Event|3|||
124802383|NCT01626495|448907681|FG000|Overall Study|Disease progression|27|||
124802384|NCT01626495|448907681|FG000|Overall Study|Withdrawal by Subject|1|||
124802385|NCT01626495|448907681|FG000|Overall Study|Administrative problem|1|||
125297824|NCT04033068|450715740|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
125297825|NCT02039856|450715741|FG000|Overall Study|Death|5|||
125297826|NCT02039856|450715742|FG001|Overall Study|Death|3|||
125297827|NCT02039856|450715741|FG000|Overall Study|Partial survey completion|61|||
124802386|NCT01626495|448907681|FG000|Overall Study|Death|2|||
124802387|NCT01626495|448907681|FG000|Overall Study|Physician Decision|1|||
124802388|NCT01626495|448907681|FG000|Overall Study|New cancer therapy|16|||
125297828|NCT02039856|450715742|FG001|Overall Study|Partial survey completion|26|||
125297829|NCT02039856|450715741|FG000|Overall Study|Lost to Follow-up|388|||
125297830|NCT02039856|450715742|FG001|Overall Study|Lost to Follow-up|206|||
124802389|NCT01626495|448907681|FG000|Overall Study|Manufacturing failure|1|||
124802390|NCT01934972|448907682|FG000|Overall Study|Withdrawal by Subject|9|||
124802391|NCT01934972|448907683|FG001|Overall Study|Withdrawal by Subject|6|||
124802392|NCT03131453|448907684|FG000|Overall Study|Study terminated by Sponsor|424|||
124802393|NCT03131453|448907685|FG001|Overall Study|Study terminated by Sponsor|222|||
124802394|NCT03131453|448907686|FG002|Overall Study|Study terminated by Sponsor|438|||
124802395|NCT03131453|448907684|FG000|Overall Study|Withdrawal by Subject|18|||
124802396|NCT03131453|448907685|FG001|Overall Study|Withdrawal by Subject|7|||
125297831|NCT02039856|450715741|FG000|Overall Study|Withdrawal by Subject|1573|||
124802397|NCT03131453|448907686|FG002|Overall Study|Withdrawal by Subject|13|||
124802398|NCT03131453|448907684|FG000|Overall Study|Adverse Event|10|||
124802399|NCT03131453|448907685|FG001|Overall Study|Adverse Event|3|||
124802400|NCT03131453|448907686|FG002|Overall Study|Adverse Event|3|||
124802401|NCT03131453|448907684|FG000|Overall Study|Lost to Follow-up|1|||
124802402|NCT03131453|448907685|FG001|Overall Study|Lost to Follow-up|0|||
124802403|NCT03131453|448907686|FG002|Overall Study|Lost to Follow-up|1|||
124802404|NCT03131453|448907684|FG000|Overall Study|Physician Decision|1|||
124802405|NCT03131453|448907685|FG001|Overall Study|Physician Decision|0|||
124802406|NCT03131453|448907686|FG002|Overall Study|Physician Decision|1|||
124802407|NCT03131453|448907684|FG000|Overall Study|Non-compliance with study treatment|1|||
124802408|NCT03131453|448907685|FG001|Overall Study|Non-compliance with study treatment|0|||
124802409|NCT03131453|448907686|FG002|Overall Study|Non-compliance with study treatment|0|||
124802410|NCT03131453|448907684|FG000|Overall Study|Technical problems|1|||
124802411|NCT03131453|448907685|FG001|Overall Study|Technical problems|0|||
124802412|NCT03131453|448907686|FG002|Overall Study|Technical problems|0|||
124802413|NCT03131453|448907684|FG000|Overall Study|Protocol deviation|0|||
124802414|NCT03131453|448907685|FG001|Overall Study|Protocol deviation|1|||
124802415|NCT03131453|448907686|FG002|Overall Study|Protocol deviation|0|||
124802416|NCT03438383|448907689|FG000|Overall Study|Protocol Violation|9|||
124802417|NCT03438383|448907690|FG001|Overall Study|Protocol Violation|3|||
124802418|NCT02766465|448907691|FG000|Overall Study|Withdrawal by Subject|0|||
124802419|NCT02766465|448907692|FG001|Overall Study|Withdrawal by Subject|10|||
124802420|NCT02435069|448907693|FG000|Dose Response - First Intervention|Adverse Event|0|||
124802421|NCT02435069|448907694|FG001|Dose Response - First Intervention|Adverse Event|1|||
124802422|NCT02435069|448907695|FG002|Dose Response - First Intervention|Adverse Event|1|||
124802423|NCT02435069|448907696|FG003|Dose Response - First Intervention|Adverse Event|0|||
124802424|NCT02435069|448907697|FG004|Dose Response - First Intervention|Adverse Event|0|||
124802425|NCT02435069|448907693|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
124802426|NCT02435069|448907694|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
124802427|NCT02435069|448907695|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
124802428|NCT02435069|448907696|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
124802429|NCT02435069|448907697|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
124802430|NCT01528033|448907698|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
124802431|NCT01528033|448907699|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
124802432|NCT01528033|448907698|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
124802433|NCT01528033|448907699|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
124802434|NCT01528033|448907698|FG000|Primary Endpoint Assessment ITT|Death|2|||
124802435|NCT01528033|448907699|FG001|Primary Endpoint Assessment ITT|Death|2|||
124802436|NCT01528033|448907698|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
124802437|NCT01528033|448907699|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
124802438|NCT01528033|448907698|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
124802439|NCT01528033|448907699|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
124802440|NCT01528033|448907698|FG000|Follow Up|No data available|46|||
124802441|NCT01528033|448907699|FG001|Follow Up|No data available|44|||
124802442|NCT02520661|448907700|FG000|Overall Study|Lost to Follow-up|7|||
124802443|NCT02520661|448907701|FG001|Overall Study|Lost to Follow-up|3|||
124802444|NCT02520661|448907700|FG000|Overall Study|Admitted from ED|49|||
124802445|NCT02520661|448907701|FG001|Overall Study|Admitted from ED|48|||
124802446|NCT02520661|448907700|FG000|Overall Study|ED greater than 24 hours|29|||
124802447|NCT02520661|448907701|FG001|Overall Study|ED greater than 24 hours|38|||
124802448|NCT02520661|448907700|FG000|Overall Study|other ineligibility|14|||
124802449|NCT02520661|448907701|FG001|Overall Study|other ineligibility|22|||
124802450|NCT02520661|448907700|FG000|Overall Study|Withdrawal by Subject|7|||
124802451|NCT02520661|448907701|FG001|Overall Study|Withdrawal by Subject|16|||
124802452|NCT05156073|448907704|FG000|Overall Study|Patient canceled appointment with PCP|1|||
124802453|NCT02891161|448907715|FG000|Study Treatment|Disease Progression|2|||
124802454|NCT02891161|448907716|FG001|Study Treatment|Disease Progression|4|||
124802455|NCT02891161|448907715|FG000|Study Treatment|AE/Side Effects/Complications|1|||
124802456|NCT02891161|448907716|FG001|Study Treatment|AE/Side Effects/Complications|5|||
124802457|NCT02891161|448907715|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
124802458|NCT02891161|448907716|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
124802459|NCT02891161|448907715|FG000|Follow up|Death|4|||
124802460|NCT02891161|448907716|FG001|Follow up|Death|8|||
124802461|NCT02891161|448907715|FG000|Follow up|Refused to Follow up|0|||
124802462|NCT02891161|448907716|FG001|Follow up|Refused to Follow up|2|||
124802463|NCT02891161|448907715|FG000|Follow up|Symptomatic deterioration|0|||
124802464|NCT02891161|448907716|FG001|Follow up|Symptomatic deterioration|1|||
124802465|NCT02891161|448907715|FG000|Follow up|Study terminated|0|||
124802466|NCT02891161|448907716|FG001|Follow up|Study terminated|6|||
124802467|NCT02734433|448907719|FG000|Overall Study|Disease progression|1|||
124802468|NCT02734433|448907720|FG001|Overall Study|Disease progression|5|||
124802469|NCT02734433|448907719|FG000|Overall Study|Clinical progression|0|||
124802470|NCT02734433|448907720|FG001|Overall Study|Clinical progression|1|||
124802471|NCT02734433|448907719|FG000|Overall Study|Withdrawal by Subject|1|||
124802472|NCT02734433|448907720|FG001|Overall Study|Withdrawal by Subject|2|||
124802473|NCT02628769|448907721|FG000|First Intervention|Adverse Event|1|||
124802474|NCT02628769|448907722|FG001|First Intervention|Adverse Event|0|||
124802475|NCT02628769|448907721|FG000|First Intervention|Withdrawal by Subject|0|||
124802476|NCT02628769|448907722|FG001|First Intervention|Withdrawal by Subject|1|||
124802477|NCT02628769|448907721|FG000|Second Intervention|Adverse Event|2|||
124802478|NCT02628769|448907722|FG001|Second Intervention|Adverse Event|0|||
124802479|NCT02628769|448907721|FG000|Second Intervention|Physician Decision|0|||
124802480|NCT02628769|448907722|FG001|Second Intervention|Physician Decision|1|||
124802481|NCT05521906|448907729|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
124802482|NCT05521906|448907730|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
124802483|NCT00560885|448907731|FG000|Overall Study|Death|7|||
124802484|NCT00560885|448907731|FG000|Overall Study|Withdrawal by Subject|1|||
124802485|NCT02887859|448907732|FG000|Overall Study|Ongoing|6|||
124802486|NCT02887859|448907732|FG000|Overall Study|Adverse Event|7|||
124802487|NCT02887859|448907732|FG000|Overall Study|Death|1|||
124802488|NCT02887859|448907732|FG000|Overall Study|Physician Decision|1|||
124802489|NCT01507298|448910057|FG000|Overall Study|Protocol Violation|0|||
124802490|NCT01507298|448910058|FG001|Overall Study|Protocol Violation|6|||
124802491|NCT01920555|448910059|FG000|Overall Study|Physician Decision|1|||
124802492|NCT01920555|448910060|FG001|Overall Study|Physician Decision|2|||
124802493|NCT01920555|448910061|FG002|Overall Study|Physician Decision|1|||
124802494|NCT01920555|448910062|FG003|Overall Study|Physician Decision|2|||
124802495|NCT01920555|448910063|FG004|Overall Study|Physician Decision|0|||
124802496|NCT01920555|448910059|FG000|Overall Study|Lack of Efficacy|2|||
124802497|NCT01920555|448910060|FG001|Overall Study|Lack of Efficacy|0|||
124802498|NCT01920555|448910061|FG002|Overall Study|Lack of Efficacy|0|||
124802499|NCT01920555|448910062|FG003|Overall Study|Lack of Efficacy|0|||
124802500|NCT01920555|448910063|FG004|Overall Study|Lack of Efficacy|0|||
124802501|NCT01920555|448910059|FG000|Overall Study|Travel Difficulties|1|||
124802502|NCT01920555|448910060|FG001|Overall Study|Travel Difficulties|1|||
124802503|NCT01920555|448910061|FG002|Overall Study|Travel Difficulties|0|||
124802504|NCT01920555|448910062|FG003|Overall Study|Travel Difficulties|0|||
124802505|NCT01920555|448910063|FG004|Overall Study|Travel Difficulties|1|||
124802506|NCT01920555|448910059|FG000|Overall Study|Lost to Follow-up|0|||
124802507|NCT01920555|448910060|FG001|Overall Study|Lost to Follow-up|1|||
124802508|NCT01920555|448910061|FG002|Overall Study|Lost to Follow-up|0|||
124802509|NCT01920555|448910062|FG003|Overall Study|Lost to Follow-up|1|||
124802510|NCT01920555|448910063|FG004|Overall Study|Lost to Follow-up|0|||
124802511|NCT03265665|448910064|FG000|24-week Data Collection|Withdrawal by Subject|2|||
124802512|NCT03265665|448910065|FG001|24-week Data Collection|Withdrawal by Subject|2|||
124802513|NCT03265665|448910064|FG000|24-week Data Collection|Lost to Follow-up|4|||
124802514|NCT03265665|448910065|FG001|24-week Data Collection|Lost to Follow-up|5|||
124802515|NCT03265665|448910064|FG000|36-week Data Collection|Lost to Follow-up|6|||
124802516|NCT03265665|448910065|FG001|36-week Data Collection|Lost to Follow-up|8|||
124802517|NCT01614600|448910066|FG000|Overall Study|Unacceptable fit|1|||
124802518|NCT01614600|448910066|FG000|Overall Study|Discomfort|1|||
124802519|NCT01614600|448910066|FG000|Overall Study|Unable to remove lens at the end of day|1|||
124802520|NCT01614600|448910066|FG000|Overall Study|Protocol deviation|1|||
124802521|NCT01680965|448910067|FG000|Overall Study|Death|0|||
124802522|NCT01680965|448910068|FG001|Overall Study|Death|0|||
124802523|NCT01680965|448910069|FG002|Overall Study|Death|0|||
124802524|NCT01680965|448910070|FG003|Overall Study|Death|6|||
124802525|NCT00195273|448910071|FG000|Overall Study|Adverse Event|9|||
124802526|NCT00195273|448910072|FG001|Overall Study|Adverse Event|9|||
124802527|NCT00195273|448910071|FG000|Overall Study|Protocol deviation|0|||
124802528|NCT00195273|448910072|FG001|Overall Study|Protocol deviation|1|||
124802529|NCT00195273|448910071|FG000|Overall Study|Lack of Efficacy|3|||
124802530|NCT00195273|448910072|FG001|Overall Study|Lack of Efficacy|1|||
124802531|NCT00195273|448910071|FG000|Overall Study|Procedural complications|9|||
124802532|NCT00195273|448910072|FG001|Overall Study|Procedural complications|3|||
124802533|NCT02186873|448910073|FG000|Overall Study|Adverse Event|1|||
124802534|NCT02186873|448910074|FG001|Overall Study|Adverse Event|3|||
124802535|NCT02186873|448910073|FG000|Overall Study|Lack of Efficacy|0|||
124802536|NCT02186873|448910074|FG001|Overall Study|Lack of Efficacy|1|||
124802537|NCT02186873|448910073|FG000|Overall Study|Lost to Follow-up|1|||
124802538|NCT02186873|448910074|FG001|Overall Study|Lost to Follow-up|2|||
124802539|NCT02186873|448910073|FG000|Overall Study|Withdrawal by Subject|7|||
124802540|NCT02186873|448910074|FG001|Overall Study|Withdrawal by Subject|2|||
124802541|NCT00595465|448910075|FG000|Overall Study|Adverse Event|4|||
124802542|NCT00595465|448910076|FG001|Overall Study|Adverse Event|3|||
124802543|NCT00595465|448910077|FG002|Overall Study|Adverse Event|3|||
124802544|NCT00595465|448910075|FG000|Overall Study|Pregnancy|0|||
124802545|NCT00595465|448910076|FG001|Overall Study|Pregnancy|0|||
124802546|NCT00595465|448910077|FG002|Overall Study|Pregnancy|1|||
124802547|NCT00595465|448910075|FG000|Overall Study|Protocol Violation|2|||
124802548|NCT00595465|448910076|FG001|Overall Study|Protocol Violation|1|||
124802549|NCT00595465|448910077|FG002|Overall Study|Protocol Violation|0|||
124802550|NCT00595465|448910075|FG000|Overall Study|Lost to Follow-up|0|||
124802551|NCT00595465|448910076|FG001|Overall Study|Lost to Follow-up|0|||
124802552|NCT00595465|448910077|FG002|Overall Study|Lost to Follow-up|2|||
124802553|NCT00595465|448910075|FG000|Overall Study|administrative reason|0|||
124802554|NCT00595465|448910076|FG001|Overall Study|administrative reason|0|||
124802555|NCT00595465|448910077|FG002|Overall Study|administrative reason|1|||
124802556|NCT02595970|448910078|FG000|Overall Study|Withdrawal by Subject|2|||
124802557|NCT02595970|448910078|FG000|Overall Study|Physician Decision|2|||
124802558|NCT02595970|448910078|FG000|Overall Study|Protocol Violation|4|||
124802559|NCT02595970|448910078|FG000|Overall Study|Adverse Event|5|||
124802560|NCT02595970|448910078|FG000|Overall Study|Lack of Efficacy|7|||
124802561|NCT00107783|448910079|FG000|Overall Study|Adverse Event|0|||
124802562|NCT00107783|448910080|FG001|Overall Study|Adverse Event|2|||
124802563|NCT00107783|448910079|FG000|Overall Study|Death|0|||
124802564|NCT00107783|448910080|FG001|Overall Study|Death|1|||
124802565|NCT00107783|448910079|FG000|Overall Study|Withdrawal by Subject|2|||
124802566|NCT00107783|448910080|FG001|Overall Study|Withdrawal by Subject|0|||
124802567|NCT00107783|448910079|FG000|Overall Study|Second hip replacement|1|||
124802568|NCT00107783|448910080|FG001|Overall Study|Second hip replacement|1|||
124802569|NCT01886716|448910081|FG000|Week 1|Lost to Follow-up|0|||
124802570|NCT01886716|448910082|FG001|Week 1|Lost to Follow-up|0|||
124802571|NCT01886716|448910083|FG002|Week 1|Lost to Follow-up|2|||
124802572|NCT01886716|448910084|FG003|Week 1|Lost to Follow-up|2|||
124802573|NCT01886716|448910081|FG000|Week 2|Lost to Follow-up|3|||
124802574|NCT01886716|448910082|FG001|Week 2|Lost to Follow-up|2|||
124802575|NCT01886716|448910083|FG002|Week 2|Lost to Follow-up|1|||
124802576|NCT01886716|448910084|FG003|Week 2|Lost to Follow-up|3|||
124802577|NCT01886716|448910081|FG000|Week 3|Lost to Follow-up|1|||
124802578|NCT01886716|448910082|FG001|Week 3|Lost to Follow-up|1|||
124802579|NCT01886716|448910083|FG002|Week 3|Lost to Follow-up|0|||
124802580|NCT01886716|448910084|FG003|Week 3|Lost to Follow-up|1|||
124802581|NCT04879225|448910087|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
124802582|NCT04879225|448910087|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
124802583|NCT03894046|448910090|FG000|Overall Study|Protocol Violation|1|||
124802584|NCT03894046|448910091|FG001|Overall Study|Protocol Violation|0|||
124802585|NCT03894046|448910092|FG002|Overall Study|Protocol Violation|0|||
124802586|NCT03894046|448910090|FG000|Overall Study|Adverse Event|0|||
124802587|NCT03894046|448910091|FG001|Overall Study|Adverse Event|1|||
124802588|NCT03894046|448910092|FG002|Overall Study|Adverse Event|0|||
124802589|NCT03894046|448910090|FG000|Overall Study|Withdrawal by Subject|2|||
124802590|NCT03894046|448910091|FG001|Overall Study|Withdrawal by Subject|3|||
124802591|NCT03894046|448910092|FG002|Overall Study|Withdrawal by Subject|1|||
124802592|NCT03894046|448910090|FG000|Overall Study|Death|15|||
124802593|NCT03894046|448910091|FG001|Overall Study|Death|21|||
124802594|NCT03894046|448910092|FG002|Overall Study|Death|4|||
124802595|NCT03894046|448910090|FG000|Overall Study|No growth of ABC|2|||
124802596|NCT03894046|448910091|FG001|Overall Study|No growth of ABC|1|||
124802597|NCT03894046|448910092|FG002|Overall Study|No growth of ABC|0|||
124802598|NCT03894046|448910090|FG000|Overall Study|Physician Decision|1|||
124802599|NCT03894046|448910091|FG001|Overall Study|Physician Decision|1|||
124802600|NCT03894046|448910092|FG002|Overall Study|Physician Decision|1|||
124802601|NCT03894046|448910090|FG000|Overall Study|Prohibited concomitant medication|1|||
124802602|NCT03894046|448910091|FG001|Overall Study|Prohibited concomitant medication|0|||
124802603|NCT03894046|448910092|FG002|Overall Study|Prohibited concomitant medication|0|||
124802604|NCT03894046|448910090|FG000|Overall Study|Transferred to other arm/group|1|||
124802605|NCT03894046|448910091|FG001|Overall Study|Transferred to other arm/group|1|||
124802606|NCT03894046|448910092|FG002|Overall Study|Transferred to other arm/group|0|||
124802607|NCT02367131|448910093|FG000|Overall Study|Adverse Event|64|||
124802608|NCT02367131|448910093|FG000|Overall Study|No visit since the first visit|3|||
124802609|NCT02367131|448910093|FG000|Overall Study|Request by patient|53|||
124802610|NCT02367131|448910093|FG000|Overall Study|Improvement/remission|2|||
124802611|NCT02367131|448910093|FG000|Overall Study|No change/progressive disease|78|||
124802612|NCT02367131|448910093|FG000|Overall Study|Other than stated above|20|||
124802613|NCT02367131|448910093|FG000|Overall Study|Not treated|2|||
124802614|NCT01973569|448910094|FG000|Overall Study|Adverse Event|9|||
124802615|NCT01973569|448910095|FG001|Overall Study|Adverse Event|2|||
124802616|NCT01973569|448910096|FG002|Overall Study|Adverse Event|4|||
124802617|NCT01973569|448910094|FG000|Overall Study|Protocol Violation|2|||
124802618|NCT01973569|448910095|FG001|Overall Study|Protocol Violation|1|||
124802619|NCT01973569|448910096|FG002|Overall Study|Protocol Violation|3|||
124802620|NCT01973569|448910094|FG000|Overall Study|Withdrawal by Subject|7|||
124802621|NCT01973569|448910095|FG001|Overall Study|Withdrawal by Subject|5|||
124802622|NCT01973569|448910096|FG002|Overall Study|Withdrawal by Subject|2|||
124802623|NCT01973569|448910094|FG000|Overall Study|Invasive dental treatment|3|||
124802624|NCT01973569|448910095|FG001|Overall Study|Invasive dental treatment|5|||
124802625|NCT01973569|448910096|FG002|Overall Study|Invasive dental treatment|6|||
124802626|NCT01973569|448910094|FG000|Overall Study|Prohibited concomitant d|1|||
124802627|NCT01973569|448910095|FG001|Overall Study|Prohibited concomitant d|5|||
124802628|NCT01973569|448910096|FG002|Overall Study|Prohibited concomitant d|0|||
124802629|NCT01973569|448910094|FG000|Overall Study|Disease progression|0|||
124802630|NCT01973569|448910095|FG001|Overall Study|Disease progression|3|||
124802631|NCT01973569|448910096|FG002|Overall Study|Disease progression|0|||
124802632|NCT01973569|448910094|FG000|Overall Study|Other|1|||
124802633|NCT01973569|448910095|FG001|Overall Study|Other|1|||
124802634|NCT01973569|448910096|FG002|Overall Study|Other|0|||
124802635|NCT01973569|448910094|FG000|Overall Study|Did not receive study drug|6|||
124802636|NCT01973569|448910095|FG001|Overall Study|Did not receive study drug|3|||
124802637|NCT01973569|448910096|FG002|Overall Study|Did not receive study drug|3|||
124802638|NCT00137631|448910099|FG000|Overall Study|Lost to Follow-up|37|||
124802639|NCT00137631|448910100|FG001|Overall Study|Lost to Follow-up|41|||
124802640|NCT02486302|448910102|FG000|Overall Study|Discontinued prematurely|410|||
124802641|NCT02486302|448910102|FG000|Overall Study|Documentation not completed|255|||
124802642|NCT02486302|448910102|FG000|Overall Study|Excluded due to legal reasons|8|||
124802643|NCT02486302|448910102|FG000|Overall Study|Not treated|3|||
124802644|NCT01871142|448910103|FG000|Overall Study|Adverse Event|1|||
124802645|NCT02063880|448910109|FG000|Overall Study|Death|21|||
124802646|NCT02063880|448910110|FG001|Overall Study|Death|18|||
124802647|NCT02063880|448910109|FG000|Overall Study|Lost to Follow-up|7|||
124802648|NCT02063880|448910110|FG001|Overall Study|Lost to Follow-up|7|||
124802649|NCT02063880|448910109|FG000|Overall Study|Ineligible|0|||
124802650|NCT02063880|448910110|FG001|Overall Study|Ineligible|2|||
124802651|NCT00567593|448910111|FG000|Overall Study|Adverse Event|1|||
124802652|NCT00567593|448910111|FG000|Overall Study|Physician Decision|1|||
124802653|NCT02106910|448910112|FG000|Overall Study|Lost to Follow-up|1|||
124802654|NCT02106910|448910113|FG001|Overall Study|Lost to Follow-up|1|||
124802655|NCT01675427|448910116|FG000|Overall Study|Withdrawal by Subject|7|||
124802656|NCT01675427|448910116|FG000|Overall Study|Participant Refused Sample Collection|18|||
124802657|NCT01675427|448910116|FG000|Overall Study|Sample not Collected by Mistake|2|||
124802658|NCT01675427|448910116|FG000|Overall Study|Lost to Follow-up|5|||
124802659|NCT01675427|448910116|FG000|Overall Study|Other|2|||
124802660|NCT00700570|448910117|FG000|Overall Study|Adverse Event|2|||
124802661|NCT00700570|448910118|FG001|Overall Study|Adverse Event|6|||
124802662|NCT00700570|448910117|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
124802663|NCT00700570|448910118|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
124802664|NCT00700570|448910117|FG000|Overall Study|Disease Progression|8|||
124802665|NCT00700570|448910118|FG001|Overall Study|Disease Progression|11|||
124802666|NCT00700570|448910117|FG000|Overall Study|Withdrawal by Subject|1|||
124802667|NCT00700570|448910118|FG001|Overall Study|Withdrawal by Subject|6|||
124802668|NCT00611533|448910119|FG000|First Intervention (6 Weeks)|Never started study|0|||
124802669|NCT00611533|448910120|FG001|First Intervention (6 Weeks)|Never started study|1|||
124802670|NCT00611533|448910119|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
124802671|NCT00611533|448910120|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
124802672|NCT00611533|448910119|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
124802673|NCT00611533|448910120|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
124802674|NCT05246397|448910123|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
124802675|NCT04327674|448910129|FG000|Overall Study|Protocol Violation|19|||
124802676|NCT01461980|448910130|FG000|Overall Study|Other|9|||
124802677|NCT01461980|448910131|FG001|Overall Study|Other|8|||
124802678|NCT01461980|448910132|FG002|Overall Study|Other|6|||
124802679|NCT01461980|448910130|FG000|Overall Study|Medication error|7|||
124802680|NCT01461980|448910131|FG001|Overall Study|Medication error|5|||
124802681|NCT01461980|448910132|FG002|Overall Study|Medication error|6|||
124802682|NCT01461980|448910130|FG000|Overall Study|Adverse Event|12|||
124802683|NCT01461980|448910131|FG001|Overall Study|Adverse Event|5|||
124802684|NCT01461980|448910132|FG002|Overall Study|Adverse Event|6|||
124802685|NCT01461980|448910130|FG000|Overall Study|Protocol Violation|12|||
124802686|NCT01461980|448910131|FG001|Overall Study|Protocol Violation|19|||
124802687|NCT01461980|448910132|FG002|Overall Study|Protocol Violation|16|||
124802688|NCT01461980|448910130|FG000|Overall Study|No longer meets eligibility criteria|18|||
124802689|NCT01461980|448910131|FG001|Overall Study|No longer meets eligibility criteria|9|||
124802690|NCT01461980|448910132|FG002|Overall Study|No longer meets eligibility criteria|19|||
124802691|NCT01461980|448910130|FG000|Overall Study|Lost to Follow-up|52|||
124802692|NCT01461980|448910131|FG001|Overall Study|Lost to Follow-up|53|||
124802693|NCT01461980|448910132|FG002|Overall Study|Lost to Follow-up|51|||
124802694|NCT01461980|448910130|FG000|Overall Study|No longer willing to participate|52|||
124802695|NCT01461980|448910131|FG001|Overall Study|No longer willing to participate|38|||
124802696|NCT01461980|448910132|FG002|Overall Study|No longer willing to participate|54|||
124802697|NCT01461980|448910130|FG000|Overall Study|Randomized but not vaccinated|4|||
124802698|NCT01461980|448910131|FG001|Overall Study|Randomized but not vaccinated|8|||
124802699|NCT01461980|448910132|FG002|Overall Study|Randomized but not vaccinated|7|||
124802700|NCT00122109|448910133|FG000|Overall Study|Did not meet criteria|6|||
124802701|NCT00122109|448910134|FG001|Overall Study|Did not meet criteria|7|||
124802702|NCT00809354|448910140|FG000|Overall Study|Adverse Event|32|||
124802703|NCT00809354|448910141|FG001|Overall Study|Adverse Event|45|||
124802704|NCT00809354|448910142|FG002|Overall Study|Adverse Event|37|||
124802705|NCT00809354|448910143|FG003|Overall Study|Adverse Event|53|||
124802706|NCT00809354|448910144|FG004|Overall Study|Adverse Event|26|||
124802707|NCT00809354|448910145|FG005|Overall Study|Adverse Event|33|||
124802708|NCT00809354|448910146|FG006|Overall Study|Adverse Event|44|||
124802709|NCT00809354|448910147|FG007|Overall Study|Adverse Event|40|||
124802710|NCT00809354|448910148|FG008|Overall Study|Adverse Event|46|||
124802711|NCT00809354|448910149|FG009|Overall Study|Adverse Event|26|||
124802712|NCT00809354|448910140|FG000|Overall Study|Lack of Efficacy|23|||
124802713|NCT00809354|448910141|FG001|Overall Study|Lack of Efficacy|23|||
124802714|NCT00809354|448910142|FG002|Overall Study|Lack of Efficacy|22|||
124802715|NCT00809354|448910143|FG003|Overall Study|Lack of Efficacy|15|||
124802716|NCT00809354|448910144|FG004|Overall Study|Lack of Efficacy|40|||
124802717|NCT00809354|448910145|FG005|Overall Study|Lack of Efficacy|19|||
124802718|NCT00809354|448910146|FG006|Overall Study|Lack of Efficacy|21|||
124802719|NCT00809354|448910147|FG007|Overall Study|Lack of Efficacy|15|||
124802720|NCT00809354|448910148|FG008|Overall Study|Lack of Efficacy|18|||
124802721|NCT00809354|448910149|FG009|Overall Study|Lack of Efficacy|38|||
124802722|NCT00809354|448910140|FG000|Overall Study|Lost to Follow-up|10|||
124802723|NCT00809354|448910141|FG001|Overall Study|Lost to Follow-up|11|||
124802724|NCT00809354|448910142|FG002|Overall Study|Lost to Follow-up|8|||
124802725|NCT00809354|448910143|FG003|Overall Study|Lost to Follow-up|13|||
124802726|NCT00809354|448910144|FG004|Overall Study|Lost to Follow-up|6|||
124802727|NCT00809354|448910145|FG005|Overall Study|Lost to Follow-up|2|||
124802728|NCT00809354|448910146|FG006|Overall Study|Lost to Follow-up|0|||
124802729|NCT00809354|448910147|FG007|Overall Study|Lost to Follow-up|5|||
124802730|NCT00809354|448910148|FG008|Overall Study|Lost to Follow-up|4|||
124802731|NCT00809354|448910149|FG009|Overall Study|Lost to Follow-up|0|||
124802732|NCT00809354|448910140|FG000|Overall Study|Protocol Violation|7|||
124802733|NCT00809354|448910141|FG001|Overall Study|Protocol Violation|14|||
124802734|NCT00809354|448910142|FG002|Overall Study|Protocol Violation|14|||
124802735|NCT00809354|448910143|FG003|Overall Study|Protocol Violation|12|||
124802736|NCT00809354|448910144|FG004|Overall Study|Protocol Violation|14|||
124802737|NCT00809354|448910145|FG005|Overall Study|Protocol Violation|6|||
124802738|NCT00809354|448910146|FG006|Overall Study|Protocol Violation|4|||
124802739|NCT00809354|448910147|FG007|Overall Study|Protocol Violation|6|||
124802740|NCT00809354|448910148|FG008|Overall Study|Protocol Violation|9|||
124802741|NCT00809354|448910149|FG009|Overall Study|Protocol Violation|3|||
124802742|NCT00809354|448910140|FG000|Overall Study|Withdrawal by Subject|32|||
124802743|NCT00809354|448910141|FG001|Overall Study|Withdrawal by Subject|27|||
124802744|NCT00809354|448910142|FG002|Overall Study|Withdrawal by Subject|31|||
124802745|NCT00809354|448910143|FG003|Overall Study|Withdrawal by Subject|33|||
124802746|NCT00809354|448910144|FG004|Overall Study|Withdrawal by Subject|34|||
124802747|NCT00809354|448910145|FG005|Overall Study|Withdrawal by Subject|29|||
124802748|NCT00809354|448910146|FG006|Overall Study|Withdrawal by Subject|27|||
124802749|NCT00809354|448910147|FG007|Overall Study|Withdrawal by Subject|19|||
124802750|NCT00809354|448910148|FG008|Overall Study|Withdrawal by Subject|18|||
124802751|NCT00809354|448910149|FG009|Overall Study|Withdrawal by Subject|20|||
124802752|NCT00809354|448910140|FG000|Overall Study|Other|10|||
124802753|NCT00809354|448910141|FG001|Overall Study|Other|2|||
124802754|NCT00809354|448910142|FG002|Overall Study|Other|7|||
124802755|NCT00809354|448910143|FG003|Overall Study|Other|10|||
124802756|NCT00809354|448910144|FG004|Overall Study|Other|5|||
124802757|NCT00809354|448910145|FG005|Overall Study|Other|3|||
124802758|NCT00809354|448910146|FG006|Overall Study|Other|2|||
124802759|NCT00809354|448910147|FG007|Overall Study|Other|3|||
124802760|NCT00809354|448910148|FG008|Overall Study|Other|4|||
124802761|NCT00809354|448910149|FG009|Overall Study|Other|3|||
124802762|NCT00809354|448910140|FG000|Overall Study|Study terminated by sponsor|138|||
124802763|NCT00809354|448910141|FG001|Overall Study|Study terminated by sponsor|134|||
125297832|NCT02039856|450715742|FG001|Overall Study|Withdrawal by Subject|618|||
125297833|NCT02409342|450715743|FG000|Overall Study|Death|211|||
124802764|NCT00809354|448910142|FG002|Overall Study|Study terminated by sponsor|129|||
124802765|NCT00809354|448910143|FG003|Overall Study|Study terminated by sponsor|120|||
124802766|NCT00809354|448910144|FG004|Overall Study|Study terminated by sponsor|126|||
125297834|NCT02409342|450715744|FG001|Overall Study|Death|201|||
124802767|NCT00809354|448910145|FG005|Overall Study|Study terminated by sponsor|133|||
124802768|NCT00809354|448910146|FG006|Overall Study|Study terminated by sponsor|124|||
124802769|NCT00809354|448910147|FG007|Overall Study|Study terminated by sponsor|148|||
124802770|NCT00809354|448910148|FG008|Overall Study|Study terminated by sponsor|127|||
124802771|NCT00809354|448910149|FG009|Overall Study|Study terminated by sponsor|135|||
124802772|NCT00809354|448910140|FG000|Overall Study|Withdrawn due to pregnancy|0|||
124802773|NCT00809354|448910141|FG001|Overall Study|Withdrawn due to pregnancy|1|||
124802774|NCT00809354|448910142|FG002|Overall Study|Withdrawn due to pregnancy|0|||
124802775|NCT00809354|448910143|FG003|Overall Study|Withdrawn due to pregnancy|0|||
124802776|NCT00809354|448910144|FG004|Overall Study|Withdrawn due to pregnancy|0|||
124802777|NCT00809354|448910145|FG005|Overall Study|Withdrawn due to pregnancy|0|||
124802778|NCT00809354|448910146|FG006|Overall Study|Withdrawn due to pregnancy|0|||
124802779|NCT00809354|448910147|FG007|Overall Study|Withdrawn due to pregnancy|0|||
124802780|NCT00809354|448910148|FG008|Overall Study|Withdrawn due to pregnancy|0|||
125297835|NCT02409342|450715743|FG000|Overall Study|Withdrawal by Subject|24|||
124802781|NCT00809354|448910149|FG009|Overall Study|Withdrawn due to pregnancy|0|||
124802782|NCT00809354|448910140|FG000|Overall Study|Randomized but not Treated|3|||
124802783|NCT00809354|448910141|FG001|Overall Study|Randomized but not Treated|1|||
124802784|NCT00809354|448910142|FG002|Overall Study|Randomized but not Treated|6|||
124802785|NCT00809354|448910143|FG003|Overall Study|Randomized but not Treated|0|||
124802786|NCT00809354|448910144|FG004|Overall Study|Randomized but not Treated|5|||
124802787|NCT00809354|448910145|FG005|Overall Study|Randomized but not Treated|0|||
124802788|NCT00809354|448910146|FG006|Overall Study|Randomized but not Treated|1|||
124802789|NCT00809354|448910147|FG007|Overall Study|Randomized but not Treated|1|||
124802790|NCT00809354|448910148|FG008|Overall Study|Randomized but not Treated|2|||
124802791|NCT00809354|448910149|FG009|Overall Study|Randomized but not Treated|1|||
124802792|NCT00809354|448910140|FG000|Overall Study|Death|0|||
124802793|NCT00809354|448910141|FG001|Overall Study|Death|0|||
124802794|NCT00809354|448910142|FG002|Overall Study|Death|0|||
125297836|NCT02409342|450715744|FG001|Overall Study|Withdrawal by Subject|17|||
125297837|NCT02409342|450715743|FG000|Overall Study|Study Terminated By Sponsor|48|||
125297838|NCT02409342|450715744|FG001|Overall Study|Study Terminated By Sponsor|59|||
125297839|NCT02409342|450715743|FG000|Overall Study|Lost to Follow-up|3|||
125297840|NCT02409342|450715744|FG001|Overall Study|Lost to Follow-up|5|||
125297841|NCT02409342|450715743|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
125297842|NCT02409342|450715744|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
125297843|NCT02409342|450715743|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
125297844|NCT02409342|450715744|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
125297845|NCT02409342|450715743|FG000|Overall Study|Sponsor Decision|1|||
125297846|NCT02409342|450715744|FG001|Overall Study|Sponsor Decision|0|||
125297847|NCT03908970|450715745|FG000|Overall Study|Adverse Event|7|||
125297848|NCT03908970|450715746|FG001|Overall Study|Adverse Event|21|||
125297849|NCT03908970|450715745|FG000|Overall Study|Physician Decision|1|||
125297850|NCT03908970|450715746|FG001|Overall Study|Physician Decision|4|||
125297851|NCT03908970|450715745|FG000|Overall Study|Withdrawal by Subject|9|||
125297852|NCT03908970|450715746|FG001|Overall Study|Withdrawal by Subject|22|||
125297853|NCT00417963|450717170|FG000|Overall Study|Lost to Follow-up|3|||
125297854|NCT00417963|450717170|FG000|Overall Study|Withdrawal by Subject|18|||
125297855|NCT00417963|450717170|FG000|Overall Study|Death|17|||
125297856|NCT00417963|450717170|FG000|Overall Study|Study device could not be deployed|3|||
125297857|NCT00477152|450717182|FG000|Overall Study|Parent withdrew consent|2|||
125297858|NCT00477152|450717182|FG000|Overall Study|Adverse Event|1|||
125297859|NCT00387725|450717185|FG000|Overall Study|Adverse Event|0|||
125297860|NCT00387725|450717186|FG001|Overall Study|Adverse Event|0|||
125297861|NCT00387725|450717187|FG002|Overall Study|Adverse Event|0|||
125297862|NCT00387725|450717188|FG003|Overall Study|Adverse Event|1|||
125297863|NCT00387725|450717185|FG000|Overall Study|Protocol Violation|0|||
125297864|NCT00387725|450717186|FG001|Overall Study|Protocol Violation|1|||
125297865|NCT00387725|450717187|FG002|Overall Study|Protocol Violation|0|||
125297866|NCT00387725|450717188|FG003|Overall Study|Protocol Violation|0|||
125297867|NCT00387725|450717185|FG000|Overall Study|Withdrawal by Subject|1|||
125297868|NCT00387725|450717186|FG001|Overall Study|Withdrawal by Subject|0|||
125297869|NCT00387725|450717187|FG002|Overall Study|Withdrawal by Subject|1|||
125297870|NCT00387725|450717188|FG003|Overall Study|Withdrawal by Subject|0|||
125297871|NCT00387725|450717185|FG000|Overall Study|Parent/legal guardian request|0|||
125297872|NCT00387725|450717186|FG001|Overall Study|Parent/legal guardian request|0|||
125297873|NCT00387725|450717187|FG002|Overall Study|Parent/legal guardian request|1|||
125297874|NCT00387725|450717188|FG003|Overall Study|Parent/legal guardian request|1|||
125297875|NCT00568126|450717189|FG000|Overall Study|Adverse Event|3|||
125297876|NCT00568126|450717190|FG001|Overall Study|Adverse Event|0|||
125297877|NCT00568126|450717189|FG000|Overall Study|Withdrawal by Subject|2|||
124802795|NCT00809354|448910143|FG003|Overall Study|Death|0|||
124802796|NCT00809354|448910144|FG004|Overall Study|Death|0|||
124802797|NCT00809354|448910145|FG005|Overall Study|Death|0|||
124802798|NCT00809354|448910146|FG006|Overall Study|Death|0|||
124802799|NCT00809354|448910147|FG007|Overall Study|Death|1|||
124802800|NCT00809354|448910148|FG008|Overall Study|Death|0|||
124802801|NCT00809354|448910149|FG009|Overall Study|Death|0|||
124802802|NCT00267189|448910150|FG000|Overall Study|Patient withdrew consent|1|||
124802803|NCT00267189|448910151|FG001|Overall Study|Patient withdrew consent|1|||
125297878|NCT00568126|450717190|FG001|Overall Study|Withdrawal by Subject|3|||
125297879|NCT00568126|450717189|FG000|Overall Study|Lost to Follow-up|4|||
125297880|NCT00568126|450717190|FG001|Overall Study|Lost to Follow-up|3|||
125297881|NCT00568126|450717189|FG000|Overall Study|Lack of Efficacy|0|||
124802804|NCT00267189|448910150|FG000|Overall Study|Death|1|||
124802805|NCT00267189|448910151|FG001|Overall Study|Death|0|||
124802806|NCT00267189|448910150|FG000|Overall Study|Missing|3|||
124802807|NCT00267189|448910151|FG001|Overall Study|Missing|0|||
124802808|NCT00100178|448910152|FG000|Overall Study|Lost to Follow-up|0|||
124802809|NCT00100178|448910153|FG001|Overall Study|Lost to Follow-up|6|||
124802810|NCT00100178|448910154|FG002|Overall Study|Lost to Follow-up|5|||
125297882|NCT00568126|450717190|FG001|Overall Study|Lack of Efficacy|1|||
125297883|NCT00568126|450717189|FG000|Overall Study|Physician Decision|2|||
124802811|NCT00100178|448910152|FG000|Overall Study|Adverse Event|2|||
124802812|NCT00100178|448910153|FG001|Overall Study|Adverse Event|2|||
124802813|NCT00100178|448910154|FG002|Overall Study|Adverse Event|1|||
124802814|NCT00100178|448910152|FG000|Overall Study|Withdrawal by Subject|1|||
124802815|NCT00100178|448910153|FG001|Overall Study|Withdrawal by Subject|1|||
124802816|NCT00100178|448910154|FG002|Overall Study|Withdrawal by Subject|1|||
124802817|NCT00100178|448910152|FG000|Overall Study|Physician Decision|6|||
124802818|NCT00100178|448910153|FG001|Overall Study|Physician Decision|1|||
124802819|NCT00100178|448910154|FG002|Overall Study|Physician Decision|3|||
124802820|NCT03257371|448910155|FG000|Overall Study|Lost to Follow-up|1|||
124802821|NCT02477839|448910158|FG000|Overall Study|Adverse Event|0|||
124802822|NCT02477839|448910159|FG001|Overall Study|Adverse Event|1|||
124802823|NCT02477839|448910158|FG000|Overall Study|Protocol Violation|0|||
124802824|NCT02477839|448910159|FG001|Overall Study|Protocol Violation|2|||
124802825|NCT02477839|448910158|FG000|Overall Study|Withdrawal by Subject|3|||
124802826|NCT02477839|448910159|FG001|Overall Study|Withdrawal by Subject|3|||
124802827|NCT02477839|448910158|FG000|Overall Study|Participant had PGS during V6|0|||
124802828|NCT02477839|448910159|FG001|Overall Study|Participant had PGS during V6|1|||
124802829|NCT02477839|448910158|FG000|Overall Study|Parents decided to stop medication|0|||
124802830|NCT02477839|448910159|FG001|Overall Study|Parents decided to stop medication|1|||
124802831|NCT02477839|448910158|FG000|Overall Study|Lack of tolerability|0|||
124802832|NCT02477839|448910159|FG001|Overall Study|Lack of tolerability|1|||
124802833|NCT02477839|448910158|FG000|Overall Study|Exclusion criterion|0|||
124802834|NCT02477839|448910159|FG001|Overall Study|Exclusion criterion|1|||
124802835|NCT01439568|448910166|FG000|Overall Study|Lost to Follow-up|1|||
124802836|NCT01439568|448910167|FG001|Overall Study|Lost to Follow-up|0|||
124802837|NCT01439568|448910166|FG000|Overall Study|Withdrawal by Subject|2|||
124802838|NCT01439568|448910167|FG001|Overall Study|Withdrawal by Subject|2|||
125297884|NCT00568126|450717190|FG001|Overall Study|Physician Decision|2|||
125297885|NCT01272869|450717191|FG000|Period 2 (14 Days)|Adverse Event|1|||
125297886|NCT01272869|450717192|FG001|Period 2 (14 Days)|Adverse Event|0|||
125297887|NCT00859937|450717193|FG000|Overall Study|Protocol Violation|1|||
125297888|NCT00859937|450717194|FG001|Overall Study|Protocol Violation|0|||
125297889|NCT02911142|450717195|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
125297890|NCT02911142|450717195|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
125297891|NCT02911142|450717195|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
125297892|NCT02911142|450717195|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
125297893|NCT02883062|450717196|FG000|Overall Study|Withdrawal by Subject|6|||
125297894|NCT02883062|450717197|FG001|Overall Study|Withdrawal by Subject|0|||
125297895|NCT02888743|450717198|FG000|Overall Study|Withdrawal by Subject|1|||
125297896|NCT02888743|450717199|FG001|Overall Study|Withdrawal by Subject|2|||
125297897|NCT02888743|450717200|FG002|Overall Study|Withdrawal by Subject|2|||
125297898|NCT02888743|450717201|FG003|Overall Study|Withdrawal by Subject|0|||
125297899|NCT02888743|450717202|FG004|Overall Study|Withdrawal by Subject|1|||
125297900|NCT02888743|450717198|FG000|Overall Study|Disease progression before treatment|2|||
125297901|NCT02888743|450717199|FG001|Overall Study|Disease progression before treatment|0|||
125297902|NCT02888743|450717200|FG002|Overall Study|Disease progression before treatment|2|||
125297903|NCT02888743|450717201|FG003|Overall Study|Disease progression before treatment|0|||
125297904|NCT02888743|450717202|FG004|Overall Study|Disease progression before treatment|0|||
125297905|NCT02888743|450717198|FG000|Overall Study|Patient ineligible|1|||
125297906|NCT02888743|450717199|FG001|Overall Study|Patient ineligible|2|||
125297907|NCT02888743|450717200|FG002|Overall Study|Patient ineligible|0|||
125297908|NCT02888743|450717201|FG003|Overall Study|Patient ineligible|0|||
125297909|NCT02888743|450717202|FG004|Overall Study|Patient ineligible|0|||
125297910|NCT05779007|450717203|FG000|Overall Study|not meeting eligibility criteria|3517|||
125297911|NCT05779007|450717204|FG001|Overall Study|not meeting eligibility criteria|2009|||
125297912|NCT01424566|450717205|FG000|Single-blind Treatment|Adverse Event|71|||
125297913|NCT01424566|450717206|FG001|Single-blind Treatment|Adverse Event|0|||
125297914|NCT01424566|450717207|FG002|Single-blind Treatment|Adverse Event|0|||
125297915|NCT01424566|450717205|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
125297916|NCT01424566|450717206|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
125297917|NCT01424566|450717207|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
125297918|NCT01424566|450717205|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
125297919|NCT01424566|450717206|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
125297920|NCT01424566|450717207|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
125297921|NCT01424566|450717205|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
124802839|NCT02607930|448910170|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
124802840|NCT02607930|448910171|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
124802841|NCT02607930|448910172|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
124802842|NCT02607930|448910173|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
124802843|NCT02607930|448910170|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
124802844|NCT02607930|448910171|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
124802845|NCT02607930|448910172|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
124802846|NCT02607930|448910173|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
125297922|NCT01424566|450717206|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
125297923|NCT01424566|450717207|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
125297924|NCT01424566|450717205|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
125297925|NCT01424566|450717206|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
125297926|NCT01424566|450717207|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
125297927|NCT01424566|450717205|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
125297928|NCT01424566|450717206|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
125297929|NCT01424566|450717207|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
125297930|NCT01424566|450717205|FG000|Double-blind Treatment|Adverse Event|0|||
125297931|NCT01424566|450717206|FG001|Double-blind Treatment|Adverse Event|21|||
125297932|NCT01424566|450717207|FG002|Double-blind Treatment|Adverse Event|13|||
125297933|NCT01424566|450717205|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
125297934|NCT01424566|450717206|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
125297935|NCT01424566|450717207|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
125297936|NCT01424566|450717205|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
125297937|NCT01424566|450717206|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
125297938|NCT01424566|450717207|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
125297939|NCT01424566|450717205|FG000|Double-blind Treatment|Lack of Efficacy|0|||
125297940|NCT01424566|450717206|FG001|Double-blind Treatment|Lack of Efficacy|1|||
125297941|NCT01424566|450717207|FG002|Double-blind Treatment|Lack of Efficacy|1|||
125297942|NCT04816721|450717208|FG000|Overall Study|Withdrawal by Subject|0|||
125297943|NCT04816721|450717209|FG001|Overall Study|Withdrawal by Subject|2|||
125297944|NCT04816721|450717210|FG002|Overall Study|Withdrawal by Subject|0|||
125297945|NCT04816721|450717211|FG003|Overall Study|Withdrawal by Subject|1|||
125297946|NCT04816721|450717212|FG004|Overall Study|Withdrawal by Subject|1|||
125297947|NCT04816721|450717213|FG005|Overall Study|Withdrawal by Subject|0|||
125297948|NCT04816721|450717214|FG006|Overall Study|Withdrawal by Subject|0|||
125297949|NCT04816721|450717215|FG007|Overall Study|Withdrawal by Subject|0|||
125297950|NCT04816721|450717208|FG000|Overall Study|Miscellaneous|0|||
125297951|NCT04816721|450717209|FG001|Overall Study|Miscellaneous|0|||
125297952|NCT04816721|450717210|FG002|Overall Study|Miscellaneous|0|||
125297953|NCT04816721|450717211|FG003|Overall Study|Miscellaneous|0|||
125297954|NCT04816721|450717212|FG004|Overall Study|Miscellaneous|0|||
125297955|NCT04816721|450717213|FG005|Overall Study|Miscellaneous|1|||
125297956|NCT04816721|450717214|FG006|Overall Study|Miscellaneous|0|||
125297957|NCT04816721|450717215|FG007|Overall Study|Miscellaneous|0|||
125297958|NCT04816721|450717208|FG000|Overall Study|Lost to Follow-up|0|||
125297959|NCT04816721|450717209|FG001|Overall Study|Lost to Follow-up|0|||
125297960|NCT04816721|450717210|FG002|Overall Study|Lost to Follow-up|0|||
125297961|NCT04816721|450717211|FG003|Overall Study|Lost to Follow-up|1|||
125297962|NCT04816721|450717212|FG004|Overall Study|Lost to Follow-up|0|||
125297963|NCT04816721|450717213|FG005|Overall Study|Lost to Follow-up|0|||
125297964|NCT04816721|450717214|FG006|Overall Study|Lost to Follow-up|0|||
125297965|NCT04816721|450717215|FG007|Overall Study|Lost to Follow-up|0|||
125297966|NCT00026312|450717216|FG000|Overall Study|Adverse Event|0|||
125297967|NCT00026312|450717217|FG001|Overall Study|Adverse Event|32|||
125297968|NCT00026312|450717216|FG000|Overall Study|Death|1|||
125297969|NCT00026312|450717217|FG001|Overall Study|Death|7|||
125297970|NCT00026312|450717216|FG000|Overall Study|Lack of Efficacy|19|||
125297971|NCT00026312|450717217|FG001|Overall Study|Lack of Efficacy|114|||
125297972|NCT00026312|450717216|FG000|Overall Study|Lost to Follow-up|0|||
125297973|NCT00026312|450717217|FG001|Overall Study|Lost to Follow-up|5|||
125297974|NCT00026312|450717216|FG000|Overall Study|Physician Decision|1|||
125297975|NCT00026312|450717217|FG001|Overall Study|Physician Decision|37|||
125297976|NCT00026312|450717216|FG000|Overall Study|Protocol Violation|0|||
125297977|NCT00026312|450717217|FG001|Overall Study|Protocol Violation|3|||
125297978|NCT00026312|450717216|FG000|Overall Study|Withdrawal by Subject|1|||
125297979|NCT00026312|450717217|FG001|Overall Study|Withdrawal by Subject|6|||
125297980|NCT00026312|450717216|FG000|Overall Study|Ineligible|4|||
125297981|NCT00026312|450717217|FG001|Overall Study|Ineligible|5|||
125297982|NCT00026312|450717216|FG000|Overall Study|Entry onto another COG study|0|||
125297983|NCT00026312|450717217|FG001|Overall Study|Entry onto another COG study|1|||
125297984|NCT00026312|450717216|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
125297985|NCT00026312|450717217|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
124802847|NCT02607930|448910170|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
125297986|NCT01638546|450717218|FG000|Overall Study|Adverse Event|1|||
125297987|NCT01638546|450717219|FG001|Overall Study|Adverse Event|3|||
125297988|NCT03194438|450717222|FG000|Overall Study|Withdrawal by Subject|2|||
125297989|NCT02294734|450717223|FG000|Overall Study|Adverse Event|5|||
125297990|NCT02294734|450717224|FG001|Overall Study|Adverse Event|5|||
125297991|NCT02294734|450717223|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
125297992|NCT02294734|450717224|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
125297993|NCT02294734|450717223|FG000|Overall Study|Lost to Follow-up|2|||
125297994|NCT02294734|450717224|FG001|Overall Study|Lost to Follow-up|0|||
125297995|NCT02294734|450717223|FG000|Overall Study|Physician Decision|2|||
125297996|NCT02294734|450717224|FG001|Overall Study|Physician Decision|1|||
125297997|NCT02294734|450717223|FG000|Overall Study|Withdrawal by Subject|4|||
125297998|NCT02294734|450717224|FG001|Overall Study|Withdrawal by Subject|2|||
125297999|NCT03157583|450717225|FG000|Overall Study|Other (did not meet study criteria)|1|||
125298000|NCT01141478|450717229|FG000|Overall Study|Withdrawal by Subject|1|||
125298001|NCT01141478|450717230|FG001|Overall Study|Withdrawal by Subject|1|||
125298002|NCT02250664|450717240|FG000|Overall Study|Lost to Follow-up|18|||
125298003|NCT02250664|450717241|FG001|Overall Study|Lost to Follow-up|28|||
125298004|NCT02250664|450717242|FG002|Overall Study|Lost to Follow-up|33|||
125298005|NCT02250664|450717240|FG000|Overall Study|Personal Reasons|7|||
125298006|NCT02250664|450717241|FG001|Overall Study|Personal Reasons|8|||
125298007|NCT02250664|450717242|FG002|Overall Study|Personal Reasons|14|||
125298008|NCT02250664|450717240|FG000|Overall Study|Adverse Event|6|||
125298009|NCT02250664|450717241|FG001|Overall Study|Adverse Event|3|||
125298010|NCT02250664|450717242|FG002|Overall Study|Adverse Event|8|||
125298011|NCT02250664|450717240|FG000|Overall Study|Incarcerated|2|||
125298012|NCT02250664|450717241|FG001|Overall Study|Incarcerated|1|||
125298013|NCT02250664|450717242|FG002|Overall Study|Incarcerated|2|||
125298014|NCT02250664|450717240|FG000|Overall Study|Withdrawal by Subject|0|||
125298015|NCT02250664|450717241|FG001|Overall Study|Withdrawal by Subject|1|||
125298016|NCT02250664|450717242|FG002|Overall Study|Withdrawal by Subject|2|||
125298017|NCT02250664|450717240|FG000|Overall Study|Death|0|||
125298018|NCT02250664|450717241|FG001|Overall Study|Death|1|||
125298019|NCT02250664|450717242|FG002|Overall Study|Death|1|||
125298020|NCT02250664|450717240|FG000|Overall Study|Physician Decision|1|||
125298021|NCT02250664|450717241|FG001|Overall Study|Physician Decision|3|||
125298022|NCT02250664|450717242|FG002|Overall Study|Physician Decision|1|||
125298023|NCT02250664|450717240|FG000|Overall Study|Protocol Violation|1|||
125298024|NCT02250664|450717241|FG001|Overall Study|Protocol Violation|0|||
125298025|NCT02250664|450717242|FG002|Overall Study|Protocol Violation|1|||
125298026|NCT02250664|450717240|FG000|Overall Study|Reason unknown|1|||
125298027|NCT02250664|450717241|FG001|Overall Study|Reason unknown|0|||
125298028|NCT02250664|450717242|FG002|Overall Study|Reason unknown|0|||
125298029|NCT03847909|450717243|FG000|Overall Study|Withdrawal by Subject|1|||
125298030|NCT03847909|450717244|FG001|Overall Study|Withdrawal by Subject|1|||
125298031|NCT00117793|450717245|FG000|Overall Study|Withdrawal by Subject|12|||
125298032|NCT04268173|450717246|FG000|Overall Study|Lost to Follow-up|75|||
125298033|NCT04268173|450717247|FG001|Overall Study|Lost to Follow-up|108|||
125298034|NCT00975143|450717248|FG000|Overall Study|Adverse Event|19|||
125298035|NCT00975143|450717249|FG001|Overall Study|Adverse Event|15|||
125298036|NCT00975143|450717248|FG000|Overall Study|Withdrawal by Subject|15|||
124802848|NCT02607930|448910171|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
124802849|NCT02607930|448910172|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
124802850|NCT02607930|448910173|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
124802851|NCT02607930|448910170|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
124802852|NCT02607930|448910171|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
124802853|NCT02607930|448910172|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
124802854|NCT02607930|448910173|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
124802855|NCT02607930|448910170|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
124802856|NCT02607930|448910171|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
124802857|NCT02607930|448910172|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
124802858|NCT02607930|448910173|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
124802859|NCT02607930|448910170|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
124802860|NCT02607930|448910171|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
124802861|NCT02607930|448910172|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
124802862|NCT02607930|448910173|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
124802863|NCT02607930|448910170|FG000|Double-Blinded Treatment Phase|Death|2|||
124802864|NCT02607930|448910171|FG001|Double-Blinded Treatment Phase|Death|1|||
124802865|NCT02607930|448910172|FG002|Double-Blinded Treatment Phase|Death|0|||
124802866|NCT02607930|448910173|FG003|Double-Blinded Treatment Phase|Death|0|||
124802867|NCT02607930|448910170|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
124802868|NCT02607930|448910171|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
124802869|NCT02607930|448910172|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
124802870|NCT02607930|448910173|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
124802871|NCT02607930|448910170|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
124802872|NCT02607930|448910171|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
124802873|NCT02607930|448910172|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
125298037|NCT00975143|450717249|FG001|Overall Study|Withdrawal by Subject|15|||
125298038|NCT00975143|450717248|FG000|Overall Study|Lost to Follow-up|20|||
125298039|NCT00975143|450717249|FG001|Overall Study|Lost to Follow-up|16|||
125298040|NCT00975143|450717248|FG000|Overall Study|Non-compliance|5|||
125298041|NCT00975143|450717249|FG001|Overall Study|Non-compliance|8|||
125298042|NCT00975143|450717248|FG000|Overall Study|Physician Decision|1|||
125298043|NCT00975143|450717249|FG001|Overall Study|Physician Decision|2|||
125298044|NCT00975143|450717248|FG000|Overall Study|Details not available|10|||
125298045|NCT00975143|450717249|FG001|Overall Study|Details not available|4|||
124802874|NCT02607930|448910173|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
124802875|NCT02607930|448910170|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
124802876|NCT02607930|448910171|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
124802877|NCT02607930|448910172|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
124802878|NCT02607930|448910173|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
124802879|NCT02607930|448910170|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
124802880|NCT02607930|448910171|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
124802881|NCT02607930|448910172|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
124802882|NCT02607930|448910173|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
124802883|NCT02607930|448910170|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
124802884|NCT02607930|448910171|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
124802885|NCT02607930|448910172|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
124802886|NCT02607930|448910173|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
125298046|NCT01375608|450717250|FG000|Overall Study|Withdrawal by Subject|2|||
125298047|NCT00545103|450717251|FG000|Overall Study|Lack of Efficacy|48|||
125298048|NCT00545103|450717252|FG001|Overall Study|Lack of Efficacy|45|||
125298049|NCT00545103|450717253|FG002|Overall Study|Lack of Efficacy|31|||
125298050|NCT00545103|450717254|FG003|Overall Study|Lack of Efficacy|27|||
125298051|NCT00545103|450717251|FG000|Overall Study|Withdrawal by Subject|6|||
125298052|NCT00545103|450717252|FG001|Overall Study|Withdrawal by Subject|10|||
125298053|NCT00545103|450717253|FG002|Overall Study|Withdrawal by Subject|18|||
125298054|NCT00545103|450717254|FG003|Overall Study|Withdrawal by Subject|22|||
125298055|NCT00545103|450717251|FG000|Overall Study|Adverse Event|11|||
125298056|NCT00545103|450717252|FG001|Overall Study|Adverse Event|12|||
125298057|NCT00545103|450717253|FG002|Overall Study|Adverse Event|17|||
125298058|NCT00545103|450717254|FG003|Overall Study|Adverse Event|10|||
125298059|NCT00545103|450717251|FG000|Overall Study|Lost to Follow-up|4|||
125298060|NCT00545103|450717252|FG001|Overall Study|Lost to Follow-up|6|||
125298061|NCT00545103|450717253|FG002|Overall Study|Lost to Follow-up|3|||
125298062|NCT00545103|450717254|FG003|Overall Study|Lost to Follow-up|4|||
125298063|NCT00545103|450717251|FG000|Overall Study|Protocol Violation|1|||
125298064|NCT00545103|450717252|FG001|Overall Study|Protocol Violation|2|||
125298065|NCT00545103|450717253|FG002|Overall Study|Protocol Violation|3|||
125298066|NCT00545103|450717254|FG003|Overall Study|Protocol Violation|0|||
125298067|NCT00545103|450717251|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
125298068|NCT00545103|450717252|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
125298069|NCT00545103|450717253|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
125298070|NCT00545103|450717254|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
125298071|NCT00545103|450717251|FG000|Overall Study|Difficult to open package|0|||
125298072|NCT00545103|450717252|FG001|Overall Study|Difficult to open package|0|||
125298073|NCT00545103|450717253|FG002|Overall Study|Difficult to open package|0|||
125298074|NCT00545103|450717254|FG003|Overall Study|Difficult to open package|1|||
125298075|NCT00545103|450717251|FG000|Overall Study|Investigational product not taken|1|||
125298076|NCT00545103|450717252|FG001|Overall Study|Investigational product not taken|0|||
125298077|NCT00545103|450717253|FG002|Overall Study|Investigational product not taken|0|||
125298078|NCT00545103|450717254|FG003|Overall Study|Investigational product not taken|1|||
125298079|NCT00545103|450717251|FG000|Overall Study|Wish to start a family|0|||
125298080|NCT00545103|450717252|FG001|Overall Study|Wish to start a family|0|||
125298081|NCT00545103|450717253|FG002|Overall Study|Wish to start a family|0|||
125298082|NCT00545103|450717254|FG003|Overall Study|Wish to start a family|1|||
125298083|NCT00545103|450717251|FG000|Overall Study|Diverticulitis crisis|0|||
125298084|NCT00545103|450717252|FG001|Overall Study|Diverticulitis crisis|0|||
125298085|NCT00545103|450717253|FG002|Overall Study|Diverticulitis crisis|0|||
125298086|NCT00545103|450717254|FG003|Overall Study|Diverticulitis crisis|1|||
125298087|NCT00545103|450717251|FG000|Overall Study|Personal reasons|1|||
125298088|NCT00545103|450717252|FG001|Overall Study|Personal reasons|0|||
125298089|NCT00545103|450717253|FG002|Overall Study|Personal reasons|0|||
125298090|NCT00545103|450717254|FG003|Overall Study|Personal reasons|0|||
125298091|NCT00545103|450717251|FG000|Overall Study|Subject's decision|1|||
125298092|NCT00545103|450717252|FG001|Overall Study|Subject's decision|0|||
125298093|NCT00545103|450717253|FG002|Overall Study|Subject's decision|0|||
125298094|NCT00545103|450717254|FG003|Overall Study|Subject's decision|0|||
124802887|NCT02607930|448910170|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
125298095|NCT00545103|450717251|FG000|Overall Study|Noncompliance|0|||
125298096|NCT00545103|450717252|FG001|Overall Study|Noncompliance|1|||
125298097|NCT00545103|450717253|FG002|Overall Study|Noncompliance|0|||
125298098|NCT00545103|450717254|FG003|Overall Study|Noncompliance|0|||
125298099|NCT00545103|450717251|FG000|Overall Study|Investigator decision|0|||
125298100|NCT00545103|450717252|FG001|Overall Study|Investigator decision|0|||
125298101|NCT00545103|450717253|FG002|Overall Study|Investigator decision|1|||
125298102|NCT00545103|450717254|FG003|Overall Study|Investigator decision|0|||
124802888|NCT02607930|448910171|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
125298103|NCT00545103|450717251|FG000|Overall Study|Subject moved|0|||
125298104|NCT00545103|450717252|FG001|Overall Study|Subject moved|1|||
125298105|NCT00545103|450717253|FG002|Overall Study|Subject moved|0|||
125298106|NCT00545103|450717254|FG003|Overall Study|Subject moved|0|||
125298107|NCT00545103|450717251|FG000|Overall Study|Use of prohibited medication|0|||
125298108|NCT00545103|450717252|FG001|Overall Study|Use of prohibited medication|0|||
125298109|NCT00545103|450717253|FG002|Overall Study|Use of prohibited medication|1|||
125298110|NCT00545103|450717254|FG003|Overall Study|Use of prohibited medication|0|||
125298111|NCT00545103|450717251|FG000|Overall Study|Does not want to take study drug anymore|1|||
125298112|NCT00545103|450717252|FG001|Overall Study|Does not want to take study drug anymore|0|||
125298113|NCT00545103|450717253|FG002|Overall Study|Does not want to take study drug anymore|1|||
125298114|NCT00545103|450717254|FG003|Overall Study|Does not want to take study drug anymore|0|||
125298115|NCT00545103|450717251|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
125298116|NCT00545103|450717252|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
125298117|NCT00545103|450717253|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
125298118|NCT00545103|450717254|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
125298119|NCT00545103|450717251|FG000|Overall Study|Death|0|||
125298120|NCT00545103|450717252|FG001|Overall Study|Death|1|||
125298121|NCT00545103|450717253|FG002|Overall Study|Death|0|||
125298122|NCT00545103|450717254|FG003|Overall Study|Death|0|||
125298123|NCT01953913|450717255|FG000|Overall Study|Disease Progression|349|||
125298124|NCT01953913|450717255|FG000|Overall Study|Worsening of underlying cancer|22|||
125298125|NCT01953913|450717255|FG000|Overall Study|Adverse Event|20|||
125298126|NCT01953913|450717255|FG000|Overall Study|Protocol Violation|6|||
125298127|NCT01953913|450717255|FG000|Overall Study|Lost to Follow-up|4|||
125298128|NCT01953913|450717255|FG000|Overall Study|Withdrawal by Subject|32|||
125298129|NCT01953913|450717255|FG000|Overall Study|Other than listed|108|||
125298130|NCT01953913|450717255|FG000|Overall Study|Not Treated|1|||
125298131|NCT00082381|450717256|FG000|Overall Study|Adverse Event|27|||
125298132|NCT00082381|450717257|FG001|Overall Study|Adverse Event|2|||
125298133|NCT00082381|450717256|FG000|Overall Study|Lost to Follow-up|5|||
125298134|NCT00082381|450717257|FG001|Overall Study|Lost to Follow-up|7|||
125298135|NCT00082381|450717256|FG000|Overall Study|Patient Decision|8|||
125298136|NCT00082381|450717257|FG001|Overall Study|Patient Decision|4|||
125298137|NCT00082381|450717256|FG000|Overall Study|Physician Decision|1|||
125298138|NCT00082381|450717257|FG001|Overall Study|Physician Decision|2|||
125298139|NCT00082381|450717256|FG000|Overall Study|Protocol Violation|10|||
125298140|NCT00082381|450717257|FG001|Overall Study|Protocol Violation|11|||
125298141|NCT00082381|450717256|FG000|Overall Study|Loss of Glucose Control|4|||
125298142|NCT00082381|450717257|FG001|Overall Study|Loss of Glucose Control|0|||
125298143|NCT02049138|450717258|FG000|Overall Study|Adverse Event|46|||
125298144|NCT02049138|450717259|FG001|Overall Study|Adverse Event|25|||
125298145|NCT02049138|450717260|FG002|Overall Study|Adverse Event|1|||
125298146|NCT02049138|450717258|FG000|Overall Study|Withdrawal by Subject|57|||
125298147|NCT02049138|450717259|FG001|Overall Study|Withdrawal by Subject|21|||
125298148|NCT02049138|450717260|FG002|Overall Study|Withdrawal by Subject|5|||
125298149|NCT02049138|450717258|FG000|Overall Study|Lost to Follow-up|18|||
125298150|NCT02049138|450717259|FG001|Overall Study|Lost to Follow-up|5|||
125298151|NCT02049138|450717260|FG002|Overall Study|Lost to Follow-up|1|||
125298152|NCT02049138|450717258|FG000|Overall Study|Lack of Efficacy|10|||
125298153|NCT02049138|450717259|FG001|Overall Study|Lack of Efficacy|26|||
125298154|NCT02049138|450717260|FG002|Overall Study|Lack of Efficacy|1|||
125298155|NCT02049138|450717258|FG000|Overall Study|Non-Compliance|15|||
125298156|NCT02049138|450717259|FG001|Overall Study|Non-Compliance|6|||
125298157|NCT02049138|450717260|FG002|Overall Study|Non-Compliance|0|||
125298158|NCT02049138|450717258|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
125298159|NCT02049138|450717259|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
125298160|NCT02049138|450717260|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
125298161|NCT02049138|450717258|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
125298162|NCT02049138|450717259|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
125298163|NCT02049138|450717260|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
125298164|NCT02049138|450717258|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
125298165|NCT02049138|450717259|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
125298166|NCT02049138|450717260|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
125298167|NCT02049138|450717258|FG000|Overall Study|Other|15|||
125298168|NCT02049138|450717259|FG001|Overall Study|Other|13|||
125298169|NCT02049138|450717260|FG002|Overall Study|Other|0|||
125298170|NCT02049138|450717258|FG000|Overall Study|Missing|0|||
125298171|NCT02049138|450717259|FG001|Overall Study|Missing|1|||
125298172|NCT02049138|450717260|FG002|Overall Study|Missing|0|||
125298173|NCT00884832|450717261|FG000|Overall Study|Withdrawal by Subject|0|||
125298174|NCT00884832|450717262|FG001|Overall Study|Withdrawal by Subject|1|||
125298175|NCT02096263|450717263|FG000|Overall Study|Adverse Event|1|||
125298176|NCT02096263|450717264|FG001|Overall Study|Adverse Event|0|||
125298177|NCT02096263|450717265|FG002|Overall Study|Adverse Event|1|||
125298178|NCT02096263|450717263|FG000|Overall Study|Lost to Follow-up|14|||
125298179|NCT02096263|450717264|FG001|Overall Study|Lost to Follow-up|18|||
125298180|NCT02096263|450717265|FG002|Overall Study|Lost to Follow-up|15|||
125298181|NCT02096263|450717263|FG000|Overall Study|Other|7|||
125298182|NCT02096263|450717264|FG001|Overall Study|Other|9|||
125298183|NCT02096263|450717265|FG002|Overall Study|Other|6|||
125298184|NCT02096263|450717263|FG000|Overall Study|Sponsor study termination|0|||
125298185|NCT02096263|450717264|FG001|Overall Study|Sponsor study termination|0|||
125298186|NCT02096263|450717265|FG002|Overall Study|Sponsor study termination|1|||
125298187|NCT02096263|450717263|FG000|Overall Study|Protocol Violation|7|||
125298188|NCT02096263|450717264|FG001|Overall Study|Protocol Violation|2|||
125298189|NCT02096263|450717265|FG002|Overall Study|Protocol Violation|8|||
125298190|NCT02096263|450717263|FG000|Overall Study|Withdrawal by Subject|5|||
125298191|NCT02096263|450717264|FG001|Overall Study|Withdrawal by Subject|7|||
125298192|NCT02096263|450717265|FG002|Overall Study|Withdrawal by Subject|8|||
125298193|NCT02337725|450717266|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
125298194|NCT02337725|450717267|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
125298195|NCT02337725|450717266|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
125298196|NCT02337725|450717267|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
125298197|NCT02337725|450717266|FG000|Overall Study|Major Protocol Deviation|0|||
125298198|NCT02337725|450717267|FG001|Overall Study|Major Protocol Deviation|1|||
125298199|NCT02337725|450717266|FG000|Overall Study|Voluntary Withdrawal|14|||
125298200|NCT02337725|450717267|FG001|Overall Study|Voluntary Withdrawal|3|||
125298201|NCT02337725|450717266|FG000|Overall Study|Lack of Efficacy|4|||
125298202|NCT02337725|450717267|FG001|Overall Study|Lack of Efficacy|0|||
125298203|NCT03322423|450717268|FG000|Period 1|Subject no longer eligible|0|||
125298204|NCT03322423|450717269|FG001|Period 1|Subject no longer eligible|1|||
125298205|NCT03322423|450717268|FG000|Period 1|Withdrawal by Subject|0|||
125298206|NCT03322423|450717269|FG001|Period 1|Withdrawal by Subject|1|||
125298207|NCT03322423|450717268|FG000|Period 1|Incorrect Lens Dispensed|1|||
125298208|NCT03322423|450717269|FG001|Period 1|Incorrect Lens Dispensed|0|||
125298209|NCT03322423|450717268|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
125298210|NCT03322423|450717269|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
125298211|NCT03322423|450717268|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
125298212|NCT03322423|450717269|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
125298213|NCT03322423|450717268|FG000|Period 2|Protocol Violation|1|||
125298214|NCT03322423|450717269|FG001|Period 2|Protocol Violation|0|||
125298215|NCT03322423|450717268|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
125298216|NCT03322423|450717269|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
125298217|NCT02453555|450717270|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
125298218|NCT02453555|450717271|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
125298219|NCT02453555|450717272|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
125298220|NCT02453555|450717273|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
125298221|NCT02453555|450717274|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
125298222|NCT02453555|450717275|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
125298223|NCT02453555|450717270|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
125298224|NCT02453555|450717271|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
125298225|NCT02453555|450717272|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
125298226|NCT02453555|450717273|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
125298227|NCT02453555|450717274|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
125298228|NCT02453555|450717275|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
125298229|NCT02453555|450717270|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
125298230|NCT02453555|450717271|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
125298231|NCT02453555|450717272|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
125298232|NCT02453555|450717273|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
125298233|NCT02453555|450717274|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
125298234|NCT02453555|450717275|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
125298235|NCT02453555|450717270|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
125298236|NCT02453555|450717271|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
125298237|NCT02453555|450717272|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
125298238|NCT02453555|450717273|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
125298239|NCT02453555|450717274|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
125298240|NCT02453555|450717275|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
125298241|NCT02453555|450717270|FG000|Extension Period|Adverse Event|0|||
125298242|NCT02453555|450717271|FG001|Extension Period|Adverse Event|0|||
125298243|NCT02453555|450717272|FG002|Extension Period|Adverse Event|1|||
125298244|NCT02453555|450717273|FG003|Extension Period|Adverse Event|2|||
125298245|NCT02453555|450717274|FG004|Extension Period|Adverse Event|1|||
125298246|NCT02453555|450717275|FG005|Extension Period|Adverse Event|1|||
125298247|NCT02453555|450717270|FG000|Extension Period|Protocol Violation|0|||
125298248|NCT02453555|450717271|FG001|Extension Period|Protocol Violation|0|||
125298249|NCT02453555|450717272|FG002|Extension Period|Protocol Violation|1|||
125298250|NCT02453555|450717273|FG003|Extension Period|Protocol Violation|0|||
125298251|NCT02453555|450717274|FG004|Extension Period|Protocol Violation|0|||
125298252|NCT02453555|450717275|FG005|Extension Period|Protocol Violation|0|||
125298253|NCT02453555|450717270|FG000|Extension Period|Withdrawal by Subject|0|||
125298254|NCT02453555|450717271|FG001|Extension Period|Withdrawal by Subject|0|||
125298255|NCT02453555|450717272|FG002|Extension Period|Withdrawal by Subject|1|||
125298256|NCT02453555|450717273|FG003|Extension Period|Withdrawal by Subject|0|||
125298257|NCT02453555|450717274|FG004|Extension Period|Withdrawal by Subject|0|||
125298258|NCT02453555|450717275|FG005|Extension Period|Withdrawal by Subject|0|||
125298259|NCT00500760|450717276|FG000|Overall Study|Death|32|||
125298260|NCT00500760|450717277|FG001|Overall Study|Death|15|||
125298261|NCT00500760|450717276|FG000|Overall Study|Withdrawal by Subject|5|||
125298262|NCT00500760|450717277|FG001|Overall Study|Withdrawal by Subject|7|||
125298263|NCT00500760|450717276|FG000|Overall Study|Administrative decision|2|||
125298264|NCT00500760|450717277|FG001|Overall Study|Administrative decision|0|||
125298265|NCT00500760|450717276|FG000|Overall Study|Lost to Follow-up|3|||
125298266|NCT00500760|450717277|FG001|Overall Study|Lost to Follow-up|0|||
125298267|NCT00500760|450717276|FG000|Overall Study|Other|1|||
125298268|NCT00500760|450717277|FG001|Overall Study|Other|2|||
125298269|NCT00129961|450717279|FG000|Overall Study|Adverse Event|1|||
125298270|NCT00129961|450717280|FG001|Overall Study|Adverse Event|0|||
125298271|NCT00129961|450717279|FG000|Overall Study|Death|1|||
125298272|NCT00129961|450717280|FG001|Overall Study|Death|1|||
125298273|NCT00129961|450717279|FG000|Overall Study|Withdrawal by Sponsor|14|||
125298274|NCT00129961|450717280|FG001|Overall Study|Withdrawal by Sponsor|20|||
125298275|NCT00129961|450717279|FG000|Overall Study|Physician Decision|1|||
125298276|NCT00129961|450717280|FG001|Overall Study|Physician Decision|0|||
125298277|NCT00129961|450717279|FG000|Overall Study|Withdrawal by Subject|2|||
125298278|NCT00129961|450717280|FG001|Overall Study|Withdrawal by Subject|1|||
125298279|NCT00129961|450717279|FG000|Overall Study|Missing Record|0|||
125298280|NCT00129961|450717280|FG001|Overall Study|Missing Record|1|||
125298281|NCT03178669|450717281|FG000|Overall Study|Adverse Event|4|||
125298282|NCT03178669|450717282|FG001|Overall Study|Adverse Event|1|||
125298283|NCT03178669|450717283|FG002|Overall Study|Adverse Event|4|||
125298284|NCT03178669|450717284|FG003|Overall Study|Adverse Event|2|||
125298285|NCT03178669|450717285|FG004|Overall Study|Adverse Event|2|||
125298286|NCT03178669|450717281|FG000|Overall Study|Lack of Efficacy|0|||
125298287|NCT03178669|450717282|FG001|Overall Study|Lack of Efficacy|0|||
125298288|NCT03178669|450717283|FG002|Overall Study|Lack of Efficacy|2|||
125298289|NCT03178669|450717284|FG003|Overall Study|Lack of Efficacy|0|||
125298290|NCT03178669|450717285|FG004|Overall Study|Lack of Efficacy|1|||
125298291|NCT03178669|450717281|FG000|Overall Study|Physician Decision|0|||
125298292|NCT03178669|450717282|FG001|Overall Study|Physician Decision|0|||
125298293|NCT03178669|450717283|FG002|Overall Study|Physician Decision|0|||
125298294|NCT03178669|450717284|FG003|Overall Study|Physician Decision|0|||
125298295|NCT03178669|450717285|FG004|Overall Study|Physician Decision|1|||
125298296|NCT03178669|450717281|FG000|Overall Study|Withdrawal by Subject|1|||
125298297|NCT03178669|450717282|FG001|Overall Study|Withdrawal by Subject|0|||
125298298|NCT03178669|450717283|FG002|Overall Study|Withdrawal by Subject|1|||
125298299|NCT03178669|450717284|FG003|Overall Study|Withdrawal by Subject|1|||
125298300|NCT03178669|450717285|FG004|Overall Study|Withdrawal by Subject|0|||
125298301|NCT03178669|450717281|FG000|Overall Study|Lost to Follow-up|0|||
125298302|NCT03178669|450717282|FG001|Overall Study|Lost to Follow-up|0|||
124802889|NCT02607930|448910172|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
124802890|NCT02607930|448910173|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
124802891|NCT02607930|448910170|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
124802892|NCT02607930|448910171|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
124802893|NCT02607930|448910172|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
124802894|NCT02607930|448910173|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
124802895|NCT02607930|448910170|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
124802896|NCT02607930|448910171|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
124802897|NCT02607930|448910172|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
125298303|NCT03178669|450717283|FG002|Overall Study|Lost to Follow-up|0|||
125298304|NCT03178669|450717284|FG003|Overall Study|Lost to Follow-up|1|||
125298305|NCT03178669|450717285|FG004|Overall Study|Lost to Follow-up|0|||
125298306|NCT01600092|450717286|FG000|Overall Study|Adverse Event|2|||
125298307|NCT01600092|450717287|FG001|Overall Study|Adverse Event|0|||
125298308|NCT01600092|450717286|FG000|Overall Study|Lost to Follow-up|4|||
124802898|NCT02607930|448910173|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
124802899|NCT02607930|448910170|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
125298309|NCT01600092|450717287|FG001|Overall Study|Lost to Follow-up|6|||
125298310|NCT01600092|450717286|FG000|Overall Study|Withdrawal by parent/guardian|8|||
125298311|NCT01600092|450717287|FG001|Overall Study|Withdrawal by parent/guardian|6|||
125298312|NCT01600092|450717286|FG000|Overall Study|Physician Decision|1|||
125298313|NCT01600092|450717287|FG001|Overall Study|Physician Decision|1|||
125298314|NCT01600092|450717286|FG000|Overall Study|Randomized but not vaccinated|3|||
125298315|NCT01600092|450717287|FG001|Overall Study|Randomized but not vaccinated|3|||
124802900|NCT02607930|448910171|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
124802901|NCT02607930|448910172|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
124802902|NCT02607930|448910173|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
124802903|NCT03198078|448910174|FG000|Overall Study|Adverse Event|0|||
124802904|NCT03198078|448910175|FG001|Overall Study|Adverse Event|1|||
124802905|NCT03198078|448910176|FG002|Overall Study|Adverse Event|2|||
124802906|NCT03198078|448910174|FG000|Overall Study|Lack of Efficacy|0|||
124802907|NCT03198078|448910175|FG001|Overall Study|Lack of Efficacy|0|||
124802908|NCT03198078|448910176|FG002|Overall Study|Lack of Efficacy|3|||
124802909|NCT03198078|448910174|FG000|Overall Study|Lost to Follow-up|1|||
124802910|NCT03198078|448910175|FG001|Overall Study|Lost to Follow-up|0|||
124802911|NCT03198078|448910176|FG002|Overall Study|Lost to Follow-up|0|||
124802912|NCT03198078|448910174|FG000|Overall Study|Pregnancy|0|||
124802913|NCT03198078|448910175|FG001|Overall Study|Pregnancy|1|||
124802914|NCT03198078|448910176|FG002|Overall Study|Pregnancy|0|||
124802915|NCT03198078|448910174|FG000|Overall Study|Withdrawal by Subject|1|||
124802916|NCT03198078|448910175|FG001|Overall Study|Withdrawal by Subject|0|||
124802917|NCT03198078|448910176|FG002|Overall Study|Withdrawal by Subject|2|||
124802918|NCT03198078|448910174|FG000|Overall Study|Withdrawal by Caregiver|1|||
124802919|NCT03198078|448910175|FG001|Overall Study|Withdrawal by Caregiver|3|||
124802920|NCT03198078|448910176|FG002|Overall Study|Withdrawal by Caregiver|5|||
124802921|NCT03711266|448910177|FG000|Overall Study|Lost to Follow-up|10|||
124802922|NCT01646073|448910178|FG000|Period A (12 Weeks)|Adverse Event|0|||
124802923|NCT01646073|448910179|FG001|Period A (12 Weeks)|Adverse Event|2|||
124802924|NCT01646073|448910178|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
124802925|NCT01646073|448910179|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
124802926|NCT01646073|448910178|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
124802927|NCT01646073|448910179|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
124802928|NCT01646073|448910178|FG000|Period A (12 Weeks)|Protocol Violation|0|||
124802929|NCT01646073|448910179|FG001|Period A (12 Weeks)|Protocol Violation|1|||
124802930|NCT01646073|448910178|FG000|Period A (12 Weeks)|Other|0|||
124802931|NCT01646073|448910179|FG001|Period A (12 Weeks)|Other|1|||
124802932|NCT01646073|448910178|FG000|Period B (12 Weeks)|Adverse Event|0|||
124802933|NCT01646073|448910179|FG001|Period B (12 Weeks)|Adverse Event|7|||
124802934|NCT01646073|448910178|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
124802935|NCT01646073|448910179|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
124802936|NCT01646073|448910178|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
125298316|NCT00079677|450717288|FG000|Overall Study|Adverse Event|5|||
125298317|NCT00079677|450717289|FG001|Overall Study|Adverse Event|6|||
125298318|NCT00079677|450717288|FG000|Overall Study|Lack of Efficacy|1|||
125298319|NCT00079677|450717289|FG001|Overall Study|Lack of Efficacy|0|||
125298320|NCT00079677|450717288|FG000|Overall Study|Lost to Follow-up|2|||
125298321|NCT00079677|450717289|FG001|Overall Study|Lost to Follow-up|2|||
125298322|NCT00079677|450717288|FG000|Overall Study|Physician Decision|3|||
125298323|NCT00079677|450717289|FG001|Overall Study|Physician Decision|0|||
125298324|NCT00079677|450717288|FG000|Overall Study|Protocol Violation|2|||
125298325|NCT00079677|450717289|FG001|Overall Study|Protocol Violation|3|||
125298326|NCT00079677|450717288|FG000|Overall Study|Withdrawal by Subject|5|||
125298327|NCT00079677|450717289|FG001|Overall Study|Withdrawal by Subject|3|||
125298328|NCT00079677|450717288|FG000|Overall Study|Miscellaneous|2|||
125298329|NCT00079677|450717289|FG001|Overall Study|Miscellaneous|0|||
125298330|NCT00565136|450717290|FG000|Overall Study|Lost to Follow-up|1|||
125298331|NCT00565136|450717290|FG000|Overall Study|Withdrawal by Subject|1|||
124802937|NCT01646073|448910179|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
124802938|NCT00057876|448910180|FG000|Overall Study|Adverse Event|8|||
124802939|NCT00057876|448910181|FG001|Overall Study|Adverse Event|8|||
125298332|NCT00565136|450717290|FG000|Overall Study|Protocol Violation|1|||
125298333|NCT04284774|450717292|FG000|Overall Study|Progressive disease|5|||
124802940|NCT00057876|448910180|FG000|Overall Study|Death|2|||
124802941|NCT00057876|448910181|FG001|Overall Study|Death|1|||
124802942|NCT00057876|448910180|FG000|Overall Study|Withdrawal by Subject|5|||
124802943|NCT00057876|448910181|FG001|Overall Study|Withdrawal by Subject|6|||
124802944|NCT00057876|448910180|FG000|Overall Study|Lack of Efficacy|10|||
124802945|NCT00057876|448910181|FG001|Overall Study|Lack of Efficacy|8|||
125298334|NCT01270256|450717293|FG000|Overall Study|Withdrawal by Subject|1|||
125298335|NCT01270256|450717294|FG001|Overall Study|Withdrawal by Subject|0|||
125298336|NCT02879578|450717295|FG000|Overall Study|Adverse Event|1|||
125298337|NCT02879578|450717296|FG001|Overall Study|Adverse Event|2|||
125298338|NCT02879578|450717297|FG002|Overall Study|Adverse Event|14|||
124802946|NCT00057876|448910180|FG000|Overall Study|Ineligible|1|||
124802947|NCT00057876|448910181|FG001|Overall Study|Ineligible|2|||
124802948|NCT00057876|448910180|FG000|Overall Study|other reason|2|||
124802949|NCT00057876|448910181|FG001|Overall Study|other reason|2|||
124802950|NCT00057876|448910180|FG000|Overall Study|other complicating disease|1|||
124802951|NCT00057876|448910181|FG001|Overall Study|other complicating disease|0|||
124802952|NCT03799211|448910188|FG000|Overall Study|Lost to Follow-up|2|||
124802953|NCT03799211|448910189|FG001|Overall Study|Lost to Follow-up|13|||
124802954|NCT03799211|448910188|FG000|Overall Study|Withdrawal by Subject|2|||
124802955|NCT03799211|448910189|FG001|Overall Study|Withdrawal by Subject|0|||
124802956|NCT00764491|448910190|FG000|Overall Study|Lost to Follow-up|35|||
124802957|NCT00764491|448910191|FG001|Overall Study|Lost to Follow-up|17|||
124802958|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
124802959|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
124802960|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Death|1|||
124802961|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Death|0|||
124802962|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
124802963|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
124802964|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
124802965|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
124802966|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
124802967|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
124802968|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
124802969|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
124802970|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
124802971|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
124802972|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
124802973|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
124802974|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
124802975|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
124802976|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
124802977|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
124802978|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
124802979|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
124802980|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
124802981|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
124802982|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
124802983|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
124802984|NCT02927262|448910198|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
124802985|NCT02927262|448910199|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
124802986|NCT02927262|448910198|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
124802987|NCT02927262|448910199|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
124802988|NCT02927262|448910198|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
124802989|NCT02927262|448910199|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
124802990|NCT00923936|448910200|FG000|Overall Study|progressive disease on study|2|||
124802991|NCT00923936|448910201|FG001|Overall Study|progressive disease on study|1|||
124802992|NCT00923936|448910200|FG000|Overall Study|Adverse Event|2|||
124802993|NCT00923936|448910201|FG001|Overall Study|Adverse Event|1|||
124802994|NCT00923936|448910200|FG000|Overall Study|Lost to follow up|2|||
124802995|NCT00923936|448910201|FG001|Overall Study|Lost to follow up|0|||
124802996|NCT00923936|448910200|FG000|Overall Study|Continuing in follow up period|2|||
124802997|NCT00923936|448910201|FG001|Overall Study|Continuing in follow up period|1|||
124802998|NCT01697358|448910202|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
124802999|NCT01697358|448910203|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
124803000|NCT01697358|448910202|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
124803001|NCT01697358|448910203|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
124803002|NCT01697358|448910202|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
124803003|NCT01697358|448910203|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
124803004|NCT01697358|448910202|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
124803005|NCT01697358|448910203|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
124803006|NCT01697358|448910202|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
124803007|NCT01697358|448910203|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
124803008|NCT01697358|448910202|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
124803009|NCT01697358|448910203|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
124803010|NCT01697358|448910202|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
124803011|NCT01697358|448910203|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
124803012|NCT01697358|448910202|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
124803013|NCT01697358|448910203|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
124803014|NCT01697358|448910202|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
124803015|NCT01697358|448910203|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
124803016|NCT01697358|448910202|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
125298339|NCT02879578|450717295|FG000|Overall Study|Protocol Violation|0|||
125298340|NCT02879578|450717296|FG001|Overall Study|Protocol Violation|1|||
125298341|NCT02879578|450717297|FG002|Overall Study|Protocol Violation|1|||
124819540|NCT05147350|448965753|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
124803017|NCT01697358|448910203|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
124803018|NCT02038452|448910204|FG000|Overall Study|Withdrawal by Subject|7|||
124803019|NCT02038452|448910205|FG001|Overall Study|Withdrawal by Subject|9|||
124803020|NCT02038452|448910204|FG000|Overall Study|Lost to Follow-up|31|||
124803021|NCT02038452|448910205|FG001|Overall Study|Lost to Follow-up|28|||
124803022|NCT01460368|448910208|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
124803023|NCT01460368|448910209|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
124803024|NCT01460368|448910210|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
124803025|NCT01460368|448910211|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
124803026|NCT01460368|448910212|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
124803027|NCT01460368|448910213|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
124803028|NCT01460368|448910214|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
124803029|NCT01460368|448910208|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
124803030|NCT01460368|448910209|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
124803031|NCT01460368|448910210|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
124803032|NCT01460368|448910211|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
124803033|NCT01460368|448910212|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
124803034|NCT01460368|448910213|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
124803035|NCT01460368|448910214|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
124803036|NCT01460368|448910208|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
124803037|NCT01460368|448910209|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
124803038|NCT01460368|448910210|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
124803039|NCT01460368|448910211|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
124803040|NCT01460368|448910212|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
124803041|NCT01460368|448910213|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
124803042|NCT01460368|448910214|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
124803043|NCT01460368|448910208|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
124803044|NCT01460368|448910209|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
124803045|NCT01460368|448910210|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
125298342|NCT02879578|450717295|FG000|Overall Study|Withdrawal by Subject|8|||
125298343|NCT02879578|450717296|FG001|Overall Study|Withdrawal by Subject|6|||
124803046|NCT01460368|448910211|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
124803047|NCT01460368|448910212|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
124803048|NCT01460368|448910213|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
124803049|NCT01460368|448910214|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
124803050|NCT01460368|448910208|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
124803051|NCT01460368|448910209|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
124803052|NCT01460368|448910210|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
124803053|NCT01460368|448910211|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
124803054|NCT01460368|448910212|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
124803055|NCT01460368|448910213|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
125298344|NCT02879578|450717297|FG002|Overall Study|Withdrawal by Subject|9|||
125298345|NCT02879578|450717295|FG000|Overall Study|Lost to Follow-up|1|||
125298346|NCT02879578|450717296|FG001|Overall Study|Lost to Follow-up|0|||
125298347|NCT02879578|450717297|FG002|Overall Study|Lost to Follow-up|4|||
125298348|NCT02879578|450717295|FG000|Overall Study|Physician Decision|0|||
125298349|NCT02879578|450717296|FG001|Overall Study|Physician Decision|0|||
125298350|NCT02879578|450717297|FG002|Overall Study|Physician Decision|4|||
125298351|NCT02925728|450717303|FG000|Overall Study|Death|3|||
125298352|NCT02925728|450717304|FG001|Overall Study|Death|5|||
125298353|NCT02925728|450717303|FG000|Overall Study|Physician Decision|1|||
125298354|NCT02925728|450717304|FG001|Overall Study|Physician Decision|0|||
125298355|NCT02925728|450717303|FG000|Overall Study|Withdrawal by Subject|1|||
125298356|NCT02925728|450717304|FG001|Overall Study|Withdrawal by Subject|0|||
125298357|NCT05098509|450717305|FG000|Overall Study|Withdrawal by Subject|0|||
125298358|NCT05098509|450717306|FG001|Overall Study|Withdrawal by Subject|0|||
125298359|NCT05098509|450717307|FG002|Overall Study|Withdrawal by Subject|1|||
125298360|NCT05098509|450717308|FG003|Overall Study|Withdrawal by Subject|0|||
125298361|NCT05098509|450717305|FG000|Overall Study|Early study termination|1|||
125298362|NCT05098509|450717306|FG001|Overall Study|Early study termination|1|||
125298363|NCT05098509|450717307|FG002|Overall Study|Early study termination|1|||
125298364|NCT05098509|450717308|FG003|Overall Study|Early study termination|0|||
125298365|NCT00324233|450717311|FG000|First Period|unable to insert catheter|1|||
125298366|NCT00324233|450717312|FG001|First Period|unable to insert catheter|0|||
124803056|NCT01460368|448910214|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
125298367|NCT00324233|450717311|FG000|Second Period|unable to insert catheter|1|||
125298368|NCT00324233|450717312|FG001|Second Period|unable to insert catheter|1|||
125298369|NCT00324233|450717311|FG000|Second Period|Protocol Violation|4|||
124803057|NCT00299182|448910224|FG000|Overall Study|Withdrawal by Subject|0|||
125298370|NCT00324233|450717312|FG001|Second Period|Protocol Violation|6|||
125298371|NCT00086411|450717320|FG000|Overall Study|Lost to Follow-up|11|||
125298372|NCT00086411|450717321|FG001|Overall Study|Lost to Follow-up|11|||
125298373|NCT00086411|450717322|FG002|Overall Study|Lost to Follow-up|13|||
125298374|NCT00086411|450717323|FG003|Overall Study|Lost to Follow-up|12|||
125298375|NCT03667690|450719887|FG000|Overall Study|Adverse Event|0|||
125298376|NCT03667690|450719888|FG001|Overall Study|Adverse Event|3|||
125298377|NCT03667690|450719887|FG000|Overall Study|Death|22|||
125298378|NCT03667690|450719888|FG001|Overall Study|Death|21|||
125298379|NCT03667690|450719887|FG000|Overall Study|Lost to Follow-up|4|||
125298380|NCT03667690|450719888|FG001|Overall Study|Lost to Follow-up|5|||
125298381|NCT03667690|450719887|FG000|Overall Study|Withdrawal by Subject|7|||
125298382|NCT03667690|450719888|FG001|Overall Study|Withdrawal by Subject|8|||
125298383|NCT03667690|450719887|FG000|Overall Study|Subject could not return for additional investigational product|1|||
125298384|NCT03667690|450719888|FG001|Overall Study|Subject could not return for additional investigational product|0|||
125298385|NCT03667690|450719887|FG000|Overall Study|Subject discharged to hospice care|2|||
125298386|NCT03667690|450719888|FG001|Overall Study|Subject discharged to hospice care|0|||
125298387|NCT03667690|450719887|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
125298388|NCT03667690|450719888|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
125298389|NCT03667690|450719887|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
125298390|NCT03667690|450719888|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
125298391|NCT03667690|450719887|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
125298392|NCT03667690|450719888|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
125298393|NCT03667690|450719887|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
125298394|NCT03667690|450719888|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
125298395|NCT03667690|450719887|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
125298396|NCT03667690|450719888|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
125298397|NCT00321464|450719892|FG000|Overall Study|Death|169|||
125298398|NCT00321464|450719893|FG001|Overall Study|Death|174|||
125298399|NCT00321464|450719892|FG000|Overall Study|Disease progression|124|||
125298400|NCT00321464|450719893|FG001|Overall Study|Disease progression|124|||
125298401|NCT00321464|450719892|FG000|Overall Study|Withdrawal by Subject|117|||
125298402|NCT00321464|450719893|FG001|Overall Study|Withdrawal by Subject|118|||
125298403|NCT00321464|450719892|FG000|Overall Study|Participant request|57|||
125298404|NCT00321464|450719893|FG001|Overall Study|Participant request|61|||
125298405|NCT00321464|450719892|FG000|Overall Study|Adverse Event|43|||
125298406|NCT00321464|450719893|FG001|Overall Study|Adverse Event|28|||
125298407|NCT00321464|450719892|FG000|Overall Study|Physician Decision|15|||
125298408|NCT00321464|450719893|FG001|Overall Study|Physician Decision|14|||
125298409|NCT00321464|450719892|FG000|Overall Study|Noncompliance|4|||
125298410|NCT00321464|450719893|FG001|Overall Study|Noncompliance|10|||
125298411|NCT00321464|450719892|FG000|Overall Study|Lost to Follow-up|7|||
125298412|NCT00321464|450719893|FG001|Overall Study|Lost to Follow-up|8|||
125298413|NCT00321464|450719892|FG000|Overall Study|Protocol deviation|0|||
125298414|NCT00321464|450719893|FG001|Overall Study|Protocol deviation|2|||
125298415|NCT00321464|450719892|FG000|Overall Study|Ineligibility determined|2|||
125298416|NCT00321464|450719893|FG001|Overall Study|Ineligibility determined|1|||
125298417|NCT00321464|450719892|FG000|Overall Study|Other|21|||
125298418|NCT00321464|450719893|FG001|Overall Study|Other|18|||
125298419|NCT04327024|450719894|FG000|Overall Study|Death|1|||
125298420|NCT04327024|450719895|FG001|Overall Study|Death|2|||
125298421|NCT04327024|450719896|FG002|Overall Study|Death|1|||
125298422|NCT04327024|450719894|FG000|Overall Study|Non-compliance with study drug|0|||
125298423|NCT04327024|450719895|FG001|Overall Study|Non-compliance with study drug|1|||
125298424|NCT04327024|450719896|FG002|Overall Study|Non-compliance with study drug|0|||
125298425|NCT04327024|450719894|FG000|Overall Study|Withdrawal by Subject|1|||
125298426|NCT04327024|450719895|FG001|Overall Study|Withdrawal by Subject|1|||
125298427|NCT04327024|450719896|FG002|Overall Study|Withdrawal by Subject|2|||
125298428|NCT01192568|450719900|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
125298429|NCT01192568|450719901|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
125298430|NCT01192568|450719902|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
125298431|NCT01192568|450719903|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
125298432|NCT01192568|450719900|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
125298433|NCT01192568|450719901|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
125298434|NCT01192568|450719902|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
125298435|NCT01192568|450719903|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
125298436|NCT00652951|450719904|FG000|Booster Phase|Adverse event, non-fatal|0|||
125298437|NCT00652951|450719905|FG001|Booster Phase|Adverse event, non-fatal|1|||
125298438|NCT00652951|450719906|FG002|Booster Phase|Adverse event, non-fatal|0|||
125298439|NCT00652951|450719904|FG000|Booster Phase|Other|1|||
125298440|NCT00652951|450719905|FG001|Booster Phase|Other|0|||
125298441|NCT00652951|450719906|FG002|Booster Phase|Other|0|||
125298442|NCT02593825|450719907|FG000|Intervention|Lost to Follow-up|10|||
125298443|NCT02593825|450719908|FG001|Intervention|Lost to Follow-up|12|||
125298444|NCT01206582|450719909|FG000|Overall Study|Withdrew prior to study|1|||
125298445|NCT01206582|450719910|FG001|Overall Study|Withdrew prior to study|0|||
125298446|NCT01206582|450719909|FG000|Overall Study|Discontinued intervention before week 8|1|||
125298447|NCT01206582|450719910|FG001|Overall Study|Discontinued intervention before week 8|2|||
125298448|NCT02522325|450719911|FG000|Overall Study|Adverse Event|0|||
125298449|NCT02522325|450719912|FG001|Overall Study|Adverse Event|1|||
125298450|NCT01209078|450719913|FG000|Overall Study|Adverse Event|5|||
125298451|NCT01209078|450719914|FG001|Overall Study|Adverse Event|0|||
125298452|NCT01209078|450719913|FG000|Overall Study|Lost to Follow-up|4|||
125298453|NCT01209078|450719914|FG001|Overall Study|Lost to Follow-up|0|||
125298454|NCT01209078|450719913|FG000|Overall Study|Physician Decision|5|||
125298455|NCT01209078|450719914|FG001|Overall Study|Physician Decision|2|||
125298456|NCT01209078|450719913|FG000|Overall Study|Withdrawal by Subject|2|||
125298457|NCT01209078|450719914|FG001|Overall Study|Withdrawal by Subject|1|||
125298458|NCT00924508|450719915|FG000|Overall Study|Withdrawal by Subject|3|||
125298459|NCT00495625|450719916|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
125298460|NCT01912339|450719917|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
125298461|NCT01912339|450719918|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
125298462|NCT01912339|450719919|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
125298463|NCT01912339|450719917|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
125298464|NCT01912339|450719918|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
125298465|NCT01912339|450719919|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
125298466|NCT01912339|450719917|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
125298467|NCT01912339|450719918|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
125298468|NCT01912339|450719919|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
125298469|NCT01912339|450719917|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
125298470|NCT01912339|450719918|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
125298471|NCT01912339|450719919|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
125298472|NCT01912339|450719917|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
125298473|NCT01912339|450719918|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
125298474|NCT01912339|450719919|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
125298475|NCT01912339|450719917|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
125298476|NCT01912339|450719918|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
125298477|NCT01912339|450719919|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
125298478|NCT01912339|450719917|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
125298479|NCT01912339|450719918|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
125298480|NCT01912339|450719919|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
125298481|NCT01912339|450719917|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
125298482|NCT01912339|450719918|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
125298483|NCT01912339|450719919|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
125298484|NCT01912339|450719917|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
125298485|NCT01912339|450719918|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
125298486|NCT01912339|450719919|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
125298487|NCT01912339|450719917|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
125298488|NCT01912339|450719918|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
125298489|NCT01912339|450719919|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
125298490|NCT01912339|450719917|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
125298491|NCT01912339|450719918|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
125298492|NCT01912339|450719919|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
125298493|NCT01912339|450719917|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
125298494|NCT01912339|450719918|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
125298495|NCT01912339|450719919|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
125298496|NCT01912339|450719917|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
125298497|NCT01912339|450719918|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
125298498|NCT01912339|450719919|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
125298499|NCT01754493|450719920|FG000|Overall Study|Adverse Event|1|||
125298500|NCT01754493|450719920|FG000|Overall Study|Lost to Follow-up|3|||
125298501|NCT01754493|450719920|FG000|Overall Study|Withdrawal by Subject|1|||
125298502|NCT01754493|450719920|FG000|Overall Study|Moved out of town|1|||
125298503|NCT01754493|450719920|FG000|Overall Study|Scheduling conflict|1|||
125298504|NCT01543776|450719921|FG000|Overall Study|Withdrawal by Subject|2|||
125298505|NCT01543776|450719922|FG001|Overall Study|Withdrawal by Subject|2|||
125298506|NCT03055013|450719924|FG000|Overall Study|Adverse Event|78|||
125298507|NCT03055013|450719925|FG001|Overall Study|Adverse Event|0|||
125298508|NCT03055013|450719924|FG000|Overall Study|Death|6|||
125298509|NCT03055013|450719925|FG001|Overall Study|Death|0|||
125298510|NCT03055013|450719924|FG000|Overall Study|Disease relapse|33|||
125298511|NCT03055013|450719925|FG001|Overall Study|Disease relapse|0|||
125298512|NCT03055013|450719924|FG000|Overall Study|Withdrawal by Subject|28|||
125298513|NCT03055013|450719925|FG001|Overall Study|Withdrawal by Subject|0|||
125298514|NCT03055013|450719924|FG000|Overall Study|Other complicating disease|5|||
125298515|NCT03055013|450719925|FG001|Overall Study|Other complicating disease|0|||
125298516|NCT03055013|450719924|FG000|Overall Study|Physician Decision|1|||
125298517|NCT03055013|450719925|FG001|Overall Study|Physician Decision|0|||
125298518|NCT03055013|450719924|FG000|Overall Study|Benign mass/non-RCC|4|||
125298519|NCT03055013|450719925|FG001|Overall Study|Benign mass/non-RCC|0|||
125298520|NCT03055013|450719924|FG000|Overall Study|Enrolled in another trial|1|||
125298521|NCT03055013|450719925|FG001|Overall Study|Enrolled in another trial|0|||
125298522|NCT03055013|450719924|FG000|Overall Study|Non-protocol therapy|1|||
125298523|NCT03055013|450719925|FG001|Overall Study|Non-protocol therapy|0|||
125298524|NCT03055013|450719924|FG000|Overall Study|Incompliance|1|||
125298525|NCT03055013|450719925|FG001|Overall Study|Incompliance|0|||
125298526|NCT03055013|450719924|FG000|Overall Study|Insurance issues|1|||
125298527|NCT03055013|450719925|FG001|Overall Study|Insurance issues|0|||
125298528|NCT03055013|450719924|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
125298529|NCT03055013|450719925|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
125298530|NCT03055013|450719924|FG000|Overall Study|Did not receive nivolumab|10|||
125298531|NCT03055013|450719925|FG001|Overall Study|Did not receive nivolumab|0|||
125298532|NCT03055013|450719924|FG000|Overall Study|Did not receive surgery|0|||
125298533|NCT03055013|450719925|FG001|Overall Study|Did not receive surgery|28|||
125298534|NCT02207491|450719926|FG000|Overall Study|Adverse Event|20|||
125298535|NCT02207491|450719927|FG001|Overall Study|Adverse Event|4|||
125298536|NCT02207491|450719926|FG000|Overall Study|Withdrawal by Subject|3|||
125298537|NCT02207491|450719927|FG001|Overall Study|Withdrawal by Subject|2|||
125298538|NCT02207491|450719926|FG000|Overall Study|Non-compliant|0|||
125298539|NCT02207491|450719927|FG001|Overall Study|Non-compliant|1|||
125298540|NCT02207491|450719926|FG000|Overall Study|Lost to Follow-up|0|||
125298541|NCT02207491|450719927|FG001|Overall Study|Lost to Follow-up|1|||
125298542|NCT02207491|450719926|FG000|Overall Study|Lack of Efficacy|3|||
125298543|NCT02207491|450719927|FG001|Overall Study|Lack of Efficacy|0|||
125298544|NCT02207491|450719926|FG000|Overall Study|Physician Decision|2|||
125298545|NCT02207491|450719927|FG001|Overall Study|Physician Decision|0|||
125298546|NCT02207491|450719926|FG000|Overall Study|Protocol Violation|3|||
125298547|NCT02207491|450719927|FG001|Overall Study|Protocol Violation|5|||
125298548|NCT00126776|450719928|FG000|Overall Study|follow up complete on all patients|0|||
125298549|NCT00126776|450719929|FG001|Overall Study|follow up complete on all patients|0|||
125298550|NCT00599755|450719930|FG000|Overall Study|Adverse Event|11|||
125298551|NCT00599755|450719930|FG000|Overall Study|Withdrawal by Subject|2|||
125298552|NCT00599755|450719930|FG000|Overall Study|Progression of Disease|3|||
125298553|NCT00599755|450719930|FG000|Overall Study|Other Reason|2|||
125298554|NCT00599755|450719930|FG000|Overall Study|No data available|1|||
125298555|NCT03626545|450719934|FG000|Overall Study|Progressive disease|3|||
125298556|NCT03626545|450719935|FG001|Overall Study|Progressive disease|82|||
125298557|NCT03626545|450719936|FG002|Overall Study|Progressive disease|85|||
125298558|NCT03626545|450719934|FG000|Overall Study|Adverse Event|3|||
125298559|NCT03626545|450719935|FG001|Overall Study|Adverse Event|13|||
125298560|NCT03626545|450719936|FG002|Overall Study|Adverse Event|10|||
125298561|NCT03626545|450719934|FG000|Overall Study|Physician Decision|1|||
125298562|NCT03626545|450719935|FG001|Overall Study|Physician Decision|18|||
125298563|NCT03626545|450719936|FG002|Overall Study|Physician Decision|14|||
125298564|NCT03626545|450719934|FG000|Overall Study|Subject Decision|0|||
125298565|NCT03626545|450719935|FG001|Overall Study|Subject Decision|5|||
125298566|NCT03626545|450719936|FG002|Overall Study|Subject Decision|5|||
125298567|NCT03626545|450719934|FG000|Overall Study|Death|1|||
125298568|NCT03626545|450719935|FG001|Overall Study|Death|1|||
125298569|NCT03626545|450719936|FG002|Overall Study|Death|1|||
124803058|NCT00299182|448910225|FG001|Overall Study|Withdrawal by Subject|0|||
124803059|NCT00299182|448910226|FG002|Overall Study|Withdrawal by Subject|1|||
124803060|NCT00299182|448910227|FG003|Overall Study|Withdrawal by Subject|0|||
124803061|NCT00299182|448910228|FG004|Overall Study|Withdrawal by Subject|1|||
125298570|NCT03626545|450719934|FG000|Overall Study|Protocol Deviation|0|||
125298571|NCT03626545|450719935|FG001|Overall Study|Protocol Deviation|1|||
125298572|NCT03626545|450719936|FG002|Overall Study|Protocol Deviation|1|||
125298573|NCT03626545|450719934|FG000|Overall Study|Guardian Decision|0|||
125298574|NCT03626545|450719935|FG001|Overall Study|Guardian Decision|0|||
125298575|NCT03626545|450719936|FG002|Overall Study|Guardian Decision|1|||
125298576|NCT01939366|450719937|FG000|Overall Study|Adverse Event|8|||
125298577|NCT01939366|450719938|FG001|Overall Study|Adverse Event|17|||
125298578|NCT01939366|450719939|FG002|Overall Study|Adverse Event|30|||
125298579|NCT01939366|450719940|FG003|Overall Study|Adverse Event|8|||
125298580|NCT01939366|450719941|FG004|Overall Study|Adverse Event|5|||
125298581|NCT01939366|450719937|FG000|Overall Study|Lack of Efficacy|2|||
125298582|NCT01939366|450719938|FG001|Overall Study|Lack of Efficacy|1|||
125298583|NCT01939366|450719939|FG002|Overall Study|Lack of Efficacy|1|||
125298584|NCT01939366|450719940|FG003|Overall Study|Lack of Efficacy|1|||
125298585|NCT01939366|450719941|FG004|Overall Study|Lack of Efficacy|3|||
125298586|NCT01939366|450719937|FG000|Overall Study|Lost to Follow-up|1|||
125298587|NCT01939366|450719938|FG001|Overall Study|Lost to Follow-up|1|||
125298588|NCT01939366|450719939|FG002|Overall Study|Lost to Follow-up|0|||
125298589|NCT01939366|450719940|FG003|Overall Study|Lost to Follow-up|0|||
125298590|NCT01939366|450719941|FG004|Overall Study|Lost to Follow-up|0|||
125298591|NCT01939366|450719937|FG000|Overall Study|Withdrawal by Subject|1|||
125298592|NCT01939366|450719938|FG001|Overall Study|Withdrawal by Subject|0|||
125298593|NCT01939366|450719939|FG002|Overall Study|Withdrawal by Subject|2|||
125298594|NCT01939366|450719940|FG003|Overall Study|Withdrawal by Subject|2|||
125298595|NCT01939366|450719941|FG004|Overall Study|Withdrawal by Subject|3|||
125298596|NCT01939366|450719937|FG000|Overall Study|Inclusion criteria not met|0|||
125298597|NCT01939366|450719938|FG001|Overall Study|Inclusion criteria not met|1|||
125298598|NCT01939366|450719939|FG002|Overall Study|Inclusion criteria not met|1|||
125298599|NCT01939366|450719940|FG003|Overall Study|Inclusion criteria not met|0|||
125298600|NCT01939366|450719941|FG004|Overall Study|Inclusion criteria not met|1|||
125298601|NCT01939366|450719937|FG000|Overall Study|Other|0|||
125298602|NCT01939366|450719938|FG001|Overall Study|Other|0|||
125298603|NCT01939366|450719939|FG002|Overall Study|Other|2|||
125298604|NCT01939366|450719940|FG003|Overall Study|Other|2|||
125298605|NCT01939366|450719941|FG004|Overall Study|Other|1|||
125298606|NCT01939366|450719937|FG000|Overall Study|Protocol Violation|0|||
124803062|NCT00299182|448910229|FG005|Overall Study|Withdrawal by Subject|2|||
124803063|NCT00299182|448910230|FG006|Overall Study|Withdrawal by Subject|0|||
125298607|NCT01939366|450719938|FG001|Overall Study|Protocol Violation|0|||
125298608|NCT01939366|450719939|FG002|Overall Study|Protocol Violation|0|||
125298609|NCT01939366|450719940|FG003|Overall Study|Protocol Violation|1|||
125298610|NCT01939366|450719941|FG004|Overall Study|Protocol Violation|0|||
125298611|NCT01939366|450719937|FG000|Overall Study|Sponsor decision|0|||
125298612|NCT01939366|450719938|FG001|Overall Study|Sponsor decision|0|||
125298613|NCT01939366|450719939|FG002|Overall Study|Sponsor decision|0|||
125298614|NCT01939366|450719940|FG003|Overall Study|Sponsor decision|0|||
125298615|NCT01939366|450719941|FG004|Overall Study|Sponsor decision|2|||
125298616|NCT01939366|450719937|FG000|Overall Study|GCP non-compliance at site|2|||
125298617|NCT01939366|450719938|FG001|Overall Study|GCP non-compliance at site|3|||
125298618|NCT01939366|450719939|FG002|Overall Study|GCP non-compliance at site|2|||
125298619|NCT01939366|450719940|FG003|Overall Study|GCP non-compliance at site|3|||
125298620|NCT01939366|450719941|FG004|Overall Study|GCP non-compliance at site|3|||
125298621|NCT03909152|450719942|FG000|Overall Study|Adverse Event|14|||
125298622|NCT03909152|450719943|FG001|Overall Study|Adverse Event|5|||
125298623|NCT03909152|450719944|FG002|Overall Study|Adverse Event|1|||
125298624|NCT03909152|450719945|FG003|Overall Study|Adverse Event|14|||
125298625|NCT02615691|450719946|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
125298626|NCT02615691|450719946|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
125298627|NCT02615691|450719946|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
125298628|NCT02615691|450719946|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
125298629|NCT02017522|450719947|FG000|Overall Study|Withdrawal by Subject|1|||
125298630|NCT00615030|450719949|FG000|Period I|Administrative problem|0|||
125298631|NCT00615030|450719950|FG001|Period I|Administrative problem|0|||
125298632|NCT00615030|450719951|FG002|Period I|Administrative problem|0|||
125298633|NCT00615030|450719952|FG003|Period I|Administrative problem|0|||
125298634|NCT00615030|450719953|FG004|Period I|Administrative problem|1|||
125298635|NCT00615030|450719954|FG005|Period I|Administrative problem|0|||
125298636|NCT00615030|450719955|FG006|Period I|Administrative problem|0|||
125298637|NCT00615030|450719956|FG007|Period I|Administrative problem|0|||
125298638|NCT00615030|450719957|FG008|Period I|Administrative problem|0|||
125298639|NCT00615030|450719958|FG009|Period I|Administrative problem|0|||
125298640|NCT00615030|450719959|FG010|Period I|Administrative problem|0|||
125298641|NCT00615030|450719960|FG011|Period I|Administrative problem|0|||
125298642|NCT00615030|450719949|FG000|Period I|Protocol deviation|1|||
125298643|NCT00615030|450719950|FG001|Period I|Protocol deviation|0|||
125298644|NCT00615030|450719951|FG002|Period I|Protocol deviation|0|||
125298645|NCT00615030|450719952|FG003|Period I|Protocol deviation|0|||
125298646|NCT00615030|450719953|FG004|Period I|Protocol deviation|0|||
125298647|NCT00615030|450719954|FG005|Period I|Protocol deviation|0|||
125298648|NCT00615030|450719955|FG006|Period I|Protocol deviation|0|||
125298649|NCT00615030|450719956|FG007|Period I|Protocol deviation|0|||
125298650|NCT00615030|450719957|FG008|Period I|Protocol deviation|0|||
125298651|NCT00615030|450719958|FG009|Period I|Protocol deviation|0|||
125298652|NCT00615030|450719959|FG010|Period I|Protocol deviation|0|||
125298653|NCT00615030|450719960|FG011|Period I|Protocol deviation|0|||
125298654|NCT00615030|450719949|FG000|Period I|Subject withdrew consent|0|||
125298655|NCT00615030|450719950|FG001|Period I|Subject withdrew consent|0|||
125298656|NCT00615030|450719951|FG002|Period I|Subject withdrew consent|0|||
125298657|NCT00615030|450719952|FG003|Period I|Subject withdrew consent|0|||
125298658|NCT00615030|450719953|FG004|Period I|Subject withdrew consent|0|||
125298659|NCT00615030|450719954|FG005|Period I|Subject withdrew consent|0|||
125298660|NCT00615030|450719955|FG006|Period I|Subject withdrew consent|0|||
125298661|NCT00615030|450719956|FG007|Period I|Subject withdrew consent|0|||
125298662|NCT00615030|450719957|FG008|Period I|Subject withdrew consent|1|||
125298663|NCT00615030|450719958|FG009|Period I|Subject withdrew consent|0|||
125298664|NCT00615030|450719959|FG010|Period I|Subject withdrew consent|1|||
125298665|NCT00615030|450719960|FG011|Period I|Subject withdrew consent|1|||
125298666|NCT00615030|450719949|FG000|Period I|Abnormal laboratory value(s)|0|||
125298667|NCT00615030|450719950|FG001|Period I|Abnormal laboratory value(s)|0|||
125298668|NCT00615030|450719951|FG002|Period I|Abnormal laboratory value(s)|0|||
125298669|NCT00615030|450719952|FG003|Period I|Abnormal laboratory value(s)|0|||
125298670|NCT00615030|450719953|FG004|Period I|Abnormal laboratory value(s)|0|||
125298671|NCT00615030|450719954|FG005|Period I|Abnormal laboratory value(s)|1|||
125298672|NCT00615030|450719955|FG006|Period I|Abnormal laboratory value(s)|0|||
125298673|NCT00615030|450719956|FG007|Period I|Abnormal laboratory value(s)|0|||
125298674|NCT00615030|450719957|FG008|Period I|Abnormal laboratory value(s)|0|||
125298675|NCT00615030|450719958|FG009|Period I|Abnormal laboratory value(s)|0|||
125298676|NCT00615030|450719959|FG010|Period I|Abnormal laboratory value(s)|0|||
125298677|NCT00615030|450719960|FG011|Period I|Abnormal laboratory value(s)|0|||
125298678|NCT00615030|450719949|FG000|Period II|Adverse Event|0|||
125298679|NCT00615030|450719950|FG001|Period II|Adverse Event|0|||
125298680|NCT00615030|450719951|FG002|Period II|Adverse Event|1|||
125298681|NCT00615030|450719952|FG003|Period II|Adverse Event|0|||
125298682|NCT00615030|450719953|FG004|Period II|Adverse Event|0|||
125298683|NCT00615030|450719954|FG005|Period II|Adverse Event|0|||
125298684|NCT00615030|450719955|FG006|Period II|Adverse Event|0|||
125298685|NCT00615030|450719956|FG007|Period II|Adverse Event|0|||
125298686|NCT00615030|450719957|FG008|Period II|Adverse Event|1|||
125298687|NCT00615030|450719958|FG009|Period II|Adverse Event|0|||
125298688|NCT00615030|450719959|FG010|Period II|Adverse Event|0|||
125298689|NCT00615030|450719960|FG011|Period II|Adverse Event|0|||
125298690|NCT00615030|450719949|FG000|Period II|Subject withdrew consent|0|||
125298691|NCT00615030|450719950|FG001|Period II|Subject withdrew consent|0|||
125298692|NCT00615030|450719951|FG002|Period II|Subject withdrew consent|0|||
125298693|NCT00615030|450719952|FG003|Period II|Subject withdrew consent|1|||
125298694|NCT00615030|450719953|FG004|Period II|Subject withdrew consent|0|||
125298695|NCT00615030|450719954|FG005|Period II|Subject withdrew consent|0|||
125298696|NCT00615030|450719955|FG006|Period II|Subject withdrew consent|1|||
125298697|NCT00615030|450719956|FG007|Period II|Subject withdrew consent|0|||
125298698|NCT00615030|450719957|FG008|Period II|Subject withdrew consent|0|||
125298699|NCT00615030|450719958|FG009|Period II|Subject withdrew consent|0|||
125298700|NCT00615030|450719959|FG010|Period II|Subject withdrew consent|0|||
125298701|NCT00615030|450719960|FG011|Period II|Subject withdrew consent|0|||
125298702|NCT00615030|450719949|FG000|Period III|Administrative problems|1|||
125298703|NCT00615030|450719950|FG001|Period III|Administrative problems|0|||
125298704|NCT00615030|450719951|FG002|Period III|Administrative problems|0|||
125298705|NCT00615030|450719952|FG003|Period III|Administrative problems|1|||
125298706|NCT00615030|450719953|FG004|Period III|Administrative problems|0|||
125298707|NCT00615030|450719954|FG005|Period III|Administrative problems|0|||
125298708|NCT00615030|450719955|FG006|Period III|Administrative problems|0|||
125298709|NCT00615030|450719956|FG007|Period III|Administrative problems|0|||
125298710|NCT00615030|450719957|FG008|Period III|Administrative problems|0|||
125298711|NCT00615030|450719958|FG009|Period III|Administrative problems|0|||
125298712|NCT00615030|450719959|FG010|Period III|Administrative problems|0|||
125298713|NCT00615030|450719960|FG011|Period III|Administrative problems|0|||
125298714|NCT00151476|450719961|FG000|FAP Identified Subjects|Protocol Violation|0|||
125298715|NCT00151476|450719962|FG001|FAP Identified Subjects|Protocol Violation|1|||
125298716|NCT00151476|450719961|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
125298717|NCT00151476|450719962|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
124803064|NCT00299182|448910224|FG000|Overall Study|Chemotherapy Changed|0|||
124803065|NCT00299182|448910225|FG001|Overall Study|Chemotherapy Changed|0|||
124803066|NCT00299182|448910226|FG002|Overall Study|Chemotherapy Changed|1|||
124803067|NCT00299182|448910227|FG003|Overall Study|Chemotherapy Changed|0|||
125298718|NCT00151476|450719961|FG000|FAP Analyzed Subjects|Other study participation|0|||
125298719|NCT00151476|450719962|FG001|FAP Analyzed Subjects|Other study participation|1|||
125298720|NCT03446456|450719963|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
125298721|NCT03446456|450719964|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
125298722|NCT03446456|450719963|FG000|Overall Study|Lost to Follow-up|1|||
125298723|NCT03446456|450719964|FG001|Overall Study|Lost to Follow-up|3|||
125298724|NCT03446456|450719963|FG000|Overall Study|Participant failed the toxicology test|1|||
125298725|NCT03446456|450719964|FG001|Overall Study|Participant failed the toxicology test|0|||
125298726|NCT03446456|450719963|FG000|Overall Study|Break down of the experimental equipment|1|||
125298727|NCT03446456|450719964|FG001|Overall Study|Break down of the experimental equipment|0|||
125298728|NCT04099511|450719971|FG000|Overall Study|Lost to Follow-up|2|||
125298729|NCT04099511|450719972|FG001|Overall Study|Lost to Follow-up|2|||
124803068|NCT00299182|448910228|FG004|Overall Study|Chemotherapy Changed|1|||
124803069|NCT00299182|448910229|FG005|Overall Study|Chemotherapy Changed|0|||
124803070|NCT00299182|448910230|FG006|Overall Study|Chemotherapy Changed|1|||
124803071|NCT00299182|448910224|FG000|Overall Study|Adverse Event|0|||
124803072|NCT00299182|448910225|FG001|Overall Study|Adverse Event|0|||
124803073|NCT00299182|448910226|FG002|Overall Study|Adverse Event|0|||
125298730|NCT04099511|450719971|FG000|Overall Study|Withdrawal by Subject|8|||
125298731|NCT04099511|450719972|FG001|Overall Study|Withdrawal by Subject|4|||
125298732|NCT03002311|450719977|FG000|Overall Study|Lost to Follow-up|13|||
125298733|NCT03002311|450719978|FG001|Overall Study|Lost to Follow-up|26|||
125298734|NCT03002311|450719977|FG000|Overall Study|Referral provider called to schedule app|3|||
125298735|NCT03002311|450719978|FG001|Overall Study|Referral provider called to schedule app|3|||
125298736|NCT03002311|450719977|FG000|Overall Study|Physician Decision|3|||
125298737|NCT03002311|450719978|FG001|Overall Study|Physician Decision|1|||
125298738|NCT03908476|450719979|FG000|Overall Study|Death|3|||
125298739|NCT03908476|450719980|FG001|Overall Study|Death|0|||
125298740|NCT03908476|450719979|FG000|Overall Study|Lost to Follow-up|3|||
125298741|NCT03908476|450719980|FG001|Overall Study|Lost to Follow-up|1|||
125298742|NCT03908476|450719979|FG000|Overall Study|Withdrawal by Subject|7|||
125298743|NCT03908476|450719980|FG001|Overall Study|Withdrawal by Subject|1|||
125298744|NCT03908476|450719979|FG000|Overall Study|Physician Decision|2|||
125298745|NCT03908476|450719980|FG001|Overall Study|Physician Decision|0|||
125298746|NCT03908476|450719979|FG000|Overall Study|System Explanted and not Replaced|4|||
125298747|NCT03908476|450719980|FG001|Overall Study|System Explanted and not Replaced|0|||
125298748|NCT03908476|450719979|FG000|Overall Study|Intrathecal Pump|1|||
125298749|NCT03908476|450719980|FG001|Overall Study|Intrathecal Pump|0|||
125298750|NCT03908476|450719979|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
125298751|NCT03908476|450719980|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
125298752|NCT05194267|450719981|FG000|Overall Study|Withdrawal by Subject|2|||
125298753|NCT00802893|450719982|FG000|Overall Study|study terminated|3|||
125298754|NCT02868229|450719983|FG000|Overall Study|Adverse Event|1|||
125298755|NCT02868229|450719984|FG001|Overall Study|Adverse Event|0|||
125298756|NCT02868229|450719985|FG002|Overall Study|Adverse Event|0|||
125298757|NCT02868229|450719986|FG003|Overall Study|Adverse Event|1|||
125298758|NCT02868229|450719983|FG000|Overall Study|Death|0|||
125298759|NCT02868229|450719984|FG001|Overall Study|Death|0|||
125298760|NCT02868229|450719985|FG002|Overall Study|Death|1|||
125298761|NCT02868229|450719986|FG003|Overall Study|Death|1|||
125298762|NCT02868229|450719983|FG000|Overall Study|Missed dose|0|||
124803074|NCT00299182|448910227|FG003|Overall Study|Adverse Event|0|||
124803075|NCT00299182|448910228|FG004|Overall Study|Adverse Event|0|||
124803076|NCT00299182|448910229|FG005|Overall Study|Adverse Event|1|||
125298763|NCT02868229|450719984|FG001|Overall Study|Missed dose|0|||
125298764|NCT02868229|450719985|FG002|Overall Study|Missed dose|0|||
125298765|NCT02868229|450719986|FG003|Overall Study|Missed dose|3|||
125298766|NCT00320424|450719987|FG000|Overall Study|Adverse Event|3|||
125298767|NCT00320424|450719987|FG000|Overall Study|Other|3|||
125298768|NCT06151288|450719988|FG000|Overall Study|Lost to Follow-up|4|||
125298769|NCT06151288|450719989|FG001|Overall Study|Lost to Follow-up|2|||
125298770|NCT06151288|450719990|FG002|Overall Study|Lost to Follow-up|4|||
125298771|NCT06151288|450719991|FG003|Overall Study|Lost to Follow-up|3|||
125298772|NCT06151288|450719988|FG000|Overall Study|Withdrawal by Subject|4|||
125298773|NCT06151288|450719989|FG001|Overall Study|Withdrawal by Subject|5|||
125298774|NCT06151288|450719990|FG002|Overall Study|Withdrawal by Subject|1|||
125298775|NCT06151288|450719991|FG003|Overall Study|Withdrawal by Subject|1|||
125298776|NCT00658814|450719992|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
125298777|NCT00658814|450719993|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
125298778|NCT00658814|450719992|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
125298779|NCT00658814|450719993|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
125298780|NCT00658814|450719992|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
125298781|NCT00658814|450719993|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
125298782|NCT00658814|450719992|FG000|Remission Induction Chemotherapy|Death|1|||
125298783|NCT00658814|450719993|FG001|Remission Induction Chemotherapy|Death|4|||
125298784|NCT00658814|450719992|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
125298785|NCT00658814|450719993|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
125298786|NCT00658814|450719992|FG000|Remission Induction Chemotherapy|Not eligible|1|||
125298787|NCT00658814|450719993|FG001|Remission Induction Chemotherapy|Not eligible|2|||
125298788|NCT00658814|450719992|FG000|Consolidation Therapy|Not protocol specified|0|||
125298789|NCT00658814|450719993|FG001|Consolidation Therapy|Not protocol specified|1|||
125298790|NCT00658814|450719992|FG000|Consolidation Therapy|Not eligible|2|||
125298791|NCT00658814|450719993|FG001|Consolidation Therapy|Not eligible|2|||
125298792|NCT00658814|450719992|FG000|Maintenance Therapy|Adverse Event|1|||
125298793|NCT00658814|450719993|FG001|Maintenance Therapy|Adverse Event|1|||
125298794|NCT00658814|450719992|FG000|Maintenance Therapy|Not protocol specified|1|||
125298795|NCT00658814|450719993|FG001|Maintenance Therapy|Not protocol specified|0|||
125298796|NCT00658814|450719992|FG000|Maintenance Therapy|Not eligible|1|||
125298797|NCT00658814|450719993|FG001|Maintenance Therapy|Not eligible|0|||
125298798|NCT00231413|450720001|FG000|Overall Study|Non-serious AE|0|||
125298799|NCT00231413|450720002|FG001|Overall Study|Non-serious AE|0|||
125298800|NCT00231413|450720003|FG002|Overall Study|Non-serious AE|1|||
125298801|NCT00231413|450720004|FG003|Overall Study|Non-serious AE|0|||
125298802|NCT00231413|450720005|FG004|Overall Study|Non-serious AE|0|||
125298803|NCT00231413|450720006|FG005|Overall Study|Non-serious AE|0|||
125298804|NCT00231413|450720007|FG006|Overall Study|Non-serious AE|1|||
125298805|NCT00231413|450720001|FG000|Overall Study|Withdrawal by Subject|3|||
125298806|NCT00231413|450720002|FG001|Overall Study|Withdrawal by Subject|1|||
125298807|NCT00231413|450720003|FG002|Overall Study|Withdrawal by Subject|4|||
125298808|NCT00231413|450720004|FG003|Overall Study|Withdrawal by Subject|2|||
125298809|NCT00231413|450720005|FG004|Overall Study|Withdrawal by Subject|2|||
125298810|NCT00231413|450720006|FG005|Overall Study|Withdrawal by Subject|0|||
124803077|NCT00299182|448910230|FG006|Overall Study|Adverse Event|0|||
124803078|NCT00299182|448910224|FG000|Overall Study|Not Eligible|0|||
124803079|NCT00299182|448910225|FG001|Overall Study|Not Eligible|0|||
124803080|NCT00299182|448910226|FG002|Overall Study|Not Eligible|0|||
124803081|NCT00299182|448910227|FG003|Overall Study|Not Eligible|0|||
124803082|NCT00299182|448910228|FG004|Overall Study|Not Eligible|1|||
125298811|NCT00231413|450720007|FG006|Overall Study|Withdrawal by Subject|3|||
125298812|NCT00231413|450720001|FG000|Overall Study|Migrated/moved from study area|0|||
125298813|NCT00231413|450720002|FG001|Overall Study|Migrated/moved from study area|0|||
125298814|NCT00231413|450720003|FG002|Overall Study|Migrated/moved from study area|1|||
125298815|NCT00231413|450720004|FG003|Overall Study|Migrated/moved from study area|0|||
125298816|NCT00231413|450720005|FG004|Overall Study|Migrated/moved from study area|0|||
125298817|NCT00231413|450720006|FG005|Overall Study|Migrated/moved from study area|1|||
125298818|NCT00231413|450720007|FG006|Overall Study|Migrated/moved from study area|0|||
125298819|NCT00231413|450720001|FG000|Overall Study|Lost to Follow-up|4|||
125298820|NCT00231413|450720002|FG001|Overall Study|Lost to Follow-up|4|||
125298821|NCT00231413|450720003|FG002|Overall Study|Lost to Follow-up|1|||
125298822|NCT00231413|450720004|FG003|Overall Study|Lost to Follow-up|1|||
125298823|NCT00231413|450720005|FG004|Overall Study|Lost to Follow-up|1|||
125298824|NCT00231413|450720006|FG005|Overall Study|Lost to Follow-up|4|||
125298825|NCT00231413|450720007|FG006|Overall Study|Lost to Follow-up|0|||
125298826|NCT00231413|450720001|FG000|Overall Study|Pregnancy|1|||
125298827|NCT00231413|450720002|FG001|Overall Study|Pregnancy|0|||
125298828|NCT00231413|450720003|FG002|Overall Study|Pregnancy|0|||
124803083|NCT00299182|448910229|FG005|Overall Study|Not Eligible|0|||
124803084|NCT00299182|448910230|FG006|Overall Study|Not Eligible|0|||
124803085|NCT01631812|448910231|FG000|Overall Study|Adverse Event|25|||
125298829|NCT00231413|450720004|FG003|Overall Study|Pregnancy|0|||
125298830|NCT00231413|450720005|FG004|Overall Study|Pregnancy|0|||
125298831|NCT00231413|450720006|FG005|Overall Study|Pregnancy|0|||
125298832|NCT00231413|450720007|FG006|Overall Study|Pregnancy|0|||
125298833|NCT02708485|450720008|FG000|Overall Study|Withdrawal by Subject|3|||
125298834|NCT02708485|450720009|FG001|Overall Study|Withdrawal by Subject|2|||
125298835|NCT03266172|450720010|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
125298836|NCT03266172|450720011|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
125298837|NCT03266172|450720012|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
125298838|NCT03266172|450720010|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
125298839|NCT03266172|450720011|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
125298840|NCT03266172|450720012|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
125298841|NCT03266172|450720010|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
125298842|NCT03266172|450720011|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
125298843|NCT03266172|450720012|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
125298844|NCT03266172|450720010|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
125298845|NCT03266172|450720011|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
125298846|NCT03266172|450720012|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
125298847|NCT03266172|450720010|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
125298848|NCT03266172|450720011|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
125298849|NCT03266172|450720012|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
125298850|NCT03266172|450720010|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
125298851|NCT03266172|450720011|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
125298852|NCT03266172|450720012|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
125298853|NCT01554514|450720015|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
125298854|NCT01554514|450720015|FG000|Overall Study|Physician Decision|1|||
125298855|NCT05222555|450720016|FG000|Overall Study|Ongoing|2|||
125298856|NCT05222555|450720017|FG001|Overall Study|Ongoing|18|||
125298857|NCT05222555|450720016|FG000|Overall Study|Adverse Event|1|||
125298858|NCT05222555|450720017|FG001|Overall Study|Adverse Event|1|||
125298859|NCT05222555|450720016|FG000|Overall Study|Death|0|||
125298860|NCT05222555|450720017|FG001|Overall Study|Death|6|||
125298861|NCT05222555|450720016|FG000|Overall Study|Withdrawal by Subject|0|||
125298862|NCT05222555|450720017|FG001|Overall Study|Withdrawal by Subject|11|||
125298863|NCT00300365|450720020|FG000|Overall Study|Lost to Follow-up|1|||
125298864|NCT00300365|450720021|FG001|Overall Study|Lost to Follow-up|0|||
125298865|NCT00300365|450720020|FG000|Overall Study|Physician Decision|2|||
125298866|NCT00300365|450720021|FG001|Overall Study|Physician Decision|0|||
125298867|NCT00300365|450720020|FG000|Overall Study|Withdrawal by Subject|1|||
125298868|NCT00300365|450720021|FG001|Overall Study|Withdrawal by Subject|0|||
125298869|NCT00300365|450720020|FG000|Overall Study|Adverse Event|0|||
125298870|NCT00300365|450720021|FG001|Overall Study|Adverse Event|2|||
125298871|NCT01422824|450720022|FG000|Overall Study|Case record form not evaluated|1|||
125298872|NCT01422824|450720022|FG000|Overall Study|Lost to Follow-up|37|||
125298873|NCT01581619|450720023|FG000|Overall Study|Withdrawal by Subject|1|||
125298874|NCT01581619|450720023|FG000|Overall Study|Lost to Follow-up|1|||
125298875|NCT01818492|450720024|FG000|Overall Study|Adverse Event|2|||
125298876|NCT01818492|450720024|FG000|Overall Study|Death|3|||
125298877|NCT01818492|450720024|FG000|Overall Study|Withdrawal by Subject|1|||
125298878|NCT01818492|450720024|FG000|Overall Study|Additional therapy when not allowed PP|4|||
125298879|NCT00109577|450720026|FG000|Overall Study|Withdrawal by Subject|3|||
125298880|NCT00109577|450720027|FG001|Overall Study|Withdrawal by Subject|3|||
125298881|NCT00587847|450720028|FG000|Overall Study|Lack of Efficacy|5|||
125298882|NCT00587847|450720028|FG000|Overall Study|Adverse Event|2|||
125298883|NCT02986854|450720030|FG000|Overall Study|Withdrawal by Subject|0|||
125298884|NCT02986854|450720031|FG001|Overall Study|Withdrawal by Subject|1|||
125298885|NCT02986854|450720032|FG002|Overall Study|Withdrawal by Subject|1|||
125298886|NCT02986854|450720030|FG000|Overall Study|Lost to Follow-up|3|||
125298887|NCT02986854|450720031|FG001|Overall Study|Lost to Follow-up|11|||
125298888|NCT02986854|450720032|FG002|Overall Study|Lost to Follow-up|2|||
125298889|NCT01972789|450720035|FG000|Overall Study|Adverse Event|11|||
125298890|NCT01972789|450720036|FG001|Overall Study|Adverse Event|4|||
125298891|NCT01972789|450720035|FG000|Overall Study|Subject withdrew consent|14|||
125298892|NCT01972789|450720036|FG001|Overall Study|Subject withdrew consent|12|||
125298893|NCT01972789|450720035|FG000|Overall Study|Lost to Follow-up|4|||
125298894|NCT01972789|450720036|FG001|Overall Study|Lost to Follow-up|7|||
125298895|NCT01972789|450720035|FG000|Overall Study|Death|7|||
125298896|NCT01972789|450720036|FG001|Overall Study|Death|5|||
125298897|NCT01972789|450720035|FG000|Overall Study|Protocol deviation|1|||
125298898|NCT01972789|450720036|FG001|Overall Study|Protocol deviation|0|||
125298899|NCT01972789|450720035|FG000|Overall Study|Physician Decision|3|||
125298900|NCT01972789|450720036|FG001|Overall Study|Physician Decision|2|||
125298901|NCT03268941|450721561|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
125298902|NCT03268941|450721562|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
125298903|NCT03268941|450721563|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
125298904|NCT03268941|450721564|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
125298905|NCT03268941|450721565|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
125298906|NCT03268941|450721566|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
125298907|NCT03268941|450721567|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
125298908|NCT03268941|450721561|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
125298909|NCT03268941|450721562|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
125298910|NCT03268941|450721563|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
125298911|NCT03268941|450721564|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
125298912|NCT03268941|450721565|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
125298913|NCT03268941|450721566|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
125298914|NCT03268941|450721567|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
125298915|NCT03268941|450721561|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
125298916|NCT03268941|450721562|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
125298917|NCT03268941|450721563|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
125298918|NCT03268941|450721564|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
125298919|NCT03268941|450721565|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
125298920|NCT03268941|450721566|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
125298921|NCT03268941|450721567|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
125298922|NCT03268941|450721561|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
125298923|NCT03268941|450721562|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
125298924|NCT03268941|450721563|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
125298925|NCT03268941|450721564|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
125298926|NCT03268941|450721565|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
124803086|NCT01631812|448910231|FG000|Overall Study|Lack of Efficacy|5|||
124803087|NCT01631812|448910231|FG000|Overall Study|Withdrawal by Subject|4|||
124803088|NCT01631812|448910231|FG000|Overall Study|Physician Decision|3|||
124803089|NCT00072176|448910234|FG000|Overall Study|Withdrawal by Subject|1|||
124803090|NCT00072176|448910235|FG001|Overall Study|Withdrawal by Subject|0|||
124803091|NCT00072176|448910234|FG000|Overall Study|Protocol Violation|0|||
125298927|NCT03268941|450721566|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
125298928|NCT03268941|450721567|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
125298929|NCT03268941|450721561|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
125298930|NCT03268941|450721562|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
125298931|NCT03268941|450721563|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
125298932|NCT03268941|450721564|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
125298933|NCT03268941|450721565|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
125298934|NCT03268941|450721566|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
125298935|NCT03268941|450721567|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
125298936|NCT01216683|450721568|FG000|Induction|Never started treatment|0|||
125298937|NCT01216683|450721569|FG001|Induction|Never started treatment|6|||
125298938|NCT01216683|450721570|FG002|Induction|Never started treatment|3|||
125298939|NCT01216683|450721568|FG000|Induction|Lack of Efficacy|4|||
125298940|NCT01216683|450721569|FG001|Induction|Lack of Efficacy|3|||
125298941|NCT01216683|450721570|FG002|Induction|Lack of Efficacy|7|||
125298942|NCT01216683|450721568|FG000|Induction|Adverse Event|0|||
125298943|NCT01216683|450721569|FG001|Induction|Adverse Event|5|||
125298944|NCT01216683|450721570|FG002|Induction|Adverse Event|5|||
125298945|NCT01216683|450721568|FG000|Induction|Death|0|||
125298946|NCT01216683|450721569|FG001|Induction|Death|0|||
125298947|NCT01216683|450721570|FG002|Induction|Death|2|||
125298948|NCT01216683|450721568|FG000|Induction|Withdrawal by Subject|0|||
125298949|NCT01216683|450721569|FG001|Induction|Withdrawal by Subject|4|||
124803092|NCT00072176|448910235|FG001|Overall Study|Protocol Violation|1|||
124803093|NCT02024555|448910239|FG000|Overall Study|Lost to Follow-up|1|||
124803094|NCT02024555|448910240|FG001|Overall Study|Lost to Follow-up|1|||
124803095|NCT02024555|448910239|FG000|Overall Study|Withdrawal by Subject|5|||
124803096|NCT02024555|448910240|FG001|Overall Study|Withdrawal by Subject|1|||
124803097|NCT03805646|448910242|FG000|Overall Study|Death|40|||
124803098|NCT03805646|448910243|FG001|Overall Study|Death|49|||
124803099|NCT03805646|448910242|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
124803100|NCT03805646|448910243|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
124803101|NCT03350620|448910246|FG000|Stage 2|Adverse Event|0|||
124803102|NCT03350620|448910247|FG001|Stage 2|Adverse Event|1|||
124803103|NCT03350620|448910248|FG002|Stage 2|Adverse Event|1|||
124803104|NCT03350620|448910246|FG000|Stage 2|Lack of Efficacy|0|||
124803105|NCT03350620|448910247|FG001|Stage 2|Lack of Efficacy|2|||
124803106|NCT03350620|448910248|FG002|Stage 2|Lack of Efficacy|0|||
124803107|NCT03350620|448910246|FG000|Stage 2|Lost to Follow-up|1|||
124803108|NCT03350620|448910247|FG001|Stage 2|Lost to Follow-up|2|||
124803109|NCT03350620|448910248|FG002|Stage 2|Lost to Follow-up|2|||
124803110|NCT03350620|448910246|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
124819541|NCT05147350|448965754|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
125298950|NCT01216683|450721570|FG002|Induction|Withdrawal by Subject|2|||
125298951|NCT01216683|450721568|FG000|Induction|Other disease|0|||
125298952|NCT01216683|450721569|FG001|Induction|Other disease|1|||
125298953|NCT01216683|450721570|FG002|Induction|Other disease|2|||
125298954|NCT01216683|450721568|FG000|Continuation|Lack of Efficacy|3|||
125298955|NCT01216683|450721569|FG001|Continuation|Lack of Efficacy|2|||
125298956|NCT01216683|450721570|FG002|Continuation|Lack of Efficacy|7|||
125298957|NCT01216683|450721568|FG000|Continuation|Adverse Event|5|||
125298958|NCT01216683|450721569|FG001|Continuation|Adverse Event|3|||
125298959|NCT01216683|450721570|FG002|Continuation|Adverse Event|16|||
125298960|NCT01216683|450721568|FG000|Continuation|Death|1|||
125298961|NCT01216683|450721569|FG001|Continuation|Death|0|||
124803111|NCT03350620|448910247|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
124803112|NCT03350620|448910248|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
124803113|NCT00257608|448911988|FG000|Chemotherapy Phase|Adverse Event|138|||
124803114|NCT00257608|448911989|FG001|Chemotherapy Phase|Adverse Event|0|||
125298962|NCT01216683|450721570|FG002|Continuation|Death|2|||
125298963|NCT01216683|450721568|FG000|Continuation|Withdrawal by Subject|4|||
125298964|NCT01216683|450721569|FG001|Continuation|Withdrawal by Subject|5|||
125298965|NCT01216683|450721570|FG002|Continuation|Withdrawal by Subject|9|||
125298966|NCT01216683|450721568|FG000|Continuation|Other diseases|0|||
125298967|NCT01216683|450721569|FG001|Continuation|Other diseases|2|||
125298968|NCT01216683|450721570|FG002|Continuation|Other diseases|1|||
125298969|NCT01216683|450721568|FG000|Continuation|Physician Decision|1|||
125298970|NCT01216683|450721569|FG001|Continuation|Physician Decision|0|||
125298971|NCT01216683|450721570|FG002|Continuation|Physician Decision|1|||
125298972|NCT01216683|450721568|FG000|Continuation|Non-compliance|1|||
125298973|NCT01216683|450721569|FG001|Continuation|Non-compliance|0|||
125298974|NCT01216683|450721570|FG002|Continuation|Non-compliance|1|||
125298975|NCT01216683|450721568|FG000|Continuation|Insurance change|0|||
125298976|NCT01216683|450721569|FG001|Continuation|Insurance change|1|||
125298977|NCT01216683|450721570|FG002|Continuation|Insurance change|0|||
125298978|NCT01216683|450721568|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
125298979|NCT01216683|450721569|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
125298980|NCT01216683|450721570|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
125298981|NCT01216683|450721568|FG000|Continuation|Not reported|0|||
125298982|NCT01216683|450721569|FG001|Continuation|Not reported|0|||
125298983|NCT01216683|450721570|FG002|Continuation|Not reported|1|||
125298984|NCT01216683|450721568|FG000|Continuation|Never started treatment|0|||
125298985|NCT01216683|450721569|FG001|Continuation|Never started treatment|1|||
125298986|NCT01216683|450721570|FG002|Continuation|Never started treatment|5|||
125298987|NCT02503501|450721572|FG000|Overall Study|Physician Decision|1|||
125298988|NCT02503501|450721573|FG001|Overall Study|Physician Decision|0|||
125298989|NCT02503501|450721572|FG000|Overall Study|Protocol Violation|0|||
125298990|NCT02503501|450721573|FG001|Overall Study|Protocol Violation|1|||
125298991|NCT02503501|450721572|FG000|Overall Study|Withdrawal by Subject|0|||
125298992|NCT02503501|450721573|FG001|Overall Study|Withdrawal by Subject|2|||
125298993|NCT01740401|450721574|FG000|Overall Study|Progression of disease|6|||
125298994|NCT01740401|450721574|FG000|Overall Study|Adverse Event|2|||
125298995|NCT01740401|450721574|FG000|Overall Study|Did not reach primary endpoint|2|||
125298996|NCT02806960|450721575|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
125298997|NCT02806960|450721576|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
125298998|NCT02806960|450721577|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
125298999|NCT02806960|450721578|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
125299000|NCT03495102|450721579|FG000|Overall Study|Adverse Event|5|||
125299001|NCT03495102|450721580|FG001|Overall Study|Adverse Event|7|||
125299002|NCT03495102|450721581|FG002|Overall Study|Adverse Event|10|||
125299003|NCT03495102|450721579|FG000|Overall Study|Death|3|||
125299004|NCT03495102|450721580|FG001|Overall Study|Death|4|||
125299005|NCT03495102|450721581|FG002|Overall Study|Death|4|||
125299006|NCT03495102|450721579|FG000|Overall Study|Lost to Follow-up|15|||
125299007|NCT03495102|450721580|FG001|Overall Study|Lost to Follow-up|16|||
125299008|NCT03495102|450721581|FG002|Overall Study|Lost to Follow-up|17|||
125299009|NCT03495102|450721579|FG000|Overall Study|Physician Decision|2|||
125299010|NCT03495102|450721580|FG001|Overall Study|Physician Decision|0|||
125299011|NCT03495102|450721581|FG002|Overall Study|Physician Decision|2|||
124803115|NCT00257608|448911990|FG002|Chemotherapy Phase|Adverse Event|0|||
124803116|NCT00257608|448911988|FG000|Chemotherapy Phase|Disease progression|139|||
124803117|NCT00257608|448911989|FG001|Chemotherapy Phase|Disease progression|0|||
125299012|NCT03495102|450721579|FG000|Overall Study|Withdrawal by Subject|25|||
125299013|NCT03495102|450721580|FG001|Overall Study|Withdrawal by Subject|36|||
125299014|NCT03495102|450721581|FG002|Overall Study|Withdrawal by Subject|18|||
125299015|NCT03495102|450721579|FG000|Overall Study|Protocol Violation|1|||
125299016|NCT03495102|450721580|FG001|Overall Study|Protocol Violation|1|||
125299017|NCT03495102|450721581|FG002|Overall Study|Protocol Violation|0|||
125299018|NCT03495102|450721579|FG000|Overall Study|Site Closure|3|||
125299019|NCT03495102|450721580|FG001|Overall Study|Site Closure|1|||
125299020|NCT03495102|450721581|FG002|Overall Study|Site Closure|2|||
125299021|NCT03495102|450721579|FG000|Overall Study|Non-compliance|1|||
125299022|NCT03495102|450721580|FG001|Overall Study|Non-compliance|0|||
125299023|NCT03495102|450721581|FG002|Overall Study|Non-compliance|0|||
125299024|NCT03495102|450721579|FG000|Overall Study|Participant Duplicated at Another Site|0|||
125299025|NCT03495102|450721580|FG001|Overall Study|Participant Duplicated at Another Site|0|||
125299026|NCT03495102|450721581|FG002|Overall Study|Participant Duplicated at Another Site|1|||
125299027|NCT03495102|450721579|FG000|Overall Study|Primary Care Physician Recommendation|0|||
125299028|NCT03495102|450721580|FG001|Overall Study|Primary Care Physician Recommendation|1|||
125299029|NCT03495102|450721581|FG002|Overall Study|Primary Care Physician Recommendation|0|||
125299030|NCT03495102|450721579|FG000|Overall Study|Relocated to Another Country|0|||
125299031|NCT03495102|450721580|FG001|Overall Study|Relocated to Another Country|1|||
125299032|NCT03495102|450721581|FG002|Overall Study|Relocated to Another Country|0|||
125299033|NCT03495102|450721579|FG000|Overall Study|Participant was in Rehabilitation|1|||
125299034|NCT03495102|450721580|FG001|Overall Study|Participant was in Rehabilitation|0|||
125299035|NCT03495102|450721581|FG002|Overall Study|Participant was in Rehabilitation|0|||
125299036|NCT01161537|450721587|FG000|Part B|Withdrawal by Subject|2|||
125299037|NCT03464019|450721591|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
125299038|NCT03464019|450721592|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
125299039|NCT03464019|450721593|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
125299040|NCT03464019|450721591|FG000|NODE-301 Part 1|Ablation|0|||
125299041|NCT03464019|450721592|FG001|NODE-301 Part 1|Ablation|0|||
125299042|NCT03464019|450721593|FG002|NODE-301 Part 1|Ablation|16|||
125299043|NCT03464019|450721591|FG000|NODE-301 Part 1|Test Dose Failure|0|||
125299044|NCT03464019|450721592|FG001|NODE-301 Part 1|Test Dose Failure|0|||
125299045|NCT03464019|450721593|FG002|NODE-301 Part 1|Test Dose Failure|8|||
125299046|NCT03464019|450721591|FG000|NODE-301 Part 1|Adverse Event|0|||
125299047|NCT03464019|450721592|FG001|NODE-301 Part 1|Adverse Event|0|||
125299048|NCT03464019|450721593|FG002|NODE-301 Part 1|Adverse Event|5|||
125299049|NCT03464019|450721591|FG000|NODE-301 Part 1|Physician Decision|0|||
125299050|NCT03464019|450721592|FG001|NODE-301 Part 1|Physician Decision|0|||
125299051|NCT03464019|450721593|FG002|NODE-301 Part 1|Physician Decision|4|||
125299052|NCT03464019|450721591|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
125299053|NCT03464019|450721592|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
125299054|NCT03464019|450721593|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
125299055|NCT03464019|450721591|FG000|NODE-301 Part 1|Protocol Violation|0|||
125299056|NCT03464019|450721592|FG001|NODE-301 Part 1|Protocol Violation|0|||
125299057|NCT03464019|450721593|FG002|NODE-301 Part 1|Protocol Violation|2|||
125299058|NCT03464019|450721591|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
125299059|NCT03464019|450721592|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
125299060|NCT03464019|450721593|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
125299061|NCT03464019|450721591|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
125299062|NCT03464019|450721592|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
125299063|NCT03464019|450721593|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
125299064|NCT03464019|450721591|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
125299065|NCT03464019|450721592|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
125299066|NCT03464019|450721593|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
125299067|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
125299068|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
125299069|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
125299070|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
125299071|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
125299072|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
125299073|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
125299074|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
125299075|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
125299076|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
125299077|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
125299078|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
125299079|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
125299080|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
125299081|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
125299082|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
125299083|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
124803118|NCT00257608|448911990|FG002|Chemotherapy Phase|Disease progression|0|||
124803119|NCT00257608|448911988|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
125299084|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
125299085|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
125299086|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
125299087|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
125299088|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
125299089|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
125299090|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
125299091|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
125299092|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
125299093|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
125299094|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
125299095|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
125299096|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
125299097|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
125299098|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
124803120|NCT00257608|448911989|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
124803121|NCT00257608|448911990|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
124803122|NCT00257608|448911988|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
124803123|NCT00257608|448911989|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
125299099|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
125299100|NCT00511134|450721594|FG000|Overall Study|Withdrawal by Subject|0|||
125299101|NCT00511134|450721595|FG001|Overall Study|Withdrawal by Subject|2|||
125299102|NCT01949090|450721596|FG000|Overall Study|Serious Adverse Event|0|||
125299103|NCT01949090|450721597|FG001|Overall Study|Serious Adverse Event|1|||
125299104|NCT01949090|450721598|FG002|Overall Study|Serious Adverse Event|2|||
125299105|NCT01949090|450721599|FG003|Overall Study|Serious Adverse Event|0|||
125299106|NCT01949090|450721600|FG004|Overall Study|Serious Adverse Event|1|||
125299107|NCT01949090|450721596|FG000|Overall Study|Withdrawal by Subject|2|||
125299108|NCT01949090|450721597|FG001|Overall Study|Withdrawal by Subject|0|||
125299109|NCT01949090|450721598|FG002|Overall Study|Withdrawal by Subject|0|||
125299110|NCT01949090|450721599|FG003|Overall Study|Withdrawal by Subject|0|||
125299111|NCT01949090|450721600|FG004|Overall Study|Withdrawal by Subject|1|||
125299112|NCT01949090|450721596|FG000|Overall Study|Protocol non-compliance|0|||
125299113|NCT01949090|450721597|FG001|Overall Study|Protocol non-compliance|0|||
125299114|NCT01949090|450721598|FG002|Overall Study|Protocol non-compliance|0|||
125299115|NCT01949090|450721599|FG003|Overall Study|Protocol non-compliance|0|||
125299116|NCT01949090|450721600|FG004|Overall Study|Protocol non-compliance|1|||
125299117|NCT01949090|450721596|FG000|Overall Study|Lost to Follow-up|2|||
125299118|NCT01949090|450721597|FG001|Overall Study|Lost to Follow-up|1|||
125299119|NCT01949090|450721598|FG002|Overall Study|Lost to Follow-up|0|||
125299120|NCT01949090|450721599|FG003|Overall Study|Lost to Follow-up|1|||
125299121|NCT01949090|450721600|FG004|Overall Study|Lost to Follow-up|1|||
125299122|NCT03459365|450721601|FG000|Overall Study|Withdrawal by Subject|6|||
125299123|NCT03459365|450721601|FG000|Overall Study|Protocol Violation|8|||
125299124|NCT00567359|450721604|FG000|Overall Study|Withdrawal by Subject|1|||
125299125|NCT00785980|450721605|FG000|7 Day Washout Period|Protocol Violation|3|||
125299126|NCT00528801|450721606|FG000|Overall Study|Withdrawal by Subject|1|||
125299127|NCT00528801|450721607|FG001|Overall Study|Withdrawal by Subject|1|||
125299128|NCT00528801|450721606|FG000|Overall Study|Protocol Violation|11|||
125299129|NCT00528801|450721607|FG001|Overall Study|Protocol Violation|5|||
125299130|NCT00528801|450721606|FG000|Overall Study|Lost to Follow-up|15|||
125299131|NCT00528801|450721607|FG001|Overall Study|Lost to Follow-up|4|||
125299132|NCT00528801|450721606|FG000|Overall Study|Administrative Reasons|0|||
125299133|NCT00528801|450721607|FG001|Overall Study|Administrative Reasons|1|||
125299134|NCT00344500|450721608|FG000|Overall Study|Adverse Event|6|||
125299135|NCT00344500|450721609|FG001|Overall Study|Adverse Event|2|||
125299136|NCT00344500|450721610|FG002|Overall Study|Adverse Event|0|||
125299137|NCT00344500|450721608|FG000|Overall Study|Lost to Follow-up|5|||
125299138|NCT00344500|450721609|FG001|Overall Study|Lost to Follow-up|13|||
125299139|NCT00344500|450721610|FG002|Overall Study|Lost to Follow-up|1|||
125299140|NCT00344500|450721608|FG000|Overall Study|Withdrawal by Subject|7|||
125299141|NCT00344500|450721609|FG001|Overall Study|Withdrawal by Subject|10|||
125299142|NCT00344500|450721610|FG002|Overall Study|Withdrawal by Subject|0|||
125299143|NCT00344500|450721608|FG000|Overall Study|Protocol Violation|4|||
125299144|NCT00344500|450721609|FG001|Overall Study|Protocol Violation|7|||
124803124|NCT00257608|448911990|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
124803125|NCT00257608|448911988|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
124803126|NCT00257608|448911989|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
124803127|NCT00257608|448911990|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
124803128|NCT00257608|448911988|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
124803129|NCT00257608|448911989|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
124803130|NCT00257608|448911990|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
124803131|NCT00257608|448911988|FG000|Chemotherapy Phase|Physician Decision|28|||
125299145|NCT00344500|450721610|FG002|Overall Study|Protocol Violation|1|||
125299146|NCT00344500|450721608|FG000|Overall Study|Not Noted|1|||
125299147|NCT00344500|450721609|FG001|Overall Study|Not Noted|3|||
125299148|NCT00344500|450721610|FG002|Overall Study|Not Noted|0|||
125299149|NCT04680975|450721616|FG000|Overall Study|Adverse Event|3|||
125299150|NCT04680975|450721616|FG000|Overall Study|Death|1|||
125299151|NCT04680975|450721616|FG000|Overall Study|Progressive Disease|1|||
125299152|NCT04680975|450721616|FG000|Overall Study|Withdrawal by Subject|1|||
125299153|NCT02702414|450721617|FG000|Overall Study|Death|96|||
125299154|NCT02702414|450721618|FG001|Overall Study|Death|42|||
125299155|NCT02702414|450721617|FG000|Overall Study|Lost to Follow-up|0|||
125299156|NCT02702414|450721618|FG001|Overall Study|Lost to Follow-up|1|||
125299157|NCT02702414|450721617|FG000|Overall Study|Withdrawal by Subject|0|||
125299158|NCT02702414|450721618|FG001|Overall Study|Withdrawal by Subject|1|||
125299159|NCT02702414|450721617|FG000|Overall Study|Protocol Violation|1|||
124803132|NCT00257608|448911989|FG001|Chemotherapy Phase|Physician Decision|0|||
125299160|NCT02702414|450721618|FG001|Overall Study|Protocol Violation|0|||
125299161|NCT02702414|450721617|FG000|Overall Study|Sponsor Decision|8|||
125299162|NCT02702414|450721618|FG001|Overall Study|Sponsor Decision|7|||
125299163|NCT02596230|450721619|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
125299164|NCT02596230|450721620|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
125299165|NCT02596230|450721621|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
125299166|NCT02596230|450721622|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
125299167|NCT02596230|450721623|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
125299168|NCT02596230|450721619|FG000|Objective 2, One Year|Lost to Follow-up|0|||
125299169|NCT02596230|450721620|FG001|Objective 2, One Year|Lost to Follow-up|41|||
125299170|NCT02596230|450721621|FG002|Objective 2, One Year|Lost to Follow-up|41|||
125299171|NCT02596230|450721622|FG003|Objective 2, One Year|Lost to Follow-up|32|||
125299172|NCT02596230|450721623|FG004|Objective 2, One Year|Lost to Follow-up|46|||
125299173|NCT02596230|450721619|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
125299174|NCT02596230|450721620|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
125299175|NCT02596230|450721621|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
125299176|NCT02596230|450721622|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
125299177|NCT02596230|450721623|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
125299178|NCT02596230|450721619|FG000|Objective 2, One Year|Adverse drug reaction|0|||
125299179|NCT02596230|450721620|FG001|Objective 2, One Year|Adverse drug reaction|1|||
125299180|NCT02596230|450721621|FG002|Objective 2, One Year|Adverse drug reaction|0|||
125299181|NCT02596230|450721622|FG003|Objective 2, One Year|Adverse drug reaction|0|||
125299182|NCT02596230|450721623|FG004|Objective 2, One Year|Adverse drug reaction|0|||
125299183|NCT02596230|450721619|FG000|Objective 2, One Year|Death|0|||
125299184|NCT02596230|450721620|FG001|Objective 2, One Year|Death|12|||
125299185|NCT02596230|450721621|FG002|Objective 2, One Year|Death|41|||
125299186|NCT02596230|450721622|FG003|Objective 2, One Year|Death|21|||
125299187|NCT02596230|450721623|FG004|Objective 2, One Year|Death|30|||
125299188|NCT02596230|450721619|FG000|Objective 2, One Year|Other|0|||
125299189|NCT02596230|450721620|FG001|Objective 2, One Year|Other|3|||
125299190|NCT02596230|450721621|FG002|Objective 2, One Year|Other|2|||
125299191|NCT02596230|450721622|FG003|Objective 2, One Year|Other|0|||
125299192|NCT02596230|450721623|FG004|Objective 2, One Year|Other|0|||
125299193|NCT02271945|450721624|FG000|Overall Study|Death|3|||
125299194|NCT02271945|450721625|FG001|Overall Study|Death|3|||
125299195|NCT02271945|450721624|FG000|Overall Study|Withdrawal by Subject|1|||
124803133|NCT00257608|448911990|FG002|Chemotherapy Phase|Physician Decision|0|||
124803134|NCT00257608|448911988|FG000|Post Chemotherapy Phase|Adverse Event|0|||
124803135|NCT00257608|448911989|FG001|Post Chemotherapy Phase|Adverse Event|34|||
124803136|NCT00257608|448911990|FG002|Post Chemotherapy Phase|Adverse Event|38|||
124803137|NCT00257608|448911988|FG000|Post Chemotherapy Phase|Disease progression|0|||
124803138|NCT00257608|448911989|FG001|Post Chemotherapy Phase|Disease progression|204|||
124803139|NCT00257608|448911990|FG002|Post Chemotherapy Phase|Disease progression|168|||
124803140|NCT00257608|448911988|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
125299196|NCT02271945|450721625|FG001|Overall Study|Withdrawal by Subject|1|||
125299197|NCT02271945|450721624|FG000|Overall Study|Other|1|||
125299198|NCT02271945|450721625|FG001|Overall Study|Other|1|||
125299199|NCT00290498|450721626|FG000|Overall Study|Death|2|||
124803141|NCT00257608|448911989|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
124803142|NCT00257608|448911990|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
124803143|NCT00257608|448911988|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
124803144|NCT00257608|448911989|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
124803145|NCT00257608|448911990|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
124803146|NCT00257608|448911988|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
124803147|NCT00257608|448911989|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
124803148|NCT00257608|448911990|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
124803149|NCT00257608|448911988|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
124803150|NCT00257608|448911989|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
124803151|NCT00257608|448911990|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
124803152|NCT00257608|448911988|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
125299200|NCT00290498|450721627|FG001|Overall Study|Death|0|||
125299201|NCT00290498|450721626|FG000|Overall Study|Physician Decision|1|||
125299202|NCT00290498|450721627|FG001|Overall Study|Physician Decision|0|||
124803153|NCT00257608|448911989|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
124803154|NCT00257608|448911990|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
125299203|NCT00290498|450721626|FG000|Overall Study|Withdrawal by Subject|1|||
125299204|NCT00290498|450721627|FG001|Overall Study|Withdrawal by Subject|0|||
125299205|NCT00290498|450721626|FG000|Overall Study|Ineligible|3|||
125299206|NCT00290498|450721627|FG001|Overall Study|Ineligible|0|||
125299207|NCT00290498|450721626|FG000|Overall Study|Non-Compliance|1|||
125299208|NCT00290498|450721627|FG001|Overall Study|Non-Compliance|0|||
125299209|NCT01716104|450721629|FG000|Overall Study|Do not meet inclusion criteria|6|||
125299210|NCT01716104|450721630|FG001|Overall Study|Do not meet inclusion criteria|7|||
125299211|NCT03129360|450721631|FG000|Overall Study|Did not meet entry criteria|0|||
125299212|NCT03129360|450721632|FG001|Overall Study|Did not meet entry criteria|2|||
125299213|NCT03129360|450721633|FG002|Overall Study|Did not meet entry criteria|1|||
125299214|NCT03129360|450721631|FG000|Overall Study|Excluded due to motion in scanner|1|||
125299215|NCT03129360|450721632|FG001|Overall Study|Excluded due to motion in scanner|0|||
125299216|NCT03129360|450721633|FG002|Overall Study|Excluded due to motion in scanner|0|||
125299217|NCT05026853|450721634|FG000|Overall Study|Cancelled appointment|1|||
125299218|NCT05026853|450721635|FG001|Overall Study|Cancelled appointment|0|||
125299219|NCT05026853|450721634|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
125299220|NCT05026853|450721635|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
125299221|NCT05026853|450721634|FG000|Overall Study|Did not complete 12-week survey|16|||
125299222|NCT05026853|450721635|FG001|Overall Study|Did not complete 12-week survey|16|||
125299223|NCT03006887|450721636|FG000|Overall Study|Adverse Event|1|||
125299224|NCT03836677|450721637|FG000|Period 1|Adverse Event|0|||
125299225|NCT03836677|450721638|FG001|Period 1|Adverse Event|1|||
125299226|NCT03836677|450721637|FG000|Period 2|Severe non-compliance to protocol|1|||
125299227|NCT03836677|450721638|FG001|Period 2|Severe non-compliance to protocol|0|||
125299228|NCT01729208|450721639|FG000|Baseline|Physician Decision|5|||
125299229|NCT01729208|450721640|FG001|Baseline|Physician Decision|4|||
125299230|NCT01729208|450721639|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
125299231|NCT01729208|450721640|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
125299232|NCT01729208|450721639|FG000|12 Months Follow-up|Lost to Follow-up|3|||
125299233|NCT01729208|450721640|FG001|12 Months Follow-up|Lost to Follow-up|3|||
125299234|NCT01729208|450721639|FG000|24 Months Follow-up|Lost to Follow-up|3|||
125299235|NCT01729208|450721640|FG001|24 Months Follow-up|Lost to Follow-up|0|||
125299236|NCT01729208|450721639|FG000|36 Months Follow-up|Physician Decision|1|||
125299237|NCT01729208|450721640|FG001|36 Months Follow-up|Physician Decision|0|||
125299238|NCT01729208|450721639|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
125299239|NCT01729208|450721640|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
125299240|NCT02428413|450721642|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
125299241|NCT02428413|450721643|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
125299242|NCT02428413|450721642|FG000|Overall Study|Protocol Violation|1|||
125299243|NCT02428413|450721643|FG001|Overall Study|Protocol Violation|2|||
125299244|NCT02428413|450721642|FG000|Overall Study|Case Cancelled|2|||
125299245|NCT02428413|450721643|FG001|Overall Study|Case Cancelled|0|||
125299246|NCT02428413|450721642|FG000|Overall Study|Missed Cases|1|||
125299247|NCT02428413|450721643|FG001|Overall Study|Missed Cases|2|||
125299248|NCT02428413|450721642|FG000|Overall Study|Nurse Refusal|1|||
125299249|NCT02428413|450721643|FG001|Overall Study|Nurse Refusal|0|||
125299250|NCT03688100|450721646|FG000|Overall Study|Lost to Follow-up|21|||
125299251|NCT03688100|450721647|FG001|Overall Study|Lost to Follow-up|15|||
125299252|NCT03688100|450721648|FG002|Overall Study|Lost to Follow-up|15|||
125299253|NCT03688100|450721649|FG003|Overall Study|Lost to Follow-up|18|||
125299254|NCT03688100|450721646|FG000|Overall Study|Withdrawal by Subject|19|||
125299255|NCT03688100|450721647|FG001|Overall Study|Withdrawal by Subject|16|||
125299256|NCT03688100|450721648|FG002|Overall Study|Withdrawal by Subject|0|||
125299257|NCT03688100|450721649|FG003|Overall Study|Withdrawal by Subject|0|||
125299258|NCT03688100|450721646|FG000|Overall Study|Death|36|||
125299259|NCT03688100|450721647|FG001|Overall Study|Death|27|||
125299260|NCT03688100|450721648|FG002|Overall Study|Death|0|||
125299261|NCT03688100|450721649|FG003|Overall Study|Death|0|||
125299262|NCT02345330|450721652|FG000|Overall Study|Death|1|||
125299263|NCT02345330|450721652|FG000|Overall Study|Progressive Disease|2|||
125299264|NCT00494507|450721653|FG000|Double-Blind Phase|Adverse Event|2|||
125299265|NCT00494507|450721654|FG001|Double-Blind Phase|Adverse Event|0|||
125299266|NCT00494507|450721655|FG002|Double-Blind Phase|Adverse Event|1|||
125299267|NCT00494507|450721656|FG003|Double-Blind Phase|Adverse Event|0|||
125299268|NCT00494507|450721653|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
125299269|NCT00494507|450721654|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
125299270|NCT00494507|450721655|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
125299271|NCT00494507|450721656|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
124803155|NCT00257608|448911988|FG000|Post Chemotherapy Phase|Physician Decision|0|||
124803156|NCT00257608|448911989|FG001|Post Chemotherapy Phase|Physician Decision|8|||
124803157|NCT00257608|448911990|FG002|Post Chemotherapy Phase|Physician Decision|11|||
124803158|NCT00257608|448911988|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
124803159|NCT00257608|448911989|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
124803160|NCT00257608|448911990|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
124803161|NCT00257608|448911988|FG000|Post Chemotherapy Phase|Not treated|0|||
125299272|NCT00494507|450721653|FG000|Double-Blind Phase|Subject Non-compliance|0|||
125299273|NCT00494507|450721654|FG001|Double-Blind Phase|Subject Non-compliance|0|||
125299274|NCT00494507|450721655|FG002|Double-Blind Phase|Subject Non-compliance|1|||
125299275|NCT00494507|450721656|FG003|Double-Blind Phase|Subject Non-compliance|0|||
125299276|NCT00494507|450721653|FG000|Double-Blind Phase|Negative DNA test|0|||
125299277|NCT00494507|450721654|FG001|Double-Blind Phase|Negative DNA test|0|||
125299278|NCT00494507|450721655|FG002|Double-Blind Phase|Negative DNA test|0|||
125299279|NCT00494507|450721656|FG003|Double-Blind Phase|Negative DNA test|1|||
125299280|NCT00494507|450721653|FG000|Open-Label Phase|Adverse Event|0|||
125299281|NCT00494507|450721654|FG001|Open-Label Phase|Adverse Event|1|||
125299282|NCT00494507|450721655|FG002|Open-Label Phase|Adverse Event|5|||
125299283|NCT00494507|450721656|FG003|Open-Label Phase|Adverse Event|3|||
125299284|NCT00494507|450721653|FG000|Open-Label Phase|Worsening Disease|0|||
125299285|NCT00494507|450721654|FG001|Open-Label Phase|Worsening Disease|0|||
125299286|NCT00494507|450721655|FG002|Open-Label Phase|Worsening Disease|0|||
125299287|NCT00494507|450721656|FG003|Open-Label Phase|Worsening Disease|2|||
125299288|NCT02437084|450721657|FG000|Overall Study|Withdrawal by Subject|2|||
125299289|NCT02437084|450721657|FG000|Overall Study|Physician Decision|1|||
125299290|NCT03729245|450721658|FG000|Overall Study|Lost to Follow-up|5|||
125299291|NCT03729245|450721659|FG001|Overall Study|Lost to Follow-up|6|||
125299292|NCT03729245|450721658|FG000|Overall Study|Withdrawal by Subject|16|||
125299293|NCT03729245|450721659|FG001|Overall Study|Withdrawal by Subject|19|||
125299294|NCT03729245|450721658|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
125299295|NCT03729245|450721659|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
125299296|NCT00989781|450721663|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
125299297|NCT00989781|450721664|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
125299298|NCT00694304|450721665|FG000|Overall Study|Adverse Event|42|||
125299299|NCT00694304|450721665|FG000|Overall Study|Lack of Efficacy|35|||
125299300|NCT00694304|450721665|FG000|Overall Study|Non-compliance With Study Product|16|||
125299301|NCT00694304|450721665|FG000|Overall Study|Protocol Violation|6|||
125299302|NCT00694304|450721665|FG000|Overall Study|Withdrawal of Consent|61|||
125299303|NCT00694304|450721665|FG000|Overall Study|Lost to Follow-up|15|||
125299304|NCT00694304|450721665|FG000|Overall Study|Administrative or Other Reasons|32|||
125299305|NCT04566692|450721666|FG000|Overall Study|Adverse Event|2|||
125299306|NCT04566692|450721667|FG001|Overall Study|Adverse Event|0|||
125299307|NCT04566692|450721666|FG000|Overall Study|Withdrawal by Subject|1|||
125299308|NCT04566692|450721667|FG001|Overall Study|Withdrawal by Subject|1|||
124803162|NCT00257608|448911989|FG001|Post Chemotherapy Phase|Not treated|4|||
124803163|NCT00257608|448911990|FG002|Post Chemotherapy Phase|Not treated|7|||
124803164|NCT02171065|448911991|FG000|Overall Study|Withdrawal by Subject|1|||
125299309|NCT00671437|450721668|FG000|Overall Study|Progressive disease before C1 week 8|8|||
125299310|NCT00671437|450721668|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
125299311|NCT00671437|450721668|FG000|Overall Study|Adverse Event|3|||
125299312|NCT00671437|450721668|FG000|Overall Study|Ineligible post-hoc|1|||
125299313|NCT03203291|450721671|FG000|Overall Study|Withdrawal by Subject|1|||
125299314|NCT00377364|450721676|FG000|Overall Study|Lost to Follow-up|1|||
125299315|NCT00377364|450721677|FG001|Overall Study|Lost to Follow-up|0|||
125299316|NCT00377364|450721676|FG000|Overall Study|Withdrawal by Subject|1|||
125299317|NCT00377364|450721677|FG001|Overall Study|Withdrawal by Subject|0|||
125299318|NCT02540265|450721680|FG000|Overall Study|Lost to Follow-up|0|||
124803165|NCT02171065|448911992|FG001|Overall Study|Withdrawal by Subject|0|||
124803166|NCT02171065|448911993|FG002|Overall Study|Withdrawal by Subject|0|||
124803167|NCT02171065|448911991|FG000|Overall Study|Lost to Follow-up|0|||
124803168|NCT02171065|448911992|FG001|Overall Study|Lost to Follow-up|0|||
124803169|NCT02171065|448911993|FG002|Overall Study|Lost to Follow-up|1|||
124803170|NCT01854658|448911996|FG000|Overall Study|Protocol Violation|6|||
125299319|NCT02540265|450721681|FG001|Overall Study|Lost to Follow-up|0|||
125299320|NCT02540265|450721682|FG002|Overall Study|Lost to Follow-up|1|||
125299321|NCT03157037|450721685|FG000|Overall Study|Death|1|||
125299322|NCT02102399|450721689|FG000|Overall Study|Withdrawal by Subject|6|||
125299323|NCT02102399|450721690|FG001|Overall Study|Withdrawal by Subject|4|||
125299324|NCT03101085|450721691|FG000|Overall Study|Lost to Follow-up|0|||
125299325|NCT03101085|450721692|FG001|Overall Study|Lost to Follow-up|1|||
125299326|NCT00695864|450721693|FG000|Placebo|Withdrawal by Subject|1|||
125299327|NCT00695864|450721693|FG000|Placebo|Physician Decision|4|||
125299328|NCT01704456|450721694|FG000|Overall Study|Lost to Follow-up|8|||
125299329|NCT01704456|450721695|FG001|Overall Study|Lost to Follow-up|14|||
125299330|NCT00718770|450721696|FG000|Overall Study|Adverse Event|1|||
125299331|NCT00718770|450721696|FG000|Overall Study|Lack of Efficacy|1|||
125299332|NCT00718770|450721696|FG000|Overall Study|Lack of Efficacy|1|||
125299333|NCT00718770|450721696|FG000|Overall Study|Adverse Event|1|||
125299334|NCT00718770|450721696|FG000|Overall Study|Lack of Efficacy|1|||
125299335|NCT00718770|450721696|FG000|Overall Study|Adverse Event|1|||
125299336|NCT00718770|450721696|FG000|Overall Study|Lack of Efficacy|1|||
125299337|NCT00718770|450721696|FG000|Overall Study|Adverse Event|1|||
125299338|NCT00498355|450721697|FG000|Overall Study|Lost to Follow-up|1|||
125299339|NCT04583956|450721698|FG000|Overall Study|Death|9|||
124803171|NCT01854658|448911997|FG001|Overall Study|Protocol Violation|2|||
124803172|NCT01854658|448911998|FG002|Overall Study|Protocol Violation|2|||
124803173|NCT01854658|448911999|FG003|Overall Study|Protocol Violation|1|||
125299340|NCT04583956|450721699|FG001|Overall Study|Death|11|||
125299341|NCT04583956|450721698|FG000|Overall Study|Lost to Follow-up|7|||
125299342|NCT04583956|450721699|FG001|Overall Study|Lost to Follow-up|9|||
125299343|NCT04583956|450721698|FG000|Overall Study|Protocol Violation|2|||
125299344|NCT04583956|450721699|FG001|Overall Study|Protocol Violation|0|||
125299345|NCT04583956|450721698|FG000|Overall Study|Withdrawal by Subject|0|||
125299346|NCT04583956|450721699|FG001|Overall Study|Withdrawal by Subject|2|||
125299347|NCT04583956|450721698|FG000|Overall Study|Randomized but not dosed|2|||
125299348|NCT04583956|450721699|FG001|Overall Study|Randomized but not dosed|3|||
125299349|NCT04583956|450721698|FG000|Overall Study|Withdrawal of consent before product administration|1|||
125299350|NCT04583956|450721699|FG001|Overall Study|Withdrawal of consent before product administration|0|||
125299351|NCT04407234|450721706|FG000|Overall Study|Adverse Event|3|||
125299352|NCT04407234|450721707|FG001|Overall Study|Adverse Event|3|||
125299353|NCT00727558|450721708|FG000|Overall Study|Lens issue|0|||
125299354|NCT00727558|450721709|FG001|Overall Study|Lens issue|1|||
125299355|NCT00727558|450721708|FG000|Overall Study|Adverse Event|0|||
125299356|NCT00727558|450721709|FG001|Overall Study|Adverse Event|1|||
125299357|NCT00727558|450721708|FG000|Overall Study|Subject unable to return for follow-up|1|||
125299358|NCT00727558|450721709|FG001|Overall Study|Subject unable to return for follow-up|1|||
125299359|NCT00727558|450721708|FG000|Overall Study|Lost to Follow-up|1|||
125299360|NCT00727558|450721709|FG001|Overall Study|Lost to Follow-up|0|||
125299361|NCT02100475|450723629|FG000|Overall Study|Unclassified|1|||
125299362|NCT02100475|450723630|FG001|Overall Study|Unclassified|2|||
125299363|NCT02100475|450723629|FG000|Overall Study|Withdrawal criteria|1|||
125299364|NCT02100475|450723630|FG001|Overall Study|Withdrawal criteria|0|||
125299365|NCT04599465|450723631|FG000|Overall Study|Physician Decision|1|||
125299366|NCT04599465|450723631|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
125299367|NCT02814175|450723634|FG000|Part 1|Adverse Event|2|||
125299368|NCT02814175|450723635|FG001|Part 1|Adverse Event|3|||
125299369|NCT02814175|450723636|FG002|Part 1|Adverse Event|0|||
125299370|NCT02814175|450723637|FG003|Part 1|Adverse Event|0|||
125299371|NCT02814175|450723638|FG004|Part 1|Adverse Event|0|||
125299372|NCT02814175|450723639|FG005|Part 1|Adverse Event|0|||
125299373|NCT02814175|450723634|FG000|Part 1|Withdrawal Consent|8|||
125299374|NCT02814175|450723635|FG001|Part 1|Withdrawal Consent|1|||
125299375|NCT02814175|450723636|FG002|Part 1|Withdrawal Consent|0|||
125299376|NCT02814175|450723637|FG003|Part 1|Withdrawal Consent|0|||
125299377|NCT02814175|450723638|FG004|Part 1|Withdrawal Consent|0|||
125299378|NCT02814175|450723639|FG005|Part 1|Withdrawal Consent|0|||
125299379|NCT02814175|450723634|FG000|Part 1|Lost to Follow-up|1|||
125299380|NCT02814175|450723635|FG001|Part 1|Lost to Follow-up|0|||
125299381|NCT02814175|450723636|FG002|Part 1|Lost to Follow-up|0|||
125299382|NCT02814175|450723637|FG003|Part 1|Lost to Follow-up|0|||
125299383|NCT02814175|450723638|FG004|Part 1|Lost to Follow-up|0|||
125299384|NCT02814175|450723639|FG005|Part 1|Lost to Follow-up|0|||
125299385|NCT02814175|450723634|FG000|Part 1|Lack of Efficacy|1|||
125299386|NCT02814175|450723635|FG001|Part 1|Lack of Efficacy|2|||
125299387|NCT02814175|450723636|FG002|Part 1|Lack of Efficacy|0|||
125299388|NCT02814175|450723637|FG003|Part 1|Lack of Efficacy|0|||
125299389|NCT02814175|450723638|FG004|Part 1|Lack of Efficacy|0|||
125299390|NCT02814175|450723639|FG005|Part 1|Lack of Efficacy|0|||
125299391|NCT02814175|450723634|FG000|Part 2|Adverse Event|0|||
125299392|NCT02814175|450723635|FG001|Part 2|Adverse Event|0|||
125299393|NCT02814175|450723636|FG002|Part 2|Adverse Event|0|||
125299394|NCT02814175|450723637|FG003|Part 2|Adverse Event|1|||
125299395|NCT02814175|450723638|FG004|Part 2|Adverse Event|1|||
125299396|NCT02814175|450723639|FG005|Part 2|Adverse Event|2|||
125299397|NCT02814175|450723634|FG000|Part 2|Withdrawal Consent|0|||
125299398|NCT02814175|450723635|FG001|Part 2|Withdrawal Consent|0|||
125299399|NCT02814175|450723636|FG002|Part 2|Withdrawal Consent|0|||
125299400|NCT02814175|450723637|FG003|Part 2|Withdrawal Consent|2|||
125299401|NCT02814175|450723638|FG004|Part 2|Withdrawal Consent|1|||
125299402|NCT02814175|450723639|FG005|Part 2|Withdrawal Consent|1|||
125299403|NCT02814175|450723634|FG000|Part 2|Lost to Follow-up|0|||
125299404|NCT02814175|450723635|FG001|Part 2|Lost to Follow-up|0|||
125299405|NCT02814175|450723636|FG002|Part 2|Lost to Follow-up|0|||
124803174|NCT01854658|448911996|FG000|Overall Study|Physician Decision|7|||
124803175|NCT01854658|448911997|FG001|Overall Study|Physician Decision|5|||
124803176|NCT01854658|448911998|FG002|Overall Study|Physician Decision|2|||
125299406|NCT02814175|450723637|FG003|Part 2|Lost to Follow-up|1|||
125299407|NCT02814175|450723638|FG004|Part 2|Lost to Follow-up|0|||
125299408|NCT02814175|450723639|FG005|Part 2|Lost to Follow-up|0|||
125299409|NCT02814175|450723634|FG000|Part 2|Lack of Efficacy|0|||
125299410|NCT02814175|450723635|FG001|Part 2|Lack of Efficacy|0|||
125299411|NCT02814175|450723636|FG002|Part 2|Lack of Efficacy|0|||
125299412|NCT02814175|450723637|FG003|Part 2|Lack of Efficacy|0|||
125299413|NCT02814175|450723638|FG004|Part 2|Lack of Efficacy|0|||
125299414|NCT02814175|450723639|FG005|Part 2|Lack of Efficacy|3|||
125299415|NCT03416127|450723640|FG000|Overall Study|Withdrawal by Subject|0|||
124803177|NCT01854658|448911999|FG003|Overall Study|Physician Decision|4|||
125299416|NCT03416127|450723641|FG001|Overall Study|Withdrawal by Subject|1|||
125299417|NCT03416127|450723642|FG002|Overall Study|Withdrawal by Subject|1|||
125299418|NCT02702180|450723643|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
125299419|NCT02702180|450723644|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
125299420|NCT02702180|450723645|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
125299421|NCT02702180|450723643|FG000|Double-blind Treatment Period|Adverse Event|0|||
125299422|NCT02702180|450723644|FG001|Double-blind Treatment Period|Adverse Event|0|||
125299423|NCT02702180|450723645|FG002|Double-blind Treatment Period|Adverse Event|1|||
125299424|NCT02702180|450723643|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
125299425|NCT02702180|450723644|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
125299426|NCT02702180|450723645|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
125299427|NCT02702180|450723643|FG000|Double-blind Treatment Period|Protocol Violation|0|||
125299428|NCT02702180|450723644|FG001|Double-blind Treatment Period|Protocol Violation|0|||
125299429|NCT02702180|450723645|FG002|Double-blind Treatment Period|Protocol Violation|2|||
125299430|NCT02702180|450723643|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
125299431|NCT02702180|450723644|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
125299432|NCT02702180|450723645|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
125299433|NCT02702180|450723643|FG000|Open-label Treatment Period|Withdrawn in error|0|||
125299434|NCT02702180|450723644|FG001|Open-label Treatment Period|Withdrawn in error|0|||
125299435|NCT02702180|450723645|FG002|Open-label Treatment Period|Withdrawn in error|1|||
125299436|NCT02397057|450723646|FG000|Overall Study|Withdrawal by Subject|6|||
125299437|NCT02397057|450723647|FG001|Overall Study|Withdrawal by Subject|7|||
125299438|NCT02397057|450723646|FG000|Overall Study|Lost to Follow-up|4|||
125299439|NCT02397057|450723647|FG001|Overall Study|Lost to Follow-up|3|||
125299440|NCT02397057|450723646|FG000|Overall Study|Death|1|||
125299441|NCT02397057|450723647|FG001|Overall Study|Death|0|||
125299442|NCT02397057|450723646|FG000|Overall Study|Adverse Event|0|||
125299443|NCT02397057|450723647|FG001|Overall Study|Adverse Event|1|||
125299444|NCT02397057|450723646|FG000|Overall Study|Physician Decision|0|||
125299445|NCT02397057|450723647|FG001|Overall Study|Physician Decision|1|||
125299446|NCT02397057|450723646|FG000|Overall Study|Subject did not receive study drug|0|||
125299447|NCT02397057|450723647|FG001|Overall Study|Subject did not receive study drug|1|||
125299448|NCT00753454|450723652|FG000|Overall Study|Adverse Event|4|||
125299449|NCT00753454|450723652|FG000|Overall Study|Lack of Efficacy|1|||
125299450|NCT00753454|450723652|FG000|Overall Study|Lost to Follow-up|3|||
125299451|NCT00753454|450723652|FG000|Overall Study|Withdrawal by Subject|5|||
125299452|NCT00753454|450723652|FG000|Overall Study|Investigator Decision|1|||
125299453|NCT03927144|450723653|FG000|Core Phase|Adverse Event|9|||
125299454|NCT03927144|450723654|FG001|Core Phase|Adverse Event|5|||
125299455|NCT03927144|450723653|FG000|Core Phase|Lost to Follow-up|3|||
125299456|NCT03927144|450723654|FG001|Core Phase|Lost to Follow-up|2|||
125299457|NCT03927144|450723653|FG000|Core Phase|New Therapy for Study Indication|0|||
125299458|NCT03927144|450723654|FG001|Core Phase|New Therapy for Study Indication|1|||
125299459|NCT03927144|450723653|FG000|Core Phase|No Longer Clinically Benefiting|4|||
125299460|NCT03927144|450723654|FG001|Core Phase|No Longer Clinically Benefiting|4|||
125299461|NCT03927144|450723653|FG000|Core Phase|Physician Decision|2|||
125299462|NCT03927144|450723654|FG001|Core Phase|Physician Decision|8|||
125299463|NCT03927144|450723653|FG000|Core Phase|Protocol Violation|2|||
125299464|NCT03927144|450723654|FG001|Core Phase|Protocol Violation|2|||
125299465|NCT03927144|450723653|FG000|Core Phase|Withdrawal by Subject|16|||
125299466|NCT03927144|450723654|FG001|Core Phase|Withdrawal by Subject|40|||
125299467|NCT03927144|450723653|FG000|Extension Phase|Adverse Event|2|||
125299468|NCT03927144|450723654|FG001|Extension Phase|Adverse Event|1|||
125299469|NCT03927144|450723653|FG000|Extension Phase|No longer clinically benefiting|4|||
125299470|NCT03927144|450723654|FG001|Extension Phase|No longer clinically benefiting|5|||
125299471|NCT03927144|450723653|FG000|Extension Phase|Pregnancy|1|||
125299472|NCT03927144|450723654|FG001|Extension Phase|Pregnancy|0|||
125299473|NCT03927144|450723653|FG000|Extension Phase|Protocol Violation|0|||
125299474|NCT03927144|450723654|FG001|Extension Phase|Protocol Violation|1|||
125299475|NCT03927144|450723653|FG000|Extension Phase|Withdrawal by Subject|8|||
125299476|NCT03927144|450723654|FG001|Extension Phase|Withdrawal by Subject|3|||
125299477|NCT01452919|450723657|FG000|Open-Label Treatment|Adverse Event|5|||
125299478|NCT01452919|450723658|FG001|Open-Label Treatment|Adverse Event|0|||
125299479|NCT01452919|450723659|FG002|Open-Label Treatment|Adverse Event|0|||
125299480|NCT01452919|450723657|FG000|Open-Label Treatment|Lost to Follow-up|4|||
125299481|NCT01452919|450723658|FG001|Open-Label Treatment|Lost to Follow-up|0|||
125299482|NCT01452919|450723659|FG002|Open-Label Treatment|Lost to Follow-up|0|||
125299483|NCT01452919|450723657|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
125299484|NCT01452919|450723658|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
125299485|NCT01452919|450723659|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
125299486|NCT01452919|450723657|FG000|Open-Label Treatment|Protocol Violation|4|||
125299487|NCT01452919|450723658|FG001|Open-Label Treatment|Protocol Violation|0|||
125299488|NCT01452919|450723659|FG002|Open-Label Treatment|Protocol Violation|0|||
125299489|NCT01452919|450723657|FG000|Open-Label Treatment|Sponsor Decision|1|||
125299490|NCT01452919|450723658|FG001|Open-Label Treatment|Sponsor Decision|0|||
125299491|NCT01452919|450723659|FG002|Open-Label Treatment|Sponsor Decision|0|||
125299492|NCT01452919|450723657|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
125299493|NCT01452919|450723658|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
125299494|NCT01452919|450723659|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
125299495|NCT01452919|450723657|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
125299496|NCT01452919|450723658|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
125299497|NCT01452919|450723659|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
125299498|NCT01452919|450723657|FG000|Randomization Treatment|Adverse Event|0|||
125299499|NCT01452919|450723658|FG001|Randomization Treatment|Adverse Event|0|||
125299500|NCT01452919|450723659|FG002|Randomization Treatment|Adverse Event|2|||
125299501|NCT01452919|450723657|FG000|Randomization Treatment|Sponsor Decision|0|||
125299502|NCT01452919|450723658|FG001|Randomization Treatment|Sponsor Decision|1|||
125299503|NCT01452919|450723659|FG002|Randomization Treatment|Sponsor Decision|0|||
125299504|NCT01452919|450723657|FG000|Randomization Treatment|Withdrawal by Subject|0|||
125299505|NCT01452919|450723658|FG001|Randomization Treatment|Withdrawal by Subject|1|||
125299506|NCT01452919|450723659|FG002|Randomization Treatment|Withdrawal by Subject|0|||
125299507|NCT01452919|450723657|FG000|Randomization Treatment|Subject is moving or has moved|0|||
125299508|NCT01452919|450723658|FG001|Randomization Treatment|Subject is moving or has moved|1|||
125299509|NCT01452919|450723659|FG002|Randomization Treatment|Subject is moving or has moved|0|||
125299510|NCT02421588|450723660|FG000|Overall Study|Non-treatment-related AE|8|||
125299511|NCT02421588|450723661|FG001|Overall Study|Non-treatment-related AE|8|||
125299512|NCT02421588|450723660|FG000|Overall Study|Progressive disease|152|||
125299513|NCT02421588|450723661|FG001|Overall Study|Progressive disease|135|||
125299514|NCT02421588|450723660|FG000|Overall Study|Death|11|||
125299515|NCT02421588|450723661|FG001|Overall Study|Death|3|||
125299516|NCT02421588|450723660|FG000|Overall Study|Physician Decision|8|||
125299517|NCT02421588|450723661|FG001|Overall Study|Physician Decision|17|||
125299518|NCT02421588|450723660|FG000|Overall Study|Other reason not specified|3|||
125299519|NCT02421588|450723661|FG001|Overall Study|Other reason not specified|1|||
125299520|NCT02421588|450723660|FG000|Overall Study|Symptomatic deterioration|13|||
125299521|NCT02421588|450723661|FG001|Overall Study|Symptomatic deterioration|19|||
125299522|NCT02421588|450723660|FG000|Overall Study|Treatment-related AE|10|||
125299523|NCT02421588|450723661|FG001|Overall Study|Treatment-related AE|14|||
125299524|NCT02421588|450723660|FG000|Overall Study|Withdrawal by Subject|14|||
125299525|NCT02421588|450723661|FG001|Overall Study|Withdrawal by Subject|16|||
125299526|NCT02421588|450723660|FG000|Overall Study|Not treated|2|||
125299527|NCT02421588|450723661|FG001|Overall Study|Not treated|8|||
125299528|NCT01359943|450723662|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
125299529|NCT01359943|450723663|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
125299530|NCT01359943|450723664|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
125299531|NCT01359943|450723662|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
125299532|NCT01359943|450723663|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
125299533|NCT01359943|450723664|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
125299534|NCT01359943|450723662|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
125299535|NCT01359943|450723663|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
125299536|NCT01359943|450723664|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
125299537|NCT01359943|450723662|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
125299538|NCT01359943|450723663|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
125299539|NCT01359943|450723664|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
125299540|NCT01359943|450723662|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
125299541|NCT01359943|450723663|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
125299542|NCT01359943|450723664|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
125299543|NCT01359943|450723662|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
125299544|NCT01359943|450723663|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
125299545|NCT01359943|450723664|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
125299546|NCT01359943|450723662|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
125299547|NCT01359943|450723663|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
125299548|NCT01359943|450723664|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
125299549|NCT01359943|450723662|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
125299550|NCT01359943|450723663|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
125299551|NCT01359943|450723664|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
125299552|NCT01359943|450723662|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
125299553|NCT01359943|450723663|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
125299554|NCT01359943|450723664|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
125299555|NCT01359943|450723662|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
125299556|NCT01359943|450723663|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
125299557|NCT01359943|450723664|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
125299558|NCT01359943|450723662|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
125299559|NCT01359943|450723663|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
125299560|NCT01359943|450723664|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
125299561|NCT01359943|450723662|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
125299562|NCT01359943|450723663|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
125299563|NCT01359943|450723664|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
125299564|NCT01359943|450723662|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
125299565|NCT01359943|450723663|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
125299566|NCT01359943|450723664|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
125299567|NCT01359943|450723662|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
124803178|NCT01854658|448911996|FG000|Overall Study|Lost to Follow-up|8|||
125299568|NCT01359943|450723663|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
125299569|NCT01359943|450723664|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
125299570|NCT01359943|450723662|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
125299571|NCT01359943|450723663|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
125299572|NCT01359943|450723664|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
125299589|NCT02540668|450723679|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
125299590|NCT02540668|450723680|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
125299591|NCT03270891|450723681|FG000|Overall Study|Lost to Follow-up|3|||
125299592|NCT03270891|450723682|FG001|Overall Study|Lost to Follow-up|6|||
125299593|NCT03270891|450723683|FG002|Overall Study|Lost to Follow-up|0|||
125299594|NCT03270891|450723681|FG000|Overall Study|Withdrawal by Subject|1|||
125299595|NCT03270891|450723682|FG001|Overall Study|Withdrawal by Subject|0|||
125299596|NCT03270891|450723683|FG002|Overall Study|Withdrawal by Subject|0|||
125299597|NCT03270891|450723681|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
125299598|NCT03270891|450723682|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
125299599|NCT03270891|450723683|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
125299600|NCT02516592|450723685|FG000|Overall Study|Patient withdrew consent|5|||
125299601|NCT02516592|450723686|FG001|Overall Study|Patient withdrew consent|2|||
125299602|NCT02516592|450723685|FG000|Overall Study|Protocol deviation|4|||
125299603|NCT02516592|450723686|FG001|Overall Study|Protocol deviation|4|||
125299604|NCT02516592|450723685|FG000|Overall Study|Lost to Follow-up|2|||
125299605|NCT02516592|450723686|FG001|Overall Study|Lost to Follow-up|3|||
125299606|NCT02516592|450723685|FG000|Overall Study|Patient/guardian decision|2|||
125299607|NCT02516592|450723686|FG001|Overall Study|Patient/guardian decision|1|||
125299608|NCT02516592|450723685|FG000|Overall Study|Adverse Event|1|||
125299609|NCT02516592|450723686|FG001|Overall Study|Adverse Event|2|||
125299610|NCT02516592|450723685|FG000|Overall Study|Abnormal test procedure result|1|||
125299611|NCT02516592|450723686|FG001|Overall Study|Abnormal test procedure result|0|||
125299612|NCT02516592|450723685|FG000|Overall Study|Death|1|||
125299613|NCT02516592|450723686|FG001|Overall Study|Death|1|||
125299614|NCT01286740|450723687|FG000|Overall Study|Enrolled but not treated|1|||
125299615|NCT01286740|450723687|FG000|Overall Study|Protocol Violation|1|||
125299616|NCT01110382|450723689|FG000|Overall Study|Withdrawal by Subject|0|||
125299617|NCT01110382|450723690|FG001|Overall Study|Withdrawal by Subject|1|||
125299618|NCT01110382|450723689|FG000|Overall Study|Protocol Violation|0|||
125299619|NCT01110382|450723690|FG001|Overall Study|Protocol Violation|1|||
125299620|NCT01753401|450723693|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
125299621|NCT01753401|450723694|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
125299622|NCT01753401|450723695|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
125299623|NCT01753401|450723696|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
125299624|NCT01753401|450723693|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
125299625|NCT01753401|450723694|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
125299626|NCT01753401|450723695|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
124803179|NCT01854658|448911997|FG001|Overall Study|Lost to Follow-up|9|||
124803180|NCT01854658|448911998|FG002|Overall Study|Lost to Follow-up|8|||
124803181|NCT01854658|448911999|FG003|Overall Study|Lost to Follow-up|4|||
125299627|NCT01753401|450723696|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
125299628|NCT01753401|450723693|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
125299629|NCT01753401|450723694|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
125299630|NCT01753401|450723695|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
125299631|NCT01753401|450723696|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
125299632|NCT01753401|450723693|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
125299633|NCT01753401|450723694|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
125299634|NCT01753401|450723695|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
125299635|NCT01753401|450723696|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
125299636|NCT01753401|450723693|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
125299637|NCT01753401|450723694|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
124803182|NCT01854658|448911996|FG000|Overall Study|Withdrawal by Subject|28|||
124803183|NCT01854658|448911997|FG001|Overall Study|Withdrawal by Subject|21|||
124803184|NCT01854658|448911998|FG002|Overall Study|Withdrawal by Subject|29|||
124803185|NCT01854658|448911999|FG003|Overall Study|Withdrawal by Subject|15|||
124803186|NCT01854658|448911996|FG000|Overall Study|Protocol-specified criteria|15|||
124803187|NCT01854658|448911997|FG001|Overall Study|Protocol-specified criteria|15|||
124803188|NCT01854658|448911998|FG002|Overall Study|Protocol-specified criteria|10|||
124803189|NCT01854658|448911999|FG003|Overall Study|Protocol-specified criteria|7|||
124803190|NCT01854658|448911996|FG000|Overall Study|Lack of Efficacy|3|||
124803191|NCT01854658|448911997|FG001|Overall Study|Lack of Efficacy|8|||
124803192|NCT01854658|448911998|FG002|Overall Study|Lack of Efficacy|4|||
124803193|NCT01854658|448911999|FG003|Overall Study|Lack of Efficacy|7|||
124803194|NCT01854658|448911996|FG000|Overall Study|Adverse Event|21|||
124803195|NCT01854658|448911997|FG001|Overall Study|Adverse Event|14|||
124803196|NCT01854658|448911998|FG002|Overall Study|Adverse Event|23|||
124803197|NCT01854658|448911999|FG003|Overall Study|Adverse Event|19|||
124803198|NCT01854658|448911996|FG000|Overall Study|Administrative reasons|5|||
124803199|NCT01854658|448911997|FG001|Overall Study|Administrative reasons|1|||
124803200|NCT01854658|448911998|FG002|Overall Study|Administrative reasons|2|||
124803201|NCT01854658|448911999|FG003|Overall Study|Administrative reasons|2|||
124803202|NCT01858376|448912000|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
124803203|NCT02203071|448912003|FG000|Overall Study|Lost to Follow-up|3|||
124803204|NCT02203071|448912004|FG001|Overall Study|Lost to Follow-up|1|||
124803205|NCT02436304|448912010|FG000|Overall Study|Lost to Follow-up|0|||
124803206|NCT02436304|448912011|FG001|Overall Study|Lost to Follow-up|1|||
124803207|NCT02436304|448912012|FG002|Overall Study|Lost to Follow-up|0|||
124803208|NCT02436304|448912010|FG000|Overall Study|Withdrawal by Subject|0|||
124803209|NCT02436304|448912011|FG001|Overall Study|Withdrawal by Subject|1|||
124803210|NCT02436304|448912012|FG002|Overall Study|Withdrawal by Subject|0|||
124803211|NCT02436304|448912010|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
124803212|NCT02436304|448912011|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
125299638|NCT01753401|450723695|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
125299639|NCT01753401|450723696|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
125299640|NCT01753401|450723693|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
125299641|NCT01753401|450723694|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
124803213|NCT02436304|448912012|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
124803214|NCT03793556|448912013|FG000|Overall Study|Withdrawal by Subject|12|||
124803215|NCT03793556|448912014|FG001|Overall Study|Withdrawal by Subject|1|||
124803216|NCT03793556|448912013|FG000|Overall Study|Lost to Follow-up|1|||
124803217|NCT03793556|448912014|FG001|Overall Study|Lost to Follow-up|1|||
124803218|NCT04416633|448912015|FG000|Overall Study|Death|1|||
124803219|NCT04416633|448912015|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
124803220|NCT04416633|448912015|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
124803221|NCT04416633|448912015|FG000|Overall Study|Adverse Event|6|||
124803222|NCT04416633|448912015|FG000|Overall Study|Withdrawal by Subject|6|||
124803223|NCT04612790|448912016|FG000|DB Period (Up to 36 Weeks)|Death|1|||
124803224|NCT04612790|448912017|FG001|DB Period (Up to 36 Weeks)|Death|1|||
124803225|NCT04612790|448912018|FG002|DB Period (Up to 36 Weeks)|Death|0|||
124803226|NCT04612790|448912019|FG003|DB Period (Up to 36 Weeks)|Death|0|||
124803227|NCT04612790|448912016|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
124803228|NCT04612790|448912017|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
124803229|NCT04612790|448912018|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
124803230|NCT04612790|448912019|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
124803231|NCT04612790|448912016|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
124803232|NCT04612790|448912017|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
124803233|NCT04612790|448912018|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
124803234|NCT04612790|448912019|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
124803235|NCT04612790|448912016|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
124803236|NCT04612790|448912017|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
124803237|NCT04612790|448912018|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
124803238|NCT04612790|448912019|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
124803239|NCT04612790|448912016|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
124803240|NCT04612790|448912017|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
124803241|NCT04612790|448912018|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
124803242|NCT04612790|448912019|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
124803243|NCT04612790|448912016|FG000|DB Period (Up to 36 Weeks)|Other|1|||
124803244|NCT04612790|448912017|FG001|DB Period (Up to 36 Weeks)|Other|0|||
124803245|NCT04612790|448912018|FG002|DB Period (Up to 36 Weeks)|Other|0|||
124803246|NCT04612790|448912019|FG003|DB Period (Up to 36 Weeks)|Other|0|||
124803247|NCT04612790|448912016|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
124803248|NCT04612790|448912017|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
125299642|NCT01753401|450723695|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
124803249|NCT04612790|448912018|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
124803250|NCT04612790|448912019|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
124803251|NCT04612790|448912016|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
124803252|NCT04612790|448912017|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
124803253|NCT04612790|448912018|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
124803254|NCT04612790|448912019|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
124803255|NCT04612790|448912016|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
124803256|NCT04612790|448912017|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
124803257|NCT04612790|448912018|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
124803258|NCT04612790|448912019|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
124803259|NCT04612790|448912016|FG000|OLE Period (Up to 1 Year)|Other|0|||
124803260|NCT04612790|448912017|FG001|OLE Period (Up to 1 Year)|Other|0|||
124803261|NCT04612790|448912018|FG002|OLE Period (Up to 1 Year)|Other|0|||
124803262|NCT04612790|448912019|FG003|OLE Period (Up to 1 Year)|Other|1|||
124803263|NCT00785928|448912020|FG000|Treatment Phase|Adverse Event|1|||
124803264|NCT00785928|448912021|FG001|Treatment Phase|Adverse Event|1|||
124803265|NCT00785928|448912022|FG002|Treatment Phase|Adverse Event|2|||
124803266|NCT00785928|448912023|FG003|Treatment Phase|Adverse Event|0|||
124803267|NCT00785928|448912024|FG004|Treatment Phase|Adverse Event|0|||
124803268|NCT00785928|448912025|FG005|Treatment Phase|Adverse Event|0|||
124803269|NCT00785928|448912026|FG006|Treatment Phase|Adverse Event|2|||
124803270|NCT00785928|448912020|FG000|Treatment Phase|Inadequate Response|0|||
124803271|NCT00785928|448912021|FG001|Treatment Phase|Inadequate Response|1|||
124803272|NCT00785928|448912022|FG002|Treatment Phase|Inadequate Response|0|||
124803273|NCT00785928|448912023|FG003|Treatment Phase|Inadequate Response|0|||
124803274|NCT00785928|448912024|FG004|Treatment Phase|Inadequate Response|0|||
124803275|NCT00785928|448912025|FG005|Treatment Phase|Inadequate Response|0|||
124803276|NCT00785928|448912026|FG006|Treatment Phase|Inadequate Response|0|||
124803277|NCT00785928|448912020|FG000|Treatment Phase|Lack of Efficacy|0|||
124803278|NCT00785928|448912021|FG001|Treatment Phase|Lack of Efficacy|1|||
124803279|NCT00785928|448912022|FG002|Treatment Phase|Lack of Efficacy|1|||
124803280|NCT00785928|448912023|FG003|Treatment Phase|Lack of Efficacy|0|||
124803281|NCT00785928|448912024|FG004|Treatment Phase|Lack of Efficacy|0|||
124803282|NCT00785928|448912025|FG005|Treatment Phase|Lack of Efficacy|0|||
124803283|NCT00785928|448912026|FG006|Treatment Phase|Lack of Efficacy|0|||
124803284|NCT00785928|448912020|FG000|Treatment Phase|Physician Decision|0|||
125299643|NCT01753401|450723696|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
125299644|NCT01753401|450723693|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
125299645|NCT01753401|450723694|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
125299646|NCT01753401|450723695|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
125299647|NCT01753401|450723696|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
125299648|NCT01353911|450723697|FG000|Overall Study|Lost to Follow-up|2|||
125299649|NCT01353911|450723698|FG001|Overall Study|Lost to Follow-up|6|||
125299650|NCT01353911|450723699|FG002|Overall Study|Lost to Follow-up|4|||
125299651|NCT01353911|450723700|FG003|Overall Study|Lost to Follow-up|0|||
125299652|NCT01353911|450723701|FG004|Overall Study|Lost to Follow-up|4|||
125299653|NCT01353911|450723702|FG005|Overall Study|Lost to Follow-up|4|||
125299654|NCT01353911|450723703|FG006|Overall Study|Lost to Follow-up|3|||
125299655|NCT01353911|450723704|FG007|Overall Study|Lost to Follow-up|6|||
125299656|NCT01353911|450723697|FG000|Overall Study|Withdrawal by Subject|2|||
125299657|NCT01353911|450723698|FG001|Overall Study|Withdrawal by Subject|3|||
125299658|NCT01353911|450723699|FG002|Overall Study|Withdrawal by Subject|4|||
125299659|NCT01353911|450723700|FG003|Overall Study|Withdrawal by Subject|2|||
125299660|NCT01353911|450723701|FG004|Overall Study|Withdrawal by Subject|2|||
125299661|NCT01353911|450723702|FG005|Overall Study|Withdrawal by Subject|3|||
125299662|NCT01353911|450723703|FG006|Overall Study|Withdrawal by Subject|3|||
125299663|NCT01353911|450723704|FG007|Overall Study|Withdrawal by Subject|9|||
125299664|NCT01353911|450723697|FG000|Overall Study|Status Not Recorded|4|||
125299665|NCT01353911|450723698|FG001|Overall Study|Status Not Recorded|0|||
125299666|NCT01353911|450723699|FG002|Overall Study|Status Not Recorded|1|||
125299667|NCT01353911|450723700|FG003|Overall Study|Status Not Recorded|0|||
125299668|NCT01353911|450723701|FG004|Overall Study|Status Not Recorded|0|||
125299669|NCT01353911|450723702|FG005|Overall Study|Status Not Recorded|0|||
125299670|NCT01353911|450723703|FG006|Overall Study|Status Not Recorded|0|||
125299671|NCT01353911|450723704|FG007|Overall Study|Status Not Recorded|0|||
125299672|NCT00462748|450723709|FG000|Overall Study|Adverse Event|7|||
125299673|NCT00462748|450723710|FG001|Overall Study|Adverse Event|5|||
125299674|NCT00462748|450723711|FG002|Overall Study|Adverse Event|9|||
125299675|NCT00462748|450723709|FG000|Overall Study|Protocol Violation|0|||
125299676|NCT00462748|450723710|FG001|Overall Study|Protocol Violation|2|||
124803285|NCT00785928|448912021|FG001|Treatment Phase|Physician Decision|0|||
124803286|NCT00785928|448912022|FG002|Treatment Phase|Physician Decision|0|||
124803287|NCT00785928|448912023|FG003|Treatment Phase|Physician Decision|0|||
124803288|NCT00785928|448912024|FG004|Treatment Phase|Physician Decision|1|||
124803289|NCT00785928|448912025|FG005|Treatment Phase|Physician Decision|0|||
125299677|NCT00462748|450723711|FG002|Overall Study|Protocol Violation|1|||
125299678|NCT00462748|450723709|FG000|Overall Study|Withdrew consent|3|||
125299679|NCT00462748|450723710|FG001|Overall Study|Withdrew consent|3|||
125299680|NCT00462748|450723711|FG002|Overall Study|Withdrew consent|0|||
125299681|NCT00462748|450723709|FG000|Overall Study|Lost to Follow-up|1|||
125299682|NCT00462748|450723710|FG001|Overall Study|Lost to Follow-up|1|||
125299683|NCT00462748|450723711|FG002|Overall Study|Lost to Follow-up|1|||
125299684|NCT00462748|450723709|FG000|Overall Study|Discontinued after 41 days Rx|1|||
125299685|NCT00462748|450723710|FG001|Overall Study|Discontinued after 41 days Rx|0|||
125299686|NCT00462748|450723711|FG002|Overall Study|Discontinued after 41 days Rx|0|||
125299687|NCT03233438|450723712|FG000|Overall Study|Lost to Follow-up|4|||
125299688|NCT03233438|450723713|FG001|Overall Study|Lost to Follow-up|9|||
125299689|NCT03233438|450723712|FG000|Overall Study|Withdrawal by Subject|2|||
125299690|NCT03233438|450723713|FG001|Overall Study|Withdrawal by Subject|1|||
125299691|NCT03233438|450723712|FG000|Overall Study|No recording of dalbavancin|0|||
125299692|NCT03233438|450723713|FG001|Overall Study|No recording of dalbavancin|1|||
125299693|NCT03429543|450723714|FG000|Overall Study|Adverse Event|1|||
125299694|NCT03429543|450723715|FG001|Overall Study|Adverse Event|1|||
125299695|NCT03429543|450723716|FG002|Overall Study|Adverse Event|0|||
125299696|NCT03429543|450723717|FG003|Overall Study|Adverse Event|0|||
125299697|NCT03429543|450723718|FG004|Overall Study|Adverse Event|0|||
125299698|NCT03429543|450723719|FG005|Overall Study|Adverse Event|2|||
125299699|NCT03429543|450723720|FG006|Overall Study|Adverse Event|0|||
125299700|NCT03429543|450723714|FG000|Overall Study|Lost to Follow-up|1|||
125299701|NCT03429543|450723715|FG001|Overall Study|Lost to Follow-up|0|||
125299702|NCT03429543|450723716|FG002|Overall Study|Lost to Follow-up|0|||
125299703|NCT03429543|450723717|FG003|Overall Study|Lost to Follow-up|0|||
125299704|NCT03429543|450723718|FG004|Overall Study|Lost to Follow-up|1|||
125299705|NCT03429543|450723719|FG005|Overall Study|Lost to Follow-up|0|||
125299706|NCT03429543|450723720|FG006|Overall Study|Lost to Follow-up|0|||
125299707|NCT03429543|450723714|FG000|Overall Study|Withdrawal by Subject|5|||
125299708|NCT03429543|450723715|FG001|Overall Study|Withdrawal by Subject|0|||
125299709|NCT03429543|450723716|FG002|Overall Study|Withdrawal by Subject|1|||
125299710|NCT03429543|450723717|FG003|Overall Study|Withdrawal by Subject|2|||
125299711|NCT03429543|450723718|FG004|Overall Study|Withdrawal by Subject|6|||
125299712|NCT03429543|450723719|FG005|Overall Study|Withdrawal by Subject|3|||
125299713|NCT03429543|450723720|FG006|Overall Study|Withdrawal by Subject|1|||
125299714|NCT03429543|450723714|FG000|Overall Study|Other reason than listed|0|||
125299715|NCT03429543|450723715|FG001|Overall Study|Other reason than listed|1|||
125299716|NCT03429543|450723716|FG002|Overall Study|Other reason than listed|0|||
125299717|NCT03429543|450723717|FG003|Overall Study|Other reason than listed|0|||
125299718|NCT03429543|450723718|FG004|Overall Study|Other reason than listed|4|||
125299719|NCT03429543|450723719|FG005|Overall Study|Other reason than listed|4|||
125299720|NCT03429543|450723720|FG006|Overall Study|Other reason than listed|0|||
125299721|NCT03429543|450723714|FG000|Overall Study|Not treated|0|||
125299722|NCT03429543|450723715|FG001|Overall Study|Not treated|0|||
125299723|NCT03429543|450723716|FG002|Overall Study|Not treated|0|||
125299724|NCT03429543|450723717|FG003|Overall Study|Not treated|0|||
125299725|NCT03429543|450723718|FG004|Overall Study|Not treated|1|||
125299726|NCT03429543|450723719|FG005|Overall Study|Not treated|0|||
125299727|NCT03429543|450723720|FG006|Overall Study|Not treated|0|||
125299728|NCT03615066|450723721|FG000|Main Study|Withdrew Consent|0|||
125299729|NCT03615066|450723722|FG001|Main Study|Withdrew Consent|1|||
125299730|NCT03615066|450723723|FG002|Main Study|Withdrew Consent|1|||
125299731|NCT03615066|450723721|FG000|Main Study|Lost to Follow-up|0|||
125299732|NCT03615066|450723722|FG001|Main Study|Lost to Follow-up|0|||
125299733|NCT03615066|450723723|FG002|Main Study|Lost to Follow-up|1|||
125299734|NCT03615066|450723721|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
125299735|NCT03615066|450723722|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
125299736|NCT03615066|450723723|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
125299737|NCT03615066|450723721|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
125299738|NCT03615066|450723722|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
125299739|NCT03615066|450723723|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
124803290|NCT00785928|448912026|FG006|Treatment Phase|Physician Decision|0|||
124803291|NCT00785928|448912020|FG000|Treatment Phase|Sponsor Decision|1|||
124803292|NCT00785928|448912021|FG001|Treatment Phase|Sponsor Decision|0|||
125299740|NCT03615066|450723721|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
125299741|NCT03615066|450723722|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
125299742|NCT03615066|450723723|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
125299743|NCT00576576|450723737|FG000|Overall Study|Lost to Follow-up|6|||
125299744|NCT00576576|450723737|FG000|Overall Study|Protocol Violation|1|||
125299745|NCT01805037|450723743|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
125299746|NCT01805037|450723744|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
125299747|NCT01805037|450723743|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
125299748|NCT01805037|450723744|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
125299749|NCT01805037|450723743|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
125299750|NCT01805037|450723744|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
125299751|NCT01805037|450723743|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
125299752|NCT01805037|450723744|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
125299753|NCT01805037|450723743|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
125299754|NCT01805037|450723744|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
125299755|NCT01805037|450723743|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
125299756|NCT01805037|450723744|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
125299757|NCT01805037|450723743|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
125299758|NCT01805037|450723744|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
125299759|NCT01805037|450723743|FG000|Follow Up (up to 3 Years)|Death|0|||
125299760|NCT01805037|450723744|FG001|Follow Up (up to 3 Years)|Death|2|||
125299761|NCT01805037|450723743|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
125299762|NCT01805037|450723744|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
125299763|NCT01805037|450723743|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
125299764|NCT01805037|450723744|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
125299765|NCT02177838|450723748|FG000|Overall Study|Withdrawal by Subject|1|||
125299766|NCT02177838|450723748|FG000|Overall Study|Physician Decision|1|||
125299767|NCT02177838|450723748|FG000|Overall Study|Death|1|||
125299768|NCT03517566|450723751|FG000|Overall Study|Adverse Event|5|||
125299769|NCT03517566|450723752|FG001|Overall Study|Adverse Event|2|||
125299770|NCT03517566|450723753|FG002|Overall Study|Adverse Event|2|||
125299771|NCT03517566|450723754|FG003|Overall Study|Adverse Event|8|||
124803293|NCT00785928|448912022|FG002|Treatment Phase|Sponsor Decision|0|||
124803294|NCT00785928|448912023|FG003|Treatment Phase|Sponsor Decision|0|||
124803295|NCT00785928|448912024|FG004|Treatment Phase|Sponsor Decision|0|||
124803296|NCT00785928|448912025|FG005|Treatment Phase|Sponsor Decision|0|||
124803297|NCT00785928|448912026|FG006|Treatment Phase|Sponsor Decision|1|||
124803298|NCT00785928|448912020|FG000|Treatment Phase|Withdrawal by Subject|1|||
124803299|NCT00785928|448912021|FG001|Treatment Phase|Withdrawal by Subject|2|||
124803300|NCT00785928|448912022|FG002|Treatment Phase|Withdrawal by Subject|0|||
124803301|NCT00785928|448912023|FG003|Treatment Phase|Withdrawal by Subject|0|||
124803302|NCT00785928|448912024|FG004|Treatment Phase|Withdrawal by Subject|1|||
124803303|NCT00785928|448912025|FG005|Treatment Phase|Withdrawal by Subject|0|||
124803304|NCT00785928|448912026|FG006|Treatment Phase|Withdrawal by Subject|0|||
124803305|NCT00570765|448912031|FG000|DB Phase|Withdrawal by Subject|1|||
124803306|NCT00570765|448912032|FG001|DB Phase|Withdrawal by Subject|0|||
124803307|NCT00570765|448912033|FG002|DB Phase|Withdrawal by Subject|0|||
124803308|NCT00570765|448912034|FG003|DB Phase|Withdrawal by Subject|0|||
124803309|NCT00570765|448912031|FG000|DB Phase|Protocol Violation|0|||
124803310|NCT00570765|448912032|FG001|DB Phase|Protocol Violation|1|||
124803311|NCT00570765|448912033|FG002|DB Phase|Protocol Violation|0|||
124803312|NCT00570765|448912034|FG003|DB Phase|Protocol Violation|0|||
124803313|NCT00570765|448912031|FG000|DB Phase|Adverse Event|3|||
124803314|NCT00570765|448912032|FG001|DB Phase|Adverse Event|6|||
124803315|NCT00570765|448912033|FG002|DB Phase|Adverse Event|0|||
124803316|NCT00570765|448912034|FG003|DB Phase|Adverse Event|0|||
124803317|NCT00570765|448912031|FG000|DB Phase|Did Not Receive Study Drug|0|||
124803318|NCT00570765|448912032|FG001|DB Phase|Did Not Receive Study Drug|0|||
124803319|NCT00570765|448912033|FG002|DB Phase|Did Not Receive Study Drug|1|||
124803320|NCT00570765|448912034|FG003|DB Phase|Did Not Receive Study Drug|0|||
124803321|NCT00570765|448912031|FG000|LTSE Phase|Withdrawal by Subject|0|||
124803322|NCT00570765|448912032|FG001|LTSE Phase|Withdrawal by Subject|0|||
124803323|NCT00570765|448912033|FG002|LTSE Phase|Withdrawal by Subject|0|||
124803324|NCT00570765|448912034|FG003|LTSE Phase|Withdrawal by Subject|1|||
124803325|NCT00570765|448912031|FG000|LTSE Phase|Adverse Event|0|||
124803326|NCT00570765|448912032|FG001|LTSE Phase|Adverse Event|0|||
124803327|NCT00570765|448912033|FG002|LTSE Phase|Adverse Event|0|||
124803328|NCT00570765|448912034|FG003|LTSE Phase|Adverse Event|7|||
124803329|NCT00570765|448912031|FG000|LTSE Phase|Physician Decision|0|||
124803330|NCT00570765|448912032|FG001|LTSE Phase|Physician Decision|0|||
124803331|NCT00570765|448912033|FG002|LTSE Phase|Physician Decision|0|||
124803332|NCT00570765|448912034|FG003|LTSE Phase|Physician Decision|4|||
124803333|NCT03387683|448912035|FG000|Overall Study|In receipt of disallowed medication|1|||
124803334|NCT03387683|448912036|FG001|Overall Study|In receipt of disallowed medication|0|||
124803335|NCT03387683|448912035|FG000|Overall Study|Did not receive treatment|1|||
124803336|NCT03387683|448912036|FG001|Overall Study|Did not receive treatment|0|||
124803337|NCT00875979|448912040|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
124803338|NCT00875979|448912041|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
124803339|NCT00875979|448912040|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
124803340|NCT00875979|448912041|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
124803341|NCT00875979|448912040|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
124803342|NCT00875979|448912041|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
124803343|NCT00875979|448912040|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
124803344|NCT00875979|448912041|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
124803345|NCT00875979|448912040|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
125299772|NCT03517566|450723755|FG004|Overall Study|Adverse Event|7|||
125299773|NCT03517566|450723751|FG000|Overall Study|Lack of Efficacy|3|||
125299774|NCT03517566|450723752|FG001|Overall Study|Lack of Efficacy|2|||
125299775|NCT03517566|450723753|FG002|Overall Study|Lack of Efficacy|1|||
125299776|NCT03517566|450723754|FG003|Overall Study|Lack of Efficacy|1|||
125299777|NCT03517566|450723755|FG004|Overall Study|Lack of Efficacy|4|||
125299778|NCT03517566|450723751|FG000|Overall Study|Lost to Follow-up|3|||
124803346|NCT00875979|448912041|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
124803347|NCT00875979|448912040|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
124803348|NCT00875979|448912041|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
124803349|NCT00875979|448912040|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
124803350|NCT00875979|448912041|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
124803351|NCT00875979|448912040|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
124803352|NCT00875979|448912041|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
124803353|NCT00875979|448912040|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
124803354|NCT00875979|448912041|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
124803355|NCT01649804|448912042|FG000|Overall Study|Administrative/Other|8|||
124803356|NCT01123850|448912049|FG000|Overall Study|Slow enrollment|45|||
124803357|NCT02083081|448912050|FG000|Overall Study|Lost to Follow-up|31|||
124803358|NCT02083081|448912051|FG001|Overall Study|Lost to Follow-up|9|||
124803359|NCT02028871|448912054|FG000|Overall Study|Positive urine drug screen|1|||
124803360|NCT02028871|448912055|FG001|Overall Study|Positive urine drug screen|1|||
124803361|NCT02028871|448912054|FG000|Overall Study|Withdrawal by Subject|1|||
124803362|NCT02028871|448912055|FG001|Overall Study|Withdrawal by Subject|2|||
124803363|NCT02028871|448912054|FG000|Overall Study|IV placement difficulty|1|||
124803364|NCT02028871|448912055|FG001|Overall Study|IV placement difficulty|0|||
124803365|NCT02028871|448912054|FG000|Overall Study|Current Illness|1|||
124803366|NCT02028871|448912055|FG001|Overall Study|Current Illness|0|||
124803367|NCT01691898|448912056|FG000|Overall Study|Death|34|||
124803368|NCT01691898|448912057|FG001|Overall Study|Death|32|||
124803369|NCT01691898|448912058|FG002|Overall Study|Death|6|||
124803370|NCT01691898|448912059|FG003|Overall Study|Death|3|||
124803371|NCT01691898|448912060|FG004|Overall Study|Death|8|||
124803372|NCT01691898|448912061|FG005|Overall Study|Death|31|||
124803373|NCT01691898|448912056|FG000|Overall Study|Adverse Event|0|||
124803374|NCT01691898|448912057|FG001|Overall Study|Adverse Event|1|||
124803375|NCT01691898|448912058|FG002|Overall Study|Adverse Event|0|||
124803376|NCT01691898|448912059|FG003|Overall Study|Adverse Event|1|||
124803377|NCT01691898|448912060|FG004|Overall Study|Adverse Event|1|||
124803378|NCT01691898|448912061|FG005|Overall Study|Adverse Event|0|||
124803379|NCT01691898|448912056|FG000|Overall Study|Progression of Disease|1|||
124803380|NCT01691898|448912057|FG001|Overall Study|Progression of Disease|2|||
124803381|NCT01691898|448912058|FG002|Overall Study|Progression of Disease|1|||
124803382|NCT01691898|448912059|FG003|Overall Study|Progression of Disease|0|||
124803383|NCT01691898|448912060|FG004|Overall Study|Progression of Disease|0|||
124803384|NCT01691898|448912061|FG005|Overall Study|Progression of Disease|1|||
124803385|NCT01691898|448912056|FG000|Overall Study|Lost to Follow-up|3|||
124803386|NCT01691898|448912057|FG001|Overall Study|Lost to Follow-up|1|||
124803387|NCT01691898|448912058|FG002|Overall Study|Lost to Follow-up|0|||
124803388|NCT01691898|448912059|FG003|Overall Study|Lost to Follow-up|0|||
124803389|NCT01691898|448912060|FG004|Overall Study|Lost to Follow-up|1|||
124803390|NCT01691898|448912061|FG005|Overall Study|Lost to Follow-up|0|||
124803391|NCT01691898|448912056|FG000|Overall Study|Withdrawal by Subject|9|||
124803392|NCT01691898|448912057|FG001|Overall Study|Withdrawal by Subject|8|||
124803393|NCT01691898|448912058|FG002|Overall Study|Withdrawal by Subject|2|||
124803394|NCT01691898|448912059|FG003|Overall Study|Withdrawal by Subject|1|||
124803395|NCT01691898|448912060|FG004|Overall Study|Withdrawal by Subject|3|||
124803396|NCT01691898|448912061|FG005|Overall Study|Withdrawal by Subject|3|||
124803397|NCT01691898|448912056|FG000|Overall Study|Non-Compliance|0|||
124803398|NCT01691898|448912057|FG001|Overall Study|Non-Compliance|0|||
124803399|NCT01691898|448912058|FG002|Overall Study|Non-Compliance|0|||
124803400|NCT01691898|448912059|FG003|Overall Study|Non-Compliance|0|||
124803401|NCT01691898|448912060|FG004|Overall Study|Non-Compliance|1|||
125299779|NCT03517566|450723752|FG001|Overall Study|Lost to Follow-up|1|||
125299780|NCT03517566|450723753|FG002|Overall Study|Lost to Follow-up|1|||
125299781|NCT03517566|450723754|FG003|Overall Study|Lost to Follow-up|1|||
125299782|NCT03517566|450723755|FG004|Overall Study|Lost to Follow-up|0|||
125299783|NCT03517566|450723751|FG000|Overall Study|Physician Decision|1|||
125299784|NCT03517566|450723752|FG001|Overall Study|Physician Decision|1|||
125299785|NCT03517566|450723753|FG002|Overall Study|Physician Decision|0|||
124803402|NCT01691898|448912061|FG005|Overall Study|Non-Compliance|0|||
124803403|NCT01104155|448912062|FG000|Overall Study|Adverse Event|15|||
124803404|NCT01104155|448912063|FG001|Overall Study|Adverse Event|8|||
124803405|NCT01104155|448912062|FG000|Overall Study|Participant choice|6|||
124803406|NCT01104155|448912063|FG001|Overall Study|Participant choice|5|||
124803407|NCT01104155|448912062|FG000|Overall Study|Withdrawal of consent|1|||
124803408|NCT01104155|448912063|FG001|Overall Study|Withdrawal of consent|1|||
124803409|NCT01104155|448912062|FG000|Overall Study|Other|3|||
124803410|NCT01104155|448912063|FG001|Overall Study|Other|4|||
124803411|NCT01484132|448912064|FG000|Overall Study|Lost to Follow-up|8|||
124803412|NCT01484132|448912064|FG000|Overall Study|Difficulty with time commitment|2|||
125299786|NCT03517566|450723754|FG003|Overall Study|Physician Decision|1|||
125299787|NCT03517566|450723755|FG004|Overall Study|Physician Decision|0|||
125299788|NCT03517566|450723751|FG000|Overall Study|Pregnancy|0|||
125299789|NCT03517566|450723752|FG001|Overall Study|Pregnancy|1|||
124803413|NCT01484132|448912064|FG000|Overall Study|Ineligible|1|||
124803414|NCT01484132|448912064|FG000|Overall Study|No pre-treatment urine sample collected|1|||
124803415|NCT01484132|448912064|FG000|Overall Study|No post-treatment urine sample collected|10|||
124803416|NCT02808650|448912066|FG000|Overall Study|Death|0|||
124803417|NCT02808650|448912067|FG001|Overall Study|Death|0|||
124803418|NCT02808650|448912068|FG002|Overall Study|Death|0|||
124803419|NCT02808650|448912069|FG003|Overall Study|Death|0|||
124803420|NCT02808650|448912070|FG004|Overall Study|Death|1|||
124803421|NCT02808650|448912066|FG000|Overall Study|Lack of Efficacy|5|||
124803422|NCT02808650|448912067|FG001|Overall Study|Lack of Efficacy|5|||
124803423|NCT02808650|448912068|FG002|Overall Study|Lack of Efficacy|6|||
124803424|NCT02808650|448912069|FG003|Overall Study|Lack of Efficacy|5|||
124803425|NCT02808650|448912070|FG004|Overall Study|Lack of Efficacy|4|||
124803426|NCT02808650|448912066|FG000|Overall Study|Physician Decision|1|||
124803427|NCT02808650|448912067|FG001|Overall Study|Physician Decision|1|||
124803428|NCT02808650|448912068|FG002|Overall Study|Physician Decision|0|||
124803429|NCT02808650|448912069|FG003|Overall Study|Physician Decision|0|||
124803430|NCT02808650|448912070|FG004|Overall Study|Physician Decision|0|||
124803431|NCT02808650|448912066|FG000|Overall Study|Withdrawal by Subject|0|||
124803432|NCT02808650|448912067|FG001|Overall Study|Withdrawal by Subject|0|||
124803433|NCT02808650|448912068|FG002|Overall Study|Withdrawal by Subject|0|||
124803434|NCT02808650|448912069|FG003|Overall Study|Withdrawal by Subject|1|||
124803435|NCT02808650|448912070|FG004|Overall Study|Withdrawal by Subject|1|||
124803436|NCT02939079|448912071|FG000|Overall Study|Adverse Event|2|||
124803437|NCT02939079|448912072|FG001|Overall Study|Adverse Event|1|||
124803438|NCT02939079|448912071|FG000|Overall Study|Lost to Follow-up|0|||
124803439|NCT02939079|448912072|FG001|Overall Study|Lost to Follow-up|2|||
124803440|NCT02939079|448912071|FG000|Overall Study|Protocol Violation|1|||
124803441|NCT02939079|448912072|FG001|Overall Study|Protocol Violation|0|||
124803442|NCT02939079|448912071|FG000|Overall Study|Withdrawal by Subject|0|||
124803443|NCT02939079|448912072|FG001|Overall Study|Withdrawal by Subject|1|||
124803444|NCT02939079|448912071|FG000|Overall Study|relapse during the study|1|||
124803445|NCT02939079|448912072|FG001|Overall Study|relapse during the study|1|||
124803446|NCT04093414|448912073|FG000|3 Month Follow up|Physician Decision|0|||
124803447|NCT04093414|448912074|FG001|3 Month Follow up|Physician Decision|1|||
124803448|NCT04093414|448912073|FG000|6month Follow up|Physician Decision|1|||
124803449|NCT04093414|448912074|FG001|6month Follow up|Physician Decision|3|||
124803450|NCT04209348|448912075|FG000|Overall Study|Lost to Follow-up|1|||
124803451|NCT04209348|448912076|FG001|Overall Study|Lost to Follow-up|0|||
124803452|NCT02770170|448912084|FG000|Overall Study|Withdrawal by Subject|0|||
124803453|NCT02770170|448912085|FG001|Overall Study|Withdrawal by Subject|0|||
124803454|NCT02770170|448912086|FG002|Overall Study|Withdrawal by Subject|0|||
124803455|NCT02770170|448912087|FG003|Overall Study|Withdrawal by Subject|2|||
124803456|NCT02770170|448912084|FG000|Overall Study|due to pregnancy|1|||
124803457|NCT02770170|448912085|FG001|Overall Study|due to pregnancy|0|||
124803458|NCT02770170|448912086|FG002|Overall Study|due to pregnancy|0|||
124803459|NCT02770170|448912087|FG003|Overall Study|due to pregnancy|0|||
124803460|NCT02770170|448912084|FG000|Overall Study|Lack of Efficacy|2|||
124803461|NCT02770170|448912085|FG001|Overall Study|Lack of Efficacy|0|||
124803462|NCT02770170|448912086|FG002|Overall Study|Lack of Efficacy|0|||
124803463|NCT02770170|448912087|FG003|Overall Study|Lack of Efficacy|1|||
124803464|NCT02770170|448912084|FG000|Overall Study|Adverse Event|4|||
124803465|NCT02770170|448912085|FG001|Overall Study|Adverse Event|3|||
124803466|NCT02770170|448912086|FG002|Overall Study|Adverse Event|5|||
124803467|NCT02770170|448912087|FG003|Overall Study|Adverse Event|3|||
124803468|NCT02770170|448912084|FG000|Overall Study|due to disease worsening|0|||
124803469|NCT02770170|448912085|FG001|Overall Study|due to disease worsening|0|||
124803470|NCT02770170|448912086|FG002|Overall Study|due to disease worsening|0|||
124803471|NCT02770170|448912087|FG003|Overall Study|due to disease worsening|1|||
124803472|NCT00445978|448912088|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
124803473|NCT00445978|448912088|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
124803474|NCT00445978|448912088|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
124803475|NCT00445978|448912088|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
124803476|NCT00445978|448912088|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
124803477|NCT00445978|448912088|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
124803478|NCT00445978|448912088|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
124803479|NCT00445978|448912088|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
124803480|NCT00445978|448912088|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
124803481|NCT01822496|448912091|FG000|Overall Study|Protocol Violation|2|||
124803482|NCT01822496|448912092|FG001|Overall Study|Protocol Violation|2|||
124803483|NCT01822496|448912093|FG002|Overall Study|Protocol Violation|0|||
124803484|NCT01822496|448912094|FG003|Overall Study|Protocol Violation|1|||
124803485|NCT01822496|448912091|FG000|Overall Study|Withdrawal by Subject|0|||
124803486|NCT01822496|448912092|FG001|Overall Study|Withdrawal by Subject|0|||
124803487|NCT01822496|448912093|FG002|Overall Study|Withdrawal by Subject|0|||
124803488|NCT01822496|448912094|FG003|Overall Study|Withdrawal by Subject|3|||
124803489|NCT00304239|448912095|FG000|Overall Study|Protocol Deviations/Violations|15|||
125299790|NCT03517566|450723753|FG002|Overall Study|Pregnancy|0|||
124803490|NCT00304239|448912096|FG001|Overall Study|Protocol Deviations/Violations|0|||
124803491|NCT00304239|448912095|FG000|Overall Study|Adverse Event|2|||
124803492|NCT00304239|448912096|FG001|Overall Study|Adverse Event|0|||
124803493|NCT02979197|448912097|FG000|Overall Study|Adverse Event|4|||
124803494|NCT02979197|448912098|FG001|Overall Study|Adverse Event|2|||
124803495|NCT02979197|448912099|FG002|Overall Study|Adverse Event|0|||
124803496|NCT02979197|448912097|FG000|Overall Study|Protocol Violation|0|||
124803497|NCT02979197|448912098|FG001|Overall Study|Protocol Violation|1|||
124803498|NCT02979197|448912099|FG002|Overall Study|Protocol Violation|0|||
124803499|NCT02979197|448912097|FG000|Overall Study|Subject unable to commit to study dates|0|||
124803500|NCT02979197|448912098|FG001|Overall Study|Subject unable to commit to study dates|1|||
124803501|NCT02979197|448912099|FG002|Overall Study|Subject unable to commit to study dates|0|||
124803502|NCT03643159|448912100|FG000|Overall Study|Adverse Event|1|||
124803503|NCT03643159|448912100|FG000|Overall Study|Withdrawal by Subject|1|||
124803504|NCT01898208|448912103|FG000|Overall Study|Positive blood culture|17|||
124803505|NCT01898208|448912104|FG001|Overall Study|Positive blood culture|23|||
124803506|NCT01898208|448912105|FG002|Overall Study|Positive blood culture|15|||
124803507|NCT01898208|448912103|FG000|Overall Study|Death/comfort care within 24 hours|10|||
124803508|NCT01898208|448912104|FG001|Overall Study|Death/comfort care within 24 hours|9|||
124803509|NCT01898208|448912105|FG002|Overall Study|Death/comfort care within 24 hours|8|||
124803510|NCT01898208|448912103|FG000|Overall Study|Negative Gram Stain|6|||
124803511|NCT01898208|448912104|FG001|Overall Study|Negative Gram Stain|9|||
124803512|NCT01898208|448912105|FG002|Overall Study|Negative Gram Stain|6|||
124803513|NCT01898208|448912103|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
124803514|NCT01898208|448912104|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
124803515|NCT01898208|448912105|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
124803516|NCT01898208|448912103|FG000|Overall Study|System/Technical Error|1|||
124803517|NCT01898208|448912104|FG001|Overall Study|System/Technical Error|2|||
124803518|NCT01898208|448912105|FG002|Overall Study|System/Technical Error|3|||
124803519|NCT01898208|448912103|FG000|Overall Study|Lost to Follow-up|3|||
124803520|NCT01898208|448912104|FG001|Overall Study|Lost to Follow-up|1|||
124803521|NCT01898208|448912105|FG002|Overall Study|Lost to Follow-up|1|||
124803522|NCT02436681|448912106|FG000|Overall Study|Lost to Follow-up|10|||
124803523|NCT02436681|448912106|FG000|Overall Study|Withdrawal by Subject|2|||
124803524|NCT02436681|448912106|FG000|Overall Study|Death|2|||
124803525|NCT02030938|448912109|FG000|Overall Study|Lost to Follow-up|4|||
124803526|NCT02030938|448912109|FG000|Overall Study|Withdrawal by Subject|1|||
124803527|NCT03954132|448912111|FG000|Overall Study|Adverse Event|2|||
124803528|NCT03954132|448912112|FG001|Overall Study|Adverse Event|0|||
124803529|NCT03954132|448912111|FG000|Overall Study|Patient's wish|5|||
124803530|NCT03954132|448912112|FG001|Overall Study|Patient's wish|0|||
124803531|NCT03954132|448912111|FG000|Overall Study|Lost to Follow-up|10|||
124803532|NCT03954132|448912112|FG001|Overall Study|Lost to Follow-up|0|||
124803533|NCT03954132|448912111|FG000|Overall Study|Screening failure|0|||
124803534|NCT03954132|448912112|FG001|Overall Study|Screening failure|1|||
124803535|NCT03954132|448912111|FG000|Overall Study|No registration after Visit 1|5|||
124803536|NCT03954132|448912112|FG001|Overall Study|No registration after Visit 1|2|||
124803537|NCT03954132|448912111|FG000|Overall Study|Other reason than listed|2|||
124803538|NCT03954132|448912112|FG001|Overall Study|Other reason than listed|2|||
124803539|NCT03954132|448912111|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
124803540|NCT03954132|448912112|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
124803541|NCT03954132|448912111|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
124803542|NCT03954132|448912112|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
124803543|NCT00932737|448912118|FG000|Overall Study|Not treated in second episode|1|||
124803544|NCT00932737|448912119|FG001|Overall Study|Not treated in second episode|0|||
124803545|NCT00932737|448912118|FG000|Overall Study|Adverse Event|0|||
124803546|NCT00932737|448912119|FG001|Overall Study|Adverse Event|1|||
124803547|NCT04399837|448912120|FG000|Overall Study|Other than listed|0|||
124803548|NCT04399837|448912121|FG001|Overall Study|Other than listed|2|||
124803549|NCT04399837|448912122|FG002|Overall Study|Other than listed|2|||
124803550|NCT04399837|448912123|FG003|Overall Study|Other than listed|3|||
124803551|NCT04399837|448912120|FG000|Overall Study|Withdrawal by Subject|1|||
124803552|NCT04399837|448912121|FG001|Overall Study|Withdrawal by Subject|2|||
124803553|NCT04399837|448912122|FG002|Overall Study|Withdrawal by Subject|1|||
124803554|NCT04399837|448912123|FG003|Overall Study|Withdrawal by Subject|1|||
124803555|NCT01554397|448912125|FG000|Overall Study|Withdrawal by Subject|1|||
124803556|NCT01554397|448912126|FG001|Overall Study|Withdrawal by Subject|0|||
124803557|NCT01554397|448912125|FG000|Overall Study|Ineligible|7|||
124803558|NCT01554397|448912126|FG001|Overall Study|Ineligible|0|||
124803559|NCT00369122|448914207|FG000|Overall Study|Ineligible|10|||
124803560|NCT00369122|448914207|FG000|Overall Study|No protocol treatment|1|||
124803561|NCT00004635|448914208|FG000|Period One|refused|2|||
124803562|NCT00004635|448914209|FG001|Period One|refused|1|||
124803563|NCT00004635|448914208|FG000|Period One|Withdrawal by Subject|1|||
124803564|NCT00004635|448914209|FG001|Period One|Withdrawal by Subject|1|||
124803565|NCT00004635|448914208|FG000|Period One|Protocol Violation|1|||
124803566|NCT00004635|448914209|FG001|Period One|Protocol Violation|0|||
124803567|NCT00004635|448914208|FG000|Period One|PSA did not go <5 ng/mL|1|||
124803568|NCT00004635|448914209|FG001|Period One|PSA did not go <5 ng/mL|0|||
124803569|NCT00004635|448914208|FG000|Period One|second malignancy|1|||
124803570|NCT00004635|448914209|FG001|Period One|second malignancy|0|||
124803571|NCT00004635|448914208|FG000|Period One|progressed|0|||
124803572|NCT00004635|448914209|FG001|Period One|progressed|2|||
124803573|NCT00004635|448914208|FG000|Period One|health problem|0|||
124803574|NCT00004635|448914209|FG001|Period One|health problem|1|||
124803575|NCT00004635|448914208|FG000|Period One|discrepancy in data entry|0|||
124803576|NCT00004635|448914209|FG001|Period One|discrepancy in data entry|1|||
124803577|NCT00004635|448914208|FG000|Period Two|progression|2|||
124803578|NCT00004635|448914209|FG001|Period Two|progression|3|||
124803579|NCT00004635|448914208|FG000|Period Two|Adverse Event|1|||
124803580|NCT00004635|448914209|FG001|Period Two|Adverse Event|0|||
124803581|NCT00004635|448914208|FG000|Period Two|refused|0|||
124803582|NCT00004635|448914209|FG001|Period Two|refused|2|||
124803583|NCT00004635|448914208|FG000|Period Two|health problem|1|||
124803584|NCT00004635|448914209|FG001|Period Two|health problem|1|||
124803585|NCT00004635|448914208|FG000|Period Two|travel issues|0|||
124803586|NCT00004635|448914209|FG001|Period Two|travel issues|1|||
124803587|NCT00004635|448914208|FG000|Period Two|secondary malignancy|1|||
124803588|NCT00004635|448914209|FG001|Period Two|secondary malignancy|1|||
124803589|NCT00004635|448914208|FG000|Period Two|Lost to Follow-up|1|||
124803590|NCT00004635|448914209|FG001|Period Two|Lost to Follow-up|0|||
124803591|NCT00004635|448914208|FG000|Period Two|discrepancy in data entry|0|||
124803592|NCT00004635|448914209|FG001|Period Two|discrepancy in data entry|1|||
124803593|NCT00408629|448914210|FG000|Overall Study|Adverse Event|13|||
124803594|NCT00408629|448914211|FG001|Overall Study|Adverse Event|27|||
124803595|NCT00408629|448914210|FG000|Overall Study|Withdrawal by Subject|8|||
124803596|NCT00408629|448914211|FG001|Overall Study|Withdrawal by Subject|4|||
124803597|NCT00408629|448914210|FG000|Overall Study|Lost to Follow-up|1|||
124803598|NCT00408629|448914211|FG001|Overall Study|Lost to Follow-up|1|||
124803599|NCT00408629|448914210|FG000|Overall Study|Lack of Efficacy|63|||
124803600|NCT00408629|448914211|FG001|Overall Study|Lack of Efficacy|73|||
124803601|NCT00408629|448914210|FG000|Overall Study|Protocol Violation|1|||
124803602|NCT00408629|448914211|FG001|Overall Study|Protocol Violation|5|||
124803603|NCT00408629|448914210|FG000|Overall Study|Miscellaneous|11|||
124803604|NCT00408629|448914211|FG001|Overall Study|Miscellaneous|15|||
124803605|NCT00191906|448914212|FG000|Study Period II|Adverse Event|0|||
124803606|NCT00191906|448914213|FG001|Study Period II|Adverse Event|1|||
124803607|NCT00191906|448914214|FG002|Study Period II|Adverse Event|0|||
124803608|NCT00191906|448914215|FG003|Study Period II|Adverse Event|0|||
124803609|NCT00191906|448914212|FG000|Study Period II|Withdrawal by Subject|0|||
124803610|NCT00191906|448914213|FG001|Study Period II|Withdrawal by Subject|3|||
124803611|NCT00191906|448914214|FG002|Study Period II|Withdrawal by Subject|0|||
124803612|NCT00191906|448914215|FG003|Study Period II|Withdrawal by Subject|0|||
124803613|NCT00191906|448914212|FG000|Study Period II|Parent/Caregiver Decision|0|||
124803614|NCT00191906|448914213|FG001|Study Period II|Parent/Caregiver Decision|1|||
124803615|NCT00191906|448914214|FG002|Study Period II|Parent/Caregiver Decision|0|||
124803616|NCT00191906|448914215|FG003|Study Period II|Parent/Caregiver Decision|0|||
124803617|NCT00191906|448914212|FG000|Study Period II|Entry Criteria Exclusion|0|||
124803618|NCT00191906|448914213|FG001|Study Period II|Entry Criteria Exclusion|0|||
124803619|NCT00191906|448914214|FG002|Study Period II|Entry Criteria Exclusion|1|||
124803620|NCT00191906|448914215|FG003|Study Period II|Entry Criteria Exclusion|0|||
124803621|NCT00191906|448914212|FG000|Study Period III|Adverse Event|1|||
124803622|NCT00191906|448914213|FG001|Study Period III|Adverse Event|0|||
124803623|NCT00191906|448914214|FG002|Study Period III|Adverse Event|0|||
124803624|NCT00191906|448914215|FG003|Study Period III|Adverse Event|0|||
124803625|NCT00191906|448914212|FG000|Study Period III|Lost to Follow-up|0|||
125299791|NCT03517566|450723754|FG003|Overall Study|Pregnancy|0|||
124803626|NCT00191906|448914213|FG001|Study Period III|Lost to Follow-up|1|||
125299792|NCT03517566|450723755|FG004|Overall Study|Pregnancy|0|||
125299793|NCT03517566|450723751|FG000|Overall Study|Protocol Deviation|0|||
124803627|NCT00191906|448914214|FG002|Study Period III|Lost to Follow-up|0|||
124803628|NCT00191906|448914215|FG003|Study Period III|Lost to Follow-up|0|||
124803629|NCT00191906|448914212|FG000|Study Period III|Parent/Caregiver Decision|1|||
124803630|NCT00191906|448914213|FG001|Study Period III|Parent/Caregiver Decision|0|||
124803631|NCT00191906|448914214|FG002|Study Period III|Parent/Caregiver Decision|0|||
124803632|NCT00191906|448914215|FG003|Study Period III|Parent/Caregiver Decision|0|||
124803633|NCT00191906|448914212|FG000|Study Period III|Lack of Efficacy|3|||
124803634|NCT00191906|448914213|FG001|Study Period III|Lack of Efficacy|3|||
124803635|NCT00191906|448914214|FG002|Study Period III|Lack of Efficacy|0|||
124803636|NCT00191906|448914215|FG003|Study Period III|Lack of Efficacy|0|||
124803637|NCT00333801|448914216|FG000|Overall Study|Moved to another state|5|||
124803638|NCT00333801|448914217|FG001|Overall Study|Moved to another state|3|||
124803639|NCT00333801|448914216|FG000|Overall Study|Lost to Follow-up|2|||
124803640|NCT00333801|448914217|FG001|Overall Study|Lost to Follow-up|0|||
124803641|NCT00333801|448914216|FG000|Overall Study|Incarcerated|1|||
125299794|NCT03517566|450723752|FG001|Overall Study|Protocol Deviation|1|||
124803642|NCT00333801|448914217|FG001|Overall Study|Incarcerated|2|||
124803643|NCT00333801|448914216|FG000|Overall Study|Withdrawal by Subject|0|||
124803644|NCT00333801|448914217|FG001|Overall Study|Withdrawal by Subject|1|||
124803645|NCT03633617|448914218|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
124803646|NCT03633617|448914219|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
124803647|NCT03633617|448914220|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
124803648|NCT03633617|448914221|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
124803649|NCT03633617|448914222|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
124803650|NCT03633617|448914223|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
124803651|NCT03633617|448914224|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
124803652|NCT03633617|448914225|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
124803653|NCT03633617|448914226|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
124803654|NCT03633617|448914227|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
124803655|NCT03633617|448914228|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
124803656|NCT03633617|448914218|FG000|Part A|Unconfirmed early termination visit|1|||
124803657|NCT03633617|448914219|FG001|Part A|Unconfirmed early termination visit|0|||
124803658|NCT03633617|448914220|FG002|Part A|Unconfirmed early termination visit|0|||
124803659|NCT03633617|448914221|FG003|Part A|Unconfirmed early termination visit|0|||
124803660|NCT03633617|448914222|FG004|Part A|Unconfirmed early termination visit|0|||
124803661|NCT03633617|448914223|FG005|Part A|Unconfirmed early termination visit|0|||
124803662|NCT03633617|448914224|FG006|Part A|Unconfirmed early termination visit|0|||
124803663|NCT03633617|448914225|FG007|Part A|Unconfirmed early termination visit|0|||
124803664|NCT03633617|448914226|FG008|Part A|Unconfirmed early termination visit|0|||
124803665|NCT03633617|448914227|FG009|Part A|Unconfirmed early termination visit|0|||
124803666|NCT03633617|448914228|FG010|Part A|Unconfirmed early termination visit|0|||
124803667|NCT03633617|448914218|FG000|Part A|Adverse Event|0|||
124803668|NCT03633617|448914219|FG001|Part A|Adverse Event|1|||
124803669|NCT03633617|448914220|FG002|Part A|Adverse Event|0|||
124803670|NCT03633617|448914221|FG003|Part A|Adverse Event|0|||
124803671|NCT03633617|448914222|FG004|Part A|Adverse Event|0|||
124803672|NCT03633617|448914223|FG005|Part A|Adverse Event|0|||
124803673|NCT03633617|448914224|FG006|Part A|Adverse Event|0|||
124803674|NCT03633617|448914225|FG007|Part A|Adverse Event|0|||
124803675|NCT03633617|448914226|FG008|Part A|Adverse Event|0|||
124803676|NCT03633617|448914227|FG009|Part A|Adverse Event|0|||
124803677|NCT03633617|448914228|FG010|Part A|Adverse Event|0|||
124803678|NCT03633617|448914218|FG000|Part A|Pregnancy|1|||
124803679|NCT03633617|448914219|FG001|Part A|Pregnancy|0|||
124803680|NCT03633617|448914220|FG002|Part A|Pregnancy|0|||
124803681|NCT03633617|448914221|FG003|Part A|Pregnancy|0|||
124803682|NCT03633617|448914222|FG004|Part A|Pregnancy|0|||
124803683|NCT03633617|448914223|FG005|Part A|Pregnancy|0|||
124803684|NCT03633617|448914224|FG006|Part A|Pregnancy|0|||
124803685|NCT03633617|448914225|FG007|Part A|Pregnancy|0|||
124803686|NCT03633617|448914226|FG008|Part A|Pregnancy|0|||
124803687|NCT03633617|448914227|FG009|Part A|Pregnancy|0|||
124803688|NCT03633617|448914228|FG010|Part A|Pregnancy|0|||
124803689|NCT03633617|448914218|FG000|Part A|Withdrawal by Subject|0|||
124803690|NCT03633617|448914219|FG001|Part A|Withdrawal by Subject|1|||
124803691|NCT03633617|448914220|FG002|Part A|Withdrawal by Subject|0|||
124803692|NCT03633617|448914221|FG003|Part A|Withdrawal by Subject|0|||
124803693|NCT03633617|448914222|FG004|Part A|Withdrawal by Subject|0|||
124803694|NCT03633617|448914223|FG005|Part A|Withdrawal by Subject|0|||
124803695|NCT03633617|448914224|FG006|Part A|Withdrawal by Subject|0|||
124803696|NCT03633617|448914225|FG007|Part A|Withdrawal by Subject|0|||
124803697|NCT03633617|448914226|FG008|Part A|Withdrawal by Subject|0|||
124803698|NCT03633617|448914227|FG009|Part A|Withdrawal by Subject|0|||
124803699|NCT03633617|448914228|FG010|Part A|Withdrawal by Subject|0|||
124803700|NCT03633617|448914218|FG000|Part B|Adverse Event|0|||
124803701|NCT03633617|448914219|FG001|Part B|Adverse Event|0|||
124803702|NCT03633617|448914220|FG002|Part B|Adverse Event|2|||
124803703|NCT03633617|448914221|FG003|Part B|Adverse Event|2|||
124803704|NCT03633617|448914222|FG004|Part B|Adverse Event|1|||
124803705|NCT03633617|448914223|FG005|Part B|Adverse Event|0|||
124803706|NCT03633617|448914224|FG006|Part B|Adverse Event|0|||
124803707|NCT03633617|448914225|FG007|Part B|Adverse Event|0|||
124803708|NCT03633617|448914226|FG008|Part B|Adverse Event|0|||
124803709|NCT03633617|448914227|FG009|Part B|Adverse Event|0|||
124803710|NCT03633617|448914228|FG010|Part B|Adverse Event|0|||
124803711|NCT03633617|448914218|FG000|Part B|Withdrawal by Subject|0|||
124803712|NCT03633617|448914219|FG001|Part B|Withdrawal by Subject|0|||
124803713|NCT03633617|448914220|FG002|Part B|Withdrawal by Subject|1|||
124803714|NCT03633617|448914221|FG003|Part B|Withdrawal by Subject|0|||
124803715|NCT03633617|448914222|FG004|Part B|Withdrawal by Subject|2|||
124803716|NCT03633617|448914223|FG005|Part B|Withdrawal by Subject|0|||
124803717|NCT03633617|448914224|FG006|Part B|Withdrawal by Subject|0|||
124803718|NCT03633617|448914225|FG007|Part B|Withdrawal by Subject|0|||
124803719|NCT03633617|448914226|FG008|Part B|Withdrawal by Subject|0|||
124803720|NCT03633617|448914227|FG009|Part B|Withdrawal by Subject|0|||
124803721|NCT03633617|448914228|FG010|Part B|Withdrawal by Subject|0|||
124803722|NCT03633617|448914218|FG000|Part B|Lost to Follow-up|0|||
124803723|NCT03633617|448914219|FG001|Part B|Lost to Follow-up|0|||
124803724|NCT03633617|448914220|FG002|Part B|Lost to Follow-up|0|||
124803725|NCT03633617|448914221|FG003|Part B|Lost to Follow-up|0|||
124803726|NCT03633617|448914222|FG004|Part B|Lost to Follow-up|1|||
124803727|NCT03633617|448914223|FG005|Part B|Lost to Follow-up|0|||
124803728|NCT03633617|448914224|FG006|Part B|Lost to Follow-up|0|||
124803729|NCT03633617|448914225|FG007|Part B|Lost to Follow-up|0|||
124803730|NCT03633617|448914226|FG008|Part B|Lost to Follow-up|0|||
124803731|NCT03633617|448914227|FG009|Part B|Lost to Follow-up|0|||
124803732|NCT03633617|448914228|FG010|Part B|Lost to Follow-up|0|||
124803733|NCT03633617|448914218|FG000|Part B|Physician Decision|0|||
124803734|NCT03633617|448914219|FG001|Part B|Physician Decision|0|||
124803735|NCT03633617|448914220|FG002|Part B|Physician Decision|0|||
124803736|NCT03633617|448914221|FG003|Part B|Physician Decision|0|||
124803737|NCT03633617|448914222|FG004|Part B|Physician Decision|1|||
124803738|NCT03633617|448914223|FG005|Part B|Physician Decision|0|||
124803739|NCT03633617|448914224|FG006|Part B|Physician Decision|0|||
124803740|NCT03633617|448914225|FG007|Part B|Physician Decision|0|||
124803741|NCT03633617|448914226|FG008|Part B|Physician Decision|0|||
124803742|NCT03633617|448914227|FG009|Part B|Physician Decision|0|||
124803743|NCT03633617|448914228|FG010|Part B|Physician Decision|0|||
124803744|NCT03633617|448914218|FG000|Part B|COVID-19 Restrictions|0|||
124803745|NCT03633617|448914219|FG001|Part B|COVID-19 Restrictions|0|||
124803746|NCT03633617|448914220|FG002|Part B|COVID-19 Restrictions|1|||
124803747|NCT03633617|448914221|FG003|Part B|COVID-19 Restrictions|0|||
124803748|NCT03633617|448914222|FG004|Part B|COVID-19 Restrictions|0|||
124803749|NCT03633617|448914223|FG005|Part B|COVID-19 Restrictions|0|||
124803750|NCT03633617|448914224|FG006|Part B|COVID-19 Restrictions|0|||
124803751|NCT03633617|448914225|FG007|Part B|COVID-19 Restrictions|0|||
124803752|NCT03633617|448914226|FG008|Part B|COVID-19 Restrictions|0|||
124803753|NCT03633617|448914227|FG009|Part B|COVID-19 Restrictions|0|||
124803754|NCT03633617|448914228|FG010|Part B|COVID-19 Restrictions|0|||
124803755|NCT03633617|448914218|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
124803756|NCT03633617|448914219|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
124803757|NCT03633617|448914220|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
124803758|NCT03633617|448914221|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
124803759|NCT03633617|448914222|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
124803760|NCT03633617|448914223|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
124803761|NCT03633617|448914224|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
124803762|NCT03633617|448914225|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
124803763|NCT03633617|448914226|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
124803764|NCT03633617|448914227|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
124803765|NCT03633617|448914228|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
124803766|NCT03633617|448914218|FG000|Part C (& Follow-up)|Adverse Event|0|||
124803767|NCT03633617|448914219|FG001|Part C (& Follow-up)|Adverse Event|0|||
124803768|NCT03633617|448914220|FG002|Part C (& Follow-up)|Adverse Event|0|||
124803769|NCT03633617|448914221|FG003|Part C (& Follow-up)|Adverse Event|0|||
124803770|NCT03633617|448914222|FG004|Part C (& Follow-up)|Adverse Event|0|||
124803771|NCT03633617|448914223|FG005|Part C (& Follow-up)|Adverse Event|1|||
124803772|NCT03633617|448914224|FG006|Part C (& Follow-up)|Adverse Event|0|||
124803773|NCT03633617|448914225|FG007|Part C (& Follow-up)|Adverse Event|1|||
124803774|NCT03633617|448914226|FG008|Part C (& Follow-up)|Adverse Event|0|||
124803775|NCT03633617|448914227|FG009|Part C (& Follow-up)|Adverse Event|0|||
124803776|NCT03633617|448914228|FG010|Part C (& Follow-up)|Adverse Event|0|||
124803777|NCT03633617|448914218|FG000|Part C (& Follow-up)|Pregnancy|0|||
124803778|NCT03633617|448914219|FG001|Part C (& Follow-up)|Pregnancy|0|||
124803779|NCT03633617|448914220|FG002|Part C (& Follow-up)|Pregnancy|0|||
124803780|NCT03633617|448914221|FG003|Part C (& Follow-up)|Pregnancy|0|||
124803781|NCT03633617|448914222|FG004|Part C (& Follow-up)|Pregnancy|0|||
124803782|NCT03633617|448914223|FG005|Part C (& Follow-up)|Pregnancy|0|||
124803783|NCT03633617|448914224|FG006|Part C (& Follow-up)|Pregnancy|0|||
125299795|NCT03517566|450723753|FG002|Overall Study|Protocol Deviation|0|||
124803784|NCT03633617|448914225|FG007|Part C (& Follow-up)|Pregnancy|0|||
124803785|NCT03633617|448914226|FG008|Part C (& Follow-up)|Pregnancy|0|||
124803786|NCT03633617|448914227|FG009|Part C (& Follow-up)|Pregnancy|1|||
124803787|NCT03633617|448914228|FG010|Part C (& Follow-up)|Pregnancy|0|||
124803788|NCT03633617|448914218|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
124803789|NCT03633617|448914219|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
124803790|NCT03633617|448914220|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
124803791|NCT03633617|448914221|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
124803792|NCT03633617|448914222|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
124803793|NCT03633617|448914223|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
124803794|NCT03633617|448914224|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
124803795|NCT03633617|448914225|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
124803796|NCT03633617|448914226|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
124803797|NCT03633617|448914227|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
124803798|NCT03633617|448914228|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
124803799|NCT03633617|448914218|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
124803800|NCT03633617|448914219|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
124803801|NCT03633617|448914220|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
124803802|NCT03633617|448914221|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
124803803|NCT03633617|448914222|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
124803804|NCT03633617|448914223|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
124803805|NCT03633617|448914224|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
124803806|NCT03633617|448914225|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
124803807|NCT03633617|448914226|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
124803808|NCT03633617|448914227|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
124803809|NCT03633617|448914228|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
124803810|NCT03633617|448914218|FG000|Part C (& Follow-up)|Physician Decision|0|||
124803811|NCT03633617|448914219|FG001|Part C (& Follow-up)|Physician Decision|0|||
124803812|NCT03633617|448914220|FG002|Part C (& Follow-up)|Physician Decision|0|||
124803813|NCT03633617|448914221|FG003|Part C (& Follow-up)|Physician Decision|0|||
124803814|NCT03633617|448914222|FG004|Part C (& Follow-up)|Physician Decision|0|||
124803815|NCT03633617|448914223|FG005|Part C (& Follow-up)|Physician Decision|0|||
124803816|NCT03633617|448914224|FG006|Part C (& Follow-up)|Physician Decision|0|||
124803817|NCT03633617|448914225|FG007|Part C (& Follow-up)|Physician Decision|1|||
124803818|NCT03633617|448914226|FG008|Part C (& Follow-up)|Physician Decision|0|||
124803819|NCT03633617|448914227|FG009|Part C (& Follow-up)|Physician Decision|0|||
124803820|NCT03633617|448914228|FG010|Part C (& Follow-up)|Physician Decision|1|||
124803821|NCT03633617|448914218|FG000|Part C (& Follow-up)|COVID-19 related|0|||
124803822|NCT03633617|448914219|FG001|Part C (& Follow-up)|COVID-19 related|0|||
124803823|NCT03633617|448914220|FG002|Part C (& Follow-up)|COVID-19 related|0|||
124803824|NCT03633617|448914221|FG003|Part C (& Follow-up)|COVID-19 related|0|||
124803825|NCT03633617|448914222|FG004|Part C (& Follow-up)|COVID-19 related|0|||
124803826|NCT03633617|448914223|FG005|Part C (& Follow-up)|COVID-19 related|1|||
124803827|NCT03633617|448914224|FG006|Part C (& Follow-up)|COVID-19 related|0|||
124803828|NCT03633617|448914225|FG007|Part C (& Follow-up)|COVID-19 related|0|||
124803829|NCT03633617|448914226|FG008|Part C (& Follow-up)|COVID-19 related|0|||
124803830|NCT03633617|448914227|FG009|Part C (& Follow-up)|COVID-19 related|0|||
124803831|NCT03633617|448914228|FG010|Part C (& Follow-up)|COVID-19 related|0|||
124803832|NCT03633617|448914218|FG000|Part C (& Follow-up)|Protocol Violation|0|||
124803833|NCT03633617|448914219|FG001|Part C (& Follow-up)|Protocol Violation|0|||
124803834|NCT03633617|448914220|FG002|Part C (& Follow-up)|Protocol Violation|0|||
124803835|NCT03633617|448914221|FG003|Part C (& Follow-up)|Protocol Violation|0|||
124803836|NCT03633617|448914222|FG004|Part C (& Follow-up)|Protocol Violation|0|||
124803837|NCT03633617|448914223|FG005|Part C (& Follow-up)|Protocol Violation|0|||
124803838|NCT03633617|448914224|FG006|Part C (& Follow-up)|Protocol Violation|0|||
124803839|NCT03633617|448914225|FG007|Part C (& Follow-up)|Protocol Violation|0|||
124803840|NCT03633617|448914226|FG008|Part C (& Follow-up)|Protocol Violation|0|||
124803841|NCT03633617|448914227|FG009|Part C (& Follow-up)|Protocol Violation|3|||
124803842|NCT03633617|448914228|FG010|Part C (& Follow-up)|Protocol Violation|1|||
124803843|NCT03633617|448914218|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
124803844|NCT03633617|448914219|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
124803845|NCT03633617|448914220|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
124803846|NCT03633617|448914221|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
124803847|NCT03633617|448914222|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
124803848|NCT03633617|448914223|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
124803849|NCT03633617|448914224|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
124803850|NCT03633617|448914225|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
124803851|NCT03633617|448914226|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
124803852|NCT03633617|448914227|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
124803853|NCT03633617|448914228|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
124803854|NCT01890746|448914229|FG000|Overall Study|Death|39|||
124803855|NCT01890746|448914230|FG001|Overall Study|Death|30|||
124803856|NCT01890746|448914229|FG000|Overall Study|Adverse Event|1|||
124803857|NCT01890746|448914230|FG001|Overall Study|Adverse Event|0|||
124803858|NCT01890746|448914229|FG000|Overall Study|Lost to Follow-up|4|||
124803859|NCT01890746|448914230|FG001|Overall Study|Lost to Follow-up|1|||
124803860|NCT01890746|448914229|FG000|Overall Study|Physician Decision|3|||
124803861|NCT01890746|448914230|FG001|Overall Study|Physician Decision|2|||
124803862|NCT01890746|448914229|FG000|Overall Study|Withdrawal by Subject|5|||
124803863|NCT01890746|448914230|FG001|Overall Study|Withdrawal by Subject|8|||
124803864|NCT02642029|448914231|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
124803865|NCT02642029|448914232|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
124803866|NCT02642029|448914233|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
124803867|NCT02642029|448914234|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
124803868|NCT02642029|448914235|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
124803869|NCT02642029|448914236|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
124803870|NCT02642029|448914231|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
124803871|NCT02642029|448914232|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
124803872|NCT02642029|448914233|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
124803873|NCT02642029|448914234|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
124803874|NCT02642029|448914235|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
124803875|NCT02642029|448914236|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
124803876|NCT02642029|448914231|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
124803877|NCT02642029|448914232|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
124803878|NCT02642029|448914233|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
124803879|NCT02642029|448914234|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
124803880|NCT02642029|448914235|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
124803881|NCT02642029|448914236|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
124803882|NCT02642029|448914231|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
124803883|NCT02642029|448914232|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
124803884|NCT02642029|448914233|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
124803885|NCT02642029|448914234|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
124803886|NCT02642029|448914235|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
124803887|NCT02642029|448914236|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
124803888|NCT02642029|448914231|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
124803889|NCT02642029|448914232|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
124803890|NCT02642029|448914233|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
124803891|NCT02642029|448914234|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
124803892|NCT02642029|448914235|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
124803893|NCT02642029|448914236|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
124803894|NCT02642029|448914231|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
124803895|NCT02642029|448914232|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
124803896|NCT02642029|448914233|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
124803897|NCT02642029|448914234|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
124803898|NCT02642029|448914235|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
124803899|NCT02642029|448914236|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
124803900|NCT01050543|448914241|FG000|Overall Study|Withdrawal by Subject|0|||
124803901|NCT01050543|448914242|FG001|Overall Study|Withdrawal by Subject|2|||
124803902|NCT01050543|448914241|FG000|Overall Study|Protocol Violation|0|||
124803903|NCT01050543|448914242|FG001|Overall Study|Protocol Violation|1|||
124803904|NCT01050543|448914241|FG000|Overall Study|Administrative|4|||
124803905|NCT01050543|448914242|FG001|Overall Study|Administrative|1|||
124803906|NCT00676338|448914243|FG000|Overall Study|Adverse Event|6|||
124803907|NCT00676338|448914244|FG001|Overall Study|Adverse Event|6|||
124803908|NCT00676338|448914245|FG002|Overall Study|Adverse Event|5|||
124803909|NCT00676338|448914246|FG003|Overall Study|Adverse Event|1|||
124803910|NCT00676338|448914243|FG000|Overall Study|Lost to Follow-up|4|||
124803911|NCT00676338|448914244|FG001|Overall Study|Lost to Follow-up|1|||
124803912|NCT00676338|448914245|FG002|Overall Study|Lost to Follow-up|3|||
124803913|NCT00676338|448914246|FG003|Overall Study|Lost to Follow-up|4|||
124803914|NCT00676338|448914243|FG000|Overall Study|Physician Decision|3|||
124803915|NCT00676338|448914244|FG001|Overall Study|Physician Decision|3|||
124803916|NCT00676338|448914245|FG002|Overall Study|Physician Decision|2|||
124803917|NCT00676338|448914246|FG003|Overall Study|Physician Decision|3|||
124803918|NCT00676338|448914243|FG000|Overall Study|Protocol Violation|5|||
124803919|NCT00676338|448914244|FG001|Overall Study|Protocol Violation|9|||
124803920|NCT00676338|448914245|FG002|Overall Study|Protocol Violation|2|||
124803921|NCT00676338|448914246|FG003|Overall Study|Protocol Violation|5|||
124803922|NCT00676338|448914243|FG000|Overall Study|Withdrawal by Subject|17|||
124803923|NCT00676338|448914244|FG001|Overall Study|Withdrawal by Subject|9|||
124803924|NCT00676338|448914245|FG002|Overall Study|Withdrawal by Subject|12|||
124803925|NCT00676338|448914246|FG003|Overall Study|Withdrawal by Subject|6|||
124803926|NCT00676338|448914243|FG000|Overall Study|Entry Criteria Not Met|0|||
124803927|NCT00676338|448914244|FG001|Overall Study|Entry Criteria Not Met|2|||
124803928|NCT00676338|448914245|FG002|Overall Study|Entry Criteria Not Met|1|||
125299796|NCT03517566|450723754|FG003|Overall Study|Protocol Deviation|1|||
125299797|NCT03517566|450723755|FG004|Overall Study|Protocol Deviation|1|||
125299798|NCT03517566|450723751|FG000|Overall Study|Study terminated by Sponsor|11|||
125299799|NCT03517566|450723752|FG001|Overall Study|Study terminated by Sponsor|5|||
125299800|NCT03517566|450723753|FG002|Overall Study|Study terminated by Sponsor|6|||
125299801|NCT03517566|450723754|FG003|Overall Study|Study terminated by Sponsor|14|||
125299802|NCT03517566|450723755|FG004|Overall Study|Study terminated by Sponsor|12|||
124803929|NCT00676338|448914246|FG003|Overall Study|Entry Criteria Not Met|1|||
124803930|NCT00676338|448914243|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
124803931|NCT00676338|448914244|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
124803932|NCT00676338|448914245|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
124803933|NCT00676338|448914246|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
124803934|NCT00412542|448914249|FG000|Overall Study|Withdrawal by Subject|0|||
124803935|NCT00412542|448914250|FG001|Overall Study|Withdrawal by Subject|2|||
124803936|NCT00412542|448914249|FG000|Overall Study|Not Eligible|0|||
124803937|NCT00412542|448914250|FG001|Overall Study|Not Eligible|1|||
124803938|NCT02124161|448914253|FG000|Overall Study|Other unspecified|0|||
124803939|NCT02124161|448914254|FG001|Overall Study|Other unspecified|1|||
124803940|NCT02124161|448914253|FG000|Overall Study|Death|1|||
124803941|NCT02124161|448914254|FG001|Overall Study|Death|0|||
124803942|NCT02124161|448914253|FG000|Overall Study|Protocol Violation|2|||
124803943|NCT02124161|448914254|FG001|Overall Study|Protocol Violation|1|||
124803944|NCT02124161|448914253|FG000|Overall Study|Withdrawal by Subject|1|||
124803945|NCT02124161|448914254|FG001|Overall Study|Withdrawal by Subject|2|||
124803946|NCT02124161|448914253|FG000|Overall Study|Adverse Event|2|||
124803947|NCT02124161|448914254|FG001|Overall Study|Adverse Event|0|||
124803948|NCT02124161|448914253|FG000|Overall Study|Does not meet entrance criteria|2|||
124803949|NCT02124161|448914254|FG001|Overall Study|Does not meet entrance criteria|3|||
124803950|NCT02124161|448914253|FG000|Overall Study|No longer meets eligibility criteria|5|||
124803951|NCT02124161|448914254|FG001|Overall Study|No longer meets eligibility criteria|4|||
124803952|NCT02124161|448914253|FG000|Overall Study|Lost to Follow-up|3|||
124803953|NCT02124161|448914254|FG001|Overall Study|Lost to Follow-up|4|||
124803954|NCT02517866|448914255|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
124803955|NCT02517866|448914256|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
124803956|NCT02517866|448914257|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
124803957|NCT02517866|448914255|FG000|Overall Study|Significant Protocol Deviation|4|||
124803958|NCT02517866|448914256|FG001|Overall Study|Significant Protocol Deviation|1|||
124803959|NCT02517866|448914257|FG002|Overall Study|Significant Protocol Deviation|0|||
124803960|NCT02517866|448914255|FG000|Overall Study|Lost to Follow-up|1|||
124803961|NCT02517866|448914256|FG001|Overall Study|Lost to Follow-up|0|||
124803962|NCT02517866|448914257|FG002|Overall Study|Lost to Follow-up|0|||
124803963|NCT02517866|448914255|FG000|Overall Study|Voluntary Withdrawal|2|||
124803964|NCT02517866|448914256|FG001|Overall Study|Voluntary Withdrawal|2|||
124803965|NCT02517866|448914257|FG002|Overall Study|Voluntary Withdrawal|0|||
124803966|NCT02517866|448914255|FG000|Overall Study|Investigator Decision|2|||
125299803|NCT03517566|450723751|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
125299804|NCT03517566|450723752|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
125299805|NCT03517566|450723753|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
125299806|NCT03517566|450723754|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
125299807|NCT03517566|450723755|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
125299808|NCT03927404|450723758|FG000|Overall Study|Withdrawal by Subject|1|||
125299809|NCT04311463|450723759|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
125299810|NCT04311463|450723760|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
125299811|NCT04311463|450723759|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
124803967|NCT02517866|448914256|FG001|Overall Study|Investigator Decision|1|||
124803968|NCT02517866|448914257|FG002|Overall Study|Investigator Decision|0|||
124803969|NCT02517866|448914255|FG000|Overall Study|Reason not specified|2|||
124803970|NCT02517866|448914256|FG001|Overall Study|Reason not specified|0|||
124803971|NCT02517866|448914257|FG002|Overall Study|Reason not specified|0|||
124803972|NCT01147640|448914258|FG000|Overall Study|Adverse Event|2|||
124803973|NCT01147640|448914259|FG001|Overall Study|Adverse Event|0|||
124803974|NCT01147640|448914258|FG000|Overall Study|Physician Decision|1|||
124803975|NCT01147640|448914259|FG001|Overall Study|Physician Decision|0|||
124803976|NCT01147640|448914258|FG000|Overall Study|Withdrawal by Subject|1|||
124803977|NCT01147640|448914259|FG001|Overall Study|Withdrawal by Subject|0|||
124803978|NCT01147640|448914258|FG000|Overall Study|Lost to Follow-up|0|||
125299812|NCT04311463|450723760|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
125299813|NCT04311463|450723759|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
125299814|NCT04311463|450723760|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
124803979|NCT01147640|448914259|FG001|Overall Study|Lost to Follow-up|1|||
124803980|NCT01147640|448914258|FG000|Overall Study|Didn't meet eligibility criteria|1|||
124803981|NCT01147640|448914259|FG001|Overall Study|Didn't meet eligibility criteria|0|||
124803982|NCT01797731|448914261|FG000|Overall Study|Didn't have proper radiographs required|3|||
124803983|NCT01797731|448914262|FG001|Overall Study|Didn't have proper radiographs required|3|||
124803984|NCT01954342|448914263|FG000|Overall Study|Missing data from 13-16week study visit|0|||
124803985|NCT01954342|448914264|FG001|Overall Study|Missing data from 13-16week study visit|0|||
124803986|NCT01954342|448914265|FG002|Overall Study|Missing data from 13-16week study visit|0|||
124803987|NCT01954342|448914266|FG003|Overall Study|Missing data from 13-16week study visit|1|||
124803988|NCT01954342|448914263|FG000|Overall Study|Miscarriage|0|||
124803989|NCT01954342|448914264|FG001|Overall Study|Miscarriage|0|||
124803990|NCT01954342|448914265|FG002|Overall Study|Miscarriage|0|||
124803991|NCT01954342|448914266|FG003|Overall Study|Miscarriage|3|||
124803992|NCT01954342|448914263|FG000|Overall Study|Lost to Follow-up|0|||
124803993|NCT01954342|448914264|FG001|Overall Study|Lost to Follow-up|0|||
124803994|NCT01954342|448914265|FG002|Overall Study|Lost to Follow-up|0|||
124803995|NCT01954342|448914266|FG003|Overall Study|Lost to Follow-up|5|||
124803996|NCT01954342|448914263|FG000|Overall Study|Preterm delivery|0|||
124803997|NCT01954342|448914264|FG001|Overall Study|Preterm delivery|0|||
124803998|NCT01954342|448914265|FG002|Overall Study|Preterm delivery|0|||
124803999|NCT01954342|448914266|FG003|Overall Study|Preterm delivery|3|||
124804000|NCT01954342|448914263|FG000|Overall Study|Pre-eclampsia|0|||
124804001|NCT01954342|448914264|FG001|Overall Study|Pre-eclampsia|0|||
124804002|NCT01954342|448914265|FG002|Overall Study|Pre-eclampsia|0|||
124804003|NCT01954342|448914266|FG003|Overall Study|Pre-eclampsia|4|||
124804004|NCT01954342|448914263|FG000|Overall Study|Unreliable Data|0|||
124804005|NCT01954342|448914264|FG001|Overall Study|Unreliable Data|0|||
124804006|NCT01954342|448914265|FG002|Overall Study|Unreliable Data|0|||
124804007|NCT01954342|448914266|FG003|Overall Study|Unreliable Data|2|||
124804008|NCT00629772|448914271|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
124804009|NCT00629772|448914272|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
124804010|NCT00629772|448914271|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
124804011|NCT00629772|448914272|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
124804012|NCT01497275|448914273|FG000|Overall Study|Death|1|||
124804013|NCT01497275|448914273|FG000|Overall Study|Adverse Event|1|||
124804014|NCT01950169|448914274|FG000|Overall Study|Withdrawal by Subject|2|||
124804015|NCT01950169|448914275|FG001|Overall Study|Withdrawal by Subject|8|||
124804016|NCT01950169|448914276|FG002|Overall Study|Withdrawal by Subject|1|||
124804017|NCT01950169|448914274|FG000|Overall Study|Death|1|||
124804018|NCT01950169|448914275|FG001|Overall Study|Death|0|||
124804019|NCT01950169|448914276|FG002|Overall Study|Death|0|||
124804020|NCT00285818|448914287|FG000|Overall Study|Withdrawal by Subject|3|||
124804021|NCT00285818|448914288|FG001|Overall Study|Withdrawal by Subject|2|||
124804022|NCT00285818|448914287|FG000|Overall Study|Lost to Follow-up|1|||
124804023|NCT00285818|448914288|FG001|Overall Study|Lost to Follow-up|0|||
124804024|NCT01230710|448914293|FG000|Overall Study|Disease Progression|41|||
124804025|NCT01230710|448914293|FG000|Overall Study|Lost to Follow-up|3|||
124804026|NCT01230710|448914293|FG000|Overall Study|Death|4|||
124804027|NCT01230710|448914293|FG000|Overall Study|Withdrawal of Consent|1|||
124804028|NCT05394350|448914294|FG000|Overall Study|Death|2|||
124804029|NCT05394350|448914295|FG001|Overall Study|Death|2|||
124804030|NCT05394350|448914296|FG002|Overall Study|Death|4|||
124804031|NCT05394350|448914297|FG003|Overall Study|Death|0|||
124804032|NCT05394350|448914298|FG004|Overall Study|Death|1|||
124804033|NCT05394350|448914299|FG005|Overall Study|Death|0|||
124804034|NCT05394350|448914294|FG000|Overall Study|Study terminated by sponsor|1|||
124804035|NCT05394350|448914295|FG001|Overall Study|Study terminated by sponsor|1|||
124804036|NCT05394350|448914296|FG002|Overall Study|Study terminated by sponsor|7|||
124804037|NCT05394350|448914297|FG003|Overall Study|Study terminated by sponsor|3|||
124804038|NCT05394350|448914298|FG004|Overall Study|Study terminated by sponsor|2|||
124804039|NCT05394350|448914299|FG005|Overall Study|Study terminated by sponsor|4|||
124804040|NCT01336569|448914300|FG000|Overall Study|Lost to Follow-up|4|||
124804041|NCT02963935|448914303|FG000|Overall Study|Adverse Event|12|||
124804042|NCT02963935|448914304|FG001|Overall Study|Adverse Event|6|||
124804043|NCT02963935|448914303|FG000|Overall Study|Protocol Violation|2|||
124804044|NCT02963935|448914304|FG001|Overall Study|Protocol Violation|1|||
124804045|NCT02963935|448914303|FG000|Overall Study|Lack of Efficacy|0|||
124804046|NCT02963935|448914304|FG001|Overall Study|Lack of Efficacy|2|||
124804047|NCT02963935|448914303|FG000|Overall Study|Lost to Follow-up|1|||
124804048|NCT02963935|448914304|FG001|Overall Study|Lost to Follow-up|6|||
124804049|NCT02963935|448914303|FG000|Overall Study|Unclassified|13|||
124804050|NCT02963935|448914304|FG001|Overall Study|Unclassified|22|||
124804051|NCT00464269|448914305|FG000|Overall Study|Lack of Efficacy|1|||
124804052|NCT00464269|448914306|FG001|Overall Study|Lack of Efficacy|0|||
124804053|NCT00464269|448914307|FG002|Overall Study|Lack of Efficacy|0|||
125299815|NCT00737633|450723766|FG000|Overall Study|Study terminated by sponsor|44|||
125299816|NCT00737633|450723767|FG001|Overall Study|Study terminated by sponsor|55|||
125299817|NCT00737633|450723766|FG000|Overall Study|Lost to Follow-up|0|||
124804054|NCT00464269|448914308|FG003|Overall Study|Lack of Efficacy|0|||
124804055|NCT00464269|448914305|FG000|Overall Study|Lost to Follow-up|0|||
124804056|NCT00464269|448914306|FG001|Overall Study|Lost to Follow-up|4|||
124804057|NCT00464269|448914307|FG002|Overall Study|Lost to Follow-up|0|||
124804058|NCT00464269|448914308|FG003|Overall Study|Lost to Follow-up|1|||
124804059|NCT00464269|448914305|FG000|Overall Study|Withdrawal by Subject|0|||
124804060|NCT00464269|448914306|FG001|Overall Study|Withdrawal by Subject|2|||
124804061|NCT00464269|448914307|FG002|Overall Study|Withdrawal by Subject|1|||
124804062|NCT00464269|448914308|FG003|Overall Study|Withdrawal by Subject|1|||
124804063|NCT00464269|448914305|FG000|Overall Study|Other reason|3|||
124804064|NCT00464269|448914306|FG001|Overall Study|Other reason|3|||
124804065|NCT00464269|448914307|FG002|Overall Study|Other reason|1|||
124804066|NCT00464269|448914308|FG003|Overall Study|Other reason|1|||
124804067|NCT00464269|448914305|FG000|Overall Study|AE, serious fatal|0|||
124804068|NCT00464269|448914306|FG001|Overall Study|AE, serious fatal|0|||
124804069|NCT00464269|448914307|FG002|Overall Study|AE, serious fatal|1|||
124804070|NCT00464269|448914308|FG003|Overall Study|AE, serious fatal|1|||
124804071|NCT00464269|448914305|FG000|Overall Study|SAE, non-fatal|0|||
124804072|NCT00464269|448914306|FG001|Overall Study|SAE, non-fatal|0|||
124804073|NCT00464269|448914307|FG002|Overall Study|SAE, non-fatal|0|||
124804074|NCT00464269|448914308|FG003|Overall Study|SAE, non-fatal|1|||
124804075|NCT00464269|448914305|FG000|Overall Study|AE, non-serious non-fatal|2|||
124804076|NCT00464269|448914306|FG001|Overall Study|AE, non-serious non-fatal|8|||
124804077|NCT00464269|448914307|FG002|Overall Study|AE, non-serious non-fatal|3|||
124804078|NCT00464269|448914308|FG003|Overall Study|AE, non-serious non-fatal|4|||
124804079|NCT00464269|448914305|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
124804080|NCT00464269|448914306|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
124804081|NCT00464269|448914307|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
124804082|NCT00464269|448914308|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
124804083|NCT02337738|448914309|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
124804084|NCT02337738|448914310|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
124804085|NCT02337738|448914311|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
124804086|NCT02337738|448914309|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
124804087|NCT02337738|448914310|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
124804088|NCT02337738|448914311|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
124804089|NCT02337738|448914309|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
124804090|NCT02337738|448914310|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
124804091|NCT02337738|448914311|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
124804092|NCT02337738|448914309|FG000|Overall Study|Voluntary Withdrawal|10|||
124804093|NCT02337738|448914310|FG001|Overall Study|Voluntary Withdrawal|5|||
124804094|NCT02337738|448914311|FG002|Overall Study|Voluntary Withdrawal|2|||
124804095|NCT02337738|448914309|FG000|Overall Study|Lack of Efficacy|2|||
124804096|NCT02337738|448914310|FG001|Overall Study|Lack of Efficacy|4|||
124804097|NCT02337738|448914311|FG002|Overall Study|Lack of Efficacy|0|||
124804098|NCT02337738|448914309|FG000|Overall Study|Investigator's Judgment|1|||
124804099|NCT02337738|448914310|FG001|Overall Study|Investigator's Judgment|1|||
124804100|NCT02337738|448914311|FG002|Overall Study|Investigator's Judgment|3|||
124804101|NCT00406354|448914312|FG000|All Randomized Patients|Protocol Violation|0|||
124804102|NCT00406354|448914313|FG001|All Randomized Patients|Protocol Violation|0|||
124804103|NCT00406354|448914314|FG002|All Randomized Patients|Protocol Violation|1|||
124804104|NCT00406354|448914312|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
124804105|NCT00406354|448914313|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
124804106|NCT00406354|448914314|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
124804107|NCT00406354|448914312|FG000|All Randomized and Treated Patients|Adverse Event|6|||
124804108|NCT00406354|448914313|FG001|All Randomized and Treated Patients|Adverse Event|2|||
124804109|NCT00406354|448914314|FG002|All Randomized and Treated Patients|Adverse Event|1|||
124804110|NCT00406354|448914312|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
124804111|NCT00406354|448914313|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
124804112|NCT00406354|448914314|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
124804113|NCT00406354|448914312|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
124804114|NCT00406354|448914313|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
124804115|NCT00406354|448914314|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
124804116|NCT00406354|448914312|FG000|All Randomized and Treated Patients|Physician Decision|0|||
124804117|NCT00406354|448914313|FG001|All Randomized and Treated Patients|Physician Decision|0|||
124804118|NCT00406354|448914314|FG002|All Randomized and Treated Patients|Physician Decision|1|||
124804119|NCT00747461|448914315|FG000|Overall Study|study terminated by sponsor|5|||
124804120|NCT01565642|448914330|FG000|Overall Study|Withdrawal by Subject|2|||
124804121|NCT01565642|448914331|FG001|Overall Study|Withdrawal by Subject|1|||
124804122|NCT00961649|448914333|FG000|Overall Study|Adverse Event|4|||
124804123|NCT00961649|448914334|FG001|Overall Study|Adverse Event|0|||
124804124|NCT00961649|448914335|FG002|Overall Study|Adverse Event|0|||
124804125|NCT00961649|448914336|FG003|Overall Study|Adverse Event|2|||
124804126|NCT00961649|448914333|FG000|Overall Study|Inadequate control of IOP|0|||
124804127|NCT00961649|448914334|FG001|Overall Study|Inadequate control of IOP|0|||
124804128|NCT00961649|448914335|FG002|Overall Study|Inadequate control of IOP|0|||
124804129|NCT00961649|448914336|FG003|Overall Study|Inadequate control of IOP|1|||
124804130|NCT00961649|448914333|FG000|Overall Study|Patient has travel plans during holidays|0|||
124804131|NCT00961649|448914334|FG001|Overall Study|Patient has travel plans during holidays|0|||
124804132|NCT00961649|448914335|FG002|Overall Study|Patient has travel plans during holidays|1|||
124804133|NCT00961649|448914336|FG003|Overall Study|Patient has travel plans during holidays|0|||
124804134|NCT00961649|448914333|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
124804135|NCT00961649|448914334|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
124804136|NCT00961649|448914335|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
124804137|NCT00961649|448914336|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
124804138|NCT00961649|448914333|FG000|Overall Study|Study terminated by sponsor|4|||
124804139|NCT00961649|448914334|FG001|Overall Study|Study terminated by sponsor|4|||
124804140|NCT00961649|448914335|FG002|Overall Study|Study terminated by sponsor|4|||
124804141|NCT00961649|448914336|FG003|Overall Study|Study terminated by sponsor|1|||
124804142|NCT02711345|448914337|FG000|Overall Study|Adverse Event|0|||
124804143|NCT02711345|448914338|FG001|Overall Study|Adverse Event|0|||
124804144|NCT02711345|448914339|FG002|Overall Study|Adverse Event|0|||
124804145|NCT02711345|448914340|FG003|Overall Study|Adverse Event|1|||
124804146|NCT02711345|448914341|FG004|Overall Study|Adverse Event|1|||
124804147|NCT02711345|448914342|FG005|Overall Study|Adverse Event|2|||
124804148|NCT02711345|448914343|FG006|Overall Study|Adverse Event|1|||
124804149|NCT02711345|448914344|FG007|Overall Study|Adverse Event|0|||
124804150|NCT02711345|448914345|FG008|Overall Study|Adverse Event|0|||
124804151|NCT02711345|448914346|FG009|Overall Study|Adverse Event|2|||
124804152|NCT02711345|448914337|FG000|Overall Study|Physician Decision|0|||
124804153|NCT02711345|448914338|FG001|Overall Study|Physician Decision|0|||
124804154|NCT02711345|448914339|FG002|Overall Study|Physician Decision|1|||
124804155|NCT02711345|448914340|FG003|Overall Study|Physician Decision|0|||
124804156|NCT02711345|448914341|FG004|Overall Study|Physician Decision|0|||
124804157|NCT02711345|448914342|FG005|Overall Study|Physician Decision|0|||
124804158|NCT02711345|448914343|FG006|Overall Study|Physician Decision|0|||
124804159|NCT02711345|448914344|FG007|Overall Study|Physician Decision|0|||
124804160|NCT02711345|448914345|FG008|Overall Study|Physician Decision|1|||
124804161|NCT02711345|448914346|FG009|Overall Study|Physician Decision|0|||
124804162|NCT02711345|448914337|FG000|Overall Study|Progressive disease|1|||
124804163|NCT02711345|448914338|FG001|Overall Study|Progressive disease|3|||
124804164|NCT02711345|448914339|FG002|Overall Study|Progressive disease|5|||
124804165|NCT02711345|448914340|FG003|Overall Study|Progressive disease|3|||
124804166|NCT02711345|448914341|FG004|Overall Study|Progressive disease|7|||
124804167|NCT02711345|448914342|FG005|Overall Study|Progressive disease|2|||
124804168|NCT02711345|448914343|FG006|Overall Study|Progressive disease|8|||
124804169|NCT02711345|448914344|FG007|Overall Study|Progressive disease|4|||
124804170|NCT02711345|448914345|FG008|Overall Study|Progressive disease|5|||
124804171|NCT02711345|448914346|FG009|Overall Study|Progressive disease|6|||
124804172|NCT02711345|448914337|FG000|Overall Study|Subject/guardian decision|0|||
124804173|NCT02711345|448914338|FG001|Overall Study|Subject/guardian decision|0|||
124804174|NCT02711345|448914339|FG002|Overall Study|Subject/guardian decision|0|||
124804175|NCT02711345|448914340|FG003|Overall Study|Subject/guardian decision|0|||
124804176|NCT02711345|448914341|FG004|Overall Study|Subject/guardian decision|0|||
124804177|NCT02711345|448914342|FG005|Overall Study|Subject/guardian decision|2|||
124804178|NCT02711345|448914343|FG006|Overall Study|Subject/guardian decision|3|||
124804179|NCT02711345|448914344|FG007|Overall Study|Subject/guardian decision|1|||
124804180|NCT02711345|448914345|FG008|Overall Study|Subject/guardian decision|0|||
124804181|NCT02711345|448914346|FG009|Overall Study|Subject/guardian decision|4|||
124804182|NCT02711345|448914337|FG000|Overall Study|Death|1|||
124804183|NCT02711345|448914338|FG001|Overall Study|Death|0|||
124804184|NCT02711345|448914339|FG002|Overall Study|Death|0|||
124804185|NCT02711345|448914340|FG003|Overall Study|Death|0|||
124804186|NCT02711345|448914341|FG004|Overall Study|Death|0|||
124804187|NCT02711345|448914342|FG005|Overall Study|Death|0|||
124804188|NCT02711345|448914343|FG006|Overall Study|Death|0|||
124804189|NCT02711345|448914344|FG007|Overall Study|Death|1|||
124804190|NCT02711345|448914345|FG008|Overall Study|Death|0|||
124804191|NCT02711345|448914346|FG009|Overall Study|Death|0|||
124804192|NCT04043728|448914347|FG000|Overall Study|Lost to Follow-up|1|||
124804193|NCT04043728|448914348|FG001|Overall Study|Lost to Follow-up|2|||
124804194|NCT04043728|448914349|FG002|Overall Study|Lost to Follow-up|0|||
124804195|NCT01033851|448914350|FG000|Overall Study|Withdrawal by Subject|3|||
124804196|NCT01033851|448914351|FG001|Overall Study|Withdrawal by Subject|7|||
124804197|NCT02349542|448914352|FG000|Overall Study|Withdrawal by Subject|5|||
124804198|NCT01011738|448914353|FG000|Overall Study|Death|12|||
124804199|NCT01011738|448914354|FG001|Overall Study|Death|3|||
124804200|NCT01011738|448914355|FG002|Overall Study|Death|0|||
124804201|NCT01011738|448914353|FG000|Overall Study|Unknown reasons|312|||
124804202|NCT01011738|448914354|FG001|Overall Study|Unknown reasons|291|||
124804203|NCT01011738|448914355|FG002|Overall Study|Unknown reasons|17|||
125299818|NCT00737633|450723767|FG001|Overall Study|Lost to Follow-up|1|||
124804204|NCT01163266|448914358|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
124804205|NCT01163266|448914359|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
124804206|NCT01163266|448914360|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
124804207|NCT01163266|448914358|FG000|Overall Study|Lack of Efficacy|1|||
124804208|NCT01163266|448914359|FG001|Overall Study|Lack of Efficacy|3|||
124804209|NCT01163266|448914360|FG002|Overall Study|Lack of Efficacy|1|||
124804210|NCT01163266|448914358|FG000|Overall Study|Noncompliance with Study Drug|0|||
124804211|NCT01163266|448914359|FG001|Overall Study|Noncompliance with Study Drug|2|||
124804212|NCT01163266|448914360|FG002|Overall Study|Noncompliance with Study Drug|0|||
124804213|NCT01163266|448914358|FG000|Overall Study|Protocol Deviations|2|||
124804214|NCT01163266|448914359|FG001|Overall Study|Protocol Deviations|2|||
124804215|NCT01163266|448914360|FG002|Overall Study|Protocol Deviations|5|||
124804216|NCT01163266|448914358|FG000|Overall Study|Withdrawal of Consent|5|||
124804217|NCT01163266|448914359|FG001|Overall Study|Withdrawal of Consent|7|||
124804218|NCT01163266|448914360|FG002|Overall Study|Withdrawal of Consent|3|||
124804219|NCT01163266|448914358|FG000|Overall Study|Lost to Follow-up|7|||
124804220|NCT01163266|448914359|FG001|Overall Study|Lost to Follow-up|7|||
124804221|NCT01163266|448914360|FG002|Overall Study|Lost to Follow-up|10|||
124804222|NCT01163266|448914358|FG000|Overall Study|Other|1|||
124804223|NCT01163266|448914359|FG001|Overall Study|Other|1|||
124804224|NCT01163266|448914360|FG002|Overall Study|Other|2|||
124804225|NCT02586064|448914361|FG000|Overall Study|Other Obligations|6|||
124804226|NCT02586064|448914362|FG001|Overall Study|Other Obligations|6|||
124804227|NCT02586064|448914361|FG000|Overall Study|Other|3|||
124804228|NCT02586064|448914362|FG001|Overall Study|Other|7|||
124804229|NCT02586064|448914361|FG000|Overall Study|Never Started|3|||
124804230|NCT02586064|448914362|FG001|Overall Study|Never Started|3|||
124804231|NCT02586064|448914361|FG000|Overall Study|Lost Interest|1|||
124804232|NCT02586064|448914362|FG001|Overall Study|Lost Interest|4|||
124804233|NCT02586064|448914361|FG000|Overall Study|Miscellaneous Life Issues|0|||
124804234|NCT02586064|448914362|FG001|Overall Study|Miscellaneous Life Issues|5|||
124804235|NCT02586064|448914361|FG000|Overall Study|Infrequent Attendance|2|||
124804236|NCT02586064|448914362|FG001|Overall Study|Infrequent Attendance|1|||
124804237|NCT02586064|448914361|FG000|Overall Study|Timed Out|2|||
124804238|NCT02586064|448914362|FG001|Overall Study|Timed Out|0|||
124804239|NCT02586064|448914361|FG000|Overall Study|AUD relapse|0|||
124804240|NCT02586064|448914362|FG001|Overall Study|AUD relapse|2|||
124804241|NCT02586064|448914361|FG000|Overall Study|Legal Issue|1|||
124804242|NCT02586064|448914362|FG001|Overall Study|Legal Issue|0|||
124804243|NCT02919696|448914363|FG000|Overall Study|Adverse Event|1|||
124804244|NCT02919696|448914364|FG001|Overall Study|Adverse Event|2|||
124804245|NCT02919696|448914363|FG000|Overall Study|Withdrawal by Subject|2|||
124804246|NCT02919696|448914364|FG001|Overall Study|Withdrawal by Subject|1|||
124804247|NCT02919696|448914363|FG000|Overall Study|Sponsor Decision|1|||
124804248|NCT02919696|448914364|FG001|Overall Study|Sponsor Decision|1|||
124804249|NCT02919696|448914363|FG000|Overall Study|Never Treated|0|||
124804250|NCT02919696|448914364|FG001|Overall Study|Never Treated|1|||
124804251|NCT04308304|448914365|FG000|Overall Study|Withdrawal by Subject|4|||
124804252|NCT04308304|448914366|FG001|Overall Study|Withdrawal by Subject|0|||
124804253|NCT04308304|448914365|FG000|Overall Study|Protocol Violation|1|||
124804254|NCT04308304|448914366|FG001|Overall Study|Protocol Violation|0|||
124804255|NCT00945555|448914367|FG000|Overall Study|Referred to another hospital|5|||
124804256|NCT00945555|448914367|FG000|Overall Study|Worsening condition, intensive care unit|1|||
124804257|NCT00945555|448914367|FG000|Overall Study|Withdrawal by Subject|2|||
124804258|NCT00945555|448914367|FG000|Overall Study|Participant continued treatment at home|1|||
124804259|NCT00945555|448914367|FG000|Overall Study|Death|18|||
124804260|NCT00945555|448914367|FG000|Overall Study|Other|1|||
124804261|NCT04502979|448914371|FG000|Overall Study|Lost to Follow-up|1|||
124804262|NCT04502979|448914372|FG001|Overall Study|Lost to Follow-up|3|||
124804263|NCT04502979|448914371|FG000|Overall Study|Withdrawal by Subject|2|||
124804264|NCT04502979|448914372|FG001|Overall Study|Withdrawal by Subject|1|||
124804265|NCT01558739|448914381|FG000|Overall Study|Adverse Event|7|||
124804266|NCT01558739|448914381|FG000|Overall Study|Withdrawal by Subject|2|||
124804267|NCT01558739|448914381|FG000|Overall Study|Death|3|||
124804268|NCT01558739|448914381|FG000|Overall Study|Disease Progression|4|||
124804269|NCT01558739|448914381|FG000|Overall Study|Protocol Violation|1|||
124804270|NCT02719327|448914385|FG000|Overall Study|Withdrawal by Subject|11|||
124804271|NCT02719327|448914386|FG001|Overall Study|Withdrawal by Subject|8|||
124804272|NCT01066000|448914389|FG000|Overall Study|Protocol Violation|4|||
124804273|NCT01066000|448914389|FG000|Overall Study|Death|3|||
124804274|NCT01066000|448914389|FG000|Overall Study|Withdrawal by Subject|1|||
124804275|NCT01066000|448914389|FG000|Overall Study|Adverse Event|1|||
124804276|NCT00566111|448914390|FG000|Overall Study|Adverse Event|0|||
124804277|NCT00566111|448914391|FG001|Overall Study|Adverse Event|2|||
124804278|NCT02497612|448916056|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
124804279|NCT02497612|448916057|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
125299819|NCT00737633|450723766|FG000|Overall Study|protocol non-compliance|0|||
125299820|NCT00737633|450723767|FG001|Overall Study|protocol non-compliance|1|||
124804280|NCT02497612|448916058|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
124804281|NCT02497612|448916059|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
124804282|NCT02497612|448916056|FG000|Overall Study|Participant's request|2|||
124804283|NCT02497612|448916057|FG001|Overall Study|Participant's request|3|||
124804284|NCT02497612|448916058|FG002|Overall Study|Participant's request|4|||
124804285|NCT02497612|448916059|FG003|Overall Study|Participant's request|1|||
124804286|NCT02497612|448916056|FG000|Overall Study|Investigator's judgement|1|||
124804287|NCT02497612|448916057|FG001|Overall Study|Investigator's judgement|0|||
124804288|NCT02497612|448916058|FG002|Overall Study|Investigator's judgement|0|||
124804289|NCT02497612|448916059|FG003|Overall Study|Investigator's judgement|2|||
124804290|NCT02497612|448916056|FG000|Overall Study|Adverse Event|3|||
124804291|NCT02497612|448916057|FG001|Overall Study|Adverse Event|1|||
124804292|NCT02497612|448916058|FG002|Overall Study|Adverse Event|4|||
124804293|NCT02497612|448916059|FG003|Overall Study|Adverse Event|1|||
124804294|NCT02497612|448916056|FG000|Overall Study|Lost to Follow-up|1|||
124804295|NCT02497612|448916057|FG001|Overall Study|Lost to Follow-up|1|||
124804296|NCT02497612|448916058|FG002|Overall Study|Lost to Follow-up|0|||
124804297|NCT02497612|448916059|FG003|Overall Study|Lost to Follow-up|1|||
124804298|NCT02497612|448916056|FG000|Overall Study|Other unspecified|1|||
124804299|NCT02497612|448916057|FG001|Overall Study|Other unspecified|1|||
124804300|NCT02497612|448916058|FG002|Overall Study|Other unspecified|2|||
124804301|NCT02497612|448916059|FG003|Overall Study|Other unspecified|0|||
124804302|NCT02497612|448916056|FG000|Overall Study|Not eligible|1|||
124804303|NCT02497612|448916057|FG001|Overall Study|Not eligible|0|||
124804304|NCT02497612|448916058|FG002|Overall Study|Not eligible|0|||
124804305|NCT02497612|448916059|FG003|Overall Study|Not eligible|1|||
124804306|NCT05021081|448916062|FG000|Phase 2|Subject enrolled in error|1|||
124804307|NCT05021081|448916063|FG001|Phase 2|Subject enrolled in error|1|||
124804308|NCT05021081|448916064|FG002|Phase 2|Subject enrolled in error|0|||
124804309|NCT02651467|448916065|FG000|Overall Study|Withdrawal by Subject|0|||
124804310|NCT02651467|448916066|FG001|Overall Study|Withdrawal by Subject|0|||
124804311|NCT02651467|448916067|FG002|Overall Study|Withdrawal by Subject|2|||
124804312|NCT02651467|448916065|FG000|Overall Study|Other (Not specified)|1|||
124804313|NCT02651467|448916066|FG001|Overall Study|Other (Not specified)|0|||
124804314|NCT02651467|448916067|FG002|Overall Study|Other (Not specified)|2|||
124804315|NCT02024529|448916070|FG000|Overall Study|Withdrawal by Subject|11|||
124804316|NCT02024529|448916071|FG001|Overall Study|Withdrawal by Subject|21|||
124804317|NCT02024529|448916070|FG000|Overall Study|Lost to Follow-up|2|||
124804318|NCT02024529|448916071|FG001|Overall Study|Lost to Follow-up|4|||
124804319|NCT00573937|448916072|FG000|Overall Study|Study Terminated|0|||
124804320|NCT00573937|448916073|FG001|Overall Study|Study Terminated|1|||
124804321|NCT04171765|448916074|FG000|Overall Study|Adverse Event|2|||
124804322|NCT04171765|448916075|FG001|Overall Study|Adverse Event|0|||
124804323|NCT04171765|448916076|FG002|Overall Study|Adverse Event|1|||
124804324|NCT04171765|448916077|FG003|Overall Study|Adverse Event|0|||
124804325|NCT04171765|448916074|FG000|Overall Study|Lost to Follow-up|0|||
124804326|NCT04171765|448916075|FG001|Overall Study|Lost to Follow-up|2|||
124804327|NCT04171765|448916076|FG002|Overall Study|Lost to Follow-up|2|||
124804328|NCT04171765|448916077|FG003|Overall Study|Lost to Follow-up|2|||
124804329|NCT04171765|448916074|FG000|Overall Study|Week 58 visit missed|0|||
124804330|NCT04171765|448916075|FG001|Overall Study|Week 58 visit missed|0|||
124804331|NCT04171765|448916076|FG002|Overall Study|Week 58 visit missed|1|||
124804332|NCT04171765|448916077|FG003|Overall Study|Week 58 visit missed|0|||
124804333|NCT04171765|448916074|FG000|Overall Study|Study terminated by sponsor|2|||
124804334|NCT04171765|448916075|FG001|Overall Study|Study terminated by sponsor|0|||
124804335|NCT04171765|448916076|FG002|Overall Study|Study terminated by sponsor|0|||
124804336|NCT04171765|448916077|FG003|Overall Study|Study terminated by sponsor|0|||
124804337|NCT04171765|448916074|FG000|Overall Study|Withdrawal by Subject|1|||
124804338|NCT04171765|448916075|FG001|Overall Study|Withdrawal by Subject|0|||
124804339|NCT04171765|448916076|FG002|Overall Study|Withdrawal by Subject|0|||
124804340|NCT04171765|448916077|FG003|Overall Study|Withdrawal by Subject|3|||
124804341|NCT00631696|448916080|FG000|Overall Study|Entered, not randomized to treatment|1|||
124804342|NCT00631696|448916081|FG001|Overall Study|Entered, not randomized to treatment|1|||
124804343|NCT00631696|448916080|FG000|Overall Study|Discontinued after database release date|1|||
124804344|NCT00631696|448916081|FG001|Overall Study|Discontinued after database release date|0|||
124804345|NCT00631696|448916080|FG000|Overall Study|Follow up after database release date|1|||
124804346|NCT00631696|448916081|FG001|Overall Study|Follow up after database release date|0|||
124804347|NCT00631696|448916080|FG000|Overall Study|Lost to Follow-up|7|||
124804348|NCT00631696|448916081|FG001|Overall Study|Lost to Follow-up|10|||
124804349|NCT00631696|448916080|FG000|Overall Study|Withdrawal by Subject|2|||
124804350|NCT00631696|448916081|FG001|Overall Study|Withdrawal by Subject|9|||
124804351|NCT00631696|448916080|FG000|Overall Study|Other|8|||
124804352|NCT00631696|448916081|FG001|Overall Study|Other|8|||
124804353|NCT00631696|448916080|FG000|Overall Study|Protocol Violation|9|||
124804354|NCT00631696|448916081|FG001|Overall Study|Protocol Violation|9|||
124804355|NCT00631696|448916080|FG000|Overall Study|Study terminated by sponsor|3|||
124804356|NCT00631696|448916081|FG001|Overall Study|Study terminated by sponsor|3|||
124804357|NCT00631696|448916080|FG000|Overall Study|Adverse Event|5|||
124804358|NCT00631696|448916081|FG001|Overall Study|Adverse Event|0|||
124804359|NCT01426438|448916083|FG000|Overall Study|Lost to Follow-up|1|||
124804360|NCT01426438|448916084|FG001|Overall Study|Lost to Follow-up|3|||
124804361|NCT01426438|448916083|FG000|Overall Study|Off study Treatment|9|||
124804362|NCT01426438|448916084|FG001|Overall Study|Off study Treatment|3|||
124804363|NCT01426438|448916083|FG000|Overall Study|Poor scan quality|3|||
124804364|NCT01426438|448916084|FG001|Overall Study|Poor scan quality|2|||
124804365|NCT01426438|448916083|FG000|Overall Study|Missed Scan|2|||
124804366|NCT01426438|448916084|FG001|Overall Study|Missed Scan|2|||
124804367|NCT01134731|448916085|FG000|Overall Study|Adverse Event|3|||
124804368|NCT01134731|448916086|FG001|Overall Study|Adverse Event|2|||
124804369|NCT01134731|448916087|FG002|Overall Study|Adverse Event|1|||
124804370|NCT01134731|448916085|FG000|Overall Study|Physician Decision|2|||
124804371|NCT01134731|448916086|FG001|Overall Study|Physician Decision|2|||
124804372|NCT01134731|448916087|FG002|Overall Study|Physician Decision|2|||
124804373|NCT01134731|448916085|FG000|Overall Study|Lack of Efficacy|0|||
124804374|NCT01134731|448916086|FG001|Overall Study|Lack of Efficacy|0|||
124804375|NCT01134731|448916087|FG002|Overall Study|Lack of Efficacy|1|||
124804376|NCT01134731|448916085|FG000|Overall Study|Withdrawal by Subject|3|||
124804377|NCT01134731|448916086|FG001|Overall Study|Withdrawal by Subject|3|||
124804378|NCT01134731|448916087|FG002|Overall Study|Withdrawal by Subject|1|||
124804379|NCT01134731|448916085|FG000|Overall Study|Lost to Follow-up|5|||
124804380|NCT01134731|448916086|FG001|Overall Study|Lost to Follow-up|4|||
124804381|NCT01134731|448916087|FG002|Overall Study|Lost to Follow-up|3|||
124804382|NCT02122458|448916088|FG000|Overall Study|Withdrawal by Subject|0|||
124804383|NCT02122458|448916089|FG001|Overall Study|Withdrawal by Subject|0|||
124804384|NCT02122458|448916090|FG002|Overall Study|Withdrawal by Subject|0|||
124804385|NCT02122458|448916091|FG003|Overall Study|Withdrawal by Subject|4|||
124804386|NCT02122458|448916092|FG004|Overall Study|Withdrawal by Subject|4|||
124804387|NCT02122458|448916093|FG005|Overall Study|Withdrawal by Subject|4|||
124804388|NCT02122458|448916094|FG006|Overall Study|Withdrawal by Subject|0|||
124804389|NCT02122458|448916088|FG000|Overall Study|Lost to Follow-up|1|||
124804390|NCT02122458|448916089|FG001|Overall Study|Lost to Follow-up|3|||
124804391|NCT02122458|448916090|FG002|Overall Study|Lost to Follow-up|0|||
124804392|NCT02122458|448916091|FG003|Overall Study|Lost to Follow-up|7|||
124804393|NCT02122458|448916092|FG004|Overall Study|Lost to Follow-up|5|||
124804394|NCT02122458|448916093|FG005|Overall Study|Lost to Follow-up|15|||
124804395|NCT02122458|448916094|FG006|Overall Study|Lost to Follow-up|1|||
124804396|NCT02122458|448916088|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
124804397|NCT02122458|448916089|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
124804398|NCT02122458|448916090|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
124804399|NCT02122458|448916091|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
124804400|NCT02122458|448916092|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
124804401|NCT02122458|448916093|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
124804402|NCT02122458|448916094|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
124804403|NCT02122458|448916088|FG000|Overall Study|Adverse Event|1|||
124804404|NCT02122458|448916089|FG001|Overall Study|Adverse Event|0|||
124804405|NCT02122458|448916090|FG002|Overall Study|Adverse Event|0|||
124804406|NCT02122458|448916091|FG003|Overall Study|Adverse Event|0|||
124804407|NCT02122458|448916092|FG004|Overall Study|Adverse Event|0|||
124804408|NCT02122458|448916093|FG005|Overall Study|Adverse Event|0|||
124804409|NCT02122458|448916094|FG006|Overall Study|Adverse Event|0|||
124804410|NCT02122458|448916088|FG000|Overall Study|Experimental Error|0|||
124804411|NCT02122458|448916089|FG001|Overall Study|Experimental Error|0|||
124804412|NCT02122458|448916090|FG002|Overall Study|Experimental Error|0|||
124804413|NCT02122458|448916091|FG003|Overall Study|Experimental Error|0|||
124804414|NCT02122458|448916092|FG004|Overall Study|Experimental Error|3|||
124804415|NCT02122458|448916093|FG005|Overall Study|Experimental Error|0|||
124804416|NCT02122458|448916094|FG006|Overall Study|Experimental Error|0|||
124804417|NCT02122458|448916088|FG000|Overall Study|Deployed or Moved|0|||
124804418|NCT02122458|448916089|FG001|Overall Study|Deployed or Moved|0|||
124804419|NCT02122458|448916090|FG002|Overall Study|Deployed or Moved|0|||
124804420|NCT02122458|448916091|FG003|Overall Study|Deployed or Moved|0|||
124804421|NCT02122458|448916092|FG004|Overall Study|Deployed or Moved|1|||
124804422|NCT02122458|448916093|FG005|Overall Study|Deployed or Moved|0|||
124804423|NCT02122458|448916094|FG006|Overall Study|Deployed or Moved|0|||
124804424|NCT02122458|448916088|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
124804425|NCT02122458|448916089|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
124804426|NCT02122458|448916090|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
124804427|NCT02122458|448916091|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
124804428|NCT02122458|448916092|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
124804429|NCT02122458|448916093|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
124804430|NCT02122458|448916094|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
124804431|NCT02122458|448916088|FG000|Overall Study|Noncompliance|0|||
124804432|NCT02122458|448916089|FG001|Overall Study|Noncompliance|1|||
124804433|NCT02122458|448916090|FG002|Overall Study|Noncompliance|0|||
124804434|NCT02122458|448916091|FG003|Overall Study|Noncompliance|0|||
124804435|NCT02122458|448916092|FG004|Overall Study|Noncompliance|0|||
124804436|NCT02122458|448916093|FG005|Overall Study|Noncompliance|0|||
124804437|NCT02122458|448916094|FG006|Overall Study|Noncompliance|0|||
124804438|NCT03161093|448916095|FG000|Overall Study|Protocol Violation|11|||
124804439|NCT03161093|448916096|FG001|Overall Study|Protocol Violation|14|||
124804440|NCT03161093|448916097|FG002|Overall Study|Protocol Violation|6|||
124804441|NCT03161093|448916098|FG003|Overall Study|Protocol Violation|13|||
124804442|NCT03161093|448916099|FG004|Overall Study|Protocol Violation|1|||
124804443|NCT03161093|448916100|FG005|Overall Study|Protocol Violation|0|||
124804444|NCT03161093|448916095|FG000|Overall Study|Adverse Event|5|||
124804445|NCT03161093|448916096|FG001|Overall Study|Adverse Event|21|||
124804446|NCT03161093|448916097|FG002|Overall Study|Adverse Event|16|||
124804447|NCT03161093|448916098|FG003|Overall Study|Adverse Event|35|||
124804448|NCT03161093|448916099|FG004|Overall Study|Adverse Event|2|||
124804449|NCT03161093|448916100|FG005|Overall Study|Adverse Event|1|||
124804450|NCT03161093|448916095|FG000|Overall Study|Lack of Efficacy|9|||
124804451|NCT03161093|448916096|FG001|Overall Study|Lack of Efficacy|13|||
124804452|NCT03161093|448916097|FG002|Overall Study|Lack of Efficacy|9|||
124804453|NCT03161093|448916098|FG003|Overall Study|Lack of Efficacy|24|||
124804454|NCT03161093|448916099|FG004|Overall Study|Lack of Efficacy|4|||
124804455|NCT03161093|448916100|FG005|Overall Study|Lack of Efficacy|1|||
124804456|NCT03161093|448916095|FG000|Overall Study|Physician Decision|0|||
124804457|NCT03161093|448916096|FG001|Overall Study|Physician Decision|1|||
124804458|NCT03161093|448916097|FG002|Overall Study|Physician Decision|0|||
124804459|NCT03161093|448916098|FG003|Overall Study|Physician Decision|2|||
124804460|NCT03161093|448916099|FG004|Overall Study|Physician Decision|17|||
124804461|NCT03161093|448916100|FG005|Overall Study|Physician Decision|15|||
124804462|NCT03161093|448916095|FG000|Overall Study|Withdrawal by Subject|24|||
124804463|NCT03161093|448916096|FG001|Overall Study|Withdrawal by Subject|73|||
124804464|NCT03161093|448916097|FG002|Overall Study|Withdrawal by Subject|44|||
124804465|NCT03161093|448916098|FG003|Overall Study|Withdrawal by Subject|97|||
124804466|NCT03161093|448916099|FG004|Overall Study|Withdrawal by Subject|11|||
124804467|NCT03161093|448916100|FG005|Overall Study|Withdrawal by Subject|10|||
124804468|NCT03161093|448916095|FG000|Overall Study|Lost to Follow-up|3|||
124804469|NCT03161093|448916096|FG001|Overall Study|Lost to Follow-up|12|||
124804470|NCT03161093|448916097|FG002|Overall Study|Lost to Follow-up|4|||
124804471|NCT03161093|448916098|FG003|Overall Study|Lost to Follow-up|7|||
124804472|NCT03161093|448916099|FG004|Overall Study|Lost to Follow-up|8|||
124804473|NCT03161093|448916100|FG005|Overall Study|Lost to Follow-up|13|||
124804474|NCT03161093|448916095|FG000|Overall Study|Death|3|||
124804475|NCT03161093|448916096|FG001|Overall Study|Death|9|||
124804476|NCT03161093|448916097|FG002|Overall Study|Death|7|||
124804477|NCT03161093|448916098|FG003|Overall Study|Death|9|||
124804478|NCT03161093|448916099|FG004|Overall Study|Death|0|||
124804479|NCT03161093|448916100|FG005|Overall Study|Death|0|||
124804480|NCT03161093|448916095|FG000|Overall Study|Unknown - Not reported|0|||
124804481|NCT03161093|448916096|FG001|Overall Study|Unknown - Not reported|1|||
124804482|NCT03161093|448916097|FG002|Overall Study|Unknown - Not reported|0|||
124804483|NCT03161093|448916098|FG003|Overall Study|Unknown - Not reported|0|||
124804484|NCT03161093|448916099|FG004|Overall Study|Unknown - Not reported|0|||
124804485|NCT03161093|448916100|FG005|Overall Study|Unknown - Not reported|1|||
124804486|NCT00091442|448916101|FG000|Overall Study|Progressive Disease|220|||
124804487|NCT00091442|448916102|FG001|Overall Study|Progressive Disease|189|||
124804488|NCT00091442|448916101|FG000|Overall Study|Physician Decision|61|||
124804489|NCT00091442|448916102|FG001|Overall Study|Physician Decision|58|||
124804490|NCT00091442|448916101|FG000|Overall Study|Withdrawal by Subject|38|||
124804491|NCT00091442|448916102|FG001|Overall Study|Withdrawal by Subject|46|||
124804492|NCT00091442|448916101|FG000|Overall Study|Adverse Event|29|||
124804493|NCT00091442|448916102|FG001|Overall Study|Adverse Event|48|||
124804494|NCT00091442|448916101|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
124804495|NCT00091442|448916102|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
124804496|NCT00091442|448916101|FG000|Overall Study|Death|9|||
124804497|NCT00091442|448916102|FG001|Overall Study|Death|7|||
124804498|NCT00091442|448916101|FG000|Overall Study|Lost to Follow-up|1|||
124804499|NCT00091442|448916102|FG001|Overall Study|Lost to Follow-up|3|||
124804500|NCT00091442|448916101|FG000|Overall Study|Other|2|||
124804501|NCT00091442|448916102|FG001|Overall Study|Other|6|||
124804502|NCT01332331|448916104|FG000|Overall Study|Lost to Follow-up|0|||
124804503|NCT01332331|448916105|FG001|Overall Study|Lost to Follow-up|1|||
124804504|NCT01332331|448916104|FG000|Overall Study|Adverse Event|1|||
124804505|NCT01332331|448916105|FG001|Overall Study|Adverse Event|1|||
124804506|NCT01332331|448916104|FG000|Overall Study|Physician Decision|1|||
124804507|NCT01332331|448916105|FG001|Overall Study|Physician Decision|0|||
124804508|NCT04810481|448916107|FG000|Overall Study|Disqualified data sets|10|||
124804509|NCT04810481|448916108|FG001|Overall Study|Disqualified data sets|28|||
124804510|NCT05055128|448916119|FG000|Overall Study|Adverse Event|0|||
124804511|NCT05055128|448916120|FG001|Overall Study|Adverse Event|0|||
124804512|NCT05055128|448916121|FG002|Overall Study|Adverse Event|0|||
124804513|NCT05055128|448916122|FG003|Overall Study|Adverse Event|1|||
124804514|NCT05055128|448916123|FG004|Overall Study|Adverse Event|1|||
124804515|NCT05055128|448916119|FG000|Overall Study|Protocol Violation|0|||
124804516|NCT05055128|448916120|FG001|Overall Study|Protocol Violation|0|||
124804517|NCT05055128|448916121|FG002|Overall Study|Protocol Violation|0|||
124804518|NCT05055128|448916122|FG003|Overall Study|Protocol Violation|1|||
124804519|NCT05055128|448916123|FG004|Overall Study|Protocol Violation|0|||
124804520|NCT05055128|448916119|FG000|Overall Study|Withdrawal by Subject|5|||
124804521|NCT05055128|448916120|FG001|Overall Study|Withdrawal by Subject|2|||
124804522|NCT05055128|448916121|FG002|Overall Study|Withdrawal by Subject|2|||
124804523|NCT05055128|448916122|FG003|Overall Study|Withdrawal by Subject|4|||
124804524|NCT05055128|448916123|FG004|Overall Study|Withdrawal by Subject|2|||
124804525|NCT05055128|448916119|FG000|Overall Study|Randomized By Mistake|0|||
124804526|NCT05055128|448916120|FG001|Overall Study|Randomized By Mistake|1|||
124804527|NCT05055128|448916121|FG002|Overall Study|Randomized By Mistake|0|||
124804528|NCT05055128|448916122|FG003|Overall Study|Randomized By Mistake|0|||
124804529|NCT05055128|448916123|FG004|Overall Study|Randomized By Mistake|0|||
124804530|NCT05055128|448916119|FG000|Overall Study|Other|1|||
124804531|NCT05055128|448916120|FG001|Overall Study|Other|0|||
124804532|NCT05055128|448916121|FG002|Overall Study|Other|0|||
124804533|NCT05055128|448916122|FG003|Overall Study|Other|0|||
124804534|NCT05055128|448916123|FG004|Overall Study|Other|0|||
124804535|NCT01385371|448916124|FG000|Overall Study|Adverse Event|54|||
124804536|NCT01385371|448916125|FG001|Overall Study|Adverse Event|19|||
124804537|NCT01385371|448916124|FG000|Overall Study|Lost to Follow-up|16|||
124804538|NCT01385371|448916125|FG001|Overall Study|Lost to Follow-up|16|||
124804539|NCT01385371|448916124|FG000|Overall Study|Withdrawal by Subject|52|||
124804540|NCT01385371|448916125|FG001|Overall Study|Withdrawal by Subject|39|||
124804541|NCT01385371|448916124|FG000|Overall Study|Protocol Violation|25|||
124804542|NCT01385371|448916125|FG001|Overall Study|Protocol Violation|21|||
124804543|NCT01385371|448916124|FG000|Overall Study|Administrative|2|||
124804544|NCT01385371|448916125|FG001|Overall Study|Administrative|2|||
124804545|NCT00936611|448916126|FG000|Overall Study|Progressive Disease|3|||
124804546|NCT00936611|448916126|FG000|Overall Study|New Systemic Therapy|22|||
124804547|NCT00936611|448916126|FG000|Overall Study|Lost to Follow-up|1|||
124804548|NCT00936611|448916126|FG000|Overall Study|Withdrawal by Subject|2|||
124804549|NCT00936611|448916126|FG000|Overall Study|Still on Follow-up|1|||
124804550|NCT00936611|448916126|FG000|Overall Study|Still on Active Therapy|7|||
124804551|NCT00936611|448916126|FG000|Overall Study|Ineligible for Study Drug|3|||
124804552|NCT01346969|448916127|FG000|Overall Study|Withdrawal by Subject|0|||
124804553|NCT01346969|448916128|FG001|Overall Study|Withdrawal by Subject|0|||
124804554|NCT01346969|448916129|FG002|Overall Study|Withdrawal by Subject|1|||
124804555|NCT01346969|448916130|FG003|Overall Study|Withdrawal by Subject|0|||
124804556|NCT01346969|448916127|FG000|Overall Study|Lost to Follow-up|1|||
124804557|NCT01346969|448916128|FG001|Overall Study|Lost to Follow-up|0|||
124804558|NCT01346969|448916129|FG002|Overall Study|Lost to Follow-up|2|||
124804559|NCT01346969|448916130|FG003|Overall Study|Lost to Follow-up|0|||
124804560|NCT01346969|448916127|FG000|Overall Study|Physician Decision|0|||
124804561|NCT01346969|448916128|FG001|Overall Study|Physician Decision|0|||
124804562|NCT01346969|448916129|FG002|Overall Study|Physician Decision|0|||
124804563|NCT01346969|448916130|FG003|Overall Study|Physician Decision|1|||
124804564|NCT01346969|448916127|FG000|Overall Study|Randomized but not treated|1|||
124804565|NCT01346969|448916128|FG001|Overall Study|Randomized but not treated|0|||
124804566|NCT01346969|448916129|FG002|Overall Study|Randomized but not treated|0|||
124804567|NCT01346969|448916130|FG003|Overall Study|Randomized but not treated|0|||
124804568|NCT02906332|448916134|FG000|Overall Study|Withdrawal by Subject|1|||
124804569|NCT02949700|448916135|FG000|Phase I|Withdrawal by Subject|1|||
124804570|NCT02949700|448916136|FG001|Phase I|Withdrawal by Subject|1|||
124804571|NCT02949700|448916137|FG002|Phase I|Withdrawal by Subject|0|||
124804572|NCT02949700|448916138|FG003|Phase I|Withdrawal by Subject|0|||
124804573|NCT02949700|448916135|FG000|Phase I|Protocol Violation|1|||
124804574|NCT02949700|448916136|FG001|Phase I|Protocol Violation|0|||
124804575|NCT02949700|448916137|FG002|Phase I|Protocol Violation|0|||
124804576|NCT02949700|448916138|FG003|Phase I|Protocol Violation|0|||
124804577|NCT02949700|448916135|FG000|Phase II|Withdrawal by Subject|0|||
124804578|NCT02949700|448916136|FG001|Phase II|Withdrawal by Subject|0|||
124804579|NCT02949700|448916137|FG002|Phase II|Withdrawal by Subject|0|||
124804580|NCT02949700|448916138|FG003|Phase II|Withdrawal by Subject|2|||
124804581|NCT02949700|448916135|FG000|Phase II|Protocol Violation|0|||
124804582|NCT02949700|448916136|FG001|Phase II|Protocol Violation|0|||
124804583|NCT02949700|448916137|FG002|Phase II|Protocol Violation|1|||
124804584|NCT02949700|448916138|FG003|Phase II|Protocol Violation|3|||
124804585|NCT03945266|448916139|FG000|Overall Study|Withdrawal by Subject|1|||
124804586|NCT03945266|448916140|FG001|Overall Study|Withdrawal by Subject|0|||
124804587|NCT03945266|448916139|FG000|Overall Study|Miscarriage|0|||
124804588|NCT03945266|448916140|FG001|Overall Study|Miscarriage|2|||
124804589|NCT03945266|448916139|FG000|Overall Study|Lost to Follow-up|1|||
124804590|NCT03945266|448916140|FG001|Overall Study|Lost to Follow-up|0|||
124804591|NCT01686828|448916141|FG000|Overall Study|Physician Decision|1|||
124804592|NCT01686828|448916142|FG001|Overall Study|Physician Decision|0|||
124804593|NCT01686828|448916143|FG002|Overall Study|Physician Decision|0|||
124804594|NCT01686828|448916144|FG003|Overall Study|Physician Decision|0|||
124804595|NCT01686828|448916141|FG000|Overall Study|New Job|0|||
124804596|NCT01686828|448916142|FG001|Overall Study|New Job|1|||
124804597|NCT01686828|448916143|FG002|Overall Study|New Job|0|||
124804598|NCT01686828|448916144|FG003|Overall Study|New Job|0|||
124804599|NCT01686828|448916141|FG000|Overall Study|Weight Loss|0|||
124804600|NCT01686828|448916142|FG001|Overall Study|Weight Loss|0|||
124804601|NCT01686828|448916143|FG002|Overall Study|Weight Loss|1|||
124804602|NCT01686828|448916144|FG003|Overall Study|Weight Loss|0|||
124804603|NCT04176705|448916147|FG000|Overall Study|Withdrawal by Subject|4|||
124804604|NCT04176705|448916148|FG001|Overall Study|Withdrawal by Subject|4|||
124804605|NCT04176705|448916147|FG000|Overall Study|Death|1|||
124804606|NCT04176705|448916148|FG001|Overall Study|Death|1|||
124804607|NCT04176705|448916147|FG000|Overall Study|Lost to Follow-up|3|||
124804608|NCT04176705|448916148|FG001|Overall Study|Lost to Follow-up|3|||
124804609|NCT02423772|448916149|FG000|Overall Study|Lost to Follow-up|3|||
124804610|NCT02423772|448916150|FG001|Overall Study|Lost to Follow-up|3|||
124804611|NCT02423772|448916149|FG000|Overall Study|Did not begin intervention|2|||
124804612|NCT02423772|448916150|FG001|Overall Study|Did not begin intervention|5|||
124804613|NCT02484690|448916154|FG000|Overall Study|Adverse Event|1|||
124804614|NCT02484690|448916155|FG001|Overall Study|Adverse Event|3|||
124804615|NCT02484690|448916156|FG002|Overall Study|Adverse Event|0|||
124804616|NCT02484690|448916157|FG003|Overall Study|Adverse Event|0|||
124804617|NCT02484690|448916158|FG004|Overall Study|Adverse Event|5|||
124804618|NCT02484690|448916154|FG000|Overall Study|Death|0|||
124804619|NCT02484690|448916155|FG001|Overall Study|Death|0|||
124804620|NCT02484690|448916156|FG002|Overall Study|Death|0|||
124804621|NCT02484690|448916157|FG003|Overall Study|Death|0|||
124804622|NCT02484690|448916158|FG004|Overall Study|Death|1|||
124804623|NCT02484690|448916154|FG000|Overall Study|Withdrawal by Subject|1|||
124804624|NCT02484690|448916155|FG001|Overall Study|Withdrawal by Subject|3|||
124804625|NCT02484690|448916156|FG002|Overall Study|Withdrawal by Subject|1|||
124804626|NCT02484690|448916157|FG003|Overall Study|Withdrawal by Subject|2|||
124804627|NCT02484690|448916158|FG004|Overall Study|Withdrawal by Subject|0|||
124804628|NCT02484690|448916154|FG000|Overall Study|Physician Decision|2|||
124804629|NCT02484690|448916155|FG001|Overall Study|Physician Decision|0|||
124804630|NCT02484690|448916156|FG002|Overall Study|Physician Decision|1|||
124804631|NCT02484690|448916157|FG003|Overall Study|Physician Decision|0|||
124804632|NCT02484690|448916158|FG004|Overall Study|Physician Decision|0|||
124804633|NCT02484690|448916154|FG000|Overall Study|Lost to Follow-up|0|||
124804634|NCT02484690|448916155|FG001|Overall Study|Lost to Follow-up|0|||
124804635|NCT02484690|448916156|FG002|Overall Study|Lost to Follow-up|1|||
124804636|NCT02484690|448916157|FG003|Overall Study|Lost to Follow-up|0|||
124804637|NCT02484690|448916158|FG004|Overall Study|Lost to Follow-up|0|||
124804638|NCT03360747|448916159|FG000|Overall Study|Voluntary Withdrawal|1|||
124804639|NCT01759511|448916162|FG000|Overall Study|Adverse Event|4|||
124804640|NCT01759511|448916162|FG000|Overall Study|Death|2|||
124804641|NCT01759511|448916162|FG000|Overall Study|Lack of Efficacy|2|||
124804642|NCT01759511|448916162|FG000|Overall Study|Physician Decision|1|||
124804643|NCT01759511|448916162|FG000|Overall Study|Progressive Disease|5|||
124804644|NCT01759511|448916162|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
124804645|NCT01759511|448916162|FG000|Overall Study|Study Terminated by Sponsor|13|||
124804646|NCT01759511|448916162|FG000|Overall Study|Withdrawal by Subject|3|||
124804647|NCT04916769|448916164|FG000|Period 1|Physician Decision|0|||
124804648|NCT04916769|448916165|FG001|Period 1|Physician Decision|0|||
124804649|NCT04916769|448916166|FG002|Period 1|Physician Decision|0|||
124804650|NCT04916769|448916167|FG003|Period 1|Physician Decision|0|||
124804651|NCT04916769|448916168|FG004|Period 1|Physician Decision|0|||
124804652|NCT04916769|448916169|FG005|Period 1|Physician Decision|1|||
124804653|NCT04916769|448916164|FG000|Period 2|Physician Decision|0|||
124804654|NCT04916769|448916165|FG001|Period 2|Physician Decision|1|||
124804655|NCT04916769|448916166|FG002|Period 2|Physician Decision|0|||
124804656|NCT04916769|448916167|FG003|Period 2|Physician Decision|0|||
124804657|NCT04916769|448916168|FG004|Period 2|Physician Decision|0|||
124804658|NCT04916769|448916169|FG005|Period 2|Physician Decision|0|||
124804659|NCT04526509|448916182|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
124804660|NCT04526509|448916183|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
124804661|NCT04526509|448916184|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
124804662|NCT04526509|448916185|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
124804663|NCT04526509|448916186|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
124804664|NCT04526509|448916187|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
124804665|NCT04526509|448916188|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
124804666|NCT04526509|448916182|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
124804667|NCT04526509|448916183|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
124804668|NCT04526509|448916184|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
124804669|NCT04526509|448916185|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
124804670|NCT04526509|448916186|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
124804671|NCT04526509|448916187|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
124804672|NCT04526509|448916188|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
124804673|NCT04526509|448916182|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
124804674|NCT04526509|448916183|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
124804675|NCT04526509|448916184|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
124804676|NCT04526509|448916185|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
124804677|NCT04526509|448916186|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
124819542|NCT05147350|448965747|FG000|Overall Study|Withdrawal by Subject|0|||
124804678|NCT04526509|448916187|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
124804679|NCT04526509|448916188|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
124804680|NCT04526509|448916182|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
124804681|NCT04526509|448916183|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
124804682|NCT04526509|448916184|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
124804683|NCT04526509|448916185|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
124804684|NCT04526509|448916186|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
124804685|NCT04526509|448916187|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
124804686|NCT04526509|448916188|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
124804687|NCT04526509|448916182|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
124804688|NCT04526509|448916183|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
124804689|NCT04526509|448916184|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
124804690|NCT04526509|448916185|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
124804691|NCT04526509|448916186|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
124804692|NCT04526509|448916187|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
124804693|NCT04526509|448916188|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
124804694|NCT04526509|448916182|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
124804695|NCT04526509|448916183|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
124804696|NCT04526509|448916184|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
124804697|NCT04526509|448916185|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
124804698|NCT04526509|448916186|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
124804699|NCT04526509|448916187|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
124804700|NCT04526509|448916188|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
124804701|NCT04526509|448916182|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
124804702|NCT04526509|448916183|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
124804703|NCT04526509|448916184|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
124804704|NCT04526509|448916185|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
124804705|NCT04526509|448916186|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
124804706|NCT04526509|448916187|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
124804707|NCT04526509|448916188|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
124804708|NCT04526509|448916182|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
124804709|NCT04526509|448916183|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
124804710|NCT04526509|448916184|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
124804711|NCT04526509|448916185|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
124804712|NCT04526509|448916186|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
124804713|NCT04526509|448916187|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
124804714|NCT04526509|448916188|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
124804715|NCT04526509|448916182|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
124804716|NCT04526509|448916183|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
124804717|NCT04526509|448916184|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
124804718|NCT04526509|448916185|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
124804719|NCT04526509|448916186|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
124804720|NCT04526509|448916187|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
124804721|NCT04526509|448916188|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
124819543|NCT05147350|448965748|FG001|Overall Study|Withdrawal by Subject|0|||
125299821|NCT01300260|450723768|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
125299822|NCT01300260|450723769|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
124804722|NCT04526509|448916182|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
124804723|NCT04526509|448916183|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
124804724|NCT04526509|448916184|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
124804725|NCT04526509|448916185|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
124804726|NCT04526509|448916186|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
124804727|NCT04526509|448916187|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
124804728|NCT04526509|448916188|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
124804729|NCT04526509|448916182|FG000|Enrolled|Study Terminated by Sponsor|0|||
124804730|NCT04526509|448916183|FG001|Enrolled|Study Terminated by Sponsor|0|||
124804731|NCT04526509|448916184|FG002|Enrolled|Study Terminated by Sponsor|0|||
124804732|NCT04526509|448916185|FG003|Enrolled|Study Terminated by Sponsor|0|||
124804733|NCT04526509|448916186|FG004|Enrolled|Study Terminated by Sponsor|0|||
124804734|NCT04526509|448916187|FG005|Enrolled|Study Terminated by Sponsor|0|||
124804735|NCT04526509|448916188|FG006|Enrolled|Study Terminated by Sponsor|1|||
124804736|NCT04526509|448916182|FG000|Enrolled|Death prior to lymphodepletion|0|||
124804737|NCT04526509|448916183|FG001|Enrolled|Death prior to lymphodepletion|0|||
124804738|NCT04526509|448916184|FG002|Enrolled|Death prior to lymphodepletion|0|||
124804739|NCT04526509|448916185|FG003|Enrolled|Death prior to lymphodepletion|1|||
124804740|NCT04526509|448916186|FG004|Enrolled|Death prior to lymphodepletion|0|||
124804741|NCT04526509|448916187|FG005|Enrolled|Death prior to lymphodepletion|0|||
124804742|NCT04526509|448916188|FG006|Enrolled|Death prior to lymphodepletion|0|||
124804743|NCT04526509|448916182|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
124804744|NCT04526509|448916183|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
124804745|NCT04526509|448916184|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
124804746|NCT04526509|448916185|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
124804747|NCT04526509|448916186|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
124804748|NCT04526509|448916187|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
124804749|NCT04526509|448916188|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
124804750|NCT04526509|448916182|FG000|Enrolled|Physician Decision|0|||
124804751|NCT04526509|448916183|FG001|Enrolled|Physician Decision|1|||
124804752|NCT04526509|448916184|FG002|Enrolled|Physician Decision|0|||
124804753|NCT04526509|448916185|FG003|Enrolled|Physician Decision|0|||
124804754|NCT04526509|448916186|FG004|Enrolled|Physician Decision|0|||
124804755|NCT04526509|448916187|FG005|Enrolled|Physician Decision|0|||
124804756|NCT04526509|448916188|FG006|Enrolled|Physician Decision|0|||
124804757|NCT04340193|448916190|FG000|Overall Study|Other reason|0|||
124804758|NCT04340193|448916191|FG001|Overall Study|Other reason|0|||
124804759|NCT04340193|448916192|FG002|Overall Study|Other reason|1|||
124804760|NCT04340193|448916190|FG000|Overall Study|Disease recurrence|0|||
124804761|NCT04340193|448916191|FG001|Overall Study|Disease recurrence|1|||
124804762|NCT04340193|448916192|FG002|Overall Study|Disease recurrence|0|||
124804763|NCT04340193|448916190|FG000|Overall Study|Study drug toxicity|1|||
124804764|NCT04340193|448916191|FG001|Overall Study|Study drug toxicity|0|||
124804765|NCT04340193|448916192|FG002|Overall Study|Study drug toxicity|0|||
124804766|NCT04340193|448916190|FG000|Overall Study|Disease progression|1|||
124804767|NCT04340193|448916191|FG001|Overall Study|Disease progression|2|||
124804768|NCT04340193|448916192|FG002|Overall Study|Disease progression|3|||
124804769|NCT04340193|448916190|FG000|Overall Study|Administrative reasons by sponsor|0|||
124804770|NCT04340193|448916191|FG001|Overall Study|Administrative reasons by sponsor|1|||
124804771|NCT04340193|448916192|FG002|Overall Study|Administrative reasons by sponsor|0|||
124804772|NCT04340193|448916190|FG000|Overall Study|Adverse Event|1|||
124804773|NCT04340193|448916191|FG001|Overall Study|Adverse Event|1|||
124804774|NCT04340193|448916192|FG002|Overall Study|Adverse Event|0|||
124804775|NCT00589290|448916193|FG000|Overall Study|Withdrawal by Subject|1|||
124804776|NCT01067976|448916194|FG000|Overall Study|Study drug never administered|20|||
124804777|NCT01067976|448916194|FG000|Overall Study|Study prematurely discontinued|2|||
124804778|NCT04449861|448916195|FG000|Overall Study|Withdrawal by Subject|4|||
124804779|NCT04449861|448916195|FG000|Overall Study|Lost to Follow-up|5|||
124804780|NCT04449861|448916195|FG000|Overall Study|Death|112|||
124804781|NCT05268055|448916196|FG000|Overall Study|Lost to Follow-up|68|||
124804782|NCT05268055|448916197|FG001|Overall Study|Lost to Follow-up|68|||
124804783|NCT05268055|448916196|FG000|Overall Study|Withdrawal by Subject|12|||
124804784|NCT05268055|448916197|FG001|Overall Study|Withdrawal by Subject|8|||
124804785|NCT03507400|448916198|FG000|Overall Study|discontinued|5|||
124804786|NCT03507400|448916199|FG001|Overall Study|discontinued|1|||
124804787|NCT03507400|448916198|FG000|Overall Study|Lost to Follow-up|8|||
124804788|NCT03507400|448916199|FG001|Overall Study|Lost to Follow-up|6|||
124804789|NCT03507400|448916198|FG000|Overall Study|Protocol Violation|0|||
124804790|NCT03507400|448916199|FG001|Overall Study|Protocol Violation|1|||
124804791|NCT01555983|448916200|FG000|Overall Study|Withdrawal by Subject|1|||
124804792|NCT01555983|448916201|FG001|Overall Study|Withdrawal by Subject|0|||
124804793|NCT01555983|448916202|FG002|Overall Study|Withdrawal by Subject|0|||
124804794|NCT01555983|448916203|FG003|Overall Study|Withdrawal by Subject|0|||
124804795|NCT01555983|448916204|FG004|Overall Study|Withdrawal by Subject|1|||
124804796|NCT01555983|448916205|FG005|Overall Study|Withdrawal by Subject|1|||
124804797|NCT02598960|448918084|FG000|Treatment Period|Disease Progression|4|||
124804798|NCT02598960|448918085|FG001|Treatment Period|Disease Progression|4|||
124804799|NCT02598960|448918086|FG002|Treatment Period|Disease Progression|4|||
124804800|NCT02598960|448918087|FG003|Treatment Period|Disease Progression|6|||
124804801|NCT02598960|448918088|FG004|Treatment Period|Disease Progression|8|||
124804802|NCT02598960|448918089|FG005|Treatment Period|Disease Progression|2|||
124804803|NCT02598960|448918090|FG006|Treatment Period|Disease Progression|2|||
124804804|NCT02598960|448918091|FG007|Treatment Period|Disease Progression|3|||
124804805|NCT02598960|448918092|FG008|Treatment Period|Disease Progression|7|||
124804806|NCT02598960|448918093|FG009|Treatment Period|Disease Progression|9|||
124804807|NCT02598960|448918094|FG010|Treatment Period|Disease Progression|7|||
124804808|NCT02598960|448918095|FG011|Treatment Period|Disease Progression|143|||
124804809|NCT02598960|448918096|FG012|Treatment Period|Disease Progression|23|||
124804810|NCT02598960|448918084|FG000|Treatment Period|Study drug toxicity|0|||
124804811|NCT02598960|448918085|FG001|Treatment Period|Study drug toxicity|0|||
124804812|NCT02598960|448918086|FG002|Treatment Period|Study drug toxicity|0|||
124804813|NCT02598960|448918087|FG003|Treatment Period|Study drug toxicity|0|||
124804814|NCT02598960|448918088|FG004|Treatment Period|Study drug toxicity|0|||
124804815|NCT02598960|448918089|FG005|Treatment Period|Study drug toxicity|0|||
124804816|NCT02598960|448918090|FG006|Treatment Period|Study drug toxicity|0|||
124804817|NCT02598960|448918091|FG007|Treatment Period|Study drug toxicity|0|||
124804818|NCT02598960|448918092|FG008|Treatment Period|Study drug toxicity|0|||
124804819|NCT02598960|448918093|FG009|Treatment Period|Study drug toxicity|1|||
124804820|NCT02598960|448918094|FG010|Treatment Period|Study drug toxicity|0|||
124804821|NCT02598960|448918095|FG011|Treatment Period|Study drug toxicity|3|||
124804822|NCT02598960|448918096|FG012|Treatment Period|Study drug toxicity|0|||
124804823|NCT02598960|448918084|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
124804824|NCT02598960|448918085|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
124804825|NCT02598960|448918086|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
124804826|NCT02598960|448918087|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
124804827|NCT02598960|448918088|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
124804828|NCT02598960|448918089|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
124804829|NCT02598960|448918090|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
124804830|NCT02598960|448918091|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
124804831|NCT02598960|448918092|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
124804832|NCT02598960|448918093|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
124804833|NCT02598960|448918094|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
124804834|NCT02598960|448918095|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
124804835|NCT02598960|448918096|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
124804836|NCT02598960|448918084|FG000|Treatment Period|participant request to discontinue|0|||
124804837|NCT02598960|448918085|FG001|Treatment Period|participant request to discontinue|1|||
124804838|NCT02598960|448918086|FG002|Treatment Period|participant request to discontinue|0|||
124804839|NCT02598960|448918087|FG003|Treatment Period|participant request to discontinue|0|||
124804840|NCT02598960|448918088|FG004|Treatment Period|participant request to discontinue|1|||
124804841|NCT02598960|448918089|FG005|Treatment Period|participant request to discontinue|0|||
124804842|NCT02598960|448918090|FG006|Treatment Period|participant request to discontinue|0|||
124804843|NCT02598960|448918091|FG007|Treatment Period|participant request to discontinue|0|||
124804844|NCT02598960|448918092|FG008|Treatment Period|participant request to discontinue|0|||
124804845|NCT02598960|448918093|FG009|Treatment Period|participant request to discontinue|0|||
124804846|NCT02598960|448918094|FG010|Treatment Period|participant request to discontinue|1|||
124804847|NCT02598960|448918095|FG011|Treatment Period|participant request to discontinue|4|||
124804848|NCT02598960|448918096|FG012|Treatment Period|participant request to discontinue|0|||
124804849|NCT02598960|448918084|FG000|Treatment Period|participant withdrew consent|0|||
124804850|NCT02598960|448918085|FG001|Treatment Period|participant withdrew consent|0|||
124804851|NCT02598960|448918086|FG002|Treatment Period|participant withdrew consent|0|||
124804852|NCT02598960|448918087|FG003|Treatment Period|participant withdrew consent|0|||
124804853|NCT02598960|448918088|FG004|Treatment Period|participant withdrew consent|0|||
124804854|NCT02598960|448918089|FG005|Treatment Period|participant withdrew consent|0|||
124804855|NCT02598960|448918090|FG006|Treatment Period|participant withdrew consent|0|||
124804856|NCT02598960|448918091|FG007|Treatment Period|participant withdrew consent|0|||
124804857|NCT02598960|448918092|FG008|Treatment Period|participant withdrew consent|0|||
124804858|NCT02598960|448918093|FG009|Treatment Period|participant withdrew consent|0|||
124804859|NCT02598960|448918094|FG010|Treatment Period|participant withdrew consent|0|||
124804860|NCT02598960|448918095|FG011|Treatment Period|participant withdrew consent|3|||
124804861|NCT02598960|448918096|FG012|Treatment Period|participant withdrew consent|0|||
124804862|NCT02598960|448918084|FG000|Treatment Period|No longer meets study criteria|0|||
124804863|NCT02598960|448918085|FG001|Treatment Period|No longer meets study criteria|0|||
124804864|NCT02598960|448918086|FG002|Treatment Period|No longer meets study criteria|0|||
124804865|NCT02598960|448918087|FG003|Treatment Period|No longer meets study criteria|0|||
124804866|NCT02598960|448918088|FG004|Treatment Period|No longer meets study criteria|0|||
124804867|NCT02598960|448918089|FG005|Treatment Period|No longer meets study criteria|0|||
124804868|NCT02598960|448918090|FG006|Treatment Period|No longer meets study criteria|0|||
124804869|NCT02598960|448918091|FG007|Treatment Period|No longer meets study criteria|0|||
124804870|NCT02598960|448918092|FG008|Treatment Period|No longer meets study criteria|0|||
124804871|NCT02598960|448918093|FG009|Treatment Period|No longer meets study criteria|0|||
124804872|NCT02598960|448918094|FG010|Treatment Period|No longer meets study criteria|0|||
124804873|NCT02598960|448918095|FG011|Treatment Period|No longer meets study criteria|1|||
124804874|NCT02598960|448918096|FG012|Treatment Period|No longer meets study criteria|0|||
124804875|NCT02598960|448918084|FG000|Treatment Period|Other Reasons|0|||
124804876|NCT02598960|448918085|FG001|Treatment Period|Other Reasons|0|||
124804877|NCT02598960|448918086|FG002|Treatment Period|Other Reasons|0|||
124804878|NCT02598960|448918087|FG003|Treatment Period|Other Reasons|0|||
124804879|NCT02598960|448918088|FG004|Treatment Period|Other Reasons|0|||
124804880|NCT02598960|448918089|FG005|Treatment Period|Other Reasons|0|||
124804881|NCT02598960|448918090|FG006|Treatment Period|Other Reasons|0|||
124804882|NCT02598960|448918091|FG007|Treatment Period|Other Reasons|0|||
124804883|NCT02598960|448918092|FG008|Treatment Period|Other Reasons|0|||
124804884|NCT02598960|448918093|FG009|Treatment Period|Other Reasons|0|||
124804885|NCT02598960|448918094|FG010|Treatment Period|Other Reasons|0|||
124804886|NCT02598960|448918095|FG011|Treatment Period|Other Reasons|0|||
124804887|NCT02598960|448918096|FG012|Treatment Period|Other Reasons|1|||
124804888|NCT02598960|448918084|FG000|Participants Entering Follow Up Period|Death|1|||
124804889|NCT02598960|448918085|FG001|Participants Entering Follow Up Period|Death|0|||
124804890|NCT02598960|448918086|FG002|Participants Entering Follow Up Period|Death|0|||
124804891|NCT02598960|448918087|FG003|Participants Entering Follow Up Period|Death|0|||
124804892|NCT02598960|448918088|FG004|Participants Entering Follow Up Period|Death|0|||
124804893|NCT02598960|448918089|FG005|Participants Entering Follow Up Period|Death|0|||
124804894|NCT02598960|448918090|FG006|Participants Entering Follow Up Period|Death|0|||
124804895|NCT02598960|448918091|FG007|Participants Entering Follow Up Period|Death|0|||
124804896|NCT02598960|448918092|FG008|Participants Entering Follow Up Period|Death|0|||
124804897|NCT02598960|448918093|FG009|Participants Entering Follow Up Period|Death|1|||
124804898|NCT02598960|448918094|FG010|Participants Entering Follow Up Period|Death|0|||
124804899|NCT02598960|448918095|FG011|Participants Entering Follow Up Period|Death|11|||
124804900|NCT02598960|448918096|FG012|Participants Entering Follow Up Period|Death|2|||
124804901|NCT02598960|448918084|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804902|NCT02598960|448918085|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804903|NCT02598960|448918086|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804904|NCT02598960|448918087|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804905|NCT02598960|448918088|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804906|NCT02598960|448918089|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804907|NCT02598960|448918090|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804908|NCT02598960|448918091|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804909|NCT02598960|448918092|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804910|NCT02598960|448918093|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804911|NCT02598960|448918094|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804912|NCT02598960|448918095|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
124804913|NCT02598960|448918096|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804914|NCT02598960|448918084|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
124804915|NCT02598960|448918085|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
124804916|NCT02598960|448918086|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
124804917|NCT02598960|448918087|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
124804918|NCT02598960|448918088|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
124804919|NCT02598960|448918089|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
124804920|NCT02598960|448918090|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
124804921|NCT02598960|448918091|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
124804922|NCT02598960|448918092|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
124804923|NCT02598960|448918093|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
124804924|NCT02598960|448918094|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
124804925|NCT02598960|448918095|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
124804926|NCT02598960|448918096|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
124804927|NCT02598960|448918084|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804928|NCT02598960|448918085|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804929|NCT02598960|448918086|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804930|NCT02598960|448918087|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804931|NCT02598960|448918088|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804932|NCT02598960|448918089|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804933|NCT02598960|448918090|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804934|NCT02598960|448918091|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804935|NCT02598960|448918092|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804936|NCT02598960|448918093|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804937|NCT02598960|448918094|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804938|NCT02598960|448918095|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
124804939|NCT02598960|448918096|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804940|NCT02598960|448918084|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
124804941|NCT02598960|448918085|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
124804942|NCT02598960|448918086|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
124804943|NCT02598960|448918087|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
124804944|NCT02598960|448918088|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
124804945|NCT02598960|448918089|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
124804946|NCT02598960|448918090|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
124804947|NCT02598960|448918091|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
124804948|NCT02598960|448918092|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
124804949|NCT02598960|448918093|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
124804950|NCT02598960|448918094|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
124804951|NCT02598960|448918095|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
124804952|NCT02598960|448918096|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
124804953|NCT00108433|448918097|FG000|Overall Study|Lack of Efficacy|1|||
124804954|NCT00108433|448918098|FG001|Overall Study|Lack of Efficacy|2|||
124804955|NCT00108433|448918097|FG000|Overall Study|Death|3|||
124804956|NCT00108433|448918098|FG001|Overall Study|Death|0|||
124804957|NCT00108433|448918097|FG000|Overall Study|Adverse Event|3|||
124804958|NCT00108433|448918098|FG001|Overall Study|Adverse Event|1|||
124804959|NCT00108433|448918097|FG000|Overall Study|Other|14|||
124804960|NCT00108433|448918098|FG001|Overall Study|Other|14|||
124804961|NCT04195906|448918099|FG000|Part 1|Adverse Event|3|||
124804962|NCT04195906|448918100|FG001|Part 1|Adverse Event|7|||
124804963|NCT04195906|448918099|FG000|Part 1|Withdrawal by Subject|0|||
124804964|NCT04195906|448918100|FG001|Part 1|Withdrawal by Subject|1|||
124804965|NCT04195906|448918099|FG000|Part 2|Adverse Event|1|||
124804966|NCT04195906|448918100|FG001|Part 2|Adverse Event|1|||
124804967|NCT04195906|448918099|FG000|Part 2|Withdrawal by Subject|0|||
124804968|NCT04195906|448918100|FG001|Part 2|Withdrawal by Subject|3|||
124804969|NCT04195906|448918099|FG000|Part 2|Other|1|||
124804970|NCT04195906|448918100|FG001|Part 2|Other|3|||
124804971|NCT00371826|448918106|FG000|Core Phase (12 Months)|Adverse Event|15|||
124804972|NCT00371826|448918107|FG001|Core Phase (12 Months)|Adverse Event|4|||
124804973|NCT00371826|448918108|FG002|Core Phase (12 Months)|Adverse Event|9|||
124804974|NCT00371826|448918106|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
124804975|NCT00371826|448918107|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
124804976|NCT00371826|448918108|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
124804977|NCT00371826|448918106|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
124804978|NCT00371826|448918107|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
124804979|NCT00371826|448918108|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
124804980|NCT00371826|448918106|FG000|Core Phase (12 Months)|Protocol Violation|1|||
124804981|NCT00371826|448918107|FG001|Core Phase (12 Months)|Protocol Violation|0|||
124804982|NCT00371826|448918108|FG002|Core Phase (12 Months)|Protocol Violation|1|||
124804983|NCT00371826|448918106|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
124804984|NCT00371826|448918107|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
124804985|NCT00371826|448918108|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
124804986|NCT00371826|448918106|FG000|Core Phase (12 Months)|Administrative problems|1|||
124804987|NCT00371826|448918107|FG001|Core Phase (12 Months)|Administrative problems|0|||
124804988|NCT00371826|448918108|FG002|Core Phase (12 Months)|Administrative problems|8|||
124804989|NCT00371826|448918106|FG000|Core Phase (12 Months)|Graft Loss|0|||
124804990|NCT00371826|448918107|FG001|Core Phase (12 Months)|Graft Loss|1|||
124804991|NCT00371826|448918108|FG002|Core Phase (12 Months)|Graft Loss|0|||
124804992|NCT00371826|448918106|FG000|Extension Phase (24 Months)|Adverse Event|4|||
124804993|NCT00371826|448918107|FG001|Extension Phase (24 Months)|Adverse Event|5|||
124804994|NCT00371826|448918108|FG002|Extension Phase (24 Months)|Adverse Event|0|||
124804995|NCT00371826|448918106|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
124804996|NCT00371826|448918107|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
124804997|NCT00371826|448918108|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
124804998|NCT00371826|448918106|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
124804999|NCT00371826|448918107|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
124805000|NCT00371826|448918108|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
124805001|NCT00371826|448918106|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
124805002|NCT00371826|448918107|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
124805003|NCT00371826|448918108|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
124805004|NCT00371826|448918106|FG000|Extension Phase (24 Months)|Administrative problems|0|||
124805005|NCT00371826|448918107|FG001|Extension Phase (24 Months)|Administrative problems|0|||
124805006|NCT00371826|448918108|FG002|Extension Phase (24 Months)|Administrative problems|2|||
124805007|NCT00734474|448918111|FG000|Overall Study|Entry Criteria Not Met|0|||
124805008|NCT00734474|448918112|FG001|Overall Study|Entry Criteria Not Met|0|||
124805009|NCT00734474|448918113|FG002|Overall Study|Entry Criteria Not Met|5|||
124805010|NCT00734474|448918114|FG003|Overall Study|Entry Criteria Not Met|0|||
124805011|NCT00734474|448918115|FG004|Overall Study|Entry Criteria Not Met|3|||
124805012|NCT00734474|448918116|FG005|Overall Study|Entry Criteria Not Met|1|||
124805013|NCT00734474|448918117|FG006|Overall Study|Entry Criteria Not Met|0|||
124805014|NCT00734474|448918118|FG007|Overall Study|Entry Criteria Not Met|1|||
124805015|NCT00734474|448918119|FG008|Overall Study|Entry Criteria Not Met|1|||
124805016|NCT00734474|448918111|FG000|Overall Study|Lost to Follow-up|1|||
124805017|NCT00734474|448918112|FG001|Overall Study|Lost to Follow-up|0|||
124805018|NCT00734474|448918113|FG002|Overall Study|Lost to Follow-up|13|||
124805019|NCT00734474|448918114|FG003|Overall Study|Lost to Follow-up|0|||
124805020|NCT00734474|448918115|FG004|Overall Study|Lost to Follow-up|11|||
124805021|NCT00734474|448918116|FG005|Overall Study|Lost to Follow-up|1|||
124805022|NCT00734474|448918117|FG006|Overall Study|Lost to Follow-up|0|||
124805023|NCT00734474|448918118|FG007|Overall Study|Lost to Follow-up|9|||
124805024|NCT00734474|448918119|FG008|Overall Study|Lost to Follow-up|4|||
124805025|NCT00734474|448918111|FG000|Overall Study|Withdrawal by Subject|2|||
124805026|NCT00734474|448918112|FG001|Overall Study|Withdrawal by Subject|1|||
124805027|NCT00734474|448918113|FG002|Overall Study|Withdrawal by Subject|18|||
124805028|NCT00734474|448918114|FG003|Overall Study|Withdrawal by Subject|0|||
124805029|NCT00734474|448918115|FG004|Overall Study|Withdrawal by Subject|24|||
124805030|NCT00734474|448918116|FG005|Overall Study|Withdrawal by Subject|2|||
124805031|NCT00734474|448918117|FG006|Overall Study|Withdrawal by Subject|0|||
124805032|NCT00734474|448918118|FG007|Overall Study|Withdrawal by Subject|36|||
124805033|NCT00734474|448918119|FG008|Overall Study|Withdrawal by Subject|21|||
124805034|NCT00734474|448918111|FG000|Overall Study|Physician Decision|0|||
124805035|NCT00734474|448918112|FG001|Overall Study|Physician Decision|0|||
124805036|NCT00734474|448918113|FG002|Overall Study|Physician Decision|4|||
124805037|NCT00734474|448918114|FG003|Overall Study|Physician Decision|1|||
124805038|NCT00734474|448918115|FG004|Overall Study|Physician Decision|11|||
124805039|NCT00734474|448918116|FG005|Overall Study|Physician Decision|0|||
124805040|NCT00734474|448918117|FG006|Overall Study|Physician Decision|0|||
124805041|NCT00734474|448918118|FG007|Overall Study|Physician Decision|9|||
124805042|NCT00734474|448918119|FG008|Overall Study|Physician Decision|9|||
124805043|NCT00734474|448918111|FG000|Overall Study|Adverse Event|4|||
124805044|NCT00734474|448918112|FG001|Overall Study|Adverse Event|4|||
124805045|NCT00734474|448918113|FG002|Overall Study|Adverse Event|63|||
124805046|NCT00734474|448918114|FG003|Overall Study|Adverse Event|1|||
124805047|NCT00734474|448918115|FG004|Overall Study|Adverse Event|64|||
124805048|NCT00734474|448918116|FG005|Overall Study|Adverse Event|0|||
124805049|NCT00734474|448918117|FG006|Overall Study|Adverse Event|1|||
124805050|NCT00734474|448918118|FG007|Overall Study|Adverse Event|65|||
124805051|NCT00734474|448918119|FG008|Overall Study|Adverse Event|39|||
124805052|NCT00734474|448918111|FG000|Overall Study|Protocol Violation|0|||
124805053|NCT00734474|448918112|FG001|Overall Study|Protocol Violation|0|||
124805054|NCT00734474|448918113|FG002|Overall Study|Protocol Violation|4|||
124805055|NCT00734474|448918114|FG003|Overall Study|Protocol Violation|0|||
124805056|NCT00734474|448918115|FG004|Overall Study|Protocol Violation|3|||
124805057|NCT00734474|448918116|FG005|Overall Study|Protocol Violation|0|||
124805058|NCT00734474|448918117|FG006|Overall Study|Protocol Violation|0|||
124805059|NCT00734474|448918118|FG007|Overall Study|Protocol Violation|3|||
124805060|NCT00734474|448918119|FG008|Overall Study|Protocol Violation|1|||
124805061|NCT00734474|448918111|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
124805062|NCT00734474|448918112|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
124805063|NCT00734474|448918113|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
125299823|NCT01300260|450723768|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
124805064|NCT00734474|448918114|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
124805065|NCT00734474|448918115|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
124805066|NCT00734474|448918116|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
124805067|NCT00734474|448918117|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
124805068|NCT00734474|448918118|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
124805069|NCT00734474|448918119|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
124805070|NCT00734474|448918111|FG000|Overall Study|Sponsor Decision|0|||
124805071|NCT00734474|448918112|FG001|Overall Study|Sponsor Decision|0|||
124805072|NCT00734474|448918113|FG002|Overall Study|Sponsor Decision|0|||
124805073|NCT00734474|448918114|FG003|Overall Study|Sponsor Decision|0|||
124805074|NCT00734474|448918115|FG004|Overall Study|Sponsor Decision|2|||
124805075|NCT00734474|448918116|FG005|Overall Study|Sponsor Decision|0|||
124805076|NCT00734474|448918117|FG006|Overall Study|Sponsor Decision|0|||
124805077|NCT00734474|448918118|FG007|Overall Study|Sponsor Decision|0|||
124805078|NCT00734474|448918119|FG008|Overall Study|Sponsor Decision|0|||
124805079|NCT00734474|448918111|FG000|Overall Study|Death|0|||
124805080|NCT00734474|448918112|FG001|Overall Study|Death|0|||
124805081|NCT00734474|448918113|FG002|Overall Study|Death|1|||
124805082|NCT00734474|448918114|FG003|Overall Study|Death|0|||
124805083|NCT00734474|448918115|FG004|Overall Study|Death|0|||
124805084|NCT00734474|448918116|FG005|Overall Study|Death|0|||
124805085|NCT00734474|448918117|FG006|Overall Study|Death|0|||
124805086|NCT00734474|448918118|FG007|Overall Study|Death|2|||
124805087|NCT00734474|448918119|FG008|Overall Study|Death|1|||
124805088|NCT00734474|448918111|FG000|Overall Study|Lack of Efficacy|0|||
124805089|NCT00734474|448918112|FG001|Overall Study|Lack of Efficacy|0|||
124805090|NCT00734474|448918113|FG002|Overall Study|Lack of Efficacy|4|||
124805091|NCT00734474|448918114|FG003|Overall Study|Lack of Efficacy|0|||
124805092|NCT00734474|448918115|FG004|Overall Study|Lack of Efficacy|0|||
124805093|NCT00734474|448918116|FG005|Overall Study|Lack of Efficacy|0|||
124805094|NCT00734474|448918117|FG006|Overall Study|Lack of Efficacy|0|||
124805095|NCT00734474|448918118|FG007|Overall Study|Lack of Efficacy|4|||
124805096|NCT00734474|448918119|FG008|Overall Study|Lack of Efficacy|6|||
124805097|NCT00385762|448918128|FG000|Overall Study|Adverse Event|1|||
124805098|NCT00385762|448918128|FG000|Overall Study|Lost to Follow-up|1|||
124805099|NCT00573183|448918129|FG000|Overall Study|Lost to Follow-up|52|||
124805100|NCT00573183|448918130|FG001|Overall Study|Lost to Follow-up|50|||
124805101|NCT00573183|448918129|FG000|Overall Study|Withdrawal by Subject|8|||
124805102|NCT00573183|448918130|FG001|Overall Study|Withdrawal by Subject|2|||
124805103|NCT00573183|448918129|FG000|Overall Study|Death|0|||
124805104|NCT00573183|448918130|FG001|Overall Study|Death|1|||
124805105|NCT00573183|448918129|FG000|Overall Study|Adverse Event|2|||
124805106|NCT00573183|448918130|FG001|Overall Study|Adverse Event|0|||
124805107|NCT00573183|448918129|FG000|Overall Study|Incarceration|5|||
124805108|NCT00573183|448918130|FG001|Overall Study|Incarceration|8|||
124805109|NCT00573183|448918129|FG000|Overall Study|Other|5|||
124805110|NCT00573183|448918130|FG001|Overall Study|Other|2|||
124805111|NCT00428792|448918133|FG000|Overall Study|Lack of Efficacy|1|||
124805112|NCT00428792|448918134|FG001|Overall Study|Lack of Efficacy|3|||
124805113|NCT00428792|448918133|FG000|Overall Study|Lost to Follow-up|0|||
124805114|NCT00428792|448918134|FG001|Overall Study|Lost to Follow-up|1|||
124805115|NCT02570074|448918135|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
124805116|NCT02570074|448918136|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
124805117|NCT03270644|448918141|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
124805118|NCT03270644|448918141|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
124805119|NCT00354614|448918143|FG000|Overall Study|Lack of Efficacy|28|||
124805120|NCT01500031|448918144|FG000|Overall Study|Death|1|||
124805121|NCT01500031|448918144|FG000|Overall Study|Withdrawal by Subject|4|||
124805122|NCT01856907|448918146|FG000|Overall Study|Pregnancy|0|||
124805123|NCT01856907|448918147|FG001|Overall Study|Pregnancy|1|||
124805124|NCT01856907|448918148|FG002|Overall Study|Pregnancy|0|||
124805125|NCT01856907|448918146|FG000|Overall Study|Pregnancy|0|||
124805126|NCT01856907|448918147|FG001|Overall Study|Pregnancy|1|||
124805127|NCT01856907|448918148|FG002|Overall Study|Pregnancy|0|||
124805128|NCT01856907|448918146|FG000|Overall Study|Withdrawal by Subject|0|||
124805129|NCT01856907|448918147|FG001|Overall Study|Withdrawal by Subject|1|||
124805130|NCT01856907|448918148|FG002|Overall Study|Withdrawal by Subject|0|||
124805131|NCT01604408|448918151|FG000|Treatment Period 1|Protocol Violation|0|||
124805132|NCT01604408|448918152|FG001|Treatment Period 1|Protocol Violation|1|||
124805133|NCT01604408|448918151|FG000|Treatment Period 2|Withdrawal by Subject|1|||
124805134|NCT01604408|448918152|FG001|Treatment Period 2|Withdrawal by Subject|1|||
124805135|NCT01604408|448918151|FG000|Treatment Period 2|Protocol Violation|1|||
124805136|NCT01604408|448918152|FG001|Treatment Period 2|Protocol Violation|0|||
124805137|NCT01604408|448918151|FG000|Treatment Period 2|Adverse Event|0|||
124805138|NCT01604408|448918152|FG001|Treatment Period 2|Adverse Event|1|||
125299824|NCT01300260|450723769|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
124805139|NCT01604408|448918151|FG000|Treatment Period 3|Protocol Violation|1|||
124805140|NCT01604408|448918152|FG001|Treatment Period 3|Protocol Violation|1|||
124805141|NCT01604408|448918151|FG000|Treatment Period 3|Adverse Event|0|||
124805142|NCT01604408|448918152|FG001|Treatment Period 3|Adverse Event|3|||
124805143|NCT01604408|448918151|FG000|Treatment Period 3|Withdrawal by Subject|3|||
124805144|NCT01604408|448918152|FG001|Treatment Period 3|Withdrawal by Subject|1|||
124805145|NCT01604408|448918151|FG000|Treatment Period 3|Sponsor Decision|1|||
124805146|NCT01604408|448918152|FG001|Treatment Period 3|Sponsor Decision|0|||
124805147|NCT01604408|448918151|FG000|Treatment Period 4|Death|1|||
124805148|NCT01604408|448918152|FG001|Treatment Period 4|Death|0|||
124805149|NCT01604408|448918151|FG000|Treatment Period 4|Withdrawal by Subject|2|||
124805150|NCT01604408|448918152|FG001|Treatment Period 4|Withdrawal by Subject|1|||
124805151|NCT01604408|448918151|FG000|Treatment Period 4|Adverse Event|0|||
124805152|NCT01604408|448918152|FG001|Treatment Period 4|Adverse Event|1|||
124805153|NCT01604408|448918151|FG000|Treatment Period 5|Adverse Event|4|||
124805154|NCT01604408|448918152|FG001|Treatment Period 5|Adverse Event|0|||
124805155|NCT01604408|448918151|FG000|Treatment Period 6|Lost to Follow-up|0|||
124805156|NCT01604408|448918152|FG001|Treatment Period 6|Lost to Follow-up|1|||
124805157|NCT01604408|448918151|FG000|Treatment Period 6|Adverse Event|2|||
124805158|NCT01604408|448918152|FG001|Treatment Period 6|Adverse Event|0|||
124805159|NCT01604408|448918151|FG000|Treatment Period 6|Sponsor decision|0|||
124805160|NCT01604408|448918152|FG001|Treatment Period 6|Sponsor decision|1|||
124805161|NCT01604408|448918151|FG000|Observation Period|Adverse Event|1|||
124805162|NCT01604408|448918152|FG001|Observation Period|Adverse Event|1|||
124805163|NCT01604408|448918151|FG000|Observation Period|Withdrawal by Subject|0|||
124805164|NCT01604408|448918152|FG001|Observation Period|Withdrawal by Subject|2|||
124805165|NCT00917501|448918154|FG000|Overall Study|Lost to Follow-up|4|||
124805166|NCT00917501|448918155|FG001|Overall Study|Lost to Follow-up|1|||
124805167|NCT00917501|448918154|FG000|Overall Study|Withdrawal by Subject|3|||
124805168|NCT00917501|448918155|FG001|Overall Study|Withdrawal by Subject|1|||
124805169|NCT00917501|448918154|FG000|Overall Study|Lack of Efficacy|1|||
124805170|NCT00917501|448918155|FG001|Overall Study|Lack of Efficacy|2|||
124805171|NCT00917501|448918154|FG000|Overall Study|trouble swollowing capsules|0|||
124805172|NCT00917501|448918155|FG001|Overall Study|trouble swollowing capsules|1|||
124805173|NCT05095454|448918156|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
124805174|NCT05095454|448918157|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
124805175|NCT01999114|448918158|FG000|Overall Study|Adverse Event|8|||
124805176|NCT01999114|448918159|FG001|Overall Study|Adverse Event|7|||
124805177|NCT01999114|448918160|FG002|Overall Study|Adverse Event|2|||
124805178|NCT01999114|448918161|FG003|Overall Study|Adverse Event|2|||
124805179|NCT01999114|448918162|FG004|Overall Study|Adverse Event|1|||
124805180|NCT01999114|448918158|FG000|Overall Study|Withdrawal by Subject|0|||
124805181|NCT01999114|448918159|FG001|Overall Study|Withdrawal by Subject|0|||
124805182|NCT01999114|448918160|FG002|Overall Study|Withdrawal by Subject|1|||
124805183|NCT01999114|448918161|FG003|Overall Study|Withdrawal by Subject|0|||
124805184|NCT01999114|448918162|FG004|Overall Study|Withdrawal by Subject|1|||
124805185|NCT01999114|448918158|FG000|Overall Study|Lost to Follow-up|0|||
124805186|NCT01999114|448918159|FG001|Overall Study|Lost to Follow-up|0|||
124805187|NCT01999114|448918160|FG002|Overall Study|Lost to Follow-up|1|||
124805188|NCT01999114|448918161|FG003|Overall Study|Lost to Follow-up|0|||
124805189|NCT01999114|448918162|FG004|Overall Study|Lost to Follow-up|0|||
124805190|NCT01999114|448918158|FG000|Overall Study|Administrative|0|||
124805191|NCT01999114|448918159|FG001|Overall Study|Administrative|0|||
124805192|NCT01999114|448918160|FG002|Overall Study|Administrative|1|||
124805193|NCT01999114|448918161|FG003|Overall Study|Administrative|1|||
124805194|NCT01999114|448918162|FG004|Overall Study|Administrative|2|||
124805195|NCT00722423|448918165|FG000|Overall Study|Protocol Violation|0|||
124805196|NCT00722423|448918166|FG001|Overall Study|Protocol Violation|1|||
124805197|NCT05085730|448918169|FG000|Overall Study|Withdrawal by Subject|4|||
124805198|NCT05085730|448918169|FG000|Overall Study|Physician Decision|1|||
124805199|NCT01453725|448918170|FG000|Overall Study|Adverse Event|3|||
124805200|NCT01453725|448918171|FG001|Overall Study|Adverse Event|3|||
124805201|NCT01453725|448918170|FG000|Overall Study|Lost to Follow-up|4|||
124805202|NCT01453725|448918171|FG001|Overall Study|Lost to Follow-up|0|||
124805203|NCT01453725|448918170|FG000|Overall Study|Non-compliance With Protocol|1|||
124805204|NCT01453725|448918171|FG001|Overall Study|Non-compliance With Protocol|2|||
124805205|NCT01453725|448918170|FG000|Overall Study|Protocol Violation|1|||
124805206|NCT01453725|448918171|FG001|Overall Study|Protocol Violation|0|||
124805207|NCT01453725|448918170|FG000|Overall Study|Withdrawal by Subject|2|||
124805208|NCT01453725|448918171|FG001|Overall Study|Withdrawal by Subject|3|||
124805209|NCT01453725|448918170|FG000|Overall Study|Pregnancy Wish|0|||
124805210|NCT01453725|448918171|FG001|Overall Study|Pregnancy Wish|2|||
124805211|NCT01453725|448918170|FG000|Overall Study|Pregnancy|1|||
124805212|NCT01453725|448918171|FG001|Overall Study|Pregnancy|0|||
124805213|NCT01453725|448918170|FG000|Overall Study|Physician Decision|1|||
124805214|NCT01453725|448918171|FG001|Overall Study|Physician Decision|1|||
124805215|NCT03605212|448918172|FG000|Treatment Period|Adverse Event|1|||
124805216|NCT03605212|448918173|FG001|Treatment Period|Adverse Event|0|||
124805217|NCT03605212|448918174|FG002|Treatment Period|Adverse Event|0|||
124805218|NCT03605212|448918175|FG003|Treatment Period|Adverse Event|0|||
124805219|NCT03605212|448918176|FG004|Treatment Period|Adverse Event|0|||
125299825|NCT01300260|450723768|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
124805220|NCT03605212|448918172|FG000|Treatment Period|Physician Decision|0|||
124805221|NCT03605212|448918173|FG001|Treatment Period|Physician Decision|0|||
124805222|NCT03605212|448918174|FG002|Treatment Period|Physician Decision|0|||
124805223|NCT03605212|448918175|FG003|Treatment Period|Physician Decision|0|||
124805224|NCT03605212|448918176|FG004|Treatment Period|Physician Decision|1|||
124805225|NCT01756053|448918177|FG000|Period 1 (10 Days)|Protocol Violation|1|||
124805226|NCT01756053|448918178|FG001|Period 1 (10 Days)|Protocol Violation|1|||
124805227|NCT01756053|448918177|FG000|Period 2 (10 Days)|Protocol Violation|0|||
124805228|NCT01756053|448918178|FG001|Period 2 (10 Days)|Protocol Violation|2|||
124805229|NCT01986140|448918179|FG000|Overall Study|Withdrawal by Subject|31|||
124805230|NCT01986140|448918180|FG001|Overall Study|Withdrawal by Subject|25|||
124805231|NCT01986140|448918179|FG000|Overall Study|alternative treatment|1|||
124805232|NCT01986140|448918180|FG001|Overall Study|alternative treatment|1|||
124805233|NCT01986140|448918179|FG000|Overall Study|found not eligible|3|||
124805234|NCT01986140|448918180|FG001|Overall Study|found not eligible|0|||
124805235|NCT01986140|448918179|FG000|Overall Study|Adverse Event|0|||
124805236|NCT01986140|448918180|FG001|Overall Study|Adverse Event|1|||
124805237|NCT01986140|448918179|FG000|Overall Study|progression disease|0|||
124805238|NCT01986140|448918180|FG001|Overall Study|progression disease|1|||
124805239|NCT01069627|448918183|FG000|Overall Study|Disease progression|7|||
124805240|NCT01069627|448918183|FG000|Overall Study|Adverse Event|12|||
124805241|NCT01069627|448918183|FG000|Overall Study|Protocol Violation|1|||
124805242|NCT00471146|448918184|FG000|Overall Study|Adverse Event|32|||
124805243|NCT00471146|448918185|FG001|Overall Study|Adverse Event|33|||
124805244|NCT00471146|448918184|FG000|Overall Study|Withdrawal by Subject|14|||
124805245|NCT00471146|448918185|FG001|Overall Study|Withdrawal by Subject|11|||
124805246|NCT00471146|448918184|FG000|Overall Study|Death|11|||
124805247|NCT00471146|448918185|FG001|Overall Study|Death|12|||
124805248|NCT00471146|448918184|FG000|Overall Study|Lost to Follow-up|4|||
124805249|NCT00471146|448918185|FG001|Overall Study|Lost to Follow-up|2|||
124805250|NCT00471146|448918184|FG000|Overall Study|Protocol Violation|2|||
124805251|NCT00471146|448918185|FG001|Overall Study|Protocol Violation|2|||
124805252|NCT00471146|448918184|FG000|Overall Study|Objective progression or relapse|84|||
124805253|NCT00471146|448918185|FG001|Overall Study|Objective progression or relapse|87|||
124805254|NCT00471146|448918184|FG000|Overall Study|Global deterioration of health status|12|||
124805255|NCT00471146|448918185|FG001|Overall Study|Global deterioration of health status|14|||
124805256|NCT00471146|448918184|FG000|Overall Study|Randomized but not treated|9|||
124805257|NCT00471146|448918185|FG001|Overall Study|Randomized but not treated|8|||
124805258|NCT00471146|448918184|FG000|Overall Study|Other|4|||
124805259|NCT00471146|448918185|FG001|Overall Study|Other|5|||
124805260|NCT02149875|448918186|FG000|Overall Study|Lost to Follow-up|3|||
124805261|NCT02149875|448918187|FG001|Overall Study|Lost to Follow-up|4|||
124805262|NCT02149875|448918188|FG002|Overall Study|Lost to Follow-up|5|||
124805263|NCT02149875|448918186|FG000|Overall Study|Withdrawal by Subject|3|||
124805264|NCT02149875|448918187|FG001|Overall Study|Withdrawal by Subject|2|||
124805265|NCT02149875|448918188|FG002|Overall Study|Withdrawal by Subject|2|||
124805266|NCT02149875|448918186|FG000|Overall Study|Physician Decision|1|||
124805267|NCT02149875|448918187|FG001|Overall Study|Physician Decision|2|||
124805268|NCT02149875|448918188|FG002|Overall Study|Physician Decision|2|||
124805269|NCT02478372|448918189|FG000|Overall Study|Protocol Violation|12|||
124805270|NCT02478372|448918190|FG001|Overall Study|Protocol Violation|8|||
124805271|NCT02478372|448918189|FG000|Overall Study|Lost to Follow-up|1|||
124805272|NCT02478372|448918190|FG001|Overall Study|Lost to Follow-up|4|||
124805273|NCT02478372|448918189|FG000|Overall Study|Death|0|||
124805274|NCT02478372|448918190|FG001|Overall Study|Death|2|||
124805275|NCT03800173|448918197|FG000|Overall Study|Lost to Follow-up|0|||
124805276|NCT03800173|448918198|FG001|Overall Study|Lost to Follow-up|0|||
124805277|NCT03800173|448918199|FG002|Overall Study|Lost to Follow-up|0|||
124805278|NCT03800173|448918200|FG003|Overall Study|Lost to Follow-up|0|||
124805279|NCT03800173|448918201|FG004|Overall Study|Lost to Follow-up|1|||
124805280|NCT02507973|448918202|FG000|Overall Study|Adverse Event|1|||
124805281|NCT00910273|448918203|FG000|Overall Study|Lack of Efficacy|6|||
124805282|NCT00910273|448918204|FG001|Overall Study|Lack of Efficacy|9|||
124805283|NCT00910273|448918203|FG000|Overall Study|Adverse Event|1|||
124805284|NCT00910273|448918204|FG001|Overall Study|Adverse Event|1|||
124805285|NCT00910273|448918203|FG000|Overall Study|Withdrawal by Subject|1|||
124805286|NCT00910273|448918204|FG001|Overall Study|Withdrawal by Subject|0|||
124805287|NCT00910273|448918203|FG000|Overall Study|Discontinuation of study by sponsor|8|||
124805288|NCT00910273|448918204|FG001|Overall Study|Discontinuation of study by sponsor|2|||
124805289|NCT00910273|448918203|FG000|Overall Study|Protocol Violation|1|||
124805290|NCT00910273|448918204|FG001|Overall Study|Protocol Violation|0|||
124805291|NCT00910273|448918203|FG000|Overall Study|Lost to Follow-up|1|||
124805292|NCT00910273|448918204|FG001|Overall Study|Lost to Follow-up|1|||
124805293|NCT03841448|448918205|FG000|Double-blind Treatment (DBT) Period|Death|1|||
124805294|NCT03841448|448918206|FG001|Double-blind Treatment (DBT) Period|Death|1|||
124805295|NCT03841448|448918207|FG002|Double-blind Treatment (DBT) Period|Death|0|||
124805296|NCT03841448|448918208|FG003|Double-blind Treatment (DBT) Period|Death|0|||
124805297|NCT03841448|448918205|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
124805298|NCT03841448|448918206|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
124805299|NCT03841448|448918207|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
124805300|NCT03841448|448918208|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
124805301|NCT03841448|448918205|FG000|Open-Label Extension (OLE) Period|Death|0|||
124805302|NCT03841448|448918206|FG001|Open-Label Extension (OLE) Period|Death|0|||
124805303|NCT03841448|448918207|FG002|Open-Label Extension (OLE) Period|Death|0|||
124805304|NCT03841448|448918208|FG003|Open-Label Extension (OLE) Period|Death|1|||
124805305|NCT03841448|448918205|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
124805306|NCT03841448|448918206|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
124805307|NCT03841448|448918207|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
124805308|NCT03841448|448918208|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
124805309|NCT03841448|448918205|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
124805310|NCT03841448|448918206|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
124805311|NCT03841448|448918207|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
124805312|NCT03841448|448918208|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
124805313|NCT03841448|448918205|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
124805314|NCT03841448|448918206|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
124805315|NCT03841448|448918207|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
124805316|NCT03841448|448918208|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
124805317|NCT00543543|448918209|FG000|Base Study|Adverse Event|1|||
124805318|NCT00543543|448918210|FG001|Base Study|Adverse Event|11|||
124805319|NCT00543543|448918211|FG002|Base Study|Adverse Event|0|||
124805320|NCT00543543|448918212|FG003|Base Study|Adverse Event|5|||
124805321|NCT00543543|448918209|FG000|Base Study|Lost to Follow-up|12|||
124805322|NCT00543543|448918210|FG001|Base Study|Lost to Follow-up|749|||
124805323|NCT00543543|448918211|FG002|Base Study|Lost to Follow-up|9|||
124805324|NCT00543543|448918212|FG003|Base Study|Lost to Follow-up|701|||
124805325|NCT00543543|448918209|FG000|Base Study|Physician Decision|0|||
124805326|NCT00543543|448918210|FG001|Base Study|Physician Decision|4|||
124805327|NCT00543543|448918211|FG002|Base Study|Physician Decision|0|||
124805328|NCT00543543|448918212|FG003|Base Study|Physician Decision|7|||
124805329|NCT00543543|448918209|FG000|Base Study|Protocol Violation|0|||
124805330|NCT00543543|448918210|FG001|Base Study|Protocol Violation|6|||
124805331|NCT00543543|448918211|FG002|Base Study|Protocol Violation|0|||
124805332|NCT00543543|448918212|FG003|Base Study|Protocol Violation|6|||
124805333|NCT00543543|448918209|FG000|Base Study|Withdrawal by Subject|7|||
124805334|NCT00543543|448918210|FG001|Base Study|Withdrawal by Subject|482|||
124805335|NCT00543543|448918211|FG002|Base Study|Withdrawal by Subject|5|||
124805336|NCT00543543|448918212|FG003|Base Study|Withdrawal by Subject|503|||
124805337|NCT00543543|448918209|FG000|Extension Study|Adverse Event|0|||
124805338|NCT00543543|448918210|FG001|Extension Study|Adverse Event|0|||
124805339|NCT00543543|448918211|FG002|Extension Study|Adverse Event|0|||
124805340|NCT00543543|448918212|FG003|Extension Study|Adverse Event|5|||
124805341|NCT00543543|448918209|FG000|Extension Study|Lost to Follow-up|0|||
124805342|NCT00543543|448918210|FG001|Extension Study|Lost to Follow-up|0|||
124805343|NCT00543543|448918211|FG002|Extension Study|Lost to Follow-up|0|||
124805344|NCT00543543|448918212|FG003|Extension Study|Lost to Follow-up|77|||
124805345|NCT00543543|448918209|FG000|Extension Study|Physician Decision|0|||
124805346|NCT00543543|448918210|FG001|Extension Study|Physician Decision|0|||
124805347|NCT00543543|448918211|FG002|Extension Study|Physician Decision|0|||
124805348|NCT00543543|448918212|FG003|Extension Study|Physician Decision|7|||
124805349|NCT00543543|448918209|FG000|Extension Study|Pregnancy|0|||
124805350|NCT00543543|448918210|FG001|Extension Study|Pregnancy|0|||
124805351|NCT00543543|448918211|FG002|Extension Study|Pregnancy|0|||
124805352|NCT00543543|448918212|FG003|Extension Study|Pregnancy|6|||
124805353|NCT00543543|448918209|FG000|Extension Study|Protocol Violation|0|||
124805354|NCT00543543|448918210|FG001|Extension Study|Protocol Violation|0|||
124805355|NCT00543543|448918211|FG002|Extension Study|Protocol Violation|0|||
124805356|NCT00543543|448918212|FG003|Extension Study|Protocol Violation|11|||
124805357|NCT00543543|448918209|FG000|Extension Study|Withdrawal by Subject|0|||
124805358|NCT00543543|448918210|FG001|Extension Study|Withdrawal by Subject|0|||
124805359|NCT00543543|448918211|FG002|Extension Study|Withdrawal by Subject|0|||
124805360|NCT00543543|448918212|FG003|Extension Study|Withdrawal by Subject|120|||
124805361|NCT01361568|448918213|FG000|Overall Study|Adverse Event|0|||
124805362|NCT01361568|448918214|FG001|Overall Study|Adverse Event|0|||
124805363|NCT01361568|448918215|FG002|Overall Study|Adverse Event|0|||
124805364|NCT01361568|448918216|FG003|Overall Study|Adverse Event|0|||
124805365|NCT01361568|448918217|FG004|Overall Study|Adverse Event|1|||
124805366|NCT01361568|448918218|FG005|Overall Study|Adverse Event|0|||
124805367|NCT01361568|448918213|FG000|Overall Study|Physician Decision|0|||
124805368|NCT01361568|448918214|FG001|Overall Study|Physician Decision|0|||
124805369|NCT01361568|448918215|FG002|Overall Study|Physician Decision|0|||
124805370|NCT01361568|448918216|FG003|Overall Study|Physician Decision|0|||
124805371|NCT01361568|448918217|FG004|Overall Study|Physician Decision|0|||
124805372|NCT01361568|448918218|FG005|Overall Study|Physician Decision|1|||
124805373|NCT01361568|448918213|FG000|Overall Study|Withdrawal by Subject|2|||
124805374|NCT01361568|448918214|FG001|Overall Study|Withdrawal by Subject|1|||
124805375|NCT01361568|448918215|FG002|Overall Study|Withdrawal by Subject|0|||
124805376|NCT01361568|448918216|FG003|Overall Study|Withdrawal by Subject|0|||
124805377|NCT01361568|448918217|FG004|Overall Study|Withdrawal by Subject|0|||
124805378|NCT01361568|448918218|FG005|Overall Study|Withdrawal by Subject|1|||
124805379|NCT02959983|448918219|FG000|Overall Study|Protocol Violation|0|||
124805380|NCT02959983|448918220|FG001|Overall Study|Protocol Violation|1|||
124805381|NCT02959983|448918219|FG000|Overall Study|Lack of Efficacy|0|||
124805382|NCT02959983|448918220|FG001|Overall Study|Lack of Efficacy|1|||
124805383|NCT02959983|448918219|FG000|Overall Study|Lost to Follow-up|12|||
124805384|NCT02959983|448918220|FG001|Overall Study|Lost to Follow-up|9|||
124805385|NCT02959983|448918219|FG000|Overall Study|Other|1|||
124805386|NCT02959983|448918220|FG001|Overall Study|Other|1|||
124805387|NCT02959983|448918219|FG000|Overall Study|Physician Decision|1|||
124805388|NCT02959983|448918220|FG001|Overall Study|Physician Decision|0|||
124805389|NCT02959983|448918219|FG000|Overall Study|Adverse Event|5|||
124805390|NCT02959983|448918220|FG001|Overall Study|Adverse Event|1|||
124805391|NCT02959983|448918219|FG000|Overall Study|Withdrawal by Subject|7|||
124805392|NCT02959983|448918220|FG001|Overall Study|Withdrawal by Subject|12|||
124805393|NCT00484094|448918221|FG000|Overall Study|Discontinued|39|||
124805394|NCT00484094|448918221|FG000|Overall Study|Other|3|||
124805395|NCT00586625|448918222|FG000|Overall Study|Adverse Event|6|||
124805396|NCT00586625|448918223|FG001|Overall Study|Adverse Event|6|||
124805397|NCT00586625|448918222|FG000|Overall Study|Protocol Violation|3|||
124805398|NCT00586625|448918223|FG001|Overall Study|Protocol Violation|0|||
124805399|NCT00586625|448918222|FG000|Overall Study|Withdrawal by Subject|32|||
124805400|NCT00586625|448918223|FG001|Overall Study|Withdrawal by Subject|10|||
124805401|NCT00586625|448918222|FG000|Overall Study|Subject non-compliance|0|||
124805402|NCT00586625|448918223|FG001|Overall Study|Subject non-compliance|1|||
124805403|NCT00586625|448918222|FG000|Overall Study|Subject unable to return for visit|2|||
124805404|NCT00586625|448918223|FG001|Overall Study|Subject unable to return for visit|0|||
124805405|NCT00165984|448918224|FG000|Overall Study|Death|15|||
124805406|NCT01736124|448918225|FG000|Post-intervention Assessment|Death|2|||
124805407|NCT01736124|448918226|FG001|Post-intervention Assessment|Death|2|||
124805408|NCT01736124|448918225|FG000|Post-intervention Assessment|lost computer access|1|||
124805409|NCT01736124|448918226|FG001|Post-intervention Assessment|lost computer access|1|||
124805410|NCT01736124|448918225|FG000|Post-intervention Assessment|Moved away|3|||
124805411|NCT01736124|448918226|FG001|Post-intervention Assessment|Moved away|1|||
124805412|NCT01736124|448918225|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
124805413|NCT01736124|448918226|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
124805414|NCT01736124|448918225|FG000|Post-intervention Assessment|Illness|3|||
124805415|NCT01736124|448918226|FG001|Post-intervention Assessment|Illness|2|||
124805416|NCT01736124|448918225|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
124805417|NCT01736124|448918226|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
124805418|NCT01736124|448918225|FG000|Post-intervention Assessment|Temporarily away|3|||
124805419|NCT01736124|448918226|FG001|Post-intervention Assessment|Temporarily away|1|||
124805420|NCT01736124|448918225|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
124805421|NCT01736124|448918226|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
124805422|NCT01736124|448918225|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
124805423|NCT01736124|448918226|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
124805424|NCT01736124|448918225|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
124805425|NCT01736124|448918226|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
124805426|NCT01736124|448918225|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
124805427|NCT01736124|448918226|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
124805428|NCT01736124|448918225|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
124805429|NCT01736124|448918226|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
124805430|NCT01736124|448918225|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
124805431|NCT01736124|448918226|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
124805432|NCT01736124|448918225|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
124805433|NCT01736124|448918226|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
124805434|NCT01736124|448918225|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
124805435|NCT01736124|448918226|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
124805436|NCT01736124|448918225|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
124805437|NCT01736124|448918226|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
124805438|NCT03553927|448918227|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
124805439|NCT03553927|448918228|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
124805440|NCT03553927|448918227|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
124805441|NCT03553927|448918228|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
124805442|NCT01193842|448918230|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
124805443|NCT01193842|448918231|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
124805444|NCT01193842|448918232|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
124805445|NCT01193842|448918233|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
124805446|NCT01193842|448918234|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
124805447|NCT01193842|448918230|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
124805448|NCT01193842|448918231|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
124805449|NCT01193842|448918232|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
124805450|NCT01193842|448918233|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
124805451|NCT01193842|448918234|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
124805452|NCT01193842|448918230|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
124805453|NCT01193842|448918231|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
124805454|NCT01193842|448918232|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
124805455|NCT01193842|448918233|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
124805456|NCT01193842|448918234|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
124805457|NCT01193842|448918230|FG000|Phase II: Randomized Groups|Death|0|||
124805458|NCT01193842|448918231|FG001|Phase II: Randomized Groups|Death|0|||
124805459|NCT01193842|448918232|FG002|Phase II: Randomized Groups|Death|0|||
124805460|NCT01193842|448918233|FG003|Phase II: Randomized Groups|Death|1|||
124805461|NCT01193842|448918234|FG004|Phase II: Randomized Groups|Death|1|||
124805462|NCT01193842|448918230|FG000|Phase II: Randomized Groups|Adverse Event|0|||
124805463|NCT01193842|448918231|FG001|Phase II: Randomized Groups|Adverse Event|0|||
124805464|NCT01193842|448918232|FG002|Phase II: Randomized Groups|Adverse Event|0|||
124805465|NCT01193842|448918233|FG003|Phase II: Randomized Groups|Adverse Event|5|||
124805466|NCT01193842|448918234|FG004|Phase II: Randomized Groups|Adverse Event|3|||
125299826|NCT01300260|450723769|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
125299827|NCT00293020|450723776|FG000|Overall Study|Withdrawal by Subject|34|||
125299828|NCT00293020|450723776|FG000|Overall Study|Adverse Event|30|||
125299829|NCT00293020|450723776|FG000|Overall Study|Death|32|||
125299830|NCT00293020|450723776|FG000|Overall Study|Lack of Efficacy|12|||
125299831|NCT00293020|450723776|FG000|Overall Study|Lost to Follow-up|4|||
125299832|NCT00293020|450723776|FG000|Overall Study|Protocol Violation|6|||
125299833|NCT00293020|450723776|FG000|Overall Study|Physician Decision|21|||
124805467|NCT01193842|448918230|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
124805468|NCT01193842|448918231|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
124805469|NCT01193842|448918232|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
124805470|NCT01193842|448918233|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
124805471|NCT01193842|448918234|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
124805472|NCT01193842|448918230|FG000|Phase II: Randomized Groups|Ineligible|0|||
124805473|NCT01193842|448918231|FG001|Phase II: Randomized Groups|Ineligible|0|||
124805474|NCT01193842|448918232|FG002|Phase II: Randomized Groups|Ineligible|0|||
124805475|NCT01193842|448918233|FG003|Phase II: Randomized Groups|Ineligible|0|||
124805476|NCT01193842|448918234|FG004|Phase II: Randomized Groups|Ineligible|1|||
124805477|NCT01193842|448918230|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
124805478|NCT01193842|448918231|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
124805479|NCT01193842|448918232|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
124805480|NCT01193842|448918233|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
124805481|NCT01193842|448918234|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
124805482|NCT03698331|448918235|FG000|Overall Study|Adverse Event|2|||
124805483|NCT03698331|448918236|FG001|Overall Study|Adverse Event|3|||
124805484|NCT03698331|448918235|FG000|Overall Study|Withdrawal by Subject|1|||
124805485|NCT03698331|448918236|FG001|Overall Study|Withdrawal by Subject|1|||
124805486|NCT03698331|448918235|FG000|Overall Study|Lost to Follow-up|0|||
124805487|NCT03698331|448918236|FG001|Overall Study|Lost to Follow-up|2|||
124805488|NCT03698331|448918235|FG000|Overall Study|Non-compliance with study drug|1|||
124805489|NCT03698331|448918236|FG001|Overall Study|Non-compliance with study drug|0|||
124805490|NCT02130024|448918238|FG000|Overall Study|Adverse Event|10|||
124805491|NCT02130024|448918239|FG001|Overall Study|Adverse Event|11|||
124805492|NCT02130024|448918238|FG000|Overall Study|Death|2|||
124805493|NCT02130024|448918239|FG001|Overall Study|Death|2|||
124805494|NCT02130024|448918238|FG000|Overall Study|Lost to Follow-up|1|||
124805495|NCT02130024|448918239|FG001|Overall Study|Lost to Follow-up|1|||
124805496|NCT02130024|448918238|FG000|Overall Study|Physician Decision|1|||
124805497|NCT02130024|448918239|FG001|Overall Study|Physician Decision|3|||
124805498|NCT02130024|448918238|FG000|Overall Study|Protocol Deviation|4|||
124805499|NCT02130024|448918239|FG001|Overall Study|Protocol Deviation|0|||
124805500|NCT02130024|448918238|FG000|Overall Study|Site Administration Problems|1|||
124805501|NCT02130024|448918239|FG001|Overall Study|Site Administration Problems|0|||
125299834|NCT00293020|450723776|FG000|Overall Study|Other Reason|22|||
125299835|NCT00293020|450723776|FG000|Overall Study|No dose taken|1|||
124805502|NCT02130024|448918238|FG000|Overall Study|Subject Withdrew Consent|6|||
124805503|NCT02130024|448918239|FG001|Overall Study|Subject Withdrew Consent|14|||
124805504|NCT01467583|448918240|FG000|Overall Study|Death|1|||
124805505|NCT01467583|448918241|FG001|Overall Study|Death|1|||
124805506|NCT01467583|448918242|FG002|Overall Study|Death|0|||
124805507|NCT01467583|448918240|FG000|Overall Study|Withdrawal by Subject|1|||
124805508|NCT01467583|448918241|FG001|Overall Study|Withdrawal by Subject|0|||
124805509|NCT01467583|448918242|FG002|Overall Study|Withdrawal by Subject|0|||
124805510|NCT01467583|448918240|FG000|Overall Study|Protocol Violation|0|||
124805511|NCT01467583|448918241|FG001|Overall Study|Protocol Violation|0|||
125299836|NCT01147848|450723779|FG000|Run-in Period|Screen Failure|623|||
124805512|NCT01467583|448918242|FG002|Overall Study|Protocol Violation|2|||
124805513|NCT05274165|448918245|FG000|Overall Study|Withdrawal by Subject|3|||
124805514|NCT05274165|448918246|FG001|Overall Study|Withdrawal by Subject|3|||
124805515|NCT01386008|448918247|FG000|Overall Study|exited w/o incident /study discontinued|17|||
124805516|NCT01386008|448918247|FG000|Overall Study|Adverse Event|3|||
124805517|NCT03001882|448918248|FG000|Overall Study|Death|1|||
124805518|NCT03001882|448918249|FG001|Overall Study|Death|0|||
124805519|NCT03001882|448918250|FG002|Overall Study|Death|0|||
124805520|NCT03001882|448918251|FG003|Overall Study|Death|3|||
125299837|NCT01147848|450723780|FG001|Run-in Period|Screen Failure|0|||
124805521|NCT03001882|448918248|FG000|Overall Study|Participant withdrew consent|0|||
124805522|NCT03001882|448918249|FG001|Overall Study|Participant withdrew consent|1|||
124805523|NCT03001882|448918250|FG002|Overall Study|Participant withdrew consent|0|||
124805524|NCT03001882|448918251|FG003|Overall Study|Participant withdrew consent|5|||
124805525|NCT03001882|448918248|FG000|Overall Study|Other reasons|1|||
124805526|NCT03001882|448918249|FG001|Overall Study|Other reasons|2|||
124805527|NCT03001882|448918250|FG002|Overall Study|Other reasons|0|||
124805528|NCT03001882|448918251|FG003|Overall Study|Other reasons|5|||
124805529|NCT03001882|448918248|FG000|Overall Study|Administrative reason by sponsor|0|||
124805530|NCT03001882|448918249|FG001|Overall Study|Administrative reason by sponsor|0|||
124805531|NCT03001882|448918250|FG002|Overall Study|Administrative reason by sponsor|0|||
124805532|NCT03001882|448918251|FG003|Overall Study|Administrative reason by sponsor|1|||
124805533|NCT03001882|448918248|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
124805534|NCT03001882|448918249|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
124805535|NCT03001882|448918250|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
124805536|NCT03001882|448918251|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
124805537|NCT03001882|448918248|FG000|Overall Study|Not reported|0|||
124805538|NCT03001882|448918249|FG001|Overall Study|Not reported|0|||
124805539|NCT03001882|448918250|FG002|Overall Study|Not reported|0|||
124805540|NCT03001882|448918251|FG003|Overall Study|Not reported|6|||
124805541|NCT03001882|448918248|FG000|Overall Study|Maximum clinical benefit|2|||
124805542|NCT03001882|448918249|FG001|Overall Study|Maximum clinical benefit|3|||
124805543|NCT03001882|448918250|FG002|Overall Study|Maximum clinical benefit|0|||
124805544|NCT03001882|448918251|FG003|Overall Study|Maximum clinical benefit|10|||
124805545|NCT03001882|448918248|FG000|Overall Study|AE unrelated to study drug|3|||
124805546|NCT03001882|448918249|FG001|Overall Study|AE unrelated to study drug|3|||
124805547|NCT03001882|448918250|FG002|Overall Study|AE unrelated to study drug|0|||
124805548|NCT03001882|448918251|FG003|Overall Study|AE unrelated to study drug|11|||
124805549|NCT03001882|448918248|FG000|Overall Study|Study Drug Toxicity|8|||
124805550|NCT03001882|448918249|FG001|Overall Study|Study Drug Toxicity|5|||
124805551|NCT03001882|448918250|FG002|Overall Study|Study Drug Toxicity|0|||
124805552|NCT03001882|448918251|FG003|Overall Study|Study Drug Toxicity|37|||
124805553|NCT03001882|448918248|FG000|Overall Study|Disease progression|16|||
124805554|NCT03001882|448918249|FG001|Overall Study|Disease progression|14|||
124805555|NCT03001882|448918250|FG002|Overall Study|Disease progression|1|||
124805556|NCT03001882|448918251|FG003|Overall Study|Disease progression|90|||
124805557|NCT00976677|448918252|FG000|Overall Study|Adverse Event|1|||
124805558|NCT00976677|448918253|FG001|Overall Study|Adverse Event|0|||
124805559|NCT00976677|448918252|FG000|Overall Study|Withdrawal by Subject|0|||
124805560|NCT00976677|448918253|FG001|Overall Study|Withdrawal by Subject|2|||
124805561|NCT00976677|448918252|FG000|Overall Study|Disease progression|1|||
124805562|NCT00976677|448918253|FG001|Overall Study|Disease progression|1|||
124805563|NCT00976677|448918252|FG000|Overall Study|Trial unblinded|2|||
124805564|NCT00976677|448918253|FG001|Overall Study|Trial unblinded|2|||
124805565|NCT00976677|448918252|FG000|Overall Study|Unknown/Missing|1|||
124805566|NCT00976677|448918253|FG001|Overall Study|Unknown/Missing|0|||
124805567|NCT00615108|448919568|FG000|Overall Study|Adverse Event|122|||
124805568|NCT00615108|448919568|FG000|Overall Study|Other|370|||
124805569|NCT00615108|448919568|FG000|Overall Study|Lost to Follow-up|15|||
124805570|NCT01393301|448919569|FG000|Overall Study|Lost to Follow-up|5|||
124805571|NCT01393301|448919570|FG001|Overall Study|Lost to Follow-up|3|||
124805572|NCT01393301|448919569|FG000|Overall Study|Withdrawal by Subject|2|||
124805573|NCT01393301|448919570|FG001|Overall Study|Withdrawal by Subject|0|||
124805574|NCT01393301|448919569|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
124805575|NCT01393301|448919570|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
124805576|NCT02758171|448919571|FG000|Wash-out|Withdrawal by Subject|1|||
124805577|NCT02758171|448919572|FG001|Wash-out|Withdrawal by Subject|0|||
124805578|NCT02758171|448919571|FG000|Wash-out|Other reason|1|||
124805579|NCT02758171|448919572|FG001|Wash-out|Other reason|0|||
124805580|NCT00853073|448919573|FG000|Overall Study|Withdrawal by Subject|3|||
124805581|NCT00853073|448919574|FG001|Overall Study|Withdrawal by Subject|2|||
125299838|NCT01147848|450723781|FG002|Run-in Period|Screen Failure|0|||
124805582|NCT03643575|448919575|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
124805583|NCT03643575|448919576|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
124805584|NCT03643575|448919577|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
124805585|NCT03643575|448919578|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
124805586|NCT03643575|448919579|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
124805587|NCT03643575|448919580|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
124805588|NCT03643575|448919575|FG000|Washout: 7 Days|Adverse Event|1|||
124805589|NCT03643575|448919576|FG001|Washout: 7 Days|Adverse Event|0|||
124805590|NCT03643575|448919577|FG002|Washout: 7 Days|Adverse Event|0|||
124805591|NCT03643575|448919578|FG003|Washout: 7 Days|Adverse Event|0|||
124805592|NCT03643575|448919579|FG004|Washout: 7 Days|Adverse Event|0|||
124805593|NCT03643575|448919580|FG005|Washout: 7 Days|Adverse Event|0|||
124805594|NCT03643575|448919575|FG000|Washout: 7 Days|Non compliance check in|0|||
124805595|NCT03643575|448919576|FG001|Washout: 7 Days|Non compliance check in|1|||
124805596|NCT03643575|448919577|FG002|Washout: 7 Days|Non compliance check in|0|||
124805597|NCT03643575|448919578|FG003|Washout: 7 Days|Non compliance check in|0|||
124805598|NCT03643575|448919579|FG004|Washout: 7 Days|Non compliance check in|0|||
124805599|NCT03643575|448919580|FG005|Washout: 7 Days|Non compliance check in|0|||
124805600|NCT01309165|448919581|FG000|Overall Study|Lost to Follow-up|4|||
124805601|NCT01309165|448919582|FG001|Overall Study|Lost to Follow-up|3|||
124805602|NCT01309165|448919581|FG000|Overall Study|Return to work|1|||
124805603|NCT01309165|448919582|FG001|Overall Study|Return to work|2|||
124805604|NCT01309165|448919581|FG000|Overall Study|Left country|0|||
124805605|NCT01309165|448919582|FG001|Overall Study|Left country|1|||
124805606|NCT01309165|448919581|FG000|Overall Study|No transportation|0|||
124805607|NCT01309165|448919582|FG001|Overall Study|No transportation|1|||
124805608|NCT01309165|448919581|FG000|Overall Study|Admitted to hospital for second stroke|1|||
124805609|NCT01309165|448919582|FG001|Overall Study|Admitted to hospital for second stroke|0|||
124805610|NCT02410551|448919584|FG000|Overall Study|Adverse Event|1|||
124805611|NCT02410551|448919584|FG000|Overall Study|Withdrawal by Subject|1|||
124805612|NCT02410551|448919584|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
124805613|NCT01739309|448919586|FG000|Overall Study|Adverse Event|1|||
124805614|NCT01739309|448919586|FG000|Overall Study|Withdrawal by Subject|1|||
124805615|NCT00986830|448919589|FG000|Overall Study|Death|1|||
124805616|NCT00986830|448919589|FG000|Overall Study|Lost to Follow-up|1|||
124805617|NCT00986830|448919589|FG000|Overall Study|Lack of Efficacy|1|||
124805618|NCT00986830|448919589|FG000|Overall Study|Unable to access sinus with device|5|||
124805619|NCT01495975|448919590|FG000|Overall Study|Lost to Follow-up|1|||
124805620|NCT01495975|448919591|FG001|Overall Study|Lost to Follow-up|0|||
124805621|NCT05447897|448919592|FG000|Overall Study|Did not participate in survey|2|||
124805622|NCT04553679|448919593|FG000|Overall Study|Withdrawal by Subject|2|||
124805623|NCT04553679|448919594|FG001|Overall Study|Withdrawal by Subject|0|||
124805624|NCT04553679|448919593|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
124805625|NCT04553679|448919594|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
124805626|NCT00333840|448919595|FG000|First-line Treatment Period|Adverse Event|38|||
124805627|NCT00333840|448919596|FG001|First-line Treatment Period|Adverse Event|37|||
124805628|NCT00333840|448919597|FG002|First-line Treatment Period|Adverse Event|0|||
124805629|NCT00333840|448919598|FG003|First-line Treatment Period|Adverse Event|0|||
124805630|NCT00333840|448919595|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
124805631|NCT00333840|448919596|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
124805632|NCT00333840|448919597|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
124805633|NCT00333840|448919598|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
124805634|NCT00333840|448919595|FG000|First-line Treatment Period|Abnormal procedure|2|||
124805635|NCT00333840|448919596|FG001|First-line Treatment Period|Abnormal procedure|0|||
124805636|NCT00333840|448919597|FG002|First-line Treatment Period|Abnormal procedure|0|||
124805637|NCT00333840|448919598|FG003|First-line Treatment Period|Abnormal procedure|0|||
124805638|NCT00333840|448919595|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
124805639|NCT00333840|448919596|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
124805640|NCT00333840|448919597|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
124805641|NCT00333840|448919598|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
124805642|NCT00333840|448919595|FG000|First-line Treatment Period|No longer required study drug|21|||
124805643|NCT00333840|448919596|FG001|First-line Treatment Period|No longer required study drug|8|||
124805644|NCT00333840|448919597|FG002|First-line Treatment Period|No longer required study drug|0|||
124805645|NCT00333840|448919598|FG003|First-line Treatment Period|No longer required study drug|0|||
124805646|NCT00333840|448919595|FG000|First-line Treatment Period|Protocol Violation|17|||
124805647|NCT00333840|448919596|FG001|First-line Treatment Period|Protocol Violation|17|||
124805648|NCT00333840|448919597|FG002|First-line Treatment Period|Protocol Violation|0|||
124805649|NCT00333840|448919598|FG003|First-line Treatment Period|Protocol Violation|0|||
124805650|NCT00333840|448919595|FG000|First-line Treatment Period|Subject withdrew consent|57|||
124805651|NCT00333840|448919596|FG001|First-line Treatment Period|Subject withdrew consent|77|||
124805652|NCT00333840|448919597|FG002|First-line Treatment Period|Subject withdrew consent|0|||
124805653|NCT00333840|448919598|FG003|First-line Treatment Period|Subject withdrew consent|0|||
124805654|NCT00333840|448919595|FG000|First-line Treatment Period|Lost to Follow-up|15|||
124805655|NCT00333840|448919596|FG001|First-line Treatment Period|Lost to Follow-up|6|||
124805656|NCT00333840|448919597|FG002|First-line Treatment Period|Lost to Follow-up|0|||
124805657|NCT00333840|448919598|FG003|First-line Treatment Period|Lost to Follow-up|0|||
124805658|NCT00333840|448919595|FG000|First-line Treatment Period|Administrative problems|12|||
124805659|NCT00333840|448919596|FG001|First-line Treatment Period|Administrative problems|6|||
124805660|NCT00333840|448919597|FG002|First-line Treatment Period|Administrative problems|0|||
124805661|NCT00333840|448919598|FG003|First-line Treatment Period|Administrative problems|0|||
124805662|NCT00333840|448919595|FG000|First-line Treatment Period|Death|19|||
124805663|NCT00333840|448919596|FG001|First-line Treatment Period|Death|2|||
124805664|NCT00333840|448919597|FG002|First-line Treatment Period|Death|0|||
124805665|NCT00333840|448919598|FG003|First-line Treatment Period|Death|0|||
124805666|NCT00333840|448919595|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
124805667|NCT00333840|448919596|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
124805668|NCT00333840|448919597|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
124805669|NCT00333840|448919598|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
124805670|NCT00333840|448919595|FG000|Second-line Treatment Period|Adverse Event|0|||
124805671|NCT00333840|448919596|FG001|Second-line Treatment Period|Adverse Event|0|||
124805672|NCT00333840|448919597|FG002|Second-line Treatment Period|Adverse Event|3|||
124805673|NCT00333840|448919598|FG003|Second-line Treatment Period|Adverse Event|34|||
124805674|NCT00333840|448919595|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
124805675|NCT00333840|448919596|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
124805676|NCT00333840|448919597|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
124805677|NCT00333840|448919598|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
124805678|NCT00333840|448919595|FG000|Second-line Treatment Period|Abnormal procedure|0|||
124805679|NCT00333840|448919596|FG001|Second-line Treatment Period|Abnormal procedure|0|||
124805680|NCT00333840|448919597|FG002|Second-line Treatment Period|Abnormal procedure|0|||
124805681|NCT00333840|448919598|FG003|Second-line Treatment Period|Abnormal procedure|1|||
124805682|NCT00333840|448919595|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
124805683|NCT00333840|448919596|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
124805684|NCT00333840|448919597|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
124805685|NCT00333840|448919598|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
124805686|NCT00333840|448919595|FG000|Second-line Treatment Period|No longer required study drug|0|||
124805687|NCT00333840|448919596|FG001|Second-line Treatment Period|No longer required study drug|0|||
124805688|NCT00333840|448919597|FG002|Second-line Treatment Period|No longer required study drug|1|||
124805689|NCT00333840|448919598|FG003|Second-line Treatment Period|No longer required study drug|14|||
124805690|NCT00333840|448919595|FG000|Second-line Treatment Period|Protocol Violation|0|||
124805691|NCT00333840|448919596|FG001|Second-line Treatment Period|Protocol Violation|0|||
124805692|NCT00333840|448919597|FG002|Second-line Treatment Period|Protocol Violation|1|||
124805693|NCT00333840|448919598|FG003|Second-line Treatment Period|Protocol Violation|10|||
124805694|NCT00333840|448919595|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
124805695|NCT00333840|448919596|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
124805696|NCT00333840|448919597|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
124805697|NCT00333840|448919598|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
124805698|NCT00333840|448919595|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
124805699|NCT00333840|448919596|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
124805700|NCT00333840|448919597|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
124805701|NCT00333840|448919598|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
124805702|NCT00333840|448919595|FG000|Second-line Treatment Period|Administrative problems|0|||
124805703|NCT00333840|448919596|FG001|Second-line Treatment Period|Administrative problems|0|||
124805704|NCT00333840|448919597|FG002|Second-line Treatment Period|Administrative problems|0|||
124805705|NCT00333840|448919598|FG003|Second-line Treatment Period|Administrative problems|7|||
124805706|NCT00333840|448919595|FG000|Second-line Treatment Period|Death|0|||
124805707|NCT00333840|448919596|FG001|Second-line Treatment Period|Death|0|||
124805708|NCT00333840|448919597|FG002|Second-line Treatment Period|Death|0|||
124805709|NCT00333840|448919598|FG003|Second-line Treatment Period|Death|9|||
124805710|NCT00074984|448919602|FG000|Overall Study|Death|1|||
124805711|NCT00074984|448919603|FG001|Overall Study|Death|2|||
124805712|NCT00074984|448919602|FG000|Overall Study|Withdrawal by Subject|2|||
124805713|NCT00074984|448919603|FG001|Overall Study|Withdrawal by Subject|3|||
124805714|NCT00074984|448919602|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
124805715|NCT00074984|448919603|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
124805716|NCT03719586|448919605|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
124805717|NCT03719586|448919606|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
124805718|NCT03719586|448919607|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
124805719|NCT03719586|448919608|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
124805720|NCT00369707|448919612|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
124805721|NCT00369707|448919612|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
124805722|NCT00369707|448919612|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
124805723|NCT00369707|448919612|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
124805724|NCT00369707|448919612|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
124805725|NCT00369707|448919612|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
124805726|NCT00369707|448919612|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
124805727|NCT00369707|448919612|FG000|Follow up for 2 Years After Treatment|Death|1|||
124805728|NCT00369707|448919612|FG000|Follow up for 2 Years After Treatment|Other|2|||
124805729|NCT02046733|448919613|FG000|Overall Study|never initiated 'treatment visits'|6|||
124805730|NCT02046733|448919614|FG001|Overall Study|never initiated 'treatment visits'|0|||
124805731|NCT01254292|448919619|FG000|Comparative Phase|Adverse Event|25|||
124805732|NCT01254292|448919620|FG001|Comparative Phase|Adverse Event|25|||
124805733|NCT01254292|448919619|FG000|Comparative Phase|Lost to Follow-up|3|||
124805734|NCT01254292|448919620|FG001|Comparative Phase|Lost to Follow-up|21|||
124805735|NCT01254292|448919619|FG000|Comparative Phase|Pregnancy|2|||
124805736|NCT01254292|448919620|FG001|Comparative Phase|Pregnancy|6|||
124805737|NCT01254292|448919619|FG000|Comparative Phase|Withdrawal by Subject|20|||
124805738|NCT01254292|448919620|FG001|Comparative Phase|Withdrawal by Subject|21|||
124805739|NCT01254292|448919619|FG000|Comparative Phase|Protocol Violation|1|||
124805740|NCT01254292|448919620|FG001|Comparative Phase|Protocol Violation|2|||
124805741|NCT01254292|448919619|FG000|Comparative Phase|Wish for pregnancy|4|||
124805742|NCT01254292|448919620|FG001|Comparative Phase|Wish for pregnancy|6|||
124805743|NCT01254292|448919619|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
124805744|NCT01254292|448919620|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
124805745|NCT01254292|448919619|FG000|LCS12 Extension Phase|Adverse Event|9|||
124805746|NCT01254292|448919620|FG001|LCS12 Extension Phase|Adverse Event|0|||
124805747|NCT01254292|448919619|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
124805748|NCT01254292|448919620|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
124805749|NCT01254292|448919619|FG000|LCS12 Extension Phase|Other unknown|4|||
124805750|NCT01254292|448919620|FG001|LCS12 Extension Phase|Other unknown|0|||
124805751|NCT01254292|448919619|FG000|LCS12 Extension Phase|Pregnancy|2|||
124805752|NCT01254292|448919620|FG001|LCS12 Extension Phase|Pregnancy|0|||
124805753|NCT01254292|448919619|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
124805754|NCT01254292|448919620|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
124805755|NCT04041375|448919621|FG000|Intervention Phase|Withdrawal by Subject|2|||
124805756|NCT04041375|448919622|FG001|Intervention Phase|Withdrawal by Subject|2|||
124805757|NCT04041375|448919621|FG000|Follow-up Phase|Death|2|||
124805758|NCT04041375|448919622|FG001|Follow-up Phase|Death|0|||
124805759|NCT04041375|448919621|FG000|Follow-up Phase|Lost to Follow-up|2|||
124805760|NCT04041375|448919622|FG001|Follow-up Phase|Lost to Follow-up|1|||
124805761|NCT04041375|448919621|FG000|Follow-up Phase|Too ill|3|||
124805762|NCT04041375|448919622|FG001|Follow-up Phase|Too ill|0|||
124805763|NCT04674644|448919628|FG000|Overall Study|with missing data|37|||
124805764|NCT00199875|448919629|FG000|Overall Study|Withdrawal by Subject|0|||
124805765|NCT00199875|448919630|FG001|Overall Study|Withdrawal by Subject|0|||
124805766|NCT00199875|448919631|FG002|Overall Study|Withdrawal by Subject|0|||
124805767|NCT00199875|448919632|FG003|Overall Study|Withdrawal by Subject|0|||
124805768|NCT00199875|448919633|FG004|Overall Study|Withdrawal by Subject|1|||
124805769|NCT03277690|448919637|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
124805770|NCT03277690|448919638|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
124805771|NCT03277690|448919637|FG000|Dose Titration and Maintenance|Physician Decision|1|||
124805772|NCT03277690|448919638|FG001|Dose Titration and Maintenance|Physician Decision|0|||
124805773|NCT03277690|448919637|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
124805774|NCT03277690|448919638|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
124805775|NCT03277690|448919637|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
124805776|NCT03277690|448919638|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
124805777|NCT03277690|448919637|FG000|Dose Titration and Maintenance|Adverse Event|15|||
124805778|NCT03277690|448919638|FG001|Dose Titration and Maintenance|Adverse Event|0|||
124805779|NCT03277690|448919637|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
124805780|NCT03277690|448919638|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
124805781|NCT03277690|448919637|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
124805782|NCT03277690|448919638|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
124805783|NCT00747812|448919639|FG000|Overall Study|Research Site Staff Relocation|5|||
124805784|NCT00747812|448919640|FG001|Overall Study|Research Site Staff Relocation|3|||
124805785|NCT01013350|448919641|FG000|Overall Study|Lost to Follow-up|15|||
124805786|NCT01013350|448919642|FG001|Overall Study|Lost to Follow-up|95|||
124805787|NCT01013350|448919641|FG000|Overall Study|Adverse Event|0|||
124805788|NCT01013350|448919642|FG001|Overall Study|Adverse Event|1|||
124805789|NCT01013350|448919641|FG000|Overall Study|Physician Decision|4|||
124805790|NCT01013350|448919642|FG001|Overall Study|Physician Decision|20|||
124805791|NCT01013350|448919641|FG000|Overall Study|Withdrawal by Subject|15|||
124805792|NCT01013350|448919642|FG001|Overall Study|Withdrawal by Subject|38|||
124805793|NCT01013350|448919641|FG000|Overall Study|Death|3|||
124805794|NCT01013350|448919642|FG001|Overall Study|Death|5|||
124805795|NCT01013350|448919641|FG000|Overall Study|Participant entered interventional study|0|||
124805796|NCT01013350|448919642|FG001|Overall Study|Participant entered interventional study|8|||
124805797|NCT01013350|448919641|FG000|Overall Study|Other|1|||
124805798|NCT01013350|448919642|FG001|Overall Study|Other|25|||
124805799|NCT01708161|448919643|FG000|Overall Study|Adverse Event|1|||
124805800|NCT01708161|448919644|FG001|Overall Study|Adverse Event|3|||
124805801|NCT01708161|448919645|FG002|Overall Study|Adverse Event|4|||
124805802|NCT01708161|448919646|FG003|Overall Study|Adverse Event|2|||
124805803|NCT01708161|448919647|FG004|Overall Study|Adverse Event|3|||
124805804|NCT01708161|448919648|FG005|Overall Study|Adverse Event|0|||
124805805|NCT01708161|448919643|FG000|Overall Study|Death|0|||
124805806|NCT01708161|448919644|FG001|Overall Study|Death|0|||
124805807|NCT01708161|448919645|FG002|Overall Study|Death|0|||
124805808|NCT01708161|448919646|FG003|Overall Study|Death|1|||
124805809|NCT01708161|448919647|FG004|Overall Study|Death|0|||
124805810|NCT01708161|448919648|FG005|Overall Study|Death|1|||
124805811|NCT01708161|448919643|FG000|Overall Study|Withdrawal by Subject|0|||
124805812|NCT01708161|448919644|FG001|Overall Study|Withdrawal by Subject|1|||
124805813|NCT01708161|448919645|FG002|Overall Study|Withdrawal by Subject|1|||
124805814|NCT01708161|448919646|FG003|Overall Study|Withdrawal by Subject|0|||
124805815|NCT01708161|448919647|FG004|Overall Study|Withdrawal by Subject|0|||
124805816|NCT01708161|448919648|FG005|Overall Study|Withdrawal by Subject|0|||
124805817|NCT01708161|448919643|FG000|Overall Study|Administrative problems|0|||
124805818|NCT01708161|448919644|FG001|Overall Study|Administrative problems|1|||
124805819|NCT01708161|448919645|FG002|Overall Study|Administrative problems|0|||
124805820|NCT01708161|448919646|FG003|Overall Study|Administrative problems|0|||
124805821|NCT01708161|448919647|FG004|Overall Study|Administrative problems|0|||
124805822|NCT01708161|448919648|FG005|Overall Study|Administrative problems|0|||
124805823|NCT01708161|448919643|FG000|Overall Study|Disease progression|3|||
124805824|NCT01708161|448919644|FG001|Overall Study|Disease progression|5|||
124805825|NCT01708161|448919645|FG002|Overall Study|Disease progression|5|||
124805826|NCT01708161|448919646|FG003|Overall Study|Disease progression|13|||
124805827|NCT01708161|448919647|FG004|Overall Study|Disease progression|3|||
124805828|NCT01708161|448919648|FG005|Overall Study|Disease progression|0|||
124805829|NCT02019277|448919649|FG000|Overall Study|Withdrawal by Subject|3|||
124805830|NCT02019277|448919649|FG000|Overall Study|Death|7|||
124805831|NCT02019277|448919649|FG000|Overall Study|Did no Cooperate|1|||
124805832|NCT02019277|448919649|FG000|Overall Study|Adverse Event|1|||
124805833|NCT02633501|448919651|FG000|Overall Study|Adverse Event|0|||
124805834|NCT02633501|448919652|FG001|Overall Study|Adverse Event|0|||
124805835|NCT02633501|448919653|FG002|Overall Study|Adverse Event|1|||
124805836|NCT02633501|448919654|FG003|Overall Study|Adverse Event|0|||
124805837|NCT02633501|448919655|FG004|Overall Study|Adverse Event|1|||
124805838|NCT02633501|448919656|FG005|Overall Study|Adverse Event|1|||
124805839|NCT02633501|448919651|FG000|Overall Study|Withdrawal by Subject|2|||
124805840|NCT02633501|448919652|FG001|Overall Study|Withdrawal by Subject|1|||
124805841|NCT02633501|448919653|FG002|Overall Study|Withdrawal by Subject|2|||
124805842|NCT02633501|448919654|FG003|Overall Study|Withdrawal by Subject|2|||
124805843|NCT02633501|448919655|FG004|Overall Study|Withdrawal by Subject|1|||
124805844|NCT02633501|448919656|FG005|Overall Study|Withdrawal by Subject|3|||
124805845|NCT02633501|448919651|FG000|Overall Study|Various other reasons|0|||
124805846|NCT02633501|448919652|FG001|Overall Study|Various other reasons|2|||
124805847|NCT02633501|448919653|FG002|Overall Study|Various other reasons|4|||
124805848|NCT02633501|448919654|FG003|Overall Study|Various other reasons|1|||
124805849|NCT02633501|448919655|FG004|Overall Study|Various other reasons|7|||
124805850|NCT02633501|448919656|FG005|Overall Study|Various other reasons|11|||
124805851|NCT02633501|448919651|FG000|Overall Study|Lost to Follow-up|0|||
124805852|NCT02633501|448919652|FG001|Overall Study|Lost to Follow-up|0|||
124805853|NCT02633501|448919653|FG002|Overall Study|Lost to Follow-up|0|||
124805854|NCT02633501|448919654|FG003|Overall Study|Lost to Follow-up|1|||
124805855|NCT02633501|448919655|FG004|Overall Study|Lost to Follow-up|2|||
124805856|NCT02633501|448919656|FG005|Overall Study|Lost to Follow-up|0|||
124805857|NCT00395733|448919657|FG000|Period 2|Withdrawal by Subject|1|||
124805858|NCT00395733|448919658|FG001|Period 2|Withdrawal by Subject|2|||
124805859|NCT00395733|448919657|FG000|Period 2|Protocol Violation|0|||
124805860|NCT00395733|448919658|FG001|Period 2|Protocol Violation|1|||
124805861|NCT00395733|448919657|FG000|Period 2|Adverse Event|0|||
124805862|NCT00395733|448919658|FG001|Period 2|Adverse Event|2|||
124805863|NCT00395733|448919657|FG000|Period 2|Technical problems|1|||
124805864|NCT00395733|448919658|FG001|Period 2|Technical problems|0|||
124805865|NCT01672736|448919660|FG000|Overall Study|Available drug expired on 31 May 16|3|||
124805866|NCT02853344|448919665|FG000|Overall Study|Lost to Follow-up|1|||
124805867|NCT02853344|448919666|FG001|Overall Study|Lost to Follow-up|1|||
124805868|NCT02853344|448919665|FG000|Overall Study|Withdrawal by Subject|2|||
124805869|NCT02853344|448919666|FG001|Overall Study|Withdrawal by Subject|4|||
124805870|NCT02853344|448919665|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
124805871|NCT02853344|448919666|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
124805872|NCT02853344|448919665|FG000|Overall Study|Death|70|||
124805873|NCT02853344|448919666|FG001|Overall Study|Death|112|||
124805874|NCT02913612|448919667|FG000|Overall Study|Lost to Follow-up|6|||
124805875|NCT02913612|448919668|FG001|Overall Study|Lost to Follow-up|5|||
124805876|NCT02913612|448919669|FG002|Overall Study|Lost to Follow-up|2|||
124805877|NCT02913612|448919670|FG003|Overall Study|Lost to Follow-up|0|||
124805878|NCT02913612|448919667|FG000|Overall Study|Physician Decision|1|||
124805879|NCT02913612|448919668|FG001|Overall Study|Physician Decision|4|||
124805880|NCT02913612|448919669|FG002|Overall Study|Physician Decision|1|||
124805881|NCT02913612|448919670|FG003|Overall Study|Physician Decision|0|||
124805882|NCT02913612|448919667|FG000|Overall Study|Withdrawal by Subject|2|||
124805883|NCT02913612|448919668|FG001|Overall Study|Withdrawal by Subject|4|||
124805884|NCT02913612|448919669|FG002|Overall Study|Withdrawal by Subject|0|||
124805885|NCT02913612|448919670|FG003|Overall Study|Withdrawal by Subject|0|||
124805886|NCT02913612|448919667|FG000|Overall Study|Hemangioma resolved|1|||
124805887|NCT02913612|448919668|FG001|Overall Study|Hemangioma resolved|0|||
124805888|NCT02913612|448919669|FG002|Overall Study|Hemangioma resolved|0|||
124805889|NCT02913612|448919670|FG003|Overall Study|Hemangioma resolved|0|||
124805890|NCT02913612|448919667|FG000|Overall Study|Local IRB decision|1|||
124805891|NCT02913612|448919668|FG001|Overall Study|Local IRB decision|0|||
124805892|NCT02913612|448919669|FG002|Overall Study|Local IRB decision|0|||
124805893|NCT02913612|448919670|FG003|Overall Study|Local IRB decision|0|||
124805894|NCT02913612|448919667|FG000|Overall Study|Study drug non-compliance|1|||
124805895|NCT02913612|448919668|FG001|Overall Study|Study drug non-compliance|1|||
124805896|NCT02913612|448919669|FG002|Overall Study|Study drug non-compliance|0|||
124805897|NCT02913612|448919670|FG003|Overall Study|Study drug non-compliance|0|||
124805898|NCT02913612|448919667|FG000|Overall Study|Insurance issues|0|||
124805899|NCT02913612|448919668|FG001|Overall Study|Insurance issues|1|||
124805900|NCT02913612|448919669|FG002|Overall Study|Insurance issues|0|||
124805901|NCT02913612|448919670|FG003|Overall Study|Insurance issues|0|||
124805902|NCT02913612|448919667|FG000|Overall Study|Needed to treat second hemangioma|0|||
124805903|NCT02913612|448919668|FG001|Overall Study|Needed to treat second hemangioma|1|||
124805904|NCT02913612|448919669|FG002|Overall Study|Needed to treat second hemangioma|0|||
124805905|NCT02913612|448919670|FG003|Overall Study|Needed to treat second hemangioma|0|||
124805906|NCT02913612|448919667|FG000|Overall Study|Study completion criteria not met|0|||
124805907|NCT02913612|448919668|FG001|Overall Study|Study completion criteria not met|1|||
124805908|NCT02913612|448919669|FG002|Overall Study|Study completion criteria not met|0|||
124805909|NCT02913612|448919670|FG003|Overall Study|Study completion criteria not met|0|||
124805910|NCT02913612|448919667|FG000|Overall Study|Ineligible|0|||
124805911|NCT02913612|448919668|FG001|Overall Study|Ineligible|1|||
124805912|NCT02913612|448919669|FG002|Overall Study|Ineligible|0|||
124805913|NCT02913612|448919670|FG003|Overall Study|Ineligible|0|||
124805914|NCT03452228|448919671|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
124805915|NCT03452228|448919672|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
124805916|NCT03452228|448919673|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
124805917|NCT03452228|448919671|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
124805918|NCT03452228|448919672|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
124805919|NCT03452228|448919673|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
124805920|NCT03452228|448919671|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
124805921|NCT03452228|448919672|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
124805922|NCT03452228|448919673|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
124805923|NCT03452228|448919671|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
124805924|NCT03452228|448919672|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
124805925|NCT03452228|448919673|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
124805926|NCT01262573|448919674|FG000|Overall Study|Withdrawal by Subject|0|||
124805927|NCT01262573|448919675|FG001|Overall Study|Withdrawal by Subject|1|||
124805928|NCT02955797|448919676|FG000|Overall Study|Protocol Violation|1|||
124805929|NCT02955797|448919677|FG001|Overall Study|Protocol Violation|0|||
124805930|NCT02955797|448919678|FG002|Overall Study|Protocol Violation|0|||
124805931|NCT02955797|448919679|FG003|Overall Study|Protocol Violation|1|||
124805932|NCT02955797|448919676|FG000|Overall Study|Withdrawal by Subject|2|||
124805933|NCT02955797|448919677|FG001|Overall Study|Withdrawal by Subject|2|||
124805934|NCT02955797|448919678|FG002|Overall Study|Withdrawal by Subject|0|||
124805935|NCT02955797|448919679|FG003|Overall Study|Withdrawal by Subject|1|||
124805936|NCT02955797|448919676|FG000|Overall Study|Lost to Follow-up|0|||
124805937|NCT02955797|448919677|FG001|Overall Study|Lost to Follow-up|1|||
124805938|NCT02955797|448919678|FG002|Overall Study|Lost to Follow-up|0|||
124805939|NCT02955797|448919679|FG003|Overall Study|Lost to Follow-up|0|||
124805940|NCT02081183|448919681|FG000|Overall Study|Lost to Follow-up|0|||
124805941|NCT02081183|448919682|FG001|Overall Study|Lost to Follow-up|1|||
124805942|NCT02081183|448919681|FG000|Overall Study|Protocol Violation|1|||
124805943|NCT02081183|448919682|FG001|Overall Study|Protocol Violation|0|||
124805944|NCT02081183|448919681|FG000|Overall Study|Other|3|||
124805945|NCT02081183|448919682|FG001|Overall Study|Other|3|||
124805946|NCT04128371|448919687|FG000|Overall Study|Lack of Efficacy|1|||
124805947|NCT00968864|448919688|FG000|Overall Study|Protocol exception/ not evaluable|1|||
125299839|NCT01147848|450723779|FG000|Run-in Period|Run-in Failure|135|||
125299840|NCT01147848|450723780|FG001|Run-in Period|Run-in Failure|0|||
124805948|NCT00397215|448919700|FG000|Month 0 (Day 0)|Adverse Event|0|||
124805949|NCT00397215|448919701|FG001|Month 0 (Day 0)|Adverse Event|1|||
124805950|NCT00397215|448919702|FG002|Month 0 (Day 0)|Adverse Event|0|||
124805951|NCT00397215|448919703|FG003|Month 0 (Day 0)|Adverse Event|0|||
124805952|NCT00397215|448919700|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
124805953|NCT00397215|448919701|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
124805954|NCT00397215|448919702|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
124805955|NCT00397215|448919703|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
124805956|NCT00397215|448919700|FG000|Month 0 (Day 0)|Other|4|||
124805957|NCT00397215|448919701|FG001|Month 0 (Day 0)|Other|1|||
124805958|NCT00397215|448919702|FG002|Month 0 (Day 0)|Other|3|||
124805959|NCT00397215|448919703|FG003|Month 0 (Day 0)|Other|3|||
125299841|NCT01147848|450723781|FG002|Run-in Period|Run-in Failure|0|||
124805960|NCT00397215|448919700|FG000|Month 6 (Day 180)|Adverse Event|0|||
124805961|NCT00397215|448919701|FG001|Month 6 (Day 180)|Adverse Event|3|||
124805962|NCT00397215|448919702|FG002|Month 6 (Day 180)|Adverse Event|2|||
124805963|NCT00397215|448919703|FG003|Month 6 (Day 180)|Adverse Event|0|||
124805964|NCT00397215|448919700|FG000|Month 6 (Day 180)|Other|2|||
124805965|NCT00397215|448919701|FG001|Month 6 (Day 180)|Other|0|||
124805966|NCT00397215|448919702|FG002|Month 6 (Day 180)|Other|3|||
124805967|NCT00397215|448919703|FG003|Month 6 (Day 180)|Other|0|||
124805968|NCT02128932|448919704|FG000|Overall Study|Withdrawal by Subject|11|||
124805969|NCT02128932|448919705|FG001|Overall Study|Withdrawal by Subject|7|||
124805970|NCT02128932|448919706|FG002|Overall Study|Withdrawal by Subject|8|||
124805971|NCT02128932|448919704|FG000|Overall Study|Death|2|||
124805972|NCT02128932|448919705|FG001|Overall Study|Death|0|||
124805973|NCT02128932|448919706|FG002|Overall Study|Death|2|||
124805974|NCT02128932|448919704|FG000|Overall Study|Lost to Follow-up|2|||
124805975|NCT02128932|448919705|FG001|Overall Study|Lost to Follow-up|1|||
124805976|NCT02128932|448919706|FG002|Overall Study|Lost to Follow-up|1|||
124805977|NCT02128932|448919704|FG000|Overall Study|No reason for withdrawal|12|||
124805978|NCT02128932|448919705|FG001|Overall Study|No reason for withdrawal|11|||
124805979|NCT02128932|448919706|FG002|Overall Study|No reason for withdrawal|7|||
124805980|NCT00657358|448919711|FG000|Overall Study|Lack of Efficacy|6|||
124805981|NCT02728596|448919712|FG000|Overall Study|Refusal unrelated to adverse event|3|||
124805982|NCT02728596|448919713|FG001|Overall Study|Refusal unrelated to adverse event|6|||
124805983|NCT02728596|448919714|FG002|Overall Study|Refusal unrelated to adverse event|7|||
124805984|NCT02728596|448919715|FG003|Overall Study|Refusal unrelated to adverse event|7|||
124805985|NCT02728596|448919712|FG000|Overall Study|Death|44|||
124805986|NCT02728596|448919713|FG001|Overall Study|Death|42|||
124805987|NCT02728596|448919714|FG002|Overall Study|Death|123|||
124805988|NCT02728596|448919715|FG003|Overall Study|Death|68|||
124805989|NCT01414608|448919721|FG000|Overall Study|Ineligible|5|||
124805990|NCT01414608|448919722|FG001|Overall Study|Ineligible|2|||
124805991|NCT03672643|448919723|FG000|Overall Study|Adverse Event|3|||
124805992|NCT03672643|448919723|FG000|Overall Study|Death|2|||
124805993|NCT03672643|448919723|FG000|Overall Study|Withdrawal by Subject|1|||
124805994|NCT03672643|448919723|FG000|Overall Study|Progressive disease|11|||
124805995|NCT03672643|448919723|FG000|Overall Study|Global deterioration of health status|1|||
124805996|NCT03672643|448919723|FG000|Overall Study|Refused further treatment|7|||
124805997|NCT03672643|448919723|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
124805998|NCT05736224|448919724|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
124805999|NCT02557295|448919725|FG000|Overall Study|Withdrawal by Subject|9|||
124806000|NCT02557295|448919726|FG001|Overall Study|Withdrawal by Subject|2|||
124806001|NCT02557295|448919727|FG002|Overall Study|Withdrawal by Subject|4|||
124806002|NCT02557295|448919728|FG003|Overall Study|Withdrawal by Subject|0|||
124806003|NCT02557295|448919729|FG004|Overall Study|Withdrawal by Subject|0|||
124806004|NCT02557295|448919730|FG005|Overall Study|Withdrawal by Subject|0|||
124806005|NCT02557295|448919731|FG006|Overall Study|Withdrawal by Subject|15|||
124806006|NCT02557295|448919732|FG007|Overall Study|Withdrawal by Subject|1|||
124806007|NCT02557295|448919733|FG008|Overall Study|Withdrawal by Subject|3|||
124806008|NCT02557295|448919725|FG000|Overall Study|Disease Progression|0|||
124806009|NCT02557295|448919726|FG001|Overall Study|Disease Progression|0|||
124806010|NCT02557295|448919727|FG002|Overall Study|Disease Progression|0|||
124806011|NCT02557295|448919728|FG003|Overall Study|Disease Progression|0|||
124806012|NCT02557295|448919729|FG004|Overall Study|Disease Progression|0|||
124806013|NCT02557295|448919730|FG005|Overall Study|Disease Progression|0|||
124806014|NCT02557295|448919731|FG006|Overall Study|Disease Progression|1|||
124806015|NCT02557295|448919732|FG007|Overall Study|Disease Progression|0|||
124806016|NCT02557295|448919733|FG008|Overall Study|Disease Progression|0|||
124806017|NCT02557295|448919725|FG000|Overall Study|Lack of Efficacy|24|||
125299842|NCT01147848|450723779|FG000|Randomized Phase|Adverse Event|0|||
125299843|NCT01147848|450723780|FG001|Randomized Phase|Adverse Event|6|||
125299844|NCT01147848|450723781|FG002|Randomized Phase|Adverse Event|8|||
125299845|NCT01147848|450723779|FG000|Randomized Phase|Lack of Efficacy|0|||
124806018|NCT02557295|448919726|FG001|Overall Study|Lack of Efficacy|1|||
124806019|NCT02557295|448919727|FG002|Overall Study|Lack of Efficacy|3|||
124806020|NCT02557295|448919728|FG003|Overall Study|Lack of Efficacy|0|||
124806021|NCT02557295|448919729|FG004|Overall Study|Lack of Efficacy|0|||
124806022|NCT02557295|448919730|FG005|Overall Study|Lack of Efficacy|0|||
125299846|NCT01147848|450723780|FG001|Randomized Phase|Lack of Efficacy|20|||
124806023|NCT02557295|448919731|FG006|Overall Study|Lack of Efficacy|12|||
124806024|NCT02557295|448919732|FG007|Overall Study|Lack of Efficacy|1|||
124806025|NCT02557295|448919733|FG008|Overall Study|Lack of Efficacy|0|||
124806026|NCT02557295|448919725|FG000|Overall Study|Adverse Event|16|||
124806027|NCT02557295|448919726|FG001|Overall Study|Adverse Event|2|||
124806028|NCT02557295|448919727|FG002|Overall Study|Adverse Event|3|||
124806029|NCT02557295|448919728|FG003|Overall Study|Adverse Event|0|||
124806030|NCT02557295|448919729|FG004|Overall Study|Adverse Event|0|||
124806031|NCT02557295|448919730|FG005|Overall Study|Adverse Event|0|||
124806032|NCT02557295|448919731|FG006|Overall Study|Adverse Event|2|||
125299847|NCT01147848|450723781|FG002|Randomized Phase|Lack of Efficacy|11|||
124806033|NCT02557295|448919732|FG007|Overall Study|Adverse Event|1|||
124806034|NCT02557295|448919733|FG008|Overall Study|Adverse Event|1|||
124806035|NCT02557295|448919725|FG000|Overall Study|Lost to Follow-up|4|||
124806036|NCT02557295|448919726|FG001|Overall Study|Lost to Follow-up|0|||
124806037|NCT02557295|448919727|FG002|Overall Study|Lost to Follow-up|0|||
124806038|NCT02557295|448919728|FG003|Overall Study|Lost to Follow-up|0|||
124806039|NCT02557295|448919729|FG004|Overall Study|Lost to Follow-up|0|||
124806040|NCT02557295|448919730|FG005|Overall Study|Lost to Follow-up|0|||
124806041|NCT02557295|448919731|FG006|Overall Study|Lost to Follow-up|9|||
124806042|NCT02557295|448919732|FG007|Overall Study|Lost to Follow-up|0|||
124806043|NCT02557295|448919733|FG008|Overall Study|Lost to Follow-up|0|||
124806044|NCT02557295|448919725|FG000|Overall Study|Study Close|54|||
124806045|NCT02557295|448919726|FG001|Overall Study|Study Close|3|||
124806046|NCT02557295|448919727|FG002|Overall Study|Study Close|5|||
124806047|NCT02557295|448919728|FG003|Overall Study|Study Close|3|||
124806048|NCT02557295|448919729|FG004|Overall Study|Study Close|0|||
124806049|NCT02557295|448919730|FG005|Overall Study|Study Close|0|||
124806050|NCT02557295|448919731|FG006|Overall Study|Study Close|37|||
124806051|NCT02557295|448919732|FG007|Overall Study|Study Close|3|||
124806052|NCT02557295|448919733|FG008|Overall Study|Study Close|19|||
124806053|NCT02557295|448919725|FG000|Overall Study|except for study close|4|||
124806054|NCT02557295|448919726|FG001|Overall Study|except for study close|0|||
124806055|NCT02557295|448919727|FG002|Overall Study|except for study close|0|||
124806056|NCT02557295|448919728|FG003|Overall Study|except for study close|0|||
124806057|NCT02557295|448919729|FG004|Overall Study|except for study close|0|||
124806058|NCT02557295|448919730|FG005|Overall Study|except for study close|0|||
124806059|NCT02557295|448919731|FG006|Overall Study|except for study close|5|||
124806060|NCT02557295|448919732|FG007|Overall Study|except for study close|1|||
124806061|NCT02557295|448919733|FG008|Overall Study|except for study close|0|||
124806062|NCT04806503|448921632|FG000|Overall Study|Lost to Follow-up|0|||
124806063|NCT04806503|448921633|FG001|Overall Study|Lost to Follow-up|0|||
124806064|NCT04806503|448921634|FG002|Overall Study|Lost to Follow-up|1|||
124806065|NCT04806503|448921635|FG003|Overall Study|Lost to Follow-up|0|||
124806066|NCT04806503|448921636|FG004|Overall Study|Lost to Follow-up|0|||
124806067|NCT04806503|448921632|FG000|Overall Study|Withdrawal by Subject|1|||
124806068|NCT04806503|448921633|FG001|Overall Study|Withdrawal by Subject|0|||
124806069|NCT04806503|448921634|FG002|Overall Study|Withdrawal by Subject|1|||
124806070|NCT04806503|448921635|FG003|Overall Study|Withdrawal by Subject|1|||
124806071|NCT04806503|448921636|FG004|Overall Study|Withdrawal by Subject|1|||
124806072|NCT04806503|448921632|FG000|Overall Study|Adverse Event|1|||
124806073|NCT04806503|448921633|FG001|Overall Study|Adverse Event|1|||
124806074|NCT04806503|448921634|FG002|Overall Study|Adverse Event|0|||
124806075|NCT04806503|448921635|FG003|Overall Study|Adverse Event|1|||
124806076|NCT04806503|448921636|FG004|Overall Study|Adverse Event|0|||
124806077|NCT03589469|448921637|FG000|Overall Study|Withdrawal by Subject|8|||
124806078|NCT03589469|448921637|FG000|Overall Study|Physician Decision|20|||
124806079|NCT03589469|448921637|FG000|Overall Study|Death|97|||
124806080|NCT03589469|448921637|FG000|Overall Study|Lost to Follow-up|8|||
124806081|NCT03589469|448921637|FG000|Overall Study|Miscellaneous|1|||
124806082|NCT00617851|448921638|FG000|Overall Study|Death|0|||
124806083|NCT00617851|448921639|FG001|Overall Study|Death|0|||
124806084|NCT00617851|448921640|FG002|Overall Study|Death|0|||
124806085|NCT00617851|448921641|FG003|Overall Study|Death|1|||
124806086|NCT00617851|448921638|FG000|Overall Study|Withdrawal by Subject|14|||
124806087|NCT00617851|448921639|FG001|Overall Study|Withdrawal by Subject|7|||
124806088|NCT00617851|448921640|FG002|Overall Study|Withdrawal by Subject|12|||
124806089|NCT00617851|448921641|FG003|Overall Study|Withdrawal by Subject|4|||
124806090|NCT00617851|448921638|FG000|Overall Study|Lost to Follow-up|27|||
124806091|NCT00617851|448921639|FG001|Overall Study|Lost to Follow-up|29|||
124806092|NCT00617851|448921640|FG002|Overall Study|Lost to Follow-up|31|||
124806093|NCT00617851|448921641|FG003|Overall Study|Lost to Follow-up|19|||
124806094|NCT00617851|448921638|FG000|Overall Study|Inappropriate Enrollment|5|||
124806095|NCT00617851|448921639|FG001|Overall Study|Inappropriate Enrollment|4|||
124806096|NCT00617851|448921640|FG002|Overall Study|Inappropriate Enrollment|1|||
124806097|NCT00617851|448921641|FG003|Overall Study|Inappropriate Enrollment|1|||
124806098|NCT00617851|448921638|FG000|Overall Study|Unable to classify|1|||
124806099|NCT00617851|448921639|FG001|Overall Study|Unable to classify|0|||
124806100|NCT00617851|448921640|FG002|Overall Study|Unable to classify|1|||
125299848|NCT01147848|450723779|FG000|Randomized Phase|Protocol Violation|0|||
124806101|NCT00617851|448921641|FG003|Overall Study|Unable to classify|0|||
124806102|NCT00902668|448921648|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
124806103|NCT01914757|448921649|FG000|Overall Study|Severe non-compliance to protocol|3|||
124806104|NCT01914757|448921650|FG001|Overall Study|Severe non-compliance to protocol|1|||
124806105|NCT01914757|448921651|FG002|Overall Study|Severe non-compliance to protocol|2|||
124806106|NCT01914757|448921649|FG000|Overall Study|Lost to Follow-up|5|||
124806107|NCT01914757|448921650|FG001|Overall Study|Lost to Follow-up|8|||
124806108|NCT01914757|448921651|FG002|Overall Study|Lost to Follow-up|6|||
124806109|NCT01914757|448921649|FG000|Overall Study|Withdrawal by Subject|15|||
124806110|NCT01914757|448921650|FG001|Overall Study|Withdrawal by Subject|27|||
124806111|NCT01914757|448921651|FG002|Overall Study|Withdrawal by Subject|19|||
124806112|NCT01914757|448921649|FG000|Overall Study|Death|2|||
124806113|NCT01914757|448921650|FG001|Overall Study|Death|2|||
124806114|NCT01914757|448921651|FG002|Overall Study|Death|1|||
124806115|NCT01914757|448921649|FG000|Overall Study|Adverse Event|4|||
124806116|NCT01914757|448921650|FG001|Overall Study|Adverse Event|3|||
124806117|NCT01914757|448921651|FG002|Overall Study|Adverse Event|4|||
124806118|NCT01914757|448921649|FG000|Overall Study|Study specific withdrawal criteria|0|||
124806119|NCT01914757|448921650|FG001|Overall Study|Study specific withdrawal criteria|1|||
124806120|NCT01914757|448921651|FG002|Overall Study|Study specific withdrawal criteria|0|||
124806121|NCT01914757|448921649|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
124806122|NCT01914757|448921650|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
124806123|NCT01914757|448921651|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
124806124|NCT01914757|448921649|FG000|Overall Study|Other reasons|5|||
124806125|NCT01914757|448921650|FG001|Overall Study|Other reasons|9|||
124806126|NCT01914757|448921651|FG002|Overall Study|Other reasons|4|||
124806127|NCT02833350|448921658|FG000|Overall Study|Adverse Event|0|||
124806128|NCT02833350|448921659|FG001|Overall Study|Adverse Event|3|||
124806129|NCT02833350|448921660|FG002|Overall Study|Adverse Event|4|||
124806130|NCT02833350|448921661|FG003|Overall Study|Adverse Event|4|||
124806131|NCT02833350|448921662|FG004|Overall Study|Adverse Event|1|||
124806132|NCT02833350|448921663|FG005|Overall Study|Adverse Event|0|||
124806133|NCT02833350|448921664|FG006|Overall Study|Adverse Event|1|||
124806134|NCT02833350|448921658|FG000|Overall Study|Death|0|||
124806135|NCT02833350|448921659|FG001|Overall Study|Death|0|||
124806136|NCT02833350|448921660|FG002|Overall Study|Death|1|||
124806137|NCT02833350|448921661|FG003|Overall Study|Death|0|||
124806138|NCT02833350|448921662|FG004|Overall Study|Death|0|||
124806139|NCT02833350|448921663|FG005|Overall Study|Death|0|||
124806140|NCT02833350|448921664|FG006|Overall Study|Death|0|||
124806141|NCT02833350|448921658|FG000|Overall Study|Lack of Efficacy|0|||
124806142|NCT02833350|448921659|FG001|Overall Study|Lack of Efficacy|2|||
124806143|NCT02833350|448921660|FG002|Overall Study|Lack of Efficacy|1|||
124806144|NCT02833350|448921661|FG003|Overall Study|Lack of Efficacy|4|||
124806145|NCT02833350|448921662|FG004|Overall Study|Lack of Efficacy|0|||
124806146|NCT02833350|448921663|FG005|Overall Study|Lack of Efficacy|1|||
124806147|NCT02833350|448921664|FG006|Overall Study|Lack of Efficacy|1|||
124806148|NCT02833350|448921658|FG000|Overall Study|Lost to Follow-up|0|||
124806149|NCT02833350|448921659|FG001|Overall Study|Lost to Follow-up|1|||
124806150|NCT02833350|448921660|FG002|Overall Study|Lost to Follow-up|0|||
124806151|NCT02833350|448921661|FG003|Overall Study|Lost to Follow-up|0|||
125299849|NCT01147848|450723780|FG001|Randomized Phase|Protocol Violation|7|||
125299850|NCT01147848|450723781|FG002|Randomized Phase|Protocol Violation|10|||
125299851|NCT01147848|450723779|FG000|Randomized Phase|Lost to Follow-up|0|||
125299852|NCT01147848|450723780|FG001|Randomized Phase|Lost to Follow-up|5|||
125299853|NCT01147848|450723781|FG002|Randomized Phase|Lost to Follow-up|7|||
125299854|NCT01147848|450723779|FG000|Randomized Phase|Physician Decision|0|||
125299855|NCT01147848|450723780|FG001|Randomized Phase|Physician Decision|0|||
125299856|NCT01147848|450723781|FG002|Randomized Phase|Physician Decision|1|||
125299857|NCT01147848|450723779|FG000|Randomized Phase|Withdrawal by Subject|0|||
125299858|NCT01147848|450723780|FG001|Randomized Phase|Withdrawal by Subject|7|||
125299859|NCT01147848|450723781|FG002|Randomized Phase|Withdrawal by Subject|9|||
125299860|NCT03180307|450723782|FG000|Overall Study|Lost to Follow-up|2|||
125299861|NCT03180307|450723783|FG001|Overall Study|Lost to Follow-up|0|||
125299862|NCT03180307|450723782|FG000|Overall Study|Death|1|||
124806152|NCT02833350|448921662|FG004|Overall Study|Lost to Follow-up|0|||
124806153|NCT02833350|448921663|FG005|Overall Study|Lost to Follow-up|0|||
124806154|NCT02833350|448921664|FG006|Overall Study|Lost to Follow-up|1|||
124806155|NCT02833350|448921658|FG000|Overall Study|Withdrawal by Subject|3|||
124806156|NCT02833350|448921659|FG001|Overall Study|Withdrawal by Subject|3|||
124806157|NCT02833350|448921660|FG002|Overall Study|Withdrawal by Subject|2|||
124806158|NCT02833350|448921661|FG003|Overall Study|Withdrawal by Subject|0|||
124806159|NCT02833350|448921662|FG004|Overall Study|Withdrawal by Subject|2|||
124806160|NCT02833350|448921663|FG005|Overall Study|Withdrawal by Subject|0|||
124806161|NCT02833350|448921664|FG006|Overall Study|Withdrawal by Subject|2|||
124806162|NCT03342963|448921665|FG000|Overall Study|Adverse Event|1|||
124806163|NCT03342963|448921666|FG001|Overall Study|Adverse Event|2|||
124806164|NCT03342963|448921667|FG002|Overall Study|Adverse Event|0|||
124806165|NCT03342963|448921668|FG003|Overall Study|Adverse Event|0|||
124806166|NCT03342963|448921665|FG000|Overall Study|Withdrawal by Subject|1|||
124806167|NCT03342963|448921666|FG001|Overall Study|Withdrawal by Subject|0|||
124806168|NCT03342963|448921667|FG002|Overall Study|Withdrawal by Subject|0|||
124806169|NCT03342963|448921668|FG003|Overall Study|Withdrawal by Subject|0|||
124806170|NCT01189604|448921672|FG000|Overall Study|Impossible to visit|0|||
124806171|NCT01189604|448921673|FG001|Overall Study|Impossible to visit|0|||
124806172|NCT01189604|448921674|FG002|Overall Study|Impossible to visit|0|||
124806173|NCT01189604|448921675|FG003|Overall Study|Impossible to visit|0|||
125299863|NCT03180307|450723783|FG001|Overall Study|Death|0|||
125299864|NCT03180307|450723782|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
124806174|NCT01189604|448921676|FG004|Overall Study|Impossible to visit|0|||
124806175|NCT01189604|448921677|FG005|Overall Study|Impossible to visit|1|||
124806176|NCT01189604|448921678|FG006|Overall Study|Impossible to visit|0|||
124806177|NCT01189604|448921672|FG000|Overall Study|Adverse Event|0|||
124806178|NCT01189604|448921673|FG001|Overall Study|Adverse Event|1|||
124806179|NCT01189604|448921674|FG002|Overall Study|Adverse Event|0|||
124806180|NCT01189604|448921675|FG003|Overall Study|Adverse Event|0|||
124806181|NCT01189604|448921676|FG004|Overall Study|Adverse Event|2|||
124806182|NCT01189604|448921677|FG005|Overall Study|Adverse Event|0|||
124806183|NCT01189604|448921678|FG006|Overall Study|Adverse Event|1|||
124806184|NCT01189604|448921672|FG000|Overall Study|Withdrawal by Subject|1|||
124806185|NCT01189604|448921673|FG001|Overall Study|Withdrawal by Subject|0|||
124806186|NCT01189604|448921674|FG002|Overall Study|Withdrawal by Subject|0|||
124806187|NCT01189604|448921675|FG003|Overall Study|Withdrawal by Subject|0|||
124806188|NCT01189604|448921676|FG004|Overall Study|Withdrawal by Subject|0|||
124806189|NCT01189604|448921677|FG005|Overall Study|Withdrawal by Subject|0|||
124806190|NCT01189604|448921678|FG006|Overall Study|Withdrawal by Subject|0|||
124806191|NCT03626168|448921679|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
124806192|NCT03626168|448921680|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
124806193|NCT03626168|448921679|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
124806194|NCT03626168|448921680|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
124806195|NCT03626168|448921679|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
124806196|NCT03626168|448921680|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
124806197|NCT02248701|448921681|FG000|Overall Study|Withdrawal by Subject|2|||
124806198|NCT02248701|448921682|FG001|Overall Study|Withdrawal by Subject|1|||
124806199|NCT02248701|448921681|FG000|Overall Study|Physician Decision|0|||
124806200|NCT02248701|448921682|FG001|Overall Study|Physician Decision|1|||
124806201|NCT02248701|448921681|FG000|Overall Study|Adverse Event|1|||
124806202|NCT02248701|448921682|FG001|Overall Study|Adverse Event|0|||
124806203|NCT02248701|448921681|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
124806204|NCT02248701|448921682|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
124806205|NCT00808483|448921683|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
124806206|NCT00808483|448921684|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
124806207|NCT00808483|448921683|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
124806208|NCT00808483|448921684|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
124806209|NCT00808483|448921683|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
124806210|NCT00808483|448921684|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
124806211|NCT02038881|448921685|FG000|Overall Study|Withdrawal by Subject|0|||
124806212|NCT02038881|448921686|FG001|Overall Study|Withdrawal by Subject|0|||
124806213|NCT02038881|448921687|FG002|Overall Study|Withdrawal by Subject|1|||
124806214|NCT02038881|448921685|FG000|Overall Study|Lost to Follow-up|2|||
124806215|NCT02038881|448921686|FG001|Overall Study|Lost to Follow-up|0|||
124806216|NCT02038881|448921687|FG002|Overall Study|Lost to Follow-up|0|||
124806217|NCT02038881|448921685|FG000|Overall Study|incarcerated|1|||
124806218|NCT02038881|448921686|FG001|Overall Study|incarcerated|0|||
124806219|NCT02038881|448921687|FG002|Overall Study|incarcerated|0|||
124806220|NCT02357979|448921688|FG000|Overall Study|Lost to Follow-up|5|||
124806221|NCT02357979|448921689|FG001|Overall Study|Lost to Follow-up|5|||
124806222|NCT03945214|448921690|FG000|Overall Study|Lost to Follow-up|3|||
124806223|NCT03945214|448921691|FG001|Overall Study|Lost to Follow-up|4|||
124806224|NCT03945214|448921692|FG002|Overall Study|Lost to Follow-up|7|||
124806225|NCT03945214|448921693|FG003|Overall Study|Lost to Follow-up|4|||
124806226|NCT00880542|448921694|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
124806227|NCT00880542|448921694|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
124806228|NCT00880542|448921694|FG000|REP: Surgical Resection|progressive disease|1|||
124806229|NCT00850070|448921695|FG000|Overall Study|Lack of Efficacy|1|||
124806230|NCT00850070|448921696|FG001|Overall Study|Lack of Efficacy|1|||
124806231|NCT00850070|448921695|FG000|Overall Study|Adverse Event|2|||
124806232|NCT00850070|448921696|FG001|Overall Study|Adverse Event|0|||
124806233|NCT05047770|448921697|FG000|Overall Study|Withdrawal by Subject|15|||
124806234|NCT05047770|448921698|FG001|Overall Study|Withdrawal by Subject|10|||
124806235|NCT05047770|448921699|FG002|Overall Study|Withdrawal by Subject|6|||
124806236|NCT05047770|448921700|FG003|Overall Study|Withdrawal by Subject|12|||
124806237|NCT05047770|448921697|FG000|Overall Study|Lost to Follow-up|7|||
124806238|NCT05047770|448921698|FG001|Overall Study|Lost to Follow-up|5|||
124806239|NCT05047770|448921699|FG002|Overall Study|Lost to Follow-up|12|||
124806240|NCT05047770|448921700|FG003|Overall Study|Lost to Follow-up|13|||
124806241|NCT05047770|448921697|FG000|Overall Study|Other|1|||
124806242|NCT05047770|448921698|FG001|Overall Study|Other|0|||
124806243|NCT05047770|448921699|FG002|Overall Study|Other|1|||
124806244|NCT05047770|448921700|FG003|Overall Study|Other|0|||
124806245|NCT04289623|448921703|FG000|Wave 1 Emails|Email was not delivered|268|||
124806246|NCT04289623|448921704|FG001|Wave 1 Emails|Email was not delivered|257|||
124806247|NCT04289623|448921705|FG002|Wave 1 Emails|Email was not delivered|0|||
124806248|NCT04289623|448921706|FG003|Wave 1 Emails|Email was not delivered|0|||
124806249|NCT04289623|448921707|FG004|Wave 1 Emails|Email was not delivered|0|||
124806250|NCT04289623|448921708|FG005|Wave 1 Emails|Email was not delivered|0|||
124806251|NCT03758443|448921709|FG000|Induction Period|Adverse Event|2|||
124806252|NCT03758443|448921710|FG001|Induction Period|Adverse Event|4|||
124806253|NCT03758443|448921711|FG002|Induction Period|Adverse Event|2|||
124806254|NCT03758443|448921712|FG003|Induction Period|Adverse Event|3|||
124806255|NCT03758443|448921709|FG000|Induction Period|Physician Decision|1|||
124806256|NCT03758443|448921710|FG001|Induction Period|Physician Decision|1|||
124806257|NCT03758443|448921711|FG002|Induction Period|Physician Decision|3|||
124806258|NCT03758443|448921712|FG003|Induction Period|Physician Decision|0|||
124806259|NCT03758443|448921709|FG000|Induction Period|Protocol Violation|0|||
124806260|NCT03758443|448921710|FG001|Induction Period|Protocol Violation|0|||
124806261|NCT03758443|448921711|FG002|Induction Period|Protocol Violation|0|||
124806262|NCT03758443|448921712|FG003|Induction Period|Protocol Violation|1|||
124806263|NCT03758443|448921709|FG000|Induction Period|Withdrawal by Subject|3|||
124806264|NCT03758443|448921710|FG001|Induction Period|Withdrawal by Subject|2|||
124806265|NCT03758443|448921711|FG002|Induction Period|Withdrawal by Subject|2|||
124806266|NCT03758443|448921712|FG003|Induction Period|Withdrawal by Subject|4|||
124806267|NCT03758443|448921709|FG000|Extended Induction Period|Adverse Event|1|||
124806268|NCT03758443|448921710|FG001|Extended Induction Period|Adverse Event|1|||
124806269|NCT03758443|448921711|FG002|Extended Induction Period|Adverse Event|0|||
124806270|NCT03758443|448921712|FG003|Extended Induction Period|Adverse Event|1|||
124806271|NCT03758443|448921709|FG000|Extended Induction Period|Lost to Follow-up|1|||
124806272|NCT03758443|448921710|FG001|Extended Induction Period|Lost to Follow-up|0|||
124806273|NCT03758443|448921711|FG002|Extended Induction Period|Lost to Follow-up|0|||
124806274|NCT03758443|448921712|FG003|Extended Induction Period|Lost to Follow-up|0|||
124806275|NCT03758443|448921709|FG000|Extended Induction Period|Physician Decision|2|||
124806276|NCT03758443|448921710|FG001|Extended Induction Period|Physician Decision|1|||
124806277|NCT03758443|448921711|FG002|Extended Induction Period|Physician Decision|2|||
124806278|NCT03758443|448921712|FG003|Extended Induction Period|Physician Decision|2|||
124806279|NCT03758443|448921709|FG000|Extended Induction Period|Protocol Violation|0|||
124806280|NCT03758443|448921710|FG001|Extended Induction Period|Protocol Violation|0|||
124806281|NCT03758443|448921711|FG002|Extended Induction Period|Protocol Violation|0|||
124806282|NCT03758443|448921712|FG003|Extended Induction Period|Protocol Violation|1|||
124806283|NCT03758443|448921709|FG000|Extended Induction Period|Withdrawal by Subject|8|||
124806284|NCT03758443|448921710|FG001|Extended Induction Period|Withdrawal by Subject|1|||
124806285|NCT03758443|448921711|FG002|Extended Induction Period|Withdrawal by Subject|7|||
124806286|NCT03758443|448921712|FG003|Extended Induction Period|Withdrawal by Subject|3|||
124806287|NCT03758443|448921709|FG000|Extended Induction Period|Miscellaneous|1|||
124806288|NCT03758443|448921710|FG001|Extended Induction Period|Miscellaneous|0|||
124806289|NCT03758443|448921711|FG002|Extended Induction Period|Miscellaneous|0|||
124806290|NCT03758443|448921712|FG003|Extended Induction Period|Miscellaneous|0|||
124806291|NCT03758443|448921709|FG000|Maintenance Period|Adverse Event|1|||
124806292|NCT03758443|448921710|FG001|Maintenance Period|Adverse Event|2|||
124806293|NCT03758443|448921711|FG002|Maintenance Period|Adverse Event|0|||
124806294|NCT03758443|448921712|FG003|Maintenance Period|Adverse Event|0|||
124806295|NCT03758443|448921709|FG000|Maintenance Period|Lost to Follow-up|0|||
124806296|NCT03758443|448921710|FG001|Maintenance Period|Lost to Follow-up|0|||
124806297|NCT03758443|448921711|FG002|Maintenance Period|Lost to Follow-up|0|||
124806298|NCT03758443|448921712|FG003|Maintenance Period|Lost to Follow-up|1|||
124806299|NCT03758443|448921709|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
124806300|NCT03758443|448921710|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
124806301|NCT03758443|448921711|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
124806302|NCT03758443|448921712|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
124806303|NCT03758443|448921709|FG000|Maintenance Period|Protocol Violation|0|||
124806304|NCT03758443|448921710|FG001|Maintenance Period|Protocol Violation|1|||
124806305|NCT03758443|448921711|FG002|Maintenance Period|Protocol Violation|0|||
124806306|NCT03758443|448921712|FG003|Maintenance Period|Protocol Violation|0|||
124806307|NCT03758443|448921709|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
124806308|NCT03758443|448921710|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
124806309|NCT03758443|448921711|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
124806310|NCT03758443|448921712|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
124806311|NCT03758443|448921709|FG000|Maintenance Period|Withdrawal by Subject|1|||
124806312|NCT03758443|448921710|FG001|Maintenance Period|Withdrawal by Subject|0|||
124806313|NCT03758443|448921711|FG002|Maintenance Period|Withdrawal by Subject|1|||
124806314|NCT03758443|448921712|FG003|Maintenance Period|Withdrawal by Subject|1|||
124806315|NCT03758443|448921709|FG000|Maintenance Period|Miscellaneous|0|||
124806316|NCT03758443|448921710|FG001|Maintenance Period|Miscellaneous|0|||
124806317|NCT03758443|448921711|FG002|Maintenance Period|Miscellaneous|1|||
124806318|NCT03758443|448921712|FG003|Maintenance Period|Miscellaneous|0|||
124806319|NCT01436396|448921713|FG000|Overall Study|Protocol Violation|7|||
124806320|NCT01436396|448921714|FG001|Overall Study|Protocol Violation|5|||
124806321|NCT01436396|448921713|FG000|Overall Study|Adverse Event|1|||
124806322|NCT01436396|448921714|FG001|Overall Study|Adverse Event|2|||
124806323|NCT01436396|448921713|FG000|Overall Study|Withdrawal by Subject|19|||
124806324|NCT01436396|448921714|FG001|Overall Study|Withdrawal by Subject|29|||
124806325|NCT01436396|448921713|FG000|Overall Study|Serious adverse event|2|||
124806326|NCT01436396|448921714|FG001|Overall Study|Serious adverse event|3|||
124806327|NCT01436396|448921713|FG000|Overall Study|Lost to Follow-up|3|||
124806328|NCT01436396|448921714|FG001|Overall Study|Lost to Follow-up|3|||
124806329|NCT01772160|448921718|FG000|Overall Study|Death|3|||
124806330|NCT01772160|448921718|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
124806331|NCT01772160|448921718|FG000|Overall Study|Consent withdrawal|3|||
124806332|NCT01772160|448921718|FG000|Overall Study|Migrated / moved from the study area|4|||
124806333|NCT01772160|448921718|FG000|Overall Study|Lost to Follow-up|30|||
124806334|NCT01772160|448921718|FG000|Overall Study|Other|5|||
124806335|NCT01522248|448921719|FG000|Overall Study|Lost to Follow-up|1|||
124806336|NCT01522248|448921720|FG001|Overall Study|Lost to Follow-up|0|||
124806337|NCT00178633|448921722|FG000|Overall Study|Lost to Follow-up|6|||
124806338|NCT00538291|448921723|FG000|Overall Study|Adverse Event|2|||
124806339|NCT00538291|448921723|FG000|Overall Study|Withdrawal by Subject|1|||
124806340|NCT00591344|448921724|FG000|Overall Study|Transportation issues|1|||
124806341|NCT00591344|448921725|FG001|Overall Study|Transportation issues|0|||
124806342|NCT00591344|448921724|FG000|Overall Study|Moved out of state|1|||
124806343|NCT00591344|448921725|FG001|Overall Study|Moved out of state|0|||
124806344|NCT00591344|448921724|FG000|Overall Study|Medical complications|1|||
124806345|NCT00591344|448921725|FG001|Overall Study|Medical complications|3|||
124806346|NCT00591344|448921724|FG000|Overall Study|Underwent DBS|2|||
124806347|NCT00591344|448921725|FG001|Overall Study|Underwent DBS|2|||
124806348|NCT00591344|448921724|FG000|Overall Study|Death|0|||
124806349|NCT00591344|448921725|FG001|Overall Study|Death|1|||
124806350|NCT00591344|448921724|FG000|Overall Study|Lost to Follow-up|0|||
124806351|NCT00591344|448921725|FG001|Overall Study|Lost to Follow-up|1|||
124806352|NCT00591344|448921724|FG000|Overall Study|Did not want to come off medication|0|||
124806353|NCT00591344|448921725|FG001|Overall Study|Did not want to come off medication|1|||
124806354|NCT00694707|448921726|FG000|Overall Study|Did Not Receive Treatment|0|||
124806355|NCT00694707|448921727|FG001|Overall Study|Did Not Receive Treatment|0|||
124806356|NCT00694707|448921728|FG002|Overall Study|Did Not Receive Treatment|1|||
124806357|NCT00694707|448921729|FG003|Overall Study|Did Not Receive Treatment|1|||
124806358|NCT00694707|448921730|FG004|Overall Study|Did Not Receive Treatment|1|||
124806359|NCT00694707|448921726|FG000|Overall Study|Adverse Event|22|||
124806360|NCT00694707|448921727|FG001|Overall Study|Adverse Event|14|||
124806361|NCT00694707|448921728|FG002|Overall Study|Adverse Event|8|||
124806362|NCT00694707|448921729|FG003|Overall Study|Adverse Event|12|||
124806363|NCT00694707|448921730|FG004|Overall Study|Adverse Event|13|||
124806364|NCT00694707|448921726|FG000|Overall Study|Insufficient Therapeutic Response|33|||
124806365|NCT00694707|448921727|FG001|Overall Study|Insufficient Therapeutic Response|18|||
124806366|NCT00694707|448921728|FG002|Overall Study|Insufficient Therapeutic Response|17|||
124806367|NCT00694707|448921729|FG003|Overall Study|Insufficient Therapeutic Response|15|||
124806368|NCT00694707|448921730|FG004|Overall Study|Insufficient Therapeutic Response|10|||
124806369|NCT00694707|448921726|FG000|Overall Study|Protocol Violation|1|||
124806370|NCT00694707|448921727|FG001|Overall Study|Protocol Violation|2|||
124806371|NCT00694707|448921728|FG002|Overall Study|Protocol Violation|1|||
124806372|NCT00694707|448921729|FG003|Overall Study|Protocol Violation|3|||
124806373|NCT00694707|448921730|FG004|Overall Study|Protocol Violation|1|||
124806374|NCT00694707|448921726|FG000|Overall Study|Withdrawal of Consent|14|||
124806375|NCT00694707|448921727|FG001|Overall Study|Withdrawal of Consent|18|||
124806376|NCT00694707|448921728|FG002|Overall Study|Withdrawal of Consent|22|||
124806377|NCT00694707|448921729|FG003|Overall Study|Withdrawal of Consent|16|||
124806378|NCT00694707|448921730|FG004|Overall Study|Withdrawal of Consent|15|||
124806379|NCT00694707|448921726|FG000|Overall Study|Lost to Follow-up|0|||
124806380|NCT00694707|448921727|FG001|Overall Study|Lost to Follow-up|1|||
124806381|NCT00694707|448921728|FG002|Overall Study|Lost to Follow-up|2|||
124806382|NCT00694707|448921729|FG003|Overall Study|Lost to Follow-up|0|||
124806383|NCT00694707|448921730|FG004|Overall Study|Lost to Follow-up|0|||
124806384|NCT00694707|448921726|FG000|Overall Study|Jeopardizing Parole Status|1|||
124806385|NCT00694707|448921727|FG001|Overall Study|Jeopardizing Parole Status|0|||
125299865|NCT03180307|450723783|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
125299866|NCT04349033|450723785|FG000|Overall Study|Lost to Follow-up|3|||
125299867|NCT04349033|450723786|FG001|Overall Study|Lost to Follow-up|1|||
124806386|NCT00694707|448921728|FG002|Overall Study|Jeopardizing Parole Status|0|||
124806387|NCT00694707|448921729|FG003|Overall Study|Jeopardizing Parole Status|0|||
124806388|NCT00694707|448921730|FG004|Overall Study|Jeopardizing Parole Status|0|||
124806389|NCT00694707|448921726|FG000|Overall Study|Death in the Family|1|||
124806390|NCT00694707|448921727|FG001|Overall Study|Death in the Family|0|||
124806391|NCT00694707|448921728|FG002|Overall Study|Death in the Family|0|||
124806392|NCT00694707|448921729|FG003|Overall Study|Death in the Family|0|||
124806393|NCT00694707|448921730|FG004|Overall Study|Death in the Family|0|||
124806394|NCT00694707|448921726|FG000|Overall Study|Arrest by Police|0|||
124806395|NCT00694707|448921727|FG001|Overall Study|Arrest by Police|1|||
124806396|NCT00694707|448921728|FG002|Overall Study|Arrest by Police|0|||
125299868|NCT04349033|450723787|FG002|Overall Study|Lost to Follow-up|1|||
124806397|NCT00694707|448921729|FG003|Overall Study|Arrest by Police|0|||
124806398|NCT00694707|448921730|FG004|Overall Study|Arrest by Police|0|||
124806399|NCT00694707|448921726|FG000|Overall Study|Administrative Reasons|0|||
124806400|NCT00694707|448921727|FG001|Overall Study|Administrative Reasons|1|||
124806401|NCT00694707|448921728|FG002|Overall Study|Administrative Reasons|0|||
124806402|NCT00694707|448921729|FG003|Overall Study|Administrative Reasons|2|||
124806403|NCT00694707|448921730|FG004|Overall Study|Administrative Reasons|0|||
124806404|NCT00694707|448921726|FG000|Overall Study|Notification of Past Head Injury|0|||
124806405|NCT00694707|448921727|FG001|Overall Study|Notification of Past Head Injury|0|||
124806406|NCT00694707|448921728|FG002|Overall Study|Notification of Past Head Injury|0|||
124806407|NCT00694707|448921729|FG003|Overall Study|Notification of Past Head Injury|1|||
124806408|NCT00694707|448921730|FG004|Overall Study|Notification of Past Head Injury|0|||
124806409|NCT01904058|448921738|FG000|Overall Study|Adverse Event|2|||
124806410|NCT01904058|448921739|FG001|Overall Study|Adverse Event|0|||
124806411|NCT01904058|448921740|FG002|Overall Study|Adverse Event|0|||
124806412|NCT01904058|448921741|FG003|Overall Study|Adverse Event|0|||
124806413|NCT01904058|448921738|FG000|Overall Study|Withdrawal by Subject|1|||
124806414|NCT01904058|448921739|FG001|Overall Study|Withdrawal by Subject|0|||
124806415|NCT01904058|448921740|FG002|Overall Study|Withdrawal by Subject|1|||
124806416|NCT01904058|448921741|FG003|Overall Study|Withdrawal by Subject|0|||
124806417|NCT01904058|448921738|FG000|Overall Study|Pregnancy|0|||
124806418|NCT01904058|448921739|FG001|Overall Study|Pregnancy|0|||
124806419|NCT01904058|448921740|FG002|Overall Study|Pregnancy|0|||
124806420|NCT01904058|448921741|FG003|Overall Study|Pregnancy|1|||
124806421|NCT03096483|448921743|FG000|Overall Study|Withdrawal by site|1|||
124806422|NCT01024231|448921749|FG000|Overall Study|Other Reasons|1|||
124806423|NCT01024231|448921750|FG001|Overall Study|Other Reasons|2|||
124806424|NCT01024231|448921751|FG002|Overall Study|Other Reasons|0|||
124806425|NCT01024231|448921752|FG003|Overall Study|Other Reasons|0|||
124806426|NCT01024231|448921753|FG004|Overall Study|Other Reasons|2|||
124806427|NCT01024231|448921754|FG005|Overall Study|Other Reasons|0|||
124806428|NCT01024231|448921755|FG006|Overall Study|Other Reasons|1|||
124806429|NCT01024231|448921749|FG000|Overall Study|Maximum Clinical Benefit|1|||
124806430|NCT01024231|448921750|FG001|Overall Study|Maximum Clinical Benefit|2|||
124806431|NCT01024231|448921751|FG002|Overall Study|Maximum Clinical Benefit|0|||
124806432|NCT01024231|448921752|FG003|Overall Study|Maximum Clinical Benefit|1|||
124806433|NCT01024231|448921753|FG004|Overall Study|Maximum Clinical Benefit|1|||
124806434|NCT01024231|448921754|FG005|Overall Study|Maximum Clinical Benefit|0|||
124806435|NCT01024231|448921755|FG006|Overall Study|Maximum Clinical Benefit|0|||
124806436|NCT01024231|448921749|FG000|Overall Study|Disease Progression|3|||
124806437|NCT01024231|448921750|FG001|Overall Study|Disease Progression|1|||
124806438|NCT01024231|448921751|FG002|Overall Study|Disease Progression|3|||
124806439|NCT01024231|448921752|FG003|Overall Study|Disease Progression|0|||
124806440|NCT01024231|448921753|FG004|Overall Study|Disease Progression|4|||
124806441|NCT01024231|448921754|FG005|Overall Study|Disease Progression|11|||
124806442|NCT01024231|448921755|FG006|Overall Study|Disease Progression|6|||
124806443|NCT01024231|448921749|FG000|Overall Study|AE unrelated to Study Drug|0|||
124806444|NCT01024231|448921750|FG001|Overall Study|AE unrelated to Study Drug|1|||
124806445|NCT01024231|448921751|FG002|Overall Study|AE unrelated to Study Drug|0|||
124806446|NCT01024231|448921752|FG003|Overall Study|AE unrelated to Study Drug|0|||
124806447|NCT01024231|448921753|FG004|Overall Study|AE unrelated to Study Drug|0|||
124806448|NCT01024231|448921754|FG005|Overall Study|AE unrelated to Study Drug|0|||
124806449|NCT01024231|448921755|FG006|Overall Study|AE unrelated to Study Drug|0|||
124806450|NCT01024231|448921749|FG000|Overall Study|No longer meets criteria|0|||
124806451|NCT01024231|448921750|FG001|Overall Study|No longer meets criteria|0|||
124806452|NCT01024231|448921751|FG002|Overall Study|No longer meets criteria|0|||
124806453|NCT01024231|448921752|FG003|Overall Study|No longer meets criteria|0|||
124806454|NCT01024231|448921753|FG004|Overall Study|No longer meets criteria|1|||
124806455|NCT01024231|448921754|FG005|Overall Study|No longer meets criteria|0|||
124806456|NCT01024231|448921755|FG006|Overall Study|No longer meets criteria|1|||
124806457|NCT01024231|448921749|FG000|Overall Study|Study Drug Toxicity|1|||
124806458|NCT01024231|448921750|FG001|Overall Study|Study Drug Toxicity|6|||
124806459|NCT01024231|448921751|FG002|Overall Study|Study Drug Toxicity|6|||
124806460|NCT01024231|448921752|FG003|Overall Study|Study Drug Toxicity|4|||
124806461|NCT01024231|448921753|FG004|Overall Study|Study Drug Toxicity|2|||
124806462|NCT01024231|448921754|FG005|Overall Study|Study Drug Toxicity|0|||
124806463|NCT01024231|448921755|FG006|Overall Study|Study Drug Toxicity|7|||
124806464|NCT01024231|448921749|FG000|Overall Study|Death|6|||
124806465|NCT01024231|448921750|FG001|Overall Study|Death|2|||
124806466|NCT01024231|448921751|FG002|Overall Study|Death|1|||
124806467|NCT01024231|448921752|FG003|Overall Study|Death|0|||
124806468|NCT01024231|448921753|FG004|Overall Study|Death|4|||
124806469|NCT01024231|448921754|FG005|Overall Study|Death|3|||
124806470|NCT01024231|448921755|FG006|Overall Study|Death|5|||
124806471|NCT01024231|448921749|FG000|Overall Study|Lost to Follow-up|0|||
124806472|NCT01024231|448921750|FG001|Overall Study|Lost to Follow-up|0|||
124806473|NCT01024231|448921751|FG002|Overall Study|Lost to Follow-up|0|||
124806474|NCT01024231|448921752|FG003|Overall Study|Lost to Follow-up|0|||
124806475|NCT01024231|448921753|FG004|Overall Study|Lost to Follow-up|0|||
124806476|NCT01024231|448921754|FG005|Overall Study|Lost to Follow-up|0|||
124806477|NCT01024231|448921755|FG006|Overall Study|Lost to Follow-up|1|||
124806478|NCT01024231|448921749|FG000|Overall Study|Withdrew Consent|0|||
124806479|NCT01024231|448921750|FG001|Overall Study|Withdrew Consent|1|||
124806480|NCT01024231|448921751|FG002|Overall Study|Withdrew Consent|0|||
124806481|NCT01024231|448921752|FG003|Overall Study|Withdrew Consent|0|||
124806482|NCT01024231|448921753|FG004|Overall Study|Withdrew Consent|0|||
124806483|NCT01024231|448921754|FG005|Overall Study|Withdrew Consent|0|||
124806484|NCT01024231|448921755|FG006|Overall Study|Withdrew Consent|0|||
124806485|NCT01024231|448921749|FG000|Overall Study|Continuing on Treatment|0|||
124806486|NCT01024231|448921750|FG001|Overall Study|Continuing on Treatment|0|||
124806487|NCT01024231|448921751|FG002|Overall Study|Continuing on Treatment|0|||
124806488|NCT01024231|448921752|FG003|Overall Study|Continuing on Treatment|0|||
124806489|NCT01024231|448921753|FG004|Overall Study|Continuing on Treatment|3|||
124806490|NCT01024231|448921754|FG005|Overall Study|Continuing on Treatment|2|||
124806491|NCT01024231|448921755|FG006|Overall Study|Continuing on Treatment|0|||
124806492|NCT00973674|448921759|FG000|Overall Study|Protocol Violation|2|||
124806493|NCT00973674|448921760|FG001|Overall Study|Protocol Violation|0|||
124806494|NCT02713204|448921761|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
124806495|NCT02713204|448921762|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
124806496|NCT02713204|448921763|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
124806497|NCT02713204|448921764|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
124806498|NCT02713204|448921765|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
124806499|NCT02713204|448921766|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
124806500|NCT02713204|448921767|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
124806501|NCT02713204|448921768|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
124806502|NCT02713204|448921761|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
124806503|NCT02713204|448921762|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
124806504|NCT02713204|448921763|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
124806505|NCT02713204|448921764|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
124806506|NCT02713204|448921765|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
124806507|NCT02713204|448921766|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
124806508|NCT02713204|448921767|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
124806509|NCT02713204|448921768|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
124806510|NCT02713204|448921761|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
124806511|NCT02713204|448921762|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
124806512|NCT02713204|448921763|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
124806513|NCT02713204|448921764|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
124806514|NCT02713204|448921765|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
124806515|NCT02713204|448921766|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
124806516|NCT02713204|448921767|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
124806517|NCT02713204|448921768|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
124806518|NCT02713204|448921761|FG000|From Week 12 up to Week 36|Adverse Event|1|||
124806519|NCT02713204|448921762|FG001|From Week 12 up to Week 36|Adverse Event|0|||
124806520|NCT02713204|448921763|FG002|From Week 12 up to Week 36|Adverse Event|0|||
124806521|NCT02713204|448921764|FG003|From Week 12 up to Week 36|Adverse Event|1|||
124806522|NCT02713204|448921765|FG004|From Week 12 up to Week 36|Adverse Event|1|||
124806523|NCT02713204|448921766|FG005|From Week 12 up to Week 36|Adverse Event|0|||
124806524|NCT02713204|448921767|FG006|From Week 12 up to Week 36|Adverse Event|2|||
124806525|NCT02713204|448921768|FG007|From Week 12 up to Week 36|Adverse Event|1|||
124806526|NCT02713204|448921761|FG000|From Week 12 up to Week 36|Death|0|||
124806527|NCT02713204|448921762|FG001|From Week 12 up to Week 36|Death|0|||
124806528|NCT02713204|448921763|FG002|From Week 12 up to Week 36|Death|0|||
124806529|NCT02713204|448921764|FG003|From Week 12 up to Week 36|Death|1|||
124806530|NCT02713204|448921765|FG004|From Week 12 up to Week 36|Death|0|||
124806531|NCT02713204|448921766|FG005|From Week 12 up to Week 36|Death|1|||
124806532|NCT02713204|448921767|FG006|From Week 12 up to Week 36|Death|0|||
124806533|NCT02713204|448921768|FG007|From Week 12 up to Week 36|Death|3|||
124806534|NCT02713204|448921761|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
125299869|NCT03596450|450723788|FG000|Overall Study|Death|9|||
125299870|NCT03596450|450723789|FG001|Overall Study|Death|9|||
125299871|NCT03596450|450723788|FG000|Overall Study|Protocol Violation|18|||
125299872|NCT03596450|450723789|FG001|Overall Study|Protocol Violation|26|||
125299873|NCT03596450|450723788|FG000|Overall Study|Lost to Follow-up|50|||
125299874|NCT03596450|450723789|FG001|Overall Study|Lost to Follow-up|56|||
124806535|NCT02713204|448921762|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
124806536|NCT02713204|448921763|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
124806537|NCT02713204|448921764|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
124806538|NCT02713204|448921765|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
124806539|NCT02713204|448921766|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
124806540|NCT02713204|448921767|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
124806541|NCT02713204|448921768|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
124806542|NCT02713204|448921761|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
125299875|NCT03596450|450723788|FG000|Overall Study|Adverse Event|14|||
124806543|NCT02713204|448921762|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
124806544|NCT02713204|448921763|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
124806545|NCT02713204|448921764|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
124806546|NCT02713204|448921765|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
124806547|NCT02713204|448921766|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
124806548|NCT02713204|448921767|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
124806549|NCT02713204|448921768|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
124806550|NCT01710046|448921770|FG000|Overall Study|Lost to Follow-up|1|||
124806551|NCT01710046|448921771|FG001|Overall Study|Lost to Follow-up|0|||
125299876|NCT03596450|450723789|FG001|Overall Study|Adverse Event|7|||
125299877|NCT03596450|450723788|FG000|Overall Study|Withdrawal by Subject|38|||
125299878|NCT03596450|450723789|FG001|Overall Study|Withdrawal by Subject|36|||
124806552|NCT03896165|448921772|FG000|Overall Study|Withdrawal by Subject|2|||
124806553|NCT03181893|448921773|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
124806554|NCT03181893|448921774|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
124806555|NCT03181893|448921775|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
124806556|NCT03181893|448921776|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
124806557|NCT03181893|448921777|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
124806558|NCT03181893|448921778|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
124806559|NCT03181893|448921779|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
124806560|NCT03181893|448921780|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
124806561|NCT03181893|448921781|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
124806562|NCT03181893|448921782|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
124806563|NCT03181893|448921783|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
124806564|NCT03181893|448921773|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
124806565|NCT03181893|448921774|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
124806566|NCT03181893|448921775|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
124806567|NCT03181893|448921776|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
124806568|NCT03181893|448921777|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
124806569|NCT03181893|448921778|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
124806570|NCT03181893|448921779|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
124806571|NCT03181893|448921780|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
124806572|NCT03181893|448921781|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
124806573|NCT03181893|448921782|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
124806574|NCT03181893|448921783|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
124806575|NCT03181893|448921773|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
124806576|NCT03181893|448921774|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
124806577|NCT03181893|448921775|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
124806578|NCT03181893|448921776|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
124806579|NCT03181893|448921777|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
124806580|NCT03181893|448921778|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
124806581|NCT03181893|448921779|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
124806582|NCT03181893|448921780|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
124806583|NCT03181893|448921781|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
124806584|NCT03181893|448921782|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
124806585|NCT03181893|448921783|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
124806586|NCT03181893|448921773|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
124806587|NCT03181893|448921774|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
124806588|NCT03181893|448921775|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
124806589|NCT03181893|448921776|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
124806590|NCT03181893|448921777|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
124806591|NCT03181893|448921778|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
124806592|NCT03181893|448921779|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
124806593|NCT03181893|448921780|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
124806594|NCT03181893|448921781|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
124806595|NCT03181893|448921782|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
124806596|NCT03181893|448921783|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
124806597|NCT03181893|448921773|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
124806598|NCT03181893|448921774|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
124806599|NCT03181893|448921775|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
124806600|NCT03181893|448921776|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
124806601|NCT03181893|448921777|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
124806602|NCT03181893|448921778|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
124806603|NCT03181893|448921779|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
124806604|NCT03181893|448921780|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
124806605|NCT03181893|448921781|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
124806606|NCT03181893|448921782|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
125299879|NCT03596450|450723788|FG000|Overall Study|Accidentally Randomized|2|||
124806607|NCT03181893|448921783|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
124806608|NCT03000569|448921784|FG000|Overall Study|Withdrawal by Subject|1|||
124806609|NCT03000569|448921785|FG001|Overall Study|Withdrawal by Subject|0|||
124806610|NCT04815031|448921786|FG000|Overall Study|No adverse event information (missing information)|33|||
124806611|NCT04122534|448921787|FG000|Overall Study|Lost to Follow-up|4|||
124806612|NCT01254630|448921791|FG000|Overall Study|Adverse Event|36|||
124806613|NCT01254630|448921792|FG001|Overall Study|Adverse Event|15|||
124806614|NCT01254630|448921793|FG002|Overall Study|Adverse Event|40|||
124806615|NCT01254630|448921794|FG003|Overall Study|Adverse Event|8|||
124806616|NCT01254630|448921791|FG000|Overall Study|Death|461|||
124806617|NCT01254630|448921792|FG001|Overall Study|Death|151|||
124806618|NCT01254630|448921793|FG002|Overall Study|Death|478|||
124806619|NCT01254630|448921794|FG003|Overall Study|Death|139|||
124806620|NCT01254630|448921791|FG000|Overall Study|Lost to Follow-up|80|||
124806621|NCT01254630|448921792|FG001|Overall Study|Lost to Follow-up|26|||
124806622|NCT01254630|448921793|FG002|Overall Study|Lost to Follow-up|89|||
124806623|NCT01254630|448921794|FG003|Overall Study|Lost to Follow-up|32|||
124806624|NCT01254630|448921791|FG000|Overall Study|Physician Decision|24|||
124806625|NCT01254630|448921792|FG001|Overall Study|Physician Decision|8|||
124806626|NCT01254630|448921793|FG002|Overall Study|Physician Decision|16|||
124806627|NCT01254630|448921794|FG003|Overall Study|Physician Decision|7|||
124806628|NCT01254630|448921791|FG000|Overall Study|Withdrawal by Subject|201|||
124806629|NCT01254630|448921792|FG001|Overall Study|Withdrawal by Subject|94|||
124806630|NCT01254630|448921793|FG002|Overall Study|Withdrawal by Subject|188|||
124806631|NCT01254630|448921794|FG003|Overall Study|Withdrawal by Subject|89|||
124806632|NCT01254630|448921791|FG000|Overall Study|Study terminated by sponsor|0|||
124806633|NCT01254630|448921792|FG001|Overall Study|Study terminated by sponsor|994|||
124806634|NCT01254630|448921793|FG002|Overall Study|Study terminated by sponsor|0|||
124806635|NCT01254630|448921794|FG003|Overall Study|Study terminated by sponsor|1010|||
124806636|NCT01254630|448921791|FG000|Overall Study|Status not recorded|0|||
124806637|NCT01254630|448921792|FG001|Overall Study|Status not recorded|0|||
124806638|NCT01254630|448921793|FG002|Overall Study|Status not recorded|1|||
124806639|NCT01254630|448921794|FG003|Overall Study|Status not recorded|0|||
124806640|NCT02020577|448921795|FG000|Overall Study|Progressive disease|3|||
124806641|NCT02020577|448921796|FG001|Overall Study|Progressive disease|38|||
124806642|NCT02020577|448921795|FG000|Overall Study|Other AE or clinical progression|0|||
124806643|NCT02020577|448921796|FG001|Overall Study|Other AE or clinical progression|15|||
124806644|NCT02020577|448921795|FG000|Overall Study|Withdrawal by Subject|0|||
124806645|NCT02020577|448921796|FG001|Overall Study|Withdrawal by Subject|1|||
124806646|NCT02020577|448921795|FG000|Overall Study|Other than stated above|0|||
124806647|NCT02020577|448921796|FG001|Overall Study|Other than stated above|1|||
124806648|NCT00761631|448921797|FG000|Overall Study|Parent/legal guardian request|8|||
124806649|NCT00761631|448921798|FG001|Overall Study|Parent/legal guardian request|3|||
124806650|NCT00761631|448921799|FG002|Overall Study|Parent/legal guardian request|8|||
124806651|NCT00761631|448921800|FG003|Overall Study|Parent/legal guardian request|0|||
124806652|NCT00761631|448921801|FG004|Overall Study|Parent/legal guardian request|5|||
124806653|NCT00761631|448921802|FG005|Overall Study|Parent/legal guardian request|0|||
124806654|NCT00761631|448921797|FG000|Overall Study|Lost to Follow-up|2|||
124806655|NCT00761631|448921798|FG001|Overall Study|Lost to Follow-up|4|||
124806656|NCT00761631|448921799|FG002|Overall Study|Lost to Follow-up|7|||
124806657|NCT00761631|448921800|FG003|Overall Study|Lost to Follow-up|1|||
124806658|NCT00761631|448921801|FG004|Overall Study|Lost to Follow-up|6|||
124806659|NCT00761631|448921802|FG005|Overall Study|Lost to Follow-up|1|||
124806660|NCT00761631|448921797|FG000|Overall Study|Protocol Violation|2|||
124806661|NCT00761631|448921798|FG001|Overall Study|Protocol Violation|0|||
124806662|NCT00761631|448921799|FG002|Overall Study|Protocol Violation|0|||
124806663|NCT00761631|448921800|FG003|Overall Study|Protocol Violation|1|||
124806664|NCT00761631|448921801|FG004|Overall Study|Protocol Violation|5|||
125299880|NCT03596450|450723789|FG001|Overall Study|Accidentally Randomized|0|||
124806665|NCT00761631|448921802|FG005|Overall Study|Protocol Violation|1|||
124806666|NCT00761631|448921797|FG000|Overall Study|Randomized, not treated|1|||
124806667|NCT00761631|448921798|FG001|Overall Study|Randomized, not treated|0|||
124806668|NCT00761631|448921799|FG002|Overall Study|Randomized, not treated|0|||
124806669|NCT00761631|448921800|FG003|Overall Study|Randomized, not treated|0|||
124806670|NCT00761631|448921801|FG004|Overall Study|Randomized, not treated|0|||
124806671|NCT00761631|448921802|FG005|Overall Study|Randomized, not treated|0|||
124806672|NCT00761631|448921797|FG000|Overall Study|Failed to return|1|||
124806673|NCT00761631|448921798|FG001|Overall Study|Failed to return|0|||
124806674|NCT00761631|448921799|FG002|Overall Study|Failed to return|1|||
124806675|NCT00761631|448921800|FG003|Overall Study|Failed to return|1|||
124806676|NCT00761631|448921801|FG004|Overall Study|Failed to return|5|||
124806677|NCT00761631|448921802|FG005|Overall Study|Failed to return|2|||
124806678|NCT00761631|448921797|FG000|Overall Study|Physician Decision|1|||
124806679|NCT00761631|448921798|FG001|Overall Study|Physician Decision|0|||
124806680|NCT00761631|448921799|FG002|Overall Study|Physician Decision|0|||
124806681|NCT00761631|448921800|FG003|Overall Study|Physician Decision|0|||
124806682|NCT00761631|448921801|FG004|Overall Study|Physician Decision|0|||
124806683|NCT00761631|448921802|FG005|Overall Study|Physician Decision|0|||
124806684|NCT00761631|448921797|FG000|Overall Study|Other|0|||
124806685|NCT00761631|448921798|FG001|Overall Study|Other|0|||
124806686|NCT00761631|448921799|FG002|Overall Study|Other|0|||
124806687|NCT00761631|448921800|FG003|Overall Study|Other|0|||
124806688|NCT00761631|448921801|FG004|Overall Study|Other|1|||
124806689|NCT00761631|448921802|FG005|Overall Study|Other|1|||
124806690|NCT03673046|448923394|FG000|Overall Study|Adverse Event|1|||
124806691|NCT03673046|448923395|FG001|Overall Study|Adverse Event|1|||
124806692|NCT03673046|448923394|FG000|Overall Study|Withdrawal by Subject|8|||
124806693|NCT03673046|448923395|FG001|Overall Study|Withdrawal by Subject|2|||
124806694|NCT03817879|448923396|FG000|Overall Study|Drop out|5|||
124806695|NCT03817879|448923397|FG001|Overall Study|Drop out|12|||
124806696|NCT03817879|448923396|FG000|Overall Study|Withdrawal by Subject|0|||
124806697|NCT03817879|448923397|FG001|Overall Study|Withdrawal by Subject|1|||
124806698|NCT01896050|448923400|FG000|Overall Study|Adverse Event|37|||
124806699|NCT01896050|448923401|FG001|Overall Study|Adverse Event|2|||
124806700|NCT01896050|448923400|FG000|Overall Study|Death|1|||
124806701|NCT01896050|448923401|FG001|Overall Study|Death|0|||
124806702|NCT00392015|448923402|FG000|Overall Study|Lost to Follow-up|2|||
124806703|NCT00392015|448923403|FG001|Overall Study|Lost to Follow-up|0|||
124806704|NCT00392015|448923404|FG002|Overall Study|Lost to Follow-up|2|||
124806705|NCT00392015|448923405|FG003|Overall Study|Lost to Follow-up|1|||
124806706|NCT00392015|448923406|FG004|Overall Study|Lost to Follow-up|1|||
124806707|NCT00392015|448923407|FG005|Overall Study|Lost to Follow-up|0|||
124806708|NCT00392015|448923402|FG000|Overall Study|Withdrawal by Subject|0|||
124806709|NCT00392015|448923403|FG001|Overall Study|Withdrawal by Subject|0|||
124806710|NCT00392015|448923404|FG002|Overall Study|Withdrawal by Subject|2|||
124806711|NCT00392015|448923405|FG003|Overall Study|Withdrawal by Subject|0|||
124806712|NCT00392015|448923406|FG004|Overall Study|Withdrawal by Subject|0|||
124806713|NCT00392015|448923407|FG005|Overall Study|Withdrawal by Subject|0|||
124806714|NCT00392015|448923402|FG000|Overall Study|Adverse Event|0|||
124806715|NCT00392015|448923403|FG001|Overall Study|Adverse Event|0|||
124806716|NCT00392015|448923404|FG002|Overall Study|Adverse Event|0|||
124806717|NCT00392015|448923405|FG003|Overall Study|Adverse Event|0|||
124806718|NCT00392015|448923406|FG004|Overall Study|Adverse Event|1|||
124806719|NCT00392015|448923407|FG005|Overall Study|Adverse Event|0|||
124806720|NCT00392015|448923402|FG000|Overall Study|Previous trial recipient|0|||
124806721|NCT00392015|448923403|FG001|Overall Study|Previous trial recipient|0|||
124806722|NCT00392015|448923404|FG002|Overall Study|Previous trial recipient|0|||
124806723|NCT00392015|448923405|FG003|Overall Study|Previous trial recipient|0|||
124806724|NCT00392015|448923406|FG004|Overall Study|Previous trial recipient|1|||
124806725|NCT00392015|448923407|FG005|Overall Study|Previous trial recipient|0|||
124806726|NCT02180724|448923408|FG000|Overall Study|Death|26|||
124806727|NCT02180724|448923409|FG001|Overall Study|Death|1|||
124806728|NCT02180724|448923408|FG000|Overall Study|Lost to Follow-up|3|||
124806729|NCT02180724|448923409|FG001|Overall Study|Lost to Follow-up|1|||
124806730|NCT02180724|448923408|FG000|Overall Study|Withdrawal by Subject|4|||
124806731|NCT02180724|448923409|FG001|Overall Study|Withdrawal by Subject|2|||
124806732|NCT02180724|448923408|FG000|Overall Study|PI Decision|5|||
124806733|NCT02180724|448923409|FG001|Overall Study|PI Decision|2|||
124806734|NCT02180724|448923408|FG000|Overall Study|Study terminated by sponsor|54|||
124806735|NCT02180724|448923409|FG001|Overall Study|Study terminated by sponsor|8|||
124806736|NCT03693300|448923410|FG000|Overall Study|Withdrawal by Subject|6|||
124806737|NCT03693300|448923411|FG001|Overall Study|Withdrawal by Subject|0|||
124806738|NCT03693300|448923410|FG000|Overall Study|Death|50|||
124806739|NCT03693300|448923411|FG001|Overall Study|Death|2|||
124806740|NCT03693300|448923410|FG000|Overall Study|Lost to Follow-up|2|||
124806741|NCT03693300|448923411|FG001|Overall Study|Lost to Follow-up|0|||
124806742|NCT02206048|448923412|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
124806743|NCT02925923|448923416|FG000|Overall Study|blood samples hemolyzed|0|||
124806744|NCT02925923|448923417|FG001|Overall Study|blood samples hemolyzed|2|||
124806745|NCT00866788|448923418|FG000|Overall Study|Adverse Event|0|||
124806746|NCT00866788|448923419|FG001|Overall Study|Adverse Event|2|||
124806747|NCT00866788|448923420|FG002|Overall Study|Adverse Event|0|||
124806748|NCT00866788|448923421|FG003|Overall Study|Adverse Event|1|||
124806749|NCT00866788|448923418|FG000|Overall Study|Lost to Follow-up|1|||
124806750|NCT00866788|448923419|FG001|Overall Study|Lost to Follow-up|1|||
124806751|NCT00866788|448923420|FG002|Overall Study|Lost to Follow-up|0|||
124806752|NCT00866788|448923421|FG003|Overall Study|Lost to Follow-up|2|||
124806753|NCT00866788|448923418|FG000|Overall Study|Withdrawal by Subject|2|||
124806754|NCT00866788|448923419|FG001|Overall Study|Withdrawal by Subject|1|||
124806755|NCT00866788|448923420|FG002|Overall Study|Withdrawal by Subject|0|||
124806756|NCT00866788|448923421|FG003|Overall Study|Withdrawal by Subject|1|||
124806757|NCT00866788|448923418|FG000|Overall Study|Pregnancy|0|||
124806758|NCT00866788|448923419|FG001|Overall Study|Pregnancy|1|||
124806759|NCT00866788|448923420|FG002|Overall Study|Pregnancy|0|||
124806760|NCT00866788|448923421|FG003|Overall Study|Pregnancy|0|||
124806761|NCT00866788|448923418|FG000|Overall Study|Disease progression|3|||
124806762|NCT00866788|448923419|FG001|Overall Study|Disease progression|1|||
124806763|NCT00866788|448923420|FG002|Overall Study|Disease progression|1|||
124806764|NCT00866788|448923421|FG003|Overall Study|Disease progression|0|||
124806765|NCT00866788|448923418|FG000|Overall Study|Physician Decision|0|||
124806766|NCT00866788|448923419|FG001|Overall Study|Physician Decision|0|||
124806767|NCT00866788|448923420|FG002|Overall Study|Physician Decision|1|||
124806768|NCT00866788|448923421|FG003|Overall Study|Physician Decision|1|||
124806769|NCT02742441|448923422|FG000|Overall Study|Lost to Follow-up|4|||
124806770|NCT02742441|448923423|FG001|Overall Study|Lost to Follow-up|4|||
124806771|NCT02742441|448923422|FG000|Overall Study|Withdrawal by Subject|2|||
124806772|NCT02742441|448923423|FG001|Overall Study|Withdrawal by Subject|2|||
124806773|NCT02742441|448923422|FG000|Overall Study|Adverse Event|0|||
124806774|NCT02742441|448923423|FG001|Overall Study|Adverse Event|2|||
124806775|NCT01824342|448923431|FG000|Overall Study|Withdrawal by Subject|0|||
124806776|NCT01824342|448923432|FG001|Overall Study|Withdrawal by Subject|3|||
124806777|NCT01824342|448923431|FG000|Overall Study|Adverse Event|1|||
124806778|NCT01824342|448923432|FG001|Overall Study|Adverse Event|1|||
124806779|NCT01824342|448923431|FG000|Overall Study|Disease Progression|1|||
124806780|NCT01824342|448923432|FG001|Overall Study|Disease Progression|1|||
124806781|NCT01824342|448923431|FG000|Overall Study|Physician Decision|5|||
124806782|NCT01824342|448923432|FG001|Overall Study|Physician Decision|0|||
124806783|NCT01824342|448923431|FG000|Overall Study|Death|2|||
124806784|NCT01824342|448923432|FG001|Overall Study|Death|0|||
124806785|NCT02008318|448923438|FG000|Overall Study|Adverse Event|4|||
124806786|NCT02008318|448923439|FG001|Overall Study|Adverse Event|0|||
124806787|NCT02008318|448923438|FG000|Overall Study|Physician Decision|2|||
124806788|NCT02008318|448923439|FG001|Overall Study|Physician Decision|0|||
124806789|NCT02008318|448923438|FG000|Overall Study|Progressive Disease|2|||
124806790|NCT02008318|448923439|FG001|Overall Study|Progressive Disease|0|||
124806791|NCT02008318|448923438|FG000|Overall Study|Protocol Violation|1|||
124806792|NCT02008318|448923439|FG001|Overall Study|Protocol Violation|1|||
124806793|NCT02008318|448923438|FG000|Overall Study|Withdrawal by Subject|3|||
124806794|NCT02008318|448923439|FG001|Overall Study|Withdrawal by Subject|0|||
124806795|NCT02281773|448923440|FG000|Overall Study|Adverse Event|6|||
124806796|NCT02281773|448923441|FG001|Overall Study|Adverse Event|1|||
124806797|NCT02281773|448923442|FG002|Overall Study|Adverse Event|4|||
124806798|NCT02281773|448923443|FG003|Overall Study|Adverse Event|8|||
124806799|NCT02281773|448923444|FG004|Overall Study|Adverse Event|9|||
124806800|NCT02281773|448923440|FG000|Overall Study|Protocol Violation|1|||
124806801|NCT02281773|448923441|FG001|Overall Study|Protocol Violation|0|||
124806802|NCT02281773|448923442|FG002|Overall Study|Protocol Violation|0|||
124806803|NCT02281773|448923443|FG003|Overall Study|Protocol Violation|2|||
124806804|NCT02281773|448923444|FG004|Overall Study|Protocol Violation|2|||
124806805|NCT02281773|448923440|FG000|Overall Study|Lost to Follow-up|2|||
124806806|NCT02281773|448923441|FG001|Overall Study|Lost to Follow-up|2|||
124806807|NCT02281773|448923442|FG002|Overall Study|Lost to Follow-up|6|||
124806808|NCT02281773|448923443|FG003|Overall Study|Lost to Follow-up|2|||
124806809|NCT02281773|448923444|FG004|Overall Study|Lost to Follow-up|10|||
124806810|NCT02281773|448923440|FG000|Overall Study|Withdrawal by Subject|2|||
124806811|NCT02281773|448923441|FG001|Overall Study|Withdrawal by Subject|8|||
124806812|NCT02281773|448923442|FG002|Overall Study|Withdrawal by Subject|6|||
124806813|NCT02281773|448923443|FG003|Overall Study|Withdrawal by Subject|6|||
124806814|NCT02281773|448923444|FG004|Overall Study|Withdrawal by Subject|8|||
124806815|NCT02281773|448923440|FG000|Overall Study|Other Reason|0|||
124806816|NCT02281773|448923441|FG001|Overall Study|Other Reason|4|||
124806817|NCT02281773|448923442|FG002|Overall Study|Other Reason|2|||
124806818|NCT02281773|448923443|FG003|Overall Study|Other Reason|3|||
124806819|NCT02281773|448923444|FG004|Overall Study|Other Reason|1|||
124806820|NCT02104752|448923445|FG000|Overall Study|Withdrawal by Subject|1|||
124806821|NCT02104752|448923446|FG001|Overall Study|Withdrawal by Subject|0|||
124806822|NCT02104752|448923445|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
124806823|NCT02104752|448923446|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
124806824|NCT05439941|448923447|FG000|Overall Study|Lack of Efficacy|8|||
125299881|NCT03596450|450723788|FG000|Overall Study|Other reasons|48|||
125299882|NCT03596450|450723789|FG001|Overall Study|Other reasons|53|||
124806825|NCT05439941|448923448|FG001|Overall Study|Lack of Efficacy|5|||
124806826|NCT05439941|448923449|FG002|Overall Study|Lack of Efficacy|3|||
124806827|NCT05439941|448923447|FG000|Overall Study|Treatment Failure|0|||
124806828|NCT05439941|448923448|FG001|Overall Study|Treatment Failure|1|||
124806829|NCT05439941|448923449|FG002|Overall Study|Treatment Failure|0|||
124806830|NCT05439941|448923447|FG000|Overall Study|Adverse Event|1|||
124806831|NCT05439941|448923448|FG001|Overall Study|Adverse Event|3|||
124806832|NCT05439941|448923449|FG002|Overall Study|Adverse Event|0|||
125299883|NCT03596450|450723788|FG000|Overall Study|Pregnancy|2|||
124806833|NCT05439941|448923447|FG000|Overall Study|Adverse Event - Parent Study|1|||
124806834|NCT05439941|448923448|FG001|Overall Study|Adverse Event - Parent Study|0|||
124806835|NCT05439941|448923449|FG002|Overall Study|Adverse Event - Parent Study|0|||
124806836|NCT05439941|448923447|FG000|Overall Study|Pregnancy|1|||
124806837|NCT05439941|448923448|FG001|Overall Study|Pregnancy|0|||
124806838|NCT05439941|448923449|FG002|Overall Study|Pregnancy|0|||
124806839|NCT05439941|448923447|FG000|Overall Study|Withdrawal by Subject|9|||
125299884|NCT03596450|450723789|FG001|Overall Study|Pregnancy|0|||
124806840|NCT05439941|448923448|FG001|Overall Study|Withdrawal by Subject|6|||
124806841|NCT05439941|448923449|FG002|Overall Study|Withdrawal by Subject|10|||
124806842|NCT05439941|448923447|FG000|Overall Study|Non-Compliance|1|||
124806843|NCT05439941|448923448|FG001|Overall Study|Non-Compliance|1|||
124806844|NCT05439941|448923449|FG002|Overall Study|Non-Compliance|1|||
124806845|NCT05439941|448923447|FG000|Overall Study|Lost to Follow-up|2|||
124806846|NCT05439941|448923448|FG001|Overall Study|Lost to Follow-up|2|||
124806847|NCT05439941|448923449|FG002|Overall Study|Lost to Follow-up|0|||
124806848|NCT05439941|448923447|FG000|Overall Study|Physician Decision|1|||
124806849|NCT05439941|448923448|FG001|Overall Study|Physician Decision|0|||
124806850|NCT05439941|448923449|FG002|Overall Study|Physician Decision|0|||
124806851|NCT05439941|448923447|FG000|Overall Study|Trial Termination by Sponsor|78|||
124806852|NCT05439941|448923448|FG001|Overall Study|Trial Termination by Sponsor|83|||
124806853|NCT05439941|448923449|FG002|Overall Study|Trial Termination by Sponsor|65|||
124806854|NCT05439941|448923447|FG000|Overall Study|Other than Reasons Listed|2|||
124806855|NCT05439941|448923448|FG001|Overall Study|Other than Reasons Listed|1|||
124806856|NCT05439941|448923449|FG002|Overall Study|Other than Reasons Listed|0|||
124806857|NCT00231842|448923450|FG000|Overall Study|Withdrawal by Subject|3|||
124806858|NCT00231842|448923450|FG000|Overall Study|Did not complete the last 3 cycle|8|||
124806859|NCT02422303|448923451|FG000|Overall Study|Lost to Follow-up|1|||
124806860|NCT02422303|448923452|FG001|Overall Study|Lost to Follow-up|1|||
124806861|NCT02899299|448923454|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
124806862|NCT02899299|448923455|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
124806863|NCT02899299|448923454|FG000|Pre-treatment|Participant withdrew consent|1|||
124806864|NCT02899299|448923455|FG001|Pre-treatment|Participant withdrew consent|11|||
124806865|NCT02899299|448923454|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
124806866|NCT02899299|448923455|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
124806867|NCT02899299|448923454|FG000|Pre-treatment|Not reported|0|||
124806868|NCT02899299|448923455|FG001|Pre-treatment|Not reported|1|||
124806869|NCT02899299|448923454|FG000|Treatment|Disease Progression|182|||
124806870|NCT02899299|448923455|FG001|Treatment|Disease Progression|43|||
124806871|NCT02899299|448923454|FG000|Treatment|Study Drug Toxicity|60|||
124806872|NCT02899299|448923455|FG001|Treatment|Study Drug Toxicity|24|||
124806873|NCT02899299|448923454|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
124806874|NCT02899299|448923455|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
124806875|NCT02899299|448923454|FG000|Treatment|Participant request to discontinue Study treatment|4|||
124806876|NCT02899299|448923455|FG001|Treatment|Participant request to discontinue Study treatment|10|||
124806877|NCT02899299|448923454|FG000|Treatment|Participant withdrew consent|6|||
124806878|NCT02899299|448923455|FG001|Treatment|Participant withdrew consent|3|||
124806879|NCT02899299|448923454|FG000|Treatment|Lost to Follow-up|0|||
124806880|NCT02899299|448923455|FG001|Treatment|Lost to Follow-up|2|||
124806881|NCT02899299|448923454|FG000|Treatment|Maximum Clinical Benefit|11|||
124806882|NCT02899299|448923455|FG001|Treatment|Maximum Clinical Benefit|2|||
124806883|NCT02899299|448923454|FG000|Treatment|Poor/Non-compliance|1|||
124806884|NCT02899299|448923455|FG001|Treatment|Poor/Non-compliance|0|||
124806885|NCT02899299|448923454|FG000|Treatment|Participant no longer meets Study criteria|4|||
124806886|NCT02899299|448923455|FG001|Treatment|Participant no longer meets Study criteria|0|||
124806887|NCT02899299|448923454|FG000|Treatment|Administrative reason by Sponsor|2|||
124806888|NCT02899299|448923455|FG001|Treatment|Administrative reason by Sponsor|0|||
124806889|NCT02899299|448923454|FG000|Treatment|Other reasons|12|||
124806890|NCT02899299|448923455|FG001|Treatment|Other reasons|2|||
124806891|NCT02899299|448923454|FG000|Treatment|Not reported|7|||
124806892|NCT02899299|448923455|FG001|Treatment|Not reported|0|||
124806893|NCT00313300|448923456|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
124806894|NCT00313300|448923457|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
124806895|NCT00313300|448923458|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
124806896|NCT00313300|448923459|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
124806897|NCT00313300|448923460|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
124806898|NCT00313300|448923456|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
124806899|NCT00313300|448923457|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
124806900|NCT00313300|448923458|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
124806901|NCT00313300|448923459|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
124806902|NCT00313300|448923460|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
124806903|NCT00313300|448923456|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
124806904|NCT00313300|448923457|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
124806905|NCT00313300|448923458|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
124806906|NCT00313300|448923459|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
124806907|NCT00313300|448923460|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
124806908|NCT00313300|448923456|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
124806909|NCT00313300|448923457|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
124806910|NCT00313300|448923458|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
124806911|NCT00313300|448923459|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
124806912|NCT00313300|448923460|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
124806913|NCT00313300|448923456|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
124806914|NCT00313300|448923457|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
124806915|NCT00313300|448923458|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
124806916|NCT00313300|448923459|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
124806917|NCT00313300|448923460|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
124806918|NCT00313300|448923456|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
124806919|NCT00313300|448923457|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
124806920|NCT00313300|448923458|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
124806921|NCT00313300|448923459|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
124806922|NCT00313300|448923460|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
124806923|NCT00313300|448923456|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
124806924|NCT00313300|448923457|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
124806925|NCT00313300|448923458|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
124806926|NCT00313300|448923459|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
124806927|NCT00313300|448923460|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
124806928|NCT00313300|448923456|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
124806929|NCT00313300|448923457|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
124806930|NCT00313300|448923458|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
124806931|NCT00313300|448923459|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
124806932|NCT00313300|448923460|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
124806933|NCT00313300|448923456|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
124806934|NCT00313300|448923457|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
124806935|NCT00313300|448923458|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
124806936|NCT00313300|448923459|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
124806937|NCT00313300|448923460|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
124806938|NCT00313300|448923456|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
124806939|NCT00313300|448923457|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
124806940|NCT00313300|448923458|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
124806941|NCT00313300|448923459|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
124806942|NCT00313300|448923460|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
124806943|NCT00313300|448923456|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
124806944|NCT00313300|448923457|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
124806945|NCT00313300|448923458|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
124806946|NCT00313300|448923459|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
124806947|NCT00313300|448923460|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
124806948|NCT00313300|448923456|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
124806949|NCT00313300|448923457|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
124806950|NCT00313300|448923458|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
124806951|NCT00313300|448923459|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
124806952|NCT00313300|448923460|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
124806953|NCT00313300|448923456|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
124806954|NCT00313300|448923457|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
124806955|NCT00313300|448923458|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
124806956|NCT00313300|448923459|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
124806957|NCT00313300|448923460|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
124806958|NCT00313300|448923456|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
124806959|NCT00313300|448923457|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
124806960|NCT00313300|448923458|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
124806961|NCT00313300|448923459|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
124806962|NCT00313300|448923460|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
124806963|NCT00313300|448923456|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
124806964|NCT00313300|448923457|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
124806965|NCT00313300|448923458|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
124806966|NCT00313300|448923459|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
124806967|NCT00313300|448923460|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
124806968|NCT00313300|448923456|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
124806969|NCT00313300|448923457|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
124806970|NCT00313300|448923458|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
124806971|NCT00313300|448923459|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
124806972|NCT00313300|448923460|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
124806973|NCT00313300|448923456|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
124806974|NCT00313300|448923457|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
124806975|NCT00313300|448923458|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
124806976|NCT00313300|448923459|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
124806977|NCT00313300|448923460|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
125299885|NCT02332291|450723790|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
124806978|NCT00313300|448923456|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
124806979|NCT00313300|448923457|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
124806980|NCT00313300|448923458|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
124806981|NCT00313300|448923459|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
124806982|NCT00313300|448923460|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
124806983|NCT00313300|448923456|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
124806984|NCT00313300|448923457|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
124806985|NCT00313300|448923458|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
124806986|NCT00313300|448923459|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
124806987|NCT00313300|448923460|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
124806988|NCT00313300|448923456|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
124806989|NCT00313300|448923457|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
124806990|NCT00313300|448923458|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
124806991|NCT00313300|448923459|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
124806992|NCT00313300|448923460|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
124806993|NCT00313300|448923456|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
124806994|NCT00313300|448923457|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
124806995|NCT00313300|448923458|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
124806996|NCT00313300|448923459|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
124806997|NCT00313300|448923460|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
124806998|NCT02336373|448923461|FG000|Overall Study|Protocol closed early|4|||
124806999|NCT02336373|448923461|FG000|Overall Study|Physician Decision|14|||
124807000|NCT00850343|448923463|FG000|Overall Study|Withdrawal by Subject|11|||
124807001|NCT00850343|448923464|FG001|Overall Study|Withdrawal by Subject|0|||
124807002|NCT00850343|448923465|FG002|Overall Study|Withdrawal by Subject|3|||
124807003|NCT00850343|448923466|FG003|Overall Study|Withdrawal by Subject|2|||
124807004|NCT00850343|448923463|FG000|Overall Study|Adverse Event|15|||
124807005|NCT00850343|448923464|FG001|Overall Study|Adverse Event|2|||
124807006|NCT00850343|448923465|FG002|Overall Study|Adverse Event|6|||
124807007|NCT00850343|448923466|FG003|Overall Study|Adverse Event|6|||
124807008|NCT00850343|448923463|FG000|Overall Study|Pregnancy|0|||
124807009|NCT00850343|448923464|FG001|Overall Study|Pregnancy|0|||
124807010|NCT00850343|448923465|FG002|Overall Study|Pregnancy|0|||
124807011|NCT00850343|448923466|FG003|Overall Study|Pregnancy|1|||
124807012|NCT00850343|448923463|FG000|Overall Study|Lack of Efficacy|17|||
124807013|NCT00850343|448923464|FG001|Overall Study|Lack of Efficacy|0|||
124807014|NCT00850343|448923465|FG002|Overall Study|Lack of Efficacy|3|||
124807015|NCT00850343|448923466|FG003|Overall Study|Lack of Efficacy|2|||
124807016|NCT00850343|448923463|FG000|Overall Study|Non-compliance with Study Procedures|1|||
124807017|NCT00850343|448923464|FG001|Overall Study|Non-compliance with Study Procedures|0|||
124807018|NCT00850343|448923465|FG002|Overall Study|Non-compliance with Study Procedures|1|||
124807019|NCT00850343|448923466|FG003|Overall Study|Non-compliance with Study Procedures|1|||
124807020|NCT00850343|448923463|FG000|Overall Study|Physician Decision|2|||
124807021|NCT00850343|448923464|FG001|Overall Study|Physician Decision|1|||
124807022|NCT00850343|448923465|FG002|Overall Study|Physician Decision|1|||
124807023|NCT00850343|448923466|FG003|Overall Study|Physician Decision|1|||
124807024|NCT01926015|448923468|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124807025|NCT01926015|448923469|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124807026|NCT01926015|448923468|FG000|Overall Study|Randomized not treated|2|||
124807027|NCT01926015|448923469|FG001|Overall Study|Randomized not treated|0|||
124807028|NCT00639678|448923470|FG000|Overall Study|Withdrawal by Subject|3|||
124807029|NCT00639678|448923471|FG001|Overall Study|Withdrawal by Subject|0|||
124807030|NCT00639678|448923472|FG002|Overall Study|Withdrawal by Subject|4|||
124807031|NCT00639678|448923473|FG003|Overall Study|Withdrawal by Subject|0|||
124807032|NCT00639678|448923470|FG000|Overall Study|Lost to Follow-up|1|||
124807033|NCT00639678|448923471|FG001|Overall Study|Lost to Follow-up|0|||
124807034|NCT00639678|448923472|FG002|Overall Study|Lost to Follow-up|6|||
125299886|NCT02332291|450723791|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
125299887|NCT02332291|450723790|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
125299888|NCT02332291|450723791|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
124807035|NCT00639678|448923473|FG003|Overall Study|Lost to Follow-up|0|||
124807036|NCT00639678|448923470|FG000|Overall Study|Adverse Event|0|||
124807037|NCT00639678|448923471|FG001|Overall Study|Adverse Event|1|||
124807038|NCT00639678|448923472|FG002|Overall Study|Adverse Event|0|||
124807039|NCT00639678|448923473|FG003|Overall Study|Adverse Event|0|||
124807040|NCT00639678|448923470|FG000|Overall Study|Lack of Compliance|0|||
124807041|NCT00639678|448923471|FG001|Overall Study|Lack of Compliance|0|||
124807042|NCT00639678|448923472|FG002|Overall Study|Lack of Compliance|1|||
124807043|NCT00639678|448923473|FG003|Overall Study|Lack of Compliance|0|||
124807044|NCT01364649|448923474|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
124807045|NCT01364649|448923475|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
124807046|NCT01364649|448923474|FG000|Overall Study|Lack of Efficacy|6|||
124807047|NCT01364649|448923475|FG001|Overall Study|Lack of Efficacy|0|||
124807048|NCT01364649|448923474|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
124807049|NCT01364649|448923475|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
124807050|NCT01364649|448923474|FG000|Overall Study|Protocol Deviations|4|||
124807051|NCT01364649|448923475|FG001|Overall Study|Protocol Deviations|8|||
124807052|NCT01364649|448923474|FG000|Overall Study|Withdrawal of Consent|9|||
124807053|NCT01364649|448923475|FG001|Overall Study|Withdrawal of Consent|7|||
124807054|NCT01364649|448923474|FG000|Overall Study|Lost to Follow-up|12|||
124807055|NCT01364649|448923475|FG001|Overall Study|Lost to Follow-up|13|||
124807056|NCT01364649|448923474|FG000|Overall Study|Other|4|||
124807057|NCT01364649|448923475|FG001|Overall Study|Other|1|||
124807058|NCT02468232|448923478|FG000|Core Part of Study|Adverse Event|0|||
124807059|NCT02468232|448923479|FG001|Core Part of Study|Adverse Event|1|||
124807060|NCT02468232|448923480|FG002|Core Part of Study|Adverse Event|0|||
124807061|NCT02468232|448923481|FG003|Core Part of Study|Adverse Event|0|||
124807062|NCT02468232|448923478|FG000|Core Part of Study|Death|20|||
124807063|NCT02468232|448923479|FG001|Core Part of Study|Death|17|||
124807064|NCT02468232|448923480|FG002|Core Part of Study|Death|0|||
125299889|NCT02332291|450723790|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
125299890|NCT02332291|450723791|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
125299891|NCT02332291|450723790|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
125299892|NCT02332291|450723791|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
125299893|NCT02332291|450723790|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
125299894|NCT02332291|450723791|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
125299895|NCT02332291|450723790|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
125299896|NCT02332291|450723791|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
125299897|NCT01990859|450723792|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
125299898|NCT01990859|450723792|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
125299899|NCT02262754|450723794|FG000|Overall Study|Adverse Event|3|||
125299900|NCT02262754|450723795|FG001|Overall Study|Adverse Event|4|||
125299901|NCT02262754|450723796|FG002|Overall Study|Adverse Event|0|||
125299902|NCT02262754|450723794|FG000|Overall Study|Lack of Efficacy|2|||
125299903|NCT02262754|450723795|FG001|Overall Study|Lack of Efficacy|0|||
125299904|NCT02262754|450723796|FG002|Overall Study|Lack of Efficacy|1|||
125299905|NCT02262754|450723794|FG000|Overall Study|Lost to Follow-up|0|||
125299906|NCT02262754|450723795|FG001|Overall Study|Lost to Follow-up|0|||
125299907|NCT02262754|450723796|FG002|Overall Study|Lost to Follow-up|1|||
125299908|NCT02262754|450723794|FG000|Overall Study|No longer meets eligibility criteria|0|||
125299909|NCT02262754|450723795|FG001|Overall Study|No longer meets eligibility criteria|1|||
125299910|NCT02262754|450723796|FG002|Overall Study|No longer meets eligibility criteria|0|||
125299911|NCT02262754|450723794|FG000|Overall Study|Study terminated by sponsor|5|||
125299912|NCT02262754|450723795|FG001|Overall Study|Study terminated by sponsor|4|||
125299913|NCT02262754|450723796|FG002|Overall Study|Study terminated by sponsor|4|||
125299914|NCT02262754|450723794|FG000|Overall Study|Protocol Violation|1|||
125299915|NCT02262754|450723795|FG001|Overall Study|Protocol Violation|0|||
125299916|NCT02262754|450723796|FG002|Overall Study|Protocol Violation|0|||
125299917|NCT02262754|450723794|FG000|Overall Study|Withdrawal by Subject|1|||
125299918|NCT02262754|450723795|FG001|Overall Study|Withdrawal by Subject|0|||
125299919|NCT02262754|450723796|FG002|Overall Study|Withdrawal by Subject|1|||
125299920|NCT02262754|450723794|FG000|Overall Study|Other|4|||
125299921|NCT02262754|450723795|FG001|Overall Study|Other|0|||
125299922|NCT02262754|450723796|FG002|Overall Study|Other|2|||
125299923|NCT02577016|450723797|FG000|Overall Study|Adverse Event|2|||
125299924|NCT02577016|450723798|FG001|Overall Study|Adverse Event|1|||
125299925|NCT02577016|450723797|FG000|Overall Study|Physician Decision|0|||
125299926|NCT02577016|450723798|FG001|Overall Study|Physician Decision|1|||
125299927|NCT02126839|450723799|FG000|Overall Study|Adverse Event|0|||
125299928|NCT02126839|450723800|FG001|Overall Study|Adverse Event|1|||
124807065|NCT02468232|448923481|FG003|Core Part of Study|Death|0|||
124807066|NCT02468232|448923478|FG000|Core Part of Study|Technical Problems|1|||
124807067|NCT02468232|448923479|FG001|Core Part of Study|Technical Problems|1|||
124807068|NCT02468232|448923480|FG002|Core Part of Study|Technical Problems|0|||
124807069|NCT02468232|448923481|FG003|Core Part of Study|Technical Problems|0|||
124807070|NCT02468232|448923478|FG000|OLE Part of Study|Adverse Event|0|||
124807071|NCT02468232|448923479|FG001|OLE Part of Study|Adverse Event|0|||
124807072|NCT02468232|448923480|FG002|OLE Part of Study|Adverse Event|4|||
124807073|NCT02468232|448923481|FG003|OLE Part of Study|Adverse Event|5|||
124807074|NCT02468232|448923478|FG000|OLE Part of Study|Death|0|||
124807075|NCT02468232|448923479|FG001|OLE Part of Study|Death|0|||
124807076|NCT02468232|448923480|FG002|OLE Part of Study|Death|4|||
124807077|NCT02468232|448923481|FG003|OLE Part of Study|Death|2|||
125299929|NCT02126839|450723799|FG000|Overall Study|Withdrawal by Subject|1|||
124807078|NCT02468232|448923478|FG000|OLE Part of Study|Physician Decision|0|||
124807079|NCT02468232|448923479|FG001|OLE Part of Study|Physician Decision|0|||
124807080|NCT02468232|448923480|FG002|OLE Part of Study|Physician Decision|4|||
125299930|NCT02126839|450723800|FG001|Overall Study|Withdrawal by Subject|0|||
125299931|NCT02126839|450723799|FG000|Overall Study|Withdrawal by parent/guardian|1|||
124807081|NCT02468232|448923481|FG003|OLE Part of Study|Physician Decision|0|||
124807082|NCT02468232|448923478|FG000|OLE Part of Study|Subject/Guardian decision|0|||
124807083|NCT02468232|448923479|FG001|OLE Part of Study|Subject/Guardian decision|0|||
124807084|NCT02468232|448923480|FG002|OLE Part of Study|Subject/Guardian decision|2|||
124807085|NCT02468232|448923481|FG003|OLE Part of Study|Subject/Guardian decision|5|||
124807086|NCT00246753|448923482|FG000|Overall Study|Withdrawal by Subject|2|||
124807087|NCT00246753|448923482|FG000|Overall Study|Physician Decision|2|||
124807088|NCT00246753|448923482|FG000|Overall Study|Adverse Event|2|||
124807089|NCT00246753|448923482|FG000|Overall Study|Unacceptable toxicity|2|||
124807090|NCT02764333|448923491|FG000|Overall Study|Ineligible|1|||
124807091|NCT01303861|448923505|FG000|Overall Study|Lost to Follow-up|34|||
124807092|NCT01303861|448923506|FG001|Overall Study|Lost to Follow-up|14|||
124807093|NCT01303861|448923507|FG002|Overall Study|Lost to Follow-up|27|||
124807094|NCT01303861|448923508|FG003|Overall Study|Lost to Follow-up|31|||
124807095|NCT01303861|448923505|FG000|Overall Study|Lack of Efficacy|3|||
124807096|NCT01303861|448923506|FG001|Overall Study|Lack of Efficacy|2|||
124807097|NCT01303861|448923507|FG002|Overall Study|Lack of Efficacy|1|||
124807098|NCT01303861|448923508|FG003|Overall Study|Lack of Efficacy|0|||
124807099|NCT01303861|448923505|FG000|Overall Study|Withdrawal by Subject|16|||
124807100|NCT01303861|448923506|FG001|Overall Study|Withdrawal by Subject|8|||
124807101|NCT01303861|448923507|FG002|Overall Study|Withdrawal by Subject|8|||
124807102|NCT01303861|448923508|FG003|Overall Study|Withdrawal by Subject|23|||
124807103|NCT01303861|448923505|FG000|Overall Study|Adverse Event|4|||
124807104|NCT01303861|448923506|FG001|Overall Study|Adverse Event|1|||
124807105|NCT01303861|448923507|FG002|Overall Study|Adverse Event|0|||
124807106|NCT01303861|448923508|FG003|Overall Study|Adverse Event|5|||
124807107|NCT01303861|448923505|FG000|Overall Study|Pregnancy|1|||
124807108|NCT01303861|448923506|FG001|Overall Study|Pregnancy|0|||
124807109|NCT01303861|448923507|FG002|Overall Study|Pregnancy|0|||
124807110|NCT01303861|448923508|FG003|Overall Study|Pregnancy|0|||
124807111|NCT01788046|448923510|FG000|Overall Study|Withdrawal by Subject|12|||
124807112|NCT01788046|448923511|FG001|Overall Study|Withdrawal by Subject|12|||
124807113|NCT01788046|448923510|FG000|Overall Study|Lost to Follow-up|12|||
124807114|NCT01788046|448923511|FG001|Overall Study|Lost to Follow-up|19|||
124807115|NCT01788046|448923510|FG000|Overall Study|Death|7|||
124807116|NCT01788046|448923511|FG001|Overall Study|Death|5|||
124807117|NCT01788046|448923510|FG000|Overall Study|Protocol Specified Criteria|25|||
124807118|NCT01788046|448923511|FG001|Overall Study|Protocol Specified Criteria|1|||
124807119|NCT01031706|448923514|FG000|Overall Study|Adverse Event|1|||
124807120|NCT01031706|448923515|FG001|Overall Study|Adverse Event|0|||
124807121|NCT01031706|448923514|FG000|Overall Study|Withdrawal by Subject|1|||
124807122|NCT01031706|448923515|FG001|Overall Study|Withdrawal by Subject|1|||
124807123|NCT03840174|448923516|FG000|Overall Study|Withdrawal by Subject|1|||
124807124|NCT03840174|448923517|FG001|Overall Study|Withdrawal by Subject|0|||
124807125|NCT03840174|448923518|FG002|Overall Study|Withdrawal by Subject|0|||
124807126|NCT03840174|448923519|FG003|Overall Study|Withdrawal by Subject|0|||
124807127|NCT00131508|448923522|FG000|Overall Study|Disease progression|0|||
124807128|NCT00131508|448923523|FG001|Overall Study|Disease progression|2|||
124807129|NCT00131508|448923522|FG000|Overall Study|Non-Compliance|2|||
124807130|NCT00131508|448923523|FG001|Overall Study|Non-Compliance|4|||
124807131|NCT00131508|448923522|FG000|Overall Study|Withdrawal by Subject|1|||
124807132|NCT00131508|448923523|FG001|Overall Study|Withdrawal by Subject|2|||
124807133|NCT01268150|448923527|FG000|Treatment Phase|Progression of disease|18|||
124807134|NCT01268150|448923527|FG000|Treatment Phase|Adverse Event|3|||
124807135|NCT01268150|448923527|FG000|Treatment Phase|Withdrawal by Subject|3|||
124807136|NCT01268150|448923527|FG000|Treatment Phase|Other|4|||
124807137|NCT01268150|448923527|FG000|Extension Phase|Adverse Event|3|||
124807138|NCT01268150|448923527|FG000|Extension Phase|Disease progression|18|||
125299932|NCT02126839|450723800|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125299933|NCT02126839|450723799|FG000|Overall Study|Protocol Violation|2|||
125299934|NCT02126839|450723800|FG001|Overall Study|Protocol Violation|3|||
124807139|NCT01268150|448923527|FG000|Extension Phase|Other|6|||
124807140|NCT04738734|448923529|FG000|Overall Study|Withdrawal by Subject|2|||
124807141|NCT04738734|448923530|FG001|Overall Study|Withdrawal by Subject|4|||
124807142|NCT04738734|448923529|FG000|Overall Study|Lost to Follow-up|5|||
124807143|NCT04738734|448923530|FG001|Overall Study|Lost to Follow-up|2|||
124807144|NCT04738734|448923529|FG000|Overall Study|Physician Decision|0|||
124807145|NCT04738734|448923530|FG001|Overall Study|Physician Decision|1|||
124807146|NCT04738734|448923529|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
124807147|NCT04738734|448923530|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
124807148|NCT02435147|448923533|FG000|Overall Study|non-evaluable DXA scan|11|||
124807149|NCT04402060|448923534|FG000|Overall Study|Death|1|||
124807150|NCT04402060|448923535|FG001|Overall Study|Death|12|||
124807151|NCT04402060|448923536|FG002|Overall Study|Death|7|||
124807152|NCT04402060|448923534|FG000|Overall Study|Adverse Event|0|||
124807153|NCT04402060|448923535|FG001|Overall Study|Adverse Event|0|||
124807154|NCT04402060|448923536|FG002|Overall Study|Adverse Event|1|||
124807155|NCT04402060|448923534|FG000|Overall Study|Withdrawal by Subject|0|||
124807156|NCT04402060|448923535|FG001|Overall Study|Withdrawal by Subject|1|||
125299935|NCT02126839|450723799|FG000|Overall Study|Sponsor request|0|||
124807157|NCT04402060|448923536|FG002|Overall Study|Withdrawal by Subject|2|||
124807158|NCT04402060|448923534|FG000|Overall Study|Sponsor Request|0|||
124807159|NCT04402060|448923535|FG001|Overall Study|Sponsor Request|2|||
124807160|NCT04402060|448923536|FG002|Overall Study|Sponsor Request|0|||
124807161|NCT04402060|448923534|FG000|Overall Study|Physician Decision|0|||
124807162|NCT04402060|448923535|FG001|Overall Study|Physician Decision|0|||
124807163|NCT04402060|448923536|FG002|Overall Study|Physician Decision|1|||
124807164|NCT04402060|448923534|FG000|Overall Study|Other|0|||
124807165|NCT04402060|448923535|FG001|Overall Study|Other|1|||
124807166|NCT04402060|448923536|FG002|Overall Study|Other|0|||
124807167|NCT06238362|448923540|FG000|Overall Study|Insufficient total sleep time|1|||
124807168|NCT06238362|448923541|FG001|Overall Study|Insufficient total sleep time|0|||
124807169|NCT06238362|448923540|FG000|Overall Study|Inadequate signal quality|1|||
124807170|NCT06238362|448923541|FG001|Overall Study|Inadequate signal quality|0|||
124807171|NCT05136690|448923542|FG000|Period 1|Withdrawal by Subject|0|||
124807172|NCT05136690|448923543|FG001|Period 1|Withdrawal by Subject|1|||
124807173|NCT05136690|448923542|FG000|Period 2|Lost to Follow-up|0|||
124807174|NCT05136690|448923543|FG001|Period 2|Lost to Follow-up|3|||
124807175|NCT05136690|448923542|FG000|Period 2|Withdrawal by Subject|0|||
124807176|NCT05136690|448923543|FG001|Period 2|Withdrawal by Subject|1|||
124807177|NCT01863953|448924762|FG000|Overall Study|Adverse Event|0|||
124807178|NCT01863953|448924763|FG001|Overall Study|Adverse Event|0|||
124807179|NCT01863953|448924764|FG002|Overall Study|Adverse Event|1|||
124807180|NCT02202837|448924765|FG000|Overall Study|Enbrel treatment discontinued|36|||
124807181|NCT02202837|448924766|FG001|Overall Study|Enbrel treatment discontinued|4|||
124807182|NCT02202837|448924765|FG000|Overall Study|Other|10|||
124807183|NCT02202837|448924766|FG001|Overall Study|Other|0|||
124807184|NCT02202837|448924765|FG000|Overall Study|Lost to Follow-up|7|||
124807185|NCT02202837|448924766|FG001|Overall Study|Lost to Follow-up|1|||
124807186|NCT01313858|448924767|FG000|Overall Study|Premature Treatment Termination|251|||
124807187|NCT01313858|448924768|FG001|Overall Study|Premature Treatment Termination|219|||
124807188|NCT01313858|448924769|FG002|Overall Study|Premature Treatment Termination|191|||
124807189|NCT01313858|448924767|FG000|Overall Study|Lost to Follow-up|35|||
124807190|NCT01313858|448924768|FG001|Overall Study|Lost to Follow-up|51|||
124807191|NCT01313858|448924769|FG002|Overall Study|Lost to Follow-up|47|||
124807192|NCT01626456|448924781|FG000|Overall Study|Withdrawal by Subject|21|||
124807193|NCT01626456|448924782|FG001|Overall Study|Withdrawal by Subject|46|||
124807194|NCT01626456|448924781|FG000|Overall Study|Adverse Event|2|||
124807195|NCT01626456|448924782|FG001|Overall Study|Adverse Event|27|||
124807196|NCT01626456|448924781|FG000|Overall Study|Lost to Follow-up|2|||
124807197|NCT01626456|448924782|FG001|Overall Study|Lost to Follow-up|27|||
124807198|NCT01626456|448924781|FG000|Overall Study|Lack of Efficacy|6|||
124807199|NCT01626456|448924782|FG001|Overall Study|Lack of Efficacy|7|||
124807200|NCT01626456|448924781|FG000|Overall Study|Physician Decision|1|||
124807201|NCT01626456|448924782|FG001|Overall Study|Physician Decision|4|||
124807202|NCT01626456|448924781|FG000|Overall Study|Protocol Violation|1|||
124807203|NCT01626456|448924782|FG001|Overall Study|Protocol Violation|1|||
124807204|NCT01626456|448924781|FG000|Overall Study|Site Closure|2|||
124807205|NCT01626456|448924782|FG001|Overall Study|Site Closure|3|||
124807206|NCT01626456|448924781|FG000|Overall Study|Incarceration|0|||
124807207|NCT01626456|448924782|FG001|Overall Study|Incarceration|2|||
124807208|NCT00506662|448924783|FG000|Overall Study|Adverse Event|0|||
124807209|NCT00506662|448924784|FG001|Overall Study|Adverse Event|2|||
124807210|NCT00506662|448924783|FG000|Overall Study|Lack of Efficacy|1|||
124807211|NCT00506662|448924784|FG001|Overall Study|Lack of Efficacy|0|||
124807212|NCT00506662|448924783|FG000|Overall Study|Protocol Violation|2|||
124807213|NCT00506662|448924784|FG001|Overall Study|Protocol Violation|4|||
124807214|NCT00506662|448924783|FG000|Overall Study|Trial terminated|10|||
124807215|NCT00506662|448924784|FG001|Overall Study|Trial terminated|16|||
125299936|NCT02126839|450723800|FG001|Overall Study|Sponsor request|1|||
125299937|NCT02126839|450723799|FG000|Overall Study|Lost to Follow-up|1|||
125299938|NCT02126839|450723800|FG001|Overall Study|Lost to Follow-up|4|||
124807216|NCT00506662|448924783|FG000|Overall Study|Not recorded|4|||
124807217|NCT00506662|448924784|FG001|Overall Study|Not recorded|6|||
124807218|NCT04015336|448924785|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
124807219|NCT01816074|448924790|FG000|Phase 1|Time commitment issues|0|||
124807220|NCT01816074|448924791|FG001|Phase 1|Time commitment issues|0|||
124807221|NCT01816074|448924792|FG002|Phase 1|Time commitment issues|1|||
124807222|NCT01816074|448924793|FG003|Phase 1|Time commitment issues|0|||
124807223|NCT01816074|448924790|FG000|Phase 2|Time commitment Issues|0|||
125299939|NCT02126839|450723799|FG000|Overall Study|Other|5|||
124807224|NCT01816074|448924791|FG001|Phase 2|Time commitment Issues|2|||
124807225|NCT01816074|448924792|FG002|Phase 2|Time commitment Issues|0|||
124807226|NCT01816074|448924793|FG003|Phase 2|Time commitment Issues|0|||
124807227|NCT01816074|448924790|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
124807228|NCT01816074|448924791|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
124807229|NCT01816074|448924792|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
124807230|NCT01816074|448924793|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
125299940|NCT02126839|450723800|FG001|Overall Study|Other|5|||
124807231|NCT01816074|448924790|FG000|Phase 2|Physician Decision|0|||
124807232|NCT01816074|448924791|FG001|Phase 2|Physician Decision|0|||
124807233|NCT01816074|448924792|FG002|Phase 2|Physician Decision|0|||
124807234|NCT01816074|448924793|FG003|Phase 2|Physician Decision|1|||
124807235|NCT01816074|448924790|FG000|Phase 2|Withdrawal by Subject|1|||
124807236|NCT01816074|448924791|FG001|Phase 2|Withdrawal by Subject|0|||
124807237|NCT01816074|448924792|FG002|Phase 2|Withdrawal by Subject|0|||
124807238|NCT01816074|448924793|FG003|Phase 2|Withdrawal by Subject|0|||
124807239|NCT01200524|448924795|FG000|Overall Study|Withdrawal by Subject|1|||
124807240|NCT01200524|448924796|FG001|Overall Study|Withdrawal by Subject|1|||
124807241|NCT01200524|448924797|FG002|Overall Study|Withdrawal by Subject|3|||
124807242|NCT01200524|448924795|FG000|Overall Study|Adverse Event|1|||
124807243|NCT01200524|448924796|FG001|Overall Study|Adverse Event|0|||
124807244|NCT01200524|448924797|FG002|Overall Study|Adverse Event|0|||
124807245|NCT01200524|448924795|FG000|Overall Study|Non availability of study nurse|0|||
124807246|NCT01200524|448924796|FG001|Overall Study|Non availability of study nurse|0|||
124807247|NCT01200524|448924797|FG002|Overall Study|Non availability of study nurse|1|||
124807248|NCT02476201|448924800|FG000|Overall Study|Unable to program MPP|9|||
124807249|NCT02476201|448924800|FG000|Overall Study|Study echo not performed|5|||
124807250|NCT02476201|448924800|FG000|Overall Study|Adverse Event|4|||
124807251|NCT02476201|448924800|FG000|Overall Study|Death|2|||
124807252|NCT02476201|448924800|FG000|Overall Study|Lost to Follow-up|2|||
124807253|NCT02476201|448924800|FG000|Overall Study|MPP programmed to OFF|2|||
124807254|NCT02476201|448924800|FG000|Overall Study|Withdrawal by Subject|1|||
124807255|NCT02476201|448924800|FG000|Overall Study|Unsuccessful implant|1|||
124807256|NCT00491764|448924805|FG000|Overall Study|Adverse Event|1|||
124807257|NCT00491764|448924806|FG001|Overall Study|Adverse Event|2|||
124807258|NCT00491764|448924807|FG002|Overall Study|Adverse Event|4|||
124807259|NCT00491764|448924808|FG003|Overall Study|Adverse Event|4|||
124807260|NCT00491764|448924809|FG004|Overall Study|Adverse Event|0|||
124807261|NCT00491764|448924810|FG005|Overall Study|Adverse Event|1|||
124807262|NCT00491764|448924805|FG000|Overall Study|Lost to Follow-up|0|||
124807263|NCT00491764|448924806|FG001|Overall Study|Lost to Follow-up|1|||
124807264|NCT00491764|448924807|FG002|Overall Study|Lost to Follow-up|0|||
124807265|NCT00491764|448924808|FG003|Overall Study|Lost to Follow-up|1|||
124807266|NCT00491764|448924809|FG004|Overall Study|Lost to Follow-up|0|||
124807267|NCT00491764|448924810|FG005|Overall Study|Lost to Follow-up|3|||
124807268|NCT00491764|448924805|FG000|Overall Study|Withdrawal by Subject|2|||
124807269|NCT00491764|448924806|FG001|Overall Study|Withdrawal by Subject|3|||
124807270|NCT00491764|448924807|FG002|Overall Study|Withdrawal by Subject|1|||
124807271|NCT00491764|448924808|FG003|Overall Study|Withdrawal by Subject|2|||
124807272|NCT00491764|448924809|FG004|Overall Study|Withdrawal by Subject|2|||
124807273|NCT00491764|448924810|FG005|Overall Study|Withdrawal by Subject|4|||
124807274|NCT00491764|448924805|FG000|Overall Study|Non Compliance with the Protocol|1|||
124807275|NCT00491764|448924806|FG001|Overall Study|Non Compliance with the Protocol|0|||
124807276|NCT00491764|448924807|FG002|Overall Study|Non Compliance with the Protocol|0|||
124807277|NCT00491764|448924808|FG003|Overall Study|Non Compliance with the Protocol|0|||
124807278|NCT00491764|448924809|FG004|Overall Study|Non Compliance with the Protocol|0|||
124807279|NCT00491764|448924810|FG005|Overall Study|Non Compliance with the Protocol|0|||
124807280|NCT00491764|448924805|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
124807281|NCT00491764|448924806|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
124807282|NCT00491764|448924807|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
124807283|NCT00491764|448924808|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
124807284|NCT00491764|448924809|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
124807285|NCT00491764|448924810|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
124807286|NCT00491764|448924805|FG000|Overall Study|Administrative|1|||
124807287|NCT00491764|448924806|FG001|Overall Study|Administrative|0|||
124807288|NCT00491764|448924807|FG002|Overall Study|Administrative|2|||
124807289|NCT00491764|448924808|FG003|Overall Study|Administrative|1|||
124807290|NCT00491764|448924809|FG004|Overall Study|Administrative|0|||
124807291|NCT00491764|448924810|FG005|Overall Study|Administrative|0|||
124807292|NCT03725852|448924821|FG000|Overall Study|Death|1|||
124807293|NCT03725852|448924822|FG001|Overall Study|Death|0|||
124807294|NCT03725852|448924821|FG000|Overall Study|Withdrawal by Subject|1|||
124807295|NCT03725852|448924822|FG001|Overall Study|Withdrawal by Subject|0|||
124807296|NCT03725852|448924821|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
124807297|NCT03725852|448924822|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
124807298|NCT00116428|448924823|FG000|Overall Study|Withdrawal by Subject|2|||
124807299|NCT00116428|448924824|FG001|Overall Study|Withdrawal by Subject|5|||
124807300|NCT00116428|448924823|FG000|Overall Study|Did not meet inclusion criteria|1|||
124807301|NCT00116428|448924824|FG001|Overall Study|Did not meet inclusion criteria|0|||
124807302|NCT00669396|448924825|FG000|Overall Study|Lost to Follow-up|10|||
124807303|NCT00669396|448924826|FG001|Overall Study|Lost to Follow-up|12|||
124807304|NCT01297920|448924827|FG000|Overall Study|Adverse Event|42|||
124807305|NCT01297920|448924828|FG001|Overall Study|Adverse Event|10|||
124807306|NCT01297920|448924829|FG002|Overall Study|Adverse Event|38|||
124807307|NCT01297920|448924827|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
124807308|NCT01297920|448924828|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
124807309|NCT01297920|448924829|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
124807310|NCT01297920|448924827|FG000|Overall Study|Noncompliance|1|||
124807311|NCT01297920|448924828|FG001|Overall Study|Noncompliance|0|||
124807312|NCT01297920|448924829|FG002|Overall Study|Noncompliance|0|||
124807313|NCT01297920|448924827|FG000|Overall Study|Protocol Violation|1|||
124807314|NCT01297920|448924828|FG001|Overall Study|Protocol Violation|3|||
124807315|NCT01297920|448924829|FG002|Overall Study|Protocol Violation|0|||
124807316|NCT01297920|448924827|FG000|Overall Study|Inadequate Control of IOP|7|||
124807317|NCT01297920|448924828|FG001|Overall Study|Inadequate Control of IOP|9|||
124807318|NCT01297920|448924829|FG002|Overall Study|Inadequate Control of IOP|17|||
124807319|NCT01297920|448924827|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
124807320|NCT01297920|448924828|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
124807321|NCT01297920|448924829|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
124807322|NCT00474760|448924830|FG000|Overall Study|Death|0|||
124807323|NCT00474760|448924831|FG001|Overall Study|Death|0|||
124807324|NCT00474760|448924832|FG002|Overall Study|Death|0|||
124807325|NCT00474760|448924833|FG003|Overall Study|Death|0|||
124807326|NCT00474760|448924834|FG004|Overall Study|Death|2|||
124807327|NCT00474760|448924835|FG005|Overall Study|Death|0|||
124807328|NCT00474760|448924836|FG006|Overall Study|Death|0|||
124807329|NCT00474760|448924830|FG000|Overall Study|Adverse Event|0|||
124807330|NCT00474760|448924831|FG001|Overall Study|Adverse Event|0|||
124807331|NCT00474760|448924832|FG002|Overall Study|Adverse Event|0|||
124807332|NCT00474760|448924833|FG003|Overall Study|Adverse Event|0|||
124807333|NCT00474760|448924834|FG004|Overall Study|Adverse Event|1|||
124807334|NCT00474760|448924835|FG005|Overall Study|Adverse Event|7|||
124807335|NCT00474760|448924836|FG006|Overall Study|Adverse Event|0|||
124807336|NCT00474760|448924830|FG000|Overall Study|Laboratory abnormality|0|||
124807337|NCT00474760|448924831|FG001|Overall Study|Laboratory abnormality|0|||
124807338|NCT00474760|448924832|FG002|Overall Study|Laboratory abnormality|0|||
124807339|NCT00474760|448924833|FG003|Overall Study|Laboratory abnormality|0|||
124807340|NCT00474760|448924834|FG004|Overall Study|Laboratory abnormality|0|||
124807341|NCT00474760|448924835|FG005|Overall Study|Laboratory abnormality|1|||
124807342|NCT00474760|448924836|FG006|Overall Study|Laboratory abnormality|0|||
124807343|NCT00474760|448924830|FG000|Overall Study|Withdrawal by Subject|0|||
124807344|NCT00474760|448924831|FG001|Overall Study|Withdrawal by Subject|0|||
124807345|NCT00474760|448924832|FG002|Overall Study|Withdrawal by Subject|0|||
124807346|NCT00474760|448924833|FG003|Overall Study|Withdrawal by Subject|1|||
124807347|NCT00474760|448924834|FG004|Overall Study|Withdrawal by Subject|0|||
124807348|NCT00474760|448924835|FG005|Overall Study|Withdrawal by Subject|1|||
124807349|NCT00474760|448924836|FG006|Overall Study|Withdrawal by Subject|1|||
124807350|NCT00474760|448924830|FG000|Overall Study|Other|0|||
124807351|NCT00474760|448924831|FG001|Overall Study|Other|1|||
124807352|NCT00474760|448924832|FG002|Overall Study|Other|0|||
124807353|NCT00474760|448924833|FG003|Overall Study|Other|0|||
124807354|NCT00474760|448924834|FG004|Overall Study|Other|1|||
124807355|NCT00474760|448924835|FG005|Overall Study|Other|0|||
124807356|NCT00474760|448924836|FG006|Overall Study|Other|0|||
124807357|NCT00474760|448924830|FG000|Overall Study|Progressive disease|3|||
124807358|NCT00474760|448924831|FG001|Overall Study|Progressive disease|2|||
124807359|NCT00474760|448924832|FG002|Overall Study|Progressive disease|3|||
124807360|NCT00474760|448924833|FG003|Overall Study|Progressive disease|2|||
124807361|NCT00474760|448924834|FG004|Overall Study|Progressive disease|8|||
124807362|NCT00474760|448924835|FG005|Overall Study|Progressive disease|20|||
124807363|NCT00474760|448924836|FG006|Overall Study|Progressive disease|7|||
124807364|NCT00474760|448924830|FG000|Overall Study|Terminated by sponsor|0|||
124807365|NCT00474760|448924831|FG001|Overall Study|Terminated by sponsor|0|||
124807366|NCT00474760|448924832|FG002|Overall Study|Terminated by sponsor|0|||
124807367|NCT00474760|448924833|FG003|Overall Study|Terminated by sponsor|0|||
124807368|NCT00474760|448924834|FG004|Overall Study|Terminated by sponsor|0|||
124807369|NCT00474760|448924835|FG005|Overall Study|Terminated by sponsor|0|||
124807370|NCT00474760|448924836|FG006|Overall Study|Terminated by sponsor|2|||
124807371|NCT02155881|448924845|FG000|Overall Study|Withdrawal by Subject|0|||
124807372|NCT02155881|448924846|FG001|Overall Study|Withdrawal by Subject|2|||
124807373|NCT02155881|448924845|FG000|Overall Study|Inappropriately randomized|2|||
124807374|NCT02155881|448924846|FG001|Overall Study|Inappropriately randomized|2|||
124807375|NCT00066729|448924847|FG000|Overall Study|Lost to Follow-up|1|||
124807376|NCT00066729|448924847|FG000|Overall Study|Disease progression|1|||
124807377|NCT01811225|448924848|FG000|Treatment Period 1|Adverse Event|2|||
124807378|NCT01811225|448924849|FG001|Treatment Period 1|Adverse Event|3|||
124807379|NCT01811225|448924848|FG000|Treatment Period 1|Lost to Follow-up|12|||
124807380|NCT01811225|448924849|FG001|Treatment Period 1|Lost to Follow-up|8|||
124807381|NCT01811225|448924848|FG000|Treatment Period 1|transporation|1|||
124807382|NCT01811225|448924849|FG001|Treatment Period 1|transporation|0|||
124807383|NCT01811225|448924848|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
124807384|NCT01811225|448924849|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
124807385|NCT01811225|448924848|FG000|Treatment Period 2|Lost to Follow-up|1|||
124807386|NCT01811225|448924849|FG001|Treatment Period 2|Lost to Follow-up|2|||
124807387|NCT01811225|448924848|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
124807388|NCT01811225|448924849|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
124807389|NCT02158975|448924850|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
124807390|NCT02840721|448924853|FG000|Treatment Period|Adverse Event|1|||
124807391|NCT02840721|448924853|FG000|Follow-Up|Lack of Efficacy|1|||
124807392|NCT02840721|448924853|FG000|Follow-Up|Withdrawal by Subject|4|||
124807393|NCT02840721|448924853|FG000|Follow-Up|Withdrawal of Consent|2|||
124807394|NCT01967173|448924854|FG000|Overall Study|Lost to Follow-up|5|||
124807395|NCT01967173|448924855|FG001|Overall Study|Lost to Follow-up|3|||
124807396|NCT01967173|448924856|FG002|Overall Study|Lost to Follow-up|2|||
124807397|NCT01967173|448924857|FG003|Overall Study|Lost to Follow-up|4|||
124807398|NCT01967173|448924858|FG004|Overall Study|Lost to Follow-up|8|||
124807399|NCT01967173|448924859|FG005|Overall Study|Lost to Follow-up|12|||
124807400|NCT01967173|448924860|FG006|Overall Study|Lost to Follow-up|6|||
124807401|NCT01967173|448924861|FG007|Overall Study|Lost to Follow-up|8|||
124807402|NCT01967173|448924854|FG000|Overall Study|Physician Decision|2|||
124807403|NCT01967173|448924855|FG001|Overall Study|Physician Decision|0|||
124807404|NCT01967173|448924856|FG002|Overall Study|Physician Decision|2|||
124807405|NCT01967173|448924857|FG003|Overall Study|Physician Decision|1|||
124807406|NCT01967173|448924858|FG004|Overall Study|Physician Decision|1|||
124807407|NCT01967173|448924859|FG005|Overall Study|Physician Decision|1|||
124807408|NCT01967173|448924860|FG006|Overall Study|Physician Decision|1|||
124807409|NCT01967173|448924861|FG007|Overall Study|Physician Decision|0|||
124807410|NCT01967173|448924854|FG000|Overall Study|Lack of Efficacy|2|||
124807411|NCT01967173|448924855|FG001|Overall Study|Lack of Efficacy|0|||
124807412|NCT01967173|448924856|FG002|Overall Study|Lack of Efficacy|2|||
124807413|NCT01967173|448924857|FG003|Overall Study|Lack of Efficacy|2|||
124807414|NCT01967173|448924858|FG004|Overall Study|Lack of Efficacy|0|||
124807415|NCT01967173|448924859|FG005|Overall Study|Lack of Efficacy|1|||
124807416|NCT01967173|448924860|FG006|Overall Study|Lack of Efficacy|0|||
124807417|NCT01967173|448924861|FG007|Overall Study|Lack of Efficacy|2|||
124807418|NCT01967173|448924854|FG000|Overall Study|Pregnancy|0|||
124807419|NCT01967173|448924855|FG001|Overall Study|Pregnancy|0|||
124807420|NCT01967173|448924856|FG002|Overall Study|Pregnancy|0|||
124807421|NCT01967173|448924857|FG003|Overall Study|Pregnancy|0|||
124807422|NCT01967173|448924858|FG004|Overall Study|Pregnancy|0|||
124807423|NCT01967173|448924859|FG005|Overall Study|Pregnancy|0|||
124807424|NCT01967173|448924860|FG006|Overall Study|Pregnancy|1|||
124807425|NCT01967173|448924861|FG007|Overall Study|Pregnancy|1|||
124807426|NCT01967173|448924854|FG000|Overall Study|Adverse Event|0|||
124807427|NCT01967173|448924855|FG001|Overall Study|Adverse Event|0|||
124807428|NCT01967173|448924856|FG002|Overall Study|Adverse Event|0|||
124807429|NCT01967173|448924857|FG003|Overall Study|Adverse Event|0|||
124807430|NCT01967173|448924858|FG004|Overall Study|Adverse Event|0|||
124807431|NCT01967173|448924859|FG005|Overall Study|Adverse Event|0|||
124807432|NCT01967173|448924860|FG006|Overall Study|Adverse Event|0|||
124807433|NCT01967173|448924861|FG007|Overall Study|Adverse Event|1|||
124807434|NCT01967173|448924854|FG000|Overall Study|Withdrawal by Subject|15|||
124807435|NCT01967173|448924855|FG001|Overall Study|Withdrawal by Subject|14|||
124807436|NCT01967173|448924856|FG002|Overall Study|Withdrawal by Subject|10|||
124807437|NCT01967173|448924857|FG003|Overall Study|Withdrawal by Subject|7|||
124807438|NCT01967173|448924858|FG004|Overall Study|Withdrawal by Subject|8|||
124807439|NCT01967173|448924859|FG005|Overall Study|Withdrawal by Subject|9|||
124807440|NCT01967173|448924860|FG006|Overall Study|Withdrawal by Subject|10|||
124807441|NCT01967173|448924861|FG007|Overall Study|Withdrawal by Subject|12|||
124807442|NCT00423514|448924862|FG000|Overall Study|Ineligible|1|||
124807443|NCT00423514|448924863|FG001|Overall Study|Ineligible|0|||
124807444|NCT03685123|448924864|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
124807445|NCT03685123|448924865|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
124807446|NCT03685123|448924866|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
124807447|NCT03685123|448924864|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
124807448|NCT03685123|448924865|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
124807449|NCT03685123|448924866|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
124807450|NCT03685123|448924864|FG000|Weight Loss Phase|Lost to Follow-up|1|||
124807451|NCT03685123|448924865|FG001|Weight Loss Phase|Lost to Follow-up|0|||
124807452|NCT03685123|448924866|FG002|Weight Loss Phase|Lost to Follow-up|0|||
124807453|NCT03685123|448924864|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
124807454|NCT03685123|448924865|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
124807455|NCT03685123|448924866|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
124807456|NCT03685123|448924864|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
124807457|NCT03685123|448924865|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
124807458|NCT03685123|448924866|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
124807459|NCT03685123|448924864|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
124807460|NCT03685123|448924865|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
124807461|NCT03685123|448924866|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
124807462|NCT00400764|448924867|FG000|Phase Ib|Adverse Event|1|||
124807463|NCT00400764|448924868|FG001|Phase Ib|Adverse Event|0|||
124807464|NCT00400764|448924869|FG002|Phase Ib|Adverse Event|0|||
124807465|NCT00400764|448924870|FG003|Phase Ib|Adverse Event|0|||
124807466|NCT00400764|448924871|FG004|Phase Ib|Adverse Event|0|||
124807467|NCT00400764|448924867|FG000|Phase Ib|Death|1|||
124807468|NCT00400764|448924868|FG001|Phase Ib|Death|0|||
124807469|NCT00400764|448924869|FG002|Phase Ib|Death|0|||
124807470|NCT00400764|448924870|FG003|Phase Ib|Death|0|||
124807471|NCT00400764|448924871|FG004|Phase Ib|Death|0|||
124807472|NCT00400764|448924867|FG000|Phase Ib|Disease Progression|4|||
124807473|NCT00400764|448924868|FG001|Phase Ib|Disease Progression|4|||
124807474|NCT00400764|448924869|FG002|Phase Ib|Disease Progression|0|||
124807475|NCT00400764|448924870|FG003|Phase Ib|Disease Progression|0|||
124807476|NCT00400764|448924871|FG004|Phase Ib|Disease Progression|0|||
124807477|NCT00400764|448924867|FG000|Phase II|Death|0|||
124807478|NCT00400764|448924868|FG001|Phase II|Death|0|||
124807479|NCT00400764|448924869|FG002|Phase II|Death|1|||
124807480|NCT00400764|448924870|FG003|Phase II|Death|2|||
124807481|NCT00400764|448924871|FG004|Phase II|Death|0|||
124807482|NCT00400764|448924867|FG000|Phase II|Lost to Follow-up|0|||
124807483|NCT00400764|448924868|FG001|Phase II|Lost to Follow-up|0|||
124807484|NCT00400764|448924869|FG002|Phase II|Lost to Follow-up|1|||
124807485|NCT00400764|448924870|FG003|Phase II|Lost to Follow-up|0|||
124807486|NCT00400764|448924871|FG004|Phase II|Lost to Follow-up|0|||
124807487|NCT00400764|448924867|FG000|Phase II|Physician Decision|0|||
124807488|NCT00400764|448924868|FG001|Phase II|Physician Decision|0|||
124807489|NCT00400764|448924869|FG002|Phase II|Physician Decision|1|||
124807490|NCT00400764|448924870|FG003|Phase II|Physician Decision|1|||
124807491|NCT00400764|448924871|FG004|Phase II|Physician Decision|0|||
124807492|NCT00400764|448924867|FG000|Phase II|Sponsor's decision to terminate|0|||
124807493|NCT00400764|448924868|FG001|Phase II|Sponsor's decision to terminate|0|||
124807494|NCT00400764|448924869|FG002|Phase II|Sponsor's decision to terminate|18|||
124807495|NCT00400764|448924870|FG003|Phase II|Sponsor's decision to terminate|22|||
124807496|NCT00400764|448924871|FG004|Phase II|Sponsor's decision to terminate|11|||
124807497|NCT00400764|448924867|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
124807498|NCT00400764|448924868|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
124807499|NCT00400764|448924869|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
124807500|NCT00400764|448924870|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
124807501|NCT00400764|448924871|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
124807502|NCT00400764|448924867|FG000|Phase II|Withdrawal by Subject|0|||
124807503|NCT00400764|448924868|FG001|Phase II|Withdrawal by Subject|0|||
124807504|NCT00400764|448924869|FG002|Phase II|Withdrawal by Subject|1|||
124807505|NCT00400764|448924870|FG003|Phase II|Withdrawal by Subject|1|||
124807506|NCT00400764|448924871|FG004|Phase II|Withdrawal by Subject|0|||
124807507|NCT02628938|448924872|FG000|Overall Study|Did not attend the follow up recall|2|||
124807508|NCT02628938|448924873|FG001|Overall Study|Did not attend the follow up recall|2|||
124807509|NCT02628938|448924874|FG002|Overall Study|Did not attend the follow up recall|1|||
124807510|NCT02628938|448924872|FG000|Overall Study|Failure to comply with the instructions|3|||
124807511|NCT02628938|448924873|FG001|Overall Study|Failure to comply with the instructions|0|||
124807512|NCT02628938|448924874|FG002|Overall Study|Failure to comply with the instructions|3|||
124807513|NCT03113916|448924875|FG000|Overall Study|Withdrawal by Subject|9|||
124807514|NCT03113916|448924876|FG001|Overall Study|Withdrawal by Subject|7|||
124807515|NCT03113916|448924875|FG000|Overall Study|Pregnancy|1|||
124807516|NCT03113916|448924876|FG001|Overall Study|Pregnancy|3|||
124807517|NCT03113916|448924875|FG000|Overall Study|Lost to Follow-up|1|||
124807518|NCT03113916|448924876|FG001|Overall Study|Lost to Follow-up|2|||
124807519|NCT00241358|448924877|FG000|Overall Study|Determined to be not ineligible|0|||
124807520|NCT00241358|448924878|FG001|Overall Study|Determined to be not ineligible|1|||
124807521|NCT00241358|448924879|FG002|Overall Study|Determined to be not ineligible|1|||
124807522|NCT01758523|448924880|FG000|Overall Study|Adverse Event|2|||
124807523|NCT01758523|448924881|FG001|Overall Study|Adverse Event|1|||
124807524|NCT01758523|448924880|FG000|Overall Study|Lack of Efficacy|4|||
124807525|NCT01758523|448924881|FG001|Overall Study|Lack of Efficacy|2|||
124807526|NCT01758523|448924880|FG000|Overall Study|Lost to Follow-up|3|||
124807527|NCT01758523|448924881|FG001|Overall Study|Lost to Follow-up|4|||
124807528|NCT01758523|448924880|FG000|Overall Study|Withdrawal by Subject|12|||
124807529|NCT01758523|448924881|FG001|Overall Study|Withdrawal by Subject|7|||
124807530|NCT00621959|448924882|FG000|Overall Study|Adverse Event|4|||
124807531|NCT00621959|448924883|FG001|Overall Study|Adverse Event|2|||
124807532|NCT00621959|448924882|FG000|Overall Study|Lack of Efficacy|1|||
124807533|NCT00621959|448924883|FG001|Overall Study|Lack of Efficacy|1|||
124807534|NCT00621959|448924882|FG000|Overall Study|Lost to Follow-up|0|||
124807535|NCT00621959|448924883|FG001|Overall Study|Lost to Follow-up|2|||
124807536|NCT00621959|448924882|FG000|Overall Study|Withdrawal by Subject|1|||
124807537|NCT00621959|448924883|FG001|Overall Study|Withdrawal by Subject|1|||
124807538|NCT00621959|448924882|FG000|Overall Study|Other|1|||
124807539|NCT00621959|448924883|FG001|Overall Study|Other|3|||
124807540|NCT00590135|448924884|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
124807541|NCT03439657|448924885|FG000|Overall Study|Adverse Event|2|||
124807542|NCT03439657|448924886|FG001|Overall Study|Adverse Event|3|||
124807543|NCT03439657|448924885|FG000|Overall Study|Lost to Follow-up|1|||
124807544|NCT03439657|448924886|FG001|Overall Study|Lost to Follow-up|0|||
124807545|NCT03439657|448924885|FG000|Overall Study|Protocol Violation|1|||
124807546|NCT03439657|448924886|FG001|Overall Study|Protocol Violation|1|||
124807547|NCT03439657|448924885|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
124807548|NCT03439657|448924886|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
124807549|NCT04032652|448924889|FG000|Overall Study|The study was terminated and the PI has|1|||
124807550|NCT04032652|448924890|FG001|Overall Study|The study was terminated and the PI has|1|||
124807551|NCT00289016|448924893|FG000|Overall Study|Disease Progression|29|||
124807552|NCT00289016|448924893|FG000|Overall Study|Death|2|||
124807553|NCT00289016|448924893|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
124807554|NCT00289016|448924893|FG000|Overall Study|Withdrawal by Subject|2|||
124807555|NCT00289016|448924893|FG000|Overall Study|Adverse Event|1|||
125299941|NCT00812565|450723801|FG000|Overall Study|Did Not Receive Study Medication|1|||
125299942|NCT00812565|450723802|FG001|Overall Study|Did Not Receive Study Medication|1|||
125299943|NCT00812565|450723803|FG002|Overall Study|Did Not Receive Study Medication|0|||
125299944|NCT00812565|450723804|FG003|Overall Study|Did Not Receive Study Medication|0|||
125299945|NCT00812565|450723805|FG004|Overall Study|Did Not Receive Study Medication|0|||
125299946|NCT00812565|450723806|FG005|Overall Study|Did Not Receive Study Medication|0|||
125299947|NCT00812565|450723807|FG006|Overall Study|Did Not Receive Study Medication|0|||
125299948|NCT00812565|450723808|FG007|Overall Study|Did Not Receive Study Medication|0|||
125299949|NCT00812565|450723801|FG000|Overall Study|Adverse Event|0|||
125299950|NCT00812565|450723802|FG001|Overall Study|Adverse Event|0|||
125299951|NCT00812565|450723803|FG002|Overall Study|Adverse Event|0|||
125299952|NCT00812565|450723804|FG003|Overall Study|Adverse Event|2|||
125299953|NCT00812565|450723805|FG004|Overall Study|Adverse Event|0|||
125299954|NCT00812565|450723806|FG005|Overall Study|Adverse Event|0|||
125299955|NCT00812565|450723807|FG006|Overall Study|Adverse Event|0|||
125299956|NCT00812565|450723808|FG007|Overall Study|Adverse Event|1|||
125299957|NCT00812565|450723801|FG000|Overall Study|Did Not Come to Study Visit|1|||
125299958|NCT00812565|450723802|FG001|Overall Study|Did Not Come to Study Visit|0|||
125299959|NCT00812565|450723803|FG002|Overall Study|Did Not Come to Study Visit|0|||
125299960|NCT00812565|450723804|FG003|Overall Study|Did Not Come to Study Visit|0|||
125299961|NCT00812565|450723805|FG004|Overall Study|Did Not Come to Study Visit|0|||
125299962|NCT00812565|450723806|FG005|Overall Study|Did Not Come to Study Visit|0|||
125299963|NCT00812565|450723807|FG006|Overall Study|Did Not Come to Study Visit|0|||
125299964|NCT00812565|450723808|FG007|Overall Study|Did Not Come to Study Visit|0|||
125299965|NCT00812565|450723801|FG000|Overall Study|Withdrawal of Consent|1|||
125299966|NCT00812565|450723802|FG001|Overall Study|Withdrawal of Consent|0|||
125299967|NCT00812565|450723803|FG002|Overall Study|Withdrawal of Consent|0|||
125299968|NCT00812565|450723804|FG003|Overall Study|Withdrawal of Consent|0|||
125299969|NCT00812565|450723805|FG004|Overall Study|Withdrawal of Consent|1|||
125299970|NCT00812565|450723806|FG005|Overall Study|Withdrawal of Consent|0|||
125299971|NCT00812565|450723807|FG006|Overall Study|Withdrawal of Consent|0|||
125299972|NCT00812565|450723808|FG007|Overall Study|Withdrawal of Consent|0|||
125299973|NCT00812565|450723801|FG000|Overall Study|Reason Not Specified|0|||
125299974|NCT00812565|450723802|FG001|Overall Study|Reason Not Specified|0|||
125299975|NCT00812565|450723803|FG002|Overall Study|Reason Not Specified|0|||
125299976|NCT00812565|450723804|FG003|Overall Study|Reason Not Specified|0|||
125299977|NCT00812565|450723805|FG004|Overall Study|Reason Not Specified|0|||
125299978|NCT00812565|450723806|FG005|Overall Study|Reason Not Specified|1|||
125299979|NCT00812565|450723807|FG006|Overall Study|Reason Not Specified|0|||
125299980|NCT00812565|450723808|FG007|Overall Study|Reason Not Specified|0|||
125299981|NCT00765063|450725854|FG000|Overall Study|Lack of Efficacy|5|||
125299982|NCT00765063|450725854|FG000|Overall Study|Withdrawal by Subject|1|||
125299983|NCT00765063|450725854|FG000|Overall Study|Other|16|||
125299984|NCT00765063|450725854|FG000|Overall Study|Protocol Violation|6|||
125299985|NCT00765063|450725854|FG000|Overall Study|Adverse Event|4|||
125299986|NCT03614325|450725855|FG000|Overall Study|Withdrawal by Subject|0|||
125299987|NCT03614325|450725856|FG001|Overall Study|Withdrawal by Subject|2|||
125299988|NCT03614325|450725855|FG000|Overall Study|Surgery Cancelled|2|||
125299989|NCT03614325|450725856|FG001|Overall Study|Surgery Cancelled|1|||
125299990|NCT03614325|450725855|FG000|Overall Study|Lost to Follow-up|2|||
125299991|NCT03614325|450725856|FG001|Overall Study|Lost to Follow-up|1|||
125299992|NCT03614325|450725855|FG000|Overall Study|Surgery never scheduled|1|||
125299993|NCT03614325|450725856|FG001|Overall Study|Surgery never scheduled|0|||
125299994|NCT01041287|450725857|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
124807556|NCT00289016|448924893|FG000|Overall Study|Other|1|||
125299995|NCT01041287|450725858|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
125299996|NCT01041287|450725857|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
125299997|NCT01041287|450725858|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
125299998|NCT01673620|450725864|FG000|Overall Study|Adverse Event|1|||
125299999|NCT01673620|450725865|FG001|Overall Study|Adverse Event|0|||
125300000|NCT01597635|450725867|FG000|Part A|Adverse Event|3|||
124807557|NCT02764697|448924894|FG000|Overall Study|Lack of Efficacy|3|||
124807558|NCT00302107|448924895|FG000|Overall Study|Lost to Follow-up|6|||
124807559|NCT00302107|448924896|FG001|Overall Study|Lost to Follow-up|5|||
125300001|NCT01597635|450725868|FG001|Part A|Adverse Event|0|||
125300002|NCT01597635|450725869|FG002|Part A|Adverse Event|0|||
125300003|NCT01597635|450725867|FG000|Part B|Adverse Event|0|||
125300004|NCT01597635|450725868|FG001|Part B|Adverse Event|0|||
125300005|NCT01597635|450725869|FG002|Part B|Adverse Event|1|||
125300006|NCT01597635|450725867|FG000|Part B|Protocol Violation|0|||
125300007|NCT01597635|450725868|FG001|Part B|Protocol Violation|1|||
125300008|NCT01597635|450725869|FG002|Part B|Protocol Violation|0|||
125300009|NCT01597635|450725867|FG000|Part B|Protocol-defined stopping criteria|0|||
125300010|NCT01597635|450725868|FG001|Part B|Protocol-defined stopping criteria|4|||
125300011|NCT01597635|450725869|FG002|Part B|Protocol-defined stopping criteria|3|||
125300012|NCT01597635|450725867|FG000|Part B|Withdrawal by Subject|0|||
125300013|NCT01597635|450725868|FG001|Part B|Withdrawal by Subject|1|||
125300014|NCT01597635|450725869|FG002|Part B|Withdrawal by Subject|0|||
125300015|NCT01363661|450725870|FG000|Overall Study|Adverse Event|9|||
124807560|NCT00302107|448924895|FG000|Overall Study|Protocol Violation|1|||
124807561|NCT00302107|448924896|FG001|Overall Study|Protocol Violation|0|||
124807562|NCT00302107|448924895|FG000|Overall Study|Relocation|0|||
124807563|NCT00302107|448924896|FG001|Overall Study|Relocation|1|||
124807564|NCT00302107|448924895|FG000|Overall Study|Withdrawal by Subject|0|||
124807565|NCT00302107|448924896|FG001|Overall Study|Withdrawal by Subject|3|||
124807566|NCT00302107|448924895|FG000|Overall Study|Adverse Event|1|||
124807567|NCT00302107|448924896|FG001|Overall Study|Adverse Event|0|||
124807568|NCT01790932|448924897|FG000|Overall Study|Disease Progression|41|||
124807569|NCT01790932|448924897|FG000|Overall Study|Adverse Event|7|||
124807570|NCT01790932|448924897|FG000|Overall Study|Physician Decision|1|||
124807571|NCT01790932|448924897|FG000|Overall Study|Withdrawal by Subject|1|||
124807572|NCT04223973|448924898|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
124807573|NCT04223973|448924899|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
124807574|NCT04223973|448924898|FG000|Overall Study|Adverse Event|4|||
124807575|NCT04223973|448924899|FG001|Overall Study|Adverse Event|0|||
124807576|NCT04223973|448924898|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
124807577|NCT04223973|448924899|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
124807578|NCT04223973|448924898|FG000|Overall Study|Physician Decision|1|||
124807579|NCT04223973|448924899|FG001|Overall Study|Physician Decision|1|||
124807580|NCT04223973|448924898|FG000|Overall Study|Withdrawal by Subject|0|||
124807581|NCT04223973|448924899|FG001|Overall Study|Withdrawal by Subject|1|||
124807582|NCT02612129|448924901|FG000|Single Dose Treatment Period|Screening Failure|1|||
124807583|NCT02612129|448924902|FG001|Single Dose Treatment Period|Screening Failure|0|||
124807584|NCT02612129|448924903|FG002|Single Dose Treatment Period|Screening Failure|0|||
124807585|NCT02612129|448924901|FG000|Continuous Treatment Period|Early Escape|0|||
124807586|NCT02612129|448924902|FG001|Continuous Treatment Period|Early Escape|2|||
124807587|NCT02612129|448924903|FG002|Continuous Treatment Period|Early Escape|0|||
124807588|NCT02612129|448924901|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
124807589|NCT02612129|448924902|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
124807590|NCT02612129|448924903|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
124807591|NCT02612129|448924901|FG000|Continuous Treatment Period|Safety Reasons|0|||
124807592|NCT02612129|448924902|FG001|Continuous Treatment Period|Safety Reasons|3|||
124807593|NCT02612129|448924903|FG002|Continuous Treatment Period|Safety Reasons|0|||
124807594|NCT02612129|448924901|FG000|Continuous Treatment Period|Death|0|||
124807595|NCT02612129|448924902|FG001|Continuous Treatment Period|Death|1|||
124807596|NCT02612129|448924903|FG002|Continuous Treatment Period|Death|0|||
124807597|NCT02612129|448924901|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
124807598|NCT02612129|448924902|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
124807599|NCT02612129|448924903|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
124807600|NCT00531934|448927203|FG000|Overall Study|Adverse Event|4|||
124807601|NCT00531934|448927204|FG001|Overall Study|Adverse Event|8|||
124807602|NCT00531934|448927203|FG000|Overall Study|Progression|52|||
124807603|NCT00531934|448927204|FG001|Overall Study|Progression|42|||
125300016|NCT01363661|450725871|FG001|Overall Study|Adverse Event|2|||
125300017|NCT01363661|450725870|FG000|Overall Study|Withdrawal by Subject|1|||
125300018|NCT01363661|450725871|FG001|Overall Study|Withdrawal by Subject|1|||
124807604|NCT00531934|448927203|FG000|Overall Study|Death|7|||
125300019|NCT01363661|450725870|FG000|Overall Study|Protocol Violation|1|||
125300020|NCT01363661|450725871|FG001|Overall Study|Protocol Violation|0|||
125300021|NCT01363661|450725870|FG000|Overall Study|Lost to Follow-up|3|||
125300022|NCT01363661|450725871|FG001|Overall Study|Lost to Follow-up|1|||
125300023|NCT01971008|450725872|FG000|Overall Study|Protocol Violation|2|||
125300024|NCT01971008|450725873|FG001|Overall Study|Protocol Violation|1|||
125300025|NCT03775512|450725874|FG000|Overall Study|Death|1|||
125300026|NCT03775512|450725875|FG001|Overall Study|Death|1|||
125300027|NCT03775512|450725874|FG000|Overall Study|Withdrawal by Subject|7|||
125300028|NCT03775512|450725875|FG001|Overall Study|Withdrawal by Subject|4|||
124807605|NCT00531934|448927204|FG001|Overall Study|Death|10|||
124807606|NCT00531934|448927203|FG000|Overall Study|Withdrawal by Subject|1|||
124807607|NCT00531934|448927204|FG001|Overall Study|Withdrawal by Subject|1|||
124807608|NCT00531934|448927203|FG000|Overall Study|Other|2|||
124807609|NCT00531934|448927204|FG001|Overall Study|Other|2|||
124807610|NCT01543698|448927209|FG000|Phase 1b|Disease progression|2|||
124807611|NCT01543698|448927210|FG001|Phase 1b|Disease progression|4|||
124807612|NCT01543698|448927211|FG002|Phase 1b|Disease progression|3|||
124807613|NCT01543698|448927212|FG003|Phase 1b|Disease progression|2|||
124807614|NCT01543698|448927213|FG004|Phase 1b|Disease progression|10|||
124807615|NCT01543698|448927214|FG005|Phase 1b|Disease progression|6|||
124807616|NCT01543698|448927215|FG006|Phase 1b|Disease progression|5|||
124807617|NCT01543698|448927216|FG007|Phase 1b|Disease progression|3|||
124807618|NCT01543698|448927217|FG008|Phase 1b|Disease progression|4|||
124807619|NCT01543698|448927218|FG009|Phase 1b|Disease progression|5|||
124807620|NCT01543698|448927219|FG010|Phase 1b|Disease progression|1|||
124807621|NCT01543698|448927220|FG011|Phase 1b|Disease progression|0|||
124807622|NCT01543698|448927221|FG012|Phase 1b|Disease progression|0|||
124807623|NCT01543698|448927222|FG013|Phase 1b|Disease progression|0|||
124807624|NCT01543698|448927223|FG014|Phase 1b|Disease progression|0|||
124807625|NCT01543698|448927209|FG000|Phase 1b|Death|0|||
124807626|NCT01543698|448927210|FG001|Phase 1b|Death|0|||
124807627|NCT01543698|448927211|FG002|Phase 1b|Death|1|||
124807628|NCT01543698|448927212|FG003|Phase 1b|Death|1|||
124807629|NCT01543698|448927213|FG004|Phase 1b|Death|0|||
124807630|NCT01543698|448927214|FG005|Phase 1b|Death|0|||
124807631|NCT01543698|448927215|FG006|Phase 1b|Death|0|||
124807632|NCT01543698|448927216|FG007|Phase 1b|Death|0|||
124807633|NCT01543698|448927217|FG008|Phase 1b|Death|0|||
124807634|NCT01543698|448927218|FG009|Phase 1b|Death|0|||
124807635|NCT01543698|448927219|FG010|Phase 1b|Death|1|||
124807636|NCT01543698|448927220|FG011|Phase 1b|Death|0|||
124807637|NCT01543698|448927221|FG012|Phase 1b|Death|0|||
124807638|NCT01543698|448927222|FG013|Phase 1b|Death|0|||
124807639|NCT01543698|448927223|FG014|Phase 1b|Death|0|||
124807640|NCT01543698|448927209|FG000|Phase 1b|Withdrawal by Subject|0|||
124807641|NCT01543698|448927210|FG001|Phase 1b|Withdrawal by Subject|1|||
124807642|NCT01543698|448927211|FG002|Phase 1b|Withdrawal by Subject|0|||
124807643|NCT01543698|448927212|FG003|Phase 1b|Withdrawal by Subject|1|||
124807644|NCT01543698|448927213|FG004|Phase 1b|Withdrawal by Subject|0|||
124807645|NCT01543698|448927214|FG005|Phase 1b|Withdrawal by Subject|0|||
124807646|NCT01543698|448927215|FG006|Phase 1b|Withdrawal by Subject|1|||
124807647|NCT01543698|448927216|FG007|Phase 1b|Withdrawal by Subject|0|||
124807648|NCT01543698|448927217|FG008|Phase 1b|Withdrawal by Subject|0|||
124807649|NCT01543698|448927218|FG009|Phase 1b|Withdrawal by Subject|0|||
124807650|NCT01543698|448927219|FG010|Phase 1b|Withdrawal by Subject|0|||
124807651|NCT01543698|448927220|FG011|Phase 1b|Withdrawal by Subject|0|||
124807652|NCT01543698|448927221|FG012|Phase 1b|Withdrawal by Subject|0|||
124807653|NCT01543698|448927222|FG013|Phase 1b|Withdrawal by Subject|0|||
124807654|NCT01543698|448927223|FG014|Phase 1b|Withdrawal by Subject|0|||
124807655|NCT01543698|448927209|FG000|Phase 1b|Adverse Event|1|||
124807656|NCT01543698|448927210|FG001|Phase 1b|Adverse Event|0|||
124807657|NCT01543698|448927211|FG002|Phase 1b|Adverse Event|0|||
124807658|NCT01543698|448927212|FG003|Phase 1b|Adverse Event|1|||
124807659|NCT01543698|448927213|FG004|Phase 1b|Adverse Event|2|||
124807660|NCT01543698|448927214|FG005|Phase 1b|Adverse Event|2|||
124807661|NCT01543698|448927215|FG006|Phase 1b|Adverse Event|0|||
124807662|NCT01543698|448927216|FG007|Phase 1b|Adverse Event|0|||
124807663|NCT01543698|448927217|FG008|Phase 1b|Adverse Event|1|||
124807664|NCT01543698|448927218|FG009|Phase 1b|Adverse Event|1|||
124807665|NCT01543698|448927219|FG010|Phase 1b|Adverse Event|2|||
124807666|NCT01543698|448927220|FG011|Phase 1b|Adverse Event|0|||
124807667|NCT01543698|448927221|FG012|Phase 1b|Adverse Event|0|||
124807668|NCT01543698|448927222|FG013|Phase 1b|Adverse Event|0|||
124807669|NCT01543698|448927223|FG014|Phase 1b|Adverse Event|0|||
124807670|NCT01543698|448927209|FG000|Phase 1b|Administrative problems|1|||
124807671|NCT01543698|448927210|FG001|Phase 1b|Administrative problems|0|||
124807672|NCT01543698|448927211|FG002|Phase 1b|Administrative problems|0|||
124807673|NCT01543698|448927212|FG003|Phase 1b|Administrative problems|0|||
124807674|NCT01543698|448927213|FG004|Phase 1b|Administrative problems|1|||
124807675|NCT01543698|448927214|FG005|Phase 1b|Administrative problems|0|||
124807676|NCT01543698|448927215|FG006|Phase 1b|Administrative problems|0|||
124807677|NCT01543698|448927216|FG007|Phase 1b|Administrative problems|1|||
124807678|NCT01543698|448927217|FG008|Phase 1b|Administrative problems|0|||
124807679|NCT01543698|448927218|FG009|Phase 1b|Administrative problems|0|||
124807680|NCT01543698|448927219|FG010|Phase 1b|Administrative problems|2|||
124807681|NCT01543698|448927220|FG011|Phase 1b|Administrative problems|0|||
124807682|NCT01543698|448927221|FG012|Phase 1b|Administrative problems|0|||
124807683|NCT01543698|448927222|FG013|Phase 1b|Administrative problems|0|||
124807684|NCT01543698|448927223|FG014|Phase 1b|Administrative problems|0|||
124807685|NCT01543698|448927209|FG000|Phase 1b|Protocol Violation|2|||
124807686|NCT01543698|448927210|FG001|Phase 1b|Protocol Violation|0|||
124807687|NCT01543698|448927211|FG002|Phase 1b|Protocol Violation|0|||
124807688|NCT01543698|448927212|FG003|Phase 1b|Protocol Violation|0|||
124807689|NCT01543698|448927213|FG004|Phase 1b|Protocol Violation|0|||
124807690|NCT01543698|448927214|FG005|Phase 1b|Protocol Violation|0|||
124807691|NCT01543698|448927215|FG006|Phase 1b|Protocol Violation|0|||
124807692|NCT01543698|448927216|FG007|Phase 1b|Protocol Violation|0|||
124807693|NCT01543698|448927217|FG008|Phase 1b|Protocol Violation|0|||
124807694|NCT01543698|448927218|FG009|Phase 1b|Protocol Violation|0|||
124807695|NCT01543698|448927219|FG010|Phase 1b|Protocol Violation|0|||
124807696|NCT01543698|448927220|FG011|Phase 1b|Protocol Violation|0|||
124807697|NCT01543698|448927221|FG012|Phase 1b|Protocol Violation|0|||
124807698|NCT01543698|448927222|FG013|Phase 1b|Protocol Violation|0|||
124807699|NCT01543698|448927223|FG014|Phase 1b|Protocol Violation|0|||
124807700|NCT01543698|448927209|FG000|Phase 2|Protocol Violation|0|||
124807701|NCT01543698|448927210|FG001|Phase 2|Protocol Violation|0|||
124807702|NCT01543698|448927211|FG002|Phase 2|Protocol Violation|0|||
124807703|NCT01543698|448927212|FG003|Phase 2|Protocol Violation|0|||
124807704|NCT01543698|448927213|FG004|Phase 2|Protocol Violation|0|||
124807705|NCT01543698|448927214|FG005|Phase 2|Protocol Violation|0|||
124807706|NCT01543698|448927215|FG006|Phase 2|Protocol Violation|0|||
124807707|NCT01543698|448927216|FG007|Phase 2|Protocol Violation|0|||
124807708|NCT01543698|448927217|FG008|Phase 2|Protocol Violation|0|||
124807709|NCT01543698|448927218|FG009|Phase 2|Protocol Violation|0|||
124807710|NCT01543698|448927219|FG010|Phase 2|Protocol Violation|0|||
124807711|NCT01543698|448927220|FG011|Phase 2|Protocol Violation|0|||
124807712|NCT01543698|448927221|FG012|Phase 2|Protocol Violation|1|||
124807713|NCT01543698|448927222|FG013|Phase 2|Protocol Violation|0|||
124807714|NCT01543698|448927223|FG014|Phase 2|Protocol Violation|0|||
124807715|NCT01543698|448927209|FG000|Phase 2|Disease progression|0|||
124807716|NCT01543698|448927210|FG001|Phase 2|Disease progression|0|||
124807717|NCT01543698|448927211|FG002|Phase 2|Disease progression|0|||
124807718|NCT01543698|448927212|FG003|Phase 2|Disease progression|0|||
124807719|NCT01543698|448927213|FG004|Phase 2|Disease progression|0|||
124807720|NCT01543698|448927214|FG005|Phase 2|Disease progression|0|||
124807721|NCT01543698|448927215|FG006|Phase 2|Disease progression|0|||
124807722|NCT01543698|448927216|FG007|Phase 2|Disease progression|0|||
124807723|NCT01543698|448927217|FG008|Phase 2|Disease progression|0|||
124807724|NCT01543698|448927218|FG009|Phase 2|Disease progression|0|||
124807725|NCT01543698|448927219|FG010|Phase 2|Disease progression|0|||
124807726|NCT01543698|448927220|FG011|Phase 2|Disease progression|10|||
124807727|NCT01543698|448927221|FG012|Phase 2|Disease progression|21|||
124807728|NCT01543698|448927222|FG013|Phase 2|Disease progression|30|||
124807729|NCT01543698|448927223|FG014|Phase 2|Disease progression|25|||
124807730|NCT01543698|448927209|FG000|Phase 2|Death|0|||
124807731|NCT01543698|448927210|FG001|Phase 2|Death|0|||
124807732|NCT01543698|448927211|FG002|Phase 2|Death|0|||
124807733|NCT01543698|448927212|FG003|Phase 2|Death|0|||
124807734|NCT01543698|448927213|FG004|Phase 2|Death|0|||
124807735|NCT01543698|448927214|FG005|Phase 2|Death|0|||
124807736|NCT01543698|448927215|FG006|Phase 2|Death|0|||
124807737|NCT01543698|448927216|FG007|Phase 2|Death|0|||
124807738|NCT01543698|448927217|FG008|Phase 2|Death|0|||
124807739|NCT01543698|448927218|FG009|Phase 2|Death|0|||
124807740|NCT01543698|448927219|FG010|Phase 2|Death|0|||
124807741|NCT01543698|448927220|FG011|Phase 2|Death|0|||
124807742|NCT01543698|448927221|FG012|Phase 2|Death|1|||
124807743|NCT01543698|448927222|FG013|Phase 2|Death|1|||
124807744|NCT01543698|448927223|FG014|Phase 2|Death|1|||
124807745|NCT01543698|448927209|FG000|Phase 2|Administrative problems|0|||
124807746|NCT01543698|448927210|FG001|Phase 2|Administrative problems|0|||
124807747|NCT01543698|448927211|FG002|Phase 2|Administrative problems|0|||
124807748|NCT01543698|448927212|FG003|Phase 2|Administrative problems|0|||
124807749|NCT01543698|448927213|FG004|Phase 2|Administrative problems|0|||
124807750|NCT01543698|448927214|FG005|Phase 2|Administrative problems|0|||
124807751|NCT01543698|448927215|FG006|Phase 2|Administrative problems|0|||
124807752|NCT01543698|448927216|FG007|Phase 2|Administrative problems|0|||
124807753|NCT01543698|448927217|FG008|Phase 2|Administrative problems|0|||
124807754|NCT01543698|448927218|FG009|Phase 2|Administrative problems|0|||
125300029|NCT03775512|450725874|FG000|Overall Study|Lost to Follow-up|5|||
124807755|NCT01543698|448927219|FG010|Phase 2|Administrative problems|0|||
124807756|NCT01543698|448927220|FG011|Phase 2|Administrative problems|0|||
124807757|NCT01543698|448927221|FG012|Phase 2|Administrative problems|0|||
124807758|NCT01543698|448927222|FG013|Phase 2|Administrative problems|3|||
124807759|NCT01543698|448927223|FG014|Phase 2|Administrative problems|1|||
124807760|NCT01543698|448927209|FG000|Phase 2|Withdrawal by Subject|0|||
124807761|NCT01543698|448927210|FG001|Phase 2|Withdrawal by Subject|0|||
124807762|NCT01543698|448927211|FG002|Phase 2|Withdrawal by Subject|0|||
124807763|NCT01543698|448927212|FG003|Phase 2|Withdrawal by Subject|0|||
124807764|NCT01543698|448927213|FG004|Phase 2|Withdrawal by Subject|0|||
124807765|NCT01543698|448927214|FG005|Phase 2|Withdrawal by Subject|0|||
124807766|NCT01543698|448927215|FG006|Phase 2|Withdrawal by Subject|0|||
124807767|NCT01543698|448927216|FG007|Phase 2|Withdrawal by Subject|0|||
124807768|NCT01543698|448927217|FG008|Phase 2|Withdrawal by Subject|0|||
124807769|NCT01543698|448927218|FG009|Phase 2|Withdrawal by Subject|0|||
124807770|NCT01543698|448927219|FG010|Phase 2|Withdrawal by Subject|0|||
124807771|NCT01543698|448927220|FG011|Phase 2|Withdrawal by Subject|0|||
124807772|NCT01543698|448927221|FG012|Phase 2|Withdrawal by Subject|0|||
124807773|NCT01543698|448927222|FG013|Phase 2|Withdrawal by Subject|3|||
124807774|NCT01543698|448927223|FG014|Phase 2|Withdrawal by Subject|1|||
124807775|NCT01543698|448927209|FG000|Phase 2|Adverse Event|0|||
124807776|NCT01543698|448927210|FG001|Phase 2|Adverse Event|0|||
124807777|NCT01543698|448927211|FG002|Phase 2|Adverse Event|0|||
124807778|NCT01543698|448927212|FG003|Phase 2|Adverse Event|0|||
124807779|NCT01543698|448927213|FG004|Phase 2|Adverse Event|0|||
124807780|NCT01543698|448927214|FG005|Phase 2|Adverse Event|0|||
124807781|NCT01543698|448927215|FG006|Phase 2|Adverse Event|0|||
124807782|NCT01543698|448927216|FG007|Phase 2|Adverse Event|0|||
124807783|NCT01543698|448927217|FG008|Phase 2|Adverse Event|0|||
124807784|NCT01543698|448927218|FG009|Phase 2|Adverse Event|0|||
124807785|NCT01543698|448927219|FG010|Phase 2|Adverse Event|0|||
124807786|NCT01543698|448927220|FG011|Phase 2|Adverse Event|1|||
124807787|NCT01543698|448927221|FG012|Phase 2|Adverse Event|3|||
124807788|NCT01543698|448927222|FG013|Phase 2|Adverse Event|5|||
124807789|NCT01543698|448927223|FG014|Phase 2|Adverse Event|14|||
124807790|NCT00150709|448927224|FG000|Overall Study|Protocol Violation|7|||
124807791|NCT00150709|448927225|FG001|Overall Study|Protocol Violation|8|||
124807792|NCT00150709|448927226|FG002|Overall Study|Protocol Violation|3|||
124807793|NCT00150709|448927227|FG003|Overall Study|Protocol Violation|1|||
124807794|NCT00150709|448927224|FG000|Overall Study|Adverse Event|8|||
124807795|NCT00150709|448927225|FG001|Overall Study|Adverse Event|2|||
124807796|NCT00150709|448927226|FG002|Overall Study|Adverse Event|2|||
124807797|NCT00150709|448927227|FG003|Overall Study|Adverse Event|3|||
124807798|NCT00150709|448927224|FG000|Overall Study|Lack of Efficacy|6|||
124807799|NCT00150709|448927225|FG001|Overall Study|Lack of Efficacy|11|||
124807800|NCT00150709|448927226|FG002|Overall Study|Lack of Efficacy|9|||
124807801|NCT00150709|448927227|FG003|Overall Study|Lack of Efficacy|0|||
124807802|NCT00150709|448927224|FG000|Overall Study|Withdrawal by Subject|7|||
124807803|NCT00150709|448927225|FG001|Overall Study|Withdrawal by Subject|10|||
124807804|NCT00150709|448927226|FG002|Overall Study|Withdrawal by Subject|5|||
124807805|NCT00150709|448927227|FG003|Overall Study|Withdrawal by Subject|0|||
124807806|NCT00150709|448927224|FG000|Overall Study|Lost to Follow-up|3|||
124807807|NCT00150709|448927225|FG001|Overall Study|Lost to Follow-up|2|||
124807808|NCT00150709|448927226|FG002|Overall Study|Lost to Follow-up|0|||
124807809|NCT00150709|448927227|FG003|Overall Study|Lost to Follow-up|0|||
124807810|NCT00150709|448927224|FG000|Overall Study|Sponsor decision|0|||
124807811|NCT00150709|448927225|FG001|Overall Study|Sponsor decision|0|||
124807812|NCT00150709|448927226|FG002|Overall Study|Sponsor decision|0|||
124807813|NCT00150709|448927227|FG003|Overall Study|Sponsor decision|1|||
124807814|NCT00150709|448927224|FG000|Overall Study|Site/Investigator discontinued the study|5|||
124807815|NCT00150709|448927225|FG001|Overall Study|Site/Investigator discontinued the study|5|||
124807816|NCT00150709|448927226|FG002|Overall Study|Site/Investigator discontinued the study|2|||
124807817|NCT00150709|448927227|FG003|Overall Study|Site/Investigator discontinued the study|0|||
124807818|NCT00150709|448927224|FG000|Overall Study|Decision of parent(s)|1|||
124807819|NCT00150709|448927225|FG001|Overall Study|Decision of parent(s)|2|||
124807820|NCT00150709|448927226|FG002|Overall Study|Decision of parent(s)|0|||
124807821|NCT00150709|448927227|FG003|Overall Study|Decision of parent(s)|0|||
124807822|NCT00150709|448927224|FG000|Overall Study|Decision of parent(s) and investigator|3|||
124807823|NCT00150709|448927225|FG001|Overall Study|Decision of parent(s) and investigator|0|||
124807824|NCT00150709|448927226|FG002|Overall Study|Decision of parent(s) and investigator|0|||
124807825|NCT00150709|448927227|FG003|Overall Study|Decision of parent(s) and investigator|0|||
124807826|NCT00150709|448927224|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
124807827|NCT00150709|448927225|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
124807828|NCT00150709|448927226|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
124807829|NCT00150709|448927227|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
124807830|NCT00150709|448927224|FG000|Overall Study|Investigator decision|1|||
124807831|NCT00150709|448927225|FG001|Overall Study|Investigator decision|0|||
124807832|NCT00150709|448927226|FG002|Overall Study|Investigator decision|0|||
124807833|NCT00150709|448927227|FG003|Overall Study|Investigator decision|1|||
124807834|NCT00150709|448927224|FG000|Overall Study|Subject relocated|2|||
124807835|NCT00150709|448927225|FG001|Overall Study|Subject relocated|2|||
124807836|NCT00150709|448927226|FG002|Overall Study|Subject relocated|1|||
124807837|NCT00150709|448927227|FG003|Overall Study|Subject relocated|0|||
124807838|NCT00150709|448927224|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
124807839|NCT00150709|448927225|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
124807840|NCT00150709|448927226|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
124807841|NCT00150709|448927227|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
125300030|NCT03775512|450725875|FG001|Overall Study|Lost to Follow-up|5|||
124807842|NCT00150709|448927224|FG000|Overall Study|Convenience|0|||
124807843|NCT00150709|448927225|FG001|Overall Study|Convenience|1|||
124807844|NCT00150709|448927226|FG002|Overall Study|Convenience|0|||
125300031|NCT03775512|450725874|FG000|Overall Study|Excluded before Catheter insertion|14|||
124807845|NCT00150709|448927227|FG003|Overall Study|Convenience|0|||
124807846|NCT00150709|448927224|FG000|Overall Study|Subject entered new drug study|0|||
124807847|NCT00150709|448927225|FG001|Overall Study|Subject entered new drug study|1|||
124807848|NCT00150709|448927226|FG002|Overall Study|Subject entered new drug study|0|||
124807849|NCT00150709|448927227|FG003|Overall Study|Subject entered new drug study|0|||
124807850|NCT00150709|448927224|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
124807851|NCT00150709|448927225|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
124807852|NCT00150709|448927226|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
124807853|NCT00150709|448927227|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
124807854|NCT00150709|448927224|FG000|Overall Study|Lack of ease of swallowing|0|||
124807855|NCT00150709|448927225|FG001|Overall Study|Lack of ease of swallowing|1|||
124807856|NCT00150709|448927226|FG002|Overall Study|Lack of ease of swallowing|0|||
124807857|NCT00150709|448927227|FG003|Overall Study|Lack of ease of swallowing|0|||
124807858|NCT02975336|448927228|FG000|DBPC (52 Weeks)|Adverse Event|16|||
124807859|NCT02975336|448927229|FG001|DBPC (52 Weeks)|Adverse Event|17|||
124807860|NCT02975336|448927230|FG002|DBPC (52 Weeks)|Adverse Event|13|||
124807861|NCT02975336|448927231|FG003|DBPC (52 Weeks)|Adverse Event|18|||
124807862|NCT02975336|448927232|FG004|DBPC (52 Weeks)|Adverse Event|0|||
124807863|NCT02975336|448927233|FG005|DBPC (52 Weeks)|Adverse Event|0|||
124807864|NCT02975336|448927234|FG006|DBPC (52 Weeks)|Adverse Event|0|||
124807865|NCT02975336|448927235|FG007|DBPC (52 Weeks)|Adverse Event|0|||
124807866|NCT02975336|448927228|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
124807867|NCT02975336|448927229|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
124807868|NCT02975336|448927230|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
124807869|NCT02975336|448927231|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
124807870|NCT02975336|448927232|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
124807871|NCT02975336|448927233|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
124807872|NCT02975336|448927234|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
124807873|NCT02975336|448927235|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
124807874|NCT02975336|448927228|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
124807875|NCT02975336|448927229|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
124807876|NCT02975336|448927230|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
124807877|NCT02975336|448927231|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
124807878|NCT02975336|448927232|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
124807879|NCT02975336|448927233|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
124807880|NCT02975336|448927234|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
124807881|NCT02975336|448927235|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
124807882|NCT02975336|448927228|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
124807883|NCT02975336|448927229|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
124807884|NCT02975336|448927230|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
124807885|NCT02975336|448927231|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
124807886|NCT02975336|448927232|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
124807887|NCT02975336|448927233|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
124807888|NCT02975336|448927234|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
124807889|NCT02975336|448927235|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
124807890|NCT02975336|448927228|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
124807891|NCT02975336|448927229|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
124807892|NCT02975336|448927230|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
124807893|NCT02975336|448927231|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
124807894|NCT02975336|448927232|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
124807895|NCT02975336|448927233|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
124807896|NCT02975336|448927234|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
124807897|NCT02975336|448927235|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
124807898|NCT02975336|448927228|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
124807899|NCT02975336|448927229|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
124807900|NCT02975336|448927230|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
124807901|NCT02975336|448927231|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
124807902|NCT02975336|448927232|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
124807903|NCT02975336|448927233|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
124807904|NCT02975336|448927234|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
124807905|NCT02975336|448927235|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
124807906|NCT02975336|448927228|FG000|LTE (104 Weeks)|Adverse Event|0|||
124807907|NCT02975336|448927229|FG001|LTE (104 Weeks)|Adverse Event|0|||
124807908|NCT02975336|448927230|FG002|LTE (104 Weeks)|Adverse Event|0|||
124807909|NCT02975336|448927231|FG003|LTE (104 Weeks)|Adverse Event|0|||
124807910|NCT02975336|448927232|FG004|LTE (104 Weeks)|Adverse Event|7|||
124807911|NCT02975336|448927233|FG005|LTE (104 Weeks)|Adverse Event|4|||
124807912|NCT02975336|448927234|FG006|LTE (104 Weeks)|Adverse Event|2|||
124807913|NCT02975336|448927235|FG007|LTE (104 Weeks)|Adverse Event|0|||
124807914|NCT02975336|448927228|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
124807915|NCT02975336|448927229|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
124807916|NCT02975336|448927230|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
124807917|NCT02975336|448927231|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
124807918|NCT02975336|448927232|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
124807919|NCT02975336|448927233|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
124807920|NCT02975336|448927234|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
124807921|NCT02975336|448927235|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
124807922|NCT02975336|448927228|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
124807923|NCT02975336|448927229|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
124807924|NCT02975336|448927230|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
124807925|NCT02975336|448927231|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
124807926|NCT02975336|448927232|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
124807927|NCT02975336|448927233|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
124807928|NCT02975336|448927234|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
124807929|NCT02975336|448927235|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
124807930|NCT02975336|448927228|FG000|LTE (104 Weeks)|Other|0|||
124807931|NCT02975336|448927229|FG001|LTE (104 Weeks)|Other|0|||
124807932|NCT02975336|448927230|FG002|LTE (104 Weeks)|Other|0|||
124807933|NCT02975336|448927231|FG003|LTE (104 Weeks)|Other|0|||
124807934|NCT02975336|448927232|FG004|LTE (104 Weeks)|Other|55|||
124807935|NCT02975336|448927233|FG005|LTE (104 Weeks)|Other|63|||
124807936|NCT02975336|448927234|FG006|LTE (104 Weeks)|Other|76|||
124807937|NCT02975336|448927235|FG007|LTE (104 Weeks)|Other|72|||
124807938|NCT03650556|448927236|FG000|Overall Study|Death|2|||
124807939|NCT03650556|448927236|FG000|Overall Study|Withdrawal by Subject|20|||
124807940|NCT03650556|448927236|FG000|Overall Study|Physician Decision|2|||
124807941|NCT03650556|448927236|FG000|Overall Study|Lost to Follow-up|8|||
124807942|NCT03650556|448927236|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
124807943|NCT03650556|448927236|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
124807944|NCT00691301|448927237|FG000|Overall Study|Adverse Event|10|||
124807945|NCT00691301|448927237|FG000|Overall Study|Death|2|||
124807946|NCT00691301|448927237|FG000|Overall Study|Lack of Efficacy|32|||
124807947|NCT00691301|448927237|FG000|Overall Study|Withdrawal by Subject|4|||
124807948|NCT00691301|448927237|FG000|Overall Study|Concurrent illness|2|||
124807949|NCT00691301|448927237|FG000|Overall Study|other reason|3|||
124807950|NCT00691301|448927237|FG000|Overall Study|Did not initiate study treatment|1|||
124807951|NCT01823146|448927238|FG000|Overall Study|Withdrawal by Subject|0|||
124807952|NCT01823146|448927239|FG001|Overall Study|Withdrawal by Subject|1|||
124807953|NCT01823146|448927238|FG000|Overall Study|Lost to Follow-up|2|||
124807954|NCT01823146|448927239|FG001|Overall Study|Lost to Follow-up|1|||
124807955|NCT00463580|448927240|FG000|Overall Study|Lost to Follow-up|1|||
124807956|NCT00463580|448927241|FG001|Overall Study|Lost to Follow-up|0|||
124807957|NCT00463580|448927240|FG000|Overall Study|Schedule conflict|2|||
124807958|NCT00463580|448927241|FG001|Overall Study|Schedule conflict|0|||
124807959|NCT00463580|448927240|FG000|Overall Study|Medical/psychiatric complications|0|||
124807960|NCT00463580|448927241|FG001|Overall Study|Medical/psychiatric complications|2|||
124807961|NCT03917459|448927242|FG000|Overall Study|Adverse Event|1|||
124807962|NCT03917459|448927243|FG001|Overall Study|Adverse Event|0|||
124807963|NCT03917459|448927242|FG000|Overall Study|Withdrawal by Subject|0|||
124807964|NCT03917459|448927243|FG001|Overall Study|Withdrawal by Subject|1|||
124807965|NCT00075218|448927244|FG000|Double-Blind Treatment|Adverse Event|23|||
124807966|NCT00075218|448927245|FG001|Double-Blind Treatment|Adverse Event|4|||
124807967|NCT00075218|448927246|FG002|Double-Blind Treatment|Adverse Event|0|||
124807968|NCT00075218|448927244|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
124807969|NCT00075218|448927245|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
124807970|NCT00075218|448927246|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
124807971|NCT00075218|448927244|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
124807972|NCT00075218|448927245|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
124807973|NCT00075218|448927246|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
124807974|NCT00075218|448927244|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
124807975|NCT00075218|448927245|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
124807976|NCT00075218|448927246|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
124807977|NCT00075218|448927244|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
124807978|NCT00075218|448927245|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
124807979|NCT00075218|448927246|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
124807980|NCT00075218|448927244|FG000|Double-Blind Treatment|No study medication taken|2|||
124807981|NCT00075218|448927245|FG001|Double-Blind Treatment|No study medication taken|0|||
124807982|NCT00075218|448927246|FG002|Double-Blind Treatment|No study medication taken|0|||
124807983|NCT00075218|448927244|FG000|Open-Label Treatment|Lack of Efficacy|0|||
124807984|NCT00075218|448927245|FG001|Open-Label Treatment|Lack of Efficacy|0|||
124807985|NCT00075218|448927246|FG002|Open-Label Treatment|Lack of Efficacy|174|||
124807986|NCT00075218|448927244|FG000|Open-Label Treatment|Adverse Event|0|||
124807987|NCT00075218|448927245|FG001|Open-Label Treatment|Adverse Event|0|||
124807988|NCT00075218|448927246|FG002|Open-Label Treatment|Adverse Event|51|||
124807989|NCT00075218|448927244|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
124807990|NCT00075218|448927245|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
124807991|NCT00075218|448927246|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
124807992|NCT00075218|448927244|FG000|Open-Label Treatment|Decision of Sponsor|0|||
124807993|NCT00075218|448927245|FG001|Open-Label Treatment|Decision of Sponsor|0|||
124807994|NCT00075218|448927246|FG002|Open-Label Treatment|Decision of Sponsor|8|||
124807995|NCT00075218|448927244|FG000|Open-Label Treatment|Protocol Violation|0|||
124807996|NCT00075218|448927245|FG001|Open-Label Treatment|Protocol Violation|0|||
124807997|NCT00075218|448927246|FG002|Open-Label Treatment|Protocol Violation|1|||
124807998|NCT00075218|448927244|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
125300032|NCT03775512|450725875|FG001|Overall Study|Excluded before Catheter insertion|5|||
124807999|NCT00075218|448927245|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
124808000|NCT00075218|448927246|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
124808001|NCT00845858|448927249|FG000|Overall Study|Withdrawal by Subject|5|||
124808002|NCT00845858|448927250|FG001|Overall Study|Withdrawal by Subject|1|||
124808003|NCT00845858|448927251|FG002|Overall Study|Withdrawal by Subject|1|||
124808004|NCT00845858|448927249|FG000|Overall Study|Adverse Event|3|||
124808005|NCT00845858|448927250|FG001|Overall Study|Adverse Event|8|||
124808006|NCT00845858|448927251|FG002|Overall Study|Adverse Event|4|||
124808007|NCT00845858|448927249|FG000|Overall Study|Protocol Violation|0|||
124808008|NCT00845858|448927250|FG001|Overall Study|Protocol Violation|0|||
124808009|NCT00845858|448927251|FG002|Overall Study|Protocol Violation|1|||
124808010|NCT00845858|448927249|FG000|Overall Study|not eligible|0|||
124808011|NCT00845858|448927250|FG001|Overall Study|not eligible|3|||
124808012|NCT00845858|448927251|FG002|Overall Study|not eligible|2|||
124808013|NCT02191137|448927252|FG000|Treatment|Death|4|||
124808014|NCT02191137|448927252|FG000|Treatment|Withdrawal by Subject|3|||
124808015|NCT02191137|448927252|FG000|Treatment|Adverse Event|2|||
124808016|NCT02191137|448927252|FG000|Treatment|Other|1|||
124808017|NCT02191137|448927252|FG000|Follow-up|Lost to Follow-up|2|||
124808018|NCT02191137|448927252|FG000|Follow-up|Ongoing/unknown|2|||
124808019|NCT02191137|448927252|FG000|Follow-up|Adverse Event|1|||
124808020|NCT02404220|448927259|FG000|Overall Study|Adverse Event|0|||
124808021|NCT02404220|448927260|FG001|Overall Study|Adverse Event|0|||
124808022|NCT02404220|448927261|FG002|Overall Study|Adverse Event|1|||
124808023|NCT02404220|448927262|FG003|Overall Study|Adverse Event|0|||
124808024|NCT02404220|448927259|FG000|Overall Study|Death|5|||
124808025|NCT02404220|448927260|FG001|Overall Study|Death|5|||
124808026|NCT02404220|448927261|FG002|Overall Study|Death|3|||
124808027|NCT02404220|448927262|FG003|Overall Study|Death|8|||
124808028|NCT02404220|448927259|FG000|Overall Study|Progressive Disease|0|||
124808029|NCT02404220|448927260|FG001|Overall Study|Progressive Disease|0|||
124808030|NCT02404220|448927261|FG002|Overall Study|Progressive Disease|1|||
124808031|NCT02404220|448927262|FG003|Overall Study|Progressive Disease|1|||
124808032|NCT02404220|448927259|FG000|Overall Study|Study Terminated by Sponsor|0|||
124808033|NCT02404220|448927260|FG001|Overall Study|Study Terminated by Sponsor|0|||
124808034|NCT02404220|448927261|FG002|Overall Study|Study Terminated by Sponsor|2|||
124808035|NCT02404220|448927262|FG003|Overall Study|Study Terminated by Sponsor|1|||
124808036|NCT02404220|448927259|FG000|Overall Study|Withdrawal by Subject|0|||
124808037|NCT02404220|448927260|FG001|Overall Study|Withdrawal by Subject|1|||
124808038|NCT02404220|448927261|FG002|Overall Study|Withdrawal by Subject|0|||
124808039|NCT02404220|448927262|FG003|Overall Study|Withdrawal by Subject|0|||
124808040|NCT02404220|448927259|FG000|Overall Study|Enrolled but Never Treated|0|||
124808041|NCT02404220|448927260|FG001|Overall Study|Enrolled but Never Treated|2|||
124808042|NCT02404220|448927261|FG002|Overall Study|Enrolled but Never Treated|0|||
124808043|NCT02404220|448927262|FG003|Overall Study|Enrolled but Never Treated|0|||
124808044|NCT03469934|448927265|FG000|Overall Study|Withdrawal by Subject|0|||
124808045|NCT03469934|448927266|FG001|Overall Study|Withdrawal by Subject|1|||
124808046|NCT02329080|448927267|FG000|Overall Study|Adverse Event|1|||
124808047|NCT02329080|448927267|FG000|Overall Study|Death|4|||
124808048|NCT02329080|448927267|FG000|Overall Study|Lack of Efficacy|22|||
124808049|NCT02329080|448927267|FG000|Overall Study|Lost to Follow-up|1|||
124808050|NCT02329080|448927267|FG000|Overall Study|Physician Decision|2|||
124808051|NCT02329080|448927267|FG000|Overall Study|Partial response|4|||
124808052|NCT02329080|448927267|FG000|Overall Study|Complete response|4|||
124808053|NCT00071396|448927274|FG000|Overall Study|Withdrawal by Subject|1|||
124808054|NCT00071396|448927274|FG000|Overall Study|Physician Decision|2|||
124808055|NCT03082261|448927275|FG000|Overall Study|Death|4|||
124808056|NCT03082261|448927275|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
124808057|NCT03082261|448927275|FG000|Overall Study|Insurance denial|1|||
124808058|NCT03082261|448927275|FG000|Overall Study|Peripheral lead added|1|||
125300033|NCT03775512|450725874|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
124808059|NCT03082261|448927275|FG000|Overall Study|Withdrawal by Subject|40|||
124808060|NCT03082261|448927275|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
124808061|NCT03082261|448927275|FG000|Overall Study|Subject implanted with device other than study device|1|||
124808062|NCT03082261|448927275|FG000|Overall Study|Lost to Follow-up|14|||
124808063|NCT03082261|448927275|FG000|Overall Study|Subject moved to a different state|1|||
124808064|NCT03082261|448927275|FG000|Overall Study|Subject non-compliance|2|||
124808065|NCT03082261|448927275|FG000|Overall Study|Subject participation terminated by investigator|9|||
124808066|NCT03082261|448927275|FG000|Overall Study|Subject participation terminated by sponsor|4|||
124808067|NCT03082261|448927275|FG000|Overall Study|System explant|19|||
124808068|NCT03082261|448927275|FG000|Overall Study|Unable to place lead(s)|2|||
124808069|NCT03082261|448927275|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
124808070|NCT02639546|448927276|FG000|Overall Study|Death|2|||
124808071|NCT02639546|448927277|FG001|Overall Study|Death|2|||
124808072|NCT02639546|448927278|FG002|Overall Study|Death|1|||
124808073|NCT02639546|448927279|FG003|Overall Study|Death|2|||
124808074|NCT02639546|448927280|FG004|Overall Study|Death|2|||
124808075|NCT02639546|448927281|FG005|Overall Study|Death|2|||
124808076|NCT02639546|448927282|FG006|Overall Study|Death|0|||
124808077|NCT02639546|448927283|FG007|Overall Study|Death|0|||
124808078|NCT02639546|448927276|FG000|Overall Study|Lost to Follow-up|0|||
124808079|NCT02639546|448927277|FG001|Overall Study|Lost to Follow-up|0|||
124808080|NCT02639546|448927278|FG002|Overall Study|Lost to Follow-up|1|||
124808081|NCT02639546|448927279|FG003|Overall Study|Lost to Follow-up|0|||
124808082|NCT02639546|448927280|FG004|Overall Study|Lost to Follow-up|1|||
124808083|NCT02639546|448927281|FG005|Overall Study|Lost to Follow-up|1|||
124808084|NCT02639546|448927282|FG006|Overall Study|Lost to Follow-up|0|||
124808085|NCT02639546|448927283|FG007|Overall Study|Lost to Follow-up|1|||
124808086|NCT02639546|448927276|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
124808087|NCT02639546|448927277|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
124808088|NCT02639546|448927278|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
124808089|NCT02639546|448927279|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
124808090|NCT02639546|448927280|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
124808091|NCT02639546|448927281|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
124808092|NCT02639546|448927282|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
124808093|NCT02639546|448927283|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
124808094|NCT02639546|448927276|FG000|Overall Study|Study Terminated By Sponsor|0|||
124808095|NCT02639546|448927277|FG001|Overall Study|Study Terminated By Sponsor|2|||
124808096|NCT02639546|448927278|FG002|Overall Study|Study Terminated By Sponsor|3|||
124808097|NCT02639546|448927279|FG003|Overall Study|Study Terminated By Sponsor|4|||
124808098|NCT02639546|448927280|FG004|Overall Study|Study Terminated By Sponsor|4|||
124808099|NCT02639546|448927281|FG005|Overall Study|Study Terminated By Sponsor|3|||
124808100|NCT02639546|448927282|FG006|Overall Study|Study Terminated By Sponsor|3|||
124808101|NCT02639546|448927283|FG007|Overall Study|Study Terminated By Sponsor|9|||
124808102|NCT02639546|448927276|FG000|Overall Study|Withdrawal by Subject|2|||
124808103|NCT02639546|448927277|FG001|Overall Study|Withdrawal by Subject|2|||
124808104|NCT02639546|448927278|FG002|Overall Study|Withdrawal by Subject|1|||
124808105|NCT02639546|448927279|FG003|Overall Study|Withdrawal by Subject|0|||
124808106|NCT02639546|448927280|FG004|Overall Study|Withdrawal by Subject|0|||
124808107|NCT02639546|448927281|FG005|Overall Study|Withdrawal by Subject|1|||
124808108|NCT02639546|448927282|FG006|Overall Study|Withdrawal by Subject|2|||
124808109|NCT02639546|448927283|FG007|Overall Study|Withdrawal by Subject|1|||
124808110|NCT01032174|448927286|FG000|Overall Study|Adverse Event|0|||
124808111|NCT01032174|448927287|FG001|Overall Study|Adverse Event|1|||
124808112|NCT00113087|448927289|FG000|Overall Study|Death or Transplant|14|||
124808113|NCT00113087|448927290|FG001|Overall Study|Death or Transplant|16|||
124808114|NCT00113087|448927289|FG000|Overall Study|Family or MD withdrew subject|10|||
124808115|NCT00113087|448927290|FG001|Overall Study|Family or MD withdrew subject|5|||
124808116|NCT01281137|448927291|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
125300034|NCT03775512|450725875|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
125300035|NCT03775512|450725874|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
125300036|NCT03775512|450725875|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
124808117|NCT01281137|448927292|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
124808118|NCT01281137|448927291|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
124808119|NCT01281137|448927292|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
124808120|NCT01281137|448927291|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
124808121|NCT01281137|448927292|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
124808122|NCT01281137|448927291|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
124808123|NCT01281137|448927292|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
124808124|NCT01281137|448927291|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
124808125|NCT01281137|448927292|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
124808126|NCT00386607|448927295|FG000|Core|Adverse Event|40|||
124808127|NCT00386607|448927296|FG001|Core|Adverse Event|0|||
124808128|NCT00386607|448927295|FG000|Core|Abnormal laboratory value(s)|3|||
124808129|NCT00386607|448927296|FG001|Core|Abnormal laboratory value(s)|0|||
124808130|NCT00386607|448927295|FG000|Core|Unsatisfactory therapeutic effect|23|||
124808131|NCT00386607|448927296|FG001|Core|Unsatisfactory therapeutic effect|0|||
124808132|NCT00386607|448927295|FG000|Core|Condition no longer requires study drug|4|||
124808133|NCT00386607|448927296|FG001|Core|Condition no longer requires study drug|0|||
124808134|NCT00386607|448927295|FG000|Core|Patient withdrew consent|15|||
124808135|NCT00386607|448927296|FG001|Core|Patient withdrew consent|0|||
124808136|NCT00386607|448927295|FG000|Core|Lost to Follow-up|23|||
124808137|NCT00386607|448927296|FG001|Core|Lost to Follow-up|0|||
124808138|NCT00386607|448927295|FG000|Core|Administrative problems|1|||
124808139|NCT00386607|448927296|FG001|Core|Administrative problems|0|||
125300037|NCT01378325|450725876|FG000|Overall Study|Protocol Violation|0|||
124808140|NCT00386607|448927295|FG000|Core|Protocol Deviation|6|||
124808141|NCT00386607|448927296|FG001|Core|Protocol Deviation|0|||
124808142|NCT00386607|448927295|FG000|Extension|Adverse Event|0|||
124808143|NCT00386607|448927296|FG001|Extension|Adverse Event|6|||
124808144|NCT00386607|448927295|FG000|Extension|Abnormal laboratory value(s)|0|||
124808145|NCT00386607|448927296|FG001|Extension|Abnormal laboratory value(s)|1|||
124808146|NCT00386607|448927295|FG000|Extension|Administrative problems|0|||
124808147|NCT00386607|448927296|FG001|Extension|Administrative problems|1|||
124808148|NCT00386607|448927295|FG000|Extension|Lost to Follow-up|0|||
124808149|NCT00386607|448927296|FG001|Extension|Lost to Follow-up|3|||
124808150|NCT00386607|448927295|FG000|Extension|Patient withdrew consent|0|||
124808151|NCT00386607|448927296|FG001|Extension|Patient withdrew consent|5|||
124808152|NCT00386607|448927295|FG000|Extension|Unsatisfactory therapeutic effect|0|||
124808153|NCT00386607|448927296|FG001|Extension|Unsatisfactory therapeutic effect|1|||
124808154|NCT04251273|448927299|FG000|Overall Study|Lost to Follow-up|331|||
124808155|NCT04251273|448927300|FG001|Overall Study|Lost to Follow-up|290|||
124808156|NCT01986907|448927301|FG000|Overall Study|Adverse Event|11|||
124808157|NCT01986907|448927301|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
124808158|NCT01986907|448927301|FG000|Overall Study|Protocol Violation|4|||
124808159|NCT01986907|448927301|FG000|Overall Study|Withdrawal by Subject|76|||
124808160|NCT01986907|448927301|FG000|Overall Study|Lost to Follow-up|38|||
124808161|NCT01986907|448927301|FG000|Overall Study|Death|9|||
124808162|NCT00810693|448927302|FG000|Treatment Period|Adverse Event|8|||
124808163|NCT00810693|448927303|FG001|Treatment Period|Adverse Event|1|||
124808164|NCT00810693|448927304|FG002|Treatment Period|Adverse Event|7|||
124808165|NCT00810693|448927302|FG000|Treatment Period|Death|0|||
124808166|NCT00810693|448927303|FG001|Treatment Period|Death|1|||
124808167|NCT00810693|448927304|FG002|Treatment Period|Death|2|||
124808168|NCT00810693|448927302|FG000|Treatment Period|Lack of Efficacy|0|||
124808169|NCT00810693|448927303|FG001|Treatment Period|Lack of Efficacy|0|||
124808170|NCT00810693|448927304|FG002|Treatment Period|Lack of Efficacy|1|||
124808171|NCT00810693|448927302|FG000|Treatment Period|Lost to Follow-up|1|||
124808172|NCT00810693|448927303|FG001|Treatment Period|Lost to Follow-up|0|||
124808173|NCT00810693|448927304|FG002|Treatment Period|Lost to Follow-up|0|||
124808174|NCT00810693|448927302|FG000|Treatment Period|Non-compliance|1|||
124808175|NCT00810693|448927303|FG001|Treatment Period|Non-compliance|0|||
124808176|NCT00810693|448927304|FG002|Treatment Period|Non-compliance|0|||
124808177|NCT00810693|448927302|FG000|Treatment Period|Protocol Violation|1|||
124808178|NCT00810693|448927303|FG001|Treatment Period|Protocol Violation|2|||
124808179|NCT00810693|448927304|FG002|Treatment Period|Protocol Violation|2|||
124808180|NCT00810693|448927302|FG000|Treatment Period|Withdrawal by Subject|6|||
124808181|NCT00810693|448927303|FG001|Treatment Period|Withdrawal by Subject|2|||
124808182|NCT00810693|448927304|FG002|Treatment Period|Withdrawal by Subject|3|||
124808183|NCT00810693|448927302|FG000|Treatment Period|Not treated|0|||
124808184|NCT00810693|448927303|FG001|Treatment Period|Not treated|1|||
124808185|NCT00810693|448927304|FG002|Treatment Period|Not treated|1|||
124808186|NCT00810693|448927302|FG000|Follow-up Period (FUP)|Adverse Event|3|||
124808187|NCT00810693|448927303|FG001|Follow-up Period (FUP)|Adverse Event|1|||
124808188|NCT00810693|448927304|FG002|Follow-up Period (FUP)|Adverse Event|1|||
124808189|NCT00810693|448927302|FG000|Follow-up Period (FUP)|Death|2|||
124808190|NCT00810693|448927303|FG001|Follow-up Period (FUP)|Death|0|||
124808191|NCT00810693|448927304|FG002|Follow-up Period (FUP)|Death|1|||
124808192|NCT00810693|448927302|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
124808193|NCT00810693|448927303|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
124808194|NCT00810693|448927304|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
124808195|NCT00810693|448927302|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
124808196|NCT00810693|448927303|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
124808197|NCT00810693|448927304|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
124808198|NCT00810693|448927302|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
124808199|NCT00810693|448927303|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
124808200|NCT00810693|448927304|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
124808201|NCT03212690|448927305|FG000|Overall Study|Protocol Violation|1|||
124808202|NCT00331422|448927308|FG000|Overall Study|Did not receive entire study regimen|5|||
124808203|NCT02345226|448927309|FG000|Double-Blind Phase|Adverse Event|5|||
124808204|NCT02345226|448927310|FG001|Double-Blind Phase|Adverse Event|6|||
124808205|NCT02345226|448927309|FG000|Double-Blind Phase|Death|3|||
124808206|NCT02345226|448927310|FG001|Double-Blind Phase|Death|0|||
124808207|NCT02345226|448927309|FG000|Double-Blind Phase|Pregnancy|0|||
124808208|NCT02345226|448927310|FG001|Double-Blind Phase|Pregnancy|1|||
124808209|NCT02345226|448927309|FG000|Double-Blind Phase|Lack of Efficacy|1|||
124808210|NCT02345226|448927310|FG001|Double-Blind Phase|Lack of Efficacy|0|||
124808211|NCT02345226|448927309|FG000|Double-Blind Phase|Investigator's Discretion|4|||
124808212|NCT02345226|448927310|FG001|Double-Blind Phase|Investigator's Discretion|3|||
124808213|NCT02345226|448927309|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
124808214|NCT02345226|448927310|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
124808215|NCT02345226|448927309|FG000|Double-Blind Phase|Withdrew Consent|41|||
124808216|NCT02345226|448927310|FG001|Double-Blind Phase|Withdrew Consent|39|||
124808217|NCT02345226|448927309|FG000|Double-Blind Phase|Lost to Follow-up|12|||
124808218|NCT02345226|448927310|FG001|Double-Blind Phase|Lost to Follow-up|16|||
124808219|NCT02345226|448927309|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
124808220|NCT02345226|448927310|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
124808221|NCT02345226|448927309|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
124808222|NCT02345226|448927310|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
124808223|NCT03386474|448927319|FG000|Overall Study|Death|1|||
124808224|NCT03386474|448927320|FG001|Overall Study|Death|0|||
124808225|NCT03386474|448927319|FG000|Overall Study|Adverse Event|0|||
124808226|NCT03386474|448927320|FG001|Overall Study|Adverse Event|1|||
125300038|NCT01378325|450725877|FG001|Overall Study|Protocol Violation|1|||
125300039|NCT00767806|450725880|FG000|Overall Study|Adverse Event|30|||
125300040|NCT00767806|450725881|FG001|Overall Study|Adverse Event|11|||
125300041|NCT00767806|450725880|FG000|Overall Study|Withdrawal by Subject|8|||
125300042|NCT00767806|450725881|FG001|Overall Study|Withdrawal by Subject|13|||
125300043|NCT00767806|450725880|FG000|Overall Study|Protocol Violation|6|||
125300044|NCT00767806|450725881|FG001|Overall Study|Protocol Violation|5|||
125300045|NCT00767806|450725880|FG000|Overall Study|Lack of Efficacy|1|||
125300046|NCT00767806|450725881|FG001|Overall Study|Lack of Efficacy|9|||
125300047|NCT00767806|450725880|FG000|Overall Study|Physician Decision|4|||
125300048|NCT00767806|450725881|FG001|Overall Study|Physician Decision|3|||
125300049|NCT00767806|450725880|FG000|Overall Study|Lost to Follow-up|1|||
125300050|NCT00767806|450725881|FG001|Overall Study|Lost to Follow-up|4|||
125300051|NCT00767806|450725880|FG000|Overall Study|Entry Criteria Not Met|1|||
125300052|NCT00767806|450725881|FG001|Overall Study|Entry Criteria Not Met|1|||
125300053|NCT00767806|450725880|FG000|Overall Study|Sponsor Decision|0|||
124808243|NCT02282358|448927325|FG000|Overall Study|Nonevaluable|1|||
124808244|NCT04203797|448927326|FG000|Overall Study|Adverse Event|1|||
124808245|NCT04203797|448927327|FG001|Overall Study|Adverse Event|0|||
124808246|NCT04203797|448927326|FG000|Overall Study|Did not complete End of Study follow-up|1|||
124808247|NCT04203797|448927327|FG001|Overall Study|Did not complete End of Study follow-up|0|||
124808248|NCT04357782|448927328|FG000|Overall Study|Discharged from hospital|1|||
124808249|NCT04357782|448927329|FG001|Overall Study|Discharged from hospital|0|||
124808250|NCT04357782|448927328|FG000|Overall Study|Death|0|||
124808251|NCT04357782|448927329|FG001|Overall Study|Death|2|||
124808252|NCT01786148|448927330|FG000|Overall Study|Lost to Follow-up|21|||
124808253|NCT01786148|448927331|FG001|Overall Study|Lost to Follow-up|13|||
124808254|NCT01786148|448927330|FG000|Overall Study|Death|0|||
124808255|NCT01786148|448927331|FG001|Overall Study|Death|1|||
124808256|NCT01786148|448927330|FG000|Overall Study|Withdrawal by Subject|0|||
124808257|NCT01786148|448927331|FG001|Overall Study|Withdrawal by Subject|7|||
124808258|NCT01786148|448927330|FG000|Overall Study|Incarceration|1|||
124808259|NCT01786148|448927331|FG001|Overall Study|Incarceration|1|||
124808260|NCT03780543|448927333|FG000|Overall Study|Adverse Event|1|||
124808261|NCT03780543|448927334|FG001|Overall Study|Adverse Event|0|||
124808262|NCT03780543|448927335|FG002|Overall Study|Adverse Event|2|||
124808263|NCT03780543|448927333|FG000|Overall Study|Lost to Follow-up|2|||
124808264|NCT03780543|448927334|FG001|Overall Study|Lost to Follow-up|0|||
124808265|NCT03780543|448927335|FG002|Overall Study|Lost to Follow-up|1|||
124808266|NCT03780543|448927333|FG000|Overall Study|Study terminated by Sponsor|8|||
124808267|NCT03780543|448927334|FG001|Overall Study|Study terminated by Sponsor|7|||
124808268|NCT03780543|448927335|FG002|Overall Study|Study terminated by Sponsor|13|||
124808269|NCT03780543|448927333|FG000|Overall Study|Withdrawal by Subject|1|||
124808270|NCT03780543|448927334|FG001|Overall Study|Withdrawal by Subject|8|||
124808271|NCT03780543|448927335|FG002|Overall Study|Withdrawal by Subject|1|||
124808272|NCT03780543|448927333|FG000|Overall Study|Noncompliance with study drug|1|||
124808273|NCT03780543|448927334|FG001|Overall Study|Noncompliance with study drug|0|||
124808274|NCT03780543|448927335|FG002|Overall Study|Noncompliance with study drug|0|||
124808275|NCT00516074|448927344|FG000|Overall Study|Adverse Event|0|||
124808276|NCT00516074|448927345|FG001|Overall Study|Adverse Event|1|||
124808277|NCT00516074|448927344|FG000|Overall Study|Subject Decision|4|||
124808278|NCT00516074|448927345|FG001|Overall Study|Subject Decision|2|||
124808279|NCT00516074|448927344|FG000|Overall Study|Loss of Glucose Control|2|||
124808280|NCT00516074|448927345|FG001|Overall Study|Loss of Glucose Control|0|||
124808281|NCT02215096|448927346|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
124808282|NCT02215096|448927347|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
124808283|NCT02215096|448927348|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
124808284|NCT02215096|448927349|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
124808285|NCT02215096|448927350|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
124808286|NCT02215096|448927346|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
124808287|NCT02215096|448927347|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
124808288|NCT02215096|448927348|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
125300054|NCT00767806|450725881|FG001|Overall Study|Sponsor Decision|1|||
125300055|NCT02489942|450725882|FG000|Overall Study|Request by patient|602|||
125300056|NCT02489942|450725882|FG000|Overall Study|Improvement/remission|157|||
125300057|NCT02489942|450725882|FG000|Overall Study|No change/Progressive disease|263|||
125300058|NCT02489942|450725882|FG000|Overall Study|Adverse Event|522|||
125300059|NCT02489942|450725882|FG000|Overall Study|Other personal reasons|1218|||
124808289|NCT02215096|448927349|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
124808290|NCT02215096|448927350|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
124808291|NCT02215096|448927346|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
124808292|NCT02215096|448927347|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
124808293|NCT02215096|448927348|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
124808294|NCT02215096|448927349|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
124808295|NCT02215096|448927350|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
124808296|NCT02215096|448927346|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
124808297|NCT02215096|448927347|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
124808298|NCT02215096|448927348|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
124808299|NCT02215096|448927349|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
124808300|NCT02215096|448927350|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
124808301|NCT00287365|448927351|FG000|Overall Study|sample not acquired|13|||
124808302|NCT03021304|448927352|FG000|Overall Study|Lack of Efficacy|1|||
124808303|NCT02663908|448927353|FG000|Overall Study|Withdrawal by Subject|8|||
124808304|NCT02663908|448927354|FG001|Overall Study|Withdrawal by Subject|5|||
124808305|NCT02663908|448927353|FG000|Overall Study|Lost to Follow-up|1|||
124808306|NCT02663908|448927354|FG001|Overall Study|Lost to Follow-up|5|||
124808307|NCT02663908|448927353|FG000|Overall Study|Adverse Event|13|||
124808308|NCT02663908|448927354|FG001|Overall Study|Adverse Event|11|||
124808309|NCT02663908|448927353|FG000|Overall Study|Protocol Violation|1|||
124808310|NCT02663908|448927354|FG001|Overall Study|Protocol Violation|2|||
124808311|NCT02663908|448927353|FG000|Overall Study|Lack of therapeutic response|2|||
124808312|NCT02663908|448927354|FG001|Overall Study|Lack of therapeutic response|0|||
124808313|NCT02663908|448927353|FG000|Overall Study|COVID-19|1|||
124808314|NCT02663908|448927354|FG001|Overall Study|COVID-19|0|||
124808315|NCT02663908|448927353|FG000|Overall Study|Site closed|1|||
124808316|NCT02663908|448927354|FG001|Overall Study|Site closed|0|||
124808317|NCT02663908|448927353|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
124808318|NCT02663908|448927354|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
124808319|NCT02663908|448927353|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
124808320|NCT02663908|448927354|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
124808321|NCT02663908|448927353|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
124808322|NCT02663908|448927354|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
124808323|NCT02663908|448927353|FG000|Overall Study|Death|1|||
124808324|NCT02663908|448927354|FG001|Overall Study|Death|0|||
124808325|NCT02663908|448927353|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
124808326|NCT02663908|448927354|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
124808327|NCT02663908|448927353|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
124808328|NCT02663908|448927354|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
124808329|NCT03308786|448927356|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
124808330|NCT00370071|448927359|FG000|Overall Study|Withdrawal by Subject|2|||
124808331|NCT01441180|448927360|FG000|Overall Study|Lost to Follow-up|1|||
124808332|NCT01441180|448927361|FG001|Overall Study|Lost to Follow-up|1|||
124808333|NCT01441180|448927362|FG002|Overall Study|Lost to Follow-up|1|||
124808334|NCT01441180|448927360|FG000|Overall Study|Discontinued|0|||
124808335|NCT01441180|448927361|FG001|Overall Study|Discontinued|0|||
124808336|NCT01441180|448927362|FG002|Overall Study|Discontinued|2|||
125300060|NCT02489942|450725882|FG000|Overall Study|Lost to Follow-up|456|||
125300061|NCT02489942|450725882|FG000|Overall Study|Not continuously investigated|7|||
125300062|NCT02489942|450725882|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
125300063|NCT02489942|450725882|FG000|Overall Study|Multiple registration|1|||
125300064|NCT02489942|450725882|FG000|Overall Study|No patient visit after entry|100|||
125300065|NCT02489942|450725882|FG000|Overall Study|No treatment with Jardiance|2|||
125300066|NCT02489942|450725882|FG000|Overall Study|Patient received Jardiance before registration|1|||
125300067|NCT02489942|450725882|FG000|Overall Study|No CRF collected|86|||
125300068|NCT00858208|450725883|FG000|Overall Study|Adverse Event|3|||
125300069|NCT00858208|450725883|FG000|Overall Study|Lost to Follow-up|26|||
125300070|NCT00858208|450725883|FG000|Overall Study|Participant refused|40|||
125300071|NCT00858208|450725883|FG000|Overall Study|Other|10|||
125300072|NCT01393639|450725884|FG000|Overall Study|Protocol Violation|0|||
125300073|NCT01393639|450725885|FG001|Overall Study|Protocol Violation|0|||
125300074|NCT01393639|450725886|FG002|Overall Study|Protocol Violation|0|||
124808337|NCT01402011|448927367|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
125300075|NCT01393639|450725887|FG003|Overall Study|Protocol Violation|1|||
125300076|NCT01393639|450725888|FG004|Overall Study|Protocol Violation|0|||
125300077|NCT01393639|450725889|FG005|Overall Study|Protocol Violation|0|||
124808338|NCT01402011|448927368|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
125300078|NCT01393639|450725890|FG006|Overall Study|Protocol Violation|0|||
125300079|NCT01393639|450725884|FG000|Overall Study|Other|0|||
125300080|NCT01393639|450725885|FG001|Overall Study|Other|2|||
124808339|NCT01402011|448927369|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
124808340|NCT01402011|448927367|FG000|Active Treatment Period|Withdrawal by Subject|1|||
124808341|NCT01402011|448927368|FG001|Active Treatment Period|Withdrawal by Subject|3|||
124808342|NCT01402011|448927369|FG002|Active Treatment Period|Withdrawal by Subject|0|||
124808343|NCT01402011|448927367|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
124808344|NCT01402011|448927368|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
124808345|NCT01402011|448927369|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
124808346|NCT00825682|448929054|FG000|Overall Study|personal reasons/ inconvenience|13|||
124808347|NCT00825682|448929055|FG001|Overall Study|personal reasons/ inconvenience|5|||
124808348|NCT00316719|448929056|FG000|Overall Study|Adverse Event|0|||
124808349|NCT00316719|448929057|FG001|Overall Study|Adverse Event|6|||
124808350|NCT00316719|448929056|FG000|Overall Study|Consent withdrawn|2|||
124808351|NCT00316719|448929057|FG001|Overall Study|Consent withdrawn|0|||
124808352|NCT01644565|448929060|FG000|Overall Study|Undisclosed Medical History|1|||
124808353|NCT01644565|448929061|FG001|Overall Study|Undisclosed Medical History|0|||
124808354|NCT01644565|448929062|FG002|Overall Study|Undisclosed Medical History|0|||
124808355|NCT01644565|448929063|FG003|Overall Study|Undisclosed Medical History|0|||
124808356|NCT01644565|448929064|FG004|Overall Study|Undisclosed Medical History|0|||
124808357|NCT01644565|448929065|FG005|Overall Study|Undisclosed Medical History|0|||
124808358|NCT01644565|448929066|FG006|Overall Study|Undisclosed Medical History|0|||
124808359|NCT01644565|448929067|FG007|Overall Study|Undisclosed Medical History|0|||
124808360|NCT01644565|448929068|FG008|Overall Study|Undisclosed Medical History|0|||
124808361|NCT01644565|448929060|FG000|Overall Study|Lost to Follow-up|0|||
124808362|NCT01644565|448929061|FG001|Overall Study|Lost to Follow-up|0|||
124808363|NCT01644565|448929062|FG002|Overall Study|Lost to Follow-up|0|||
124808364|NCT01644565|448929063|FG003|Overall Study|Lost to Follow-up|1|||
124808365|NCT01644565|448929064|FG004|Overall Study|Lost to Follow-up|0|||
124808366|NCT01644565|448929065|FG005|Overall Study|Lost to Follow-up|0|||
124808367|NCT01644565|448929066|FG006|Overall Study|Lost to Follow-up|0|||
124808368|NCT01644565|448929067|FG007|Overall Study|Lost to Follow-up|2|||
124808369|NCT01644565|448929068|FG008|Overall Study|Lost to Follow-up|0|||
124808370|NCT01644565|448929060|FG000|Overall Study|Family emergency|0|||
124808371|NCT01644565|448929061|FG001|Overall Study|Family emergency|0|||
124808372|NCT01644565|448929062|FG002|Overall Study|Family emergency|0|||
124808373|NCT01644565|448929063|FG003|Overall Study|Family emergency|0|||
124808374|NCT01644565|448929064|FG004|Overall Study|Family emergency|1|||
124808375|NCT01644565|448929065|FG005|Overall Study|Family emergency|0|||
124808376|NCT01644565|448929066|FG006|Overall Study|Family emergency|0|||
124808377|NCT01644565|448929067|FG007|Overall Study|Family emergency|0|||
124808378|NCT01644565|448929068|FG008|Overall Study|Family emergency|0|||
124808379|NCT01644565|448929060|FG000|Overall Study|Relocation|0|||
124808380|NCT01644565|448929061|FG001|Overall Study|Relocation|0|||
124808381|NCT01644565|448929062|FG002|Overall Study|Relocation|0|||
124808382|NCT01644565|448929063|FG003|Overall Study|Relocation|0|||
124808383|NCT01644565|448929064|FG004|Overall Study|Relocation|0|||
124808384|NCT01644565|448929065|FG005|Overall Study|Relocation|0|||
124808385|NCT01644565|448929066|FG006|Overall Study|Relocation|0|||
124808386|NCT01644565|448929067|FG007|Overall Study|Relocation|0|||
124808387|NCT01644565|448929068|FG008|Overall Study|Relocation|1|||
124808388|NCT01550289|448929069|FG000|Overall Study|Protocol Violation|1|||
124808389|NCT01550289|448929070|FG001|Overall Study|Protocol Violation|0|||
124808390|NCT01550289|448929069|FG000|Overall Study|Lost to Follow-up|1|||
124808391|NCT01550289|448929070|FG001|Overall Study|Lost to Follow-up|1|||
124808392|NCT01550289|448929069|FG000|Overall Study|Withdrawal by Subject|11|||
124808393|NCT01550289|448929070|FG001|Overall Study|Withdrawal by Subject|3|||
125300081|NCT01393639|450725886|FG002|Overall Study|Other|0|||
125300082|NCT01393639|450725887|FG003|Overall Study|Other|2|||
125300083|NCT01393639|450725888|FG004|Overall Study|Other|1|||
125300084|NCT01393639|450725889|FG005|Overall Study|Other|0|||
125300085|NCT01393639|450725890|FG006|Overall Study|Other|1|||
125300086|NCT01393639|450725884|FG000|Overall Study|Withdrawal by Subject|1|||
125300087|NCT01393639|450725885|FG001|Overall Study|Withdrawal by Subject|1|||
125300088|NCT01393639|450725886|FG002|Overall Study|Withdrawal by Subject|0|||
125300089|NCT01393639|450725887|FG003|Overall Study|Withdrawal by Subject|0|||
125300090|NCT01393639|450725888|FG004|Overall Study|Withdrawal by Subject|0|||
125300091|NCT01393639|450725889|FG005|Overall Study|Withdrawal by Subject|0|||
125300092|NCT01393639|450725890|FG006|Overall Study|Withdrawal by Subject|1|||
124808394|NCT00094172|448929076|FG000|Overall Study|Adverse Event|0|||
124808395|NCT00094172|448929077|FG001|Overall Study|Adverse Event|1|||
124808396|NCT00094172|448929076|FG000|Overall Study|Lost to Follow-up|2|||
125300093|NCT01393639|450725884|FG000|Overall Study|Medication error without associated AE|0|||
124808397|NCT00094172|448929077|FG001|Overall Study|Lost to Follow-up|0|||
124808398|NCT00094172|448929076|FG000|Overall Study|Protocol Violation|0|||
124808399|NCT00094172|448929077|FG001|Overall Study|Protocol Violation|1|||
124808400|NCT00094172|448929076|FG000|Overall Study|Withdrawal by Subject|10|||
124808401|NCT00094172|448929077|FG001|Overall Study|Withdrawal by Subject|5|||
124808402|NCT00094172|448929076|FG000|Overall Study|Primary endpoint met.|1|||
124808403|NCT00094172|448929077|FG001|Overall Study|Primary endpoint met.|0|||
125300094|NCT01393639|450725885|FG001|Overall Study|Medication error without associated AE|0|||
125300095|NCT01393639|450725886|FG002|Overall Study|Medication error without associated AE|0|||
125300096|NCT01393639|450725887|FG003|Overall Study|Medication error without associated AE|0|||
125300097|NCT01393639|450725888|FG004|Overall Study|Medication error without associated AE|0|||
125300098|NCT01393639|450725889|FG005|Overall Study|Medication error without associated AE|0|||
125300099|NCT01393639|450725890|FG006|Overall Study|Medication error without associated AE|1|||
125300100|NCT01393639|450725884|FG000|Overall Study|Lost to Follow-up|0|||
125300101|NCT01393639|450725885|FG001|Overall Study|Lost to Follow-up|1|||
125300102|NCT01393639|450725886|FG002|Overall Study|Lost to Follow-up|0|||
125300103|NCT01393639|450725887|FG003|Overall Study|Lost to Follow-up|0|||
125300104|NCT01393639|450725888|FG004|Overall Study|Lost to Follow-up|0|||
125300105|NCT01393639|450725889|FG005|Overall Study|Lost to Follow-up|0|||
125300106|NCT01393639|450725890|FG006|Overall Study|Lost to Follow-up|1|||
124808404|NCT00094172|448929076|FG000|Overall Study|Started other MS therapy due to disease|1|||
124808405|NCT00094172|448929077|FG001|Overall Study|Started other MS therapy due to disease|0|||
124808406|NCT00713323|448929078|FG000|Overall Study|Adverse Event|75|||
124808407|NCT00713323|448929078|FG000|Overall Study|Withdrawal by Subject|15|||
124808408|NCT00713323|448929078|FG000|Overall Study|Lost to Follow-up|11|||
124808409|NCT00713323|448929078|FG000|Overall Study|Lack of Efficacy|36|||
124808410|NCT00713323|448929078|FG000|Overall Study|Low creatine clearance at screening|1|||
124808411|NCT00713323|448929078|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
124808412|NCT00713323|448929078|FG000|Overall Study|Surgery cured allodynic pain|1|||
124808413|NCT00713323|448929078|FG000|Overall Study|Pain free|1|||
124808414|NCT00713323|448929078|FG000|Overall Study|Non-compliance|1|||
124808415|NCT00713323|448929078|FG000|Overall Study|Pain resolved|1|||
124808416|NCT00713323|448929078|FG000|Overall Study|Subject travelling to USA|1|||
124808417|NCT00713323|448929078|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
124808418|NCT00713323|448929078|FG000|Overall Study|Treatment that may interact with Sativex|1|||
124808419|NCT02478632|448929079|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
124808420|NCT02478632|448929080|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
124808421|NCT02478632|448929079|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
124808422|NCT02478632|448929080|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
124808423|NCT02478632|448929079|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
124808424|NCT02478632|448929080|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
124808425|NCT04622306|448929081|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
124808426|NCT04622306|448929082|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
124808427|NCT04622306|448929083|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
124808428|NCT04622306|448929084|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
124808429|NCT04622306|448929085|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
124808430|NCT04622306|448929086|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
124808431|NCT04622306|448929081|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
124808432|NCT04622306|448929082|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
124808433|NCT04622306|448929083|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
124808434|NCT04622306|448929084|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
124808435|NCT04622306|448929085|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
124808436|NCT04622306|448929086|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
124808437|NCT00864721|448929087|FG000|Overall Study|Patient request|11|||
124808438|NCT00864721|448929087|FG000|Overall Study|Hospitalized|1|||
124808439|NCT00864721|448929087|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
124808440|NCT00864721|448929087|FG000|Overall Study|Adverse Event|21|||
124808441|NCT01868503|448929088|FG000|Overall Study|Withdrawal by Subject|1|||
124808442|NCT01868503|448929088|FG000|Overall Study|Protocol Violation|1|||
124808443|NCT00736944|448929089|FG000|Induction|Death|1|||
124808444|NCT00736944|448929089|FG000|Definitive Treatment|Physician Decision|1|||
124808445|NCT05350410|448929090|FG000|Overall Study|Withdrawal by Subject|1|||
124808446|NCT01601132|448929091|FG000|Overall Study|Patient withdrew consent|1|||
124808447|NCT01601132|448929091|FG000|Overall Study|Protocol deviation|1|||
124808448|NCT02110238|448929092|FG000|12 Week Pivotal Phase|Adverse Event|3|||
124808449|NCT02110238|448929093|FG001|12 Week Pivotal Phase|Adverse Event|0|||
124808450|NCT02110238|448929092|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
124808451|NCT02110238|448929093|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
124808452|NCT02110238|448929092|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
124808453|NCT02110238|448929093|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
124808454|NCT02110238|448929092|FG000|12 Week Pivotal Phase|Physician Decision|0|||
124808455|NCT02110238|448929093|FG001|12 Week Pivotal Phase|Physician Decision|2|||
124808456|NCT02110238|448929092|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
124808457|NCT02110238|448929093|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
124808458|NCT02110238|448929092|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
124808459|NCT02110238|448929093|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
125300107|NCT01393639|450725884|FG000|Overall Study|Lack of Efficacy|0|||
125300108|NCT01393639|450725885|FG001|Overall Study|Lack of Efficacy|0|||
125300109|NCT01393639|450725886|FG002|Overall Study|Lack of Efficacy|0|||
124808460|NCT02110238|448929092|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
124808461|NCT02110238|448929093|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
124808462|NCT02110238|448929092|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
124808463|NCT02110238|448929093|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
124808464|NCT02110238|448929092|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
124808465|NCT02110238|448929093|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
124808466|NCT02110238|448929092|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
124808467|NCT02110238|448929093|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
124808468|NCT02110238|448929092|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
124808469|NCT02110238|448929093|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
124808470|NCT00697788|448929094|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
124808471|NCT00697788|448929095|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
124808472|NCT00697788|448929096|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
124808473|NCT00697788|448929097|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
124808474|NCT00697788|448929098|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
124808475|NCT00697788|448929099|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
124808476|NCT00697788|448929100|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
124808477|NCT00697788|448929101|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
124808478|NCT00697788|448929094|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
124808479|NCT00697788|448929095|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
124808480|NCT00697788|448929096|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
124808481|NCT00697788|448929097|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
124808482|NCT00697788|448929098|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
124808483|NCT00697788|448929099|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
124808484|NCT00697788|448929100|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
124808485|NCT00697788|448929101|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
124808486|NCT01419626|448929105|FG000|Overall Study|Protocol Violation|3|||
124808487|NCT01419626|448929106|FG001|Overall Study|Protocol Violation|2|||
124808488|NCT01419626|448929107|FG002|Overall Study|Protocol Violation|2|||
124808489|NCT01419626|448929105|FG000|Overall Study|Withdrawal by Subject|1|||
124808490|NCT01419626|448929106|FG001|Overall Study|Withdrawal by Subject|0|||
124808491|NCT01419626|448929107|FG002|Overall Study|Withdrawal by Subject|0|||
124808492|NCT01419626|448929105|FG000|Overall Study|Lost to Follow-up|0|||
124808493|NCT01419626|448929106|FG001|Overall Study|Lost to Follow-up|1|||
124808494|NCT01419626|448929107|FG002|Overall Study|Lost to Follow-up|1|||
124808495|NCT01365052|448929108|FG000|Overall Study|Adverse Event|4|||
124808496|NCT01365052|448929109|FG001|Overall Study|Adverse Event|4|||
124808497|NCT01145625|448929110|FG000|Overall Study|Lost to Follow-up|8|||
124808498|NCT01145625|448929111|FG001|Overall Study|Lost to Follow-up|9|||
124808499|NCT01145625|448929110|FG000|Overall Study|Adverse Event|6|||
124808500|NCT01145625|448929111|FG001|Overall Study|Adverse Event|4|||
124808501|NCT01145625|448929110|FG000|Overall Study|Protocol Violation|3|||
124808502|NCT01145625|448929111|FG001|Overall Study|Protocol Violation|1|||
124808503|NCT01145625|448929110|FG000|Overall Study|Withdrawal by Subject|7|||
124808504|NCT01145625|448929111|FG001|Overall Study|Withdrawal by Subject|16|||
124808505|NCT01145625|448929110|FG000|Overall Study|Pregnancy|0|||
124808506|NCT01145625|448929111|FG001|Overall Study|Pregnancy|1|||
124808507|NCT03080454|448929112|FG000|Baseline|Adverse Event|2|||
124808508|NCT03080454|448929112|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
124808509|NCT03080454|448929112|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
124808510|NCT00216476|448929113|FG000|Overall Study|Withdrawal by Subject|59|||
124808511|NCT00216476|448929114|FG001|Overall Study|Withdrawal by Subject|72|||
124808512|NCT00216476|448929115|FG002|Overall Study|Withdrawal by Subject|9|||
124808513|NCT00216476|448929113|FG000|Overall Study|Lost to Follow-up|10|||
124808514|NCT00216476|448929114|FG001|Overall Study|Lost to Follow-up|9|||
124808515|NCT00216476|448929115|FG002|Overall Study|Lost to Follow-up|1|||
124808516|NCT00216476|448929113|FG000|Overall Study|Adverse Event|6|||
124808517|NCT00216476|448929114|FG001|Overall Study|Adverse Event|10|||
124808518|NCT00216476|448929115|FG002|Overall Study|Adverse Event|1|||
124808519|NCT00216476|448929113|FG000|Overall Study|Lack of Efficacy|4|||
124808520|NCT00216476|448929114|FG001|Overall Study|Lack of Efficacy|3|||
124808521|NCT00216476|448929115|FG002|Overall Study|Lack of Efficacy|0|||
124808522|NCT00216476|448929113|FG000|Overall Study|Death|2|||
124808523|NCT00216476|448929114|FG001|Overall Study|Death|0|||
124808524|NCT00216476|448929115|FG002|Overall Study|Death|0|||
124808525|NCT00216476|448929113|FG000|Overall Study|Pregnancy|0|||
125300110|NCT01393639|450725887|FG003|Overall Study|Lack of Efficacy|0|||
125300111|NCT01393639|450725888|FG004|Overall Study|Lack of Efficacy|0|||
125300112|NCT01393639|450725889|FG005|Overall Study|Lack of Efficacy|0|||
124808526|NCT00216476|448929114|FG001|Overall Study|Pregnancy|1|||
124808527|NCT00216476|448929115|FG002|Overall Study|Pregnancy|1|||
124808528|NCT00216476|448929113|FG000|Overall Study|Other|0|||
124808529|NCT00216476|448929114|FG001|Overall Study|Other|0|||
124808530|NCT00216476|448929115|FG002|Overall Study|Other|1|||
124808531|NCT00216476|448929113|FG000|Overall Study|Refuses Injection|11|||
124808532|NCT00216476|448929114|FG001|Overall Study|Refuses Injection|0|||
124808533|NCT00216476|448929115|FG002|Overall Study|Refuses Injection|0|||
124808534|NCT00216476|448929113|FG000|Overall Study|No Further Need for Treatment|3|||
124808535|NCT00216476|448929114|FG001|Overall Study|No Further Need for Treatment|4|||
124808536|NCT00216476|448929115|FG002|Overall Study|No Further Need for Treatment|1|||
124808537|NCT00216476|448929113|FG000|Overall Study|Non-compliance|0|||
124808538|NCT00216476|448929114|FG001|Overall Study|Non-compliance|4|||
124808539|NCT00216476|448929115|FG002|Overall Study|Non-compliance|1|||
124808540|NCT00216476|448929113|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
124808541|NCT00216476|448929114|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
124808542|NCT00216476|448929115|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
124808543|NCT00216476|448929113|FG000|Overall Study|Administrative Reasons|1|||
124808544|NCT00216476|448929114|FG001|Overall Study|Administrative Reasons|1|||
124808545|NCT00216476|448929115|FG002|Overall Study|Administrative Reasons|0|||
124808546|NCT00216476|448929113|FG000|Overall Study|Protocol Deviation|5|||
124808547|NCT00216476|448929114|FG001|Overall Study|Protocol Deviation|1|||
124808548|NCT00216476|448929115|FG002|Overall Study|Protocol Deviation|0|||
124808549|NCT00216476|448929113|FG000|Overall Study|Patient Moved|2|||
124808550|NCT00216476|448929114|FG001|Overall Study|Patient Moved|2|||
124808551|NCT00216476|448929115|FG002|Overall Study|Patient Moved|0|||
124808552|NCT02202980|448929116|FG000|Overall Study|Lack of Efficacy|1|||
124808553|NCT02202980|448929117|FG001|Overall Study|Lack of Efficacy|0|||
124808554|NCT02202980|448929118|FG002|Overall Study|Lack of Efficacy|7|||
124808555|NCT02202980|448929119|FG003|Overall Study|Lack of Efficacy|0|||
124808556|NCT02202980|448929120|FG004|Overall Study|Lack of Efficacy|3|||
124808557|NCT02202980|448929121|FG005|Overall Study|Lack of Efficacy|1|||
124808558|NCT02202980|448929122|FG006|Overall Study|Lack of Efficacy|11|||
124808559|NCT02202980|448929123|FG007|Overall Study|Lack of Efficacy|2|||
124808560|NCT02202980|448929124|FG008|Overall Study|Lack of Efficacy|2|||
124808561|NCT02202980|448929125|FG009|Overall Study|Lack of Efficacy|0|||
124808562|NCT02202980|448929126|FG010|Overall Study|Lack of Efficacy|0|||
124808563|NCT02202980|448929127|FG011|Overall Study|Lack of Efficacy|3|||
124808564|NCT02202980|448929128|FG012|Overall Study|Lack of Efficacy|10|||
124808565|NCT02202980|448929129|FG013|Overall Study|Lack of Efficacy|0|||
124808566|NCT02202980|448929116|FG000|Overall Study|Protocol Violation|0|||
124808567|NCT02202980|448929117|FG001|Overall Study|Protocol Violation|0|||
124808568|NCT02202980|448929118|FG002|Overall Study|Protocol Violation|0|||
124808569|NCT02202980|448929119|FG003|Overall Study|Protocol Violation|3|||
124808570|NCT02202980|448929120|FG004|Overall Study|Protocol Violation|3|||
124808571|NCT02202980|448929121|FG005|Overall Study|Protocol Violation|0|||
124808572|NCT02202980|448929122|FG006|Overall Study|Protocol Violation|0|||
124808573|NCT02202980|448929123|FG007|Overall Study|Protocol Violation|0|||
124808574|NCT02202980|448929124|FG008|Overall Study|Protocol Violation|0|||
124808575|NCT02202980|448929125|FG009|Overall Study|Protocol Violation|0|||
124808576|NCT02202980|448929126|FG010|Overall Study|Protocol Violation|0|||
124808577|NCT02202980|448929127|FG011|Overall Study|Protocol Violation|0|||
124808578|NCT02202980|448929128|FG012|Overall Study|Protocol Violation|0|||
124808579|NCT02202980|448929129|FG013|Overall Study|Protocol Violation|0|||
124808580|NCT02202980|448929116|FG000|Overall Study|Lost to Follow-up|0|||
124808581|NCT02202980|448929117|FG001|Overall Study|Lost to Follow-up|1|||
124808582|NCT02202980|448929118|FG002|Overall Study|Lost to Follow-up|1|||
124808583|NCT02202980|448929119|FG003|Overall Study|Lost to Follow-up|1|||
124808584|NCT02202980|448929120|FG004|Overall Study|Lost to Follow-up|0|||
124808585|NCT02202980|448929121|FG005|Overall Study|Lost to Follow-up|0|||
124808586|NCT02202980|448929122|FG006|Overall Study|Lost to Follow-up|0|||
124808587|NCT02202980|448929123|FG007|Overall Study|Lost to Follow-up|1|||
124808588|NCT02202980|448929124|FG008|Overall Study|Lost to Follow-up|1|||
124808589|NCT02202980|448929125|FG009|Overall Study|Lost to Follow-up|0|||
124808590|NCT02202980|448929126|FG010|Overall Study|Lost to Follow-up|0|||
124808591|NCT02202980|448929127|FG011|Overall Study|Lost to Follow-up|0|||
124808592|NCT02202980|448929128|FG012|Overall Study|Lost to Follow-up|1|||
124808593|NCT02202980|448929129|FG013|Overall Study|Lost to Follow-up|0|||
124808594|NCT02202980|448929116|FG000|Overall Study|Withdrew Consent|0|||
124808595|NCT02202980|448929117|FG001|Overall Study|Withdrew Consent|1|||
124808596|NCT02202980|448929118|FG002|Overall Study|Withdrew Consent|2|||
124808597|NCT02202980|448929119|FG003|Overall Study|Withdrew Consent|0|||
124808598|NCT02202980|448929120|FG004|Overall Study|Withdrew Consent|0|||
124808599|NCT02202980|448929121|FG005|Overall Study|Withdrew Consent|0|||
124808600|NCT02202980|448929122|FG006|Overall Study|Withdrew Consent|0|||
124808601|NCT02202980|448929123|FG007|Overall Study|Withdrew Consent|0|||
124808602|NCT02202980|448929124|FG008|Overall Study|Withdrew Consent|1|||
124808603|NCT02202980|448929125|FG009|Overall Study|Withdrew Consent|0|||
124808604|NCT02202980|448929126|FG010|Overall Study|Withdrew Consent|0|||
124808605|NCT02202980|448929127|FG011|Overall Study|Withdrew Consent|0|||
124808606|NCT02202980|448929128|FG012|Overall Study|Withdrew Consent|0|||
124808607|NCT02202980|448929129|FG013|Overall Study|Withdrew Consent|0|||
124808608|NCT00696800|448929132|FG000|Overall Study|Adverse Event|16|||
124808609|NCT00696800|448929133|FG001|Overall Study|Adverse Event|3|||
124808610|NCT00696800|448929132|FG000|Overall Study|Insufficient compliance with medication|2|||
124808611|NCT00696800|448929133|FG001|Overall Study|Insufficient compliance with medication|1|||
124808612|NCT00696800|448929132|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
124808613|NCT00696800|448929133|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
124808614|NCT00696800|448929132|FG000|Overall Study|Insufficient ovarian response|4|||
124808615|NCT00696800|448929133|FG001|Overall Study|Insufficient ovarian response|1|||
124808616|NCT00696800|448929132|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
124808617|NCT00696800|448929133|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
124808618|NCT00696800|448929132|FG000|Overall Study|Too high ovarian response|6|||
124808619|NCT00696800|448929133|FG001|Overall Study|Too high ovarian response|1|||
124808620|NCT00696800|448929132|FG000|Overall Study|No/too few/bad quality oocytes|4|||
124808621|NCT00696800|448929133|FG001|Overall Study|No/too few/bad quality oocytes|3|||
125300113|NCT01393639|450725890|FG006|Overall Study|Lack of Efficacy|1|||
125300114|NCT01393639|450725884|FG000|Overall Study|Adverse Event|2|||
125300115|NCT01393639|450725885|FG001|Overall Study|Adverse Event|3|||
125300116|NCT01393639|450725886|FG002|Overall Study|Adverse Event|1|||
125300117|NCT01393639|450725887|FG003|Overall Study|Adverse Event|2|||
125300118|NCT01393639|450725888|FG004|Overall Study|Adverse Event|0|||
125300119|NCT01393639|450725889|FG005|Overall Study|Adverse Event|2|||
124808622|NCT00696800|448929132|FG000|Overall Study|No/abnormal fertilization|11|||
124808623|NCT00696800|448929133|FG001|Overall Study|No/abnormal fertilization|13|||
124808624|NCT00696800|448929132|FG000|Overall Study|No/too few/bad quality embryos|24|||
124808625|NCT00696800|448929133|FG001|Overall Study|No/too few/bad quality embryos|18|||
124808626|NCT00696800|448929132|FG000|Overall Study|Other Reasons|5|||
124808627|NCT00696800|448929133|FG001|Overall Study|Other Reasons|3|||
124808628|NCT00696800|448929132|FG000|Overall Study|Not treated|1|||
124808629|NCT00696800|448929133|FG001|Overall Study|Not treated|2|||
124808630|NCT05224141|448929138|FG000|Overall Study|Ongoing|75|||
124808631|NCT05224141|448929139|FG001|Overall Study|Ongoing|88|||
124808632|NCT05224141|448929138|FG000|Overall Study|Withdrawal by Subject|2|||
124808633|NCT05224141|448929139|FG001|Overall Study|Withdrawal by Subject|4|||
124808634|NCT05224141|448929138|FG000|Overall Study|Death|153|||
124808635|NCT05224141|448929139|FG001|Overall Study|Death|138|||
124808636|NCT01609231|448929148|FG000|Overall Study|Adverse Event|1|||
124808637|NCT01609231|448929149|FG001|Overall Study|Adverse Event|3|||
124808638|NCT01609231|448929148|FG000|Overall Study|Physician Decision|1|||
124808639|NCT01609231|448929149|FG001|Overall Study|Physician Decision|0|||
124808640|NCT01609231|448929148|FG000|Overall Study|Withdrawal by Subject|1|||
124808641|NCT01609231|448929149|FG001|Overall Study|Withdrawal by Subject|0|||
124808642|NCT01927627|448929156|FG000|Overall Study|Adverse Event|3|||
124808643|NCT01927627|448929156|FG000|Overall Study|Lack of Efficacy|1|||
124808644|NCT01927627|448929156|FG000|Overall Study|Financial Concerns|1|||
124808645|NCT00467857|448929157|FG000|Overall Study|Adverse Event|1|||
124808646|NCT00467857|448929158|FG001|Overall Study|Adverse Event|0|||
124808647|NCT00467857|448929157|FG000|Overall Study|Withdrew consent|2|||
124808648|NCT00467857|448929158|FG001|Overall Study|Withdrew consent|0|||
124808649|NCT00467857|448929157|FG000|Overall Study|Death|0|||
124808650|NCT00467857|448929158|FG001|Overall Study|Death|1|||
124808651|NCT00467857|448929157|FG000|Overall Study|Discharged from court service|0|||
124808652|NCT00467857|448929158|FG001|Overall Study|Discharged from court service|1|||
124808653|NCT00467857|448929157|FG000|Overall Study|Emergency care required|0|||
124808654|NCT00467857|448929158|FG001|Overall Study|Emergency care required|1|||
124808655|NCT00467857|448929157|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
124808656|NCT00467857|448929158|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
124808657|NCT00467857|448929157|FG000|Overall Study|Discontinuation reason missing|0|||
124808658|NCT00467857|448929158|FG001|Overall Study|Discontinuation reason missing|3|||
124808659|NCT00338104|448929159|FG000|Overall Study|Protocol Violation|2|||
124808660|NCT00338104|448929160|FG001|Overall Study|Protocol Violation|1|||
124808661|NCT00338104|448929161|FG002|Overall Study|Protocol Violation|3|||
124808662|NCT02298023|448929164|FG000|Overall Study|Withdrawal by Subject|1|||
124808663|NCT02298023|448929165|FG001|Overall Study|Withdrawal by Subject|0|||
124808664|NCT02298023|448929166|FG002|Overall Study|Withdrawal by Subject|0|||
124808665|NCT03307785|448929170|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
124808666|NCT03307785|448929171|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
124808667|NCT03307785|448929172|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
124808668|NCT03307785|448929173|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
124808669|NCT03307785|448929174|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
124808670|NCT03307785|448929175|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
124808671|NCT03307785|448929176|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
124808672|NCT03307785|448929177|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
125300120|NCT01393639|450725890|FG006|Overall Study|Adverse Event|3|||
125300121|NCT00679172|450725891|FG000|Overall Study|Non-compliance|1|||
125300122|NCT00679172|450725892|FG001|Overall Study|Non-compliance|1|||
124808673|NCT03307785|448929178|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
124808674|NCT03307785|448929179|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
124808675|NCT03307785|448929180|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
124808676|NCT03307785|448929170|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
125300123|NCT00679172|450725893|FG002|Overall Study|Non-compliance|0|||
124808677|NCT03307785|448929171|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
124808678|NCT03307785|448929172|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
124808679|NCT03307785|448929173|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
124808680|NCT03307785|448929174|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
124808681|NCT03307785|448929175|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
124808682|NCT03307785|448929176|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
124808683|NCT03307785|448929177|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
124808684|NCT03307785|448929178|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
124808685|NCT03307785|448929179|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
124808686|NCT03307785|448929180|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
124808687|NCT03307785|448929170|FG000|Part A: Up to 28.5 Months|Death|4|||
124808688|NCT03307785|448929171|FG001|Part A: Up to 28.5 Months|Death|4|||
124808689|NCT03307785|448929172|FG002|Part A: Up to 28.5 Months|Death|0|||
124808690|NCT03307785|448929173|FG003|Part A: Up to 28.5 Months|Death|0|||
124808691|NCT03307785|448929174|FG004|Part A: Up to 28.5 Months|Death|0|||
124808692|NCT03307785|448929175|FG005|Part A: Up to 28.5 Months|Death|0|||
124808693|NCT03307785|448929176|FG006|Part A: Up to 28.5 Months|Death|0|||
124808694|NCT03307785|448929177|FG007|Part A: Up to 28.5 Months|Death|0|||
124808695|NCT03307785|448929178|FG008|Part A: Up to 28.5 Months|Death|0|||
124808696|NCT03307785|448929179|FG009|Part A: Up to 28.5 Months|Death|0|||
124808697|NCT03307785|448929180|FG010|Part A: Up to 28.5 Months|Death|0|||
124808698|NCT03307785|448929170|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
124808699|NCT03307785|448929171|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
124808700|NCT03307785|448929172|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
124808701|NCT03307785|448929173|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
124808702|NCT03307785|448929174|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
124808703|NCT03307785|448929175|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
124808704|NCT03307785|448929176|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
124808705|NCT03307785|448929177|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
124808706|NCT03307785|448929178|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
124808707|NCT03307785|448929179|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
124808708|NCT03307785|448929180|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
124808709|NCT03307785|448929170|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
124808710|NCT03307785|448929171|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
124808711|NCT03307785|448929172|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
124808712|NCT03307785|448929173|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
124808713|NCT03307785|448929174|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
124808714|NCT03307785|448929175|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
124808715|NCT03307785|448929176|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
124808716|NCT03307785|448929177|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
124808717|NCT03307785|448929178|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
124808718|NCT03307785|448929179|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
124808719|NCT03307785|448929180|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
124808720|NCT03307785|448929170|FG000|Part B: Up to Approx. 66 Months|Death|0|||
124808721|NCT03307785|448929171|FG001|Part B: Up to Approx. 66 Months|Death|0|||
124808722|NCT03307785|448929172|FG002|Part B: Up to Approx. 66 Months|Death|7|||
124808723|NCT03307785|448929173|FG003|Part B: Up to Approx. 66 Months|Death|0|||
124808724|NCT03307785|448929174|FG004|Part B: Up to Approx. 66 Months|Death|0|||
124808725|NCT03307785|448929175|FG005|Part B: Up to Approx. 66 Months|Death|0|||
124808726|NCT03307785|448929176|FG006|Part B: Up to Approx. 66 Months|Death|0|||
124808727|NCT03307785|448929177|FG007|Part B: Up to Approx. 66 Months|Death|0|||
124808728|NCT03307785|448929178|FG008|Part B: Up to Approx. 66 Months|Death|0|||
124808729|NCT03307785|448929179|FG009|Part B: Up to Approx. 66 Months|Death|0|||
124808730|NCT03307785|448929180|FG010|Part B: Up to Approx. 66 Months|Death|0|||
124808731|NCT03307785|448929170|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
124808732|NCT03307785|448929171|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
124808733|NCT03307785|448929172|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
124808734|NCT03307785|448929173|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
124808735|NCT03307785|448929174|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
124808736|NCT03307785|448929175|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
124808737|NCT03307785|448929176|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
124808738|NCT03307785|448929177|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
124808739|NCT03307785|448929178|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
124808740|NCT03307785|448929179|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
124808741|NCT03307785|448929180|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
124808742|NCT03307785|448929170|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
124808743|NCT03307785|448929171|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
124808744|NCT03307785|448929172|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
124808745|NCT03307785|448929173|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
124808746|NCT03307785|448929174|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
124808747|NCT03307785|448929175|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
124808748|NCT03307785|448929176|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
124808749|NCT03307785|448929177|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
124808750|NCT03307785|448929178|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
124808751|NCT03307785|448929179|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
124808752|NCT03307785|448929180|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
124808753|NCT03307785|448929170|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
124808754|NCT03307785|448929171|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
124808755|NCT03307785|448929172|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
124808756|NCT03307785|448929173|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
124808757|NCT03307785|448929174|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
124808758|NCT03307785|448929175|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
124808759|NCT03307785|448929176|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
124808760|NCT03307785|448929177|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
124808761|NCT03307785|448929178|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
124808762|NCT03307785|448929179|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
124808763|NCT03307785|448929180|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
124808764|NCT03307785|448929170|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
124808765|NCT03307785|448929171|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
124808766|NCT03307785|448929172|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
124808767|NCT03307785|448929173|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
124808768|NCT03307785|448929174|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
124808769|NCT03307785|448929175|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
124808770|NCT03307785|448929176|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
124808771|NCT03307785|448929177|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
124808772|NCT03307785|448929178|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
124808773|NCT03307785|448929179|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
124808774|NCT03307785|448929180|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
124808775|NCT03307785|448929170|FG000|Part C: Up to Approx. 60 Months|Death|0|||
124808776|NCT03307785|448929171|FG001|Part C: Up to Approx. 60 Months|Death|0|||
124808777|NCT03307785|448929172|FG002|Part C: Up to Approx. 60 Months|Death|0|||
124808778|NCT03307785|448929173|FG003|Part C: Up to Approx. 60 Months|Death|2|||
124808779|NCT03307785|448929174|FG004|Part C: Up to Approx. 60 Months|Death|5|||
124808780|NCT03307785|448929175|FG005|Part C: Up to Approx. 60 Months|Death|0|||
124808781|NCT03307785|448929176|FG006|Part C: Up to Approx. 60 Months|Death|0|||
124808782|NCT03307785|448929177|FG007|Part C: Up to Approx. 60 Months|Death|0|||
124808783|NCT03307785|448929178|FG008|Part C: Up to Approx. 60 Months|Death|0|||
124808784|NCT03307785|448929179|FG009|Part C: Up to Approx. 60 Months|Death|0|||
124808785|NCT03307785|448929180|FG010|Part C: Up to Approx. 60 Months|Death|0|||
124808786|NCT03307785|448929170|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
124808787|NCT03307785|448929171|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
124808788|NCT03307785|448929172|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
124808789|NCT03307785|448929173|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
124808790|NCT03307785|448929174|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
124808791|NCT03307785|448929175|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
124808792|NCT03307785|448929176|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
124808793|NCT03307785|448929177|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
124808794|NCT03307785|448929178|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
124808795|NCT03307785|448929179|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
124808796|NCT03307785|448929180|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
124808797|NCT03307785|448929170|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
124808798|NCT03307785|448929171|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
124808799|NCT03307785|448929172|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
124808800|NCT03307785|448929173|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
124808801|NCT03307785|448929174|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
124808802|NCT03307785|448929175|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
124808803|NCT03307785|448929176|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
124808804|NCT03307785|448929177|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
124808805|NCT03307785|448929178|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
124808806|NCT03307785|448929179|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
124808807|NCT03307785|448929180|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
125300124|NCT00679172|450725894|FG003|Overall Study|Non-compliance|1|||
125300125|NCT00679172|450725895|FG004|Overall Study|Non-compliance|0|||
125300126|NCT00679172|450725891|FG000|Overall Study|Other not specified|0|||
125300127|NCT00679172|450725892|FG001|Overall Study|Other not specified|0|||
125300128|NCT00679172|450725893|FG002|Overall Study|Other not specified|1|||
124808808|NCT03307785|448929170|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
124808809|NCT03307785|448929171|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
124808810|NCT03307785|448929172|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
124808811|NCT03307785|448929173|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
124808812|NCT03307785|448929174|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
124808813|NCT03307785|448929175|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
124808814|NCT03307785|448929176|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
124808815|NCT03307785|448929177|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
124808816|NCT03307785|448929178|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
124808817|NCT03307785|448929179|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
124808818|NCT03307785|448929180|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
124808819|NCT03307785|448929170|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
124808820|NCT03307785|448929171|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
124808821|NCT03307785|448929172|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
124808822|NCT03307785|448929173|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
124808823|NCT03307785|448929174|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
124808824|NCT03307785|448929175|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
124808825|NCT03307785|448929176|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
124808826|NCT03307785|448929177|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
124808827|NCT03307785|448929178|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
124808828|NCT03307785|448929179|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
124808829|NCT03307785|448929180|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
124808830|NCT03307785|448929170|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
124808831|NCT03307785|448929171|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
124808832|NCT03307785|448929172|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
124808833|NCT03307785|448929173|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
124808834|NCT03307785|448929174|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
124808835|NCT03307785|448929175|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
124808836|NCT03307785|448929176|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
124808837|NCT03307785|448929177|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
124808838|NCT03307785|448929178|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
124808839|NCT03307785|448929179|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
124808840|NCT03307785|448929180|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
124808841|NCT03307785|448929170|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
124808842|NCT03307785|448929171|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
124808843|NCT03307785|448929172|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
124808844|NCT03307785|448929173|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
124808845|NCT03307785|448929174|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
124808846|NCT03307785|448929175|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
124808847|NCT03307785|448929176|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
124808848|NCT03307785|448929177|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
124808849|NCT03307785|448929178|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
124808850|NCT03307785|448929179|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
124808851|NCT03307785|448929180|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
124808852|NCT03307785|448929170|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
124808853|NCT03307785|448929171|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
124808854|NCT03307785|448929172|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
124808855|NCT03307785|448929173|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
124808856|NCT03307785|448929174|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
124808857|NCT03307785|448929175|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
124808858|NCT03307785|448929176|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
124808859|NCT03307785|448929177|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
124808860|NCT03307785|448929178|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
124808861|NCT03307785|448929179|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
124808862|NCT03307785|448929180|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
124808863|NCT03307785|448929170|FG000|Part E: Up to 4.4 Months|Death|0|||
124808864|NCT03307785|448929171|FG001|Part E: Up to 4.4 Months|Death|0|||
124808865|NCT03307785|448929172|FG002|Part E: Up to 4.4 Months|Death|0|||
124808866|NCT03307785|448929173|FG003|Part E: Up to 4.4 Months|Death|0|||
124808867|NCT03307785|448929174|FG004|Part E: Up to 4.4 Months|Death|0|||
124808868|NCT03307785|448929175|FG005|Part E: Up to 4.4 Months|Death|0|||
124808869|NCT03307785|448929176|FG006|Part E: Up to 4.4 Months|Death|1|||
124808870|NCT03307785|448929177|FG007|Part E: Up to 4.4 Months|Death|0|||
124808871|NCT03307785|448929178|FG008|Part E: Up to 4.4 Months|Death|0|||
125300129|NCT00679172|450725894|FG003|Overall Study|Other not specified|0|||
125300130|NCT00679172|450725895|FG004|Overall Study|Other not specified|0|||
124808872|NCT03307785|448929179|FG009|Part E: Up to 4.4 Months|Death|0|||
124808873|NCT03307785|448929180|FG010|Part E: Up to 4.4 Months|Death|0|||
124808874|NCT03307785|448929170|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
124808875|NCT03307785|448929171|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
124808876|NCT03307785|448929172|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
124808877|NCT03307785|448929173|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
124808878|NCT03307785|448929174|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
124808879|NCT03307785|448929175|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
124808880|NCT03307785|448929176|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
124808881|NCT03307785|448929177|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
124808882|NCT03307785|448929178|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
124808883|NCT03307785|448929179|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
124808884|NCT03307785|448929180|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
124808885|NCT03307785|448929170|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
124808886|NCT03307785|448929171|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
124808887|NCT03307785|448929172|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
124808888|NCT03307785|448929173|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
124808889|NCT03307785|448929174|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
124808890|NCT03307785|448929175|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
124808891|NCT03307785|448929176|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
124808892|NCT03307785|448929177|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
124808893|NCT03307785|448929178|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
124808894|NCT03307785|448929179|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
124808895|NCT03307785|448929180|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
124808896|NCT00492531|448929182|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
124808897|NCT00492531|448929183|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
124808898|NCT00843856|448929185|FG000|Overall Study|Lost to Follow-up|1|||
124808899|NCT00843856|448929186|FG001|Overall Study|Lost to Follow-up|2|||
124808900|NCT04729621|448929187|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
124808901|NCT04729621|448929188|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
124808902|NCT04729621|448929189|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
124808903|NCT04729621|448929190|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
124808904|NCT04729621|448929191|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
124808905|NCT04729621|448929187|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
124808906|NCT04729621|448929188|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
124808907|NCT04729621|448929189|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
124808908|NCT04729621|448929190|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
124808909|NCT04729621|448929191|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
124808910|NCT04729621|448929187|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
124808911|NCT04729621|448929188|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
124808912|NCT04729621|448929189|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
124808913|NCT04729621|448929190|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
124808914|NCT04729621|448929191|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
124808915|NCT04729621|448929187|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
124808916|NCT04729621|448929188|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
124808917|NCT04729621|448929189|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
124808918|NCT04729621|448929190|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
124808919|NCT04729621|448929191|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
124808920|NCT04729621|448929187|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
124808921|NCT04729621|448929188|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
124808922|NCT04729621|448929189|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
124808923|NCT04729621|448929190|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
124808924|NCT04729621|448929191|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
124808925|NCT04729621|448929187|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
124808926|NCT04729621|448929188|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
124808927|NCT04729621|448929189|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
124808928|NCT04729621|448929190|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
124808929|NCT04729621|448929191|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
124808930|NCT00319501|448929196|FG000|Double-blind Period|Withdrawal by Subject|0|||
124808931|NCT00319501|448929197|FG001|Double-blind Period|Withdrawal by Subject|3|||
124808932|NCT00319501|448929196|FG000|Double-blind Period|Sponsor Request|1|||
124808933|NCT00319501|448929197|FG001|Double-blind Period|Sponsor Request|0|||
124808934|NCT00319501|448929196|FG000|Double-blind Period|Did not receive treatment|42|||
124808935|NCT00319501|448929197|FG001|Double-blind Period|Did not receive treatment|29|||
124808936|NCT00319501|448929196|FG000|Open-label Period|Adverse Event|5|||
124808937|NCT00319501|448929197|FG001|Open-label Period|Adverse Event|0|||
124808938|NCT00319501|448929196|FG000|Open-label Period|Protocol Violation|6|||
124808939|NCT00319501|448929197|FG001|Open-label Period|Protocol Violation|0|||
124808940|NCT00319501|448929196|FG000|Open-label Period|Withdrawal by Subject|38|||
124808941|NCT00319501|448929197|FG001|Open-label Period|Withdrawal by Subject|0|||
124808942|NCT00319501|448929196|FG000|Open-label Period|Principal Investigator decision|6|||
124808943|NCT00319501|448929197|FG001|Open-label Period|Principal Investigator decision|0|||
124808944|NCT00319501|448929196|FG000|Open-label Period|Sponsor request|12|||
124808945|NCT00319501|448929197|FG001|Open-label Period|Sponsor request|0|||
124808946|NCT00319501|448929196|FG000|Open-label Period|Lost to Follow-up|5|||
124808947|NCT00319501|448929197|FG001|Open-label Period|Lost to Follow-up|0|||
124808948|NCT00319501|448929196|FG000|Open-label Period|Did not receive treatment|33|||
124808949|NCT00319501|448929197|FG001|Open-label Period|Did not receive treatment|0|||
124808950|NCT00319501|448929196|FG000|Open-label Period|Other|11|||
124808951|NCT00319501|448929197|FG001|Open-label Period|Other|0|||
124808952|NCT00319501|448929196|FG000|Open-label Extension Period|Adverse Event|2|||
124808953|NCT00319501|448929197|FG001|Open-label Extension Period|Adverse Event|0|||
124808954|NCT00319501|448929196|FG000|Open-label Extension Period|Did not receive treatment|18|||
124808955|NCT00319501|448929197|FG001|Open-label Extension Period|Did not receive treatment|0|||
124808956|NCT00319501|448929196|FG000|Open-label Extension Period|Other|1|||
124808957|NCT00319501|448929197|FG001|Open-label Extension Period|Other|0|||
124808958|NCT00319501|448929196|FG000|Open-label Extension Period|Principal investigator decision|2|||
124808959|NCT00319501|448929197|FG001|Open-label Extension Period|Principal investigator decision|0|||
124808960|NCT00319501|448929196|FG000|Open-label Extension Period|Sponsor request|26|||
124808961|NCT00319501|448929197|FG001|Open-label Extension Period|Sponsor request|0|||
124808962|NCT00319501|448929196|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
124808963|NCT00319501|448929197|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
124808964|NCT01696071|448929203|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
124808965|NCT01696071|448929204|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
124808966|NCT02569671|448929210|FG000|Overall Study|Lost to Follow-up|2|||
124808967|NCT02569671|448929211|FG001|Overall Study|Lost to Follow-up|1|||
124808968|NCT02569671|448929210|FG000|Overall Study|Withdrawal by Subject|1|||
124808969|NCT02569671|448929211|FG001|Overall Study|Withdrawal by Subject|3|||
124808970|NCT03487549|448929212|FG000|Overall Study|Protocol Violation|0|||
124808971|NCT03487549|448929213|FG001|Overall Study|Protocol Violation|1|||
124808972|NCT03487549|448929212|FG000|Overall Study|Lost to Follow-up|2|||
124808973|NCT03487549|448929213|FG001|Overall Study|Lost to Follow-up|1|||
124808974|NCT03487549|448929212|FG000|Overall Study|Withdrawal by Subject|2|||
124808975|NCT03487549|448929213|FG001|Overall Study|Withdrawal by Subject|0|||
124808976|NCT01977794|448930784|FG000|Overall Study|Adverse Event|2|||
124808977|NCT01977794|448930785|FG001|Overall Study|Adverse Event|2|||
124808978|NCT01977794|448930784|FG000|Overall Study|Lost to Follow-up|2|||
124808979|NCT01977794|448930785|FG001|Overall Study|Lost to Follow-up|1|||
124808980|NCT01977794|448930784|FG000|Overall Study|Protocol Violation|1|||
124808981|NCT01977794|448930785|FG001|Overall Study|Protocol Violation|0|||
124808982|NCT01977794|448930784|FG000|Overall Study|Death|1|||
124808983|NCT01977794|448930785|FG001|Overall Study|Death|1|||
124808984|NCT01977794|448930784|FG000|Overall Study|Withdrew consent|2|||
124808985|NCT01977794|448930785|FG001|Overall Study|Withdrew consent|1|||
124808986|NCT01977794|448930784|FG000|Overall Study|Other|0|||
124808987|NCT01977794|448930785|FG001|Overall Study|Other|1|||
124808988|NCT00827502|448930788|FG000|Overall Study|randomized but not treated|11|||
124808989|NCT00827502|448930788|FG000|Overall Study|Adverse Event|1|||
124808990|NCT00827502|448930788|FG000|Overall Study|Lost to Follow-up|4|||
124808991|NCT00827502|448930788|FG000|Overall Study|Withdrawal by Subject|5|||
124808992|NCT01705730|448930793|FG000|Overall Study|Lack of Efficacy|1|||
124808993|NCT01705730|448930793|FG000|Overall Study|Adverse Event|3|||
124808994|NCT01705730|448930793|FG000|Overall Study|Lost to Follow-up|1|||
125300131|NCT00793325|450725896|FG000|Overall Study|Protocol Violation|18|||
125300132|NCT00793325|450725896|FG000|Overall Study|Lost to Follow-up|1|||
125300133|NCT01815840|450725897|FG000|Overall Study|Missing|1|||
125300134|NCT01815840|450725898|FG001|Overall Study|Missing|0|||
125300135|NCT01815840|450725897|FG000|Overall Study|Withdrew Consent|31|||
125300136|NCT01815840|450725898|FG001|Overall Study|Withdrew Consent|30|||
125300137|NCT01815840|450725897|FG000|Overall Study|Administrative/Other|1|||
125300138|NCT01815840|450725898|FG001|Overall Study|Administrative/Other|3|||
125300139|NCT01815840|450725897|FG000|Overall Study|Adverse Event|10|||
125300140|NCT01815840|450725898|FG001|Overall Study|Adverse Event|16|||
125300141|NCT01815840|450725897|FG000|Overall Study|Death|2|||
125300142|NCT01815840|450725898|FG001|Overall Study|Death|2|||
125300143|NCT01815840|450725897|FG000|Overall Study|Disease progression|3|||
124808995|NCT01705730|448930793|FG000|Overall Study|Reason not Specified|4|||
124808996|NCT03228433|448930794|FG000|Overall Study|Lost to Follow-up|1|||
124808997|NCT03228433|448930795|FG001|Overall Study|Lost to Follow-up|0|||
124808998|NCT03228433|448930796|FG002|Overall Study|Lost to Follow-up|0|||
124808999|NCT03228433|448930797|FG003|Overall Study|Lost to Follow-up|0|||
124809000|NCT03228433|448930798|FG004|Overall Study|Lost to Follow-up|0|||
124809001|NCT03228433|448930799|FG005|Overall Study|Lost to Follow-up|0|||
124809002|NCT03228433|448930794|FG000|Overall Study|Positive alcohol test|0|||
125300144|NCT01815840|450725898|FG001|Overall Study|Disease progression|2|||
125300145|NCT01815840|450725897|FG000|Overall Study|Investigators Decision|2|||
124809003|NCT03228433|448930795|FG001|Overall Study|Positive alcohol test|0|||
124809004|NCT03228433|448930796|FG002|Overall Study|Positive alcohol test|0|||
124809005|NCT03228433|448930797|FG003|Overall Study|Positive alcohol test|1|||
124809006|NCT03228433|448930798|FG004|Overall Study|Positive alcohol test|0|||
124809007|NCT03228433|448930799|FG005|Overall Study|Positive alcohol test|0|||
124809008|NCT01773733|448930800|FG000|Overall Study|Adverse Event|3286|||
124809009|NCT01773733|448930801|FG001|Overall Study|Adverse Event|540|||
124809010|NCT01773733|448930800|FG000|Overall Study|Pregnancy|28|||
124809011|NCT01773733|448930801|FG001|Overall Study|Pregnancy|0|||
124809012|NCT01773733|448930800|FG000|Overall Study|Other different categories of not compl|55415|||
124809013|NCT01773733|448930801|FG001|Overall Study|Other different categories of not compl|7781|||
124809014|NCT01030536|448930802|FG000|Overall Study|Withdrawal by Subject|0|||
124809015|NCT01030536|448930803|FG001|Overall Study|Withdrawal by Subject|0|||
124809016|NCT01030536|448930804|FG002|Overall Study|Withdrawal by Subject|1|||
124809017|NCT01030536|448930805|FG003|Overall Study|Withdrawal by Subject|0|||
124809018|NCT01030536|448930806|FG004|Overall Study|Withdrawal by Subject|0|||
124809019|NCT01030536|448930802|FG000|Overall Study|undefined|1|||
124809020|NCT01030536|448930803|FG001|Overall Study|undefined|0|||
124809021|NCT01030536|448930804|FG002|Overall Study|undefined|1|||
124809022|NCT01030536|448930805|FG003|Overall Study|undefined|1|||
124809023|NCT01030536|448930806|FG004|Overall Study|undefined|0|||
124809024|NCT01030536|448930802|FG000|Overall Study|Adverse Event|0|||
124809025|NCT01030536|448930803|FG001|Overall Study|Adverse Event|3|||
124809026|NCT01030536|448930804|FG002|Overall Study|Adverse Event|1|||
124809027|NCT01030536|448930805|FG003|Overall Study|Adverse Event|0|||
124809028|NCT01030536|448930806|FG004|Overall Study|Adverse Event|1|||
124809029|NCT01030536|448930802|FG000|Overall Study|Progressive disease|6|||
124809030|NCT01030536|448930803|FG001|Overall Study|Progressive disease|2|||
124809031|NCT01030536|448930804|FG002|Overall Study|Progressive disease|3|||
124809032|NCT01030536|448930805|FG003|Overall Study|Progressive disease|2|||
124809033|NCT01030536|448930806|FG004|Overall Study|Progressive disease|0|||
124809034|NCT01030536|448930802|FG000|Overall Study|Death|0|||
124809035|NCT01030536|448930803|FG001|Overall Study|Death|1|||
124809036|NCT01030536|448930804|FG002|Overall Study|Death|0|||
124809037|NCT01030536|448930805|FG003|Overall Study|Death|0|||
124809038|NCT01030536|448930806|FG004|Overall Study|Death|0|||
124809039|NCT01330030|448930811|FG000|Overall Study|Lost to Follow-up|16|||
124809040|NCT01330030|448930812|FG001|Overall Study|Lost to Follow-up|17|||
124809041|NCT04891978|448930816|FG000|Baseline|Protocol Violation|2|||
124809042|NCT04891978|448930817|FG001|Baseline|Protocol Violation|1|||
124809043|NCT04891978|448930818|FG002|Baseline|Protocol Violation|0|||
124809044|NCT04891978|448930816|FG000|Baseline|Missing AIRQ|1|||
124809045|NCT04891978|448930817|FG001|Baseline|Missing AIRQ|0|||
124809046|NCT04891978|448930818|FG002|Baseline|Missing AIRQ|0|||
124809047|NCT04891978|448930816|FG000|Baseline|Did not attend a baseline visit|0|||
124809048|NCT04891978|448930817|FG001|Baseline|Did not attend a baseline visit|0|||
124809049|NCT04891978|448930818|FG002|Baseline|Did not attend a baseline visit|9|||
124809050|NCT01781975|448930824|FG000|Overall Study|Death|1|||
124809051|NCT01781975|448930825|FG001|Overall Study|Death|0|||
124809052|NCT01781975|448930824|FG000|Overall Study|Withdrawal by Subject|1|||
124809053|NCT01781975|448930825|FG001|Overall Study|Withdrawal by Subject|1|||
124809054|NCT01622231|448930826|FG000|Overall Study|Physician Decision|1|||
124809055|NCT01622231|448930826|FG000|Overall Study|Withdrawal by Subject|1|||
124809056|NCT02264639|448930827|FG000|Overall Study|Death (after completing single-dose phase)|1|||
124809057|NCT02264639|448930828|FG001|Overall Study|Death (after completing single-dose phase)|0|||
124809058|NCT02264639|448930829|FG002|Overall Study|Death (after completing single-dose phase)|0|||
124809059|NCT02264639|448930830|FG003|Overall Study|Death (after completing single-dose phase)|0|||
124809060|NCT02264639|448930831|FG004|Overall Study|Death (after completing single-dose phase)|0|||
124809061|NCT02264639|448930827|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
124809062|NCT02264639|448930828|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
124809063|NCT02264639|448930829|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
124809064|NCT02264639|448930830|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
124809065|NCT02264639|448930831|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
124809066|NCT02264639|448930827|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
124809067|NCT02264639|448930828|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
124809068|NCT02264639|448930829|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
124809069|NCT02264639|448930830|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
124809070|NCT02264639|448930831|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
124809071|NCT02264639|448930827|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
124809072|NCT02264639|448930828|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
124809073|NCT02264639|448930829|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
124809074|NCT02264639|448930830|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
124809075|NCT02264639|448930831|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
124809076|NCT04889222|448930835|FG000|Overall Study|Did not meet eligibility criteria|8|||
124809077|NCT04889222|448930835|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
124809078|NCT04889222|448930835|FG000|Overall Study|Did not proceed due to time constraints|5|||
124809079|NCT01180647|448930836|FG000|Overall Study|Lost to Follow-up|5|||
124809080|NCT01180647|448930837|FG001|Overall Study|Lost to Follow-up|6|||
124809081|NCT00702689|448930840|FG000|Overall Study|Withdrawal by Subject|4|||
124809082|NCT00702689|448930840|FG000|Overall Study|Recurrent malignancy|1|||
124809083|NCT00702689|448930840|FG000|Overall Study|Adverse Event|1|||
124809084|NCT02716805|448930848|FG000|Overall Study|Progressive disease|2|||
124809085|NCT02716805|448930849|FG001|Overall Study|Progressive disease|0|||
124809086|NCT02716805|448930850|FG002|Overall Study|Progressive disease|0|||
124809087|NCT02716805|448930851|FG003|Overall Study|Progressive disease|0|||
124809088|NCT02121522|448930858|FG000|Overall Study|Adverse Event|1|||
124809089|NCT00633750|448930860|FG000|Overall Study|Adverse Event|2|||
124809090|NCT00633750|448930860|FG000|Overall Study|Withdrawal by Subject|3|||
124809091|NCT01903031|448930861|FG000|Overall Study|Not Able to Attend Clinic|1|||
124809092|NCT01903031|448930862|FG001|Overall Study|Not Able to Attend Clinic|1|||
124809093|NCT01903031|448930863|FG002|Overall Study|Not Able to Attend Clinic|0|||
124809094|NCT01903031|448930861|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
124809095|NCT01903031|448930862|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
124809096|NCT01903031|448930863|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
124809097|NCT01903031|448930861|FG000|Overall Study|Adverse Event|0|||
124809098|NCT01903031|448930862|FG001|Overall Study|Adverse Event|1|||
124809099|NCT01903031|448930863|FG002|Overall Study|Adverse Event|0|||
124809100|NCT01903031|448930861|FG000|Overall Study|Withdrawal by Subject|0|||
124809101|NCT01903031|448930862|FG001|Overall Study|Withdrawal by Subject|1|||
124809102|NCT01903031|448930863|FG002|Overall Study|Withdrawal by Subject|1|||
124809103|NCT01903031|448930861|FG000|Overall Study|Protocol Violation|0|||
124809104|NCT01903031|448930862|FG001|Overall Study|Protocol Violation|0|||
124809105|NCT01903031|448930863|FG002|Overall Study|Protocol Violation|2|||
124809106|NCT01903031|448930861|FG000|Overall Study|Lost to Follow-up|0|||
124809107|NCT01903031|448930862|FG001|Overall Study|Lost to Follow-up|0|||
124809108|NCT01903031|448930863|FG002|Overall Study|Lost to Follow-up|1|||
124809109|NCT01903031|448930861|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
124809110|NCT01903031|448930862|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
124809111|NCT01903031|448930863|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
124809112|NCT03540030|448930864|FG000|Overall Study|Withdrawal by Subject|2|||
124809113|NCT03540030|448930865|FG001|Overall Study|Withdrawal by Subject|1|||
124809114|NCT03540030|448930864|FG000|Overall Study|screen fail|7|||
124809115|NCT03540030|448930865|FG001|Overall Study|screen fail|1|||
124809116|NCT03540030|448930864|FG000|Overall Study|never had surgery after signing consent|9|||
124809117|NCT03540030|448930865|FG001|Overall Study|never had surgery after signing consent|1|||
124809118|NCT03666624|448930870|FG000|Overall Study|participant grieving over recent death of parent|1|||
124809119|NCT03666624|448930871|FG001|Overall Study|participant grieving over recent death of parent|0|||
124809120|NCT00569270|448930873|FG000|Period: First Intervention|Protocol Violation|0|||
124809121|NCT00569270|448930874|FG001|Period: First Intervention|Protocol Violation|1|||
124809122|NCT00447005|448930875|FG000|Overall Study|Adverse Event|1|||
124809123|NCT00447005|448930875|FG000|Overall Study|Lack of Efficacy|11|||
124809124|NCT03822182|448930876|FG000|Overall Study|Protocol Violation|0|||
124809125|NCT03822182|448930877|FG001|Overall Study|Protocol Violation|1|||
124809126|NCT03822182|448930878|FG002|Overall Study|Protocol Violation|1|||
124809127|NCT00810355|448930882|FG000|Overall Study|Lost to Follow-up|13|||
124809128|NCT00810355|448930883|FG001|Overall Study|Lost to Follow-up|17|||
124809129|NCT00810355|448930884|FG002|Overall Study|Lost to Follow-up|11|||
124809130|NCT00810355|448930882|FG000|Overall Study|Withdrawal by Subject|1|||
124809131|NCT00810355|448930883|FG001|Overall Study|Withdrawal by Subject|0|||
124809132|NCT00810355|448930884|FG002|Overall Study|Withdrawal by Subject|0|||
124809133|NCT01484275|448930885|FG000|Overall Study|Study terminated by sponsor|28|||
124809134|NCT01484275|448930886|FG001|Overall Study|Study terminated by sponsor|32|||
124809135|NCT01484275|448930885|FG000|Overall Study|Other|10|||
124809136|NCT01484275|448930886|FG001|Overall Study|Other|0|||
124809137|NCT01484275|448930885|FG000|Overall Study|Death|3|||
124809138|NCT01484275|448930886|FG001|Overall Study|Death|4|||
124809139|NCT01484275|448930885|FG000|Overall Study|Withdrawal by Subject|1|||
124809140|NCT01484275|448930886|FG001|Overall Study|Withdrawal by Subject|5|||
124809141|NCT01484275|448930885|FG000|Overall Study|Lost to Follow-up|1|||
124809142|NCT01484275|448930886|FG001|Overall Study|Lost to Follow-up|1|||
124809143|NCT04154930|448930889|FG000|Overall Study|Withdrawal by Subject|15|||
124809144|NCT04154930|448930890|FG001|Overall Study|Withdrawal by Subject|6|||
124809145|NCT04154930|448930889|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
124809146|NCT04154930|448930890|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
124809147|NCT04154930|448930889|FG000|Overall Study|Lost to Follow-up|14|||
124809148|NCT04154930|448930890|FG001|Overall Study|Lost to Follow-up|6|||
124809149|NCT04154930|448930889|FG000|Overall Study|Other|6|||
124809150|NCT04154930|448930890|FG001|Overall Study|Other|0|||
124809151|NCT02130297|448930891|FG000|Overall Study|Lost to Follow-up|4|||
124809152|NCT00347360|448930892|FG000|Overall Study|Adverse Event|1|||
124809153|NCT00347360|448930893|FG001|Overall Study|Adverse Event|2|||
124809154|NCT00347360|448930894|FG002|Overall Study|Adverse Event|0|||
124809155|NCT00347360|448930895|FG003|Overall Study|Adverse Event|4|||
124809156|NCT00347360|448930896|FG004|Overall Study|Adverse Event|1|||
124809157|NCT00347360|448930897|FG005|Overall Study|Adverse Event|2|||
124809158|NCT00347360|448930898|FG006|Overall Study|Adverse Event|2|||
124809159|NCT00347360|448930899|FG007|Overall Study|Adverse Event|0|||
124809160|NCT00347360|448930900|FG008|Overall Study|Adverse Event|2|||
124809161|NCT00347360|448930901|FG009|Overall Study|Adverse Event|3|||
124809162|NCT00347360|448930902|FG010|Overall Study|Adverse Event|3|||
124809163|NCT00347360|448930903|FG011|Overall Study|Adverse Event|1|||
124809164|NCT00347360|448930904|FG012|Overall Study|Adverse Event|3|||
124809165|NCT00347360|448930905|FG013|Overall Study|Adverse Event|2|||
124809166|NCT00347360|448930906|FG014|Overall Study|Adverse Event|2|||
124809167|NCT00347360|448930892|FG000|Overall Study|Lost to Follow-up|0|||
124809168|NCT00347360|448930893|FG001|Overall Study|Lost to Follow-up|0|||
124809169|NCT00347360|448930894|FG002|Overall Study|Lost to Follow-up|0|||
124809170|NCT00347360|448930895|FG003|Overall Study|Lost to Follow-up|2|||
124809171|NCT00347360|448930896|FG004|Overall Study|Lost to Follow-up|1|||
124809172|NCT00347360|448930897|FG005|Overall Study|Lost to Follow-up|1|||
124809173|NCT00347360|448930898|FG006|Overall Study|Lost to Follow-up|0|||
124809174|NCT00347360|448930899|FG007|Overall Study|Lost to Follow-up|1|||
124809175|NCT00347360|448930900|FG008|Overall Study|Lost to Follow-up|1|||
124809176|NCT00347360|448930901|FG009|Overall Study|Lost to Follow-up|2|||
124809177|NCT00347360|448930902|FG010|Overall Study|Lost to Follow-up|0|||
124809178|NCT00347360|448930903|FG011|Overall Study|Lost to Follow-up|0|||
124809179|NCT00347360|448930904|FG012|Overall Study|Lost to Follow-up|1|||
124809180|NCT00347360|448930905|FG013|Overall Study|Lost to Follow-up|0|||
124809181|NCT00347360|448930906|FG014|Overall Study|Lost to Follow-up|0|||
124809182|NCT00347360|448930892|FG000|Overall Study|Protocol Violation|2|||
124809183|NCT00347360|448930893|FG001|Overall Study|Protocol Violation|3|||
124809184|NCT00347360|448930894|FG002|Overall Study|Protocol Violation|1|||
124809185|NCT00347360|448930895|FG003|Overall Study|Protocol Violation|2|||
124809186|NCT00347360|448930896|FG004|Overall Study|Protocol Violation|1|||
124809187|NCT00347360|448930897|FG005|Overall Study|Protocol Violation|2|||
124809188|NCT00347360|448930898|FG006|Overall Study|Protocol Violation|0|||
124809189|NCT00347360|448930899|FG007|Overall Study|Protocol Violation|0|||
124809190|NCT00347360|448930900|FG008|Overall Study|Protocol Violation|1|||
124809191|NCT00347360|448930901|FG009|Overall Study|Protocol Violation|2|||
124809192|NCT00347360|448930902|FG010|Overall Study|Protocol Violation|0|||
124809193|NCT00347360|448930903|FG011|Overall Study|Protocol Violation|0|||
124809194|NCT00347360|448930904|FG012|Overall Study|Protocol Violation|0|||
124809195|NCT00347360|448930905|FG013|Overall Study|Protocol Violation|1|||
124809196|NCT00347360|448930906|FG014|Overall Study|Protocol Violation|0|||
124809197|NCT00347360|448930892|FG000|Overall Study|Withdrawal by Subject|0|||
124809198|NCT00347360|448930893|FG001|Overall Study|Withdrawal by Subject|1|||
124809199|NCT00347360|448930894|FG002|Overall Study|Withdrawal by Subject|2|||
124809200|NCT00347360|448930895|FG003|Overall Study|Withdrawal by Subject|4|||
124809201|NCT00347360|448930896|FG004|Overall Study|Withdrawal by Subject|1|||
124809202|NCT00347360|448930897|FG005|Overall Study|Withdrawal by Subject|2|||
124809203|NCT00347360|448930898|FG006|Overall Study|Withdrawal by Subject|1|||
125300146|NCT01815840|450725898|FG001|Overall Study|Investigators Decision|3|||
125300147|NCT01815840|450725897|FG000|Overall Study|Lost to Follow-up|3|||
124809204|NCT00347360|448930899|FG007|Overall Study|Withdrawal by Subject|1|||
124809205|NCT00347360|448930900|FG008|Overall Study|Withdrawal by Subject|1|||
124809206|NCT00347360|448930901|FG009|Overall Study|Withdrawal by Subject|1|||
124809207|NCT00347360|448930902|FG010|Overall Study|Withdrawal by Subject|0|||
124809208|NCT00347360|448930903|FG011|Overall Study|Withdrawal by Subject|3|||
124809209|NCT00347360|448930904|FG012|Overall Study|Withdrawal by Subject|4|||
124809210|NCT00347360|448930905|FG013|Overall Study|Withdrawal by Subject|2|||
124809211|NCT00347360|448930906|FG014|Overall Study|Withdrawal by Subject|1|||
124809212|NCT00347360|448930892|FG000|Overall Study|Lack of Efficacy|1|||
124809213|NCT00347360|448930893|FG001|Overall Study|Lack of Efficacy|1|||
124809214|NCT00347360|448930894|FG002|Overall Study|Lack of Efficacy|3|||
124809215|NCT00347360|448930895|FG003|Overall Study|Lack of Efficacy|1|||
124809216|NCT00347360|448930896|FG004|Overall Study|Lack of Efficacy|0|||
124809217|NCT00347360|448930897|FG005|Overall Study|Lack of Efficacy|1|||
124809218|NCT00347360|448930898|FG006|Overall Study|Lack of Efficacy|0|||
124809219|NCT00347360|448930899|FG007|Overall Study|Lack of Efficacy|1|||
124809220|NCT00347360|448930900|FG008|Overall Study|Lack of Efficacy|1|||
124809221|NCT00347360|448930901|FG009|Overall Study|Lack of Efficacy|0|||
124809222|NCT00347360|448930902|FG010|Overall Study|Lack of Efficacy|0|||
124809223|NCT00347360|448930903|FG011|Overall Study|Lack of Efficacy|0|||
124809224|NCT00347360|448930904|FG012|Overall Study|Lack of Efficacy|0|||
124809225|NCT00347360|448930905|FG013|Overall Study|Lack of Efficacy|0|||
124809226|NCT00347360|448930906|FG014|Overall Study|Lack of Efficacy|0|||
124809227|NCT00347360|448930892|FG000|Overall Study|Reason not listed/blank|1|||
124809228|NCT00347360|448930893|FG001|Overall Study|Reason not listed/blank|0|||
124809229|NCT00347360|448930894|FG002|Overall Study|Reason not listed/blank|0|||
125300148|NCT01815840|450725898|FG001|Overall Study|Lost to Follow-up|6|||
124809230|NCT00347360|448930895|FG003|Overall Study|Reason not listed/blank|0|||
124809231|NCT00347360|448930896|FG004|Overall Study|Reason not listed/blank|0|||
124809232|NCT00347360|448930897|FG005|Overall Study|Reason not listed/blank|0|||
124809233|NCT00347360|448930898|FG006|Overall Study|Reason not listed/blank|1|||
124809234|NCT00347360|448930899|FG007|Overall Study|Reason not listed/blank|0|||
124809235|NCT00347360|448930900|FG008|Overall Study|Reason not listed/blank|0|||
124809236|NCT00347360|448930901|FG009|Overall Study|Reason not listed/blank|0|||
124809237|NCT00347360|448930902|FG010|Overall Study|Reason not listed/blank|0|||
124809238|NCT00347360|448930903|FG011|Overall Study|Reason not listed/blank|0|||
124809239|NCT00347360|448930904|FG012|Overall Study|Reason not listed/blank|0|||
124809240|NCT00347360|448930905|FG013|Overall Study|Reason not listed/blank|1|||
124809241|NCT00347360|448930906|FG014|Overall Study|Reason not listed/blank|0|||
124809242|NCT00347360|448930892|FG000|Overall Study|Per sponsors instruction|0|||
124809243|NCT00347360|448930893|FG001|Overall Study|Per sponsors instruction|1|||
124809244|NCT00347360|448930894|FG002|Overall Study|Per sponsors instruction|0|||
124809245|NCT00347360|448930895|FG003|Overall Study|Per sponsors instruction|0|||
124809246|NCT00347360|448930896|FG004|Overall Study|Per sponsors instruction|0|||
124809247|NCT00347360|448930897|FG005|Overall Study|Per sponsors instruction|0|||
124809248|NCT00347360|448930898|FG006|Overall Study|Per sponsors instruction|0|||
124809249|NCT00347360|448930899|FG007|Overall Study|Per sponsors instruction|0|||
124809250|NCT00347360|448930900|FG008|Overall Study|Per sponsors instruction|0|||
124809251|NCT00347360|448930901|FG009|Overall Study|Per sponsors instruction|0|||
124809252|NCT00347360|448930902|FG010|Overall Study|Per sponsors instruction|0|||
124809253|NCT00347360|448930903|FG011|Overall Study|Per sponsors instruction|0|||
124809254|NCT00347360|448930904|FG012|Overall Study|Per sponsors instruction|0|||
124809255|NCT00347360|448930905|FG013|Overall Study|Per sponsors instruction|0|||
124809256|NCT00347360|448930906|FG014|Overall Study|Per sponsors instruction|0|||
124809257|NCT00347360|448930892|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
124809258|NCT00347360|448930893|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
124809259|NCT00347360|448930894|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
124809260|NCT00347360|448930895|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
124809261|NCT00347360|448930896|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
124809262|NCT00347360|448930897|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
124809263|NCT00347360|448930898|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
124809264|NCT00347360|448930899|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
124809265|NCT00347360|448930900|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
124809266|NCT00347360|448930901|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
124809267|NCT00347360|448930902|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
124809268|NCT00347360|448930903|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
124809269|NCT00347360|448930904|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
124809270|NCT00347360|448930905|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
124809271|NCT00347360|448930906|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
124809272|NCT00347360|448930892|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
124809273|NCT00347360|448930893|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
124809274|NCT00347360|448930894|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
124809275|NCT00347360|448930895|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
124809276|NCT00347360|448930896|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
124809277|NCT00347360|448930897|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
124809278|NCT00347360|448930898|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
124809279|NCT00347360|448930899|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
124809280|NCT00347360|448930900|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
124809281|NCT00347360|448930901|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
124809282|NCT00347360|448930902|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
124809283|NCT00347360|448930903|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
124809284|NCT00347360|448930904|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
124809285|NCT00347360|448930905|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
124809286|NCT00347360|448930906|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
124809287|NCT00347360|448930892|FG000|Overall Study|Abnormal lab values|0|||
124809288|NCT00347360|448930893|FG001|Overall Study|Abnormal lab values|0|||
125300149|NCT01815840|450725897|FG000|Overall Study|Refused Treatment|5|||
124809289|NCT00347360|448930894|FG002|Overall Study|Abnormal lab values|0|||
125300150|NCT01815840|450725898|FG001|Overall Study|Refused Treatment|1|||
124809290|NCT00347360|448930895|FG003|Overall Study|Abnormal lab values|0|||
124809291|NCT00347360|448930896|FG004|Overall Study|Abnormal lab values|0|||
124809292|NCT00347360|448930897|FG005|Overall Study|Abnormal lab values|0|||
124809293|NCT00347360|448930898|FG006|Overall Study|Abnormal lab values|1|||
124809294|NCT00347360|448930899|FG007|Overall Study|Abnormal lab values|0|||
124809295|NCT00347360|448930900|FG008|Overall Study|Abnormal lab values|0|||
124809296|NCT00347360|448930901|FG009|Overall Study|Abnormal lab values|0|||
124809297|NCT00347360|448930902|FG010|Overall Study|Abnormal lab values|0|||
124809298|NCT00347360|448930903|FG011|Overall Study|Abnormal lab values|0|||
125300151|NCT01815840|450725897|FG000|Overall Study|Sponsor Termination Treatment|1|||
124809299|NCT00347360|448930904|FG012|Overall Study|Abnormal lab values|0|||
124809300|NCT00347360|448930905|FG013|Overall Study|Abnormal lab values|0|||
124809301|NCT00347360|448930906|FG014|Overall Study|Abnormal lab values|0|||
124809302|NCT00347360|448930892|FG000|Overall Study|PI recommended early withdrawal|0|||
124809303|NCT00347360|448930893|FG001|Overall Study|PI recommended early withdrawal|0|||
124809304|NCT00347360|448930894|FG002|Overall Study|PI recommended early withdrawal|0|||
124809305|NCT00347360|448930895|FG003|Overall Study|PI recommended early withdrawal|0|||
124809306|NCT00347360|448930896|FG004|Overall Study|PI recommended early withdrawal|0|||
124809307|NCT00347360|448930897|FG005|Overall Study|PI recommended early withdrawal|0|||
124809308|NCT00347360|448930898|FG006|Overall Study|PI recommended early withdrawal|0|||
124809309|NCT00347360|448930899|FG007|Overall Study|PI recommended early withdrawal|0|||
124809310|NCT00347360|448930900|FG008|Overall Study|PI recommended early withdrawal|0|||
124809311|NCT00347360|448930901|FG009|Overall Study|PI recommended early withdrawal|1|||
124809312|NCT00347360|448930902|FG010|Overall Study|PI recommended early withdrawal|0|||
124809313|NCT00347360|448930903|FG011|Overall Study|PI recommended early withdrawal|0|||
124809314|NCT00347360|448930904|FG012|Overall Study|PI recommended early withdrawal|0|||
124809315|NCT00347360|448930905|FG013|Overall Study|PI recommended early withdrawal|0|||
124809316|NCT00347360|448930906|FG014|Overall Study|PI recommended early withdrawal|0|||
124809317|NCT00347360|448930892|FG000|Overall Study|Did not meet criteria before ABPM|0|||
124809318|NCT00347360|448930893|FG001|Overall Study|Did not meet criteria before ABPM|0|||
124809319|NCT00347360|448930894|FG002|Overall Study|Did not meet criteria before ABPM|0|||
124809320|NCT00347360|448930895|FG003|Overall Study|Did not meet criteria before ABPM|0|||
124809321|NCT00347360|448930896|FG004|Overall Study|Did not meet criteria before ABPM|0|||
124809322|NCT00347360|448930897|FG005|Overall Study|Did not meet criteria before ABPM|0|||
124809323|NCT00347360|448930898|FG006|Overall Study|Did not meet criteria before ABPM|0|||
124809324|NCT00347360|448930899|FG007|Overall Study|Did not meet criteria before ABPM|0|||
124809325|NCT00347360|448930900|FG008|Overall Study|Did not meet criteria before ABPM|0|||
124809326|NCT00347360|448930901|FG009|Overall Study|Did not meet criteria before ABPM|0|||
124809327|NCT00347360|448930902|FG010|Overall Study|Did not meet criteria before ABPM|1|||
124809328|NCT00347360|448930903|FG011|Overall Study|Did not meet criteria before ABPM|0|||
124809329|NCT00347360|448930904|FG012|Overall Study|Did not meet criteria before ABPM|0|||
124809330|NCT00347360|448930905|FG013|Overall Study|Did not meet criteria before ABPM|0|||
124809331|NCT00347360|448930906|FG014|Overall Study|Did not meet criteria before ABPM|0|||
124809332|NCT00347360|448930892|FG000|Overall Study|Randomized in error|0|||
124809333|NCT00347360|448930893|FG001|Overall Study|Randomized in error|0|||
124809334|NCT00347360|448930894|FG002|Overall Study|Randomized in error|0|||
124809335|NCT00347360|448930895|FG003|Overall Study|Randomized in error|0|||
124809336|NCT00347360|448930896|FG004|Overall Study|Randomized in error|0|||
124809337|NCT00347360|448930897|FG005|Overall Study|Randomized in error|0|||
124809338|NCT00347360|448930898|FG006|Overall Study|Randomized in error|0|||
124809339|NCT00347360|448930899|FG007|Overall Study|Randomized in error|0|||
124809340|NCT00347360|448930900|FG008|Overall Study|Randomized in error|0|||
124809341|NCT00347360|448930901|FG009|Overall Study|Randomized in error|0|||
124809342|NCT00347360|448930902|FG010|Overall Study|Randomized in error|0|||
124809343|NCT00347360|448930903|FG011|Overall Study|Randomized in error|1|||
124809344|NCT00347360|448930904|FG012|Overall Study|Randomized in error|0|||
124809345|NCT00347360|448930905|FG013|Overall Study|Randomized in error|0|||
124809346|NCT00347360|448930906|FG014|Overall Study|Randomized in error|0|||
124809347|NCT00347360|448930892|FG000|Overall Study|Failed inclusion criteria #4|0|||
124809348|NCT00347360|448930893|FG001|Overall Study|Failed inclusion criteria #4|0|||
124809349|NCT00347360|448930894|FG002|Overall Study|Failed inclusion criteria #4|0|||
124809350|NCT00347360|448930895|FG003|Overall Study|Failed inclusion criteria #4|0|||
124809351|NCT00347360|448930896|FG004|Overall Study|Failed inclusion criteria #4|0|||
124809352|NCT00347360|448930897|FG005|Overall Study|Failed inclusion criteria #4|0|||
124809353|NCT00347360|448930898|FG006|Overall Study|Failed inclusion criteria #4|0|||
124809354|NCT00347360|448930899|FG007|Overall Study|Failed inclusion criteria #4|0|||
124809355|NCT00347360|448930900|FG008|Overall Study|Failed inclusion criteria #4|0|||
124809356|NCT00347360|448930901|FG009|Overall Study|Failed inclusion criteria #4|0|||
124809357|NCT00347360|448930902|FG010|Overall Study|Failed inclusion criteria #4|0|||
124809358|NCT00347360|448930903|FG011|Overall Study|Failed inclusion criteria #4|1|||
124809359|NCT00347360|448930904|FG012|Overall Study|Failed inclusion criteria #4|0|||
124809360|NCT00347360|448930905|FG013|Overall Study|Failed inclusion criteria #4|0|||
124809361|NCT00347360|448930906|FG014|Overall Study|Failed inclusion criteria #4|0|||
124809362|NCT00347360|448930892|FG000|Overall Study|Prolonged duration between visits|0|||
124809363|NCT00347360|448930893|FG001|Overall Study|Prolonged duration between visits|0|||
124809364|NCT00347360|448930894|FG002|Overall Study|Prolonged duration between visits|0|||
124809365|NCT00347360|448930895|FG003|Overall Study|Prolonged duration between visits|0|||
124809366|NCT00347360|448930896|FG004|Overall Study|Prolonged duration between visits|0|||
124809367|NCT00347360|448930897|FG005|Overall Study|Prolonged duration between visits|0|||
124809368|NCT00347360|448930898|FG006|Overall Study|Prolonged duration between visits|0|||
124809369|NCT00347360|448930899|FG007|Overall Study|Prolonged duration between visits|0|||
124809370|NCT00347360|448930900|FG008|Overall Study|Prolonged duration between visits|0|||
124809371|NCT00347360|448930901|FG009|Overall Study|Prolonged duration between visits|0|||
124809372|NCT00347360|448930902|FG010|Overall Study|Prolonged duration between visits|0|||
124809373|NCT00347360|448930903|FG011|Overall Study|Prolonged duration between visits|0|||
124809374|NCT00347360|448930904|FG012|Overall Study|Prolonged duration between visits|1|||
124809375|NCT00347360|448930905|FG013|Overall Study|Prolonged duration between visits|0|||
124809376|NCT00347360|448930906|FG014|Overall Study|Prolonged duration between visits|0|||
124809377|NCT00347360|448930892|FG000|Overall Study|Subject left town, ran out of study drug|0|||
124809378|NCT00347360|448930893|FG001|Overall Study|Subject left town, ran out of study drug|0|||
124809379|NCT00347360|448930894|FG002|Overall Study|Subject left town, ran out of study drug|0|||
124809380|NCT00347360|448930895|FG003|Overall Study|Subject left town, ran out of study drug|0|||
124809381|NCT00347360|448930896|FG004|Overall Study|Subject left town, ran out of study drug|0|||
124809382|NCT00347360|448930897|FG005|Overall Study|Subject left town, ran out of study drug|0|||
124809383|NCT00347360|448930898|FG006|Overall Study|Subject left town, ran out of study drug|0|||
124809384|NCT00347360|448930899|FG007|Overall Study|Subject left town, ran out of study drug|0|||
124809385|NCT00347360|448930900|FG008|Overall Study|Subject left town, ran out of study drug|0|||
124809386|NCT00347360|448930901|FG009|Overall Study|Subject left town, ran out of study drug|0|||
124809387|NCT00347360|448930902|FG010|Overall Study|Subject left town, ran out of study drug|0|||
124809388|NCT00347360|448930903|FG011|Overall Study|Subject left town, ran out of study drug|0|||
124809389|NCT00347360|448930904|FG012|Overall Study|Subject left town, ran out of study drug|0|||
124809390|NCT00347360|448930905|FG013|Overall Study|Subject left town, ran out of study drug|1|||
124809391|NCT00347360|448930906|FG014|Overall Study|Subject left town, ran out of study drug|0|||
124809392|NCT00347360|448930892|FG000|Overall Study|Subject refuse to sign updated consent|0|||
124809393|NCT00347360|448930893|FG001|Overall Study|Subject refuse to sign updated consent|0|||
124809394|NCT00347360|448930894|FG002|Overall Study|Subject refuse to sign updated consent|0|||
124809395|NCT00347360|448930895|FG003|Overall Study|Subject refuse to sign updated consent|0|||
124809396|NCT00347360|448930896|FG004|Overall Study|Subject refuse to sign updated consent|0|||
124809397|NCT00347360|448930897|FG005|Overall Study|Subject refuse to sign updated consent|0|||
124809398|NCT00347360|448930898|FG006|Overall Study|Subject refuse to sign updated consent|0|||
124809399|NCT00347360|448930899|FG007|Overall Study|Subject refuse to sign updated consent|0|||
124809400|NCT00347360|448930900|FG008|Overall Study|Subject refuse to sign updated consent|0|||
124809401|NCT00347360|448930901|FG009|Overall Study|Subject refuse to sign updated consent|0|||
124809402|NCT00347360|448930902|FG010|Overall Study|Subject refuse to sign updated consent|0|||
124809403|NCT00347360|448930903|FG011|Overall Study|Subject refuse to sign updated consent|0|||
124809404|NCT00347360|448930904|FG012|Overall Study|Subject refuse to sign updated consent|0|||
124809405|NCT00347360|448930905|FG013|Overall Study|Subject refuse to sign updated consent|0|||
124809406|NCT00347360|448930906|FG014|Overall Study|Subject refuse to sign updated consent|1|||
124809407|NCT00347360|448930892|FG000|Overall Study|Visits conflicted with new job|0|||
124809408|NCT00347360|448930893|FG001|Overall Study|Visits conflicted with new job|0|||
124809409|NCT00347360|448930894|FG002|Overall Study|Visits conflicted with new job|0|||
124809410|NCT00347360|448930895|FG003|Overall Study|Visits conflicted with new job|0|||
124809411|NCT00347360|448930896|FG004|Overall Study|Visits conflicted with new job|0|||
124809412|NCT00347360|448930897|FG005|Overall Study|Visits conflicted with new job|0|||
124809413|NCT00347360|448930898|FG006|Overall Study|Visits conflicted with new job|1|||
124809414|NCT00347360|448930899|FG007|Overall Study|Visits conflicted with new job|0|||
124809415|NCT00347360|448930900|FG008|Overall Study|Visits conflicted with new job|0|||
124809416|NCT00347360|448930901|FG009|Overall Study|Visits conflicted with new job|0|||
124809417|NCT00347360|448930902|FG010|Overall Study|Visits conflicted with new job|0|||
124809418|NCT00347360|448930903|FG011|Overall Study|Visits conflicted with new job|0|||
124809419|NCT00347360|448930904|FG012|Overall Study|Visits conflicted with new job|0|||
124809420|NCT00347360|448930905|FG013|Overall Study|Visits conflicted with new job|0|||
124809421|NCT00347360|448930906|FG014|Overall Study|Visits conflicted with new job|0|||
124809422|NCT00913380|448930912|FG000|Clinical Outcomes|Lost to Follow-up|6|||
124809423|NCT00913380|448930913|FG001|Clinical Outcomes|Lost to Follow-up|6|||
124809424|NCT00806351|448930914|FG000|Overall Study|Death|5|||
124809425|NCT00806351|448930915|FG001|Overall Study|Death|4|||
124809426|NCT02187744|448930916|FG000|Study|Participant refused further follow-up|1|||
124809427|NCT02187744|448930917|FG001|Study|Participant refused further follow-up|0|||
124809428|NCT02187744|448930916|FG000|Study|Other|2|||
124809429|NCT02187744|448930917|FG001|Study|Other|1|||
124809430|NCT02187744|448930916|FG000|Study|Lost to Follow-up|0|||
124809431|NCT02187744|448930917|FG001|Study|Lost to Follow-up|2|||
124809432|NCT02187744|448930916|FG000|Study|Related adverse event, not serious|0|||
124809433|NCT02187744|448930917|FG001|Study|Related adverse event, not serious|2|||
124809434|NCT02187744|448930916|FG000|Study|Death|1|||
124809435|NCT02187744|448930917|FG001|Study|Death|0|||
124809436|NCT02187744|448930916|FG000|Study|Related adverse event, serious non-fatal|0|||
124809437|NCT02187744|448930917|FG001|Study|Related adverse event, serious non-fatal|1|||
124809438|NCT02187744|448930916|FG000|Treatment|Death|1|||
124809439|NCT02187744|448930917|FG001|Treatment|Death|0|||
124809440|NCT02187744|448930916|FG000|Treatment|Related adverse event, serious non-fatal|0|||
124809441|NCT02187744|448930917|FG001|Treatment|Related adverse event, serious non-fatal|1|||
124809442|NCT02187744|448930916|FG000|Treatment|Related adverse event, not serious|0|||
124809443|NCT02187744|448930917|FG001|Treatment|Related adverse event, not serious|2|||
124809444|NCT02187744|448930916|FG000|Treatment|Lost to Follow-up|0|||
124809445|NCT02187744|448930917|FG001|Treatment|Lost to Follow-up|1|||
124809446|NCT02187744|448930916|FG000|Treatment|Other|2|||
124809447|NCT02187744|448930917|FG001|Treatment|Other|0|||
124809448|NCT02187744|448930916|FG000|Treatment|Participant refused continued treatment|1|||
124809449|NCT02187744|448930917|FG001|Treatment|Participant refused continued treatment|1|||
124809450|NCT00508755|448930923|FG000|Overall Study|Withdrawal by Subject|1|||
124809451|NCT02004522|448930929|FG000|Overall Study|Adverse Event|55|||
124809452|NCT02004522|448930930|FG001|Overall Study|Adverse Event|6|||
124809453|NCT02004522|448930929|FG000|Overall Study|Withdrawal by Subject|13|||
124809454|NCT02004522|448930930|FG001|Overall Study|Withdrawal by Subject|7|||
124809455|NCT02004522|448930929|FG000|Overall Study|Death|12|||
124809456|NCT02004522|448930930|FG001|Overall Study|Death|3|||
124809457|NCT02004522|448930929|FG000|Overall Study|Physician Decision|3|||
124809458|NCT02004522|448930930|FG001|Overall Study|Physician Decision|4|||
124809459|NCT02004522|448930929|FG000|Overall Study|Protocol Violation|1|||
124809460|NCT02004522|448930930|FG001|Overall Study|Protocol Violation|0|||
124809461|NCT02004522|448930929|FG000|Overall Study|Other is reason listed by PI|4|||
124809462|NCT02004522|448930930|FG001|Overall Study|Other is reason listed by PI|1|||
124809463|NCT02004522|448930929|FG000|Overall Study|Never Dosed|2|||
124809464|NCT02004522|448930930|FG001|Overall Study|Never Dosed|4|||
124809465|NCT02004522|448930929|FG000|Overall Study|Disease Progression|35|||
124809466|NCT02004522|448930930|FG001|Overall Study|Disease Progression|31|||
124809467|NCT02004522|448930929|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
124809468|NCT02004522|448930930|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
124809469|NCT01787331|448930931|FG000|Overall Study|Physician Decision|1|||
124809470|NCT01787331|448930931|FG000|Overall Study|Withdrawal by Subject|1|||
124809471|NCT01999868|448930932|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
124809472|NCT01999868|448930933|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
124809473|NCT01999868|448930934|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
124809474|NCT01999868|448930932|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
124809475|NCT01999868|448930933|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
124809476|NCT01999868|448930934|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
124809477|NCT01999868|448930932|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
124809478|NCT01999868|448930933|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
124809479|NCT01999868|448930934|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
124809480|NCT01999868|448930932|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
124809481|NCT01999868|448930933|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
124809482|NCT01999868|448930934|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
124809483|NCT01999868|448930932|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
124809484|NCT01999868|448930933|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
124809485|NCT01999868|448930934|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
124809486|NCT01999868|448930932|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
124809487|NCT01999868|448930933|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
124809488|NCT01999868|448930934|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
124809489|NCT01999868|448930932|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
124809490|NCT01999868|448930933|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
124809491|NCT01999868|448930934|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
124809492|NCT01999868|448930932|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
124809493|NCT01999868|448930933|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
124809494|NCT01999868|448930934|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
124809495|NCT01999868|448930932|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
124809496|NCT01999868|448930933|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
124809497|NCT01999868|448930934|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
124809498|NCT01999868|448930932|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
124809499|NCT01999868|448930933|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
124809500|NCT01999868|448930934|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
124809501|NCT01999868|448930932|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
124809502|NCT01999868|448930933|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
124809503|NCT01999868|448930934|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
124809504|NCT01999868|448930932|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
124809505|NCT01999868|448930933|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
124809506|NCT01999868|448930934|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
124809507|NCT01999868|448930932|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
124809508|NCT01999868|448930933|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
124809509|NCT01999868|448930934|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
124809510|NCT01999868|448930932|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
124809511|NCT01999868|448930933|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
124809512|NCT01999868|448930934|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
124809513|NCT01999868|448930932|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
124809514|NCT01999868|448930933|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
124809515|NCT01999868|448930934|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
124809516|NCT00450255|448930940|FG000|Overall Study|Prior RFA ablation of liver|1|||
124809517|NCT01757535|448930941|FG000|Overall Study|Disease Relapse|151|||
124809518|NCT01757535|448930942|FG001|Overall Study|Disease Relapse|181|||
124809519|NCT01757535|448930941|FG000|Overall Study|Other Reasons|28|||
124809520|NCT01757535|448930942|FG001|Overall Study|Other Reasons|27|||
124809521|NCT01757535|448930941|FG000|Overall Study|Adverse Event|31|||
124809522|NCT01757535|448930942|FG001|Overall Study|Adverse Event|11|||
124809523|NCT01757535|448930941|FG000|Overall Study|Withdrew Consent|19|||
124809524|NCT01757535|448930942|FG001|Overall Study|Withdrew Consent|13|||
124809525|NCT01757535|448930941|FG000|Overall Study|Physician Decision|7|||
124809526|NCT01757535|448930942|FG001|Overall Study|Physician Decision|0|||
124809527|NCT01757535|448930941|FG000|Overall Study|Death|2|||
124809528|NCT01757535|448930942|FG001|Overall Study|Death|2|||
124809529|NCT03730012|448930943|FG000|Overall Study|Adverse Event|0|||
124809530|NCT03730012|448930944|FG001|Overall Study|Adverse Event|1|||
124809531|NCT03730012|448930943|FG000|Overall Study|Lack of Efficacy|1|||
124809532|NCT03730012|448930944|FG001|Overall Study|Lack of Efficacy|5|||
124809533|NCT03730012|448930943|FG000|Overall Study|Withdrawal by Subject|0|||
124809534|NCT03730012|448930944|FG001|Overall Study|Withdrawal by Subject|1|||
124809535|NCT03730012|448930943|FG000|Overall Study|Miscellaneous|2|||
124809536|NCT03730012|448930944|FG001|Overall Study|Miscellaneous|1|||
124809537|NCT05147428|448930945|FG000|Overall Study|Removed prior to mailing|289|||
124809538|NCT05147428|448930946|FG001|Overall Study|Removed prior to mailing|306|||
124809539|NCT05147428|448930947|FG002|Overall Study|Removed prior to mailing|270|||
124809540|NCT05147428|448930945|FG000|Overall Study|Died or disenrolled during blackout period|239|||
124809541|NCT05147428|448930946|FG001|Overall Study|Died or disenrolled during blackout period|278|||
124809542|NCT05147428|448930947|FG002|Overall Study|Died or disenrolled during blackout period|273|||
124809543|NCT04680052|448932666|FG000|Overall Study|Ongoing|244|||
124809544|NCT04680052|448932667|FG001|Overall Study|Ongoing|229|||
124809545|NCT04680052|448932668|FG002|Overall Study|Ongoing|39|||
124809546|NCT04680052|448932669|FG003|Overall Study|Ongoing|46|||
124809547|NCT04680052|448932666|FG000|Overall Study|Death|15|||
124809548|NCT04680052|448932667|FG001|Overall Study|Death|22|||
124809549|NCT04680052|448932668|FG002|Overall Study|Death|7|||
124809550|NCT04680052|448932669|FG003|Overall Study|Death|1|||
124809551|NCT04680052|448932666|FG000|Overall Study|Lost to Follow-up|3|||
124809552|NCT04680052|448932667|FG001|Overall Study|Lost to Follow-up|2|||
124809553|NCT04680052|448932668|FG002|Overall Study|Lost to Follow-up|0|||
124809554|NCT04680052|448932669|FG003|Overall Study|Lost to Follow-up|1|||
124809555|NCT04680052|448932666|FG000|Overall Study|Withdrawal by Subject|11|||
124809556|NCT04680052|448932667|FG001|Overall Study|Withdrawal by Subject|19|||
124809557|NCT04680052|448932668|FG002|Overall Study|Withdrawal by Subject|7|||
124809558|NCT04680052|448932669|FG003|Overall Study|Withdrawal by Subject|5|||
124809559|NCT04680052|448932666|FG000|Overall Study|Missing|0|||
124809560|NCT04680052|448932667|FG001|Overall Study|Missing|1|||
124809561|NCT04680052|448932668|FG002|Overall Study|Missing|0|||
124809562|NCT04680052|448932669|FG003|Overall Study|Missing|0|||
124809563|NCT04680052|448932666|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
124809564|NCT04680052|448932667|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
124809565|NCT04680052|448932668|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
124809566|NCT04680052|448932669|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
124809567|NCT04680052|448932666|FG000|Overall Study|Physician Decision|0|||
124809568|NCT04680052|448932667|FG001|Overall Study|Physician Decision|1|||
124809569|NCT04680052|448932668|FG002|Overall Study|Physician Decision|0|||
124809570|NCT04680052|448932669|FG003|Overall Study|Physician Decision|0|||
124809571|NCT03320057|448932670|FG000|Overall Study|Lost to Follow-up|4|||
124809572|NCT03320057|448932671|FG001|Overall Study|Lost to Follow-up|17|||
124809573|NCT03320057|448932670|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
124809574|NCT03320057|448932671|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
124809575|NCT01367002|448932674|FG000|Overall Study|Withdrawal by Subject|1|||
124809576|NCT01367002|448932675|FG001|Overall Study|Withdrawal by Subject|0|||
124809577|NCT01367002|448932674|FG000|Overall Study|Physician Decision|0|||
124809578|NCT01367002|448932675|FG001|Overall Study|Physician Decision|2|||
124809579|NCT00717093|448932677|FG000|Overall Study|Adverse Event|19|||
124809580|NCT00717093|448932678|FG001|Overall Study|Adverse Event|9|||
124809581|NCT00717093|448932677|FG000|Overall Study|Lack of Efficacy|3|||
124809582|NCT00717093|448932678|FG001|Overall Study|Lack of Efficacy|13|||
124809583|NCT00717093|448932677|FG000|Overall Study|Lost to Follow-up|9|||
124809584|NCT00717093|448932678|FG001|Overall Study|Lost to Follow-up|6|||
124809585|NCT00717093|448932677|FG000|Overall Study|Withdrawal by Subject|12|||
124809586|NCT00717093|448932678|FG001|Overall Study|Withdrawal by Subject|19|||
124809587|NCT00717093|448932677|FG000|Overall Study|Other|0|||
124809588|NCT00717093|448932678|FG001|Overall Study|Other|1|||
124809589|NCT00717093|448932677|FG000|Overall Study|Randomized but not treated|1|||
124809590|NCT00717093|448932678|FG001|Overall Study|Randomized but not treated|0|||
124809591|NCT01516437|448932679|FG000|Overall Study|Reason not specified|0|||
124809592|NCT01516437|448932680|FG001|Overall Study|Reason not specified|0|||
124809593|NCT01516437|448932681|FG002|Overall Study|Reason not specified|1|||
124809594|NCT01516437|448932682|FG003|Overall Study|Reason not specified|1|||
124809595|NCT00217620|448932683|FG000|Overall Study|Adverse Event|2|||
124809596|NCT00217620|448932683|FG000|Overall Study|Progression|31|||
124809597|NCT00217620|448932683|FG000|Overall Study|Not Protocol Specified|4|||
124809598|NCT00217620|448932683|FG000|Overall Study|Ineligible|13|||
124809599|NCT00217620|448932683|FG000|Overall Study|Never received treatment|1|||
125300152|NCT01815840|450725898|FG001|Overall Study|Sponsor Termination Treatment|0|||
125300153|NCT03221842|450725900|FG000|Period 1 (Open-label)|Adverse Event|4|||
125300154|NCT03221842|450725901|FG001|Period 1 (Open-label)|Adverse Event|0|||
125300155|NCT03221842|450725900|FG000|Period 1 (Open-label)|Physician Decision|2|||
125300156|NCT03221842|450725901|FG001|Period 1 (Open-label)|Physician Decision|0|||
125300157|NCT03221842|450725900|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
125300158|NCT03221842|450725901|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
125300159|NCT03221842|450725900|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
125300160|NCT03221842|450725901|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
125300161|NCT03221842|450725900|FG000|Period 1 (Open-label)|Other|2|||
125300162|NCT03221842|450725901|FG001|Period 1 (Open-label)|Other|0|||
125300163|NCT03221842|450725900|FG000|Period 2 (Randomized, Blinded)|Death|0|||
125300164|NCT03221842|450725901|FG001|Period 2 (Randomized, Blinded)|Death|1|||
125300165|NCT03221842|450725900|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
125300166|NCT03221842|450725901|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
125300167|NCT00704288|450725902|FG000|Overall Treatment Period|Adverse Event|11|||
124809600|NCT02468674|448932688|FG000|Overall Study|Adverse Event|0|||
124809601|NCT02468674|448932689|FG001|Overall Study|Adverse Event|0|||
124809602|NCT02468674|448932690|FG002|Overall Study|Adverse Event|0|||
124809603|NCT02468674|448932691|FG003|Overall Study|Adverse Event|1|||
124809604|NCT02468674|448932692|FG004|Overall Study|Adverse Event|0|||
124809605|NCT02468674|448932693|FG005|Overall Study|Adverse Event|1|||
124809606|NCT02468674|448932694|FG006|Overall Study|Adverse Event|0|||
124809607|NCT02468674|448932695|FG007|Overall Study|Adverse Event|0|||
124809608|NCT02468674|448932696|FG008|Overall Study|Adverse Event|0|||
124809609|NCT02468674|448932688|FG000|Overall Study|Lost to Follow-up|1|||
124809610|NCT02468674|448932689|FG001|Overall Study|Lost to Follow-up|0|||
124809611|NCT02468674|448932690|FG002|Overall Study|Lost to Follow-up|0|||
124809612|NCT02468674|448932691|FG003|Overall Study|Lost to Follow-up|0|||
124809613|NCT02468674|448932692|FG004|Overall Study|Lost to Follow-up|0|||
124809614|NCT02468674|448932693|FG005|Overall Study|Lost to Follow-up|0|||
124809615|NCT02468674|448932694|FG006|Overall Study|Lost to Follow-up|0|||
124809616|NCT02468674|448932695|FG007|Overall Study|Lost to Follow-up|1|||
124809617|NCT02468674|448932696|FG008|Overall Study|Lost to Follow-up|1|||
124809618|NCT02468674|448932688|FG000|Overall Study|Physician Decision|0|||
124809619|NCT02468674|448932689|FG001|Overall Study|Physician Decision|0|||
124809620|NCT02468674|448932690|FG002|Overall Study|Physician Decision|0|||
124809621|NCT02468674|448932691|FG003|Overall Study|Physician Decision|0|||
124809622|NCT02468674|448932692|FG004|Overall Study|Physician Decision|0|||
124809623|NCT02468674|448932693|FG005|Overall Study|Physician Decision|0|||
124809624|NCT02468674|448932694|FG006|Overall Study|Physician Decision|1|||
124809625|NCT02468674|448932695|FG007|Overall Study|Physician Decision|0|||
124809626|NCT02468674|448932696|FG008|Overall Study|Physician Decision|0|||
124809627|NCT02468674|448932688|FG000|Overall Study|Patient/Guardian Decision|0|||
124809628|NCT02468674|448932689|FG001|Overall Study|Patient/Guardian Decision|0|||
124809629|NCT02468674|448932690|FG002|Overall Study|Patient/Guardian Decision|0|||
124809630|NCT02468674|448932691|FG003|Overall Study|Patient/Guardian Decision|0|||
124809631|NCT02468674|448932692|FG004|Overall Study|Patient/Guardian Decision|1|||
124809632|NCT02468674|448932693|FG005|Overall Study|Patient/Guardian Decision|0|||
124809633|NCT02468674|448932694|FG006|Overall Study|Patient/Guardian Decision|0|||
124809634|NCT02468674|448932695|FG007|Overall Study|Patient/Guardian Decision|2|||
124809635|NCT02468674|448932696|FG008|Overall Study|Patient/Guardian Decision|1|||
125300168|NCT00704288|450725903|FG001|Overall Treatment Period|Adverse Event|8|||
124809636|NCT02468674|448932688|FG000|Overall Study|Protocol Deviation|0|||
124809637|NCT02468674|448932689|FG001|Overall Study|Protocol Deviation|0|||
124809638|NCT02468674|448932690|FG002|Overall Study|Protocol Deviation|0|||
124809639|NCT02468674|448932691|FG003|Overall Study|Protocol Deviation|0|||
124809640|NCT02468674|448932692|FG004|Overall Study|Protocol Deviation|0|||
124809641|NCT02468674|448932693|FG005|Overall Study|Protocol Deviation|0|||
125300169|NCT00704288|450725904|FG002|Overall Treatment Period|Adverse Event|22|||
124809642|NCT02468674|448932694|FG006|Overall Study|Protocol Deviation|0|||
124809643|NCT02468674|448932695|FG007|Overall Study|Protocol Deviation|1|||
124809644|NCT02468674|448932696|FG008|Overall Study|Protocol Deviation|1|||
124809645|NCT01897454|448932697|FG000|Overall Study|Withdrawal by Subject|1|||
124809646|NCT03689530|448932702|FG000|Overall Study|Withdrawal by Subject|53|||
124809647|NCT03689530|448932703|FG001|Overall Study|Withdrawal by Subject|16|||
124809648|NCT01392443|448932704|FG000|Overall Study|Disease progression|30|||
124809649|NCT01392443|448932704|FG000|Overall Study|Adverse Event|24|||
124809650|NCT01392443|448932704|FG000|Overall Study|Death|7|||
124809651|NCT01392443|448932704|FG000|Overall Study|Withdrawal by Subject|5|||
124809652|NCT01392443|448932704|FG000|Overall Study|Lost to Follow-up|1|||
124809653|NCT01392443|448932704|FG000|Overall Study|Protocol Violation|1|||
124809654|NCT00533897|448932707|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
124809655|NCT00533897|448932708|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
124809656|NCT00533897|448932709|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
124809657|NCT00533897|448932710|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
124809658|NCT00533897|448932711|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
124809659|NCT00533897|448932712|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
124809660|NCT00533897|448932713|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
124809661|NCT00533897|448932714|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
124809662|NCT00533897|448932707|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
124809663|NCT00533897|448932708|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
124809664|NCT00533897|448932709|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
124809665|NCT00533897|448932710|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
124809666|NCT00533897|448932711|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
124809667|NCT00533897|448932712|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
124809668|NCT00533897|448932713|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
124809669|NCT00533897|448932714|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
124809670|NCT00533897|448932707|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
124809671|NCT00533897|448932708|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
124809672|NCT00533897|448932709|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
124809673|NCT00533897|448932710|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
124809674|NCT00533897|448932711|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
124809675|NCT00533897|448932712|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
124809676|NCT00533897|448932713|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
124809677|NCT00533897|448932714|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
124809678|NCT00533897|448932707|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
124809679|NCT00533897|448932708|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
124809680|NCT00533897|448932709|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
124809681|NCT00533897|448932710|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
124809682|NCT00533897|448932711|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
124809683|NCT00533897|448932712|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
124809684|NCT00533897|448932713|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
124809685|NCT00533897|448932714|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
124809686|NCT00533897|448932707|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
124809687|NCT00533897|448932708|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
124809688|NCT00533897|448932709|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
124809689|NCT00533897|448932710|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
124809690|NCT00533897|448932711|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
124809691|NCT00533897|448932712|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
124809692|NCT00533897|448932713|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
124809693|NCT00533897|448932714|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
124809694|NCT00533897|448932707|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
124809695|NCT00533897|448932708|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
124809696|NCT00533897|448932709|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
124809697|NCT00533897|448932710|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
124809698|NCT00533897|448932711|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
124809699|NCT00533897|448932712|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
124809700|NCT00533897|448932713|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
124809701|NCT00533897|448932714|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
124809702|NCT00533897|448932707|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
124809703|NCT00533897|448932708|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
124809704|NCT00533897|448932709|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
124809705|NCT00533897|448932710|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
124809706|NCT00533897|448932711|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
124809707|NCT00533897|448932712|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
124809708|NCT00533897|448932713|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
124809709|NCT00533897|448932714|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
124809710|NCT00533897|448932707|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
124809711|NCT00533897|448932708|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
124809712|NCT00533897|448932709|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
124809713|NCT00533897|448932710|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
124809714|NCT00533897|448932711|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
124809715|NCT00533897|448932712|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
124809716|NCT00533897|448932713|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
124809717|NCT00533897|448932714|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
124809718|NCT00533897|448932707|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
124809719|NCT00533897|448932708|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
124809720|NCT00533897|448932709|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
124809721|NCT00533897|448932710|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
124809722|NCT00533897|448932711|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
124809723|NCT00533897|448932712|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
124809724|NCT00533897|448932713|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
124809725|NCT00533897|448932714|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
124809726|NCT00533897|448932707|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
124809727|NCT00533897|448932708|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
124809728|NCT00533897|448932709|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
124809729|NCT00533897|448932710|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
124809730|NCT00533897|448932711|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
124809731|NCT00533897|448932712|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
124809732|NCT00533897|448932713|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
124809733|NCT00533897|448932714|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
124809734|NCT00533897|448932707|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
124809735|NCT00533897|448932708|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
124809736|NCT00533897|448932709|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
124809737|NCT00533897|448932710|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
124809738|NCT00533897|448932711|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
124809739|NCT00533897|448932712|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
124809740|NCT00533897|448932713|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
124809741|NCT00533897|448932714|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
124809742|NCT00533897|448932707|FG000|Long Term Extension (LTE)|Death|0|||
124809743|NCT00533897|448932708|FG001|Long Term Extension (LTE)|Death|0|||
124809744|NCT00533897|448932709|FG002|Long Term Extension (LTE)|Death|0|||
124809745|NCT00533897|448932710|FG003|Long Term Extension (LTE)|Death|0|||
124809746|NCT00533897|448932711|FG004|Long Term Extension (LTE)|Death|0|||
124809747|NCT00533897|448932712|FG005|Long Term Extension (LTE)|Death|0|||
124809748|NCT00533897|448932713|FG006|Long Term Extension (LTE)|Death|1|||
124809749|NCT00533897|448932714|FG007|Long Term Extension (LTE)|Death|3|||
124809750|NCT00533897|448932707|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
124809751|NCT00533897|448932708|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
124809752|NCT00533897|448932709|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
124809753|NCT00533897|448932710|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
124809754|NCT00533897|448932711|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
124809755|NCT00533897|448932712|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
124809756|NCT00533897|448932713|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
124809757|NCT00533897|448932714|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
124809758|NCT00533897|448932707|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
124809759|NCT00533897|448932708|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
124809760|NCT00533897|448932709|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
124809761|NCT00533897|448932710|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
124809762|NCT00533897|448932711|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
124809763|NCT00533897|448932712|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
124809764|NCT00533897|448932713|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
124809765|NCT00533897|448932714|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
124809766|NCT00533897|448932707|FG000|Long Term Extension (LTE)|Adverse Event|0|||
124809767|NCT00533897|448932708|FG001|Long Term Extension (LTE)|Adverse Event|0|||
124809768|NCT00533897|448932709|FG002|Long Term Extension (LTE)|Adverse Event|0|||
124809769|NCT00533897|448932710|FG003|Long Term Extension (LTE)|Adverse Event|0|||
124809770|NCT00533897|448932711|FG004|Long Term Extension (LTE)|Adverse Event|0|||
124809771|NCT00533897|448932712|FG005|Long Term Extension (LTE)|Adverse Event|0|||
124809772|NCT00533897|448932713|FG006|Long Term Extension (LTE)|Adverse Event|2|||
124809773|NCT00533897|448932714|FG007|Long Term Extension (LTE)|Adverse Event|5|||
124809774|NCT00533897|448932707|FG000|Long Term Extension (LTE)|Pregnancy|0|||
124809775|NCT00533897|448932708|FG001|Long Term Extension (LTE)|Pregnancy|0|||
124809776|NCT00533897|448932709|FG002|Long Term Extension (LTE)|Pregnancy|0|||
124809777|NCT00533897|448932710|FG003|Long Term Extension (LTE)|Pregnancy|0|||
124809778|NCT00533897|448932711|FG004|Long Term Extension (LTE)|Pregnancy|0|||
124809779|NCT00533897|448932712|FG005|Long Term Extension (LTE)|Pregnancy|0|||
124809780|NCT00533897|448932713|FG006|Long Term Extension (LTE)|Pregnancy|0|||
124809781|NCT00533897|448932714|FG007|Long Term Extension (LTE)|Pregnancy|2|||
124809782|NCT00533897|448932707|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
124809783|NCT00533897|448932708|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
124809784|NCT00533897|448932709|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
124809785|NCT00533897|448932710|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
124809786|NCT00533897|448932711|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
124809787|NCT00533897|448932712|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
124809788|NCT00533897|448932713|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
124809789|NCT00533897|448932714|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
124809790|NCT00533897|448932707|FG000|Long Term Extension (LTE)|Other|0|||
124809791|NCT00533897|448932708|FG001|Long Term Extension (LTE)|Other|0|||
124809792|NCT00533897|448932709|FG002|Long Term Extension (LTE)|Other|0|||
124809793|NCT00533897|448932710|FG003|Long Term Extension (LTE)|Other|0|||
124809794|NCT00533897|448932711|FG004|Long Term Extension (LTE)|Other|0|||
124809795|NCT00533897|448932712|FG005|Long Term Extension (LTE)|Other|0|||
124809796|NCT00533897|448932713|FG006|Long Term Extension (LTE)|Other|1|||
124809797|NCT00533897|448932714|FG007|Long Term Extension (LTE)|Other|6|||
124809798|NCT02555683|448932715|FG000|Overall Study|Physician Decision|1|||
124809799|NCT02555683|448932716|FG001|Overall Study|Physician Decision|0|||
124809800|NCT02555683|448932717|FG002|Overall Study|Physician Decision|2|||
124809801|NCT02555683|448932715|FG000|Overall Study|Lost to Follow-up|2|||
124809802|NCT02555683|448932716|FG001|Overall Study|Lost to Follow-up|1|||
124809803|NCT02555683|448932717|FG002|Overall Study|Lost to Follow-up|2|||
124809804|NCT02555683|448932715|FG000|Overall Study|Technical Problems|1|||
124809805|NCT02555683|448932716|FG001|Overall Study|Technical Problems|1|||
124809806|NCT02555683|448932717|FG002|Overall Study|Technical Problems|0|||
124809807|NCT02555683|448932715|FG000|Overall Study|Protocol deviation|0|||
124809808|NCT02555683|448932716|FG001|Overall Study|Protocol deviation|1|||
124809809|NCT02555683|448932717|FG002|Overall Study|Protocol deviation|0|||
124809810|NCT02555683|448932715|FG000|Overall Study|Lack of Efficacy|2|||
124809811|NCT02555683|448932716|FG001|Overall Study|Lack of Efficacy|0|||
124809812|NCT02555683|448932717|FG002|Overall Study|Lack of Efficacy|0|||
124809813|NCT02555683|448932715|FG000|Overall Study|Death|0|||
124809814|NCT02555683|448932716|FG001|Overall Study|Death|1|||
124809815|NCT02555683|448932717|FG002|Overall Study|Death|2|||
124809816|NCT02555683|448932715|FG000|Overall Study|Adverse Event|1|||
124809817|NCT02555683|448932716|FG001|Overall Study|Adverse Event|0|||
124809818|NCT02555683|448932717|FG002|Overall Study|Adverse Event|1|||
124809819|NCT02555683|448932715|FG000|Overall Study|Subject/guardian decision|12|||
124809820|NCT02555683|448932716|FG001|Overall Study|Subject/guardian decision|12|||
124809821|NCT02555683|448932717|FG002|Overall Study|Subject/guardian decision|22|||
124809822|NCT02555683|448932715|FG000|Overall Study|Death post Treatment/safety period|0|||
124809823|NCT02555683|448932716|FG001|Overall Study|Death post Treatment/safety period|1|||
124809824|NCT02555683|448932717|FG002|Overall Study|Death post Treatment/safety period|0|||
124809825|NCT05074667|448932718|FG000|Overall Study|Death|1|||
124809826|NCT05074667|448932718|FG000|Overall Study|Withdrawal by Subject|4|||
124809827|NCT05074667|448932718|FG000|Overall Study|Lost to Follow-up|10|||
124809828|NCT01826604|448932720|FG000|Overall Study|Lost to Follow-up|8|||
124809829|NCT01826604|448932721|FG001|Overall Study|Lost to Follow-up|9|||
124809830|NCT00491075|448932722|FG000|Overall Study|Withdrawal by Subject|1|||
124809831|NCT00491075|448932722|FG000|Overall Study|Physician Decision|1|||
124809832|NCT03019185|448932729|FG000|Overall Study|Lost to Follow-up|3|||
124809833|NCT03019185|448932730|FG001|Overall Study|Lost to Follow-up|0|||
124809834|NCT03019185|448932731|FG002|Overall Study|Lost to Follow-up|2|||
124809835|NCT03019185|448932729|FG000|Overall Study|Withdrawal by Subject|1|||
124809836|NCT03019185|448932730|FG001|Overall Study|Withdrawal by Subject|1|||
124809837|NCT03019185|448932731|FG002|Overall Study|Withdrawal by Subject|0|||
124809838|NCT03019185|448932729|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
124809839|NCT03019185|448932730|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
124809840|NCT03019185|448932731|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
124809841|NCT03019185|448932729|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
124809842|NCT03019185|448932730|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
124809843|NCT03019185|448932731|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
124809844|NCT00705289|448932734|FG000|Overall Study|Subject or treating physician's choice|131|||
124809845|NCT02601027|448932735|FG000|Registration to Surgery|Withdrawal by Subject|20|||
124809846|NCT02601027|448932736|FG001|Registration to Surgery|Withdrawal by Subject|10|||
124809847|NCT01146912|448932737|FG000|Overall Study|Already received influenza vaccination|817|||
124809848|NCT01146912|448932738|FG001|Overall Study|Already received influenza vaccination|822|||
125300170|NCT00704288|450725902|FG000|Overall Treatment Period|Death|0|||
125300171|NCT00704288|450725903|FG001|Overall Treatment Period|Death|0|||
124809849|NCT01146912|448932739|FG002|Overall Study|Already received influenza vaccination|13|||
124809850|NCT01146912|448932740|FG003|Overall Study|Already received influenza vaccination|15|||
124809851|NCT01146912|448932741|FG004|Overall Study|Already received influenza vaccination|41|||
124809852|NCT01146912|448932742|FG005|Overall Study|Already received influenza vaccination|61|||
124809853|NCT01146912|448932743|FG006|Overall Study|Already received influenza vaccination|56|||
124809854|NCT01146912|448932744|FG007|Overall Study|Already received influenza vaccination|0|||
124809855|NCT01146912|448932737|FG000|Overall Study|< 14 weeks gestational age|0|||
124809856|NCT01146912|448932738|FG001|Overall Study|< 14 weeks gestational age|0|||
124809857|NCT01146912|448932739|FG002|Overall Study|< 14 weeks gestational age|3|||
124809858|NCT01146912|448932740|FG003|Overall Study|< 14 weeks gestational age|2|||
124809859|NCT01146912|448932741|FG004|Overall Study|< 14 weeks gestational age|0|||
124809860|NCT01146912|448932742|FG005|Overall Study|< 14 weeks gestational age|0|||
124809861|NCT01146912|448932743|FG006|Overall Study|< 14 weeks gestational age|0|||
124809862|NCT01146912|448932744|FG007|Overall Study|< 14 weeks gestational age|0|||
124809863|NCT01146912|448932737|FG000|Overall Study|Duplicate patient|0|||
124809864|NCT01146912|448932738|FG001|Overall Study|Duplicate patient|0|||
124809865|NCT01146912|448932739|FG002|Overall Study|Duplicate patient|1|||
124809866|NCT01146912|448932740|FG003|Overall Study|Duplicate patient|0|||
124809867|NCT01146912|448932741|FG004|Overall Study|Duplicate patient|0|||
124809868|NCT01146912|448932742|FG005|Overall Study|Duplicate patient|0|||
124809869|NCT01146912|448932743|FG006|Overall Study|Duplicate patient|0|||
124809870|NCT01146912|448932744|FG007|Overall Study|Duplicate patient|0|||
124809871|NCT02609828|448932747|FG000|Overall Study|Adverse Event|8|||
124809872|NCT02609828|448932748|FG001|Overall Study|Adverse Event|1|||
124809873|NCT02609828|448932749|FG002|Overall Study|Adverse Event|0|||
124809874|NCT02609828|448932750|FG003|Overall Study|Adverse Event|6|||
124809875|NCT02609828|448932747|FG000|Overall Study|Death|15|||
124809876|NCT02609828|448932748|FG001|Overall Study|Death|1|||
124809877|NCT02609828|448932749|FG002|Overall Study|Death|1|||
124809878|NCT02609828|448932750|FG003|Overall Study|Death|19|||
124809879|NCT02609828|448932747|FG000|Overall Study|Insufficient clinical response|2|||
124809880|NCT02609828|448932748|FG001|Overall Study|Insufficient clinical response|1|||
124809881|NCT02609828|448932749|FG002|Overall Study|Insufficient clinical response|0|||
124809882|NCT02609828|448932750|FG003|Overall Study|Insufficient clinical response|0|||
124809883|NCT02609828|448932747|FG000|Overall Study|Lost to Follow-up|0|||
124809884|NCT02609828|448932748|FG001|Overall Study|Lost to Follow-up|0|||
124809885|NCT02609828|448932749|FG002|Overall Study|Lost to Follow-up|0|||
124809886|NCT02609828|448932750|FG003|Overall Study|Lost to Follow-up|1|||
124809887|NCT02609828|448932747|FG000|Overall Study|Protocol Violation|2|||
124809888|NCT02609828|448932748|FG001|Overall Study|Protocol Violation|0|||
124809889|NCT02609828|448932749|FG002|Overall Study|Protocol Violation|0|||
124809890|NCT02609828|448932750|FG003|Overall Study|Protocol Violation|1|||
124809891|NCT02609828|448932747|FG000|Overall Study|Withdrawal by Subject|12|||
124809892|NCT02609828|448932748|FG001|Overall Study|Withdrawal by Subject|1|||
124809893|NCT02609828|448932749|FG002|Overall Study|Withdrawal by Subject|0|||
124809894|NCT02609828|448932750|FG003|Overall Study|Withdrawal by Subject|10|||
124809895|NCT02609828|448932747|FG000|Overall Study|Other|3|||
124809896|NCT02609828|448932748|FG001|Overall Study|Other|0|||
124809897|NCT02609828|448932749|FG002|Overall Study|Other|0|||
124809898|NCT02609828|448932750|FG003|Overall Study|Other|6|||
124809899|NCT02609828|448932747|FG000|Overall Study|Randomized but not treated|1|||
124809900|NCT02609828|448932748|FG001|Overall Study|Randomized but not treated|0|||
124809901|NCT02609828|448932749|FG002|Overall Study|Randomized but not treated|0|||
124809902|NCT02609828|448932750|FG003|Overall Study|Randomized but not treated|0|||
124809903|NCT02980783|448932751|FG000|Overall Study|Lost to Follow-up|1|||
124809904|NCT01696695|448932752|FG000|Overall Study|Disease progression|373|||
124809905|NCT01696695|448932752|FG000|Overall Study|Death|29|||
124809906|NCT01696695|448932752|FG000|Overall Study|Adverse Event|74|||
124809907|NCT01696695|448932752|FG000|Overall Study|Withdrawal by Subject|92|||
124809908|NCT01696695|448932752|FG000|Overall Study|Lost to Follow-up|48|||
124809909|NCT01696695|448932752|FG000|Overall Study|Other|74|||
124809910|NCT01696695|448932752|FG000|Overall Study|Major Protocol Violation|192|||
124809911|NCT03173313|448932755|FG000|Overall Study|Lost to Follow-up|2|||
124809912|NCT03173313|448932756|FG001|Overall Study|Lost to Follow-up|3|||
124809913|NCT03173313|448932755|FG000|Overall Study|Withdrawal by Subject|0|||
124809914|NCT03173313|448932756|FG001|Overall Study|Withdrawal by Subject|1|||
124809915|NCT03173313|448932755|FG000|Overall Study|Death|5|||
124809916|NCT03173313|448932756|FG001|Overall Study|Death|0|||
124809917|NCT03173313|448932755|FG000|Overall Study|Physician Decision|1|||
124809918|NCT03173313|448932756|FG001|Overall Study|Physician Decision|0|||
124809919|NCT03173313|448932755|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
124809920|NCT03173313|448932756|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
124809921|NCT03173313|448932755|FG000|Overall Study|Bone Fracture|1|||
124809922|NCT03173313|448932756|FG001|Overall Study|Bone Fracture|0|||
124809923|NCT03863197|448932757|FG000|Overall Study|Lost to Follow-up|2|||
124809924|NCT03863197|448932758|FG001|Overall Study|Lost to Follow-up|3|||
124809925|NCT03863197|448932757|FG000|Overall Study|Withdrawal by Subject|4|||
124809926|NCT03863197|448932758|FG001|Overall Study|Withdrawal by Subject|0|||
124809927|NCT03863197|448932757|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
124809928|NCT03863197|448932758|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
124809929|NCT01065597|448932766|FG000|Overall Study|Adverse Event|1|||
124809930|NCT02589405|448932769|FG000|Overall Study|Adverse Event|3|||
124809931|NCT02589405|448932769|FG000|Overall Study|Withdrawal by Subject|1|||
124809932|NCT02905149|448932771|FG000|Overall Study|Lost to Follow-up|2|||
124809933|NCT02905149|448932772|FG001|Overall Study|Lost to Follow-up|0|||
124809934|NCT00839852|448932774|FG000|Overall Study|Adverse Event|10|||
124809935|NCT00839852|448932774|FG000|Overall Study|Insufficient Therapeutic Response|3|||
124809936|NCT00839852|448932774|FG000|Overall Study|Protocol Violation|9|||
124809937|NCT00839852|448932774|FG000|Overall Study|Withdrawal of Consent|16|||
124809938|NCT00839852|448932774|FG000|Overall Study|Lost to Follow-up|7|||
124809939|NCT00839852|448932774|FG000|Overall Study|Lack of Compliance While in Jail|1|||
124809940|NCT00839852|448932774|FG000|Overall Study|Pregnancy|1|||
124809941|NCT02761733|448932775|FG000|Overall Study|Death|3|||
124809942|NCT02761733|448932776|FG001|Overall Study|Death|5|||
124809943|NCT02761733|448932777|FG002|Overall Study|Death|1|||
124809944|NCT02761733|448932778|FG003|Overall Study|Death|1|||
124809945|NCT02761733|448932775|FG000|Overall Study|Lost to Follow-up|6|||
124809946|NCT02761733|448932776|FG001|Overall Study|Lost to Follow-up|7|||
124809947|NCT02761733|448932777|FG002|Overall Study|Lost to Follow-up|0|||
124809948|NCT02761733|448932778|FG003|Overall Study|Lost to Follow-up|3|||
124809949|NCT02761733|448932775|FG000|Overall Study|Physician Decision|4|||
124809950|NCT02761733|448932776|FG001|Overall Study|Physician Decision|0|||
124809951|NCT02761733|448932777|FG002|Overall Study|Physician Decision|0|||
124809952|NCT02761733|448932778|FG003|Overall Study|Physician Decision|0|||
124809953|NCT02761733|448932775|FG000|Overall Study|Withdrawal by Subject|2|||
124809954|NCT02761733|448932776|FG001|Overall Study|Withdrawal by Subject|0|||
124809955|NCT02761733|448932777|FG002|Overall Study|Withdrawal by Subject|0|||
124809956|NCT02761733|448932778|FG003|Overall Study|Withdrawal by Subject|0|||
124809957|NCT02761733|448932775|FG000|Overall Study|Discharged from Study Site|10|||
124809958|NCT02761733|448932776|FG001|Overall Study|Discharged from Study Site|9|||
124809959|NCT02761733|448932777|FG002|Overall Study|Discharged from Study Site|25|||
124809960|NCT02761733|448932778|FG003|Overall Study|Discharged from Study Site|11|||
124809961|NCT02761733|448932775|FG000|Overall Study|Cognitive Impairment|5|||
124809962|NCT02761733|448932776|FG001|Overall Study|Cognitive Impairment|0|||
124809963|NCT02761733|448932777|FG002|Overall Study|Cognitive Impairment|1|||
124809964|NCT02761733|448932778|FG003|Overall Study|Cognitive Impairment|0|||
124809965|NCT04295772|448932781|FG000|Overall Study|Protocol Violation|1|||
124809966|NCT04295772|448932782|FG001|Overall Study|Protocol Violation|0|||
124809967|NCT04295772|448932781|FG000|Overall Study|Ongoing for safety monitoring|14|||
124809968|NCT04295772|448932782|FG001|Overall Study|Ongoing for safety monitoring|1|||
124809969|NCT04295772|448932781|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
124809970|NCT04295772|448932782|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
124809971|NCT02846324|448932783|FG000|Overall Study|Other|1|||
124809972|NCT02846324|448932784|FG001|Overall Study|Other|0|||
124809973|NCT02846324|448932785|FG002|Overall Study|Other|0|||
124809974|NCT02846324|448932786|FG003|Overall Study|Other|0|||
124809975|NCT02846324|448932783|FG000|Overall Study|Withdrawal by Subject|1|||
124809976|NCT02846324|448932784|FG001|Overall Study|Withdrawal by Subject|0|||
124809977|NCT02846324|448932785|FG002|Overall Study|Withdrawal by Subject|4|||
124809978|NCT02846324|448932786|FG003|Overall Study|Withdrawal by Subject|0|||
124809979|NCT02805972|448932791|FG000|Washout Period|Lost to Follow-up|3|||
124809980|NCT02805972|448932792|FG001|Washout Period|Lost to Follow-up|0|||
124809981|NCT01206166|448932793|FG000|Overall Study|No evaluable data|2|||
124809982|NCT01206166|448932794|FG001|Overall Study|No evaluable data|3|||
124809983|NCT00932126|448932795|FG000|Overall Study|Adverse Event|0|||
124809984|NCT00932126|448932796|FG001|Overall Study|Adverse Event|0|||
124809985|NCT00932126|448932797|FG002|Overall Study|Adverse Event|0|||
124809986|NCT00932126|448932798|FG003|Overall Study|Adverse Event|0|||
124809987|NCT00932126|448932799|FG004|Overall Study|Adverse Event|0|||
124809988|NCT00932126|448932800|FG005|Overall Study|Adverse Event|0|||
124809989|NCT00932126|448932801|FG006|Overall Study|Adverse Event|1|||
124809990|NCT00932126|448932802|FG007|Overall Study|Adverse Event|2|||
124809991|NCT00932126|448932795|FG000|Overall Study|Protocol Violation|0|||
124809992|NCT00932126|448932796|FG001|Overall Study|Protocol Violation|0|||
124809993|NCT00932126|448932797|FG002|Overall Study|Protocol Violation|0|||
124809994|NCT00932126|448932798|FG003|Overall Study|Protocol Violation|0|||
124809995|NCT00932126|448932799|FG004|Overall Study|Protocol Violation|1|||
124809996|NCT00932126|448932800|FG005|Overall Study|Protocol Violation|0|||
124809997|NCT00932126|448932801|FG006|Overall Study|Protocol Violation|0|||
124809998|NCT00932126|448932802|FG007|Overall Study|Protocol Violation|0|||
124809999|NCT00932126|448932795|FG000|Overall Study|Withdrawal by Subject|0|||
124810000|NCT00932126|448932796|FG001|Overall Study|Withdrawal by Subject|0|||
124810001|NCT00932126|448932797|FG002|Overall Study|Withdrawal by Subject|1|||
124810002|NCT00932126|448932798|FG003|Overall Study|Withdrawal by Subject|0|||
124810003|NCT00932126|448932799|FG004|Overall Study|Withdrawal by Subject|0|||
124810004|NCT00932126|448932800|FG005|Overall Study|Withdrawal by Subject|0|||
124810005|NCT00932126|448932801|FG006|Overall Study|Withdrawal by Subject|0|||
124810006|NCT00932126|448932802|FG007|Overall Study|Withdrawal by Subject|1|||
124810007|NCT00932126|448932795|FG000|Overall Study|Objective progression or relapse|3|||
124810008|NCT00932126|448932796|FG001|Overall Study|Objective progression or relapse|3|||
124810009|NCT00932126|448932797|FG002|Overall Study|Objective progression or relapse|2|||
124810010|NCT00932126|448932798|FG003|Overall Study|Objective progression or relapse|3|||
124810011|NCT00932126|448932799|FG004|Overall Study|Objective progression or relapse|3|||
124810012|NCT00932126|448932800|FG005|Overall Study|Objective progression or relapse|3|||
124810013|NCT00932126|448932801|FG006|Overall Study|Objective progression or relapse|3|||
124810014|NCT00932126|448932802|FG007|Overall Study|Objective progression or relapse|5|||
124810015|NCT00932126|448932795|FG000|Overall Study|Other|0|||
124810016|NCT00932126|448932796|FG001|Overall Study|Other|0|||
124810017|NCT00932126|448932797|FG002|Overall Study|Other|0|||
124810018|NCT00932126|448932798|FG003|Overall Study|Other|0|||
124810019|NCT00932126|448932799|FG004|Overall Study|Other|1|||
124810020|NCT00932126|448932800|FG005|Overall Study|Other|0|||
124810021|NCT00932126|448932801|FG006|Overall Study|Other|1|||
124810022|NCT00932126|448932802|FG007|Overall Study|Other|2|||
124810023|NCT03576495|448932806|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
124810024|NCT03576495|448932807|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
124810025|NCT02635776|448932809|FG000|Overall Study|Physician Decision|1|||
124810026|NCT02635776|448932810|FG001|Overall Study|Physician Decision|0|||
124810027|NCT02635776|448932809|FG000|Overall Study|Adverse Event|51|||
124810028|NCT02635776|448932810|FG001|Overall Study|Adverse Event|3|||
124810029|NCT02635776|448932809|FG000|Overall Study|Withdrawal by Subject|41|||
124810030|NCT02635776|448932810|FG001|Overall Study|Withdrawal by Subject|7|||
124810031|NCT02635776|448932809|FG000|Overall Study|Lost to Follow-up|4|||
124810032|NCT02635776|448932810|FG001|Overall Study|Lost to Follow-up|0|||
124810033|NCT02635776|448932809|FG000|Overall Study|Other reasons|5|||
124810034|NCT02635776|448932810|FG001|Overall Study|Other reasons|1|||
124810035|NCT00788073|448932811|FG000|STX209 Then Placebo|Adverse Event|1|||
124810036|NCT00788073|448932812|FG001|STX209 Then Placebo|Adverse Event|0|||
124810037|NCT00788073|448932811|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
124810038|NCT00788073|448932812|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
124810039|NCT00788073|448932811|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
124810040|NCT00788073|448932812|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
124810041|NCT00788073|448932811|FG000|STX209 Then Placebo|unable to return due to travel|0|||
124810042|NCT00788073|448932812|FG001|STX209 Then Placebo|unable to return due to travel|1|||
125300172|NCT00704288|450725904|FG002|Overall Treatment Period|Death|1|||
125300173|NCT00704288|450725902|FG000|Overall Treatment Period|Physician Decision|0|||
125300174|NCT00704288|450725903|FG001|Overall Treatment Period|Physician Decision|2|||
125300175|NCT00704288|450725904|FG002|Overall Treatment Period|Physician Decision|0|||
124810043|NCT00788073|448932811|FG000|Placebo Then STX209|Adverse Event|2|||
124810044|NCT00788073|448932812|FG001|Placebo Then STX209|Adverse Event|0|||
124810045|NCT00788073|448932811|FG000|Placebo Then STX209|Protocol Violation|0|||
124810046|NCT00788073|448932812|FG001|Placebo Then STX209|Protocol Violation|1|||
124810047|NCT03608254|448932813|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
124810048|NCT03608254|448932813|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
125300176|NCT00704288|450725902|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
125300177|NCT00704288|450725903|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
125300178|NCT00704288|450725904|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
125300179|NCT00704288|450725902|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
125300180|NCT00704288|450725903|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
125300181|NCT00704288|450725904|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
124810049|NCT00660673|448932815|FG000|Overall Study|Adverse Event|84|||
124810050|NCT00660673|448932815|FG000|Overall Study|Lack of Efficacy|7|||
124810051|NCT00660673|448932815|FG000|Overall Study|Withdrawal by Subject|22|||
124810052|NCT00660673|448932815|FG000|Overall Study|Administrative|2|||
124810053|NCT00660673|448932815|FG000|Overall Study|Protocol Violation|2|||
124810054|NCT03208127|448932816|FG000|Overall Study|Death|1|||
124810055|NCT00579098|448932817|FG000|Overall Study|Lost to Follow-up|2|||
124810056|NCT00579098|448932818|FG001|Overall Study|Lost to Follow-up|0|||
124810057|NCT00579098|448932817|FG000|Overall Study|Adverse Event|2|||
124810058|NCT00579098|448932818|FG001|Overall Study|Adverse Event|3|||
124810059|NCT00579098|448932817|FG000|Overall Study|Withdrawal by Subject|2|||
124810060|NCT00579098|448932818|FG001|Overall Study|Withdrawal by Subject|3|||
124810061|NCT00579098|448932817|FG000|Overall Study|AF returned after ablation|3|||
124810062|NCT00579098|448932818|FG001|Overall Study|AF returned after ablation|2|||
124810063|NCT00003487|448932823|FG000|Overall Study|Not evaluable|2|||
125300182|NCT00704288|450725902|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
125300183|NCT00704288|450725903|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
124810064|NCT03855228|448932830|FG000|Overall Study|Adverse Event|2|||
124810065|NCT03855228|448932831|FG001|Overall Study|Adverse Event|4|||
124810066|NCT03855228|448932832|FG002|Overall Study|Adverse Event|4|||
124810067|NCT03855228|448932833|FG003|Overall Study|Adverse Event|8|||
124810068|NCT03855228|448932830|FG000|Overall Study|Treatment Failure|1|||
124810069|NCT03855228|448932831|FG001|Overall Study|Treatment Failure|2|||
124810070|NCT03855228|448932832|FG002|Overall Study|Treatment Failure|1|||
124810071|NCT03855228|448932833|FG003|Overall Study|Treatment Failure|8|||
124810072|NCT03855228|448932830|FG000|Overall Study|Lost to Follow-up|0|||
124810073|NCT03855228|448932831|FG001|Overall Study|Lost to Follow-up|0|||
124810074|NCT03855228|448932832|FG002|Overall Study|Lost to Follow-up|0|||
124810075|NCT03855228|448932833|FG003|Overall Study|Lost to Follow-up|1|||
124810076|NCT03855228|448932830|FG000|Overall Study|Protocol Violation|0|||
124810077|NCT03855228|448932831|FG001|Overall Study|Protocol Violation|1|||
124810078|NCT03855228|448932832|FG002|Overall Study|Protocol Violation|2|||
124810079|NCT03855228|448932833|FG003|Overall Study|Protocol Violation|1|||
124810080|NCT03855228|448932830|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
124810081|NCT03855228|448932831|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
124810082|NCT03855228|448932832|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
124810083|NCT03855228|448932833|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
124810084|NCT01893203|448932835|FG000|Overall Study|Withdrawal by Subject|1|||
124810085|NCT00678080|448932846|FG000|Overall Study|Physician Decision|2|||
124810086|NCT00678080|448932847|FG001|Overall Study|Physician Decision|0|||
124810087|NCT00678080|448932846|FG000|Overall Study|Lost to Follow-up|1|||
124810088|NCT00678080|448932847|FG001|Overall Study|Lost to Follow-up|0|||
124810089|NCT00678080|448932846|FG000|Overall Study|Withdrawal by Subject|0|||
124810090|NCT00678080|448932847|FG001|Overall Study|Withdrawal by Subject|1|||
124810091|NCT01546207|448934156|FG000|Overall Study|Death|1|||
124810092|NCT03355365|448934159|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
124810093|NCT03355365|448934160|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
124810094|NCT03355365|448934159|FG000|Year 1, First Intervention|Protocol Violation|1|||
124810095|NCT03355365|448934160|FG001|Year 1, First Intervention|Protocol Violation|0|||
124810096|NCT03355365|448934159|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
124810097|NCT03355365|448934160|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
124810098|NCT03355365|448934159|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
124810099|NCT03355365|448934160|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
124810100|NCT03355365|448934159|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
124810101|NCT03355365|448934160|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
124810102|NCT03355365|448934159|FG000|Year 2, Crossover Intervention|severe COVID|0|||
124810103|NCT03355365|448934160|FG001|Year 2, Crossover Intervention|severe COVID|1|||
124810104|NCT03355365|448934159|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
124810105|NCT03355365|448934160|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
124810106|NCT01952145|448934161|FG000|Overall Study|Protocol Violation|2|||
124810107|NCT01952145|448934162|FG001|Overall Study|Protocol Violation|1|||
124810108|NCT01952145|448934161|FG000|Overall Study|Death|0|||
124810109|NCT01952145|448934162|FG001|Overall Study|Death|1|||
124810110|NCT01952145|448934161|FG000|Overall Study|Adverse Event|9|||
124810111|NCT01952145|448934162|FG001|Overall Study|Adverse Event|0|||
124810112|NCT01952145|448934161|FG000|Overall Study|Withdrawal Criteria|16|||
124810113|NCT01952145|448934162|FG001|Overall Study|Withdrawal Criteria|11|||
124810114|NCT01952145|448934161|FG000|Overall Study|Unclassified|1|||
124810115|NCT01952145|448934162|FG001|Overall Study|Unclassified|1|||
124810116|NCT00493025|448934165|FG000|Overall Study|Physician Decision|19|||
124810117|NCT05338216|448934166|FG000|Overall Study|Withdrawal by Subject|1|||
124810118|NCT05338216|448934167|FG001|Overall Study|Withdrawal by Subject|1|||
124810119|NCT00413244|448934168|FG000|Overall Study|Withdrawal by Subject|10|||
124810120|NCT00413244|448934169|FG001|Overall Study|Withdrawal by Subject|1|||
124810121|NCT00446251|448934170|FG000|Overall Study|On-study Transplants|2|||
124810122|NCT00446251|448934170|FG000|Overall Study|Rituximab Infusion Reaction|2|||
124810123|NCT00446251|448934170|FG000|Overall Study|Lost to Follow-up|1|||
124810124|NCT00753766|448934175|FG000|Overall Study|Physician Decision|1|||
124810125|NCT00753766|448934176|FG001|Overall Study|Physician Decision|0|||
124810126|NCT04545554|448934177|FG000|Overall Study|Withdrawal by Subject|0|||
124810127|NCT04545554|448934178|FG001|Overall Study|Withdrawal by Subject|0|||
124810128|NCT04545554|448934179|FG002|Overall Study|Withdrawal by Subject|0|||
124810129|NCT04545554|448934180|FG003|Overall Study|Withdrawal by Subject|1|||
124810130|NCT04545554|448934181|FG004|Overall Study|Withdrawal by Subject|0|||
124810131|NCT04545554|448934182|FG005|Overall Study|Withdrawal by Subject|0|||
124810132|NCT00494299|448934183|FG000|Overall Study|Adverse Event|93|||
124810133|NCT00494299|448934184|FG001|Overall Study|Adverse Event|13|||
124810134|NCT00494299|448934183|FG000|Overall Study|Lost to Follow-up|1|||
124810135|NCT00494299|448934184|FG001|Overall Study|Lost to Follow-up|0|||
124810136|NCT00494299|448934183|FG000|Overall Study|Physician Decision|0|||
124810137|NCT00494299|448934184|FG001|Overall Study|Physician Decision|2|||
124810138|NCT00494299|448934183|FG000|Overall Study|Protocol Violation|1|||
124810139|NCT00494299|448934184|FG001|Overall Study|Protocol Violation|2|||
124810140|NCT00494299|448934183|FG000|Overall Study|Withdrawal by Subject|8|||
124810141|NCT00494299|448934184|FG001|Overall Study|Withdrawal by Subject|3|||
124810142|NCT00494299|448934183|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
124810143|NCT00494299|448934184|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
124810144|NCT00494299|448934183|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
124810145|NCT00494299|448934184|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
124810146|NCT00494299|448934183|FG000|Overall Study|Site Closed by Sponsor|6|||
124810147|NCT00494299|448934184|FG001|Overall Study|Site Closed by Sponsor|0|||
124810148|NCT00494299|448934183|FG000|Overall Study|Protocol Driven Decision Point|11|||
124810149|NCT00494299|448934184|FG001|Overall Study|Protocol Driven Decision Point|22|||
124810150|NCT00066365|448934185|FG000|Overall Study|Adverse Event|1|||
124810151|NCT00066365|448934186|FG001|Overall Study|Adverse Event|0|||
124810152|NCT00066365|448934185|FG000|Overall Study|Lack of Efficacy|15|||
124810153|NCT00066365|448934186|FG001|Overall Study|Lack of Efficacy|12|||
124810154|NCT00066365|448934185|FG000|Overall Study|Physician Decision|1|||
124810155|NCT00066365|448934186|FG001|Overall Study|Physician Decision|0|||
124810156|NCT00066365|448934185|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
124810157|NCT00066365|448934186|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
124810158|NCT00066365|448934185|FG000|Overall Study|Ineligible|4|||
124810159|NCT00066365|448934186|FG001|Overall Study|Ineligible|2|||
124810160|NCT00239590|448934189|FG000|Randomized|Lost to Follow-up|0|||
124810161|NCT00239590|448934190|FG001|Randomized|Lost to Follow-up|1|||
124810162|NCT00239590|448934189|FG000|Randomized|Withdrawal by Subject|0|||
124810163|NCT00239590|448934190|FG001|Randomized|Withdrawal by Subject|1|||
124810164|NCT00239590|448934189|FG000|Completed Study Protocol|Adverse Event|1|||
124810165|NCT00239590|448934190|FG001|Completed Study Protocol|Adverse Event|1|||
124810166|NCT00239590|448934189|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
124810167|NCT00239590|448934190|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
124810168|NCT02362269|448934194|FG000|Overall Study|Moved|1|||
124810169|NCT02362269|448934195|FG001|Overall Study|Moved|0|||
124810170|NCT02362269|448934194|FG000|Overall Study|Lost to Follow-up|0|||
124810171|NCT02362269|448934195|FG001|Overall Study|Lost to Follow-up|6|||
124810172|NCT05213481|448934196|FG000|Overall Study|Adverse Event|3|||
124810173|NCT05213481|448934196|FG000|Overall Study|Lost to Follow-up|1|||
124810174|NCT00415168|448934200|FG000|Overall Study|Death|26|||
124810175|NCT00415168|448934200|FG000|Overall Study|Lost to Follow-up|3|||
124810176|NCT00415168|448934200|FG000|Overall Study|Physician Decision|13|||
124810177|NCT00415168|448934200|FG000|Overall Study|Sponsor Decision|4|||
124810178|NCT00415168|448934200|FG000|Overall Study|Withdrawal by Subject|6|||
124810179|NCT02058693|448934206|FG000|Phase 1|Withdrawal by Subject|3|||
124810180|NCT02058693|448934207|FG001|Phase 1|Withdrawal by Subject|2|||
124810181|NCT02058693|448934206|FG000|Phase 1|Adverse Event|0|||
124810182|NCT02058693|448934207|FG001|Phase 1|Adverse Event|1|||
124810183|NCT02058693|448934206|FG000|Phase 1|Lack of Efficacy|1|||
124810184|NCT02058693|448934207|FG001|Phase 1|Lack of Efficacy|0|||
124810185|NCT02058693|448934206|FG000|Phase 1|Physician Decision|1|||
124810186|NCT02058693|448934207|FG001|Phase 1|Physician Decision|1|||
124810187|NCT02058693|448934206|FG000|Phase 2|Withdrawal by Subject|0|||
124810188|NCT02058693|448934207|FG001|Phase 2|Withdrawal by Subject|2|||
124810189|NCT00722800|448934208|FG000|Overall Study|Withdrawal by Subject|1|||
124810190|NCT00722800|448934209|FG001|Overall Study|Withdrawal by Subject|0|||
124810191|NCT00722800|448934208|FG000|Overall Study|Physician Decision|1|||
124810192|NCT00722800|448934209|FG001|Overall Study|Physician Decision|0|||
124810193|NCT02925117|448934212|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
124810194|NCT02925117|448934213|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
124810195|NCT02925117|448934214|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
124810196|NCT02925117|448934215|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
124810197|NCT02925117|448934216|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
124810198|NCT02925117|448934217|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
124810199|NCT02925117|448934218|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
124810200|NCT02925117|448934219|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
124810201|NCT02925117|448934220|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
124810202|NCT02925117|448934221|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
124810203|NCT02925117|448934222|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
124810204|NCT02925117|448934223|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
124810205|NCT02925117|448934212|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
124810206|NCT02925117|448934213|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
124810207|NCT02925117|448934214|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
124810208|NCT02925117|448934215|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
124810209|NCT02925117|448934216|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
124810210|NCT02925117|448934217|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
124810211|NCT02925117|448934218|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
124810212|NCT02925117|448934219|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
124810213|NCT02925117|448934220|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
124810214|NCT02925117|448934221|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
124810215|NCT02925117|448934222|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
124810216|NCT02925117|448934223|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
124810217|NCT02925117|448934212|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
124810218|NCT02925117|448934213|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
124810219|NCT02925117|448934214|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
124810220|NCT02925117|448934215|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
124810221|NCT02925117|448934216|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
124810222|NCT02925117|448934217|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
124810223|NCT02925117|448934218|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
124810224|NCT02925117|448934219|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
124810225|NCT02925117|448934220|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
124810226|NCT02925117|448934221|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
124810227|NCT02925117|448934222|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
124810228|NCT02925117|448934223|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
124810229|NCT02925117|448934212|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
124810230|NCT02925117|448934213|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
124810231|NCT02925117|448934214|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
124810232|NCT02925117|448934215|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
124810233|NCT02925117|448934216|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
124810234|NCT02925117|448934217|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
124810235|NCT02925117|448934218|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
124810236|NCT02925117|448934219|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
124810237|NCT02925117|448934220|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
124810238|NCT02925117|448934221|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
124810239|NCT02925117|448934222|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
124810240|NCT02925117|448934223|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
124810241|NCT02925117|448934212|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
124810242|NCT02925117|448934213|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
124810243|NCT02925117|448934214|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
124810244|NCT02925117|448934215|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
124810245|NCT02925117|448934216|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
124810246|NCT02925117|448934217|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
124810247|NCT02925117|448934218|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
124810248|NCT02925117|448934219|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
124810249|NCT02925117|448934220|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
124810250|NCT02925117|448934221|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
124810251|NCT02925117|448934222|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
124810252|NCT02925117|448934223|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
124810253|NCT02925117|448934212|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
124810254|NCT02925117|448934213|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
124810255|NCT02925117|448934214|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
124810256|NCT02925117|448934215|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
124810257|NCT02925117|448934216|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
124810258|NCT02925117|448934217|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
124810259|NCT02925117|448934218|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
124810260|NCT02925117|448934219|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
124810261|NCT02925117|448934220|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
124810262|NCT02925117|448934221|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
124810263|NCT02925117|448934222|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
124810264|NCT02925117|448934223|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
124810265|NCT02925117|448934212|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
124810266|NCT02925117|448934213|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
124810267|NCT02925117|448934214|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
124810268|NCT02925117|448934215|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
124810269|NCT02925117|448934216|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
124810270|NCT02925117|448934217|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
124810271|NCT02925117|448934218|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
124810272|NCT02925117|448934219|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
124810273|NCT02925117|448934220|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
124810274|NCT02925117|448934221|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
124810275|NCT02925117|448934222|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
124810276|NCT02925117|448934223|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
124810277|NCT02925117|448934212|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
124810278|NCT02925117|448934213|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
124810279|NCT02925117|448934214|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
124810280|NCT02925117|448934215|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
124810281|NCT02925117|448934216|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
124810282|NCT02925117|448934217|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
124810283|NCT02925117|448934218|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
124810284|NCT02925117|448934219|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
124810285|NCT02925117|448934220|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
124810286|NCT02925117|448934221|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
124810287|NCT02925117|448934222|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
124810288|NCT02925117|448934223|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
124810289|NCT01449539|448934228|FG000|Overall Study|Withdrawal by Subject|3|||
124810290|NCT01449539|448934228|FG000|Overall Study|Toxicity not study related|1|||
124810291|NCT01972568|448934229|FG000|Overall Study|Other events|3|||
124810292|NCT01972568|448934230|FG001|Overall Study|Other events|0|||
124810293|NCT01972568|448934231|FG002|Overall Study|Other events|0|||
124810294|NCT01972568|448934229|FG000|Overall Study|Lack of Efficacy|0|||
124810295|NCT01972568|448934230|FG001|Overall Study|Lack of Efficacy|1|||
124810296|NCT01972568|448934231|FG002|Overall Study|Lack of Efficacy|2|||
124810297|NCT01972568|448934229|FG000|Overall Study|Protocol Violation|1|||
124810298|NCT01972568|448934230|FG001|Overall Study|Protocol Violation|2|||
124810299|NCT01972568|448934231|FG002|Overall Study|Protocol Violation|2|||
124810300|NCT01972568|448934229|FG000|Overall Study|Withdrawal by Subject|6|||
124810301|NCT01972568|448934230|FG001|Overall Study|Withdrawal by Subject|3|||
124810302|NCT01972568|448934231|FG002|Overall Study|Withdrawal by Subject|7|||
124810303|NCT01972568|448934229|FG000|Overall Study|Lost to Follow-up|1|||
124810304|NCT01972568|448934230|FG001|Overall Study|Lost to Follow-up|0|||
124810305|NCT01972568|448934231|FG002|Overall Study|Lost to Follow-up|0|||
124810306|NCT01972568|448934229|FG000|Overall Study|Adverse Event|5|||
124810307|NCT01972568|448934230|FG001|Overall Study|Adverse Event|6|||
124810308|NCT01972568|448934231|FG002|Overall Study|Adverse Event|5|||
124810309|NCT00306189|448934232|FG000|Overall Study|Physician Decision|0|||
124810310|NCT00306189|448934233|FG001|Overall Study|Physician Decision|0|||
124810311|NCT00306189|448934234|FG002|Overall Study|Physician Decision|0|||
124810312|NCT00306189|448934235|FG003|Overall Study|Physician Decision|1|||
124810313|NCT00306189|448934232|FG000|Overall Study|Adverse Event|3|||
124810314|NCT00306189|448934233|FG001|Overall Study|Adverse Event|3|||
124810315|NCT00306189|448934234|FG002|Overall Study|Adverse Event|2|||
124810316|NCT00306189|448934235|FG003|Overall Study|Adverse Event|2|||
124810317|NCT00306189|448934232|FG000|Overall Study|Withdrawal by Subject|4|||
124810318|NCT00306189|448934233|FG001|Overall Study|Withdrawal by Subject|2|||
124810319|NCT00306189|448934234|FG002|Overall Study|Withdrawal by Subject|8|||
124810320|NCT00306189|448934235|FG003|Overall Study|Withdrawal by Subject|1|||
124810321|NCT00306189|448934232|FG000|Overall Study|Ineligibility determined|1|||
124810322|NCT00306189|448934233|FG001|Overall Study|Ineligibility determined|1|||
124810323|NCT00306189|448934234|FG002|Overall Study|Ineligibility determined|1|||
124810324|NCT00306189|448934235|FG003|Overall Study|Ineligibility determined|1|||
124810325|NCT00306189|448934232|FG000|Overall Study|Other|1|||
124810326|NCT00306189|448934233|FG001|Overall Study|Other|0|||
124810327|NCT00306189|448934234|FG002|Overall Study|Other|0|||
124810328|NCT00306189|448934235|FG003|Overall Study|Other|0|||
124810329|NCT02572401|448934236|FG000|Overall Study|Lost to Follow-up|5|||
124810330|NCT02572401|448934237|FG001|Overall Study|Lost to Follow-up|8|||
124810331|NCT02572401|448934238|FG002|Overall Study|Lost to Follow-up|9|||
124810332|NCT02572401|448934239|FG003|Overall Study|Lost to Follow-up|9|||
124810333|NCT02572401|448934236|FG000|Overall Study|Death|0|||
124810334|NCT02572401|448934237|FG001|Overall Study|Death|0|||
124810335|NCT02572401|448934238|FG002|Overall Study|Death|0|||
124810336|NCT02572401|448934239|FG003|Overall Study|Death|1|||
124810337|NCT02059408|448934240|FG000|Overall Study|Did not get tested|0|||
124810338|NCT02059408|448934241|FG001|Overall Study|Did not get tested|330|||
124810339|NCT02059408|448934242|FG002|Overall Study|Did not get tested|358|||
124810340|NCT00945893|448934243|FG000|Overall Study|Lost to Follow-up|2|||
124810341|NCT00945893|448934244|FG001|Overall Study|Lost to Follow-up|8|||
124810342|NCT00945893|448934243|FG000|Overall Study|Withdrawal of consent|1|||
124810343|NCT00945893|448934244|FG001|Overall Study|Withdrawal of consent|2|||
124810344|NCT01681472|448934246|FG000|Overall Study|Adverse Event|0|||
124810345|NCT01681472|448934247|FG001|Overall Study|Adverse Event|1|||
124810346|NCT01681472|448934248|FG002|Overall Study|Adverse Event|0|||
124810347|NCT01681472|448934249|FG003|Overall Study|Adverse Event|0|||
124810348|NCT00667875|448934250|FG000|Overall Study|Adverse Event|0|||
124810349|NCT00667875|448934251|FG001|Overall Study|Adverse Event|2|||
124810350|NCT00667875|448934252|FG002|Overall Study|Adverse Event|6|||
124810351|NCT00667875|448934250|FG000|Overall Study|Withdrawal by Subject|10|||
124810352|NCT00667875|448934251|FG001|Overall Study|Withdrawal by Subject|9|||
124810353|NCT00667875|448934252|FG002|Overall Study|Withdrawal by Subject|7|||
124810354|NCT01187433|448934260|FG000|Overall Study|Protocol Violation|6|||
124810355|NCT01187433|448934261|FG001|Overall Study|Protocol Violation|2|||
124810356|NCT01187433|448934260|FG000|Overall Study|Withdrawal by Subject|5|||
124810357|NCT01187433|448934261|FG001|Overall Study|Withdrawal by Subject|2|||
124810358|NCT00437983|448934265|FG000|Overall Study|Adverse Event|6|||
124810359|NCT00437983|448934266|FG001|Overall Study|Adverse Event|6|||
124810360|NCT00437983|448934265|FG000|Overall Study|Protocol Violation|2|||
124810361|NCT00437983|448934266|FG001|Overall Study|Protocol Violation|1|||
124810362|NCT00437983|448934265|FG000|Overall Study|Withdrawal by Subject|5|||
124810363|NCT00437983|448934266|FG001|Overall Study|Withdrawal by Subject|6|||
124810364|NCT00672646|448934269|FG000|Overall Study|Lost to Follow-up|0|||
124810365|NCT00672646|448934270|FG001|Overall Study|Lost to Follow-up|1|||
124810366|NCT00672646|448934271|FG002|Overall Study|Lost to Follow-up|2|||
124810367|NCT00672646|448934269|FG000|Overall Study|Withdrawal by Subject|0|||
124810368|NCT00672646|448934270|FG001|Overall Study|Withdrawal by Subject|0|||
124810369|NCT00672646|448934271|FG002|Overall Study|Withdrawal by Subject|1|||
124810370|NCT00142298|448934274|FG000|Overall Study|Adverse Event|10|||
124810371|NCT00142298|448934275|FG001|Overall Study|Adverse Event|10|||
124810372|NCT00142298|448934276|FG002|Overall Study|Adverse Event|1|||
124810373|NCT00142298|448934277|FG003|Overall Study|Adverse Event|5|||
124810374|NCT00142298|448934278|FG004|Overall Study|Adverse Event|2|||
124810375|NCT00142298|448934279|FG005|Overall Study|Adverse Event|2|||
124810376|NCT00142298|448934280|FG006|Overall Study|Adverse Event|0|||
124810377|NCT00142298|448934281|FG007|Overall Study|Adverse Event|0|||
124810378|NCT00142298|448934282|FG008|Overall Study|Adverse Event|0|||
124810379|NCT00142298|448934283|FG009|Overall Study|Adverse Event|0|||
124810380|NCT00142298|448934274|FG000|Overall Study|Clinical disease progression|1|||
124810381|NCT00142298|448934275|FG001|Overall Study|Clinical disease progression|0|||
124810382|NCT00142298|448934276|FG002|Overall Study|Clinical disease progression|0|||
124810383|NCT00142298|448934277|FG003|Overall Study|Clinical disease progression|0|||
124810384|NCT00142298|448934278|FG004|Overall Study|Clinical disease progression|0|||
124810385|NCT00142298|448934279|FG005|Overall Study|Clinical disease progression|0|||
124810386|NCT00142298|448934280|FG006|Overall Study|Clinical disease progression|0|||
124810387|NCT00142298|448934281|FG007|Overall Study|Clinical disease progression|0|||
124810388|NCT00142298|448934282|FG008|Overall Study|Clinical disease progression|0|||
124810389|NCT00142298|448934283|FG009|Overall Study|Clinical disease progression|0|||
124810390|NCT00142298|448934274|FG000|Overall Study|Death|1|||
124810391|NCT00142298|448934275|FG001|Overall Study|Death|1|||
124810392|NCT00142298|448934276|FG002|Overall Study|Death|1|||
124810393|NCT00142298|448934277|FG003|Overall Study|Death|0|||
124810394|NCT00142298|448934278|FG004|Overall Study|Death|0|||
124810395|NCT00142298|448934279|FG005|Overall Study|Death|6|||
124810396|NCT00142298|448934280|FG006|Overall Study|Death|0|||
124810397|NCT00142298|448934281|FG007|Overall Study|Death|0|||
124810398|NCT00142298|448934282|FG008|Overall Study|Death|0|||
124810399|NCT00142298|448934283|FG009|Overall Study|Death|0|||
124810400|NCT00142298|448934274|FG000|Overall Study|Lack of Efficacy|44|||
124810401|NCT00142298|448934275|FG001|Overall Study|Lack of Efficacy|62|||
124810402|NCT00142298|448934276|FG002|Overall Study|Lack of Efficacy|9|||
124810403|NCT00142298|448934277|FG003|Overall Study|Lack of Efficacy|12|||
124810404|NCT00142298|448934278|FG004|Overall Study|Lack of Efficacy|1|||
124810405|NCT00142298|448934279|FG005|Overall Study|Lack of Efficacy|0|||
124810406|NCT00142298|448934280|FG006|Overall Study|Lack of Efficacy|0|||
124810407|NCT00142298|448934281|FG007|Overall Study|Lack of Efficacy|1|||
124810408|NCT00142298|448934282|FG008|Overall Study|Lack of Efficacy|0|||
124810409|NCT00142298|448934283|FG009|Overall Study|Lack of Efficacy|0|||
124810410|NCT00142298|448934274|FG000|Overall Study|Non-compliance|15|||
124810411|NCT00142298|448934275|FG001|Overall Study|Non-compliance|13|||
124810412|NCT00142298|448934276|FG002|Overall Study|Non-compliance|0|||
124810413|NCT00142298|448934277|FG003|Overall Study|Non-compliance|6|||
124810414|NCT00142298|448934278|FG004|Overall Study|Non-compliance|1|||
124810415|NCT00142298|448934279|FG005|Overall Study|Non-compliance|0|||
124810416|NCT00142298|448934280|FG006|Overall Study|Non-compliance|0|||
124810417|NCT00142298|448934281|FG007|Overall Study|Non-compliance|3|||
124810418|NCT00142298|448934282|FG008|Overall Study|Non-compliance|3|||
124810419|NCT00142298|448934283|FG009|Overall Study|Non-compliance|0|||
124810420|NCT00142298|448934274|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
124810421|NCT00142298|448934275|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
124810422|NCT00142298|448934276|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
124810423|NCT00142298|448934277|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
124810424|NCT00142298|448934278|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
124810425|NCT00142298|448934279|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
124810426|NCT00142298|448934280|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
124810427|NCT00142298|448934281|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
124810428|NCT00142298|448934282|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
124810429|NCT00142298|448934283|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
124810430|NCT00142298|448934274|FG000|Overall Study|Pregnancy|4|||
124810431|NCT00142298|448934275|FG001|Overall Study|Pregnancy|4|||
124810432|NCT00142298|448934276|FG002|Overall Study|Pregnancy|2|||
124810433|NCT00142298|448934277|FG003|Overall Study|Pregnancy|3|||
124810434|NCT00142298|448934278|FG004|Overall Study|Pregnancy|0|||
124810435|NCT00142298|448934279|FG005|Overall Study|Pregnancy|0|||
124810436|NCT00142298|448934280|FG006|Overall Study|Pregnancy|0|||
124810437|NCT00142298|448934281|FG007|Overall Study|Pregnancy|0|||
124810438|NCT00142298|448934282|FG008|Overall Study|Pregnancy|1|||
124810439|NCT00142298|448934283|FG009|Overall Study|Pregnancy|0|||
124810440|NCT00142298|448934274|FG000|Overall Study|Virologic breakthrough|19|||
124810441|NCT00142298|448934275|FG001|Overall Study|Virologic breakthrough|23|||
124810442|NCT00142298|448934276|FG002|Overall Study|Virologic breakthrough|9|||
124810443|NCT00142298|448934277|FG003|Overall Study|Virologic breakthrough|7|||
124810444|NCT00142298|448934278|FG004|Overall Study|Virologic breakthrough|2|||
124810445|NCT00142298|448934279|FG005|Overall Study|Virologic breakthrough|3|||
124810446|NCT00142298|448934280|FG006|Overall Study|Virologic breakthrough|3|||
124810447|NCT00142298|448934281|FG007|Overall Study|Virologic breakthrough|0|||
124810448|NCT00142298|448934282|FG008|Overall Study|Virologic breakthrough|0|||
124810449|NCT00142298|448934283|FG009|Overall Study|Virologic breakthrough|0|||
124810450|NCT00142298|448934274|FG000|Overall Study|Other- not specified|0|||
124810451|NCT00142298|448934275|FG001|Overall Study|Other- not specified|3|||
124810452|NCT00142298|448934276|FG002|Overall Study|Other- not specified|0|||
124810453|NCT00142298|448934277|FG003|Overall Study|Other- not specified|1|||
124810454|NCT00142298|448934278|FG004|Overall Study|Other- not specified|0|||
124810455|NCT00142298|448934279|FG005|Overall Study|Other- not specified|0|||
124810456|NCT00142298|448934280|FG006|Overall Study|Other- not specified|0|||
124810457|NCT00142298|448934281|FG007|Overall Study|Other- not specified|0|||
124810458|NCT00142298|448934282|FG008|Overall Study|Other- not specified|0|||
124810459|NCT00142298|448934283|FG009|Overall Study|Other- not specified|0|||
124810460|NCT00142298|448934274|FG000|Overall Study|Lost to Follow-up|0|||
124810461|NCT00142298|448934275|FG001|Overall Study|Lost to Follow-up|0|||
124810462|NCT00142298|448934276|FG002|Overall Study|Lost to Follow-up|0|||
124810463|NCT00142298|448934277|FG003|Overall Study|Lost to Follow-up|0|||
124810464|NCT00142298|448934278|FG004|Overall Study|Lost to Follow-up|0|||
124810465|NCT00142298|448934279|FG005|Overall Study|Lost to Follow-up|0|||
124810466|NCT00142298|448934280|FG006|Overall Study|Lost to Follow-up|2|||
124810467|NCT00142298|448934281|FG007|Overall Study|Lost to Follow-up|0|||
124810468|NCT00142298|448934282|FG008|Overall Study|Lost to Follow-up|0|||
124810469|NCT00142298|448934283|FG009|Overall Study|Lost to Follow-up|0|||
124810470|NCT00142298|448934274|FG000|Overall Study|Treatment Failure|0|||
124810471|NCT00142298|448934275|FG001|Overall Study|Treatment Failure|0|||
124810472|NCT00142298|448934276|FG002|Overall Study|Treatment Failure|0|||
124810473|NCT00142298|448934277|FG003|Overall Study|Treatment Failure|0|||
124810474|NCT00142298|448934278|FG004|Overall Study|Treatment Failure|0|||
124810475|NCT00142298|448934279|FG005|Overall Study|Treatment Failure|2|||
124810476|NCT00142298|448934280|FG006|Overall Study|Treatment Failure|2|||
124810477|NCT00142298|448934281|FG007|Overall Study|Treatment Failure|0|||
124810478|NCT00142298|448934282|FG008|Overall Study|Treatment Failure|0|||
124810479|NCT00142298|448934283|FG009|Overall Study|Treatment Failure|0|||
124810480|NCT00300274|448934284|FG000|Overall Study|Withdrawal by Subject|12|||
124810481|NCT00300274|448934285|FG001|Overall Study|Withdrawal by Subject|3|||
124810482|NCT00300274|448934286|FG002|Overall Study|Withdrawal by Subject|14|||
124810483|NCT00300274|448934284|FG000|Overall Study|Lost to Follow-up|3|||
124810484|NCT00300274|448934285|FG001|Overall Study|Lost to Follow-up|4|||
124810485|NCT00300274|448934286|FG002|Overall Study|Lost to Follow-up|5|||
124810486|NCT00300274|448934284|FG000|Overall Study|Death|31|||
124810487|NCT00300274|448934285|FG001|Overall Study|Death|20|||
124810488|NCT00300274|448934286|FG002|Overall Study|Death|25|||
124810489|NCT00300274|448934284|FG000|Overall Study|Re-transplant|0|||
124810490|NCT00300274|448934285|FG001|Overall Study|Re-transplant|0|||
124810491|NCT00300274|448934286|FG002|Overall Study|Re-transplant|1|||
124810492|NCT00242216|448934287|FG000|Overall Study|Lost to Follow-up|12|||
124810493|NCT00242216|448934288|FG001|Overall Study|Lost to Follow-up|17|||
124810494|NCT00242216|448934287|FG000|Overall Study|Death|4|||
124810495|NCT00242216|448934288|FG001|Overall Study|Death|2|||
124810496|NCT00242216|448934287|FG000|Overall Study|Lack of Efficacy|1|||
124810497|NCT00242216|448934288|FG001|Overall Study|Lack of Efficacy|2|||
124810498|NCT00242216|448934287|FG000|Overall Study|no medicaiton dispensed|1|||
124810499|NCT00242216|448934288|FG001|Overall Study|no medicaiton dispensed|1|||
124810500|NCT04439201|448934289|FG000|Overall Study|Ineligible|2|||
124810501|NCT04439201|448934289|FG000|Overall Study|Never start protocol therapy|1|||
124810502|NCT04439201|448934289|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
124810503|NCT04439201|448934289|FG000|Overall Study|Mutation status not confirmed|4|||
124810504|NCT04439201|448934289|FG000|Overall Study|Adverse Event|1|||
124810505|NCT04439201|448934289|FG000|Overall Study|Death|7|||
124810506|NCT04439201|448934289|FG000|Overall Study|Withdrawal by Subject|2|||
124810507|NCT04439201|448934289|FG000|Overall Study|Disease progression|20|||
124810508|NCT04439201|448934289|FG000|Overall Study|Alternative therapy|1|||
124810509|NCT04439201|448934289|FG000|Overall Study|Physician Decision|1|||
124810510|NCT06956170|448936128|FG000|Overall Study|Death|2|||
124810511|NCT06956170|448936129|FG001|Overall Study|Death|1|||
124810512|NCT06956170|448936128|FG000|Overall Study|Withdrawal by Subject|1|||
124810513|NCT06956170|448936129|FG001|Overall Study|Withdrawal by Subject|0|||
124810514|NCT06956170|448936128|FG000|Overall Study|Ongoing|7|||
124810515|NCT06956170|448936129|FG001|Overall Study|Ongoing|10|||
124810516|NCT01385566|448936130|FG000|Overall Study|Lost to Follow-up|1|||
124810517|NCT01385566|448936131|FG001|Overall Study|Lost to Follow-up|0|||
124810518|NCT01385566|448936132|FG002|Overall Study|Lost to Follow-up|0|||
124810519|NCT01385566|448936133|FG003|Overall Study|Lost to Follow-up|0|||
124810520|NCT01385566|448936134|FG004|Overall Study|Lost to Follow-up|0|||
124810521|NCT01385566|448936135|FG005|Overall Study|Lost to Follow-up|0|||
124810522|NCT01385566|448936130|FG000|Overall Study|Withdrawal by Subject|0|||
124810523|NCT01385566|448936131|FG001|Overall Study|Withdrawal by Subject|0|||
124810524|NCT01385566|448936132|FG002|Overall Study|Withdrawal by Subject|0|||
124810525|NCT01385566|448936133|FG003|Overall Study|Withdrawal by Subject|1|||
124810526|NCT01385566|448936134|FG004|Overall Study|Withdrawal by Subject|0|||
124810527|NCT01385566|448936135|FG005|Overall Study|Withdrawal by Subject|0|||
124810528|NCT00403234|448936138|FG000|Overall Study|Withdrawal by Subject|0|||
124810529|NCT00403234|448936139|FG001|Overall Study|Withdrawal by Subject|1|||
124810530|NCT00403234|448936140|FG002|Overall Study|Withdrawal by Subject|0|||
124810531|NCT00403234|448936141|FG003|Overall Study|Withdrawal by Subject|0|||
124810532|NCT00403234|448936138|FG000|Overall Study|Adverse Event|1|||
124810533|NCT00403234|448936139|FG001|Overall Study|Adverse Event|0|||
124810534|NCT00403234|448936140|FG002|Overall Study|Adverse Event|1|||
124810535|NCT00403234|448936141|FG003|Overall Study|Adverse Event|0|||
124810536|NCT02280304|448936142|FG000|Overall Study|Lost to Follow-up|7|||
124810537|NCT02280304|448936143|FG001|Overall Study|Lost to Follow-up|8|||
124810538|NCT04218695|448936147|FG000|Overall Study|Adverse Event|1|||
124810539|NCT04218695|448936148|FG001|Overall Study|Adverse Event|0|||
124810540|NCT03166735|448936149|FG000|Overall Study|Not Treated|1|||
124810541|NCT03166735|448936150|FG001|Overall Study|Not Treated|0|||
124810542|NCT03166735|448936151|FG002|Overall Study|Not Treated|0|||
124810543|NCT03166735|448936152|FG003|Overall Study|Not Treated|0|||
124810544|NCT03166735|448936153|FG004|Overall Study|Not Treated|0|||
124810545|NCT03166735|448936149|FG000|Overall Study|follow-up not completed as planned|0|||
124810546|NCT03166735|448936150|FG001|Overall Study|follow-up not completed as planned|1|||
124810547|NCT03166735|448936151|FG002|Overall Study|follow-up not completed as planned|1|||
124810548|NCT03166735|448936152|FG003|Overall Study|follow-up not completed as planned|0|||
124810549|NCT03166735|448936153|FG004|Overall Study|follow-up not completed as planned|1|||
124810550|NCT03166735|448936149|FG000|Overall Study|Withdrawal by Subject|0|||
124810551|NCT03166735|448936150|FG001|Overall Study|Withdrawal by Subject|0|||
124810552|NCT03166735|448936151|FG002|Overall Study|Withdrawal by Subject|1|||
124810553|NCT03166735|448936152|FG003|Overall Study|Withdrawal by Subject|1|||
124810554|NCT03166735|448936153|FG004|Overall Study|Withdrawal by Subject|2|||
124810555|NCT03166735|448936149|FG000|Overall Study|Lost to Follow-up|0|||
124810556|NCT03166735|448936150|FG001|Overall Study|Lost to Follow-up|2|||
124810557|NCT03166735|448936151|FG002|Overall Study|Lost to Follow-up|1|||
124810558|NCT03166735|448936152|FG003|Overall Study|Lost to Follow-up|0|||
124810559|NCT03166735|448936153|FG004|Overall Study|Lost to Follow-up|1|||
124810560|NCT00003473|448936154|FG000|Overall Study|Three patients were not evaluable.|3|||
124810561|NCT03372096|448936159|FG000|Overall Study|Study Closed|8|||
124810562|NCT01947582|448936164|FG000|Overall Study|Withdrawal by Subject|1|||
124810563|NCT01603355|448936165|FG000|Overall Study|Lack of Efficacy|2|||
124810564|NCT05154578|448936166|FG000|Overall Study|Withdrawal by Subject|2|||
124810565|NCT05154578|448936167|FG001|Overall Study|Withdrawal by Subject|3|||
124810566|NCT05154578|448936168|FG002|Overall Study|Withdrawal by Subject|2|||
124810567|NCT05154578|448936169|FG003|Overall Study|Withdrawal by Subject|4|||
124810568|NCT05154578|448936170|FG004|Overall Study|Withdrawal by Subject|0|||
124810569|NCT05154578|448936166|FG000|Overall Study|Lost to Follow-up|0|||
124810570|NCT05154578|448936167|FG001|Overall Study|Lost to Follow-up|1|||
124810571|NCT05154578|448936168|FG002|Overall Study|Lost to Follow-up|0|||
124810572|NCT05154578|448936169|FG003|Overall Study|Lost to Follow-up|3|||
124810573|NCT05154578|448936170|FG004|Overall Study|Lost to Follow-up|0|||
124810574|NCT05154578|448936166|FG000|Overall Study|Adverse Event|0|||
124810575|NCT05154578|448936167|FG001|Overall Study|Adverse Event|0|||
124810576|NCT05154578|448936168|FG002|Overall Study|Adverse Event|0|||
124810577|NCT05154578|448936169|FG003|Overall Study|Adverse Event|1|||
124810578|NCT05154578|448936170|FG004|Overall Study|Adverse Event|0|||
124810579|NCT05154578|448936166|FG000|Overall Study|Relocated to another province|0|||
124810580|NCT05154578|448936167|FG001|Overall Study|Relocated to another province|0|||
124810581|NCT05154578|448936168|FG002|Overall Study|Relocated to another province|1|||
124810582|NCT05154578|448936169|FG003|Overall Study|Relocated to another province|0|||
124810583|NCT05154578|448936170|FG004|Overall Study|Relocated to another province|1|||
124810584|NCT05154578|448936166|FG000|Overall Study|Baby loss|0|||
124810585|NCT05154578|448936167|FG001|Overall Study|Baby loss|1|||
124810586|NCT05154578|448936168|FG002|Overall Study|Baby loss|0|||
124810587|NCT05154578|448936169|FG003|Overall Study|Baby loss|0|||
124810588|NCT05154578|448936170|FG004|Overall Study|Baby loss|0|||
124810589|NCT02924571|448936176|FG000|Overall Study|Lost to Follow-up|1|||
124810590|NCT02924571|448936177|FG001|Overall Study|Lost to Follow-up|1|||
124810591|NCT02924571|448936178|FG002|Overall Study|Lost to Follow-up|0|||
124810592|NCT00434954|448936179|FG000|Overall Study|Adverse Event|17|||
124810593|NCT00434954|448936180|FG001|Overall Study|Adverse Event|2|||
124810594|NCT00434954|448936179|FG000|Overall Study|Entry criteria not met|14|||
124810595|NCT00434954|448936180|FG001|Overall Study|Entry criteria not met|16|||
124810596|NCT00434954|448936179|FG000|Overall Study|Lost to Follow-up|0|||
124810597|NCT00434954|448936180|FG001|Overall Study|Lost to Follow-up|1|||
124810598|NCT00434954|448936179|FG000|Overall Study|Physician Decision|6|||
124810599|NCT00434954|448936180|FG001|Overall Study|Physician Decision|3|||
124810600|NCT00434954|448936179|FG000|Overall Study|Protocol Violation|36|||
124810601|NCT00434954|448936180|FG001|Overall Study|Protocol Violation|27|||
124810602|NCT00434954|448936179|FG000|Overall Study|Sponsor decision|1|||
124810603|NCT00434954|448936180|FG001|Overall Study|Sponsor decision|0|||
124810604|NCT00434954|448936179|FG000|Overall Study|Subject decision|8|||
124810605|NCT00434954|448936180|FG001|Overall Study|Subject decision|22|||
124810606|NCT00894166|448936181|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
124810607|NCT00894166|448936182|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
124810608|NCT00894166|448936183|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
124810609|NCT00894166|448936184|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
124810610|NCT00894166|448936185|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
124810611|NCT00894166|448936186|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
124810612|NCT00894166|448936187|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
124810613|NCT00894166|448936188|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
124810614|NCT00894166|448936181|FG000|Overall Study|Death|0|||
124810615|NCT00894166|448936182|FG001|Overall Study|Death|0|||
124810616|NCT00894166|448936183|FG002|Overall Study|Death|0|||
124810617|NCT00894166|448936184|FG003|Overall Study|Death|1|||
124810618|NCT00894166|448936185|FG004|Overall Study|Death|0|||
124810619|NCT00894166|448936186|FG005|Overall Study|Death|0|||
124810620|NCT00894166|448936187|FG006|Overall Study|Death|0|||
124810621|NCT00894166|448936188|FG007|Overall Study|Death|0|||
124810622|NCT03750955|448936196|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
124810623|NCT03750955|448936197|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
124810624|NCT03750955|448936196|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
124810625|NCT03750955|448936197|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
124810626|NCT00142935|448936200|FG000|Overall Study|Other reason|1|||
124810627|NCT00142935|448936201|FG001|Overall Study|Other reason|1|||
124810628|NCT00142935|448936202|FG002|Overall Study|Other reason|1|||
124810629|NCT00142935|448936200|FG000|Overall Study|Lost to Follow-up|2|||
124810630|NCT00142935|448936201|FG001|Overall Study|Lost to Follow-up|5|||
124810631|NCT00142935|448936202|FG002|Overall Study|Lost to Follow-up|5|||
124810632|NCT00142935|448936200|FG000|Overall Study|Death|0|||
124810633|NCT00142935|448936201|FG001|Overall Study|Death|2|||
124810634|NCT00142935|448936202|FG002|Overall Study|Death|1|||
124810635|NCT01180985|448936203|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
124810636|NCT01180985|448936204|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
124810637|NCT00129272|448936212|FG000|Overall Study|Lost to Follow-up|12|||
124810638|NCT00129272|448936213|FG001|Overall Study|Lost to Follow-up|11|||
124810639|NCT00129272|448936212|FG000|Overall Study|Withdrawal by Subject|5|||
124810640|NCT00129272|448936213|FG001|Overall Study|Withdrawal by Subject|11|||
124810641|NCT03345914|448936214|FG000|Overall Study|Transition to another study at week 16|80|||
124810642|NCT03345914|448936215|FG001|Overall Study|Transition to another study at week 16|86|||
124810643|NCT03345914|448936216|FG002|Overall Study|Transition to another study at week 16|78|||
124810644|NCT03345914|448936214|FG000|Overall Study|Transition to OLE during follow-up|37|||
124810645|NCT03345914|448936215|FG001|Overall Study|Transition to OLE during follow-up|33|||
124810646|NCT03345914|448936216|FG002|Overall Study|Transition to OLE during follow-up|39|||
124810647|NCT03345914|448936214|FG000|Overall Study|Physician Decision|0|||
124810648|NCT03345914|448936215|FG001|Overall Study|Physician Decision|1|||
124810649|NCT03345914|448936216|FG002|Overall Study|Physician Decision|1|||
124810650|NCT03345914|448936214|FG000|Overall Study|Withdrawal by Subject|5|||
124810651|NCT03345914|448936215|FG001|Overall Study|Withdrawal by Subject|1|||
124810652|NCT03345914|448936216|FG002|Overall Study|Withdrawal by Subject|2|||
124810653|NCT03345914|448936214|FG000|Overall Study|Other|1|||
124810654|NCT03345914|448936215|FG001|Overall Study|Other|1|||
124810655|NCT03345914|448936216|FG002|Overall Study|Other|1|||
124810656|NCT03345914|448936214|FG000|Overall Study|Ongoing|0|||
124810657|NCT03345914|448936215|FG001|Overall Study|Ongoing|0|||
124810658|NCT03345914|448936216|FG002|Overall Study|Ongoing|1|||
124810659|NCT03758066|448936219|FG000|Overall Study|Lost to Follow-up|14|||
124810660|NCT04138810|448936223|FG000|Overall Study|Withdrawal by Subject|0|||
124810661|NCT04138810|448936224|FG001|Overall Study|Withdrawal by Subject|1|||
124810662|NCT04138810|448936223|FG000|Overall Study|Subject cancelled surgery|1|||
124810663|NCT04138810|448936224|FG001|Overall Study|Subject cancelled surgery|0|||
124810664|NCT01786668|448936225|FG000|Overall Study|Adverse Event|0|||
124810665|NCT01786668|448936226|FG001|Overall Study|Adverse Event|1|||
124810666|NCT01786668|448936227|FG002|Overall Study|Adverse Event|1|||
124810667|NCT01786668|448936228|FG003|Overall Study|Adverse Event|2|||
124810668|NCT01786668|448936225|FG000|Overall Study|Withdrawal by Subject|0|||
124810669|NCT01786668|448936226|FG001|Overall Study|Withdrawal by Subject|0|||
124810670|NCT01786668|448936227|FG002|Overall Study|Withdrawal by Subject|3|||
124810671|NCT01786668|448936228|FG003|Overall Study|Withdrawal by Subject|1|||
124810672|NCT01786668|448936225|FG000|Overall Study|Pregnancy|0|||
124810673|NCT01786668|448936226|FG001|Overall Study|Pregnancy|0|||
124810674|NCT01786668|448936227|FG002|Overall Study|Pregnancy|0|||
124810675|NCT01786668|448936228|FG003|Overall Study|Pregnancy|1|||
124810676|NCT01786668|448936225|FG000|Overall Study|Lost to Follow-up|1|||
124810677|NCT01786668|448936226|FG001|Overall Study|Lost to Follow-up|0|||
124810678|NCT01786668|448936227|FG002|Overall Study|Lost to Follow-up|1|||
124810679|NCT01786668|448936228|FG003|Overall Study|Lost to Follow-up|0|||
124810680|NCT00762385|448936229|FG000|First Intervention|Lens Issue|1|||
124810681|NCT00762385|448936230|FG001|First Intervention|Lens Issue|1|||
124810682|NCT00762385|448936229|FG000|First Intervention|Lost to Follow-up|0|||
124810683|NCT00762385|448936230|FG001|First Intervention|Lost to Follow-up|2|||
124810684|NCT00762385|448936229|FG000|First Intervention|Ineligible|1|||
124810685|NCT00762385|448936230|FG001|First Intervention|Ineligible|0|||
124810686|NCT00762385|448936229|FG000|First Intervention|Protocol Violation|0|||
124810687|NCT00762385|448936230|FG001|First Intervention|Protocol Violation|1|||
124810688|NCT00762385|448936229|FG000|Second Intervention|Protocol Violation|3|||
124810689|NCT00762385|448936230|FG001|Second Intervention|Protocol Violation|3|||
124810690|NCT01540838|448936231|FG000|Overall Study|Open nasogastric tube|9|||
124810691|NCT01540838|448936232|FG001|Overall Study|Open nasogastric tube|7|||
124810692|NCT01540838|448936231|FG000|Overall Study|Treatment doses missing|8|||
124810693|NCT01540838|448936232|FG001|Overall Study|Treatment doses missing|12|||
124810694|NCT01540838|448936231|FG000|Overall Study|Additional antibiotic treatment|1|||
124810695|NCT01540838|448936232|FG001|Overall Study|Additional antibiotic treatment|2|||
124810696|NCT01540838|448936231|FG000|Overall Study|Died before treatment initiation|1|||
124810697|NCT01540838|448936232|FG001|Overall Study|Died before treatment initiation|1|||
124810698|NCT01540838|448936231|FG000|Overall Study|Not BM. Other treatment|3|||
124810699|NCT01540838|448936232|FG001|Overall Study|Not BM. Other treatment|1|||
124810700|NCT02130570|448936233|FG000|Overall Study|Death|3|||
124810701|NCT02130570|448936234|FG001|Overall Study|Death|5|||
124810702|NCT02130570|448936233|FG000|Overall Study|Withdrawal by Subject|6|||
124810703|NCT02130570|448936234|FG001|Overall Study|Withdrawal by Subject|3|||
124810704|NCT02130570|448936233|FG000|Overall Study|Part of practice that discontinued study|0|||
124810705|NCT02130570|448936234|FG001|Overall Study|Part of practice that discontinued study|5|||
124810706|NCT01849783|448936235|FG000|Overall Study|Adverse Event|5|||
124810707|NCT01849783|448936235|FG000|Overall Study|Death|2|||
124810708|NCT01849783|448936235|FG000|Overall Study|Physician Decision|1|||
124810709|NCT01849783|448936235|FG000|Overall Study|Withdrawal by Subject|1|||
124810710|NCT01849783|448936235|FG000|Overall Study|Unable to comply|2|||
124810711|NCT01849783|448936235|FG000|Overall Study|Disease progression|11|||
124810712|NCT01776840|448936236|FG000|Overall Study|Lost to Follow-up|12|||
124810713|NCT01776840|448936237|FG001|Overall Study|Lost to Follow-up|7|||
124810714|NCT01776840|448936236|FG000|Overall Study|Withdrawal by Subject|32|||
124810715|NCT01776840|448936237|FG001|Overall Study|Withdrawal by Subject|48|||
124810716|NCT01776840|448936236|FG000|Overall Study|Sponsor decision|89|||
124810717|NCT01776840|448936237|FG001|Overall Study|Sponsor decision|87|||
124810718|NCT03641339|448936239|FG000|Overall Study|Physician Decision|1|||
124810719|NCT03641339|448936240|FG001|Overall Study|Physician Decision|0|||
124810720|NCT03641339|448936241|FG002|Overall Study|Physician Decision|0|||
124810721|NCT03641339|448936242|FG003|Overall Study|Physician Decision|0|||
124810722|NCT03641339|448936243|FG004|Overall Study|Physician Decision|0|||
124810723|NCT03641339|448936244|FG005|Overall Study|Physician Decision|0|||
124810724|NCT03641339|448936239|FG000|Overall Study|Withdrawal by Subject|0|||
124810725|NCT03641339|448936240|FG001|Overall Study|Withdrawal by Subject|2|||
124810726|NCT03641339|448936241|FG002|Overall Study|Withdrawal by Subject|0|||
124810727|NCT03641339|448936242|FG003|Overall Study|Withdrawal by Subject|2|||
124810728|NCT03641339|448936243|FG004|Overall Study|Withdrawal by Subject|0|||
124810729|NCT03641339|448936244|FG005|Overall Study|Withdrawal by Subject|1|||
124810730|NCT01042678|448936245|FG000|Overall Study|Physician Decision|1|||
124810731|NCT01042678|448936246|FG001|Overall Study|Physician Decision|0|||
124810732|NCT01042678|448936247|FG002|Overall Study|Physician Decision|0|||
124810733|NCT01042678|448936248|FG003|Overall Study|Physician Decision|0|||
124810734|NCT01042678|448936249|FG004|Overall Study|Physician Decision|0|||
124810735|NCT01042678|448936250|FG005|Overall Study|Physician Decision|0|||
124810736|NCT01058655|448936255|FG000|Overall Study|Withdrawal by Subject|1|||
124810737|NCT01058655|448936256|FG001|Overall Study|Withdrawal by Subject|0|||
124810738|NCT01058655|448936257|FG002|Overall Study|Withdrawal by Subject|3|||
124810739|NCT01058655|448936258|FG003|Overall Study|Withdrawal by Subject|4|||
124810740|NCT01058655|448936255|FG000|Overall Study|Prolonged Treatment Delay|0|||
124810741|NCT01058655|448936256|FG001|Overall Study|Prolonged Treatment Delay|0|||
124810742|NCT01058655|448936257|FG002|Overall Study|Prolonged Treatment Delay|0|||
124810743|NCT01058655|448936258|FG003|Overall Study|Prolonged Treatment Delay|2|||
124810744|NCT01058655|448936255|FG000|Overall Study|Symptomatic Deterioration|0|||
124810745|NCT01058655|448936256|FG001|Overall Study|Symptomatic Deterioration|0|||
124810746|NCT01058655|448936257|FG002|Overall Study|Symptomatic Deterioration|0|||
124810747|NCT01058655|448936258|FG003|Overall Study|Symptomatic Deterioration|1|||
124810748|NCT01058655|448936255|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
124810749|NCT01058655|448936256|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
124810750|NCT01058655|448936257|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
124810751|NCT01058655|448936258|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
124810752|NCT01058655|448936255|FG000|Overall Study|Death|0|||
124810753|NCT01058655|448936256|FG001|Overall Study|Death|1|||
124810754|NCT01058655|448936257|FG002|Overall Study|Death|1|||
124810755|NCT01058655|448936258|FG003|Overall Study|Death|0|||
124810756|NCT01058655|448936255|FG000|Overall Study|Disease Progression|1|||
124810757|NCT01058655|448936256|FG001|Overall Study|Disease Progression|2|||
124810758|NCT01058655|448936257|FG002|Overall Study|Disease Progression|4|||
124810759|NCT01058655|448936258|FG003|Overall Study|Disease Progression|24|||
124810760|NCT01058655|448936255|FG000|Overall Study|Other|0|||
124810761|NCT01058655|448936256|FG001|Overall Study|Other|0|||
124810762|NCT01058655|448936257|FG002|Overall Study|Other|0|||
124810763|NCT01058655|448936258|FG003|Overall Study|Other|4|||
124810764|NCT04545060|448936261|FG000|Overall Study|Adverse Event|0|||
124810765|NCT04545060|448936262|FG001|Overall Study|Adverse Event|1|||
124810766|NCT04545060|448936261|FG000|Overall Study|Death|0|||
124810767|NCT04545060|448936262|FG001|Overall Study|Death|5|||
124810768|NCT04545060|448936261|FG000|Overall Study|Lost to Follow-up|10|||
124810769|NCT04545060|448936262|FG001|Overall Study|Lost to Follow-up|13|||
124810770|NCT04545060|448936261|FG000|Overall Study|Physician Decision|3|||
124810771|NCT04545060|448936262|FG001|Overall Study|Physician Decision|0|||
124810772|NCT04545060|448936261|FG000|Overall Study|Withdrawal by Subject|17|||
124810773|NCT04545060|448936262|FG001|Overall Study|Withdrawal by Subject|22|||
124810774|NCT00619177|448936265|FG000|Overall Study|Adverse Event|18|||
124810775|NCT00619177|448936265|FG000|Overall Study|Lost to Follow-up|2|||
124810776|NCT00619177|448936265|FG000|Overall Study|Lack of Efficacy|1|||
124810777|NCT00619177|448936265|FG000|Overall Study|Missing termination information|481|||
124810778|NCT00619177|448936265|FG000|Overall Study|Not specified reasons|6|||
124810779|NCT02319837|448936266|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
124810780|NCT02319837|448936267|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
124810781|NCT02319837|448936268|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
124810782|NCT02319837|448936266|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
124810783|NCT02319837|448936267|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
124810784|NCT02319837|448936268|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
124810785|NCT02319837|448936266|FG000|Study Treatment Phase|Adverse Event|73|||
124810786|NCT02319837|448936267|FG001|Study Treatment Phase|Adverse Event|36|||
124810787|NCT02319837|448936268|FG002|Study Treatment Phase|Adverse Event|63|||
124810788|NCT02319837|448936266|FG000|Study Treatment Phase|Development of castration resistance|0|||
124810789|NCT02319837|448936267|FG001|Study Treatment Phase|Development of castration resistance|2|||
124810790|NCT02319837|448936268|FG002|Study Treatment Phase|Development of castration resistance|0|||
124810791|NCT02319837|448936266|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
124810792|NCT02319837|448936267|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
124810793|NCT02319837|448936268|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
124810794|NCT02319837|448936266|FG000|Study Treatment Phase|Protocol Violation|2|||
124810795|NCT02319837|448936267|FG001|Study Treatment Phase|Protocol Violation|2|||
124810796|NCT02319837|448936268|FG002|Study Treatment Phase|Protocol Violation|1|||
124810797|NCT02319837|448936266|FG000|Study Treatment Phase|Lost to Follow-up|0|||
124810798|NCT02319837|448936267|FG001|Study Treatment Phase|Lost to Follow-up|1|||
124810799|NCT02319837|448936268|FG002|Study Treatment Phase|Lost to Follow-up|0|||
124810800|NCT02319837|448936266|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
124810801|NCT02319837|448936267|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
124810802|NCT02319837|448936268|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
124810803|NCT02319837|448936266|FG000|Study Treatment Phase|Other|0|||
124810804|NCT02319837|448936267|FG001|Study Treatment Phase|Other|1|||
124810805|NCT02319837|448936268|FG002|Study Treatment Phase|Other|0|||
124810806|NCT02319837|448936266|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
124810807|NCT02319837|448936267|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
124810808|NCT02319837|448936268|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
124810809|NCT02319837|448936266|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
124810810|NCT02319837|448936267|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
124810811|NCT02319837|448936268|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
124810812|NCT02319837|448936266|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
124810813|NCT02319837|448936267|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
124810814|NCT02319837|448936268|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
124810815|NCT02319837|448936266|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
124810816|NCT02319837|448936267|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
124810817|NCT02319837|448936268|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
124810818|NCT02319837|448936266|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
124810819|NCT02319837|448936267|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
125300184|NCT00704288|450725904|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
125300185|NCT00704288|450725902|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
125300186|NCT00704288|450725903|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
125300187|NCT00704288|450725904|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
125300188|NCT00704288|450725902|FG000|Overall Treatment Period|Roll-over to another study|1|||
125300189|NCT00704288|450725903|FG001|Overall Treatment Period|Roll-over to another study|0|||
125300190|NCT00704288|450725904|FG002|Overall Treatment Period|Roll-over to another study|4|||
125300191|NCT00704288|450725902|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
125300192|NCT00704288|450725903|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
125300193|NCT00704288|450725904|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
125300194|NCT00704288|450725902|FG000|Extended Post Treatment Follow Up Period|Death|41|||
125300195|NCT00704288|450725903|FG001|Extended Post Treatment Follow Up Period|Death|50|||
125300196|NCT00704288|450725904|FG002|Extended Post Treatment Follow Up Period|Death|93|||
125300197|NCT00704288|450725902|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
125300198|NCT00704288|450725903|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
125300199|NCT00704288|450725904|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
125300200|NCT00704288|450725902|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
125300201|NCT00704288|450725903|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
125300202|NCT00704288|450725904|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
125300203|NCT00704288|450725902|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
125300204|NCT00704288|450725903|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
125300205|NCT00704288|450725904|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
125300206|NCT04395690|450725905|FG000|Overall Study|Lost to Follow-up|1|||
125300207|NCT04395690|450725906|FG001|Overall Study|Lost to Follow-up|1|||
125300208|NCT03387020|450725908|FG000|Overall Study|Adverse Event|0|||
125300209|NCT03387020|450725909|FG001|Overall Study|Adverse Event|2|||
125300210|NCT03387020|450725910|FG002|Overall Study|Adverse Event|0|||
125300211|NCT03387020|450725908|FG000|Overall Study|Withdrawal by Subject|2|||
124810820|NCT02319837|448936268|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
124810821|NCT02319837|448936266|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
124810822|NCT02319837|448936267|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
124810823|NCT02319837|448936268|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
124810824|NCT02319837|448936266|FG000|Long-Term Follow-Up Phase|Death|33|||
124810825|NCT02319837|448936267|FG001|Long-Term Follow-Up Phase|Death|54|||
124810826|NCT02319837|448936268|FG002|Long-Term Follow-Up Phase|Death|42|||
124810827|NCT00892047|448936269|FG000|Overall Study|Adverse Event|2|||
124810828|NCT00892047|448936270|FG001|Overall Study|Adverse Event|2|||
124810829|NCT00892047|448936269|FG000|Overall Study|subject burden|2|||
124810830|NCT00892047|448936270|FG001|Overall Study|subject burden|3|||
124810831|NCT00892047|448936269|FG000|Overall Study|Lack of Efficacy|0|||
124810832|NCT00892047|448936270|FG001|Overall Study|Lack of Efficacy|2|||
124810833|NCT05306977|448936271|FG000|Overall Study|Withdrawal by Subject|1|||
124810834|NCT01387789|448936277|FG000|Overall Study|Adverse Event|5|||
124810835|NCT01387789|448936277|FG000|Overall Study|Lack of Efficacy|2|||
124810836|NCT01387789|448936277|FG000|Overall Study|Lost to Follow-up|1|||
124810837|NCT00181155|448936278|FG000|Overall Study|Physician Decision|1|||
124810838|NCT00181155|448936279|FG001|Overall Study|Physician Decision|0|||
124810839|NCT00181155|448936278|FG000|Overall Study|Withdrawal by Subject|1|||
124810840|NCT00181155|448936279|FG001|Overall Study|Withdrawal by Subject|0|||
124810841|NCT01788228|448936280|FG000|Overall Study|Migrated/moved from study area|1|||
124810842|NCT01788228|448936281|FG001|Overall Study|Migrated/moved from study area|0|||
124810843|NCT01548287|448936284|FG000|Screening|No reason provided|0|||
124810844|NCT01548287|448936285|FG001|Screening|No reason provided|0|||
124810845|NCT01548287|448936286|FG002|Screening|No reason provided|0|||
124810846|NCT01548287|448936287|FG003|Screening|No reason provided|0|||
124810847|NCT01548287|448936288|FG004|Screening|No reason provided|9|||
124810848|NCT01548287|448936284|FG000|Screening|Did not meet eligibility criteria|0|||
124810849|NCT01548287|448936285|FG001|Screening|Did not meet eligibility criteria|0|||
124810850|NCT01548287|448936286|FG002|Screening|Did not meet eligibility criteria|0|||
124810851|NCT01548287|448936287|FG003|Screening|Did not meet eligibility criteria|0|||
124810852|NCT01548287|448936288|FG004|Screening|Did not meet eligibility criteria|74|||
124810853|NCT01548287|448936284|FG000|Randomized Period|Did not meet inclusion criteria|0|||
124810854|NCT01548287|448936285|FG001|Randomized Period|Did not meet inclusion criteria|0|||
124810855|NCT01548287|448936286|FG002|Randomized Period|Did not meet inclusion criteria|2|||
124810856|NCT01548287|448936287|FG003|Randomized Period|Did not meet inclusion criteria|0|||
124810857|NCT01548287|448936288|FG004|Randomized Period|Did not meet inclusion criteria|0|||
124810858|NCT01548287|448936284|FG000|Randomized Period|Adverse Event|0|||
124810859|NCT01548287|448936285|FG001|Randomized Period|Adverse Event|2|||
124810860|NCT01548287|448936286|FG002|Randomized Period|Adverse Event|5|||
124810861|NCT01548287|448936287|FG003|Randomized Period|Adverse Event|0|||
124810862|NCT01548287|448936288|FG004|Randomized Period|Adverse Event|0|||
124810863|NCT00289783|448936292|FG000|Primary Phase|Adverse Event|10|||
124810864|NCT00289783|448936293|FG001|Primary Phase|Adverse Event|1|||
124810865|NCT00289783|448936292|FG000|Primary Phase|Protocol Violation|27|||
124810866|NCT00289783|448936293|FG001|Primary Phase|Protocol Violation|6|||
124810867|NCT00289783|448936292|FG000|Primary Phase|Withdrawal by Subject|93|||
124810868|NCT00289783|448936293|FG001|Primary Phase|Withdrawal by Subject|40|||
124810869|NCT00289783|448936292|FG000|Primary Phase|Lost to Follow-up|60|||
125300212|NCT03387020|450725909|FG001|Overall Study|Withdrawal by Subject|0|||
125300213|NCT03387020|450725910|FG002|Overall Study|Withdrawal by Subject|0|||
124810870|NCT00289783|448936293|FG001|Primary Phase|Lost to Follow-up|14|||
124810871|NCT00289783|448936292|FG000|Primary Phase|Migration from the study area|26|||
124810872|NCT00289783|448936293|FG001|Primary Phase|Migration from the study area|10|||
124810873|NCT00289783|448936292|FG000|Primary Phase|Other|32|||
124810874|NCT00289783|448936293|FG001|Primary Phase|Other|12|||
124810875|NCT00289783|448936292|FG000|Fourth Dose Phase|Adverse Event|1|||
124810876|NCT00289783|448936293|FG001|Fourth Dose Phase|Adverse Event|0|||
124810877|NCT00289783|448936292|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
124810878|NCT00289783|448936293|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
124810879|NCT00289783|448936292|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
125300214|NCT00434642|450725911|FG000|Blinded Treatment Phase|Adverse Event|12|||
124810880|NCT00289783|448936293|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
124810881|NCT00289783|448936292|FG000|Fourth Dose Phase|Migration from the study area|1|||
124810882|NCT00289783|448936293|FG001|Fourth Dose Phase|Migration from the study area|1|||
124810883|NCT00289783|448936292|FG000|Fourth Dose Phase|Other|22|||
124810884|NCT00289783|448936293|FG001|Fourth Dose Phase|Other|10|||
124810885|NCT00566995|448936296|FG000|Overall Study|Toxicity|4|||
124810886|NCT00566995|448936296|FG000|Overall Study|Withdrew consent|3|||
124810887|NCT03128047|448936297|FG000|Overall Study|Withdrawal by Subject|1|||
124810888|NCT01995825|448937606|FG000|Overall Study|Withdrawal by Subject|1|||
124810889|NCT01995825|448937607|FG001|Overall Study|Withdrawal by Subject|0|||
124810890|NCT00560105|448937610|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
124810891|NCT00560105|448937611|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
124810892|NCT02400333|448937614|FG000|Overall Study|Withdrawal by Subject|0|||
124810893|NCT02400333|448937615|FG001|Overall Study|Withdrawal by Subject|1|||
124810894|NCT02400333|448937616|FG002|Overall Study|Withdrawal by Subject|0|||
124810895|NCT02400333|448937617|FG003|Overall Study|Withdrawal by Subject|1|||
124810896|NCT02400333|448937614|FG000|Overall Study|Protocol Violation|1|||
124810897|NCT02400333|448937615|FG001|Overall Study|Protocol Violation|0|||
124810898|NCT02400333|448937616|FG002|Overall Study|Protocol Violation|2|||
124810899|NCT02400333|448937617|FG003|Overall Study|Protocol Violation|1|||
124810900|NCT01034631|448937624|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
124810901|NCT01034631|448937625|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
124810902|NCT01034631|448937626|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
124810903|NCT01034631|448937624|FG000|Phase II|Not Evaluable per protocol|0|||
124810904|NCT01034631|448937625|FG001|Phase II|Not Evaluable per protocol|0|||
124810905|NCT01034631|448937626|FG002|Phase II|Not Evaluable per protocol|2|||
124810906|NCT01034631|448937624|FG000|Phase II|Determined Ineligible per protocol|0|||
124810907|NCT01034631|448937625|FG001|Phase II|Determined Ineligible per protocol|1|||
124810908|NCT01034631|448937626|FG002|Phase II|Determined Ineligible per protocol|0|||
124810909|NCT01560403|448937627|FG000|Overall Study|Lost to Follow-up|0|||
124810910|NCT01560403|448937628|FG001|Overall Study|Lost to Follow-up|1|||
124810911|NCT00983437|448937629|FG000|Overall Study|Adverse Event|9|||
124810912|NCT00983437|448937629|FG000|Overall Study|Lack of Efficacy|1|||
124810913|NCT00983437|448937629|FG000|Overall Study|Withdrawal by Subject|8|||
124810914|NCT00983437|448937629|FG000|Overall Study|Noncompliance to Study Procedures|1|||
124810915|NCT00983437|448937629|FG000|Overall Study|Lost to Follow-up|2|||
124810916|NCT00983437|448937629|FG000|Overall Study|Other Reason|26|||
124810917|NCT01890473|448937630|FG000|Overall Study|Lost to Follow-up|1|||
124810918|NCT01890473|448937631|FG001|Overall Study|Lost to Follow-up|0|||
124810919|NCT01890473|448937630|FG000|Overall Study|Poor/non-compliance|1|||
124810920|NCT01890473|448937631|FG001|Overall Study|Poor/non-compliance|0|||
124810921|NCT04019288|448937632|FG000|Overall Study|Death|1|||
124810922|NCT04019288|448937633|FG001|Overall Study|Death|0|||
124810923|NCT04019288|448937634|FG002|Overall Study|Death|0|||
124810924|NCT00934089|448937635|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
124810925|NCT00934089|448937636|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
124810926|NCT00934089|448937635|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
124810927|NCT00934089|448937636|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
124810928|NCT00541931|448937642|FG000|Overall Study|Adverse Event|1|||
124810929|NCT00541931|448937643|FG001|Overall Study|Adverse Event|0|||
124810930|NCT00541931|448937642|FG000|Overall Study|Lost to Follow-up|3|||
124810931|NCT00541931|448937643|FG001|Overall Study|Lost to Follow-up|3|||
124810932|NCT00541931|448937642|FG000|Overall Study|Withdrawal by Subject|1|||
124810933|NCT00541931|448937643|FG001|Overall Study|Withdrawal by Subject|0|||
124810934|NCT00541931|448937642|FG000|Overall Study|Transportation Issue|0|||
124810935|NCT00541931|448937643|FG001|Overall Study|Transportation Issue|1|||
124810936|NCT00040365|448937644|FG000|Overall Study|Death|1|||
124810937|NCT00040365|448937644|FG000|Overall Study|Progressive disease|7|||
124810938|NCT00040365|448937644|FG000|Overall Study|Lost to Follow-up|3|||
124810939|NCT00680017|448937645|FG000|Overall Study|Adverse Event|13|||
124810940|NCT00680017|448937646|FG001|Overall Study|Adverse Event|7|||
124810941|NCT00680017|448937645|FG000|Overall Study|Withdrawal by Subject|2|||
124810942|NCT00680017|448937646|FG001|Overall Study|Withdrawal by Subject|5|||
124810943|NCT00680017|448937645|FG000|Overall Study|Lost to Follow-up|2|||
124810944|NCT00680017|448937646|FG001|Overall Study|Lost to Follow-up|0|||
124810945|NCT00612040|448937647|FG000|Overall Study|Adverse Event|0|||
124810946|NCT00612040|448937648|FG001|Overall Study|Adverse Event|2|||
124810947|NCT00612040|448937649|FG002|Overall Study|Adverse Event|1|||
124810948|NCT00612040|448937647|FG000|Overall Study|Protocol Violation|1|||
124810949|NCT00612040|448937648|FG001|Overall Study|Protocol Violation|2|||
124810950|NCT00612040|448937649|FG002|Overall Study|Protocol Violation|1|||
124810951|NCT00612040|448937647|FG000|Overall Study|Lack of Efficacy|2|||
124810952|NCT00612040|448937648|FG001|Overall Study|Lack of Efficacy|1|||
124810953|NCT00612040|448937649|FG002|Overall Study|Lack of Efficacy|0|||
124810954|NCT00612040|448937647|FG000|Overall Study|Unclassified|2|||
124810955|NCT00612040|448937648|FG001|Overall Study|Unclassified|2|||
124810956|NCT00612040|448937649|FG002|Overall Study|Unclassified|5|||
124810957|NCT01086033|448937651|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
124810958|NCT01086033|448937651|FG000|Overall Study|Lost to Follow-up|86|||
124810959|NCT01086033|448937651|FG000|Overall Study|Adverse Event|42|||
124810960|NCT01086033|448937651|FG000|Overall Study|Withdrawal by Subject|41|||
124810961|NCT01086033|448937651|FG000|Overall Study|Other|14|||
124810962|NCT01086033|448937651|FG000|Overall Study|Other|13|||
124810963|NCT01086033|448937651|FG000|Overall Study|AE and Withdrew Consent|5|||
124810964|NCT01086033|448937651|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
124810965|NCT01086033|448937651|FG000|Overall Study|Withdrew consent and Other Reason|4|||
124810966|NCT01086033|448937651|FG000|Overall Study|AE and Lack of Efficacy|4|||
124810967|NCT01086033|448937651|FG000|Overall Study|Death|1|||
124810968|NCT01086033|448937651|FG000|Overall Study|AE and Lost to Follow-up|1|||
124810969|NCT01086033|448937651|FG000|Overall Study|AE and Other Reason|1|||
124810970|NCT01086033|448937651|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
124810971|NCT04572633|448937652|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
124810972|NCT03478657|448937658|FG000|Overall Study|Withdrawal by Subject|0|||
124810973|NCT03478657|448937659|FG001|Overall Study|Withdrawal by Subject|1|||
124810974|NCT02590003|448937660|FG000|Overall Study|Death|1|||
124810975|NCT02590003|448937661|FG001|Overall Study|Death|2|||
124810976|NCT03570697|448937662|FG000|Overall Study|Lost to Follow-up|0|||
124810977|NCT03570697|448937663|FG001|Overall Study|Lost to Follow-up|1|||
124810978|NCT03570697|448937662|FG000|Overall Study|Death|2|||
124810979|NCT03570697|448937663|FG001|Overall Study|Death|0|||
124810980|NCT03570697|448937662|FG000|Overall Study|Withdrawal by Subject|4|||
124810981|NCT03570697|448937663|FG001|Overall Study|Withdrawal by Subject|2|||
124810982|NCT03948581|448937664|FG000|Overall Study|Lost to Follow-up|0|||
124810983|NCT03948581|448937665|FG001|Overall Study|Lost to Follow-up|1|||
124810984|NCT03068455|448937666|FG000|Pre-treatment Period|Disease progression|0|||
124810985|NCT03068455|448937667|FG001|Pre-treatment Period|Disease progression|1|||
124810986|NCT03068455|448937666|FG000|Pre-treatment Period|Participant withdrew consent|1|||
124810987|NCT03068455|448937667|FG001|Pre-treatment Period|Participant withdrew consent|1|||
124810988|NCT03068455|448937666|FG000|Pre-treatment Period|Poor/non-compliance|0|||
124810989|NCT03068455|448937667|FG001|Pre-treatment Period|Poor/non-compliance|1|||
124810990|NCT03068455|448937666|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
124810991|NCT03068455|448937667|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
124810992|NCT03068455|448937666|FG000|Pre-treatment Period|Not reported|2|||
124810993|NCT03068455|448937667|FG001|Pre-treatment Period|Not reported|1|||
124810994|NCT03068455|448937666|FG000|Treatment Period|Disease progression|166|||
124810995|NCT03068455|448937667|FG001|Treatment Period|Disease progression|208|||
124810996|NCT03068455|448937666|FG000|Treatment Period|Study drug toxicity|317|||
124810997|NCT03068455|448937667|FG001|Treatment Period|Study drug toxicity|104|||
124810998|NCT03068455|448937666|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
124810999|NCT03068455|448937667|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
124811000|NCT03068455|448937666|FG000|Treatment Period|Participant request to stop therapy|33|||
124811001|NCT03068455|448937667|FG001|Treatment Period|Participant request to stop therapy|20|||
124811002|NCT03068455|448937666|FG000|Treatment Period|Participant withdrew consent|5|||
124811003|NCT03068455|448937667|FG001|Treatment Period|Participant withdrew consent|10|||
124811004|NCT03068455|448937666|FG000|Treatment Period|Poor/non-compliance|3|||
124811005|NCT03068455|448937667|FG001|Treatment Period|Poor/non-compliance|0|||
124811006|NCT03068455|448937666|FG000|Treatment Period|Participant no longer meets study criteria|1|||
124811007|NCT03068455|448937667|FG001|Treatment Period|Participant no longer meets study criteria|3|||
124811008|NCT03068455|448937666|FG000|Treatment Period|Other reasons|12|||
124811009|NCT03068455|448937667|FG001|Treatment Period|Other reasons|4|||
124811010|NCT01876420|448937669|FG000|Overall Study|Missed 30 day visit|1|||
124811011|NCT04472429|448937670|FG000|Randomized Period|Ongoing|90|||
124811012|NCT04472429|448937671|FG001|Randomized Period|Ongoing|40|||
124811013|NCT04472429|448937672|FG002|Randomized Period|Ongoing|0|||
124811014|NCT04472429|448937670|FG000|Randomized Period|Death|52|||
124811015|NCT04472429|448937671|FG001|Randomized Period|Death|37|||
124811016|NCT04472429|448937672|FG002|Randomized Period|Death|0|||
124811017|NCT04472429|448937670|FG000|Randomized Period|Lost to Follow-up|4|||
124811018|NCT04472429|448937671|FG001|Randomized Period|Lost to Follow-up|0|||
124811019|NCT04472429|448937672|FG002|Randomized Period|Lost to Follow-up|0|||
124811020|NCT04472429|448937670|FG000|Randomized Period|Physician Decision|1|||
124811021|NCT04472429|448937671|FG001|Randomized Period|Physician Decision|2|||
124811022|NCT04472429|448937672|FG002|Randomized Period|Physician Decision|0|||
124811023|NCT04472429|448937670|FG000|Randomized Period|Withdrawal by Subject|6|||
124811024|NCT04472429|448937671|FG001|Randomized Period|Withdrawal by Subject|5|||
124811025|NCT04472429|448937672|FG002|Randomized Period|Withdrawal by Subject|0|||
124811026|NCT04472429|448937670|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
124811027|NCT04472429|448937671|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
124811028|NCT04472429|448937672|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
124811029|NCT04472429|448937670|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
124811030|NCT04472429|448937671|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
124811031|NCT04472429|448937672|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
124811032|NCT04472429|448937670|FG000|Open-label Monotherapy Period|Ongoing|0|||
124811033|NCT04472429|448937671|FG001|Open-label Monotherapy Period|Ongoing|0|||
124811034|NCT04472429|448937672|FG002|Open-label Monotherapy Period|Ongoing|32|||
124811035|NCT04472429|448937670|FG000|Open-label Monotherapy Period|Death|0|||
124811036|NCT04472429|448937671|FG001|Open-label Monotherapy Period|Death|0|||
124811037|NCT04472429|448937672|FG002|Open-label Monotherapy Period|Death|35|||
124811038|NCT04472429|448937670|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
124811039|NCT04472429|448937671|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
124811040|NCT04472429|448937672|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
124811041|NCT01416272|448937675|FG000|Overall Study|Unacceptable distance visual acuity|2|||
124811042|NCT01416272|448937675|FG000|Overall Study|Lost to Follow-up|1|||
124811043|NCT01416272|448937675|FG000|Overall Study|Study related complaints|1|||
124811044|NCT01719783|448937676|FG000|Dose 2|Physician Decision|1|||
124811045|NCT01719783|448937677|FG001|Dose 2|Physician Decision|0|||
124811046|NCT01313312|448937678|FG000|Overall Study|Adverse Event|5|||
124811047|NCT01313312|448937678|FG000|Overall Study|Withdrawal by Subject|18|||
124811048|NCT01313312|448937678|FG000|Overall Study|Lack of Efficacy|3|||
124811049|NCT01313312|448937678|FG000|Overall Study|Investigator Decision|1|||
124811050|NCT01313312|448937678|FG000|Overall Study|Observational Phase|1|||
124811051|NCT01313312|448937678|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
124811052|NCT01313312|448937678|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
124811053|NCT01612858|448937680|FG000|Overall Study|Withdrawal by Subject|5|||
124811054|NCT01612858|448937681|FG001|Overall Study|Withdrawal by Subject|1|||
124811055|NCT03988088|448937682|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
124811056|NCT03988088|448937683|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
124811057|NCT03988088|448937684|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
124811058|NCT03988088|448937685|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
124811059|NCT03988088|448937682|FG000|Open-Label Addendum|Lost to Follow-up|0|||
124811060|NCT03988088|448937683|FG001|Open-Label Addendum|Lost to Follow-up|0|||
124811061|NCT03988088|448937684|FG002|Open-Label Addendum|Lost to Follow-up|1|||
124811062|NCT03988088|448937685|FG003|Open-Label Addendum|Lost to Follow-up|0|||
124811063|NCT03113071|448937686|FG000|Overall Study|Withdrawal by Subject|1|||
124811064|NCT03113071|448937687|FG001|Overall Study|Withdrawal by Subject|0|||
124811065|NCT00868608|448937694|FG000|Overall Study|Withdrawal by Subject|3|||
124811066|NCT00868608|448937695|FG001|Overall Study|Withdrawal by Subject|1|||
124811067|NCT00868608|448937696|FG002|Overall Study|Withdrawal by Subject|0|||
124811068|NCT00868608|448937694|FG000|Overall Study|Lost to Follow-up|3|||
124811069|NCT00868608|448937695|FG001|Overall Study|Lost to Follow-up|0|||
124811070|NCT00868608|448937696|FG002|Overall Study|Lost to Follow-up|1|||
124811071|NCT00868608|448937694|FG000|Overall Study|Death|16|||
124811072|NCT00868608|448937695|FG001|Overall Study|Death|2|||
124811073|NCT00868608|448937696|FG002|Overall Study|Death|4|||
124811074|NCT00868608|448937694|FG000|Overall Study|Other - Unspecified|1|||
124811075|NCT00868608|448937695|FG001|Overall Study|Other - Unspecified|0|||
124811076|NCT00868608|448937696|FG002|Overall Study|Other - Unspecified|0|||
124811077|NCT03344796|448937697|FG000|Overall Study|Lost to Follow-up|0|||
124811078|NCT03344796|448937698|FG001|Overall Study|Lost to Follow-up|0|||
124811079|NCT03344796|448937699|FG002|Overall Study|Lost to Follow-up|0|||
124811080|NCT03344796|448937700|FG003|Overall Study|Lost to Follow-up|0|||
124811081|NCT03344796|448937701|FG004|Overall Study|Lost to Follow-up|0|||
124811082|NCT03344796|448937702|FG005|Overall Study|Lost to Follow-up|2|||
124811083|NCT01999179|448937703|FG000|Overall Study|Adverse Event|1|||
124811084|NCT01999179|448937703|FG000|Overall Study|Lost to Follow-up|1|||
124811085|NCT01999179|448937703|FG000|Overall Study|Change in Therapy|3|||
124811086|NCT01999179|448937703|FG000|Overall Study|New catheter|2|||
124811087|NCT02564796|448937707|FG000|Overall Study|Physician Decision|2|||
124811088|NCT02564796|448937708|FG001|Overall Study|Physician Decision|2|||
124811089|NCT00594659|448937716|FG000|Overall Study|Lost to Follow-up|13|||
124811090|NCT00594659|448937717|FG001|Overall Study|Lost to Follow-up|9|||
124811091|NCT00594659|448937718|FG002|Overall Study|Lost to Follow-up|7|||
124811092|NCT00660699|448937719|FG000|Overall Study|Withdrawal by Subject|2|||
124811093|NCT05358444|448937730|FG000|Overall Study|Withdrawal by Subject|0|||
124811094|NCT05358444|448937731|FG001|Overall Study|Withdrawal by Subject|1|||
124811095|NCT05358444|448937730|FG000|Overall Study|Lost to Follow-up|0|||
124811096|NCT05358444|448937731|FG001|Overall Study|Lost to Follow-up|3|||
124811097|NCT02900976|448937734|FG000|Overall Study|Adverse Event|0|||
124811098|NCT02900976|448937735|FG001|Overall Study|Adverse Event|1|||
124811099|NCT02900976|448937734|FG000|Overall Study|Physician Decision|0|||
124811100|NCT02900976|448937735|FG001|Overall Study|Physician Decision|2|||
124811101|NCT02900976|448937734|FG000|Overall Study|Progressive disease|0|||
124811102|NCT02900976|448937735|FG001|Overall Study|Progressive disease|6|||
125300215|NCT00434642|450725912|FG001|Blinded Treatment Phase|Adverse Event|58|||
125300216|NCT00434642|450725911|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
125300217|NCT00434642|450725912|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
125300218|NCT00434642|450725911|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
125300219|NCT00434642|450725912|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
125300220|NCT00434642|450725911|FG000|Blinded Treatment Phase|Physician Decision|19|||
125300221|NCT00434642|450725912|FG001|Blinded Treatment Phase|Physician Decision|27|||
125300222|NCT00434642|450725911|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
125300223|NCT00434642|450725912|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
124811112|NCT04997304|448937739|FG000|Overall Study|Lost to Follow-up|11|||
124811113|NCT04997304|448937739|FG000|Overall Study|Death|1|||
124811114|NCT04997304|448937739|FG000|Overall Study|Withdrawal by Subject|14|||
124811115|NCT01752985|448937740|FG000|Treatment Period|Subject request to discontinue treatment|1|||
124811116|NCT01752985|448937741|FG001|Treatment Period|Subject request to discontinue treatment|0|||
124811117|NCT01752985|448937742|FG002|Treatment Period|Subject request to discontinue treatment|1|||
124811118|NCT01752985|448937740|FG000|Treatment Period|Subject no longer meets study criteria|0|||
124811119|NCT01752985|448937741|FG001|Treatment Period|Subject no longer meets study criteria|1|||
124811120|NCT01752985|448937742|FG002|Treatment Period|Subject no longer meets study criteria|1|||
124811121|NCT01752985|448937740|FG000|Treatment Period|Adverse Event|2|||
124811122|NCT01752985|448937741|FG001|Treatment Period|Adverse Event|1|||
124811123|NCT01752985|448937742|FG002|Treatment Period|Adverse Event|2|||
124811124|NCT01752985|448937740|FG000|Treatment Period|Withdrawal by Subject|1|||
124811125|NCT01752985|448937741|FG001|Treatment Period|Withdrawal by Subject|1|||
124811126|NCT01752985|448937742|FG002|Treatment Period|Withdrawal by Subject|0|||
124811127|NCT01752985|448937740|FG000|Treatment Period|Lost to Follow-up|0|||
124811128|NCT01752985|448937741|FG001|Treatment Period|Lost to Follow-up|0|||
124811129|NCT01752985|448937742|FG002|Treatment Period|Lost to Follow-up|1|||
124811130|NCT06934993|448937743|FG000|Overall Study|Withdrawal by Subject|29|||
124811131|NCT06934993|448937743|FG000|Overall Study|elevated postoperative creatinine level|11|||
124811132|NCT06934993|448937743|FG000|Overall Study|Death|3|||
124811133|NCT04092582|448939237|FG000|Overall Study|Death|1|||
124811134|NCT04092582|448939238|FG001|Overall Study|Death|1|||
124811135|NCT04092582|448939237|FG000|Overall Study|Withdrawal by Subject|4|||
124811136|NCT04092582|448939238|FG001|Overall Study|Withdrawal by Subject|1|||
124811137|NCT04092582|448939237|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
124811138|NCT04092582|448939238|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
124811139|NCT01871532|448939248|FG000|Overall Study|Withdrawal by Subject|1|||
124811140|NCT01871532|448939249|FG001|Overall Study|Withdrawal by Subject|2|||
124811141|NCT00283400|448939250|FG000|Overall Study|Withdrawal by Subject|1|||
124811142|NCT00283400|448939251|FG001|Overall Study|Withdrawal by Subject|1|||
124811143|NCT00283400|448939252|FG002|Overall Study|Withdrawal by Subject|0|||
124811144|NCT00283400|448939253|FG003|Overall Study|Withdrawal by Subject|0|||
124811145|NCT00283400|448939250|FG000|Overall Study|Death|1|||
124811146|NCT00283400|448939251|FG001|Overall Study|Death|0|||
124811147|NCT00283400|448939252|FG002|Overall Study|Death|1|||
124811148|NCT00283400|448939253|FG003|Overall Study|Death|0|||
124811149|NCT04401423|448939254|FG000|Overall Study|Withdrawal by Subject|3|||
124811150|NCT04401423|448939255|FG001|Overall Study|Withdrawal by Subject|1|||
124811151|NCT04401423|448939254|FG000|Overall Study|Physician Decision|2|||
124811152|NCT04401423|448939255|FG001|Overall Study|Physician Decision|1|||
124811153|NCT01020981|448939256|FG000|Overall Study|Did not return mailed survey|74|||
124811154|NCT01020981|448939257|FG001|Overall Study|Did not return mailed survey|58|||
124811155|NCT01020981|448939256|FG000|Overall Study|Survey returned undeliverable|8|||
124811156|NCT01020981|448939257|FG001|Overall Study|Survey returned undeliverable|32|||
124811157|NCT01020981|448939256|FG000|Overall Study|Participant declined to complete survey|2|||
124811158|NCT01020981|448939257|FG001|Overall Study|Participant declined to complete survey|0|||
124811159|NCT00064337|448939260|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
124811160|NCT00064337|448939260|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
124811161|NCT00064337|448939260|FG000|PBSCC or Induction/PBSCC|Progression|3|||
124811162|NCT00064337|448939260|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
124811163|NCT00064337|448939260|FG000|PBSCC or Induction/PBSCC|Death|2|||
124811164|NCT00064337|448939260|FG000|Transplant|Adverse Event|9|||
124811165|NCT00064337|448939260|FG000|Transplant|Not protocol-specified|5|||
124811166|NCT00064337|448939260|FG000|Transplant|Death|3|||
124811167|NCT00064337|448939260|FG000|Transplant|Patient Refusal|2|||
124811168|NCT00064337|448939260|FG000|Transplant|Progression|2|||
124811169|NCT00064337|448939260|FG000|Maintenance|Adverse Event|3|||
124811170|NCT00064337|448939260|FG000|Maintenance|Progression|2|||
124811171|NCT00064337|448939260|FG000|Maintenance|On treatment at time of analysis|2|||
124811172|NCT00064337|448939260|FG000|Maintenance|Not protocol-specified|2|||
124811173|NCT00064337|448939260|FG000|Maintenance|Death|1|||
124811174|NCT02279420|448939261|FG000|Overall Study|Lost to Follow-up|23|||
124811175|NCT05096221|448939264|FG000|Part 2|Physician Decision|0|||
124811176|NCT05096221|448939265|FG001|Part 2|Physician Decision|1|||
124811177|NCT01896102|448939266|FG000|Overall Study|Death|1|||
124811178|NCT01896102|448939266|FG000|Overall Study|Participant to receive allogenic transplant|2|||
124811179|NCT04515394|448939281|FG000|Overall Study|Participant did not receive treatment|1|||
124811180|NCT03330288|448939282|FG000|Overall Study|Other reason|1|||
124811181|NCT03330288|448939283|FG001|Overall Study|Other reason|1|||
124811182|NCT03330288|448939282|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
124811183|NCT03330288|448939283|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
124811184|NCT03330288|448939282|FG000|Overall Study|Adverse Event|1|||
124811185|NCT03330288|448939283|FG001|Overall Study|Adverse Event|0|||
124811186|NCT03330288|448939282|FG000|Overall Study|Withdrawal by Subject|1|||
124811187|NCT03330288|448939283|FG001|Overall Study|Withdrawal by Subject|0|||
124811188|NCT03330288|448939282|FG000|Overall Study|Lost to Follow-up|26|||
124811189|NCT03330288|448939283|FG001|Overall Study|Lost to Follow-up|7|||
124811190|NCT01254331|448939290|FG000|Initial Phase|Adverse Event|3|||
124811191|NCT01254331|448939290|FG000|Initial Phase|Withdrawal by Subject|1|||
124811192|NCT01254331|448939290|FG000|Initial Phase|Pregnancy|1|||
124811193|NCT01254331|448939290|FG000|Extension Phase|Lack of Efficacy|1|||
124811194|NCT01254331|448939290|FG000|Extension Phase|Lost to Follow-up|3|||
124811195|NCT01443078|448939291|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
124811196|NCT01443078|448939291|FG000|Overall Study|Withdrawal by Subject|1|||
124811197|NCT01443078|448939291|FG000|Overall Study|Patient had brain mets|1|||
124811198|NCT02993757|448939303|FG000|Overall Study|Non compliance with the protocol|155|||
124811199|NCT02993757|448939304|FG001|Overall Study|Non compliance with the protocol|170|||
124811200|NCT02993757|448939303|FG000|Overall Study|Lost to Follow-up|1|||
124811201|NCT02993757|448939304|FG001|Overall Study|Lost to Follow-up|0|||
124811202|NCT02993757|448939303|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
124811203|NCT02993757|448939304|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
124811204|NCT02762578|448939305|FG000|Overall Study|Adverse Event|1|||
124811205|NCT02762578|448939306|FG001|Overall Study|Adverse Event|6|||
124811206|NCT02762578|448939305|FG000|Overall Study|Protocol Violation|4|||
124811207|NCT02762578|448939306|FG001|Overall Study|Protocol Violation|2|||
124811208|NCT02762578|448939305|FG000|Overall Study|Withdrawal by Subject|4|||
124811209|NCT02762578|448939306|FG001|Overall Study|Withdrawal by Subject|2|||
124811210|NCT02762578|448939305|FG000|Overall Study|Unclassified|6|||
124811211|NCT02762578|448939306|FG001|Overall Study|Unclassified|0|||
124811212|NCT00259610|448939309|FG000|Overall Study|Withdrawal by Subject|33|||
124811213|NCT00259610|448939310|FG001|Overall Study|Withdrawal by Subject|25|||
124811214|NCT00259610|448939311|FG002|Overall Study|Withdrawal by Subject|29|||
124811215|NCT00259610|448939312|FG003|Overall Study|Withdrawal by Subject|19|||
124811216|NCT00259610|448939309|FG000|Overall Study|Lost to Follow-up|19|||
124811217|NCT00259610|448939310|FG001|Overall Study|Lost to Follow-up|8|||
124811218|NCT00259610|448939311|FG002|Overall Study|Lost to Follow-up|18|||
124811219|NCT00259610|448939312|FG003|Overall Study|Lost to Follow-up|15|||
124811220|NCT00259610|448939309|FG000|Overall Study|Physician Decision|6|||
124811221|NCT00259610|448939310|FG001|Overall Study|Physician Decision|4|||
124811222|NCT00259610|448939311|FG002|Overall Study|Physician Decision|7|||
124811223|NCT00259610|448939312|FG003|Overall Study|Physician Decision|2|||
124811224|NCT00259610|448939309|FG000|Overall Study|Death|1|||
124811225|NCT00259610|448939310|FG001|Overall Study|Death|1|||
124811226|NCT00259610|448939311|FG002|Overall Study|Death|2|||
124811227|NCT00259610|448939312|FG003|Overall Study|Death|0|||
124811228|NCT00259610|448939309|FG000|Overall Study|non medical reason|6|||
124811229|NCT00259610|448939310|FG001|Overall Study|non medical reason|2|||
124811230|NCT00259610|448939311|FG002|Overall Study|non medical reason|10|||
124811231|NCT00259610|448939312|FG003|Overall Study|non medical reason|3|||
124811232|NCT00259610|448939309|FG000|Overall Study|Adverse Event|3|||
124811233|NCT00259610|448939310|FG001|Overall Study|Adverse Event|4|||
124811234|NCT00259610|448939311|FG002|Overall Study|Adverse Event|5|||
124811235|NCT00259610|448939312|FG003|Overall Study|Adverse Event|2|||
124811236|NCT00259610|448939309|FG000|Overall Study|Serious Adverse Event|8|||
124811237|NCT00259610|448939310|FG001|Overall Study|Serious Adverse Event|2|||
124811238|NCT00259610|448939311|FG002|Overall Study|Serious Adverse Event|2|||
124811239|NCT00259610|448939312|FG003|Overall Study|Serious Adverse Event|2|||
124811240|NCT00957580|448939315|FG000|Overall Study|Ongoing at data cut-off|0|||
124811241|NCT00957580|448939316|FG001|Overall Study|Ongoing at data cut-off|1|||
124811242|NCT00957580|448939317|FG002|Overall Study|Ongoing at data cut-off|0|||
124811243|NCT00957580|448939315|FG000|Overall Study|Enrolled but not treated|0|||
124811244|NCT00957580|448939316|FG001|Overall Study|Enrolled but not treated|1|||
124811245|NCT00957580|448939317|FG002|Overall Study|Enrolled but not treated|0|||
124811246|NCT01090492|448939318|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
124811247|NCT01090492|448939319|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
124811248|NCT01090492|448939320|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
124811249|NCT01090492|448939321|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
124811250|NCT01090492|448939322|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
124811251|NCT01090492|448939323|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
124811252|NCT01090492|448939324|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
124811253|NCT01090492|448939325|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
124811254|NCT01090492|448939318|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
124811255|NCT01090492|448939319|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
124811256|NCT01090492|448939320|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
124811257|NCT01090492|448939321|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
124811258|NCT01090492|448939322|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
124811259|NCT01090492|448939323|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
124811260|NCT01090492|448939324|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
124811261|NCT01090492|448939325|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
124811262|NCT01090492|448939318|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811263|NCT01090492|448939319|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811264|NCT01090492|448939320|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
124811265|NCT01090492|448939321|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811266|NCT01090492|448939322|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811267|NCT01090492|448939323|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811268|NCT01090492|448939324|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811269|NCT01090492|448939325|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811270|NCT01090492|448939318|FG000|First Intervention Period (4 Weeks)|Other|0|||
124811271|NCT01090492|448939319|FG001|First Intervention Period (4 Weeks)|Other|0|||
124811272|NCT01090492|448939320|FG002|First Intervention Period (4 Weeks)|Other|1|||
124811273|NCT01090492|448939321|FG003|First Intervention Period (4 Weeks)|Other|1|||
124811274|NCT01090492|448939322|FG004|First Intervention Period (4 Weeks)|Other|2|||
124811275|NCT01090492|448939323|FG005|First Intervention Period (4 Weeks)|Other|0|||
124811276|NCT01090492|448939324|FG006|First Intervention Period (4 Weeks)|Other|0|||
124811277|NCT01090492|448939325|FG007|First Intervention Period (4 Weeks)|Other|0|||
124811278|NCT01090492|448939318|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
124811279|NCT01090492|448939319|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
124811280|NCT01090492|448939320|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
124811281|NCT01090492|448939321|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
124811282|NCT01090492|448939322|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
124811283|NCT01090492|448939323|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
124811284|NCT01090492|448939324|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
124811285|NCT01090492|448939325|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
124811286|NCT01090492|448939318|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
124811287|NCT01090492|448939319|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
124811288|NCT01090492|448939320|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
124811289|NCT01090492|448939321|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
124811290|NCT01090492|448939322|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
124811291|NCT01090492|448939323|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
124811292|NCT01090492|448939324|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
124811293|NCT01090492|448939325|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
124811294|NCT01090492|448939318|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
124811295|NCT01090492|448939319|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
124811296|NCT01090492|448939320|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
124811297|NCT01090492|448939321|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
124811298|NCT01090492|448939322|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
124811299|NCT01090492|448939323|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
124811300|NCT01090492|448939324|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
124811301|NCT01090492|448939325|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
124811302|NCT01090492|448939318|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
124811303|NCT01090492|448939319|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
124811304|NCT01090492|448939320|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
124811305|NCT01090492|448939321|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
124811306|NCT01090492|448939322|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
124811307|NCT01090492|448939323|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
124811308|NCT01090492|448939324|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
124811309|NCT01090492|448939325|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
124811310|NCT01090492|448939318|FG000|Second Intervention Period (4 Weeks)|Other|0|||
124811311|NCT01090492|448939319|FG001|Second Intervention Period (4 Weeks)|Other|1|||
124811312|NCT01090492|448939320|FG002|Second Intervention Period (4 Weeks)|Other|1|||
124811313|NCT01090492|448939321|FG003|Second Intervention Period (4 Weeks)|Other|0|||
124811314|NCT01090492|448939322|FG004|Second Intervention Period (4 Weeks)|Other|0|||
124811315|NCT01090492|448939323|FG005|Second Intervention Period (4 Weeks)|Other|0|||
124811316|NCT01090492|448939324|FG006|Second Intervention Period (4 Weeks)|Other|0|||
124811317|NCT01090492|448939325|FG007|Second Intervention Period (4 Weeks)|Other|0|||
124811318|NCT01090492|448939318|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
124811319|NCT01090492|448939319|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
124811320|NCT01090492|448939320|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
124811321|NCT01090492|448939321|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
124811322|NCT01090492|448939322|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
124811323|NCT01090492|448939323|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
124811324|NCT01090492|448939324|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
124811325|NCT01090492|448939325|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
124811326|NCT01090492|448939318|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811327|NCT01090492|448939319|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811328|NCT01090492|448939320|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811329|NCT01090492|448939321|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811330|NCT01090492|448939322|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811331|NCT01090492|448939323|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811332|NCT01090492|448939324|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
124811333|NCT01090492|448939325|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811334|NCT01768286|448939326|FG000|Overall Study|Randomized But Not Treated|0|||
124811335|NCT01768286|448939327|FG001|Overall Study|Randomized But Not Treated|0|||
124811336|NCT01768286|448939328|FG002|Overall Study|Randomized But Not Treated|1|||
124811337|NCT01768286|448939329|FG003|Overall Study|Randomized But Not Treated|0|||
124811338|NCT01768286|448939326|FG000|Overall Study|Lack of Efficacy|7|||
124811339|NCT01768286|448939327|FG001|Overall Study|Lack of Efficacy|4|||
124811340|NCT01768286|448939328|FG002|Overall Study|Lack of Efficacy|0|||
124811341|NCT01768286|448939329|FG003|Overall Study|Lack of Efficacy|1|||
124811342|NCT01768286|448939326|FG000|Overall Study|Withdrew Consent|0|||
124811343|NCT01768286|448939327|FG001|Overall Study|Withdrew Consent|0|||
124811344|NCT01768286|448939328|FG002|Overall Study|Withdrew Consent|1|||
124811345|NCT01768286|448939329|FG003|Overall Study|Withdrew Consent|0|||
124811346|NCT01602120|448939330|FG000|Overall Study|Adverse Event|3|||
124811347|NCT01602120|448939331|FG001|Overall Study|Adverse Event|6|||
124811348|NCT01602120|448939332|FG002|Overall Study|Adverse Event|0|||
124811349|NCT01602120|448939333|FG003|Overall Study|Adverse Event|2|||
124811350|NCT01602120|448939330|FG000|Overall Study|Death|0|||
124811351|NCT01602120|448939331|FG001|Overall Study|Death|4|||
124811352|NCT01602120|448939332|FG002|Overall Study|Death|0|||
124811353|NCT01602120|448939333|FG003|Overall Study|Death|0|||
124811354|NCT01602120|448939330|FG000|Overall Study|Lost to Follow-up|0|||
124811355|NCT01602120|448939331|FG001|Overall Study|Lost to Follow-up|1|||
124811356|NCT01602120|448939332|FG002|Overall Study|Lost to Follow-up|0|||
124811357|NCT01602120|448939333|FG003|Overall Study|Lost to Follow-up|1|||
124811358|NCT01602120|448939330|FG000|Overall Study|Protocol Violation|1|||
124811359|NCT01602120|448939331|FG001|Overall Study|Protocol Violation|1|||
124811360|NCT01602120|448939332|FG002|Overall Study|Protocol Violation|0|||
124811361|NCT01602120|448939333|FG003|Overall Study|Protocol Violation|0|||
124811362|NCT01602120|448939330|FG000|Overall Study|Non-compliance|0|||
124811363|NCT01602120|448939331|FG001|Overall Study|Non-compliance|3|||
124811364|NCT01602120|448939332|FG002|Overall Study|Non-compliance|0|||
124811365|NCT01602120|448939333|FG003|Overall Study|Non-compliance|1|||
124811366|NCT01602120|448939330|FG000|Overall Study|Withdrawal by Subject|8|||
124811367|NCT01602120|448939331|FG001|Overall Study|Withdrawal by Subject|17|||
124811368|NCT01602120|448939332|FG002|Overall Study|Withdrawal by Subject|0|||
124811369|NCT01602120|448939333|FG003|Overall Study|Withdrawal by Subject|3|||
124811370|NCT01602120|448939330|FG000|Overall Study|Study Terminated by Sponsor|12|||
124811371|NCT01602120|448939331|FG001|Overall Study|Study Terminated by Sponsor|24|||
124811372|NCT01602120|448939332|FG002|Overall Study|Study Terminated by Sponsor|17|||
124811373|NCT01602120|448939333|FG003|Overall Study|Study Terminated by Sponsor|44|||
124811374|NCT01602120|448939330|FG000|Overall Study|Physician Decision|2|||
124811375|NCT01602120|448939331|FG001|Overall Study|Physician Decision|3|||
124811376|NCT01602120|448939332|FG002|Overall Study|Physician Decision|0|||
124811377|NCT01602120|448939333|FG003|Overall Study|Physician Decision|0|||
124811378|NCT01602120|448939330|FG000|Overall Study|Unspecified Reason|3|||
124811379|NCT01602120|448939331|FG001|Overall Study|Unspecified Reason|1|||
124811380|NCT01602120|448939332|FG002|Overall Study|Unspecified Reason|0|||
124811381|NCT01602120|448939333|FG003|Overall Study|Unspecified Reason|2|||
124811382|NCT01611155|448939334|FG000|Overall Study|Adverse Event|1|||
124811383|NCT01611155|448939335|FG001|Overall Study|Adverse Event|1|||
124811384|NCT01611155|448939334|FG000|Overall Study|Refused further treatment|6|||
124811385|NCT01611155|448939335|FG001|Overall Study|Refused further treatment|4|||
124811386|NCT01611155|448939334|FG000|Overall Study|Disease progression|1|||
124811387|NCT01611155|448939335|FG001|Overall Study|Disease progression|0|||
125300224|NCT00434642|450725911|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
124811388|NCT01611155|448939334|FG000|Overall Study|Withdrawal by Subject|1|||
124811389|NCT01611155|448939335|FG001|Overall Study|Withdrawal by Subject|0|||
125300225|NCT00434642|450725912|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
125300226|NCT00434642|450725911|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
124811390|NCT01611155|448939334|FG000|Overall Study|Alternative treatment|0|||
124811391|NCT01611155|448939335|FG001|Overall Study|Alternative treatment|1|||
124811392|NCT01611155|448939334|FG000|Overall Study|Ineligible patient|0|||
124811393|NCT01611155|448939335|FG001|Overall Study|Ineligible patient|1|||
124811394|NCT02699593|448939337|FG000|Period 1|Unsatisfactory Visual Response|0|||
124811395|NCT02699593|448939338|FG001|Period 1|Unsatisfactory Visual Response|1|||
124811396|NCT02699593|448939337|FG000|Period 1|Torn Contact Len|4|||
124811397|NCT02699593|448939338|FG001|Period 1|Torn Contact Len|3|||
124811398|NCT02699593|448939337|FG000|Period 1|Protocol Violation|0|||
124811399|NCT02699593|448939338|FG001|Period 1|Protocol Violation|1|||
124811400|NCT02699593|448939337|FG000|Period 1|Withdrawal by Subject|0|||
124811401|NCT02699593|448939338|FG001|Period 1|Withdrawal by Subject|1|||
124811402|NCT02699593|448939337|FG000|Period 1|Adverse Event|1|||
124811403|NCT02699593|448939338|FG001|Period 1|Adverse Event|1|||
124811404|NCT02699593|448939337|FG000|Period 2|Adverse Event|1|||
124811405|NCT02699593|448939338|FG001|Period 2|Adverse Event|1|||
124811406|NCT02699593|448939337|FG000|Period 2|Lost Contact Lens|0|||
124811407|NCT02699593|448939338|FG001|Period 2|Lost Contact Lens|1|||
124811408|NCT02699593|448939337|FG000|Period 2|Torn Contact Lens|1|||
124811409|NCT02699593|448939338|FG001|Period 2|Torn Contact Lens|0|||
124811410|NCT00911547|448939339|FG000|Overall Study|Adverse Event|8|||
124811411|NCT00911547|448939340|FG001|Overall Study|Adverse Event|27|||
124811412|NCT00911547|448939341|FG002|Overall Study|Adverse Event|11|||
124811413|NCT00911547|448939342|FG003|Overall Study|Adverse Event|6|||
124811414|NCT00911547|448939339|FG000|Overall Study|Lost to Follow-up|0|||
124811415|NCT00911547|448939340|FG001|Overall Study|Lost to Follow-up|0|||
124811416|NCT00911547|448939341|FG002|Overall Study|Lost to Follow-up|2|||
124811417|NCT00911547|448939342|FG003|Overall Study|Lost to Follow-up|1|||
124811418|NCT00911547|448939339|FG000|Overall Study|Protocol Violation|0|||
124811419|NCT00911547|448939340|FG001|Overall Study|Protocol Violation|5|||
124811420|NCT00911547|448939341|FG002|Overall Study|Protocol Violation|5|||
124811421|NCT00911547|448939342|FG003|Overall Study|Protocol Violation|1|||
124811422|NCT00911547|448939339|FG000|Overall Study|Withdrawal by Subject|3|||
124811423|NCT00911547|448939340|FG001|Overall Study|Withdrawal by Subject|10|||
124811424|NCT00911547|448939341|FG002|Overall Study|Withdrawal by Subject|4|||
124811425|NCT00911547|448939342|FG003|Overall Study|Withdrawal by Subject|8|||
124811426|NCT00915278|448939343|FG000|Overall Study|Death|1|||
124811427|NCT00915278|448939344|FG001|Overall Study|Death|0|||
124811428|NCT00915278|448939345|FG002|Overall Study|Death|0|||
124811429|NCT00915278|448939346|FG003|Overall Study|Death|0|||
124811430|NCT00915278|448939347|FG004|Overall Study|Death|0|||
124811431|NCT00915278|448939348|FG005|Overall Study|Death|0|||
124811432|NCT00915278|448939343|FG000|Overall Study|Lost to Follow-up|0|||
124811433|NCT00915278|448939344|FG001|Overall Study|Lost to Follow-up|1|||
124811434|NCT00915278|448939345|FG002|Overall Study|Lost to Follow-up|0|||
124811435|NCT00915278|448939346|FG003|Overall Study|Lost to Follow-up|0|||
124811436|NCT00915278|448939347|FG004|Overall Study|Lost to Follow-up|0|||
124811437|NCT00915278|448939348|FG005|Overall Study|Lost to Follow-up|0|||
124811438|NCT00915278|448939343|FG000|Overall Study|Withdrawal by Subject|0|||
124811439|NCT00915278|448939344|FG001|Overall Study|Withdrawal by Subject|1|||
124811440|NCT00915278|448939345|FG002|Overall Study|Withdrawal by Subject|0|||
124811441|NCT00915278|448939346|FG003|Overall Study|Withdrawal by Subject|0|||
124811442|NCT00915278|448939347|FG004|Overall Study|Withdrawal by Subject|1|||
124811443|NCT00915278|448939348|FG005|Overall Study|Withdrawal by Subject|4|||
124811444|NCT00915278|448939343|FG000|Overall Study|Adverse Event|4|||
124811445|NCT00915278|448939344|FG001|Overall Study|Adverse Event|1|||
124811446|NCT00915278|448939345|FG002|Overall Study|Adverse Event|0|||
124811447|NCT00915278|448939346|FG003|Overall Study|Adverse Event|0|||
124811448|NCT00915278|448939347|FG004|Overall Study|Adverse Event|0|||
124811449|NCT00915278|448939348|FG005|Overall Study|Adverse Event|0|||
124811450|NCT00915278|448939343|FG000|Overall Study|Progressive disease/clinical progression|0|||
124811451|NCT00915278|448939344|FG001|Overall Study|Progressive disease/clinical progression|0|||
124811452|NCT00915278|448939345|FG002|Overall Study|Progressive disease/clinical progression|0|||
124811453|NCT00915278|448939346|FG003|Overall Study|Progressive disease/clinical progression|3|||
124811454|NCT00915278|448939347|FG004|Overall Study|Progressive disease/clinical progression|1|||
124811455|NCT00915278|448939348|FG005|Overall Study|Progressive disease/clinical progression|2|||
124811456|NCT00915278|448939343|FG000|Overall Study|Infusion related AEs|0|||
124811457|NCT00915278|448939344|FG001|Overall Study|Infusion related AEs|0|||
125300227|NCT00434642|450725912|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
125300228|NCT00434642|450725911|FG000|Open-label Treatment Phase|Adverse Event|0|||
124811458|NCT00915278|448939345|FG002|Overall Study|Infusion related AEs|0|||
124811459|NCT00915278|448939346|FG003|Overall Study|Infusion related AEs|0|||
124811460|NCT00915278|448939347|FG004|Overall Study|Infusion related AEs|0|||
124811461|NCT00915278|448939348|FG005|Overall Study|Infusion related AEs|2|||
124811462|NCT00915278|448939343|FG000|Overall Study|Admission to hospice|0|||
124811463|NCT00915278|448939344|FG001|Overall Study|Admission to hospice|0|||
124811464|NCT00915278|448939345|FG002|Overall Study|Admission to hospice|1|||
124811465|NCT00915278|448939346|FG003|Overall Study|Admission to hospice|0|||
124811466|NCT00915278|448939347|FG004|Overall Study|Admission to hospice|0|||
124811467|NCT00915278|448939348|FG005|Overall Study|Admission to hospice|0|||
124811468|NCT00453063|448939353|FG000|Overall Study|Adverse Event|1|||
124811469|NCT00453063|448939354|FG001|Overall Study|Adverse Event|2|||
124811470|NCT00453063|448939353|FG000|Overall Study|Withdrawal by Subject|1|||
124811471|NCT00453063|448939354|FG001|Overall Study|Withdrawal by Subject|1|||
124811472|NCT00453063|448939353|FG000|Overall Study|Protocol Violation|1|||
124811473|NCT00453063|448939354|FG001|Overall Study|Protocol Violation|0|||
124811474|NCT00228384|448939355|FG000|Overall Study|Death|9|||
124811475|NCT00228384|448939356|FG001|Overall Study|Death|3|||
124811476|NCT00228384|448939355|FG000|Overall Study|Lost to Follow-up|6|||
124811477|NCT00228384|448939356|FG001|Overall Study|Lost to Follow-up|10|||
124811478|NCT00228384|448939355|FG000|Overall Study|Surgical Intervention (bypass)|5|||
124811479|NCT00228384|448939356|FG001|Overall Study|Surgical Intervention (bypass)|5|||
124811480|NCT00228384|448939355|FG000|Overall Study|Withdrawal by Subject|9|||
124811481|NCT00228384|448939356|FG001|Overall Study|Withdrawal by Subject|10|||
124811482|NCT00228384|448939355|FG000|Overall Study|Physician Decision|0|||
124811483|NCT00228384|448939356|FG001|Overall Study|Physician Decision|1|||
124811484|NCT01785069|448939362|FG000|Overall Study|Implanted with nonstudy device|1|||
124811485|NCT01785069|448939363|FG001|Overall Study|Implanted with nonstudy device|2|||
124811486|NCT01785069|448939364|FG002|Overall Study|Implanted with nonstudy device|1|||
124811487|NCT01785069|448939365|FG003|Overall Study|Implanted with nonstudy device|0|||
124811488|NCT01785069|448939362|FG000|Overall Study|Death|0|||
124811489|NCT01785069|448939363|FG001|Overall Study|Death|0|||
124811490|NCT01785069|448939364|FG002|Overall Study|Death|2|||
124811491|NCT01785069|448939365|FG003|Overall Study|Death|0|||
124811492|NCT01785069|448939362|FG000|Overall Study|Subject choice|2|||
124811493|NCT01785069|448939363|FG001|Overall Study|Subject choice|2|||
124811494|NCT01785069|448939364|FG002|Overall Study|Subject choice|0|||
124811495|NCT01785069|448939365|FG003|Overall Study|Subject choice|1|||
124811496|NCT01785069|448939362|FG000|Overall Study|Lost to Follow-up|1|||
124811497|NCT01785069|448939363|FG001|Overall Study|Lost to Follow-up|2|||
124811498|NCT01785069|448939364|FG002|Overall Study|Lost to Follow-up|4|||
124811499|NCT01785069|448939365|FG003|Overall Study|Lost to Follow-up|1|||
124811500|NCT01785069|448939362|FG000|Overall Study|Reason not Specified|1|||
124811501|NCT01785069|448939363|FG001|Overall Study|Reason not Specified|2|||
124811502|NCT01785069|448939364|FG002|Overall Study|Reason not Specified|1|||
124811503|NCT01785069|448939365|FG003|Overall Study|Reason not Specified|4|||
124811504|NCT01785069|448939362|FG000|Overall Study|Not evaluable|7|||
124811505|NCT01785069|448939363|FG001|Overall Study|Not evaluable|4|||
124811506|NCT01785069|448939364|FG002|Overall Study|Not evaluable|5|||
124811507|NCT01785069|448939365|FG003|Overall Study|Not evaluable|8|||
124811508|NCT01453361|448939368|FG000|Overall Study|Disease Progression|6|||
124811509|NCT01453361|448939368|FG000|Overall Study|Screen-Failures|10|||
124811510|NCT04560998|448939369|FG000|Overall Study|Withdrawal by Subject|18|||
124811511|NCT04560998|448939370|FG001|Overall Study|Withdrawal by Subject|12|||
124811512|NCT04560998|448939369|FG000|Overall Study|Lost to Follow-up|8|||
124811513|NCT04560998|448939370|FG001|Overall Study|Lost to Follow-up|5|||
124811514|NCT04560998|448939369|FG000|Overall Study|Physician Decision|4|||
124811515|NCT04560998|448939370|FG001|Overall Study|Physician Decision|0|||
124811516|NCT02025621|448941011|FG000|Overall Study|Withdrawal by Subject|1|||
124811517|NCT02025621|448941012|FG001|Overall Study|Withdrawal by Subject|0|||
124811518|NCT02025621|448941011|FG000|Overall Study|Death|0|||
124811519|NCT02025621|448941012|FG001|Overall Study|Death|1|||
124811520|NCT02025621|448941011|FG000|Overall Study|No longer eligible|10|||
124811521|NCT02025621|448941012|FG001|Overall Study|No longer eligible|15|||
124811522|NCT02025621|448941011|FG000|Overall Study|Surgery initiated before infusion|3|||
124811523|NCT02025621|448941012|FG001|Overall Study|Surgery initiated before infusion|3|||
124811524|NCT00739674|448941013|FG000|Overall Study|Screening failures|19|||
124811525|NCT00739674|448941014|FG001|Overall Study|Screening failures|17|||
124811526|NCT00739674|448941013|FG000|Overall Study|Site 212 removal|19|||
124811527|NCT00739674|448941014|FG001|Overall Study|Site 212 removal|13|||
124811528|NCT00739674|448941013|FG000|Overall Study|No follow-up data|33|||
124811529|NCT00739674|448941014|FG001|Overall Study|No follow-up data|18|||
124811530|NCT00739674|448941013|FG000|Overall Study|Dietician consultation >30 days|1|||
124811531|NCT00739674|448941014|FG001|Overall Study|Dietician consultation >30 days|9|||
124811532|NCT00739674|448941013|FG000|Overall Study|Adverse Event|22|||
124811533|NCT00739674|448941014|FG001|Overall Study|Adverse Event|13|||
124811534|NCT00739674|448941013|FG000|Overall Study|Death|1|||
124811535|NCT00739674|448941014|FG001|Overall Study|Death|0|||
125300229|NCT00434642|450725912|FG001|Open-label Treatment Phase|Adverse Event|5|||
124811536|NCT00739674|448941013|FG000|Overall Study|Lack of Efficacy|1|||
124811537|NCT00739674|448941014|FG001|Overall Study|Lack of Efficacy|0|||
124811538|NCT00739674|448941013|FG000|Overall Study|Lost to Follow-up|52|||
124811539|NCT00739674|448941014|FG001|Overall Study|Lost to Follow-up|30|||
124811540|NCT00739674|448941013|FG000|Overall Study|Protocol Violation|5|||
124811541|NCT00739674|448941014|FG001|Overall Study|Protocol Violation|5|||
124811542|NCT00739674|448941013|FG000|Overall Study|Withdrawal by Subject|9|||
124811543|NCT00739674|448941014|FG001|Overall Study|Withdrawal by Subject|9|||
124811544|NCT00739674|448941013|FG000|Overall Study|Reason missing|2|||
124811545|NCT00739674|448941014|FG001|Overall Study|Reason missing|0|||
124811546|NCT00739674|448941013|FG000|Overall Study|Clinic closed|6|||
124811547|NCT00739674|448941014|FG001|Overall Study|Clinic closed|4|||
124811548|NCT00739674|448941013|FG000|Overall Study|Patient moved|3|||
124811549|NCT00739674|448941014|FG001|Overall Study|Patient moved|2|||
124811550|NCT00739674|448941013|FG000|Overall Study|Non compliant|4|||
124811551|NCT00739674|448941014|FG001|Overall Study|Non compliant|0|||
124811552|NCT00739674|448941013|FG000|Overall Study|Unable to attend visit|3|||
124811553|NCT00739674|448941014|FG001|Overall Study|Unable to attend visit|1|||
124811554|NCT00739674|448941013|FG000|Overall Study|Home monitoring off meds|1|||
124811555|NCT00739674|448941014|FG001|Overall Study|Home monitoring off meds|0|||
124811556|NCT00739674|448941013|FG000|Overall Study|Erectile dysfunction|0|||
124811557|NCT00739674|448941014|FG001|Overall Study|Erectile dysfunction|1|||
124811558|NCT01594281|448941015|FG000|Interventional Core Phase|Protocol Deviation|1|||
124811559|NCT01594281|448941016|FG001|Interventional Core Phase|Protocol Deviation|0|||
124811560|NCT01594281|448941017|FG002|Interventional Core Phase|Protocol Deviation|0|||
124811561|NCT01594281|448941015|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
124811562|NCT01594281|448941016|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
124811563|NCT01594281|448941017|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
124811564|NCT01594281|448941015|FG000|Interventional Core Phase|Death|1|||
124811565|NCT01594281|448941016|FG001|Interventional Core Phase|Death|1|||
124811566|NCT01594281|448941017|FG002|Interventional Core Phase|Death|2|||
124811567|NCT01594281|448941015|FG000|Interventional Core Phase|Lost to Follow-up|1|||
124811568|NCT01594281|448941016|FG001|Interventional Core Phase|Lost to Follow-up|4|||
124811569|NCT01594281|448941017|FG002|Interventional Core Phase|Lost to Follow-up|1|||
124811570|NCT01594281|448941015|FG000|Interventional Core Phase|Adverse Event|4|||
124811571|NCT01594281|448941016|FG001|Interventional Core Phase|Adverse Event|4|||
124811572|NCT01594281|448941017|FG002|Interventional Core Phase|Adverse Event|4|||
124811573|NCT01594281|448941015|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
124811574|NCT01594281|448941016|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
124811575|NCT01594281|448941017|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
124811576|NCT01594281|448941015|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
124811577|NCT01594281|448941016|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
124811578|NCT01594281|448941017|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
124811579|NCT01594281|448941015|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
124811580|NCT01594281|448941016|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
124811581|NCT01594281|448941017|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
124811582|NCT04805541|448941019|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
124811583|NCT01543958|448941022|FG000|Overall Study|Loss to follow-up|3|||
124811584|NCT01543958|448941022|FG000|Overall Study|ART initiation|1|||
124811585|NCT01945281|448941023|FG000|Overall Study|Adverse Event|1|||
124811586|NCT01945281|448941024|FG001|Overall Study|Adverse Event|0|||
124811587|NCT01945281|448941023|FG000|Overall Study|Death|3|||
124811588|NCT01945281|448941024|FG001|Overall Study|Death|3|||
124811589|NCT01945281|448941023|FG000|Overall Study|Physician Decision|1|||
124811590|NCT01945281|448941024|FG001|Overall Study|Physician Decision|1|||
124811591|NCT01945281|448941023|FG000|Overall Study|Technical Problems|1|||
124811592|NCT01945281|448941024|FG001|Overall Study|Technical Problems|0|||
124811593|NCT00799383|448941030|FG000|Overall Study|Protocol Violation|1|||
124811594|NCT00799383|448941031|FG001|Overall Study|Protocol Violation|1|||
124811595|NCT00799383|448941030|FG000|Overall Study|Adverse Event|0|||
124811596|NCT00799383|448941031|FG001|Overall Study|Adverse Event|1|||
124811597|NCT00799383|448941030|FG000|Overall Study|Lost to Follow-up|1|||
124811598|NCT00799383|448941031|FG001|Overall Study|Lost to Follow-up|2|||
124811599|NCT00799383|448941030|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
124811600|NCT00799383|448941031|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
124811601|NCT00799383|448941030|FG000|Overall Study|Withdrawal by Subject|0|||
124811602|NCT00799383|448941031|FG001|Overall Study|Withdrawal by Subject|1|||
124811603|NCT00726986|448941032|FG000|Induction Phase|Adverse Event|4|||
124811604|NCT00726986|448941032|FG000|Induction Phase|Withdrawal by Subject|2|||
124811605|NCT00726986|448941032|FG000|Induction Phase|Death|2|||
124811606|NCT00726986|448941032|FG000|Induction Phase|Lack of Efficacy|5|||
124811607|NCT00726986|448941032|FG000|Induction Phase|Secondary Disease|2|||
124811608|NCT00726986|448941032|FG000|Maintenance Phase|Adverse Event|1|||
124811609|NCT00726986|448941032|FG000|Maintenance Phase|Lack of Efficacy|2|||
125300230|NCT00434642|450725911|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
125300231|NCT00434642|450725912|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
125300232|NCT04512976|450725917|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
125300233|NCT04512976|450725918|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
125300234|NCT04512976|450725919|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
125300235|NCT04512976|450725920|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
124811610|NCT02165215|448941039|FG000|Induction Phase|Adverse Event|1|||
124811611|NCT02165215|448941040|FG001|Induction Phase|Adverse Event|0|||
124811612|NCT02165215|448941041|FG002|Induction Phase|Adverse Event|0|||
124811613|NCT02165215|448941039|FG000|Induction Phase|Withdrawal by Subject|10|||
124811614|NCT02165215|448941040|FG001|Induction Phase|Withdrawal by Subject|0|||
124811615|NCT02165215|448941041|FG002|Induction Phase|Withdrawal by Subject|0|||
124811616|NCT02165215|448941039|FG000|Induction Phase|Protocol Violation|1|||
124811617|NCT02165215|448941040|FG001|Induction Phase|Protocol Violation|0|||
124811618|NCT02165215|448941041|FG002|Induction Phase|Protocol Violation|0|||
124811619|NCT02165215|448941039|FG000|Induction Phase|Physician Decision|1|||
124811620|NCT02165215|448941040|FG001|Induction Phase|Physician Decision|0|||
124811621|NCT02165215|448941041|FG002|Induction Phase|Physician Decision|0|||
124811622|NCT02165215|448941039|FG000|Induction Phase|Lack of Efficacy|2|||
124811623|NCT02165215|448941040|FG001|Induction Phase|Lack of Efficacy|0|||
124811624|NCT02165215|448941041|FG002|Induction Phase|Lack of Efficacy|0|||
124811625|NCT02165215|448941039|FG000|Induction Phase|Non-Compliance|2|||
124811626|NCT02165215|448941040|FG001|Induction Phase|Non-Compliance|0|||
124811627|NCT02165215|448941041|FG002|Induction Phase|Non-Compliance|0|||
124811628|NCT02165215|448941039|FG000|Induction Phase|Lost to Follow-up|6|||
124811629|NCT02165215|448941040|FG001|Induction Phase|Lost to Follow-up|0|||
124811630|NCT02165215|448941041|FG002|Induction Phase|Lost to Follow-up|0|||
124811631|NCT02165215|448941039|FG000|Maintenance Phase|Withdrawal by Subject|0|||
124811632|NCT02165215|448941040|FG001|Maintenance Phase|Withdrawal by Subject|7|||
124811633|NCT02165215|448941041|FG002|Maintenance Phase|Withdrawal by Subject|3|||
124811634|NCT02165215|448941039|FG000|Maintenance Phase|Multiple reasons|0|||
124811635|NCT02165215|448941040|FG001|Maintenance Phase|Multiple reasons|2|||
124811636|NCT02165215|448941041|FG002|Maintenance Phase|Multiple reasons|1|||
124811637|NCT02165215|448941039|FG000|Maintenance Phase|Lost to Follow-up|0|||
124811638|NCT02165215|448941040|FG001|Maintenance Phase|Lost to Follow-up|2|||
124811639|NCT02165215|448941041|FG002|Maintenance Phase|Lost to Follow-up|0|||
124811640|NCT02165215|448941039|FG000|Maintenance Phase|Adverse Event|0|||
124811641|NCT02165215|448941040|FG001|Maintenance Phase|Adverse Event|1|||
124811642|NCT02165215|448941041|FG002|Maintenance Phase|Adverse Event|1|||
124811643|NCT04678661|448941042|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
124811644|NCT04678661|448941043|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
124811645|NCT04678661|448941042|FG000|Overall Study|Protocol Violation|2|||
124811646|NCT04678661|448941043|FG001|Overall Study|Protocol Violation|0|||
124811647|NCT04678661|448941042|FG000|Overall Study|Withdrawal by Subject|1|||
124811648|NCT04678661|448941043|FG001|Overall Study|Withdrawal by Subject|0|||
124811649|NCT04678661|448941042|FG000|Overall Study|Lost to Follow-up|2|||
124811650|NCT04678661|448941043|FG001|Overall Study|Lost to Follow-up|0|||
124811651|NCT04678661|448941042|FG000|Overall Study|Death|2|||
124811652|NCT04678661|448941043|FG001|Overall Study|Death|0|||
124811653|NCT01397890|448941044|FG000|Overall Study|Withdrawal by Subject|7|||
124811654|NCT01397890|448941045|FG001|Overall Study|Withdrawal by Subject|11|||
124811655|NCT01397890|448941044|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
124811656|NCT01397890|448941045|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
124811657|NCT01397890|448941044|FG000|Overall Study|Death|2|||
124811658|NCT01397890|448941045|FG001|Overall Study|Death|3|||
124811659|NCT01397890|448941044|FG000|Overall Study|Lost to Follow-up|1|||
124811660|NCT01397890|448941045|FG001|Overall Study|Lost to Follow-up|4|||
124811661|NCT01397890|448941044|FG000|Overall Study|Condition under Investigation Worsened|1|||
124811662|NCT01397890|448941045|FG001|Overall Study|Condition under Investigation Worsened|3|||
124811663|NCT01397890|448941044|FG000|Overall Study|Adverse Event|1|||
124811664|NCT01397890|448941045|FG001|Overall Study|Adverse Event|2|||
124811665|NCT01397890|448941044|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
124811666|NCT01397890|448941045|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
124811667|NCT01397890|448941044|FG000|Overall Study|Others|2|||
124811668|NCT01397890|448941045|FG001|Overall Study|Others|1|||
124811669|NCT03094169|448941046|FG000|Overall Study|Lack of Efficacy|0|||
124811670|NCT03094169|448941047|FG001|Overall Study|Lack of Efficacy|0|||
124811671|NCT03094169|448941048|FG002|Overall Study|Lack of Efficacy|0|||
124811672|NCT03094169|448941049|FG003|Overall Study|Lack of Efficacy|0|||
124811673|NCT03094169|448941050|FG004|Overall Study|Lack of Efficacy|0|||
124811674|NCT03094169|448941051|FG005|Overall Study|Lack of Efficacy|0|||
124811675|NCT03094169|448941052|FG006|Overall Study|Lack of Efficacy|0|||
124811676|NCT03094169|448941053|FG007|Overall Study|Lack of Efficacy|21|||
124811677|NCT03094169|448941046|FG000|Overall Study|Adverse Event|0|||
124811678|NCT03094169|448941047|FG001|Overall Study|Adverse Event|0|||
124811679|NCT03094169|448941048|FG002|Overall Study|Adverse Event|0|||
125300236|NCT04512976|450725921|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
125300237|NCT04512976|450725922|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
125300238|NCT00527982|450725923|FG000|Overall Study|Physician Decision|1|||
125300239|NCT00527982|450725924|FG001|Overall Study|Physician Decision|0|||
124811680|NCT03094169|448941049|FG003|Overall Study|Adverse Event|0|||
125300240|NCT02241343|450725929|FG000|Overall Study|Adverse Event|1|||
124811681|NCT03094169|448941050|FG004|Overall Study|Adverse Event|0|||
124811682|NCT03094169|448941051|FG005|Overall Study|Adverse Event|0|||
124811683|NCT03094169|448941052|FG006|Overall Study|Adverse Event|0|||
124811684|NCT03094169|448941053|FG007|Overall Study|Adverse Event|2|||
124811685|NCT03094169|448941046|FG000|Overall Study|Withdrawal by Subject|0|||
124811686|NCT03094169|448941047|FG001|Overall Study|Withdrawal by Subject|0|||
124811687|NCT03094169|448941048|FG002|Overall Study|Withdrawal by Subject|0|||
124811688|NCT03094169|448941049|FG003|Overall Study|Withdrawal by Subject|0|||
124811689|NCT03094169|448941050|FG004|Overall Study|Withdrawal by Subject|0|||
124811690|NCT03094169|448941051|FG005|Overall Study|Withdrawal by Subject|0|||
124811691|NCT03094169|448941052|FG006|Overall Study|Withdrawal by Subject|1|||
124811692|NCT03094169|448941053|FG007|Overall Study|Withdrawal by Subject|1|||
124811693|NCT03094169|448941046|FG000|Overall Study|Trial Termination|0|||
124811694|NCT03094169|448941047|FG001|Overall Study|Trial Termination|0|||
124811695|NCT03094169|448941048|FG002|Overall Study|Trial Termination|0|||
124811696|NCT03094169|448941049|FG003|Overall Study|Trial Termination|0|||
125300241|NCT04541628|450725932|FG000|Overall Study|Study Terminated|1|||
125300242|NCT04541628|450725933|FG001|Overall Study|Study Terminated|1|||
125300243|NCT04541628|450725934|FG002|Overall Study|Study Terminated|1|||
125300244|NCT05011058|450725938|FG000|Overall Study|Sponsor Decision|2|||
125300245|NCT05011058|450725939|FG001|Overall Study|Sponsor Decision|0|||
125300246|NCT05011058|450725940|FG002|Overall Study|Sponsor Decision|14|||
124811697|NCT03094169|448941050|FG004|Overall Study|Trial Termination|0|||
124811698|NCT03094169|448941051|FG005|Overall Study|Trial Termination|0|||
124811699|NCT03094169|448941052|FG006|Overall Study|Trial Termination|0|||
124811700|NCT03094169|448941053|FG007|Overall Study|Trial Termination|1|||
124811701|NCT04645953|448941054|FG000|Overall Study|Lost to Follow-up|2|||
124811702|NCT04645953|448941055|FG001|Overall Study|Lost to Follow-up|1|||
124811703|NCT04645953|448941056|FG002|Overall Study|Lost to Follow-up|1|||
124811704|NCT04645953|448941054|FG000|Overall Study|Withdrawal by Subject|0|||
124811705|NCT04645953|448941055|FG001|Overall Study|Withdrawal by Subject|1|||
124811706|NCT04645953|448941056|FG002|Overall Study|Withdrawal by Subject|0|||
124811707|NCT04645953|448941054|FG000|Overall Study|Physician Decision|0|||
124811708|NCT04645953|448941055|FG001|Overall Study|Physician Decision|1|||
124811709|NCT04645953|448941056|FG002|Overall Study|Physician Decision|0|||
124811710|NCT04645953|448941054|FG000|Overall Study|Discontinued Prior to Dosing|0|||
124811711|NCT04645953|448941055|FG001|Overall Study|Discontinued Prior to Dosing|0|||
124811712|NCT04645953|448941056|FG002|Overall Study|Discontinued Prior to Dosing|2|||
124811713|NCT00002651|448941057|FG000|Induction|Adverse Event|44|||
124811714|NCT00002651|448941058|FG001|Induction|Adverse Event|0|||
124811715|NCT00002651|448941059|FG002|Induction|Adverse Event|0|||
124811716|NCT00002651|448941057|FG000|Induction|Refusal unrelated to adverse event|50|||
124811717|NCT00002651|448941058|FG001|Induction|Refusal unrelated to adverse event|0|||
124811718|NCT00002651|448941059|FG002|Induction|Refusal unrelated to adverse event|0|||
124811719|NCT00002651|448941057|FG000|Induction|Progression/relapse|274|||
124811720|NCT00002651|448941058|FG001|Induction|Progression/relapse|0|||
124811721|NCT00002651|448941059|FG002|Induction|Progression/relapse|0|||
124811722|NCT00002651|448941057|FG000|Induction|Death|62|||
124811723|NCT00002651|448941058|FG001|Induction|Death|0|||
124811724|NCT00002651|448941059|FG002|Induction|Death|0|||
124811725|NCT00002651|448941057|FG000|Induction|Other|823|||
124811726|NCT00002651|448941058|FG001|Induction|Other|0|||
124811727|NCT00002651|448941059|FG002|Induction|Other|0|||
124811728|NCT00002651|448941057|FG000|Induction|not eligible|90|||
124811729|NCT00002651|448941058|FG001|Induction|not eligible|0|||
124811730|NCT00002651|448941059|FG002|Induction|not eligible|0|||
124811731|NCT00002651|448941057|FG000|Consolidation and Randomization|Adverse Event|0|||
124811732|NCT00002651|448941058|FG001|Consolidation and Randomization|Adverse Event|36|||
124811733|NCT00002651|448941059|FG002|Consolidation and Randomization|Adverse Event|14|||
124811734|NCT00002651|448941057|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
124811735|NCT00002651|448941058|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
124811736|NCT00002651|448941059|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
124811737|NCT00002651|448941057|FG000|Consolidation and Randomization|Progression/relapse|0|||
124811738|NCT00002651|448941058|FG001|Consolidation and Randomization|Progression/relapse|295|||
124811739|NCT00002651|448941059|FG002|Consolidation and Randomization|Progression/relapse|298|||
124811740|NCT00002651|448941057|FG000|Consolidation and Randomization|Death|0|||
124811741|NCT00002651|448941058|FG001|Consolidation and Randomization|Death|38|||
124811742|NCT00002651|448941059|FG002|Consolidation and Randomization|Death|48|||
124811743|NCT00002651|448941057|FG000|Consolidation and Randomization|Other|0|||
124811744|NCT00002651|448941058|FG001|Consolidation and Randomization|Other|314|||
124811745|NCT00002651|448941059|FG002|Consolidation and Randomization|Other|313|||
124811746|NCT00002651|448941057|FG000|Consolidation and Randomization|not eligible|0|||
125300247|NCT05011058|450725941|FG003|Overall Study|Sponsor Decision|0|||
125300248|NCT05011058|450725942|FG004|Overall Study|Sponsor Decision|0|||
124811747|NCT00002651|448941058|FG001|Consolidation and Randomization|not eligible|102|||
124811748|NCT00002651|448941059|FG002|Consolidation and Randomization|not eligible|112|||
124811749|NCT03741062|448941060|FG000|Overall Study|Protocol Violation|1|||
124811750|NCT03741062|448941061|FG001|Overall Study|Protocol Violation|0|||
124811751|NCT02763462|448941065|FG000|Overall Study|Protocol Violation|6|||
124811752|NCT03417219|448941066|FG000|Overall Study|Lost to Follow-up|0|||
124811753|NCT03417219|448941067|FG001|Overall Study|Lost to Follow-up|3|||
124811754|NCT00261807|448941068|FG000|Overall Study|Lost to Follow-up|2|||
124811755|NCT00261807|448941068|FG000|Overall Study|Adverse Event|2|||
124811756|NCT00261807|448941068|FG000|Overall Study|Death|1|||
124811757|NCT00261807|448941068|FG000|Overall Study|Protocol Violation|2|||
124811758|NCT00675948|448941071|FG000|Overall Study|Adverse Event|23|||
124811759|NCT00675948|448941072|FG001|Overall Study|Adverse Event|1|||
125300249|NCT05011058|450725943|FG005|Overall Study|Sponsor Decision|1|||
124811760|NCT00675948|448941071|FG000|Overall Study|Lack of Efficacy|3|||
124811761|NCT00675948|448941072|FG001|Overall Study|Lack of Efficacy|0|||
124811762|NCT00675948|448941071|FG000|Overall Study|Withdrawal by Subject|7|||
124811763|NCT00675948|448941072|FG001|Overall Study|Withdrawal by Subject|0|||
124811764|NCT00675948|448941071|FG000|Overall Study|Lost to Follow-up|2|||
124811765|NCT00675948|448941072|FG001|Overall Study|Lost to Follow-up|0|||
124811766|NCT00675948|448941071|FG000|Overall Study|Protocol Violation|1|||
124811767|NCT00675948|448941072|FG001|Overall Study|Protocol Violation|0|||
124811768|NCT00675948|448941071|FG000|Overall Study|Pain under control|1|||
124811769|NCT00675948|448941072|FG001|Overall Study|Pain under control|0|||
124811770|NCT00675948|448941071|FG000|Overall Study|Sponsor decision|0|||
124811771|NCT00675948|448941072|FG001|Overall Study|Sponsor decision|1|||
124811772|NCT00675948|448941071|FG000|Overall Study|Patient died|1|||
124811773|NCT00675948|448941072|FG001|Overall Study|Patient died|0|||
124811774|NCT00675948|448941071|FG000|Overall Study|Patient unable to comply with diaries|1|||
124811775|NCT00675948|448941072|FG001|Overall Study|Patient unable to comply with diaries|0|||
124811776|NCT00675948|448941071|FG000|Overall Study|Patient feels unable to take medication|0|||
124811777|NCT00675948|448941072|FG001|Overall Study|Patient feels unable to take medication|1|||
124811778|NCT02527161|448941073|FG000|Overall Study|Failed MRI|52|||
124811779|NCT02527161|448941073|FG000|Overall Study|Withdrawal by Subject|19|||
124811780|NCT02527161|448941073|FG000|Overall Study|Delay in or unfit for surgery|16|||
124811781|NCT02527161|448941073|FG000|Overall Study|MRI contraindication|6|||
124811782|NCT02527161|448941073|FG000|Overall Study|Consent violation|4|||
124811783|NCT02527161|448941073|FG000|Overall Study|Only Recruited to Part A|27|||
124811784|NCT02527161|448941073|FG000|Overall Study|Physician Decision|1|||
124811785|NCT02527161|448941073|FG000|Overall Study|Adverse Event|1|||
124811786|NCT02527161|448941073|FG000|Overall Study|Lost to Follow-up|6|||
124811787|NCT05209360|448941074|FG000|Overall Study|Withdrawal by Subject|0|||
124811788|NCT05209360|448941075|FG001|Overall Study|Withdrawal by Subject|0|||
124811789|NCT05209360|448941076|FG002|Overall Study|Withdrawal by Subject|1|||
124811790|NCT05209360|448941077|FG003|Overall Study|Withdrawal by Subject|0|||
124811791|NCT05209360|448941078|FG004|Overall Study|Withdrawal by Subject|0|||
124811792|NCT05209360|448941079|FG005|Overall Study|Withdrawal by Subject|0|||
124811793|NCT02100514|448941080|FG000|Treatment Period|Adverse Event|0|||
124811794|NCT02100514|448941081|FG001|Treatment Period|Adverse Event|5|||
124811795|NCT02100514|448941082|FG002|Treatment Period|Adverse Event|0|||
124811796|NCT02100514|448941083|FG003|Treatment Period|Adverse Event|0|||
124811797|NCT02100514|448941084|FG004|Treatment Period|Adverse Event|0|||
124811798|NCT02100514|448941080|FG000|Treatment Period|Death|2|||
124811799|NCT02100514|448941081|FG001|Treatment Period|Death|2|||
124811800|NCT02100514|448941082|FG002|Treatment Period|Death|0|||
124811801|NCT02100514|448941083|FG003|Treatment Period|Death|0|||
124811802|NCT02100514|448941084|FG004|Treatment Period|Death|0|||
124811803|NCT02100514|448941080|FG000|Treatment Period|Lost to Follow-up|5|||
124811804|NCT02100514|448941081|FG001|Treatment Period|Lost to Follow-up|17|||
124811805|NCT02100514|448941082|FG002|Treatment Period|Lost to Follow-up|0|||
124811806|NCT02100514|448941083|FG003|Treatment Period|Lost to Follow-up|0|||
124811807|NCT02100514|448941084|FG004|Treatment Period|Lost to Follow-up|0|||
124811808|NCT02100514|448941080|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
124811809|NCT02100514|448941081|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
124811810|NCT02100514|448941082|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
124811811|NCT02100514|448941083|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
124811812|NCT02100514|448941084|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
124811813|NCT02100514|448941080|FG000|Treatment Period|Protocol Violation|1|||
124811814|NCT02100514|448941081|FG001|Treatment Period|Protocol Violation|1|||
124811815|NCT02100514|448941082|FG002|Treatment Period|Protocol Violation|0|||
124811816|NCT02100514|448941083|FG003|Treatment Period|Protocol Violation|0|||
124811817|NCT02100514|448941084|FG004|Treatment Period|Protocol Violation|0|||
124811818|NCT02100514|448941080|FG000|Treatment Period|Withdrawal by Subject|12|||
124811819|NCT02100514|448941081|FG001|Treatment Period|Withdrawal by Subject|37|||
124811820|NCT02100514|448941082|FG002|Treatment Period|Withdrawal by Subject|0|||
124811821|NCT02100514|448941083|FG003|Treatment Period|Withdrawal by Subject|0|||
124811822|NCT02100514|448941084|FG004|Treatment Period|Withdrawal by Subject|0|||
125300250|NCT05011058|450725944|FG006|Overall Study|Sponsor Decision|0|||
125300251|NCT05011058|450725945|FG007|Overall Study|Sponsor Decision|5|||
125300252|NCT01192412|450725946|FG000|Overall Study|Lost to Follow-up|2|||
124811823|NCT02100514|448941080|FG000|Treatment Period|Other|9|||
124811824|NCT02100514|448941081|FG001|Treatment Period|Other|11|||
124811825|NCT02100514|448941082|FG002|Treatment Period|Other|0|||
124811826|NCT02100514|448941083|FG003|Treatment Period|Other|0|||
124811827|NCT02100514|448941084|FG004|Treatment Period|Other|0|||
124811828|NCT02100514|448941080|FG000|Extension Period|Withdrew consent|0|||
124811829|NCT02100514|448941081|FG001|Extension Period|Withdrew consent|0|||
124811830|NCT02100514|448941082|FG002|Extension Period|Withdrew consent|2|||
124811831|NCT02100514|448941083|FG003|Extension Period|Withdrew consent|0|||
124811832|NCT02100514|448941084|FG004|Extension Period|Withdrew consent|0|||
124811833|NCT00724932|448941085|FG000|Overall Study|Lost to Follow-up|1|||
124811834|NCT00724932|448941086|FG001|Overall Study|Lost to Follow-up|0|||
124811835|NCT00724932|448941085|FG000|Overall Study|Not treated|4|||
124811836|NCT00724932|448941086|FG001|Overall Study|Not treated|3|||
124811837|NCT02021331|448941087|FG000|Overall Study|Adverse Event|0|||
124811838|NCT02021331|448941088|FG001|Overall Study|Adverse Event|2|||
124811839|NCT00762229|448941089|FG000|Overall Study|Lost to Follow-up|1|||
124811840|NCT00762229|448941090|FG001|Overall Study|Lost to Follow-up|1|||
124811841|NCT00762229|448941089|FG000|Overall Study|did not recveive intervention|0|||
124811842|NCT00762229|448941090|FG001|Overall Study|did not recveive intervention|1|||
124811843|NCT00319553|448941095|FG000|Overall Study|Protocol Violation|1|||
124811844|NCT00319553|448941096|FG001|Overall Study|Protocol Violation|2|||
124811845|NCT00319553|448941095|FG000|Overall Study|Lost to Follow-up|2|||
124811846|NCT00319553|448941096|FG001|Overall Study|Lost to Follow-up|1|||
124811847|NCT00319553|448941095|FG000|Overall Study|Withdrawal by Subject|1|||
124811848|NCT00319553|448941096|FG001|Overall Study|Withdrawal by Subject|1|||
124811849|NCT00885846|448941098|FG000|Overall Study|Withdrawal by Subject|2|||
124811850|NCT00885846|448941099|FG001|Overall Study|Withdrawal by Subject|5|||
124811851|NCT00885846|448941100|FG002|Overall Study|Withdrawal by Subject|2|||
124811852|NCT01081678|448941102|FG000|Overall Study|Ineligibility Determined|0|||
124811853|NCT01081678|448941103|FG001|Overall Study|Ineligibility Determined|0|||
124811854|NCT01081678|448941104|FG002|Overall Study|Ineligibility Determined|1|||
124811855|NCT01081678|448941105|FG003|Overall Study|Ineligibility Determined|1|||
124811856|NCT01081678|448941102|FG000|Overall Study|Noncompliance|3|||
124811857|NCT01081678|448941103|FG001|Overall Study|Noncompliance|4|||
124811858|NCT01081678|448941104|FG002|Overall Study|Noncompliance|5|||
124811859|NCT01081678|448941105|FG003|Overall Study|Noncompliance|2|||
124811860|NCT01081678|448941102|FG000|Overall Study|Adverse Event|2|||
124811861|NCT01081678|448941103|FG001|Overall Study|Adverse Event|1|||
124811862|NCT01081678|448941104|FG002|Overall Study|Adverse Event|2|||
124811863|NCT01081678|448941105|FG003|Overall Study|Adverse Event|2|||
124811864|NCT01081678|448941102|FG000|Overall Study|Withdrawal by Subject|15|||
124811865|NCT01081678|448941103|FG001|Overall Study|Withdrawal by Subject|7|||
124811866|NCT01081678|448941104|FG002|Overall Study|Withdrawal by Subject|17|||
124811867|NCT01081678|448941105|FG003|Overall Study|Withdrawal by Subject|14|||
124811868|NCT01081678|448941102|FG000|Overall Study|Administrative Decision|1|||
124811869|NCT01081678|448941103|FG001|Overall Study|Administrative Decision|0|||
124811870|NCT01081678|448941104|FG002|Overall Study|Administrative Decision|0|||
124811871|NCT01081678|448941105|FG003|Overall Study|Administrative Decision|1|||
124811872|NCT01081678|448941102|FG000|Overall Study|Lost to Follow-up|4|||
124811873|NCT01081678|448941103|FG001|Overall Study|Lost to Follow-up|1|||
124811874|NCT01081678|448941104|FG002|Overall Study|Lost to Follow-up|4|||
124811875|NCT01081678|448941105|FG003|Overall Study|Lost to Follow-up|3|||
124811876|NCT01081678|448941102|FG000|Overall Study|Death|2|||
124811877|NCT01081678|448941103|FG001|Overall Study|Death|2|||
124811878|NCT01081678|448941104|FG002|Overall Study|Death|2|||
124811879|NCT01081678|448941105|FG003|Overall Study|Death|6|||
124811880|NCT01081678|448941102|FG000|Overall Study|Other|0|||
124811881|NCT01081678|448941103|FG001|Overall Study|Other|1|||
124811882|NCT01081678|448941104|FG002|Overall Study|Other|0|||
124811883|NCT01081678|448941105|FG003|Overall Study|Other|0|||
124811884|NCT00444912|448941108|FG000|Overall Study|Death|1|||
124811885|NCT00444912|448941109|FG001|Overall Study|Death|2|||
124811886|NCT00444912|448941108|FG000|Overall Study|Lost to Follow-up|1|||
124811887|NCT00444912|448941109|FG001|Overall Study|Lost to Follow-up|0|||
124811888|NCT00444912|448941108|FG000|Overall Study|Participant Failed Mobilization|1|||
124811889|NCT00444912|448941109|FG001|Overall Study|Participant Failed Mobilization|0|||
124811890|NCT01281865|448941110|FG000|Overall Study|Adverse Event|1|||
124811891|NCT01281865|448941111|FG001|Overall Study|Adverse Event|1|||
124811892|NCT01281865|448941110|FG000|Overall Study|Withdrawal by Subject|1|||
124811893|NCT01281865|448941111|FG001|Overall Study|Withdrawal by Subject|0|||
124811894|NCT01281865|448941110|FG000|Overall Study|Lack of Efficacy|1|||
124811895|NCT01281865|448941111|FG001|Overall Study|Lack of Efficacy|0|||
124811896|NCT02747875|448941112|FG000|Overall Study|Physician Decision|1|||
124811897|NCT02747875|448941113|FG001|Overall Study|Physician Decision|0|||
124811898|NCT02747875|448941112|FG000|Overall Study|Adverse Event|0|||
124811899|NCT02747875|448941113|FG001|Overall Study|Adverse Event|1|||
124811900|NCT01702805|448941115|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
124811901|NCT01702805|448941116|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
124811902|NCT01702805|448941115|FG000|Overall Study|Incomplete Follow-up|18|||
124811903|NCT01702805|448941116|FG001|Overall Study|Incomplete Follow-up|15|||
124811904|NCT01702805|448941115|FG000|Overall Study|Vital Status Assessment Only|40|||
124811905|NCT01702805|448941116|FG001|Overall Study|Vital Status Assessment Only|39|||
124811906|NCT01702805|448941115|FG000|Overall Study|Lost to Follow-up|5|||
124811907|NCT01702805|448941116|FG001|Overall Study|Lost to Follow-up|5|||
124811908|NCT02499783|448941117|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
124811909|NCT02499783|448941118|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
124811910|NCT02499783|448941119|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
124811911|NCT02499783|448941117|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
124811912|NCT02499783|448941118|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
124811913|NCT02499783|448941119|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
124811914|NCT02499783|448941117|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
124811915|NCT02499783|448941118|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
124811916|NCT02499783|448941119|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
124811917|NCT02499783|448941117|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
124811918|NCT02499783|448941118|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
124811919|NCT02499783|448941119|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
124811920|NCT02499783|448941117|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
124811921|NCT02499783|448941118|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
124811922|NCT02499783|448941119|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
124811923|NCT02499783|448941117|FG000|DB Period: Weeks 0-8|Other|1|||
124811924|NCT02499783|448941118|FG001|DB Period: Weeks 0-8|Other|1|||
124811925|NCT02499783|448941119|FG002|DB Period: Weeks 0-8|Other|0|||
124811926|NCT02499783|448941117|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
124811927|NCT02499783|448941118|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
124811928|NCT02499783|448941119|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
124811929|NCT02499783|448941117|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
124811930|NCT02499783|448941118|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
124811931|NCT02499783|448941119|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
124811932|NCT02499783|448941117|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
124811933|NCT02499783|448941118|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
124811934|NCT02499783|448941119|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
124811935|NCT02499783|448941117|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
124811936|NCT02499783|448941118|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
124811937|NCT02499783|448941119|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
124811938|NCT01866293|448941120|FG000|Overall Study|Adverse Event|2|||
124811939|NCT04457336|448941121|FG000|Period 2: Part A|Withdrawal by Subject|0|||
124811940|NCT04457336|448941122|FG001|Period 2: Part A|Withdrawal by Subject|1|||
124811941|NCT04457336|448941123|FG002|Period 2: Part A|Withdrawal by Subject|1|||
124811942|NCT04457336|448941124|FG003|Period 2: Part A|Withdrawal by Subject|1|||
124811943|NCT04457336|448941125|FG004|Period 2: Part A|Withdrawal by Subject|0|||
124811944|NCT04457336|448941126|FG005|Period 2: Part A|Withdrawal by Subject|0|||
124811945|NCT04457336|448941127|FG006|Period 2: Part A|Withdrawal by Subject|0|||
124811946|NCT04457336|448941128|FG007|Period 2: Part A|Withdrawal by Subject|0|||
124811947|NCT04457336|448941121|FG000|Period 2: Part A|Adverse Event|0|||
124811948|NCT04457336|448941122|FG001|Period 2: Part A|Adverse Event|0|||
124811949|NCT04457336|448941123|FG002|Period 2: Part A|Adverse Event|1|||
124811950|NCT04457336|448941124|FG003|Period 2: Part A|Adverse Event|1|||
124811951|NCT04457336|448941125|FG004|Period 2: Part A|Adverse Event|0|||
124811952|NCT04457336|448941126|FG005|Period 2: Part A|Adverse Event|0|||
124811953|NCT04457336|448941127|FG006|Period 2: Part A|Adverse Event|0|||
124811954|NCT04457336|448941128|FG007|Period 2: Part A|Adverse Event|0|||
124811955|NCT04457336|448941121|FG000|Period 2: Part A|Study Terminated|0|||
124811956|NCT04457336|448941122|FG001|Period 2: Part A|Study Terminated|0|||
124811957|NCT04457336|448941123|FG002|Period 2: Part A|Study Terminated|1|||
124811958|NCT04457336|448941124|FG003|Period 2: Part A|Study Terminated|0|||
124811959|NCT04457336|448941125|FG004|Period 2: Part A|Study Terminated|0|||
124811960|NCT04457336|448941126|FG005|Period 2: Part A|Study Terminated|0|||
124811961|NCT04457336|448941127|FG006|Period 2: Part A|Study Terminated|0|||
124811962|NCT04457336|448941128|FG007|Period 2: Part A|Study Terminated|0|||
124811963|NCT04457336|448941121|FG000|Period 2: Part A|Protocol Violation|0|||
124811964|NCT04457336|448941122|FG001|Period 2: Part A|Protocol Violation|1|||
124811965|NCT04457336|448941123|FG002|Period 2: Part A|Protocol Violation|0|||
124811966|NCT04457336|448941124|FG003|Period 2: Part A|Protocol Violation|0|||
124811967|NCT04457336|448941125|FG004|Period 2: Part A|Protocol Violation|0|||
124811968|NCT04457336|448941126|FG005|Period 2: Part A|Protocol Violation|0|||
124811969|NCT04457336|448941127|FG006|Period 2: Part A|Protocol Violation|0|||
124811970|NCT04457336|448941128|FG007|Period 2: Part A|Protocol Violation|0|||
124811971|NCT04457336|448941121|FG000|Period 2: Part A|Lost to Follow-up|0|||
124811972|NCT04457336|448941122|FG001|Period 2: Part A|Lost to Follow-up|1|||
124811973|NCT04457336|448941123|FG002|Period 2: Part A|Lost to Follow-up|0|||
124811974|NCT04457336|448941124|FG003|Period 2: Part A|Lost to Follow-up|0|||
124811975|NCT04457336|448941125|FG004|Period 2: Part A|Lost to Follow-up|0|||
124811976|NCT04457336|448941126|FG005|Period 2: Part A|Lost to Follow-up|0|||
124811977|NCT04457336|448941127|FG006|Period 2: Part A|Lost to Follow-up|0|||
124811978|NCT04457336|448941128|FG007|Period 2: Part A|Lost to Follow-up|0|||
124811979|NCT04457336|448941121|FG000|Period 2: Part A|Other|0|||
124811980|NCT04457336|448941122|FG001|Period 2: Part A|Other|1|||
124811981|NCT04457336|448941123|FG002|Period 2: Part A|Other|0|||
124811982|NCT04457336|448941124|FG003|Period 2: Part A|Other|0|||
124811983|NCT04457336|448941125|FG004|Period 2: Part A|Other|0|||
124811984|NCT04457336|448941126|FG005|Period 2: Part A|Other|0|||
124811985|NCT04457336|448941127|FG006|Period 2: Part A|Other|0|||
124811986|NCT04457336|448941128|FG007|Period 2: Part A|Other|0|||
124811987|NCT04457336|448941121|FG000|Period 2: Part A|Physician Decision|0|||
124811988|NCT04457336|448941122|FG001|Period 2: Part A|Physician Decision|0|||
124811989|NCT04457336|448941123|FG002|Period 2: Part A|Physician Decision|0|||
124811990|NCT04457336|448941124|FG003|Period 2: Part A|Physician Decision|1|||
124811991|NCT04457336|448941125|FG004|Period 2: Part A|Physician Decision|0|||
124811992|NCT04457336|448941126|FG005|Period 2: Part A|Physician Decision|0|||
124811993|NCT04457336|448941127|FG006|Period 2: Part A|Physician Decision|0|||
124811994|NCT04457336|448941128|FG007|Period 2: Part A|Physician Decision|0|||
124811995|NCT04457336|448941121|FG000|Period 3: Part B|Study Terminated|0|||
124811996|NCT04457336|448941122|FG001|Period 3: Part B|Study Terminated|0|||
124811997|NCT04457336|448941123|FG002|Period 3: Part B|Study Terminated|0|||
124811998|NCT04457336|448941124|FG003|Period 3: Part B|Study Terminated|0|||
124811999|NCT04457336|448941125|FG004|Period 3: Part B|Study Terminated|1|||
124812000|NCT04457336|448941126|FG005|Period 3: Part B|Study Terminated|10|||
124812001|NCT04457336|448941127|FG006|Period 3: Part B|Study Terminated|13|||
124812002|NCT04457336|448941128|FG007|Period 3: Part B|Study Terminated|0|||
124812003|NCT04457336|448941121|FG000|Period 3: Part B|Withdrawal by Subject|0|||
124812004|NCT04457336|448941122|FG001|Period 3: Part B|Withdrawal by Subject|0|||
124812005|NCT04457336|448941123|FG002|Period 3: Part B|Withdrawal by Subject|0|||
124812006|NCT04457336|448941124|FG003|Period 3: Part B|Withdrawal by Subject|0|||
124812007|NCT04457336|448941125|FG004|Period 3: Part B|Withdrawal by Subject|0|||
124812008|NCT04457336|448941126|FG005|Period 3: Part B|Withdrawal by Subject|1|||
124812009|NCT04457336|448941127|FG006|Period 3: Part B|Withdrawal by Subject|2|||
124812010|NCT04457336|448941128|FG007|Period 3: Part B|Withdrawal by Subject|0|||
124812011|NCT04457336|448941121|FG000|Period 4: Part C|Study Terminated|0|||
124812012|NCT04457336|448941122|FG001|Period 4: Part C|Study Terminated|0|||
124812013|NCT04457336|448941123|FG002|Period 4: Part C|Study Terminated|0|||
124812014|NCT04457336|448941124|FG003|Period 4: Part C|Study Terminated|0|||
124812015|NCT04457336|448941125|FG004|Period 4: Part C|Study Terminated|0|||
124812016|NCT04457336|448941126|FG005|Period 4: Part C|Study Terminated|0|||
124812017|NCT04457336|448941127|FG006|Period 4: Part C|Study Terminated|0|||
124812018|NCT04457336|448941128|FG007|Period 4: Part C|Study Terminated|30|||
124812019|NCT04457336|448941121|FG000|Period 4: Part C|Adverse Event|0|||
124812020|NCT04457336|448941122|FG001|Period 4: Part C|Adverse Event|0|||
124812021|NCT04457336|448941123|FG002|Period 4: Part C|Adverse Event|0|||
124812022|NCT04457336|448941124|FG003|Period 4: Part C|Adverse Event|0|||
124812023|NCT04457336|448941125|FG004|Period 4: Part C|Adverse Event|0|||
124812024|NCT04457336|448941126|FG005|Period 4: Part C|Adverse Event|0|||
124812025|NCT04457336|448941127|FG006|Period 4: Part C|Adverse Event|0|||
124812026|NCT04457336|448941128|FG007|Period 4: Part C|Adverse Event|2|||
124812027|NCT04457336|448941121|FG000|Period 4: Part C|Site Terminated|0|||
124812028|NCT04457336|448941122|FG001|Period 4: Part C|Site Terminated|0|||
124812029|NCT04457336|448941123|FG002|Period 4: Part C|Site Terminated|0|||
124812030|NCT04457336|448941124|FG003|Period 4: Part C|Site Terminated|0|||
124812031|NCT04457336|448941125|FG004|Period 4: Part C|Site Terminated|0|||
124812032|NCT04457336|448941126|FG005|Period 4: Part C|Site Terminated|0|||
124812033|NCT04457336|448941127|FG006|Period 4: Part C|Site Terminated|0|||
124812034|NCT04457336|448941128|FG007|Period 4: Part C|Site Terminated|1|||
124812035|NCT04457336|448941121|FG000|Period 4: Part C|Other|0|||
124812036|NCT04457336|448941122|FG001|Period 4: Part C|Other|0|||
124812037|NCT04457336|448941123|FG002|Period 4: Part C|Other|0|||
124812038|NCT04457336|448941124|FG003|Period 4: Part C|Other|0|||
124812039|NCT04457336|448941125|FG004|Period 4: Part C|Other|0|||
124812040|NCT04457336|448941126|FG005|Period 4: Part C|Other|0|||
124812041|NCT04457336|448941127|FG006|Period 4: Part C|Other|0|||
124812042|NCT04457336|448941128|FG007|Period 4: Part C|Other|2|||
124812043|NCT04457336|448941121|FG000|Period 4: Part C|Withdrawal by Subject|0|||
124812044|NCT04457336|448941122|FG001|Period 4: Part C|Withdrawal by Subject|0|||
124812045|NCT04457336|448941123|FG002|Period 4: Part C|Withdrawal by Subject|0|||
124812046|NCT04457336|448941124|FG003|Period 4: Part C|Withdrawal by Subject|0|||
124812047|NCT04457336|448941125|FG004|Period 4: Part C|Withdrawal by Subject|0|||
124812048|NCT04457336|448941126|FG005|Period 4: Part C|Withdrawal by Subject|0|||
124812049|NCT04457336|448941127|FG006|Period 4: Part C|Withdrawal by Subject|0|||
124812050|NCT04457336|448941128|FG007|Period 4: Part C|Withdrawal by Subject|3|||
125300253|NCT01192412|450725947|FG001|Overall Study|Lost to Follow-up|1|||
125300254|NCT01192412|450725946|FG000|Overall Study|Withdrawal by Subject|2|||
125300255|NCT01192412|450725947|FG001|Overall Study|Withdrawal by Subject|1|||
124812051|NCT02571075|448941133|FG000|Overall Study|Lost to Follow-up|20|||
124812052|NCT02571075|448941134|FG001|Overall Study|Lost to Follow-up|24|||
124812053|NCT02693119|448941135|FG000|Open-Label Period|Withdrawal by Subject|0|||
124812054|NCT02693119|448941136|FG001|Open-Label Period|Withdrawal by Subject|1|||
124812055|NCT04203498|448941137|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
124812056|NCT04203498|448941138|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
124812057|NCT04203498|448941137|FG000|Overall Study|Withdrawal of patient consent|7|||
124812058|NCT04203498|448941138|FG001|Overall Study|Withdrawal of patient consent|2|||
124812059|NCT04203498|448941137|FG000|Overall Study|Adverse Event|4|||
124812060|NCT04203498|448941138|FG001|Overall Study|Adverse Event|1|||
124812061|NCT04203498|448941137|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
125300256|NCT00308074|450725951|FG000|Overall Study|Withdrawal by Subject|1|||
124812062|NCT04203498|448941138|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
124812063|NCT04203498|448941137|FG000|Overall Study|Did not receive IMP|2|||
124812064|NCT04203498|448941138|FG001|Overall Study|Did not receive IMP|0|||
124812065|NCT02106975|448941139|FG000|Overall Study|Death|25|||
124812066|NCT02106975|448941140|FG001|Overall Study|Death|39|||
124812067|NCT02935842|448941142|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
124812068|NCT02935842|448941143|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
124812069|NCT02935842|448941144|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
124812070|NCT02935842|448941145|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
124812071|NCT02935842|448941142|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
124812072|NCT02935842|448941143|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
124812073|NCT02935842|448941144|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
124812074|NCT02935842|448941145|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
124812075|NCT02935842|448941142|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
124812076|NCT02935842|448941143|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
124812077|NCT02935842|448941144|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
124812078|NCT02935842|448941145|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
124812079|NCT02935842|448941142|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
124812080|NCT02935842|448941143|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
124812081|NCT02935842|448941144|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
124812082|NCT02935842|448941145|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
124812083|NCT02935842|448941142|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
124812084|NCT02935842|448941143|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
124812085|NCT02935842|448941144|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
124812086|NCT02935842|448941145|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
124812087|NCT01201785|448941146|FG000|Overall Study|Lost to Follow-up|16|||
124812088|NCT04545385|448941147|FG000|Overall Study|Withdrawal by Subject|2|||
124812089|NCT04545385|448941148|FG001|Overall Study|Withdrawal by Subject|0|||
124812090|NCT04545385|448941147|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
124812091|NCT04545385|448941148|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
124812092|NCT04545385|448941147|FG000|Overall Study|Study termination|10|||
124812093|NCT04545385|448941148|FG001|Overall Study|Study termination|10|||
124812094|NCT04545385|448941147|FG000|Overall Study|Sponsor decision|2|||
124812095|NCT04545385|448941148|FG001|Overall Study|Sponsor decision|2|||
124812096|NCT04545385|448941147|FG000|Overall Study|Other than specified|1|||
124812097|NCT04545385|448941148|FG001|Overall Study|Other than specified|0|||
124812098|NCT00939770|448941149|FG000|Overall Study|Adverse Event|1|||
124812099|NCT00939770|448941150|FG001|Overall Study|Adverse Event|1|||
124812100|NCT00939770|448941151|FG002|Overall Study|Adverse Event|0|||
124812101|NCT00939770|448941152|FG003|Overall Study|Adverse Event|0|||
124812102|NCT00939770|448941153|FG004|Overall Study|Adverse Event|6|||
124812103|NCT00939770|448941154|FG005|Overall Study|Adverse Event|2|||
124812104|NCT00939770|448941155|FG006|Overall Study|Adverse Event|1|||
124812105|NCT00939770|448941156|FG007|Overall Study|Adverse Event|1|||
124812106|NCT00939770|448941149|FG000|Overall Study|Lack of Efficacy|4|||
124812107|NCT00939770|448941150|FG001|Overall Study|Lack of Efficacy|6|||
124812108|NCT00939770|448941151|FG002|Overall Study|Lack of Efficacy|13|||
124812109|NCT00939770|448941152|FG003|Overall Study|Lack of Efficacy|9|||
124812110|NCT00939770|448941153|FG004|Overall Study|Lack of Efficacy|16|||
124812111|NCT00939770|448941154|FG005|Overall Study|Lack of Efficacy|8|||
124812112|NCT00939770|448941155|FG006|Overall Study|Lack of Efficacy|11|||
124812113|NCT00939770|448941156|FG007|Overall Study|Lack of Efficacy|1|||
124812114|NCT00939770|448941149|FG000|Overall Study|Lost to Follow-up|0|||
124812115|NCT00939770|448941150|FG001|Overall Study|Lost to Follow-up|0|||
124812116|NCT00939770|448941151|FG002|Overall Study|Lost to Follow-up|0|||
124812117|NCT00939770|448941152|FG003|Overall Study|Lost to Follow-up|0|||
124812118|NCT00939770|448941153|FG004|Overall Study|Lost to Follow-up|1|||
124812119|NCT00939770|448941154|FG005|Overall Study|Lost to Follow-up|0|||
124812120|NCT00939770|448941155|FG006|Overall Study|Lost to Follow-up|0|||
124812121|NCT00939770|448941156|FG007|Overall Study|Lost to Follow-up|0|||
124812122|NCT00939770|448941149|FG000|Overall Study|Physician Decision|0|||
124812123|NCT00939770|448941150|FG001|Overall Study|Physician Decision|0|||
124812124|NCT00939770|448941151|FG002|Overall Study|Physician Decision|2|||
124812125|NCT00939770|448941152|FG003|Overall Study|Physician Decision|0|||
124812126|NCT00939770|448941153|FG004|Overall Study|Physician Decision|7|||
124812127|NCT00939770|448941154|FG005|Overall Study|Physician Decision|1|||
124812128|NCT00939770|448941155|FG006|Overall Study|Physician Decision|0|||
124812129|NCT00939770|448941156|FG007|Overall Study|Physician Decision|6|||
124812130|NCT00939770|448941149|FG000|Overall Study|Protocol Violation|0|||
124812131|NCT00939770|448941150|FG001|Overall Study|Protocol Violation|0|||
124812132|NCT00939770|448941151|FG002|Overall Study|Protocol Violation|0|||
124812133|NCT00939770|448941152|FG003|Overall Study|Protocol Violation|0|||
124812134|NCT00939770|448941153|FG004|Overall Study|Protocol Violation|1|||
124812135|NCT00939770|448941154|FG005|Overall Study|Protocol Violation|0|||
124812136|NCT00939770|448941155|FG006|Overall Study|Protocol Violation|0|||
124812137|NCT00939770|448941156|FG007|Overall Study|Protocol Violation|0|||
124812138|NCT00939770|448941149|FG000|Overall Study|Withdrawal by Subject|0|||
124812139|NCT00939770|448941150|FG001|Overall Study|Withdrawal by Subject|1|||
124812140|NCT00939770|448941151|FG002|Overall Study|Withdrawal by Subject|5|||
124812141|NCT00939770|448941152|FG003|Overall Study|Withdrawal by Subject|2|||
124812142|NCT00939770|448941153|FG004|Overall Study|Withdrawal by Subject|6|||
124812143|NCT00939770|448941154|FG005|Overall Study|Withdrawal by Subject|0|||
124812144|NCT00939770|448941155|FG006|Overall Study|Withdrawal by Subject|2|||
124812145|NCT00939770|448941156|FG007|Overall Study|Withdrawal by Subject|2|||
124812146|NCT00191139|448941157|FG000|Overall Study|Adverse Event|2|||
124812147|NCT00191139|448941158|FG001|Overall Study|Adverse Event|6|||
124812148|NCT00191139|448941157|FG000|Overall Study|Death|2|||
124812149|NCT00191139|448941158|FG001|Overall Study|Death|0|||
124812150|NCT00191139|448941157|FG000|Overall Study|Withdrawal by Subject|0|||
124812151|NCT00191139|448941158|FG001|Overall Study|Withdrawal by Subject|3|||
124812152|NCT00191139|448941157|FG000|Overall Study|Disease Progression|0|||
124812153|NCT00191139|448941158|FG001|Overall Study|Disease Progression|1|||
124812154|NCT00191139|448941157|FG000|Overall Study|Other|1|||
124812155|NCT00191139|448941158|FG001|Overall Study|Other|2|||
124812156|NCT03128411|448941165|FG000|Treatment Phase|Adverse Event|21|||
124812157|NCT03128411|448941165|FG000|Treatment Phase|Physician Decision|1|||
124812158|NCT03128411|448941165|FG000|Treatment Phase|Other|2|||
124812159|NCT03128411|448941165|FG000|Long Term Follow-up Phase|Death|2|||
124819544|NCT05147350|448965749|FG002|Overall Study|Withdrawal by Subject|3|||
124819545|NCT05147350|448965750|FG003|Overall Study|Withdrawal by Subject|1|||
124819546|NCT05147350|448965751|FG004|Overall Study|Withdrawal by Subject|1|||
124819547|NCT05147350|448965752|FG005|Overall Study|Withdrawal by Subject|0|||
124819548|NCT05147350|448965753|FG006|Overall Study|Withdrawal by Subject|1|||
124819549|NCT05147350|448965754|FG007|Overall Study|Withdrawal by Subject|0|||
124819550|NCT05147350|448965747|FG000|Overall Study|Other Reasons|0|||
124819551|NCT05147350|448965748|FG001|Overall Study|Other Reasons|0|||
124819552|NCT05147350|448965749|FG002|Overall Study|Other Reasons|2|||
124819553|NCT05147350|448965750|FG003|Overall Study|Other Reasons|0|||
124819554|NCT05147350|448965751|FG004|Overall Study|Other Reasons|0|||
124819555|NCT05147350|448965752|FG005|Overall Study|Other Reasons|2|||
124819556|NCT05147350|448965753|FG006|Overall Study|Other Reasons|1|||
124819557|NCT05147350|448965754|FG007|Overall Study|Other Reasons|1|||
124819558|NCT02627144|448965758|FG000|Overall Study|Serious adverse event|32|||
124819559|NCT02627144|448965758|FG000|Overall Study|Cancer progression|171|||
124819560|NCT02627144|448965758|FG000|Overall Study|Death from cancer|20|||
124819561|NCT02627144|448965758|FG000|Overall Study|Death from other cause|8|||
124819562|NCT02627144|448965758|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
124819563|NCT02627144|448965758|FG000|Overall Study|Administrative reasons|65|||
124819564|NCT02627144|448965758|FG000|Overall Study|Lost to Follow-up|8|||
124819565|NCT02627144|448965758|FG000|Overall Study|Enrolled, not treated|6|||
124819566|NCT02627144|448965758|FG000|Overall Study|Other|17|||
124819567|NCT00420927|448965761|FG000|Period 1|Adverse Event|19|||
125300257|NCT01329939|450725954|FG000|Overall Study|Lost to Follow-up|3|||
125300258|NCT01329939|450725955|FG001|Overall Study|Lost to Follow-up|0|||
125300259|NCT01329939|450725956|FG002|Overall Study|Lost to Follow-up|1|||
125300260|NCT01329939|450725957|FG003|Overall Study|Lost to Follow-up|2|||
125300261|NCT01329939|450725954|FG000|Overall Study|Withdrawal by Subject|0|||
125300262|NCT01329939|450725955|FG001|Overall Study|Withdrawal by Subject|1|||
125300263|NCT01329939|450725956|FG002|Overall Study|Withdrawal by Subject|0|||
125300264|NCT01329939|450725957|FG003|Overall Study|Withdrawal by Subject|0|||
125300265|NCT01329939|450725954|FG000|Overall Study|Adverse Event|0|||
125300266|NCT01329939|450725955|FG001|Overall Study|Adverse Event|0|||
125300267|NCT01329939|450725956|FG002|Overall Study|Adverse Event|0|||
125300268|NCT01329939|450725957|FG003|Overall Study|Adverse Event|3|||
125300269|NCT02942485|450725958|FG000|Overall Study|Lost to Follow-up|1|||
125300270|NCT02942485|450725959|FG001|Overall Study|Lost to Follow-up|0|||
125300271|NCT04369950|450725961|FG000|Overall Study|Protocol Violation|2|||
125300272|NCT04369950|450725962|FG001|Overall Study|Protocol Violation|2|||
125300273|NCT00989963|450725963|FG000|Overall Study|Adverse Event|1|||
125300274|NCT00989963|450725964|FG001|Overall Study|Adverse Event|1|||
125300275|NCT00989963|450725965|FG002|Overall Study|Adverse Event|1|||
125300276|NCT01240200|450725966|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
124819568|NCT00420927|448965762|FG001|Period 1|Adverse Event|15|||
124819569|NCT00420927|448965763|FG002|Period 1|Adverse Event|0|||
124819570|NCT00420927|448965764|FG003|Period 1|Adverse Event|0|||
124819571|NCT00420927|448965765|FG004|Period 1|Adverse Event|0|||
125300277|NCT01240200|450725967|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
125300278|NCT01529034|450725968|FG000|Overall Study|Discontinued prior to study treatment|14|||
124819572|NCT00420927|448965766|FG005|Period 1|Adverse Event|0|||
124819573|NCT00420927|448965767|FG006|Period 1|Adverse Event|0|||
124819574|NCT00420927|448965761|FG000|Period 1|Withdrawal by Subject|7|||
124819575|NCT00420927|448965762|FG001|Period 1|Withdrawal by Subject|12|||
124819576|NCT00420927|448965763|FG002|Period 1|Withdrawal by Subject|0|||
124819577|NCT00420927|448965764|FG003|Period 1|Withdrawal by Subject|0|||
124819578|NCT00420927|448965765|FG004|Period 1|Withdrawal by Subject|0|||
124819579|NCT00420927|448965766|FG005|Period 1|Withdrawal by Subject|0|||
125300279|NCT01529034|450725968|FG000|Overall Study|Site closure|62|||
125300280|NCT01529034|450725968|FG000|Overall Study|Study termination|29|||
125300281|NCT01529034|450725968|FG000|Overall Study|Withdrawal by Subject|25|||
125300282|NCT01529034|450725968|FG000|Overall Study|No treated SCs within protocol window|13|||
125300283|NCT01529034|450725968|FG000|Overall Study|Noncompliance|8|||
125300284|NCT01529034|450725968|FG000|Overall Study|Caregiver no longer available|7|||
125300285|NCT01529034|450725968|FG000|Overall Study|Adverse Event|4|||
125300286|NCT01529034|450725968|FG000|Overall Study|Protocol Violation|4|||
125300287|NCT01529034|450725968|FG000|Overall Study|Lack of Efficacy|4|||
125300288|NCT01529034|450725968|FG000|Overall Study|Investigator no longer available|2|||
125300289|NCT01529034|450725968|FG000|Overall Study|Study drug not available|2|||
125300290|NCT03194646|450725972|FG000|Overall Study|Adverse Event|24|||
125300291|NCT03194646|450725973|FG001|Overall Study|Adverse Event|25|||
125300292|NCT03194646|450725974|FG002|Overall Study|Adverse Event|14|||
125300293|NCT03194646|450725975|FG003|Overall Study|Adverse Event|17|||
125300294|NCT03194646|450725972|FG000|Overall Study|Lack of Efficacy|4|||
125300295|NCT03194646|450725973|FG001|Overall Study|Lack of Efficacy|2|||
125300296|NCT03194646|450725974|FG002|Overall Study|Lack of Efficacy|2|||
125300297|NCT03194646|450725975|FG003|Overall Study|Lack of Efficacy|12|||
125300298|NCT03194646|450725972|FG000|Overall Study|Lost to Follow-up|30|||
125300299|NCT03194646|450725973|FG001|Overall Study|Lost to Follow-up|22|||
125300300|NCT03194646|450725974|FG002|Overall Study|Lost to Follow-up|12|||
125300301|NCT03194646|450725975|FG003|Overall Study|Lost to Follow-up|35|||
125300302|NCT03194646|450725972|FG000|Overall Study|Non-compliance with study drug|4|||
125300303|NCT03194646|450725973|FG001|Overall Study|Non-compliance with study drug|0|||
125300304|NCT03194646|450725974|FG002|Overall Study|Non-compliance with study drug|1|||
125300305|NCT03194646|450725975|FG003|Overall Study|Non-compliance with study drug|1|||
125300306|NCT03194646|450725972|FG000|Overall Study|Other|89|||
125300307|NCT03194646|450725973|FG001|Overall Study|Other|68|||
125300308|NCT03194646|450725974|FG002|Overall Study|Other|34|||
125300309|NCT03194646|450725975|FG003|Overall Study|Other|31|||
125300310|NCT03194646|450725972|FG000|Overall Study|Physician Decision|7|||
125300311|NCT03194646|450725973|FG001|Overall Study|Physician Decision|9|||
125300312|NCT03194646|450725974|FG002|Overall Study|Physician Decision|5|||
125300313|NCT03194646|450725975|FG003|Overall Study|Physician Decision|4|||
125300314|NCT03194646|450725972|FG000|Overall Study|Pregnancy|4|||
125300315|NCT03194646|450725973|FG001|Overall Study|Pregnancy|5|||
125300316|NCT03194646|450725974|FG002|Overall Study|Pregnancy|1|||
125300317|NCT03194646|450725975|FG003|Overall Study|Pregnancy|2|||
125300318|NCT03194646|450725972|FG000|Overall Study|Protocol Violation|4|||
125300319|NCT03194646|450725973|FG001|Overall Study|Protocol Violation|2|||
125300320|NCT03194646|450725974|FG002|Overall Study|Protocol Violation|1|||
125300321|NCT03194646|450725975|FG003|Overall Study|Protocol Violation|1|||
125300322|NCT03194646|450725972|FG000|Overall Study|Site terminated by sponsor|0|||
125300323|NCT03194646|450725973|FG001|Overall Study|Site terminated by sponsor|0|||
125300324|NCT03194646|450725974|FG002|Overall Study|Site terminated by sponsor|2|||
125300325|NCT03194646|450725975|FG003|Overall Study|Site terminated by sponsor|0|||
125300326|NCT03194646|450725972|FG000|Overall Study|Study terminated by sponsor|62|||
125300327|NCT03194646|450725973|FG001|Overall Study|Study terminated by sponsor|61|||
125300328|NCT03194646|450725974|FG002|Overall Study|Study terminated by sponsor|30|||
125300329|NCT03194646|450725975|FG003|Overall Study|Study terminated by sponsor|34|||
125300330|NCT03194646|450725972|FG000|Overall Study|Withdrawal by Subject|75|||
125300331|NCT03194646|450725973|FG001|Overall Study|Withdrawal by Subject|74|||
125300332|NCT03194646|450725974|FG002|Overall Study|Withdrawal by Subject|36|||
125300333|NCT03194646|450725975|FG003|Overall Study|Withdrawal by Subject|131|||
125300334|NCT03194646|450725972|FG000|Overall Study|Missing|1|||
125300335|NCT03194646|450725973|FG001|Overall Study|Missing|0|||
125300336|NCT03194646|450725974|FG002|Overall Study|Missing|1|||
125300337|NCT03194646|450725975|FG003|Overall Study|Missing|12|||
124812160|NCT01798004|448942575|FG000|Overall Study|Death|2|||
124812161|NCT01798004|448942575|FG000|Overall Study|Lack of Efficacy|8|||
124812162|NCT01798004|448942575|FG000|Overall Study|Physician Decision|25|||
124812163|NCT01798004|448942575|FG000|Overall Study|Withdrawal by Subject|4|||
124812164|NCT01798004|448942575|FG000|Overall Study|Ineligible|4|||
124812165|NCT01798004|448942575|FG000|Overall Study|Patient/parent refusal|7|||
125300338|NCT02649894|450725976|FG000|Overall Study|Adverse Event|1|||
125300339|NCT02649894|450725977|FG001|Overall Study|Adverse Event|0|||
125300340|NCT02649894|450725976|FG000|Overall Study|Physician Decision|0|||
125300341|NCT02649894|450725977|FG001|Overall Study|Physician Decision|1|||
125300342|NCT02649894|450725976|FG000|Overall Study|Withdrawal by Subject|5|||
125300343|NCT02649894|450725977|FG001|Overall Study|Withdrawal by Subject|2|||
125300344|NCT02649894|450725976|FG000|Overall Study|Lost to Follow-up|2|||
125300345|NCT02649894|450725977|FG001|Overall Study|Lost to Follow-up|1|||
125300346|NCT02649894|450725976|FG000|Overall Study|Death|30|||
125300347|NCT02649894|450725977|FG001|Overall Study|Death|7|||
125300348|NCT02649894|450725976|FG000|Overall Study|Other, not specified|6|||
125300349|NCT02649894|450725977|FG001|Overall Study|Other, not specified|0|||
125300350|NCT00719680|450725978|FG000|Overall Study|Adverse Event|1|||
125300351|NCT00719680|450725978|FG000|Overall Study|Lost to Follow-up|1|||
125300352|NCT00719680|450725978|FG000|Overall Study|Withdrawal by Subject|3|||
125300353|NCT02141360|450725979|FG000|Overall Study|Withdrawal by Subject|6|||
125300354|NCT02141360|450725980|FG001|Overall Study|Withdrawal by Subject|0|||
125300355|NCT02141360|450725981|FG002|Overall Study|Withdrawal by Subject|0|||
125300356|NCT02141360|450725979|FG000|Overall Study|Study Terminated before Visit|1|||
125300357|NCT02141360|450725980|FG001|Overall Study|Study Terminated before Visit|0|||
125300358|NCT02141360|450725981|FG002|Overall Study|Study Terminated before Visit|0|||
125300359|NCT04071158|450725982|FG000|Overall Study|Lost to Follow-up|1|||
125300360|NCT04071158|450725983|FG001|Overall Study|Lost to Follow-up|2|||
125300361|NCT04071158|450725984|FG002|Overall Study|Lost to Follow-up|3|||
125300362|NCT04071158|450725985|FG003|Overall Study|Lost to Follow-up|3|||
125300363|NCT04071158|450725986|FG004|Overall Study|Lost to Follow-up|5|||
125300364|NCT04071158|450725982|FG000|Overall Study|Randomized but not treated|2|||
125300365|NCT04071158|450725983|FG001|Overall Study|Randomized but not treated|2|||
125300366|NCT04071158|450725984|FG002|Overall Study|Randomized but not treated|0|||
125300367|NCT04071158|450725985|FG003|Overall Study|Randomized but not treated|0|||
125300368|NCT04071158|450725986|FG004|Overall Study|Randomized but not treated|0|||
125300369|NCT01178099|450725987|FG000|Overall Study|Physician Decision|0|||
125300370|NCT01178099|450725988|FG001|Overall Study|Physician Decision|1|||
125300371|NCT05198843|450725989|FG000|Overall Study|Lack of Efficacy|1|||
125300372|NCT01641822|450725991|FG000|Run-in Phase|Noncompliance with study drug|1|||
125300373|NCT01641822|450725992|FG001|Run-in Phase|Noncompliance with study drug|0|||
125300374|NCT01641822|450725993|FG002|Run-in Phase|Noncompliance with study drug|0|||
125300375|NCT01641822|450725991|FG000|Run-in Phase|Adverse Event|3|||
125300376|NCT01641822|450725992|FG001|Run-in Phase|Adverse Event|0|||
125300377|NCT01641822|450725993|FG002|Run-in Phase|Adverse Event|0|||
125300378|NCT01641822|450725991|FG000|Run-in Phase|Withdrew consent|1|||
125300379|NCT01641822|450725992|FG001|Run-in Phase|Withdrew consent|0|||
125300380|NCT01641822|450725993|FG002|Run-in Phase|Withdrew consent|0|||
125300381|NCT01641822|450725991|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
125300382|NCT01641822|450725992|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
125300383|NCT01641822|450725993|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
125300384|NCT01641822|450725991|FG000|Comparative Phase|Noncompliance with study drug|0|||
125300385|NCT01641822|450725992|FG001|Comparative Phase|Noncompliance with study drug|1|||
125300386|NCT01641822|450725993|FG002|Comparative Phase|Noncompliance with study drug|0|||
125300387|NCT01641822|450725991|FG000|Comparative Phase|Investigator's discretion|0|||
125300388|NCT01641822|450725992|FG001|Comparative Phase|Investigator's discretion|0|||
125300389|NCT01641822|450725993|FG002|Comparative Phase|Investigator's discretion|1|||
125300390|NCT01641822|450725991|FG000|Comparative Phase|Pregnancy|0|||
125300391|NCT01641822|450725992|FG001|Comparative Phase|Pregnancy|0|||
125300392|NCT01641822|450725993|FG002|Comparative Phase|Pregnancy|1|||
125300393|NCT01641822|450725991|FG000|Comparative Phase|Adverse event, serious fatal|0|||
125300394|NCT01641822|450725992|FG001|Comparative Phase|Adverse event, serious fatal|1|||
125300395|NCT01641822|450725993|FG002|Comparative Phase|Adverse event, serious fatal|0|||
125300396|NCT01641822|450725991|FG000|Comparative Phase|Withdrew consent|0|||
125300397|NCT01641822|450725992|FG001|Comparative Phase|Withdrew consent|3|||
125300398|NCT01641822|450725993|FG002|Comparative Phase|Withdrew consent|7|||
125300399|NCT01641822|450725991|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
125300400|NCT01641822|450725992|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
125300401|NCT01641822|450725993|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
125300402|NCT00454584|450725994|FG000|Controlled Period|Adverse Event|5|||
125300403|NCT00454584|450725995|FG001|Controlled Period|Adverse Event|2|||
125300404|NCT00454584|450725996|FG002|Controlled Period|Adverse Event|1|||
125300405|NCT00454584|450725997|FG003|Controlled Period|Adverse Event|0|||
125300406|NCT00454584|450725998|FG004|Controlled Period|Adverse Event|0|||
125300407|NCT00454584|450725999|FG005|Controlled Period|Adverse Event|0|||
125300408|NCT00454584|450725994|FG000|Controlled Period|Lost to Follow-up|1|||
125300409|NCT00454584|450725995|FG001|Controlled Period|Lost to Follow-up|2|||
125300410|NCT00454584|450725996|FG002|Controlled Period|Lost to Follow-up|2|||
125300411|NCT00454584|450725997|FG003|Controlled Period|Lost to Follow-up|0|||
125300412|NCT00454584|450725998|FG004|Controlled Period|Lost to Follow-up|0|||
125300413|NCT00454584|450725999|FG005|Controlled Period|Lost to Follow-up|0|||
125300414|NCT00454584|450725994|FG000|Controlled Period|Other|5|||
125300415|NCT00454584|450725995|FG001|Controlled Period|Other|4|||
125300416|NCT00454584|450725996|FG002|Controlled Period|Other|2|||
125300417|NCT00454584|450725997|FG003|Controlled Period|Other|0|||
125300418|NCT00454584|450725998|FG004|Controlled Period|Other|0|||
125300419|NCT00454584|450725999|FG005|Controlled Period|Other|0|||
125300420|NCT00454584|450725994|FG000|After Controlled Period|Adverse Event|0|||
125300421|NCT00454584|450725995|FG001|After Controlled Period|Adverse Event|0|||
125300422|NCT00454584|450725996|FG002|After Controlled Period|Adverse Event|0|||
125300423|NCT00454584|450725997|FG003|After Controlled Period|Adverse Event|9|||
125300424|NCT00454584|450725998|FG004|After Controlled Period|Adverse Event|3|||
125300425|NCT00454584|450725999|FG005|After Controlled Period|Adverse Event|9|||
125300426|NCT00454584|450725994|FG000|After Controlled Period|Lack of Efficacy|0|||
125300427|NCT00454584|450725995|FG001|After Controlled Period|Lack of Efficacy|0|||
125300428|NCT00454584|450725996|FG002|After Controlled Period|Lack of Efficacy|0|||
125300429|NCT00454584|450725997|FG003|After Controlled Period|Lack of Efficacy|1|||
125300430|NCT00454584|450725998|FG004|After Controlled Period|Lack of Efficacy|0|||
125300431|NCT00454584|450725999|FG005|After Controlled Period|Lack of Efficacy|0|||
125300432|NCT00454584|450725994|FG000|After Controlled Period|Lost to Follow-up|0|||
125300433|NCT00454584|450725995|FG001|After Controlled Period|Lost to Follow-up|0|||
125300434|NCT00454584|450725996|FG002|After Controlled Period|Lost to Follow-up|0|||
125300435|NCT00454584|450725997|FG003|After Controlled Period|Lost to Follow-up|2|||
125300436|NCT00454584|450725998|FG004|After Controlled Period|Lost to Follow-up|4|||
125300437|NCT00454584|450725999|FG005|After Controlled Period|Lost to Follow-up|6|||
125300438|NCT00454584|450725994|FG000|After Controlled Period|Other|0|||
125300439|NCT00454584|450725995|FG001|After Controlled Period|Other|0|||
125300440|NCT00454584|450725996|FG002|After Controlled Period|Other|0|||
125300441|NCT00454584|450725997|FG003|After Controlled Period|Other|1|||
125300442|NCT00454584|450725998|FG004|After Controlled Period|Other|0|||
125300443|NCT00454584|450725999|FG005|After Controlled Period|Other|0|||
125300444|NCT00454584|450725994|FG000|After Controlled Period|Other|0|||
125300445|NCT00454584|450725995|FG001|After Controlled Period|Other|0|||
125300446|NCT00454584|450725996|FG002|After Controlled Period|Other|0|||
125300447|NCT00454584|450725997|FG003|After Controlled Period|Other|13|||
125300448|NCT00454584|450725998|FG004|After Controlled Period|Other|5|||
125300449|NCT00454584|450725999|FG005|After Controlled Period|Other|17|||
125300450|NCT02421601|450726000|FG000|Overall Study|Adverse Event|4|||
125300451|NCT02421601|450726000|FG000|Overall Study|Lack of Efficacy|5|||
125300452|NCT02421601|450726000|FG000|Overall Study|Physician Decision|1|||
125300453|NCT02421601|450726000|FG000|Overall Study|Withdrawal by Subject|31|||
125300454|NCT02421601|450726000|FG000|Overall Study|Others|41|||
125300455|NCT00470418|450726001|FG000|Overall Study|Withdrawal by Subject|1|||
125300456|NCT00470418|450726002|FG001|Overall Study|Withdrawal by Subject|0|||
125300457|NCT00599638|450726003|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
125300458|NCT00599638|450726004|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
125300459|NCT00599638|450726005|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
125300460|NCT00599638|450726006|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
125300461|NCT00599638|450726003|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
125300462|NCT00599638|450726004|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
125300463|NCT00599638|450726005|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
125300464|NCT00599638|450726006|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
125300465|NCT00599638|450726003|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
125300466|NCT00599638|450726004|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
125300467|NCT00599638|450726005|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
125300468|NCT00599638|450726006|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
125300469|NCT00599638|450726003|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
125300470|NCT00599638|450726004|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
125300471|NCT00599638|450726005|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
125300472|NCT00599638|450726006|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
125300473|NCT00599638|450726003|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
125300474|NCT00599638|450726004|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
125300475|NCT00599638|450726005|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
125300476|NCT00599638|450726006|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
125300477|NCT00599638|450726003|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
125300478|NCT00599638|450726004|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
125300479|NCT00599638|450726005|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
125300480|NCT00599638|450726006|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
125300481|NCT00599638|450726003|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
125300482|NCT00599638|450726004|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
125300483|NCT00599638|450726005|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
125300484|NCT00599638|450726006|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
125300485|NCT00599638|450726003|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
125300486|NCT00599638|450726004|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
125300487|NCT00599638|450726005|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
125300488|NCT00599638|450726006|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
125300489|NCT00599638|450726003|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
125300490|NCT00599638|450726004|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
125300491|NCT00599638|450726005|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
125300492|NCT00599638|450726006|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
125300493|NCT04058886|450726021|FG000|Overall Study|Withdrawal by Subject|4|||
125300494|NCT04058886|450726021|FG000|Overall Study|Inadequate deafness interpreter service|1|||
125300495|NCT02220712|450726029|FG000|Overall Study|Adverse Event|1|||
125300496|NCT02220712|450726029|FG000|Overall Study|Withdrawal by Subject|2|||
125300497|NCT02220712|450726029|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
125300498|NCT00760838|450726031|FG000|Overall Study|Adverse Event|1|||
125300499|NCT00760838|450726032|FG001|Overall Study|Adverse Event|1|||
124819580|NCT00420927|448965767|FG006|Period 1|Withdrawal by Subject|0|||
125300500|NCT00760838|450726031|FG000|Overall Study|Lack of Efficacy|1|||
125300501|NCT00760838|450726032|FG001|Overall Study|Lack of Efficacy|0|||
125300502|NCT00760838|450726031|FG000|Overall Study|Lost to Follow-up|2|||
125300503|NCT00760838|450726032|FG001|Overall Study|Lost to Follow-up|0|||
125300504|NCT00760838|450726031|FG000|Overall Study|Withdrawal by Subject|1|||
125300505|NCT00760838|450726032|FG001|Overall Study|Withdrawal by Subject|1|||
125300506|NCT03624127|450726033|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
125300507|NCT03624127|450726034|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
125300508|NCT03624127|450726035|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
125300509|NCT03624127|450726033|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
125300510|NCT03624127|450726034|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
125300511|NCT03624127|450726035|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
125300512|NCT03624127|450726033|FG000|Treatment Week 0 - Week 16|Death|0|||
125300513|NCT03624127|450726034|FG001|Treatment Week 0 - Week 16|Death|1|||
125300514|NCT03624127|450726035|FG002|Treatment Week 0 - Week 16|Death|0|||
125300515|NCT03624127|450726033|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
125300516|NCT03624127|450726034|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
125300517|NCT03624127|450726035|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
125300518|NCT03624127|450726033|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
125300519|NCT03624127|450726034|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
125300520|NCT03624127|450726035|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
125300521|NCT03624127|450726033|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
125300522|NCT03624127|450726034|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
125300523|NCT03624127|450726035|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
125300524|NCT03624127|450726033|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
125300525|NCT03624127|450726034|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
125300526|NCT03624127|450726035|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
125300527|NCT03624127|450726033|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
125300528|NCT03624127|450726034|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
125300529|NCT03624127|450726035|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
125300530|NCT03624127|450726033|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
125300531|NCT03624127|450726034|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
125300532|NCT03624127|450726035|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
125300533|NCT03624127|450726033|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
125300534|NCT03624127|450726034|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
125300535|NCT03624127|450726035|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
125300536|NCT03624127|450726033|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
125300537|NCT03624127|450726034|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
125300538|NCT03624127|450726035|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
125300539|NCT03624127|450726033|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
125300540|NCT03624127|450726034|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
125300541|NCT03624127|450726035|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
125300542|NCT03624127|450726033|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
125300543|NCT03624127|450726034|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
125300544|NCT03624127|450726035|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
125300545|NCT03624127|450726033|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
125300546|NCT03624127|450726034|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
125300547|NCT03624127|450726035|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
125300548|NCT03624127|450726033|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
125300549|NCT03624127|450726034|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
125300550|NCT03624127|450726035|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
125300551|NCT03624127|450726033|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
125300552|NCT03624127|450726034|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
125300553|NCT03624127|450726035|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
125300554|NCT03624127|450726033|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
125300555|NCT03624127|450726034|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
125300556|NCT03624127|450726035|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
125300557|NCT03624127|450726033|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
125300558|NCT03624127|450726034|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
125300559|NCT03624127|450726035|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
125300560|NCT03624127|450726033|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
125300561|NCT03624127|450726034|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
125300562|NCT03624127|450726035|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
125300563|NCT03624127|450726033|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
125300564|NCT03624127|450726034|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
125300565|NCT03624127|450726035|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
125300566|NCT03624127|450726033|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
125300567|NCT03624127|450726034|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
125300568|NCT03624127|450726035|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
125300569|NCT02999633|450726036|FG000|Overall Study|Adverse Event|2|||
125300570|NCT02999633|450726036|FG000|Overall Study|Progressive disease|12|||
125300571|NCT02607228|450726037|FG000|Overall Study|Progressive Disease|4|||
125300572|NCT02607228|450726038|FG001|Overall Study|Progressive Disease|3|||
125300573|NCT02607228|450726039|FG002|Overall Study|Progressive Disease|1|||
125300574|NCT02607228|450726040|FG003|Overall Study|Progressive Disease|5|||
125300575|NCT02607228|450726041|FG004|Overall Study|Progressive Disease|4|||
125300576|NCT02607228|450726042|FG005|Overall Study|Progressive Disease|3|||
125300577|NCT02607228|450726043|FG006|Overall Study|Progressive Disease|1|||
125300578|NCT02607228|450726037|FG000|Overall Study|Adverse Event|1|||
125300579|NCT02607228|450726038|FG001|Overall Study|Adverse Event|0|||
125300580|NCT02607228|450726039|FG002|Overall Study|Adverse Event|1|||
125300581|NCT02607228|450726040|FG003|Overall Study|Adverse Event|0|||
125300582|NCT02607228|450726041|FG004|Overall Study|Adverse Event|1|||
125300583|NCT02607228|450726042|FG005|Overall Study|Adverse Event|1|||
125300584|NCT02607228|450726043|FG006|Overall Study|Adverse Event|1|||
125300585|NCT02607228|450726037|FG000|Overall Study|Investigator's Discretion|0|||
125300586|NCT02607228|450726038|FG001|Overall Study|Investigator's Discretion|0|||
125300587|NCT02607228|450726039|FG002|Overall Study|Investigator's Discretion|1|||
125300588|NCT02607228|450726040|FG003|Overall Study|Investigator's Discretion|0|||
125300589|NCT02607228|450726041|FG004|Overall Study|Investigator's Discretion|0|||
125300590|NCT02607228|450726042|FG005|Overall Study|Investigator's Discretion|1|||
125300591|NCT02607228|450726043|FG006|Overall Study|Investigator's Discretion|0|||
125300592|NCT02607228|450726037|FG000|Overall Study|Withdrew Consent|0|||
125300593|NCT02607228|450726038|FG001|Overall Study|Withdrew Consent|1|||
125300594|NCT02607228|450726039|FG002|Overall Study|Withdrew Consent|0|||
125300595|NCT02607228|450726040|FG003|Overall Study|Withdrew Consent|0|||
125300596|NCT02607228|450726041|FG004|Overall Study|Withdrew Consent|0|||
125300597|NCT02607228|450726042|FG005|Overall Study|Withdrew Consent|1|||
125300598|NCT02607228|450726043|FG006|Overall Study|Withdrew Consent|0|||
125300599|NCT02607228|450726037|FG000|Overall Study|Study Terminated by Sponsor|0|||
125300600|NCT02607228|450726038|FG001|Overall Study|Study Terminated by Sponsor|0|||
125300601|NCT02607228|450726039|FG002|Overall Study|Study Terminated by Sponsor|0|||
125300602|NCT02607228|450726040|FG003|Overall Study|Study Terminated by Sponsor|1|||
125300603|NCT02607228|450726041|FG004|Overall Study|Study Terminated by Sponsor|0|||
125300604|NCT02607228|450726042|FG005|Overall Study|Study Terminated by Sponsor|0|||
125300605|NCT02607228|450726043|FG006|Overall Study|Study Terminated by Sponsor|0|||
125300606|NCT00788710|450726044|FG000|Overall Study|Adverse Event|1|||
125300607|NCT00788710|450726045|FG001|Overall Study|Adverse Event|3|||
125300608|NCT00788710|450726046|FG002|Overall Study|Adverse Event|4|||
125300609|NCT00788710|450726044|FG000|Overall Study|Lack of Efficacy|0|||
125300610|NCT00788710|450726045|FG001|Overall Study|Lack of Efficacy|0|||
125300611|NCT00788710|450726046|FG002|Overall Study|Lack of Efficacy|1|||
125300612|NCT00788710|450726044|FG000|Overall Study|Lost to Follow-up|0|||
125300613|NCT00788710|450726045|FG001|Overall Study|Lost to Follow-up|1|||
125300614|NCT00788710|450726046|FG002|Overall Study|Lost to Follow-up|0|||
125300615|NCT00788710|450726044|FG000|Overall Study|Physician Decision|2|||
125300616|NCT00788710|450726045|FG001|Overall Study|Physician Decision|1|||
125300617|NCT00788710|450726046|FG002|Overall Study|Physician Decision|0|||
125300618|NCT00788710|450726044|FG000|Overall Study|Protocol Violation|0|||
125300619|NCT00788710|450726045|FG001|Overall Study|Protocol Violation|1|||
125300620|NCT00788710|450726046|FG002|Overall Study|Protocol Violation|1|||
125300621|NCT00788710|450726044|FG000|Overall Study|Withdrawal by Subject|2|||
125300622|NCT00788710|450726045|FG001|Overall Study|Withdrawal by Subject|2|||
125300623|NCT00788710|450726046|FG002|Overall Study|Withdrawal by Subject|0|||
125300624|NCT00605345|450726051|FG000|Overall Study|Withdrawal by Subject|1|||
125300625|NCT00605345|450726052|FG001|Overall Study|Withdrawal by Subject|0|||
125300626|NCT00605345|450726051|FG000|Overall Study|Adverse Event|0|||
125300627|NCT00605345|450726052|FG001|Overall Study|Adverse Event|1|||
125300628|NCT00605345|450726051|FG000|Overall Study|Protocol Violation|0|||
125300629|NCT00605345|450726052|FG001|Overall Study|Protocol Violation|2|||
125300630|NCT05066165|450727787|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
125300631|NCT05066165|450727788|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
125300632|NCT05066165|450727787|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
125300633|NCT05066165|450727788|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
125300634|NCT00742417|450727789|FG000|Randomized|Withdrawal by legal representative|0|||
125300635|NCT00742417|450727790|FG001|Randomized|Withdrawal by legal representative|1|||
125300636|NCT00742417|450727789|FG000|Randomized|Withdrawal by Subject|1|||
125300637|NCT00742417|450727790|FG001|Randomized|Withdrawal by Subject|0|||
125300638|NCT00742417|450727789|FG000|Randomized|Physician Decision|1|||
125300639|NCT00742417|450727790|FG001|Randomized|Physician Decision|0|||
125300640|NCT00742417|450727789|FG000|Intensive Period|Withdrawal by Subject|1|||
125300641|NCT00742417|450727790|FG001|Intensive Period|Withdrawal by Subject|1|||
125300642|NCT00742417|450727789|FG000|Intensive Period|Adverse Event|2|||
125300643|NCT00742417|450727790|FG001|Intensive Period|Adverse Event|0|||
125300644|NCT04566601|450727795|FG000|Overall Study|Other than listed|13|||
125300645|NCT04566601|450727796|FG001|Overall Study|Other than listed|4|||
125300646|NCT04566601|450727797|FG002|Overall Study|Other than listed|2|||
125300647|NCT04566601|450727798|FG003|Overall Study|Other than listed|1|||
125300648|NCT04566601|450727799|FG004|Overall Study|Other than listed|4|||
125300649|NCT04566601|450727795|FG000|Overall Study|Protocol deviation|3|||
125300650|NCT04566601|450727796|FG001|Overall Study|Protocol deviation|0|||
125300651|NCT04566601|450727797|FG002|Overall Study|Protocol deviation|1|||
125300652|NCT04566601|450727798|FG003|Overall Study|Protocol deviation|1|||
125300653|NCT04566601|450727799|FG004|Overall Study|Protocol deviation|1|||
125300654|NCT04566601|450727795|FG000|Overall Study|Technical problems|0|||
125300655|NCT04566601|450727796|FG001|Overall Study|Technical problems|0|||
125300656|NCT04566601|450727797|FG002|Overall Study|Technical problems|1|||
125300657|NCT04566601|450727798|FG003|Overall Study|Technical problems|0|||
125300658|NCT04566601|450727799|FG004|Overall Study|Technical problems|0|||
125300659|NCT04566601|450727795|FG000|Overall Study|No reason available|3|||
125300660|NCT04566601|450727796|FG001|Overall Study|No reason available|2|||
125300661|NCT04566601|450727797|FG002|Overall Study|No reason available|7|||
125300662|NCT04566601|450727798|FG003|Overall Study|No reason available|1|||
125300663|NCT04566601|450727799|FG004|Overall Study|No reason available|5|||
125300664|NCT04566601|450727795|FG000|Overall Study|Burden of study procedures|3|||
125300665|NCT04566601|450727796|FG001|Overall Study|Burden of study procedures|0|||
125300666|NCT04566601|450727797|FG002|Overall Study|Burden of study procedures|0|||
125300667|NCT04566601|450727798|FG003|Overall Study|Burden of study procedures|3|||
125300668|NCT04566601|450727799|FG004|Overall Study|Burden of study procedures|1|||
125300669|NCT04566601|450727795|FG000|Overall Study|Change of residence|2|||
125300670|NCT04566601|450727796|FG001|Overall Study|Change of residence|2|||
125300671|NCT04566601|450727797|FG002|Overall Study|Change of residence|0|||
125300672|NCT04566601|450727798|FG003|Overall Study|Change of residence|1|||
125300673|NCT04566601|450727799|FG004|Overall Study|Change of residence|2|||
125300674|NCT04566601|450727795|FG000|Overall Study|Perceived lack of efficacy|2|||
125300675|NCT04566601|450727796|FG001|Overall Study|Perceived lack of efficacy|0|||
125300676|NCT04566601|450727797|FG002|Overall Study|Perceived lack of efficacy|1|||
125300677|NCT04566601|450727798|FG003|Overall Study|Perceived lack of efficacy|1|||
125300678|NCT04566601|450727799|FG004|Overall Study|Perceived lack of efficacy|2|||
125300679|NCT04566601|450727795|FG000|Overall Study|Adverse Event|7|||
125300680|NCT04566601|450727796|FG001|Overall Study|Adverse Event|4|||
125300681|NCT04566601|450727797|FG002|Overall Study|Adverse Event|6|||
125300682|NCT04566601|450727798|FG003|Overall Study|Adverse Event|5|||
125300683|NCT04566601|450727799|FG004|Overall Study|Adverse Event|12|||
125300684|NCT00372697|450727802|FG000|Overall Study|Protocol Violation|1|||
125300685|NCT00372697|450727803|FG001|Overall Study|Protocol Violation|1|||
125300686|NCT01055314|450727804|FG000|Overall Study|Adverse Event|7|||
125300687|NCT01055314|450727805|FG001|Overall Study|Adverse Event|4|||
125300688|NCT01055314|450727804|FG000|Overall Study|Death|2|||
125300689|NCT01055314|450727805|FG001|Overall Study|Death|1|||
125300690|NCT01055314|450727804|FG000|Overall Study|Lack of Efficacy|11|||
125300691|NCT01055314|450727805|FG001|Overall Study|Lack of Efficacy|19|||
125300692|NCT01055314|450727804|FG000|Overall Study|Physician Decision|10|||
125300693|NCT01055314|450727805|FG001|Overall Study|Physician Decision|5|||
125300694|NCT01055314|450727804|FG000|Overall Study|Withdrawal by Subject|1|||
125300695|NCT01055314|450727805|FG001|Overall Study|Withdrawal by Subject|0|||
125300696|NCT01055314|450727804|FG000|Overall Study|Ineligible|3|||
125300697|NCT01055314|450727805|FG001|Overall Study|Ineligible|5|||
125300698|NCT01055314|450727804|FG000|Overall Study|Refusal of further protocol therapy|10|||
125300699|NCT01055314|450727805|FG001|Overall Study|Refusal of further protocol therapy|4|||
125300700|NCT01055314|450727804|FG000|Overall Study|No treatment|1|||
125300701|NCT01055314|450727805|FG001|Overall Study|No treatment|0|||
124812166|NCT01798004|448942575|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
124812167|NCT01798004|448942575|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
124812168|NCT03539081|448942583|FG000|Overall Study|Withdrawal by Subject|2|||
124812169|NCT03539081|448942584|FG001|Overall Study|Withdrawal by Subject|3|||
125300702|NCT01279616|450727806|FG000|Overall Study|donor could not be located|5|||
125300703|NCT01279616|450727806|FG000|Overall Study|no signs of sickle cell disease|2|||
124812170|NCT03539081|448942585|FG002|Overall Study|Withdrawal by Subject|0|||
124812171|NCT03539081|448942583|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
124812172|NCT03539081|448942584|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
125300704|NCT02462720|450727807|FG000|Part 2|Withdrawal by Subject|1|||
125300705|NCT02462720|450727808|FG001|Part 2|Withdrawal by Subject|0|||
125300706|NCT02462720|450727807|FG000|Part 2|Protocol Violation|0|||
125300707|NCT02462720|450727808|FG001|Part 2|Protocol Violation|1|||
124812173|NCT03539081|448942585|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
124812174|NCT01673867|448942589|FG000|Randomization|Adverse event unrelated to study drug|1|||
124819581|NCT00420927|448965761|FG000|Period 1|Lost to Follow-up|8|||
125300708|NCT00183625|450727811|FG000|Overall Study|Withdrawal by Subject|18|||
125300709|NCT00183625|450727812|FG001|Overall Study|Withdrawal by Subject|18|||
125300710|NCT00183625|450727813|FG002|Overall Study|Withdrawal by Subject|19|||
125300711|NCT00183625|450727814|FG003|Overall Study|Withdrawal by Subject|14|||
125300712|NCT05249569|450727817|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
125300713|NCT03722524|450727818|FG000|Overall Study|Protocol Violation|86|||
125300714|NCT03722524|450727818|FG000|Overall Study|Adverse Event|7|||
125300715|NCT03722524|450727818|FG000|Overall Study|Lost to Follow-up|1|||
125300716|NCT03722524|450727818|FG000|Overall Study|Reason is not stated|1|||
125300717|NCT03722524|450727818|FG000|Overall Study|Physician Decision|1|||
125300718|NCT03722524|450727818|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
125300719|NCT00646399|450727822|FG000|Overall Study|Death|63|||
125300720|NCT00646399|450727823|FG001|Overall Study|Death|53|||
125300721|NCT00646399|450727822|FG000|Overall Study|Withdrawal by Subject|9|||
125300722|NCT00646399|450727823|FG001|Overall Study|Withdrawal by Subject|10|||
125300723|NCT00646399|450727822|FG000|Overall Study|Other Reason|11|||
125300724|NCT00646399|450727823|FG001|Overall Study|Other Reason|11|||
125300725|NCT02473367|450727826|FG000|Wait 1|Withdrawal by Subject|1|||
125300726|NCT02473367|450727826|FG000|Period 4|Lost to Follow-up|1|||
125300727|NCT02678923|450727827|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
125300728|NCT02678923|450727828|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
125300729|NCT02678923|450727827|FG000|Overall Study|Withdrawal by Subject|3|||
125300730|NCT02678923|450727828|FG001|Overall Study|Withdrawal by Subject|2|||
125300731|NCT02678923|450727827|FG000|Overall Study|Lost to Follow-up|1|||
125300732|NCT02678923|450727828|FG001|Overall Study|Lost to Follow-up|0|||
125300733|NCT02678923|450727827|FG000|Overall Study|Did Not Return for Study Visits|1|||
125300734|NCT02678923|450727828|FG001|Overall Study|Did Not Return for Study Visits|0|||
125300735|NCT00455143|450727829|FG000|Overall Study|Physician Decision|1|||
125300736|NCT00455143|450727829|FG000|Overall Study|Withdrawal by Subject|1|||
125300737|NCT00455143|450727829|FG000|Overall Study|Staff was not avail to follow patient|2|||
125300738|NCT00455143|450727829|FG000|Overall Study|No longer met Inclusion Criteria|1|||
125300739|NCT00455143|450727829|FG000|Overall Study|Surgical time, staff not available|1|||
125300740|NCT01423916|450727832|FG000|Overall Study|Adverse Event|5|||
125300741|NCT01423916|450727833|FG001|Overall Study|Adverse Event|9|||
125300742|NCT01423916|450727834|FG002|Overall Study|Adverse Event|2|||
125300743|NCT01423916|450727832|FG000|Overall Study|Met Withdrawal Criteria|1|||
125300744|NCT01423916|450727833|FG001|Overall Study|Met Withdrawal Criteria|1|||
125300745|NCT01423916|450727834|FG002|Overall Study|Met Withdrawal Criteria|1|||
125300746|NCT01423916|450727832|FG000|Overall Study|Physician Decision|1|||
125300747|NCT01423916|450727833|FG001|Overall Study|Physician Decision|0|||
125300748|NCT01423916|450727834|FG002|Overall Study|Physician Decision|1|||
125300749|NCT01423916|450727832|FG000|Overall Study|Withdrawal by Subject|3|||
125300750|NCT01423916|450727833|FG001|Overall Study|Withdrawal by Subject|10|||
125300751|NCT01423916|450727834|FG002|Overall Study|Withdrawal by Subject|3|||
125300752|NCT01423916|450727832|FG000|Overall Study|Protocol Deviation|1|||
125300753|NCT01423916|450727833|FG001|Overall Study|Protocol Deviation|0|||
125300754|NCT01423916|450727834|FG002|Overall Study|Protocol Deviation|0|||
125300755|NCT01966445|450727837|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
125300756|NCT01966445|450727838|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
125300757|NCT01966445|450727839|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
125300758|NCT01966445|450727840|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
125300759|NCT01966445|450727841|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
125300760|NCT01966445|450727842|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
125300761|NCT01966445|450727843|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
125300762|NCT01966445|450727837|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
125300763|NCT01966445|450727838|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
125300764|NCT01966445|450727839|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
125300765|NCT01966445|450727840|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
125300766|NCT01966445|450727841|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
125300767|NCT01966445|450727842|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
125300768|NCT01966445|450727843|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
125300769|NCT01966445|450727837|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
125300770|NCT01966445|450727838|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
125300771|NCT01966445|450727839|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
125300772|NCT01966445|450727840|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
125300773|NCT01966445|450727841|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
125300774|NCT01966445|450727842|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
125300775|NCT01966445|450727843|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
125300776|NCT01966445|450727837|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
125300777|NCT01966445|450727838|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
125300778|NCT01966445|450727839|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
125300779|NCT01966445|450727840|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
125300780|NCT01966445|450727841|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
125300781|NCT01966445|450727842|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
125300782|NCT01966445|450727843|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
125300783|NCT01966445|450727837|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
125300784|NCT01966445|450727838|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
125300785|NCT01966445|450727839|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
125300786|NCT01966445|450727840|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
125300787|NCT01966445|450727841|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
125300788|NCT01966445|450727842|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
125300789|NCT01966445|450727843|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
125300790|NCT01374178|450727846|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
125300791|NCT01374178|450727847|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
125300792|NCT01374178|450727846|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
125300793|NCT01374178|450727847|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
125300794|NCT04856904|450727850|FG000|Overall Study|Physician Decision|1|||
125300795|NCT04856904|450727851|FG001|Overall Study|Physician Decision|1|||
125300796|NCT04856904|450727850|FG000|Overall Study|Withdrawal by Subject|13|||
125300797|NCT04856904|450727851|FG001|Overall Study|Withdrawal by Subject|13|||
125300798|NCT04856904|450727850|FG000|Overall Study|Adverse Event|1|||
125300799|NCT04856904|450727851|FG001|Overall Study|Adverse Event|1|||
125300800|NCT04856904|450727850|FG000|Overall Study|Non-compliance with study drug|1|||
125300801|NCT04856904|450727851|FG001|Overall Study|Non-compliance with study drug|1|||
125300802|NCT04856904|450727850|FG000|Overall Study|Lost to Follow-up|4|||
124812175|NCT01673867|448942590|FG001|Randomization|Adverse event unrelated to study drug|0|||
124812176|NCT01673867|448942589|FG000|Randomization|Participant request to discontinue study treatment|0|||
124812177|NCT01673867|448942590|FG001|Randomization|Participant request to discontinue study treatment|4|||
124812178|NCT01673867|448942589|FG000|Randomization|Withdrawal by participant|0|||
124812179|NCT01673867|448942590|FG001|Randomization|Withdrawal by participant|12|||
124812180|NCT01673867|448942589|FG000|Randomization|Lost to Follow-up|0|||
124812181|NCT01673867|448942590|FG001|Randomization|Lost to Follow-up|1|||
125300803|NCT04856904|450727851|FG001|Overall Study|Lost to Follow-up|4|||
125300804|NCT04856904|450727850|FG000|Overall Study|Withdrawal by Subject|1|||
125300805|NCT04856904|450727851|FG001|Overall Study|Withdrawal by Subject|1|||
125300806|NCT04856904|450727850|FG000|Overall Study|Protocol Violation|1|||
125300807|NCT04856904|450727851|FG001|Overall Study|Protocol Violation|1|||
125300808|NCT00902174|450727852|FG000|Overall Study|Adverse Event|27|||
125300809|NCT00902174|450727853|FG001|Overall Study|Adverse Event|7|||
125300810|NCT00902174|450727852|FG000|Overall Study|Lack of Efficacy|1|||
125300811|NCT00902174|450727853|FG001|Overall Study|Lack of Efficacy|5|||
125300812|NCT00902174|450727852|FG000|Overall Study|Death|2|||
125300813|NCT00902174|450727853|FG001|Overall Study|Death|2|||
125300814|NCT00902174|450727852|FG000|Overall Study|Withdrawal by Subject|2|||
125300815|NCT00902174|450727853|FG001|Overall Study|Withdrawal by Subject|1|||
125300816|NCT00902174|450727852|FG000|Overall Study|Abnormal labs|1|||
125300817|NCT00902174|450727853|FG001|Overall Study|Abnormal labs|1|||
125300818|NCT00902174|450727852|FG000|Overall Study|Protocol Violation|1|||
125300819|NCT00902174|450727853|FG001|Overall Study|Protocol Violation|1|||
125300820|NCT00902174|450727852|FG000|Overall Study|Administration problem|0|||
125300821|NCT00902174|450727853|FG001|Overall Study|Administration problem|1|||
125300822|NCT00077649|450727854|FG000|Overall Study|Adverse Event|5|||
125300823|NCT00077649|450727855|FG001|Overall Study|Adverse Event|1|||
125300824|NCT00077649|450727856|FG002|Overall Study|Adverse Event|7|||
125300825|NCT00077649|450727857|FG003|Overall Study|Adverse Event|9|||
125300826|NCT00077649|450727854|FG000|Overall Study|Lack of Efficacy|5|||
125300827|NCT00077649|450727855|FG001|Overall Study|Lack of Efficacy|3|||
125300828|NCT00077649|450727856|FG002|Overall Study|Lack of Efficacy|3|||
125300829|NCT00077649|450727857|FG003|Overall Study|Lack of Efficacy|2|||
125300830|NCT00077649|450727854|FG000|Overall Study|Withdrawal by Subject|0|||
125300831|NCT00077649|450727855|FG001|Overall Study|Withdrawal by Subject|1|||
125300832|NCT00077649|450727856|FG002|Overall Study|Withdrawal by Subject|1|||
125300833|NCT00077649|450727857|FG003|Overall Study|Withdrawal by Subject|2|||
125300834|NCT00077649|450727854|FG000|Overall Study|Lost to Follow-up|2|||
125300835|NCT00077649|450727855|FG001|Overall Study|Lost to Follow-up|2|||
125300836|NCT00077649|450727856|FG002|Overall Study|Lost to Follow-up|3|||
125300837|NCT00077649|450727857|FG003|Overall Study|Lost to Follow-up|2|||
125300838|NCT00077649|450727854|FG000|Overall Study|Abnormality of Laboratory Test|1|||
125300839|NCT00077649|450727855|FG001|Overall Study|Abnormality of Laboratory Test|2|||
124812182|NCT01673867|448942589|FG000|Randomization|Participant no longer meets study criteria|4|||
124819582|NCT00420927|448965762|FG001|Period 1|Lost to Follow-up|6|||
125300840|NCT00077649|450727856|FG002|Overall Study|Abnormality of Laboratory Test|1|||
125300841|NCT00077649|450727857|FG003|Overall Study|Abnormality of Laboratory Test|2|||
125300842|NCT00077649|450727854|FG000|Overall Study|Randomized but never dosed|1|||
125300843|NCT00077649|450727855|FG001|Overall Study|Randomized but never dosed|0|||
125300844|NCT00077649|450727856|FG002|Overall Study|Randomized but never dosed|0|||
125300845|NCT00077649|450727857|FG003|Overall Study|Randomized but never dosed|0|||
125300846|NCT02895945|450727859|FG000|Overall Study|Physician Decision|2|||
125300847|NCT02895945|450727860|FG001|Overall Study|Physician Decision|1|||
125300848|NCT00454181|450727864|FG000|Overall Study|Adverse Event|1|||
125300849|NCT00454181|450727865|FG001|Overall Study|Adverse Event|1|||
125300850|NCT00454181|450727864|FG000|Overall Study|Lost to Follow-up|11|||
125300851|NCT00454181|450727865|FG001|Overall Study|Lost to Follow-up|1|||
125300852|NCT00454181|450727864|FG000|Overall Study|Protocol Violation|1|||
125300853|NCT00454181|450727865|FG001|Overall Study|Protocol Violation|1|||
125300854|NCT00454181|450727864|FG000|Overall Study|Withdrawal by Subject|2|||
125300855|NCT00454181|450727865|FG001|Overall Study|Withdrawal by Subject|0|||
125300856|NCT04032080|450727866|FG000|Overall Study|Death|6|||
125300857|NCT03689855|450727871|FG000|Overall Study|Adverse Event|3|||
125300858|NCT03689855|450727871|FG000|Overall Study|Withdrawal by Subject|1|||
125300859|NCT00764673|450727872|FG000|Overall Study|Death|1|||
125300860|NCT00764673|450727872|FG000|Overall Study|Lost to Follow-up|3|||
125300861|NCT00764673|450727872|FG000|Overall Study|Withdrawal by Subject|6|||
125300862|NCT00764673|450727872|FG000|Overall Study|Revision of Device|2|||
125300863|NCT01438177|450727873|FG000|Overall Study|Withdrawal by Subject|1|||
125300864|NCT01438177|450727873|FG000|Overall Study|Initiation of new therapy|1|||
125300865|NCT01727336|450727874|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
125300866|NCT01727336|450727875|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
125300867|NCT01727336|450727876|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
125300868|NCT01727336|450727877|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
125300869|NCT01727336|450727878|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
125300870|NCT01727336|450727879|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
125300871|NCT01727336|450727874|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
125300872|NCT01727336|450727875|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
125300873|NCT01727336|450727876|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
125300874|NCT01727336|450727877|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
125300875|NCT01727336|450727878|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
125300876|NCT01727336|450727879|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
125300877|NCT01727336|450727874|FG000|Part 2 Blinded|Death|0|||
125300878|NCT01727336|450727875|FG001|Part 2 Blinded|Death|0|||
125300879|NCT01727336|450727876|FG002|Part 2 Blinded|Death|0|||
125300880|NCT01727336|450727877|FG003|Part 2 Blinded|Death|0|||
125300881|NCT01727336|450727878|FG004|Part 2 Blinded|Death|20|||
125300882|NCT01727336|450727879|FG005|Part 2 Blinded|Death|16|||
125300883|NCT01727336|450727874|FG000|Part 2 Blinded|Lack of Efficacy|0|||
125300884|NCT01727336|450727875|FG001|Part 2 Blinded|Lack of Efficacy|0|||
125300885|NCT01727336|450727876|FG002|Part 2 Blinded|Lack of Efficacy|0|||
125300886|NCT01727336|450727877|FG003|Part 2 Blinded|Lack of Efficacy|0|||
125300887|NCT01727336|450727878|FG004|Part 2 Blinded|Lack of Efficacy|42|||
125300888|NCT01727336|450727879|FG005|Part 2 Blinded|Lack of Efficacy|44|||
125300889|NCT01727336|450727874|FG000|Part 2 Blinded|Lost to Follow-up|0|||
125300890|NCT01727336|450727875|FG001|Part 2 Blinded|Lost to Follow-up|0|||
125300891|NCT01727336|450727876|FG002|Part 2 Blinded|Lost to Follow-up|0|||
125300892|NCT01727336|450727877|FG003|Part 2 Blinded|Lost to Follow-up|0|||
125300893|NCT01727336|450727878|FG004|Part 2 Blinded|Lost to Follow-up|0|||
125300894|NCT01727336|450727879|FG005|Part 2 Blinded|Lost to Follow-up|1|||
125300895|NCT01727336|450727874|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
125300896|NCT01727336|450727875|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
125300897|NCT01727336|450727876|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
125300898|NCT01727336|450727877|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
125300899|NCT01727336|450727878|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
125300900|NCT01727336|450727879|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
125300901|NCT01727336|450727874|FG000|Part 2 Blinded|use of prohibited medications|0|||
125300902|NCT01727336|450727875|FG001|Part 2 Blinded|use of prohibited medications|0|||
124812183|NCT01673867|448942590|FG001|Randomization|Participant no longer meets study criteria|5|||
124812184|NCT01673867|448942589|FG000|Treatment|Disease Progression|208|||
124812185|NCT01673867|448942590|FG001|Treatment|Disease Progression|178|||
124812186|NCT01673867|448942589|FG000|Treatment|Study Drug Toxicity|23|||
124812187|NCT01673867|448942590|FG001|Treatment|Study Drug Toxicity|43|||
124812188|NCT01673867|448942589|FG000|Treatment|Death|2|||
124812189|NCT01673867|448942590|FG001|Treatment|Death|3|||
124812190|NCT01673867|448942589|FG000|Treatment|Adverse event unrelated to study drug|23|||
125300903|NCT01727336|450727876|FG002|Part 2 Blinded|use of prohibited medications|0|||
125300904|NCT01727336|450727877|FG003|Part 2 Blinded|use of prohibited medications|0|||
125300905|NCT01727336|450727878|FG004|Part 2 Blinded|use of prohibited medications|1|||
125300906|NCT01727336|450727879|FG005|Part 2 Blinded|use of prohibited medications|3|||
125300907|NCT00619099|450727880|FG000|Overall Study|Progressive Disease|7|||
125300908|NCT00619099|450727881|FG001|Overall Study|Progressive Disease|5|||
125300909|NCT00619099|450727880|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
125300910|NCT00619099|450727881|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
125300911|NCT00619099|450727880|FG000|Overall Study|Adverse Event|4|||
125300912|NCT00619099|450727881|FG001|Overall Study|Adverse Event|3|||
125300913|NCT00619099|450727880|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
125300914|NCT00619099|450727881|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
124812191|NCT01673867|448942590|FG001|Treatment|Adverse event unrelated to study drug|10|||
124812192|NCT01673867|448942589|FG000|Treatment|Participant request to discontinue study treatment|7|||
125300915|NCT00619099|450727880|FG000|Overall Study|Withdrawal by Subject|10|||
125300916|NCT00619099|450727881|FG001|Overall Study|Withdrawal by Subject|2|||
125300917|NCT00619099|450727880|FG000|Overall Study|Physician Decision|9|||
125300918|NCT00619099|450727881|FG001|Overall Study|Physician Decision|6|||
125300919|NCT00885482|450727882|FG000|Overall Study|Pregnancy|1|||
125300920|NCT00885482|450727882|FG000|Overall Study|Lack of Efficacy|1|||
125300921|NCT00885482|450727882|FG000|Overall Study|Death|1|||
125300922|NCT00885482|450727882|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
125300923|NCT00084656|450727883|FG000|Overall Study|Other reasons|0|||
125300924|NCT00084656|450727884|FG001|Overall Study|Other reasons|12|||
125300925|NCT00084656|450727885|FG002|Overall Study|Other reasons|11|||
125300926|NCT00084656|450727883|FG000|Overall Study|Withdrawal by Subject|15|||
125300927|NCT00084656|450727884|FG001|Overall Study|Withdrawal by Subject|4|||
125300928|NCT00084656|450727885|FG002|Overall Study|Withdrawal by Subject|4|||
125300929|NCT00084656|450727883|FG000|Overall Study|Disease relapse|0|||
125300930|NCT00084656|450727884|FG001|Overall Study|Disease relapse|9|||
125300931|NCT00084656|450727885|FG002|Overall Study|Disease relapse|10|||
125300932|NCT00084656|450727883|FG000|Overall Study|Disease progression|9|||
125300933|NCT00084656|450727884|FG001|Overall Study|Disease progression|0|||
125300934|NCT00084656|450727885|FG002|Overall Study|Disease progression|0|||
125300935|NCT00084656|450727883|FG000|Overall Study|Lost to Follow-up|1|||
125300936|NCT00084656|450727884|FG001|Overall Study|Lost to Follow-up|0|||
125300937|NCT00084656|450727885|FG002|Overall Study|Lost to Follow-up|1|||
125300938|NCT02772978|450727886|FG000|Overall Study|Withdrawal by Subject|1|||
125300939|NCT02772978|450727887|FG001|Overall Study|Withdrawal by Subject|1|||
125300940|NCT00129467|450727888|FG000|Received Intervention|Death|1|||
125300941|NCT00129467|450727889|FG001|Received Intervention|Death|1|||
125300942|NCT00129467|450727888|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
125300943|NCT00129467|450727889|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
125300944|NCT00129467|450727888|FG000|Received Intervention|Delirium|2|||
125300945|NCT00129467|450727889|FG001|Received Intervention|Delirium|0|||
125300946|NCT00129467|450727888|FG000|Received Intervention|Withdrawal by Subject|1|||
125300947|NCT00129467|450727889|FG001|Received Intervention|Withdrawal by Subject|0|||
125300948|NCT00129467|450727888|FG000|Received Intervention|Nausea|1|||
125300949|NCT00129467|450727889|FG001|Received Intervention|Nausea|0|||
124812193|NCT01673867|448942590|FG001|Treatment|Participant request to discontinue study treatment|17|||
124812194|NCT01673867|448942589|FG000|Treatment|Withdrawal by participant|5|||
124812195|NCT01673867|448942590|FG001|Treatment|Withdrawal by participant|5|||
124812196|NCT01673867|448942589|FG000|Treatment|Maximum clinical benefit|1|||
124812197|NCT01673867|448942590|FG001|Treatment|Maximum clinical benefit|10|||
124812198|NCT01673867|448942589|FG000|Treatment|Participant no longer meets study criteria|2|||
124812199|NCT01673867|448942590|FG001|Treatment|Participant no longer meets study criteria|0|||
124812200|NCT01673867|448942589|FG000|Treatment|Administrative reason by sponsor|3|||
124812201|NCT01673867|448942590|FG001|Treatment|Administrative reason by sponsor|0|||
124812202|NCT01673867|448942589|FG000|Treatment|Other reason|11|||
125300950|NCT00129467|450727888|FG000|Received Intervention|Intolerance to citalopram|0|||
125300951|NCT00129467|450727889|FG001|Received Intervention|Intolerance to citalopram|1|||
125300952|NCT00129467|450727888|FG000|Received Intervention|Dizzyness, fatigue|0|||
125300953|NCT00129467|450727889|FG001|Received Intervention|Dizzyness, fatigue|1|||
125300954|NCT00129467|450727888|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
125300955|NCT00129467|450727889|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
125300956|NCT00129467|450727888|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
125300957|NCT00129467|450727889|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
125300958|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
125300959|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
125300960|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
125300961|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
125300962|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
125300963|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
125300964|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
125300965|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
125300966|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
125300967|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
125300968|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
125300969|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
125300970|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
124812203|NCT01673867|448942590|FG001|Treatment|Other reason|2|||
124812204|NCT02550106|448942593|FG000|Overall Study|Adverse Event|1|||
125300971|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
125300972|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
125300973|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
125300974|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
124812205|NCT02550106|448942593|FG000|Overall Study|Lack of Efficacy|3|||
124812206|NCT02550106|448942593|FG000|Overall Study|Protocol Violation|6|||
125300975|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
125300976|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
125300977|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
125300978|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
125300979|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
125300980|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
125300981|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
125300982|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
125300983|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
125300984|NCT01532869|450727890|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
124812207|NCT02550106|448942593|FG000|Overall Study|Withdrawal by Subject|2|||
124812208|NCT02195583|448942594|FG000|Overall Study|Lost to Follow-up|1|||
124812209|NCT02195583|448942594|FG000|Overall Study|Withdrawal by Subject|4|||
124812210|NCT02195583|448942594|FG000|Overall Study|Adverse Event|2|||
124812211|NCT02195583|448942594|FG000|Overall Study|Other Reason|2|||
124812212|NCT01709513|448942595|FG000|Overall Study|Randomized but not treated|0|||
124812213|NCT01709513|448942596|FG001|Overall Study|Randomized but not treated|1|||
124812214|NCT01709513|448942597|FG002|Overall Study|Randomized but not treated|0|||
124812215|NCT01709513|448942595|FG000|Overall Study|Adverse Event|16|||
124812216|NCT01709513|448942596|FG001|Overall Study|Adverse Event|31|||
124812217|NCT01709513|448942597|FG002|Overall Study|Adverse Event|23|||
124812218|NCT01709513|448942595|FG000|Overall Study|Poor compliance to protocol|2|||
124812219|NCT01709513|448942596|FG001|Overall Study|Poor compliance to protocol|0|||
124812220|NCT01709513|448942597|FG002|Overall Study|Poor compliance to protocol|0|||
124812221|NCT01709513|448942595|FG000|Overall Study|Other|3|||
124812222|NCT01709513|448942596|FG001|Overall Study|Other|11|||
124812223|NCT01709513|448942597|FG002|Overall Study|Other|7|||
124812224|NCT00926328|448942598|FG000|Overall Study|Lost to Follow-up|12|||
124812225|NCT00926328|448942599|FG001|Overall Study|Lost to Follow-up|14|||
124812226|NCT00289133|448942600|FG000|Overall Study|Non-study device implanted|12|||
124812227|NCT00289133|448942601|FG001|Overall Study|Non-study device implanted|0|||
124812228|NCT00289133|448942600|FG000|Overall Study|Protocol Violation|32|||
125300985|NCT01532869|450727891|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
125300986|NCT01532869|450727890|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
125300987|NCT01532869|450727891|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
125300988|NCT01532869|450727890|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
125300989|NCT01532869|450727891|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
125300990|NCT01532869|450727890|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
125300991|NCT01532869|450727891|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
125300992|NCT01331291|450727892|FG000|Overall Study|Lack of Efficacy|2|||
125300993|NCT01331291|450727893|FG001|Overall Study|Lack of Efficacy|8|||
125300994|NCT01331291|450727892|FG000|Overall Study|Death|0|||
125300995|NCT01331291|450727893|FG001|Overall Study|Death|1|||
125300996|NCT01026220|450727894|FG000|Induction|Death|1|||
125300997|NCT01026220|450727895|FG001|Induction|Death|0|||
125300998|NCT01026220|450727896|FG002|Induction|Death|0|||
125300999|NCT01026220|450727894|FG000|Induction|Lack of Efficacy|2|||
125301000|NCT01026220|450727895|FG001|Induction|Lack of Efficacy|0|||
125301001|NCT01026220|450727896|FG002|Induction|Lack of Efficacy|0|||
125301002|NCT01026220|450727894|FG000|Induction|Physician Decision|12|||
125301003|NCT01026220|450727895|FG001|Induction|Physician Decision|0|||
125301004|NCT01026220|450727896|FG002|Induction|Physician Decision|0|||
125301005|NCT01026220|450727894|FG000|Induction|Withdrawal by Subject|9|||
125301006|NCT01026220|450727895|FG001|Induction|Withdrawal by Subject|0|||
125301007|NCT01026220|450727896|FG002|Induction|Withdrawal by Subject|0|||
125301008|NCT01026220|450727894|FG000|Induction|Ineligible|1|||
125301009|NCT01026220|450727895|FG001|Induction|Ineligible|0|||
125301010|NCT01026220|450727896|FG002|Induction|Ineligible|0|||
125301011|NCT01026220|450727894|FG000|Consolidation Maintenance|Death|0|||
125301012|NCT01026220|450727895|FG001|Consolidation Maintenance|Death|1|||
125301013|NCT01026220|450727896|FG002|Consolidation Maintenance|Death|0|||
125301014|NCT01026220|450727894|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
125301015|NCT01026220|450727895|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
125301016|NCT01026220|450727896|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
124812229|NCT00289133|448942601|FG001|Overall Study|Protocol Violation|38|||
124812230|NCT00289133|448942600|FG000|Overall Study|Withdrawal by Subject|9|||
124812231|NCT00289133|448942601|FG001|Overall Study|Withdrawal by Subject|10|||
125301017|NCT01026220|450727894|FG000|Consolidation Maintenance|Physician Decision|0|||
125301018|NCT01026220|450727895|FG001|Consolidation Maintenance|Physician Decision|2|||
125301019|NCT01026220|450727896|FG002|Consolidation Maintenance|Physician Decision|7|||
125301020|NCT01026220|450727894|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
125301021|NCT01026220|450727895|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
124812232|NCT00289133|448942600|FG000|Overall Study|Death|5|||
124812233|NCT00289133|448942601|FG001|Overall Study|Death|10|||
124812234|NCT00289133|448942600|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
124812235|NCT00289133|448942601|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
125301022|NCT01026220|450727896|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
124812236|NCT00289133|448942600|FG000|Overall Study|Physician Decision|41|||
124812237|NCT00289133|448942601|FG001|Overall Study|Physician Decision|45|||
125301023|NCT00409344|450727898|FG000|Overall Study|no enrollment|0|||
125301024|NCT00409344|450727899|FG001|Overall Study|no enrollment|0|||
125301025|NCT01389323|450727900|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
125301026|NCT01389323|450727900|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
125301027|NCT01389323|450727900|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
125301028|NCT01389323|450727900|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
125301029|NCT01389323|450727900|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
125301030|NCT01389323|450727900|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
125301031|NCT01389323|450727900|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
125301032|NCT01389323|450727900|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
125301033|NCT01389323|450727900|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
125301034|NCT01389323|450727900|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
125301035|NCT01389323|450727900|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
125301036|NCT01424228|450727901|FG000|Overall Study|Withdrawal by Subject|27|||
125301037|NCT01424228|450727902|FG001|Overall Study|Withdrawal by Subject|11|||
125301038|NCT01424228|450727901|FG000|Overall Study|Adverse Event|10|||
125301039|NCT01424228|450727902|FG001|Overall Study|Adverse Event|14|||
125301040|NCT01424228|450727901|FG000|Overall Study|Sponsor's decision|9|||
125301041|NCT01424228|450727902|FG001|Overall Study|Sponsor's decision|12|||
125301042|NCT01424228|450727901|FG000|Overall Study|Lack of Efficacy|5|||
125301043|NCT01424228|450727902|FG001|Overall Study|Lack of Efficacy|7|||
125301044|NCT01424228|450727901|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
125301045|NCT01424228|450727902|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
125301046|NCT01424228|450727901|FG000|Overall Study|Non-compliance|2|||
125301047|NCT01424228|450727902|FG001|Overall Study|Non-compliance|0|||
125301048|NCT01424228|450727901|FG000|Overall Study|Worsening of symptoms|1|||
125301049|NCT01424228|450727902|FG001|Overall Study|Worsening of symptoms|0|||
125301050|NCT01424228|450727901|FG000|Overall Study|Unplanned journey|0|||
125301051|NCT01424228|450727902|FG001|Overall Study|Unplanned journey|1|||
125301052|NCT00844558|450727903|FG000|Overall Study|Withdrawal by Subject|9|||
125301053|NCT00844558|450727904|FG001|Overall Study|Withdrawal by Subject|2|||
125301054|NCT00844558|450727903|FG000|Overall Study|Death|1|||
125301055|NCT00844558|450727904|FG001|Overall Study|Death|0|||
125301056|NCT00844558|450727903|FG000|Overall Study|Protocol Violation|1|||
125301057|NCT00844558|450727904|FG001|Overall Study|Protocol Violation|1|||
125301058|NCT00844558|450727903|FG000|Overall Study|Lost to Follow-up|0|||
125301059|NCT00844558|450727904|FG001|Overall Study|Lost to Follow-up|1|||
125301060|NCT00844558|450727903|FG000|Overall Study|Physician Decision|1|||
125301061|NCT00844558|450727904|FG001|Overall Study|Physician Decision|0|||
125301062|NCT01894022|450727906|FG000|Overall Study|Death|1|||
125301063|NCT01894022|450727907|FG001|Overall Study|Death|0|||
125301064|NCT01894022|450727906|FG000|Overall Study|Adverse Event, non-fatal|1|||
125301065|NCT01894022|450727907|FG001|Overall Study|Adverse Event, non-fatal|0|||
125301066|NCT01894022|450727906|FG000|Overall Study|Study Closed/terminated|7|||
125301067|NCT01894022|450727907|FG001|Overall Study|Study Closed/terminated|10|||
125301068|NCT04496453|450727909|FG000|Overall Study|Lost to Follow-up|6|||
125301069|NCT00410605|450727910|FG000|Overall Study|Adverse Event|12|||
125301070|NCT00410605|450727910|FG000|Overall Study|Physician Decision|3|||
125301071|NCT00410605|450727910|FG000|Overall Study|Withdrawal by Subject|5|||
125301072|NCT00410605|450727910|FG000|Overall Study|Started Non-Protocol Therapy|3|||
125301073|NCT00410605|450727910|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
125301074|NCT00410605|450727910|FG000|Overall Study|Transferred to another Institution|1|||
125301075|NCT03235089|450727918|FG000|Overall Study|Lost to Follow-up|1|||
125301076|NCT03235089|450727919|FG001|Overall Study|Lost to Follow-up|1|||
125301077|NCT03235089|450727918|FG000|Overall Study|Physician Decision|2|||
125301078|NCT03235089|450727919|FG001|Overall Study|Physician Decision|2|||
125301079|NCT03238924|450727920|FG000|Overall Study|Withdrawal by Subject|2|||
125301080|NCT03238924|450727921|FG001|Overall Study|Withdrawal by Subject|2|||
125301081|NCT03576716|450727922|FG000|Overall Study|Withdrawal by Subject|0|||
125301082|NCT03576716|450727923|FG001|Overall Study|Withdrawal by Subject|1|||
125301083|NCT04356040|450727924|FG000|Overall Study|Death|2|||
125301084|NCT04356040|450727925|FG001|Overall Study|Death|0|||
125301085|NCT04356040|450727924|FG000|Overall Study|Lost to Follow-up|1|||
125301086|NCT04356040|450727925|FG001|Overall Study|Lost to Follow-up|0|||
125301087|NCT04356040|450727924|FG000|Overall Study|Physician Decision|0|||
125301088|NCT04356040|450727925|FG001|Overall Study|Physician Decision|1|||
124812238|NCT00289133|448942600|FG000|Overall Study|Revision|8|||
125301089|NCT04356040|450727924|FG000|Overall Study|Withdrawal by Subject|13|||
125301090|NCT04356040|450727925|FG001|Overall Study|Withdrawal by Subject|1|||
125301091|NCT04356040|450727924|FG000|Overall Study|Enrollment Pause|10|||
125301092|NCT04356040|450727925|FG001|Overall Study|Enrollment Pause|0|||
125301093|NCT04356040|450727924|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
125301094|NCT04356040|450727925|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
125301095|NCT04356040|450727924|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
124812239|NCT00289133|448942601|FG001|Overall Study|Revision|6|||
124812240|NCT00289133|448942600|FG000|Overall Study|Lost to Follow-up|92|||
125301096|NCT04356040|450727925|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
125301097|NCT04356040|450727924|FG000|Overall Study|PI left institution|3|||
125301098|NCT04356040|450727925|FG001|Overall Study|PI left institution|0|||
125301099|NCT01717326|450727926|FG000|Overall Study|Death|0|||
125301100|NCT01717326|450727927|FG001|Overall Study|Death|0|||
125301101|NCT01717326|450727928|FG002|Overall Study|Death|0|||
125301102|NCT01717326|450727929|FG003|Overall Study|Death|0|||
125301103|NCT01717326|450727930|FG004|Overall Study|Death|0|||
125301104|NCT01717326|450727931|FG005|Overall Study|Death|0|||
125301105|NCT01717326|450727932|FG006|Overall Study|Death|0|||
125301106|NCT01717326|450727933|FG007|Overall Study|Death|0|||
125301107|NCT01717326|450727934|FG008|Overall Study|Death|0|||
125301108|NCT01717326|450727935|FG009|Overall Study|Death|0|||
125301109|NCT01717326|450727936|FG010|Overall Study|Death|1|||
125301110|NCT01717326|450727937|FG011|Overall Study|Death|0|||
125301111|NCT01717326|450727938|FG012|Overall Study|Death|0|||
124812241|NCT00289133|448942601|FG001|Overall Study|Lost to Follow-up|115|||
124812242|NCT04613375|448942605|FG000|Overall Study|Death|198|||
124812243|NCT04613375|448942605|FG000|Overall Study|Withdrawal by Subject|3|||
124812244|NCT01921387|448942608|FG000|Overall Study|Adverse Event|1|||
124812245|NCT03095612|448942612|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
124812246|NCT03095612|448942613|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
125301112|NCT01717326|450727939|FG013|Overall Study|Death|0|||
125301113|NCT01717326|450727940|FG014|Overall Study|Death|0|||
124812247|NCT03095612|448942614|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
124812248|NCT03095612|448942615|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
124812249|NCT03095612|448942616|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
124812250|NCT03095612|448942617|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
124812251|NCT03095612|448942618|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
124812252|NCT04447794|448942619|FG000|Overall Study|Lost to Follow-up|2|||
124812253|NCT04447794|448942620|FG001|Overall Study|Lost to Follow-up|3|||
124812254|NCT04447794|448942621|FG002|Overall Study|Lost to Follow-up|8|||
124812255|NCT04447794|448942619|FG000|Overall Study|Withdrawal by Subject|1|||
124812256|NCT04447794|448942620|FG001|Overall Study|Withdrawal by Subject|1|||
124812257|NCT04447794|448942621|FG002|Overall Study|Withdrawal by Subject|0|||
124812258|NCT00621582|448942622|FG000|Overall Study|Adverse Event|7|||
124812259|NCT00621582|448942622|FG000|Overall Study|Protocol Violation|57|||
124812260|NCT00621582|448942622|FG000|Overall Study|Lost to Follow-up|24|||
124812261|NCT00621582|448942622|FG000|Overall Study|issues not identified by investigators|18|||
124812262|NCT01387932|448942623|FG000|Randomized and Treated|Physician Decision|3|||
124812263|NCT01387932|448942624|FG001|Randomized and Treated|Physician Decision|2|||
124812264|NCT01387932|448942623|FG000|Randomized and Treated|Withdrawal by Subject|4|||
124812265|NCT01387932|448942624|FG001|Randomized and Treated|Withdrawal by Subject|2|||
124812266|NCT01387932|448942623|FG000|Survival Follow-up|Liver Transplant|24|||
124812267|NCT01387932|448942624|FG001|Survival Follow-up|Liver Transplant|28|||
124812268|NCT01387932|448942623|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
124812269|NCT01387932|448942624|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
124812270|NCT01387932|448942623|FG000|Survival Follow-up|Withdrawal by Subject|2|||
124812271|NCT01387932|448942624|FG001|Survival Follow-up|Withdrawal by Subject|4|||
124812272|NCT01387932|448942623|FG000|Survival Follow-up|Lost to Follow-up|6|||
124812273|NCT01387932|448942624|FG001|Survival Follow-up|Lost to Follow-up|5|||
124812274|NCT00963937|448942625|FG000|Overall Study|Protocol Violation|1|||
125301114|NCT01717326|450727941|FG015|Overall Study|Death|0|||
125301115|NCT01717326|450727942|FG016|Overall Study|Death|0|||
125301116|NCT01717326|450727943|FG017|Overall Study|Death|0|||
125301117|NCT01717326|450727944|FG018|Overall Study|Death|0|||
125301118|NCT01717326|450727945|FG019|Overall Study|Death|0|||
125301119|NCT01717326|450727926|FG000|Overall Study|Lost to Follow-up|3|||
125301120|NCT01717326|450727927|FG001|Overall Study|Lost to Follow-up|0|||
125301121|NCT01717326|450727928|FG002|Overall Study|Lost to Follow-up|0|||
125301122|NCT01717326|450727929|FG003|Overall Study|Lost to Follow-up|2|||
125301123|NCT01717326|450727930|FG004|Overall Study|Lost to Follow-up|1|||
125301124|NCT01717326|450727931|FG005|Overall Study|Lost to Follow-up|0|||
125301125|NCT01717326|450727932|FG006|Overall Study|Lost to Follow-up|1|||
124812275|NCT00963937|448942626|FG001|Overall Study|Protocol Violation|1|||
124812276|NCT00963937|448942627|FG002|Overall Study|Protocol Violation|0|||
124812277|NCT00963937|448942625|FG000|Overall Study|Physician Decision|18|||
124812278|NCT00963937|448942626|FG001|Overall Study|Physician Decision|10|||
124812279|NCT00963937|448942627|FG002|Overall Study|Physician Decision|4|||
124812280|NCT00939640|448942630|FG000|Overall Study|Physician Decision|1|||
125301126|NCT01717326|450727933|FG007|Overall Study|Lost to Follow-up|0|||
125301127|NCT01717326|450727934|FG008|Overall Study|Lost to Follow-up|0|||
125301128|NCT01717326|450727935|FG009|Overall Study|Lost to Follow-up|0|||
125301129|NCT01717326|450727936|FG010|Overall Study|Lost to Follow-up|1|||
125301130|NCT01717326|450727937|FG011|Overall Study|Lost to Follow-up|0|||
125301131|NCT01717326|450727938|FG012|Overall Study|Lost to Follow-up|0|||
125301132|NCT01717326|450727939|FG013|Overall Study|Lost to Follow-up|0|||
125301133|NCT01717326|450727940|FG014|Overall Study|Lost to Follow-up|0|||
125301134|NCT01717326|450727941|FG015|Overall Study|Lost to Follow-up|2|||
125301135|NCT01717326|450727942|FG016|Overall Study|Lost to Follow-up|1|||
125301136|NCT01717326|450727943|FG017|Overall Study|Lost to Follow-up|0|||
125301137|NCT01717326|450727944|FG018|Overall Study|Lost to Follow-up|2|||
125301138|NCT01717326|450727945|FG019|Overall Study|Lost to Follow-up|3|||
125301139|NCT01717326|450727926|FG000|Overall Study|Physician Decision|0|||
125301140|NCT01717326|450727927|FG001|Overall Study|Physician Decision|0|||
125301141|NCT01717326|450727928|FG002|Overall Study|Physician Decision|0|||
125301142|NCT01717326|450727929|FG003|Overall Study|Physician Decision|0|||
125301143|NCT01717326|450727930|FG004|Overall Study|Physician Decision|0|||
125301144|NCT01717326|450727931|FG005|Overall Study|Physician Decision|0|||
125301145|NCT01717326|450727932|FG006|Overall Study|Physician Decision|0|||
125301146|NCT01717326|450727933|FG007|Overall Study|Physician Decision|0|||
125301147|NCT01717326|450727934|FG008|Overall Study|Physician Decision|0|||
125301148|NCT01717326|450727935|FG009|Overall Study|Physician Decision|1|||
125301149|NCT01717326|450727936|FG010|Overall Study|Physician Decision|0|||
125301150|NCT01717326|450727937|FG011|Overall Study|Physician Decision|0|||
125301151|NCT01717326|450727938|FG012|Overall Study|Physician Decision|0|||
125301152|NCT01717326|450727939|FG013|Overall Study|Physician Decision|0|||
125301153|NCT01717326|450727940|FG014|Overall Study|Physician Decision|0|||
125301154|NCT01717326|450727941|FG015|Overall Study|Physician Decision|0|||
125301155|NCT01717326|450727942|FG016|Overall Study|Physician Decision|0|||
125301156|NCT01717326|450727943|FG017|Overall Study|Physician Decision|0|||
125301157|NCT01717326|450727944|FG018|Overall Study|Physician Decision|0|||
125301158|NCT01717326|450727945|FG019|Overall Study|Physician Decision|0|||
125301159|NCT01717326|450727926|FG000|Overall Study|Protocol Violation|0|||
125301160|NCT01717326|450727927|FG001|Overall Study|Protocol Violation|0|||
125301161|NCT01717326|450727928|FG002|Overall Study|Protocol Violation|0|||
125301162|NCT01717326|450727929|FG003|Overall Study|Protocol Violation|0|||
125301163|NCT01717326|450727930|FG004|Overall Study|Protocol Violation|1|||
125301164|NCT01717326|450727931|FG005|Overall Study|Protocol Violation|0|||
125301165|NCT01717326|450727932|FG006|Overall Study|Protocol Violation|0|||
125301166|NCT01717326|450727933|FG007|Overall Study|Protocol Violation|0|||
125301167|NCT01717326|450727934|FG008|Overall Study|Protocol Violation|0|||
125301168|NCT01717326|450727935|FG009|Overall Study|Protocol Violation|0|||
125301169|NCT01717326|450727936|FG010|Overall Study|Protocol Violation|0|||
125301170|NCT01717326|450727937|FG011|Overall Study|Protocol Violation|0|||
125301171|NCT01717326|450727938|FG012|Overall Study|Protocol Violation|0|||
125301172|NCT01717326|450727939|FG013|Overall Study|Protocol Violation|0|||
125301173|NCT01717326|450727940|FG014|Overall Study|Protocol Violation|0|||
125301174|NCT01717326|450727941|FG015|Overall Study|Protocol Violation|0|||
125301175|NCT01717326|450727942|FG016|Overall Study|Protocol Violation|0|||
125301176|NCT01717326|450727943|FG017|Overall Study|Protocol Violation|0|||
125301177|NCT01717326|450727944|FG018|Overall Study|Protocol Violation|0|||
125301178|NCT01717326|450727945|FG019|Overall Study|Protocol Violation|0|||
125301179|NCT01717326|450727926|FG000|Overall Study|Withdrawal by Subject|0|||
125301180|NCT01717326|450727927|FG001|Overall Study|Withdrawal by Subject|1|||
125301181|NCT01717326|450727928|FG002|Overall Study|Withdrawal by Subject|0|||
125301182|NCT01717326|450727929|FG003|Overall Study|Withdrawal by Subject|0|||
125301183|NCT01717326|450727930|FG004|Overall Study|Withdrawal by Subject|0|||
125301184|NCT01717326|450727931|FG005|Overall Study|Withdrawal by Subject|0|||
125301185|NCT01717326|450727932|FG006|Overall Study|Withdrawal by Subject|0|||
125301186|NCT01717326|450727933|FG007|Overall Study|Withdrawal by Subject|0|||
125301187|NCT01717326|450727934|FG008|Overall Study|Withdrawal by Subject|0|||
125301188|NCT01717326|450727935|FG009|Overall Study|Withdrawal by Subject|1|||
125301189|NCT01717326|450727936|FG010|Overall Study|Withdrawal by Subject|0|||
124812281|NCT01235689|448942636|FG000|Overall Study|Adverse Event|12|||
124812282|NCT01235689|448942637|FG001|Overall Study|Adverse Event|16|||
124812283|NCT01235689|448942636|FG000|Overall Study|Lack of Efficacy|12|||
124812284|NCT01235689|448942637|FG001|Overall Study|Lack of Efficacy|5|||
124812285|NCT01235689|448942636|FG000|Overall Study|Withdrawal by Subject|3|||
124812286|NCT01235689|448942637|FG001|Overall Study|Withdrawal by Subject|4|||
124812287|NCT01235689|448942636|FG000|Overall Study|Lost to Follow-up|1|||
124812288|NCT01235689|448942637|FG001|Overall Study|Lost to Follow-up|2|||
125301190|NCT01717326|450727937|FG011|Overall Study|Withdrawal by Subject|0|||
125301191|NCT01717326|450727938|FG012|Overall Study|Withdrawal by Subject|1|||
125301192|NCT01717326|450727939|FG013|Overall Study|Withdrawal by Subject|0|||
125301193|NCT01717326|450727940|FG014|Overall Study|Withdrawal by Subject|0|||
125301194|NCT01717326|450727941|FG015|Overall Study|Withdrawal by Subject|1|||
125301195|NCT01717326|450727942|FG016|Overall Study|Withdrawal by Subject|0|||
125301196|NCT01717326|450727943|FG017|Overall Study|Withdrawal by Subject|0|||
125301197|NCT01717326|450727944|FG018|Overall Study|Withdrawal by Subject|2|||
125301198|NCT01717326|450727945|FG019|Overall Study|Withdrawal by Subject|3|||
125301199|NCT02596945|450727948|FG000|Overall Study|No documentation of study drug dosing|3|||
125301200|NCT02596945|450727948|FG000|Overall Study|Other|32|||
125301201|NCT02596945|450727948|FG000|Overall Study|Change to hemodialysis|15|||
124812289|NCT01235689|448942636|FG000|Overall Study|Miscellaneous|1|||
124812290|NCT01235689|448942637|FG001|Overall Study|Miscellaneous|5|||
125301202|NCT02596945|450727948|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
125301203|NCT02596945|450727948|FG000|Overall Study|Withdrawal by Subject|1|||
125301204|NCT02596945|450727948|FG000|Overall Study|Missing|1|||
125301205|NCT00422383|450727949|FG000|Overall Study|Adverse Event|5|||
125301206|NCT00422383|450727950|FG001|Overall Study|Adverse Event|3|||
125301207|NCT00422383|450727951|FG002|Overall Study|Adverse Event|1|||
125301208|NCT00422383|450727952|FG003|Overall Study|Adverse Event|1|||
125301209|NCT00422383|450727953|FG004|Overall Study|Adverse Event|0|||
125301210|NCT00422383|450727949|FG000|Overall Study|Lack of Efficacy|4|||
125301211|NCT00422383|450727950|FG001|Overall Study|Lack of Efficacy|4|||
125301212|NCT00422383|450727951|FG002|Overall Study|Lack of Efficacy|2|||
125301213|NCT00422383|450727952|FG003|Overall Study|Lack of Efficacy|1|||
125301214|NCT00422383|450727953|FG004|Overall Study|Lack of Efficacy|1|||
125301215|NCT00422383|450727949|FG000|Overall Study|Lost to Follow-up|0|||
125301216|NCT00422383|450727950|FG001|Overall Study|Lost to Follow-up|1|||
125301217|NCT00422383|450727951|FG002|Overall Study|Lost to Follow-up|0|||
125301218|NCT00422383|450727952|FG003|Overall Study|Lost to Follow-up|0|||
125301219|NCT00422383|450727953|FG004|Overall Study|Lost to Follow-up|1|||
125301220|NCT00422383|450727949|FG000|Overall Study|Protocol Violation|1|||
125301221|NCT00422383|450727950|FG001|Overall Study|Protocol Violation|1|||
125301222|NCT00422383|450727951|FG002|Overall Study|Protocol Violation|1|||
125301223|NCT00422383|450727952|FG003|Overall Study|Protocol Violation|0|||
125301224|NCT00422383|450727953|FG004|Overall Study|Protocol Violation|0|||
125301225|NCT00422383|450727949|FG000|Overall Study|Withdrawal by Subject|5|||
125301226|NCT00422383|450727950|FG001|Overall Study|Withdrawal by Subject|5|||
125301227|NCT00422383|450727951|FG002|Overall Study|Withdrawal by Subject|0|||
125301228|NCT00422383|450727952|FG003|Overall Study|Withdrawal by Subject|0|||
125301229|NCT00422383|450727953|FG004|Overall Study|Withdrawal by Subject|1|||
125301230|NCT03738618|450730220|FG000|Overall Study|Protocol deviation|23|||
125301231|NCT03738618|450730221|FG001|Overall Study|Protocol deviation|0|||
125301232|NCT03738618|450730220|FG000|Overall Study|Adverse Event|4|||
124812291|NCT00389597|448942638|FG000|Overall Study|Lost to Follow-up|8|||
124812292|NCT00389597|448942639|FG001|Overall Study|Lost to Follow-up|6|||
124812293|NCT00389597|448942640|FG002|Overall Study|Lost to Follow-up|4|||
124812294|NCT00389597|448942641|FG003|Overall Study|Lost to Follow-up|6|||
124812295|NCT00005044|448942642|FG000|Overall Study|Protocol Violation|37|||
124812296|NCT00005044|448942643|FG001|Overall Study|Protocol Violation|46|||
124812297|NCT00005044|448942642|FG000|Overall Study|Withdrawal by Subject|1|||
124812298|NCT00005044|448942643|FG001|Overall Study|Withdrawal by Subject|5|||
124812299|NCT00005044|448942642|FG000|Overall Study|No protocol treatment|0|||
124812300|NCT00005044|448942643|FG001|Overall Study|No protocol treatment|1|||
125301233|NCT03738618|450730221|FG001|Overall Study|Adverse Event|0|||
125301234|NCT03738618|450730220|FG000|Overall Study|Lost to Follow-up|2|||
125301235|NCT03738618|450730221|FG001|Overall Study|Lost to Follow-up|0|||
125301236|NCT03738618|450730220|FG000|Overall Study|Randomization failure|1|||
125301237|NCT03738618|450730221|FG001|Overall Study|Randomization failure|0|||
125301238|NCT03738618|450730220|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
125301239|NCT03738618|450730221|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
125301240|NCT03738618|450730220|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
125301241|NCT03738618|450730221|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
125301242|NCT00649428|450730222|FG000|Overall Study|Adverse Event|2|||
125301243|NCT00649428|450730223|FG001|Overall Study|Adverse Event|2|||
125301244|NCT00649428|450730222|FG000|Overall Study|Withdrawal by Subject|6|||
125301245|NCT00649428|450730223|FG001|Overall Study|Withdrawal by Subject|6|||
125301246|NCT00649428|450730222|FG000|Overall Study|Lost to Follow-up|1|||
125301247|NCT00649428|450730223|FG001|Overall Study|Lost to Follow-up|3|||
125301248|NCT00649428|450730222|FG000|Overall Study|Insufficient manufacturing yield|5|||
125301249|NCT00649428|450730223|FG001|Overall Study|Insufficient manufacturing yield|1|||
125301250|NCT00649428|450730222|FG000|Overall Study|Protocol Violation|6|||
125301251|NCT00649428|450730223|FG001|Overall Study|Protocol Violation|2|||
125301252|NCT00649428|450730222|FG000|Overall Study|Physician Decision|0|||
125301253|NCT00649428|450730223|FG001|Overall Study|Physician Decision|1|||
124812301|NCT04431453|448942644|FG000|Overall Study|Withdrew Consent|0|||
124812302|NCT04431453|448942645|FG001|Overall Study|Withdrew Consent|1|||
124812303|NCT04431453|448942646|FG002|Overall Study|Withdrew Consent|0|||
125301254|NCT01450098|450730224|FG000|Period 3|Protocol Violation|0|||
125301255|NCT01450098|450730225|FG001|Period 3|Protocol Violation|1|||
125301256|NCT01450098|450730224|FG000|Period 3|Withdrawal by Subject|0|||
125301257|NCT01450098|450730225|FG001|Period 3|Withdrawal by Subject|2|||
125301258|NCT01272635|450730228|FG000|Overall Study|Lost to Follow-up|31|||
125301259|NCT01272635|450730229|FG001|Overall Study|Lost to Follow-up|20|||
125301260|NCT01272635|450730230|FG002|Overall Study|Lost to Follow-up|31|||
125301261|NCT01272635|450730231|FG003|Overall Study|Lost to Follow-up|23|||
125301262|NCT01832155|450730232|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
124812304|NCT04431453|448942647|FG003|Overall Study|Withdrew Consent|2|||
124812305|NCT04431453|448942648|FG004|Overall Study|Withdrew Consent|0|||
124812306|NCT04431453|448942649|FG005|Overall Study|Withdrew Consent|0|||
125301263|NCT01832155|450730233|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
125301264|NCT01832155|450730232|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
125301265|NCT01832155|450730233|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
125301266|NCT02409719|450730241|FG000|Overall Study|Lost to Follow-up|3|||
125301267|NCT02409719|450730242|FG001|Overall Study|Lost to Follow-up|3|||
125301268|NCT02479139|450730243|FG000|Overall Study|Lost to Follow-up|2|||
125301269|NCT02479139|450730244|FG001|Overall Study|Lost to Follow-up|4|||
125301270|NCT02479139|450730245|FG002|Overall Study|Lost to Follow-up|4|||
125301271|NCT02479139|450730246|FG003|Overall Study|Lost to Follow-up|2|||
125301272|NCT02479139|450730247|FG004|Overall Study|Lost to Follow-up|3|||
125301273|NCT02479139|450730248|FG005|Overall Study|Lost to Follow-up|5|||
125301274|NCT02479139|450730243|FG000|Overall Study|Withdrew Consent|5|||
125301275|NCT02479139|450730244|FG001|Overall Study|Withdrew Consent|6|||
125301276|NCT02479139|450730245|FG002|Overall Study|Withdrew Consent|1|||
125301277|NCT02479139|450730246|FG003|Overall Study|Withdrew Consent|4|||
125301278|NCT02479139|450730247|FG004|Overall Study|Withdrew Consent|1|||
125301279|NCT02479139|450730248|FG005|Overall Study|Withdrew Consent|1|||
125301280|NCT02479139|450730243|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
125301281|NCT02479139|450730244|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
125301282|NCT02479139|450730245|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
125301283|NCT02479139|450730246|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
125301284|NCT02479139|450730247|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
125301285|NCT02479139|450730248|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
125301286|NCT02479139|450730243|FG000|Overall Study|Other Miscellaneous Reasons|1|||
125301287|NCT02479139|450730244|FG001|Overall Study|Other Miscellaneous Reasons|0|||
125301288|NCT02479139|450730245|FG002|Overall Study|Other Miscellaneous Reasons|1|||
125301289|NCT02479139|450730246|FG003|Overall Study|Other Miscellaneous Reasons|1|||
125301290|NCT02479139|450730247|FG004|Overall Study|Other Miscellaneous Reasons|1|||
125301291|NCT02479139|450730248|FG005|Overall Study|Other Miscellaneous Reasons|0|||
125301292|NCT00778895|450730251|FG000|Active Phase|Adverse Event|3|||
125301293|NCT00778895|450730252|FG001|Active Phase|Adverse Event|1|||
125301294|NCT00778895|450730253|FG002|Active Phase|Adverse Event|0|||
125301295|NCT00778895|450730251|FG000|Active Phase|Withdrawal by Subject|1|||
125301296|NCT00778895|450730252|FG001|Active Phase|Withdrawal by Subject|4|||
125301297|NCT00778895|450730253|FG002|Active Phase|Withdrawal by Subject|0|||
125301298|NCT00778895|450730251|FG000|Active Phase|Lost to Follow-up|1|||
125301299|NCT00778895|450730252|FG001|Active Phase|Lost to Follow-up|1|||
125301300|NCT00778895|450730253|FG002|Active Phase|Lost to Follow-up|0|||
125301301|NCT00778895|450730251|FG000|Active Phase|Other|2|||
125301302|NCT00778895|450730252|FG001|Active Phase|Other|0|||
125301303|NCT00778895|450730253|FG002|Active Phase|Other|0|||
125301304|NCT00778895|450730251|FG000|ESFU Phase|Adverse Event|2|||
125301305|NCT00778895|450730252|FG001|ESFU Phase|Adverse Event|1|||
125301306|NCT00778895|450730253|FG002|ESFU Phase|Adverse Event|0|||
125301307|NCT00778895|450730251|FG000|ESFU Phase|Withdrawal by Subject|1|||
125301308|NCT00778895|450730252|FG001|ESFU Phase|Withdrawal by Subject|4|||
125301309|NCT00778895|450730253|FG002|ESFU Phase|Withdrawal by Subject|0|||
125301310|NCT00778895|450730251|FG000|ESFU Phase|Lost to Follow-up|6|||
125301311|NCT00778895|450730252|FG001|ESFU Phase|Lost to Follow-up|7|||
125301312|NCT00778895|450730253|FG002|ESFU Phase|Lost to Follow-up|2|||
125301313|NCT00778895|450730251|FG000|ESFU Phase|Other|2|||
125301314|NCT00778895|450730252|FG001|ESFU Phase|Other|0|||
125301315|NCT00778895|450730253|FG002|ESFU Phase|Other|0|||
125301316|NCT02540993|450730254|FG000|Overall Study|Lost to Follow-up|5|||
125301317|NCT02540993|450730255|FG001|Overall Study|Lost to Follow-up|3|||
125301318|NCT02540993|450730254|FG000|Overall Study|Withdrawal by Subject|4|||
125301319|NCT02540993|450730255|FG001|Overall Study|Withdrawal by Subject|6|||
125301320|NCT02540993|450730254|FG000|Overall Study|GCP violations|33|||
125301321|NCT02540993|450730255|FG001|Overall Study|GCP violations|27|||
125301322|NCT03550404|450730256|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
125301323|NCT03550404|450730257|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
124812307|NCT04431453|448942650|FG006|Overall Study|Withdrew Consent|0|||
124812308|NCT04431453|448942651|FG007|Overall Study|Withdrew Consent|0|||
124812309|NCT04431453|448942644|FG000|Overall Study|Death|1|||
125301324|NCT03550404|450730258|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
125301325|NCT03550404|450730256|FG000|Phase 2|Vacated position|1|||
125301326|NCT03550404|450730257|FG001|Phase 2|Vacated position|0|||
125301327|NCT03550404|450730258|FG002|Phase 2|Vacated position|0|||
125301328|NCT01009086|450730260|FG000|Overall Study|Lack of Efficacy|16|||
125301329|NCT01009086|450730261|FG001|Overall Study|Lack of Efficacy|15|||
125301330|NCT01009086|450730262|FG002|Overall Study|Lack of Efficacy|9|||
125301331|NCT01009086|450730260|FG000|Overall Study|Lost to Follow-up|4|||
125301332|NCT01009086|450730261|FG001|Overall Study|Lost to Follow-up|5|||
125301333|NCT01009086|450730262|FG002|Overall Study|Lost to Follow-up|3|||
124812310|NCT04431453|448942645|FG001|Overall Study|Death|0|||
125301334|NCT01009086|450730260|FG000|Overall Study|Adverse Event|12|||
125301335|NCT01009086|450730261|FG001|Overall Study|Adverse Event|11|||
124812311|NCT04431453|448942646|FG002|Overall Study|Death|0|||
125301336|NCT01009086|450730262|FG002|Overall Study|Adverse Event|8|||
125301337|NCT01009086|450730260|FG000|Overall Study|Withdrawal by Subject|9|||
125301338|NCT01009086|450730261|FG001|Overall Study|Withdrawal by Subject|11|||
125301339|NCT01009086|450730262|FG002|Overall Study|Withdrawal by Subject|13|||
125301340|NCT01009086|450730260|FG000|Overall Study|Other|3|||
125301341|NCT01009086|450730261|FG001|Overall Study|Other|5|||
125301342|NCT01009086|450730262|FG002|Overall Study|Other|1|||
125301343|NCT05096312|450730263|FG000|Overall Study|Lost to Follow-up|2|||
125301344|NCT05096312|450730264|FG001|Overall Study|Lost to Follow-up|4|||
125301345|NCT05096312|450730263|FG000|Overall Study|Adverse Event|1|||
125301346|NCT05096312|450730264|FG001|Overall Study|Adverse Event|0|||
125301347|NCT03135210|450730265|FG000|Overall Study|Death|0|||
125301348|NCT03135210|450730266|FG001|Overall Study|Death|1|||
125301349|NCT00820222|450730269|FG000|Overall Study|Lost to Follow-up|10|||
125301350|NCT00820222|450730270|FG001|Overall Study|Lost to Follow-up|9|||
125301351|NCT00820222|450730269|FG000|Overall Study|Withdrawal by Subject|19|||
125301352|NCT00820222|450730270|FG001|Overall Study|Withdrawal by Subject|21|||
125301353|NCT00820222|450730269|FG000|Overall Study|Physician Decision|93|||
125301354|NCT00820222|450730270|FG001|Overall Study|Physician Decision|88|||
125301355|NCT00820222|450730269|FG000|Overall Study|Sponsor Terminated Study|43|||
125301356|NCT00820222|450730270|FG001|Overall Study|Sponsor Terminated Study|65|||
125301357|NCT00820222|450730269|FG000|Overall Study|Unkown|11|||
125301358|NCT00820222|450730270|FG001|Overall Study|Unkown|7|||
125301359|NCT00590577|450730271|FG000|Overall Study|Lack of Efficacy|31|||
125301360|NCT00590577|450730272|FG001|Overall Study|Lack of Efficacy|28|||
125301361|NCT00590577|450730273|FG002|Overall Study|Lack of Efficacy|23|||
125301362|NCT00590577|450730274|FG003|Overall Study|Lack of Efficacy|45|||
125301363|NCT00590577|450730271|FG000|Overall Study|Withdrawal by Subject|23|||
125301364|NCT00590577|450730272|FG001|Overall Study|Withdrawal by Subject|28|||
125301365|NCT00590577|450730273|FG002|Overall Study|Withdrawal by Subject|30|||
125301366|NCT00590577|450730274|FG003|Overall Study|Withdrawal by Subject|26|||
125301367|NCT00590577|450730271|FG000|Overall Study|Adverse Event|10|||
125301368|NCT00590577|450730272|FG001|Overall Study|Adverse Event|10|||
125301369|NCT00590577|450730273|FG002|Overall Study|Adverse Event|13|||
125301370|NCT00590577|450730274|FG003|Overall Study|Adverse Event|11|||
125301371|NCT00590577|450730271|FG000|Overall Study|Lost to Follow-up|12|||
125301372|NCT00590577|450730272|FG001|Overall Study|Lost to Follow-up|6|||
125301373|NCT00590577|450730273|FG002|Overall Study|Lost to Follow-up|6|||
125301374|NCT00590577|450730274|FG003|Overall Study|Lost to Follow-up|9|||
125301375|NCT00590577|450730271|FG000|Overall Study|Pregnancy|0|||
125301376|NCT00590577|450730272|FG001|Overall Study|Pregnancy|1|||
125301377|NCT00590577|450730273|FG002|Overall Study|Pregnancy|0|||
125301378|NCT00590577|450730274|FG003|Overall Study|Pregnancy|0|||
125301379|NCT00590577|450730271|FG000|Overall Study|Various reasons|1|||
124812312|NCT04431453|448942647|FG003|Overall Study|Death|0|||
124812313|NCT04431453|448942648|FG004|Overall Study|Death|0|||
124812314|NCT04431453|448942649|FG005|Overall Study|Death|0|||
124812315|NCT04431453|448942650|FG006|Overall Study|Death|0|||
124812316|NCT04431453|448942651|FG007|Overall Study|Death|1|||
124812317|NCT04431453|448942644|FG000|Overall Study|Lost to Follow-up|0|||
124812318|NCT04431453|448942645|FG001|Overall Study|Lost to Follow-up|0|||
124812319|NCT04431453|448942646|FG002|Overall Study|Lost to Follow-up|1|||
124812320|NCT04431453|448942647|FG003|Overall Study|Lost to Follow-up|1|||
124812321|NCT04431453|448942648|FG004|Overall Study|Lost to Follow-up|0|||
124812322|NCT04431453|448942649|FG005|Overall Study|Lost to Follow-up|0|||
124812323|NCT04431453|448942650|FG006|Overall Study|Lost to Follow-up|0|||
124812324|NCT04431453|448942651|FG007|Overall Study|Lost to Follow-up|0|||
124812325|NCT04431453|448942644|FG000|Overall Study|Enrolled but Never Treated|0|||
124812326|NCT04431453|448942645|FG001|Overall Study|Enrolled but Never Treated|0|||
125301380|NCT00590577|450730272|FG001|Overall Study|Various reasons|3|||
125301381|NCT00590577|450730273|FG002|Overall Study|Various reasons|1|||
125301382|NCT00590577|450730274|FG003|Overall Study|Various reasons|2|||
125301383|NCT01229449|450730275|FG000|Overall Study|Withdrawal by Subject|0|||
124812327|NCT04431453|448942646|FG002|Overall Study|Enrolled but Never Treated|0|||
124812328|NCT04431453|448942647|FG003|Overall Study|Enrolled but Never Treated|0|||
125301384|NCT01229449|450730276|FG001|Overall Study|Withdrawal by Subject|3|||
125301385|NCT01229449|450730277|FG002|Overall Study|Withdrawal by Subject|0|||
125301386|NCT01229449|450730278|FG003|Overall Study|Withdrawal by Subject|1|||
125301387|NCT01229449|450730279|FG004|Overall Study|Withdrawal by Subject|1|||
125301388|NCT01229449|450730275|FG000|Overall Study|Lost to Follow-up|1|||
125301389|NCT01229449|450730276|FG001|Overall Study|Lost to Follow-up|1|||
125301390|NCT01229449|450730277|FG002|Overall Study|Lost to Follow-up|1|||
125301391|NCT01229449|450730278|FG003|Overall Study|Lost to Follow-up|0|||
124812329|NCT04431453|448942648|FG004|Overall Study|Enrolled but Never Treated|1|||
124812330|NCT04431453|448942649|FG005|Overall Study|Enrolled but Never Treated|0|||
124812331|NCT04431453|448942650|FG006|Overall Study|Enrolled but Never Treated|0|||
124819583|NCT00420927|448965763|FG002|Period 1|Lost to Follow-up|0|||
125301392|NCT01229449|450730279|FG004|Overall Study|Lost to Follow-up|0|||
125301393|NCT01229449|450730275|FG000|Overall Study|Physician Decision|0|||
125301394|NCT01229449|450730276|FG001|Overall Study|Physician Decision|0|||
125301395|NCT01229449|450730277|FG002|Overall Study|Physician Decision|1|||
125301396|NCT01229449|450730278|FG003|Overall Study|Physician Decision|0|||
125301397|NCT01229449|450730279|FG004|Overall Study|Physician Decision|0|||
124812332|NCT04431453|448942651|FG007|Overall Study|Enrolled but Never Treated|0|||
124812333|NCT03546062|448942652|FG000|Overall Study|Adverse Event|6|||
124812334|NCT03546062|448942653|FG001|Overall Study|Adverse Event|5|||
124812335|NCT03546062|448942654|FG002|Overall Study|Adverse Event|8|||
124812336|NCT02083965|448942656|FG000|Treatment Period|Other|1|||
124812337|NCT02083965|448942657|FG001|Treatment Period|Other|0|||
124812338|NCT04502433|448942658|FG000|Overall Study|Death|2|||
124812339|NCT04502433|448942659|FG001|Overall Study|Death|4|||
124812340|NCT04502433|448942658|FG000|Overall Study|Lost to Follow-up|1|||
124812341|NCT04502433|448942659|FG001|Overall Study|Lost to Follow-up|0|||
124812342|NCT04502433|448942658|FG000|Overall Study|Physician Decision|0|||
124812343|NCT04502433|448942659|FG001|Overall Study|Physician Decision|1|||
124812344|NCT01702961|448942662|FG000|Overall Study|Additional treatment|3|||
124812345|NCT01702961|448942662|FG000|Overall Study|Progressive disease|5|||
124812346|NCT01702961|448942662|FG000|Overall Study|Relapse|20|||
124812347|NCT01702961|448942662|FG000|Overall Study|Death|6|||
124812348|NCT01702961|448942662|FG000|Overall Study|Lost to Follow-up|2|||
124812349|NCT01702961|448942662|FG000|Overall Study|Ongoing|11|||
124812350|NCT02229383|448942663|FG000|Overall Study|Adverse Event|7|||
124812351|NCT02229383|448942664|FG001|Overall Study|Adverse Event|4|||
124812352|NCT02229383|448942663|FG000|Overall Study|Death|0|||
124812353|NCT02229383|448942664|FG001|Overall Study|Death|1|||
124812354|NCT02229383|448942663|FG000|Overall Study|Lost to Follow-up|5|||
124812355|NCT02229383|448942664|FG001|Overall Study|Lost to Follow-up|3|||
124812356|NCT02229383|448942663|FG000|Overall Study|Withdrawal by Subject|4|||
124812357|NCT02229383|448942664|FG001|Overall Study|Withdrawal by Subject|6|||
124812358|NCT02229383|448942663|FG000|Overall Study|Did not receive treatment|1|||
124812359|NCT02229383|448942664|FG001|Overall Study|Did not receive treatment|0|||
124812360|NCT02229383|448942663|FG000|Overall Study|Other|3|||
124812361|NCT02229383|448942664|FG001|Overall Study|Other|8|||
125301398|NCT01887353|450730296|FG000|Overall Study|Study stopped early|4|||
125301399|NCT01887353|450730297|FG001|Overall Study|Study stopped early|3|||
125301400|NCT00699335|450730298|FG000|Overall Study|Combination of multiple reasons|176|||
125301401|NCT00699335|450730298|FG000|Overall Study|Missing data|52|||
125301402|NCT03262441|450730299|FG000|Overall Study|Withdrawal by Subject|1|||
125301403|NCT01545050|450730300|FG000|Overall Study|Lack of Efficacy|0|||
125301404|NCT01545050|450730301|FG001|Overall Study|Lack of Efficacy|0|||
125301405|NCT01545050|450730302|FG002|Overall Study|Lack of Efficacy|0|||
125301406|NCT01545050|450730303|FG003|Overall Study|Lack of Efficacy|3|||
125301407|NCT01545050|450730304|FG004|Overall Study|Lack of Efficacy|2|||
125301408|NCT01545050|450730300|FG000|Overall Study|Adverse Event|1|||
125301409|NCT01545050|450730301|FG001|Overall Study|Adverse Event|1|||
125301410|NCT01545050|450730302|FG002|Overall Study|Adverse Event|2|||
125301411|NCT01545050|450730303|FG003|Overall Study|Adverse Event|2|||
125301412|NCT01545050|450730304|FG004|Overall Study|Adverse Event|0|||
125301413|NCT01545050|450730300|FG000|Overall Study|Discontinued study treatment|1|||
125301414|NCT01545050|450730301|FG001|Overall Study|Discontinued study treatment|0|||
125301415|NCT01545050|450730302|FG002|Overall Study|Discontinued study treatment|0|||
125301416|NCT01545050|450730303|FG003|Overall Study|Discontinued study treatment|0|||
125301417|NCT01545050|450730304|FG004|Overall Study|Discontinued study treatment|0|||
125301418|NCT01545050|450730300|FG000|Overall Study|Withdrawal by Subject|1|||
125301419|NCT01545050|450730301|FG001|Overall Study|Withdrawal by Subject|0|||
125301420|NCT01545050|450730302|FG002|Overall Study|Withdrawal by Subject|0|||
125301421|NCT01545050|450730303|FG003|Overall Study|Withdrawal by Subject|2|||
125301422|NCT01545050|450730304|FG004|Overall Study|Withdrawal by Subject|1|||
125301423|NCT01545050|450730300|FG000|Overall Study|Participant no longer meets study criteria|0|||
125301424|NCT01545050|450730301|FG001|Overall Study|Participant no longer meets study criteria|2|||
125301425|NCT01545050|450730302|FG002|Overall Study|Participant no longer meets study criteria|0|||
125301426|NCT01545050|450730303|FG003|Overall Study|Participant no longer meets study criteria|0|||
125301427|NCT01545050|450730304|FG004|Overall Study|Participant no longer meets study criteria|1|||
125301428|NCT01545050|450730300|FG000|Overall Study|Administrative reason by sponsor|4|||
125301429|NCT01545050|450730301|FG001|Overall Study|Administrative reason by sponsor|2|||
124812362|NCT00674362|448942667|FG000|Double Blind|Adverse Event|6|||
124812363|NCT00674362|448942668|FG001|Double Blind|Adverse Event|6|||
124812364|NCT00674362|448942667|FG000|Double Blind|Lack of Efficacy|2|||
124812365|NCT00674362|448942668|FG001|Double Blind|Lack of Efficacy|6|||
125301430|NCT01545050|450730302|FG002|Overall Study|Administrative reason by sponsor|3|||
125301431|NCT01545050|450730303|FG003|Overall Study|Administrative reason by sponsor|5|||
125301432|NCT01545050|450730304|FG004|Overall Study|Administrative reason by sponsor|5|||
125301433|NCT00559988|450730308|FG000|Overall Study|Death|147|||
124812366|NCT00674362|448942667|FG000|Double Blind|Loss of efficacy|0|||
124812367|NCT00674362|448942668|FG001|Double Blind|Loss of efficacy|1|||
124812368|NCT00674362|448942667|FG000|Double Blind|Withdrawal by Subject|4|||
124812369|NCT00674362|448942668|FG001|Double Blind|Withdrawal by Subject|3|||
124812370|NCT00674362|448942667|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
124812371|NCT00674362|448942668|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
125301434|NCT00559988|450730309|FG001|Overall Study|Death|140|||
125301435|NCT00559988|450730308|FG000|Overall Study|Withdrawal by Subject|152|||
125301436|NCT00559988|450730309|FG001|Overall Study|Withdrawal by Subject|139|||
125301437|NCT00559988|450730308|FG000|Overall Study|Lost to Follow-up|42|||
125301438|NCT00559988|450730309|FG001|Overall Study|Lost to Follow-up|56|||
125301439|NCT00559988|450730308|FG000|Overall Study|ICD device explanted|10|||
125301440|NCT00559988|450730309|FG001|Overall Study|ICD device explanted|17|||
125301441|NCT02249182|450730310|FG000|Treatment Phase|Lost to Follow-up|4|||
125301442|NCT02249182|450730311|FG001|Treatment Phase|Lost to Follow-up|0|||
125301443|NCT02249182|450730312|FG002|Treatment Phase|Lost to Follow-up|0|||
125301444|NCT02249182|450730313|FG003|Treatment Phase|Lost to Follow-up|0|||
125301445|NCT02249182|450730314|FG004|Treatment Phase|Lost to Follow-up|0|||
125301446|NCT01455194|450730315|FG000|Overall Study|Screen Failure|20|||
125301447|NCT01455194|450730316|FG001|Overall Study|Screen Failure|0|||
125301448|NCT01455194|450730317|FG002|Overall Study|Screen Failure|0|||
125301449|NCT01455194|450730318|FG003|Overall Study|Screen Failure|0|||
125301450|NCT01455194|450730315|FG000|Overall Study|Randomisation Failure|90|||
125301451|NCT01455194|450730316|FG001|Overall Study|Randomisation Failure|0|||
125301452|NCT01455194|450730317|FG002|Overall Study|Randomisation Failure|0|||
125301453|NCT01455194|450730318|FG003|Overall Study|Randomisation Failure|0|||
125301454|NCT01455194|450730315|FG000|Overall Study|Deterioration in asthma|12|||
125301455|NCT01455194|450730316|FG001|Overall Study|Deterioration in asthma|6|||
125301456|NCT01455194|450730317|FG002|Overall Study|Deterioration in asthma|14|||
125301457|NCT01455194|450730318|FG003|Overall Study|Deterioration in asthma|9|||
125301458|NCT01455194|450730315|FG000|Overall Study|Adverse Event|1|||
125301459|NCT01455194|450730316|FG001|Overall Study|Adverse Event|1|||
125301460|NCT01455194|450730317|FG002|Overall Study|Adverse Event|1|||
125301461|NCT01455194|450730318|FG003|Overall Study|Adverse Event|3|||
125301462|NCT01455194|450730315|FG000|Overall Study|Withdrawal by Subject|21|||
125301463|NCT01455194|450730316|FG001|Overall Study|Withdrawal by Subject|16|||
125301464|NCT01455194|450730317|FG002|Overall Study|Withdrawal by Subject|12|||
125301465|NCT01455194|450730318|FG003|Overall Study|Withdrawal by Subject|9|||
125301466|NCT01455194|450730315|FG000|Overall Study|Lost to Follow-up|2|||
125301467|NCT01455194|450730316|FG001|Overall Study|Lost to Follow-up|0|||
125301468|NCT01455194|450730317|FG002|Overall Study|Lost to Follow-up|1|||
125301469|NCT01455194|450730318|FG003|Overall Study|Lost to Follow-up|1|||
125301470|NCT01455194|450730315|FG000|Overall Study|Pregnancy|0|||
125301471|NCT01455194|450730316|FG001|Overall Study|Pregnancy|1|||
125301472|NCT01455194|450730317|FG002|Overall Study|Pregnancy|1|||
125301473|NCT01455194|450730318|FG003|Overall Study|Pregnancy|0|||
125301474|NCT01455194|450730315|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
125301475|NCT01455194|450730316|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
125301476|NCT01455194|450730317|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
125301477|NCT01455194|450730318|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
125301478|NCT01455194|450730315|FG000|Overall Study|Miscellaneous|4|||
125301479|NCT01455194|450730316|FG001|Overall Study|Miscellaneous|5|||
125301480|NCT01455194|450730317|FG002|Overall Study|Miscellaneous|1|||
125301481|NCT01455194|450730318|FG003|Overall Study|Miscellaneous|4|||
125301482|NCT02516228|450730321|FG000|Overall Study|Lost to Follow-up|1|||
125301483|NCT02516228|450730321|FG000|Overall Study|Withdrawal by Subject|1|||
125301484|NCT02516228|450730321|FG000|Overall Study|Physician Decision|1|||
125301485|NCT03916484|450730322|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
125301486|NCT03916484|450730323|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
125301487|NCT03916484|450730324|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
125301488|NCT03916484|450730325|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
125301489|NCT03916484|450730322|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
125301490|NCT03916484|450730323|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
125301491|NCT03916484|450730324|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
125301492|NCT03916484|450730325|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
125301493|NCT01092663|450730328|FG000|Overall Study|Withdrawal by Subject|3|||
125301494|NCT01092663|450730329|FG001|Overall Study|Withdrawal by Subject|2|||
125301495|NCT01092663|450730328|FG000|Overall Study|Glucose >300mg/dL|1|||
125301496|NCT01092663|450730329|FG001|Overall Study|Glucose >300mg/dL|0|||
124812372|NCT00674362|448942667|FG000|Double Blind|Other: Surgery|0|||
124812373|NCT00674362|448942668|FG001|Double Blind|Other: Surgery|1|||
125301497|NCT01092663|450730328|FG000|Overall Study|High fasting triglyceride|2|||
125301498|NCT01092663|450730329|FG001|Overall Study|High fasting triglyceride|0|||
125301499|NCT01092663|450730328|FG000|Overall Study|Adverse Event|1|||
125301500|NCT01092663|450730329|FG001|Overall Study|Adverse Event|1|||
125301501|NCT01092663|450730328|FG000|Overall Study|Protocol Violation|0|||
125301502|NCT01092663|450730329|FG001|Overall Study|Protocol Violation|1|||
125301503|NCT03688620|450730330|FG000|Overall Study|Other|0|||
125301504|NCT03688620|450730331|FG001|Overall Study|Other|0|||
125301505|NCT03688620|450730332|FG002|Overall Study|Other|1|||
124812374|NCT00674362|448942667|FG000|Open Label|Adverse Event|1|||
125301506|NCT03688620|450730330|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
125301507|NCT03688620|450730331|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
125301508|NCT03688620|450730332|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
125301509|NCT03688620|450730330|FG000|Overall Study|Lost to Follow-up|16|||
125301510|NCT03688620|450730331|FG001|Overall Study|Lost to Follow-up|0|||
125301511|NCT03688620|450730332|FG002|Overall Study|Lost to Follow-up|1|||
125301512|NCT03688620|450730330|FG000|Overall Study|Withdrawal by Subject|0|||
125301513|NCT03688620|450730331|FG001|Overall Study|Withdrawal by Subject|0|||
125301514|NCT03688620|450730332|FG002|Overall Study|Withdrawal by Subject|6|||
125301515|NCT01008904|450730333|FG000|Overall Study|Lost to Follow-up|1|||
125301516|NCT01008904|450730333|FG000|Overall Study|Adverse Event|2|||
125301517|NCT01008904|450730333|FG000|Overall Study|unexpected unrelated surgery|1|||
125301518|NCT01183065|450730334|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
125301519|NCT02456857|450730335|FG000|Overall Study|Disease Progression|4|||
125301520|NCT00781859|450730336|FG000|Overall Study|Adverse Event|2|||
125301521|NCT00781859|450730337|FG001|Overall Study|Adverse Event|2|||
125301522|NCT00781859|450730336|FG000|Overall Study|Withdrawal by Subject|8|||
125301523|NCT00781859|450730337|FG001|Overall Study|Withdrawal by Subject|4|||
125301524|NCT00781859|450730336|FG000|Overall Study|Lost to Follow-up|6|||
125301525|NCT00781859|450730337|FG001|Overall Study|Lost to Follow-up|3|||
125301526|NCT00781859|450730336|FG000|Overall Study|Death|3|||
125301527|NCT00781859|450730337|FG001|Overall Study|Death|0|||
125301528|NCT01983774|450730341|FG000|Overall Study|Lung Transplant|0|||
125301529|NCT01983774|450730342|FG001|Overall Study|Lung Transplant|1|||
125301530|NCT01983774|450730341|FG000|Overall Study|Lost to Follow-up|1|||
125301531|NCT01983774|450730342|FG001|Overall Study|Lost to Follow-up|0|||
125301532|NCT01008449|450730343|FG000|Overall Study|Lost to Follow-up|29|||
125301533|NCT01008449|450730344|FG001|Overall Study|Lost to Follow-up|19|||
125301534|NCT01220180|450730345|FG000|Overall Study|Lost to Follow-up|76|||
125301535|NCT01220180|450730345|FG000|Overall Study|Other|72|||
125301536|NCT01220180|450730345|FG000|Overall Study|Adverse Event|35|||
125301537|NCT01220180|450730345|FG000|Overall Study|Lack of Efficacy|22|||
125301538|NCT01220180|450730345|FG000|Overall Study|Death|1|||
125301539|NCT01220180|450730345|FG000|Overall Study|Randomized but not treated|1|||
125301540|NCT01067469|450730351|FG000|Overall Study|Withdrawal by Subject|0|||
125301541|NCT01067469|450730352|FG001|Overall Study|Withdrawal by Subject|1|||
125301542|NCT01067469|450730351|FG000|Overall Study|Disease Progression|0|||
125301543|NCT01067469|450730352|FG001|Overall Study|Disease Progression|1|||
125301544|NCT01299116|450730354|FG000|Overall Study|Lost to Follow-up|65|||
125301545|NCT01299116|450730355|FG001|Overall Study|Lost to Follow-up|9|||
125301546|NCT01299116|450730356|FG002|Overall Study|Lost to Follow-up|11|||
125301547|NCT01123707|450730358|FG000|Overall Study|Lost to Follow-up|3|||
125301548|NCT01123707|450730359|FG001|Overall Study|Lost to Follow-up|1|||
125301549|NCT01123707|450730360|FG002|Overall Study|Lost to Follow-up|3|||
125301550|NCT01123707|450730361|FG003|Overall Study|Lost to Follow-up|2|||
125301551|NCT01123707|450730358|FG000|Overall Study|Adverse Event|5|||
125301552|NCT01123707|450730359|FG001|Overall Study|Adverse Event|7|||
125301553|NCT01123707|450730360|FG002|Overall Study|Adverse Event|5|||
125301554|NCT01123707|450730361|FG003|Overall Study|Adverse Event|3|||
125301555|NCT01123707|450730358|FG000|Overall Study|Sponsor Discontinued Study|30|||
125301556|NCT01123707|450730359|FG001|Overall Study|Sponsor Discontinued Study|24|||
125301557|NCT01123707|450730360|FG002|Overall Study|Sponsor Discontinued Study|25|||
125301558|NCT01123707|450730361|FG003|Overall Study|Sponsor Discontinued Study|40|||
125301559|NCT01123707|450730358|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
125301560|NCT01123707|450730359|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
125301561|NCT01123707|450730360|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
125301562|NCT01123707|450730361|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
125301563|NCT01123707|450730358|FG000|Overall Study|Investigator Withdrew Participant|0|||
125301564|NCT01123707|450730359|FG001|Overall Study|Investigator Withdrew Participant|1|||
125301565|NCT01123707|450730360|FG002|Overall Study|Investigator Withdrew Participant|1|||
125301566|NCT01123707|450730361|FG003|Overall Study|Investigator Withdrew Participant|1|||
125301567|NCT01123707|450730358|FG000|Overall Study|Subject Withdrew Consent|4|||
125301568|NCT01123707|450730359|FG001|Overall Study|Subject Withdrew Consent|5|||
125301569|NCT01123707|450730360|FG002|Overall Study|Subject Withdrew Consent|1|||
125301570|NCT01123707|450730361|FG003|Overall Study|Subject Withdrew Consent|2|||
125301571|NCT01123707|450730358|FG000|Overall Study|Lack of Efficacy|1|||
125301572|NCT01123707|450730359|FG001|Overall Study|Lack of Efficacy|2|||
125301573|NCT01123707|450730360|FG002|Overall Study|Lack of Efficacy|1|||
125301574|NCT01123707|450730361|FG003|Overall Study|Lack of Efficacy|0|||
125301575|NCT01123707|450730358|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
125301576|NCT01123707|450730359|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
125301577|NCT01123707|450730360|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
125301578|NCT01123707|450730361|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
125301579|NCT04378114|450730364|FG000|Overall Study|Withdrawal by Subject|5|||
125301580|NCT00629798|450730365|FG000|Overall Study|Not Treated|4|||
125301581|NCT01959243|450730368|FG000|Overall Study|Investigator Decision|3|||
125301582|NCT01959243|450730369|FG001|Overall Study|Investigator Decision|0|||
125301583|NCT01959243|450730368|FG000|Overall Study|Adverse Event|5|||
125301584|NCT01959243|450730369|FG001|Overall Study|Adverse Event|2|||
125301585|NCT01959243|450730368|FG000|Overall Study|Administrative reasons|2|||
125301586|NCT01959243|450730369|FG001|Overall Study|Administrative reasons|1|||
125301587|NCT01959243|450730368|FG000|Overall Study|Lost to Follow-up|3|||
125301588|NCT01959243|450730369|FG001|Overall Study|Lost to Follow-up|1|||
125301589|NCT00428844|450730370|FG000|Completed Study Drug Treatment|Adverse Event|2|||
125301590|NCT00428844|450730371|FG001|Completed Study Drug Treatment|Adverse Event|4|||
125301591|NCT00428844|450730372|FG002|Completed Study Drug Treatment|Adverse Event|4|||
125301592|NCT00428844|450730370|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
125301593|NCT00428844|450730371|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
125301594|NCT00428844|450730372|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
125301595|NCT00428844|450730370|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
125301596|NCT00428844|450730371|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
125301597|NCT00428844|450730372|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
125301598|NCT00428844|450730370|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
125301599|NCT00428844|450730371|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
125301600|NCT00428844|450730372|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
125301601|NCT00428844|450730370|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
125301602|NCT00428844|450730371|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
125301603|NCT00428844|450730372|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
125301604|NCT00428844|450730370|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
125301605|NCT00428844|450730371|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
125301606|NCT00428844|450730372|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
125301607|NCT00428844|450730370|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
125301608|NCT00428844|450730371|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
125301609|NCT00428844|450730372|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
125301610|NCT00428844|450730370|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
125301611|NCT00428844|450730371|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
125301612|NCT00428844|450730372|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
125301613|NCT00428844|450730370|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
125301614|NCT00428844|450730371|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
125301615|NCT00428844|450730372|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
125301616|NCT00488826|450730375|FG000|Overall Study|Withdrawal by Subject|40|||
125301617|NCT00488826|450730376|FG001|Overall Study|Withdrawal by Subject|35|||
125301618|NCT00488826|450730377|FG002|Overall Study|Withdrawal by Subject|19|||
125301619|NCT00488826|450730375|FG000|Overall Study|Protocol Violation|0|||
125301620|NCT00488826|450730376|FG001|Overall Study|Protocol Violation|0|||
125301621|NCT00488826|450730377|FG002|Overall Study|Protocol Violation|2|||
125301622|NCT00488826|450730375|FG000|Overall Study|Adverse Event|9|||
125301623|NCT00488826|450730376|FG001|Overall Study|Adverse Event|15|||
125301624|NCT00488826|450730377|FG002|Overall Study|Adverse Event|4|||
125301625|NCT00488826|450730375|FG000|Overall Study|Lost to Follow-up|5|||
125301626|NCT00488826|450730376|FG001|Overall Study|Lost to Follow-up|1|||
125301627|NCT00488826|450730377|FG002|Overall Study|Lost to Follow-up|0|||
125301628|NCT00488826|450730375|FG000|Overall Study|Protocol Deviations|2|||
125301629|NCT00488826|450730376|FG001|Overall Study|Protocol Deviations|1|||
125301630|NCT00488826|450730377|FG002|Overall Study|Protocol Deviations|1|||
125301631|NCT02292706|450730379|FG000|Overall Study|Lost to Follow-up|20|||
125301632|NCT02292706|450730380|FG001|Overall Study|Lost to Follow-up|44|||
125301633|NCT02292706|450730381|FG002|Overall Study|Lost to Follow-up|24|||
125301634|NCT02292706|450730382|FG003|Overall Study|Lost to Follow-up|61|||
125301635|NCT02292706|450730383|FG004|Overall Study|Lost to Follow-up|21|||
125301636|NCT02292706|450730384|FG005|Overall Study|Lost to Follow-up|52|||
125301637|NCT02292706|450730385|FG006|Overall Study|Lost to Follow-up|25|||
125301638|NCT02292706|450730386|FG007|Overall Study|Lost to Follow-up|0|||
125301639|NCT02292706|450730379|FG000|Overall Study|Withdrew consent|15|||
125301640|NCT02292706|450730380|FG001|Overall Study|Withdrew consent|56|||
125301641|NCT02292706|450730381|FG002|Overall Study|Withdrew consent|43|||
125301642|NCT02292706|450730382|FG003|Overall Study|Withdrew consent|36|||
125301643|NCT02292706|450730383|FG004|Overall Study|Withdrew consent|13|||
125301644|NCT02292706|450730384|FG005|Overall Study|Withdrew consent|51|||
125301645|NCT02292706|450730385|FG006|Overall Study|Withdrew consent|20|||
125301646|NCT02292706|450730386|FG007|Overall Study|Withdrew consent|0|||
125301647|NCT02292706|450730379|FG000|Overall Study|Death|3|||
125301648|NCT02292706|450730380|FG001|Overall Study|Death|11|||
125301649|NCT02292706|450730381|FG002|Overall Study|Death|16|||
125301650|NCT02292706|450730382|FG003|Overall Study|Death|22|||
125301651|NCT02292706|450730383|FG004|Overall Study|Death|8|||
125301652|NCT02292706|450730384|FG005|Overall Study|Death|17|||
125301653|NCT02292706|450730385|FG006|Overall Study|Death|3|||
125301654|NCT02292706|450730386|FG007|Overall Study|Death|0|||
125301655|NCT02292706|450730379|FG000|Overall Study|Study terminated by sponsor|0|||
125301656|NCT02292706|450730380|FG001|Overall Study|Study terminated by sponsor|9|||
125301657|NCT02292706|450730381|FG002|Overall Study|Study terminated by sponsor|4|||
125301658|NCT02292706|450730382|FG003|Overall Study|Study terminated by sponsor|21|||
125301659|NCT02292706|450730383|FG004|Overall Study|Study terminated by sponsor|11|||
125301660|NCT02292706|450730384|FG005|Overall Study|Study terminated by sponsor|13|||
125301661|NCT02292706|450730385|FG006|Overall Study|Study terminated by sponsor|3|||
125301662|NCT02292706|450730386|FG007|Overall Study|Study terminated by sponsor|0|||
125301663|NCT02292706|450730379|FG000|Overall Study|Investigator's discretion|4|||
125301664|NCT02292706|450730380|FG001|Overall Study|Investigator's discretion|9|||
125301665|NCT02292706|450730381|FG002|Overall Study|Investigator's discretion|7|||
125301666|NCT02292706|450730382|FG003|Overall Study|Investigator's discretion|11|||
125301667|NCT02292706|450730383|FG004|Overall Study|Investigator's discretion|4|||
125301668|NCT02292706|450730384|FG005|Overall Study|Investigator's discretion|10|||
125301669|NCT02292706|450730385|FG006|Overall Study|Investigator's discretion|1|||
125301670|NCT02292706|450730386|FG007|Overall Study|Investigator's discretion|0|||
125301671|NCT02292706|450730379|FG000|Overall Study|Liver transplant|1|||
125301672|NCT02292706|450730380|FG001|Overall Study|Liver transplant|1|||
125301673|NCT02292706|450730381|FG002|Overall Study|Liver transplant|11|||
125301674|NCT02292706|450730382|FG003|Overall Study|Liver transplant|16|||
125301675|NCT02292706|450730383|FG004|Overall Study|Liver transplant|5|||
125301676|NCT02292706|450730384|FG005|Overall Study|Liver transplant|6|||
125301677|NCT02292706|450730385|FG006|Overall Study|Liver transplant|5|||
125301678|NCT02292706|450730386|FG007|Overall Study|Liver transplant|0|||
125301679|NCT02292706|450730379|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
125301680|NCT02292706|450730380|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
125301681|NCT02292706|450730381|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
125301682|NCT02292706|450730382|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
125301683|NCT02292706|450730383|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
125301684|NCT02292706|450730384|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
125301685|NCT02292706|450730385|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
125301686|NCT02292706|450730386|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
125301687|NCT02292706|450730379|FG000|Overall Study|Subject terminated by sponsor|1|||
125301688|NCT02292706|450730380|FG001|Overall Study|Subject terminated by sponsor|0|||
125301689|NCT02292706|450730381|FG002|Overall Study|Subject terminated by sponsor|0|||
125301690|NCT02292706|450730382|FG003|Overall Study|Subject terminated by sponsor|2|||
125301691|NCT02292706|450730383|FG004|Overall Study|Subject terminated by sponsor|1|||
125301692|NCT02292706|450730384|FG005|Overall Study|Subject terminated by sponsor|0|||
125301693|NCT02292706|450730385|FG006|Overall Study|Subject terminated by sponsor|0|||
125301694|NCT02292706|450730386|FG007|Overall Study|Subject terminated by sponsor|0|||
125301695|NCT02292706|450730379|FG000|Overall Study|Missing|0|||
125301696|NCT02292706|450730380|FG001|Overall Study|Missing|0|||
125301697|NCT02292706|450730381|FG002|Overall Study|Missing|1|||
125301698|NCT02292706|450730382|FG003|Overall Study|Missing|1|||
125301699|NCT02292706|450730383|FG004|Overall Study|Missing|0|||
125301700|NCT02292706|450730384|FG005|Overall Study|Missing|1|||
125301701|NCT02292706|450730385|FG006|Overall Study|Missing|0|||
125301702|NCT02292706|450730386|FG007|Overall Study|Missing|0|||
125301703|NCT02292706|450730379|FG000|Overall Study|Virologic relapse or reinfection|1|||
125301704|NCT02292706|450730380|FG001|Overall Study|Virologic relapse or reinfection|0|||
125301705|NCT02292706|450730381|FG002|Overall Study|Virologic relapse or reinfection|0|||
125301706|NCT02292706|450730382|FG003|Overall Study|Virologic relapse or reinfection|1|||
125301707|NCT02292706|450730383|FG004|Overall Study|Virologic relapse or reinfection|0|||
125301708|NCT02292706|450730384|FG005|Overall Study|Virologic relapse or reinfection|1|||
125301709|NCT02292706|450730385|FG006|Overall Study|Virologic relapse or reinfection|0|||
125301710|NCT02292706|450730386|FG007|Overall Study|Virologic relapse or reinfection|0|||
125301711|NCT02725866|450730389|FG000|Overall Study|Failure to return|6|||
125301712|NCT02725866|450730389|FG000|Overall Study|Withdrew consent|3|||
125301713|NCT02725866|450730389|FG000|Overall Study|Insufficient virological response|1|||
125301714|NCT02725866|450730389|FG000|Overall Study|Other, not specified|4|||
125301715|NCT04667104|450730395|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
125301716|NCT04667104|450730396|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
125301717|NCT04667104|450730397|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
125301718|NCT03043651|450730398|FG000|Overall Study|Death|1|||
125301719|NCT03043651|450730398|FG000|Overall Study|Progressive Disease|2|||
125301720|NCT03043651|450730398|FG000|Overall Study|Adverse Event|2|||
125301721|NCT03043651|450730398|FG000|Overall Study|Withdrawal by Subject|4|||
125301722|NCT03043651|450730398|FG000|Overall Study|Study Terminated by Sponsor|39|||
125301723|NCT01630889|450730399|FG000|Overall Study|Death|2|||
125301724|NCT01630889|450730399|FG000|Overall Study|Withdrawal by Subject|1|||
125301725|NCT01630889|450730399|FG000|Overall Study|Other than Specified|2|||
125301726|NCT01630889|450730399|FG000|Overall Study|Lost to Follow-up|4|||
125301727|NCT01630889|450730399|FG000|Overall Study|Other|1|||
125301728|NCT03208088|450730404|FG000|Period 2|Withdrawal by Subject|0|||
125301729|NCT03208088|450730405|FG001|Period 2|Withdrawal by Subject|0|||
125301730|NCT03208088|450730406|FG002|Period 2|Withdrawal by Subject|0|||
125301731|NCT03208088|450730407|FG003|Period 2|Withdrawal by Subject|0|||
125301732|NCT03208088|450730408|FG004|Period 2|Withdrawal by Subject|0|||
125301733|NCT03208088|450730409|FG005|Period 2|Withdrawal by Subject|0|||
125301734|NCT03208088|450730410|FG006|Period 2|Withdrawal by Subject|0|||
125301735|NCT03208088|450730411|FG007|Period 2|Withdrawal by Subject|0|||
125301736|NCT03208088|450730412|FG008|Period 2|Withdrawal by Subject|1|||
125301737|NCT03208088|450730413|FG009|Period 2|Withdrawal by Subject|0|||
125301738|NCT03208088|450730404|FG000|Period 3|Unsatisfactory Test Article|0|||
125301739|NCT03208088|450730405|FG001|Period 3|Unsatisfactory Test Article|0|||
125301740|NCT03208088|450730406|FG002|Period 3|Unsatisfactory Test Article|0|||
125301741|NCT03208088|450730407|FG003|Period 3|Unsatisfactory Test Article|1|||
125301742|NCT03208088|450730408|FG004|Period 3|Unsatisfactory Test Article|0|||
125301743|NCT03208088|450730409|FG005|Period 3|Unsatisfactory Test Article|0|||
125301744|NCT03208088|450730410|FG006|Period 3|Unsatisfactory Test Article|0|||
125301745|NCT03208088|450730411|FG007|Period 3|Unsatisfactory Test Article|0|||
125301746|NCT03208088|450730412|FG008|Period 3|Unsatisfactory Test Article|0|||
125301747|NCT03208088|450730413|FG009|Period 3|Unsatisfactory Test Article|0|||
125301748|NCT03208088|450730404|FG000|Period 4|Unsatisfactory Test Article|0|||
125301749|NCT03208088|450730405|FG001|Period 4|Unsatisfactory Test Article|0|||
125301750|NCT03208088|450730406|FG002|Period 4|Unsatisfactory Test Article|0|||
125301751|NCT03208088|450730407|FG003|Period 4|Unsatisfactory Test Article|1|||
125301752|NCT03208088|450730408|FG004|Period 4|Unsatisfactory Test Article|0|||
125301753|NCT03208088|450730409|FG005|Period 4|Unsatisfactory Test Article|0|||
125301754|NCT03208088|450730410|FG006|Period 4|Unsatisfactory Test Article|0|||
125301755|NCT03208088|450730411|FG007|Period 4|Unsatisfactory Test Article|0|||
125301756|NCT03208088|450730412|FG008|Period 4|Unsatisfactory Test Article|0|||
125301757|NCT03208088|450730413|FG009|Period 4|Unsatisfactory Test Article|0|||
125301758|NCT00566254|450730415|FG000|Overall Study|Adverse Event|3|||
125301759|NCT00566254|450730416|FG001|Overall Study|Adverse Event|1|||
125301760|NCT00566254|450730415|FG000|Overall Study|Protocol Violation|1|||
125301761|NCT00566254|450730416|FG001|Overall Study|Protocol Violation|3|||
125301762|NCT00566254|450730415|FG000|Overall Study|Withdrawal by Subject|1|||
125301763|NCT00566254|450730416|FG001|Overall Study|Withdrawal by Subject|2|||
125301764|NCT00566254|450730415|FG000|Overall Study|Lack of Efficacy|5|||
125301765|NCT00566254|450730416|FG001|Overall Study|Lack of Efficacy|6|||
125301766|NCT00566254|450730415|FG000|Overall Study|Other|0|||
125301767|NCT00566254|450730416|FG001|Overall Study|Other|2|||
125301768|NCT00238238|450730417|FG000|Overall Study|Withdrawal by Subject|0|||
125301769|NCT00238238|450730418|FG001|Overall Study|Withdrawal by Subject|3|||
125301770|NCT00238238|450730419|FG002|Overall Study|Withdrawal by Subject|0|||
125301771|NCT01345669|450730420|FG000|Overall Study|Primary tumour recurrence|53|||
125301772|NCT01345669|450730421|FG001|Overall Study|Primary tumour recurrence|32|||
125301773|NCT01345669|450730420|FG000|Overall Study|Second primary tumour|4|||
125301774|NCT01345669|450730421|FG001|Overall Study|Second primary tumour|3|||
125301775|NCT01345669|450730420|FG000|Overall Study|Adverse Event|63|||
125301776|NCT01345669|450730421|FG001|Overall Study|Adverse Event|9|||
125301777|NCT01345669|450730420|FG000|Overall Study|Protocol Violation|3|||
125301778|NCT01345669|450730421|FG001|Overall Study|Protocol Violation|1|||
125301779|NCT01345669|450730420|FG000|Overall Study|Lost to Follow-up|1|||
125301780|NCT01345669|450730421|FG001|Overall Study|Lost to Follow-up|1|||
125301781|NCT01345669|450730420|FG000|Overall Study|Withdrawal by Subject|52|||
125301782|NCT01345669|450730421|FG001|Overall Study|Withdrawal by Subject|13|||
125301783|NCT01345669|450730420|FG000|Overall Study|Other Reasons|111|||
125301784|NCT01345669|450730421|FG001|Overall Study|Other Reasons|60|||
125301785|NCT01793883|450730422|FG000|Overall Study|Withdrawal by Subject|3|||
125301786|NCT01793883|450730423|FG001|Overall Study|Withdrawal by Subject|7|||
125301787|NCT01793883|450730424|FG002|Overall Study|Withdrawal by Subject|3|||
125301788|NCT01793883|450730422|FG000|Overall Study|Subject noncompliance|0|||
125301789|NCT01793883|450730423|FG001|Overall Study|Subject noncompliance|1|||
125301790|NCT01793883|450730424|FG002|Overall Study|Subject noncompliance|1|||
125301791|NCT01793883|450730422|FG000|Overall Study|Lost to Follow-up|5|||
125301792|NCT01793883|450730423|FG001|Overall Study|Lost to Follow-up|1|||
125301793|NCT01793883|450730424|FG002|Overall Study|Lost to Follow-up|3|||
125301794|NCT01793883|450730422|FG000|Overall Study|Randomized in error|1|||
125301795|NCT01793883|450730423|FG001|Overall Study|Randomized in error|0|||
125301796|NCT01793883|450730424|FG002|Overall Study|Randomized in error|0|||
125301797|NCT01793883|450730422|FG000|Overall Study|Unable to complete spriometry|1|||
125301798|NCT01793883|450730423|FG001|Overall Study|Unable to complete spriometry|0|||
125301799|NCT01793883|450730424|FG002|Overall Study|Unable to complete spriometry|0|||
125301800|NCT01793883|450730422|FG000|Overall Study|Unable to complete measurements|1|||
125301801|NCT01793883|450730423|FG001|Overall Study|Unable to complete measurements|0|||
125301802|NCT01793883|450730424|FG002|Overall Study|Unable to complete measurements|0|||
125301803|NCT01793883|450730422|FG000|Overall Study|Met exclusion criteria|1|||
125301804|NCT01793883|450730423|FG001|Overall Study|Met exclusion criteria|0|||
125301805|NCT01793883|450730424|FG002|Overall Study|Met exclusion criteria|0|||
125301806|NCT01793883|450730422|FG000|Overall Study|Dosing error|0|||
125301807|NCT01793883|450730423|FG001|Overall Study|Dosing error|1|||
125301808|NCT01793883|450730424|FG002|Overall Study|Dosing error|0|||
125301809|NCT01793883|450730422|FG000|Overall Study|Respiratory distress during spirometry|0|||
125301810|NCT01793883|450730423|FG001|Overall Study|Respiratory distress during spirometry|0|||
125301811|NCT01793883|450730424|FG002|Overall Study|Respiratory distress during spirometry|1|||
125301812|NCT02478255|450730425|FG000|Overall Study|Physician Decision|6|||
125301813|NCT02478255|450730426|FG001|Overall Study|Physician Decision|0|||
125301814|NCT02478255|450730425|FG000|Overall Study|Withdrawal by Subject|2|||
125301815|NCT02478255|450730426|FG001|Overall Study|Withdrawal by Subject|0|||
125301816|NCT00761527|450730427|FG000|Overall Study|Adverse Event|3|||
125301817|NCT00761527|450730427|FG000|Overall Study|Poor Compliance|8|||
125301818|NCT00761527|450730427|FG000|Overall Study|Lost to Follow-up|9|||
125301819|NCT00761527|450730427|FG000|Overall Study|Unknown reason|2|||
125301820|NCT01730586|450730428|FG000|Overall Study|Progressive Disease|2|||
125301821|NCT01730586|450730428|FG000|Overall Study|Inadequate Trial|8|||
125301822|NCT01730586|450730428|FG000|Overall Study|Adverse Event|2|||
125301823|NCT01730586|450730428|FG000|Overall Study|Hospice|1|||
125301824|NCT01431963|450730429|FG000|Overall Study|Adverse Event|18|||
125301825|NCT01431963|450730429|FG000|Overall Study|Lack of Efficacy|7|||
125301826|NCT01431963|450730429|FG000|Overall Study|Protocol Violation|1|||
125301827|NCT01431963|450730429|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
125301828|NCT01431963|450730429|FG000|Overall Study|Physician Decision|4|||
125301829|NCT01431963|450730429|FG000|Overall Study|Withdrawal by Subject|3|||
125301830|NCT00619307|450730430|FG000|Overall Study|Adverse Event|0|||
125301831|NCT00619307|450730431|FG001|Overall Study|Adverse Event|1|||
125301832|NCT00619307|450730430|FG000|Overall Study|Lost to Follow-up|0|||
125301833|NCT00619307|450730431|FG001|Overall Study|Lost to Follow-up|1|||
125301834|NCT00619307|450730430|FG000|Overall Study|Protocol Violation|3|||
125301835|NCT00619307|450730431|FG001|Overall Study|Protocol Violation|0|||
125301836|NCT00619307|450730430|FG000|Overall Study|Withdrew consent|1|||
125301837|NCT00619307|450730431|FG001|Overall Study|Withdrew consent|0|||
125301838|NCT00619307|450730430|FG000|Overall Study|Severe migraine|0|||
125301839|NCT00619307|450730431|FG001|Overall Study|Severe migraine|1|||
125301840|NCT00619307|450730430|FG000|Overall Study|MS attack plus steroids|0|||
125301841|NCT00619307|450730431|FG001|Overall Study|MS attack plus steroids|1|||
125301842|NCT00547521|450730432|FG000|Short Term Study (4 Months)|Adverse Event|1|||
125301843|NCT00547521|450730433|FG001|Short Term Study (4 Months)|Adverse Event|0|||
125301844|NCT00547521|450730432|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
125301845|NCT00547521|450730433|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
125301846|NCT00547521|450730432|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
125301847|NCT00547521|450730433|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
125301848|NCT00547521|450730432|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
125301849|NCT00547521|450730433|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
125301850|NCT00547521|450730432|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
125301851|NCT00547521|450730433|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
125301852|NCT00547521|450730432|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
125301853|NCT00547521|450730433|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
125301854|NCT00547521|450730432|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
125301855|NCT00547521|450730433|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
125301856|NCT00547521|450730432|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
125301857|NCT00547521|450730433|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
125301858|NCT00547521|450730432|FG000|Long Term Extension (LTE) Study|Other|0|||
125301859|NCT00547521|450730433|FG001|Long Term Extension (LTE) Study|Other|2|||
125301860|NCT00547521|450730432|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
125301861|NCT00547521|450730433|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
125301862|NCT01769196|450731854|FG000|Overall Study|Adverse Event|24|||
125301863|NCT01769196|450731855|FG001|Overall Study|Adverse Event|20|||
125301864|NCT01769196|450731854|FG000|Overall Study|Death|21|||
125301865|NCT01769196|450731855|FG001|Overall Study|Death|26|||
125301866|NCT01769196|450731854|FG000|Overall Study|Investigator Discretion|7|||
125301867|NCT01769196|450731855|FG001|Overall Study|Investigator Discretion|3|||
125301868|NCT01769196|450731854|FG000|Overall Study|Lack of Efficacy|3|||
125301869|NCT01769196|450731855|FG001|Overall Study|Lack of Efficacy|2|||
125301870|NCT01769196|450731854|FG000|Overall Study|Progressive disease|11|||
125301871|NCT01769196|450731855|FG001|Overall Study|Progressive disease|6|||
125301872|NCT01769196|450731854|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
125301873|NCT01769196|450731855|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
125301874|NCT01769196|450731854|FG000|Overall Study|Protocol Violation|0|||
125301875|NCT01769196|450731855|FG001|Overall Study|Protocol Violation|3|||
125301876|NCT01769196|450731854|FG000|Overall Study|Study terminated by sponsor|160|||
125301877|NCT01769196|450731855|FG001|Overall Study|Study terminated by sponsor|161|||
125301878|NCT01769196|450731854|FG000|Overall Study|Participant never dosed with study drug|1|||
125301879|NCT01769196|450731855|FG001|Overall Study|Participant never dosed with study drug|0|||
125301880|NCT01769196|450731854|FG000|Overall Study|Withdrew consent|36|||
125301881|NCT01769196|450731855|FG001|Overall Study|Withdrew consent|40|||
125301882|NCT03499314|450731856|FG000|Overall Study|Time Commitment|1|||
125301883|NCT03499314|450731857|FG001|Overall Study|Time Commitment|2|||
125301884|NCT03499314|450731856|FG000|Overall Study|Medical issue unrelated to research study|1|||
125301885|NCT03499314|450731857|FG001|Overall Study|Medical issue unrelated to research study|1|||
125301886|NCT00655629|450731860|FG000|Overall Study|Adverse Event|4|||
125301887|NCT00655629|450731861|FG001|Overall Study|Adverse Event|1|||
125301888|NCT00655629|450731860|FG000|Overall Study|Lack of Efficacy|2|||
125301889|NCT00655629|450731861|FG001|Overall Study|Lack of Efficacy|12|||
125301890|NCT00655629|450731860|FG000|Overall Study|Lost to Follow-up|4|||
125301891|NCT00655629|450731861|FG001|Overall Study|Lost to Follow-up|3|||
125301892|NCT00655629|450731860|FG000|Overall Study|Protocol Violation|5|||
125301893|NCT00655629|450731861|FG001|Overall Study|Protocol Violation|3|||
124812375|NCT00674362|448942668|FG001|Open Label|Adverse Event|0|||
124812376|NCT00674362|448942667|FG000|Open Label|Other: Subject moved to extension study|1|||
124812377|NCT00674362|448942668|FG001|Open Label|Other: Subject moved to extension study|0|||
124812378|NCT03137537|448942671|FG000|Overall Study|Adverse Event|0|||
124812379|NCT03137537|448942672|FG001|Overall Study|Adverse Event|1|||
124812380|NCT03386448|448942673|FG000|Overall Study|Adverse Event|0|||
124812381|NCT03386448|448942674|FG001|Overall Study|Adverse Event|2|||
124812382|NCT01146665|448942675|FG000|Overall Study|Withdrawal by Subject|10|||
124812383|NCT01146665|448942676|FG001|Overall Study|Withdrawal by Subject|16|||
124812384|NCT01817530|448942678|FG000|Overall Study|Exclusionary Medication Received|0|||
124812385|NCT01817530|448942679|FG001|Overall Study|Exclusionary Medication Received|0|||
124812386|NCT01817530|448942680|FG002|Overall Study|Exclusionary Medication Received|0|||
124812387|NCT01817530|448942681|FG003|Overall Study|Exclusionary Medication Received|0|||
124812388|NCT01817530|448942682|FG004|Overall Study|Exclusionary Medication Received|1|||
124812389|NCT01817530|448942683|FG005|Overall Study|Exclusionary Medication Received|0|||
124812390|NCT01817530|448942684|FG006|Overall Study|Exclusionary Medication Received|0|||
124812391|NCT01817530|448942685|FG007|Overall Study|Exclusionary Medication Received|0|||
124812392|NCT01817530|448942678|FG000|Overall Study|Adverse Event|6|||
124812393|NCT01817530|448942679|FG001|Overall Study|Adverse Event|3|||
124812394|NCT01817530|448942680|FG002|Overall Study|Adverse Event|2|||
124812395|NCT01817530|448942681|FG003|Overall Study|Adverse Event|5|||
124812396|NCT01817530|448942682|FG004|Overall Study|Adverse Event|0|||
124812397|NCT01817530|448942683|FG005|Overall Study|Adverse Event|10|||
124812398|NCT01817530|448942684|FG006|Overall Study|Adverse Event|5|||
124812399|NCT01817530|448942685|FG007|Overall Study|Adverse Event|8|||
124812400|NCT01817530|448942678|FG000|Overall Study|Subject Noncompliant|3|||
124812401|NCT01817530|448942679|FG001|Overall Study|Subject Noncompliant|1|||
124812402|NCT01817530|448942680|FG002|Overall Study|Subject Noncompliant|0|||
124812403|NCT01817530|448942681|FG003|Overall Study|Subject Noncompliant|4|||
124812404|NCT01817530|448942682|FG004|Overall Study|Subject Noncompliant|0|||
124812405|NCT01817530|448942683|FG005|Overall Study|Subject Noncompliant|1|||
124812406|NCT01817530|448942684|FG006|Overall Study|Subject Noncompliant|1|||
124812407|NCT01817530|448942685|FG007|Overall Study|Subject Noncompliant|1|||
124812408|NCT01817530|448942678|FG000|Overall Study|Lack of Efficacy|1|||
124812409|NCT01817530|448942679|FG001|Overall Study|Lack of Efficacy|0|||
124812410|NCT01817530|448942680|FG002|Overall Study|Lack of Efficacy|0|||
124812411|NCT01817530|448942681|FG003|Overall Study|Lack of Efficacy|0|||
124812412|NCT01817530|448942682|FG004|Overall Study|Lack of Efficacy|0|||
124812413|NCT01817530|448942683|FG005|Overall Study|Lack of Efficacy|1|||
124812414|NCT01817530|448942684|FG006|Overall Study|Lack of Efficacy|0|||
124812415|NCT01817530|448942685|FG007|Overall Study|Lack of Efficacy|1|||
124812416|NCT01817530|448942678|FG000|Overall Study|Pregnancy|0|||
124812417|NCT01817530|448942679|FG001|Overall Study|Pregnancy|0|||
124812418|NCT01817530|448942680|FG002|Overall Study|Pregnancy|0|||
124812419|NCT01817530|448942681|FG003|Overall Study|Pregnancy|0|||
124812420|NCT01817530|448942682|FG004|Overall Study|Pregnancy|0|||
124812421|NCT01817530|448942683|FG005|Overall Study|Pregnancy|1|||
124812422|NCT01817530|448942684|FG006|Overall Study|Pregnancy|0|||
124812423|NCT01817530|448942685|FG007|Overall Study|Pregnancy|0|||
124812424|NCT01817530|448942678|FG000|Overall Study|Other|0|||
124812425|NCT01817530|448942679|FG001|Overall Study|Other|1|||
124812426|NCT01817530|448942680|FG002|Overall Study|Other|0|||
124812427|NCT01817530|448942681|FG003|Overall Study|Other|0|||
124812428|NCT01817530|448942682|FG004|Overall Study|Other|1|||
124812429|NCT01817530|448942683|FG005|Overall Study|Other|0|||
124812430|NCT01817530|448942684|FG006|Overall Study|Other|5|||
124812431|NCT01817530|448942685|FG007|Overall Study|Other|0|||
124812432|NCT01817530|448942678|FG000|Overall Study|Surgery or Invasive Intervention|1|||
124812433|NCT01817530|448942679|FG001|Overall Study|Surgery or Invasive Intervention|0|||
124812434|NCT01817530|448942680|FG002|Overall Study|Surgery or Invasive Intervention|0|||
124812435|NCT01817530|448942681|FG003|Overall Study|Surgery or Invasive Intervention|0|||
124812436|NCT01817530|448942682|FG004|Overall Study|Surgery or Invasive Intervention|1|||
125301894|NCT00655629|450731860|FG000|Overall Study|consent withdrawn|6|||
124812437|NCT01817530|448942683|FG005|Overall Study|Surgery or Invasive Intervention|1|||
124812438|NCT01817530|448942684|FG006|Overall Study|Surgery or Invasive Intervention|1|||
125301895|NCT00655629|450731861|FG001|Overall Study|consent withdrawn|4|||
124812439|NCT01817530|448942685|FG007|Overall Study|Surgery or Invasive Intervention|0|||
124812440|NCT01817530|448942678|FG000|Overall Study|Consent Withdrawn by Subject|3|||
124812441|NCT01817530|448942679|FG001|Overall Study|Consent Withdrawn by Subject|4|||
124812442|NCT01817530|448942680|FG002|Overall Study|Consent Withdrawn by Subject|7|||
124812443|NCT01817530|448942681|FG003|Overall Study|Consent Withdrawn by Subject|3|||
124812444|NCT01817530|448942682|FG004|Overall Study|Consent Withdrawn by Subject|5|||
124812445|NCT01817530|448942683|FG005|Overall Study|Consent Withdrawn by Subject|3|||
124812446|NCT01817530|448942684|FG006|Overall Study|Consent Withdrawn by Subject|3|||
124812447|NCT01817530|448942685|FG007|Overall Study|Consent Withdrawn by Subject|10|||
124812448|NCT01817530|448942678|FG000|Overall Study|Lost to Follow-up|1|||
124812449|NCT01817530|448942679|FG001|Overall Study|Lost to Follow-up|4|||
124812450|NCT01817530|448942680|FG002|Overall Study|Lost to Follow-up|2|||
124812451|NCT01817530|448942681|FG003|Overall Study|Lost to Follow-up|1|||
124812452|NCT01817530|448942682|FG004|Overall Study|Lost to Follow-up|3|||
124812453|NCT01817530|448942683|FG005|Overall Study|Lost to Follow-up|2|||
124812454|NCT01817530|448942684|FG006|Overall Study|Lost to Follow-up|8|||
124812455|NCT01817530|448942685|FG007|Overall Study|Lost to Follow-up|4|||
124812456|NCT03846804|448942686|FG000|Overall Study|Refused blood draw|1|||
124812457|NCT03846804|448942686|FG000|Overall Study|Protocol Violation|1|||
124812458|NCT00404235|448942687|FG000|Overall Study|Withdrawal by Subject|1|||
124812459|NCT00404235|448942688|FG001|Overall Study|Withdrawal by Subject|2|||
124812460|NCT00345839|448942689|FG000|Overall Study|Withdrawal by Subject|91|||
124812461|NCT00345839|448942690|FG001|Overall Study|Withdrawal by Subject|98|||
124812462|NCT00345839|448942689|FG000|Overall Study|Lost to Follow-up|58|||
124812463|NCT00345839|448942690|FG001|Overall Study|Lost to Follow-up|61|||
124812464|NCT03298867|448942693|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
124812465|NCT03298867|448942694|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
124812466|NCT03298867|448942693|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
124812467|NCT03298867|448942694|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
124812468|NCT03298867|448942693|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
124812469|NCT03298867|448942694|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
124812470|NCT03298867|448942693|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
124812471|NCT03298867|448942694|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
124812472|NCT03298867|448942693|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
124812473|NCT03298867|448942694|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
124812474|NCT03298867|448942693|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
124812475|NCT03298867|448942694|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
124812476|NCT03298867|448942693|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
124812477|NCT03298867|448942694|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
124812478|NCT03298867|448942693|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
124812479|NCT03298867|448942694|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
124812480|NCT03298867|448942693|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
124812481|NCT03298867|448942694|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
124812482|NCT00743483|448942695|FG000|Baseline Period|Physician Decision|1|||
124812483|NCT00743483|448942695|FG000|Treatment Period|Adverse Event|1|||
124812484|NCT01466153|448942696|FG000|Overall Study|Disease Progression|2|||
124812485|NCT01466153|448942697|FG001|Overall Study|Disease Progression|2|||
124812486|NCT01466153|448942698|FG002|Overall Study|Disease Progression|0|||
124812487|NCT01466153|448942696|FG000|Overall Study|Adverse Event|14|||
124812488|NCT01466153|448942697|FG001|Overall Study|Adverse Event|13|||
124812489|NCT01466153|448942698|FG002|Overall Study|Adverse Event|17|||
124812490|NCT01466153|448942696|FG000|Overall Study|Withdrawal of Consent|2|||
124812491|NCT01466153|448942697|FG001|Overall Study|Withdrawal of Consent|0|||
124812492|NCT01466153|448942698|FG002|Overall Study|Withdrawal of Consent|0|||
124812493|NCT01466153|448942696|FG000|Overall Study|Investigator Discretion|3|||
124812494|NCT01466153|448942697|FG001|Overall Study|Investigator Discretion|2|||
124812495|NCT01466153|448942698|FG002|Overall Study|Investigator Discretion|2|||
124812496|NCT01466153|448942696|FG000|Overall Study|Randomized-Not Treated|2|||
124812497|NCT01466153|448942697|FG001|Overall Study|Randomized-Not Treated|3|||
124812498|NCT01466153|448942698|FG002|Overall Study|Randomized-Not Treated|4|||
124812499|NCT01466153|448942696|FG000|Overall Study|Other-Unspecified|6|||
124812500|NCT01466153|448942697|FG001|Overall Study|Other-Unspecified|4|||
124812501|NCT01466153|448942698|FG002|Overall Study|Other-Unspecified|2|||
124812502|NCT03281577|448944575|FG000|Overall Study|Adverse Event|0|||
124812503|NCT03281577|448944576|FG001|Overall Study|Adverse Event|0|||
124812504|NCT03281577|448944577|FG002|Overall Study|Adverse Event|0|||
124812505|NCT03281577|448944578|FG003|Overall Study|Adverse Event|1|||
124812506|NCT03281577|448944575|FG000|Overall Study|Withdrawal by Subject|1|||
125301896|NCT00705367|450731864|FG000|Long-term Extension Period|Adverse Event|2|||
124812507|NCT03281577|448944576|FG001|Overall Study|Withdrawal by Subject|0|||
124812508|NCT03281577|448944577|FG002|Overall Study|Withdrawal by Subject|0|||
125301897|NCT00705367|450731865|FG001|Long-term Extension Period|Adverse Event|0|||
124812509|NCT03281577|448944578|FG003|Overall Study|Withdrawal by Subject|0|||
124812510|NCT02323113|448944579|FG000|Overall Study|Adverse Event|3|||
124812511|NCT02323113|448944580|FG001|Overall Study|Adverse Event|3|||
124812512|NCT02323113|448944581|FG002|Overall Study|Adverse Event|2|||
124812513|NCT02323113|448944582|FG003|Overall Study|Adverse Event|5|||
124812514|NCT02323113|448944583|FG004|Overall Study|Adverse Event|8|||
124812515|NCT02323113|448944584|FG005|Overall Study|Adverse Event|3|||
124812516|NCT02323113|448944585|FG006|Overall Study|Adverse Event|6|||
124812517|NCT02323113|448944586|FG007|Overall Study|Adverse Event|0|||
124812518|NCT02323113|448944579|FG000|Overall Study|Progressive Disease|0|||
124812519|NCT02323113|448944580|FG001|Overall Study|Progressive Disease|1|||
124812520|NCT02323113|448944581|FG002|Overall Study|Progressive Disease|1|||
124812521|NCT02323113|448944582|FG003|Overall Study|Progressive Disease|0|||
124812522|NCT02323113|448944583|FG004|Overall Study|Progressive Disease|0|||
124812523|NCT02323113|448944584|FG005|Overall Study|Progressive Disease|3|||
124812524|NCT02323113|448944585|FG006|Overall Study|Progressive Disease|0|||
124812525|NCT02323113|448944586|FG007|Overall Study|Progressive Disease|0|||
124812526|NCT02323113|448944579|FG000|Overall Study|Symptomatic Deterioration|0|||
124812527|NCT02323113|448944580|FG001|Overall Study|Symptomatic Deterioration|0|||
124812528|NCT02323113|448944581|FG002|Overall Study|Symptomatic Deterioration|1|||
124812529|NCT02323113|448944582|FG003|Overall Study|Symptomatic Deterioration|0|||
124812530|NCT02323113|448944583|FG004|Overall Study|Symptomatic Deterioration|1|||
124812531|NCT02323113|448944584|FG005|Overall Study|Symptomatic Deterioration|0|||
124812532|NCT02323113|448944585|FG006|Overall Study|Symptomatic Deterioration|0|||
124812533|NCT02323113|448944586|FG007|Overall Study|Symptomatic Deterioration|0|||
124812534|NCT02323113|448944579|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
124812535|NCT02323113|448944580|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
124812536|NCT02323113|448944581|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
124812537|NCT02323113|448944582|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
124812538|NCT02323113|448944583|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
124812539|NCT02323113|448944584|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
124812540|NCT02323113|448944585|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
124812541|NCT02323113|448944586|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
124812542|NCT02323113|448944579|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
124812543|NCT02323113|448944580|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
124812544|NCT02323113|448944581|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
124812545|NCT02323113|448944582|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
124812546|NCT02323113|448944583|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
124812547|NCT02323113|448944584|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
124812548|NCT02323113|448944585|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
124812549|NCT02323113|448944586|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
124812550|NCT01663532|448944587|FG000|Overall Study|Lost to Follow-up|9|||
124812551|NCT01663532|448944588|FG001|Overall Study|Lost to Follow-up|10|||
124812552|NCT01663532|448944587|FG000|Overall Study|Adverse Event|7|||
124812553|NCT01663532|448944588|FG001|Overall Study|Adverse Event|13|||
124812554|NCT01663532|448944587|FG000|Overall Study|Met Withdrawal Criteria|7|||
124812555|NCT01663532|448944588|FG001|Overall Study|Met Withdrawal Criteria|6|||
124812556|NCT01663532|448944587|FG000|Overall Study|Physician Decision|1|||
124812557|NCT01663532|448944588|FG001|Overall Study|Physician Decision|1|||
124812558|NCT01663532|448944587|FG000|Overall Study|Withdrawal by Subject|35|||
124812559|NCT01663532|448944588|FG001|Overall Study|Withdrawal by Subject|17|||
124812560|NCT01663532|448944587|FG000|Overall Study|Lack of Efficacy|15|||
124812561|NCT01663532|448944588|FG001|Overall Study|Lack of Efficacy|60|||
124812562|NCT00354744|448944589|FG000|Overall Study|Adverse Event|2|||
124812563|NCT00354744|448944589|FG000|Overall Study|Death|2|||
124812564|NCT00354744|448944589|FG000|Overall Study|Lack of Efficacy|11|||
124812565|NCT00354744|448944589|FG000|Overall Study|Lost to Follow-up|2|||
124812566|NCT00354744|448944589|FG000|Overall Study|Physician Decision|11|||
124812567|NCT00354744|448944589|FG000|Overall Study|Withdrawal by Subject|14|||
124812568|NCT01513343|448944590|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
124812569|NCT01513343|448944591|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
124812570|NCT01513343|448944590|FG000|Post Data Collection|Dropped/withdrew from study|7|||
124812571|NCT01513343|448944591|FG001|Post Data Collection|Dropped/withdrew from study|1|||
124812572|NCT01513343|448944590|FG000|Post Data Collection|Lost to Follow-up|10|||
124812573|NCT01513343|448944591|FG001|Post Data Collection|Lost to Follow-up|23|||
124812574|NCT01513343|448944590|FG000|6-month Follow-up|Lost to Follow-up|28|||
124812575|NCT01513343|448944591|FG001|6-month Follow-up|Lost to Follow-up|17|||
124812576|NCT01513343|448944590|FG000|12-month Follow-up|Lost to Follow-up|10|||
125301898|NCT00705367|450731864|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
125301899|NCT00705367|450731865|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
125301900|NCT00705367|450731864|FG000|Long-term Extension Period|Lack of Efficacy|1|||
125301901|NCT00705367|450731865|FG001|Long-term Extension Period|Lack of Efficacy|0|||
124812577|NCT01513343|448944591|FG001|12-month Follow-up|Lost to Follow-up|3|||
124812578|NCT01749137|448944592|FG000|Overall Study|Adverse Event|4|||
125301902|NCT00705367|450731864|FG000|Long-term Extension Period|No longer met study criteria|1|||
124812579|NCT01749137|448944593|FG001|Overall Study|Adverse Event|4|||
124812580|NCT01749137|448944592|FG000|Overall Study|Lost to Follow-up|2|||
124812581|NCT01749137|448944593|FG001|Overall Study|Lost to Follow-up|3|||
124812582|NCT01749137|448944592|FG000|Overall Study|Physician Decision|1|||
124812583|NCT01749137|448944593|FG001|Overall Study|Physician Decision|0|||
124812584|NCT01749137|448944592|FG000|Overall Study|Withdrawal by Subject|8|||
124812585|NCT01749137|448944593|FG001|Overall Study|Withdrawal by Subject|4|||
124812586|NCT02587234|448944594|FG000|Overall Study|Withdrawal by Subject|1|||
124812587|NCT02587234|448944595|FG001|Overall Study|Withdrawal by Subject|1|||
124812588|NCT02587234|448944594|FG000|Overall Study|Lost to Follow-up|0|||
124812589|NCT02587234|448944595|FG001|Overall Study|Lost to Follow-up|2|||
124812590|NCT01153347|448944596|FG000|Overall Study|Withdrawal by Subject|7|||
124812591|NCT01153347|448944597|FG001|Overall Study|Withdrawal by Subject|7|||
124812592|NCT01153347|448944598|FG002|Overall Study|Withdrawal by Subject|7|||
124812593|NCT01153347|448944599|FG003|Overall Study|Withdrawal by Subject|7|||
124812594|NCT01153347|448944596|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124812595|NCT01153347|448944597|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
124812596|NCT01153347|448944598|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
124812597|NCT01153347|448944599|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
124812598|NCT01153347|448944596|FG000|Overall Study|Adverse Event|3|||
124812599|NCT01153347|448944597|FG001|Overall Study|Adverse Event|9|||
124812600|NCT01153347|448944598|FG002|Overall Study|Adverse Event|21|||
124812601|NCT01153347|448944599|FG003|Overall Study|Adverse Event|7|||
124812602|NCT01153347|448944596|FG000|Overall Study|Severe non-compliance to protocol|6|||
124812603|NCT01153347|448944597|FG001|Overall Study|Severe non-compliance to protocol|7|||
124812604|NCT01153347|448944598|FG002|Overall Study|Severe non-compliance to protocol|4|||
124812605|NCT01153347|448944599|FG003|Overall Study|Severe non-compliance to protocol|3|||
124812606|NCT01153347|448944596|FG000|Overall Study|Condition under investigation worsened|1|||
124812607|NCT01153347|448944597|FG001|Overall Study|Condition under investigation worsened|1|||
124812608|NCT01153347|448944598|FG002|Overall Study|Condition under investigation worsened|0|||
124812609|NCT01153347|448944599|FG003|Overall Study|Condition under investigation worsened|0|||
124812610|NCT01153347|448944596|FG000|Overall Study|Lack of Efficacy|2|||
124812611|NCT01153347|448944597|FG001|Overall Study|Lack of Efficacy|2|||
124812612|NCT01153347|448944598|FG002|Overall Study|Lack of Efficacy|0|||
124812613|NCT01153347|448944599|FG003|Overall Study|Lack of Efficacy|4|||
124812614|NCT01153347|448944596|FG000|Overall Study|Study-specific withdrawal criteria|4|||
124812615|NCT01153347|448944597|FG001|Overall Study|Study-specific withdrawal criteria|3|||
124812616|NCT01153347|448944598|FG002|Overall Study|Study-specific withdrawal criteria|1|||
124812617|NCT01153347|448944599|FG003|Overall Study|Study-specific withdrawal criteria|2|||
124812618|NCT01153347|448944596|FG000|Overall Study|Lost to Follow-up|4|||
124812619|NCT01153347|448944597|FG001|Overall Study|Lost to Follow-up|9|||
124812620|NCT01153347|448944598|FG002|Overall Study|Lost to Follow-up|11|||
124812621|NCT01153347|448944599|FG003|Overall Study|Lost to Follow-up|8|||
124812622|NCT01153347|448944596|FG000|Overall Study|Other|5|||
124812623|NCT01153347|448944597|FG001|Overall Study|Other|5|||
124812624|NCT01153347|448944598|FG002|Overall Study|Other|4|||
124812625|NCT01153347|448944599|FG003|Overall Study|Other|0|||
124812626|NCT01153347|448944596|FG000|Overall Study|Death|1|||
124812627|NCT01153347|448944597|FG001|Overall Study|Death|0|||
124812628|NCT01153347|448944598|FG002|Overall Study|Death|0|||
124812629|NCT01153347|448944599|FG003|Overall Study|Death|0|||
124812630|NCT01706146|448944600|FG000|Overall Study|Withdrawal by Subject|1|||
124812631|NCT01706146|448944600|FG000|Overall Study|Adverse Event|3|||
124812632|NCT01706146|448944600|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
124812633|NCT02582983|448944601|FG000|Overall Study|Death|3|||
124812634|NCT02582983|448944601|FG000|Overall Study|Withdrawal by Subject|2|||
124812635|NCT02582983|448944601|FG000|Overall Study|Adverse Event|1|||
124812636|NCT01751178|448944602|FG000|Overall Study|Adverse Event|2|||
124812637|NCT01751178|448944603|FG001|Overall Study|Adverse Event|0|||
124812638|NCT01751178|448944604|FG002|Overall Study|Adverse Event|0|||
124812639|NCT01751178|448944602|FG000|Overall Study|Other Reason (unknown)|1|||
124812640|NCT01751178|448944603|FG001|Overall Study|Other Reason (unknown)|0|||
124812641|NCT01751178|448944604|FG002|Overall Study|Other Reason (unknown)|2|||
124812642|NCT00289991|448944605|FG000|Overall Study|Death|35|||
125301903|NCT00705367|450731865|FG001|Long-term Extension Period|No longer met study criteria|0|||
125301904|NCT00705367|450731864|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
124812643|NCT00289991|448944606|FG001|Overall Study|Death|38|||
124812644|NCT00289991|448944605|FG000|Overall Study|Adverse Event|15|||
124812645|NCT00289991|448944606|FG001|Overall Study|Adverse Event|13|||
124812646|NCT00289991|448944605|FG000|Overall Study|Failure of prophylaxis|1|||
124812647|NCT00289991|448944606|FG001|Overall Study|Failure of prophylaxis|1|||
124812648|NCT00289991|448944605|FG000|Overall Study|Fungal breakthrough infection|0|||
124812649|NCT00289991|448944606|FG001|Overall Study|Fungal breakthrough infection|1|||
124812650|NCT00289991|448944605|FG000|Overall Study|Lost to Follow-up|0|||
124812651|NCT00289991|448944606|FG001|Overall Study|Lost to Follow-up|1|||
124812652|NCT00289991|448944605|FG000|Overall Study|Withdrawal by Subject|2|||
124812653|NCT00289991|448944606|FG001|Overall Study|Withdrawal by Subject|12|||
124812654|NCT00289991|448944605|FG000|Overall Study|Other|5|||
124812655|NCT00289991|448944606|FG001|Overall Study|Other|14|||
124812656|NCT01606007|448944611|FG000|Overall Study|Reason 'Other' in the protocol|0|||
124812657|NCT01606007|448944612|FG001|Overall Study|Reason 'Other' in the protocol|1|||
124812658|NCT01606007|448944613|FG002|Overall Study|Reason 'Other' in the protocol|1|||
124812659|NCT01606007|448944611|FG000|Overall Study|Pregnancy|0|||
124812660|NCT01606007|448944612|FG001|Overall Study|Pregnancy|1|||
124812661|NCT01606007|448944613|FG002|Overall Study|Pregnancy|1|||
124812662|NCT01606007|448944611|FG000|Overall Study|Withdrawal by Subject|8|||
124812663|NCT01606007|448944612|FG001|Overall Study|Withdrawal by Subject|6|||
124812664|NCT01606007|448944613|FG002|Overall Study|Withdrawal by Subject|1|||
124812665|NCT01606007|448944611|FG000|Overall Study|Adverse Event|0|||
124812666|NCT01606007|448944612|FG001|Overall Study|Adverse Event|1|||
124812667|NCT01606007|448944613|FG002|Overall Study|Adverse Event|1|||
124812668|NCT01606007|448944611|FG000|Overall Study|discontinue study treatment|0|||
124812669|NCT01606007|448944612|FG001|Overall Study|discontinue study treatment|2|||
124812670|NCT01606007|448944613|FG002|Overall Study|discontinue study treatment|1|||
124812671|NCT01606007|448944611|FG000|Overall Study|Lost to Follow-up|6|||
124812672|NCT01606007|448944612|FG001|Overall Study|Lost to Follow-up|8|||
124812673|NCT01606007|448944613|FG002|Overall Study|Lost to Follow-up|5|||
124812674|NCT01606007|448944611|FG000|Overall Study|Poor/Non-compliance|1|||
124812675|NCT01606007|448944612|FG001|Overall Study|Poor/Non-compliance|0|||
124812676|NCT01606007|448944613|FG002|Overall Study|Poor/Non-compliance|0|||
124812677|NCT01007812|448944616|FG000|Period 1, One Week|Lost to Follow-up|0|||
124812678|NCT01007812|448944617|FG001|Period 1, One Week|Lost to Follow-up|1|||
124812679|NCT01007812|448944616|FG000|Period 1, One Week|Discomfort|1|||
124812680|NCT01007812|448944617|FG001|Period 1, One Week|Discomfort|0|||
124812681|NCT01091974|448944618|FG000|Overall Study|Did not start intervention|3|||
124812682|NCT01091974|448944619|FG001|Overall Study|Did not start intervention|1|||
124812683|NCT01091974|448944620|FG002|Overall Study|Did not start intervention|3|||
124812684|NCT01091974|448944621|FG003|Overall Study|Did not start intervention|1|||
124812685|NCT01091974|448944618|FG000|Overall Study|resumed sleep medication|0|||
124812686|NCT01091974|448944619|FG001|Overall Study|resumed sleep medication|0|||
124812687|NCT01091974|448944620|FG002|Overall Study|resumed sleep medication|1|||
124812688|NCT01091974|448944621|FG003|Overall Study|resumed sleep medication|2|||
124812689|NCT01091974|448944618|FG000|Overall Study|Withdrawal by Subject|1|||
124812690|NCT01091974|448944619|FG001|Overall Study|Withdrawal by Subject|3|||
124812691|NCT01091974|448944620|FG002|Overall Study|Withdrawal by Subject|2|||
124812692|NCT01091974|448944621|FG003|Overall Study|Withdrawal by Subject|2|||
124812693|NCT01091974|448944618|FG000|Overall Study|side-effects|1|||
124812694|NCT01091974|448944619|FG001|Overall Study|side-effects|1|||
124812695|NCT01091974|448944620|FG002|Overall Study|side-effects|0|||
124812696|NCT01091974|448944621|FG003|Overall Study|side-effects|2|||
124812697|NCT00555971|448944622|FG000|Overall Study|Adverse Event|1|||
124812698|NCT00555971|448944623|FG001|Overall Study|Adverse Event|1|||
124812699|NCT00518284|448944624|FG000|Overall Study|Adverse Event|0|||
124812700|NCT00518284|448944625|FG001|Overall Study|Adverse Event|1|||
124812701|NCT00518284|448944626|FG002|Overall Study|Adverse Event|0|||
124812702|NCT00518284|448944627|FG003|Overall Study|Adverse Event|0|||
124812703|NCT00518284|448944624|FG000|Overall Study|Study Termination|0|||
124812704|NCT00518284|448944625|FG001|Overall Study|Study Termination|2|||
124812705|NCT00518284|448944626|FG002|Overall Study|Study Termination|1|||
124812706|NCT00518284|448944627|FG003|Overall Study|Study Termination|2|||
124812707|NCT02571777|448944628|FG000|Overall Study|Subject/guardian decision|34|||
124812708|NCT02571777|448944629|FG001|Overall Study|Subject/guardian decision|26|||
124812709|NCT02571777|448944630|FG002|Overall Study|Subject/guardian decision|26|||
124812710|NCT02571777|448944631|FG003|Overall Study|Subject/guardian decision|25|||
124812711|NCT02571777|448944632|FG004|Overall Study|Subject/guardian decision|27|||
124812712|NCT02571777|448944628|FG000|Overall Study|Protocol Deviation|2|||
124812713|NCT02571777|448944629|FG001|Overall Study|Protocol Deviation|3|||
124812714|NCT02571777|448944630|FG002|Overall Study|Protocol Deviation|4|||
124812715|NCT02571777|448944631|FG003|Overall Study|Protocol Deviation|8|||
124812716|NCT02571777|448944632|FG004|Overall Study|Protocol Deviation|4|||
124812717|NCT02571777|448944628|FG000|Overall Study|Death|1|||
124812718|NCT02571777|448944629|FG001|Overall Study|Death|1|||
124812719|NCT02571777|448944630|FG002|Overall Study|Death|4|||
124812720|NCT02571777|448944631|FG003|Overall Study|Death|0|||
124812721|NCT02571777|448944632|FG004|Overall Study|Death|0|||
124812722|NCT02571777|448944628|FG000|Overall Study|Lost to Follow-up|1|||
124812723|NCT02571777|448944629|FG001|Overall Study|Lost to Follow-up|1|||
124812724|NCT02571777|448944630|FG002|Overall Study|Lost to Follow-up|2|||
124812725|NCT02571777|448944631|FG003|Overall Study|Lost to Follow-up|0|||
124812726|NCT02571777|448944632|FG004|Overall Study|Lost to Follow-up|1|||
124812727|NCT02571777|448944628|FG000|Overall Study|Physician Decision|1|||
124812728|NCT02571777|448944629|FG001|Overall Study|Physician Decision|7|||
124812729|NCT02571777|448944630|FG002|Overall Study|Physician Decision|5|||
124812730|NCT02571777|448944631|FG003|Overall Study|Physician Decision|2|||
124812731|NCT02571777|448944632|FG004|Overall Study|Physician Decision|4|||
124812732|NCT02571777|448944628|FG000|Overall Study|Pregnancy|0|||
124812733|NCT02571777|448944629|FG001|Overall Study|Pregnancy|0|||
124812734|NCT02571777|448944630|FG002|Overall Study|Pregnancy|0|||
124812735|NCT02571777|448944631|FG003|Overall Study|Pregnancy|2|||
124812736|NCT02571777|448944632|FG004|Overall Study|Pregnancy|0|||
124812737|NCT00801632|448944633|FG000|Overall Study|Re-transplant|1|||
124812738|NCT01350492|448944639|FG000|Intervention|Lost to Follow-up|2|||
124812739|NCT01350492|448944640|FG001|Intervention|Lost to Follow-up|5|||
124812740|NCT01350492|448944639|FG000|Intervention|Withdrawal by Subject|3|||
124812741|NCT01350492|448944640|FG001|Intervention|Withdrawal by Subject|1|||
124812742|NCT01350492|448944639|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
124812743|NCT01350492|448944640|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
124812744|NCT01350492|448944639|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
124812745|NCT01350492|448944640|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
124812746|NCT00205881|448944641|FG000|Overall Study|Withdrawal by Subject|16|||
124812747|NCT00781274|448944650|FG000|Overall Study|Withdrawal by Subject|2|||
124812748|NCT01534962|448944651|FG000|Overall Study|Randomized but did not start treatment|2|||
124812749|NCT01534962|448944652|FG001|Overall Study|Randomized but did not start treatment|0|||
124812750|NCT01534962|448944653|FG002|Overall Study|Randomized but did not start treatment|0|||
124812751|NCT01534962|448944654|FG003|Overall Study|Randomized but did not start treatment|1|||
124812752|NCT01534962|448944651|FG000|Overall Study|Discontinued at AF recurrence|35|||
124812753|NCT01534962|448944652|FG001|Overall Study|Discontinued at AF recurrence|26|||
124812754|NCT01534962|448944653|FG002|Overall Study|Discontinued at AF recurrence|24|||
124812755|NCT01534962|448944654|FG003|Overall Study|Discontinued at AF recurrence|31|||
124812756|NCT00282984|448944655|FG000|Overall Study|Death|2|||
124812757|NCT00282984|448944656|FG001|Overall Study|Death|5|||
124812758|NCT00282984|448944655|FG000|Overall Study|Adverse Event|8|||
124812759|NCT00282984|448944656|FG001|Overall Study|Adverse Event|5|||
124812760|NCT00282984|448944655|FG000|Overall Study|Lack of Efficacy|0|||
124812761|NCT00282984|448944656|FG001|Overall Study|Lack of Efficacy|2|||
124812762|NCT00282984|448944655|FG000|Overall Study|Lost to Follow-up|14|||
124812763|NCT00282984|448944656|FG001|Overall Study|Lost to Follow-up|10|||
124812764|NCT00282984|448944655|FG000|Overall Study|Withdrawal by Participant|22|||
124812765|NCT00282984|448944656|FG001|Overall Study|Withdrawal by Participant|34|||
124812766|NCT00282984|448944655|FG000|Overall Study|Participant stopped study medication|2|||
124812767|NCT00282984|448944656|FG001|Overall Study|Participant stopped study medication|2|||
124812768|NCT00282984|448944655|FG000|Overall Study|Participant only allowed phone follow-up|0|||
124812769|NCT00282984|448944656|FG001|Overall Study|Participant only allowed phone follow-up|1|||
124812770|NCT00282984|448944655|FG000|Overall Study|Participant used antipsychosis meds|0|||
124812771|NCT00282984|448944656|FG001|Overall Study|Participant used antipsychosis meds|1|||
124812772|NCT00282984|448944655|FG000|Overall Study|lack of motivation|1|||
124812773|NCT00282984|448944656|FG001|Overall Study|lack of motivation|0|||
124812774|NCT00282984|448944655|FG000|Overall Study|in prison|0|||
124812775|NCT00282984|448944656|FG001|Overall Study|in prison|1|||
124812776|NCT00282984|448944655|FG000|Overall Study|Protocol Violation|2|||
124812777|NCT00282984|448944656|FG001|Overall Study|Protocol Violation|0|||
124812778|NCT00191269|448944657|FG000|Overall Study|Protocol Violation|0|||
124812779|NCT00191269|448944658|FG001|Overall Study|Protocol Violation|2|||
124812780|NCT00191269|448944657|FG000|Overall Study|Adverse Event|1|||
124812781|NCT00191269|448944658|FG001|Overall Study|Adverse Event|4|||
124812782|NCT00191269|448944657|FG000|Overall Study|Progression of Disease|4|||
124812783|NCT00191269|448944658|FG001|Overall Study|Progression of Disease|42|||
124812784|NCT00191269|448944657|FG000|Overall Study|Lack of Efficacy|1|||
124812785|NCT00191269|448944658|FG001|Overall Study|Lack of Efficacy|5|||
124812786|NCT00191269|448944657|FG000|Overall Study|Withdrawal by Subject|0|||
124812787|NCT00191269|448944658|FG001|Overall Study|Withdrawal by Subject|1|||
124812788|NCT00191269|448944657|FG000|Overall Study|Pathologic Aggrevation|0|||
124812789|NCT00191269|448944658|FG001|Overall Study|Pathologic Aggrevation|1|||
124812790|NCT00191269|448944657|FG000|Overall Study|Physician Decision|0|||
124812791|NCT00191269|448944658|FG001|Overall Study|Physician Decision|3|||
124812792|NCT02151110|448944664|FG000|Overall Study|Withdrawal by Subject|0|||
124812793|NCT02151110|448944665|FG001|Overall Study|Withdrawal by Subject|0|||
124812794|NCT02151110|448944666|FG002|Overall Study|Withdrawal by Subject|0|||
124812795|NCT02151110|448944667|FG003|Overall Study|Withdrawal by Subject|0|||
124812796|NCT02151110|448944668|FG004|Overall Study|Withdrawal by Subject|0|||
125301905|NCT00705367|450731865|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
124812797|NCT02151110|448944669|FG005|Overall Study|Withdrawal by Subject|0|||
124812798|NCT02151110|448944670|FG006|Overall Study|Withdrawal by Subject|0|||
124812799|NCT02151110|448944671|FG007|Overall Study|Withdrawal by Subject|1|||
124812800|NCT02151110|448944664|FG000|Overall Study|Lost to Follow-up|0|||
124812801|NCT02151110|448944665|FG001|Overall Study|Lost to Follow-up|0|||
124812802|NCT02151110|448944666|FG002|Overall Study|Lost to Follow-up|0|||
124812803|NCT02151110|448944667|FG003|Overall Study|Lost to Follow-up|0|||
124812804|NCT02151110|448944668|FG004|Overall Study|Lost to Follow-up|0|||
124812805|NCT02151110|448944669|FG005|Overall Study|Lost to Follow-up|0|||
124812806|NCT02151110|448944670|FG006|Overall Study|Lost to Follow-up|0|||
124812807|NCT02151110|448944671|FG007|Overall Study|Lost to Follow-up|2|||
124812808|NCT02015754|448944672|FG000|Overall Study|Disease progression|5|||
124812809|NCT02015754|448944672|FG000|Overall Study|Change in treatment modality|5|||
124812810|NCT02015754|448944672|FG000|Overall Study|Lost to Follow-up|1|||
124812811|NCT01128842|448944673|FG000|Overall Study|Adverse Event|1|||
124812812|NCT01128842|448944673|FG000|Overall Study|Disease Progression|6|||
124812813|NCT04528732|448944674|FG000|Overall Study|Death|1|||
124812814|NCT04528732|448944675|FG001|Overall Study|Death|0|||
124812815|NCT04528732|448944676|FG002|Overall Study|Death|1|||
124812816|NCT04528732|448944674|FG000|Overall Study|Lost to Follow-up|0|||
124812817|NCT04528732|448944675|FG001|Overall Study|Lost to Follow-up|1|||
124812818|NCT04528732|448944676|FG002|Overall Study|Lost to Follow-up|2|||
124812819|NCT01300650|448944683|FG000|Overall Study|Adverse Event|1|||
124812820|NCT02369016|448944684|FG000|Overall Study|AE associated with clinical disease progression|2|||
124812821|NCT02369016|448944685|FG001|Overall Study|AE associated with clinical disease progression|1|||
124812822|NCT02369016|448944684|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
124812823|NCT02369016|448944685|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
124812824|NCT02369016|448944684|FG000|Overall Study|Progressive disease - clinical progression|1|||
124812825|NCT02369016|448944685|FG001|Overall Study|Progressive disease - clinical progression|4|||
124812826|NCT02369016|448944684|FG000|Overall Study|withdrawal by patient|4|||
124812827|NCT02369016|448944685|FG001|Overall Study|withdrawal by patient|0|||
124812828|NCT02369016|448944684|FG000|Overall Study|Progressive disease - radiological progression|6|||
124812829|NCT02369016|448944685|FG001|Overall Study|Progressive disease - radiological progression|2|||
124812830|NCT00668707|448944686|FG000|Overall Study|Cancer Recurrence|58|||
124812831|NCT00668707|448944687|FG001|Overall Study|Cancer Recurrence|58|||
124812832|NCT00668707|448944686|FG000|Overall Study|Withdrawal by Subject|117|||
124812833|NCT00668707|448944687|FG001|Overall Study|Withdrawal by Subject|100|||
124812834|NCT00668707|448944686|FG000|Overall Study|Lost to Follow-up|3|||
124812835|NCT00668707|448944687|FG001|Overall Study|Lost to Follow-up|6|||
124812836|NCT00668707|448944686|FG000|Overall Study|Protocol Violation|10|||
124812837|NCT00668707|448944687|FG001|Overall Study|Protocol Violation|12|||
124812838|NCT00668707|448944686|FG000|Overall Study|Death|11|||
124812839|NCT00668707|448944687|FG001|Overall Study|Death|4|||
124812840|NCT00923156|448944688|FG000|Overall Study|Adverse Event|0|||
124812841|NCT00923156|448944689|FG001|Overall Study|Adverse Event|2|||
124812842|NCT00923156|448944690|FG002|Overall Study|Adverse Event|1|||
124812843|NCT00923156|448944688|FG000|Overall Study|Abnormal laboratory values|0|||
124812844|NCT00923156|448944689|FG001|Overall Study|Abnormal laboratory values|0|||
124812845|NCT00923156|448944690|FG002|Overall Study|Abnormal laboratory values|1|||
124812846|NCT00923156|448944688|FG000|Overall Study|Withdrawal by Subject|0|||
124812847|NCT00923156|448944689|FG001|Overall Study|Withdrawal by Subject|1|||
124812848|NCT00923156|448944690|FG002|Overall Study|Withdrawal by Subject|0|||
124812849|NCT00923156|448944688|FG000|Overall Study|Death|0|||
124812850|NCT00923156|448944689|FG001|Overall Study|Death|1|||
124812851|NCT00923156|448944690|FG002|Overall Study|Death|0|||
124812852|NCT00923156|448944688|FG000|Overall Study|Lack of Efficacy|0|||
124812853|NCT00923156|448944689|FG001|Overall Study|Lack of Efficacy|0|||
124812854|NCT00923156|448944690|FG002|Overall Study|Lack of Efficacy|1|||
124812855|NCT01201850|448944691|FG000|Overall Study|Tumor progression|4|||
124812856|NCT03338010|448944692|FG000|Overall Study|Withdrawal by Subject|14|||
124812857|NCT03338010|448944693|FG001|Overall Study|Withdrawal by Subject|8|||
124812858|NCT03338010|448944692|FG000|Overall Study|Lost to Follow-up|4|||
124812859|NCT03338010|448944693|FG001|Overall Study|Lost to Follow-up|2|||
124812860|NCT03338010|448944692|FG000|Overall Study|Adverse Event|3|||
124812861|NCT03338010|448944693|FG001|Overall Study|Adverse Event|2|||
124812862|NCT03338010|448944692|FG000|Overall Study|Physician Decision|2|||
124812863|NCT03338010|448944693|FG001|Overall Study|Physician Decision|2|||
124812864|NCT03338010|448944692|FG000|Overall Study|Non-Compliance with Study Drug|0|||
124812865|NCT03338010|448944693|FG001|Overall Study|Non-Compliance with Study Drug|3|||
124812866|NCT03338010|448944692|FG000|Overall Study|Protocol Violation|0|||
124812867|NCT03338010|448944693|FG001|Overall Study|Protocol Violation|1|||
124812868|NCT02465515|448944696|FG000|Overall Study|Investigator site closed|4|||
124812869|NCT02465515|448944697|FG001|Overall Study|Investigator site closed|5|||
124812870|NCT02465515|448944696|FG000|Overall Study|Withdrawal by Subject|74|||
124812871|NCT02465515|448944697|FG001|Overall Study|Withdrawal by Subject|43|||
124812872|NCT02465515|448944696|FG000|Overall Study|Physician Decision|8|||
124812873|NCT02465515|448944697|FG001|Overall Study|Physician Decision|12|||
124812874|NCT02465515|448944696|FG000|Overall Study|Lost to Follow-up|68|||
124812875|NCT02465515|448944697|FG001|Overall Study|Lost to Follow-up|51|||
124812876|NCT00816595|448944698|FG000|Overall Study|Withdrawal by Subject|2|||
124812877|NCT00816595|448944699|FG001|Overall Study|Withdrawal by Subject|0|||
124812878|NCT00293033|448944700|FG000|Open-label Titration Period|Adverse Event|10|||
124812879|NCT00293033|448944700|FG000|Open-label Titration Period|Death|3|||
124812880|NCT00293033|448944700|FG000|Open-label Titration Period|Lack of Efficacy|5|||
124812881|NCT00293033|448944700|FG000|Open-label Titration Period|Protocol Violation|2|||
124812882|NCT00293033|448944700|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
124812883|NCT00293033|448944700|FG000|Open-label Titration Period|Noncompliance and other|27|||
124812884|NCT00293033|448944700|FG000|Double-blind Treatment Period|Adverse Event|3|||
124812885|NCT00293033|448944700|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
124812886|NCT00293033|448944700|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
124812887|NCT00293033|448944700|FG000|Double-blind Treatment Period|Noncompliance|4|||
124812888|NCT03583697|448944701|FG000|Overall Study|Withdrawal by Subject|0|||
124812889|NCT03583697|448944702|FG001|Overall Study|Withdrawal by Subject|0|||
124812890|NCT03583697|448944703|FG002|Overall Study|Withdrawal by Subject|1|||
124812891|NCT03583697|448944701|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
124812892|NCT03583697|448944702|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
124812893|NCT03583697|448944703|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
124812894|NCT00114530|448944705|FG000|Overall Study|Death|3|||
124812895|NCT00114530|448944706|FG001|Overall Study|Death|11|||
124812896|NCT00114530|448944705|FG000|Overall Study|Lost to Follow-up|1|||
124812897|NCT00114530|448944706|FG001|Overall Study|Lost to Follow-up|1|||
124812898|NCT00114530|448944705|FG000|Overall Study|Physician Decision|1|||
124812899|NCT00114530|448944706|FG001|Overall Study|Physician Decision|1|||
124812900|NCT00114530|448944705|FG000|Overall Study|Withdrawal by Subject|2|||
124812901|NCT00114530|448944706|FG001|Overall Study|Withdrawal by Subject|6|||
124812902|NCT00114530|448944705|FG000|Overall Study|Breast Cancer|1|||
124812903|NCT00114530|448944706|FG001|Overall Study|Breast Cancer|0|||
124812904|NCT00114530|448944705|FG000|Overall Study|Subject decision after endpoint failure|0|||
124812905|NCT00114530|448944706|FG001|Overall Study|Subject decision after endpoint failure|1|||
124812906|NCT00114530|448944705|FG000|Overall Study|Ineligible|1|||
124812907|NCT00114530|448944706|FG001|Overall Study|Ineligible|0|||
124812908|NCT00365508|448944709|FG000|Overall Study|Lost to Follow-up|139|||
124812909|NCT00365508|448944710|FG001|Overall Study|Lost to Follow-up|154|||
124812910|NCT01064310|448944712|FG000|Period 1|Adverse Event|7|||
124812911|NCT01064310|448944713|FG001|Period 1|Adverse Event|10|||
124812912|NCT01064310|448944714|FG002|Period 1|Adverse Event|0|||
124812913|NCT01064310|448944712|FG000|Period 1|Physician Decision|1|||
124812914|NCT01064310|448944713|FG001|Period 1|Physician Decision|0|||
124812915|NCT01064310|448944714|FG002|Period 1|Physician Decision|0|||
124812916|NCT01064310|448944712|FG000|Period 1|Withdrawal by Subject|2|||
124812917|NCT01064310|448944713|FG001|Period 1|Withdrawal by Subject|2|||
124812918|NCT01064310|448944714|FG002|Period 1|Withdrawal by Subject|0|||
124812919|NCT01064310|448944712|FG000|Period 1|Lack of Efficacy|3|||
124812920|NCT01064310|448944713|FG001|Period 1|Lack of Efficacy|5|||
124812921|NCT01064310|448944714|FG002|Period 1|Lack of Efficacy|0|||
124812922|NCT01064310|448944712|FG000|Period 1|Entered Open-label Period|1|||
124812923|NCT01064310|448944713|FG001|Period 1|Entered Open-label Period|1|||
124812924|NCT01064310|448944714|FG002|Period 1|Entered Open-label Period|0|||
124812925|NCT01064310|448944712|FG000|Period 2|Adverse Event|2|||
124812926|NCT01064310|448944713|FG001|Period 2|Adverse Event|1|||
124812927|NCT01064310|448944714|FG002|Period 2|Adverse Event|0|||
124812928|NCT01064310|448944712|FG000|Period 2|Physician Decision|0|||
124812929|NCT01064310|448944713|FG001|Period 2|Physician Decision|1|||
124812930|NCT01064310|448944714|FG002|Period 2|Physician Decision|0|||
124812931|NCT01064310|448944712|FG000|Period 2|Entered Open-label Period|1|||
124812932|NCT01064310|448944713|FG001|Period 2|Entered Open-label Period|0|||
124812933|NCT01064310|448944714|FG002|Period 2|Entered Open-label Period|0|||
124812934|NCT01064310|448944712|FG000|Period 2|Lack of Efficacy|1|||
124812935|NCT01064310|448944713|FG001|Period 2|Lack of Efficacy|4|||
124812936|NCT01064310|448944714|FG002|Period 2|Lack of Efficacy|0|||
124812937|NCT01064310|448944712|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
124812938|NCT01064310|448944713|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
124812939|NCT01064310|448944714|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
124812940|NCT01064310|448944712|FG000|Open Label Pazopinib|Adverse Event|0|||
124812941|NCT01064310|448944713|FG001|Open Label Pazopinib|Adverse Event|0|||
124812942|NCT01064310|448944714|FG002|Open Label Pazopinib|Adverse Event|12|||
124812943|NCT01064310|448944712|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
124812944|NCT01064310|448944713|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
124812945|NCT01064310|448944714|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
124812946|NCT01064310|448944712|FG000|Open Label Pazopinib|Physician Decision|0|||
124812947|NCT01064310|448944713|FG001|Open Label Pazopinib|Physician Decision|0|||
124812948|NCT01064310|448944714|FG002|Open Label Pazopinib|Physician Decision|20|||
124812949|NCT00679432|448944715|FG000|Overall Study|Adverse Event|5|||
124812950|NCT00679432|448944716|FG001|Overall Study|Adverse Event|6|||
124812951|NCT00679432|448944717|FG002|Overall Study|Adverse Event|10|||
124812952|NCT00679432|448944718|FG003|Overall Study|Adverse Event|7|||
124812953|NCT00679432|448944715|FG000|Overall Study|Protocol Violation|1|||
124812954|NCT00679432|448944716|FG001|Overall Study|Protocol Violation|1|||
124812955|NCT00679432|448944717|FG002|Overall Study|Protocol Violation|2|||
124812956|NCT00679432|448944718|FG003|Overall Study|Protocol Violation|1|||
124812957|NCT00679432|448944715|FG000|Overall Study|Withdrawal by Subject|8|||
124812958|NCT00679432|448944716|FG001|Overall Study|Withdrawal by Subject|11|||
124812959|NCT00679432|448944717|FG002|Overall Study|Withdrawal by Subject|10|||
124812960|NCT00679432|448944718|FG003|Overall Study|Withdrawal by Subject|9|||
124812961|NCT00679432|448944715|FG000|Overall Study|Lost to Follow-up|1|||
124812962|NCT00679432|448944716|FG001|Overall Study|Lost to Follow-up|5|||
124812963|NCT00679432|448944717|FG002|Overall Study|Lost to Follow-up|4|||
124812964|NCT00679432|448944718|FG003|Overall Study|Lost to Follow-up|2|||
124812965|NCT00679432|448944715|FG000|Overall Study|Physician Decision|3|||
124812966|NCT00679432|448944716|FG001|Overall Study|Physician Decision|2|||
124812967|NCT00679432|448944717|FG002|Overall Study|Physician Decision|2|||
124812968|NCT00679432|448944718|FG003|Overall Study|Physician Decision|2|||
124812969|NCT00679432|448944715|FG000|Overall Study|Sponsor decision|1|||
124812970|NCT00679432|448944716|FG001|Overall Study|Sponsor decision|0|||
124812971|NCT00679432|448944717|FG002|Overall Study|Sponsor decision|0|||
124812972|NCT00679432|448944718|FG003|Overall Study|Sponsor decision|0|||
124812973|NCT00679432|448944715|FG000|Overall Study|Lack of Efficacy|13|||
124812974|NCT00679432|448944716|FG001|Overall Study|Lack of Efficacy|9|||
124812975|NCT00679432|448944717|FG002|Overall Study|Lack of Efficacy|14|||
124812976|NCT00679432|448944718|FG003|Overall Study|Lack of Efficacy|8|||
124812977|NCT00679432|448944715|FG000|Overall Study|Infectious colitis, normal histology|5|||
124812978|NCT00679432|448944716|FG001|Overall Study|Infectious colitis, normal histology|4|||
124812979|NCT00679432|448944717|FG002|Overall Study|Infectious colitis, normal histology|8|||
124812980|NCT00679432|448944718|FG003|Overall Study|Infectious colitis, normal histology|3|||
124812981|NCT00679432|448944715|FG000|Overall Study|Randomization error, return to prior Rx|0|||
124812982|NCT00679432|448944716|FG001|Overall Study|Randomization error, return to prior Rx|0|||
124812983|NCT00679432|448944717|FG002|Overall Study|Randomization error, return to prior Rx|3|||
124812984|NCT00679432|448944718|FG003|Overall Study|Randomization error, return to prior Rx|0|||
124812985|NCT00873015|448944720|FG000|Overall Study|Withdrawal by Subject|0|||
124812986|NCT00873015|448944721|FG001|Overall Study|Withdrawal by Subject|1|||
124812987|NCT00873015|448944722|FG002|Overall Study|Withdrawal by Subject|0|||
124812988|NCT00873015|448944723|FG003|Overall Study|Withdrawal by Subject|0|||
124812989|NCT02339584|448944724|FG000|Overall Study|Adverse Event|11|||
124812990|NCT02339584|448944725|FG001|Overall Study|Adverse Event|7|||
124812991|NCT02339584|448944724|FG000|Overall Study|Lack of Efficacy|0|||
124812992|NCT02339584|448944725|FG001|Overall Study|Lack of Efficacy|1|||
124812993|NCT02339584|448944724|FG000|Overall Study|Physician Decision|1|||
124812994|NCT02339584|448944725|FG001|Overall Study|Physician Decision|2|||
124812995|NCT02339584|448944724|FG000|Overall Study|Protocol Violation|1|||
124812996|NCT02339584|448944725|FG001|Overall Study|Protocol Violation|1|||
124812997|NCT02339584|448944724|FG000|Overall Study|Withdrawal by Subject|2|||
124812998|NCT02339584|448944725|FG001|Overall Study|Withdrawal by Subject|4|||
124812999|NCT01382212|448944726|FG000|Overall Study|Kidney transplant|1|||
124813000|NCT01382212|448944726|FG000|Overall Study|Withdrew consent|1|||
124813001|NCT00873912|448944728|FG000|Overall Study|Withdrawal by Subject|1|||
124813002|NCT00873912|448944729|FG001|Overall Study|Withdrawal by Subject|0|||
124813003|NCT00873912|448944728|FG000|Overall Study|Lost to Follow-up|2|||
124813004|NCT00873912|448944729|FG001|Overall Study|Lost to Follow-up|0|||
124813005|NCT01980940|448944731|FG000|Overall Study|Protocol Violation|0|||
124813006|NCT01980940|448944732|FG001|Overall Study|Protocol Violation|0|||
124813007|NCT01980940|448944733|FG002|Overall Study|Protocol Violation|0|||
124813008|NCT01980940|448944734|FG003|Overall Study|Protocol Violation|0|||
124813009|NCT01980940|448944735|FG004|Overall Study|Protocol Violation|0|||
124813010|NCT01980940|448944736|FG005|Overall Study|Protocol Violation|2|||
124813011|NCT01980940|448944737|FG006|Overall Study|Protocol Violation|0|||
124813012|NCT01980940|448944738|FG007|Overall Study|Protocol Violation|0|||
124813013|NCT00259649|448946247|FG000|Overall Study|Lost to Follow-up|7|||
124813014|NCT00259649|448946247|FG000|Overall Study|irregular menses|3|||
124813015|NCT00709761|448946248|FG000|Overall Study|Withdrawal by Subject|8|||
124813016|NCT00709761|448946248|FG000|Overall Study|study closed/terminated|17|||
124813017|NCT00709761|448946248|FG000|Overall Study|Lost to Follow-up|2|||
124813018|NCT00443261|448946249|FG000|Overall Study|Death|1|||
124813019|NCT03311724|448946250|FG000|Overall Study|Physician Decision|0|||
124813020|NCT03311724|448946251|FG001|Overall Study|Physician Decision|0|||
124813021|NCT03311724|448946252|FG002|Overall Study|Physician Decision|0|||
124813022|NCT03311724|448946253|FG003|Overall Study|Physician Decision|1|||
124813023|NCT03311724|448946250|FG000|Overall Study|Protocol Violation|1|||
124813024|NCT03311724|448946251|FG001|Overall Study|Protocol Violation|0|||
124813025|NCT03311724|448946252|FG002|Overall Study|Protocol Violation|1|||
124813026|NCT03311724|448946253|FG003|Overall Study|Protocol Violation|0|||
124813027|NCT03311724|448946250|FG000|Overall Study|Withdrawal by Subject|1|||
124813028|NCT03311724|448946251|FG001|Overall Study|Withdrawal by Subject|1|||
124813029|NCT03311724|448946252|FG002|Overall Study|Withdrawal by Subject|0|||
124813030|NCT03311724|448946253|FG003|Overall Study|Withdrawal by Subject|0|||
124813031|NCT03311724|448946250|FG000|Overall Study|Lost to Follow-up|1|||
124813032|NCT03311724|448946251|FG001|Overall Study|Lost to Follow-up|0|||
124813033|NCT03311724|448946252|FG002|Overall Study|Lost to Follow-up|0|||
124813034|NCT03311724|448946253|FG003|Overall Study|Lost to Follow-up|0|||
124813035|NCT03311724|448946250|FG000|Overall Study|Sponsor Decision|0|||
124813036|NCT03311724|448946251|FG001|Overall Study|Sponsor Decision|0|||
124813037|NCT03311724|448946252|FG002|Overall Study|Sponsor Decision|1|||
124813038|NCT03311724|448946253|FG003|Overall Study|Sponsor Decision|0|||
124813039|NCT01433991|448946255|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
124813040|NCT01433991|448946256|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
124813041|NCT01433991|448946257|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
124813042|NCT01433991|448946258|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
124813043|NCT01433991|448946255|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
125301906|NCT03149055|450731870|FG000|Overall Study|Not treated|4|||
125301907|NCT04440813|450731871|FG000|Overall Study|Lost to Follow-up|5|||
125301908|NCT04440813|450731872|FG001|Overall Study|Lost to Follow-up|5|||
125301909|NCT02629822|450731873|FG000|Base Study|Lost to Follow-up|2|||
125301910|NCT02629822|450731873|FG000|Base Study|Non-Compliance With Study Drug|1|||
125301911|NCT02629822|450731873|FG000|Extension Study|Adverse Event|1|||
125301912|NCT02629822|450731873|FG000|Extension Study|Lost to Follow-up|1|||
125301913|NCT00741013|450731874|FG000|Overall Study|Adverse Event|1|||
125301914|NCT00741013|450731875|FG001|Overall Study|Adverse Event|0|||
125301915|NCT00741013|450731876|FG002|Overall Study|Adverse Event|0|||
125301916|NCT00741013|450731874|FG000|Overall Study|Withdrawal by Subject|0|||
125301917|NCT00741013|450731875|FG001|Overall Study|Withdrawal by Subject|0|||
125301918|NCT00741013|450731876|FG002|Overall Study|Withdrawal by Subject|1|||
125301919|NCT00741013|450731874|FG000|Overall Study|Discovered failed screen after enrolled|0|||
125301920|NCT00741013|450731875|FG001|Overall Study|Discovered failed screen after enrolled|2|||
125301921|NCT00741013|450731876|FG002|Overall Study|Discovered failed screen after enrolled|0|||
125301922|NCT00193180|450731880|FG000|Overall Study|Lack of Efficacy|1|||
125301923|NCT00193180|450731880|FG000|Overall Study|Adverse Event|8|||
125301924|NCT00193180|450731880|FG000|Overall Study|Protocol Violation|1|||
125301925|NCT00539305|450731881|FG000|Overall Study|Adverse Event|1|||
125301926|NCT00539305|450731882|FG001|Overall Study|Adverse Event|0|||
125301927|NCT00539305|450731881|FG000|Overall Study|Substance Use|0|||
125301928|NCT00539305|450731882|FG001|Overall Study|Substance Use|1|||
125301929|NCT00539305|450731881|FG000|Overall Study|Withdrawal by Subject|0|||
125301930|NCT00539305|450731882|FG001|Overall Study|Withdrawal by Subject|1|||
125301931|NCT01331109|450731894|FG000|Overall Study|Adverse Event|6|||
125301932|NCT01331109|450731894|FG000|Overall Study|Lack of Efficacy|2|||
125301933|NCT01331109|450731894|FG000|Overall Study|Protocol Violation|3|||
125301934|NCT01331109|450731894|FG000|Overall Study|Withdrawal by Subject|7|||
125301935|NCT01331109|450731894|FG000|Overall Study|Lost to Follow-up|1|||
125301936|NCT01331109|450731894|FG000|Overall Study|Study Terminated by Sponsor|38|||
125301937|NCT00661622|450731897|FG000|Overall Study|Protocol Violation|1|||
125301938|NCT00661622|450731898|FG001|Overall Study|Protocol Violation|0|||
125301939|NCT00098306|450731903|FG000|Double Blind|Randomized, not treated|9|||
125301940|NCT00098306|450731904|FG001|Double Blind|Randomized, not treated|5|||
125301941|NCT00098306|450731905|FG002|Double Blind|Randomized, not treated|2|||
125301942|NCT00098306|450731906|FG003|Double Blind|Randomized, not treated|0|||
125301943|NCT00098306|450731907|FG004|Double Blind|Randomized, not treated|0|||
125301944|NCT00098306|450731908|FG005|Double Blind|Randomized, not treated|0|||
124813044|NCT01433991|448946256|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
124813045|NCT01433991|448946257|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
124813046|NCT01433991|448946258|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
124813047|NCT01433991|448946255|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
124813048|NCT01433991|448946256|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
124813049|NCT01433991|448946257|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
124813050|NCT01433991|448946258|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
124813051|NCT01433991|448946255|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
124813052|NCT01433991|448946256|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
124813053|NCT01433991|448946257|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
124813054|NCT01433991|448946258|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
124813055|NCT01433991|448946255|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
124813056|NCT01433991|448946256|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
124813057|NCT01433991|448946257|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
124813058|NCT01433991|448946258|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
124813059|NCT01433991|448946255|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
124813060|NCT01433991|448946256|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
124813061|NCT01433991|448946257|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
124813062|NCT01433991|448946258|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
124813063|NCT01433991|448946255|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
124813064|NCT01433991|448946256|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
124813065|NCT01433991|448946257|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
124813066|NCT01433991|448946258|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
124813067|NCT00844831|448946259|FG000|Overall Study|Withdrawal by Subject|4|||
125301945|NCT00098306|450731909|FG006|Double Blind|Randomized, not treated|0|||
125301946|NCT00098306|450731903|FG000|Double Blind|Ongoing at cut-off date|151|||
125301947|NCT00098306|450731904|FG001|Double Blind|Ongoing at cut-off date|166|||
125301948|NCT00098306|450731905|FG002|Double Blind|Ongoing at cut-off date|72|||
125301949|NCT00098306|450731906|FG003|Double Blind|Ongoing at cut-off date|0|||
124813068|NCT00844831|448946259|FG000|Overall Study|Adverse Event|1|||
125301950|NCT00098306|450731907|FG004|Double Blind|Ongoing at cut-off date|0|||
125301951|NCT00098306|450731908|FG005|Double Blind|Ongoing at cut-off date|0|||
125301952|NCT00098306|450731909|FG006|Double Blind|Ongoing at cut-off date|0|||
124813069|NCT00844831|448946259|FG000|Overall Study|Physician Decision|1|||
124813070|NCT01193530|448946262|FG000|Overall Study|Withdrawal by Subject|2|||
124813071|NCT01193530|448946263|FG001|Overall Study|Withdrawal by Subject|2|||
125301953|NCT00098306|450731903|FG000|Double Blind|Adverse Event|11|||
125301954|NCT00098306|450731904|FG001|Double Blind|Adverse Event|10|||
125301955|NCT00098306|450731905|FG002|Double Blind|Adverse Event|6|||
125301956|NCT00098306|450731906|FG003|Double Blind|Adverse Event|0|||
125301957|NCT00098306|450731907|FG004|Double Blind|Adverse Event|0|||
125301958|NCT00098306|450731908|FG005|Double Blind|Adverse Event|0|||
125301959|NCT00098306|450731909|FG006|Double Blind|Adverse Event|0|||
125301960|NCT00098306|450731903|FG000|Double Blind|Lack of Efficacy|43|||
125301961|NCT00098306|450731904|FG001|Double Blind|Lack of Efficacy|34|||
125301962|NCT00098306|450731905|FG002|Double Blind|Lack of Efficacy|17|||
125301963|NCT00098306|450731906|FG003|Double Blind|Lack of Efficacy|0|||
125301964|NCT00098306|450731907|FG004|Double Blind|Lack of Efficacy|0|||
125301965|NCT00098306|450731908|FG005|Double Blind|Lack of Efficacy|0|||
125301966|NCT00098306|450731909|FG006|Double Blind|Lack of Efficacy|0|||
125301967|NCT00098306|450731903|FG000|Double Blind|Death|1|||
125301968|NCT00098306|450731904|FG001|Double Blind|Death|4|||
125301969|NCT00098306|450731905|FG002|Double Blind|Death|1|||
125301970|NCT00098306|450731906|FG003|Double Blind|Death|0|||
125301971|NCT00098306|450731907|FG004|Double Blind|Death|0|||
125301972|NCT00098306|450731908|FG005|Double Blind|Death|0|||
125301973|NCT00098306|450731909|FG006|Double Blind|Death|0|||
125301974|NCT00098306|450731903|FG000|Double Blind|Participant defaulted|19|||
125301975|NCT00098306|450731904|FG001|Double Blind|Participant defaulted|18|||
125301976|NCT00098306|450731905|FG002|Double Blind|Participant defaulted|11|||
125301977|NCT00098306|450731906|FG003|Double Blind|Participant defaulted|0|||
125301978|NCT00098306|450731907|FG004|Double Blind|Participant defaulted|0|||
125301979|NCT00098306|450731908|FG005|Double Blind|Participant defaulted|0|||
125301980|NCT00098306|450731909|FG006|Double Blind|Participant defaulted|0|||
125301981|NCT00098306|450731903|FG000|Double Blind|Un-specified|7|||
125301982|NCT00098306|450731904|FG001|Double Blind|Un-specified|3|||
125301983|NCT00098306|450731905|FG002|Double Blind|Un-specified|11|||
125301984|NCT00098306|450731906|FG003|Double Blind|Un-specified|0|||
125301985|NCT00098306|450731907|FG004|Double Blind|Un-specified|0|||
125301986|NCT00098306|450731908|FG005|Double Blind|Un-specified|0|||
125301987|NCT00098306|450731909|FG006|Double Blind|Un-specified|0|||
125301988|NCT00098306|450731903|FG000|Open Label|Lack of Efficacy|0|||
125301989|NCT00098306|450731904|FG001|Open Label|Lack of Efficacy|0|||
125301990|NCT00098306|450731905|FG002|Open Label|Lack of Efficacy|0|||
125301991|NCT00098306|450731906|FG003|Open Label|Lack of Efficacy|13|||
125301992|NCT00098306|450731907|FG004|Open Label|Lack of Efficacy|0|||
125301993|NCT00098306|450731908|FG005|Open Label|Lack of Efficacy|0|||
125301994|NCT00098306|450731909|FG006|Open Label|Lack of Efficacy|0|||
125301995|NCT00098306|450731903|FG000|Open Label|Adverse Event|0|||
125301996|NCT00098306|450731904|FG001|Open Label|Adverse Event|0|||
125301997|NCT00098306|450731905|FG002|Open Label|Adverse Event|0|||
125301998|NCT00098306|450731906|FG003|Open Label|Adverse Event|2|||
125301999|NCT00098306|450731907|FG004|Open Label|Adverse Event|0|||
125302000|NCT00098306|450731908|FG005|Open Label|Adverse Event|0|||
125302001|NCT00098306|450731909|FG006|Open Label|Adverse Event|0|||
125302002|NCT00098306|450731903|FG000|Open Label|Death|0|||
125302003|NCT00098306|450731904|FG001|Open Label|Death|0|||
125302004|NCT00098306|450731905|FG002|Open Label|Death|0|||
125302005|NCT00098306|450731906|FG003|Open Label|Death|4|||
125302006|NCT00098306|450731907|FG004|Open Label|Death|0|||
125302007|NCT00098306|450731908|FG005|Open Label|Death|0|||
124813072|NCT01193530|448946262|FG000|Overall Study|Began Contraindicated Therapy|1|||
124813073|NCT01193530|448946263|FG001|Overall Study|Began Contraindicated Therapy|0|||
124813074|NCT01193530|448946262|FG000|Overall Study|Lost Light Box|0|||
124813075|NCT01193530|448946263|FG001|Overall Study|Lost Light Box|1|||
125302008|NCT00098306|450731909|FG006|Open Label|Death|0|||
125302009|NCT00098306|450731903|FG000|Open Label|Participant defaulted|0|||
125302010|NCT00098306|450731904|FG001|Open Label|Participant defaulted|0|||
125302011|NCT00098306|450731905|FG002|Open Label|Participant defaulted|0|||
125302012|NCT00098306|450731906|FG003|Open Label|Participant defaulted|24|||
125302013|NCT00098306|450731907|FG004|Open Label|Participant defaulted|0|||
125302014|NCT00098306|450731908|FG005|Open Label|Participant defaulted|0|||
125302015|NCT00098306|450731909|FG006|Open Label|Participant defaulted|0|||
124813076|NCT01193530|448946262|FG000|Overall Study|Returned home - out of state|0|||
124813077|NCT01193530|448946263|FG001|Overall Study|Returned home - out of state|1|||
125302016|NCT00098306|450731903|FG000|Open Label|Un-specified|0|||
125302017|NCT00098306|450731904|FG001|Open Label|Un-specified|0|||
125302018|NCT00098306|450731905|FG002|Open Label|Un-specified|0|||
125302019|NCT00098306|450731906|FG003|Open Label|Un-specified|15|||
125302020|NCT00098306|450731907|FG004|Open Label|Un-specified|0|||
125302021|NCT00098306|450731908|FG005|Open Label|Un-specified|0|||
125302022|NCT00098306|450731909|FG006|Open Label|Un-specified|0|||
125302023|NCT00098306|450731903|FG000|Open Label|Ongoing at cut-off date|0|||
125302024|NCT00098306|450731904|FG001|Open Label|Ongoing at cut-off date|0|||
125302025|NCT00098306|450731905|FG002|Open Label|Ongoing at cut-off date|0|||
125302026|NCT00098306|450731906|FG003|Open Label|Ongoing at cut-off date|269|||
125302027|NCT00098306|450731907|FG004|Open Label|Ongoing at cut-off date|62|||
125302028|NCT00098306|450731908|FG005|Open Label|Ongoing at cut-off date|0|||
125302029|NCT00098306|450731909|FG006|Open Label|Ongoing at cut-off date|0|||
125302030|NCT00098306|450731903|FG000|Observational Phase|Death|0|||
125302031|NCT00098306|450731904|FG001|Observational Phase|Death|0|||
125302032|NCT00098306|450731905|FG002|Observational Phase|Death|0|||
125302033|NCT00098306|450731906|FG003|Observational Phase|Death|0|||
125302034|NCT00098306|450731907|FG004|Observational Phase|Death|0|||
125302035|NCT00098306|450731908|FG005|Observational Phase|Death|5|||
125302036|NCT00098306|450731909|FG006|Observational Phase|Death|4|||
125302037|NCT00098306|450731903|FG000|Observational Phase|Participant defaulted|0|||
125302038|NCT00098306|450731904|FG001|Observational Phase|Participant defaulted|0|||
125302039|NCT00098306|450731905|FG002|Observational Phase|Participant defaulted|0|||
124813078|NCT01193530|448946262|FG000|Overall Study|Non-Compliance|0|||
124813079|NCT01193530|448946263|FG001|Overall Study|Non-Compliance|1|||
124813080|NCT03305575|448946274|FG000|Overall Study|Physician Decision|1|||
124813081|NCT03305575|448946275|FG001|Overall Study|Physician Decision|0|||
124813082|NCT03486223|448946284|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
124813083|NCT03486223|448946285|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
124813084|NCT01819831|448946286|FG000|Overall Study|Withdrawal by Subject|1|||
124813085|NCT03068130|448946306|FG000|Overall Study|Adverse Event|19|||
124813086|NCT03068130|448946306|FG000|Overall Study|Death|14|||
124813087|NCT03068130|448946306|FG000|Overall Study|Lost to Follow-up|4|||
124813088|NCT03068130|448946306|FG000|Overall Study|Withdrawal by Subject|26|||
124813089|NCT03068130|448946306|FG000|Overall Study|Administrative Reasons|3|||
124813090|NCT03068130|448946306|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
124813091|NCT03068130|448946306|FG000|Overall Study|Study terminated by sponsor|194|||
124813092|NCT03130257|448946307|FG000|Overall Study|Withdrawal by Subject|1|||
124813093|NCT03130257|448946308|FG001|Overall Study|Withdrawal by Subject|0|||
124813094|NCT03130257|448946309|FG002|Overall Study|Withdrawal by Subject|2|||
124813095|NCT00297830|448946310|FG000|6 Month Visit|Death|1|||
124813096|NCT00297830|448946311|FG001|6 Month Visit|Death|0|||
124813097|NCT00297830|448946312|FG002|6 Month Visit|Death|2|||
124813098|NCT00297830|448946310|FG000|6 Month Visit|Withdrawal by Subject|2|||
124813099|NCT00297830|448946311|FG001|6 Month Visit|Withdrawal by Subject|1|||
124813100|NCT00297830|448946312|FG002|6 Month Visit|Withdrawal by Subject|1|||
124813101|NCT00297830|448946310|FG000|6 Month Visit|Adverse Event|0|||
124813102|NCT00297830|448946311|FG001|6 Month Visit|Adverse Event|1|||
124813103|NCT00297830|448946312|FG002|6 Month Visit|Adverse Event|0|||
124813104|NCT00297830|448946310|FG000|12 Month Visit|Lost to Follow-up|1|||
124813105|NCT00297830|448946311|FG001|12 Month Visit|Lost to Follow-up|0|||
124813106|NCT00297830|448946312|FG002|12 Month Visit|Lost to Follow-up|0|||
124813107|NCT00297830|448946310|FG000|12 Month Visit|Adverse Event|0|||
124813108|NCT00297830|448946311|FG001|12 Month Visit|Adverse Event|3|||
124813109|NCT00297830|448946312|FG002|12 Month Visit|Adverse Event|0|||
124813110|NCT00297830|448946310|FG000|12 Month Visit|Withdrawal by Subject|0|||
124813111|NCT00297830|448946311|FG001|12 Month Visit|Withdrawal by Subject|3|||
124813112|NCT00297830|448946312|FG002|12 Month Visit|Withdrawal by Subject|0|||
124813113|NCT04377620|448946315|FG000|Overall Study|Death|42|||
124813114|NCT04377620|448946316|FG001|Overall Study|Death|48|||
124813115|NCT04377620|448946317|FG002|Overall Study|Death|36|||
124813116|NCT04377620|448946315|FG000|Overall Study|Withdrawal by Subject|0|||
124813117|NCT04377620|448946316|FG001|Overall Study|Withdrawal by Subject|2|||
124813118|NCT04377620|448946317|FG002|Overall Study|Withdrawal by Subject|0|||
124813119|NCT00288054|448946318|FG000|Overall Study|Protocol Violation|2|||
124813120|NCT00288054|448946318|FG000|Overall Study|Lack of Efficacy|16|||
124813121|NCT00288054|448946318|FG000|Overall Study|Adverse Event|3|||
124813122|NCT00288054|448946318|FG000|Overall Study|Withdrawal by Subject|1|||
124813123|NCT00288054|448946318|FG000|Overall Study|Not protocol specified|2|||
124813124|NCT03733470|448946329|FG000|Overall Study|PI Decision|1|||
125302040|NCT00098306|450731906|FG003|Observational Phase|Participant defaulted|0|||
124813125|NCT03733470|448946330|FG001|Overall Study|PI Decision|1|||
124813126|NCT01010061|448946331|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
124813127|NCT01010061|448946332|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
124813128|NCT01010061|448946331|FG000|Overall Study|Disease Progression|2|||
125302041|NCT00098306|450731907|FG004|Observational Phase|Participant defaulted|0|||
125302042|NCT00098306|450731908|FG005|Observational Phase|Participant defaulted|34|||
125302043|NCT00098306|450731909|FG006|Observational Phase|Participant defaulted|18|||
124813129|NCT01010061|448946332|FG001|Overall Study|Disease Progression|8|||
124813130|NCT01010061|448946331|FG000|Overall Study|Withdrew Consent|5|||
124813131|NCT01010061|448946332|FG001|Overall Study|Withdrew Consent|1|||
124813132|NCT01010061|448946331|FG000|Overall Study|Death|3|||
125302044|NCT00098306|450731903|FG000|Observational Phase|Un-specified|0|||
125302045|NCT00098306|450731904|FG001|Observational Phase|Un-specified|0|||
124813133|NCT01010061|448946332|FG001|Overall Study|Death|6|||
124813134|NCT01010061|448946331|FG000|Overall Study|Administrative/Other|0|||
124813135|NCT01010061|448946332|FG001|Overall Study|Administrative/Other|1|||
125302046|NCT00098306|450731905|FG002|Observational Phase|Un-specified|0|||
124813136|NCT01010061|448946331|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
124813137|NCT01010061|448946332|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
124813138|NCT01010061|448946331|FG000|Overall Study|Insufficient Therapeutic Response|1|||
124813139|NCT01010061|448946332|FG001|Overall Study|Insufficient Therapeutic Response|5|||
124813140|NCT01010061|448946331|FG000|Overall Study|Violation of Selection Criteria|0|||
124813141|NCT01010061|448946332|FG001|Overall Study|Violation of Selection Criteria|1|||
124813142|NCT01010061|448946331|FG000|Overall Study|Did Not Receive Treatment|2|||
124813143|NCT01010061|448946332|FG001|Overall Study|Did Not Receive Treatment|2|||
124813144|NCT02197520|448946340|FG000|Period 1|Withdrawal by Subject|1|||
124813145|NCT02197520|448946341|FG001|Period 1|Withdrawal by Subject|0|||
124813146|NCT02197520|448946340|FG000|Period 2|Adverse Event|0|||
124813147|NCT02197520|448946341|FG001|Period 2|Adverse Event|2|||
124813148|NCT02197520|448946340|FG000|Period 2|Withdrawal by Subject|1|||
124813149|NCT02197520|448946341|FG001|Period 2|Withdrawal by Subject|0|||
124813150|NCT01306942|448946342|FG000|Phase I|Adverse Event|2|||
124813151|NCT01306942|448946343|FG001|Phase I|Adverse Event|2|||
124813152|NCT01306942|448946344|FG002|Phase I|Adverse Event|0|||
124813153|NCT01306942|448946345|FG003|Phase I|Adverse Event|0|||
124813154|NCT01306942|448946342|FG000|Phase I|Physician Decision|3|||
124813155|NCT01306942|448946343|FG001|Phase I|Physician Decision|1|||
124813156|NCT01306942|448946344|FG002|Phase I|Physician Decision|0|||
124813157|NCT01306942|448946345|FG003|Phase I|Physician Decision|0|||
124813158|NCT01306942|448946342|FG000|Phase II|Adverse Event|0|||
124813159|NCT01306942|448946343|FG001|Phase II|Adverse Event|0|||
124813160|NCT01306942|448946344|FG002|Phase II|Adverse Event|0|||
124813161|NCT01306942|448946345|FG003|Phase II|Adverse Event|6|||
124813162|NCT01306942|448946342|FG000|Phase II|Physician Decision|2|||
124813163|NCT01306942|448946343|FG001|Phase II|Physician Decision|0|||
124813164|NCT01306942|448946344|FG002|Phase II|Physician Decision|0|||
124813165|NCT01306942|448946345|FG003|Phase II|Physician Decision|5|||
124813166|NCT01306942|448946342|FG000|Phase II|Withdrawal by Subject|0|||
124813167|NCT01306942|448946343|FG001|Phase II|Withdrawal by Subject|0|||
124813168|NCT01306942|448946344|FG002|Phase II|Withdrawal by Subject|0|||
124813169|NCT01306942|448946345|FG003|Phase II|Withdrawal by Subject|2|||
124813170|NCT01306942|448946342|FG000|Phase II|Death|0|||
124813171|NCT01306942|448946343|FG001|Phase II|Death|0|||
124813172|NCT01306942|448946344|FG002|Phase II|Death|0|||
124813173|NCT01306942|448946345|FG003|Phase II|Death|1|||
124813174|NCT01306942|448946342|FG000|Phase II|Not finished treatment|0|||
124813175|NCT01306942|448946343|FG001|Phase II|Not finished treatment|0|||
124813176|NCT01306942|448946344|FG002|Phase II|Not finished treatment|0|||
124813177|NCT01306942|448946345|FG003|Phase II|Not finished treatment|1|||
124813178|NCT01306942|448946342|FG000|Phase II|Protocol Violation|0|||
124813179|NCT01306942|448946343|FG001|Phase II|Protocol Violation|0|||
124813180|NCT01306942|448946344|FG002|Phase II|Protocol Violation|0|||
124813181|NCT01306942|448946345|FG003|Phase II|Protocol Violation|1|||
124813182|NCT02021773|448946349|FG000|Overall Study|Adverse Event|1|||
124813183|NCT02021773|448946350|FG001|Overall Study|Adverse Event|4|||
124813184|NCT02021773|448946351|FG002|Overall Study|Adverse Event|3|||
124813185|NCT02021773|448946349|FG000|Overall Study|Lack of Efficacy|2|||
124813186|NCT02021773|448946350|FG001|Overall Study|Lack of Efficacy|2|||
124813187|NCT02021773|448946351|FG002|Overall Study|Lack of Efficacy|2|||
124813188|NCT02021773|448946349|FG000|Overall Study|Protocol Violation|2|||
124813189|NCT02021773|448946350|FG001|Overall Study|Protocol Violation|3|||
124813190|NCT02021773|448946351|FG002|Overall Study|Protocol Violation|1|||
124813191|NCT02021773|448946349|FG000|Overall Study|Withdrawal by Subject|3|||
124813192|NCT02021773|448946350|FG001|Overall Study|Withdrawal by Subject|4|||
124813193|NCT02021773|448946351|FG002|Overall Study|Withdrawal by Subject|5|||
124813194|NCT02021773|448946349|FG000|Overall Study|Lost to Follow-up|1|||
124813195|NCT02021773|448946350|FG001|Overall Study|Lost to Follow-up|3|||
124813196|NCT02021773|448946351|FG002|Overall Study|Lost to Follow-up|0|||
124813197|NCT02021773|448946349|FG000|Overall Study|Reason not specified|3|||
124813198|NCT02021773|448946350|FG001|Overall Study|Reason not specified|0|||
124813199|NCT02021773|448946351|FG002|Overall Study|Reason not specified|0|||
124813200|NCT02243696|448946352|FG000|Overall Study|Death|282|||
124813201|NCT02243696|448946352|FG000|Overall Study|Withdrawal by Subject|79|||
124813202|NCT02243696|448946352|FG000|Overall Study|Lost to Follow-up|57|||
124813203|NCT02243696|448946352|FG000|Overall Study|Subject No Longer has Study System|42|||
124813204|NCT02243696|448946352|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
124813205|NCT02243696|448946352|FG000|Overall Study|Study Terminated for EP PASSION|961|||
124813206|NCT00087607|448946353|FG000|Overall Study|Adverse Event|14|||
124813207|NCT00087607|448946354|FG001|Overall Study|Adverse Event|24|||
124813208|NCT00087607|448946353|FG000|Overall Study|Death|0|||
124813209|NCT00087607|448946354|FG001|Overall Study|Death|1|||
124813210|NCT00087607|448946353|FG000|Overall Study|Insufficient Therapeutic Response|53|||
124813211|NCT00087607|448946354|FG001|Overall Study|Insufficient Therapeutic Response|42|||
124813212|NCT00087607|448946353|FG000|Overall Study|Failure to return|21|||
124813213|NCT00087607|448946354|FG001|Overall Study|Failure to return|17|||
124813214|NCT00087607|448946353|FG000|Overall Study|Withdrew Consent|12|||
124813215|NCT00087607|448946354|FG001|Overall Study|Withdrew Consent|16|||
124813216|NCT00087607|448946353|FG000|Overall Study|Administrative|12|||
124813217|NCT00087607|448946354|FG001|Overall Study|Administrative|12|||
124813218|NCT00087607|448946353|FG000|Overall Study|Refused Treatment|5|||
124813219|NCT00087607|448946354|FG001|Overall Study|Refused Treatment|7|||
124813220|NCT00087607|448946353|FG000|Overall Study|Other Protocol Violation|5|||
124813221|NCT00087607|448946354|FG001|Overall Study|Other Protocol Violation|2|||
124813222|NCT00087607|448946353|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
124813223|NCT00087607|448946354|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
124813224|NCT00190671|448946355|FG000|Overall Study|Satisfactory Response|4|||
124813225|NCT00190671|448946356|FG001|Overall Study|Satisfactory Response|7|||
124813226|NCT00190671|448946355|FG000|Overall Study|Lack of Efficacy|19|||
124813227|NCT00190671|448946356|FG001|Overall Study|Lack of Efficacy|24|||
124813228|NCT00190671|448946355|FG000|Overall Study|Death from Study Disease|1|||
124813229|NCT00190671|448946356|FG001|Overall Study|Death from Study Disease|1|||
124813230|NCT00190671|448946355|FG000|Overall Study|Adverse Event|3|||
124813231|NCT00190671|448946356|FG001|Overall Study|Adverse Event|2|||
124813232|NCT00190671|448946355|FG000|Overall Study|Clinical Relapse|0|||
124813233|NCT00190671|448946356|FG001|Overall Study|Clinical Relapse|1|||
124813234|NCT00190671|448946355|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
124813235|NCT00190671|448946356|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
124813236|NCT00190671|448946355|FG000|Overall Study|Death from Other Causes|0|||
124813237|NCT00190671|448946356|FG001|Overall Study|Death from Other Causes|2|||
124813238|NCT00190671|448946355|FG000|Overall Study|Protocol Violation|0|||
124813239|NCT00190671|448946356|FG001|Overall Study|Protocol Violation|1|||
124813240|NCT00190671|448946355|FG000|Overall Study|Withdrawal by Subject|0|||
124813241|NCT00190671|448946356|FG001|Overall Study|Withdrawal by Subject|2|||
124813242|NCT02094677|448946357|FG000|Overall Study|Screening|3|||
124813243|NCT02094677|448946358|FG001|Overall Study|Screening|1|||
124813244|NCT03408483|448946359|FG000|Overall Study|Physician Decision|3|||
124813245|NCT03408483|448946360|FG001|Overall Study|Physician Decision|3|||
124813246|NCT03408483|448946359|FG000|Overall Study|Lost to Follow-up|3|||
124813247|NCT03408483|448946360|FG001|Overall Study|Lost to Follow-up|0|||
124813248|NCT05399641|448946361|FG000|Overall Study|Adverse Event|0|||
124813249|NCT05399641|448946362|FG001|Overall Study|Adverse Event|1|||
124813250|NCT05399641|448946363|FG002|Overall Study|Adverse Event|1|||
124813251|NCT05399641|448946361|FG000|Overall Study|Lost to Follow-up|1|||
124813252|NCT05399641|448946362|FG001|Overall Study|Lost to Follow-up|2|||
124813253|NCT05399641|448946363|FG002|Overall Study|Lost to Follow-up|2|||
124813254|NCT05399641|448946361|FG000|Overall Study|Physician Decision|1|||
124813255|NCT05399641|448946362|FG001|Overall Study|Physician Decision|3|||
124813256|NCT05399641|448946363|FG002|Overall Study|Physician Decision|3|||
124813257|NCT05399641|448946361|FG000|Overall Study|Withdrawal by Subject|4|||
124813258|NCT05399641|448946362|FG001|Overall Study|Withdrawal by Subject|11|||
124813259|NCT05399641|448946363|FG002|Overall Study|Withdrawal by Subject|7|||
124813260|NCT05399641|448946361|FG000|Overall Study|Reason not defined|3|||
124813261|NCT05399641|448946362|FG001|Overall Study|Reason not defined|5|||
124813262|NCT05399641|448946363|FG002|Overall Study|Reason not defined|6|||
124813263|NCT00478231|448946364|FG000|Overall Study|Death|7|||
124813264|NCT00478231|448946364|FG000|Overall Study|Lack of Efficacy|47|||
124813265|NCT00478231|448946364|FG000|Overall Study|Lost to Follow-up|7|||
124813266|NCT00478231|448946364|FG000|Overall Study|Withdrawal by Subject|6|||
124813267|NCT00478231|448946364|FG000|Overall Study|Other|9|||
124813268|NCT00478231|448946364|FG000|Overall Study|Adverse Event|5|||
124813269|NCT00478231|448946364|FG000|Overall Study|Randomized, not treated|3|||
124813270|NCT04066023|448946370|FG000|Overall Study|Adverse Event|0|||
124813271|NCT04066023|448946371|FG001|Overall Study|Adverse Event|0|||
124813272|NCT04066023|448946372|FG002|Overall Study|Adverse Event|1|||
124813273|NCT04066023|448946370|FG000|Overall Study|Sponsor decision|3|||
124813274|NCT04066023|448946371|FG001|Overall Study|Sponsor decision|6|||
124813275|NCT04066023|448946372|FG002|Overall Study|Sponsor decision|2|||
124813276|NCT04066023|448946370|FG000|Overall Study|Physician Decision|0|||
124813277|NCT04066023|448946371|FG001|Overall Study|Physician Decision|0|||
124813278|NCT04066023|448946372|FG002|Overall Study|Physician Decision|1|||
124813279|NCT04066023|448946370|FG000|Overall Study|Lost to Follow-up|0|||
124813280|NCT04066023|448946371|FG001|Overall Study|Lost to Follow-up|1|||
124813281|NCT04066023|448946372|FG002|Overall Study|Lost to Follow-up|1|||
124813282|NCT04066023|448946370|FG000|Overall Study|Noncompliance|0|||
124813283|NCT04066023|448946371|FG001|Overall Study|Noncompliance|1|||
124813284|NCT04066023|448946372|FG002|Overall Study|Noncompliance|1|||
124813285|NCT00751933|448946373|FG000|Overall Study|Withdrawal by Subject|0|||
124813286|NCT00751933|448946374|FG001|Overall Study|Withdrawal by Subject|1|||
124813287|NCT00751933|448946375|FG002|Overall Study|Withdrawal by Subject|0|||
124813288|NCT00751933|448946376|FG003|Overall Study|Withdrawal by Subject|0|||
124813289|NCT00751933|448946373|FG000|Overall Study|Physician Decision|0|||
124813290|NCT00751933|448946374|FG001|Overall Study|Physician Decision|0|||
124813291|NCT00751933|448946375|FG002|Overall Study|Physician Decision|1|||
124813292|NCT00751933|448946376|FG003|Overall Study|Physician Decision|1|||
124813293|NCT05248867|448946378|FG000|Double-blind Period|Lost to Follow-up|0|||
124813294|NCT05248867|448946379|FG001|Double-blind Period|Lost to Follow-up|3|||
124813295|NCT05248867|448946380|FG002|Double-blind Period|Lost to Follow-up|0|||
124813296|NCT05248867|448946381|FG003|Double-blind Period|Lost to Follow-up|0|||
124813297|NCT05248867|448946382|FG004|Double-blind Period|Lost to Follow-up|0|||
124813298|NCT05248867|448946383|FG005|Double-blind Period|Lost to Follow-up|0|||
124813299|NCT05248867|448946378|FG000|Double-blind Period|Withdrawal by Subject|5|||
124813300|NCT05248867|448946379|FG001|Double-blind Period|Withdrawal by Subject|14|||
124813301|NCT05248867|448946380|FG002|Double-blind Period|Withdrawal by Subject|0|||
124813302|NCT05248867|448946381|FG003|Double-blind Period|Withdrawal by Subject|0|||
124813303|NCT05248867|448946382|FG004|Double-blind Period|Withdrawal by Subject|0|||
124813304|NCT05248867|448946383|FG005|Double-blind Period|Withdrawal by Subject|0|||
124813305|NCT05248867|448946378|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
124813306|NCT05248867|448946379|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
124813307|NCT05248867|448946380|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
124813308|NCT05248867|448946381|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
124813309|NCT05248867|448946382|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
124813310|NCT05248867|448946383|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
124813311|NCT05248867|448946378|FG000|Double-blind Period|Other, not specified|3|||
124813312|NCT05248867|448946379|FG001|Double-blind Period|Other, not specified|8|||
124813313|NCT05248867|448946380|FG002|Double-blind Period|Other, not specified|0|||
124813314|NCT05248867|448946381|FG003|Double-blind Period|Other, not specified|0|||
124813315|NCT05248867|448946382|FG004|Double-blind Period|Other, not specified|0|||
124813316|NCT05248867|448946383|FG005|Double-blind Period|Other, not specified|0|||
124813317|NCT05248867|448946378|FG000|Open-label Period|Withdrawal by Subject|0|||
124813318|NCT05248867|448946379|FG001|Open-label Period|Withdrawal by Subject|0|||
124813319|NCT05248867|448946380|FG002|Open-label Period|Withdrawal by Subject|3|||
124813320|NCT05248867|448946381|FG003|Open-label Period|Withdrawal by Subject|1|||
124813321|NCT05248867|448946382|FG004|Open-label Period|Withdrawal by Subject|7|||
124813322|NCT05248867|448946383|FG005|Open-label Period|Withdrawal by Subject|9|||
124813323|NCT05248867|448946378|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
124813324|NCT05248867|448946379|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
124813325|NCT05248867|448946380|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
124813326|NCT05248867|448946381|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
124813327|NCT05248867|448946382|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
124813328|NCT05248867|448946383|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
124813329|NCT05248867|448946378|FG000|Open-label Period|Lost to Follow-up|0|||
124813330|NCT05248867|448946379|FG001|Open-label Period|Lost to Follow-up|0|||
124813331|NCT05248867|448946380|FG002|Open-label Period|Lost to Follow-up|0|||
124813332|NCT05248867|448946381|FG003|Open-label Period|Lost to Follow-up|0|||
124813333|NCT05248867|448946382|FG004|Open-label Period|Lost to Follow-up|5|||
124813334|NCT05248867|448946383|FG005|Open-label Period|Lost to Follow-up|2|||
124813335|NCT05248867|448946378|FG000|Open-label Period|COVID-19 Infection|0|||
124813336|NCT05248867|448946379|FG001|Open-label Period|COVID-19 Infection|0|||
124813337|NCT05248867|448946380|FG002|Open-label Period|COVID-19 Infection|0|||
124813338|NCT05248867|448946381|FG003|Open-label Period|COVID-19 Infection|0|||
124813339|NCT05248867|448946382|FG004|Open-label Period|COVID-19 Infection|1|||
124813340|NCT05248867|448946383|FG005|Open-label Period|COVID-19 Infection|0|||
124813341|NCT05248867|448946378|FG000|Open-label Period|Other, not specified|0|||
124813342|NCT05248867|448946379|FG001|Open-label Period|Other, not specified|0|||
124813343|NCT05248867|448946380|FG002|Open-label Period|Other, not specified|0|||
124813344|NCT05248867|448946381|FG003|Open-label Period|Other, not specified|0|||
124813345|NCT05248867|448946382|FG004|Open-label Period|Other, not specified|4|||
124813346|NCT05248867|448946383|FG005|Open-label Period|Other, not specified|0|||
124813347|NCT01084083|448946386|FG000|Overall Study|Adverse Event|5|||
124813348|NCT01084083|448946386|FG000|Overall Study|Death|1|||
124813349|NCT01084083|448946386|FG000|Overall Study|Withdrawal by Subject|2|||
124813350|NCT01084083|448946386|FG000|Overall Study|Complicating disease|1|||
124813351|NCT01084083|448946386|FG000|Overall Study|Other|2|||
124813352|NCT01084083|448946386|FG000|Overall Study|Never started assigned therapy|1|||
124813353|NCT01273597|448946387|FG000|Overall Study|Adverse Event|5|||
124813354|NCT01273597|448946387|FG000|Overall Study|Underwent Kidney Transplantation|2|||
124813355|NCT01273597|448946387|FG000|Overall Study|Reason Not Reported|1|||
124813356|NCT01088997|448946388|FG000|Overall Study|Physician Decision|1|||
124813357|NCT01088997|448946389|FG001|Overall Study|Physician Decision|1|||
124813358|NCT01088997|448946388|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
124813359|NCT01088997|448946389|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
124813360|NCT01088997|448946388|FG000|Overall Study|Excluded prior to receiving drug|1|||
124813361|NCT01088997|448946389|FG001|Overall Study|Excluded prior to receiving drug|1|||
124813362|NCT05695209|448946392|FG000|3-months|Withdrawal by Subject|2|||
124813363|NCT05695209|448946393|FG001|3-months|Withdrawal by Subject|0|||
124813364|NCT05695209|448946392|FG000|3-months|Unable to contact for 3-month data collection|0|||
124813365|NCT05695209|448946393|FG001|3-months|Unable to contact for 3-month data collection|1|||
124813366|NCT05695209|448946392|FG000|6-months|Lost to Follow-up|1|||
124813367|NCT05695209|448946393|FG001|6-months|Lost to Follow-up|1|||
124813368|NCT04731363|448946394|FG000|Overall Study|Could not obtain samples|0|||
124813369|NCT04731363|448946395|FG001|Overall Study|Could not obtain samples|1|||
124813370|NCT04731363|448946396|FG002|Overall Study|Could not obtain samples|0|||
124813371|NCT04731363|448946397|FG003|Overall Study|Could not obtain samples|0|||
124813372|NCT04731363|448946394|FG000|Overall Study|Physician Decision|0|||
124813373|NCT04731363|448946395|FG001|Overall Study|Physician Decision|1|||
124813374|NCT04731363|448946396|FG002|Overall Study|Physician Decision|0|||
124813375|NCT04731363|448946397|FG003|Overall Study|Physician Decision|0|||
124813376|NCT02513394|448946398|FG000|Overall Study|Withdrawal by Subject|11|||
124813377|NCT02513394|448946399|FG001|Overall Study|Withdrawal by Subject|23|||
124813378|NCT02513394|448946398|FG000|Overall Study|Ineligible|1|||
124813379|NCT02513394|448946399|FG001|Overall Study|Ineligible|0|||
124813380|NCT05766423|448946400|FG000|Overall Study|Withdrawal by Subject|1|||
124813381|NCT05766423|448946401|FG001|Overall Study|Withdrawal by Subject|0|||
124813382|NCT05766423|448946400|FG000|Overall Study|Consented, not scheduled|3|||
124813383|NCT05766423|448946401|FG001|Overall Study|Consented, not scheduled|5|||
124813384|NCT00688753|448948446|FG000|Overall Study|Disease progression|55|||
124813385|NCT00688753|448948446|FG000|Overall Study|Missing|1|||
124813386|NCT00688753|448948446|FG000|Overall Study|Death|9|||
124813387|NCT00688753|448948446|FG000|Overall Study|Withdrawal by Subject|3|||
124813388|NCT00688753|448948446|FG000|Overall Study|Adverse Event|20|||
124813389|NCT00688753|448948446|FG000|Overall Study|Protocol Violation|1|||
124813390|NCT00688753|448948446|FG000|Overall Study|Lost to Follow-up|3|||
124813391|NCT03749447|448948447|FG000|Overall Study|Adverse Event|11|||
124813392|NCT03749447|448948448|FG001|Overall Study|Adverse Event|3|||
124813393|NCT03749447|448948447|FG000|Overall Study|Death|1|||
124813394|NCT03749447|448948448|FG001|Overall Study|Death|1|||
124813395|NCT03749447|448948447|FG000|Overall Study|Lost to Follow-up|2|||
124813396|NCT03749447|448948448|FG001|Overall Study|Lost to Follow-up|2|||
124813397|NCT03749447|448948447|FG000|Overall Study|Reason Not Specified|0|||
124813398|NCT03749447|448948448|FG001|Overall Study|Reason Not Specified|3|||
124813399|NCT03749447|448948447|FG000|Overall Study|Physician Decision|4|||
124813400|NCT03749447|448948448|FG001|Overall Study|Physician Decision|3|||
124813401|NCT03749447|448948447|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
124813402|NCT03749447|448948448|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
124813403|NCT03749447|448948447|FG000|Overall Study|Study Terminated By Sponsor|112|||
124813404|NCT03749447|448948448|FG001|Overall Study|Study Terminated By Sponsor|105|||
124813405|NCT03749447|448948447|FG000|Overall Study|Withdrawal by Subject|12|||
124813406|NCT03749447|448948448|FG001|Overall Study|Withdrawal by Subject|6|||
124813407|NCT03749447|448948447|FG000|Overall Study|Non-compliance With Study Drug|0|||
124813408|NCT03749447|448948448|FG001|Overall Study|Non-compliance With Study Drug|1|||
124813409|NCT05996718|448948449|FG000|Overall Study|Lost to Follow-up|3|||
124813410|NCT01218113|448948450|FG000|Overall Study|Withdrawal by Subject|1|||
124813411|NCT01218113|448948451|FG001|Overall Study|Withdrawal by Subject|0|||
124813412|NCT01218113|448948452|FG002|Overall Study|Withdrawal by Subject|1|||
124813413|NCT01218113|448948450|FG000|Overall Study|Lost to Follow-up|4|||
124813414|NCT01218113|448948451|FG001|Overall Study|Lost to Follow-up|1|||
124813415|NCT01218113|448948452|FG002|Overall Study|Lost to Follow-up|4|||
124813416|NCT01218113|448948450|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
124813417|NCT01218113|448948451|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
124813418|NCT01218113|448948452|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
124813419|NCT01713686|448948453|FG000|Overall Study|Lost to Follow-up|9|||
124813420|NCT01713686|448948453|FG000|Overall Study|Withdrawal by Subject|6|||
124813421|NCT04840615|448948454|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
124813422|NCT04840615|448948455|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
124813423|NCT04840615|448948456|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
124813424|NCT00967668|448948457|FG000|Overall Study|Withdrawal by Subject|13|||
124813425|NCT00967668|448948458|FG001|Overall Study|Withdrawal by Subject|8|||
124813426|NCT00967668|448948459|FG002|Overall Study|Withdrawal by Subject|8|||
124813427|NCT00967668|448948457|FG000|Overall Study|Death|0|||
124813428|NCT00967668|448948458|FG001|Overall Study|Death|2|||
124813429|NCT00967668|448948459|FG002|Overall Study|Death|4|||
124813430|NCT00967668|448948457|FG000|Overall Study|Removed due to behavior|1|||
124813431|NCT00967668|448948458|FG001|Overall Study|Removed due to behavior|1|||
124813432|NCT00967668|448948459|FG002|Overall Study|Removed due to behavior|2|||
124813433|NCT00967668|448948457|FG000|Overall Study|Refused Year 2|11|||
124813434|NCT00967668|448948458|FG001|Overall Study|Refused Year 2|6|||
124813435|NCT00967668|448948459|FG002|Overall Study|Refused Year 2|4|||
124813436|NCT00967668|448948457|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
124813437|NCT00967668|448948458|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
124813438|NCT00967668|448948459|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
124813439|NCT00967668|448948457|FG000|Overall Study|Lost to Follow-up|15|||
124813440|NCT00967668|448948458|FG001|Overall Study|Lost to Follow-up|9|||
124813441|NCT00967668|448948459|FG002|Overall Study|Lost to Follow-up|16|||
124813442|NCT00967668|448948457|FG000|Overall Study|Refused 12-mo assessment|3|||
124813443|NCT00967668|448948458|FG001|Overall Study|Refused 12-mo assessment|1|||
124813444|NCT00967668|448948459|FG002|Overall Study|Refused 12-mo assessment|9|||
124813445|NCT00967668|448948457|FG000|Overall Study|Pregnancy|1|||
124813446|NCT00967668|448948458|FG001|Overall Study|Pregnancy|0|||
124813447|NCT00967668|448948459|FG002|Overall Study|Pregnancy|0|||
124813448|NCT00115739|448948460|FG000|Overall Study|Lost to Follow-up|3|||
124813449|NCT02200211|448948463|FG000|Overall Study|Lost to Follow-up|7|||
124813450|NCT02200211|448948464|FG001|Overall Study|Lost to Follow-up|7|||
124813451|NCT02200211|448948465|FG002|Overall Study|Lost to Follow-up|1|||
124813452|NCT02200211|448948466|FG003|Overall Study|Lost to Follow-up|2|||
124813453|NCT02200211|448948463|FG000|Overall Study|Withdrawal by Subject|1|||
124813454|NCT02200211|448948464|FG001|Overall Study|Withdrawal by Subject|0|||
124813455|NCT02200211|448948465|FG002|Overall Study|Withdrawal by Subject|0|||
124813456|NCT02200211|448948466|FG003|Overall Study|Withdrawal by Subject|0|||
124813457|NCT01918774|448948467|FG000|Overall Study|Lost prior to first CBTw session|4|||
124813458|NCT01918774|448948467|FG000|Overall Study|Lost to Follow-up|1|||
124813459|NCT01606800|448948468|FG000|Overall Study|Adverse Event|3|||
124813460|NCT01606800|448948469|FG001|Overall Study|Adverse Event|1|||
124813461|NCT01606800|448948468|FG000|Overall Study|Participant withdrew consent|0|||
124813462|NCT01606800|448948469|FG001|Overall Study|Participant withdrew consent|1|||
124813463|NCT01606800|448948468|FG000|Overall Study|Missing completion status|2|||
124813464|NCT01606800|448948469|FG001|Overall Study|Missing completion status|0|||
124813465|NCT00042289|448948470|FG000|Overall Study|Lost to Follow-up|3|||
124813466|NCT00042289|448948471|FG001|Overall Study|Lost to Follow-up|0|||
124813467|NCT00042289|448948472|FG002|Overall Study|Lost to Follow-up|0|||
124813468|NCT00042289|448948473|FG003|Overall Study|Lost to Follow-up|1|||
124813469|NCT00042289|448948474|FG004|Overall Study|Lost to Follow-up|3|||
124813470|NCT00042289|448948475|FG005|Overall Study|Lost to Follow-up|3|||
124813471|NCT00042289|448948476|FG006|Overall Study|Lost to Follow-up|6|||
124813472|NCT00042289|448948477|FG007|Overall Study|Lost to Follow-up|1|||
124813473|NCT00042289|448948478|FG008|Overall Study|Lost to Follow-up|1|||
124813474|NCT00042289|448948479|FG009|Overall Study|Lost to Follow-up|0|||
124813475|NCT00042289|448948480|FG010|Overall Study|Lost to Follow-up|0|||
124813476|NCT00042289|448948481|FG011|Overall Study|Lost to Follow-up|0|||
124813477|NCT00042289|448948482|FG012|Overall Study|Lost to Follow-up|0|||
124813478|NCT00042289|448948483|FG013|Overall Study|Lost to Follow-up|0|||
124813479|NCT00042289|448948484|FG014|Overall Study|Lost to Follow-up|0|||
124813480|NCT00042289|448948485|FG015|Overall Study|Lost to Follow-up|1|||
124813481|NCT00042289|448948486|FG016|Overall Study|Lost to Follow-up|1|||
124813482|NCT00042289|448948487|FG017|Overall Study|Lost to Follow-up|0|||
124813483|NCT00042289|448948488|FG018|Overall Study|Lost to Follow-up|3|||
124813484|NCT00042289|448948489|FG019|Overall Study|Lost to Follow-up|2|||
124813485|NCT00042289|448948490|FG020|Overall Study|Lost to Follow-up|0|||
124813486|NCT00042289|448948491|FG021|Overall Study|Lost to Follow-up|0|||
124813487|NCT00042289|448948492|FG022|Overall Study|Lost to Follow-up|0|||
124813488|NCT00042289|448948493|FG023|Overall Study|Lost to Follow-up|0|||
124813489|NCT00042289|448948494|FG024|Overall Study|Lost to Follow-up|0|||
124813490|NCT00042289|448948495|FG025|Overall Study|Lost to Follow-up|0|||
124813491|NCT00042289|448948496|FG026|Overall Study|Lost to Follow-up|2|||
124813492|NCT00042289|448948497|FG027|Overall Study|Lost to Follow-up|2|||
124813493|NCT00042289|448948498|FG028|Overall Study|Lost to Follow-up|2|||
124813494|NCT00042289|448948499|FG029|Overall Study|Lost to Follow-up|0|||
124813495|NCT00042289|448948500|FG030|Overall Study|Lost to Follow-up|0|||
124813496|NCT00042289|448948501|FG031|Overall Study|Lost to Follow-up|2|||
124813497|NCT00042289|448948502|FG032|Overall Study|Lost to Follow-up|1|||
124813498|NCT00042289|448948503|FG033|Overall Study|Lost to Follow-up|1|||
124813499|NCT00042289|448948504|FG034|Overall Study|Lost to Follow-up|1|||
124813500|NCT00042289|448948505|FG035|Overall Study|Lost to Follow-up|2|||
124813501|NCT00042289|448948506|FG036|Overall Study|Lost to Follow-up|1|||
124813502|NCT00042289|448948507|FG037|Overall Study|Lost to Follow-up|1|||
124813503|NCT00042289|448948508|FG038|Overall Study|Lost to Follow-up|0|||
124813504|NCT00042289|448948509|FG039|Overall Study|Lost to Follow-up|5|||
124813505|NCT00042289|448948510|FG040|Overall Study|Lost to Follow-up|0|||
124813506|NCT00042289|448948511|FG041|Overall Study|Lost to Follow-up|2|||
124813507|NCT00042289|448948512|FG042|Overall Study|Lost to Follow-up|2|||
124813508|NCT00042289|448948513|FG043|Overall Study|Lost to Follow-up|0|||
124813509|NCT00042289|448948514|FG044|Overall Study|Lost to Follow-up|0|||
124813510|NCT00042289|448948515|FG045|Overall Study|Lost to Follow-up|1|||
124813511|NCT00042289|448948516|FG046|Overall Study|Lost to Follow-up|0|||
124813512|NCT00042289|448948470|FG000|Overall Study|Other reason|0|||
124813513|NCT00042289|448948471|FG001|Overall Study|Other reason|0|||
124813514|NCT00042289|448948472|FG002|Overall Study|Other reason|0|||
124813515|NCT00042289|448948473|FG003|Overall Study|Other reason|2|||
124813516|NCT00042289|448948474|FG004|Overall Study|Other reason|0|||
124813517|NCT00042289|448948475|FG005|Overall Study|Other reason|0|||
124813518|NCT00042289|448948476|FG006|Overall Study|Other reason|0|||
124813519|NCT00042289|448948477|FG007|Overall Study|Other reason|0|||
124813520|NCT00042289|448948478|FG008|Overall Study|Other reason|0|||
124813521|NCT00042289|448948479|FG009|Overall Study|Other reason|0|||
124813522|NCT00042289|448948480|FG010|Overall Study|Other reason|0|||
124813523|NCT00042289|448948481|FG011|Overall Study|Other reason|0|||
124813524|NCT00042289|448948482|FG012|Overall Study|Other reason|0|||
124813525|NCT00042289|448948483|FG013|Overall Study|Other reason|0|||
124813526|NCT00042289|448948484|FG014|Overall Study|Other reason|0|||
124813527|NCT00042289|448948485|FG015|Overall Study|Other reason|0|||
124813528|NCT00042289|448948486|FG016|Overall Study|Other reason|0|||
124813529|NCT00042289|448948487|FG017|Overall Study|Other reason|0|||
124813530|NCT00042289|448948488|FG018|Overall Study|Other reason|1|||
124813531|NCT00042289|448948489|FG019|Overall Study|Other reason|0|||
124813532|NCT00042289|448948490|FG020|Overall Study|Other reason|0|||
124813533|NCT00042289|448948491|FG021|Overall Study|Other reason|0|||
124813534|NCT00042289|448948492|FG022|Overall Study|Other reason|0|||
124813535|NCT00042289|448948493|FG023|Overall Study|Other reason|1|||
124813536|NCT00042289|448948494|FG024|Overall Study|Other reason|0|||
124813537|NCT00042289|448948495|FG025|Overall Study|Other reason|0|||
124813538|NCT00042289|448948496|FG026|Overall Study|Other reason|1|||
124813539|NCT00042289|448948497|FG027|Overall Study|Other reason|0|||
124813540|NCT00042289|448948498|FG028|Overall Study|Other reason|3|||
124813541|NCT00042289|448948499|FG029|Overall Study|Other reason|0|||
124813542|NCT00042289|448948500|FG030|Overall Study|Other reason|0|||
124813543|NCT00042289|448948501|FG031|Overall Study|Other reason|1|||
124813544|NCT00042289|448948502|FG032|Overall Study|Other reason|0|||
124813545|NCT00042289|448948503|FG033|Overall Study|Other reason|1|||
124813546|NCT00042289|448948504|FG034|Overall Study|Other reason|0|||
124813547|NCT00042289|448948505|FG035|Overall Study|Other reason|2|||
124813548|NCT00042289|448948506|FG036|Overall Study|Other reason|0|||
124813549|NCT00042289|448948507|FG037|Overall Study|Other reason|0|||
124813550|NCT00042289|448948508|FG038|Overall Study|Other reason|0|||
124813551|NCT00042289|448948509|FG039|Overall Study|Other reason|0|||
124813552|NCT00042289|448948510|FG040|Overall Study|Other reason|0|||
124813553|NCT00042289|448948511|FG041|Overall Study|Other reason|0|||
124813554|NCT00042289|448948512|FG042|Overall Study|Other reason|0|||
124813555|NCT00042289|448948513|FG043|Overall Study|Other reason|1|||
124813556|NCT00042289|448948514|FG044|Overall Study|Other reason|0|||
124813557|NCT00042289|448948515|FG045|Overall Study|Other reason|0|||
124813558|NCT00042289|448948516|FG046|Overall Study|Other reason|0|||
124813559|NCT00042289|448948470|FG000|Overall Study|Severe debilitation, unable to continue|0|||
124813560|NCT00042289|448948471|FG001|Overall Study|Severe debilitation, unable to continue|0|||
124813561|NCT00042289|448948472|FG002|Overall Study|Severe debilitation, unable to continue|0|||
124813562|NCT00042289|448948473|FG003|Overall Study|Severe debilitation, unable to continue|0|||
124813563|NCT00042289|448948474|FG004|Overall Study|Severe debilitation, unable to continue|0|||
124813564|NCT00042289|448948475|FG005|Overall Study|Severe debilitation, unable to continue|0|||
124813565|NCT00042289|448948476|FG006|Overall Study|Severe debilitation, unable to continue|0|||
124813566|NCT00042289|448948477|FG007|Overall Study|Severe debilitation, unable to continue|0|||
124813567|NCT00042289|448948478|FG008|Overall Study|Severe debilitation, unable to continue|0|||
124813568|NCT00042289|448948479|FG009|Overall Study|Severe debilitation, unable to continue|0|||
124813569|NCT00042289|448948480|FG010|Overall Study|Severe debilitation, unable to continue|0|||
124813570|NCT00042289|448948481|FG011|Overall Study|Severe debilitation, unable to continue|0|||
124813571|NCT00042289|448948482|FG012|Overall Study|Severe debilitation, unable to continue|0|||
124813572|NCT00042289|448948483|FG013|Overall Study|Severe debilitation, unable to continue|0|||
124813573|NCT00042289|448948484|FG014|Overall Study|Severe debilitation, unable to continue|0|||
124813574|NCT00042289|448948485|FG015|Overall Study|Severe debilitation, unable to continue|0|||
124813575|NCT00042289|448948486|FG016|Overall Study|Severe debilitation, unable to continue|0|||
124813576|NCT00042289|448948487|FG017|Overall Study|Severe debilitation, unable to continue|0|||
124813577|NCT00042289|448948488|FG018|Overall Study|Severe debilitation, unable to continue|0|||
124813578|NCT00042289|448948489|FG019|Overall Study|Severe debilitation, unable to continue|0|||
124813579|NCT00042289|448948490|FG020|Overall Study|Severe debilitation, unable to continue|0|||
124813580|NCT00042289|448948491|FG021|Overall Study|Severe debilitation, unable to continue|1|||
125302047|NCT00098306|450731906|FG003|Observational Phase|Un-specified|0|||
125302048|NCT00098306|450731907|FG004|Observational Phase|Un-specified|0|||
125302049|NCT00098306|450731908|FG005|Observational Phase|Un-specified|7|||
125302050|NCT00098306|450731909|FG006|Observational Phase|Un-specified|4|||
125302051|NCT00932165|450731910|FG000|Overall Study|Lost to Follow-up|1|||
125302052|NCT00588094|450731911|FG000|Overall Study|Adverse Event|3|||
125302053|NCT00588094|450731911|FG000|Overall Study|Progression of Disease|2|||
125302054|NCT01336023|450731912|FG000|Week 0 to Week 26|Adverse Event|8|||
125302055|NCT01336023|450731913|FG001|Week 0 to Week 26|Adverse Event|10|||
125302056|NCT01336023|450731914|FG002|Week 0 to Week 26|Adverse Event|24|||
124813581|NCT00042289|448948492|FG022|Overall Study|Severe debilitation, unable to continue|0|||
124813582|NCT00042289|448948493|FG023|Overall Study|Severe debilitation, unable to continue|1|||
124813583|NCT00042289|448948494|FG024|Overall Study|Severe debilitation, unable to continue|0|||
124813584|NCT00042289|448948495|FG025|Overall Study|Severe debilitation, unable to continue|0|||
125302057|NCT01336023|450731912|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
125302058|NCT01336023|450731913|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
125302059|NCT01336023|450731914|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
125302060|NCT01336023|450731912|FG000|Week 0 to Week 26|Protocol Violation|1|||
124813585|NCT00042289|448948496|FG026|Overall Study|Severe debilitation, unable to continue|0|||
124813586|NCT00042289|448948497|FG027|Overall Study|Severe debilitation, unable to continue|1|||
124813587|NCT00042289|448948498|FG028|Overall Study|Severe debilitation, unable to continue|0|||
124813588|NCT00042289|448948499|FG029|Overall Study|Severe debilitation, unable to continue|0|||
124813589|NCT00042289|448948500|FG030|Overall Study|Severe debilitation, unable to continue|0|||
124813590|NCT00042289|448948501|FG031|Overall Study|Severe debilitation, unable to continue|1|||
124813591|NCT00042289|448948502|FG032|Overall Study|Severe debilitation, unable to continue|1|||
124813592|NCT00042289|448948503|FG033|Overall Study|Severe debilitation, unable to continue|0|||
124813593|NCT00042289|448948504|FG034|Overall Study|Severe debilitation, unable to continue|0|||
124813594|NCT00042289|448948505|FG035|Overall Study|Severe debilitation, unable to continue|0|||
124813595|NCT00042289|448948506|FG036|Overall Study|Severe debilitation, unable to continue|0|||
124813596|NCT00042289|448948507|FG037|Overall Study|Severe debilitation, unable to continue|0|||
124813597|NCT00042289|448948508|FG038|Overall Study|Severe debilitation, unable to continue|0|||
124813598|NCT00042289|448948509|FG039|Overall Study|Severe debilitation, unable to continue|0|||
124813599|NCT00042289|448948510|FG040|Overall Study|Severe debilitation, unable to continue|0|||
124813600|NCT00042289|448948511|FG041|Overall Study|Severe debilitation, unable to continue|0|||
124813601|NCT00042289|448948512|FG042|Overall Study|Severe debilitation, unable to continue|0|||
124813602|NCT00042289|448948513|FG043|Overall Study|Severe debilitation, unable to continue|0|||
124813603|NCT00042289|448948514|FG044|Overall Study|Severe debilitation, unable to continue|0|||
124813604|NCT00042289|448948515|FG045|Overall Study|Severe debilitation, unable to continue|0|||
124813605|NCT00042289|448948516|FG046|Overall Study|Severe debilitation, unable to continue|0|||
124813606|NCT00042289|448948470|FG000|Overall Study|Site closed|0|||
124813607|NCT00042289|448948471|FG001|Overall Study|Site closed|0|||
124813608|NCT00042289|448948472|FG002|Overall Study|Site closed|0|||
124813609|NCT00042289|448948473|FG003|Overall Study|Site closed|0|||
124813610|NCT00042289|448948474|FG004|Overall Study|Site closed|0|||
124813611|NCT00042289|448948475|FG005|Overall Study|Site closed|0|||
124813612|NCT00042289|448948476|FG006|Overall Study|Site closed|0|||
124813613|NCT00042289|448948477|FG007|Overall Study|Site closed|0|||
124813614|NCT00042289|448948478|FG008|Overall Study|Site closed|0|||
124813615|NCT00042289|448948479|FG009|Overall Study|Site closed|0|||
124813616|NCT00042289|448948480|FG010|Overall Study|Site closed|0|||
124813617|NCT00042289|448948481|FG011|Overall Study|Site closed|0|||
124813618|NCT00042289|448948482|FG012|Overall Study|Site closed|0|||
124813619|NCT00042289|448948483|FG013|Overall Study|Site closed|0|||
124813620|NCT00042289|448948484|FG014|Overall Study|Site closed|0|||
124813621|NCT00042289|448948485|FG015|Overall Study|Site closed|0|||
124813622|NCT00042289|448948486|FG016|Overall Study|Site closed|0|||
124813623|NCT00042289|448948487|FG017|Overall Study|Site closed|0|||
124813624|NCT00042289|448948488|FG018|Overall Study|Site closed|0|||
124813625|NCT00042289|448948489|FG019|Overall Study|Site closed|0|||
124813626|NCT00042289|448948490|FG020|Overall Study|Site closed|0|||
124813627|NCT00042289|448948491|FG021|Overall Study|Site closed|0|||
124813628|NCT00042289|448948492|FG022|Overall Study|Site closed|0|||
124813629|NCT00042289|448948493|FG023|Overall Study|Site closed|0|||
124813630|NCT00042289|448948494|FG024|Overall Study|Site closed|0|||
124813631|NCT00042289|448948495|FG025|Overall Study|Site closed|0|||
124813632|NCT00042289|448948496|FG026|Overall Study|Site closed|0|||
124813633|NCT00042289|448948497|FG027|Overall Study|Site closed|0|||
124813634|NCT00042289|448948498|FG028|Overall Study|Site closed|0|||
124813635|NCT00042289|448948499|FG029|Overall Study|Site closed|0|||
124813636|NCT00042289|448948500|FG030|Overall Study|Site closed|0|||
124813637|NCT00042289|448948501|FG031|Overall Study|Site closed|3|||
124813638|NCT00042289|448948502|FG032|Overall Study|Site closed|0|||
124813639|NCT00042289|448948503|FG033|Overall Study|Site closed|0|||
124813640|NCT00042289|448948504|FG034|Overall Study|Site closed|0|||
124813641|NCT00042289|448948505|FG035|Overall Study|Site closed|0|||
124813642|NCT00042289|448948506|FG036|Overall Study|Site closed|1|||
124813643|NCT00042289|448948507|FG037|Overall Study|Site closed|0|||
124813644|NCT00042289|448948508|FG038|Overall Study|Site closed|0|||
124813645|NCT00042289|448948509|FG039|Overall Study|Site closed|0|||
124813646|NCT00042289|448948510|FG040|Overall Study|Site closed|0|||
124813647|NCT00042289|448948511|FG041|Overall Study|Site closed|0|||
125302061|NCT01336023|450731913|FG001|Week 0 to Week 26|Protocol Violation|2|||
125302062|NCT01336023|450731914|FG002|Week 0 to Week 26|Protocol Violation|0|||
124813648|NCT00042289|448948512|FG042|Overall Study|Site closed|1|||
125302063|NCT01336023|450731912|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
125302064|NCT01336023|450731913|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
124813649|NCT00042289|448948513|FG043|Overall Study|Site closed|0|||
124813650|NCT00042289|448948514|FG044|Overall Study|Site closed|0|||
124813651|NCT00042289|448948515|FG045|Overall Study|Site closed|0|||
124813652|NCT00042289|448948516|FG046|Overall Study|Site closed|0|||
124813653|NCT00042289|448948470|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
125302065|NCT01336023|450731914|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
124813654|NCT00042289|448948471|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
124813655|NCT00042289|448948472|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
124813656|NCT00042289|448948473|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
124813657|NCT00042289|448948474|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
124813658|NCT00042289|448948475|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
124813659|NCT00042289|448948476|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
124813660|NCT00042289|448948477|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
124813661|NCT00042289|448948478|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
124813662|NCT00042289|448948479|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
124813663|NCT00042289|448948480|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
124813664|NCT00042289|448948481|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
124813665|NCT00042289|448948482|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
124813666|NCT00042289|448948483|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
124813667|NCT00042289|448948484|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
124813668|NCT00042289|448948485|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
124813669|NCT00042289|448948486|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
124813670|NCT00042289|448948487|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
124813671|NCT00042289|448948488|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
124813672|NCT00042289|448948489|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
124813673|NCT00042289|448948490|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
124813674|NCT00042289|448948491|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
124813675|NCT00042289|448948492|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
124813676|NCT00042289|448948493|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
124813677|NCT00042289|448948494|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
124813678|NCT00042289|448948495|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
124813679|NCT00042289|448948496|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
124813680|NCT00042289|448948497|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
124813681|NCT00042289|448948498|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
124813682|NCT00042289|448948499|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
124813683|NCT00042289|448948500|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
124813684|NCT00042289|448948501|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
124813685|NCT00042289|448948502|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
124813686|NCT00042289|448948503|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
124813687|NCT00042289|448948504|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
124813688|NCT00042289|448948505|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
124813689|NCT00042289|448948506|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
124813690|NCT00042289|448948507|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
124813691|NCT00042289|448948508|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
124813692|NCT00042289|448948509|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
124813693|NCT00042289|448948510|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
124813694|NCT00042289|448948511|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
124813695|NCT00042289|448948512|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
124813696|NCT00042289|448948513|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
124813697|NCT00042289|448948514|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
124813698|NCT00042289|448948515|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
124813699|NCT00042289|448948516|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
124813700|NCT00042289|448948470|FG000|Overall Study|Protocol Violation|0|||
124813701|NCT00042289|448948471|FG001|Overall Study|Protocol Violation|0|||
124813702|NCT00042289|448948472|FG002|Overall Study|Protocol Violation|0|||
124813703|NCT00042289|448948473|FG003|Overall Study|Protocol Violation|0|||
124813704|NCT00042289|448948474|FG004|Overall Study|Protocol Violation|0|||
124813705|NCT00042289|448948475|FG005|Overall Study|Protocol Violation|1|||
124813706|NCT00042289|448948476|FG006|Overall Study|Protocol Violation|0|||
124813707|NCT00042289|448948477|FG007|Overall Study|Protocol Violation|1|||
124813708|NCT00042289|448948478|FG008|Overall Study|Protocol Violation|0|||
124813709|NCT00042289|448948479|FG009|Overall Study|Protocol Violation|0|||
124813710|NCT00042289|448948480|FG010|Overall Study|Protocol Violation|0|||
124813711|NCT00042289|448948481|FG011|Overall Study|Protocol Violation|0|||
124813712|NCT00042289|448948482|FG012|Overall Study|Protocol Violation|0|||
124813713|NCT00042289|448948483|FG013|Overall Study|Protocol Violation|0|||
124813714|NCT00042289|448948484|FG014|Overall Study|Protocol Violation|0|||
124813715|NCT00042289|448948485|FG015|Overall Study|Protocol Violation|0|||
124813716|NCT00042289|448948486|FG016|Overall Study|Protocol Violation|0|||
124813717|NCT00042289|448948487|FG017|Overall Study|Protocol Violation|0|||
124813718|NCT00042289|448948488|FG018|Overall Study|Protocol Violation|0|||
124813719|NCT00042289|448948489|FG019|Overall Study|Protocol Violation|0|||
124813720|NCT00042289|448948490|FG020|Overall Study|Protocol Violation|0|||
124813721|NCT00042289|448948491|FG021|Overall Study|Protocol Violation|0|||
124813722|NCT00042289|448948492|FG022|Overall Study|Protocol Violation|0|||
124813723|NCT00042289|448948493|FG023|Overall Study|Protocol Violation|1|||
124813724|NCT00042289|448948494|FG024|Overall Study|Protocol Violation|1|||
124813725|NCT00042289|448948495|FG025|Overall Study|Protocol Violation|0|||
124813726|NCT00042289|448948496|FG026|Overall Study|Protocol Violation|2|||
124813727|NCT00042289|448948497|FG027|Overall Study|Protocol Violation|0|||
124813728|NCT00042289|448948498|FG028|Overall Study|Protocol Violation|0|||
124813729|NCT00042289|448948499|FG029|Overall Study|Protocol Violation|0|||
124813730|NCT00042289|448948500|FG030|Overall Study|Protocol Violation|1|||
124813731|NCT00042289|448948501|FG031|Overall Study|Protocol Violation|0|||
124813732|NCT00042289|448948502|FG032|Overall Study|Protocol Violation|0|||
124813733|NCT00042289|448948503|FG033|Overall Study|Protocol Violation|0|||
124813734|NCT00042289|448948504|FG034|Overall Study|Protocol Violation|0|||
124813735|NCT00042289|448948505|FG035|Overall Study|Protocol Violation|0|||
124813736|NCT00042289|448948506|FG036|Overall Study|Protocol Violation|0|||
124813737|NCT00042289|448948507|FG037|Overall Study|Protocol Violation|0|||
124813738|NCT00042289|448948508|FG038|Overall Study|Protocol Violation|0|||
124813739|NCT00042289|448948509|FG039|Overall Study|Protocol Violation|0|||
124813740|NCT00042289|448948510|FG040|Overall Study|Protocol Violation|0|||
124813741|NCT00042289|448948511|FG041|Overall Study|Protocol Violation|1|||
124813742|NCT00042289|448948512|FG042|Overall Study|Protocol Violation|1|||
124813743|NCT00042289|448948513|FG043|Overall Study|Protocol Violation|1|||
124813744|NCT00042289|448948514|FG044|Overall Study|Protocol Violation|0|||
124813745|NCT00042289|448948515|FG045|Overall Study|Protocol Violation|0|||
124813746|NCT00042289|448948516|FG046|Overall Study|Protocol Violation|0|||
124813747|NCT00042289|448948470|FG000|Overall Study|Withdrawal by Subject|4|||
124813748|NCT00042289|448948471|FG001|Overall Study|Withdrawal by Subject|1|||
124813749|NCT00042289|448948472|FG002|Overall Study|Withdrawal by Subject|0|||
124813750|NCT00042289|448948473|FG003|Overall Study|Withdrawal by Subject|2|||
124813751|NCT00042289|448948474|FG004|Overall Study|Withdrawal by Subject|0|||
124813752|NCT00042289|448948475|FG005|Overall Study|Withdrawal by Subject|2|||
124813753|NCT00042289|448948476|FG006|Overall Study|Withdrawal by Subject|0|||
124813754|NCT00042289|448948477|FG007|Overall Study|Withdrawal by Subject|0|||
124813755|NCT00042289|448948478|FG008|Overall Study|Withdrawal by Subject|0|||
124813756|NCT00042289|448948479|FG009|Overall Study|Withdrawal by Subject|1|||
124813757|NCT00042289|448948480|FG010|Overall Study|Withdrawal by Subject|0|||
124813758|NCT00042289|448948481|FG011|Overall Study|Withdrawal by Subject|0|||
124813759|NCT00042289|448948482|FG012|Overall Study|Withdrawal by Subject|2|||
124813760|NCT00042289|448948483|FG013|Overall Study|Withdrawal by Subject|0|||
124813761|NCT00042289|448948484|FG014|Overall Study|Withdrawal by Subject|0|||
124813762|NCT00042289|448948485|FG015|Overall Study|Withdrawal by Subject|0|||
124813763|NCT00042289|448948486|FG016|Overall Study|Withdrawal by Subject|0|||
124813764|NCT00042289|448948487|FG017|Overall Study|Withdrawal by Subject|0|||
124813765|NCT00042289|448948488|FG018|Overall Study|Withdrawal by Subject|0|||
124813766|NCT00042289|448948489|FG019|Overall Study|Withdrawal by Subject|0|||
124813767|NCT00042289|448948490|FG020|Overall Study|Withdrawal by Subject|0|||
124813768|NCT00042289|448948491|FG021|Overall Study|Withdrawal by Subject|1|||
124813769|NCT00042289|448948492|FG022|Overall Study|Withdrawal by Subject|1|||
124813770|NCT00042289|448948493|FG023|Overall Study|Withdrawal by Subject|1|||
124813771|NCT00042289|448948494|FG024|Overall Study|Withdrawal by Subject|0|||
124813772|NCT00042289|448948495|FG025|Overall Study|Withdrawal by Subject|0|||
124813773|NCT00042289|448948496|FG026|Overall Study|Withdrawal by Subject|1|||
124813774|NCT00042289|448948497|FG027|Overall Study|Withdrawal by Subject|0|||
124813775|NCT00042289|448948498|FG028|Overall Study|Withdrawal by Subject|2|||
124813776|NCT00042289|448948499|FG029|Overall Study|Withdrawal by Subject|0|||
124813777|NCT00042289|448948500|FG030|Overall Study|Withdrawal by Subject|0|||
124813778|NCT00042289|448948501|FG031|Overall Study|Withdrawal by Subject|1|||
124813779|NCT00042289|448948502|FG032|Overall Study|Withdrawal by Subject|2|||
124813780|NCT00042289|448948503|FG033|Overall Study|Withdrawal by Subject|1|||
125302066|NCT01336023|450731912|FG000|Week 0 to Week 26|Unclassified|5|||
125302067|NCT01336023|450731913|FG001|Week 0 to Week 26|Unclassified|16|||
125302068|NCT01336023|450731914|FG002|Week 0 to Week 26|Unclassified|9|||
125302069|NCT01336023|450731912|FG000|Week 27 to 52|Adverse Event|1|||
125302070|NCT01336023|450731913|FG001|Week 27 to 52|Adverse Event|5|||
125302071|NCT01336023|450731914|FG002|Week 27 to 52|Adverse Event|2|||
125302072|NCT01336023|450731912|FG000|Week 27 to 52|Protocol Violation|0|||
125302073|NCT01336023|450731913|FG001|Week 27 to 52|Protocol Violation|2|||
125302074|NCT01336023|450731914|FG002|Week 27 to 52|Protocol Violation|1|||
124813781|NCT00042289|448948504|FG034|Overall Study|Withdrawal by Subject|0|||
124813782|NCT00042289|448948505|FG035|Overall Study|Withdrawal by Subject|0|||
124813783|NCT00042289|448948506|FG036|Overall Study|Withdrawal by Subject|0|||
124813784|NCT00042289|448948507|FG037|Overall Study|Withdrawal by Subject|1|||
124813785|NCT00042289|448948508|FG038|Overall Study|Withdrawal by Subject|0|||
124813786|NCT00042289|448948509|FG039|Overall Study|Withdrawal by Subject|0|||
124813787|NCT00042289|448948510|FG040|Overall Study|Withdrawal by Subject|0|||
125302075|NCT01336023|450731912|FG000|Week 27 to 52|Withdrawal Criteria|14|||
124813788|NCT00042289|448948511|FG041|Overall Study|Withdrawal by Subject|0|||
124813789|NCT00042289|448948512|FG042|Overall Study|Withdrawal by Subject|1|||
124813790|NCT00042289|448948513|FG043|Overall Study|Withdrawal by Subject|0|||
124813791|NCT00042289|448948514|FG044|Overall Study|Withdrawal by Subject|0|||
124813792|NCT00042289|448948515|FG045|Overall Study|Withdrawal by Subject|0|||
125302076|NCT01336023|450731913|FG001|Week 27 to 52|Withdrawal Criteria|19|||
125302077|NCT01336023|450731914|FG002|Week 27 to 52|Withdrawal Criteria|16|||
125302078|NCT01336023|450731912|FG000|Week 27 to 52|Unclassified|13|||
125302079|NCT01336023|450731913|FG001|Week 27 to 52|Unclassified|18|||
124813793|NCT00042289|448948516|FG046|Overall Study|Withdrawal by Subject|0|||
124813794|NCT00745823|448948517|FG000|Overall Study|Adverse Event|5|||
124813795|NCT00745823|448948518|FG001|Overall Study|Adverse Event|3|||
124813796|NCT00745823|448948517|FG000|Overall Study|Lack of Efficacy|20|||
124813797|NCT00745823|448948518|FG001|Overall Study|Lack of Efficacy|6|||
124813798|NCT00745823|448948517|FG000|Overall Study|Lost to Follow-up|10|||
124813799|NCT00745823|448948518|FG001|Overall Study|Lost to Follow-up|11|||
124813800|NCT00745823|448948517|FG000|Overall Study|Physician Decision|10|||
124813801|NCT00745823|448948518|FG001|Overall Study|Physician Decision|5|||
124813802|NCT00745823|448948517|FG000|Overall Study|Pregnancy|0|||
124813803|NCT00745823|448948518|FG001|Overall Study|Pregnancy|4|||
124813804|NCT00745823|448948517|FG000|Overall Study|Withdrawal by Subject|14|||
124813805|NCT00745823|448948518|FG001|Overall Study|Withdrawal by Subject|8|||
124813806|NCT00745823|448948517|FG000|Overall Study|Study Terminated by Sponsor|326|||
124813807|NCT00745823|448948518|FG001|Overall Study|Study Terminated by Sponsor|349|||
124813808|NCT01687998|448948519|FG000|Overall Study|Withdrawal by Subject|49|||
124813809|NCT01687998|448948520|FG001|Overall Study|Withdrawal by Subject|51|||
124813810|NCT01687998|448948519|FG000|Overall Study|Known to be Alive at Study End|54|||
124813811|NCT01687998|448948520|FG001|Overall Study|Known to be Alive at Study End|62|||
124813812|NCT01687998|448948519|FG000|Overall Study|Lost to Follow-up|9|||
124813813|NCT01687998|448948520|FG001|Overall Study|Lost to Follow-up|7|||
124813814|NCT00717197|448948527|FG000|Overall Study|Unable to purchase study drug|5|||
124813815|NCT00717197|448948527|FG000|Overall Study|Tumor Progression|1|||
124813816|NCT00717197|448948527|FG000|Overall Study|Physician Decision|1|||
124813817|NCT00982137|448948528|FG000|Overall Study|Lost to Follow-up|0|||
124813818|NCT00982137|448948529|FG001|Overall Study|Lost to Follow-up|0|||
124813819|NCT00982137|448948530|FG002|Overall Study|Lost to Follow-up|0|||
124813820|NCT00982137|448948531|FG003|Overall Study|Lost to Follow-up|1|||
124813821|NCT00982137|448948528|FG000|Overall Study|Withdrawal by Subject|0|||
124813822|NCT00982137|448948529|FG001|Overall Study|Withdrawal by Subject|1|||
124813823|NCT00982137|448948530|FG002|Overall Study|Withdrawal by Subject|0|||
124813824|NCT00982137|448948531|FG003|Overall Study|Withdrawal by Subject|0|||
124813825|NCT00612690|448948540|FG000|Overall Study|Lost to Follow-up|72|||
124813826|NCT00612690|448948541|FG001|Overall Study|Lost to Follow-up|98|||
124813827|NCT00612690|448948540|FG000|Overall Study|Withdrawal by Subject|32|||
124813828|NCT00612690|448948541|FG001|Overall Study|Withdrawal by Subject|20|||
124813829|NCT00612690|448948540|FG000|Overall Study|Withdrawal by Site|11|||
124813830|NCT00612690|448948541|FG001|Overall Study|Withdrawal by Site|0|||
124813831|NCT00787891|448948543|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
124813832|NCT00787891|448948544|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
124813833|NCT00787891|448948543|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
124813834|NCT00787891|448948544|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
124813835|NCT00787891|448948543|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
124813836|NCT00787891|448948544|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
124813837|NCT00787891|448948543|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
124813838|NCT00787891|448948544|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
124813839|NCT00787891|448948543|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
124813840|NCT00787891|448948544|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
124813841|NCT00787891|448948543|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
124813842|NCT00787891|448948544|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
124813843|NCT00787891|448948543|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
124813844|NCT00787891|448948544|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
124813845|NCT00787891|448948543|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
124813846|NCT00787891|448948544|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
124813847|NCT00787891|448948543|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
124813848|NCT00787891|448948544|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
124813849|NCT00787891|448948543|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
124813850|NCT00787891|448948544|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
125302080|NCT01336023|450731914|FG002|Week 27 to 52|Unclassified|9|||
125302081|NCT01361178|450731920|FG000|Overall Study|Death|13|||
125302082|NCT01361178|450731921|FG001|Overall Study|Death|0|||
124813851|NCT02955602|448948545|FG000|Overall Study|Adverse Event|0|||
124813852|NCT02955602|448948546|FG001|Overall Study|Adverse Event|3|||
124813853|NCT02955602|448948547|FG002|Overall Study|Adverse Event|0|||
124813854|NCT02955602|448948545|FG000|Overall Study|Withdrawal of informed consent|1|||
125302083|NCT00391625|450731922|FG000|Month 14|Withdrawal by Subject|1|||
124813855|NCT02955602|448948546|FG001|Overall Study|Withdrawal of informed consent|3|||
124813856|NCT02955602|448948547|FG002|Overall Study|Withdrawal of informed consent|2|||
124813857|NCT02955602|448948545|FG000|Overall Study|Lost to Follow-up|0|||
124813858|NCT02955602|448948546|FG001|Overall Study|Lost to Follow-up|0|||
124813859|NCT02955602|448948547|FG002|Overall Study|Lost to Follow-up|1|||
124813860|NCT02955602|448948545|FG000|Overall Study|Other|0|||
124813861|NCT02955602|448948546|FG001|Overall Study|Other|1|||
124813862|NCT02955602|448948547|FG002|Overall Study|Other|3|||
124813863|NCT02980601|448948550|FG000|Overall Study|Lost to Follow-up|2|||
124813864|NCT02980601|448948551|FG001|Overall Study|Lost to Follow-up|2|||
124813865|NCT02980601|448948550|FG000|Overall Study|Death|0|||
124813866|NCT02980601|448948551|FG001|Overall Study|Death|1|||
124813867|NCT02980601|448948550|FG000|Overall Study|Graft loss|1|||
124813868|NCT02980601|448948551|FG001|Overall Study|Graft loss|0|||
124813869|NCT02980601|448948550|FG000|Overall Study|Failed to sign consent|2|||
124813870|NCT02980601|448948551|FG001|Overall Study|Failed to sign consent|0|||
124813871|NCT01575769|448948552|FG000|Overall Study|Adverse Event|1|||
124813872|NCT01575769|448948552|FG000|Overall Study|Study terminated by sponsor|40|||
124813873|NCT03156543|448948555|FG000|Overall Study|Withdrawal by Subject|1|||
124813874|NCT03156543|448948556|FG001|Overall Study|Withdrawal by Subject|0|||
124813875|NCT00674700|448948557|FG000|Year 1|Adverse Event|17|||
124813876|NCT00674700|448948558|FG001|Year 1|Adverse Event|20|||
124813877|NCT00674700|448948559|FG002|Year 1|Adverse Event|5|||
124813878|NCT00674700|448948557|FG000|Year 1|Withdrawal by Subject|7|||
124813879|NCT00674700|448948558|FG001|Year 1|Withdrawal by Subject|7|||
124813880|NCT00674700|448948559|FG002|Year 1|Withdrawal by Subject|6|||
124813881|NCT00674700|448948557|FG000|Year 1|Any other reason not above-mentioned|7|||
124813882|NCT00674700|448948558|FG001|Year 1|Any other reason not above-mentioned|7|||
124813883|NCT00674700|448948559|FG002|Year 1|Any other reason not above-mentioned|6|||
124813884|NCT00674700|448948557|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
124813885|NCT00674700|448948558|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
124813886|NCT00674700|448948559|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
124813887|NCT00674700|448948557|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
124813888|NCT00674700|448948558|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
124813889|NCT00674700|448948559|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
124813890|NCT00674700|448948557|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
124813891|NCT00674700|448948558|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
124813892|NCT00674700|448948559|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
124813893|NCT00395304|448948560|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124813894|NCT00395304|448948561|FG001|Treatment Period 1|Withdrawal by Subject|3|||
124813895|NCT00395304|448948562|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124813896|NCT00395304|448948563|FG003|Treatment Period 1|Withdrawal by Subject|2|||
124813897|NCT00395304|448948564|FG004|Treatment Period 1|Withdrawal by Subject|1|||
124813898|NCT00395304|448948565|FG005|Treatment Period 1|Withdrawal by Subject|1|||
124813899|NCT00395304|448948560|FG000|Treatment Period 1|Lost to Follow-up|1|||
124813900|NCT00395304|448948561|FG001|Treatment Period 1|Lost to Follow-up|0|||
124813901|NCT00395304|448948562|FG002|Treatment Period 1|Lost to Follow-up|0|||
124813902|NCT00395304|448948563|FG003|Treatment Period 1|Lost to Follow-up|1|||
124813903|NCT00395304|448948564|FG004|Treatment Period 1|Lost to Follow-up|0|||
124813904|NCT00395304|448948565|FG005|Treatment Period 1|Lost to Follow-up|1|||
124813905|NCT00395304|448948560|FG000|Treatment Period 1|Physician Decision|0|||
124813906|NCT00395304|448948561|FG001|Treatment Period 1|Physician Decision|1|||
125302084|NCT00391625|450731922|FG000|Month 50|Physician Decision|1|||
125302085|NCT03997825|450731923|FG000|Overall Study|Death|3|||
125302086|NCT03997825|450731923|FG000|Overall Study|Lost to Follow-up|10|||
125302087|NCT03997825|450731923|FG000|Overall Study|Withdrawal by Subject|3|||
125302088|NCT03997825|450731923|FG000|Overall Study|Refused participation|1|||
125302089|NCT00383162|450731924|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
125302090|NCT00383162|450731925|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
125302091|NCT00383162|450731924|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
125302092|NCT00383162|450731925|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
125302093|NCT00383162|450731924|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
124813907|NCT00395304|448948562|FG002|Treatment Period 1|Physician Decision|0|||
124813908|NCT00395304|448948563|FG003|Treatment Period 1|Physician Decision|0|||
124813909|NCT00395304|448948564|FG004|Treatment Period 1|Physician Decision|0|||
124813910|NCT00395304|448948565|FG005|Treatment Period 1|Physician Decision|0|||
124813911|NCT00395304|448948560|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124813912|NCT00395304|448948561|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124813913|NCT00395304|448948562|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124813914|NCT00395304|448948563|FG003|Treatment Period 2|Withdrawal by Subject|1|||
124813915|NCT00395304|448948564|FG004|Treatment Period 2|Withdrawal by Subject|0|||
124813916|NCT00395304|448948565|FG005|Treatment Period 2|Withdrawal by Subject|2|||
124813917|NCT00395304|448948560|FG000|Treatment Period 2|Lost to Follow-up|0|||
124813918|NCT00395304|448948561|FG001|Treatment Period 2|Lost to Follow-up|3|||
124813919|NCT00395304|448948562|FG002|Treatment Period 2|Lost to Follow-up|0|||
124813920|NCT00395304|448948563|FG003|Treatment Period 2|Lost to Follow-up|0|||
124813921|NCT00395304|448948564|FG004|Treatment Period 2|Lost to Follow-up|0|||
124813922|NCT00395304|448948565|FG005|Treatment Period 2|Lost to Follow-up|0|||
124813923|NCT00395304|448948560|FG000|Treatment Period 2|Physician Decision|0|||
125302094|NCT00383162|450731925|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
124813924|NCT00395304|448948561|FG001|Treatment Period 2|Physician Decision|0|||
124813925|NCT00395304|448948562|FG002|Treatment Period 2|Physician Decision|1|||
124813926|NCT00395304|448948563|FG003|Treatment Period 2|Physician Decision|0|||
124813927|NCT00395304|448948564|FG004|Treatment Period 2|Physician Decision|0|||
124813928|NCT00395304|448948565|FG005|Treatment Period 2|Physician Decision|0|||
124813929|NCT00395304|448948560|FG000|Treatment Period 2|Other|0|||
124813930|NCT00395304|448948561|FG001|Treatment Period 2|Other|1|||
124813931|NCT00395304|448948562|FG002|Treatment Period 2|Other|0|||
124813932|NCT00395304|448948563|FG003|Treatment Period 2|Other|0|||
124813933|NCT00395304|448948564|FG004|Treatment Period 2|Other|0|||
124813934|NCT00395304|448948565|FG005|Treatment Period 2|Other|0|||
124813935|NCT00395304|448948560|FG000|Treatment Period 3|Withdrawal by Subject|0|||
124813936|NCT00395304|448948561|FG001|Treatment Period 3|Withdrawal by Subject|0|||
124813937|NCT00395304|448948562|FG002|Treatment Period 3|Withdrawal by Subject|0|||
124813938|NCT00395304|448948563|FG003|Treatment Period 3|Withdrawal by Subject|1|||
124813939|NCT00395304|448948564|FG004|Treatment Period 3|Withdrawal by Subject|0|||
124813940|NCT00395304|448948565|FG005|Treatment Period 3|Withdrawal by Subject|1|||
124813941|NCT00395304|448948560|FG000|Treatment Period 3|Lost to Follow-up|1|||
124813942|NCT00395304|448948561|FG001|Treatment Period 3|Lost to Follow-up|1|||
124813943|NCT00395304|448948562|FG002|Treatment Period 3|Lost to Follow-up|0|||
124813944|NCT00395304|448948563|FG003|Treatment Period 3|Lost to Follow-up|0|||
124813945|NCT00395304|448948564|FG004|Treatment Period 3|Lost to Follow-up|0|||
124813946|NCT00395304|448948565|FG005|Treatment Period 3|Lost to Follow-up|0|||
124813947|NCT00395304|448948560|FG000|Treatment Period 3|Physician Decision|0|||
124813948|NCT00395304|448948561|FG001|Treatment Period 3|Physician Decision|1|||
124813949|NCT00395304|448948562|FG002|Treatment Period 3|Physician Decision|0|||
124813950|NCT00395304|448948563|FG003|Treatment Period 3|Physician Decision|0|||
124813951|NCT00395304|448948564|FG004|Treatment Period 3|Physician Decision|0|||
124813952|NCT00395304|448948565|FG005|Treatment Period 3|Physician Decision|0|||
124813953|NCT00395304|448948560|FG000|Treatment Period 3|Other|0|||
124813954|NCT00395304|448948561|FG001|Treatment Period 3|Other|0|||
124813955|NCT00395304|448948562|FG002|Treatment Period 3|Other|0|||
124813956|NCT00395304|448948563|FG003|Treatment Period 3|Other|1|||
124813957|NCT00395304|448948564|FG004|Treatment Period 3|Other|0|||
124813958|NCT00395304|448948565|FG005|Treatment Period 3|Other|0|||
124813959|NCT03797014|448948567|FG000|Overall Study|Withdrawal by Subject|1|||
124813960|NCT03797014|448948567|FG000|Overall Study|Lost to Follow-up|1|||
124813961|NCT03797014|448948567|FG000|Overall Study|Protocol Violation|1|||
124813962|NCT01970397|448948568|FG000|Overall Study|Adverse Event|0|||
124813963|NCT01970397|448948569|FG001|Overall Study|Adverse Event|1|||
124813964|NCT01970397|448948568|FG000|Overall Study|Lost to Follow-up|0|||
124813965|NCT01970397|448948569|FG001|Overall Study|Lost to Follow-up|1|||
124813966|NCT01970397|448948568|FG000|Overall Study|Personal Reasons|1|||
124813967|NCT01970397|448948569|FG001|Overall Study|Personal Reasons|2|||
124813968|NCT01970397|448948568|FG000|Overall Study|Protocol Violation|1|||
124813969|NCT01970397|448948569|FG001|Overall Study|Protocol Violation|1|||
124813970|NCT01389817|448948572|FG000|Overall Study|Physician Decision|1|||
124813971|NCT01389817|448948573|FG001|Overall Study|Physician Decision|0|||
124813972|NCT01389817|448948572|FG000|Overall Study|Lost to Follow-up|1|||
124813973|NCT01389817|448948573|FG001|Overall Study|Lost to Follow-up|0|||
124813974|NCT01389817|448948572|FG000|Overall Study|Withdrawal by Subject|2|||
124813975|NCT01389817|448948573|FG001|Overall Study|Withdrawal by Subject|0|||
124813976|NCT01434667|448948579|FG000|Overall Study|Lost to Follow-up|5|||
124813977|NCT01434667|448948580|FG001|Overall Study|Lost to Follow-up|10|||
124813978|NCT04115839|448948581|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
124813979|NCT04115839|448948582|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
124813980|NCT04115839|448948583|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
124813981|NCT04115839|448948584|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
124813982|NCT04115839|448948585|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
124813983|NCT04115839|448948586|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
124813984|NCT04115839|448948587|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
124813985|NCT04115839|448948581|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
124813986|NCT04115839|448948582|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
124813987|NCT04115839|448948583|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
124813988|NCT04115839|448948584|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
124813989|NCT04115839|448948585|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
124813990|NCT04115839|448948586|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
124813991|NCT04115839|448948587|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
124813992|NCT04115839|448948581|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
124813993|NCT04115839|448948582|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
124813994|NCT04115839|448948583|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
124813995|NCT04115839|448948584|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
124813996|NCT04115839|448948585|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
124813997|NCT04115839|448948586|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
124813998|NCT04115839|448948587|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
124813999|NCT04115839|448948581|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
124814000|NCT04115839|448948582|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
124814001|NCT04115839|448948583|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
124814002|NCT04115839|448948584|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
124814003|NCT04115839|448948585|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
124814004|NCT04115839|448948586|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
124814005|NCT04115839|448948587|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
124814006|NCT04115839|448948581|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
124814007|NCT04115839|448948582|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
124814008|NCT04115839|448948583|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
124814009|NCT04115839|448948584|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
124814010|NCT04115839|448948585|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
124814011|NCT04115839|448948586|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
124814012|NCT04115839|448948587|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
124814013|NCT04115839|448948581|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
124814014|NCT04115839|448948582|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
124814015|NCT04115839|448948583|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
124814016|NCT04115839|448948584|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
124814017|NCT04115839|448948585|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
124814018|NCT04115839|448948586|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
124814019|NCT04115839|448948587|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
124814020|NCT02966028|448948588|FG000|Overall Study|Adverse Event|7|||
124814021|NCT02966028|448948589|FG001|Overall Study|Adverse Event|13|||
124814022|NCT02966028|448948590|FG002|Overall Study|Adverse Event|10|||
124814023|NCT02966028|448948588|FG000|Overall Study|Physician Decision|1|||
124814024|NCT02966028|448948589|FG001|Overall Study|Physician Decision|0|||
124814025|NCT02966028|448948590|FG002|Overall Study|Physician Decision|2|||
124814026|NCT02966028|448948588|FG000|Overall Study|Withdrawal by Subject|7|||
124814027|NCT02966028|448948589|FG001|Overall Study|Withdrawal by Subject|5|||
124814028|NCT02966028|448948590|FG002|Overall Study|Withdrawal by Subject|5|||
124814029|NCT02966028|448948588|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
124814030|NCT02966028|448948589|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
124814031|NCT02966028|448948590|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
124814032|NCT03535844|448948597|FG000|Overall Study|Withdrawal by Subject|0|||
124814033|NCT03535844|448948598|FG001|Overall Study|Withdrawal by Subject|1|||
124814034|NCT02835820|448948601|FG000|Overall Study|Baseline Screen Failure|0|||
124814035|NCT02835820|448948602|FG001|Overall Study|Baseline Screen Failure|3|||
124814036|NCT00160693|448948606|FG000|Overall Study|Adverse Event|97|||
124814037|NCT00160693|448948606|FG000|Overall Study|Lack of Efficacy|30|||
124814038|NCT00160693|448948606|FG000|Overall Study|Protocol Violation|24|||
124814039|NCT00160693|448948606|FG000|Overall Study|Lost to Follow-up|15|||
124814040|NCT00160693|448948606|FG000|Overall Study|Withdrawal by Subject|54|||
124814041|NCT00160693|448948606|FG000|Overall Study|Study terminated by sponsor|15|||
124814042|NCT03039283|448948609|FG000|Overall Study|Protocol Violation|2|||
124814043|NCT01867424|448948610|FG000|Overall Study|Patient noncompliance|2|||
124814044|NCT01867424|448948611|FG001|Overall Study|Patient noncompliance|1|||
124814045|NCT01056653|448948612|FG000|Overall Study|Lost to Follow-up|0|||
124814046|NCT01056653|448948613|FG001|Overall Study|Lost to Follow-up|0|||
124814047|NCT01056653|448948614|FG002|Overall Study|Lost to Follow-up|2|||
124814048|NCT05386680|448948615|FG000|Overall Study|Guardian decision|2|||
124814049|NCT01847274|448948616|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
124814050|NCT01847274|448948617|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
124814051|NCT01847274|448948618|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
124814052|NCT01847274|448948619|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
124814053|NCT01847274|448948620|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
124814054|NCT01847274|448948621|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
124814055|NCT01847274|448948622|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
124814056|NCT01847274|448948623|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
124814057|NCT01847274|448948624|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
124814058|NCT01847274|448948625|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
124814059|NCT01847274|448948626|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
124814060|NCT01847274|448948616|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
124814061|NCT01847274|448948617|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
124814062|NCT01847274|448948618|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
124814063|NCT01847274|448948619|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
124814064|NCT01847274|448948620|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
124814065|NCT01847274|448948621|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
124814066|NCT01847274|448948622|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
124819584|NCT00420927|448965764|FG003|Period 1|Lost to Follow-up|0|||
124814067|NCT01847274|448948623|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
124814068|NCT01847274|448948624|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
124814069|NCT01847274|448948625|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
124814070|NCT01847274|448948626|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
124814071|NCT01847274|448948616|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
124814072|NCT01847274|448948617|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
124814073|NCT01847274|448948618|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
124814074|NCT01847274|448948619|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
124814075|NCT01847274|448948620|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
124814076|NCT01847274|448948621|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
124814077|NCT01847274|448948622|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
124814078|NCT01847274|448948623|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
124814079|NCT01847274|448948624|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
124814080|NCT01847274|448948625|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
124814081|NCT01847274|448948626|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
124814082|NCT01847274|448948616|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
124814083|NCT01847274|448948617|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
124814084|NCT01847274|448948618|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
124814085|NCT01847274|448948619|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
124814086|NCT01847274|448948620|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
124814087|NCT01847274|448948621|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
124814088|NCT01847274|448948622|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
124814089|NCT01847274|448948623|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
124814090|NCT01847274|448948624|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
124814091|NCT01847274|448948625|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
124814092|NCT01847274|448948626|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
124814093|NCT01847274|448948616|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
124814094|NCT01847274|448948617|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
124814095|NCT01847274|448948618|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
124814096|NCT01847274|448948619|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
124814097|NCT01847274|448948620|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
124814098|NCT01847274|448948621|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
124814099|NCT01847274|448948622|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
124814100|NCT01847274|448948623|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
124814101|NCT01847274|448948624|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
124814102|NCT01847274|448948625|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
124814103|NCT01847274|448948626|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
124814104|NCT01847274|448948616|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
124814105|NCT01847274|448948617|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
124814106|NCT01847274|448948618|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
124814107|NCT01847274|448948619|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
124814108|NCT01847274|448948620|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
124814109|NCT01847274|448948621|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
124814110|NCT01847274|448948622|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
124814111|NCT01847274|448948623|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
124814112|NCT01847274|448948624|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
124814113|NCT01847274|448948625|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
124814114|NCT01847274|448948626|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
124814115|NCT01847274|448948616|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
124814116|NCT01847274|448948617|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
124814117|NCT01847274|448948618|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
124814118|NCT01847274|448948619|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
124814119|NCT01847274|448948620|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
124814120|NCT01847274|448948621|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
124814121|NCT01847274|448948622|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
124814122|NCT01847274|448948623|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
124814123|NCT01847274|448948624|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
124814124|NCT01847274|448948625|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
124814125|NCT01847274|448948626|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
124814126|NCT01847274|448948616|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
124814127|NCT01847274|448948617|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
124814128|NCT01847274|448948618|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
124814129|NCT01847274|448948619|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
124814130|NCT01847274|448948620|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
124814131|NCT01847274|448948621|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
124814132|NCT01847274|448948622|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
124814133|NCT01847274|448948623|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
124814134|NCT01847274|448948624|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
124814135|NCT01847274|448948625|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
124814136|NCT01847274|448948626|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
124814137|NCT01847274|448948616|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
124814138|NCT01847274|448948617|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
124814139|NCT01847274|448948618|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
124814140|NCT01847274|448948619|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
124814141|NCT01847274|448948620|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
124814142|NCT01847274|448948621|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
124814143|NCT01847274|448948622|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
124814144|NCT01847274|448948623|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
124814145|NCT01847274|448948624|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
124814146|NCT01847274|448948625|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
124814147|NCT01847274|448948626|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
124814148|NCT01847274|448948616|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
124814149|NCT01847274|448948617|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
124814150|NCT01847274|448948618|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
124814151|NCT01847274|448948619|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
124814152|NCT01847274|448948620|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
124814153|NCT01847274|448948621|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
124814154|NCT01847274|448948622|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
124814155|NCT01847274|448948623|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
124814156|NCT01847274|448948624|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
124814157|NCT01847274|448948625|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
124814158|NCT01847274|448948626|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
124814159|NCT01847274|448948616|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
124814160|NCT01847274|448948617|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
124814161|NCT01847274|448948618|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
124814162|NCT01847274|448948619|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
124814163|NCT01847274|448948620|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
124814164|NCT01847274|448948621|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
124814165|NCT01847274|448948622|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
124814166|NCT01847274|448948623|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
124814167|NCT01847274|448948624|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
124814168|NCT01847274|448948625|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
124814169|NCT01847274|448948626|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
124814170|NCT01847274|448948616|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
124814171|NCT01847274|448948617|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
124814172|NCT01847274|448948618|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
124814173|NCT01847274|448948619|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
124814174|NCT01847274|448948620|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
124814175|NCT01847274|448948621|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
124814176|NCT01847274|448948622|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
124814177|NCT01847274|448948623|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
124814178|NCT01847274|448948624|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
124814179|NCT01847274|448948625|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
124814180|NCT01847274|448948626|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
124814181|NCT01847274|448948616|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
124814182|NCT01847274|448948617|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
124814183|NCT01847274|448948618|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
124814184|NCT01847274|448948619|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
124814185|NCT01847274|448948620|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
124814186|NCT01847274|448948621|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
124814187|NCT01847274|448948622|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
124814188|NCT01847274|448948623|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
124814189|NCT01847274|448948624|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
124814190|NCT01847274|448948625|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
124814191|NCT01847274|448948626|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
124814192|NCT01847274|448948616|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
124814193|NCT01847274|448948617|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
124814194|NCT01847274|448948618|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
124814195|NCT01847274|448948619|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
124814196|NCT01847274|448948620|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
124814197|NCT01847274|448948621|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
124814198|NCT01847274|448948622|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
124814199|NCT01847274|448948623|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
124814200|NCT01847274|448948624|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
124814201|NCT01847274|448948625|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
124814202|NCT01847274|448948626|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
124814203|NCT01847274|448948616|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
124814204|NCT01847274|448948617|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
124814205|NCT01847274|448948618|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
124814206|NCT01847274|448948619|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
124814207|NCT01847274|448948620|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
124814208|NCT01847274|448948621|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
124814209|NCT01847274|448948622|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
124814210|NCT01847274|448948623|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
124814211|NCT01847274|448948624|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
124814212|NCT01847274|448948625|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
124814213|NCT01847274|448948626|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
124814214|NCT01847274|448948616|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
124814215|NCT01847274|448948617|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
124814216|NCT01847274|448948618|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
124814217|NCT01847274|448948619|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
124814218|NCT01847274|448948620|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
124814219|NCT01847274|448948621|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
124814220|NCT01847274|448948622|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
124814221|NCT01847274|448948623|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
124814222|NCT01847274|448948624|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
124814223|NCT01847274|448948625|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
124814224|NCT01847274|448948626|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
124814225|NCT03727230|448948627|FG000|Overall Study|Lost to Follow-up|12|||
124814226|NCT03470441|448948632|FG000|Overall Study|Death|0|||
124814227|NCT03470441|448948633|FG001|Overall Study|Death|1|||
124814228|NCT03470441|448948634|FG002|Overall Study|Death|1|||
124814229|NCT03470441|448948635|FG003|Overall Study|Death|0|||
124814230|NCT03470441|448948632|FG000|Overall Study|Adverse Event|0|||
124814231|NCT03470441|448948633|FG001|Overall Study|Adverse Event|0|||
124814232|NCT03470441|448948634|FG002|Overall Study|Adverse Event|0|||
124814233|NCT03470441|448948635|FG003|Overall Study|Adverse Event|1|||
124814234|NCT03470441|448948632|FG000|Overall Study|Withdrawal by Subject|1|||
124814235|NCT03470441|448948633|FG001|Overall Study|Withdrawal by Subject|4|||
124814236|NCT03470441|448948634|FG002|Overall Study|Withdrawal by Subject|1|||
124814237|NCT03470441|448948635|FG003|Overall Study|Withdrawal by Subject|3|||
124814238|NCT03768414|448948636|FG000|Overall Study|Adverse Event or side effects|72|||
124814239|NCT03768414|448948637|FG001|Overall Study|Adverse Event or side effects|28|||
124814240|NCT03768414|448948636|FG000|Overall Study|Refusal unrelated to adverse event|33|||
124814241|NCT03768414|448948637|FG001|Overall Study|Refusal unrelated to adverse event|33|||
124814242|NCT03768414|448948636|FG000|Overall Study|Progression/relapse|132|||
124814243|NCT03768414|448948637|FG001|Overall Study|Progression/relapse|60|||
124814244|NCT03768414|448948636|FG000|Overall Study|Death|9|||
124814245|NCT03768414|448948637|FG001|Overall Study|Death|6|||
124814246|NCT03768414|448948636|FG000|Overall Study|Other - not protocol specified|45|||
124814247|NCT03768414|448948637|FG001|Overall Study|Other - not protocol specified|18|||
124814248|NCT03768414|448948636|FG000|Overall Study|Reason under review|3|||
124814249|NCT03768414|448948637|FG001|Overall Study|Reason under review|2|||
124814250|NCT02538029|448948640|FG000|Overall Study|unable to complete cognitive assessments|1|||
124814251|NCT02538029|448948641|FG001|Overall Study|unable to complete cognitive assessments|0|||
124814252|NCT02538029|448948642|FG002|Overall Study|unable to complete cognitive assessments|1|||
124814253|NCT04292743|448948646|FG000|Overall Study|Physician Decision|1|||
124814254|NCT04292743|448948647|FG001|Overall Study|Physician Decision|3|||
124814255|NCT04292743|448948648|FG002|Overall Study|Physician Decision|0|||
124814256|NCT04292743|448948649|FG003|Overall Study|Physician Decision|0|||
124814257|NCT04292743|448948646|FG000|Overall Study|Withdrawal by Subject|0|||
124814258|NCT04292743|448948647|FG001|Overall Study|Withdrawal by Subject|5|||
124814259|NCT04292743|448948648|FG002|Overall Study|Withdrawal by Subject|0|||
125302095|NCT00383162|450731924|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
125302096|NCT00383162|450731925|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
125302097|NCT00383162|450731924|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
124814260|NCT04292743|448948649|FG003|Overall Study|Withdrawal by Subject|0|||
124814261|NCT04292743|448948646|FG000|Overall Study|Death|0|||
124814262|NCT04292743|448948647|FG001|Overall Study|Death|1|||
124814263|NCT04292743|448948648|FG002|Overall Study|Death|0|||
124814264|NCT04292743|448948649|FG003|Overall Study|Death|0|||
124814265|NCT04292743|448948646|FG000|Overall Study|Progression of Disease|2|||
124814266|NCT04292743|448948647|FG001|Overall Study|Progression of Disease|5|||
124814267|NCT04292743|448948648|FG002|Overall Study|Progression of Disease|0|||
124814268|NCT04292743|448948649|FG003|Overall Study|Progression of Disease|0|||
124814269|NCT04292743|448948646|FG000|Overall Study|No Treatment per protocol|0|||
124814270|NCT04292743|448948647|FG001|Overall Study|No Treatment per protocol|2|||
124814271|NCT04292743|448948648|FG002|Overall Study|No Treatment per protocol|0|||
124814272|NCT04292743|448948649|FG003|Overall Study|No Treatment per protocol|0|||
124814273|NCT03187197|448950463|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
124814274|NCT03187197|448950464|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
124814275|NCT03187197|448950465|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
124814276|NCT03187197|448950463|FG000|Overall Study|Withdrawal by Subject|8|||
124814277|NCT03187197|448950464|FG001|Overall Study|Withdrawal by Subject|63|||
124814278|NCT03187197|448950465|FG002|Overall Study|Withdrawal by Subject|4|||
124814279|NCT03187197|448950463|FG000|Overall Study|Lost to Follow-up|1|||
124814280|NCT03187197|448950464|FG001|Overall Study|Lost to Follow-up|60|||
124814281|NCT03187197|448950465|FG002|Overall Study|Lost to Follow-up|7|||
124814282|NCT03187197|448950463|FG000|Overall Study|Adverse Event|6|||
124814283|NCT03187197|448950464|FG001|Overall Study|Adverse Event|29|||
124814284|NCT03187197|448950465|FG002|Overall Study|Adverse Event|0|||
124814285|NCT03187197|448950463|FG000|Overall Study|Death|0|||
124814286|NCT03187197|448950464|FG001|Overall Study|Death|11|||
124814287|NCT03187197|448950465|FG002|Overall Study|Death|0|||
124814288|NCT03187197|448950463|FG000|Overall Study|Administrative problem|1|||
124814289|NCT03187197|448950464|FG001|Overall Study|Administrative problem|1|||
124814290|NCT03187197|448950465|FG002|Overall Study|Administrative problem|0|||
124814291|NCT03187197|448950463|FG000|Overall Study|Reason not listed|2|||
124814292|NCT03187197|448950464|FG001|Overall Study|Reason not listed|54|||
124814293|NCT03187197|448950465|FG002|Overall Study|Reason not listed|1|||
124814294|NCT03187197|448950463|FG000|Overall Study|Missing|1|||
124814295|NCT03187197|448950464|FG001|Overall Study|Missing|32|||
124814296|NCT03187197|448950465|FG002|Overall Study|Missing|3|||
124814297|NCT03187197|448950463|FG000|Overall Study|Status missing|2|||
124814298|NCT03187197|448950464|FG001|Overall Study|Status missing|33|||
124814299|NCT03187197|448950465|FG002|Overall Study|Status missing|3|||
124814300|NCT03187197|448950463|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
124814301|NCT03187197|448950464|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
124814302|NCT03187197|448950465|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
124814303|NCT02385045|448950466|FG000|Overall Study|Endoscopy could not be completed|4|||
124814304|NCT02871297|448950467|FG000|Overall Study|Adverse Event|34|||
124814305|NCT02871297|448950467|FG000|Overall Study|Lack of Efficacy|10|||
124814306|NCT02871297|448950467|FG000|Overall Study|Non-compliance with study drug|15|||
124814307|NCT02871297|448950467|FG000|Overall Study|Protocol Violation|3|||
124814308|NCT02871297|448950467|FG000|Overall Study|Withdrawal by Subject|20|||
124814309|NCT02871297|448950467|FG000|Overall Study|Lost to Follow-up|13|||
124814310|NCT02871297|448950467|FG000|Overall Study|Rolled over to 13546A|2|||
124814311|NCT02871297|448950467|FG000|Overall Study|Other than specified|39|||
124814312|NCT02034110|448950468|FG000|Overall Study|Physician Decision|0|||
124814313|NCT02034110|448950469|FG001|Overall Study|Physician Decision|0|||
124814314|NCT02034110|448950470|FG002|Overall Study|Physician Decision|0|||
124814315|NCT02034110|448950471|FG003|Overall Study|Physician Decision|0|||
124814316|NCT02034110|448950472|FG004|Overall Study|Physician Decision|2|||
124814317|NCT02034110|448950473|FG005|Overall Study|Physician Decision|0|||
124814318|NCT02034110|448950474|FG006|Overall Study|Physician Decision|1|||
124814319|NCT02034110|448950475|FG007|Overall Study|Physician Decision|0|||
124814320|NCT02034110|448950468|FG000|Overall Study|Lost to Follow-up|1|||
124814321|NCT02034110|448950469|FG001|Overall Study|Lost to Follow-up|0|||
124814322|NCT02034110|448950470|FG002|Overall Study|Lost to Follow-up|0|||
124814323|NCT02034110|448950471|FG003|Overall Study|Lost to Follow-up|0|||
124814324|NCT02034110|448950472|FG004|Overall Study|Lost to Follow-up|1|||
124814325|NCT02034110|448950473|FG005|Overall Study|Lost to Follow-up|0|||
124814326|NCT02034110|448950474|FG006|Overall Study|Lost to Follow-up|1|||
124814327|NCT02034110|448950475|FG007|Overall Study|Lost to Follow-up|0|||
124814328|NCT02034110|448950468|FG000|Overall Study|Withdrawal by Subject|5|||
124814329|NCT02034110|448950469|FG001|Overall Study|Withdrawal by Subject|7|||
124814330|NCT02034110|448950470|FG002|Overall Study|Withdrawal by Subject|0|||
124814331|NCT02034110|448950471|FG003|Overall Study|Withdrawal by Subject|3|||
124814332|NCT02034110|448950472|FG004|Overall Study|Withdrawal by Subject|7|||
124814333|NCT02034110|448950473|FG005|Overall Study|Withdrawal by Subject|0|||
124814334|NCT02034110|448950474|FG006|Overall Study|Withdrawal by Subject|3|||
124814335|NCT02034110|448950475|FG007|Overall Study|Withdrawal by Subject|1|||
124814336|NCT02034110|448950468|FG000|Overall Study|Study closed by sponsor|6|||
124814337|NCT02034110|448950469|FG001|Overall Study|Study closed by sponsor|2|||
124814338|NCT02034110|448950470|FG002|Overall Study|Study closed by sponsor|0|||
124814339|NCT02034110|448950471|FG003|Overall Study|Study closed by sponsor|6|||
124814340|NCT02034110|448950472|FG004|Overall Study|Study closed by sponsor|7|||
124814341|NCT02034110|448950473|FG005|Overall Study|Study closed by sponsor|0|||
124814342|NCT02034110|448950474|FG006|Overall Study|Study closed by sponsor|42|||
124814343|NCT02034110|448950475|FG007|Overall Study|Study closed by sponsor|0|||
124814344|NCT00621985|448950476|FG000|Dexamethasone Admission|Adverse Event|1|||
124814345|NCT01877265|448950478|FG000|Treatment Period 1|Sponsor Decision|0|||
124814346|NCT01877265|448950479|FG001|Treatment Period 1|Sponsor Decision|0|||
124814347|NCT01877265|448950480|FG002|Treatment Period 1|Sponsor Decision|1|||
124814348|NCT01877265|448950481|FG003|Treatment Period 1|Sponsor Decision|0|||
124814349|NCT01877265|448950482|FG004|Treatment Period 1|Sponsor Decision|0|||
124814350|NCT01877265|448950483|FG005|Treatment Period 1|Sponsor Decision|0|||
124814351|NCT01877265|448950478|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
124814352|NCT01877265|448950479|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
124814353|NCT01877265|448950480|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
124814354|NCT01877265|448950481|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
124814355|NCT01877265|448950482|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
124814356|NCT01877265|448950483|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
124814357|NCT01877265|448950478|FG000|Treatment Period 3|Lost to Follow-up|1|||
124814358|NCT01877265|448950479|FG001|Treatment Period 3|Lost to Follow-up|0|||
124814359|NCT01877265|448950480|FG002|Treatment Period 3|Lost to Follow-up|0|||
124814360|NCT01877265|448950481|FG003|Treatment Period 3|Lost to Follow-up|0|||
124814361|NCT01877265|448950482|FG004|Treatment Period 3|Lost to Follow-up|0|||
124814362|NCT01877265|448950483|FG005|Treatment Period 3|Lost to Follow-up|0|||
124814363|NCT00691015|448950484|FG000|Overall Study|Refused further treatment|1|||
124814364|NCT04160195|448950485|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
124814365|NCT04160195|448950486|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
124814366|NCT00684593|448950490|FG000|Overall Study|Adverse Event|0|||
124814367|NCT00684593|448950491|FG001|Overall Study|Adverse Event|2|||
124814368|NCT00590720|448950494|FG000|Overall Study|Lost to Follow-up|1|||
124814369|NCT00590720|448950495|FG001|Overall Study|Lost to Follow-up|0|||
124814370|NCT00590720|448950494|FG000|Overall Study|Withdrawal by Subject|0|||
124814371|NCT00590720|448950495|FG001|Overall Study|Withdrawal by Subject|1|||
124814372|NCT01001377|448950496|FG000|Overall Study|Ineligibility determined|2|||
124814373|NCT01001377|448950497|FG001|Overall Study|Ineligibility determined|0|||
124814374|NCT01001377|448950496|FG000|Overall Study|Withdrawal by Subject|19|||
124814375|NCT01001377|448950497|FG001|Overall Study|Withdrawal by Subject|20|||
124814376|NCT01001377|448950496|FG000|Overall Study|Lost to Follow-up|14|||
124814377|NCT01001377|448950497|FG001|Overall Study|Lost to Follow-up|17|||
124814378|NCT01001377|448950496|FG000|Overall Study|Death|391|||
124814379|NCT01001377|448950497|FG001|Overall Study|Death|384|||
124814380|NCT02193867|448950500|FG000|Overall Study|Death|2|||
124814381|NCT02193867|448950500|FG000|Overall Study|Sponsor Study Termination|2|||
124814382|NCT03616600|448950501|FG000|Overall Study|Withdrawal by Subject|1|||
124814383|NCT03616600|448950502|FG001|Overall Study|Withdrawal by Subject|0|||
124814384|NCT03600818|448950503|FG000|Overall Study|Adverse Event|4|||
124814385|NCT03600818|448950504|FG001|Overall Study|Adverse Event|7|||
124814386|NCT03600818|448950503|FG000|Overall Study|Lack of Efficacy|9|||
124814387|NCT03600818|448950504|FG001|Overall Study|Lack of Efficacy|4|||
124814388|NCT03600818|448950503|FG000|Overall Study|Withdrawal by Subject|4|||
124814389|NCT03600818|448950504|FG001|Overall Study|Withdrawal by Subject|3|||
124814390|NCT03600818|448950503|FG000|Overall Study|Other-unspecified|5|||
124814391|NCT03600818|448950504|FG001|Overall Study|Other-unspecified|3|||
124814392|NCT03600818|448950503|FG000|Overall Study|Randomized and not treated|0|||
124814393|NCT03600818|448950504|FG001|Overall Study|Randomized and not treated|1|||
124814394|NCT01488370|448950508|FG000|Overall Study|Protocol Violation|0|||
124814395|NCT01488370|448950509|FG001|Overall Study|Protocol Violation|1|||
124814396|NCT01488370|448950510|FG002|Overall Study|Protocol Violation|1|||
124814397|NCT01471171|448950511|FG000|Treatment Period 1|Adverse Event|4|||
124814398|NCT01471171|448950512|FG001|Treatment Period 1|Adverse Event|1|||
124814399|NCT01471171|448950511|FG000|Treatment Period 2|Adverse Event|1|||
124814400|NCT01471171|448950512|FG001|Treatment Period 2|Adverse Event|0|||
124814401|NCT03478930|448950514|FG000|Overall Study|Adverse Event|0|||
124814402|NCT03478930|448950515|FG001|Overall Study|Adverse Event|1|||
124814403|NCT03478930|448950514|FG000|Overall Study|Lack of Efficacy|3|||
124814404|NCT03478930|448950515|FG001|Overall Study|Lack of Efficacy|3|||
124814405|NCT03478930|448950514|FG000|Overall Study|Withdrawal by Subject|6|||
124814406|NCT03478930|448950515|FG001|Overall Study|Withdrawal by Subject|5|||
124814407|NCT04189081|448950516|FG000|Overall Study|Lost to Follow-up|1|||
124814408|NCT04189081|448950517|FG001|Overall Study|Lost to Follow-up|0|||
124814409|NCT04189081|448950518|FG002|Overall Study|Lost to Follow-up|0|||
124814410|NCT04189081|448950516|FG000|Overall Study|Withdrawal by Subject|0|||
124814411|NCT04189081|448950517|FG001|Overall Study|Withdrawal by Subject|0|||
124819585|NCT00420927|448965765|FG004|Period 1|Lost to Follow-up|0|||
124814412|NCT04189081|448950518|FG002|Overall Study|Withdrawal by Subject|1|||
124814413|NCT00705484|448950521|FG000|Overall Study|Adverse Event|28|||
124814414|NCT00705484|448950522|FG001|Overall Study|Adverse Event|27|||
124814415|NCT00705484|448950521|FG000|Overall Study|Lost to Follow-up|169|||
124814416|NCT00705484|448950522|FG001|Overall Study|Lost to Follow-up|250|||
124814417|NCT00705484|448950521|FG000|Overall Study|Withdrawal by Subject|96|||
124814418|NCT00705484|448950522|FG001|Overall Study|Withdrawal by Subject|72|||
124814419|NCT00705484|448950521|FG000|Overall Study|Administrative|89|||
124814420|NCT00705484|448950522|FG001|Overall Study|Administrative|59|||
124814421|NCT03982368|448950530|FG000|Overall Study|Adverse Event|6|||
124814422|NCT03982368|448950531|FG001|Overall Study|Adverse Event|4|||
124814423|NCT03982368|448950532|FG002|Overall Study|Adverse Event|3|||
124814424|NCT03982368|448950530|FG000|Overall Study|Lost to Follow-up|2|||
124814425|NCT03982368|448950531|FG001|Overall Study|Lost to Follow-up|1|||
124814426|NCT03982368|448950532|FG002|Overall Study|Lost to Follow-up|0|||
124814427|NCT03982368|448950530|FG000|Overall Study|Withdrawal by Subject|1|||
124814428|NCT03982368|448950531|FG001|Overall Study|Withdrawal by Subject|2|||
124814429|NCT03982368|448950532|FG002|Overall Study|Withdrawal by Subject|0|||
124814430|NCT03982368|448950530|FG000|Overall Study|unknow|4|||
124814431|NCT03982368|448950531|FG001|Overall Study|unknow|0|||
124814432|NCT03982368|448950532|FG002|Overall Study|unknow|2|||
124814433|NCT03706079|448950533|FG000|Predecessor Study|Death|0|||
124814434|NCT03706079|448950534|FG001|Predecessor Study|Death|2|||
124814435|NCT03706079|448950535|FG002|Predecessor Study|Death|0|||
124814436|NCT03706079|448950536|FG003|Predecessor Study|Death|1|||
124814437|NCT03706079|448950537|FG004|Predecessor Study|Death|0|||
124814438|NCT03706079|448950538|FG005|Predecessor Study|Death|0|||
124814439|NCT03706079|448950533|FG000|Predecessor Study|Lost to Follow-up|5|||
124814440|NCT03706079|448950534|FG001|Predecessor Study|Lost to Follow-up|2|||
124814441|NCT03706079|448950535|FG002|Predecessor Study|Lost to Follow-up|0|||
124814442|NCT03706079|448950536|FG003|Predecessor Study|Lost to Follow-up|0|||
124814443|NCT03706079|448950537|FG004|Predecessor Study|Lost to Follow-up|1|||
124814444|NCT03706079|448950538|FG005|Predecessor Study|Lost to Follow-up|0|||
124814445|NCT03706079|448950533|FG000|Predecessor Study|Withdrawal by Subject|8|||
124814446|NCT03706079|448950534|FG001|Predecessor Study|Withdrawal by Subject|15|||
124814447|NCT03706079|448950535|FG002|Predecessor Study|Withdrawal by Subject|0|||
124814448|NCT03706079|448950536|FG003|Predecessor Study|Withdrawal by Subject|5|||
124814449|NCT03706079|448950537|FG004|Predecessor Study|Withdrawal by Subject|2|||
124814450|NCT03706079|448950538|FG005|Predecessor Study|Withdrawal by Subject|0|||
124814451|NCT03706079|448950533|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
124814452|NCT03706079|448950534|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
124814453|NCT03706079|448950535|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
124814454|NCT03706079|448950536|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
124814455|NCT03706079|448950537|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
124814456|NCT03706079|448950538|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
124814457|NCT03706079|448950533|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
124814458|NCT03706079|448950534|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
124814459|NCT03706079|448950535|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
124814460|NCT03706079|448950536|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
124814461|NCT03706079|448950537|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
124814462|NCT03706079|448950538|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
124814463|NCT03706079|448950533|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
124814464|NCT03706079|448950534|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
124814465|NCT03706079|448950535|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
124814466|NCT03706079|448950536|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
124814467|NCT03706079|448950537|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
124814468|NCT03706079|448950538|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
124814469|NCT03706079|448950533|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
124814470|NCT03706079|448950534|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
124814471|NCT03706079|448950535|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
124814472|NCT03706079|448950536|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
124814473|NCT03706079|448950537|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
124814474|NCT03706079|448950538|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
124814475|NCT03706079|448950533|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
124814476|NCT03706079|448950534|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
124814477|NCT03706079|448950535|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
124814478|NCT03706079|448950536|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
124814479|NCT03706079|448950537|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
124814480|NCT03706079|448950538|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
124814481|NCT03706079|448950533|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
124814482|NCT03706079|448950534|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
124814483|NCT03706079|448950535|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
124814484|NCT03706079|448950536|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
124814485|NCT03706079|448950537|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
124814486|NCT03706079|448950538|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
124814487|NCT03706079|448950533|FG000|Long Term Extension (DESTINATION)|Death|8|||
124814488|NCT03706079|448950534|FG001|Long Term Extension (DESTINATION)|Death|2|||
124814489|NCT03706079|448950535|FG002|Long Term Extension (DESTINATION)|Death|2|||
124814490|NCT03706079|448950536|FG003|Long Term Extension (DESTINATION)|Death|1|||
124814491|NCT03706079|448950537|FG004|Long Term Extension (DESTINATION)|Death|0|||
124814492|NCT03706079|448950538|FG005|Long Term Extension (DESTINATION)|Death|0|||
124814493|NCT00329238|448950539|FG000|Overall Study|Adverse Event|147|||
124814494|NCT00329238|448950540|FG001|Overall Study|Adverse Event|129|||
124814495|NCT00329238|448950539|FG000|Overall Study|Protocol Violation|23|||
124814496|NCT00329238|448950540|FG001|Overall Study|Protocol Violation|34|||
124814497|NCT00329238|448950539|FG000|Overall Study|Lost to Follow-up|2|||
124814498|NCT00329238|448950540|FG001|Overall Study|Lost to Follow-up|6|||
124814499|NCT00329238|448950539|FG000|Overall Study|Withdrawal by Subject|64|||
124814500|NCT00329238|448950540|FG001|Overall Study|Withdrawal by Subject|58|||
124814501|NCT00329238|448950539|FG000|Overall Study|Other reason (not specified)|40|||
124814502|NCT00329238|448950540|FG001|Overall Study|Other reason (not specified)|54|||
124814503|NCT05393895|448950543|FG000|Overall Study|Adverse Event|2|||
124814504|NCT05393895|448950544|FG001|Overall Study|Adverse Event|3|||
124814505|NCT05393895|448950543|FG000|Overall Study|Lost to Follow-up|4|||
124814506|NCT05393895|448950544|FG001|Overall Study|Lost to Follow-up|3|||
124814507|NCT05393895|448950543|FG000|Overall Study|Protocol Violation|1|||
124814508|NCT05393895|448950544|FG001|Overall Study|Protocol Violation|0|||
124814509|NCT05393895|448950543|FG000|Overall Study|Withdrawal by Subject|1|||
124814510|NCT05393895|448950544|FG001|Overall Study|Withdrawal by Subject|4|||
124814511|NCT00968513|448950547|FG000|Overall Study|Death|4|||
124814512|NCT00968513|448950548|FG001|Overall Study|Death|10|||
124814513|NCT00968513|448950549|FG002|Overall Study|Death|15|||
124814514|NCT05537883|448950550|FG000|Overall Study|revisional surgery|4|||
124814515|NCT05537883|448950551|FG001|Overall Study|revisional surgery|2|||
124814516|NCT05537883|448950550|FG000|Overall Study|surgeries were cancelled|0|||
124814517|NCT05537883|448950551|FG001|Overall Study|surgeries were cancelled|2|||
124814518|NCT05537883|448950550|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
124814519|NCT05537883|448950551|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
124814520|NCT01302834|448950552|FG000|Overall Study|Protocol Violation|17|||
124814521|NCT01302834|448950553|FG001|Overall Study|Protocol Violation|23|||
124814522|NCT01302834|448950552|FG000|Overall Study|HIV positive|1|||
124814523|NCT01302834|448950553|FG001|Overall Study|HIV positive|3|||
124814524|NCT01328431|448950554|FG000|Baseline|Protocol Violation|0|||
124814525|NCT01328431|448950555|FG001|Baseline|Protocol Violation|2|||
124814526|NCT01328431|448950554|FG000|1 Month (1M)|Lost to Follow-up|55|||
124814527|NCT01328431|448950555|FG001|1 Month (1M)|Lost to Follow-up|58|||
124814528|NCT01328431|448950554|FG000|3 Month (3M)|Death|2|||
124814529|NCT01328431|448950555|FG001|3 Month (3M)|Death|2|||
124814530|NCT01328431|448950554|FG000|3 Month (3M)|Lost to Follow-up|75|||
124814531|NCT01328431|448950555|FG001|3 Month (3M)|Lost to Follow-up|70|||
124814532|NCT01328431|448950554|FG000|12 Month (12M)|Death|2|||
124814533|NCT01328431|448950555|FG001|12 Month (12M)|Death|6|||
124814534|NCT01328431|448950554|FG000|12 Month (12M)|Lost to Follow-up|82|||
124814535|NCT01328431|448950555|FG001|12 Month (12M)|Lost to Follow-up|91|||
124814536|NCT05379231|448950556|FG000|Home Visit|Withdrawal by Subject|2|||
124814537|NCT05379231|448950556|FG000|In-lab Visit|Withdrawal by Subject|2|||
124814538|NCT02296320|448950563|FG000|Overall Study|Withdrawal by Subject|4|||
124814539|NCT02296320|448950564|FG001|Overall Study|Withdrawal by Subject|0|||
124814540|NCT02296320|448950565|FG002|Overall Study|Withdrawal by Subject|2|||
124814541|NCT02296320|448950563|FG000|Overall Study|Death|24|||
124814542|NCT02296320|448950564|FG001|Overall Study|Death|3|||
124814543|NCT02296320|448950565|FG002|Overall Study|Death|27|||
124814544|NCT02296320|448950563|FG000|Overall Study|Lost to Follow-up|5|||
124814545|NCT02296320|448950564|FG001|Overall Study|Lost to Follow-up|2|||
124814546|NCT02296320|448950565|FG002|Overall Study|Lost to Follow-up|7|||
124814547|NCT02296320|448950563|FG000|Overall Study|Not treated|2|||
124814548|NCT02296320|448950564|FG001|Overall Study|Not treated|0|||
124814549|NCT02296320|448950565|FG002|Overall Study|Not treated|0|||
124814550|NCT02296320|448950563|FG000|Overall Study|Not - specified|0|||
124814551|NCT02296320|448950564|FG001|Overall Study|Not - specified|0|||
124814552|NCT02296320|448950565|FG002|Overall Study|Not - specified|1|||
124814553|NCT01203098|448950572|FG000|Overall Study|Adverse Event|3|||
124814554|NCT01203098|448950573|FG001|Overall Study|Adverse Event|1|||
124814555|NCT01203098|448950574|FG002|Overall Study|Adverse Event|7|||
124814556|NCT01203098|448950572|FG000|Overall Study|Lost to Follow-up|0|||
124814557|NCT01203098|448950573|FG001|Overall Study|Lost to Follow-up|0|||
124814558|NCT01203098|448950574|FG002|Overall Study|Lost to Follow-up|1|||
124814559|NCT01203098|448950572|FG000|Overall Study|Physician Decision|2|||
124814560|NCT01203098|448950573|FG001|Overall Study|Physician Decision|2|||
124814561|NCT01203098|448950574|FG002|Overall Study|Physician Decision|0|||
124814562|NCT01203098|448950572|FG000|Overall Study|Withdrawal by Subject|1|||
124814563|NCT01203098|448950573|FG001|Overall Study|Withdrawal by Subject|1|||
124814564|NCT01203098|448950574|FG002|Overall Study|Withdrawal by Subject|3|||
124814565|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
124814566|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
124814567|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
124814568|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
124814569|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
124814570|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
124814571|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
124814572|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
124814573|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
124814574|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
124814575|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
124814576|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
124814577|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
124814578|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
124814579|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
124814580|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
124814581|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
124814582|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
124814583|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
124814584|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
124814585|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
124814586|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
124814587|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
124814588|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
124814589|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
124814590|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
124814591|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
124814592|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
124814593|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
124814594|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
124814595|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
124814596|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
124814597|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
124814598|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
124814599|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
124814600|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
124814601|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
124814602|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
124814603|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
124814604|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
124814605|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
124814606|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
124814607|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
124814608|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
124814609|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
124814610|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
124814611|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
124814612|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
124814613|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
124814614|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
124814615|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
124814616|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
124814617|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
124814618|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
124814619|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
124814620|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
124814621|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
124814622|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
124814623|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
124814624|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
124814625|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
124814626|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
124814627|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
124814628|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
124814629|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
124814630|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
124814631|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
124814632|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
124814633|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
124814634|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
124814635|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Change of location|0|||
124814636|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Change of location|0|||
124814637|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Change of location|0|||
124814638|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Change of location|1|||
124814639|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Change of location|0|||
124814640|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
124814641|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
124814642|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
124814643|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
124814644|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
124814645|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
124814646|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
124814647|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
124814648|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
124814649|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
124814650|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
124814651|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
124814652|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
124814653|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
124814654|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
124814655|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
124814656|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
124814657|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
124814658|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
124814659|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
124814660|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
124814661|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
124814662|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
124814663|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
124814664|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
124814665|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
124814666|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
124814667|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
124814668|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
124814669|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
124814670|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Death|0|||
124814671|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Death|1|||
124814672|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Death|0|||
124814673|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Death|1|||
124814674|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Death|0|||
124814675|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Change of location|1|||
124814676|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Change of location|1|||
124814677|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Change of location|0|||
124814678|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Change of location|1|||
124814679|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Change of location|0|||
124814680|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
124814681|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
124814682|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
124814683|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
124814684|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
124814685|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
124814686|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
124814687|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
124814688|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
124814689|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
124814690|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
124814691|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
124814692|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
124814693|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
124814694|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
124814695|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
124814696|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
124814697|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
124814698|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
124814699|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
124814700|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
124814701|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
124814702|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
124814703|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
124814704|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
124814705|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
124814706|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
124814707|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
124814708|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
124814709|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
124814710|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
124814711|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
124814712|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
124814713|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
124814714|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
124814715|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
124814716|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
124814717|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
124814718|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
124814719|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
124814720|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
124814721|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
124814722|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
124814723|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
124814724|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
124814725|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
124814726|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
124814727|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
124814728|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
124814729|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
124814730|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Missing|0|||
124814731|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Missing|0|||
124814732|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Missing|2|||
124814733|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Missing|0|||
124814734|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Missing|0|||
124814735|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
124814736|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
124814737|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
124814738|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
124814739|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
124814740|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
124814741|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
124814742|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
124814743|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
124814744|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
124814745|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
124814746|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
124814747|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
124814748|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
124814749|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
124814750|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
124814751|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
124814752|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
124814753|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
124814754|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
124814755|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
124814756|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
124814757|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
124814758|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
124814759|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
124814760|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
124814761|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
124814762|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
124814763|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
124814764|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
124814765|NCT03851705|448950582|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
124814766|NCT03851705|448950583|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
124814767|NCT03851705|448950584|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
124814768|NCT03851705|448950585|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
124814769|NCT03851705|448950582|FG000|Part 1: Double-Blind Period|Other reason|1|||
124814770|NCT03851705|448950583|FG001|Part 1: Double-Blind Period|Other reason|0|||
124814771|NCT03851705|448950584|FG002|Part 1: Double-Blind Period|Other reason|0|||
124814772|NCT03851705|448950585|FG003|Part 1: Double-Blind Period|Other reason|0|||
124814773|NCT03851705|448950582|FG000|Part 2: Open-Label Period|Other reason|0|||
124814774|NCT03851705|448950583|FG001|Part 2: Open-Label Period|Other reason|0|||
124814775|NCT03851705|448950584|FG002|Part 2: Open-Label Period|Other reason|0|||
124814776|NCT03851705|448950585|FG003|Part 2: Open-Label Period|Other reason|1|||
124814777|NCT03851705|448950582|FG000|Part 2: Open-Label Period|Death|0|||
124814778|NCT03851705|448950583|FG001|Part 2: Open-Label Period|Death|0|||
124814779|NCT03851705|448950584|FG002|Part 2: Open-Label Period|Death|3|||
124814780|NCT03851705|448950585|FG003|Part 2: Open-Label Period|Death|0|||
124814781|NCT03851705|448950582|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
124814782|NCT03851705|448950583|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
124814783|NCT03851705|448950584|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
124814784|NCT03851705|448950585|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
124814785|NCT01496807|448950589|FG000|Overall Study|Progressive Disease|21|||
124814786|NCT01496807|448950589|FG000|Overall Study|Participant preference/toxicity|8|||
124814787|NCT01496807|448950589|FG000|Overall Study|Change in diagnosis|1|||
124814788|NCT02591290|448950596|FG000|Overall Study|Withdrawal by Subject|2|||
124814789|NCT00913497|448950597|FG000|Overall Study|Adverse Event|1|||
124814790|NCT00913497|448950597|FG000|Overall Study|Withdrawal by Subject|2|||
124814791|NCT01390649|448950604|FG000|Overall Study|Physician Decision|1|||
124814792|NCT02217878|448950605|FG000|Overall Study|required morphine due to chest pain|1|||
124814793|NCT02217878|448950606|FG001|Overall Study|required morphine due to chest pain|2|||
124814794|NCT02217878|448950605|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
124814795|NCT02217878|448950606|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
124814796|NCT00334958|448950607|FG000|Overall Study|Medication Noncompliance|0|||
124814797|NCT00334958|448950608|FG001|Overall Study|Medication Noncompliance|3|||
124814798|NCT00334958|448950607|FG000|Overall Study|Protocol Violation|2|||
124814799|NCT00334958|448950608|FG001|Overall Study|Protocol Violation|2|||
124814800|NCT00334958|448950607|FG000|Overall Study|Request of the investigator or sponsor|0|||
124814801|NCT00334958|448950608|FG001|Overall Study|Request of the investigator or sponsor|1|||
124814802|NCT00334958|448950607|FG000|Overall Study|Withdrawal by Subject|7|||
124814803|NCT00334958|448950608|FG001|Overall Study|Withdrawal by Subject|4|||
124814804|NCT00334958|448950607|FG000|Overall Study|Adverse Event|27|||
124814805|NCT00334958|448950608|FG001|Overall Study|Adverse Event|12|||
124814806|NCT00334958|448950607|FG000|Overall Study|Other|1|||
124814807|NCT00334958|448950608|FG001|Overall Study|Other|2|||
124814808|NCT03087643|448950616|FG000|Overall Study|Withdrawal by Subject|2|||
124814809|NCT03087643|448950617|FG001|Overall Study|Withdrawal by Subject|4|||
124814810|NCT03087643|448950616|FG000|Overall Study|Death|2|||
124814811|NCT03087643|448950617|FG001|Overall Study|Death|2|||
124814812|NCT02083783|448950620|FG000|Overall Study|Withdrawal by Subject|1|||
124814813|NCT02083783|448950621|FG001|Overall Study|Withdrawal by Subject|0|||
124814814|NCT01546883|448950622|FG000|Overall Study|Withdrawal by Subject|3|||
124814815|NCT01546883|448950622|FG000|Overall Study|Adverse Event|4|||
124814816|NCT01546883|448950622|FG000|Overall Study|Lost to Follow-up|2|||
124814817|NCT01546883|448950622|FG000|Overall Study|early closure of study|2|||
124814818|NCT01546883|448950622|FG000|Overall Study|other unrelated illness|1|||
124814819|NCT02256631|448950623|FG000|Overall Study|Lost to Follow-up|1|||
124814820|NCT02256631|448950624|FG001|Overall Study|Lost to Follow-up|1|||
124814821|NCT02256631|448950625|FG002|Overall Study|Lost to Follow-up|0|||
124814822|NCT02256631|448950626|FG003|Overall Study|Lost to Follow-up|2|||
124814823|NCT02256631|448950627|FG004|Overall Study|Lost to Follow-up|0|||
124814824|NCT02256631|448950628|FG005|Overall Study|Lost to Follow-up|4|||
124814825|NCT02256631|448950629|FG006|Overall Study|Lost to Follow-up|1|||
124814826|NCT02256631|448950623|FG000|Overall Study|Withdrawal by Subject|0|||
124814827|NCT02256631|448950624|FG001|Overall Study|Withdrawal by Subject|0|||
124814828|NCT02256631|448950625|FG002|Overall Study|Withdrawal by Subject|0|||
124814829|NCT02256631|448950626|FG003|Overall Study|Withdrawal by Subject|1|||
124814830|NCT02256631|448950627|FG004|Overall Study|Withdrawal by Subject|1|||
124814831|NCT02256631|448950628|FG005|Overall Study|Withdrawal by Subject|0|||
124814832|NCT02256631|448950629|FG006|Overall Study|Withdrawal by Subject|1|||
124814833|NCT02256631|448950623|FG000|Overall Study|Unable to get to clinic|0|||
124814834|NCT02256631|448950624|FG001|Overall Study|Unable to get to clinic|2|||
124814835|NCT02256631|448950625|FG002|Overall Study|Unable to get to clinic|0|||
124814836|NCT02256631|448950626|FG003|Overall Study|Unable to get to clinic|1|||
124814837|NCT02256631|448950627|FG004|Overall Study|Unable to get to clinic|0|||
124814838|NCT02256631|448950628|FG005|Overall Study|Unable to get to clinic|1|||
124814839|NCT02256631|448950629|FG006|Overall Study|Unable to get to clinic|2|||
124814840|NCT01427972|448950630|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814841|NCT01427972|448950631|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814842|NCT01427972|448950632|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814843|NCT01427972|448950633|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814844|NCT01427972|448950634|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814845|NCT01427972|448950635|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814846|NCT01427972|448950636|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814847|NCT01427972|448950637|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
124814848|NCT01427972|448950638|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814849|NCT01427972|448950639|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814850|NCT01427972|448950640|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814851|NCT01427972|448950641|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814852|NCT01427972|448950630|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814853|NCT01427972|448950631|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814854|NCT01427972|448950632|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814855|NCT01427972|448950633|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814856|NCT01427972|448950634|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814857|NCT01427972|448950635|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
124814858|NCT01427972|448950636|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814859|NCT01427972|448950637|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814860|NCT01427972|448950638|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814861|NCT01427972|448950639|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814862|NCT01427972|448950640|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814863|NCT01427972|448950641|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814864|NCT01427972|448950630|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814865|NCT01427972|448950631|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
124814866|NCT01427972|448950632|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814867|NCT01427972|448950633|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814868|NCT01427972|448950634|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814869|NCT01427972|448950635|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814870|NCT01427972|448950636|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814871|NCT01427972|448950637|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814872|NCT01427972|448950638|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814873|NCT01427972|448950639|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814874|NCT01427972|448950640|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814875|NCT01427972|448950641|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814876|NCT00824720|448950644|FG000|Overall Study|failed plug insertion|3|||
124814877|NCT00824720|448950645|FG001|Overall Study|failed plug insertion|1|||
124814878|NCT00824720|448950646|FG002|Overall Study|failed plug insertion|0|||
124814879|NCT00824720|448950644|FG000|Overall Study|Protocol Violation|0|||
124814880|NCT00824720|448950645|FG001|Overall Study|Protocol Violation|0|||
124814881|NCT00824720|448950646|FG002|Overall Study|Protocol Violation|1|||
124814882|NCT02777333|448950652|FG000|Overall Study|Withdrawal by Subject|0|||
124814883|NCT02777333|448950653|FG001|Overall Study|Withdrawal by Subject|1|||
124814884|NCT02777333|448950652|FG000|Overall Study|Lost to Follow-up|0|||
124814885|NCT02777333|448950653|FG001|Overall Study|Lost to Follow-up|1|||
124814886|NCT00837811|448950654|FG000|Overall Study|Adverse Event|4|||
124814887|NCT00837811|448950655|FG001|Overall Study|Adverse Event|6|||
124814888|NCT00837811|448950656|FG002|Overall Study|Adverse Event|0|||
124814889|NCT00837811|448950654|FG000|Overall Study|Death|1|||
124814890|NCT00837811|448950655|FG001|Overall Study|Death|1|||
124814891|NCT00837811|448950656|FG002|Overall Study|Death|0|||
124814892|NCT00837811|448950654|FG000|Overall Study|Lack of Efficacy|0|||
124814893|NCT00837811|448950655|FG001|Overall Study|Lack of Efficacy|11|||
124814894|NCT00837811|448950656|FG002|Overall Study|Lack of Efficacy|0|||
124814895|NCT00837811|448950654|FG000|Overall Study|Lost to Follow-up|1|||
124814896|NCT00837811|448950655|FG001|Overall Study|Lost to Follow-up|3|||
124814897|NCT00837811|448950656|FG002|Overall Study|Lost to Follow-up|0|||
124814898|NCT00837811|448950654|FG000|Overall Study|Physician Decision|0|||
124814899|NCT00837811|448950655|FG001|Overall Study|Physician Decision|2|||
124814900|NCT00837811|448950656|FG002|Overall Study|Physician Decision|1|||
124814901|NCT00837811|448950654|FG000|Overall Study|Withdrawal by Subject|1|||
124814902|NCT00837811|448950655|FG001|Overall Study|Withdrawal by Subject|9|||
124814903|NCT00837811|448950656|FG002|Overall Study|Withdrawal by Subject|0|||
124814904|NCT00837811|448950654|FG000|Overall Study|Sponsor Decision|0|||
124814905|NCT00837811|448950655|FG001|Overall Study|Sponsor Decision|2|||
124814906|NCT00837811|448950656|FG002|Overall Study|Sponsor Decision|0|||
124814907|NCT02849678|448952812|FG000|Overall Study|Protocol Violation|3|||
124814908|NCT02849678|448952813|FG001|Overall Study|Protocol Violation|6|||
124814909|NCT03310021|448952817|FG000|Overall Study|Withdrawal by Subject|0|||
124814910|NCT03310021|448952818|FG001|Overall Study|Withdrawal by Subject|0|||
124814911|NCT03310021|448952819|FG002|Overall Study|Withdrawal by Subject|0|||
124814912|NCT03310021|448952820|FG003|Overall Study|Withdrawal by Subject|0|||
124814913|NCT03310021|448952821|FG004|Overall Study|Withdrawal by Subject|0|||
124814914|NCT03310021|448952822|FG005|Overall Study|Withdrawal by Subject|0|||
124814915|NCT03310021|448952823|FG006|Overall Study|Withdrawal by Subject|1|||
124814916|NCT03310021|448952824|FG007|Overall Study|Withdrawal by Subject|0|||
124814917|NCT03310021|448952825|FG008|Overall Study|Withdrawal by Subject|0|||
124814918|NCT03310021|448952826|FG009|Overall Study|Withdrawal by Subject|0|||
124814919|NCT03310021|448952827|FG010|Overall Study|Withdrawal by Subject|0|||
124814920|NCT03310021|448952828|FG011|Overall Study|Withdrawal by Subject|0|||
124814921|NCT03310021|448952829|FG012|Overall Study|Withdrawal by Subject|0|||
124814922|NCT03310021|448952830|FG013|Overall Study|Withdrawal by Subject|0|||
124814923|NCT03310021|448952831|FG014|Overall Study|Withdrawal by Subject|0|||
124814924|NCT03310021|448952832|FG015|Overall Study|Withdrawal by Subject|0|||
124814925|NCT03310021|448952833|FG016|Overall Study|Withdrawal by Subject|0|||
124814926|NCT03310021|448952834|FG017|Overall Study|Withdrawal by Subject|0|||
124814927|NCT03310021|448952835|FG018|Overall Study|Withdrawal by Subject|0|||
124814928|NCT03310021|448952836|FG019|Overall Study|Withdrawal by Subject|0|||
124814929|NCT03310021|448952817|FG000|Overall Study|Lost to Follow-up|0|||
124814930|NCT03310021|448952818|FG001|Overall Study|Lost to Follow-up|0|||
124814931|NCT03310021|448952819|FG002|Overall Study|Lost to Follow-up|0|||
124814932|NCT03310021|448952820|FG003|Overall Study|Lost to Follow-up|0|||
124814933|NCT03310021|448952821|FG004|Overall Study|Lost to Follow-up|0|||
124814934|NCT03310021|448952822|FG005|Overall Study|Lost to Follow-up|0|||
124814935|NCT03310021|448952823|FG006|Overall Study|Lost to Follow-up|0|||
124814936|NCT03310021|448952824|FG007|Overall Study|Lost to Follow-up|0|||
124814937|NCT03310021|448952825|FG008|Overall Study|Lost to Follow-up|0|||
124814938|NCT03310021|448952826|FG009|Overall Study|Lost to Follow-up|0|||
124814939|NCT03310021|448952827|FG010|Overall Study|Lost to Follow-up|1|||
124814940|NCT03310021|448952828|FG011|Overall Study|Lost to Follow-up|0|||
124814941|NCT03310021|448952829|FG012|Overall Study|Lost to Follow-up|0|||
124814942|NCT03310021|448952830|FG013|Overall Study|Lost to Follow-up|0|||
124814943|NCT03310021|448952831|FG014|Overall Study|Lost to Follow-up|0|||
124814944|NCT03310021|448952832|FG015|Overall Study|Lost to Follow-up|0|||
124814945|NCT03310021|448952833|FG016|Overall Study|Lost to Follow-up|0|||
124814946|NCT03310021|448952834|FG017|Overall Study|Lost to Follow-up|0|||
124814947|NCT03310021|448952835|FG018|Overall Study|Lost to Follow-up|0|||
124814948|NCT03310021|448952836|FG019|Overall Study|Lost to Follow-up|0|||
124814949|NCT01874054|448952837|FG000|Overall Study|Withdrawal by Subject|3|||
124814950|NCT01874054|448952837|FG000|Overall Study|Study Termination by Sponsor|42|||
124814951|NCT01874054|448952837|FG000|Overall Study|Lost to Follow-up|5|||
124814952|NCT01874054|448952837|FG000|Overall Study|Death|5|||
124814953|NCT00702923|448952838|FG000|Overall Study|Adverse Event|1|||
124814954|NCT02002091|448952844|FG000|Screening|Lost to Follow-up|10|||
124814955|NCT02002091|448952845|FG001|Screening|Lost to Follow-up|12|||
124814956|NCT02002091|448952844|FG000|Screening|Death|3|||
124814957|NCT02002091|448952845|FG001|Screening|Death|2|||
124814958|NCT00369824|448952846|FG000|Overall Study|Adverse Event|0|||
124814959|NCT00369824|448952847|FG001|Overall Study|Adverse Event|2|||
124814960|NCT00369824|448952848|FG002|Overall Study|Adverse Event|0|||
124814961|NCT00369824|448952849|FG003|Overall Study|Adverse Event|0|||
124814962|NCT00369824|448952850|FG004|Overall Study|Adverse Event|1|||
124814963|NCT00369824|448952851|FG005|Overall Study|Adverse Event|0|||
124814964|NCT00369824|448952846|FG000|Overall Study|Protocol Violation|0|||
124814965|NCT00369824|448952847|FG001|Overall Study|Protocol Violation|1|||
124814966|NCT00369824|448952848|FG002|Overall Study|Protocol Violation|0|||
124814967|NCT00369824|448952849|FG003|Overall Study|Protocol Violation|1|||
124814968|NCT00369824|448952850|FG004|Overall Study|Protocol Violation|1|||
124814969|NCT00369824|448952851|FG005|Overall Study|Protocol Violation|0|||
124814970|NCT00369824|448952846|FG000|Overall Study|Withdrawal by Subject|9|||
124814971|NCT00369824|448952847|FG001|Overall Study|Withdrawal by Subject|5|||
124814972|NCT00369824|448952848|FG002|Overall Study|Withdrawal by Subject|5|||
124814973|NCT00369824|448952849|FG003|Overall Study|Withdrawal by Subject|4|||
124814974|NCT00369824|448952850|FG004|Overall Study|Withdrawal by Subject|6|||
124814975|NCT00369824|448952851|FG005|Overall Study|Withdrawal by Subject|2|||
124814976|NCT00369824|448952846|FG000|Overall Study|Lost to Follow-up|6|||
124814977|NCT00369824|448952847|FG001|Overall Study|Lost to Follow-up|11|||
124814978|NCT00369824|448952848|FG002|Overall Study|Lost to Follow-up|7|||
124814979|NCT00369824|448952849|FG003|Overall Study|Lost to Follow-up|8|||
124814980|NCT00369824|448952850|FG004|Overall Study|Lost to Follow-up|9|||
124814981|NCT00369824|448952851|FG005|Overall Study|Lost to Follow-up|6|||
124814982|NCT00369824|448952846|FG000|Overall Study|Other|0|||
124814983|NCT00369824|448952847|FG001|Overall Study|Other|0|||
124814984|NCT00369824|448952848|FG002|Overall Study|Other|0|||
124814985|NCT00369824|448952849|FG003|Overall Study|Other|2|||
124814986|NCT00369824|448952850|FG004|Overall Study|Other|1|||
124814987|NCT00369824|448952851|FG005|Overall Study|Other|3|||
124814988|NCT03953820|448952852|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
124814989|NCT03953820|448952853|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
124814990|NCT03953820|448952854|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
124814991|NCT03953820|448952852|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
124814992|NCT03953820|448952853|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
124814993|NCT03953820|448952854|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
124814994|NCT03385564|448952856|FG000|Overall Study|Adverse Event|0|||
124814995|NCT03385564|448952857|FG001|Overall Study|Adverse Event|0|||
124814996|NCT03385564|448952858|FG002|Overall Study|Adverse Event|3|||
124814997|NCT03385564|448952859|FG003|Overall Study|Adverse Event|3|||
124814998|NCT03385564|448952856|FG000|Overall Study|Other than listed|0|||
124814999|NCT03385564|448952857|FG001|Overall Study|Other than listed|0|||
124815000|NCT03385564|448952858|FG002|Overall Study|Other than listed|0|||
124815001|NCT03385564|448952859|FG003|Overall Study|Other than listed|5|||
124815002|NCT03385564|448952856|FG000|Overall Study|Withdrawal by Subject|0|||
124815003|NCT03385564|448952857|FG001|Overall Study|Withdrawal by Subject|1|||
124815004|NCT03385564|448952858|FG002|Overall Study|Withdrawal by Subject|1|||
124815005|NCT03385564|448952859|FG003|Overall Study|Withdrawal by Subject|0|||
124815006|NCT03385564|448952856|FG000|Overall Study|Lack of Efficacy|0|||
124815007|NCT03385564|448952857|FG001|Overall Study|Lack of Efficacy|0|||
124815008|NCT03385564|448952858|FG002|Overall Study|Lack of Efficacy|0|||
124815009|NCT03385564|448952859|FG003|Overall Study|Lack of Efficacy|1|||
124815010|NCT03385564|448952856|FG000|Overall Study|Death|0|||
124815011|NCT03385564|448952857|FG001|Overall Study|Death|0|||
124815012|NCT03385564|448952858|FG002|Overall Study|Death|1|||
124815013|NCT03385564|448952859|FG003|Overall Study|Death|0|||
124815014|NCT00622401|448952860|FG000|Overall Study|Disease progression prior to treatment|3|||
124815015|NCT00622401|448952861|FG001|Overall Study|Disease progression prior to treatment|2|||
124815016|NCT00622401|448952862|FG002|Overall Study|Disease progression prior to treatment|0|||
124815017|NCT00799422|448952869|FG000|First Week of Wear|Lost to Follow-up|0|||
124815018|NCT00799422|448952870|FG001|First Week of Wear|Lost to Follow-up|0|||
124815019|NCT00799422|448952871|FG002|First Week of Wear|Lost to Follow-up|1|||
124815020|NCT00799422|448952872|FG003|First Week of Wear|Lost to Follow-up|0|||
124815021|NCT00799422|448952873|FG004|First Week of Wear|Lost to Follow-up|0|||
124815022|NCT00799422|448952874|FG005|First Week of Wear|Lost to Follow-up|0|||
124815023|NCT00799422|448952869|FG000|First Week of Wear|Adverse Event|0|||
124815024|NCT00799422|448952870|FG001|First Week of Wear|Adverse Event|0|||
124815025|NCT00799422|448952871|FG002|First Week of Wear|Adverse Event|0|||
124815026|NCT00799422|448952872|FG003|First Week of Wear|Adverse Event|1|||
124815027|NCT00799422|448952873|FG004|First Week of Wear|Adverse Event|0|||
124815028|NCT00799422|448952874|FG005|First Week of Wear|Adverse Event|0|||
124815029|NCT00530946|448952876|FG000|Overall Study|Adverse Event|1|||
124815030|NCT00530946|448952877|FG001|Overall Study|Adverse Event|2|||
124815031|NCT00530946|448952878|FG002|Overall Study|Adverse Event|1|||
124815032|NCT00530946|448952879|FG003|Overall Study|Adverse Event|1|||
124815033|NCT00530946|448952876|FG000|Overall Study|Protocol Violation|0|||
124815034|NCT00530946|448952877|FG001|Overall Study|Protocol Violation|0|||
124815035|NCT00530946|448952878|FG002|Overall Study|Protocol Violation|0|||
124815036|NCT00530946|448952879|FG003|Overall Study|Protocol Violation|1|||
124815037|NCT00530946|448952876|FG000|Overall Study|Noncompliance|1|||
124815038|NCT00530946|448952877|FG001|Overall Study|Noncompliance|0|||
124815039|NCT00530946|448952878|FG002|Overall Study|Noncompliance|0|||
124815040|NCT00530946|448952879|FG003|Overall Study|Noncompliance|0|||
124815041|NCT00622284|448952880|FG000|Overall Study|Lack of Efficacy|45|||
124815042|NCT00622284|448952881|FG001|Overall Study|Lack of Efficacy|15|||
124815043|NCT00622284|448952880|FG000|Overall Study|Adverse Event|61|||
124815044|NCT00622284|448952881|FG001|Overall Study|Adverse Event|90|||
124815045|NCT00622284|448952880|FG000|Overall Study|Protocol Violation|12|||
124815046|NCT00622284|448952881|FG001|Overall Study|Protocol Violation|5|||
124815047|NCT00622284|448952880|FG000|Overall Study|Lost to Follow-up|11|||
124815048|NCT00622284|448952881|FG001|Overall Study|Lost to Follow-up|13|||
124815049|NCT00622284|448952880|FG000|Overall Study|Withdrawal by Subject|27|||
124815050|NCT00622284|448952881|FG001|Overall Study|Withdrawal by Subject|24|||
124815051|NCT00622284|448952880|FG000|Overall Study|Other reason (not specified)|33|||
124815052|NCT00622284|448952881|FG001|Overall Study|Other reason (not specified)|24|||
124815053|NCT00880009|448952886|FG000|Overall Study|Study terminated by sponsor|14|||
124815054|NCT00880009|448952886|FG000|Overall Study|Withdrawal by Subject|1|||
124815055|NCT00880009|448952886|FG000|Overall Study|Protocol Violation|1|||
124815056|NCT00457301|448952887|FG000|Overall Study|Withdrawal by Subject|3|||
124815057|NCT00457301|448952888|FG001|Overall Study|Withdrawal by Subject|3|||
124815058|NCT00457301|448952887|FG000|Overall Study|Censored out of the study|15|||
124815059|NCT00457301|448952888|FG001|Overall Study|Censored out of the study|14|||
124815060|NCT00457301|448952887|FG000|Overall Study|Death|5|||
124815061|NCT00457301|448952888|FG001|Overall Study|Death|7|||
124815062|NCT03322631|448952889|FG000|Overall Study|Withdrawal by Subject|0|||
124815063|NCT03322631|448952890|FG001|Overall Study|Withdrawal by Subject|1|||
124815064|NCT03322631|448952891|FG002|Overall Study|Withdrawal by Subject|0|||
124815065|NCT03322631|448952892|FG003|Overall Study|Withdrawal by Subject|0|||
124815066|NCT03322631|448952889|FG000|Overall Study|Adverse Event|0|||
124815067|NCT03322631|448952890|FG001|Overall Study|Adverse Event|0|||
124815068|NCT03322631|448952891|FG002|Overall Study|Adverse Event|1|||
124815069|NCT03322631|448952892|FG003|Overall Study|Adverse Event|0|||
124815070|NCT02412618|448952893|FG000|Overall Study|Withdrawal by Subject|1|||
124815071|NCT02412618|448952894|FG001|Overall Study|Withdrawal by Subject|1|||
124815072|NCT02412618|448952893|FG000|Overall Study|Expulsion|1|||
124815073|NCT02412618|448952894|FG001|Overall Study|Expulsion|1|||
124815074|NCT02378961|448952896|FG000|Overall Study|Lack of Efficacy|4|||
124815075|NCT02378961|448952897|FG001|Overall Study|Lack of Efficacy|2|||
124815076|NCT02378961|448952898|FG002|Overall Study|Lack of Efficacy|0|||
124815077|NCT02378961|448952899|FG003|Overall Study|Lack of Efficacy|1|||
124815078|NCT02378961|448952896|FG000|Overall Study|Death|0|||
124815079|NCT02378961|448952897|FG001|Overall Study|Death|0|||
124815080|NCT02378961|448952898|FG002|Overall Study|Death|1|||
124815081|NCT02378961|448952899|FG003|Overall Study|Death|0|||
124815082|NCT01253408|448952900|FG000|Overall Study|Adverse Event|0|||
124815083|NCT01253408|448952901|FG001|Overall Study|Adverse Event|1|||
124815084|NCT01253408|448952902|FG002|Overall Study|Adverse Event|0|||
124815085|NCT01217801|448952903|FG000|Period 1|Protocol Violation|1|||
124815086|NCT01217801|448952904|FG001|Period 1|Protocol Violation|1|||
124815087|NCT01217801|448952903|FG000|Period 1|Withdrawal by Subject|0|||
124815088|NCT01217801|448952904|FG001|Period 1|Withdrawal by Subject|1|||
124815089|NCT03035409|448952908|FG000|Overall Study|Adverse Event|5|||
124815090|NCT03035409|448952908|FG000|Overall Study|Death|2|||
124815091|NCT03035409|448952908|FG000|Overall Study|Withdrawal by Subject|2|||
124815092|NCT03035409|448952908|FG000|Overall Study|Non compliance|4|||
124815093|NCT03035409|448952908|FG000|Overall Study|Patient was jittery|1|||
124815094|NCT03035409|448952908|FG000|Overall Study|Did not like Questionnaire|1|||
124815095|NCT03035409|448952908|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
124815096|NCT03035409|448952908|FG000|Overall Study|Did not like taking drugs|1|||
124815097|NCT00291577|448952911|FG000|Overall Study|Adverse Event|1|||
124815098|NCT00291577|448952911|FG000|Overall Study|Other|4|||
124815099|NCT00291577|448952911|FG000|Overall Study|Withdrawal by Subject|2|||
124815100|NCT00291577|448952911|FG000|Overall Study|Lack of Efficacy|14|||
124815101|NCT04967443|448952912|FG000|Open Label Treatment|Death|1|||
124815102|NCT04967443|448952913|FG001|Open Label Treatment|Death|0|||
124815103|NCT04967443|448952914|FG002|Open Label Treatment|Death|0|||
124815104|NCT04967443|448952915|FG003|Open Label Treatment|Death|0|||
124815105|NCT04967443|448952916|FG004|Open Label Treatment|Death|0|||
124815106|NCT04967443|448952917|FG005|Open Label Treatment|Death|0|||
124815107|NCT04967443|448952918|FG006|Open Label Treatment|Death|0|||
124815108|NCT04967443|448952919|FG007|Open Label Treatment|Death|0|||
124815109|NCT04967443|448952912|FG000|Open Label Treatment|Lost to Follow-up|0|||
124815110|NCT04967443|448952913|FG001|Open Label Treatment|Lost to Follow-up|0|||
124815111|NCT04967443|448952914|FG002|Open Label Treatment|Lost to Follow-up|1|||
124815112|NCT04967443|448952915|FG003|Open Label Treatment|Lost to Follow-up|0|||
124815113|NCT04967443|448952916|FG004|Open Label Treatment|Lost to Follow-up|0|||
124815114|NCT04967443|448952917|FG005|Open Label Treatment|Lost to Follow-up|0|||
124815115|NCT04967443|448952918|FG006|Open Label Treatment|Lost to Follow-up|0|||
124815116|NCT04967443|448952919|FG007|Open Label Treatment|Lost to Follow-up|0|||
124815117|NCT04967443|448952912|FG000|Open Label Treatment|Withdrawal by Subject|0|||
124815118|NCT04967443|448952913|FG001|Open Label Treatment|Withdrawal by Subject|1|||
124815119|NCT04967443|448952914|FG002|Open Label Treatment|Withdrawal by Subject|0|||
124815120|NCT04967443|448952915|FG003|Open Label Treatment|Withdrawal by Subject|1|||
124815121|NCT04967443|448952916|FG004|Open Label Treatment|Withdrawal by Subject|0|||
124815122|NCT04967443|448952917|FG005|Open Label Treatment|Withdrawal by Subject|1|||
124815123|NCT04967443|448952918|FG006|Open Label Treatment|Withdrawal by Subject|2|||
124815124|NCT04967443|448952919|FG007|Open Label Treatment|Withdrawal by Subject|3|||
124815125|NCT04967443|448952912|FG000|Follow-Up|Death|1|||
124815126|NCT04967443|448952913|FG001|Follow-Up|Death|0|||
124815127|NCT04967443|448952914|FG002|Follow-Up|Death|0|||
124815128|NCT04967443|448952915|FG003|Follow-Up|Death|0|||
124815129|NCT04967443|448952916|FG004|Follow-Up|Death|0|||
124815130|NCT04967443|448952917|FG005|Follow-Up|Death|0|||
124815131|NCT04967443|448952918|FG006|Follow-Up|Death|0|||
124815132|NCT04967443|448952919|FG007|Follow-Up|Death|0|||
124815133|NCT04967443|448952912|FG000|Follow-Up|Lost to Follow-up|0|||
124815134|NCT04967443|448952913|FG001|Follow-Up|Lost to Follow-up|0|||
124815135|NCT04967443|448952914|FG002|Follow-Up|Lost to Follow-up|1|||
124815136|NCT04967443|448952915|FG003|Follow-Up|Lost to Follow-up|1|||
124815137|NCT04967443|448952916|FG004|Follow-Up|Lost to Follow-up|0|||
124815138|NCT04967443|448952917|FG005|Follow-Up|Lost to Follow-up|0|||
124815139|NCT04967443|448952918|FG006|Follow-Up|Lost to Follow-up|0|||
124815140|NCT04967443|448952919|FG007|Follow-Up|Lost to Follow-up|0|||
124815141|NCT04967443|448952912|FG000|Follow-Up|Withdrawal by Subject|0|||
124815142|NCT04967443|448952913|FG001|Follow-Up|Withdrawal by Subject|1|||
124815143|NCT04967443|448952914|FG002|Follow-Up|Withdrawal by Subject|0|||
124815144|NCT04967443|448952915|FG003|Follow-Up|Withdrawal by Subject|1|||
124815145|NCT04967443|448952916|FG004|Follow-Up|Withdrawal by Subject|0|||
124815146|NCT04967443|448952917|FG005|Follow-Up|Withdrawal by Subject|1|||
124815147|NCT04967443|448952918|FG006|Follow-Up|Withdrawal by Subject|2|||
124815148|NCT04967443|448952919|FG007|Follow-Up|Withdrawal by Subject|3|||
124815149|NCT04502693|448952921|FG000|Overall Study|Adverse Event|7|||
124815150|NCT04502693|448952922|FG001|Overall Study|Adverse Event|6|||
124815151|NCT04502693|448952923|FG002|Overall Study|Adverse Event|11|||
124815152|NCT04502693|448952924|FG003|Overall Study|Adverse Event|1|||
124815153|NCT04502693|448952921|FG000|Overall Study|Lost to Follow-up|32|||
124815154|NCT04502693|448952922|FG001|Overall Study|Lost to Follow-up|36|||
124815155|NCT04502693|448952923|FG002|Overall Study|Lost to Follow-up|69|||
124815156|NCT04502693|448952924|FG003|Overall Study|Lost to Follow-up|4|||
124815157|NCT04502693|448952921|FG000|Overall Study|Protocol Violation|8|||
124815158|NCT04502693|448952922|FG001|Overall Study|Protocol Violation|8|||
124815159|NCT04502693|448952923|FG002|Overall Study|Protocol Violation|16|||
124815160|NCT04502693|448952924|FG003|Overall Study|Protocol Violation|1|||
124815161|NCT04502693|448952921|FG000|Overall Study|Withdrawal by Subject|46|||
124815162|NCT04502693|448952922|FG001|Overall Study|Withdrawal by Subject|38|||
124815163|NCT04502693|448952923|FG002|Overall Study|Withdrawal by Subject|54|||
124815164|NCT04502693|448952924|FG003|Overall Study|Withdrawal by Subject|7|||
124815165|NCT04502693|448952921|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
124815166|NCT04502693|448952922|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
124815167|NCT04502693|448952923|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
124815168|NCT04502693|448952924|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
124815169|NCT04502693|448952921|FG000|Overall Study|Other|1|||
124815170|NCT04502693|448952922|FG001|Overall Study|Other|0|||
124815171|NCT04502693|448952923|FG002|Overall Study|Other|1|||
124815172|NCT04502693|448952924|FG003|Overall Study|Other|1|||
124815173|NCT01552694|448952925|FG000|Overall Study|Lost to Follow-up|0|||
124815174|NCT01552694|448952926|FG001|Overall Study|Lost to Follow-up|1|||
124815175|NCT01552694|448952925|FG000|Overall Study|Protocol Violation|0|||
124815176|NCT01552694|448952926|FG001|Overall Study|Protocol Violation|1|||
124815177|NCT03943147|448952928|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
124815178|NCT03943147|448952929|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
124815179|NCT03943147|448952928|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
124815180|NCT03943147|448952929|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
124815181|NCT03943147|448952928|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
124815182|NCT03943147|448952929|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
124815183|NCT03943147|448952928|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
124815184|NCT03943147|448952929|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
124815185|NCT03943147|448952928|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
124815186|NCT03943147|448952929|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
124815187|NCT03943147|448952928|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
124815188|NCT03943147|448952929|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
124815189|NCT02756013|448952930|FG000|Overall Study|Adverse Event|1|||
124815190|NCT02756013|448952930|FG000|Overall Study|Hypersensitivity|1|||
124815191|NCT00629707|448952931|FG000|Overall Study|Withdrawal by Subject|0|||
124815192|NCT00629707|448952932|FG001|Overall Study|Withdrawal by Subject|1|||
124815193|NCT00629707|448952931|FG000|Overall Study|Physician Decision|0|||
124815194|NCT00629707|448952932|FG001|Overall Study|Physician Decision|1|||
124815195|NCT03724032|448952935|FG000|Overall Study|Physician Decision|1|||
124815196|NCT03724032|448952936|FG001|Overall Study|Physician Decision|0|||
124815197|NCT03724032|448952937|FG002|Overall Study|Physician Decision|0|||
124815198|NCT03724032|448952935|FG000|Overall Study|Protocol Violation|2|||
124815199|NCT03724032|448952936|FG001|Overall Study|Protocol Violation|2|||
124815200|NCT03724032|448952937|FG002|Overall Study|Protocol Violation|1|||
124815201|NCT00001880|448952941|FG000|Overall Study|Death|14|||
124815202|NCT02657369|448952942|FG000|Overall Study|Death|27|||
124815203|NCT02657369|448952942|FG000|Overall Study|Study terminated by sponsor|7|||
124815204|NCT02639065|448952943|FG000|Study Treatment|Disease Progression|13|||
124815205|NCT02639065|448952943|FG000|Study Treatment|Adverse Event|9|||
124815206|NCT02639065|448952943|FG000|Study Treatment|Withdrawal by Subject|1|||
124815207|NCT02639065|448952943|FG000|Follow up|Subject refused to follow up|1|||
124815208|NCT02639065|448952943|FG000|Follow up|Symptomatic Deterioration|2|||
124815209|NCT02639065|448952943|FG000|Follow up|Death|2|||
124815210|NCT02639065|448952943|FG000|Follow up|Study Terminated|1|||
124815211|NCT02639065|448952943|FG000|Follow up|Disease Progression|3|||
124815212|NCT00481078|448952944|FG000|Overall Study|Progression of disease|11|||
124819586|NCT00420927|448965766|FG005|Period 1|Lost to Follow-up|0|||
124815213|NCT00481078|448952945|FG001|Overall Study|Progression of disease|11|||
124815214|NCT00481078|448952944|FG000|Overall Study|Adverse Event|15|||
124815215|NCT00481078|448952945|FG001|Overall Study|Adverse Event|3|||
124815216|NCT00481078|448952944|FG000|Overall Study|Death|5|||
124815217|NCT00481078|448952945|FG001|Overall Study|Death|3|||
124815218|NCT00481078|448952944|FG000|Overall Study|Intercurrent illness|1|||
124815219|NCT00481078|448952945|FG001|Overall Study|Intercurrent illness|0|||
124815220|NCT00481078|448952944|FG000|Overall Study|Withdrawal by Subject|7|||
124815221|NCT00481078|448952945|FG001|Overall Study|Withdrawal by Subject|1|||
124815222|NCT00481078|448952944|FG000|Overall Study|Information not available|1|||
124815223|NCT00481078|448952945|FG001|Overall Study|Information not available|0|||
124815224|NCT00481078|448952944|FG000|Overall Study|Received other treatment|2|||
124815225|NCT00481078|448952945|FG001|Overall Study|Received other treatment|1|||
124815226|NCT00481078|448952944|FG000|Overall Study|Brain metastasis|0|||
124815227|NCT00481078|448952945|FG001|Overall Study|Brain metastasis|1|||
124815228|NCT01845831|448952946|FG000|Inpatient Phase|Withdrawal by Subject|1|||
124815229|NCT01845831|448952947|FG001|Inpatient Phase|Withdrawal by Subject|1|||
124815230|NCT01845831|448952948|FG002|Inpatient Phase|Withdrawal by Subject|0|||
124815231|NCT01845831|448952949|FG003|Inpatient Phase|Withdrawal by Subject|0|||
124815232|NCT01845831|448952950|FG004|Inpatient Phase|Withdrawal by Subject|0|||
124815233|NCT02610725|448952951|FG000|Overall Study|Lost to Follow-up|197|||
124815234|NCT02610725|448952951|FG000|Overall Study|self-reported contraindication|9|||
124815235|NCT04094883|448952952|FG000|Overall Study|Withdrawal by Subject|1|||
124815236|NCT00826943|448952953|FG000|Overall Study|Withdrawal by Subject|0|||
124815237|NCT00826943|448952954|FG001|Overall Study|Withdrawal by Subject|0|||
124815238|NCT00826943|448952955|FG002|Overall Study|Withdrawal by Subject|0|||
124815239|NCT00826943|448952956|FG003|Overall Study|Withdrawal by Subject|0|||
124815240|NCT00826943|448952957|FG004|Overall Study|Withdrawal by Subject|1|||
124815241|NCT00826943|448952958|FG005|Overall Study|Withdrawal by Subject|0|||
124815242|NCT01348165|448952959|FG000|Overall Study|Adverse Event|0|||
124815243|NCT01348165|448952960|FG001|Overall Study|Adverse Event|0|||
124815244|NCT01348165|448952961|FG002|Overall Study|Adverse Event|0|||
124815245|NCT01348165|448952962|FG003|Overall Study|Adverse Event|0|||
124815246|NCT01348165|448952963|FG004|Overall Study|Adverse Event|0|||
124815247|NCT01348165|448952964|FG005|Overall Study|Adverse Event|0|||
124815248|NCT01348165|448952965|FG006|Overall Study|Adverse Event|1|||
124815249|NCT00382252|448952966|FG000|Overall Study|Death|4|||
124815250|NCT00382252|448952966|FG000|Overall Study|Protocol Violation|8|||
124815251|NCT00382252|448952966|FG000|Overall Study|Not treated by RFA|1|||
124815252|NCT05570500|448952969|FG000|Overall Study|Lost to Follow-up|7|||
124815253|NCT05570500|448952970|FG001|Overall Study|Lost to Follow-up|5|||
124815254|NCT04706091|448952971|FG000|Treatment 2|Withdrawal by Subject|1|||
124815255|NCT04706091|448952972|FG001|Treatment 2|Withdrawal by Subject|0|||
124815256|NCT02612727|448952973|FG000|Overall Study|Parent request|4|||
124815257|NCT02612727|448952974|FG001|Overall Study|Parent request|1|||
124815258|NCT02612727|448952973|FG000|Overall Study|Needed treatment incompatible with PT|1|||
124815259|NCT02612727|448952974|FG001|Overall Study|Needed treatment incompatible with PT|1|||
124815260|NCT02612727|448952973|FG000|Overall Study|Direct hyperbilirubinemia|0|||
124815261|NCT02612727|448952974|FG001|Overall Study|Direct hyperbilirubinemia|2|||
124815262|NCT01063868|448952975|FG000|Overall Study|Adverse Event|9|||
124815263|NCT01063868|448952976|FG001|Overall Study|Adverse Event|7|||
124815264|NCT01063868|448952975|FG000|Overall Study|Withdrawal by Subject|3|||
124815265|NCT01063868|448952976|FG001|Overall Study|Withdrawal by Subject|1|||
124815266|NCT01063868|448952975|FG000|Overall Study|Study Terminated By Sponsor|23|||
124815267|NCT01063868|448952976|FG001|Overall Study|Study Terminated By Sponsor|4|||
124815268|NCT01446289|448952979|FG000|Overall Study|Withdrawal by Subject|1|||
124815269|NCT01446289|448952980|FG001|Overall Study|Withdrawal by Subject|0|||
124815270|NCT01446289|448952981|FG002|Overall Study|Withdrawal by Subject|1|||
124815271|NCT01446289|448952982|FG003|Overall Study|Withdrawal by Subject|0|||
124815272|NCT02302807|448952983|FG000|Overall Study|Withdrawal by Subject|28|||
124815273|NCT02302807|448952984|FG001|Overall Study|Withdrawal by Subject|11|||
124815274|NCT02302807|448952983|FG000|Overall Study|Lost to Follow-up|4|||
124815275|NCT02302807|448952984|FG001|Overall Study|Lost to Follow-up|6|||
124815276|NCT02302807|448952983|FG000|Overall Study|Death|397|||
124815277|NCT02302807|448952984|FG001|Overall Study|Death|385|||
124815278|NCT02302807|448952983|FG000|Overall Study|Study Terminated By Sponsor|35|||
124815279|NCT02302807|448952984|FG001|Overall Study|Study Terminated By Sponsor|64|||
124815280|NCT02302807|448952983|FG000|Overall Study|Physician Decision|0|||
124815281|NCT02302807|448952984|FG001|Overall Study|Physician Decision|1|||
124815282|NCT03329573|448952985|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
124815283|NCT03329573|448952986|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
124815284|NCT03329573|448952987|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
124815285|NCT03329573|448952988|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
124815286|NCT03329573|448952985|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
124815287|NCT03329573|448952986|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
124815288|NCT03329573|448952987|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124815289|NCT03329573|448952988|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124815290|NCT03329573|448952985|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
124815291|NCT03329573|448952986|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
124815292|NCT03329573|448952987|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
124815293|NCT03329573|448952988|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
124815294|NCT03329573|448952985|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
124815295|NCT03329573|448952986|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
124815296|NCT03329573|448952987|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
124815297|NCT03329573|448952988|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
124815298|NCT03307967|448952991|FG000|Overall Study|Lost to Follow-up|4|||
124815299|NCT02578316|448952992|FG000|Extension Phase|Progression of disease|6|||
124815300|NCT02166905|448952993|FG000|Overall Study|Withdrawal by Subject|1|||
124815301|NCT02166905|448952994|FG001|Overall Study|Withdrawal by Subject|0|||
124815302|NCT02166905|448952995|FG002|Overall Study|Withdrawal by Subject|0|||
124815303|NCT02166905|448952996|FG003|Overall Study|Withdrawal by Subject|0|||
124815304|NCT02617628|448952997|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
124815305|NCT02617628|448952998|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
124815306|NCT03278873|448953002|FG000|Overall Study|Withdrawal by Subject|0|||
124815307|NCT03278873|448953003|FG001|Overall Study|Withdrawal by Subject|1|||
124815308|NCT03278873|448953004|FG002|Overall Study|Withdrawal by Subject|0|||
124815309|NCT03278873|448953005|FG003|Overall Study|Withdrawal by Subject|0|||
124815310|NCT03278873|448953002|FG000|Overall Study|Sponsor's decision|0|||
124815311|NCT03278873|448953003|FG001|Overall Study|Sponsor's decision|1|||
124815312|NCT03278873|448953004|FG002|Overall Study|Sponsor's decision|0|||
124815313|NCT03278873|448953005|FG003|Overall Study|Sponsor's decision|0|||
124815314|NCT03278873|448953002|FG000|Overall Study|Early Termination|2|||
124815315|NCT03278873|448953003|FG001|Overall Study|Early Termination|6|||
124815316|NCT03278873|448953004|FG002|Overall Study|Early Termination|0|||
124815317|NCT03278873|448953005|FG003|Overall Study|Early Termination|4|||
124815318|NCT03278873|448953002|FG000|Overall Study|Lost to Follow-up|0|||
124815319|NCT03278873|448953003|FG001|Overall Study|Lost to Follow-up|0|||
124815320|NCT03278873|448953004|FG002|Overall Study|Lost to Follow-up|2|||
124815321|NCT03278873|448953005|FG003|Overall Study|Lost to Follow-up|0|||
124815322|NCT03278873|448953002|FG000|Overall Study|The patient decided to withdraw via email|1|||
124815323|NCT03278873|448953003|FG001|Overall Study|The patient decided to withdraw via email|0|||
124815324|NCT03278873|448953004|FG002|Overall Study|The patient decided to withdraw via email|0|||
124815325|NCT03278873|448953005|FG003|Overall Study|The patient decided to withdraw via email|0|||
124815326|NCT03278873|448953002|FG000|Overall Study|The patient was unresponsive to contact|0|||
124815327|NCT03278873|448953003|FG001|Overall Study|The patient was unresponsive to contact|0|||
124815328|NCT03278873|448953004|FG002|Overall Study|The patient was unresponsive to contact|0|||
124815329|NCT03278873|448953005|FG003|Overall Study|The patient was unresponsive to contact|4|||
124815330|NCT03278873|448953002|FG000|Overall Study|The patient wished to participate no longer|0|||
124815331|NCT03278873|448953003|FG001|Overall Study|The patient wished to participate no longer|1|||
124815332|NCT03278873|448953004|FG002|Overall Study|The patient wished to participate no longer|0|||
124815333|NCT03278873|448953005|FG003|Overall Study|The patient wished to participate no longer|0|||
124815334|NCT03278873|448953002|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
124815335|NCT03278873|448953003|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
124815336|NCT03278873|448953004|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
124815337|NCT03278873|448953005|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
124815338|NCT05243641|448953006|FG000|Overall Study|Adverse Event|3|||
124815339|NCT05243641|448953007|FG001|Overall Study|Adverse Event|0|||
124815340|NCT05243641|448953008|FG002|Overall Study|Adverse Event|0|||
124815341|NCT05243641|448953009|FG003|Overall Study|Adverse Event|1|||
124815342|NCT05243641|448953010|FG004|Overall Study|Adverse Event|0|||
124815343|NCT05243641|448953011|FG005|Overall Study|Adverse Event|0|||
124815344|NCT05243641|448953006|FG000|Overall Study|Disease progression|4|||
124815345|NCT05243641|448953007|FG001|Overall Study|Disease progression|0|||
124815346|NCT05243641|448953008|FG002|Overall Study|Disease progression|0|||
124815347|NCT05243641|448953009|FG003|Overall Study|Disease progression|2|||
124815348|NCT05243641|448953010|FG004|Overall Study|Disease progression|0|||
124815349|NCT05243641|448953011|FG005|Overall Study|Disease progression|0|||
124815350|NCT04518306|448953012|FG000|Double-Blind Period|Run in failure|0|||
124815351|NCT04518306|448953013|FG001|Double-Blind Period|Run in failure|0|||
124815352|NCT04518306|448953014|FG002|Double-Blind Period|Run in failure|1|||
124815353|NCT04518306|448953012|FG000|Double-Blind Period|Adverse Event|0|||
124815354|NCT04518306|448953013|FG001|Double-Blind Period|Adverse Event|2|||
124815355|NCT04518306|448953014|FG002|Double-Blind Period|Adverse Event|2|||
124815356|NCT04518306|448953012|FG000|Double-Blind Period|Lost to Follow-up|1|||
124815357|NCT04518306|448953013|FG001|Double-Blind Period|Lost to Follow-up|2|||
124815358|NCT04518306|448953014|FG002|Double-Blind Period|Lost to Follow-up|2|||
124815359|NCT04518306|448953012|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
124815360|NCT04518306|448953013|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
124815361|NCT04518306|448953014|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
124815362|NCT04518306|448953012|FG000|Double-Blind Period|Other|0|||
124815363|NCT04518306|448953013|FG001|Double-Blind Period|Other|2|||
124815364|NCT04518306|448953014|FG002|Double-Blind Period|Other|0|||
124815365|NCT04518306|448953012|FG000|Double-Blind Period|Missing|0|||
124815366|NCT04518306|448953013|FG001|Double-Blind Period|Missing|1|||
124815367|NCT04518306|448953014|FG002|Double-Blind Period|Missing|0|||
124815368|NCT05372419|448953015|FG000|Overall Study|Protocol Deviation|1|||
124815369|NCT05372419|448953015|FG000|Overall Study|Withdrawal by Subject|5|||
124815370|NCT05372419|448953015|FG000|Overall Study|Lost to Follow-up|7|||
124815371|NCT02801331|448953016|FG000|Overall Study|Transferred to another hospital|8|||
124815372|NCT02801331|448953017|FG001|Overall Study|Transferred to another hospital|7|||
124815373|NCT02801331|448953016|FG000|Overall Study|Withdrawal by Subject|0|||
124815374|NCT02801331|448953017|FG001|Overall Study|Withdrawal by Subject|4|||
124815375|NCT02801331|448953016|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
124815376|NCT02801331|448953017|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
124815377|NCT03253744|448953019|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
124815378|NCT03253744|448953020|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
124815379|NCT03253744|448953021|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
124815380|NCT03253744|448953022|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
124815381|NCT04698187|448953031|FG000|Overall Study|Withdrawal by Subject|7|||
124815382|NCT04698187|448953031|FG000|Overall Study|Death|21|||
124815383|NCT04698187|448953031|FG000|Overall Study|Sponsor Decision|15|||
124815384|NCT04698187|448953031|FG000|Overall Study|In-transit Disease|1|||
124815385|NCT03904043|448953032|FG000|Overall Study|Adverse Event|1|||
124815386|NCT03904043|448953033|FG001|Overall Study|Adverse Event|1|||
124815387|NCT03904043|448953032|FG000|Overall Study|Withdrawal by Subject|1|||
124815388|NCT03904043|448953033|FG001|Overall Study|Withdrawal by Subject|0|||
124815389|NCT03904043|448953032|FG000|Overall Study|Non-compliance|1|||
124815390|NCT03904043|448953033|FG001|Overall Study|Non-compliance|0|||
124815391|NCT03904043|448953032|FG000|Overall Study|Did not start treatment|1|||
124815392|NCT03904043|448953033|FG001|Overall Study|Did not start treatment|0|||
124815393|NCT04362072|448953034|FG000|Treatment|Adverse Event|1|||
124815394|NCT04362072|448953034|FG000|Treatment|Death|9|||
124815395|NCT04362072|448953034|FG000|Treatment|Physician Decision|2|||
124815396|NCT04362072|448953034|FG000|Treatment|Progressive disease|27|||
124815397|NCT04362072|448953034|FG000|Treatment|Withdrawal by Subject|4|||
124815398|NCT04362072|448953034|FG000|Treatment|Global deterioration of health status|1|||
124815399|NCT04362072|448953034|FG000|Treatment|Switched to commercial Lorlatinib|13|||
124815400|NCT04362072|448953034|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
124815401|NCT04362072|448953034|FG000|Treatment|Other|3|||
124815402|NCT04362072|448953034|FG000|Follow up|Death|2|||
124815403|NCT04362072|448953034|FG000|Follow up|Other|2|||
124815404|NCT01133522|448953035|FG000|Overall Study|Withdrawal by Subject|0|||
124815405|NCT01133522|448953036|FG001|Overall Study|Withdrawal by Subject|1|||
124815406|NCT01133522|448953037|FG002|Overall Study|Withdrawal by Subject|0|||
124815407|NCT01133522|448953038|FG003|Overall Study|Withdrawal by Subject|1|||
124815408|NCT01133522|448953039|FG004|Overall Study|Withdrawal by Subject|0|||
124815409|NCT01133522|448953040|FG005|Overall Study|Withdrawal by Subject|0|||
124815410|NCT01133522|448953041|FG006|Overall Study|Withdrawal by Subject|0|||
124815411|NCT01133522|448953042|FG007|Overall Study|Withdrawal by Subject|0|||
124815412|NCT01133522|448953043|FG008|Overall Study|Withdrawal by Subject|0|||
124815413|NCT01133522|448953044|FG009|Overall Study|Withdrawal by Subject|0|||
124815414|NCT01133522|448953035|FG000|Overall Study|Physician Decision|0|||
124815415|NCT01133522|448953036|FG001|Overall Study|Physician Decision|0|||
124815416|NCT01133522|448953037|FG002|Overall Study|Physician Decision|0|||
124815417|NCT01133522|448953038|FG003|Overall Study|Physician Decision|0|||
124815418|NCT01133522|448953039|FG004|Overall Study|Physician Decision|1|||
124815419|NCT01133522|448953040|FG005|Overall Study|Physician Decision|0|||
124815420|NCT01133522|448953041|FG006|Overall Study|Physician Decision|0|||
124815421|NCT01133522|448953042|FG007|Overall Study|Physician Decision|0|||
124815422|NCT01133522|448953043|FG008|Overall Study|Physician Decision|0|||
124815423|NCT01133522|448953044|FG009|Overall Study|Physician Decision|0|||
124815424|NCT00381485|448954671|FG000|Open-Label Run-In Period|Adverse Event|9|||
124815425|NCT00381485|448954672|FG001|Open-Label Run-In Period|Adverse Event|0|||
124815426|NCT00381485|448954673|FG002|Open-Label Run-In Period|Adverse Event|0|||
124815427|NCT00381485|448954674|FG003|Open-Label Run-In Period|Adverse Event|0|||
124815428|NCT00381485|448954671|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
124815429|NCT00381485|448954672|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
124815430|NCT00381485|448954673|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
124815431|NCT00381485|448954674|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
124815432|NCT00381485|448954671|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
124815433|NCT00381485|448954672|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
124815434|NCT00381485|448954673|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
124815435|NCT00381485|448954674|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
124815436|NCT00381485|448954671|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
124815437|NCT00381485|448954672|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
124815438|NCT00381485|448954673|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
124815439|NCT00381485|448954674|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
124815440|NCT00381485|448954671|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
124815441|NCT00381485|448954672|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
124815442|NCT00381485|448954673|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
124815443|NCT00381485|448954674|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
124815444|NCT00381485|448954671|FG000|Open-Label Run-In Period|Treatment failure|1|||
125302098|NCT00383162|450731925|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
125302099|NCT00383162|450731924|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
125302100|NCT00383162|450731925|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
125302101|NCT00383162|450731924|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
125302102|NCT00383162|450731925|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
125302103|NCT00383162|450731924|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
125302104|NCT00383162|450731925|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
125302105|NCT00383162|450731924|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
125302106|NCT00383162|450731925|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
125302107|NCT05392803|450731926|FG000|Overall Study|Lost to Follow-up|0|||
125302108|NCT05392803|450731927|FG001|Overall Study|Lost to Follow-up|2|||
125302109|NCT01069705|450731928|FG000|Overall Study|Adverse Event|1|||
125302110|NCT01069705|450731928|FG000|Overall Study|Withdrawal by Subject|2|||
125302111|NCT02726022|450731929|FG000|Overall Study|Adverse Event|14|||
125302112|NCT02726022|450731929|FG000|Overall Study|Treatment Failure|8|||
125302113|NCT02726022|450731929|FG000|Overall Study|Poor Compliance|13|||
125302114|NCT02726022|450731929|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
125302115|NCT00915551|450731930|FG000|Overall Study|Withdrawal by Subject|0|||
125302116|NCT00915551|450731931|FG001|Overall Study|Withdrawal by Subject|1|||
125302117|NCT00235716|450731932|FG000|Overall Study|Death|26|||
125302118|NCT00235716|450731933|FG001|Overall Study|Death|39|||
125302119|NCT00235716|450731934|FG002|Overall Study|Death|32|||
125302120|NCT00235716|450731935|FG003|Overall Study|Death|31|||
125302121|NCT00235716|450731932|FG000|Overall Study|Withdrawal by Subject|23|||
125302122|NCT00235716|450731933|FG001|Overall Study|Withdrawal by Subject|19|||
125302123|NCT00235716|450731934|FG002|Overall Study|Withdrawal by Subject|17|||
125302124|NCT00235716|450731935|FG003|Overall Study|Withdrawal by Subject|18|||
125302125|NCT00235716|450731932|FG000|Overall Study|Lost to Follow-up|12|||
125302126|NCT00235716|450731933|FG001|Overall Study|Lost to Follow-up|7|||
125302127|NCT00235716|450731934|FG002|Overall Study|Lost to Follow-up|14|||
125302128|NCT00235716|450731935|FG003|Overall Study|Lost to Follow-up|10|||
125302129|NCT00235716|450731932|FG000|Overall Study|Adverse Event|1|||
125302130|NCT00235716|450731933|FG001|Overall Study|Adverse Event|1|||
125302131|NCT00235716|450731934|FG002|Overall Study|Adverse Event|1|||
125302132|NCT00235716|450731935|FG003|Overall Study|Adverse Event|0|||
125302133|NCT00235716|450731932|FG000|Overall Study|Physician Decision|0|||
125302134|NCT00235716|450731933|FG001|Overall Study|Physician Decision|1|||
125302135|NCT00235716|450731934|FG002|Overall Study|Physician Decision|1|||
125302136|NCT00235716|450731935|FG003|Overall Study|Physician Decision|3|||
125302137|NCT04390841|450731936|FG000|Overall Study|Withdrawal by Subject|2|||
125302138|NCT02188849|450731947|FG000|Overall Study|Lost to Follow-up|3|||
125302139|NCT02188849|450731948|FG001|Overall Study|Lost to Follow-up|8|||
125302140|NCT05090852|450731959|FG000|Overall Study|Physician Decision|5|||
125302141|NCT01196416|450731960|FG000|Overall Study|Withdrawal by Subject|2|||
125302142|NCT00504894|450731961|FG000|Overall Study|fMRI technical problems|1|||
125302143|NCT00504894|450731962|FG001|Overall Study|fMRI technical problems|1|||
125302144|NCT00504894|450731963|FG002|Overall Study|fMRI technical problems|0|||
125302145|NCT00504894|450731961|FG000|Overall Study|Withdrawal by Subject|0|||
125302146|NCT00504894|450731962|FG001|Overall Study|Withdrawal by Subject|1|||
125302147|NCT00504894|450731963|FG002|Overall Study|Withdrawal by Subject|0|||
125302148|NCT00504894|450731961|FG000|Overall Study|Infusion technical problems|0|||
125302149|NCT00504894|450731962|FG001|Overall Study|Infusion technical problems|1|||
125302150|NCT00504894|450731963|FG002|Overall Study|Infusion technical problems|0|||
124815445|NCT00381485|448954672|FG001|Open-Label Run-In Period|Treatment failure|0|||
124815446|NCT00381485|448954673|FG002|Open-Label Run-In Period|Treatment failure|0|||
125302151|NCT00504894|450731961|FG000|Overall Study|poor subject data|2|||
125302152|NCT00504894|450731962|FG001|Overall Study|poor subject data|0|||
125302153|NCT00504894|450731963|FG002|Overall Study|poor subject data|0|||
125302154|NCT00148941|450731965|FG000|Overall Study|Lost to Follow-up|17|||
125302155|NCT00148941|450731966|FG001|Overall Study|Lost to Follow-up|24|||
125302156|NCT00148941|450731967|FG002|Overall Study|Lost to Follow-up|18|||
125302157|NCT00148941|450731968|FG003|Overall Study|Lost to Follow-up|22|||
125302158|NCT00148941|450731965|FG000|Overall Study|Withdrawal by Subject|1|||
125302159|NCT00148941|450731966|FG001|Overall Study|Withdrawal by Subject|0|||
125302160|NCT00148941|450731967|FG002|Overall Study|Withdrawal by Subject|1|||
125302161|NCT00148941|450731968|FG003|Overall Study|Withdrawal by Subject|0|||
125302162|NCT00148941|450731965|FG000|Overall Study|Other|0|||
125302163|NCT00148941|450731966|FG001|Overall Study|Other|0|||
125302164|NCT00148941|450731967|FG002|Overall Study|Other|1|||
125302165|NCT00148941|450731968|FG003|Overall Study|Other|2|||
125302166|NCT03244826|450731969|FG000|Overall Study|Withdrawal by Subject|2|||
125302167|NCT03244826|450731970|FG001|Overall Study|Withdrawal by Subject|0|||
125302168|NCT03244826|450731969|FG000|Overall Study|Transplant delayed or withdrawn|12|||
125302169|NCT03244826|450731970|FG001|Overall Study|Transplant delayed or withdrawn|10|||
125302170|NCT02673684|450731971|FG000|Overall Study|Study not completed d/t loss of funding|9|||
125302171|NCT02673684|450731972|FG001|Overall Study|Study not completed d/t loss of funding|8|||
125302172|NCT00416455|450731978|FG000|Overall Study|PET / CT not done|3|||
125302173|NCT00416455|450731979|FG001|Overall Study|PET / CT not done|5|||
125302174|NCT00416455|450731978|FG000|Overall Study|PET / CT poor quality|2|||
125302175|NCT00416455|450731979|FG001|Overall Study|PET / CT poor quality|1|||
125302176|NCT00416455|450731978|FG000|Overall Study|Inadequate pathology|11|||
125302177|NCT00416455|450731979|FG001|Overall Study|Inadequate pathology|2|||
125302178|NCT04079114|450731981|FG000|Overall Study|Study prematuely terminated.|166|||
125302179|NCT04699461|450731988|FG000|Overall Study|Withdrawal by Subject|1|||
125302180|NCT04699461|450731989|FG001|Overall Study|Withdrawal by Subject|0|||
125302181|NCT04699461|450731988|FG000|Overall Study|Study termination by sponsor|2|||
125302182|NCT04699461|450731989|FG001|Overall Study|Study termination by sponsor|1|||
125302183|NCT04699461|450731988|FG000|Overall Study|Death|1|||
125302184|NCT04699461|450731989|FG001|Overall Study|Death|0|||
125302185|NCT04699461|450731988|FG000|Overall Study|Radiographic progression|0|||
125302186|NCT04699461|450731989|FG001|Overall Study|Radiographic progression|1|||
125302187|NCT03068767|450731991|FG000|Overall Study|Lost to Follow-up|7|||
124815447|NCT00381485|448954674|FG003|Open-Label Run-In Period|Treatment failure|0|||
124815448|NCT00381485|448954671|FG000|Double-Blind Treatment Period|Adverse Event|0|||
124815449|NCT00381485|448954672|FG001|Double-Blind Treatment Period|Adverse Event|2|||
124815450|NCT00381485|448954673|FG002|Double-Blind Treatment Period|Adverse Event|2|||
124815451|NCT00381485|448954674|FG003|Double-Blind Treatment Period|Adverse Event|5|||
124815452|NCT00381485|448954671|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
124815453|NCT00381485|448954672|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
124815454|NCT00381485|448954673|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
124815455|NCT00381485|448954674|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
124815456|NCT00381485|448954671|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
124815457|NCT00381485|448954672|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
124815458|NCT00381485|448954673|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
124815459|NCT00381485|448954674|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
124815460|NCT00381485|448954671|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
124815461|NCT00381485|448954672|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
124815462|NCT00381485|448954673|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
124815463|NCT00381485|448954674|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
124815464|NCT00381485|448954671|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
124815465|NCT00381485|448954672|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
124815466|NCT00381485|448954673|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
124815467|NCT00381485|448954674|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
124815468|NCT00381485|448954671|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
124815469|NCT00381485|448954672|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
124815470|NCT00381485|448954673|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
124815471|NCT00381485|448954674|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
124815472|NCT00381485|448954671|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
124815473|NCT00381485|448954672|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
124815474|NCT00381485|448954673|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
124815475|NCT00381485|448954674|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
124815476|NCT00381485|448954671|FG000|Double-Blind Treatment Period|Administrative|0|||
124815477|NCT00381485|448954672|FG001|Double-Blind Treatment Period|Administrative|1|||
124815478|NCT00381485|448954673|FG002|Double-Blind Treatment Period|Administrative|0|||
124815479|NCT00381485|448954674|FG003|Double-Blind Treatment Period|Administrative|1|||
124815480|NCT00126191|448954677|FG000|Overall Study|Physician Decision|0|||
124815481|NCT00126191|448954678|FG001|Overall Study|Physician Decision|1|||
124815482|NCT00126191|448954677|FG000|Overall Study|Death|0|||
124815483|NCT00126191|448954678|FG001|Overall Study|Death|1|||
124815484|NCT01898806|448954679|FG000|Overall Study|Withdrawal by Subject|2|||
124815485|NCT01898806|448954679|FG000|Overall Study|Physician Decision|1|||
125302188|NCT03068767|450731992|FG001|Overall Study|Lost to Follow-up|3|||
125302189|NCT03068767|450731991|FG000|Overall Study|Protocol Violation|3|||
125302190|NCT03068767|450731992|FG001|Overall Study|Protocol Violation|0|||
125302191|NCT00061633|450731993|FG000|Overall Study|Adverse Event|1|||
125302192|NCT00061633|450731994|FG001|Overall Study|Adverse Event|2|||
125302193|NCT00061633|450731993|FG000|Overall Study|Withdrawal by Subject|2|||
125302194|NCT00061633|450731994|FG001|Overall Study|Withdrawal by Subject|2|||
125302195|NCT00061633|450731993|FG000|Overall Study|Lost to Follow-up|1|||
125302196|NCT00061633|450731994|FG001|Overall Study|Lost to Follow-up|4|||
125302197|NCT00061633|450731993|FG000|Overall Study|Other|1|||
125302198|NCT00061633|450731994|FG001|Overall Study|Other|1|||
125302199|NCT00061633|450731993|FG000|Overall Study|Never received study treatment|0|||
125302200|NCT00061633|450731994|FG001|Overall Study|Never received study treatment|2|||
125302201|NCT02921087|450731997|FG000|Overall Study|Withdrawal by Subject|0|||
125302202|NCT02921087|450731998|FG001|Overall Study|Withdrawal by Subject|1|||
125302203|NCT00687531|450731999|FG000|Overall Study|Did not meet protocol eligibility|104|||
125302204|NCT00687531|450731999|FG000|Overall Study|Adverse Event|5|||
125302205|NCT00687531|450731999|FG000|Overall Study|Lost to Follow-up|26|||
125302206|NCT03848949|450732000|FG000|Overall Study|Lost to Follow-up|5|||
125302207|NCT03848949|450732001|FG001|Overall Study|Lost to Follow-up|7|||
125302208|NCT02353728|450732002|FG000|Overall Study|Subject non-compliance|1|||
125302209|NCT02301624|450732005|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
125302210|NCT02301624|450732006|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
125302211|NCT02301624|450732005|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
125302212|NCT02301624|450732006|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
125302213|NCT02301624|450732005|FG000|Open-label Maintenance Phase|Adverse Event|2|||
125302214|NCT02301624|450732006|FG001|Open-label Maintenance Phase|Adverse Event|5|||
125302215|NCT02301624|450732005|FG000|Open-label Maintenance Phase|Physician Decision|3|||
125302216|NCT02301624|450732006|FG001|Open-label Maintenance Phase|Physician Decision|3|||
125302217|NCT02301624|450732005|FG000|Open-label Maintenance Phase|Death|2|||
125302218|NCT02301624|450732006|FG001|Open-label Maintenance Phase|Death|1|||
125302219|NCT02301624|450732005|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
125302220|NCT02301624|450732006|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
125302221|NCT00895310|450732007|FG000|Overall Study|Withdrawal by Subject|1|||
125302222|NCT03109184|450733919|FG000|Overall Study|Lost to Follow-up|6|||
125302223|NCT03109184|450733920|FG001|Overall Study|Lost to Follow-up|6|||
125302224|NCT03109184|450733919|FG000|Overall Study|Withdrawal by Subject|1|||
125302225|NCT03109184|450733920|FG001|Overall Study|Withdrawal by Subject|1|||
125302226|NCT00602420|450733921|FG000|Overall Study|Death|1|||
125302227|NCT00602420|450733922|FG001|Overall Study|Death|4|||
125302228|NCT00602420|450733921|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
125302229|NCT00602420|450733922|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
125302230|NCT00602420|450733921|FG000|Overall Study|Withdrawal by Subject|18|||
125302231|NCT00602420|450733922|FG001|Overall Study|Withdrawal by Subject|17|||
125302232|NCT00602420|450733921|FG000|Overall Study|Adverse Event|1|||
125302233|NCT00602420|450733922|FG001|Overall Study|Adverse Event|0|||
125302234|NCT00703924|450733931|FG000|Overall Study|Withdrawal by Subject|1|||
125302235|NCT00703924|450733932|FG001|Overall Study|Withdrawal by Subject|1|||
125302236|NCT03077919|450733933|FG000|Overall Study|Lost to Follow-up|4|||
125302237|NCT03077919|450733934|FG001|Overall Study|Lost to Follow-up|1|||
125302238|NCT01031979|450733937|FG000|Overall Study|Lost to Follow-up|5|||
125302239|NCT01031979|450733938|FG001|Overall Study|Lost to Follow-up|4|||
125302240|NCT03592368|450733940|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
125302241|NCT03592368|450733941|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
125302242|NCT03592368|450733942|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
125302243|NCT03592368|450733943|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
125302244|NCT03592368|450733940|FG000|Overall Study|Adverse Event|0|||
125302245|NCT03592368|450733941|FG001|Overall Study|Adverse Event|0|||
125302246|NCT03592368|450733942|FG002|Overall Study|Adverse Event|0|||
125302247|NCT03592368|450733943|FG003|Overall Study|Adverse Event|1|||
125302248|NCT03592368|450733940|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
125302249|NCT03592368|450733941|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
125302250|NCT03592368|450733942|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
125302251|NCT03592368|450733943|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
125302252|NCT03831100|450733944|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
125302253|NCT03831100|450733945|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
125302254|NCT02008227|450733949|FG000|Overall Study|Lost to Follow-up|7|||
125302255|NCT02008227|450733950|FG001|Overall Study|Lost to Follow-up|9|||
125302256|NCT02008227|450733949|FG000|Overall Study|Death|494|||
125302257|NCT02008227|450733950|FG001|Overall Study|Death|485|||
125302258|NCT02008227|450733949|FG000|Overall Study|Withdrawal by Subject|67|||
125302259|NCT02008227|450733950|FG001|Overall Study|Withdrawal by Subject|36|||
124815486|NCT01648101|448954680|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
124815487|NCT01648101|448954681|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
125302260|NCT02008227|450733949|FG000|Overall Study|Study Terminated By Sponsor|44|||
124815488|NCT01648101|448954682|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
125302261|NCT02008227|450733950|FG001|Overall Study|Study Terminated By Sponsor|83|||
124815489|NCT01648101|448954680|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
124815490|NCT01648101|448954681|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
124815491|NCT01648101|448954682|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
124815492|NCT01648101|448954680|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
124815493|NCT01648101|448954681|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
124815494|NCT01648101|448954682|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
124815495|NCT01648101|448954680|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
124815496|NCT01648101|448954681|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
124815497|NCT01648101|448954682|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
124815498|NCT01648101|448954680|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
124815499|NCT01648101|448954681|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
124815500|NCT01648101|448954682|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
124815501|NCT01648101|448954680|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
124815502|NCT01648101|448954681|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
124815503|NCT01648101|448954682|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
125302262|NCT01618695|450733954|FG000|Core Phase|Adverse Event|4|||
125302263|NCT01618695|450733955|FG001|Core Phase|Adverse Event|5|||
125302264|NCT01618695|450733956|FG002|Core Phase|Adverse Event|15|||
125302265|NCT01618695|450733957|FG003|Core Phase|Adverse Event|20|||
125302266|NCT01618695|450733954|FG000|Core Phase|Lost to Follow-up|0|||
124815504|NCT01648101|448954680|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
124815505|NCT01648101|448954681|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
124815506|NCT01648101|448954682|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
124815507|NCT01648101|448954680|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
124815508|NCT01648101|448954681|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
124815509|NCT01648101|448954682|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
124815510|NCT01648101|448954680|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
124815511|NCT01648101|448954681|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
125302267|NCT01618695|450733955|FG001|Core Phase|Lost to Follow-up|0|||
125302268|NCT01618695|450733956|FG002|Core Phase|Lost to Follow-up|1|||
124815512|NCT01648101|448954682|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
124815513|NCT01648101|448954680|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
124815514|NCT01648101|448954681|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
124815515|NCT01648101|448954682|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
124815516|NCT01648101|448954680|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
124815517|NCT01648101|448954681|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
124815518|NCT01648101|448954682|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
124815519|NCT02469298|448954696|FG000|Overall Study|Protocol Violation|0|||
124815520|NCT02469298|448954697|FG001|Overall Study|Protocol Violation|1|||
124815521|NCT02469298|448954698|FG002|Overall Study|Protocol Violation|1|||
124815522|NCT02469298|448954699|FG003|Overall Study|Protocol Violation|0|||
124815523|NCT02469298|448954696|FG000|Overall Study|Lost to Follow-up|1|||
124815524|NCT02469298|448954697|FG001|Overall Study|Lost to Follow-up|0|||
124815525|NCT02469298|448954698|FG002|Overall Study|Lost to Follow-up|1|||
124815526|NCT02469298|448954699|FG003|Overall Study|Lost to Follow-up|0|||
124815527|NCT02469298|448954696|FG000|Overall Study|Physician Decision|0|||
124815528|NCT02469298|448954697|FG001|Overall Study|Physician Decision|0|||
124815529|NCT02469298|448954698|FG002|Overall Study|Physician Decision|0|||
124815530|NCT02469298|448954699|FG003|Overall Study|Physician Decision|1|||
124815531|NCT02469298|448954696|FG000|Overall Study|Withdrawal by Subject|0|||
124815532|NCT02469298|448954697|FG001|Overall Study|Withdrawal by Subject|0|||
124815533|NCT02469298|448954698|FG002|Overall Study|Withdrawal by Subject|0|||
124815534|NCT02469298|448954699|FG003|Overall Study|Withdrawal by Subject|1|||
124815535|NCT03000439|448954702|FG000|Open Label Part 1|Adverse Event|6|||
124815536|NCT03000439|448954703|FG001|Open Label Part 1|Adverse Event|0|||
125302269|NCT01618695|450733957|FG003|Core Phase|Lost to Follow-up|0|||
125302270|NCT01618695|450733954|FG000|Core Phase|Withdrawal by Subject|16|||
125302271|NCT01618695|450733955|FG001|Core Phase|Withdrawal by Subject|11|||
125302272|NCT01618695|450733956|FG002|Core Phase|Withdrawal by Subject|9|||
125302273|NCT01618695|450733957|FG003|Core Phase|Withdrawal by Subject|13|||
125302274|NCT01618695|450733954|FG000|Core Phase|Pregnancy|2|||
125302275|NCT01618695|450733955|FG001|Core Phase|Pregnancy|0|||
124815537|NCT03000439|448954704|FG002|Open Label Part 1|Adverse Event|0|||
124815538|NCT03000439|448954705|FG003|Open Label Part 1|Adverse Event|0|||
124815539|NCT03000439|448954702|FG000|Open Label Part 1|Other|2|||
124815540|NCT03000439|448954703|FG001|Open Label Part 1|Other|0|||
124815541|NCT03000439|448954704|FG002|Open Label Part 1|Other|0|||
124815542|NCT03000439|448954705|FG003|Open Label Part 1|Other|0|||
124815543|NCT03000439|448954702|FG000|Open Label Part 1|Insufficient clinical response|16|||
124815544|NCT03000439|448954703|FG001|Open Label Part 1|Insufficient clinical response|0|||
124815545|NCT03000439|448954704|FG002|Open Label Part 1|Insufficient clinical response|0|||
125302276|NCT01618695|450733956|FG002|Core Phase|Pregnancy|0|||
125302277|NCT01618695|450733957|FG003|Core Phase|Pregnancy|0|||
125302278|NCT01618695|450733954|FG000|Core Phase|Lack of Efficacy|1|||
125302279|NCT01618695|450733955|FG001|Core Phase|Lack of Efficacy|2|||
125302280|NCT01618695|450733956|FG002|Core Phase|Lack of Efficacy|1|||
125302281|NCT01618695|450733957|FG003|Core Phase|Lack of Efficacy|1|||
125302282|NCT01618695|450733954|FG000|Core Phase|Other than specified|1|||
125302283|NCT01618695|450733955|FG001|Core Phase|Other than specified|2|||
125302284|NCT01618695|450733956|FG002|Core Phase|Other than specified|2|||
125302285|NCT01618695|450733957|FG003|Core Phase|Other than specified|2|||
125302286|NCT01618695|450733954|FG000|Core Phase|Not treated|1|||
125302287|NCT01618695|450733955|FG001|Core Phase|Not treated|0|||
125302288|NCT01618695|450733956|FG002|Core Phase|Not treated|2|||
125302289|NCT01618695|450733957|FG003|Core Phase|Not treated|0|||
125302290|NCT01618695|450733954|FG000|Extension Phase|Lack of Efficacy|17|||
125302291|NCT01618695|450733955|FG001|Extension Phase|Lack of Efficacy|33|||
125302292|NCT01618695|450733956|FG002|Extension Phase|Lack of Efficacy|26|||
125302293|NCT01618695|450733957|FG003|Extension Phase|Lack of Efficacy|24|||
125302294|NCT01618695|450733954|FG000|Extension Phase|Pregnancy|2|||
125302295|NCT01618695|450733955|FG001|Extension Phase|Pregnancy|0|||
125302296|NCT01618695|450733956|FG002|Extension Phase|Pregnancy|1|||
125302297|NCT01618695|450733957|FG003|Extension Phase|Pregnancy|1|||
125302298|NCT01618695|450733954|FG000|Extension Phase|Withdrawal by Subject|43|||
125302299|NCT01618695|450733955|FG001|Extension Phase|Withdrawal by Subject|48|||
125302300|NCT01618695|450733956|FG002|Extension Phase|Withdrawal by Subject|42|||
125302301|NCT01618695|450733957|FG003|Extension Phase|Withdrawal by Subject|33|||
125302302|NCT01618695|450733954|FG000|Extension Phase|Adverse Event|18|||
125302303|NCT01618695|450733955|FG001|Extension Phase|Adverse Event|16|||
125302304|NCT01618695|450733956|FG002|Extension Phase|Adverse Event|9|||
125302305|NCT01618695|450733957|FG003|Extension Phase|Adverse Event|20|||
125302306|NCT01618695|450733954|FG000|Extension Phase|Lost to Follow-up|2|||
125302307|NCT01618695|450733955|FG001|Extension Phase|Lost to Follow-up|1|||
125302308|NCT01618695|450733956|FG002|Extension Phase|Lost to Follow-up|1|||
124815546|NCT03000439|448954705|FG003|Open Label Part 1|Insufficient clinical response|0|||
125302309|NCT01618695|450733957|FG003|Extension Phase|Lost to Follow-up|1|||
125302310|NCT01618695|450733954|FG000|Extension Phase|Other than specified|13|||
125302311|NCT01618695|450733955|FG001|Extension Phase|Other than specified|18|||
125302312|NCT01618695|450733956|FG002|Extension Phase|Other than specified|13|||
125302313|NCT01618695|450733957|FG003|Extension Phase|Other than specified|18|||
125302314|NCT02454478|450733959|FG000|Overall Study|Incomplete DLT Evaluation|1|||
125302315|NCT01271725|450733963|FG000|Part A|Progressive disease according to RECIST|8|||
125302316|NCT01271725|450733964|FG001|Part A|Progressive disease according to RECIST|0|||
124815547|NCT03000439|448954702|FG000|Open Label Part 2|Other|0|||
124815548|NCT03000439|448954703|FG001|Open Label Part 2|Other|5|||
124815549|NCT03000439|448954704|FG002|Open Label Part 2|Other|0|||
124815550|NCT03000439|448954705|FG003|Open Label Part 2|Other|0|||
124815551|NCT03000439|448954702|FG000|Open Label Part 2|Insufficient clinical response|0|||
124815552|NCT03000439|448954703|FG001|Open Label Part 2|Insufficient clinical response|12|||
124815553|NCT03000439|448954704|FG002|Open Label Part 2|Insufficient clinical response|0|||
124815554|NCT03000439|448954705|FG003|Open Label Part 2|Insufficient clinical response|0|||
124815555|NCT03000439|448954702|FG000|Double Blind Phase|Adverse Event|0|||
125302317|NCT01271725|450733963|FG000|Part A|Clinical signs/symptoms of progression|2|||
125302318|NCT01271725|450733964|FG001|Part A|Clinical signs/symptoms of progression|0|||
125302319|NCT01271725|450733963|FG000|Part A|Other Adverse Event|8|||
125302320|NCT01271725|450733964|FG001|Part A|Other Adverse Event|0|||
125302321|NCT01271725|450733963|FG000|Part A|Lost to Follow-up|1|||
125302322|NCT01271725|450733964|FG001|Part A|Lost to Follow-up|0|||
125302323|NCT01271725|450733963|FG000|Part A|Withdrawal by Subject|12|||
125302324|NCT01271725|450733964|FG001|Part A|Withdrawal by Subject|0|||
124815556|NCT03000439|448954703|FG001|Double Blind Phase|Adverse Event|0|||
124815557|NCT03000439|448954704|FG002|Double Blind Phase|Adverse Event|2|||
124815558|NCT03000439|448954705|FG003|Double Blind Phase|Adverse Event|1|||
124815559|NCT03000439|448954702|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
124815560|NCT03000439|448954703|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
125302325|NCT01271725|450733963|FG000|Part A|Other than specified|3|||
125302326|NCT01271725|450733964|FG001|Part A|Other than specified|0|||
125302327|NCT01271725|450733963|FG000|Part A|Protocol Violation|1|||
125302328|NCT01271725|450733964|FG001|Part A|Protocol Violation|0|||
125302329|NCT01271725|450733963|FG000|Part B|Other than specified|0|||
125302330|NCT01271725|450733964|FG001|Part B|Other than specified|2|||
125302331|NCT01271725|450733963|FG000|Part B|Clinical signs/symptoms of progression|0|||
125302332|NCT01271725|450733964|FG001|Part B|Clinical signs/symptoms of progression|2|||
125302333|NCT01271725|450733963|FG000|Part B|Other Adverse Event|0|||
125302334|NCT01271725|450733964|FG001|Part B|Other Adverse Event|1|||
125302335|NCT01271725|450733963|FG000|Part B|Protocol Violation|0|||
125302336|NCT01271725|450733964|FG001|Part B|Protocol Violation|1|||
125302337|NCT01271725|450733963|FG000|Part B|Withdrawal by Subject|0|||
125302338|NCT01271725|450733964|FG001|Part B|Withdrawal by Subject|6|||
125302339|NCT03354273|450733965|FG000|Overall Study|Adverse Event|5|||
125302340|NCT03354273|450733965|FG000|Overall Study|Screen Failure|21|||
125302341|NCT03354273|450733965|FG000|Overall Study|Withdrawal by Subject|34|||
125302342|NCT03354273|450733965|FG000|Overall Study|Technical Problems|30|||
125302343|NCT03354273|450733965|FG000|Overall Study|Lost to Follow-up|4|||
125302344|NCT03354273|450733965|FG000|Overall Study|Investigator Decision|3|||
125302345|NCT03354273|450733965|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
125302346|NCT03354273|450733965|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
125302347|NCT03354273|450733965|FG000|Overall Study|COVID-19 Restrictions|9|||
125302348|NCT03354273|450733965|FG000|Overall Study|Other|5|||
125302349|NCT02950480|450733971|FG000|Overall Study|Withdrawal by Subject|1|||
125302350|NCT02950480|450733972|FG001|Overall Study|Withdrawal by Subject|0|||
125302351|NCT03229109|450733977|FG000|Overall Study|Withdrawal by Subject|0|||
125302352|NCT03229109|450733978|FG001|Overall Study|Withdrawal by Subject|0|||
125302353|NCT03229109|450733979|FG002|Overall Study|Withdrawal by Subject|0|||
125302354|NCT03229109|450733980|FG003|Overall Study|Withdrawal by Subject|1|||
125302355|NCT01835223|450733981|FG000|Overall Study|Adverse Event|1|||
124815561|NCT03000439|448954704|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
124815562|NCT03000439|448954705|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
124815563|NCT03000439|448954702|FG000|Double Blind Phase|Other|0|||
124815564|NCT03000439|448954703|FG001|Double Blind Phase|Other|0|||
124815565|NCT03000439|448954704|FG002|Double Blind Phase|Other|10|||
124815566|NCT03000439|448954705|FG003|Double Blind Phase|Other|11|||
124815567|NCT03000439|448954702|FG000|Double Blind Phase|Insufficient clinical response|0|||
124815568|NCT03000439|448954703|FG001|Double Blind Phase|Insufficient clinical response|0|||
124815569|NCT03000439|448954704|FG002|Double Blind Phase|Insufficient clinical response|0|||
124815570|NCT03000439|448954705|FG003|Double Blind Phase|Insufficient clinical response|2|||
124815571|NCT02954237|448954708|FG000|Overall Study|Withdrawal by Subject|25|||
124815572|NCT02954237|448954708|FG000|Overall Study|Missed visit|16|||
124815573|NCT02954237|448954708|FG000|Overall Study|Death|2|||
124815574|NCT03292588|448954709|FG000|Overall Study|Death|1|||
124815575|NCT03292588|448954710|FG001|Overall Study|Death|0|||
124815576|NCT03292588|448954709|FG000|Overall Study|Lost to Follow-up|12|||
124815577|NCT03292588|448954710|FG001|Overall Study|Lost to Follow-up|16|||
124815578|NCT03292588|448954709|FG000|Overall Study|Physician Decision|0|||
124815579|NCT03292588|448954710|FG001|Overall Study|Physician Decision|1|||
124815580|NCT03292588|448954709|FG000|Overall Study|Withdrawal by Subject|4|||
124815581|NCT03292588|448954710|FG001|Overall Study|Withdrawal by Subject|4|||
124815582|NCT03292588|448954709|FG000|Overall Study|Move out of town|1|||
124815583|NCT03292588|448954710|FG001|Overall Study|Move out of town|0|||
124815584|NCT03292588|448954709|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
124815585|NCT03292588|448954710|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
124815586|NCT02151591|448954711|FG000|Overall Study|Lost to Follow-up|6|||
124815587|NCT02151591|448954712|FG001|Overall Study|Lost to Follow-up|3|||
124815588|NCT03633695|448954715|FG000|Overall Study|Lost to Follow-up|4|||
124815589|NCT03633695|448954716|FG001|Overall Study|Lost to Follow-up|5|||
124815590|NCT03633695|448954715|FG000|Overall Study|Discontinued|8|||
124815591|NCT03633695|448954716|FG001|Overall Study|Discontinued|4|||
125302356|NCT01835223|450733982|FG001|Overall Study|Adverse Event|0|||
125302357|NCT01835223|450733981|FG000|Overall Study|Withdrawal by Subject|2|||
125302358|NCT01835223|450733982|FG001|Overall Study|Withdrawal by Subject|0|||
125302359|NCT01835223|450733981|FG000|Overall Study|Disease progression|2|||
125302360|NCT01835223|450733982|FG001|Overall Study|Disease progression|1|||
125302361|NCT01835223|450733981|FG000|Overall Study|Became Inelligible|4|||
125302362|NCT01835223|450733982|FG001|Overall Study|Became Inelligible|0|||
125302363|NCT01504841|450733983|FG000|Overall Study|Withdrawal by Subject|1|||
125302364|NCT01504841|450733984|FG001|Overall Study|Withdrawal by Subject|1|||
125302365|NCT01504841|450733985|FG002|Overall Study|Withdrawal by Subject|0|||
125302366|NCT03679624|450733986|FG000|Overall Study|Adverse Event|1|||
125302367|NCT03679624|450733987|FG001|Overall Study|Adverse Event|0|||
125302368|NCT01610336|450733988|FG000|Overall Study|Progressive Disease|4|||
125302369|NCT01610336|450733989|FG001|Overall Study|Progressive Disease|6|||
125302370|NCT01610336|450733990|FG002|Overall Study|Progressive Disease|6|||
124815592|NCT02853604|448954725|FG000|Overall Study|Withdrawal by Subject|12|||
124815593|NCT02853604|448954726|FG001|Overall Study|Withdrawal by Subject|35|||
124815594|NCT02853604|448954725|FG000|Overall Study|Lost to Follow-up|4|||
124815595|NCT02853604|448954726|FG001|Overall Study|Lost to Follow-up|8|||
124815596|NCT02853604|448954725|FG000|Overall Study|Death|1|||
124815597|NCT02853604|448954726|FG001|Overall Study|Death|5|||
124815598|NCT02853604|448954725|FG000|Overall Study|Miscellaneous|11|||
125302371|NCT01610336|450733991|FG003|Overall Study|Progressive Disease|5|||
125302372|NCT01610336|450733992|FG004|Overall Study|Progressive Disease|3|||
125302373|NCT01610336|450733993|FG005|Overall Study|Progressive Disease|10|||
125302374|NCT01610336|450733994|FG006|Overall Study|Progressive Disease|1|||
125302375|NCT01610336|450733995|FG007|Overall Study|Progressive Disease|6|||
124815599|NCT02853604|448954726|FG001|Overall Study|Miscellaneous|2|||
124815600|NCT02853604|448954725|FG000|Overall Study|Progressive Disease|0|||
125302376|NCT01610336|450733996|FG008|Overall Study|Progressive Disease|6|||
125302377|NCT01610336|450733997|FG009|Overall Study|Progressive Disease|40|||
125302378|NCT01610336|450733998|FG010|Overall Study|Progressive Disease|36|||
125302379|NCT01610336|450733988|FG000|Overall Study|Adverse Event|0|||
125302380|NCT01610336|450733989|FG001|Overall Study|Adverse Event|0|||
125302381|NCT01610336|450733990|FG002|Overall Study|Adverse Event|0|||
125302382|NCT01610336|450733991|FG003|Overall Study|Adverse Event|1|||
125302383|NCT01610336|450733992|FG004|Overall Study|Adverse Event|1|||
125302384|NCT01610336|450733993|FG005|Overall Study|Adverse Event|1|||
125302385|NCT01610336|450733994|FG006|Overall Study|Adverse Event|0|||
125302386|NCT01610336|450733995|FG007|Overall Study|Adverse Event|0|||
125302387|NCT01610336|450733996|FG008|Overall Study|Adverse Event|2|||
125302388|NCT01610336|450733997|FG009|Overall Study|Adverse Event|8|||
125302389|NCT01610336|450733998|FG010|Overall Study|Adverse Event|6|||
125302390|NCT01610336|450733988|FG000|Overall Study|Subject/Guardian decision|1|||
125302391|NCT01610336|450733989|FG001|Overall Study|Subject/Guardian decision|1|||
125302392|NCT01610336|450733990|FG002|Overall Study|Subject/Guardian decision|0|||
125302393|NCT01610336|450733991|FG003|Overall Study|Subject/Guardian decision|1|||
125302394|NCT01610336|450733992|FG004|Overall Study|Subject/Guardian decision|0|||
125302395|NCT01610336|450733993|FG005|Overall Study|Subject/Guardian decision|0|||
125302396|NCT01610336|450733994|FG006|Overall Study|Subject/Guardian decision|0|||
125302397|NCT01610336|450733995|FG007|Overall Study|Subject/Guardian decision|1|||
125302398|NCT01610336|450733996|FG008|Overall Study|Subject/Guardian decision|0|||
125302399|NCT01610336|450733997|FG009|Overall Study|Subject/Guardian decision|2|||
125302400|NCT01610336|450733998|FG010|Overall Study|Subject/Guardian decision|2|||
125302401|NCT01610336|450733988|FG000|Overall Study|Death|0|||
125302402|NCT01610336|450733989|FG001|Overall Study|Death|0|||
125302403|NCT01610336|450733990|FG002|Overall Study|Death|0|||
125302404|NCT01610336|450733991|FG003|Overall Study|Death|0|||
125302405|NCT01610336|450733992|FG004|Overall Study|Death|0|||
125302406|NCT01610336|450733993|FG005|Overall Study|Death|1|||
125302407|NCT01610336|450733994|FG006|Overall Study|Death|3|||
125302408|NCT01610336|450733995|FG007|Overall Study|Death|0|||
125302409|NCT01610336|450733996|FG008|Overall Study|Death|0|||
125302410|NCT01610336|450733997|FG009|Overall Study|Death|1|||
125302411|NCT01610336|450733998|FG010|Overall Study|Death|2|||
125302412|NCT01610336|450733988|FG000|Overall Study|Non-Compliance with study treatment|0|||
125302413|NCT01610336|450733989|FG001|Overall Study|Non-Compliance with study treatment|0|||
125302414|NCT01610336|450733990|FG002|Overall Study|Non-Compliance with study treatment|0|||
125302415|NCT01610336|450733991|FG003|Overall Study|Non-Compliance with study treatment|0|||
125302416|NCT01610336|450733992|FG004|Overall Study|Non-Compliance with study treatment|0|||
125302417|NCT01610336|450733993|FG005|Overall Study|Non-Compliance with study treatment|0|||
125302418|NCT01610336|450733994|FG006|Overall Study|Non-Compliance with study treatment|0|||
125302419|NCT01610336|450733995|FG007|Overall Study|Non-Compliance with study treatment|0|||
125302420|NCT01610336|450733996|FG008|Overall Study|Non-Compliance with study treatment|0|||
125302421|NCT01610336|450733997|FG009|Overall Study|Non-Compliance with study treatment|1|||
125302422|NCT01610336|450733998|FG010|Overall Study|Non-Compliance with study treatment|0|||
124815601|NCT02853604|448954726|FG001|Overall Study|Progressive Disease|2|||
124815602|NCT05275400|448954727|FG000|Treatment Period|Adverse Event|7|||
124815603|NCT05275400|448954728|FG001|Treatment Period|Adverse Event|1|||
124815604|NCT05275400|448954727|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
124815605|NCT05275400|448954728|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
124815606|NCT05275400|448954727|FG000|Treatment Period|Death|5|||
124815607|NCT05275400|448954728|FG001|Treatment Period|Death|2|||
124815608|NCT05275400|448954727|FG000|Treatment Period|Protocol Violation|1|||
124815609|NCT05275400|448954728|FG001|Treatment Period|Protocol Violation|0|||
124815610|NCT05275400|448954727|FG000|Treatment Period|Physician Decision|5|||
124815611|NCT05275400|448954728|FG001|Treatment Period|Physician Decision|4|||
124815612|NCT05275400|448954727|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
124815613|NCT05275400|448954728|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
124815614|NCT05275400|448954727|FG000|Treatment Period|Withdrawal by Subject|30|||
124815615|NCT05275400|448954728|FG001|Treatment Period|Withdrawal by Subject|12|||
124815616|NCT05275400|448954727|FG000|Treatment Period|Lost to Follow-up|1|||
124815617|NCT05275400|448954728|FG001|Treatment Period|Lost to Follow-up|5|||
124815618|NCT05275400|448954727|FG000|Treatment Period|Lack of Efficacy|1|||
125302423|NCT01610336|450733988|FG000|Overall Study|Physician Decision|0|||
125302424|NCT01610336|450733989|FG001|Overall Study|Physician Decision|0|||
125302425|NCT01610336|450733990|FG002|Overall Study|Physician Decision|0|||
125302426|NCT01610336|450733991|FG003|Overall Study|Physician Decision|0|||
125302427|NCT01610336|450733992|FG004|Overall Study|Physician Decision|0|||
125302428|NCT01610336|450733993|FG005|Overall Study|Physician Decision|0|||
125302429|NCT01610336|450733994|FG006|Overall Study|Physician Decision|1|||
125302430|NCT01610336|450733995|FG007|Overall Study|Physician Decision|0|||
125302431|NCT01610336|450733996|FG008|Overall Study|Physician Decision|0|||
125302432|NCT01610336|450733997|FG009|Overall Study|Physician Decision|0|||
125302433|NCT01610336|450733998|FG010|Overall Study|Physician Decision|0|||
125302434|NCT01610336|450733988|FG000|Overall Study|Protocol Deviation|0|||
125302435|NCT01610336|450733989|FG001|Overall Study|Protocol Deviation|0|||
125302436|NCT01610336|450733990|FG002|Overall Study|Protocol Deviation|0|||
124815619|NCT05275400|448954728|FG001|Treatment Period|Lack of Efficacy|0|||
124815620|NCT05275400|448954727|FG000|Treatment Period|Sponsor Decision|1|||
124815621|NCT05275400|448954728|FG001|Treatment Period|Sponsor Decision|0|||
125302437|NCT01610336|450733991|FG003|Overall Study|Protocol Deviation|0|||
125302438|NCT01610336|450733992|FG004|Overall Study|Protocol Deviation|0|||
125302439|NCT01610336|450733993|FG005|Overall Study|Protocol Deviation|0|||
125302440|NCT01610336|450733994|FG006|Overall Study|Protocol Deviation|0|||
125302441|NCT01610336|450733995|FG007|Overall Study|Protocol Deviation|0|||
125302442|NCT01610336|450733996|FG008|Overall Study|Protocol Deviation|0|||
125302443|NCT01610336|450733997|FG009|Overall Study|Protocol Deviation|1|||
125302444|NCT01610336|450733998|FG010|Overall Study|Protocol Deviation|0|||
125302445|NCT01610336|450733988|FG000|Overall Study|Transfer to another trial|0|||
125302446|NCT01610336|450733989|FG001|Overall Study|Transfer to another trial|0|||
125302447|NCT01610336|450733990|FG002|Overall Study|Transfer to another trial|0|||
125302448|NCT01610336|450733991|FG003|Overall Study|Transfer to another trial|0|||
125302449|NCT01610336|450733992|FG004|Overall Study|Transfer to another trial|0|||
125302450|NCT01610336|450733993|FG005|Overall Study|Transfer to another trial|0|||
125302451|NCT01610336|450733994|FG006|Overall Study|Transfer to another trial|0|||
125302452|NCT01610336|450733995|FG007|Overall Study|Transfer to another trial|0|||
125302453|NCT01610336|450733996|FG008|Overall Study|Transfer to another trial|0|||
125302454|NCT01610336|450733997|FG009|Overall Study|Transfer to another trial|0|||
125302455|NCT01610336|450733998|FG010|Overall Study|Transfer to another trial|1|||
125302456|NCT01559675|450734001|FG000|Overall Study|Protocol Violation|1|||
125302457|NCT01559675|450734002|FG001|Overall Study|Protocol Violation|2|||
125302458|NCT01559675|450734001|FG000|Overall Study|2nd operation on same patient excluded|14|||
125302459|NCT01559675|450734002|FG001|Overall Study|2nd operation on same patient excluded|12|||
125302460|NCT01496469|450734003|FG000|Overall Study|Adverse Event|1|||
125302461|NCT01496469|450734004|FG001|Overall Study|Adverse Event|0|||
125302462|NCT01496469|450734003|FG000|Overall Study|Protocol Violation|2|||
125302463|NCT01496469|450734004|FG001|Overall Study|Protocol Violation|0|||
125302464|NCT01496469|450734003|FG000|Overall Study|Lost to Follow-up|1|||
125302465|NCT01496469|450734004|FG001|Overall Study|Lost to Follow-up|1|||
125302466|NCT01496469|450734003|FG000|Overall Study|Withdrawal by Subject|4|||
125302467|NCT01496469|450734004|FG001|Overall Study|Withdrawal by Subject|4|||
125302468|NCT01496469|450734003|FG000|Overall Study|BP exceeds protocol limits|1|||
125302469|NCT01496469|450734004|FG001|Overall Study|BP exceeds protocol limits|2|||
125302470|NCT01496469|450734003|FG000|Overall Study|Other|1|||
125302471|NCT01496469|450734004|FG001|Overall Study|Other|1|||
125302472|NCT00291018|450734005|FG000|Overall Study|Not Consented or Declined PAS|12|||
125302473|NCT00291018|450734006|FG001|Overall Study|Not Consented or Declined PAS|15|||
125302474|NCT00291018|450734007|FG002|Overall Study|Not Consented or Declined PAS|15|||
125302475|NCT00291018|450734005|FG000|Overall Study|Death|3|||
125302476|NCT00291018|450734006|FG001|Overall Study|Death|3|||
125302477|NCT00291018|450734007|FG002|Overall Study|Death|4|||
125302478|NCT00291018|450734005|FG000|Overall Study|Withdrawal by Subject|2|||
125302479|NCT00291018|450734006|FG001|Overall Study|Withdrawal by Subject|8|||
125302480|NCT00291018|450734007|FG002|Overall Study|Withdrawal by Subject|1|||
125302481|NCT00291018|450734005|FG000|Overall Study|Failures|5|||
125302482|NCT00291018|450734006|FG001|Overall Study|Failures|12|||
125302483|NCT00291018|450734007|FG002|Overall Study|Failures|5|||
125302484|NCT00291018|450734005|FG000|Overall Study|Lost to Follow-up|3|||
125302485|NCT00291018|450734006|FG001|Overall Study|Lost to Follow-up|4|||
125302486|NCT00291018|450734007|FG002|Overall Study|Lost to Follow-up|18|||
125302487|NCT00630344|450734008|FG000|Overall Study|Adverse Event|5|||
125302488|NCT00630344|450734008|FG000|Overall Study|Progressive Disease|19|||
125302489|NCT00630344|450734008|FG000|Overall Study|Physician Decision|9|||
125302490|NCT00630344|450734008|FG000|Overall Study|Withdrawal by Subject|1|||
125302491|NCT00630344|450734008|FG000|Overall Study|Intercurrent Illness|1|||
125302492|NCT00630344|450734008|FG000|Overall Study|Other|1|||
125302493|NCT01357551|450734009|FG000|Overall Study|Withdrawal by Subject|6|||
125302494|NCT01357551|450734010|FG001|Overall Study|Withdrawal by Subject|4|||
125302495|NCT01357551|450734009|FG000|Overall Study|Death|0|||
125302496|NCT01357551|450734010|FG001|Overall Study|Death|1|||
125302497|NCT01357551|450734009|FG000|Overall Study|Lost to Follow-up|16|||
125302498|NCT01357551|450734010|FG001|Overall Study|Lost to Follow-up|6|||
125302499|NCT00774800|450734011|FG000|Intervention 4|Withdrawal by Subject|1|||
125302500|NCT03068754|450734018|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
125302501|NCT03068754|450734019|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
125302502|NCT03068754|450734020|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
125302503|NCT03068754|450734021|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
125302504|NCT03068754|450734018|FG000|Randomized Treatment Period (RTP)|Death|2|||
125302505|NCT03068754|450734019|FG001|Randomized Treatment Period (RTP)|Death|2|||
125302506|NCT03068754|450734020|FG002|Randomized Treatment Period (RTP)|Death|0|||
125302507|NCT03068754|450734021|FG003|Randomized Treatment Period (RTP)|Death|0|||
125302508|NCT03068754|450734018|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
125302509|NCT03068754|450734019|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
125302510|NCT03068754|450734020|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
125302511|NCT03068754|450734021|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
125302512|NCT03068754|450734018|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
125302513|NCT03068754|450734019|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
125302514|NCT03068754|450734020|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
125302515|NCT03068754|450734021|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
125302516|NCT03068754|450734018|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
125302517|NCT03068754|450734019|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
125302518|NCT03068754|450734020|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
125302519|NCT03068754|450734021|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
125302520|NCT03068754|450734018|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
125302521|NCT03068754|450734019|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
125302522|NCT03068754|450734020|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
125302523|NCT03068754|450734021|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
125302524|NCT03068754|450734018|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
125302525|NCT03068754|450734019|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
125302526|NCT03068754|450734020|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
125302527|NCT03068754|450734021|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
125302528|NCT03068754|450734018|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
125302529|NCT03068754|450734019|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
125302530|NCT03068754|450734020|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
125302531|NCT03068754|450734021|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
125302532|NCT03068754|450734018|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
125302533|NCT03068754|450734019|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
125302534|NCT03068754|450734020|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
125302535|NCT03068754|450734021|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
125302536|NCT03068754|450734018|FG000|Open Label Extension Period (OLE)|Death|0|||
125302537|NCT03068754|450734019|FG001|Open Label Extension Period (OLE)|Death|0|||
125302538|NCT03068754|450734020|FG002|Open Label Extension Period (OLE)|Death|0|||
125302539|NCT03068754|450734021|FG003|Open Label Extension Period (OLE)|Death|1|||
125302540|NCT03068754|450734018|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
125302541|NCT03068754|450734019|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
125302542|NCT03068754|450734020|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
125302543|NCT03068754|450734021|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
125302544|NCT03068754|450734018|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
125302545|NCT03068754|450734019|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
125302546|NCT03068754|450734020|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
125302547|NCT03068754|450734021|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
125302548|NCT03068754|450734018|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
125302549|NCT03068754|450734019|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
125302550|NCT03068754|450734020|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
125302551|NCT03068754|450734021|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
125302552|NCT03068754|450734018|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
125302553|NCT03068754|450734019|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
125302554|NCT03068754|450734020|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
125302555|NCT03068754|450734021|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
125302556|NCT00666965|450734022|FG000|Overall Study|Adverse Event|0|||
125302557|NCT00666965|450734023|FG001|Overall Study|Adverse Event|2|||
125302558|NCT00666965|450734024|FG002|Overall Study|Adverse Event|1|||
125302559|NCT00666965|450734025|FG003|Overall Study|Adverse Event|9|||
125302560|NCT00666965|450734022|FG000|Overall Study|Lack of Efficacy|1|||
125302561|NCT00666965|450734023|FG001|Overall Study|Lack of Efficacy|1|||
125302562|NCT00666965|450734024|FG002|Overall Study|Lack of Efficacy|0|||
125302563|NCT00666965|450734025|FG003|Overall Study|Lack of Efficacy|0|||
125302564|NCT00666965|450734022|FG000|Overall Study|Protocol Violation|0|||
125302565|NCT00666965|450734023|FG001|Overall Study|Protocol Violation|0|||
125302566|NCT00666965|450734024|FG002|Overall Study|Protocol Violation|0|||
125302567|NCT00666965|450734025|FG003|Overall Study|Protocol Violation|2|||
125302568|NCT00666965|450734022|FG000|Overall Study|Discontinuation criteria|2|||
125302569|NCT00666965|450734023|FG001|Overall Study|Discontinuation criteria|1|||
125302570|NCT00666965|450734024|FG002|Overall Study|Discontinuation criteria|1|||
125302571|NCT00666965|450734025|FG003|Overall Study|Discontinuation criteria|2|||
125302572|NCT00666965|450734022|FG000|Overall Study|Withdrawal by Subject|0|||
125302573|NCT00666965|450734023|FG001|Overall Study|Withdrawal by Subject|0|||
125302574|NCT00666965|450734024|FG002|Overall Study|Withdrawal by Subject|0|||
125302575|NCT00666965|450734025|FG003|Overall Study|Withdrawal by Subject|2|||
125302576|NCT02202538|450734029|FG000|Overall Study|Withdrawal by Subject|5|||
125302577|NCT02202538|450734029|FG000|Overall Study|Did not meet all inclusion criteria|2|||
125302578|NCT02202538|450734029|FG000|Overall Study|Investigator Decision|1|||
124815622|NCT05275400|448954727|FG000|Follow-Up Period|Death|2|||
124815623|NCT05275400|448954728|FG001|Follow-Up Period|Death|0|||
125302579|NCT01853878|450734030|FG000|Overall Study|Recurrence|2|||
125302580|NCT01853878|450734031|FG001|Overall Study|Recurrence|0|||
125302581|NCT01853878|450734030|FG000|Overall Study|Adverse Event|2|||
125302582|NCT01853878|450734031|FG001|Overall Study|Adverse Event|0|||
124815624|NCT05275400|448954727|FG000|Follow-Up Period|Protocol Violation|1|||
124815625|NCT05275400|448954728|FG001|Follow-Up Period|Protocol Violation|0|||
124815626|NCT05275400|448954727|FG000|Follow-Up Period|Withdrawal by Subject|3|||
124815627|NCT05275400|448954728|FG001|Follow-Up Period|Withdrawal by Subject|0|||
124815628|NCT06333613|448954729|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
124815629|NCT03648541|448954735|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
124815630|NCT03648541|448954736|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
124815631|NCT03648541|448954735|FG000|Re-induction Period Only|Lack of Efficacy|7|||
124815632|NCT03648541|448954736|FG001|Re-induction Period Only|Lack of Efficacy|0|||
124815633|NCT03648541|448954735|FG000|Maintenance Period Only|Missing|0|||
124815634|NCT03648541|448954736|FG001|Maintenance Period Only|Missing|1|||
124815635|NCT03648541|448954735|FG000|Maintenance Period Only|Other not listed below|0|||
124815636|NCT03648541|448954736|FG001|Maintenance Period Only|Other not listed below|4|||
124815637|NCT03648541|448954735|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
124815638|NCT03648541|448954736|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
124815639|NCT03648541|448954735|FG000|Maintenance Period Only|Protocol Violation|0|||
124815640|NCT03648541|448954736|FG001|Maintenance Period Only|Protocol Violation|1|||
124815641|NCT03648541|448954735|FG000|Maintenance Period Only|Lack of Efficacy|0|||
124815642|NCT03648541|448954736|FG001|Maintenance Period Only|Lack of Efficacy|18|||
124815643|NCT03648541|448954735|FG000|Maintenance Period Only|Adverse Event|0|||
124815644|NCT03648541|448954736|FG001|Maintenance Period Only|Adverse Event|4|||
124815645|NCT03648541|448954735|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
124815646|NCT03648541|448954736|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
124815647|NCT04623216|448954737|FG000|Overall Study|Death|5|||
124815648|NCT04623216|448954738|FG001|Overall Study|Death|2|||
124815649|NCT04623216|448954739|FG002|Overall Study|Death|0|||
124815650|NCT04623216|448954740|FG003|Overall Study|Death|0|||
124815651|NCT04623216|448954737|FG000|Overall Study|Terminated by Sponsor|3|||
124815652|NCT04623216|448954738|FG001|Overall Study|Terminated by Sponsor|2|||
124815653|NCT04623216|448954739|FG002|Overall Study|Terminated by Sponsor|2|||
124815654|NCT04623216|448954740|FG003|Overall Study|Terminated by Sponsor|0|||
124815655|NCT04623216|448954737|FG000|Overall Study|Physician Decision|1|||
124815656|NCT04623216|448954738|FG001|Overall Study|Physician Decision|0|||
124815657|NCT04623216|448954739|FG002|Overall Study|Physician Decision|0|||
124815658|NCT04623216|448954740|FG003|Overall Study|Physician Decision|0|||
124815659|NCT01651039|448954741|FG000|Overall Study|Non-evaluables|5|||
124815660|NCT01651039|448954741|FG000|Overall Study|Physician Decision|2|||
124815661|NCT01651039|448954741|FG000|Overall Study|Withdrawal by Subject|1|||
124815662|NCT01651039|448954741|FG000|Overall Study|Progressive Disease|22|||
124815663|NCT04930965|448954744|FG000|Overall Study|Lost to Follow-up|7|||
124815664|NCT04930965|448954745|FG001|Overall Study|Lost to Follow-up|5|||
124815665|NCT00134082|448954746|FG000|Overall Study|Adverse Event|2|||
124815666|NCT00134082|448954746|FG000|Overall Study|Death|1|||
124815667|NCT02197247|448954749|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
124815668|NCT02197247|448954749|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
125302583|NCT01853878|450734030|FG000|Overall Study|Withdrawal by Subject|3|||
125302584|NCT01853878|450734031|FG001|Overall Study|Withdrawal by Subject|1|||
125302585|NCT01853878|450734030|FG000|Overall Study|Migrated/moved from the study area|1|||
125302586|NCT01853878|450734031|FG001|Overall Study|Migrated/moved from the study area|0|||
125302587|NCT01853878|450734030|FG000|Overall Study|Other|55|||
125302588|NCT01853878|450734031|FG001|Overall Study|Other|43|||
125302589|NCT02161757|450734032|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
125302590|NCT02161757|450734033|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
125302591|NCT02161757|450734034|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
125302592|NCT02161757|450734032|FG000|Treatment Through Study Completion|Adverse Event|1|||
125302593|NCT02161757|450734033|FG001|Treatment Through Study Completion|Adverse Event|1|||
125302594|NCT02161757|450734034|FG002|Treatment Through Study Completion|Adverse Event|0|||
125302595|NCT02161757|450734032|FG000|Treatment Through Study Completion|Protocol Violation|0|||
125302596|NCT02161757|450734033|FG001|Treatment Through Study Completion|Protocol Violation|1|||
125302597|NCT02161757|450734034|FG002|Treatment Through Study Completion|Protocol Violation|2|||
125302598|NCT02161757|450734032|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
125302599|NCT02161757|450734033|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
125302600|NCT02161757|450734034|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
124815669|NCT02197247|448954749|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
124815670|NCT02197247|448954749|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
124815671|NCT02197247|448954749|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
124815672|NCT02197247|448954749|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
124815673|NCT02197247|448954749|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
124815674|NCT02197247|448954749|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
125302601|NCT02161757|450734032|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
125302602|NCT02161757|450734033|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
125302603|NCT02161757|450734034|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
125302604|NCT02161757|450734032|FG000|Treatment Through Study Completion|Other|20|||
125302605|NCT02161757|450734033|FG001|Treatment Through Study Completion|Other|19|||
125302606|NCT02161757|450734034|FG002|Treatment Through Study Completion|Other|12|||
125302607|NCT02161757|450734032|FG000|Treatment Through Study Completion|Death|2|||
125302608|NCT02161757|450734033|FG001|Treatment Through Study Completion|Death|1|||
124815675|NCT02228460|448954762|FG000|Overall Study|Adverse Event|1|||
124815676|NCT02228460|448954762|FG000|Overall Study|Lost to Follow-up|1|||
125302609|NCT02161757|450734034|FG002|Treatment Through Study Completion|Death|1|||
125302610|NCT00767819|450734037|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
125302611|NCT00767819|450734038|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
125302612|NCT00767819|450734039|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
125302613|NCT00767819|450734037|FG000|Overall Study|Withdrawal by Subject|1|||
125302614|NCT00767819|450734038|FG001|Overall Study|Withdrawal by Subject|1|||
125302615|NCT00767819|450734039|FG002|Overall Study|Withdrawal by Subject|0|||
125302616|NCT00767819|450734037|FG000|Overall Study|Administrative problems|0|||
125302617|NCT00767819|450734038|FG001|Overall Study|Administrative problems|1|||
125302618|NCT00767819|450734039|FG002|Overall Study|Administrative problems|0|||
125302619|NCT00767819|450734037|FG000|Overall Study|Death|2|||
125302620|NCT00767819|450734038|FG001|Overall Study|Death|3|||
125302621|NCT00767819|450734039|FG002|Overall Study|Death|0|||
125302622|NCT00767819|450734037|FG000|Overall Study|Adverse Event|2|||
125302623|NCT00767819|450734038|FG001|Overall Study|Adverse Event|0|||
125302624|NCT00767819|450734039|FG002|Overall Study|Adverse Event|0|||
125302625|NCT00767819|450734037|FG000|Overall Study|Abnormal lab values|1|||
125302626|NCT00767819|450734038|FG001|Overall Study|Abnormal lab values|0|||
125302627|NCT00767819|450734039|FG002|Overall Study|Abnormal lab values|0|||
125302628|NCT00767819|450734037|FG000|Overall Study|Lost to Follow-up|1|||
125302629|NCT00767819|450734038|FG001|Overall Study|Lost to Follow-up|0|||
125302630|NCT00767819|450734039|FG002|Overall Study|Lost to Follow-up|0|||
125302631|NCT00465647|450734044|FG000|Overall Study|Administrative|2|||
125302632|NCT00465647|450734045|FG001|Overall Study|Administrative|2|||
125302633|NCT00465647|450734046|FG002|Overall Study|Administrative|3|||
125302634|NCT00465647|450734047|FG003|Overall Study|Administrative|2|||
125302635|NCT00465647|450734044|FG000|Overall Study|Adverse Event|2|||
125302636|NCT00465647|450734045|FG001|Overall Study|Adverse Event|0|||
125302637|NCT00465647|450734046|FG002|Overall Study|Adverse Event|3|||
125302638|NCT00465647|450734047|FG003|Overall Study|Adverse Event|2|||
125302639|NCT00465647|450734044|FG000|Overall Study|Withdrawal by Subject|1|||
125302640|NCT00465647|450734045|FG001|Overall Study|Withdrawal by Subject|2|||
125302641|NCT00465647|450734046|FG002|Overall Study|Withdrawal by Subject|2|||
125302642|NCT00465647|450734047|FG003|Overall Study|Withdrawal by Subject|7|||
125302643|NCT00465647|450734044|FG000|Overall Study|"The other reasons included loss of IV"|8|||
125302644|NCT00465647|450734045|FG001|Overall Study|"The other reasons included loss of IV"|4|||
125302645|NCT00465647|450734046|FG002|Overall Study|"The other reasons included loss of IV"|3|||
125302646|NCT00465647|450734047|FG003|Overall Study|"The other reasons included loss of IV"|2|||
125302647|NCT03916081|450734048|FG000|Overall Study|Adverse Event|1|||
125302648|NCT03916081|450734049|FG001|Overall Study|Adverse Event|0|||
125302649|NCT03916081|450734050|FG002|Overall Study|Adverse Event|0|||
125302650|NCT03916081|450734048|FG000|Overall Study|Physician Decision|0|||
125302651|NCT03916081|450734049|FG001|Overall Study|Physician Decision|0|||
125302652|NCT03916081|450734050|FG002|Overall Study|Physician Decision|1|||
124815677|NCT01243892|448954763|FG000|Overall Study|Did not meet eligibility criteria|2|||
124815678|NCT01243892|448954764|FG001|Overall Study|Did not meet eligibility criteria|0|||
124815679|NCT00119106|448954765|FG000|Overall Study|HIV infected at baseline|179|||
124815680|NCT00119106|448954766|FG001|Overall Study|HIV infected at baseline|178|||
125302653|NCT03916081|450734048|FG000|Overall Study|Lost to Follow-up|0|||
125302654|NCT03916081|450734049|FG001|Overall Study|Lost to Follow-up|1|||
125302655|NCT03916081|450734050|FG002|Overall Study|Lost to Follow-up|0|||
125302656|NCT03916081|450734048|FG000|Overall Study|Withdrawal by Subject|3|||
125302657|NCT03916081|450734049|FG001|Overall Study|Withdrawal by Subject|0|||
125302658|NCT03916081|450734050|FG002|Overall Study|Withdrawal by Subject|1|||
125302659|NCT03916081|450734048|FG000|Overall Study|Worsening of AD|0|||
125302660|NCT03916081|450734049|FG001|Overall Study|Worsening of AD|0|||
125302661|NCT03916081|450734050|FG002|Overall Study|Worsening of AD|1|||
125302662|NCT01339897|450734051|FG000|Overall Study|Adverse Event|1|||
125302663|NCT01339897|450734052|FG001|Overall Study|Adverse Event|0|||
125302664|NCT01339897|450734053|FG002|Overall Study|Adverse Event|0|||
125302665|NCT01339897|450734054|FG003|Overall Study|Adverse Event|1|||
125302666|NCT00847197|450734057|FG000|Overall Study|Adverse Event|21|||
125302667|NCT00847197|450734058|FG001|Overall Study|Adverse Event|3|||
124815681|NCT03066804|448954767|FG000|Overall Study|Physician Decision|0|||
124815682|NCT03066804|448954768|FG001|Overall Study|Physician Decision|4|||
124815683|NCT03066804|448954767|FG000|Overall Study|Death|23|||
125302668|NCT00847197|450734057|FG000|Overall Study|Protocol Violation|0|||
125302669|NCT00847197|450734058|FG001|Overall Study|Protocol Violation|1|||
125302670|NCT00847197|450734057|FG000|Overall Study|Withdrawal by Subject|3|||
125302671|NCT00847197|450734058|FG001|Overall Study|Withdrawal by Subject|1|||
125302672|NCT00622388|450734059|FG000|Overall Study|Disease Progression|47|||
125302673|NCT00622388|450734059|FG000|Overall Study|Adverse Event|6|||
125302674|NCT00622388|450734059|FG000|Overall Study|Protocol Violation|3|||
125302675|NCT00622388|450734059|FG000|Overall Study|Participant Refusal|1|||
125302676|NCT00622388|450734059|FG000|Overall Study|Death|3|||
125302677|NCT00622388|450734059|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
125302678|NCT00622388|450734059|FG000|Overall Study|Took Prohibited Medication|2|||
125302679|NCT00622388|450734059|FG000|Overall Study|Withdrew Consent|1|||
125302680|NCT00622388|450734059|FG000|Overall Study|Insurance Expired|1|||
125302681|NCT00348309|450734060|FG000|Overall Study|Adverse Event|56|||
125302682|NCT00348309|450734061|FG001|Overall Study|Adverse Event|28|||
125302683|NCT00348309|450734062|FG002|Overall Study|Adverse Event|63|||
125302684|NCT00348309|450734060|FG000|Overall Study|Lost to Follow-up|6|||
125302685|NCT00348309|450734061|FG001|Overall Study|Lost to Follow-up|7|||
125302686|NCT00348309|450734062|FG002|Overall Study|Lost to Follow-up|4|||
125302687|NCT00348309|450734060|FG000|Overall Study|Protocol Violation|7|||
125302688|NCT00348309|450734061|FG001|Overall Study|Protocol Violation|12|||
124815684|NCT03066804|448954768|FG001|Overall Study|Death|17|||
124815685|NCT03066804|448954767|FG000|Overall Study|Withdrawal by Subject|19|||
124815686|NCT03066804|448954768|FG001|Overall Study|Withdrawal by Subject|25|||
124815687|NCT03066804|448954767|FG000|Overall Study|Lost to Follow-up|2|||
124815688|NCT03066804|448954768|FG001|Overall Study|Lost to Follow-up|0|||
124815689|NCT03066804|448954767|FG000|Overall Study|Adverse Event|2|||
124815690|NCT03066804|448954768|FG001|Overall Study|Adverse Event|3|||
124815691|NCT03066804|448954767|FG000|Overall Study|Technical problems|5|||
124815692|NCT03066804|448954768|FG001|Overall Study|Technical problems|1|||
124815693|NCT02099708|448954769|FG000|Overall Study|Data Not Available|30|||
125302689|NCT00348309|450734062|FG002|Overall Study|Protocol Violation|7|||
125302690|NCT00348309|450734060|FG000|Overall Study|Withdrawal by Subject|33|||
125302691|NCT00348309|450734061|FG001|Overall Study|Withdrawal by Subject|37|||
125302692|NCT00348309|450734062|FG002|Overall Study|Withdrawal by Subject|40|||
125302693|NCT00348309|450734060|FG000|Overall Study|Non-compliance|8|||
125302694|NCT00348309|450734061|FG001|Overall Study|Non-compliance|6|||
125302695|NCT00348309|450734062|FG002|Overall Study|Non-compliance|8|||
125302696|NCT00348309|450734060|FG000|Overall Study|Death of caregiver|1|||
124815694|NCT02099708|448954769|FG000|Overall Study|Lost to Follow-up|141|||
124815695|NCT02099708|448954769|FG000|Overall Study|Other|29|||
124815696|NCT05466682|448954773|FG000|Overall Study|Withdrawal by Subject|0|||
124815697|NCT05466682|448954774|FG001|Overall Study|Withdrawal by Subject|2|||
124815698|NCT05466682|448954773|FG000|Overall Study|Lost to Follow-up|2|||
124815699|NCT05466682|448954774|FG001|Overall Study|Lost to Follow-up|1|||
124815700|NCT01930123|448954775|FG000|Overall Study|Adverse Event|1|||
124815701|NCT01930123|448954776|FG001|Overall Study|Adverse Event|0|||
124815702|NCT01930123|448954775|FG000|Overall Study|Physician Decision|21|||
124815703|NCT01930123|448954776|FG001|Overall Study|Physician Decision|8|||
124815704|NCT01930123|448954775|FG000|Overall Study|Withdrawal by Subject|1|||
124815705|NCT01930123|448954776|FG001|Overall Study|Withdrawal by Subject|0|||
124815706|NCT01447433|448954779|FG000|Overall Study|Lost to Follow-up|0|||
124815707|NCT01447433|448954780|FG001|Overall Study|Lost to Follow-up|2|||
124815708|NCT01447433|448954779|FG000|Overall Study|Withdrawal by Subject|3|||
124815709|NCT01447433|448954780|FG001|Overall Study|Withdrawal by Subject|3|||
124815710|NCT01447433|448954779|FG000|Overall Study|Protocol Violation|1|||
124815711|NCT01447433|448954780|FG001|Overall Study|Protocol Violation|1|||
124815712|NCT00036270|448954781|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
124815713|NCT00036270|448954782|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
124815714|NCT00036270|448954781|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
125302697|NCT00348309|450734061|FG001|Overall Study|Death of caregiver|0|||
125302698|NCT00348309|450734062|FG002|Overall Study|Death of caregiver|1|||
125302699|NCT00348309|450734060|FG000|Overall Study|Lack of insight, dementia|1|||
125302700|NCT00348309|450734061|FG001|Overall Study|Lack of insight, dementia|0|||
125302701|NCT00348309|450734062|FG002|Overall Study|Lack of insight, dementia|0|||
125302702|NCT00348309|450734060|FG000|Overall Study|Wrong bottle allocated|1|||
125302703|NCT00348309|450734061|FG001|Overall Study|Wrong bottle allocated|0|||
124815715|NCT00036270|448954782|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
124815716|NCT00036270|448954781|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
124815717|NCT00036270|448954782|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
124815718|NCT00036270|448954781|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
124815719|NCT00036270|448954782|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
124815720|NCT00036270|448954781|FG000|Study Treatment to 5 Year Report|Other|277|||
124815721|NCT00036270|448954782|FG001|Study Treatment to 5 Year Report|Other|288|||
124815722|NCT00036270|448954781|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
124815723|NCT00036270|448954782|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
124815724|NCT00036270|448954781|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
124815725|NCT00036270|448954782|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
124819587|NCT00420927|448965767|FG006|Period 1|Lost to Follow-up|0|||
125302704|NCT00348309|450734062|FG002|Overall Study|Wrong bottle allocated|0|||
125302705|NCT00348309|450734060|FG000|Overall Study|Caregiver sick|1|||
124815726|NCT00036270|448954781|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
124815727|NCT00036270|448954782|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
124815728|NCT00036270|448954781|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
124815729|NCT00036270|448954782|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
124815730|NCT00036270|448954781|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
124815731|NCT00036270|448954782|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
124815732|NCT00036270|448954781|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
124815733|NCT00036270|448954782|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
124815734|NCT01578187|448954783|FG000|Usability Phase|Withdrawal by Subject|1|||
124815735|NCT01964430|448954784|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
124815736|NCT01964430|448954785|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
124815737|NCT01964430|448954784|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
125302706|NCT00348309|450734061|FG001|Overall Study|Caregiver sick|0|||
125302707|NCT00348309|450734062|FG002|Overall Study|Caregiver sick|0|||
125302708|NCT00348309|450734060|FG000|Overall Study|Use of prohibited medication|5|||
125302709|NCT00348309|450734061|FG001|Overall Study|Use of prohibited medication|2|||
125302710|NCT00348309|450734062|FG002|Overall Study|Use of prohibited medication|2|||
125302711|NCT00348309|450734060|FG000|Overall Study|Caregiver withdrawal|3|||
125302712|NCT00348309|450734061|FG001|Overall Study|Caregiver withdrawal|0|||
125302713|NCT00348309|450734062|FG002|Overall Study|Caregiver withdrawal|7|||
125302714|NCT00348309|450734060|FG000|Overall Study|Unable to complete ET visit|1|||
124815738|NCT01964430|448954785|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
124815739|NCT01964430|448954784|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
124815740|NCT01964430|448954785|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
124815741|NCT01964430|448954784|FG000|Treatment Period|Adverse Event|71|||
124815742|NCT01964430|448954785|FG001|Treatment Period|Adverse Event|37|||
124815743|NCT01964430|448954784|FG000|Treatment Period|Withdrawal by Subject|36|||
124815744|NCT01964430|448954785|FG001|Treatment Period|Withdrawal by Subject|27|||
124815745|NCT01964430|448954784|FG000|Treatment Period|Death|1|||
124815746|NCT01964430|448954785|FG001|Treatment Period|Death|3|||
124815747|NCT01964430|448954784|FG000|Treatment Period|Protocol Deviation|0|||
124815748|NCT01964430|448954785|FG001|Treatment Period|Protocol Deviation|1|||
124815749|NCT01964430|448954784|FG000|Treatment Period|Physician Decision|5|||
124815750|NCT01964430|448954785|FG001|Treatment Period|Physician Decision|4|||
124815751|NCT01964430|448954784|FG000|Treatment Period|Disease Relapse|28|||
125302715|NCT00348309|450734061|FG001|Overall Study|Unable to complete ET visit|0|||
125302716|NCT00348309|450734062|FG002|Overall Study|Unable to complete ET visit|0|||
125302717|NCT00348309|450734060|FG000|Overall Study|PI closing medical practice|1|||
125302718|NCT00348309|450734061|FG001|Overall Study|PI closing medical practice|0|||
125302719|NCT00348309|450734062|FG002|Overall Study|PI closing medical practice|0|||
125302720|NCT00348309|450734060|FG000|Overall Study|Principal investigator's decision|1|||
125302721|NCT00348309|450734061|FG001|Overall Study|Principal investigator's decision|0|||
125302722|NCT00348309|450734062|FG002|Overall Study|Principal investigator's decision|0|||
125302723|NCT00348309|450734060|FG000|Overall Study|No disponibility of medication|1|||
125302724|NCT00348309|450734061|FG001|Overall Study|No disponibility of medication|0|||
125302725|NCT00348309|450734062|FG002|Overall Study|No disponibility of medication|0|||
125302726|NCT00348309|450734060|FG000|Overall Study|Worsened neurodegenerative disease|1|||
125302727|NCT00348309|450734061|FG001|Overall Study|Worsened neurodegenerative disease|0|||
125302728|NCT00348309|450734062|FG002|Overall Study|Worsened neurodegenerative disease|0|||
125302729|NCT00348309|450734060|FG000|Overall Study|Cognitive and behaviour worsening|2|||
125302730|NCT00348309|450734061|FG001|Overall Study|Cognitive and behaviour worsening|0|||
125302731|NCT00348309|450734062|FG002|Overall Study|Cognitive and behaviour worsening|0|||
125302732|NCT00348309|450734060|FG000|Overall Study|Worsening of alzheimer|1|||
125302733|NCT00348309|450734061|FG001|Overall Study|Worsening of alzheimer|0|||
125302734|NCT00348309|450734062|FG002|Overall Study|Worsening of alzheimer|1|||
125302735|NCT00348309|450734060|FG000|Overall Study|Did not appear in time for Visit 3|1|||
125302736|NCT00348309|450734061|FG001|Overall Study|Did not appear in time for Visit 3|0|||
125302737|NCT00348309|450734062|FG002|Overall Study|Did not appear in time for Visit 3|0|||
125302738|NCT00348309|450734060|FG000|Overall Study|Participant died|2|||
125302739|NCT00348309|450734061|FG001|Overall Study|Participant died|1|||
125302740|NCT00348309|450734062|FG002|Overall Study|Participant died|1|||
125302741|NCT00348309|450734060|FG000|Overall Study|Decision of sponsor|1|||
125302742|NCT00348309|450734061|FG001|Overall Study|Decision of sponsor|0|||
125302743|NCT00348309|450734062|FG002|Overall Study|Decision of sponsor|0|||
125302744|NCT00348309|450734060|FG000|Overall Study|Ineffectiveness of treatment|0|||
125302745|NCT00348309|450734061|FG001|Overall Study|Ineffectiveness of treatment|1|||
125302746|NCT00348309|450734062|FG002|Overall Study|Ineffectiveness of treatment|0|||
125302747|NCT00348309|450734060|FG000|Overall Study|A foul of exclusion criteria|0|||
124815752|NCT01964430|448954785|FG001|Treatment Period|Disease Relapse|38|||
124815753|NCT01964430|448954784|FG000|Treatment Period|Other reasons|1|||
124815754|NCT01964430|448954785|FG001|Treatment Period|Other reasons|3|||
125302748|NCT00348309|450734061|FG001|Overall Study|A foul of exclusion criteria|1|||
125302749|NCT00348309|450734062|FG002|Overall Study|A foul of exclusion criteria|0|||
125302750|NCT00348309|450734060|FG000|Overall Study|Participant was hospitalized|0|||
125302751|NCT00348309|450734061|FG001|Overall Study|Participant was hospitalized|1|||
125302752|NCT00348309|450734062|FG002|Overall Study|Participant was hospitalized|0|||
125302753|NCT00348309|450734060|FG000|Overall Study|Sponsor refuseal|0|||
125302754|NCT00348309|450734061|FG001|Overall Study|Sponsor refuseal|1|||
125302755|NCT00348309|450734062|FG002|Overall Study|Sponsor refuseal|1|||
125302756|NCT00348309|450734060|FG000|Overall Study|Forgot often medication|0|||
125302757|NCT00348309|450734061|FG001|Overall Study|Forgot often medication|1|||
125302758|NCT00348309|450734062|FG002|Overall Study|Forgot often medication|0|||
125302759|NCT00348309|450734060|FG000|Overall Study|Medical Monitor decision|0|||
125302760|NCT00348309|450734061|FG001|Overall Study|Medical Monitor decision|0|||
125302761|NCT00348309|450734062|FG002|Overall Study|Medical Monitor decision|1|||
125302762|NCT00348309|450734060|FG000|Overall Study|Increased dose of Aricept|0|||
125302763|NCT00348309|450734061|FG001|Overall Study|Increased dose of Aricept|0|||
125302764|NCT00348309|450734062|FG002|Overall Study|Increased dose of Aricept|1|||
125302765|NCT00348309|450734060|FG000|Overall Study|Site closure|0|||
125302766|NCT00348309|450734061|FG001|Overall Study|Site closure|0|||
125302767|NCT00348309|450734062|FG002|Overall Study|Site closure|1|||
125302768|NCT00348309|450734060|FG000|Overall Study|Adverse event not attended|0|||
125302769|NCT00348309|450734061|FG001|Overall Study|Adverse event not attended|0|||
125302770|NCT00348309|450734062|FG002|Overall Study|Adverse event not attended|1|||
125302771|NCT00348309|450734060|FG000|Overall Study|ECG abnormal|0|||
125302772|NCT00348309|450734061|FG001|Overall Study|ECG abnormal|0|||
125302773|NCT00348309|450734062|FG002|Overall Study|ECG abnormal|2|||
125302774|NCT00348309|450734060|FG000|Overall Study|Cardiologist recommendations|0|||
125302775|NCT00348309|450734061|FG001|Overall Study|Cardiologist recommendations|0|||
125302776|NCT00348309|450734062|FG002|Overall Study|Cardiologist recommendations|1|||
125302777|NCT00348309|450734060|FG000|Overall Study|HCV career|0|||
125302778|NCT00348309|450734061|FG001|Overall Study|HCV career|0|||
125302779|NCT00348309|450734062|FG002|Overall Study|HCV career|1|||
125302780|NCT01894243|450734063|FG000|Overall Study|Adverse Event|0|||
125302781|NCT01894243|450734064|FG001|Overall Study|Adverse Event|1|||
125302782|NCT01894243|450734065|FG002|Overall Study|Adverse Event|2|||
125302783|NCT01894243|450734063|FG000|Overall Study|Death|0|||
124815755|NCT02516163|448954786|FG000|Overall Study|Withdrawal by Subject|1|||
125302784|NCT01894243|450734064|FG001|Overall Study|Death|0|||
125302785|NCT01894243|450734065|FG002|Overall Study|Death|3|||
125302786|NCT01894243|450734063|FG000|Overall Study|Lack of Efficacy|3|||
125302787|NCT01894243|450734064|FG001|Overall Study|Lack of Efficacy|3|||
125302788|NCT01894243|450734065|FG002|Overall Study|Lack of Efficacy|1|||
125302789|NCT01894243|450734063|FG000|Overall Study|Condition under investigation worsened|8|||
125302790|NCT01894243|450734064|FG001|Overall Study|Condition under investigation worsened|6|||
125302791|NCT01894243|450734065|FG002|Overall Study|Condition under investigation worsened|2|||
125302792|NCT01894243|450734063|FG000|Overall Study|Subject decision|1|||
125302793|NCT01894243|450734064|FG001|Overall Study|Subject decision|0|||
125302794|NCT01894243|450734065|FG002|Overall Study|Subject decision|0|||
125302795|NCT01894243|450734063|FG000|Overall Study|Other|1|||
125302796|NCT01894243|450734064|FG001|Overall Study|Other|0|||
125302797|NCT01894243|450734065|FG002|Overall Study|Other|0|||
125302798|NCT01620944|450734069|FG000|Overall Study|Early termination of Study|2|||
125302799|NCT01620944|450734070|FG001|Overall Study|Early termination of Study|1|||
124815756|NCT02516163|448954786|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
124815757|NCT02516163|448954786|FG000|Overall Study|Unfit/delay in surgery|3|||
124815758|NCT02516163|448954786|FG000|Overall Study|Use of incorrect measurement technique|5|||
125302800|NCT01364389|450734072|FG000|Overall Study|Withdrawal by Subject|0|||
125302801|NCT01364389|450734073|FG001|Overall Study|Withdrawal by Subject|1|||
125302802|NCT01364389|450734074|FG002|Overall Study|Withdrawal by Subject|0|||
125302803|NCT01364389|450734072|FG000|Overall Study|Protocol deviation|0|||
125302804|NCT01364389|450734073|FG001|Overall Study|Protocol deviation|0|||
125302805|NCT01364389|450734074|FG002|Overall Study|Protocol deviation|1|||
125302806|NCT01364389|450734072|FG000|Overall Study|Administrative problems|1|||
125302807|NCT01364389|450734073|FG001|Overall Study|Administrative problems|0|||
125302808|NCT01364389|450734074|FG002|Overall Study|Administrative problems|0|||
125302809|NCT01364389|450734072|FG000|Overall Study|Adverse Event|1|||
125302810|NCT01364389|450734073|FG001|Overall Study|Adverse Event|0|||
125302811|NCT01364389|450734074|FG002|Overall Study|Adverse Event|0|||
124815759|NCT02516163|448954786|FG000|Overall Study|Data not recorded|2|||
125302812|NCT02687581|450734075|FG000|Overall Study|Withdrawal by Subject|1|||
125302813|NCT02687581|450734076|FG001|Overall Study|Withdrawal by Subject|0|||
125302814|NCT02687581|450734077|FG002|Overall Study|Withdrawal by Subject|0|||
125302815|NCT02687581|450734078|FG003|Overall Study|Withdrawal by Subject|1|||
125302816|NCT02687581|450734075|FG000|Overall Study|Lost to Follow-up|2|||
125302817|NCT02687581|450734076|FG001|Overall Study|Lost to Follow-up|2|||
125302818|NCT02687581|450734077|FG002|Overall Study|Lost to Follow-up|0|||
125302819|NCT02687581|450734078|FG003|Overall Study|Lost to Follow-up|0|||
125302820|NCT02687581|450734075|FG000|Overall Study|the device is too small for the patient.|1|||
125302821|NCT02687581|450734076|FG001|Overall Study|the device is too small for the patient.|0|||
125302822|NCT02687581|450734077|FG002|Overall Study|the device is too small for the patient.|0|||
125302823|NCT02687581|450734078|FG003|Overall Study|the device is too small for the patient.|0|||
125302824|NCT02554981|450734081|FG000|Overall Study|Adverse Event|1|||
125302825|NCT02554981|450734081|FG000|Overall Study|Administrative Reasons|1|||
125302826|NCT02554981|450734081|FG000|Overall Study|Other Miscellaneous Reasons|3|||
125302827|NCT01114438|450734082|FG000|Overall Study|Adverse Event|10|||
125302828|NCT01114438|450734082|FG000|Overall Study|concomitant medication|1|||
125302829|NCT01114438|450734082|FG000|Overall Study|Physician Decision|1|||
124815760|NCT02516163|448954786|FG000|Overall Study|MRI contraindication exclusion|6|||
124815761|NCT02801396|448954787|FG000|Period 1|Withdrawal by Subject|0|||
124815762|NCT02801396|448954788|FG001|Period 1|Withdrawal by Subject|0|||
124815763|NCT02801396|448954789|FG002|Period 1|Withdrawal by Subject|0|||
124815764|NCT02801396|448954790|FG003|Period 1|Withdrawal by Subject|0|||
124815765|NCT02801396|448954791|FG004|Period 1|Withdrawal by Subject|1|||
125302830|NCT01114438|450734082|FG000|Overall Study|Withdrawal by Subject|2|||
125302831|NCT00991406|450734087|FG000|Overall Study|One participant did not respond to FES.|1|||
125302832|NCT03597061|450734088|FG000|Overall Study|Lost to Follow-up|1|||
125302833|NCT03597061|450734089|FG001|Overall Study|Lost to Follow-up|0|||
125302834|NCT03597061|450734088|FG000|Overall Study|Protocol Violation|0|||
125302835|NCT03597061|450734089|FG001|Overall Study|Protocol Violation|1|||
125302836|NCT02160145|450734090|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
125302837|NCT02160145|450734091|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
124815766|NCT02801396|448954792|FG005|Period 1|Withdrawal by Subject|0|||
124815767|NCT01658072|448954795|FG000|Overall Study|Protocol Violation|4|||
124815768|NCT01658072|448954796|FG001|Overall Study|Protocol Violation|2|||
124815769|NCT03208244|448954797|FG000|Overall Study|Death|1|||
124815770|NCT00602797|448954805|FG000|Overall Study|Adverse Event|1|||
124815771|NCT01318993|448954813|FG000|Overall Study|Adverse Event|53|||
125302838|NCT02160145|450734092|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
125302839|NCT02160145|450734090|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
125302840|NCT02160145|450734091|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
125302841|NCT02160145|450734092|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
125302842|NCT02160145|450734090|FG000|Randomized Double-blind Period|Subject decision|0|||
125302843|NCT02160145|450734091|FG001|Randomized Double-blind Period|Subject decision|21|||
125302844|NCT02160145|450734092|FG002|Randomized Double-blind Period|Subject decision|20|||
125302845|NCT02160145|450734090|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
125302846|NCT02160145|450734091|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
125302847|NCT02160145|450734092|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
125302848|NCT02160145|450734090|FG000|Randomized Double-blind Period|Physician Decision|0|||
125302849|NCT02160145|450734091|FG001|Randomized Double-blind Period|Physician Decision|7|||
125302850|NCT02160145|450734092|FG002|Randomized Double-blind Period|Physician Decision|5|||
125302851|NCT00375518|450734093|FG000|Overall Study|Withdrawal by Subject|2|||
125302852|NCT00375518|450734094|FG001|Overall Study|Withdrawal by Subject|10|||
125302853|NCT00375518|450734093|FG000|Overall Study|Patient Not Treated|6|||
125302854|NCT00375518|450734094|FG001|Overall Study|Patient Not Treated|6|||
124815772|NCT01318993|448954813|FG000|Overall Study|Lack of Efficacy|121|||
124815773|NCT01318993|448954813|FG000|Overall Study|Protocol Violation|3|||
124815774|NCT01318993|448954813|FG000|Overall Study|Protocol based stopping criteria|6|||
124815775|NCT01318993|448954813|FG000|Overall Study|Study closed or terminated|174|||
124815776|NCT01318993|448954813|FG000|Overall Study|Lost to Follow-up|4|||
124815777|NCT01318993|448954813|FG000|Overall Study|Physician Decision|13|||
124815778|NCT01318993|448954813|FG000|Overall Study|Withdrawal by Subject|24|||
124815779|NCT00361569|448954814|FG000|Overall Study|Protocol Violation|3|||
124815780|NCT00361569|448954815|FG001|Overall Study|Protocol Violation|2|||
124815781|NCT00361569|448954816|FG002|Overall Study|Protocol Violation|4|||
124815782|NCT00361569|448954817|FG003|Overall Study|Protocol Violation|2|||
125302855|NCT00375518|450734093|FG000|Overall Study|Death|0|||
125302856|NCT00375518|450734094|FG001|Overall Study|Death|1|||
125302857|NCT01108523|450734095|FG000|Overall Study|Protocol Violation|4|||
125302858|NCT03755661|450734100|FG000|Overall Study|Lost to Follow-up|1|||
125302859|NCT03755661|450734101|FG001|Overall Study|Lost to Follow-up|0|||
125302860|NCT02277119|450734102|FG000|Overall Study|Lack of Efficacy|1|||
125302861|NCT02277119|450734103|FG001|Overall Study|Lack of Efficacy|1|||
125302862|NCT02277119|450734104|FG002|Overall Study|Lack of Efficacy|1|||
125302863|NCT02277119|450734102|FG000|Overall Study|Protocol Violation|2|||
125302864|NCT02277119|450734103|FG001|Overall Study|Protocol Violation|3|||
125302865|NCT02277119|450734104|FG002|Overall Study|Protocol Violation|7|||
124815783|NCT00361569|448954814|FG000|Overall Study|Withdrawal by Subject|2|||
124815784|NCT00361569|448954815|FG001|Overall Study|Withdrawal by Subject|1|||
124815785|NCT00361569|448954816|FG002|Overall Study|Withdrawal by Subject|9|||
124815786|NCT00361569|448954817|FG003|Overall Study|Withdrawal by Subject|14|||
124815787|NCT00361569|448954814|FG000|Overall Study|Adverse Event|3|||
124815788|NCT00361569|448954815|FG001|Overall Study|Adverse Event|5|||
124815789|NCT00361569|448954816|FG002|Overall Study|Adverse Event|2|||
124815790|NCT00361569|448954817|FG003|Overall Study|Adverse Event|2|||
124815791|NCT00361569|448954814|FG000|Overall Study|Lost to Follow-up|2|||
124815792|NCT00361569|448954815|FG001|Overall Study|Lost to Follow-up|3|||
124815793|NCT00361569|448954816|FG002|Overall Study|Lost to Follow-up|3|||
124815794|NCT00361569|448954817|FG003|Overall Study|Lost to Follow-up|2|||
124815795|NCT00361569|448954814|FG000|Overall Study|Not specified by investigator|2|||
124815796|NCT00361569|448954815|FG001|Overall Study|Not specified by investigator|0|||
124815797|NCT00361569|448954816|FG002|Overall Study|Not specified by investigator|0|||
124815798|NCT00361569|448954817|FG003|Overall Study|Not specified by investigator|1|||
124815799|NCT01558271|448954818|FG000|Overall Study|Adverse Event|6|||
124815800|NCT01558271|448954819|FG001|Overall Study|Adverse Event|3|||
124815801|NCT01558271|448954820|FG002|Overall Study|Adverse Event|4|||
124815802|NCT01558271|448954818|FG000|Overall Study|Lost to Follow-up|1|||
124815803|NCT01558271|448954819|FG001|Overall Study|Lost to Follow-up|0|||
124815804|NCT01558271|448954820|FG002|Overall Study|Lost to Follow-up|0|||
124815805|NCT01558271|448954818|FG000|Overall Study|Protocol Violation|1|||
124815806|NCT01558271|448954819|FG001|Overall Study|Protocol Violation|0|||
124815807|NCT01558271|448954820|FG002|Overall Study|Protocol Violation|0|||
125302866|NCT03521141|450736598|FG000|Overall Study|Death|1|||
125302867|NCT03521141|450736599|FG001|Overall Study|Death|0|||
125302868|NCT03521141|450736600|FG002|Overall Study|Death|1|||
125302869|NCT01702025|450736603|FG000|Overall Study|Equipment failure|1|||
125302870|NCT01702025|450736604|FG001|Overall Study|Equipment failure|0|||
125302871|NCT01702025|450736605|FG002|Overall Study|Equipment failure|0|||
125302872|NCT01702025|450736606|FG003|Overall Study|Equipment failure|0|||
125302873|NCT01702025|450736603|FG000|Overall Study|Adverse Event|1|||
125302874|NCT01702025|450736604|FG001|Overall Study|Adverse Event|1|||
125302875|NCT01702025|450736605|FG002|Overall Study|Adverse Event|1|||
125302876|NCT01702025|450736606|FG003|Overall Study|Adverse Event|0|||
125302877|NCT04207749|450736609|FG000|Overall Study|Lost to Follow-up|0|||
125302878|NCT04207749|450736610|FG001|Overall Study|Lost to Follow-up|2|||
125302879|NCT04207749|450736609|FG000|Overall Study|Protocol Violation|0|||
125302880|NCT04207749|450736610|FG001|Overall Study|Protocol Violation|1|||
125302881|NCT04207749|450736609|FG000|Overall Study|Withdrawal by Subject|3|||
125302882|NCT04207749|450736610|FG001|Overall Study|Withdrawal by Subject|0|||
125302883|NCT04207749|450736609|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
125302884|NCT04207749|450736610|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
125302885|NCT05362058|450736611|FG000|Treatment Period|Adverse Event|3|||
125302886|NCT05362058|450736612|FG001|Treatment Period|Adverse Event|3|||
125302887|NCT05362058|450736611|FG000|Treatment Period|Assigned treatment by mistake|3|||
125302888|NCT05362058|450736612|FG001|Treatment Period|Assigned treatment by mistake|4|||
125302889|NCT05362058|450736611|FG000|Treatment Period|Death|1|||
125302890|NCT05362058|450736612|FG001|Treatment Period|Death|1|||
125302891|NCT05362058|450736611|FG000|Treatment Period|Lost to Follow-up|6|||
125302892|NCT05362058|450736612|FG001|Treatment Period|Lost to Follow-up|3|||
125302893|NCT05362058|450736611|FG000|Treatment Period|Non-compliance with study drug|0|||
125302894|NCT05362058|450736612|FG001|Treatment Period|Non-compliance with study drug|1|||
125302895|NCT05362058|450736611|FG000|Treatment Period|Physician Decision|1|||
125302896|NCT05362058|450736612|FG001|Treatment Period|Physician Decision|0|||
125302897|NCT05362058|450736611|FG000|Treatment Period|Protocol deviation|1|||
125302898|NCT05362058|450736612|FG001|Treatment Period|Protocol deviation|0|||
125302899|NCT05362058|450736611|FG000|Treatment Period|Withdrawal by Subject|10|||
125302900|NCT05362058|450736612|FG001|Treatment Period|Withdrawal by Subject|11|||
125302901|NCT05362058|450736611|FG000|Follow-Up Period|Death|1|||
125302902|NCT05362058|450736612|FG001|Follow-Up Period|Death|0|||
125302903|NCT05362058|450736611|FG000|Follow-Up Period|Lost to Follow-up|2|||
125302904|NCT05362058|450736612|FG001|Follow-Up Period|Lost to Follow-up|1|||
125302905|NCT05362058|450736611|FG000|Follow-Up Period|Protocol deviation|1|||
125302906|NCT05362058|450736612|FG001|Follow-Up Period|Protocol deviation|1|||
125302907|NCT05362058|450736611|FG000|Follow-Up Period|Withdrawal by Subject|0|||
125302908|NCT05362058|450736612|FG001|Follow-Up Period|Withdrawal by Subject|3|||
125302909|NCT00930553|450736615|FG000|Overall Study|Adverse Event|1|||
125302910|NCT00930553|450736615|FG000|Overall Study|Lack of Efficacy|7|||
125302911|NCT00930553|450736615|FG000|Overall Study|Physician Decision|39|||
125302912|NCT00930553|450736615|FG000|Overall Study|Protocol Violation|1|||
124815808|NCT01558271|448954818|FG000|Overall Study|Withdrawal by Subject|10|||
124815809|NCT01558271|448954819|FG001|Overall Study|Withdrawal by Subject|6|||
124815810|NCT01558271|448954820|FG002|Overall Study|Withdrawal by Subject|12|||
124815811|NCT01558271|448954818|FG000|Overall Study|Physician Decision|0|||
125302913|NCT00930553|450736615|FG000|Overall Study|Pregnancy|1|||
125302914|NCT00930553|450736615|FG000|Overall Study|Withdrawal by Subject|88|||
124815812|NCT01558271|448954819|FG001|Overall Study|Physician Decision|2|||
124815813|NCT01558271|448954820|FG002|Overall Study|Physician Decision|1|||
124815814|NCT01594762|448954821|FG000|Overall Study|Withdrawal by Subject|1|||
124815815|NCT01594762|448954822|FG001|Overall Study|Withdrawal by Subject|0|||
125302915|NCT00930553|450736615|FG000|Overall Study|Lost to Follow-up|25|||
125302916|NCT00930553|450736615|FG000|Overall Study|Death|9|||
125302917|NCT00930553|450736615|FG000|Overall Study|Study terminated by sponsor|24|||
125302918|NCT00930553|450736615|FG000|Overall Study|Other than specified above|28|||
125302919|NCT00413036|450736616|FG000|Overall Study|Adverse Event|44|||
125302920|NCT00413036|450736616|FG000|Overall Study|Lack of Efficacy|129|||
125302921|NCT00413036|450736616|FG000|Overall Study|Withdrawal by Subject|7|||
125302922|NCT00413036|450736616|FG000|Overall Study|Death|9|||
125302923|NCT00413036|450736616|FG000|Overall Study|Other|26|||
125302924|NCT00413036|450736616|FG000|Overall Study|Missing|2|||
125302925|NCT04042909|450736617|FG000|Overall Study|Withdrawal by Subject|1|||
125302926|NCT04042909|450736618|FG001|Overall Study|Withdrawal by Subject|0|||
125302927|NCT04042909|450736619|FG002|Overall Study|Withdrawal by Subject|0|||
125302928|NCT04042909|450736617|FG000|Overall Study|duplicate cases|2|||
125302929|NCT04042909|450736618|FG001|Overall Study|duplicate cases|0|||
125302930|NCT04042909|450736619|FG002|Overall Study|duplicate cases|0|||
125302931|NCT04042909|450736617|FG000|Overall Study|technical problem|0|||
125302932|NCT04042909|450736618|FG001|Overall Study|technical problem|1|||
125302933|NCT04042909|450736619|FG002|Overall Study|technical problem|0|||
125302934|NCT01369641|450736620|FG000|Overall Study|Withdrawal by Subject|1|||
125302935|NCT00842543|450736621|FG000|Overall Study|Withdrawal by Subject|2|||
125302936|NCT00842543|450736622|FG001|Overall Study|Withdrawal by Subject|0|||
125302937|NCT00842543|450736623|FG002|Overall Study|Withdrawal by Subject|3|||
125302938|NCT00842543|450736624|FG003|Overall Study|Withdrawal by Subject|4|||
125302939|NCT01483183|450736629|FG000|Overall Study|Physician Decision|0|||
125302940|NCT01483183|450736630|FG001|Overall Study|Physician Decision|0|||
125302941|NCT01483183|450736631|FG002|Overall Study|Physician Decision|0|||
125302942|NCT01483183|450736632|FG003|Overall Study|Physician Decision|0|||
125302943|NCT01483183|450736633|FG004|Overall Study|Physician Decision|0|||
125302944|NCT01483183|450736634|FG005|Overall Study|Physician Decision|0|||
125302945|NCT01483183|450736635|FG006|Overall Study|Physician Decision|2|||
125302946|NCT01483183|450736636|FG007|Overall Study|Physician Decision|0|||
125302947|NCT01483183|450736637|FG008|Overall Study|Physician Decision|0|||
125302948|NCT01483183|450736638|FG009|Overall Study|Physician Decision|0|||
125302949|NCT01483183|450736629|FG000|Overall Study|Withdrawal by Subject|0|||
125302950|NCT01483183|450736630|FG001|Overall Study|Withdrawal by Subject|0|||
125302951|NCT01483183|450736631|FG002|Overall Study|Withdrawal by Subject|0|||
125302952|NCT01483183|450736632|FG003|Overall Study|Withdrawal by Subject|0|||
125302953|NCT01483183|450736633|FG004|Overall Study|Withdrawal by Subject|0|||
125302954|NCT01483183|450736634|FG005|Overall Study|Withdrawal by Subject|0|||
125302955|NCT01483183|450736635|FG006|Overall Study|Withdrawal by Subject|0|||
125302956|NCT01483183|450736636|FG007|Overall Study|Withdrawal by Subject|0|||
125302957|NCT01483183|450736637|FG008|Overall Study|Withdrawal by Subject|0|||
125302958|NCT01483183|450736638|FG009|Overall Study|Withdrawal by Subject|1|||
125302959|NCT00239928|450736639|FG000|Overall Study|Lack of Efficacy|1|||
125302960|NCT00239928|450736639|FG000|Overall Study|Adverse Event|4|||
125302961|NCT00239928|450736639|FG000|Overall Study|Not need to continue study|3|||
125302962|NCT00239928|450736639|FG000|Overall Study|Withdrawal by Subject|2|||
125302963|NCT00286494|450736640|FG000|Overall Study|Hyperglycemic rescue|12|||
125302964|NCT00286494|450736641|FG001|Overall Study|Hyperglycemic rescue|19|||
125302965|NCT00286494|450736642|FG002|Overall Study|Hyperglycemic rescue|18|||
125302966|NCT00286494|450736640|FG000|Overall Study|Withdrawal by Subject|2|||
125302967|NCT00286494|450736641|FG001|Overall Study|Withdrawal by Subject|10|||
125302968|NCT00286494|450736642|FG002|Overall Study|Withdrawal by Subject|9|||
125302969|NCT00286494|450736640|FG000|Overall Study|Adverse Event|3|||
125302970|NCT00286494|450736641|FG001|Overall Study|Adverse Event|8|||
125302971|NCT00286494|450736642|FG002|Overall Study|Adverse Event|6|||
125302972|NCT00286494|450736640|FG000|Overall Study|Physician Decision|5|||
125302973|NCT00286494|450736641|FG001|Overall Study|Physician Decision|5|||
125302974|NCT00286494|450736642|FG002|Overall Study|Physician Decision|1|||
125302975|NCT00286494|450736640|FG000|Overall Study|Lost to Follow-up|3|||
125302976|NCT00286494|450736641|FG001|Overall Study|Lost to Follow-up|1|||
125302977|NCT00286494|450736642|FG002|Overall Study|Lost to Follow-up|3|||
125302978|NCT00286494|450736640|FG000|Overall Study|Protocol Violation|1|||
125302979|NCT00286494|450736641|FG001|Overall Study|Protocol Violation|1|||
125302980|NCT00286494|450736642|FG002|Overall Study|Protocol Violation|2|||
125302981|NCT04776317|450736643|FG000|Overall Study|Physician Decision|0|||
125302982|NCT04776317|450736644|FG001|Overall Study|Physician Decision|1|||
125302983|NCT04776317|450736645|FG002|Overall Study|Physician Decision|0|||
125302984|NCT04776317|450736646|FG003|Overall Study|Physician Decision|0|||
125302985|NCT04776317|450736647|FG004|Overall Study|Physician Decision|0|||
125302986|NCT04776317|450736648|FG005|Overall Study|Physician Decision|0|||
125302987|NCT04776317|450736649|FG006|Overall Study|Physician Decision|0|||
125302988|NCT04776317|450736650|FG007|Overall Study|Physician Decision|0|||
125302989|NCT04776317|450736651|FG008|Overall Study|Physician Decision|0|||
124815816|NCT01594762|448954821|FG000|Overall Study|Lost to Follow-up|10|||
125302990|NCT04776317|450736652|FG009|Overall Study|Physician Decision|0|||
125302991|NCT04776317|450736653|FG010|Overall Study|Physician Decision|0|||
125302992|NCT04776317|450736654|FG011|Overall Study|Physician Decision|0|||
125302993|NCT04776317|450736655|FG012|Overall Study|Physician Decision|0|||
125302994|NCT04776317|450736656|FG013|Overall Study|Physician Decision|0|||
125302995|NCT04776317|450736657|FG014|Overall Study|Physician Decision|0|||
125302996|NCT04776317|450736643|FG000|Overall Study|Protocol Violation|0|||
125302997|NCT04776317|450736644|FG001|Overall Study|Protocol Violation|0|||
125302998|NCT04776317|450736645|FG002|Overall Study|Protocol Violation|1|||
125302999|NCT04776317|450736646|FG003|Overall Study|Protocol Violation|0|||
125303000|NCT04776317|450736647|FG004|Overall Study|Protocol Violation|0|||
125303001|NCT04776317|450736648|FG005|Overall Study|Protocol Violation|0|||
125303002|NCT04776317|450736649|FG006|Overall Study|Protocol Violation|0|||
125303003|NCT04776317|450736650|FG007|Overall Study|Protocol Violation|0|||
125303004|NCT04776317|450736651|FG008|Overall Study|Protocol Violation|0|||
125303005|NCT04776317|450736652|FG009|Overall Study|Protocol Violation|0|||
125303006|NCT04776317|450736653|FG010|Overall Study|Protocol Violation|0|||
125303007|NCT04776317|450736654|FG011|Overall Study|Protocol Violation|0|||
125303008|NCT04776317|450736655|FG012|Overall Study|Protocol Violation|0|||
125303009|NCT04776317|450736656|FG013|Overall Study|Protocol Violation|0|||
125303010|NCT04776317|450736657|FG014|Overall Study|Protocol Violation|0|||
125303011|NCT04776317|450736643|FG000|Overall Study|Withdrawal by Subject|0|||
125303012|NCT04776317|450736644|FG001|Overall Study|Withdrawal by Subject|0|||
125303013|NCT04776317|450736645|FG002|Overall Study|Withdrawal by Subject|0|||
125303014|NCT04776317|450736646|FG003|Overall Study|Withdrawal by Subject|0|||
125303015|NCT04776317|450736647|FG004|Overall Study|Withdrawal by Subject|1|||
125303016|NCT04776317|450736648|FG005|Overall Study|Withdrawal by Subject|0|||
125303017|NCT04776317|450736649|FG006|Overall Study|Withdrawal by Subject|0|||
124815817|NCT01594762|448954822|FG001|Overall Study|Lost to Follow-up|10|||
124815818|NCT03547583|448954823|FG000|Overall Study|Adverse Event|16|||
124815819|NCT03547583|448954824|FG001|Overall Study|Adverse Event|11|||
124815820|NCT03547583|448954825|FG002|Overall Study|Adverse Event|10|||
124815821|NCT03547583|448954823|FG000|Overall Study|Death|11|||
124815822|NCT03547583|448954824|FG001|Overall Study|Death|7|||
124815823|NCT03547583|448954825|FG002|Overall Study|Death|4|||
124815824|NCT03547583|448954823|FG000|Overall Study|Lost to Follow-up|1|||
124815825|NCT03547583|448954824|FG001|Overall Study|Lost to Follow-up|0|||
124815826|NCT03547583|448954825|FG002|Overall Study|Lost to Follow-up|0|||
124815827|NCT03547583|448954823|FG000|Overall Study|Non-compliance with study drug|0|||
124815828|NCT03547583|448954824|FG001|Overall Study|Non-compliance with study drug|0|||
124815829|NCT03547583|448954825|FG002|Overall Study|Non-compliance with study drug|1|||
124815830|NCT03547583|448954823|FG000|Overall Study|Physician Decision|1|||
124815831|NCT03547583|448954824|FG001|Overall Study|Physician Decision|0|||
124815832|NCT03547583|448954825|FG002|Overall Study|Physician Decision|3|||
124815833|NCT03547583|448954823|FG000|Overall Study|Protocol Violation|2|||
124815834|NCT03547583|448954824|FG001|Overall Study|Protocol Violation|1|||
124815835|NCT03547583|448954825|FG002|Overall Study|Protocol Violation|1|||
124815836|NCT03547583|448954823|FG000|Overall Study|Withdrawal by Subject|12|||
124815837|NCT03547583|448954824|FG001|Overall Study|Withdrawal by Subject|19|||
124815838|NCT03547583|448954825|FG002|Overall Study|Withdrawal by Subject|10|||
124815839|NCT03547583|448954823|FG000|Overall Study|Other|2|||
124815840|NCT03547583|448954824|FG001|Overall Study|Other|2|||
124815841|NCT03547583|448954825|FG002|Overall Study|Other|3|||
124815842|NCT01235351|448956546|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
124815843|NCT01235351|448956547|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
124815844|NCT03003390|448956551|FG000|Overall Study|Physician Decision|2|||
124815845|NCT03003390|448956552|FG001|Overall Study|Physician Decision|0|||
124815846|NCT03003390|448956551|FG000|Overall Study|Parent refused intervention|2|||
124815847|NCT03003390|448956552|FG001|Overall Study|Parent refused intervention|0|||
124815848|NCT00307294|448956553|FG000|Overall Study|Withdrawal by Subject|1|||
124815849|NCT01664533|448956556|FG000|Overall Study|Death|42|||
124815850|NCT01664533|448956556|FG000|Overall Study|Lost to Follow-up|3|||
124815851|NCT01664533|448956556|FG000|Overall Study|Study termination|9|||
124815852|NCT01664533|448956556|FG000|Overall Study|Protocol Violation|3|||
124815853|NCT00290888|448956558|FG000|Overall Study|Physician Decision|3|||
124815854|NCT00290888|448956559|FG001|Overall Study|Physician Decision|1|||
124815855|NCT02370160|448956562|FG000|Overall Study|Death|3|||
124815856|NCT02370160|448956563|FG001|Overall Study|Death|4|||
124815857|NCT02370160|448956564|FG002|Overall Study|Death|1|||
124815858|NCT04487730|448956565|FG000|Overall Study|Withdrawal by Subject|3|||
124815859|NCT04487730|448956566|FG001|Overall Study|Withdrawal by Subject|1|||
124815860|NCT04487730|448956565|FG000|Overall Study|Lost to Follow-up|0|||
124815861|NCT04487730|448956566|FG001|Overall Study|Lost to Follow-up|1|||
125303018|NCT04776317|450736650|FG007|Overall Study|Withdrawal by Subject|0|||
125303019|NCT04776317|450736651|FG008|Overall Study|Withdrawal by Subject|0|||
125303020|NCT04776317|450736652|FG009|Overall Study|Withdrawal by Subject|0|||
125303021|NCT04776317|450736653|FG010|Overall Study|Withdrawal by Subject|0|||
124815862|NCT04487730|448956565|FG000|Overall Study|Physician Decision|0|||
124815863|NCT04487730|448956566|FG001|Overall Study|Physician Decision|1|||
125303022|NCT04776317|450736654|FG011|Overall Study|Withdrawal by Subject|0|||
124815864|NCT01581931|448956567|FG000|Washout|Adverse Event|0|||
124815865|NCT01581931|448956568|FG001|Washout|Adverse Event|1|||
124815866|NCT03291808|448956573|FG000|Overall Study|Lost to Follow-up|6|||
124815867|NCT03291808|448956573|FG000|Overall Study|Research burden|4|||
124815868|NCT01892293|448956584|FG000|Overall Study|Apheresed but not treated|4|||
124815869|NCT03602482|448956589|FG000|Overall Study|Withdrawal by Subject|6|||
124815870|NCT03602482|448956590|FG001|Overall Study|Withdrawal by Subject|7|||
124815871|NCT03602482|448956591|FG002|Overall Study|Withdrawal by Subject|0|||
124815872|NCT03602482|448956592|FG003|Overall Study|Withdrawal by Subject|0|||
124815873|NCT02397278|448956593|FG000|Overall Study|Withdrawal by Subject|0|||
124815874|NCT02397278|448956594|FG001|Overall Study|Withdrawal by Subject|2|||
124815875|NCT02397278|448956593|FG000|Overall Study|Deemed ineligible following surgery|1|||
124815876|NCT02397278|448956594|FG001|Overall Study|Deemed ineligible following surgery|1|||
124815877|NCT02161731|448956595|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
124815878|NCT02161731|448956596|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
124815879|NCT02161731|448956595|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
124815880|NCT02161731|448956596|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
124815881|NCT01397084|448956601|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
124815882|NCT01397084|448956601|FG000|Overall Study|Protocol Violation|2|||
124815883|NCT01397084|448956601|FG000|Overall Study|Adverse Event|2|||
124815884|NCT01397084|448956601|FG000|Overall Study|Withdrawal by Subject|1|||
124815885|NCT01397084|448956601|FG000|Overall Study|Lost to Follow-up|1|||
124815886|NCT01397084|448956601|FG000|Overall Study|Used other proton pump inhibitor|1|||
124815887|NCT00618072|448956604|FG000|Overall Study|Lost to Follow-up|2|||
124815888|NCT00618072|448956605|FG001|Overall Study|Lost to Follow-up|0|||
124815889|NCT00618072|448956606|FG002|Overall Study|Lost to Follow-up|3|||
124815890|NCT00618072|448956604|FG000|Overall Study|Physician Decision|0|||
124815891|NCT00618072|448956605|FG001|Overall Study|Physician Decision|1|||
124815892|NCT00618072|448956606|FG002|Overall Study|Physician Decision|1|||
124815893|NCT00592384|448956607|FG000|Overall Study|Withdrawal by Subject|5|||
124815894|NCT00592384|448956608|FG001|Overall Study|Withdrawal by Subject|6|||
124815895|NCT02380677|448956612|FG000|Overall Study|Adverse Event|0|||
124815896|NCT02380677|448956613|FG001|Overall Study|Adverse Event|0|||
124815897|NCT02380677|448956614|FG002|Overall Study|Adverse Event|0|||
124815898|NCT02380677|448956615|FG003|Overall Study|Adverse Event|1|||
124815899|NCT02380677|448956616|FG004|Overall Study|Adverse Event|1|||
124815900|NCT02380677|448956617|FG005|Overall Study|Adverse Event|4|||
124815901|NCT02380677|448956618|FG006|Overall Study|Adverse Event|2|||
124815902|NCT02380677|448956619|FG007|Overall Study|Adverse Event|2|||
124815903|NCT02380677|448956620|FG008|Overall Study|Adverse Event|2|||
124815904|NCT02380677|448956621|FG009|Overall Study|Adverse Event|1|||
124815905|NCT02380677|448956622|FG010|Overall Study|Adverse Event|2|||
124815906|NCT02380677|448956623|FG011|Overall Study|Adverse Event|1|||
124815907|NCT02380677|448956612|FG000|Overall Study|Physician Decision|1|||
124815908|NCT02380677|448956613|FG001|Overall Study|Physician Decision|0|||
124815909|NCT02380677|448956614|FG002|Overall Study|Physician Decision|1|||
124815910|NCT02380677|448956615|FG003|Overall Study|Physician Decision|1|||
124815911|NCT02380677|448956616|FG004|Overall Study|Physician Decision|0|||
124815912|NCT02380677|448956617|FG005|Overall Study|Physician Decision|0|||
124815913|NCT02380677|448956618|FG006|Overall Study|Physician Decision|0|||
124815914|NCT02380677|448956619|FG007|Overall Study|Physician Decision|0|||
124815915|NCT02380677|448956620|FG008|Overall Study|Physician Decision|0|||
124815916|NCT02380677|448956621|FG009|Overall Study|Physician Decision|0|||
124815917|NCT02380677|448956622|FG010|Overall Study|Physician Decision|0|||
124815918|NCT02380677|448956623|FG011|Overall Study|Physician Decision|0|||
124815919|NCT02380677|448956612|FG000|Overall Study|Lack of Efficacy|0|||
124815920|NCT02380677|448956613|FG001|Overall Study|Lack of Efficacy|1|||
124815921|NCT02380677|448956614|FG002|Overall Study|Lack of Efficacy|2|||
124815922|NCT02380677|448956615|FG003|Overall Study|Lack of Efficacy|0|||
124815923|NCT02380677|448956616|FG004|Overall Study|Lack of Efficacy|4|||
124815924|NCT02380677|448956617|FG005|Overall Study|Lack of Efficacy|1|||
124815925|NCT02380677|448956618|FG006|Overall Study|Lack of Efficacy|1|||
124815926|NCT02380677|448956619|FG007|Overall Study|Lack of Efficacy|2|||
124815927|NCT02380677|448956620|FG008|Overall Study|Lack of Efficacy|2|||
124815928|NCT02380677|448956621|FG009|Overall Study|Lack of Efficacy|0|||
124815929|NCT02380677|448956622|FG010|Overall Study|Lack of Efficacy|2|||
124815930|NCT02380677|448956623|FG011|Overall Study|Lack of Efficacy|1|||
124815931|NCT02380677|448956612|FG000|Overall Study|Withdrawal by Subject|0|||
124815932|NCT02380677|448956613|FG001|Overall Study|Withdrawal by Subject|0|||
124815933|NCT02380677|448956614|FG002|Overall Study|Withdrawal by Subject|0|||
124815934|NCT02380677|448956615|FG003|Overall Study|Withdrawal by Subject|0|||
124815935|NCT02380677|448956616|FG004|Overall Study|Withdrawal by Subject|0|||
124815936|NCT02380677|448956617|FG005|Overall Study|Withdrawal by Subject|0|||
124815937|NCT02380677|448956618|FG006|Overall Study|Withdrawal by Subject|0|||
124815938|NCT02380677|448956619|FG007|Overall Study|Withdrawal by Subject|0|||
124815939|NCT02380677|448956620|FG008|Overall Study|Withdrawal by Subject|0|||
124815940|NCT02380677|448956621|FG009|Overall Study|Withdrawal by Subject|1|||
124815941|NCT02380677|448956622|FG010|Overall Study|Withdrawal by Subject|0|||
124815942|NCT02380677|448956623|FG011|Overall Study|Withdrawal by Subject|3|||
124815943|NCT02380677|448956612|FG000|Overall Study|Other|0|||
124815944|NCT02380677|448956613|FG001|Overall Study|Other|0|||
124815945|NCT02380677|448956614|FG002|Overall Study|Other|0|||
124815946|NCT02380677|448956615|FG003|Overall Study|Other|1|||
124815947|NCT02380677|448956616|FG004|Overall Study|Other|1|||
124815948|NCT02380677|448956617|FG005|Overall Study|Other|1|||
124815949|NCT02380677|448956618|FG006|Overall Study|Other|0|||
124815950|NCT02380677|448956619|FG007|Overall Study|Other|0|||
124815951|NCT02380677|448956620|FG008|Overall Study|Other|0|||
124815952|NCT02380677|448956621|FG009|Overall Study|Other|0|||
124815953|NCT02380677|448956622|FG010|Overall Study|Other|0|||
124815954|NCT02380677|448956623|FG011|Overall Study|Other|0|||
124815955|NCT04932096|448956624|FG000|Overall Study|Withdrawal by Subject|1|||
124815956|NCT04932096|448956625|FG001|Overall Study|Withdrawal by Subject|1|||
124815957|NCT04932096|448956624|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
124815958|NCT04932096|448956625|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
124815959|NCT00133952|448956633|FG000|Overall Study|Adverse Event|1|||
124815960|NCT00133952|448956634|FG001|Overall Study|Adverse Event|2|||
124815961|NCT00133952|448956633|FG000|Overall Study|Death|3|||
124815962|NCT00133952|448956634|FG001|Overall Study|Death|2|||
124815963|NCT00133952|448956633|FG000|Overall Study|Lost to Follow-up|9|||
124815964|NCT00133952|448956634|FG001|Overall Study|Lost to Follow-up|14|||
124815965|NCT00133952|448956633|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
124815966|NCT00133952|448956634|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
124815967|NCT00133952|448956633|FG000|Overall Study|Protocol Violation|1|||
124815968|NCT00133952|448956634|FG001|Overall Study|Protocol Violation|1|||
124815969|NCT00133952|448956633|FG000|Overall Study|Withdrawal by Subject|20|||
124815970|NCT00133952|448956634|FG001|Overall Study|Withdrawal by Subject|4|||
124815971|NCT00133952|448956633|FG000|Overall Study|Physician Decision|4|||
124815972|NCT00133952|448956634|FG001|Overall Study|Physician Decision|3|||
124815973|NCT00133952|448956633|FG000|Overall Study|Sponsor Decision|0|||
124815974|NCT00133952|448956634|FG001|Overall Study|Sponsor Decision|1|||
124815975|NCT01976338|448956636|FG000|Overall Study|Physician Decision|0|||
124815976|NCT01976338|448956637|FG001|Overall Study|Physician Decision|1|||
124815977|NCT01976338|448956636|FG000|Overall Study|Lost to Follow-up|3|||
124815978|NCT01976338|448956637|FG001|Overall Study|Lost to Follow-up|0|||
124815979|NCT01976338|448956636|FG000|Overall Study|Withdrawal by Subject|5|||
124815980|NCT01976338|448956637|FG001|Overall Study|Withdrawal by Subject|2|||
124815981|NCT01976338|448956636|FG000|Overall Study|Adverse Event|5|||
124815982|NCT01976338|448956637|FG001|Overall Study|Adverse Event|1|||
124815983|NCT00777608|448956638|FG000|Overall Study|Lost to Follow-up|1|||
124815984|NCT00777608|448956639|FG001|Overall Study|Lost to Follow-up|1|||
124815985|NCT00777608|448956638|FG000|Overall Study|Withdrawal by Subject|1|||
124815986|NCT00777608|448956639|FG001|Overall Study|Withdrawal by Subject|3|||
124815987|NCT00777608|448956638|FG000|Overall Study|Protocol Violation|1|||
124815988|NCT00777608|448956639|FG001|Overall Study|Protocol Violation|0|||
124815989|NCT00777608|448956638|FG000|Overall Study|Investigator Decision|1|||
124815990|NCT00777608|448956639|FG001|Overall Study|Investigator Decision|2|||
124815991|NCT04213079|448956640|FG000|Overall Study|Lost to Follow-up|0|||
124815992|NCT04213079|448956641|FG001|Overall Study|Lost to Follow-up|2|||
124815993|NCT03766581|448956644|FG000|Randomization|Other reasons|2|||
124815994|NCT03766581|448956645|FG001|Randomization|Other reasons|1|||
124815995|NCT03766581|448956646|FG002|Randomization|Other reasons|0|||
124815996|NCT03766581|448956647|FG003|Randomization|Other reasons|1|||
124815997|NCT03766581|448956648|FG004|Randomization|Other reasons|0|||
124815998|NCT03766581|448956649|FG005|Randomization|Other reasons|0|||
124815999|NCT03766581|448956650|FG006|Randomization|Other reasons|0|||
124816000|NCT03766581|448956651|FG007|Randomization|Other reasons|0|||
124816001|NCT03766581|448956644|FG000|Randomization|Participant no longer meets study criteria|5|||
124816002|NCT03766581|448956645|FG001|Randomization|Participant no longer meets study criteria|3|||
124816003|NCT03766581|448956646|FG002|Randomization|Participant no longer meets study criteria|4|||
124816004|NCT03766581|448956647|FG003|Randomization|Participant no longer meets study criteria|0|||
124816005|NCT03766581|448956648|FG004|Randomization|Participant no longer meets study criteria|2|||
124816006|NCT03766581|448956649|FG005|Randomization|Participant no longer meets study criteria|3|||
124816007|NCT03766581|448956650|FG006|Randomization|Participant no longer meets study criteria|0|||
124816008|NCT03766581|448956651|FG007|Randomization|Participant no longer meets study criteria|1|||
124816009|NCT03766581|448956644|FG000|Randomization|Participant request to discontinue study treatment|1|||
124816010|NCT03766581|448956645|FG001|Randomization|Participant request to discontinue study treatment|0|||
124816011|NCT03766581|448956646|FG002|Randomization|Participant request to discontinue study treatment|0|||
124816012|NCT03766581|448956647|FG003|Randomization|Participant request to discontinue study treatment|0|||
124816013|NCT03766581|448956648|FG004|Randomization|Participant request to discontinue study treatment|1|||
124816014|NCT03766581|448956649|FG005|Randomization|Participant request to discontinue study treatment|2|||
124816015|NCT03766581|448956650|FG006|Randomization|Participant request to discontinue study treatment|0|||
124816016|NCT03766581|448956651|FG007|Randomization|Participant request to discontinue study treatment|0|||
124816017|NCT03766581|448956644|FG000|Randomization|Participant withdrew consent|1|||
124816018|NCT03766581|448956645|FG001|Randomization|Participant withdrew consent|0|||
124816019|NCT03766581|448956646|FG002|Randomization|Participant withdrew consent|1|||
124816020|NCT03766581|448956647|FG003|Randomization|Participant withdrew consent|2|||
124816021|NCT03766581|448956648|FG004|Randomization|Participant withdrew consent|1|||
124816022|NCT03766581|448956649|FG005|Randomization|Participant withdrew consent|1|||
124816023|NCT03766581|448956650|FG006|Randomization|Participant withdrew consent|0|||
124816024|NCT03766581|448956651|FG007|Randomization|Participant withdrew consent|0|||
124816025|NCT03766581|448956644|FG000|Treatment|Adverse Event|82|||
124816026|NCT03766581|448956645|FG001|Treatment|Adverse Event|44|||
124816027|NCT03766581|448956646|FG002|Treatment|Adverse Event|47|||
124816028|NCT03766581|448956647|FG003|Treatment|Adverse Event|46|||
124816029|NCT03766581|448956648|FG004|Treatment|Adverse Event|50|||
124816030|NCT03766581|448956649|FG005|Treatment|Adverse Event|77|||
124816031|NCT03766581|448956650|FG006|Treatment|Adverse Event|5|||
124816032|NCT03766581|448956651|FG007|Treatment|Adverse Event|2|||
124816033|NCT03766581|448956644|FG000|Treatment|Participant request to discontinue treatment|34|||
124816034|NCT03766581|448956645|FG001|Treatment|Participant request to discontinue treatment|6|||
124816035|NCT03766581|448956646|FG002|Treatment|Participant request to discontinue treatment|10|||
124816036|NCT03766581|448956647|FG003|Treatment|Participant request to discontinue treatment|10|||
124816037|NCT03766581|448956648|FG004|Treatment|Participant request to discontinue treatment|14|||
124816038|NCT03766581|448956649|FG005|Treatment|Participant request to discontinue treatment|15|||
124816039|NCT03766581|448956650|FG006|Treatment|Participant request to discontinue treatment|0|||
124816040|NCT03766581|448956651|FG007|Treatment|Participant request to discontinue treatment|1|||
124816041|NCT03766581|448956644|FG000|Treatment|Participant withdrew consent|11|||
124816042|NCT03766581|448956645|FG001|Treatment|Participant withdrew consent|4|||
124816043|NCT03766581|448956646|FG002|Treatment|Participant withdrew consent|5|||
124816044|NCT03766581|448956647|FG003|Treatment|Participant withdrew consent|5|||
124816045|NCT03766581|448956648|FG004|Treatment|Participant withdrew consent|4|||
124816046|NCT03766581|448956649|FG005|Treatment|Participant withdrew consent|4|||
124816047|NCT03766581|448956650|FG006|Treatment|Participant withdrew consent|0|||
124816048|NCT03766581|448956651|FG007|Treatment|Participant withdrew consent|0|||
124816049|NCT03766581|448956644|FG000|Treatment|Death|1|||
124816050|NCT03766581|448956645|FG001|Treatment|Death|0|||
124816051|NCT03766581|448956646|FG002|Treatment|Death|0|||
124816052|NCT03766581|448956647|FG003|Treatment|Death|0|||
124816053|NCT03766581|448956648|FG004|Treatment|Death|0|||
124816054|NCT03766581|448956649|FG005|Treatment|Death|0|||
124816055|NCT03766581|448956650|FG006|Treatment|Death|0|||
124816056|NCT03766581|448956651|FG007|Treatment|Death|0|||
124816057|NCT03766581|448956644|FG000|Treatment|Lost to Follow-up|1|||
124816058|NCT03766581|448956645|FG001|Treatment|Lost to Follow-up|0|||
124816059|NCT03766581|448956646|FG002|Treatment|Lost to Follow-up|0|||
124816060|NCT03766581|448956647|FG003|Treatment|Lost to Follow-up|1|||
124816061|NCT03766581|448956648|FG004|Treatment|Lost to Follow-up|0|||
124816062|NCT03766581|448956649|FG005|Treatment|Lost to Follow-up|0|||
124816063|NCT03766581|448956650|FG006|Treatment|Lost to Follow-up|0|||
124816064|NCT03766581|448956651|FG007|Treatment|Lost to Follow-up|0|||
124816065|NCT03766581|448956644|FG000|Treatment|Poor/Non compliance|2|||
124816066|NCT03766581|448956645|FG001|Treatment|Poor/Non compliance|2|||
124816067|NCT03766581|448956646|FG002|Treatment|Poor/Non compliance|1|||
124816068|NCT03766581|448956647|FG003|Treatment|Poor/Non compliance|1|||
124816069|NCT03766581|448956648|FG004|Treatment|Poor/Non compliance|1|||
124816070|NCT03766581|448956649|FG005|Treatment|Poor/Non compliance|1|||
124816071|NCT03766581|448956650|FG006|Treatment|Poor/Non compliance|0|||
124816072|NCT03766581|448956651|FG007|Treatment|Poor/Non compliance|0|||
124816073|NCT03766581|448956644|FG000|Treatment|Participant no longer meets study criteria|9|||
124816074|NCT03766581|448956645|FG001|Treatment|Participant no longer meets study criteria|1|||
124816075|NCT03766581|448956646|FG002|Treatment|Participant no longer meets study criteria|5|||
124816076|NCT03766581|448956647|FG003|Treatment|Participant no longer meets study criteria|4|||
124816077|NCT03766581|448956648|FG004|Treatment|Participant no longer meets study criteria|4|||
124816078|NCT03766581|448956649|FG005|Treatment|Participant no longer meets study criteria|4|||
124816079|NCT03766581|448956650|FG006|Treatment|Participant no longer meets study criteria|2|||
124816080|NCT03766581|448956651|FG007|Treatment|Participant no longer meets study criteria|0|||
124816081|NCT03766581|448956644|FG000|Treatment|Other reasons|13|||
124816082|NCT03766581|448956645|FG001|Treatment|Other reasons|8|||
124816083|NCT03766581|448956646|FG002|Treatment|Other reasons|3|||
124816084|NCT03766581|448956647|FG003|Treatment|Other reasons|7|||
124816085|NCT03766581|448956648|FG004|Treatment|Other reasons|3|||
124816086|NCT03766581|448956649|FG005|Treatment|Other reasons|3|||
124816087|NCT03766581|448956650|FG006|Treatment|Other reasons|0|||
124816088|NCT03766581|448956651|FG007|Treatment|Other reasons|0|||
124816089|NCT02732119|448956652|FG000|Phase I|Adverse Event|1|||
124816090|NCT02732119|448956653|FG001|Phase I|Adverse Event|3|||
124816091|NCT02732119|448956654|FG002|Phase I|Adverse Event|1|||
124816092|NCT02732119|448956655|FG003|Phase I|Adverse Event|0|||
124816093|NCT02732119|448956656|FG004|Phase I|Adverse Event|0|||
124816094|NCT02732119|448956652|FG000|Phase I|Progressive disease|7|||
124816095|NCT02732119|448956653|FG001|Phase I|Progressive disease|3|||
124816096|NCT02732119|448956654|FG002|Phase I|Progressive disease|2|||
124816097|NCT02732119|448956655|FG003|Phase I|Progressive disease|0|||
124816098|NCT02732119|448956656|FG004|Phase I|Progressive disease|0|||
124816099|NCT02732119|448956652|FG000|Phase I|Protocol deviation|0|||
124816100|NCT02732119|448956653|FG001|Phase I|Protocol deviation|1|||
124816101|NCT02732119|448956654|FG002|Phase I|Protocol deviation|0|||
124816102|NCT02732119|448956655|FG003|Phase I|Protocol deviation|0|||
124816103|NCT02732119|448956656|FG004|Phase I|Protocol deviation|0|||
124816104|NCT02732119|448956652|FG000|Phase I|Physician Decision|0|||
124816105|NCT02732119|448956653|FG001|Phase I|Physician Decision|3|||
124816106|NCT02732119|448956654|FG002|Phase I|Physician Decision|4|||
124816107|NCT02732119|448956655|FG003|Phase I|Physician Decision|0|||
124816108|NCT02732119|448956656|FG004|Phase I|Physician Decision|0|||
124816109|NCT02732119|448956652|FG000|Phase II|Adverse Event|0|||
124816110|NCT02732119|448956653|FG001|Phase II|Adverse Event|0|||
124816111|NCT02732119|448956654|FG002|Phase II|Adverse Event|0|||
124816112|NCT02732119|448956655|FG003|Phase II|Adverse Event|3|||
124816113|NCT02732119|448956656|FG004|Phase II|Adverse Event|3|||
124816114|NCT02732119|448956652|FG000|Phase II|Death|0|||
124816115|NCT02732119|448956653|FG001|Phase II|Death|0|||
124816116|NCT02732119|448956654|FG002|Phase II|Death|0|||
124816117|NCT02732119|448956655|FG003|Phase II|Death|1|||
124816118|NCT02732119|448956656|FG004|Phase II|Death|0|||
124816119|NCT02732119|448956652|FG000|Phase II|Progressive dissease|0|||
124816120|NCT02732119|448956653|FG001|Phase II|Progressive dissease|0|||
124816121|NCT02732119|448956654|FG002|Phase II|Progressive dissease|0|||
124816122|NCT02732119|448956655|FG003|Phase II|Progressive dissease|30|||
124816123|NCT02732119|448956656|FG004|Phase II|Progressive dissease|23|||
124816124|NCT02732119|448956652|FG000|Phase II|Study terminated by sponsor|0|||
124816125|NCT02732119|448956653|FG001|Phase II|Study terminated by sponsor|0|||
124816126|NCT02732119|448956654|FG002|Phase II|Study terminated by sponsor|0|||
124816127|NCT02732119|448956655|FG003|Phase II|Study terminated by sponsor|2|||
124816128|NCT02732119|448956656|FG004|Phase II|Study terminated by sponsor|2|||
124816129|NCT02732119|448956652|FG000|Phase II|Other|0|||
124816130|NCT02732119|448956653|FG001|Phase II|Other|0|||
124816131|NCT02732119|448956654|FG002|Phase II|Other|0|||
124816132|NCT02732119|448956655|FG003|Phase II|Other|2|||
124816133|NCT02732119|448956656|FG004|Phase II|Other|0|||
124816134|NCT02732119|448956652|FG000|Phase II|Physician Decision|0|||
124816135|NCT02732119|448956653|FG001|Phase II|Physician Decision|0|||
124816136|NCT02732119|448956654|FG002|Phase II|Physician Decision|0|||
124816137|NCT02732119|448956655|FG003|Phase II|Physician Decision|8|||
124816138|NCT02732119|448956656|FG004|Phase II|Physician Decision|5|||
124816139|NCT00520936|448956657|FG000|Overall Study|Physician Decision|0|||
124816140|NCT00520936|448956658|FG001|Overall Study|Physician Decision|2|||
124816141|NCT00520936|448956659|FG002|Overall Study|Physician Decision|1|||
124816142|NCT00520936|448956660|FG003|Overall Study|Physician Decision|0|||
124816143|NCT00520936|448956661|FG004|Overall Study|Physician Decision|0|||
124816144|NCT00520936|448956662|FG005|Overall Study|Physician Decision|0|||
124816145|NCT00520936|448956663|FG006|Overall Study|Physician Decision|0|||
124816146|NCT00520936|448956664|FG007|Overall Study|Physician Decision|0|||
124816147|NCT00520936|448956657|FG000|Overall Study|Withdrawal by Subject|0|||
124816148|NCT00520936|448956658|FG001|Overall Study|Withdrawal by Subject|0|||
124816149|NCT00520936|448956659|FG002|Overall Study|Withdrawal by Subject|0|||
124816150|NCT00520936|448956660|FG003|Overall Study|Withdrawal by Subject|0|||
124816151|NCT00520936|448956661|FG004|Overall Study|Withdrawal by Subject|0|||
124816152|NCT00520936|448956662|FG005|Overall Study|Withdrawal by Subject|0|||
124816153|NCT00520936|448956663|FG006|Overall Study|Withdrawal by Subject|0|||
124816154|NCT00520936|448956664|FG007|Overall Study|Withdrawal by Subject|1|||
124816155|NCT00520936|448956657|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
124816156|NCT00520936|448956658|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
124816157|NCT00520936|448956659|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
124816158|NCT00520936|448956660|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
124816159|NCT00520936|448956661|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
124816160|NCT00520936|448956662|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
124816161|NCT00520936|448956663|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
124816162|NCT00520936|448956664|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
124816163|NCT00520936|448956657|FG000|Overall Study|Death|0|||
124816164|NCT00520936|448956658|FG001|Overall Study|Death|0|||
124816165|NCT00520936|448956659|FG002|Overall Study|Death|0|||
124816166|NCT00520936|448956660|FG003|Overall Study|Death|0|||
124816167|NCT00520936|448956661|FG004|Overall Study|Death|0|||
124816168|NCT00520936|448956662|FG005|Overall Study|Death|0|||
124816169|NCT00520936|448956663|FG006|Overall Study|Death|1|||
124816170|NCT00520936|448956664|FG007|Overall Study|Death|0|||
124816171|NCT00520936|448956657|FG000|Overall Study|Protocol Violation|0|||
124816172|NCT00520936|448956658|FG001|Overall Study|Protocol Violation|1|||
124816173|NCT00520936|448956659|FG002|Overall Study|Protocol Violation|1|||
124816174|NCT00520936|448956660|FG003|Overall Study|Protocol Violation|0|||
124816175|NCT00520936|448956661|FG004|Overall Study|Protocol Violation|1|||
124816176|NCT00520936|448956662|FG005|Overall Study|Protocol Violation|0|||
124816177|NCT00520936|448956663|FG006|Overall Study|Protocol Violation|1|||
124816178|NCT00520936|448956664|FG007|Overall Study|Protocol Violation|0|||
124816179|NCT00964860|448956665|FG000|Overall Study|Withdrawal by Subject|0|||
124816180|NCT00964860|448956666|FG001|Overall Study|Withdrawal by Subject|1|||
124816181|NCT03716024|448956667|FG000|Overall Study|Randomized, not Treated|7|||
124816182|NCT03716024|448956668|FG001|Overall Study|Randomized, not Treated|8|||
124816183|NCT03716024|448956667|FG000|Overall Study|Adverse Event|1|||
124816184|NCT03716024|448956668|FG001|Overall Study|Adverse Event|2|||
124816185|NCT03716024|448956667|FG000|Overall Study|Treatment Failure|1|||
124816186|NCT03716024|448956668|FG001|Overall Study|Treatment Failure|0|||
124816187|NCT03716024|448956667|FG000|Overall Study|Lost to Follow-up|2|||
124816188|NCT03716024|448956668|FG001|Overall Study|Lost to Follow-up|6|||
124816189|NCT03716024|448956667|FG000|Overall Study|Withdrawal by Subject|0|||
124816190|NCT03716024|448956668|FG001|Overall Study|Withdrawal by Subject|1|||
124816191|NCT03716024|448956667|FG000|Overall Study|Missing Reason|0|||
124816192|NCT03716024|448956668|FG001|Overall Study|Missing Reason|1|||
124816193|NCT00867568|448956669|FG000|Overall Study|Lack of Efficacy|10|||
124816194|NCT00867568|448956669|FG000|Overall Study|Adverse Event|4|||
124816195|NCT00867568|448956669|FG000|Overall Study|Withdrawal by Subject|1|||
124816196|NCT04343261|448956670|FG000|Overall Study|Adverse Event|1|||
124816197|NCT04343261|448956670|FG000|Overall Study|received inadequate amount of antibodies|7|||
124816198|NCT02585960|448956678|FG000|PK/Safety Assessment Period|Physician Decision|0|||
124816199|NCT02585960|448956679|FG001|PK/Safety Assessment Period|Physician Decision|1|||
124816200|NCT02585960|448956680|FG002|PK/Safety Assessment Period|Physician Decision|0|||
124816201|NCT02585960|448956678|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
124816202|NCT02585960|448956679|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
124816203|NCT02585960|448956680|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
124816204|NCT02585960|448956678|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
124816205|NCT02585960|448956679|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
124816206|NCT02585960|448956680|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
124816207|NCT02585960|448956678|FG000|PK/Safety Assessment Period|Other|4|||
124816208|NCT02585960|448956679|FG001|PK/Safety Assessment Period|Other|4|||
124816209|NCT02585960|448956680|FG002|PK/Safety Assessment Period|Other|0|||
124816210|NCT02585960|448956678|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
124816211|NCT02585960|448956679|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
124816212|NCT02585960|448956680|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
124816213|NCT02585960|448956678|FG000|PK/Safety Assessment Period|Screen Failure|0|||
124816214|NCT02585960|448956679|FG001|PK/Safety Assessment Period|Screen Failure|0|||
124816215|NCT02585960|448956680|FG002|PK/Safety Assessment Period|Screen Failure|1|||
124816216|NCT02585960|448956678|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
124816217|NCT02585960|448956679|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
124816218|NCT02585960|448956680|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
124816219|NCT02585960|448956678|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
124816220|NCT02585960|448956679|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
124816221|NCT02585960|448956680|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
124816222|NCT03639935|448956681|FG000|Overall Study|Death|3|||
124816223|NCT03639935|448956681|FG000|Overall Study|Adverse Event|1|||
124816224|NCT00003479|448956683|FG000|Overall Study|Not evaluable|3|||
124816225|NCT01061177|448956684|FG000|Overall Study|Adverse Event|117|||
124816226|NCT01061177|448956684|FG000|Overall Study|Withdrawal by Subject|27|||
124816227|NCT01061177|448956684|FG000|Overall Study|Disease progression|17|||
124816228|NCT01061177|448956684|FG000|Overall Study|Protocol Violation|11|||
124816229|NCT01061177|448956684|FG000|Overall Study|Lost to Follow-up|9|||
124816230|NCT01061177|448956684|FG000|Overall Study|New cancer therapy|9|||
124816231|NCT01061177|448956684|FG000|Overall Study|Abnormal laboratory values|6|||
124816232|NCT01061177|448956684|FG000|Overall Study|Abnormal test procedure results|4|||
124816233|NCT01061177|448956684|FG000|Overall Study|Administratie problems|4|||
124816234|NCT01061177|448956684|FG000|Overall Study|Death|4|||
124816235|NCT00299104|448956685|FG000|Treatment Period|Adverse Event|14|||
124816236|NCT00299104|448956686|FG001|Treatment Period|Adverse Event|9|||
124816237|NCT00299104|448956687|FG002|Treatment Period|Adverse Event|7|||
124816238|NCT00299104|448956685|FG000|Treatment Period|Death|1|||
124816239|NCT00299104|448956686|FG001|Treatment Period|Death|1|||
124816240|NCT00299104|448956687|FG002|Treatment Period|Death|1|||
124816241|NCT00299104|448956685|FG000|Treatment Period|Insufficient therapeutic response|34|||
124816242|NCT00299104|448956686|FG001|Treatment Period|Insufficient therapeutic response|13|||
124816243|NCT00299104|448956687|FG002|Treatment Period|Insufficient therapeutic response|8|||
124816244|NCT00299104|448956685|FG000|Treatment Period|Failure to return|9|||
124816245|NCT00299104|448956686|FG001|Treatment Period|Failure to return|8|||
124816246|NCT00299104|448956687|FG002|Treatment Period|Failure to return|8|||
124816247|NCT00299104|448956685|FG000|Treatment Period|Violation of selection criteria|1|||
124816248|NCT00299104|448956686|FG001|Treatment Period|Violation of selection criteria|2|||
124816249|NCT00299104|448956687|FG002|Treatment Period|Violation of selection criteria|0|||
124816250|NCT00299104|448956685|FG000|Treatment Period|Protocol Violation|1|||
124816251|NCT00299104|448956686|FG001|Treatment Period|Protocol Violation|1|||
124816252|NCT00299104|448956687|FG002|Treatment Period|Protocol Violation|0|||
124816253|NCT00299104|448956685|FG000|Treatment Period|Refused treatment|9|||
124816254|NCT00299104|448956686|FG001|Treatment Period|Refused treatment|2|||
124816255|NCT00299104|448956687|FG002|Treatment Period|Refused treatment|2|||
124816256|NCT00299104|448956685|FG000|Treatment Period|Withdrew consent|14|||
124816257|NCT00299104|448956686|FG001|Treatment Period|Withdrew consent|19|||
124816258|NCT00299104|448956687|FG002|Treatment Period|Withdrew consent|9|||
124816259|NCT00299104|448956685|FG000|Treatment Period|Administrative reasons|106|||
124816260|NCT00299104|448956686|FG001|Treatment Period|Administrative reasons|120|||
124816261|NCT00299104|448956687|FG002|Treatment Period|Administrative reasons|137|||
124816262|NCT00299104|448956685|FG000|Safety Follow-Up (SFU) Period|Death|3|||
124816263|NCT00299104|448956686|FG001|Safety Follow-Up (SFU) Period|Death|2|||
124816264|NCT00299104|448956687|FG002|Safety Follow-Up (SFU) Period|Death|1|||
124816265|NCT00299104|448956685|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
124816266|NCT00299104|448956686|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
124816267|NCT00299104|448956687|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
124816268|NCT00299104|448956685|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
124816269|NCT00299104|448956686|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
124816270|NCT00299104|448956687|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
124816271|NCT00299104|448956685|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
124816272|NCT00299104|448956686|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
124816273|NCT00299104|448956687|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
124816274|NCT00299104|448956685|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
124816275|NCT00299104|448956686|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
124816276|NCT00299104|448956687|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
124816277|NCT00299104|448956685|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
124816278|NCT00299104|448956686|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
124816279|NCT00299104|448956687|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
124816280|NCT00299104|448956685|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
124816281|NCT00299104|448956686|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
124816282|NCT00299104|448956687|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
124816283|NCT00299104|448956685|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
124816284|NCT00299104|448956686|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
124816285|NCT00299104|448956687|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
124816286|NCT00587054|448956688|FG000|Overall Study|Patient not treated|9|||
124816287|NCT02059395|448956699|FG000|Overall Study|Lost to Follow-up|2|||
124816288|NCT02059395|448956700|FG001|Overall Study|Lost to Follow-up|4|||
124816289|NCT00044083|448956701|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
124816290|NCT00044083|448956702|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
124816291|NCT00044083|448956701|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
124816292|NCT00044083|448956702|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
124816293|NCT00044083|448956701|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
124816294|NCT00044083|448956702|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
124816295|NCT00044083|448956701|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
124816296|NCT00044083|448956702|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
124816297|NCT00044083|448956701|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
124816298|NCT00044083|448956702|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
124816299|NCT00044083|448956701|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
124816300|NCT00044083|448956702|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
124816301|NCT00044083|448956701|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
124816302|NCT00044083|448956702|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
124816303|NCT00044083|448956701|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
124816304|NCT00044083|448956702|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
124816305|NCT00044083|448956701|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
124816306|NCT00044083|448956702|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
124816307|NCT00044083|448956701|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
124816308|NCT00044083|448956702|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
124816309|NCT01619423|448956703|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
124816310|NCT01619423|448956704|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
124816311|NCT01619423|448956705|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
124816312|NCT01619423|448956706|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
124816313|NCT02340975|448956707|FG000|Overall Study|Death|6|||
124816314|NCT02340975|448956708|FG001|Overall Study|Death|23|||
124816315|NCT02340975|448956709|FG002|Overall Study|Death|21|||
124816316|NCT02340975|448956710|FG003|Overall Study|Death|7|||
124816317|NCT02340975|448956711|FG004|Overall Study|Death|21|||
124816318|NCT02340975|448956712|FG005|Overall Study|Death|13|||
124816319|NCT02340975|448956707|FG000|Overall Study|Lost to Follow-up|0|||
124816320|NCT02340975|448956708|FG001|Overall Study|Lost to Follow-up|0|||
124816321|NCT02340975|448956709|FG002|Overall Study|Lost to Follow-up|0|||
124816322|NCT02340975|448956710|FG003|Overall Study|Lost to Follow-up|0|||
124816323|NCT02340975|448956711|FG004|Overall Study|Lost to Follow-up|2|||
124816324|NCT02340975|448956712|FG005|Overall Study|Lost to Follow-up|0|||
124816325|NCT02340975|448956707|FG000|Overall Study|Withdrawal by Subject|0|||
124816326|NCT02340975|448956708|FG001|Overall Study|Withdrawal by Subject|0|||
124816327|NCT02340975|448956709|FG002|Overall Study|Withdrawal by Subject|3|||
124816328|NCT02340975|448956710|FG003|Overall Study|Withdrawal by Subject|3|||
124816329|NCT02340975|448956711|FG004|Overall Study|Withdrawal by Subject|2|||
124816330|NCT02340975|448956712|FG005|Overall Study|Withdrawal by Subject|0|||
124816331|NCT02340975|448956707|FG000|Overall Study|Other|0|||
124816332|NCT02340975|448956708|FG001|Overall Study|Other|4|||
124816333|NCT02340975|448956709|FG002|Overall Study|Other|0|||
124816334|NCT02340975|448956710|FG003|Overall Study|Other|2|||
124816335|NCT02340975|448956711|FG004|Overall Study|Other|0|||
124816336|NCT02340975|448956712|FG005|Overall Study|Other|6|||
124816337|NCT00601458|448956721|FG000|Overall Study|Dosing Error|1|||
124816338|NCT00601458|448956722|FG001|Overall Study|Dosing Error|0|||
124816339|NCT00601458|448956723|FG002|Overall Study|Dosing Error|0|||
124816340|NCT00601458|448956721|FG000|Overall Study|Incomplete Data|0|||
124816341|NCT00601458|448956722|FG001|Overall Study|Incomplete Data|2|||
124816342|NCT00601458|448956723|FG002|Overall Study|Incomplete Data|0|||
124816343|NCT00601458|448956721|FG000|Overall Study|Protocol Violation|3|||
124816344|NCT00601458|448956722|FG001|Overall Study|Protocol Violation|2|||
124816345|NCT00601458|448956723|FG002|Overall Study|Protocol Violation|1|||
124816346|NCT00601458|448956721|FG000|Overall Study|Early Termination|0|||
124816347|NCT00601458|448956722|FG001|Overall Study|Early Termination|1|||
124816348|NCT00601458|448956723|FG002|Overall Study|Early Termination|1|||
124816349|NCT01697566|448956725|FG000|Overall Study|Withdrawal by Subject|0|||
124816350|NCT01697566|448956726|FG001|Overall Study|Withdrawal by Subject|0|||
124816351|NCT01697566|448956727|FG002|Overall Study|Withdrawal by Subject|1|||
124816352|NCT01697566|448956728|FG003|Overall Study|Withdrawal by Subject|1|||
124816353|NCT01697566|448956725|FG000|Overall Study|Final biopsy not obtained|0|||
124816354|NCT01697566|448956726|FG001|Overall Study|Final biopsy not obtained|0|||
124816355|NCT01697566|448956727|FG002|Overall Study|Final biopsy not obtained|1|||
124816356|NCT01697566|448956728|FG003|Overall Study|Final biopsy not obtained|0|||
124816357|NCT01709162|448956729|FG000|Overall Study|Disease progression|3|||
124816358|NCT01709162|448956730|FG001|Overall Study|Disease progression|3|||
124816359|NCT01709162|448956729|FG000|Overall Study|Study drug toxicity|2|||
124816360|NCT01709162|448956730|FG001|Overall Study|Study drug toxicity|0|||
124816361|NCT01709162|448956729|FG000|Overall Study|Administrative reason by sponsor|0|||
124816362|NCT01709162|448956730|FG001|Overall Study|Administrative reason by sponsor|1|||
124816363|NCT01709162|448956729|FG000|Overall Study|Other|1|||
124816364|NCT01709162|448956730|FG001|Overall Study|Other|0|||
124816365|NCT01709162|448956729|FG000|Overall Study|Withdrawal by Subject|0|||
124816366|NCT01709162|448956730|FG001|Overall Study|Withdrawal by Subject|1|||
124816367|NCT02405780|448956733|FG000|Period I|Adverse Event|8|||
124816368|NCT02405780|448956734|FG001|Period I|Adverse Event|0|||
124816369|NCT02405780|448956735|FG002|Period I|Adverse Event|3|||
124816370|NCT02405780|448956736|FG003|Period I|Adverse Event|7|||
124816371|NCT02405780|448956733|FG000|Period I|Medical reasons|1|||
124816372|NCT02405780|448956734|FG001|Period I|Medical reasons|1|||
124816373|NCT02405780|448956735|FG002|Period I|Medical reasons|0|||
124816374|NCT02405780|448956736|FG003|Period I|Medical reasons|1|||
124816375|NCT02405780|448956733|FG000|Period I|Screening Failure|1|||
124816376|NCT02405780|448956734|FG001|Period I|Screening Failure|0|||
124816377|NCT02405780|448956735|FG002|Period I|Screening Failure|1|||
124816378|NCT02405780|448956736|FG003|Period I|Screening Failure|0|||
124816379|NCT02405780|448956733|FG000|Period I|Withdrawal by Subject|9|||
124816380|NCT02405780|448956734|FG001|Period I|Withdrawal by Subject|1|||
124816381|NCT02405780|448956735|FG002|Period I|Withdrawal by Subject|3|||
124816382|NCT02405780|448956736|FG003|Period I|Withdrawal by Subject|4|||
124816383|NCT02405780|448956733|FG000|Period I|Non-compliance with study procedures|8|||
124816384|NCT02405780|448956734|FG001|Period I|Non-compliance with study procedures|6|||
124816385|NCT02405780|448956735|FG002|Period I|Non-compliance with study procedures|8|||
124816386|NCT02405780|448956736|FG003|Period I|Non-compliance with study procedures|11|||
124816387|NCT02405780|448956733|FG000|Period II|Adverse Event|3|||
124816388|NCT02405780|448956734|FG001|Period II|Adverse Event|5|||
124816389|NCT02405780|448956735|FG002|Period II|Adverse Event|4|||
124816390|NCT02405780|448956736|FG003|Period II|Adverse Event|11|||
124816391|NCT02405780|448956733|FG000|Period II|Medical reason|0|||
124816392|NCT02405780|448956734|FG001|Period II|Medical reason|1|||
124816393|NCT02405780|448956735|FG002|Period II|Medical reason|0|||
124816394|NCT02405780|448956736|FG003|Period II|Medical reason|0|||
124816395|NCT02405780|448956733|FG000|Period II|Pregnancy|0|||
124816396|NCT02405780|448956734|FG001|Period II|Pregnancy|0|||
124816397|NCT02405780|448956735|FG002|Period II|Pregnancy|1|||
124816398|NCT02405780|448956736|FG003|Period II|Pregnancy|0|||
124816399|NCT02405780|448956733|FG000|Period II|Withdrawal by Subject|7|||
124816400|NCT02405780|448956734|FG001|Period II|Withdrawal by Subject|4|||
124816401|NCT02405780|448956735|FG002|Period II|Withdrawal by Subject|0|||
124816402|NCT02405780|448956736|FG003|Period II|Withdrawal by Subject|3|||
124816403|NCT02405780|448956733|FG000|Period II|Non-compliance with study procedures|5|||
124816404|NCT02405780|448956734|FG001|Period II|Non-compliance with study procedures|2|||
124816405|NCT02405780|448956735|FG002|Period II|Non-compliance with study procedures|7|||
124816406|NCT02405780|448956736|FG003|Period II|Non-compliance with study procedures|4|||
124816407|NCT01654536|448956737|FG000|Overall Study|Lost to Follow-up|5|||
124816408|NCT01654536|448956738|FG001|Overall Study|Lost to Follow-up|5|||
124816409|NCT01654536|448956737|FG000|Overall Study|Physician Decision|12|||
124816410|NCT01654536|448956738|FG001|Overall Study|Physician Decision|8|||
124816411|NCT01654536|448956737|FG000|Overall Study|Withdrawal by Subject|27|||
124816412|NCT01654536|448956738|FG001|Overall Study|Withdrawal by Subject|25|||
124816413|NCT01587001|448956739|FG000|Overall Study|Lost to Follow-up|2|||
124816414|NCT01587001|448956740|FG001|Overall Study|Lost to Follow-up|0|||
124816415|NCT01587001|448956739|FG000|Overall Study|Insufficient samples to complete testing|4|||
124816416|NCT01587001|448956740|FG001|Overall Study|Insufficient samples to complete testing|1|||
124816417|NCT00074152|448956741|FG000|Overall Study|Death|21|||
124816418|NCT00074152|448956742|FG001|Overall Study|Death|9|||
124816419|NCT00074152|448956741|FG000|Overall Study|Lack of Efficacy|34|||
124816420|NCT00074152|448956742|FG001|Overall Study|Lack of Efficacy|24|||
124816421|NCT02197130|448956743|FG000|Overall Study|Adverse Event|13|||
124816422|NCT02197130|448956744|FG001|Overall Study|Adverse Event|4|||
124816423|NCT02197130|448956745|FG002|Overall Study|Adverse Event|23|||
124816424|NCT02197130|448956743|FG000|Overall Study|Death|0|||
124816425|NCT02197130|448956744|FG001|Overall Study|Death|1|||
124816426|NCT02197130|448956745|FG002|Overall Study|Death|0|||
124816427|NCT02197130|448956743|FG000|Overall Study|Lost to Follow-up|2|||
124816428|NCT02197130|448956744|FG001|Overall Study|Lost to Follow-up|0|||
124816429|NCT02197130|448956745|FG002|Overall Study|Lost to Follow-up|1|||
124816430|NCT02197130|448956743|FG000|Overall Study|Does not meet entrance criteria|0|||
124816431|NCT02197130|448956744|FG001|Overall Study|Does not meet entrance criteria|0|||
124816432|NCT02197130|448956745|FG002|Overall Study|Does not meet entrance criteria|1|||
124816433|NCT02197130|448956743|FG000|Overall Study|Withdrawal by Subject|0|||
124816434|NCT02197130|448956744|FG001|Overall Study|Withdrawal by Subject|3|||
124816435|NCT02197130|448956745|FG002|Overall Study|Withdrawal by Subject|4|||
124816436|NCT02197130|448956743|FG000|Overall Study|Other|1|||
124816437|NCT02197130|448956744|FG001|Overall Study|Other|0|||
124816438|NCT02197130|448956745|FG002|Overall Study|Other|3|||
124816439|NCT01473836|448958713|FG000|Overall Study|Adverse Event|4|||
124816440|NCT01473836|448958713|FG000|Overall Study|Lack of Efficacy|1|||
124816441|NCT01473836|448958713|FG000|Overall Study|Does not meet entrance criteria|1|||
124816442|NCT03364023|448958714|FG000|Overall Study|Lost to Follow-up|3|||
124816443|NCT03364023|448958714|FG000|Overall Study|Death|14|||
124816444|NCT00105469|448958717|FG000|Overall Study|Adverse Event|9|||
124816445|NCT00105469|448958718|FG001|Overall Study|Adverse Event|8|||
124816446|NCT00105469|448958717|FG000|Overall Study|Protocol Violation|4|||
124816447|NCT00105469|448958718|FG001|Overall Study|Protocol Violation|0|||
124816448|NCT00105469|448958717|FG000|Overall Study|Withdrawal by Subject|2|||
124816449|NCT00105469|448958718|FG001|Overall Study|Withdrawal by Subject|3|||
124816450|NCT00105469|448958717|FG000|Overall Study|Lost to Follow-up|1|||
124816451|NCT00105469|448958718|FG001|Overall Study|Lost to Follow-up|0|||
124816452|NCT00105469|448958717|FG000|Overall Study|Lack of Efficacy|2|||
124816453|NCT00105469|448958718|FG001|Overall Study|Lack of Efficacy|0|||
124816454|NCT00105469|448958717|FG000|Overall Study|Other Reason|4|||
124816455|NCT00105469|448958718|FG001|Overall Study|Other Reason|0|||
124816456|NCT00599924|448958720|FG000|Overall Study|Lack of Efficacy|3|||
124816457|NCT00599924|448958721|FG001|Overall Study|Lack of Efficacy|5|||
124816458|NCT00599924|448958722|FG002|Overall Study|Lack of Efficacy|1|||
124816459|NCT00599924|448958723|FG003|Overall Study|Lack of Efficacy|2|||
124816460|NCT00599924|448958724|FG004|Overall Study|Lack of Efficacy|3|||
124816461|NCT00599924|448958725|FG005|Overall Study|Lack of Efficacy|2|||
124816462|NCT00599924|448958726|FG006|Overall Study|Lack of Efficacy|0|||
124816463|NCT00599924|448958720|FG000|Overall Study|Adverse Event|0|||
124816464|NCT00599924|448958721|FG001|Overall Study|Adverse Event|0|||
124816465|NCT00599924|448958722|FG002|Overall Study|Adverse Event|0|||
124816466|NCT00599924|448958723|FG003|Overall Study|Adverse Event|2|||
124816467|NCT00599924|448958724|FG004|Overall Study|Adverse Event|0|||
124816468|NCT00599924|448958725|FG005|Overall Study|Adverse Event|0|||
124816469|NCT00599924|448958726|FG006|Overall Study|Adverse Event|2|||
124816470|NCT00599924|448958720|FG000|Overall Study|Death|0|||
124816471|NCT00599924|448958721|FG001|Overall Study|Death|0|||
124816472|NCT00599924|448958722|FG002|Overall Study|Death|0|||
124816473|NCT00599924|448958723|FG003|Overall Study|Death|2|||
124816474|NCT00599924|448958724|FG004|Overall Study|Death|0|||
124816475|NCT00599924|448958725|FG005|Overall Study|Death|2|||
124816476|NCT00599924|448958726|FG006|Overall Study|Death|1|||
124816477|NCT00599924|448958720|FG000|Overall Study|Protocol Violation|0|||
124816478|NCT00599924|448958721|FG001|Overall Study|Protocol Violation|0|||
124816479|NCT00599924|448958722|FG002|Overall Study|Protocol Violation|0|||
124816480|NCT00599924|448958723|FG003|Overall Study|Protocol Violation|1|||
124816481|NCT00599924|448958724|FG004|Overall Study|Protocol Violation|0|||
124816482|NCT00599924|448958725|FG005|Overall Study|Protocol Violation|0|||
124816483|NCT00599924|448958726|FG006|Overall Study|Protocol Violation|0|||
124816484|NCT00599924|448958720|FG000|Overall Study|Withdrawal by Subject|0|||
124816485|NCT00599924|448958721|FG001|Overall Study|Withdrawal by Subject|0|||
124816486|NCT00599924|448958722|FG002|Overall Study|Withdrawal by Subject|1|||
124816487|NCT00599924|448958723|FG003|Overall Study|Withdrawal by Subject|0|||
124816488|NCT00599924|448958724|FG004|Overall Study|Withdrawal by Subject|1|||
124816489|NCT00599924|448958725|FG005|Overall Study|Withdrawal by Subject|0|||
124816490|NCT00599924|448958726|FG006|Overall Study|Withdrawal by Subject|0|||
124816491|NCT00599924|448958720|FG000|Overall Study|Other|0|||
124816492|NCT00599924|448958721|FG001|Overall Study|Other|0|||
124816493|NCT00599924|448958722|FG002|Overall Study|Other|0|||
124816494|NCT00599924|448958723|FG003|Overall Study|Other|1|||
124816495|NCT00599924|448958724|FG004|Overall Study|Other|2|||
124816496|NCT00599924|448958725|FG005|Overall Study|Other|0|||
124816497|NCT00599924|448958726|FG006|Overall Study|Other|2|||
124816498|NCT02601469|448958727|FG000|Overall Study|Enrolled in Error|1|||
124816499|NCT02601469|448958728|FG001|Overall Study|Enrolled in Error|0|||
124816500|NCT01806298|448958729|FG000|Overall Study|Adverse Event|3|||
124816501|NCT01806298|448958729|FG000|Overall Study|Protocol Non-compliance|1|||
124816502|NCT01806298|448958729|FG000|Overall Study|Withdrawal by Subject|1|||
124816503|NCT01806298|448958729|FG000|Overall Study|Other|5|||
124816504|NCT03808545|448958730|FG000|Overall Study|Withdrawal by Subject|1|||
124816505|NCT03808545|448958731|FG001|Overall Study|Withdrawal by Subject|1|||
124816506|NCT00980057|448958736|FG000|Overall Study|Death|13|||
124816507|NCT00980057|448958737|FG001|Overall Study|Death|3|||
124816508|NCT00980057|448958736|FG000|Overall Study|Adverse Event|0|||
124816509|NCT00980057|448958737|FG001|Overall Study|Adverse Event|1|||
124816510|NCT00980057|448958736|FG000|Overall Study|Physician Decision|4|||
124816511|NCT00980057|448958737|FG001|Overall Study|Physician Decision|0|||
124816512|NCT00980057|448958736|FG000|Overall Study|Lost to Follow-up|1|||
124816513|NCT00980057|448958737|FG001|Overall Study|Lost to Follow-up|0|||
124816514|NCT00980057|448958736|FG000|Overall Study|Withdrawal by Subject|1|||
124816515|NCT00980057|448958737|FG001|Overall Study|Withdrawal by Subject|1|||
124816516|NCT04980040|448958738|FG000|Overall Study|Violated the Inclusion Criteria|260|||
124816517|NCT04980040|448958738|FG000|Overall Study|Violated the Administration & Dosage|225|||
124816518|NCT04980040|448958738|FG000|Overall Study|Lost to Safety-Follow-up|4|||
124816519|NCT04980040|448958738|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
124816520|NCT02820753|448958739|FG000|2 Month|Withdrawal by Subject|3|||
124816521|NCT02820753|448958740|FG001|2 Month|Withdrawal by Subject|3|||
124816522|NCT02820753|448958739|FG000|2 Month|Lost to Follow-up|24|||
124816523|NCT02820753|448958740|FG001|2 Month|Lost to Follow-up|26|||
124816524|NCT02820753|448958739|FG000|2 Month|Stopped per NIH Hold|51|||
124816525|NCT02820753|448958740|FG001|2 Month|Stopped per NIH Hold|13|||
124816526|NCT02820753|448958739|FG000|6 Month|Withdrawal by Subject|2|||
124816527|NCT02820753|448958740|FG001|6 Month|Withdrawal by Subject|2|||
124816528|NCT02820753|448958739|FG000|6 Month|Lost to Follow-up|20|||
124816529|NCT02820753|448958740|FG001|6 Month|Lost to Follow-up|27|||
124816530|NCT02820753|448958739|FG000|6 Month|Stopped per NIH Hold|81|||
124816531|NCT02820753|448958740|FG001|6 Month|Stopped per NIH Hold|81|||
124816532|NCT02820753|448958739|FG000|6 Month|Death|0|||
124816533|NCT02820753|448958740|FG001|6 Month|Death|1|||
124816534|NCT00062374|448958744|FG000|Overall Study|Not treated|12|||
124816535|NCT03555591|448958745|FG000|Overall Study|Protocol Violation|77|||
124816536|NCT00840450|448958746|FG000|Overall Study|Adverse Event|1|||
124816537|NCT00840450|448958746|FG000|Overall Study|Lack of Efficacy|2|||
124816538|NCT00617123|448958747|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
124816539|NCT00617123|448958748|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
124816540|NCT00617123|448958747|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
124816541|NCT00617123|448958748|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
124816542|NCT00617123|448958747|FG000|Referral Screening Period|Adverse Event|0|||
124816543|NCT00617123|448958748|FG001|Referral Screening Period|Adverse Event|1|||
124816544|NCT00617123|448958747|FG000|Study Treatment Period|Withdrawal by Subject|8|||
124816545|NCT00617123|448958748|FG001|Study Treatment Period|Withdrawal by Subject|12|||
124816546|NCT00617123|448958747|FG000|Study Treatment Period|Adverse Event|7|||
124816547|NCT00617123|448958748|FG001|Study Treatment Period|Adverse Event|3|||
124816548|NCT00617123|448958747|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
124816549|NCT00617123|448958748|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
124816550|NCT00617123|448958747|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
124816551|NCT00617123|448958748|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
124816552|NCT02170298|448958749|FG000|Overall Study|Withdrawal by Subject|0|||
124816553|NCT02170298|448958750|FG001|Overall Study|Withdrawal by Subject|1|||
124816554|NCT02170298|448958749|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
124816555|NCT02170298|448958750|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
124816556|NCT02128113|448958751|FG000|Overall Study|Withdrawal by Subject|3|||
124816557|NCT02128113|448958752|FG001|Overall Study|Withdrawal by Subject|1|||
124816558|NCT02128113|448958753|FG002|Overall Study|Withdrawal by Subject|0|||
124816559|NCT02128113|448958751|FG000|Overall Study|Protocol Violation|0|||
124816560|NCT02128113|448958752|FG001|Overall Study|Protocol Violation|1|||
124816561|NCT02128113|448958753|FG002|Overall Study|Protocol Violation|0|||
124816562|NCT02128113|448958751|FG000|Overall Study|Surgery cancelled|0|||
124816563|NCT02128113|448958752|FG001|Overall Study|Surgery cancelled|1|||
124816564|NCT02128113|448958753|FG002|Overall Study|Surgery cancelled|0|||
124816565|NCT02128113|448958751|FG000|Overall Study|Adverse Event|0|||
124816566|NCT02128113|448958752|FG001|Overall Study|Adverse Event|0|||
124816567|NCT02128113|448958753|FG002|Overall Study|Adverse Event|1|||
124816568|NCT00003499|448958757|FG000|Overall Study|Not evaluable|8|||
124816569|NCT01854710|448958764|FG000|Overall Study|Withdrawal by Subject|2|||
124816570|NCT01854710|448958765|FG001|Overall Study|Withdrawal by Subject|1|||
124816571|NCT01854710|448958766|FG002|Overall Study|Withdrawal by Subject|0|||
124816572|NCT01854710|448958767|FG003|Overall Study|Withdrawal by Subject|0|||
124816573|NCT01854710|448958768|FG004|Overall Study|Withdrawal by Subject|0|||
124816574|NCT01854710|448958769|FG005|Overall Study|Withdrawal by Subject|0|||
124816575|NCT01854710|448958764|FG000|Overall Study|CRI procedural error|2|||
124816576|NCT01854710|448958765|FG001|Overall Study|CRI procedural error|2|||
124816577|NCT01854710|448958766|FG002|Overall Study|CRI procedural error|2|||
124816578|NCT01854710|448958767|FG003|Overall Study|CRI procedural error|2|||
124816579|NCT01854710|448958768|FG004|Overall Study|CRI procedural error|2|||
124816580|NCT01854710|448958769|FG005|Overall Study|CRI procedural error|2|||
124816581|NCT00370032|448958770|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
124816582|NCT00370032|448958771|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
124816583|NCT00370032|448958770|FG000|Washout Period|Withdrawal by Subject|0|||
124816584|NCT00370032|448958771|FG001|Washout Period|Withdrawal by Subject|1|||
124816585|NCT00370032|448958770|FG000|Washout Period|Lost to Follow-up|0|||
124816586|NCT00370032|448958771|FG001|Washout Period|Lost to Follow-up|1|||
124816587|NCT00370032|448958770|FG000|Washout Period|Adverse Event|1|||
124816588|NCT00370032|448958771|FG001|Washout Period|Adverse Event|0|||
124816589|NCT00370032|448958770|FG000|Follow-up Period|Withdrawal by Subject|1|||
124816590|NCT00370032|448958771|FG001|Follow-up Period|Withdrawal by Subject|0|||
124816591|NCT01844518|448958777|FG000|Overall Study|Adverse Event|7|||
124816592|NCT01844518|448958778|FG001|Overall Study|Adverse Event|1|||
124816593|NCT01844518|448958777|FG000|Overall Study|Lack of Efficacy|17|||
124816594|NCT01844518|448958778|FG001|Overall Study|Lack of Efficacy|5|||
124816595|NCT01844518|448958777|FG000|Overall Study|Participant's request to discontinue|4|||
124816596|NCT01844518|448958778|FG001|Overall Study|Participant's request to discontinue|1|||
124816597|NCT01844518|448958777|FG000|Overall Study|Poor/Non-compliance|1|||
124816598|NCT01844518|448958778|FG001|Overall Study|Poor/Non-compliance|0|||
124816599|NCT01844518|448958777|FG000|Overall Study|No Longer Met Study Criteria|2|||
124816600|NCT01844518|448958778|FG001|Overall Study|No Longer Met Study Criteria|0|||
124816601|NCT01844518|448958777|FG000|Overall Study|Withdrawal by Subject|9|||
124816602|NCT01844518|448958778|FG001|Overall Study|Withdrawal by Subject|0|||
124816603|NCT01844518|448958777|FG000|Overall Study|Pregnancy|1|||
124816604|NCT01844518|448958778|FG001|Overall Study|Pregnancy|0|||
124816605|NCT04584645|448958780|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
124816606|NCT04584645|448958781|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
124816607|NCT00390468|448958782|FG000|Overall Study|Protocol Violation|2|||
124816608|NCT00390468|448958782|FG000|Overall Study|Lack of Efficacy|1|||
124816609|NCT03129100|448958785|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
124816610|NCT03129100|448958786|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
124816611|NCT03129100|448958787|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
124816612|NCT03129100|448958788|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
124816613|NCT03129100|448958789|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
124816614|NCT03129100|448958790|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
124816615|NCT03129100|448958791|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
124816616|NCT03129100|448958792|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
124816617|NCT03129100|448958793|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
124816618|NCT03129100|448958794|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
124816619|NCT03129100|448958795|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
124816620|NCT03129100|448958796|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
124816621|NCT03129100|448958797|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
124816622|NCT03129100|448958798|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
124816623|NCT03129100|448958799|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
124816624|NCT03129100|448958800|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
124816625|NCT03129100|448958801|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
124816626|NCT03129100|448958802|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
124816627|NCT03129100|448958803|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
124816628|NCT03129100|448958804|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
124816629|NCT03129100|448958805|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
124816630|NCT03129100|448958806|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
124816631|NCT03129100|448958807|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
124816632|NCT03129100|448958808|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
124816633|NCT03129100|448958809|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
124816634|NCT03129100|448958810|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
124816635|NCT03129100|448958785|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
124816636|NCT03129100|448958786|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816637|NCT03129100|448958787|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816638|NCT03129100|448958788|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816639|NCT03129100|448958789|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816640|NCT03129100|448958790|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816641|NCT03129100|448958791|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816642|NCT03129100|448958792|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816643|NCT03129100|448958793|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816644|NCT03129100|448958794|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816645|NCT03129100|448958795|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816646|NCT03129100|448958796|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816647|NCT03129100|448958797|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816648|NCT03129100|448958798|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816649|NCT03129100|448958799|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816650|NCT03129100|448958800|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816651|NCT03129100|448958801|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816652|NCT03129100|448958802|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816653|NCT03129100|448958803|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816654|NCT03129100|448958804|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816655|NCT03129100|448958805|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816656|NCT03129100|448958806|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816657|NCT03129100|448958807|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816658|NCT03129100|448958808|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816659|NCT03129100|448958809|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816660|NCT03129100|448958810|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816661|NCT03129100|448958785|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
124816662|NCT03129100|448958786|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
124816663|NCT03129100|448958787|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816664|NCT03129100|448958788|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816665|NCT03129100|448958789|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816666|NCT03129100|448958790|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816667|NCT03129100|448958791|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816668|NCT03129100|448958792|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816669|NCT03129100|448958793|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816670|NCT03129100|448958794|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816671|NCT03129100|448958795|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816672|NCT03129100|448958796|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816673|NCT03129100|448958797|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816674|NCT03129100|448958798|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816675|NCT03129100|448958799|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816676|NCT03129100|448958800|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816677|NCT03129100|448958801|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816678|NCT03129100|448958802|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816679|NCT03129100|448958803|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816680|NCT03129100|448958804|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816681|NCT03129100|448958805|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816682|NCT03129100|448958806|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816683|NCT03129100|448958807|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816684|NCT03129100|448958808|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816685|NCT03129100|448958809|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816686|NCT03129100|448958810|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816687|NCT03129100|448958785|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
124816688|NCT03129100|448958786|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
124816689|NCT03129100|448958787|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816690|NCT03129100|448958788|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816691|NCT03129100|448958789|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816692|NCT03129100|448958790|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816693|NCT03129100|448958791|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816694|NCT03129100|448958792|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816695|NCT03129100|448958793|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816696|NCT03129100|448958794|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816697|NCT03129100|448958795|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816698|NCT03129100|448958796|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816699|NCT03129100|448958797|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816700|NCT03129100|448958798|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816701|NCT03129100|448958799|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816702|NCT03129100|448958800|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816703|NCT03129100|448958801|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816704|NCT03129100|448958802|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816705|NCT03129100|448958803|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816706|NCT03129100|448958804|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816707|NCT03129100|448958805|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125303023|NCT04776317|450736655|FG012|Overall Study|Withdrawal by Subject|0|||
124816708|NCT03129100|448958806|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816709|NCT03129100|448958807|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816710|NCT03129100|448958808|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816711|NCT03129100|448958809|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816712|NCT03129100|448958810|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816713|NCT03129100|448958785|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816714|NCT03129100|448958786|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
124816715|NCT03129100|448958787|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816716|NCT03129100|448958788|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816717|NCT03129100|448958789|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816718|NCT03129100|448958790|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816719|NCT03129100|448958791|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816720|NCT03129100|448958792|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816721|NCT03129100|448958793|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816722|NCT03129100|448958794|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816723|NCT03129100|448958795|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816724|NCT03129100|448958796|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816725|NCT03129100|448958797|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816726|NCT03129100|448958798|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816727|NCT03129100|448958799|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816728|NCT03129100|448958800|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816729|NCT03129100|448958801|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816730|NCT03129100|448958802|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816731|NCT03129100|448958803|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816732|NCT03129100|448958804|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816733|NCT03129100|448958805|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816734|NCT03129100|448958806|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816735|NCT03129100|448958807|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816736|NCT03129100|448958808|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816737|NCT03129100|448958809|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816738|NCT03129100|448958810|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816739|NCT03129100|448958785|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816740|NCT03129100|448958786|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816741|NCT03129100|448958787|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
124816742|NCT03129100|448958788|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
124816743|NCT03129100|448958789|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816744|NCT03129100|448958790|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
124816745|NCT03129100|448958791|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816746|NCT03129100|448958792|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816747|NCT03129100|448958793|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816748|NCT03129100|448958794|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816749|NCT03129100|448958795|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816750|NCT03129100|448958796|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816751|NCT03129100|448958797|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816752|NCT03129100|448958798|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816753|NCT03129100|448958799|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816754|NCT03129100|448958800|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816755|NCT03129100|448958801|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816756|NCT03129100|448958802|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816757|NCT03129100|448958803|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816758|NCT03129100|448958804|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816759|NCT03129100|448958805|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816760|NCT03129100|448958806|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816761|NCT03129100|448958807|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816762|NCT03129100|448958808|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816763|NCT03129100|448958809|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816764|NCT03129100|448958810|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816765|NCT03129100|448958785|FG000|Period2 Extension Period (Group A and B)|Death|0|||
124816766|NCT03129100|448958786|FG001|Period2 Extension Period (Group A and B)|Death|0|||
124816767|NCT03129100|448958787|FG002|Period2 Extension Period (Group A and B)|Death|1|||
124816768|NCT03129100|448958788|FG003|Period2 Extension Period (Group A and B)|Death|0|||
124816769|NCT03129100|448958789|FG004|Period2 Extension Period (Group A and B)|Death|0|||
124816770|NCT03129100|448958790|FG005|Period2 Extension Period (Group A and B)|Death|0|||
124816771|NCT03129100|448958791|FG006|Period2 Extension Period (Group A and B)|Death|0|||
124816772|NCT03129100|448958792|FG007|Period2 Extension Period (Group A and B)|Death|0|||
124816773|NCT03129100|448958793|FG008|Period2 Extension Period (Group A and B)|Death|0|||
124816774|NCT03129100|448958794|FG009|Period2 Extension Period (Group A and B)|Death|0|||
124816775|NCT03129100|448958795|FG010|Period2 Extension Period (Group A and B)|Death|0|||
124816776|NCT03129100|448958796|FG011|Period2 Extension Period (Group A and B)|Death|0|||
124816777|NCT03129100|448958797|FG012|Period2 Extension Period (Group A and B)|Death|0|||
124816778|NCT03129100|448958798|FG013|Period2 Extension Period (Group A and B)|Death|0|||
124816779|NCT03129100|448958799|FG014|Period2 Extension Period (Group A and B)|Death|0|||
124816780|NCT03129100|448958800|FG015|Period2 Extension Period (Group A and B)|Death|0|||
124816781|NCT03129100|448958801|FG016|Period2 Extension Period (Group A and B)|Death|0|||
124816782|NCT03129100|448958802|FG017|Period2 Extension Period (Group A and B)|Death|0|||
124816783|NCT03129100|448958803|FG018|Period2 Extension Period (Group A and B)|Death|0|||
124816784|NCT03129100|448958804|FG019|Period2 Extension Period (Group A and B)|Death|0|||
124816785|NCT03129100|448958805|FG020|Period2 Extension Period (Group A and B)|Death|0|||
124816786|NCT03129100|448958806|FG021|Period2 Extension Period (Group A and B)|Death|0|||
124816787|NCT03129100|448958807|FG022|Period2 Extension Period (Group A and B)|Death|0|||
124816788|NCT03129100|448958808|FG023|Period2 Extension Period (Group A and B)|Death|0|||
124816789|NCT03129100|448958809|FG024|Period2 Extension Period (Group A and B)|Death|0|||
124816790|NCT03129100|448958810|FG025|Period2 Extension Period (Group A and B)|Death|0|||
124816791|NCT03129100|448958785|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816792|NCT03129100|448958786|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816793|NCT03129100|448958787|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
124816794|NCT03129100|448958788|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
124816795|NCT03129100|448958789|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
124816796|NCT03129100|448958790|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
124816797|NCT03129100|448958791|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
124816798|NCT03129100|448958792|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816799|NCT03129100|448958793|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816800|NCT03129100|448958794|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816801|NCT03129100|448958795|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816802|NCT03129100|448958796|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816803|NCT03129100|448958797|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816804|NCT03129100|448958798|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816805|NCT03129100|448958799|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816806|NCT03129100|448958800|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816807|NCT03129100|448958801|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816808|NCT03129100|448958802|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816809|NCT03129100|448958803|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816810|NCT03129100|448958804|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816811|NCT03129100|448958805|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816812|NCT03129100|448958806|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816813|NCT03129100|448958807|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816814|NCT03129100|448958808|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816815|NCT03129100|448958809|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816816|NCT03129100|448958810|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816817|NCT03129100|448958785|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816818|NCT03129100|448958786|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816819|NCT03129100|448958787|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
124816820|NCT03129100|448958788|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816821|NCT03129100|448958789|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816822|NCT03129100|448958790|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816823|NCT03129100|448958791|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816824|NCT03129100|448958792|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816825|NCT03129100|448958793|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816826|NCT03129100|448958794|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816827|NCT03129100|448958795|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816828|NCT03129100|448958796|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816829|NCT03129100|448958797|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816830|NCT03129100|448958798|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816831|NCT03129100|448958799|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816832|NCT03129100|448958800|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816833|NCT03129100|448958801|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816834|NCT03129100|448958802|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816835|NCT03129100|448958803|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816836|NCT03129100|448958804|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816837|NCT03129100|448958805|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816838|NCT03129100|448958806|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816839|NCT03129100|448958807|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816840|NCT03129100|448958808|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816841|NCT03129100|448958809|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816842|NCT03129100|448958810|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816843|NCT03129100|448958785|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816844|NCT03129100|448958786|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816845|NCT03129100|448958787|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
124816846|NCT03129100|448958788|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816847|NCT03129100|448958789|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816848|NCT03129100|448958790|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816849|NCT03129100|448958791|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816850|NCT03129100|448958792|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816851|NCT03129100|448958793|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816852|NCT03129100|448958794|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816853|NCT03129100|448958795|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816854|NCT03129100|448958796|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816855|NCT03129100|448958797|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816856|NCT03129100|448958798|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816857|NCT03129100|448958799|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816858|NCT03129100|448958800|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816859|NCT03129100|448958801|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816860|NCT03129100|448958802|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816861|NCT03129100|448958803|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816862|NCT03129100|448958804|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816863|NCT03129100|448958805|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816864|NCT03129100|448958806|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816865|NCT03129100|448958807|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816866|NCT03129100|448958808|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816867|NCT03129100|448958809|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816868|NCT03129100|448958810|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816869|NCT03129100|448958785|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816870|NCT03129100|448958786|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816871|NCT03129100|448958787|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
124816872|NCT03129100|448958788|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816873|NCT03129100|448958789|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816874|NCT03129100|448958790|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816875|NCT03129100|448958791|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816876|NCT03129100|448958792|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816877|NCT03129100|448958793|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816878|NCT03129100|448958794|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816879|NCT03129100|448958795|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816880|NCT03129100|448958796|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816881|NCT03129100|448958797|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816882|NCT03129100|448958798|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816883|NCT03129100|448958799|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816884|NCT03129100|448958800|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816885|NCT03129100|448958801|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816886|NCT03129100|448958802|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816887|NCT03129100|448958803|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816888|NCT03129100|448958804|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816889|NCT03129100|448958805|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816890|NCT03129100|448958806|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816891|NCT03129100|448958807|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816892|NCT03129100|448958808|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816893|NCT03129100|448958809|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816894|NCT03129100|448958810|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816895|NCT03129100|448958785|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816896|NCT03129100|448958786|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816897|NCT03129100|448958787|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816898|NCT03129100|448958788|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816899|NCT03129100|448958789|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
124816900|NCT03129100|448958790|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
124816901|NCT03129100|448958791|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
124816902|NCT03129100|448958792|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816903|NCT03129100|448958793|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816904|NCT03129100|448958794|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816905|NCT03129100|448958795|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816906|NCT03129100|448958796|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816907|NCT03129100|448958797|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816908|NCT03129100|448958798|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816909|NCT03129100|448958799|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816910|NCT03129100|448958800|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816911|NCT03129100|448958801|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816912|NCT03129100|448958802|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816913|NCT03129100|448958803|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816914|NCT03129100|448958804|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816915|NCT03129100|448958805|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816916|NCT03129100|448958806|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816917|NCT03129100|448958807|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816918|NCT03129100|448958808|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816919|NCT03129100|448958809|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816920|NCT03129100|448958810|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816921|NCT03129100|448958785|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816922|NCT03129100|448958786|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816923|NCT03129100|448958787|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816924|NCT03129100|448958788|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816925|NCT03129100|448958789|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816926|NCT03129100|448958790|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816927|NCT03129100|448958791|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816928|NCT03129100|448958792|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816929|NCT03129100|448958793|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816930|NCT03129100|448958794|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
124816931|NCT03129100|448958795|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816932|NCT03129100|448958796|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816933|NCT03129100|448958797|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816934|NCT03129100|448958798|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816935|NCT03129100|448958799|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816936|NCT03129100|448958800|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816937|NCT03129100|448958801|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816938|NCT03129100|448958802|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816939|NCT03129100|448958803|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816940|NCT03129100|448958804|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816941|NCT03129100|448958805|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816942|NCT03129100|448958806|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816943|NCT03129100|448958807|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816944|NCT03129100|448958808|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816945|NCT03129100|448958809|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816946|NCT03129100|448958810|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816947|NCT03129100|448958785|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816948|NCT03129100|448958786|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816949|NCT03129100|448958787|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816950|NCT03129100|448958788|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816951|NCT03129100|448958789|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816952|NCT03129100|448958790|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816953|NCT03129100|448958791|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816954|NCT03129100|448958792|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816955|NCT03129100|448958793|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816956|NCT03129100|448958794|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816957|NCT03129100|448958795|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816958|NCT03129100|448958796|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
124816959|NCT03129100|448958797|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816960|NCT03129100|448958798|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816961|NCT03129100|448958799|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816962|NCT03129100|448958800|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816963|NCT03129100|448958801|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816964|NCT03129100|448958802|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816965|NCT03129100|448958803|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816966|NCT03129100|448958804|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816967|NCT03129100|448958805|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816968|NCT03129100|448958806|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816969|NCT03129100|448958807|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816970|NCT03129100|448958808|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816971|NCT03129100|448958809|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816972|NCT03129100|448958810|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816973|NCT03129100|448958785|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816974|NCT03129100|448958786|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816975|NCT03129100|448958787|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816976|NCT03129100|448958788|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816977|NCT03129100|448958789|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816978|NCT03129100|448958790|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816979|NCT03129100|448958791|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816980|NCT03129100|448958792|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816981|NCT03129100|448958793|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816982|NCT03129100|448958794|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816983|NCT03129100|448958795|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816984|NCT03129100|448958796|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
124816985|NCT03129100|448958797|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
124816986|NCT03129100|448958798|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
124816987|NCT03129100|448958799|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
124816988|NCT03129100|448958800|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816989|NCT03129100|448958801|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816990|NCT03129100|448958802|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816991|NCT03129100|448958803|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816992|NCT03129100|448958804|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816993|NCT03129100|448958805|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816994|NCT03129100|448958806|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816995|NCT03129100|448958807|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816996|NCT03129100|448958808|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816997|NCT03129100|448958809|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816998|NCT03129100|448958810|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816999|NCT03129100|448958785|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817000|NCT03129100|448958786|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817001|NCT03129100|448958787|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817002|NCT03129100|448958788|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817003|NCT03129100|448958789|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817004|NCT03129100|448958790|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817005|NCT03129100|448958791|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817006|NCT03129100|448958792|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817007|NCT03129100|448958793|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817008|NCT03129100|448958794|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817009|NCT03129100|448958795|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817010|NCT03129100|448958796|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
124817011|NCT03129100|448958797|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817012|NCT03129100|448958798|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
124817013|NCT03129100|448958799|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
124817014|NCT03129100|448958800|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817015|NCT03129100|448958801|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817016|NCT03129100|448958802|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817017|NCT03129100|448958803|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817018|NCT03129100|448958804|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817019|NCT03129100|448958805|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817020|NCT03129100|448958806|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817021|NCT03129100|448958807|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817022|NCT03129100|448958808|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817023|NCT03129100|448958809|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817024|NCT03129100|448958810|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817025|NCT03129100|448958785|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817026|NCT03129100|448958786|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817027|NCT03129100|448958787|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817028|NCT03129100|448958788|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817029|NCT03129100|448958789|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817030|NCT03129100|448958790|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817031|NCT03129100|448958791|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817032|NCT03129100|448958792|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817033|NCT03129100|448958793|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817034|NCT03129100|448958794|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817035|NCT03129100|448958795|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817036|NCT03129100|448958796|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817037|NCT03129100|448958797|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817038|NCT03129100|448958798|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817039|NCT03129100|448958799|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817040|NCT03129100|448958800|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
124817041|NCT03129100|448958801|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817042|NCT03129100|448958802|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817043|NCT03129100|448958803|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817044|NCT03129100|448958804|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817045|NCT03129100|448958805|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817046|NCT03129100|448958806|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817047|NCT03129100|448958807|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817048|NCT03129100|448958808|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817049|NCT03129100|448958809|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817050|NCT03129100|448958810|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817051|NCT03129100|448958785|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817052|NCT03129100|448958786|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817053|NCT03129100|448958787|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817054|NCT03129100|448958788|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817055|NCT03129100|448958789|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817056|NCT03129100|448958790|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817057|NCT03129100|448958791|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817058|NCT03129100|448958792|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817059|NCT03129100|448958793|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817060|NCT03129100|448958794|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817061|NCT03129100|448958795|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817062|NCT03129100|448958796|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817063|NCT03129100|448958797|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
124817064|NCT03129100|448958798|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817065|NCT03129100|448958799|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
124817066|NCT03129100|448958800|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
124817067|NCT03129100|448958801|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817068|NCT03129100|448958802|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817069|NCT03129100|448958803|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817070|NCT03129100|448958804|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817071|NCT03129100|448958805|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817072|NCT03129100|448958806|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817073|NCT03129100|448958807|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817074|NCT03129100|448958808|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817075|NCT03129100|448958809|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817076|NCT03129100|448958810|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817077|NCT03129100|448958785|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817078|NCT03129100|448958786|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817079|NCT03129100|448958787|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817080|NCT03129100|448958788|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817081|NCT03129100|448958789|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817082|NCT03129100|448958790|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817083|NCT03129100|448958791|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817084|NCT03129100|448958792|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817085|NCT03129100|448958793|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817086|NCT03129100|448958794|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817087|NCT03129100|448958795|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817088|NCT03129100|448958796|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817089|NCT03129100|448958797|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817090|NCT03129100|448958798|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817091|NCT03129100|448958799|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817092|NCT03129100|448958800|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817093|NCT03129100|448958801|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817094|NCT03129100|448958802|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
124817095|NCT03129100|448958803|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817096|NCT03129100|448958804|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
124817097|NCT03129100|448958805|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817098|NCT03129100|448958806|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817099|NCT03129100|448958807|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817100|NCT03129100|448958808|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817101|NCT03129100|448958809|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817102|NCT03129100|448958810|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817103|NCT03129100|448958785|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817104|NCT03129100|448958786|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817105|NCT03129100|448958787|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817106|NCT03129100|448958788|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817107|NCT03129100|448958789|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817108|NCT03129100|448958790|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817109|NCT03129100|448958791|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817110|NCT03129100|448958792|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817111|NCT03129100|448958793|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817112|NCT03129100|448958794|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817113|NCT03129100|448958795|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817114|NCT03129100|448958796|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817115|NCT03129100|448958797|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817116|NCT03129100|448958798|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817117|NCT03129100|448958799|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817118|NCT03129100|448958800|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817119|NCT03129100|448958801|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817120|NCT03129100|448958802|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817121|NCT03129100|448958803|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817122|NCT03129100|448958804|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817123|NCT03129100|448958805|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
124817124|NCT03129100|448958806|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817125|NCT03129100|448958807|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817126|NCT03129100|448958808|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817127|NCT03129100|448958809|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817128|NCT03129100|448958810|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817129|NCT03129100|448958785|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
124817130|NCT03129100|448958786|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
124817131|NCT03129100|448958787|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
124817132|NCT03129100|448958788|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
124817133|NCT03129100|448958789|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
124817134|NCT03129100|448958790|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
124817135|NCT03129100|448958791|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
124817136|NCT03129100|448958792|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
124817137|NCT03129100|448958793|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
124817138|NCT03129100|448958794|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
124817139|NCT03129100|448958795|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
124817140|NCT03129100|448958796|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
124817141|NCT03129100|448958797|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
124817142|NCT03129100|448958798|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
124817143|NCT03129100|448958799|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
124817144|NCT03129100|448958800|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
124817145|NCT03129100|448958801|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
124817146|NCT03129100|448958802|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
124817147|NCT03129100|448958803|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
124817148|NCT03129100|448958804|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
124817149|NCT03129100|448958805|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
124817150|NCT03129100|448958806|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
124817151|NCT03129100|448958807|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
124817152|NCT03129100|448958808|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
124817153|NCT03129100|448958809|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
124817154|NCT03129100|448958810|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
124817155|NCT03129100|448958785|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817156|NCT03129100|448958786|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817157|NCT03129100|448958787|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817158|NCT03129100|448958788|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817159|NCT03129100|448958789|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817160|NCT03129100|448958790|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817161|NCT03129100|448958791|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817162|NCT03129100|448958792|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817163|NCT03129100|448958793|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817164|NCT03129100|448958794|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817165|NCT03129100|448958795|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817166|NCT03129100|448958796|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817167|NCT03129100|448958797|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817168|NCT03129100|448958798|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817169|NCT03129100|448958799|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817170|NCT03129100|448958800|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817171|NCT03129100|448958801|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817172|NCT03129100|448958802|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817173|NCT03129100|448958803|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817174|NCT03129100|448958804|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817175|NCT03129100|448958805|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
124817176|NCT03129100|448958806|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817177|NCT03129100|448958807|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817178|NCT03129100|448958808|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817179|NCT03129100|448958809|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817180|NCT03129100|448958810|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817181|NCT03129100|448958785|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
124817182|NCT03129100|448958786|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
124817183|NCT03129100|448958787|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
124817184|NCT03129100|448958788|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
124817185|NCT03129100|448958789|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
124817186|NCT03129100|448958790|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
124817187|NCT03129100|448958791|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
124817188|NCT03129100|448958792|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
124817189|NCT03129100|448958793|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
124817190|NCT03129100|448958794|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
124817191|NCT03129100|448958795|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
124817192|NCT03129100|448958796|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
124817193|NCT03129100|448958797|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
124817194|NCT03129100|448958798|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
124817195|NCT03129100|448958799|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
124817196|NCT03129100|448958800|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
124817197|NCT03129100|448958801|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
124817198|NCT03129100|448958802|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
124817199|NCT03129100|448958803|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
124817200|NCT03129100|448958804|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
124817201|NCT03129100|448958805|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
124817202|NCT03129100|448958806|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
124817203|NCT03129100|448958807|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
124817204|NCT03129100|448958808|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
124817205|NCT03129100|448958809|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
124817206|NCT03129100|448958810|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
124817207|NCT03129100|448958785|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817208|NCT03129100|448958786|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817209|NCT03129100|448958787|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817210|NCT03129100|448958788|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817211|NCT03129100|448958789|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817212|NCT03129100|448958790|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817213|NCT03129100|448958791|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817214|NCT03129100|448958792|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817215|NCT03129100|448958793|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817216|NCT03129100|448958794|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817217|NCT03129100|448958795|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817218|NCT03129100|448958796|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817219|NCT03129100|448958797|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817220|NCT03129100|448958798|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817221|NCT03129100|448958799|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817222|NCT03129100|448958800|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817223|NCT03129100|448958801|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817224|NCT03129100|448958802|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817225|NCT03129100|448958803|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817226|NCT03129100|448958804|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817227|NCT03129100|448958805|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817228|NCT03129100|448958806|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817229|NCT03129100|448958807|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817230|NCT03129100|448958808|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817231|NCT03129100|448958809|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
124817232|NCT03129100|448958810|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
124817233|NCT03129100|448958785|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817234|NCT03129100|448958786|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817235|NCT03129100|448958787|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817236|NCT03129100|448958788|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817237|NCT03129100|448958789|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817238|NCT03129100|448958790|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817239|NCT03129100|448958791|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817240|NCT03129100|448958792|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817241|NCT03129100|448958793|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817242|NCT03129100|448958794|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817243|NCT03129100|448958795|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817244|NCT03129100|448958796|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817245|NCT03129100|448958797|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817246|NCT03129100|448958798|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817247|NCT03129100|448958799|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817248|NCT03129100|448958800|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817249|NCT03129100|448958801|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817250|NCT03129100|448958802|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817251|NCT03129100|448958803|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817252|NCT03129100|448958804|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817253|NCT03129100|448958805|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817254|NCT03129100|448958806|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817255|NCT03129100|448958807|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817256|NCT03129100|448958808|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
124817257|NCT03129100|448958809|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
124817258|NCT03129100|448958810|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
124817259|NCT03129100|448958785|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817260|NCT03129100|448958786|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817261|NCT03129100|448958787|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817262|NCT03129100|448958788|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817263|NCT03129100|448958789|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817264|NCT03129100|448958790|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817265|NCT03129100|448958791|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817266|NCT03129100|448958792|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817267|NCT03129100|448958793|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817268|NCT03129100|448958794|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817269|NCT03129100|448958795|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817270|NCT03129100|448958796|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817271|NCT03129100|448958797|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817272|NCT03129100|448958798|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817273|NCT03129100|448958799|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817274|NCT03129100|448958800|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817275|NCT03129100|448958801|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817276|NCT03129100|448958802|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817277|NCT03129100|448958803|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817278|NCT03129100|448958804|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817279|NCT03129100|448958805|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817280|NCT03129100|448958806|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817281|NCT03129100|448958807|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817282|NCT03129100|448958808|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817283|NCT03129100|448958809|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
124817284|NCT03129100|448958810|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817285|NCT03129100|448958785|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817286|NCT03129100|448958786|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817287|NCT03129100|448958787|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817288|NCT03129100|448958788|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817289|NCT03129100|448958789|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817290|NCT03129100|448958790|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817291|NCT03129100|448958791|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817292|NCT03129100|448958792|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817293|NCT03129100|448958793|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817294|NCT03129100|448958794|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817295|NCT03129100|448958795|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817296|NCT03129100|448958796|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817297|NCT03129100|448958797|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817298|NCT03129100|448958798|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817299|NCT03129100|448958799|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817300|NCT03129100|448958800|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817301|NCT03129100|448958801|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817302|NCT03129100|448958802|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817303|NCT03129100|448958803|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817304|NCT03129100|448958804|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817305|NCT03129100|448958805|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817306|NCT03129100|448958806|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817307|NCT03129100|448958807|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817308|NCT03129100|448958808|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817309|NCT03129100|448958809|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817310|NCT03129100|448958810|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
124817311|NCT03129100|448958785|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
124817312|NCT03129100|448958786|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
124817313|NCT03129100|448958787|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
124817314|NCT03129100|448958788|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
124817315|NCT03129100|448958789|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
124817316|NCT03129100|448958790|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
124817317|NCT03129100|448958791|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
124817318|NCT03129100|448958792|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
124817319|NCT03129100|448958793|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
124817320|NCT03129100|448958794|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
124817321|NCT03129100|448958795|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
124817322|NCT03129100|448958796|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
124817323|NCT03129100|448958797|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
124817324|NCT03129100|448958798|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
124817325|NCT03129100|448958799|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
124817326|NCT03129100|448958800|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
124817327|NCT03129100|448958801|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
124817328|NCT03129100|448958802|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
124817329|NCT03129100|448958803|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
124817330|NCT03129100|448958804|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
124817331|NCT03129100|448958805|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
124817332|NCT03129100|448958806|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
124817333|NCT03129100|448958807|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
124817334|NCT03129100|448958808|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
124817335|NCT03129100|448958809|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
124817336|NCT03129100|448958810|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
124817337|NCT03845985|448958811|FG000|Overall Study|Lost to Follow-up|2|||
124817338|NCT03845985|448958812|FG001|Overall Study|Lost to Follow-up|1|||
124817339|NCT03845985|448958811|FG000|Overall Study|Physician Decision|1|||
124817340|NCT03845985|448958812|FG001|Overall Study|Physician Decision|0|||
124817341|NCT03845985|448958811|FG000|Overall Study|Withdrawal by Subject|4|||
124817342|NCT03845985|448958812|FG001|Overall Study|Withdrawal by Subject|1|||
124817343|NCT03334539|448958815|FG000|Overall Study|Adverse Event|3|||
124817344|NCT03334539|448958816|FG001|Overall Study|Adverse Event|5|||
124817345|NCT03334539|448958817|FG002|Overall Study|Adverse Event|0|||
124817346|NCT03334539|448958815|FG000|Overall Study|Withdrawal by Subject|0|||
124817347|NCT03334539|448958816|FG001|Overall Study|Withdrawal by Subject|1|||
124817348|NCT03334539|448958817|FG002|Overall Study|Withdrawal by Subject|1|||
124817349|NCT03334539|448958815|FG000|Overall Study|Administrative Reasons|1|||
124817350|NCT03334539|448958816|FG001|Overall Study|Administrative Reasons|0|||
124817351|NCT03334539|448958817|FG002|Overall Study|Administrative Reasons|0|||
124817352|NCT03334539|448958815|FG000|Overall Study|Hypertension Not Controlled|0|||
124817353|NCT03334539|448958816|FG001|Overall Study|Hypertension Not Controlled|1|||
124817354|NCT03334539|448958817|FG002|Overall Study|Hypertension Not Controlled|0|||
124817355|NCT03736447|448958819|FG000|Overall Study|Adverse Event|5|||
124817356|NCT03736447|448958820|FG001|Overall Study|Adverse Event|1|||
124817357|NCT03736447|448958819|FG000|Overall Study|Withdrawal by Subject|5|||
124817358|NCT03736447|448958820|FG001|Overall Study|Withdrawal by Subject|1|||
124817359|NCT03736447|448958819|FG000|Overall Study|Lost to Follow-up|1|||
124817360|NCT03736447|448958820|FG001|Overall Study|Lost to Follow-up|0|||
124817361|NCT03736447|448958819|FG000|Overall Study|Physician Decision|1|||
124817362|NCT03736447|448958820|FG001|Overall Study|Physician Decision|0|||
124817363|NCT03736447|448958819|FG000|Overall Study|Continued commitment to study treatment|3|||
124817364|NCT03736447|448958820|FG001|Overall Study|Continued commitment to study treatment|0|||
124817365|NCT03736447|448958819|FG000|Overall Study|Taste aversion to study product|0|||
124817366|NCT03736447|448958820|FG001|Overall Study|Taste aversion to study product|1|||
124817367|NCT00968201|448958821|FG000|Base Study - (Period II)|Adverse Event|8|||
124817368|NCT00968201|448958822|FG001|Base Study - (Period II)|Adverse Event|0|||
124817369|NCT00968201|448958823|FG002|Base Study - (Period II)|Adverse Event|16|||
124817370|NCT00968201|448958821|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
124817371|NCT00968201|448958822|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
124817372|NCT00968201|448958823|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
124817373|NCT00968201|448958821|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
124817374|NCT00968201|448958822|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
124817375|NCT00968201|448958823|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
124817376|NCT00968201|448958821|FG000|Base Study - (Period II)|Protocol Violation|12|||
124817377|NCT00968201|448958822|FG001|Base Study - (Period II)|Protocol Violation|0|||
124817378|NCT00968201|448958823|FG002|Base Study - (Period II)|Protocol Violation|12|||
124817379|NCT00968201|448958821|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
124817380|NCT00968201|448958822|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
124817381|NCT00968201|448958823|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
124817382|NCT00968201|448958821|FG000|Base Study - (Period II)|Site Error|0|||
124817383|NCT00968201|448958822|FG001|Base Study - (Period II)|Site Error|0|||
124817384|NCT00968201|448958823|FG002|Base Study - (Period II)|Site Error|1|||
124817385|NCT00968201|448958821|FG000|Extension Study - (Period III)|Adverse Event|0|||
124817386|NCT00968201|448958822|FG001|Extension Study - (Period III)|Adverse Event|5|||
124817387|NCT00968201|448958823|FG002|Extension Study - (Period III)|Adverse Event|22|||
124817388|NCT00968201|448958821|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
124817389|NCT00968201|448958822|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
124817390|NCT00968201|448958823|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
124817391|NCT00968201|448958821|FG000|Extension Study - (Period III)|Protocol Violation|0|||
124817392|NCT00968201|448958822|FG001|Extension Study - (Period III)|Protocol Violation|17|||
124817393|NCT00968201|448958823|FG002|Extension Study - (Period III)|Protocol Violation|14|||
124817394|NCT00968201|448958821|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
124817395|NCT00968201|448958822|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
124817396|NCT00968201|448958823|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
124817397|NCT00968201|448958821|FG000|Extension Study - (Period III)|Patient Relocated|0|||
124817398|NCT00968201|448958822|FG001|Extension Study - (Period III)|Patient Relocated|1|||
124817399|NCT00968201|448958823|FG002|Extension Study - (Period III)|Patient Relocated|1|||
124817400|NCT00968201|448958821|FG000|Extension Study - (Period III)|Noncompliance|0|||
124817401|NCT00968201|448958822|FG001|Extension Study - (Period III)|Noncompliance|0|||
124817402|NCT00968201|448958823|FG002|Extension Study - (Period III)|Noncompliance|3|||
124817403|NCT00968201|448958821|FG000|Extension Study - (Period III)|Other|0|||
124817404|NCT00968201|448958822|FG001|Extension Study - (Period III)|Other|0|||
124817405|NCT00968201|448958823|FG002|Extension Study - (Period III)|Other|2|||
124817406|NCT00968201|448958821|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
124817407|NCT00968201|448958822|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
124817408|NCT00968201|448958823|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
124817409|NCT02619175|448958824|FG000|Overall Study|Withdrawal by Subject|1|||
124817410|NCT02619175|448958825|FG001|Overall Study|Withdrawal by Subject|0|||
124817411|NCT02619175|448958824|FG000|Overall Study|foot pain|1|||
124817412|NCT02619175|448958825|FG001|Overall Study|foot pain|0|||
124817413|NCT04974697|448958826|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
124817414|NCT04974697|448958826|FG000|Overall Study|Lens discomfort|1|||
124817415|NCT03706456|448958828|FG000|Overall Study|Adverse Event|1|||
124817416|NCT03706456|448958828|FG000|Overall Study|Lack of Efficacy|2|||
124817417|NCT02784431|448958829|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
124817418|NCT02784431|448958829|FG000|Overall Study|Early Study Termination|19|||
124817419|NCT03302234|448958832|FG000|Overall Study|Death|191|||
124817420|NCT03302234|448958833|FG001|Overall Study|Death|192|||
124817421|NCT03302234|448958832|FG000|Overall Study|Withdrawal by Subject|2|||
124817422|NCT03302234|448958833|FG001|Overall Study|Withdrawal by Subject|2|||
124817423|NCT03302234|448958832|FG000|Overall Study|Sponsor Decision|90|||
124817424|NCT03302234|448958833|FG001|Overall Study|Sponsor Decision|89|||
124817425|NCT03302234|448958832|FG000|Overall Study|Laryngeal carcinoma|0|||
124817426|NCT03302234|448958833|FG001|Overall Study|Laryngeal carcinoma|1|||
124817427|NCT03302234|448958832|FG000|Overall Study|Not Reported|1|||
124817428|NCT03302234|448958833|FG001|Overall Study|Not Reported|0|||
124817429|NCT02795832|448958834|FG000|Overall Study|Adverse Event|0|||
124817430|NCT02795832|448958835|FG001|Overall Study|Adverse Event|0|||
124817431|NCT02795832|448958836|FG002|Overall Study|Adverse Event|0|||
124817432|NCT02795832|448958837|FG003|Overall Study|Adverse Event|0|||
124817433|NCT02795832|448958838|FG004|Overall Study|Adverse Event|0|||
124817434|NCT02795832|448958839|FG005|Overall Study|Adverse Event|3|||
124817435|NCT04523220|448958840|FG000|Main Treatment Period|Physician Decision|1|||
124817436|NCT04523220|448958841|FG001|Main Treatment Period|Physician Decision|1|||
124817437|NCT04523220|448958842|FG002|Main Treatment Period|Physician Decision|0|||
124817438|NCT04523220|448958840|FG000|Main Treatment Period|Other|5|||
124817439|NCT04523220|448958841|FG001|Main Treatment Period|Other|2|||
124817440|NCT04523220|448958842|FG002|Main Treatment Period|Other|4|||
124817441|NCT04523220|448958840|FG000|Main Treatment Period|Subject Decision|5|||
124817442|NCT04523220|448958841|FG001|Main Treatment Period|Subject Decision|7|||
124817443|NCT04523220|448958842|FG002|Main Treatment Period|Subject Decision|3|||
124817444|NCT04523220|448958840|FG000|Main Treatment Period|Death|5|||
124817445|NCT04523220|448958841|FG001|Main Treatment Period|Death|11|||
124817446|NCT04523220|448958842|FG002|Main Treatment Period|Death|4|||
124817447|NCT04523220|448958840|FG000|Main Treatment Period|Adverse Event|11|||
124817448|NCT04523220|448958841|FG001|Main Treatment Period|Adverse Event|9|||
124817449|NCT04523220|448958842|FG002|Main Treatment Period|Adverse Event|9|||
124817450|NCT04523220|448958840|FG000|Main Treatment Period|Withdrawal by Subject|3|||
124817451|NCT04523220|448958841|FG001|Main Treatment Period|Withdrawal by Subject|3|||
124817452|NCT04523220|448958842|FG002|Main Treatment Period|Withdrawal by Subject|4|||
124817453|NCT04523220|448958840|FG000|Main Treatment Period|Study drug never adminstered|10|||
124817454|NCT04523220|448958841|FG001|Main Treatment Period|Study drug never adminstered|3|||
124817455|NCT04523220|448958842|FG002|Main Treatment Period|Study drug never adminstered|5|||
124817456|NCT04523220|448958840|FG000|Extension Treatment Period|Physician Decision|1|||
124817457|NCT04523220|448958841|FG001|Extension Treatment Period|Physician Decision|0|||
124817458|NCT04523220|448958842|FG002|Extension Treatment Period|Physician Decision|3|||
124817459|NCT04523220|448958840|FG000|Extension Treatment Period|Other|2|||
124817460|NCT04523220|448958841|FG001|Extension Treatment Period|Other|6|||
124817461|NCT04523220|448958842|FG002|Extension Treatment Period|Other|6|||
124817462|NCT04523220|448958840|FG000|Extension Treatment Period|Subject Decision|5|||
124817463|NCT04523220|448958841|FG001|Extension Treatment Period|Subject Decision|2|||
124817464|NCT04523220|448958842|FG002|Extension Treatment Period|Subject Decision|4|||
124817465|NCT04523220|448958840|FG000|Extension Treatment Period|Death|6|||
124817466|NCT04523220|448958841|FG001|Extension Treatment Period|Death|4|||
124817467|NCT04523220|448958842|FG002|Extension Treatment Period|Death|7|||
124817468|NCT04523220|448958840|FG000|Extension Treatment Period|Adverse Event|6|||
124817469|NCT04523220|448958841|FG001|Extension Treatment Period|Adverse Event|7|||
124817470|NCT04523220|448958842|FG002|Extension Treatment Period|Adverse Event|9|||
124817471|NCT04523220|448958840|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
124817472|NCT04523220|448958841|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
124817473|NCT04523220|448958842|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
124817474|NCT04523220|448958840|FG000|Extension Treatment Period|Study drug never administered|0|||
124817475|NCT04523220|448958841|FG001|Extension Treatment Period|Study drug never administered|1|||
124817476|NCT04523220|448958842|FG002|Extension Treatment Period|Study drug never administered|0|||
124817477|NCT00571948|448958843|FG000|Overall Study|Lost to Follow-up|2|||
124817478|NCT00571948|448958844|FG001|Overall Study|Lost to Follow-up|0|||
124817479|NCT00571948|448958843|FG000|Overall Study|Withdrawal by Subject|1|||
124817480|NCT00571948|448958844|FG001|Overall Study|Withdrawal by Subject|2|||
124817481|NCT00571948|448958843|FG000|Overall Study|Protocol Violation|3|||
124817482|NCT00571948|448958844|FG001|Overall Study|Protocol Violation|3|||
124817483|NCT00571948|448958843|FG000|Overall Study|infant refused study meal|3|||
124817484|NCT00571948|448958844|FG001|Overall Study|infant refused study meal|4|||
124817485|NCT00571948|448958843|FG000|Overall Study|Parent were afraid of blood colection|2|||
124817486|NCT00571948|448958844|FG001|Overall Study|Parent were afraid of blood colection|5|||
124817487|NCT04112784|448958845|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
124817488|NCT04112784|448958845|FG000|Overall Study|Screen Failures|4|||
124817489|NCT00221403|448958846|FG000|Overall Study|Protocol Violation|1|||
124817490|NCT00221403|448958847|FG001|Overall Study|Protocol Violation|0|||
124817491|NCT00221403|448958848|FG002|Overall Study|Protocol Violation|0|||
124817492|NCT00221403|448958846|FG000|Overall Study|Physician Decision|1|||
124817493|NCT00221403|448958847|FG001|Overall Study|Physician Decision|0|||
124817494|NCT00221403|448958848|FG002|Overall Study|Physician Decision|0|||
124817495|NCT00221403|448958846|FG000|Overall Study|Withdrawal by Subject|0|||
124817496|NCT00221403|448958847|FG001|Overall Study|Withdrawal by Subject|3|||
124817497|NCT00221403|448958848|FG002|Overall Study|Withdrawal by Subject|0|||
124817498|NCT00221403|448958846|FG000|Overall Study|Lack of Efficacy|0|||
124817499|NCT00221403|448958847|FG001|Overall Study|Lack of Efficacy|1|||
124817500|NCT00221403|448958848|FG002|Overall Study|Lack of Efficacy|0|||
124817501|NCT00221403|448958846|FG000|Overall Study|Adverse Event|0|||
124817502|NCT00221403|448958847|FG001|Overall Study|Adverse Event|1|||
124817503|NCT00221403|448958848|FG002|Overall Study|Adverse Event|0|||
124817504|NCT02010775|448958849|FG000|Overall Study|Adverse Event|0|||
124817505|NCT02010775|448958850|FG001|Overall Study|Adverse Event|0|||
124817506|NCT02010775|448958851|FG002|Overall Study|Adverse Event|0|||
124817507|NCT02010775|448958852|FG003|Overall Study|Adverse Event|0|||
124817508|NCT02010775|448958853|FG004|Overall Study|Adverse Event|1|||
124817509|NCT02010775|448958849|FG000|Overall Study|Pregnancy|0|||
124817510|NCT02010775|448958850|FG001|Overall Study|Pregnancy|0|||
124817511|NCT02010775|448958851|FG002|Overall Study|Pregnancy|2|||
124817512|NCT02010775|448958852|FG003|Overall Study|Pregnancy|0|||
124817513|NCT02010775|448958853|FG004|Overall Study|Pregnancy|0|||
124817514|NCT02010775|448958849|FG000|Overall Study|Lost to Follow-up|2|||
124817515|NCT02010775|448958850|FG001|Overall Study|Lost to Follow-up|0|||
124817516|NCT02010775|448958851|FG002|Overall Study|Lost to Follow-up|0|||
124817517|NCT02010775|448958852|FG003|Overall Study|Lost to Follow-up|1|||
124817518|NCT02010775|448958853|FG004|Overall Study|Lost to Follow-up|1|||
124817519|NCT02010775|448958849|FG000|Overall Study|Personal Reasons|3|||
124817520|NCT02010775|448958850|FG001|Overall Study|Personal Reasons|3|||
124817521|NCT02010775|448958851|FG002|Overall Study|Personal Reasons|1|||
124817522|NCT02010775|448958852|FG003|Overall Study|Personal Reasons|2|||
124817523|NCT02010775|448958853|FG004|Overall Study|Personal Reasons|4|||
124817524|NCT00256750|448958856|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
124817525|NCT00256750|448958857|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
124817526|NCT00256750|448958858|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
124817527|NCT00256750|448958856|FG000|Transplanted Pre-Treatment|Other|2|||
124817528|NCT00256750|448958857|FG001|Transplanted Pre-Treatment|Other|0|||
124817529|NCT00256750|448958858|FG002|Transplanted Pre-Treatment|Other|0|||
124817530|NCT00256750|448958856|FG000|Transplanted Pre-Treatment|Death|1|||
124817531|NCT00256750|448958857|FG001|Transplanted Pre-Treatment|Death|0|||
124817532|NCT00256750|448958858|FG002|Transplanted Pre-Treatment|Death|0|||
124817533|NCT00256750|448958856|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
124817534|NCT00256750|448958857|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
124817535|NCT00256750|448958858|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
124817536|NCT00256750|448958856|FG000|Post-Transplant Treated (12 Months)|Death|3|||
124817537|NCT00256750|448958857|FG001|Post-Transplant Treated (12 Months)|Death|2|||
124817538|NCT00256750|448958858|FG002|Post-Transplant Treated (12 Months)|Death|4|||
124817539|NCT00256750|448958856|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
124817540|NCT00256750|448958857|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
124817541|NCT00256750|448958858|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
124817542|NCT00256750|448958856|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
124817543|NCT00256750|448958857|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
124817544|NCT00256750|448958858|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
124817545|NCT00256750|448958856|FG000|Post-Transplant Treated (12 Months)|Other|5|||
124817546|NCT00256750|448958857|FG001|Post-Transplant Treated (12 Months)|Other|4|||
124817547|NCT00256750|448958858|FG002|Post-Transplant Treated (12 Months)|Other|2|||
124817548|NCT00256750|448958856|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
124817549|NCT00256750|448958857|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
124817550|NCT00256750|448958858|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
124817551|NCT00256750|448958856|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
124817552|NCT00256750|448958857|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
124817553|NCT00256750|448958858|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
124817554|NCT00256750|448958856|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
124817555|NCT00256750|448958857|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
124817556|NCT00256750|448958858|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
124817557|NCT00256750|448958856|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
124817558|NCT00256750|448958857|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
124817559|NCT00256750|448958858|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
124817560|NCT00256750|448958856|FG000|Post-Transplant Treated (24 Months)|Death|3|||
124817561|NCT00256750|448958857|FG001|Post-Transplant Treated (24 Months)|Death|0|||
124817562|NCT00256750|448958858|FG002|Post-Transplant Treated (24 Months)|Death|0|||
124817563|NCT00256750|448958856|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
124817564|NCT00256750|448958857|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
124817565|NCT00256750|448958858|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
124817566|NCT00256750|448958856|FG000|Post-Transplant Treated (24 Months)|Other|2|||
124817567|NCT00256750|448958857|FG001|Post-Transplant Treated (24 Months)|Other|0|||
124817568|NCT00256750|448958858|FG002|Post-Transplant Treated (24 Months)|Other|1|||
124817569|NCT00256750|448958856|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
124817570|NCT00256750|448958857|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
124817571|NCT00256750|448958858|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
124817572|NCT00256750|448958856|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
124817573|NCT00256750|448958857|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
124817574|NCT00256750|448958858|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
124817575|NCT00256750|448958856|FG000|Post-Transplant Treated (36 Months)|Death|0|||
124817576|NCT00256750|448958857|FG001|Post-Transplant Treated (36 Months)|Death|2|||
124817577|NCT00256750|448958858|FG002|Post-Transplant Treated (36 Months)|Death|1|||
124817578|NCT00256750|448958856|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
124817579|NCT00256750|448958857|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
124817580|NCT00256750|448958858|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
124817581|NCT00256750|448958856|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
124817582|NCT00256750|448958857|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
124817583|NCT00256750|448958858|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
124817584|NCT00256750|448958856|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
125303024|NCT04776317|450736656|FG013|Overall Study|Withdrawal by Subject|0|||
125303025|NCT04776317|450736657|FG014|Overall Study|Withdrawal by Subject|0|||
124817585|NCT00256750|448958857|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
124817586|NCT00256750|448958858|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
124817587|NCT00256750|448958856|FG000|Post-Transplant Treated (36 Months)|Other|0|||
124817588|NCT00256750|448958857|FG001|Post-Transplant Treated (36 Months)|Other|1|||
124817589|NCT00256750|448958858|FG002|Post-Transplant Treated (36 Months)|Other|1|||
124817590|NCT00256750|448958856|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
124817591|NCT00256750|448958857|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
124817592|NCT00256750|448958858|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
124817593|NCT00256750|448958856|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
124817594|NCT00256750|448958857|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
124817595|NCT00256750|448958858|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
124817596|NCT00256750|448958856|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
124817597|NCT00256750|448958857|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
124817598|NCT00256750|448958858|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
124817599|NCT00256750|448958856|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
124817600|NCT00256750|448958857|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
124817601|NCT00256750|448958858|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
124817602|NCT00256750|448958856|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
124817603|NCT00256750|448958857|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
124817604|NCT00256750|448958858|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
124817605|NCT00256750|448958856|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
124817606|NCT00256750|448958857|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
124817607|NCT00256750|448958858|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
124817608|NCT00256750|448958856|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
124817609|NCT00256750|448958857|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
124817610|NCT00256750|448958858|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
124817611|NCT00256750|448958856|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
124817612|NCT00256750|448958857|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
124817613|NCT00256750|448958858|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
124817614|NCT00256750|448958856|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
124817615|NCT00256750|448958857|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
124817616|NCT00256750|448958858|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
124817617|NCT02030041|448958859|FG000|Overall Study|Withdrawal by Subject|2|||
124817618|NCT02030041|448958860|FG001|Overall Study|Withdrawal by Subject|2|||
124817619|NCT02030041|448958861|FG002|Overall Study|Withdrawal by Subject|1|||
124817620|NCT01197560|448958863|FG000|Overall Study|Adverse Event|6|||
124817621|NCT01197560|448958864|FG001|Overall Study|Adverse Event|8|||
124817622|NCT01197560|448958863|FG000|Overall Study|Death|3|||
124817623|NCT01197560|448958864|FG001|Overall Study|Death|5|||
124817624|NCT01197560|448958863|FG000|Overall Study|Withdrawal by Subject|1|||
124817625|NCT01197560|448958864|FG001|Overall Study|Withdrawal by Subject|1|||
124817626|NCT01197560|448958863|FG000|Overall Study|Disease progression|40|||
124817627|NCT01197560|448958864|FG001|Overall Study|Disease progression|35|||
124817628|NCT01197560|448958863|FG000|Overall Study|Miscellaneous|4|||
124817629|NCT01197560|448958864|FG001|Overall Study|Miscellaneous|3|||
124817630|NCT01197560|448958863|FG000|Overall Study|Missing|0|||
124817631|NCT01197560|448958864|FG001|Overall Study|Missing|1|||
124817632|NCT02006719|448958865|FG000|Overall Study|Withdrawal by Subject|10|||
124817633|NCT02006719|448958866|FG001|Overall Study|Withdrawal by Subject|2|||
124817634|NCT02006719|448958865|FG000|Overall Study|Lost to Follow-up|5|||
124817635|NCT02006719|448958866|FG001|Overall Study|Lost to Follow-up|1|||
124817636|NCT02006719|448958865|FG000|Overall Study|Protocol Violation|2|||
124817637|NCT02006719|448958866|FG001|Overall Study|Protocol Violation|0|||
124817638|NCT02006719|448958865|FG000|Overall Study|Adverse Event|1|||
124817639|NCT02006719|448958866|FG001|Overall Study|Adverse Event|1|||
124817640|NCT02006719|448958865|FG000|Overall Study|Other/Unknown|0|||
124817641|NCT02006719|448958866|FG001|Overall Study|Other/Unknown|1|||
124817642|NCT04659161|448958867|FG000|Overall Study|Adverse Event|10|||
124817643|NCT04659161|448958868|FG001|Overall Study|Adverse Event|6|||
124817644|NCT04659161|448958867|FG000|Overall Study|Withdrawal by Subject|13|||
124817645|NCT04659161|448958868|FG001|Overall Study|Withdrawal by Subject|12|||
124817646|NCT04659161|448958867|FG000|Overall Study|Other|9|||
124817647|NCT04659161|448958868|FG001|Overall Study|Other|8|||
124817648|NCT01929343|448958869|FG000|Overall Study|Physician Decision|0|||
124817649|NCT01929343|448958870|FG001|Overall Study|Physician Decision|2|||
124817650|NCT01929343|448958871|FG002|Overall Study|Physician Decision|0|||
124817651|NCT01929343|448958869|FG000|Overall Study|Withdrawal by Subject|1|||
124817652|NCT01929343|448958870|FG001|Overall Study|Withdrawal by Subject|0|||
124817653|NCT01929343|448958871|FG002|Overall Study|Withdrawal by Subject|0|||
124817654|NCT01737697|448958879|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817655|NCT01737697|448958880|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
124817656|NCT01737697|448958881|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817657|NCT01737697|448958882|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
124817658|NCT01737697|448958883|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
124817659|NCT01737697|448958884|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817660|NCT01737697|448958885|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817661|NCT01737697|448958886|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817662|NCT01737697|448958887|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817663|NCT01737697|448958888|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817664|NCT01737697|448958889|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817665|NCT01737697|448958890|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817666|NCT01737697|448958891|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817667|NCT01737697|448958892|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817668|NCT01737697|448958893|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817669|NCT01737697|448958879|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
124817670|NCT01737697|448958880|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
124817671|NCT01737697|448958881|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
124817672|NCT01737697|448958882|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817673|NCT01737697|448958883|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817674|NCT01737697|448958884|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817675|NCT01737697|448958885|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817676|NCT01737697|448958886|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817677|NCT01737697|448958887|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817678|NCT01737697|448958888|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817679|NCT01737697|448958889|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817680|NCT01737697|448958890|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817681|NCT01737697|448958891|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817682|NCT01737697|448958892|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817683|NCT01737697|448958893|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817684|NCT01737697|448958879|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817685|NCT01737697|448958880|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817686|NCT01737697|448958881|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817687|NCT01737697|448958882|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
124817688|NCT01737697|448958883|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817689|NCT01737697|448958884|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817690|NCT01737697|448958885|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817691|NCT01737697|448958886|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817692|NCT01737697|448958887|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817693|NCT01737697|448958888|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817694|NCT01737697|448958889|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817695|NCT01737697|448958890|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817696|NCT01737697|448958891|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817697|NCT01737697|448958892|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817698|NCT01737697|448958893|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817699|NCT01737697|448958879|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817700|NCT01737697|448958880|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
124817701|NCT01737697|448958881|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817702|NCT01737697|448958882|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817703|NCT01737697|448958883|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817704|NCT01737697|448958884|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817705|NCT01737697|448958885|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817706|NCT01737697|448958886|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817707|NCT01737697|448958887|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817708|NCT01737697|448958888|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817709|NCT01737697|448958889|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817710|NCT01737697|448958890|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817711|NCT01737697|448958891|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817712|NCT01737697|448958892|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817713|NCT01737697|448958893|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817714|NCT01737697|448958879|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817715|NCT01737697|448958880|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817716|NCT01737697|448958881|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817717|NCT01737697|448958882|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817718|NCT01737697|448958883|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
124817719|NCT01737697|448958884|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817720|NCT01737697|448958885|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817721|NCT01737697|448958886|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817722|NCT01737697|448958887|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817723|NCT01737697|448958888|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817724|NCT01737697|448958889|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817725|NCT01737697|448958890|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817726|NCT01737697|448958891|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817727|NCT01737697|448958892|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817728|NCT01737697|448958893|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817729|NCT01737697|448958879|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817730|NCT01737697|448958880|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
124817731|NCT01737697|448958881|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
124817732|NCT01737697|448958882|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
124817733|NCT01737697|448958883|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
124817734|NCT01737697|448958884|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817735|NCT01737697|448958885|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817736|NCT01737697|448958886|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817737|NCT01737697|448958887|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817738|NCT01737697|448958888|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817739|NCT01737697|448958889|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817740|NCT01737697|448958890|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817741|NCT01737697|448958891|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817742|NCT01737697|448958892|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817743|NCT01737697|448958893|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817744|NCT01737697|448958879|FG000|Subacute Phase|Adverse Event|0|||
124817745|NCT01737697|448958880|FG001|Subacute Phase|Adverse Event|0|||
124817746|NCT01737697|448958881|FG002|Subacute Phase|Adverse Event|0|||
124817747|NCT01737697|448958882|FG003|Subacute Phase|Adverse Event|0|||
124817748|NCT01737697|448958883|FG004|Subacute Phase|Adverse Event|0|||
124817749|NCT01737697|448958884|FG005|Subacute Phase|Adverse Event|1|||
124817750|NCT01737697|448958885|FG006|Subacute Phase|Adverse Event|1|||
124817751|NCT01737697|448958886|FG007|Subacute Phase|Adverse Event|1|||
124817752|NCT01737697|448958887|FG008|Subacute Phase|Adverse Event|1|||
124817753|NCT01737697|448958888|FG009|Subacute Phase|Adverse Event|1|||
124817754|NCT01737697|448958889|FG010|Subacute Phase|Adverse Event|4|||
124817755|NCT01737697|448958890|FG011|Subacute Phase|Adverse Event|1|||
124817756|NCT01737697|448958891|FG012|Subacute Phase|Adverse Event|1|||
124817757|NCT01737697|448958892|FG013|Subacute Phase|Adverse Event|0|||
124817758|NCT01737697|448958893|FG014|Subacute Phase|Adverse Event|0|||
124817759|NCT01737697|448958879|FG000|Subacute Phase|Withdrawal by Subject|0|||
124817760|NCT01737697|448958880|FG001|Subacute Phase|Withdrawal by Subject|0|||
124817761|NCT01737697|448958881|FG002|Subacute Phase|Withdrawal by Subject|0|||
124817762|NCT01737697|448958882|FG003|Subacute Phase|Withdrawal by Subject|0|||
124817763|NCT01737697|448958883|FG004|Subacute Phase|Withdrawal by Subject|0|||
124817764|NCT01737697|448958884|FG005|Subacute Phase|Withdrawal by Subject|1|||
124817765|NCT01737697|448958885|FG006|Subacute Phase|Withdrawal by Subject|0|||
124817766|NCT01737697|448958886|FG007|Subacute Phase|Withdrawal by Subject|2|||
124817767|NCT01737697|448958887|FG008|Subacute Phase|Withdrawal by Subject|0|||
124817768|NCT01737697|448958888|FG009|Subacute Phase|Withdrawal by Subject|1|||
124817769|NCT01737697|448958889|FG010|Subacute Phase|Withdrawal by Subject|0|||
124817770|NCT01737697|448958890|FG011|Subacute Phase|Withdrawal by Subject|1|||
124817771|NCT01737697|448958891|FG012|Subacute Phase|Withdrawal by Subject|1|||
124817772|NCT01737697|448958892|FG013|Subacute Phase|Withdrawal by Subject|1|||
124817773|NCT01737697|448958893|FG014|Subacute Phase|Withdrawal by Subject|0|||
124817774|NCT01737697|448958879|FG000|Subacute Phase|Lost to Follow-up|0|||
124817775|NCT01737697|448958880|FG001|Subacute Phase|Lost to Follow-up|0|||
124817776|NCT01737697|448958881|FG002|Subacute Phase|Lost to Follow-up|0|||
124817777|NCT01737697|448958882|FG003|Subacute Phase|Lost to Follow-up|0|||
124817778|NCT01737697|448958883|FG004|Subacute Phase|Lost to Follow-up|0|||
124817779|NCT01737697|448958884|FG005|Subacute Phase|Lost to Follow-up|0|||
124817780|NCT01737697|448958885|FG006|Subacute Phase|Lost to Follow-up|0|||
124817781|NCT01737697|448958886|FG007|Subacute Phase|Lost to Follow-up|0|||
124817782|NCT01737697|448958887|FG008|Subacute Phase|Lost to Follow-up|0|||
124817783|NCT01737697|448958888|FG009|Subacute Phase|Lost to Follow-up|0|||
124817784|NCT01737697|448958889|FG010|Subacute Phase|Lost to Follow-up|0|||
124817785|NCT01737697|448958890|FG011|Subacute Phase|Lost to Follow-up|0|||
124817786|NCT01737697|448958891|FG012|Subacute Phase|Lost to Follow-up|0|||
124817787|NCT01737697|448958892|FG013|Subacute Phase|Lost to Follow-up|0|||
124817788|NCT01737697|448958893|FG014|Subacute Phase|Lost to Follow-up|1|||
124817789|NCT01737697|448958879|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
124817790|NCT01737697|448958880|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
124817791|NCT01737697|448958881|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
124817792|NCT01737697|448958882|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
124817793|NCT01737697|448958883|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
124817794|NCT01737697|448958884|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
124817795|NCT01737697|448958885|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
124817796|NCT01737697|448958886|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
125303026|NCT02524158|450736659|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
125303027|NCT02524158|450736660|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
125303028|NCT02524158|450736659|FG000|12-weeks Assessment|Lost to Follow-up|18|||
124817797|NCT01737697|448958887|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
124817798|NCT01737697|448958888|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
124817799|NCT01737697|448958889|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
124817800|NCT01737697|448958890|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
124817801|NCT01737697|448958891|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
124817802|NCT01737697|448958892|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
124817803|NCT01737697|448958893|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
125303029|NCT02524158|450736660|FG001|12-weeks Assessment|Lost to Follow-up|12|||
124817804|NCT01737697|448958879|FG000|Subacute Phase|Protocol Violation|0|||
124817805|NCT01737697|448958880|FG001|Subacute Phase|Protocol Violation|0|||
124817806|NCT01737697|448958881|FG002|Subacute Phase|Protocol Violation|0|||
124817807|NCT01737697|448958882|FG003|Subacute Phase|Protocol Violation|0|||
124817808|NCT01737697|448958883|FG004|Subacute Phase|Protocol Violation|0|||
124817809|NCT01737697|448958884|FG005|Subacute Phase|Protocol Violation|1|||
124817810|NCT01737697|448958885|FG006|Subacute Phase|Protocol Violation|0|||
124817811|NCT01737697|448958886|FG007|Subacute Phase|Protocol Violation|0|||
124817812|NCT01737697|448958887|FG008|Subacute Phase|Protocol Violation|0|||
124817813|NCT01737697|448958888|FG009|Subacute Phase|Protocol Violation|0|||
124817814|NCT01737697|448958889|FG010|Subacute Phase|Protocol Violation|1|||
124817815|NCT01737697|448958890|FG011|Subacute Phase|Protocol Violation|0|||
124817816|NCT01737697|448958891|FG012|Subacute Phase|Protocol Violation|0|||
124817817|NCT01737697|448958892|FG013|Subacute Phase|Protocol Violation|0|||
124817818|NCT01737697|448958893|FG014|Subacute Phase|Protocol Violation|0|||
124817819|NCT01737697|448958879|FG000|Subacute Phase|Physician Decision|0|||
124817820|NCT01737697|448958880|FG001|Subacute Phase|Physician Decision|0|||
124817821|NCT01737697|448958881|FG002|Subacute Phase|Physician Decision|0|||
124817822|NCT01737697|448958882|FG003|Subacute Phase|Physician Decision|0|||
124817823|NCT01737697|448958883|FG004|Subacute Phase|Physician Decision|0|||
124817824|NCT01737697|448958884|FG005|Subacute Phase|Physician Decision|0|||
124817825|NCT01737697|448958885|FG006|Subacute Phase|Physician Decision|0|||
124817826|NCT01737697|448958886|FG007|Subacute Phase|Physician Decision|0|||
124817827|NCT01737697|448958887|FG008|Subacute Phase|Physician Decision|1|||
124817828|NCT01737697|448958888|FG009|Subacute Phase|Physician Decision|0|||
124817829|NCT01737697|448958889|FG010|Subacute Phase|Physician Decision|0|||
124817830|NCT01737697|448958890|FG011|Subacute Phase|Physician Decision|0|||
124817831|NCT01737697|448958891|FG012|Subacute Phase|Physician Decision|0|||
124817832|NCT01737697|448958892|FG013|Subacute Phase|Physician Decision|0|||
124817833|NCT01737697|448958893|FG014|Subacute Phase|Physician Decision|0|||
124817834|NCT01737697|448958879|FG000|Subacute Phase|Death|0|||
124817835|NCT01737697|448958880|FG001|Subacute Phase|Death|0|||
124817836|NCT01737697|448958881|FG002|Subacute Phase|Death|0|||
124817837|NCT01737697|448958882|FG003|Subacute Phase|Death|0|||
124817838|NCT01737697|448958883|FG004|Subacute Phase|Death|0|||
124817839|NCT01737697|448958884|FG005|Subacute Phase|Death|0|||
124817840|NCT01737697|448958885|FG006|Subacute Phase|Death|0|||
124817841|NCT01737697|448958886|FG007|Subacute Phase|Death|0|||
124817842|NCT01737697|448958887|FG008|Subacute Phase|Death|0|||
124817843|NCT01737697|448958888|FG009|Subacute Phase|Death|0|||
124817844|NCT01737697|448958889|FG010|Subacute Phase|Death|1|||
124817845|NCT01737697|448958890|FG011|Subacute Phase|Death|0|||
124817846|NCT01737697|448958891|FG012|Subacute Phase|Death|0|||
124817847|NCT01737697|448958892|FG013|Subacute Phase|Death|0|||
124817848|NCT01737697|448958893|FG014|Subacute Phase|Death|0|||
124817849|NCT03338998|448958895|FG000|Treatment Period|Withdrawal by Subject|1|||
124817850|NCT03338998|448958896|FG001|Treatment Period|Withdrawal by Subject|1|||
124817851|NCT03338998|448958895|FG000|Treatment Period|Adverse Event|0|||
124817852|NCT03338998|448958896|FG001|Treatment Period|Adverse Event|2|||
124817853|NCT03338998|448958895|FG000|Treatment Period|Protocol deviation|1|||
124817854|NCT03338998|448958896|FG001|Treatment Period|Protocol deviation|0|||
124817855|NCT03338998|448958895|FG000|Treatment Period|Physician Decision|2|||
124817856|NCT03338998|448958896|FG001|Treatment Period|Physician Decision|0|||
124817857|NCT03338998|448958895|FG000|Treatment Period|Subject failed swallow test|4|||
124817858|NCT03338998|448958896|FG001|Treatment Period|Subject failed swallow test|0|||
124817859|NCT03338998|448958895|FG000|Safety Follow-Up Period|Adverse Event|0|||
124817860|NCT03338998|448958896|FG001|Safety Follow-Up Period|Adverse Event|1|||
124817861|NCT03338998|448958895|FG000|Safety Follow-Up Period|Protocol deviation|1|||
124817862|NCT03338998|448958896|FG001|Safety Follow-Up Period|Protocol deviation|0|||
124817863|NCT03338998|448958895|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
124817864|NCT03338998|448958896|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
124817865|NCT03288129|448958897|FG000|Overall Study|Adverse Event|10|||
124817866|NCT03288129|448958897|FG000|Overall Study|Lost to Follow-up|3|||
124817867|NCT03288129|448958897|FG000|Overall Study|Withdrawal by Subject|3|||
124817868|NCT03288129|448958897|FG000|Overall Study|Withdrawal of consent/assent|1|||
124817869|NCT03288129|448958897|FG000|Overall Study|Other|5|||
124817870|NCT04404361|448958902|FG000|Overall Study|Death|12|||
124817871|NCT04404361|448958903|FG001|Overall Study|Death|12|||
124817872|NCT04404361|448958902|FG000|Overall Study|Withdrawal by Subject|13|||
124817873|NCT04404361|448958903|FG001|Overall Study|Withdrawal by Subject|5|||
124817874|NCT04404361|448958902|FG000|Overall Study|Lost to Follow-up|6|||
124817875|NCT04404361|448958903|FG001|Overall Study|Lost to Follow-up|3|||
124817876|NCT04404361|448958902|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
124817877|NCT04404361|448958903|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
124817878|NCT00558558|448958904|FG000|Overall Study|Unable to swallow|1|||
124817879|NCT00558558|448958904|FG000|Overall Study|Withdrawal by Subject|1|||
124817880|NCT00558558|448958904|FG000|Overall Study|Lack of Efficacy|4|||
124817881|NCT02144012|448958905|FG000|Overall Study|Adverse Event|1|||
124817882|NCT02144012|448958906|FG001|Overall Study|Adverse Event|0|||
124817883|NCT02144012|448958905|FG000|Overall Study|Death|1|||
124817884|NCT02144012|448958906|FG001|Overall Study|Death|0|||
124817885|NCT02144012|448958905|FG000|Overall Study|Withdrawal by Subject|11|||
124817886|NCT02144012|448958906|FG001|Overall Study|Withdrawal by Subject|3|||
124817887|NCT02144012|448958905|FG000|Overall Study|Study Terminated by Sponsor|18|||
124817888|NCT02144012|448958906|FG001|Overall Study|Study Terminated by Sponsor|12|||
124817889|NCT02144012|448958905|FG000|Overall Study|Other|3|||
124817890|NCT02144012|448958906|FG001|Overall Study|Other|0|||
124817891|NCT02915016|448958907|FG000|Overall Study|Lost to Follow-up|4|||
124817892|NCT02915016|448958908|FG001|Overall Study|Lost to Follow-up|2|||
124817893|NCT02915016|448958909|FG002|Overall Study|Lost to Follow-up|5|||
124817894|NCT02915016|448958910|FG003|Overall Study|Lost to Follow-up|3|||
124817895|NCT02915016|448958911|FG004|Overall Study|Lost to Follow-up|5|||
124817896|NCT02915016|448958912|FG005|Overall Study|Lost to Follow-up|2|||
124817897|NCT02915016|448958913|FG006|Overall Study|Lost to Follow-up|8|||
124817898|NCT02915016|448958914|FG007|Overall Study|Lost to Follow-up|2|||
124817899|NCT02915016|448958907|FG000|Overall Study|Physician Decision|0|||
124817900|NCT02915016|448958908|FG001|Overall Study|Physician Decision|0|||
124817901|NCT02915016|448958909|FG002|Overall Study|Physician Decision|1|||
124817902|NCT02915016|448958910|FG003|Overall Study|Physician Decision|0|||
124817903|NCT02915016|448958911|FG004|Overall Study|Physician Decision|0|||
124817904|NCT02915016|448958912|FG005|Overall Study|Physician Decision|1|||
124817905|NCT02915016|448958913|FG006|Overall Study|Physician Decision|2|||
124817906|NCT02915016|448958914|FG007|Overall Study|Physician Decision|0|||
124817907|NCT02915016|448958907|FG000|Overall Study|Withdrawal by Subject|2|||
124817908|NCT02915016|448958908|FG001|Overall Study|Withdrawal by Subject|0|||
124817909|NCT02915016|448958909|FG002|Overall Study|Withdrawal by Subject|1|||
124817910|NCT02915016|448958910|FG003|Overall Study|Withdrawal by Subject|0|||
124817911|NCT02915016|448958911|FG004|Overall Study|Withdrawal by Subject|1|||
124817912|NCT02915016|448958912|FG005|Overall Study|Withdrawal by Subject|3|||
124817913|NCT02915016|448958913|FG006|Overall Study|Withdrawal by Subject|1|||
124817914|NCT02915016|448958914|FG007|Overall Study|Withdrawal by Subject|1|||
124817915|NCT02915016|448958907|FG000|Overall Study|Elected not to continue|0|||
124817916|NCT02915016|448958908|FG001|Overall Study|Elected not to continue|0|||
124817917|NCT02915016|448958909|FG002|Overall Study|Elected not to continue|0|||
124817918|NCT02915016|448958910|FG003|Overall Study|Elected not to continue|1|||
124817919|NCT02915016|448958911|FG004|Overall Study|Elected not to continue|0|||
124817920|NCT02915016|448958912|FG005|Overall Study|Elected not to continue|0|||
124817921|NCT02915016|448958913|FG006|Overall Study|Elected not to continue|1|||
124817922|NCT02915016|448958914|FG007|Overall Study|Elected not to continue|0|||
124817923|NCT02915016|448958907|FG000|Overall Study|HIV infection|1|||
124817924|NCT02915016|448958908|FG001|Overall Study|HIV infection|1|||
124817925|NCT02915016|448958909|FG002|Overall Study|HIV infection|1|||
124817926|NCT02915016|448958910|FG003|Overall Study|HIV infection|0|||
124817927|NCT02915016|448958911|FG004|Overall Study|HIV infection|1|||
124817928|NCT02915016|448958912|FG005|Overall Study|HIV infection|0|||
124817929|NCT02915016|448958913|FG006|Overall Study|HIV infection|0|||
124817930|NCT02915016|448958914|FG007|Overall Study|HIV infection|0|||
124817931|NCT02915016|448958907|FG000|Overall Study|Participant unable to adhere|0|||
124817932|NCT02915016|448958908|FG001|Overall Study|Participant unable to adhere|0|||
124817933|NCT02915016|448958909|FG002|Overall Study|Participant unable to adhere|0|||
124817934|NCT02915016|448958910|FG003|Overall Study|Participant unable to adhere|0|||
124817935|NCT02915016|448958911|FG004|Overall Study|Participant unable to adhere|0|||
124817936|NCT02915016|448958912|FG005|Overall Study|Participant unable to adhere|0|||
124817937|NCT02915016|448958913|FG006|Overall Study|Participant unable to adhere|0|||
124817938|NCT02915016|448958914|FG007|Overall Study|Participant unable to adhere|1|||
124817939|NCT01408485|448960046|FG000|Overall Study|Withdrawal by Subject|21|||
124817940|NCT01315678|448960047|FG000|Overall Study|Withdrawal by Subject|7|||
124817941|NCT01315678|448960048|FG001|Overall Study|Withdrawal by Subject|3|||
124817942|NCT01315678|448960047|FG000|Overall Study|Adverse Event|3|||
124817943|NCT01315678|448960048|FG001|Overall Study|Adverse Event|1|||
124817944|NCT01315678|448960047|FG000|Overall Study|Lost to Follow-up|1|||
124817945|NCT01315678|448960048|FG001|Overall Study|Lost to Follow-up|0|||
124817946|NCT01315678|448960047|FG000|Overall Study|similar reason to those listed above|3|||
124817947|NCT01315678|448960048|FG001|Overall Study|similar reason to those listed above|2|||
124817948|NCT01532414|448960049|FG000|Overall Study|Lost to Follow-up|3|||
124817949|NCT01532414|448960050|FG001|Overall Study|Lost to Follow-up|0|||
124817950|NCT01532414|448960051|FG002|Overall Study|Lost to Follow-up|1|||
124817951|NCT01532414|448960049|FG000|Overall Study|Withdrawal by Subject|3|||
124817952|NCT01532414|448960050|FG001|Overall Study|Withdrawal by Subject|0|||
124817953|NCT01532414|448960051|FG002|Overall Study|Withdrawal by Subject|0|||
124817954|NCT01532414|448960049|FG000|Overall Study|No V6 semen sample|0|||
124817955|NCT01532414|448960050|FG001|Overall Study|No V6 semen sample|1|||
124817956|NCT01532414|448960051|FG002|Overall Study|No V6 semen sample|0|||
124817957|NCT01532414|448960049|FG000|Overall Study|Adverse Event|0|||
124817958|NCT01532414|448960050|FG001|Overall Study|Adverse Event|1|||
124817959|NCT01532414|448960051|FG002|Overall Study|Adverse Event|1|||
124817960|NCT01532414|448960049|FG000|Overall Study|Unable to complete 24 hour PK|0|||
124817961|NCT01532414|448960050|FG001|Overall Study|Unable to complete 24 hour PK|0|||
124817962|NCT01532414|448960051|FG002|Overall Study|Unable to complete 24 hour PK|1|||
124817963|NCT01532414|448960049|FG000|Overall Study|Withdrawn by sponsor|1|||
124817964|NCT01532414|448960050|FG001|Overall Study|Withdrawn by sponsor|0|||
124817965|NCT01532414|448960051|FG002|Overall Study|Withdrawn by sponsor|0|||
124817966|NCT00187486|448960052|FG000|Overall Study|Protocol Violation|1|||
124817967|NCT00578812|448960056|FG000|Overall Study|Not treated|6|||
124817968|NCT00578812|448960057|FG001|Overall Study|Not treated|7|||
124817969|NCT00617773|448960058|FG000|Overall Study|Physician Decision|1|||
124817970|NCT00617773|448960058|FG000|Overall Study|Lack of compliance with the protocol|1|||
124817971|NCT00617773|448960058|FG000|Overall Study|Withdrawal by Subject|1|||
124817972|NCT00617773|448960058|FG000|Overall Study|Death|1|||
124817973|NCT00617773|448960058|FG000|Overall Study|Progressive disease|19|||
124817974|NCT00617773|448960058|FG000|Overall Study|Protocol Violation|1|||
124817975|NCT03217175|448960061|FG000|Overall Study|Physician Decision|4|||
124817976|NCT03217175|448960062|FG001|Overall Study|Physician Decision|1|||
124817977|NCT05035550|448960074|FG000|Overall Study|Withdrawal by Subject|3|||
124817978|NCT05035550|448960075|FG001|Overall Study|Withdrawal by Subject|0|||
124817979|NCT01751867|448960076|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
124817980|NCT01751867|448960077|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
124817981|NCT01751867|448960076|FG000|Overall Study|Diease Progression|4|||
124817982|NCT01751867|448960077|FG001|Overall Study|Diease Progression|18|||
124817983|NCT01751867|448960076|FG000|Overall Study|Adverse Event|8|||
124817984|NCT01751867|448960077|FG001|Overall Study|Adverse Event|15|||
124817985|NCT01751867|448960076|FG000|Overall Study|Poor Compliance|0|||
124817986|NCT01751867|448960077|FG001|Overall Study|Poor Compliance|5|||
124817987|NCT01751867|448960076|FG000|Overall Study|Withdrawal by Subject|3|||
124817988|NCT01751867|448960077|FG001|Overall Study|Withdrawal by Subject|1|||
124817989|NCT01751867|448960076|FG000|Overall Study|Physician Decision|4|||
124817990|NCT01751867|448960077|FG001|Overall Study|Physician Decision|7|||
124817991|NCT01751867|448960076|FG000|Overall Study|Protocol Violation|0|||
124817992|NCT01751867|448960077|FG001|Overall Study|Protocol Violation|2|||
124817993|NCT01751867|448960076|FG000|Overall Study|Death|0|||
124817994|NCT01751867|448960077|FG001|Overall Study|Death|5|||
124817995|NCT01751867|448960076|FG000|Overall Study|Other|11|||
124817996|NCT01751867|448960077|FG001|Overall Study|Other|37|||
124817997|NCT01751867|448960076|FG000|Overall Study|Randomized but not treated.|2|||
124817998|NCT01751867|448960077|FG001|Overall Study|Randomized but not treated.|1|||
124817999|NCT01806545|448960078|FG000|Overall Study|Adverse Event|2|||
124818000|NCT01806545|448960079|FG001|Overall Study|Adverse Event|3|||
124818001|NCT01806545|448960078|FG000|Overall Study|Lost to Follow-up|1|||
124818002|NCT01806545|448960079|FG001|Overall Study|Lost to Follow-up|0|||
124818003|NCT01806545|448960078|FG000|Overall Study|Withdrawal by Subject|3|||
124818004|NCT01806545|448960079|FG001|Overall Study|Withdrawal by Subject|2|||
124818005|NCT01396148|448960080|FG000|Overall Study|Patient Decision|1|||
124818006|NCT00884312|448960083|FG000|Overall Study|Non-fatal Progressive Disease|0|||
124818007|NCT00884312|448960084|FG001|Overall Study|Non-fatal Progressive Disease|8|||
124818008|NCT00884312|448960083|FG000|Overall Study|Fatal Progressive Disease|0|||
124818009|NCT00884312|448960084|FG001|Overall Study|Fatal Progressive Disease|1|||
124818010|NCT00884312|448960083|FG000|Overall Study|Non-fatal Adverse Event|1|||
124818011|NCT00884312|448960084|FG001|Overall Study|Non-fatal Adverse Event|0|||
124818012|NCT00884312|448960083|FG000|Overall Study|Fatal Adverse Event|1|||
124818013|NCT00884312|448960084|FG001|Overall Study|Fatal Adverse Event|4|||
124818014|NCT00884312|448960083|FG000|Overall Study|Withdrawal by Subject|0|||
124818015|NCT00884312|448960084|FG001|Overall Study|Withdrawal by Subject|6|||
124818016|NCT00884312|448960083|FG000|Overall Study|Physician Decision|0|||
124818017|NCT00884312|448960084|FG001|Overall Study|Physician Decision|1|||
124818018|NCT00884312|448960083|FG000|Overall Study|Other|0|||
124818019|NCT00884312|448960084|FG001|Overall Study|Other|4|||
124818020|NCT00884312|448960083|FG000|Overall Study|Did Not Receive Study Drug|0|||
124818021|NCT00884312|448960084|FG001|Overall Study|Did Not Receive Study Drug|1|||
124818022|NCT00224042|448960085|FG000|Overall Study|Adverse Event|2|||
124818023|NCT00224042|448960086|FG001|Overall Study|Adverse Event|1|||
124818024|NCT00224042|448960085|FG000|Overall Study|Protocol Violation|0|||
124818025|NCT00224042|448960086|FG001|Overall Study|Protocol Violation|1|||
124818026|NCT00224042|448960085|FG000|Overall Study|Physician Decision|0|||
124818027|NCT00224042|448960086|FG001|Overall Study|Physician Decision|1|||
124818028|NCT00224042|448960085|FG000|Overall Study|Did not meet lab incusion criteria|2|||
124818029|NCT00224042|448960086|FG001|Overall Study|Did not meet lab incusion criteria|3|||
124818030|NCT00224042|448960085|FG000|Overall Study|Other|2|||
124818031|NCT00224042|448960086|FG001|Overall Study|Other|0|||
124818032|NCT03052725|448960087|FG000|Overall Study|Adverse Event|2|||
124818033|NCT03052725|448960088|FG001|Overall Study|Adverse Event|0|||
124818034|NCT03052725|448960087|FG000|Overall Study|Withdrawal by Subject|3|||
124818035|NCT03052725|448960088|FG001|Overall Study|Withdrawal by Subject|4|||
124818036|NCT03052725|448960087|FG000|Overall Study|Pregnancy|0|||
124818037|NCT03052725|448960088|FG001|Overall Study|Pregnancy|1|||
124818038|NCT03052725|448960087|FG000|Overall Study|Site closure|0|||
124818039|NCT03052725|448960088|FG001|Overall Study|Site closure|1|||
124818040|NCT03052725|448960087|FG000|Overall Study|Study terminated by sponsor|143|||
124818041|NCT03052725|448960088|FG001|Overall Study|Study terminated by sponsor|144|||
124818042|NCT02548650|448960095|FG000|Triple Therapy|Adverse Event|1|||
124818043|NCT02548650|448960096|FG001|Triple Therapy|Adverse Event|0|||
124818044|NCT02548650|448960095|FG000|Triple Therapy|Withdrawal by Subject|0|||
124818045|NCT02548650|448960096|FG001|Triple Therapy|Withdrawal by Subject|4|||
124818046|NCT02548650|448960095|FG000|Double Therapy|Adverse Event|1|||
124818047|NCT02548650|448960096|FG001|Double Therapy|Adverse Event|1|||
124818048|NCT02548650|448960095|FG000|Double Therapy|Withdrawal by Subject|0|||
124818049|NCT02548650|448960096|FG001|Double Therapy|Withdrawal by Subject|1|||
124818050|NCT01539538|448960097|FG000|Overall Study|Adverse Event|13|||
124818051|NCT01539538|448960098|FG001|Overall Study|Adverse Event|18|||
124818052|NCT01539538|448960097|FG000|Overall Study|Lack of Efficacy|13|||
124818053|NCT01539538|448960098|FG001|Overall Study|Lack of Efficacy|16|||
124818054|NCT01539538|448960097|FG000|Overall Study|Withdrawal by Subject|2|||
124818055|NCT01539538|448960098|FG001|Overall Study|Withdrawal by Subject|3|||
124818056|NCT01539538|448960097|FG000|Overall Study|PCA no longer required or PCA problem|3|||
124818057|NCT01539538|448960098|FG001|Overall Study|PCA no longer required or PCA problem|7|||
124818058|NCT01909674|448960099|FG000|Overall Study|Withdrawal by Subject|5|||
125303030|NCT02524158|450736659|FG000|6-month Assessment|Withdrawal by Subject|1|||
125303031|NCT02524158|450736660|FG001|6-month Assessment|Withdrawal by Subject|1|||
124818059|NCT01909674|448960100|FG001|Overall Study|Withdrawal by Subject|2|||
125303032|NCT02524158|450736659|FG000|6-month Assessment|Lost to Follow-up|21|||
125303033|NCT02524158|450736660|FG001|6-month Assessment|Lost to Follow-up|20|||
125303034|NCT03100058|450736661|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
125303035|NCT03100058|450736662|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
125303036|NCT03100058|450736663|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
124818060|NCT00847379|448960101|FG000|Overall Study|Study terminated by Sponsor|59|||
124818061|NCT00847379|448960102|FG001|Overall Study|Study terminated by Sponsor|57|||
124818062|NCT00847379|448960103|FG002|Overall Study|Study terminated by Sponsor|57|||
124818063|NCT02969369|448960104|FG000|Study|Adverse Event|1|||
124818064|NCT02969369|448960105|FG001|Study|Adverse Event|6|||
124818065|NCT02969369|448960104|FG000|Study|Lack of Efficacy|0|||
124818066|NCT02969369|448960105|FG001|Study|Lack of Efficacy|1|||
124818067|NCT02969369|448960104|FG000|Study|Lost to Follow-up|0|||
125303037|NCT03100058|450736664|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
125303038|NCT03100058|450736665|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
124818068|NCT02969369|448960105|FG001|Study|Lost to Follow-up|1|||
124818069|NCT02969369|448960104|FG000|Study|Withdrawal by Subject|3|||
124818070|NCT02969369|448960105|FG001|Study|Withdrawal by Subject|5|||
124818071|NCT02969369|448960104|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
124818072|NCT02969369|448960105|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
124818073|NCT02969369|448960104|FG000|Double-blind Period|Adverse Event|1|||
124818074|NCT02969369|448960105|FG001|Double-blind Period|Adverse Event|5|||
124818075|NCT02969369|448960104|FG000|Double-blind Period|Lost to Follow-up|0|||
124818076|NCT02969369|448960105|FG001|Double-blind Period|Lost to Follow-up|1|||
124818077|NCT02969369|448960104|FG000|Double-blind Period|Withdrawal by Subject|2|||
124818078|NCT02969369|448960105|FG001|Double-blind Period|Withdrawal by Subject|3|||
124818079|NCT02969369|448960104|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
124818080|NCT02969369|448960105|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
124818081|NCT02969369|448960104|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
124818082|NCT02969369|448960105|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
124818083|NCT02969369|448960104|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
124818084|NCT02969369|448960105|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
124818085|NCT02969369|448960104|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
124818086|NCT02969369|448960105|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
124818087|NCT00521014|448960106|FG000|Overall Study|Inevaluable, not treated|1|||
124818088|NCT02794883|448960107|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
124818089|NCT02794883|448960108|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
124818090|NCT02794883|448960109|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
124818091|NCT02794883|448960107|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
124818092|NCT02794883|448960108|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
124818093|NCT02794883|448960109|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
124818094|NCT02794883|448960107|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
124818095|NCT02794883|448960108|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
124818096|NCT02794883|448960109|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
124818097|NCT02794883|448960107|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
124818098|NCT02794883|448960108|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
124818099|NCT02794883|448960109|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
124818100|NCT02794883|448960107|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
124818101|NCT02794883|448960108|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
124818102|NCT02794883|448960109|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
124818103|NCT02794883|448960107|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
124818104|NCT02794883|448960108|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
124818105|NCT02794883|448960109|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
124818106|NCT02794883|448960107|FG000|Follow-up Period (up to 2 Years)|Death|12|||
124818107|NCT02794883|448960108|FG001|Follow-up Period (up to 2 Years)|Death|10|||
124818108|NCT02794883|448960109|FG002|Follow-up Period (up to 2 Years)|Death|10|||
124818109|NCT05201703|448960114|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
124818110|NCT05201703|448960115|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
124818111|NCT05201703|448960114|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
124818112|NCT05201703|448960115|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
124818113|NCT00393029|448960116|FG000|Overall Study|Not treated|0|||
124818114|NCT00393029|448960117|FG001|Overall Study|Not treated|1|||
124818115|NCT03715530|448960118|FG000|Overall Study|Lost to Follow-up|3|||
124818116|NCT03715530|448960119|FG001|Overall Study|Lost to Follow-up|1|||
124818117|NCT03715530|448960120|FG002|Overall Study|Lost to Follow-up|2|||
124818118|NCT00211510|448960124|FG000|Overall Study|Physician Decision|3|||
124818119|NCT00211510|448960125|FG001|Overall Study|Physician Decision|1|||
124818120|NCT00211510|448960124|FG000|Overall Study|Withdrawal by Subject|3|||
124818121|NCT00211510|448960125|FG001|Overall Study|Withdrawal by Subject|1|||
124818122|NCT03648983|448960129|FG000|Overall Study|Study was terminated due to PI departure|95|||
124818123|NCT01269463|448960130|FG000|First Intervention|Withdrawal by Subject|1|||
124818124|NCT01269463|448960131|FG001|First Intervention|Withdrawal by Subject|0|||
124818125|NCT01269463|448960130|FG000|First Intervention|Adverse Event|1|||
124818126|NCT01269463|448960131|FG001|First Intervention|Adverse Event|0|||
124818127|NCT01269463|448960130|FG000|First Intervention|Lack of Efficacy|0|||
124818128|NCT01269463|448960131|FG001|First Intervention|Lack of Efficacy|1|||
124818129|NCT01269463|448960130|FG000|First Intervention|Physician Decision|0|||
124818130|NCT01269463|448960131|FG001|First Intervention|Physician Decision|1|||
124818131|NCT02862171|448960134|FG000|Overall Study|Death|1|||
124818132|NCT02862171|448960134|FG000|Overall Study|Lost to Follow-up|13|||
124818133|NCT02862171|448960134|FG000|Overall Study|Withdrawal by Subject|57|||
124818134|NCT02862171|448960134|FG000|Overall Study|Non-compliance|4|||
124818135|NCT02862171|448960134|FG000|Overall Study|HIV-1 seroconversion|18|||
124818136|NCT02549937|448960136|FG000|Overall Study|Death|0|||
124818137|NCT02549937|448960137|FG001|Overall Study|Death|1|||
124818138|NCT02549937|448960138|FG002|Overall Study|Death|0|||
124818139|NCT02549937|448960139|FG003|Overall Study|Death|1|||
124818140|NCT02549937|448960140|FG004|Overall Study|Death|0|||
124818141|NCT02549937|448960141|FG005|Overall Study|Death|8|||
124818142|NCT02549937|448960142|FG006|Overall Study|Death|0|||
124818143|NCT02549937|448960143|FG007|Overall Study|Death|0|||
124818144|NCT02549937|448960144|FG008|Overall Study|Death|19|||
124818145|NCT02549937|448960136|FG000|Overall Study|No follow up required|3|||
124818146|NCT02549937|448960137|FG001|Overall Study|No follow up required|6|||
124818147|NCT02549937|448960138|FG002|Overall Study|No follow up required|3|||
124818148|NCT02549937|448960139|FG003|Overall Study|No follow up required|8|||
124818149|NCT02549937|448960140|FG004|Overall Study|No follow up required|12|||
124818150|NCT02549937|448960141|FG005|Overall Study|No follow up required|21|||
124818151|NCT02549937|448960142|FG006|Overall Study|No follow up required|9|||
124818152|NCT02549937|448960143|FG007|Overall Study|No follow up required|11|||
124818153|NCT02549937|448960144|FG008|Overall Study|No follow up required|0|||
124818154|NCT02549937|448960136|FG000|Overall Study|Other|0|||
124818155|NCT02549937|448960137|FG001|Overall Study|Other|0|||
124818156|NCT02549937|448960138|FG002|Overall Study|Other|0|||
124818157|NCT02549937|448960139|FG003|Overall Study|Other|0|||
124818158|NCT02549937|448960140|FG004|Overall Study|Other|1|||
124818159|NCT02549937|448960141|FG005|Overall Study|Other|0|||
124818160|NCT02549937|448960142|FG006|Overall Study|Other|3|||
124818161|NCT02549937|448960143|FG007|Overall Study|Other|2|||
124818162|NCT02549937|448960144|FG008|Overall Study|Other|3|||
124818163|NCT02549937|448960136|FG000|Overall Study|Lost to Follow-up|0|||
124818164|NCT02549937|448960137|FG001|Overall Study|Lost to Follow-up|0|||
124818165|NCT02549937|448960138|FG002|Overall Study|Lost to Follow-up|0|||
124818166|NCT02549937|448960139|FG003|Overall Study|Lost to Follow-up|0|||
124818167|NCT02549937|448960140|FG004|Overall Study|Lost to Follow-up|0|||
124818168|NCT02549937|448960141|FG005|Overall Study|Lost to Follow-up|0|||
124818169|NCT02549937|448960142|FG006|Overall Study|Lost to Follow-up|0|||
124818170|NCT02549937|448960143|FG007|Overall Study|Lost to Follow-up|0|||
124818171|NCT02549937|448960144|FG008|Overall Study|Lost to Follow-up|3|||
124818172|NCT02549937|448960136|FG000|Overall Study|Withdrawal by Subject|0|||
124818173|NCT02549937|448960137|FG001|Overall Study|Withdrawal by Subject|0|||
124818174|NCT02549937|448960138|FG002|Overall Study|Withdrawal by Subject|0|||
124818175|NCT02549937|448960139|FG003|Overall Study|Withdrawal by Subject|0|||
124818176|NCT02549937|448960140|FG004|Overall Study|Withdrawal by Subject|0|||
124818177|NCT02549937|448960141|FG005|Overall Study|Withdrawal by Subject|1|||
124818178|NCT02549937|448960142|FG006|Overall Study|Withdrawal by Subject|4|||
124818179|NCT02549937|448960143|FG007|Overall Study|Withdrawal by Subject|3|||
124818180|NCT02549937|448960144|FG008|Overall Study|Withdrawal by Subject|2|||
124818181|NCT02549937|448960136|FG000|Overall Study|Sponsor Decision|0|||
124818182|NCT02549937|448960137|FG001|Overall Study|Sponsor Decision|0|||
124818183|NCT02549937|448960138|FG002|Overall Study|Sponsor Decision|0|||
124818184|NCT02549937|448960139|FG003|Overall Study|Sponsor Decision|0|||
124818185|NCT02549937|448960140|FG004|Overall Study|Sponsor Decision|0|||
124818186|NCT02549937|448960141|FG005|Overall Study|Sponsor Decision|0|||
124818187|NCT02549937|448960142|FG006|Overall Study|Sponsor Decision|0|||
124818188|NCT02549937|448960143|FG007|Overall Study|Sponsor Decision|0|||
124818189|NCT02549937|448960144|FG008|Overall Study|Sponsor Decision|6|||
124818190|NCT00662012|448960145|FG000|Overall Study|Lost to Follow-up|85|||
124818191|NCT00662012|448960145|FG000|Overall Study|Death|1|||
124818192|NCT00662012|448960145|FG000|Overall Study|Withdrawal by Subject|1|||
124818193|NCT01949506|448960150|FG000|Overall Study|Physician Decision|1|||
124818194|NCT05475236|448960152|FG000|Overall Study|Withdrawal by Subject|0|||
124818195|NCT05475236|448960153|FG001|Overall Study|Withdrawal by Subject|1|||
124818196|NCT05425745|448960155|FG000|Overall Study|Withdrawal of Consent|3|||
124818197|NCT05425745|448960156|FG001|Overall Study|Withdrawal of Consent|3|||
124818198|NCT05425745|448960155|FG000|Overall Study|Death|2|||
124818199|NCT05425745|448960156|FG001|Overall Study|Death|3|||
124818200|NCT05425745|448960155|FG000|Overall Study|Lost to Follow-up|1|||
124818201|NCT05425745|448960156|FG001|Overall Study|Lost to Follow-up|2|||
124818202|NCT05425745|448960155|FG000|Overall Study|Adverse Event|0|||
124818203|NCT05425745|448960156|FG001|Overall Study|Adverse Event|1|||
124818204|NCT05425745|448960155|FG000|Overall Study|Did not return for end of study visit|0|||
124818205|NCT05425745|448960156|FG001|Overall Study|Did not return for end of study visit|1|||
124818206|NCT05425745|448960155|FG000|Overall Study|End of study visit completed by phone|1|||
124818207|NCT05425745|448960156|FG001|Overall Study|End of study visit completed by phone|0|||
124818208|NCT05425745|448960155|FG000|Overall Study|Subject decision|1|||
124818209|NCT05425745|448960156|FG001|Overall Study|Subject decision|0|||
124818210|NCT05255068|448961908|FG000|Overall Study|Lost to Follow-up|0|||
124818211|NCT05255068|448961909|FG001|Overall Study|Lost to Follow-up|1|||
124818212|NCT00907777|448961912|FG000|Overall Study|Withdrawal by Subject|0|||
124818213|NCT00907777|448961913|FG001|Overall Study|Withdrawal by Subject|1|||
124818214|NCT02674529|448961914|FG000|Overall Study|Lost to Follow-up|1|||
124818215|NCT02674529|448961915|FG001|Overall Study|Lost to Follow-up|2|||
124818216|NCT02674529|448961914|FG000|Overall Study|Withdrawal by Subject|2|||
124818217|NCT02674529|448961915|FG001|Overall Study|Withdrawal by Subject|1|||
124818218|NCT02674529|448961914|FG000|Overall Study|Physician Decision|0|||
124818219|NCT02674529|448961915|FG001|Overall Study|Physician Decision|1|||
124818220|NCT02674529|448961914|FG000|Overall Study|Protocol Violation|0|||
124818221|NCT02674529|448961915|FG001|Overall Study|Protocol Violation|1|||
124818222|NCT02891850|448961916|FG000|Overall Study|Adverse Event|3|||
124818223|NCT02891850|448961917|FG001|Overall Study|Adverse Event|0|||
124818224|NCT02891850|448961916|FG000|Overall Study|Death|0|||
124818225|NCT02891850|448961917|FG001|Overall Study|Death|4|||
124818226|NCT02891850|448961916|FG000|Overall Study|Physician Decision|1|||
124818227|NCT02891850|448961917|FG001|Overall Study|Physician Decision|0|||
124818228|NCT02891850|448961916|FG000|Overall Study|Pregnancy|1|||
124818229|NCT02891850|448961917|FG001|Overall Study|Pregnancy|0|||
124818230|NCT02891850|448961916|FG000|Overall Study|Withdrawal by Subject|2|||
124818231|NCT02891850|448961917|FG001|Overall Study|Withdrawal by Subject|3|||
124818232|NCT00331682|448961920|FG000|Overall Study|Adverse Event|1|||
124818233|NCT00573469|448961921|FG000|Overall Study|Adverse Event|1|||
124818234|NCT00573469|448961922|FG001|Overall Study|Adverse Event|1|||
124818235|NCT00573469|448961923|FG002|Overall Study|Adverse Event|1|||
124818236|NCT00573469|448961921|FG000|Overall Study|Withdrawal by Subject|0|||
124818237|NCT00573469|448961922|FG001|Overall Study|Withdrawal by Subject|2|||
124818238|NCT00573469|448961923|FG002|Overall Study|Withdrawal by Subject|0|||
124818239|NCT00573469|448961921|FG000|Overall Study|Other|5|||
124818240|NCT00573469|448961922|FG001|Overall Study|Other|1|||
124818241|NCT00573469|448961923|FG002|Overall Study|Other|3|||
124818242|NCT03761277|448961924|FG000|Enrollment to Implant|Screen Failure|17|||
124818243|NCT03761277|448961924|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
124818244|NCT03761277|448961924|FG000|Enrollment to Implant|Physician Decision|2|||
124818245|NCT03761277|448961924|FG000|Enrollment to Implant|Site Closure|3|||
124818246|NCT03761277|448961924|FG000|Enrollment to Implant|Sponsor Request|2|||
124818247|NCT03761277|448961924|FG000|Post-Implant to 6 Months|Adverse Event|2|||
124818248|NCT03761277|448961924|FG000|Post-Implant to 6 Months|Death|1|||
124818249|NCT03761277|448961924|FG000|Post-Implant to 6 Months|Site Closure|2|||
124818250|NCT03761277|448961924|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
124818251|NCT03761277|448961924|FG000|6 Months to 12 Months|Physician Decision|2|||
124818252|NCT03761277|448961924|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
124818253|NCT00004978|448961925|FG000|Overall Study|Death|107|||
124818254|NCT00004978|448961926|FG001|Overall Study|Death|116|||
124818255|NCT00004978|448961925|FG000|Overall Study|Lost to Follow-up|101|||
124818256|NCT00004978|448961926|FG001|Overall Study|Lost to Follow-up|108|||
124818257|NCT00004978|448961925|FG000|Overall Study|Withdrawal by Subject|17|||
124818258|NCT00004978|448961926|FG001|Overall Study|Withdrawal by Subject|26|||
124818259|NCT00004978|448961925|FG000|Overall Study|site closure - not in analysis cohort|19|||
124818260|NCT00004978|448961926|FG001|Overall Study|site closure - not in analysis cohort|20|||
124818261|NCT01508650|448961927|FG000|Overall Study|Lost to Follow-up|0|||
124818262|NCT01508650|448961928|FG001|Overall Study|Lost to Follow-up|3|||
124818263|NCT02064894|448961929|FG000|Overall Study|Withdrawal by Subject|43|||
124818264|NCT02064894|448961930|FG001|Overall Study|Withdrawal by Subject|102|||
124818265|NCT02064894|448961931|FG002|Overall Study|Withdrawal by Subject|115|||
124818266|NCT02864498|448961932|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
124818267|NCT02864498|448961933|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
124818268|NCT02864498|448961934|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
124818269|NCT02864498|448961932|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
124818270|NCT02864498|448961933|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
124818271|NCT02864498|448961934|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
124818272|NCT02864498|448961932|FG000|Overall Study|Investigator Discretion|0|||
124818273|NCT02864498|448961933|FG001|Overall Study|Investigator Discretion|2|||
124818274|NCT02864498|448961934|FG002|Overall Study|Investigator Discretion|1|||
124818275|NCT02864498|448961932|FG000|Overall Study|Lost to Follow-up|8|||
124818276|NCT02864498|448961933|FG001|Overall Study|Lost to Follow-up|6|||
124818277|NCT02864498|448961934|FG002|Overall Study|Lost to Follow-up|3|||
124818278|NCT02864498|448961932|FG000|Overall Study|Lack of Efficacy|5|||
124818279|NCT02864498|448961933|FG001|Overall Study|Lack of Efficacy|3|||
124818280|NCT02864498|448961934|FG002|Overall Study|Lack of Efficacy|3|||
124818281|NCT02864498|448961932|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
124818282|NCT02864498|448961933|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
124818283|NCT02864498|448961934|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
124818284|NCT02864498|448961932|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
124818285|NCT02864498|448961933|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
124818286|NCT02864498|448961934|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
124818287|NCT02864498|448961932|FG000|Overall Study|Subject moved out of the country.|0|||
124818288|NCT02864498|448961933|FG001|Overall Study|Subject moved out of the country.|0|||
124818289|NCT02864498|448961934|FG002|Overall Study|Subject moved out of the country.|1|||
124818290|NCT01812174|448961935|FG000|Overall Study|Death|1|||
124818291|NCT01812174|448961936|FG001|Overall Study|Death|0|||
124818292|NCT01812174|448961935|FG000|Overall Study|Protocol Violation|2|||
124818293|NCT01812174|448961936|FG001|Overall Study|Protocol Violation|0|||
124818294|NCT00851747|448961940|FG000|Overall Study|Physician Decision|6|||
124818295|NCT00851747|448961941|FG001|Overall Study|Physician Decision|6|||
124818296|NCT00851747|448961942|FG002|Overall Study|Physician Decision|6|||
124818297|NCT01051323|448961943|FG000|Overall Study|Discontinuation of treatment|103|||
124818298|NCT01051323|448961943|FG000|Overall Study|Transplantation|28|||
124818299|NCT01051323|448961943|FG000|Overall Study|Dialysis dependency|22|||
124818300|NCT01051323|448961943|FG000|Overall Study|Withdrawal by Subject|13|||
124818301|NCT01051323|448961943|FG000|Overall Study|Lost to Follow-up|31|||
124818302|NCT01051323|448961943|FG000|Overall Study|Death|129|||
124818303|NCT01051323|448961943|FG000|Overall Study|Hospitalization|28|||
124818304|NCT01051323|448961943|FG000|Overall Study|Other|148|||
124818305|NCT01051323|448961943|FG000|Overall Study|Missing|37|||
124818306|NCT01537393|448961944|FG000|Overall Study|Exclude prior to study|32|||
124818307|NCT01537393|448961945|FG001|Overall Study|Exclude prior to study|44|||
124818308|NCT01537393|448961944|FG000|Overall Study|Death|20|||
124818309|NCT01537393|448961945|FG001|Overall Study|Death|32|||
124818310|NCT01537393|448961944|FG000|Overall Study|Withdrawal by Subject|18|||
124818311|NCT01537393|448961945|FG001|Overall Study|Withdrawal by Subject|17|||
124818312|NCT01537393|448961944|FG000|Overall Study|Lost to Follow-up|53|||
124818313|NCT01537393|448961945|FG001|Overall Study|Lost to Follow-up|48|||
124818314|NCT01537393|448961944|FG000|Overall Study|Failure - Regrafted|28|||
124818315|NCT01537393|448961945|FG001|Overall Study|Failure - Regrafted|43|||
124818316|NCT01537393|448961944|FG000|Overall Study|Failure - Not regrafted|2|||
124818317|NCT01537393|448961945|FG001|Overall Study|Failure - Not regrafted|6|||
124818318|NCT01537393|448961944|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
124818319|NCT01537393|448961945|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
124818320|NCT01233258|448961952|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
124818321|NCT01233258|448961953|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
124818322|NCT01233258|448961954|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
124818323|NCT01233258|448961955|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
124818324|NCT01233258|448961956|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
124818325|NCT01233258|448961957|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
124818326|NCT01233258|448961952|FG000|First Intervention (6 Months)|Protocol Violation|0|||
124818327|NCT01233258|448961953|FG001|First Intervention (6 Months)|Protocol Violation|0|||
124818328|NCT01233258|448961954|FG002|First Intervention (6 Months)|Protocol Violation|1|||
124818329|NCT01233258|448961955|FG003|First Intervention (6 Months)|Protocol Violation|0|||
124818330|NCT01233258|448961956|FG004|First Intervention (6 Months)|Protocol Violation|0|||
124818331|NCT01233258|448961957|FG005|First Intervention (6 Months)|Protocol Violation|0|||
124818332|NCT01233258|448961952|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
124818333|NCT01233258|448961953|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
124818334|NCT01233258|448961954|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
124818335|NCT01233258|448961955|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
124818336|NCT01233258|448961956|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
124818337|NCT01233258|448961957|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
124818338|NCT01637272|448961958|FG000|Overall Study|Adverse Event|6|||
124818339|NCT01637272|448961958|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124818340|NCT01637272|448961958|FG000|Overall Study|Withdrawal by Subject|3|||
124818341|NCT01637272|448961958|FG000|Overall Study|Lost to Follow-up|2|||
124818342|NCT01637272|448961958|FG000|Overall Study|completed core, did not enter ext. phase|4|||
124818343|NCT01637272|448961958|FG000|Overall Study|Administrative problems|1|||
124818344|NCT01637272|448961958|FG000|Overall Study|Protocol Violation|2|||
124818345|NCT01496612|448961959|FG000|1st Intervention|Adverse Event|1|||
124818346|NCT01496612|448961960|FG001|1st Intervention|Adverse Event|0|||
124818347|NCT01496612|448961959|FG000|1st Intervention|Withdrawal by Subject|1|||
124818348|NCT01496612|448961960|FG001|1st Intervention|Withdrawal by Subject|0|||
124818349|NCT03708328|448961971|FG000|Overall Study|Death|3|||
124818350|NCT03708328|448961972|FG001|Overall Study|Death|3|||
124818351|NCT03708328|448961973|FG002|Overall Study|Death|4|||
124818352|NCT03708328|448961974|FG003|Overall Study|Death|2|||
124818353|NCT03708328|448961975|FG004|Overall Study|Death|2|||
124818354|NCT03708328|448961976|FG005|Overall Study|Death|13|||
124818355|NCT03708328|448961977|FG006|Overall Study|Death|26|||
124818356|NCT03708328|448961978|FG007|Overall Study|Death|18|||
124818357|NCT03708328|448961979|FG008|Overall Study|Death|13|||
124818358|NCT03708328|448961980|FG009|Overall Study|Death|8|||
124818359|NCT03708328|448961971|FG000|Overall Study|Lost to Follow-up|0|||
124818360|NCT03708328|448961972|FG001|Overall Study|Lost to Follow-up|1|||
124818361|NCT03708328|448961973|FG002|Overall Study|Lost to Follow-up|0|||
124818362|NCT03708328|448961974|FG003|Overall Study|Lost to Follow-up|1|||
124818363|NCT03708328|448961975|FG004|Overall Study|Lost to Follow-up|0|||
124818364|NCT03708328|448961976|FG005|Overall Study|Lost to Follow-up|3|||
124818365|NCT03708328|448961977|FG006|Overall Study|Lost to Follow-up|3|||
124818366|NCT03708328|448961978|FG007|Overall Study|Lost to Follow-up|0|||
124818367|NCT03708328|448961979|FG008|Overall Study|Lost to Follow-up|0|||
124818368|NCT03708328|448961980|FG009|Overall Study|Lost to Follow-up|1|||
124818369|NCT03708328|448961971|FG000|Overall Study|Physician Decision|0|||
124818370|NCT03708328|448961972|FG001|Overall Study|Physician Decision|0|||
124818371|NCT03708328|448961973|FG002|Overall Study|Physician Decision|0|||
124818372|NCT03708328|448961974|FG003|Overall Study|Physician Decision|0|||
124818373|NCT03708328|448961975|FG004|Overall Study|Physician Decision|0|||
124818374|NCT03708328|448961976|FG005|Overall Study|Physician Decision|1|||
124818375|NCT03708328|448961977|FG006|Overall Study|Physician Decision|0|||
124818376|NCT03708328|448961978|FG007|Overall Study|Physician Decision|0|||
124818377|NCT03708328|448961979|FG008|Overall Study|Physician Decision|0|||
124818378|NCT03708328|448961980|FG009|Overall Study|Physician Decision|0|||
124818379|NCT03708328|448961971|FG000|Overall Study|Withdrawal by Subject|0|||
124818380|NCT03708328|448961972|FG001|Overall Study|Withdrawal by Subject|0|||
124818381|NCT03708328|448961973|FG002|Overall Study|Withdrawal by Subject|0|||
124818382|NCT03708328|448961974|FG003|Overall Study|Withdrawal by Subject|0|||
124818383|NCT03708328|448961975|FG004|Overall Study|Withdrawal by Subject|1|||
124818384|NCT03708328|448961976|FG005|Overall Study|Withdrawal by Subject|0|||
124818385|NCT03708328|448961977|FG006|Overall Study|Withdrawal by Subject|2|||
124818386|NCT03708328|448961978|FG007|Overall Study|Withdrawal by Subject|4|||
124818387|NCT03708328|448961979|FG008|Overall Study|Withdrawal by Subject|1|||
124818388|NCT03708328|448961980|FG009|Overall Study|Withdrawal by Subject|5|||
124818389|NCT03708328|448961971|FG000|Overall Study|Study Closed Locally|0|||
124818390|NCT03708328|448961972|FG001|Overall Study|Study Closed Locally|0|||
124818391|NCT03708328|448961973|FG002|Overall Study|Study Closed Locally|0|||
124818392|NCT03708328|448961974|FG003|Overall Study|Study Closed Locally|0|||
124818393|NCT03708328|448961975|FG004|Overall Study|Study Closed Locally|0|||
124818394|NCT03708328|448961976|FG005|Overall Study|Study Closed Locally|0|||
124818395|NCT03708328|448961977|FG006|Overall Study|Study Closed Locally|0|||
124818396|NCT03708328|448961978|FG007|Overall Study|Study Closed Locally|1|||
124818397|NCT03708328|448961979|FG008|Overall Study|Study Closed Locally|0|||
124818398|NCT03708328|448961980|FG009|Overall Study|Study Closed Locally|0|||
124818399|NCT03708328|448961971|FG000|Overall Study|Study Ended By Sponsor|0|||
124818400|NCT03708328|448961972|FG001|Overall Study|Study Ended By Sponsor|0|||
124818401|NCT03708328|448961973|FG002|Overall Study|Study Ended By Sponsor|0|||
124818402|NCT03708328|448961974|FG003|Overall Study|Study Ended By Sponsor|0|||
124818403|NCT03708328|448961975|FG004|Overall Study|Study Ended By Sponsor|0|||
124818404|NCT03708328|448961976|FG005|Overall Study|Study Ended By Sponsor|1|||
124818405|NCT03708328|448961977|FG006|Overall Study|Study Ended By Sponsor|0|||
124818406|NCT03708328|448961978|FG007|Overall Study|Study Ended By Sponsor|1|||
124818407|NCT03708328|448961979|FG008|Overall Study|Study Ended By Sponsor|0|||
124818408|NCT03708328|448961980|FG009|Overall Study|Study Ended By Sponsor|0|||
124818409|NCT03708328|448961971|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
124818410|NCT03708328|448961972|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
124818411|NCT03708328|448961973|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
124818412|NCT03708328|448961974|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
124818413|NCT03708328|448961975|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
124818414|NCT03708328|448961976|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
124818415|NCT03708328|448961977|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
124818416|NCT03708328|448961978|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
124818417|NCT03708328|448961979|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
124818418|NCT03708328|448961980|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
124818419|NCT02605824|448961981|FG000|Overall Study|Physician Decision|1|||
124818420|NCT02605824|448961982|FG001|Overall Study|Physician Decision|0|||
124818421|NCT02695329|448961985|FG000|Overall Study|Adverse Event|1|||
124818422|NCT02695329|448961986|FG001|Overall Study|Adverse Event|0|||
124818423|NCT02695329|448961985|FG000|Overall Study|Poor X-ray quality for measurement|4|||
124818424|NCT02695329|448961986|FG001|Overall Study|Poor X-ray quality for measurement|5|||
124818425|NCT01032837|448961988|FG000|Overall Study|Adverse event/internal illness|0|||
124818426|NCT01032837|448961989|FG001|Overall Study|Adverse event/internal illness|1|||
124818427|NCT01032837|448961990|FG002|Overall Study|Adverse event/internal illness|0|||
124818428|NCT01032837|448961991|FG003|Overall Study|Adverse event/internal illness|1|||
124818429|NCT01032837|448961988|FG000|Overall Study|Withdrew consent|0|||
124818430|NCT01032837|448961989|FG001|Overall Study|Withdrew consent|2|||
124818431|NCT01032837|448961990|FG002|Overall Study|Withdrew consent|0|||
124818432|NCT01032837|448961991|FG003|Overall Study|Withdrew consent|1|||
124818433|NCT01032837|448961988|FG000|Overall Study|Failed to return|0|||
124818434|NCT01032837|448961989|FG001|Overall Study|Failed to return|0|||
124818435|NCT01032837|448961990|FG002|Overall Study|Failed to return|1|||
125303039|NCT03100058|450736666|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
124818436|NCT01032837|448961991|FG003|Overall Study|Failed to return|0|||
124818437|NCT01032837|448961988|FG000|Overall Study|Refused treatment|0|||
124818438|NCT01032837|448961989|FG001|Overall Study|Refused treatment|0|||
124818439|NCT01032837|448961990|FG002|Overall Study|Refused treatment|0|||
124818440|NCT01032837|448961991|FG003|Overall Study|Refused treatment|1|||
124818441|NCT00843024|448961992|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
124818442|NCT00843024|448961993|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
125303040|NCT03100058|450736667|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
124818443|NCT00843024|448961994|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
124818444|NCT00843024|448961995|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
124818445|NCT00843024|448961996|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
124818446|NCT00843024|448961997|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
124818447|NCT00843024|448961992|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
124818448|NCT00843024|448961993|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
124818449|NCT00843024|448961994|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
124818450|NCT00843024|448961995|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
124818451|NCT00843024|448961996|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
124818452|NCT00843024|448961997|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
124818453|NCT00843024|448961992|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
124818454|NCT00843024|448961993|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
124818455|NCT00843024|448961994|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
124818456|NCT00843024|448961995|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
124818457|NCT00843024|448961996|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
124818458|NCT00843024|448961997|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
124818459|NCT00843024|448961992|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
124818460|NCT00843024|448961993|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
124818461|NCT00843024|448961994|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
124818462|NCT00843024|448961995|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
124818463|NCT00843024|448961996|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
124818464|NCT00843024|448961997|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
124818465|NCT00843024|448961992|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
124818466|NCT00843024|448961993|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
124818467|NCT00843024|448961994|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
124818468|NCT00843024|448961995|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
124818469|NCT00843024|448961996|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
124818470|NCT00843024|448961997|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
124818471|NCT00843024|448961992|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
124818472|NCT00843024|448961993|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
124818473|NCT00843024|448961994|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
124818474|NCT00843024|448961995|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
124818475|NCT00843024|448961996|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
124818476|NCT00843024|448961997|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
124818477|NCT00843024|448961992|FG000|Single-blind Placebo Run-In Phase|Other|0|||
124818478|NCT00843024|448961993|FG001|Single-blind Placebo Run-In Phase|Other|1|||
124818479|NCT00843024|448961994|FG002|Single-blind Placebo Run-In Phase|Other|0|||
124818480|NCT00843024|448961995|FG003|Single-blind Placebo Run-In Phase|Other|0|||
124818481|NCT00843024|448961996|FG004|Single-blind Placebo Run-In Phase|Other|0|||
124818482|NCT00843024|448961997|FG005|Single-blind Placebo Run-In Phase|Other|0|||
124818483|NCT00843024|448961992|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
124818484|NCT00843024|448961993|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
124818485|NCT00843024|448961994|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
124818486|NCT00843024|448961995|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
124818487|NCT00843024|448961996|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
124818488|NCT00843024|448961997|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
124818489|NCT00843024|448961992|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
124818490|NCT00843024|448961993|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
124818491|NCT00843024|448961994|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
124818492|NCT00843024|448961995|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
124818493|NCT00843024|448961996|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
124818494|NCT00843024|448961997|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
124818495|NCT00843024|448961992|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
124818496|NCT00843024|448961993|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
124818497|NCT00843024|448961994|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
124818498|NCT00843024|448961995|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
124818499|NCT00843024|448961996|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
124818500|NCT00843024|448961997|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
124818501|NCT00843024|448961992|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
124818502|NCT00843024|448961993|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
124818503|NCT00843024|448961994|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
124818504|NCT00843024|448961995|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
125303041|NCT03100058|450736668|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
125303042|NCT03100058|450736669|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
125303043|NCT03100058|450736670|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
124818505|NCT00843024|448961996|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
124818506|NCT00843024|448961997|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
124818507|NCT00843024|448961992|FG000|Double-blind Treatment Phase|Physician Decision|0|||
124818508|NCT00843024|448961993|FG001|Double-blind Treatment Phase|Physician Decision|0|||
124818509|NCT00843024|448961994|FG002|Double-blind Treatment Phase|Physician Decision|0|||
124818510|NCT00843024|448961995|FG003|Double-blind Treatment Phase|Physician Decision|3|||
124818511|NCT00843024|448961996|FG004|Double-blind Treatment Phase|Physician Decision|1|||
124818512|NCT00843024|448961997|FG005|Double-blind Treatment Phase|Physician Decision|1|||
124818513|NCT00843024|448961992|FG000|Double-blind Treatment Phase|Adverse Event|0|||
124818514|NCT00843024|448961993|FG001|Double-blind Treatment Phase|Adverse Event|0|||
124818515|NCT00843024|448961994|FG002|Double-blind Treatment Phase|Adverse Event|0|||
124818516|NCT00843024|448961995|FG003|Double-blind Treatment Phase|Adverse Event|0|||
124818517|NCT00843024|448961996|FG004|Double-blind Treatment Phase|Adverse Event|1|||
124818518|NCT00843024|448961997|FG005|Double-blind Treatment Phase|Adverse Event|1|||
124818519|NCT00843024|448961992|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
124818520|NCT00843024|448961993|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
124818521|NCT00843024|448961994|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
124818522|NCT00843024|448961995|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
124818523|NCT00843024|448961996|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
124818524|NCT00843024|448961997|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
124818525|NCT02439138|448961999|FG000|Overall Study|Adverse Event|1|||
124818526|NCT02439138|448961999|FG000|Overall Study|PI decision to terminate the study|2|||
124818527|NCT00006237|448962004|FG000|Overall Study|Adverse Event|39|||
124818528|NCT00006237|448962005|FG001|Overall Study|Adverse Event|29|||
124818529|NCT00006237|448962004|FG000|Overall Study|Death|1|||
124818530|NCT00006237|448962005|FG001|Overall Study|Death|0|||
124818531|NCT00006237|448962004|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
124818532|NCT00006237|448962005|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
124818533|NCT00006237|448962004|FG000|Overall Study|Progression/relapse|54|||
124818534|NCT00006237|448962005|FG001|Overall Study|Progression/relapse|2|||
124818535|NCT00006237|448962004|FG000|Overall Study|Not eligible|9|||
124818536|NCT00006237|448962005|FG001|Overall Study|Not eligible|20|||
124818537|NCT00006237|448962004|FG000|Overall Study|Withdrawal by Subject|0|||
124818538|NCT00006237|448962005|FG001|Overall Study|Withdrawal by Subject|1|||
124818539|NCT00006237|448962004|FG000|Overall Study|Not protocol specified|14|||
124818540|NCT00006237|448962005|FG001|Overall Study|Not protocol specified|5|||
124818541|NCT01846416|448962008|FG000|Treatment Phase|Death|2|||
124818542|NCT01846416|448962009|FG001|Treatment Phase|Death|9|||
124818543|NCT01846416|448962010|FG002|Treatment Phase|Death|1|||
124818544|NCT01846416|448962008|FG000|Treatment Phase|Withdrawal by Subject|2|||
124818545|NCT01846416|448962009|FG001|Treatment Phase|Withdrawal by Subject|4|||
124818546|NCT01846416|448962010|FG002|Treatment Phase|Withdrawal by Subject|2|||
124818547|NCT01846416|448962008|FG000|Treatment Phase|Other|1|||
124818548|NCT01846416|448962009|FG001|Treatment Phase|Other|5|||
124818549|NCT01846416|448962010|FG002|Treatment Phase|Other|1|||
124818550|NCT01846416|448962008|FG000|Treatment Phase|Physician Decision|1|||
124818551|NCT01846416|448962009|FG001|Treatment Phase|Physician Decision|2|||
124818552|NCT01846416|448962010|FG002|Treatment Phase|Physician Decision|0|||
124818553|NCT01846416|448962008|FG000|Treatment Phase|Adverse Event|3|||
124818554|NCT01846416|448962009|FG001|Treatment Phase|Adverse Event|4|||
124818555|NCT01846416|448962010|FG002|Treatment Phase|Adverse Event|0|||
124818556|NCT01846416|448962008|FG000|Treatment Phase|Non-compliance|0|||
124818557|NCT01846416|448962009|FG001|Treatment Phase|Non-compliance|2|||
124818558|NCT01846416|448962010|FG002|Treatment Phase|Non-compliance|0|||
124818559|NCT01846416|448962008|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
124818560|NCT01846416|448962009|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
124818561|NCT01846416|448962010|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
124818562|NCT01846416|448962008|FG000|Treatment Phase|Progressive Disease|21|||
124818563|NCT01846416|448962009|FG001|Treatment Phase|Progressive Disease|63|||
124818564|NCT01846416|448962010|FG002|Treatment Phase|Progressive Disease|9|||
124818565|NCT01846416|448962008|FG000|Survival Follow-up|Death|21|||
124818566|NCT01846416|448962009|FG001|Survival Follow-up|Death|62|||
124818567|NCT01846416|448962010|FG002|Survival Follow-up|Death|9|||
124818568|NCT01846416|448962008|FG000|Survival Follow-up|Lost to Follow-up|0|||
124818569|NCT01846416|448962009|FG001|Survival Follow-up|Lost to Follow-up|2|||
124818570|NCT01846416|448962010|FG002|Survival Follow-up|Lost to Follow-up|2|||
124818571|NCT01846416|448962008|FG000|Survival Follow-up|Withdrawal by Subject|2|||
124818572|NCT01846416|448962009|FG001|Survival Follow-up|Withdrawal by Subject|7|||
124818573|NCT01846416|448962010|FG002|Survival Follow-up|Withdrawal by Subject|0|||
124818574|NCT01846416|448962008|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
124818575|NCT01846416|448962009|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
124818576|NCT01846416|448962010|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
124818577|NCT01846416|448962008|FG000|Survival Follow-up|Other|3|||
124818578|NCT01846416|448962009|FG001|Survival Follow-up|Other|1|||
124818579|NCT01846416|448962010|FG002|Survival Follow-up|Other|1|||
124818580|NCT01487200|448962011|FG000|Overall Study|Withdrawal by Subject|0|||
124818581|NCT01487200|448962012|FG001|Overall Study|Withdrawal by Subject|1|||
124818582|NCT01487200|448962013|FG002|Overall Study|Withdrawal by Subject|0|||
124818583|NCT01487200|448962014|FG003|Overall Study|Withdrawal by Subject|0|||
124818584|NCT02837783|448962015|FG000|Overall Study|Adverse Event|1|||
124818585|NCT02837783|448962016|FG001|Overall Study|Adverse Event|0|||
124818586|NCT02837783|448962015|FG000|Overall Study|Other, Not Specified|1|||
124818587|NCT02837783|448962016|FG001|Overall Study|Other, Not Specified|2|||
124818588|NCT01962896|448962017|FG000|Overall Study|Lack of Efficacy|4|||
124818589|NCT02216591|448962018|FG000|Overall Study|Lost to Follow-up|0|||
124818590|NCT02216591|448962019|FG001|Overall Study|Lost to Follow-up|1|||
124818591|NCT02207244|448962020|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
124818592|NCT02207244|448962021|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
124818593|NCT02207244|448962022|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
124818594|NCT02207244|448962023|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
124818595|NCT02207244|448962024|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
124818596|NCT02207244|448962025|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
124818597|NCT02207244|448962026|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
124818598|NCT02207244|448962027|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
124818599|NCT02207244|448962028|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
124818600|NCT02207244|448962029|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
124818601|NCT02207244|448962030|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
124818602|NCT02207244|448962020|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
124818603|NCT02207244|448962021|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
124818604|NCT02207244|448962022|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
124818605|NCT02207244|448962023|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
124818606|NCT02207244|448962024|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
124818607|NCT02207244|448962025|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
124818608|NCT02207244|448962026|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
124818609|NCT02207244|448962027|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
124818610|NCT02207244|448962028|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
124818611|NCT02207244|448962029|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
124818612|NCT02207244|448962030|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
124818613|NCT02207244|448962020|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
124818614|NCT02207244|448962021|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
124818615|NCT02207244|448962022|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
124818616|NCT02207244|448962023|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
124818617|NCT02207244|448962024|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
124818618|NCT02207244|448962025|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
124818619|NCT02207244|448962026|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
124818620|NCT02207244|448962027|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
124818621|NCT02207244|448962028|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
124818622|NCT02207244|448962029|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
124818623|NCT02207244|448962030|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
124818624|NCT02207244|448962020|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
124818625|NCT02207244|448962021|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
124818626|NCT02207244|448962022|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
124818627|NCT02207244|448962023|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
124818628|NCT02207244|448962024|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
124818629|NCT02207244|448962025|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
124818630|NCT02207244|448962026|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
124818631|NCT02207244|448962027|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
124818632|NCT02207244|448962028|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
124818633|NCT02207244|448962029|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
124818634|NCT02207244|448962030|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
124818635|NCT02207244|448962020|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
124818636|NCT02207244|448962021|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
124818637|NCT02207244|448962022|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
124818638|NCT02207244|448962023|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
124818639|NCT02207244|448962024|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
124818640|NCT02207244|448962025|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
124818641|NCT02207244|448962026|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
124818642|NCT02207244|448962027|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
124818643|NCT02207244|448962028|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
124818644|NCT02207244|448962029|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
124818645|NCT02207244|448962030|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
124818646|NCT02207244|448962020|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
124818647|NCT02207244|448962021|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
124818648|NCT02207244|448962022|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
124818649|NCT02207244|448962023|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
124818650|NCT02207244|448962024|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
124818651|NCT02207244|448962025|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
124818652|NCT02207244|448962026|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
124818653|NCT02207244|448962027|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
124818654|NCT02207244|448962028|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
124818655|NCT02207244|448962029|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
124818656|NCT02207244|448962030|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
124818657|NCT02207244|448962020|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
124818658|NCT02207244|448962021|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
124818659|NCT02207244|448962022|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
124818660|NCT02207244|448962023|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
124818661|NCT02207244|448962024|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
124818662|NCT02207244|448962025|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
124818663|NCT02207244|448962026|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
124818664|NCT02207244|448962027|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
124818665|NCT02207244|448962028|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
124818666|NCT02207244|448962029|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
124818667|NCT02207244|448962030|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
124818668|NCT02207244|448962020|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
124818669|NCT02207244|448962021|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
124818670|NCT02207244|448962022|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
124818671|NCT02207244|448962023|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
124818672|NCT02207244|448962024|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
124818673|NCT02207244|448962025|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
124818674|NCT02207244|448962026|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
124818675|NCT02207244|448962027|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
124818676|NCT02207244|448962028|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
124818677|NCT02207244|448962029|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
124818678|NCT02207244|448962030|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
124818679|NCT02207244|448962020|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
124818680|NCT02207244|448962021|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
124818681|NCT02207244|448962022|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
124818682|NCT02207244|448962023|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
124818683|NCT02207244|448962024|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
124818684|NCT02207244|448962025|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
124818685|NCT02207244|448962026|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
124818686|NCT02207244|448962027|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
124818687|NCT02207244|448962028|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
124818688|NCT02207244|448962029|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
124818689|NCT02207244|448962030|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
124818690|NCT02207244|448962020|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
124818691|NCT02207244|448962021|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
124818692|NCT02207244|448962022|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
124818693|NCT02207244|448962023|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
124818694|NCT02207244|448962024|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
124818695|NCT02207244|448962025|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
124818696|NCT02207244|448962026|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
124818697|NCT02207244|448962027|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
124818698|NCT02207244|448962028|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
124818699|NCT02207244|448962029|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
124818700|NCT02207244|448962030|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
124818701|NCT02207244|448962020|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
124818702|NCT02207244|448962021|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
124818703|NCT02207244|448962022|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
124818704|NCT02207244|448962023|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
124818705|NCT02207244|448962024|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
124818706|NCT02207244|448962025|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
124818707|NCT02207244|448962026|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
124818708|NCT02207244|448962027|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
124818709|NCT02207244|448962028|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
124818710|NCT02207244|448962029|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
124818711|NCT02207244|448962030|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
124818712|NCT02207244|448962020|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
124818713|NCT02207244|448962021|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
124818714|NCT02207244|448962022|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
124818715|NCT02207244|448962023|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
124818716|NCT02207244|448962024|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
124818717|NCT02207244|448962025|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
124818718|NCT02207244|448962026|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
124818719|NCT02207244|448962027|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
124818720|NCT02207244|448962028|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
124818721|NCT02207244|448962029|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
124818722|NCT02207244|448962030|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
124818723|NCT02207244|448962020|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
124818724|NCT02207244|448962021|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
124818725|NCT02207244|448962022|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
124818726|NCT02207244|448962023|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
124818727|NCT02207244|448962024|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
124818728|NCT02207244|448962025|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
124818729|NCT02207244|448962026|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
124818730|NCT02207244|448962027|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
124818731|NCT02207244|448962028|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
124818732|NCT02207244|448962029|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
124818733|NCT02207244|448962030|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
124818734|NCT02207244|448962020|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
124818735|NCT02207244|448962021|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
124818736|NCT02207244|448962022|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
124818737|NCT02207244|448962023|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
124818738|NCT02207244|448962024|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
124818739|NCT02207244|448962025|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
124818740|NCT02207244|448962026|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
124818741|NCT02207244|448962027|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
124818742|NCT02207244|448962028|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
124818743|NCT02207244|448962029|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
124818744|NCT02207244|448962030|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
124818745|NCT02207244|448962020|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
124818746|NCT02207244|448962021|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
124818747|NCT02207244|448962022|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
124818748|NCT02207244|448962023|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
124818749|NCT02207244|448962024|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
125303044|NCT03100058|450736671|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
125303045|NCT03100058|450736672|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
124818750|NCT02207244|448962025|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
124818751|NCT02207244|448962026|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
124818752|NCT02207244|448962027|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
124818753|NCT02207244|448962028|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
124818754|NCT02207244|448962029|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
124818755|NCT02207244|448962030|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
124818756|NCT02207244|448962020|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
124818757|NCT02207244|448962021|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
124818758|NCT02207244|448962022|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
124818759|NCT02207244|448962023|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
124818760|NCT02207244|448962024|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
124818761|NCT02207244|448962025|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
124818762|NCT02207244|448962026|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
124818763|NCT02207244|448962027|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
124818764|NCT02207244|448962028|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
124818765|NCT02207244|448962029|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
124818766|NCT02207244|448962030|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
124818767|NCT02207244|448962020|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
124818768|NCT02207244|448962021|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
124818769|NCT02207244|448962022|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
124818770|NCT02207244|448962023|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
124818771|NCT02207244|448962024|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
124818772|NCT02207244|448962025|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
124818773|NCT02207244|448962026|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
124818774|NCT02207244|448962027|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
124818775|NCT02207244|448962028|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
124818776|NCT02207244|448962029|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
124818777|NCT02207244|448962030|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
125303046|NCT03100058|450736673|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
124818778|NCT02207244|448962020|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
124818779|NCT02207244|448962021|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
124818780|NCT02207244|448962022|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
124818781|NCT02207244|448962023|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
124818782|NCT02207244|448962024|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
124818783|NCT02207244|448962025|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
124818784|NCT02207244|448962026|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
124818785|NCT02207244|448962027|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
124818786|NCT02207244|448962028|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
124818787|NCT02207244|448962029|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
124818788|NCT02207244|448962030|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
124818789|NCT02207244|448962020|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
124818790|NCT02207244|448962021|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
124818791|NCT02207244|448962022|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
124818792|NCT02207244|448962023|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
124818793|NCT02207244|448962024|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
124818794|NCT02207244|448962025|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
124818795|NCT02207244|448962026|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
124818796|NCT02207244|448962027|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
124818797|NCT02207244|448962028|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
124818798|NCT02207244|448962029|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
124818799|NCT02207244|448962030|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
124818800|NCT02207244|448962020|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
124818801|NCT02207244|448962021|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
124818802|NCT02207244|448962022|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
124818803|NCT02207244|448962023|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
124818804|NCT02207244|448962024|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
124818805|NCT02207244|448962025|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
124818806|NCT02207244|448962026|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
124818807|NCT02207244|448962027|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
124818808|NCT02207244|448962028|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
124818809|NCT02207244|448962029|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
124818810|NCT02207244|448962030|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
124818811|NCT02207244|448962020|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
124818812|NCT02207244|448962021|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
124818813|NCT02207244|448962022|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
124818814|NCT02207244|448962023|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
124818815|NCT02207244|448962024|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
124818816|NCT02207244|448962025|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
124818817|NCT02207244|448962026|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
124818818|NCT02207244|448962027|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
124818819|NCT02207244|448962028|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
124818820|NCT02207244|448962029|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
125303047|NCT03100058|450736661|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
125303048|NCT03100058|450736662|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
124818821|NCT02207244|448962030|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
124818822|NCT02207244|448962020|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
124818823|NCT02207244|448962021|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
124818824|NCT02207244|448962022|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
124818825|NCT02207244|448962023|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
124818826|NCT02207244|448962024|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
124818827|NCT02207244|448962025|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
124818828|NCT02207244|448962026|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
124818829|NCT02207244|448962027|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
124818830|NCT02207244|448962028|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
124818831|NCT02207244|448962029|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
124818832|NCT02207244|448962030|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
124818833|NCT02207244|448962020|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
124818834|NCT02207244|448962021|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
124818835|NCT02207244|448962022|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
125303049|NCT03100058|450736663|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
125303050|NCT03100058|450736664|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
124818836|NCT02207244|448962023|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
124818837|NCT02207244|448962024|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
124818838|NCT02207244|448962025|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
124818839|NCT02207244|448962026|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
124818840|NCT02207244|448962027|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
124818841|NCT02207244|448962028|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
124818842|NCT02207244|448962029|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
124818843|NCT02207244|448962030|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
124818844|NCT02207244|448962020|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
124818845|NCT02207244|448962021|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
124818846|NCT02207244|448962022|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
124818847|NCT02207244|448962023|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
124818848|NCT02207244|448962024|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
124818849|NCT02207244|448962025|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
124818850|NCT02207244|448962026|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
124818851|NCT02207244|448962027|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
124818852|NCT02207244|448962028|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
124818853|NCT02207244|448962029|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
124818854|NCT02207244|448962030|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
124818855|NCT02207244|448962020|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
124818856|NCT02207244|448962021|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
124818857|NCT02207244|448962022|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
124818858|NCT02207244|448962023|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
124818859|NCT02207244|448962024|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
124818860|NCT02207244|448962025|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
124818861|NCT02207244|448962026|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
124818862|NCT02207244|448962027|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
124818863|NCT02207244|448962028|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
124818864|NCT02207244|448962029|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
124818865|NCT02207244|448962030|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
124818866|NCT02207244|448962020|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
124818867|NCT02207244|448962021|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
124818868|NCT02207244|448962022|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
124818869|NCT02207244|448962023|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
124818870|NCT02207244|448962024|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
124818871|NCT02207244|448962025|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
124818872|NCT02207244|448962026|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
124818873|NCT02207244|448962027|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
124818874|NCT02207244|448962028|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
124818875|NCT02207244|448962029|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
124818876|NCT02207244|448962030|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
124818877|NCT02207244|448962020|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
124818878|NCT02207244|448962021|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
124818879|NCT02207244|448962022|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
124818880|NCT02207244|448962023|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
124818881|NCT02207244|448962024|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
124818882|NCT02207244|448962025|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
124818883|NCT02207244|448962026|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
124818884|NCT02207244|448962027|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
124818885|NCT02207244|448962028|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
124818886|NCT02207244|448962029|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
124818887|NCT02207244|448962030|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
124818888|NCT02207244|448962020|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
124818889|NCT02207244|448962021|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
124818890|NCT02207244|448962022|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
124818891|NCT02207244|448962023|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
124818892|NCT02207244|448962024|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
124818893|NCT02207244|448962025|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
124818894|NCT02207244|448962026|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
124818895|NCT02207244|448962027|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
124818896|NCT02207244|448962028|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
124818897|NCT02207244|448962029|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
124818898|NCT02207244|448962030|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
124818899|NCT02207244|448962020|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
124818900|NCT02207244|448962021|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
124818901|NCT02207244|448962022|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
124818902|NCT02207244|448962023|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
124818903|NCT02207244|448962024|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
124818904|NCT02207244|448962025|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
124818905|NCT02207244|448962026|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
124818906|NCT02207244|448962027|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
124818907|NCT02207244|448962028|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
124818908|NCT02207244|448962029|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
124818909|NCT02207244|448962030|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
124818910|NCT00039130|448962031|FG000|Overall Study|Adverse Event|11|||
124818911|NCT00039130|448962031|FG000|Overall Study|Death|9|||
124818912|NCT00039130|448962031|FG000|Overall Study|Withdrawal by Subject|3|||
124818913|NCT00039130|448962031|FG000|Overall Study|Progression|2|||
124818914|NCT00039130|448962031|FG000|Overall Study|Subsequent treatment|2|||
124818915|NCT00039130|448962031|FG000|Overall Study|Physician Decision|3|||
124818916|NCT01866930|448962032|FG000|Treatment Period|Other|1|||
124818917|NCT01866930|448962033|FG001|Treatment Period|Other|0|||
124818918|NCT01866930|448962032|FG000|Treatment Period|Death|0|||
124818919|NCT01866930|448962033|FG001|Treatment Period|Death|2|||
124818920|NCT01866930|448962032|FG000|Treatment Period|Poor/non compliance|0|||
124818921|NCT01866930|448962033|FG001|Treatment Period|Poor/non compliance|2|||
124818922|NCT01866930|448962032|FG000|Treatment Period|No longer meets study criteria|0|||
124818923|NCT01866930|448962033|FG001|Treatment Period|No longer meets study criteria|1|||
124818924|NCT01866930|448962032|FG000|Treatment Period|Withdrawal by Subject|2|||
124818925|NCT01866930|448962033|FG001|Treatment Period|Withdrawal by Subject|8|||
124818926|NCT01866930|448962032|FG000|Treatment Period|Lack of Efficacy|1|||
124818927|NCT01866930|448962033|FG001|Treatment Period|Lack of Efficacy|9|||
124818928|NCT01866930|448962032|FG000|Treatment Period|Adverse Event|4|||
124818929|NCT01866930|448962033|FG001|Treatment Period|Adverse Event|12|||
124818930|NCT01866930|448962032|FG000|Treatment Period|Lost to Follow-up|1|||
124818931|NCT01866930|448962033|FG001|Treatment Period|Lost to Follow-up|1|||
124818932|NCT01866930|448962032|FG000|Follow-up Period|Lost to Follow-up|1|||
124818933|NCT01866930|448962033|FG001|Follow-up Period|Lost to Follow-up|1|||
124818934|NCT01866930|448962032|FG000|Follow-up Period|Other|1|||
124818935|NCT01866930|448962033|FG001|Follow-up Period|Other|5|||
124818936|NCT01866930|448962032|FG000|Follow-up Period|No longer required per protocol|1|||
124818937|NCT01866930|448962033|FG001|Follow-up Period|No longer required per protocol|0|||
124818938|NCT01866930|448962032|FG000|Follow-up Period|Withdrawal by Subject|3|||
124818939|NCT01866930|448962033|FG001|Follow-up Period|Withdrawal by Subject|3|||
124818940|NCT00279305|448962036|FG000|Overall Study|Pregnancy|1|||
124818941|NCT00279305|448962037|FG001|Overall Study|Pregnancy|0|||
124818942|NCT00279305|448962036|FG000|Overall Study|Withdrawal by Subject|2|||
124818943|NCT00279305|448962037|FG001|Overall Study|Withdrawal by Subject|0|||
124818944|NCT00279305|448962036|FG000|Overall Study|Dificulting establishing IV|1|||
124818945|NCT00279305|448962037|FG001|Overall Study|Dificulting establishing IV|0|||
124818946|NCT00279305|448962036|FG000|Overall Study|FDA Safety Alert|4|||
124818947|NCT00279305|448962037|FG001|Overall Study|FDA Safety Alert|1|||
124818948|NCT03930797|448962039|FG000|Overall Study|Lost to Follow-up|3|||
124818949|NCT03930797|448962040|FG001|Overall Study|Lost to Follow-up|10|||
124818950|NCT00317356|448962044|FG000|Overall Study|Adverse Event|0|||
124818951|NCT00317356|448962045|FG001|Overall Study|Adverse Event|0|||
124818952|NCT00317356|448962046|FG002|Overall Study|Adverse Event|1|||
124818953|NCT00317356|448962047|FG003|Overall Study|Adverse Event|0|||
124818954|NCT00317356|448962044|FG000|Overall Study|Lack of Efficacy|1|||
124818955|NCT00317356|448962045|FG001|Overall Study|Lack of Efficacy|1|||
124818956|NCT00317356|448962046|FG002|Overall Study|Lack of Efficacy|0|||
124818957|NCT00317356|448962047|FG003|Overall Study|Lack of Efficacy|3|||
124818958|NCT00317356|448962044|FG000|Overall Study|Physician Decision|0|||
124818959|NCT00317356|448962045|FG001|Overall Study|Physician Decision|1|||
124818960|NCT00317356|448962046|FG002|Overall Study|Physician Decision|0|||
124818961|NCT00317356|448962047|FG003|Overall Study|Physician Decision|0|||
124818962|NCT04212650|448962052|FG000|Overall Study|Withdrawal by Subject|1|||
124818963|NCT04212650|448962053|FG001|Overall Study|Withdrawal by Subject|0|||
124818964|NCT03919799|448962054|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
124818965|NCT03919799|448962055|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
124818966|NCT03919799|448962056|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
124818967|NCT03919799|448962057|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
124818968|NCT03919799|448962058|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
124818969|NCT03919799|448962054|FG000|DB Period (28 Weeks)|Adverse Event|1|||
124818970|NCT03919799|448962055|FG001|DB Period (28 Weeks)|Adverse Event|1|||
124818971|NCT03919799|448962056|FG002|DB Period (28 Weeks)|Adverse Event|1|||
124818972|NCT03919799|448962057|FG003|DB Period (28 Weeks)|Adverse Event|0|||
124818973|NCT03919799|448962058|FG004|DB Period (28 Weeks)|Adverse Event|0|||
124818974|NCT03919799|448962054|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
124818975|NCT03919799|448962055|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
124818976|NCT03919799|448962056|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
124818977|NCT03919799|448962057|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
124818978|NCT03919799|448962058|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
124818979|NCT03919799|448962054|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
124818980|NCT03919799|448962055|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
124818981|NCT03919799|448962056|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
124818982|NCT03919799|448962057|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
124818983|NCT03919799|448962058|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
124818984|NCT03919799|448962054|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
124818985|NCT03919799|448962055|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
124818986|NCT03919799|448962056|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
124818987|NCT03919799|448962057|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
124818988|NCT03919799|448962058|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
124818989|NCT00630396|448963952|FG000|Overall Study|Death|4|||
124818990|NCT00630396|448963952|FG000|Overall Study|Lost to Follow-up|3|||
124818991|NCT00790023|448963958|FG000|Overall Study|Adverse Event|2|||
124818992|NCT00790023|448963959|FG001|Overall Study|Adverse Event|1|||
124818993|NCT00790023|448963960|FG002|Overall Study|Adverse Event|4|||
124818994|NCT00790023|448963958|FG000|Overall Study|Protocol Violation|2|||
124818995|NCT00790023|448963959|FG001|Overall Study|Protocol Violation|4|||
124818996|NCT00790023|448963960|FG002|Overall Study|Protocol Violation|2|||
124818997|NCT00790023|448963958|FG000|Overall Study|Withdrawal by Subject|2|||
124818998|NCT00790023|448963959|FG001|Overall Study|Withdrawal by Subject|0|||
124818999|NCT00790023|448963960|FG002|Overall Study|Withdrawal by Subject|6|||
124819000|NCT00790023|448963958|FG000|Overall Study|Lost to Follow-up|0|||
124819001|NCT00790023|448963959|FG001|Overall Study|Lost to Follow-up|0|||
124819002|NCT00790023|448963960|FG002|Overall Study|Lost to Follow-up|1|||
124819003|NCT00790023|448963958|FG000|Overall Study|Other|5|||
124819004|NCT00790023|448963959|FG001|Overall Study|Other|5|||
124819005|NCT00790023|448963960|FG002|Overall Study|Other|8|||
124819006|NCT01338792|448963961|FG000|Overall Study|Adverse Event|2|||
124819007|NCT01338792|448963961|FG000|Overall Study|Death|1|||
124819008|NCT01338792|448963961|FG000|Overall Study|Withdrawal by Subject|1|||
124819009|NCT01652703|448963965|FG000|Overall Study|Withdrawal by Subject|0|||
124819010|NCT01652703|448963966|FG001|Overall Study|Withdrawal by Subject|1|||
124819011|NCT01652703|448963967|FG002|Overall Study|Withdrawal by Subject|3|||
124819012|NCT01652703|448963968|FG003|Overall Study|Withdrawal by Subject|1|||
124819013|NCT01652703|448963969|FG004|Overall Study|Withdrawal by Subject|0|||
124819014|NCT01652703|448963970|FG005|Overall Study|Withdrawal by Subject|1|||
124819015|NCT01652703|448963965|FG000|Overall Study|Other|0|||
124819016|NCT01652703|448963966|FG001|Overall Study|Other|0|||
124819017|NCT01652703|448963967|FG002|Overall Study|Other|0|||
124819018|NCT01652703|448963968|FG003|Overall Study|Other|1|||
124819019|NCT01652703|448963969|FG004|Overall Study|Other|1|||
124819020|NCT01652703|448963970|FG005|Overall Study|Other|1|||
124819021|NCT02155608|448963971|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
124819022|NCT02155608|448963972|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
124819023|NCT02155608|448963971|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
124819024|NCT02155608|448963972|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
124819025|NCT04532164|448963973|FG000|Overall Study|Adverse Event|1|||
124819026|NCT04532164|448963973|FG000|Overall Study|Protocol Violation|5|||
124819027|NCT04532164|448963973|FG000|Overall Study|Lost to Follow-up|1|||
124819028|NCT04532164|448963973|FG000|Overall Study|Found to be Ineligible|3|||
124819029|NCT04532164|448963973|FG000|Overall Study|Withdrawal by Subject|14|||
124819030|NCT02599129|448963974|FG000|Overall Study|Lack of Efficacy|2|||
124819031|NCT02599129|448963975|FG001|Overall Study|Lack of Efficacy|2|||
124819032|NCT02599129|448963974|FG000|Overall Study|Lost to Follow-up|1|||
124819033|NCT02599129|448963975|FG001|Overall Study|Lost to Follow-up|0|||
124819034|NCT02599129|448963974|FG000|Overall Study|Withdrawal by Subject|2|||
124819035|NCT02599129|448963975|FG001|Overall Study|Withdrawal by Subject|1|||
124819036|NCT01029795|448963983|FG000|Overall Study|Entry Criteria Not Met|2|||
124819037|NCT01029795|448963984|FG001|Overall Study|Entry Criteria Not Met|1|||
124819038|NCT01029795|448963983|FG000|Overall Study|Physician Decision|2|||
124819039|NCT01029795|448963984|FG001|Overall Study|Physician Decision|1|||
124819040|NCT01029795|448963983|FG000|Overall Study|Sponsor Decision|11|||
124819041|NCT01029795|448963984|FG001|Overall Study|Sponsor Decision|17|||
124819042|NCT01029795|448963983|FG000|Overall Study|Withdrawal by Subject|1|||
124819043|NCT01029795|448963984|FG001|Overall Study|Withdrawal by Subject|3|||
124819044|NCT00429273|448963994|FG000|Overall Study|Lost to Follow-up|1|||
124819045|NCT00429273|448963995|FG001|Overall Study|Lost to Follow-up|2|||
124819046|NCT00429273|448963996|FG002|Overall Study|Lost to Follow-up|2|||
124819047|NCT00429273|448963994|FG000|Overall Study|Physician Decision|6|||
124819048|NCT00429273|448963995|FG001|Overall Study|Physician Decision|5|||
124819049|NCT00429273|448963996|FG002|Overall Study|Physician Decision|5|||
124819050|NCT00429273|448963994|FG000|Overall Study|Adverse Event|1|||
124819051|NCT00429273|448963995|FG001|Overall Study|Adverse Event|1|||
124819052|NCT00429273|448963996|FG002|Overall Study|Adverse Event|2|||
124819053|NCT01438957|448963997|FG000|Overall Study|Physician Decision|1|||
124819054|NCT01438957|448963998|FG001|Overall Study|Physician Decision|1|||
124819055|NCT01438957|448963999|FG002|Overall Study|Physician Decision|0|||
124819056|NCT01438957|448964000|FG003|Overall Study|Physician Decision|1|||
124819057|NCT01438957|448964001|FG004|Overall Study|Physician Decision|0|||
124819058|NCT02495168|448964003|FG000|Overall Study|Other than Specified|18|||
124819059|NCT02495168|448964004|FG001|Overall Study|Other than Specified|22|||
124819060|NCT02495168|448964005|FG002|Overall Study|Other than Specified|5|||
124819061|NCT02495168|448964003|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
124819062|NCT02495168|448964004|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
124819063|NCT02495168|448964005|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
124819064|NCT02495168|448964003|FG000|Overall Study|Physician Decision|1|||
124819065|NCT02495168|448964004|FG001|Overall Study|Physician Decision|1|||
124819066|NCT02495168|448964005|FG002|Overall Study|Physician Decision|0|||
124819067|NCT02495168|448964003|FG000|Overall Study|Lost to Follow-up|10|||
124819068|NCT02495168|448964004|FG001|Overall Study|Lost to Follow-up|6|||
124819069|NCT02495168|448964005|FG002|Overall Study|Lost to Follow-up|1|||
124819070|NCT02495168|448964003|FG000|Overall Study|Withdrawal by Subject|1|||
124819071|NCT02495168|448964004|FG001|Overall Study|Withdrawal by Subject|4|||
124819072|NCT02495168|448964005|FG002|Overall Study|Withdrawal by Subject|2|||
124819073|NCT02495168|448964003|FG000|Overall Study|Protocol Violation|0|||
124819074|NCT02495168|448964004|FG001|Overall Study|Protocol Violation|10|||
124819075|NCT02495168|448964005|FG002|Overall Study|Protocol Violation|1|||
124819076|NCT02495168|448964003|FG000|Overall Study|Adverse Event|4|||
124819077|NCT02495168|448964004|FG001|Overall Study|Adverse Event|8|||
124819078|NCT02495168|448964005|FG002|Overall Study|Adverse Event|3|||
124819079|NCT02495168|448964003|FG000|Overall Study|Lack of Efficacy|0|||
124819080|NCT02495168|448964004|FG001|Overall Study|Lack of Efficacy|0|||
124819081|NCT02495168|448964005|FG002|Overall Study|Lack of Efficacy|3|||
124819082|NCT00727025|448964006|FG000|Overall Study|Physician Decision|23|||
124819083|NCT02269241|448964007|FG000|Overall Study|Lost to Follow-up|269|||
124819084|NCT02269241|448964007|FG000|Overall Study|Withdrawal by Subject|155|||
124819085|NCT02269241|448964007|FG000|Overall Study|Protocol Violation|1|||
124819086|NCT02269241|448964007|FG000|Overall Study|Physician Decision|7|||
124819087|NCT02269241|448964007|FG000|Overall Study|Pregnancy|15|||
124819088|NCT02269241|448964007|FG000|Overall Study|Wish for pregnancy|5|||
124819089|NCT02269241|448964007|FG000|Overall Study|Development of an exclusion criteria|16|||
124819090|NCT02269241|448964007|FG000|Overall Study|Adverse Event|113|||
124819091|NCT02269241|448964007|FG000|Overall Study|At the specific request of the sponsor|20|||
124819092|NCT02269241|448964007|FG000|Overall Study|Several reasons not classified|53|||
124819093|NCT02269241|448964007|FG000|Overall Study|Screening failures|546|||
124819094|NCT02270957|448964008|FG000|Overall Study|Lack of Efficacy|2|||
124819095|NCT02270957|448964009|FG001|Overall Study|Lack of Efficacy|4|||
124819096|NCT02270957|448964008|FG000|Overall Study|Adverse Event|2|||
124819097|NCT02270957|448964009|FG001|Overall Study|Adverse Event|0|||
124819098|NCT00489541|448964014|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
124819099|NCT00489541|448964015|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
124819100|NCT00489541|448964014|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
124819101|NCT00489541|448964015|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
124819102|NCT00489541|448964014|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
124819103|NCT00489541|448964015|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
124819104|NCT00489541|448964014|FG000|12-Month Clinical Follow-up|Death|3|||
124819105|NCT00489541|448964015|FG001|12-Month Clinical Follow-up|Death|2|||
124819106|NCT00489541|448964014|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
124819107|NCT00489541|448964015|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
124819108|NCT00489541|448964014|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
124819109|NCT00489541|448964015|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
124819110|NCT04390191|448964020|FG000|Overall Study|Withdrawal by Subject|1|||
124819111|NCT04390191|448964021|FG001|Overall Study|Withdrawal by Subject|0|||
124819112|NCT03978832|448964026|FG000|Overall Study|Adverse Event|1|||
124819113|NCT03978832|448964026|FG000|Overall Study|Lost to Follow-up|1|||
124819114|NCT03978832|448964026|FG000|Overall Study|Withdrawal by Subject|6|||
124819115|NCT03978832|448964026|FG000|Overall Study|Physician Decision|2|||
124819116|NCT03978832|448964026|FG000|Overall Study|did not pass screening criteria|44|||
124819117|NCT01727297|448964027|FG000|Overall Study|Death|13|||
124819118|NCT01727297|448964028|FG001|Overall Study|Death|0|||
124819119|NCT01727297|448964027|FG000|Overall Study|Protocol Violation|1|||
124819120|NCT01727297|448964028|FG001|Overall Study|Protocol Violation|10|||
124819121|NCT01727297|448964027|FG000|Overall Study|Adverse Event|3|||
124819122|NCT01727297|448964028|FG001|Overall Study|Adverse Event|1|||
124819123|NCT01727297|448964027|FG000|Overall Study|Lost to Follow-up|11|||
124819124|NCT01727297|448964028|FG001|Overall Study|Lost to Follow-up|0|||
124819125|NCT01727297|448964027|FG000|Overall Study|Withdrawal by Subject|26|||
124819126|NCT01727297|448964028|FG001|Overall Study|Withdrawal by Subject|27|||
124819127|NCT01727297|448964027|FG000|Overall Study|Physician Decision|19|||
124819128|NCT01727297|448964028|FG001|Overall Study|Physician Decision|5|||
125303051|NCT03100058|450736665|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
125303052|NCT03100058|450736666|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
124819129|NCT01727297|448964027|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
124819130|NCT01727297|448964028|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
124819131|NCT02042183|448964029|FG000|Overall Study|Physician Decision|7|||
124819132|NCT02042183|448964030|FG001|Overall Study|Physician Decision|2|||
124819133|NCT02042183|448964029|FG000|Overall Study|Lack of Efficacy|4|||
124819134|NCT02042183|448964030|FG001|Overall Study|Lack of Efficacy|3|||
124819135|NCT02042183|448964029|FG000|Overall Study|Non-compliance with Study Drug|2|||
124819136|NCT02042183|448964030|FG001|Overall Study|Non-compliance with Study Drug|3|||
124819137|NCT02042183|448964029|FG000|Overall Study|Adverse Event|17|||
124819138|NCT02042183|448964030|FG001|Overall Study|Adverse Event|6|||
124819139|NCT02042183|448964029|FG000|Overall Study|Other|3|||
124819140|NCT02042183|448964030|FG001|Overall Study|Other|3|||
124819141|NCT02042183|448964029|FG000|Overall Study|Withdrawal by Subject|21|||
124819142|NCT02042183|448964030|FG001|Overall Study|Withdrawal by Subject|16|||
124819143|NCT02042183|448964029|FG000|Overall Study|Site Terminated by Sponsor|2|||
124819144|NCT02042183|448964030|FG001|Overall Study|Site Terminated by Sponsor|1|||
124819145|NCT02042183|448964029|FG000|Overall Study|Lost to Follow-up|9|||
124819146|NCT02042183|448964030|FG001|Overall Study|Lost to Follow-up|2|||
124819147|NCT01192516|448964031|FG000|Overall Study|Lost to Follow-up|7|||
124819148|NCT01192516|448964032|FG001|Overall Study|Lost to Follow-up|10|||
124819149|NCT01192516|448964033|FG002|Overall Study|Lost to Follow-up|7|||
124819150|NCT01192516|448964031|FG000|Overall Study|Withdrawal by Subject|4|||
124819151|NCT01192516|448964032|FG001|Overall Study|Withdrawal by Subject|4|||
124819152|NCT01192516|448964033|FG002|Overall Study|Withdrawal by Subject|1|||
124819153|NCT01192516|448964031|FG000|Overall Study|started new treatment|5|||
124819154|NCT01192516|448964032|FG001|Overall Study|started new treatment|1|||
124819155|NCT01192516|448964033|FG002|Overall Study|started new treatment|0|||
124819156|NCT01192516|448964031|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
124819157|NCT01192516|448964032|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
124819158|NCT01192516|448964033|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
124819159|NCT01256008|448964034|FG000|Overall Study|Lost to Follow-up|6|||
124819160|NCT01256008|448964035|FG001|Overall Study|Lost to Follow-up|4|||
124819161|NCT01256008|448964036|FG002|Overall Study|Lost to Follow-up|11|||
124819162|NCT01256008|448964034|FG000|Overall Study|Withdrawal by Subject|2|||
124819163|NCT01256008|448964035|FG001|Overall Study|Withdrawal by Subject|3|||
124819164|NCT01256008|448964036|FG002|Overall Study|Withdrawal by Subject|10|||
124819165|NCT02244606|448964037|FG000|Overall Study|Adverse Event|0|||
124819166|NCT02244606|448964038|FG001|Overall Study|Adverse Event|1|||
124819167|NCT02244606|448964039|FG002|Overall Study|Adverse Event|1|||
124819168|NCT02244606|448964040|FG003|Overall Study|Adverse Event|0|||
124819169|NCT02244606|448964037|FG000|Overall Study|Lost to Follow-up|2|||
124819170|NCT02244606|448964038|FG001|Overall Study|Lost to Follow-up|2|||
124819171|NCT02244606|448964039|FG002|Overall Study|Lost to Follow-up|1|||
124819172|NCT02244606|448964040|FG003|Overall Study|Lost to Follow-up|0|||
124819173|NCT02244606|448964037|FG000|Overall Study|Protocol Violation|0|||
124819174|NCT02244606|448964038|FG001|Overall Study|Protocol Violation|0|||
124819175|NCT02244606|448964039|FG002|Overall Study|Protocol Violation|0|||
124819176|NCT02244606|448964040|FG003|Overall Study|Protocol Violation|1|||
124819177|NCT02244606|448964037|FG000|Overall Study|Withdrawal by Subject|1|||
124819178|NCT02244606|448964038|FG001|Overall Study|Withdrawal by Subject|1|||
124819179|NCT02244606|448964039|FG002|Overall Study|Withdrawal by Subject|0|||
124819180|NCT02244606|448964040|FG003|Overall Study|Withdrawal by Subject|0|||
124819181|NCT02244606|448964037|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
124819182|NCT02244606|448964038|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
124819183|NCT02244606|448964039|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
124819184|NCT02244606|448964040|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
124819185|NCT00378378|448964045|FG000|Overall Study|Withdrawal by Subject|0|||
124819186|NCT00378378|448964046|FG001|Overall Study|Withdrawal by Subject|1|||
124819187|NCT00378378|448964047|FG002|Overall Study|Withdrawal by Subject|0|||
124819188|NCT00378378|448964045|FG000|Overall Study|Treatment Failure|0|||
124819189|NCT00378378|448964046|FG001|Overall Study|Treatment Failure|0|||
124819190|NCT00378378|448964047|FG002|Overall Study|Treatment Failure|1|||
124819191|NCT00378378|448964045|FG000|Overall Study|Non-compliance with protocol|0|||
124819192|NCT00378378|448964046|FG001|Overall Study|Non-compliance with protocol|0|||
124819193|NCT00378378|448964047|FG002|Overall Study|Non-compliance with protocol|1|||
124819194|NCT00407797|448964048|FG000|Overall Study|Lost to Follow-up|2|||
124819195|NCT00407797|448964048|FG000|Overall Study|Adverse Event|6|||
124819196|NCT00407797|448964048|FG000|Overall Study|Other|7|||
124819197|NCT00407797|448964048|FG000|Overall Study|Withdrawal by Subject|3|||
124819198|NCT00553644|448964049|FG000|Overall Study|Adverse Event|17|||
124819199|NCT00553644|448964049|FG000|Overall Study|Withdrawal by Subject|4|||
124819200|NCT00553644|448964049|FG000|Overall Study|Physician Decision|1|||
124819201|NCT00553644|448964049|FG000|Overall Study|Alternative therapy|6|||
124819202|NCT03782792|448964050|FG000|Overall Study|Patient left the country|0|||
124819203|NCT03782792|448964051|FG001|Overall Study|Patient left the country|1|||
124819204|NCT03782792|448964050|FG000|Overall Study|Withdrawal by Subject|1|||
124819205|NCT03782792|448964051|FG001|Overall Study|Withdrawal by Subject|2|||
124819206|NCT00814164|448964053|FG000|Overall Study|Progression|7|||
124819207|NCT00814164|448964053|FG000|Overall Study|not stated|7|||
124819208|NCT00814164|448964053|FG000|Overall Study|Death|5|||
124819209|NCT02321800|448964054|FG000|Overall Study|Withdrawal by Subject|3|||
124819210|NCT02321800|448964055|FG001|Overall Study|Withdrawal by Subject|3|||
124819211|NCT02321800|448964054|FG000|Overall Study|Death|1|||
124819212|NCT02321800|448964055|FG001|Overall Study|Death|0|||
124819213|NCT02321800|448964054|FG000|Overall Study|Protocol Violation|1|||
124819214|NCT02321800|448964055|FG001|Overall Study|Protocol Violation|0|||
124819215|NCT02321800|448964054|FG000|Overall Study|Lost to Follow-up|10|||
124819216|NCT02321800|448964055|FG001|Overall Study|Lost to Follow-up|4|||
124819217|NCT02321800|448964054|FG000|Overall Study|Adverse Event|2|||
124819218|NCT02321800|448964055|FG001|Overall Study|Adverse Event|3|||
124819219|NCT02321800|448964054|FG000|Overall Study|Other, Miscellaneous|3|||
124819220|NCT02321800|448964055|FG001|Overall Study|Other, Miscellaneous|1|||
124819221|NCT00982878|448964056|FG000|Overall Study|Physician Decision|1|||
124819222|NCT03132220|448964062|FG000|Overall Study|Lost to Follow-up|17|||
124819223|NCT03132220|448964063|FG001|Overall Study|Lost to Follow-up|8|||
124819224|NCT03132220|448964062|FG000|Overall Study|Withdrawal by Subject|1|||
124819225|NCT03132220|448964063|FG001|Overall Study|Withdrawal by Subject|4|||
124819226|NCT01169493|448964064|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
124819227|NCT01169493|448964065|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
124819228|NCT01169493|448964066|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
124819229|NCT01169493|448964067|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
124819230|NCT01169493|448964068|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
124819231|NCT01169493|448964069|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
124819232|NCT01169493|448964064|FG000|Period 3 (6 Months)|Adverse Event|0|||
124819233|NCT01169493|448964065|FG001|Period 3 (6 Months)|Adverse Event|1|||
124819234|NCT01169493|448964066|FG002|Period 3 (6 Months)|Adverse Event|0|||
124819235|NCT01169493|448964067|FG003|Period 3 (6 Months)|Adverse Event|0|||
124819236|NCT01169493|448964068|FG004|Period 3 (6 Months)|Adverse Event|0|||
124819237|NCT01169493|448964069|FG005|Period 3 (6 Months)|Adverse Event|0|||
124819238|NCT01169493|448964064|FG000|Period 3 (6 Months)|Physician Decision|0|||
124819239|NCT01169493|448964065|FG001|Period 3 (6 Months)|Physician Decision|1|||
124819240|NCT01169493|448964066|FG002|Period 3 (6 Months)|Physician Decision|1|||
124819241|NCT01169493|448964067|FG003|Period 3 (6 Months)|Physician Decision|0|||
124819242|NCT01169493|448964068|FG004|Period 3 (6 Months)|Physician Decision|0|||
124819243|NCT01169493|448964069|FG005|Period 3 (6 Months)|Physician Decision|0|||
124819244|NCT05228132|448964070|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
124819245|NCT05228132|448964070|FG000|Overall Study|Adverse Event|3|||
124819246|NCT05228132|448964070|FG000|Overall Study|Lost to Follow-up|1|||
124819247|NCT05228132|448964070|FG000|Overall Study|Arteriovenous-fistula mature|1|||
124819248|NCT01336764|448964071|FG000|Overall Study|Withdrawal by Subject|5|||
124819249|NCT01336764|448964072|FG001|Overall Study|Withdrawal by Subject|5|||
124819250|NCT01906008|448964082|FG000|Overall Study|Lost to Follow-up|2|||
124819251|NCT01906008|448964083|FG001|Overall Study|Lost to Follow-up|0|||
124819252|NCT01906008|448964082|FG000|Overall Study|Oxaliplatin toxicity|2|||
124819253|NCT01906008|448964083|FG001|Overall Study|Oxaliplatin toxicity|0|||
124819254|NCT01906008|448964082|FG000|Overall Study|Protocol Violation|0|||
124819255|NCT01906008|448964083|FG001|Overall Study|Protocol Violation|1|||
124819256|NCT01906008|448964082|FG000|Overall Study|Withdrawal by Subject|1|||
124819257|NCT01906008|448964083|FG001|Overall Study|Withdrawal by Subject|5|||
124819258|NCT01906008|448964082|FG000|Overall Study|Did not start study med|3|||
124819259|NCT01906008|448964083|FG001|Overall Study|Did not start study med|4|||
124819260|NCT01906008|448964082|FG000|Overall Study|Oxaliplatin stops|10|||
124819261|NCT01906008|448964083|FG001|Overall Study|Oxaliplatin stops|8|||
124819262|NCT01906008|448964082|FG000|Overall Study|Hospice|1|||
124819263|NCT01906008|448964083|FG001|Overall Study|Hospice|0|||
124819264|NCT01906008|448964082|FG000|Overall Study|Physician Decision|3|||
124819265|NCT01906008|448964083|FG001|Overall Study|Physician Decision|3|||
124819266|NCT01906008|448964082|FG000|Overall Study|Lack of compliance of study med|5|||
124819267|NCT01906008|448964083|FG001|Overall Study|Lack of compliance of study med|3|||
124819268|NCT01906008|448964082|FG000|Overall Study|Adverse Event|0|||
124819269|NCT01906008|448964083|FG001|Overall Study|Adverse Event|3|||
124819270|NCT00730132|448964084|FG000|Overall Study|Protocol Violation|154|||
124819271|NCT00730132|448964084|FG000|Overall Study|Death|1|||
124819272|NCT01626391|448964085|FG000|Overall Study|Physician Decision|1|||
124819273|NCT01626391|448964086|FG001|Overall Study|Physician Decision|0|||
124819274|NCT01626391|448964085|FG000|Overall Study|Withdrawal by Subject|1|||
124819275|NCT01626391|448964086|FG001|Overall Study|Withdrawal by Subject|0|||
124819276|NCT02220205|448964087|FG000|Overall Study|Withdrawal by Subject|1|||
124819277|NCT02220205|448964088|FG001|Overall Study|Withdrawal by Subject|0|||
124819278|NCT00518986|448964090|FG000|Overall Study|Adverse Event|12|||
124819279|NCT00518986|448964091|FG001|Overall Study|Adverse Event|7|||
124819280|NCT00518986|448964090|FG000|Overall Study|Lack of Efficacy|0|||
124819281|NCT00518986|448964091|FG001|Overall Study|Lack of Efficacy|2|||
124819282|NCT00518986|448964090|FG000|Overall Study|Lost to Follow-up|3|||
124819283|NCT00518986|448964091|FG001|Overall Study|Lost to Follow-up|2|||
124819284|NCT00518986|448964090|FG000|Overall Study|Physician Decision|0|||
124819285|NCT00518986|448964091|FG001|Overall Study|Physician Decision|3|||
124819286|NCT00518986|448964090|FG000|Overall Study|Protocol Violation|5|||
124819287|NCT00518986|448964091|FG001|Overall Study|Protocol Violation|7|||
124819288|NCT00518986|448964090|FG000|Overall Study|Withdrawal by Subject|4|||
124819289|NCT00518986|448964091|FG001|Overall Study|Withdrawal by Subject|4|||
124819290|NCT00518986|448964090|FG000|Overall Study|Non-Specific|2|||
124819291|NCT00518986|448964091|FG001|Overall Study|Non-Specific|1|||
124819292|NCT02088047|448964092|FG000|Overall Study|Withdrawal by Subject|1|||
124819293|NCT02088047|448964093|FG001|Overall Study|Withdrawal by Subject|0|||
124819294|NCT04171531|448964096|FG000|Overall Study|Lost to Follow-up|4|||
124819295|NCT04171531|448964097|FG001|Overall Study|Lost to Follow-up|5|||
124819296|NCT04171531|448964096|FG000|Overall Study|Consent only through 6 months|1|||
124819297|NCT04171531|448964097|FG001|Overall Study|Consent only through 6 months|1|||
124819298|NCT04171531|448964096|FG000|Overall Study|Insurance did not cover procedure|0|||
124819299|NCT04171531|448964097|FG001|Overall Study|Insurance did not cover procedure|1|||
124819300|NCT04171531|448964096|FG000|Overall Study|Physician Decision|0|||
124819301|NCT04171531|448964097|FG001|Overall Study|Physician Decision|3|||
124819302|NCT04171531|448964096|FG000|Overall Study|Withdrawal by Subject|1|||
124819303|NCT04171531|448964097|FG001|Overall Study|Withdrawal by Subject|5|||
124819304|NCT04862585|448964098|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
124819305|NCT04862585|448964099|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
124819306|NCT04862585|448964098|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
124819307|NCT04862585|448964099|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
124819308|NCT04862585|448964098|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
124819309|NCT04862585|448964099|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
124819310|NCT04862585|448964098|FG000|Overall Study|one withdrew without providing a reason|0|||
124819311|NCT04862585|448964099|FG001|Overall Study|one withdrew without providing a reason|1|||
124819312|NCT03366337|448964100|FG000|Overall Study|Lost to Follow-up|1|||
124819313|NCT03366337|448964101|FG001|Overall Study|Lost to Follow-up|0|||
124819314|NCT03366337|448964102|FG002|Overall Study|Lost to Follow-up|1|||
124819315|NCT03366337|448964103|FG003|Overall Study|Lost to Follow-up|0|||
124819316|NCT03366337|448964100|FG000|Overall Study|Withdrawal by Subject|2|||
124819317|NCT03366337|448964101|FG001|Overall Study|Withdrawal by Subject|0|||
124819318|NCT03366337|448964102|FG002|Overall Study|Withdrawal by Subject|1|||
124819319|NCT03366337|448964103|FG003|Overall Study|Withdrawal by Subject|1|||
124819320|NCT05229406|448964104|FG000|Overall Study|Withdrawal by Subject|1|||
124819321|NCT05229406|448964105|FG001|Overall Study|Withdrawal by Subject|2|||
124819322|NCT00459953|448964106|FG000|Overall Study|not analyzed-household member in study|1|||
124819323|NCT00459953|448964107|FG001|Overall Study|not analyzed-household member in study|1|||
124819324|NCT00496470|448964108|FG000|Overall Study|Adverse Event|8|||
124819325|NCT00496470|448964109|FG001|Overall Study|Adverse Event|10|||
124819326|NCT00496470|448964108|FG000|Overall Study|Withdrawal by Subject|5|||
124819327|NCT00496470|448964109|FG001|Overall Study|Withdrawal by Subject|12|||
124819328|NCT00496470|448964108|FG000|Overall Study|Incorrectly enrolled|13|||
124819329|NCT00496470|448964109|FG001|Overall Study|Incorrectly enrolled|5|||
124819330|NCT00496470|448964108|FG000|Overall Study|Other reason|0|||
124819331|NCT00496470|448964109|FG001|Overall Study|Other reason|2|||
124819332|NCT00621153|448964114|FG000|Overall Study|Safety Reason|8|||
124819333|NCT00621153|448964115|FG001|Overall Study|Safety Reason|7|||
124819334|NCT00621153|448964114|FG000|Overall Study|Adverse Event|3|||
124819335|NCT00621153|448964115|FG001|Overall Study|Adverse Event|2|||
124819336|NCT00621153|448964114|FG000|Overall Study|Lost to Follow-up|5|||
124819337|NCT00621153|448964115|FG001|Overall Study|Lost to Follow-up|1|||
124819338|NCT00621153|448964114|FG000|Overall Study|Withdrawal by Subject|4|||
124819339|NCT00621153|448964115|FG001|Overall Study|Withdrawal by Subject|5|||
124819340|NCT00753415|448964116|FG000|Part A|Disease progression|1|||
124819341|NCT00753415|448964117|FG001|Part A|Disease progression|0|||
124819342|NCT00753415|448964118|FG002|Part A|Disease progression|1|||
124819343|NCT00753415|448964119|FG003|Part A|Disease progression|2|||
124819344|NCT00753415|448964120|FG004|Part A|Disease progression|0|||
124819345|NCT00753415|448964121|FG005|Part A|Disease progression|0|||
124819346|NCT00753415|448964122|FG006|Part A|Disease progression|0|||
124819347|NCT00753415|448964123|FG007|Part A|Disease progression|0|||
124819348|NCT00753415|448964124|FG008|Part A|Disease progression|0|||
124819349|NCT00753415|448964125|FG009|Part A|Disease progression|0|||
124819350|NCT00753415|448964116|FG000|Part A|Withdrawal by Subject|0|||
124819351|NCT00753415|448964117|FG001|Part A|Withdrawal by Subject|0|||
124819352|NCT00753415|448964118|FG002|Part A|Withdrawal by Subject|1|||
124819353|NCT00753415|448964119|FG003|Part A|Withdrawal by Subject|0|||
124819354|NCT00753415|448964120|FG004|Part A|Withdrawal by Subject|0|||
124819355|NCT00753415|448964121|FG005|Part A|Withdrawal by Subject|0|||
124819356|NCT00753415|448964122|FG006|Part A|Withdrawal by Subject|0|||
125303053|NCT03100058|450736667|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
124819357|NCT00753415|448964123|FG007|Part A|Withdrawal by Subject|0|||
124819358|NCT00753415|448964124|FG008|Part A|Withdrawal by Subject|0|||
124819359|NCT00753415|448964125|FG009|Part A|Withdrawal by Subject|0|||
124819360|NCT00753415|448964116|FG000|Part B|Lost to Follow-up|0|||
124819361|NCT00753415|448964117|FG001|Part B|Lost to Follow-up|0|||
125303054|NCT03100058|450736668|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
124819362|NCT00753415|448964118|FG002|Part B|Lost to Follow-up|0|||
124819363|NCT00753415|448964119|FG003|Part B|Lost to Follow-up|0|||
124819364|NCT00753415|448964120|FG004|Part B|Lost to Follow-up|0|||
124819365|NCT00753415|448964121|FG005|Part B|Lost to Follow-up|0|||
124819366|NCT00753415|448964122|FG006|Part B|Lost to Follow-up|0|||
124819367|NCT00753415|448964123|FG007|Part B|Lost to Follow-up|1|||
124819368|NCT00753415|448964124|FG008|Part B|Lost to Follow-up|1|||
124819369|NCT00753415|448964125|FG009|Part B|Lost to Follow-up|0|||
124819370|NCT00753415|448964116|FG000|Part B|Disease progression|0|||
124819371|NCT00753415|448964117|FG001|Part B|Disease progression|0|||
124819372|NCT00753415|448964118|FG002|Part B|Disease progression|0|||
124819373|NCT00753415|448964119|FG003|Part B|Disease progression|0|||
124819374|NCT00753415|448964120|FG004|Part B|Disease progression|0|||
124819375|NCT00753415|448964121|FG005|Part B|Disease progression|0|||
124819376|NCT00753415|448964122|FG006|Part B|Disease progression|0|||
124819377|NCT00753415|448964123|FG007|Part B|Disease progression|0|||
124819378|NCT00753415|448964124|FG008|Part B|Disease progression|2|||
124819379|NCT00753415|448964125|FG009|Part B|Disease progression|1|||
124819380|NCT04419714|448964126|FG000|Overall Study|Technical Fault|5|||
124819381|NCT04419714|448964126|FG000|Overall Study|Protocol Deviation|2|||
124819382|NCT04419714|448964126|FG000|Overall Study|Withdrawal by Subject|1|||
124819383|NCT04023526|448965680|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
124819384|NCT04023526|448965681|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
124819385|NCT04023526|448965680|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
124819386|NCT04023526|448965681|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
124819387|NCT00540514|448965686|FG000|Overall Study|Still on treatment|3|||
124819388|NCT00540514|448965687|FG001|Overall Study|Still on treatment|0|||
124819389|NCT00540514|448965686|FG000|Overall Study|Unacceptable Toxicity|61|||
124819390|NCT00540514|448965687|FG001|Overall Study|Unacceptable Toxicity|62|||
124819391|NCT00540514|448965686|FG000|Overall Study|Adverse Event|20|||
124819392|NCT00540514|448965687|FG001|Overall Study|Adverse Event|24|||
124819393|NCT00540514|448965686|FG000|Overall Study|Physician Decision|86|||
124819394|NCT00540514|448965687|FG001|Overall Study|Physician Decision|99|||
124819395|NCT00540514|448965686|FG000|Overall Study|Protocol Deviation|3|||
124819396|NCT00540514|448965687|FG001|Overall Study|Protocol Deviation|4|||
124819397|NCT00540514|448965686|FG000|Overall Study|Lost to Follow-up|1|||
124819398|NCT00540514|448965687|FG001|Overall Study|Lost to Follow-up|1|||
124819399|NCT00540514|448965686|FG000|Overall Study|Withdrawal by Subject|65|||
124819400|NCT00540514|448965687|FG001|Overall Study|Withdrawal by Subject|67|||
124819401|NCT00540514|448965686|FG000|Overall Study|Excluded prior to treatment|7|||
124819402|NCT00540514|448965687|FG001|Overall Study|Excluded prior to treatment|7|||
124819403|NCT00540514|448965686|FG000|Overall Study|Paclitaxel not available|0|||
124819404|NCT00540514|448965687|FG001|Overall Study|Paclitaxel not available|2|||
124819405|NCT02501473|448965688|FG000|Overall Study|Study Terminated|2|||
124819406|NCT02501473|448965689|FG001|Overall Study|Study Terminated|3|||
124819407|NCT02501473|448965690|FG002|Overall Study|Study Terminated|7|||
124819408|NCT02501473|448965691|FG003|Overall Study|Study Terminated|9|||
124819409|NCT02501473|448965692|FG004|Overall Study|Study Terminated|2|||
124819410|NCT02501473|448965693|FG005|Overall Study|Study Terminated|10|||
124819411|NCT02501473|448965694|FG006|Overall Study|Study Terminated|1|||
124819412|NCT02501473|448965695|FG007|Overall Study|Study Terminated|0|||
124819413|NCT02501473|448965688|FG000|Overall Study|Withdrawal by Subject|0|||
124819414|NCT02501473|448965689|FG001|Overall Study|Withdrawal by Subject|0|||
124819415|NCT02501473|448965690|FG002|Overall Study|Withdrawal by Subject|3|||
124819416|NCT02501473|448965691|FG003|Overall Study|Withdrawal by Subject|3|||
124819417|NCT02501473|448965692|FG004|Overall Study|Withdrawal by Subject|2|||
124819418|NCT02501473|448965693|FG005|Overall Study|Withdrawal by Subject|2|||
124819419|NCT02501473|448965694|FG006|Overall Study|Withdrawal by Subject|0|||
124819420|NCT02501473|448965695|FG007|Overall Study|Withdrawal by Subject|0|||
124819421|NCT02501473|448965688|FG000|Overall Study|Death|0|||
124819422|NCT02501473|448965689|FG001|Overall Study|Death|0|||
124819423|NCT02501473|448965690|FG002|Overall Study|Death|1|||
124819424|NCT02501473|448965691|FG003|Overall Study|Death|1|||
124819425|NCT02501473|448965692|FG004|Overall Study|Death|0|||
124819426|NCT02501473|448965693|FG005|Overall Study|Death|1|||
124819427|NCT02501473|448965694|FG006|Overall Study|Death|0|||
124819428|NCT02501473|448965695|FG007|Overall Study|Death|0|||
124819429|NCT02501473|448965688|FG000|Overall Study|Lost to Follow-up|1|||
124819430|NCT02501473|448965689|FG001|Overall Study|Lost to Follow-up|0|||
124819431|NCT02501473|448965690|FG002|Overall Study|Lost to Follow-up|1|||
124819432|NCT02501473|448965691|FG003|Overall Study|Lost to Follow-up|0|||
124819433|NCT02501473|448965692|FG004|Overall Study|Lost to Follow-up|0|||
124819434|NCT02501473|448965693|FG005|Overall Study|Lost to Follow-up|1|||
125303055|NCT03100058|450736669|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
124819435|NCT02501473|448965694|FG006|Overall Study|Lost to Follow-up|0|||
124819436|NCT02501473|448965695|FG007|Overall Study|Lost to Follow-up|0|||
124819437|NCT02501473|448965688|FG000|Overall Study|Reason not specified|0|||
124819438|NCT02501473|448965689|FG001|Overall Study|Reason not specified|0|||
124819439|NCT02501473|448965690|FG002|Overall Study|Reason not specified|1|||
124819440|NCT02501473|448965691|FG003|Overall Study|Reason not specified|1|||
124819441|NCT02501473|448965692|FG004|Overall Study|Reason not specified|0|||
124819442|NCT02501473|448965693|FG005|Overall Study|Reason not specified|0|||
124819443|NCT02501473|448965694|FG006|Overall Study|Reason not specified|0|||
124819444|NCT02501473|448965695|FG007|Overall Study|Reason not specified|0|||
124819445|NCT02324569|448965696|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
124819446|NCT02324569|448965697|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
124819447|NCT02324569|448965696|FG000|Overall Study|Voluntary Withdrawal|3|||
124819448|NCT02324569|448965697|FG001|Overall Study|Voluntary Withdrawal|6|||
124819449|NCT02324569|448965696|FG000|Overall Study|Lack of Efficacy|2|||
124819450|NCT02324569|448965697|FG001|Overall Study|Lack of Efficacy|3|||
124819451|NCT02324569|448965696|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
124819452|NCT02324569|448965697|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
124819453|NCT02324569|448965696|FG000|Overall Study|Inconvenient Schedule|2|||
124819454|NCT02324569|448965697|FG001|Overall Study|Inconvenient Schedule|0|||
124819455|NCT00911820|448965698|FG000|Overall Study|RECIST progression|12|||
124819456|NCT00911820|448965699|FG001|Overall Study|RECIST progression|8|||
124819457|NCT00911820|448965698|FG000|Overall Study|Adverse Event|8|||
124819458|NCT00911820|448965699|FG001|Overall Study|Adverse Event|8|||
124819459|NCT00911820|448965698|FG000|Overall Study|Clinical Progression|7|||
124819460|NCT00911820|448965699|FG001|Overall Study|Clinical Progression|5|||
124819461|NCT00911820|448965698|FG000|Overall Study|Physician Decision|5|||
124819462|NCT00911820|448965699|FG001|Overall Study|Physician Decision|9|||
124819463|NCT00911820|448965698|FG000|Overall Study|Decline in Performance Status|4|||
124819464|NCT00911820|448965699|FG001|Overall Study|Decline in Performance Status|2|||
124819465|NCT00911820|448965698|FG000|Overall Study|Withdrawal by Subject|3|||
124819466|NCT00911820|448965699|FG001|Overall Study|Withdrawal by Subject|4|||
124819467|NCT00911820|448965698|FG000|Overall Study|Death|1|||
124819468|NCT00911820|448965699|FG001|Overall Study|Death|2|||
124819469|NCT00911820|448965698|FG000|Overall Study|Pursue surgery|1|||
124819470|NCT00911820|448965699|FG001|Overall Study|Pursue surgery|1|||
124819471|NCT00911820|448965698|FG000|Overall Study|Pursue Radiation|1|||
124819472|NCT00911820|448965699|FG001|Overall Study|Pursue Radiation|0|||
124819473|NCT00911820|448965698|FG000|Overall Study|Still on Therapy|2|||
124819474|NCT00911820|448965699|FG001|Overall Study|Still on Therapy|2|||
124819475|NCT00911820|448965698|FG000|Overall Study|Pathology Not Confirmed|1|||
124819476|NCT00911820|448965699|FG001|Overall Study|Pathology Not Confirmed|0|||
124819477|NCT00911820|448965698|FG000|Overall Study|Withdraw before Receive Treatment|0|||
124819478|NCT00911820|448965699|FG001|Overall Study|Withdraw before Receive Treatment|2|||
124819479|NCT03098550|448965706|FG000|Overall Study|Disease Progression|30|||
124819480|NCT03098550|448965707|FG001|Overall Study|Disease Progression|19|||
124819481|NCT03098550|448965708|FG002|Overall Study|Disease Progression|41|||
124819482|NCT03098550|448965706|FG000|Overall Study|Study Drug Toxicity|2|||
124819483|NCT03098550|448965707|FG001|Overall Study|Study Drug Toxicity|1|||
124819484|NCT03098550|448965708|FG002|Overall Study|Study Drug Toxicity|0|||
124819485|NCT03098550|448965706|FG000|Overall Study|Death|1|||
124819486|NCT03098550|448965707|FG001|Overall Study|Death|0|||
124819487|NCT03098550|448965708|FG002|Overall Study|Death|0|||
124819488|NCT03098550|448965706|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
124819489|NCT03098550|448965707|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
124819490|NCT03098550|448965708|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
124819491|NCT03098550|448965706|FG000|Overall Study|Administrative reason by sponsor|0|||
124819492|NCT03098550|448965707|FG001|Overall Study|Administrative reason by sponsor|0|||
124819493|NCT03098550|448965708|FG002|Overall Study|Administrative reason by sponsor|1|||
124819494|NCT03098550|448965706|FG000|Overall Study|Other reasons|2|||
124819495|NCT03098550|448965707|FG001|Overall Study|Other reasons|0|||
124819496|NCT03098550|448965708|FG002|Overall Study|Other reasons|0|||
124819497|NCT01411774|448965723|FG000|Overall Study|Withdrawal by Subject|0|||
124819498|NCT01411774|448965724|FG001|Overall Study|Withdrawal by Subject|3|||
124819499|NCT00056316|448965725|FG000|Overall Study|Withdrawal by Subject|2|||
124819500|NCT00056316|448965726|FG001|Overall Study|Withdrawal by Subject|2|||
124819501|NCT00056316|448965725|FG000|Overall Study|Death/NH placement of pt|1|||
124819502|NCT00056316|448965726|FG001|Overall Study|Death/NH placement of pt|1|||
124819503|NCT02990910|448965728|FG000|Overall Study|Lack of Efficacy|6|||
124819504|NCT02990910|448965729|FG001|Overall Study|Lack of Efficacy|10|||
124819505|NCT02468414|448965734|FG000|Overall Study|Early Study Termination by Sponsor|1|||
124819506|NCT02468414|448965735|FG001|Overall Study|Early Study Termination by Sponsor|0|||
124819507|NCT02468414|448965734|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
124819508|NCT02468414|448965735|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
124819509|NCT02468414|448965734|FG000|Overall Study|Screen Failure|1|||
124819510|NCT02468414|448965735|FG001|Overall Study|Screen Failure|0|||
124819511|NCT00903695|448965736|FG000|Overall Study|medical exclusion after 1st testing|1|||
124819512|NCT00903695|448965737|FG001|Overall Study|medical exclusion after 1st testing|0|||
124819513|NCT00903695|448965736|FG000|Overall Study|lung cancer|1|||
124819514|NCT00903695|448965737|FG001|Overall Study|lung cancer|0|||
124819515|NCT00543140|448965739|FG000|Overall Study|Lost to Follow-up|33|||
124819516|NCT00543140|448965739|FG000|Overall Study|Withdrawal by Subject|13|||
124819517|NCT00543140|448965739|FG000|Overall Study|Protocol Violation|10|||
124819518|NCT00543140|448965739|FG000|Overall Study|Insufficient weight loss|10|||
124819519|NCT00543140|448965739|FG000|Overall Study|SAE leading to explant of SAGB|3|||
124819520|NCT00543140|448965739|FG000|Overall Study|Death|1|||
124819521|NCT00543140|448965739|FG000|Overall Study|Subject moved|1|||
124819588|NCT00420927|448965761|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
124819589|NCT00420927|448965762|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
124819590|NCT00420927|448965763|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
124819591|NCT00420927|448965764|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
124819592|NCT00420927|448965765|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
124819593|NCT00420927|448965766|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
124819594|NCT00420927|448965767|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
124819595|NCT00420927|448965761|FG000|Period 1|Death|2|||
124819596|NCT00420927|448965762|FG001|Period 1|Death|0|||
124819597|NCT00420927|448965763|FG002|Period 1|Death|0|||
124819598|NCT00420927|448965764|FG003|Period 1|Death|0|||
124819599|NCT00420927|448965765|FG004|Period 1|Death|0|||
124819600|NCT00420927|448965766|FG005|Period 1|Death|0|||
124819601|NCT00420927|448965767|FG006|Period 1|Death|0|||
124819602|NCT00420927|448965761|FG000|Period 1|Subject moved/relocated|0|||
124819603|NCT00420927|448965762|FG001|Period 1|Subject moved/relocated|2|||
124819604|NCT00420927|448965763|FG002|Period 1|Subject moved/relocated|0|||
124819605|NCT00420927|448965764|FG003|Period 1|Subject moved/relocated|0|||
124819606|NCT00420927|448965765|FG004|Period 1|Subject moved/relocated|0|||
124819607|NCT00420927|448965766|FG005|Period 1|Subject moved/relocated|0|||
124819608|NCT00420927|448965767|FG006|Period 1|Subject moved/relocated|0|||
124819609|NCT00420927|448965761|FG000|Period 1|Noncompliant with study drug|1|||
124819610|NCT00420927|448965762|FG001|Period 1|Noncompliant with study drug|1|||
124819611|NCT00420927|448965763|FG002|Period 1|Noncompliant with study drug|0|||
124819612|NCT00420927|448965764|FG003|Period 1|Noncompliant with study drug|0|||
124819613|NCT00420927|448965765|FG004|Period 1|Noncompliant with study drug|0|||
124819614|NCT00420927|448965766|FG005|Period 1|Noncompliant with study drug|0|||
124819615|NCT00420927|448965767|FG006|Period 1|Noncompliant with study drug|0|||
124819616|NCT00420927|448965761|FG000|Period 1|Randomization error|1|||
124819617|NCT00420927|448965762|FG001|Period 1|Randomization error|0|||
124819618|NCT00420927|448965763|FG002|Period 1|Randomization error|0|||
124819619|NCT00420927|448965764|FG003|Period 1|Randomization error|0|||
124819620|NCT00420927|448965765|FG004|Period 1|Randomization error|0|||
124819621|NCT00420927|448965766|FG005|Period 1|Randomization error|0|||
124819622|NCT00420927|448965767|FG006|Period 1|Randomization error|0|||
124819623|NCT00420927|448965761|FG000|Period 1|Suspected tuberculosis/positive test|1|||
124819624|NCT00420927|448965762|FG001|Period 1|Suspected tuberculosis/positive test|1|||
124819625|NCT00420927|448965763|FG002|Period 1|Suspected tuberculosis/positive test|0|||
124819626|NCT00420927|448965764|FG003|Period 1|Suspected tuberculosis/positive test|0|||
124819627|NCT00420927|448965765|FG004|Period 1|Suspected tuberculosis/positive test|0|||
124819628|NCT00420927|448965766|FG005|Period 1|Suspected tuberculosis/positive test|0|||
124819629|NCT00420927|448965767|FG006|Period 1|Suspected tuberculosis/positive test|0|||
124819630|NCT00420927|448965761|FG000|Period 1|Study site closure|0|||
124819631|NCT00420927|448965762|FG001|Period 1|Study site closure|1|||
124819632|NCT00420927|448965763|FG002|Period 1|Study site closure|0|||
124819633|NCT00420927|448965764|FG003|Period 1|Study site closure|0|||
124819634|NCT00420927|448965765|FG004|Period 1|Study site closure|0|||
124819635|NCT00420927|448965766|FG005|Period 1|Study site closure|0|||
124819636|NCT00420927|448965767|FG006|Period 1|Study site closure|0|||
124819637|NCT00420927|448965761|FG000|Period 1|Subject received new diagnosis|0|||
124819638|NCT00420927|448965762|FG001|Period 1|Subject received new diagnosis|2|||
124819639|NCT00420927|448965763|FG002|Period 1|Subject received new diagnosis|0|||
124819640|NCT00420927|448965764|FG003|Period 1|Subject received new diagnosis|0|||
124819641|NCT00420927|448965765|FG004|Period 1|Subject received new diagnosis|0|||
124819642|NCT00420927|448965766|FG005|Period 1|Subject received new diagnosis|0|||
124819643|NCT00420927|448965767|FG006|Period 1|Subject received new diagnosis|0|||
124819644|NCT00420927|448965761|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
124819645|NCT00420927|448965762|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
124819646|NCT00420927|448965763|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
124819647|NCT00420927|448965764|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
124819648|NCT00420927|448965765|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
124819649|NCT00420927|448965766|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
124819650|NCT00420927|448965767|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
124819651|NCT00420927|448965761|FG000|Period 1|Failed to meet entry criteria|8|||
124819652|NCT00420927|448965762|FG001|Period 1|Failed to meet entry criteria|7|||
124819653|NCT00420927|448965763|FG002|Period 1|Failed to meet entry criteria|0|||
124819654|NCT00420927|448965764|FG003|Period 1|Failed to meet entry criteria|0|||
124819655|NCT00420927|448965765|FG004|Period 1|Failed to meet entry criteria|0|||
124819656|NCT00420927|448965766|FG005|Period 1|Failed to meet entry criteria|0|||
124819657|NCT00420927|448965767|FG006|Period 1|Failed to meet entry criteria|0|||
124819658|NCT00420927|448965761|FG000|Period 1|Took prohibited medication|1|||
124819659|NCT00420927|448965762|FG001|Period 1|Took prohibited medication|3|||
124819660|NCT00420927|448965763|FG002|Period 1|Took prohibited medication|0|||
124819661|NCT00420927|448965764|FG003|Period 1|Took prohibited medication|0|||
124819662|NCT00420927|448965765|FG004|Period 1|Took prohibited medication|0|||
124819663|NCT00420927|448965766|FG005|Period 1|Took prohibited medication|0|||
124819664|NCT00420927|448965767|FG006|Period 1|Took prohibited medication|0|||
124819665|NCT00420927|448965761|FG000|Period 2|Adverse Event|0|||
124819666|NCT00420927|448965762|FG001|Period 2|Adverse Event|0|||
124819667|NCT00420927|448965763|FG002|Period 2|Adverse Event|7|||
124819668|NCT00420927|448965764|FG003|Period 2|Adverse Event|3|||
124819669|NCT00420927|448965765|FG004|Period 2|Adverse Event|17|||
124819670|NCT00420927|448965766|FG005|Period 2|Adverse Event|6|||
124819671|NCT00420927|448965767|FG006|Period 2|Adverse Event|20|||
124819672|NCT00420927|448965761|FG000|Period 2|Withdrawal by Subject|0|||
124819673|NCT00420927|448965762|FG001|Period 2|Withdrawal by Subject|0|||
124819674|NCT00420927|448965763|FG002|Period 2|Withdrawal by Subject|1|||
124819675|NCT00420927|448965764|FG003|Period 2|Withdrawal by Subject|3|||
124819676|NCT00420927|448965765|FG004|Period 2|Withdrawal by Subject|11|||
124819677|NCT00420927|448965766|FG005|Period 2|Withdrawal by Subject|2|||
124819678|NCT00420927|448965767|FG006|Period 2|Withdrawal by Subject|12|||
124819679|NCT00420927|448965761|FG000|Period 2|Lost to Follow-up|0|||
124819680|NCT00420927|448965762|FG001|Period 2|Lost to Follow-up|0|||
124819681|NCT00420927|448965763|FG002|Period 2|Lost to Follow-up|2|||
124819682|NCT00420927|448965764|FG003|Period 2|Lost to Follow-up|2|||
124819683|NCT00420927|448965765|FG004|Period 2|Lost to Follow-up|6|||
124819684|NCT00420927|448965766|FG005|Period 2|Lost to Follow-up|3|||
124819685|NCT00420927|448965767|FG006|Period 2|Lost to Follow-up|9|||
124819686|NCT00420927|448965761|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
124819687|NCT00420927|448965762|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
124819688|NCT00420927|448965763|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
124819689|NCT00420927|448965764|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
124819690|NCT00420927|448965765|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
124819691|NCT00420927|448965766|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
124819692|NCT00420927|448965767|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
124819693|NCT00420927|448965761|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
124819694|NCT00420927|448965762|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
124819695|NCT00420927|448965763|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
124819696|NCT00420927|448965764|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
124819697|NCT00420927|448965765|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
124819698|NCT00420927|448965766|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
124819699|NCT00420927|448965767|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
124819700|NCT00420927|448965761|FG000|Period 2|Subject unable to find transportation|0|||
124819701|NCT00420927|448965762|FG001|Period 2|Subject unable to find transportation|0|||
124819702|NCT00420927|448965763|FG002|Period 2|Subject unable to find transportation|0|||
124819703|NCT00420927|448965764|FG003|Period 2|Subject unable to find transportation|0|||
124819704|NCT00420927|448965765|FG004|Period 2|Subject unable to find transportation|0|||
125303183|NCT03100058|450736667|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
125303184|NCT03100058|450736668|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
125303185|NCT03100058|450736669|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
125303186|NCT03100058|450736670|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
125303187|NCT03100058|450736671|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
125303188|NCT03100058|450736672|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
125303189|NCT03100058|450736673|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
125303190|NCT03100058|450736661|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
124819705|NCT00420927|448965766|FG005|Period 2|Subject unable to find transportation|0|||
124819706|NCT00420927|448965767|FG006|Period 2|Subject unable to find transportation|1|||
124819707|NCT00420927|448965761|FG000|Period 2|Physician Decision|0|||
124819708|NCT00420927|448965762|FG001|Period 2|Physician Decision|0|||
124819709|NCT00420927|448965763|FG002|Period 2|Physician Decision|0|||
124819710|NCT00420927|448965764|FG003|Period 2|Physician Decision|0|||
124819711|NCT00420927|448965765|FG004|Period 2|Physician Decision|1|||
124819712|NCT00420927|448965766|FG005|Period 2|Physician Decision|1|||
124819713|NCT00420927|448965767|FG006|Period 2|Physician Decision|0|||
124819714|NCT00420927|448965761|FG000|Period 2|Sponsor decision|0|||
124819715|NCT00420927|448965762|FG001|Period 2|Sponsor decision|0|||
124819716|NCT00420927|448965763|FG002|Period 2|Sponsor decision|1|||
124819717|NCT00420927|448965764|FG003|Period 2|Sponsor decision|0|||
125303191|NCT03100058|450736662|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
124819718|NCT00420927|448965765|FG004|Period 2|Sponsor decision|0|||
124819719|NCT00420927|448965766|FG005|Period 2|Sponsor decision|0|||
124819720|NCT00420927|448965767|FG006|Period 2|Sponsor decision|1|||
124819721|NCT00420927|448965761|FG000|Period 2|Randomization error|0|||
124819722|NCT00420927|448965762|FG001|Period 2|Randomization error|0|||
124819723|NCT00420927|448965763|FG002|Period 2|Randomization error|0|||
124819724|NCT00420927|448965764|FG003|Period 2|Randomization error|0|||
125303192|NCT03100058|450736663|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
124819725|NCT00420927|448965765|FG004|Period 2|Randomization error|1|||
124819726|NCT00420927|448965766|FG005|Period 2|Randomization error|1|||
124819727|NCT00420927|448965767|FG006|Period 2|Randomization error|0|||
125309878|NCT00947115|450760199|FG000|Overall Study|Lost to Follow-up|11|||
124819728|NCT00420927|448965761|FG000|Period 2|Noncompliant with study drug|0|||
124819729|NCT00420927|448965762|FG001|Period 2|Noncompliant with study drug|0|||
124819730|NCT00420927|448965763|FG002|Period 2|Noncompliant with study drug|0|||
124819731|NCT00420927|448965764|FG003|Period 2|Noncompliant with study drug|1|||
124819732|NCT00420927|448965765|FG004|Period 2|Noncompliant with study drug|0|||
124819733|NCT00420927|448965766|FG005|Period 2|Noncompliant with study drug|0|||
124819734|NCT00420927|448965767|FG006|Period 2|Noncompliant with study drug|2|||
124819735|NCT00420927|448965761|FG000|Period 2|Methotrexate intolerance|0|||
124819736|NCT00420927|448965762|FG001|Period 2|Methotrexate intolerance|0|||
124819737|NCT00420927|448965763|FG002|Period 2|Methotrexate intolerance|0|||
124819738|NCT00420927|448965764|FG003|Period 2|Methotrexate intolerance|0|||
124819739|NCT00420927|448965765|FG004|Period 2|Methotrexate intolerance|0|||
124819740|NCT00420927|448965766|FG005|Period 2|Methotrexate intolerance|0|||
124819741|NCT00420927|448965767|FG006|Period 2|Methotrexate intolerance|1|||
124819742|NCT00420927|448965761|FG000|Period 2|Took prohibited medication|0|||
124819743|NCT00420927|448965762|FG001|Period 2|Took prohibited medication|0|||
124819744|NCT00420927|448965763|FG002|Period 2|Took prohibited medication|0|||
124819745|NCT00420927|448965764|FG003|Period 2|Took prohibited medication|0|||
124819746|NCT00420927|448965765|FG004|Period 2|Took prohibited medication|1|||
124819747|NCT00420927|448965766|FG005|Period 2|Took prohibited medication|0|||
124819748|NCT00420927|448965767|FG006|Period 2|Took prohibited medication|0|||
124819749|NCT04605484|448965770|FG000|Overall Study|Lost to Follow-up|0|||
124819750|NCT04605484|448965771|FG001|Overall Study|Lost to Follow-up|1|||
124819751|NCT04605484|448965772|FG002|Overall Study|Lost to Follow-up|1|||
124819752|NCT04605484|448965770|FG000|Overall Study|Other|0|||
124819753|NCT04605484|448965771|FG001|Overall Study|Other|1|||
124819754|NCT04605484|448965772|FG002|Overall Study|Other|0|||
124819755|NCT01370356|448965775|FG000|Overall Study|Death|1|||
124819756|NCT01370356|448965776|FG001|Overall Study|Death|0|||
124819757|NCT01370356|448965775|FG000|Overall Study|Lack of Efficacy|6|||
124819758|NCT01370356|448965776|FG001|Overall Study|Lack of Efficacy|28|||
124819759|NCT01370356|448965775|FG000|Overall Study|Lost to Follow-up|76|||
124819760|NCT01370356|448965776|FG001|Overall Study|Lost to Follow-up|81|||
124819761|NCT01370356|448965775|FG000|Overall Study|Withdrawal by Subject|54|||
124819762|NCT01370356|448965776|FG001|Overall Study|Withdrawal by Subject|59|||
124819763|NCT01370356|448965775|FG000|Overall Study|Reason not specified|39|||
124819764|NCT01370356|448965776|FG001|Overall Study|Reason not specified|43|||
124819765|NCT01370356|448965775|FG000|Overall Study|Protocol Violation|3|||
124819766|NCT01370356|448965776|FG001|Overall Study|Protocol Violation|3|||
124819767|NCT01370356|448965775|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
124819768|NCT01370356|448965776|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
124819769|NCT01370356|448965775|FG000|Overall Study|AE Not Related to Study Drug|1|||
124819770|NCT01370356|448965776|FG001|Overall Study|AE Not Related to Study Drug|4|||
124819771|NCT00040664|448965777|FG000|Overall Study|Adverse Event|12|||
124819772|NCT00040664|448965778|FG001|Overall Study|Adverse Event|3|||
124819773|NCT00040664|448965779|FG002|Overall Study|Adverse Event|2|||
124819774|NCT00040664|448965780|FG003|Overall Study|Adverse Event|7|||
124819775|NCT00040664|448965777|FG000|Overall Study|Lack of Efficacy|9|||
124819776|NCT00040664|448965778|FG001|Overall Study|Lack of Efficacy|2|||
124819777|NCT00040664|448965779|FG002|Overall Study|Lack of Efficacy|3|||
124819778|NCT00040664|448965780|FG003|Overall Study|Lack of Efficacy|4|||
124819779|NCT00040664|448965777|FG000|Overall Study|Insufficient CD4 response|1|||
124819780|NCT00040664|448965778|FG001|Overall Study|Insufficient CD4 response|0|||
124819781|NCT00040664|448965779|FG002|Overall Study|Insufficient CD4 response|1|||
124819782|NCT00040664|448965780|FG003|Overall Study|Insufficient CD4 response|0|||
124819783|NCT00040664|448965777|FG000|Overall Study|Lost to Follow-up|4|||
124819784|NCT00040664|448965778|FG001|Overall Study|Lost to Follow-up|2|||
124819785|NCT00040664|448965779|FG002|Overall Study|Lost to Follow-up|0|||
124819786|NCT00040664|448965780|FG003|Overall Study|Lost to Follow-up|2|||
124819787|NCT00040664|448965777|FG000|Overall Study|Protocol Violation|2|||
124819788|NCT00040664|448965778|FG001|Overall Study|Protocol Violation|1|||
124819789|NCT00040664|448965779|FG002|Overall Study|Protocol Violation|0|||
124819790|NCT00040664|448965780|FG003|Overall Study|Protocol Violation|1|||
124819791|NCT00040664|448965777|FG000|Overall Study|Withdrawal by Subject|7|||
124819792|NCT00040664|448965778|FG001|Overall Study|Withdrawal by Subject|0|||
124819793|NCT00040664|448965779|FG002|Overall Study|Withdrawal by Subject|3|||
124819794|NCT00040664|448965780|FG003|Overall Study|Withdrawal by Subject|4|||
124819795|NCT00040664|448965777|FG000|Overall Study|Pregnancy|3|||
124819796|NCT00040664|448965778|FG001|Overall Study|Pregnancy|0|||
124819797|NCT00040664|448965779|FG002|Overall Study|Pregnancy|0|||
124819798|NCT00040664|448965780|FG003|Overall Study|Pregnancy|3|||
124819799|NCT00040664|448965777|FG000|Overall Study|Medication adherence/compliance problems|8|||
124819800|NCT00040664|448965778|FG001|Overall Study|Medication adherence/compliance problems|2|||
124819801|NCT00040664|448965779|FG002|Overall Study|Medication adherence/compliance problems|1|||
124819802|NCT00040664|448965780|FG003|Overall Study|Medication adherence/compliance problems|5|||
124819803|NCT00040664|448965777|FG000|Overall Study|Poor taste|2|||
124819804|NCT00040664|448965778|FG001|Overall Study|Poor taste|0|||
124819805|NCT00040664|448965779|FG002|Overall Study|Poor taste|2|||
124819806|NCT00040664|448965780|FG003|Overall Study|Poor taste|0|||
124819807|NCT00040664|448965777|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
124819808|NCT00040664|448965778|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
124819809|NCT00040664|448965779|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
124819810|NCT00040664|448965780|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
124819811|NCT00040664|448965777|FG000|Overall Study|Change of formulation|2|||
124819812|NCT00040664|448965778|FG001|Overall Study|Change of formulation|2|||
124819813|NCT00040664|448965779|FG002|Overall Study|Change of formulation|0|||
124819814|NCT00040664|448965780|FG003|Overall Study|Change of formulation|0|||
124819815|NCT00040664|448965777|FG000|Overall Study|Non-viability of oral suspension|1|||
124819816|NCT00040664|448965778|FG001|Overall Study|Non-viability of oral suspension|0|||
124819817|NCT00040664|448965779|FG002|Overall Study|Non-viability of oral suspension|1|||
124819818|NCT00040664|448965780|FG003|Overall Study|Non-viability of oral suspension|0|||
124819819|NCT02925494|448965781|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
124819820|NCT02925494|448965782|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
124819821|NCT02925494|448965783|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
124819822|NCT02925494|448965784|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
124819823|NCT02925494|448965781|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
124819824|NCT02925494|448965782|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
124819825|NCT02925494|448965783|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
124819826|NCT02925494|448965784|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
124819827|NCT02925494|448965781|FG000|Post-Treatment Follow-Up Period|Other|1|||
124819828|NCT02925494|448965782|FG001|Post-Treatment Follow-Up Period|Other|4|||
124819829|NCT02925494|448965783|FG002|Post-Treatment Follow-Up Period|Other|3|||
124819830|NCT02925494|448965784|FG003|Post-Treatment Follow-Up Period|Other|6|||
124819831|NCT02925494|448965781|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
124819832|NCT02925494|448965782|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
124819833|NCT02925494|448965783|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
124819834|NCT02925494|448965784|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
124819835|NCT02925494|448965781|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
124819836|NCT02925494|448965782|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
124819837|NCT02925494|448965783|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
124819838|NCT02925494|448965784|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
124819839|NCT02925494|448965781|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
124819840|NCT02925494|448965782|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
124819841|NCT02925494|448965783|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
124819842|NCT02925494|448965784|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
124819843|NCT02925494|448965781|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
124819844|NCT02925494|448965782|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
124819845|NCT02925494|448965783|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
124819846|NCT02925494|448965784|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
124819847|NCT06149247|448965789|FG000|Overall Study|Adverse Event|0|||
124819848|NCT06149247|448965790|FG001|Overall Study|Adverse Event|1|||
124819849|NCT05182125|448965791|FG000|Overall Study|Withdrawal by Subject|0|||
124819850|NCT05182125|448965792|FG001|Overall Study|Withdrawal by Subject|0|||
124819851|NCT05182125|448965793|FG002|Overall Study|Withdrawal by Subject|0|||
124819852|NCT05182125|448965794|FG003|Overall Study|Withdrawal by Subject|0|||
124819853|NCT05182125|448965795|FG004|Overall Study|Withdrawal by Subject|2|||
124819854|NCT05182125|448965796|FG005|Overall Study|Withdrawal by Subject|0|||
124819855|NCT05182125|448965791|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
124819856|NCT05182125|448965792|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
124819857|NCT05182125|448965793|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
124819858|NCT05182125|448965794|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
124819859|NCT05182125|448965795|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
124819860|NCT05182125|448965796|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
124819861|NCT05182125|448965791|FG000|Overall Study|Death|0|||
124819862|NCT05182125|448965792|FG001|Overall Study|Death|0|||
124819863|NCT05182125|448965793|FG002|Overall Study|Death|0|||
124819864|NCT05182125|448965794|FG003|Overall Study|Death|0|||
124819865|NCT05182125|448965795|FG004|Overall Study|Death|1|||
124819866|NCT05182125|448965796|FG005|Overall Study|Death|0|||
124819867|NCT05182125|448965791|FG000|Overall Study|Health Contact Follow-up|5|||
124819868|NCT05182125|448965792|FG001|Overall Study|Health Contact Follow-up|5|||
124819869|NCT05182125|448965793|FG002|Overall Study|Health Contact Follow-up|2|||
125303193|NCT03100058|450736664|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
124819870|NCT05182125|448965794|FG003|Overall Study|Health Contact Follow-up|9|||
124819871|NCT05182125|448965795|FG004|Overall Study|Health Contact Follow-up|7|||
124819872|NCT05182125|448965796|FG005|Overall Study|Health Contact Follow-up|2|||
124819873|NCT01218243|448965797|FG000|Overall Study|Lack of Efficacy|1|||
124819874|NCT01218243|448965798|FG001|Overall Study|Lack of Efficacy|1|||
125303194|NCT03100058|450736665|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
124819875|NCT01218243|448965797|FG000|Overall Study|Lost to Follow-up|3|||
124819876|NCT01218243|448965798|FG001|Overall Study|Lost to Follow-up|3|||
124819877|NCT01218243|448965797|FG000|Overall Study|Protocol Violation|5|||
125303195|NCT03100058|450736666|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
124819878|NCT01218243|448965798|FG001|Overall Study|Protocol Violation|10|||
124819879|NCT02615145|448965800|FG000|Overall Study|Did Not Start Treatment|0|||
124819880|NCT02615145|448965801|FG001|Overall Study|Did Not Start Treatment|0|||
124819881|NCT02615145|448965802|FG002|Overall Study|Did Not Start Treatment|1|||
124819882|NCT02615145|448965803|FG003|Overall Study|Did Not Start Treatment|1|||
124819883|NCT02615145|448965800|FG000|Overall Study|Failure to Return|20|||
124819884|NCT02615145|448965801|FG001|Overall Study|Failure to Return|10|||
124819885|NCT02615145|448965802|FG002|Overall Study|Failure to Return|7|||
124819886|NCT02615145|448965803|FG003|Overall Study|Failure to Return|0|||
124819887|NCT02615145|448965800|FG000|Overall Study|Death|2|||
124819888|NCT02615145|448965801|FG001|Overall Study|Death|3|||
124819889|NCT02615145|448965802|FG002|Overall Study|Death|0|||
124819890|NCT02615145|448965803|FG003|Overall Study|Death|0|||
124819891|NCT02615145|448965800|FG000|Overall Study|Other, Not Specified|5|||
124819892|NCT02615145|448965801|FG001|Overall Study|Other, Not Specified|2|||
124819893|NCT02615145|448965802|FG002|Overall Study|Other, Not Specified|0|||
124819894|NCT02615145|448965803|FG003|Overall Study|Other, Not Specified|0|||
124819895|NCT03727347|448965804|FG000|Overall Study|Withdrawal by Subject|2|||
124819896|NCT03727347|448965804|FG000|Overall Study|Lost to Follow-up|1|||
124819897|NCT03200860|448965805|FG000|Overall Study|Withdrawal by Subject|1|||
124819898|NCT03200860|448965806|FG001|Overall Study|Withdrawal by Subject|0|||
124819899|NCT01744197|448965808|FG000|Overall Study|Received 1 patch|2|||
124819900|NCT01744197|448965809|FG001|Overall Study|Received 1 patch|1|||
124819901|NCT01744197|448965808|FG000|Overall Study|No patch received|2|||
124819902|NCT01744197|448965809|FG001|Overall Study|No patch received|2|||
124819903|NCT04342897|448965810|FG000|Overall Study|Death|7|||
124819904|NCT04342897|448965811|FG001|Overall Study|Death|4|||
124819905|NCT04342897|448965810|FG000|Overall Study|Lost to Follow-up|6|||
124819906|NCT04342897|448965811|FG001|Overall Study|Lost to Follow-up|6|||
124819907|NCT04342897|448965810|FG000|Overall Study|Withdrawal by Subject|1|||
124819908|NCT04342897|448965811|FG001|Overall Study|Withdrawal by Subject|2|||
124819909|NCT01325584|448965819|FG000|Overall Study|Death|1|||
124819910|NCT00887978|448965820|FG000|Overall Study|Adverse Event|18|||
124819911|NCT00887978|448965821|FG001|Overall Study|Adverse Event|5|||
124819912|NCT00887978|448965820|FG000|Overall Study|Clinical Worsening|4|||
124819913|NCT00887978|448965821|FG001|Overall Study|Clinical Worsening|4|||
124819914|NCT00887978|448965820|FG000|Overall Study|Death|2|||
124819915|NCT00887978|448965821|FG001|Overall Study|Death|3|||
124819916|NCT00887978|448965820|FG000|Overall Study|Withdrawal by Subject|1|||
124819917|NCT00887978|448965821|FG001|Overall Study|Withdrawal by Subject|2|||
124819918|NCT00887978|448965820|FG000|Overall Study|Lost to Follow-up|0|||
124819919|NCT00887978|448965821|FG001|Overall Study|Lost to Follow-up|1|||
124819920|NCT00309387|448967512|FG000|Overall Study|Death|72|||
124819921|NCT00309387|448967513|FG001|Overall Study|Death|73|||
124819922|NCT00309387|448967512|FG000|Overall Study|Lost to Follow-up|70|||
124819923|NCT00309387|448967513|FG001|Overall Study|Lost to Follow-up|86|||
124819924|NCT02483520|448967515|FG000|Overall Study|Lost to Follow-up|3|||
124819925|NCT02483520|448967516|FG001|Overall Study|Lost to Follow-up|4|||
124819926|NCT02483520|448967515|FG000|Overall Study|Withdrawal by Subject|4|||
124819927|NCT02483520|448967516|FG001|Overall Study|Withdrawal by Subject|14|||
124819928|NCT02483520|448967515|FG000|Overall Study|Hospitalized|2|||
124819929|NCT02483520|448967516|FG001|Overall Study|Hospitalized|3|||
124819930|NCT02483520|448967515|FG000|Overall Study|Moved to LTC|2|||
124819931|NCT02483520|448967516|FG001|Overall Study|Moved to LTC|3|||
124819932|NCT04492618|448967518|FG000|Overall Study|Withdrawal by Subject|1|||
124819933|NCT01401283|448967519|FG000|Overall Study|surgery cancelled|5|||
124819934|NCT01401283|448967520|FG001|Overall Study|surgery cancelled|8|||
124819935|NCT01401283|448967519|FG000|Overall Study|preoperative arrhythmia|5|||
124819936|NCT01401283|448967520|FG001|Overall Study|preoperative arrhythmia|0|||
124819937|NCT01401283|448967519|FG000|Overall Study|no central venous access|0|||
124819938|NCT01401283|448967520|FG001|Overall Study|no central venous access|1|||
124819939|NCT01401283|448967519|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
124819940|NCT01401283|448967520|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
124819941|NCT02101060|448967526|FG000|Overall Study|Adverse Event|1|||
124819942|NCT02101060|448967527|FG001|Overall Study|Adverse Event|0|||
124819943|NCT02101060|448967526|FG000|Overall Study|Withdrawal by Subject|1|||
124819944|NCT02101060|448967527|FG001|Overall Study|Withdrawal by Subject|1|||
124819945|NCT02101060|448967526|FG000|Overall Study|Lost to Follow-up|3|||
124819946|NCT02101060|448967527|FG001|Overall Study|Lost to Follow-up|3|||
124819947|NCT03462082|448967531|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
124819948|NCT03462082|448967532|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
124819949|NCT03462082|448967533|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
124819950|NCT03462082|448967534|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
124819951|NCT03462082|448967535|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
124819952|NCT03462082|448967536|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
124819953|NCT03462082|448967537|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
124819954|NCT03462082|448967538|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
124819955|NCT00166114|448967541|FG000|Overall Study|Protocol Violation|2|||
124819956|NCT00166114|448967542|FG001|Overall Study|Protocol Violation|1|||
124819957|NCT00166114|448967541|FG000|Overall Study|Withdrawal by Subject|10|||
124819958|NCT00166114|448967542|FG001|Overall Study|Withdrawal by Subject|4|||
124819959|NCT00166114|448967541|FG000|Overall Study|Adverse Event|2|||
124819960|NCT00166114|448967542|FG001|Overall Study|Adverse Event|1|||
124819961|NCT00545168|448967549|FG000|Overall Study|Lost to Follow-up|5|||
124819962|NCT00545168|448967550|FG001|Overall Study|Lost to Follow-up|5|||
124819963|NCT00545168|448967551|FG002|Overall Study|Lost to Follow-up|5|||
124819964|NCT00545168|448967549|FG000|Overall Study|Withdrawal by Subject|9|||
124819965|NCT00545168|448967550|FG001|Overall Study|Withdrawal by Subject|0|||
124819966|NCT00545168|448967551|FG002|Overall Study|Withdrawal by Subject|13|||
124819967|NCT00545168|448967549|FG000|Overall Study|Protocol Violation|1|||
124819968|NCT00545168|448967550|FG001|Overall Study|Protocol Violation|0|||
124819969|NCT00545168|448967551|FG002|Overall Study|Protocol Violation|1|||
124819970|NCT00545168|448967549|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
124819971|NCT00545168|448967550|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
124819972|NCT00545168|448967551|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
124819973|NCT01218204|448967552|FG000|Part B Washout|Adverse Event|0|||
124819974|NCT01218204|448967553|FG001|Part B Washout|Adverse Event|1|||
124819975|NCT01218204|448967554|FG002|Part B Washout|Adverse Event|0|||
124819976|NCT01218204|448967555|FG003|Part B Washout|Adverse Event|0|||
124819977|NCT01218204|448967552|FG000|Part B Washout|Lost to Follow-up|0|||
124819978|NCT01218204|448967553|FG001|Part B Washout|Lost to Follow-up|2|||
124819979|NCT01218204|448967554|FG002|Part B Washout|Lost to Follow-up|0|||
124819980|NCT01218204|448967555|FG003|Part B Washout|Lost to Follow-up|0|||
124819981|NCT01218204|448967552|FG000|Part B Washout|Physician Decision|0|||
124819982|NCT01218204|448967553|FG001|Part B Washout|Physician Decision|14|||
124819983|NCT01218204|448967554|FG002|Part B Washout|Physician Decision|0|||
124819984|NCT01218204|448967555|FG003|Part B Washout|Physician Decision|0|||
124819985|NCT01218204|448967552|FG000|Part B Washout|Withdrawal by Subject|0|||
124819986|NCT01218204|448967553|FG001|Part B Washout|Withdrawal by Subject|14|||
124819987|NCT01218204|448967554|FG002|Part B Washout|Withdrawal by Subject|0|||
124819988|NCT01218204|448967555|FG003|Part B Washout|Withdrawal by Subject|0|||
124819989|NCT01218204|448967552|FG000|Part B Washout|Reached defined stopping criteria|0|||
124819990|NCT01218204|448967553|FG001|Part B Washout|Reached defined stopping criteria|2|||
124819991|NCT01218204|448967554|FG002|Part B Washout|Reached defined stopping criteria|0|||
124819992|NCT01218204|448967555|FG003|Part B Washout|Reached defined stopping criteria|0|||
124819993|NCT01218204|448967552|FG000|Part B Washout|Did not meet continuation criteria|0|||
124819994|NCT01218204|448967553|FG001|Part B Washout|Did not meet continuation criteria|112|||
124819995|NCT01218204|448967554|FG002|Part B Washout|Did not meet continuation criteria|0|||
124819996|NCT01218204|448967555|FG003|Part B Washout|Did not meet continuation criteria|0|||
124819997|NCT01218204|448967552|FG000|Part B Run-in|Adverse Event|0|||
124819998|NCT01218204|448967553|FG001|Part B Run-in|Adverse Event|0|||
124819999|NCT01218204|448967554|FG002|Part B Run-in|Adverse Event|1|||
124820000|NCT01218204|448967555|FG003|Part B Run-in|Adverse Event|0|||
124820001|NCT01218204|448967552|FG000|Part B Run-in|Protocol Violation|0|||
124820002|NCT01218204|448967553|FG001|Part B Run-in|Protocol Violation|0|||
124820003|NCT01218204|448967554|FG002|Part B Run-in|Protocol Violation|2|||
124820004|NCT01218204|448967555|FG003|Part B Run-in|Protocol Violation|0|||
124820005|NCT01218204|448967552|FG000|Part B Run-in|Withdrawal by Subject|0|||
124820006|NCT01218204|448967553|FG001|Part B Run-in|Withdrawal by Subject|0|||
124820007|NCT01218204|448967554|FG002|Part B Run-in|Withdrawal by Subject|3|||
124820008|NCT01218204|448967555|FG003|Part B Run-in|Withdrawal by Subject|0|||
124820009|NCT01218204|448967552|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
124820010|NCT01218204|448967553|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
124820011|NCT01218204|448967554|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
124820012|NCT01218204|448967555|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
124820013|NCT01218204|448967552|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
124820014|NCT01218204|448967553|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
124820015|NCT01218204|448967554|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
124820016|NCT01218204|448967555|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
124820017|NCT00127660|448967561|FG000|Overall Study|Protocol Violation|3|||
124820018|NCT00127660|448967562|FG001|Overall Study|Protocol Violation|3|||
124820019|NCT00127660|448967563|FG002|Overall Study|Protocol Violation|5|||
124820020|NCT00127660|448967564|FG003|Overall Study|Protocol Violation|0|||
124820021|NCT01987505|448967565|FG000|Overall Study|Other|9|||
124820022|NCT01987505|448967565|FG000|Overall Study|Withdrawal by Subject|2|||
124820023|NCT01987505|448967565|FG000|Overall Study|Other Reason|2|||
124820024|NCT01987505|448967565|FG000|Overall Study|Lost to Follow-up|15|||
124820025|NCT01987505|448967565|FG000|Overall Study|Investigator Decision|2|||
124820026|NCT01987505|448967565|FG000|Overall Study|Death|4|||
124820027|NCT05131646|448967566|FG000|Overall Study|Withdrawal by Subject|1|||
124820028|NCT05131646|448967567|FG001|Overall Study|Withdrawal by Subject|0|||
124820029|NCT05131646|448967568|FG002|Overall Study|Withdrawal by Subject|0|||
124820030|NCT03266107|448967569|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
124820031|NCT03266107|448967569|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
124820032|NCT03266107|448967569|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
124820033|NCT03266107|448967569|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
125303196|NCT03100058|450736667|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
125303197|NCT03100058|450736668|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
125303198|NCT03100058|450736669|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
125303199|NCT03100058|450736670|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
125303200|NCT03100058|450736671|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
125303201|NCT03100058|450736672|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
125303202|NCT03100058|450736673|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
125303203|NCT03100058|450736661|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125303204|NCT03100058|450736662|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125303205|NCT03100058|450736663|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125303206|NCT03100058|450736664|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125303207|NCT03100058|450736665|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125303208|NCT03100058|450736666|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125303209|NCT03100058|450736667|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125303210|NCT03100058|450736668|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125303211|NCT03100058|450736669|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125303212|NCT03100058|450736670|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125303213|NCT03100058|450736671|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
124820034|NCT03454997|448967570|FG000|Overall Study|Staff Coach - Left Oranization|1|||
124820035|NCT03454997|448967571|FG001|Overall Study|Staff Coach - Left Oranization|1|||
124820036|NCT03454997|448967570|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
124820037|NCT03454997|448967571|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
124820038|NCT03454997|448967570|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
124820039|NCT03454997|448967571|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
124820040|NCT03454997|448967570|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
124820041|NCT03454997|448967571|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
124820042|NCT03454997|448967570|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
124820043|NCT03454997|448967571|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
124820044|NCT03454997|448967570|FG000|Overall Study|Client with SMI - Left organization|0|||
124820045|NCT03454997|448967571|FG001|Overall Study|Client with SMI - Left organization|1|||
124820046|NCT03454997|448967570|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
124820047|NCT03454997|448967571|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
124820048|NCT01191801|448967574|FG000|Overall Study|Death|36|||
124820049|NCT01191801|448967575|FG001|Overall Study|Death|12|||
124820050|NCT01191801|448967574|FG000|Overall Study|Lack of Efficacy|176|||
124820051|NCT01191801|448967575|FG001|Overall Study|Lack of Efficacy|258|||
124820052|NCT01191801|448967574|FG000|Overall Study|Adverse Event|9|||
124820053|NCT01191801|448967575|FG001|Overall Study|Adverse Event|8|||
124820054|NCT01191801|448967574|FG000|Overall Study|Protocol Violation|2|||
124820055|NCT01191801|448967575|FG001|Overall Study|Protocol Violation|4|||
124820056|NCT01191801|448967574|FG000|Overall Study|Physician Decision|47|||
124820057|NCT01191801|448967575|FG001|Overall Study|Physician Decision|24|||
124820058|NCT01191801|448967574|FG000|Overall Study|Withdrawal by Subject|1|||
124820059|NCT01191801|448967575|FG001|Overall Study|Withdrawal by Subject|4|||
124820060|NCT01191801|448967574|FG000|Overall Study|Not Provided|45|||
124820061|NCT01191801|448967575|FG001|Overall Study|Not Provided|27|||
124820062|NCT00299975|448967586|FG000|Overall Study|Adverse Event|1|||
124820063|NCT00299975|448967587|FG001|Overall Study|Adverse Event|0|||
124820064|NCT00299975|448967588|FG002|Overall Study|Adverse Event|2|||
124820065|NCT00299975|448967586|FG000|Overall Study|Pregnancy|0|||
124820066|NCT00299975|448967587|FG001|Overall Study|Pregnancy|0|||
124820067|NCT00299975|448967588|FG002|Overall Study|Pregnancy|1|||
124820068|NCT00299975|448967586|FG000|Overall Study|Lack of Efficacy|1|||
124820069|NCT00299975|448967587|FG001|Overall Study|Lack of Efficacy|0|||
124820070|NCT00299975|448967588|FG002|Overall Study|Lack of Efficacy|1|||
124820071|NCT00299975|448967586|FG000|Overall Study|Lost to Follow-up|1|||
124820072|NCT00299975|448967587|FG001|Overall Study|Lost to Follow-up|0|||
124820073|NCT00299975|448967588|FG002|Overall Study|Lost to Follow-up|0|||
125303214|NCT03100058|450736672|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
124820074|NCT00299975|448967586|FG000|Overall Study|Withdrawal by Subject|0|||
124820075|NCT00299975|448967587|FG001|Overall Study|Withdrawal by Subject|1|||
124820076|NCT00299975|448967588|FG002|Overall Study|Withdrawal by Subject|3|||
124820077|NCT00299975|448967586|FG000|Overall Study|Physician Decision|0|||
124820078|NCT00299975|448967587|FG001|Overall Study|Physician Decision|0|||
124820079|NCT00299975|448967588|FG002|Overall Study|Physician Decision|1|||
124820080|NCT00171730|448967591|FG000|Overall Study|Adverse Event|3|||
124820081|NCT00171730|448967591|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
124820082|NCT00171730|448967591|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
124820083|NCT00171730|448967591|FG000|Overall Study|Withdrawal by Subject|3|||
124820084|NCT05025241|448967592|FG000|Screening|Failed Screening|5|||
124820085|NCT05025241|448967592|FG000|Treatment and Follow Up|Adverse Event|3|||
124820086|NCT01053221|448967593|FG000|Overall Study|The study was closed prematurely|5|||
124820087|NCT01053221|448967594|FG001|Overall Study|The study was closed prematurely|9|||
124820088|NCT02266225|448967595|FG000|Overall Study|Lost to Follow-up|2|||
124820089|NCT02266225|448967595|FG000|Overall Study|Death|1|||
124820090|NCT02266225|448967595|FG000|Overall Study|Withdrawal by Subject|13|||
124820091|NCT01465997|448967596|FG000|Overall Study|Adverse Event|12|||
124820092|NCT01465997|448967597|FG001|Overall Study|Adverse Event|22|||
124820093|NCT01465997|448967596|FG000|Overall Study|Lack of Efficacy|13|||
124820094|NCT01465997|448967597|FG001|Overall Study|Lack of Efficacy|1|||
124820095|NCT01465997|448967596|FG000|Overall Study|Protocol Violation|1|||
124820096|NCT01465997|448967597|FG001|Overall Study|Protocol Violation|4|||
124820097|NCT01465997|448967596|FG000|Overall Study|Lost to Follow-up|6|||
124820098|NCT01465997|448967597|FG001|Overall Study|Lost to Follow-up|9|||
124820099|NCT01465997|448967596|FG000|Overall Study|Withdrawal by Subject|32|||
124820100|NCT01465997|448967597|FG001|Overall Study|Withdrawal by Subject|35|||
124820101|NCT01465997|448967596|FG000|Overall Study|investigator's decision|1|||
124820102|NCT01465997|448967597|FG001|Overall Study|investigator's decision|1|||
124820103|NCT01465997|448967596|FG000|Overall Study|Death|0|||
124820104|NCT01465997|448967597|FG001|Overall Study|Death|1|||
124820105|NCT01465997|448967596|FG000|Overall Study|sponsor's decision|1|||
124820106|NCT01465997|448967597|FG001|Overall Study|sponsor's decision|1|||
124820107|NCT01465997|448967596|FG000|Overall Study|subject withdrew consent|1|||
124820108|NCT01465997|448967597|FG001|Overall Study|subject withdrew consent|0|||
124820109|NCT01465997|448967596|FG000|Overall Study|local lab unblinded site|1|||
124820110|NCT01465997|448967597|FG001|Overall Study|local lab unblinded site|0|||
124820111|NCT01465997|448967596|FG000|Overall Study|withdrew before follow-up|0|||
124820112|NCT01465997|448967597|FG001|Overall Study|withdrew before follow-up|13|||
124820113|NCT01465997|448967596|FG000|Overall Study|decision by site staff|0|||
124820114|NCT01465997|448967597|FG001|Overall Study|decision by site staff|1|||
124820115|NCT01465997|448967596|FG000|Overall Study|subject left participation SP0993|0|||
124820116|NCT01465997|448967597|FG001|Overall Study|subject left participation SP0993|1|||
124820117|NCT02246660|448967598|FG000|Overall Study|Withdrawal by Subject|0|||
124820118|NCT02246660|448967599|FG001|Overall Study|Withdrawal by Subject|1|||
124820119|NCT02246660|448967600|FG002|Overall Study|Withdrawal by Subject|0|||
124820120|NCT02246660|448967598|FG000|Overall Study|Death|0|||
124820121|NCT02246660|448967599|FG001|Overall Study|Death|0|||
124820122|NCT02246660|448967600|FG002|Overall Study|Death|1|||
124820123|NCT03018704|448967601|FG000|Overall Study|Lost to Follow-up|1|||
124820124|NCT03018704|448967602|FG001|Overall Study|Lost to Follow-up|1|||
124820125|NCT00642460|448967605|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
124820126|NCT00642460|448967606|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
124820127|NCT00642460|448967607|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
124820128|NCT00642460|448967608|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
124820129|NCT00642460|448967609|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
124820130|NCT00642460|448967610|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
124820131|NCT00642460|448967605|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
124820132|NCT00642460|448967606|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
124820133|NCT00642460|448967607|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
124820134|NCT00642460|448967608|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
124820135|NCT00642460|448967609|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
124820136|NCT00642460|448967610|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
124820137|NCT00642460|448967605|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
124820138|NCT00642460|448967606|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
124820139|NCT00642460|448967607|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
124820140|NCT00642460|448967608|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
124820141|NCT00642460|448967609|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
124820142|NCT00642460|448967610|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
124820143|NCT00642460|448967605|FG000|Part II: Open-Label Up to Week 92|Death|0|||
124820144|NCT00642460|448967606|FG001|Part II: Open-Label Up to Week 92|Death|1|||
124820145|NCT00642460|448967607|FG002|Part II: Open-Label Up to Week 92|Death|0|||
124820146|NCT00642460|448967608|FG003|Part II: Open-Label Up to Week 92|Death|2|||
124820147|NCT00642460|448967609|FG004|Part II: Open-Label Up to Week 92|Death|0|||
124820148|NCT00642460|448967610|FG005|Part II: Open-Label Up to Week 92|Death|0|||
124820149|NCT00642460|448967605|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
125303215|NCT03100058|450736673|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
125303216|NCT03100058|450736661|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
124820150|NCT00642460|448967606|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
124820151|NCT00642460|448967607|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
124820152|NCT00642460|448967608|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
124820153|NCT00642460|448967609|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
124820154|NCT00642460|448967610|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
124820155|NCT00642460|448967605|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
124820156|NCT00642460|448967606|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
124820157|NCT00642460|448967607|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
125303217|NCT03100058|450736662|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
124820158|NCT00642460|448967608|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
124820159|NCT00642460|448967609|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
124820160|NCT00642460|448967610|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
124820161|NCT00642460|448967605|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
124820162|NCT00642460|448967606|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
124820163|NCT00642460|448967607|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
124820164|NCT00642460|448967608|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
124820165|NCT00642460|448967609|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
124820166|NCT00642460|448967610|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
124820167|NCT00642460|448967605|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
124820168|NCT00642460|448967606|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
124820169|NCT00642460|448967607|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
124820170|NCT00642460|448967608|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
124820171|NCT00642460|448967609|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
124820172|NCT00642460|448967610|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
124820173|NCT00642460|448967605|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
124820174|NCT00642460|448967606|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
124820175|NCT00642460|448967607|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
124820176|NCT00642460|448967608|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
124820177|NCT00642460|448967609|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
124820178|NCT00642460|448967610|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
124820179|NCT00642460|448967605|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
124820180|NCT00642460|448967606|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
124820181|NCT00642460|448967607|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
124820182|NCT00642460|448967608|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
124820183|NCT00642460|448967609|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
124820184|NCT00642460|448967610|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
124820185|NCT00642460|448967605|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
124820186|NCT00642460|448967606|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
124820187|NCT00642460|448967607|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
124820188|NCT00642460|448967608|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
124820189|NCT00642460|448967609|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
124820190|NCT00642460|448967610|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
124820191|NCT00642460|448967605|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
124820192|NCT00642460|448967606|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
124820193|NCT00642460|448967607|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
124820194|NCT00642460|448967608|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
124820195|NCT00642460|448967609|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
124820196|NCT00642460|448967610|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
124820197|NCT00642460|448967605|FG000|Part III: Open-Label Up to Week 260|Other|0|||
124820198|NCT00642460|448967606|FG001|Part III: Open-Label Up to Week 260|Other|0|||
124820199|NCT00642460|448967607|FG002|Part III: Open-Label Up to Week 260|Other|0|||
124820200|NCT00642460|448967608|FG003|Part III: Open-Label Up to Week 260|Other|0|||
124820201|NCT00642460|448967609|FG004|Part III: Open-Label Up to Week 260|Other|2|||
124820202|NCT00642460|448967610|FG005|Part III: Open-Label Up to Week 260|Other|2|||
124820203|NCT00642460|448967605|FG000|Part III: Open-Label Up to Week 260|Death|0|||
124820204|NCT00642460|448967606|FG001|Part III: Open-Label Up to Week 260|Death|0|||
124820205|NCT00642460|448967607|FG002|Part III: Open-Label Up to Week 260|Death|0|||
124820206|NCT00642460|448967608|FG003|Part III: Open-Label Up to Week 260|Death|0|||
124820207|NCT00642460|448967609|FG004|Part III: Open-Label Up to Week 260|Death|0|||
124820208|NCT00642460|448967610|FG005|Part III: Open-Label Up to Week 260|Death|3|||
124820209|NCT00642460|448967605|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
124820210|NCT00642460|448967606|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
124820211|NCT00642460|448967607|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
124820212|NCT00642460|448967608|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
124820213|NCT00642460|448967609|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
124820214|NCT00642460|448967610|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
124820215|NCT00642460|448967605|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
124820216|NCT00642460|448967606|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
124820217|NCT00642460|448967607|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
125303218|NCT03100058|450736663|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
125303219|NCT03100058|450736664|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
125303220|NCT03100058|450736665|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
124820218|NCT00642460|448967608|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
124820219|NCT00642460|448967609|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
124820220|NCT00642460|448967610|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
124820221|NCT00320411|448967611|FG000|Overall Study|No investigational product admin.|4|||
124820222|NCT02557646|448967614|FG000|Overall Study|Adverse Event|40|||
124820223|NCT02557646|448967614|FG000|Overall Study|Death|1|||
124820224|NCT02557646|448967614|FG000|Overall Study|Lack of Efficacy|186|||
124820225|NCT02557646|448967614|FG000|Overall Study|Withdrawal by Subject|18|||
124820226|NCT02557646|448967614|FG000|Overall Study|Lost to Follow-up|17|||
124820227|NCT02557646|448967614|FG000|Overall Study|Other|14|||
124820228|NCT04448171|448967615|FG000|Overall Study|Procedure Cancelled|1|||
124820229|NCT04448171|448967616|FG001|Overall Study|Procedure Cancelled|0|||
124820230|NCT04448171|448967615|FG000|Overall Study|Protocol Violation|1|||
124820231|NCT04448171|448967616|FG001|Overall Study|Protocol Violation|0|||
124820232|NCT00660309|448967617|FG000|Overall Study|Adverse Event|2|||
124820233|NCT00660309|448967618|FG001|Overall Study|Adverse Event|0|||
124820234|NCT00660309|448967617|FG000|Overall Study|Withdrawal by Subject|0|||
124820235|NCT00660309|448967618|FG001|Overall Study|Withdrawal by Subject|3|||
124820236|NCT02573311|448967619|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
124820237|NCT02573311|448967620|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
124820238|NCT02573311|448967619|FG000|Disposition for Part 2|Physician Decision|25|||
124820239|NCT02573311|448967620|FG001|Disposition for Part 2|Physician Decision|7|||
124820240|NCT02573311|448967619|FG000|Disposition for Part 2|Adverse Event|36|||
124820241|NCT02573311|448967620|FG001|Disposition for Part 2|Adverse Event|5|||
124820242|NCT02573311|448967619|FG000|Disposition for Part 2|Lost to Follow-up|76|||
124820243|NCT02573311|448967620|FG001|Disposition for Part 2|Lost to Follow-up|7|||
124820244|NCT02573311|448967619|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
124820245|NCT02573311|448967620|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
124820246|NCT02573311|448967619|FG000|Disposition for Part 2|Investigator decision|0|||
124820247|NCT02573311|448967620|FG001|Disposition for Part 2|Investigator decision|1|||
124820248|NCT02573311|448967619|FG000|Disposition for Part 2|Other than specified above|13|||
124820249|NCT02573311|448967620|FG001|Disposition for Part 2|Other than specified above|3|||
124820250|NCT05683249|448967622|FG000|Overall Study|Adverse Event|3|||
124820251|NCT05683249|448967623|FG001|Overall Study|Adverse Event|1|||
124820252|NCT05683249|448967622|FG000|Overall Study|Lack of Efficacy|0|||
124820253|NCT05683249|448967623|FG001|Overall Study|Lack of Efficacy|2|||
124820254|NCT05683249|448967622|FG000|Overall Study|Lost to Follow-up|6|||
124820255|NCT05683249|448967623|FG001|Overall Study|Lost to Follow-up|5|||
124820256|NCT05683249|448967622|FG000|Overall Study|Non-compliance with Study Drug|2|||
124820257|NCT05683249|448967623|FG001|Overall Study|Non-compliance with Study Drug|0|||
124820258|NCT05683249|448967622|FG000|Overall Study|Protocol Violation|6|||
124820259|NCT05683249|448967623|FG001|Overall Study|Protocol Violation|3|||
124820260|NCT05683249|448967622|FG000|Overall Study|Withdrawal by Subject|9|||
124820261|NCT05683249|448967623|FG001|Overall Study|Withdrawal by Subject|8|||
124820262|NCT05683249|448967622|FG000|Overall Study|Other|0|||
124820263|NCT05683249|448967623|FG001|Overall Study|Other|2|||
124820264|NCT05288062|448967628|FG000|Overall Study|Ineligible|0|||
124820265|NCT05288062|448967629|FG001|Overall Study|Ineligible|0|||
124820266|NCT05288062|448967630|FG002|Overall Study|Ineligible|1|||
124820267|NCT05288062|448967631|FG003|Overall Study|Ineligible|0|||
124820268|NCT05288062|448967628|FG000|Overall Study|Withdrawal by Subject|0|||
124820269|NCT05288062|448967629|FG001|Overall Study|Withdrawal by Subject|0|||
124820270|NCT05288062|448967630|FG002|Overall Study|Withdrawal by Subject|1|||
124820271|NCT05288062|448967631|FG003|Overall Study|Withdrawal by Subject|0|||
124820272|NCT01217814|448967632|FG000|Overall Study|Adverse Event|1|||
124820273|NCT01217814|448967633|FG001|Overall Study|Adverse Event|1|||
124820274|NCT01217814|448967634|FG002|Overall Study|Adverse Event|0|||
124820275|NCT01217814|448967632|FG000|Overall Study|Lack of Efficacy|0|||
125303221|NCT03100058|450736666|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
125303222|NCT03100058|450736667|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
125303223|NCT03100058|450736668|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
125303224|NCT03100058|450736669|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
124820276|NCT01217814|448967633|FG001|Overall Study|Lack of Efficacy|0|||
124820277|NCT01217814|448967634|FG002|Overall Study|Lack of Efficacy|1|||
124820278|NCT03926169|448967638|FG000|Period A|Adverse Event|2|||
124820279|NCT03926169|448967639|FG001|Period A|Adverse Event|2|||
124820280|NCT03926169|448967640|FG002|Period A|Adverse Event|1|||
124820281|NCT03926169|448967638|FG000|Period A|Withdrawal by Subject|2|||
124820282|NCT03926169|448967639|FG001|Period A|Withdrawal by Subject|2|||
124820283|NCT03926169|448967640|FG002|Period A|Withdrawal by Subject|2|||
124820284|NCT03926169|448967638|FG000|Period A|Lost to Follow-up|3|||
124820285|NCT03926169|448967639|FG001|Period A|Lost to Follow-up|1|||
124820286|NCT03926169|448967640|FG002|Period A|Lost to Follow-up|0|||
124820287|NCT03926169|448967638|FG000|Period A|Lack of Efficacy|0|||
124820288|NCT03926169|448967639|FG001|Period A|Lack of Efficacy|2|||
124820289|NCT03926169|448967640|FG002|Period A|Lack of Efficacy|2|||
124820290|NCT03926169|448967638|FG000|Period A|COVID-19 Infection|0|||
124820291|NCT03926169|448967639|FG001|Period A|COVID-19 Infection|1|||
124820292|NCT03926169|448967640|FG002|Period A|COVID-19 Infection|0|||
124820293|NCT03926169|448967638|FG000|Period A|COVID-19 Logistical Restrictions|0|||
124820294|NCT03926169|448967639|FG001|Period A|COVID-19 Logistical Restrictions|2|||
124820295|NCT03926169|448967640|FG002|Period A|COVID-19 Logistical Restrictions|1|||
124820296|NCT03926169|448967638|FG000|Period A|Other, Not Specified|1|||
124820297|NCT03926169|448967639|FG001|Period A|Other, Not Specified|0|||
124820298|NCT03926169|448967640|FG002|Period A|Other, Not Specified|0|||
124820299|NCT03926169|448967638|FG000|Period B|Adverse Event|3|||
124820300|NCT03926169|448967639|FG001|Period B|Adverse Event|1|||
124820301|NCT03926169|448967640|FG002|Period B|Adverse Event|1|||
124820302|NCT03926169|448967638|FG000|Period B|Withdrawal by Subject|1|||
124820303|NCT03926169|448967639|FG001|Period B|Withdrawal by Subject|3|||
124820304|NCT03926169|448967640|FG002|Period B|Withdrawal by Subject|0|||
124820305|NCT03926169|448967638|FG000|Period B|Lack of Efficacy|3|||
124820306|NCT03926169|448967639|FG001|Period B|Lack of Efficacy|1|||
124820307|NCT03926169|448967640|FG002|Period B|Lack of Efficacy|1|||
124820308|NCT03926169|448967638|FG000|Period B|Lost to Follow-up|1|||
124820309|NCT03926169|448967639|FG001|Period B|Lost to Follow-up|1|||
124820310|NCT03926169|448967640|FG002|Period B|Lost to Follow-up|4|||
124820311|NCT03926169|448967638|FG000|Period B|Other, Not Specified|62|||
124820312|NCT03926169|448967639|FG001|Period B|Other, Not Specified|57|||
124820313|NCT03926169|448967640|FG002|Period B|Other, Not Specified|65|||
124820314|NCT00844896|448967641|FG000|Overall Study|Lost to Follow-up|12|||
124820315|NCT00844896|448967642|FG001|Overall Study|Lost to Follow-up|16|||
124820316|NCT00844896|448967641|FG000|Overall Study|Parents did not have time to complete|0|||
124820317|NCT00844896|448967642|FG001|Overall Study|Parents did not have time to complete|1|||
124820318|NCT02233647|448967643|FG000|Overall Study|Adverse Event|1|||
124820319|NCT01835587|448967647|FG000|Overall Study|Disease Recurrence or Relapse|0|||
124820320|NCT01835587|448967648|FG001|Overall Study|Disease Recurrence or Relapse|3|||
124820321|NCT01835587|448967649|FG002|Overall Study|Disease Recurrence or Relapse|0|||
124820322|NCT01835587|448967650|FG003|Overall Study|Disease Recurrence or Relapse|3|||
124820323|NCT01835587|448967647|FG000|Overall Study|Withdrawal by Subject|2|||
124820324|NCT01835587|448967648|FG001|Overall Study|Withdrawal by Subject|0|||
124820325|NCT01835587|448967649|FG002|Overall Study|Withdrawal by Subject|0|||
124820326|NCT01835587|448967650|FG003|Overall Study|Withdrawal by Subject|3|||
124820327|NCT01835587|448967647|FG000|Overall Study|Adverse Event|0|||
124820328|NCT01835587|448967648|FG001|Overall Study|Adverse Event|0|||
124820329|NCT01835587|448967649|FG002|Overall Study|Adverse Event|2|||
124820330|NCT01835587|448967650|FG003|Overall Study|Adverse Event|2|||
124820331|NCT01835587|448967647|FG000|Overall Study|Death|0|||
124820332|NCT01835587|448967648|FG001|Overall Study|Death|0|||
124820333|NCT01835587|448967649|FG002|Overall Study|Death|0|||
124820334|NCT01835587|448967650|FG003|Overall Study|Death|1|||
124820335|NCT01835587|448967647|FG000|Overall Study|Miscellaneous|0|||
124820336|NCT01835587|448967648|FG001|Overall Study|Miscellaneous|1|||
124820337|NCT01835587|448967649|FG002|Overall Study|Miscellaneous|0|||
124820338|NCT01835587|448967650|FG003|Overall Study|Miscellaneous|0|||
124820339|NCT03199274|448967660|FG000|Overall Study|Withdrawal by Subject|4|||
124820340|NCT03199274|448967661|FG001|Overall Study|Withdrawal by Subject|0|||
124820341|NCT03199274|448967660|FG000|Overall Study|Lost to Follow-up|0|||
124820342|NCT03199274|448967661|FG001|Overall Study|Lost to Follow-up|1|||
124820343|NCT03199274|448967660|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
124820344|NCT03199274|448967661|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
125303225|NCT03100058|450736670|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
125303226|NCT03100058|450736671|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
125303227|NCT03100058|450736672|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
125303228|NCT03100058|450736673|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
125303229|NCT03671304|450736675|FG000|Overall Study|study terminated|7|||
124820347|NCT02846779|448967664|FG000|Overall Study|Lost Enrollment|83|||
124820348|NCT02846779|448967665|FG001|Overall Study|Lost Enrollment|82|||
124820349|NCT02846779|448967666|FG002|Overall Study|Lost Enrollment|86|||
124820350|NCT02846779|448967664|FG000|Overall Study|Less than 31 days of follow-up|56|||
124820351|NCT02846779|448967665|FG001|Overall Study|Less than 31 days of follow-up|45|||
124820352|NCT02846779|448967666|FG002|Overall Study|Less than 31 days of follow-up|52|||
124820353|NCT02239978|448968798|FG000|Overall Study|Withdrawal by Subject|2|||
124820354|NCT02239978|448968799|FG001|Overall Study|Withdrawal by Subject|0|||
124820355|NCT01943292|448968814|FG000|Overall Study|Withdrawal by Subject|1|||
124820356|NCT01943292|448968815|FG001|Overall Study|Withdrawal by Subject|0|||
124820357|NCT01943292|448968816|FG002|Overall Study|Withdrawal by Subject|0|||
124820358|NCT00638378|448968817|FG000|Overall Study|Death|2|||
124820359|NCT00638378|448968817|FG000|Overall Study|Adverse Event|1|||
124820360|NCT00638378|448968817|FG000|Overall Study|Disease progression|15|||
124820361|NCT00638378|448968817|FG000|Overall Study|Physician Decision|4|||
124820362|NCT01852110|448968818|FG000|Overall Study|Adverse Event|12|||
124820363|NCT01852110|448968819|FG001|Overall Study|Adverse Event|5|||
124820364|NCT01852110|448968820|FG002|Overall Study|Adverse Event|0|||
124820365|NCT01852110|448968821|FG003|Overall Study|Adverse Event|0|||
124820366|NCT01852110|448968822|FG004|Overall Study|Adverse Event|0|||
124820367|NCT01852110|448968823|FG005|Overall Study|Adverse Event|0|||
124820368|NCT01852110|448968818|FG000|Overall Study|Lost to Follow-up|1|||
124820369|NCT01852110|448968819|FG001|Overall Study|Lost to Follow-up|3|||
124820370|NCT01852110|448968820|FG002|Overall Study|Lost to Follow-up|0|||
124820371|NCT01852110|448968821|FG003|Overall Study|Lost to Follow-up|0|||
124820372|NCT01852110|448968822|FG004|Overall Study|Lost to Follow-up|0|||
124820373|NCT01852110|448968823|FG005|Overall Study|Lost to Follow-up|0|||
124820374|NCT01852110|448968818|FG000|Overall Study|Non-compliance with Study Drug|2|||
124820375|NCT01852110|448968819|FG001|Overall Study|Non-compliance with Study Drug|1|||
124820376|NCT01852110|448968820|FG002|Overall Study|Non-compliance with Study Drug|0|||
124820377|NCT01852110|448968821|FG003|Overall Study|Non-compliance with Study Drug|0|||
124820378|NCT01852110|448968822|FG004|Overall Study|Non-compliance with Study Drug|0|||
124820379|NCT01852110|448968823|FG005|Overall Study|Non-compliance with Study Drug|0|||
124820380|NCT01852110|448968818|FG000|Overall Study|Physician Decision|1|||
124820381|NCT01852110|448968819|FG001|Overall Study|Physician Decision|0|||
124820382|NCT01852110|448968820|FG002|Overall Study|Physician Decision|0|||
124820383|NCT01852110|448968821|FG003|Overall Study|Physician Decision|0|||
124820384|NCT01852110|448968822|FG004|Overall Study|Physician Decision|0|||
124820385|NCT01852110|448968823|FG005|Overall Study|Physician Decision|0|||
124820386|NCT01852110|448968818|FG000|Overall Study|Protocol Violation|0|||
124820387|NCT01852110|448968819|FG001|Overall Study|Protocol Violation|1|||
124820388|NCT01852110|448968820|FG002|Overall Study|Protocol Violation|0|||
124820389|NCT01852110|448968821|FG003|Overall Study|Protocol Violation|0|||
124820390|NCT01852110|448968822|FG004|Overall Study|Protocol Violation|0|||
124820391|NCT01852110|448968823|FG005|Overall Study|Protocol Violation|0|||
124820392|NCT01852110|448968818|FG000|Overall Study|Study Terminated by Sponsor|30|||
124820393|NCT01852110|448968819|FG001|Overall Study|Study Terminated by Sponsor|32|||
124820394|NCT01852110|448968820|FG002|Overall Study|Study Terminated by Sponsor|0|||
124820395|NCT01852110|448968821|FG003|Overall Study|Study Terminated by Sponsor|0|||
124820396|NCT01852110|448968822|FG004|Overall Study|Study Terminated by Sponsor|0|||
124820397|NCT01852110|448968823|FG005|Overall Study|Study Terminated by Sponsor|0|||
124820398|NCT01852110|448968818|FG000|Overall Study|Withdrawal by Subject|4|||
124820399|NCT01852110|448968819|FG001|Overall Study|Withdrawal by Subject|4|||
124820400|NCT01852110|448968820|FG002|Overall Study|Withdrawal by Subject|0|||
124820401|NCT01852110|448968821|FG003|Overall Study|Withdrawal by Subject|0|||
124820402|NCT01852110|448968822|FG004|Overall Study|Withdrawal by Subject|0|||
124820403|NCT01852110|448968823|FG005|Overall Study|Withdrawal by Subject|0|||
124820404|NCT00759031|448968824|FG000|First Intervention (1 Day)|Physician Decision|1|||
124820405|NCT00759031|448968825|FG001|First Intervention (1 Day)|Physician Decision|0|||
124820406|NCT00759031|448968824|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
124820407|NCT00759031|448968825|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
124820408|NCT00759031|448968824|FG000|First Intervention (1 Day)|Screening failure|1|||
124820409|NCT00759031|448968825|FG001|First Intervention (1 Day)|Screening failure|0|||
124820410|NCT02430311|448968826|FG000|Part A|Adverse Event|0|||
124820411|NCT02430311|448968827|FG001|Part A|Adverse Event|1|||
124820412|NCT02430311|448968826|FG000|Part A|Withdrawal by Subject|1|||
124820413|NCT02430311|448968827|FG001|Part A|Withdrawal by Subject|0|||
124820414|NCT02430311|448968826|FG000|Part B|Meet study-specific withdrawal criteria|6|||
124820415|NCT02430311|448968827|FG001|Part B|Meet study-specific withdrawal criteria|6|||
124820416|NCT02430311|448968826|FG000|Part B|Withdrawal by Subject|2|||
124820417|NCT02430311|448968827|FG001|Part B|Withdrawal by Subject|2|||
124820418|NCT02430311|448968826|FG000|Part B|Adverse Event|1|||
124820419|NCT02430311|448968827|FG001|Part B|Adverse Event|0|||
124820420|NCT02430311|448968826|FG000|Part B|Death|1|||
125303230|NCT00479856|450736677|FG000|Overall Study|Adverse Event|1|||
125303231|NCT00479856|450736677|FG000|Overall Study|Withdrawal by Subject|1|||
125303232|NCT00479856|450736677|FG000|Overall Study|Physician Decision|1|||
125303233|NCT02760810|450736678|FG000|Overall Study|Protocol Violation|1|||
124820421|NCT02430311|448968827|FG001|Part B|Death|0|||
124820422|NCT04180488|448968828|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
124820423|NCT04180488|448968829|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
124820424|NCT04180488|448968830|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
124820425|NCT04180488|448968831|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
124820426|NCT04180488|448968832|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
124820427|NCT04180488|448968833|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
124820428|NCT04180488|448968828|FG000|Overall Study|Withdrawal by Subject|8|||
125303234|NCT02690714|450736679|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
125303235|NCT02690714|450736679|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
125303236|NCT04294147|450736680|FG000|Overall Study|Protocol Violation|2|||
125303237|NCT04294147|450736681|FG001|Overall Study|Protocol Violation|0|||
125303238|NCT01240135|450736682|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
124820429|NCT04180488|448968829|FG001|Overall Study|Withdrawal by Subject|4|||
124820430|NCT04180488|448968830|FG002|Overall Study|Withdrawal by Subject|5|||
124820431|NCT04180488|448968831|FG003|Overall Study|Withdrawal by Subject|2|||
124820432|NCT04180488|448968832|FG004|Overall Study|Withdrawal by Subject|8|||
124820433|NCT04180488|448968833|FG005|Overall Study|Withdrawal by Subject|6|||
124820434|NCT04180488|448968828|FG000|Overall Study|Adverse Event|3|||
124820435|NCT04180488|448968829|FG001|Overall Study|Adverse Event|2|||
124820436|NCT04180488|448968830|FG002|Overall Study|Adverse Event|0|||
124820437|NCT04180488|448968831|FG003|Overall Study|Adverse Event|0|||
125303239|NCT01240135|450736683|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
125303240|NCT01240135|450736682|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
124820438|NCT04180488|448968832|FG004|Overall Study|Adverse Event|0|||
124820439|NCT04180488|448968833|FG005|Overall Study|Adverse Event|0|||
124820440|NCT04180488|448968828|FG000|Overall Study|Poor compliance to protocol|0|||
124820441|NCT04180488|448968829|FG001|Overall Study|Poor compliance to protocol|0|||
124820442|NCT04180488|448968830|FG002|Overall Study|Poor compliance to protocol|1|||
124820443|NCT04180488|448968831|FG003|Overall Study|Poor compliance to protocol|0|||
124820444|NCT04180488|448968832|FG004|Overall Study|Poor compliance to protocol|0|||
124820445|NCT04180488|448968833|FG005|Overall Study|Poor compliance to protocol|0|||
124820446|NCT00381095|448968841|FG000|Overall Study|Death|3|||
124820447|NCT00381095|448968842|FG001|Overall Study|Death|4|||
124820448|NCT00381095|448968841|FG000|Overall Study|Lack of Efficacy|2|||
124820449|NCT00381095|448968842|FG001|Overall Study|Lack of Efficacy|4|||
124820450|NCT00381095|448968841|FG000|Overall Study|Other|2|||
124820451|NCT00381095|448968842|FG001|Overall Study|Other|2|||
124820452|NCT00381095|448968841|FG000|Overall Study|Protocol Violation|1|||
124820453|NCT00381095|448968842|FG001|Overall Study|Protocol Violation|1|||
124820454|NCT00381095|448968841|FG000|Overall Study|Withdrawal by Subject|3|||
124820455|NCT00381095|448968842|FG001|Overall Study|Withdrawal by Subject|3|||
124820456|NCT00381095|448968841|FG000|Overall Study|Adverse Event|2|||
124820457|NCT00381095|448968842|FG001|Overall Study|Adverse Event|7|||
124820458|NCT01104493|448968843|FG000|Overall Study|Lost to Follow-up|0|||
124820459|NCT01104493|448968844|FG001|Overall Study|Lost to Follow-up|2|||
124820460|NCT01342796|448968846|FG000|Overall Study|Withdrawal by Subject|2|||
124820461|NCT01342796|448968847|FG001|Overall Study|Withdrawal by Subject|0|||
124820462|NCT01342796|448968846|FG000|Overall Study|Lost to Follow-up|0|||
124820463|NCT01342796|448968847|FG001|Overall Study|Lost to Follow-up|3|||
124820464|NCT01342796|448968846|FG000|Overall Study|Inappropriate enrollment|1|||
124820465|NCT01342796|448968847|FG001|Overall Study|Inappropriate enrollment|0|||
124820466|NCT01599234|448968848|FG000|Overall Study|Adverse Event|9|||
124820467|NCT01599234|448968849|FG001|Overall Study|Adverse Event|5|||
124820468|NCT01599234|448968848|FG000|Overall Study|Withdrawal by Subject|2|||
124820469|NCT01599234|448968849|FG001|Overall Study|Withdrawal by Subject|1|||
124820470|NCT01599234|448968848|FG000|Overall Study|Lost to Follow-up|1|||
124820471|NCT01599234|448968849|FG001|Overall Study|Lost to Follow-up|2|||
124820472|NCT01599234|448968848|FG000|Overall Study|Lack of Efficacy|2|||
124820473|NCT01599234|448968849|FG001|Overall Study|Lack of Efficacy|4|||
124820474|NCT01599234|448968848|FG000|Overall Study|Unable to operate spray|1|||
124820475|NCT01599234|448968849|FG001|Overall Study|Unable to operate spray|0|||
124820476|NCT01599234|448968848|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
124820477|NCT01599234|448968849|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
124820478|NCT01599234|448968848|FG000|Overall Study|Death|1|||
124820479|NCT01599234|448968849|FG001|Overall Study|Death|0|||
124820480|NCT01599234|448968848|FG000|Overall Study|Patient would not stop driving|1|||
124820481|NCT01599234|448968849|FG001|Overall Study|Patient would not stop driving|0|||
124820482|NCT01599234|448968848|FG000|Overall Study|Contra-indication discovered|0|||
124820483|NCT01599234|448968849|FG001|Overall Study|Contra-indication discovered|1|||
124820484|NCT01599234|448968848|FG000|Overall Study|Pregnancy|0|||
124820485|NCT01599234|448968849|FG001|Overall Study|Pregnancy|1|||
124820486|NCT02433483|448968850|FG000|Overall Study|Unacceptable toxicity|1|||
124820487|NCT02433483|448968850|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
124820488|NCT03489720|448968851|FG000|Overall Study|Withdrawal by Subject|2|||
124820489|NCT03489720|448968852|FG001|Overall Study|Withdrawal by Subject|0|||
124820490|NCT03342690|448968853|FG000|Overall Study|Missing Information|9|||
124820491|NCT03342690|448968853|FG000|Overall Study|Protocol Violation|16|||
124820492|NCT04626297|448968856|FG000|Overall Study|Adverse Event|5|||
124820493|NCT04626297|448968857|FG001|Overall Study|Adverse Event|3|||
124820494|NCT04626297|448968856|FG000|Overall Study|Lost to Follow-up|7|||
124820495|NCT04626297|448968857|FG001|Overall Study|Lost to Follow-up|3|||
124820496|NCT04626297|448968856|FG000|Overall Study|Protocol Violation|5|||
125303241|NCT01240135|450736683|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
125303242|NCT01371305|450736684|FG000|Overall Study|Adverse Event|0|||
124820497|NCT04626297|448968857|FG001|Overall Study|Protocol Violation|1|||
124820498|NCT04626297|448968856|FG000|Overall Study|Withdrawal by Subject|20|||
124820499|NCT04626297|448968857|FG001|Overall Study|Withdrawal by Subject|6|||
124820500|NCT04626297|448968856|FG000|Overall Study|Sponsor decision|2|||
124820501|NCT04626297|448968857|FG001|Overall Study|Sponsor decision|1|||
124820502|NCT03167411|448968858|FG000|Overall Study|Adverse Event|0|||
124820503|NCT03167411|448968859|FG001|Overall Study|Adverse Event|1|||
124820504|NCT02651922|448968863|FG000|Overall Study|due to exclusion criteria|2|||
124820505|NCT00729651|448968864|FG000|Overall Study|Withdrawal by Subject|5|||
124820506|NCT00729651|448968865|FG001|Overall Study|Withdrawal by Subject|6|||
124820507|NCT00729651|448968864|FG000|Overall Study|Lost to Follow-up|5|||
125303243|NCT01371305|450736685|FG001|Overall Study|Adverse Event|0|||
124820508|NCT00729651|448968865|FG001|Overall Study|Lost to Follow-up|4|||
124820509|NCT00729651|448968864|FG000|Overall Study|Protocol Violation|0|||
124820510|NCT00729651|448968865|FG001|Overall Study|Protocol Violation|1|||
124820511|NCT00729651|448968864|FG000|Overall Study|Adverse Event|7|||
124820512|NCT00729651|448968865|FG001|Overall Study|Adverse Event|3|||
124820513|NCT00729651|448968864|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
124820514|NCT00729651|448968865|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
124820515|NCT00729651|448968864|FG000|Overall Study|Subject's private reason|2|||
124820516|NCT00729651|448968865|FG001|Overall Study|Subject's private reason|0|||
124820517|NCT01950741|448968876|FG000|Overall Study|Lost to Follow-up|1|||
124820518|NCT01950741|448968876|FG000|Overall Study|Death|1|||
124820519|NCT01950741|448968876|FG000|Overall Study|Withdrawal by Subject|1|||
124820520|NCT02521870|448968877|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820521|NCT02521870|448968878|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
124820522|NCT02521870|448968879|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820523|NCT02521870|448968880|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820524|NCT02521870|448968881|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820525|NCT02521870|448968882|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820526|NCT02521870|448968883|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820527|NCT02521870|448968884|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820528|NCT02521870|448968885|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820529|NCT02521870|448968886|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820530|NCT02521870|448968887|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820531|NCT02521870|448968888|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820532|NCT02521870|448968877|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
124820533|NCT02521870|448968878|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
124820534|NCT02521870|448968879|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
124820535|NCT02521870|448968880|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
124820536|NCT02521870|448968881|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
124820537|NCT02521870|448968882|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
124820538|NCT02521870|448968883|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
124820539|NCT02521870|448968884|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
124820540|NCT02521870|448968885|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
124820541|NCT02521870|448968886|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
124820542|NCT02521870|448968887|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
124820543|NCT02521870|448968888|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
124820544|NCT02521870|448968877|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
124820545|NCT02521870|448968878|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
124820546|NCT02521870|448968879|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
124820547|NCT02521870|448968880|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
124820548|NCT02521870|448968881|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
124820549|NCT02521870|448968882|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
124820550|NCT02521870|448968883|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
124820551|NCT02521870|448968884|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
124820552|NCT02521870|448968885|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
124820553|NCT02521870|448968886|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
124820554|NCT02521870|448968887|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
124820555|NCT02521870|448968888|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
124820556|NCT02521870|448968877|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
124820557|NCT02521870|448968878|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
124820558|NCT02521870|448968879|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
124820559|NCT02521870|448968880|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
124820560|NCT02521870|448968881|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
124820561|NCT02521870|448968882|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
124820562|NCT02521870|448968883|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
124820563|NCT02521870|448968884|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
124820564|NCT02521870|448968885|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
124820565|NCT02521870|448968886|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
124820566|NCT02521870|448968887|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
124820567|NCT02521870|448968888|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125303244|NCT01371305|450736686|FG002|Overall Study|Adverse Event|0|||
125303245|NCT01371305|450736687|FG003|Overall Study|Adverse Event|2|||
125303246|NCT01371305|450736688|FG004|Overall Study|Adverse Event|1|||
125303247|NCT01371305|450736689|FG005|Overall Study|Adverse Event|0|||
125303248|NCT01371305|450736684|FG000|Overall Study|Study terminated by sponsor|0|||
125303249|NCT01371305|450736685|FG001|Overall Study|Study terminated by sponsor|0|||
124820568|NCT02521870|448968877|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
124820569|NCT02521870|448968878|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
124820570|NCT02521870|448968879|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
124820571|NCT02521870|448968880|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
124820572|NCT02521870|448968881|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
124820573|NCT02521870|448968882|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
124820574|NCT02521870|448968883|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
124820575|NCT02521870|448968884|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
124820576|NCT02521870|448968885|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
124820577|NCT02521870|448968886|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
124820578|NCT02521870|448968887|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
124820579|NCT02521870|448968888|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
124820580|NCT02521870|448968877|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
124820581|NCT02521870|448968878|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
124820582|NCT02521870|448968879|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
124820583|NCT02521870|448968880|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
124820584|NCT02521870|448968881|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
124820585|NCT02521870|448968882|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
124820586|NCT02521870|448968883|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
124820587|NCT02521870|448968884|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
124820588|NCT02521870|448968885|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
124820589|NCT02521870|448968886|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
124820590|NCT02521870|448968887|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
124820591|NCT02521870|448968888|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
124820592|NCT02521870|448968877|FG000|Phase 2: Dose Expansion|Death|0|||
124820593|NCT02521870|448968878|FG001|Phase 2: Dose Expansion|Death|0|||
124820594|NCT02521870|448968879|FG002|Phase 2: Dose Expansion|Death|0|||
124820595|NCT02521870|448968880|FG003|Phase 2: Dose Expansion|Death|0|||
124820596|NCT02521870|448968881|FG004|Phase 2: Dose Expansion|Death|1|||
124820597|NCT02521870|448968882|FG005|Phase 2: Dose Expansion|Death|1|||
124820598|NCT02521870|448968883|FG006|Phase 2: Dose Expansion|Death|3|||
124820599|NCT02521870|448968884|FG007|Phase 2: Dose Expansion|Death|1|||
124820600|NCT02521870|448968885|FG008|Phase 2: Dose Expansion|Death|1|||
124820601|NCT02521870|448968886|FG009|Phase 2: Dose Expansion|Death|5|||
124820602|NCT02521870|448968887|FG010|Phase 2: Dose Expansion|Death|2|||
124820603|NCT02521870|448968888|FG011|Phase 2: Dose Expansion|Death|2|||
124820604|NCT02521870|448968877|FG000|Phase 2: Dose Expansion|Other|0|||
124820605|NCT02521870|448968878|FG001|Phase 2: Dose Expansion|Other|0|||
124820606|NCT02521870|448968879|FG002|Phase 2: Dose Expansion|Other|0|||
124820607|NCT02521870|448968880|FG003|Phase 2: Dose Expansion|Other|0|||
124820608|NCT02521870|448968881|FG004|Phase 2: Dose Expansion|Other|10|||
124820609|NCT02521870|448968882|FG005|Phase 2: Dose Expansion|Other|3|||
124820610|NCT02521870|448968883|FG006|Phase 2: Dose Expansion|Other|2|||
124820611|NCT02521870|448968884|FG007|Phase 2: Dose Expansion|Other|0|||
124820612|NCT02521870|448968885|FG008|Phase 2: Dose Expansion|Other|10|||
124820613|NCT02521870|448968886|FG009|Phase 2: Dose Expansion|Other|5|||
124820614|NCT02521870|448968887|FG010|Phase 2: Dose Expansion|Other|1|||
124820615|NCT02521870|448968888|FG011|Phase 2: Dose Expansion|Other|7|||
124820616|NCT02521870|448968877|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820617|NCT02521870|448968878|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820618|NCT02521870|448968879|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820619|NCT02521870|448968880|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820620|NCT02521870|448968881|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
124820621|NCT02521870|448968882|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820622|NCT02521870|448968883|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820623|NCT02521870|448968884|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820624|NCT02521870|448968885|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820625|NCT02521870|448968886|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820626|NCT02521870|448968887|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820627|NCT02521870|448968888|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820628|NCT02521870|448968877|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820629|NCT02521870|448968878|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820630|NCT02521870|448968879|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820631|NCT02521870|448968880|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820632|NCT02521870|448968881|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
124820633|NCT02521870|448968882|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820634|NCT02521870|448968883|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820635|NCT02521870|448968884|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820636|NCT02521870|448968885|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820637|NCT02521870|448968886|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820638|NCT02521870|448968887|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820639|NCT02521870|448968888|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820640|NCT00519831|448968889|FG000|Overall Study|Adverse Event|3|||
124820641|NCT02854631|448968890|FG000|Overall Study|Adverse Event|1|||
124820642|NCT02854631|448968891|FG001|Overall Study|Adverse Event|2|||
124820643|NCT02854631|448968890|FG000|Overall Study|Withdrew Consent|3|||
124820644|NCT02854631|448968891|FG001|Overall Study|Withdrew Consent|2|||
124820645|NCT02854631|448968890|FG000|Overall Study|Investigator's Discretion|2|||
124820646|NCT02854631|448968891|FG001|Overall Study|Investigator's Discretion|0|||
124820647|NCT02854631|448968890|FG000|Overall Study|Death|12|||
124820648|NCT02854631|448968891|FG001|Overall Study|Death|8|||
124820649|NCT02854631|448968890|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
124820650|NCT02854631|448968891|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
124820651|NCT02854631|448968890|FG000|Overall Study|Protocol Violation|0|||
124820652|NCT02854631|448968891|FG001|Overall Study|Protocol Violation|1|||
124820653|NCT02854631|448968890|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
124820654|NCT02854631|448968891|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
124820655|NCT02854631|448968890|FG000|Overall Study|Lost to Follow-up|4|||
124820656|NCT02854631|448968891|FG001|Overall Study|Lost to Follow-up|2|||
124820657|NCT04656691|448968897|FG000|Overall Study|Adverse Event|1|||
124820658|NCT00600483|448968898|FG000|Overall Study|Lost to Follow-up|26|||
124820659|NCT00600483|448968899|FG001|Overall Study|Lost to Follow-up|47|||
124820660|NCT00600483|448968898|FG000|Overall Study|Randomized but not treated|10|||
124820661|NCT00600483|448968899|FG001|Overall Study|Randomized but not treated|0|||
124820662|NCT01482884|448968905|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
124820663|NCT01482884|448968906|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
124820664|NCT01482884|448968905|FG000|Overall Study|Protocol Violation|1|||
124820665|NCT01482884|448968906|FG001|Overall Study|Protocol Violation|0|||
124820666|NCT01482884|448968905|FG000|Overall Study|Lost to Follow-up|2|||
124820667|NCT01482884|448968906|FG001|Overall Study|Lost to Follow-up|2|||
124820668|NCT01482884|448968905|FG000|Overall Study|Lack of Efficacy|0|||
124820669|NCT01482884|448968906|FG001|Overall Study|Lack of Efficacy|1|||
124820670|NCT01482884|448968905|FG000|Overall Study|Adverse Event|2|||
124820671|NCT01482884|448968906|FG001|Overall Study|Adverse Event|1|||
124820672|NCT01482884|448968905|FG000|Overall Study|Withdrawal by Subject|8|||
124820673|NCT01482884|448968906|FG001|Overall Study|Withdrawal by Subject|13|||
124820674|NCT04102020|448968907|FG000|Overall Study|Adverse Event|1|||
124820675|NCT04102020|448968908|FG001|Overall Study|Adverse Event|0|||
124820676|NCT04102020|448968909|FG002|Overall Study|Adverse Event|0|||
124820677|NCT04102020|448968910|FG003|Overall Study|Adverse Event|1|||
124820678|NCT04102020|448968911|FG004|Overall Study|Adverse Event|0|||
124820679|NCT04102020|448968907|FG000|Overall Study|Withdrawal by Subject|0|||
124820680|NCT04102020|448968908|FG001|Overall Study|Withdrawal by Subject|1|||
124820681|NCT04102020|448968909|FG002|Overall Study|Withdrawal by Subject|1|||
124820682|NCT04102020|448968910|FG003|Overall Study|Withdrawal by Subject|1|||
124820683|NCT04102020|448968911|FG004|Overall Study|Withdrawal by Subject|1|||
124820684|NCT04102020|448968907|FG000|Overall Study|Death|1|||
124820685|NCT04102020|448968908|FG001|Overall Study|Death|4|||
124820686|NCT04102020|448968909|FG002|Overall Study|Death|1|||
124820687|NCT04102020|448968910|FG003|Overall Study|Death|1|||
124820688|NCT04102020|448968911|FG004|Overall Study|Death|0|||
124820689|NCT04102020|448968907|FG000|Overall Study|Physician Decision|1|||
124820690|NCT04102020|448968908|FG001|Overall Study|Physician Decision|2|||
124820691|NCT04102020|448968909|FG002|Overall Study|Physician Decision|2|||
124820692|NCT04102020|448968910|FG003|Overall Study|Physician Decision|0|||
124820693|NCT04102020|448968911|FG004|Overall Study|Physician Decision|1|||
124820694|NCT04102020|448968907|FG000|Overall Study|COVID-19 Infection|1|||
124820695|NCT04102020|448968908|FG001|Overall Study|COVID-19 Infection|0|||
124820696|NCT04102020|448968909|FG002|Overall Study|COVID-19 Infection|0|||
124820697|NCT04102020|448968910|FG003|Overall Study|COVID-19 Infection|0|||
124820698|NCT04102020|448968911|FG004|Overall Study|COVID-19 Infection|0|||
124820699|NCT04102020|448968907|FG000|Overall Study|Not disclosed|5|||
124820700|NCT04102020|448968908|FG001|Overall Study|Not disclosed|3|||
124820701|NCT04102020|448968909|FG002|Overall Study|Not disclosed|8|||
124820702|NCT04102020|448968910|FG003|Overall Study|Not disclosed|0|||
124820703|NCT04102020|448968911|FG004|Overall Study|Not disclosed|1|||
124820704|NCT04102020|448968907|FG000|Overall Study|MIssing|1|||
124820705|NCT04102020|448968908|FG001|Overall Study|MIssing|0|||
124820706|NCT04102020|448968909|FG002|Overall Study|MIssing|1|||
124820707|NCT04102020|448968910|FG003|Overall Study|MIssing|1|||
124820708|NCT04102020|448968911|FG004|Overall Study|MIssing|1|||
124820709|NCT04102020|448968907|FG000|Overall Study|Continuing in ongoing study|13|||
124820710|NCT04102020|448968908|FG001|Overall Study|Continuing in ongoing study|13|||
124820711|NCT04102020|448968909|FG002|Overall Study|Continuing in ongoing study|7|||
124820712|NCT04102020|448968910|FG003|Overall Study|Continuing in ongoing study|26|||
124820713|NCT04102020|448968911|FG004|Overall Study|Continuing in ongoing study|12|||
124820714|NCT05980182|448968923|FG000|Overall Study|Lost to Follow-up|10|||
124820715|NCT04600921|448968924|FG000|Overall Study|Withdrawal by Subject|3|||
124820716|NCT04600921|448968925|FG001|Overall Study|Withdrawal by Subject|5|||
125303250|NCT01371305|450736686|FG002|Overall Study|Study terminated by sponsor|0|||
125303251|NCT01371305|450736687|FG003|Overall Study|Study terminated by sponsor|0|||
124820717|NCT04600921|448968924|FG000|Overall Study|Death|0|||
124820718|NCT04600921|448968925|FG001|Overall Study|Death|1|||
124820719|NCT00410046|448970835|FG000|Overall Study|Adverse Event|3|||
124820720|NCT00410046|448970835|FG000|Overall Study|Withdrawal by Subject|1|||
124820721|NCT00410046|448970835|FG000|Overall Study|Lost to Follow-up|1|||
124820722|NCT01384760|448970836|FG000|Overall Study|Lost to Follow-up|0|||
124820723|NCT01384760|448970837|FG001|Overall Study|Lost to Follow-up|6|||
124820724|NCT01384760|448970836|FG000|Overall Study|Protocol Violation|16|||
124820725|NCT01384760|448970837|FG001|Overall Study|Protocol Violation|0|||
124820726|NCT00963547|448970838|FG000|Overall Study|Adverse Event|0|||
124820727|NCT00963547|448970839|FG001|Overall Study|Adverse Event|1|||
124820728|NCT00963547|448970840|FG002|Overall Study|Adverse Event|0|||
124820729|NCT00963547|448970841|FG003|Overall Study|Adverse Event|1|||
124820730|NCT00963547|448970842|FG004|Overall Study|Adverse Event|0|||
124820731|NCT00963547|448970843|FG005|Overall Study|Adverse Event|0|||
124820732|NCT00963547|448970844|FG006|Overall Study|Adverse Event|0|||
124820733|NCT00963547|448970838|FG000|Overall Study|Physician Decision|1|||
124820734|NCT00963547|448970839|FG001|Overall Study|Physician Decision|1|||
124820735|NCT00963547|448970840|FG002|Overall Study|Physician Decision|0|||
124820736|NCT00963547|448970841|FG003|Overall Study|Physician Decision|0|||
124820737|NCT00963547|448970842|FG004|Overall Study|Physician Decision|0|||
124820738|NCT00963547|448970843|FG005|Overall Study|Physician Decision|0|||
124820739|NCT00963547|448970844|FG006|Overall Study|Physician Decision|0|||
124820740|NCT00963547|448970838|FG000|Overall Study|Progressive Disease|3|||
124820741|NCT00963547|448970839|FG001|Overall Study|Progressive Disease|8|||
124820742|NCT00963547|448970840|FG002|Overall Study|Progressive Disease|9|||
124820743|NCT00963547|448970841|FG003|Overall Study|Progressive Disease|5|||
124820744|NCT00963547|448970842|FG004|Overall Study|Progressive Disease|0|||
124820745|NCT00963547|448970843|FG005|Overall Study|Progressive Disease|0|||
124820746|NCT00963547|448970844|FG006|Overall Study|Progressive Disease|0|||
124820747|NCT00963547|448970838|FG000|Overall Study|Withdrawal by Subject|0|||
124820748|NCT00963547|448970839|FG001|Overall Study|Withdrawal by Subject|0|||
124820749|NCT00963547|448970840|FG002|Overall Study|Withdrawal by Subject|3|||
124820750|NCT00963547|448970841|FG003|Overall Study|Withdrawal by Subject|0|||
124820751|NCT00963547|448970842|FG004|Overall Study|Withdrawal by Subject|0|||
124820752|NCT00963547|448970843|FG005|Overall Study|Withdrawal by Subject|0|||
124820753|NCT00963547|448970844|FG006|Overall Study|Withdrawal by Subject|0|||
124820754|NCT00963547|448970838|FG000|Overall Study|Reason Unknown|0|||
124820755|NCT00963547|448970839|FG001|Overall Study|Reason Unknown|1|||
124820756|NCT00963547|448970840|FG002|Overall Study|Reason Unknown|0|||
124820757|NCT00963547|448970841|FG003|Overall Study|Reason Unknown|0|||
124820758|NCT00963547|448970842|FG004|Overall Study|Reason Unknown|0|||
124820759|NCT00963547|448970843|FG005|Overall Study|Reason Unknown|0|||
124820760|NCT00963547|448970844|FG006|Overall Study|Reason Unknown|0|||
124820761|NCT00482612|448970851|FG000|In-treatment Period|No study medication administered|0|||
124820762|NCT00482612|448970852|FG001|In-treatment Period|No study medication administered|0|||
124820763|NCT00482612|448970853|FG002|In-treatment Period|No study medication administered|1|||
124820764|NCT00482612|448970854|FG003|In-treatment Period|No study medication administered|0|||
124820765|NCT00482612|448970851|FG000|Follow-up Period|Other|4|||
124820766|NCT00482612|448970852|FG001|Follow-up Period|Other|2|||
124820767|NCT00482612|448970853|FG002|Follow-up Period|Other|1|||
124820768|NCT00482612|448970854|FG003|Follow-up Period|Other|2|||
124820769|NCT00482612|448970851|FG000|Follow-up Period|Lack of compliance|0|||
124820770|NCT00482612|448970852|FG001|Follow-up Period|Lack of compliance|0|||
124820771|NCT00482612|448970853|FG002|Follow-up Period|Lack of compliance|1|||
124820772|NCT00482612|448970854|FG003|Follow-up Period|Lack of compliance|0|||
124820773|NCT00482612|448970851|FG000|Follow-up Period|Lost to Follow-up|0|||
124820774|NCT00482612|448970852|FG001|Follow-up Period|Lost to Follow-up|4|||
124820775|NCT00482612|448970853|FG002|Follow-up Period|Lost to Follow-up|2|||
124820776|NCT00482612|448970854|FG003|Follow-up Period|Lost to Follow-up|1|||
124820777|NCT00482612|448970851|FG000|Follow-up Period|Adverse Event|4|||
124820778|NCT00482612|448970852|FG001|Follow-up Period|Adverse Event|7|||
124820779|NCT00482612|448970853|FG002|Follow-up Period|Adverse Event|9|||
124820780|NCT00482612|448970854|FG003|Follow-up Period|Adverse Event|0|||
124820781|NCT00482612|448970851|FG000|Follow-up Period|Lack of Efficacy|2|||
124820782|NCT00482612|448970852|FG001|Follow-up Period|Lack of Efficacy|0|||
124820783|NCT00482612|448970853|FG002|Follow-up Period|Lack of Efficacy|1|||
124820784|NCT00482612|448970854|FG003|Follow-up Period|Lack of Efficacy|0|||
124820785|NCT00482612|448970851|FG000|Follow-up Period|Withdrawal by Subject|3|||
124820786|NCT00482612|448970852|FG001|Follow-up Period|Withdrawal by Subject|5|||
124820787|NCT00482612|448970853|FG002|Follow-up Period|Withdrawal by Subject|7|||
124820788|NCT00482612|448970854|FG003|Follow-up Period|Withdrawal by Subject|2|||
124820789|NCT00482612|448970851|FG000|Follow-up Period|Reasons not related to trial|1|||
124820790|NCT00482612|448970852|FG001|Follow-up Period|Reasons not related to trial|0|||
124820791|NCT00482612|448970853|FG002|Follow-up Period|Reasons not related to trial|1|||
124820792|NCT00482612|448970854|FG003|Follow-up Period|Reasons not related to trial|3|||
124820793|NCT01366521|448970855|FG000|Overall Study|Adverse Event|1|||
124820794|NCT01366521|448970856|FG001|Overall Study|Adverse Event|0|||
124820795|NCT01366521|448970857|FG002|Overall Study|Adverse Event|0|||
124820796|NCT01366521|448970858|FG003|Overall Study|Adverse Event|0|||
124820797|NCT01366521|448970855|FG000|Overall Study|Protocol Violation|0|||
124820798|NCT01366521|448970856|FG001|Overall Study|Protocol Violation|0|||
124820799|NCT01366521|448970857|FG002|Overall Study|Protocol Violation|1|||
124820800|NCT01366521|448970858|FG003|Overall Study|Protocol Violation|0|||
124820801|NCT01366521|448970855|FG000|Overall Study|Physician Decision|0|||
124820802|NCT01366521|448970856|FG001|Overall Study|Physician Decision|0|||
124820803|NCT01366521|448970857|FG002|Overall Study|Physician Decision|1|||
124820804|NCT01366521|448970858|FG003|Overall Study|Physician Decision|0|||
124820805|NCT01366521|448970855|FG000|Overall Study|Withdrawal by Subject|0|||
124820806|NCT01366521|448970856|FG001|Overall Study|Withdrawal by Subject|1|||
124820807|NCT01366521|448970857|FG002|Overall Study|Withdrawal by Subject|0|||
124820808|NCT01366521|448970858|FG003|Overall Study|Withdrawal by Subject|0|||
124820809|NCT00660023|448970859|FG000|Overall Study|Adverse Event|2|||
124820810|NCT00660023|448970859|FG000|Overall Study|Death|8|||
124820811|NCT00660023|448970859|FG000|Overall Study|Blood Transfusion|5|||
124820812|NCT00660023|448970859|FG000|Overall Study|Renal Transplantation|3|||
124820813|NCT00660023|448970859|FG000|Overall Study|Withdrawal by Subject|1|||
124820814|NCT00660023|448970859|FG000|Overall Study|Missed Pregnancy Test|1|||
124820815|NCT00660023|448970859|FG000|Overall Study|Other Screening Failure|9|||
124820816|NCT00684307|448970860|FG000|Overall Study|Adverse Event|11|||
124820817|NCT00684307|448970861|FG001|Overall Study|Adverse Event|6|||
124820818|NCT00684307|448970862|FG002|Overall Study|Adverse Event|15|||
124820819|NCT00684307|448970863|FG003|Overall Study|Adverse Event|16|||
124820820|NCT00684307|448970864|FG004|Overall Study|Adverse Event|8|||
124820821|NCT00684307|448970860|FG000|Overall Study|Development of increasing Liver Function|0|||
124820822|NCT00684307|448970861|FG001|Overall Study|Development of increasing Liver Function|2|||
124820823|NCT00684307|448970862|FG002|Overall Study|Development of increasing Liver Function|0|||
124820824|NCT00684307|448970863|FG003|Overall Study|Development of increasing Liver Function|1|||
124820825|NCT00684307|448970864|FG004|Overall Study|Development of increasing Liver Function|0|||
124820826|NCT00684307|448970860|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
124820827|NCT00684307|448970861|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
124820828|NCT00684307|448970862|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
124820829|NCT00684307|448970863|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
124820830|NCT00684307|448970864|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
124820831|NCT00684307|448970860|FG000|Overall Study|Incorrect enrolment or randomization|4|||
124820832|NCT00684307|448970861|FG001|Overall Study|Incorrect enrolment or randomization|0|||
124820833|NCT00684307|448970862|FG002|Overall Study|Incorrect enrolment or randomization|0|||
124820834|NCT00684307|448970863|FG003|Overall Study|Incorrect enrolment or randomization|0|||
124820835|NCT00684307|448970864|FG004|Overall Study|Incorrect enrolment or randomization|0|||
124820836|NCT00684307|448970860|FG000|Overall Study|Interupted IP for more than 7 days|0|||
124820837|NCT00684307|448970861|FG001|Overall Study|Interupted IP for more than 7 days|4|||
124820838|NCT00684307|448970862|FG002|Overall Study|Interupted IP for more than 7 days|1|||
124820839|NCT00684307|448970863|FG003|Overall Study|Interupted IP for more than 7 days|3|||
124820840|NCT00684307|448970864|FG004|Overall Study|Interupted IP for more than 7 days|3|||
124820841|NCT00684307|448970860|FG000|Overall Study|Severe non compliance to protocol|1|||
124820842|NCT00684307|448970861|FG001|Overall Study|Severe non compliance to protocol|0|||
124820843|NCT00684307|448970862|FG002|Overall Study|Severe non compliance to protocol|0|||
124820844|NCT00684307|448970863|FG003|Overall Study|Severe non compliance to protocol|1|||
124820845|NCT00684307|448970864|FG004|Overall Study|Severe non compliance to protocol|2|||
124820846|NCT00684307|448970860|FG000|Overall Study|Participant not willing to continue|7|||
124820847|NCT00684307|448970861|FG001|Overall Study|Participant not willing to continue|10|||
124820848|NCT00684307|448970862|FG002|Overall Study|Participant not willing to continue|11|||
124820849|NCT00684307|448970863|FG003|Overall Study|Participant not willing to continue|5|||
124820850|NCT00684307|448970864|FG004|Overall Study|Participant not willing to continue|8|||
124820851|NCT00684307|448970860|FG000|Overall Study|Criteria from the CSR|0|||
124820852|NCT00684307|448970861|FG001|Overall Study|Criteria from the CSR|0|||
124820853|NCT00684307|448970862|FG002|Overall Study|Criteria from the CSR|1|||
124820854|NCT00684307|448970863|FG003|Overall Study|Criteria from the CSR|3|||
124820855|NCT00684307|448970864|FG004|Overall Study|Criteria from the CSR|3|||
124820856|NCT03506815|448970865|FG000|Overall Study|Adverse Event|8|||
124820857|NCT03506815|448970866|FG001|Overall Study|Adverse Event|0|||
124820858|NCT03506815|448970865|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
124820859|NCT03506815|448970866|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
124820860|NCT03506815|448970865|FG000|Overall Study|Protocol Violation|1|||
124820861|NCT03506815|448970866|FG001|Overall Study|Protocol Violation|0|||
124820862|NCT03506815|448970865|FG000|Overall Study|Elective Surgery|1|||
124820863|NCT03506815|448970866|FG001|Overall Study|Elective Surgery|0|||
124820864|NCT04160091|448970867|FG000|Overall Study|Terminated by Sponsor|7|||
124820865|NCT04160091|448970868|FG001|Overall Study|Terminated by Sponsor|3|||
124820866|NCT04160091|448970869|FG002|Overall Study|Terminated by Sponsor|5|||
124820867|NCT04160091|448970870|FG003|Overall Study|Terminated by Sponsor|2|||
124820868|NCT04160091|448970867|FG000|Overall Study|Noncompliance|0|||
124820869|NCT04160091|448970868|FG001|Overall Study|Noncompliance|0|||
124820870|NCT04160091|448970869|FG002|Overall Study|Noncompliance|0|||
124820871|NCT04160091|448970870|FG003|Overall Study|Noncompliance|1|||
124820872|NCT04160091|448970867|FG000|Overall Study|Withdrawal by Subject|0|||
124820873|NCT04160091|448970868|FG001|Overall Study|Withdrawal by Subject|0|||
124820874|NCT04160091|448970869|FG002|Overall Study|Withdrawal by Subject|0|||
125303252|NCT01371305|450736688|FG004|Overall Study|Study terminated by sponsor|3|||
124820875|NCT04160091|448970870|FG003|Overall Study|Withdrawal by Subject|1|||
125303253|NCT01371305|450736689|FG005|Overall Study|Study terminated by sponsor|1|||
124820876|NCT02899988|448970872|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
124820877|NCT02899988|448970873|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
124820878|NCT02899988|448970874|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124820879|NCT02899988|448970875|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124820880|NCT02899988|448970876|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124820881|NCT02899988|448970877|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124820882|NCT02899988|448970878|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124820883|NCT02899988|448970879|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124820884|NCT02899988|448970880|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124820885|NCT02899988|448970881|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124820886|NCT02899988|448970882|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124820887|NCT02899988|448970872|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
124820888|NCT02899988|448970873|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
124820889|NCT02899988|448970874|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
124820890|NCT02899988|448970875|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
124820891|NCT02899988|448970876|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
124820892|NCT02899988|448970877|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
124820893|NCT02899988|448970878|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
124820894|NCT02899988|448970879|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
124820895|NCT02899988|448970880|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
124820896|NCT02899988|448970881|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
124820897|NCT02899988|448970882|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
124820898|NCT02899988|448970872|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
124820899|NCT02899988|448970873|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
124820900|NCT02899988|448970874|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
124820901|NCT02899988|448970875|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
124820902|NCT02899988|448970876|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
124820903|NCT02899988|448970877|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
124820904|NCT02899988|448970878|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
124820905|NCT02899988|448970879|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
124820906|NCT02899988|448970880|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
124820907|NCT02899988|448970881|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
124820908|NCT02899988|448970882|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
124820909|NCT02899988|448970872|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
124820910|NCT02899988|448970873|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
124820911|NCT02899988|448970874|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
124820912|NCT02899988|448970875|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
124820913|NCT02899988|448970876|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
124820914|NCT02899988|448970877|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
124820915|NCT02899988|448970878|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
124820916|NCT02899988|448970879|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
124820917|NCT02899988|448970880|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
124820918|NCT02899988|448970881|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
124820919|NCT02899988|448970882|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
124820920|NCT02899988|448970872|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
124820921|NCT02899988|448970873|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
124820922|NCT02899988|448970874|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
124820923|NCT02899988|448970875|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
124820924|NCT02899988|448970876|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
124820925|NCT02899988|448970877|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
124820926|NCT02899988|448970878|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
124820927|NCT02899988|448970879|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
124820928|NCT02899988|448970880|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
124820929|NCT02899988|448970881|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
124820930|NCT02899988|448970882|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
124820931|NCT02899988|448970872|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
124820932|NCT02899988|448970873|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
125303254|NCT01371305|450736684|FG000|Overall Study|Subject request|0|||
125303255|NCT01371305|450736685|FG001|Overall Study|Subject request|0|||
124820933|NCT02899988|448970874|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
124820934|NCT02899988|448970875|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
124820935|NCT02899988|448970876|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
124820936|NCT02899988|448970877|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
124820937|NCT02899988|448970878|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
124820938|NCT02899988|448970879|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
124820939|NCT02899988|448970880|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
124820940|NCT02899988|448970881|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
125303256|NCT01371305|450736686|FG002|Overall Study|Subject request|0|||
124820941|NCT02899988|448970882|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
125303257|NCT01371305|450736687|FG003|Overall Study|Subject request|0|||
125303258|NCT01371305|450736688|FG004|Overall Study|Subject request|0|||
124820942|NCT01059825|448970884|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
124820943|NCT01059825|448970885|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
124820944|NCT01059825|448970886|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
124820945|NCT01059825|448970887|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
124820946|NCT01059825|448970888|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
124820947|NCT01059825|448970889|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
124820948|NCT01059825|448970890|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
124820949|NCT01059825|448970884|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
124820950|NCT01059825|448970885|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
124820951|NCT01059825|448970886|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
124820952|NCT01059825|448970887|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
124820953|NCT01059825|448970888|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
124820954|NCT01059825|448970889|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
124820955|NCT01059825|448970890|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
124820956|NCT01059825|448970884|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
124820957|NCT01059825|448970885|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
124820958|NCT01059825|448970886|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
124820959|NCT01059825|448970887|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
124820960|NCT01059825|448970888|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
124820961|NCT01059825|448970889|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
124820962|NCT01059825|448970890|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
124820963|NCT01059825|448970884|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
124820964|NCT01059825|448970885|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
124820965|NCT01059825|448970886|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
124820966|NCT01059825|448970887|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
124820967|NCT01059825|448970888|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
124820968|NCT01059825|448970889|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
124820969|NCT01059825|448970890|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
124820970|NCT01059825|448970884|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
124820971|NCT01059825|448970885|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
124820972|NCT01059825|448970886|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
124820973|NCT01059825|448970887|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
124820974|NCT01059825|448970888|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
124820975|NCT01059825|448970889|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
124820976|NCT01059825|448970890|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
124820977|NCT01059825|448970884|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
124820978|NCT01059825|448970885|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
124820979|NCT01059825|448970886|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
124820980|NCT01059825|448970887|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
124820981|NCT01059825|448970888|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
124820982|NCT01059825|448970889|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
124820983|NCT01059825|448970890|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
124820984|NCT01059825|448970884|FG000|Treatment Period|Lost to Follow-up|2|||
124820985|NCT01059825|448970885|FG001|Treatment Period|Lost to Follow-up|1|||
124820986|NCT01059825|448970886|FG002|Treatment Period|Lost to Follow-up|0|||
124820987|NCT01059825|448970887|FG003|Treatment Period|Lost to Follow-up|1|||
124820988|NCT01059825|448970888|FG004|Treatment Period|Lost to Follow-up|2|||
124820989|NCT01059825|448970889|FG005|Treatment Period|Lost to Follow-up|0|||
124820990|NCT01059825|448970890|FG006|Treatment Period|Lost to Follow-up|0|||
124820991|NCT01059825|448970884|FG000|Treatment Period|Withdrawal by Subject|3|||
124820992|NCT01059825|448970885|FG001|Treatment Period|Withdrawal by Subject|0|||
124820993|NCT01059825|448970886|FG002|Treatment Period|Withdrawal by Subject|1|||
124820994|NCT01059825|448970887|FG003|Treatment Period|Withdrawal by Subject|5|||
124820995|NCT01059825|448970888|FG004|Treatment Period|Withdrawal by Subject|4|||
124820996|NCT01059825|448970889|FG005|Treatment Period|Withdrawal by Subject|1|||
124820997|NCT01059825|448970890|FG006|Treatment Period|Withdrawal by Subject|0|||
124820998|NCT01059825|448970884|FG000|Treatment Period|Other reason not specified|1|||
124820999|NCT01059825|448970885|FG001|Treatment Period|Other reason not specified|2|||
124821000|NCT01059825|448970886|FG002|Treatment Period|Other reason not specified|1|||
124821001|NCT01059825|448970887|FG003|Treatment Period|Other reason not specified|2|||
124821002|NCT01059825|448970888|FG004|Treatment Period|Other reason not specified|0|||
124821003|NCT01059825|448970889|FG005|Treatment Period|Other reason not specified|0|||
124821004|NCT01059825|448970890|FG006|Treatment Period|Other reason not specified|0|||
124821005|NCT01059825|448970884|FG000|Treatment Period|Protocol Violation|0|||
124821006|NCT01059825|448970885|FG001|Treatment Period|Protocol Violation|0|||
124821007|NCT01059825|448970886|FG002|Treatment Period|Protocol Violation|1|||
124821008|NCT01059825|448970887|FG003|Treatment Period|Protocol Violation|1|||
124821009|NCT01059825|448970888|FG004|Treatment Period|Protocol Violation|1|||
124821010|NCT01059825|448970889|FG005|Treatment Period|Protocol Violation|1|||
124821011|NCT01059825|448970890|FG006|Treatment Period|Protocol Violation|0|||
124821012|NCT01059825|448970884|FG000|Treatment Period|Adverse event related to study drug|1|||
124821013|NCT01059825|448970885|FG001|Treatment Period|Adverse event related to study drug|0|||
124821014|NCT01059825|448970886|FG002|Treatment Period|Adverse event related to study drug|1|||
124821015|NCT01059825|448970887|FG003|Treatment Period|Adverse event related to study drug|1|||
124821016|NCT01059825|448970888|FG004|Treatment Period|Adverse event related to study drug|0|||
124821017|NCT01059825|448970889|FG005|Treatment Period|Adverse event related to study drug|0|||
124821018|NCT01059825|448970890|FG006|Treatment Period|Adverse event related to study drug|0|||
124821019|NCT01059825|448970884|FG000|Treatment Period|Insufficient clinical response|3|||
124821020|NCT01059825|448970885|FG001|Treatment Period|Insufficient clinical response|0|||
124821021|NCT01059825|448970886|FG002|Treatment Period|Insufficient clinical response|0|||
124821022|NCT01059825|448970887|FG003|Treatment Period|Insufficient clinical response|0|||
124821023|NCT01059825|448970888|FG004|Treatment Period|Insufficient clinical response|0|||
124821024|NCT01059825|448970889|FG005|Treatment Period|Insufficient clinical response|0|||
124821025|NCT01059825|448970890|FG006|Treatment Period|Insufficient clinical response|0|||
124821026|NCT01059825|448970884|FG000|Treatment Period|Adverse event not related to study drug|0|||
124821027|NCT01059825|448970885|FG001|Treatment Period|Adverse event not related to study drug|1|||
124821028|NCT01059825|448970886|FG002|Treatment Period|Adverse event not related to study drug|2|||
124821029|NCT01059825|448970887|FG003|Treatment Period|Adverse event not related to study drug|1|||
124821030|NCT01059825|448970888|FG004|Treatment Period|Adverse event not related to study drug|1|||
124821031|NCT01059825|448970889|FG005|Treatment Period|Adverse event not related to study drug|1|||
124821032|NCT01059825|448970890|FG006|Treatment Period|Adverse event not related to study drug|0|||
124821033|NCT00549302|448970891|FG000|Double-Blind|Death|2|||
124821034|NCT00549302|448970892|FG001|Double-Blind|Death|9|||
124821035|NCT00549302|448970893|FG002|Double-Blind|Death|0|||
124821036|NCT00549302|448970891|FG000|Double-Blind|Adverse Event|3|||
124821037|NCT00549302|448970892|FG001|Double-Blind|Adverse Event|16|||
124821038|NCT00549302|448970893|FG002|Double-Blind|Adverse Event|0|||
124821039|NCT00549302|448970891|FG000|Double-Blind|Withdrawal by Subject|3|||
124821040|NCT00549302|448970892|FG001|Double-Blind|Withdrawal by Subject|8|||
124821041|NCT00549302|448970893|FG002|Double-Blind|Withdrawal by Subject|0|||
124821042|NCT00549302|448970891|FG000|Double-Blind|Investigator Decision|1|||
124821043|NCT00549302|448970892|FG001|Double-Blind|Investigator Decision|5|||
124821044|NCT00549302|448970893|FG002|Double-Blind|Investigator Decision|0|||
124821045|NCT00549302|448970891|FG000|Double-Blind|Sponsor Decision|0|||
124821046|NCT00549302|448970892|FG001|Double-Blind|Sponsor Decision|1|||
124821047|NCT00549302|448970893|FG002|Double-Blind|Sponsor Decision|0|||
124821048|NCT00549302|448970891|FG000|Double-Blind|Lost to Follow-up|1|||
124821049|NCT00549302|448970892|FG001|Double-Blind|Lost to Follow-up|2|||
124821050|NCT00549302|448970893|FG002|Double-Blind|Lost to Follow-up|0|||
124821051|NCT00549302|448970891|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
124821052|NCT00549302|448970892|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
124821053|NCT00549302|448970893|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
124821054|NCT00549302|448970891|FG000|Double-Blind|New condition or starts new therapy|0|||
124821055|NCT00549302|448970892|FG001|Double-Blind|New condition or starts new therapy|2|||
124821056|NCT00549302|448970893|FG002|Double-Blind|New condition or starts new therapy|0|||
124821057|NCT00549302|448970891|FG000|Open-Label|Adverse Event|0|||
124821058|NCT00549302|448970892|FG001|Open-Label|Adverse Event|0|||
124821059|NCT00549302|448970893|FG002|Open-Label|Adverse Event|11|||
124821060|NCT00549302|448970891|FG000|Open-Label|Death|0|||
124821061|NCT00549302|448970892|FG001|Open-Label|Death|0|||
124821062|NCT00549302|448970893|FG002|Open-Label|Death|40|||
124821063|NCT00549302|448970891|FG000|Open-Label|Investigator Decision|0|||
124821064|NCT00549302|448970892|FG001|Open-Label|Investigator Decision|0|||
124821065|NCT00549302|448970893|FG002|Open-Label|Investigator Decision|5|||
124821066|NCT00549302|448970891|FG000|Open-Label|Lost to Follow-up|0|||
124821067|NCT00549302|448970892|FG001|Open-Label|Lost to Follow-up|0|||
124821068|NCT00549302|448970893|FG002|Open-Label|Lost to Follow-up|2|||
124821069|NCT00549302|448970891|FG000|Open-Label|Other|0|||
124821070|NCT00549302|448970892|FG001|Open-Label|Other|0|||
124821071|NCT00549302|448970893|FG002|Open-Label|Other|3|||
124821072|NCT00549302|448970891|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
124821073|NCT00549302|448970892|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
124821074|NCT00549302|448970893|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
125303259|NCT01371305|450736689|FG005|Overall Study|Subject request|1|||
125303260|NCT02891382|450736692|FG000|Overall Study|Lost to Follow-up|3|||
124821075|NCT00549302|448970891|FG000|Open-Label|Withdrawal by Subject|0|||
124821076|NCT00549302|448970892|FG001|Open-Label|Withdrawal by Subject|0|||
124821077|NCT00549302|448970893|FG002|Open-Label|Withdrawal by Subject|6|||
124821078|NCT03585504|448970894|FG000|Overall Study|Lost to Follow-up|26|||
125303261|NCT02891382|450736693|FG001|Overall Study|Lost to Follow-up|4|||
124821079|NCT03585504|448970895|FG001|Overall Study|Lost to Follow-up|29|||
124821080|NCT01414114|448970896|FG000|Overall Study|Adverse Event|2|||
125303262|NCT02891382|450736694|FG002|Overall Study|Lost to Follow-up|5|||
124821081|NCT01414114|448970896|FG000|Overall Study|Withdrawal by Subject|1|||
124821082|NCT01414114|448970896|FG000|Overall Study|Other|2|||
124821083|NCT00105482|448970897|FG000|Overall Study|Adverse Event|1|||
124821084|NCT00105482|448970898|FG001|Overall Study|Adverse Event|1|||
124821085|NCT00105482|448970897|FG000|Overall Study|Lost to Follow-up|26|||
124821086|NCT00105482|448970898|FG001|Overall Study|Lost to Follow-up|17|||
124821087|NCT00105482|448970897|FG000|Overall Study|Withdrawal by Subject|0|||
124821088|NCT00105482|448970898|FG001|Overall Study|Withdrawal by Subject|1|||
124821089|NCT00105482|448970897|FG000|Overall Study|Lost Interest|29|||
124821090|NCT00105482|448970898|FG001|Overall Study|Lost Interest|32|||
124821091|NCT00105482|448970897|FG000|Overall Study|Scheduling Conflict|2|||
124821092|NCT00105482|448970898|FG001|Overall Study|Scheduling Conflict|3|||
124821093|NCT00105482|448970897|FG000|Overall Study|Withdrawn by PI|1|||
124821094|NCT00105482|448970898|FG001|Overall Study|Withdrawn by PI|1|||
124821095|NCT05620563|448970899|FG000|Overall Study|Adverse Event|3|||
124821096|NCT05620563|448970900|FG001|Overall Study|Adverse Event|1|||
124821097|NCT05620563|448970899|FG000|Overall Study|Lost to Follow-up|0|||
124821098|NCT05620563|448970900|FG001|Overall Study|Lost to Follow-up|2|||
124821099|NCT05620563|448970899|FG000|Overall Study|Protocol Deviation|1|||
124821100|NCT05620563|448970900|FG001|Overall Study|Protocol Deviation|2|||
124821101|NCT05620563|448970899|FG000|Overall Study|Withdrawal by Subject|3|||
124821102|NCT05620563|448970900|FG001|Overall Study|Withdrawal by Subject|3|||
124821103|NCT05620563|448970899|FG000|Overall Study|Physician Decision|0|||
124821104|NCT05620563|448970900|FG001|Overall Study|Physician Decision|1|||
124821105|NCT00411645|448970903|FG000|Overall Study|Consent Withdrawn|13|||
124821106|NCT00411645|448970904|FG001|Overall Study|Consent Withdrawn|22|||
124821107|NCT00411645|448970903|FG000|Overall Study|Death|56|||
124821108|NCT00411645|448970904|FG001|Overall Study|Death|135|||
124821109|NCT00411645|448970903|FG000|Overall Study|Investigator/Sponsor Decision|10|||
124821110|NCT00411645|448970904|FG001|Overall Study|Investigator/Sponsor Decision|7|||
124821111|NCT00411645|448970903|FG000|Overall Study|Lost to Follow-up|2|||
124821112|NCT00411645|448970904|FG001|Overall Study|Lost to Follow-up|0|||
124821113|NCT04118166|448970907|FG000|Overall Study|Adverse Event|1|||
124821114|NCT03521934|448970908|FG000|Overall Study|Death|65|||
124821115|NCT03521934|448970909|FG001|Overall Study|Death|73|||
124821116|NCT03521934|448970908|FG000|Overall Study|Withdrawal by Subject|18|||
124821117|NCT03521934|448970909|FG001|Overall Study|Withdrawal by Subject|23|||
124821118|NCT03521934|448970908|FG000|Overall Study|Site Terminated by Sponsor|39|||
124821119|NCT03521934|448970909|FG001|Overall Study|Site Terminated by Sponsor|35|||
124821120|NCT03521934|448970908|FG000|Overall Study|Study Terminated by Sponsor|483|||
124821121|NCT03521934|448970909|FG001|Overall Study|Study Terminated by Sponsor|477|||
124821122|NCT03521934|448970908|FG000|Overall Study|Reason not Specified|3|||
124821123|NCT03521934|448970909|FG001|Overall Study|Reason not Specified|6|||
124821124|NCT03020160|448970912|FG000|Overall Study|Withdrawal by Subject|1|||
124821125|NCT03020160|448970913|FG001|Overall Study|Withdrawal by Subject|0|||
124821126|NCT01513473|448970914|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
124821127|NCT01513473|448970915|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
124821128|NCT01513473|448970914|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
124821129|NCT01513473|448970915|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
124821130|NCT01513473|448970914|FG000|Main Trial (26 Weeks)|Unclassified|0|||
124821131|NCT01513473|448970915|FG001|Main Trial (26 Weeks)|Unclassified|2|||
124821132|NCT01513473|448970914|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
124821133|NCT01513473|448970915|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
124821134|NCT01513473|448970914|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
124821135|NCT01513473|448970915|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
124821136|NCT00211809|448970918|FG000|Overall Study|Lack of Efficacy|1|||
124821137|NCT00211809|448970918|FG000|Overall Study|Lost to Follow-up|2|||
124821138|NCT00211809|448970918|FG000|Overall Study|Pregnancy|1|||
124821139|NCT00211809|448970918|FG000|Overall Study|side effects|2|||
124821140|NCT04294472|448970919|FG000|Overall Study|Adverse Event|0|||
124821141|NCT04294472|448970920|FG001|Overall Study|Adverse Event|1|||
124821142|NCT04294472|448970921|FG002|Overall Study|Adverse Event|1|||
124821143|NCT04294472|448970919|FG000|Overall Study|Randomized but not treated|0|||
124821144|NCT04294472|448970920|FG001|Overall Study|Randomized but not treated|1|||
124821145|NCT04294472|448970921|FG002|Overall Study|Randomized but not treated|1|||
124821146|NCT02603419|448970927|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
124821147|NCT02603419|448970928|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
124821148|NCT02603419|448970929|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
124821149|NCT02603419|448970930|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
125303263|NCT02891382|450736695|FG003|Overall Study|Lost to Follow-up|3|||
125303264|NCT02891382|450736696|FG004|Overall Study|Lost to Follow-up|4|||
124821150|NCT02603419|448970931|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
124821151|NCT02603419|448970932|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
125303265|NCT01628965|450736697|FG000|Overall Study|Adverse Event|30|||
124821152|NCT02603419|448970927|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
124821153|NCT02603419|448970928|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
124821154|NCT02603419|448970929|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
124821155|NCT02603419|448970930|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
124821156|NCT02603419|448970931|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
124821157|NCT02603419|448970932|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
124821158|NCT02603419|448970927|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
124821159|NCT02603419|448970928|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
124821160|NCT02603419|448970929|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
124821161|NCT02603419|448970930|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
124821162|NCT02603419|448970931|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
124821163|NCT02603419|448970932|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
124821164|NCT02603419|448970927|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
124821165|NCT02603419|448970928|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
124821166|NCT02603419|448970929|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
124821167|NCT02603419|448970930|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
124821168|NCT02603419|448970931|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
124821169|NCT02603419|448970932|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
124821170|NCT02603419|448970927|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
124821171|NCT02603419|448970928|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
124821172|NCT02603419|448970929|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
124821173|NCT02603419|448970930|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
124821174|NCT02603419|448970931|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
124821175|NCT02603419|448970932|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
124821176|NCT02603419|448970927|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
124821177|NCT02603419|448970928|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
124821178|NCT02603419|448970929|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
124821179|NCT02603419|448970930|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
124821180|NCT02603419|448970931|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
124821181|NCT02603419|448970932|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
124821182|NCT02603419|448970927|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
124821183|NCT02603419|448970928|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
124821184|NCT02603419|448970929|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
124821185|NCT02603419|448970930|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
125303266|NCT01628965|450736697|FG000|Overall Study|Lack of Efficacy|7|||
125303267|NCT01628965|450736697|FG000|Overall Study|Withdrawal by Subject|3|||
124821186|NCT02603419|448970931|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
124821187|NCT02603419|448970932|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
124821188|NCT02603419|448970927|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
124821189|NCT02603419|448970928|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
124821190|NCT02603419|448970929|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
124821191|NCT02603419|448970930|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
124821192|NCT02603419|448970931|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
124821193|NCT02603419|448970932|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
125303268|NCT01628965|450736697|FG000|Overall Study|Lost to Follow-up|1|||
125303269|NCT01628965|450736697|FG000|Overall Study|Discontinuation criteria|8|||
125303270|NCT02828020|450736698|FG000|Treatment Period|Adverse Event|3|||
125303271|NCT02828020|450736699|FG001|Treatment Period|Adverse Event|1|||
125303272|NCT02828020|450736700|FG002|Treatment Period|Adverse Event|1|||
125303273|NCT02828020|450736698|FG000|Treatment Period|Withdrawal of Consent|10|||
125303274|NCT02828020|450736699|FG001|Treatment Period|Withdrawal of Consent|14|||
125303275|NCT02828020|450736700|FG002|Treatment Period|Withdrawal of Consent|9|||
125303276|NCT02828020|450736698|FG000|Treatment Period|Lost to Follow-up|21|||
125303277|NCT02828020|450736699|FG001|Treatment Period|Lost to Follow-up|24|||
125303278|NCT02828020|450736700|FG002|Treatment Period|Lost to Follow-up|18|||
125303279|NCT02828020|450736698|FG000|Treatment Period|Lack of Qualifying Event|44|||
125303280|NCT02828020|450736699|FG001|Treatment Period|Lack of Qualifying Event|53|||
125303281|NCT02828020|450736700|FG002|Treatment Period|Lack of Qualifying Event|43|||
125303282|NCT02828020|450736698|FG000|Treatment Period|Pregnancy|0|||
125303283|NCT02828020|450736699|FG001|Treatment Period|Pregnancy|2|||
125303284|NCT02828020|450736700|FG002|Treatment Period|Pregnancy|0|||
125303285|NCT02828020|450736698|FG000|Treatment Period|Protocol Violation|2|||
125303286|NCT02828020|450736699|FG001|Treatment Period|Protocol Violation|4|||
124821194|NCT02603419|448970927|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
124821195|NCT02603419|448970928|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
124821196|NCT02603419|448970929|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
124821197|NCT02603419|448970930|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
124821198|NCT02603419|448970931|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
124821199|NCT02603419|448970932|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
125303287|NCT02828020|450736700|FG002|Treatment Period|Protocol Violation|7|||
125303288|NCT02828020|450736698|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
125303289|NCT02828020|450736699|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
124821200|NCT02603419|448970927|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
124821201|NCT02603419|448970928|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
124821202|NCT02603419|448970929|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
124821203|NCT02603419|448970930|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
124821204|NCT02603419|448970931|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
124821205|NCT02603419|448970932|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
124821206|NCT01049308|448970934|FG000|Pill Counts|Withdrawal by Subject|83|||
124821207|NCT02289417|448970935|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
124821208|NCT02289417|448970936|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
124821209|NCT02289417|448970937|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
124821210|NCT02289417|448970938|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
124821211|NCT02289417|448970939|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
124821212|NCT02289417|448970940|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
124821213|NCT02289417|448970941|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
124821214|NCT02289417|448970942|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
124821215|NCT02289417|448970943|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
124821216|NCT02289417|448970935|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
124821217|NCT02289417|448970936|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
124821218|NCT02289417|448970937|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
124821219|NCT02289417|448970938|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
124821220|NCT02289417|448970939|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
124821221|NCT02289417|448970940|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
124821222|NCT02289417|448970941|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
124821223|NCT02289417|448970942|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
124821224|NCT02289417|448970943|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
124821225|NCT02289417|448970935|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
124821226|NCT02289417|448970936|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
124821227|NCT02289417|448970937|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
124821228|NCT02289417|448970938|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
124821229|NCT02289417|448970939|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
124821230|NCT02289417|448970940|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
124821231|NCT02289417|448970941|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
124821232|NCT02289417|448970942|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
124821233|NCT02289417|448970943|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
124821234|NCT02289417|448970935|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
124821235|NCT02289417|448970936|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
124821236|NCT02289417|448970937|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
124821237|NCT02289417|448970938|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
124821238|NCT02289417|448970939|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
124821239|NCT02289417|448970940|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
124821240|NCT02289417|448970941|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
124821241|NCT02289417|448970942|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
124821242|NCT02289417|448970943|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
124821243|NCT02289417|448970935|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
124821244|NCT02289417|448970936|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
124821245|NCT02289417|448970937|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
124821246|NCT02289417|448970938|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
124821247|NCT02289417|448970939|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
124821248|NCT02289417|448970940|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
124821249|NCT02289417|448970941|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
124821250|NCT02289417|448970942|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
124821251|NCT02289417|448970943|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
124821252|NCT02289417|448970935|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
124821253|NCT02289417|448970936|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
124821254|NCT02289417|448970937|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
124821255|NCT02289417|448970938|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
124821256|NCT02289417|448970939|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
124821257|NCT02289417|448970940|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
124821258|NCT02289417|448970941|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
124821259|NCT02289417|448970942|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
124821260|NCT02289417|448970943|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
124821261|NCT02289417|448970935|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
124821262|NCT02289417|448970936|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
124821263|NCT02289417|448970937|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
124821264|NCT02289417|448970938|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
124821265|NCT02289417|448970939|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
124821266|NCT02289417|448970940|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
124821267|NCT02289417|448970941|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
124821268|NCT02289417|448970942|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
124821269|NCT02289417|448970943|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
124821270|NCT02289417|448970935|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
124821271|NCT02289417|448970936|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
124821272|NCT02289417|448970937|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
124821273|NCT02289417|448970938|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
124821274|NCT02289417|448970939|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
124821275|NCT02289417|448970940|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
124821276|NCT02289417|448970941|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
124821277|NCT02289417|448970942|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
124821278|NCT02289417|448970943|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
124821279|NCT02289417|448970935|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
124821280|NCT02289417|448970936|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
124821281|NCT02289417|448970937|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
124821282|NCT02289417|448970938|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
124821283|NCT02289417|448970939|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
124821284|NCT02289417|448970940|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
124821285|NCT02289417|448970941|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
124821286|NCT02289417|448970942|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
124821287|NCT02289417|448970943|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
124821288|NCT02289417|448970935|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
124821289|NCT02289417|448970936|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
124821290|NCT02289417|448970937|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
124821291|NCT02289417|448970938|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
124821292|NCT02289417|448970939|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
124821293|NCT02289417|448970940|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
124821294|NCT02289417|448970941|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
124821295|NCT02289417|448970942|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
124821296|NCT02289417|448970943|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
124821297|NCT02289417|448970935|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
124821298|NCT02289417|448970936|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
124821299|NCT02289417|448970937|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
124821300|NCT02289417|448970938|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
124821301|NCT02289417|448970939|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
124821302|NCT02289417|448970940|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
124821303|NCT02289417|448970941|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
124821304|NCT02289417|448970942|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
124821305|NCT02289417|448970943|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
124821306|NCT02289417|448970935|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
124821307|NCT02289417|448970936|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
124821308|NCT02289417|448970937|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
124821309|NCT02289417|448970938|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
124821310|NCT02289417|448970939|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
124821311|NCT02289417|448970940|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
124821312|NCT02289417|448970941|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
124821313|NCT02289417|448970942|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
124821314|NCT02289417|448970943|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
124821315|NCT02289417|448970935|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
124821316|NCT02289417|448970936|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
124821317|NCT02289417|448970937|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
124821318|NCT02289417|448970938|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
124821319|NCT02289417|448970939|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
124821320|NCT02289417|448970940|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
124821321|NCT02289417|448970941|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
124821322|NCT02289417|448970942|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
124821323|NCT02289417|448970943|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
124821324|NCT02289417|448970935|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
125303290|NCT02828020|450736700|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
125303291|NCT02828020|450736698|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
125303292|NCT02828020|450736699|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
125303293|NCT02828020|450736700|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
124821325|NCT02289417|448970936|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
124821326|NCT02289417|448970937|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
124821327|NCT02289417|448970938|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
124821328|NCT02289417|448970939|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
124821329|NCT02289417|448970940|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
124821330|NCT02289417|448970941|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
124821331|NCT02289417|448970942|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
124821332|NCT02289417|448970943|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
124821333|NCT04786990|448970944|FG000|Overall Study|Withdrawal by Subject|1|||
124821334|NCT04786990|448970944|FG000|Overall Study|Adverse Event|1|||
124821335|NCT04786990|448970944|FG000|Overall Study|Lost to Follow-up|1|||
124821336|NCT04786990|448970944|FG000|Overall Study|Noncompliance|1|||
124821337|NCT04786990|448970944|FG000|Overall Study|Unable to complete site visits|1|||
124821338|NCT04786990|448970944|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
124821339|NCT01782222|448970947|FG000|Overall Study|Adverse Event|4|||
124821340|NCT01782222|448970948|FG001|Overall Study|Adverse Event|5|||
124821341|NCT01782222|448970949|FG002|Overall Study|Adverse Event|3|||
124821342|NCT01782222|448970947|FG000|Overall Study|Lack of Efficacy|2|||
124821343|NCT01782222|448970948|FG001|Overall Study|Lack of Efficacy|1|||
124821344|NCT01782222|448970949|FG002|Overall Study|Lack of Efficacy|0|||
124821345|NCT01782222|448970947|FG000|Overall Study|Protocol Violation|1|||
124821346|NCT01782222|448970948|FG001|Overall Study|Protocol Violation|0|||
124821347|NCT01782222|448970949|FG002|Overall Study|Protocol Violation|0|||
124821348|NCT01782222|448970947|FG000|Overall Study|Withdrawal by Subject|1|||
124821349|NCT01782222|448970948|FG001|Overall Study|Withdrawal by Subject|4|||
124821350|NCT01782222|448970949|FG002|Overall Study|Withdrawal by Subject|1|||
124821351|NCT01782222|448970947|FG000|Overall Study|Moved to other state|0|||
124821352|NCT01782222|448970948|FG001|Overall Study|Moved to other state|1|||
124821353|NCT01782222|448970949|FG002|Overall Study|Moved to other state|0|||
124821354|NCT01756898|448970953|FG000|Overall Study|Adverse Event|7|||
124821355|NCT01756898|448970954|FG001|Overall Study|Adverse Event|1|||
124821356|NCT01756898|448970955|FG002|Overall Study|Adverse Event|0|||
124821357|NCT01756898|448970956|FG003|Overall Study|Adverse Event|0|||
124821358|NCT01756898|448970953|FG000|Overall Study|Lack of Efficacy|4|||
124821359|NCT01756898|448970954|FG001|Overall Study|Lack of Efficacy|7|||
124821360|NCT01756898|448970955|FG002|Overall Study|Lack of Efficacy|6|||
124821361|NCT01756898|448970956|FG003|Overall Study|Lack of Efficacy|6|||
124821362|NCT01756898|448970953|FG000|Overall Study|Lost to Follow-up|2|||
124821363|NCT01756898|448970954|FG001|Overall Study|Lost to Follow-up|4|||
124821364|NCT01756898|448970955|FG002|Overall Study|Lost to Follow-up|2|||
124821365|NCT01756898|448970956|FG003|Overall Study|Lost to Follow-up|3|||
124821366|NCT01756898|448970953|FG000|Overall Study|Protocol Violation|1|||
124821367|NCT01756898|448970954|FG001|Overall Study|Protocol Violation|2|||
124821368|NCT01756898|448970955|FG002|Overall Study|Protocol Violation|2|||
124821369|NCT01756898|448970956|FG003|Overall Study|Protocol Violation|1|||
124821370|NCT01756898|448970953|FG000|Overall Study|Withdrew Consent|5|||
124821371|NCT01756898|448970954|FG001|Overall Study|Withdrew Consent|3|||
124821372|NCT01756898|448970955|FG002|Overall Study|Withdrew Consent|5|||
124821373|NCT01756898|448970956|FG003|Overall Study|Withdrew Consent|6|||
124821374|NCT01756898|448970953|FG000|Overall Study|Other|0|||
124821375|NCT01756898|448970954|FG001|Overall Study|Other|2|||
124821376|NCT01756898|448970955|FG002|Overall Study|Other|2|||
124821377|NCT01756898|448970956|FG003|Overall Study|Other|0|||
124821378|NCT01500694|448970957|FG000|Overall Study|Adverse Event|4|||
124821379|NCT01500694|448970958|FG001|Overall Study|Adverse Event|3|||
124821380|NCT01500694|448970957|FG000|Overall Study|Protocol Violation|0|||
124821381|NCT01500694|448970958|FG001|Overall Study|Protocol Violation|1|||
124821382|NCT01500694|448970957|FG000|Overall Study|Withdrawal by Subject|23|||
124821383|NCT01500694|448970958|FG001|Overall Study|Withdrawal by Subject|14|||
124821384|NCT01500694|448970957|FG000|Overall Study|Lost to Follow-up|2|||
124821385|NCT01500694|448970958|FG001|Overall Study|Lost to Follow-up|3|||
124821386|NCT01500694|448970957|FG000|Overall Study|Lack of Efficacy|14|||
124821387|NCT01500694|448970958|FG001|Overall Study|Lack of Efficacy|5|||
124821388|NCT01500694|448970957|FG000|Overall Study|Other|9|||
124821389|NCT01500694|448970958|FG001|Overall Study|Other|3|||
124821390|NCT00496054|448970963|FG000|Overall Study|Adverse Event|1|||
124821391|NCT00496054|448970963|FG000|Overall Study|Lost to Follow-up|7|||
124821392|NCT01858389|448970966|FG000|Overall Study|Death|1|||
124821393|NCT01858389|448970967|FG001|Overall Study|Death|3|||
124821394|NCT01858389|448970966|FG000|Overall Study|Study terminated by sponsor|0|||
124821395|NCT01858389|448970967|FG001|Overall Study|Study terminated by sponsor|2|||
124821396|NCT01858389|448970966|FG000|Overall Study|Withdrawal by Subject|0|||
124821397|NCT01858389|448970967|FG001|Overall Study|Withdrawal by Subject|1|||
124821398|NCT01858389|448970966|FG000|Overall Study|Progressive disease|10|||
124821399|NCT01858389|448970967|FG001|Overall Study|Progressive disease|11|||
124821400|NCT01858389|448970966|FG000|Overall Study|Other|2|||
124821401|NCT01858389|448970967|FG001|Overall Study|Other|4|||
124821402|NCT01858389|448970966|FG000|Overall Study|Adverse Event|3|||
124821403|NCT01858389|448970967|FG001|Overall Study|Adverse Event|1|||
124821404|NCT01858389|448970966|FG000|Overall Study|Did not receive treatment|0|||
124821405|NCT01858389|448970967|FG001|Overall Study|Did not receive treatment|3|||
124821406|NCT03572062|448970968|FG000|Overall Study|Adverse Event|0|||
124821407|NCT03572062|448970969|FG001|Overall Study|Adverse Event|0|||
124821408|NCT03572062|448970970|FG002|Overall Study|Adverse Event|0|||
124821409|NCT03572062|448970971|FG003|Overall Study|Adverse Event|0|||
124821410|NCT03572062|448970972|FG004|Overall Study|Adverse Event|0|||
124821411|NCT03572062|448970973|FG005|Overall Study|Adverse Event|0|||
124821412|NCT03572062|448970974|FG006|Overall Study|Adverse Event|0|||
124821413|NCT03572062|448970975|FG007|Overall Study|Adverse Event|0|||
124821414|NCT03572062|448970976|FG008|Overall Study|Adverse Event|1|||
124821415|NCT03572062|448970977|FG009|Overall Study|Adverse Event|3|||
124821416|NCT03572062|448970968|FG000|Overall Study|Death|0|||
124821417|NCT03572062|448970969|FG001|Overall Study|Death|0|||
124821418|NCT03572062|448970970|FG002|Overall Study|Death|0|||
124821419|NCT03572062|448970971|FG003|Overall Study|Death|0|||
124821420|NCT03572062|448970972|FG004|Overall Study|Death|0|||
124821421|NCT03572062|448970973|FG005|Overall Study|Death|1|||
124821422|NCT03572062|448970974|FG006|Overall Study|Death|0|||
124821423|NCT03572062|448970975|FG007|Overall Study|Death|0|||
124821424|NCT03572062|448970976|FG008|Overall Study|Death|0|||
124821425|NCT03572062|448970977|FG009|Overall Study|Death|0|||
124821426|NCT03572062|448970968|FG000|Overall Study|Lost to Follow-up|0|||
124821427|NCT03572062|448970969|FG001|Overall Study|Lost to Follow-up|0|||
124821428|NCT03572062|448970970|FG002|Overall Study|Lost to Follow-up|0|||
124821429|NCT03572062|448970971|FG003|Overall Study|Lost to Follow-up|0|||
124821430|NCT03572062|448970972|FG004|Overall Study|Lost to Follow-up|0|||
124821431|NCT03572062|448970973|FG005|Overall Study|Lost to Follow-up|1|||
124821432|NCT03572062|448970974|FG006|Overall Study|Lost to Follow-up|1|||
124821433|NCT03572062|448970975|FG007|Overall Study|Lost to Follow-up|0|||
124821434|NCT03572062|448970976|FG008|Overall Study|Lost to Follow-up|0|||
124821435|NCT03572062|448970977|FG009|Overall Study|Lost to Follow-up|0|||
124821436|NCT03572062|448970968|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
124821437|NCT03572062|448970969|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
124821438|NCT03572062|448970970|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
124821439|NCT03572062|448970971|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
124821440|NCT03572062|448970972|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
124821441|NCT03572062|448970973|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
124821442|NCT03572062|448970974|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
124821443|NCT03572062|448970975|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
124821444|NCT03572062|448970976|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
124821445|NCT03572062|448970977|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
124821446|NCT03572062|448970968|FG000|Overall Study|Study Terminated By Sponsor|0|||
124821447|NCT03572062|448970969|FG001|Overall Study|Study Terminated By Sponsor|0|||
124821448|NCT03572062|448970970|FG002|Overall Study|Study Terminated By Sponsor|0|||
124821449|NCT03572062|448970971|FG003|Overall Study|Study Terminated By Sponsor|0|||
124821450|NCT03572062|448970972|FG004|Overall Study|Study Terminated By Sponsor|0|||
124821451|NCT03572062|448970973|FG005|Overall Study|Study Terminated By Sponsor|0|||
124821452|NCT03572062|448970974|FG006|Overall Study|Study Terminated By Sponsor|0|||
124821453|NCT03572062|448970975|FG007|Overall Study|Study Terminated By Sponsor|0|||
124821454|NCT03572062|448970976|FG008|Overall Study|Study Terminated By Sponsor|29|||
124821455|NCT03572062|448970977|FG009|Overall Study|Study Terminated By Sponsor|27|||
124821456|NCT03572062|448970968|FG000|Overall Study|Physician Decision|0|||
124821457|NCT03572062|448970969|FG001|Overall Study|Physician Decision|0|||
124821458|NCT03572062|448970970|FG002|Overall Study|Physician Decision|0|||
124821459|NCT03572062|448970971|FG003|Overall Study|Physician Decision|0|||
124821460|NCT03572062|448970972|FG004|Overall Study|Physician Decision|0|||
124821461|NCT03572062|448970973|FG005|Overall Study|Physician Decision|0|||
124821462|NCT03572062|448970974|FG006|Overall Study|Physician Decision|0|||
124821463|NCT03572062|448970975|FG007|Overall Study|Physician Decision|0|||
124821464|NCT03572062|448970976|FG008|Overall Study|Physician Decision|1|||
124821465|NCT03572062|448970977|FG009|Overall Study|Physician Decision|0|||
124821466|NCT03572062|448970968|FG000|Overall Study|Withdrawal by Subject|0|||
124821467|NCT03572062|448970969|FG001|Overall Study|Withdrawal by Subject|0|||
124821468|NCT03572062|448970970|FG002|Overall Study|Withdrawal by Subject|0|||
124821469|NCT03572062|448970971|FG003|Overall Study|Withdrawal by Subject|0|||
124821470|NCT03572062|448970972|FG004|Overall Study|Withdrawal by Subject|0|||
124821471|NCT03572062|448970973|FG005|Overall Study|Withdrawal by Subject|0|||
125303294|NCT02828020|450736698|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
125303295|NCT02828020|450736699|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
125303296|NCT02828020|450736700|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
124821472|NCT03572062|448970974|FG006|Overall Study|Withdrawal by Subject|0|||
124821473|NCT03572062|448970975|FG007|Overall Study|Withdrawal by Subject|0|||
124821474|NCT03572062|448970976|FG008|Overall Study|Withdrawal by Subject|0|||
124821475|NCT03572062|448970977|FG009|Overall Study|Withdrawal by Subject|1|||
124821476|NCT03572062|448970968|FG000|Overall Study|Randomized But Not Treated|0|||
124821477|NCT03572062|448970969|FG001|Overall Study|Randomized But Not Treated|0|||
124821478|NCT03572062|448970970|FG002|Overall Study|Randomized But Not Treated|0|||
124821479|NCT03572062|448970971|FG003|Overall Study|Randomized But Not Treated|0|||
124821480|NCT03572062|448970972|FG004|Overall Study|Randomized But Not Treated|1|||
124821481|NCT03572062|448970973|FG005|Overall Study|Randomized But Not Treated|2|||
124821482|NCT03572062|448970974|FG006|Overall Study|Randomized But Not Treated|0|||
124821483|NCT03572062|448970975|FG007|Overall Study|Randomized But Not Treated|1|||
124821484|NCT03572062|448970976|FG008|Overall Study|Randomized But Not Treated|0|||
124821485|NCT03572062|448970977|FG009|Overall Study|Randomized But Not Treated|0|||
124821486|NCT00471328|448970978|FG000|Core Phase|Adverse Event|18|||
124821487|NCT00471328|448970979|FG001|Core Phase|Adverse Event|6|||
124821488|NCT00471328|448970978|FG000|Core Phase|Death|8|||
124821489|NCT00471328|448970979|FG001|Core Phase|Death|4|||
124821490|NCT00471328|448970978|FG000|Core Phase|Withdrawal by Subject|2|||
124821491|NCT00471328|448970979|FG001|Core Phase|Withdrawal by Subject|2|||
124821492|NCT00471328|448970978|FG000|Core Phase|Abnormal laboratory value|1|||
124821493|NCT00471328|448970979|FG001|Core Phase|Abnormal laboratory value|0|||
124821494|NCT00471328|448970978|FG000|Core Phase|Disease Progression|78|||
124821495|NCT00471328|448970979|FG001|Core Phase|Disease Progression|53|||
124821496|NCT00471328|448970978|FG000|Core Phase|Administrative Problem|0|||
124821497|NCT00471328|448970979|FG001|Core Phase|Administrative Problem|1|||
124821498|NCT00471328|448970978|FG000|Core Phase|Protocol Deviation|0|||
124821499|NCT00471328|448970979|FG001|Core Phase|Protocol Deviation|1|||
124821500|NCT00471328|448970978|FG000|Extension Phase|Adverse Event|3|||
124821501|NCT00471328|448970979|FG001|Extension Phase|Adverse Event|12|||
124821502|NCT00471328|448970978|FG000|Extension Phase|Withdrawal by Subject|0|||
124821503|NCT00471328|448970979|FG001|Extension Phase|Withdrawal by Subject|2|||
124821504|NCT00471328|448970978|FG000|Extension Phase|Death|1|||
124821505|NCT00471328|448970979|FG001|Extension Phase|Death|7|||
124821506|NCT00471328|448970978|FG000|Extension Phase|Protocol Deviation|3|||
124821507|NCT00471328|448970979|FG001|Extension Phase|Protocol Deviation|1|||
124821508|NCT00471328|448970978|FG000|Extension Phase|Treatment duration as per protocol|0|||
124821509|NCT00471328|448970979|FG001|Extension Phase|Treatment duration as per protocol|1|||
124821510|NCT00471328|448970978|FG000|Extension Phase|Disease Progression|32|||
124821511|NCT00471328|448970979|FG001|Extension Phase|Disease Progression|44|||
124821512|NCT00471328|448970978|FG000|Extension Phase|New cancer Therapy|1|||
124821513|NCT00471328|448970979|FG001|Extension Phase|New cancer Therapy|0|||
124821514|NCT00471328|448970978|FG000|Extension Phase|Administrative Problem|1|||
124821515|NCT00471328|448970979|FG001|Extension Phase|Administrative Problem|0|||
124821516|NCT04051008|448970980|FG000|Overall Study|Withdrawal by Subject|2|||
124821517|NCT04051008|448970981|FG001|Overall Study|Withdrawal by Subject|0|||
124821518|NCT04051008|448970982|FG002|Overall Study|Withdrawal by Subject|1|||
124821519|NCT01605877|448970983|FG000|Overall Study|Withdrawal by Subject|1|||
124821520|NCT00458211|448970984|FG000|Overall Study|Lack of Efficacy|12|||
124821521|NCT00458211|448970984|FG000|Overall Study|Withdrawal by Subject|2|||
124821522|NCT00458211|448970984|FG000|Overall Study|Protocol Violation|2|||
124821523|NCT02634320|448970992|FG000|Overall Study|Adverse Event|2|||
124821524|NCT02634320|448970992|FG000|Overall Study|Lost to Follow-up|3|||
124821525|NCT02634320|448970992|FG000|Overall Study|Moved out of area|2|||
124821526|NCT02634320|448970992|FG000|Overall Study|Out of window for study visits|1|||
124821527|NCT02634320|448970992|FG000|Overall Study|Protocol Violation|1|||
124821528|NCT02634320|448970992|FG000|Overall Study|Withdrawal by Subject|5|||
124821529|NCT02634320|448970992|FG000|Overall Study|Lack of Efficacy|2|||
124821530|NCT00687323|448970993|FG000|Overall Study|Death|25|||
124821531|NCT00687323|448970993|FG000|Overall Study|Withdrawal by Subject|1|||
124821532|NCT00687323|448970993|FG000|Overall Study|Excluded from efficacy evaluations|6|||
124821533|NCT00687323|448970993|FG000|Overall Study|Screen failure|148|||
124821534|NCT02132130|448970997|FG000|Overall Study|Lost to Follow-up|0|||
124821535|NCT02132130|448970998|FG001|Overall Study|Lost to Follow-up|2|||
124821536|NCT02132130|448970999|FG002|Overall Study|Lost to Follow-up|0|||
124821537|NCT02132130|448971000|FG003|Overall Study|Lost to Follow-up|0|||
124821538|NCT02132130|448970997|FG000|Overall Study|Withdrawal by Subject|0|||
124821539|NCT02132130|448970998|FG001|Overall Study|Withdrawal by Subject|0|||
124821540|NCT02132130|448970999|FG002|Overall Study|Withdrawal by Subject|0|||
124821541|NCT02132130|448971000|FG003|Overall Study|Withdrawal by Subject|1|||
124821542|NCT03310775|448971007|FG000|Overall Study|Lost to Follow-up|2|||
124821543|NCT03310775|448971008|FG001|Overall Study|Lost to Follow-up|3|||
124821544|NCT03310775|448971007|FG000|Overall Study|aggravation of depression|0|||
124821545|NCT03310775|448971008|FG001|Overall Study|aggravation of depression|1|||
124821546|NCT00838578|448971009|FG000|Overall Study|Protocol Violation|2|||
124821547|NCT00357968|448971010|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
124821548|NCT00357968|448971011|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
124821549|NCT00357968|448971010|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
124821550|NCT00357968|448971011|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
124821551|NCT04847557|448971016|FG000|Overall Study|Adverse Event|1|||
124821552|NCT04847557|448971017|FG001|Overall Study|Adverse Event|0|||
124821553|NCT04847557|448971016|FG000|Overall Study|Death|19|||
124821554|NCT04847557|448971017|FG001|Overall Study|Death|15|||
124821555|NCT04847557|448971016|FG000|Overall Study|Lost to Follow-up|3|||
124821556|NCT04847557|448971017|FG001|Overall Study|Lost to Follow-up|6|||
124821557|NCT04847557|448971016|FG000|Overall Study|Physician Decision|1|||
124821558|NCT04847557|448971017|FG001|Overall Study|Physician Decision|0|||
124821559|NCT04847557|448971016|FG000|Overall Study|Protocol Violation|0|||
124821560|NCT04847557|448971017|FG001|Overall Study|Protocol Violation|1|||
124821561|NCT04847557|448971016|FG000|Overall Study|Withdrawal by Subject|8|||
124821562|NCT04847557|448971017|FG001|Overall Study|Withdrawal by Subject|14|||
124821563|NCT00996216|448973941|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
124821564|NCT00996216|448973941|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
124821565|NCT00996216|448973941|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
124821566|NCT00793403|448973944|FG000|Overall Study|Other|73|||
124821567|NCT00842712|448973945|FG000|Safety Run-in Part|Adverse Event|0|||
124821568|NCT00842712|448973946|FG001|Safety Run-in Part|Adverse Event|1|||
124821569|NCT00842712|448973947|FG002|Safety Run-in Part|Adverse Event|0|||
124821570|NCT00842712|448973948|FG003|Safety Run-in Part|Adverse Event|0|||
124821571|NCT00842712|448973949|FG004|Safety Run-in Part|Adverse Event|0|||
124821572|NCT00842712|448973950|FG005|Safety Run-in Part|Adverse Event|0|||
124821573|NCT00842712|448973951|FG006|Safety Run-in Part|Adverse Event|0|||
124821574|NCT00842712|448973945|FG000|Safety Run-in Part|Progressive disease|3|||
124821575|NCT00842712|448973946|FG001|Safety Run-in Part|Progressive disease|1|||
124821576|NCT00842712|448973947|FG002|Safety Run-in Part|Progressive disease|0|||
124821577|NCT00842712|448973948|FG003|Safety Run-in Part|Progressive disease|1|||
124821578|NCT00842712|448973949|FG004|Safety Run-in Part|Progressive disease|0|||
124821579|NCT00842712|448973950|FG005|Safety Run-in Part|Progressive disease|0|||
124821580|NCT00842712|448973951|FG006|Safety Run-in Part|Progressive disease|0|||
124821581|NCT00842712|448973945|FG000|Randomized Part|Randomized but not treated|0|||
124821582|NCT00842712|448973946|FG001|Randomized Part|Randomized but not treated|0|||
124821583|NCT00842712|448973947|FG002|Randomized Part|Randomized but not treated|0|||
124821584|NCT00842712|448973948|FG003|Randomized Part|Randomized but not treated|0|||
124821585|NCT00842712|448973949|FG004|Randomized Part|Randomized but not treated|0|||
124821586|NCT00842712|448973950|FG005|Randomized Part|Randomized but not treated|1|||
124821587|NCT00842712|448973951|FG006|Randomized Part|Randomized but not treated|4|||
124821588|NCT00842712|448973945|FG000|Randomized Part|Ongoing at cut-off date|0|||
124821589|NCT00842712|448973946|FG001|Randomized Part|Ongoing at cut-off date|0|||
124821590|NCT00842712|448973947|FG002|Randomized Part|Ongoing at cut-off date|0|||
124821591|NCT00842712|448973948|FG003|Randomized Part|Ongoing at cut-off date|0|||
124821592|NCT00842712|448973949|FG004|Randomized Part|Ongoing at cut-off date|0|||
124821593|NCT00842712|448973950|FG005|Randomized Part|Ongoing at cut-off date|0|||
124821594|NCT00842712|448973951|FG006|Randomized Part|Ongoing at cut-off date|2|||
124821595|NCT01549860|448973957|FG000|Overall Study|Withdrawal by Subject|1|||
124821596|NCT01549860|448973958|FG001|Overall Study|Withdrawal by Subject|0|||
124821597|NCT01549860|448973957|FG000|Overall Study|Physician Decision|1|||
124821598|NCT01549860|448973958|FG001|Overall Study|Physician Decision|1|||
124821599|NCT04271605|448973970|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
124821600|NCT02485301|448973971|FG000|Overall Study|Serious Adverse Events|2|||
124821601|NCT02485301|448973972|FG001|Overall Study|Serious Adverse Events|1|||
124821602|NCT02485301|448973971|FG000|Overall Study|Protocol Violation|0|||
124821603|NCT02485301|448973972|FG001|Overall Study|Protocol Violation|1|||
124821604|NCT02485301|448973971|FG000|Overall Study|Withdrawal by Subject|6|||
124821605|NCT02485301|448973972|FG001|Overall Study|Withdrawal by Subject|7|||
124821606|NCT02485301|448973971|FG000|Overall Study|Migrated/moved from study area|10|||
124821607|NCT02485301|448973972|FG001|Overall Study|Migrated/moved from study area|19|||
124821608|NCT02485301|448973971|FG000|Overall Study|Lost to Follow-up|17|||
124821609|NCT02485301|448973972|FG001|Overall Study|Lost to Follow-up|17|||
124821610|NCT02485301|448973971|FG000|Overall Study|Other|3|||
124821611|NCT02485301|448973972|FG001|Overall Study|Other|4|||
124821612|NCT00085631|448973978|FG000|Overall Study|Missing Data|4|||
124821613|NCT00085631|448973979|FG001|Overall Study|Missing Data|11|||
124821614|NCT00085631|448973980|FG002|Overall Study|Missing Data|7|||
124821615|NCT01349790|448973981|FG000|Overall Study|Investigator Judgement|3|||
124821616|NCT01349790|448973981|FG000|Overall Study|Death|2|||
124821617|NCT01349790|448973981|FG000|Overall Study|Withdrawal by Patient|2|||
124821618|NCT01349790|448973981|FG000|Overall Study|Adverse Event|1|||
125303297|NCT02828020|450736698|FG000|Safety Follow-up Period|Protocol Violation|0|||
125303298|NCT02828020|450736699|FG001|Safety Follow-up Period|Protocol Violation|2|||
124821619|NCT01349790|448973981|FG000|Overall Study|Lost to Follow-up|1|||
124821620|NCT02085785|448973984|FG000|Overall Study|Withdrawal by Subject|2|||
124821621|NCT02085785|448973985|FG001|Overall Study|Withdrawal by Subject|1|||
124821622|NCT02085785|448973984|FG000|Overall Study|Lost to Follow-up|0|||
124821623|NCT02085785|448973985|FG001|Overall Study|Lost to Follow-up|1|||
124821624|NCT00779467|448973986|FG000|Overall Study|Lack of Efficacy|11|||
124821625|NCT00779467|448973987|FG001|Overall Study|Lack of Efficacy|2|||
124821626|NCT00779467|448973988|FG002|Overall Study|Lack of Efficacy|6|||
124821627|NCT00779467|448973989|FG003|Overall Study|Lack of Efficacy|11|||
124821628|NCT00779467|448973986|FG000|Overall Study|failed inclusion criteria|3|||
124821629|NCT00779467|448973987|FG001|Overall Study|failed inclusion criteria|3|||
124821630|NCT00779467|448973988|FG002|Overall Study|failed inclusion criteria|1|||
124821631|NCT00779467|448973989|FG003|Overall Study|failed inclusion criteria|2|||
124821632|NCT00779467|448973986|FG000|Overall Study|missing data|1|||
124821633|NCT00779467|448973987|FG001|Overall Study|missing data|0|||
124821634|NCT00779467|448973988|FG002|Overall Study|missing data|1|||
124821635|NCT00779467|448973989|FG003|Overall Study|missing data|4|||
124821636|NCT00779467|448973986|FG000|Overall Study|technical issue|0|||
124821637|NCT00779467|448973987|FG001|Overall Study|technical issue|0|||
124821638|NCT00779467|448973988|FG002|Overall Study|technical issue|2|||
124821639|NCT00779467|448973989|FG003|Overall Study|technical issue|1|||
124821640|NCT00779467|448973986|FG000|Overall Study|unavailable research staff|0|||
124821641|NCT00779467|448973987|FG001|Overall Study|unavailable research staff|0|||
124821642|NCT00779467|448973988|FG002|Overall Study|unavailable research staff|0|||
124821643|NCT00779467|448973989|FG003|Overall Study|unavailable research staff|1|||
124821644|NCT02692703|448973990|FG000|Overall Study|Lost to Follow-up|1|||
124821645|NCT02692703|448973990|FG000|Overall Study|Other|1|||
124821646|NCT05048784|448973997|FG000|Period 1|Adverse Event|3|||
124821647|NCT05048784|448973998|FG001|Period 1|Adverse Event|1|||
124821648|NCT05048784|448973999|FG002|Period 1|Adverse Event|0|||
124821649|NCT05048784|448974000|FG003|Period 1|Adverse Event|0|||
124821650|NCT05048784|448973997|FG000|Period 2|Lost to Follow-up|0|||
124821651|NCT05048784|448973998|FG001|Period 2|Lost to Follow-up|1|||
124821652|NCT05048784|448973999|FG002|Period 2|Lost to Follow-up|0|||
124821653|NCT05048784|448974000|FG003|Period 2|Lost to Follow-up|0|||
124821654|NCT00885105|448974001|FG000|Overall Study|Withdrawal by Subject|0|||
124821655|NCT00885105|448974002|FG001|Overall Study|Withdrawal by Subject|8|||
124821656|NCT00885105|448974001|FG000|Overall Study|Adverse Event|1|||
124821657|NCT00885105|448974002|FG001|Overall Study|Adverse Event|0|||
124821658|NCT00885105|448974001|FG000|Overall Study|Protocol Violation|0|||
124821659|NCT00885105|448974002|FG001|Overall Study|Protocol Violation|2|||
124821660|NCT03519932|448974003|FG000|First Intervention|Adverse Event|1|||
124821661|NCT03519932|448974004|FG001|First Intervention|Adverse Event|3|||
124821662|NCT00284050|448974005|FG000|Overall Study|Adverse Event|1|||
124821663|NCT00284050|448974006|FG001|Overall Study|Adverse Event|1|||
124821664|NCT00284050|448974007|FG002|Overall Study|Adverse Event|1|||
124821665|NCT00284050|448974005|FG000|Overall Study|Lack of Efficacy|0|||
124821666|NCT00284050|448974006|FG001|Overall Study|Lack of Efficacy|1|||
124821667|NCT00284050|448974007|FG002|Overall Study|Lack of Efficacy|3|||
124821668|NCT00284050|448974005|FG000|Overall Study|Protocol Violation|0|||
124821669|NCT00284050|448974006|FG001|Overall Study|Protocol Violation|1|||
124821670|NCT00284050|448974007|FG002|Overall Study|Protocol Violation|2|||
124821671|NCT00284050|448974005|FG000|Overall Study|Withdrawal by Subject|2|||
124821672|NCT00284050|448974006|FG001|Overall Study|Withdrawal by Subject|2|||
124821673|NCT00284050|448974007|FG002|Overall Study|Withdrawal by Subject|2|||
124821674|NCT00284050|448974005|FG000|Overall Study|Lost to Follow-up|1|||
124821675|NCT00284050|448974006|FG001|Overall Study|Lost to Follow-up|0|||
124821676|NCT00284050|448974007|FG002|Overall Study|Lost to Follow-up|1|||
124821677|NCT00284050|448974005|FG000|Overall Study|Death|1|||
124821678|NCT00284050|448974006|FG001|Overall Study|Death|0|||
124821679|NCT00284050|448974007|FG002|Overall Study|Death|0|||
124821680|NCT02573350|448974010|FG000|Overall Study|Lost to Follow-up|2|||
124821681|NCT02573350|448974011|FG001|Overall Study|Lost to Follow-up|1|||
124821682|NCT02573350|448974010|FG000|Overall Study|Adverse Event|3|||
124821683|NCT02573350|448974011|FG001|Overall Study|Adverse Event|4|||
124821684|NCT02573350|448974010|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
124821685|NCT02573350|448974011|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
124821686|NCT02573350|448974010|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
124821687|NCT02573350|448974011|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
124821688|NCT02573350|448974010|FG000|Overall Study|Subject withdrew consent to participate|6|||
124821689|NCT02573350|448974011|FG001|Overall Study|Subject withdrew consent to participate|1|||
124821690|NCT02573350|448974010|FG000|Overall Study|Protocol Deviation|1|||
124821691|NCT02573350|448974011|FG001|Overall Study|Protocol Deviation|1|||
124821692|NCT00743340|448974012|FG000|Overall Study|Study medication non-compliance|1|||
124821693|NCT00743340|448974012|FG000|Overall Study|Lost to Follow-up|1|||
124821694|NCT00743340|448974012|FG000|Overall Study|Withdrawal from the Study|5|||
124821695|NCT00743340|448974012|FG000|Overall Study|Protocol Violation|1|||
124821696|NCT00743340|448974012|FG000|Overall Study|Virologic failure|8|||
124821697|NCT00743340|448974012|FG000|Overall Study|Pregnancy|1|||
124821698|NCT00743340|448974012|FG000|Overall Study|Rolled over to other Gilead Study|23|||
124821699|NCT00743340|448974012|FG000|Overall Study|Participant Relocated|1|||
124821700|NCT02708121|448974015|FG000|Overall Study|Withdrawn by Study Team|1|||
124821701|NCT02708121|448974016|FG001|Overall Study|Withdrawn by Study Team|1|||
124821702|NCT02708121|448974015|FG000|Overall Study|Withdrawal by Subject|0|||
124821703|NCT02708121|448974016|FG001|Overall Study|Withdrawal by Subject|4|||
124821704|NCT01425281|448974019|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
124821705|NCT01425281|448974020|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
124821706|NCT01425281|448974019|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
124821707|NCT01425281|448974020|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
124821708|NCT01425281|448974019|FG000|At 180-day Clinical Follow-up|Death|0|||
124821709|NCT01425281|448974020|FG001|At 180-day Clinical Follow-up|Death|1|||
124821710|NCT01425281|448974019|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
124821711|NCT01425281|448974020|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
124821712|NCT01425281|448974019|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
124821713|NCT01425281|448974020|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
124821714|NCT01425281|448974019|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
124821715|NCT01425281|448974020|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
124821716|NCT01425281|448974019|FG000|At 2-year Clinical Follow-up|Death|2|||
124821717|NCT01425281|448974020|FG001|At 2-year Clinical Follow-up|Death|0|||
124821718|NCT01425281|448974019|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
124821719|NCT01425281|448974020|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
124821720|NCT01425281|448974019|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
124821721|NCT01425281|448974020|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
124821722|NCT01425281|448974019|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
124821723|NCT01425281|448974020|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
124821724|NCT01425281|448974019|FG000|At 3-year Clinical Follow-up|Death|2|||
124821725|NCT01425281|448974020|FG001|At 3-year Clinical Follow-up|Death|3|||
124821726|NCT01425281|448974019|FG000|At 4-year Clinical Follow-up|Death|7|||
124821727|NCT01425281|448974020|FG001|At 4-year Clinical Follow-up|Death|3|||
124821728|NCT01425281|448974019|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
124821729|NCT01425281|448974020|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
124821730|NCT01425281|448974019|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
124821731|NCT01425281|448974020|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
124821732|NCT01425281|448974019|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
124821733|NCT01425281|448974020|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
124821734|NCT01425281|448974019|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
124821735|NCT01425281|448974020|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
124821736|NCT01425281|448974019|FG000|At 5-year Clinical Follow-up|Death|2|||
124821737|NCT01425281|448974020|FG001|At 5-year Clinical Follow-up|Death|0|||
124821738|NCT01425281|448974019|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
124821739|NCT01425281|448974020|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
124821740|NCT01425281|448974019|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
124821741|NCT01425281|448974020|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
124821742|NCT01425281|448974019|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
124821743|NCT01425281|448974020|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
124821744|NCT01833520|448974021|FG000|Overall Study|Lack of Efficacy|3|||
124821745|NCT01833520|448974022|FG001|Overall Study|Lack of Efficacy|3|||
124821746|NCT01833520|448974023|FG002|Overall Study|Lack of Efficacy|8|||
124821747|NCT01833520|448974024|FG003|Overall Study|Lack of Efficacy|3|||
124821748|NCT02743520|448974025|FG000|Overall Study|Withdrawal by Subject|1|||
124821749|NCT01749514|448974026|FG000|Overall Study|Lost to Follow-up|0|||
124821750|NCT01749514|448974027|FG001|Overall Study|Lost to Follow-up|0|||
124821751|NCT01749514|448974028|FG002|Overall Study|Lost to Follow-up|0|||
124821752|NCT01749514|448974029|FG003|Overall Study|Lost to Follow-up|0|||
124821753|NCT01749514|448974030|FG004|Overall Study|Lost to Follow-up|0|||
124821754|NCT01749514|448974031|FG005|Overall Study|Lost to Follow-up|0|||
124821755|NCT01749514|448974032|FG006|Overall Study|Lost to Follow-up|0|||
124821756|NCT01749514|448974033|FG007|Overall Study|Lost to Follow-up|1|||
124821757|NCT01749514|448974026|FG000|Overall Study|Withdrawal by Subject|0|||
124821758|NCT01749514|448974027|FG001|Overall Study|Withdrawal by Subject|0|||
124821759|NCT01749514|448974028|FG002|Overall Study|Withdrawal by Subject|0|||
124821760|NCT01749514|448974029|FG003|Overall Study|Withdrawal by Subject|0|||
124821761|NCT01749514|448974030|FG004|Overall Study|Withdrawal by Subject|0|||
124821762|NCT01749514|448974031|FG005|Overall Study|Withdrawal by Subject|1|||
124821763|NCT01749514|448974032|FG006|Overall Study|Withdrawal by Subject|0|||
124821764|NCT01749514|448974033|FG007|Overall Study|Withdrawal by Subject|1|||
124821765|NCT01749514|448974026|FG000|Overall Study|Not Reported|0|||
124821766|NCT01749514|448974027|FG001|Overall Study|Not Reported|0|||
124821767|NCT01749514|448974028|FG002|Overall Study|Not Reported|0|||
124821768|NCT01749514|448974029|FG003|Overall Study|Not Reported|0|||
124821769|NCT01749514|448974030|FG004|Overall Study|Not Reported|0|||
124821770|NCT01749514|448974031|FG005|Overall Study|Not Reported|0|||
124821771|NCT01749514|448974032|FG006|Overall Study|Not Reported|0|||
124821772|NCT01749514|448974033|FG007|Overall Study|Not Reported|5|||
124821773|NCT01979016|448974034|FG000|Overall Study|Withdrawal by Subject|2|||
124821774|NCT01979016|448974035|FG001|Overall Study|Withdrawal by Subject|0|||
124821775|NCT01979016|448974034|FG000|Overall Study|Adverse Event|0|||
124821776|NCT01979016|448974035|FG001|Overall Study|Adverse Event|1|||
124821777|NCT04983264|448974037|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
125303299|NCT02828020|450736700|FG002|Safety Follow-up Period|Protocol Violation|1|||
124821778|NCT04983264|448974038|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
124821779|NCT04983264|448974039|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
124821780|NCT04983264|448974037|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
124821781|NCT04983264|448974038|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
124821782|NCT04983264|448974039|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
124821783|NCT00938639|448974040|FG000|Overall Study|Moved away from study area|0|||
125303300|NCT02828020|450736698|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
124821784|NCT00938639|448974041|FG001|Overall Study|Moved away from study area|1|||
124821785|NCT00938639|448974040|FG000|Overall Study|Lost to Follow-up|1|||
124821786|NCT00938639|448974041|FG001|Overall Study|Lost to Follow-up|2|||
124821787|NCT00938639|448974040|FG000|Overall Study|Family issues|1|||
124821788|NCT00938639|448974041|FG001|Overall Study|Family issues|1|||
124821789|NCT00938639|448974040|FG000|Overall Study|Participant noncompliance|1|||
124821790|NCT00938639|448974041|FG001|Overall Study|Participant noncompliance|0|||
124821791|NCT02509156|448974044|FG000|Randomized Phase|Death|1|||
124821792|NCT02509156|448974045|FG001|Randomized Phase|Death|0|||
124821793|NCT02509156|448974044|FG000|Randomized Phase|Withdrawal by Subject|1|||
124821794|NCT02509156|448974045|FG001|Randomized Phase|Withdrawal by Subject|1|||
124821795|NCT02547649|448974046|FG000|Overall Study|Lost to Follow-up|3|||
124821796|NCT02547649|448974047|FG001|Overall Study|Lost to Follow-up|1|||
124821797|NCT02547649|448974048|FG002|Overall Study|Lost to Follow-up|1|||
124821798|NCT02547649|448974046|FG000|Overall Study|Not vaccinated|0|||
124821799|NCT02547649|448974047|FG001|Overall Study|Not vaccinated|0|||
124821800|NCT02547649|448974048|FG002|Overall Study|Not vaccinated|1|||
124821801|NCT02547649|448974046|FG000|Overall Study|Withdrawal by Subject|0|||
124821802|NCT02547649|448974047|FG001|Overall Study|Withdrawal by Subject|4|||
124821803|NCT02547649|448974048|FG002|Overall Study|Withdrawal by Subject|2|||
124821804|NCT04326231|448974049|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
124821805|NCT02551731|448974052|FG000|Overall Study|Withdrawal by Subject|2|||
124821806|NCT01750242|448974061|FG000|Overall Study|Unreadable Images|3|||
124821807|NCT03765918|448974064|FG000|Overall Study|Death|109|||
124821808|NCT03765918|448974065|FG001|Overall Study|Death|127|||
124821809|NCT03765918|448974064|FG000|Overall Study|Lost to Follow-up|2|||
124821810|NCT03765918|448974065|FG001|Overall Study|Lost to Follow-up|3|||
124821811|NCT03765918|448974064|FG000|Overall Study|Withdrawal by Subject|12|||
124821812|NCT03765918|448974065|FG001|Overall Study|Withdrawal by Subject|16|||
124821813|NCT03765918|448974064|FG000|Overall Study|Participants Ongoing|240|||
124821814|NCT03765918|448974065|FG001|Overall Study|Participants Ongoing|205|||
124821815|NCT04202965|448974066|FG000|Overall Study|Adverse Event|3|||
124821816|NCT04202965|448974066|FG000|Overall Study|Did not meet inclusion criteria|1|||
124821817|NCT00006903|448974067|FG000|Overall Study|Still receiving treatment|0|||
124821818|NCT00006903|448974068|FG001|Overall Study|Still receiving treatment|0|||
124821819|NCT00006903|448974069|FG002|Overall Study|Still receiving treatment|1|||
124821820|NCT00006903|448974067|FG000|Overall Study|Refused further treatment|0|||
124821821|NCT00006903|448974068|FG001|Overall Study|Refused further treatment|2|||
124821822|NCT00006903|448974069|FG002|Overall Study|Refused further treatment|1|||
124821823|NCT00006903|448974067|FG000|Overall Study|Adverse Event|0|||
124821824|NCT00006903|448974068|FG001|Overall Study|Adverse Event|0|||
124821825|NCT00006903|448974069|FG002|Overall Study|Adverse Event|1|||
124821826|NCT00006903|448974067|FG000|Overall Study|Death|0|||
124821827|NCT00006903|448974068|FG001|Overall Study|Death|1|||
124821828|NCT00006903|448974069|FG002|Overall Study|Death|0|||
124821829|NCT00006903|448974067|FG000|Overall Study|Patient never treated|0|||
124821830|NCT00006903|448974068|FG001|Overall Study|Patient never treated|0|||
124821831|NCT00006903|448974069|FG002|Overall Study|Patient never treated|1|||
124821832|NCT00006903|448974067|FG000|Overall Study|Ineligible|10|||
124821833|NCT00006903|448974068|FG001|Overall Study|Ineligible|1|||
124821834|NCT00006903|448974069|FG002|Overall Study|Ineligible|2|||
124821835|NCT01678911|448974079|FG000|Second Intervention|Lost to Follow-up|2|||
124821836|NCT01678911|448974080|FG001|Second Intervention|Lost to Follow-up|0|||
124821837|NCT02706691|448974082|FG000|Overall Study|Adverse Event|1|||
124821838|NCT01402492|448974083|FG000|Overall Study|Withdrawal by Subject|17|||
124821839|NCT01402492|448974084|FG001|Overall Study|Withdrawal by Subject|11|||
124821840|NCT01402492|448974085|FG002|Overall Study|Withdrawal by Subject|11|||
124821841|NCT01402492|448974083|FG000|Overall Study|Adverse Event|2|||
124821842|NCT01402492|448974084|FG001|Overall Study|Adverse Event|3|||
124821843|NCT01402492|448974085|FG002|Overall Study|Adverse Event|4|||
124821844|NCT01402492|448974083|FG000|Overall Study|Physician Decision|0|||
124821845|NCT01402492|448974084|FG001|Overall Study|Physician Decision|3|||
124821846|NCT01402492|448974085|FG002|Overall Study|Physician Decision|0|||
124821847|NCT01402492|448974083|FG000|Overall Study|Incarcerated (N=3)|2|||
124821848|NCT01402492|448974084|FG001|Overall Study|Incarcerated (N=3)|0|||
124821849|NCT01402492|448974085|FG002|Overall Study|Incarcerated (N=3)|1|||
124821850|NCT01980992|448974086|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
124821851|NCT01980992|448974087|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
124821852|NCT01980992|448974086|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
124821853|NCT01980992|448974087|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
125303301|NCT02828020|450736699|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
124821854|NCT01980992|448974086|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
124821855|NCT01980992|448974087|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
124821856|NCT01980992|448974086|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
124821857|NCT01980992|448974087|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
124821858|NCT01980992|448974086|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
124821859|NCT01980992|448974087|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
124821860|NCT01980992|448974086|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
124821861|NCT01980992|448974087|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
124821862|NCT01366209|448974092|FG000|Overall Study|Adverse Event|6|||
124821863|NCT01366209|448974093|FG001|Overall Study|Adverse Event|7|||
124821864|NCT01366209|448974092|FG000|Overall Study|Withdrawal by Subject|4|||
124821865|NCT01366209|448974093|FG001|Overall Study|Withdrawal by Subject|4|||
124821866|NCT01366209|448974092|FG000|Overall Study|Death|12|||
124821867|NCT01366209|448974093|FG001|Overall Study|Death|19|||
124821868|NCT01366209|448974092|FG000|Overall Study|Lung transplantation|6|||
124821869|NCT01366209|448974093|FG001|Overall Study|Lung transplantation|1|||
124821870|NCT01366209|448974092|FG000|Overall Study|Lost to Follow-up|2|||
124821871|NCT01366209|448974093|FG001|Overall Study|Lost to Follow-up|1|||
124821872|NCT01366209|448974092|FG000|Overall Study|Physician Decision|1|||
124821873|NCT01366209|448974093|FG001|Overall Study|Physician Decision|0|||
124821874|NCT01366209|448974092|FG000|Overall Study|Sponsors decision|0|||
124821875|NCT01366209|448974093|FG001|Overall Study|Sponsors decision|1|||
124821876|NCT01366209|448974092|FG000|Overall Study|Withdrew consent|4|||
124821877|NCT01366209|448974093|FG001|Overall Study|Withdrew consent|3|||
124821878|NCT01985867|448974094|FG000|Overall Study|Lost to Follow-up|3|||
124821879|NCT01985867|448974095|FG001|Overall Study|Lost to Follow-up|4|||
124821880|NCT01985867|448974094|FG000|Overall Study|Adverse Event|3|||
124821881|NCT01985867|448974095|FG001|Overall Study|Adverse Event|2|||
124821882|NCT01985867|448974094|FG000|Overall Study|Lack of Efficacy|1|||
124821883|NCT01985867|448974095|FG001|Overall Study|Lack of Efficacy|0|||
124821884|NCT02670837|448974096|FG000|Overall Study|Death|2|||
124821885|NCT02670837|448974097|FG001|Overall Study|Death|0|||
124821886|NCT02670837|448974098|FG002|Overall Study|Death|0|||
124821887|NCT00553514|448974101|FG000|Overall Study|Protocol deviation|0|||
124821888|NCT00553514|448974102|FG001|Overall Study|Protocol deviation|0|||
124821889|NCT00553514|448974103|FG002|Overall Study|Protocol deviation|0|||
124821890|NCT00553514|448974104|FG003|Overall Study|Protocol deviation|1|||
124821891|NCT00553514|448974105|FG004|Overall Study|Protocol deviation|0|||
124821892|NCT00553514|448974101|FG000|Overall Study|Lack of ovarian response|4|||
124821893|NCT00553514|448974102|FG001|Overall Study|Lack of ovarian response|5|||
124821894|NCT00553514|448974103|FG002|Overall Study|Lack of ovarian response|5|||
124821895|NCT00553514|448974104|FG003|Overall Study|Lack of ovarian response|5|||
124821896|NCT00553514|448974105|FG004|Overall Study|Lack of ovarian response|6|||
124821897|NCT00553514|448974101|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
124821898|NCT00553514|448974102|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
124821899|NCT00553514|448974103|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
124821900|NCT00553514|448974104|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
124821901|NCT00553514|448974105|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
124821902|NCT00553514|448974101|FG000|Overall Study|Risk of multiple pregnancy|0|||
124821903|NCT00553514|448974102|FG001|Overall Study|Risk of multiple pregnancy|2|||
124821904|NCT00553514|448974103|FG002|Overall Study|Risk of multiple pregnancy|0|||
124821905|NCT00553514|448974104|FG003|Overall Study|Risk of multiple pregnancy|1|||
124821906|NCT00553514|448974105|FG004|Overall Study|Risk of multiple pregnancy|0|||
124821907|NCT00553514|448974101|FG000|Overall Study|Other|1|||
124821908|NCT00553514|448974102|FG001|Overall Study|Other|1|||
124821909|NCT00553514|448974103|FG002|Overall Study|Other|0|||
124821910|NCT00553514|448974104|FG003|Overall Study|Other|0|||
124821911|NCT00553514|448974105|FG004|Overall Study|Other|1|||
124821912|NCT01442675|448974108|FG000|Overall Study|Protocol Violation|6|||
124821913|NCT01442675|448974108|FG000|Overall Study|Lost to Follow-up|2|||
124821914|NCT01442675|448974108|FG000|Overall Study|Withdrawal by Subject|4|||
124821915|NCT01919723|448974109|FG000|Overall Study|Blood Samples Hemolyzed|2|||
124821916|NCT01919723|448974110|FG001|Overall Study|Blood Samples Hemolyzed|2|||
124821917|NCT00752232|448974111|FG000|Overall Study|Protocol Violation|0|||
124821918|NCT00752232|448974112|FG001|Overall Study|Protocol Violation|0|||
124821919|NCT00752232|448974113|FG002|Overall Study|Protocol Violation|0|||
124821920|NCT00752232|448974114|FG003|Overall Study|Protocol Violation|0|||
124821921|NCT00752232|448974115|FG004|Overall Study|Protocol Violation|0|||
124821922|NCT00752232|448974116|FG005|Overall Study|Protocol Violation|1|||
124821923|NCT00752232|448974117|FG006|Overall Study|Protocol Violation|0|||
124821924|NCT00752232|448974111|FG000|Overall Study|Caregiver request|2|||
124821925|NCT00752232|448974112|FG001|Overall Study|Caregiver request|0|||
124821926|NCT00752232|448974113|FG002|Overall Study|Caregiver request|0|||
124821927|NCT00752232|448974114|FG003|Overall Study|Caregiver request|0|||
124821928|NCT00752232|448974115|FG004|Overall Study|Caregiver request|1|||
124821929|NCT00752232|448974116|FG005|Overall Study|Caregiver request|0|||
124821930|NCT00752232|448974117|FG006|Overall Study|Caregiver request|0|||
124821931|NCT00752232|448974111|FG000|Overall Study|Investigator request|0|||
124821932|NCT00752232|448974112|FG001|Overall Study|Investigator request|0|||
124821933|NCT00752232|448974113|FG002|Overall Study|Investigator request|0|||
124821934|NCT00752232|448974114|FG003|Overall Study|Investigator request|0|||
124821935|NCT00752232|448974115|FG004|Overall Study|Investigator request|1|||
124821936|NCT00752232|448974116|FG005|Overall Study|Investigator request|0|||
124821937|NCT00752232|448974117|FG006|Overall Study|Investigator request|0|||
124821938|NCT00752232|448974111|FG000|Overall Study|Subject request|0|||
124821939|NCT00752232|448974112|FG001|Overall Study|Subject request|0|||
124821940|NCT00752232|448974113|FG002|Overall Study|Subject request|1|||
124821941|NCT00752232|448974114|FG003|Overall Study|Subject request|0|||
124821942|NCT00752232|448974115|FG004|Overall Study|Subject request|0|||
124821943|NCT00752232|448974116|FG005|Overall Study|Subject request|0|||
124821944|NCT00752232|448974117|FG006|Overall Study|Subject request|0|||
124821945|NCT00752232|448974111|FG000|Overall Study|Group home admission|0|||
124821946|NCT00752232|448974112|FG001|Overall Study|Group home admission|0|||
124821947|NCT00752232|448974113|FG002|Overall Study|Group home admission|0|||
124821948|NCT00752232|448974114|FG003|Overall Study|Group home admission|1|||
124821949|NCT00752232|448974115|FG004|Overall Study|Group home admission|0|||
124821950|NCT00752232|448974116|FG005|Overall Study|Group home admission|0|||
124821951|NCT00752232|448974117|FG006|Overall Study|Group home admission|0|||
124821952|NCT00752232|448974111|FG000|Overall Study|Caregiver could not attend the subject|0|||
124821953|NCT00752232|448974112|FG001|Overall Study|Caregiver could not attend the subject|0|||
124821954|NCT00752232|448974113|FG002|Overall Study|Caregiver could not attend the subject|0|||
124821955|NCT00752232|448974114|FG003|Overall Study|Caregiver could not attend the subject|0|||
124821956|NCT00752232|448974115|FG004|Overall Study|Caregiver could not attend the subject|1|||
124821957|NCT00752232|448974116|FG005|Overall Study|Caregiver could not attend the subject|0|||
124821958|NCT00752232|448974117|FG006|Overall Study|Caregiver could not attend the subject|0|||
124821959|NCT04502589|448974118|FG000|Overall Study|Physician Decision|1|||
124821960|NCT04502589|448974119|FG001|Overall Study|Physician Decision|0|||
124821961|NCT00555321|448974120|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
124821962|NCT00555321|448974121|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
124821963|NCT00555321|448974122|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
124821964|NCT00555321|448974123|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
124821965|NCT00555321|448974124|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
124821966|NCT00555321|448974120|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
124821967|NCT00555321|448974121|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
124821968|NCT00555321|448974122|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
124821969|NCT00555321|448974123|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
124821970|NCT00555321|448974124|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
124821971|NCT00555321|448974120|FG000|Treatment Phase up to 12-months|Death|2|||
124821972|NCT00555321|448974121|FG001|Treatment Phase up to 12-months|Death|1|||
124821973|NCT00555321|448974122|FG002|Treatment Phase up to 12-months|Death|4|||
124821974|NCT00555321|448974123|FG003|Treatment Phase up to 12-months|Death|0|||
124821975|NCT00555321|448974124|FG004|Treatment Phase up to 12-months|Death|0|||
124821976|NCT00555321|448974120|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
124821977|NCT00555321|448974121|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
124821978|NCT00555321|448974122|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
124821979|NCT00555321|448974123|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
124821980|NCT00555321|448974124|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
124821981|NCT00555321|448974120|FG000|Treatment Phase up to 12-months|Other Reason|1|||
124821982|NCT00555321|448974121|FG001|Treatment Phase up to 12-months|Other Reason|3|||
124821983|NCT00555321|448974122|FG002|Treatment Phase up to 12-months|Other Reason|2|||
124821984|NCT00555321|448974123|FG003|Treatment Phase up to 12-months|Other Reason|0|||
124821985|NCT00555321|448974124|FG004|Treatment Phase up to 12-months|Other Reason|0|||
124821986|NCT00555321|448974120|FG000|Treatment Phase up to 12-months|Never treated|2|||
124821987|NCT00555321|448974121|FG001|Treatment Phase up to 12-months|Never treated|3|||
124821988|NCT00555321|448974122|FG002|Treatment Phase up to 12-months|Never treated|1|||
124821989|NCT00555321|448974123|FG003|Treatment Phase up to 12-months|Never treated|0|||
124821990|NCT00555321|448974124|FG004|Treatment Phase up to 12-months|Never treated|4|||
124821991|NCT00555321|448974120|FG000|Long-term Extension Phase|Adverse Event|2|||
124821992|NCT00555321|448974121|FG001|Long-term Extension Phase|Adverse Event|5|||
124821993|NCT00555321|448974122|FG002|Long-term Extension Phase|Adverse Event|2|||
124821994|NCT00555321|448974123|FG003|Long-term Extension Phase|Adverse Event|1|||
124821995|NCT00555321|448974124|FG004|Long-term Extension Phase|Adverse Event|0|||
124821996|NCT00555321|448974120|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
124821997|NCT00555321|448974121|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
124821998|NCT00555321|448974122|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
124821999|NCT00555321|448974123|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
124822000|NCT00555321|448974124|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
124822001|NCT00555321|448974120|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
124822002|NCT00555321|448974121|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
124822003|NCT00555321|448974122|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
124822004|NCT00555321|448974123|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
124822005|NCT00555321|448974124|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
124822006|NCT00555321|448974120|FG000|Long-term Extension Phase|Death|2|||
124822007|NCT00555321|448974121|FG001|Long-term Extension Phase|Death|0|||
124822008|NCT00555321|448974122|FG002|Long-term Extension Phase|Death|0|||
124822009|NCT00555321|448974123|FG003|Long-term Extension Phase|Death|3|||
124822010|NCT00555321|448974124|FG004|Long-term Extension Phase|Death|0|||
124822011|NCT00555321|448974120|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
124822012|NCT00555321|448974121|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
124822013|NCT00555321|448974122|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
124822014|NCT00555321|448974123|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
124822015|NCT00555321|448974124|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
124822016|NCT00555321|448974120|FG000|Long-term Extension Phase|Other Reason|1|||
124822017|NCT00555321|448974121|FG001|Long-term Extension Phase|Other Reason|0|||
124822018|NCT00555321|448974122|FG002|Long-term Extension Phase|Other Reason|2|||
124822019|NCT00555321|448974123|FG003|Long-term Extension Phase|Other Reason|0|||
124822020|NCT00555321|448974124|FG004|Long-term Extension Phase|Other Reason|0|||
124822021|NCT00160251|448974125|FG000|Prior to Amendment 2|Adverse Event|2|||
124822022|NCT00160251|448974126|FG001|Prior to Amendment 2|Adverse Event|1|||
124822023|NCT00160251|448974127|FG002|Prior to Amendment 2|Adverse Event|3|||
124822024|NCT00160251|448974128|FG003|Prior to Amendment 2|Adverse Event|1|||
124822025|NCT00160251|448974129|FG004|Prior to Amendment 2|Adverse Event|1|||
124822026|NCT00160251|448974130|FG005|Prior to Amendment 2|Adverse Event|1|||
124822027|NCT00160251|448974131|FG006|Prior to Amendment 2|Adverse Event|1|||
124822028|NCT00160251|448974132|FG007|Prior to Amendment 2|Adverse Event|0|||
124822029|NCT00160251|448974125|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
124822030|NCT00160251|448974126|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
124822031|NCT00160251|448974127|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
124822032|NCT00160251|448974128|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
124822033|NCT00160251|448974129|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
124822034|NCT00160251|448974130|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
124822035|NCT00160251|448974131|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
124822036|NCT00160251|448974132|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
124822037|NCT00160251|448974125|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
124822038|NCT00160251|448974126|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
124822039|NCT00160251|448974127|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
124822040|NCT00160251|448974128|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
124822041|NCT00160251|448974129|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
124822042|NCT00160251|448974130|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
124822043|NCT00160251|448974131|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
124822044|NCT00160251|448974132|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
124822045|NCT00160251|448974125|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
124822046|NCT00160251|448974126|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
124822047|NCT00160251|448974127|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
124822048|NCT00160251|448974128|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
124822049|NCT00160251|448974129|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
124822050|NCT00160251|448974130|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
124822051|NCT00160251|448974131|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
124822052|NCT00160251|448974132|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
124822053|NCT00160251|448974125|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
124822054|NCT00160251|448974126|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
124822055|NCT00160251|448974127|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
124822056|NCT00160251|448974128|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
124822057|NCT00160251|448974129|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
124822058|NCT00160251|448974130|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
124822059|NCT00160251|448974131|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
124822060|NCT00160251|448974132|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
124822061|NCT00160251|448974125|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
124822062|NCT00160251|448974126|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
124822063|NCT00160251|448974127|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
124822064|NCT00160251|448974128|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
124822065|NCT00160251|448974129|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
125303302|NCT02828020|450736700|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
125303303|NCT00379912|450736703|FG000|Overall Study|Lack of Efficacy|1|||
125303304|NCT00379912|450736704|FG001|Overall Study|Lack of Efficacy|0|||
125303305|NCT01128946|450736705|FG000|Period I|Protocol Violation|0|||
125303306|NCT01128946|450736706|FG001|Period I|Protocol Violation|1|||
125303307|NCT01128946|450736707|FG002|Period I|Protocol Violation|0|||
125303308|NCT01128946|450736708|FG003|Period I|Protocol Violation|0|||
125303309|NCT01128946|450736705|FG000|Period I|Withdrawal by Subject|0|||
125303310|NCT01128946|450736706|FG001|Period I|Withdrawal by Subject|0|||
125303311|NCT01128946|450736707|FG002|Period I|Withdrawal by Subject|1|||
124822066|NCT00160251|448974130|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
124822067|NCT00160251|448974131|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
125303312|NCT01128946|450736708|FG003|Period I|Withdrawal by Subject|1|||
125303313|NCT01128946|450736705|FG000|Period II|Protocol Violation|0|||
125303314|NCT01128946|450736706|FG001|Period II|Protocol Violation|1|||
124822068|NCT00160251|448974132|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
124822069|NCT00160251|448974125|FG000|Post-amendment 2|Adverse Event|0|||
124822070|NCT00160251|448974126|FG001|Post-amendment 2|Adverse Event|0|||
124822071|NCT00160251|448974127|FG002|Post-amendment 2|Adverse Event|0|||
124822072|NCT00160251|448974128|FG003|Post-amendment 2|Adverse Event|0|||
124822073|NCT00160251|448974129|FG004|Post-amendment 2|Adverse Event|0|||
124822074|NCT00160251|448974130|FG005|Post-amendment 2|Adverse Event|0|||
124822075|NCT00160251|448974131|FG006|Post-amendment 2|Adverse Event|0|||
124822076|NCT00160251|448974132|FG007|Post-amendment 2|Adverse Event|20|||
124822077|NCT00160251|448974125|FG000|Post-amendment 2|Lack of Efficacy|0|||
124822078|NCT00160251|448974126|FG001|Post-amendment 2|Lack of Efficacy|0|||
124822079|NCT00160251|448974127|FG002|Post-amendment 2|Lack of Efficacy|0|||
124822080|NCT00160251|448974128|FG003|Post-amendment 2|Lack of Efficacy|0|||
124822081|NCT00160251|448974129|FG004|Post-amendment 2|Lack of Efficacy|0|||
124822082|NCT00160251|448974130|FG005|Post-amendment 2|Lack of Efficacy|0|||
124822083|NCT00160251|448974131|FG006|Post-amendment 2|Lack of Efficacy|0|||
124822084|NCT00160251|448974132|FG007|Post-amendment 2|Lack of Efficacy|24|||
124822085|NCT00160251|448974125|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
124822086|NCT00160251|448974126|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
124822087|NCT00160251|448974127|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
124822088|NCT00160251|448974128|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
124822089|NCT00160251|448974129|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
124822090|NCT00160251|448974130|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
124822091|NCT00160251|448974131|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
124822092|NCT00160251|448974132|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
124822093|NCT00582166|448974135|FG000|Overall Study|Death|1|||
124822094|NCT00582166|448974135|FG000|Overall Study|Ineligible pathology|1|||
124822095|NCT00126568|448974136|FG000|Overall Study|Death|2|||
124822096|NCT00580606|448974140|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
124822097|NCT00580606|448974141|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
124822098|NCT00580606|448974140|FG000|Open Label (OL)|Withdrawal by Subject|4|||
124822099|NCT00580606|448974141|FG001|Open Label (OL)|Withdrawal by Subject|6|||
124822100|NCT00580606|448974140|FG000|Open Label (OL)|Dosing Symptoms|0|||
124822101|NCT00580606|448974141|FG001|Open Label (OL)|Dosing Symptoms|1|||
124822102|NCT00580606|448974140|FG000|Open Label (OL)|Lost to Follow-up|0|||
124822103|NCT00580606|448974141|FG001|Open Label (OL)|Lost to Follow-up|1|||
124822104|NCT00580606|448974140|FG000|Open Label (OL)|Pregnancy|0|||
124822105|NCT00580606|448974141|FG001|Open Label (OL)|Pregnancy|1|||
124822106|NCT00580606|448974140|FG000|Open Label (OL)|Non-compliance|2|||
124822107|NCT00580606|448974141|FG001|Open Label (OL)|Non-compliance|0|||
124822108|NCT00580606|448974140|FG000|Open Label (OL)|Physician Decision|1|||
124822109|NCT00580606|448974141|FG001|Open Label (OL)|Physician Decision|1|||
124822110|NCT00580606|448974140|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
124822111|NCT00580606|448974141|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
124822112|NCT03918447|448974144|FG000|Overall Study|Death|1|||
124822113|NCT03918447|448974145|FG001|Overall Study|Death|0|||
124822114|NCT03918447|448974144|FG000|Overall Study|Lost to Follow-up|13|||
124822115|NCT03918447|448974145|FG001|Overall Study|Lost to Follow-up|6|||
124822116|NCT03918447|448974144|FG000|Overall Study|Withdrawal by Subject|19|||
124822117|NCT03918447|448974145|FG001|Overall Study|Withdrawal by Subject|17|||
124822118|NCT03918447|448974144|FG000|Overall Study|Study Terminated by Sponsor|195|||
124822119|NCT03918447|448974145|FG001|Overall Study|Study Terminated by Sponsor|197|||
124822120|NCT03918447|448974144|FG000|Overall Study|Reason not Specified|0|||
124822121|NCT03918447|448974145|FG001|Overall Study|Reason not Specified|1|||
124822122|NCT03278613|448974146|FG000|Overall Study|Lost to Follow-up|3|||
124822123|NCT03278613|448974147|FG001|Overall Study|Lost to Follow-up|1|||
124822124|NCT01405456|448974148|FG000|Overall Study|Lost to Follow-up|2|||
124822125|NCT01405456|448974149|FG001|Overall Study|Lost to Follow-up|1|||
124822126|NCT01405456|448974148|FG000|Overall Study|Physician Decision|1|||
124822127|NCT01405456|448974149|FG001|Overall Study|Physician Decision|0|||
125303315|NCT01128946|450736707|FG002|Period II|Protocol Violation|0|||
124822128|NCT05353985|448974150|FG000|Overall Study|Adverse Event|5|||
124822129|NCT05353985|448974151|FG001|Overall Study|Adverse Event|7|||
124822130|NCT05353985|448974150|FG000|Overall Study|Lost to Follow-up|1|||
124822131|NCT05353985|448974151|FG001|Overall Study|Lost to Follow-up|1|||
124822132|NCT05353985|448974150|FG000|Overall Study|Protocol Violation|1|||
124822133|NCT05353985|448974151|FG001|Overall Study|Protocol Violation|0|||
124822134|NCT05353985|448974150|FG000|Overall Study|Withdrawal by Subject|13|||
124822135|NCT05353985|448974151|FG001|Overall Study|Withdrawal by Subject|17|||
124822136|NCT05353985|448974150|FG000|Overall Study|Reason Not Specified|1|||
124822137|NCT05353985|448974151|FG001|Overall Study|Reason Not Specified|0|||
124822138|NCT05353985|448974150|FG000|Overall Study|Randomized in Error & Not Treated|0|||
124822139|NCT05353985|448974151|FG001|Overall Study|Randomized in Error & Not Treated|1|||
124822140|NCT02989194|448975843|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
124822141|NCT02989194|448975844|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
124822142|NCT02989194|448975845|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
124822143|NCT02989194|448975843|FG000|Overall Study|Lost to Follow-up|0|||
124822144|NCT02989194|448975844|FG001|Overall Study|Lost to Follow-up|1|||
124822145|NCT02989194|448975845|FG002|Overall Study|Lost to Follow-up|0|||
124822146|NCT02989194|448975843|FG000|Overall Study|Withdrawal by Subject|0|||
124822147|NCT02989194|448975844|FG001|Overall Study|Withdrawal by Subject|1|||
124822148|NCT02989194|448975845|FG002|Overall Study|Withdrawal by Subject|0|||
124822149|NCT01327885|448975846|FG000|Overall Study|Disease progression-according to RECIST|173|||
124822150|NCT01327885|448975847|FG001|Overall Study|Disease progression-according to RECIST|165|||
124822151|NCT01327885|448975846|FG000|Overall Study|Clinical progression|24|||
124822152|NCT01327885|448975847|FG001|Overall Study|Clinical progression|27|||
124822153|NCT01327885|448975846|FG000|Overall Study|Adverse Event|14|||
124822154|NCT01327885|448975847|FG001|Overall Study|Adverse Event|10|||
124822155|NCT01327885|448975846|FG000|Overall Study|Subject choice|5|||
124822156|NCT01327885|448975847|FG001|Overall Study|Subject choice|10|||
124822157|NCT01327885|448975846|FG000|Overall Study|Other|8|||
124822158|NCT01327885|448975847|FG001|Overall Study|Other|6|||
124822159|NCT01327885|448975846|FG000|Overall Study|Withdrawal of consent from study|3|||
124822160|NCT01327885|448975847|FG001|Overall Study|Withdrawal of consent from study|4|||
124822161|NCT01327885|448975846|FG000|Overall Study|Not treated|1|||
124822162|NCT01327885|448975847|FG001|Overall Study|Not treated|1|||
124822163|NCT01327885|448975846|FG000|Overall Study|Administrative decision|0|||
124822164|NCT01327885|448975847|FG001|Overall Study|Administrative decision|1|||
124822165|NCT03824912|448975848|FG000|Overall Study|Lost to Follow-up|18|||
124822166|NCT03824912|448975849|FG001|Overall Study|Lost to Follow-up|15|||
124822167|NCT03824912|448975850|FG002|Overall Study|Lost to Follow-up|8|||
124822168|NCT03824912|448975848|FG000|Overall Study|Negative Baseline Culture Result|118|||
124822169|NCT03824912|448975849|FG001|Overall Study|Negative Baseline Culture Result|112|||
124822170|NCT03824912|448975850|FG002|Overall Study|Negative Baseline Culture Result|57|||
124822171|NCT03824912|448975848|FG000|Overall Study|Non-Compliance with Study Drug|0|||
124822172|NCT03824912|448975849|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124822173|NCT03824912|448975850|FG002|Overall Study|Non-Compliance with Study Drug|1|||
124822174|NCT03824912|448975848|FG000|Overall Study|Protocol Violation|1|||
124822175|NCT03824912|448975849|FG001|Overall Study|Protocol Violation|4|||
124822176|NCT03824912|448975850|FG002|Overall Study|Protocol Violation|1|||
124822177|NCT03824912|448975848|FG000|Overall Study|Withdrawal by Subject|3|||
124822178|NCT03824912|448975849|FG001|Overall Study|Withdrawal by Subject|2|||
124822179|NCT03824912|448975850|FG002|Overall Study|Withdrawal by Subject|1|||
124822180|NCT03824912|448975848|FG000|Overall Study|Participation in another study|0|||
124822181|NCT03824912|448975849|FG001|Overall Study|Participation in another study|1|||
124822182|NCT03824912|448975850|FG002|Overall Study|Participation in another study|0|||
124822183|NCT02254486|448975857|FG000|Overall Study|Adverse Event|1|||
124822184|NCT02254486|448975858|FG001|Overall Study|Adverse Event|1|||
124822185|NCT02254486|448975857|FG000|Overall Study|Lack of Efficacy|1|||
124822186|NCT02254486|448975858|FG001|Overall Study|Lack of Efficacy|0|||
124822187|NCT02254486|448975857|FG000|Overall Study|Lost to Follow-up|2|||
124822188|NCT02254486|448975858|FG001|Overall Study|Lost to Follow-up|4|||
124822189|NCT02254486|448975857|FG000|Overall Study|Protocol Violation|1|||
124822190|NCT02254486|448975858|FG001|Overall Study|Protocol Violation|2|||
124822191|NCT02254486|448975857|FG000|Overall Study|Withdrawal by Subject|17|||
124822192|NCT02254486|448975858|FG001|Overall Study|Withdrawal by Subject|15|||
124822193|NCT02254486|448975857|FG000|Overall Study|GFR<60mL/min|16|||
124822194|NCT02254486|448975858|FG001|Overall Study|GFR<60mL/min|21|||
124822195|NCT02254486|448975857|FG000|Overall Study|Various|12|||
124822196|NCT02254486|448975858|FG001|Overall Study|Various|12|||
124822197|NCT01350414|448975865|FG000|Overall Study|Lost to Follow-up|13|||
124822198|NCT01350414|448975865|FG000|Overall Study|Withdrawal by Subject|4|||
124822199|NCT01350414|448975865|FG000|Overall Study|Physician Decision|2|||
124822200|NCT04166435|448975866|FG000|Overall Study|2 patients ineligible for response|2|||
124822201|NCT01484197|448975867|FG000|Treatment Period 1|Adverse Event|1|||
124822202|NCT01484197|448975868|FG001|Treatment Period 1|Adverse Event|0|||
124822203|NCT01484197|448975869|FG002|Treatment Period 1|Adverse Event|0|||
124822204|NCT01484197|448975870|FG003|Treatment Period 1|Adverse Event|0|||
124822205|NCT01484197|448975867|FG000|Treatment Period 2|Subject withdrew consent|0|||
124822206|NCT01484197|448975868|FG001|Treatment Period 2|Subject withdrew consent|0|||
124822207|NCT01484197|448975869|FG002|Treatment Period 2|Subject withdrew consent|0|||
125303316|NCT01128946|450736708|FG003|Period II|Protocol Violation|0|||
124822208|NCT01484197|448975870|FG003|Treatment Period 2|Subject withdrew consent|1|||
124822209|NCT03033394|448975873|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
124822210|NCT03033394|448975873|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
124822211|NCT03033394|448975873|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
124822212|NCT03033394|448975873|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
124822213|NCT03033394|448975873|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
124822214|NCT02036294|448975874|FG000|Overall Study|Death|7|||
124822215|NCT02036294|448975875|FG001|Overall Study|Death|8|||
124822216|NCT02036294|448975874|FG000|Overall Study|Withdrawal by Subject|2|||
124822217|NCT02036294|448975875|FG001|Overall Study|Withdrawal by Subject|3|||
124822218|NCT00356369|448975876|FG000|Active Phase|Withdrawal by Subject|2|||
124822219|NCT00356369|448975877|FG001|Active Phase|Withdrawal by Subject|1|||
124822220|NCT02117648|448975879|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
124822221|NCT02117648|448975879|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
124822222|NCT02117648|448975879|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
124822223|NCT02117648|448975879|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
124822224|NCT02117648|448975879|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
124822225|NCT02117648|448975879|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
124822226|NCT02117648|448975879|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
124822227|NCT02117648|448975879|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
124822228|NCT02117648|448975879|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
124822229|NCT02117648|448975879|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
124822230|NCT02117648|448975879|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
124822231|NCT02532972|448975884|FG000|Overall Study|Withdrawal by Subject|1|||
124822232|NCT01606436|448975885|FG000|Overall Study|Withdrawal by Subject|0|||
124822233|NCT01606436|448975886|FG001|Overall Study|Withdrawal by Subject|0|||
124822234|NCT01606436|448975887|FG002|Overall Study|Withdrawal by Subject|1|||
124822235|NCT01606436|448975888|FG003|Overall Study|Withdrawal by Subject|1|||
124822236|NCT01606436|448975889|FG004|Overall Study|Withdrawal by Subject|1|||
124822237|NCT01606436|448975890|FG005|Overall Study|Withdrawal by Subject|0|||
124822238|NCT01606436|448975885|FG000|Overall Study|Adverse Event|0|||
124822239|NCT01606436|448975886|FG001|Overall Study|Adverse Event|0|||
124822240|NCT01606436|448975887|FG002|Overall Study|Adverse Event|1|||
124822241|NCT01606436|448975888|FG003|Overall Study|Adverse Event|0|||
124822242|NCT01606436|448975889|FG004|Overall Study|Adverse Event|0|||
124822243|NCT01606436|448975890|FG005|Overall Study|Adverse Event|0|||
124822244|NCT01606436|448975885|FG000|Overall Study|Sponsor Decision|0|||
124822245|NCT01606436|448975886|FG001|Overall Study|Sponsor Decision|0|||
124822246|NCT01606436|448975887|FG002|Overall Study|Sponsor Decision|0|||
124822247|NCT01606436|448975888|FG003|Overall Study|Sponsor Decision|1|||
124822248|NCT01606436|448975889|FG004|Overall Study|Sponsor Decision|0|||
124822249|NCT01606436|448975890|FG005|Overall Study|Sponsor Decision|0|||
124822250|NCT02859454|448975891|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
124822251|NCT01025752|448975892|FG000|Overall Study|Lost to Follow-up|7|||
124822252|NCT01025752|448975893|FG001|Overall Study|Lost to Follow-up|10|||
124822253|NCT01025752|448975892|FG000|Overall Study|Physician Decision|1|||
124822254|NCT01025752|448975893|FG001|Overall Study|Physician Decision|3|||
124822255|NCT01417234|448975896|FG000|Overall Study|Subject non-compliant|3|||
124822256|NCT00023764|448975897|FG000|Overall Study|Other|1|||
124822257|NCT00023764|448975897|FG000|Overall Study|Adverse Event|4|||
124822258|NCT00023764|448975897|FG000|Overall Study|Withdrawal by Subject|1|||
124822259|NCT00023764|448975897|FG000|Overall Study|Progression of disease|6|||
124822260|NCT00023764|448975897|FG000|Overall Study|patient received other treatment|1|||
124822261|NCT00023764|448975897|FG000|Overall Study|delay in obtaining staging images|1|||
124822262|NCT02407704|448975900|FG000|Overall Study|Lost to Follow-up|0|||
124822263|NCT02407704|448975901|FG001|Overall Study|Lost to Follow-up|0|||
124822264|NCT02407704|448975902|FG002|Overall Study|Lost to Follow-up|0|||
124822265|NCT02407704|448975903|FG003|Overall Study|Lost to Follow-up|2|||
124822266|NCT02407704|448975900|FG000|Overall Study|Protocol Violation|0|||
124822267|NCT02407704|448975901|FG001|Overall Study|Protocol Violation|0|||
124822268|NCT02407704|448975902|FG002|Overall Study|Protocol Violation|0|||
124822269|NCT02407704|448975903|FG003|Overall Study|Protocol Violation|1|||
124822270|NCT02407704|448975900|FG000|Overall Study|Withdrawal by Subject|0|||
124822271|NCT02407704|448975901|FG001|Overall Study|Withdrawal by Subject|0|||
124822272|NCT02407704|448975902|FG002|Overall Study|Withdrawal by Subject|1|||
124822273|NCT02407704|448975903|FG003|Overall Study|Withdrawal by Subject|0|||
124822274|NCT03944954|448975904|FG000|Overall Study|Withdrawal by Subject|22|||
124822275|NCT03944954|448975905|FG001|Overall Study|Withdrawal by Subject|4|||
124822276|NCT03944954|448975904|FG000|Overall Study|Lost to Follow-up|18|||
124822277|NCT03944954|448975905|FG001|Overall Study|Lost to Follow-up|0|||
124822278|NCT03944954|448975904|FG000|Overall Study|Failed Medical Screening|7|||
124822279|NCT03944954|448975905|FG001|Overall Study|Failed Medical Screening|0|||
124822280|NCT02268084|448975912|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
124822281|NCT02268084|448975913|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
124822282|NCT02268084|448975912|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
124822283|NCT02268084|448975913|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
124822284|NCT05227027|448975914|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
124822285|NCT05227027|448975915|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
124822286|NCT03334448|448975921|FG000|Washout|Personal Reason|0|||
124822287|NCT03334448|448975922|FG001|Washout|Personal Reason|1|||
124822288|NCT03334448|448975923|FG002|Washout|Personal Reason|0|||
124822289|NCT03334448|448975924|FG003|Washout|Personal Reason|0|||
124822290|NCT03334448|448975921|FG000|Washout|Protocol Violation|0|||
124822291|NCT03334448|448975922|FG001|Washout|Protocol Violation|0|||
124822292|NCT03334448|448975923|FG002|Washout|Protocol Violation|0|||
124822293|NCT03334448|448975924|FG003|Washout|Protocol Violation|1|||
124822294|NCT01683383|448975925|FG000|Overall Study|Infant was not transported|1|||
124822295|NCT01683383|448975926|FG001|Overall Study|Infant was not transported|0|||
124822296|NCT00855920|448975927|FG000|Overall Study|Protocol Violation|0|||
124822297|NCT00855920|448975928|FG001|Overall Study|Protocol Violation|0|||
124822298|NCT00855920|448975929|FG002|Overall Study|Protocol Violation|2|||
124822299|NCT00855920|448975927|FG000|Overall Study|Adverse Event|2|||
124822300|NCT00855920|448975928|FG001|Overall Study|Adverse Event|1|||
124822301|NCT00855920|448975929|FG002|Overall Study|Adverse Event|1|||
124822302|NCT00855920|448975927|FG000|Overall Study|Lack of Efficacy|2|||
124822303|NCT00855920|448975928|FG001|Overall Study|Lack of Efficacy|2|||
124822304|NCT00855920|448975929|FG002|Overall Study|Lack of Efficacy|2|||
124822305|NCT00855920|448975927|FG000|Overall Study|Withdrawal by Subject|2|||
124822306|NCT00855920|448975928|FG001|Overall Study|Withdrawal by Subject|3|||
124822307|NCT00855920|448975929|FG002|Overall Study|Withdrawal by Subject|2|||
124822308|NCT00855920|448975927|FG000|Overall Study|Lost to Follow-up|1|||
124822309|NCT00855920|448975928|FG001|Overall Study|Lost to Follow-up|0|||
124822310|NCT00855920|448975929|FG002|Overall Study|Lost to Follow-up|2|||
124822311|NCT00855920|448975927|FG000|Overall Study|Death|0|||
124822312|NCT00855920|448975928|FG001|Overall Study|Death|1|||
124822313|NCT00855920|448975929|FG002|Overall Study|Death|0|||
124822314|NCT00855920|448975927|FG000|Overall Study|Decision by the sponsor|0|||
124822315|NCT00855920|448975928|FG001|Overall Study|Decision by the sponsor|1|||
124822316|NCT00855920|448975929|FG002|Overall Study|Decision by the sponsor|1|||
124822317|NCT00855920|448975927|FG000|Overall Study|Other than specified above|1|||
124822318|NCT00855920|448975928|FG001|Overall Study|Other than specified above|1|||
124822319|NCT00855920|448975929|FG002|Overall Study|Other than specified above|1|||
124822320|NCT00996307|448975930|FG000|Overall Study|Adverse Event|0|||
124822321|NCT00996307|448975931|FG001|Overall Study|Adverse Event|1|||
124822322|NCT00996307|448975932|FG002|Overall Study|Adverse Event|0|||
124822323|NCT00996307|448975933|FG003|Overall Study|Adverse Event|0|||
124822324|NCT00996307|448975930|FG000|Overall Study|Withdrawal by Subject|3|||
124822325|NCT00996307|448975931|FG001|Overall Study|Withdrawal by Subject|2|||
124822326|NCT00996307|448975932|FG002|Overall Study|Withdrawal by Subject|5|||
124822327|NCT00996307|448975933|FG003|Overall Study|Withdrawal by Subject|5|||
124822328|NCT00996307|448975930|FG000|Overall Study|Lost to Follow-up|13|||
124822329|NCT00996307|448975931|FG001|Overall Study|Lost to Follow-up|13|||
124822330|NCT00996307|448975932|FG002|Overall Study|Lost to Follow-up|7|||
124822331|NCT00996307|448975933|FG003|Overall Study|Lost to Follow-up|15|||
124822332|NCT00996307|448975930|FG000|Overall Study|Administrative reason|0|||
124822333|NCT00996307|448975931|FG001|Overall Study|Administrative reason|1|||
124822334|NCT00996307|448975932|FG002|Overall Study|Administrative reason|0|||
124822335|NCT00996307|448975933|FG003|Overall Study|Administrative reason|0|||
124822336|NCT00996307|448975930|FG000|Overall Study|Unable to classify|4|||
124822337|NCT00996307|448975931|FG001|Overall Study|Unable to classify|0|||
124822338|NCT00996307|448975932|FG002|Overall Study|Unable to classify|2|||
124822339|NCT00996307|448975933|FG003|Overall Study|Unable to classify|1|||
124822340|NCT02496611|448975936|FG000|Overall Study|Lost to Follow-up|2|||
124822341|NCT02496611|448975937|FG001|Overall Study|Lost to Follow-up|1|||
124822342|NCT02496611|448975936|FG000|Overall Study|Withdrawal by Subject|5|||
124822343|NCT02496611|448975937|FG001|Overall Study|Withdrawal by Subject|2|||
124822344|NCT02850965|448975938|FG000|Overall Study|Other than listed|3|||
124822345|NCT02850965|448975939|FG001|Overall Study|Other than listed|4|||
124822346|NCT02850965|448975938|FG000|Overall Study|Protocol Violation|0|||
124822347|NCT02850965|448975939|FG001|Overall Study|Protocol Violation|2|||
124822348|NCT02850965|448975938|FG000|Overall Study|Lost to Follow-up|5|||
124822349|NCT02850965|448975939|FG001|Overall Study|Lost to Follow-up|3|||
124822350|NCT02850965|448975938|FG000|Overall Study|Lack of Efficacy|4|||
124822351|NCT02850965|448975939|FG001|Overall Study|Lack of Efficacy|8|||
124822352|NCT02850965|448975938|FG000|Overall Study|Adverse Event|3|||
124822353|NCT02850965|448975939|FG001|Overall Study|Adverse Event|2|||
125303317|NCT01128946|450736705|FG000|Period II|Withdrawal by Subject|0|||
125303318|NCT01128946|450736706|FG001|Period II|Withdrawal by Subject|0|||
125303319|NCT01128946|450736707|FG002|Period II|Withdrawal by Subject|0|||
125303320|NCT01128946|450736708|FG003|Period II|Withdrawal by Subject|1|||
125303321|NCT01128946|450736705|FG000|Period III|Protocol Violation|1|||
124822354|NCT02850965|448975938|FG000|Overall Study|Withdrawal by Subject|3|||
124822355|NCT02850965|448975939|FG001|Overall Study|Withdrawal by Subject|4|||
124822356|NCT02850965|448975938|FG000|Overall Study|Physician Decision|0|||
124822357|NCT02850965|448975939|FG001|Overall Study|Physician Decision|1|||
124822358|NCT02850965|448975938|FG000|Overall Study|Randomized but not treated|0|||
124822359|NCT02850965|448975939|FG001|Overall Study|Randomized but not treated|1|||
124822360|NCT02788357|448975942|FG000|Overall Study|Lost to Follow-up|3|||
124822361|NCT02788357|448975943|FG001|Overall Study|Lost to Follow-up|0|||
124822362|NCT00371137|448975944|FG000|Overall Study|Adverse Event|20|||
125303322|NCT01128946|450736706|FG001|Period III|Protocol Violation|0|||
124822363|NCT00371137|448975945|FG001|Overall Study|Adverse Event|35|||
124822364|NCT00371137|448975946|FG002|Overall Study|Adverse Event|42|||
124822365|NCT00371137|448975944|FG000|Overall Study|Withdrawal by Subject|11|||
124822366|NCT00371137|448975945|FG001|Overall Study|Withdrawal by Subject|10|||
124822367|NCT00371137|448975946|FG002|Overall Study|Withdrawal by Subject|15|||
124822368|NCT00371137|448975944|FG000|Overall Study|Lost to Follow-up|6|||
124822369|NCT00371137|448975945|FG001|Overall Study|Lost to Follow-up|3|||
124822370|NCT00371137|448975946|FG002|Overall Study|Lost to Follow-up|5|||
124822371|NCT00371137|448975944|FG000|Overall Study|Lack of Efficacy|30|||
124822372|NCT00371137|448975945|FG001|Overall Study|Lack of Efficacy|12|||
124822373|NCT00371137|448975946|FG002|Overall Study|Lack of Efficacy|13|||
124822374|NCT00371137|448975944|FG000|Overall Study|Sponsor Decision|2|||
124822375|NCT00371137|448975945|FG001|Overall Study|Sponsor Decision|1|||
124822376|NCT00371137|448975946|FG002|Overall Study|Sponsor Decision|2|||
124822377|NCT00371137|448975944|FG000|Overall Study|Physician Decision|1|||
124822378|NCT00371137|448975945|FG001|Overall Study|Physician Decision|1|||
124822379|NCT00371137|448975946|FG002|Overall Study|Physician Decision|1|||
124822380|NCT00371137|448975944|FG000|Overall Study|Protocol Violation|2|||
124822381|NCT00371137|448975945|FG001|Overall Study|Protocol Violation|1|||
124822382|NCT00371137|448975946|FG002|Overall Study|Protocol Violation|1|||
124822383|NCT00536198|448975947|FG000|Overall Study|Lost to Follow-up|15|||
124822384|NCT00536198|448975948|FG001|Overall Study|Lost to Follow-up|14|||
124822385|NCT00536198|448975947|FG000|Overall Study|Withdrawal by Subject|16|||
124822386|NCT00536198|448975948|FG001|Overall Study|Withdrawal by Subject|12|||
124822387|NCT00536198|448975947|FG000|Overall Study|Adverse Event|2|||
124822388|NCT00536198|448975948|FG001|Overall Study|Adverse Event|2|||
124822389|NCT00536198|448975947|FG000|Overall Study|Rescue|3|||
124822390|NCT00536198|448975948|FG001|Overall Study|Rescue|9|||
124822391|NCT00536198|448975947|FG000|Overall Study|Pregnancy|1|||
124822392|NCT00536198|448975948|FG001|Overall Study|Pregnancy|1|||
124822393|NCT00536198|448975947|FG000|Overall Study|Protocol Violation|0|||
124822394|NCT00536198|448975948|FG001|Overall Study|Protocol Violation|1|||
124822395|NCT02013791|448975949|FG000|Period 1|Lost to Follow-up|0|||
124822396|NCT02013791|448975950|FG001|Period 1|Lost to Follow-up|0|||
124822397|NCT02013791|448975951|FG002|Period 1|Lost to Follow-up|0|||
124822398|NCT02013791|448975952|FG003|Period 1|Lost to Follow-up|1|||
124822399|NCT02013791|448975953|FG004|Period 1|Lost to Follow-up|0|||
124822400|NCT02013791|448975954|FG005|Period 1|Lost to Follow-up|0|||
124822401|NCT02013791|448975955|FG006|Period 1|Lost to Follow-up|1|||
124822402|NCT02013791|448975956|FG007|Period 1|Lost to Follow-up|1|||
124822403|NCT02013791|448975957|FG008|Period 1|Lost to Follow-up|0|||
124822404|NCT02013791|448975949|FG000|Period 1|Other Miscellaneous Reasons|0|||
124822405|NCT02013791|448975950|FG001|Period 1|Other Miscellaneous Reasons|2|||
124822406|NCT02013791|448975951|FG002|Period 1|Other Miscellaneous Reasons|0|||
124822407|NCT02013791|448975952|FG003|Period 1|Other Miscellaneous Reasons|0|||
124822408|NCT02013791|448975953|FG004|Period 1|Other Miscellaneous Reasons|0|||
124822409|NCT02013791|448975954|FG005|Period 1|Other Miscellaneous Reasons|0|||
124822410|NCT02013791|448975955|FG006|Period 1|Other Miscellaneous Reasons|0|||
124822411|NCT02013791|448975956|FG007|Period 1|Other Miscellaneous Reasons|0|||
124822412|NCT02013791|448975957|FG008|Period 1|Other Miscellaneous Reasons|0|||
124822413|NCT03798483|448975958|FG000|Overall Study|Lost to Follow-up|2|||
124822414|NCT00640601|448975963|FG000|Overall Study|Adverse Event|43|||
124822415|NCT00640601|448975963|FG000|Overall Study|Withdrawal by Subject|20|||
124822416|NCT00640601|448975963|FG000|Overall Study|Protocol Violation|6|||
124822417|NCT00640601|448975963|FG000|Overall Study|Lack of Efficacy|16|||
124822418|NCT00640601|448975963|FG000|Overall Study|Lost to Follow-up|9|||
124822419|NCT00640601|448975963|FG000|Overall Study|Physician Decision|8|||
124822420|NCT00640601|448975963|FG000|Overall Study|treatment naive, combination therapy|10|||
124822421|NCT02007109|448975964|FG000|Overall Study|Diary not returned or excluded|102|||
124822422|NCT02007109|448975964|FG000|Overall Study|Excluded - Age<7yo|9|||
124822423|NCT01918085|448975965|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
124822424|NCT01918085|448975966|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
124822425|NCT00646776|448975969|FG000|Overall Study|Adverse Event|1|||
124822426|NCT00646776|448975970|FG001|Overall Study|Adverse Event|9|||
125303323|NCT01128946|450736707|FG002|Period III|Protocol Violation|0|||
124822427|NCT00646776|448975969|FG000|Overall Study|Investigator discretion|0|||
124822428|NCT00646776|448975970|FG001|Overall Study|Investigator discretion|4|||
124822429|NCT00439244|448975971|FG000|Overall Study|Adverse Event|5|||
124822430|NCT00439244|448975972|FG001|Overall Study|Adverse Event|2|||
124822431|NCT00439244|448975973|FG002|Overall Study|Adverse Event|3|||
124822432|NCT00439244|448975971|FG000|Overall Study|Withdrawal by Subject|3|||
124822433|NCT00439244|448975972|FG001|Overall Study|Withdrawal by Subject|1|||
124822434|NCT00439244|448975973|FG002|Overall Study|Withdrawal by Subject|2|||
124822435|NCT00439244|448975971|FG000|Overall Study|Lost to Follow-up|2|||
124822436|NCT00439244|448975972|FG001|Overall Study|Lost to Follow-up|1|||
124822437|NCT00439244|448975973|FG002|Overall Study|Lost to Follow-up|2|||
124822438|NCT00439244|448975971|FG000|Overall Study|Death|0|||
124822439|NCT00439244|448975972|FG001|Overall Study|Death|1|||
124822440|NCT00439244|448975973|FG002|Overall Study|Death|0|||
124822441|NCT00439244|448975971|FG000|Overall Study|Protocol Violation|0|||
124822442|NCT00439244|448975972|FG001|Overall Study|Protocol Violation|1|||
124822443|NCT00439244|448975973|FG002|Overall Study|Protocol Violation|0|||
124822444|NCT00439244|448975971|FG000|Overall Study|Administrative problems|1|||
124822445|NCT00439244|448975972|FG001|Overall Study|Administrative problems|0|||
124822446|NCT00439244|448975973|FG002|Overall Study|Administrative problems|0|||
124822447|NCT03655691|448975974|FG000|Overall Study|Adverse Event|0|||
124822448|NCT03655691|448975975|FG001|Overall Study|Adverse Event|0|||
124822449|NCT03655691|448975976|FG002|Overall Study|Adverse Event|1|||
124822450|NCT03655691|448975974|FG000|Overall Study|Lost to Follow-up|1|||
124822451|NCT03655691|448975975|FG001|Overall Study|Lost to Follow-up|1|||
124822452|NCT03655691|448975976|FG002|Overall Study|Lost to Follow-up|2|||
124822453|NCT03655691|448975974|FG000|Overall Study|Protocol Violation|0|||
124822454|NCT03655691|448975975|FG001|Overall Study|Protocol Violation|1|||
124822455|NCT03655691|448975976|FG002|Overall Study|Protocol Violation|0|||
124822456|NCT03655691|448975974|FG000|Overall Study|Withdrawal by Subject|1|||
124822457|NCT03655691|448975975|FG001|Overall Study|Withdrawal by Subject|1|||
124822458|NCT03655691|448975976|FG002|Overall Study|Withdrawal by Subject|0|||
124822459|NCT01753856|448975977|FG000|Overall Study|Adverse Event|1|||
124822460|NCT01753856|448975978|FG001|Overall Study|Adverse Event|0|||
124822461|NCT01753856|448975977|FG000|Overall Study|Withdrawal by Subject|0|||
124822462|NCT01753856|448975978|FG001|Overall Study|Withdrawal by Subject|2|||
124822463|NCT01753856|448975977|FG000|Overall Study|Sponsor Decision|2|||
124822464|NCT01753856|448975978|FG001|Overall Study|Sponsor Decision|0|||
124822465|NCT05109442|448975979|FG000|Overall Study|Withdrawal by Subject|0|||
124822466|NCT05109442|448975980|FG001|Overall Study|Withdrawal by Subject|0|||
124822467|NCT05109442|448975981|FG002|Overall Study|Withdrawal by Subject|1|||
124822468|NCT05109442|448975982|FG003|Overall Study|Withdrawal by Subject|0|||
124822469|NCT05109442|448975983|FG004|Overall Study|Withdrawal by Subject|0|||
124822470|NCT05109442|448975984|FG005|Overall Study|Withdrawal by Subject|0|||
124822471|NCT05109442|448975979|FG000|Overall Study|Adverse Event|0|||
124822472|NCT05109442|448975980|FG001|Overall Study|Adverse Event|1|||
124822473|NCT05109442|448975981|FG002|Overall Study|Adverse Event|5|||
124822474|NCT05109442|448975982|FG003|Overall Study|Adverse Event|0|||
124822475|NCT05109442|448975983|FG004|Overall Study|Adverse Event|0|||
124822476|NCT05109442|448975984|FG005|Overall Study|Adverse Event|2|||
124822477|NCT05109442|448975979|FG000|Overall Study|Death|0|||
124822478|NCT05109442|448975980|FG001|Overall Study|Death|0|||
124822479|NCT05109442|448975981|FG002|Overall Study|Death|4|||
124822480|NCT05109442|448975982|FG003|Overall Study|Death|0|||
124822481|NCT05109442|448975983|FG004|Overall Study|Death|0|||
124822482|NCT05109442|448975984|FG005|Overall Study|Death|1|||
124822483|NCT05109442|448975979|FG000|Overall Study|Physician Decision|1|||
124822484|NCT05109442|448975980|FG001|Overall Study|Physician Decision|0|||
124822485|NCT05109442|448975981|FG002|Overall Study|Physician Decision|1|||
124822486|NCT05109442|448975982|FG003|Overall Study|Physician Decision|0|||
124822487|NCT05109442|448975983|FG004|Overall Study|Physician Decision|0|||
124822488|NCT05109442|448975984|FG005|Overall Study|Physician Decision|2|||
124822489|NCT05109442|448975979|FG000|Overall Study|Other than listed|0|||
124822490|NCT05109442|448975980|FG001|Overall Study|Other than listed|0|||
124822491|NCT05109442|448975981|FG002|Overall Study|Other than listed|9|||
124822492|NCT05109442|448975982|FG003|Overall Study|Other than listed|2|||
124822493|NCT05109442|448975983|FG004|Overall Study|Other than listed|0|||
124822494|NCT05109442|448975984|FG005|Overall Study|Other than listed|8|||
124822495|NCT05109442|448975979|FG000|Overall Study|Lack of Efficacy|3|||
124822496|NCT05109442|448975980|FG001|Overall Study|Lack of Efficacy|5|||
124822497|NCT05109442|448975981|FG002|Overall Study|Lack of Efficacy|29|||
124822498|NCT05109442|448975982|FG003|Overall Study|Lack of Efficacy|10|||
124822499|NCT05109442|448975983|FG004|Overall Study|Lack of Efficacy|11|||
124822500|NCT05109442|448975984|FG005|Overall Study|Lack of Efficacy|17|||
124822501|NCT04853225|448975985|FG000|Overall Study|Withdrawal by Subject|81|||
124822502|NCT04853225|448975986|FG001|Overall Study|Withdrawal by Subject|4|||
124822503|NCT04853225|448975987|FG002|Overall Study|Withdrawal by Subject|1|||
124822504|NCT04853225|448975985|FG000|Overall Study|Physician Decision|12|||
124822505|NCT04853225|448975986|FG001|Overall Study|Physician Decision|4|||
124822506|NCT04853225|448975987|FG002|Overall Study|Physician Decision|1|||
124822507|NCT04853225|448975985|FG000|Overall Study|Lost to Follow-up|50|||
124822508|NCT04853225|448975986|FG001|Overall Study|Lost to Follow-up|0|||
124822509|NCT04853225|448975987|FG002|Overall Study|Lost to Follow-up|0|||
124822510|NCT04853225|448975985|FG000|Overall Study|Other|102|||
124822511|NCT04853225|448975986|FG001|Overall Study|Other|11|||
124822512|NCT04853225|448975987|FG002|Overall Study|Other|5|||
124822513|NCT04853225|448975985|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
124822514|NCT04853225|448975986|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
124822515|NCT04853225|448975987|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
124822516|NCT04853225|448975985|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
124822517|NCT04853225|448975986|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
124822518|NCT04853225|448975987|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
124822519|NCT00793598|448977250|FG000|Overall Study|Patient Request|0|||
124822520|NCT00793598|448977251|FG001|Overall Study|Patient Request|1|||
124822521|NCT00793598|448977252|FG002|Overall Study|Patient Request|0|||
124822522|NCT00793598|448977253|FG003|Overall Study|Patient Request|0|||
124822523|NCT00793598|448977254|FG004|Overall Study|Patient Request|0|||
124822524|NCT00793598|448977255|FG005|Overall Study|Patient Request|0|||
124822525|NCT00793598|448977256|FG006|Overall Study|Patient Request|0|||
124822526|NCT00793598|448977257|FG007|Overall Study|Patient Request|0|||
124822527|NCT00793598|448977250|FG000|Overall Study|Protocol Violation|0|||
124822528|NCT00793598|448977251|FG001|Overall Study|Protocol Violation|0|||
124822529|NCT00793598|448977252|FG002|Overall Study|Protocol Violation|0|||
124822530|NCT00793598|448977253|FG003|Overall Study|Protocol Violation|0|||
124822531|NCT00793598|448977254|FG004|Overall Study|Protocol Violation|0|||
124822532|NCT00793598|448977255|FG005|Overall Study|Protocol Violation|0|||
124822533|NCT00793598|448977256|FG006|Overall Study|Protocol Violation|0|||
124822534|NCT00793598|448977257|FG007|Overall Study|Protocol Violation|1|||
124822535|NCT00793598|448977250|FG000|Overall Study|Subject not dosed|0|||
124822536|NCT00793598|448977251|FG001|Overall Study|Subject not dosed|0|||
124822537|NCT00793598|448977252|FG002|Overall Study|Subject not dosed|0|||
124822538|NCT00793598|448977253|FG003|Overall Study|Subject not dosed|0|||
124822539|NCT00793598|448977254|FG004|Overall Study|Subject not dosed|0|||
124822540|NCT00793598|448977255|FG005|Overall Study|Subject not dosed|1|||
124822541|NCT00793598|448977256|FG006|Overall Study|Subject not dosed|0|||
124822542|NCT00793598|448977257|FG007|Overall Study|Subject not dosed|0|||
124822543|NCT02154490|448977258|FG000|Overall Study|No tissue submitted|23|||
124822544|NCT02154490|448977258|FG000|Overall Study|No biomarker results|167|||
124822545|NCT02154490|448977258|FG000|Overall Study|Not assigned to a sub-study|270|||
124822546|NCT02154490|448977258|FG000|Overall Study|Did not register to a sub-study|749|||
124822547|NCT02961751|448977259|FG000|Overall Study|Lost to Follow-up|11|||
124822548|NCT02961751|448977259|FG000|Overall Study|Physician Decision|2|||
124822549|NCT02961751|448977259|FG000|Overall Study|Not Eligible at Enrollment|1|||
124822550|NCT02961751|448977259|FG000|Overall Study|Protocol Violation|1|||
124822551|NCT02373202|448977260|FG000|Overall Study|Adverse Event|2|||
124822552|NCT02373202|448977261|FG001|Overall Study|Adverse Event|5|||
124822553|NCT02373202|448977262|FG002|Overall Study|Adverse Event|2|||
124822554|NCT02373202|448977263|FG003|Overall Study|Adverse Event|1|||
124822555|NCT02373202|448977260|FG000|Overall Study|Lack of Efficacy|0|||
124822556|NCT02373202|448977261|FG001|Overall Study|Lack of Efficacy|0|||
124822557|NCT02373202|448977262|FG002|Overall Study|Lack of Efficacy|1|||
124822558|NCT02373202|448977263|FG003|Overall Study|Lack of Efficacy|0|||
124822559|NCT02373202|448977260|FG000|Overall Study|Other|0|||
124822560|NCT02373202|448977261|FG001|Overall Study|Other|1|||
124822561|NCT02373202|448977262|FG002|Overall Study|Other|0|||
124822562|NCT02373202|448977263|FG003|Overall Study|Other|0|||
124822563|NCT02310568|448977270|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
124822564|NCT02310568|448977271|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
124822565|NCT02310568|448977272|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
124822566|NCT02310568|448977273|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
124822567|NCT02310568|448977274|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
124822568|NCT02310568|448977270|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
124822569|NCT02310568|448977271|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
124822570|NCT02310568|448977272|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
124822571|NCT02310568|448977273|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
124822572|NCT02310568|448977274|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
124822573|NCT02310568|448977270|FG000|Stage 1 ( 4 Weeks)|Other|1|||
124822574|NCT02310568|448977271|FG001|Stage 1 ( 4 Weeks)|Other|1|||
124822575|NCT02310568|448977272|FG002|Stage 1 ( 4 Weeks)|Other|0|||
124822576|NCT02310568|448977273|FG003|Stage 1 ( 4 Weeks)|Other|0|||
124822577|NCT02310568|448977274|FG004|Stage 1 ( 4 Weeks)|Other|0|||
124822578|NCT02310568|448977270|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
124822579|NCT02310568|448977271|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
124822580|NCT02310568|448977272|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
124822581|NCT02310568|448977273|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
124822582|NCT02310568|448977274|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
124822583|NCT02310568|448977270|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
124822584|NCT02310568|448977271|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
124822585|NCT02310568|448977272|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
124822586|NCT02310568|448977273|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
124822587|NCT02310568|448977274|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
124822588|NCT02310568|448977270|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
124822589|NCT02310568|448977271|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
124822590|NCT02310568|448977272|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
124822591|NCT02310568|448977273|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
124822592|NCT02310568|448977274|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
124822593|NCT02310568|448977270|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
124822594|NCT02310568|448977271|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
124822595|NCT02310568|448977272|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
124822596|NCT02310568|448977273|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
124822597|NCT02310568|448977274|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
124822598|NCT02310568|448977270|FG000|Stage 2 (4 Weeks)|Other|0|||
124822599|NCT02310568|448977271|FG001|Stage 2 (4 Weeks)|Other|1|||
124822600|NCT02310568|448977272|FG002|Stage 2 (4 Weeks)|Other|1|||
124822601|NCT02310568|448977273|FG003|Stage 2 (4 Weeks)|Other|0|||
124822602|NCT02310568|448977274|FG004|Stage 2 (4 Weeks)|Other|0|||
124822603|NCT02310568|448977270|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
124822604|NCT02310568|448977271|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
124822605|NCT02310568|448977272|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
124822606|NCT02310568|448977273|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
124822607|NCT02310568|448977274|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
124822608|NCT02310568|448977270|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
124822609|NCT02310568|448977271|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
124822610|NCT02310568|448977272|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
124822611|NCT02310568|448977273|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
124822612|NCT02310568|448977274|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
124822613|NCT02310568|448977270|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
124822614|NCT02310568|448977271|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
124822615|NCT02310568|448977272|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
124822616|NCT02310568|448977273|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
124822617|NCT02310568|448977274|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
124822618|NCT01224431|448977282|FG000|Overall Study|not randomized|0|||
124822619|NCT01224431|448977283|FG001|Overall Study|not randomized|4|||
124822620|NCT01224431|448977282|FG000|Overall Study|no video record|0|||
124822621|NCT01224431|448977283|FG001|Overall Study|no video record|1|||
124822622|NCT02511184|448977290|FG000|Overall Study|Death|1|||
124822623|NCT02511184|448977291|FG001|Overall Study|Death|0|||
124822624|NCT02511184|448977290|FG000|Overall Study|Lost to Follow-up|0|||
124822625|NCT02511184|448977291|FG001|Overall Study|Lost to Follow-up|1|||
124822626|NCT02511184|448977290|FG000|Overall Study|Study terminated by sponsor|1|||
124822627|NCT02511184|448977291|FG001|Overall Study|Study terminated by sponsor|5|||
124822628|NCT02511184|448977290|FG000|Overall Study|Withdrawal by Subject|0|||
124822629|NCT02511184|448977291|FG001|Overall Study|Withdrawal by Subject|1|||
124822630|NCT02041286|448977296|FG000|Overall Study|Adverse Event|1|||
124822631|NCT01963403|448977303|FG000|Overall Study|Lost to Follow-up|2|||
124822632|NCT01963403|448977304|FG001|Overall Study|Lost to Follow-up|3|||
124822633|NCT01963403|448977303|FG000|Overall Study|Implant removal|0|||
124822634|NCT01963403|448977304|FG001|Overall Study|Implant removal|1|||
124822635|NCT02289690|448977305|FG000|Overall Study|Adverse Event Related to Progression|0|||
124822636|NCT02289690|448977306|FG001|Overall Study|Adverse Event Related to Progression|1|||
124822637|NCT02289690|448977307|FG002|Overall Study|Adverse Event Related to Progression|1|||
124822638|NCT02289690|448977308|FG003|Overall Study|Adverse Event Related to Progression|0|||
124822639|NCT02289690|448977309|FG004|Overall Study|Adverse Event Related to Progression|1|||
124822640|NCT02289690|448977310|FG005|Overall Study|Adverse Event Related to Progression|0|||
124822641|NCT02289690|448977311|FG006|Overall Study|Adverse Event Related to Progression|1|||
124822642|NCT02289690|448977312|FG007|Overall Study|Adverse Event Related to Progression|0|||
124822643|NCT02289690|448977313|FG008|Overall Study|Adverse Event Related to Progression|0|||
124822644|NCT02289690|448977314|FG009|Overall Study|Adverse Event Related to Progression|0|||
124822645|NCT02289690|448977305|FG000|Overall Study|Withdrawal by Subject|1|||
125303324|NCT01128946|450736708|FG003|Period III|Protocol Violation|0|||
125303325|NCT00621140|450736709|FG000|Overall Study|Adverse Event|4|||
125303326|NCT00621140|450736710|FG001|Overall Study|Adverse Event|5|||
125303327|NCT00621140|450736709|FG000|Overall Study|Lost to Follow-up|1|||
125303328|NCT00621140|450736710|FG001|Overall Study|Lost to Follow-up|2|||
125303329|NCT00621140|450736709|FG000|Overall Study|Withdrawal by Subject|4|||
125303330|NCT00621140|450736710|FG001|Overall Study|Withdrawal by Subject|6|||
125303331|NCT00621140|450736709|FG000|Overall Study|Other incl. lack of efficacy|6|||
125303332|NCT00621140|450736710|FG001|Overall Study|Other incl. lack of efficacy|5|||
125303333|NCT01138501|450736711|FG000|Overall Study|Protocol Violation|2|||
125303334|NCT01138501|450736711|FG000|Overall Study|Withdrawal by Subject|3|||
125303335|NCT00360568|450736713|FG000|Overall Study|Adverse Event|1|||
125303336|NCT00360568|450736714|FG001|Overall Study|Adverse Event|2|||
125303337|NCT00360568|450736713|FG000|Overall Study|Lack of Efficacy|1|||
125303338|NCT00360568|450736714|FG001|Overall Study|Lack of Efficacy|0|||
125303339|NCT00360568|450736713|FG000|Overall Study|Withdrawal by Subject|0|||
125303340|NCT00360568|450736714|FG001|Overall Study|Withdrawal by Subject|3|||
125303341|NCT02873338|450736719|FG000|Overall Study|Adverse Event|0|||
125303342|NCT02873338|450736720|FG001|Overall Study|Adverse Event|2|||
124822646|NCT02289690|448977306|FG001|Overall Study|Withdrawal by Subject|0|||
124822647|NCT02289690|448977307|FG002|Overall Study|Withdrawal by Subject|0|||
124822648|NCT02289690|448977308|FG003|Overall Study|Withdrawal by Subject|0|||
124822649|NCT02289690|448977309|FG004|Overall Study|Withdrawal by Subject|1|||
125303343|NCT02873338|450736721|FG002|Overall Study|Adverse Event|1|||
125303344|NCT02873338|450736719|FG000|Overall Study|Death|2|||
125303345|NCT02873338|450736720|FG001|Overall Study|Death|1|||
125303346|NCT02873338|450736721|FG002|Overall Study|Death|1|||
125303347|NCT02873338|450736719|FG000|Overall Study|Withdrawal by Subject|2|||
124822650|NCT02289690|448977310|FG005|Overall Study|Withdrawal by Subject|1|||
124822651|NCT02289690|448977311|FG006|Overall Study|Withdrawal by Subject|0|||
124822652|NCT02289690|448977312|FG007|Overall Study|Withdrawal by Subject|0|||
124822653|NCT02289690|448977313|FG008|Overall Study|Withdrawal by Subject|4|||
124822654|NCT02289690|448977314|FG009|Overall Study|Withdrawal by Subject|2|||
124822655|NCT02289690|448977305|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
124822656|NCT02289690|448977306|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
124822657|NCT02289690|448977307|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
124822658|NCT02289690|448977308|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
124822659|NCT02289690|448977309|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
124822660|NCT02289690|448977310|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
124822661|NCT02289690|448977311|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
124822662|NCT02289690|448977312|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
124822663|NCT02289690|448977313|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
124822664|NCT02289690|448977314|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
124822665|NCT02289690|448977305|FG000|Overall Study|Lost to Follow-up|0|||
124822666|NCT02289690|448977306|FG001|Overall Study|Lost to Follow-up|0|||
124822667|NCT02289690|448977307|FG002|Overall Study|Lost to Follow-up|0|||
124822668|NCT02289690|448977308|FG003|Overall Study|Lost to Follow-up|0|||
124822669|NCT02289690|448977309|FG004|Overall Study|Lost to Follow-up|0|||
124822670|NCT02289690|448977310|FG005|Overall Study|Lost to Follow-up|0|||
124822671|NCT02289690|448977311|FG006|Overall Study|Lost to Follow-up|0|||
124822672|NCT02289690|448977312|FG007|Overall Study|Lost to Follow-up|1|||
124822673|NCT02289690|448977313|FG008|Overall Study|Lost to Follow-up|0|||
124822674|NCT02289690|448977314|FG009|Overall Study|Lost to Follow-up|2|||
124822675|NCT02289690|448977305|FG000|Overall Study|Death|0|||
124822676|NCT02289690|448977306|FG001|Overall Study|Death|0|||
124822677|NCT02289690|448977307|FG002|Overall Study|Death|0|||
124822678|NCT02289690|448977308|FG003|Overall Study|Death|0|||
124822679|NCT02289690|448977309|FG004|Overall Study|Death|0|||
124822680|NCT02289690|448977310|FG005|Overall Study|Death|0|||
124822681|NCT02289690|448977311|FG006|Overall Study|Death|0|||
124822682|NCT02289690|448977312|FG007|Overall Study|Death|49|||
124822683|NCT02289690|448977313|FG008|Overall Study|Death|45|||
124822684|NCT02289690|448977314|FG009|Overall Study|Death|41|||
124822685|NCT02289690|448977305|FG000|Overall Study|Sponsor Discontinued Study|0|||
124822686|NCT02289690|448977306|FG001|Overall Study|Sponsor Discontinued Study|0|||
124822687|NCT02289690|448977307|FG002|Overall Study|Sponsor Discontinued Study|0|||
124822688|NCT02289690|448977308|FG003|Overall Study|Sponsor Discontinued Study|0|||
124822689|NCT02289690|448977309|FG004|Overall Study|Sponsor Discontinued Study|0|||
124822690|NCT02289690|448977310|FG005|Overall Study|Sponsor Discontinued Study|0|||
124822691|NCT02289690|448977311|FG006|Overall Study|Sponsor Discontinued Study|0|||
124822692|NCT02289690|448977312|FG007|Overall Study|Sponsor Discontinued Study|9|||
124822693|NCT02289690|448977313|FG008|Overall Study|Sponsor Discontinued Study|7|||
124822694|NCT02289690|448977314|FG009|Overall Study|Sponsor Discontinued Study|15|||
124822695|NCT02289690|448977305|FG000|Overall Study|Other|0|||
124822696|NCT02289690|448977306|FG001|Overall Study|Other|0|||
124822697|NCT02289690|448977307|FG002|Overall Study|Other|0|||
124822698|NCT02289690|448977308|FG003|Overall Study|Other|1|||
124822699|NCT02289690|448977309|FG004|Overall Study|Other|1|||
124822700|NCT02289690|448977310|FG005|Overall Study|Other|0|||
124822701|NCT02289690|448977311|FG006|Overall Study|Other|1|||
124822702|NCT02289690|448977312|FG007|Overall Study|Other|2|||
124822703|NCT02289690|448977313|FG008|Overall Study|Other|3|||
124822704|NCT02289690|448977314|FG009|Overall Study|Other|1|||
124822705|NCT04016285|448977317|FG000|Overall Study|Did not progress to surgery|2|||
124822706|NCT04016285|448977318|FG001|Overall Study|Did not progress to surgery|5|||
124822707|NCT04016285|448977317|FG000|Overall Study|Failed to collect outcome data|5|||
124822708|NCT04016285|448977318|FG001|Overall Study|Failed to collect outcome data|3|||
124822709|NCT00460408|448977321|FG000|Overall Study|Adverse Event|1|||
124822710|NCT00460408|448977322|FG001|Overall Study|Adverse Event|0|||
124822711|NCT00460408|448977323|FG002|Overall Study|Adverse Event|0|||
124822712|NCT00460408|448977324|FG003|Overall Study|Adverse Event|0|||
124822713|NCT00460408|448977321|FG000|Overall Study|Death|7|||
124822714|NCT00460408|448977322|FG001|Overall Study|Death|0|||
124822715|NCT00460408|448977323|FG002|Overall Study|Death|0|||
124822716|NCT00460408|448977324|FG003|Overall Study|Death|0|||
124822717|NCT00460408|448977321|FG000|Overall Study|Lost to Follow-up|11|||
124822718|NCT00460408|448977322|FG001|Overall Study|Lost to Follow-up|0|||
124822719|NCT00460408|448977323|FG002|Overall Study|Lost to Follow-up|1|||
124822720|NCT00460408|448977324|FG003|Overall Study|Lost to Follow-up|0|||
124822721|NCT00460408|448977321|FG000|Overall Study|Withdrawal by Subject|31|||
124822722|NCT00460408|448977322|FG001|Overall Study|Withdrawal by Subject|0|||
124822723|NCT00460408|448977323|FG002|Overall Study|Withdrawal by Subject|0|||
124822724|NCT00460408|448977324|FG003|Overall Study|Withdrawal by Subject|0|||
124822725|NCT00460408|448977321|FG000|Overall Study|Insufficient clinical response|5|||
124822726|NCT00460408|448977322|FG001|Overall Study|Insufficient clinical response|1|||
124822727|NCT00460408|448977323|FG002|Overall Study|Insufficient clinical response|5|||
124822728|NCT00460408|448977324|FG003|Overall Study|Insufficient clinical response|0|||
124822729|NCT00460408|448977321|FG000|Overall Study|Other|12|||
124822730|NCT00460408|448977322|FG001|Overall Study|Other|2|||
124822731|NCT00460408|448977323|FG002|Overall Study|Other|0|||
124822732|NCT00460408|448977324|FG003|Overall Study|Other|0|||
124822733|NCT01442493|448977325|FG000|Overall Study|withdrawn from study|3|||
124822734|NCT01442493|448977326|FG001|Overall Study|withdrawn from study|2|||
124822735|NCT01111149|448977331|FG000|Overall Study|Protocol Violation|1|||
124822736|NCT01111149|448977332|FG001|Overall Study|Protocol Violation|1|||
124822737|NCT01111149|448977333|FG002|Overall Study|Protocol Violation|2|||
124822738|NCT01111149|448977331|FG000|Overall Study|Withdrawal by Subject|1|||
124822739|NCT01111149|448977332|FG001|Overall Study|Withdrawal by Subject|0|||
124822740|NCT01111149|448977333|FG002|Overall Study|Withdrawal by Subject|2|||
124822741|NCT00759954|448977334|FG000|Overall Study|Personal reason|1|||
124822742|NCT00759954|448977335|FG001|Overall Study|Personal reason|0|||
124822743|NCT00759954|448977334|FG000|Overall Study|Adverse Event|1|||
124822744|NCT00759954|448977335|FG001|Overall Study|Adverse Event|2|||
124822745|NCT01365910|448977353|FG000|Overall Study|Withdrawal by Subject|7|||
124822746|NCT01365910|448977353|FG000|Overall Study|disease progression|18|||
124822747|NCT01365910|448977353|FG000|Overall Study|Adverse Event|3|||
124822748|NCT01365910|448977353|FG000|Overall Study|other complicating disease|1|||
124822749|NCT01365910|448977353|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
124822750|NCT03681405|448977355|FG000|Overall Study|Found to be ineligible after randomized|1|||
124822751|NCT03681405|448977356|FG001|Overall Study|Found to be ineligible after randomized|0|||
124822752|NCT00833794|448977357|FG000|Open-label Phase|Adverse Event|225|||
124822753|NCT00833794|448977358|FG001|Open-label Phase|Adverse Event|0|||
124822754|NCT00833794|448977357|FG000|Open-label Phase|Lack of Efficacy|28|||
124822755|NCT00833794|448977358|FG001|Open-label Phase|Lack of Efficacy|0|||
124822756|NCT00833794|448977357|FG000|Open-label Phase|Withdrawal by Subject|48|||
124822757|NCT00833794|448977358|FG001|Open-label Phase|Withdrawal by Subject|0|||
124822758|NCT00833794|448977357|FG000|Open-label Phase|Physician Decision|20|||
124822759|NCT00833794|448977358|FG001|Open-label Phase|Physician Decision|0|||
124822760|NCT00833794|448977357|FG000|Open-label Phase|Administrative reason|1|||
124822761|NCT00833794|448977358|FG001|Open-label Phase|Administrative reason|0|||
124822762|NCT00833794|448977357|FG000|Open-label Phase|Protocol Violation|47|||
124822763|NCT00833794|448977358|FG001|Open-label Phase|Protocol Violation|0|||
124822764|NCT00833794|448977357|FG000|Open-label Phase|Did not complete wash-out period|12|||
124822765|NCT00833794|448977358|FG001|Open-label Phase|Did not complete wash-out period|0|||
124822766|NCT00833794|448977357|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
124822767|NCT00833794|448977358|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
124822768|NCT00833794|448977357|FG000|Double-blind Phase|Adverse Event|44|||
124822769|NCT00833794|448977358|FG001|Double-blind Phase|Adverse Event|11|||
124822770|NCT00833794|448977357|FG000|Double-blind Phase|Lack of Efficacy|34|||
124822771|NCT00833794|448977358|FG001|Double-blind Phase|Lack of Efficacy|22|||
124822772|NCT00833794|448977357|FG000|Double-blind Phase|Withdrawal by Subject|23|||
124822773|NCT00833794|448977358|FG001|Double-blind Phase|Withdrawal by Subject|6|||
124822774|NCT00833794|448977357|FG000|Double-blind Phase|Physician Decision|4|||
124822775|NCT00833794|448977358|FG001|Double-blind Phase|Physician Decision|7|||
124822776|NCT00833794|448977357|FG000|Double-blind Phase|Administrative reason|1|||
124822777|NCT00833794|448977358|FG001|Double-blind Phase|Administrative reason|3|||
124822778|NCT01927367|448977360|FG000|Overall Study|Withdrawal by Subject|7|||
124822779|NCT01927367|448977361|FG001|Overall Study|Withdrawal by Subject|4|||
124822780|NCT01927367|448977360|FG000|Overall Study|No baseline data|0|||
124822781|NCT01927367|448977361|FG001|Overall Study|No baseline data|1|||
124822782|NCT00598832|448977364|FG000|Overall Study|Lack of Efficacy|3|||
124822783|NCT00598832|448977365|FG001|Overall Study|Lack of Efficacy|7|||
124822784|NCT00598832|448977364|FG000|Overall Study|Adverse Event|6|||
124822785|NCT00598832|448977365|FG001|Overall Study|Adverse Event|2|||
124822786|NCT00598832|448977364|FG000|Overall Study|Withdrawal by Subject|25|||
124822787|NCT00598832|448977365|FG001|Overall Study|Withdrawal by Subject|36|||
125303348|NCT02873338|450736720|FG001|Overall Study|Withdrawal by Subject|1|||
125303349|NCT02873338|450736721|FG002|Overall Study|Withdrawal by Subject|3|||
125303350|NCT02873338|450736719|FG000|Overall Study|Lack of Efficacy|0|||
124822788|NCT00598832|448977364|FG000|Overall Study|Protocol Violation|0|||
124822789|NCT00598832|448977365|FG001|Overall Study|Protocol Violation|2|||
124822790|NCT00598832|448977364|FG000|Overall Study|Lost to Follow-up|24|||
124822791|NCT00598832|448977365|FG001|Overall Study|Lost to Follow-up|29|||
125303351|NCT02873338|450736720|FG001|Overall Study|Lack of Efficacy|2|||
125303352|NCT02873338|450736721|FG002|Overall Study|Lack of Efficacy|0|||
124822792|NCT00598832|448977364|FG000|Overall Study|Pregnancy|2|||
124822793|NCT00598832|448977365|FG001|Overall Study|Pregnancy|2|||
124822794|NCT00598832|448977364|FG000|Overall Study|Physician Decision|1|||
124822795|NCT00598832|448977365|FG001|Overall Study|Physician Decision|4|||
124822796|NCT00598832|448977364|FG000|Overall Study|Non compliance|1|||
124822797|NCT00598832|448977365|FG001|Overall Study|Non compliance|0|||
124822798|NCT02760069|448977366|FG000|Overall Study|Withdrawal by Subject|0|||
124822799|NCT02760069|448977367|FG001|Overall Study|Withdrawal by Subject|1|||
124822800|NCT02760069|448977368|FG002|Overall Study|Withdrawal by Subject|1|||
125303353|NCT02873338|450736719|FG000|Overall Study|Other or Missing|14|||
124822801|NCT01648205|448977374|FG000|Placebo|Pregnancy|1|||
124822802|NCT01648205|448977374|FG000|Placebo|Withdrawal by Subject|1|||
124822803|NCT01648205|448977374|FG000|Placebo|Protocol Violation|2|||
124822804|NCT01648205|448977374|FG000|Ranolazine|Death|1|||
124822805|NCT01648205|448977374|FG000|Ranolazine|Withdrawal by Subject|1|||
124822806|NCT01648205|448977374|FG000|Ranolazine|Protocol Violation|3|||
124822807|NCT02142959|448977382|FG000|Overall Study|Adverse Event|1|||
124822808|NCT02142959|448977383|FG001|Overall Study|Adverse Event|0|||
124822809|NCT02142959|448977384|FG002|Overall Study|Adverse Event|0|||
124822810|NCT02142959|448977382|FG000|Overall Study|Death|0|||
124822811|NCT02142959|448977383|FG001|Overall Study|Death|1|||
124822812|NCT02142959|448977384|FG002|Overall Study|Death|0|||
124822813|NCT02142959|448977382|FG000|Overall Study|Withdrawal by Subject|3|||
124822814|NCT02142959|448977383|FG001|Overall Study|Withdrawal by Subject|1|||
124822815|NCT02142959|448977384|FG002|Overall Study|Withdrawal by Subject|3|||
124822816|NCT02142959|448977382|FG000|Overall Study|Administrative Reasons|1|||
124822817|NCT02142959|448977383|FG001|Overall Study|Administrative Reasons|0|||
124822818|NCT02142959|448977384|FG002|Overall Study|Administrative Reasons|1|||
124822819|NCT02142959|448977382|FG000|Overall Study|Missing|0|||
124822820|NCT02142959|448977383|FG001|Overall Study|Missing|1|||
124822821|NCT02142959|448977384|FG002|Overall Study|Missing|0|||
124822822|NCT02142959|448977382|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
124822823|NCT02142959|448977383|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
124822824|NCT02142959|448977384|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
124822825|NCT02142959|448977382|FG000|Overall Study|Patient didn't complete end of study visit|0|||
124822826|NCT02142959|448977383|FG001|Overall Study|Patient didn't complete end of study visit|0|||
124822827|NCT02142959|448977384|FG002|Overall Study|Patient didn't complete end of study visit|1|||
124822828|NCT03547687|448977385|FG000|Overall Study|Withdrawal by Subject|1|||
124822829|NCT03547687|448977385|FG000|Overall Study|Death|1|||
124822830|NCT00679302|448977386|FG000|Overall Study|Lost to Follow-up|8|||
124822831|NCT00679302|448977387|FG001|Overall Study|Lost to Follow-up|4|||
124822832|NCT03031678|448977389|FG000|Overall Study|Study closed prior to completion|1|||
124822833|NCT00434330|448977390|FG000|Overall Study|Adverse Event|0|||
124822834|NCT00434330|448977391|FG001|Overall Study|Adverse Event|0|||
124822835|NCT00434330|448977392|FG002|Overall Study|Adverse Event|1|||
124822836|NCT00434330|448977393|FG003|Overall Study|Adverse Event|0|||
124822837|NCT00434330|448977394|FG004|Overall Study|Adverse Event|0|||
124822838|NCT00434330|448977395|FG005|Overall Study|Adverse Event|0|||
124822839|NCT00434330|448977390|FG000|Overall Study|Death|1|||
124822840|NCT00434330|448977391|FG001|Overall Study|Death|0|||
124822841|NCT00434330|448977392|FG002|Overall Study|Death|0|||
124822842|NCT00434330|448977393|FG003|Overall Study|Death|0|||
124822843|NCT00434330|448977394|FG004|Overall Study|Death|1|||
124822844|NCT00434330|448977395|FG005|Overall Study|Death|1|||
124822845|NCT00434330|448977390|FG000|Overall Study|Withdrawal by Subject|0|||
124822846|NCT00434330|448977391|FG001|Overall Study|Withdrawal by Subject|0|||
124822847|NCT00434330|448977392|FG002|Overall Study|Withdrawal by Subject|1|||
124822848|NCT00434330|448977393|FG003|Overall Study|Withdrawal by Subject|1|||
124822849|NCT00434330|448977394|FG004|Overall Study|Withdrawal by Subject|0|||
124822850|NCT00434330|448977395|FG005|Overall Study|Withdrawal by Subject|0|||
124822851|NCT00434330|448977390|FG000|Overall Study|Renal transplant|0|||
124822852|NCT00434330|448977391|FG001|Overall Study|Renal transplant|0|||
124822853|NCT00434330|448977392|FG002|Overall Study|Renal transplant|0|||
124822854|NCT00434330|448977393|FG003|Overall Study|Renal transplant|1|||
124822855|NCT00434330|448977394|FG004|Overall Study|Renal transplant|0|||
124822856|NCT00434330|448977395|FG005|Overall Study|Renal transplant|0|||
124822857|NCT00434330|448977390|FG000|Overall Study|Subject Not Compliant With Study|0|||
124822858|NCT00434330|448977391|FG001|Overall Study|Subject Not Compliant With Study|0|||
124822859|NCT00434330|448977392|FG002|Overall Study|Subject Not Compliant With Study|1|||
124822860|NCT00434330|448977393|FG003|Overall Study|Subject Not Compliant With Study|0|||
124822861|NCT00434330|448977394|FG004|Overall Study|Subject Not Compliant With Study|0|||
124822862|NCT00434330|448977395|FG005|Overall Study|Subject Not Compliant With Study|0|||
124822863|NCT00850564|448977400|FG000|Overall Study|Withdrawal by Subject|2|||
124822864|NCT05355805|448977401|FG000|Overall Study|Lost to Follow-up|6|||
124822865|NCT05355805|448977402|FG001|Overall Study|Lost to Follow-up|11|||
124822866|NCT05355805|448977403|FG002|Overall Study|Lost to Follow-up|10|||
125303354|NCT02873338|450736720|FG001|Overall Study|Other or Missing|15|||
125303355|NCT02873338|450736721|FG002|Overall Study|Other or Missing|13|||
125303356|NCT03657095|450736722|FG000|Overall Study|Withdrawal by Subject|1|||
124822867|NCT05355805|448977404|FG003|Overall Study|Lost to Follow-up|6|||
124822868|NCT05355805|448977401|FG000|Overall Study|Decision by Sponsor|0|||
124822869|NCT05355805|448977402|FG001|Overall Study|Decision by Sponsor|0|||
124822870|NCT05355805|448977403|FG002|Overall Study|Decision by Sponsor|1|||
124822871|NCT05355805|448977404|FG003|Overall Study|Decision by Sponsor|0|||
124822872|NCT05355805|448977401|FG000|Overall Study|Withdrawal by Subject|7|||
124822873|NCT05355805|448977402|FG001|Overall Study|Withdrawal by Subject|14|||
124822874|NCT05355805|448977403|FG002|Overall Study|Withdrawal by Subject|15|||
124822875|NCT05355805|448977404|FG003|Overall Study|Withdrawal by Subject|13|||
124822876|NCT02167893|448977405|FG000|Overall Study|Investigator transferred|85|||
124822877|NCT02167893|448977405|FG000|Overall Study|Investigator health reasons|10|||
124822878|NCT02167893|448977405|FG000|Overall Study|Case report forms not collected|68|||
124822879|NCT04818840|448977406|FG000|Overall Study|Lost to Follow-up|0|||
124822880|NCT04818840|448977407|FG001|Overall Study|Lost to Follow-up|5|||
124822881|NCT04818840|448977406|FG000|Overall Study|Physician Decision|1|||
124822882|NCT04818840|448977407|FG001|Overall Study|Physician Decision|0|||
124822883|NCT04818840|448977406|FG000|Overall Study|Site Terminated by Sponsor|0|||
124822884|NCT04818840|448977407|FG001|Overall Study|Site Terminated by Sponsor|3|||
124822885|NCT04818840|448977406|FG000|Overall Study|Study Terminated by Sponsor|43|||
124822886|NCT04818840|448977407|FG001|Overall Study|Study Terminated by Sponsor|7|||
124822887|NCT04818840|448977406|FG000|Overall Study|Withdrawal by Subject|0|||
124822888|NCT04818840|448977407|FG001|Overall Study|Withdrawal by Subject|1|||
124822889|NCT02345850|448979220|FG000|Overall Study|Not transplanted|10|||
124822890|NCT02345850|448979221|FG001|Overall Study|Not transplanted|5|||
124822891|NCT02345850|448979222|FG002|Overall Study|Not transplanted|4|||
124822892|NCT02345850|448979220|FG000|Overall Study|Lost to Follow-up|2|||
124822893|NCT02345850|448979221|FG001|Overall Study|Lost to Follow-up|3|||
124822894|NCT02345850|448979222|FG002|Overall Study|Lost to Follow-up|2|||
124822895|NCT02345850|448979220|FG000|Overall Study|Withdrawal by Subject|1|||
124822896|NCT02345850|448979221|FG001|Overall Study|Withdrawal by Subject|0|||
124822897|NCT02345850|448979222|FG002|Overall Study|Withdrawal by Subject|0|||
124822898|NCT01991067|448979224|FG000|Overall Study|Lost to Follow-up|6|||
124822899|NCT01991067|448979225|FG001|Overall Study|Lost to Follow-up|5|||
124822900|NCT03909295|448979227|FG000|Overall Study|Adverse Event|2|||
124822901|NCT03909295|448979227|FG000|Overall Study|Study terminated by sponsor|50|||
124822902|NCT01411228|448979228|FG000|Overall Study|Lost to Follow-up|0|||
124822903|NCT01411228|448979229|FG001|Overall Study|Lost to Follow-up|0|||
124822904|NCT01411228|448979230|FG002|Overall Study|Lost to Follow-up|1|||
124822905|NCT01411228|448979228|FG000|Overall Study|Withdrawal by Subject|1|||
124822906|NCT01411228|448979229|FG001|Overall Study|Withdrawal by Subject|0|||
124822907|NCT01411228|448979230|FG002|Overall Study|Withdrawal by Subject|0|||
124822908|NCT01752907|448979231|FG000|Overall Study|Withdrawal by Subject|4|||
124822909|NCT01752907|448979232|FG001|Overall Study|Withdrawal by Subject|10|||
124822910|NCT01752907|448979231|FG000|Overall Study|Lost to Follow-up|2|||
124822911|NCT01752907|448979232|FG001|Overall Study|Lost to Follow-up|1|||
124822912|NCT01752907|448979231|FG000|Overall Study|Decision by Sponsor|6|||
124822913|NCT01752907|448979232|FG001|Overall Study|Decision by Sponsor|9|||
124822914|NCT02670083|448979238|FG000|Overall Study|Adverse Event|16|||
124822915|NCT02670083|448979239|FG001|Overall Study|Adverse Event|13|||
124822916|NCT02670083|448979238|FG000|Overall Study|Death|4|||
124822917|NCT02670083|448979239|FG001|Overall Study|Death|6|||
124822918|NCT02670083|448979238|FG000|Overall Study|Lost to Follow-up|2|||
124822919|NCT02670083|448979239|FG001|Overall Study|Lost to Follow-up|2|||
124822920|NCT02670083|448979238|FG000|Overall Study|Multiple Reasons|9|||
124822921|NCT02670083|448979239|FG001|Overall Study|Multiple Reasons|9|||
124822922|NCT02670083|448979238|FG000|Overall Study|Physician Decision|0|||
124822923|NCT02670083|448979239|FG001|Overall Study|Physician Decision|2|||
124822924|NCT02670083|448979238|FG000|Overall Study|Study Terminated By Sponsor|257|||
124822925|NCT02670083|448979239|FG001|Overall Study|Study Terminated By Sponsor|254|||
124822926|NCT02670083|448979238|FG000|Overall Study|Symptomatic Deterioration|0|||
124822927|NCT02670083|448979239|FG001|Overall Study|Symptomatic Deterioration|2|||
124822928|NCT02670083|448979238|FG000|Overall Study|Withdrawal by Subject|32|||
124822929|NCT02670083|448979239|FG001|Overall Study|Withdrawal by Subject|31|||
124822930|NCT02670083|448979238|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124822931|NCT02670083|448979239|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124822932|NCT02014597|448979240|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
124822933|NCT02014597|448979241|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
124822934|NCT00464087|448979244|FG000|Overall Study|No PCI per inclusion criteria|0|||
124822935|NCT00464087|448979245|FG001|Overall Study|No PCI per inclusion criteria|0|||
124822936|NCT00464087|448979246|FG002|Overall Study|No PCI per inclusion criteria|29|||
124822937|NCT02425046|448979247|FG000|Overall Study|Lost to Follow-up|52|||
124822938|NCT02425046|448979248|FG001|Overall Study|Lost to Follow-up|50|||
124822939|NCT02425046|448979249|FG002|Overall Study|Lost to Follow-up|56|||
124822940|NCT02425046|448979247|FG000|Overall Study|Withdrawal by Subject|16|||
124822941|NCT02425046|448979248|FG001|Overall Study|Withdrawal by Subject|12|||
124822942|NCT02425046|448979249|FG002|Overall Study|Withdrawal by Subject|0|||
124822943|NCT00931762|448979250|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
124822944|NCT00931762|448979250|FG000|Overall Study|Administrative Problems|5|||
124822945|NCT00931762|448979250|FG000|Overall Study|Death|1|||
124822946|NCT00931762|448979250|FG000|Overall Study|Disease Progression|3|||
124822947|NCT00931762|448979250|FG000|Overall Study|Adverse Event (s)|11|||
124822948|NCT00931762|448979250|FG000|Overall Study|Subject withdrew consent|13|||
124822949|NCT02692716|448979253|FG000|Overall Study|Lost to Follow-up|2|||
124822950|NCT02692716|448979254|FG001|Overall Study|Lost to Follow-up|5|||
124822951|NCT02692716|448979253|FG000|Overall Study|Withdrawal by Subject|3|||
124822952|NCT02692716|448979254|FG001|Overall Study|Withdrawal by Subject|1|||
124822953|NCT02782780|448979259|FG000|Overall Study|dropped out after randomization.|7|||
124822954|NCT02782780|448979260|FG001|Overall Study|dropped out after randomization.|5|||
124822955|NCT02782780|448979259|FG000|Overall Study|Protocol Violation|0|||
124822956|NCT02782780|448979260|FG001|Overall Study|Protocol Violation|2|||
124822957|NCT03562481|448979261|FG000|First Intervention|Lost to Follow-up|1|||
124822958|NCT03562481|448979262|FG001|First Intervention|Lost to Follow-up|0|||
124822959|NCT02664441|448979263|FG000|Randomization|Withdrawal by Subject|0|||
124822960|NCT02664441|448979264|FG001|Randomization|Withdrawal by Subject|1|||
124822961|NCT02664441|448979263|FG000|36-week Randomized Trial|Adverse Event|2|||
124822962|NCT02664441|448979264|FG001|36-week Randomized Trial|Adverse Event|0|||
124822963|NCT02664441|448979263|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
124822964|NCT02664441|448979264|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
124822965|NCT02664441|448979263|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
124822966|NCT02664441|448979264|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
124822967|NCT02664441|448979263|FG000|18-week Open Label Extension|Adverse Event|1|||
124822968|NCT02664441|448979264|FG001|18-week Open Label Extension|Adverse Event|0|||
124822969|NCT02664441|448979263|FG000|18-week Open Label Extension|Physician Decision|1|||
124822970|NCT02664441|448979264|FG001|18-week Open Label Extension|Physician Decision|0|||
124822971|NCT02664441|448979263|FG000|18-week Open Label Extension|Death|1|||
124822972|NCT02664441|448979264|FG001|18-week Open Label Extension|Death|0|||
124822973|NCT02664441|448979263|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
124822974|NCT02664441|448979264|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
124822975|NCT01413191|448979265|FG000|Overall Study|Lost to Follow-up|5|||
124822976|NCT01413191|448979265|FG000|Overall Study|Disease Progression|5|||
124822977|NCT01413191|448979265|FG000|Overall Study|Death|1|||
124822978|NCT03654651|448979266|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
124822979|NCT03654651|448979267|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
124822980|NCT01702454|448979268|FG000|Overall Study|Consent withdrawal|0|||
124822981|NCT01702454|448979269|FG001|Overall Study|Consent withdrawal|1|||
124822982|NCT01702454|448979268|FG000|Overall Study|Migrated/moved from study area|0|||
124822983|NCT01702454|448979269|FG001|Overall Study|Migrated/moved from study area|1|||
124822984|NCT01702454|448979268|FG000|Overall Study|Lost to Follow-up|3|||
124822985|NCT01702454|448979269|FG001|Overall Study|Lost to Follow-up|6|||
124822986|NCT03510884|448979274|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
124822987|NCT03510884|448979275|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
124822988|NCT03510884|448979276|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
124822989|NCT03510884|448979277|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
124822990|NCT03510884|448979274|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
124822991|NCT03510884|448979275|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
124822992|NCT03510884|448979276|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
124822993|NCT03510884|448979277|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
124822994|NCT03510884|448979274|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
124822995|NCT03510884|448979275|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
124822996|NCT03510884|448979276|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
124822997|NCT03510884|448979277|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
124822998|NCT03510884|448979274|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
124822999|NCT03510884|448979275|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
124823000|NCT03510884|448979276|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
124823001|NCT03510884|448979277|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
124823002|NCT03510884|448979274|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
124823003|NCT03510884|448979275|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
124823004|NCT03510884|448979276|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
124823005|NCT03510884|448979277|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
124823006|NCT03510884|448979274|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
124823007|NCT03510884|448979275|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
124823008|NCT03510884|448979276|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
124823009|NCT03510884|448979277|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
124823010|NCT03510884|448979274|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
124823011|NCT03510884|448979275|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
124823012|NCT03510884|448979276|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
124823013|NCT03510884|448979277|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
124823014|NCT03510884|448979274|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
124823015|NCT03510884|448979275|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
124823016|NCT03510884|448979276|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
124823017|NCT03510884|448979277|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
124823018|NCT03510884|448979274|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
124823019|NCT03510884|448979275|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
124823020|NCT03510884|448979276|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
125309879|NCT00947115|450760200|FG001|Overall Study|Lost to Follow-up|12|||
124823021|NCT03510884|448979277|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
124823022|NCT03510884|448979274|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
124823023|NCT03510884|448979275|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
124823024|NCT03510884|448979276|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
124823025|NCT03510884|448979277|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
124823026|NCT00856284|448979278|FG000|Overall Study|Hyperglycemic rescue|231|||
124823027|NCT00856284|448979279|FG001|Overall Study|Hyperglycemic rescue|201|||
124823028|NCT00856284|448979280|FG002|Overall Study|Hyperglycemic rescue|235|||
124823029|NCT00856284|448979278|FG000|Overall Study|Adverse Event|60|||
124823030|NCT00856284|448979279|FG001|Overall Study|Adverse Event|74|||
124823031|NCT00856284|448979280|FG002|Overall Study|Adverse Event|82|||
124823032|NCT00856284|448979278|FG000|Overall Study|Major protocol deviation|24|||
124823033|NCT00856284|448979279|FG001|Overall Study|Major protocol deviation|16|||
124823034|NCT00856284|448979280|FG002|Overall Study|Major protocol deviation|15|||
124823035|NCT00856284|448979278|FG000|Overall Study|Lost to Follow-up|20|||
124823036|NCT00856284|448979279|FG001|Overall Study|Lost to Follow-up|22|||
124823037|NCT00856284|448979280|FG002|Overall Study|Lost to Follow-up|28|||
124823038|NCT00856284|448979278|FG000|Overall Study|Voluntary withdrawal|48|||
124823039|NCT00856284|448979279|FG001|Overall Study|Voluntary withdrawal|52|||
124823040|NCT00856284|448979280|FG002|Overall Study|Voluntary withdrawal|62|||
124823041|NCT00856284|448979278|FG000|Overall Study|Pregnancy|1|||
124823042|NCT00856284|448979279|FG001|Overall Study|Pregnancy|2|||
124823043|NCT00856284|448979280|FG002|Overall Study|Pregnancy|0|||
124823044|NCT00856284|448979278|FG000|Overall Study|Investigator discretion|9|||
124823045|NCT00856284|448979279|FG001|Overall Study|Investigator discretion|8|||
124823046|NCT00856284|448979280|FG002|Overall Study|Investigator discretion|10|||
124823047|NCT00856284|448979278|FG000|Overall Study|Other|15|||
124823048|NCT00856284|448979279|FG001|Overall Study|Other|17|||
124823049|NCT00856284|448979280|FG002|Overall Study|Other|14|||
124823050|NCT00856284|448979278|FG000|Overall Study|Randomized in error|0|||
124823051|NCT00856284|448979279|FG001|Overall Study|Randomized in error|0|||
124823052|NCT00856284|448979280|FG002|Overall Study|Randomized in error|1|||
124823053|NCT02904512|448979283|FG000|Overall Study|Withdrawal by Subject|1|||
124823054|NCT02904512|448979284|FG001|Overall Study|Withdrawal by Subject|0|||
124823055|NCT02904512|448979283|FG000|Overall Study|Transferred to ICU|1|||
124823056|NCT02904512|448979284|FG001|Overall Study|Transferred to ICU|0|||
124823057|NCT02904512|448979283|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
124823058|NCT02904512|448979284|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
124823059|NCT00267046|448979291|FG000|Overall Study|Disease progression|4|||
124823060|NCT00267046|448979292|FG001|Overall Study|Disease progression|2|||
124823061|NCT00267046|448979291|FG000|Overall Study|Chemotoxicity|2|||
124823062|NCT00267046|448979292|FG001|Overall Study|Chemotoxicity|0|||
124823063|NCT00267046|448979291|FG000|Overall Study|Open-label palifermin|2|||
124823064|NCT00267046|448979292|FG001|Overall Study|Open-label palifermin|7|||
124823065|NCT00267046|448979291|FG000|Overall Study|Surgery|3|||
124823066|NCT00267046|448979292|FG001|Overall Study|Surgery|1|||
124823067|NCT00267046|448979291|FG000|Overall Study|Withdrawal by Subject|1|||
124823068|NCT00267046|448979292|FG001|Overall Study|Withdrawal by Subject|0|||
124823069|NCT00267046|448979291|FG000|Overall Study|Radiation|0|||
124823070|NCT00267046|448979292|FG001|Overall Study|Radiation|1|||
124823071|NCT01124422|448979299|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
124823072|NCT01124422|448979300|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
124823073|NCT01124422|448979301|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
124823074|NCT01124422|448979299|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
124823075|NCT01124422|448979300|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
124823076|NCT01124422|448979301|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
124823077|NCT01124422|448979299|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
124823078|NCT01124422|448979300|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
124823079|NCT01124422|448979301|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
124823080|NCT01124422|448979299|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
124823081|NCT01124422|448979300|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
124823082|NCT01124422|448979301|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
124823083|NCT01124422|448979299|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
124823084|NCT01124422|448979300|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
124823085|NCT01124422|448979301|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
124823086|NCT01124422|448979299|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
124823087|NCT01124422|448979300|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
124823088|NCT01124422|448979301|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
124823089|NCT01124422|448979299|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
124823090|NCT01124422|448979300|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
124823091|NCT01124422|448979301|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
124823092|NCT01124422|448979299|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
124823093|NCT01124422|448979300|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
124823094|NCT01124422|448979301|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
124823095|NCT01124422|448979299|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
124823096|NCT01124422|448979300|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
124823097|NCT01124422|448979301|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
124823098|NCT01124422|448979299|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
124823099|NCT01124422|448979300|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
124823100|NCT01124422|448979301|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
124823101|NCT00137046|448979304|FG000|Overall Study|Death|2|||
124823102|NCT00137046|448979305|FG001|Overall Study|Death|1|||
124823103|NCT00137046|448979304|FG000|Overall Study|Adverse Event|16|||
124823104|NCT00137046|448979305|FG001|Overall Study|Adverse Event|5|||
124823105|NCT00137046|448979304|FG000|Overall Study|Laboratory Abnormality|2|||
124823106|NCT00137046|448979305|FG001|Overall Study|Laboratory Abnormality|0|||
124823107|NCT00137046|448979304|FG000|Overall Study|Lack of Efficacy|13|||
124823108|NCT00137046|448979305|FG001|Overall Study|Lack of Efficacy|1|||
124823109|NCT00137046|448979304|FG000|Overall Study|Lost to Follow-up|8|||
124823110|NCT00137046|448979305|FG001|Overall Study|Lost to Follow-up|24|||
124823111|NCT00137046|448979304|FG000|Overall Study|Other|23|||
124823112|NCT00137046|448979305|FG001|Overall Study|Other|19|||
124823113|NCT00137046|448979304|FG000|Overall Study|Withdrawal by Subject|33|||
124823114|NCT00137046|448979305|FG001|Overall Study|Withdrawal by Subject|42|||
124823115|NCT00137046|448979304|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
124823116|NCT00137046|448979305|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
124823117|NCT00137046|448979304|FG000|Overall Study|Withdrew prior to study treatment|1|||
124823118|NCT00137046|448979305|FG001|Overall Study|Withdrew prior to study treatment|1|||
124823119|NCT02730455|448979308|FG000|Overall Study|Death|5|||
124823120|NCT02730455|448979309|FG001|Overall Study|Death|6|||
124823121|NCT02730455|448979310|FG002|Overall Study|Death|4|||
124823122|NCT02730455|448979308|FG000|Overall Study|Consent withdrawn|2|||
124823123|NCT02730455|448979309|FG001|Overall Study|Consent withdrawn|4|||
124823124|NCT02730455|448979310|FG002|Overall Study|Consent withdrawn|1|||
124823125|NCT02730455|448979308|FG000|Overall Study|Lost to Follow-up|3|||
124823126|NCT02730455|448979309|FG001|Overall Study|Lost to Follow-up|1|||
124823127|NCT02730455|448979310|FG002|Overall Study|Lost to Follow-up|4|||
124823128|NCT02730455|448979308|FG000|Overall Study|Other|1|||
124823129|NCT02730455|448979309|FG001|Overall Study|Other|1|||
124823130|NCT02730455|448979310|FG002|Overall Study|Other|2|||
124823131|NCT02730455|448979308|FG000|Overall Study|Other|2|||
124823132|NCT02730455|448979309|FG001|Overall Study|Other|2|||
124823133|NCT02730455|448979310|FG002|Overall Study|Other|0|||
124823134|NCT03235154|448979311|FG000|Overall Study|Withdrawal by Subject|1|||
124823135|NCT03235154|448979311|FG000|Overall Study|Adverse Event|1|||
124823136|NCT03235154|448979311|FG000|Overall Study|Lost to Follow-up|2|||
124823137|NCT02725710|448979314|FG000|Overall Study|Lost to Follow-up|1|||
124823138|NCT02725710|448979315|FG001|Overall Study|Lost to Follow-up|0|||
124823139|NCT01666782|448979318|FG000|Overall Study|Received 2 doses of vaccine|0|||
124823140|NCT01666782|448979319|FG001|Overall Study|Received 2 doses of vaccine|1|||
124823141|NCT01666782|448979318|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
124823142|NCT01666782|448979319|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
124823143|NCT01691781|448979331|FG000|Overall Study|Withdrawal by Subject|4|||
124823144|NCT01691781|448979332|FG001|Overall Study|Withdrawal by Subject|3|||
124823145|NCT01691781|448979331|FG000|Overall Study|Physician Decision|1|||
124823146|NCT01691781|448979332|FG001|Overall Study|Physician Decision|1|||
124823147|NCT01691781|448979331|FG000|Overall Study|Protocol Violation|2|||
124823148|NCT01691781|448979332|FG001|Overall Study|Protocol Violation|2|||
124823149|NCT01691781|448979331|FG000|Overall Study|Adverse Event|0|||
124823150|NCT01691781|448979332|FG001|Overall Study|Adverse Event|1|||
124823151|NCT03978520|448979333|FG000|Overall Study|Adverse Event|2|||
124823152|NCT03978520|448979334|FG001|Overall Study|Adverse Event|5|||
124823153|NCT03978520|448979335|FG002|Overall Study|Adverse Event|3|||
124823154|NCT03978520|448979336|FG003|Overall Study|Adverse Event|5|||
124823155|NCT03978520|448979337|FG004|Overall Study|Adverse Event|6|||
124823156|NCT03978520|448979333|FG000|Overall Study|Withdrawal by Subject|10|||
124823157|NCT03978520|448979334|FG001|Overall Study|Withdrawal by Subject|4|||
124823158|NCT03978520|448979335|FG002|Overall Study|Withdrawal by Subject|5|||
124823159|NCT03978520|448979336|FG003|Overall Study|Withdrawal by Subject|6|||
124823160|NCT03978520|448979337|FG004|Overall Study|Withdrawal by Subject|5|||
124823161|NCT03978520|448979333|FG000|Overall Study|Lost to Follow-up|2|||
124823162|NCT03978520|448979334|FG001|Overall Study|Lost to Follow-up|2|||
125303357|NCT03657095|450736723|FG001|Overall Study|Withdrawal by Subject|1|||
124823163|NCT03978520|448979335|FG002|Overall Study|Lost to Follow-up|2|||
124823164|NCT03978520|448979336|FG003|Overall Study|Lost to Follow-up|0|||
124823165|NCT03978520|448979337|FG004|Overall Study|Lost to Follow-up|1|||
124823166|NCT03978520|448979333|FG000|Overall Study|COVID-19 infection|0|||
124823167|NCT03978520|448979334|FG001|Overall Study|COVID-19 infection|1|||
124823168|NCT03978520|448979335|FG002|Overall Study|COVID-19 infection|0|||
124823169|NCT03978520|448979336|FG003|Overall Study|COVID-19 infection|0|||
124823170|NCT03978520|448979337|FG004|Overall Study|COVID-19 infection|0|||
124823171|NCT03978520|448979333|FG000|Overall Study|Other, not specified|9|||
124823172|NCT03978520|448979334|FG001|Overall Study|Other, not specified|4|||
124823173|NCT03978520|448979335|FG002|Overall Study|Other, not specified|1|||
124823174|NCT03978520|448979336|FG003|Overall Study|Other, not specified|1|||
124823175|NCT03978520|448979337|FG004|Overall Study|Other, not specified|2|||
124823176|NCT03978520|448979333|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
124823177|NCT03978520|448979334|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
124823178|NCT03978520|448979335|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
124823179|NCT03978520|448979336|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
124823180|NCT03978520|448979337|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
124823181|NCT00230607|448979338|FG000|Overall Study|Other|3|||
124823182|NCT02547454|448979344|FG000|Overall Study|Due to hemodialysis|53|||
124823183|NCT02547454|448979344|FG000|Overall Study|Due to transplantation|1|||
124823184|NCT02547454|448979344|FG000|Overall Study|Due to no further need to treat|4|||
124823185|NCT02547454|448979344|FG000|Overall Study|Death|38|||
124823186|NCT02547454|448979344|FG000|Overall Study|Lost to Follow-up|26|||
124823187|NCT02547454|448979344|FG000|Overall Study|Other|39|||
124823188|NCT02547454|448979344|FG000|Overall Study|No data|11|||
124823189|NCT04557371|448979347|FG000|Overall Study|Covid-19-related|0|||
124823190|NCT04557371|448979348|FG001|Overall Study|Covid-19-related|1|||
124823191|NCT04557371|448979349|FG002|Overall Study|Covid-19-related|0|||
124823192|NCT04557371|448979347|FG000|Overall Study|Withdrawal by Subject|0|||
124823193|NCT04557371|448979348|FG001|Overall Study|Withdrawal by Subject|1|||
124823194|NCT04557371|448979349|FG002|Overall Study|Withdrawal by Subject|0|||
124823195|NCT04557371|448979347|FG000|Overall Study|Adverse Event|1|||
124823196|NCT04557371|448979348|FG001|Overall Study|Adverse Event|0|||
124823197|NCT04557371|448979349|FG002|Overall Study|Adverse Event|0|||
124823198|NCT03694821|448979350|FG000|Overall Study|Study terminated|4|||
124823199|NCT03694821|448979351|FG001|Overall Study|Study terminated|8|||
124823200|NCT03694821|448979352|FG002|Overall Study|Study terminated|4|||
124823201|NCT00203996|448979353|FG000|Overall Study|Lost to Follow-up|0|||
124823202|NCT00203996|448979354|FG001|Overall Study|Lost to Follow-up|0|||
124823203|NCT00203996|448979355|FG002|Overall Study|Lost to Follow-up|0|||
124823204|NCT00203996|448979356|FG003|Overall Study|Lost to Follow-up|1|||
124823205|NCT00203996|448979357|FG004|Overall Study|Lost to Follow-up|0|||
124823206|NCT00203996|448979358|FG005|Overall Study|Lost to Follow-up|0|||
124823207|NCT00203996|448979359|FG006|Overall Study|Lost to Follow-up|0|||
124823208|NCT00203996|448979360|FG007|Overall Study|Lost to Follow-up|0|||
124823209|NCT00203996|448979361|FG008|Overall Study|Lost to Follow-up|0|||
124823210|NCT00203996|448979362|FG009|Overall Study|Lost to Follow-up|0|||
124823211|NCT00203996|448979353|FG000|Overall Study|Protocol Violation|0|||
124823212|NCT00203996|448979354|FG001|Overall Study|Protocol Violation|0|||
124823213|NCT00203996|448979355|FG002|Overall Study|Protocol Violation|0|||
124823214|NCT00203996|448979356|FG003|Overall Study|Protocol Violation|6|||
124823215|NCT00203996|448979357|FG004|Overall Study|Protocol Violation|1|||
124823216|NCT00203996|448979358|FG005|Overall Study|Protocol Violation|0|||
124823217|NCT00203996|448979359|FG006|Overall Study|Protocol Violation|0|||
124823218|NCT00203996|448979360|FG007|Overall Study|Protocol Violation|0|||
124823219|NCT00203996|448979361|FG008|Overall Study|Protocol Violation|0|||
124823220|NCT00203996|448979362|FG009|Overall Study|Protocol Violation|0|||
124823221|NCT00203996|448979353|FG000|Overall Study|Physician Decision|0|||
124823222|NCT00203996|448979354|FG001|Overall Study|Physician Decision|0|||
124823223|NCT00203996|448979355|FG002|Overall Study|Physician Decision|0|||
124823224|NCT00203996|448979356|FG003|Overall Study|Physician Decision|2|||
124823225|NCT00203996|448979357|FG004|Overall Study|Physician Decision|0|||
124823226|NCT00203996|448979358|FG005|Overall Study|Physician Decision|0|||
124823227|NCT00203996|448979359|FG006|Overall Study|Physician Decision|0|||
124823228|NCT00203996|448979360|FG007|Overall Study|Physician Decision|0|||
124823229|NCT00203996|448979361|FG008|Overall Study|Physician Decision|0|||
124823230|NCT00203996|448979362|FG009|Overall Study|Physician Decision|1|||
124823231|NCT00203996|448979353|FG000|Overall Study|CPAP machine malfunction|0|||
124823232|NCT00203996|448979354|FG001|Overall Study|CPAP machine malfunction|0|||
125303358|NCT03657095|450736722|FG000|Overall Study|Adverse Event|0|||
124823233|NCT00203996|448979355|FG002|Overall Study|CPAP machine malfunction|0|||
124823234|NCT00203996|448979356|FG003|Overall Study|CPAP machine malfunction|1|||
124823235|NCT00203996|448979357|FG004|Overall Study|CPAP machine malfunction|0|||
124823236|NCT00203996|448979358|FG005|Overall Study|CPAP machine malfunction|0|||
124823237|NCT00203996|448979359|FG006|Overall Study|CPAP machine malfunction|0|||
124823238|NCT00203996|448979360|FG007|Overall Study|CPAP machine malfunction|0|||
124823239|NCT00203996|448979361|FG008|Overall Study|CPAP machine malfunction|0|||
124823240|NCT00203996|448979362|FG009|Overall Study|CPAP machine malfunction|0|||
125303359|NCT03657095|450736723|FG001|Overall Study|Adverse Event|3|||
124823241|NCT00203996|448979353|FG000|Overall Study|Scheduling issue|0|||
124823242|NCT00203996|448979354|FG001|Overall Study|Scheduling issue|0|||
124823243|NCT00203996|448979355|FG002|Overall Study|Scheduling issue|0|||
124823244|NCT00203996|448979356|FG003|Overall Study|Scheduling issue|0|||
124823245|NCT00203996|448979357|FG004|Overall Study|Scheduling issue|0|||
124823246|NCT00203996|448979358|FG005|Overall Study|Scheduling issue|0|||
124823247|NCT00203996|448979359|FG006|Overall Study|Scheduling issue|0|||
124823248|NCT00203996|448979360|FG007|Overall Study|Scheduling issue|2|||
124823249|NCT00203996|448979361|FG008|Overall Study|Scheduling issue|0|||
124823250|NCT00203996|448979362|FG009|Overall Study|Scheduling issue|0|||
124823251|NCT03064451|448979363|FG000|Overall Study|Lost to Follow-up|1|||
124823252|NCT03064451|448979363|FG000|Overall Study|Mapping Failure|4|||
125303360|NCT03657095|450736722|FG000|Overall Study|Study Terminated by Sponsor|58|||
125303361|NCT03657095|450736723|FG001|Overall Study|Study Terminated by Sponsor|49|||
124823253|NCT03064451|448979363|FG000|Overall Study|Exited prior to procedure|8|||
124823254|NCT03064451|448979363|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
124823255|NCT02700815|448981023|FG000|Overall Study|Adverse Event|0|||
124823256|NCT02700815|448981024|FG001|Overall Study|Adverse Event|6|||
124823257|NCT02700815|448981025|FG002|Overall Study|Adverse Event|2|||
125303362|NCT00830180|450736724|FG000|Overall Study|Adverse Event|6|||
125303363|NCT00830180|450736724|FG000|Overall Study|Death|11|||
125303364|NCT00830180|450736724|FG000|Overall Study|Insufficient clinical response|1|||
125303365|NCT00830180|450736724|FG000|Overall Study|Withdrawal by Subject|5|||
125303366|NCT00830180|450736724|FG000|Overall Study|Progressive disease|2|||
124823258|NCT02700815|448981026|FG003|Overall Study|Adverse Event|3|||
124823259|NCT02700815|448981023|FG000|Overall Study|Lack of Efficacy|0|||
124823260|NCT02700815|448981024|FG001|Overall Study|Lack of Efficacy|0|||
124823261|NCT02700815|448981025|FG002|Overall Study|Lack of Efficacy|1|||
124823262|NCT02700815|448981026|FG003|Overall Study|Lack of Efficacy|2|||
124823263|NCT02700815|448981023|FG000|Overall Study|Lost to Follow-up|1|||
124823264|NCT02700815|448981024|FG001|Overall Study|Lost to Follow-up|0|||
124823265|NCT02700815|448981025|FG002|Overall Study|Lost to Follow-up|0|||
124823266|NCT02700815|448981026|FG003|Overall Study|Lost to Follow-up|1|||
124823267|NCT02700815|448981023|FG000|Overall Study|Refusal to continue medication|0|||
124823268|NCT02700815|448981024|FG001|Overall Study|Refusal to continue medication|1|||
124823269|NCT02700815|448981025|FG002|Overall Study|Refusal to continue medication|0|||
124823270|NCT02700815|448981026|FG003|Overall Study|Refusal to continue medication|1|||
124823271|NCT02700815|448981023|FG000|Overall Study|Withdrawal by Subject|0|||
124823272|NCT02700815|448981024|FG001|Overall Study|Withdrawal by Subject|0|||
124823273|NCT02700815|448981025|FG002|Overall Study|Withdrawal by Subject|1|||
124823274|NCT02700815|448981026|FG003|Overall Study|Withdrawal by Subject|0|||
124823275|NCT00524368|448981027|FG000|Overall Study|Adverse Event|10|||
124823276|NCT00524368|448981028|FG001|Overall Study|Adverse Event|12|||
124823277|NCT00524368|448981027|FG000|Overall Study|Lost to Follow-up|9|||
124823278|NCT00524368|448981028|FG001|Overall Study|Lost to Follow-up|13|||
124823279|NCT00524368|448981027|FG000|Overall Study|Withdrawal by Subject|4|||
124823280|NCT00524368|448981028|FG001|Overall Study|Withdrawal by Subject|5|||
124823281|NCT00524368|448981027|FG000|Overall Study|Non-compliant|8|||
124823282|NCT00524368|448981028|FG001|Overall Study|Non-compliant|9|||
124823283|NCT00524368|448981027|FG000|Overall Study|Reached a Virologic Endpoint|3|||
124823284|NCT00524368|448981028|FG001|Overall Study|Reached a Virologic Endpoint|2|||
124823285|NCT00524368|448981027|FG000|Overall Study|Sponsor's Decision|2|||
124823286|NCT00524368|448981028|FG001|Overall Study|Sponsor's Decision|0|||
124823287|NCT00524368|448981027|FG000|Overall Study|Ineligible to Continue the study|2|||
124823288|NCT00524368|448981028|FG001|Overall Study|Ineligible to Continue the study|5|||
124823289|NCT00524368|448981027|FG000|Overall Study|Other|3|||
124823290|NCT00524368|448981028|FG001|Overall Study|Other|2|||
124823291|NCT00531232|448981029|FG000|Overall Study|Investigator decision|0|||
124823292|NCT00531232|448981030|FG001|Overall Study|Investigator decision|0|||
124823293|NCT00531232|448981031|FG002|Overall Study|Investigator decision|4|||
124823294|NCT00531232|448981029|FG000|Overall Study|Participants refused further treatment|0|||
124823295|NCT00531232|448981030|FG001|Overall Study|Participants refused further treatment|1|||
124823296|NCT00531232|448981031|FG002|Overall Study|Participants refused further treatment|2|||
124823297|NCT00531232|448981029|FG000|Overall Study|Adverse events (AEs)|1|||
124823298|NCT00531232|448981030|FG001|Overall Study|Adverse events (AEs)|2|||
124823299|NCT00531232|448981031|FG002|Overall Study|Adverse events (AEs)|2|||
125303367|NCT00830180|450736724|FG000|Overall Study|Other - Unspecified|1|||
125303368|NCT01990612|450736725|FG000|Overall Study|Lost to Follow-up|2|||
125303369|NCT01990612|450736726|FG001|Overall Study|Lost to Follow-up|1|||
124823300|NCT00531232|448981029|FG000|Overall Study|Treatment failure|1|||
124823301|NCT00531232|448981030|FG001|Overall Study|Treatment failure|3|||
124823302|NCT00531232|448981031|FG002|Overall Study|Treatment failure|7|||
124823303|NCT00531232|448981029|FG000|Overall Study|Disease recurrence|0|||
124823304|NCT00531232|448981030|FG001|Overall Study|Disease recurrence|0|||
124823305|NCT00531232|448981031|FG002|Overall Study|Disease recurrence|1|||
124823306|NCT00531232|448981029|FG000|Overall Study|Deceased|2|||
124823307|NCT00531232|448981030|FG001|Overall Study|Deceased|2|||
124823308|NCT00531232|448981031|FG002|Overall Study|Deceased|2|||
124823309|NCT00531232|448981029|FG000|Overall Study|Withdrawal by Subject|0|||
124823310|NCT00531232|448981030|FG001|Overall Study|Withdrawal by Subject|1|||
124823311|NCT00531232|448981031|FG002|Overall Study|Withdrawal by Subject|2|||
125303370|NCT01990612|450736725|FG000|Overall Study|Withdrawal by Subject|5|||
125303371|NCT01990612|450736726|FG001|Overall Study|Withdrawal by Subject|2|||
124823312|NCT00531232|448981029|FG000|Overall Study|Other|0|||
124823313|NCT00531232|448981030|FG001|Overall Study|Other|0|||
124823314|NCT00531232|448981031|FG002|Overall Study|Other|5|||
124823315|NCT00609492|448981036|FG000|Overall Study|Withdrawal by Subject|0|||
124823316|NCT00609492|448981037|FG001|Overall Study|Withdrawal by Subject|2|||
124823317|NCT00609492|448981038|FG002|Overall Study|Withdrawal by Subject|3|||
124823318|NCT00609492|448981036|FG000|Overall Study|Lost to Follow-up|1|||
124823319|NCT00609492|448981037|FG001|Overall Study|Lost to Follow-up|1|||
124823320|NCT00609492|448981038|FG002|Overall Study|Lost to Follow-up|4|||
124823321|NCT00720434|448981039|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
124823322|NCT00720434|448981040|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
124823323|NCT00720434|448981041|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
124823324|NCT00720434|448981042|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
124823325|NCT00720434|448981039|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
124823326|NCT00720434|448981040|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
124823327|NCT00720434|448981041|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
124823328|NCT00720434|448981042|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
124823329|NCT00720434|448981039|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
124823330|NCT00720434|448981040|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
124823331|NCT00720434|448981041|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
124823332|NCT00720434|448981042|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
124823333|NCT00720434|448981039|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
124823334|NCT00720434|448981040|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
124823335|NCT00720434|448981041|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
124823336|NCT00720434|448981042|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
124823337|NCT00720434|448981039|FG000|Open-Label Period (Week 5-72)|Other|4|||
124823338|NCT00720434|448981040|FG001|Open-Label Period (Week 5-72)|Other|3|||
124823339|NCT00720434|448981041|FG002|Open-Label Period (Week 5-72)|Other|3|||
124823340|NCT00720434|448981042|FG003|Open-Label Period (Week 5-72)|Other|2|||
124823341|NCT02057406|448981043|FG000|Overall Study|Physician Decision|0|||
124823342|NCT02057406|448981044|FG001|Overall Study|Physician Decision|0|||
124823343|NCT02057406|448981045|FG002|Overall Study|Physician Decision|2|||
124823344|NCT02057406|448981043|FG000|Overall Study|Withdrawal by Subject|0|||
124823345|NCT02057406|448981044|FG001|Overall Study|Withdrawal by Subject|2|||
124823346|NCT02057406|448981045|FG002|Overall Study|Withdrawal by Subject|0|||
124823347|NCT02057406|448981043|FG000|Overall Study|Lost to Follow-up|0|||
124823348|NCT02057406|448981044|FG001|Overall Study|Lost to Follow-up|0|||
124823349|NCT02057406|448981045|FG002|Overall Study|Lost to Follow-up|1|||
124823350|NCT02057406|448981043|FG000|Overall Study|Death|1|||
124823351|NCT02057406|448981044|FG001|Overall Study|Death|0|||
124823352|NCT02057406|448981045|FG002|Overall Study|Death|0|||
124823353|NCT02057406|448981043|FG000|Overall Study|Protocol Violation|0|||
124823354|NCT02057406|448981044|FG001|Overall Study|Protocol Violation|1|||
124823355|NCT02057406|448981045|FG002|Overall Study|Protocol Violation|0|||
124823356|NCT02057406|448981043|FG000|Overall Study|Patient transportation issues|0|||
124823357|NCT02057406|448981044|FG001|Overall Study|Patient transportation issues|0|||
124823358|NCT02057406|448981045|FG002|Overall Study|Patient transportation issues|1|||
124823359|NCT03138889|448981048|FG000|Overall Study|Withdrawal by Subject|5|||
124823360|NCT03138889|448981049|FG001|Overall Study|Withdrawal by Subject|5|||
124823361|NCT03138889|448981050|FG002|Overall Study|Withdrawal by Subject|0|||
124823362|NCT03138889|448981051|FG003|Overall Study|Withdrawal by Subject|2|||
124823363|NCT03138889|448981052|FG004|Overall Study|Withdrawal by Subject|1|||
124823364|NCT03138889|448981053|FG005|Overall Study|Withdrawal by Subject|3|||
124823365|NCT03138889|448981054|FG006|Overall Study|Withdrawal by Subject|0|||
124823366|NCT03138889|448981055|FG007|Overall Study|Withdrawal by Subject|1|||
124823367|NCT00865124|448981058|FG000|Overall Study|Physician Decision|2|||
124823368|NCT00865124|448981059|FG001|Overall Study|Physician Decision|1|||
124823369|NCT00865124|448981060|FG002|Overall Study|Physician Decision|0|||
124823370|NCT00865124|448981058|FG000|Overall Study|Withdrawn consent|2|||
124823371|NCT00865124|448981059|FG001|Overall Study|Withdrawn consent|0|||
124823372|NCT00865124|448981060|FG002|Overall Study|Withdrawn consent|0|||
124823373|NCT03247530|448981061|FG000|Overall Study|Withdrawal by caregiver|19|||
124823374|NCT03247530|448981062|FG001|Overall Study|Withdrawal by caregiver|8|||
124823375|NCT03247530|448981063|FG002|Overall Study|Withdrawal by caregiver|10|||
124823376|NCT03247530|448981061|FG000|Overall Study|Lost to Follow-up|3|||
124823377|NCT03247530|448981062|FG001|Overall Study|Lost to Follow-up|9|||
124823378|NCT03247530|448981063|FG002|Overall Study|Lost to Follow-up|6|||
124823379|NCT03247530|448981061|FG000|Overall Study|Adverse Event|2|||
124823380|NCT03247530|448981062|FG001|Overall Study|Adverse Event|5|||
124823381|NCT03247530|448981063|FG002|Overall Study|Adverse Event|2|||
124823382|NCT03247530|448981061|FG000|Overall Study|Failure to follow procedure|1|||
124823383|NCT03247530|448981062|FG001|Overall Study|Failure to follow procedure|1|||
124823384|NCT03247530|448981063|FG002|Overall Study|Failure to follow procedure|1|||
124823385|NCT03247530|448981061|FG000|Overall Study|Withdrawal by Subject|1|||
124823386|NCT03247530|448981062|FG001|Overall Study|Withdrawal by Subject|1|||
124823387|NCT03247530|448981063|FG002|Overall Study|Withdrawal by Subject|0|||
124823388|NCT03247530|448981061|FG000|Overall Study|Study medication misuse|0|||
124823389|NCT03247530|448981062|FG001|Overall Study|Study medication misuse|1|||
124823390|NCT03247530|448981063|FG002|Overall Study|Study medication misuse|0|||
124823391|NCT03247530|448981061|FG000|Overall Study|Other, multiple categories|1|||
124823392|NCT03247530|448981062|FG001|Overall Study|Other, multiple categories|3|||
124823393|NCT03247530|448981063|FG002|Overall Study|Other, multiple categories|1|||
124823394|NCT03454893|448981065|FG000|Overall Study|Study Terminated by the Sponsor|5|||
124823395|NCT03454893|448981065|FG000|Overall Study|Did not pass screening|4|||
124823396|NCT01986985|448981070|FG000|Overall Study|Withdrawal by Subject|4|||
124823397|NCT01986985|448981070|FG000|Overall Study|Scan not completed due to malfunction|3|||
124823398|NCT03042533|448981071|FG000|Overall Study|MD left program|1|||
124823399|NCT03042533|448981072|FG001|Overall Study|MD left program|4|||
124823400|NCT03042533|448981073|FG002|Overall Study|MD left program|1|||
124823401|NCT02288559|448981075|FG000|Overall Study|Adverse Event|1|||
124823402|NCT02288559|448981076|FG001|Overall Study|Adverse Event|1|||
124823403|NCT02288559|448981077|FG002|Overall Study|Adverse Event|5|||
124823404|NCT02288559|448981078|FG003|Overall Study|Adverse Event|0|||
124823405|NCT02288559|448981075|FG000|Overall Study|Death|0|||
124823406|NCT02288559|448981076|FG001|Overall Study|Death|0|||
124823407|NCT02288559|448981077|FG002|Overall Study|Death|1|||
124823408|NCT02288559|448981078|FG003|Overall Study|Death|0|||
124823409|NCT02288559|448981075|FG000|Overall Study|Lost to Follow-up|0|||
124823410|NCT02288559|448981076|FG001|Overall Study|Lost to Follow-up|0|||
124823411|NCT02288559|448981077|FG002|Overall Study|Lost to Follow-up|0|||
124823412|NCT02288559|448981078|FG003|Overall Study|Lost to Follow-up|1|||
124823413|NCT02288559|448981075|FG000|Overall Study|Withdrawal by Subject|0|||
124823414|NCT02288559|448981076|FG001|Overall Study|Withdrawal by Subject|0|||
124823415|NCT02288559|448981077|FG002|Overall Study|Withdrawal by Subject|2|||
124823416|NCT02288559|448981078|FG003|Overall Study|Withdrawal by Subject|1|||
124823417|NCT02288559|448981075|FG000|Overall Study|Reason Not Specified|0|||
124823418|NCT02288559|448981076|FG001|Overall Study|Reason Not Specified|0|||
124823419|NCT02288559|448981077|FG002|Overall Study|Reason Not Specified|3|||
124823420|NCT02288559|448981078|FG003|Overall Study|Reason Not Specified|0|||
124823421|NCT03303079|448981079|FG000|Overall Study|Adverse Event|0|||
124823422|NCT03303079|448981080|FG001|Overall Study|Adverse Event|1|||
124823423|NCT03303079|448981081|FG002|Overall Study|Adverse Event|3|||
124823424|NCT03303079|448981079|FG000|Overall Study|Protocol Violation|5|||
124823425|NCT03303079|448981080|FG001|Overall Study|Protocol Violation|4|||
124823426|NCT03303079|448981081|FG002|Overall Study|Protocol Violation|7|||
124823427|NCT03303079|448981079|FG000|Overall Study|Withdrawal by Subject|2|||
124823428|NCT03303079|448981080|FG001|Overall Study|Withdrawal by Subject|4|||
124823429|NCT03303079|448981081|FG002|Overall Study|Withdrawal by Subject|2|||
124823430|NCT03303079|448981079|FG000|Overall Study|Other than specified|0|||
124823431|NCT03303079|448981080|FG001|Overall Study|Other than specified|2|||
124823432|NCT03303079|448981081|FG002|Overall Study|Other than specified|0|||
124823433|NCT02005445|448981082|FG000|Overall Study|Dual study enrollment|0|||
124823434|NCT02005445|448981083|FG001|Overall Study|Dual study enrollment|1|||
124823435|NCT00449540|448981085|FG000|Pretreatment Phase|No migraine experienced|66|||
124823436|NCT00449540|448981086|FG001|Pretreatment Phase|No migraine experienced|0|||
124823437|NCT00449540|448981087|FG002|Pretreatment Phase|No migraine experienced|0|||
124823438|NCT00449540|448981085|FG000|Treatment Phase|did not experience or treat migraine|0|||
124823439|NCT00449540|448981086|FG001|Treatment Phase|did not experience or treat migraine|20|||
124823440|NCT00449540|448981087|FG002|Treatment Phase|did not experience or treat migraine|17|||
124823441|NCT02709785|448981088|FG000|Overall Study|Withdrawal by Subject|1|||
124823442|NCT02709785|448981089|FG001|Overall Study|Withdrawal by Subject|2|||
124823443|NCT02709785|448981090|FG002|Overall Study|Withdrawal by Subject|1|||
124823444|NCT01961323|448981091|FG000|Overall Study|Withdrawal by Subject|7|||
124823445|NCT01961323|448981091|FG000|Overall Study|Lost to Follow-up|8|||
124823446|NCT01961323|448981091|FG000|Overall Study|screen failure|34|||
125303372|NCT01068158|450736734|FG000|Overall Study|Withdrawal by Subject|1|||
124823447|NCT02746874|448981094|FG000|Overall Study|Withdrawal by Subject|0|||
124823448|NCT02746874|448981095|FG001|Overall Study|Withdrawal by Subject|1|||
124823449|NCT02746874|448981094|FG000|Overall Study|Surgery Date Changed|0|||
124823450|NCT02746874|448981095|FG001|Overall Study|Surgery Date Changed|2|||
124823451|NCT02320149|448981098|FG000|Overall Study|Adverse Event|3|||
124823452|NCT02320149|448981099|FG001|Overall Study|Adverse Event|7|||
124823453|NCT02320149|448981098|FG000|Overall Study|Withdrawal of Consent|28|||
124823454|NCT02320149|448981099|FG001|Overall Study|Withdrawal of Consent|32|||
124823455|NCT02320149|448981098|FG000|Overall Study|Lost to Follow-up|21|||
125303373|NCT01068158|450736735|FG001|Overall Study|Withdrawal by Subject|2|||
124823456|NCT02320149|448981099|FG001|Overall Study|Lost to Follow-up|34|||
124823457|NCT02320149|448981098|FG000|Overall Study|Protocol Violation|2|||
124823458|NCT02320149|448981099|FG001|Overall Study|Protocol Violation|1|||
124823459|NCT02320149|448981098|FG000|Overall Study|Noncompliance with Study Treatment|7|||
124823460|NCT02320149|448981099|FG001|Overall Study|Noncompliance with Study Treatment|2|||
124823461|NCT02320149|448981098|FG000|Overall Study|Lack of Efficacy|0|||
125303374|NCT01068158|450736734|FG000|Overall Study|Lost to Follow-up|7|||
125303375|NCT01068158|450736735|FG001|Overall Study|Lost to Follow-up|0|||
124823462|NCT02320149|448981099|FG001|Overall Study|Lack of Efficacy|1|||
124823463|NCT02320149|448981098|FG000|Overall Study|Other Miscellaneous Reasons|2|||
124823464|NCT02320149|448981099|FG001|Overall Study|Other Miscellaneous Reasons|3|||
124823465|NCT01156311|448981103|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
124823466|NCT01156311|448981104|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
124823467|NCT01156311|448981105|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
124823468|NCT01156311|448981106|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
124823469|NCT01156311|448981103|FG000|2-Month Monotherapy Period|Physician Decision|0|||
124823470|NCT01156311|448981104|FG001|2-Month Monotherapy Period|Physician Decision|1|||
124823471|NCT01156311|448981105|FG002|2-Month Monotherapy Period|Physician Decision|0|||
124823472|NCT01156311|448981106|FG003|2-Month Monotherapy Period|Physician Decision|0|||
124823473|NCT01156311|448981103|FG000|2-Month Monotherapy Period|Other|1|||
124823474|NCT01156311|448981104|FG001|2-Month Monotherapy Period|Other|0|||
124823475|NCT01156311|448981105|FG002|2-Month Monotherapy Period|Other|0|||
124823476|NCT01156311|448981106|FG003|2-Month Monotherapy Period|Other|0|||
124823477|NCT01156311|448981103|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
124823478|NCT01156311|448981104|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
124823479|NCT01156311|448981105|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
124823480|NCT01156311|448981106|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
124823481|NCT01156311|448981103|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
124823482|NCT01156311|448981104|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
124823483|NCT01156311|448981105|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
124823484|NCT01156311|448981106|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
124823485|NCT01156311|448981103|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
124823486|NCT01156311|448981104|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
124823487|NCT01156311|448981105|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
124823488|NCT01156311|448981106|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
124823489|NCT01156311|448981103|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
124823490|NCT01156311|448981104|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
124823491|NCT01156311|448981105|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
124823492|NCT01156311|448981106|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
124823493|NCT01156311|448981103|FG000|6-month Add-on Therapy Period|Other|0|||
124823494|NCT01156311|448981104|FG001|6-month Add-on Therapy Period|Other|0|||
124823495|NCT01156311|448981105|FG002|6-month Add-on Therapy Period|Other|1|||
124823496|NCT01156311|448981106|FG003|6-month Add-on Therapy Period|Other|2|||
124823497|NCT01741701|448981107|FG000|Overall Study|Adverse Event|5|||
124823498|NCT01741701|448981108|FG001|Overall Study|Adverse Event|1|||
124823499|NCT01741701|448981107|FG000|Overall Study|Withdrawal by Subject|0|||
124823500|NCT01741701|448981108|FG001|Overall Study|Withdrawal by Subject|1|||
124823501|NCT00487747|448981109|FG000|Overall Study|Adverse Event|1|||
124823502|NCT00487747|448981109|FG000|Overall Study|Lost to Follow-up|9|||
124823503|NCT00487747|448981109|FG000|Overall Study|Lack of Efficacy|1|||
124823504|NCT00372112|448981114|FG000|Overall Study|Adverse Event|0|||
124823505|NCT00372112|448981115|FG001|Overall Study|Adverse Event|1|||
124823506|NCT00372112|448981116|FG002|Overall Study|Adverse Event|1|||
124823507|NCT00372112|448981117|FG003|Overall Study|Adverse Event|1|||
124823508|NCT00372112|448981114|FG000|Overall Study|Withdrawal by Subject|0|||
124823509|NCT00372112|448981115|FG001|Overall Study|Withdrawal by Subject|0|||
124823510|NCT00372112|448981116|FG002|Overall Study|Withdrawal by Subject|2|||
124823511|NCT00372112|448981117|FG003|Overall Study|Withdrawal by Subject|1|||
124823512|NCT00372112|448981114|FG000|Overall Study|Exacerbation|0|||
124823513|NCT00372112|448981115|FG001|Overall Study|Exacerbation|0|||
124823514|NCT00372112|448981116|FG002|Overall Study|Exacerbation|0|||
124823515|NCT00372112|448981117|FG003|Overall Study|Exacerbation|1|||
124823516|NCT00372112|448981114|FG000|Overall Study|PR >240 at Visit 3|0|||
124823517|NCT00372112|448981115|FG001|Overall Study|PR >240 at Visit 3|0|||
124823518|NCT00372112|448981116|FG002|Overall Study|PR >240 at Visit 3|0|||
124823519|NCT00372112|448981117|FG003|Overall Study|PR >240 at Visit 3|1|||
124823520|NCT00372112|448981114|FG000|Overall Study|Hepatitis B|1|||
124823521|NCT00372112|448981115|FG001|Overall Study|Hepatitis B|0|||
124823522|NCT00372112|448981116|FG002|Overall Study|Hepatitis B|0|||
125303376|NCT01068158|450736734|FG000|Overall Study|Protocol Violation|0|||
124823523|NCT00372112|448981117|FG003|Overall Study|Hepatitis B|0|||
124823524|NCT00372112|448981114|FG000|Overall Study|Other-protocol violation|0|||
124823525|NCT00372112|448981115|FG001|Overall Study|Other-protocol violation|0|||
124823526|NCT00372112|448981116|FG002|Overall Study|Other-protocol violation|1|||
124823527|NCT00372112|448981117|FG003|Overall Study|Other-protocol violation|0|||
124823528|NCT04649060|448981132|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
124823529|NCT04649060|448981133|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
124823530|NCT04649060|448981132|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
124823531|NCT04649060|448981133|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
124823532|NCT04649060|448981132|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
124823533|NCT04649060|448981133|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
124823534|NCT04649060|448981132|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
124823535|NCT04649060|448981133|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
124823536|NCT04649060|448981132|FG000|Arm A/Arm B Treatment|Patient Request|1|||
124823537|NCT04649060|448981133|FG001|Arm A/Arm B Treatment|Patient Request|0|||
124823538|NCT04649060|448981132|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
124823539|NCT04649060|448981133|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
124823540|NCT04649060|448981132|FG000|Arm A/Arm B Treatment|Other|1|||
124823541|NCT04649060|448981133|FG001|Arm A/Arm B Treatment|Other|0|||
124823542|NCT04649060|448981132|FG000|Crossover (Arm B)|Adverse Event|0|||
124823543|NCT04649060|448981133|FG001|Crossover (Arm B)|Adverse Event|1|||
124823544|NCT04649060|448981132|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
124823545|NCT04649060|448981133|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
124823546|NCT01830972|448981134|FG000|Part II|Withdrawal by Subject|2|||
124823547|NCT01830972|448981135|FG001|Part II|Withdrawal by Subject|2|||
124823548|NCT01830972|448981134|FG000|Part III|Withdrawal by Subject|1|||
124823549|NCT01830972|448981135|FG001|Part III|Withdrawal by Subject|0|||
124823550|NCT01830972|448981134|FG000|Part III|Noncompliance|1|||
124823551|NCT01830972|448981135|FG001|Part III|Noncompliance|0|||
124823552|NCT01830972|448981134|FG000|Part IV|Withdrawal by Subject|2|||
124823553|NCT01830972|448981135|FG001|Part IV|Withdrawal by Subject|1|||
124823554|NCT01830972|448981134|FG000|Part IV|Non-Compliance|1|||
124823555|NCT01830972|448981135|FG001|Part IV|Non-Compliance|0|||
124823556|NCT01907815|448981138|FG000|Overall Study|Withdrawal by Subject|1|||
124823557|NCT01907815|448981139|FG001|Overall Study|Withdrawal by Subject|0|||
124823558|NCT02205814|448981140|FG000|Overall Study|Lost to Follow-up|0|||
124823559|NCT02205814|448981141|FG001|Overall Study|Lost to Follow-up|0|||
124823560|NCT02205814|448981142|FG002|Overall Study|Lost to Follow-up|0|||
124823561|NCT02205814|448981143|FG003|Overall Study|Lost to Follow-up|1|||
124823562|NCT02205814|448981140|FG000|Overall Study|Lack of Efficacy|1|||
124823563|NCT02205814|448981141|FG001|Overall Study|Lack of Efficacy|0|||
124823564|NCT02205814|448981142|FG002|Overall Study|Lack of Efficacy|1|||
124823565|NCT02205814|448981143|FG003|Overall Study|Lack of Efficacy|1|||
124823566|NCT02205814|448981140|FG000|Overall Study|Physician Decision|0|||
124823567|NCT02205814|448981141|FG001|Overall Study|Physician Decision|0|||
124823568|NCT02205814|448981142|FG002|Overall Study|Physician Decision|1|||
124823569|NCT02205814|448981143|FG003|Overall Study|Physician Decision|0|||
124823570|NCT02205814|448981140|FG000|Overall Study|Protocol Violation|1|||
124823571|NCT02205814|448981141|FG001|Overall Study|Protocol Violation|0|||
124823572|NCT02205814|448981142|FG002|Overall Study|Protocol Violation|0|||
124823573|NCT02205814|448981143|FG003|Overall Study|Protocol Violation|1|||
124823574|NCT02205814|448981140|FG000|Overall Study|Withdrawal by Subject|0|||
124823575|NCT02205814|448981141|FG001|Overall Study|Withdrawal by Subject|1|||
124823576|NCT02205814|448981142|FG002|Overall Study|Withdrawal by Subject|2|||
124823577|NCT02205814|448981143|FG003|Overall Study|Withdrawal by Subject|1|||
124823578|NCT02205814|448981140|FG000|Overall Study|not compliant with study procedures|0|||
124823579|NCT02205814|448981141|FG001|Overall Study|not compliant with study procedures|0|||
124823580|NCT02205814|448981142|FG002|Overall Study|not compliant with study procedures|1|||
124823581|NCT02205814|448981143|FG003|Overall Study|not compliant with study procedures|0|||
124823582|NCT01426373|448981144|FG000|Overall Study|Adverse Event|6|||
124823583|NCT01426373|448981144|FG000|Overall Study|Lost to Follow-up|14|||
124823584|NCT01426373|448981144|FG000|Overall Study|Participant Convenience|10|||
124823585|NCT01426373|448981144|FG000|Overall Study|Miscellaneous Reasons|4|||
124823586|NCT04952402|448981145|FG000|Overall Study|Lost to Follow-up|1|||
124823587|NCT04952402|448981146|FG001|Overall Study|Lost to Follow-up|3|||
124823588|NCT04952402|448981145|FG000|Overall Study|Lack Of Venous Access|0|||
124823589|NCT04952402|448981146|FG001|Overall Study|Lack Of Venous Access|1|||
124823590|NCT01018186|448981150|FG000|2-week Run-in Period|Protocol Violation|1|||
124823591|NCT01018186|448981151|FG001|2-week Run-in Period|Protocol Violation|0|||
124823592|NCT01018186|448981152|FG002|2-week Run-in Period|Protocol Violation|0|||
124823593|NCT01018186|448981153|FG003|2-week Run-in Period|Protocol Violation|0|||
124823594|NCT01018186|448981150|FG000|2-week Run-in Period|Lost to Follow-up|2|||
124823595|NCT01018186|448981151|FG001|2-week Run-in Period|Lost to Follow-up|0|||
124823596|NCT01018186|448981152|FG002|2-week Run-in Period|Lost to Follow-up|0|||
124823597|NCT01018186|448981153|FG003|2-week Run-in Period|Lost to Follow-up|0|||
124823598|NCT01018186|448981150|FG000|2-week Run-in Period|Physician Decision|3|||
124823599|NCT01018186|448981151|FG001|2-week Run-in Period|Physician Decision|0|||
124823600|NCT01018186|448981152|FG002|2-week Run-in Period|Physician Decision|0|||
124823601|NCT01018186|448981153|FG003|2-week Run-in Period|Physician Decision|0|||
124823602|NCT01018186|448981150|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
124823603|NCT01018186|448981151|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
124823604|NCT01018186|448981152|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
124823605|NCT01018186|448981153|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
124823606|NCT01018186|448981150|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
124823607|NCT01018186|448981151|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
124823608|NCT01018186|448981152|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
124823609|NCT01018186|448981153|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
124823610|NCT01018186|448981150|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
124823611|NCT01018186|448981151|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
124823612|NCT01018186|448981152|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
124823613|NCT01018186|448981153|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
124823614|NCT01018186|448981150|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
124823615|NCT01018186|448981151|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
124823616|NCT01018186|448981152|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
124823617|NCT01018186|448981153|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
124823618|NCT01018186|448981150|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
124823619|NCT01018186|448981151|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
124823620|NCT01018186|448981152|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
124823621|NCT01018186|448981153|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
124823622|NCT01018186|448981150|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
124823623|NCT01018186|448981151|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
124823624|NCT01018186|448981152|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
124823625|NCT01018186|448981153|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
124823626|NCT01018186|448981150|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
124823627|NCT01018186|448981151|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
124823628|NCT01018186|448981152|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
124823629|NCT01018186|448981153|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
124823630|NCT01018186|448981150|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
124823631|NCT01018186|448981151|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
124823632|NCT01018186|448981152|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
124823633|NCT01018186|448981153|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
124823634|NCT01018186|448981150|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
124823635|NCT01018186|448981151|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
124823636|NCT01018186|448981152|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
124823637|NCT01018186|448981153|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
124823638|NCT03049280|448981154|FG000|Overall Study|Physician Decision|1|||
124823639|NCT03552198|448981155|FG000|Overall Study|Lost to Follow-up|42|||
124823640|NCT03552198|448981156|FG001|Overall Study|Lost to Follow-up|48|||
124823641|NCT03552198|448981157|FG002|Overall Study|Lost to Follow-up|15|||
124823642|NCT03552198|448981158|FG003|Overall Study|Lost to Follow-up|19|||
124823643|NCT03552198|448981155|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
124823644|NCT03552198|448981156|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
124823645|NCT03552198|448981157|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
124823646|NCT03552198|448981158|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
124823647|NCT03552198|448981155|FG000|Overall Study|Did not receive air alerts|1|||
124823648|NCT03552198|448981156|FG001|Overall Study|Did not receive air alerts|0|||
124823649|NCT03552198|448981157|FG002|Overall Study|Did not receive air alerts|0|||
124823650|NCT03552198|448981158|FG003|Overall Study|Did not receive air alerts|1|||
124823651|NCT02326025|448981161|FG000|Overall Study|Adverse Event|3|||
124823652|NCT02326025|448981162|FG001|Overall Study|Adverse Event|0|||
124823653|NCT02326025|448981161|FG000|Overall Study|Physician Decision|1|||
124823654|NCT02326025|448981162|FG001|Overall Study|Physician Decision|2|||
124823655|NCT02326025|448981161|FG000|Overall Study|Physician and Participant Decision|1|||
124823656|NCT02326025|448981162|FG001|Overall Study|Physician and Participant Decision|0|||
124823657|NCT02326025|448981161|FG000|Overall Study|Withdrawal by Subject|0|||
124823658|NCT02326025|448981162|FG001|Overall Study|Withdrawal by Subject|2|||
124823659|NCT02326025|448981161|FG000|Overall Study|Protocol Violation|0|||
124823660|NCT02326025|448981162|FG001|Overall Study|Protocol Violation|1|||
124823661|NCT00001723|448981163|FG000|Overall Study|Lack of Efficacy|6|||
124823662|NCT00001723|448981164|FG001|Overall Study|Lack of Efficacy|7|||
124823663|NCT00001723|448981163|FG000|Overall Study|Lack of family interest|4|||
124823664|NCT00001723|448981164|FG001|Overall Study|Lack of family interest|5|||
124823665|NCT00001723|448981163|FG000|Overall Study|Lost to Follow-up|2|||
124823666|NCT00001723|448981164|FG001|Overall Study|Lost to Follow-up|2|||
124823667|NCT00001723|448981163|FG000|Overall Study|medication intolerance|1|||
124823668|NCT00001723|448981164|FG001|Overall Study|medication intolerance|2|||
124823669|NCT02643082|448981165|FG000|Period 1|Adverse Event|1|||
124823670|NCT02643082|448981166|FG001|Period 1|Adverse Event|0|||
124823671|NCT01324999|448981167|FG000|Overall Study|Adverse Event|3|||
124823672|NCT01324999|448981167|FG000|Overall Study|Withdrawal by Subject|2|||
124823673|NCT02505867|448981170|FG000|Overall Study|Lack of Efficacy|6|||
124823674|NCT02505867|448981171|FG001|Overall Study|Lack of Efficacy|6|||
124823675|NCT01862874|448981172|FG000|Overall Study|Randomized not treated|1|||
124823676|NCT01862874|448981173|FG001|Overall Study|Randomized not treated|0|||
124823677|NCT01862874|448981172|FG000|Overall Study|Adverse Event|0|||
124823678|NCT01862874|448981173|FG001|Overall Study|Adverse Event|3|||
124823679|NCT01862874|448981172|FG000|Overall Study|Lost to Follow-up|26|||
125303377|NCT01068158|450736735|FG001|Overall Study|Protocol Violation|2|||
124823680|NCT01862874|448981173|FG001|Overall Study|Lost to Follow-up|29|||
124823681|NCT01862874|448981172|FG000|Overall Study|Physician Decision|5|||
125303378|NCT01300572|450736736|FG000|Overall Study|HAMA + post dosimetry|1|||
125303379|NCT00411632|450736738|FG000|Overall Study|Death|1|||
124823682|NCT01862874|448981173|FG001|Overall Study|Physician Decision|3|||
124823683|NCT01862874|448981172|FG000|Overall Study|Withdrawn by parent/guardian|1|||
124823684|NCT01862874|448981173|FG001|Overall Study|Withdrawn by parent/guardian|1|||
124823685|NCT01862874|448981172|FG000|Overall Study|Withdrawal by Subject|46|||
124823686|NCT01862874|448981173|FG001|Overall Study|Withdrawal by Subject|40|||
124823687|NCT01862874|448981172|FG000|Overall Study|Death|0|||
124823688|NCT01862874|448981173|FG001|Overall Study|Death|1|||
124823689|NCT01714635|448981176|FG000|Overall Study|Discontinued|1|||
124823690|NCT01714635|448981177|FG001|Overall Study|Discontinued|0|||
124823691|NCT01714635|448981178|FG002|Overall Study|Discontinued|2|||
124823692|NCT01714635|448981176|FG000|Overall Study|Missed 6-month exam|1|||
124823693|NCT01714635|448981177|FG001|Overall Study|Missed 6-month exam|0|||
124823694|NCT01714635|448981178|FG002|Overall Study|Missed 6-month exam|0|||
124823695|NCT02860169|448981179|FG000|Part A|Withdrawal by Subject|1|||
124823696|NCT02860169|448981179|FG000|Part A|Other (Screening failure)|6|||
124823697|NCT02860169|448981179|FG000|Part A|Other (Survey not completed)|3|||
124823698|NCT02860169|448981179|FG000|Part A|Other (did not completed consent)|1|||
124823699|NCT02860169|448981179|FG000|Part B|Other (Screening failure)|10|||
124823700|NCT02860169|448981179|FG000|Part B|Withdrawal by Subject|1|||
124823701|NCT02860169|448981179|FG000|Part C|Other (Screening failure)|1|||
124823702|NCT03667924|448981180|FG000|Baseline Completed|Lost to Follow-up|0|||
124823703|NCT03667924|448981181|FG001|Baseline Completed|Lost to Follow-up|2|||
124823704|NCT03667924|448981182|FG002|Baseline Completed|Lost to Follow-up|0|||
124823705|NCT03667924|448981180|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
124823706|NCT03667924|448981181|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
124823707|NCT03667924|448981182|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
124823708|NCT03667924|448981180|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
124823709|NCT03667924|448981181|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
124823710|NCT03667924|448981182|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
124823711|NCT03667924|448981180|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
124823712|NCT03667924|448981181|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
124823713|NCT03667924|448981182|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
124823714|NCT03667924|448981180|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
124823715|NCT03667924|448981181|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
124823716|NCT03667924|448981182|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
124823717|NCT03667924|448981180|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
124823718|NCT03667924|448981181|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
124823719|NCT03667924|448981182|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
124823720|NCT03667924|448981180|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
124823721|NCT03667924|448981181|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
124823722|NCT03667924|448981182|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
124823723|NCT01937559|448981187|FG000|Overall Study|Physician Decision|3|||
124823724|NCT01937559|448981188|FG001|Overall Study|Physician Decision|3|||
124823725|NCT01937559|448981189|FG002|Overall Study|Physician Decision|0|||
124823726|NCT01937559|448981187|FG000|Overall Study|Withdrawal by Subject|6|||
124823727|NCT01937559|448981188|FG001|Overall Study|Withdrawal by Subject|4|||
124823728|NCT01937559|448981189|FG002|Overall Study|Withdrawal by Subject|0|||
124823729|NCT01937559|448981187|FG000|Overall Study|screen fail|2|||
124823730|NCT01937559|448981188|FG001|Overall Study|screen fail|4|||
124823731|NCT01937559|448981189|FG002|Overall Study|screen fail|0|||
124823732|NCT04203238|448982961|FG000|Overall Study|Withdrawal by Subject|1|||
124823733|NCT04203238|448982962|FG001|Overall Study|Withdrawal by Subject|1|||
124823734|NCT04203238|448982961|FG000|Overall Study|Covid-19|3|||
124823735|NCT04203238|448982962|FG001|Overall Study|Covid-19|0|||
124823736|NCT00733408|448982963|FG000|Overall Study|Adverse Event|4|||
124823737|NCT01134783|448982965|FG000|Overall Study|Pregnancy|16|||
124823738|NCT01134783|448982966|FG001|Overall Study|Pregnancy|8|||
124823739|NCT01134783|448982965|FG000|Overall Study|Withdrawal by Subject|15|||
124823740|NCT01134783|448982966|FG001|Overall Study|Withdrawal by Subject|9|||
124823741|NCT01134783|448982965|FG000|Overall Study|Lost to Follow-up|5|||
124823742|NCT01134783|448982966|FG001|Overall Study|Lost to Follow-up|20|||
124823743|NCT04221009|448982967|FG000|Overall Study|Withdrawal by Subject|4|||
124823744|NCT04232124|448982968|FG000|Overall Study|Lost to Follow-up|3|||
124823745|NCT02392247|448982971|FG000|Overall Study|Withdrawal by Subject|1|||
124823746|NCT02392247|448982971|FG000|Overall Study|Surgery cancelled; no data|1|||
124823747|NCT01500629|448982980|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
124823748|NCT01500629|448982981|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
124823749|NCT00588848|448982982|FG000|Overall Study|Physician Decision|0|||
124823750|NCT00588848|448982983|FG001|Overall Study|Physician Decision|3|||
124823751|NCT00589914|448982984|FG000|Overall Study|Adverse Event|19|||
124823752|NCT00589914|448982985|FG001|Overall Study|Adverse Event|10|||
124823753|NCT00589914|448982984|FG000|Overall Study|Death|2|||
125303380|NCT01748825|450736753|FG000|Dose Escalation|Refused further treatment|2|||
124823754|NCT00589914|448982985|FG001|Overall Study|Death|0|||
124823755|NCT00589914|448982984|FG000|Overall Study|Lack of Efficacy|40|||
124823756|NCT00589914|448982985|FG001|Overall Study|Lack of Efficacy|43|||
124823757|NCT00589914|448982984|FG000|Overall Study|Lost to Follow-up|11|||
124823758|NCT00589914|448982985|FG001|Overall Study|Lost to Follow-up|18|||
124823759|NCT00589914|448982984|FG000|Overall Study|Pregnancy|1|||
124823760|NCT00589914|448982985|FG001|Overall Study|Pregnancy|0|||
124823761|NCT00589914|448982984|FG000|Overall Study|Withdrawal by Subject|55|||
124823762|NCT00589914|448982985|FG001|Overall Study|Withdrawal by Subject|49|||
124823763|NCT00589914|448982984|FG000|Overall Study|Other|22|||
124823764|NCT00589914|448982985|FG001|Overall Study|Other|17|||
124823765|NCT00531050|448982986|FG000|Part 1: Period 1|Adverse Event|0|||
124823766|NCT00531050|448982987|FG001|Part 1: Period 1|Adverse Event|1|||
124823767|NCT00531050|448982988|FG002|Part 1: Period 1|Adverse Event|0|||
124823768|NCT00531050|448982989|FG003|Part 1: Period 1|Adverse Event|0|||
124823769|NCT00531050|448982990|FG004|Part 1: Period 1|Adverse Event|0|||
124823770|NCT00531050|448982991|FG005|Part 1: Period 1|Adverse Event|0|||
124823771|NCT00531050|448982986|FG000|Part 1: Period 1|Protocol Deviation|0|||
124823772|NCT00531050|448982987|FG001|Part 1: Period 1|Protocol Deviation|0|||
124823773|NCT00531050|448982988|FG002|Part 1: Period 1|Protocol Deviation|0|||
124823774|NCT00531050|448982989|FG003|Part 1: Period 1|Protocol Deviation|1|||
124823775|NCT00531050|448982990|FG004|Part 1: Period 1|Protocol Deviation|0|||
124823776|NCT00531050|448982991|FG005|Part 1: Period 1|Protocol Deviation|0|||
124823777|NCT00531050|448982986|FG000|Part 1: Period 3|Adverse Event|1|||
124823778|NCT00531050|448982987|FG001|Part 1: Period 3|Adverse Event|0|||
124823779|NCT00531050|448982988|FG002|Part 1: Period 3|Adverse Event|0|||
124823780|NCT00531050|448982989|FG003|Part 1: Period 3|Adverse Event|0|||
124823781|NCT00531050|448982990|FG004|Part 1: Period 3|Adverse Event|0|||
124823782|NCT00531050|448982991|FG005|Part 1: Period 3|Adverse Event|0|||
124823783|NCT00531050|448982986|FG000|Part 2: Period 1|Adverse Event|0|||
124823784|NCT00531050|448982987|FG001|Part 2: Period 1|Adverse Event|0|||
124823785|NCT00531050|448982988|FG002|Part 2: Period 1|Adverse Event|0|||
124823786|NCT00531050|448982989|FG003|Part 2: Period 1|Adverse Event|0|||
124823787|NCT00531050|448982990|FG004|Part 2: Period 1|Adverse Event|0|||
124823788|NCT00531050|448982991|FG005|Part 2: Period 1|Adverse Event|1|||
124823789|NCT00531050|448982986|FG000|Part 2: Period 3|Abnormal test procedure|1|||
124823790|NCT00531050|448982987|FG001|Part 2: Period 3|Abnormal test procedure|0|||
124823791|NCT00531050|448982988|FG002|Part 2: Period 3|Abnormal test procedure|0|||
124823792|NCT00531050|448982989|FG003|Part 2: Period 3|Abnormal test procedure|0|||
124823793|NCT00531050|448982990|FG004|Part 2: Period 3|Abnormal test procedure|0|||
124823794|NCT00531050|448982991|FG005|Part 2: Period 3|Abnormal test procedure|1|||
124823795|NCT02233309|448982995|FG000|Overall Study|Physician Decision|5|||
124823796|NCT00799487|448983000|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
124823797|NCT00799487|448983001|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
124823798|NCT00799487|448983002|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
124823799|NCT00799487|448983000|FG000|Dose Adjustment Period|Adverse Event|2|||
124823800|NCT00799487|448983001|FG001|Dose Adjustment Period|Adverse Event|0|||
124823801|NCT00799487|448983002|FG002|Dose Adjustment Period|Adverse Event|0|||
124823802|NCT00799487|448983000|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
124823803|NCT00799487|448983001|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
124823804|NCT00799487|448983002|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
124823805|NCT00799487|448983000|FG000|Dose Adjustment Period|Investigator Discretion|2|||
124823806|NCT00799487|448983001|FG001|Dose Adjustment Period|Investigator Discretion|0|||
124823807|NCT00799487|448983002|FG002|Dose Adjustment Period|Investigator Discretion|0|||
124823808|NCT00799487|448983000|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
124823809|NCT00799487|448983001|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
124823810|NCT00799487|448983002|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
124823811|NCT00799487|448983000|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
124823812|NCT00799487|448983001|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
124823813|NCT00799487|448983002|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
124823814|NCT00799487|448983000|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
124823815|NCT00799487|448983001|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
124823816|NCT00799487|448983002|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
124823817|NCT00799487|448983000|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
124823818|NCT00799487|448983001|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
124823819|NCT00799487|448983002|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
124823820|NCT00799487|448983000|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
124823821|NCT00799487|448983001|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
124823822|NCT00799487|448983002|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
124823823|NCT00799487|448983000|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
124823824|NCT00799487|448983001|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
124823825|NCT00799487|448983002|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
124823826|NCT00799487|448983000|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
124823827|NCT00799487|448983001|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
124823828|NCT00799487|448983002|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
124823829|NCT00799487|448983000|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
124823830|NCT00799487|448983001|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
124823831|NCT00799487|448983002|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
124823832|NCT01402544|448983003|FG000|Overall Study|Withdrawal by Subject|6|||
124823833|NCT01828281|448983004|FG000|Overall Study|Withdrawal by Subject|1|||
124823834|NCT01828281|448983005|FG001|Overall Study|Withdrawal by Subject|0|||
124823835|NCT04876274|448983008|FG000|Overall Study|Lost to Follow-up|9|||
124823836|NCT04876274|448983009|FG001|Overall Study|Lost to Follow-up|12|||
124823837|NCT02051608|448983010|FG000|Part 1: Double Blind Treatment|Death|3|||
124823838|NCT02051608|448983011|FG001|Part 1: Double Blind Treatment|Death|3|||
124823839|NCT02051608|448983012|FG002|Part 1: Double Blind Treatment|Death|0|||
124823840|NCT02051608|448983013|FG003|Part 1: Double Blind Treatment|Death|0|||
124823841|NCT02051608|448983010|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
124823842|NCT02051608|448983011|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
124823843|NCT02051608|448983012|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
124823844|NCT02051608|448983013|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
124823845|NCT02051608|448983010|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
124823846|NCT02051608|448983011|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
124823847|NCT02051608|448983012|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
124823848|NCT02051608|448983013|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
124823849|NCT02051608|448983010|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
124823850|NCT02051608|448983011|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
124823851|NCT02051608|448983012|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
124823852|NCT02051608|448983013|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
124823853|NCT02051608|448983010|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
124823854|NCT02051608|448983011|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
124823855|NCT02051608|448983012|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
124823856|NCT02051608|448983013|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
124823857|NCT02051608|448983010|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
124823858|NCT02051608|448983011|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
124823859|NCT02051608|448983012|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
124823860|NCT02051608|448983013|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
124823861|NCT02051608|448983010|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
124823862|NCT02051608|448983011|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
124823863|NCT02051608|448983012|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
124823864|NCT02051608|448983013|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
124823865|NCT02051608|448983010|FG000|Part 1: Double Blind Treatment|Other|6|||
124823866|NCT02051608|448983011|FG001|Part 1: Double Blind Treatment|Other|3|||
124823867|NCT02051608|448983012|FG002|Part 1: Double Blind Treatment|Other|0|||
124823868|NCT02051608|448983013|FG003|Part 1: Double Blind Treatment|Other|0|||
124823869|NCT02051608|448983010|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
124823870|NCT02051608|448983011|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
124823871|NCT02051608|448983012|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
124823872|NCT02051608|448983013|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
124823873|NCT02051608|448983010|FG000|Part 2: Open-label Extension|Adverse Event|0|||
124823874|NCT02051608|448983011|FG001|Part 2: Open-label Extension|Adverse Event|0|||
124823875|NCT02051608|448983012|FG002|Part 2: Open-label Extension|Adverse Event|6|||
124823876|NCT02051608|448983013|FG003|Part 2: Open-label Extension|Adverse Event|8|||
124823877|NCT02051608|448983010|FG000|Part 2: Open-label Extension|Death|0|||
124823878|NCT02051608|448983011|FG001|Part 2: Open-label Extension|Death|0|||
124823879|NCT02051608|448983012|FG002|Part 2: Open-label Extension|Death|7|||
124823880|NCT02051608|448983013|FG003|Part 2: Open-label Extension|Death|4|||
124823881|NCT02051608|448983010|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
124823882|NCT02051608|448983011|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
124823883|NCT02051608|448983012|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
124823884|NCT02051608|448983013|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
124823885|NCT02051608|448983010|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
125303381|NCT01748825|450736754|FG001|Dose Escalation|Refused further treatment|2|||
125303382|NCT01748825|450736755|FG002|Dose Escalation|Refused further treatment|0|||
124823886|NCT02051608|448983011|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
124823887|NCT02051608|448983012|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
124823888|NCT02051608|448983013|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
124823889|NCT02051608|448983010|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
125303383|NCT01748825|450736756|FG003|Dose Escalation|Refused further treatment|0|||
125303384|NCT01748825|450736757|FG004|Dose Escalation|Refused further treatment|1|||
124823890|NCT02051608|448983011|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
124823891|NCT02051608|448983012|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
124823892|NCT02051608|448983013|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
124823893|NCT02051608|448983010|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
124823894|NCT02051608|448983011|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
124823895|NCT02051608|448983012|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
124823896|NCT02051608|448983013|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
124823897|NCT02051608|448983010|FG000|Part 2: Open-label Extension|Physician Decision|0|||
124823898|NCT02051608|448983011|FG001|Part 2: Open-label Extension|Physician Decision|0|||
124823899|NCT02051608|448983012|FG002|Part 2: Open-label Extension|Physician Decision|8|||
124823900|NCT02051608|448983013|FG003|Part 2: Open-label Extension|Physician Decision|5|||
124823901|NCT02051608|448983010|FG000|Part 2: Open-label Extension|Other|0|||
124823902|NCT02051608|448983011|FG001|Part 2: Open-label Extension|Other|0|||
124823903|NCT02051608|448983012|FG002|Part 2: Open-label Extension|Other|9|||
124823904|NCT02051608|448983013|FG003|Part 2: Open-label Extension|Other|9|||
124823905|NCT00142584|448983014|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
124823906|NCT00142584|448983015|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
124823907|NCT00142584|448983014|FG000|Overall Study|Withdrawal by Subject|30|||
124823908|NCT00142584|448983015|FG001|Overall Study|Withdrawal by Subject|16|||
124823909|NCT00142584|448983014|FG000|Overall Study|Lost to Follow-up|22|||
124823910|NCT00142584|448983015|FG001|Overall Study|Lost to Follow-up|12|||
124823911|NCT00142584|448983014|FG000|Overall Study|Adverse Event|14|||
124823912|NCT00142584|448983015|FG001|Overall Study|Adverse Event|5|||
124823913|NCT00142584|448983014|FG000|Overall Study|Protocol Violation|4|||
124823914|NCT00142584|448983015|FG001|Overall Study|Protocol Violation|7|||
124823915|NCT00142584|448983014|FG000|Overall Study|Treatment Failure|2|||
124823916|NCT00142584|448983015|FG001|Overall Study|Treatment Failure|0|||
124823917|NCT03070782|448983017|FG000|Overall Study|Adverse Event|3|||
124823918|NCT03070782|448983018|FG001|Overall Study|Adverse Event|0|||
124823919|NCT03070782|448983019|FG002|Overall Study|Adverse Event|3|||
124823920|NCT03070782|448983020|FG003|Overall Study|Adverse Event|1|||
124823921|NCT03070782|448983021|FG004|Overall Study|Adverse Event|6|||
124823922|NCT03070782|448983022|FG005|Overall Study|Adverse Event|2|||
124823923|NCT03070782|448983017|FG000|Overall Study|Withdrawal by Subject|2|||
124823924|NCT03070782|448983018|FG001|Overall Study|Withdrawal by Subject|1|||
124823925|NCT03070782|448983019|FG002|Overall Study|Withdrawal by Subject|1|||
124823926|NCT03070782|448983020|FG003|Overall Study|Withdrawal by Subject|0|||
124823927|NCT03070782|448983021|FG004|Overall Study|Withdrawal by Subject|4|||
124823928|NCT03070782|448983022|FG005|Overall Study|Withdrawal by Subject|3|||
124823929|NCT03070782|448983017|FG000|Overall Study|Reason Not Specified|2|||
124823930|NCT03070782|448983018|FG001|Overall Study|Reason Not Specified|0|||
124823931|NCT03070782|448983019|FG002|Overall Study|Reason Not Specified|0|||
124823932|NCT03070782|448983020|FG003|Overall Study|Reason Not Specified|1|||
124823933|NCT03070782|448983021|FG004|Overall Study|Reason Not Specified|2|||
124823934|NCT03070782|448983022|FG005|Overall Study|Reason Not Specified|1|||
124823935|NCT03070782|448983017|FG000|Overall Study|Ineligibility|0|||
124823936|NCT03070782|448983018|FG001|Overall Study|Ineligibility|0|||
124823937|NCT03070782|448983019|FG002|Overall Study|Ineligibility|0|||
124823938|NCT03070782|448983020|FG003|Overall Study|Ineligibility|1|||
124823939|NCT03070782|448983021|FG004|Overall Study|Ineligibility|0|||
124823940|NCT03070782|448983022|FG005|Overall Study|Ineligibility|1|||
124823941|NCT03070782|448983017|FG000|Overall Study|Pregnancy|0|||
124823942|NCT03070782|448983018|FG001|Overall Study|Pregnancy|0|||
124823943|NCT03070782|448983019|FG002|Overall Study|Pregnancy|0|||
124823944|NCT03070782|448983020|FG003|Overall Study|Pregnancy|1|||
124823945|NCT03070782|448983021|FG004|Overall Study|Pregnancy|0|||
124823946|NCT03070782|448983022|FG005|Overall Study|Pregnancy|0|||
124823947|NCT03070782|448983017|FG000|Overall Study|Investigator Judgement|0|||
124823948|NCT03070782|448983018|FG001|Overall Study|Investigator Judgement|0|||
124823949|NCT03070782|448983019|FG002|Overall Study|Investigator Judgement|0|||
124823950|NCT03070782|448983020|FG003|Overall Study|Investigator Judgement|1|||
124823951|NCT03070782|448983021|FG004|Overall Study|Investigator Judgement|0|||
124823952|NCT03070782|448983022|FG005|Overall Study|Investigator Judgement|0|||
124823953|NCT01083576|448983023|FG000|Overall Study|Treatment Failure|6|||
124823954|NCT01083576|448983024|FG001|Overall Study|Treatment Failure|1|||
125303385|NCT01748825|450736758|FG005|Dose Escalation|Refused further treatment|2|||
125303386|NCT01748825|450736759|FG006|Dose Escalation|Refused further treatment|0|||
125303387|NCT01748825|450736760|FG007|Dose Escalation|Refused further treatment|0|||
124823955|NCT01948050|448983025|FG000|Overall Study|Withdrawal by Subject|0|||
124823956|NCT01948050|448983026|FG001|Overall Study|Withdrawal by Subject|1|||
124823957|NCT01314443|448983027|FG000|Overall Study|Withdrawal by Subject|2|||
124823958|NCT01314443|448983028|FG001|Overall Study|Withdrawal by Subject|1|||
125303388|NCT01748825|450736761|FG008|Dose Escalation|Refused further treatment|0|||
124823959|NCT01314443|448983029|FG002|Overall Study|Withdrawal by Subject|1|||
124823960|NCT01314443|448983030|FG003|Overall Study|Withdrawal by Subject|1|||
124823961|NCT01314443|448983027|FG000|Overall Study|Protocol Violation|2|||
124823962|NCT01314443|448983028|FG001|Overall Study|Protocol Violation|2|||
124823963|NCT01314443|448983029|FG002|Overall Study|Protocol Violation|1|||
124823964|NCT01314443|448983030|FG003|Overall Study|Protocol Violation|1|||
124823965|NCT00010374|448983031|FG000|Overall Study|False positive phrenic nerve test|1|||
124823966|NCT02875860|448983033|FG000|Overall Study|Withdrawal by Subject|0|||
124823967|NCT02875860|448983034|FG001|Overall Study|Withdrawal by Subject|1|||
124823968|NCT01881776|448983035|FG000|Overall Study|Lost to Follow-up|1|||
124823969|NCT01881776|448983036|FG001|Overall Study|Lost to Follow-up|2|||
124823970|NCT01881776|448983037|FG002|Overall Study|Lost to Follow-up|1|||
124823971|NCT01881776|448983035|FG000|Overall Study|Protocol Violation|0|||
124823972|NCT01881776|448983036|FG001|Overall Study|Protocol Violation|2|||
124823973|NCT01881776|448983037|FG002|Overall Study|Protocol Violation|1|||
124823974|NCT04044716|448983038|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
124823975|NCT04044716|448983039|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
124823976|NCT04044716|448983040|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
124823977|NCT04044716|448983038|FG000|Overall Study|Lost to Follow-up|2|||
124823978|NCT04044716|448983039|FG001|Overall Study|Lost to Follow-up|3|||
124823979|NCT04044716|448983040|FG002|Overall Study|Lost to Follow-up|0|||
124823980|NCT00276744|448983042|FG000|PART A|Reason unknown|98|||
124823981|NCT03060629|448983043|FG000|Overall Study|Death|4|||
124823982|NCT03060629|448983044|FG001|Overall Study|Death|5|||
124823983|NCT03060629|448983043|FG000|Overall Study|Withdrawal by Subject|50|||
124823984|NCT03060629|448983044|FG001|Overall Study|Withdrawal by Subject|35|||
124823985|NCT03060629|448983043|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
124823986|NCT03060629|448983044|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
124823987|NCT03060629|448983043|FG000|Overall Study|Participant Relocate|15|||
124823988|NCT03060629|448983044|FG001|Overall Study|Participant Relocate|15|||
124823989|NCT03060629|448983043|FG000|Overall Study|Unable to Contact Participant|34|||
124823990|NCT03060629|448983044|FG001|Overall Study|Unable to Contact Participant|23|||
124823991|NCT03060629|448983043|FG000|Overall Study|Investigator Decision|7|||
124823992|NCT03060629|448983044|FG001|Overall Study|Investigator Decision|7|||
124823993|NCT03060629|448983043|FG000|Overall Study|Study Terminated by Sponsor|1100|||
124823994|NCT03060629|448983044|FG001|Overall Study|Study Terminated by Sponsor|1123|||
124823995|NCT03060629|448983043|FG000|Overall Study|Other|4|||
124823996|NCT03060629|448983044|FG001|Overall Study|Other|4|||
124823997|NCT01782495|448983049|FG000|Overall Study|Adverse Event|0|||
124823998|NCT01782495|448983050|FG001|Overall Study|Adverse Event|0|||
124823999|NCT01782495|448983051|FG002|Overall Study|Adverse Event|0|||
124824000|NCT01782495|448983052|FG003|Overall Study|Adverse Event|0|||
124824001|NCT01782495|448983053|FG004|Overall Study|Adverse Event|0|||
124824002|NCT01782495|448983054|FG005|Overall Study|Adverse Event|0|||
124824003|NCT01782495|448983055|FG006|Overall Study|Adverse Event|0|||
124824004|NCT01782495|448983056|FG007|Overall Study|Adverse Event|2|||
124824005|NCT01782495|448983057|FG008|Overall Study|Adverse Event|0|||
124824006|NCT01782495|448983058|FG009|Overall Study|Adverse Event|0|||
124824007|NCT01782495|448983059|FG010|Overall Study|Adverse Event|0|||
124824008|NCT01782495|448983049|FG000|Overall Study|Withdrew Consent|0|||
124824009|NCT01782495|448983050|FG001|Overall Study|Withdrew Consent|1|||
124824010|NCT01782495|448983051|FG002|Overall Study|Withdrew Consent|0|||
124824011|NCT01782495|448983052|FG003|Overall Study|Withdrew Consent|0|||
124824012|NCT01782495|448983053|FG004|Overall Study|Withdrew Consent|0|||
124824013|NCT01782495|448983054|FG005|Overall Study|Withdrew Consent|0|||
124824014|NCT01782495|448983055|FG006|Overall Study|Withdrew Consent|0|||
124824015|NCT01782495|448983056|FG007|Overall Study|Withdrew Consent|1|||
124824016|NCT01782495|448983057|FG008|Overall Study|Withdrew Consent|0|||
124824017|NCT01782495|448983058|FG009|Overall Study|Withdrew Consent|0|||
124824018|NCT01782495|448983059|FG010|Overall Study|Withdrew Consent|0|||
124824019|NCT00071513|448983060|FG000|Intervention Component|Withdrawal by Subject|2|||
124824020|NCT00071513|448983061|FG001|Intervention Component|Withdrawal by Subject|3|||
124824021|NCT00071513|448983060|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
124824022|NCT00071513|448983061|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
124824023|NCT02260921|448983062|FG000|Overall Study|Adverse Event|1|||
124824024|NCT02260921|448983063|FG001|Overall Study|Adverse Event|0|||
124824025|NCT02260921|448983062|FG000|Overall Study|Lost to Follow-up|4|||
124824026|NCT02260921|448983063|FG001|Overall Study|Lost to Follow-up|3|||
124824027|NCT02260921|448983062|FG000|Overall Study|Withdraw Consent|4|||
124824028|NCT02260921|448983063|FG001|Overall Study|Withdraw Consent|1|||
124824029|NCT02260921|448983062|FG000|Overall Study|Death|1|||
124824030|NCT02260921|448983063|FG001|Overall Study|Death|0|||
124824031|NCT02260921|448983062|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
125303389|NCT01748825|450736762|FG009|Dose Escalation|Refused further treatment|0|||
124824032|NCT02260921|448983063|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
125303390|NCT01748825|450736753|FG000|Dose Escalation|Switched to alternative treatment|0|||
124824033|NCT01244425|448983064|FG000|Overall Study|Withdrawal by Subject|2|||
124824034|NCT01244425|448983065|FG001|Overall Study|Withdrawal by Subject|2|||
124824035|NCT01244425|448983064|FG000|Overall Study|Adverse Event|1|||
124824036|NCT01244425|448983065|FG001|Overall Study|Adverse Event|1|||
124824037|NCT02743871|448983067|FG000|Overall Study|Lost to Follow-up|0|||
124824038|NCT02743871|448983068|FG001|Overall Study|Lost to Follow-up|0|||
124824039|NCT02743871|448983069|FG002|Overall Study|Lost to Follow-up|0|||
124824040|NCT02743871|448983070|FG003|Overall Study|Lost to Follow-up|1|||
124824041|NCT02743871|448983071|FG004|Overall Study|Lost to Follow-up|0|||
124824042|NCT02743871|448983072|FG005|Overall Study|Lost to Follow-up|0|||
124824043|NCT02743871|448983073|FG006|Overall Study|Lost to Follow-up|1|||
124824044|NCT02743871|448983074|FG007|Overall Study|Lost to Follow-up|0|||
124824045|NCT02743871|448983075|FG008|Overall Study|Lost to Follow-up|0|||
124824046|NCT02743871|448983076|FG009|Overall Study|Lost to Follow-up|0|||
124824047|NCT02743871|448983077|FG010|Overall Study|Lost to Follow-up|0|||
124824048|NCT02743871|448983078|FG011|Overall Study|Lost to Follow-up|2|||
124824049|NCT02743871|448983079|FG012|Overall Study|Lost to Follow-up|0|||
124824050|NCT02743871|448983080|FG013|Overall Study|Lost to Follow-up|0|||
124824051|NCT02743871|448983067|FG000|Overall Study|Withdrawal by Subject|0|||
124824052|NCT02743871|448983068|FG001|Overall Study|Withdrawal by Subject|0|||
124824053|NCT02743871|448983069|FG002|Overall Study|Withdrawal by Subject|0|||
124824054|NCT02743871|448983070|FG003|Overall Study|Withdrawal by Subject|0|||
124824055|NCT02743871|448983071|FG004|Overall Study|Withdrawal by Subject|0|||
124824056|NCT02743871|448983072|FG005|Overall Study|Withdrawal by Subject|0|||
124824057|NCT02743871|448983073|FG006|Overall Study|Withdrawal by Subject|0|||
124824058|NCT02743871|448983074|FG007|Overall Study|Withdrawal by Subject|0|||
124824059|NCT02743871|448983075|FG008|Overall Study|Withdrawal by Subject|0|||
124824060|NCT02743871|448983076|FG009|Overall Study|Withdrawal by Subject|0|||
124824061|NCT02743871|448983077|FG010|Overall Study|Withdrawal by Subject|1|||
124824062|NCT02743871|448983078|FG011|Overall Study|Withdrawal by Subject|0|||
124824063|NCT02743871|448983079|FG012|Overall Study|Withdrawal by Subject|12|||
124824064|NCT02743871|448983080|FG013|Overall Study|Withdrawal by Subject|6|||
124824065|NCT02743871|448983067|FG000|Overall Study|Adverse Event|1|||
124824066|NCT02743871|448983068|FG001|Overall Study|Adverse Event|0|||
124824067|NCT02743871|448983069|FG002|Overall Study|Adverse Event|0|||
124824068|NCT02743871|448983070|FG003|Overall Study|Adverse Event|0|||
124824069|NCT02743871|448983071|FG004|Overall Study|Adverse Event|0|||
124824070|NCT02743871|448983072|FG005|Overall Study|Adverse Event|0|||
124824071|NCT02743871|448983073|FG006|Overall Study|Adverse Event|0|||
124824072|NCT02743871|448983074|FG007|Overall Study|Adverse Event|0|||
124824073|NCT02743871|448983075|FG008|Overall Study|Adverse Event|0|||
124824074|NCT02743871|448983076|FG009|Overall Study|Adverse Event|0|||
124824075|NCT02743871|448983077|FG010|Overall Study|Adverse Event|0|||
124824076|NCT02743871|448983078|FG011|Overall Study|Adverse Event|0|||
124824077|NCT02743871|448983079|FG012|Overall Study|Adverse Event|0|||
124824078|NCT02743871|448983080|FG013|Overall Study|Adverse Event|0|||
124824079|NCT02743871|448983067|FG000|Overall Study|Other|0|||
124824080|NCT02743871|448983068|FG001|Overall Study|Other|0|||
124824081|NCT02743871|448983069|FG002|Overall Study|Other|0|||
124824082|NCT02743871|448983070|FG003|Overall Study|Other|0|||
124824083|NCT02743871|448983071|FG004|Overall Study|Other|0|||
124824084|NCT02743871|448983072|FG005|Overall Study|Other|0|||
124824085|NCT02743871|448983073|FG006|Overall Study|Other|0|||
124824086|NCT02743871|448983074|FG007|Overall Study|Other|0|||
124824087|NCT02743871|448983075|FG008|Overall Study|Other|0|||
124824088|NCT02743871|448983076|FG009|Overall Study|Other|0|||
124824089|NCT02743871|448983077|FG010|Overall Study|Other|0|||
124824090|NCT02743871|448983078|FG011|Overall Study|Other|1|||
124824091|NCT02743871|448983079|FG012|Overall Study|Other|1|||
124824092|NCT02743871|448983080|FG013|Overall Study|Other|1|||
124824093|NCT02743871|448983067|FG000|Overall Study|Protocol Violation|0|||
124824094|NCT02743871|448983068|FG001|Overall Study|Protocol Violation|0|||
124824095|NCT02743871|448983069|FG002|Overall Study|Protocol Violation|0|||
124824096|NCT02743871|448983070|FG003|Overall Study|Protocol Violation|0|||
124824097|NCT02743871|448983071|FG004|Overall Study|Protocol Violation|0|||
124824098|NCT02743871|448983072|FG005|Overall Study|Protocol Violation|0|||
124824099|NCT02743871|448983073|FG006|Overall Study|Protocol Violation|0|||
124824100|NCT02743871|448983074|FG007|Overall Study|Protocol Violation|0|||
124824101|NCT02743871|448983075|FG008|Overall Study|Protocol Violation|0|||
124824102|NCT02743871|448983076|FG009|Overall Study|Protocol Violation|0|||
124824103|NCT02743871|448983077|FG010|Overall Study|Protocol Violation|0|||
124824104|NCT02743871|448983078|FG011|Overall Study|Protocol Violation|0|||
124824105|NCT02743871|448983079|FG012|Overall Study|Protocol Violation|2|||
124824106|NCT02743871|448983080|FG013|Overall Study|Protocol Violation|0|||
124824107|NCT02848651|448983081|FG000|Overall Study|Death|85|||
124824108|NCT02848651|448983081|FG000|Overall Study|Lost to Follow-up|1|||
124824109|NCT02848651|448983081|FG000|Overall Study|Non-Compliance|1|||
124824110|NCT02848651|448983081|FG000|Overall Study|Symptomatic Deterioration|1|||
124824111|NCT02848651|448983081|FG000|Overall Study|Physician Decision|4|||
124824112|NCT02848651|448983081|FG000|Overall Study|Withdrawal by Subject|14|||
124824113|NCT00897104|448983090|FG000|Overall Study|Lost to Follow-up|12|||
124824114|NCT00897104|448983091|FG001|Overall Study|Lost to Follow-up|17|||
124824115|NCT00897104|448983092|FG002|Overall Study|Lost to Follow-up|2|||
124824116|NCT00897104|448983090|FG000|Overall Study|Pregnancy|0|||
125303391|NCT01748825|450736754|FG001|Dose Escalation|Switched to alternative treatment|0|||
124824117|NCT00897104|448983091|FG001|Overall Study|Pregnancy|1|||
124824118|NCT00897104|448983092|FG002|Overall Study|Pregnancy|0|||
124824119|NCT00897104|448983090|FG000|Overall Study|Protocol Violation|0|||
124824120|NCT00897104|448983091|FG001|Overall Study|Protocol Violation|1|||
124824121|NCT00897104|448983092|FG002|Overall Study|Protocol Violation|0|||
124824122|NCT00897104|448983090|FG000|Overall Study|Withdrawal by Subject|23|||
124824123|NCT00897104|448983091|FG001|Overall Study|Withdrawal by Subject|27|||
124824124|NCT00897104|448983092|FG002|Overall Study|Withdrawal by Subject|3|||
124824125|NCT00897104|448983090|FG000|Overall Study|Abnormal Prestudy Labs|2|||
124824126|NCT00897104|448983091|FG001|Overall Study|Abnormal Prestudy Labs|0|||
124824127|NCT00897104|448983092|FG002|Overall Study|Abnormal Prestudy Labs|0|||
124824128|NCT00897104|448983090|FG000|Overall Study|Abnormal Baseline ECG|2|||
124824129|NCT00897104|448983091|FG001|Overall Study|Abnormal Baseline ECG|2|||
124824130|NCT00897104|448983092|FG002|Overall Study|Abnormal Baseline ECG|0|||
124824131|NCT00897104|448983090|FG000|Overall Study|Need for Concom. Med.|0|||
124824132|NCT00897104|448983091|FG001|Overall Study|Need for Concom. Med.|1|||
124824133|NCT00897104|448983092|FG002|Overall Study|Need for Concom. Med.|1|||
124824134|NCT00897104|448983090|FG000|Overall Study|Lack of Migraine Attack|20|||
124824135|NCT00897104|448983091|FG001|Overall Study|Lack of Migraine Attack|22|||
124824136|NCT00897104|448983092|FG002|Overall Study|Lack of Migraine Attack|1|||
124824137|NCT00897104|448983090|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
124824138|NCT00897104|448983091|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
124824139|NCT00897104|448983092|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
124824140|NCT00897104|448983090|FG000|Overall Study|Other|3|||
124824141|NCT00897104|448983091|FG001|Overall Study|Other|0|||
124824142|NCT00897104|448983092|FG002|Overall Study|Other|0|||
124824143|NCT00897104|448983090|FG000|Overall Study|Protocol Violation|1|||
124824144|NCT00897104|448983091|FG001|Overall Study|Protocol Violation|0|||
124824145|NCT00897104|448983092|FG002|Overall Study|Protocol Violation|0|||
124824146|NCT00897104|448983090|FG000|Overall Study|Withdrawal by Subject|0|||
124824147|NCT00897104|448983091|FG001|Overall Study|Withdrawal by Subject|0|||
124824148|NCT00897104|448983092|FG002|Overall Study|Withdrawal by Subject|1|||
124824149|NCT01059799|448983095|FG000|Overall Study|Adverse Event|2|||
124824150|NCT01059799|448983096|FG001|Overall Study|Adverse Event|3|||
124824151|NCT01059799|448983095|FG000|Overall Study|Lack of Efficacy|1|||
124824152|NCT01059799|448983096|FG001|Overall Study|Lack of Efficacy|0|||
124824153|NCT01059799|448983095|FG000|Overall Study|Protocol Violation|3|||
124824154|NCT01059799|448983096|FG001|Overall Study|Protocol Violation|2|||
124824155|NCT01059799|448983095|FG000|Overall Study|Withdrawal criteria|13|||
124824156|NCT01059799|448983096|FG001|Overall Study|Withdrawal criteria|2|||
124824157|NCT01059799|448983095|FG000|Overall Study|Other|12|||
124824158|NCT01059799|448983096|FG001|Overall Study|Other|3|||
124824159|NCT00750204|448983097|FG000|Overall Study|study halted prematurely|1|||
124824160|NCT00750204|448983098|FG001|Overall Study|study halted prematurely|1|||
124824161|NCT00662363|448983099|FG000|Overall Study|Withdrawal by Subject|6|||
124824162|NCT00662363|448983100|FG001|Overall Study|Withdrawal by Subject|5|||
124824163|NCT00662363|448983099|FG000|Overall Study|Adverse Event|0|||
124824164|NCT00662363|448983100|FG001|Overall Study|Adverse Event|3|||
124824165|NCT00662363|448983099|FG000|Overall Study|Discharged early from rehab|4|||
124824166|NCT00662363|448983100|FG001|Overall Study|Discharged early from rehab|1|||
124824167|NCT00662363|448983099|FG000|Overall Study|Protocol Violation|1|||
124824168|NCT00662363|448983100|FG001|Overall Study|Protocol Violation|1|||
124824169|NCT01428453|448983101|FG000|Overall Study|Adverse Event|2|||
124824170|NCT01428453|448983102|FG001|Overall Study|Adverse Event|7|||
124824171|NCT01428453|448983101|FG000|Overall Study|Protocol Violation|1|||
124824172|NCT01428453|448983102|FG001|Overall Study|Protocol Violation|0|||
124824173|NCT01428453|448983101|FG000|Overall Study|Lost to Follow-up|0|||
124824174|NCT01428453|448983102|FG001|Overall Study|Lost to Follow-up|1|||
124824175|NCT01428453|448983101|FG000|Overall Study|Withdrawal by Subject|3|||
124824176|NCT01428453|448983102|FG001|Overall Study|Withdrawal by Subject|1|||
124824177|NCT03789318|448983108|FG000|Overall Study|Adverse Event|0|||
124824178|NCT03789318|448983109|FG001|Overall Study|Adverse Event|0|||
124824179|NCT03789318|448983110|FG002|Overall Study|Adverse Event|1|||
124824180|NCT03789318|448983111|FG003|Overall Study|Adverse Event|1|||
124824181|NCT03789318|448983112|FG004|Overall Study|Adverse Event|0|||
125303392|NCT01748825|450736755|FG002|Dose Escalation|Switched to alternative treatment|0|||
124824182|NCT03789318|448983108|FG000|Overall Study|Lost to Follow-up|0|||
124824183|NCT03789318|448983109|FG001|Overall Study|Lost to Follow-up|0|||
124824184|NCT03789318|448983110|FG002|Overall Study|Lost to Follow-up|1|||
124824185|NCT03789318|448983111|FG003|Overall Study|Lost to Follow-up|0|||
124824186|NCT03789318|448983112|FG004|Overall Study|Lost to Follow-up|0|||
124824187|NCT03789318|448983108|FG000|Overall Study|Withdrawal by Subject|0|||
124824188|NCT03789318|448983109|FG001|Overall Study|Withdrawal by Subject|0|||
124824189|NCT03789318|448983110|FG002|Overall Study|Withdrawal by Subject|1|||
125303393|NCT01748825|450736756|FG003|Dose Escalation|Switched to alternative treatment|1|||
124824190|NCT03789318|448983111|FG003|Overall Study|Withdrawal by Subject|0|||
124824191|NCT03789318|448983112|FG004|Overall Study|Withdrawal by Subject|0|||
124824192|NCT02480114|448983113|FG000|Overall Study|Not completing surveys|3|||
124824193|NCT02480114|448983114|FG001|Overall Study|Not completing surveys|2|||
124824194|NCT02480114|448983113|FG000|Overall Study|Withdrawal by Subject|2|||
124824195|NCT02480114|448983114|FG001|Overall Study|Withdrawal by Subject|4|||
124824196|NCT02480114|448983113|FG000|Overall Study|Disease progression|3|||
124824197|NCT02480114|448983114|FG001|Overall Study|Disease progression|0|||
124824198|NCT02480114|448983113|FG000|Overall Study|Improper completion of survey|1|||
124824199|NCT02480114|448983114|FG001|Overall Study|Improper completion of survey|1|||
124824200|NCT02480114|448983113|FG000|Overall Study|Not eligible|0|||
124824201|NCT02480114|448983114|FG001|Overall Study|Not eligible|1|||
124824202|NCT01535053|448983115|FG000|Overall Study|Ineligible|1|||
124824203|NCT01535053|448983116|FG001|Overall Study|Ineligible|2|||
124824204|NCT00512707|448983117|FG000|Overall Study|Lost to Follow-up|5|||
124824205|NCT00512707|448983118|FG001|Overall Study|Lost to Follow-up|11|||
124824206|NCT00512707|448983117|FG000|Overall Study|Developed skin irritation|2|||
124824207|NCT00512707|448983118|FG001|Overall Study|Developed skin irritation|1|||
124824208|NCT00512707|448983117|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
124824209|NCT00512707|448983118|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
124824210|NCT00512707|448983117|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
124824211|NCT00512707|448983118|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
124824212|NCT00477971|448983119|FG000|Overall Study|Disease progression|6|||
124824213|NCT00477971|448983120|FG001|Overall Study|Disease progression|0|||
124824214|NCT00477971|448983119|FG000|Overall Study|Withdrawal by Subject|3|||
124824215|NCT00477971|448983120|FG001|Overall Study|Withdrawal by Subject|1|||
124824216|NCT00477971|448983119|FG000|Overall Study|Adverse Event|3|||
124824217|NCT00477971|448983120|FG001|Overall Study|Adverse Event|0|||
124824218|NCT00477971|448983119|FG000|Overall Study|Death|2|||
124824219|NCT00477971|448983120|FG001|Overall Study|Death|4|||
124824220|NCT00477971|448983119|FG000|Overall Study|Alternative treatment|3|||
124824221|NCT00477971|448983120|FG001|Overall Study|Alternative treatment|1|||
124824222|NCT03700671|448983121|FG000|Overall Study|Lack of Efficacy|1|||
124824223|NCT03700671|448983122|FG001|Overall Study|Lack of Efficacy|2|||
124824224|NCT01317160|448983123|FG000|Overall Study|Incorrect inclusion|1|||
124824225|NCT01317160|448983124|FG001|Overall Study|Incorrect inclusion|1|||
124824226|NCT01317160|448983123|FG000|Overall Study|Lost to Follow-up|3|||
124824227|NCT01317160|448983124|FG001|Overall Study|Lost to Follow-up|3|||
124824228|NCT01317160|448983123|FG000|Overall Study|Withdrawal by Subject|0|||
124824229|NCT01317160|448983124|FG001|Overall Study|Withdrawal by Subject|2|||
124824230|NCT01774968|448983125|FG000|Overall Study|Adverse Event|4|||
124824231|NCT01774968|448983126|FG001|Overall Study|Adverse Event|4|||
124824232|NCT01774968|448983125|FG000|Overall Study|Death|0|||
124824233|NCT01774968|448983126|FG001|Overall Study|Death|1|||
124824234|NCT01774968|448983125|FG000|Overall Study|Lost to Follow-up|1|||
124824235|NCT01774968|448983126|FG001|Overall Study|Lost to Follow-up|3|||
124824236|NCT01774968|448983125|FG000|Overall Study|Physician Decision|5|||
124824237|NCT01774968|448983126|FG001|Overall Study|Physician Decision|1|||
124824238|NCT01774968|448983125|FG000|Overall Study|Protocol Violation|14|||
124824239|NCT01774968|448983126|FG001|Overall Study|Protocol Violation|13|||
124824240|NCT01774968|448983125|FG000|Overall Study|Sponsor Decision|0|||
124824241|NCT01774968|448983126|FG001|Overall Study|Sponsor Decision|2|||
124824242|NCT01774968|448983125|FG000|Overall Study|Withdrawal by Subject|6|||
124824243|NCT01774968|448983126|FG001|Overall Study|Withdrawal by Subject|11|||
124824244|NCT04405037|448983133|FG000|Overall Study|Withdrawal by Subject|1|||
124824245|NCT04405037|448983134|FG001|Overall Study|Withdrawal by Subject|0|||
124824246|NCT04405037|448983133|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
124824247|NCT04405037|448983134|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
124824248|NCT02759471|448983135|FG000|Overall Study|discomfort|2|||
124824249|NCT02879305|448983136|FG000|Overall Study|Investigator Site Closed|55|||
124824250|NCT02879305|448983137|FG001|Overall Study|Investigator Site Closed|57|||
124824251|NCT02879305|448983136|FG000|Overall Study|Withdrawal by Subject|44|||
124824252|NCT02879305|448983137|FG001|Overall Study|Withdrawal by Subject|42|||
124824253|NCT02879305|448983136|FG000|Overall Study|Lost to Follow-up|17|||
124824254|NCT02879305|448983137|FG001|Overall Study|Lost to Follow-up|12|||
124824255|NCT02879305|448983136|FG000|Overall Study|Other|1|||
124824256|NCT02879305|448983137|FG001|Overall Study|Other|0|||
124824257|NCT01955733|448984852|FG000|Period 1|Lost to Follow-up|1|||
124824258|NCT01955733|448984853|FG001|Period 1|Lost to Follow-up|0|||
124824259|NCT01955733|448984854|FG002|Period 1|Lost to Follow-up|0|||
124824260|NCT01955733|448984852|FG000|Period 2|Adverse Event|1|||
124824261|NCT01955733|448984853|FG001|Period 2|Adverse Event|0|||
124824262|NCT01955733|448984854|FG002|Period 2|Adverse Event|0|||
125303394|NCT01748825|450736757|FG004|Dose Escalation|Switched to alternative treatment|0|||
124824263|NCT01955733|448984852|FG000|Period 2|Physician Decision|0|||
124824264|NCT01955733|448984853|FG001|Period 2|Physician Decision|0|||
124824265|NCT01955733|448984854|FG002|Period 2|Physician Decision|1|||
124824266|NCT01955733|448984852|FG000|Period 2|Withdrawal by Subject|1|||
124824267|NCT01955733|448984853|FG001|Period 2|Withdrawal by Subject|3|||
124824268|NCT01955733|448984854|FG002|Period 2|Withdrawal by Subject|2|||
124824269|NCT01955733|448984852|FG000|Period 2|Study terminated by sponsor|8|||
124824270|NCT01955733|448984853|FG001|Period 2|Study terminated by sponsor|14|||
124824271|NCT01955733|448984854|FG002|Period 2|Study terminated by sponsor|16|||
124824272|NCT01955733|448984852|FG000|Period 2|Lost to Follow-up|2|||
124824273|NCT01955733|448984853|FG001|Period 2|Lost to Follow-up|0|||
124824274|NCT01955733|448984854|FG002|Period 2|Lost to Follow-up|0|||
124824275|NCT01955733|448984852|FG000|Period 2|Other not defined above|0|||
124824276|NCT01955733|448984853|FG001|Period 2|Other not defined above|2|||
124824277|NCT01955733|448984854|FG002|Period 2|Other not defined above|2|||
124824278|NCT02762266|448984855|FG000|Overall Study|Physician Decision|2|||
124824279|NCT02762266|448984856|FG001|Overall Study|Physician Decision|0|||
124824280|NCT01438424|448984857|FG000|Overall Study|Continuing treatment|29|||
124824281|NCT01438424|448984857|FG000|Overall Study|Minimal virologic response|95|||
124824282|NCT01438424|448984857|FG000|Overall Study|Not identified|55|||
124824283|NCT01438424|448984857|FG000|Overall Study|Withdrawal by Subject|104|||
124824284|NCT01438424|448984857|FG000|Overall Study|Progression of chronic hepatitis B|22|||
124824285|NCT01438424|448984857|FG000|Overall Study|Death|22|||
124824286|NCT01438424|448984857|FG000|Overall Study|Adverse Event|17|||
124824287|NCT01438424|448984857|FG000|Overall Study|Lost to Follow-up|17|||
124824288|NCT01438424|448984857|FG000|Overall Study|Abnormal laboratory test result|14|||
124824289|NCT01438424|448984857|FG000|Overall Study|Need for drug prohibited by protocol|14|||
124824290|NCT01438424|448984857|FG000|Overall Study|Pregnancy|7|||
124824291|NCT01438424|448984857|FG000|Overall Study|No longer met inclusion criteria|1|||
124824292|NCT01438424|448984857|FG000|Overall Study|Participant noncompliance|20|||
124824293|NCT02329730|448984860|FG000|Overall Study|Protocol Violation|0|||
124824294|NCT02329730|448984861|FG001|Overall Study|Protocol Violation|0|||
124824295|NCT02329730|448984862|FG002|Overall Study|Protocol Violation|0|||
124824296|NCT02329730|448984863|FG003|Overall Study|Protocol Violation|0|||
124824297|NCT02329730|448984864|FG004|Overall Study|Protocol Violation|2|||
124824298|NCT02329730|448984865|FG005|Overall Study|Protocol Violation|2|||
124824299|NCT02329730|448984866|FG006|Overall Study|Protocol Violation|0|||
124824300|NCT02329730|448984867|FG007|Overall Study|Protocol Violation|0|||
124824301|NCT02329730|448984868|FG008|Overall Study|Protocol Violation|0|||
124824302|NCT02329730|448984869|FG009|Overall Study|Protocol Violation|0|||
124824303|NCT02329730|448984870|FG010|Overall Study|Protocol Violation|0|||
124824304|NCT02329730|448984871|FG011|Overall Study|Protocol Violation|0|||
124824305|NCT02329730|448984860|FG000|Overall Study|Withdrawal by Subject|0|||
124824306|NCT02329730|448984861|FG001|Overall Study|Withdrawal by Subject|0|||
124824307|NCT02329730|448984862|FG002|Overall Study|Withdrawal by Subject|0|||
124824308|NCT02329730|448984863|FG003|Overall Study|Withdrawal by Subject|0|||
124824309|NCT02329730|448984864|FG004|Overall Study|Withdrawal by Subject|1|||
124824310|NCT02329730|448984865|FG005|Overall Study|Withdrawal by Subject|0|||
124824311|NCT02329730|448984866|FG006|Overall Study|Withdrawal by Subject|1|||
124824312|NCT02329730|448984867|FG007|Overall Study|Withdrawal by Subject|1|||
124824313|NCT02329730|448984868|FG008|Overall Study|Withdrawal by Subject|1|||
124824314|NCT02329730|448984869|FG009|Overall Study|Withdrawal by Subject|1|||
124824315|NCT02329730|448984870|FG010|Overall Study|Withdrawal by Subject|0|||
124824316|NCT02329730|448984871|FG011|Overall Study|Withdrawal by Subject|0|||
124824317|NCT03010254|448984874|FG000|Overall Study|Adverse Event|0|||
124824318|NCT03010254|448984875|FG001|Overall Study|Adverse Event|1|||
124824319|NCT03010254|448984874|FG000|Overall Study|Lost to Follow-up|4|||
124824320|NCT03010254|448984875|FG001|Overall Study|Lost to Follow-up|0|||
124824321|NCT03010254|448984874|FG000|Overall Study|Withdrawal by Subject|1|||
124824322|NCT03010254|448984875|FG001|Overall Study|Withdrawal by Subject|1|||
124824323|NCT03010254|448984874|FG000|Overall Study|Other|2|||
124824324|NCT03010254|448984875|FG001|Overall Study|Other|3|||
124824325|NCT01404325|448984876|FG000|Overall Study|Lost to Follow-up|1|||
124824326|NCT01404325|448984877|FG001|Overall Study|Lost to Follow-up|0|||
124824327|NCT01404325|448984876|FG000|Overall Study|Death|2|||
124824328|NCT01404325|448984877|FG001|Overall Study|Death|0|||
124824329|NCT01404325|448984876|FG000|Overall Study|Graft loss/Retransplantation|1|||
124824330|NCT01404325|448984877|FG001|Overall Study|Graft loss/Retransplantation|0|||
124824331|NCT01404325|448984876|FG000|Overall Study|non-specified reason|0|||
124824332|NCT01404325|448984877|FG001|Overall Study|non-specified reason|2|||
124824333|NCT02141282|448984883|FG000|Overall Study|Adverse event, not related to progression|8|||
124824334|NCT02141282|448984884|FG001|Overall Study|Adverse event, not related to progression|1|||
124824335|NCT02141282|448984885|FG002|Overall Study|Adverse event, not related to progression|3|||
124824336|NCT02141282|448984886|FG003|Overall Study|Adverse event, not related to progression|1|||
124824337|NCT02141282|448984883|FG000|Overall Study|Adverse event, related to progression|1|||
125309880|NCT00947115|450760201|FG002|Overall Study|Lost to Follow-up|8|||
124824338|NCT02141282|448984884|FG001|Overall Study|Adverse event, related to progression|0|||
124824339|NCT02141282|448984885|FG002|Overall Study|Adverse event, related to progression|2|||
124824340|NCT02141282|448984886|FG003|Overall Study|Adverse event, related to progression|0|||
124824341|NCT02141282|448984883|FG000|Overall Study|COVID-19 infection|1|||
124824342|NCT02141282|448984884|FG001|Overall Study|COVID-19 infection|0|||
124824343|NCT02141282|448984885|FG002|Overall Study|COVID-19 infection|0|||
124824344|NCT02141282|448984886|FG003|Overall Study|COVID-19 infection|0|||
124824345|NCT02141282|448984883|FG000|Overall Study|Lost to Follow-up|0|||
124824346|NCT02141282|448984884|FG001|Overall Study|Lost to Follow-up|0|||
124824347|NCT02141282|448984885|FG002|Overall Study|Lost to Follow-up|4|||
124824348|NCT02141282|448984886|FG003|Overall Study|Lost to Follow-up|2|||
124824349|NCT02141282|448984883|FG000|Overall Study|Other, not specified|14|||
124824350|NCT02141282|448984884|FG001|Overall Study|Other, not specified|11|||
124824351|NCT02141282|448984885|FG002|Overall Study|Other, not specified|23|||
124824352|NCT02141282|448984886|FG003|Overall Study|Other, not specified|9|||
124824353|NCT02141282|448984883|FG000|Overall Study|Progressive disease, Richter's|4|||
124824354|NCT02141282|448984884|FG001|Overall Study|Progressive disease, Richter's|1|||
124824355|NCT02141282|448984885|FG002|Overall Study|Progressive disease, Richter's|1|||
124824356|NCT02141282|448984886|FG003|Overall Study|Progressive disease, Richter's|1|||
124824357|NCT02141282|448984883|FG000|Overall Study|Progressive disease per protocol|12|||
124824358|NCT02141282|448984884|FG001|Overall Study|Progressive disease per protocol|7|||
124824359|NCT02141282|448984885|FG002|Overall Study|Progressive disease per protocol|9|||
124824360|NCT02141282|448984886|FG003|Overall Study|Progressive disease per protocol|2|||
124824361|NCT02141282|448984883|FG000|Overall Study|Stem cell transplant|1|||
124824362|NCT02141282|448984884|FG001|Overall Study|Stem cell transplant|0|||
124824363|NCT02141282|448984885|FG002|Overall Study|Stem cell transplant|1|||
124824364|NCT02141282|448984886|FG003|Overall Study|Stem cell transplant|0|||
124824365|NCT02141282|448984883|FG000|Overall Study|Study terminated by Sponsor|0|||
124824366|NCT02141282|448984884|FG001|Overall Study|Study terminated by Sponsor|1|||
124824367|NCT02141282|448984885|FG002|Overall Study|Study terminated by Sponsor|0|||
124824368|NCT02141282|448984886|FG003|Overall Study|Study terminated by Sponsor|0|||
124824369|NCT02141282|448984883|FG000|Overall Study|Subject non-compliance|0|||
124824370|NCT02141282|448984884|FG001|Overall Study|Subject non-compliance|0|||
124824371|NCT02141282|448984885|FG002|Overall Study|Subject non-compliance|1|||
124824372|NCT02141282|448984886|FG003|Overall Study|Subject non-compliance|0|||
124824373|NCT02141282|448984883|FG000|Overall Study|Withdrew consent|2|||
124824374|NCT02141282|448984884|FG001|Overall Study|Withdrew consent|0|||
124824375|NCT02141282|448984885|FG002|Overall Study|Withdrew consent|4|||
124824376|NCT02141282|448984886|FG003|Overall Study|Withdrew consent|0|||
124824377|NCT03312933|448984887|FG000|Overall Study|Protocol Violation|15|||
124824378|NCT03312933|448984887|FG000|Overall Study|Lost to Follow-up|36|||
124824379|NCT03312933|448984887|FG000|Overall Study|Withdrawal by Subject|3|||
124824380|NCT00224055|448984893|FG000|Overall Study|Adverse Event|9|||
124824381|NCT00224055|448984894|FG001|Overall Study|Adverse Event|3|||
124824382|NCT00224055|448984893|FG000|Overall Study|Lost to Follow-up|1|||
124824383|NCT00224055|448984894|FG001|Overall Study|Lost to Follow-up|2|||
124824384|NCT00224055|448984893|FG000|Overall Study|Protocol Violation|1|||
124824385|NCT00224055|448984894|FG001|Overall Study|Protocol Violation|1|||
124824386|NCT00224055|448984893|FG000|Overall Study|Inclusion Violation|3|||
124824387|NCT00224055|448984894|FG001|Overall Study|Inclusion Violation|6|||
124824388|NCT00224055|448984893|FG000|Overall Study|Withdrawal by Subject|0|||
124824389|NCT00224055|448984894|FG001|Overall Study|Withdrawal by Subject|2|||
124824390|NCT00224055|448984893|FG000|Overall Study|Other|1|||
124824391|NCT00224055|448984894|FG001|Overall Study|Other|0|||
124824392|NCT02068443|448984895|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
124824393|NCT02068443|448984896|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
124824394|NCT02068443|448984897|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
124824395|NCT02068443|448984895|FG000|Overall Study|Voluntary Withdrawal|4|||
124824396|NCT02068443|448984896|FG001|Overall Study|Voluntary Withdrawal|0|||
124824397|NCT02068443|448984897|FG002|Overall Study|Voluntary Withdrawal|1|||
124824398|NCT02068443|448984895|FG000|Overall Study|Lack of Efficacy|2|||
124824399|NCT02068443|448984896|FG001|Overall Study|Lack of Efficacy|1|||
124824400|NCT02068443|448984897|FG002|Overall Study|Lack of Efficacy|0|||
124824401|NCT02068443|448984895|FG000|Overall Study|Other Reason Not Specified|1|||
124824402|NCT02068443|448984896|FG001|Overall Study|Other Reason Not Specified|0|||
124824403|NCT02068443|448984897|FG002|Overall Study|Other Reason Not Specified|0|||
124824404|NCT01986855|448984898|FG000|Overall Study|Adverse Event|1|||
124824405|NCT01986855|448984899|FG001|Overall Study|Adverse Event|0|||
124824406|NCT01986855|448984900|FG002|Overall Study|Adverse Event|0|||
124824407|NCT01986855|448984898|FG000|Overall Study|Death|3|||
124824408|NCT01986855|448984899|FG001|Overall Study|Death|4|||
124824409|NCT01986855|448984900|FG002|Overall Study|Death|4|||
124824410|NCT01986855|448984898|FG000|Overall Study|Lost to Follow-up|2|||
124824411|NCT01986855|448984899|FG001|Overall Study|Lost to Follow-up|1|||
124824412|NCT01986855|448984900|FG002|Overall Study|Lost to Follow-up|0|||
124824413|NCT01986855|448984898|FG000|Overall Study|Screen Failure|0|||
124824414|NCT01986855|448984899|FG001|Overall Study|Screen Failure|1|||
124824415|NCT01986855|448984900|FG002|Overall Study|Screen Failure|0|||
124824416|NCT01986855|448984898|FG000|Overall Study|Participant Moved|0|||
124824417|NCT01986855|448984899|FG001|Overall Study|Participant Moved|0|||
124824418|NCT01986855|448984900|FG002|Overall Study|Participant Moved|2|||
124824419|NCT01986855|448984898|FG000|Overall Study|Withdrawal by Subject|7|||
124824420|NCT01986855|448984899|FG001|Overall Study|Withdrawal by Subject|8|||
124824421|NCT01986855|448984900|FG002|Overall Study|Withdrawal by Subject|5|||
124824422|NCT00664742|448984901|FG000|Overall Study|Withdrawn due to adverse events|3|||
124824423|NCT00664742|448984901|FG000|Overall Study|Withdrawal by Subject|31|||
124824424|NCT00664742|448984901|FG000|Overall Study|Lost to Follow-up|92|||
124824425|NCT04317066|448984902|FG000|Overall Study|Sponsor decision|5|||
124824426|NCT04317066|448984902|FG000|Overall Study|Death|2|||
124824427|NCT00848081|448984905|FG000|Overall Study|Adverse Event|6|||
124824428|NCT00848081|448984906|FG001|Overall Study|Adverse Event|7|||
124824429|NCT00848081|448984905|FG000|Overall Study|Protocol Violation|8|||
124824430|NCT00848081|448984906|FG001|Overall Study|Protocol Violation|5|||
124824431|NCT00848081|448984905|FG000|Overall Study|Lost to Follow-up|1|||
124824432|NCT00848081|448984906|FG001|Overall Study|Lost to Follow-up|0|||
124824433|NCT00848081|448984905|FG000|Overall Study|Physician Decision|0|||
124824434|NCT00848081|448984906|FG001|Overall Study|Physician Decision|3|||
124824435|NCT00848081|448984905|FG000|Overall Study|Withdrawal by Subject|5|||
124824436|NCT00848081|448984906|FG001|Overall Study|Withdrawal by Subject|3|||
124824437|NCT02064868|448984907|FG000|Overall Study|Lost to Follow-up|14|||
124824438|NCT02064868|448984908|FG001|Overall Study|Lost to Follow-up|8|||
124824439|NCT02064868|448984907|FG000|Overall Study|Physician Decision|1|||
124824440|NCT02064868|448984908|FG001|Overall Study|Physician Decision|0|||
124824441|NCT02064868|448984907|FG000|Overall Study|Withdrawal by Subject|14|||
124824442|NCT02064868|448984908|FG001|Overall Study|Withdrawal by Subject|3|||
124824443|NCT02064868|448984907|FG000|Overall Study|Technical Problems or Missing|5|||
124824444|NCT02064868|448984908|FG001|Overall Study|Technical Problems or Missing|2|||
124824445|NCT00754624|448984912|FG000|Overall Study|Adverse Event|16|||
124824446|NCT00754624|448984912|FG000|Overall Study|Death|1|||
124824447|NCT00754624|448984912|FG000|Overall Study|Physician Decision|8|||
124824448|NCT00754624|448984912|FG000|Overall Study|Protocol Violation|1|||
124824449|NCT00754624|448984912|FG000|Overall Study|Withdrawal by Subject|28|||
124824450|NCT00754624|448984912|FG000|Overall Study|Various|12|||
124824451|NCT00754624|448984912|FG000|Overall Study|Lost to Follow-up|3|||
124824452|NCT00418314|448984913|FG000|Overall Study|Withdrawal by Subject|1|||
124824453|NCT00418314|448984914|FG001|Overall Study|Withdrawal by Subject|2|||
124824454|NCT00710710|448984915|FG000|Overall Study|Consent withdrawn|2|||
124824455|NCT00710710|448984916|FG001|Overall Study|Consent withdrawn|2|||
124824456|NCT00710710|448984915|FG000|Overall Study|Protocol Violation|0|||
124824457|NCT00710710|448984916|FG001|Overall Study|Protocol Violation|1|||
124824458|NCT00710710|448984915|FG000|Overall Study|Adverse Event|3|||
124824459|NCT00710710|448984916|FG001|Overall Study|Adverse Event|3|||
124824460|NCT00710710|448984915|FG000|Overall Study|Progressive disease|40|||
124824461|NCT00710710|448984916|FG001|Overall Study|Progressive disease|38|||
124824462|NCT00715078|448984917|FG000|Overall Study|Death|29|||
124824463|NCT00715078|448984918|FG001|Overall Study|Death|36|||
124824464|NCT00715078|448984919|FG002|Overall Study|Death|36|||
124824465|NCT00715078|448984917|FG000|Overall Study|Withdrawal by Subject|1|||
124824466|NCT00715078|448984918|FG001|Overall Study|Withdrawal by Subject|0|||
124824467|NCT00715078|448984919|FG002|Overall Study|Withdrawal by Subject|1|||
124824468|NCT00715078|448984917|FG000|Overall Study|Unable to start due to disease prog.|0|||
124824469|NCT00715078|448984918|FG001|Overall Study|Unable to start due to disease prog.|0|||
124824470|NCT00715078|448984919|FG002|Overall Study|Unable to start due to disease prog.|1|||
124824471|NCT03263442|448984925|FG000|Inpatient Phase|Death|1|||
124824472|NCT03263442|448984926|FG001|Inpatient Phase|Death|0|||
124824473|NCT03263442|448984925|FG000|Inpatient Phase|Withdrawal by Subject|1|||
124824474|NCT03263442|448984926|FG001|Inpatient Phase|Withdrawal by Subject|0|||
124824475|NCT03263442|448984925|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
124824476|NCT03263442|448984926|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
124824477|NCT03263442|448984925|FG000|1-month Follow-Up|Lost to Follow-up|1|||
124824478|NCT03263442|448984926|FG001|1-month Follow-Up|Lost to Follow-up|0|||
124824479|NCT03263442|448984925|FG000|3-month Follow-Up|Lost to Follow-up|1|||
124824480|NCT03263442|448984926|FG001|3-month Follow-Up|Lost to Follow-up|3|||
124824481|NCT03263442|448984925|FG000|6-month Follow-Up|Lost to Follow-up|2|||
124824482|NCT03263442|448984926|FG001|6-month Follow-Up|Lost to Follow-up|2|||
124824483|NCT01463878|448984927|FG000|Overall Study|no longer met criteria for tube feed|2|||
124824484|NCT01463878|448984928|FG001|Overall Study|no longer met criteria for tube feed|2|||
124824485|NCT03804879|448984929|FG000|Overall Study|Adverse Event|3|||
124824486|NCT03804879|448984930|FG001|Overall Study|Adverse Event|0|||
124824487|NCT03804879|448984929|FG000|Overall Study|Study Terminated By Sponsor|10|||
124824488|NCT03804879|448984930|FG001|Overall Study|Study Terminated By Sponsor|12|||
124824489|NCT03804879|448984929|FG000|Overall Study|Withdrawal by Subject|3|||
124824490|NCT03804879|448984930|FG001|Overall Study|Withdrawal by Subject|1|||
124824491|NCT01585428|448984931|FG000|Overall Study|Death during treatment|1|||
124824492|NCT01585428|448984932|FG001|Overall Study|Death during treatment|0|||
124824493|NCT01084174|448984933|FG000|Overall Study|gastrointestinal symptoms|1|||
124824494|NCT01084174|448984934|FG001|Overall Study|gastrointestinal symptoms|1|||
124824495|NCT01084174|448984933|FG000|Overall Study|Eosinophilic esophagitis|0|||
124824496|NCT01084174|448984934|FG001|Overall Study|Eosinophilic esophagitis|1|||
124824497|NCT01084174|448984933|FG000|Overall Study|Anaphylaxis|0|||
124824498|NCT01084174|448984934|FG001|Overall Study|Anaphylaxis|1|||
124824499|NCT01084174|448984933|FG000|Overall Study|Participant noncompliance|0|||
124824500|NCT01084174|448984934|FG001|Overall Study|Participant noncompliance|1|||
124824501|NCT00673465|448984938|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
125303395|NCT01748825|450736758|FG005|Dose Escalation|Switched to alternative treatment|0|||
124824502|NCT00673465|448984939|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
124824503|NCT00673465|448984940|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
124824504|NCT00673465|448984941|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
124824505|NCT00673465|448984942|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
124824506|NCT00673465|448984943|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
124824507|NCT00673465|448984944|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
124824508|NCT00673465|448984945|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
124824509|NCT00673465|448984946|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
124824510|NCT00673465|448984947|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
124824511|NCT00673465|448984948|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
124824512|NCT00673465|448984949|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
124824513|NCT00673465|448984938|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824514|NCT00673465|448984939|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824515|NCT00673465|448984940|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824516|NCT00673465|448984941|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824517|NCT00673465|448984942|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
124824518|NCT00673465|448984943|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824519|NCT00673465|448984944|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824520|NCT00673465|448984945|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824521|NCT00673465|448984946|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824522|NCT00673465|448984947|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824523|NCT00673465|448984948|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824524|NCT00673465|448984949|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824525|NCT01829191|448984950|FG000|Overall Study|Relocation|0|||
124824526|NCT01829191|448984951|FG001|Overall Study|Relocation|1|||
124824527|NCT01829191|448984950|FG000|Overall Study|Lens discomfort|0|||
124824528|NCT01829191|448984951|FG001|Overall Study|Lens discomfort|3|||
124824529|NCT01829191|448984950|FG000|Overall Study|Lens handling difficulty|1|||
124824530|NCT01829191|448984951|FG001|Overall Study|Lens handling difficulty|4|||
124824531|NCT01829191|448984950|FG000|Overall Study|Protocol Violation|4|||
124824532|NCT01829191|448984951|FG001|Overall Study|Protocol Violation|1|||
124824533|NCT01829191|448984950|FG000|Overall Study|Withdrawal by Subject|2|||
124824534|NCT01829191|448984951|FG001|Overall Study|Withdrawal by Subject|3|||
124824535|NCT01829191|448984950|FG000|Overall Study|Lost to Follow-up|0|||
124824536|NCT01829191|448984951|FG001|Overall Study|Lost to Follow-up|1|||
124824537|NCT01829191|448984950|FG000|Overall Study|Subject was fit for ortho - k|0|||
124824538|NCT01829191|448984951|FG001|Overall Study|Subject was fit for ortho - k|1|||
124824539|NCT00726661|448984952|FG000|Overall Study|Lost to Follow-up|36|||
124824540|NCT00726661|448984953|FG001|Overall Study|Lost to Follow-up|11|||
124824541|NCT00726661|448984952|FG000|Overall Study|Withdrawal by Subject|17|||
124824542|NCT00726661|448984953|FG001|Overall Study|Withdrawal by Subject|13|||
124824543|NCT00726661|448984952|FG000|Overall Study|Trial terminated by sponsor|214|||
124824544|NCT00726661|448984953|FG001|Overall Study|Trial terminated by sponsor|187|||
124824545|NCT00726661|448984952|FG000|Overall Study|Death|475|||
124824546|NCT00726661|448984953|FG001|Overall Study|Death|159|||
124824547|NCT00726661|448984952|FG000|Overall Study|Physician Decision|25|||
124824548|NCT00726661|448984953|FG001|Overall Study|Physician Decision|13|||
124824549|NCT00726661|448984952|FG000|Overall Study|Other|47|||
124824550|NCT00726661|448984953|FG001|Overall Study|Other|35|||
124824551|NCT01996982|448984956|FG000|Overall Study|PI/team left institution|7|||
124824552|NCT01574326|448984957|FG000|Overall Study|Randomized but not treated|0|||
124824553|NCT01574326|448984958|FG001|Overall Study|Randomized but not treated|1|||
124824554|NCT01574326|448984957|FG000|Overall Study|Withdrawal by Participant|2|||
124824555|NCT01574326|448984958|FG001|Overall Study|Withdrawal by Participant|4|||
124824556|NCT01574326|448984957|FG000|Overall Study|Physician Decision|5|||
124824557|NCT01574326|448984958|FG001|Overall Study|Physician Decision|3|||
124824558|NCT01574326|448984957|FG000|Overall Study|Adverse Event|1|||
124824559|NCT01574326|448984958|FG001|Overall Study|Adverse Event|3|||
124824560|NCT01574326|448984957|FG000|Overall Study|Other: Mainly kidney transplant|8|||
125303396|NCT01748825|450736759|FG006|Dose Escalation|Switched to alternative treatment|0|||
125303397|NCT01748825|450736760|FG007|Dose Escalation|Switched to alternative treatment|0|||
125303398|NCT01748825|450736761|FG008|Dose Escalation|Switched to alternative treatment|0|||
125303399|NCT01748825|450736762|FG009|Dose Escalation|Switched to alternative treatment|0|||
125303400|NCT01748825|450736753|FG000|Dose Escalation|Adverse Event|0|||
125303401|NCT01748825|450736754|FG001|Dose Escalation|Adverse Event|0|||
125303402|NCT01748825|450736755|FG002|Dose Escalation|Adverse Event|0|||
125303403|NCT01748825|450736756|FG003|Dose Escalation|Adverse Event|0|||
125303404|NCT01748825|450736757|FG004|Dose Escalation|Adverse Event|0|||
124824561|NCT01574326|448984958|FG001|Overall Study|Other: Mainly kidney transplant|8|||
124824562|NCT04997161|448984981|FG000|Overall Study|Study terminated by sponsor|3|||
124824563|NCT00005937|448984984|FG000|Overall Study|Lack of Efficacy|5|||
124824564|NCT01288469|448984985|FG000|Overall Study|Adverse Event|4|||
124824565|NCT01288469|448984986|FG001|Overall Study|Adverse Event|1|||
124824566|NCT01288469|448984987|FG002|Overall Study|Adverse Event|1|||
124824567|NCT01288469|448984985|FG000|Overall Study|Poor compliance to protocol|0|||
124824568|NCT01288469|448984986|FG001|Overall Study|Poor compliance to protocol|1|||
124824569|NCT01288469|448984987|FG002|Overall Study|Poor compliance to protocol|0|||
124824570|NCT01288469|448984985|FG000|Overall Study|Participant Moved|1|||
124824571|NCT01288469|448984986|FG001|Overall Study|Participant Moved|0|||
124824572|NCT01288469|448984987|FG002|Overall Study|Participant Moved|0|||
124824573|NCT01288469|448984985|FG000|Overall Study|Consent withdrawn by subject|1|||
124824574|NCT01288469|448984986|FG001|Overall Study|Consent withdrawn by subject|1|||
124824575|NCT01288469|448984987|FG002|Overall Study|Consent withdrawn by subject|1|||
124824576|NCT01288469|448984985|FG000|Overall Study|Exclusion criteria finally met|1|||
124824577|NCT01288469|448984986|FG001|Overall Study|Exclusion criteria finally met|0|||
124824578|NCT01288469|448984987|FG002|Overall Study|Exclusion criteria finally met|0|||
124824579|NCT00255047|448984988|FG000|Overall Study|Serious Adverse Events|2|||
124824580|NCT00255047|448984989|FG001|Overall Study|Serious Adverse Events|1|||
124824581|NCT00255047|448984990|FG002|Overall Study|Serious Adverse Events|2|||
124824582|NCT00255047|448984991|FG003|Overall Study|Serious Adverse Events|1|||
124824583|NCT00255047|448984988|FG000|Overall Study|Adverse Event|0|||
124824584|NCT00255047|448984989|FG001|Overall Study|Adverse Event|3|||
124824585|NCT00255047|448984990|FG002|Overall Study|Adverse Event|2|||
124824586|NCT00255047|448984991|FG003|Overall Study|Adverse Event|1|||
124824587|NCT00255047|448984988|FG000|Overall Study|Protocol Violation|13|||
124824588|NCT00255047|448984989|FG001|Overall Study|Protocol Violation|13|||
124824589|NCT00255047|448984990|FG002|Overall Study|Protocol Violation|16|||
124824590|NCT00255047|448984991|FG003|Overall Study|Protocol Violation|20|||
124824591|NCT00255047|448984988|FG000|Overall Study|Lost to Follow-up|9|||
124824592|NCT00255047|448984989|FG001|Overall Study|Lost to Follow-up|8|||
124824593|NCT00255047|448984990|FG002|Overall Study|Lost to Follow-up|5|||
124824594|NCT00255047|448984991|FG003|Overall Study|Lost to Follow-up|6|||
124824595|NCT00255047|448984988|FG000|Overall Study|Withdrawal by Subject|24|||
124824596|NCT00255047|448984989|FG001|Overall Study|Withdrawal by Subject|23|||
124824597|NCT00255047|448984990|FG002|Overall Study|Withdrawal by Subject|25|||
124824598|NCT00255047|448984991|FG003|Overall Study|Withdrawal by Subject|18|||
124824599|NCT01574612|448984992|FG000|Overall Study|Adverse Event|3|||
124824600|NCT01574612|448984992|FG000|Overall Study|non compliant with drug|2|||
124824601|NCT01574612|448984992|FG000|Overall Study|Withdrawal by Subject|1|||
124824602|NCT01574612|448984992|FG000|Overall Study|Lost to Follow-up|2|||
124824603|NCT02452398|448984993|FG000|Overall Study|Adverse Event|1|||
124824604|NCT02452398|448984993|FG000|Overall Study|Lost to Follow-up|28|||
124824605|NCT02452398|448984993|FG000|Overall Study|Physician Decision|2|||
124824606|NCT02452398|448984993|FG000|Overall Study|Withdrawal by Subject|6|||
124824607|NCT02452398|448984993|FG000|Overall Study|Moved away|4|||
124824608|NCT01957644|448984996|FG000|Overall Study|Adverse Event|4|||
124824609|NCT01957644|448984997|FG001|Overall Study|Adverse Event|2|||
124824610|NCT01957644|448984998|FG002|Overall Study|Adverse Event|0|||
124824611|NCT01957644|448984999|FG003|Overall Study|Adverse Event|0|||
124824612|NCT01957644|448985000|FG004|Overall Study|Adverse Event|1|||
124824613|NCT01957644|448984996|FG000|Overall Study|Progressive disease / relapse|0|||
124824614|NCT01957644|448984997|FG001|Overall Study|Progressive disease / relapse|1|||
124824615|NCT01957644|448984998|FG002|Overall Study|Progressive disease / relapse|0|||
124824616|NCT01957644|448984999|FG003|Overall Study|Progressive disease / relapse|1|||
124824617|NCT01957644|448985000|FG004|Overall Study|Progressive disease / relapse|0|||
124824618|NCT01957644|448984996|FG000|Overall Study|Other reason|1|||
124824619|NCT01957644|448984997|FG001|Overall Study|Other reason|2|||
124824620|NCT01957644|448984998|FG002|Overall Study|Other reason|1|||
124824621|NCT01957644|448984999|FG003|Overall Study|Other reason|1|||
124824622|NCT01957644|448985000|FG004|Overall Study|Other reason|0|||
124824623|NCT01957644|448984996|FG000|Overall Study|Withdrawal by Subject|1|||
124824624|NCT01957644|448984997|FG001|Overall Study|Withdrawal by Subject|0|||
124824625|NCT01957644|448984998|FG002|Overall Study|Withdrawal by Subject|0|||
124824626|NCT01957644|448984999|FG003|Overall Study|Withdrawal by Subject|0|||
124824627|NCT01957644|448985000|FG004|Overall Study|Withdrawal by Subject|0|||
124824628|NCT01957644|448984996|FG000|Overall Study|Protocol Violation|0|||
124824629|NCT01957644|448984997|FG001|Overall Study|Protocol Violation|1|||
124824630|NCT01957644|448984998|FG002|Overall Study|Protocol Violation|0|||
124824631|NCT01957644|448984999|FG003|Overall Study|Protocol Violation|0|||
124824632|NCT01957644|448985000|FG004|Overall Study|Protocol Violation|0|||
124824633|NCT00927784|448985001|FG000|Overall Study|Death|1|||
124824634|NCT00927784|448985002|FG001|Overall Study|Death|0|||
124824635|NCT00927784|448985001|FG000|Overall Study|Withdrawal by Subject|1|||
125303405|NCT01748825|450736758|FG005|Dose Escalation|Adverse Event|0|||
124824636|NCT00927784|448985002|FG001|Overall Study|Withdrawal by Subject|0|||
125303406|NCT01748825|450736759|FG006|Dose Escalation|Adverse Event|1|||
124824637|NCT02170051|448985003|FG000|Overall Study|Withdrawal by Subject|10|||
124824638|NCT02170051|448985004|FG001|Overall Study|Withdrawal by Subject|10|||
124824639|NCT02170051|448985003|FG000|Overall Study|Lost to Follow-up|1|||
124824640|NCT02170051|448985004|FG001|Overall Study|Lost to Follow-up|3|||
124824641|NCT01867021|448985005|FG000|Overall Study|Adverse Event|0|||
124824642|NCT01867021|448985006|FG001|Overall Study|Adverse Event|1|||
124824643|NCT01867021|448985005|FG000|Overall Study|Not Eligible|0|||
124824644|NCT01867021|448985006|FG001|Overall Study|Not Eligible|1|||
124824645|NCT01867021|448985005|FG000|Overall Study|Death|1|||
124824646|NCT01867021|448985006|FG001|Overall Study|Death|0|||
124824647|NCT01867021|448985005|FG000|Overall Study|Lost to Follow-up|0|||
124824648|NCT01867021|448985006|FG001|Overall Study|Lost to Follow-up|2|||
124824649|NCT01867021|448985005|FG000|Overall Study|Withdrawal by Subject|1|||
124824650|NCT01867021|448985006|FG001|Overall Study|Withdrawal by Subject|6|||
124824651|NCT00881712|448985007|FG000|Overall Study|Death|1|||
124824652|NCT00881712|448985008|FG001|Overall Study|Death|0|||
124824653|NCT00881712|448985009|FG002|Overall Study|Death|0|||
124824654|NCT00881712|448985007|FG000|Overall Study|Withdrawal by Subject|1|||
124824655|NCT00881712|448985008|FG001|Overall Study|Withdrawal by Subject|0|||
124824656|NCT00881712|448985009|FG002|Overall Study|Withdrawal by Subject|0|||
124824657|NCT01405742|448985017|FG000|Overall Study|Lost to Follow-up|1|||
124824658|NCT01405742|448985018|FG001|Overall Study|Lost to Follow-up|0|||
124824659|NCT03672747|448985020|FG000|Overall Study|Lost to Follow-up|1|||
124824660|NCT03672747|448985021|FG001|Overall Study|Lost to Follow-up|1|||
124824661|NCT03672747|448985022|FG002|Overall Study|Lost to Follow-up|2|||
124824662|NCT03672747|448985023|FG003|Overall Study|Lost to Follow-up|2|||
124824663|NCT03672747|448985024|FG004|Overall Study|Lost to Follow-up|2|||
124824664|NCT03672747|448985025|FG005|Overall Study|Lost to Follow-up|1|||
124824665|NCT03428360|448985026|FG000|Overall Study|Informed consent withdrawn|5|||
124824666|NCT03428360|448985026|FG000|Overall Study|Withdrawal by Subject|4|||
124824667|NCT03428360|448985026|FG000|Overall Study|Lost to Follow-up|5|||
124824668|NCT03428360|448985026|FG000|Overall Study|Physician Decision|2|||
124824669|NCT03428360|448985026|FG000|Overall Study|Informed consent withdrawn|5|||
124824670|NCT03428360|448985026|FG000|Overall Study|Study terminated by sponsor|10|||
124824671|NCT03428360|448985026|FG000|Overall Study|Non-compliant with study|1|||
124824672|NCT03428360|448985026|FG000|Overall Study|Non-compliant with study drug|3|||
124824673|NCT03428360|448985026|FG000|Overall Study|Death|3|||
124824674|NCT03428360|448985026|FG000|Overall Study|Adverse Event|1|||
124824675|NCT03428360|448985026|FG000|Overall Study|Not on antiepileptic drug|1|||
124824676|NCT01529346|448987168|FG000|Overall Study|Lost to Follow-up|2|||
124824677|NCT01529346|448987169|FG001|Overall Study|Lost to Follow-up|0|||
124824678|NCT01529346|448987170|FG002|Overall Study|Lost to Follow-up|1|||
124824679|NCT01529346|448987171|FG003|Overall Study|Lost to Follow-up|0|||
124824680|NCT01529346|448987172|FG004|Overall Study|Lost to Follow-up|0|||
124824681|NCT01529346|448987168|FG000|Overall Study|Other|0|||
124824682|NCT01529346|448987169|FG001|Overall Study|Other|1|||
124824683|NCT01529346|448987170|FG002|Overall Study|Other|1|||
124824684|NCT01529346|448987171|FG003|Overall Study|Other|0|||
124824685|NCT01529346|448987172|FG004|Overall Study|Other|0|||
124824686|NCT00386776|448987173|FG000|Overall Study|Withdrawal by Subject|8|||
124824687|NCT02902965|448987177|FG000|Overall Study|Withdrawal by Subject|10|||
124824688|NCT00232817|448987178|FG000|Overall Study|Protocol Violation|2|||
124824689|NCT00232817|448987179|FG001|Overall Study|Protocol Violation|1|||
124824690|NCT04481750|448987180|FG000|Period 1 (Fasted)|Adverse Event|0|||
124824691|NCT04481750|448987181|FG001|Period 1 (Fasted)|Adverse Event|0|||
124824692|NCT04481750|448987182|FG002|Period 1 (Fasted)|Adverse Event|1|||
124824693|NCT04481750|448987183|FG003|Period 1 (Fasted)|Adverse Event|0|||
124824694|NCT04481750|448987184|FG004|Period 1 (Fasted)|Adverse Event|0|||
124824695|NCT04481750|448987185|FG005|Period 1 (Fasted)|Adverse Event|0|||
124824696|NCT04481750|448987186|FG006|Period 1 (Fasted)|Adverse Event|0|||
124824697|NCT04481750|448987187|FG007|Period 1 (Fasted)|Adverse Event|0|||
124824698|NCT04481750|448987188|FG008|Period 1 (Fasted)|Adverse Event|0|||
124824699|NCT04481750|448987189|FG009|Period 1 (Fasted)|Adverse Event|0|||
124824700|NCT04481750|448987190|FG010|Period 1 (Fasted)|Adverse Event|0|||
124824701|NCT01594125|448987191|FG000|Overall Study|Withdrawal by Subject|1|||
124824702|NCT01594125|448987192|FG001|Overall Study|Withdrawal by Subject|0|||
124824703|NCT01594125|448987193|FG002|Overall Study|Withdrawal by Subject|0|||
124824704|NCT01594125|448987194|FG003|Overall Study|Withdrawal by Subject|1|||
124824705|NCT01594125|448987195|FG004|Overall Study|Withdrawal by Subject|0|||
124824706|NCT01594125|448987191|FG000|Overall Study|Progressive Disease|3|||
124824707|NCT01594125|448987192|FG001|Overall Study|Progressive Disease|12|||
124824708|NCT01594125|448987193|FG002|Overall Study|Progressive Disease|3|||
124824709|NCT01594125|448987194|FG003|Overall Study|Progressive Disease|3|||
124824710|NCT01594125|448987195|FG004|Overall Study|Progressive Disease|7|||
124824711|NCT01484873|448987196|FG000|Overall Study|Withdrawal by Subject|2|||
124824712|NCT02564042|448987197|FG000|Overall Study|Adverse Event|4|||
124824713|NCT02564042|448987198|FG001|Overall Study|Adverse Event|4|||
124824714|NCT02564042|448987199|FG002|Overall Study|Adverse Event|3|||
124824715|NCT02564042|448987200|FG003|Overall Study|Adverse Event|0|||
124824716|NCT02564042|448987201|FG004|Overall Study|Adverse Event|0|||
124824717|NCT02564042|448987202|FG005|Overall Study|Adverse Event|1|||
124824718|NCT02564042|448987197|FG000|Overall Study|Lost to Follow-up|1|||
124824719|NCT02564042|448987198|FG001|Overall Study|Lost to Follow-up|1|||
124824720|NCT02564042|448987199|FG002|Overall Study|Lost to Follow-up|1|||
124824721|NCT02564042|448987200|FG003|Overall Study|Lost to Follow-up|0|||
124824722|NCT02564042|448987201|FG004|Overall Study|Lost to Follow-up|1|||
124824723|NCT02564042|448987202|FG005|Overall Study|Lost to Follow-up|1|||
124824724|NCT02564042|448987197|FG000|Overall Study|Physician Decision|1|||
124824725|NCT02564042|448987198|FG001|Overall Study|Physician Decision|0|||
124824726|NCT02564042|448987199|FG002|Overall Study|Physician Decision|0|||
124824727|NCT02564042|448987200|FG003|Overall Study|Physician Decision|1|||
124824728|NCT02564042|448987201|FG004|Overall Study|Physician Decision|0|||
124824729|NCT02564042|448987202|FG005|Overall Study|Physician Decision|0|||
124824730|NCT02564042|448987197|FG000|Overall Study|Withdrawal by Subject|5|||
124824731|NCT02564042|448987198|FG001|Overall Study|Withdrawal by Subject|3|||
124824732|NCT02564042|448987199|FG002|Overall Study|Withdrawal by Subject|2|||
124824733|NCT02564042|448987200|FG003|Overall Study|Withdrawal by Subject|2|||
124824734|NCT02564042|448987201|FG004|Overall Study|Withdrawal by Subject|10|||
124824735|NCT02564042|448987202|FG005|Overall Study|Withdrawal by Subject|12|||
124824736|NCT01549392|448987203|FG000|Overall Study|Withdrawal by Subject|1|||
124824737|NCT01549392|448987204|FG001|Overall Study|Withdrawal by Subject|0|||
124824738|NCT01356966|448987205|FG000|Overall Study|Withdrawal by Subject|1|||
124824739|NCT01356966|448987206|FG001|Overall Study|Withdrawal by Subject|2|||
124824740|NCT01356966|448987205|FG000|Overall Study|Physician Decision|1|||
124824741|NCT01356966|448987206|FG001|Overall Study|Physician Decision|0|||
124824742|NCT02743806|448987207|FG000|Overall Study|Adverse Event|9|||
124824743|NCT02743806|448987207|FG000|Overall Study|Lost to Follow-up|8|||
124824744|NCT02743806|448987207|FG000|Overall Study|Voluntary Withdrawal|54|||
124824745|NCT02743806|448987207|FG000|Overall Study|Study Termination|65|||
124824746|NCT02743806|448987207|FG000|Overall Study|Pregnancy|6|||
124824747|NCT02743806|448987207|FG000|Overall Study|No Longer Clinically Benefiting|27|||
124824748|NCT02743806|448987207|FG000|Overall Study|Reason Not Specified|12|||
124824749|NCT00849381|448987209|FG000|Overall Study|Adverse Event|1|||
124824750|NCT00849381|448987209|FG000|Overall Study|Lost to Follow-up|129|||
124824751|NCT00849381|448987209|FG000|Overall Study|Protocol Violation|5|||
124824752|NCT00849381|448987209|FG000|Overall Study|Withdrawal by Subject|6|||
124824753|NCT00849381|448987209|FG000|Overall Study|Other|4|||
124824754|NCT00303498|448987210|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
124824755|NCT00303498|448987211|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
124824756|NCT00303498|448987210|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
124824757|NCT00303498|448987211|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
124824758|NCT00303498|448987210|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
124824759|NCT00303498|448987211|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
124824760|NCT00303498|448987210|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
124824761|NCT00303498|448987211|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
124824762|NCT00303498|448987210|FG000|Run-In-Phase (10 Weeks)|Other|4|||
124824763|NCT00303498|448987211|FG001|Run-In-Phase (10 Weeks)|Other|1|||
124824764|NCT00303498|448987210|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
124824765|NCT00303498|448987211|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
124824766|NCT00303498|448987210|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
124824767|NCT00303498|448987211|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
124824768|NCT00303498|448987210|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
124824769|NCT00303498|448987211|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
124824770|NCT00303498|448987210|FG000|Maintenance Phase (24 Weeks)|Death|1|||
124824771|NCT00303498|448987211|FG001|Maintenance Phase (24 Weeks)|Death|0|||
124824772|NCT00303498|448987210|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
124824773|NCT00303498|448987211|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
124824774|NCT00303498|448987210|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
124824775|NCT00303498|448987211|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
124824776|NCT00303498|448987210|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
124824777|NCT00303498|448987211|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
124824778|NCT00303498|448987210|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
124824779|NCT00303498|448987211|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
124824780|NCT00303498|448987210|FG000|Maintenance Phase (24 Weeks)|Other|1|||
124824781|NCT00303498|448987211|FG001|Maintenance Phase (24 Weeks)|Other|0|||
124824782|NCT00303498|448987210|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
124824783|NCT00303498|448987211|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
124824784|NCT00303498|448987210|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
124824785|NCT00303498|448987211|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
125303407|NCT01748825|450736760|FG007|Dose Escalation|Adverse Event|0|||
124824786|NCT01988103|448987217|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
124824787|NCT01988103|448987218|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
124824788|NCT01988103|448987219|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
124824789|NCT01988103|448987220|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
124824790|NCT01988103|448987221|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
124824791|NCT01988103|448987217|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
124824792|NCT01988103|448987218|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
124824793|NCT01988103|448987219|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
124824794|NCT01988103|448987220|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
124824795|NCT01988103|448987221|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
125303408|NCT01748825|450736761|FG008|Dose Escalation|Adverse Event|0|||
124824796|NCT01988103|448987217|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
124824797|NCT01988103|448987218|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
124824798|NCT01988103|448987219|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
124824799|NCT01988103|448987220|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
124824800|NCT01988103|448987221|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
124824801|NCT01988103|448987217|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
124824802|NCT01988103|448987218|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
124824803|NCT01988103|448987219|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
124824804|NCT01988103|448987220|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
124824805|NCT01988103|448987221|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
124824806|NCT01988103|448987217|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
124824807|NCT01988103|448987218|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
124824808|NCT01988103|448987219|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
124824809|NCT01988103|448987220|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
124824810|NCT01988103|448987221|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
124824811|NCT01988103|448987217|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
124824812|NCT01988103|448987218|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
124824813|NCT01988103|448987219|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
124824814|NCT01988103|448987220|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
124824815|NCT01988103|448987221|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
124824816|NCT01988103|448987217|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
124824817|NCT01988103|448987218|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
124824818|NCT01988103|448987219|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
124824819|NCT01988103|448987220|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
124824820|NCT01988103|448987221|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
124824821|NCT03590041|448987222|FG000|Overall Study|Protocol Violation|4|||
124824822|NCT03590041|448987223|FG001|Overall Study|Protocol Violation|3|||
124824823|NCT03590041|448987222|FG000|Overall Study|No session data recorded|14|||
124824824|NCT03590041|448987223|FG001|Overall Study|No session data recorded|2|||
124824825|NCT02289898|448987227|FG000|Overall Study|Death|5|||
124824826|NCT02289898|448987228|FG001|Overall Study|Death|4|||
124824827|NCT02289898|448987229|FG002|Overall Study|Death|3|||
124824828|NCT02289898|448987227|FG000|Overall Study|Physician Decision|2|||
124824829|NCT02289898|448987228|FG001|Overall Study|Physician Decision|5|||
124824830|NCT02289898|448987229|FG002|Overall Study|Physician Decision|2|||
124824831|NCT02289898|448987227|FG000|Overall Study|Withdrawal by Subject|0|||
124824832|NCT02289898|448987228|FG001|Overall Study|Withdrawal by Subject|4|||
124824833|NCT02289898|448987229|FG002|Overall Study|Withdrawal by Subject|1|||
124824834|NCT02289898|448987227|FG000|Overall Study|Adverse Event|3|||
124824835|NCT02289898|448987228|FG001|Overall Study|Adverse Event|5|||
124824836|NCT02289898|448987229|FG002|Overall Study|Adverse Event|5|||
124824837|NCT02289898|448987227|FG000|Overall Study|Disease progression|34|||
124824838|NCT02289898|448987228|FG001|Overall Study|Disease progression|28|||
124824839|NCT02289898|448987229|FG002|Overall Study|Disease progression|34|||
124824840|NCT02289898|448987227|FG000|Overall Study|Use of another anticancer therapy|0|||
124824841|NCT02289898|448987228|FG001|Overall Study|Use of another anticancer therapy|0|||
124824842|NCT02289898|448987229|FG002|Overall Study|Use of another anticancer therapy|1|||
124824843|NCT02289898|448987227|FG000|Overall Study|Other|8|||
124824844|NCT02289898|448987228|FG001|Overall Study|Other|7|||
124824845|NCT02289898|448987229|FG002|Overall Study|Other|10|||
124824846|NCT00103142|448987235|FG000|Overall Study|Adverse Event|1|||
124824847|NCT00103142|448987236|FG001|Overall Study|Adverse Event|0|||
124824848|NCT00103142|448987235|FG000|Overall Study|Progression of disease|2|||
124824849|NCT00103142|448987236|FG001|Overall Study|Progression of disease|1|||
124824850|NCT02598076|448987238|FG000|Overall Study|Lost to Follow-up|2|||
124824851|NCT02598076|448987239|FG001|Overall Study|Lost to Follow-up|3|||
124824852|NCT01946425|448987240|FG000|Overall Study|Protocol Violation|1|||
124824853|NCT01946425|448987241|FG001|Overall Study|Protocol Violation|0|||
124824854|NCT01946425|448987240|FG000|Overall Study|Withdrawal by Subject|1|||
124824855|NCT01946425|448987241|FG001|Overall Study|Withdrawal by Subject|0|||
125303409|NCT01748825|450736762|FG009|Dose Escalation|Adverse Event|0|||
125303410|NCT01748825|450736753|FG000|Dose Expansion|Refused further treatment|0|||
124824856|NCT03527966|448987242|FG000|Overall Study|Lost to Follow-up|3|||
124824857|NCT03527966|448987243|FG001|Overall Study|Lost to Follow-up|0|||
124824858|NCT00558025|448987244|FG000|Overall Study|Adverse Event|1|||
124824859|NCT00558025|448987245|FG001|Overall Study|Adverse Event|1|||
124824860|NCT00558025|448987244|FG000|Overall Study|Withdrawal by Subject|2|||
125303411|NCT01748825|450736754|FG001|Dose Expansion|Refused further treatment|0|||
125303412|NCT01748825|450736755|FG002|Dose Expansion|Refused further treatment|0|||
124824861|NCT00558025|448987245|FG001|Overall Study|Withdrawal by Subject|2|||
124824862|NCT00558025|448987244|FG000|Overall Study|Protocol Violation|1|||
124824863|NCT00558025|448987245|FG001|Overall Study|Protocol Violation|0|||
124824864|NCT03315208|448987246|FG000|Overall Study|Lost to Follow-up|11|||
124824865|NCT03315208|448987247|FG001|Overall Study|Lost to Follow-up|6|||
124824866|NCT03315208|448987246|FG000|Overall Study|Withdrawal by Subject|2|||
124824867|NCT03315208|448987247|FG001|Overall Study|Withdrawal by Subject|0|||
124824868|NCT00276159|448987253|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
124824869|NCT00333866|448987256|FG000|Overall Study|Adverse Event|23|||
124824870|NCT00333866|448987257|FG001|Overall Study|Adverse Event|37|||
124824871|NCT00333866|448987258|FG002|Overall Study|Adverse Event|38|||
124824872|NCT00333866|448987259|FG003|Overall Study|Adverse Event|47|||
124824873|NCT00333866|448987256|FG000|Overall Study|Other|3|||
124824874|NCT00333866|448987257|FG001|Overall Study|Other|2|||
124824875|NCT00333866|448987258|FG002|Overall Study|Other|2|||
124824876|NCT00333866|448987259|FG003|Overall Study|Other|2|||
124824877|NCT00333866|448987256|FG000|Overall Study|Lack of Efficacy|8|||
124824878|NCT00333866|448987257|FG001|Overall Study|Lack of Efficacy|6|||
124824879|NCT00333866|448987258|FG002|Overall Study|Lack of Efficacy|3|||
124824880|NCT00333866|448987259|FG003|Overall Study|Lack of Efficacy|5|||
124824881|NCT00333866|448987256|FG000|Overall Study|Lost to Follow-up|1|||
124824882|NCT00333866|448987257|FG001|Overall Study|Lost to Follow-up|2|||
124824883|NCT00333866|448987258|FG002|Overall Study|Lost to Follow-up|2|||
124824884|NCT00333866|448987259|FG003|Overall Study|Lost to Follow-up|2|||
124824885|NCT00333866|448987256|FG000|Overall Study|Withdrawal by Subject|8|||
124824886|NCT00333866|448987257|FG001|Overall Study|Withdrawal by Subject|14|||
124824887|NCT00333866|448987258|FG002|Overall Study|Withdrawal by Subject|4|||
124824888|NCT00333866|448987259|FG003|Overall Study|Withdrawal by Subject|9|||
124824889|NCT00333866|448987256|FG000|Overall Study|Randomized but not Treated|5|||
124824890|NCT00333866|448987257|FG001|Overall Study|Randomized but not Treated|3|||
124824891|NCT00333866|448987258|FG002|Overall Study|Randomized but not Treated|2|||
124824892|NCT00333866|448987259|FG003|Overall Study|Randomized but not Treated|1|||
124824893|NCT01359449|448987272|FG000|Overall Study|Lost to Follow-up|1|||
124824894|NCT01359449|448987273|FG001|Overall Study|Lost to Follow-up|0|||
124824895|NCT01359449|448987272|FG000|Overall Study|Protocol Violation|0|||
124824896|NCT01359449|448987273|FG001|Overall Study|Protocol Violation|2|||
124824897|NCT01359449|448987272|FG000|Overall Study|Withdrawal by Subject|3|||
124824898|NCT01359449|448987273|FG001|Overall Study|Withdrawal by Subject|2|||
124824899|NCT02393547|448987275|FG000|Overall Study|Adverse Event|2|||
124824900|NCT02393547|448987275|FG000|Overall Study|Withdrawal by Subject|3|||
124824901|NCT02393547|448987275|FG000|Overall Study|Lost to Follow-up|1|||
124824902|NCT02927431|448987276|FG000|Overall Study|Withdrawal by Subject|0|||
124824903|NCT02927431|448987277|FG001|Overall Study|Withdrawal by Subject|0|||
124824904|NCT02927431|448987278|FG002|Overall Study|Withdrawal by Subject|1|||
124824905|NCT00429104|448987279|FG000|Overall Study|Protocol Violation|1|||
124824906|NCT01285310|448987281|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
124824907|NCT01285310|448987282|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
124824908|NCT01285310|448987283|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
124824909|NCT01285310|448987284|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
124824910|NCT01285310|448987285|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
124824911|NCT01285310|448987281|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
124824912|NCT01285310|448987282|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
124824913|NCT01285310|448987283|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
124824914|NCT01285310|448987284|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
124824915|NCT01285310|448987285|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
124824916|NCT01285310|448987281|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
124824917|NCT01285310|448987282|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
124824918|NCT01285310|448987283|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
124824919|NCT01285310|448987284|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
124824920|NCT01285310|448987285|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
124824921|NCT01285310|448987281|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
124824922|NCT01285310|448987282|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
125303413|NCT01748825|450736756|FG003|Dose Expansion|Refused further treatment|0|||
125303414|NCT01748825|450736757|FG004|Dose Expansion|Refused further treatment|0|||
125303415|NCT01748825|450736758|FG005|Dose Expansion|Refused further treatment|0|||
124824923|NCT01285310|448987283|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
124824924|NCT01285310|448987284|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
124824925|NCT01285310|448987285|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
124824926|NCT01285310|448987281|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
124824927|NCT01285310|448987282|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
124824928|NCT01285310|448987283|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
124824929|NCT01285310|448987284|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
124824930|NCT01285310|448987285|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
124824931|NCT01285310|448987281|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
124824932|NCT01285310|448987282|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
124824933|NCT01285310|448987283|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
124824934|NCT01285310|448987284|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
124824935|NCT01285310|448987285|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
124824936|NCT01285310|448987281|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
124824937|NCT01285310|448987282|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
124824938|NCT01285310|448987283|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
124824939|NCT01285310|448987284|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
124824940|NCT01285310|448987285|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
124824941|NCT01285310|448987281|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
124824942|NCT01285310|448987282|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
124824943|NCT01285310|448987283|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
124824944|NCT01285310|448987284|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
124824945|NCT01285310|448987285|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
124824946|NCT01285310|448987281|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
124824947|NCT01285310|448987282|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
124824948|NCT01285310|448987283|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
124824949|NCT01285310|448987284|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
124824950|NCT01285310|448987285|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
124824951|NCT01285310|448987281|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
124824952|NCT01285310|448987282|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
124824953|NCT01285310|448987283|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
124824954|NCT01285310|448987284|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
124824955|NCT01285310|448987285|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
124824956|NCT01285310|448987281|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
124824957|NCT01285310|448987282|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
124824958|NCT01285310|448987283|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
124824959|NCT01285310|448987284|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
124824960|NCT01285310|448987285|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
124824961|NCT01285310|448987281|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
124824962|NCT01285310|448987282|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
124824963|NCT01285310|448987283|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
124824964|NCT01285310|448987284|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
124824965|NCT01285310|448987285|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
124824966|NCT00143403|448987286|FG000|Overall Study|Adverse Event|3|||
124824967|NCT00143403|448987287|FG001|Overall Study|Adverse Event|8|||
124824968|NCT00143403|448987286|FG000|Overall Study|Death|1|||
124824969|NCT00143403|448987287|FG001|Overall Study|Death|0|||
124824970|NCT00143403|448987286|FG000|Overall Study|Withdrawal by Subject|3|||
124824971|NCT00143403|448987287|FG001|Overall Study|Withdrawal by Subject|12|||
124824972|NCT00143403|448987286|FG000|Overall Study|Relapse|15|||
124824973|NCT00143403|448987287|FG001|Overall Study|Relapse|7|||
124824974|NCT00143403|448987286|FG000|Overall Study|Protocol Violation|2|||
124824975|NCT00143403|448987287|FG001|Overall Study|Protocol Violation|2|||
124824976|NCT00143403|448987286|FG000|Overall Study|specified by site|4|||
124824977|NCT00143403|448987287|FG001|Overall Study|specified by site|9|||
124824978|NCT00143403|448987286|FG000|Overall Study|Randomized Not Treated|7|||
124824979|NCT00143403|448987287|FG001|Overall Study|Randomized Not Treated|8|||
124824980|NCT00514540|448987288|FG000|First-Line Chemo|Withdrawal by Subject|1|||
124824981|NCT00514540|448987288|FG000|First-Line Chemo|Protocol Violation|7|||
124824982|NCT00514540|448987288|FG000|Second-Line|Physician/Patient Decision|31|||
124824983|NCT00587639|448987289|FG000|Overall Study|Withdrawal by Subject|1|||
124824984|NCT03402386|448987290|FG000|Overall Study|Adverse Event|3|||
124824985|NCT03402386|448987290|FG000|Overall Study|Physician Decision|1|||
124824986|NCT03402386|448987290|FG000|Overall Study|Difficult to control Hb|2|||
124824987|NCT01896531|448987291|FG000|Overall Study|Death|57|||
124824988|NCT01896531|448987292|FG001|Overall Study|Death|59|||
124824989|NCT01896531|448987291|FG000|Overall Study|Lost to Follow-up|3|||
124824990|NCT01896531|448987292|FG001|Overall Study|Lost to Follow-up|0|||
124824991|NCT01896531|448987291|FG000|Overall Study|Non-compliance|0|||
124824992|NCT01896531|448987292|FG001|Overall Study|Non-compliance|1|||
124824993|NCT01896531|448987291|FG000|Overall Study|Study Ended by Sponsor|7|||
124824994|NCT01896531|448987292|FG001|Overall Study|Study Ended by Sponsor|20|||
124824995|NCT01896531|448987291|FG000|Overall Study|Withdrawal by Subject|3|||
124824996|NCT01896531|448987292|FG001|Overall Study|Withdrawal by Subject|2|||
124824997|NCT01896531|448987291|FG000|Overall Study|Death Prior to Treatment|1|||
124824998|NCT01896531|448987292|FG001|Overall Study|Death Prior to Treatment|0|||
124824999|NCT01195415|448987295|FG000|Overall Study|No repeat biopsy due to progression|2|||
124825000|NCT00533845|448987296|FG000|Overall Study|Physician Decision|1|||
124825001|NCT00533845|448987297|FG001|Overall Study|Physician Decision|0|||
124825002|NCT02956486|448987298|FG000|Core Phase|Adverse Event|51|||
124825003|NCT02956486|448987299|FG001|Core Phase|Adverse Event|88|||
124825004|NCT02956486|448987300|FG002|Core Phase|Adverse Event|0|||
124825005|NCT02956486|448987298|FG000|Core Phase|Lost to Follow-up|8|||
124825006|NCT02956486|448987299|FG001|Core Phase|Lost to Follow-up|6|||
124825007|NCT02956486|448987300|FG002|Core Phase|Lost to Follow-up|0|||
124825008|NCT02956486|448987298|FG000|Core Phase|Inadequate therapeutic effect|4|||
124825009|NCT02956486|448987299|FG001|Core Phase|Inadequate therapeutic effect|5|||
124825010|NCT02956486|448987300|FG002|Core Phase|Inadequate therapeutic effect|0|||
124825011|NCT02956486|448987298|FG000|Core Phase|Withdrawal by Subject|101|||
124825012|NCT02956486|448987299|FG001|Core Phase|Withdrawal by Subject|104|||
124825013|NCT02956486|448987300|FG002|Core Phase|Withdrawal by Subject|0|||
124825014|NCT02956486|448987298|FG000|Core Phase|Study terminated by sponsor|888|||
124825015|NCT02956486|448987299|FG001|Core Phase|Study terminated by sponsor|848|||
124825016|NCT02956486|448987300|FG002|Core Phase|Study terminated by sponsor|0|||
124825017|NCT02956486|448987298|FG000|Core Phase|Other|27|||
124825018|NCT02956486|448987299|FG001|Core Phase|Other|18|||
124825019|NCT02956486|448987300|FG002|Core Phase|Other|0|||
124825020|NCT02956486|448987298|FG000|Core Phase|Not treated|0|||
124825021|NCT02956486|448987299|FG001|Core Phase|Not treated|3|||
124825022|NCT02956486|448987300|FG002|Core Phase|Not treated|0|||
124825023|NCT02956486|448987298|FG000|Extension Phase|Adverse Event|0|||
124825024|NCT02956486|448987299|FG001|Extension Phase|Adverse Event|0|||
124825025|NCT02956486|448987300|FG002|Extension Phase|Adverse Event|2|||
124825026|NCT02956486|448987298|FG000|Extension Phase|Study terminated by sponsor|0|||
124825027|NCT02956486|448987299|FG001|Extension Phase|Study terminated by sponsor|0|||
124825028|NCT02956486|448987300|FG002|Extension Phase|Study terminated by sponsor|16|||
124825029|NCT02956486|448987298|FG000|Extension Phase|Not Treated|0|||
124825030|NCT02956486|448987299|FG001|Extension Phase|Not Treated|0|||
124825031|NCT02956486|448987300|FG002|Extension Phase|Not Treated|1|||
124825032|NCT03241342|448987301|FG000|Overall Study|Adverse Event|5|||
124825033|NCT03241342|448987302|FG001|Overall Study|Adverse Event|8|||
124825034|NCT03241342|448987303|FG002|Overall Study|Adverse Event|4|||
124825035|NCT03241342|448987301|FG000|Overall Study|Lack of Efficacy|0|||
124825036|NCT03241342|448987302|FG001|Overall Study|Lack of Efficacy|0|||
124825037|NCT03241342|448987303|FG002|Overall Study|Lack of Efficacy|1|||
124825038|NCT03241342|448987301|FG000|Overall Study|noncompliance with study drug|2|||
124825039|NCT03241342|448987302|FG001|Overall Study|noncompliance with study drug|1|||
124825040|NCT03241342|448987303|FG002|Overall Study|noncompliance with study drug|1|||
124825041|NCT03241342|448987301|FG000|Overall Study|sponsor decision|0|||
124825042|NCT03241342|448987302|FG001|Overall Study|sponsor decision|1|||
124825043|NCT03241342|448987303|FG002|Overall Study|sponsor decision|2|||
124825044|NCT03241342|448987301|FG000|Overall Study|not reported|15|||
124825045|NCT03241342|448987302|FG001|Overall Study|not reported|21|||
124825046|NCT03241342|448987303|FG002|Overall Study|not reported|19|||
124825047|NCT01846611|448987306|FG000|Overall Study|Lost to Follow-up|4|||
124825048|NCT01846611|448987307|FG001|Overall Study|Lost to Follow-up|6|||
124825049|NCT01846611|448987306|FG000|Overall Study|Withdrawal by Subject|15|||
124825050|NCT01846611|448987307|FG001|Overall Study|Withdrawal by Subject|19|||
125303416|NCT01748825|450736759|FG006|Dose Expansion|Refused further treatment|0|||
125303417|NCT01748825|450736760|FG007|Dose Expansion|Refused further treatment|0|||
125303418|NCT01748825|450736761|FG008|Dose Expansion|Refused further treatment|1|||
125303419|NCT01748825|450736762|FG009|Dose Expansion|Refused further treatment|1|||
125303420|NCT01748825|450736753|FG000|Dose Expansion|Switched to alternative treatment|0|||
125303421|NCT01748825|450736754|FG001|Dose Expansion|Switched to alternative treatment|0|||
125303422|NCT01748825|450736755|FG002|Dose Expansion|Switched to alternative treatment|0|||
125303423|NCT01748825|450736756|FG003|Dose Expansion|Switched to alternative treatment|0|||
125303424|NCT01748825|450736757|FG004|Dose Expansion|Switched to alternative treatment|0|||
125303425|NCT01748825|450736758|FG005|Dose Expansion|Switched to alternative treatment|0|||
125303426|NCT01748825|450736759|FG006|Dose Expansion|Switched to alternative treatment|0|||
125303427|NCT01748825|450736760|FG007|Dose Expansion|Switched to alternative treatment|0|||
125303428|NCT01748825|450736761|FG008|Dose Expansion|Switched to alternative treatment|0|||
125303429|NCT01748825|450736762|FG009|Dose Expansion|Switched to alternative treatment|1|||
125303430|NCT01748825|450736753|FG000|Dose Expansion|Adverse Event|0|||
125303431|NCT01748825|450736754|FG001|Dose Expansion|Adverse Event|0|||
125303432|NCT01748825|450736755|FG002|Dose Expansion|Adverse Event|0|||
125303433|NCT01748825|450736756|FG003|Dose Expansion|Adverse Event|0|||
125303434|NCT01748825|450736757|FG004|Dose Expansion|Adverse Event|0|||
125303435|NCT01748825|450736758|FG005|Dose Expansion|Adverse Event|0|||
125303436|NCT01748825|450736759|FG006|Dose Expansion|Adverse Event|0|||
125303437|NCT01748825|450736760|FG007|Dose Expansion|Adverse Event|0|||
125303438|NCT01748825|450736761|FG008|Dose Expansion|Adverse Event|0|||
125303439|NCT01748825|450736762|FG009|Dose Expansion|Adverse Event|3|||
125303440|NCT01748825|450736753|FG000|Dose Expansion|Physician Decision|0|||
125303441|NCT01748825|450736754|FG001|Dose Expansion|Physician Decision|0|||
124825051|NCT01846611|448987306|FG000|Overall Study|Other|19|||
124825052|NCT01846611|448987307|FG001|Overall Study|Other|18|||
124825053|NCT02671422|448987311|FG000|Overall Study|Lost to Follow-up|1|||
124825054|NCT02671422|448987311|FG000|Overall Study|Adverse Event|68|||
124825055|NCT02671422|448987311|FG000|Overall Study|Lack of Efficacy|1|||
124825056|NCT02671422|448987311|FG000|Overall Study|Lost to Follow-up|4|||
124825057|NCT02671422|448987311|FG000|Overall Study|Withdrawal by Subject|7|||
124825058|NCT02671422|448987311|FG000|Overall Study|Progressive Disease|156|||
124825059|NCT02671422|448987311|FG000|Overall Study|Worsening of Disease|4|||
124825060|NCT02671422|448987311|FG000|Overall Study|Sponsor decision|5|||
124825061|NCT02671422|448987311|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
124825062|NCT02671422|448987311|FG000|Overall Study|Not treated with Vargatef®|3|||
124825063|NCT02671422|448987311|FG000|Overall Study|Other not defined above|3|||
124825064|NCT04772755|448987312|FG000|Overall Study|Withdrawal by Subject|1|||
124825065|NCT04772755|448987313|FG001|Overall Study|Withdrawal by Subject|0|||
124825066|NCT04772755|448987312|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
124825067|NCT04772755|448987313|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
124825068|NCT01905657|448987314|FG000|Overall Study|Adverse Event|23|||
124825069|NCT01905657|448987315|FG001|Overall Study|Adverse Event|17|||
124825070|NCT01905657|448987316|FG002|Overall Study|Adverse Event|18|||
124825071|NCT01905657|448987314|FG000|Overall Study|Clinical Progression|103|||
124825072|NCT01905657|448987315|FG001|Overall Study|Clinical Progression|78|||
124825073|NCT01905657|448987316|FG002|Overall Study|Clinical Progression|59|||
124825074|NCT01905657|448987314|FG000|Overall Study|Death|40|||
124825075|NCT01905657|448987315|FG001|Overall Study|Death|43|||
124825076|NCT01905657|448987316|FG002|Overall Study|Death|47|||
124825077|NCT01905657|448987314|FG000|Overall Study|Excluded Medication|13|||
124825078|NCT01905657|448987315|FG001|Overall Study|Excluded Medication|16|||
124825079|NCT01905657|448987316|FG002|Overall Study|Excluded Medication|9|||
124825080|NCT01905657|448987314|FG000|Overall Study|Lost to Follow-up|1|||
124825081|NCT01905657|448987315|FG001|Overall Study|Lost to Follow-up|2|||
124825082|NCT01905657|448987316|FG002|Overall Study|Lost to Follow-up|1|||
124825083|NCT01905657|448987314|FG000|Overall Study|Physician Decision|5|||
124825084|NCT01905657|448987315|FG001|Overall Study|Physician Decision|8|||
124825085|NCT01905657|448987316|FG002|Overall Study|Physician Decision|12|||
124825086|NCT01905657|448987314|FG000|Overall Study|Protocol Violation|2|||
124825087|NCT01905657|448987315|FG001|Overall Study|Protocol Violation|1|||
124825088|NCT01905657|448987316|FG002|Overall Study|Protocol Violation|1|||
124825089|NCT01905657|448987314|FG000|Overall Study|Screen Failure|0|||
124825090|NCT01905657|448987315|FG001|Overall Study|Screen Failure|1|||
124825091|NCT01905657|448987316|FG002|Overall Study|Screen Failure|0|||
124825092|NCT01905657|448987314|FG000|Overall Study|Withdrawal by Subject|15|||
124825093|NCT01905657|448987315|FG001|Overall Study|Withdrawal by Subject|21|||
124825094|NCT01905657|448987316|FG002|Overall Study|Withdrawal by Subject|53|||
124825095|NCT01905657|448987314|FG000|Overall Study|Sponsor Decision|1|||
124825096|NCT01905657|448987315|FG001|Overall Study|Sponsor Decision|0|||
124825097|NCT01905657|448987316|FG002|Overall Study|Sponsor Decision|0|||
124825098|NCT02744391|448987318|FG000|Overall Study|Lost to Follow-up|9|||
124825099|NCT02744391|448987318|FG000|Overall Study|Physician Decision|2|||
124825100|NCT02744391|448987318|FG000|Overall Study|Withdrawal by Subject|3|||
124825101|NCT01996709|448987319|FG000|Overall Study|Withdrawal by Subject|1|||
124825102|NCT01996709|448987320|FG001|Overall Study|Withdrawal by Subject|0|||
124825103|NCT01996709|448987319|FG000|Overall Study|Lost to Follow-up|3|||
124825104|NCT01996709|448987320|FG001|Overall Study|Lost to Follow-up|0|||
124825105|NCT01996709|448987319|FG000|Overall Study|Subject Non-Compliant|1|||
124825106|NCT01996709|448987320|FG001|Overall Study|Subject Non-Compliant|0|||
124825107|NCT01996709|448987319|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
124825108|NCT01996709|448987320|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
124825109|NCT04702997|448987321|FG000|Overall Study|Withdrawal by Subject|1|||
124825110|NCT04702997|448987322|FG001|Overall Study|Withdrawal by Subject|1|||
124825111|NCT03915496|448987324|FG000|Overall Study|Adverse Event|2|||
124825112|NCT03915496|448987325|FG001|Overall Study|Adverse Event|1|||
124825113|NCT03915496|448987326|FG002|Overall Study|Adverse Event|2|||
124825114|NCT03032705|448987335|FG000|Overall Study|Lost to Follow-up|16|||
124825115|NCT03032705|448987336|FG001|Overall Study|Lost to Follow-up|17|||
124825116|NCT03032705|448987335|FG000|Overall Study|did not quality|6|||
124825117|NCT03032705|448987336|FG001|Overall Study|did not quality|6|||
124825118|NCT02825992|448988892|FG000|Overall Study|Withdrawal by Subject|4|||
124825119|NCT02825992|448988892|FG000|Overall Study|Lost to Follow-up|2|||
124825120|NCT02825992|448988892|FG000|Overall Study|Procedure terminated|2|||
124825121|NCT02279173|448988893|FG000|Overall Study|Protocol-specified Criteria|67|||
124825122|NCT02279173|448988893|FG000|Overall Study|Withdrawal by Subject|20|||
124825123|NCT02279173|448988893|FG000|Overall Study|Decision by Sponsor|4|||
124825124|NCT02279173|448988893|FG000|Overall Study|Lost to Follow-up|3|||
124825125|NCT00157950|448988894|FG000|Overall Study|Death|1|||
124825126|NCT00157950|448988895|FG001|Overall Study|Death|0|||
124825127|NCT02892760|448988896|FG000|Overall Study|Withdrawal by Subject|3|||
124825128|NCT01499667|448988897|FG000|Overall Study|administrative problems|4|||
124825129|NCT01499667|448988898|FG001|Overall Study|administrative problems|5|||
124825130|NCT01499667|448988899|FG002|Overall Study|administrative problems|5|||
124825131|NCT01499667|448988897|FG000|Overall Study|Protocol Violation|1|||
124825132|NCT01499667|448988898|FG001|Overall Study|Protocol Violation|3|||
124825133|NCT01499667|448988899|FG002|Overall Study|Protocol Violation|2|||
124825134|NCT01499667|448988897|FG000|Overall Study|Adverse Event|0|||
124825135|NCT01499667|448988898|FG001|Overall Study|Adverse Event|2|||
124825136|NCT01499667|448988899|FG002|Overall Study|Adverse Event|2|||
124825137|NCT01499667|448988897|FG000|Overall Study|Withdrawal by Subject|2|||
124825138|NCT01499667|448988898|FG001|Overall Study|Withdrawal by Subject|1|||
124825139|NCT01499667|448988899|FG002|Overall Study|Withdrawal by Subject|1|||
124825140|NCT01499667|448988897|FG000|Overall Study|Lack of Efficacy|2|||
124825141|NCT01499667|448988898|FG001|Overall Study|Lack of Efficacy|0|||
124825142|NCT01499667|448988899|FG002|Overall Study|Lack of Efficacy|0|||
124825143|NCT02673489|448988900|FG000|Treatment Period|Lost to Follow-up|3|||
124825144|NCT02673489|448988901|FG001|Treatment Period|Lost to Follow-up|0|||
124825145|NCT02673489|448988900|FG000|Treatment Period|Participant request to discontinue|1|||
124825146|NCT02673489|448988901|FG001|Treatment Period|Participant request to discontinue|1|||
125303442|NCT01748825|450736755|FG002|Dose Expansion|Physician Decision|0|||
125303443|NCT01748825|450736756|FG003|Dose Expansion|Physician Decision|0|||
125303444|NCT01748825|450736757|FG004|Dose Expansion|Physician Decision|0|||
125303445|NCT01748825|450736758|FG005|Dose Expansion|Physician Decision|0|||
125303446|NCT01748825|450736759|FG006|Dose Expansion|Physician Decision|0|||
125303447|NCT01748825|450736760|FG007|Dose Expansion|Physician Decision|0|||
125303448|NCT01748825|450736761|FG008|Dose Expansion|Physician Decision|1|||
125303449|NCT01748825|450736762|FG009|Dose Expansion|Physician Decision|0|||
124825147|NCT02673489|448988900|FG000|Treatment Period|Participant moved to another province|1|||
124825148|NCT02673489|448988901|FG001|Treatment Period|Participant moved to another province|0|||
124825149|NCT02673489|448988900|FG000|Treatment Period|Participant was incarcerated|0|||
124825150|NCT02673489|448988901|FG001|Treatment Period|Participant was incarcerated|1|||
124825151|NCT02673489|448988900|FG000|Treatment Period|Adverse Event|0|||
124825152|NCT02673489|448988901|FG001|Treatment Period|Adverse Event|1|||
124825153|NCT02673489|448988900|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
124825154|NCT02673489|448988901|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
124825155|NCT02673489|448988900|FG000|Follow Up Period|Unable to return for follow-up|0|||
124825156|NCT02673489|448988901|FG001|Follow Up Period|Unable to return for follow-up|1|||
124825157|NCT00293254|448988902|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
124825158|NCT00293254|448988903|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
125303450|NCT00852241|450736764|FG000|Overall Study|Physician Decision|18|||
125303451|NCT00118430|450736766|FG000|Overall Study|Withdrawal by Subject|6|||
125303452|NCT00118430|450736767|FG001|Overall Study|Withdrawal by Subject|2|||
124825159|NCT00293254|448988902|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
124825160|NCT00293254|448988903|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
124825161|NCT00293254|448988902|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
124825162|NCT00293254|448988903|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
124825163|NCT00293254|448988902|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
124825164|NCT00293254|448988903|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
124825165|NCT00293254|448988902|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
124825166|NCT00293254|448988903|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
124825167|NCT00293254|448988902|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
124825168|NCT00293254|448988903|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
124825169|NCT00293254|448988902|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
124825170|NCT00293254|448988903|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
124825171|NCT00293254|448988902|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
124825172|NCT00293254|448988903|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
124825173|NCT00293254|448988902|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
124825174|NCT00293254|448988903|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
124825175|NCT00293254|448988902|FG000|Extension - Double-Blind Week 49-156|Death|4|||
124825176|NCT00293254|448988903|FG001|Extension - Double-Blind Week 49-156|Death|1|||
124825177|NCT00293254|448988902|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
124825178|NCT00293254|448988903|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
124825179|NCT00293254|448988902|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
124825180|NCT00293254|448988903|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
124825181|NCT00293254|448988902|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
124825182|NCT00293254|448988903|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
124825183|NCT00293254|448988902|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
124825184|NCT00293254|448988903|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
124825185|NCT00293254|448988902|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
124825186|NCT00293254|448988903|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
124825187|NCT00293254|448988902|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
124825188|NCT00293254|448988903|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
124825189|NCT00293254|448988902|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
124825190|NCT00293254|448988903|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
124825191|NCT00293254|448988902|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
124825192|NCT00293254|448988903|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
124825193|NCT00293254|448988902|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
124825194|NCT00293254|448988903|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
124825195|NCT00293254|448988902|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
125303453|NCT00118430|450736768|FG002|Overall Study|Withdrawal by Subject|0|||
125303454|NCT00118430|450736766|FG000|Overall Study|Lost to Follow-up|15|||
124825196|NCT00293254|448988903|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
124825197|NCT00293254|448988902|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
124825198|NCT00293254|448988903|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
124825199|NCT00293254|448988902|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
124825200|NCT00293254|448988903|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
124825201|NCT00293254|448988902|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
124825202|NCT00293254|448988903|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
124825203|NCT00293254|448988902|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
124825204|NCT00293254|448988903|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
124825205|NCT00293254|448988902|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
124825206|NCT00293254|448988903|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
124825207|NCT00293254|448988902|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
124825208|NCT00293254|448988903|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
124825209|NCT00293254|448988902|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
124825210|NCT00293254|448988903|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
124825211|NCT02335489|448988904|FG000|Overall Study|Sponsor terminated study|4|||
124825212|NCT02335489|448988904|FG000|Overall Study|Lost to Follow-up|1|||
124825213|NCT02335489|448988904|FG000|Overall Study|Withdrawal by Subject|2|||
124825214|NCT02335489|448988904|FG000|Overall Study|Physician Decision|2|||
124825215|NCT02335489|448988904|FG000|Overall Study|Lack of Efficacy|1|||
124825216|NCT02259582|448988905|FG000|Overall Study|Physician Decision|0|||
124825217|NCT02259582|448988906|FG001|Overall Study|Physician Decision|1|||
124825218|NCT02259582|448988907|FG002|Overall Study|Physician Decision|0|||
124825219|NCT02259582|448988905|FG000|Overall Study|Death|0|||
124825220|NCT02259582|448988906|FG001|Overall Study|Death|0|||
124825221|NCT02259582|448988907|FG002|Overall Study|Death|1|||
124825222|NCT02259582|448988905|FG000|Overall Study|Adverse Event|1|||
124825223|NCT02259582|448988906|FG001|Overall Study|Adverse Event|0|||
124825224|NCT02259582|448988907|FG002|Overall Study|Adverse Event|1|||
124825225|NCT02259582|448988905|FG000|Overall Study|Withdrawal by Subject|0|||
124825226|NCT02259582|448988906|FG001|Overall Study|Withdrawal by Subject|0|||
124825227|NCT02259582|448988907|FG002|Overall Study|Withdrawal by Subject|1|||
124825228|NCT02259582|448988905|FG000|Overall Study|Disease progression|14|||
124825229|NCT02259582|448988906|FG001|Overall Study|Disease progression|15|||
124825230|NCT02259582|448988907|FG002|Overall Study|Disease progression|17|||
124825231|NCT02259582|448988905|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
124825232|NCT02259582|448988906|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
124825233|NCT02259582|448988907|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
124825234|NCT00759863|448988908|FG000|Overall Study|Death, moved, or lost contact|20|||
124825235|NCT00759863|448988909|FG001|Overall Study|Death, moved, or lost contact|18|||
124825236|NCT00503308|448988913|FG000|Overall Study|Protocol Violation|2|||
124825237|NCT00503308|448988914|FG001|Overall Study|Protocol Violation|1|||
124825238|NCT00475176|448988915|FG000|Overall Study|Adverse Event|2|||
124825239|NCT00475176|448988915|FG000|Overall Study|Withdrawal by Subject|1|||
124825240|NCT00475176|448988915|FG000|Overall Study|Protocol Violation|1|||
124825241|NCT02436889|448988916|FG000|Overall Study|No improvement in symptoms|1|||
124825242|NCT02436889|448988917|FG001|Overall Study|No improvement in symptoms|0|||
124825243|NCT02436889|448988916|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
124825244|NCT02436889|448988917|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
124825245|NCT01034462|448988918|FG000|Overall Study|Adverse Event|7|||
124825246|NCT01034462|448988919|FG001|Overall Study|Adverse Event|17|||
124825247|NCT01034462|448988918|FG000|Overall Study|Lack of Efficacy|4|||
124825248|NCT01034462|448988919|FG001|Overall Study|Lack of Efficacy|4|||
124825249|NCT01034462|448988918|FG000|Overall Study|Protocol Violation|10|||
124825250|NCT01034462|448988919|FG001|Overall Study|Protocol Violation|7|||
124825251|NCT01034462|448988918|FG000|Overall Study|Withdrawal by Subject|9|||
124825252|NCT01034462|448988919|FG001|Overall Study|Withdrawal by Subject|8|||
124825253|NCT01034462|448988918|FG000|Overall Study|Lost to Follow-up|14|||
124825254|NCT01034462|448988919|FG001|Overall Study|Lost to Follow-up|16|||
124825255|NCT01034462|448988918|FG000|Overall Study|Other reasons|1|||
124825256|NCT01034462|448988919|FG001|Overall Study|Other reasons|2|||
124825257|NCT04273217|448988920|FG000|Overall Study|Lost to Follow-up|0|||
124825258|NCT04273217|448988921|FG001|Overall Study|Lost to Follow-up|0|||
124825259|NCT04273217|448988922|FG002|Overall Study|Lost to Follow-up|0|||
124825260|NCT04273217|448988923|FG003|Overall Study|Lost to Follow-up|0|||
124825261|NCT04273217|448988924|FG004|Overall Study|Lost to Follow-up|0|||
124825262|NCT04273217|448988925|FG005|Overall Study|Lost to Follow-up|1|||
124825263|NCT04273217|448988920|FG000|Overall Study|Participant non-compliance|0|||
124825264|NCT04273217|448988921|FG001|Overall Study|Participant non-compliance|0|||
124825265|NCT04273217|448988922|FG002|Overall Study|Participant non-compliance|0|||
124825266|NCT04273217|448988923|FG003|Overall Study|Participant non-compliance|0|||
124825267|NCT04273217|448988924|FG004|Overall Study|Participant non-compliance|1|||
124825268|NCT04273217|448988925|FG005|Overall Study|Participant non-compliance|0|||
124825269|NCT04273217|448988920|FG000|Overall Study|Positive urine drug screen|1|||
124825270|NCT04273217|448988921|FG001|Overall Study|Positive urine drug screen|0|||
124825271|NCT04273217|448988922|FG002|Overall Study|Positive urine drug screen|1|||
124825272|NCT04273217|448988923|FG003|Overall Study|Positive urine drug screen|0|||
124825273|NCT04273217|448988924|FG004|Overall Study|Positive urine drug screen|0|||
124825274|NCT04273217|448988925|FG005|Overall Study|Positive urine drug screen|1|||
124825275|NCT02618434|448988926|FG000|Overall Study|Withdrawal by Subject|0|||
124825276|NCT02618434|448988927|FG001|Overall Study|Withdrawal by Subject|2|||
124825277|NCT02618434|448988928|FG002|Overall Study|Withdrawal by Subject|3|||
124825278|NCT02618434|448988926|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
124825279|NCT02618434|448988927|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
124825280|NCT02618434|448988928|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
124825281|NCT02618434|448988926|FG000|Overall Study|Lost to Follow-up|3|||
124825282|NCT02618434|448988927|FG001|Overall Study|Lost to Follow-up|1|||
124825283|NCT02618434|448988928|FG002|Overall Study|Lost to Follow-up|3|||
124825284|NCT02618434|448988926|FG000|Overall Study|Adverse Event|1|||
124825285|NCT02618434|448988927|FG001|Overall Study|Adverse Event|0|||
124825286|NCT02618434|448988928|FG002|Overall Study|Adverse Event|12|||
124825287|NCT02618434|448988926|FG000|Overall Study|Physician Decision|0|||
124825288|NCT02618434|448988927|FG001|Overall Study|Physician Decision|1|||
124825289|NCT02618434|448988928|FG002|Overall Study|Physician Decision|0|||
124825290|NCT02618434|448988926|FG000|Overall Study|Protocol Violation|0|||
124825291|NCT02618434|448988927|FG001|Overall Study|Protocol Violation|0|||
124825292|NCT02618434|448988928|FG002|Overall Study|Protocol Violation|1|||
124825293|NCT02618434|448988926|FG000|Overall Study|Other, Multiple categories|1|||
124825294|NCT02618434|448988927|FG001|Overall Study|Other, Multiple categories|1|||
124825295|NCT02618434|448988928|FG002|Overall Study|Other, Multiple categories|1|||
124825296|NCT00022633|448988937|FG000|Overall Study|Adverse Event|11|||
124825297|NCT00022633|448988938|FG001|Overall Study|Adverse Event|1|||
124825298|NCT00022633|448988937|FG000|Overall Study|Refusal unrelated to adverse event|1|||
124825299|NCT00022633|448988938|FG001|Overall Study|Refusal unrelated to adverse event|0|||
124825300|NCT00022633|448988937|FG000|Overall Study|Progression/relapse|9|||
124825301|NCT00022633|448988938|FG001|Overall Study|Progression/relapse|2|||
124825302|NCT00022633|448988937|FG000|Overall Study|Death|4|||
124825303|NCT00022633|448988938|FG001|Overall Study|Death|0|||
124825304|NCT00022633|448988937|FG000|Overall Study|Other - not protocol specified|3|||
124825305|NCT00022633|448988938|FG001|Overall Study|Other - not protocol specified|2|||
124825306|NCT00022633|448988937|FG000|Overall Study|Ineligible|4|||
124825307|NCT00022633|448988938|FG001|Overall Study|Ineligible|0|||
124825308|NCT01276353|448988939|FG000|Double-blind|Adverse Event|2|||
124825309|NCT01276353|448988940|FG001|Double-blind|Adverse Event|0|||
124825310|NCT01276353|448988939|FG000|Double-blind|Withdrawal by Subject|1|||
124825311|NCT01276353|448988940|FG001|Double-blind|Withdrawal by Subject|0|||
124825312|NCT01276353|448988939|FG000|Extension|Adverse Event|2|||
124825313|NCT01276353|448988940|FG001|Extension|Adverse Event|5|||
124825314|NCT01276353|448988939|FG000|Extension|Withdrawal by Subject|1|||
124825315|NCT01276353|448988940|FG001|Extension|Withdrawal by Subject|2|||
124825316|NCT01276353|448988939|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
124825317|NCT01276353|448988940|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
124825318|NCT01276353|448988939|FG000|Extension|Physician Decision|1|||
124825319|NCT01276353|448988940|FG001|Extension|Physician Decision|0|||
124825320|NCT01276353|448988939|FG000|Extension|Prohibited concomitant medications|0|||
124825321|NCT01276353|448988940|FG001|Extension|Prohibited concomitant medications|1|||
124825322|NCT03325075|448988947|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
124825323|NCT03325075|448988948|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
124825324|NCT03325075|448988949|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
124825325|NCT03325075|448988950|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
124825326|NCT03325075|448988947|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
124825327|NCT03325075|448988948|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
124825328|NCT03325075|448988949|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
124825329|NCT03325075|448988950|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
124825330|NCT03325075|448988947|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
125303455|NCT00118430|450736767|FG001|Overall Study|Lost to Follow-up|22|||
124825331|NCT03325075|448988948|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
124825332|NCT03325075|448988949|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
124825333|NCT03325075|448988950|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
124825334|NCT00422591|448988951|FG000|Overall Study|Physician Decision|4|||
124825335|NCT00422591|448988951|FG000|Overall Study|Withdrawal by Subject|2|||
124825336|NCT02659631|448988954|FG000|Overall Study|Lost to Follow-up|0|||
124825337|NCT02659631|448988955|FG001|Overall Study|Lost to Follow-up|0|||
124825338|NCT02659631|448988956|FG002|Overall Study|Lost to Follow-up|2|||
125303456|NCT00118430|450736768|FG002|Overall Study|Lost to Follow-up|28|||
124825339|NCT02659631|448988957|FG003|Overall Study|Lost to Follow-up|0|||
124825340|NCT02659631|448988958|FG004|Overall Study|Lost to Follow-up|0|||
124825341|NCT02659631|448988959|FG005|Overall Study|Lost to Follow-up|1|||
124825342|NCT02659631|448988960|FG006|Overall Study|Lost to Follow-up|0|||
125303457|NCT00659230|450736769|FG000|Overall Study|Lost to Follow-up|2|||
124825343|NCT02659631|448988961|FG007|Overall Study|Lost to Follow-up|0|||
124825344|NCT02659631|448988962|FG008|Overall Study|Lost to Follow-up|0|||
124825345|NCT02659631|448988963|FG009|Overall Study|Lost to Follow-up|0|||
124825346|NCT02659631|448988954|FG000|Overall Study|Withdrawal prior to treatment|0|||
124825347|NCT02659631|448988955|FG001|Overall Study|Withdrawal prior to treatment|0|||
124825348|NCT02659631|448988956|FG002|Overall Study|Withdrawal prior to treatment|0|||
124825349|NCT02659631|448988957|FG003|Overall Study|Withdrawal prior to treatment|0|||
124825350|NCT02659631|448988958|FG004|Overall Study|Withdrawal prior to treatment|1|||
124825351|NCT02659631|448988959|FG005|Overall Study|Withdrawal prior to treatment|0|||
124825352|NCT02659631|448988960|FG006|Overall Study|Withdrawal prior to treatment|0|||
124825353|NCT02659631|448988961|FG007|Overall Study|Withdrawal prior to treatment|0|||
124825354|NCT02659631|448988962|FG008|Overall Study|Withdrawal prior to treatment|0|||
124825355|NCT02659631|448988963|FG009|Overall Study|Withdrawal prior to treatment|0|||
124825356|NCT02659631|448988954|FG000|Overall Study|Participant refused further follow-up|0|||
124825357|NCT02659631|448988955|FG001|Overall Study|Participant refused further follow-up|0|||
124825358|NCT02659631|448988956|FG002|Overall Study|Participant refused further follow-up|0|||
124825359|NCT02659631|448988957|FG003|Overall Study|Participant refused further follow-up|1|||
124825360|NCT02659631|448988958|FG004|Overall Study|Participant refused further follow-up|0|||
124825361|NCT02659631|448988959|FG005|Overall Study|Participant refused further follow-up|0|||
124825362|NCT02659631|448988960|FG006|Overall Study|Participant refused further follow-up|0|||
124825363|NCT02659631|448988961|FG007|Overall Study|Participant refused further follow-up|0|||
124825364|NCT02659631|448988962|FG008|Overall Study|Participant refused further follow-up|1|||
124825365|NCT02659631|448988963|FG009|Overall Study|Participant refused further follow-up|0|||
124825366|NCT02659631|448988954|FG000|Overall Study|Death (follow-up phase)|1|||
124825367|NCT02659631|448988955|FG001|Overall Study|Death (follow-up phase)|2|||
124825368|NCT02659631|448988956|FG002|Overall Study|Death (follow-up phase)|1|||
124825369|NCT02659631|448988957|FG003|Overall Study|Death (follow-up phase)|1|||
124825370|NCT02659631|448988958|FG004|Overall Study|Death (follow-up phase)|3|||
124825371|NCT02659631|448988959|FG005|Overall Study|Death (follow-up phase)|2|||
124825372|NCT02659631|448988960|FG006|Overall Study|Death (follow-up phase)|0|||
124825373|NCT02659631|448988961|FG007|Overall Study|Death (follow-up phase)|3|||
124825374|NCT02659631|448988962|FG008|Overall Study|Death (follow-up phase)|1|||
124825375|NCT02659631|448988963|FG009|Overall Study|Death (follow-up phase)|0|||
124825376|NCT02659631|448988954|FG000|Overall Study|Death (treatment phase)|0|||
124825377|NCT02659631|448988955|FG001|Overall Study|Death (treatment phase)|0|||
124825378|NCT02659631|448988956|FG002|Overall Study|Death (treatment phase)|0|||
124825379|NCT02659631|448988957|FG003|Overall Study|Death (treatment phase)|0|||
124825380|NCT02659631|448988958|FG004|Overall Study|Death (treatment phase)|1|||
124825381|NCT02659631|448988959|FG005|Overall Study|Death (treatment phase)|0|||
124825382|NCT02659631|448988960|FG006|Overall Study|Death (treatment phase)|1|||
124825383|NCT02659631|448988961|FG007|Overall Study|Death (treatment phase)|0|||
124825384|NCT02659631|448988962|FG008|Overall Study|Death (treatment phase)|0|||
124825385|NCT02659631|448988963|FG009|Overall Study|Death (treatment phase)|0|||
124825386|NCT02377466|448988964|FG000|Overall Study|Other: Randomized and not treated|0|||
124825387|NCT02377466|448988965|FG001|Overall Study|Other: Randomized and not treated|2|||
124825388|NCT02485574|448988974|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
124825389|NCT00110149|448988982|FG000|Overall Study|Physician Decision|3|||
124825390|NCT00563381|448988983|FG000|Overall Study|Adverse Event|264|||
124825391|NCT00563381|448988984|FG001|Overall Study|Adverse Event|292|||
124825392|NCT00563381|448988983|FG000|Overall Study|Protocol Violation|66|||
124825393|NCT00563381|448988984|FG001|Overall Study|Protocol Violation|74|||
124825394|NCT00563381|448988983|FG000|Overall Study|Lost to Follow-up|7|||
124825395|NCT00563381|448988984|FG001|Overall Study|Lost to Follow-up|15|||
124825396|NCT00563381|448988983|FG000|Overall Study|Withdrawal by Subject|192|||
124825397|NCT00563381|448988984|FG001|Overall Study|Withdrawal by Subject|209|||
124825398|NCT00563381|448988983|FG000|Overall Study|Lack of Efficacy|32|||
124825399|NCT00563381|448988984|FG001|Overall Study|Lack of Efficacy|24|||
124825400|NCT00563381|448988983|FG000|Overall Study|Individual different reasons|24|||
124825401|NCT00563381|448988984|FG001|Overall Study|Individual different reasons|34|||
124825402|NCT00667368|448988985|FG000|Overall Study|Lost to Follow-up|176|||
125303458|NCT00659230|450736770|FG001|Overall Study|Lost to Follow-up|5|||
124825403|NCT00667368|448988986|FG001|Overall Study|Lost to Follow-up|155|||
125303459|NCT00659230|450736769|FG000|Overall Study|Lost source documentation|5|||
125303460|NCT00659230|450736770|FG001|Overall Study|Lost source documentation|4|||
125303461|NCT00659230|450736769|FG000|Overall Study|Did not return post-randomization|2|||
125303462|NCT00659230|450736770|FG001|Overall Study|Did not return post-randomization|3|||
125303463|NCT02069392|450736773|FG000|Overall Study|Withdrawal by Subject|4|||
124825404|NCT00667368|448988985|FG000|Overall Study|Discontinued early|24|||
124825405|NCT00667368|448988986|FG001|Overall Study|Discontinued early|17|||
124825406|NCT00732615|448988991|FG000|Overall Study|Withdrawal by Subject|3|||
124825407|NCT00732615|448988992|FG001|Overall Study|Withdrawal by Subject|1|||
124825408|NCT00732615|448988991|FG000|Overall Study|Lost to Follow-up|0|||
125303464|NCT02069392|450736774|FG001|Overall Study|Withdrawal by Subject|2|||
124825409|NCT00732615|448988992|FG001|Overall Study|Lost to Follow-up|1|||
124825410|NCT00732615|448988991|FG000|Overall Study|Adverse Event|0|||
124825411|NCT00732615|448988992|FG001|Overall Study|Adverse Event|2|||
124825412|NCT00732615|448988991|FG000|Overall Study|Physician Decision|3|||
124825413|NCT00732615|448988992|FG001|Overall Study|Physician Decision|0|||
124825414|NCT00732615|448988991|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
124825415|NCT00732615|448988992|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
124825416|NCT03566823|448988993|FG000|Overall Study|Lack of Efficacy|0|||
124825417|NCT03566823|448988994|FG001|Overall Study|Lack of Efficacy|1|||
124825418|NCT03566823|448988995|FG002|Overall Study|Lack of Efficacy|0|||
124825419|NCT03566823|448988993|FG000|Overall Study|Withdrawal by Subject|1|||
124825420|NCT03566823|448988994|FG001|Overall Study|Withdrawal by Subject|2|||
124825421|NCT03566823|448988995|FG002|Overall Study|Withdrawal by Subject|0|||
124825422|NCT03566823|448988993|FG000|Overall Study|Adverse Event|1|||
124825423|NCT03566823|448988994|FG001|Overall Study|Adverse Event|0|||
124825424|NCT03566823|448988995|FG002|Overall Study|Adverse Event|2|||
124825425|NCT01348347|448988996|FG000|Overall Study|Withdrawal by Subject|1|||
124825426|NCT01348347|448988997|FG001|Overall Study|Withdrawal by Subject|1|||
124825427|NCT01348347|448988998|FG002|Overall Study|Withdrawal by Subject|1|||
124825428|NCT01348347|448988996|FG000|Overall Study|Progressive disease|2|||
124825429|NCT01348347|448988997|FG001|Overall Study|Progressive disease|5|||
124825430|NCT01348347|448988998|FG002|Overall Study|Progressive disease|5|||
124825431|NCT00191789|448988999|FG000|Overall Study|Adverse Event|5|||
124825432|NCT00191789|448988999|FG000|Overall Study|Patient: Satisfactory Response|5|||
124825433|NCT00191789|448988999|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
124825434|NCT00191789|448988999|FG000|Overall Study|Withdrawal by Subject|4|||
124825435|NCT00191789|448988999|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
124825436|NCT00191789|448988999|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
124825437|NCT00191789|448988999|FG000|Overall Study|Death - Not Study-Drug Related|1|||
124825438|NCT01129960|448989011|FG000|Overall Study|Withdrawal by Subject|3|||
124825439|NCT01129960|448989012|FG001|Overall Study|Withdrawal by Subject|0|||
124825440|NCT01129960|448989013|FG002|Overall Study|Withdrawal by Subject|3|||
124825441|NCT01129960|448989014|FG003|Overall Study|Withdrawal by Subject|2|||
124825442|NCT01129960|448989011|FG000|Overall Study|Lack of Efficacy|1|||
124825443|NCT01129960|448989012|FG001|Overall Study|Lack of Efficacy|1|||
124825444|NCT01129960|448989013|FG002|Overall Study|Lack of Efficacy|1|||
124825445|NCT01129960|448989014|FG003|Overall Study|Lack of Efficacy|1|||
124825446|NCT01129960|448989011|FG000|Overall Study|Adverse Event|23|||
124825447|NCT01129960|448989012|FG001|Overall Study|Adverse Event|16|||
124825448|NCT01129960|448989013|FG002|Overall Study|Adverse Event|16|||
124825449|NCT01129960|448989014|FG003|Overall Study|Adverse Event|7|||
124825450|NCT01129960|448989011|FG000|Overall Study|Protocol Violation|1|||
124825451|NCT01129960|448989012|FG001|Overall Study|Protocol Violation|2|||
124825452|NCT01129960|448989013|FG002|Overall Study|Protocol Violation|3|||
124825453|NCT01129960|448989014|FG003|Overall Study|Protocol Violation|0|||
124825454|NCT01129960|448989011|FG000|Overall Study|Lost to Follow-up|0|||
124825455|NCT01129960|448989012|FG001|Overall Study|Lost to Follow-up|2|||
124825456|NCT01129960|448989013|FG002|Overall Study|Lost to Follow-up|3|||
124825457|NCT01129960|448989014|FG003|Overall Study|Lost to Follow-up|3|||
124825458|NCT01129960|448989011|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
124825459|NCT01129960|448989012|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
124825460|NCT01129960|448989013|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
124825461|NCT01129960|448989014|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
124825462|NCT01129960|448989011|FG000|Overall Study|Physician Decision|1|||
124825463|NCT01129960|448989012|FG001|Overall Study|Physician Decision|0|||
124825464|NCT01129960|448989013|FG002|Overall Study|Physician Decision|0|||
124825465|NCT01129960|448989014|FG003|Overall Study|Physician Decision|0|||
124825466|NCT01129960|448989011|FG000|Overall Study|Pregnancy|1|||
124825467|NCT01129960|448989012|FG001|Overall Study|Pregnancy|0|||
124825468|NCT01129960|448989013|FG002|Overall Study|Pregnancy|0|||
124825469|NCT01129960|448989014|FG003|Overall Study|Pregnancy|0|||
124825470|NCT00165776|448989015|FG000|Overall Study|Lack of Efficacy|0|||
124825471|NCT00165776|448989016|FG001|Overall Study|Lack of Efficacy|0|||
124825472|NCT00165776|448989017|FG002|Overall Study|Lack of Efficacy|0|||
124825473|NCT00165776|448989018|FG003|Overall Study|Lack of Efficacy|1|||
124825474|NCT00165776|448989015|FG000|Overall Study|Withdrawal by Subject|4|||
124825475|NCT00165776|448989016|FG001|Overall Study|Withdrawal by Subject|1|||
124825476|NCT00165776|448989017|FG002|Overall Study|Withdrawal by Subject|2|||
124825477|NCT00165776|448989018|FG003|Overall Study|Withdrawal by Subject|0|||
124825478|NCT00165776|448989015|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
124825479|NCT00165776|448989016|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
124825480|NCT00165776|448989017|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
124825481|NCT00165776|448989018|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
124825482|NCT02622321|448989021|FG000|Overall Study|Withdrawal by Subject|2|||
124825483|NCT02622321|448989022|FG001|Overall Study|Withdrawal by Subject|0|||
124825484|NCT02622321|448989023|FG002|Overall Study|Withdrawal by Subject|0|||
124825485|NCT02622321|448989024|FG003|Overall Study|Withdrawal by Subject|0|||
124825486|NCT02622321|448989021|FG000|Overall Study|Death|0|||
124825487|NCT02622321|448989022|FG001|Overall Study|Death|0|||
124825488|NCT02622321|448989023|FG002|Overall Study|Death|1|||
124825489|NCT02622321|448989024|FG003|Overall Study|Death|0|||
124825490|NCT02622321|448989021|FG000|Overall Study|Physician Decision|1|||
124825491|NCT02622321|448989022|FG001|Overall Study|Physician Decision|0|||
124825492|NCT02622321|448989023|FG002|Overall Study|Physician Decision|0|||
124825493|NCT02622321|448989024|FG003|Overall Study|Physician Decision|0|||
124825494|NCT00965718|448989026|FG000|Overall Study|Withdrawal by Subject|4|||
124825495|NCT00241280|448989028|FG000|Overall Study|Adverse Event|2|||
124825496|NCT00241280|448989029|FG001|Overall Study|Adverse Event|6|||
124825497|NCT00241280|448989028|FG000|Overall Study|Discomfort|11|||
124825498|NCT00241280|448989029|FG001|Overall Study|Discomfort|16|||
124825499|NCT00241280|448989028|FG000|Overall Study|Pregnancy|1|||
124825500|NCT00241280|448989029|FG001|Overall Study|Pregnancy|5|||
124825501|NCT00241280|448989028|FG000|Overall Study|Lost to Follow-up|5|||
124825502|NCT00241280|448989029|FG001|Overall Study|Lost to Follow-up|8|||
124825503|NCT00241280|448989028|FG000|Overall Study|Withdrawal by Subject|7|||
124825504|NCT00241280|448989029|FG001|Overall Study|Withdrawal by Subject|4|||
124825505|NCT00241280|448989028|FG000|Overall Study|Protocol Violation|4|||
124825506|NCT00241280|448989029|FG001|Overall Study|Protocol Violation|10|||
124825507|NCT00241280|448989028|FG000|Overall Study|Relocation|4|||
124825508|NCT00241280|448989029|FG001|Overall Study|Relocation|4|||
124825509|NCT00241280|448989028|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
124825510|NCT00241280|448989029|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
124825511|NCT00241280|448989028|FG000|Overall Study|Unsatisfactory Visual Response|1|||
124825512|NCT00241280|448989029|FG001|Overall Study|Unsatisfactory Visual Response|1|||
124825513|NCT00241280|448989028|FG000|Overall Study|Diabetic|1|||
124825514|NCT00241280|448989029|FG001|Overall Study|Diabetic|0|||
124825515|NCT00241280|448989028|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
124825516|NCT00241280|448989029|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
124825517|NCT00241280|448989028|FG000|Overall Study|Dispensed incorrect test article|1|||
124825518|NCT00241280|448989029|FG001|Overall Study|Dispensed incorrect test article|2|||
124825519|NCT00241280|448989028|FG000|Overall Study|Unacceptable Fit|0|||
124825520|NCT00241280|448989029|FG001|Overall Study|Unacceptable Fit|1|||
124825521|NCT00241280|448989028|FG000|Overall Study|Scheduling Conflict|0|||
124825522|NCT00241280|448989029|FG001|Overall Study|Scheduling Conflict|2|||
124825523|NCT00241280|448989028|FG000|Overall Study|History of Ocular Surgery|0|||
124825524|NCT00241280|448989029|FG001|Overall Study|History of Ocular Surgery|1|||
124825525|NCT00241280|448989028|FG000|Overall Study|Coating on Lens|1|||
124825526|NCT00241280|448989029|FG001|Overall Study|Coating on Lens|0|||
124825527|NCT00241280|448989028|FG000|Overall Study|Excessive Dryness|0|||
124825528|NCT00241280|448989029|FG001|Overall Study|Excessive Dryness|1|||
124825529|NCT01414855|448989032|FG000|Overall Study|Death|17|||
124825530|NCT01414855|448989032|FG000|Overall Study|Lost to Follow-up|5|||
124825531|NCT01414855|448989032|FG000|Overall Study|Withdrawal by Subject|7|||
124825532|NCT00368355|448989033|FG000|Overall Study|Adverse Event|1|||
124825533|NCT00368355|448989034|FG001|Overall Study|Adverse Event|0|||
124825534|NCT00368355|448989033|FG000|Overall Study|Death|2|||
124825535|NCT00368355|448989034|FG001|Overall Study|Death|4|||
124825536|NCT00368355|448989033|FG000|Overall Study|Relapse|6|||
124825537|NCT00368355|448989034|FG001|Overall Study|Relapse|10|||
124825538|NCT00368355|448989033|FG000|Overall Study|Subsequent transplant|0|||
124825539|NCT00368355|448989034|FG001|Overall Study|Subsequent transplant|3|||
124825540|NCT00368355|448989033|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
124825541|NCT00368355|448989034|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
124825542|NCT02999854|448989038|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
124825543|NCT02999854|448989039|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
124825544|NCT02999854|448989038|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
124825545|NCT02999854|448989039|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
124825546|NCT02999854|448989038|FG000|Active Study Phase (up to 18 Months)|Death|7|||
124825547|NCT02999854|448989039|FG001|Active Study Phase (up to 18 Months)|Death|5|||
124825548|NCT02999854|448989038|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
124825549|NCT02999854|448989039|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
124825550|NCT02999854|448989038|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
124825551|NCT02999854|448989039|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
124825552|NCT02999854|448989038|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
124825553|NCT02999854|448989039|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
124825554|NCT02999854|448989038|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
124825555|NCT02999854|448989039|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
124825556|NCT02999854|448989038|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
124825557|NCT02999854|448989039|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
124825558|NCT01013701|448989040|FG000|Overall Study|study prematurely terminated|7|||
124825559|NCT01386554|448989041|FG000|Overall Study|Lost to Follow-up|0|||
124825560|NCT01386554|448989042|FG001|Overall Study|Lost to Follow-up|0|||
124825561|NCT01386554|448989043|FG002|Overall Study|Lost to Follow-up|1|||
124825562|NCT01386554|448989041|FG000|Overall Study|Adverse Event|2|||
124825563|NCT01386554|448989042|FG001|Overall Study|Adverse Event|5|||
124825564|NCT01386554|448989043|FG002|Overall Study|Adverse Event|2|||
124825565|NCT01386554|448989041|FG000|Overall Study|Progressive disease|1|||
124825566|NCT01386554|448989042|FG001|Overall Study|Progressive disease|2|||
124825567|NCT01386554|448989043|FG002|Overall Study|Progressive disease|2|||
124825568|NCT01386554|448989041|FG000|Overall Study|Administration of live vaccines|0|||
124825569|NCT01386554|448989042|FG001|Overall Study|Administration of live vaccines|1|||
124825570|NCT01386554|448989043|FG002|Overall Study|Administration of live vaccines|0|||
124825571|NCT01386554|448989041|FG000|Overall Study|Investigator discretion|0|||
124825572|NCT01386554|448989042|FG001|Overall Study|Investigator discretion|0|||
124825573|NCT01386554|448989043|FG002|Overall Study|Investigator discretion|1|||
124825574|NCT01386554|448989041|FG000|Overall Study|Reason not collected|0|||
124825575|NCT01386554|448989042|FG001|Overall Study|Reason not collected|1|||
124825576|NCT01386554|448989043|FG002|Overall Study|Reason not collected|0|||
124825577|NCT00001596|448990692|FG000|Overall Study|Death|1|||
124825578|NCT00001596|448990693|FG001|Overall Study|Death|0|||
124825579|NCT00001596|448990692|FG000|Overall Study|Withdrawal by Subject|3|||
124825580|NCT00001596|448990693|FG001|Overall Study|Withdrawal by Subject|1|||
124825581|NCT00001596|448990692|FG000|Overall Study|Study Termination|12|||
124825582|NCT00001596|448990693|FG001|Overall Study|Study Termination|9|||
124825583|NCT00001596|448990692|FG000|Overall Study|Adverse Event|1|||
124825584|NCT00001596|448990693|FG001|Overall Study|Adverse Event|0|||
124825585|NCT00180414|448990699|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
124825586|NCT00180414|448990700|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
124825587|NCT02927080|448990701|FG000|Overall Study|Withdrawal by Subject|0|||
124825588|NCT02927080|448990702|FG001|Overall Study|Withdrawal by Subject|0|||
124825589|NCT02927080|448990703|FG002|Overall Study|Withdrawal by Subject|0|||
124825590|NCT02927080|448990704|FG003|Overall Study|Withdrawal by Subject|0|||
124825591|NCT02927080|448990705|FG004|Overall Study|Withdrawal by Subject|1|||
124825592|NCT02927080|448990706|FG005|Overall Study|Withdrawal by Subject|0|||
124825593|NCT02927080|448990707|FG006|Overall Study|Withdrawal by Subject|1|||
124825594|NCT02927080|448990708|FG007|Overall Study|Withdrawal by Subject|1|||
124825595|NCT02927080|448990709|FG008|Overall Study|Withdrawal by Subject|0|||
124825596|NCT02927080|448990710|FG009|Overall Study|Withdrawal by Subject|2|||
124825597|NCT02927080|448990701|FG000|Overall Study|Willingness to comply with protocol|0|||
124825598|NCT02927080|448990702|FG001|Overall Study|Willingness to comply with protocol|0|||
124825599|NCT02927080|448990703|FG002|Overall Study|Willingness to comply with protocol|0|||
124825600|NCT02927080|448990704|FG003|Overall Study|Willingness to comply with protocol|0|||
124825601|NCT02927080|448990705|FG004|Overall Study|Willingness to comply with protocol|0|||
124825602|NCT02927080|448990706|FG005|Overall Study|Willingness to comply with protocol|0|||
124825603|NCT02927080|448990707|FG006|Overall Study|Willingness to comply with protocol|0|||
124825604|NCT02927080|448990708|FG007|Overall Study|Willingness to comply with protocol|0|||
124825605|NCT02927080|448990709|FG008|Overall Study|Willingness to comply with protocol|0|||
124825606|NCT02927080|448990710|FG009|Overall Study|Willingness to comply with protocol|1|||
124825607|NCT02927080|448990701|FG000|Overall Study|Study terminated by Sponsor|0|||
124825608|NCT02927080|448990702|FG001|Overall Study|Study terminated by Sponsor|0|||
124825609|NCT02927080|448990703|FG002|Overall Study|Study terminated by Sponsor|0|||
124825610|NCT02927080|448990704|FG003|Overall Study|Study terminated by Sponsor|0|||
124825611|NCT02927080|448990705|FG004|Overall Study|Study terminated by Sponsor|0|||
124825612|NCT02927080|448990706|FG005|Overall Study|Study terminated by Sponsor|0|||
124825613|NCT02927080|448990707|FG006|Overall Study|Study terminated by Sponsor|6|||
124825614|NCT02927080|448990708|FG007|Overall Study|Study terminated by Sponsor|7|||
124825615|NCT02927080|448990709|FG008|Overall Study|Study terminated by Sponsor|2|||
124825616|NCT02927080|448990710|FG009|Overall Study|Study terminated by Sponsor|3|||
124825617|NCT02927080|448990701|FG000|Overall Study|Adverse Event|0|||
124825618|NCT02927080|448990702|FG001|Overall Study|Adverse Event|1|||
124825619|NCT02927080|448990703|FG002|Overall Study|Adverse Event|0|||
124825620|NCT02927080|448990704|FG003|Overall Study|Adverse Event|0|||
124825621|NCT02927080|448990705|FG004|Overall Study|Adverse Event|0|||
124825622|NCT02927080|448990706|FG005|Overall Study|Adverse Event|0|||
124825623|NCT02927080|448990707|FG006|Overall Study|Adverse Event|0|||
124825624|NCT02927080|448990708|FG007|Overall Study|Adverse Event|1|||
124825625|NCT02927080|448990709|FG008|Overall Study|Adverse Event|0|||
124825626|NCT02927080|448990710|FG009|Overall Study|Adverse Event|1|||
125303465|NCT00269633|450736775|FG000|Overall Study|Withdrawal by Subject|1|||
125303466|NCT00269633|450736776|FG001|Overall Study|Withdrawal by Subject|0|||
124825627|NCT02927080|448990701|FG000|Overall Study|Other|0|||
124825628|NCT02927080|448990702|FG001|Overall Study|Other|0|||
124825629|NCT02927080|448990703|FG002|Overall Study|Other|0|||
124825630|NCT02927080|448990704|FG003|Overall Study|Other|0|||
124825631|NCT02927080|448990705|FG004|Overall Study|Other|0|||
124825632|NCT02927080|448990706|FG005|Overall Study|Other|0|||
124825633|NCT02927080|448990707|FG006|Overall Study|Other|1|||
124825634|NCT02927080|448990708|FG007|Overall Study|Other|0|||
124825635|NCT02927080|448990709|FG008|Overall Study|Other|1|||
124825636|NCT02927080|448990710|FG009|Overall Study|Other|0|||
124825637|NCT01199289|448990711|FG000|Overall Study|Ineligibility determined|2|||
124825638|NCT01199289|448990712|FG001|Overall Study|Ineligibility determined|1|||
124825639|NCT01199289|448990713|FG002|Overall Study|Ineligibility determined|0|||
124825640|NCT01199289|448990714|FG003|Overall Study|Ineligibility determined|0|||
124825641|NCT01199289|448990711|FG000|Overall Study|Protocol Violation|1|||
124825642|NCT01199289|448990712|FG001|Overall Study|Protocol Violation|0|||
124825643|NCT01199289|448990713|FG002|Overall Study|Protocol Violation|0|||
124825644|NCT01199289|448990714|FG003|Overall Study|Protocol Violation|1|||
124825645|NCT01199289|448990711|FG000|Overall Study|Noncompliance|1|||
124825646|NCT01199289|448990712|FG001|Overall Study|Noncompliance|0|||
124825647|NCT01199289|448990713|FG002|Overall Study|Noncompliance|2|||
124825648|NCT01199289|448990714|FG003|Overall Study|Noncompliance|0|||
124825649|NCT01199289|448990711|FG000|Overall Study|Adverse Event|0|||
124825650|NCT01199289|448990712|FG001|Overall Study|Adverse Event|3|||
124825651|NCT01199289|448990713|FG002|Overall Study|Adverse Event|1|||
124825652|NCT01199289|448990714|FG003|Overall Study|Adverse Event|4|||
124825653|NCT01199289|448990711|FG000|Overall Study|Full consent withdrawn|2|||
124825654|NCT01199289|448990712|FG001|Overall Study|Full consent withdrawn|2|||
124825655|NCT01199289|448990713|FG002|Overall Study|Full consent withdrawn|2|||
124825656|NCT01199289|448990714|FG003|Overall Study|Full consent withdrawn|3|||
124825657|NCT01199289|448990711|FG000|Overall Study|Administrative decision|0|||
124825658|NCT01199289|448990712|FG001|Overall Study|Administrative decision|0|||
124825659|NCT01199289|448990713|FG002|Overall Study|Administrative decision|0|||
124825660|NCT01199289|448990714|FG003|Overall Study|Administrative decision|1|||
124825661|NCT01199289|448990711|FG000|Overall Study|Lost to Follow-up|0|||
124825662|NCT01199289|448990712|FG001|Overall Study|Lost to Follow-up|0|||
124825663|NCT01199289|448990713|FG002|Overall Study|Lost to Follow-up|0|||
124825664|NCT01199289|448990714|FG003|Overall Study|Lost to Follow-up|1|||
124825665|NCT01199289|448990711|FG000|Overall Study|Protocol-specified criteria|3|||
124825666|NCT01199289|448990712|FG001|Overall Study|Protocol-specified criteria|0|||
124825667|NCT01199289|448990713|FG002|Overall Study|Protocol-specified criteria|0|||
124825668|NCT01199289|448990714|FG003|Overall Study|Protocol-specified criteria|1|||
124825669|NCT01199289|448990711|FG000|Overall Study|Pregnancy|0|||
124825670|NCT01199289|448990712|FG001|Overall Study|Pregnancy|1|||
124825671|NCT01199289|448990713|FG002|Overall Study|Pregnancy|0|||
124825672|NCT01199289|448990714|FG003|Overall Study|Pregnancy|1|||
124825673|NCT00127712|448990718|FG000|Overall Study|Adverse Event|3|||
124825674|NCT00127712|448990719|FG001|Overall Study|Adverse Event|0|||
124825675|NCT00127712|448990718|FG000|Overall Study|Lack of GI access to continue|2|||
124825676|NCT00127712|448990719|FG001|Overall Study|Lack of GI access to continue|0|||
124825677|NCT02642614|448990720|FG000|Overall Study|Adverse Event|1|||
124825678|NCT02642614|448990721|FG001|Overall Study|Adverse Event|1|||
124825679|NCT02642614|448990722|FG002|Overall Study|Adverse Event|2|||
124825680|NCT02642614|448990723|FG003|Overall Study|Adverse Event|2|||
124825681|NCT02642614|448990720|FG000|Overall Study|Lost to Follow-up|1|||
124825682|NCT02642614|448990721|FG001|Overall Study|Lost to Follow-up|0|||
124825683|NCT02642614|448990722|FG002|Overall Study|Lost to Follow-up|0|||
124825684|NCT02642614|448990723|FG003|Overall Study|Lost to Follow-up|0|||
124825685|NCT02642614|448990720|FG000|Overall Study|Withdrawal by Subject|1|||
124825686|NCT02642614|448990721|FG001|Overall Study|Withdrawal by Subject|1|||
124825687|NCT02642614|448990722|FG002|Overall Study|Withdrawal by Subject|0|||
124825688|NCT02642614|448990723|FG003|Overall Study|Withdrawal by Subject|0|||
124825689|NCT04067544|448990724|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
124825690|NCT01320085|448990725|FG000|Overall Study|Disease Progression|26|||
124825691|NCT01320085|448990726|FG001|Overall Study|Disease Progression|93|||
124825692|NCT01320085|448990727|FG002|Overall Study|Disease Progression|17|||
124825693|NCT01320085|448990725|FG000|Overall Study|Adverse Event|12|||
124825694|NCT01320085|448990726|FG001|Overall Study|Adverse Event|20|||
124825695|NCT01320085|448990727|FG002|Overall Study|Adverse Event|5|||
124825696|NCT01320085|448990725|FG000|Overall Study|Withdrawal by Subject|2|||
124825697|NCT01320085|448990726|FG001|Overall Study|Withdrawal by Subject|4|||
124825698|NCT01320085|448990727|FG002|Overall Study|Withdrawal by Subject|1|||
124825699|NCT01320085|448990725|FG000|Overall Study|Protocol Deviation|1|||
124825700|NCT01320085|448990726|FG001|Overall Study|Protocol Deviation|0|||
124825701|NCT01320085|448990727|FG002|Overall Study|Protocol Deviation|1|||
124825702|NCT01320085|448990725|FG000|Overall Study|Administrative problems|0|||
124825703|NCT01320085|448990726|FG001|Overall Study|Administrative problems|0|||
124825704|NCT01320085|448990727|FG002|Overall Study|Administrative problems|1|||
124825705|NCT03316131|448990728|FG000|Treatment Period 2|Protocol deviation|1|||
124825706|NCT03316131|448990729|FG001|Treatment Period 2|Protocol deviation|0|||
124825707|NCT02282020|448990735|FG000|Overall Study|Objective Disease Progression|128|||
124825708|NCT02282020|448990736|FG001|Overall Study|Objective Disease Progression|30|||
124825709|NCT02282020|448990735|FG000|Overall Study|Adverse Event|18|||
124825710|NCT02282020|448990736|FG001|Overall Study|Adverse Event|15|||
124825711|NCT02282020|448990735|FG000|Overall Study|Withdrawal by Subject|7|||
124825712|NCT02282020|448990736|FG001|Overall Study|Withdrawal by Subject|10|||
124825713|NCT02282020|448990735|FG000|Overall Study|Miscellaneous|5|||
124825714|NCT02282020|448990736|FG001|Overall Study|Miscellaneous|19|||
124825715|NCT02282020|448990735|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
124825716|NCT02282020|448990736|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
124825717|NCT02282020|448990735|FG000|Overall Study|Developed Discontinuation Criteria|0|||
124825718|NCT02282020|448990736|FG001|Overall Study|Developed Discontinuation Criteria|2|||
124825719|NCT02282020|448990735|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
124825720|NCT02282020|448990736|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
124825721|NCT00100815|448990737|FG000|Overall Study|Progression|24|||
124825722|NCT00100815|448990737|FG000|Overall Study|Adverse Event|18|||
124825723|NCT00100815|448990737|FG000|Overall Study|Death|4|||
124825724|NCT00100815|448990737|FG000|Overall Study|Other|3|||
124825725|NCT01647282|448990738|FG000|Overall Study|Physician Decision|7|||
124825726|NCT01647282|448990739|FG001|Overall Study|Physician Decision|5|||
124825727|NCT00311623|448990740|FG000|Overall Study|Physician Decision|0|||
124825728|NCT00311623|448990741|FG001|Overall Study|Physician Decision|0|||
124825729|NCT00311623|448990742|FG002|Overall Study|Physician Decision|2|||
124825730|NCT03998189|448990743|FG000|Overall Study|Lack of Efficacy|0|||
124825731|NCT03998189|448990744|FG001|Overall Study|Lack of Efficacy|1|||
124825732|NCT03227029|448990745|FG000|Overall Study|Child Wheezed (no treatment)|0|||
124825733|NCT03227029|448990746|FG001|Overall Study|Child Wheezed (no treatment)|1|||
124825734|NCT03227029|448990747|FG002|Overall Study|Child Wheezed (no treatment)|0|||
124825735|NCT03227029|448990745|FG000|Overall Study|No post RSV season visit due to COVID|3|||
124825736|NCT03227029|448990746|FG001|Overall Study|No post RSV season visit due to COVID|3|||
124825737|NCT03227029|448990747|FG002|Overall Study|No post RSV season visit due to COVID|2|||
124825738|NCT03227029|448990745|FG000|Overall Study|Not able to get to clinic|0|||
124825739|NCT03227029|448990746|FG001|Overall Study|Not able to get to clinic|0|||
124825740|NCT03227029|448990747|FG002|Overall Study|Not able to get to clinic|1|||
124825741|NCT03227029|448990745|FG000|Overall Study|Withdrawal by Subject|1|||
124825742|NCT03227029|448990746|FG001|Overall Study|Withdrawal by Subject|0|||
124825743|NCT03227029|448990747|FG002|Overall Study|Withdrawal by Subject|0|||
124825744|NCT03227029|448990745|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
124825745|NCT03227029|448990746|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
124825746|NCT03227029|448990747|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
124825747|NCT03414424|448990748|FG000|Overall Study|Screened out after consent|0|||
124825748|NCT03414424|448990749|FG001|Overall Study|Screened out after consent|2|||
124825749|NCT03414424|448990748|FG000|Overall Study|Lost to Follow-up|0|||
124825750|NCT03414424|448990749|FG001|Overall Study|Lost to Follow-up|1|||
124825751|NCT01113801|448990750|FG000|Overall Study|Adverse Event|4|||
124825752|NCT01113801|448990751|FG001|Overall Study|Adverse Event|0|||
124825753|NCT01113801|448990752|FG002|Overall Study|Adverse Event|2|||
124825754|NCT01113801|448990753|FG003|Overall Study|Adverse Event|6|||
124825755|NCT01113801|448990750|FG000|Overall Study|Death|4|||
124825756|NCT01113801|448990751|FG001|Overall Study|Death|5|||
124825757|NCT01113801|448990752|FG002|Overall Study|Death|3|||
124825758|NCT01113801|448990753|FG003|Overall Study|Death|4|||
124825759|NCT01113801|448990750|FG000|Overall Study|Protocol Violation|0|||
124825760|NCT01113801|448990751|FG001|Overall Study|Protocol Violation|1|||
124825761|NCT01113801|448990752|FG002|Overall Study|Protocol Violation|0|||
124825762|NCT01113801|448990753|FG003|Overall Study|Protocol Violation|0|||
124825763|NCT01113801|448990750|FG000|Overall Study|Withdrawal by Subject|9|||
124825764|NCT01113801|448990751|FG001|Overall Study|Withdrawal by Subject|7|||
124825765|NCT01113801|448990752|FG002|Overall Study|Withdrawal by Subject|7|||
124825766|NCT01113801|448990753|FG003|Overall Study|Withdrawal by Subject|8|||
124825767|NCT01113801|448990750|FG000|Overall Study|Physician Decision|2|||
124825768|NCT01113801|448990751|FG001|Overall Study|Physician Decision|2|||
124825769|NCT01113801|448990752|FG002|Overall Study|Physician Decision|3|||
124825770|NCT01113801|448990753|FG003|Overall Study|Physician Decision|3|||
124825771|NCT01113801|448990750|FG000|Overall Study|Sponsor Decision|15|||
124825772|NCT01113801|448990751|FG001|Overall Study|Sponsor Decision|21|||
124825773|NCT01113801|448990752|FG002|Overall Study|Sponsor Decision|20|||
124825774|NCT01113801|448990753|FG003|Overall Study|Sponsor Decision|15|||
124825775|NCT01113801|448990750|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
124825776|NCT01113801|448990751|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
124825777|NCT01113801|448990752|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
124825778|NCT01113801|448990753|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
124825779|NCT00770289|448990756|FG000|Overall Study|Other|6|||
124825780|NCT00495170|448990757|FG000|Overall Study|Lost to Follow-up|9|||
124825781|NCT00495170|448990757|FG000|Overall Study|Withdrawal by Subject|3|||
124825782|NCT00495170|448990757|FG000|Overall Study|Inappropriate staging|8|||
124825783|NCT01408914|448990758|FG000|Overall Study|Could not complete tx in protocol period|5|||
124825784|NCT01408914|448990759|FG001|Overall Study|Could not complete tx in protocol period|5|||
124825785|NCT01408914|448990760|FG002|Overall Study|Could not complete tx in protocol period|6|||
124825786|NCT01408914|448990758|FG000|Overall Study|Lost to Follow-up|4|||
124825787|NCT01408914|448990759|FG001|Overall Study|Lost to Follow-up|1|||
124825788|NCT01408914|448990760|FG002|Overall Study|Lost to Follow-up|2|||
124825789|NCT01408914|448990758|FG000|Overall Study|Physician Decision|1|||
124825790|NCT01408914|448990759|FG001|Overall Study|Physician Decision|1|||
124825791|NCT01408914|448990760|FG002|Overall Study|Physician Decision|0|||
124825792|NCT01408914|448990758|FG000|Overall Study|Withdrawal by Subject|1|||
124825793|NCT01408914|448990759|FG001|Overall Study|Withdrawal by Subject|0|||
124825794|NCT01408914|448990760|FG002|Overall Study|Withdrawal by Subject|1|||
124825795|NCT01408914|448990758|FG000|Overall Study|Moved out of study jurisdiction|1|||
124825796|NCT01408914|448990759|FG001|Overall Study|Moved out of study jurisdiction|1|||
124825797|NCT01408914|448990760|FG002|Overall Study|Moved out of study jurisdiction|0|||
124825798|NCT01408914|448990758|FG000|Overall Study|Late exclusion|0|||
124825799|NCT01408914|448990759|FG001|Overall Study|Late exclusion|3|||
124825800|NCT01408914|448990760|FG002|Overall Study|Late exclusion|3|||
124825801|NCT01408914|448990758|FG000|Overall Study|Change in local TB/HIV norms|0|||
124825802|NCT01408914|448990759|FG001|Overall Study|Change in local TB/HIV norms|1|||
124825803|NCT01408914|448990760|FG002|Overall Study|Change in local TB/HIV norms|1|||
124825804|NCT00330616|448990761|FG000|Overall Study|Adverse Event|13|||
124825805|NCT00330616|448990761|FG000|Overall Study|Lack of Efficacy|1|||
124825806|NCT00330616|448990761|FG000|Overall Study|Lost to Follow-up|2|||
124825807|NCT00330616|448990761|FG000|Overall Study|Withdrawal by Subject|4|||
124825808|NCT00330616|448990761|FG000|Overall Study|Other|1|||
124825809|NCT00811473|448990766|FG000|Overall Study|Adverse Event|3|||
124825810|NCT00811473|448990767|FG001|Overall Study|Adverse Event|12|||
124825811|NCT00811473|448990766|FG000|Overall Study|Lost to Follow-up|5|||
124825812|NCT00811473|448990767|FG001|Overall Study|Lost to Follow-up|1|||
124825813|NCT00811473|448990766|FG000|Overall Study|Withdrawal by Subject|2|||
124825814|NCT00811473|448990767|FG001|Overall Study|Withdrawal by Subject|4|||
124825815|NCT00811473|448990766|FG000|Overall Study|Severe non-compliance to protocol|2|||
124825816|NCT00811473|448990767|FG001|Overall Study|Severe non-compliance to protocol|4|||
125303467|NCT04412707|450736777|FG000|Cycle 1|Death|0|||
125303468|NCT04412707|450736778|FG001|Cycle 1|Death|3|||
125303469|NCT04412707|450736777|FG000|Cycle 1|Disease progression|1|||
125303470|NCT04412707|450736778|FG001|Cycle 1|Disease progression|2|||
125303471|NCT04412707|450736777|FG000|Cycle 2|Death|0|||
125303472|NCT04412707|450736778|FG001|Cycle 2|Death|1|||
125303473|NCT04412707|450736777|FG000|Cycle 2|Disease progression|3|||
125303474|NCT04412707|450736778|FG001|Cycle 2|Disease progression|0|||
125303475|NCT04412707|450736777|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
125303476|NCT04412707|450736778|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
125303477|NCT04412707|450736777|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
125303478|NCT04412707|450736778|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
125303479|NCT04412707|450736777|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
125303480|NCT04412707|450736778|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
125303481|NCT04412707|450736777|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
125303482|NCT04412707|450736778|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
125303483|NCT02476006|450736779|FG000|Overall Study|Death|4|||
125303484|NCT02476006|450736779|FG000|Overall Study|Lack of treatment efficacy|2|||
125303485|NCT02476006|450736779|FG000|Overall Study|Pregnancy|1|||
125303486|NCT02476006|450736779|FG000|Overall Study|Participant did not wish to continue|39|||
125303487|NCT02476006|450736779|FG000|Overall Study|Adverse Event|41|||
125303488|NCT02476006|450736779|FG000|Overall Study|Poor compliance to study protocol|3|||
125303489|NCT02476006|450736779|FG000|Overall Study|Sponsor decision|6|||
125303490|NCT02476006|450736779|FG000|Overall Study|Lost to Follow-up|5|||
125303491|NCT02476006|450736779|FG000|Overall Study|Physician Decision|5|||
125303492|NCT02476006|450736779|FG000|Overall Study|Study ended treatment not available|4|||
125303493|NCT02476006|450736779|FG000|Overall Study|Switched to commercial drug|4|||
125303494|NCT02476006|450736779|FG000|Overall Study|Excluded from study|1|||
125303495|NCT02476006|450736779|FG000|Overall Study|Protocol Violation|1|||
125303496|NCT02476006|450736779|FG000|Overall Study|Enrolled but not treated|4|||
125303497|NCT03210961|450739445|FG000|Overall Study|Adverse Event|0|||
125303498|NCT03210961|450739446|FG001|Overall Study|Adverse Event|0|||
125303499|NCT03210961|450739447|FG002|Overall Study|Adverse Event|0|||
125303500|NCT03210961|450739448|FG003|Overall Study|Adverse Event|0|||
125303501|NCT03210961|450739449|FG004|Overall Study|Adverse Event|0|||
125303502|NCT03210961|450739450|FG005|Overall Study|Adverse Event|0|||
125303503|NCT03210961|450739451|FG006|Overall Study|Adverse Event|0|||
125303504|NCT03210961|450739452|FG007|Overall Study|Adverse Event|0|||
124825817|NCT00811473|448990766|FG000|Overall Study|Lack of therapeutic response|4|||
124825818|NCT00811473|448990767|FG001|Overall Study|Lack of therapeutic response|1|||
124825819|NCT00811473|448990766|FG000|Overall Study|Condition under investigation worsened|1|||
124825820|NCT00811473|448990767|FG001|Overall Study|Condition under investigation worsened|3|||
125303505|NCT03210961|450739453|FG008|Overall Study|Adverse Event|0|||
125303506|NCT03210961|450739454|FG009|Overall Study|Adverse Event|0|||
125303507|NCT03210961|450739455|FG010|Overall Study|Adverse Event|0|||
125303508|NCT03210961|450739456|FG011|Overall Study|Adverse Event|0|||
125303509|NCT03210961|450739457|FG012|Overall Study|Adverse Event|0|||
124825821|NCT00811473|448990766|FG000|Overall Study|Other 2|4|||
125303510|NCT03210961|450739458|FG013|Overall Study|Adverse Event|1|||
125303511|NCT03210961|450739459|FG014|Overall Study|Adverse Event|0|||
125303512|NCT03210961|450739445|FG000|Overall Study|Lost to Follow-up|0|||
124825822|NCT00811473|448990767|FG001|Overall Study|Other 2|1|||
124825823|NCT00811473|448990766|FG000|Overall Study|Incorrect Enrollment|1|||
124825824|NCT00811473|448990767|FG001|Overall Study|Incorrect Enrollment|0|||
124825825|NCT00811473|448990766|FG000|Overall Study|Safety Reasons|1|||
124825826|NCT00811473|448990767|FG001|Overall Study|Safety Reasons|0|||
124825827|NCT01585194|448990771|FG000|Overall Study|Withdrawal by Subject|1|||
124825828|NCT01585194|448990771|FG000|Overall Study|Physician Decision|2|||
124825829|NCT01585194|448990771|FG000|Overall Study|Lack of insurance|1|||
124825830|NCT01957553|448990772|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
124825831|NCT01957553|448990773|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
124825832|NCT01957553|448990772|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
124825833|NCT01957553|448990773|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
124825834|NCT01957553|448990772|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
124825835|NCT01957553|448990773|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
124825836|NCT01957553|448990772|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
124825837|NCT01957553|448990773|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
124825838|NCT01957553|448990772|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
124825839|NCT01957553|448990773|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
124825840|NCT01957553|448990772|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
124825841|NCT01957553|448990773|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
124825842|NCT01957553|448990772|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
124825843|NCT01957553|448990773|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
124825844|NCT01957553|448990772|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
124825845|NCT01957553|448990773|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
124825846|NCT01957553|448990772|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
124825847|NCT01957553|448990773|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
124825848|NCT00993291|448990775|FG000|Overall Study|Withdrawal by Subject|1|||
124825849|NCT01333059|448990777|FG000|Overall Study|Physician Decision|3|||
124825850|NCT01333059|448990778|FG001|Overall Study|Physician Decision|3|||
124825851|NCT01333059|448990777|FG000|Overall Study|Protocol Violation|3|||
124825852|NCT01333059|448990778|FG001|Overall Study|Protocol Violation|0|||
124825853|NCT02733367|448990779|FG000|Overall Study|Withdrawal by Subject|6|||
124825854|NCT00748033|448990783|FG000|Overall Study|Adverse Event|0|||
124825855|NCT00748033|448990784|FG001|Overall Study|Adverse Event|1|||
124825856|NCT02049957|448990787|FG000|Overall Study|Progressive Disease|5|||
124825857|NCT02049957|448990788|FG001|Overall Study|Progressive Disease|4|||
124825858|NCT02049957|448990789|FG002|Overall Study|Progressive Disease|2|||
124825859|NCT02049957|448990790|FG003|Overall Study|Progressive Disease|2|||
124825860|NCT02049957|448990791|FG004|Overall Study|Progressive Disease|6|||
124825861|NCT02049957|448990792|FG005|Overall Study|Progressive Disease|35|||
124825862|NCT02049957|448990793|FG006|Overall Study|Progressive Disease|7|||
124825863|NCT02049957|448990794|FG007|Overall Study|Progressive Disease|26|||
124825864|NCT02049957|448990795|FG008|Overall Study|Progressive Disease|6|||
124825865|NCT02049957|448990787|FG000|Overall Study|Adverse Event|1|||
124825866|NCT02049957|448990788|FG001|Overall Study|Adverse Event|1|||
124825867|NCT02049957|448990789|FG002|Overall Study|Adverse Event|1|||
124825868|NCT02049957|448990790|FG003|Overall Study|Adverse Event|0|||
124825869|NCT02049957|448990791|FG004|Overall Study|Adverse Event|0|||
124825870|NCT02049957|448990792|FG005|Overall Study|Adverse Event|5|||
124825871|NCT02049957|448990793|FG006|Overall Study|Adverse Event|0|||
124825872|NCT02049957|448990794|FG007|Overall Study|Adverse Event|6|||
124825873|NCT02049957|448990795|FG008|Overall Study|Adverse Event|1|||
124825874|NCT02049957|448990787|FG000|Overall Study|Study Terminated by Sponsor|0|||
124825875|NCT02049957|448990788|FG001|Overall Study|Study Terminated by Sponsor|1|||
124825876|NCT02049957|448990789|FG002|Overall Study|Study Terminated by Sponsor|0|||
124825877|NCT02049957|448990790|FG003|Overall Study|Study Terminated by Sponsor|0|||
124825878|NCT02049957|448990791|FG004|Overall Study|Study Terminated by Sponsor|0|||
124825879|NCT02049957|448990792|FG005|Overall Study|Study Terminated by Sponsor|0|||
124825880|NCT02049957|448990793|FG006|Overall Study|Study Terminated by Sponsor|1|||
124825881|NCT02049957|448990794|FG007|Overall Study|Study Terminated by Sponsor|0|||
124825882|NCT02049957|448990795|FG008|Overall Study|Study Terminated by Sponsor|0|||
124825883|NCT02049957|448990787|FG000|Overall Study|Withdrawal by Subject|0|||
124825884|NCT02049957|448990788|FG001|Overall Study|Withdrawal by Subject|0|||
124825885|NCT02049957|448990789|FG002|Overall Study|Withdrawal by Subject|0|||
124825886|NCT02049957|448990790|FG003|Overall Study|Withdrawal by Subject|1|||
124825887|NCT02049957|448990791|FG004|Overall Study|Withdrawal by Subject|0|||
124825888|NCT02049957|448990792|FG005|Overall Study|Withdrawal by Subject|2|||
124825889|NCT02049957|448990793|FG006|Overall Study|Withdrawal by Subject|0|||
124825890|NCT02049957|448990794|FG007|Overall Study|Withdrawal by Subject|3|||
124825891|NCT02049957|448990795|FG008|Overall Study|Withdrawal by Subject|1|||
124825892|NCT02049957|448990787|FG000|Overall Study|Physician Decision|0|||
124825893|NCT02049957|448990788|FG001|Overall Study|Physician Decision|0|||
124825894|NCT02049957|448990789|FG002|Overall Study|Physician Decision|0|||
124825895|NCT02049957|448990790|FG003|Overall Study|Physician Decision|0|||
124825896|NCT02049957|448990791|FG004|Overall Study|Physician Decision|0|||
124825897|NCT02049957|448990792|FG005|Overall Study|Physician Decision|1|||
124825898|NCT02049957|448990793|FG006|Overall Study|Physician Decision|0|||
124825899|NCT02049957|448990794|FG007|Overall Study|Physician Decision|0|||
124825900|NCT02049957|448990795|FG008|Overall Study|Physician Decision|0|||
124825901|NCT03557151|448990796|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
124825902|NCT03557151|448990797|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
124825903|NCT03557151|448990796|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
124825904|NCT03557151|448990797|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
124825905|NCT03557151|448990796|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
124825906|NCT03557151|448990797|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
124825907|NCT01414075|448990798|FG000|Overall Study|Adverse Event|1|||
124825908|NCT01414075|448990799|FG001|Overall Study|Adverse Event|0|||
124825909|NCT01414075|448990800|FG002|Overall Study|Adverse Event|1|||
124825910|NCT01414075|448990801|FG003|Overall Study|Adverse Event|0|||
124825911|NCT01414075|448990798|FG000|Overall Study|Death|1|||
124825912|NCT01414075|448990799|FG001|Overall Study|Death|0|||
124825913|NCT01414075|448990800|FG002|Overall Study|Death|0|||
124825914|NCT01414075|448990801|FG003|Overall Study|Death|1|||
124825915|NCT01414075|448990798|FG000|Overall Study|Withdrawal by Subject|0|||
124825916|NCT01414075|448990799|FG001|Overall Study|Withdrawal by Subject|0|||
124825917|NCT01414075|448990800|FG002|Overall Study|Withdrawal by Subject|0|||
124825918|NCT01414075|448990801|FG003|Overall Study|Withdrawal by Subject|1|||
124825919|NCT01414075|448990798|FG000|Overall Study|Other than specified|1|||
124825920|NCT01414075|448990799|FG001|Overall Study|Other than specified|0|||
124825921|NCT01414075|448990800|FG002|Overall Study|Other than specified|1|||
124825922|NCT01414075|448990801|FG003|Overall Study|Other than specified|0|||
124825923|NCT01922089|448990805|FG000|Overall Study|Adverse Event|18|||
124825924|NCT01922089|448990806|FG001|Overall Study|Adverse Event|13|||
124825925|NCT01922089|448990805|FG000|Overall Study|Protocol Deviation|10|||
124825926|NCT01922089|448990806|FG001|Overall Study|Protocol Deviation|7|||
124825927|NCT01922089|448990805|FG000|Overall Study|Withdrawal by Subject|3|||
124825928|NCT01922089|448990806|FG001|Overall Study|Withdrawal by Subject|4|||
124825929|NCT01922089|448990805|FG000|Overall Study|administrative problems|4|||
124825930|NCT01922089|448990806|FG001|Overall Study|administrative problems|1|||
124825931|NCT01922089|448990805|FG000|Overall Study|Physician Decision|2|||
124825932|NCT01922089|448990806|FG001|Overall Study|Physician Decision|3|||
124825933|NCT01922089|448990805|FG000|Overall Study|Death|2|||
124825934|NCT01922089|448990806|FG001|Overall Study|Death|1|||
124825935|NCT01922089|448990805|FG000|Overall Study|Lost to Follow-up|0|||
124825936|NCT01922089|448990806|FG001|Overall Study|Lost to Follow-up|1|||
124825937|NCT04903626|448990810|FG000|Overall Study|Lost to Follow-up|6|||
124825938|NCT04903626|448990810|FG000|Overall Study|Withdrawal by Subject|1|||
124825939|NCT04903626|448990810|FG000|Overall Study|Other, Not Specified|1|||
124825940|NCT00573534|448990811|FG000|Overall Study|oppositional behavior|3|||
124825941|NCT00467259|448990817|FG000|Overall Study|Adverse Event|24|||
124825942|NCT00467259|448990818|FG001|Overall Study|Adverse Event|90|||
124825943|NCT00467259|448990817|FG000|Overall Study|Protocol Violation|1|||
124825944|NCT00467259|448990818|FG001|Overall Study|Protocol Violation|7|||
124825945|NCT00467259|448990817|FG000|Overall Study|Withdrawal by Subject|34|||
124825946|NCT00467259|448990818|FG001|Overall Study|Withdrawal by Subject|108|||
124825947|NCT00467259|448990817|FG000|Overall Study|Physician Decision|0|||
124825948|NCT00467259|448990818|FG001|Overall Study|Physician Decision|2|||
124825949|NCT00467259|448990817|FG000|Overall Study|Lost to Follow-up|14|||
124825950|NCT00467259|448990818|FG001|Overall Study|Lost to Follow-up|34|||
124825951|NCT00467259|448990817|FG000|Overall Study|Site Closed|2|||
124825952|NCT00467259|448990818|FG001|Overall Study|Site Closed|1|||
124825953|NCT04285879|448990821|FG000|Overall Study|Lost to Follow-up|1|||
124825954|NCT04285879|448990822|FG001|Overall Study|Lost to Follow-up|8|||
124825955|NCT04285879|448990821|FG000|Overall Study|medical/surgical exclusion|16|||
124825956|NCT04285879|448990822|FG001|Overall Study|medical/surgical exclusion|0|||
124825957|NCT01958008|448990824|FG000|Overall Study|Worsening of disease under study|0|||
124825958|NCT01958008|448990825|FG001|Overall Study|Worsening of disease under study|0|||
124825959|NCT01958008|448990826|FG002|Overall Study|Worsening of disease under study|1|||
124825960|NCT01958008|448990827|FG003|Overall Study|Worsening of disease under study|0|||
124825961|NCT01958008|448990824|FG000|Overall Study|Other adverse event|1|||
124825962|NCT01958008|448990825|FG001|Overall Study|Other adverse event|0|||
124825963|NCT01958008|448990826|FG002|Overall Study|Other adverse event|0|||
124825964|NCT01958008|448990827|FG003|Overall Study|Other adverse event|0|||
124825965|NCT01634360|448990828|FG000|Overall Study|Adverse Event|10|||
124825966|NCT01634360|448990829|FG001|Overall Study|Adverse Event|34|||
124825967|NCT01634360|448990828|FG000|Overall Study|subject withdrew consent|13|||
124825968|NCT01634360|448990829|FG001|Overall Study|subject withdrew consent|23|||
124825969|NCT01634360|448990828|FG000|Overall Study|Protocol Violation|1|||
124825970|NCT01634360|448990829|FG001|Overall Study|Protocol Violation|1|||
124825971|NCT01634360|448990828|FG000|Overall Study|Lack of Efficacy|4|||
124825972|NCT01634360|448990829|FG001|Overall Study|Lack of Efficacy|14|||
124825973|NCT01634360|448990828|FG000|Overall Study|Other|3|||
124825974|NCT01634360|448990829|FG001|Overall Study|Other|20|||
124825975|NCT01634360|448990828|FG000|Overall Study|Study termination by sponsor|18|||
124825976|NCT01634360|448990829|FG001|Overall Study|Study termination by sponsor|44|||
124825977|NCT02028065|448990830|FG000|Randomization Through Start Treatment|Not treated|1|||
124825978|NCT02028065|448990831|FG001|Randomization Through Start Treatment|Not treated|3|||
124825979|NCT02028065|448990832|FG002|Randomization Through Start Treatment|Not treated|3|||
124825980|NCT02028065|448990830|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
124825981|NCT02028065|448990831|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
124825982|NCT02028065|448990832|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
124825983|NCT02028065|448990830|FG000|Treatment Through Study Completion|Physician Decision|1|||
124825984|NCT02028065|448990831|FG001|Treatment Through Study Completion|Physician Decision|0|||
124825985|NCT02028065|448990832|FG002|Treatment Through Study Completion|Physician Decision|0|||
124825986|NCT02028065|448990830|FG000|Treatment Through Study Completion|Protocol Violation|1|||
124825987|NCT02028065|448990831|FG001|Treatment Through Study Completion|Protocol Violation|4|||
124825988|NCT02028065|448990832|FG002|Treatment Through Study Completion|Protocol Violation|0|||
124825989|NCT02028065|448990830|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
124825990|NCT02028065|448990831|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
124825991|NCT02028065|448990832|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
124825992|NCT02028065|448990830|FG000|Treatment Through Study Completion|Adverse Event|3|||
124825993|NCT02028065|448990831|FG001|Treatment Through Study Completion|Adverse Event|3|||
124825994|NCT02028065|448990832|FG002|Treatment Through Study Completion|Adverse Event|5|||
124825995|NCT04851314|448990833|FG000|Overall Study|Unable to complete research set-up procedures|0|||
124825996|NCT04851314|448990834|FG001|Overall Study|Unable to complete research set-up procedures|2|||
124825997|NCT04851314|448990833|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
125303513|NCT03210961|450739446|FG001|Overall Study|Lost to Follow-up|0|||
125303514|NCT03210961|450739447|FG002|Overall Study|Lost to Follow-up|0|||
125303515|NCT03210961|450739448|FG003|Overall Study|Lost to Follow-up|0|||
125303516|NCT03210961|450739449|FG004|Overall Study|Lost to Follow-up|0|||
125303517|NCT03210961|450739450|FG005|Overall Study|Lost to Follow-up|0|||
125303518|NCT03210961|450739451|FG006|Overall Study|Lost to Follow-up|0|||
125303519|NCT03210961|450739452|FG007|Overall Study|Lost to Follow-up|0|||
125303520|NCT03210961|450739453|FG008|Overall Study|Lost to Follow-up|0|||
125303521|NCT03210961|450739454|FG009|Overall Study|Lost to Follow-up|0|||
125303522|NCT03210961|450739455|FG010|Overall Study|Lost to Follow-up|0|||
125303523|NCT03210961|450739456|FG011|Overall Study|Lost to Follow-up|0|||
125303524|NCT03210961|450739457|FG012|Overall Study|Lost to Follow-up|0|||
125303525|NCT03210961|450739458|FG013|Overall Study|Lost to Follow-up|0|||
125303526|NCT03210961|450739459|FG014|Overall Study|Lost to Follow-up|1|||
125303527|NCT03210961|450739445|FG000|Overall Study|Withdrawal by Subject|0|||
125303528|NCT03210961|450739446|FG001|Overall Study|Withdrawal by Subject|0|||
125303529|NCT03210961|450739447|FG002|Overall Study|Withdrawal by Subject|0|||
125303530|NCT03210961|450739448|FG003|Overall Study|Withdrawal by Subject|0|||
125303531|NCT03210961|450739449|FG004|Overall Study|Withdrawal by Subject|0|||
125303532|NCT03210961|450739450|FG005|Overall Study|Withdrawal by Subject|0|||
125303533|NCT03210961|450739451|FG006|Overall Study|Withdrawal by Subject|0|||
125303534|NCT03210961|450739452|FG007|Overall Study|Withdrawal by Subject|0|||
125303535|NCT03210961|450739453|FG008|Overall Study|Withdrawal by Subject|0|||
125303536|NCT03210961|450739454|FG009|Overall Study|Withdrawal by Subject|0|||
125303537|NCT03210961|450739455|FG010|Overall Study|Withdrawal by Subject|0|||
125303538|NCT03210961|450739456|FG011|Overall Study|Withdrawal by Subject|0|||
125303539|NCT03210961|450739457|FG012|Overall Study|Withdrawal by Subject|0|||
125303540|NCT03210961|450739458|FG013|Overall Study|Withdrawal by Subject|0|||
125303541|NCT03210961|450739459|FG014|Overall Study|Withdrawal by Subject|1|||
125303542|NCT03210961|450739445|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303543|NCT03210961|450739446|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303544|NCT03210961|450739447|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303545|NCT03210961|450739448|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303546|NCT03210961|450739449|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303547|NCT03210961|450739450|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303548|NCT03210961|450739451|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303549|NCT03210961|450739452|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303550|NCT03210961|450739453|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303551|NCT03210961|450739454|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
124825998|NCT04851314|448990834|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
125303552|NCT03210961|450739455|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303553|NCT03210961|450739456|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303554|NCT03210961|450739457|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303555|NCT03210961|450739458|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
125303556|NCT03210961|450739459|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
124825999|NCT00877383|448990835|FG000|Overall Study|Adverse Event|13|||
125303557|NCT03210961|450739445|FG000|Overall Study|Other|0|||
125303558|NCT03210961|450739446|FG001|Overall Study|Other|0|||
125303559|NCT03210961|450739447|FG002|Overall Study|Other|0|||
124826000|NCT00877383|448990836|FG001|Overall Study|Adverse Event|14|||
124826001|NCT00877383|448990835|FG000|Overall Study|Lost to Follow-up|5|||
124826002|NCT00877383|448990836|FG001|Overall Study|Lost to Follow-up|3|||
124826003|NCT00877383|448990835|FG000|Overall Study|Subject withdrew consent|3|||
124826004|NCT00877383|448990836|FG001|Overall Study|Subject withdrew consent|12|||
124826005|NCT00877383|448990835|FG000|Overall Study|Subject no longer requires study drug|2|||
124826006|NCT00877383|448990836|FG001|Overall Study|Subject no longer requires study drug|0|||
124826007|NCT00877383|448990835|FG000|Overall Study|Administrative problems|2|||
124826008|NCT00877383|448990836|FG001|Overall Study|Administrative problems|0|||
124826009|NCT00877383|448990835|FG000|Overall Study|Protocol deviation|2|||
124826010|NCT00877383|448990836|FG001|Overall Study|Protocol deviation|6|||
124826011|NCT00877383|448990835|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124826012|NCT00877383|448990836|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124826013|NCT00877383|448990835|FG000|Overall Study|Death|1|||
124826014|NCT00877383|448990836|FG001|Overall Study|Death|2|||
124826015|NCT02107482|448990843|FG000|Overall Study|inconveinence|2|||
124826016|NCT02107482|448990843|FG000|Overall Study|Lost to Follow-up|1|||
124826017|NCT02107482|448990843|FG000|Overall Study|Lack of Efficacy|1|||
124826018|NCT04868890|448990844|FG000|Overall Study|Death|2|||
124826019|NCT04868890|448990845|FG001|Overall Study|Death|1|||
124826020|NCT04868890|448990844|FG000|Overall Study|Withdrawal by Subject|1|||
124826021|NCT04868890|448990845|FG001|Overall Study|Withdrawal by Subject|5|||
124826022|NCT00867009|448990846|FG000|Induction Period|Nonserious Adverse Event|5|||
124826023|NCT00867009|448990846|FG000|Induction Period|Serious Adverse Event|10|||
124826024|NCT00867009|448990846|FG000|Induction Period|Death due to serious adverse event|6|||
124826025|NCT00867009|448990846|FG000|Induction Period|Death due to Study Disease|4|||
125303560|NCT03210961|450739448|FG003|Overall Study|Other|1|||
125303561|NCT03210961|450739449|FG004|Overall Study|Other|0|||
125303562|NCT03210961|450739450|FG005|Overall Study|Other|0|||
125303563|NCT03210961|450739451|FG006|Overall Study|Other|1|||
125303564|NCT03210961|450739452|FG007|Overall Study|Other|0|||
125303565|NCT03210961|450739453|FG008|Overall Study|Other|0|||
125303566|NCT03210961|450739454|FG009|Overall Study|Other|0|||
125303567|NCT03210961|450739455|FG010|Overall Study|Other|1|||
125303568|NCT03210961|450739456|FG011|Overall Study|Other|0|||
125303569|NCT03210961|450739457|FG012|Overall Study|Other|2|||
125303570|NCT03210961|450739458|FG013|Overall Study|Other|2|||
125303571|NCT03210961|450739459|FG014|Overall Study|Other|0|||
125303572|NCT01487265|450739460|FG000|Overall Study|Adverse Event|8|||
125303573|NCT01487265|450739460|FG000|Overall Study|Withdrawal by Subject|5|||
125303574|NCT01487265|450739460|FG000|Overall Study|Disease Progression|21|||
125303575|NCT01487265|450739460|FG000|Overall Study|Death|2|||
125303576|NCT01487265|450739460|FG000|Overall Study|Still on Treatment|1|||
125303577|NCT02291419|450739461|FG000|Overall Study|Early study termination|1|||
125303578|NCT02291419|450739462|FG001|Overall Study|Early study termination|5|||
125303579|NCT00965575|450739466|FG000|Overall Study|subject unwillingness to swallow study c|1|||
125303580|NCT00965575|450739467|FG001|Overall Study|subject unwillingness to swallow study c|0|||
125303581|NCT01732770|450739474|FG000|Overall Study|Lost to Follow-up|2|||
125303582|NCT01732770|450739475|FG001|Overall Study|Lost to Follow-up|3|||
125303583|NCT01732770|450739474|FG000|Overall Study|Withdrawal by Subject|5|||
125303584|NCT01732770|450739475|FG001|Overall Study|Withdrawal by Subject|3|||
125303585|NCT01732770|450739474|FG000|Overall Study|Decision by Sponsor|2|||
125303586|NCT01732770|450739475|FG001|Overall Study|Decision by Sponsor|2|||
125303587|NCT01732770|450739474|FG000|Overall Study|Death|1|||
125303588|NCT01732770|450739475|FG001|Overall Study|Death|0|||
125303589|NCT03047031|450739476|FG000|Overall Study|Other than listed|1|||
125303590|NCT03047031|450739477|FG001|Overall Study|Other than listed|0|||
125303591|NCT03047031|450739478|FG002|Overall Study|Other than listed|0|||
125303592|NCT03047031|450739476|FG000|Overall Study|Lost to Follow-up|4|||
125303593|NCT03047031|450739477|FG001|Overall Study|Lost to Follow-up|0|||
125303594|NCT03047031|450739478|FG002|Overall Study|Lost to Follow-up|0|||
125303595|NCT03047031|450739476|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
125303596|NCT03047031|450739477|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
125303597|NCT03047031|450739478|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
125303598|NCT03047031|450739476|FG000|Overall Study|Adverse Event|1|||
125303599|NCT03047031|450739477|FG001|Overall Study|Adverse Event|0|||
125303600|NCT03047031|450739478|FG002|Overall Study|Adverse Event|0|||
125303601|NCT03047031|450739476|FG000|Overall Study|Withdrawal by Subject|2|||
125303602|NCT03047031|450739477|FG001|Overall Study|Withdrawal by Subject|0|||
125303603|NCT03047031|450739478|FG002|Overall Study|Withdrawal by Subject|0|||
125303604|NCT03047031|450739476|FG000|Overall Study|Change to other medication|2|||
125303605|NCT03047031|450739477|FG001|Overall Study|Change to other medication|0|||
124826026|NCT00867009|448990846|FG000|Induction Period|Protocol Violation|1|||
124826027|NCT00867009|448990846|FG000|Induction Period|Withdrawal by Subject|8|||
125303606|NCT03047031|450739478|FG002|Overall Study|Change to other medication|0|||
124826028|NCT00867009|448990846|FG000|Induction Period|Physician Decision|3|||
125303607|NCT03047031|450739476|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
125303608|NCT03047031|450739477|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
124826029|NCT00867009|448990846|FG000|Induction Period|Progressive Disease (PD)|25|||
124826030|NCT00867009|448990846|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
125303609|NCT03047031|450739478|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
125303610|NCT01959841|450739479|FG000|Overall Study|Adverse Event|1|||
125303611|NCT01959841|450739480|FG001|Overall Study|Adverse Event|3|||
125303612|NCT01959841|450739481|FG002|Overall Study|Adverse Event|2|||
124826031|NCT01850524|448990851|FG000|Overall Study|Lost to Follow-up|5|||
124826032|NCT01850524|448990852|FG001|Overall Study|Lost to Follow-up|10|||
124826033|NCT01850524|448990851|FG000|Overall Study|Withdrawal by Subject|24|||
124826034|NCT01850524|448990852|FG001|Overall Study|Withdrawal by Subject|22|||
124826035|NCT01850524|448990851|FG000|Overall Study|Reason not Specified|142|||
124826036|NCT01850524|448990852|FG001|Overall Study|Reason not Specified|141|||
124826037|NCT03358290|448990854|FG000|Overall Study|Study discontinued by Sponsor|0|||
124826038|NCT03358290|448990855|FG001|Overall Study|Study discontinued by Sponsor|1|||
124826039|NCT03358290|448990856|FG002|Overall Study|Study discontinued by Sponsor|1|||
124826040|NCT03358290|448990857|FG003|Overall Study|Study discontinued by Sponsor|0|||
124826041|NCT03358290|448990858|FG004|Overall Study|Study discontinued by Sponsor|0|||
124826042|NCT03358290|448990854|FG000|Overall Study|Adverse Event|0|||
124826043|NCT03358290|448990855|FG001|Overall Study|Adverse Event|0|||
124826044|NCT03358290|448990856|FG002|Overall Study|Adverse Event|1|||
124826045|NCT03358290|448990857|FG003|Overall Study|Adverse Event|2|||
124826046|NCT03358290|448990858|FG004|Overall Study|Adverse Event|0|||
124826047|NCT03358290|448990854|FG000|Overall Study|Withdrawal by Subject|0|||
124826048|NCT03358290|448990855|FG001|Overall Study|Withdrawal by Subject|0|||
124826049|NCT03358290|448990856|FG002|Overall Study|Withdrawal by Subject|0|||
124826050|NCT03358290|448990857|FG003|Overall Study|Withdrawal by Subject|0|||
124826051|NCT03358290|448990858|FG004|Overall Study|Withdrawal by Subject|1|||
124826052|NCT04140292|448990862|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
124826053|NCT04140292|448990863|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
124826054|NCT00459667|448990864|FG000|Overall Study|Adverse Event|9|||
124826055|NCT00459667|448990865|FG001|Overall Study|Adverse Event|12|||
124826056|NCT00459667|448990866|FG002|Overall Study|Adverse Event|8|||
124826057|NCT00459667|448990864|FG000|Overall Study|Lost to Follow-up|5|||
124826058|NCT00459667|448990865|FG001|Overall Study|Lost to Follow-up|9|||
124826059|NCT00459667|448990866|FG002|Overall Study|Lost to Follow-up|3|||
124826060|NCT00459667|448990864|FG000|Overall Study|Pregnancy|1|||
124826061|NCT00459667|448990865|FG001|Overall Study|Pregnancy|1|||
124826062|NCT00459667|448990866|FG002|Overall Study|Pregnancy|1|||
124826063|NCT00459667|448990864|FG000|Overall Study|Protocol Violation|1|||
124826064|NCT00459667|448990865|FG001|Overall Study|Protocol Violation|0|||
124826065|NCT00459667|448990866|FG002|Overall Study|Protocol Violation|0|||
124826066|NCT00459667|448990864|FG000|Overall Study|Withdrawal by Subject|3|||
124826067|NCT00459667|448990865|FG001|Overall Study|Withdrawal by Subject|5|||
124826068|NCT00459667|448990866|FG002|Overall Study|Withdrawal by Subject|5|||
124826069|NCT00459667|448990864|FG000|Overall Study|Other disease modifying treatment|1|||
124826070|NCT00459667|448990865|FG001|Overall Study|Other disease modifying treatment|2|||
124826071|NCT00459667|448990866|FG002|Overall Study|Other disease modifying treatment|1|||
124826072|NCT00459667|448990864|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
124826073|NCT00459667|448990865|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
124826074|NCT00459667|448990866|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
124826075|NCT00459667|448990864|FG000|Overall Study|No treatment administered|6|||
124826076|NCT00459667|448990865|FG001|Overall Study|No treatment administered|3|||
124826077|NCT00459667|448990866|FG002|Overall Study|No treatment administered|1|||
124826078|NCT00556712|448990867|FG000|Overall Study|Adverse Event|7|||
124826079|NCT00556712|448990868|FG001|Overall Study|Adverse Event|19|||
124826080|NCT00556712|448990867|FG000|Overall Study|Death|5|||
124826081|NCT00556712|448990868|FG001|Overall Study|Death|10|||
124826082|NCT00556712|448990867|FG000|Overall Study|Progressive Disease|383|||
124826083|NCT00556712|448990868|FG001|Overall Study|Progressive Disease|320|||
124826084|NCT00556712|448990867|FG000|Overall Study|Protocol Violation|3|||
124826085|NCT00556712|448990868|FG001|Overall Study|Protocol Violation|2|||
124826086|NCT00556712|448990867|FG000|Overall Study|Refused Treatment|17|||
124826087|NCT00556712|448990868|FG001|Overall Study|Refused Treatment|16|||
124826088|NCT00556712|448990867|FG000|Overall Study|Failure to Return|2|||
124826089|NCT00556712|448990868|FG001|Overall Study|Failure to Return|3|||
124826090|NCT00556712|448990867|FG000|Overall Study|Other|2|||
125303613|NCT01959841|450739479|FG000|Overall Study|Lack of Efficacy|5|||
124826091|NCT00556712|448990868|FG001|Overall Study|Other|2|||
124826092|NCT00556712|448990867|FG000|Overall Study|Ongoing at Data Cutoff|32|||
124826093|NCT00556712|448990868|FG001|Overall Study|Ongoing at Data Cutoff|66|||
124826094|NCT04080297|448990869|FG000|Overall Study|Adverse Event|1|||
124826095|NCT04080297|448990870|FG001|Overall Study|Adverse Event|3|||
124826096|NCT04080297|448990869|FG000|Overall Study|concurrent illness|1|||
125303614|NCT01959841|450739480|FG001|Overall Study|Lack of Efficacy|0|||
124826097|NCT04080297|448990870|FG001|Overall Study|concurrent illness|0|||
124826098|NCT02626520|448990871|FG000|Overall Study|Physician Decision|1|||
124826099|NCT02626520|448990872|FG001|Overall Study|Physician Decision|1|||
124826100|NCT02626520|448990871|FG000|Overall Study|Adverse Event|0|||
124826101|NCT02626520|448990872|FG001|Overall Study|Adverse Event|4|||
124826102|NCT02626520|448990871|FG000|Overall Study|Lack of Efficacy|0|||
124826103|NCT02626520|448990872|FG001|Overall Study|Lack of Efficacy|2|||
124826104|NCT02626520|448990871|FG000|Overall Study|Did not start protocol therapy|0|||
124826105|NCT02626520|448990872|FG001|Overall Study|Did not start protocol therapy|2|||
124826106|NCT02626520|448990871|FG000|Overall Study|Study terminated|0|||
124826107|NCT02626520|448990872|FG001|Overall Study|Study terminated|1|||
124826108|NCT00353262|448990873|FG000|Overall Study|Adverse Event|8|||
124826109|NCT00353262|448990873|FG000|Overall Study|Withdrawal by Subject|2|||
124826110|NCT00353262|448990873|FG000|Overall Study|Insufficient Therapeutic Response|13|||
124826111|NCT00353262|448990873|FG000|Overall Study|Progression|1|||
124826112|NCT00353262|448990873|FG000|Overall Study|Surgery|4|||
124826113|NCT00353262|448990873|FG000|Overall Study|Break from Chemotherapy|1|||
124826114|NCT00463346|448992730|FG000|Overall Study|Withdrawal by Subject|3|||
124826115|NCT00463346|448992731|FG001|Overall Study|Withdrawal by Subject|3|||
124826116|NCT01572909|448992732|FG000|Overall Study|Adverse Event|7|||
124826117|NCT01572909|448992733|FG001|Overall Study|Adverse Event|2|||
124826118|NCT01572909|448992732|FG000|Overall Study|Death|3|||
124826119|NCT01572909|448992733|FG001|Overall Study|Death|1|||
124826120|NCT01572909|448992732|FG000|Overall Study|Lost to Follow-up|8|||
124826121|NCT01572909|448992733|FG001|Overall Study|Lost to Follow-up|7|||
124826122|NCT01572909|448992732|FG000|Overall Study|Physician Decision|1|||
124826123|NCT01572909|448992733|FG001|Overall Study|Physician Decision|1|||
124826124|NCT01572909|448992732|FG000|Overall Study|Technical Issues|1|||
124826125|NCT01572909|448992733|FG001|Overall Study|Technical Issues|0|||
124826126|NCT01572909|448992732|FG000|Overall Study|Withdrawal by Subject|12|||
124826127|NCT01572909|448992733|FG001|Overall Study|Withdrawal by Subject|11|||
124826128|NCT01572909|448992732|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
124826129|NCT01572909|448992733|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
124826130|NCT03641651|448992734|FG000|Overall Study|organizational issues at one study site|1|||
124826131|NCT04779489|448992735|FG000|Overall Study|Physician Decision|1|||
124826132|NCT00951665|448992736|FG000|Phase 1b|Adverse Event|2|||
124826133|NCT00951665|448992737|FG001|Phase 1b|Adverse Event|1|||
124826134|NCT00951665|448992738|FG002|Phase 1b|Adverse Event|0|||
124826135|NCT00951665|448992739|FG003|Phase 1b|Adverse Event|1|||
124826136|NCT00951665|448992740|FG004|Phase 1b|Adverse Event|0|||
124826137|NCT00951665|448992741|FG005|Phase 1b|Adverse Event|0|||
124826138|NCT00951665|448992736|FG000|Phase 1b|Death|1|||
124826139|NCT00951665|448992737|FG001|Phase 1b|Death|0|||
124826140|NCT00951665|448992738|FG002|Phase 1b|Death|2|||
124826141|NCT00951665|448992739|FG003|Phase 1b|Death|0|||
124826142|NCT00951665|448992740|FG004|Phase 1b|Death|0|||
124826143|NCT00951665|448992741|FG005|Phase 1b|Death|0|||
124826144|NCT00951665|448992736|FG000|Phase 1b|Physician Decision|4|||
124826145|NCT00951665|448992737|FG001|Phase 1b|Physician Decision|0|||
124826146|NCT00951665|448992738|FG002|Phase 1b|Physician Decision|1|||
124826147|NCT00951665|448992739|FG003|Phase 1b|Physician Decision|0|||
124826148|NCT00951665|448992740|FG004|Phase 1b|Physician Decision|0|||
124826149|NCT00951665|448992741|FG005|Phase 1b|Physician Decision|0|||
124826150|NCT00951665|448992736|FG000|Phase 1b|Withdrawal by Subject|0|||
124826151|NCT00951665|448992737|FG001|Phase 1b|Withdrawal by Subject|1|||
124826152|NCT00951665|448992738|FG002|Phase 1b|Withdrawal by Subject|0|||
124826153|NCT00951665|448992739|FG003|Phase 1b|Withdrawal by Subject|0|||
124826154|NCT00951665|448992740|FG004|Phase 1b|Withdrawal by Subject|0|||
124826155|NCT00951665|448992741|FG005|Phase 1b|Withdrawal by Subject|0|||
124826156|NCT00951665|448992736|FG000|Phase 1b|Disease Progression|13|||
124826157|NCT00951665|448992737|FG001|Phase 1b|Disease Progression|2|||
124826158|NCT00951665|448992738|FG002|Phase 1b|Disease Progression|14|||
124826159|NCT00951665|448992739|FG003|Phase 1b|Disease Progression|0|||
124826160|NCT00951665|448992740|FG004|Phase 1b|Disease Progression|0|||
124826161|NCT00951665|448992741|FG005|Phase 1b|Disease Progression|0|||
124826162|NCT00951665|448992736|FG000|Phase 1b|Protocol Violation|2|||
124826163|NCT00951665|448992737|FG001|Phase 1b|Protocol Violation|0|||
124826164|NCT00951665|448992738|FG002|Phase 1b|Protocol Violation|0|||
124826165|NCT00951665|448992739|FG003|Phase 1b|Protocol Violation|0|||
124826166|NCT00951665|448992740|FG004|Phase 1b|Protocol Violation|0|||
124826167|NCT00951665|448992741|FG005|Phase 1b|Protocol Violation|0|||
124826168|NCT00951665|448992736|FG000|Phase 2a|Adverse Event|0|||
124826169|NCT00951665|448992737|FG001|Phase 2a|Adverse Event|0|||
124826170|NCT00951665|448992738|FG002|Phase 2a|Adverse Event|0|||
124826171|NCT00951665|448992739|FG003|Phase 2a|Adverse Event|0|||
124826172|NCT00951665|448992740|FG004|Phase 2a|Adverse Event|2|||
124826173|NCT00951665|448992741|FG005|Phase 2a|Adverse Event|0|||
124826174|NCT00951665|448992736|FG000|Phase 2a|Death|0|||
124826175|NCT00951665|448992737|FG001|Phase 2a|Death|0|||
124826176|NCT00951665|448992738|FG002|Phase 2a|Death|0|||
124826177|NCT00951665|448992739|FG003|Phase 2a|Death|0|||
124826178|NCT00951665|448992740|FG004|Phase 2a|Death|1|||
124826179|NCT00951665|448992741|FG005|Phase 2a|Death|1|||
124826180|NCT00951665|448992736|FG000|Phase 2a|Lost to Follow-up|0|||
124826181|NCT00951665|448992737|FG001|Phase 2a|Lost to Follow-up|0|||
124826182|NCT00951665|448992738|FG002|Phase 2a|Lost to Follow-up|0|||
124826183|NCT00951665|448992739|FG003|Phase 2a|Lost to Follow-up|0|||
124826184|NCT00951665|448992740|FG004|Phase 2a|Lost to Follow-up|1|||
124826185|NCT00951665|448992741|FG005|Phase 2a|Lost to Follow-up|0|||
124826186|NCT00951665|448992736|FG000|Phase 2a|Physician Decision|0|||
124826187|NCT00951665|448992737|FG001|Phase 2a|Physician Decision|0|||
124826188|NCT00951665|448992738|FG002|Phase 2a|Physician Decision|0|||
124826189|NCT00951665|448992739|FG003|Phase 2a|Physician Decision|0|||
124826190|NCT00951665|448992740|FG004|Phase 2a|Physician Decision|0|||
124826191|NCT00951665|448992741|FG005|Phase 2a|Physician Decision|1|||
124826192|NCT00951665|448992736|FG000|Phase 2a|Withdrawal by Subject|0|||
124826193|NCT00951665|448992737|FG001|Phase 2a|Withdrawal by Subject|0|||
124826194|NCT00951665|448992738|FG002|Phase 2a|Withdrawal by Subject|0|||
124826195|NCT00951665|448992739|FG003|Phase 2a|Withdrawal by Subject|0|||
124826196|NCT00951665|448992740|FG004|Phase 2a|Withdrawal by Subject|2|||
124826197|NCT00951665|448992741|FG005|Phase 2a|Withdrawal by Subject|0|||
124826198|NCT00951665|448992736|FG000|Phase 2a|Disease Progression|0|||
124826199|NCT00951665|448992737|FG001|Phase 2a|Disease Progression|0|||
124826200|NCT00951665|448992738|FG002|Phase 2a|Disease Progression|0|||
124826201|NCT00951665|448992739|FG003|Phase 2a|Disease Progression|0|||
124826202|NCT00951665|448992740|FG004|Phase 2a|Disease Progression|6|||
124826203|NCT00951665|448992741|FG005|Phase 2a|Disease Progression|5|||
124826204|NCT02723084|448992742|FG000|Overall Study|Withdrawal by Subject|1|||
124826205|NCT02723084|448992743|FG001|Overall Study|Withdrawal by Subject|1|||
124826206|NCT02723084|448992742|FG000|Overall Study|Lost to Follow-up|3|||
124826207|NCT02723084|448992743|FG001|Overall Study|Lost to Follow-up|0|||
124826208|NCT02450903|448992746|FG000|Overall Study|Adverse Event|3|||
124826209|NCT02450903|448992746|FG000|Overall Study|Progressive disease|15|||
124826210|NCT02450903|448992746|FG000|Overall Study|Switched to commercial drug|1|||
124826211|NCT02450903|448992746|FG000|Overall Study|Subject/guardian decision|1|||
124826212|NCT01164956|448992747|FG000|Overall Study|Side Effects|1|||
124826213|NCT01164956|448992748|FG001|Overall Study|Side Effects|0|||
124826214|NCT01164956|448992749|FG002|Overall Study|Side Effects|1|||
124826215|NCT00967798|448992750|FG000|Overall Study|Withdrawal by Subject|5|||
124826216|NCT00967798|448992751|FG001|Overall Study|Withdrawal by Subject|2|||
124826217|NCT00967798|448992750|FG000|Overall Study|Lost to Follow-up|4|||
124826218|NCT00967798|448992751|FG001|Overall Study|Lost to Follow-up|1|||
124826219|NCT01409564|448992752|FG000|Overall Study|low medication compliance|4|||
124826220|NCT01409564|448992753|FG001|Overall Study|low medication compliance|3|||
124826221|NCT01409564|448992752|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
124826222|NCT01409564|448992753|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
124826223|NCT00788151|448992758|FG000|Overall Study|Other adverse event|0|||
124826224|NCT00788151|448992759|FG001|Overall Study|Other adverse event|2|||
124826225|NCT00788151|448992758|FG000|Overall Study|Protocol Violation|0|||
124826226|NCT00788151|448992759|FG001|Overall Study|Protocol Violation|1|||
124826227|NCT00788151|448992758|FG000|Overall Study|Withdrawal by Subject|13|||
124826228|NCT00788151|448992759|FG001|Overall Study|Withdrawal by Subject|6|||
124826229|NCT00788151|448992758|FG000|Overall Study|Enrolled but not treated|1|||
124826230|NCT00788151|448992759|FG001|Overall Study|Enrolled but not treated|1|||
124826231|NCT00503009|448992760|FG000|Overall Study|Protocol Violation|1|||
124826232|NCT00503009|448992761|FG001|Overall Study|Protocol Violation|0|||
124826233|NCT00503009|448992762|FG002|Overall Study|Protocol Violation|1|||
124826234|NCT00503009|448992760|FG000|Overall Study|Withdrawal by Subject|0|||
124826235|NCT00503009|448992761|FG001|Overall Study|Withdrawal by Subject|1|||
124826236|NCT00503009|448992762|FG002|Overall Study|Withdrawal by Subject|1|||
124826237|NCT00503009|448992760|FG000|Overall Study|Physician Decision|0|||
124826238|NCT00503009|448992761|FG001|Overall Study|Physician Decision|1|||
124826239|NCT00503009|448992762|FG002|Overall Study|Physician Decision|1|||
124826240|NCT01349803|448992763|FG000|Overall Study|Adverse Event|0|||
124826241|NCT01349803|448992764|FG001|Overall Study|Adverse Event|0|||
124826242|NCT01349803|448992765|FG002|Overall Study|Adverse Event|0|||
124826243|NCT01349803|448992766|FG003|Overall Study|Adverse Event|2|||
124826244|NCT01349803|448992763|FG000|Overall Study|Withdrawal by Subject|1|||
124826245|NCT01349803|448992764|FG001|Overall Study|Withdrawal by Subject|0|||
124826246|NCT01349803|448992765|FG002|Overall Study|Withdrawal by Subject|0|||
124826247|NCT01349803|448992766|FG003|Overall Study|Withdrawal by Subject|0|||
124826248|NCT01349803|448992763|FG000|Overall Study|Protocol-specified criteria|0|||
124826249|NCT01349803|448992764|FG001|Overall Study|Protocol-specified criteria|1|||
124826250|NCT01349803|448992765|FG002|Overall Study|Protocol-specified criteria|3|||
124826251|NCT01349803|448992766|FG003|Overall Study|Protocol-specified criteria|0|||
124826252|NCT02169739|448992767|FG000|Overall Study|Lost to Follow-up|0|||
124826253|NCT02169739|448992768|FG001|Overall Study|Lost to Follow-up|4|||
124826254|NCT01710033|448992769|FG000|Stage 2|Adverse Event|0|||
124826255|NCT01710033|448992770|FG001|Stage 2|Adverse Event|0|||
124826256|NCT01710033|448992771|FG002|Stage 2|Adverse Event|0|||
124826257|NCT01710033|448992772|FG003|Stage 2|Adverse Event|0|||
124826258|NCT01710033|448992773|FG004|Stage 2|Adverse Event|1|||
124826259|NCT01244906|448992778|FG000|Overall Study|Death|2|||
124826260|NCT01244906|448992778|FG000|Overall Study|Progression of disease post treatment|6|||
124826261|NCT03720470|448992783|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
124826262|NCT03720470|448992784|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
124826263|NCT03720470|448992785|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
124826264|NCT03720470|448992786|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
124826265|NCT03720470|448992787|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
124826266|NCT03720470|448992788|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
124826267|NCT03720470|448992783|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
124826268|NCT03720470|448992784|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
124826269|NCT03720470|448992785|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
124826270|NCT03720470|448992786|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
124826271|NCT03720470|448992787|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
124826272|NCT03720470|448992788|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
124826273|NCT03720470|448992783|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
124826274|NCT03720470|448992784|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
124826275|NCT03720470|448992785|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
124826276|NCT03720470|448992786|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
124826277|NCT03720470|448992787|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
124826278|NCT03720470|448992788|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
124826279|NCT03720470|448992783|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
124826280|NCT03720470|448992784|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
124826281|NCT03720470|448992785|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
124826282|NCT03720470|448992786|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
124826283|NCT03720470|448992787|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
124826284|NCT03720470|448992788|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
124826285|NCT03720470|448992783|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
124826286|NCT03720470|448992784|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
124826287|NCT03720470|448992785|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
124826288|NCT03720470|448992786|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
124826289|NCT03720470|448992787|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
124826290|NCT03720470|448992788|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
124826291|NCT03720470|448992783|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
124826292|NCT03720470|448992784|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
124826293|NCT03720470|448992785|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
124826294|NCT03720470|448992786|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
124826295|NCT03720470|448992787|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
124826296|NCT03720470|448992788|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
124826297|NCT03720470|448992783|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
124826298|NCT03720470|448992784|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
124826299|NCT03720470|448992785|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
124826300|NCT03720470|448992786|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
124826301|NCT03720470|448992787|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
124826302|NCT03720470|448992788|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
124826303|NCT03720470|448992783|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
124826304|NCT03720470|448992784|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
124826305|NCT03720470|448992785|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
124826306|NCT03720470|448992786|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
124826307|NCT03720470|448992787|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
124826308|NCT03720470|448992788|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
124826309|NCT03720470|448992783|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
124826310|NCT03720470|448992784|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
124826311|NCT03720470|448992785|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
124826312|NCT03720470|448992786|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
124826313|NCT03720470|448992787|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
124826314|NCT03720470|448992788|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
124826315|NCT03720470|448992783|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
124826316|NCT03720470|448992784|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
124826317|NCT03720470|448992785|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
124826318|NCT03720470|448992786|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
124826319|NCT03720470|448992787|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
124826320|NCT03720470|448992788|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
124826321|NCT03720470|448992783|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
124826322|NCT03720470|448992784|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
124826323|NCT03720470|448992785|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
124826324|NCT03720470|448992786|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
124826325|NCT03720470|448992787|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
124826326|NCT03720470|448992788|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
124826327|NCT03720470|448992783|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
124826328|NCT03720470|448992784|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
124826329|NCT03720470|448992785|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
124826330|NCT03720470|448992786|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
124826331|NCT03720470|448992787|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
124826332|NCT03720470|448992788|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
124826333|NCT03720470|448992783|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
124826334|NCT03720470|448992784|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
124826335|NCT03720470|448992785|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
124826336|NCT03720470|448992786|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
124826337|NCT03720470|448992787|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
124826338|NCT03720470|448992788|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
124826339|NCT03720470|448992783|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
124826340|NCT03720470|448992784|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
124826341|NCT03720470|448992785|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
124826342|NCT03720470|448992786|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
124826343|NCT03720470|448992787|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
124826344|NCT03720470|448992788|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
124826345|NCT03720470|448992783|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
124826346|NCT03720470|448992784|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
124826347|NCT03720470|448992785|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
124826348|NCT03720470|448992786|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
124826349|NCT03720470|448992787|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
124826350|NCT03720470|448992788|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
124826351|NCT03720470|448992783|FG000|Treatment Period: Final 4 Weeks|Other|0|||
124826352|NCT03720470|448992784|FG001|Treatment Period: Final 4 Weeks|Other|1|||
124826353|NCT03720470|448992785|FG002|Treatment Period: Final 4 Weeks|Other|0|||
124826354|NCT03720470|448992786|FG003|Treatment Period: Final 4 Weeks|Other|2|||
124826355|NCT03720470|448992787|FG004|Treatment Period: Final 4 Weeks|Other|1|||
124826356|NCT03720470|448992788|FG005|Treatment Period: Final 4 Weeks|Other|0|||
124826357|NCT00453921|448992789|FG000|Overall Study|Withdrawal by Subject|1|||
124826358|NCT00453921|448992790|FG001|Overall Study|Withdrawal by Subject|1|||
124826359|NCT00453921|448992791|FG002|Overall Study|Withdrawal by Subject|1|||
124826360|NCT00453921|448992792|FG003|Overall Study|Withdrawal by Subject|1|||
124826361|NCT00453921|448992789|FG000|Overall Study|Lost to Follow-up|0|||
124826362|NCT00453921|448992790|FG001|Overall Study|Lost to Follow-up|0|||
124826363|NCT00453921|448992791|FG002|Overall Study|Lost to Follow-up|1|||
124826364|NCT00453921|448992792|FG003|Overall Study|Lost to Follow-up|0|||
124826365|NCT00460031|448992793|FG000|Overall Study|Adverse Event|5|||
124826366|NCT00460031|448992793|FG000|Overall Study|Withdrawal by Subject|5|||
124826367|NCT00460031|448992793|FG000|Overall Study|Death|1|||
124826368|NCT04532099|448992794|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
124826369|NCT04532099|448992795|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
124826370|NCT04532099|448992796|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
124826371|NCT00644995|448992801|FG000|Overall Study|Lost to Follow-up|1|||
124826372|NCT00644995|448992802|FG001|Overall Study|Lost to Follow-up|4|||
124826373|NCT00644995|448992801|FG000|Overall Study|Refused|1|||
124826374|NCT00644995|448992802|FG001|Overall Study|Refused|0|||
124826375|NCT02066233|448992803|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
124826376|NCT02066233|448992804|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
124826377|NCT02772081|448992805|FG000|Overall Study|Physician Decision|1|||
124826378|NCT02772081|448992806|FG001|Overall Study|Physician Decision|1|||
124826379|NCT02772081|448992805|FG000|Overall Study|Death|1|||
124826380|NCT02772081|448992806|FG001|Overall Study|Death|1|||
124826381|NCT03103919|448992813|FG000|Overall Study|Adverse Event|2|||
124826382|NCT03103919|448992814|FG001|Overall Study|Adverse Event|2|||
124826383|NCT01291173|448992815|FG000|Overall Study|Adverse Event|0|||
124826384|NCT01291173|448992816|FG001|Overall Study|Adverse Event|3|||
124826385|NCT01291173|448992817|FG002|Overall Study|Adverse Event|1|||
124826386|NCT01291173|448992818|FG003|Overall Study|Adverse Event|3|||
124826387|NCT01291173|448992815|FG000|Overall Study|Protocol Violation|7|||
124826388|NCT01291173|448992816|FG001|Overall Study|Protocol Violation|2|||
124826389|NCT01291173|448992817|FG002|Overall Study|Protocol Violation|2|||
124826390|NCT01291173|448992818|FG003|Overall Study|Protocol Violation|5|||
124826391|NCT01291173|448992815|FG000|Overall Study|Withdrawal by Subject|6|||
124826392|NCT01291173|448992816|FG001|Overall Study|Withdrawal by Subject|4|||
124826393|NCT01291173|448992817|FG002|Overall Study|Withdrawal by Subject|4|||
124826394|NCT01291173|448992818|FG003|Overall Study|Withdrawal by Subject|2|||
124826395|NCT01291173|448992815|FG000|Overall Study|Lost to Follow-up|4|||
124826396|NCT01291173|448992816|FG001|Overall Study|Lost to Follow-up|6|||
124826397|NCT01291173|448992817|FG002|Overall Study|Lost to Follow-up|3|||
124826398|NCT01291173|448992818|FG003|Overall Study|Lost to Follow-up|2|||
124826399|NCT01291173|448992815|FG000|Overall Study|Unable to meet visit schedule|0|||
124826400|NCT01291173|448992816|FG001|Overall Study|Unable to meet visit schedule|0|||
124826401|NCT01291173|448992817|FG002|Overall Study|Unable to meet visit schedule|1|||
124826402|NCT01291173|448992818|FG003|Overall Study|Unable to meet visit schedule|0|||
124826403|NCT01291173|448992815|FG000|Overall Study|Lack of compliance|0|||
124826404|NCT01291173|448992816|FG001|Overall Study|Lack of compliance|0|||
124826405|NCT01291173|448992817|FG002|Overall Study|Lack of compliance|0|||
124826406|NCT01291173|448992818|FG003|Overall Study|Lack of compliance|1|||
124826407|NCT01291173|448992815|FG000|Overall Study|Subject was unblinded|0|||
124826408|NCT01291173|448992816|FG001|Overall Study|Subject was unblinded|0|||
124826409|NCT01291173|448992817|FG002|Overall Study|Subject was unblinded|1|||
124826410|NCT01291173|448992818|FG003|Overall Study|Subject was unblinded|0|||
124826411|NCT01291173|448992815|FG000|Overall Study|Excluded therapy|0|||
124826412|NCT01291173|448992816|FG001|Overall Study|Excluded therapy|0|||
124826413|NCT01291173|448992817|FG002|Overall Study|Excluded therapy|1|||
124826414|NCT01291173|448992818|FG003|Overall Study|Excluded therapy|0|||
124826415|NCT00390858|448992819|FG000|Overall Study|Adverse Event|6|||
124826416|NCT00390858|448992820|FG001|Overall Study|Adverse Event|2|||
124826417|NCT00390858|448992819|FG000|Overall Study|Lack of Efficacy|0|||
124826418|NCT00390858|448992820|FG001|Overall Study|Lack of Efficacy|1|||
124826419|NCT00390858|448992819|FG000|Overall Study|Withdrawal by Subject|3|||
124826420|NCT00390858|448992820|FG001|Overall Study|Withdrawal by Subject|4|||
124826421|NCT02728895|448992821|FG000|Overall Study|Other|1|||
124826422|NCT02728895|448992822|FG001|Overall Study|Other|2|||
124826423|NCT02728895|448992821|FG000|Overall Study|Withdrawal by Subject|0|||
124826424|NCT02728895|448992822|FG001|Overall Study|Withdrawal by Subject|3|||
124826425|NCT01949051|448992827|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
124826426|NCT01949051|448992828|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
124826427|NCT01949051|448992829|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
124826428|NCT01949051|448992830|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
124826429|NCT01949051|448992831|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
124826430|NCT01949051|448992832|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
124826431|NCT01949051|448992827|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
124826432|NCT01949051|448992828|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124826433|NCT01949051|448992829|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124826434|NCT01949051|448992830|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124826435|NCT01949051|448992831|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124826436|NCT01949051|448992832|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124826437|NCT01949051|448992827|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
124826438|NCT01949051|448992828|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
124826439|NCT01949051|448992829|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
124826440|NCT01949051|448992830|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
124826441|NCT01949051|448992831|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
124826442|NCT01949051|448992832|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
124826443|NCT01949051|448992827|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
124826444|NCT01949051|448992828|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
124826445|NCT01949051|448992829|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
124826446|NCT01949051|448992830|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
124826447|NCT01949051|448992831|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
124826448|NCT01949051|448992832|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
124826449|NCT01949051|448992827|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
124826450|NCT01949051|448992828|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
124826451|NCT01949051|448992829|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
124826452|NCT01949051|448992830|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
124826453|NCT01949051|448992831|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
124826454|NCT01949051|448992832|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
124826455|NCT01506479|448992833|FG000|Overall Study|Lost to Follow-up|1|||
124826456|NCT01506479|448992834|FG001|Overall Study|Lost to Follow-up|2|||
124826457|NCT01506479|448992835|FG002|Overall Study|Lost to Follow-up|2|||
124826458|NCT01506479|448992833|FG000|Overall Study|Withdrawal by Subject|1|||
125303615|NCT01959841|450739481|FG002|Overall Study|Lack of Efficacy|0|||
125303616|NCT01959841|450739479|FG000|Overall Study|Lost to Follow-up|1|||
125303617|NCT01959841|450739480|FG001|Overall Study|Lost to Follow-up|1|||
125303618|NCT01959841|450739481|FG002|Overall Study|Lost to Follow-up|0|||
125303619|NCT01959841|450739479|FG000|Overall Study|Physician Decision|0|||
125303620|NCT01959841|450739480|FG001|Overall Study|Physician Decision|2|||
125303621|NCT01959841|450739481|FG002|Overall Study|Physician Decision|3|||
124826459|NCT01506479|448992834|FG001|Overall Study|Withdrawal by Subject|2|||
124826460|NCT01506479|448992835|FG002|Overall Study|Withdrawal by Subject|1|||
124826461|NCT01506479|448992833|FG000|Overall Study|Missing assessment|1|||
124826462|NCT01506479|448992834|FG001|Overall Study|Missing assessment|0|||
125303622|NCT01959841|450739479|FG000|Overall Study|Protocol Violation|16|||
125303623|NCT01959841|450739480|FG001|Overall Study|Protocol Violation|23|||
125303624|NCT01959841|450739481|FG002|Overall Study|Protocol Violation|16|||
124826463|NCT01506479|448992835|FG002|Overall Study|Missing assessment|0|||
124826464|NCT01506479|448992833|FG000|Overall Study|Adverse Event|0|||
125303625|NCT01959841|450739479|FG000|Overall Study|Withdrawal by Subject|7|||
125303626|NCT01959841|450739480|FG001|Overall Study|Withdrawal by Subject|7|||
124826465|NCT01506479|448992834|FG001|Overall Study|Adverse Event|1|||
124826466|NCT01506479|448992835|FG002|Overall Study|Adverse Event|0|||
124826467|NCT01782859|448992836|FG000|Overall Study|Protocol Violation|6|||
124826468|NCT01782859|448992837|FG001|Overall Study|Protocol Violation|6|||
124826469|NCT01782859|448992836|FG000|Overall Study|Withdrawal by Subject|0|||
124826470|NCT01782859|448992837|FG001|Overall Study|Withdrawal by Subject|1|||
124826471|NCT02611778|448992840|FG000|Overall Study|Withdrawal by Subject|2|||
124826472|NCT02611778|448992841|FG001|Overall Study|Withdrawal by Subject|8|||
124826473|NCT02611778|448992840|FG000|Overall Study|Adverse Event|1|||
124826474|NCT02611778|448992841|FG001|Overall Study|Adverse Event|2|||
124826475|NCT02611778|448992840|FG000|Overall Study|Death|2|||
124826476|NCT02611778|448992841|FG001|Overall Study|Death|1|||
124826477|NCT02611778|448992840|FG000|Overall Study|Protocol Violation|1|||
124826478|NCT02611778|448992841|FG001|Overall Study|Protocol Violation|0|||
124826479|NCT02611778|448992840|FG000|Overall Study|Lost to Follow-up|3|||
124826480|NCT02611778|448992841|FG001|Overall Study|Lost to Follow-up|1|||
124826481|NCT02611778|448992840|FG000|Overall Study|Need for alternative treatment|1|||
124826482|NCT02611778|448992841|FG001|Overall Study|Need for alternative treatment|0|||
124826483|NCT02611778|448992840|FG000|Overall Study|Other Reason|2|||
124826484|NCT02611778|448992841|FG001|Overall Study|Other Reason|1|||
124826485|NCT02426892|448992842|FG000|Overall Study|Adverse Event|2|||
124826486|NCT02426892|448992842|FG000|Overall Study|Lack of Efficacy|17|||
124826487|NCT02426892|448992842|FG000|Overall Study|Withdrawal by Subject|1|||
124826488|NCT03198234|448992847|FG000|Overall Study|Relapse of primary disease|0|||
124826489|NCT03198234|448992848|FG001|Overall Study|Relapse of primary disease|1|||
124826490|NCT03198234|448992849|FG002|Overall Study|Relapse of primary disease|0|||
124826491|NCT01340898|448992850|FG000|Primary Phase|Serious Adverse Events|0|||
124826492|NCT01340898|448992851|FG001|Primary Phase|Serious Adverse Events|0|||
124826493|NCT01340898|448992852|FG002|Primary Phase|Serious Adverse Events|1|||
124826494|NCT01340898|448992850|FG000|Primary Phase|Withdrawal by Subject|8|||
124826495|NCT01340898|448992851|FG001|Primary Phase|Withdrawal by Subject|7|||
124826496|NCT01340898|448992852|FG002|Primary Phase|Withdrawal by Subject|5|||
124826497|NCT01340898|448992850|FG000|Primary Phase|Migrated/moved from study area|4|||
124826498|NCT01340898|448992851|FG001|Primary Phase|Migrated/moved from study area|1|||
124826499|NCT01340898|448992852|FG002|Primary Phase|Migrated/moved from study area|0|||
124826500|NCT01340898|448992850|FG000|Primary Phase|Lost to Follow-up|4|||
124826501|NCT01340898|448992851|FG001|Primary Phase|Lost to Follow-up|1|||
124826502|NCT01340898|448992852|FG002|Primary Phase|Lost to Follow-up|0|||
124826503|NCT01340898|448992850|FG000|Booster Phase|Withdrawal by Subject|3|||
124826504|NCT01340898|448992851|FG001|Booster Phase|Withdrawal by Subject|0|||
124826505|NCT01340898|448992852|FG002|Booster Phase|Withdrawal by Subject|4|||
124826506|NCT01340898|448992850|FG000|Booster Phase|Migrated/moved from study area|3|||
124826507|NCT01340898|448992851|FG001|Booster Phase|Migrated/moved from study area|0|||
124826508|NCT01340898|448992852|FG002|Booster Phase|Migrated/moved from study area|0|||
124826509|NCT01340898|448992850|FG000|Booster Phase|Lost to Follow-up|4|||
124826510|NCT01340898|448992851|FG001|Booster Phase|Lost to Follow-up|2|||
124826511|NCT01340898|448992852|FG002|Booster Phase|Lost to Follow-up|3|||
124826512|NCT02056340|448992853|FG000|Overall Study|Lost to Follow-up|5|||
124826513|NCT02056340|448992854|FG001|Overall Study|Lost to Follow-up|5|||
124826514|NCT02056340|448992853|FG000|Overall Study|Withdrawal by Subject|2|||
124826515|NCT02056340|448992854|FG001|Overall Study|Withdrawal by Subject|6|||
124826516|NCT02669433|448992862|FG000|Overall Study|Protocol Violation|0|||
124826517|NCT02669433|448992863|FG001|Overall Study|Protocol Violation|4|||
124826518|NCT02669433|448992864|FG002|Overall Study|Protocol Violation|1|||
124826519|NCT02669433|448992862|FG000|Overall Study|Disease Progression|1|||
124826520|NCT02669433|448992863|FG001|Overall Study|Disease Progression|0|||
124826521|NCT02669433|448992864|FG002|Overall Study|Disease Progression|0|||
124826522|NCT02669433|448992862|FG000|Overall Study|Physician Decision|1|||
124826523|NCT02669433|448992863|FG001|Overall Study|Physician Decision|1|||
124826524|NCT02669433|448992864|FG002|Overall Study|Physician Decision|0|||
124826525|NCT02669433|448992862|FG000|Overall Study|Adverse Event|6|||
124826526|NCT02669433|448992863|FG001|Overall Study|Adverse Event|7|||
124826527|NCT02669433|448992864|FG002|Overall Study|Adverse Event|10|||
124826528|NCT02669433|448992862|FG000|Overall Study|Sponsor Termination|1|||
124826529|NCT02669433|448992863|FG001|Overall Study|Sponsor Termination|0|||
124826530|NCT02669433|448992864|FG002|Overall Study|Sponsor Termination|1|||
124826531|NCT02669433|448992862|FG000|Overall Study|Withdrawal by Subject|5|||
124826532|NCT02669433|448992863|FG001|Overall Study|Withdrawal by Subject|1|||
124826533|NCT02669433|448992864|FG002|Overall Study|Withdrawal by Subject|0|||
124826534|NCT02669433|448992862|FG000|Overall Study|Withdrawal by Caregiver|1|||
124826535|NCT02669433|448992863|FG001|Overall Study|Withdrawal by Caregiver|0|||
124826536|NCT02669433|448992864|FG002|Overall Study|Withdrawal by Caregiver|2|||
124826537|NCT02669433|448992862|FG000|Overall Study|Death|0|||
124826538|NCT02669433|448992863|FG001|Overall Study|Death|1|||
124826539|NCT02669433|448992864|FG002|Overall Study|Death|1|||
124826540|NCT03128892|448992865|FG000|Overall Study|Withdrawal by Subject|2|||
124826541|NCT03128892|448992865|FG000|Overall Study|Physician Decision|1|||
124826542|NCT00459108|448992866|FG000|Overall Study|Withdrawal by Subject|5|||
124826543|NCT00459108|448992866|FG000|Overall Study|Adverse Event|3|||
124826544|NCT00459108|448992866|FG000|Overall Study|Death|2|||
124826545|NCT00459108|448992866|FG000|Overall Study|Progression|1|||
124826546|NCT03473808|448992872|FG000|Overall Study|Withdrawal by Subject|1|||
124826547|NCT02157298|448992873|FG000|Overall Study|Adverse Event|1|||
124826548|NCT02157298|448992874|FG001|Overall Study|Adverse Event|0|||
124826549|NCT02157298|448992873|FG000|Overall Study|Subject no longer meets study criteria|1|||
124826550|NCT02157298|448992874|FG001|Overall Study|Subject no longer meets study criteria|2|||
124826551|NCT02157298|448992873|FG000|Overall Study|Poor/Non-compliance|1|||
124826552|NCT02157298|448992874|FG001|Overall Study|Poor/Non-compliance|0|||
124826553|NCT02157298|448992873|FG000|Overall Study|Withdrawal by Subject|1|||
124826554|NCT02157298|448992874|FG001|Overall Study|Withdrawal by Subject|0|||
124826555|NCT01339429|448992875|FG000|Overall Study|Withdrawal by Subject|1|||
124826556|NCT01339429|448992875|FG000|Overall Study|Physician Decision|3|||
124826557|NCT01085591|448992876|FG000|Overall Study|Adverse Event|0|||
124826558|NCT01085591|448992877|FG001|Overall Study|Adverse Event|1|||
124826559|NCT01085591|448992878|FG002|Overall Study|Adverse Event|3|||
124826560|NCT01085591|448992876|FG000|Overall Study|Physician Decision|1|||
124826561|NCT01085591|448992877|FG001|Overall Study|Physician Decision|0|||
124826562|NCT01085591|448992878|FG002|Overall Study|Physician Decision|1|||
124826563|NCT01085591|448992876|FG000|Overall Study|Withdrawal by Subject|0|||
124826564|NCT01085591|448992877|FG001|Overall Study|Withdrawal by Subject|2|||
124826565|NCT01085591|448992878|FG002|Overall Study|Withdrawal by Subject|1|||
124826566|NCT01085591|448992876|FG000|Overall Study|Lost to Follow-up|0|||
124826567|NCT01085591|448992877|FG001|Overall Study|Lost to Follow-up|1|||
124826568|NCT01085591|448992878|FG002|Overall Study|Lost to Follow-up|1|||
124826569|NCT01085591|448992876|FG000|Overall Study|Protocol Violation|1|||
124826570|NCT01085591|448992877|FG001|Overall Study|Protocol Violation|1|||
124826571|NCT01085591|448992878|FG002|Overall Study|Protocol Violation|1|||
124826572|NCT01085591|448992876|FG000|Overall Study|Other|0|||
124826573|NCT01085591|448992877|FG001|Overall Study|Other|1|||
124826574|NCT01085591|448992878|FG002|Overall Study|Other|0|||
124826575|NCT01085591|448992876|FG000|Overall Study|Not Properly Consented|1|||
124826576|NCT01085591|448992877|FG001|Overall Study|Not Properly Consented|0|||
124826577|NCT01085591|448992878|FG002|Overall Study|Not Properly Consented|0|||
124826578|NCT00396591|448992879|FG000|Overall Study|Disease Progression|13|||
124826579|NCT00396591|448992879|FG000|Overall Study|Adverse Event|2|||
124826580|NCT00396591|448992879|FG000|Overall Study|Participant request|1|||
124826581|NCT00818662|448992883|FG000|Overall Study|Adverse Event|5|||
124826582|NCT00818662|448992884|FG001|Overall Study|Adverse Event|14|||
124826583|NCT00818662|448992885|FG002|Overall Study|Adverse Event|4|||
124826584|NCT00818662|448992886|FG003|Overall Study|Adverse Event|3|||
124826585|NCT00818662|448992883|FG000|Overall Study|Withdrawal by Subject|5|||
124826586|NCT00818662|448992884|FG001|Overall Study|Withdrawal by Subject|4|||
124826587|NCT00818662|448992885|FG002|Overall Study|Withdrawal by Subject|2|||
124826588|NCT00818662|448992886|FG003|Overall Study|Withdrawal by Subject|2|||
124826589|NCT00818662|448992883|FG000|Overall Study|Death|1|||
124826590|NCT00818662|448992884|FG001|Overall Study|Death|3|||
124826591|NCT00818662|448992885|FG002|Overall Study|Death|0|||
124826592|NCT00818662|448992886|FG003|Overall Study|Death|0|||
124826593|NCT00818662|448992883|FG000|Overall Study|Physician Decision|1|||
124826594|NCT00818662|448992884|FG001|Overall Study|Physician Decision|0|||
124826595|NCT00818662|448992885|FG002|Overall Study|Physician Decision|0|||
124826596|NCT00818662|448992886|FG003|Overall Study|Physician Decision|0|||
124826597|NCT00818662|448992883|FG000|Overall Study|Lost to Follow-up|0|||
124826598|NCT00818662|448992884|FG001|Overall Study|Lost to Follow-up|0|||
124826599|NCT00818662|448992885|FG002|Overall Study|Lost to Follow-up|0|||
124826600|NCT00818662|448992886|FG003|Overall Study|Lost to Follow-up|1|||
124826601|NCT00818662|448992883|FG000|Overall Study|Unwilling or Unable to Participate|4|||
124826602|NCT00818662|448992884|FG001|Overall Study|Unwilling or Unable to Participate|6|||
124826603|NCT00818662|448992885|FG002|Overall Study|Unwilling or Unable to Participate|2|||
124826604|NCT00818662|448992886|FG003|Overall Study|Unwilling or Unable to Participate|4|||
124826605|NCT00818662|448992883|FG000|Overall Study|Protocol Violation|1|||
124826606|NCT00818662|448992884|FG001|Overall Study|Protocol Violation|1|||
124826607|NCT00818662|448992885|FG002|Overall Study|Protocol Violation|0|||
124826608|NCT00818662|448992886|FG003|Overall Study|Protocol Violation|0|||
124826609|NCT00818662|448992883|FG000|Overall Study|Requires a Prohibited Medication|1|||
124826610|NCT00818662|448992884|FG001|Overall Study|Requires a Prohibited Medication|0|||
124826611|NCT00818662|448992885|FG002|Overall Study|Requires a Prohibited Medication|0|||
124826612|NCT00818662|448992886|FG003|Overall Study|Requires a Prohibited Medication|0|||
124826613|NCT00818662|448992883|FG000|Overall Study|Safety Risk|1|||
124826614|NCT00818662|448992884|FG001|Overall Study|Safety Risk|1|||
124826615|NCT00818662|448992885|FG002|Overall Study|Safety Risk|0|||
124826616|NCT00818662|448992886|FG003|Overall Study|Safety Risk|1|||
124826617|NCT00818662|448992883|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
124826618|NCT00818662|448992884|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
124826619|NCT00818662|448992885|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
124826620|NCT00818662|448992886|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
124826621|NCT00818662|448992883|FG000|Overall Study|Participant's health declined|0|||
124826622|NCT00818662|448992884|FG001|Overall Study|Participant's health declined|0|||
124826623|NCT00818662|448992885|FG002|Overall Study|Participant's health declined|0|||
124826624|NCT00818662|448992886|FG003|Overall Study|Participant's health declined|1|||
124826625|NCT00818662|448992883|FG000|Overall Study|Caregiver to pursue other treatment|0|||
124826626|NCT00818662|448992884|FG001|Overall Study|Caregiver to pursue other treatment|1|||
124826627|NCT00818662|448992885|FG002|Overall Study|Caregiver to pursue other treatment|0|||
124826628|NCT00818662|448992886|FG003|Overall Study|Caregiver to pursue other treatment|0|||
124826629|NCT00818662|448992883|FG000|Overall Study|Moving out of state|0|||
124826630|NCT00818662|448992884|FG001|Overall Study|Moving out of state|0|||
124826631|NCT00818662|448992885|FG002|Overall Study|Moving out of state|0|||
124826632|NCT00818662|448992886|FG003|Overall Study|Moving out of state|1|||
124826633|NCT00818662|448992883|FG000|Overall Study|Declined move to another study site|1|||
124826634|NCT00818662|448992884|FG001|Overall Study|Declined move to another study site|0|||
124826635|NCT00818662|448992885|FG002|Overall Study|Declined move to another study site|0|||
124826636|NCT00818662|448992886|FG003|Overall Study|Declined move to another study site|0|||
124826637|NCT00818662|448992883|FG000|Overall Study|Change in living situation|0|||
124826638|NCT00818662|448992884|FG001|Overall Study|Change in living situation|0|||
124826639|NCT00818662|448992885|FG002|Overall Study|Change in living situation|0|||
124826640|NCT00818662|448992886|FG003|Overall Study|Change in living situation|1|||
124826641|NCT00818662|448992883|FG000|Overall Study|Study partner decision|0|||
124826642|NCT00818662|448992884|FG001|Overall Study|Study partner decision|0|||
124826643|NCT00818662|448992885|FG002|Overall Study|Study partner decision|0|||
124826644|NCT00818662|448992886|FG003|Overall Study|Study partner decision|1|||
124826645|NCT00818662|448992883|FG000|Overall Study|Admitted to long term nursing care|0|||
124826646|NCT00818662|448992884|FG001|Overall Study|Admitted to long term nursing care|1|||
124826647|NCT00818662|448992885|FG002|Overall Study|Admitted to long term nursing care|0|||
124826648|NCT00818662|448992886|FG003|Overall Study|Admitted to long term nursing care|0|||
124826649|NCT01472081|448992887|FG000|Overall Study|Continuing treatment at time of analysis|1|||
124826650|NCT01472081|448992888|FG001|Overall Study|Continuing treatment at time of analysis|4|||
124826651|NCT01472081|448992889|FG002|Overall Study|Continuing treatment at time of analysis|1|||
124826652|NCT01472081|448992890|FG003|Overall Study|Continuing treatment at time of analysis|8|||
124826653|NCT01472081|448992891|FG004|Overall Study|Continuing treatment at time of analysis|9|||
124826654|NCT01472081|448992892|FG005|Overall Study|Continuing treatment at time of analysis|0|||
124826655|NCT01472081|448992887|FG000|Overall Study|Disease Progression|4|||
124826656|NCT01472081|448992888|FG001|Overall Study|Disease Progression|10|||
124826657|NCT01472081|448992889|FG002|Overall Study|Disease Progression|12|||
124826658|NCT01472081|448992890|FG003|Overall Study|Disease Progression|31|||
124826659|NCT01472081|448992891|FG004|Overall Study|Disease Progression|22|||
124826660|NCT01472081|448992892|FG005|Overall Study|Disease Progression|3|||
124826661|NCT01472081|448992887|FG000|Overall Study|Study drug toxicity|2|||
124826662|NCT01472081|448992888|FG001|Overall Study|Study drug toxicity|9|||
124826663|NCT01472081|448992889|FG002|Overall Study|Study drug toxicity|4|||
124826664|NCT01472081|448992890|FG003|Overall Study|Study drug toxicity|6|||
124826665|NCT01472081|448992891|FG004|Overall Study|Study drug toxicity|13|||
124826666|NCT01472081|448992892|FG005|Overall Study|Study drug toxicity|2|||
124826667|NCT01472081|448992887|FG000|Overall Study|Death|0|||
124826668|NCT01472081|448992888|FG001|Overall Study|Death|0|||
124826669|NCT01472081|448992889|FG002|Overall Study|Death|0|||
124826670|NCT01472081|448992890|FG003|Overall Study|Death|0|||
124826671|NCT01472081|448992891|FG004|Overall Study|Death|1|||
124826672|NCT01472081|448992892|FG005|Overall Study|Death|0|||
124826673|NCT01472081|448992887|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
124826674|NCT01472081|448992888|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
124826675|NCT01472081|448992889|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
124826676|NCT01472081|448992890|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
124826677|NCT01472081|448992891|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
124826678|NCT01472081|448992892|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
124826679|NCT01472081|448992887|FG000|Overall Study|Withdrawal by Subject|0|||
124826680|NCT01472081|448992888|FG001|Overall Study|Withdrawal by Subject|0|||
124826681|NCT01472081|448992889|FG002|Overall Study|Withdrawal by Subject|0|||
124826682|NCT01472081|448992890|FG003|Overall Study|Withdrawal by Subject|0|||
124826683|NCT01472081|448992891|FG004|Overall Study|Withdrawal by Subject|0|||
124826684|NCT01472081|448992892|FG005|Overall Study|Withdrawal by Subject|1|||
124826685|NCT01472081|448992887|FG000|Overall Study|Poor/non-compliance|0|||
124826686|NCT01472081|448992888|FG001|Overall Study|Poor/non-compliance|0|||
124826687|NCT01472081|448992889|FG002|Overall Study|Poor/non-compliance|1|||
124826688|NCT01472081|448992890|FG003|Overall Study|Poor/non-compliance|0|||
124826689|NCT01472081|448992891|FG004|Overall Study|Poor/non-compliance|1|||
124826690|NCT01472081|448992892|FG005|Overall Study|Poor/non-compliance|0|||
124826691|NCT01472081|448992887|FG000|Overall Study|No longer meets study criteria|0|||
124826692|NCT01472081|448992888|FG001|Overall Study|No longer meets study criteria|0|||
124826693|NCT01472081|448992889|FG002|Overall Study|No longer meets study criteria|1|||
124826694|NCT01472081|448992890|FG003|Overall Study|No longer meets study criteria|0|||
124826695|NCT01472081|448992891|FG004|Overall Study|No longer meets study criteria|0|||
124826696|NCT01472081|448992892|FG005|Overall Study|No longer meets study criteria|0|||
124826697|NCT01472081|448992887|FG000|Overall Study|Subject request to discontinue treatment|0|||
124826698|NCT01472081|448992888|FG001|Overall Study|Subject request to discontinue treatment|3|||
124826699|NCT01472081|448992889|FG002|Overall Study|Subject request to discontinue treatment|1|||
124826700|NCT01472081|448992890|FG003|Overall Study|Subject request to discontinue treatment|1|||
124826701|NCT01472081|448992891|FG004|Overall Study|Subject request to discontinue treatment|0|||
124826702|NCT01472081|448992892|FG005|Overall Study|Subject request to discontinue treatment|0|||
124826703|NCT03605303|448992893|FG000|Period 1|Study Terminated|2|||
124826704|NCT03605303|448992894|FG001|Period 1|Study Terminated|1|||
124826705|NCT02200445|448992897|FG000|Overall Study|Lack of Efficacy|1|||
124826706|NCT02200445|448992898|FG001|Overall Study|Lack of Efficacy|2|||
124826707|NCT02200445|448992899|FG002|Overall Study|Lack of Efficacy|2|||
124826708|NCT02200445|448992897|FG000|Overall Study|Adverse Event|0|||
124826709|NCT02200445|448992898|FG001|Overall Study|Adverse Event|2|||
124826710|NCT02200445|448992899|FG002|Overall Study|Adverse Event|0|||
124826711|NCT03334903|448992900|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
124826712|NCT03334903|448992901|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
124826713|NCT03334903|448992900|FG000|Overall Study|Protocol Violation|1|||
124826714|NCT03334903|448992901|FG001|Overall Study|Protocol Violation|3|||
124826715|NCT03334903|448992900|FG000|Overall Study|Surgery postponed|1|||
124826716|NCT03334903|448992901|FG001|Overall Study|Surgery postponed|0|||
124826717|NCT03334903|448992900|FG000|Overall Study|Adverse Event|1|||
124826718|NCT03334903|448992901|FG001|Overall Study|Adverse Event|1|||
124826719|NCT03334903|448992900|FG000|Overall Study|Withdrawal by Subject|0|||
124826720|NCT03334903|448992901|FG001|Overall Study|Withdrawal by Subject|1|||
124826721|NCT00623727|448995074|FG000|Double Blind (DB)|Adverse Event|1|||
124826722|NCT00623727|448995075|FG001|Double Blind (DB)|Adverse Event|3|||
124826723|NCT00623727|448995074|FG000|Double Blind (DB)|Physician Decision|0|||
124826724|NCT00623727|448995075|FG001|Double Blind (DB)|Physician Decision|1|||
124826725|NCT00623727|448995074|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
124826726|NCT00623727|448995075|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
124826727|NCT00623727|448995074|FG000|Double Blind (DB)|Lack of Efficacy|2|||
124826728|NCT00623727|448995075|FG001|Double Blind (DB)|Lack of Efficacy|2|||
124826729|NCT00623727|448995074|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
124826730|NCT00623727|448995075|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
124826731|NCT00623727|448995074|FG000|Double Blind (DB)|Lost to Follow-up|1|||
124826732|NCT00623727|448995075|FG001|Double Blind (DB)|Lost to Follow-up|1|||
124826733|NCT00623727|448995074|FG000|Double Blind (DB)|Protocol Violation|2|||
124826734|NCT00623727|448995075|FG001|Double Blind (DB)|Protocol Violation|2|||
124826735|NCT00623727|448995074|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
124826736|NCT00623727|448995075|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
124826737|NCT00623727|448995074|FG000|Open Label Follow-up|Study termination|0|||
124826738|NCT00623727|448995075|FG001|Open Label Follow-up|Study termination|6|||
124826739|NCT00623727|448995074|FG000|Open Label Follow-up|Participant convenience|0|||
124826740|NCT00623727|448995075|FG001|Open Label Follow-up|Participant convenience|1|||
124826741|NCT00501293|448995076|FG000|Optimization Period|Enrolled in error|1|||
124826742|NCT00501293|448995077|FG001|Optimization Period|Enrolled in error|0|||
124826743|NCT00501293|448995076|FG000|Maintenance Period|Withdrawal by Subject|14|||
124826744|NCT00501293|448995077|FG001|Maintenance Period|Withdrawal by Subject|13|||
124826745|NCT00501293|448995076|FG000|Maintenance Period|Lost to Follow-up|12|||
124826746|NCT00501293|448995077|FG001|Maintenance Period|Lost to Follow-up|7|||
124826747|NCT00501293|448995076|FG000|Maintenance Period|Adverse Event|6|||
124826748|NCT00501293|448995077|FG001|Maintenance Period|Adverse Event|6|||
124826749|NCT00501293|448995076|FG000|Maintenance Period|Protocol Violation|2|||
124826750|NCT00501293|448995077|FG001|Maintenance Period|Protocol Violation|1|||
124826751|NCT00501293|448995076|FG000|Maintenance Period|Lack of Efficacy|4|||
124826752|NCT00501293|448995077|FG001|Maintenance Period|Lack of Efficacy|1|||
124826753|NCT00501293|448995076|FG000|Maintenance Period|Noncompliant with study medication|5|||
124826754|NCT00501293|448995077|FG001|Maintenance Period|Noncompliant with study medication|0|||
124826755|NCT00501293|448995076|FG000|Maintenance Period|Went into rehabilitation|1|||
124826756|NCT00501293|448995077|FG001|Maintenance Period|Went into rehabilitation|0|||
124826757|NCT00501293|448995076|FG000|Maintenance Period|Would not wear patch|1|||
124826758|NCT00501293|448995077|FG001|Maintenance Period|Would not wear patch|0|||
124826759|NCT00501293|448995076|FG000|Maintenance Period|Application site reaction|1|||
124826760|NCT00501293|448995077|FG001|Maintenance Period|Application site reaction|0|||
124826761|NCT01104636|448995081|FG000|Overall Study|Lack of Efficacy|43|||
124826762|NCT01104636|448995081|FG000|Overall Study|Lost to Follow-up|24|||
124826763|NCT01104636|448995081|FG000|Overall Study|Withdrawal by Subject|4|||
124826764|NCT01104636|448995081|FG000|Overall Study|Other|43|||
124826765|NCT01104636|448995081|FG000|Overall Study|Study terminated by sponsor|1|||
124826766|NCT01104636|448995081|FG000|Overall Study|Pregnancy|2|||
124826767|NCT01104636|448995081|FG000|Overall Study|Adverse Event|40|||
124826768|NCT01104636|448995081|FG000|Overall Study|Ongoing|21|||
124826769|NCT01706003|448995082|FG000|Overall Study|Withdrawal by Subject|2|||
124826770|NCT01706003|448995083|FG001|Overall Study|Withdrawal by Subject|0|||
124826771|NCT01706003|448995082|FG000|Overall Study|Not scheduled|3|||
124826772|NCT01706003|448995083|FG001|Overall Study|Not scheduled|0|||
124826773|NCT01706003|448995082|FG000|Overall Study|Lost to Follow-up|6|||
124826774|NCT01706003|448995083|FG001|Overall Study|Lost to Follow-up|4|||
124826775|NCT00696696|448995086|FG000|Overall Study|Adverse Event|5|||
124826776|NCT00696696|448995086|FG000|Overall Study|Withdrawal by Subject|8|||
124826777|NCT00696696|448995086|FG000|Overall Study|Physician Decision|2|||
124826778|NCT00696696|448995086|FG000|Overall Study|Death|3|||
124826779|NCT01313767|448995092|FG000|Overall Study|Adverse Event|1|||
124826780|NCT01313767|448995093|FG001|Overall Study|Adverse Event|0|||
124826781|NCT01313767|448995092|FG000|Overall Study|Lost to Follow-up|1|||
124826782|NCT01313767|448995093|FG001|Overall Study|Lost to Follow-up|0|||
124826783|NCT01313767|448995092|FG000|Overall Study|Withdrawal by Subject|2|||
124826784|NCT01313767|448995093|FG001|Overall Study|Withdrawal by Subject|1|||
124826785|NCT01313767|448995092|FG000|Overall Study|Protocol Violation|3|||
124826786|NCT01313767|448995093|FG001|Overall Study|Protocol Violation|1|||
124826787|NCT01287897|448995099|FG000|Overall Study|Adverse Event|5|||
124826788|NCT01287897|448995100|FG001|Overall Study|Adverse Event|3|||
124826789|NCT01287897|448995101|FG002|Overall Study|Adverse Event|6|||
124826790|NCT01287897|448995102|FG003|Overall Study|Adverse Event|4|||
124826791|NCT01287897|448995099|FG000|Overall Study|Lack of Efficacy|2|||
124826792|NCT01287897|448995100|FG001|Overall Study|Lack of Efficacy|0|||
124826793|NCT01287897|448995101|FG002|Overall Study|Lack of Efficacy|0|||
124826794|NCT01287897|448995102|FG003|Overall Study|Lack of Efficacy|0|||
124826795|NCT01287897|448995099|FG000|Overall Study|Protocol Violation|1|||
124826796|NCT01287897|448995100|FG001|Overall Study|Protocol Violation|1|||
124826797|NCT01287897|448995101|FG002|Overall Study|Protocol Violation|0|||
124826798|NCT01287897|448995102|FG003|Overall Study|Protocol Violation|1|||
124826799|NCT01287897|448995099|FG000|Overall Study|Lost to Follow-up|0|||
124826800|NCT01287897|448995100|FG001|Overall Study|Lost to Follow-up|0|||
124826801|NCT01287897|448995101|FG002|Overall Study|Lost to Follow-up|2|||
124826802|NCT01287897|448995102|FG003|Overall Study|Lost to Follow-up|0|||
124826803|NCT01287897|448995099|FG000|Overall Study|Withdrawal by Subject|1|||
124826804|NCT01287897|448995100|FG001|Overall Study|Withdrawal by Subject|5|||
124826805|NCT01287897|448995101|FG002|Overall Study|Withdrawal by Subject|3|||
124826806|NCT01287897|448995102|FG003|Overall Study|Withdrawal by Subject|2|||
124826807|NCT01287897|448995099|FG000|Overall Study|Not consented properly|0|||
124826808|NCT01287897|448995100|FG001|Overall Study|Not consented properly|1|||
124826809|NCT01287897|448995101|FG002|Overall Study|Not consented properly|0|||
124826810|NCT01287897|448995102|FG003|Overall Study|Not consented properly|0|||
124826811|NCT01287897|448995099|FG000|Overall Study|Not meeting entrance criteria|1|||
124826812|NCT01287897|448995100|FG001|Overall Study|Not meeting entrance criteria|1|||
124826813|NCT01287897|448995101|FG002|Overall Study|Not meeting entrance criteria|0|||
124826814|NCT01287897|448995102|FG003|Overall Study|Not meeting entrance criteria|0|||
124826815|NCT01287897|448995099|FG000|Overall Study|Other|1|||
124826816|NCT01287897|448995100|FG001|Overall Study|Other|0|||
124826817|NCT01287897|448995101|FG002|Overall Study|Other|1|||
124826818|NCT01287897|448995102|FG003|Overall Study|Other|0|||
124826819|NCT00249444|448995103|FG000|Overall Study|Lost to Follow-up|2|||
124826820|NCT00249444|448995104|FG001|Overall Study|Lost to Follow-up|2|||
124826821|NCT00249444|448995103|FG000|Overall Study|non-compliant|9|||
124826822|NCT00249444|448995104|FG001|Overall Study|non-compliant|11|||
124826823|NCT00249444|448995103|FG000|Overall Study|Adverse Event|1|||
124826824|NCT00249444|448995104|FG001|Overall Study|Adverse Event|1|||
124826825|NCT00249444|448995103|FG000|Overall Study|life event|0|||
124826826|NCT00249444|448995104|FG001|Overall Study|life event|1|||
124826827|NCT00082355|448995105|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
124826828|NCT00082355|448995105|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
124826829|NCT00082355|448995105|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
124826830|NCT00936910|448995109|FG000|Overall Study|Lack of Efficacy|3|||
124826831|NCT00412854|448995110|FG000|Overall Study|Withdrawn due to adverse events|1|||
124826832|NCT00412854|448995111|FG001|Overall Study|Withdrawn due to adverse events|5|||
124826833|NCT00412854|448995110|FG000|Overall Study|Withdrawn for other reasons|13|||
124826834|NCT00412854|448995111|FG001|Overall Study|Withdrawn for other reasons|11|||
124826835|NCT04483011|448995115|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
124826836|NCT04483011|448995116|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
124826837|NCT03518073|448995117|FG000|Overall Study|Adverse Event|2|||
124826838|NCT03518073|448995118|FG001|Overall Study|Adverse Event|4|||
124826839|NCT03518073|448995119|FG002|Overall Study|Adverse Event|2|||
124826840|NCT03518073|448995117|FG000|Overall Study|Death|2|||
124826841|NCT03518073|448995118|FG001|Overall Study|Death|1|||
124826842|NCT03518073|448995119|FG002|Overall Study|Death|3|||
124826843|NCT03518073|448995117|FG000|Overall Study|Lost to Follow-up|1|||
124826844|NCT03518073|448995118|FG001|Overall Study|Lost to Follow-up|0|||
124826845|NCT03518073|448995119|FG002|Overall Study|Lost to Follow-up|1|||
124826846|NCT03518073|448995117|FG000|Overall Study|Physician Decision|5|||
124826847|NCT03518073|448995118|FG001|Overall Study|Physician Decision|0|||
124826848|NCT03518073|448995119|FG002|Overall Study|Physician Decision|2|||
124826849|NCT03518073|448995117|FG000|Overall Study|Progressive disease|1|||
124826850|NCT03518073|448995118|FG001|Overall Study|Progressive disease|1|||
124826851|NCT03518073|448995119|FG002|Overall Study|Progressive disease|1|||
124826852|NCT03518073|448995117|FG000|Overall Study|Protocol Violation|1|||
124826853|NCT03518073|448995118|FG001|Overall Study|Protocol Violation|0|||
124826854|NCT03518073|448995119|FG002|Overall Study|Protocol Violation|0|||
124826855|NCT03518073|448995117|FG000|Overall Study|Withdrawal by Subject|30|||
124826856|NCT03518073|448995118|FG001|Overall Study|Withdrawal by Subject|34|||
124826857|NCT03518073|448995119|FG002|Overall Study|Withdrawal by Subject|29|||
124826858|NCT03518073|448995117|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
124826859|NCT03518073|448995118|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
124826860|NCT03518073|448995119|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
124826861|NCT03518073|448995117|FG000|Overall Study|Covid-19|1|||
124826862|NCT03518073|448995118|FG001|Overall Study|Covid-19|2|||
124826863|NCT03518073|448995119|FG002|Overall Study|Covid-19|1|||
124826864|NCT03045081|448995120|FG000|Overall Study|Withdrawal by Subject|6|||
124826865|NCT03045081|448995121|FG001|Overall Study|Withdrawal by Subject|11|||
124826866|NCT01485640|448995122|FG000|Overall Study|Adverse Event|10|||
124826867|NCT01485640|448995122|FG000|Overall Study|Lack of Efficacy|2|||
124826868|NCT01485640|448995122|FG000|Overall Study|Protocol Violation|1|||
124826869|NCT01485640|448995122|FG000|Overall Study|Withdrawal by Subject|14|||
124826870|NCT01485640|448995122|FG000|Overall Study|Terminated by Sponsor|95|||
124826871|NCT01853046|448995123|FG000|Overall Study|Withdrawal by Subject|1|||
124826872|NCT01853046|448995124|FG001|Overall Study|Withdrawal by Subject|1|||
124826873|NCT01853046|448995123|FG000|Overall Study|Adverse Event|4|||
124826874|NCT01853046|448995124|FG001|Overall Study|Adverse Event|2|||
124826875|NCT01853046|448995123|FG000|Overall Study|Disease progression|13|||
124826876|NCT01853046|448995124|FG001|Overall Study|Disease progression|3|||
124826877|NCT03020407|448995131|FG000|Overall Study|Withdrawal by Subject|2|||
124826878|NCT03020407|448995132|FG001|Overall Study|Withdrawal by Subject|1|||
124826879|NCT03020407|448995131|FG000|Overall Study|Lost to Follow-up|2|||
124826880|NCT03020407|448995132|FG001|Overall Study|Lost to Follow-up|3|||
124826881|NCT03020407|448995131|FG000|Overall Study|Protocol Violation|0|||
124826882|NCT03020407|448995132|FG001|Overall Study|Protocol Violation|1|||
124826883|NCT00708162|448995133|FG000|Randomized Phase|Randomized but Not Treated|7|||
124826884|NCT00708162|448995134|FG001|Randomized Phase|Randomized but Not Treated|5|||
124826885|NCT00708162|448995133|FG000|Randomized Phase|Participant Noncompliance|40|||
124826886|NCT00708162|448995134|FG001|Randomized Phase|Participant Noncompliance|32|||
124826887|NCT00708162|448995133|FG000|Randomized Phase|Lost to Follow-up|34|||
124826888|NCT00708162|448995134|FG001|Randomized Phase|Lost to Follow-up|34|||
124826889|NCT00708162|448995133|FG000|Randomized Phase|Withdrew Consent|31|||
124826890|NCT00708162|448995134|FG001|Randomized Phase|Withdrew Consent|22|||
124826891|NCT00708162|448995133|FG000|Randomized Phase|Lack of Efficacy|14|||
124826892|NCT00708162|448995134|FG001|Randomized Phase|Lack of Efficacy|19|||
124826893|NCT00708162|448995133|FG000|Randomized Phase|Protocol Violation|10|||
124826894|NCT00708162|448995134|FG001|Randomized Phase|Protocol Violation|11|||
124826895|NCT00708162|448995133|FG000|Randomized Phase|Adverse Event|8|||
124826896|NCT00708162|448995134|FG001|Randomized Phase|Adverse Event|12|||
124826897|NCT00708162|448995133|FG000|Randomized Phase|Investigator's Discretion|7|||
124826898|NCT00708162|448995134|FG001|Randomized Phase|Investigator's Discretion|10|||
124826899|NCT00708162|448995133|FG000|Randomized Phase|Death|2|||
124826900|NCT00708162|448995134|FG001|Randomized Phase|Death|9|||
124826901|NCT00708162|448995133|FG000|Randomized Phase|Pregnancy|3|||
124826902|NCT00708162|448995134|FG001|Randomized Phase|Pregnancy|0|||
124826903|NCT00708162|448995133|FG000|Open-Label Phase|Lost to Follow-up|10|||
124826904|NCT00708162|448995134|FG001|Open-Label Phase|Lost to Follow-up|8|||
124826905|NCT00708162|448995133|FG000|Open-Label Phase|Withdrew Consent|12|||
124826906|NCT00708162|448995134|FG001|Open-Label Phase|Withdrew Consent|6|||
125303627|NCT01959841|450739481|FG002|Overall Study|Withdrawal by Subject|5|||
125303628|NCT01959841|450739479|FG000|Overall Study|Clinical laboratory value|2|||
125303629|NCT01959841|450739480|FG001|Overall Study|Clinical laboratory value|6|||
125303630|NCT01959841|450739481|FG002|Overall Study|Clinical laboratory value|6|||
124826907|NCT00708162|448995133|FG000|Open-Label Phase|Participant Noncompliance|7|||
124826908|NCT00708162|448995134|FG001|Open-Label Phase|Participant Noncompliance|7|||
125303631|NCT01959841|450739479|FG000|Overall Study|Platelet count below on day1 or 4|11|||
124826909|NCT00708162|448995133|FG000|Open-Label Phase|Lack of Efficacy|7|||
124826910|NCT00708162|448995134|FG001|Open-Label Phase|Lack of Efficacy|4|||
124826911|NCT00708162|448995133|FG000|Open-Label Phase|Investigator's Discretion|3|||
124826912|NCT00708162|448995134|FG001|Open-Label Phase|Investigator's Discretion|2|||
124826913|NCT00708162|448995133|FG000|Open-Label Phase|Death|3|||
124826914|NCT00708162|448995134|FG001|Open-Label Phase|Death|1|||
124826915|NCT00708162|448995133|FG000|Open-Label Phase|Adverse Event|1|||
124826916|NCT00708162|448995134|FG001|Open-Label Phase|Adverse Event|2|||
124826917|NCT00708162|448995133|FG000|Open-Label Phase|Other|1|||
124826918|NCT00708162|448995134|FG001|Open-Label Phase|Other|0|||
124826919|NCT02699554|448995135|FG000|Overall Study|Lost to Follow-up|9|||
124826920|NCT00708643|448995136|FG000|Overall Study|Adverse Event|0|||
124826921|NCT00708643|448995137|FG001|Overall Study|Adverse Event|1|||
124826922|NCT00065507|448995138|FG000|Overall Study|Death|16|||
124826923|NCT00065507|448995139|FG001|Overall Study|Death|17|||
124826924|NCT00065507|448995138|FG000|Overall Study|Adverse Event|4|||
124826925|NCT00065507|448995139|FG001|Overall Study|Adverse Event|3|||
124826926|NCT00065507|448995138|FG000|Overall Study|Lack of Efficacy|0|||
124826927|NCT00065507|448995139|FG001|Overall Study|Lack of Efficacy|6|||
124826928|NCT00065507|448995138|FG000|Overall Study|Poor/Non-compliance|3|||
124826929|NCT00065507|448995139|FG001|Overall Study|Poor/Non-compliance|2|||
124826930|NCT00065507|448995138|FG000|Overall Study|Lost to Follow-up|3|||
124826931|NCT00065507|448995139|FG001|Overall Study|Lost to Follow-up|0|||
124826932|NCT00065507|448995138|FG000|Overall Study|Subject Withdrew Consent|2|||
124826933|NCT00065507|448995139|FG001|Overall Study|Subject Withdrew Consent|1|||
124826934|NCT00065507|448995138|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
124826935|NCT00065507|448995139|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
124826936|NCT03635957|448995140|FG000|Run-In Period|Lost to Follow-up|1|||
124826937|NCT03635957|448995140|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
124826938|NCT00350636|448995141|FG000|Overall Study|Adverse Event|19|||
124826939|NCT00350636|448995142|FG001|Overall Study|Adverse Event|13|||
124826940|NCT00350636|448995141|FG000|Overall Study|Protocol Violation|1|||
124826941|NCT00350636|448995142|FG001|Overall Study|Protocol Violation|3|||
124826942|NCT00350636|448995141|FG000|Overall Study|Withdrawal by Subject|13|||
124826943|NCT00350636|448995142|FG001|Overall Study|Withdrawal by Subject|17|||
124826944|NCT00350636|448995141|FG000|Overall Study|Lost to Follow-up|9|||
124826945|NCT00350636|448995142|FG001|Overall Study|Lost to Follow-up|8|||
124826946|NCT00350636|448995141|FG000|Overall Study|Physician Decision|0|||
124826947|NCT00350636|448995142|FG001|Overall Study|Physician Decision|2|||
124826948|NCT00350636|448995141|FG000|Overall Study|Other|1|||
124826949|NCT00350636|448995142|FG001|Overall Study|Other|2|||
124826950|NCT01525550|448995143|FG000|Overall Study|Lost to Follow-up|8|||
124826951|NCT01525550|448995144|FG001|Overall Study|Lost to Follow-up|2|||
124826952|NCT01525550|448995143|FG000|Overall Study|Death|19|||
124826953|NCT01525550|448995144|FG001|Overall Study|Death|28|||
124826954|NCT01525550|448995143|FG000|Overall Study|Other|0|||
124826955|NCT01525550|448995144|FG001|Overall Study|Other|4|||
124826956|NCT01525550|448995143|FG000|Overall Study|Sponsor's Decision|30|||
124826957|NCT01525550|448995144|FG001|Overall Study|Sponsor's Decision|11|||
124826958|NCT01525550|448995143|FG000|Overall Study|Withdrawal by Subject|4|||
124826959|NCT01525550|448995144|FG001|Overall Study|Withdrawal by Subject|0|||
124826960|NCT04577118|448995149|FG000|Overall Study|Withdrawal by Subject|4|||
124826961|NCT03108027|448995153|FG000|Period 1|Subject/Guardian Decision|0|||
124826962|NCT03108027|448995154|FG001|Period 1|Subject/Guardian Decision|0|||
124826963|NCT03108027|448995155|FG002|Period 1|Subject/Guardian Decision|0|||
125303632|NCT01959841|450739480|FG001|Overall Study|Platelet count below on day1 or 4|15|||
125303633|NCT01959841|450739481|FG002|Overall Study|Platelet count below on day1 or 4|11|||
125303634|NCT00780416|450739482|FG000|Overall Study|Physician Decision|3|||
125303635|NCT00780416|450739483|FG001|Overall Study|Physician Decision|3|||
125303636|NCT00780416|450739482|FG000|Overall Study|Protocol Violation|1|||
125303637|NCT00780416|450739483|FG001|Overall Study|Protocol Violation|0|||
125303638|NCT00780416|450739482|FG000|Overall Study|Withdrawal by Subject|8|||
125303639|NCT00780416|450739483|FG001|Overall Study|Withdrawal by Subject|6|||
125303640|NCT00666224|450739486|FG000|Double-Blind|Adverse Event|15|||
125303641|NCT00666224|450739487|FG001|Double-Blind|Adverse Event|5|||
125303642|NCT00666224|450739486|FG000|Double-Blind|Lost to Follow-up|2|||
125303643|NCT00666224|450739487|FG001|Double-Blind|Lost to Follow-up|2|||
125303644|NCT00666224|450739486|FG000|Double-Blind|Withdrawal by Subject|18|||
125303645|NCT00666224|450739487|FG001|Double-Blind|Withdrawal by Subject|14|||
125303646|NCT00666224|450739486|FG000|Double-Blind|Physician Decision|0|||
125303647|NCT00666224|450739487|FG001|Double-Blind|Physician Decision|3|||
125303648|NCT00666224|450739486|FG000|Double-Blind|Sponsor decision|1|||
125303649|NCT00666224|450739487|FG001|Double-Blind|Sponsor decision|0|||
125303650|NCT00666224|450739486|FG000|Double-Blind|Pregnancy|3|||
125303651|NCT00666224|450739487|FG001|Double-Blind|Pregnancy|2|||
125303652|NCT00666224|450739486|FG000|Double-Blind|Noncompliance|1|||
125303653|NCT00666224|450739487|FG001|Double-Blind|Noncompliance|0|||
125303654|NCT00666224|450739486|FG000|Double-Blind|Death|1|||
125303655|NCT00666224|450739487|FG001|Double-Blind|Death|0|||
124826964|NCT03108027|448995156|FG003|Period 1|Subject/Guardian Decision|2|||
124826965|NCT03108027|448995157|FG004|Period 1|Subject/Guardian Decision|0|||
124826966|NCT03108027|448995158|FG005|Period 1|Subject/Guardian Decision|0|||
124826967|NCT03108027|448995153|FG000|Period 3|Adverse Event|0|||
124826968|NCT03108027|448995154|FG001|Period 3|Adverse Event|1|||
124826969|NCT03108027|448995155|FG002|Period 3|Adverse Event|0|||
124826970|NCT03108027|448995156|FG003|Period 3|Adverse Event|0|||
124826971|NCT03108027|448995157|FG004|Period 3|Adverse Event|0|||
124826972|NCT03108027|448995158|FG005|Period 3|Adverse Event|0|||
124826973|NCT00268996|448995159|FG000|Overall Study|Adverse Event|11|||
124826974|NCT00268996|448995160|FG001|Overall Study|Adverse Event|7|||
124826975|NCT00268996|448995159|FG000|Overall Study|Lost to Follow-up|3|||
124826976|NCT00268996|448995160|FG001|Overall Study|Lost to Follow-up|1|||
124826977|NCT00268996|448995159|FG000|Overall Study|Withdrawal by Subject|5|||
124826978|NCT00268996|448995160|FG001|Overall Study|Withdrawal by Subject|11|||
124826979|NCT00268996|448995159|FG000|Overall Study|Non-compliance|1|||
124826980|NCT00268996|448995160|FG001|Overall Study|Non-compliance|0|||
124826981|NCT00268996|448995159|FG000|Overall Study|Other|1|||
124826982|NCT00268996|448995160|FG001|Overall Study|Other|1|||
124826983|NCT02763189|448995163|FG000|Overall Study|Device failure|0|||
124826984|NCT02763189|448995164|FG001|Overall Study|Device failure|2|||
124826985|NCT04900220|448995166|FG000|Overall Study|Lost to Follow-up|1|||
124826986|NCT04900220|448995167|FG001|Overall Study|Lost to Follow-up|1|||
124826987|NCT01214629|448995168|FG000|Overall Study|Progressive Disease|1|||
124826988|NCT01214629|448995169|FG001|Overall Study|Progressive Disease|1|||
124826989|NCT01214629|448995170|FG002|Overall Study|Progressive Disease|0|||
124826990|NCT01214629|448995171|FG003|Overall Study|Progressive Disease|1|||
124826991|NCT01214629|448995172|FG004|Overall Study|Progressive Disease|2|||
124826992|NCT01214629|448995173|FG005|Overall Study|Progressive Disease|3|||
124826993|NCT01214629|448995174|FG006|Overall Study|Progressive Disease|1|||
124826994|NCT01214629|448995175|FG007|Overall Study|Progressive Disease|1|||
124826995|NCT01214629|448995176|FG008|Overall Study|Progressive Disease|1|||
124826996|NCT01214629|448995177|FG009|Overall Study|Progressive Disease|5|||
124826997|NCT01214629|448995178|FG010|Overall Study|Progressive Disease|1|||
124826998|NCT01214629|448995168|FG000|Overall Study|Adverse Event|0|||
124826999|NCT01214629|448995169|FG001|Overall Study|Adverse Event|0|||
124827000|NCT01214629|448995170|FG002|Overall Study|Adverse Event|0|||
124827001|NCT01214629|448995171|FG003|Overall Study|Adverse Event|1|||
124827002|NCT01214629|448995172|FG004|Overall Study|Adverse Event|0|||
124827003|NCT01214629|448995173|FG005|Overall Study|Adverse Event|1|||
124827004|NCT01214629|448995174|FG006|Overall Study|Adverse Event|0|||
124827005|NCT01214629|448995175|FG007|Overall Study|Adverse Event|0|||
124827006|NCT01214629|448995176|FG008|Overall Study|Adverse Event|0|||
124827007|NCT01214629|448995177|FG009|Overall Study|Adverse Event|1|||
124827008|NCT01214629|448995178|FG010|Overall Study|Adverse Event|0|||
124827009|NCT01214629|448995168|FG000|Overall Study|Physician Decision|0|||
124827010|NCT01214629|448995169|FG001|Overall Study|Physician Decision|0|||
124827011|NCT01214629|448995170|FG002|Overall Study|Physician Decision|0|||
124827012|NCT01214629|448995171|FG003|Overall Study|Physician Decision|0|||
124827013|NCT01214629|448995172|FG004|Overall Study|Physician Decision|0|||
124827014|NCT01214629|448995173|FG005|Overall Study|Physician Decision|0|||
124827015|NCT01214629|448995174|FG006|Overall Study|Physician Decision|0|||
124827016|NCT01214629|448995175|FG007|Overall Study|Physician Decision|0|||
124827017|NCT01214629|448995176|FG008|Overall Study|Physician Decision|0|||
124827018|NCT01214629|448995177|FG009|Overall Study|Physician Decision|0|||
124827019|NCT01214629|448995178|FG010|Overall Study|Physician Decision|1|||
124827020|NCT01214629|448995168|FG000|Overall Study|Withdrawal by Subject|0|||
124827021|NCT01214629|448995169|FG001|Overall Study|Withdrawal by Subject|0|||
124827022|NCT01214629|448995170|FG002|Overall Study|Withdrawal by Subject|0|||
124827023|NCT01214629|448995171|FG003|Overall Study|Withdrawal by Subject|0|||
124827024|NCT01214629|448995172|FG004|Overall Study|Withdrawal by Subject|0|||
124827025|NCT01214629|448995173|FG005|Overall Study|Withdrawal by Subject|0|||
124827026|NCT01214629|448995174|FG006|Overall Study|Withdrawal by Subject|0|||
124827027|NCT01214629|448995175|FG007|Overall Study|Withdrawal by Subject|0|||
124827028|NCT01214629|448995176|FG008|Overall Study|Withdrawal by Subject|0|||
124827029|NCT01214629|448995177|FG009|Overall Study|Withdrawal by Subject|1|||
124827030|NCT01214629|448995178|FG010|Overall Study|Withdrawal by Subject|0|||
124827031|NCT00576927|448995179|FG000|Clinical Assessment|Lack of Efficacy|24|||
124827032|NCT00576927|448995179|FG000|Clinical Assessment|Death|1|||
124827033|NCT00576927|448995179|FG000|Clinical Assessment|Withdrawal by Subject|10|||
124827034|NCT00576927|448995179|FG000|Clinical Assessment|Physician Decision|1|||
124827035|NCT00576927|448995179|FG000|Baseline|Physician Decision|9|||
124827036|NCT00576927|448995179|FG000|Baseline|Medication Change by PCP of subject|1|||
124827037|NCT00576927|448995179|FG000|Baseline|Withdrawal by Subject|3|||
124827038|NCT00576927|448995179|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
124827039|NCT00576927|448995179|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
124827040|NCT00576927|448995179|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
124827041|NCT00576927|448995179|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
124827042|NCT00576927|448995179|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
125303656|NCT00666224|450739486|FG000|Double-Blind|Undefined/Unknown|4|||
124827043|NCT03266094|448995180|FG000|Overall Study|Lost to Follow-up|1|||
124827044|NCT03266094|448995180|FG000|Overall Study|Withdrawal by Subject|1|||
124827045|NCT03171415|448995181|FG000|Overall Study|Lost to Follow-up|0|||
124827046|NCT03171415|448995182|FG001|Overall Study|Lost to Follow-up|0|||
124827047|NCT03171415|448995183|FG002|Overall Study|Lost to Follow-up|0|||
124827048|NCT03171415|448995184|FG003|Overall Study|Lost to Follow-up|0|||
124827049|NCT03171415|448995185|FG004|Overall Study|Lost to Follow-up|2|||
124827050|NCT03715764|448995186|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
124827051|NCT03715764|448995187|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
124827052|NCT03715764|448995186|FG000|3 Month Follow-up|Lost to Follow-up|2|||
124827053|NCT03715764|448995187|FG001|3 Month Follow-up|Lost to Follow-up|2|||
124827054|NCT03715764|448995186|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
124827055|NCT03715764|448995187|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
124827056|NCT03715764|448995186|FG000|6 Month Follow-up|Lost to Follow-up|3|||
124827057|NCT03715764|448995187|FG001|6 Month Follow-up|Lost to Follow-up|0|||
124827058|NCT03715764|448995186|FG000|12 Month Follow-up|Lost to Follow-up|2|||
124827059|NCT03715764|448995187|FG001|12 Month Follow-up|Lost to Follow-up|3|||
124827060|NCT03715764|448995186|FG000|12 Month Follow-up|Pregnancy|0|||
124827061|NCT03715764|448995187|FG001|12 Month Follow-up|Pregnancy|1|||
124827062|NCT03715764|448995186|FG000|12 Month Follow-up|Surgery|2|||
124827063|NCT03715764|448995187|FG001|12 Month Follow-up|Surgery|0|||
124827064|NCT03715764|448995186|FG000|12 Month Follow-up|Wrong address|1|||
124827065|NCT03715764|448995187|FG001|12 Month Follow-up|Wrong address|0|||
124827066|NCT03715764|448995186|FG000|12 Month Follow-up|No symptoms|1|||
124827067|NCT03715764|448995187|FG001|12 Month Follow-up|No symptoms|0|||
124827068|NCT03715764|448995186|FG000|12 Month Follow-up|Changed primary care centre|0|||
124827069|NCT03715764|448995187|FG001|12 Month Follow-up|Changed primary care centre|1|||
124827070|NCT01338493|448995190|FG000|Enrolled|Withdrawal by Subject|1|||
124827071|NCT01338493|448995190|FG000|Enrolled|Patient not implanted|4|||
124827072|NCT01338493|448995190|FG000|Discharge|Death|1|||
124827073|NCT01338493|448995190|FG000|Discharge|Missed visit|1|||
124827074|NCT01338493|448995190|FG000|6 Months Follow up|Lost to Follow-up|11|||
124827075|NCT01338493|448995190|FG000|6 Months Follow up|Missed visit|8|||
124827076|NCT01338493|448995190|FG000|12 Months Follow up|Lost to Follow-up|9|||
124827077|NCT01705652|448995191|FG000|Overall Study|Adverse Event|1|||
124827078|NCT01705652|448995192|FG001|Overall Study|Adverse Event|0|||
124827079|NCT01705652|448995191|FG000|Overall Study|Withdrawal by Subject|1|||
124827080|NCT01705652|448995192|FG001|Overall Study|Withdrawal by Subject|2|||
124827081|NCT01705652|448995191|FG000|Overall Study|non-compliance|1|||
124827082|NCT01705652|448995192|FG001|Overall Study|non-compliance|1|||
124827083|NCT00541034|448995193|FG000|Overall Study|Non-Compliance|3|||
124827084|NCT00656474|448995194|FG000|Overall Study|Other Reason|1|||
124827085|NCT01962207|448995195|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
124827086|NCT01962207|448995196|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
124827087|NCT01962207|448995197|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
124827088|NCT01962207|448995198|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
124827089|NCT01962207|448995195|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
124827090|NCT01962207|448995196|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
124827091|NCT01962207|448995197|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
124827092|NCT01962207|448995198|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
124827093|NCT01962207|448995195|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
124827094|NCT01962207|448995196|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
124827095|NCT01962207|448995197|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
124827096|NCT01962207|448995198|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
124827097|NCT01962207|448995195|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
124827098|NCT01962207|448995196|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
124827099|NCT01962207|448995197|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
124827100|NCT01962207|448995198|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
124827101|NCT01962207|448995195|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
124827102|NCT01962207|448995196|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
124827103|NCT01962207|448995197|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
124827104|NCT01962207|448995198|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
124827105|NCT01962207|448995195|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
124827106|NCT01962207|448995196|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
124827107|NCT01962207|448995197|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
124827108|NCT01962207|448995198|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
124827109|NCT02484729|448995199|FG000|Overall Study|Failure of IntelliCap Error|0|||
124827110|NCT02484729|448995200|FG001|Overall Study|Failure of IntelliCap Error|0|||
124827111|NCT02484729|448995201|FG002|Overall Study|Failure of IntelliCap Error|0|||
124827112|NCT02484729|448995202|FG003|Overall Study|Failure of IntelliCap Error|0|||
124827113|NCT02484729|448995203|FG004|Overall Study|Failure of IntelliCap Error|0|||
124827114|NCT02484729|448995204|FG005|Overall Study|Failure of IntelliCap Error|0|||
124827115|NCT02484729|448995205|FG006|Overall Study|Failure of IntelliCap Error|0|||
124827116|NCT02484729|448995206|FG007|Overall Study|Failure of IntelliCap Error|0|||
124827117|NCT02484729|448995207|FG008|Overall Study|Failure of IntelliCap Error|0|||
124827118|NCT02484729|448995208|FG009|Overall Study|Failure of IntelliCap Error|1|||
124827119|NCT01980875|448995211|FG000|Overall Study|Withdrew Consent|1|||
124827120|NCT01980875|448995212|FG001|Overall Study|Withdrew Consent|1|||
124827121|NCT01980875|448995213|FG002|Overall Study|Withdrew Consent|1|||
124827122|NCT01980875|448995211|FG000|Overall Study|Study Terminated by Sponsor|7|||
124827123|NCT01980875|448995212|FG001|Overall Study|Study Terminated by Sponsor|24|||
125303657|NCT00666224|450739487|FG001|Double-Blind|Undefined/Unknown|1|||
124827124|NCT01980875|448995213|FG002|Overall Study|Study Terminated by Sponsor|22|||
124827125|NCT01980875|448995211|FG000|Overall Study|Lost to Follow-up|0|||
124827126|NCT01980875|448995212|FG001|Overall Study|Lost to Follow-up|0|||
124827127|NCT01980875|448995213|FG002|Overall Study|Lost to Follow-up|1|||
124827128|NCT02625259|448995214|FG000|First Intervention (Day 1)|Other|0|||
124827129|NCT02625259|448995215|FG001|First Intervention (Day 1)|Other|0|||
124827130|NCT02625259|448995216|FG002|First Intervention (Day 1)|Other|1|||
124827131|NCT02625259|448995217|FG003|First Intervention (Day 1)|Other|0|||
124827132|NCT02625259|448995218|FG004|First Intervention (Day 1)|Other|0|||
124827133|NCT02625259|448995214|FG000|First Intervention (Day 1)|Adverse Event|2|||
124827134|NCT02625259|448995215|FG001|First Intervention (Day 1)|Adverse Event|1|||
124827135|NCT02625259|448995216|FG002|First Intervention (Day 1)|Adverse Event|0|||
124827136|NCT02625259|448995217|FG003|First Intervention (Day 1)|Adverse Event|0|||
124827137|NCT02625259|448995218|FG004|First Intervention (Day 1)|Adverse Event|0|||
124827138|NCT02625259|448995214|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
125303658|NCT00666224|450739486|FG000|Open-Label|Adverse Event|8|||
125303659|NCT00666224|450739487|FG001|Open-Label|Adverse Event|43|||
125303660|NCT00666224|450739486|FG000|Open-Label|Lost to Follow-up|4|||
125303661|NCT00666224|450739487|FG001|Open-Label|Lost to Follow-up|5|||
125303662|NCT00666224|450739486|FG000|Open-Label|Withdrawal by Subject|12|||
125303663|NCT00666224|450739487|FG001|Open-Label|Withdrawal by Subject|25|||
125303664|NCT00666224|450739486|FG000|Open-Label|Physician Decision|7|||
125303665|NCT00666224|450739487|FG001|Open-Label|Physician Decision|5|||
125303666|NCT00666224|450739486|FG000|Open-Label|Pregnancy|1|||
125303667|NCT00666224|450739487|FG001|Open-Label|Pregnancy|5|||
125303668|NCT00666224|450739486|FG000|Open-Label|Noncompliance|2|||
125303669|NCT00666224|450739487|FG001|Open-Label|Noncompliance|1|||
125303670|NCT00666224|450739486|FG000|Open-Label|Undefined/Unknown|1|||
125303671|NCT00666224|450739487|FG001|Open-Label|Undefined/Unknown|1|||
125303672|NCT00871338|450739491|FG000|Prior to Booster|Withdrawal by Subject|1|||
125303673|NCT00871338|450739492|FG001|Prior to Booster|Withdrawal by Subject|3|||
125303674|NCT00871338|450739491|FG000|Prior to Booster|Lost to Follow-up|1|||
125303675|NCT00871338|450739492|FG001|Prior to Booster|Lost to Follow-up|0|||
125303676|NCT01959139|450739500|FG000|Phase II|Disease progression|0|||
125303677|NCT01959139|450739501|FG001|Phase II|Disease progression|0|||
125303678|NCT01959139|450739502|FG002|Phase II|Disease progression|26|||
125303679|NCT01959139|450739503|FG003|Phase II|Disease progression|34|||
125303680|NCT01959139|450739500|FG000|Phase II|Adverse Event|0|||
125303681|NCT01959139|450739501|FG001|Phase II|Adverse Event|0|||
125303682|NCT01959139|450739502|FG002|Phase II|Adverse Event|10|||
125303683|NCT01959139|450739503|FG003|Phase II|Adverse Event|11|||
125303684|NCT01959139|450739500|FG000|Phase II|Patient Refusal|0|||
125303685|NCT01959139|450739501|FG001|Phase II|Patient Refusal|0|||
125303686|NCT01959139|450739502|FG002|Phase II|Patient Refusal|5|||
125303687|NCT01959139|450739503|FG003|Phase II|Patient Refusal|4|||
125303688|NCT01959139|450739500|FG000|Phase II|Death|0|||
125303689|NCT01959139|450739501|FG001|Phase II|Death|0|||
125303690|NCT01959139|450739502|FG002|Phase II|Death|3|||
125303691|NCT01959139|450739503|FG003|Phase II|Death|1|||
125303692|NCT01959139|450739500|FG000|Phase II|Other/Unknown|0|||
125303693|NCT01959139|450739501|FG001|Phase II|Other/Unknown|0|||
125303694|NCT01959139|450739502|FG002|Phase II|Other/Unknown|8|||
125303695|NCT01959139|450739503|FG003|Phase II|Other/Unknown|5|||
125303696|NCT01959139|450739500|FG000|Phase II|On treatment|0|||
125303697|NCT01959139|450739501|FG001|Phase II|On treatment|0|||
125303698|NCT01959139|450739502|FG002|Phase II|On treatment|4|||
125303699|NCT01959139|450739503|FG003|Phase II|On treatment|0|||
125303700|NCT01964963|450739506|FG000|Overall Study|Case Report Forms Uncollected|888|||
125303701|NCT01964963|450739506|FG000|Overall Study|Protocol Deviation|50|||
125303702|NCT01964963|450739506|FG000|Overall Study|Data Reliability was not Assured|5|||
125303703|NCT01235234|450739507|FG000|Overall Study|Adverse Event|2|||
125303704|NCT01235234|450739508|FG001|Overall Study|Adverse Event|2|||
125303705|NCT01235234|450739509|FG002|Overall Study|Adverse Event|1|||
125303706|NCT02352753|450739510|FG000|6-Month Dosing Period|Decision by sponsor|2|||
125303707|NCT02352753|450739510|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
125303708|NCT02352753|450739510|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
125303709|NCT02352753|450739510|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
125303710|NCT02352753|450739510|FG000|3-Month Dosing Period|Decision by sponsor|14|||
125303711|NCT02352753|450739510|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
124827139|NCT02625259|448995215|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
124827140|NCT02625259|448995216|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
124827141|NCT02625259|448995217|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
124827142|NCT02625259|448995218|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
124827143|NCT00665847|448995219|FG000|Overall Study|Adverse Event|8|||
125303712|NCT00711971|450739513|FG000|Overall Study|Lost to Follow-up|3|||
125303713|NCT00711971|450739514|FG001|Overall Study|Lost to Follow-up|4|||
125303714|NCT00711971|450739515|FG002|Overall Study|Lost to Follow-up|1|||
125303715|NCT00536471|450739520|FG000|Overall Study|Lost to Follow-up|48|||
125303716|NCT00536471|450739521|FG001|Overall Study|Lost to Follow-up|23|||
125303717|NCT00536471|450739522|FG002|Overall Study|Lost to Follow-up|48|||
125303718|NCT00536471|450739523|FG003|Overall Study|Lost to Follow-up|22|||
125303719|NCT00536471|450739520|FG000|Overall Study|Adverse Event|32|||
125303720|NCT00536471|450739521|FG001|Overall Study|Adverse Event|16|||
125303721|NCT00536471|450739522|FG002|Overall Study|Adverse Event|28|||
125303722|NCT00536471|450739523|FG003|Overall Study|Adverse Event|13|||
124827144|NCT00665847|448995219|FG000|Overall Study|Withdrawal by Subject|2|||
124827145|NCT00665847|448995219|FG000|Overall Study|Subject non-compliant|8|||
124827146|NCT00665847|448995219|FG000|Overall Study|Subject reached a virologic endpoint|4|||
124827147|NCT00665847|448995219|FG000|Overall Study|Resistance to TMC125|1|||
124827148|NCT00665847|448995219|FG000|Overall Study|Subject ineligible to continue the trial|1|||
124827149|NCT00665847|448995219|FG000|Overall Study|Switch to Commercial Medication|1|||
124827150|NCT00492115|448995226|FG000|Overall Study|Withdrawal by Subject|3|||
124827151|NCT00492115|448995227|FG001|Overall Study|Withdrawal by Subject|4|||
124827152|NCT03564145|448995228|FG000|Overall Study|Adverse Event|4|||
124827153|NCT03564145|448995228|FG000|Overall Study|Lost to Follow-up|21|||
124827154|NCT03564145|448995228|FG000|Overall Study|Protocol Violation|2|||
124827155|NCT03564145|448995228|FG000|Overall Study|Withdrawal by Subject|48|||
124827156|NCT03564145|448995228|FG000|Overall Study|Study Terminated by Sponsor|146|||
124827157|NCT03564145|448995228|FG000|Overall Study|Physician Decision|1|||
124827158|NCT03564145|448995228|FG000|Overall Study|Other Than Specified|1|||
124827159|NCT03564145|448995228|FG000|Overall Study|Pregnancy|1|||
124827160|NCT02663674|448995231|FG000|Overall Study|Lost to Follow-up|5|||
124827161|NCT02663674|448995232|FG001|Overall Study|Lost to Follow-up|4|||
124827162|NCT02663674|448995231|FG000|Overall Study|Withdrawal by Subject|1|||
124827163|NCT02663674|448995232|FG001|Overall Study|Withdrawal by Subject|4|||
124827164|NCT02663674|448995231|FG000|Overall Study|Physician Decision|1|||
124827165|NCT02663674|448995232|FG001|Overall Study|Physician Decision|1|||
124827166|NCT02663674|448995231|FG000|Overall Study|Other Event (Health Related)|0|||
124827167|NCT02663674|448995232|FG001|Overall Study|Other Event (Health Related)|1|||
124827168|NCT01031069|448995233|FG000|Overall Study|Serious Adverse Event|0|||
124827169|NCT01031069|448995234|FG001|Overall Study|Serious Adverse Event|1|||
124827170|NCT01031069|448995235|FG002|Overall Study|Serious Adverse Event|0|||
124827171|NCT01031069|448995236|FG003|Overall Study|Serious Adverse Event|0|||
124827172|NCT01031069|448995233|FG000|Overall Study|Withdrawal by Subject|2|||
124827173|NCT01031069|448995234|FG001|Overall Study|Withdrawal by Subject|3|||
124827174|NCT01031069|448995235|FG002|Overall Study|Withdrawal by Subject|18|||
124827175|NCT01031069|448995236|FG003|Overall Study|Withdrawal by Subject|18|||
124827176|NCT01031069|448995233|FG000|Overall Study|Migrated/moved from study area|1|||
124827177|NCT01031069|448995234|FG001|Overall Study|Migrated/moved from study area|2|||
124827178|NCT01031069|448995235|FG002|Overall Study|Migrated/moved from study area|1|||
124827179|NCT01031069|448995236|FG003|Overall Study|Migrated/moved from study area|1|||
124827180|NCT01031069|448995233|FG000|Overall Study|Lost to Follow-up|9|||
124827181|NCT01031069|448995234|FG001|Overall Study|Lost to Follow-up|5|||
124827182|NCT01031069|448995235|FG002|Overall Study|Lost to Follow-up|21|||
124827183|NCT01031069|448995236|FG003|Overall Study|Lost to Follow-up|15|||
124827184|NCT01031069|448995233|FG000|Overall Study|Other|0|||
124827185|NCT01031069|448995234|FG001|Overall Study|Other|0|||
124827186|NCT01031069|448995235|FG002|Overall Study|Other|1|||
124827187|NCT01031069|448995236|FG003|Overall Study|Other|0|||
124827188|NCT05286307|448995237|FG000|Overall Study|Incomplete outcome assessments|2|||
124827189|NCT05286307|448995238|FG001|Overall Study|Incomplete outcome assessments|1|||
124827190|NCT05286307|448995237|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
124827191|NCT05286307|448995238|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
124827192|NCT05286307|448995237|FG000|Overall Study|Lost to follow up at 6 months|25|||
124827193|NCT05286307|448995238|FG001|Overall Study|Lost to follow up at 6 months|35|||
124827194|NCT05286307|448995237|FG000|Overall Study|Study medication not available|1|||
124827195|NCT05286307|448995238|FG001|Overall Study|Study medication not available|1|||
124827196|NCT01103284|448995239|FG000|Overall Study|Death|2|||
124827197|NCT01103284|448995240|FG001|Overall Study|Death|0|||
124827198|NCT01103284|448995239|FG000|Overall Study|Lost to Follow-up|9|||
124827199|NCT01103284|448995240|FG001|Overall Study|Lost to Follow-up|10|||
124827200|NCT01103284|448995239|FG000|Overall Study|Pregnancy|3|||
124827201|NCT01103284|448995240|FG001|Overall Study|Pregnancy|1|||
124827202|NCT01103284|448995239|FG000|Overall Study|Protocol Violation|12|||
124827203|NCT01103284|448995240|FG001|Overall Study|Protocol Violation|5|||
125303723|NCT00536471|450739520|FG000|Overall Study|Withdrawal by Subject|40|||
125303724|NCT00536471|450739521|FG001|Overall Study|Withdrawal by Subject|24|||
124827204|NCT01103284|448995239|FG000|Overall Study|Adverse Event|0|||
124827205|NCT01103284|448995240|FG001|Overall Study|Adverse Event|5|||
124827206|NCT01103284|448995239|FG000|Overall Study|Withdrawal by Subject|14|||
124827207|NCT01103284|448995240|FG001|Overall Study|Withdrawal by Subject|18|||
124827208|NCT01103284|448995239|FG000|Overall Study|Dermal Hypersensitivity|0|||
124827209|NCT01103284|448995240|FG001|Overall Study|Dermal Hypersensitivity|1|||
124827210|NCT01103284|448995239|FG000|Overall Study|Termination by the Sponsor|0|||
124827211|NCT01103284|448995240|FG001|Overall Study|Termination by the Sponsor|1|||
124827212|NCT01103284|448995239|FG000|Overall Study|Not described|2|||
124827213|NCT01103284|448995240|FG001|Overall Study|Not described|1|||
124827214|NCT01103284|448995239|FG000|Overall Study|Missing CRF entries for study completion|0|||
124827215|NCT01103284|448995240|FG001|Overall Study|Missing CRF entries for study completion|2|||
124827216|NCT02057198|448996792|FG000|Overall Study|Death|0|||
124827217|NCT02057198|448996793|FG001|Overall Study|Death|0|||
124827218|NCT02057198|448996794|FG002|Overall Study|Death|1|||
124827219|NCT02057198|448996792|FG000|Overall Study|Discharged early; lost to followup|0|||
124827220|NCT02057198|448996793|FG001|Overall Study|Discharged early; lost to followup|1|||
124827221|NCT02057198|448996794|FG002|Overall Study|Discharged early; lost to followup|0|||
124827222|NCT01042236|448996801|FG000|Treatment Period 1|Adverse Event|0|||
124827223|NCT01042236|448996802|FG001|Treatment Period 1|Adverse Event|1|||
124827224|NCT01042236|448996803|FG002|Treatment Period 1|Adverse Event|0|||
124827225|NCT01042236|448996804|FG003|Treatment Period 1|Adverse Event|0|||
124827226|NCT01042236|448996805|FG004|Treatment Period 1|Adverse Event|1|||
124827227|NCT01042236|448996806|FG005|Treatment Period 1|Adverse Event|0|||
124827228|NCT01042236|448996801|FG000|Treatment Period 3|Adverse Event|0|||
124827229|NCT01042236|448996802|FG001|Treatment Period 3|Adverse Event|0|||
124827230|NCT01042236|448996803|FG002|Treatment Period 3|Adverse Event|0|||
124827231|NCT01042236|448996804|FG003|Treatment Period 3|Adverse Event|1|||
124827232|NCT01042236|448996805|FG004|Treatment Period 3|Adverse Event|0|||
124827233|NCT01042236|448996806|FG005|Treatment Period 3|Adverse Event|0|||
124827234|NCT01042236|448996801|FG000|Treatment Period 3|Protocol Violation|0|||
124827235|NCT01042236|448996802|FG001|Treatment Period 3|Protocol Violation|0|||
124827236|NCT01042236|448996803|FG002|Treatment Period 3|Protocol Violation|0|||
124827237|NCT01042236|448996804|FG003|Treatment Period 3|Protocol Violation|1|||
124827238|NCT01042236|448996805|FG004|Treatment Period 3|Protocol Violation|0|||
124827239|NCT01042236|448996806|FG005|Treatment Period 3|Protocol Violation|0|||
124827240|NCT00227903|448996809|FG000|Overall Study|Withdrawal by Subject|2|||
124827241|NCT00227903|448996810|FG001|Overall Study|Withdrawal by Subject|5|||
124827242|NCT00227903|448996809|FG000|Overall Study|Subject moved out of area|1|||
124827243|NCT00227903|448996810|FG001|Overall Study|Subject moved out of area|2|||
124827244|NCT00227903|448996809|FG000|Overall Study|Lost to Follow-up|1|||
124827245|NCT00227903|448996810|FG001|Overall Study|Lost to Follow-up|3|||
124827246|NCT00227903|448996809|FG000|Overall Study|Miscarriage|1|||
124827247|NCT00227903|448996810|FG001|Overall Study|Miscarriage|0|||
124827248|NCT01475331|448996811|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
124827249|NCT01475331|448996812|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
124827250|NCT01475331|448996811|FG000|Overall Study|excessive main duct communication|1|||
124827251|NCT01475331|448996812|FG001|Overall Study|excessive main duct communication|1|||
124827252|NCT01475331|448996811|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
124827253|NCT01475331|448996812|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
124827254|NCT01475331|448996811|FG000|Overall Study|Sign of malignancy during the procedure|2|||
124827255|NCT01475331|448996812|FG001|Overall Study|Sign of malignancy during the procedure|0|||
124827256|NCT01475331|448996811|FG000|Overall Study|cyst found to be prohibitively small|0|||
124827257|NCT01475331|448996812|FG001|Overall Study|cyst found to be prohibitively small|1|||
124827258|NCT02345811|448996814|FG000|First Intervention|Withdrawal by Subject|1|||
124827259|NCT02345811|448996815|FG001|First Intervention|Withdrawal by Subject|1|||
124827260|NCT02877082|448996816|FG000|Overall Study|Trial was closed early|5|||
124827261|NCT02489344|448996818|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
124827262|NCT02489344|448996818|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
124827263|NCT02489344|448996818|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
124827264|NCT02489344|448996818|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
124827265|NCT03480750|448996819|FG000|Overall Study|Withdrawal by Subject|0|||
124827266|NCT03480750|448996820|FG001|Overall Study|Withdrawal by Subject|1|||
124827267|NCT03480750|448996821|FG002|Overall Study|Withdrawal by Subject|0|||
124827268|NCT03480750|448996822|FG003|Overall Study|Withdrawal by Subject|0|||
124827269|NCT03480750|448996823|FG004|Overall Study|Withdrawal by Subject|0|||
124827270|NCT03480750|448996824|FG005|Overall Study|Withdrawal by Subject|0|||
124827271|NCT03480750|448996819|FG000|Overall Study|The interruption in Trientine shippment|0|||
124827272|NCT03480750|448996820|FG001|Overall Study|The interruption in Trientine shippment|0|||
124827273|NCT03480750|448996821|FG002|Overall Study|The interruption in Trientine shippment|0|||
124827274|NCT03480750|448996822|FG003|Overall Study|The interruption in Trientine shippment|0|||
124827275|NCT03480750|448996823|FG004|Overall Study|The interruption in Trientine shippment|0|||
124827276|NCT03480750|448996824|FG005|Overall Study|The interruption in Trientine shippment|1|||
124827277|NCT01132482|448996825|FG000|Overall Study|Adverse Event|1|||
124827278|NCT01132482|448996826|FG001|Overall Study|Adverse Event|0|||
124827279|NCT03683758|448996827|FG000|Overall Study|Non-study commitment conflict|1|||
125303725|NCT00536471|450739522|FG002|Overall Study|Withdrawal by Subject|43|||
125303726|NCT00536471|450739523|FG003|Overall Study|Withdrawal by Subject|21|||
124827280|NCT03683758|448996828|FG001|Overall Study|Non-study commitment conflict|3|||
124827281|NCT03683758|448996827|FG000|Overall Study|Illness preventing participation|1|||
124827282|NCT03683758|448996828|FG001|Overall Study|Illness preventing participation|0|||
124827283|NCT03683758|448996827|FG000|Overall Study|Adverse Event|1|||
124827284|NCT03683758|448996828|FG001|Overall Study|Adverse Event|0|||
124827285|NCT00723892|448996831|FG000|Overall Study|Participant not tracked|33|||
124827286|NCT00723892|448996832|FG001|Overall Study|Participant not tracked|35|||
124827287|NCT00723892|448996831|FG000|Overall Study|Virological criterion|24|||
125303727|NCT00536471|450739520|FG000|Overall Study|Lack of Efficacy|17|||
125303728|NCT00536471|450739521|FG001|Overall Study|Lack of Efficacy|18|||
124827288|NCT00723892|448996832|FG001|Overall Study|Virological criterion|9|||
124827289|NCT00723892|448996831|FG000|Overall Study|Withdrawal by Subject|6|||
124827290|NCT00723892|448996832|FG001|Overall Study|Withdrawal by Subject|9|||
124827291|NCT00723892|448996831|FG000|Overall Study|End planned|11|||
124827292|NCT00723892|448996832|FG001|Overall Study|End planned|7|||
124827293|NCT00723892|448996831|FG000|Overall Study|Bad tolerance|5|||
124827294|NCT00723892|448996832|FG001|Overall Study|Bad tolerance|5|||
124827295|NCT00723892|448996831|FG000|Overall Study|Multiple reasons|17|||
124827296|NCT00723892|448996832|FG001|Overall Study|Multiple reasons|12|||
124827297|NCT00723892|448996831|FG000|Overall Study|Other|6|||
124827298|NCT00723892|448996832|FG001|Overall Study|Other|3|||
124827299|NCT00723892|448996831|FG000|Overall Study|Study end|1|||
124827300|NCT00723892|448996832|FG001|Overall Study|Study end|3|||
124827301|NCT00723892|448996831|FG000|Overall Study|Weight loss|1|||
124827302|NCT00723892|448996832|FG001|Overall Study|Weight loss|3|||
124827303|NCT00723892|448996831|FG000|Overall Study|Alcohol abuse|0|||
124827304|NCT00723892|448996832|FG001|Overall Study|Alcohol abuse|1|||
124827305|NCT00723892|448996831|FG000|Overall Study|Intercurrent infection|2|||
124827306|NCT00723892|448996832|FG001|Overall Study|Intercurrent infection|0|||
124827307|NCT00723892|448996831|FG000|Overall Study|Drug addiction|1|||
124827308|NCT00723892|448996832|FG001|Overall Study|Drug addiction|0|||
124827309|NCT01172847|448996835|FG000|Overall Study|Withdrawal by Subject|3|||
124827310|NCT01163279|448996836|FG000|Overall Study|Withdrawal by Subject|2|||
124827311|NCT01163279|448996837|FG001|Overall Study|Withdrawal by Subject|0|||
124827312|NCT02411292|448996839|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
124827313|NCT02411292|448996839|FG000|Overall Study|Death|2|||
124827314|NCT02411292|448996839|FG000|Overall Study|Lost to Follow-up|3|||
124827315|NCT02232425|448996842|FG000|Overall Study|Lost to Follow-up|6|||
124827316|NCT02232425|448996843|FG001|Overall Study|Lost to Follow-up|2|||
124827317|NCT02232425|448996842|FG000|Overall Study|Adverse Event|2|||
124827318|NCT02232425|448996843|FG001|Overall Study|Adverse Event|0|||
124827319|NCT02232425|448996842|FG000|Overall Study|Withdrawal by Subject|5|||
124827320|NCT02232425|448996843|FG001|Overall Study|Withdrawal by Subject|6|||
124827321|NCT02232425|448996842|FG000|Overall Study|Lack of Efficacy|1|||
124827322|NCT02232425|448996843|FG001|Overall Study|Lack of Efficacy|0|||
124827323|NCT00665353|448996844|FG000|Study Step 1|Adverse Event|1|||
124827324|NCT00665353|448996844|FG000|Study Step 1|Withdrawal by Subject|2|||
124827325|NCT00665353|448996844|FG000|Study Step 2|Lost to Follow-up|2|||
124827326|NCT00665353|448996844|FG000|Study Step 2|Lack of Efficacy|12|||
124827327|NCT01601626|448996845|FG000|Overall Study|Death|1|||
124827328|NCT01601626|448996846|FG001|Overall Study|Death|1|||
124827329|NCT01601626|448996847|FG002|Overall Study|Death|1|||
124827330|NCT01601626|448996845|FG000|Overall Study|Lost to Follow-up|1|||
124827331|NCT01601626|448996846|FG001|Overall Study|Lost to Follow-up|2|||
124827332|NCT01601626|448996847|FG002|Overall Study|Lost to Follow-up|0|||
124827333|NCT01601626|448996845|FG000|Overall Study|Unable to Get to Clinic|0|||
124827334|NCT01601626|448996846|FG001|Overall Study|Unable to Get to Clinic|1|||
124827335|NCT01601626|448996847|FG002|Overall Study|Unable to Get to Clinic|0|||
124827336|NCT01601626|448996845|FG000|Overall Study|Withdrawal by Subject|0|||
124827337|NCT01601626|448996846|FG001|Overall Study|Withdrawal by Subject|1|||
124827338|NCT01601626|448996847|FG002|Overall Study|Withdrawal by Subject|1|||
124827339|NCT01601626|448996845|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
124827340|NCT01601626|448996846|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
124827341|NCT01601626|448996847|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
124827342|NCT00498602|448996848|FG000|Overall Study|Death|0|||
124827343|NCT00498602|448996849|FG001|Overall Study|Death|0|||
124827344|NCT00498602|448996850|FG002|Overall Study|Death|0|||
124827345|NCT00498602|448996851|FG003|Overall Study|Death|0|||
124827346|NCT00498602|448996852|FG004|Overall Study|Death|0|||
125303729|NCT00536471|450739522|FG002|Overall Study|Lack of Efficacy|11|||
125303730|NCT00536471|450739523|FG003|Overall Study|Lack of Efficacy|9|||
125303731|NCT00536471|450739520|FG000|Overall Study|Protocol Violation|8|||
124827347|NCT00498602|448996853|FG005|Overall Study|Death|1|||
124827348|NCT00498602|448996854|FG006|Overall Study|Death|0|||
124827349|NCT00498602|448996848|FG000|Overall Study|Lack of Efficacy|1|||
124827350|NCT00498602|448996849|FG001|Overall Study|Lack of Efficacy|0|||
124827351|NCT00498602|448996850|FG002|Overall Study|Lack of Efficacy|0|||
124827352|NCT00498602|448996851|FG003|Overall Study|Lack of Efficacy|0|||
124827353|NCT00498602|448996852|FG004|Overall Study|Lack of Efficacy|0|||
124827354|NCT00498602|448996853|FG005|Overall Study|Lack of Efficacy|0|||
124827355|NCT00498602|448996854|FG006|Overall Study|Lack of Efficacy|0|||
124827356|NCT00498602|448996848|FG000|Overall Study|Lost to Follow-up|0|||
124827357|NCT00498602|448996849|FG001|Overall Study|Lost to Follow-up|2|||
124827358|NCT00498602|448996850|FG002|Overall Study|Lost to Follow-up|0|||
124827359|NCT00498602|448996851|FG003|Overall Study|Lost to Follow-up|2|||
124827360|NCT00498602|448996852|FG004|Overall Study|Lost to Follow-up|0|||
124827361|NCT00498602|448996853|FG005|Overall Study|Lost to Follow-up|0|||
124827362|NCT00498602|448996854|FG006|Overall Study|Lost to Follow-up|0|||
124827363|NCT00498602|448996848|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
125303732|NCT00536471|450739521|FG001|Overall Study|Protocol Violation|1|||
124827364|NCT00498602|448996849|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
124827365|NCT00498602|448996850|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
124827366|NCT00498602|448996851|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
124827367|NCT00498602|448996852|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
124827368|NCT00498602|448996853|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
124827369|NCT00498602|448996854|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
124827370|NCT00498602|448996848|FG000|Overall Study|AE not related to Study Drug|1|||
124827371|NCT00498602|448996849|FG001|Overall Study|AE not related to Study Drug|3|||
124827372|NCT00498602|448996850|FG002|Overall Study|AE not related to Study Drug|0|||
124827373|NCT00498602|448996851|FG003|Overall Study|AE not related to Study Drug|0|||
124827374|NCT00498602|448996852|FG004|Overall Study|AE not related to Study Drug|2|||
124827375|NCT00498602|448996853|FG005|Overall Study|AE not related to Study Drug|2|||
124827376|NCT00498602|448996854|FG006|Overall Study|AE not related to Study Drug|1|||
124827377|NCT00498602|448996848|FG000|Overall Study|Caregiver Request|2|||
124827378|NCT00498602|448996849|FG001|Overall Study|Caregiver Request|2|||
124827379|NCT00498602|448996850|FG002|Overall Study|Caregiver Request|2|||
124827380|NCT00498602|448996851|FG003|Overall Study|Caregiver Request|0|||
124827381|NCT00498602|448996852|FG004|Overall Study|Caregiver Request|1|||
124827382|NCT00498602|448996853|FG005|Overall Study|Caregiver Request|2|||
124827383|NCT00498602|448996854|FG006|Overall Study|Caregiver Request|0|||
124827384|NCT00498602|448996848|FG000|Overall Study|Investigator Request|0|||
124827385|NCT00498602|448996849|FG001|Overall Study|Investigator Request|0|||
124827386|NCT00498602|448996850|FG002|Overall Study|Investigator Request|1|||
124827387|NCT00498602|448996851|FG003|Overall Study|Investigator Request|0|||
124827388|NCT00498602|448996852|FG004|Overall Study|Investigator Request|0|||
124827389|NCT00498602|448996853|FG005|Overall Study|Investigator Request|0|||
124827390|NCT00498602|448996854|FG006|Overall Study|Investigator Request|0|||
124827391|NCT00498602|448996848|FG000|Overall Study|Subject Request|3|||
124827392|NCT00498602|448996849|FG001|Overall Study|Subject Request|0|||
124827393|NCT00498602|448996850|FG002|Overall Study|Subject Request|1|||
124827394|NCT00498602|448996851|FG003|Overall Study|Subject Request|1|||
124827395|NCT00498602|448996852|FG004|Overall Study|Subject Request|1|||
124827396|NCT00498602|448996853|FG005|Overall Study|Subject Request|4|||
124827397|NCT00498602|448996854|FG006|Overall Study|Subject Request|1|||
124827398|NCT00498602|448996848|FG000|Overall Study|Other|2|||
124827399|NCT00498602|448996849|FG001|Overall Study|Other|3|||
124827400|NCT00498602|448996850|FG002|Overall Study|Other|1|||
124827401|NCT00498602|448996851|FG003|Overall Study|Other|0|||
124827402|NCT00498602|448996852|FG004|Overall Study|Other|0|||
124827403|NCT00498602|448996853|FG005|Overall Study|Other|3|||
124827404|NCT00498602|448996854|FG006|Overall Study|Other|0|||
124827405|NCT02632552|448996857|FG000|Overall Study|Lost to Follow-up|14|||
124827406|NCT02632552|448996858|FG001|Overall Study|Lost to Follow-up|8|||
124827407|NCT02632552|448996857|FG000|Overall Study|Withdrawal by Subject|2|||
124827408|NCT02632552|448996858|FG001|Overall Study|Withdrawal by Subject|0|||
124827409|NCT02632552|448996857|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
124827410|NCT02632552|448996858|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
124827411|NCT00546637|448996859|FG000|Overall Study|Adverse Event|46|||
124827412|NCT00546637|448996860|FG001|Overall Study|Adverse Event|20|||
124827413|NCT00546637|448996859|FG000|Overall Study|Lack of Efficacy|5|||
124827414|NCT00546637|448996860|FG001|Overall Study|Lack of Efficacy|5|||
124827415|NCT00546637|448996859|FG000|Overall Study|Lost to Follow-up|2|||
124827416|NCT00546637|448996860|FG001|Overall Study|Lost to Follow-up|2|||
124827417|NCT00546637|448996859|FG000|Overall Study|Other|10|||
124827418|NCT00546637|448996860|FG001|Overall Study|Other|12|||
124827419|NCT00546637|448996859|FG000|Overall Study|Withdrawal by Subject|7|||
124827420|NCT00546637|448996860|FG001|Overall Study|Withdrawal by Subject|9|||
124827421|NCT00546637|448996859|FG000|Overall Study|Randomized, but not treated|3|||
124827422|NCT00546637|448996860|FG001|Overall Study|Randomized, but not treated|1|||
124827423|NCT01074450|448996861|FG000|First Intervention|Emesis in Dosing Interval|0|||
124827424|NCT01074450|448996862|FG001|First Intervention|Emesis in Dosing Interval|2|||
124827425|NCT01074450|448996861|FG000|Second Intervention|Protocol Violation|1|||
124827426|NCT01074450|448996862|FG001|Second Intervention|Protocol Violation|0|||
124827427|NCT01074450|448996861|FG000|Second Intervention|Physician Decision|0|||
124827428|NCT01074450|448996862|FG001|Second Intervention|Physician Decision|1|||
124827429|NCT01846507|448996863|FG000|Overall Study|Lost to Follow-up|4|||
124827430|NCT01846507|448996863|FG000|Overall Study|Protocol Violation|1|||
124827431|NCT01846507|448996863|FG000|Overall Study|Missing data|2|||
124827432|NCT00450450|448996864|FG000|Overall Study|Death|1|||
124827433|NCT00450450|448996865|FG001|Overall Study|Death|3|||
124827434|NCT00450450|448996864|FG000|Overall Study|Relapse|2|||
124827435|NCT00450450|448996865|FG001|Overall Study|Relapse|0|||
124827436|NCT00450450|448996864|FG000|Overall Study|Missing Data|2|||
124827437|NCT00450450|448996865|FG001|Overall Study|Missing Data|0|||
124827438|NCT04984993|448996866|FG000|Overall Study|Withdrawal by Subject|8|||
124827439|NCT04984993|448996867|FG001|Overall Study|Withdrawal by Subject|2|||
124827440|NCT04984993|448996866|FG000|Overall Study|Lost to Follow-up|2|||
124827441|NCT04984993|448996867|FG001|Overall Study|Lost to Follow-up|2|||
124827442|NCT04984993|448996866|FG000|Overall Study|Both patients moved to another country|4|||
124827443|NCT04984993|448996867|FG001|Overall Study|Both patients moved to another country|0|||
124827444|NCT02865187|448996870|FG000|Overall Study|Lost to Follow-up|12|||
124827445|NCT02865187|448996871|FG001|Overall Study|Lost to Follow-up|7|||
125303733|NCT00536471|450739522|FG002|Overall Study|Protocol Violation|2|||
125303734|NCT00536471|450739523|FG003|Overall Study|Protocol Violation|3|||
125303735|NCT00536471|450739520|FG000|Overall Study|Physician Decision|11|||
125303736|NCT00536471|450739521|FG001|Overall Study|Physician Decision|1|||
125303737|NCT00536471|450739522|FG002|Overall Study|Physician Decision|3|||
125303738|NCT00536471|450739523|FG003|Overall Study|Physician Decision|2|||
125303739|NCT00536471|450739520|FG000|Overall Study|Death|0|||
125303740|NCT00536471|450739521|FG001|Overall Study|Death|0|||
125303741|NCT00536471|450739522|FG002|Overall Study|Death|1|||
125303742|NCT00536471|450739523|FG003|Overall Study|Death|2|||
125303743|NCT00536471|450739520|FG000|Overall Study|Sponsor Decision|0|||
125303744|NCT00536471|450739521|FG001|Overall Study|Sponsor Decision|1|||
125303745|NCT00536471|450739522|FG002|Overall Study|Sponsor Decision|3|||
125303746|NCT00536471|450739523|FG003|Overall Study|Sponsor Decision|2|||
125303747|NCT01440816|450739528|FG000|Overall Study|Disease Progression|0|||
125303748|NCT01440816|450739529|FG001|Overall Study|Disease Progression|9|||
125303749|NCT01440816|450739528|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
125303750|NCT01440816|450739529|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
125303751|NCT01687101|450739530|FG000|Overall Study|Lost to Follow-up|7|||
125303752|NCT03250182|450739533|FG000|Overall Study|Withdrawal by Subject|1|||
125303753|NCT01858740|450739534|FG000|Overall Study|Death|4|||
125303754|NCT00894361|450739541|FG000|Overall Study|deaths and less than 2 years followup|24|||
125303755|NCT00894361|450739542|FG001|Overall Study|deaths and less than 2 years followup|64|||
125303756|NCT04207060|450739547|FG000|Overall Study|Lost to Follow-up|2|||
125303757|NCT04207060|450739548|FG001|Overall Study|Lost to Follow-up|0|||
125303758|NCT02718716|450739550|FG000|Overall Study|Lack of Efficacy|1|||
125303759|NCT02718716|450739551|FG001|Overall Study|Lack of Efficacy|0|||
125303760|NCT02718716|450739552|FG002|Overall Study|Lack of Efficacy|0|||
125303761|NCT02718716|450739553|FG003|Overall Study|Lack of Efficacy|0|||
125303762|NCT02718716|450739554|FG004|Overall Study|Lack of Efficacy|0|||
125303763|NCT00296140|450739555|FG000|Overall Study|Lost to Follow-up|1|||
125303764|NCT00296140|450739556|FG001|Overall Study|Lost to Follow-up|0|||
125303765|NCT00296140|450739555|FG000|Overall Study|Withdrawal by Subject|1|||
125303766|NCT00296140|450739556|FG001|Overall Study|Withdrawal by Subject|0|||
125303767|NCT00296140|450739555|FG000|Overall Study|Discharge to Nursing Home|1|||
125303768|NCT00296140|450739556|FG001|Overall Study|Discharge to Nursing Home|0|||
125303769|NCT01856582|450739560|FG000|Overall Study|Died prior to Boost infusion|1|||
125303770|NCT03245398|450739565|FG000|Overall Study|Travelled to another island|1|||
125303771|NCT03245398|450739566|FG001|Overall Study|Travelled to another island|0|||
125303772|NCT00596830|450739567|FG000|Overall Study|Death|258|||
125303773|NCT00596830|450739568|FG001|Overall Study|Death|247|||
125303774|NCT00596830|450739567|FG000|Overall Study|Lost to Follow-up|7|||
125303775|NCT00596830|450739568|FG001|Overall Study|Lost to Follow-up|11|||
125303776|NCT00596830|450739567|FG000|Overall Study|Withdrawal by Subject|22|||
125303777|NCT00596830|450739568|FG001|Overall Study|Withdrawal by Subject|12|||
125303778|NCT00596830|450739567|FG000|Overall Study|Study terminated by sponsor|51|||
125303779|NCT00596830|450739568|FG001|Overall Study|Study terminated by sponsor|62|||
125303780|NCT00596830|450739567|FG000|Overall Study|Follow-up was discontinued|1|||
125303781|NCT00596830|450739568|FG001|Overall Study|Follow-up was discontinued|0|||
125303782|NCT00596830|450739567|FG000|Overall Study|Randomized but not treated|3|||
125303783|NCT00596830|450739568|FG001|Overall Study|Randomized but not treated|7|||
125303784|NCT00887926|450739571|FG000|Overall Study|Withdrawal by Subject|0|||
125303785|NCT00887926|450739572|FG001|Overall Study|Withdrawal by Subject|1|||
125303786|NCT00887926|450739573|FG002|Overall Study|Withdrawal by Subject|0|||
125303787|NCT00887926|450739574|FG003|Overall Study|Withdrawal by Subject|0|||
125303788|NCT00880191|450739575|FG000|Overall Study|Refused further treatment|4|||
124827446|NCT02865187|448996870|FG000|Overall Study|Adverse Event|1|||
124827447|NCT02865187|448996871|FG001|Overall Study|Adverse Event|0|||
124827448|NCT03318315|448996872|FG000|Overall Study|Lost to Follow-up|3|||
125303789|NCT00880191|450739576|FG001|Overall Study|Refused further treatment|1|||
125303790|NCT00880191|450739575|FG000|Overall Study|Adverse Event|8|||
125303791|NCT00880191|450739576|FG001|Overall Study|Adverse Event|6|||
125303792|NCT00880191|450739575|FG000|Overall Study|Hospitalization/efficacy|1|||
125303793|NCT00880191|450739576|FG001|Overall Study|Hospitalization/efficacy|1|||
124827449|NCT03318315|448996873|FG001|Overall Study|Lost to Follow-up|2|||
124827450|NCT03318315|448996874|FG002|Overall Study|Lost to Follow-up|1|||
124827451|NCT03318315|448996872|FG000|Overall Study|Protocol Violation|1|||
125303794|NCT02097030|450739577|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
125303795|NCT02097030|450739578|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
124827452|NCT03318315|448996873|FG001|Overall Study|Protocol Violation|1|||
125303796|NCT02097030|450739577|FG000|First Intervention (3 Days)|Visual Acuity|0|||
125303797|NCT02097030|450739578|FG001|First Intervention (3 Days)|Visual Acuity|1|||
125303798|NCT01919801|450739579|FG000|Overall Study|Withdrawal by Subject|1|||
124827453|NCT03318315|448996874|FG002|Overall Study|Protocol Violation|1|||
124827454|NCT03318315|448996872|FG000|Overall Study|Withdrawal by Subject|0|||
124827455|NCT03318315|448996873|FG001|Overall Study|Withdrawal by Subject|0|||
124827456|NCT03318315|448996874|FG002|Overall Study|Withdrawal by Subject|2|||
124827457|NCT02436356|448996875|FG000|Overall Study|Excluded by MRI Screening|0|||
124827458|NCT02436356|448996876|FG001|Overall Study|Excluded by MRI Screening|0|||
124827459|NCT02436356|448996877|FG002|Overall Study|Excluded by MRI Screening|2|||
124827460|NCT02436356|448996875|FG000|Overall Study|Lost to Follow-up|0|||
124827461|NCT02436356|448996876|FG001|Overall Study|Lost to Follow-up|1|||
124827462|NCT02436356|448996877|FG002|Overall Study|Lost to Follow-up|0|||
124827463|NCT02436356|448996875|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
124827464|NCT02436356|448996876|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
124827465|NCT02436356|448996877|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
124827466|NCT02436356|448996875|FG000|Overall Study|Excluded due to other medical conditions|3|||
124827467|NCT02436356|448996876|FG001|Overall Study|Excluded due to other medical conditions|0|||
124827468|NCT02436356|448996877|FG002|Overall Study|Excluded due to other medical conditions|0|||
124827469|NCT02436356|448996875|FG000|Overall Study|Withdrawal by Subject|1|||
124827470|NCT02436356|448996876|FG001|Overall Study|Withdrawal by Subject|0|||
124827471|NCT02436356|448996877|FG002|Overall Study|Withdrawal by Subject|0|||
124827472|NCT00810407|448996878|FG000|Overall Study|Protocol Violation|3|||
124827473|NCT00810407|448996878|FG000|Overall Study|No Visit After First Day of Treatment|3|||
124827474|NCT00674661|448996879|FG000|Overall Study|Other|5|||
124827475|NCT00674661|448996880|FG001|Overall Study|Other|7|||
125303799|NCT01919801|450739580|FG001|Overall Study|Withdrawal by Subject|0|||
125303800|NCT01919801|450739579|FG000|Overall Study|Physician Decision|0|||
125303801|NCT01919801|450739580|FG001|Overall Study|Physician Decision|1|||
125303802|NCT01919801|450739579|FG000|Overall Study|Lost to Follow-up|0|||
125303803|NCT01919801|450739580|FG001|Overall Study|Lost to Follow-up|1|||
125303804|NCT01919801|450739579|FG000|Overall Study|Other|0|||
125303805|NCT01919801|450739580|FG001|Overall Study|Other|1|||
125303806|NCT01843062|450739581|FG000|Overall Study|Protocol Violation|1|||
125303807|NCT01843062|450739582|FG001|Overall Study|Protocol Violation|0|||
125303808|NCT01843062|450739581|FG000|Overall Study|New treatment following progression|2|||
125303809|NCT01843062|450739582|FG001|Overall Study|New treatment following progression|0|||
125303810|NCT01843062|450739581|FG000|Overall Study|Pregnancy|1|||
125303811|NCT01843062|450739582|FG001|Overall Study|Pregnancy|0|||
125303812|NCT01843062|450739581|FG000|Overall Study|Adverse Event|2|||
125303813|NCT01843062|450739582|FG001|Overall Study|Adverse Event|0|||
125303814|NCT01843062|450739581|FG000|Overall Study|Incorrect randomisation|1|||
125303815|NCT01843062|450739582|FG001|Overall Study|Incorrect randomisation|0|||
125303816|NCT01843062|450739581|FG000|Overall Study|Withdrawal by Subject|12|||
125303817|NCT01843062|450739582|FG001|Overall Study|Withdrawal by Subject|3|||
125303818|NCT01843062|450739581|FG000|Overall Study|Death|1|||
125303819|NCT01843062|450739582|FG001|Overall Study|Death|2|||
125303820|NCT01843062|450739581|FG000|Overall Study|Lost to Follow-up|2|||
125303821|NCT01843062|450739582|FG001|Overall Study|Lost to Follow-up|4|||
125303822|NCT01677858|450739583|FG000|Overall Study|Adverse Event|0|||
125303823|NCT01677858|450739584|FG001|Overall Study|Adverse Event|0|||
125303824|NCT01677858|450739585|FG002|Overall Study|Adverse Event|2|||
125303825|NCT01677858|450739586|FG003|Overall Study|Adverse Event|3|||
125303826|NCT01677858|450739587|FG004|Overall Study|Adverse Event|13|||
125303827|NCT01677858|450739583|FG000|Overall Study|Death|0|||
125303828|NCT01677858|450739584|FG001|Overall Study|Death|0|||
125303829|NCT01677858|450739585|FG002|Overall Study|Death|0|||
125303830|NCT01677858|450739586|FG003|Overall Study|Death|0|||
124827476|NCT00674661|448996879|FG000|Overall Study|Lost to Follow-up|6|||
124827477|NCT00674661|448996880|FG001|Overall Study|Lost to Follow-up|3|||
124827478|NCT00674661|448996879|FG000|Overall Study|Withdrawal by Subject|0|||
124827479|NCT00674661|448996880|FG001|Overall Study|Withdrawal by Subject|5|||
124827480|NCT02574247|448996881|FG000|Overall Study|Withdrawal by Subject|1|||
124827481|NCT02574247|448996882|FG001|Overall Study|Withdrawal by Subject|0|||
124827482|NCT02574247|448996883|FG002|Overall Study|Withdrawal by Subject|0|||
124827483|NCT02574247|448996881|FG000|Overall Study|Did not meet inclusion criteria|4|||
124827484|NCT02574247|448996882|FG001|Overall Study|Did not meet inclusion criteria|3|||
124827485|NCT02574247|448996883|FG002|Overall Study|Did not meet inclusion criteria|5|||
125303831|NCT01677858|450739587|FG004|Overall Study|Death|1|||
125303832|NCT01677858|450739583|FG000|Overall Study|Physician Decision|1|||
125303833|NCT01677858|450739584|FG001|Overall Study|Physician Decision|0|||
125303834|NCT01677858|450739585|FG002|Overall Study|Physician Decision|2|||
125303835|NCT01677858|450739586|FG003|Overall Study|Physician Decision|0|||
125303836|NCT01677858|450739587|FG004|Overall Study|Physician Decision|12|||
125303837|NCT01677858|450739583|FG000|Overall Study|Progressive Disease|2|||
125303838|NCT01677858|450739584|FG001|Overall Study|Progressive Disease|1|||
125303839|NCT01677858|450739585|FG002|Overall Study|Progressive Disease|9|||
125303840|NCT01677858|450739586|FG003|Overall Study|Progressive Disease|3|||
124827486|NCT01382446|448996884|FG000|Overall Study|Withdrawal by Subject|0|||
124827487|NCT01382446|448996885|FG001|Overall Study|Withdrawal by Subject|1|||
125303841|NCT01677858|450739587|FG004|Overall Study|Progressive Disease|43|||
124827488|NCT01382446|448996884|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
124827489|NCT01382446|448996885|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
124827490|NCT02707991|448996886|FG000|Overall Study|Protocol Violation|1|||
124827491|NCT02707991|448996887|FG001|Overall Study|Protocol Violation|0|||
124827492|NCT02707991|448996886|FG000|Overall Study|Became ineligible|0|||
124827493|NCT02707991|448996887|FG001|Overall Study|Became ineligible|1|||
124827494|NCT04210310|448996888|FG000|Overall Study|Lost to Follow-up|32|||
124827495|NCT04210310|448996889|FG001|Overall Study|Lost to Follow-up|1|||
124827496|NCT01528254|448996893|FG000|Overall Study|Administrative problems|96|||
124827497|NCT01528254|448996894|FG001|Overall Study|Administrative problems|94|||
124827498|NCT01528254|448996893|FG000|Overall Study|Adverse Event|28|||
124827499|NCT01528254|448996894|FG001|Overall Study|Adverse Event|44|||
124827500|NCT01528254|448996893|FG000|Overall Study|Lost to Follow-up|17|||
124827501|NCT01528254|448996894|FG001|Overall Study|Lost to Follow-up|24|||
124827502|NCT01528254|448996893|FG000|Overall Study|Death|13|||
124827503|NCT01528254|448996894|FG001|Overall Study|Death|9|||
124827504|NCT01528254|448996893|FG000|Overall Study|Protocol deviation|9|||
124827505|NCT01528254|448996894|FG001|Overall Study|Protocol deviation|19|||
124827506|NCT01528254|448996893|FG000|Overall Study|New therapy for study indication|8|||
124827507|NCT01528254|448996894|FG001|Overall Study|New therapy for study indication|6|||
124827508|NCT01528254|448996893|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
124827509|NCT01528254|448996894|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
124827510|NCT01528254|448996893|FG000|Overall Study|Withdrawal by Subject|5|||
124827511|NCT01528254|448996894|FG001|Overall Study|Withdrawal by Subject|4|||
124827512|NCT01528254|448996893|FG000|Overall Study|Abnormal laboratory value(s)|3|||
124827513|NCT01528254|448996894|FG001|Overall Study|Abnormal laboratory value(s)|7|||
124827514|NCT01528254|448996893|FG000|Overall Study|Abnormal test procedure result(s)|1|||
124827515|NCT01528254|448996894|FG001|Overall Study|Abnormal test procedure result(s)|0|||
124827516|NCT01528254|448996893|FG000|Overall Study|No longer requires study drug|1|||
124827517|NCT01528254|448996894|FG001|Overall Study|No longer requires study drug|1|||
125303842|NCT01677858|450739583|FG000|Overall Study|Withdrawal by Subject|0|||
125303843|NCT01677858|450739584|FG001|Overall Study|Withdrawal by Subject|1|||
125303844|NCT01677858|450739585|FG002|Overall Study|Withdrawal by Subject|1|||
125303845|NCT01677858|450739586|FG003|Overall Study|Withdrawal by Subject|0|||
125303846|NCT01677858|450739587|FG004|Overall Study|Withdrawal by Subject|15|||
125303847|NCT01677858|450739583|FG000|Overall Study|Lost to Follow-up|0|||
125303848|NCT01677858|450739584|FG001|Overall Study|Lost to Follow-up|0|||
125303849|NCT01677858|450739585|FG002|Overall Study|Lost to Follow-up|0|||
125303850|NCT01677858|450739586|FG003|Overall Study|Lost to Follow-up|0|||
125303851|NCT01677858|450739587|FG004|Overall Study|Lost to Follow-up|1|||
125303852|NCT00773747|450739588|FG000|Overall Study|Lack of Efficacy|112|||
125303853|NCT00773747|450739589|FG001|Overall Study|Lack of Efficacy|144|||
125303854|NCT00773747|450739588|FG000|Overall Study|Physician Decision|26|||
125303855|NCT00773747|450739589|FG001|Overall Study|Physician Decision|18|||
125303856|NCT00773747|450739588|FG000|Overall Study|Lost to Follow-up|0|||
125303857|NCT00773747|450739589|FG001|Overall Study|Lost to Follow-up|1|||
125303858|NCT00773747|450739588|FG000|Overall Study|Protocol Violation|2|||
125303859|NCT00773747|450739589|FG001|Overall Study|Protocol Violation|2|||
125303860|NCT00773747|450739588|FG000|Overall Study|Withdrawal by Subject|89|||
125303861|NCT00773747|450739589|FG001|Overall Study|Withdrawal by Subject|61|||
125303862|NCT00773747|450739588|FG000|Overall Study|Adverse Event|61|||
125303863|NCT00773747|450739589|FG001|Overall Study|Adverse Event|62|||
125303864|NCT00773747|450739588|FG000|Overall Study|Death|5|||
125303865|NCT00773747|450739589|FG001|Overall Study|Death|8|||
125303866|NCT00773747|450739588|FG000|Overall Study|Not Treated|2|||
125303867|NCT00773747|450739589|FG001|Overall Study|Not Treated|0|||
125303868|NCT02669212|450739592|FG000|Overall Study|Lost to Follow-up|1|||
125303869|NCT02669212|450739593|FG001|Overall Study|Lost to Follow-up|0|||
125303870|NCT02669212|450739592|FG000|Overall Study|Medical Condition|3|||
125303871|NCT02669212|450739593|FG001|Overall Study|Medical Condition|4|||
125303872|NCT02669212|450739592|FG000|Overall Study|Withdrawal by Subject|0|||
125303873|NCT02669212|450739593|FG001|Overall Study|Withdrawal by Subject|2|||
125303874|NCT02669212|450739592|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
124827518|NCT01166763|448996895|FG000|Overall Study|Withdrawal by Subject|3|||
125303875|NCT02669212|450739593|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
124827519|NCT04339296|448996896|FG000|Overall Study|Refuse to participate after allocation|1|||
124827520|NCT04339296|448996897|FG001|Overall Study|Refuse to participate after allocation|1|||
124827521|NCT04339296|448996896|FG000|Overall Study|Withdrew after completion of baseline|2|||
124827522|NCT04339296|448996897|FG001|Overall Study|Withdrew after completion of baseline|1|||
125303876|NCT03549104|450739594|FG000|Overall Study|Withdrawal by Subject|5|||
125303877|NCT03549104|450739595|FG001|Overall Study|Withdrawal by Subject|2|||
125303878|NCT03549104|450739594|FG000|Overall Study|Covid shelter in place|1|||
124827523|NCT04339296|448996896|FG000|Overall Study|Lost to Follow-up|0|||
124827524|NCT04339296|448996897|FG001|Overall Study|Lost to Follow-up|4|||
125303879|NCT03549104|450739595|FG001|Overall Study|Covid shelter in place|2|||
125303880|NCT04869358|450739596|FG000|Overall Study|Wish to have children.|1|||
125303881|NCT04869358|450739597|FG001|Overall Study|Wish to have children.|0|||
124827525|NCT04339296|448996896|FG000|Overall Study|Discontinued intervention|5|||
124827526|NCT04339296|448996897|FG001|Overall Study|Discontinued intervention|3|||
124827527|NCT01909479|448996898|FG000|From Baseline to Week 26|Adverse Event|3|||
124827528|NCT01909479|448996899|FG001|From Baseline to Week 26|Adverse Event|2|||
124827529|NCT01909479|448996898|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
124827530|NCT01909479|448996899|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
124827531|NCT01909479|448996898|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
124827532|NCT01909479|448996899|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
124827533|NCT01909479|448996898|FG000|26 - 52 Weeks|Adverse Event|0|||
124827534|NCT01909479|448996899|FG001|26 - 52 Weeks|Adverse Event|1|||
124827535|NCT01909479|448996898|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
124827536|NCT01909479|448996899|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
124827537|NCT01909479|448996898|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
124827538|NCT01909479|448996899|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
124827539|NCT01909479|448996898|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
124827540|NCT01909479|448996899|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
124827541|NCT01909479|448996898|FG000|52 Weeks to End of Study|Adverse Event|2|||
124827542|NCT01909479|448996899|FG001|52 Weeks to End of Study|Adverse Event|1|||
124827543|NCT01909479|448996898|FG000|52 Weeks to End of Study|Death|0|||
124827544|NCT01909479|448996899|FG001|52 Weeks to End of Study|Death|1|||
124827545|NCT01909479|448996898|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
124827546|NCT01909479|448996899|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
124827547|NCT01909479|448996898|FG000|52 Weeks to End of Study|Protocol Violation|1|||
124827548|NCT01909479|448996899|FG001|52 Weeks to End of Study|Protocol Violation|0|||
124827549|NCT01909479|448996898|FG000|52 Weeks to End of Study|Progressive disease|1|||
124827550|NCT01909479|448996899|FG001|52 Weeks to End of Study|Progressive disease|1|||
124827551|NCT01909479|448996898|FG000|52 Weeks to End of Study|Personal reasons|2|||
124827552|NCT01909479|448996899|FG001|52 Weeks to End of Study|Personal reasons|1|||
124827553|NCT01909479|448996898|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
124827554|NCT01909479|448996899|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
124827555|NCT01909479|448996898|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
124827556|NCT01909479|448996899|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
124827557|NCT01909479|448996898|FG000|52 Weeks to End of Study|Lack of contact|1|||
124827558|NCT01909479|448996899|FG001|52 Weeks to End of Study|Lack of contact|0|||
124827559|NCT01909479|448996898|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
124827560|NCT01909479|448996899|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
124827561|NCT01909479|448996898|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
124827562|NCT01909479|448996899|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
124827563|NCT04446377|448996900|FG000|Overall Study|Withdrawal by Subject|6|||
124827564|NCT04446377|448996901|FG001|Overall Study|Withdrawal by Subject|1|||
124827565|NCT04446377|448996900|FG000|Overall Study|Physician Decision|1|||
124827566|NCT04446377|448996901|FG001|Overall Study|Physician Decision|1|||
124827567|NCT04446377|448996900|FG000|Overall Study|Lost to Follow-up|0|||
124827568|NCT04446377|448996901|FG001|Overall Study|Lost to Follow-up|2|||
124827569|NCT04446377|448996900|FG000|Overall Study|Not eligible|0|||
124827570|NCT04446377|448996901|FG001|Overall Study|Not eligible|1|||
124827571|NCT00737282|448996904|FG000|Overall Study|Study prematurely terminated|175|||
124827572|NCT02810392|448996906|FG000|Overall Study|Subject too ill to continue|1|||
124827573|NCT02810392|448996907|FG001|Overall Study|Subject too ill to continue|0|||
124827574|NCT02810392|448996906|FG000|Overall Study|COVID 19 research restrictions|0|||
124827575|NCT02810392|448996907|FG001|Overall Study|COVID 19 research restrictions|1|||
124827576|NCT00840294|448996908|FG000|Overall Study|Withdrawal by Subject|2|||
124827577|NCT00840294|448996909|FG001|Overall Study|Withdrawal by Subject|1|||
124827578|NCT00840294|448996908|FG000|Overall Study|Protocol Violation|1|||
124827579|NCT00840294|448996909|FG001|Overall Study|Protocol Violation|3|||
124827580|NCT00840294|448996908|FG000|Overall Study|Illness|0|||
124827581|NCT00840294|448996909|FG001|Overall Study|Illness|1|||
124827582|NCT01187043|448996910|FG000|Overall Study|Adverse Event|0|||
124827583|NCT01187043|448996911|FG001|Overall Study|Adverse Event|0|||
124827584|NCT01187043|448996912|FG002|Overall Study|Adverse Event|0|||
124827585|NCT01187043|448996913|FG003|Overall Study|Adverse Event|0|||
124827586|NCT01187043|448996914|FG004|Overall Study|Adverse Event|1|||
124827587|NCT01187043|448996910|FG000|Overall Study|Unable to make scheduled visits|1|||
124827588|NCT01187043|448996911|FG001|Overall Study|Unable to make scheduled visits|0|||
124827589|NCT01187043|448996912|FG002|Overall Study|Unable to make scheduled visits|4|||
124827590|NCT01187043|448996913|FG003|Overall Study|Unable to make scheduled visits|0|||
125303882|NCT04869358|450739598|FG002|Overall Study|Wish to have children.|0|||
125303883|NCT04869358|450739599|FG003|Overall Study|Wish to have children.|0|||
125303884|NCT04164732|450739600|FG000|Treatment run-in Period|Adverse Event|4|||
125303885|NCT04164732|450739601|FG001|Treatment run-in Period|Adverse Event|0|||
125303886|NCT04164732|450739602|FG002|Treatment run-in Period|Adverse Event|0|||
125303887|NCT04164732|450739600|FG000|Treatment run-in Period|Physician Decision|1|||
124827591|NCT01187043|448996914|FG004|Overall Study|Unable to make scheduled visits|1|||
125303888|NCT04164732|450739601|FG001|Treatment run-in Period|Physician Decision|0|||
124827592|NCT02196558|448996915|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
124827593|NCT02196558|448996916|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
124827594|NCT02196558|448996917|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
124827595|NCT02196558|448996915|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
124827596|NCT02196558|448996916|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
124827597|NCT02196558|448996917|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
124827598|NCT02196558|448996915|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
124827599|NCT02196558|448996916|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
124827600|NCT02196558|448996917|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
124827601|NCT02196558|448996915|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
124827602|NCT02196558|448996916|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
124827603|NCT02196558|448996917|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
124827604|NCT02196558|448996915|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
124827605|NCT02196558|448996916|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
124827606|NCT02196558|448996917|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
124827607|NCT04059094|448996921|FG000|Overall Study|Adverse Event|0|||
124827608|NCT04059094|448996922|FG001|Overall Study|Adverse Event|0|||
124827609|NCT04059094|448996923|FG002|Overall Study|Adverse Event|0|||
124827610|NCT04059094|448996924|FG003|Overall Study|Adverse Event|0|||
124827611|NCT04059094|448996925|FG004|Overall Study|Adverse Event|1|||
124827612|NCT04059094|448996921|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
124827613|NCT04059094|448996922|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
124827614|NCT04059094|448996923|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
124827615|NCT04059094|448996924|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
124827616|NCT04059094|448996925|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
124827617|NCT01853826|448998652|FG000|Overall Study|Patients who switched to commercial drug|11|||
124827618|NCT01853826|448998652|FG000|Overall Study|Patient refused to continue medication|21|||
124827619|NCT01853826|448998652|FG000|Overall Study|Lost to Follow-up|2|||
124827620|NCT01853826|448998652|FG000|Overall Study|Non-compliant with protocol|4|||
124827621|NCT01853826|448998652|FG000|Overall Study|Other adverse events (AE)|62|||
124827622|NCT01853826|448998652|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
124827623|NCT01853826|448998652|FG000|Overall Study|Progressive disease|342|||
124827624|NCT01853826|448998652|FG000|Overall Study|Other than listed|13|||
124827625|NCT01853826|448998652|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
124827626|NCT02081690|448998654|FG000|Overall Study|Death|3|||
124827627|NCT02081690|448998654|FG000|Overall Study|Physician Decision|3|||
124827628|NCT02081690|448998654|FG000|Overall Study|Withdrawal by Subject|1|||
124827629|NCT00982488|448998656|FG000|Overall Study|Administrative reason by sponsor|81|||
124827630|NCT00982488|448998657|FG001|Overall Study|Administrative reason by sponsor|3|||
124827631|NCT00982488|448998658|FG002|Overall Study|Administrative reason by sponsor|11|||
124827632|NCT00982488|448998659|FG003|Overall Study|Administrative reason by sponsor|0|||
124827633|NCT00982488|448998660|FG004|Overall Study|Administrative reason by sponsor|0|||
124827634|NCT00982488|448998656|FG000|Overall Study|Adverse event unrelated to study drug|5|||
124827635|NCT00982488|448998657|FG001|Overall Study|Adverse event unrelated to study drug|1|||
124827636|NCT00982488|448998658|FG002|Overall Study|Adverse event unrelated to study drug|0|||
124827637|NCT00982488|448998659|FG003|Overall Study|Adverse event unrelated to study drug|0|||
124827638|NCT00982488|448998660|FG004|Overall Study|Adverse event unrelated to study drug|0|||
124827639|NCT00982488|448998656|FG000|Overall Study|Death|11|||
124827640|NCT00982488|448998657|FG001|Overall Study|Death|0|||
124827641|NCT00982488|448998658|FG002|Overall Study|Death|2|||
124827642|NCT00982488|448998659|FG003|Overall Study|Death|0|||
124827643|NCT00982488|448998660|FG004|Overall Study|Death|0|||
124827644|NCT00982488|448998656|FG000|Overall Study|Disease progression|30|||
124827645|NCT00982488|448998657|FG001|Overall Study|Disease progression|5|||
124827646|NCT00982488|448998658|FG002|Overall Study|Disease progression|10|||
124827647|NCT00982488|448998659|FG003|Overall Study|Disease progression|1|||
124827648|NCT00982488|448998660|FG004|Overall Study|Disease progression|1|||
125303889|NCT04164732|450739602|FG002|Treatment run-in Period|Physician Decision|0|||
125303890|NCT04164732|450739600|FG000|Treatment run-in Period|Screen Failure|1|||
125303891|NCT04164732|450739601|FG001|Treatment run-in Period|Screen Failure|0|||
124827649|NCT00982488|448998656|FG000|Overall Study|Lost to Follow-up|1|||
124827650|NCT00982488|448998657|FG001|Overall Study|Lost to Follow-up|0|||
124827651|NCT00982488|448998658|FG002|Overall Study|Lost to Follow-up|0|||
124827652|NCT00982488|448998659|FG003|Overall Study|Lost to Follow-up|0|||
125303892|NCT04164732|450739602|FG002|Treatment run-in Period|Screen Failure|0|||
125303893|NCT04164732|450739600|FG000|Randomized Treatment Period|Adverse Event|0|||
125303894|NCT04164732|450739601|FG001|Randomized Treatment Period|Adverse Event|1|||
124827653|NCT00982488|448998660|FG004|Overall Study|Lost to Follow-up|0|||
124827654|NCT00982488|448998656|FG000|Overall Study|Maximum clinical benefit|1|||
124827655|NCT00982488|448998657|FG001|Overall Study|Maximum clinical benefit|1|||
124827656|NCT00982488|448998658|FG002|Overall Study|Maximum clinical benefit|1|||
124827657|NCT00982488|448998659|FG003|Overall Study|Maximum clinical benefit|0|||
124827658|NCT00982488|448998660|FG004|Overall Study|Maximum clinical benefit|0|||
124827659|NCT00982488|448998656|FG000|Overall Study|Other|15|||
124827660|NCT00982488|448998657|FG001|Overall Study|Other|1|||
124827661|NCT00982488|448998658|FG002|Overall Study|Other|3|||
124827662|NCT00982488|448998659|FG003|Overall Study|Other|1|||
124827663|NCT00982488|448998660|FG004|Overall Study|Other|0|||
124827664|NCT00982488|448998656|FG000|Overall Study|Poor compliance/noncompliance|0|||
124827665|NCT00982488|448998657|FG001|Overall Study|Poor compliance/noncompliance|1|||
124827666|NCT00982488|448998658|FG002|Overall Study|Poor compliance/noncompliance|0|||
124827667|NCT00982488|448998659|FG003|Overall Study|Poor compliance/noncompliance|0|||
124827668|NCT00982488|448998660|FG004|Overall Study|Poor compliance/noncompliance|0|||
124827669|NCT00982488|448998656|FG000|Overall Study|Stem cell transplant|2|||
124827670|NCT00982488|448998657|FG001|Overall Study|Stem cell transplant|0|||
124827671|NCT00982488|448998658|FG002|Overall Study|Stem cell transplant|0|||
124827672|NCT00982488|448998659|FG003|Overall Study|Stem cell transplant|1|||
124827673|NCT00982488|448998660|FG004|Overall Study|Stem cell transplant|0|||
124827674|NCT00982488|448998656|FG000|Overall Study|Study drug toxicity|34|||
124827675|NCT00982488|448998657|FG001|Overall Study|Study drug toxicity|1|||
124827676|NCT00982488|448998658|FG002|Overall Study|Study drug toxicity|6|||
124827677|NCT00982488|448998659|FG003|Overall Study|Study drug toxicity|0|||
124827678|NCT00982488|448998660|FG004|Overall Study|Study drug toxicity|0|||
124827679|NCT00982488|448998656|FG000|Overall Study|Withdrawal by Subject|5|||
124827680|NCT00982488|448998657|FG001|Overall Study|Withdrawal by Subject|1|||
124827681|NCT00982488|448998658|FG002|Overall Study|Withdrawal by Subject|1|||
124827682|NCT00982488|448998659|FG003|Overall Study|Withdrawal by Subject|0|||
124827683|NCT00982488|448998660|FG004|Overall Study|Withdrawal by Subject|0|||
124827684|NCT03204981|448998661|FG000|Overall Study|Physician Decision|2|||
124827685|NCT03204981|448998661|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
125303895|NCT04164732|450739602|FG002|Randomized Treatment Period|Adverse Event|0|||
125303896|NCT04164732|450739600|FG000|Randomized Treatment Period|Protocol Deviation|0|||
125303897|NCT04164732|450739601|FG001|Randomized Treatment Period|Protocol Deviation|1|||
125303898|NCT04164732|450739602|FG002|Randomized Treatment Period|Protocol Deviation|1|||
125303899|NCT04164732|450739600|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
125303900|NCT04164732|450739601|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
125303901|NCT04164732|450739602|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
125303902|NCT01844778|450739608|FG000|Overall Study|Protocol deviation|0|||
125303903|NCT01844778|450739609|FG001|Overall Study|Protocol deviation|1|||
125303904|NCT01844778|450739610|FG002|Overall Study|Protocol deviation|2|||
125303905|NCT01844778|450739608|FG000|Overall Study|Withdrawal by Subject|2|||
125303906|NCT01844778|450739609|FG001|Overall Study|Withdrawal by Subject|0|||
125303907|NCT01844778|450739610|FG002|Overall Study|Withdrawal by Subject|0|||
125303908|NCT01844778|450739608|FG000|Overall Study|Adverse Event|0|||
125303909|NCT01844778|450739609|FG001|Overall Study|Adverse Event|2|||
125303910|NCT01844778|450739610|FG002|Overall Study|Adverse Event|2|||
125303911|NCT02951429|450739616|FG000|Overall Study|Adverse Event|3|||
125303912|NCT02951429|450739617|FG001|Overall Study|Adverse Event|7|||
125303913|NCT02951429|450739616|FG000|Overall Study|Death|28|||
125303914|NCT02951429|450739617|FG001|Overall Study|Death|36|||
125303915|NCT02951429|450739616|FG000|Overall Study|Lack of Efficacy|0|||
125303916|NCT02951429|450739617|FG001|Overall Study|Lack of Efficacy|1|||
125303917|NCT02951429|450739616|FG000|Overall Study|Lost to Follow-up|0|||
125303918|NCT02951429|450739617|FG001|Overall Study|Lost to Follow-up|1|||
125303919|NCT02951429|450739616|FG000|Overall Study|Lung Transplantation|9|||
125303920|NCT02951429|450739617|FG001|Overall Study|Lung Transplantation|6|||
125303921|NCT02951429|450739616|FG000|Overall Study|Other|1|||
125303922|NCT02951429|450739617|FG001|Overall Study|Other|3|||
125303923|NCT02951429|450739616|FG000|Overall Study|Progressive Disease|1|||
125303924|NCT02951429|450739617|FG001|Overall Study|Progressive Disease|1|||
125303925|NCT02951429|450739616|FG000|Overall Study|Withdrawal by Subject|7|||
125303926|NCT02951429|450739617|FG001|Overall Study|Withdrawal by Subject|11|||
125303927|NCT02951429|450739616|FG000|Overall Study|Participant ongoing in the study|23|||
125303928|NCT02951429|450739617|FG001|Overall Study|Participant ongoing in the study|17|||
125303929|NCT01620528|450739618|FG000|Treatment Period|Did Not Receive Study Drug|0|||
124827686|NCT00397982|448998665|FG000|Overall Study|Withdrawal by Subject|1|||
124827687|NCT00397982|448998665|FG000|Overall Study|Adverse Event|1|||
124827688|NCT00397982|448998665|FG000|Overall Study|noncompliance|1|||
124827689|NCT00397982|448998665|FG000|Overall Study|Unrelated health issues|1|||
124827690|NCT04244786|448998666|FG000|Overall Study|Adverse Event|0|||
124827691|NCT04244786|448998667|FG001|Overall Study|Adverse Event|0|||
124827692|NCT04244786|448998668|FG002|Overall Study|Adverse Event|2|||
124827693|NCT04244786|448998666|FG000|Overall Study|Withdrawal by Subject|0|||
124827694|NCT04244786|448998667|FG001|Overall Study|Withdrawal by Subject|0|||
124827695|NCT04244786|448998668|FG002|Overall Study|Withdrawal by Subject|5|||
125303930|NCT01620528|450739619|FG001|Treatment Period|Did Not Receive Study Drug|0|||
125303931|NCT01620528|450739620|FG002|Treatment Period|Did Not Receive Study Drug|1|||
125303932|NCT01620528|450739618|FG000|Treatment Period|Withdrawal by Subject|35|||
125303933|NCT01620528|450739619|FG001|Treatment Period|Withdrawal by Subject|21|||
124827696|NCT00613938|448998675|FG000|Overall Study|Withdrawal by Subject|2|||
125303934|NCT01620528|450739620|FG002|Treatment Period|Withdrawal by Subject|16|||
124827697|NCT00613938|448998676|FG001|Overall Study|Withdrawal by Subject|4|||
124827698|NCT00613938|448998677|FG002|Overall Study|Withdrawal by Subject|9|||
124827699|NCT00613938|448998678|FG003|Overall Study|Withdrawal by Subject|9|||
124827700|NCT00613938|448998675|FG000|Overall Study|Adverse Event|1|||
124827701|NCT00613938|448998676|FG001|Overall Study|Adverse Event|4|||
124827702|NCT00613938|448998677|FG002|Overall Study|Adverse Event|8|||
124827703|NCT00613938|448998678|FG003|Overall Study|Adverse Event|5|||
124827704|NCT00613938|448998675|FG000|Overall Study|Lack of Efficacy|16|||
124827705|NCT00613938|448998676|FG001|Overall Study|Lack of Efficacy|18|||
124827706|NCT00613938|448998677|FG002|Overall Study|Lack of Efficacy|5|||
124827707|NCT00613938|448998678|FG003|Overall Study|Lack of Efficacy|9|||
124827708|NCT00613938|448998675|FG000|Overall Study|Other|1|||
124827709|NCT00613938|448998676|FG001|Overall Study|Other|2|||
124827710|NCT00613938|448998677|FG002|Overall Study|Other|1|||
124827711|NCT00613938|448998678|FG003|Overall Study|Other|3|||
124827712|NCT02636868|448998679|FG000|Overall Study|Death|0|||
124827713|NCT02636868|448998680|FG001|Overall Study|Death|1|||
124827714|NCT02636868|448998681|FG002|Overall Study|Death|2|||
124827715|NCT03220217|448998682|FG000|Overall Study|Withdrawal by Subject|0|||
124827716|NCT03220217|448998683|FG001|Overall Study|Withdrawal by Subject|1|||
124827717|NCT03220217|448998684|FG002|Overall Study|Withdrawal by Subject|0|||
124827718|NCT03220217|448998682|FG000|Overall Study|Subject Missed Procedure|0|||
124827719|NCT03220217|448998683|FG001|Overall Study|Subject Missed Procedure|0|||
124827720|NCT03220217|448998684|FG002|Overall Study|Subject Missed Procedure|1|||
124827721|NCT03025542|448998685|FG000|Overall Study|Adverse Event|0|||
124827722|NCT03025542|448998686|FG001|Overall Study|Adverse Event|2|||
124827723|NCT03025542|448998685|FG000|Overall Study|Lost to Follow-up|1|||
124827724|NCT03025542|448998686|FG001|Overall Study|Lost to Follow-up|0|||
124827725|NCT03025542|448998685|FG000|Overall Study|Withdrawal by Subject|1|||
124827726|NCT03025542|448998686|FG001|Overall Study|Withdrawal by Subject|0|||
124827727|NCT03745937|448998687|FG000|Overall Study|Withdrawal by Subject|0|||
124827728|NCT03745937|448998688|FG001|Overall Study|Withdrawal by Subject|0|||
124827729|NCT03745937|448998689|FG002|Overall Study|Withdrawal by Subject|0|||
124827730|NCT03745937|448998690|FG003|Overall Study|Withdrawal by Subject|1|||
124827731|NCT03745937|448998687|FG000|Overall Study|Not-specifed|0|||
124827732|NCT03745937|448998688|FG001|Overall Study|Not-specifed|1|||
124827733|NCT03745937|448998689|FG002|Overall Study|Not-specifed|0|||
124827734|NCT03745937|448998690|FG003|Overall Study|Not-specifed|1|||
124827735|NCT05024058|448998692|FG000|Treatment|Study terminated by sponsor|5|||
124827736|NCT05024058|448998693|FG001|Treatment|Study terminated by sponsor|6|||
124827737|NCT05024058|448998694|FG002|Treatment|Study terminated by sponsor|4|||
124827738|NCT05024058|448998695|FG003|Treatment|Study terminated by sponsor|2|||
124827739|NCT05024058|448998696|FG004|Treatment|Study terminated by sponsor|3|||
124827740|NCT05024058|448998697|FG005|Treatment|Study terminated by sponsor|3|||
124827741|NCT05024058|448998698|FG006|Treatment|Study terminated by sponsor|1|||
124827742|NCT05024058|448998699|FG007|Treatment|Study terminated by sponsor|3|||
124827743|NCT05024058|448998700|FG008|Treatment|Study terminated by sponsor|6|||
124827744|NCT05024058|448998701|FG009|Treatment|Study terminated by sponsor|6|||
124827745|NCT05024058|448998692|FG000|Follow-up|Withdrawal by Subject|1|||
124827746|NCT05024058|448998693|FG001|Follow-up|Withdrawal by Subject|0|||
124827747|NCT05024058|448998694|FG002|Follow-up|Withdrawal by Subject|1|||
124827748|NCT05024058|448998695|FG003|Follow-up|Withdrawal by Subject|0|||
124827749|NCT05024058|448998696|FG004|Follow-up|Withdrawal by Subject|0|||
124827750|NCT05024058|448998697|FG005|Follow-up|Withdrawal by Subject|0|||
124827751|NCT05024058|448998698|FG006|Follow-up|Withdrawal by Subject|0|||
124827752|NCT05024058|448998699|FG007|Follow-up|Withdrawal by Subject|1|||
124827753|NCT05024058|448998700|FG008|Follow-up|Withdrawal by Subject|0|||
124827754|NCT05024058|448998701|FG009|Follow-up|Withdrawal by Subject|1|||
124827755|NCT02734810|448998705|FG000|Overall Study|Adverse Event|1|||
124827756|NCT02734810|448998706|FG001|Overall Study|Adverse Event|0|||
124827757|NCT02734810|448998705|FG000|Overall Study|Lack of Efficacy|1|||
124827758|NCT02734810|448998706|FG001|Overall Study|Lack of Efficacy|0|||
124827759|NCT00488345|448998708|FG000|Overall Study|Adverse Event|0|||
124827760|NCT00488345|448998709|FG001|Overall Study|Adverse Event|1|||
124827761|NCT00488345|448998710|FG002|Overall Study|Adverse Event|1|||
124827762|NCT00488345|448998708|FG000|Overall Study|Unable to administer antibiotics at home|0|||
124827763|NCT00488345|448998709|FG001|Overall Study|Unable to administer antibiotics at home|1|||
124827764|NCT00488345|448998710|FG002|Overall Study|Unable to administer antibiotics at home|0|||
124827765|NCT00488345|448998708|FG000|Overall Study|Institutional Review Board review|0|||
124827766|NCT00488345|448998709|FG001|Overall Study|Institutional Review Board review|0|||
124827767|NCT00488345|448998710|FG002|Overall Study|Institutional Review Board review|1|||
124827768|NCT00488345|448998708|FG000|Overall Study|Surgical team recommendation|0|||
124827769|NCT00488345|448998709|FG001|Overall Study|Surgical team recommendation|1|||
124827770|NCT00488345|448998710|FG002|Overall Study|Surgical team recommendation|0|||
124827771|NCT00488345|448998708|FG000|Overall Study|Parent/legal guardian request|0|||
124827772|NCT00488345|448998709|FG001|Overall Study|Parent/legal guardian request|1|||
124827773|NCT00488345|448998710|FG002|Overall Study|Parent/legal guardian request|1|||
124827774|NCT00903617|448998713|FG000|Overall Study|Adverse Event|0|||
124827775|NCT00903617|448998714|FG001|Overall Study|Adverse Event|1|||
124827776|NCT00903617|448998715|FG002|Overall Study|Adverse Event|1|||
124827777|NCT00903617|448998716|FG003|Overall Study|Adverse Event|0|||
124827778|NCT00903617|448998713|FG000|Overall Study|Protocol-defined stopping criteria|0|||
124827779|NCT00903617|448998714|FG001|Overall Study|Protocol-defined stopping criteria|2|||
124827780|NCT00903617|448998715|FG002|Overall Study|Protocol-defined stopping criteria|0|||
124827781|NCT00903617|448998716|FG003|Overall Study|Protocol-defined stopping criteria|0|||
124827782|NCT00903617|448998713|FG000|Overall Study|Lost to Follow-up|2|||
124827783|NCT00903617|448998714|FG001|Overall Study|Lost to Follow-up|0|||
124827784|NCT00903617|448998715|FG002|Overall Study|Lost to Follow-up|1|||
124827785|NCT00903617|448998716|FG003|Overall Study|Lost to Follow-up|1|||
124827786|NCT00903617|448998713|FG000|Overall Study|Withdrawal by Subject|1|||
124827787|NCT00903617|448998714|FG001|Overall Study|Withdrawal by Subject|2|||
124827788|NCT00903617|448998715|FG002|Overall Study|Withdrawal by Subject|3|||
124827789|NCT00903617|448998716|FG003|Overall Study|Withdrawal by Subject|0|||
124827790|NCT00407563|448998717|FG000|Overall Study|Patient continues on treatment|1|||
124827791|NCT03055260|448998718|FG000|Overall Study|Withdrawal by Subject|1|||
124827792|NCT03055260|448998719|FG001|Overall Study|Withdrawal by Subject|0|||
124827793|NCT02507505|448998720|FG000|Overall Study|Withdrawal by Subject|13|||
124827794|NCT02507505|448998721|FG001|Overall Study|Withdrawal by Subject|11|||
124827795|NCT02507505|448998720|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
124827796|NCT02507505|448998721|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
124827797|NCT02507505|448998720|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
124827798|NCT02507505|448998721|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
124827799|NCT02507505|448998720|FG000|Overall Study|Death before receipt of anesthesia|0|||
124827800|NCT02507505|448998721|FG001|Overall Study|Death before receipt of anesthesia|1|||
124827801|NCT03182829|448998722|FG000|Overall Study|Protocol Violation|12|||
124827802|NCT03182829|448998723|FG001|Overall Study|Protocol Violation|12|||
124827803|NCT03182829|448998722|FG000|Overall Study|Other|4|||
124827804|NCT03182829|448998723|FG001|Overall Study|Other|3|||
124827805|NCT00254540|448998724|FG000|Overall Study|Adverse Event|6|||
124827806|NCT00254540|448998725|FG001|Overall Study|Adverse Event|7|||
124827807|NCT00254540|448998724|FG000|Overall Study|Lack of Efficacy|13|||
124827808|NCT00254540|448998725|FG001|Overall Study|Lack of Efficacy|13|||
124827809|NCT00254540|448998724|FG000|Overall Study|Death|0|||
124827810|NCT00254540|448998725|FG001|Overall Study|Death|1|||
124827811|NCT00254540|448998724|FG000|Overall Study|Laboratory Test Abnormality|0|||
124827812|NCT00254540|448998725|FG001|Overall Study|Laboratory Test Abnormality|1|||
124827813|NCT00225251|448998726|FG000|Overall Study|Withdrawal by Subject|1|||
124827814|NCT00225251|448998727|FG001|Overall Study|Withdrawal by Subject|1|||
124827815|NCT03045328|448998728|FG000|Overall Study|Withdrawal by Subject|2|||
124827816|NCT00592839|448998729|FG000|Overall Study|Withdrawal by Subject|1|||
124827817|NCT00592839|448998730|FG001|Overall Study|Withdrawal by Subject|1|||
124827818|NCT00592839|448998731|FG002|Overall Study|Withdrawal by Subject|3|||
124827819|NCT00592839|448998729|FG000|Overall Study|Protocol Violation|1|||
124827820|NCT00592839|448998730|FG001|Overall Study|Protocol Violation|1|||
124827821|NCT00592839|448998731|FG002|Overall Study|Protocol Violation|2|||
124827822|NCT00592839|448998729|FG000|Overall Study|Adverse Event|0|||
124827823|NCT00592839|448998730|FG001|Overall Study|Adverse Event|1|||
124827824|NCT00592839|448998731|FG002|Overall Study|Adverse Event|0|||
124827825|NCT00592839|448998729|FG000|Overall Study|Lost to Follow-up|0|||
124827826|NCT00592839|448998730|FG001|Overall Study|Lost to Follow-up|1|||
124827827|NCT00592839|448998731|FG002|Overall Study|Lost to Follow-up|1|||
124827828|NCT02355691|448998736|FG000|Overall Study|Loss of Research Personnel|7|||
124827829|NCT02355691|448998737|FG001|Overall Study|Loss of Research Personnel|9|||
124827830|NCT00462761|448998738|FG000|Overall Study|Adverse Event|6|||
124827831|NCT00462761|448998738|FG000|Overall Study|Withdrawal by Subject|9|||
124827832|NCT00462761|448998738|FG000|Overall Study|Physician Decision|5|||
124827833|NCT00462761|448998738|FG000|Overall Study|Disease progression|43|||
124827834|NCT00462761|448998738|FG000|Overall Study|Death|12|||
124827835|NCT00462761|448998738|FG000|Overall Study|Other|1|||
124827836|NCT03060447|448998739|FG000|Overall Study|Withdrawal by Subject|2|||
124827837|NCT03060447|448998740|FG001|Overall Study|Withdrawal by Subject|0|||
124827838|NCT03274440|448998744|FG000|Overall Study|Time commitment too great|1|||
124827839|NCT03274440|448998745|FG001|Overall Study|Time commitment too great|0|||
124827840|NCT03274440|448998746|FG002|Overall Study|Time commitment too great|0|||
124827841|NCT03274440|448998747|FG003|Overall Study|Time commitment too great|1|||
124827842|NCT03274440|448998748|FG004|Overall Study|Time commitment too great|0|||
125303935|NCT01620528|450739618|FG000|Treatment Period|Adverse Event|17|||
124827843|NCT03274440|448998749|FG005|Overall Study|Time commitment too great|0|||
124827844|NCT01110707|448998750|FG000|Overall Study|Protocol Violation|0|||
124827845|NCT01110707|448998751|FG001|Overall Study|Protocol Violation|3|||
124827846|NCT02369341|448998752|FG000|Overall Study|Migrated/moved from study area|1|||
124827847|NCT02369341|448998753|FG001|Overall Study|Migrated/moved from study area|0|||
124827848|NCT02710045|448998756|FG000|Overall Study|Death|1|||
124827849|NCT02710045|448998757|FG001|Overall Study|Death|2|||
124827850|NCT02710045|448998758|FG002|Overall Study|Death|0|||
124827851|NCT02710045|448998756|FG000|Overall Study|Withdrawal by Subject|6|||
124827852|NCT02710045|448998757|FG001|Overall Study|Withdrawal by Subject|6|||
124827853|NCT02710045|448998758|FG002|Overall Study|Withdrawal by Subject|2|||
124827854|NCT02710045|448998756|FG000|Overall Study|Protocol Violation|1|||
124827855|NCT02710045|448998757|FG001|Overall Study|Protocol Violation|2|||
124827856|NCT02710045|448998758|FG002|Overall Study|Protocol Violation|3|||
124827857|NCT02710045|448998756|FG000|Overall Study|Lost to Follow-up|3|||
124827858|NCT02710045|448998757|FG001|Overall Study|Lost to Follow-up|6|||
124827859|NCT02710045|448998758|FG002|Overall Study|Lost to Follow-up|7|||
124827860|NCT02710045|448998756|FG000|Overall Study|Physician Decision|0|||
124827861|NCT02710045|448998757|FG001|Overall Study|Physician Decision|0|||
124827862|NCT02710045|448998758|FG002|Overall Study|Physician Decision|1|||
124827863|NCT02710045|448998756|FG000|Overall Study|Poor Attendance|0|||
124827864|NCT02710045|448998757|FG001|Overall Study|Poor Attendance|1|||
124827865|NCT02710045|448998758|FG002|Overall Study|Poor Attendance|0|||
124827866|NCT03178773|448998759|FG000|Overall Study|Death|0|||
124827867|NCT03178773|448998760|FG001|Overall Study|Death|1|||
124827868|NCT03178773|448998759|FG000|Overall Study|Lost to Follow-up|29|||
124827869|NCT03178773|448998760|FG001|Overall Study|Lost to Follow-up|25|||
124827870|NCT03178773|448998759|FG000|Overall Study|Withdrawal by Subject|10|||
124827871|NCT03178773|448998760|FG001|Overall Study|Withdrawal by Subject|14|||
124827872|NCT01928329|448998765|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
124827873|NCT01928329|448998766|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
124827874|NCT01928329|448998765|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
124827875|NCT01928329|448998766|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
124827876|NCT01928329|448998765|FG000|Overall Study|Adverse Event|5|||
124827877|NCT01928329|448998766|FG001|Overall Study|Adverse Event|3|||
124827878|NCT01928329|448998765|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
124827879|NCT01928329|448998766|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
124827880|NCT01928329|448998765|FG000|Overall Study|Withdrawal by Subject|1|||
124827881|NCT01928329|448998766|FG001|Overall Study|Withdrawal by Subject|5|||
124827882|NCT01928329|448998765|FG000|Overall Study|Physician Decision|1|||
124827883|NCT01928329|448998766|FG001|Overall Study|Physician Decision|1|||
124827884|NCT03187262|448998767|FG000|Induction|Lack of Efficacy|2|||
124827885|NCT03187262|448998767|FG000|Induction|Progressive Disease|4|||
124827886|NCT03187262|448998767|FG000|Consolidation|Progressive Disease|5|||
124827887|NCT02604212|448998770|FG000|Overall Study|Study Terminated by Sponsor|2|||
124827888|NCT02604212|448998771|FG001|Overall Study|Study Terminated by Sponsor|1|||
124827889|NCT02604212|448998772|FG002|Overall Study|Study Terminated by Sponsor|3|||
124827890|NCT02604212|448998773|FG003|Overall Study|Study Terminated by Sponsor|3|||
124827891|NCT02604212|448998770|FG000|Overall Study|Withdrawal by Subject|0|||
124827892|NCT02604212|448998771|FG001|Overall Study|Withdrawal by Subject|0|||
124827893|NCT02604212|448998772|FG002|Overall Study|Withdrawal by Subject|1|||
124827894|NCT02604212|448998773|FG003|Overall Study|Withdrawal by Subject|0|||
124827895|NCT00451321|448998774|FG000|Overall Study|Lost to Follow-up|3|||
124827896|NCT00451321|448998775|FG001|Overall Study|Lost to Follow-up|3|||
124827897|NCT00451321|448998776|FG002|Overall Study|Lost to Follow-up|1|||
124827898|NCT00451321|448998777|FG003|Overall Study|Lost to Follow-up|3|||
124827899|NCT00451321|448998778|FG004|Overall Study|Lost to Follow-up|0|||
124827900|NCT00451321|448998779|FG005|Overall Study|Lost to Follow-up|1|||
124827901|NCT00451321|448998780|FG006|Overall Study|Lost to Follow-up|0|||
124827902|NCT00451321|448998781|FG007|Overall Study|Lost to Follow-up|0|||
124827903|NCT00451321|448998774|FG000|Overall Study|Withdrawal by Subject|3|||
124827904|NCT00451321|448998775|FG001|Overall Study|Withdrawal by Subject|1|||
124827905|NCT00451321|448998776|FG002|Overall Study|Withdrawal by Subject|0|||
124827906|NCT00451321|448998777|FG003|Overall Study|Withdrawal by Subject|4|||
124827907|NCT00451321|448998778|FG004|Overall Study|Withdrawal by Subject|0|||
124827908|NCT00451321|448998779|FG005|Overall Study|Withdrawal by Subject|0|||
124827909|NCT00451321|448998780|FG006|Overall Study|Withdrawal by Subject|0|||
124827910|NCT00451321|448998781|FG007|Overall Study|Withdrawal by Subject|0|||
125303936|NCT01620528|450739619|FG001|Treatment Period|Adverse Event|13|||
124827911|NCT00451321|448998774|FG000|Overall Study|Study closed/terminated|1|||
124827912|NCT00451321|448998775|FG001|Overall Study|Study closed/terminated|1|||
124827913|NCT00451321|448998776|FG002|Overall Study|Study closed/terminated|17|||
124827914|NCT00451321|448998777|FG003|Overall Study|Study closed/terminated|5|||
124827915|NCT00451321|448998778|FG004|Overall Study|Study closed/terminated|7|||
124827916|NCT00451321|448998779|FG005|Overall Study|Study closed/terminated|7|||
125303937|NCT01620528|450739620|FG002|Treatment Period|Adverse Event|21|||
125303938|NCT01620528|450739618|FG000|Treatment Period|Lost to Follow-up|16|||
125303939|NCT01620528|450739619|FG001|Treatment Period|Lost to Follow-up|8|||
124827917|NCT00451321|448998780|FG006|Overall Study|Study closed/terminated|5|||
124827918|NCT00451321|448998781|FG007|Overall Study|Study closed/terminated|3|||
124827919|NCT00451321|448998774|FG000|Overall Study|Sponsor decision to amend protocol|0|||
124827920|NCT00451321|448998775|FG001|Overall Study|Sponsor decision to amend protocol|0|||
124827921|NCT00451321|448998776|FG002|Overall Study|Sponsor decision to amend protocol|0|||
125303940|NCT01620528|450739620|FG002|Treatment Period|Lost to Follow-up|14|||
124827922|NCT00451321|448998777|FG003|Overall Study|Sponsor decision to amend protocol|0|||
124827923|NCT00451321|448998778|FG004|Overall Study|Sponsor decision to amend protocol|0|||
124827924|NCT00451321|448998779|FG005|Overall Study|Sponsor decision to amend protocol|1|||
124827925|NCT00451321|448998780|FG006|Overall Study|Sponsor decision to amend protocol|1|||
124827926|NCT00451321|448998781|FG007|Overall Study|Sponsor decision to amend protocol|3|||
124827927|NCT01119131|448998784|FG000|Overall Study|Adverse Event|1|||
124827928|NCT01119131|448998785|FG001|Overall Study|Adverse Event|1|||
124827929|NCT01119131|448998786|FG002|Overall Study|Adverse Event|1|||
124827930|NCT01119131|448998784|FG000|Overall Study|Non-Compliance|1|||
124827931|NCT01119131|448998785|FG001|Overall Study|Non-Compliance|0|||
124827932|NCT01119131|448998786|FG002|Overall Study|Non-Compliance|4|||
124827933|NCT01119131|448998784|FG000|Overall Study|Physician Decision|0|||
124827934|NCT01119131|448998785|FG001|Overall Study|Physician Decision|0|||
124827935|NCT01119131|448998786|FG002|Overall Study|Physician Decision|1|||
124827936|NCT00909389|448998789|FG000|Overall Study|Adverse Event|6|||
124827937|NCT00909389|448998789|FG000|Overall Study|Death|4|||
124827938|NCT00909389|448998789|FG000|Overall Study|Poor Compliance|16|||
124827939|NCT00909389|448998789|FG000|Overall Study|Lost to Follow-up|4|||
124827940|NCT00909389|448998789|FG000|Overall Study|No Information|103|||
124827941|NCT00003492|448998790|FG000|Overall Study|Not evaluable|6|||
124827942|NCT00597766|448998793|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
124827943|NCT00597766|448998794|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
124827944|NCT00597766|448998795|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
124827945|NCT00597766|448998793|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
124827946|NCT00597766|448998794|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
124827947|NCT00597766|448998795|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
124827948|NCT00847704|448998798|FG000|Overall Study|Withdrawal by Subject|1|||
124827949|NCT03036072|448998801|FG000|Overall Study|Death|0|||
124827950|NCT03036072|448998802|FG001|Overall Study|Death|1|||
124827951|NCT03036072|448998801|FG000|Overall Study|Withdrawal by Subject|0|||
124827952|NCT03036072|448998802|FG001|Overall Study|Withdrawal by Subject|1|||
124827953|NCT03036072|448998801|FG000|Overall Study|Physician Decision|0|||
124827954|NCT03036072|448998802|FG001|Overall Study|Physician Decision|1|||
124827955|NCT02111850|448998803|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
124827956|NCT02111850|448998804|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
124827957|NCT02111850|448998805|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
124827958|NCT02111850|448998806|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
124827959|NCT02111850|448998807|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
124827960|NCT02111850|448998808|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
124827961|NCT02111850|448998809|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
124827962|NCT02111850|448998810|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
124827963|NCT02111850|448998811|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
124827964|NCT02111850|448998812|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
124827965|NCT02111850|448998813|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
124827966|NCT00513474|448998814|FG000|Overall Study|Death|6|||
124827967|NCT00513474|448998815|FG001|Overall Study|Death|9|||
124827968|NCT00513474|448998814|FG000|Overall Study|Participant Withdrew Consent|1|||
124827969|NCT00513474|448998815|FG001|Overall Study|Participant Withdrew Consent|0|||
124827970|NCT00605813|449000825|FG000|Overall Study|Protocol Violation|25|||
124827971|NCT00573755|449000826|FG000|Overall Study|Still receiving treatment|1|||
124827972|NCT00573755|449000827|FG001|Overall Study|Still receiving treatment|0|||
124827973|NCT02132767|449000830|FG000|Overall Study|Death|3|||
124827974|NCT02132767|449000831|FG001|Overall Study|Death|2|||
124827975|NCT02132767|449000830|FG000|Overall Study|Withdrawal by Subject|10|||
124827976|NCT02132767|449000831|FG001|Overall Study|Withdrawal by Subject|9|||
124827977|NCT02132767|449000830|FG000|Overall Study|Lost to Follow-up|4|||
124827978|NCT02132767|449000831|FG001|Overall Study|Lost to Follow-up|4|||
124827979|NCT00778700|449000834|FG000|Overall Study|Adverse Event|6|||
124827980|NCT00778700|449000835|FG001|Overall Study|Adverse Event|1|||
124827981|NCT00778700|449000836|FG002|Overall Study|Adverse Event|3|||
124827982|NCT00778700|449000837|FG003|Overall Study|Adverse Event|5|||
124827983|NCT00778700|449000834|FG000|Overall Study|Protocol Violation|1|||
124827984|NCT00778700|449000835|FG001|Overall Study|Protocol Violation|1|||
124827985|NCT00778700|449000836|FG002|Overall Study|Protocol Violation|0|||
124827986|NCT00778700|449000837|FG003|Overall Study|Protocol Violation|0|||
124827987|NCT00778700|449000834|FG000|Overall Study|Subject Withdrew Consent|6|||
124827988|NCT00778700|449000835|FG001|Overall Study|Subject Withdrew Consent|4|||
124827989|NCT00778700|449000836|FG002|Overall Study|Subject Withdrew Consent|1|||
124827990|NCT00778700|449000837|FG003|Overall Study|Subject Withdrew Consent|4|||
124827991|NCT00778700|449000834|FG000|Overall Study|Lost to Follow-up|3|||
124827992|NCT00778700|449000835|FG001|Overall Study|Lost to Follow-up|1|||
124827993|NCT00778700|449000836|FG002|Overall Study|Lost to Follow-up|0|||
124827994|NCT00778700|449000837|FG003|Overall Study|Lost to Follow-up|1|||
124827995|NCT00778700|449000834|FG000|Overall Study|Reason not Specified|2|||
124827996|NCT00778700|449000835|FG001|Overall Study|Reason not Specified|0|||
124827997|NCT00778700|449000836|FG002|Overall Study|Reason not Specified|1|||
124827998|NCT00778700|449000837|FG003|Overall Study|Reason not Specified|3|||
124827999|NCT00778700|449000834|FG000|Overall Study|Other|0|||
124828000|NCT00778700|449000835|FG001|Overall Study|Other|0|||
124828001|NCT00778700|449000836|FG002|Overall Study|Other|1|||
124828002|NCT00778700|449000837|FG003|Overall Study|Other|0|||
124828003|NCT00383149|449000851|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
124828004|NCT00383149|449000851|FG000|Overall Study|Death|2|||
124828005|NCT00383149|449000851|FG000|Overall Study|Disease Progression|38|||
124828006|NCT00383149|449000851|FG000|Overall Study|Lost to Follow-up|1|||
124828007|NCT00383149|449000851|FG000|Overall Study|Other|1|||
124828008|NCT00383149|449000851|FG000|Overall Study|Study Drug Toxicity|4|||
124828009|NCT00383149|449000851|FG000|Overall Study|Request to Discontinue Treatment|4|||
124828010|NCT00383149|449000851|FG000|Overall Study|Participant Withdrew Consent|1|||
124828011|NCT00453544|449000852|FG000|Overall Study|Withdrawal by Subject|1|||
124828012|NCT00453544|449000853|FG001|Overall Study|Withdrawal by Subject|0|||
124828013|NCT00453544|449000854|FG002|Overall Study|Withdrawal by Subject|0|||
124828014|NCT00453544|449000855|FG003|Overall Study|Withdrawal by Subject|0|||
124828015|NCT00453544|449000852|FG000|Overall Study|Primary outcome measure not completed|1|||
124828016|NCT00453544|449000853|FG001|Overall Study|Primary outcome measure not completed|1|||
124828017|NCT00453544|449000854|FG002|Overall Study|Primary outcome measure not completed|0|||
124828018|NCT00453544|449000855|FG003|Overall Study|Primary outcome measure not completed|1|||
124828019|NCT02457910|449000856|FG000|Overall Study|Withdrawal by Subject|0|||
124828020|NCT02457910|449000857|FG001|Overall Study|Withdrawal by Subject|0|||
124828021|NCT02457910|449000858|FG002|Overall Study|Withdrawal by Subject|0|||
124828022|NCT02457910|449000859|FG003|Overall Study|Withdrawal by Subject|0|||
124828023|NCT02457910|449000860|FG004|Overall Study|Withdrawal by Subject|0|||
124828024|NCT02457910|449000861|FG005|Overall Study|Withdrawal by Subject|1|||
124828025|NCT02457910|449000856|FG000|Overall Study|Adverse Event|0|||
124828026|NCT02457910|449000857|FG001|Overall Study|Adverse Event|2|||
124828027|NCT02457910|449000858|FG002|Overall Study|Adverse Event|1|||
124828028|NCT02457910|449000859|FG003|Overall Study|Adverse Event|1|||
124828029|NCT02457910|449000860|FG004|Overall Study|Adverse Event|1|||
124828030|NCT02457910|449000861|FG005|Overall Study|Adverse Event|3|||
124828031|NCT02457910|449000856|FG000|Overall Study|Disease progression|3|||
124828032|NCT02457910|449000857|FG001|Overall Study|Disease progression|3|||
124828033|NCT02457910|449000858|FG002|Overall Study|Disease progression|1|||
124828034|NCT02457910|449000859|FG003|Overall Study|Disease progression|1|||
124828035|NCT02457910|449000860|FG004|Overall Study|Disease progression|4|||
124828036|NCT02457910|449000861|FG005|Overall Study|Disease progression|6|||
124828037|NCT02457910|449000856|FG000|Overall Study|Other complicating illness|0|||
124828038|NCT02457910|449000857|FG001|Overall Study|Other complicating illness|0|||
124828039|NCT02457910|449000858|FG002|Overall Study|Other complicating illness|0|||
124828040|NCT02457910|449000859|FG003|Overall Study|Other complicating illness|0|||
124828041|NCT02457910|449000860|FG004|Overall Study|Other complicating illness|0|||
124828042|NCT02457910|449000861|FG005|Overall Study|Other complicating illness|1|||
124828043|NCT02457910|449000856|FG000|Overall Study|Death|0|||
124828044|NCT02457910|449000857|FG001|Overall Study|Death|0|||
124828045|NCT02457910|449000858|FG002|Overall Study|Death|1|||
124828046|NCT02457910|449000859|FG003|Overall Study|Death|0|||
124828047|NCT02457910|449000860|FG004|Overall Study|Death|0|||
124828048|NCT02457910|449000861|FG005|Overall Study|Death|0|||
124828049|NCT03721276|449000864|FG000|Overall Study|Lost to Follow-up|5|||
124828050|NCT03721276|449000865|FG001|Overall Study|Lost to Follow-up|3|||
124828051|NCT03721276|449000864|FG000|Overall Study|Adverse Event|0|||
124828052|NCT03721276|449000865|FG001|Overall Study|Adverse Event|1|||
124828053|NCT00450333|449000866|FG000|Overall Study|Study terminated|47|||
125303941|NCT01620528|450739618|FG000|Treatment Period|Other|9|||
125303942|NCT01620528|450739619|FG001|Treatment Period|Other|5|||
125303943|NCT01620528|450739620|FG002|Treatment Period|Other|7|||
125303944|NCT01620528|450739618|FG000|Treatment Period|Subject Noncompliant|11|||
125303945|NCT01620528|450739619|FG001|Treatment Period|Subject Noncompliant|2|||
125303946|NCT01620528|450739620|FG002|Treatment Period|Subject Noncompliant|2|||
125303947|NCT01620528|450739618|FG000|Treatment Period|Pregnancy|7|||
125303948|NCT01620528|450739619|FG001|Treatment Period|Pregnancy|2|||
125303949|NCT01620528|450739620|FG002|Treatment Period|Pregnancy|2|||
124828054|NCT00450333|449000867|FG001|Overall Study|Study terminated|54|||
124828055|NCT00450333|449000868|FG002|Overall Study|Study terminated|16|||
124828056|NCT00450333|449000869|FG003|Overall Study|Study terminated|21|||
124828057|NCT00450333|449000866|FG000|Overall Study|Adverse Event|1|||
124828058|NCT00450333|449000867|FG001|Overall Study|Adverse Event|7|||
124828059|NCT00450333|449000868|FG002|Overall Study|Adverse Event|2|||
124828060|NCT00450333|449000869|FG003|Overall Study|Adverse Event|2|||
124828061|NCT00450333|449000866|FG000|Overall Study|Protocol Violation|1|||
124828062|NCT00450333|449000867|FG001|Overall Study|Protocol Violation|0|||
124828063|NCT00450333|449000868|FG002|Overall Study|Protocol Violation|1|||
125303950|NCT01620528|450739618|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
125303951|NCT01620528|450739619|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
124828064|NCT00450333|449000869|FG003|Overall Study|Protocol Violation|0|||
124828065|NCT00450333|449000866|FG000|Overall Study|Withdrawal by Subject|1|||
124828066|NCT00450333|449000867|FG001|Overall Study|Withdrawal by Subject|0|||
124828067|NCT00450333|449000868|FG002|Overall Study|Withdrawal by Subject|3|||
124828068|NCT00450333|449000869|FG003|Overall Study|Withdrawal by Subject|0|||
124828069|NCT00450333|449000866|FG000|Overall Study|Kidney transplant|1|||
124828070|NCT00450333|449000867|FG001|Overall Study|Kidney transplant|0|||
124828071|NCT00450333|449000868|FG002|Overall Study|Kidney transplant|1|||
124828072|NCT00450333|449000869|FG003|Overall Study|Kidney transplant|3|||
124828073|NCT00450333|449000866|FG000|Overall Study|Death|3|||
124828074|NCT00450333|449000867|FG001|Overall Study|Death|2|||
124828075|NCT00450333|449000868|FG002|Overall Study|Death|2|||
124828076|NCT00450333|449000869|FG003|Overall Study|Death|2|||
124828077|NCT02375113|449000872|FG000|Overall Study|Undisclosed Reason(s).|1|||
124828078|NCT02375113|449000873|FG001|Overall Study|Undisclosed Reason(s).|1|||
124828079|NCT02375113|449000872|FG000|Overall Study|Poor adherence (<70%).|1|||
124828080|NCT02375113|449000873|FG001|Overall Study|Poor adherence (<70%).|0|||
124828081|NCT02375113|449000872|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
124828082|NCT02375113|449000873|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
124828083|NCT00416078|449000886|FG000|Overall Study|Death|3|||
124828084|NCT00416078|449000887|FG001|Overall Study|Death|4|||
124828085|NCT00416078|449000886|FG000|Overall Study|Withdrawal by Subject|3|||
124828086|NCT00416078|449000887|FG001|Overall Study|Withdrawal by Subject|2|||
124828087|NCT00416078|449000886|FG000|Overall Study|Physician Decision|1|||
124828088|NCT00416078|449000887|FG001|Overall Study|Physician Decision|0|||
124828089|NCT00416078|449000886|FG000|Overall Study|Lost to Follow-up|4|||
124828090|NCT00416078|449000887|FG001|Overall Study|Lost to Follow-up|2|||
124828091|NCT01829230|449000892|FG000|Overall Study|Protocol Violation|0|||
124828092|NCT01829230|449000893|FG001|Overall Study|Protocol Violation|2|||
124828093|NCT01829230|449000892|FG000|Overall Study|Withdrawal by Subject|0|||
124828094|NCT01829230|449000893|FG001|Overall Study|Withdrawal by Subject|1|||
124828095|NCT01829230|449000892|FG000|Overall Study|Lost to Follow-up|1|||
125303952|NCT01620528|450739620|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
125303953|NCT01620528|450739618|FG000|Treatment Period|Exclusionary Medication Received|0|||
125303954|NCT01620528|450739619|FG001|Treatment Period|Exclusionary Medication Received|1|||
125303955|NCT01620528|450739620|FG002|Treatment Period|Exclusionary Medication Received|0|||
125303956|NCT01620528|450739618|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
125303957|NCT01620528|450739619|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
125303958|NCT01620528|450739620|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
125303959|NCT01620528|450739618|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
125303960|NCT01620528|450739619|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
125303961|NCT01620528|450739620|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
125303962|NCT01620528|450739618|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
125303963|NCT01620528|450739619|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
125303964|NCT01620528|450739620|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
125303965|NCT01620528|450739618|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
125303966|NCT01620528|450739619|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
125303967|NCT01620528|450739620|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
125303968|NCT01620528|450739618|FG000|Post-Treatment Follow-Up Period|Other|6|||
125303969|NCT01620528|450739619|FG001|Post-Treatment Follow-Up Period|Other|4|||
125303970|NCT01620528|450739620|FG002|Post-Treatment Follow-Up Period|Other|2|||
125303971|NCT01457846|450739621|FG000|Overall Study|Death before treatment|1|||
125303972|NCT01457846|450739622|FG001|Overall Study|Death before treatment|2|||
125303973|NCT01457846|450739621|FG000|Overall Study|Did not receive treatment|0|||
125303974|NCT01457846|450739622|FG001|Overall Study|Did not receive treatment|1|||
125303975|NCT01457846|450739621|FG000|Overall Study|Death|27|||
125303976|NCT01457846|450739622|FG001|Overall Study|Death|16|||
125303977|NCT01457846|450739621|FG000|Overall Study|Unclassified reason for not completed|11|||
125303978|NCT01457846|450739622|FG001|Overall Study|Unclassified reason for not completed|10|||
125303979|NCT01457846|450739621|FG000|Overall Study|Withdrawal by Subject|1|||
125303980|NCT01457846|450739622|FG001|Overall Study|Withdrawal by Subject|1|||
125303981|NCT01457846|450739621|FG000|Overall Study|Lost to Follow-up|1|||
125303982|NCT01457846|450739622|FG001|Overall Study|Lost to Follow-up|0|||
125303983|NCT01743040|450739623|FG000|Overall Study|Death|1|||
125303984|NCT01743040|450739623|FG000|Overall Study|Lost to Follow-up|66|||
125303985|NCT01743040|450739623|FG000|Overall Study|Physician Decision|40|||
125303986|NCT01743040|450739623|FG000|Overall Study|Protocol Violation|1|||
125303987|NCT01743040|450739623|FG000|Overall Study|Withdrawal by Subject|121|||
125303988|NCT02974842|450739624|FG000|Overall Study|Withdrawal by Subject|4|||
125303989|NCT02974842|450739624|FG000|Overall Study|Screen failures|4|||
125303990|NCT03824587|450739625|FG000|Run-in Period|Screen Failure|0|||
125303991|NCT03824587|450739626|FG001|Run-in Period|Screen Failure|275|||
124828096|NCT01829230|449000893|FG001|Overall Study|Lost to Follow-up|1|||
124828097|NCT04387435|449000897|FG000|Overall Study|Physician Decision|1|||
124828098|NCT03855280|449000898|FG000|Treatment Phase|Adverse Event|1|||
124828099|NCT03855280|449000898|FG000|Treatment Phase|Withdrawal by Subject|1|||
124828100|NCT03855280|449000898|FG000|Continuation Phase|Protocol Violation|1|||
124828101|NCT03855280|449000898|FG000|Continuation Phase|Adverse Event|1|||
124828102|NCT03855280|449000898|FG000|Continuation Phase|Sponsor Concluded Study|1|||
124828103|NCT00969150|449000903|FG000|Overall Study|Adverse Event|4|||
124828104|NCT00969150|449000904|FG001|Overall Study|Adverse Event|14|||
124828105|NCT00969150|449000903|FG000|Overall Study|Lack of Efficacy|1|||
124828106|NCT00969150|449000904|FG001|Overall Study|Lack of Efficacy|1|||
124828107|NCT00969150|449000903|FG000|Overall Study|Protocol Violation|9|||
124828108|NCT00969150|449000904|FG001|Overall Study|Protocol Violation|12|||
124828109|NCT00969150|449000903|FG000|Overall Study|Withdrawal by Subject|13|||
124828110|NCT00969150|449000904|FG001|Overall Study|Withdrawal by Subject|9|||
124828111|NCT00969150|449000903|FG000|Overall Study|Lost to Follow-up|5|||
124828112|NCT00969150|449000904|FG001|Overall Study|Lost to Follow-up|4|||
124828113|NCT00969150|449000903|FG000|Overall Study|Other reasons|1|||
124828114|NCT00969150|449000904|FG001|Overall Study|Other reasons|0|||
124828115|NCT00461682|449000908|FG000|Overall Study|Protocol Violation|1|||
124828116|NCT00883116|449000911|FG000|Overall Study|Adverse event unrelated to study drug|5|||
124828117|NCT00883116|449000912|FG001|Overall Study|Adverse event unrelated to study drug|10|||
124828118|NCT00883116|449000911|FG000|Overall Study|Death|6|||
124828119|NCT00883116|449000912|FG001|Overall Study|Death|2|||
124828120|NCT00883116|449000911|FG000|Overall Study|Disease progression|130|||
124828121|NCT00883116|449000912|FG001|Overall Study|Disease progression|128|||
124828122|NCT00883116|449000911|FG000|Overall Study|Lost to Follow-up|0|||
124828123|NCT00883116|449000912|FG001|Overall Study|Lost to Follow-up|1|||
124828124|NCT00883116|449000911|FG000|Overall Study|Maximum clinical benefit|13|||
124828125|NCT00883116|449000912|FG001|Overall Study|Maximum clinical benefit|46|||
124828126|NCT00883116|449000911|FG000|Overall Study|Not identified|3|||
124828127|NCT00883116|449000912|FG001|Overall Study|Not identified|6|||
124828128|NCT00883116|449000911|FG000|Overall Study|Study drug toxicity|36|||
124828129|NCT00883116|449000912|FG001|Overall Study|Study drug toxicity|16|||
124828130|NCT00883116|449000911|FG000|Overall Study|Withdrawal by Subject|14|||
124828131|NCT00883116|449000912|FG001|Overall Study|Withdrawal by Subject|8|||
124828132|NCT00883116|449000911|FG000|Overall Study|No longer meets study criteria|2|||
124828133|NCT00883116|449000912|FG001|Overall Study|No longer meets study criteria|2|||
124828134|NCT01361464|449000913|FG000|Overall Study|Death|1|||
124828135|NCT01361464|449000913|FG000|Overall Study|Withdrawal by Subject|2|||
124828136|NCT04128267|449000922|FG000|Overall Study|Withdrawal by Subject|6|||
124828137|NCT04128267|449000922|FG000|Overall Study|Death|2|||
124828138|NCT04128267|449000922|FG000|Overall Study|Disease progression|1|||
124828139|NCT04128267|449000922|FG000|Overall Study|Participant had other medical issues|4|||
124828140|NCT04128267|449000922|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
124828141|NCT04501666|449000923|FG000|Overall Study|Physician Decision|0|||
124828142|NCT04501666|449000924|FG001|Overall Study|Physician Decision|1|||
124828143|NCT04501666|449000923|FG000|Overall Study|Adverse Event|12|||
124828144|NCT04501666|449000924|FG001|Overall Study|Adverse Event|4|||
124828145|NCT04501666|449000923|FG000|Overall Study|Subject's request|10|||
124828146|NCT04501666|449000924|FG001|Overall Study|Subject's request|6|||
124828147|NCT04501666|449000923|FG000|Overall Study|Protocol Deviation|2|||
124828148|NCT04501666|449000924|FG001|Overall Study|Protocol Deviation|1|||
124828149|NCT04501666|449000923|FG000|Overall Study|Other-- site permanently closing|0|||
124828150|NCT04501666|449000924|FG001|Overall Study|Other-- site permanently closing|1|||
124828151|NCT03021265|449000925|FG000|Overall Study|Adverse Event|29|||
124828152|NCT03021265|449000925|FG000|Overall Study|Lack of Efficacy|3|||
124828153|NCT03021265|449000925|FG000|Overall Study|Improved|17|||
124828154|NCT03021265|449000925|FG000|Overall Study|Lost to Follow-up|67|||
124828155|NCT03021265|449000925|FG000|Overall Study|No reason given|2|||
124828156|NCT03021265|449000925|FG000|Overall Study|No visit since the first visit|4|||
124828157|NCT01722071|449000926|FG000|Overall Study|Protocol Violation|1|||
124828158|NCT01722071|449000927|FG001|Overall Study|Protocol Violation|0|||
124828159|NCT00642941|449000928|FG000|Overall Study|Physician Decision|3|||
124828160|NCT00642941|449000929|FG001|Overall Study|Physician Decision|1|||
124828161|NCT00642941|449000930|FG002|Overall Study|Physician Decision|0|||
124828162|NCT00642941|449000931|FG003|Overall Study|Physician Decision|0|||
124828163|NCT00642941|449000932|FG004|Overall Study|Physician Decision|0|||
124828164|NCT00642941|449000933|FG005|Overall Study|Physician Decision|0|||
124828165|NCT00642941|449000934|FG006|Overall Study|Physician Decision|1|||
124828166|NCT00642941|449000935|FG007|Overall Study|Physician Decision|0|||
124828167|NCT00642941|449000936|FG008|Overall Study|Physician Decision|0|||
124828168|NCT00642941|449000937|FG009|Overall Study|Physician Decision|1|||
124828169|NCT00642941|449000938|FG010|Overall Study|Physician Decision|0|||
124828170|NCT00642941|449000939|FG011|Overall Study|Physician Decision|1|||
124828171|NCT00642941|449000928|FG000|Overall Study|Death|4|||
124828172|NCT00642941|449000929|FG001|Overall Study|Death|0|||
124828173|NCT00642941|449000930|FG002|Overall Study|Death|1|||
124828174|NCT00642941|449000931|FG003|Overall Study|Death|1|||
124828175|NCT00642941|449000932|FG004|Overall Study|Death|2|||
124828176|NCT00642941|449000933|FG005|Overall Study|Death|1|||
124828177|NCT00642941|449000934|FG006|Overall Study|Death|0|||
124828178|NCT00642941|449000935|FG007|Overall Study|Death|0|||
124828179|NCT00642941|449000936|FG008|Overall Study|Death|0|||
124828180|NCT00642941|449000937|FG009|Overall Study|Death|0|||
124828181|NCT00642941|449000938|FG010|Overall Study|Death|0|||
124828182|NCT00642941|449000939|FG011|Overall Study|Death|1|||
124828183|NCT00642941|449000928|FG000|Overall Study|Study closed by Sponsor|0|||
124828184|NCT00642941|449000929|FG001|Overall Study|Study closed by Sponsor|1|||
124828185|NCT00642941|449000930|FG002|Overall Study|Study closed by Sponsor|0|||
124828186|NCT00642941|449000931|FG003|Overall Study|Study closed by Sponsor|0|||
124828187|NCT00642941|449000932|FG004|Overall Study|Study closed by Sponsor|0|||
124828188|NCT00642941|449000933|FG005|Overall Study|Study closed by Sponsor|0|||
124828189|NCT00642941|449000934|FG006|Overall Study|Study closed by Sponsor|0|||
124828190|NCT00642941|449000935|FG007|Overall Study|Study closed by Sponsor|0|||
124828191|NCT00642941|449000936|FG008|Overall Study|Study closed by Sponsor|0|||
124828192|NCT00642941|449000937|FG009|Overall Study|Study closed by Sponsor|0|||
124828193|NCT00642941|449000938|FG010|Overall Study|Study closed by Sponsor|0|||
124828194|NCT00642941|449000939|FG011|Overall Study|Study closed by Sponsor|0|||
124828195|NCT00642941|449000928|FG000|Overall Study|Withdrawal by Subject|1|||
124828196|NCT00642941|449000929|FG001|Overall Study|Withdrawal by Subject|0|||
124828197|NCT00642941|449000930|FG002|Overall Study|Withdrawal by Subject|0|||
124828198|NCT00642941|449000931|FG003|Overall Study|Withdrawal by Subject|2|||
124828199|NCT00642941|449000932|FG004|Overall Study|Withdrawal by Subject|0|||
124828200|NCT00642941|449000933|FG005|Overall Study|Withdrawal by Subject|0|||
124828201|NCT00642941|449000934|FG006|Overall Study|Withdrawal by Subject|2|||
124828202|NCT00642941|449000935|FG007|Overall Study|Withdrawal by Subject|0|||
124828203|NCT00642941|449000936|FG008|Overall Study|Withdrawal by Subject|1|||
124828204|NCT00642941|449000937|FG009|Overall Study|Withdrawal by Subject|0|||
124828205|NCT00642941|449000938|FG010|Overall Study|Withdrawal by Subject|0|||
124828206|NCT00642941|449000939|FG011|Overall Study|Withdrawal by Subject|1|||
124828207|NCT00642941|449000928|FG000|Overall Study|Protocol Violation|0|||
124828208|NCT00642941|449000929|FG001|Overall Study|Protocol Violation|0|||
124828209|NCT00642941|449000930|FG002|Overall Study|Protocol Violation|0|||
124828210|NCT00642941|449000931|FG003|Overall Study|Protocol Violation|0|||
124828211|NCT00642941|449000932|FG004|Overall Study|Protocol Violation|0|||
124828212|NCT00642941|449000933|FG005|Overall Study|Protocol Violation|0|||
124828213|NCT00642941|449000934|FG006|Overall Study|Protocol Violation|1|||
124828214|NCT00642941|449000935|FG007|Overall Study|Protocol Violation|0|||
124828215|NCT00642941|449000936|FG008|Overall Study|Protocol Violation|0|||
124828216|NCT00642941|449000937|FG009|Overall Study|Protocol Violation|0|||
124828217|NCT00642941|449000938|FG010|Overall Study|Protocol Violation|0|||
124828218|NCT00642941|449000939|FG011|Overall Study|Protocol Violation|0|||
124828219|NCT00642941|449000928|FG000|Overall Study|Adverse Event|1|||
124828220|NCT00642941|449000929|FG001|Overall Study|Adverse Event|1|||
124828221|NCT00642941|449000930|FG002|Overall Study|Adverse Event|0|||
124828222|NCT00642941|449000931|FG003|Overall Study|Adverse Event|0|||
124828223|NCT00642941|449000932|FG004|Overall Study|Adverse Event|0|||
124828224|NCT00642941|449000933|FG005|Overall Study|Adverse Event|0|||
124828225|NCT00642941|449000934|FG006|Overall Study|Adverse Event|1|||
124828226|NCT00642941|449000935|FG007|Overall Study|Adverse Event|1|||
124828227|NCT00642941|449000936|FG008|Overall Study|Adverse Event|0|||
124828228|NCT00642941|449000937|FG009|Overall Study|Adverse Event|1|||
124828229|NCT00642941|449000938|FG010|Overall Study|Adverse Event|0|||
124828230|NCT00642941|449000939|FG011|Overall Study|Adverse Event|0|||
124828231|NCT00642941|449000928|FG000|Overall Study|Other|1|||
124828232|NCT00642941|449000929|FG001|Overall Study|Other|1|||
125303992|NCT03824587|450739625|FG000|Treatment Period|Adverse Event|4|||
125303993|NCT03824587|450739626|FG001|Treatment Period|Adverse Event|1|||
125303994|NCT03824587|450739625|FG000|Treatment Period|Withdrawal by Subject|0|||
125303995|NCT03824587|450739626|FG001|Treatment Period|Withdrawal by Subject|1|||
125303996|NCT03824587|450739625|FG000|Treatment Period|Kidney Transplant|1|||
125303997|NCT03824587|450739626|FG001|Treatment Period|Kidney Transplant|1|||
125303998|NCT00986362|450739627|FG000|Overall Study|Death|2|||
124828233|NCT00642941|449000930|FG002|Overall Study|Other|1|||
124828234|NCT00642941|449000931|FG003|Overall Study|Other|1|||
124828235|NCT00642941|449000932|FG004|Overall Study|Other|0|||
124828236|NCT00642941|449000933|FG005|Overall Study|Other|1|||
124828237|NCT00642941|449000934|FG006|Overall Study|Other|0|||
124828238|NCT00642941|449000935|FG007|Overall Study|Other|1|||
124828239|NCT00642941|449000936|FG008|Overall Study|Other|0|||
124828240|NCT00642941|449000937|FG009|Overall Study|Other|0|||
124828241|NCT00642941|449000938|FG010|Overall Study|Other|0|||
124828242|NCT00642941|449000939|FG011|Overall Study|Other|1|||
124828243|NCT00642941|449000928|FG000|Overall Study|Disease progression|60|||
124828244|NCT00642941|449000929|FG001|Overall Study|Disease progression|50|||
124828245|NCT00642941|449000930|FG002|Overall Study|Disease progression|5|||
124828246|NCT00642941|449000931|FG003|Overall Study|Disease progression|36|||
124828247|NCT00642941|449000932|FG004|Overall Study|Disease progression|23|||
124828248|NCT00642941|449000933|FG005|Overall Study|Disease progression|39|||
124828249|NCT00642941|449000934|FG006|Overall Study|Disease progression|18|||
124828250|NCT00642941|449000935|FG007|Overall Study|Disease progression|12|||
124828251|NCT00642941|449000936|FG008|Overall Study|Disease progression|10|||
124828252|NCT00642941|449000937|FG009|Overall Study|Disease progression|7|||
124828253|NCT00642941|449000938|FG010|Overall Study|Disease progression|12|||
124828254|NCT00642941|449000939|FG011|Overall Study|Disease progression|7|||
124828255|NCT01614067|449000940|FG000|Overall Study|Pregnancy|1|||
124828256|NCT01614067|449000941|FG001|Overall Study|Pregnancy|0|||
124828257|NCT01614067|449000940|FG000|Overall Study|Physician Decision|6|||
124828258|NCT01614067|449000941|FG001|Overall Study|Physician Decision|5|||
124828259|NCT01614067|449000940|FG000|Overall Study|Withdrawal by Subject|0|||
124828260|NCT01614067|449000941|FG001|Overall Study|Withdrawal by Subject|1|||
124828261|NCT01614067|449000940|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
124828262|NCT01614067|449000941|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
124828263|NCT01505868|449000942|FG000|Overall Study|Withdrawal by Subject|1|||
124828264|NCT01505868|449000943|FG001|Overall Study|Withdrawal by Subject|0|||
124828265|NCT01505868|449000944|FG002|Overall Study|Withdrawal by Subject|0|||
124828266|NCT01505868|449000945|FG003|Overall Study|Withdrawal by Subject|0|||
124828267|NCT01505868|449000946|FG004|Overall Study|Withdrawal by Subject|0|||
124828268|NCT02289079|449000947|FG000|Overall Study|Physician Decision|2|||
124828269|NCT02289079|449000948|FG001|Overall Study|Physician Decision|0|||
124828270|NCT02289079|449000947|FG000|Overall Study|Lost to Follow-up|0|||
124828271|NCT02289079|449000948|FG001|Overall Study|Lost to Follow-up|1|||
124828272|NCT00680043|449000949|FG000|Overall Study|Withdrawal by Subject|1|||
124828273|NCT00680043|449000950|FG001|Overall Study|Withdrawal by Subject|0|||
124828274|NCT00680043|449000951|FG002|Overall Study|Withdrawal by Subject|0|||
124828275|NCT00680043|449000949|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
124828276|NCT00680043|449000950|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
124828277|NCT00680043|449000951|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
124828278|NCT00680043|449000949|FG000|Overall Study|Renal Transplant|1|||
124828279|NCT00680043|449000950|FG001|Overall Study|Renal Transplant|0|||
124828280|NCT00680043|449000951|FG002|Overall Study|Renal Transplant|4|||
124828281|NCT00553150|449000952|FG000|Overall Study|Withdrawal by Subject|0|||
124828282|NCT00553150|449000953|FG001|Overall Study|Withdrawal by Subject|0|||
124828283|NCT00553150|449000954|FG002|Overall Study|Withdrawal by Subject|0|||
124828284|NCT00553150|449000955|FG003|Overall Study|Withdrawal by Subject|2|||
124828285|NCT00553150|449000952|FG000|Overall Study|Protocol Violation|0|||
124828286|NCT00553150|449000953|FG001|Overall Study|Protocol Violation|0|||
124828287|NCT00553150|449000954|FG002|Overall Study|Protocol Violation|0|||
124828288|NCT00553150|449000955|FG003|Overall Study|Protocol Violation|1|||
124828289|NCT00553150|449000952|FG000|Overall Study|Ineligible|0|||
124828290|NCT00553150|449000953|FG001|Overall Study|Ineligible|0|||
124828291|NCT00553150|449000954|FG002|Overall Study|Ineligible|0|||
124828292|NCT00553150|449000955|FG003|Overall Study|Ineligible|1|||
124828293|NCT03061331|449000956|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
124828294|NCT03061331|449000957|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
124828295|NCT02998840|449000961|FG000|Overall Study|Lost to Follow-up|1|||
124828296|NCT02998840|449000962|FG001|Overall Study|Lost to Follow-up|1|||
124828297|NCT02998840|449000963|FG002|Overall Study|Lost to Follow-up|2|||
124828298|NCT02998840|449000964|FG003|Overall Study|Lost to Follow-up|3|||
124828299|NCT02998840|449000961|FG000|Overall Study|Withdrawal by Subject|1|||
124828300|NCT02998840|449000962|FG001|Overall Study|Withdrawal by Subject|1|||
124828301|NCT02998840|449000963|FG002|Overall Study|Withdrawal by Subject|0|||
124828302|NCT02998840|449000964|FG003|Overall Study|Withdrawal by Subject|1|||
124828303|NCT02998840|449000961|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
124828304|NCT02998840|449000962|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
124828305|NCT02998840|449000963|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
124828306|NCT02998840|449000964|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
124828307|NCT01686633|449000965|FG000|Overall Study|Lack of Efficacy|33|||
124828308|NCT01686633|449000966|FG001|Overall Study|Lack of Efficacy|13|||
124828309|NCT01686633|449000967|FG002|Overall Study|Lack of Efficacy|11|||
125303999|NCT00986362|450739628|FG001|Overall Study|Death|0|||
125304000|NCT00986362|450739627|FG000|Overall Study|Lost to Follow-up|0|||
125304001|NCT00986362|450739628|FG001|Overall Study|Lost to Follow-up|1|||
125304002|NCT00384332|450739629|FG000|Overall Study|Lost to Follow-up|4|||
124828310|NCT01686633|449000965|FG000|Overall Study|Withdrawal by Subject|8|||
124828311|NCT01686633|449000966|FG001|Overall Study|Withdrawal by Subject|8|||
124828312|NCT01686633|449000967|FG002|Overall Study|Withdrawal by Subject|5|||
124828313|NCT01686633|449000965|FG000|Overall Study|Physician Decision|3|||
124828314|NCT01686633|449000966|FG001|Overall Study|Physician Decision|4|||
124828315|NCT01686633|449000967|FG002|Overall Study|Physician Decision|4|||
124828316|NCT01686633|449000965|FG000|Overall Study|Adverse Event|4|||
124828317|NCT01686633|449000966|FG001|Overall Study|Adverse Event|3|||
124828318|NCT01686633|449000967|FG002|Overall Study|Adverse Event|3|||
124828319|NCT01686633|449000965|FG000|Overall Study|Protocol Violation|2|||
124828320|NCT01686633|449000966|FG001|Overall Study|Protocol Violation|3|||
124828321|NCT01686633|449000967|FG002|Overall Study|Protocol Violation|0|||
125304003|NCT00384332|450739630|FG001|Overall Study|Lost to Follow-up|0|||
124828322|NCT01686633|449000965|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
124828323|NCT01686633|449000966|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
124828324|NCT01686633|449000967|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
124828325|NCT01686633|449000965|FG000|Overall Study|Lost to Follow-up|0|||
124828326|NCT01686633|449000966|FG001|Overall Study|Lost to Follow-up|1|||
124828327|NCT01686633|449000967|FG002|Overall Study|Lost to Follow-up|1|||
124828328|NCT00195676|449000969|FG000|Period O - Open-label Treatment|Adverse Event|82|||
124828329|NCT00195676|449000969|FG000|Period O - Open-label Treatment|Death|6|||
124828330|NCT00195676|449000969|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
124828331|NCT00195676|449000969|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
125304004|NCT02006979|450739631|FG000|Overall Study|Withdrawal by Subject|1|||
125304005|NCT02006979|450739632|FG001|Overall Study|Withdrawal by Subject|1|||
125304006|NCT02006979|450739631|FG000|Overall Study|Protocol Violation|0|||
125304007|NCT02006979|450739632|FG001|Overall Study|Protocol Violation|1|||
125304008|NCT03170193|450739633|FG000|Overall Study|Withdrawal by Subject|0|||
125304009|NCT03170193|450739634|FG001|Overall Study|Withdrawal by Subject|0|||
125304010|NCT03170193|450739635|FG002|Overall Study|Withdrawal by Subject|0|||
125304011|NCT03170193|450739636|FG003|Overall Study|Withdrawal by Subject|1|||
125304012|NCT03170193|450739637|FG004|Overall Study|Withdrawal by Subject|0|||
125304013|NCT03170193|450739638|FG005|Overall Study|Withdrawal by Subject|0|||
125304014|NCT03170193|450739639|FG006|Overall Study|Withdrawal by Subject|0|||
125304015|NCT03170193|450739633|FG000|Overall Study|Lost to Follow-up|1|||
125304016|NCT03170193|450739634|FG001|Overall Study|Lost to Follow-up|1|||
125304017|NCT03170193|450739635|FG002|Overall Study|Lost to Follow-up|0|||
125304018|NCT03170193|450739636|FG003|Overall Study|Lost to Follow-up|0|||
125304019|NCT03170193|450739637|FG004|Overall Study|Lost to Follow-up|0|||
125304020|NCT03170193|450739638|FG005|Overall Study|Lost to Follow-up|0|||
125304021|NCT03170193|450739639|FG006|Overall Study|Lost to Follow-up|0|||
125304022|NCT02560012|450739640|FG000|Overall Study|Study Terminated|2|||
125304023|NCT01007838|450739641|FG000|Overall Study|Withdrawal by Subject|1|||
125304024|NCT01007838|450739642|FG001|Overall Study|Withdrawal by Subject|0|||
125304025|NCT01007838|450739643|FG002|Overall Study|Withdrawal by Subject|0|||
125304026|NCT01007838|450739644|FG003|Overall Study|Withdrawal by Subject|0|||
125304027|NCT01007838|450739641|FG000|Overall Study|Physician Decision|1|||
125304028|NCT01007838|450739642|FG001|Overall Study|Physician Decision|0|||
125304029|NCT01007838|450739643|FG002|Overall Study|Physician Decision|0|||
125304030|NCT01007838|450739644|FG003|Overall Study|Physician Decision|0|||
125304031|NCT01007838|450739641|FG000|Overall Study|Started home haemodialysis|1|||
125304032|NCT01007838|450739642|FG001|Overall Study|Started home haemodialysis|0|||
125304033|NCT01007838|450739643|FG002|Overall Study|Started home haemodialysis|0|||
125304034|NCT01007838|450739644|FG003|Overall Study|Started home haemodialysis|0|||
125304035|NCT04167137|450739645|FG000|Overall Study|Disease progression|1|||
125304036|NCT04167137|450739646|FG001|Overall Study|Disease progression|1|||
125304037|NCT04167137|450739647|FG002|Overall Study|Disease progression|3|||
125304038|NCT04167137|450739648|FG003|Overall Study|Disease progression|3|||
125304039|NCT04167137|450739649|FG004|Overall Study|Disease progression|2|||
125304040|NCT04167137|450739650|FG005|Overall Study|Disease progression|3|||
125304041|NCT04167137|450739651|FG006|Overall Study|Disease progression|2|||
125304042|NCT04167137|450739652|FG007|Overall Study|Disease progression|2|||
125304043|NCT04167137|450739645|FG000|Overall Study|Withdrawal by Subject|1|||
125304044|NCT04167137|450739646|FG001|Overall Study|Withdrawal by Subject|0|||
125304045|NCT04167137|450739647|FG002|Overall Study|Withdrawal by Subject|0|||
125304046|NCT04167137|450739648|FG003|Overall Study|Withdrawal by Subject|1|||
125304047|NCT04167137|450739649|FG004|Overall Study|Withdrawal by Subject|0|||
125304048|NCT04167137|450739650|FG005|Overall Study|Withdrawal by Subject|2|||
125304049|NCT04167137|450739651|FG006|Overall Study|Withdrawal by Subject|1|||
125304050|NCT04167137|450739652|FG007|Overall Study|Withdrawal by Subject|0|||
125304051|NCT04167137|450739645|FG000|Overall Study|Adverse Event|0|||
125304052|NCT04167137|450739646|FG001|Overall Study|Adverse Event|0|||
125304053|NCT04167137|450739647|FG002|Overall Study|Adverse Event|0|||
125304054|NCT04167137|450739648|FG003|Overall Study|Adverse Event|0|||
125304055|NCT04167137|450739649|FG004|Overall Study|Adverse Event|0|||
125304056|NCT04167137|450739650|FG005|Overall Study|Adverse Event|1|||
124828332|NCT00195676|449000969|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
125304057|NCT04167137|450739651|FG006|Overall Study|Adverse Event|0|||
125304058|NCT04167137|450739652|FG007|Overall Study|Adverse Event|1|||
125304059|NCT04167137|450739645|FG000|Overall Study|Physician Decision|0|||
125304060|NCT04167137|450739646|FG001|Overall Study|Physician Decision|0|||
125304061|NCT04167137|450739647|FG002|Overall Study|Physician Decision|0|||
125304062|NCT04167137|450739648|FG003|Overall Study|Physician Decision|1|||
125304063|NCT04167137|450739649|FG004|Overall Study|Physician Decision|0|||
125304064|NCT04167137|450739650|FG005|Overall Study|Physician Decision|0|||
124828333|NCT00195676|449000969|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
125304065|NCT04167137|450739651|FG006|Overall Study|Physician Decision|1|||
125304066|NCT04167137|450739652|FG007|Overall Study|Physician Decision|0|||
125304067|NCT04167137|450739645|FG000|Overall Study|Death|0|||
125304068|NCT04167137|450739646|FG001|Overall Study|Death|1|||
125304069|NCT04167137|450739647|FG002|Overall Study|Death|0|||
124828334|NCT00195676|449000969|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
124828335|NCT00195676|449000969|FG000|Period O - Open-label Treatment|Other reasons|68|||
124828336|NCT00195676|449000969|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
124828337|NCT00195676|449000969|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
124828338|NCT00195676|449000969|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
124828339|NCT00195676|449000969|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
124828340|NCT00195676|449000969|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
124828341|NCT00195676|449000969|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
124828342|NCT00195676|449000969|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
124828343|NCT00195676|449000969|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
124828344|NCT00195676|449000969|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
124828345|NCT00195676|449000969|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
124828346|NCT00195676|449000969|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
124828347|NCT00195676|449000969|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
124828348|NCT00195676|449000969|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
124828349|NCT01189812|449000970|FG000|Overall Study|Withdrawal by Subject|2|||
124828350|NCT01189812|449000971|FG001|Overall Study|Withdrawal by Subject|3|||
124828351|NCT01189812|449000970|FG000|Overall Study|Adverse Event|1|||
124828352|NCT01189812|449000971|FG001|Overall Study|Adverse Event|0|||
124828353|NCT01189812|449000970|FG000|Overall Study|Out of Window|4|||
124828354|NCT01189812|449000971|FG001|Overall Study|Out of Window|3|||
124828355|NCT01189812|449000970|FG000|Overall Study|Moved out of State|1|||
124828356|NCT01189812|449000971|FG001|Overall Study|Moved out of State|2|||
124828357|NCT00616655|449000972|FG000|Overall Study|Adverse Event|10|||
124828358|NCT00616655|449000973|FG001|Overall Study|Adverse Event|7|||
124828359|NCT00616655|449000974|FG002|Overall Study|Adverse Event|12|||
124828360|NCT00616655|449000972|FG000|Overall Study|Lack of Efficacy|5|||
124828361|NCT00616655|449000973|FG001|Overall Study|Lack of Efficacy|5|||
124828362|NCT00616655|449000974|FG002|Overall Study|Lack of Efficacy|5|||
124828363|NCT00616655|449000972|FG000|Overall Study|Lost to Follow-up|3|||
124828364|NCT00616655|449000973|FG001|Overall Study|Lost to Follow-up|12|||
124828365|NCT00616655|449000974|FG002|Overall Study|Lost to Follow-up|10|||
124828366|NCT00616655|449000972|FG000|Overall Study|Protocol Violation|2|||
124828367|NCT00616655|449000973|FG001|Overall Study|Protocol Violation|4|||
124828368|NCT00616655|449000974|FG002|Overall Study|Protocol Violation|3|||
124828369|NCT00616655|449000972|FG000|Overall Study|Withdrawal by Subject|9|||
124828370|NCT00616655|449000973|FG001|Overall Study|Withdrawal by Subject|7|||
124828371|NCT00616655|449000974|FG002|Overall Study|Withdrawal by Subject|11|||
124828372|NCT00616655|449000972|FG000|Overall Study|Does not meet in/ex criteria|0|||
124828373|NCT00616655|449000973|FG001|Overall Study|Does not meet in/ex criteria|0|||
124828374|NCT00616655|449000974|FG002|Overall Study|Does not meet in/ex criteria|2|||
124828375|NCT00616655|449000972|FG000|Overall Study|Other|6|||
124828376|NCT00616655|449000973|FG001|Overall Study|Other|6|||
124828377|NCT00616655|449000974|FG002|Overall Study|Other|5|||
124828378|NCT03761147|449000975|FG000|Overall Study|Withdrawal by Subject|6|||
124828379|NCT03761147|449000976|FG001|Overall Study|Withdrawal by Subject|1|||
124828380|NCT03761147|449000975|FG000|Overall Study|Adverse Event|1|||
124828381|NCT03761147|449000976|FG001|Overall Study|Adverse Event|3|||
124828382|NCT00309842|449000978|FG000|Overall Study|Lost to Follow-up|1|||
124828383|NCT01026792|449000979|FG000|Overall Study|Protocol Violation|1|||
124828384|NCT00423150|449000980|FG000|Overall Study|Adverse Event|11|||
124828385|NCT00423150|449000980|FG000|Overall Study|Progression of disease being studied|69|||
124828386|NCT00423150|449000980|FG000|Overall Study|Withdrawal by Subject|1|||
124828387|NCT00423150|449000980|FG000|Overall Study|Non-compliance with protocol|1|||
124828388|NCT00423150|449000980|FG000|Overall Study|Administrative|4|||
124828389|NCT03204305|449000981|FG000|Overall Study|Lost to Follow-up|6|||
124828390|NCT03204305|449000982|FG001|Overall Study|Lost to Follow-up|4|||
124828391|NCT03204305|449000983|FG002|Overall Study|Lost to Follow-up|0|||
124828392|NCT03204305|449000984|FG003|Overall Study|Lost to Follow-up|0|||
124828393|NCT03204305|449000981|FG000|Overall Study|Physician Decision|1|||
124828394|NCT03204305|449000982|FG001|Overall Study|Physician Decision|0|||
125304070|NCT04167137|450739648|FG003|Overall Study|Death|0|||
125304071|NCT04167137|450739649|FG004|Overall Study|Death|0|||
124828395|NCT03204305|449000983|FG002|Overall Study|Physician Decision|0|||
124828396|NCT03204305|449000984|FG003|Overall Study|Physician Decision|0|||
124828397|NCT03204305|449000981|FG000|Overall Study|failure to place arterial line|2|||
124828398|NCT03204305|449000982|FG001|Overall Study|failure to place arterial line|1|||
124828399|NCT03204305|449000983|FG002|Overall Study|failure to place arterial line|0|||
124828400|NCT03204305|449000984|FG003|Overall Study|failure to place arterial line|0|||
124828401|NCT03204305|449000981|FG000|Overall Study|Withdrawal by Subject|2|||
124828402|NCT03204305|449000982|FG001|Overall Study|Withdrawal by Subject|0|||
124828403|NCT03204305|449000983|FG002|Overall Study|Withdrawal by Subject|0|||
124828404|NCT03204305|449000984|FG003|Overall Study|Withdrawal by Subject|0|||
124828405|NCT00535223|449000985|FG000|Overall Study|Withdrawal by Subject|4|||
124828406|NCT00535223|449000986|FG001|Overall Study|Withdrawal by Subject|1|||
124828407|NCT02953314|449000987|FG000|Overall Study|Adverse Event|0|||
124828408|NCT02953314|449000988|FG001|Overall Study|Adverse Event|1|||
124828409|NCT02953314|449000987|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
124828410|NCT02953314|449000988|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
124828411|NCT02335099|449000989|FG000|Treatment|Withdrawal by Subject|1|||
124828412|NCT02335099|449000990|FG001|Treatment|Withdrawal by Subject|3|||
124828413|NCT02335099|449000989|FG000|Treatment|Lost to Follow-up|2|||
124828414|NCT02335099|449000990|FG001|Treatment|Lost to Follow-up|0|||
124828415|NCT02335099|449000989|FG000|Treatment|Death|1|||
124828416|NCT02335099|449000990|FG001|Treatment|Death|0|||
124828417|NCT02335099|449000989|FG000|Treatment|Adverse Event|1|||
124828418|NCT02335099|449000990|FG001|Treatment|Adverse Event|2|||
124828419|NCT02335099|449000989|FG000|Follow-up|Death|0|||
124828420|NCT02335099|449000990|FG001|Follow-up|Death|1|||
124828421|NCT02045797|449000991|FG000|Overall Study|Adverse Event|3|||
124828422|NCT02045797|449000992|FG001|Overall Study|Adverse Event|1|||
124828423|NCT02045797|449000993|FG002|Overall Study|Adverse Event|0|||
124828424|NCT02045797|449000991|FG000|Overall Study|Lack of Efficacy|1|||
124828425|NCT02045797|449000992|FG001|Overall Study|Lack of Efficacy|0|||
124828426|NCT02045797|449000993|FG002|Overall Study|Lack of Efficacy|0|||
124828427|NCT02045797|449000991|FG000|Overall Study|Lost to Follow-up|2|||
124828428|NCT02045797|449000992|FG001|Overall Study|Lost to Follow-up|3|||
124828429|NCT02045797|449000993|FG002|Overall Study|Lost to Follow-up|1|||
124828430|NCT02045797|449000991|FG000|Overall Study|Physician Decision|0|||
124828431|NCT02045797|449000992|FG001|Overall Study|Physician Decision|1|||
124828432|NCT02045797|449000993|FG002|Overall Study|Physician Decision|0|||
124828433|NCT02045797|449000991|FG000|Overall Study|Withdrawal by Subject|1|||
124828434|NCT02045797|449000992|FG001|Overall Study|Withdrawal by Subject|2|||
124828435|NCT02045797|449000993|FG002|Overall Study|Withdrawal by Subject|0|||
124828436|NCT01765153|449000994|FG000|Training Phase 1|Format of intervention differed|1|||
124828437|NCT01765153|449000995|FG001|Training Phase 1|Format of intervention differed|0|||
124828438|NCT01765153|449000994|FG000|Training Phase 1|Poor participation in intervention|0|||
124828439|NCT01765153|449000995|FG001|Training Phase 1|Poor participation in intervention|1|||
124828440|NCT01765153|449000994|FG000|Rest Phase 1|Withdrawal by Subject|0|||
124828441|NCT01765153|449000995|FG001|Rest Phase 1|Withdrawal by Subject|1|||
124828442|NCT01765153|449000994|FG000|Training Phase 2|Withdrawal by Subject|0|||
124828443|NCT01765153|449000995|FG001|Training Phase 2|Withdrawal by Subject|1|||
124828444|NCT01765153|449000994|FG000|Rest Phase 2|Lost to Follow-up|2|||
124828445|NCT01765153|449000995|FG001|Rest Phase 2|Lost to Follow-up|1|||
124828446|NCT02554812|449001000|FG000|Overall Study|Adverse Event|2|||
124828447|NCT02554812|449001001|FG001|Overall Study|Adverse Event|5|||
124828448|NCT02554812|449001002|FG002|Overall Study|Adverse Event|3|||
124828449|NCT02554812|449001003|FG003|Overall Study|Adverse Event|0|||
124828450|NCT02554812|449001004|FG004|Overall Study|Adverse Event|5|||
124828451|NCT02554812|449001005|FG005|Overall Study|Adverse Event|0|||
124828452|NCT02554812|449001006|FG006|Overall Study|Adverse Event|1|||
124828453|NCT02554812|449001007|FG007|Overall Study|Adverse Event|6|||
124828454|NCT02554812|449001008|FG008|Overall Study|Adverse Event|2|||
124828455|NCT02554812|449001009|FG009|Overall Study|Adverse Event|2|||
124828456|NCT02554812|449001010|FG010|Overall Study|Adverse Event|1|||
124828457|NCT02554812|449001011|FG011|Overall Study|Adverse Event|2|||
124828458|NCT02554812|449001012|FG012|Overall Study|Adverse Event|0|||
124828459|NCT02554812|449001013|FG013|Overall Study|Adverse Event|3|||
124828460|NCT02554812|449001014|FG014|Overall Study|Adverse Event|2|||
124828461|NCT02554812|449001015|FG015|Overall Study|Adverse Event|1|||
124828462|NCT02554812|449001016|FG016|Overall Study|Adverse Event|0|||
124828463|NCT02554812|449001017|FG017|Overall Study|Adverse Event|1|||
124828464|NCT02554812|449001018|FG018|Overall Study|Adverse Event|0|||
124828465|NCT02554812|449001019|FG019|Overall Study|Adverse Event|0|||
124828466|NCT02554812|449001020|FG020|Overall Study|Adverse Event|0|||
124828467|NCT02554812|449001021|FG021|Overall Study|Adverse Event|2|||
124828468|NCT02554812|449001022|FG022|Overall Study|Adverse Event|1|||
124828469|NCT02554812|449001023|FG023|Overall Study|Adverse Event|1|||
124828470|NCT02554812|449001024|FG024|Overall Study|Adverse Event|1|||
124828471|NCT02554812|449001025|FG025|Overall Study|Adverse Event|2|||
124828472|NCT02554812|449001026|FG026|Overall Study|Adverse Event|1|||
124828473|NCT02554812|449001000|FG000|Overall Study|Death|1|||
124828474|NCT02554812|449001001|FG001|Overall Study|Death|2|||
124828475|NCT02554812|449001002|FG002|Overall Study|Death|2|||
124828476|NCT02554812|449001003|FG003|Overall Study|Death|2|||
124828477|NCT02554812|449001004|FG004|Overall Study|Death|0|||
124828478|NCT02554812|449001005|FG005|Overall Study|Death|1|||
124828479|NCT02554812|449001006|FG006|Overall Study|Death|1|||
124828480|NCT02554812|449001007|FG007|Overall Study|Death|1|||
124828481|NCT02554812|449001008|FG008|Overall Study|Death|0|||
124828482|NCT02554812|449001009|FG009|Overall Study|Death|0|||
124828483|NCT02554812|449001010|FG010|Overall Study|Death|0|||
124828484|NCT02554812|449001011|FG011|Overall Study|Death|0|||
124828485|NCT02554812|449001012|FG012|Overall Study|Death|0|||
124828486|NCT02554812|449001013|FG013|Overall Study|Death|0|||
124828487|NCT02554812|449001014|FG014|Overall Study|Death|1|||
124828488|NCT02554812|449001015|FG015|Overall Study|Death|1|||
124828489|NCT02554812|449001016|FG016|Overall Study|Death|1|||
124828490|NCT02554812|449001017|FG017|Overall Study|Death|0|||
124828491|NCT02554812|449001018|FG018|Overall Study|Death|1|||
124828492|NCT02554812|449001019|FG019|Overall Study|Death|2|||
124828493|NCT02554812|449001020|FG020|Overall Study|Death|0|||
124828494|NCT02554812|449001021|FG021|Overall Study|Death|1|||
124828495|NCT02554812|449001022|FG022|Overall Study|Death|1|||
124828496|NCT02554812|449001023|FG023|Overall Study|Death|0|||
124828497|NCT02554812|449001024|FG024|Overall Study|Death|0|||
124828498|NCT02554812|449001025|FG025|Overall Study|Death|0|||
124828499|NCT02554812|449001026|FG026|Overall Study|Death|0|||
124828500|NCT02554812|449001000|FG000|Overall Study|Lost to Follow-up|0|||
124828501|NCT02554812|449001001|FG001|Overall Study|Lost to Follow-up|1|||
124828502|NCT02554812|449001002|FG002|Overall Study|Lost to Follow-up|0|||
124828503|NCT02554812|449001003|FG003|Overall Study|Lost to Follow-up|0|||
124828504|NCT02554812|449001004|FG004|Overall Study|Lost to Follow-up|0|||
124828505|NCT02554812|449001005|FG005|Overall Study|Lost to Follow-up|0|||
124828506|NCT02554812|449001006|FG006|Overall Study|Lost to Follow-up|0|||
124828507|NCT02554812|449001007|FG007|Overall Study|Lost to Follow-up|0|||
124828508|NCT02554812|449001008|FG008|Overall Study|Lost to Follow-up|0|||
124828509|NCT02554812|449001009|FG009|Overall Study|Lost to Follow-up|0|||
124828510|NCT02554812|449001010|FG010|Overall Study|Lost to Follow-up|0|||
124828511|NCT02554812|449001011|FG011|Overall Study|Lost to Follow-up|0|||
124828512|NCT02554812|449001012|FG012|Overall Study|Lost to Follow-up|0|||
124828513|NCT02554812|449001013|FG013|Overall Study|Lost to Follow-up|0|||
124828514|NCT02554812|449001014|FG014|Overall Study|Lost to Follow-up|0|||
124828515|NCT02554812|449001015|FG015|Overall Study|Lost to Follow-up|0|||
124828516|NCT02554812|449001016|FG016|Overall Study|Lost to Follow-up|0|||
124828517|NCT02554812|449001017|FG017|Overall Study|Lost to Follow-up|0|||
124828518|NCT02554812|449001018|FG018|Overall Study|Lost to Follow-up|0|||
124828519|NCT02554812|449001019|FG019|Overall Study|Lost to Follow-up|0|||
124828520|NCT02554812|449001020|FG020|Overall Study|Lost to Follow-up|0|||
124828521|NCT02554812|449001021|FG021|Overall Study|Lost to Follow-up|0|||
124828522|NCT02554812|449001022|FG022|Overall Study|Lost to Follow-up|0|||
124828523|NCT02554812|449001023|FG023|Overall Study|Lost to Follow-up|0|||
124828524|NCT02554812|449001024|FG024|Overall Study|Lost to Follow-up|0|||
124828525|NCT02554812|449001025|FG025|Overall Study|Lost to Follow-up|0|||
124828526|NCT02554812|449001026|FG026|Overall Study|Lost to Follow-up|0|||
124828527|NCT02554812|449001000|FG000|Overall Study|Global deterioration of health status|4|||
124828528|NCT02554812|449001001|FG001|Overall Study|Global deterioration of health status|3|||
124828529|NCT02554812|449001002|FG002|Overall Study|Global deterioration of health status|3|||
124828530|NCT02554812|449001003|FG003|Overall Study|Global deterioration of health status|2|||
124828531|NCT02554812|449001004|FG004|Overall Study|Global deterioration of health status|5|||
124828532|NCT02554812|449001005|FG005|Overall Study|Global deterioration of health status|0|||
124828533|NCT02554812|449001006|FG006|Overall Study|Global deterioration of health status|2|||
124828534|NCT02554812|449001007|FG007|Overall Study|Global deterioration of health status|1|||
124828535|NCT02554812|449001008|FG008|Overall Study|Global deterioration of health status|1|||
124828536|NCT02554812|449001009|FG009|Overall Study|Global deterioration of health status|1|||
124828537|NCT02554812|449001010|FG010|Overall Study|Global deterioration of health status|2|||
124828538|NCT02554812|449001011|FG011|Overall Study|Global deterioration of health status|1|||
124828539|NCT02554812|449001012|FG012|Overall Study|Global deterioration of health status|0|||
124828540|NCT02554812|449001013|FG013|Overall Study|Global deterioration of health status|0|||
124828541|NCT02554812|449001014|FG014|Overall Study|Global deterioration of health status|0|||
124828542|NCT02554812|449001015|FG015|Overall Study|Global deterioration of health status|1|||
124828543|NCT02554812|449001016|FG016|Overall Study|Global deterioration of health status|0|||
124828544|NCT02554812|449001017|FG017|Overall Study|Global deterioration of health status|0|||
124828545|NCT02554812|449001018|FG018|Overall Study|Global deterioration of health status|0|||
124828546|NCT02554812|449001019|FG019|Overall Study|Global deterioration of health status|0|||
125304072|NCT04167137|450739650|FG005|Overall Study|Death|0|||
124828547|NCT02554812|449001020|FG020|Overall Study|Global deterioration of health status|0|||
124828548|NCT02554812|449001021|FG021|Overall Study|Global deterioration of health status|0|||
124828549|NCT02554812|449001022|FG022|Overall Study|Global deterioration of health status|0|||
124828550|NCT02554812|449001023|FG023|Overall Study|Global deterioration of health status|0|||
124828551|NCT02554812|449001024|FG024|Overall Study|Global deterioration of health status|0|||
124828552|NCT02554812|449001025|FG025|Overall Study|Global deterioration of health status|0|||
124828553|NCT02554812|449001026|FG026|Overall Study|Global deterioration of health status|0|||
124828554|NCT02554812|449001000|FG000|Overall Study|Progressive disease|20|||
124828555|NCT02554812|449001001|FG001|Overall Study|Progressive disease|16|||
124828556|NCT02554812|449001002|FG002|Overall Study|Progressive disease|19|||
124828557|NCT02554812|449001003|FG003|Overall Study|Progressive disease|18|||
124828558|NCT02554812|449001004|FG004|Overall Study|Progressive disease|21|||
124828559|NCT02554812|449001005|FG005|Overall Study|Progressive disease|15|||
124828560|NCT02554812|449001006|FG006|Overall Study|Progressive disease|6|||
124828561|NCT02554812|449001007|FG007|Overall Study|Progressive disease|13|||
124828562|NCT02554812|449001008|FG008|Overall Study|Progressive disease|6|||
124828563|NCT02554812|449001009|FG009|Overall Study|Progressive disease|6|||
125304073|NCT04167137|450739651|FG006|Overall Study|Death|0|||
124828564|NCT02554812|449001010|FG010|Overall Study|Progressive disease|8|||
124828565|NCT02554812|449001011|FG011|Overall Study|Progressive disease|8|||
124828566|NCT02554812|449001012|FG012|Overall Study|Progressive disease|6|||
124828567|NCT02554812|449001013|FG013|Overall Study|Progressive disease|10|||
124828568|NCT02554812|449001014|FG014|Overall Study|Progressive disease|20|||
124828569|NCT02554812|449001015|FG015|Overall Study|Progressive disease|6|||
124828570|NCT02554812|449001016|FG016|Overall Study|Progressive disease|3|||
124828571|NCT02554812|449001017|FG017|Overall Study|Progressive disease|3|||
124828572|NCT02554812|449001018|FG018|Overall Study|Progressive disease|11|||
124828573|NCT02554812|449001019|FG019|Overall Study|Progressive disease|7|||
124828574|NCT02554812|449001020|FG020|Overall Study|Progressive disease|11|||
124828575|NCT02554812|449001021|FG021|Overall Study|Progressive disease|6|||
124828576|NCT02554812|449001022|FG022|Overall Study|Progressive disease|9|||
124828577|NCT02554812|449001023|FG023|Overall Study|Progressive disease|9|||
124828578|NCT02554812|449001024|FG024|Overall Study|Progressive disease|4|||
124828579|NCT02554812|449001025|FG025|Overall Study|Progressive disease|5|||
124828580|NCT02554812|449001026|FG026|Overall Study|Progressive disease|5|||
124828581|NCT02554812|449001000|FG000|Overall Study|Other|0|||
124828582|NCT02554812|449001001|FG001|Overall Study|Other|0|||
124828583|NCT02554812|449001002|FG002|Overall Study|Other|2|||
124828584|NCT02554812|449001003|FG003|Overall Study|Other|3|||
124828585|NCT02554812|449001004|FG004|Overall Study|Other|2|||
124828586|NCT02554812|449001005|FG005|Overall Study|Other|1|||
124828587|NCT02554812|449001006|FG006|Overall Study|Other|0|||
124828588|NCT02554812|449001007|FG007|Overall Study|Other|0|||
124828589|NCT02554812|449001008|FG008|Overall Study|Other|1|||
124828590|NCT02554812|449001009|FG009|Overall Study|Other|1|||
124828591|NCT02554812|449001010|FG010|Overall Study|Other|0|||
124828592|NCT02554812|449001011|FG011|Overall Study|Other|0|||
124828593|NCT02554812|449001012|FG012|Overall Study|Other|1|||
124828594|NCT02554812|449001013|FG013|Overall Study|Other|0|||
124828595|NCT02554812|449001014|FG014|Overall Study|Other|1|||
124828596|NCT02554812|449001015|FG015|Overall Study|Other|0|||
124828597|NCT02554812|449001016|FG016|Overall Study|Other|0|||
124828598|NCT02554812|449001017|FG017|Overall Study|Other|0|||
124828599|NCT02554812|449001018|FG018|Overall Study|Other|0|||
124828600|NCT02554812|449001019|FG019|Overall Study|Other|0|||
124828601|NCT02554812|449001020|FG020|Overall Study|Other|0|||
124828602|NCT02554812|449001021|FG021|Overall Study|Other|2|||
124828603|NCT02554812|449001022|FG022|Overall Study|Other|0|||
124828604|NCT02554812|449001023|FG023|Overall Study|Other|0|||
124828605|NCT02554812|449001024|FG024|Overall Study|Other|0|||
124828606|NCT02554812|449001025|FG025|Overall Study|Other|0|||
124828607|NCT02554812|449001026|FG026|Overall Study|Other|0|||
124828608|NCT02554812|449001000|FG000|Overall Study|Withdrawal by Subject|1|||
124828609|NCT02554812|449001001|FG001|Overall Study|Withdrawal by Subject|0|||
124828610|NCT02554812|449001002|FG002|Overall Study|Withdrawal by Subject|0|||
124828611|NCT02554812|449001003|FG003|Overall Study|Withdrawal by Subject|2|||
124828612|NCT02554812|449001004|FG004|Overall Study|Withdrawal by Subject|2|||
124828613|NCT02554812|449001005|FG005|Overall Study|Withdrawal by Subject|3|||
124828614|NCT02554812|449001006|FG006|Overall Study|Withdrawal by Subject|0|||
124828615|NCT02554812|449001007|FG007|Overall Study|Withdrawal by Subject|0|||
124828616|NCT02554812|449001008|FG008|Overall Study|Withdrawal by Subject|1|||
124828617|NCT02554812|449001009|FG009|Overall Study|Withdrawal by Subject|1|||
124828618|NCT02554812|449001010|FG010|Overall Study|Withdrawal by Subject|0|||
124828619|NCT02554812|449001011|FG011|Overall Study|Withdrawal by Subject|1|||
124828620|NCT02554812|449001012|FG012|Overall Study|Withdrawal by Subject|1|||
124828621|NCT02554812|449001013|FG013|Overall Study|Withdrawal by Subject|1|||
124828622|NCT02554812|449001014|FG014|Overall Study|Withdrawal by Subject|1|||
124828623|NCT02554812|449001015|FG015|Overall Study|Withdrawal by Subject|1|||
124828624|NCT02554812|449001016|FG016|Overall Study|Withdrawal by Subject|3|||
124828625|NCT02554812|449001017|FG017|Overall Study|Withdrawal by Subject|1|||
124828626|NCT02554812|449001018|FG018|Overall Study|Withdrawal by Subject|0|||
124828627|NCT02554812|449001019|FG019|Overall Study|Withdrawal by Subject|2|||
124828628|NCT02554812|449001020|FG020|Overall Study|Withdrawal by Subject|0|||
124828629|NCT02554812|449001021|FG021|Overall Study|Withdrawal by Subject|1|||
124828630|NCT02554812|449001022|FG022|Overall Study|Withdrawal by Subject|0|||
124828631|NCT02554812|449001023|FG023|Overall Study|Withdrawal by Subject|1|||
124828632|NCT02554812|449001024|FG024|Overall Study|Withdrawal by Subject|0|||
124828633|NCT02554812|449001025|FG025|Overall Study|Withdrawal by Subject|0|||
124828634|NCT02554812|449001026|FG026|Overall Study|Withdrawal by Subject|1|||
124828635|NCT02554812|449001000|FG000|Overall Study|Physician Decision|1|||
124828636|NCT02554812|449001001|FG001|Overall Study|Physician Decision|0|||
124828637|NCT02554812|449001002|FG002|Overall Study|Physician Decision|0|||
124828638|NCT02554812|449001003|FG003|Overall Study|Physician Decision|1|||
124828639|NCT02554812|449001004|FG004|Overall Study|Physician Decision|0|||
124828640|NCT02554812|449001005|FG005|Overall Study|Physician Decision|1|||
124828641|NCT02554812|449001006|FG006|Overall Study|Physician Decision|0|||
124828642|NCT02554812|449001007|FG007|Overall Study|Physician Decision|0|||
124828643|NCT02554812|449001008|FG008|Overall Study|Physician Decision|0|||
124828644|NCT02554812|449001009|FG009|Overall Study|Physician Decision|0|||
124828645|NCT02554812|449001010|FG010|Overall Study|Physician Decision|1|||
124828646|NCT02554812|449001011|FG011|Overall Study|Physician Decision|0|||
124828647|NCT02554812|449001012|FG012|Overall Study|Physician Decision|0|||
124828648|NCT02554812|449001013|FG013|Overall Study|Physician Decision|0|||
124828649|NCT02554812|449001014|FG014|Overall Study|Physician Decision|0|||
124828650|NCT02554812|449001015|FG015|Overall Study|Physician Decision|0|||
124828651|NCT02554812|449001016|FG016|Overall Study|Physician Decision|1|||
124828652|NCT02554812|449001017|FG017|Overall Study|Physician Decision|1|||
124828653|NCT02554812|449001018|FG018|Overall Study|Physician Decision|0|||
124828654|NCT02554812|449001019|FG019|Overall Study|Physician Decision|1|||
124828655|NCT02554812|449001020|FG020|Overall Study|Physician Decision|1|||
124828656|NCT02554812|449001021|FG021|Overall Study|Physician Decision|0|||
124828657|NCT02554812|449001022|FG022|Overall Study|Physician Decision|1|||
124828658|NCT02554812|449001023|FG023|Overall Study|Physician Decision|0|||
124828659|NCT02554812|449001024|FG024|Overall Study|Physician Decision|0|||
124828660|NCT02554812|449001025|FG025|Overall Study|Physician Decision|0|||
124828661|NCT02554812|449001026|FG026|Overall Study|Physician Decision|0|||
124828662|NCT02554812|449001000|FG000|Overall Study|Study terminated by sponsor|0|||
124828663|NCT02554812|449001001|FG001|Overall Study|Study terminated by sponsor|0|||
124828664|NCT02554812|449001002|FG002|Overall Study|Study terminated by sponsor|0|||
124828665|NCT02554812|449001003|FG003|Overall Study|Study terminated by sponsor|0|||
124828666|NCT02554812|449001004|FG004|Overall Study|Study terminated by sponsor|0|||
124828667|NCT02554812|449001005|FG005|Overall Study|Study terminated by sponsor|0|||
124828668|NCT02554812|449001006|FG006|Overall Study|Study terminated by sponsor|0|||
124828669|NCT02554812|449001007|FG007|Overall Study|Study terminated by sponsor|0|||
124828670|NCT02554812|449001008|FG008|Overall Study|Study terminated by sponsor|0|||
124828671|NCT02554812|449001009|FG009|Overall Study|Study terminated by sponsor|0|||
124828672|NCT02554812|449001010|FG010|Overall Study|Study terminated by sponsor|0|||
124828673|NCT02554812|449001011|FG011|Overall Study|Study terminated by sponsor|0|||
124828674|NCT02554812|449001012|FG012|Overall Study|Study terminated by sponsor|0|||
124828675|NCT02554812|449001013|FG013|Overall Study|Study terminated by sponsor|0|||
124828676|NCT02554812|449001014|FG014|Overall Study|Study terminated by sponsor|0|||
124828677|NCT02554812|449001015|FG015|Overall Study|Study terminated by sponsor|0|||
124828678|NCT02554812|449001016|FG016|Overall Study|Study terminated by sponsor|0|||
124828679|NCT02554812|449001017|FG017|Overall Study|Study terminated by sponsor|0|||
124828680|NCT02554812|449001018|FG018|Overall Study|Study terminated by sponsor|0|||
124828681|NCT02554812|449001019|FG019|Overall Study|Study terminated by sponsor|0|||
124828682|NCT02554812|449001020|FG020|Overall Study|Study terminated by sponsor|0|||
124828683|NCT02554812|449001021|FG021|Overall Study|Study terminated by sponsor|0|||
124828684|NCT02554812|449001022|FG022|Overall Study|Study terminated by sponsor|0|||
124828685|NCT02554812|449001023|FG023|Overall Study|Study terminated by sponsor|0|||
124828686|NCT02554812|449001024|FG024|Overall Study|Study terminated by sponsor|1|||
124828687|NCT02554812|449001025|FG025|Overall Study|Study terminated by sponsor|0|||
124828688|NCT02554812|449001026|FG026|Overall Study|Study terminated by sponsor|0|||
124828689|NCT02554812|449001000|FG000|Overall Study|No longer meets eligibility criteria|0|||
124828690|NCT02554812|449001001|FG001|Overall Study|No longer meets eligibility criteria|1|||
124828691|NCT02554812|449001002|FG002|Overall Study|No longer meets eligibility criteria|0|||
124828692|NCT02554812|449001003|FG003|Overall Study|No longer meets eligibility criteria|0|||
124828693|NCT02554812|449001004|FG004|Overall Study|No longer meets eligibility criteria|0|||
124828694|NCT02554812|449001005|FG005|Overall Study|No longer meets eligibility criteria|0|||
124828695|NCT02554812|449001006|FG006|Overall Study|No longer meets eligibility criteria|0|||
124828696|NCT02554812|449001007|FG007|Overall Study|No longer meets eligibility criteria|0|||
124828697|NCT02554812|449001008|FG008|Overall Study|No longer meets eligibility criteria|0|||
124828698|NCT02554812|449001009|FG009|Overall Study|No longer meets eligibility criteria|0|||
124828699|NCT02554812|449001010|FG010|Overall Study|No longer meets eligibility criteria|0|||
124828700|NCT02554812|449001011|FG011|Overall Study|No longer meets eligibility criteria|0|||
124828701|NCT02554812|449001012|FG012|Overall Study|No longer meets eligibility criteria|0|||
124828702|NCT02554812|449001013|FG013|Overall Study|No longer meets eligibility criteria|0|||
124828703|NCT02554812|449001014|FG014|Overall Study|No longer meets eligibility criteria|0|||
124828704|NCT02554812|449001015|FG015|Overall Study|No longer meets eligibility criteria|0|||
124828705|NCT02554812|449001016|FG016|Overall Study|No longer meets eligibility criteria|0|||
124828706|NCT02554812|449001017|FG017|Overall Study|No longer meets eligibility criteria|0|||
124828707|NCT02554812|449001018|FG018|Overall Study|No longer meets eligibility criteria|0|||
124828708|NCT02554812|449001019|FG019|Overall Study|No longer meets eligibility criteria|0|||
124828709|NCT02554812|449001020|FG020|Overall Study|No longer meets eligibility criteria|0|||
124828710|NCT02554812|449001021|FG021|Overall Study|No longer meets eligibility criteria|0|||
125304074|NCT04167137|450739652|FG007|Overall Study|Death|0|||
125304075|NCT04167137|450739645|FG000|Overall Study|Study terminated by Sponsor|0|||
125304076|NCT04167137|450739646|FG001|Overall Study|Study terminated by Sponsor|0|||
124828711|NCT02554812|449001022|FG022|Overall Study|No longer meets eligibility criteria|0|||
124828712|NCT02554812|449001023|FG023|Overall Study|No longer meets eligibility criteria|0|||
125304077|NCT04167137|450739647|FG002|Overall Study|Study terminated by Sponsor|0|||
125304078|NCT04167137|450739648|FG003|Overall Study|Study terminated by Sponsor|0|||
124828713|NCT02554812|449001024|FG024|Overall Study|No longer meets eligibility criteria|0|||
124828714|NCT02554812|449001025|FG025|Overall Study|No longer meets eligibility criteria|0|||
124828715|NCT02554812|449001026|FG026|Overall Study|No longer meets eligibility criteria|0|||
124828716|NCT00415909|449001956|FG000|Overall Study|Withdrawal by Subject|2|||
124828717|NCT00415909|449001956|FG000|Overall Study|Death|1|||
124828718|NCT03232281|449001957|FG000|Overall Study|Adverse Event|1|||
124828719|NCT03232281|449001958|FG001|Overall Study|Adverse Event|1|||
124828720|NCT03232281|449001957|FG000|Overall Study|Withdrawal by Subject|5|||
124828721|NCT03232281|449001958|FG001|Overall Study|Withdrawal by Subject|4|||
124828722|NCT03232281|449001957|FG000|Overall Study|Protocol Deviation|1|||
124828723|NCT03232281|449001958|FG001|Overall Study|Protocol Deviation|1|||
124828724|NCT02522286|449001960|FG000|Overall Study|Withdrawal by Subject|3|||
124828725|NCT02522286|449001961|FG001|Overall Study|Withdrawal by Subject|0|||
124828726|NCT02522286|449001962|FG002|Overall Study|Withdrawal by Subject|0|||
124828727|NCT02522286|449001963|FG003|Overall Study|Withdrawal by Subject|3|||
124828728|NCT00174915|449001964|FG000|Overall Study|Lost to Follow-up|19|||
124828729|NCT00174915|449001965|FG001|Overall Study|Lost to Follow-up|17|||
124828730|NCT00174915|449001966|FG002|Overall Study|Lost to Follow-up|9|||
124828731|NCT00174915|449001967|FG003|Overall Study|Lost to Follow-up|17|||
124828732|NCT00174915|449001968|FG004|Overall Study|Lost to Follow-up|10|||
124828733|NCT00174915|449001964|FG000|Overall Study|Adverse Event|18|||
124828734|NCT00174915|449001965|FG001|Overall Study|Adverse Event|16|||
124828735|NCT00174915|449001966|FG002|Overall Study|Adverse Event|11|||
124828736|NCT00174915|449001967|FG003|Overall Study|Adverse Event|18|||
124828737|NCT00174915|449001968|FG004|Overall Study|Adverse Event|5|||
124828738|NCT00174915|449001964|FG000|Overall Study|Personal Reason(s)|16|||
124828739|NCT00174915|449001965|FG001|Overall Study|Personal Reason(s)|16|||
124828740|NCT00174915|449001966|FG002|Overall Study|Personal Reason(s)|9|||
124828741|NCT00174915|449001967|FG003|Overall Study|Personal Reason(s)|9|||
124828742|NCT00174915|449001968|FG004|Overall Study|Personal Reason(s)|9|||
124828743|NCT00174915|449001964|FG000|Overall Study|Other|15|||
124828744|NCT00174915|449001965|FG001|Overall Study|Other|8|||
124828745|NCT00174915|449001966|FG002|Overall Study|Other|6|||
124828746|NCT00174915|449001967|FG003|Overall Study|Other|5|||
124828747|NCT00174915|449001968|FG004|Overall Study|Other|3|||
124828748|NCT00174915|449001964|FG000|Overall Study|Gout Flare|13|||
124828749|NCT00174915|449001965|FG001|Overall Study|Gout Flare|6|||
124828750|NCT00174915|449001966|FG002|Overall Study|Gout Flare|8|||
124828751|NCT00174915|449001967|FG003|Overall Study|Gout Flare|1|||
124828752|NCT00174915|449001968|FG004|Overall Study|Gout Flare|0|||
124828753|NCT00174915|449001964|FG000|Overall Study|Protocol Violation|6|||
124828754|NCT00174915|449001965|FG001|Overall Study|Protocol Violation|3|||
124828755|NCT00174915|449001966|FG002|Overall Study|Protocol Violation|3|||
124828756|NCT00174915|449001967|FG003|Overall Study|Protocol Violation|6|||
124828757|NCT00174915|449001968|FG004|Overall Study|Protocol Violation|3|||
124828758|NCT00174915|449001964|FG000|Overall Study|Therapeutic Failure|6|||
124828759|NCT00174915|449001965|FG001|Overall Study|Therapeutic Failure|3|||
124828760|NCT00174915|449001966|FG002|Overall Study|Therapeutic Failure|2|||
124828761|NCT00174915|449001967|FG003|Overall Study|Therapeutic Failure|1|||
124828762|NCT00174915|449001968|FG004|Overall Study|Therapeutic Failure|3|||
124828763|NCT01870583|449001975|FG000|Overall Study|Protocol Violation|0|||
124828764|NCT01870583|449001976|FG001|Overall Study|Protocol Violation|5|||
124828765|NCT01870583|449001977|FG002|Overall Study|Protocol Violation|3|||
124828766|NCT01870583|449001975|FG000|Overall Study|Lost to Follow-up|11|||
124828767|NCT01870583|449001976|FG001|Overall Study|Lost to Follow-up|13|||
124828768|NCT01870583|449001977|FG002|Overall Study|Lost to Follow-up|5|||
124828769|NCT00937157|449001978|FG000|Overall Study|Pregnancy|1|||
124828770|NCT00937157|449001978|FG000|Overall Study|Lost to Follow-up|3|||
124828771|NCT00469092|449001979|FG000|Overall Study|Adverse Event|5|||
124828772|NCT00469092|449001980|FG001|Overall Study|Adverse Event|4|||
124828773|NCT00469092|449001979|FG000|Overall Study|Lack of Efficacy|1|||
124828774|NCT00469092|449001980|FG001|Overall Study|Lack of Efficacy|0|||
124828775|NCT00469092|449001979|FG000|Overall Study|Lost to Follow-up|1|||
124828776|NCT00469092|449001980|FG001|Overall Study|Lost to Follow-up|2|||
124828777|NCT00469092|449001979|FG000|Overall Study|Protocol Violation|3|||
124828778|NCT00469092|449001980|FG001|Overall Study|Protocol Violation|3|||
124828779|NCT00469092|449001979|FG000|Overall Study|Withdrawal by Subject|4|||
124828780|NCT00469092|449001980|FG001|Overall Study|Withdrawal by Subject|4|||
124828781|NCT00469092|449001979|FG000|Overall Study|Withdrawal Criteria|3|||
124828782|NCT00469092|449001980|FG001|Overall Study|Withdrawal Criteria|4|||
124828783|NCT00469092|449001979|FG000|Overall Study|Incorrectly Randomised|4|||
124828784|NCT00469092|449001980|FG001|Overall Study|Incorrectly Randomised|3|||
124828785|NCT00469092|449001979|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
124828786|NCT00469092|449001980|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
124828787|NCT00469092|449001979|FG000|Overall Study|Use of lipid lowering drug|1|||
124828788|NCT00469092|449001980|FG001|Overall Study|Use of lipid lowering drug|0|||
124828789|NCT00469092|449001979|FG000|Overall Study|Hypoglycaemic Episodes|1|||
124828790|NCT00469092|449001980|FG001|Overall Study|Hypoglycaemic Episodes|1|||
124828791|NCT00469092|449001979|FG000|Overall Study|Abnormal lab value|1|||
124828792|NCT00469092|449001980|FG001|Overall Study|Abnormal lab value|0|||
124828793|NCT00469092|449001979|FG000|Overall Study|Use of Corticosteroid|1|||
124828794|NCT00469092|449001980|FG001|Overall Study|Use of Corticosteroid|0|||
124828795|NCT02024867|449001981|FG000|Overall Study|Protocol Violation|3|||
124828796|NCT02024867|449001982|FG001|Overall Study|Protocol Violation|3|||
124828797|NCT02024867|449001981|FG000|Overall Study|Lost to Follow-up|6|||
124828798|NCT02024867|449001982|FG001|Overall Study|Lost to Follow-up|4|||
124828799|NCT04267133|449001983|FG000|Overall Study|Withdrawal by Subject|1|||
124828800|NCT04267133|449001983|FG000|Overall Study|Adverse Event|4|||
124828801|NCT01998633|449001984|FG000|Overall Study|Death|1|||
124828802|NCT02968563|449001994|FG000|Overall Study|Adverse Event|0|||
124828803|NCT02968563|449001995|FG001|Overall Study|Adverse Event|6|||
124828804|NCT02968563|449001994|FG000|Overall Study|Death|1|||
124828805|NCT02968563|449001995|FG001|Overall Study|Death|1|||
124828806|NCT02968563|449001994|FG000|Overall Study|Lost to Follow-up|0|||
124828807|NCT02968563|449001995|FG001|Overall Study|Lost to Follow-up|1|||
124828808|NCT03992781|449001996|FG000|Overall Study|Lost to Follow-up|5|||
124828809|NCT03992781|449001996|FG000|Overall Study|Adverse Event|1|||
124828810|NCT03992781|449001996|FG000|Overall Study|Lack of Efficacy|5|||
124828811|NCT03287804|449001997|FG000|Overall Study|Death|1|||
124828812|NCT03287804|449001997|FG000|Overall Study|Physician Decision|2|||
124828813|NCT03287804|449001997|FG000|Overall Study|Progressive disease|8|||
124828814|NCT01275833|449002001|FG000|Overall Study|Study terminated|1|||
124828815|NCT01275833|449002002|FG001|Overall Study|Study terminated|1|||
124828816|NCT02733991|449002003|FG000|Overall Study|Adverse Event|1|||
124828817|NCT02733991|449002004|FG001|Overall Study|Adverse Event|0|||
124828818|NCT02733991|449002003|FG000|Overall Study|Withdrawal by Subject|0|||
124828819|NCT02733991|449002004|FG001|Overall Study|Withdrawal by Subject|5|||
124828820|NCT00857220|449002007|FG000|Overall Study|Adverse Event|35|||
124828821|NCT00857220|449002007|FG000|Overall Study|Death|1|||
124828822|NCT00857220|449002007|FG000|Overall Study|Lack of Efficacy|11|||
124828823|NCT00857220|449002007|FG000|Overall Study|Lost to Follow-up|30|||
124828824|NCT00857220|449002007|FG000|Overall Study|Physician Decision|4|||
124828825|NCT00857220|449002007|FG000|Overall Study|Protocol Violation|16|||
124828826|NCT00857220|449002007|FG000|Overall Study|Withdrawal by Subject|67|||
124828827|NCT00857220|449002007|FG000|Overall Study|Clinical Hold|6|||
124828828|NCT00857220|449002007|FG000|Overall Study|Site Closed|5|||
124828829|NCT00857220|449002007|FG000|Overall Study|Miscellaneous|8|||
124828830|NCT00680745|449002008|FG000|Overall Study|Withdrawal by Subject|8|||
124828831|NCT00680745|449002009|FG001|Overall Study|Withdrawal by Subject|3|||
124828832|NCT00680745|449002010|FG002|Overall Study|Withdrawal by Subject|2|||
124828833|NCT00680745|449002011|FG003|Overall Study|Withdrawal by Subject|8|||
124828834|NCT00680745|449002008|FG000|Overall Study|Lost to Follow-up|0|||
124828835|NCT00680745|449002009|FG001|Overall Study|Lost to Follow-up|1|||
124828836|NCT00680745|449002010|FG002|Overall Study|Lost to Follow-up|1|||
124828837|NCT00680745|449002011|FG003|Overall Study|Lost to Follow-up|0|||
124828838|NCT00680745|449002008|FG000|Overall Study|Death|1|||
124828839|NCT00680745|449002009|FG001|Overall Study|Death|0|||
124828840|NCT00680745|449002010|FG002|Overall Study|Death|1|||
124828841|NCT00680745|449002011|FG003|Overall Study|Death|0|||
124828842|NCT00680745|449002008|FG000|Overall Study|Adverse Event|5|||
124828843|NCT00680745|449002009|FG001|Overall Study|Adverse Event|3|||
124828844|NCT00680745|449002010|FG002|Overall Study|Adverse Event|3|||
124828845|NCT00680745|449002011|FG003|Overall Study|Adverse Event|3|||
124828846|NCT00680745|449002008|FG000|Overall Study|Poor/Non-compliance|0|||
124828847|NCT00680745|449002009|FG001|Overall Study|Poor/Non-compliance|3|||
124828848|NCT00680745|449002010|FG002|Overall Study|Poor/Non-compliance|0|||
124828849|NCT00680745|449002011|FG003|Overall Study|Poor/Non-compliance|0|||
124828850|NCT00680745|449002008|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
124828851|NCT00680745|449002009|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
124828852|NCT00680745|449002010|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
124828853|NCT00680745|449002011|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
124828854|NCT00680745|449002008|FG000|Overall Study|False Treatment|0|||
124828855|NCT00680745|449002009|FG001|Overall Study|False Treatment|1|||
124828856|NCT00680745|449002010|FG002|Overall Study|False Treatment|3|||
124828857|NCT00680745|449002011|FG003|Overall Study|False Treatment|0|||
124828858|NCT02612428|449002012|FG000|VTL-308|Death|14|||
125304079|NCT04167137|450739649|FG004|Overall Study|Study terminated by Sponsor|0|||
125304080|NCT04167137|450739650|FG005|Overall Study|Study terminated by Sponsor|0|||
125304081|NCT04167137|450739651|FG006|Overall Study|Study terminated by Sponsor|0|||
125304082|NCT04167137|450739652|FG007|Overall Study|Study terminated by Sponsor|1|||
125304083|NCT02147288|450739653|FG000|Overall Study|post-operative hematoma|1|||
125304084|NCT02147288|450739654|FG001|Overall Study|post-operative hematoma|1|||
125304085|NCT02147288|450739655|FG002|Overall Study|post-operative hematoma|0|||
124828859|NCT02612428|449002013|FG001|VTL-308|Death|16|||
124828860|NCT02612428|449002012|FG000|VTL-308|Withdrawal by Subject|0|||
124828861|NCT02612428|449002013|FG001|VTL-308|Withdrawal by Subject|1|||
124828862|NCT02612428|449002012|FG000|VTL-308E|Death|9|||
124828863|NCT02612428|449002013|FG001|VTL-308E|Death|7|||
124828864|NCT02612428|449002012|FG000|VTL-308E|Lost to Follow-up|2|||
124828865|NCT02612428|449002013|FG001|VTL-308E|Lost to Follow-up|0|||
124828866|NCT00137423|449002014|FG000|Overall Study|Adverse Event|7|||
124828867|NCT00137423|449002015|FG001|Overall Study|Adverse Event|9|||
124828868|NCT00137423|449002014|FG000|Overall Study|consent withdrawn|1|||
124828869|NCT00137423|449002015|FG001|Overall Study|consent withdrawn|1|||
124828870|NCT00137423|449002014|FG000|Overall Study|Lack of Efficacy|31|||
124828871|NCT00137423|449002015|FG001|Overall Study|Lack of Efficacy|33|||
124828872|NCT00137423|449002014|FG000|Overall Study|Death|0|||
124828873|NCT00137423|449002015|FG001|Overall Study|Death|1|||
124828874|NCT02141997|449002017|FG000|Overall Study|Adverse Event|0|||
124828875|NCT02141997|449002018|FG001|Overall Study|Adverse Event|2|||
124828876|NCT02141997|449002019|FG002|Overall Study|Adverse Event|0|||
124828877|NCT02141997|449002020|FG003|Overall Study|Adverse Event|1|||
124828878|NCT02141997|449002017|FG000|Overall Study|Participant noncompliance|1|||
124828879|NCT02141997|449002018|FG001|Overall Study|Participant noncompliance|0|||
124828880|NCT02141997|449002019|FG002|Overall Study|Participant noncompliance|0|||
124828881|NCT02141997|449002020|FG003|Overall Study|Participant noncompliance|0|||
124828882|NCT02141997|449002017|FG000|Overall Study|Withdrew consent|1|||
124828883|NCT02141997|449002018|FG001|Overall Study|Withdrew consent|0|||
124828884|NCT02141997|449002019|FG002|Overall Study|Withdrew consent|3|||
124828885|NCT02141997|449002020|FG003|Overall Study|Withdrew consent|0|||
124828886|NCT02141997|449002017|FG000|Overall Study|Other|1|||
124828887|NCT02141997|449002018|FG001|Overall Study|Other|4|||
124828888|NCT02141997|449002019|FG002|Overall Study|Other|0|||
124828889|NCT02141997|449002020|FG003|Overall Study|Other|0|||
124828890|NCT04105998|449002023|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
124828891|NCT04105998|449002024|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
124828892|NCT00278109|449002028|FG000|Overall Study|Adverse Event|3|||
124828893|NCT00278109|449002028|FG000|Overall Study|social circumstances|1|||
124828894|NCT02580357|449002029|FG000|Overall Study|Lost to Follow-up|2|||
124828895|NCT02580357|449002030|FG001|Overall Study|Lost to Follow-up|0|||
124828896|NCT02580357|449002031|FG002|Overall Study|Lost to Follow-up|0|||
124828897|NCT02580357|449002029|FG000|Overall Study|Protocol Violation|1|||
124828898|NCT02580357|449002030|FG001|Overall Study|Protocol Violation|0|||
124828899|NCT02580357|449002031|FG002|Overall Study|Protocol Violation|0|||
124828900|NCT02064166|449002032|FG000|Overall Study|Adverse Event|1|||
124828901|NCT02064166|449002033|FG001|Overall Study|Adverse Event|0|||
124828902|NCT00619801|449002036|FG000|Overall Study|Lack of Efficacy|0|||
124828903|NCT00619801|449002037|FG001|Overall Study|Lack of Efficacy|1|||
124828904|NCT00619801|449002036|FG000|Overall Study|Withdrawal by Subject|1|||
124828905|NCT00619801|449002037|FG001|Overall Study|Withdrawal by Subject|1|||
124828906|NCT00619801|449002036|FG000|Overall Study|Loss of efficacy|0|||
124828907|NCT00619801|449002037|FG001|Overall Study|Loss of efficacy|1|||
124828908|NCT01106898|449002039|FG000|Overall Study|Adverse Event|6|||
124828909|NCT01698801|449002040|FG000|Treatment Phase|Adverse Event|4|||
124828910|NCT01698801|449002040|FG000|Treatment Phase|Protocol Violation|1|||
124828911|NCT01698801|449002040|FG000|Treatment Phase|Other|4|||
124828912|NCT01698801|449002040|FG000|Treatment Phase|Withdrawal by Subject|1|||
124828913|NCT01698801|449002040|FG000|Treatment Phase|Disease progression|1|||
124828914|NCT01698801|449002040|FG000|Follow Up Phase|Withdrawal by Subject|1|||
124828915|NCT01698801|449002040|FG000|Follow Up Phase|Death|4|||
124828916|NCT02062879|449002043|FG000|Overall Study|Withdrawal by Subject|4|||
124828917|NCT02062879|449002044|FG001|Overall Study|Withdrawal by Subject|1|||
124828918|NCT03251079|449002045|FG000|Overall Study|Withdrawal by Subject|1|||
124828919|NCT04219891|449002046|FG000|Overall Study|Lost to Follow-up|3|||
124828920|NCT04219891|449002046|FG000|Overall Study|Withdrawal by Subject|2|||
124828921|NCT00312494|449004178|FG000|Overall Study|Randomized; not treated with study drug|9|||
124828922|NCT00312494|449004179|FG001|Overall Study|Randomized; not treated with study drug|10|||
124828923|NCT00312494|449004180|FG002|Overall Study|Randomized; not treated with study drug|5|||
124828924|NCT00312494|449004178|FG000|Overall Study|Adverse Event|33|||
124828925|NCT00312494|449004179|FG001|Overall Study|Adverse Event|15|||
124828926|NCT00312494|449004180|FG002|Overall Study|Adverse Event|11|||
124828927|NCT00312494|449004178|FG000|Overall Study|Lack of Efficacy|4|||
124828928|NCT00312494|449004179|FG001|Overall Study|Lack of Efficacy|6|||
124828929|NCT00312494|449004180|FG002|Overall Study|Lack of Efficacy|8|||
124828930|NCT00312494|449004178|FG000|Overall Study|Laboratory abnormality|1|||
125304086|NCT02147288|450739656|FG003|Overall Study|post-operative hematoma|0|||
124828931|NCT00312494|449004179|FG001|Overall Study|Laboratory abnormality|0|||
124828932|NCT00312494|449004180|FG002|Overall Study|Laboratory abnormality|0|||
124828933|NCT00312494|449004178|FG000|Overall Study|Lost to Follow-up|8|||
125304087|NCT02147288|450739657|FG004|Overall Study|post-operative hematoma|0|||
124828934|NCT00312494|449004179|FG001|Overall Study|Lost to Follow-up|8|||
124828935|NCT00312494|449004180|FG002|Overall Study|Lost to Follow-up|8|||
124828936|NCT00312494|449004178|FG000|Overall Study|Withdrawal by Subject|6|||
124828937|NCT00312494|449004179|FG001|Overall Study|Withdrawal by Subject|9|||
124828938|NCT00312494|449004180|FG002|Overall Study|Withdrawal by Subject|10|||
124828939|NCT00312494|449004178|FG000|Overall Study|Other|10|||
124828940|NCT00312494|449004179|FG001|Overall Study|Other|10|||
124828941|NCT00312494|449004180|FG002|Overall Study|Other|1|||
124828942|NCT00413192|449004181|FG000|Overall Study|Disease progression|26|||
124828943|NCT00413192|449004182|FG001|Overall Study|Disease progression|31|||
124828944|NCT00413192|449004183|FG002|Overall Study|Disease progression|16|||
124828945|NCT00413192|449004184|FG003|Overall Study|Disease progression|25|||
124828946|NCT00413192|449004181|FG000|Overall Study|Toxicity|3|||
124828947|NCT00413192|449004182|FG001|Overall Study|Toxicity|2|||
124828948|NCT00413192|449004183|FG002|Overall Study|Toxicity|2|||
124828949|NCT00413192|449004184|FG003|Overall Study|Toxicity|2|||
124828950|NCT00413192|449004181|FG000|Overall Study|Withdrawal by Subject|3|||
124828951|NCT00413192|449004182|FG001|Overall Study|Withdrawal by Subject|5|||
124828952|NCT00413192|449004183|FG002|Overall Study|Withdrawal by Subject|0|||
124828953|NCT00413192|449004184|FG003|Overall Study|Withdrawal by Subject|1|||
124828954|NCT00413192|449004181|FG000|Overall Study|Intercurrent illness|0|||
124828955|NCT00413192|449004182|FG001|Overall Study|Intercurrent illness|0|||
124828956|NCT00413192|449004183|FG002|Overall Study|Intercurrent illness|0|||
124828957|NCT00413192|449004184|FG003|Overall Study|Intercurrent illness|1|||
124828958|NCT00413192|449004181|FG000|Overall Study|Intercurrent death|0|||
124828959|NCT00413192|449004182|FG001|Overall Study|Intercurrent death|1|||
124828960|NCT00413192|449004183|FG002|Overall Study|Intercurrent death|0|||
124828961|NCT00413192|449004184|FG003|Overall Study|Intercurrent death|0|||
124828962|NCT00413192|449004181|FG000|Overall Study|Other|5|||
124828963|NCT00413192|449004182|FG001|Overall Study|Other|1|||
124828964|NCT00413192|449004183|FG002|Overall Study|Other|1|||
124828965|NCT00413192|449004184|FG003|Overall Study|Other|2|||
124828966|NCT00413192|449004181|FG000|Overall Study|Not treated|0|||
124828967|NCT00413192|449004182|FG001|Overall Study|Not treated|0|||
124828968|NCT00413192|449004183|FG002|Overall Study|Not treated|0|||
124828969|NCT00413192|449004184|FG003|Overall Study|Not treated|1|||
124828970|NCT00003901|449004189|FG000|Overall Study|Adverse Event|1|||
124828971|NCT00003901|449004189|FG000|Overall Study|Withdrawal by Subject|1|||
124828972|NCT00003901|449004189|FG000|Overall Study|Ineligible|6|||
124828973|NCT00003901|449004189|FG000|Overall Study|CT Scan not within protocol requirement|2|||
124828974|NCT00003901|449004189|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
124828975|NCT00003901|449004189|FG000|Overall Study|Medical problems|6|||
124828976|NCT02268864|449004191|FG000|Overall Study|Withdrawal by Subject|2|||
124828977|NCT02268864|449004192|FG001|Overall Study|Withdrawal by Subject|0|||
124828978|NCT02268864|449004193|FG002|Overall Study|Withdrawal by Subject|0|||
124828979|NCT02268864|449004191|FG000|Overall Study|Death|0|||
124828980|NCT02268864|449004192|FG001|Overall Study|Death|1|||
124828981|NCT02268864|449004193|FG002|Overall Study|Death|0|||
124828982|NCT00742001|449004196|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
124828983|NCT00742001|449004197|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
124828984|NCT00742001|449004198|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
124828985|NCT02617511|449004199|FG000|Overall Study|Withdrawal by Subject|1|||
124828986|NCT02617511|449004200|FG001|Overall Study|Withdrawal by Subject|0|||
124828987|NCT01050257|449004201|FG000|Overall Study|Adverse Event|4|||
124828988|NCT01050257|449004202|FG001|Overall Study|Adverse Event|4|||
124828989|NCT01050257|449004203|FG002|Overall Study|Adverse Event|2|||
124828990|NCT01050257|449004201|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
124828991|NCT01050257|449004202|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
124828992|NCT01050257|449004203|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
124828993|NCT01050257|449004201|FG000|Overall Study|Withdrawal by Subject|0|||
124828994|NCT01050257|449004202|FG001|Overall Study|Withdrawal by Subject|3|||
124828995|NCT01050257|449004203|FG002|Overall Study|Withdrawal by Subject|0|||
124828996|NCT01050257|449004201|FG000|Overall Study|No reason specified|0|||
124828997|NCT01050257|449004202|FG001|Overall Study|No reason specified|0|||
124828998|NCT01050257|449004203|FG002|Overall Study|No reason specified|2|||
124828999|NCT01050257|449004201|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
124829000|NCT01050257|449004202|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
124829001|NCT01050257|449004203|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
124829002|NCT01050257|449004201|FG000|Overall Study|Violation criteria|0|||
124829003|NCT01050257|449004202|FG001|Overall Study|Violation criteria|1|||
124829004|NCT01050257|449004203|FG002|Overall Study|Violation criteria|0|||
124829005|NCT01050257|449004201|FG000|Overall Study|Failure to return|0|||
124829006|NCT01050257|449004202|FG001|Overall Study|Failure to return|2|||
124829007|NCT01050257|449004203|FG002|Overall Study|Failure to return|0|||
124829008|NCT01050257|449004201|FG000|Overall Study|Death|0|||
124829009|NCT01050257|449004202|FG001|Overall Study|Death|0|||
124829010|NCT01050257|449004203|FG002|Overall Study|Death|1|||
124829011|NCT00171223|449004204|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
124829012|NCT00171223|449004205|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
124829013|NCT00171223|449004206|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
124829014|NCT00171223|449004204|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
124829015|NCT00171223|449004205|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
124829016|NCT00171223|449004206|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
124829017|NCT00171223|449004204|FG000|Overall Study|Abnormal Procedure|1|||
124829018|NCT00171223|449004205|FG001|Overall Study|Abnormal Procedure|0|||
124829019|NCT00171223|449004206|FG002|Overall Study|Abnormal Procedure|0|||
124829020|NCT00171223|449004204|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
124829021|NCT00171223|449004205|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
124829022|NCT00171223|449004206|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
124829023|NCT00171223|449004204|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
124829024|NCT00171223|449004205|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
124829025|NCT00171223|449004206|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
124829026|NCT00171223|449004204|FG000|Overall Study|Protocol Violation|2|||
124829027|NCT00171223|449004205|FG001|Overall Study|Protocol Violation|2|||
124829028|NCT00171223|449004206|FG002|Overall Study|Protocol Violation|3|||
124829029|NCT00171223|449004204|FG000|Overall Study|Participant Withdrew Consent|12|||
124829030|NCT00171223|449004205|FG001|Overall Study|Participant Withdrew Consent|21|||
124829031|NCT00171223|449004206|FG002|Overall Study|Participant Withdrew Consent|15|||
124829032|NCT00171223|449004204|FG000|Overall Study|Lost to Follow-up|5|||
124829033|NCT00171223|449004205|FG001|Overall Study|Lost to Follow-up|2|||
124829034|NCT00171223|449004206|FG002|Overall Study|Lost to Follow-up|3|||
124829035|NCT00171223|449004204|FG000|Overall Study|Administrative Problems|4|||
124829036|NCT00171223|449004205|FG001|Overall Study|Administrative Problems|7|||
124829037|NCT00171223|449004206|FG002|Overall Study|Administrative Problems|6|||
124829038|NCT00171223|449004204|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
124829039|NCT00171223|449004205|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
124829040|NCT00171223|449004206|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
124829041|NCT00171223|449004204|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
124829042|NCT00171223|449004205|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
124829043|NCT00171223|449004206|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
124829044|NCT00730912|449004215|FG000|Overall Study|Discontinued|0|||
124829045|NCT00730912|449004216|FG001|Overall Study|Discontinued|0|||
124829046|NCT00730912|449004217|FG002|Overall Study|Discontinued|1|||
124829047|NCT03311659|449004222|FG000|Overall Study|Protocol Violation|1|||
124829048|NCT04053023|449004223|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
124829049|NCT04053023|449004224|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
124829050|NCT00071760|449004225|FG000|Overall Study|Adverse Event|2|||
124829051|NCT00071760|449004226|FG001|Overall Study|Adverse Event|1|||
124829052|NCT00071760|449004225|FG000|Overall Study|Lost to Follow-up|0|||
124829053|NCT00071760|449004226|FG001|Overall Study|Lost to Follow-up|3|||
124829054|NCT00071760|449004225|FG000|Overall Study|Protocol Violation|1|||
124829055|NCT00071760|449004226|FG001|Overall Study|Protocol Violation|0|||
124829056|NCT00071760|449004225|FG000|Overall Study|Withdrawal by Subject|0|||
124829057|NCT00071760|449004226|FG001|Overall Study|Withdrawal by Subject|1|||
124829058|NCT00071760|449004225|FG000|Overall Study|Insufficient Viral Load Response|1|||
124829059|NCT00071760|449004226|FG001|Overall Study|Insufficient Viral Load Response|1|||
124829060|NCT00071760|449004225|FG000|Overall Study|Lack of availability of RTV|1|||
124829061|NCT00071760|449004226|FG001|Overall Study|Lack of availability of RTV|0|||
124829062|NCT00071760|449004225|FG000|Overall Study|Physician Decision|2|||
124829063|NCT00071760|449004226|FG001|Overall Study|Physician Decision|1|||
124829064|NCT00071760|449004225|FG000|Overall Study|Relocation|0|||
124829065|NCT00071760|449004226|FG001|Overall Study|Relocation|1|||
124829066|NCT01994629|449004227|FG000|Overall Study|Withdrawal by Subject|1|||
124829067|NCT01994629|449004228|FG001|Overall Study|Withdrawal by Subject|0|||
124829068|NCT01994629|449004227|FG000|Overall Study|Lost to Follow-up|0|||
124829069|NCT01994629|449004228|FG001|Overall Study|Lost to Follow-up|3|||
124829070|NCT03424265|449004229|FG000|Overall Study|screening failure|1|||
124829071|NCT03424265|449004230|FG001|Overall Study|screening failure|0|||
124829072|NCT03424265|449004229|FG000|Overall Study|Withdrawal by Subject|0|||
124829073|NCT03424265|449004230|FG001|Overall Study|Withdrawal by Subject|2|||
124829074|NCT01558752|449004231|FG000|Overall Study|Physician Decision|2|||
124829075|NCT01558752|449004232|FG001|Overall Study|Physician Decision|0|||
124829076|NCT00894322|449004241|FG000|Overall Study|Withdrawal by Subject|1|||
124829077|NCT00894322|449004242|FG001|Overall Study|Withdrawal by Subject|0|||
124829078|NCT00894322|449004243|FG002|Overall Study|Withdrawal by Subject|0|||
124829079|NCT03338855|449004245|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
124829080|NCT03338855|449004246|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
124829081|NCT00511667|449004247|FG000|Overall Study|Adverse Event|1|||
124829082|NCT00511667|449004248|FG001|Overall Study|Adverse Event|0|||
124829083|NCT00511667|449004247|FG000|Overall Study|Protocol Violation|1|||
124829084|NCT00511667|449004248|FG001|Overall Study|Protocol Violation|1|||
124829085|NCT00511667|449004247|FG000|Overall Study|Withdrawal by Subject|2|||
124829086|NCT00511667|449004248|FG001|Overall Study|Withdrawal by Subject|0|||
124829087|NCT00511667|449004247|FG000|Overall Study|Site terminated|6|||
124829088|NCT00511667|449004248|FG001|Overall Study|Site terminated|1|||
124829089|NCT00511667|449004247|FG000|Overall Study|Other|2|||
124829090|NCT00511667|449004248|FG001|Overall Study|Other|1|||
124829091|NCT00056407|449004249|FG000|Overall Study|Adverse Event|282|||
125304088|NCT02147288|450739658|FG005|Overall Study|post-operative hematoma|0|||
124829092|NCT00056407|449004250|FG001|Overall Study|Adverse Event|364|||
124829093|NCT00056407|449004249|FG000|Overall Study|Withdrawal by Subject|377|||
124829094|NCT00056407|449004250|FG001|Overall Study|Withdrawal by Subject|361|||
124829095|NCT00056407|449004249|FG000|Overall Study|Lost to Follow-up|123|||
124829096|NCT00056407|449004250|FG001|Overall Study|Lost to Follow-up|113|||
124829097|NCT00056407|449004249|FG000|Overall Study|Protocol Violation|104|||
124829098|NCT00056407|449004250|FG001|Overall Study|Protocol Violation|95|||
124829099|NCT00056407|449004249|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
124829100|NCT00056407|449004250|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
124829101|NCT00056407|449004249|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
124829102|NCT00056407|449004250|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
124829103|NCT00056407|449004249|FG000|Overall Study|Missing|25|||
124829104|NCT00056407|449004250|FG001|Overall Study|Missing|34|||
124829105|NCT02738450|449004251|FG000|Overall Study|Withdrawal by Subject|0|||
124829106|NCT02738450|449004252|FG001|Overall Study|Withdrawal by Subject|2|||
124829107|NCT02738450|449004253|FG002|Overall Study|Withdrawal by Subject|0|||
124829108|NCT00455429|449004260|FG000|Overall Study|Study Terminated by Sponsor|0|||
124829109|NCT00455429|449004261|FG001|Overall Study|Study Terminated by Sponsor|0|||
124829110|NCT00455429|449004262|FG002|Overall Study|Study Terminated by Sponsor|0|||
124829111|NCT00455429|449004263|FG003|Overall Study|Study Terminated by Sponsor|3|||
124829112|NCT00455429|449004260|FG000|Overall Study|Lost to Follow-up|1|||
124829113|NCT00455429|449004261|FG001|Overall Study|Lost to Follow-up|0|||
124829114|NCT00455429|449004262|FG002|Overall Study|Lost to Follow-up|0|||
124829115|NCT00455429|449004263|FG003|Overall Study|Lost to Follow-up|3|||
124829116|NCT00455429|449004260|FG000|Overall Study|Withdrawal by Subject|0|||
124829117|NCT00455429|449004261|FG001|Overall Study|Withdrawal by Subject|1|||
124829118|NCT00455429|449004262|FG002|Overall Study|Withdrawal by Subject|1|||
124829119|NCT00455429|449004263|FG003|Overall Study|Withdrawal by Subject|0|||
124829120|NCT00455429|449004260|FG000|Overall Study|Lack of Efficacy|0|||
124829121|NCT00455429|449004261|FG001|Overall Study|Lack of Efficacy|1|||
124829122|NCT00455429|449004262|FG002|Overall Study|Lack of Efficacy|0|||
124829123|NCT00455429|449004263|FG003|Overall Study|Lack of Efficacy|1|||
124829124|NCT00455429|449004260|FG000|Overall Study|Adverse Event|0|||
124829125|NCT00455429|449004261|FG001|Overall Study|Adverse Event|1|||
124829126|NCT00455429|449004262|FG002|Overall Study|Adverse Event|0|||
124829127|NCT00455429|449004263|FG003|Overall Study|Adverse Event|3|||
124829128|NCT00455429|449004260|FG000|Overall Study|Randomly assigned but not treated|0|||
124829129|NCT00455429|449004261|FG001|Overall Study|Randomly assigned but not treated|0|||
124829130|NCT00455429|449004262|FG002|Overall Study|Randomly assigned but not treated|0|||
124829131|NCT00455429|449004263|FG003|Overall Study|Randomly assigned but not treated|2|||
124829132|NCT00455429|449004260|FG000|Overall Study|Personal Reason|1|||
124829133|NCT00455429|449004261|FG001|Overall Study|Personal Reason|0|||
124829134|NCT00455429|449004262|FG002|Overall Study|Personal Reason|0|||
124829135|NCT00455429|449004263|FG003|Overall Study|Personal Reason|0|||
124829136|NCT00455429|449004260|FG000|Overall Study|Non-compliance|0|||
124829137|NCT00455429|449004261|FG001|Overall Study|Non-compliance|0|||
124829138|NCT00455429|449004262|FG002|Overall Study|Non-compliance|0|||
124829139|NCT00455429|449004263|FG003|Overall Study|Non-compliance|1|||
124829140|NCT00455429|449004260|FG000|Overall Study|Other|0|||
124829141|NCT00455429|449004261|FG001|Overall Study|Other|2|||
124829142|NCT00455429|449004262|FG002|Overall Study|Other|0|||
124829143|NCT00455429|449004263|FG003|Overall Study|Other|1|||
124829144|NCT01165554|449004264|FG000|Overall Study|Withdrawal by Subject|23|||
124829145|NCT02951156|449004271|FG000|Overall Study|Death|3|||
124829146|NCT02951156|449004272|FG001|Overall Study|Death|8|||
124829147|NCT02951156|449004273|FG002|Overall Study|Death|5|||
124829148|NCT02951156|449004271|FG000|Overall Study|Progressive disease|1|||
124829149|NCT02951156|449004272|FG001|Overall Study|Progressive disease|0|||
124829150|NCT02951156|449004273|FG002|Overall Study|Progressive disease|1|||
124829151|NCT02951156|449004271|FG000|Overall Study|Withdrawal by Subject|0|||
124829152|NCT02951156|449004272|FG001|Overall Study|Withdrawal by Subject|0|||
124829153|NCT02951156|449004273|FG002|Overall Study|Withdrawal by Subject|1|||
124829154|NCT02951156|449004271|FG000|Overall Study|Study terminated by sponsor|0|||
124829155|NCT02951156|449004272|FG001|Overall Study|Study terminated by sponsor|0|||
124829156|NCT02951156|449004273|FG002|Overall Study|Study terminated by sponsor|1|||
124829157|NCT02951156|449004271|FG000|Overall Study|Other|5|||
124829158|NCT02951156|449004272|FG001|Overall Study|Other|1|||
124829159|NCT02951156|449004273|FG002|Overall Study|Other|2|||
124829160|NCT04351087|449004274|FG000|Overall Study|Lost to Follow-up|7|||
124829161|NCT04351087|449004275|FG001|Overall Study|Lost to Follow-up|3|||
124829162|NCT04351087|449004274|FG000|Overall Study|Withdrawal by Subject|3|||
124829163|NCT04351087|449004275|FG001|Overall Study|Withdrawal by Subject|4|||
124829164|NCT04351087|449004274|FG000|Overall Study|Lack of Efficacy|3|||
124829165|NCT04351087|449004275|FG001|Overall Study|Lack of Efficacy|2|||
124829166|NCT03519347|449004278|FG000|Interventional Crossover Period 1|Death|0|||
124829167|NCT03519347|449004279|FG001|Interventional Crossover Period 1|Death|0|||
124829168|NCT03519347|449004280|FG002|Interventional Crossover Period 1|Death|0|||
124829169|NCT03519347|449004281|FG003|Interventional Crossover Period 1|Death|1|||
124829170|NCT05517382|449004282|FG000|Overall Study|Lost to Follow-up|0|||
124829171|NCT05517382|449004283|FG001|Overall Study|Lost to Follow-up|1|||
124829172|NCT01641692|449004284|FG000|Treatment Period 1|Adverse Event|1|||
124829173|NCT01641692|449004285|FG001|Treatment Period 1|Adverse Event|0|||
124829174|NCT01641692|449004286|FG002|Treatment Period 1|Adverse Event|0|||
124829175|NCT01641692|449004287|FG003|Treatment Period 1|Adverse Event|0|||
124829176|NCT01641692|449004288|FG004|Treatment Period 1|Adverse Event|0|||
124829177|NCT01641692|449004289|FG005|Treatment Period 1|Adverse Event|0|||
124829178|NCT01641692|449004290|FG006|Treatment Period 1|Adverse Event|0|||
124829179|NCT01641692|449004291|FG007|Treatment Period 1|Adverse Event|0|||
124829180|NCT01641692|449004284|FG000|Treatment Period 1|Lack of Efficacy|0|||
124829181|NCT01641692|449004285|FG001|Treatment Period 1|Lack of Efficacy|0|||
124829182|NCT01641692|449004286|FG002|Treatment Period 1|Lack of Efficacy|0|||
124829183|NCT01641692|449004287|FG003|Treatment Period 1|Lack of Efficacy|0|||
124829184|NCT01641692|449004288|FG004|Treatment Period 1|Lack of Efficacy|0|||
124829185|NCT01641692|449004289|FG005|Treatment Period 1|Lack of Efficacy|0|||
124829186|NCT01641692|449004290|FG006|Treatment Period 1|Lack of Efficacy|0|||
124829187|NCT01641692|449004291|FG007|Treatment Period 1|Lack of Efficacy|1|||
125304089|NCT02147288|450739659|FG006|Overall Study|post-operative hematoma|0|||
125304090|NCT02147288|450739660|FG007|Overall Study|post-operative hematoma|0|||
125304091|NCT02147288|450739661|FG008|Overall Study|post-operative hematoma|0|||
125304092|NCT02147288|450739662|FG009|Overall Study|post-operative hematoma|0|||
125304093|NCT02147288|450739653|FG000|Overall Study|complications from concurrent hernia rep|0|||
124829188|NCT01641692|449004284|FG000|Treatment Period 1|Protocol Violation|1|||
124829189|NCT01641692|449004285|FG001|Treatment Period 1|Protocol Violation|0|||
124829190|NCT01641692|449004286|FG002|Treatment Period 1|Protocol Violation|0|||
124829191|NCT01641692|449004287|FG003|Treatment Period 1|Protocol Violation|0|||
124829192|NCT01641692|449004288|FG004|Treatment Period 1|Protocol Violation|2|||
124829193|NCT01641692|449004289|FG005|Treatment Period 1|Protocol Violation|0|||
124829194|NCT01641692|449004290|FG006|Treatment Period 1|Protocol Violation|0|||
124829195|NCT01641692|449004291|FG007|Treatment Period 1|Protocol Violation|0|||
124829196|NCT01641692|449004284|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
124829197|NCT01641692|449004285|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
124829198|NCT01641692|449004286|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
124829199|NCT01641692|449004287|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
124829200|NCT01641692|449004288|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
124829201|NCT01641692|449004289|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
124829202|NCT01641692|449004290|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
124829203|NCT01641692|449004291|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
124829204|NCT01641692|449004284|FG000|Treatment Period 1|Lost to Follow-up|0|||
124829205|NCT01641692|449004285|FG001|Treatment Period 1|Lost to Follow-up|0|||
124829206|NCT01641692|449004286|FG002|Treatment Period 1|Lost to Follow-up|1|||
124829207|NCT01641692|449004287|FG003|Treatment Period 1|Lost to Follow-up|0|||
124829208|NCT01641692|449004288|FG004|Treatment Period 1|Lost to Follow-up|0|||
124829209|NCT01641692|449004289|FG005|Treatment Period 1|Lost to Follow-up|0|||
124829210|NCT01641692|449004290|FG006|Treatment Period 1|Lost to Follow-up|0|||
124829211|NCT01641692|449004291|FG007|Treatment Period 1|Lost to Follow-up|0|||
124829212|NCT01641692|449004284|FG000|Treatment Period 1|Physician Decision|0|||
124829213|NCT01641692|449004285|FG001|Treatment Period 1|Physician Decision|0|||
124829214|NCT01641692|449004286|FG002|Treatment Period 1|Physician Decision|0|||
124829215|NCT01641692|449004287|FG003|Treatment Period 1|Physician Decision|0|||
124829216|NCT01641692|449004288|FG004|Treatment Period 1|Physician Decision|1|||
124829217|NCT01641692|449004289|FG005|Treatment Period 1|Physician Decision|0|||
124829218|NCT01641692|449004290|FG006|Treatment Period 1|Physician Decision|0|||
124829219|NCT01641692|449004291|FG007|Treatment Period 1|Physician Decision|0|||
124829220|NCT01641692|449004284|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124829221|NCT01641692|449004285|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124829222|NCT01641692|449004286|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124829223|NCT01641692|449004287|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124829224|NCT01641692|449004288|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124829225|NCT01641692|449004289|FG005|Treatment Period 1|Withdrawal by Subject|2|||
124829226|NCT01641692|449004290|FG006|Treatment Period 1|Withdrawal by Subject|0|||
124829227|NCT01641692|449004291|FG007|Treatment Period 1|Withdrawal by Subject|1|||
124829228|NCT01641692|449004284|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
124829229|NCT01641692|449004285|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
124829230|NCT01641692|449004286|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
124829231|NCT01641692|449004287|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
124829232|NCT01641692|449004288|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
124829233|NCT01641692|449004289|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
124829234|NCT01641692|449004290|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
124829235|NCT01641692|449004291|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
124829236|NCT01641692|449004284|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124829237|NCT01641692|449004285|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124829238|NCT01641692|449004286|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124829239|NCT01641692|449004287|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124829240|NCT01641692|449004288|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124829241|NCT01641692|449004289|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124829242|NCT01641692|449004290|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
124829243|NCT01641692|449004291|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124829244|NCT01641692|449004284|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
124829245|NCT01641692|449004285|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
124829246|NCT01641692|449004286|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
124829247|NCT01641692|449004287|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
124829248|NCT01641692|449004288|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
124829249|NCT01641692|449004289|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
124829250|NCT01641692|449004290|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
125304094|NCT02147288|450739654|FG001|Overall Study|complications from concurrent hernia rep|1|||
125304095|NCT02147288|450739655|FG002|Overall Study|complications from concurrent hernia rep|0|||
124829251|NCT01641692|449004291|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
124829252|NCT01641692|449004284|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
124829253|NCT01641692|449004285|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
124829254|NCT01641692|449004286|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
125304096|NCT02147288|450739656|FG003|Overall Study|complications from concurrent hernia rep|0|||
124829255|NCT01641692|449004287|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
124829256|NCT01641692|449004288|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
124829257|NCT01641692|449004289|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
124829258|NCT01641692|449004290|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
124829259|NCT01641692|449004291|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
124829260|NCT01641692|449004284|FG000|Treatment Period 2|Lack of Efficacy|1|||
124829261|NCT01641692|449004285|FG001|Treatment Period 2|Lack of Efficacy|0|||
124829262|NCT01641692|449004286|FG002|Treatment Period 2|Lack of Efficacy|0|||
124829263|NCT01641692|449004287|FG003|Treatment Period 2|Lack of Efficacy|0|||
124829264|NCT01641692|449004288|FG004|Treatment Period 2|Lack of Efficacy|0|||
124829265|NCT01641692|449004289|FG005|Treatment Period 2|Lack of Efficacy|0|||
124829266|NCT01641692|449004290|FG006|Treatment Period 2|Lack of Efficacy|0|||
124829267|NCT01641692|449004291|FG007|Treatment Period 2|Lack of Efficacy|0|||
124829268|NCT01641692|449004284|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
124829269|NCT01641692|449004285|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124829270|NCT01641692|449004286|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124829271|NCT01641692|449004287|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124829272|NCT01641692|449004288|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124829273|NCT01641692|449004289|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124829274|NCT01641692|449004290|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124829275|NCT01641692|449004291|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124829276|NCT01641692|449004284|FG000|Treatment Period 2|Lost to Follow-up|0|||
124829277|NCT01641692|449004285|FG001|Treatment Period 2|Lost to Follow-up|0|||
124829278|NCT01641692|449004286|FG002|Treatment Period 2|Lost to Follow-up|0|||
124829279|NCT01641692|449004287|FG003|Treatment Period 2|Lost to Follow-up|0|||
124829280|NCT01641692|449004288|FG004|Treatment Period 2|Lost to Follow-up|0|||
124829281|NCT01641692|449004289|FG005|Treatment Period 2|Lost to Follow-up|1|||
124829282|NCT01641692|449004290|FG006|Treatment Period 2|Lost to Follow-up|0|||
124829283|NCT01641692|449004291|FG007|Treatment Period 2|Lost to Follow-up|0|||
124829284|NCT01641692|449004284|FG000|Treatment Period 2|Withdrawal by Subject|1|||
124829285|NCT01641692|449004285|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124829286|NCT01641692|449004286|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124829287|NCT01641692|449004287|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124829288|NCT01641692|449004288|FG004|Treatment Period 2|Withdrawal by Subject|0|||
124829289|NCT01641692|449004289|FG005|Treatment Period 2|Withdrawal by Subject|1|||
124829290|NCT01641692|449004290|FG006|Treatment Period 2|Withdrawal by Subject|0|||
124829291|NCT01641692|449004291|FG007|Treatment Period 2|Withdrawal by Subject|1|||
124829292|NCT01641692|449004284|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
124829293|NCT01641692|449004285|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
124829294|NCT01641692|449004286|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
124829295|NCT01641692|449004287|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
124829296|NCT01641692|449004288|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
124829297|NCT01641692|449004289|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
124829298|NCT01641692|449004290|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
124829299|NCT01641692|449004291|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
124829300|NCT01641692|449004284|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
124829301|NCT01641692|449004285|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
124829302|NCT01641692|449004286|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
124829303|NCT01641692|449004287|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
124829304|NCT01641692|449004288|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
124829305|NCT01641692|449004289|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
124829306|NCT01641692|449004290|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
124829307|NCT01641692|449004291|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
124829308|NCT01641692|449004284|FG000|Treatment Period 3|Adverse Event|0|||
124829309|NCT01641692|449004285|FG001|Treatment Period 3|Adverse Event|0|||
124829310|NCT01641692|449004286|FG002|Treatment Period 3|Adverse Event|0|||
124829311|NCT01641692|449004287|FG003|Treatment Period 3|Adverse Event|0|||
124829312|NCT01641692|449004288|FG004|Treatment Period 3|Adverse Event|0|||
124829313|NCT01641692|449004289|FG005|Treatment Period 3|Adverse Event|0|||
124829314|NCT01641692|449004290|FG006|Treatment Period 3|Adverse Event|1|||
124829315|NCT01641692|449004291|FG007|Treatment Period 3|Adverse Event|0|||
124829316|NCT01641692|449004284|FG000|Treatment Period 3|Protocol Violation|0|||
124829317|NCT01641692|449004285|FG001|Treatment Period 3|Protocol Violation|0|||
124829318|NCT01641692|449004286|FG002|Treatment Period 3|Protocol Violation|1|||
124829319|NCT01641692|449004287|FG003|Treatment Period 3|Protocol Violation|0|||
124829320|NCT01641692|449004288|FG004|Treatment Period 3|Protocol Violation|0|||
124829321|NCT01641692|449004289|FG005|Treatment Period 3|Protocol Violation|0|||
124829322|NCT01641692|449004290|FG006|Treatment Period 3|Protocol Violation|0|||
124829323|NCT01641692|449004291|FG007|Treatment Period 3|Protocol Violation|0|||
124829324|NCT01641692|449004284|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124829325|NCT01641692|449004285|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124829326|NCT01641692|449004286|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124829327|NCT01641692|449004287|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124829328|NCT01641692|449004288|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124829329|NCT01641692|449004289|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124829330|NCT01641692|449004290|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
124829331|NCT01641692|449004291|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124829332|NCT01641692|449004284|FG000|Treatment Period 3|Lost to Follow-up|0|||
124829333|NCT01641692|449004285|FG001|Treatment Period 3|Lost to Follow-up|1|||
124829334|NCT01641692|449004286|FG002|Treatment Period 3|Lost to Follow-up|0|||
124829335|NCT01641692|449004287|FG003|Treatment Period 3|Lost to Follow-up|0|||
124829336|NCT01641692|449004288|FG004|Treatment Period 3|Lost to Follow-up|0|||
124829337|NCT01641692|449004289|FG005|Treatment Period 3|Lost to Follow-up|0|||
124829338|NCT01641692|449004290|FG006|Treatment Period 3|Lost to Follow-up|0|||
124829339|NCT01641692|449004291|FG007|Treatment Period 3|Lost to Follow-up|0|||
124829340|NCT01641692|449004284|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
124829341|NCT01641692|449004285|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
124829342|NCT01641692|449004286|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
124829343|NCT01641692|449004287|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
124829344|NCT01641692|449004288|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
124829345|NCT01641692|449004289|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
124829346|NCT01641692|449004290|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
124829347|NCT01641692|449004291|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
124829348|NCT01641692|449004284|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
124829349|NCT01641692|449004285|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
124829350|NCT01641692|449004286|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
124829351|NCT01641692|449004287|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
124829352|NCT01641692|449004288|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
124829353|NCT01641692|449004289|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
124829354|NCT01641692|449004290|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
124829355|NCT01641692|449004291|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
124829356|NCT00484939|449004298|FG000|Overall Study|Death|9|||
124829357|NCT00484939|449004299|FG001|Overall Study|Death|13|||
124829358|NCT00484939|449004298|FG000|Overall Study|Adverse Event|22|||
124829359|NCT00484939|449004299|FG001|Overall Study|Adverse Event|12|||
124829360|NCT00484939|449004298|FG000|Overall Study|Patient Withdrew Consent|19|||
124829361|NCT00484939|449004299|FG001|Overall Study|Patient Withdrew Consent|10|||
124829362|NCT00484939|449004298|FG000|Overall Study|Protocol Violation|3|||
124829363|NCT00484939|449004299|FG001|Overall Study|Protocol Violation|3|||
124829364|NCT00484939|449004298|FG000|Overall Study|Lost to Follow-up|0|||
124829365|NCT00484939|449004299|FG001|Overall Study|Lost to Follow-up|3|||
124829366|NCT00484939|449004298|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
124829367|NCT00484939|449004299|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
124829368|NCT00484939|449004298|FG000|Overall Study|Disease progression|67|||
124829369|NCT00484939|449004299|FG001|Overall Study|Disease progression|88|||
124829370|NCT00484939|449004298|FG000|Overall Study|Screen Failure|2|||
124829371|NCT00484939|449004299|FG001|Overall Study|Screen Failure|2|||
124829372|NCT00484939|449004298|FG000|Overall Study|Reason Not Specified|11|||
124829373|NCT00484939|449004299|FG001|Overall Study|Reason Not Specified|6|||
124829374|NCT04948450|449004300|FG000|Overall Study|Return home|1|||
124829375|NCT04948450|449004301|FG001|Overall Study|Return home|3|||
124829376|NCT01173718|449004320|FG000|Overall Study|Death|17|||
124829377|NCT01173718|449004320|FG000|Overall Study|Abandonment of study graft|27|||
124829378|NCT01367158|449004321|FG000|Overall Study|Withdrew consent|0|||
124829379|NCT01367158|449004322|FG001|Overall Study|Withdrew consent|2|||
124829380|NCT01367158|449004323|FG002|Overall Study|Withdrew consent|1|||
124829381|NCT01367158|449004324|FG003|Overall Study|Withdrew consent|0|||
124829382|NCT01367158|449004325|FG004|Overall Study|Withdrew consent|2|||
124829383|NCT01367158|449004326|FG005|Overall Study|Withdrew consent|0|||
124829384|NCT01367158|449004327|FG006|Overall Study|Withdrew consent|0|||
125304097|NCT02147288|450739657|FG004|Overall Study|complications from concurrent hernia rep|0|||
125309881|NCT00511238|450760204|FG000|Overall Study|Adverse Event|13|||
124829385|NCT01367158|449004328|FG007|Overall Study|Withdrew consent|1|||
124829386|NCT01367158|449004329|FG008|Overall Study|Withdrew consent|0|||
124829387|NCT01367158|449004330|FG009|Overall Study|Withdrew consent|0|||
124829388|NCT01367158|449004331|FG010|Overall Study|Withdrew consent|0|||
124829389|NCT01367158|449004321|FG000|Overall Study|Lost to Follow-up|0|||
124829390|NCT01367158|449004322|FG001|Overall Study|Lost to Follow-up|0|||
124829391|NCT01367158|449004323|FG002|Overall Study|Lost to Follow-up|0|||
124829392|NCT01367158|449004324|FG003|Overall Study|Lost to Follow-up|1|||
124829393|NCT01367158|449004325|FG004|Overall Study|Lost to Follow-up|0|||
124829394|NCT01367158|449004326|FG005|Overall Study|Lost to Follow-up|2|||
124829395|NCT01367158|449004327|FG006|Overall Study|Lost to Follow-up|0|||
124829396|NCT01367158|449004328|FG007|Overall Study|Lost to Follow-up|1|||
124829397|NCT01367158|449004329|FG008|Overall Study|Lost to Follow-up|0|||
124829398|NCT01367158|449004330|FG009|Overall Study|Lost to Follow-up|0|||
124829399|NCT01367158|449004331|FG010|Overall Study|Lost to Follow-up|1|||
124829400|NCT01367158|449004321|FG000|Overall Study|Protocol Violation|0|||
124829401|NCT01367158|449004322|FG001|Overall Study|Protocol Violation|1|||
124829402|NCT01367158|449004323|FG002|Overall Study|Protocol Violation|0|||
124829403|NCT01367158|449004324|FG003|Overall Study|Protocol Violation|0|||
124829404|NCT01367158|449004325|FG004|Overall Study|Protocol Violation|0|||
124829405|NCT01367158|449004326|FG005|Overall Study|Protocol Violation|0|||
124829406|NCT01367158|449004327|FG006|Overall Study|Protocol Violation|0|||
124829407|NCT01367158|449004328|FG007|Overall Study|Protocol Violation|0|||
124829408|NCT01367158|449004329|FG008|Overall Study|Protocol Violation|0|||
124829409|NCT01367158|449004330|FG009|Overall Study|Protocol Violation|0|||
124829410|NCT01367158|449004331|FG010|Overall Study|Protocol Violation|0|||
124829411|NCT02226003|449004333|FG000|Overall Study|Lost to Follow-up|2|||
124829412|NCT02226003|449004334|FG001|Overall Study|Lost to Follow-up|1|||
124829413|NCT02226003|449004335|FG002|Overall Study|Lost to Follow-up|3|||
124829414|NCT02226003|449004333|FG000|Overall Study|Withdrawal by Subject|0|||
124829415|NCT02226003|449004334|FG001|Overall Study|Withdrawal by Subject|0|||
124829416|NCT02226003|449004335|FG002|Overall Study|Withdrawal by Subject|3|||
124829417|NCT00296374|449004345|FG000|Overall Study|Adverse Event|14|||
124829418|NCT00296374|449004346|FG001|Overall Study|Adverse Event|10|||
124829419|NCT00296374|449004347|FG002|Overall Study|Adverse Event|7|||
124829420|NCT00296374|449004345|FG000|Overall Study|Withdrawal by Subject|3|||
124829421|NCT00296374|449004346|FG001|Overall Study|Withdrawal by Subject|5|||
124829422|NCT00296374|449004347|FG002|Overall Study|Withdrawal by Subject|11|||
124829423|NCT00296374|449004345|FG000|Overall Study|Incorrect enrollment|3|||
124829424|NCT00296374|449004346|FG001|Overall Study|Incorrect enrollment|3|||
124829425|NCT00296374|449004347|FG002|Overall Study|Incorrect enrollment|4|||
124829426|NCT00296374|449004345|FG000|Overall Study|Protocol Violation|1|||
124829427|NCT00296374|449004346|FG001|Overall Study|Protocol Violation|2|||
124829428|NCT00296374|449004347|FG002|Overall Study|Protocol Violation|3|||
124829429|NCT00296374|449004345|FG000|Overall Study|Lost to Follow-up|3|||
124829430|NCT00296374|449004346|FG001|Overall Study|Lost to Follow-up|1|||
124829431|NCT00296374|449004347|FG002|Overall Study|Lost to Follow-up|1|||
124829432|NCT00296374|449004345|FG000|Overall Study|Relocated to another state|1|||
124829433|NCT00296374|449004346|FG001|Overall Study|Relocated to another state|0|||
124829434|NCT00296374|449004347|FG002|Overall Study|Relocated to another state|0|||
124829435|NCT00296374|449004345|FG000|Overall Study|Stopped drug before end of study visit|0|||
124829436|NCT00296374|449004346|FG001|Overall Study|Stopped drug before end of study visit|1|||
124829437|NCT00296374|449004347|FG002|Overall Study|Stopped drug before end of study visit|0|||
124829438|NCT00296374|449004345|FG000|Overall Study|Nephrologist introduced ACE|0|||
124829439|NCT00296374|449004346|FG001|Overall Study|Nephrologist introduced ACE|1|||
124829440|NCT00296374|449004347|FG002|Overall Study|Nephrologist introduced ACE|0|||
124829441|NCT00296374|449004345|FG000|Overall Study|Pregnancy|0|||
124829442|NCT00296374|449004346|FG001|Overall Study|Pregnancy|0|||
124829443|NCT00296374|449004347|FG002|Overall Study|Pregnancy|2|||
124829444|NCT00296374|449004345|FG000|Overall Study|Other|0|||
124829445|NCT00296374|449004346|FG001|Overall Study|Other|0|||
124829446|NCT00296374|449004347|FG002|Overall Study|Other|1|||
124829447|NCT00670800|449005927|FG000|Overall Study|2 controls were insulin resistant|0|||
124829448|NCT00670800|449005928|FG001|Overall Study|2 controls were insulin resistant|2|||
124829449|NCT01786629|449005929|FG000|Overall Study|Lack of Efficacy|0|||
124829450|NCT01786629|449005930|FG001|Overall Study|Lack of Efficacy|4|||
124829451|NCT01786629|449005929|FG000|Overall Study|Adverse Event|0|||
124829452|NCT01786629|449005930|FG001|Overall Study|Adverse Event|1|||
124829453|NCT02926924|449005931|FG000|Overall Study|withdrawal - reason unknown|0|||
124829454|NCT02926924|449005932|FG001|Overall Study|withdrawal - reason unknown|1|||
124829455|NCT01852942|449005935|FG000|Overall Study|Physician Decision|1|||
124829456|NCT01852942|449005936|FG001|Overall Study|Physician Decision|0|||
124829457|NCT01852942|449005935|FG000|Overall Study|Death|1|||
124829458|NCT01852942|449005936|FG001|Overall Study|Death|1|||
124829459|NCT01852942|449005935|FG000|Overall Study|Withdrawal by Subject|2|||
124829460|NCT01852942|449005936|FG001|Overall Study|Withdrawal by Subject|3|||
124829461|NCT01852942|449005935|FG000|Overall Study|Lost to Follow-up|1|||
124829462|NCT01852942|449005936|FG001|Overall Study|Lost to Follow-up|2|||
124829463|NCT01921179|449005937|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
124829464|NCT01921179|449005938|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
125304098|NCT02147288|450739658|FG005|Overall Study|complications from concurrent hernia rep|0|||
124829465|NCT01921179|449005937|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
124829466|NCT01921179|449005938|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
124829467|NCT04568590|449005940|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
124829468|NCT00858442|449005944|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
124829469|NCT00858442|449005945|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
124829470|NCT00202644|449005950|FG000|Overall Study|Adverse Event|12|||
124829471|NCT00202644|449005951|FG001|Overall Study|Adverse Event|13|||
125304099|NCT02147288|450739659|FG006|Overall Study|complications from concurrent hernia rep|0|||
124829472|NCT00202644|449005950|FG000|Overall Study|Withdrawal by Subject|8|||
124829473|NCT00202644|449005951|FG001|Overall Study|Withdrawal by Subject|6|||
124829474|NCT00202644|449005950|FG000|Overall Study|Lack of Efficacy|6|||
124829475|NCT00202644|449005951|FG001|Overall Study|Lack of Efficacy|6|||
124829476|NCT00202644|449005950|FG000|Overall Study|Lost to Follow-up|0|||
124829477|NCT00202644|449005951|FG001|Overall Study|Lost to Follow-up|1|||
124829478|NCT00202644|449005950|FG000|Overall Study|Other|9|||
124829479|NCT00202644|449005951|FG001|Overall Study|Other|1|||
124829480|NCT02750592|449005957|FG000|Overall Study|Adverse Event|3|||
124829481|NCT02750592|449005957|FG000|Overall Study|Lack of Efficacy|2|||
124829482|NCT02981342|449005960|FG000|Overall Study|Adverse Event|0|||
124829483|NCT02981342|449005961|FG001|Overall Study|Adverse Event|0|||
124829484|NCT02981342|449005962|FG002|Overall Study|Adverse Event|0|||
124829485|NCT02981342|449005963|FG003|Overall Study|Adverse Event|1|||
124829486|NCT02981342|449005960|FG000|Overall Study|Death|0|||
124829487|NCT02981342|449005961|FG001|Overall Study|Death|9|||
124829488|NCT02981342|449005962|FG002|Overall Study|Death|9|||
124829489|NCT02981342|449005963|FG003|Overall Study|Death|4|||
124829490|NCT02981342|449005960|FG000|Overall Study|Withdrawal by Subject|0|||
124829491|NCT02981342|449005961|FG001|Overall Study|Withdrawal by Subject|0|||
124829492|NCT02981342|449005962|FG002|Overall Study|Withdrawal by Subject|3|||
124829493|NCT02981342|449005963|FG003|Overall Study|Withdrawal by Subject|1|||
124829494|NCT02981342|449005960|FG000|Overall Study|Study closed by sponsor|0|||
124829495|NCT02981342|449005961|FG001|Overall Study|Study closed by sponsor|0|||
124829496|NCT02981342|449005962|FG002|Overall Study|Study closed by sponsor|1|||
124829497|NCT02981342|449005963|FG003|Overall Study|Study closed by sponsor|1|||
124829498|NCT02981342|449005960|FG000|Overall Study|Randomized, Never Treated|0|||
124829499|NCT02981342|449005961|FG001|Overall Study|Randomized, Never Treated|1|||
124829500|NCT02981342|449005962|FG002|Overall Study|Randomized, Never Treated|0|||
124829501|NCT02981342|449005963|FG003|Overall Study|Randomized, Never Treated|7|||
124829502|NCT02981342|449005960|FG000|Overall Study|Lost to Follow-up|0|||
124829503|NCT02981342|449005961|FG001|Overall Study|Lost to Follow-up|1|||
124829504|NCT02981342|449005962|FG002|Overall Study|Lost to Follow-up|0|||
124829505|NCT02981342|449005963|FG003|Overall Study|Lost to Follow-up|0|||
124829506|NCT01372501|449005964|FG000|Overall Study|Adverse Event|4|||
124829507|NCT01372501|449005964|FG000|Overall Study|Device migration|1|||
124829508|NCT01466348|449005965|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
124829509|NCT01466348|449005966|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
124829510|NCT03989440|449005967|FG000|Overall Study|COVID-19 travel restrictions|0|||
124829511|NCT03989440|449005968|FG001|Overall Study|COVID-19 travel restrictions|0|||
124829512|NCT03989440|449005969|FG002|Overall Study|COVID-19 travel restrictions|1|||
124829513|NCT03989440|449005970|FG003|Overall Study|COVID-19 travel restrictions|0|||
124829514|NCT03989440|449005971|FG004|Overall Study|COVID-19 travel restrictions|0|||
124829515|NCT03989440|449005972|FG005|Overall Study|COVID-19 travel restrictions|0|||
124829516|NCT03989440|449005967|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
124829517|NCT03989440|449005968|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
124829518|NCT03989440|449005969|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
124829519|NCT03989440|449005970|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
124829520|NCT03989440|449005971|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
124829521|NCT03989440|449005972|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
124829522|NCT03970733|449005975|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
124829523|NCT03970733|449005976|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
124829524|NCT03970733|449005977|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
124829525|NCT03970733|449005978|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
124829526|NCT03970733|449005979|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
124829527|NCT03970733|449005975|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
124829528|NCT03970733|449005976|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
124829529|NCT03970733|449005977|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
124829530|NCT03970733|449005978|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
124829531|NCT03970733|449005979|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
124829532|NCT03970733|449005975|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
124829533|NCT03970733|449005976|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
124829534|NCT03970733|449005977|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
124829535|NCT03970733|449005978|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
124829536|NCT03970733|449005979|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
124829537|NCT03970733|449005975|FG000|Main Study Phase (18 Months)|Other|1|||
125304100|NCT02147288|450739660|FG007|Overall Study|complications from concurrent hernia rep|0|||
125304101|NCT02147288|450739661|FG008|Overall Study|complications from concurrent hernia rep|0|||
125304102|NCT02147288|450739662|FG009|Overall Study|complications from concurrent hernia rep|0|||
125304103|NCT02467582|450741192|FG000|Allocation|Withdrawal by Subject|1|||
125304104|NCT02467582|450741193|FG001|Allocation|Withdrawal by Subject|0|||
125304105|NCT02467582|450741192|FG000|Follow-up|Death|5|||
124829538|NCT03970733|449005976|FG001|Main Study Phase (18 Months)|Other|1|||
124829539|NCT03970733|449005977|FG002|Main Study Phase (18 Months)|Other|0|||
124829540|NCT03970733|449005978|FG003|Main Study Phase (18 Months)|Other|0|||
125304106|NCT02467582|450741193|FG001|Follow-up|Death|4|||
124829541|NCT03970733|449005979|FG004|Main Study Phase (18 Months)|Other|0|||
124829542|NCT03970733|449005975|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
124829543|NCT03970733|449005976|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
124829544|NCT03970733|449005977|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
124829545|NCT03970733|449005978|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
124829546|NCT03970733|449005979|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
124829547|NCT02189473|449005983|FG000|Overall Study|Death|22|||
124829548|NCT02189473|449005984|FG001|Overall Study|Death|23|||
124829549|NCT02189473|449005983|FG000|Overall Study|Lost to Follow-up|1|||
124829550|NCT02189473|449005984|FG001|Overall Study|Lost to Follow-up|2|||
124829551|NCT01955161|449005985|FG000|Overall Study|Withdrawal before treatment|2|||
124829552|NCT01955161|449005986|FG001|Overall Study|Withdrawal before treatment|0|||
124829553|NCT01955161|449005987|FG002|Overall Study|Withdrawal before treatment|1|||
124829554|NCT01955161|449005985|FG000|Overall Study|Adverse Event|10|||
124829555|NCT01955161|449005986|FG001|Overall Study|Adverse Event|14|||
124829556|NCT01955161|449005987|FG002|Overall Study|Adverse Event|15|||
124829557|NCT01955161|449005985|FG000|Overall Study|Death|1|||
124829558|NCT01955161|449005986|FG001|Overall Study|Death|1|||
124829559|NCT01955161|449005987|FG002|Overall Study|Death|3|||
124829560|NCT01955161|449005985|FG000|Overall Study|Withdrawal by Subject|9|||
124829561|NCT01955161|449005986|FG001|Overall Study|Withdrawal by Subject|8|||
124829562|NCT01955161|449005987|FG002|Overall Study|Withdrawal by Subject|12|||
124829563|NCT01955161|449005985|FG000|Overall Study|Protocol Violation|2|||
124829564|NCT01955161|449005986|FG001|Overall Study|Protocol Violation|0|||
124829565|NCT01955161|449005987|FG002|Overall Study|Protocol Violation|0|||
124829566|NCT01955161|449005985|FG000|Overall Study|Other reason: physician decision|0|||
124829567|NCT01955161|449005986|FG001|Overall Study|Other reason: physician decision|1|||
124829568|NCT01955161|449005987|FG002|Overall Study|Other reason: physician decision|1|||
124829569|NCT01955161|449005985|FG000|Overall Study|Other reason: disallowed medication|1|||
124829570|NCT01955161|449005986|FG001|Overall Study|Other reason: disallowed medication|0|||
124829571|NCT01955161|449005987|FG002|Overall Study|Other reason: disallowed medication|1|||
124829572|NCT01955161|449005985|FG000|Overall Study|Other reason: caregiver unavailable|1|||
124829573|NCT01955161|449005986|FG001|Overall Study|Other reason: caregiver unavailable|0|||
124829574|NCT01955161|449005987|FG002|Overall Study|Other reason: caregiver unavailable|0|||
124829575|NCT01955161|449005985|FG000|Overall Study|Other reason: moved to nursing home|0|||
124829576|NCT01955161|449005986|FG001|Overall Study|Other reason: moved to nursing home|1|||
124829577|NCT01955161|449005987|FG002|Overall Study|Other reason: moved to nursing home|0|||
124829578|NCT01955161|449005985|FG000|Overall Study|Other reason: insufficient compliance|0|||
124829579|NCT01955161|449005986|FG001|Overall Study|Other reason: insufficient compliance|0|||
124829580|NCT01955161|449005987|FG002|Overall Study|Other reason: insufficient compliance|1|||
124829581|NCT01955161|449005985|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
124829582|NCT01955161|449005986|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
124829583|NCT01955161|449005987|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
124829584|NCT01955161|449005985|FG000|Overall Study|Other reason: patient's will|0|||
124829585|NCT01955161|449005986|FG001|Overall Study|Other reason: patient's will|0|||
124829586|NCT01955161|449005987|FG002|Overall Study|Other reason: patient's will|1|||
124829587|NCT02784821|449005990|FG000|Overall Study|Death|0|||
124829588|NCT02784821|449005991|FG001|Overall Study|Death|5|||
124829589|NCT02784821|449005992|FG002|Overall Study|Death|4|||
124829590|NCT02784821|449005993|FG003|Overall Study|Death|5|||
124829591|NCT05333900|449005994|FG000|Overall Study|Protocol Violation|0|||
124829592|NCT05333900|449005995|FG001|Overall Study|Protocol Violation|1|||
124829593|NCT05333900|449005994|FG000|Overall Study|Withdrawal by Subject|0|||
124829594|NCT05333900|449005995|FG001|Overall Study|Withdrawal by Subject|1|||
124829595|NCT05333900|449005994|FG000|Overall Study|COVID-19 Pandemic|1|||
124829596|NCT05333900|449005995|FG001|Overall Study|COVID-19 Pandemic|1|||
124829597|NCT03724812|449005998|FG000|Overall Study|Missed Visit|1|||
124829598|NCT03724812|449005998|FG000|Overall Study|Death|2|||
124829599|NCT03724812|449005998|FG000|Overall Study|Withdrawal by Subject|1|||
125304107|NCT02467582|450741192|FG000|Follow-up|Lost to Follow-up|6|||
125304108|NCT02467582|450741193|FG001|Follow-up|Lost to Follow-up|5|||
124829600|NCT01851720|449005999|FG000|Overall Study|Lost to Follow-up|0|||
124829601|NCT01851720|449006000|FG001|Overall Study|Lost to Follow-up|1|||
124829602|NCT01394523|449006001|FG000|Overall Study|Unable to place block|1|||
124829603|NCT01394523|449006002|FG001|Overall Study|Unable to place block|0|||
124829604|NCT01394523|449006003|FG002|Overall Study|Unable to place block|0|||
124829605|NCT04741074|449006006|FG000|Overall Study|Withdrawal by Subject|1|||
124829606|NCT04741074|449006007|FG001|Overall Study|Withdrawal by Subject|1|||
124829607|NCT04741074|449006006|FG000|Overall Study|Study terminated prematurely|1|||
124829608|NCT04741074|449006007|FG001|Overall Study|Study terminated prematurely|0|||
124829609|NCT02432846|449006008|FG000|Overall Study (4 Arms/Strata)|Death|3|||
124829610|NCT02432846|449006009|FG001|Overall Study (4 Arms/Strata)|Death|2|||
124829611|NCT02432846|449006010|FG002|Overall Study (4 Arms/Strata)|Death|4|||
124829612|NCT02432846|449006011|FG003|Overall Study (4 Arms/Strata)|Death|3|||
125304109|NCT01370265|450741194|FG000|First Intervention|Adverse Event|1|||
124829613|NCT02432846|449006012|FG004|Overall Study (4 Arms/Strata)|Death|0|||
124829614|NCT02432846|449006013|FG005|Overall Study (4 Arms/Strata)|Death|0|||
124829615|NCT02432846|449006008|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
124829616|NCT02432846|449006009|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
124829617|NCT02432846|449006010|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
124829618|NCT02432846|449006011|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
124829619|NCT02432846|449006012|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
124829620|NCT02432846|449006013|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
124829621|NCT02432846|449006008|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
124829622|NCT02432846|449006009|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
124829623|NCT02432846|449006010|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
124829624|NCT02432846|449006011|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
124829625|NCT02432846|449006012|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
124829626|NCT02432846|449006013|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
124829627|NCT02432846|449006008|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
124829628|NCT02432846|449006009|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
124829629|NCT02432846|449006010|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
124829630|NCT02432846|449006011|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
124829631|NCT02432846|449006012|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
124829632|NCT02432846|449006013|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
124829633|NCT02432846|449006008|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
124829634|NCT02432846|449006009|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
124829635|NCT02432846|449006010|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
124829636|NCT02432846|449006011|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
124829637|NCT02432846|449006012|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
124829638|NCT02432846|449006013|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
124829639|NCT02432846|449006008|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
124829640|NCT02432846|449006009|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
124829641|NCT02432846|449006010|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
124829642|NCT02432846|449006011|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
124829643|NCT02432846|449006012|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
124829644|NCT02432846|449006013|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
124829645|NCT02432846|449006008|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
124829646|NCT02432846|449006009|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
124829647|NCT02432846|449006010|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
124829648|NCT02432846|449006011|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
124829649|NCT02432846|449006012|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
124829650|NCT02432846|449006013|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
124829651|NCT02432846|449006008|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
124829652|NCT02432846|449006009|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
124829653|NCT02432846|449006010|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
124829654|NCT02432846|449006011|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
124829655|NCT02432846|449006012|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
124829656|NCT02432846|449006013|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
124829657|NCT02432846|449006008|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
124829658|NCT02432846|449006009|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
124829659|NCT02432846|449006010|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
124829660|NCT02432846|449006011|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
124829661|NCT02432846|449006012|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
124829662|NCT02432846|449006013|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
124829663|NCT02432846|449006008|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
124829664|NCT02432846|449006009|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
124829665|NCT02432846|449006010|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
124829666|NCT02432846|449006011|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
124829667|NCT02432846|449006012|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
124829668|NCT02432846|449006013|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
124829669|NCT02432846|449006008|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
124829670|NCT02432846|449006009|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
124829671|NCT02432846|449006010|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
124829672|NCT02432846|449006011|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
124829673|NCT02432846|449006012|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
125304110|NCT01370265|450741195|FG001|First Intervention|Adverse Event|1|||
125304111|NCT02611817|450741196|FG000|Open-label Induction Phase|Reason not Specified|9|||
125304112|NCT02611817|450741197|FG001|Open-label Induction Phase|Reason not Specified|0|||
124829674|NCT02432846|449006013|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
124976564|NCT03832595|449540001|FG000|Overall Study|Medical management without dialysis|37|||
125304113|NCT02611817|450741198|FG002|Open-label Induction Phase|Reason not Specified|0|||
124829675|NCT02432846|449006008|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
124829676|NCT02432846|449006009|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
124829677|NCT02432846|449006010|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
124829678|NCT02432846|449006011|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
124829679|NCT02432846|449006012|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
124829680|NCT02432846|449006013|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
124829681|NCT02432846|449006008|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
124829682|NCT02432846|449006009|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
124829683|NCT02432846|449006010|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
124829684|NCT02432846|449006011|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
124829685|NCT02432846|449006012|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
124829686|NCT02432846|449006013|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
124829687|NCT02432846|449006008|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
124829688|NCT02432846|449006009|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
124829689|NCT02432846|449006010|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
124829690|NCT02432846|449006011|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
124829691|NCT02432846|449006012|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
124829692|NCT02432846|449006013|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
124829693|NCT01770379|449006014|FG000|Overall Study|Technical issues|1|||
124829694|NCT01770379|449006015|FG001|Overall Study|Technical issues|0|||
124829695|NCT01770379|449006016|FG002|Overall Study|Technical issues|0|||
124829696|NCT01770379|449006014|FG000|Overall Study|Withdrawal by Subject|7|||
124829697|NCT01770379|449006015|FG001|Overall Study|Withdrawal by Subject|10|||
124829698|NCT01770379|449006016|FG002|Overall Study|Withdrawal by Subject|7|||
124829699|NCT01770379|449006014|FG000|Overall Study|study terminated by sponsor|22|||
124829700|NCT01770379|449006015|FG001|Overall Study|study terminated by sponsor|23|||
124829701|NCT01770379|449006016|FG002|Overall Study|study terminated by sponsor|22|||
124829702|NCT01770379|449006014|FG000|Overall Study|Protocol Violation|0|||
124829703|NCT01770379|449006015|FG001|Overall Study|Protocol Violation|1|||
124829704|NCT01770379|449006016|FG002|Overall Study|Protocol Violation|1|||
124829705|NCT01770379|449006014|FG000|Overall Study|Physician Decision|0|||
124829706|NCT01770379|449006015|FG001|Overall Study|Physician Decision|1|||
124829707|NCT01770379|449006016|FG002|Overall Study|Physician Decision|2|||
124829708|NCT01770379|449006014|FG000|Overall Study|Lost to Follow-up|0|||
124829709|NCT01770379|449006015|FG001|Overall Study|Lost to Follow-up|0|||
124829710|NCT01770379|449006016|FG002|Overall Study|Lost to Follow-up|2|||
124829711|NCT01770379|449006014|FG000|Overall Study|Lack of Efficacy|8|||
124829712|NCT01770379|449006015|FG001|Overall Study|Lack of Efficacy|6|||
124829713|NCT01770379|449006016|FG002|Overall Study|Lack of Efficacy|6|||
124829714|NCT01770379|449006014|FG000|Overall Study|Adverse Event|1|||
124829715|NCT01770379|449006015|FG001|Overall Study|Adverse Event|3|||
124829716|NCT01770379|449006016|FG002|Overall Study|Adverse Event|2|||
124829717|NCT03045887|449006017|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
124829718|NCT03045887|449006018|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
124829719|NCT03045887|449006019|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
124829720|NCT03045887|449006020|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
124829721|NCT03045887|449006021|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
124829722|NCT03045887|449006022|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
124829723|NCT03045887|449006023|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
124829724|NCT03045887|449006024|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
124829725|NCT03045887|449006025|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
124829726|NCT03045887|449006026|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
124829727|NCT03045887|449006017|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
124829728|NCT03045887|449006018|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
124829729|NCT03045887|449006019|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
124829730|NCT03045887|449006020|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
124829731|NCT03045887|449006021|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
124829732|NCT03045887|449006022|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
124829733|NCT03045887|449006023|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
124829734|NCT03045887|449006024|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
124829735|NCT03045887|449006025|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
124829736|NCT03045887|449006026|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
124829737|NCT03045887|449006017|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
124829738|NCT03045887|449006018|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
124829739|NCT03045887|449006019|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
124829740|NCT03045887|449006020|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
124829741|NCT03045887|449006021|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
124829742|NCT03045887|449006022|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
124829743|NCT03045887|449006023|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
124829744|NCT03045887|449006024|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
124829745|NCT03045887|449006025|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
124829746|NCT03045887|449006026|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
124829747|NCT03045887|449006017|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
124829748|NCT03045887|449006018|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
124829749|NCT03045887|449006019|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
124829750|NCT03045887|449006020|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
124829751|NCT03045887|449006021|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
124829752|NCT03045887|449006022|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
124829753|NCT03045887|449006023|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
124829754|NCT03045887|449006024|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
124829755|NCT03045887|449006025|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
124829756|NCT03045887|449006026|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
124829757|NCT03045887|449006017|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124829758|NCT03045887|449006018|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124829759|NCT03045887|449006019|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124829760|NCT03045887|449006020|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
124829761|NCT03045887|449006021|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124829762|NCT03045887|449006022|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124829763|NCT03045887|449006023|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124829764|NCT03045887|449006024|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124829765|NCT03045887|449006025|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124829766|NCT03045887|449006026|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124829767|NCT01912287|449006028|FG000|Overall Study|Ineligible|1|||
124829768|NCT01912287|449006029|FG001|Overall Study|Ineligible|0|||
124829769|NCT01912287|449006030|FG002|Overall Study|Ineligible|1|||
124829770|NCT01912287|449006028|FG000|Overall Study|No-show|0|||
124829771|NCT01912287|449006029|FG001|Overall Study|No-show|0|||
124829772|NCT01912287|449006030|FG002|Overall Study|No-show|1|||
124829773|NCT01912287|449006028|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
124829774|NCT01912287|449006029|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
124829775|NCT01912287|449006030|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
124829776|NCT01912287|449006028|FG000|Overall Study|Felt treatment no longer needed|0|||
124829777|NCT01912287|449006029|FG001|Overall Study|Felt treatment no longer needed|1|||
124829778|NCT01912287|449006030|FG002|Overall Study|Felt treatment no longer needed|0|||
124829779|NCT01912287|449006028|FG000|Overall Study|Life circumstances|4|||
124829780|NCT01912287|449006029|FG001|Overall Study|Life circumstances|2|||
124829781|NCT01912287|449006030|FG002|Overall Study|Life circumstances|0|||
124829782|NCT01912287|449006028|FG000|Overall Study|Lost Interest|1|||
124829783|NCT01912287|449006029|FG001|Overall Study|Lost Interest|0|||
124829784|NCT01912287|449006030|FG002|Overall Study|Lost Interest|0|||
124829785|NCT01912287|449006028|FG000|Overall Study|Uknown reason - subject drop out|5|||
124829786|NCT01912287|449006029|FG001|Overall Study|Uknown reason - subject drop out|7|||
124829787|NCT01912287|449006030|FG002|Overall Study|Uknown reason - subject drop out|3|||
124829788|NCT01912287|449006028|FG000|Overall Study|Missed Assesment|1|||
124829789|NCT01912287|449006029|FG001|Overall Study|Missed Assesment|1|||
124829790|NCT01912287|449006030|FG002|Overall Study|Missed Assesment|1|||
124829791|NCT01912287|449006028|FG000|Overall Study|Scheduling/change in availability|17|||
124829792|NCT01912287|449006029|FG001|Overall Study|Scheduling/change in availability|10|||
124829793|NCT01912287|449006030|FG002|Overall Study|Scheduling/change in availability|8|||
124829794|NCT03226392|449006034|FG000|Overall Study|Protocol Deviation|1|||
124829795|NCT03226392|449006035|FG001|Overall Study|Protocol Deviation|0|||
124829796|NCT03226392|449006034|FG000|Overall Study|Physician Decision|1|||
124829797|NCT03226392|449006035|FG001|Overall Study|Physician Decision|0|||
124829798|NCT03226392|449006034|FG000|Overall Study|Lost to Follow-up|1|||
124829799|NCT03226392|449006035|FG001|Overall Study|Lost to Follow-up|0|||
124829800|NCT03226392|449006034|FG000|Overall Study|Adverse Event|1|||
124829801|NCT03226392|449006035|FG001|Overall Study|Adverse Event|0|||
124829802|NCT03226392|449006034|FG000|Overall Study|Technical Problems|0|||
124829803|NCT03226392|449006035|FG001|Overall Study|Technical Problems|2|||
124829804|NCT03226392|449006034|FG000|Overall Study|Subject/Guardian Decision|7|||
124829805|NCT03226392|449006035|FG001|Overall Study|Subject/Guardian Decision|6|||
124829806|NCT02357901|449006036|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
124829807|NCT02357901|449006037|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
124829808|NCT02357901|449006038|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
124829809|NCT02357901|449006039|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
124829810|NCT02357901|449006036|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
124829811|NCT02357901|449006037|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
124829812|NCT02357901|449006038|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
124829813|NCT02357901|449006039|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
124829814|NCT02357901|449006036|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
124829815|NCT02357901|449006037|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
124829816|NCT02357901|449006038|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
124829817|NCT02357901|449006039|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
124829818|NCT02357901|449006036|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
124829819|NCT02357901|449006037|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
124829820|NCT02357901|449006038|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
124829821|NCT02357901|449006039|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
124829822|NCT02357901|449006036|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
124829823|NCT02357901|449006037|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
124829824|NCT02357901|449006038|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
124829825|NCT02357901|449006039|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
124829826|NCT02357901|449006036|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
124829827|NCT02357901|449006037|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
124829828|NCT02357901|449006038|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
124829829|NCT02357901|449006039|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
124829830|NCT02357901|449006036|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
124829831|NCT02357901|449006037|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
124829832|NCT02357901|449006038|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
124829833|NCT02357901|449006039|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
124829834|NCT02357901|449006036|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
124829835|NCT02357901|449006037|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
124829836|NCT02357901|449006038|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
124829837|NCT02357901|449006039|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
124829838|NCT02357901|449006036|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
124829839|NCT02357901|449006037|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
124829840|NCT02357901|449006038|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
124829841|NCT02357901|449006039|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
124829842|NCT02357901|449006036|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
124829843|NCT02357901|449006037|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
124829844|NCT02357901|449006038|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
124829845|NCT02357901|449006039|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
124829846|NCT02357901|449006036|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
124829847|NCT02357901|449006037|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
124829848|NCT02357901|449006038|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
124829849|NCT02357901|449006039|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
124829850|NCT00491387|449006040|FG000|Overall Study|study terminated|20|||
124829851|NCT02631850|449006042|FG000|Treatment Period|Lost to Follow-up|0|||
124829852|NCT02631850|449006043|FG001|Treatment Period|Lost to Follow-up|1|||
124829853|NCT02631850|449006044|FG002|Treatment Period|Lost to Follow-up|0|||
124829854|NCT02631850|449006045|FG003|Treatment Period|Lost to Follow-up|0|||
124829855|NCT02631850|449006042|FG000|Treatment Period|Protocol Violation|1|||
124829856|NCT02631850|449006043|FG001|Treatment Period|Protocol Violation|0|||
124829857|NCT02631850|449006044|FG002|Treatment Period|Protocol Violation|0|||
124829858|NCT02631850|449006045|FG003|Treatment Period|Protocol Violation|0|||
124829859|NCT02631850|449006042|FG000|Treatment Period|Withdrawal by Subject|0|||
124829860|NCT02631850|449006043|FG001|Treatment Period|Withdrawal by Subject|5|||
124829861|NCT02631850|449006044|FG002|Treatment Period|Withdrawal by Subject|2|||
124829862|NCT02631850|449006045|FG003|Treatment Period|Withdrawal by Subject|2|||
124829863|NCT02631850|449006042|FG000|Treatment Period|Adverse Event|1|||
124829864|NCT02631850|449006043|FG001|Treatment Period|Adverse Event|0|||
124829865|NCT02631850|449006044|FG002|Treatment Period|Adverse Event|2|||
124829866|NCT02631850|449006045|FG003|Treatment Period|Adverse Event|3|||
124829867|NCT02631850|449006042|FG000|Treatment Period|Family medical issue|1|||
124829868|NCT02631850|449006043|FG001|Treatment Period|Family medical issue|0|||
124829869|NCT02631850|449006044|FG002|Treatment Period|Family medical issue|0|||
124829870|NCT02631850|449006045|FG003|Treatment Period|Family medical issue|0|||
124829871|NCT02631850|449006042|FG000|6 Month Follow up|Lost to Follow-up|5|||
124829872|NCT02631850|449006043|FG001|6 Month Follow up|Lost to Follow-up|8|||
124829873|NCT02631850|449006044|FG002|6 Month Follow up|Lost to Follow-up|3|||
124829874|NCT02631850|449006045|FG003|6 Month Follow up|Lost to Follow-up|5|||
124829875|NCT02631850|449006042|FG000|6 Month Follow up|Withdrawal by Subject|1|||
124829876|NCT02631850|449006043|FG001|6 Month Follow up|Withdrawal by Subject|0|||
124829877|NCT02631850|449006044|FG002|6 Month Follow up|Withdrawal by Subject|0|||
124829878|NCT02631850|449006045|FG003|6 Month Follow up|Withdrawal by Subject|2|||
124829879|NCT02631850|449006042|FG000|6 Month Follow up|Adverse Event|1|||
124829880|NCT02631850|449006043|FG001|6 Month Follow up|Adverse Event|4|||
124829881|NCT02631850|449006044|FG002|6 Month Follow up|Adverse Event|1|||
124829882|NCT02631850|449006045|FG003|6 Month Follow up|Adverse Event|3|||
124829883|NCT02631850|449006042|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
124829884|NCT02631850|449006043|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
124829885|NCT02631850|449006044|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
124829886|NCT02631850|449006045|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
124829887|NCT01086540|449006047|FG000|Overall Study|Death|3|||
124829888|NCT01086540|449006048|FG001|Overall Study|Death|1|||
124829889|NCT01086540|449006047|FG000|Overall Study|Physician Decision|2|||
124829890|NCT01086540|449006048|FG001|Overall Study|Physician Decision|1|||
124829891|NCT01086540|449006047|FG000|Overall Study|Addition of new therapy for PAH|1|||
124829892|NCT01086540|449006048|FG001|Overall Study|Addition of new therapy for PAH|0|||
124829893|NCT02278263|449006049|FG000|Overall Study|Protocol Violation|7|||
124829894|NCT02278263|449006050|FG001|Overall Study|Protocol Violation|0|||
124829895|NCT02278263|449006051|FG002|Overall Study|Protocol Violation|9|||
124829896|NCT03164928|449006052|FG000|Overall Study|Lost to Follow-up|1|||
124829897|NCT03164928|449006053|FG001|Overall Study|Lost to Follow-up|0|||
124829898|NCT01998737|449006054|FG000|Overall Study|Corrupted database|23|||
124829899|NCT01998737|449006055|FG001|Overall Study|Corrupted database|0|||
124829900|NCT00101907|449006058|FG000|Overall Study|Adverse Event|1|||
124829901|NCT00101907|449006059|FG001|Overall Study|Adverse Event|0|||
124829902|NCT00101907|449006060|FG002|Overall Study|Adverse Event|0|||
124829903|NCT00101907|449006061|FG003|Overall Study|Adverse Event|0|||
124829904|NCT00101907|449006062|FG004|Overall Study|Adverse Event|0|||
124829905|NCT00101907|449006063|FG005|Overall Study|Adverse Event|0|||
124829906|NCT00101907|449006058|FG000|Overall Study|Death|0|||
124829907|NCT00101907|449006059|FG001|Overall Study|Death|1|||
124829908|NCT00101907|449006060|FG002|Overall Study|Death|0|||
124829909|NCT00101907|449006061|FG003|Overall Study|Death|0|||
124829910|NCT00101907|449006062|FG004|Overall Study|Death|3|||
124829911|NCT00101907|449006063|FG005|Overall Study|Death|0|||
124829912|NCT00101907|449006058|FG000|Overall Study|Physician Decision|0|||
124829913|NCT00101907|449006059|FG001|Overall Study|Physician Decision|0|||
124829914|NCT00101907|449006060|FG002|Overall Study|Physician Decision|0|||
124829915|NCT00101907|449006061|FG003|Overall Study|Physician Decision|1|||
124829916|NCT00101907|449006062|FG004|Overall Study|Physician Decision|1|||
124829917|NCT00101907|449006063|FG005|Overall Study|Physician Decision|0|||
124829918|NCT00101907|449006058|FG000|Overall Study|Withdrawal by Subject|1|||
124829919|NCT00101907|449006059|FG001|Overall Study|Withdrawal by Subject|0|||
124829920|NCT00101907|449006060|FG002|Overall Study|Withdrawal by Subject|1|||
124829921|NCT00101907|449006061|FG003|Overall Study|Withdrawal by Subject|0|||
124829922|NCT00101907|449006062|FG004|Overall Study|Withdrawal by Subject|1|||
124829923|NCT00101907|449006063|FG005|Overall Study|Withdrawal by Subject|0|||
124829924|NCT01474876|449006066|FG000|Overall Study|Adverse Event|11|||
124829925|NCT01474876|449006067|FG001|Overall Study|Adverse Event|5|||
124829926|NCT01474876|449006068|FG002|Overall Study|Adverse Event|0|||
124829927|NCT01474876|449006066|FG000|Overall Study|Serious Adverse Event|2|||
124829928|NCT01474876|449006067|FG001|Overall Study|Serious Adverse Event|3|||
124829929|NCT01474876|449006068|FG002|Overall Study|Serious Adverse Event|0|||
124829930|NCT01474876|449006066|FG000|Overall Study|Lost to Follow-up|5|||
124829931|NCT01474876|449006067|FG001|Overall Study|Lost to Follow-up|4|||
124829932|NCT01474876|449006068|FG002|Overall Study|Lost to Follow-up|0|||
124829933|NCT01474876|449006066|FG000|Overall Study|Investigator's decision|28|||
124829934|NCT01474876|449006067|FG001|Overall Study|Investigator's decision|6|||
124829935|NCT01474876|449006068|FG002|Overall Study|Investigator's decision|0|||
124829936|NCT01474876|449006066|FG000|Overall Study|Patient's request|19|||
124829937|NCT01474876|449006067|FG001|Overall Study|Patient's request|5|||
124829938|NCT01474876|449006068|FG002|Overall Study|Patient's request|0|||
124829939|NCT01474876|449006066|FG000|Overall Study|Investigator's decision and pt request|1|||
124829940|NCT01474876|449006067|FG001|Overall Study|Investigator's decision and pt request|0|||
124829941|NCT01474876|449006068|FG002|Overall Study|Investigator's decision and pt request|0|||
124829942|NCT01523886|449006071|FG000|Overall Study|surgery cancelled|0|||
124829943|NCT01523886|449006072|FG001|Overall Study|surgery cancelled|1|||
124829944|NCT01721330|449006073|FG000|Overall Study|Withdrawal by Subject|0|||
124829945|NCT01721330|449006074|FG001|Overall Study|Withdrawal by Subject|1|||
124829946|NCT04736199|449007624|FG000|Overall Study|Adverse Event|28|||
124829947|NCT04736199|449007625|FG001|Overall Study|Adverse Event|22|||
124829948|NCT04736199|449007624|FG000|Overall Study|Death|9|||
124829949|NCT04736199|449007625|FG001|Overall Study|Death|3|||
124829950|NCT04736199|449007624|FG000|Overall Study|Lost to Follow-up|4|||
124829951|NCT04736199|449007625|FG001|Overall Study|Lost to Follow-up|1|||
124829952|NCT04736199|449007624|FG000|Overall Study|Physician Decision|5|||
124829953|NCT04736199|449007625|FG001|Overall Study|Physician Decision|9|||
124829954|NCT04736199|449007624|FG000|Overall Study|Withdrawal by Subject|21|||
124829955|NCT04736199|449007625|FG001|Overall Study|Withdrawal by Subject|9|||
124829956|NCT04736199|449007624|FG000|Overall Study|Progressive disease|120|||
124829957|NCT04736199|449007625|FG001|Overall Study|Progressive disease|101|||
124829958|NCT04736199|449007624|FG000|Overall Study|Subject decision|13|||
124829959|NCT04736199|449007625|FG001|Overall Study|Subject decision|13|||
124829960|NCT04736199|449007624|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
124829961|NCT04736199|449007625|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
124829962|NCT04736199|449007624|FG000|Overall Study|Additional primary malignancy|1|||
124829963|NCT04736199|449007625|FG001|Overall Study|Additional primary malignancy|0|||
124829964|NCT04736199|449007624|FG000|Overall Study|Non-compliance with study drug|0|||
124829965|NCT04736199|449007625|FG001|Overall Study|Non-compliance with study drug|1|||
124829966|NCT04736199|449007624|FG000|Overall Study|Other reason|0|||
124829967|NCT04736199|449007625|FG001|Overall Study|Other reason|1|||
124829968|NCT04736199|449007624|FG000|Overall Study|Ongoing with study drug|240|||
124829969|NCT04736199|449007625|FG001|Overall Study|Ongoing with study drug|63|||
124829970|NCT04736199|449007624|FG000|Overall Study|Study drug never administered|3|||
124829971|NCT04736199|449007625|FG001|Overall Study|Study drug never administered|0|||
124829972|NCT04318080|449007626|FG000|Overall Study|Study closed by sponsor|10|||
124829973|NCT04318080|449007627|FG001|Overall Study|Study closed by sponsor|22|||
124829974|NCT04318080|449007626|FG000|Overall Study|Death|3|||
124829975|NCT04318080|449007627|FG001|Overall Study|Death|9|||
124829976|NCT04318080|449007626|FG000|Overall Study|Withdrawal by Subject|1|||
124829977|NCT04318080|449007627|FG001|Overall Study|Withdrawal by Subject|0|||
124829978|NCT04318080|449007626|FG000|Overall Study|Protocol Deviation|1|||
124829979|NCT04318080|449007627|FG001|Overall Study|Protocol Deviation|0|||
124829980|NCT00410761|449007628|FG000|Randomized Treatment Period|Adverse Event|34|||
124829981|NCT00410761|449007629|FG001|Randomized Treatment Period|Adverse Event|3|||
124829982|NCT00410761|449007628|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
124829983|NCT00410761|449007629|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
124829984|NCT00410761|449007628|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
124829985|NCT00410761|449007629|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
124829986|NCT00410761|449007628|FG000|Randomized Treatment Period|Other|69|||
124829987|NCT00410761|449007629|FG001|Randomized Treatment Period|Other|21|||
124829988|NCT00410761|449007628|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
124829989|NCT00410761|449007629|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
124829990|NCT00410761|449007628|FG000|Open-Label Treatment Period|Adverse Event|13|||
124829991|NCT00410761|449007629|FG001|Open-Label Treatment Period|Adverse Event|15|||
124829992|NCT00410761|449007628|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
124829993|NCT00410761|449007629|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
124829994|NCT00410761|449007628|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
124829995|NCT00410761|449007629|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
124829996|NCT00410761|449007628|FG000|Open-Label Treatment Period|Other|18|||
124829997|NCT00410761|449007629|FG001|Open-Label Treatment Period|Other|9|||
124829998|NCT06308822|449007630|FG000|Overall Study|Mutation Status Not Confirmed|17|||
124829999|NCT06308822|449007630|FG000|Overall Study|Adverse Event|1|||
124830000|NCT06308822|449007630|FG000|Overall Study|Death|5|||
124830001|NCT06308822|449007630|FG000|Overall Study|Disease progression|8|||
124830002|NCT06308822|449007630|FG000|Overall Study|Withdrawal by Subject|1|||
124830003|NCT06308822|449007630|FG000|Overall Study|Physician Decision|3|||
124830004|NCT03712904|449007631|FG000|Overall Study|Death|0|||
124830005|NCT03712904|449007632|FG001|Overall Study|Death|1|||
124830006|NCT03712904|449007631|FG000|Overall Study|Withdrawal by Subject|0|||
124830007|NCT03712904|449007632|FG001|Overall Study|Withdrawal by Subject|1|||
124830008|NCT03712904|449007631|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
124830009|NCT03712904|449007632|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
124830010|NCT05608005|449007633|FG000|Overall Study|Adverse Event|2|||
124830011|NCT05608005|449007634|FG001|Overall Study|Adverse Event|1|||
124830012|NCT05608005|449007635|FG002|Overall Study|Adverse Event|3|||
124830013|NCT05608005|449007633|FG000|Overall Study|Protocol Violation|2|||
124830014|NCT05608005|449007634|FG001|Overall Study|Protocol Violation|3|||
124830015|NCT05608005|449007635|FG002|Overall Study|Protocol Violation|0|||
124830016|NCT05608005|449007633|FG000|Overall Study|Withdrawal by Subject|10|||
124830017|NCT05608005|449007634|FG001|Overall Study|Withdrawal by Subject|12|||
124830018|NCT05608005|449007635|FG002|Overall Study|Withdrawal by Subject|4|||
124830019|NCT05608005|449007633|FG000|Overall Study|Lost to Follow-up|25|||
124830020|NCT05608005|449007634|FG001|Overall Study|Lost to Follow-up|27|||
124830021|NCT05608005|449007635|FG002|Overall Study|Lost to Follow-up|15|||
124830022|NCT05608005|449007633|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
124830023|NCT05608005|449007634|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
125304114|NCT02611817|450741196|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
125304115|NCT02611817|450741197|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
125304116|NCT02611817|450741198|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
125304117|NCT02611817|450741196|FG000|Open-label Induction Phase|Pregnancy|1|||
124830024|NCT05608005|449007635|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
124830025|NCT04708886|449007636|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
124830026|NCT04708886|449007636|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
124830027|NCT03525574|449007639|FG000|Overall Study|Adverse Event|15|||
124830028|NCT03525574|449007640|FG001|Overall Study|Adverse Event|0|||
124830029|NCT03525574|449007639|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
124830030|NCT03525574|449007640|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
124830031|NCT03525574|449007639|FG000|Overall Study|Lost to Follow-up|4|||
124830032|NCT03525574|449007640|FG001|Overall Study|Lost to Follow-up|0|||
124830033|NCT03525574|449007639|FG000|Overall Study|Commercial drug is Available for participant|48|||
124830034|NCT03525574|449007640|FG001|Overall Study|Commercial drug is Available for participant|0|||
124830035|NCT03525574|449007639|FG000|Overall Study|Death|1|||
125304118|NCT02611817|450741197|FG001|Open-label Induction Phase|Pregnancy|0|||
125304119|NCT02611817|450741198|FG002|Open-label Induction Phase|Pregnancy|0|||
125304120|NCT02611817|450741196|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
125304121|NCT02611817|450741197|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
125304122|NCT02611817|450741198|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
125304123|NCT02611817|450741196|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
125304124|NCT02611817|450741197|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
125304125|NCT02611817|450741198|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
125304126|NCT02611817|450741196|FG000|Open-label Induction Phase|Protocol Violation|5|||
125304127|NCT02611817|450741197|FG001|Open-label Induction Phase|Protocol Violation|0|||
125304128|NCT02611817|450741198|FG002|Open-label Induction Phase|Protocol Violation|0|||
125304129|NCT02611817|450741196|FG000|Open-label Induction Phase|Adverse Event|16|||
125304130|NCT02611817|450741197|FG001|Open-label Induction Phase|Adverse Event|0|||
125304131|NCT02611817|450741198|FG002|Open-label Induction Phase|Adverse Event|0|||
125304132|NCT02611817|450741196|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
125304133|NCT02611817|450741197|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
125304134|NCT02611817|450741198|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
125304135|NCT02611817|450741196|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
125304136|NCT02611817|450741197|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
125304137|NCT02611817|450741198|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
125304138|NCT02611817|450741196|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
125304139|NCT02611817|450741197|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
125304140|NCT02611817|450741198|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
125304141|NCT02611817|450741196|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
125304142|NCT02611817|450741197|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
125304143|NCT02611817|450741198|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
125304144|NCT02611817|450741196|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
125304145|NCT02611817|450741197|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
125304146|NCT02611817|450741198|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
125304147|NCT02611817|450741196|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
125304148|NCT02611817|450741197|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
125304149|NCT02611817|450741198|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
125304150|NCT02611817|450741196|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
125304151|NCT02611817|450741197|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
125304152|NCT02611817|450741198|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
125304153|NCT00265317|450741199|FG000|Lead-In|Objective progression or relapse|6|||
125304154|NCT00265317|450741200|FG001|Lead-In|Objective progression or relapse|11|||
125304155|NCT00265317|450741201|FG002|Lead-In|Objective progression or relapse|0|||
125304156|NCT00265317|450741202|FG003|Lead-In|Objective progression or relapse|0|||
125304157|NCT00265317|450741199|FG000|Lead-In|Adverse Event|2|||
125304158|NCT00265317|450741200|FG001|Lead-In|Adverse Event|1|||
125304159|NCT00265317|450741201|FG002|Lead-In|Adverse Event|0|||
125304160|NCT00265317|450741202|FG003|Lead-In|Adverse Event|0|||
125304161|NCT00265317|450741199|FG000|Lead-In|Death|3|||
125304162|NCT00265317|450741200|FG001|Lead-In|Death|5|||
125304163|NCT00265317|450741201|FG002|Lead-In|Death|0|||
125304164|NCT00265317|450741202|FG003|Lead-In|Death|0|||
125304165|NCT00265317|450741199|FG000|Lead-In|Withdrawal/other than adverse event|1|||
125304166|NCT00265317|450741200|FG001|Lead-In|Withdrawal/other than adverse event|0|||
125304167|NCT00265317|450741201|FG002|Lead-In|Withdrawal/other than adverse event|0|||
125304168|NCT00265317|450741202|FG003|Lead-In|Withdrawal/other than adverse event|0|||
125304169|NCT00265317|450741199|FG000|Phase 2|Objective progression or relapse|0|||
124830036|NCT03525574|449007640|FG001|Overall Study|Death|0|||
124830037|NCT03525574|449007639|FG000|Overall Study|Other non-compliance|2|||
124830038|NCT03525574|449007640|FG001|Overall Study|Other non-compliance|0|||
124830039|NCT03525574|449007639|FG000|Overall Study|Physician Decision|6|||
124830040|NCT03525574|449007640|FG001|Overall Study|Physician Decision|0|||
124830041|NCT03525574|449007639|FG000|Overall Study|Other|58|||
124830042|NCT03525574|449007640|FG001|Overall Study|Other|0|||
124830043|NCT03525574|449007639|FG000|Overall Study|Enrolled but never dosed|1|||
124830044|NCT03525574|449007640|FG001|Overall Study|Enrolled but never dosed|0|||
124830045|NCT03525574|449007639|FG000|Overall Study|Not enrolled in 105 study|0|||
124830046|NCT03525574|449007640|FG001|Overall Study|Not enrolled in 105 study|3|||
125304170|NCT00265317|450741200|FG001|Phase 2|Objective progression or relapse|0|||
125304171|NCT00265317|450741201|FG002|Phase 2|Objective progression or relapse|37|||
125304172|NCT00265317|450741202|FG003|Phase 2|Objective progression or relapse|38|||
125304173|NCT00265317|450741199|FG000|Phase 2|Global deterioration of health status|0|||
125304174|NCT00265317|450741200|FG001|Phase 2|Global deterioration of health status|0|||
125304175|NCT00265317|450741201|FG002|Phase 2|Global deterioration of health status|3|||
125304176|NCT00265317|450741202|FG003|Phase 2|Global deterioration of health status|0|||
124830047|NCT03914326|449007643|FG000|Overall Study|Withdrawal by Subject|27|||
124830048|NCT03914326|449007644|FG001|Overall Study|Withdrawal by Subject|34|||
124830049|NCT03914326|449007643|FG000|Overall Study|Lost to Follow-up|43|||
124830050|NCT03914326|449007644|FG001|Overall Study|Lost to Follow-up|51|||
124830051|NCT03914326|449007643|FG000|Overall Study|Randomised more than once|0|||
124830052|NCT03914326|449007644|FG001|Overall Study|Randomised more than once|1|||
124830053|NCT02769247|449007651|FG000|Overall Study|Withdrawal by Subject|1|||
124830054|NCT02769247|449007652|FG001|Overall Study|Withdrawal by Subject|0|||
124830055|NCT02769247|449007653|FG002|Overall Study|Withdrawal by Subject|0|||
124830056|NCT02769247|449007654|FG003|Overall Study|Withdrawal by Subject|1|||
124830057|NCT02769247|449007651|FG000|Overall Study|Protocol Violation|0|||
124830058|NCT02769247|449007652|FG001|Overall Study|Protocol Violation|0|||
124830059|NCT02769247|449007653|FG002|Overall Study|Protocol Violation|1|||
124830060|NCT02769247|449007654|FG003|Overall Study|Protocol Violation|0|||
124830061|NCT02769247|449007651|FG000|Overall Study|Physician Decision|1|||
124830062|NCT02769247|449007652|FG001|Overall Study|Physician Decision|0|||
124830063|NCT02769247|449007653|FG002|Overall Study|Physician Decision|0|||
124830064|NCT02769247|449007654|FG003|Overall Study|Physician Decision|0|||
124830065|NCT04788953|449007655|FG000|Overall Study|Adverse Event|1|||
124830066|NCT04788953|449007656|FG001|Overall Study|Adverse Event|1|||
124830067|NCT04788953|449007655|FG000|Overall Study|Withdrawal by Subject|1|||
124830068|NCT04788953|449007656|FG001|Overall Study|Withdrawal by Subject|0|||
124830069|NCT04788953|449007655|FG000|Overall Study|Protocol Violation|0|||
124830070|NCT04788953|449007656|FG001|Overall Study|Protocol Violation|1|||
124830071|NCT02150954|449007659|FG000|Overall Study|Protocol Violation|1|||
124830072|NCT02150954|449007660|FG001|Overall Study|Protocol Violation|0|||
124830073|NCT03814746|449007664|FG000|Overall Study|Participant decision|9|||
124830074|NCT03814746|449007665|FG001|Overall Study|Participant decision|6|||
124830075|NCT03814746|449007666|FG002|Overall Study|Participant decision|15|||
124830076|NCT03814746|449007664|FG000|Overall Study|Physician Decision|2|||
124830077|NCT03814746|449007665|FG001|Overall Study|Physician Decision|2|||
124830078|NCT03814746|449007666|FG002|Overall Study|Physician Decision|4|||
124830079|NCT03814746|449007664|FG000|Overall Study|Death|2|||
124830080|NCT03814746|449007665|FG001|Overall Study|Death|2|||
124830081|NCT03814746|449007666|FG002|Overall Study|Death|2|||
124830082|NCT03814746|449007664|FG000|Overall Study|Adverse Event|2|||
124830083|NCT03814746|449007665|FG001|Overall Study|Adverse Event|2|||
124830084|NCT03814746|449007666|FG002|Overall Study|Adverse Event|1|||
124830085|NCT03814746|449007664|FG000|Overall Study|Lost to Follow-up|2|||
124830086|NCT03814746|449007665|FG001|Overall Study|Lost to Follow-up|1|||
124830087|NCT03814746|449007666|FG002|Overall Study|Lost to Follow-up|2|||
124830088|NCT03814746|449007664|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124830089|NCT03814746|449007665|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
124830090|NCT03814746|449007666|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
124830091|NCT03814746|449007664|FG000|Overall Study|Pregnancy|0|||
124830092|NCT03814746|449007665|FG001|Overall Study|Pregnancy|1|||
124830093|NCT03814746|449007666|FG002|Overall Study|Pregnancy|1|||
124830094|NCT03814746|449007664|FG000|Overall Study|Protocol Violation|1|||
124830095|NCT03814746|449007665|FG001|Overall Study|Protocol Violation|0|||
124830096|NCT03814746|449007666|FG002|Overall Study|Protocol Violation|0|||
124830097|NCT03997383|449007671|FG000|Double-blind Treatment Period|Adverse Event|4|||
124830098|NCT03997383|449007672|FG001|Double-blind Treatment Period|Adverse Event|3|||
124830099|NCT03997383|449007671|FG000|Double-blind Treatment Period|Death|4|||
124830100|NCT03997383|449007672|FG001|Double-blind Treatment Period|Death|4|||
124830101|NCT03997383|449007671|FG000|Double-blind Treatment Period|Physician Decision|2|||
124830102|NCT03997383|449007672|FG001|Double-blind Treatment Period|Physician Decision|0|||
124830103|NCT03997383|449007671|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
124830104|NCT03997383|449007672|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
124830105|NCT03997383|449007671|FG000|Open-label Extension Period|Ongoing|148|||
124830106|NCT03997383|449007672|FG001|Open-label Extension Period|Ongoing|151|||
124830107|NCT03997383|449007671|FG000|Open-label Extension Period|Adverse Event|4|||
124830108|NCT03997383|449007672|FG001|Open-label Extension Period|Adverse Event|1|||
124830109|NCT03997383|449007671|FG000|Open-label Extension Period|Death|8|||
124830110|NCT03997383|449007672|FG001|Open-label Extension Period|Death|9|||
124830111|NCT03997383|449007671|FG000|Open-label Extension Period|Physician Decision|1|||
124830112|NCT03997383|449007672|FG001|Open-label Extension Period|Physician Decision|1|||
124830113|NCT03997383|449007671|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
124830114|NCT03997383|449007672|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
124830115|NCT03997383|449007671|FG000|Open-label Extension Period|Reason Not Specified|2|||
124830116|NCT03997383|449007672|FG001|Open-label Extension Period|Reason Not Specified|0|||
124830117|NCT03880019|449007673|FG000|Overall Study|Competing disease|1|||
124830118|NCT00326950|449007674|FG000|Overall Study|Progressive Disease|1|||
124830119|NCT01266460|449007678|FG000|Overall Study|Adverse Event|3|||
124830120|NCT01266460|449007678|FG000|Overall Study|Withdrawal by Subject|5|||
124830121|NCT01266460|449007678|FG000|Overall Study|Disease Progression|18|||
124830122|NCT01266460|449007678|FG000|Overall Study|Not otherwise specified|8|||
124830123|NCT01132547|449007683|FG000|Overall Study|Withdrawal by Subject|3|||
124830124|NCT01132547|449007684|FG001|Overall Study|Withdrawal by Subject|1|||
124830125|NCT01132547|449007683|FG000|Overall Study|Death|1|||
124830126|NCT01132547|449007684|FG001|Overall Study|Death|0|||
124830127|NCT05811234|449007685|FG000|Overall Study|Loss of Effectiveness|2|||
124830128|NCT05811234|449007685|FG000|Overall Study|Adverse Event|4|||
124830129|NCT05811234|449007685|FG000|Overall Study|Pregnancy|1|||
124830130|NCT05811234|449007685|FG000|Overall Study|Disease progression|1|||
124830131|NCT05811234|449007685|FG000|Overall Study|Withdrawal by Subject|4|||
124830132|NCT05811234|449007685|FG000|Overall Study|Lost to Follow-up|13|||
124830133|NCT05811234|449007685|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
124830134|NCT04499781|449007686|FG000|Overall Study|Lost to Follow-up|2|||
124830135|NCT04499781|449007687|FG001|Overall Study|Lost to Follow-up|3|||
124830136|NCT04499781|449007686|FG000|Overall Study|Withdrawal by Subject|2|||
124830137|NCT04499781|449007687|FG001|Overall Study|Withdrawal by Subject|0|||
124830138|NCT00227305|449007692|FG000|Overall Study|Adverse Event|40|||
124830139|NCT00227305|449007692|FG000|Overall Study|Withdrawal by Subject|42|||
124830140|NCT00227305|449007692|FG000|Overall Study|Lost to Follow-up|33|||
124830141|NCT00227305|449007692|FG000|Overall Study|Study specific discontinuation|13|||
124830142|NCT00227305|449007692|FG000|Overall Study|MOVED OUT OF AREA|3|||
124830143|NCT00227305|449007692|FG000|Overall Study|Lack of Efficacy|7|||
124830144|NCT00227305|449007692|FG000|Overall Study|Physician Decision|3|||
124830145|NCT00227305|449007692|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
124830146|NCT00227305|449007692|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
124830147|NCT00227305|449007692|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
124830148|NCT02118012|449007693|FG000|Overall Study|Adverse Event|0|||
124830149|NCT02118012|449007694|FG001|Overall Study|Adverse Event|1|||
124830150|NCT02118012|449007693|FG000|Overall Study|Physician Decision|0|||
124830151|NCT02118012|449007694|FG001|Overall Study|Physician Decision|1|||
124830152|NCT00483379|449007695|FG000|Treatment Period|Adverse Event|1|||
124830153|NCT00483379|449007696|FG001|Treatment Period|Adverse Event|0|||
124830154|NCT00483379|449007695|FG000|Treatment Period|Withdrawal by Subject|1|||
124830155|NCT00483379|449007696|FG001|Treatment Period|Withdrawal by Subject|0|||
124830156|NCT03698994|449007699|FG000|Overall Study|Adverse Event|2|||
124830157|NCT03698994|449007699|FG000|Overall Study|Death|1|||
124830158|NCT03698994|449007699|FG000|Overall Study|Physician Decision|1|||
124830159|NCT03698994|449007699|FG000|Overall Study|Withdrawal by Subject|3|||
124830160|NCT03698994|449007699|FG000|Overall Study|Progressive Disease|12|||
124830161|NCT04969224|449007700|FG000|Overall Study|Adverse Event|1|||
124830162|NCT04969224|449007700|FG000|Overall Study|Enrolled but never dosed|1|||
124830163|NCT03165110|449007701|FG000|Overall Study|Anroid phone software incompatibility|1|||
124830164|NCT05533632|449007702|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
124830165|NCT05533632|449007702|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
124830166|NCT05533632|449007702|FG000|Overall Study|Lost to Follow-up|1|||
124830167|NCT05533632|449007702|FG000|Overall Study|Withdrawal by Subject|4|||
124830168|NCT05533632|449007702|FG000|Overall Study|Adverse Event|4|||
124830169|NCT04327388|449007712|FG000|Overall Study|Adverse Event|17|||
124830170|NCT04327388|449007713|FG001|Overall Study|Adverse Event|18|||
124830171|NCT04327388|449007714|FG002|Overall Study|Adverse Event|9|||
124830172|NCT04327388|449007712|FG000|Overall Study|Other|1|||
124830173|NCT04327388|449007713|FG001|Overall Study|Other|2|||
124830174|NCT04327388|449007714|FG002|Overall Study|Other|0|||
124830175|NCT04327388|449007712|FG000|Overall Study|Randomized and not treated|2|||
124830176|NCT04327388|449007713|FG001|Overall Study|Randomized and not treated|0|||
124830177|NCT04327388|449007714|FG002|Overall Study|Randomized and not treated|2|||
124830178|NCT03051607|449007719|FG000|Overall Study|Adverse Event|66|||
124830179|NCT01603459|449007729|FG000|Overall Study|Adverse Event|5|||
124830180|NCT01603459|449007729|FG000|Overall Study|Withdrawal by Subject|5|||
124830181|NCT01603459|449007729|FG000|Overall Study|Lost to Follow-up|3|||
124830182|NCT01603459|449007729|FG000|Overall Study|Predefined discontinuation criteria|3|||
124830183|NCT01603459|449007729|FG000|Overall Study|Non-compliance|1|||
124830184|NCT01603459|449007729|FG000|Overall Study|Administrative reason|1|||
124830185|NCT00399360|449007731|FG000|Overall Study|Lost to Follow-up|2|||
124830186|NCT00399360|449007732|FG001|Overall Study|Lost to Follow-up|1|||
124830187|NCT00399360|449007733|FG002|Overall Study|Lost to Follow-up|2|||
124830188|NCT00399360|449007734|FG003|Overall Study|Lost to Follow-up|4|||
124830189|NCT00399360|449007731|FG000|Overall Study|Adverse Event|0|||
124830190|NCT00399360|449007732|FG001|Overall Study|Adverse Event|0|||
124830191|NCT00399360|449007733|FG002|Overall Study|Adverse Event|1|||
124830192|NCT00399360|449007734|FG003|Overall Study|Adverse Event|0|||
124830193|NCT00399360|449007731|FG000|Overall Study|Withdrawal by Subject|0|||
124830194|NCT00399360|449007732|FG001|Overall Study|Withdrawal by Subject|2|||
124830195|NCT00399360|449007733|FG002|Overall Study|Withdrawal by Subject|0|||
124830196|NCT00399360|449007734|FG003|Overall Study|Withdrawal by Subject|2|||
124830197|NCT01412021|449007735|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
124830198|NCT01412021|449007735|FG000|Overall Study|Treatment Prior to Approval|3|||
124830199|NCT01412021|449007735|FG000|Overall Study|Transferred to Other Hospital|9|||
124830200|NCT01166178|449007736|FG000|Overall Study|Withdrawal by Subject|1|||
124830201|NCT01166178|449007737|FG001|Overall Study|Withdrawal by Subject|0|||
124830202|NCT01166178|449007736|FG000|Overall Study|Study was terminated|20|||
124830203|NCT01166178|449007737|FG001|Overall Study|Study was terminated|8|||
124830204|NCT00529542|449007741|FG000|Overall Study|Withdrawal by Subject|1|||
124830205|NCT00529542|449007742|FG001|Overall Study|Withdrawal by Subject|0|||
124830206|NCT00529542|449007741|FG000|Overall Study|Lost to Follow-up|0|||
124830207|NCT00529542|449007742|FG001|Overall Study|Lost to Follow-up|1|||
124830208|NCT05778786|449007743|FG000|Period 1|COVID-19 Related|3|||
124830209|NCT05778786|449007744|FG001|Period 1|COVID-19 Related|3|||
124830210|NCT05778786|449007743|FG000|Period 1|Withdrew Consent during Study|1|||
124830211|NCT05778786|449007744|FG001|Period 1|Withdrew Consent during Study|0|||
124830212|NCT05778786|449007743|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
124830213|NCT05778786|449007744|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
124830214|NCT05778786|449007743|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
124830215|NCT05778786|449007744|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
124830216|NCT00099437|449008482|FG000|Overall Study|Lost to Follow-up|30|||
124830217|NCT00099437|449008483|FG001|Overall Study|Lost to Follow-up|33|||
124830218|NCT00099437|449008482|FG000|Overall Study|Death|293|||
124830219|NCT00099437|449008483|FG001|Overall Study|Death|261|||
124830220|NCT00099437|449008482|FG000|Overall Study|Withdrawal by Subject|6|||
124830221|NCT00099437|449008483|FG001|Overall Study|Withdrawal by Subject|10|||
124830222|NCT00099437|449008482|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
124830223|NCT00099437|449008483|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
124830224|NCT05413369|449008484|FG000|Overall Study|Adverse Event|1|||
124830225|NCT05413369|449008485|FG001|Overall Study|Adverse Event|1|||
124830226|NCT05413369|449008484|FG000|Overall Study|Withdrawal by Subject|13|||
124830227|NCT05413369|449008485|FG001|Overall Study|Withdrawal by Subject|4|||
124830228|NCT05413369|449008484|FG000|Overall Study|Non-compliance with study schedule|2|||
124830229|NCT05413369|449008485|FG001|Overall Study|Non-compliance with study schedule|1|||
124830230|NCT05413369|449008484|FG000|Overall Study|Other|1|||
124830231|NCT05413369|449008485|FG001|Overall Study|Other|1|||
124830232|NCT02809677|449008486|FG000|Overall Study|Withdrawal by Subject|8|||
124830233|NCT04103892|449008487|FG000|Overall Study|Adverse Event|0|||
124830234|NCT04103892|449008488|FG001|Overall Study|Adverse Event|0|||
124830235|NCT04103892|449008489|FG002|Overall Study|Adverse Event|0|||
124830236|NCT04103892|449008490|FG003|Overall Study|Adverse Event|3|||
124830237|NCT04103892|449008487|FG000|Overall Study|Lost to Follow-up|0|||
124830238|NCT04103892|449008488|FG001|Overall Study|Lost to Follow-up|0|||
124830239|NCT04103892|449008489|FG002|Overall Study|Lost to Follow-up|2|||
124830240|NCT04103892|449008490|FG003|Overall Study|Lost to Follow-up|0|||
124830241|NCT04103892|449008487|FG000|Overall Study|Protocol Violation|0|||
124830242|NCT04103892|449008488|FG001|Overall Study|Protocol Violation|0|||
124830243|NCT04103892|449008489|FG002|Overall Study|Protocol Violation|1|||
124830244|NCT04103892|449008490|FG003|Overall Study|Protocol Violation|1|||
124830245|NCT04103892|449008487|FG000|Overall Study|Withdrawal by Subject|1|||
124830246|NCT04103892|449008488|FG001|Overall Study|Withdrawal by Subject|0|||
124830247|NCT04103892|449008489|FG002|Overall Study|Withdrawal by Subject|2|||
124830248|NCT04103892|449008490|FG003|Overall Study|Withdrawal by Subject|5|||
124830249|NCT04103892|449008487|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
124830250|NCT04103892|449008488|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
124830251|NCT04103892|449008489|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
124830252|NCT04103892|449008490|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
124830253|NCT04340362|449008491|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
124830254|NCT04170348|449008496|FG000|Overall Study|Lost to Follow-up|2|||
124830255|NCT04170348|449008497|FG001|Overall Study|Lost to Follow-up|2|||
124830256|NCT04170348|449008496|FG000|Overall Study|Withdrawal by Subject|1|||
124830257|NCT04170348|449008497|FG001|Overall Study|Withdrawal by Subject|5|||
124830258|NCT04170348|449008496|FG000|Overall Study|Non-adherence|1|||
124830259|NCT04170348|449008497|FG001|Overall Study|Non-adherence|1|||
124830260|NCT04170348|449008496|FG000|Overall Study|Adverse Event|1|||
124830261|NCT04170348|449008497|FG001|Overall Study|Adverse Event|0|||
124830262|NCT05104567|449008498|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
124830263|NCT05104567|449008499|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
124830264|NCT05104567|449008500|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
124830265|NCT05104567|449008501|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
124830266|NCT05104567|449008502|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
124830267|NCT05104567|449008503|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
124830268|NCT05104567|449008504|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
124830269|NCT05104567|449008498|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
124830270|NCT05104567|449008499|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
124830271|NCT05104567|449008500|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
124830272|NCT05104567|449008501|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
124830273|NCT05104567|449008502|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
124830274|NCT05104567|449008503|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
124830275|NCT05104567|449008504|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
124830276|NCT05104567|449008498|FG000|Overall Study|Progressive disease|3|||
124830277|NCT05104567|449008499|FG001|Overall Study|Progressive disease|13|||
124830278|NCT05104567|449008500|FG002|Overall Study|Progressive disease|13|||
124830279|NCT05104567|449008501|FG003|Overall Study|Progressive disease|17|||
124830280|NCT05104567|449008502|FG004|Overall Study|Progressive disease|17|||
124830281|NCT05104567|449008503|FG005|Overall Study|Progressive disease|28|||
124830282|NCT05104567|449008504|FG006|Overall Study|Progressive disease|24|||
124830283|NCT05104567|449008498|FG000|Overall Study|Withdrawal by Subject|1|||
124830284|NCT05104567|449008499|FG001|Overall Study|Withdrawal by Subject|1|||
124830285|NCT05104567|449008500|FG002|Overall Study|Withdrawal by Subject|2|||
124830286|NCT05104567|449008501|FG003|Overall Study|Withdrawal by Subject|0|||
124830287|NCT05104567|449008502|FG004|Overall Study|Withdrawal by Subject|0|||
124830288|NCT05104567|449008503|FG005|Overall Study|Withdrawal by Subject|0|||
124830289|NCT05104567|449008504|FG006|Overall Study|Withdrawal by Subject|0|||
124830290|NCT05104567|449008498|FG000|Overall Study|Other|1|||
125304177|NCT00265317|450741199|FG000|Phase 2|Adverse Event|0|||
125304178|NCT00265317|450741200|FG001|Phase 2|Adverse Event|0|||
125304179|NCT00265317|450741201|FG002|Phase 2|Adverse Event|7|||
125304180|NCT00265317|450741202|FG003|Phase 2|Adverse Event|5|||
125304181|NCT00265317|450741199|FG000|Phase 2|Death|0|||
125304182|NCT00265317|450741200|FG001|Phase 2|Death|0|||
125304183|NCT00265317|450741201|FG002|Phase 2|Death|12|||
125304184|NCT00265317|450741202|FG003|Phase 2|Death|15|||
125304185|NCT00265317|450741199|FG000|Phase 2|Protocol Violation|0|||
125304186|NCT00265317|450741200|FG001|Phase 2|Protocol Violation|0|||
125304187|NCT00265317|450741201|FG002|Phase 2|Protocol Violation|1|||
125304188|NCT00265317|450741202|FG003|Phase 2|Protocol Violation|4|||
125304189|NCT00265317|450741199|FG000|Phase 2|Lost to Follow-up|0|||
125304190|NCT00265317|450741200|FG001|Phase 2|Lost to Follow-up|0|||
125304191|NCT00265317|450741201|FG002|Phase 2|Lost to Follow-up|0|||
125304192|NCT00265317|450741202|FG003|Phase 2|Lost to Follow-up|1|||
125304193|NCT00265317|450741199|FG000|Phase 2|Withdrawal/other than adverse event|0|||
125304194|NCT00265317|450741200|FG001|Phase 2|Withdrawal/other than adverse event|0|||
125304195|NCT00265317|450741201|FG002|Phase 2|Withdrawal/other than adverse event|2|||
125304196|NCT00265317|450741202|FG003|Phase 2|Withdrawal/other than adverse event|1|||
125304197|NCT00265317|450741199|FG000|Phase 2|Study terminated by sponsor|0|||
125304198|NCT00265317|450741200|FG001|Phase 2|Study terminated by sponsor|0|||
125304199|NCT00265317|450741201|FG002|Phase 2|Study terminated by sponsor|1|||
125304200|NCT00265317|450741202|FG003|Phase 2|Study terminated by sponsor|0|||
125304201|NCT00265317|450741199|FG000|Phase 2|Other|0|||
125304202|NCT00265317|450741200|FG001|Phase 2|Other|0|||
125304203|NCT00265317|450741201|FG002|Phase 2|Other|1|||
125304204|NCT00265317|450741202|FG003|Phase 2|Other|1|||
125304205|NCT02510001|450741203|FG000|Overall Study|Early disease progression|0|||
125304206|NCT02510001|450741204|FG001|Overall Study|Early disease progression|0|||
125304207|NCT02510001|450741205|FG002|Overall Study|Early disease progression|0|||
125304208|NCT02510001|450741206|FG003|Overall Study|Early disease progression|1|||
125304209|NCT02510001|450741207|FG004|Overall Study|Early disease progression|1|||
125304210|NCT02510001|450741208|FG005|Overall Study|Early disease progression|1|||
125304211|NCT02510001|450741209|FG006|Overall Study|Early disease progression|0|||
125304212|NCT02510001|450741210|FG007|Overall Study|Early disease progression|0|||
125304213|NCT02510001|450741203|FG000|Overall Study|Adverse Event|0|||
125304214|NCT02510001|450741204|FG001|Overall Study|Adverse Event|0|||
125304215|NCT02510001|450741205|FG002|Overall Study|Adverse Event|0|||
125304216|NCT02510001|450741206|FG003|Overall Study|Adverse Event|1|||
125304217|NCT02510001|450741207|FG004|Overall Study|Adverse Event|2|||
125304218|NCT02510001|450741208|FG005|Overall Study|Adverse Event|1|||
125304219|NCT02510001|450741209|FG006|Overall Study|Adverse Event|2|||
125304220|NCT02510001|450741210|FG007|Overall Study|Adverse Event|5|||
125304221|NCT02510001|450741203|FG000|Overall Study|Physician Decision|0|||
124830291|NCT05104567|449008499|FG001|Overall Study|Other|1|||
124830292|NCT05104567|449008500|FG002|Overall Study|Other|1|||
124830293|NCT05104567|449008501|FG003|Overall Study|Other|0|||
125304222|NCT02510001|450741204|FG001|Overall Study|Physician Decision|0|||
125304223|NCT02510001|450741205|FG002|Overall Study|Physician Decision|0|||
125304224|NCT02510001|450741206|FG003|Overall Study|Physician Decision|0|||
124830294|NCT05104567|449008502|FG004|Overall Study|Other|0|||
124830295|NCT05104567|449008503|FG005|Overall Study|Other|0|||
124830296|NCT05104567|449008504|FG006|Overall Study|Other|0|||
124830297|NCT01602380|449008508|FG000|Overall Study|Death|147|||
125304225|NCT02510001|450741207|FG004|Overall Study|Physician Decision|1|||
125304226|NCT02510001|450741208|FG005|Overall Study|Physician Decision|0|||
125304227|NCT02510001|450741209|FG006|Overall Study|Physician Decision|0|||
125304228|NCT02510001|450741210|FG007|Overall Study|Physician Decision|0|||
125304229|NCT02510001|450741203|FG000|Overall Study|Withdrawal by Subject|0|||
125304230|NCT02510001|450741204|FG001|Overall Study|Withdrawal by Subject|0|||
124830298|NCT01602380|449008509|FG001|Overall Study|Death|145|||
125304231|NCT02510001|450741205|FG002|Overall Study|Withdrawal by Subject|0|||
125304232|NCT02510001|450741206|FG003|Overall Study|Withdrawal by Subject|0|||
124830299|NCT01602380|449008508|FG000|Overall Study|Withdrawal by Subject|39|||
124830300|NCT01602380|449008509|FG001|Overall Study|Withdrawal by Subject|41|||
124830301|NCT01602380|449008508|FG000|Overall Study|Lost to Follow-up|15|||
124830302|NCT01602380|449008509|FG001|Overall Study|Lost to Follow-up|12|||
124830303|NCT01602380|449008508|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
124830304|NCT01602380|449008509|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
124830305|NCT01602380|449008508|FG000|Overall Study|Other|2|||
124830306|NCT01602380|449008509|FG001|Overall Study|Other|0|||
124830307|NCT03658538|449008510|FG000|Overall Study|Death|2|||
124830308|NCT03658538|449008511|FG001|Overall Study|Death|1|||
124830309|NCT03658538|449008510|FG000|Overall Study|Cancer diagnosis|1|||
124830310|NCT03658538|449008511|FG001|Overall Study|Cancer diagnosis|0|||
124830311|NCT03658538|449008510|FG000|Overall Study|Change residence|1|||
124830312|NCT03658538|449008511|FG001|Overall Study|Change residence|2|||
124830313|NCT03658538|449008510|FG000|Overall Study|Lost to Follow-up|3|||
124830314|NCT03658538|449008511|FG001|Overall Study|Lost to Follow-up|3|||
124830315|NCT03658538|449008510|FG000|Overall Study|Unblinded|2|||
124830316|NCT03658538|449008511|FG001|Overall Study|Unblinded|3|||
124830317|NCT03658538|449008510|FG000|Overall Study|Physician Decision|0|||
124830318|NCT03658538|449008511|FG001|Overall Study|Physician Decision|1|||
124830319|NCT03658538|449008510|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
124830320|NCT03658538|449008511|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
124830321|NCT03658538|449008510|FG000|Overall Study|Evicted from home|1|||
124830322|NCT03658538|449008511|FG001|Overall Study|Evicted from home|0|||
124830323|NCT03333044|449008512|FG000|Overall Study|Pregnancy|1|||
124830324|NCT03333044|449008513|FG001|Overall Study|Pregnancy|0|||
124830325|NCT03333044|449008514|FG002|Overall Study|Pregnancy|0|||
124830326|NCT03333044|449008512|FG000|Overall Study|Lost to Follow-up|0|||
124830327|NCT03333044|449008513|FG001|Overall Study|Lost to Follow-up|14|||
124830328|NCT03333044|449008514|FG002|Overall Study|Lost to Follow-up|6|||
124830329|NCT03188094|449008515|FG000|Overall Study|Screen failure|1|||
124830330|NCT03188094|449008516|FG001|Overall Study|Screen failure|0|||
124830331|NCT03188094|449008517|FG002|Overall Study|Screen failure|0|||
124830332|NCT03188094|449008515|FG000|Overall Study|Pregnancy|3|||
124830333|NCT03188094|449008516|FG001|Overall Study|Pregnancy|0|||
124830334|NCT03188094|449008517|FG002|Overall Study|Pregnancy|0|||
124830335|NCT03188094|449008515|FG000|Overall Study|Ineligible|1|||
124830336|NCT03188094|449008516|FG001|Overall Study|Ineligible|0|||
124830337|NCT03188094|449008517|FG002|Overall Study|Ineligible|0|||
124830338|NCT03188094|449008515|FG000|Overall Study|Lost to Follow-up|0|||
124830339|NCT03188094|449008516|FG001|Overall Study|Lost to Follow-up|0|||
124830340|NCT03188094|449008517|FG002|Overall Study|Lost to Follow-up|17|||
124830341|NCT04537234|449008521|FG000|Overall Study|Withdrawal by Subject|2|||
124830342|NCT04537234|449008522|FG001|Overall Study|Withdrawal by Subject|0|||
124830343|NCT02070744|449008525|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
124830344|NCT02070744|449008526|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
124830345|NCT02070744|449008527|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
124830346|NCT02070744|449008528|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
124830347|NCT02070744|449008529|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
124830348|NCT02070744|449008525|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
124830349|NCT02070744|449008526|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
124830350|NCT02070744|449008527|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
124830351|NCT02070744|449008528|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
124830352|NCT02070744|449008529|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
124830353|NCT02070744|449008525|FG000|OLE Phase (48 Weeks)|Other|0|||
124830354|NCT02070744|449008526|FG001|OLE Phase (48 Weeks)|Other|0|||
124830355|NCT02070744|449008527|FG002|OLE Phase (48 Weeks)|Other|0|||
124830356|NCT02070744|449008528|FG003|OLE Phase (48 Weeks)|Other|0|||
124830357|NCT02070744|449008529|FG004|OLE Phase (48 Weeks)|Other|1|||
124830358|NCT04199117|449008530|FG000|Overall Study|Withdrawal by Subject|3|||
124830359|NCT04199117|449008531|FG001|Overall Study|Withdrawal by Subject|0|||
124830360|NCT04199117|449008532|FG002|Overall Study|Withdrawal by Subject|0|||
124830361|NCT04199117|449008533|FG003|Overall Study|Withdrawal by Subject|1|||
124830362|NCT04199117|449008534|FG004|Overall Study|Withdrawal by Subject|1|||
124830363|NCT04199117|449008535|FG005|Overall Study|Withdrawal by Subject|0|||
124830364|NCT04199117|449008536|FG006|Overall Study|Withdrawal by Subject|0|||
124830365|NCT04199117|449008537|FG007|Overall Study|Withdrawal by Subject|2|||
124830366|NCT04199117|449008538|FG008|Overall Study|Withdrawal by Subject|0|||
124830367|NCT04199117|449008539|FG009|Overall Study|Withdrawal by Subject|0|||
124830368|NCT04199117|449008540|FG010|Overall Study|Withdrawal by Subject|1|||
124830369|NCT04199117|449008541|FG011|Overall Study|Withdrawal by Subject|1|||
124830370|NCT04199117|449008542|FG012|Overall Study|Withdrawal by Subject|2|||
124830371|NCT04199117|449008543|FG013|Overall Study|Withdrawal by Subject|1|||
124830372|NCT04199117|449008544|FG014|Overall Study|Withdrawal by Subject|1|||
124830373|NCT04199117|449008545|FG015|Overall Study|Withdrawal by Subject|1|||
124830374|NCT04199117|449008530|FG000|Overall Study|Death|1|||
124830375|NCT04199117|449008531|FG001|Overall Study|Death|1|||
124830376|NCT04199117|449008532|FG002|Overall Study|Death|0|||
124830377|NCT04199117|449008533|FG003|Overall Study|Death|0|||
124830378|NCT04199117|449008534|FG004|Overall Study|Death|0|||
124830379|NCT04199117|449008535|FG005|Overall Study|Death|0|||
124830380|NCT04199117|449008536|FG006|Overall Study|Death|0|||
124830381|NCT04199117|449008537|FG007|Overall Study|Death|0|||
124830382|NCT04199117|449008538|FG008|Overall Study|Death|0|||
124830383|NCT04199117|449008539|FG009|Overall Study|Death|0|||
124830384|NCT04199117|449008540|FG010|Overall Study|Death|0|||
124830385|NCT04199117|449008541|FG011|Overall Study|Death|1|||
124830386|NCT04199117|449008542|FG012|Overall Study|Death|0|||
124830387|NCT04199117|449008543|FG013|Overall Study|Death|1|||
124830388|NCT04199117|449008544|FG014|Overall Study|Death|0|||
124830389|NCT04199117|449008545|FG015|Overall Study|Death|0|||
124830390|NCT04199117|449008530|FG000|Overall Study|Withdrawal by PI|0|||
124830391|NCT04199117|449008531|FG001|Overall Study|Withdrawal by PI|0|||
124830392|NCT04199117|449008532|FG002|Overall Study|Withdrawal by PI|0|||
124830393|NCT04199117|449008533|FG003|Overall Study|Withdrawal by PI|0|||
124830394|NCT04199117|449008534|FG004|Overall Study|Withdrawal by PI|0|||
124830395|NCT04199117|449008535|FG005|Overall Study|Withdrawal by PI|0|||
124830396|NCT04199117|449008536|FG006|Overall Study|Withdrawal by PI|0|||
124830397|NCT04199117|449008537|FG007|Overall Study|Withdrawal by PI|0|||
124830398|NCT04199117|449008538|FG008|Overall Study|Withdrawal by PI|0|||
124830399|NCT04199117|449008539|FG009|Overall Study|Withdrawal by PI|0|||
124830400|NCT04199117|449008540|FG010|Overall Study|Withdrawal by PI|0|||
124830401|NCT04199117|449008541|FG011|Overall Study|Withdrawal by PI|0|||
124830402|NCT04199117|449008542|FG012|Overall Study|Withdrawal by PI|1|||
124830403|NCT04199117|449008543|FG013|Overall Study|Withdrawal by PI|0|||
124830404|NCT04199117|449008544|FG014|Overall Study|Withdrawal by PI|0|||
124830405|NCT04199117|449008545|FG015|Overall Study|Withdrawal by PI|0|||
124830406|NCT05478252|449008546|FG000|Overall Study|Withdrawal by Subject|2|||
124830407|NCT05478252|449008547|FG001|Overall Study|Withdrawal by Subject|3|||
124830408|NCT05478252|449008546|FG000|Overall Study|Lost to Follow-up|4|||
124830409|NCT05478252|449008547|FG001|Overall Study|Lost to Follow-up|2|||
124830410|NCT05478252|449008546|FG000|Overall Study|Physician Decision|1|||
124830411|NCT05478252|449008547|FG001|Overall Study|Physician Decision|1|||
124830412|NCT05478252|449008546|FG000|Overall Study|Death|1|||
125304233|NCT02510001|450741207|FG004|Overall Study|Withdrawal by Subject|0|||
125304234|NCT02510001|450741208|FG005|Overall Study|Withdrawal by Subject|0|||
125304235|NCT02510001|450741209|FG006|Overall Study|Withdrawal by Subject|0|||
125304236|NCT02510001|450741210|FG007|Overall Study|Withdrawal by Subject|2|||
125304237|NCT00303485|450741214|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
125304238|NCT00303485|450741215|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
125304239|NCT00303485|450741214|FG000|Overall Study|Failure to return|0|||
125304240|NCT00303485|450741215|FG001|Overall Study|Failure to return|1|||
125304241|NCT00303485|450741214|FG000|Overall Study|Withdrawal by Subject|1|||
125304242|NCT00303485|450741215|FG001|Overall Study|Withdrawal by Subject|0|||
125304243|NCT01363908|450741224|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
125304244|NCT01363908|450741225|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
125304245|NCT01363908|450741224|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
125304246|NCT01363908|450741225|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
125304247|NCT01363908|450741224|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
125304248|NCT01363908|450741225|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
125304249|NCT01363908|450741224|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
125304250|NCT01363908|450741225|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
125304251|NCT02644343|450741226|FG000|Overall Study|Withdrawal by Subject|1|||
125304252|NCT03437577|450741227|FG000|Pre-Randomization|Withdrawal by Subject|0|||
125304253|NCT03437577|450741228|FG001|Pre-Randomization|Withdrawal by Subject|0|||
125304254|NCT03437577|450741229|FG002|Pre-Randomization|Withdrawal by Subject|10|||
125304255|NCT03437577|450741227|FG000|Post-Randomization|Physician Decision|0|||
125304256|NCT03437577|450741228|FG001|Post-Randomization|Physician Decision|2|||
125304257|NCT03437577|450741229|FG002|Post-Randomization|Physician Decision|0|||
125304258|NCT04774926|450741236|FG000|Overall Study|Adverse Event|15|||
125304259|NCT04774926|450741236|FG000|Overall Study|Lost to Follow-up|3|||
125304260|NCT04774926|450741236|FG000|Overall Study|Physician Decision|6|||
124830413|NCT05478252|449008547|FG001|Overall Study|Death|0|||
124830414|NCT07114198|449008554|FG000|Overall Study|Protocol Violation|1|||
124830415|NCT07114198|449008555|FG001|Overall Study|Protocol Violation|1|||
124830416|NCT00939809|449010044|FG000|Overall Study|Adverse Event|2|||
124830417|NCT00939809|449010044|FG000|Overall Study|Death|1|||
124830418|NCT01277523|449010045|FG000|Overall Study|Adverse Event|1|||
125304261|NCT04774926|450741236|FG000|Overall Study|Withdrawal by Subject|3|||
125304262|NCT04774926|450741236|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
125304263|NCT03078855|450741237|FG000|Overall Study|Lack of Efficacy|62|||
124830419|NCT01277523|449010046|FG001|Overall Study|Adverse Event|0|||
124830420|NCT01277523|449010047|FG002|Overall Study|Adverse Event|0|||
124830421|NCT01277523|449010045|FG000|Overall Study|Protocol Violation|2|||
124830422|NCT01277523|449010046|FG001|Overall Study|Protocol Violation|0|||
124830423|NCT01277523|449010047|FG002|Overall Study|Protocol Violation|0|||
124830424|NCT01277523|449010045|FG000|Overall Study|Other Reason not Defined|0|||
124830425|NCT01277523|449010046|FG001|Overall Study|Other Reason not Defined|1|||
124830426|NCT01277523|449010047|FG002|Overall Study|Other Reason not Defined|0|||
124830427|NCT01030523|449010048|FG000|Initial Study (5 Years)|Death|1|||
124830428|NCT01030523|449010049|FG001|Initial Study (5 Years)|Death|0|||
124830429|NCT01030523|449010048|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
124830430|NCT01030523|449010049|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
124830431|NCT01030523|449010048|FG000|Initial Study (5 Years)|Implant failure|1|||
124830432|NCT01030523|449010049|FG001|Initial Study (5 Years)|Implant failure|0|||
124830433|NCT01030523|449010048|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
124830434|NCT01030523|449010049|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
124830435|NCT01030523|449010048|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
124830436|NCT01030523|449010049|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
124830437|NCT01030523|449010048|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
124830438|NCT01030523|449010049|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
124830439|NCT02389998|449010054|FG000|Overall Study|car accident|1|||
124830440|NCT02389998|449010055|FG001|Overall Study|car accident|0|||
124830441|NCT05089682|449010056|FG000|Overall Study|Withdrawal by Subject|2|||
124830442|NCT01996826|449010059|FG000|Overall Study|Lost to Follow-up|6|||
124830443|NCT01996826|449010060|FG001|Overall Study|Lost to Follow-up|2|||
124830444|NCT01996826|449010059|FG000|Overall Study|Physician Decision|1|||
124830445|NCT01996826|449010060|FG001|Overall Study|Physician Decision|1|||
124830446|NCT02255981|449010062|FG000|Overall Study|Lost to Follow-up|3|||
124830447|NCT02255981|449010062|FG000|Overall Study|Withdrawal by Subject|1|||
124830448|NCT00518323|449010063|FG000|Overall Study|Lack of Efficacy|14|||
124830449|NCT00518323|449010064|FG001|Overall Study|Lack of Efficacy|2|||
124830450|NCT00518323|449010065|FG002|Overall Study|Lack of Efficacy|4|||
124830451|NCT00518323|449010066|FG003|Overall Study|Lack of Efficacy|20|||
124830452|NCT00518323|449010063|FG000|Overall Study|Withdrawal by Subject|1|||
124830453|NCT00518323|449010064|FG001|Overall Study|Withdrawal by Subject|2|||
124830454|NCT00518323|449010065|FG002|Overall Study|Withdrawal by Subject|4|||
124830455|NCT00518323|449010066|FG003|Overall Study|Withdrawal by Subject|2|||
124830456|NCT00518323|449010063|FG000|Overall Study|Lost to Follow-up|0|||
124830457|NCT00518323|449010064|FG001|Overall Study|Lost to Follow-up|2|||
124830458|NCT00518323|449010065|FG002|Overall Study|Lost to Follow-up|1|||
124830459|NCT00518323|449010066|FG003|Overall Study|Lost to Follow-up|3|||
124830460|NCT00518323|449010063|FG000|Overall Study|Adverse Event|1|||
124830461|NCT00518323|449010064|FG001|Overall Study|Adverse Event|1|||
124830462|NCT00518323|449010065|FG002|Overall Study|Adverse Event|1|||
124830463|NCT00518323|449010066|FG003|Overall Study|Adverse Event|0|||
124830464|NCT00518323|449010063|FG000|Overall Study|Prohibited medication and others|3|||
124830465|NCT00518323|449010064|FG001|Overall Study|Prohibited medication and others|1|||
124830466|NCT00518323|449010065|FG002|Overall Study|Prohibited medication and others|1|||
124830467|NCT00518323|449010066|FG003|Overall Study|Prohibited medication and others|0|||
124830468|NCT01514760|449010067|FG000|Overall Study|Lost to Follow-up|2|||
124830469|NCT02092662|449010068|FG000|Overall Study|Lost to Follow-up|13|||
124830470|NCT02092662|449010069|FG001|Overall Study|Lost to Follow-up|0|||
124830471|NCT03329690|449010072|FG000|Overall Study|Progressive disease per RECIST|85|||
124830472|NCT03329690|449010073|FG001|Overall Study|Progressive disease per RECIST|44|||
124830473|NCT03329690|449010074|FG002|Overall Study|Progressive disease per RECIST|6|||
124830474|NCT03329690|449010075|FG003|Overall Study|Progressive disease per RECIST|16|||
124830475|NCT03329690|449010076|FG004|Overall Study|Progressive disease per RECIST|20|||
124830476|NCT03329690|449010072|FG000|Overall Study|Clinical progression|7|||
124830477|NCT03329690|449010073|FG001|Overall Study|Clinical progression|4|||
124830478|NCT03329690|449010074|FG002|Overall Study|Clinical progression|1|||
124830479|NCT03329690|449010075|FG003|Overall Study|Clinical progression|1|||
124830480|NCT03329690|449010076|FG004|Overall Study|Clinical progression|1|||
124830481|NCT03329690|449010072|FG000|Overall Study|Adverse Event|22|||
124830482|NCT03329690|449010073|FG001|Overall Study|Adverse Event|4|||
124830483|NCT03329690|449010074|FG002|Overall Study|Adverse Event|0|||
124830484|NCT03329690|449010075|FG003|Overall Study|Adverse Event|1|||
125304264|NCT03078855|450741238|FG001|Overall Study|Lack of Efficacy|31|||
125304265|NCT03078855|450741237|FG000|Overall Study|Death|1|||
124830485|NCT03329690|449010076|FG004|Overall Study|Adverse Event|2|||
124830486|NCT03329690|449010072|FG000|Overall Study|Death|2|||
124830487|NCT03329690|449010073|FG001|Overall Study|Death|0|||
124830488|NCT03329690|449010074|FG002|Overall Study|Death|0|||
124830489|NCT03329690|449010075|FG003|Overall Study|Death|1|||
124830490|NCT03329690|449010076|FG004|Overall Study|Death|0|||
124830491|NCT03329690|449010072|FG000|Overall Study|Withdrawal by Subject|2|||
124830492|NCT03329690|449010073|FG001|Overall Study|Withdrawal by Subject|3|||
124830493|NCT03329690|449010074|FG002|Overall Study|Withdrawal by Subject|0|||
124830494|NCT03329690|449010075|FG003|Overall Study|Withdrawal by Subject|1|||
124830495|NCT03329690|449010076|FG004|Overall Study|Withdrawal by Subject|0|||
124830496|NCT03329690|449010072|FG000|Overall Study|Physician Decision|1|||
124830497|NCT03329690|449010073|FG001|Overall Study|Physician Decision|0|||
124830498|NCT03329690|449010074|FG002|Overall Study|Physician Decision|0|||
124830499|NCT03329690|449010075|FG003|Overall Study|Physician Decision|0|||
124830500|NCT03329690|449010076|FG004|Overall Study|Physician Decision|1|||
124830501|NCT03329690|449010072|FG000|Overall Study|Miscellaneous|6|||
124830502|NCT03329690|449010073|FG001|Overall Study|Miscellaneous|0|||
124830503|NCT03329690|449010074|FG002|Overall Study|Miscellaneous|0|||
124830504|NCT03329690|449010075|FG003|Overall Study|Miscellaneous|0|||
124830505|NCT03329690|449010076|FG004|Overall Study|Miscellaneous|0|||
124830506|NCT03329690|449010072|FG000|Overall Study|Did not receive treatment|1|||
124830507|NCT03329690|449010073|FG001|Overall Study|Did not receive treatment|0|||
124830508|NCT03329690|449010074|FG002|Overall Study|Did not receive treatment|0|||
124830509|NCT03329690|449010075|FG003|Overall Study|Did not receive treatment|1|||
124830510|NCT03329690|449010076|FG004|Overall Study|Did not receive treatment|0|||
124830511|NCT02418468|449010078|FG000|Overall Study|Adverse Event|1|||
124830512|NCT02418468|449010079|FG001|Overall Study|Adverse Event|0|||
124830513|NCT02418468|449010078|FG000|Overall Study|Withdrawal of informed consent|1|||
124830514|NCT02418468|449010079|FG001|Overall Study|Withdrawal of informed consent|1|||
124830515|NCT02914769|449010080|FG000|Overall Study|Protocol Violation|3|||
124830516|NCT02914769|449010081|FG001|Overall Study|Protocol Violation|2|||
124830517|NCT02914769|449010080|FG000|Overall Study|Withdrawal by Subject|0|||
124830518|NCT02914769|449010081|FG001|Overall Study|Withdrawal by Subject|1|||
124830519|NCT02337907|449010084|FG000|Overall Study|Other than listed|1|||
124830520|NCT02337907|449010085|FG001|Overall Study|Other than listed|0|||
124830521|NCT02337907|449010086|FG002|Overall Study|Other than listed|0|||
124830522|NCT02337907|449010087|FG003|Overall Study|Other than listed|1|||
124830523|NCT02337907|449010088|FG004|Overall Study|Other than listed|1|||
124830524|NCT02337907|449010089|FG005|Overall Study|Other than listed|0|||
124830525|NCT02337907|449010084|FG000|Overall Study|Withdrawal by Subject|2|||
124830526|NCT02337907|449010085|FG001|Overall Study|Withdrawal by Subject|3|||
124830527|NCT02337907|449010086|FG002|Overall Study|Withdrawal by Subject|0|||
124830528|NCT02337907|449010087|FG003|Overall Study|Withdrawal by Subject|2|||
124830529|NCT02337907|449010088|FG004|Overall Study|Withdrawal by Subject|5|||
124830530|NCT02337907|449010089|FG005|Overall Study|Withdrawal by Subject|0|||
124830531|NCT02337907|449010084|FG000|Overall Study|Lost to Follow-up|0|||
124830532|NCT02337907|449010085|FG001|Overall Study|Lost to Follow-up|0|||
124830533|NCT02337907|449010086|FG002|Overall Study|Lost to Follow-up|0|||
124830534|NCT02337907|449010087|FG003|Overall Study|Lost to Follow-up|0|||
124830535|NCT02337907|449010088|FG004|Overall Study|Lost to Follow-up|0|||
124830536|NCT02337907|449010089|FG005|Overall Study|Lost to Follow-up|1|||
124830537|NCT02337907|449010084|FG000|Overall Study|Adverse Event|1|||
124830538|NCT02337907|449010085|FG001|Overall Study|Adverse Event|1|||
124830539|NCT02337907|449010086|FG002|Overall Study|Adverse Event|1|||
124830540|NCT02337907|449010087|FG003|Overall Study|Adverse Event|1|||
124830541|NCT02337907|449010088|FG004|Overall Study|Adverse Event|4|||
124830542|NCT02337907|449010089|FG005|Overall Study|Adverse Event|0|||
124830543|NCT01592344|449010093|FG000|Overall Study|Adverse Event|1|||
124830544|NCT01592344|449010094|FG001|Overall Study|Adverse Event|1|||
124830545|NCT01592344|449010093|FG000|Overall Study|Lack of Efficacy|1|||
124830546|NCT01592344|449010094|FG001|Overall Study|Lack of Efficacy|0|||
124830547|NCT01592344|449010093|FG000|Overall Study|not available at primary outcome visit|2|||
124830548|NCT01592344|449010094|FG001|Overall Study|not available at primary outcome visit|4|||
124830549|NCT02488681|449010098|FG000|Overall Study|Implant unsuccessful|7|||
124830550|NCT00720057|449010099|FG000|Overall Study|Lost to Follow-up|0|||
124830551|NCT00720057|449010100|FG001|Overall Study|Lost to Follow-up|2|||
124830552|NCT00720057|449010099|FG000|Overall Study|Protocol Violation|1|||
124830553|NCT00720057|449010100|FG001|Overall Study|Protocol Violation|0|||
124830554|NCT00720057|449010099|FG000|Overall Study|Withdrawal by Subject|0|||
124830555|NCT00720057|449010100|FG001|Overall Study|Withdrawal by Subject|1|||
124830556|NCT00613015|449010106|FG000|Overall Study|Lost to Follow-up|0|||
124830557|NCT00613015|449010107|FG001|Overall Study|Lost to Follow-up|1|||
124830558|NCT00613015|449010108|FG002|Overall Study|Lost to Follow-up|3|||
124830559|NCT00613015|449010109|FG003|Overall Study|Lost to Follow-up|3|||
124830560|NCT00613015|449010110|FG004|Overall Study|Lost to Follow-up|2|||
124830561|NCT00613015|449010111|FG005|Overall Study|Lost to Follow-up|3|||
124830562|NCT01170091|449010112|FG000|Overall Study|Missing efficacy evaluation|3|||
124830563|NCT01170091|449010112|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
124830564|NCT00391274|449010117|FG000|Overall Study|Death Due to Study Disease|55|||
124830565|NCT00391274|449010118|FG001|Overall Study|Death Due to Study Disease|45|||
124830566|NCT00391274|449010117|FG000|Overall Study|Lost to Follow-up|0|||
124830567|NCT00391274|449010118|FG001|Overall Study|Lost to Follow-up|3|||
124830568|NCT00391274|449010117|FG000|Overall Study|Physician Decision|4|||
124830569|NCT00391274|449010118|FG001|Overall Study|Physician Decision|2|||
124830570|NCT00391274|449010117|FG000|Overall Study|Withdrawal by Subject|0|||
124830571|NCT00391274|449010118|FG001|Overall Study|Withdrawal by Subject|3|||
124830572|NCT00391274|449010117|FG000|Overall Study|Death Due to Adverse Event|1|||
124830573|NCT00391274|449010118|FG001|Overall Study|Death Due to Adverse Event|3|||
124830574|NCT00391274|449010117|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
124830575|NCT00391274|449010118|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
124830576|NCT00391274|449010117|FG000|Overall Study|Death Not Study Related|0|||
124830577|NCT00391274|449010118|FG001|Overall Study|Death Not Study Related|1|||
124830578|NCT03341533|449010119|FG000|Overall Study|Withdrawal by Subject|1|||
124830579|NCT03341533|449010120|FG001|Overall Study|Withdrawal by Subject|1|||
124830580|NCT03341533|449010119|FG000|Overall Study|Not eligible after randomization|2|||
124830581|NCT03341533|449010120|FG001|Overall Study|Not eligible after randomization|1|||
124830582|NCT03447990|449010122|FG000|Overall Study|Withdrawal by Subject|0|||
124830583|NCT03447990|449010123|FG001|Overall Study|Withdrawal by Subject|0|||
124830584|NCT03447990|449010124|FG002|Overall Study|Withdrawal by Subject|0|||
124830585|NCT03447990|449010125|FG003|Overall Study|Withdrawal by Subject|0|||
124830586|NCT03447990|449010126|FG004|Overall Study|Withdrawal by Subject|0|||
124830587|NCT03447990|449010127|FG005|Overall Study|Withdrawal by Subject|0|||
124830588|NCT03447990|449010128|FG006|Overall Study|Withdrawal by Subject|1|||
124830589|NCT03559257|449010129|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
124830590|NCT03559257|449010130|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
124830591|NCT03559257|449010129|FG000|Double Blind Treatment Period|Protocol Violation|1|||
124830592|NCT03559257|449010130|FG001|Double Blind Treatment Period|Protocol Violation|4|||
124830593|NCT03559257|449010129|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
124830594|NCT03559257|449010130|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
124830595|NCT03559257|449010129|FG000|Double Blind Treatment Period|Adverse Event|0|||
124830596|NCT03559257|449010130|FG001|Double Blind Treatment Period|Adverse Event|1|||
124830597|NCT03559257|449010129|FG000|Double Blind Treatment Period|Screen Failure|0|||
124830598|NCT03559257|449010130|FG001|Double Blind Treatment Period|Screen Failure|1|||
124830599|NCT03559257|449010129|FG000|Open-label Treatment Period|Adverse Event|1|||
124830600|NCT03559257|449010130|FG001|Open-label Treatment Period|Adverse Event|4|||
124830601|NCT03559257|449010129|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
124830602|NCT03559257|449010130|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
124830603|NCT03559257|449010129|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
124830604|NCT03559257|449010130|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
124830605|NCT03559257|449010129|FG000|Open-label Treatment Period|Protocol Violation|2|||
124830606|NCT03559257|449010130|FG001|Open-label Treatment Period|Protocol Violation|0|||
124830607|NCT03559257|449010129|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
124830608|NCT03559257|449010130|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
124830609|NCT03559257|449010129|FG000|Open-label Treatment Period|Physician Decision|0|||
124830610|NCT03559257|449010130|FG001|Open-label Treatment Period|Physician Decision|1|||
124830611|NCT03630120|449010131|FG000|Overall Study|Disease progression|0|||
124830612|NCT03630120|449010132|FG001|Overall Study|Disease progression|1|||
124830613|NCT03630120|449010133|FG002|Overall Study|Disease progression|1|||
124830614|NCT03630120|449010134|FG003|Overall Study|Disease progression|1|||
124830615|NCT01519960|449010135|FG000|Overall Study|Withdrawal from the study|26|||
124830616|NCT01519960|449010136|FG001|Overall Study|Withdrawal from the study|22|||
124830617|NCT01519960|449010137|FG002|Overall Study|Withdrawal from the study|5|||
124830618|NCT01387347|449010138|FG000|Overall Study|Lost to Follow-up|2|||
124830619|NCT01387347|449010139|FG001|Overall Study|Lost to Follow-up|1|||
124830620|NCT02153112|449010142|FG000|Overall Study|Adverse Event|0|||
124830621|NCT02153112|449010143|FG001|Overall Study|Adverse Event|0|||
124830622|NCT02153112|449010144|FG002|Overall Study|Adverse Event|1|||
124830623|NCT02153112|449010145|FG003|Overall Study|Adverse Event|0|||
124830624|NCT02153112|449010146|FG004|Overall Study|Adverse Event|0|||
124830625|NCT02153112|449010147|FG005|Overall Study|Adverse Event|0|||
124830626|NCT02153112|449010148|FG006|Overall Study|Adverse Event|0|||
124830627|NCT02153112|449010149|FG007|Overall Study|Adverse Event|0|||
124830628|NCT02153112|449010150|FG008|Overall Study|Adverse Event|0|||
124830629|NCT02153112|449010151|FG009|Overall Study|Adverse Event|0|||
124830630|NCT02153112|449010142|FG000|Overall Study|Lost to Follow-up|1|||
124830631|NCT02153112|449010143|FG001|Overall Study|Lost to Follow-up|1|||
124830632|NCT02153112|449010144|FG002|Overall Study|Lost to Follow-up|0|||
124830633|NCT02153112|449010145|FG003|Overall Study|Lost to Follow-up|0|||
124830634|NCT02153112|449010146|FG004|Overall Study|Lost to Follow-up|2|||
124830635|NCT02153112|449010147|FG005|Overall Study|Lost to Follow-up|1|||
124830636|NCT02153112|449010148|FG006|Overall Study|Lost to Follow-up|1|||
124830637|NCT02153112|449010149|FG007|Overall Study|Lost to Follow-up|0|||
124830638|NCT02153112|449010150|FG008|Overall Study|Lost to Follow-up|1|||
124830639|NCT02153112|449010151|FG009|Overall Study|Lost to Follow-up|1|||
124830640|NCT02153112|449010142|FG000|Overall Study|Withdrawal by Subject|3|||
124830641|NCT02153112|449010143|FG001|Overall Study|Withdrawal by Subject|1|||
124830642|NCT02153112|449010144|FG002|Overall Study|Withdrawal by Subject|2|||
124830643|NCT02153112|449010145|FG003|Overall Study|Withdrawal by Subject|2|||
124830644|NCT02153112|449010146|FG004|Overall Study|Withdrawal by Subject|1|||
124830645|NCT02153112|449010147|FG005|Overall Study|Withdrawal by Subject|1|||
124830646|NCT02153112|449010148|FG006|Overall Study|Withdrawal by Subject|7|||
124830647|NCT02153112|449010149|FG007|Overall Study|Withdrawal by Subject|2|||
124830648|NCT02153112|449010150|FG008|Overall Study|Withdrawal by Subject|13|||
124830649|NCT02153112|449010151|FG009|Overall Study|Withdrawal by Subject|12|||
124830650|NCT02153112|449010142|FG000|Overall Study|Reason not Specified|0|||
124830651|NCT02153112|449010143|FG001|Overall Study|Reason not Specified|0|||
124830652|NCT02153112|449010144|FG002|Overall Study|Reason not Specified|0|||
124830653|NCT02153112|449010145|FG003|Overall Study|Reason not Specified|0|||
124830654|NCT02153112|449010146|FG004|Overall Study|Reason not Specified|0|||
124830655|NCT02153112|449010147|FG005|Overall Study|Reason not Specified|0|||
124830656|NCT02153112|449010148|FG006|Overall Study|Reason not Specified|0|||
124830657|NCT02153112|449010149|FG007|Overall Study|Reason not Specified|0|||
124830658|NCT02153112|449010150|FG008|Overall Study|Reason not Specified|1|||
124830659|NCT02153112|449010151|FG009|Overall Study|Reason not Specified|1|||
124830660|NCT00561080|449010152|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
124830661|NCT00561080|449010153|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
124830662|NCT00561080|449010154|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
124830663|NCT00561080|449010152|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
124830664|NCT00561080|449010153|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
124830665|NCT00561080|449010154|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
124830666|NCT00561080|449010152|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
124830667|NCT00561080|449010153|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
124830668|NCT00561080|449010154|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
124830669|NCT00561080|449010152|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
124830670|NCT00561080|449010153|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
124830671|NCT00561080|449010154|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
124830672|NCT00561080|449010152|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
124830673|NCT00561080|449010153|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
124830674|NCT00561080|449010154|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
124830675|NCT00561080|449010152|FG000|Vaccination Period (up to Month 4)|Other|0|||
124830676|NCT00561080|449010153|FG001|Vaccination Period (up to Month 4)|Other|2|||
124830677|NCT00561080|449010154|FG002|Vaccination Period (up to Month 4)|Other|1|||
124830678|NCT00561080|449010152|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
124830679|NCT00561080|449010153|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
124830680|NCT00561080|449010154|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
124830681|NCT00561080|449010152|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
124830682|NCT00561080|449010153|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
124830683|NCT00561080|449010154|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
124830684|NCT00561080|449010152|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
124830685|NCT00561080|449010153|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
124830686|NCT00561080|449010154|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
124830687|NCT00561080|449010152|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
124830688|NCT00561080|449010153|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
124830689|NCT00561080|449010154|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
124830690|NCT01498458|449010157|FG000|Overall Study|Adverse Event|4|||
124830691|NCT01498458|449010157|FG000|Overall Study|Physician Decision|3|||
124830692|NCT02446990|449010160|FG000|Overall Study|Death|485|||
124830693|NCT02446990|449010161|FG001|Overall Study|Death|458|||
124830694|NCT02446990|449010160|FG000|Overall Study|Lost to Follow-up|3|||
124830695|NCT02446990|449010161|FG001|Overall Study|Lost to Follow-up|1|||
124830696|NCT02446990|449010160|FG000|Overall Study|Physician Decision|1|||
124830697|NCT02446990|449010161|FG001|Overall Study|Physician Decision|0|||
124830698|NCT02446990|449010160|FG000|Overall Study|Withdrawal by Subject|231|||
124830699|NCT02446990|449010161|FG001|Overall Study|Withdrawal by Subject|199|||
124830700|NCT03158051|449010162|FG000|Overall Study|Lost to Follow-up|41|||
124830701|NCT03158051|449010163|FG001|Overall Study|Lost to Follow-up|47|||
124830702|NCT03158051|449010162|FG000|Overall Study|Physician Decision|6|||
124830703|NCT03158051|449010163|FG001|Overall Study|Physician Decision|7|||
124830704|NCT03158051|449010162|FG000|Overall Study|Withdrawal by Subject|24|||
124830705|NCT03158051|449010163|FG001|Overall Study|Withdrawal by Subject|15|||
124830706|NCT03158051|449010162|FG000|Overall Study|Death|0|||
124830707|NCT03158051|449010163|FG001|Overall Study|Death|1|||
124830708|NCT02738151|449010164|FG000|Overall Study|Randomized but not treated|4|||
124830709|NCT02738151|449010165|FG001|Overall Study|Randomized but not treated|1|||
124830710|NCT02738151|449010164|FG000|Overall Study|Adverse Event|4|||
124830711|NCT02738151|449010165|FG001|Overall Study|Adverse Event|5|||
124830712|NCT02738151|449010164|FG000|Overall Study|Hypoglycemia|0|||
124830713|NCT02738151|449010165|FG001|Overall Study|Hypoglycemia|1|||
125304266|NCT03078855|450741238|FG001|Overall Study|Death|0|||
125304267|NCT03078855|450741237|FG000|Overall Study|Withdrawal by Subject|12|||
125304268|NCT03078855|450741238|FG001|Overall Study|Withdrawal by Subject|6|||
125304269|NCT03078855|450741237|FG000|Overall Study|Physician Decision|3|||
124830714|NCT02738151|449010164|FG000|Overall Study|Poor Compliance to Protocol|4|||
125304270|NCT03078855|450741238|FG001|Overall Study|Physician Decision|2|||
124830715|NCT02738151|449010165|FG001|Overall Study|Poor Compliance to Protocol|3|||
124830716|NCT02738151|449010164|FG000|Overall Study|Other than specified above|11|||
124830717|NCT02738151|449010165|FG001|Overall Study|Other than specified above|21|||
124830718|NCT03649711|449010167|FG000|Overall Study|Adverse Event|0|||
124830719|NCT03649711|449010168|FG001|Overall Study|Adverse Event|1|||
125304271|NCT03078855|450741237|FG000|Overall Study|Second Malignancy|4|||
125304272|NCT03078855|450741238|FG001|Overall Study|Second Malignancy|0|||
124830720|NCT03649711|449010169|FG002|Overall Study|Adverse Event|0|||
124830721|NCT03649711|449010167|FG000|Overall Study|Kidney Transplant|1|||
124830722|NCT03649711|449010168|FG001|Overall Study|Kidney Transplant|0|||
124830723|NCT03649711|449010169|FG002|Overall Study|Kidney Transplant|0|||
124830724|NCT00702403|449012095|FG000|From Consent to Engraftment|Progressive leukemia|6|||
124830725|NCT00702403|449012095|FG000|From Consent to Engraftment|Critically ill|2|||
124830726|NCT00702403|449012095|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
124830727|NCT00702403|449012095|FG000|From Consent to Engraftment|Myocardial infarction|1|||
124830728|NCT00702403|449012095|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
124830729|NCT00702403|449012095|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
124830730|NCT00702403|449012095|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
124830731|NCT00702403|449012095|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
124830732|NCT00702403|449012095|FG000|From Engraftment to Study Completion|Non-compliance|2|||
124830733|NCT00702403|449012095|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
124830734|NCT00702403|449012095|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
124830735|NCT00702403|449012095|FG000|From Engraftment to Study Completion|Suicide|1|||
124830736|NCT00702403|449012095|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
124830737|NCT00702403|449012095|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
124830738|NCT00702403|449012095|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
124830739|NCT02016625|449012096|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
124830740|NCT02016625|449012097|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
124830741|NCT02016625|449012096|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
124830742|NCT02016625|449012097|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
124830743|NCT02016625|449012096|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
124830744|NCT02016625|449012097|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
124830745|NCT02356783|449012099|FG000|Overall Study|Lost to Follow-up|1|||
124830746|NCT02356783|449012100|FG001|Overall Study|Lost to Follow-up|3|||
124830747|NCT00380978|449012101|FG000|Overall Study|Refused allocated intervention|0|||
124830748|NCT00380978|449012102|FG001|Overall Study|Refused allocated intervention|6|||
124830749|NCT00380978|449012101|FG000|Overall Study|Wrong study envelope|0|||
124830750|NCT00380978|449012102|FG001|Overall Study|Wrong study envelope|2|||
124830751|NCT00380978|449012101|FG000|Overall Study|Allocation prior to analgesia request|1|||
124830752|NCT00380978|449012102|FG001|Overall Study|Allocation prior to analgesia request|2|||
124830753|NCT00380978|449012101|FG000|Overall Study|Parous patient|1|||
124830754|NCT00380978|449012102|FG001|Overall Study|Parous patient|0|||
124830755|NCT04146545|449012103|FG000|Overall Study|deemed ineligible after randomization|1|||
124830756|NCT04146545|449012104|FG001|Overall Study|deemed ineligible after randomization|0|||
124830757|NCT01729754|449012105|FG000|Part 1|Adverse Event|2|||
124830758|NCT01729754|449012106|FG001|Part 1|Adverse Event|0|||
124830759|NCT01729754|449012107|FG002|Part 1|Adverse Event|0|||
124830760|NCT01729754|449012108|FG003|Part 1|Adverse Event|1|||
124830761|NCT01729754|449012109|FG004|Part 1|Adverse Event|0|||
124830762|NCT01729754|449012110|FG005|Part 1|Adverse Event|0|||
124830763|NCT01729754|449012111|FG006|Part 1|Adverse Event|2|||
124830764|NCT01729754|449012112|FG007|Part 1|Adverse Event|0|||
124830765|NCT01729754|449012113|FG008|Part 1|Adverse Event|0|||
124830766|NCT01729754|449012114|FG009|Part 1|Adverse Event|5|||
124830767|NCT01729754|449012105|FG000|Part 1|Lack of Efficacy|1|||
124830768|NCT01729754|449012106|FG001|Part 1|Lack of Efficacy|0|||
124830769|NCT01729754|449012107|FG002|Part 1|Lack of Efficacy|0|||
124830770|NCT01729754|449012108|FG003|Part 1|Lack of Efficacy|0|||
124830771|NCT01729754|449012109|FG004|Part 1|Lack of Efficacy|0|||
124830772|NCT01729754|449012110|FG005|Part 1|Lack of Efficacy|0|||
124830773|NCT01729754|449012111|FG006|Part 1|Lack of Efficacy|2|||
124830774|NCT01729754|449012112|FG007|Part 1|Lack of Efficacy|0|||
124830775|NCT01729754|449012113|FG008|Part 1|Lack of Efficacy|0|||
125304273|NCT03078855|450741237|FG000|Overall Study|Ineligible|2|||
125304274|NCT03078855|450741238|FG001|Overall Study|Ineligible|0|||
125304275|NCT03078855|450741237|FG000|Overall Study|Withdrew before day 1 treatment|2|||
124830776|NCT01729754|449012114|FG009|Part 1|Lack of Efficacy|0|||
124830777|NCT01729754|449012105|FG000|Part 1|Lost to Follow-up|1|||
124830778|NCT01729754|449012106|FG001|Part 1|Lost to Follow-up|0|||
124830779|NCT01729754|449012107|FG002|Part 1|Lost to Follow-up|0|||
124830780|NCT01729754|449012108|FG003|Part 1|Lost to Follow-up|2|||
124830781|NCT01729754|449012109|FG004|Part 1|Lost to Follow-up|0|||
124830782|NCT01729754|449012110|FG005|Part 1|Lost to Follow-up|0|||
124830783|NCT01729754|449012111|FG006|Part 1|Lost to Follow-up|3|||
124830784|NCT01729754|449012112|FG007|Part 1|Lost to Follow-up|0|||
124830785|NCT01729754|449012113|FG008|Part 1|Lost to Follow-up|0|||
124830786|NCT01729754|449012114|FG009|Part 1|Lost to Follow-up|3|||
124830787|NCT01729754|449012105|FG000|Part 1|Non-compliance with Study Drug|1|||
124830788|NCT01729754|449012106|FG001|Part 1|Non-compliance with Study Drug|0|||
124830789|NCT01729754|449012107|FG002|Part 1|Non-compliance with Study Drug|0|||
124830790|NCT01729754|449012108|FG003|Part 1|Non-compliance with Study Drug|0|||
124830791|NCT01729754|449012109|FG004|Part 1|Non-compliance with Study Drug|0|||
124830792|NCT01729754|449012110|FG005|Part 1|Non-compliance with Study Drug|0|||
124830793|NCT01729754|449012111|FG006|Part 1|Non-compliance with Study Drug|0|||
124830794|NCT01729754|449012112|FG007|Part 1|Non-compliance with Study Drug|0|||
124830795|NCT01729754|449012113|FG008|Part 1|Non-compliance with Study Drug|0|||
124830796|NCT01729754|449012114|FG009|Part 1|Non-compliance with Study Drug|0|||
125304276|NCT03078855|450741238|FG001|Overall Study|Withdrew before day 1 treatment|1|||
125304277|NCT00391027|450741240|FG000|Overall Study|Adverse Event|8|||
125304278|NCT00391027|450741241|FG001|Overall Study|Adverse Event|8|||
125304279|NCT00391027|450741240|FG000|Overall Study|Lack of Efficacy|3|||
125304280|NCT00391027|450741241|FG001|Overall Study|Lack of Efficacy|0|||
125304281|NCT00391027|450741240|FG000|Overall Study|Withdrawal by Subject|10|||
125304282|NCT00391027|450741241|FG001|Overall Study|Withdrawal by Subject|1|||
125304283|NCT00391027|450741240|FG000|Overall Study|Other|4|||
125304284|NCT00391027|450741241|FG001|Overall Study|Other|3|||
125304285|NCT04124705|450741244|FG000|Titration Period|Adverse Event|9|||
125304286|NCT04124705|450741245|FG001|Titration Period|Adverse Event|5|||
125304287|NCT04124705|450741244|FG000|Titration Period|Withdrawal by Subject|6|||
125304288|NCT04124705|450741245|FG001|Titration Period|Withdrawal by Subject|3|||
125304289|NCT04124705|450741244|FG000|Titration Period|Lost to Follow-up|0|||
125304290|NCT04124705|450741245|FG001|Titration Period|Lost to Follow-up|1|||
125304291|NCT04124705|450741244|FG000|Titration Period|Death|1|||
125304292|NCT04124705|450741245|FG001|Titration Period|Death|1|||
125304293|NCT04124705|450741244|FG000|Titration Period|Lack of Efficacy|2|||
125304294|NCT04124705|450741245|FG001|Titration Period|Lack of Efficacy|0|||
125304295|NCT04124705|450741244|FG000|Titration Period|Physician Decision|2|||
125304296|NCT04124705|450741245|FG001|Titration Period|Physician Decision|0|||
125304297|NCT04124705|450741244|FG000|Titration Period|Non-compliance with Study Drug|2|||
125304298|NCT04124705|450741245|FG001|Titration Period|Non-compliance with Study Drug|0|||
125304299|NCT04124705|450741244|FG000|Titration Period|Other|4|||
125304300|NCT04124705|450741245|FG001|Titration Period|Other|9|||
125304301|NCT04124705|450741244|FG000|Stabilization Period|Adverse Event|4|||
125304302|NCT04124705|450741245|FG001|Stabilization Period|Adverse Event|2|||
125304303|NCT04124705|450741244|FG000|Stabilization Period|Withdrawal by Subject|1|||
125304304|NCT04124705|450741245|FG001|Stabilization Period|Withdrawal by Subject|1|||
125304305|NCT04124705|450741244|FG000|Stabilization Period|Lost to Follow-up|0|||
125304306|NCT04124705|450741245|FG001|Stabilization Period|Lost to Follow-up|1|||
125304307|NCT04124705|450741244|FG000|Stabilization Period|Lack of Efficacy|4|||
125304308|NCT04124705|450741245|FG001|Stabilization Period|Lack of Efficacy|2|||
125304309|NCT04124705|450741244|FG000|Stabilization Period|Protocol Deviation|0|||
125304310|NCT04124705|450741245|FG001|Stabilization Period|Protocol Deviation|2|||
125304311|NCT04124705|450741244|FG000|Stabilization Period|Other|2|||
125304312|NCT04124705|450741245|FG001|Stabilization Period|Other|2|||
125304313|NCT01973998|450741246|FG000|Overall Study|Death|2|||
125304314|NCT01973998|450741247|FG001|Overall Study|Death|2|||
125304315|NCT04302545|450741250|FG000|Overall Study|Lost to Follow-up|3|||
125304316|NCT04302545|450741251|FG001|Overall Study|Lost to Follow-up|4|||
125304317|NCT01636986|450741255|FG000|Overall Study|Withdrawal by Subject|0|||
125304318|NCT01636986|450741256|FG001|Overall Study|Withdrawal by Subject|1|||
125304319|NCT01636986|450741255|FG000|Overall Study|Corneal Staining|0|||
125304320|NCT01636986|450741256|FG001|Overall Study|Corneal Staining|1|||
125304321|NCT02106403|450741261|FG000|Follow-Up Visit 3|Other Reason|0|||
125304322|NCT02106403|450741262|FG001|Follow-Up Visit 3|Other Reason|0|||
125304323|NCT02106403|450741263|FG002|Follow-Up Visit 3|Other Reason|0|||
125304324|NCT02106403|450741264|FG003|Follow-Up Visit 3|Other Reason|0|||
125304325|NCT02106403|450741265|FG004|Follow-Up Visit 3|Other Reason|0|||
125304326|NCT02106403|450741266|FG005|Follow-Up Visit 3|Other Reason|1|||
125304327|NCT04038567|450741268|FG000|Overall Study|Lost to Follow-up|6|||
125304328|NCT04038567|450741269|FG001|Overall Study|Lost to Follow-up|4|||
125304329|NCT04038567|450741270|FG002|Overall Study|Lost to Follow-up|5|||
125304330|NCT04038567|450741271|FG003|Overall Study|Lost to Follow-up|4|||
125304331|NCT04038567|450741272|FG004|Overall Study|Lost to Follow-up|6|||
125304332|NCT04038567|450741273|FG005|Overall Study|Lost to Follow-up|4|||
125304333|NCT04038567|450741274|FG006|Overall Study|Lost to Follow-up|4|||
125304334|NCT04038567|450741275|FG007|Overall Study|Lost to Follow-up|1|||
125304335|NCT04038567|450741268|FG000|Overall Study|Withdrawal by Subject|2|||
125304336|NCT04038567|450741269|FG001|Overall Study|Withdrawal by Subject|1|||
125304337|NCT04038567|450741270|FG002|Overall Study|Withdrawal by Subject|1|||
125304338|NCT04038567|450741271|FG003|Overall Study|Withdrawal by Subject|1|||
125304339|NCT04038567|450741272|FG004|Overall Study|Withdrawal by Subject|4|||
125304340|NCT04038567|450741273|FG005|Overall Study|Withdrawal by Subject|1|||
125304341|NCT04038567|450741274|FG006|Overall Study|Withdrawal by Subject|1|||
125304342|NCT04038567|450741275|FG007|Overall Study|Withdrawal by Subject|1|||
125304343|NCT04038567|450741268|FG000|Overall Study|missed survey window|1|||
125304344|NCT04038567|450741269|FG001|Overall Study|missed survey window|2|||
124830797|NCT01729754|449012105|FG000|Part 1|Physician Decision|0|||
125304345|NCT04038567|450741270|FG002|Overall Study|missed survey window|0|||
125304346|NCT04038567|450741271|FG003|Overall Study|missed survey window|0|||
125304347|NCT04038567|450741272|FG004|Overall Study|missed survey window|1|||
125304348|NCT04038567|450741273|FG005|Overall Study|missed survey window|1|||
124830798|NCT01729754|449012106|FG001|Part 1|Physician Decision|0|||
124830799|NCT01729754|449012107|FG002|Part 1|Physician Decision|0|||
124830800|NCT01729754|449012108|FG003|Part 1|Physician Decision|0|||
124830801|NCT01729754|449012109|FG004|Part 1|Physician Decision|0|||
124830802|NCT01729754|449012110|FG005|Part 1|Physician Decision|0|||
124830803|NCT01729754|449012111|FG006|Part 1|Physician Decision|0|||
124830804|NCT01729754|449012112|FG007|Part 1|Physician Decision|0|||
124830805|NCT01729754|449012113|FG008|Part 1|Physician Decision|0|||
124830806|NCT01729754|449012114|FG009|Part 1|Physician Decision|4|||
124830807|NCT01729754|449012105|FG000|Part 1|Pregnancy|0|||
124830808|NCT01729754|449012106|FG001|Part 1|Pregnancy|0|||
124830809|NCT01729754|449012107|FG002|Part 1|Pregnancy|0|||
124830810|NCT01729754|449012108|FG003|Part 1|Pregnancy|1|||
124830811|NCT01729754|449012109|FG004|Part 1|Pregnancy|0|||
124830812|NCT01729754|449012110|FG005|Part 1|Pregnancy|0|||
124830813|NCT01729754|449012111|FG006|Part 1|Pregnancy|0|||
124830814|NCT01729754|449012112|FG007|Part 1|Pregnancy|0|||
124830815|NCT01729754|449012113|FG008|Part 1|Pregnancy|0|||
124830816|NCT01729754|449012114|FG009|Part 1|Pregnancy|1|||
124830817|NCT01729754|449012105|FG000|Part 1|Progressive Disease|0|||
124830818|NCT01729754|449012106|FG001|Part 1|Progressive Disease|0|||
124830819|NCT01729754|449012107|FG002|Part 1|Progressive Disease|0|||
124830820|NCT01729754|449012108|FG003|Part 1|Progressive Disease|0|||
124830821|NCT01729754|449012109|FG004|Part 1|Progressive Disease|0|||
124830822|NCT01729754|449012110|FG005|Part 1|Progressive Disease|0|||
124830823|NCT01729754|449012111|FG006|Part 1|Progressive Disease|0|||
124830824|NCT01729754|449012112|FG007|Part 1|Progressive Disease|0|||
124830825|NCT01729754|449012113|FG008|Part 1|Progressive Disease|0|||
124830826|NCT01729754|449012114|FG009|Part 1|Progressive Disease|1|||
124830827|NCT01729754|449012105|FG000|Part 1|Protocol Violation|2|||
124830828|NCT01729754|449012106|FG001|Part 1|Protocol Violation|0|||
124830829|NCT01729754|449012107|FG002|Part 1|Protocol Violation|0|||
124830830|NCT01729754|449012108|FG003|Part 1|Protocol Violation|1|||
124830831|NCT01729754|449012109|FG004|Part 1|Protocol Violation|0|||
124830832|NCT01729754|449012110|FG005|Part 1|Protocol Violation|0|||
124830833|NCT01729754|449012111|FG006|Part 1|Protocol Violation|1|||
124830834|NCT01729754|449012112|FG007|Part 1|Protocol Violation|0|||
124830835|NCT01729754|449012113|FG008|Part 1|Protocol Violation|0|||
124830836|NCT01729754|449012114|FG009|Part 1|Protocol Violation|0|||
124830837|NCT01729754|449012105|FG000|Part 1|Withdrawal by Subject|5|||
124830838|NCT01729754|449012106|FG001|Part 1|Withdrawal by Subject|0|||
124830839|NCT01729754|449012107|FG002|Part 1|Withdrawal by Subject|0|||
124830840|NCT01729754|449012108|FG003|Part 1|Withdrawal by Subject|7|||
124830841|NCT01729754|449012109|FG004|Part 1|Withdrawal by Subject|0|||
124830842|NCT01729754|449012110|FG005|Part 1|Withdrawal by Subject|0|||
124830843|NCT01729754|449012111|FG006|Part 1|Withdrawal by Subject|5|||
124830844|NCT01729754|449012112|FG007|Part 1|Withdrawal by Subject|0|||
124830845|NCT01729754|449012113|FG008|Part 1|Withdrawal by Subject|0|||
124830846|NCT01729754|449012114|FG009|Part 1|Withdrawal by Subject|6|||
124830847|NCT01729754|449012105|FG000|Part 1|Other Protocol Specified Criteria|2|||
124830848|NCT01729754|449012106|FG001|Part 1|Other Protocol Specified Criteria|0|||
124830849|NCT01729754|449012107|FG002|Part 1|Other Protocol Specified Criteria|0|||
124830850|NCT01729754|449012108|FG003|Part 1|Other Protocol Specified Criteria|0|||
124830851|NCT01729754|449012109|FG004|Part 1|Other Protocol Specified Criteria|0|||
124830852|NCT01729754|449012110|FG005|Part 1|Other Protocol Specified Criteria|0|||
124830853|NCT01729754|449012111|FG006|Part 1|Other Protocol Specified Criteria|1|||
124830854|NCT01729754|449012112|FG007|Part 1|Other Protocol Specified Criteria|0|||
124830855|NCT01729754|449012113|FG008|Part 1|Other Protocol Specified Criteria|0|||
124830856|NCT01729754|449012114|FG009|Part 1|Other Protocol Specified Criteria|4|||
124830857|NCT01729754|449012105|FG000|Part 2|Adverse Event|2|||
124830858|NCT01729754|449012106|FG001|Part 2|Adverse Event|0|||
124830859|NCT01729754|449012107|FG002|Part 2|Adverse Event|0|||
124830860|NCT01729754|449012108|FG003|Part 2|Adverse Event|0|||
124830861|NCT01729754|449012109|FG004|Part 2|Adverse Event|0|||
124830862|NCT01729754|449012110|FG005|Part 2|Adverse Event|0|||
124830863|NCT01729754|449012111|FG006|Part 2|Adverse Event|0|||
125304349|NCT04038567|450741274|FG006|Overall Study|missed survey window|2|||
125304350|NCT04038567|450741275|FG007|Overall Study|missed survey window|2|||
125304351|NCT04038567|450741268|FG000|Overall Study|technical issues|0|||
124830864|NCT01729754|449012112|FG007|Part 2|Adverse Event|0|||
124830865|NCT01729754|449012113|FG008|Part 2|Adverse Event|1|||
124830866|NCT01729754|449012114|FG009|Part 2|Adverse Event|2|||
124830867|NCT01729754|449012105|FG000|Part 2|Lack of Efficacy|0|||
124830868|NCT01729754|449012106|FG001|Part 2|Lack of Efficacy|0|||
124830869|NCT01729754|449012107|FG002|Part 2|Lack of Efficacy|0|||
124830870|NCT01729754|449012108|FG003|Part 2|Lack of Efficacy|0|||
124830871|NCT01729754|449012109|FG004|Part 2|Lack of Efficacy|0|||
124830872|NCT01729754|449012110|FG005|Part 2|Lack of Efficacy|0|||
124830873|NCT01729754|449012111|FG006|Part 2|Lack of Efficacy|0|||
124830874|NCT01729754|449012112|FG007|Part 2|Lack of Efficacy|0|||
124830875|NCT01729754|449012113|FG008|Part 2|Lack of Efficacy|2|||
124830876|NCT01729754|449012114|FG009|Part 2|Lack of Efficacy|2|||
124830877|NCT01729754|449012105|FG000|Part 2|Lost to Follow-up|0|||
124830878|NCT01729754|449012106|FG001|Part 2|Lost to Follow-up|0|||
124830879|NCT01729754|449012107|FG002|Part 2|Lost to Follow-up|0|||
124830880|NCT01729754|449012108|FG003|Part 2|Lost to Follow-up|2|||
124830881|NCT01729754|449012109|FG004|Part 2|Lost to Follow-up|0|||
124830882|NCT01729754|449012110|FG005|Part 2|Lost to Follow-up|0|||
124830883|NCT01729754|449012111|FG006|Part 2|Lost to Follow-up|0|||
124830884|NCT01729754|449012112|FG007|Part 2|Lost to Follow-up|1|||
124830885|NCT01729754|449012113|FG008|Part 2|Lost to Follow-up|0|||
124830886|NCT01729754|449012114|FG009|Part 2|Lost to Follow-up|2|||
124830887|NCT01729754|449012105|FG000|Part 2|Non-Compliance with Study Drug|0|||
124830888|NCT01729754|449012106|FG001|Part 2|Non-Compliance with Study Drug|0|||
124830889|NCT01729754|449012107|FG002|Part 2|Non-Compliance with Study Drug|0|||
124830890|NCT01729754|449012108|FG003|Part 2|Non-Compliance with Study Drug|0|||
124830891|NCT01729754|449012109|FG004|Part 2|Non-Compliance with Study Drug|0|||
124830892|NCT01729754|449012110|FG005|Part 2|Non-Compliance with Study Drug|0|||
124830893|NCT01729754|449012111|FG006|Part 2|Non-Compliance with Study Drug|0|||
124830894|NCT01729754|449012112|FG007|Part 2|Non-Compliance with Study Drug|0|||
124830895|NCT01729754|449012113|FG008|Part 2|Non-Compliance with Study Drug|0|||
124830896|NCT01729754|449012114|FG009|Part 2|Non-Compliance with Study Drug|1|||
124830897|NCT01729754|449012105|FG000|Part 2|Pregnancy|0|||
124830898|NCT01729754|449012106|FG001|Part 2|Pregnancy|0|||
124830899|NCT01729754|449012107|FG002|Part 2|Pregnancy|0|||
124830900|NCT01729754|449012108|FG003|Part 2|Pregnancy|1|||
124830901|NCT01729754|449012109|FG004|Part 2|Pregnancy|0|||
124830902|NCT01729754|449012110|FG005|Part 2|Pregnancy|0|||
124830903|NCT01729754|449012111|FG006|Part 2|Pregnancy|0|||
124830904|NCT01729754|449012112|FG007|Part 2|Pregnancy|0|||
124830905|NCT01729754|449012113|FG008|Part 2|Pregnancy|0|||
124830906|NCT01729754|449012114|FG009|Part 2|Pregnancy|1|||
124830907|NCT01729754|449012105|FG000|Part 2|Withdrawal by Subject|3|||
124830908|NCT01729754|449012106|FG001|Part 2|Withdrawal by Subject|0|||
124830909|NCT01729754|449012107|FG002|Part 2|Withdrawal by Subject|0|||
124830910|NCT01729754|449012108|FG003|Part 2|Withdrawal by Subject|2|||
124830911|NCT01729754|449012109|FG004|Part 2|Withdrawal by Subject|0|||
124830912|NCT01729754|449012110|FG005|Part 2|Withdrawal by Subject|0|||
124830913|NCT01729754|449012111|FG006|Part 2|Withdrawal by Subject|0|||
124830914|NCT01729754|449012112|FG007|Part 2|Withdrawal by Subject|1|||
124830915|NCT01729754|449012113|FG008|Part 2|Withdrawal by Subject|1|||
124830916|NCT01729754|449012114|FG009|Part 2|Withdrawal by Subject|4|||
124830917|NCT01729754|449012105|FG000|Part 2|Other Protocol Specified Criteria|1|||
124830918|NCT01729754|449012106|FG001|Part 2|Other Protocol Specified Criteria|0|||
124830919|NCT01729754|449012107|FG002|Part 2|Other Protocol Specified Criteria|0|||
124830920|NCT01729754|449012108|FG003|Part 2|Other Protocol Specified Criteria|0|||
124830921|NCT01729754|449012109|FG004|Part 2|Other Protocol Specified Criteria|0|||
124830922|NCT01729754|449012110|FG005|Part 2|Other Protocol Specified Criteria|0|||
124830923|NCT01729754|449012111|FG006|Part 2|Other Protocol Specified Criteria|0|||
124830924|NCT01729754|449012112|FG007|Part 2|Other Protocol Specified Criteria|1|||
124830925|NCT01729754|449012113|FG008|Part 2|Other Protocol Specified Criteria|0|||
124830926|NCT01729754|449012114|FG009|Part 2|Other Protocol Specified Criteria|0|||
124830927|NCT01729754|449012105|FG000|Part 3|Adverse Event|0|||
124830928|NCT01729754|449012106|FG001|Part 3|Adverse Event|0|||
124830929|NCT01729754|449012107|FG002|Part 3|Adverse Event|1|||
124830930|NCT01729754|449012108|FG003|Part 3|Adverse Event|0|||
124830931|NCT01729754|449012109|FG004|Part 3|Adverse Event|0|||
124830932|NCT01729754|449012110|FG005|Part 3|Adverse Event|5|||
124830933|NCT01729754|449012111|FG006|Part 3|Adverse Event|0|||
124830934|NCT01729754|449012112|FG007|Part 3|Adverse Event|0|||
124830935|NCT01729754|449012113|FG008|Part 3|Adverse Event|0|||
124830936|NCT01729754|449012114|FG009|Part 3|Adverse Event|3|||
124830937|NCT01729754|449012105|FG000|Part 3|Death|0|||
124830938|NCT01729754|449012106|FG001|Part 3|Death|0|||
124830939|NCT01729754|449012107|FG002|Part 3|Death|0|||
124830940|NCT01729754|449012108|FG003|Part 3|Death|0|||
124830941|NCT01729754|449012109|FG004|Part 3|Death|0|||
124830942|NCT01729754|449012110|FG005|Part 3|Death|2|||
124830943|NCT01729754|449012111|FG006|Part 3|Death|0|||
124830944|NCT01729754|449012112|FG007|Part 3|Death|0|||
124830945|NCT01729754|449012113|FG008|Part 3|Death|0|||
124830946|NCT01729754|449012114|FG009|Part 3|Death|0|||
124830947|NCT01729754|449012105|FG000|Part 3|Lack of Efficacy|0|||
124830948|NCT01729754|449012106|FG001|Part 3|Lack of Efficacy|0|||
124830949|NCT01729754|449012107|FG002|Part 3|Lack of Efficacy|0|||
124830950|NCT01729754|449012108|FG003|Part 3|Lack of Efficacy|0|||
124830951|NCT01729754|449012109|FG004|Part 3|Lack of Efficacy|2|||
124830952|NCT01729754|449012110|FG005|Part 3|Lack of Efficacy|0|||
124830953|NCT01729754|449012111|FG006|Part 3|Lack of Efficacy|0|||
124830954|NCT01729754|449012112|FG007|Part 3|Lack of Efficacy|0|||
124830955|NCT01729754|449012113|FG008|Part 3|Lack of Efficacy|0|||
124830956|NCT01729754|449012114|FG009|Part 3|Lack of Efficacy|4|||
124830957|NCT01729754|449012105|FG000|Part 3|Lost to Follow-up|0|||
124830958|NCT01729754|449012106|FG001|Part 3|Lost to Follow-up|1|||
124830959|NCT01729754|449012107|FG002|Part 3|Lost to Follow-up|2|||
124830960|NCT01729754|449012108|FG003|Part 3|Lost to Follow-up|0|||
124830961|NCT01729754|449012109|FG004|Part 3|Lost to Follow-up|0|||
124830962|NCT01729754|449012110|FG005|Part 3|Lost to Follow-up|3|||
124830963|NCT01729754|449012111|FG006|Part 3|Lost to Follow-up|0|||
124830964|NCT01729754|449012112|FG007|Part 3|Lost to Follow-up|0|||
124830965|NCT01729754|449012113|FG008|Part 3|Lost to Follow-up|1|||
124830966|NCT01729754|449012114|FG009|Part 3|Lost to Follow-up|0|||
124830967|NCT01729754|449012105|FG000|Part 3|Physician Decision|0|||
124830968|NCT01729754|449012106|FG001|Part 3|Physician Decision|0|||
124830969|NCT01729754|449012107|FG002|Part 3|Physician Decision|1|||
124830970|NCT01729754|449012108|FG003|Part 3|Physician Decision|0|||
124830971|NCT01729754|449012109|FG004|Part 3|Physician Decision|0|||
124830972|NCT01729754|449012110|FG005|Part 3|Physician Decision|0|||
124830973|NCT01729754|449012111|FG006|Part 3|Physician Decision|0|||
124830974|NCT01729754|449012112|FG007|Part 3|Physician Decision|0|||
124830975|NCT01729754|449012113|FG008|Part 3|Physician Decision|0|||
124830976|NCT01729754|449012114|FG009|Part 3|Physician Decision|0|||
124830977|NCT01729754|449012105|FG000|Part 3|Withdrawal by Subject|0|||
124830978|NCT01729754|449012106|FG001|Part 3|Withdrawal by Subject|4|||
124830979|NCT01729754|449012107|FG002|Part 3|Withdrawal by Subject|1|||
124830980|NCT01729754|449012108|FG003|Part 3|Withdrawal by Subject|0|||
124830981|NCT01729754|449012109|FG004|Part 3|Withdrawal by Subject|2|||
124830982|NCT01729754|449012110|FG005|Part 3|Withdrawal by Subject|1|||
124830983|NCT01729754|449012111|FG006|Part 3|Withdrawal by Subject|0|||
124830984|NCT01729754|449012112|FG007|Part 3|Withdrawal by Subject|2|||
124830985|NCT01729754|449012113|FG008|Part 3|Withdrawal by Subject|0|||
124830986|NCT01729754|449012114|FG009|Part 3|Withdrawal by Subject|0|||
124830987|NCT01729754|449012105|FG000|Part 3|Other Protocol Specified Criteria|0|||
124830988|NCT01729754|449012106|FG001|Part 3|Other Protocol Specified Criteria|0|||
124830989|NCT01729754|449012107|FG002|Part 3|Other Protocol Specified Criteria|0|||
124830990|NCT01729754|449012108|FG003|Part 3|Other Protocol Specified Criteria|0|||
124830991|NCT01729754|449012109|FG004|Part 3|Other Protocol Specified Criteria|0|||
124830992|NCT01729754|449012110|FG005|Part 3|Other Protocol Specified Criteria|2|||
124830993|NCT01729754|449012111|FG006|Part 3|Other Protocol Specified Criteria|0|||
124830994|NCT01729754|449012112|FG007|Part 3|Other Protocol Specified Criteria|1|||
124830995|NCT01729754|449012113|FG008|Part 3|Other Protocol Specified Criteria|0|||
124830996|NCT01729754|449012114|FG009|Part 3|Other Protocol Specified Criteria|0|||
124830997|NCT00773292|449012115|FG000|Treatment 48 Weeks|Adverse Event|1|||
124830998|NCT00773292|449012115|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
124830999|NCT00192504|449012120|FG000|Overall Study|Lost to Follow-up|1|||
124831000|NCT00192504|449012121|FG001|Overall Study|Lost to Follow-up|0|||
124831001|NCT00192504|449012122|FG002|Overall Study|Lost to Follow-up|0|||
124831002|NCT00192504|449012123|FG003|Overall Study|Lost to Follow-up|0|||
124831003|NCT00192504|449012120|FG000|Overall Study|Dosing window missed|0|||
124831004|NCT00192504|449012121|FG001|Overall Study|Dosing window missed|0|||
124831005|NCT00192504|449012122|FG002|Overall Study|Dosing window missed|1|||
124831006|NCT00192504|449012123|FG003|Overall Study|Dosing window missed|0|||
124831007|NCT01139450|449012124|FG000|Overall Study|Withdrawal by Subject|7|||
124831008|NCT01139450|449012125|FG001|Overall Study|Withdrawal by Subject|10|||
124831009|NCT01139450|449012126|FG002|Overall Study|Withdrawal by Subject|13|||
124831010|NCT01139450|449012124|FG000|Overall Study|Lack of Efficacy|3|||
124831011|NCT01139450|449012125|FG001|Overall Study|Lack of Efficacy|1|||
124831012|NCT01139450|449012126|FG002|Overall Study|Lack of Efficacy|8|||
124831013|NCT01139450|449012124|FG000|Overall Study|Protocol Violation|6|||
124831014|NCT01139450|449012125|FG001|Overall Study|Protocol Violation|5|||
124831015|NCT01139450|449012126|FG002|Overall Study|Protocol Violation|2|||
124831016|NCT01139450|449012124|FG000|Overall Study|Lost to Follow-up|9|||
124831017|NCT01139450|449012125|FG001|Overall Study|Lost to Follow-up|7|||
124831018|NCT01139450|449012126|FG002|Overall Study|Lost to Follow-up|11|||
124831019|NCT01139450|449012124|FG000|Overall Study|Administrative|0|||
124831020|NCT01139450|449012125|FG001|Overall Study|Administrative|0|||
124831021|NCT01139450|449012126|FG002|Overall Study|Administrative|1|||
124831022|NCT01139450|449012124|FG000|Overall Study|Adverse Event|2|||
124831023|NCT01139450|449012125|FG001|Overall Study|Adverse Event|2|||
124831024|NCT01139450|449012126|FG002|Overall Study|Adverse Event|3|||
124831025|NCT04608500|449012127|FG000|Overall Study|Adverse Event|2|||
124831026|NCT04608500|449012128|FG001|Overall Study|Adverse Event|0|||
125304352|NCT04038567|450741269|FG001|Overall Study|technical issues|0|||
125304353|NCT04038567|450741270|FG002|Overall Study|technical issues|0|||
125304354|NCT04038567|450741271|FG003|Overall Study|technical issues|0|||
124831027|NCT04608500|449012127|FG000|Overall Study|Lost to Follow-up|15|||
124831028|NCT04608500|449012128|FG001|Overall Study|Lost to Follow-up|9|||
124831029|NCT04608500|449012127|FG000|Overall Study|Participant request|11|||
124831030|NCT04608500|449012128|FG001|Overall Study|Participant request|7|||
124831031|NCT04608500|449012127|FG000|Overall Study|Protocol Violation|1|||
125304355|NCT04038567|450741272|FG004|Overall Study|technical issues|0|||
124831032|NCT04608500|449012128|FG001|Overall Study|Protocol Violation|0|||
124831033|NCT04608500|449012127|FG000|Overall Study|Other|6|||
124831034|NCT04608500|449012128|FG001|Overall Study|Other|2|||
124831035|NCT00542919|449012140|FG000|Overall Study|Adverse Event|1|||
124831036|NCT00542919|449012141|FG001|Overall Study|Adverse Event|5|||
125304356|NCT04038567|450741273|FG005|Overall Study|technical issues|0|||
124831037|NCT00542919|449012142|FG002|Overall Study|Adverse Event|1|||
124831038|NCT00542919|449012140|FG000|Overall Study|Withdrawal by Subject|1|||
124831039|NCT00542919|449012141|FG001|Overall Study|Withdrawal by Subject|0|||
124831040|NCT00542919|449012142|FG002|Overall Study|Withdrawal by Subject|3|||
124831041|NCT00542919|449012140|FG000|Overall Study|Physician Decision|2|||
124831042|NCT00542919|449012141|FG001|Overall Study|Physician Decision|2|||
124831043|NCT00542919|449012142|FG002|Overall Study|Physician Decision|1|||
124831044|NCT00542919|449012140|FG000|Overall Study|Sponsor Decision|1|||
124831045|NCT00542919|449012141|FG001|Overall Study|Sponsor Decision|0|||
124831046|NCT00542919|449012142|FG002|Overall Study|Sponsor Decision|0|||
124831047|NCT00542919|449012140|FG000|Overall Study|Lost to Follow-up|2|||
124831048|NCT00542919|449012141|FG001|Overall Study|Lost to Follow-up|0|||
124831049|NCT00542919|449012142|FG002|Overall Study|Lost to Follow-up|1|||
124831050|NCT01881230|449012143|FG000|Overall Study|Death|2|||
124831051|NCT01881230|449012144|FG001|Overall Study|Death|0|||
124831052|NCT01881230|449012145|FG002|Overall Study|Death|1|||
124831053|NCT01881230|449012143|FG000|Overall Study|Adverse Event|9|||
124831054|NCT01881230|449012144|FG001|Overall Study|Adverse Event|13|||
124831055|NCT01881230|449012145|FG002|Overall Study|Adverse Event|12|||
124831056|NCT01881230|449012143|FG000|Overall Study|Progressive Disease|31|||
124831057|NCT01881230|449012144|FG001|Overall Study|Progressive Disease|35|||
124831058|NCT01881230|449012145|FG002|Overall Study|Progressive Disease|36|||
124831059|NCT01881230|449012143|FG000|Overall Study|Symptomatic Deterioration|3|||
124831060|NCT01881230|449012144|FG001|Overall Study|Symptomatic Deterioration|3|||
124831061|NCT01881230|449012145|FG002|Overall Study|Symptomatic Deterioration|1|||
124831062|NCT01881230|449012143|FG000|Overall Study|Withdrawal by Subject|6|||
124831063|NCT01881230|449012144|FG001|Overall Study|Withdrawal by Subject|4|||
124831064|NCT01881230|449012145|FG002|Overall Study|Withdrawal by Subject|6|||
124831065|NCT01881230|449012143|FG000|Overall Study|Physician Decision|4|||
124831066|NCT01881230|449012144|FG001|Overall Study|Physician Decision|3|||
124831067|NCT01881230|449012145|FG002|Overall Study|Physician Decision|6|||
124831068|NCT01881230|449012143|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124831069|NCT01881230|449012144|FG001|Overall Study|Non-Compliance with Study Drug|2|||
124831070|NCT01881230|449012145|FG002|Overall Study|Non-Compliance with Study Drug|0|||
124831071|NCT01881230|449012143|FG000|Overall Study|Given Commercially Available Drug|0|||
124831072|NCT01881230|449012144|FG001|Overall Study|Given Commercially Available Drug|0|||
124831073|NCT01881230|449012145|FG002|Overall Study|Given Commercially Available Drug|2|||
124831074|NCT01881230|449012143|FG000|Overall Study|Protocol Violation|1|||
124831075|NCT01881230|449012144|FG001|Overall Study|Protocol Violation|1|||
124831076|NCT01881230|449012145|FG002|Overall Study|Protocol Violation|0|||
124831077|NCT01881230|449012143|FG000|Overall Study|Miscellaneous|3|||
124831078|NCT01881230|449012144|FG001|Overall Study|Miscellaneous|3|||
124831079|NCT01881230|449012145|FG002|Overall Study|Miscellaneous|0|||
124831080|NCT01881230|449012143|FG000|Overall Study|Untreated: Other|0|||
124831081|NCT01881230|449012144|FG001|Overall Study|Untreated: Other|0|||
124831082|NCT01881230|449012145|FG002|Overall Study|Untreated: Other|1|||
124831083|NCT01881230|449012143|FG000|Overall Study|Untreated: Death|0|||
124831084|NCT01881230|449012144|FG001|Overall Study|Untreated: Death|0|||
124831085|NCT01881230|449012145|FG002|Overall Study|Untreated: Death|1|||
124831086|NCT01881230|449012143|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
124831087|NCT01881230|449012144|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
124831088|NCT01881230|449012145|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
124831089|NCT00112502|449012146|FG000|Overall Study|Withdrawal by Subject|0|||
124831090|NCT00112502|449012147|FG001|Overall Study|Withdrawal by Subject|1|||
124831091|NCT00112502|449012148|FG002|Overall Study|Withdrawal by Subject|1|||
124831092|NCT00112502|449012149|FG003|Overall Study|Withdrawal by Subject|4|||
124831093|NCT00112502|449012150|FG004|Overall Study|Withdrawal by Subject|2|||
124831094|NCT00112502|449012151|FG005|Overall Study|Withdrawal by Subject|5|||
124831095|NCT00112502|449012152|FG006|Overall Study|Withdrawal by Subject|3|||
124831096|NCT00112502|449012153|FG007|Overall Study|Withdrawal by Subject|7|||
124831097|NCT02385266|449012154|FG000|Overall Study|Withdrawal by Subject|1|||
124831098|NCT02385266|449012155|FG001|Overall Study|Withdrawal by Subject|3|||
124831099|NCT02747420|449012156|FG000|Overall Study|Lost to Follow-up|4|||
124831100|NCT02747420|449012157|FG001|Overall Study|Lost to Follow-up|2|||
124831101|NCT02747420|449012156|FG000|Overall Study|Withdrawal by Subject|3|||
124831102|NCT02747420|449012157|FG001|Overall Study|Withdrawal by Subject|2|||
124831103|NCT03662542|449012158|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
124831104|NCT03662542|449012159|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
124831105|NCT03662542|449012160|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
124831106|NCT03662542|449012161|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
124831107|NCT03662542|449012162|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
124831108|NCT03662542|449012163|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
124831109|NCT03662542|449012164|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
124831110|NCT03662542|449012165|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
124831111|NCT03662542|449012166|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
124831112|NCT03662542|449012158|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
124831113|NCT03662542|449012159|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
124831114|NCT03662542|449012160|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
124831115|NCT03662542|449012161|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
124831116|NCT03662542|449012162|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
124831117|NCT03662542|449012163|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
124831118|NCT03662542|449012164|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
124831119|NCT03662542|449012165|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
124831120|NCT03662542|449012166|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
124831121|NCT03662542|449012158|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
124831122|NCT03662542|449012159|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
124831123|NCT03662542|449012160|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
124831124|NCT03662542|449012161|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
124831125|NCT03662542|449012162|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
124831126|NCT03662542|449012163|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
124831127|NCT03662542|449012164|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
124831128|NCT03662542|449012165|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
124831129|NCT03662542|449012166|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
124831130|NCT03662542|449012158|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
124831131|NCT03662542|449012159|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
124831132|NCT03662542|449012160|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
124831133|NCT03662542|449012161|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
124831134|NCT03662542|449012162|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
124831135|NCT03662542|449012163|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
124831136|NCT03662542|449012164|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
124831137|NCT03662542|449012165|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
124831138|NCT03662542|449012166|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
124831139|NCT03662542|449012158|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
124831140|NCT03662542|449012159|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
124831141|NCT03662542|449012160|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
124831142|NCT03662542|449012161|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
124831143|NCT03662542|449012162|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
124831144|NCT03662542|449012163|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
124831145|NCT03662542|449012164|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
124831146|NCT03662542|449012165|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
124831147|NCT03662542|449012166|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
124831148|NCT03662542|449012158|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
124831149|NCT03662542|449012159|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
124831150|NCT03662542|449012160|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
124831151|NCT03662542|449012161|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
124831152|NCT03662542|449012162|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
124831153|NCT03662542|449012163|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
124831154|NCT03662542|449012164|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
124831155|NCT03662542|449012165|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
124831156|NCT03662542|449012166|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
124831157|NCT03662542|449012158|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
124831158|NCT03662542|449012159|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
124831159|NCT03662542|449012160|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
124831160|NCT03662542|449012161|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
124831161|NCT03662542|449012162|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
124831162|NCT03662542|449012163|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
124831163|NCT03662542|449012164|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
124831164|NCT03662542|449012165|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
124831165|NCT03662542|449012166|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
124831166|NCT03662542|449012158|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
124831167|NCT03662542|449012159|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
124831168|NCT03662542|449012160|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
124831169|NCT03662542|449012161|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
124831170|NCT03662542|449012162|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
124831171|NCT03662542|449012163|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
124831172|NCT03662542|449012164|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
124831173|NCT03662542|449012165|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
124831174|NCT03662542|449012166|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
124831175|NCT03662542|449012158|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
124831176|NCT03662542|449012159|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
124831177|NCT03662542|449012160|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
124831178|NCT03662542|449012161|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
124831179|NCT03662542|449012162|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
124831180|NCT03662542|449012163|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
124831181|NCT03662542|449012164|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
124831182|NCT03662542|449012165|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
124831183|NCT03662542|449012166|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
124831184|NCT03662542|449012158|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
124831185|NCT03662542|449012159|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
124831186|NCT03662542|449012160|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
124831187|NCT03662542|449012161|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
124831188|NCT03662542|449012162|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
124831189|NCT03662542|449012163|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
124831190|NCT03662542|449012164|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
124831191|NCT03662542|449012165|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
124831192|NCT03662542|449012166|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
124831193|NCT03662542|449012158|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
124831194|NCT03662542|449012159|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
124831195|NCT03662542|449012160|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
124831196|NCT03662542|449012161|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
124831197|NCT03662542|449012162|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
124831198|NCT03662542|449012163|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
124831199|NCT03662542|449012164|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
124831200|NCT03662542|449012165|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
124831201|NCT03662542|449012166|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
124831202|NCT03662542|449012158|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
124831203|NCT03662542|449012159|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
124831204|NCT03662542|449012160|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
124831205|NCT03662542|449012161|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
124831206|NCT03662542|449012162|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
124831207|NCT03662542|449012163|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
124831208|NCT03662542|449012164|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
124831209|NCT03662542|449012165|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
124831210|NCT03662542|449012166|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
124831211|NCT03662542|449012158|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
124831212|NCT03662542|449012159|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
124831213|NCT03662542|449012160|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
124831214|NCT03662542|449012161|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
124831215|NCT03662542|449012162|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
124831216|NCT03662542|449012163|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
124831217|NCT03662542|449012164|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
124831218|NCT03662542|449012165|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
124831219|NCT03662542|449012166|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
124831220|NCT01217060|449012167|FG000|Overall Study|Withdrawal by Subject|1|||
124831221|NCT03739112|449012168|FG000|Overall Study|Adverse Event|2|||
124831222|NCT03739112|449012169|FG001|Overall Study|Adverse Event|2|||
124831223|NCT03739112|449012168|FG000|Overall Study|Withdrawal by Subject|38|||
124831224|NCT03739112|449012169|FG001|Overall Study|Withdrawal by Subject|19|||
124831225|NCT03739112|449012168|FG000|Overall Study|Lost to Follow-up|31|||
124831226|NCT03739112|449012169|FG001|Overall Study|Lost to Follow-up|33|||
124831227|NCT03739112|449012168|FG000|Overall Study|Protocol Deviation|12|||
124831228|NCT03739112|449012169|FG001|Overall Study|Protocol Deviation|9|||
124831229|NCT03739112|449012168|FG000|Overall Study|Physician Decision|1|||
124831230|NCT03739112|449012169|FG001|Overall Study|Physician Decision|0|||
124831231|NCT03739112|449012168|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
124831232|NCT03739112|449012169|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
124831233|NCT03739112|449012168|FG000|Overall Study|Site went on hold|65|||
124831234|NCT03739112|449012169|FG001|Overall Study|Site went on hold|67|||
124831235|NCT03739112|449012168|FG000|Overall Study|Other than specified|8|||
124831236|NCT03739112|449012169|FG001|Overall Study|Other than specified|5|||
124831237|NCT03739112|449012168|FG000|Overall Study|Randomized but not vaccinated|31|||
124831238|NCT03739112|449012169|FG001|Overall Study|Randomized but not vaccinated|25|||
124831239|NCT03388138|449012174|FG000|Overall Study|Protocol Violation|1|||
124831240|NCT03388138|449012175|FG001|Overall Study|Protocol Violation|0|||
124831241|NCT01528072|449012176|FG000|Overall Study|Withdrawal by Subject|5|||
124831242|NCT01528072|449012176|FG000|Overall Study|Physician Decision|1|||
124831243|NCT01528072|449012176|FG000|Overall Study|Determined not eligible by AEAC|1|||
125304357|NCT04038567|450741274|FG006|Overall Study|technical issues|1|||
125304358|NCT04038567|450741275|FG007|Overall Study|technical issues|0|||
124831244|NCT01528072|449012176|FG000|Overall Study|Missed Visit|2|||
124831245|NCT01528072|449012176|FG000|Overall Study|Lost to Follow-up|5|||
124831246|NCT01528072|449012176|FG000|Overall Study|Explanted|2|||
124831247|NCT01528072|449012176|FG000|Overall Study|Site Closure|4|||
124831248|NCT01528072|449012176|FG000|Overall Study|Death|2|||
124831249|NCT01528072|449012176|FG000|Overall Study|Early Termination of Study|52|||
124831250|NCT01859494|449012179|FG000|Overall Study|Adverse Event|1|||
124831251|NCT02529137|449012184|FG000|Overall Study|Discontinuation for different reasons|8|||
124831252|NCT02063854|449012185|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
124831253|NCT02063854|449012186|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
124831254|NCT02063854|449012187|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
125304359|NCT04038567|450741268|FG000|Overall Study|Medical issues (i.e., illness)|0|||
124831255|NCT02063854|449012188|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
124831256|NCT02063854|449012189|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
124831257|NCT02063854|449012190|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
124831258|NCT02063854|449012191|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
124831259|NCT02063854|449012185|FG000|Overall Study|Major Protocol Deviation|0|||
124831260|NCT02063854|449012186|FG001|Overall Study|Major Protocol Deviation|0|||
124831261|NCT02063854|449012187|FG002|Overall Study|Major Protocol Deviation|3|||
124831262|NCT02063854|449012188|FG003|Overall Study|Major Protocol Deviation|0|||
124831263|NCT02063854|449012189|FG004|Overall Study|Major Protocol Deviation|0|||
124831264|NCT02063854|449012190|FG005|Overall Study|Major Protocol Deviation|0|||
124831265|NCT02063854|449012191|FG006|Overall Study|Major Protocol Deviation|0|||
124831266|NCT02063854|449012185|FG000|Overall Study|Voluntary Withdrawal|2|||
124831267|NCT02063854|449012186|FG001|Overall Study|Voluntary Withdrawal|0|||
124831268|NCT02063854|449012187|FG002|Overall Study|Voluntary Withdrawal|8|||
124831269|NCT02063854|449012188|FG003|Overall Study|Voluntary Withdrawal|1|||
124831270|NCT02063854|449012189|FG004|Overall Study|Voluntary Withdrawal|3|||
124831271|NCT02063854|449012190|FG005|Overall Study|Voluntary Withdrawal|6|||
124831272|NCT02063854|449012191|FG006|Overall Study|Voluntary Withdrawal|1|||
124831273|NCT02063854|449012185|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
124831274|NCT02063854|449012186|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
124831275|NCT02063854|449012187|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
124831276|NCT02063854|449012188|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
124831277|NCT02063854|449012189|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
124831278|NCT02063854|449012190|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
124831279|NCT02063854|449012191|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
124831280|NCT02063854|449012185|FG000|Overall Study|Reason Not Specified|1|||
124831281|NCT02063854|449012186|FG001|Overall Study|Reason Not Specified|0|||
124831282|NCT02063854|449012187|FG002|Overall Study|Reason Not Specified|0|||
124831283|NCT02063854|449012188|FG003|Overall Study|Reason Not Specified|0|||
124831284|NCT02063854|449012189|FG004|Overall Study|Reason Not Specified|0|||
124831285|NCT02063854|449012190|FG005|Overall Study|Reason Not Specified|0|||
124831286|NCT02063854|449012191|FG006|Overall Study|Reason Not Specified|0|||
124831287|NCT02063854|449012185|FG000|Overall Study|Did Not Receive Study Drug|0|||
124831288|NCT02063854|449012186|FG001|Overall Study|Did Not Receive Study Drug|0|||
124831289|NCT02063854|449012187|FG002|Overall Study|Did Not Receive Study Drug|0|||
124831290|NCT02063854|449012188|FG003|Overall Study|Did Not Receive Study Drug|0|||
124831291|NCT02063854|449012189|FG004|Overall Study|Did Not Receive Study Drug|0|||
124831292|NCT02063854|449012190|FG005|Overall Study|Did Not Receive Study Drug|1|||
124831293|NCT02063854|449012191|FG006|Overall Study|Did Not Receive Study Drug|0|||
124831294|NCT01462084|449012192|FG000|Overall Study|Withdrawal by Subject|1|||
124831295|NCT01462084|449012193|FG001|Overall Study|Withdrawal by Subject|0|||
124831296|NCT01462084|449012192|FG000|Overall Study|Protocol Violation|1|||
124831297|NCT01462084|449012193|FG001|Overall Study|Protocol Violation|1|||
124831298|NCT03538158|449012194|FG000|Overall Study|Lost to Follow-up|13|||
124831299|NCT03538158|449012195|FG001|Overall Study|Lost to Follow-up|7|||
124831300|NCT03538158|449012194|FG000|Overall Study|Withdrawal by Subject|2|||
124831301|NCT03538158|449012195|FG001|Overall Study|Withdrawal by Subject|1|||
124831302|NCT00930579|449012196|FG000|Overall Study|Withdrawal by Subject|1|||
124831303|NCT00930579|449012196|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
124831304|NCT00695396|449012197|FG000|Overall Study|Study Closed Prematurely|5|||
124831305|NCT00695396|449012198|FG001|Overall Study|Study Closed Prematurely|6|||
124831306|NCT00695396|449012199|FG002|Overall Study|Study Closed Prematurely|8|||
124831307|NCT00695396|449012197|FG000|Overall Study|Withdrawal by Subject|2|||
124831308|NCT00695396|449012198|FG001|Overall Study|Withdrawal by Subject|2|||
124831309|NCT00695396|449012199|FG002|Overall Study|Withdrawal by Subject|0|||
124831310|NCT00772707|449012200|FG000|Overall Study|Withdrawn|3|||
124831311|NCT04120974|449012204|FG000|Overall Study|Death|1|||
124831312|NCT04120974|449012204|FG000|Overall Study|Physician Decision|1|||
124831313|NCT04120974|449012204|FG000|Overall Study|Lost to Follow-up|6|||
124831314|NCT03338062|449012205|FG000|Overall Study|Alternative Therapy|1|||
124831315|NCT03338062|449012206|FG001|Overall Study|Alternative Therapy|0|||
125304360|NCT04038567|450741269|FG001|Overall Study|Medical issues (i.e., illness)|1|||
124831316|NCT04256785|449012207|FG000|Overall Study|Adverse Event|8|||
124831317|NCT04256785|449012208|FG001|Overall Study|Adverse Event|6|||
124831318|NCT04256785|449012207|FG000|Overall Study|Lack of Efficacy|3|||
124831319|NCT04256785|449012208|FG001|Overall Study|Lack of Efficacy|4|||
125304361|NCT04038567|450741270|FG002|Overall Study|Medical issues (i.e., illness)|2|||
124831320|NCT04256785|449012207|FG000|Overall Study|Lost to Follow-up|7|||
124831321|NCT04256785|449012208|FG001|Overall Study|Lost to Follow-up|7|||
124831322|NCT04256785|449012207|FG000|Overall Study|Protocol Violation|1|||
124831323|NCT04256785|449012208|FG001|Overall Study|Protocol Violation|0|||
124831324|NCT04256785|449012207|FG000|Overall Study|Withdrawal by Subject|4|||
124831325|NCT04256785|449012208|FG001|Overall Study|Withdrawal by Subject|1|||
124831326|NCT04256785|449012207|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
125304362|NCT04038567|450741271|FG003|Overall Study|Medical issues (i.e., illness)|1|||
124831327|NCT04256785|449012208|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
124831328|NCT03194321|449012212|FG000|Overall Study|Withdrawal by Subject|1|||
124831329|NCT03194321|449012212|FG000|Overall Study|Lost to Follow-up|1|||
124831330|NCT03194321|449012212|FG000|Overall Study|Travel for Follow-up|1|||
124831331|NCT01288287|449012214|FG000|Overall Study|Lost to Follow-up|8|||
124831332|NCT01288287|449012214|FG000|Overall Study|Withdrawal by Subject|4|||
124831333|NCT01288287|449012214|FG000|Overall Study|Lack of Efficacy|13|||
124831334|NCT01288287|449012214|FG000|Overall Study|Other Reason|13|||
124831335|NCT01288287|449012214|FG000|Overall Study|Unknown Reason|1|||
124831336|NCT01288287|449012214|FG000|Overall Study|Unknown Status|7|||
124831337|NCT00238121|449012218|FG000|Overall Study|Withdrawal by Subject|1|||
124831338|NCT00238121|449012219|FG001|Overall Study|Withdrawal by Subject|1|||
124831339|NCT00238121|449012218|FG000|Overall Study|Adverse Event|2|||
124831340|NCT00238121|449012219|FG001|Overall Study|Adverse Event|1|||
124831341|NCT01675128|449012224|FG000|Overall Study|Disease progression on study|1|||
124831342|NCT01675128|449012225|FG001|Overall Study|Disease progression on study|1|||
124831343|NCT01675128|449012226|FG002|Overall Study|Disease progression on study|1|||
124831344|NCT01675128|449012224|FG000|Overall Study|Refused further treatment|1|||
124831345|NCT01675128|449012225|FG001|Overall Study|Refused further treatment|0|||
124831346|NCT01675128|449012226|FG002|Overall Study|Refused further treatment|0|||
124831347|NCT01675128|449012224|FG000|Overall Study|Pulmonary complication; off study|0|||
124831348|NCT01675128|449012225|FG001|Overall Study|Pulmonary complication; off study|1|||
124831349|NCT01675128|449012226|FG002|Overall Study|Pulmonary complication; off study|0|||
124831350|NCT00832585|449012235|FG000|Overall Study|Withdrawal by Subject|1|||
124831351|NCT00832585|449012235|FG000|Overall Study|Lost to Follow-up|1|||
124831352|NCT01374087|449012239|FG000|Overall Study|Adverse Event|1|||
124831353|NCT01374087|449012240|FG001|Overall Study|Adverse Event|0|||
124831354|NCT01374087|449012239|FG000|Overall Study|Disease progression|2|||
124831355|NCT01374087|449012240|FG001|Overall Study|Disease progression|2|||
124831356|NCT01374087|449012239|FG000|Overall Study|Study discontinued|13|||
124831357|NCT01374087|449012240|FG001|Overall Study|Study discontinued|13|||
124831358|NCT03526458|449012241|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
124831359|NCT03526458|449012242|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
124831360|NCT03526458|449012241|FG000|Overall Study|Stone passed, surgery cancelled|2|||
124831361|NCT03526458|449012242|FG001|Overall Study|Stone passed, surgery cancelled|1|||
124831362|NCT03526458|449012241|FG000|Overall Study|Withdrawal by Subject|1|||
124831363|NCT03526458|449012242|FG001|Overall Study|Withdrawal by Subject|0|||
124831364|NCT03526458|449012241|FG000|Overall Study|Physician Decision|2|||
124831365|NCT03526458|449012242|FG001|Overall Study|Physician Decision|1|||
124831366|NCT03526458|449012241|FG000|Overall Study|Lack of equipment|1|||
124831367|NCT03526458|449012242|FG001|Overall Study|Lack of equipment|1|||
124831368|NCT00271947|449012243|FG000|Overall Study|Lost to Follow-up|1|||
124831369|NCT01782664|449012244|FG000|Overall Study|Adverse Event|2|||
124831370|NCT01782664|449012245|FG001|Overall Study|Adverse Event|2|||
124831371|NCT01782664|449012246|FG002|Overall Study|Adverse Event|2|||
124831372|NCT01782664|449012247|FG003|Overall Study|Adverse Event|2|||
124831373|NCT01782664|449012248|FG004|Overall Study|Adverse Event|0|||
124831374|NCT01782664|449012249|FG005|Overall Study|Adverse Event|0|||
124831375|NCT01782664|449012244|FG000|Overall Study|Lack of Efficacy|2|||
124831376|NCT01782664|449012245|FG001|Overall Study|Lack of Efficacy|0|||
124831377|NCT01782664|449012246|FG002|Overall Study|Lack of Efficacy|2|||
124831378|NCT01782664|449012247|FG003|Overall Study|Lack of Efficacy|2|||
124831379|NCT01782664|449012248|FG004|Overall Study|Lack of Efficacy|0|||
124831380|NCT01782664|449012249|FG005|Overall Study|Lack of Efficacy|0|||
124831381|NCT01782664|449012244|FG000|Overall Study|Protocol Violation|0|||
124831382|NCT01782664|449012245|FG001|Overall Study|Protocol Violation|1|||
124831383|NCT01782664|449012246|FG002|Overall Study|Protocol Violation|0|||
124831384|NCT01782664|449012247|FG003|Overall Study|Protocol Violation|1|||
124831385|NCT01782664|449012248|FG004|Overall Study|Protocol Violation|0|||
124831386|NCT01782664|449012249|FG005|Overall Study|Protocol Violation|0|||
124831387|NCT01782664|449012244|FG000|Overall Study|Withdrawal by Subject|2|||
124831388|NCT01782664|449012245|FG001|Overall Study|Withdrawal by Subject|2|||
124831389|NCT01782664|449012246|FG002|Overall Study|Withdrawal by Subject|0|||
124831390|NCT01782664|449012247|FG003|Overall Study|Withdrawal by Subject|0|||
124831391|NCT01782664|449012248|FG004|Overall Study|Withdrawal by Subject|0|||
124831392|NCT01782664|449012249|FG005|Overall Study|Withdrawal by Subject|0|||
124831393|NCT01522365|449012252|FG000|Overall Study|Withdrawal by Subject|1|||
124831394|NCT01522365|449012253|FG001|Overall Study|Withdrawal by Subject|1|||
124831395|NCT01522365|449012252|FG000|Overall Study|Lost to Follow-up|1|||
124831396|NCT01522365|449012253|FG001|Overall Study|Lost to Follow-up|1|||
124831397|NCT00673179|449012254|FG000|Overall Study|Toxicity/Complications|3|||
124831398|NCT00673179|449012255|FG001|Overall Study|Toxicity/Complications|0|||
124831399|NCT02466555|449012258|FG000|Overall Study|Lost to Follow-up|2|||
124831400|NCT01082965|449012259|FG000|Overall Study|Protocol Violation|0|||
124831401|NCT01082965|449012260|FG001|Overall Study|Protocol Violation|1|||
124831402|NCT01082965|449012259|FG000|Overall Study|Other|1|||
124831403|NCT01082965|449012260|FG001|Overall Study|Other|1|||
124831404|NCT02587065|449012262|FG000|Overall Study|Adverse Event|14|||
125304363|NCT04038567|450741272|FG004|Overall Study|Medical issues (i.e., illness)|1|||
125304364|NCT04038567|450741273|FG005|Overall Study|Medical issues (i.e., illness)|1|||
125304365|NCT04038567|450741274|FG006|Overall Study|Medical issues (i.e., illness)|0|||
125304366|NCT04038567|450741275|FG007|Overall Study|Medical issues (i.e., illness)|0|||
125304367|NCT04038567|450741268|FG000|Overall Study|Death|0|||
125304368|NCT04038567|450741269|FG001|Overall Study|Death|0|||
125304369|NCT04038567|450741270|FG002|Overall Study|Death|0|||
125304370|NCT04038567|450741271|FG003|Overall Study|Death|1|||
125304371|NCT04038567|450741272|FG004|Overall Study|Death|1|||
125304372|NCT04038567|450741273|FG005|Overall Study|Death|0|||
125304373|NCT04038567|450741274|FG006|Overall Study|Death|0|||
125304374|NCT04038567|450741275|FG007|Overall Study|Death|1|||
125304375|NCT01496846|450741279|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
125304376|NCT01496846|450741280|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
125304377|NCT01496846|450741281|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
125304378|NCT01496846|450741282|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
125304379|NCT01496846|450741283|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
125304380|NCT01496846|450741284|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
125304381|NCT01772576|450741285|FG000|Overall Study|Death|15|||
125304382|NCT01772576|450741285|FG000|Overall Study|Protocol Violation|1|||
125304383|NCT01772576|450741285|FG000|Overall Study|Lost to Follow-up|3|||
125304384|NCT01772576|450741285|FG000|Overall Study|Study device not used|3|||
125304385|NCT01772576|450741285|FG000|Overall Study|Adverse Event|6|||
125304386|NCT01772576|450741285|FG000|Overall Study|Withdrawal by Subject|6|||
125304387|NCT00923845|450741288|FG000|Induction Therapy|Poor performance status|0|||
125304388|NCT00923845|450741289|FG001|Induction Therapy|Poor performance status|2|||
125304389|NCT04356352|450741296|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
125304390|NCT04356352|450741297|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
125304391|NCT04356352|450741298|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
125304392|NCT04356352|450741296|FG000|Overall Study|Protocol Violation|0|||
125304393|NCT04356352|450741297|FG001|Overall Study|Protocol Violation|3|||
125304394|NCT04356352|450741298|FG002|Overall Study|Protocol Violation|1|||
125304395|NCT01371734|450741301|FG000|Overall Study|Other|2|||
125304396|NCT01371734|450741302|FG001|Overall Study|Other|1|||
125304397|NCT01371734|450741303|FG002|Overall Study|Other|2|||
125304398|NCT01371734|450741301|FG000|Overall Study|Withdrawal by Subject|3|||
125304399|NCT01371734|450741302|FG001|Overall Study|Withdrawal by Subject|4|||
125304400|NCT01371734|450741303|FG002|Overall Study|Withdrawal by Subject|9|||
125304401|NCT01371734|450741301|FG000|Overall Study|Lost to Follow-up|5|||
125304402|NCT01371734|450741302|FG001|Overall Study|Lost to Follow-up|3|||
125304403|NCT01371734|450741303|FG002|Overall Study|Lost to Follow-up|1|||
125304404|NCT01371734|450741301|FG000|Overall Study|Protocol Violation|3|||
125304405|NCT01371734|450741302|FG001|Overall Study|Protocol Violation|1|||
125304406|NCT01371734|450741303|FG002|Overall Study|Protocol Violation|2|||
125304407|NCT01371734|450741301|FG000|Overall Study|Adverse Event|8|||
125304408|NCT01371734|450741302|FG001|Overall Study|Adverse Event|8|||
125304409|NCT01371734|450741303|FG002|Overall Study|Adverse Event|3|||
125304410|NCT01371734|450741301|FG000|Overall Study|Lack of Efficacy|2|||
125304411|NCT01371734|450741302|FG001|Overall Study|Lack of Efficacy|2|||
125304412|NCT01371734|450741303|FG002|Overall Study|Lack of Efficacy|0|||
125304413|NCT03565237|450741304|FG000|Overall Study|Non-compliance of Investigational Product|1|||
125304414|NCT03565237|450741304|FG000|Overall Study|Physician Decision|1|||
125304415|NCT00828750|450741305|FG000|Overall Study|Lack of Efficacy|3|||
125304416|NCT00828750|450741305|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
125304417|NCT04006392|450741306|FG000|Overall Study|Lost to Follow-up|0|||
125304418|NCT04006392|450741307|FG001|Overall Study|Lost to Follow-up|1|||
125304419|NCT01832532|450741308|FG000|Overall Study|Withdrawal by Subject|5|||
125304420|NCT01832532|450741309|FG001|Overall Study|Withdrawal by Subject|2|||
125304421|NCT01534195|450741310|FG000|Overall Study|Withdrawal by Subject|1|||
125304422|NCT01534195|450741311|FG001|Overall Study|Withdrawal by Subject|1|||
125304423|NCT01368081|450741312|FG000|Overall Study|Adverse Event|4|||
125304424|NCT01368081|450741313|FG001|Overall Study|Adverse Event|4|||
125304425|NCT01368081|450741314|FG002|Overall Study|Adverse Event|3|||
125304426|NCT01368081|450741315|FG003|Overall Study|Adverse Event|2|||
125304427|NCT01368081|450741316|FG004|Overall Study|Adverse Event|2|||
125304428|NCT01368081|450741317|FG005|Overall Study|Adverse Event|5|||
125304429|NCT01368081|450741318|FG006|Overall Study|Adverse Event|6|||
125304430|NCT01368081|450741319|FG007|Overall Study|Adverse Event|2|||
125304431|NCT01368081|450741320|FG008|Overall Study|Adverse Event|3|||
125304432|NCT01368081|450741321|FG009|Overall Study|Adverse Event|5|||
125304433|NCT01368081|450741322|FG010|Overall Study|Adverse Event|6|||
125304434|NCT01368081|450741323|FG011|Overall Study|Adverse Event|1|||
125304435|NCT01368081|450741324|FG012|Overall Study|Adverse Event|3|||
125304436|NCT01368081|450741312|FG000|Overall Study|Lack of Efficacy|0|||
125304437|NCT01368081|450741313|FG001|Overall Study|Lack of Efficacy|1|||
125304438|NCT01368081|450741314|FG002|Overall Study|Lack of Efficacy|0|||
125304439|NCT01368081|450741315|FG003|Overall Study|Lack of Efficacy|1|||
124831405|NCT02587065|449012262|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
124831406|NCT02587065|449012262|FG000|Overall Study|Non-adherence to the Protocol|3|||
124831407|NCT02587065|449012262|FG000|Overall Study|Discontinuation of Study Medication|2|||
124831408|NCT02587065|449012262|FG000|Overall Study|Reason not Specified|3|||
124831409|NCT00445965|449012265|FG000|Overall Study|Adverse Event|2|||
124831410|NCT00445965|449012265|FG000|Overall Study|Physician Decision|1|||
124831411|NCT00445965|449012265|FG000|Overall Study|Enrolled but not treated|1|||
124831412|NCT00445965|449012265|FG000|Overall Study|Removed due to progressive disease|29|||
124831413|NCT02295995|449012273|FG000|Overall Study|Lost to Follow-up|5|||
124831414|NCT02295995|449012274|FG001|Overall Study|Lost to Follow-up|1|||
124831415|NCT02447081|449012275|FG000|Overall Study|Death|161|||
124831416|NCT02447081|449012275|FG000|Overall Study|Lost to Follow-up|36|||
124831417|NCT02447081|449012275|FG000|Overall Study|Visit not completed|17|||
124831418|NCT02447081|449012275|FG000|Overall Study|unsuccessful implant procedure|10|||
124831419|NCT02113956|449012279|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
124831420|NCT02113956|449012280|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
124831421|NCT02113956|449012279|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
124831422|NCT02113956|449012280|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
125304440|NCT01368081|450741316|FG004|Overall Study|Lack of Efficacy|0|||
125304441|NCT01368081|450741317|FG005|Overall Study|Lack of Efficacy|0|||
125304442|NCT01368081|450741318|FG006|Overall Study|Lack of Efficacy|0|||
125304443|NCT01368081|450741319|FG007|Overall Study|Lack of Efficacy|2|||
125304444|NCT01368081|450741320|FG008|Overall Study|Lack of Efficacy|0|||
125304445|NCT01368081|450741321|FG009|Overall Study|Lack of Efficacy|0|||
125304446|NCT01368081|450741322|FG010|Overall Study|Lack of Efficacy|0|||
125304447|NCT01368081|450741323|FG011|Overall Study|Lack of Efficacy|0|||
125304448|NCT01368081|450741324|FG012|Overall Study|Lack of Efficacy|0|||
125304449|NCT01368081|450741312|FG000|Overall Study|Protocol Violation|0|||
125304450|NCT01368081|450741313|FG001|Overall Study|Protocol Violation|0|||
125304451|NCT01368081|450741314|FG002|Overall Study|Protocol Violation|0|||
125304452|NCT01368081|450741315|FG003|Overall Study|Protocol Violation|0|||
125304453|NCT01368081|450741316|FG004|Overall Study|Protocol Violation|0|||
125304454|NCT01368081|450741317|FG005|Overall Study|Protocol Violation|1|||
125304455|NCT01368081|450741318|FG006|Overall Study|Protocol Violation|0|||
125304456|NCT01368081|450741319|FG007|Overall Study|Protocol Violation|1|||
125304457|NCT01368081|450741320|FG008|Overall Study|Protocol Violation|0|||
125304458|NCT01368081|450741321|FG009|Overall Study|Protocol Violation|0|||
125304459|NCT01368081|450741322|FG010|Overall Study|Protocol Violation|0|||
125304460|NCT01368081|450741323|FG011|Overall Study|Protocol Violation|0|||
125304461|NCT01368081|450741324|FG012|Overall Study|Protocol Violation|0|||
125304462|NCT01368081|450741312|FG000|Overall Study|Lost to Follow-up|0|||
125304463|NCT01368081|450741313|FG001|Overall Study|Lost to Follow-up|0|||
125304464|NCT01368081|450741314|FG002|Overall Study|Lost to Follow-up|0|||
125304465|NCT01368081|450741315|FG003|Overall Study|Lost to Follow-up|0|||
125304466|NCT01368081|450741316|FG004|Overall Study|Lost to Follow-up|0|||
125304467|NCT01368081|450741317|FG005|Overall Study|Lost to Follow-up|0|||
125304468|NCT01368081|450741318|FG006|Overall Study|Lost to Follow-up|0|||
125304469|NCT01368081|450741319|FG007|Overall Study|Lost to Follow-up|0|||
125304470|NCT01368081|450741320|FG008|Overall Study|Lost to Follow-up|0|||
125304471|NCT01368081|450741321|FG009|Overall Study|Lost to Follow-up|0|||
125304472|NCT01368081|450741322|FG010|Overall Study|Lost to Follow-up|0|||
125304473|NCT01368081|450741323|FG011|Overall Study|Lost to Follow-up|0|||
125304474|NCT01368081|450741324|FG012|Overall Study|Lost to Follow-up|1|||
125304475|NCT01368081|450741312|FG000|Overall Study|Withdrawal by Subject|4|||
125304476|NCT01368081|450741313|FG001|Overall Study|Withdrawal by Subject|4|||
125304477|NCT01368081|450741314|FG002|Overall Study|Withdrawal by Subject|1|||
125304478|NCT01368081|450741315|FG003|Overall Study|Withdrawal by Subject|1|||
125304479|NCT01368081|450741316|FG004|Overall Study|Withdrawal by Subject|0|||
125304480|NCT01368081|450741317|FG005|Overall Study|Withdrawal by Subject|3|||
125304481|NCT01368081|450741318|FG006|Overall Study|Withdrawal by Subject|4|||
125304482|NCT01368081|450741319|FG007|Overall Study|Withdrawal by Subject|2|||
125304483|NCT01368081|450741320|FG008|Overall Study|Withdrawal by Subject|5|||
125304484|NCT01368081|450741321|FG009|Overall Study|Withdrawal by Subject|4|||
125304485|NCT01368081|450741322|FG010|Overall Study|Withdrawal by Subject|3|||
124831423|NCT02113956|449012279|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
125304486|NCT01368081|450741323|FG011|Overall Study|Withdrawal by Subject|2|||
125304487|NCT01368081|450741324|FG012|Overall Study|Withdrawal by Subject|0|||
125304488|NCT01368081|450741312|FG000|Overall Study|Other reason not defined above|2|||
125304489|NCT01368081|450741313|FG001|Overall Study|Other reason not defined above|0|||
125304490|NCT01368081|450741314|FG002|Overall Study|Other reason not defined above|0|||
125304491|NCT01368081|450741315|FG003|Overall Study|Other reason not defined above|1|||
125304492|NCT01368081|450741316|FG004|Overall Study|Other reason not defined above|0|||
125304493|NCT01368081|450741317|FG005|Overall Study|Other reason not defined above|1|||
125304494|NCT01368081|450741318|FG006|Overall Study|Other reason not defined above|2|||
125304495|NCT01368081|450741319|FG007|Overall Study|Other reason not defined above|0|||
125304496|NCT01368081|450741320|FG008|Overall Study|Other reason not defined above|0|||
124831424|NCT02113956|449012280|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
124831425|NCT02406651|449012281|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
124831426|NCT02005250|449012283|FG000|Overall Study|Lost to Follow-up|15|||
124831427|NCT02005250|449012284|FG001|Overall Study|Lost to Follow-up|5|||
124831428|NCT02588833|449012285|FG000|Part 1|Withdrawal by Subject|1|||
124831429|NCT02588833|449012286|FG001|Part 1|Withdrawal by Subject|0|||
124831430|NCT02588833|449012285|FG000|Part 2A|Physician Decision|0|||
124831431|NCT02588833|449012286|FG001|Part 2A|Physician Decision|1|||
124831432|NCT02588833|449012285|FG000|Part 2A|Withdrawal by Subject|0|||
124831433|NCT02588833|449012286|FG001|Part 2A|Withdrawal by Subject|1|||
124831434|NCT02588833|449012285|FG000|Part 2B|Adverse Event|0|||
124831435|NCT02588833|449012286|FG001|Part 2B|Adverse Event|1|||
124831436|NCT02588833|449012285|FG000|Part 2C|Adverse Event|0|||
124831437|NCT02588833|449012286|FG001|Part 2C|Adverse Event|1|||
124831438|NCT02588833|449012285|FG000|Part 2C|Withdrawal by Subject|0|||
124831439|NCT02588833|449012286|FG001|Part 2C|Withdrawal by Subject|1|||
124831440|NCT02588833|449012285|FG000|Part 3 (Safety Follow-up)|Other|0|||
124831441|NCT02588833|449012286|FG001|Part 3 (Safety Follow-up)|Other|2|||
124831442|NCT02921776|449012287|FG000|Overall Study|patient deterioration, fatigue|2|||
124831443|NCT02921776|449012288|FG001|Overall Study|patient deterioration, fatigue|6|||
124831444|NCT02921776|449012289|FG002|Overall Study|patient deterioration, fatigue|0|||
124831445|NCT02921776|449012290|FG003|Overall Study|patient deterioration, fatigue|0|||
124831446|NCT02921776|449012291|FG004|Overall Study|patient deterioration, fatigue|0|||
124831447|NCT02921776|449012292|FG005|Overall Study|patient deterioration, fatigue|0|||
124831448|NCT02921776|449012293|FG006|Overall Study|patient deterioration, fatigue|0|||
124831449|NCT02921776|449012294|FG007|Overall Study|patient deterioration, fatigue|0|||
124831450|NCT02921776|449012287|FG000|Overall Study|Withdrawal by Subject|0|||
124831451|NCT02921776|449012288|FG001|Overall Study|Withdrawal by Subject|2|||
124831452|NCT02921776|449012289|FG002|Overall Study|Withdrawal by Subject|0|||
124831453|NCT02921776|449012290|FG003|Overall Study|Withdrawal by Subject|1|||
124831454|NCT02921776|449012291|FG004|Overall Study|Withdrawal by Subject|1|||
124831455|NCT02921776|449012292|FG005|Overall Study|Withdrawal by Subject|0|||
124831456|NCT02921776|449012293|FG006|Overall Study|Withdrawal by Subject|8|||
124831457|NCT02921776|449012294|FG007|Overall Study|Withdrawal by Subject|1|||
124831458|NCT02921776|449012287|FG000|Overall Study|Death|0|||
124831459|NCT02921776|449012288|FG001|Overall Study|Death|0|||
124831460|NCT02921776|449012289|FG002|Overall Study|Death|0|||
124831461|NCT02921776|449012290|FG003|Overall Study|Death|2|||
124831462|NCT02921776|449012291|FG004|Overall Study|Death|0|||
124831463|NCT02921776|449012292|FG005|Overall Study|Death|0|||
124831464|NCT02921776|449012293|FG006|Overall Study|Death|0|||
124831465|NCT02921776|449012294|FG007|Overall Study|Death|0|||
124831466|NCT02921776|449012287|FG000|Overall Study|extubation or early discharge|0|||
124831467|NCT02921776|449012288|FG001|Overall Study|extubation or early discharge|0|||
124831468|NCT02921776|449012289|FG002|Overall Study|extubation or early discharge|0|||
124831469|NCT02921776|449012290|FG003|Overall Study|extubation or early discharge|5|||
124831470|NCT02921776|449012291|FG004|Overall Study|extubation or early discharge|5|||
124831471|NCT02921776|449012292|FG005|Overall Study|extubation or early discharge|0|||
124831472|NCT02921776|449012293|FG006|Overall Study|extubation or early discharge|0|||
124831473|NCT02921776|449012294|FG007|Overall Study|extubation or early discharge|0|||
124831474|NCT02921776|449012287|FG000|Overall Study|Lost to Follow-up|0|||
124831475|NCT02921776|449012288|FG001|Overall Study|Lost to Follow-up|0|||
124831476|NCT02921776|449012289|FG002|Overall Study|Lost to Follow-up|0|||
124831477|NCT02921776|449012290|FG003|Overall Study|Lost to Follow-up|0|||
124831478|NCT02921776|449012291|FG004|Overall Study|Lost to Follow-up|0|||
124831479|NCT02921776|449012292|FG005|Overall Study|Lost to Follow-up|2|||
124831480|NCT02921776|449012293|FG006|Overall Study|Lost to Follow-up|3|||
124831481|NCT02921776|449012294|FG007|Overall Study|Lost to Follow-up|6|||
124831482|NCT02946047|449012295|FG000|Overall Study|Adverse Event|1|||
124831483|NCT02946047|449012296|FG001|Overall Study|Adverse Event|0|||
124831484|NCT02946047|449012297|FG002|Overall Study|Adverse Event|0|||
124831485|NCT02946047|449012298|FG003|Overall Study|Adverse Event|0|||
124831486|NCT04814433|449012302|FG000|Overall Study|Survey not returned|4|||
124831487|NCT04814433|449012303|FG001|Overall Study|Survey not returned|8|||
124831488|NCT04814433|449012304|FG002|Overall Study|Survey not returned|4|||
124831489|NCT04814433|449012305|FG003|Overall Study|Survey not returned|5|||
124831490|NCT02496533|449012306|FG000|Overall Study|Lack of data on outcome|3|||
124831491|NCT02496533|449012307|FG001|Overall Study|Lack of data on outcome|0|||
124831492|NCT02496533|449012306|FG000|Overall Study|Patient did not complete all measures|0|||
124831493|NCT02496533|449012307|FG001|Overall Study|Patient did not complete all measures|4|||
124831494|NCT02496533|449012306|FG000|Overall Study|Late for radiologic testing|0|||
124831495|NCT02496533|449012307|FG001|Overall Study|Late for radiologic testing|2|||
124831496|NCT01816893|449012309|FG000|Washout Period|Withdrawal by Subject|2|||
124831497|NCT01816893|449012310|FG001|Washout Period|Withdrawal by Subject|0|||
125309882|NCT00511238|450760205|FG001|Overall Study|Adverse Event|33|||
124831498|NCT04729127|449014125|FG000|Overall Study|Suspended/Terminated EI Services|4|||
124831499|NCT04729127|449014126|FG001|Overall Study|Suspended/Terminated EI Services|0|||
124831500|NCT04729127|449014127|FG002|Overall Study|Suspended/Terminated EI Services|4|||
124831501|NCT04729127|449014128|FG003|Overall Study|Suspended/Terminated EI Services|6|||
124831502|NCT04729127|449014129|FG004|Overall Study|Suspended/Terminated EI Services|0|||
124831503|NCT04729127|449014130|FG005|Overall Study|Suspended/Terminated EI Services|6|||
124831504|NCT04729127|449014131|FG006|Overall Study|Suspended/Terminated EI Services|2|||
124831505|NCT04729127|449014132|FG007|Overall Study|Suspended/Terminated EI Services|0|||
124831506|NCT04729127|449014133|FG008|Overall Study|Suspended/Terminated EI Services|2|||
124831507|NCT04729127|449014125|FG000|Overall Study|Withdrawal by Subject|1|||
124831508|NCT04729127|449014126|FG001|Overall Study|Withdrawal by Subject|0|||
124831509|NCT04729127|449014127|FG002|Overall Study|Withdrawal by Subject|1|||
124831510|NCT04729127|449014128|FG003|Overall Study|Withdrawal by Subject|0|||
124831511|NCT04729127|449014129|FG004|Overall Study|Withdrawal by Subject|0|||
124831512|NCT04729127|449014130|FG005|Overall Study|Withdrawal by Subject|0|||
124831513|NCT04729127|449014131|FG006|Overall Study|Withdrawal by Subject|0|||
124831514|NCT04729127|449014132|FG007|Overall Study|Withdrawal by Subject|0|||
124831515|NCT04729127|449014133|FG008|Overall Study|Withdrawal by Subject|0|||
124831516|NCT04729127|449014125|FG000|Overall Study|Switched Agency/Setting|1|||
124831517|NCT04729127|449014126|FG001|Overall Study|Switched Agency/Setting|0|||
124831518|NCT04729127|449014127|FG002|Overall Study|Switched Agency/Setting|1|||
124831519|NCT04729127|449014128|FG003|Overall Study|Switched Agency/Setting|1|||
124831520|NCT04729127|449014129|FG004|Overall Study|Switched Agency/Setting|0|||
124831521|NCT04729127|449014130|FG005|Overall Study|Switched Agency/Setting|1|||
124831522|NCT04729127|449014131|FG006|Overall Study|Switched Agency/Setting|1|||
124831523|NCT04729127|449014132|FG007|Overall Study|Switched Agency/Setting|0|||
124831524|NCT04729127|449014133|FG008|Overall Study|Switched Agency/Setting|1|||
124831525|NCT01365507|449014134|FG000|Overall Study|Withdrawal Criteria|8|||
124831526|NCT01365507|449014135|FG001|Overall Study|Withdrawal Criteria|5|||
124831527|NCT01365507|449014134|FG000|Overall Study|Unclassified|1|||
124831528|NCT01365507|449014135|FG001|Overall Study|Unclassified|4|||
124831529|NCT02794103|449014136|FG000|Overall Study|Loss to follow up due to high sedation|3|||
124831530|NCT04782856|449014139|FG000|Overall Study|Withdrawal by Subject|0|||
124831531|NCT04782856|449014140|FG001|Overall Study|Withdrawal by Subject|1|||
124831532|NCT01465022|449014145|FG000|Overall Study|Lost to Follow-up|15|||
124831533|NCT01465022|449014146|FG001|Overall Study|Lost to Follow-up|14|||
124831534|NCT01465022|449014147|FG002|Overall Study|Lost to Follow-up|0|||
124831535|NCT01465022|449014145|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
124831536|NCT01465022|449014146|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
124831537|NCT01465022|449014147|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
124831538|NCT01465022|449014145|FG000|Overall Study|Not Randomized|0|||
124831539|NCT01465022|449014146|FG001|Overall Study|Not Randomized|0|||
124831540|NCT01465022|449014147|FG002|Overall Study|Not Randomized|70|||
124831541|NCT01327300|449014148|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
124831542|NCT01327300|449014149|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
124831543|NCT03020823|449014152|FG000|Overall Study|Physician Decision|4|||
124831544|NCT03020823|449014152|FG000|Overall Study|Lack of Efficacy|4|||
124831545|NCT03020823|449014152|FG000|Overall Study|Adverse Event|2|||
124831546|NCT04307446|449014160|FG000|Overall Study|Lost to Follow-up|2|||
124831547|NCT04307446|449014161|FG001|Overall Study|Lost to Follow-up|0|||
124831548|NCT03257631|449014167|FG000|Overall Study|Death|1|||
124831549|NCT03257631|449014168|FG001|Overall Study|Death|0|||
124831550|NCT03257631|449014169|FG002|Overall Study|Death|1|||
124831551|NCT03257631|449014170|FG003|Overall Study|Death|1|||
124831552|NCT03257631|449014167|FG000|Overall Study|Progressive Disease|10|||
124831553|NCT03257631|449014168|FG001|Overall Study|Progressive Disease|9|||
124831554|NCT03257631|449014169|FG002|Overall Study|Progressive Disease|17|||
124831555|NCT03257631|449014170|FG003|Overall Study|Progressive Disease|8|||
124831556|NCT03257631|449014167|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124831557|NCT03257631|449014168|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124831558|NCT03257631|449014169|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
124831559|NCT03257631|449014170|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
124831560|NCT03257631|449014167|FG000|Overall Study|Adverse Event|0|||
124831561|NCT03257631|449014168|FG001|Overall Study|Adverse Event|0|||
124831562|NCT03257631|449014169|FG002|Overall Study|Adverse Event|2|||
124831563|NCT03257631|449014170|FG003|Overall Study|Adverse Event|0|||
124831564|NCT02672423|449014176|FG000|Period 1|Adverse Event|0|||
124831565|NCT02672423|449014177|FG001|Period 1|Adverse Event|0|||
124831566|NCT02672423|449014178|FG002|Period 1|Adverse Event|0|||
124831567|NCT02672423|449014179|FG003|Period 1|Adverse Event|0|||
124831568|NCT02672423|449014180|FG004|Period 1|Adverse Event|1|||
124831569|NCT02672423|449014181|FG005|Period 1|Adverse Event|0|||
124831570|NCT02672423|449014182|FG006|Period 1|Adverse Event|0|||
124831571|NCT02672423|449014183|FG007|Period 1|Adverse Event|0|||
124831572|NCT02672423|449014184|FG008|Period 1|Adverse Event|0|||
124831573|NCT02672423|449014185|FG009|Period 1|Adverse Event|0|||
124831574|NCT02672423|449014176|FG000|Period 2|Withdrawal by Subject|0|||
124831575|NCT02672423|449014177|FG001|Period 2|Withdrawal by Subject|0|||
124831576|NCT02672423|449014178|FG002|Period 2|Withdrawal by Subject|1|||
124831577|NCT02672423|449014179|FG003|Period 2|Withdrawal by Subject|0|||
124831578|NCT02672423|449014180|FG004|Period 2|Withdrawal by Subject|0|||
124831579|NCT02672423|449014181|FG005|Period 2|Withdrawal by Subject|0|||
124831580|NCT02672423|449014182|FG006|Period 2|Withdrawal by Subject|0|||
124831581|NCT02672423|449014183|FG007|Period 2|Withdrawal by Subject|0|||
124831582|NCT02672423|449014184|FG008|Period 2|Withdrawal by Subject|0|||
124831583|NCT02672423|449014185|FG009|Period 2|Withdrawal by Subject|0|||
124831584|NCT02672423|449014176|FG000|Period 3|Withdrawal by Subject|0|||
124831585|NCT02672423|449014177|FG001|Period 3|Withdrawal by Subject|0|||
124831586|NCT02672423|449014178|FG002|Period 3|Withdrawal by Subject|0|||
124831587|NCT02672423|449014179|FG003|Period 3|Withdrawal by Subject|0|||
124831588|NCT02672423|449014180|FG004|Period 3|Withdrawal by Subject|0|||
124831589|NCT02672423|449014181|FG005|Period 3|Withdrawal by Subject|0|||
124831590|NCT02672423|449014182|FG006|Period 3|Withdrawal by Subject|0|||
124831591|NCT02672423|449014183|FG007|Period 3|Withdrawal by Subject|1|||
124831592|NCT02672423|449014184|FG008|Period 3|Withdrawal by Subject|0|||
124831593|NCT02672423|449014185|FG009|Period 3|Withdrawal by Subject|0|||
124831594|NCT02672423|449014176|FG000|Period 3|Physician Decision|0|||
124831595|NCT02672423|449014177|FG001|Period 3|Physician Decision|0|||
124831596|NCT02672423|449014178|FG002|Period 3|Physician Decision|0|||
124831597|NCT02672423|449014179|FG003|Period 3|Physician Decision|0|||
124831598|NCT02672423|449014180|FG004|Period 3|Physician Decision|0|||
124831599|NCT02672423|449014181|FG005|Period 3|Physician Decision|1|||
124831600|NCT02672423|449014182|FG006|Period 3|Physician Decision|0|||
124831601|NCT02672423|449014183|FG007|Period 3|Physician Decision|0|||
124831602|NCT02672423|449014184|FG008|Period 3|Physician Decision|0|||
124831603|NCT02672423|449014185|FG009|Period 3|Physician Decision|0|||
124831604|NCT01046682|449014187|FG000|Overall Study|Adverse Event|2|||
124831605|NCT01046682|449014188|FG001|Overall Study|Adverse Event|0|||
124831606|NCT01454570|449014191|FG000|Overall Study|Withdrawal by Subject|2|||
124831607|NCT01454570|449014191|FG000|Overall Study|Screen Failure|7|||
124831608|NCT00536107|449014192|FG000|Overall Study|Death|5|||
124831609|NCT00536107|449014193|FG001|Overall Study|Death|1|||
124831610|NCT00536107|449014192|FG000|Overall Study|Incorrect enrolment|1|||
124831611|NCT00536107|449014193|FG001|Overall Study|Incorrect enrolment|0|||
124831612|NCT00536107|449014192|FG000|Overall Study|Withdrawal by Subject|0|||
124831613|NCT00536107|449014193|FG001|Overall Study|Withdrawal by Subject|1|||
124831614|NCT00536107|449014192|FG000|Overall Study|Study Termination|2|||
124831615|NCT00536107|449014193|FG001|Overall Study|Study Termination|4|||
124831616|NCT00371254|449014195|FG000|Overall Study|Disease progression|13|||
124831617|NCT00371254|449014196|FG001|Overall Study|Disease progression|13|||
124831618|NCT00371254|449014195|FG000|Overall Study|Study drug toxicity|3|||
124831619|NCT00371254|449014196|FG001|Overall Study|Study drug toxicity|5|||
124831620|NCT00371254|449014195|FG000|Overall Study|Subject request|5|||
124831621|NCT00371254|449014196|FG001|Overall Study|Subject request|0|||
124831622|NCT00371254|449014195|FG000|Overall Study|Investigator Decision|2|||
124831623|NCT00371254|449014196|FG001|Overall Study|Investigator Decision|0|||
124831624|NCT00371254|449014195|FG000|Overall Study|Adverse event unrelated to study drug|0|||
124831625|NCT00371254|449014196|FG001|Overall Study|Adverse event unrelated to study drug|1|||
124831626|NCT00371254|449014195|FG000|Overall Study|Lost to Follow-up|0|||
124831627|NCT00371254|449014196|FG001|Overall Study|Lost to Follow-up|1|||
124831628|NCT00371254|449014195|FG000|Overall Study|Withdrawal by Subject|0|||
124831629|NCT00371254|449014196|FG001|Overall Study|Withdrawal by Subject|1|||
124831630|NCT02246673|449014199|FG000|Overall Study|Sponsor Decision|1|||
124831631|NCT02246673|449014200|FG001|Overall Study|Sponsor Decision|0|||
124831632|NCT02246673|449014201|FG002|Overall Study|Sponsor Decision|0|||
124831633|NCT02246673|449014202|FG003|Overall Study|Sponsor Decision|0|||
124831634|NCT02246673|449014203|FG004|Overall Study|Sponsor Decision|0|||
124831635|NCT02246673|449014199|FG000|Overall Study|Withdrawal by Subject|0|||
124831636|NCT02246673|449014200|FG001|Overall Study|Withdrawal by Subject|0|||
124831637|NCT02246673|449014201|FG002|Overall Study|Withdrawal by Subject|0|||
124831638|NCT02246673|449014202|FG003|Overall Study|Withdrawal by Subject|0|||
124831639|NCT02246673|449014203|FG004|Overall Study|Withdrawal by Subject|1|||
124831640|NCT02246673|449014199|FG000|Overall Study|Lost to Follow-up|0|||
124831641|NCT02246673|449014200|FG001|Overall Study|Lost to Follow-up|0|||
124831642|NCT02246673|449014201|FG002|Overall Study|Lost to Follow-up|0|||
124831643|NCT02246673|449014202|FG003|Overall Study|Lost to Follow-up|1|||
124831644|NCT02246673|449014203|FG004|Overall Study|Lost to Follow-up|0|||
124831645|NCT02246673|449014199|FG000|Overall Study|Protocol Violation|0|||
124831646|NCT02246673|449014200|FG001|Overall Study|Protocol Violation|0|||
124831647|NCT02246673|449014201|FG002|Overall Study|Protocol Violation|0|||
124831648|NCT02246673|449014202|FG003|Overall Study|Protocol Violation|1|||
124831649|NCT02246673|449014203|FG004|Overall Study|Protocol Violation|0|||
124831650|NCT04356963|449014205|FG000|First Session|Withdrawal by Subject|1|||
124831651|NCT04356963|449014205|FG000|Second Session|Withdrawal by Subject|3|||
124831652|NCT04356963|449014205|FG000|Second Session|Lost to Follow-up|1|||
124831653|NCT04356963|449014205|FG000|Third Session|Lost to Follow-up|6|||
124831654|NCT04356963|449014205|FG000|Third Session|Withdrawal by Subject|1|||
124831655|NCT02726074|449014211|FG000|Overall Study|Withdrawal by Subject|4|||
124831656|NCT02726074|449014211|FG000|Overall Study|Adverse Event|14|||
124831657|NCT02726074|449014211|FG000|Overall Study|Protocol Violation|3|||
124831658|NCT02726074|449014211|FG000|Overall Study|Lost to Follow-up|2|||
124831659|NCT02726074|449014211|FG000|Overall Study|Others|3|||
124831660|NCT01679002|449014212|FG000|Overall Study|Adverse Event|1|||
124831661|NCT01679002|449014213|FG001|Overall Study|Adverse Event|1|||
124831662|NCT01679002|449014214|FG002|Overall Study|Adverse Event|0|||
124831663|NCT01176266|449014215|FG000|Overall Study|Death|6|||
124831664|NCT01176266|449014215|FG000|Overall Study|Withdrawal by Subject|3|||
124831665|NCT01179477|449014216|FG000|Overall Study|Death|542|||
124831666|NCT01179477|449014216|FG000|Overall Study|Unsuccessful implant|80|||
124831667|NCT01179477|449014216|FG000|Overall Study|Non-death withdrawal|438|||
124831668|NCT01179477|449014216|FG000|Overall Study|Did not complete final visit|27|||
124831669|NCT05075850|449014224|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
124831670|NCT01265849|449014225|FG000|Overall Study|Randomized//Treatment not initiated|1|||
124831671|NCT01265849|449014226|FG001|Overall Study|Randomized//Treatment not initiated|4|||
124831672|NCT01265849|449014227|FG002|Overall Study|Randomized//Treatment not initiated|0|||
124831673|NCT01265849|449014225|FG000|Overall Study|Physician Decision|1|||
124831674|NCT01265849|449014226|FG001|Overall Study|Physician Decision|2|||
124831675|NCT01265849|449014227|FG002|Overall Study|Physician Decision|0|||
124831676|NCT01265849|449014225|FG000|Overall Study|Lost to Follow-up|18|||
124831677|NCT01265849|449014226|FG001|Overall Study|Lost to Follow-up|15|||
124831678|NCT01265849|449014227|FG002|Overall Study|Lost to Follow-up|5|||
124831679|NCT01265849|449014225|FG000|Overall Study|Not otherwise specified|1|||
124831680|NCT01265849|449014226|FG001|Overall Study|Not otherwise specified|6|||
124831681|NCT01265849|449014227|FG002|Overall Study|Not otherwise specified|1|||
124831682|NCT01265849|449014225|FG000|Overall Study|Withdrawal by Subject|25|||
124831683|NCT01265849|449014226|FG001|Overall Study|Withdrawal by Subject|34|||
124831684|NCT01265849|449014227|FG002|Overall Study|Withdrawal by Subject|13|||
124831685|NCT02154581|449014233|FG000|Overall Study|Lost to Follow-up|7|||
124831686|NCT02154581|449014234|FG001|Overall Study|Lost to Follow-up|8|||
124831687|NCT01092182|449014235|FG000|Overall Study|Death|0|||
124831688|NCT01092182|449014236|FG001|Overall Study|Death|5|||
124831689|NCT01092182|449014237|FG002|Overall Study|Death|3|||
124831690|NCT01092182|449014235|FG000|Overall Study|participant safety|1|||
124831691|NCT01092182|449014236|FG001|Overall Study|participant safety|2|||
124831692|NCT01092182|449014237|FG002|Overall Study|participant safety|0|||
124831693|NCT01092182|449014235|FG000|Overall Study|Physician Decision|0|||
124831694|NCT01092182|449014236|FG001|Overall Study|Physician Decision|6|||
124831695|NCT01092182|449014237|FG002|Overall Study|Physician Decision|0|||
124831696|NCT01092182|449014235|FG000|Overall Study|Did not meet criteria|0|||
124831697|NCT01092182|449014236|FG001|Overall Study|Did not meet criteria|0|||
124831698|NCT01092182|449014237|FG002|Overall Study|Did not meet criteria|25|||
124831699|NCT01092182|449014235|FG000|Overall Study|Non-compliance|0|||
124831700|NCT01092182|449014236|FG001|Overall Study|Non-compliance|3|||
124831701|NCT01092182|449014237|FG002|Overall Study|Non-compliance|0|||
124831702|NCT01092182|449014235|FG000|Overall Study|Participant refused follow-up|0|||
124831703|NCT01092182|449014236|FG001|Overall Study|Participant refused follow-up|2|||
124831704|NCT01092182|449014237|FG002|Overall Study|Participant refused follow-up|0|||
124831705|NCT02515045|449014240|FG000|Overall Study|Adverse Event|0|||
124831706|NCT02515045|449014241|FG001|Overall Study|Adverse Event|3|||
124831707|NCT02515045|449014242|FG002|Overall Study|Adverse Event|3|||
124831708|NCT02515045|449014240|FG000|Overall Study|Lost to Follow-up|0|||
124831709|NCT02515045|449014241|FG001|Overall Study|Lost to Follow-up|1|||
124831710|NCT02515045|449014242|FG002|Overall Study|Lost to Follow-up|1|||
124831711|NCT03255382|449014245|FG000|Overall Study|Adverse Event|3|||
124831712|NCT03255382|449014246|FG001|Overall Study|Adverse Event|0|||
124831713|NCT03255382|449014245|FG000|Overall Study|Lost to Follow-up|2|||
124831714|NCT03255382|449014246|FG001|Overall Study|Lost to Follow-up|0|||
124831715|NCT03255382|449014245|FG000|Overall Study|Withdrawal by Subject|2|||
124831716|NCT03255382|449014246|FG001|Overall Study|Withdrawal by Subject|0|||
124831717|NCT03255382|449014245|FG000|Overall Study|Other|6|||
124831718|NCT03255382|449014246|FG001|Overall Study|Other|0|||
124831719|NCT02221284|449014247|FG000|Overall Study|Case Report Forms Uncollected|56|||
124831720|NCT02221284|449014247|FG000|Overall Study|Protocol Deviation|5|||
124831721|NCT03011307|449014250|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
124831722|NCT03011307|449014251|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
124831723|NCT03011307|449014250|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
124831724|NCT03011307|449014251|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
124831725|NCT03011307|449014250|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
124831726|NCT03011307|449014251|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
124831727|NCT02677987|449014253|FG000|Overall Study|Withdrawal by Subject|3|||
124831728|NCT02677987|449014254|FG001|Overall Study|Withdrawal by Subject|0|||
124831729|NCT02677987|449014253|FG000|Overall Study|Lost to Follow-up|1|||
124831730|NCT02677987|449014254|FG001|Overall Study|Lost to Follow-up|0|||
124831731|NCT00651755|449014255|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
124831732|NCT00651755|449014256|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
124831733|NCT00651755|449014255|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
124831734|NCT00651755|449014256|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
124831735|NCT00624052|449014257|FG000|Overall Study|Adverse Event|7|||
124831736|NCT00624052|449014258|FG001|Overall Study|Adverse Event|6|||
124831737|NCT00624052|449014259|FG002|Overall Study|Adverse Event|0|||
124831738|NCT00624052|449014260|FG003|Overall Study|Adverse Event|3|||
124831739|NCT00624052|449014257|FG000|Overall Study|Lack of Efficacy|1|||
124831740|NCT00624052|449014258|FG001|Overall Study|Lack of Efficacy|1|||
124831741|NCT00624052|449014259|FG002|Overall Study|Lack of Efficacy|0|||
124831742|NCT00624052|449014260|FG003|Overall Study|Lack of Efficacy|0|||
124831743|NCT00624052|449014257|FG000|Overall Study|Lost to Follow-up|2|||
124831744|NCT00624052|449014258|FG001|Overall Study|Lost to Follow-up|3|||
124831745|NCT00624052|449014259|FG002|Overall Study|Lost to Follow-up|1|||
124831746|NCT00624052|449014260|FG003|Overall Study|Lost to Follow-up|0|||
124831747|NCT00624052|449014257|FG000|Overall Study|Non compliant with the protocol|2|||
124831748|NCT00624052|449014258|FG001|Overall Study|Non compliant with the protocol|1|||
124831749|NCT00624052|449014259|FG002|Overall Study|Non compliant with the protocol|1|||
124831750|NCT00624052|449014260|FG003|Overall Study|Non compliant with the protocol|1|||
124831751|NCT00624052|449014257|FG000|Overall Study|Consent withdrawn|3|||
124831752|NCT00624052|449014258|FG001|Overall Study|Consent withdrawn|1|||
124831753|NCT00624052|449014259|FG002|Overall Study|Consent withdrawn|1|||
124831754|NCT00624052|449014260|FG003|Overall Study|Consent withdrawn|0|||
124831755|NCT00624052|449014257|FG000|Overall Study|Changed job/ran out if meds|0|||
124831756|NCT00624052|449014258|FG001|Overall Study|Changed job/ran out if meds|2|||
124831757|NCT00624052|449014259|FG002|Overall Study|Changed job/ran out if meds|0|||
124831758|NCT00624052|449014260|FG003|Overall Study|Changed job/ran out if meds|0|||
124831759|NCT00281684|449014261|FG000|Overall Study|Lost to Follow-up|0|||
124831760|NCT00281684|449014262|FG001|Overall Study|Lost to Follow-up|0|||
124831761|NCT00281684|449014263|FG002|Overall Study|Lost to Follow-up|1|||
124831762|NCT00281684|449014264|FG003|Overall Study|Lost to Follow-up|0|||
124831763|NCT00281684|449014261|FG000|Overall Study|Withdrawal by Subject|1|||
124831764|NCT00281684|449014262|FG001|Overall Study|Withdrawal by Subject|0|||
124831765|NCT00281684|449014263|FG002|Overall Study|Withdrawal by Subject|0|||
124831766|NCT00281684|449014264|FG003|Overall Study|Withdrawal by Subject|0|||
124831767|NCT03760146|449014268|FG000|Overall Study|Adverse Event|11|||
124831768|NCT03760146|449014269|FG001|Overall Study|Adverse Event|8|||
124831769|NCT03760146|449014270|FG002|Overall Study|Adverse Event|0|||
124831770|NCT03760146|449014271|FG003|Overall Study|Adverse Event|0|||
124831771|NCT03760146|449014272|FG004|Overall Study|Adverse Event|0|||
124831772|NCT03760146|449014273|FG005|Overall Study|Adverse Event|0|||
124831773|NCT03760146|449014268|FG000|Overall Study|Death|1|||
124831774|NCT03760146|449014269|FG001|Overall Study|Death|0|||
124831775|NCT03760146|449014270|FG002|Overall Study|Death|0|||
124831776|NCT03760146|449014271|FG003|Overall Study|Death|0|||
124831777|NCT03760146|449014272|FG004|Overall Study|Death|0|||
124831778|NCT03760146|449014273|FG005|Overall Study|Death|0|||
124831779|NCT03760146|449014268|FG000|Overall Study|Lost to Follow-up|41|||
124831780|NCT03760146|449014269|FG001|Overall Study|Lost to Follow-up|28|||
124831781|NCT03760146|449014270|FG002|Overall Study|Lost to Follow-up|9|||
124831782|NCT03760146|449014271|FG003|Overall Study|Lost to Follow-up|2|||
124831783|NCT03760146|449014272|FG004|Overall Study|Lost to Follow-up|14|||
124831784|NCT03760146|449014273|FG005|Overall Study|Lost to Follow-up|8|||
124831785|NCT03760146|449014268|FG000|Overall Study|No longer met eligibility criteria|3|||
124831786|NCT03760146|449014269|FG001|Overall Study|No longer met eligibility criteria|9|||
124831787|NCT03760146|449014270|FG002|Overall Study|No longer met eligibility criteria|0|||
124831788|NCT03760146|449014271|FG003|Overall Study|No longer met eligibility criteria|0|||
124831789|NCT03760146|449014272|FG004|Overall Study|No longer met eligibility criteria|1|||
124831790|NCT03760146|449014273|FG005|Overall Study|No longer met eligibility criteria|0|||
124831791|NCT03760146|449014268|FG000|Overall Study|Protocol Violation|21|||
124831792|NCT03760146|449014269|FG001|Overall Study|Protocol Violation|13|||
124831793|NCT03760146|449014270|FG002|Overall Study|Protocol Violation|1|||
124831794|NCT03760146|449014271|FG003|Overall Study|Protocol Violation|0|||
124831795|NCT03760146|449014272|FG004|Overall Study|Protocol Violation|1|||
124831796|NCT03760146|449014273|FG005|Overall Study|Protocol Violation|0|||
124831797|NCT03760146|449014268|FG000|Overall Study|Withdrawal by Subject|19|||
124831798|NCT03760146|449014269|FG001|Overall Study|Withdrawal by Subject|20|||
124831799|NCT03760146|449014270|FG002|Overall Study|Withdrawal by Subject|1|||
124831800|NCT03760146|449014271|FG003|Overall Study|Withdrawal by Subject|0|||
124831801|NCT03760146|449014272|FG004|Overall Study|Withdrawal by Subject|1|||
124831802|NCT03760146|449014273|FG005|Overall Study|Withdrawal by Subject|0|||
124831803|NCT03839212|449014274|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
124831804|NCT00679263|449014275|FG000|Visit 2/Dose 1|Adverse Event|1|||
124831805|NCT00679263|449014276|FG001|Visit 2/Dose 1|Adverse Event|0|||
124831806|NCT00679263|449014277|FG002|Visit 2/Dose 1|Adverse Event|0|||
124831807|NCT00679263|449014275|FG000|Visit 2/Dose 1|subject not compliance|1|||
124831808|NCT00679263|449014276|FG001|Visit 2/Dose 1|subject not compliance|1|||
124831809|NCT00679263|449014277|FG002|Visit 2/Dose 1|subject not compliance|0|||
124831810|NCT01464346|449014278|FG000|Overall Study|Withdrawal by Subject|0|||
124831811|NCT01464346|449014279|FG001|Overall Study|Withdrawal by Subject|0|||
124831812|NCT01464346|449014280|FG002|Overall Study|Withdrawal by Subject|1|||
124831813|NCT03245008|449014281|FG000|Overall Study|Adverse Event|15|||
124831814|NCT03245008|449014282|FG001|Overall Study|Adverse Event|18|||
124831815|NCT03245008|449014283|FG002|Overall Study|Adverse Event|15|||
124831816|NCT03245008|449014284|FG003|Overall Study|Adverse Event|0|||
124831817|NCT03245008|449014285|FG004|Overall Study|Adverse Event|1|||
124831818|NCT03245008|449014281|FG000|Overall Study|Lack of Efficacy|0|||
124831819|NCT03245008|449014282|FG001|Overall Study|Lack of Efficacy|1|||
124831820|NCT03245008|449014283|FG002|Overall Study|Lack of Efficacy|0|||
124831821|NCT03245008|449014284|FG003|Overall Study|Lack of Efficacy|0|||
124831822|NCT03245008|449014285|FG004|Overall Study|Lack of Efficacy|0|||
124831823|NCT03245008|449014281|FG000|Overall Study|Lost to Follow-up|4|||
124831824|NCT03245008|449014282|FG001|Overall Study|Lost to Follow-up|1|||
124831825|NCT03245008|449014283|FG002|Overall Study|Lost to Follow-up|0|||
124831826|NCT03245008|449014284|FG003|Overall Study|Lost to Follow-up|0|||
124831827|NCT03245008|449014285|FG004|Overall Study|Lost to Follow-up|1|||
124831828|NCT03245008|449014281|FG000|Overall Study|Physician Decision|1|||
124831829|NCT03245008|449014282|FG001|Overall Study|Physician Decision|3|||
124831830|NCT03245008|449014283|FG002|Overall Study|Physician Decision|4|||
124831831|NCT03245008|449014284|FG003|Overall Study|Physician Decision|0|||
124831832|NCT03245008|449014285|FG004|Overall Study|Physician Decision|0|||
124831833|NCT03245008|449014281|FG000|Overall Study|Protocol Violation|0|||
124831834|NCT03245008|449014282|FG001|Overall Study|Protocol Violation|1|||
124831835|NCT03245008|449014283|FG002|Overall Study|Protocol Violation|0|||
124831836|NCT03245008|449014284|FG003|Overall Study|Protocol Violation|0|||
124831837|NCT03245008|449014285|FG004|Overall Study|Protocol Violation|0|||
124831838|NCT03245008|449014281|FG000|Overall Study|Withdrawal by Subject|20|||
124831839|NCT03245008|449014282|FG001|Overall Study|Withdrawal by Subject|19|||
124831840|NCT03245008|449014283|FG002|Overall Study|Withdrawal by Subject|11|||
124831841|NCT03245008|449014284|FG003|Overall Study|Withdrawal by Subject|0|||
124831842|NCT03245008|449014285|FG004|Overall Study|Withdrawal by Subject|0|||
124831843|NCT03245008|449014281|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
124831844|NCT03245008|449014282|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
124831845|NCT03245008|449014283|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
124831846|NCT03245008|449014284|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
124831847|NCT03245008|449014285|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
124831848|NCT03245008|449014281|FG000|Overall Study|Failure to meet randomization criteria|0|||
124831849|NCT03245008|449014282|FG001|Overall Study|Failure to meet randomization criteria|1|||
124831850|NCT03245008|449014283|FG002|Overall Study|Failure to meet randomization criteria|0|||
124831851|NCT03245008|449014284|FG003|Overall Study|Failure to meet randomization criteria|1|||
124831852|NCT03245008|449014285|FG004|Overall Study|Failure to meet randomization criteria|0|||
124831853|NCT02075658|449014286|FG000|Overall Study|Physician Decision|2|||
124831854|NCT02075658|449014287|FG001|Overall Study|Physician Decision|2|||
124831855|NCT01286012|449014288|FG000|Overall Study|Adverse Event|3|||
124831856|NCT01286012|449014289|FG001|Overall Study|Adverse Event|3|||
124831857|NCT01286012|449014288|FG000|Overall Study|Death|2|||
124831858|NCT01286012|449014289|FG001|Overall Study|Death|3|||
124831859|NCT01286012|449014288|FG000|Overall Study|Protocol Violation|1|||
124831860|NCT01286012|449014289|FG001|Overall Study|Protocol Violation|1|||
124831861|NCT01286012|449014288|FG000|Overall Study|Withdrawal by Subject|4|||
124831862|NCT01286012|449014289|FG001|Overall Study|Withdrawal by Subject|4|||
124831863|NCT01286012|449014288|FG000|Overall Study|Physician Decision|2|||
124831864|NCT01286012|449014289|FG001|Overall Study|Physician Decision|0|||
124831865|NCT01286012|449014288|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
124831866|NCT01286012|449014289|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
124831867|NCT00718328|449014290|FG000|Overall Study|Lost to Follow-up|1|||
124831868|NCT00718328|449014291|FG001|Overall Study|Lost to Follow-up|0|||
124831869|NCT01064401|449014292|FG000|Overall Study|Adverse Event|47|||
124831870|NCT01064401|449014293|FG001|Overall Study|Adverse Event|56|||
125304497|NCT01368081|450741321|FG009|Overall Study|Other reason not defined above|1|||
125304498|NCT01368081|450741322|FG010|Overall Study|Other reason not defined above|0|||
125304499|NCT01368081|450741323|FG011|Overall Study|Other reason not defined above|0|||
125304500|NCT01368081|450741324|FG012|Overall Study|Other reason not defined above|3|||
125304501|NCT01736618|450741327|FG000|Overall Study|Death|294|||
125304502|NCT01736618|450741327|FG000|Overall Study|Lost to Follow-up|193|||
125304503|NCT01736618|450741327|FG000|Overall Study|Withdrawal by Subject|54|||
125304504|NCT01736618|450741327|FG000|Overall Study|Subject unable to be followed at study location|223|||
125304505|NCT01736618|450741327|FG000|Overall Study|Physician Decision|33|||
125304506|NCT01736618|450741327|FG000|Overall Study|Transplant or removal of target organ|19|||
125304507|NCT01736618|450741327|FG000|Overall Study|Change in indication or condition|78|||
124831871|NCT01064401|449014292|FG000|Overall Study|Lack of Efficacy|46|||
124831872|NCT01064401|449014293|FG001|Overall Study|Lack of Efficacy|23|||
124831873|NCT01064401|449014292|FG000|Overall Study|Lost to Follow-up|12|||
124831874|NCT01064401|449014293|FG001|Overall Study|Lost to Follow-up|9|||
124831875|NCT01064401|449014292|FG000|Overall Study|Consent Withdrawn|98|||
124831876|NCT01064401|449014293|FG001|Overall Study|Consent Withdrawn|80|||
124831877|NCT01064401|449014292|FG000|Overall Study|Investigator Decision|4|||
124831878|NCT01064401|449014293|FG001|Overall Study|Investigator Decision|6|||
124831879|NCT01064401|449014292|FG000|Overall Study|Death|4|||
124831880|NCT01064401|449014293|FG001|Overall Study|Death|0|||
124831881|NCT01064401|449014292|FG000|Overall Study|Pregnancy|4|||
124831882|NCT01064401|449014293|FG001|Overall Study|Pregnancy|7|||
124831883|NCT01064401|449014292|FG000|Overall Study|Noncompliance|7|||
124831884|NCT01064401|449014293|FG001|Overall Study|Noncompliance|8|||
124831885|NCT01064401|449014292|FG000|Overall Study|Site Closure|4|||
124831886|NCT01064401|449014293|FG001|Overall Study|Site Closure|5|||
124831887|NCT01064401|449014292|FG000|Overall Study|Other|2|||
124831888|NCT01064401|449014293|FG001|Overall Study|Other|1|||
124831889|NCT04007094|449014294|FG000|Overall Study|Lost to Follow-up|1|||
124831890|NCT04007094|449014295|FG001|Overall Study|Lost to Follow-up|1|||
124831891|NCT01581307|449014296|FG000|Overall Study|Withdrawal by Subject|1|||
124831892|NCT00378209|449014301|FG000|Overall Study|Progressive disease|11|||
124831893|NCT00378209|449014301|FG000|Overall Study|Adverse Event|3|||
124831894|NCT00378209|449014301|FG000|Overall Study|Initiation of non-protocol therapy|3|||
124831895|NCT00378209|449014301|FG000|Overall Study|Physician Decision|3|||
124831896|NCT00378209|449014301|FG000|Overall Study|Death|1|||
124831897|NCT00378209|449014301|FG000|Overall Study|Treatment delay|1|||
124831898|NCT01536379|449015721|FG000|Overall Study|Adverse Event|1|||
124831899|NCT01536379|449015722|FG001|Overall Study|Adverse Event|2|||
124831900|NCT01536379|449015721|FG000|Overall Study|Withdrawal by Subject|1|||
124831901|NCT01536379|449015722|FG001|Overall Study|Withdrawal by Subject|1|||
124831902|NCT04439253|449015726|FG000|Overall Study|Adverse Event|1|||
124831903|NCT04439253|449015726|FG000|Overall Study|Disease progression|2|||
124831904|NCT04439253|449015726|FG000|Overall Study|Complicating disease|1|||
124831905|NCT03971695|449015727|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
124831906|NCT03971695|449015728|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
124831907|NCT03971695|449015729|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
124831908|NCT03971695|449015730|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
124831909|NCT03971695|449015731|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
124831910|NCT03971695|449015732|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
124831911|NCT03971695|449015733|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
124831912|NCT03971695|449015734|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
124831913|NCT03971695|449015735|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
124831914|NCT03971695|449015736|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
124831915|NCT03971695|449015737|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
124831916|NCT03971695|449015738|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
124831917|NCT03971695|449015739|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
124831918|NCT04447417|449015740|FG000|Overall Study|Withdrawal by Subject|1|||
124831919|NCT04447417|449015741|FG001|Overall Study|Withdrawal by Subject|0|||
124831920|NCT04447417|449015740|FG000|Overall Study|Failure to meet inclusion criteria|1|||
124831921|NCT04447417|449015741|FG001|Overall Study|Failure to meet inclusion criteria|0|||
124831922|NCT04447417|449015740|FG000|Overall Study|Lost to Follow-up|1|||
124831923|NCT04447417|449015741|FG001|Overall Study|Lost to Follow-up|0|||
124831924|NCT02155738|449015749|FG000|Overall Study|Missing critical information|1|||
124831925|NCT02155738|449015750|FG001|Overall Study|Missing critical information|0|||
124831926|NCT02155738|449015751|FG002|Overall Study|Missing critical information|0|||
124831927|NCT02155738|449015752|FG003|Overall Study|Missing critical information|1|||
124831928|NCT01190254|449015753|FG000|Overall Study|Adverse Event|3|||
124831929|NCT01190254|449015754|FG001|Overall Study|Adverse Event|6|||
124831930|NCT01190254|449015755|FG002|Overall Study|Adverse Event|8|||
124831931|NCT01190254|449015753|FG000|Overall Study|Lack of Efficacy|7|||
124831932|NCT01190254|449015754|FG001|Overall Study|Lack of Efficacy|4|||
124831933|NCT01190254|449015755|FG002|Overall Study|Lack of Efficacy|5|||
124831934|NCT01190254|449015753|FG000|Overall Study|Lost to Follow-up|4|||
124831935|NCT01190254|449015754|FG001|Overall Study|Lost to Follow-up|2|||
124831936|NCT01190254|449015755|FG002|Overall Study|Lost to Follow-up|0|||
124831937|NCT01190254|449015753|FG000|Overall Study|Withdrawal by Subject|4|||
124831938|NCT01190254|449015754|FG001|Overall Study|Withdrawal by Subject|5|||
124831939|NCT01190254|449015755|FG002|Overall Study|Withdrawal by Subject|7|||
124831940|NCT01190254|449015753|FG000|Overall Study|Protocol Violation|2|||
124831941|NCT01190254|449015754|FG001|Overall Study|Protocol Violation|0|||
124831942|NCT01190254|449015755|FG002|Overall Study|Protocol Violation|2|||
124831943|NCT01190254|449015753|FG000|Overall Study|Did not meet protocol eligibility|1|||
124831944|NCT01190254|449015754|FG001|Overall Study|Did not meet protocol eligibility|0|||
124831945|NCT01190254|449015755|FG002|Overall Study|Did not meet protocol eligibility|0|||
124831946|NCT02603809|449015756|FG000|Overall Study|Withdrawal by Subject|4|||
124831947|NCT02603809|449015757|FG001|Overall Study|Withdrawal by Subject|1|||
124831948|NCT02603809|449015758|FG002|Overall Study|Withdrawal by Subject|2|||
124831949|NCT02603809|449015759|FG003|Overall Study|Withdrawal by Subject|3|||
124831950|NCT02603809|449015760|FG004|Overall Study|Withdrawal by Subject|3|||
124831951|NCT02603809|449015761|FG005|Overall Study|Withdrawal by Subject|4|||
124831952|NCT02603809|449015756|FG000|Overall Study|Lost to Follow-up|2|||
124831953|NCT02603809|449015757|FG001|Overall Study|Lost to Follow-up|3|||
124831954|NCT02603809|449015758|FG002|Overall Study|Lost to Follow-up|1|||
124831955|NCT02603809|449015759|FG003|Overall Study|Lost to Follow-up|4|||
124831956|NCT02603809|449015760|FG004|Overall Study|Lost to Follow-up|2|||
124831957|NCT02603809|449015761|FG005|Overall Study|Lost to Follow-up|2|||
124831958|NCT02603809|449015756|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
124831959|NCT02603809|449015757|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
124831960|NCT02603809|449015758|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
124831961|NCT02603809|449015759|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
124831962|NCT02603809|449015760|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
124831963|NCT02603809|449015761|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
124831964|NCT02603809|449015756|FG000|Overall Study|Physician Decision|0|||
124831965|NCT02603809|449015757|FG001|Overall Study|Physician Decision|0|||
124831966|NCT02603809|449015758|FG002|Overall Study|Physician Decision|0|||
124831967|NCT02603809|449015759|FG003|Overall Study|Physician Decision|1|||
124831968|NCT02603809|449015760|FG004|Overall Study|Physician Decision|2|||
124831969|NCT02603809|449015761|FG005|Overall Study|Physician Decision|1|||
124831970|NCT02603809|449015756|FG000|Overall Study|Adverse Event|3|||
124831971|NCT02603809|449015757|FG001|Overall Study|Adverse Event|0|||
124831972|NCT02603809|449015758|FG002|Overall Study|Adverse Event|2|||
124831973|NCT02603809|449015759|FG003|Overall Study|Adverse Event|2|||
124831974|NCT02603809|449015760|FG004|Overall Study|Adverse Event|1|||
124831975|NCT02603809|449015761|FG005|Overall Study|Adverse Event|1|||
124831976|NCT02603809|449015756|FG000|Overall Study|Lack of Efficacy|0|||
124831977|NCT02603809|449015757|FG001|Overall Study|Lack of Efficacy|1|||
124831978|NCT02603809|449015758|FG002|Overall Study|Lack of Efficacy|0|||
124831979|NCT02603809|449015759|FG003|Overall Study|Lack of Efficacy|0|||
124831980|NCT02603809|449015760|FG004|Overall Study|Lack of Efficacy|0|||
124831981|NCT02603809|449015761|FG005|Overall Study|Lack of Efficacy|1|||
124831982|NCT00156533|449015762|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
124831983|NCT00156533|449015763|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
124831984|NCT00156533|449015764|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
124831985|NCT00156533|449015765|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
124831986|NCT00156533|449015762|FG000|Overall Study|Withdrawal by Subject|1|||
124831987|NCT00156533|449015763|FG001|Overall Study|Withdrawal by Subject|0|||
124831988|NCT00156533|449015764|FG002|Overall Study|Withdrawal by Subject|0|||
124831989|NCT00156533|449015765|FG003|Overall Study|Withdrawal by Subject|1|||
124831990|NCT00156533|449015762|FG000|Overall Study|Failed Screening|1|||
124831991|NCT00156533|449015763|FG001|Overall Study|Failed Screening|0|||
124831992|NCT00156533|449015764|FG002|Overall Study|Failed Screening|1|||
124831993|NCT00156533|449015765|FG003|Overall Study|Failed Screening|1|||
124831994|NCT00887354|449015766|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
124831995|NCT00887354|449015767|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
124831996|NCT00887354|449015766|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
124831997|NCT00887354|449015767|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
124831998|NCT00887354|449015766|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
124831999|NCT00887354|449015767|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
124832000|NCT00887354|449015766|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
124832001|NCT00887354|449015767|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
124832002|NCT00887354|449015766|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
124832003|NCT00887354|449015767|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
124832004|NCT00887354|449015766|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
124832005|NCT00887354|449015767|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
124832006|NCT00887354|449015766|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
124832007|NCT00887354|449015767|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
124832008|NCT00887354|449015766|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
124832009|NCT00887354|449015767|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
124832010|NCT00887354|449015766|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
124832011|NCT00887354|449015767|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
124832012|NCT00887354|449015766|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
124832013|NCT00887354|449015767|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
124832014|NCT00887354|449015766|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
124832015|NCT00887354|449015767|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
124832016|NCT00887354|449015766|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
124832017|NCT00887354|449015767|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
124832018|NCT00887354|449015766|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
124832019|NCT00887354|449015767|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
124832020|NCT00887354|449015766|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
124832021|NCT00887354|449015767|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
124832022|NCT00887354|449015766|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
124832023|NCT00887354|449015767|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
124832024|NCT03265249|449015768|FG000|Overall Study|Withdrawal by Subject|0|||
124832025|NCT03265249|449015769|FG001|Overall Study|Withdrawal by Subject|1|||
124832026|NCT00914810|449015770|FG000|Overall Study|Withdrawal by Subject|1|||
124832027|NCT00914810|449015771|FG001|Overall Study|Withdrawal by Subject|0|||
124832028|NCT00914810|449015770|FG000|Overall Study|Relocated out of state|1|||
124832029|NCT00914810|449015771|FG001|Overall Study|Relocated out of state|0|||
124832030|NCT00914810|449015770|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
124832031|NCT00914810|449015771|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
124832032|NCT01290666|449015780|FG000|Overall Study|Lost to Follow-up|11|||
124832033|NCT01290666|449015780|FG000|Overall Study|Withdrawal by Subject|23|||
124832034|NCT01290666|449015780|FG000|Overall Study|Early Termination of Study|4|||
124832035|NCT00507442|449015783|FG000|Overall Study|Adverse Event|8|||
124832036|NCT00507442|449015784|FG001|Overall Study|Adverse Event|11|||
124832037|NCT00507442|449015785|FG002|Overall Study|Adverse Event|4|||
124832038|NCT00507442|449015786|FG003|Overall Study|Adverse Event|1|||
124832039|NCT00507442|449015783|FG000|Overall Study|Protocol Violation|0|||
124832040|NCT00507442|449015784|FG001|Overall Study|Protocol Violation|1|||
124832041|NCT00507442|449015785|FG002|Overall Study|Protocol Violation|0|||
124832042|NCT00507442|449015786|FG003|Overall Study|Protocol Violation|0|||
124832043|NCT00507442|449015783|FG000|Overall Study|Lost to Follow-up|0|||
124832044|NCT00507442|449015784|FG001|Overall Study|Lost to Follow-up|0|||
124832045|NCT00507442|449015785|FG002|Overall Study|Lost to Follow-up|1|||
124832046|NCT00507442|449015786|FG003|Overall Study|Lost to Follow-up|0|||
124832047|NCT00507442|449015783|FG000|Overall Study|Physician Decision|0|||
124832048|NCT00507442|449015784|FG001|Overall Study|Physician Decision|2|||
124832049|NCT00507442|449015785|FG002|Overall Study|Physician Decision|4|||
124832050|NCT00507442|449015786|FG003|Overall Study|Physician Decision|1|||
124832051|NCT00507442|449015783|FG000|Overall Study|Progressive Disease|2|||
124832052|NCT00507442|449015784|FG001|Overall Study|Progressive Disease|4|||
124832053|NCT00507442|449015785|FG002|Overall Study|Progressive Disease|2|||
124832054|NCT00507442|449015786|FG003|Overall Study|Progressive Disease|0|||
124832055|NCT00507442|449015783|FG000|Overall Study|Withdrawal by Subject|4|||
124832056|NCT00507442|449015784|FG001|Overall Study|Withdrawal by Subject|4|||
124832057|NCT00507442|449015785|FG002|Overall Study|Withdrawal by Subject|2|||
124832058|NCT00507442|449015786|FG003|Overall Study|Withdrawal by Subject|1|||
124832059|NCT00507442|449015783|FG000|Overall Study|Other|2|||
124832060|NCT00507442|449015784|FG001|Overall Study|Other|5|||
124832061|NCT00507442|449015785|FG002|Overall Study|Other|2|||
124832062|NCT00507442|449015786|FG003|Overall Study|Other|2|||
124832063|NCT02410954|449015791|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
124832064|NCT02410954|449015792|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
124832065|NCT02410954|449015791|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
124832066|NCT02410954|449015792|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
124832067|NCT00271609|449015793|FG000|Overall Study|Adverse Event|11|||
124832068|NCT00271609|449015794|FG001|Overall Study|Adverse Event|3|||
124832069|NCT00271609|449015793|FG000|Overall Study|Withdrawal by Subject|2|||
124832070|NCT00271609|449015794|FG001|Overall Study|Withdrawal by Subject|0|||
124832071|NCT02188589|449015795|FG000|Overall Study|Withdrawal by Subject|5|||
124832072|NCT00975481|449015798|FG000|Second Intervention Period|Adverse Event|2|||
124832073|NCT00975481|449015799|FG001|Second Intervention Period|Adverse Event|1|||
124832074|NCT00975481|449015800|FG002|Second Intervention Period|Adverse Event|0|||
124832075|NCT00975481|449015801|FG003|Second Intervention Period|Adverse Event|0|||
124832076|NCT00975481|449015802|FG004|Second Intervention Period|Adverse Event|0|||
124832077|NCT00975481|449015803|FG005|Second Intervention Period|Adverse Event|0|||
124832078|NCT00975481|449015798|FG000|Second Intervention Period|Withdrawal by Subject|0|||
124832079|NCT00975481|449015799|FG001|Second Intervention Period|Withdrawal by Subject|0|||
124832080|NCT00975481|449015800|FG002|Second Intervention Period|Withdrawal by Subject|1|||
124832081|NCT00975481|449015801|FG003|Second Intervention Period|Withdrawal by Subject|0|||
124832082|NCT00975481|449015802|FG004|Second Intervention Period|Withdrawal by Subject|0|||
124832083|NCT00975481|449015803|FG005|Second Intervention Period|Withdrawal by Subject|0|||
124832084|NCT00975481|449015798|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
124832085|NCT00975481|449015799|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
124832086|NCT00975481|449015800|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
124832087|NCT00975481|449015801|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
124832088|NCT00975481|449015802|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
124832089|NCT00975481|449015803|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
124832090|NCT00975481|449015798|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
124832091|NCT00975481|449015799|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
124832092|NCT00975481|449015800|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
124832093|NCT00975481|449015801|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
124832094|NCT00975481|449015802|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
124832095|NCT00975481|449015803|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
124832096|NCT00643682|449015804|FG000|Overall Study|did not keep appointment|522|||
124832097|NCT00643682|449015805|FG001|Overall Study|did not keep appointment|509|||
124832098|NCT01826487|449015808|FG000|Overall Study|Adverse Event|1|||
124832099|NCT01826487|449015809|FG001|Overall Study|Adverse Event|1|||
124832100|NCT01826487|449015808|FG000|Overall Study|Lost to Follow-up|1|||
124832101|NCT01826487|449015809|FG001|Overall Study|Lost to Follow-up|0|||
124832102|NCT01826487|449015808|FG000|Overall Study|Withdrawal by Subject|1|||
124832103|NCT01826487|449015809|FG001|Overall Study|Withdrawal by Subject|3|||
124832104|NCT01826487|449015808|FG000|Overall Study|Protocol Violation|1|||
124832105|NCT01826487|449015809|FG001|Overall Study|Protocol Violation|1|||
124832106|NCT01408030|449015810|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
124832107|NCT01408030|449015811|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
124832108|NCT01408030|449015812|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
124832109|NCT01408030|449015813|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
124832110|NCT01408030|449015810|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
124832111|NCT01408030|449015811|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
124832112|NCT01408030|449015812|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
124832113|NCT01408030|449015813|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
124832114|NCT01408030|449015810|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
124832115|NCT01408030|449015811|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
124832116|NCT01408030|449015812|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
124832117|NCT01408030|449015813|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
124832118|NCT01408030|449015810|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
124832119|NCT01408030|449015811|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
124832120|NCT01408030|449015812|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
124832121|NCT01408030|449015813|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
124832122|NCT01408030|449015810|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
124832123|NCT01408030|449015811|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
124832124|NCT01408030|449015812|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
124832125|NCT01408030|449015813|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
124832126|NCT01408030|449015810|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
124832127|NCT01408030|449015811|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
124832128|NCT01408030|449015812|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
124832129|NCT01408030|449015813|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
124832130|NCT01408030|449015810|FG000|Observation Phase (Off Drug)|Other|1|||
124832131|NCT01408030|449015811|FG001|Observation Phase (Off Drug)|Other|1|||
124832132|NCT01408030|449015812|FG002|Observation Phase (Off Drug)|Other|1|||
124832133|NCT01408030|449015813|FG003|Observation Phase (Off Drug)|Other|1|||
124832134|NCT03755414|449015815|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
124832135|NCT03755414|449015816|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
124832136|NCT03755414|449015817|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
124832137|NCT03755414|449015815|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
124832138|NCT03755414|449015816|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
124832139|NCT03755414|449015817|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
124832140|NCT03755414|449015815|FG000|Overall Study|Non-compliance|0|||
124832141|NCT03755414|449015816|FG001|Overall Study|Non-compliance|1|||
124832142|NCT03755414|449015817|FG002|Overall Study|Non-compliance|0|||
124832143|NCT00741039|449015825|FG000|Overall Study|Patient non-compliance|2|||
124832144|NCT00741039|449015826|FG001|Overall Study|Patient non-compliance|0|||
124832145|NCT02081079|449015827|FG000|Overall Study|Lack of Efficacy|3|||
124832146|NCT02081079|449015828|FG001|Overall Study|Lack of Efficacy|2|||
124832147|NCT02081079|449015827|FG000|Overall Study|Lost to Follow-up|1|||
124832148|NCT02081079|449015828|FG001|Overall Study|Lost to Follow-up|0|||
124832149|NCT01712854|449015829|FG000|Overall Study|Physician Decision|1|||
124832150|NCT02225743|449015833|FG000|Overall Study|Withdrawal by Subject|18|||
124832151|NCT03886220|449015836|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
124832152|NCT03886220|449015837|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
124832153|NCT03886220|449015836|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
124832154|NCT03886220|449015837|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124832155|NCT03886220|449015836|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
124832156|NCT03886220|449015837|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
124832157|NCT00768300|449015838|FG000|Overall Study|Randomized but not treated|1|||
124832158|NCT00768300|449015839|FG001|Overall Study|Randomized but not treated|1|||
124832159|NCT00768300|449015838|FG000|Overall Study|Adverse Event|10|||
124832160|NCT00768300|449015839|FG001|Overall Study|Adverse Event|2|||
124832161|NCT00768300|449015838|FG000|Overall Study|Protocol Violation|6|||
124832162|NCT00768300|449015839|FG001|Overall Study|Protocol Violation|1|||
124832163|NCT00768300|449015838|FG000|Overall Study|Withdrawal by Subject|13|||
124832164|NCT00768300|449015839|FG001|Overall Study|Withdrawal by Subject|7|||
124832165|NCT00768300|449015838|FG000|Overall Study|Physician Decision|2|||
124832166|NCT00768300|449015839|FG001|Overall Study|Physician Decision|3|||
124832167|NCT00768300|449015838|FG000|Overall Study|Study discontinued by Sponsor|271|||
124832168|NCT00768300|449015839|FG001|Overall Study|Study discontinued by Sponsor|140|||
124832169|NCT00768300|449015838|FG000|Overall Study|Death|21|||
124832170|NCT00768300|449015839|FG001|Overall Study|Death|5|||
124832171|NCT00768300|449015838|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
124832172|NCT00768300|449015839|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
124832173|NCT00768300|449015838|FG000|Overall Study|Screen failure following randomization|1|||
124832174|NCT00768300|449015839|FG001|Overall Study|Screen failure following randomization|0|||
124832175|NCT00768300|449015838|FG000|Overall Study|Received lung transplant|1|||
124832176|NCT00768300|449015839|FG001|Overall Study|Received lung transplant|1|||
124832177|NCT00768300|449015838|FG000|Overall Study|Lost to Follow-up|0|||
124832178|NCT00768300|449015839|FG001|Overall Study|Lost to Follow-up|1|||
124832179|NCT00768300|449015838|FG000|Overall Study|Began prohibited concomitant medication|0|||
124832180|NCT00768300|449015839|FG001|Overall Study|Began prohibited concomitant medication|1|||
124832181|NCT00768300|449015838|FG000|Overall Study|Treated but never dosed with Study drug|1|||
124832182|NCT00768300|449015839|FG001|Overall Study|Treated but never dosed with Study drug|0|||
124832183|NCT00768300|449015838|FG000|Overall Study|Missing data|1|||
124832184|NCT00768300|449015839|FG001|Overall Study|Missing data|0|||
124832185|NCT02068222|449015846|FG000|Overall Study|Lost to Follow-up|1|||
124832186|NCT01120756|449015849|FG000|Overall Study|Withdrawal by Subject|1|||
124832187|NCT01120756|449015850|FG001|Overall Study|Withdrawal by Subject|1|||
124832188|NCT00698581|449015855|FG000|Overall Study|Lack of Efficacy|23|||
124832189|NCT00698581|449015856|FG001|Overall Study|Lack of Efficacy|11|||
124832190|NCT00698581|449015855|FG000|Overall Study|Withdrawal by Subject|6|||
124832191|NCT00698581|449015856|FG001|Overall Study|Withdrawal by Subject|0|||
124832192|NCT00698581|449015855|FG000|Overall Study|Other reason|9|||
124832193|NCT00698581|449015856|FG001|Overall Study|Other reason|1|||
124832194|NCT00698581|449015855|FG000|Overall Study|SAE, non-fatal|1|||
124832195|NCT00698581|449015856|FG001|Overall Study|SAE, non-fatal|0|||
124832196|NCT00698581|449015855|FG000|Overall Study|AE, non-serious non-fatal|4|||
124832197|NCT00698581|449015856|FG001|Overall Study|AE, non-serious non-fatal|0|||
124832198|NCT00698581|449015855|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
124832199|NCT00698581|449015856|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
124832200|NCT00698581|449015855|FG000|Overall Study|AE of unknown type|1|||
124832201|NCT00698581|449015856|FG001|Overall Study|AE of unknown type|0|||
124832202|NCT00449644|449015857|FG000|Overall Study|Adverse Event|0|||
124832203|NCT00449644|449015858|FG001|Overall Study|Adverse Event|0|||
124832204|NCT00449644|449015859|FG002|Overall Study|Adverse Event|3|||
124832205|NCT00449644|449015860|FG003|Overall Study|Adverse Event|5|||
124832206|NCT00449644|449015857|FG000|Overall Study|Death|1|||
124832207|NCT00449644|449015858|FG001|Overall Study|Death|0|||
124832208|NCT00449644|449015859|FG002|Overall Study|Death|6|||
124832209|NCT00449644|449015860|FG003|Overall Study|Death|1|||
124832210|NCT00449644|449015857|FG000|Overall Study|Lost to Follow-up|1|||
124832211|NCT00449644|449015858|FG001|Overall Study|Lost to Follow-up|1|||
124832212|NCT00449644|449015859|FG002|Overall Study|Lost to Follow-up|5|||
124832213|NCT00449644|449015860|FG003|Overall Study|Lost to Follow-up|3|||
124832214|NCT00449644|449015857|FG000|Overall Study|Pregnancy|0|||
124832215|NCT00449644|449015858|FG001|Overall Study|Pregnancy|0|||
124832216|NCT00449644|449015859|FG002|Overall Study|Pregnancy|3|||
124832217|NCT00449644|449015860|FG003|Overall Study|Pregnancy|2|||
124832218|NCT00449644|449015857|FG000|Overall Study|Protocol Violation|4|||
124832219|NCT00449644|449015858|FG001|Overall Study|Protocol Violation|4|||
124832220|NCT00449644|449015859|FG002|Overall Study|Protocol Violation|3|||
124832221|NCT00449644|449015860|FG003|Overall Study|Protocol Violation|7|||
124832222|NCT00449644|449015857|FG000|Overall Study|Withdrawal by Subject|3|||
124832223|NCT00449644|449015858|FG001|Overall Study|Withdrawal by Subject|4|||
124832224|NCT00449644|449015859|FG002|Overall Study|Withdrawal by Subject|6|||
124832225|NCT00449644|449015860|FG003|Overall Study|Withdrawal by Subject|7|||
124832226|NCT00449644|449015857|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
124832227|NCT00449644|449015858|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
124832228|NCT00449644|449015859|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
124832229|NCT00449644|449015860|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
124832230|NCT00449644|449015857|FG000|Overall Study|Other|1|||
124832231|NCT00449644|449015858|FG001|Overall Study|Other|4|||
124832232|NCT00449644|449015859|FG002|Overall Study|Other|1|||
124832233|NCT00449644|449015860|FG003|Overall Study|Other|0|||
124832234|NCT00449644|449015857|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
124832235|NCT00449644|449015858|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
124832236|NCT00449644|449015859|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
124832237|NCT00449644|449015860|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
124832238|NCT03642717|449015861|FG000|Overall Study|Lost to Follow-up|2|||
124832239|NCT03642717|449015861|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
124832240|NCT03642717|449015861|FG000|Overall Study|Taken study drug prior to contract date|3|||
124832241|NCT01559012|449015864|FG000|Overall Study|Withdrawal by Subject|0|||
124832242|NCT01559012|449015865|FG001|Overall Study|Withdrawal by Subject|1|||
124832243|NCT00946712|449015866|FG000|Overall Study|Adverse Event|118|||
124832244|NCT00946712|449015867|FG001|Overall Study|Adverse Event|124|||
124832245|NCT00946712|449015866|FG000|Overall Study|Disease progression|308|||
124832246|NCT00946712|449015867|FG001|Overall Study|Disease progression|404|||
124832247|NCT00946712|449015866|FG000|Overall Study|Death|21|||
124832248|NCT00946712|449015867|FG001|Overall Study|Death|22|||
124832249|NCT00946712|449015866|FG000|Overall Study|No treatment given|25|||
124832250|NCT00946712|449015867|FG001|Overall Study|No treatment given|29|||
124832251|NCT00946712|449015866|FG000|Overall Study|Other reasons|61|||
124832252|NCT00946712|449015867|FG001|Overall Study|Other reasons|73|||
124832253|NCT00946712|449015866|FG000|Overall Study|On Treatment|0|||
124832254|NCT00946712|449015867|FG001|Overall Study|On Treatment|4|||
124832255|NCT00946712|449015866|FG000|Overall Study|Ineligible|14|||
124832256|NCT00946712|449015867|FG001|Overall Study|Ineligible|6|||
124832257|NCT00302458|449015868|FG000|Overall Study|Lost to Follow-up|1|||
124832258|NCT00302458|449015868|FG000|Overall Study|Ineligible after screening|1|||
124832259|NCT00302458|449015868|FG000|Overall Study|Withdrawal by Subject|1|||
124832260|NCT02291055|449015871|FG000|Overall Study|Death|2|||
124832261|NCT02291055|449015872|FG001|Overall Study|Death|2|||
124832262|NCT02291055|449015873|FG002|Overall Study|Death|5|||
124832263|NCT02291055|449015874|FG003|Overall Study|Death|8|||
124832264|NCT02291055|449015875|FG004|Overall Study|Death|12|||
124832265|NCT02291055|449015871|FG000|Overall Study|Lost to Follow-up|0|||
124832266|NCT02291055|449015872|FG001|Overall Study|Lost to Follow-up|0|||
124832267|NCT02291055|449015873|FG002|Overall Study|Lost to Follow-up|0|||
124832268|NCT02291055|449015874|FG003|Overall Study|Lost to Follow-up|1|||
124832269|NCT02291055|449015875|FG004|Overall Study|Lost to Follow-up|2|||
124832270|NCT02291055|449015871|FG000|Overall Study|Withdrawal by Subject|3|||
124832271|NCT02291055|449015872|FG001|Overall Study|Withdrawal by Subject|1|||
124832272|NCT02291055|449015873|FG002|Overall Study|Withdrawal by Subject|1|||
124832273|NCT02291055|449015874|FG003|Overall Study|Withdrawal by Subject|5|||
124832274|NCT02291055|449015875|FG004|Overall Study|Withdrawal by Subject|10|||
124832275|NCT02291055|449015871|FG000|Overall Study|Progressive Disease|0|||
124832276|NCT02291055|449015872|FG001|Overall Study|Progressive Disease|0|||
124832277|NCT02291055|449015873|FG002|Overall Study|Progressive Disease|1|||
124832278|NCT02291055|449015874|FG003|Overall Study|Progressive Disease|4|||
124832279|NCT02291055|449015875|FG004|Overall Study|Progressive Disease|2|||
124832280|NCT02291055|449015871|FG000|Overall Study|Study Terminated by Sponsor|0|||
124832281|NCT02291055|449015872|FG001|Overall Study|Study Terminated by Sponsor|0|||
124832282|NCT02291055|449015873|FG002|Overall Study|Study Terminated by Sponsor|0|||
124832283|NCT02291055|449015874|FG003|Overall Study|Study Terminated by Sponsor|5|||
124832284|NCT02291055|449015875|FG004|Overall Study|Study Terminated by Sponsor|1|||
124832285|NCT02291055|449015871|FG000|Overall Study|Other|0|||
124832286|NCT02291055|449015872|FG001|Overall Study|Other|2|||
124832287|NCT02291055|449015873|FG002|Overall Study|Other|1|||
124832288|NCT02291055|449015874|FG003|Overall Study|Other|4|||
124832289|NCT02291055|449015875|FG004|Overall Study|Other|0|||
124832290|NCT00853723|449015876|FG000|Overall Study|Adverse Event|3|||
124832291|NCT00853723|449015877|FG001|Overall Study|Adverse Event|4|||
124832292|NCT00853723|449015878|FG002|Overall Study|Adverse Event|1|||
124832293|NCT00853723|449015876|FG000|Overall Study|Withdrawal by Subject|2|||
124832294|NCT00853723|449015877|FG001|Overall Study|Withdrawal by Subject|1|||
124832295|NCT00853723|449015878|FG002|Overall Study|Withdrawal by Subject|0|||
124832296|NCT00853723|449015876|FG000|Overall Study|Protocol Violation|1|||
124832297|NCT00853723|449015877|FG001|Overall Study|Protocol Violation|2|||
124832298|NCT00853723|449015878|FG002|Overall Study|Protocol Violation|1|||
124832299|NCT01531387|449015879|FG000|Overall Study|Early termination of study|11|||
124832300|NCT01531387|449015880|FG001|Overall Study|Early termination of study|11|||
124832301|NCT02642432|449015883|FG000|Overall Study|Adverse Event|2|||
124832302|NCT02642432|449015883|FG000|Overall Study|Withdrew Consent|1|||
125304508|NCT01736618|450741327|FG000|Overall Study|Study device explant|103|||
125304509|NCT01736618|450741327|FG000|Overall Study|Unable to complete implant|2|||
125304510|NCT00400569|450741332|FG000|Overall Study|Death|1|||
124832303|NCT02642432|449015883|FG000|Overall Study|Lost to Follow-up|2|||
124832304|NCT02642432|449015883|FG000|Overall Study|Other|3|||
125304511|NCT00620113|450741335|FG000|Overall Study|Adverse Event|3|||
124832305|NCT00733746|449015884|FG000|Overall Study|Ineligible|5|||
124832306|NCT03999892|449015885|FG000|Overall Study|Lost to Follow-up|1|||
124832307|NCT01848756|449015886|FG000|Overall Study|Adverse Event|1|||
124832308|NCT01848756|449015886|FG000|Overall Study|Withdrawal by Subject|1|||
124832309|NCT01848756|449015886|FG000|Overall Study|Enrolled in Error|1|||
124832310|NCT01894581|449015887|FG000|Overall Study|Withdrawal by Subject|2|||
124832311|NCT01894581|449015888|FG001|Overall Study|Withdrawal by Subject|3|||
124832312|NCT01894581|449015887|FG000|Overall Study|Screen Failure|3|||
124832313|NCT01894581|449015888|FG001|Overall Study|Screen Failure|4|||
124832314|NCT01252940|449015889|FG000|Main Study Phase|Randomized but not treated|4|||
124832315|NCT01252940|449015890|FG001|Main Study Phase|Randomized but not treated|2|||
124832316|NCT01252940|449015889|FG000|Main Study Phase|Adverse Event|3|||
124832317|NCT01252940|449015890|FG001|Main Study Phase|Adverse Event|1|||
124832318|NCT01252940|449015889|FG000|Main Study Phase|Lack of Efficacy|1|||
124832319|NCT01252940|449015890|FG001|Main Study Phase|Lack of Efficacy|0|||
124832320|NCT01252940|449015889|FG000|Main Study Phase|Lost to Follow-up|6|||
124832321|NCT01252940|449015890|FG001|Main Study Phase|Lost to Follow-up|1|||
124832322|NCT01252940|449015889|FG000|Main Study Phase|Physician Decision|1|||
124832323|NCT01252940|449015890|FG001|Main Study Phase|Physician Decision|0|||
124832324|NCT01252940|449015889|FG000|Main Study Phase|Protocol Violation|4|||
124832325|NCT01252940|449015890|FG001|Main Study Phase|Protocol Violation|2|||
124832326|NCT01252940|449015889|FG000|Main Study Phase|Withdrawal by Subject|6|||
124832327|NCT01252940|449015890|FG001|Main Study Phase|Withdrawal by Subject|5|||
124832328|NCT01252940|449015889|FG000|Main Study Phase|Subject Non-compliance|1|||
124832329|NCT01252940|449015890|FG001|Main Study Phase|Subject Non-compliance|1|||
124832330|NCT01252940|449015889|FG000|Extension Phase|Adverse Event|2|||
124832331|NCT01252940|449015890|FG001|Extension Phase|Adverse Event|1|||
124832332|NCT01252940|449015889|FG000|Extension Phase|Lack of Efficacy|1|||
124832333|NCT01252940|449015890|FG001|Extension Phase|Lack of Efficacy|0|||
124832334|NCT01252940|449015889|FG000|Extension Phase|Lost to Follow-up|5|||
124832335|NCT01252940|449015890|FG001|Extension Phase|Lost to Follow-up|0|||
124832336|NCT01252940|449015889|FG000|Extension Phase|Physician Decision|0|||
124832337|NCT01252940|449015890|FG001|Extension Phase|Physician Decision|1|||
124832338|NCT01252940|449015889|FG000|Extension Phase|Subject Non-compliance|1|||
124832339|NCT01252940|449015890|FG001|Extension Phase|Subject Non-compliance|0|||
124832340|NCT01252940|449015889|FG000|Extension Phase|Withdrawal by Subject|1|||
124832341|NCT01252940|449015890|FG001|Extension Phase|Withdrawal by Subject|1|||
124832342|NCT03759379|449017372|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
124832343|NCT03759379|449017373|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
124832344|NCT03759379|449017372|FG000|Treatment Period|Death|2|||
124832345|NCT03759379|449017373|FG001|Treatment Period|Death|3|||
124832346|NCT03759379|449017372|FG000|Treatment Period|Lost to Follow-up|1|||
124832347|NCT03759379|449017373|FG001|Treatment Period|Lost to Follow-up|0|||
124832348|NCT03759379|449017372|FG000|Treatment Period|Physician Decision|0|||
124832349|NCT03759379|449017373|FG001|Treatment Period|Physician Decision|1|||
124832350|NCT01254227|449017376|FG000|Overall Study|Withdrawal by Subject|6|||
124832351|NCT01254227|449017376|FG000|Overall Study|Lost to Follow-up|6|||
124832352|NCT01254227|449017376|FG000|Overall Study|Adverse Event|5|||
124832353|NCT01254227|449017376|FG000|Overall Study|Abnormal test procedure result|5|||
124832354|NCT01254227|449017376|FG000|Overall Study|Administrative problems|2|||
124832355|NCT01254227|449017376|FG000|Overall Study|Death|1|||
124832356|NCT01254227|449017376|FG000|Overall Study|Protocol deviation|1|||
124832357|NCT02535741|449017383|FG000|Overall Study|Adverse Event|3|||
124832358|NCT02535741|449017383|FG000|Overall Study|Withdrawal by Subject|9|||
124832359|NCT02535741|449017383|FG000|Overall Study|Lost to Follow-up|10|||
124832360|NCT02535741|449017383|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
124832361|NCT02535741|449017383|FG000|Overall Study|Missing data|6|||
124832362|NCT03873987|449017384|FG000|Overall Study|Adverse Event|1|||
124832363|NCT03873987|449017385|FG001|Overall Study|Adverse Event|0|||
124832364|NCT03873987|449017384|FG000|Overall Study|staff was unable to start a new IV line|1|||
124832365|NCT03873987|449017385|FG001|Overall Study|staff was unable to start a new IV line|0|||
124832366|NCT03873987|449017384|FG000|Overall Study|Lost to Follow-up|0|||
124832367|NCT03873987|449017385|FG001|Overall Study|Lost to Follow-up|1|||
124832368|NCT00798369|449017386|FG000|Overall Study|Subject withdrew consent|0|||
124832369|NCT00798369|449017387|FG001|Overall Study|Subject withdrew consent|0|||
124832370|NCT00798369|449017388|FG002|Overall Study|Subject withdrew consent|1|||
124832371|NCT00798369|449017389|FG003|Overall Study|Subject withdrew consent|1|||
124832372|NCT00798369|449017390|FG004|Overall Study|Subject withdrew consent|0|||
124832373|NCT00798369|449017391|FG005|Overall Study|Subject withdrew consent|2|||
124832374|NCT00798369|449017386|FG000|Overall Study|Lost to Follow-up|1|||
124832375|NCT00798369|449017387|FG001|Overall Study|Lost to Follow-up|1|||
124832376|NCT00798369|449017388|FG002|Overall Study|Lost to Follow-up|1|||
124832377|NCT00798369|449017389|FG003|Overall Study|Lost to Follow-up|0|||
124832378|NCT00798369|449017390|FG004|Overall Study|Lost to Follow-up|1|||
124832379|NCT00798369|449017391|FG005|Overall Study|Lost to Follow-up|0|||
124832380|NCT00798369|449017386|FG000|Overall Study|Adminstrative problems|0|||
124832381|NCT00798369|449017387|FG001|Overall Study|Adminstrative problems|0|||
124832382|NCT00798369|449017388|FG002|Overall Study|Adminstrative problems|0|||
124832383|NCT00798369|449017389|FG003|Overall Study|Adminstrative problems|0|||
124832384|NCT00798369|449017390|FG004|Overall Study|Adminstrative problems|0|||
124832385|NCT00798369|449017391|FG005|Overall Study|Adminstrative problems|1|||
124832386|NCT04475588|449017392|FG000|Overall Study|Adverse Event|2|||
124832387|NCT04475588|449017393|FG001|Overall Study|Adverse Event|0|||
124832388|NCT00588822|449017394|FG000|Overall Study|progression of disease|8|||
124832389|NCT02082210|449017396|FG000|Overall Study|Death|0|||
124832390|NCT02082210|449017397|FG001|Overall Study|Death|0|||
124832391|NCT02082210|449017398|FG002|Overall Study|Death|1|||
124832392|NCT02082210|449017399|FG003|Overall Study|Death|1|||
124832393|NCT02082210|449017400|FG004|Overall Study|Death|1|||
124832394|NCT02082210|449017401|FG005|Overall Study|Death|0|||
125304512|NCT00620113|450741336|FG001|Overall Study|Adverse Event|2|||
124832395|NCT02082210|449017396|FG000|Overall Study|Withdrawal by Subject|0|||
124832396|NCT02082210|449017397|FG001|Overall Study|Withdrawal by Subject|0|||
124832397|NCT02082210|449017398|FG002|Overall Study|Withdrawal by Subject|0|||
124832398|NCT02082210|449017399|FG003|Overall Study|Withdrawal by Subject|1|||
124832399|NCT02082210|449017400|FG004|Overall Study|Withdrawal by Subject|2|||
124832400|NCT02082210|449017401|FG005|Overall Study|Withdrawal by Subject|2|||
124832401|NCT02082210|449017396|FG000|Overall Study|Clinical Progression|0|||
124832402|NCT02082210|449017397|FG001|Overall Study|Clinical Progression|0|||
124832403|NCT02082210|449017398|FG002|Overall Study|Clinical Progression|0|||
124832404|NCT02082210|449017399|FG003|Overall Study|Clinical Progression|1|||
124832405|NCT02082210|449017400|FG004|Overall Study|Clinical Progression|0|||
124832406|NCT02082210|449017401|FG005|Overall Study|Clinical Progression|0|||
124832407|NCT02082210|449017396|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
124832408|NCT02082210|449017397|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
124832409|NCT02082210|449017398|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
124832410|NCT02082210|449017399|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
124832411|NCT02082210|449017400|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
124832412|NCT02082210|449017401|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
124832413|NCT02082210|449017396|FG000|Overall Study|Physician Decision|0|||
124832414|NCT02082210|449017397|FG001|Overall Study|Physician Decision|0|||
124832415|NCT02082210|449017398|FG002|Overall Study|Physician Decision|1|||
124832416|NCT02082210|449017399|FG003|Overall Study|Physician Decision|1|||
124832417|NCT02082210|449017400|FG004|Overall Study|Physician Decision|0|||
124832418|NCT02082210|449017401|FG005|Overall Study|Physician Decision|0|||
124832419|NCT02520011|449017402|FG000|Overall Study|Adverse Event|0|||
124832420|NCT02520011|449017403|FG001|Overall Study|Adverse Event|1|||
124832421|NCT02520011|449017404|FG002|Overall Study|Adverse Event|2|||
124832422|NCT02520011|449017402|FG000|Overall Study|Death|0|||
124832423|NCT02520011|449017403|FG001|Overall Study|Death|8|||
124832424|NCT02520011|449017404|FG002|Overall Study|Death|1|||
124832425|NCT02520011|449017402|FG000|Overall Study|Lack of Efficacy|4|||
124832426|NCT02520011|449017403|FG001|Overall Study|Lack of Efficacy|26|||
124832427|NCT02520011|449017404|FG002|Overall Study|Lack of Efficacy|4|||
124832428|NCT02520011|449017402|FG000|Overall Study|Physician Decision|0|||
124832429|NCT02520011|449017403|FG001|Overall Study|Physician Decision|2|||
124832430|NCT02520011|449017404|FG002|Overall Study|Physician Decision|0|||
124832431|NCT02520011|449017402|FG000|Overall Study|Withdrawal by Subject|1|||
124832432|NCT02520011|449017403|FG001|Overall Study|Withdrawal by Subject|3|||
124832433|NCT02520011|449017404|FG002|Overall Study|Withdrawal by Subject|0|||
124832434|NCT02520011|449017402|FG000|Overall Study|Protocol Deviation|0|||
124832435|NCT02520011|449017403|FG001|Overall Study|Protocol Deviation|1|||
124832436|NCT02520011|449017404|FG002|Overall Study|Protocol Deviation|0|||
124832437|NCT02520011|449017402|FG000|Overall Study|Patient went to hospice|0|||
124832438|NCT02520011|449017403|FG001|Overall Study|Patient went to hospice|1|||
124832439|NCT02520011|449017404|FG002|Overall Study|Patient went to hospice|0|||
124832440|NCT02520011|449017402|FG000|Overall Study|Progressive disease following response|0|||
124832441|NCT02520011|449017403|FG001|Overall Study|Progressive disease following response|4|||
124832442|NCT02520011|449017404|FG002|Overall Study|Progressive disease following response|2|||
124832443|NCT02436759|449017405|FG000|Overall Study|Adverse Event|3|||
124832444|NCT02436759|449017406|FG001|Overall Study|Adverse Event|0|||
124832445|NCT02436759|449017405|FG000|Overall Study|Protocol Violation|1|||
124832446|NCT02436759|449017406|FG001|Overall Study|Protocol Violation|0|||
124832447|NCT02436759|449017405|FG000|Overall Study|Withdrawal by Subject|0|||
124832448|NCT02436759|449017406|FG001|Overall Study|Withdrawal by Subject|1|||
124832449|NCT01727141|449017409|FG000|Overall Study|Physician Decision|0|||
124832450|NCT01727141|449017410|FG001|Overall Study|Physician Decision|1|||
124832451|NCT01727141|449017411|FG002|Overall Study|Physician Decision|0|||
124832452|NCT01727141|449017412|FG003|Overall Study|Physician Decision|2|||
124832453|NCT01727141|449017409|FG000|Overall Study|Lost to Follow-up|0|||
124832454|NCT01727141|449017410|FG001|Overall Study|Lost to Follow-up|2|||
124832455|NCT01727141|449017411|FG002|Overall Study|Lost to Follow-up|0|||
124832456|NCT01727141|449017412|FG003|Overall Study|Lost to Follow-up|0|||
124832457|NCT01727141|449017409|FG000|Overall Study|Death|0|||
124832458|NCT01727141|449017410|FG001|Overall Study|Death|1|||
124832459|NCT01727141|449017411|FG002|Overall Study|Death|1|||
124832460|NCT01727141|449017412|FG003|Overall Study|Death|1|||
124832461|NCT01727141|449017409|FG000|Overall Study|Protocol deviation|1|||
124832462|NCT01727141|449017410|FG001|Overall Study|Protocol deviation|1|||
124832463|NCT01727141|449017411|FG002|Overall Study|Protocol deviation|0|||
124832464|NCT01727141|449017412|FG003|Overall Study|Protocol deviation|1|||
124832465|NCT01727141|449017409|FG000|Overall Study|Withdrawal by Subject|4|||
124832466|NCT01727141|449017410|FG001|Overall Study|Withdrawal by Subject|4|||
124832467|NCT01727141|449017411|FG002|Overall Study|Withdrawal by Subject|2|||
124832468|NCT01727141|449017412|FG003|Overall Study|Withdrawal by Subject|11|||
124832469|NCT04014075|449017413|FG000|Overall Study|Progressive Disease|53|||
124832470|NCT04014075|449017413|FG000|Overall Study|Adverse Event|15|||
124832471|NCT04014075|449017413|FG000|Overall Study|Clinical Progression|4|||
124832472|NCT04014075|449017413|FG000|Overall Study|Death|2|||
124832473|NCT04014075|449017413|FG000|Overall Study|Withdrawal by Subject|2|||
124832474|NCT04014075|449017413|FG000|Overall Study|Miscellaneous|2|||
124832475|NCT04014075|449017413|FG000|Overall Study|Physician Decision|1|||
124832476|NCT03616912|449017417|FG000|Overall Study|Adverse Event|17|||
124832477|NCT03616912|449017418|FG001|Overall Study|Adverse Event|21|||
124832478|NCT03616912|449017419|FG002|Overall Study|Adverse Event|9|||
124832479|NCT03616912|449017420|FG003|Overall Study|Adverse Event|0|||
124832480|NCT03616912|449017421|FG004|Overall Study|Adverse Event|0|||
124832481|NCT03616912|449017422|FG005|Overall Study|Adverse Event|0|||
124832482|NCT03616912|449017417|FG000|Overall Study|Death|1|||
124832483|NCT03616912|449017418|FG001|Overall Study|Death|1|||
124832484|NCT03616912|449017419|FG002|Overall Study|Death|0|||
124832485|NCT03616912|449017420|FG003|Overall Study|Death|0|||
124832486|NCT03616912|449017421|FG004|Overall Study|Death|0|||
124832487|NCT03616912|449017422|FG005|Overall Study|Death|0|||
124832488|NCT03616912|449017417|FG000|Overall Study|Lack of Efficacy|13|||
124832489|NCT03616912|449017418|FG001|Overall Study|Lack of Efficacy|6|||
124832490|NCT03616912|449017419|FG002|Overall Study|Lack of Efficacy|8|||
124832491|NCT03616912|449017420|FG003|Overall Study|Lack of Efficacy|4|||
124832492|NCT03616912|449017421|FG004|Overall Study|Lack of Efficacy|5|||
124832493|NCT03616912|449017422|FG005|Overall Study|Lack of Efficacy|1|||
124832494|NCT03616912|449017417|FG000|Overall Study|Lost to Follow-up|1|||
124832495|NCT03616912|449017418|FG001|Overall Study|Lost to Follow-up|2|||
124832496|NCT03616912|449017419|FG002|Overall Study|Lost to Follow-up|3|||
124832497|NCT03616912|449017420|FG003|Overall Study|Lost to Follow-up|0|||
124832498|NCT03616912|449017421|FG004|Overall Study|Lost to Follow-up|0|||
124832499|NCT03616912|449017422|FG005|Overall Study|Lost to Follow-up|0|||
124832500|NCT03616912|449017417|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
124832501|NCT03616912|449017418|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
124832502|NCT03616912|449017419|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
124832503|NCT03616912|449017420|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
124832504|NCT03616912|449017421|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
124832505|NCT03616912|449017422|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
124832506|NCT03616912|449017417|FG000|Overall Study|Withdrawal by Subject|12|||
124832507|NCT03616912|449017418|FG001|Overall Study|Withdrawal by Subject|12|||
124832508|NCT03616912|449017419|FG002|Overall Study|Withdrawal by Subject|15|||
124832509|NCT03616912|449017420|FG003|Overall Study|Withdrawal by Subject|2|||
124832510|NCT03616912|449017421|FG004|Overall Study|Withdrawal by Subject|0|||
124832511|NCT03616912|449017422|FG005|Overall Study|Withdrawal by Subject|2|||
124832512|NCT03616912|449017417|FG000|Overall Study|Study Terminated by Sponsor|0|||
124832513|NCT03616912|449017418|FG001|Overall Study|Study Terminated by Sponsor|0|||
124832514|NCT03616912|449017419|FG002|Overall Study|Study Terminated by Sponsor|0|||
124832515|NCT03616912|449017420|FG003|Overall Study|Study Terminated by Sponsor|10|||
124832516|NCT03616912|449017421|FG004|Overall Study|Study Terminated by Sponsor|9|||
124832517|NCT03616912|449017422|FG005|Overall Study|Study Terminated by Sponsor|11|||
124832518|NCT03616912|449017417|FG000|Overall Study|Protocol Deviation|1|||
124832519|NCT03616912|449017418|FG001|Overall Study|Protocol Deviation|1|||
124832520|NCT03616912|449017419|FG002|Overall Study|Protocol Deviation|0|||
124832521|NCT03616912|449017420|FG003|Overall Study|Protocol Deviation|0|||
124832522|NCT03616912|449017421|FG004|Overall Study|Protocol Deviation|0|||
124832523|NCT03616912|449017422|FG005|Overall Study|Protocol Deviation|0|||
124832524|NCT03616912|449017417|FG000|Overall Study|Pregnancy|1|||
124832525|NCT03616912|449017418|FG001|Overall Study|Pregnancy|0|||
124832526|NCT03616912|449017419|FG002|Overall Study|Pregnancy|4|||
124832527|NCT03616912|449017420|FG003|Overall Study|Pregnancy|0|||
124832528|NCT03616912|449017421|FG004|Overall Study|Pregnancy|0|||
125304513|NCT00620113|450741337|FG002|Overall Study|Adverse Event|2|||
125304514|NCT00620113|450741338|FG003|Overall Study|Adverse Event|1|||
125304515|NCT00620113|450741335|FG000|Overall Study|Lack of Efficacy|2|||
125304516|NCT00620113|450741336|FG001|Overall Study|Lack of Efficacy|3|||
124832529|NCT03616912|449017422|FG005|Overall Study|Pregnancy|0|||
124832530|NCT03616912|449017417|FG000|Overall Study|Protocol Violation|1|||
124832531|NCT03616912|449017418|FG001|Overall Study|Protocol Violation|0|||
124832532|NCT03616912|449017419|FG002|Overall Study|Protocol Violation|2|||
124832533|NCT03616912|449017420|FG003|Overall Study|Protocol Violation|0|||
124832534|NCT03616912|449017421|FG004|Overall Study|Protocol Violation|0|||
124832535|NCT03616912|449017422|FG005|Overall Study|Protocol Violation|0|||
124832536|NCT03616912|449017417|FG000|Overall Study|Physician Decision|2|||
124832537|NCT03616912|449017418|FG001|Overall Study|Physician Decision|0|||
124832538|NCT03616912|449017419|FG002|Overall Study|Physician Decision|0|||
124832539|NCT03616912|449017420|FG003|Overall Study|Physician Decision|0|||
124832540|NCT03616912|449017421|FG004|Overall Study|Physician Decision|1|||
124832541|NCT03616912|449017422|FG005|Overall Study|Physician Decision|0|||
124832542|NCT03616912|449017417|FG000|Overall Study|Randomized But Never Treated|0|||
125304517|NCT00620113|450741337|FG002|Overall Study|Lack of Efficacy|0|||
124832543|NCT03616912|449017418|FG001|Overall Study|Randomized But Never Treated|2|||
124832544|NCT03616912|449017419|FG002|Overall Study|Randomized But Never Treated|0|||
124832545|NCT03616912|449017420|FG003|Overall Study|Randomized But Never Treated|0|||
124832546|NCT03616912|449017421|FG004|Overall Study|Randomized But Never Treated|0|||
125304518|NCT00620113|450741338|FG003|Overall Study|Lack of Efficacy|2|||
124832547|NCT03616912|449017422|FG005|Overall Study|Randomized But Never Treated|0|||
124832548|NCT02584504|449017423|FG000|Double-blind Treatment|Participant withdrew consent|0|||
124832549|NCT02584504|449017424|FG001|Double-blind Treatment|Participant withdrew consent|0|||
124832550|NCT02584504|449017425|FG002|Double-blind Treatment|Participant withdrew consent|1|||
124832551|NCT02584504|449017423|FG000|Double-blind Treatment|Adverse Event|0|||
124832552|NCT02584504|449017424|FG001|Double-blind Treatment|Adverse Event|1|||
124832553|NCT02584504|449017425|FG002|Double-blind Treatment|Adverse Event|0|||
124832554|NCT02584504|449017423|FG000|Double-blind Treatment|Family Matter|0|||
124832555|NCT02584504|449017424|FG001|Double-blind Treatment|Family Matter|1|||
124832556|NCT02584504|449017425|FG002|Double-blind Treatment|Family Matter|0|||
124832557|NCT02584504|449017423|FG000|Open-label Treatment|Participant withdrew consent|0|||
124832558|NCT02584504|449017424|FG001|Open-label Treatment|Participant withdrew consent|0|||
124832559|NCT02584504|449017425|FG002|Open-label Treatment|Participant withdrew consent|4|||
124832560|NCT02584504|449017423|FG000|Open-label Treatment|Adverse Event|2|||
124832561|NCT02584504|449017424|FG001|Open-label Treatment|Adverse Event|2|||
124832562|NCT02584504|449017425|FG002|Open-label Treatment|Adverse Event|3|||
124832563|NCT02584504|449017423|FG000|Open-label Treatment|Physician Decision|0|||
124832564|NCT02584504|449017424|FG001|Open-label Treatment|Physician Decision|1|||
124832565|NCT02584504|449017425|FG002|Open-label Treatment|Physician Decision|0|||
124832566|NCT02584504|449017423|FG000|Open-label Treatment|Entered but not treated|0|||
124832567|NCT02584504|449017424|FG001|Open-label Treatment|Entered but not treated|1|||
124832568|NCT02584504|449017425|FG002|Open-label Treatment|Entered but not treated|1|||
124832569|NCT03446040|449017430|FG000|Overall Study|Disease progression|3|||
124832570|NCT03446040|449017431|FG001|Overall Study|Disease progression|3|||
124832571|NCT03446040|449017432|FG002|Overall Study|Disease progression|3|||
124832572|NCT03446040|449017433|FG003|Overall Study|Disease progression|4|||
124832573|NCT03446040|449017434|FG004|Overall Study|Disease progression|4|||
124832574|NCT03446040|449017435|FG005|Overall Study|Disease progression|6|||
124832575|NCT03446040|449017436|FG006|Overall Study|Disease progression|3|||
124832576|NCT03446040|449017437|FG007|Overall Study|Disease progression|4|||
124832577|NCT03446040|449017438|FG008|Overall Study|Disease progression|2|||
124832578|NCT03446040|449017439|FG009|Overall Study|Disease progression|4|||
124832579|NCT03446040|449017440|FG010|Overall Study|Disease progression|9|||
124832580|NCT03446040|449017441|FG011|Overall Study|Disease progression|3|||
124832581|NCT03446040|449017442|FG012|Overall Study|Disease progression|7|||
124832582|NCT03446040|449017443|FG013|Overall Study|Disease progression|7|||
124832583|NCT03446040|449017430|FG000|Overall Study|Study drug toxicity|0|||
124832584|NCT03446040|449017431|FG001|Overall Study|Study drug toxicity|0|||
124832585|NCT03446040|449017432|FG002|Overall Study|Study drug toxicity|0|||
124832586|NCT03446040|449017433|FG003|Overall Study|Study drug toxicity|0|||
124832587|NCT03446040|449017434|FG004|Overall Study|Study drug toxicity|0|||
124832588|NCT03446040|449017435|FG005|Overall Study|Study drug toxicity|0|||
124832589|NCT03446040|449017436|FG006|Overall Study|Study drug toxicity|0|||
124832590|NCT03446040|449017437|FG007|Overall Study|Study drug toxicity|0|||
124832591|NCT03446040|449017438|FG008|Overall Study|Study drug toxicity|1|||
124832592|NCT03446040|449017439|FG009|Overall Study|Study drug toxicity|0|||
124832593|NCT03446040|449017440|FG010|Overall Study|Study drug toxicity|0|||
124832594|NCT03446040|449017441|FG011|Overall Study|Study drug toxicity|0|||
124832595|NCT03446040|449017442|FG012|Overall Study|Study drug toxicity|0|||
124832596|NCT03446040|449017443|FG013|Overall Study|Study drug toxicity|0|||
124832597|NCT03446040|449017430|FG000|Overall Study|Adverse Event|0|||
124832598|NCT03446040|449017431|FG001|Overall Study|Adverse Event|0|||
124832599|NCT03446040|449017432|FG002|Overall Study|Adverse Event|0|||
124832600|NCT03446040|449017433|FG003|Overall Study|Adverse Event|0|||
124832601|NCT03446040|449017434|FG004|Overall Study|Adverse Event|0|||
124832602|NCT03446040|449017435|FG005|Overall Study|Adverse Event|2|||
124832603|NCT03446040|449017436|FG006|Overall Study|Adverse Event|0|||
124832604|NCT03446040|449017437|FG007|Overall Study|Adverse Event|0|||
124832605|NCT03446040|449017438|FG008|Overall Study|Adverse Event|1|||
124832606|NCT03446040|449017439|FG009|Overall Study|Adverse Event|0|||
124832607|NCT03446040|449017440|FG010|Overall Study|Adverse Event|0|||
124832608|NCT03446040|449017441|FG011|Overall Study|Adverse Event|0|||
124832609|NCT03446040|449017442|FG012|Overall Study|Adverse Event|0|||
124832610|NCT03446040|449017443|FG013|Overall Study|Adverse Event|0|||
125304519|NCT00620113|450741335|FG000|Overall Study|Physician Decision|1|||
125304520|NCT00620113|450741336|FG001|Overall Study|Physician Decision|0|||
125304521|NCT00620113|450741337|FG002|Overall Study|Physician Decision|0|||
125304522|NCT00620113|450741338|FG003|Overall Study|Physician Decision|2|||
125304523|NCT00620113|450741335|FG000|Overall Study|Protocol Violation|2|||
125304524|NCT00620113|450741336|FG001|Overall Study|Protocol Violation|1|||
125304525|NCT00620113|450741337|FG002|Overall Study|Protocol Violation|0|||
125304526|NCT00620113|450741338|FG003|Overall Study|Protocol Violation|0|||
124832611|NCT03446040|449017430|FG000|Overall Study|Death|0|||
124832612|NCT03446040|449017431|FG001|Overall Study|Death|0|||
125304527|NCT00620113|450741335|FG000|Overall Study|Withdrawal by Subject|5|||
125304528|NCT00620113|450741336|FG001|Overall Study|Withdrawal by Subject|1|||
124832613|NCT03446040|449017432|FG002|Overall Study|Death|0|||
124832614|NCT03446040|449017433|FG003|Overall Study|Death|0|||
124832615|NCT03446040|449017434|FG004|Overall Study|Death|0|||
124832616|NCT03446040|449017435|FG005|Overall Study|Death|0|||
124832617|NCT03446040|449017436|FG006|Overall Study|Death|0|||
124832618|NCT03446040|449017437|FG007|Overall Study|Death|0|||
124832619|NCT03446040|449017438|FG008|Overall Study|Death|0|||
124832620|NCT03446040|449017439|FG009|Overall Study|Death|0|||
124832621|NCT03446040|449017440|FG010|Overall Study|Death|1|||
124832622|NCT03446040|449017441|FG011|Overall Study|Death|0|||
124832623|NCT03446040|449017442|FG012|Overall Study|Death|0|||
124832624|NCT03446040|449017443|FG013|Overall Study|Death|2|||
124832625|NCT03446040|449017430|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
124832626|NCT03446040|449017431|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
124832627|NCT03446040|449017432|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
124832628|NCT03446040|449017433|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
124832629|NCT03446040|449017434|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
124832630|NCT03446040|449017435|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
124832631|NCT03446040|449017436|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
124832632|NCT03446040|449017437|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
124832633|NCT03446040|449017438|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
124832634|NCT03446040|449017439|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
124832635|NCT03446040|449017440|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
124832636|NCT03446040|449017441|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
124832637|NCT03446040|449017442|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
124832638|NCT03446040|449017443|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
124832639|NCT03446040|449017430|FG000|Overall Study|Participant withdrew consent|0|||
124832640|NCT03446040|449017431|FG001|Overall Study|Participant withdrew consent|0|||
124832641|NCT03446040|449017432|FG002|Overall Study|Participant withdrew consent|0|||
124832642|NCT03446040|449017433|FG003|Overall Study|Participant withdrew consent|0|||
124832643|NCT03446040|449017434|FG004|Overall Study|Participant withdrew consent|0|||
124832644|NCT03446040|449017435|FG005|Overall Study|Participant withdrew consent|1|||
124832645|NCT03446040|449017436|FG006|Overall Study|Participant withdrew consent|0|||
124832646|NCT03446040|449017437|FG007|Overall Study|Participant withdrew consent|1|||
124832647|NCT03446040|449017438|FG008|Overall Study|Participant withdrew consent|0|||
124832648|NCT03446040|449017439|FG009|Overall Study|Participant withdrew consent|0|||
124832649|NCT03446040|449017440|FG010|Overall Study|Participant withdrew consent|0|||
124832650|NCT03446040|449017441|FG011|Overall Study|Participant withdrew consent|0|||
124832651|NCT03446040|449017442|FG012|Overall Study|Participant withdrew consent|0|||
124832652|NCT03446040|449017443|FG013|Overall Study|Participant withdrew consent|0|||
124832653|NCT03446040|449017430|FG000|Overall Study|Not reported|0|||
124832654|NCT03446040|449017431|FG001|Overall Study|Not reported|0|||
124832655|NCT03446040|449017432|FG002|Overall Study|Not reported|1|||
124832656|NCT03446040|449017433|FG003|Overall Study|Not reported|0|||
124832657|NCT03446040|449017434|FG004|Overall Study|Not reported|0|||
124832658|NCT03446040|449017435|FG005|Overall Study|Not reported|0|||
124832659|NCT03446040|449017436|FG006|Overall Study|Not reported|0|||
124832660|NCT03446040|449017437|FG007|Overall Study|Not reported|0|||
124832661|NCT03446040|449017438|FG008|Overall Study|Not reported|0|||
124832662|NCT03446040|449017439|FG009|Overall Study|Not reported|0|||
124832663|NCT03446040|449017440|FG010|Overall Study|Not reported|0|||
124832664|NCT03446040|449017441|FG011|Overall Study|Not reported|0|||
124832665|NCT03446040|449017442|FG012|Overall Study|Not reported|0|||
124832666|NCT03446040|449017443|FG013|Overall Study|Not reported|0|||
124832667|NCT01652664|449017444|FG000|Overall Study|Treatment Failure|5|||
124832668|NCT01652664|449017445|FG001|Overall Study|Treatment Failure|1|||
124832669|NCT01652664|449017444|FG000|Overall Study|Inadequate IOP control|1|||
124832670|NCT01652664|449017445|FG001|Overall Study|Inadequate IOP control|0|||
124832671|NCT03036098|449017448|FG000|Pre-Treatment|Other Reasons|1|||
124832672|NCT03036098|449017449|FG001|Pre-Treatment|Other Reasons|2|||
124832673|NCT03036098|449017450|FG002|Pre-Treatment|Other Reasons|0|||
125304529|NCT00620113|450741337|FG002|Overall Study|Withdrawal by Subject|3|||
125304530|NCT00620113|450741338|FG003|Overall Study|Withdrawal by Subject|5|||
125304531|NCT02461745|450741341|FG000|Overall Study|Lack of Efficacy|9|||
124832674|NCT03036098|449017451|FG003|Pre-Treatment|Other Reasons|5|||
124832675|NCT03036098|449017448|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
124832676|NCT03036098|449017449|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
124832677|NCT03036098|449017450|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
124832678|NCT03036098|449017451|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
124832679|NCT03036098|449017448|FG000|Pre-Treatment|Withdrawal by Subject|1|||
124832680|NCT03036098|449017449|FG001|Pre-Treatment|Withdrawal by Subject|14|||
124832681|NCT03036098|449017450|FG002|Pre-Treatment|Withdrawal by Subject|0|||
124832682|NCT03036098|449017451|FG003|Pre-Treatment|Withdrawal by Subject|5|||
124832683|NCT03036098|449017448|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
124832684|NCT03036098|449017449|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
124832685|NCT03036098|449017450|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
124832686|NCT03036098|449017451|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
124832687|NCT03036098|449017448|FG000|Treatment|Disease Progression|130|||
124832688|NCT03036098|449017449|FG001|Treatment|Disease Progression|77|||
124832689|NCT03036098|449017450|FG002|Treatment|Disease Progression|168|||
124832690|NCT03036098|449017451|FG003|Treatment|Disease Progression|50|||
124832691|NCT03036098|449017448|FG000|Treatment|Study Drug Toxicity|95|||
124832692|NCT03036098|449017449|FG001|Treatment|Study Drug Toxicity|45|||
124832693|NCT03036098|449017450|FG002|Treatment|Study Drug Toxicity|26|||
124832694|NCT03036098|449017451|FG003|Treatment|Study Drug Toxicity|22|||
124832695|NCT03036098|449017448|FG000|Treatment|Death|9|||
124832696|NCT03036098|449017449|FG001|Treatment|Death|3|||
124832697|NCT03036098|449017450|FG002|Treatment|Death|1|||
124832698|NCT03036098|449017451|FG003|Treatment|Death|2|||
124832699|NCT03036098|449017448|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
124832700|NCT03036098|449017449|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
124832701|NCT03036098|449017450|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
124832702|NCT03036098|449017451|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
124832703|NCT03036098|449017448|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
124832704|NCT03036098|449017449|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
124832705|NCT03036098|449017450|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
124832706|NCT03036098|449017451|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
124832707|NCT03036098|449017448|FG000|Treatment|Withdrawal by Subject|2|||
124832708|NCT03036098|449017449|FG001|Treatment|Withdrawal by Subject|9|||
124832709|NCT03036098|449017450|FG002|Treatment|Withdrawal by Subject|2|||
124832710|NCT03036098|449017451|FG003|Treatment|Withdrawal by Subject|4|||
124832711|NCT03036098|449017448|FG000|Treatment|Maximum Clinical Benefit|6|||
124832712|NCT03036098|449017449|FG001|Treatment|Maximum Clinical Benefit|1|||
124832713|NCT03036098|449017450|FG002|Treatment|Maximum Clinical Benefit|6|||
124832714|NCT03036098|449017451|FG003|Treatment|Maximum Clinical Benefit|10|||
124832715|NCT03036098|449017448|FG000|Treatment|Poor/Non Compliance|1|||
124832716|NCT03036098|449017449|FG001|Treatment|Poor/Non Compliance|2|||
124832717|NCT03036098|449017450|FG002|Treatment|Poor/Non Compliance|0|||
124832718|NCT03036098|449017451|FG003|Treatment|Poor/Non Compliance|1|||
124832719|NCT03036098|449017448|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
124832720|NCT03036098|449017449|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
124832721|NCT03036098|449017450|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
124832722|NCT03036098|449017451|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
124832723|NCT03036098|449017448|FG000|Treatment|Administrative Reason by Sponsor|1|||
124832724|NCT03036098|449017449|FG001|Treatment|Administrative Reason by Sponsor|0|||
124832725|NCT03036098|449017450|FG002|Treatment|Administrative Reason by Sponsor|2|||
124832726|NCT03036098|449017451|FG003|Treatment|Administrative Reason by Sponsor|1|||
124832727|NCT03036098|449017448|FG000|Treatment|Other Reasons|31|||
124832728|NCT03036098|449017449|FG001|Treatment|Other Reasons|5|||
124832729|NCT03036098|449017450|FG002|Treatment|Other Reasons|21|||
124832730|NCT03036098|449017451|FG003|Treatment|Other Reasons|8|||
124832731|NCT03036098|449017448|FG000|Treatment|Ongoing Treatment|0|||
124832732|NCT03036098|449017449|FG001|Treatment|Ongoing Treatment|0|||
124832733|NCT03036098|449017450|FG002|Treatment|Ongoing Treatment|23|||
124832734|NCT03036098|449017451|FG003|Treatment|Ongoing Treatment|0|||
124832735|NCT00464568|449017455|FG000|Overall Study|Adverse Event|2|||
124832736|NCT00885755|449017458|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
124832737|NCT00885755|449017459|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
124832738|NCT00885755|449017460|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
124832739|NCT00885755|449017458|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
124832740|NCT00885755|449017459|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
124832741|NCT00885755|449017460|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
124832742|NCT00885755|449017458|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
124832743|NCT00885755|449017459|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
124832744|NCT00885755|449017460|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
124832745|NCT00885755|449017458|FG000|Part I: Trastuzumab+Taxane|Death|0|||
124832746|NCT00885755|449017459|FG001|Part I: Trastuzumab+Taxane|Death|0|||
124832747|NCT00885755|449017460|FG002|Part I: Trastuzumab+Taxane|Death|1|||
124832748|NCT00885755|449017458|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
124832749|NCT00885755|449017459|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
124832750|NCT00885755|449017460|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
124832751|NCT04343521|449017461|FG000|Overall Study|Adverse Event|0|||
124832752|NCT04343521|449017462|FG001|Overall Study|Adverse Event|2|||
124832753|NCT04343521|449017461|FG000|Overall Study|Death|1|||
124832754|NCT04343521|449017462|FG001|Overall Study|Death|2|||
124832755|NCT04343521|449017461|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
124832756|NCT04343521|449017462|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
124832757|NCT04343521|449017461|FG000|Overall Study|Withdrawal by Subject|70|||
124832758|NCT04343521|449017462|FG001|Overall Study|Withdrawal by Subject|95|||
124832759|NCT04343521|449017461|FG000|Overall Study|Withdrawal by study team|6|||
124832760|NCT04343521|449017462|FG001|Overall Study|Withdrawal by study team|12|||
124832761|NCT00107198|449017463|FG000|Overall Study|Lack of Efficacy|28|||
124832762|NCT00107198|449017463|FG000|Overall Study|Lost to Follow-up|12|||
124832763|NCT00107198|449017463|FG000|Overall Study|Protocol Violation|1|||
124832764|NCT00107198|449017463|FG000|Overall Study|Withdrawal by Subject|6|||
124832765|NCT00107198|449017463|FG000|Overall Study|Ineligible|5|||
124832766|NCT00751348|449017464|FG000|Overall Study|Withdrawal by Subject|5|||
124832767|NCT00751348|449017465|FG001|Overall Study|Withdrawal by Subject|2|||
124832768|NCT00751348|449017464|FG000|Overall Study|Migration from study area|1|||
124832769|NCT00751348|449017465|FG001|Overall Study|Migration from study area|0|||
124832770|NCT04191382|449017466|FG000|Overall Study|Withdrawal by Subject|1|||
124832771|NCT04191382|449017467|FG001|Overall Study|Withdrawal by Subject|0|||
124832772|NCT04191382|449017468|FG002|Overall Study|Withdrawal by Subject|0|||
124832773|NCT05237206|449017469|FG000|Overall Study|screen failure-did not receive treatment|8|||
124832774|NCT05237206|449017469|FG000|Overall Study|did not receive treatment|3|||
124832775|NCT02867709|449017471|FG000|Treatment Period|Adverse Event|1|||
124832776|NCT02867709|449017472|FG001|Treatment Period|Adverse Event|1|||
124832777|NCT02867709|449017473|FG002|Treatment Period|Adverse Event|2|||
124832778|NCT02867709|449017471|FG000|Treatment Period|Withdrawal of Consent|7|||
124832779|NCT02867709|449017472|FG001|Treatment Period|Withdrawal of Consent|9|||
124832780|NCT02867709|449017473|FG002|Treatment Period|Withdrawal of Consent|8|||
124832781|NCT02867709|449017471|FG000|Treatment Period|Lost to Follow-up|17|||
124832782|NCT02867709|449017472|FG001|Treatment Period|Lost to Follow-up|20|||
124832783|NCT02867709|449017473|FG002|Treatment Period|Lost to Follow-up|20|||
124832784|NCT02867709|449017471|FG000|Treatment Period|Lack of Qualifying Event|42|||
124832785|NCT02867709|449017472|FG001|Treatment Period|Lack of Qualifying Event|55|||
124832786|NCT02867709|449017473|FG002|Treatment Period|Lack of Qualifying Event|42|||
124832787|NCT02867709|449017471|FG000|Treatment Period|Protocol Violation|3|||
124832788|NCT02867709|449017472|FG001|Treatment Period|Protocol Violation|2|||
124832789|NCT02867709|449017473|FG002|Treatment Period|Protocol Violation|3|||
124832790|NCT02867709|449017471|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
124832791|NCT02867709|449017472|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
124832792|NCT02867709|449017473|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
124832793|NCT02867709|449017471|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
124832794|NCT02867709|449017472|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
124832795|NCT02867709|449017473|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
124832796|NCT02867709|449017471|FG000|Safety Follow-up Period|Pregnancy|0|||
124832797|NCT02867709|449017472|FG001|Safety Follow-up Period|Pregnancy|1|||
124832798|NCT02867709|449017473|FG002|Safety Follow-up Period|Pregnancy|0|||
124832799|NCT02867709|449017471|FG000|Safety Follow-up Period|Protocol Violation|0|||
124832800|NCT02867709|449017472|FG001|Safety Follow-up Period|Protocol Violation|1|||
124832801|NCT02867709|449017473|FG002|Safety Follow-up Period|Protocol Violation|1|||
124832802|NCT02865915|449017477|FG000|Overall Study|Pregnancy|1|||
124832803|NCT02865915|449017478|FG001|Overall Study|Pregnancy|0|||
124832804|NCT02865915|449017477|FG000|Overall Study|Withdrawal by Subject|1|||
124832805|NCT02865915|449017478|FG001|Overall Study|Withdrawal by Subject|1|||
124832806|NCT02865915|449017477|FG000|Overall Study|Adverse Event|0|||
124832807|NCT02865915|449017478|FG001|Overall Study|Adverse Event|4|||
124832808|NCT02865915|449017477|FG000|Overall Study|Lost to Follow-up|0|||
124832809|NCT02865915|449017478|FG001|Overall Study|Lost to Follow-up|1|||
124832810|NCT02865915|449017477|FG000|Overall Study|Protocol Violation|0|||
124832811|NCT02865915|449017478|FG001|Overall Study|Protocol Violation|1|||
124832812|NCT02865915|449017477|FG000|Overall Study|Study terminated by sponsor|23|||
124832813|NCT02865915|449017478|FG001|Overall Study|Study terminated by sponsor|18|||
124832814|NCT02865915|449017477|FG000|Overall Study|Dosing group discontinued|0|||
124832815|NCT02865915|449017478|FG001|Overall Study|Dosing group discontinued|5|||
124832816|NCT00663052|449017479|FG000|Overall Study|Adverse Event|6|||
124832817|NCT00663052|449017480|FG001|Overall Study|Adverse Event|3|||
124832818|NCT00663052|449017479|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
124832819|NCT00663052|449017480|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
124832820|NCT00663052|449017479|FG000|Overall Study|Protocol Violation|1|||
124832821|NCT00663052|449017480|FG001|Overall Study|Protocol Violation|0|||
124832822|NCT00663052|449017479|FG000|Overall Study|Withdrawal by Subject|2|||
124832823|NCT00663052|449017480|FG001|Overall Study|Withdrawal by Subject|5|||
124832824|NCT00663052|449017479|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
124832825|NCT00663052|449017480|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
124832826|NCT00663052|449017479|FG000|Overall Study|Other|0|||
124832827|NCT00663052|449017480|FG001|Overall Study|Other|1|||
124832828|NCT05760300|449017481|FG000|Overall Study|Adverse Event|0|||
124832829|NCT05760300|449017482|FG001|Overall Study|Adverse Event|0|||
124832830|NCT05760300|449017483|FG002|Overall Study|Adverse Event|1|||
124832831|NCT05760300|449017484|FG003|Overall Study|Adverse Event|0|||
124832832|NCT05760300|449017481|FG000|Overall Study|Participant Decision|1|||
124832833|NCT05760300|449017482|FG001|Overall Study|Participant Decision|0|||
124832834|NCT05760300|449017483|FG002|Overall Study|Participant Decision|0|||
124832835|NCT05760300|449017484|FG003|Overall Study|Participant Decision|0|||
124832836|NCT04350788|449017502|FG000|Overall Study|Lost to Follow-up|6|||
124832837|NCT04350788|449017503|FG001|Overall Study|Lost to Follow-up|2|||
124832838|NCT04350788|449017502|FG000|Overall Study|Withdrawal by Subject|2|||
124832839|NCT04350788|449017503|FG001|Overall Study|Withdrawal by Subject|4|||
124832840|NCT04350788|449017502|FG000|Overall Study|Protocol Violation|4|||
124832841|NCT04350788|449017503|FG001|Overall Study|Protocol Violation|0|||
124832842|NCT03615105|449017504|FG000|Overall Study|Protocol Violation|1|||
124832843|NCT03615105|449017505|FG001|Overall Study|Protocol Violation|0|||
124832844|NCT03615105|449017506|FG002|Overall Study|Protocol Violation|0|||
124832845|NCT03615105|449017504|FG000|Overall Study|Death|0|||
124832846|NCT03615105|449017505|FG001|Overall Study|Death|2|||
124832847|NCT03615105|449017506|FG002|Overall Study|Death|0|||
124832848|NCT03313804|449017507|FG000|Treatment|Death|5|||
124832849|NCT03313804|449017507|FG000|Treatment|still on treatment|2|||
124832850|NCT03313804|449017507|FG000|Follow Up|still on follow up|3|||
125304532|NCT02461745|450741342|FG001|Overall Study|Lack of Efficacy|1|||
125304533|NCT02461745|450741341|FG000|Overall Study|Lost to Follow-up|2|||
125304534|NCT02461745|450741342|FG001|Overall Study|Lost to Follow-up|2|||
125304535|NCT02461745|450741341|FG000|Overall Study|Withdrawal by Subject|3|||
125304536|NCT02461745|450741342|FG001|Overall Study|Withdrawal by Subject|1|||
125304537|NCT00211887|450741345|FG000|Overall Study|Adverse Event|8|||
125304538|NCT00211887|450741346|FG001|Overall Study|Adverse Event|4|||
125304539|NCT00211887|450741347|FG002|Overall Study|Adverse Event|6|||
125304540|NCT00211887|450741345|FG000|Overall Study|Death|1|||
125304541|NCT00211887|450741346|FG001|Overall Study|Death|1|||
125304542|NCT00211887|450741347|FG002|Overall Study|Death|1|||
125304543|NCT00211887|450741345|FG000|Overall Study|Lost to Follow-up|28|||
125304544|NCT00211887|450741346|FG001|Overall Study|Lost to Follow-up|13|||
125304545|NCT00211887|450741347|FG002|Overall Study|Lost to Follow-up|9|||
125304546|NCT00211887|450741345|FG000|Overall Study|Non-medical reason|31|||
125304547|NCT00211887|450741346|FG001|Overall Study|Non-medical reason|14|||
125304548|NCT00211887|450741347|FG002|Overall Study|Non-medical reason|8|||
125304549|NCT00211887|450741345|FG000|Overall Study|Other medical reason|15|||
125304550|NCT00211887|450741346|FG001|Overall Study|Other medical reason|11|||
125304551|NCT00211887|450741347|FG002|Overall Study|Other medical reason|7|||
125304552|NCT00211887|450741345|FG000|Overall Study|Side effects|19|||
124832851|NCT04383743|449017508|FG000|Overall Study|Withdrawal by Subject|1|||
124832852|NCT04383743|449017508|FG000|Overall Study|Adverse Event|1|||
124832853|NCT04837131|449017509|FG000|Overall Study|Death|1|||
124832854|NCT04837131|449017509|FG000|Overall Study|Withdrawal by Subject|1|||
124832855|NCT04837131|449017509|FG000|Overall Study|Adverse Event|1|||
124832856|NCT04837131|449017509|FG000|Overall Study|Protocol Violation|1|||
124832857|NCT03482791|449017510|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
124832858|NCT03482791|449017511|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
124832859|NCT01239368|449019050|FG000|Overall Study|Principal investigator discretion|1|||
124832860|NCT01239368|449019051|FG001|Overall Study|Principal investigator discretion|0|||
124832861|NCT01239368|449019052|FG002|Overall Study|Principal investigator discretion|0|||
124832862|NCT01239368|449019053|FG003|Overall Study|Principal investigator discretion|0|||
124832863|NCT01239368|449019054|FG004|Overall Study|Principal investigator discretion|1|||
124832864|NCT01239368|449019055|FG005|Overall Study|Principal investigator discretion|2|||
124832865|NCT01239368|449019056|FG006|Overall Study|Principal investigator discretion|0|||
124832866|NCT01239368|449019057|FG007|Overall Study|Principal investigator discretion|0|||
124832867|NCT01239368|449019058|FG008|Overall Study|Principal investigator discretion|0|||
124832868|NCT01239368|449019059|FG009|Overall Study|Principal investigator discretion|1|||
124832869|NCT01239368|449019050|FG000|Overall Study|Disease progression on study|1|||
124832870|NCT01239368|449019051|FG001|Overall Study|Disease progression on study|1|||
124832871|NCT01239368|449019052|FG002|Overall Study|Disease progression on study|1|||
124832872|NCT01239368|449019053|FG003|Overall Study|Disease progression on study|1|||
124832873|NCT01239368|449019054|FG004|Overall Study|Disease progression on study|4|||
124832874|NCT01239368|449019055|FG005|Overall Study|Disease progression on study|2|||
124832875|NCT01239368|449019056|FG006|Overall Study|Disease progression on study|5|||
124832876|NCT01239368|449019057|FG007|Overall Study|Disease progression on study|0|||
124832877|NCT01239368|449019058|FG008|Overall Study|Disease progression on study|0|||
124832878|NCT01239368|449019059|FG009|Overall Study|Disease progression on study|2|||
124832879|NCT01239368|449019050|FG000|Overall Study|Refused further treatment|0|||
124832880|NCT01239368|449019051|FG001|Overall Study|Refused further treatment|0|||
124832881|NCT01239368|449019052|FG002|Overall Study|Refused further treatment|0|||
125304553|NCT00211887|450741346|FG001|Overall Study|Side effects|13|||
125304554|NCT00211887|450741347|FG002|Overall Study|Side effects|5|||
125304555|NCT00965419|450741351|FG000|Open Label Treatment for Responders|Adverse Event|33|||
125304556|NCT00965419|450741351|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
125304557|NCT00965419|450741351|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
125304558|NCT00965419|450741351|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
124832882|NCT01239368|449019053|FG003|Overall Study|Refused further treatment|0|||
124832883|NCT01239368|449019054|FG004|Overall Study|Refused further treatment|0|||
124832884|NCT01239368|449019055|FG005|Overall Study|Refused further treatment|0|||
124832885|NCT01239368|449019056|FG006|Overall Study|Refused further treatment|0|||
124832886|NCT01239368|449019057|FG007|Overall Study|Refused further treatment|0|||
124832887|NCT01239368|449019058|FG008|Overall Study|Refused further treatment|0|||
124832888|NCT01239368|449019059|FG009|Overall Study|Refused further treatment|1|||
124832889|NCT01239368|449019050|FG000|Overall Study|Death|0|||
124832890|NCT01239368|449019051|FG001|Overall Study|Death|0|||
124832891|NCT01239368|449019052|FG002|Overall Study|Death|0|||
124832892|NCT01239368|449019053|FG003|Overall Study|Death|0|||
124832893|NCT01239368|449019054|FG004|Overall Study|Death|0|||
124832894|NCT01239368|449019055|FG005|Overall Study|Death|0|||
124832895|NCT01239368|449019056|FG006|Overall Study|Death|1|||
124832896|NCT01239368|449019057|FG007|Overall Study|Death|0|||
124832897|NCT01239368|449019058|FG008|Overall Study|Death|0|||
124832898|NCT01239368|449019059|FG009|Overall Study|Death|0|||
124832899|NCT02967692|449019060|FG000|Overall Study|Progressive disease|3|||
124832900|NCT02967692|449019061|FG001|Overall Study|Progressive disease|15|||
124832901|NCT02967692|449019062|FG002|Overall Study|Progressive disease|114|||
124832902|NCT02967692|449019063|FG003|Overall Study|Progressive disease|151|||
124832903|NCT02967692|449019060|FG000|Overall Study|Subject/guardian decision|1|||
124832904|NCT02967692|449019061|FG001|Overall Study|Subject/guardian decision|1|||
124832905|NCT02967692|449019062|FG002|Overall Study|Subject/guardian decision|14|||
124832906|NCT02967692|449019063|FG003|Overall Study|Subject/guardian decision|22|||
124832907|NCT02967692|449019060|FG000|Overall Study|Death|0|||
124832908|NCT02967692|449019061|FG001|Overall Study|Death|1|||
124832909|NCT02967692|449019062|FG002|Overall Study|Death|13|||
124832910|NCT02967692|449019063|FG003|Overall Study|Death|13|||
124832911|NCT02967692|449019060|FG000|Overall Study|Protocol deviation|1|||
124832912|NCT02967692|449019061|FG001|Overall Study|Protocol deviation|0|||
124832913|NCT02967692|449019062|FG002|Overall Study|Protocol deviation|1|||
124832914|NCT02967692|449019063|FG003|Overall Study|Protocol deviation|1|||
124832915|NCT02967692|449019060|FG000|Overall Study|Lost to Follow-up|0|||
124832916|NCT02967692|449019061|FG001|Overall Study|Lost to Follow-up|0|||
124832917|NCT02967692|449019062|FG002|Overall Study|Lost to Follow-up|1|||
124832918|NCT02967692|449019063|FG003|Overall Study|Lost to Follow-up|0|||
124832919|NCT02967692|449019060|FG000|Overall Study|Physician Decision|0|||
124832920|NCT02967692|449019061|FG001|Overall Study|Physician Decision|0|||
124832921|NCT02967692|449019062|FG002|Overall Study|Physician Decision|22|||
124832922|NCT02967692|449019063|FG003|Overall Study|Physician Decision|13|||
124832923|NCT02967692|449019060|FG000|Overall Study|Adverse Event|2|||
124832924|NCT02967692|449019061|FG001|Overall Study|Adverse Event|9|||
124832925|NCT02967692|449019062|FG002|Overall Study|Adverse Event|60|||
124832926|NCT02967692|449019063|FG003|Overall Study|Adverse Event|28|||
124832927|NCT02967692|449019060|FG000|Overall Study|Study terminated by sponsor|2|||
124832928|NCT02967692|449019061|FG001|Overall Study|Study terminated by sponsor|1|||
124832929|NCT02967692|449019062|FG002|Overall Study|Study terminated by sponsor|42|||
124832930|NCT02967692|449019063|FG003|Overall Study|Study terminated by sponsor|37|||
124832931|NCT01541969|449019068|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
124832932|NCT01541969|449019069|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
124832933|NCT01541969|449019068|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
124832934|NCT01541969|449019069|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
124832935|NCT01541969|449019068|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
124832936|NCT01541969|449019069|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
124832937|NCT01541969|449019068|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
124832938|NCT01541969|449019069|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
124832939|NCT01541969|449019068|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
124832940|NCT01541969|449019069|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
124832941|NCT01541969|449019068|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
124832942|NCT01541969|449019069|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
124832943|NCT01541969|449019068|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
125304559|NCT00965419|450741351|FG000|Open Label Treatment for Responders|Physician Decision|6|||
125304560|NCT00965419|450741351|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
125304561|NCT00965419|450741351|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
125304562|NCT00965419|450741351|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
125304563|NCT00965419|450741351|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
125304564|NCT00965419|450741351|FG000|Follow-up Phase|Adverse Event|9|||
125304565|NCT00965419|450741351|FG000|Follow-up Phase|Protocol Violation|4|||
125304566|NCT00965419|450741351|FG000|Follow-up Phase|Withdrawal by Subject|8|||
124832944|NCT01541969|449019069|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
124832945|NCT01541969|449019068|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
125304567|NCT00965419|450741351|FG000|Follow-up Phase|Physician Decision|4|||
124832946|NCT01541969|449019069|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
124832947|NCT01541969|449019068|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
124832948|NCT01541969|449019069|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
124832949|NCT01541969|449019068|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
124832950|NCT01541969|449019069|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
124832951|NCT01614990|449019070|FG000|Overall Study|Protocol Violation|1|||
124832952|NCT01614990|449019071|FG001|Overall Study|Protocol Violation|1|||
124832953|NCT01012622|449019072|FG000|Overall Study|Withdrawal by Subject|6|||
124832954|NCT01012622|449019072|FG000|Overall Study|Lost to Follow-up|5|||
124832955|NCT01012622|449019072|FG000|Overall Study|Adverse Event|7|||
124832956|NCT01012622|449019072|FG000|Overall Study|non-compliance with the drug|9|||
124832957|NCT01012622|449019072|FG000|Overall Study|Other|1|||
124832958|NCT01012622|449019072|FG000|Overall Study|screening failure|1|||
124832959|NCT01012622|449019072|FG000|Overall Study|withdrawal of consent by a parent|2|||
124832960|NCT04762680|449019073|FG000|Phase 2|Adverse Event|0|||
124832961|NCT04762680|449019074|FG001|Phase 2|Adverse Event|1|||
124832962|NCT04762680|449019075|FG002|Phase 2|Adverse Event|0|||
124832963|NCT04762680|449019076|FG003|Phase 2|Adverse Event|0|||
124832964|NCT04762680|449019077|FG004|Phase 2|Adverse Event|0|||
124832965|NCT04762680|449019078|FG005|Phase 2|Adverse Event|0|||
124832966|NCT04762680|449019079|FG006|Phase 2|Adverse Event|0|||
124832967|NCT04762680|449019080|FG007|Phase 2|Adverse Event|0|||
124832968|NCT04762680|449019081|FG008|Phase 2|Adverse Event|0|||
124832969|NCT04762680|449019082|FG009|Phase 2|Adverse Event|0|||
124832970|NCT04762680|449019083|FG010|Phase 2|Adverse Event|0|||
124832971|NCT04762680|449019084|FG011|Phase 2|Adverse Event|0|||
124832972|NCT04762680|449019085|FG012|Phase 2|Adverse Event|0|||
124832973|NCT04762680|449019086|FG013|Phase 2|Adverse Event|0|||
124832974|NCT04762680|449019087|FG014|Phase 2|Adverse Event|0|||
124832975|NCT04762680|449019088|FG015|Phase 2|Adverse Event|0|||
124832976|NCT04762680|449019089|FG016|Phase 2|Adverse Event|0|||
124832977|NCT04762680|449019090|FG017|Phase 2|Adverse Event|0|||
124832978|NCT04762680|449019091|FG018|Phase 2|Adverse Event|0|||
124832979|NCT04762680|449019092|FG019|Phase 2|Adverse Event|0|||
124832980|NCT04762680|449019093|FG020|Phase 2|Adverse Event|0|||
124832981|NCT04762680|449019094|FG021|Phase 2|Adverse Event|0|||
124832982|NCT04762680|449019073|FG000|Phase 2|Protocol Violation|5|||
124832983|NCT04762680|449019074|FG001|Phase 2|Protocol Violation|5|||
124832984|NCT04762680|449019075|FG002|Phase 2|Protocol Violation|1|||
124832985|NCT04762680|449019076|FG003|Phase 2|Protocol Violation|0|||
124832986|NCT04762680|449019077|FG004|Phase 2|Protocol Violation|0|||
124832987|NCT04762680|449019078|FG005|Phase 2|Protocol Violation|0|||
124832988|NCT04762680|449019079|FG006|Phase 2|Protocol Violation|0|||
124832989|NCT04762680|449019080|FG007|Phase 2|Protocol Violation|0|||
124832990|NCT04762680|449019081|FG008|Phase 2|Protocol Violation|0|||
124832991|NCT04762680|449019082|FG009|Phase 2|Protocol Violation|0|||
124832992|NCT04762680|449019083|FG010|Phase 2|Protocol Violation|0|||
124832993|NCT04762680|449019084|FG011|Phase 2|Protocol Violation|0|||
124832994|NCT04762680|449019085|FG012|Phase 2|Protocol Violation|0|||
124832995|NCT04762680|449019086|FG013|Phase 2|Protocol Violation|0|||
124832996|NCT04762680|449019087|FG014|Phase 2|Protocol Violation|0|||
124832997|NCT04762680|449019088|FG015|Phase 2|Protocol Violation|0|||
124832998|NCT04762680|449019089|FG016|Phase 2|Protocol Violation|0|||
124832999|NCT04762680|449019090|FG017|Phase 2|Protocol Violation|0|||
124833000|NCT04762680|449019091|FG018|Phase 2|Protocol Violation|0|||
124833001|NCT04762680|449019092|FG019|Phase 2|Protocol Violation|0|||
124833002|NCT04762680|449019093|FG020|Phase 2|Protocol Violation|0|||
124833003|NCT04762680|449019094|FG021|Phase 2|Protocol Violation|0|||
124833004|NCT04762680|449019073|FG000|Phase 2|Withdrawal by Subject|23|||
124833005|NCT04762680|449019074|FG001|Phase 2|Withdrawal by Subject|21|||
124833006|NCT04762680|449019075|FG002|Phase 2|Withdrawal by Subject|28|||
124833007|NCT04762680|449019076|FG003|Phase 2|Withdrawal by Subject|0|||
124833008|NCT04762680|449019077|FG004|Phase 2|Withdrawal by Subject|0|||
124833009|NCT04762680|449019078|FG005|Phase 2|Withdrawal by Subject|0|||
124833010|NCT04762680|449019079|FG006|Phase 2|Withdrawal by Subject|0|||
124833011|NCT04762680|449019080|FG007|Phase 2|Withdrawal by Subject|0|||
124833012|NCT04762680|449019081|FG008|Phase 2|Withdrawal by Subject|0|||
124833013|NCT04762680|449019082|FG009|Phase 2|Withdrawal by Subject|0|||
124833014|NCT04762680|449019083|FG010|Phase 2|Withdrawal by Subject|0|||
124833015|NCT04762680|449019084|FG011|Phase 2|Withdrawal by Subject|0|||
124833016|NCT04762680|449019085|FG012|Phase 2|Withdrawal by Subject|0|||
124833017|NCT04762680|449019086|FG013|Phase 2|Withdrawal by Subject|0|||
124833018|NCT04762680|449019087|FG014|Phase 2|Withdrawal by Subject|0|||
124833019|NCT04762680|449019088|FG015|Phase 2|Withdrawal by Subject|0|||
124833020|NCT04762680|449019089|FG016|Phase 2|Withdrawal by Subject|0|||
124833021|NCT04762680|449019090|FG017|Phase 2|Withdrawal by Subject|0|||
124833022|NCT04762680|449019091|FG018|Phase 2|Withdrawal by Subject|0|||
124833023|NCT04762680|449019092|FG019|Phase 2|Withdrawal by Subject|0|||
124833024|NCT04762680|449019093|FG020|Phase 2|Withdrawal by Subject|0|||
124833025|NCT04762680|449019094|FG021|Phase 2|Withdrawal by Subject|0|||
124833026|NCT04762680|449019073|FG000|Phase 2|Lost to Follow-up|14|||
124833027|NCT04762680|449019074|FG001|Phase 2|Lost to Follow-up|8|||
124833028|NCT04762680|449019075|FG002|Phase 2|Lost to Follow-up|9|||
124833029|NCT04762680|449019076|FG003|Phase 2|Lost to Follow-up|0|||
124833030|NCT04762680|449019077|FG004|Phase 2|Lost to Follow-up|0|||
124833031|NCT04762680|449019078|FG005|Phase 2|Lost to Follow-up|0|||
124833032|NCT04762680|449019079|FG006|Phase 2|Lost to Follow-up|0|||
124833033|NCT04762680|449019080|FG007|Phase 2|Lost to Follow-up|0|||
124833034|NCT04762680|449019081|FG008|Phase 2|Lost to Follow-up|0|||
124833035|NCT04762680|449019082|FG009|Phase 2|Lost to Follow-up|0|||
124833036|NCT04762680|449019083|FG010|Phase 2|Lost to Follow-up|0|||
124833037|NCT04762680|449019084|FG011|Phase 2|Lost to Follow-up|0|||
124833038|NCT04762680|449019085|FG012|Phase 2|Lost to Follow-up|0|||
124833039|NCT04762680|449019086|FG013|Phase 2|Lost to Follow-up|0|||
124833040|NCT04762680|449019087|FG014|Phase 2|Lost to Follow-up|0|||
124833041|NCT04762680|449019088|FG015|Phase 2|Lost to Follow-up|0|||
124833042|NCT04762680|449019089|FG016|Phase 2|Lost to Follow-up|0|||
124833043|NCT04762680|449019090|FG017|Phase 2|Lost to Follow-up|0|||
124833044|NCT04762680|449019091|FG018|Phase 2|Lost to Follow-up|0|||
124833045|NCT04762680|449019092|FG019|Phase 2|Lost to Follow-up|0|||
124833046|NCT04762680|449019093|FG020|Phase 2|Lost to Follow-up|0|||
124833047|NCT04762680|449019094|FG021|Phase 2|Lost to Follow-up|0|||
124833048|NCT04762680|449019073|FG000|Phase 3|Adverse Event|0|||
124833049|NCT04762680|449019074|FG001|Phase 3|Adverse Event|0|||
124833050|NCT04762680|449019075|FG002|Phase 3|Adverse Event|0|||
124833051|NCT04762680|449019076|FG003|Phase 3|Adverse Event|1|||
124833052|NCT04762680|449019077|FG004|Phase 3|Adverse Event|0|||
124833053|NCT04762680|449019078|FG005|Phase 3|Adverse Event|0|||
124833054|NCT04762680|449019079|FG006|Phase 3|Adverse Event|0|||
124833055|NCT04762680|449019080|FG007|Phase 3|Adverse Event|0|||
124833056|NCT04762680|449019081|FG008|Phase 3|Adverse Event|0|||
124833057|NCT04762680|449019082|FG009|Phase 3|Adverse Event|0|||
124833058|NCT04762680|449019083|FG010|Phase 3|Adverse Event|0|||
124833059|NCT04762680|449019084|FG011|Phase 3|Adverse Event|0|||
124833060|NCT04762680|449019085|FG012|Phase 3|Adverse Event|0|||
124833061|NCT04762680|449019086|FG013|Phase 3|Adverse Event|0|||
124833062|NCT04762680|449019087|FG014|Phase 3|Adverse Event|0|||
124833063|NCT04762680|449019088|FG015|Phase 3|Adverse Event|0|||
124833064|NCT04762680|449019089|FG016|Phase 3|Adverse Event|0|||
124833065|NCT04762680|449019090|FG017|Phase 3|Adverse Event|3|||
124833066|NCT04762680|449019091|FG018|Phase 3|Adverse Event|0|||
124833067|NCT04762680|449019092|FG019|Phase 3|Adverse Event|0|||
124833068|NCT04762680|449019093|FG020|Phase 3|Adverse Event|0|||
124833069|NCT04762680|449019094|FG021|Phase 3|Adverse Event|0|||
124833070|NCT04762680|449019073|FG000|Phase 3|Protocol Violation|0|||
124833071|NCT04762680|449019074|FG001|Phase 3|Protocol Violation|0|||
124833072|NCT04762680|449019075|FG002|Phase 3|Protocol Violation|0|||
124833073|NCT04762680|449019076|FG003|Phase 3|Protocol Violation|4|||
124833074|NCT04762680|449019077|FG004|Phase 3|Protocol Violation|1|||
124833075|NCT04762680|449019078|FG005|Phase 3|Protocol Violation|5|||
124833076|NCT04762680|449019079|FG006|Phase 3|Protocol Violation|1|||
124833077|NCT04762680|449019080|FG007|Phase 3|Protocol Violation|0|||
124833078|NCT04762680|449019081|FG008|Phase 3|Protocol Violation|0|||
124833079|NCT04762680|449019082|FG009|Phase 3|Protocol Violation|0|||
124833080|NCT04762680|449019083|FG010|Phase 3|Protocol Violation|0|||
124833081|NCT04762680|449019084|FG011|Phase 3|Protocol Violation|2|||
124833082|NCT04762680|449019085|FG012|Phase 3|Protocol Violation|3|||
124833083|NCT04762680|449019086|FG013|Phase 3|Protocol Violation|0|||
124833084|NCT04762680|449019087|FG014|Phase 3|Protocol Violation|0|||
124833085|NCT04762680|449019088|FG015|Phase 3|Protocol Violation|1|||
124833086|NCT04762680|449019089|FG016|Phase 3|Protocol Violation|0|||
124833087|NCT04762680|449019090|FG017|Phase 3|Protocol Violation|10|||
124833088|NCT04762680|449019091|FG018|Phase 3|Protocol Violation|0|||
124833089|NCT04762680|449019092|FG019|Phase 3|Protocol Violation|0|||
124833090|NCT04762680|449019093|FG020|Phase 3|Protocol Violation|0|||
124833091|NCT04762680|449019094|FG021|Phase 3|Protocol Violation|0|||
124833092|NCT04762680|449019073|FG000|Phase 3|Withdrawal by Subject|0|||
124833093|NCT04762680|449019074|FG001|Phase 3|Withdrawal by Subject|0|||
124833094|NCT04762680|449019075|FG002|Phase 3|Withdrawal by Subject|0|||
124833095|NCT04762680|449019076|FG003|Phase 3|Withdrawal by Subject|13|||
124833096|NCT04762680|449019077|FG004|Phase 3|Withdrawal by Subject|17|||
124833097|NCT04762680|449019078|FG005|Phase 3|Withdrawal by Subject|12|||
124833098|NCT04762680|449019079|FG006|Phase 3|Withdrawal by Subject|8|||
124833099|NCT04762680|449019080|FG007|Phase 3|Withdrawal by Subject|3|||
124833100|NCT04762680|449019081|FG008|Phase 3|Withdrawal by Subject|2|||
124833101|NCT04762680|449019082|FG009|Phase 3|Withdrawal by Subject|4|||
124833102|NCT04762680|449019083|FG010|Phase 3|Withdrawal by Subject|3|||
124833103|NCT04762680|449019084|FG011|Phase 3|Withdrawal by Subject|1|||
124833104|NCT04762680|449019085|FG012|Phase 3|Withdrawal by Subject|3|||
124833105|NCT04762680|449019086|FG013|Phase 3|Withdrawal by Subject|2|||
124833106|NCT04762680|449019087|FG014|Phase 3|Withdrawal by Subject|1|||
124833107|NCT04762680|449019088|FG015|Phase 3|Withdrawal by Subject|4|||
124833108|NCT04762680|449019089|FG016|Phase 3|Withdrawal by Subject|6|||
124833109|NCT04762680|449019090|FG017|Phase 3|Withdrawal by Subject|32|||
124833110|NCT04762680|449019091|FG018|Phase 3|Withdrawal by Subject|0|||
124833111|NCT04762680|449019092|FG019|Phase 3|Withdrawal by Subject|0|||
124833112|NCT04762680|449019093|FG020|Phase 3|Withdrawal by Subject|0|||
124833113|NCT04762680|449019094|FG021|Phase 3|Withdrawal by Subject|0|||
124833114|NCT04762680|449019073|FG000|Phase 3|Lost to Follow-up|0|||
124833115|NCT04762680|449019074|FG001|Phase 3|Lost to Follow-up|0|||
124833116|NCT04762680|449019075|FG002|Phase 3|Lost to Follow-up|0|||
124833117|NCT04762680|449019076|FG003|Phase 3|Lost to Follow-up|9|||
124833118|NCT04762680|449019077|FG004|Phase 3|Lost to Follow-up|22|||
124833119|NCT04762680|449019078|FG005|Phase 3|Lost to Follow-up|24|||
124833120|NCT04762680|449019079|FG006|Phase 3|Lost to Follow-up|2|||
124833121|NCT04762680|449019080|FG007|Phase 3|Lost to Follow-up|4|||
124833122|NCT04762680|449019081|FG008|Phase 3|Lost to Follow-up|6|||
124833123|NCT04762680|449019082|FG009|Phase 3|Lost to Follow-up|4|||
124833124|NCT04762680|449019083|FG010|Phase 3|Lost to Follow-up|3|||
124833125|NCT04762680|449019084|FG011|Phase 3|Lost to Follow-up|0|||
124833126|NCT04762680|449019085|FG012|Phase 3|Lost to Follow-up|5|||
124833127|NCT04762680|449019086|FG013|Phase 3|Lost to Follow-up|4|||
124833128|NCT04762680|449019087|FG014|Phase 3|Lost to Follow-up|6|||
124833129|NCT04762680|449019088|FG015|Phase 3|Lost to Follow-up|1|||
124833130|NCT04762680|449019089|FG016|Phase 3|Lost to Follow-up|1|||
124833131|NCT04762680|449019090|FG017|Phase 3|Lost to Follow-up|66|||
124833132|NCT04762680|449019091|FG018|Phase 3|Lost to Follow-up|0|||
124833133|NCT04762680|449019092|FG019|Phase 3|Lost to Follow-up|0|||
124833134|NCT04762680|449019093|FG020|Phase 3|Lost to Follow-up|0|||
124833135|NCT04762680|449019094|FG021|Phase 3|Lost to Follow-up|0|||
124833136|NCT04762680|449019073|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833137|NCT04762680|449019074|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833138|NCT04762680|449019075|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833139|NCT04762680|449019076|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833140|NCT04762680|449019077|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833141|NCT04762680|449019078|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833142|NCT04762680|449019079|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833143|NCT04762680|449019080|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833144|NCT04762680|449019081|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833145|NCT04762680|449019082|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833146|NCT04762680|449019083|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833147|NCT04762680|449019084|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833148|NCT04762680|449019085|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833149|NCT04762680|449019086|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833150|NCT04762680|449019087|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833151|NCT04762680|449019088|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833152|NCT04762680|449019089|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833153|NCT04762680|449019090|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833154|NCT04762680|449019091|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833155|NCT04762680|449019092|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833156|NCT04762680|449019093|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833157|NCT04762680|449019094|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
124833158|NCT04762680|449019073|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833159|NCT04762680|449019074|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833160|NCT04762680|449019075|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833161|NCT04762680|449019076|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833162|NCT04762680|449019077|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833163|NCT04762680|449019078|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833164|NCT04762680|449019079|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833165|NCT04762680|449019080|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833166|NCT04762680|449019081|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833167|NCT04762680|449019082|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833168|NCT04762680|449019083|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833169|NCT04762680|449019084|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833170|NCT04762680|449019085|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833171|NCT04762680|449019086|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833172|NCT04762680|449019087|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833173|NCT04762680|449019088|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833174|NCT04762680|449019089|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833175|NCT04762680|449019090|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833176|NCT04762680|449019091|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833177|NCT04762680|449019092|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
124833178|NCT04762680|449019093|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833179|NCT04762680|449019094|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833180|NCT01063764|449019098|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
124833181|NCT01063764|449019098|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
124833182|NCT01063764|449019098|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
124833183|NCT01063764|449019098|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
124833184|NCT01063764|449019098|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
124833185|NCT01063764|449019098|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
124833186|NCT01063764|449019098|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
124833187|NCT00697515|449019101|FG000|Dose Optimization Period|Adverse Event|4|||
124833188|NCT00697515|449019102|FG001|Dose Optimization Period|Adverse Event|0|||
124833189|NCT00697515|449019101|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
124833190|NCT00697515|449019102|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
124833191|NCT00697515|449019101|FG000|Dose Optimization Period|Lost to Follow-up|2|||
124833192|NCT00697515|449019102|FG001|Dose Optimization Period|Lost to Follow-up|0|||
124833193|NCT00697515|449019101|FG000|Dose Optimization Period|sponsor request|2|||
124833194|NCT00697515|449019102|FG001|Dose Optimization Period|sponsor request|0|||
124833195|NCT00697515|449019101|FG000|Dose Optimization Period|called to active duty|1|||
124833196|NCT00697515|449019102|FG001|Dose Optimization Period|called to active duty|0|||
124833197|NCT00697515|449019101|FG000|Dose Optimization Period|elevated QTc|1|||
124833198|NCT00697515|449019102|FG001|Dose Optimization Period|elevated QTc|0|||
124833199|NCT00697515|449019101|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
124833200|NCT00697515|449019102|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
124833201|NCT00697515|449019101|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
124833202|NCT00697515|449019102|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
124833203|NCT00697515|449019101|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
124833204|NCT00697515|449019102|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
124833205|NCT00697515|449019101|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
124833206|NCT00697515|449019102|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
124833207|NCT02603432|449019103|FG000|Overall Study|Adverse Event|1|||
124833208|NCT02603432|449019104|FG001|Overall Study|Adverse Event|0|||
124833209|NCT02603432|449019103|FG000|Overall Study|Death|221|||
124833210|NCT02603432|449019104|FG001|Overall Study|Death|242|||
124833211|NCT02603432|449019103|FG000|Overall Study|Lost to Follow-up|3|||
124833212|NCT02603432|449019104|FG001|Overall Study|Lost to Follow-up|9|||
124833213|NCT02603432|449019103|FG000|Overall Study|Progressive Disease|7|||
124833214|NCT02603432|449019104|FG001|Overall Study|Progressive Disease|5|||
124833215|NCT02603432|449019103|FG000|Overall Study|Withdrawal by Subject|12|||
124833216|NCT02603432|449019104|FG001|Overall Study|Withdrawal by Subject|18|||
124833217|NCT02603432|449019103|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
124833218|NCT02603432|449019104|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
124833219|NCT02603432|449019103|FG000|Overall Study|Study terminated by sponsor|74|||
124833220|NCT02603432|449019104|FG001|Overall Study|Study terminated by sponsor|75|||
124833221|NCT02603432|449019103|FG000|Overall Study|Other|13|||
124833222|NCT02603432|449019104|FG001|Overall Study|Other|0|||
124833223|NCT01957462|449019105|FG000|Test Period 1|Withdrawal by Subject|1|||
124833224|NCT01957462|449019106|FG001|Test Period 1|Withdrawal by Subject|0|||
124833225|NCT01957462|449019105|FG000|Test Period 1|Adverse Event|1|||
124833226|NCT01957462|449019106|FG001|Test Period 1|Adverse Event|0|||
124833227|NCT05954052|449019107|FG000|Overall Study|Adverse Event|1|||
124833228|NCT01856790|449019108|FG000|Closed Loop Control|Withdrawal by Subject|2|||
124833229|NCT01856790|449019108|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
124833230|NCT01124604|449019109|FG000|Overall Study|Adverse Event|10|||
124833231|NCT01124604|449019110|FG001|Overall Study|Adverse Event|1|||
124833232|NCT01124604|449019109|FG000|Overall Study|Lack of Efficacy|1|||
124833233|NCT01124604|449019110|FG001|Overall Study|Lack of Efficacy|0|||
124833234|NCT01124604|449019109|FG000|Overall Study|Withdrawal by Subject|4|||
124833235|NCT01124604|449019110|FG001|Overall Study|Withdrawal by Subject|0|||
124833236|NCT01124604|449019109|FG000|Overall Study|Disease Progression|0|||
124833237|NCT01124604|449019110|FG001|Overall Study|Disease Progression|1|||
124833238|NCT02596854|449019113|FG000|Overall Study|Withdrawn|8|||
124833239|NCT06027866|449019118|FG000|Overall Study|Withdrawal by Subject|2|||
124833240|NCT03425331|449019121|FG000|Overall Study|Withdrawal by Subject|1|||
124833241|NCT03425331|449019121|FG000|Overall Study|Death|1|||
124833242|NCT03425331|449019121|FG000|Overall Study|Adverse Event|1|||
124833243|NCT03425331|449019121|FG000|Overall Study|Disease Progression|2|||
124833244|NCT02864251|449019123|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
124833245|NCT02864251|449019124|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
124833246|NCT02864251|449019125|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
124833247|NCT02864251|449019123|FG000|Pre-Treatment|Withdrawal by Participant|0|||
124833248|NCT02864251|449019124|FG001|Pre-Treatment|Withdrawal by Participant|0|||
124833249|NCT02864251|449019125|FG002|Pre-Treatment|Withdrawal by Participant|4|||
124833250|NCT02864251|449019123|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
124833251|NCT02864251|449019124|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
124833252|NCT02864251|449019125|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
125304568|NCT00965419|450741351|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
125304569|NCT00965419|450741351|FG000|Follow-up Phase|Lack of Efficacy|28|||
124833253|NCT02864251|449019123|FG000|Pre-Treatment|Other Reasons|0|||
125304570|NCT02927938|450741352|FG000|Overall Study|Death|0|||
125304571|NCT02927938|450741353|FG001|Overall Study|Death|1|||
124833254|NCT02864251|449019124|FG001|Pre-Treatment|Other Reasons|1|||
124833255|NCT02864251|449019125|FG002|Pre-Treatment|Other Reasons|1|||
124833256|NCT02864251|449019123|FG000|Treatment|Disease Progression|109|||
124833257|NCT02864251|449019124|FG001|Treatment|Disease Progression|52|||
124833258|NCT02864251|449019125|FG002|Treatment|Disease Progression|101|||
124833259|NCT02864251|449019123|FG000|Treatment|Study Drug Toxicity|9|||
124833260|NCT02864251|449019124|FG001|Treatment|Study Drug Toxicity|4|||
124833261|NCT02864251|449019125|FG002|Treatment|Study Drug Toxicity|10|||
124833262|NCT02864251|449019123|FG000|Treatment|Death|0|||
124833263|NCT02864251|449019124|FG001|Treatment|Death|2|||
124833264|NCT02864251|449019125|FG002|Treatment|Death|3|||
124833265|NCT02864251|449019123|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
124833266|NCT02864251|449019124|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
124833267|NCT02864251|449019125|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
124833268|NCT02864251|449019123|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
124833269|NCT02864251|449019124|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
124833270|NCT02864251|449019125|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
124833271|NCT02864251|449019123|FG000|Treatment|Withdrawal by Participant|8|||
124833272|NCT02864251|449019124|FG001|Treatment|Withdrawal by Participant|5|||
124833273|NCT02864251|449019125|FG002|Treatment|Withdrawal by Participant|13|||
124833274|NCT02864251|449019123|FG000|Treatment|Maximum Clinical Benefit|1|||
124833275|NCT02864251|449019124|FG001|Treatment|Maximum Clinical Benefit|0|||
124833276|NCT02864251|449019125|FG002|Treatment|Maximum Clinical Benefit|1|||
124833277|NCT02864251|449019123|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
124833278|NCT02864251|449019124|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
124833279|NCT02864251|449019125|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
124833280|NCT02864251|449019123|FG000|Treatment|Other Reasons|1|||
124833281|NCT02864251|449019124|FG001|Treatment|Other Reasons|1|||
124833282|NCT02864251|449019125|FG002|Treatment|Other Reasons|4|||
124833283|NCT02864251|449019123|FG000|Treatment|Administrative Reason by Sponsor|1|||
124833284|NCT02864251|449019124|FG001|Treatment|Administrative Reason by Sponsor|0|||
124833285|NCT02864251|449019125|FG002|Treatment|Administrative Reason by Sponsor|0|||
124833286|NCT05442554|449019126|FG000|Overall Study|Adverse Event|1|||
124833287|NCT02438722|449019128|FG000|Overall Study|Adverse Event|12|||
124833288|NCT02438722|449019129|FG001|Overall Study|Adverse Event|9|||
124833289|NCT02438722|449019128|FG000|Overall Study|Refusal unrelated to AE|2|||
124833290|NCT02438722|449019129|FG001|Overall Study|Refusal unrelated to AE|5|||
124833291|NCT02438722|449019128|FG000|Overall Study|Disease progression/relapse|46|||
124833292|NCT02438722|449019129|FG001|Overall Study|Disease progression/relapse|51|||
124833293|NCT02438722|449019128|FG000|Overall Study|Death|0|||
124833294|NCT02438722|449019129|FG001|Overall Study|Death|3|||
124833295|NCT02438722|449019128|FG000|Overall Study|Physician Decision|2|||
124833296|NCT02438722|449019129|FG001|Overall Study|Physician Decision|2|||
124833297|NCT02438722|449019128|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
124833298|NCT02438722|449019129|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
124833299|NCT02438722|449019128|FG000|Overall Study|Withdrawal by Subject|0|||
124833300|NCT02438722|449019129|FG001|Overall Study|Withdrawal by Subject|1|||
124833301|NCT02438722|449019128|FG000|Overall Study|On protocol treatment|15|||
124833302|NCT02438722|449019129|FG001|Overall Study|On protocol treatment|14|||
124833303|NCT02438722|449019128|FG000|Overall Study|Did not receive protocol treatment|5|||
124833304|NCT02438722|449019129|FG001|Overall Study|Did not receive protocol treatment|0|||
124833305|NCT05172544|449019134|FG000|Overall Study|Withdrawal by Subject|1|||
124833306|NCT05172544|449019135|FG001|Overall Study|Withdrawal by Subject|0|||
124833307|NCT05172544|449019136|FG002|Overall Study|Withdrawal by Subject|0|||
124833308|NCT05172544|449019134|FG000|Overall Study|Physician Decision|0|||
124833309|NCT05172544|449019135|FG001|Overall Study|Physician Decision|0|||
124833310|NCT05172544|449019136|FG002|Overall Study|Physician Decision|1|||
124833311|NCT04829318|449019137|FG000|Overall Study|Adverse Event|6|||
124833312|NCT04829318|449019137|FG000|Overall Study|Death|1|||
124833313|NCT04829318|449019137|FG000|Overall Study|Lost to Follow-up|1|||
124833314|NCT04829318|449019137|FG000|Overall Study|Physician Decision|1|||
124833315|NCT04829318|449019137|FG000|Overall Study|Withdrawal by Subject|19|||
124833316|NCT04829318|449019137|FG000|Overall Study|Site terminated by sponsor|1|||
124833317|NCT04829318|449019137|FG000|Overall Study|Sponsor decision|5|||
124833318|NCT04829318|449019137|FG000|Overall Study|Other|1|||
124833319|NCT01737047|449019140|FG000|Overall Study|Death|10|||
124833320|NCT01737047|449019141|FG001|Overall Study|Death|0|||
124833321|NCT01737047|449019142|FG002|Overall Study|Death|1|||
124833322|NCT01737047|449019140|FG000|Overall Study|Withdrawal by Subject|17|||
124833323|NCT01737047|449019141|FG001|Overall Study|Withdrawal by Subject|11|||
124833324|NCT01737047|449019142|FG002|Overall Study|Withdrawal by Subject|4|||
124833325|NCT03965962|449019143|FG000|Overall Study|Adverse Event|1|||
124833326|NCT03965962|449019144|FG001|Overall Study|Adverse Event|0|||
124833327|NCT03965962|449019145|FG002|Overall Study|Adverse Event|0|||
124833328|NCT03965962|449019146|FG003|Overall Study|Adverse Event|0|||
124833329|NCT03965962|449019143|FG000|Overall Study|Protocol Violation|21|||
124833330|NCT03965962|449019144|FG001|Overall Study|Protocol Violation|4|||
124833331|NCT03965962|449019145|FG002|Overall Study|Protocol Violation|10|||
124833332|NCT03965962|449019146|FG003|Overall Study|Protocol Violation|5|||
124833333|NCT03965962|449019143|FG000|Overall Study|Lost to Follow-up|0|||
124833334|NCT03965962|449019144|FG001|Overall Study|Lost to Follow-up|1|||
124833335|NCT03965962|449019145|FG002|Overall Study|Lost to Follow-up|0|||
124833336|NCT03965962|449019146|FG003|Overall Study|Lost to Follow-up|0|||
124833337|NCT03965962|449019143|FG000|Overall Study|Withdrawal by Subject|3|||
124833338|NCT03965962|449019144|FG001|Overall Study|Withdrawal by Subject|0|||
124833339|NCT03965962|449019145|FG002|Overall Study|Withdrawal by Subject|0|||
124833340|NCT03965962|449019146|FG003|Overall Study|Withdrawal by Subject|1|||
124833341|NCT00003641|449019147|FG000|Overall Study|Withdrawal by Subject|0|||
124833342|NCT00003641|449019148|FG001|Overall Study|Withdrawal by Subject|100|||
124833343|NCT00003641|449019147|FG000|Overall Study|Adverse Event|0|||
124833344|NCT00003641|449019148|FG001|Overall Study|Adverse Event|38|||
124833345|NCT00003641|449019147|FG000|Overall Study|Disease progression|0|||
124833346|NCT00003641|449019148|FG001|Overall Study|Disease progression|2|||
124833347|NCT00003641|449019147|FG000|Overall Study|Unknown/missing|0|||
124833348|NCT00003641|449019148|FG001|Overall Study|Unknown/missing|22|||
124833349|NCT00003641|449019147|FG000|Overall Study|Should not receive interferon therapy|2|||
124833350|NCT00003641|449019148|FG001|Overall Study|Should not receive interferon therapy|0|||
124833351|NCT00003641|449019147|FG000|Overall Study|Never started interferon|567|||
124833352|NCT00003641|449019148|FG001|Overall Study|Never started interferon|12|||
124833353|NCT03659916|449019149|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
124833354|NCT03659916|449019150|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
124833355|NCT03659916|449019151|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
124833356|NCT03659916|449019149|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
124833357|NCT03659916|449019150|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
124833358|NCT03659916|449019151|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
124833359|NCT03659916|449019149|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
124833360|NCT03659916|449019150|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
124833361|NCT03659916|449019151|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
124833362|NCT03659916|449019149|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
124833363|NCT03659916|449019150|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
124833364|NCT03659916|449019151|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
124833365|NCT03659916|449019149|FG000|Treatment Period (72 Weeks)|Other|1|||
124833366|NCT03659916|449019150|FG001|Treatment Period (72 Weeks)|Other|3|||
124833367|NCT03659916|449019151|FG002|Treatment Period (72 Weeks)|Other|9|||
124833368|NCT03659916|449019149|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
124833369|NCT03659916|449019150|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
124833370|NCT03659916|449019151|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
124833371|NCT03659916|449019149|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
124833372|NCT03659916|449019150|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
124833373|NCT03659916|449019151|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
124833374|NCT03659916|449019149|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
124833375|NCT03659916|449019150|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
124833376|NCT03659916|449019151|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
124833377|NCT03659916|449019149|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
124833378|NCT03659916|449019150|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
124833379|NCT03659916|449019151|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
124833380|NCT03659916|449019149|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
124833381|NCT03659916|449019150|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
124833382|NCT03659916|449019151|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
124833383|NCT03659916|449019149|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
124833384|NCT03659916|449019150|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
124833385|NCT03659916|449019151|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
124833386|NCT00878709|449019152|FG000|Overall Study|Withdrawal by Subject|197|||
124833387|NCT00878709|449019153|FG001|Overall Study|Withdrawal by Subject|120|||
124833388|NCT00878709|449019152|FG000|Overall Study|Lost to Follow-up|35|||
124833389|NCT00878709|449019153|FG001|Overall Study|Lost to Follow-up|33|||
124833390|NCT00878709|449019152|FG000|Overall Study|Other Reasons|93|||
124833391|NCT00878709|449019153|FG001|Overall Study|Other Reasons|84|||
124833392|NCT00322842|449019154|FG000|Overall Study|Withdrawal by Subject|0|||
124833393|NCT00322842|449019155|FG001|Overall Study|Withdrawal by Subject|1|||
124833394|NCT00322842|449019154|FG000|Overall Study|Lost to Follow-up|0|||
124833395|NCT00322842|449019155|FG001|Overall Study|Lost to Follow-up|1|||
124833396|NCT00322842|449019154|FG000|Overall Study|Refused transplant|1|||
124833397|NCT00322842|449019155|FG001|Overall Study|Refused transplant|0|||
124833398|NCT00322842|449019154|FG000|Overall Study|Death|1|||
124833399|NCT00322842|449019155|FG001|Overall Study|Death|0|||
124833400|NCT05214768|449019156|FG000|Induction Period|Withdrawal by Subject|1|||
124833401|NCT05214768|449019157|FG001|Induction Period|Withdrawal by Subject|0|||
124833402|NCT05214768|449019158|FG002|Induction Period|Withdrawal by Subject|0|||
124833403|NCT05214768|449019159|FG003|Induction Period|Withdrawal by Subject|0|||
124833404|NCT05214768|449019160|FG004|Induction Period|Withdrawal by Subject|0|||
124833405|NCT05214768|449019161|FG005|Induction Period|Withdrawal by Subject|0|||
124833406|NCT05214768|449019156|FG000|Induction Period|Physician Decision|1|||
124833407|NCT05214768|449019157|FG001|Induction Period|Physician Decision|0|||
124833408|NCT05214768|449019158|FG002|Induction Period|Physician Decision|0|||
124833409|NCT05214768|449019159|FG003|Induction Period|Physician Decision|0|||
124833410|NCT05214768|449019160|FG004|Induction Period|Physician Decision|0|||
124833411|NCT05214768|449019161|FG005|Induction Period|Physician Decision|0|||
125304572|NCT02927938|450741354|FG002|Overall Study|Death|0|||
124833412|NCT05214768|449019156|FG000|Maintenance Period|Other Reasons|0|||
124833413|NCT05214768|449019157|FG001|Maintenance Period|Other Reasons|0|||
124833414|NCT05214768|449019158|FG002|Maintenance Period|Other Reasons|1|||
124833415|NCT05214768|449019159|FG003|Maintenance Period|Other Reasons|1|||
124833416|NCT05214768|449019160|FG004|Maintenance Period|Other Reasons|0|||
124833417|NCT05214768|449019161|FG005|Maintenance Period|Other Reasons|0|||
124833418|NCT05214768|449019156|FG000|Maintenance Period|Withdrawal by Subject|0|||
124833419|NCT05214768|449019157|FG001|Maintenance Period|Withdrawal by Subject|0|||
124833420|NCT05214768|449019158|FG002|Maintenance Period|Withdrawal by Subject|0|||
124833421|NCT05214768|449019159|FG003|Maintenance Period|Withdrawal by Subject|1|||
124833422|NCT05214768|449019160|FG004|Maintenance Period|Withdrawal by Subject|0|||
124833423|NCT05214768|449019161|FG005|Maintenance Period|Withdrawal by Subject|0|||
124833424|NCT05214768|449019156|FG000|Maintenance Period|Lack of Efficacy|0|||
124833425|NCT05214768|449019157|FG001|Maintenance Period|Lack of Efficacy|0|||
124833426|NCT05214768|449019158|FG002|Maintenance Period|Lack of Efficacy|1|||
124833427|NCT05214768|449019159|FG003|Maintenance Period|Lack of Efficacy|0|||
124833428|NCT05214768|449019160|FG004|Maintenance Period|Lack of Efficacy|1|||
124833429|NCT05214768|449019161|FG005|Maintenance Period|Lack of Efficacy|0|||
124833430|NCT05214768|449019156|FG000|Open Label Extension Period|Physician Decision|0|||
124833431|NCT05214768|449019157|FG001|Open Label Extension Period|Physician Decision|0|||
124833432|NCT05214768|449019158|FG002|Open Label Extension Period|Physician Decision|0|||
124833433|NCT05214768|449019159|FG003|Open Label Extension Period|Physician Decision|0|||
124833434|NCT05214768|449019160|FG004|Open Label Extension Period|Physician Decision|0|||
124833435|NCT05214768|449019161|FG005|Open Label Extension Period|Physician Decision|1|||
124833436|NCT05214768|449019156|FG000|Open Label Extension Period|Lack of Efficacy|0|||
124833437|NCT05214768|449019157|FG001|Open Label Extension Period|Lack of Efficacy|0|||
124833438|NCT05214768|449019158|FG002|Open Label Extension Period|Lack of Efficacy|0|||
124833439|NCT05214768|449019159|FG003|Open Label Extension Period|Lack of Efficacy|0|||
124833440|NCT05214768|449019160|FG004|Open Label Extension Period|Lack of Efficacy|0|||
124833441|NCT05214768|449019161|FG005|Open Label Extension Period|Lack of Efficacy|1|||
124833442|NCT05214768|449019156|FG000|Open Label Extension Period|Ongoing Study|0|||
124833443|NCT05214768|449019157|FG001|Open Label Extension Period|Ongoing Study|0|||
124833444|NCT05214768|449019158|FG002|Open Label Extension Period|Ongoing Study|0|||
124833445|NCT05214768|449019159|FG003|Open Label Extension Period|Ongoing Study|0|||
124833446|NCT05214768|449019160|FG004|Open Label Extension Period|Ongoing Study|0|||
124833447|NCT05214768|449019161|FG005|Open Label Extension Period|Ongoing Study|42|||
124833448|NCT05041322|449019162|FG000|Baseline|Withdrawal by Subject|1|||
124833449|NCT05041322|449019163|FG001|Baseline|Withdrawal by Subject|0|||
124833450|NCT05041322|449019162|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
124833451|NCT05041322|449019163|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
124833452|NCT05041322|449019162|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
124833453|NCT05041322|449019163|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
124833454|NCT03795298|449019164|FG000|Overall Study|Death|34|||
124833455|NCT03795298|449019165|FG001|Overall Study|Death|29|||
124833456|NCT03795298|449019164|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
124833457|NCT03795298|449019165|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
124833458|NCT03795298|449019164|FG000|Overall Study|Lost to Follow-up|28|||
124833459|NCT03795298|449019165|FG001|Overall Study|Lost to Follow-up|17|||
124833460|NCT03795298|449019164|FG000|Overall Study|Physician Decision|5|||
124833461|NCT03795298|449019165|FG001|Overall Study|Physician Decision|4|||
124833462|NCT03795298|449019164|FG000|Overall Study|Withdrawal by Subject|43|||
124833463|NCT03795298|449019165|FG001|Overall Study|Withdrawal by Subject|28|||
124833464|NCT03795298|449019164|FG000|Overall Study|Reason not reported|7|||
124833465|NCT03795298|449019165|FG001|Overall Study|Reason not reported|9|||
124833466|NCT04303780|449019166|FG000|Overall Study|Death|104|||
124833467|NCT04303780|449019167|FG001|Overall Study|Death|85|||
124833468|NCT04303780|449019166|FG000|Overall Study|Lost to Follow-up|5|||
124833469|NCT04303780|449019167|FG001|Overall Study|Lost to Follow-up|2|||
124833470|NCT04303780|449019166|FG000|Overall Study|Withdrawal by Subject|12|||
124833471|NCT04303780|449019167|FG001|Overall Study|Withdrawal by Subject|39|||
124833472|NCT04303780|449019166|FG000|Overall Study|Ongoing in study|50|||
124833473|NCT04303780|449019167|FG001|Overall Study|Ongoing in study|45|||
124833474|NCT01344161|449019169|FG000|Overall Study|Lost to Follow-up|4|||
124833475|NCT01344161|449019170|FG001|Overall Study|Lost to Follow-up|1|||
124833476|NCT01344161|449019169|FG000|Overall Study|Pregnancy|0|||
124833477|NCT01344161|449019170|FG001|Overall Study|Pregnancy|1|||
124833478|NCT01344161|449019169|FG000|Overall Study|Protocol Violation|1|||
124833479|NCT01344161|449019170|FG001|Overall Study|Protocol Violation|1|||
124833480|NCT04690751|449019171|FG000|Overall Study|Protocol Violation|0|||
124833481|NCT04690751|449019172|FG001|Overall Study|Protocol Violation|1|||
124833482|NCT04690751|449019173|FG002|Overall Study|Protocol Violation|0|||
124833483|NCT04690751|449019174|FG003|Overall Study|Protocol Violation|1|||
124833484|NCT04690751|449019175|FG004|Overall Study|Protocol Violation|2|||
124833485|NCT04690751|449019176|FG005|Overall Study|Protocol Violation|0|||
124833486|NCT04690751|449019171|FG000|Overall Study|Adverse Event|0|||
124833487|NCT04690751|449019172|FG001|Overall Study|Adverse Event|0|||
124833488|NCT04690751|449019173|FG002|Overall Study|Adverse Event|1|||
124833489|NCT04690751|449019174|FG003|Overall Study|Adverse Event|0|||
124833490|NCT04690751|449019175|FG004|Overall Study|Adverse Event|0|||
124833491|NCT04690751|449019176|FG005|Overall Study|Adverse Event|0|||
124833492|NCT04690751|449019171|FG000|Overall Study|Positive urine drug screen test|0|||
124833493|NCT04690751|449019172|FG001|Overall Study|Positive urine drug screen test|0|||
124833494|NCT04690751|449019173|FG002|Overall Study|Positive urine drug screen test|0|||
124833495|NCT04690751|449019174|FG003|Overall Study|Positive urine drug screen test|0|||
124833496|NCT04690751|449019175|FG004|Overall Study|Positive urine drug screen test|1|||
124833497|NCT04690751|449019176|FG005|Overall Study|Positive urine drug screen test|0|||
124833498|NCT04364620|449019177|FG000|Overall Study|Disease Progression|20|||
124833499|NCT04364620|449019177|FG000|Overall Study|Adverse Event|5|||
124833500|NCT04364620|449019177|FG000|Overall Study|Physician Decision|4|||
124833501|NCT04364620|449019177|FG000|Overall Study|Death|3|||
124833502|NCT04364620|449019177|FG000|Overall Study|Other|2|||
124833503|NCT04364620|449019177|FG000|Overall Study|Withdrawal by Subject|1|||
124833504|NCT04579380|449021527|FG000|Overall Study|Death|9|||
124833505|NCT04579380|449021528|FG001|Overall Study|Death|22|||
124833506|NCT04579380|449021529|FG002|Overall Study|Death|22|||
124833507|NCT04579380|449021530|FG003|Overall Study|Death|17|||
124833508|NCT04579380|449021531|FG004|Overall Study|Death|6|||
124833509|NCT04579380|449021532|FG005|Overall Study|Death|21|||
124833510|NCT04579380|449021533|FG006|Overall Study|Death|10|||
124833511|NCT04579380|449021534|FG007|Overall Study|Death|11|||
124833512|NCT04579380|449021535|FG008|Overall Study|Death|25|||
124833513|NCT04579380|449021527|FG000|Overall Study|Withdrawal by Subject|0|||
124833514|NCT04579380|449021528|FG001|Overall Study|Withdrawal by Subject|3|||
124833515|NCT04579380|449021529|FG002|Overall Study|Withdrawal by Subject|4|||
124833516|NCT04579380|449021530|FG003|Overall Study|Withdrawal by Subject|0|||
124833517|NCT04579380|449021531|FG004|Overall Study|Withdrawal by Subject|1|||
124833518|NCT04579380|449021532|FG005|Overall Study|Withdrawal by Subject|2|||
124833519|NCT04579380|449021533|FG006|Overall Study|Withdrawal by Subject|0|||
124833520|NCT04579380|449021534|FG007|Overall Study|Withdrawal by Subject|1|||
124833521|NCT04579380|449021535|FG008|Overall Study|Withdrawal by Subject|2|||
124833522|NCT04579380|449021527|FG000|Overall Study|Ongoing|2|||
124833523|NCT04579380|449021528|FG001|Overall Study|Ongoing|6|||
124833524|NCT04579380|449021529|FG002|Overall Study|Ongoing|4|||
124833525|NCT04579380|449021530|FG003|Overall Study|Ongoing|8|||
124833526|NCT04579380|449021531|FG004|Overall Study|Ongoing|5|||
124833527|NCT04579380|449021532|FG005|Overall Study|Ongoing|8|||
124833528|NCT04579380|449021533|FG006|Overall Study|Ongoing|3|||
124833529|NCT04579380|449021534|FG007|Overall Study|Ongoing|19|||
124833530|NCT04579380|449021535|FG008|Overall Study|Ongoing|6|||
124833531|NCT00066066|449021538|FG000|Overall Study|Lost to Follow-up|6|||
124833532|NCT00066066|449021539|FG001|Overall Study|Lost to Follow-up|4|||
124833533|NCT00066066|449021540|FG002|Overall Study|Lost to Follow-up|7|||
124833534|NCT00066066|449021541|FG003|Overall Study|Lost to Follow-up|4|||
124833535|NCT00066066|449021542|FG004|Overall Study|Lost to Follow-up|3|||
124833536|NCT00066066|449021543|FG005|Overall Study|Lost to Follow-up|5|||
124833537|NCT02268409|449021544|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
124833538|NCT02268409|449021544|FG000|Overall Study|Death|1|||
124833539|NCT02268409|449021544|FG000|Overall Study|Lost to Follow-up|1|||
124833540|NCT02268409|449021544|FG000|Overall Study|Protocol Violation|3|||
124833541|NCT02268409|449021544|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
124833542|NCT02268409|449021544|FG000|Overall Study|Withdrawal by Subject|5|||
124833543|NCT00489853|449021549|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
124833544|NCT00489853|449021550|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
124833545|NCT00489853|449021551|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
124833546|NCT00489853|449021549|FG000|Wash-out Period 1|Adverse Event|0|||
124833547|NCT00489853|449021550|FG001|Wash-out Period 1|Adverse Event|1|||
124833548|NCT00489853|449021551|FG002|Wash-out Period 1|Adverse Event|1|||
124833549|NCT00489853|449021549|FG000|Wash-out Period 1|Protocol Violation|0|||
124833550|NCT00489853|449021550|FG001|Wash-out Period 1|Protocol Violation|1|||
124833551|NCT00489853|449021551|FG002|Wash-out Period 1|Protocol Violation|1|||
124833552|NCT00489853|449021549|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
124833553|NCT00489853|449021550|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
124833554|NCT00489853|449021551|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
124833555|NCT00489853|449021549|FG000|Wash-out Period 2|Adverse Event|1|||
124833556|NCT00489853|449021550|FG001|Wash-out Period 2|Adverse Event|1|||
124833557|NCT00489853|449021551|FG002|Wash-out Period 2|Adverse Event|0|||
124833558|NCT00489853|449021549|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
124833559|NCT00489853|449021550|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
124833560|NCT00489853|449021551|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
124833561|NCT00489853|449021549|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
125304573|NCT02927938|450741355|FG003|Overall Study|Death|4|||
124833562|NCT00489853|449021550|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
124833563|NCT00489853|449021551|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
124833564|NCT02255500|449021559|FG000|Overall Study|Withdrawal by Subject|1|||
124833565|NCT02255500|449021560|FG001|Overall Study|Withdrawal by Subject|0|||
124833566|NCT05129488|449021561|FG000|Overall Study|Protocol Violation|3|||
124833567|NCT02608268|449021562|FG000|Overall Study|Adverse Event|0|||
124833568|NCT02608268|449021563|FG001|Overall Study|Adverse Event|0|||
124833569|NCT02608268|449021564|FG002|Overall Study|Adverse Event|1|||
124833570|NCT02608268|449021565|FG003|Overall Study|Adverse Event|0|||
124833571|NCT02608268|449021566|FG004|Overall Study|Adverse Event|0|||
124833572|NCT02608268|449021567|FG005|Overall Study|Adverse Event|0|||
124833573|NCT02608268|449021568|FG006|Overall Study|Adverse Event|0|||
124833574|NCT02608268|449021569|FG007|Overall Study|Adverse Event|0|||
124833575|NCT02608268|449021570|FG008|Overall Study|Adverse Event|0|||
124833576|NCT02608268|449021571|FG009|Overall Study|Adverse Event|0|||
124833577|NCT02608268|449021572|FG010|Overall Study|Adverse Event|0|||
124833578|NCT02608268|449021573|FG011|Overall Study|Adverse Event|0|||
124833579|NCT02608268|449021574|FG012|Overall Study|Adverse Event|2|||
124833580|NCT02608268|449021575|FG013|Overall Study|Adverse Event|0|||
124833581|NCT02608268|449021576|FG014|Overall Study|Adverse Event|0|||
124833582|NCT02608268|449021577|FG015|Overall Study|Adverse Event|0|||
124833583|NCT02608268|449021578|FG016|Overall Study|Adverse Event|0|||
124833584|NCT02608268|449021579|FG017|Overall Study|Adverse Event|0|||
124833585|NCT02608268|449021580|FG018|Overall Study|Adverse Event|0|||
124833586|NCT02608268|449021581|FG019|Overall Study|Adverse Event|0|||
124833587|NCT02608268|449021582|FG020|Overall Study|Adverse Event|1|||
124833588|NCT02608268|449021583|FG021|Overall Study|Adverse Event|1|||
124833589|NCT02608268|449021584|FG022|Overall Study|Adverse Event|0|||
124833590|NCT02608268|449021585|FG023|Overall Study|Adverse Event|0|||
124833591|NCT02608268|449021586|FG024|Overall Study|Adverse Event|1|||
124833592|NCT02608268|449021587|FG025|Overall Study|Adverse Event|0|||
124833593|NCT02608268|449021588|FG026|Overall Study|Adverse Event|0|||
124833594|NCT02608268|449021589|FG027|Overall Study|Adverse Event|0|||
124833595|NCT02608268|449021590|FG028|Overall Study|Adverse Event|1|||
124833596|NCT02608268|449021591|FG029|Overall Study|Adverse Event|0|||
124833597|NCT02608268|449021562|FG000|Overall Study|Death|1|||
124833598|NCT02608268|449021563|FG001|Overall Study|Death|0|||
124833599|NCT02608268|449021564|FG002|Overall Study|Death|0|||
124833600|NCT02608268|449021565|FG003|Overall Study|Death|0|||
124833601|NCT02608268|449021566|FG004|Overall Study|Death|0|||
124833602|NCT02608268|449021567|FG005|Overall Study|Death|0|||
124833603|NCT02608268|449021568|FG006|Overall Study|Death|0|||
124833604|NCT02608268|449021569|FG007|Overall Study|Death|0|||
124833605|NCT02608268|449021570|FG008|Overall Study|Death|1|||
124833606|NCT02608268|449021571|FG009|Overall Study|Death|1|||
124833607|NCT02608268|449021572|FG010|Overall Study|Death|0|||
124833608|NCT02608268|449021573|FG011|Overall Study|Death|0|||
124833609|NCT02608268|449021574|FG012|Overall Study|Death|0|||
124833610|NCT02608268|449021575|FG013|Overall Study|Death|0|||
124833611|NCT02608268|449021576|FG014|Overall Study|Death|0|||
124833612|NCT02608268|449021577|FG015|Overall Study|Death|1|||
124833613|NCT02608268|449021578|FG016|Overall Study|Death|0|||
124833614|NCT02608268|449021579|FG017|Overall Study|Death|1|||
124833615|NCT02608268|449021580|FG018|Overall Study|Death|0|||
124833616|NCT02608268|449021581|FG019|Overall Study|Death|1|||
124833617|NCT02608268|449021582|FG020|Overall Study|Death|1|||
124833618|NCT02608268|449021583|FG021|Overall Study|Death|0|||
124833619|NCT02608268|449021584|FG022|Overall Study|Death|0|||
124833620|NCT02608268|449021585|FG023|Overall Study|Death|0|||
124833621|NCT02608268|449021586|FG024|Overall Study|Death|1|||
124833622|NCT02608268|449021587|FG025|Overall Study|Death|2|||
124833623|NCT02608268|449021588|FG026|Overall Study|Death|0|||
124833624|NCT02608268|449021589|FG027|Overall Study|Death|1|||
124833625|NCT02608268|449021590|FG028|Overall Study|Death|4|||
124833626|NCT02608268|449021591|FG029|Overall Study|Death|0|||
124833627|NCT02608268|449021562|FG000|Overall Study|Physician Decision|0|||
124833628|NCT02608268|449021563|FG001|Overall Study|Physician Decision|0|||
124833629|NCT02608268|449021564|FG002|Overall Study|Physician Decision|0|||
124833630|NCT02608268|449021565|FG003|Overall Study|Physician Decision|0|||
124833631|NCT02608268|449021566|FG004|Overall Study|Physician Decision|0|||
124833632|NCT02608268|449021567|FG005|Overall Study|Physician Decision|0|||
124833633|NCT02608268|449021568|FG006|Overall Study|Physician Decision|0|||
124833634|NCT02608268|449021569|FG007|Overall Study|Physician Decision|0|||
124833635|NCT02608268|449021570|FG008|Overall Study|Physician Decision|0|||
124833636|NCT02608268|449021571|FG009|Overall Study|Physician Decision|0|||
124833637|NCT02608268|449021572|FG010|Overall Study|Physician Decision|1|||
124833638|NCT02608268|449021573|FG011|Overall Study|Physician Decision|0|||
124833639|NCT02608268|449021574|FG012|Overall Study|Physician Decision|0|||
124833640|NCT02608268|449021575|FG013|Overall Study|Physician Decision|1|||
124833641|NCT02608268|449021576|FG014|Overall Study|Physician Decision|0|||
124833642|NCT02608268|449021577|FG015|Overall Study|Physician Decision|0|||
124833643|NCT02608268|449021578|FG016|Overall Study|Physician Decision|0|||
124833644|NCT02608268|449021579|FG017|Overall Study|Physician Decision|0|||
124833645|NCT02608268|449021580|FG018|Overall Study|Physician Decision|0|||
124833646|NCT02608268|449021581|FG019|Overall Study|Physician Decision|0|||
124833647|NCT02608268|449021582|FG020|Overall Study|Physician Decision|0|||
124833648|NCT02608268|449021583|FG021|Overall Study|Physician Decision|0|||
124833649|NCT02608268|449021584|FG022|Overall Study|Physician Decision|1|||
124833650|NCT02608268|449021585|FG023|Overall Study|Physician Decision|1|||
124833651|NCT02608268|449021586|FG024|Overall Study|Physician Decision|1|||
124833652|NCT02608268|449021587|FG025|Overall Study|Physician Decision|0|||
124833653|NCT02608268|449021588|FG026|Overall Study|Physician Decision|0|||
124833654|NCT02608268|449021589|FG027|Overall Study|Physician Decision|2|||
124833655|NCT02608268|449021590|FG028|Overall Study|Physician Decision|1|||
124833656|NCT02608268|449021591|FG029|Overall Study|Physician Decision|1|||
124833657|NCT02608268|449021562|FG000|Overall Study|Progressive disease|12|||
124833658|NCT02608268|449021563|FG001|Overall Study|Progressive disease|8|||
124833659|NCT02608268|449021564|FG002|Overall Study|Progressive disease|13|||
124833660|NCT02608268|449021565|FG003|Overall Study|Progressive disease|5|||
124833661|NCT02608268|449021566|FG004|Overall Study|Progressive disease|2|||
124833662|NCT02608268|449021567|FG005|Overall Study|Progressive disease|4|||
124833663|NCT02608268|449021568|FG006|Overall Study|Progressive disease|6|||
124833664|NCT02608268|449021569|FG007|Overall Study|Progressive disease|2|||
124833665|NCT02608268|449021570|FG008|Overall Study|Progressive disease|5|||
124833666|NCT02608268|449021571|FG009|Overall Study|Progressive disease|6|||
124833667|NCT02608268|449021572|FG010|Overall Study|Progressive disease|5|||
124833668|NCT02608268|449021573|FG011|Overall Study|Progressive disease|5|||
124833669|NCT02608268|449021574|FG012|Overall Study|Progressive disease|4|||
124833670|NCT02608268|449021575|FG013|Overall Study|Progressive disease|11|||
124833671|NCT02608268|449021576|FG014|Overall Study|Progressive disease|6|||
124833672|NCT02608268|449021577|FG015|Overall Study|Progressive disease|3|||
124833673|NCT02608268|449021578|FG016|Overall Study|Progressive disease|5|||
124833674|NCT02608268|449021579|FG017|Overall Study|Progressive disease|5|||
124833675|NCT02608268|449021580|FG018|Overall Study|Progressive disease|5|||
124833676|NCT02608268|449021581|FG019|Overall Study|Progressive disease|2|||
124833677|NCT02608268|449021582|FG020|Overall Study|Progressive disease|10|||
124833678|NCT02608268|449021583|FG021|Overall Study|Progressive disease|4|||
124833679|NCT02608268|449021584|FG022|Overall Study|Progressive disease|5|||
124833680|NCT02608268|449021585|FG023|Overall Study|Progressive disease|5|||
124833681|NCT02608268|449021586|FG024|Overall Study|Progressive disease|3|||
124833682|NCT02608268|449021587|FG025|Overall Study|Progressive disease|11|||
124833683|NCT02608268|449021588|FG026|Overall Study|Progressive disease|16|||
124833684|NCT02608268|449021589|FG027|Overall Study|Progressive disease|11|||
124833685|NCT02608268|449021590|FG028|Overall Study|Progressive disease|10|||
124833686|NCT02608268|449021591|FG029|Overall Study|Progressive disease|15|||
124833687|NCT02608268|449021562|FG000|Overall Study|Subject/guardian decision|1|||
124833688|NCT02608268|449021563|FG001|Overall Study|Subject/guardian decision|1|||
124833689|NCT02608268|449021564|FG002|Overall Study|Subject/guardian decision|2|||
124833690|NCT02608268|449021565|FG003|Overall Study|Subject/guardian decision|0|||
124833691|NCT02608268|449021566|FG004|Overall Study|Subject/guardian decision|0|||
124833692|NCT02608268|449021567|FG005|Overall Study|Subject/guardian decision|0|||
124833693|NCT02608268|449021568|FG006|Overall Study|Subject/guardian decision|0|||
124833694|NCT02608268|449021569|FG007|Overall Study|Subject/guardian decision|0|||
124833695|NCT02608268|449021570|FG008|Overall Study|Subject/guardian decision|2|||
124833696|NCT02608268|449021571|FG009|Overall Study|Subject/guardian decision|2|||
124833697|NCT02608268|449021572|FG010|Overall Study|Subject/guardian decision|0|||
124833698|NCT02608268|449021573|FG011|Overall Study|Subject/guardian decision|1|||
124833699|NCT02608268|449021574|FG012|Overall Study|Subject/guardian decision|0|||
124833700|NCT02608268|449021575|FG013|Overall Study|Subject/guardian decision|1|||
124833701|NCT02608268|449021576|FG014|Overall Study|Subject/guardian decision|0|||
124833702|NCT02608268|449021577|FG015|Overall Study|Subject/guardian decision|1|||
124833703|NCT02608268|449021578|FG016|Overall Study|Subject/guardian decision|0|||
124833704|NCT02608268|449021579|FG017|Overall Study|Subject/guardian decision|0|||
124833705|NCT02608268|449021580|FG018|Overall Study|Subject/guardian decision|1|||
124833706|NCT02608268|449021581|FG019|Overall Study|Subject/guardian decision|0|||
124833707|NCT02608268|449021582|FG020|Overall Study|Subject/guardian decision|0|||
124833708|NCT02608268|449021583|FG021|Overall Study|Subject/guardian decision|0|||
124833709|NCT02608268|449021584|FG022|Overall Study|Subject/guardian decision|1|||
124833710|NCT02608268|449021585|FG023|Overall Study|Subject/guardian decision|0|||
124833711|NCT02608268|449021586|FG024|Overall Study|Subject/guardian decision|0|||
124833712|NCT02608268|449021587|FG025|Overall Study|Subject/guardian decision|1|||
124833713|NCT02608268|449021588|FG026|Overall Study|Subject/guardian decision|1|||
124833714|NCT02608268|449021589|FG027|Overall Study|Subject/guardian decision|1|||
125304574|NCT02927938|450741352|FG000|Overall Study|Early Study Termination|1|||
124833715|NCT02608268|449021590|FG028|Overall Study|Subject/guardian decision|1|||
125304575|NCT02927938|450741353|FG001|Overall Study|Early Study Termination|5|||
124833716|NCT02608268|449021591|FG029|Overall Study|Subject/guardian decision|0|||
124833717|NCT04091646|449021596|FG000|Overall Study|Adverse Event|2|||
124833718|NCT04091646|449021597|FG001|Overall Study|Adverse Event|1|||
125304576|NCT02927938|450741354|FG002|Overall Study|Early Study Termination|4|||
124833719|NCT04091646|449021596|FG000|Overall Study|Lost to Follow-up|6|||
124833720|NCT04091646|449021597|FG001|Overall Study|Lost to Follow-up|2|||
124833721|NCT04091646|449021596|FG000|Overall Study|Protocol Violation|0|||
124833722|NCT04091646|449021597|FG001|Overall Study|Protocol Violation|1|||
124833723|NCT04091646|449021596|FG000|Overall Study|Withdrawal by Subject|4|||
124833724|NCT04091646|449021597|FG001|Overall Study|Withdrawal by Subject|1|||
124833725|NCT04091646|449021596|FG000|Overall Study|Participant Incarcerated|1|||
124833726|NCT04091646|449021597|FG001|Overall Study|Participant Incarcerated|0|||
124833727|NCT03102918|449021598|FG000|Overall Study|Protocol Violation|1|||
124833728|NCT03102918|449021599|FG001|Overall Study|Protocol Violation|0|||
124833729|NCT04765358|449021603|FG000|Overall Study|Withdrawal by Subject|1|||
124833730|NCT02731729|449021604|FG000|Overall Study|Death|2|||
124833731|NCT02731729|449021605|FG001|Overall Study|Death|2|||
124833732|NCT02731729|449021604|FG000|Overall Study|Study terminated by Sponsor|6|||
124833733|NCT02731729|449021605|FG001|Overall Study|Study terminated by Sponsor|6|||
124833734|NCT02731729|449021604|FG000|Overall Study|Withdrawal by Subject|1|||
124833735|NCT02731729|449021605|FG001|Overall Study|Withdrawal by Subject|0|||
124833736|NCT00159588|449021606|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
124833737|NCT00159588|449021607|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
124833738|NCT00159588|449021608|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
124833739|NCT02066467|449021609|FG000|Overall Study|Did not undergo implant procedure|24|||
124833740|NCT02066467|449021609|FG000|Overall Study|Attempted to implant withoput success|43|||
124833741|NCT02066467|449021609|FG000|Overall Study|Consent ineligible|1|||
124833742|NCT02066467|449021609|FG000|Overall Study|Death|54|||
124833743|NCT02066467|449021609|FG000|Overall Study|Lost to Follow-up|51|||
124833744|NCT02066467|449021609|FG000|Overall Study|Adverse Event|20|||
124833745|NCT02066467|449021609|FG000|Overall Study|Withdrawal by Subject|16|||
124833746|NCT02066467|449021609|FG000|Overall Study|Physician Decision|2|||
124833747|NCT02066467|449021609|FG000|Overall Study|Not defined|4|||
124833748|NCT00456521|449021610|FG000|Overall Study|Adverse Event|150|||
124833749|NCT00456521|449021611|FG001|Overall Study|Adverse Event|25|||
124833750|NCT00456521|449021610|FG000|Overall Study|Withdrawal by Subject|43|||
124833751|NCT00456521|449021611|FG001|Overall Study|Withdrawal by Subject|24|||
124833752|NCT00456521|449021610|FG000|Overall Study|Lost to Follow-up|22|||
124833753|NCT00456521|449021611|FG001|Overall Study|Lost to Follow-up|17|||
124833754|NCT00456521|449021610|FG000|Overall Study|Lack of Efficacy|3|||
124833755|NCT00456521|449021611|FG001|Overall Study|Lack of Efficacy|6|||
124833756|NCT00456521|449021610|FG000|Overall Study|Protocol Violation|4|||
124833757|NCT00456521|449021611|FG001|Overall Study|Protocol Violation|0|||
124833758|NCT00456521|449021610|FG000|Overall Study|Pregnancy|1|||
124833759|NCT00456521|449021611|FG001|Overall Study|Pregnancy|1|||
124833760|NCT00456521|449021610|FG000|Overall Study|Drug non-compliance, moved, other|26|||
124833761|NCT00456521|449021611|FG001|Overall Study|Drug non-compliance, moved, other|11|||
124833762|NCT01316276|449021612|FG000|Overall Study|Death|1|||
124833763|NCT01316276|449021612|FG000|Overall Study|Adverse Event|19|||
124833764|NCT01316276|449021612|FG000|Overall Study|Withdrawal of consent|24|||
124833765|NCT01316276|449021612|FG000|Overall Study|Lost to Follow-up|1|||
124833766|NCT01316276|449021612|FG000|Overall Study|Other|22|||
124833767|NCT00605475|449021613|FG000|Overall Study|Abnormal Laboratory Values|0|||
124833768|NCT00605475|449021614|FG001|Overall Study|Abnormal Laboratory Values|0|||
124833769|NCT00605475|449021615|FG002|Overall Study|Abnormal Laboratory Values|0|||
124833770|NCT00605475|449021616|FG003|Overall Study|Abnormal Laboratory Values|0|||
124833771|NCT00605475|449021617|FG004|Overall Study|Abnormal Laboratory Values|0|||
124833772|NCT00605475|449021618|FG005|Overall Study|Abnormal Laboratory Values|0|||
124833773|NCT00605475|449021619|FG006|Overall Study|Abnormal Laboratory Values|0|||
124833774|NCT00605475|449021620|FG007|Overall Study|Abnormal Laboratory Values|0|||
124833775|NCT00605475|449021621|FG008|Overall Study|Abnormal Laboratory Values|1|||
124833776|NCT00605475|449021622|FG009|Overall Study|Abnormal Laboratory Values|0|||
124833777|NCT00605475|449021613|FG000|Overall Study|Administrative problems|0|||
124833778|NCT00605475|449021614|FG001|Overall Study|Administrative problems|0|||
124833779|NCT00605475|449021615|FG002|Overall Study|Administrative problems|0|||
124833780|NCT00605475|449021616|FG003|Overall Study|Administrative problems|0|||
124833781|NCT00605475|449021617|FG004|Overall Study|Administrative problems|0|||
124833782|NCT00605475|449021618|FG005|Overall Study|Administrative problems|0|||
124833783|NCT00605475|449021619|FG006|Overall Study|Administrative problems|1|||
124833784|NCT00605475|449021620|FG007|Overall Study|Administrative problems|0|||
124833785|NCT00605475|449021621|FG008|Overall Study|Administrative problems|0|||
124833786|NCT00605475|449021622|FG009|Overall Study|Administrative problems|0|||
125304577|NCT02927938|450741355|FG003|Overall Study|Early Study Termination|3|||
124833787|NCT00605475|449021613|FG000|Overall Study|Lost to Follow-up|0|||
124833788|NCT00605475|449021614|FG001|Overall Study|Lost to Follow-up|0|||
124833789|NCT00605475|449021615|FG002|Overall Study|Lost to Follow-up|0|||
124833790|NCT00605475|449021616|FG003|Overall Study|Lost to Follow-up|0|||
124833791|NCT00605475|449021617|FG004|Overall Study|Lost to Follow-up|0|||
124833792|NCT00605475|449021618|FG005|Overall Study|Lost to Follow-up|0|||
124833793|NCT00605475|449021619|FG006|Overall Study|Lost to Follow-up|0|||
124833794|NCT00605475|449021620|FG007|Overall Study|Lost to Follow-up|0|||
124833795|NCT00605475|449021621|FG008|Overall Study|Lost to Follow-up|1|||
124833796|NCT00605475|449021622|FG009|Overall Study|Lost to Follow-up|1|||
124833797|NCT00605475|449021613|FG000|Overall Study|Protocol Violation|0|||
124833798|NCT00605475|449021614|FG001|Overall Study|Protocol Violation|0|||
124833799|NCT00605475|449021615|FG002|Overall Study|Protocol Violation|0|||
124833800|NCT00605475|449021616|FG003|Overall Study|Protocol Violation|0|||
124833801|NCT00605475|449021617|FG004|Overall Study|Protocol Violation|1|||
124833802|NCT00605475|449021618|FG005|Overall Study|Protocol Violation|0|||
124833803|NCT00605475|449021619|FG006|Overall Study|Protocol Violation|0|||
124833804|NCT00605475|449021620|FG007|Overall Study|Protocol Violation|0|||
124833805|NCT00605475|449021621|FG008|Overall Study|Protocol Violation|0|||
124833806|NCT00605475|449021622|FG009|Overall Study|Protocol Violation|0|||
124833807|NCT00605475|449021613|FG000|Overall Study|Withdrawal by Subject|0|||
124833808|NCT00605475|449021614|FG001|Overall Study|Withdrawal by Subject|0|||
124833809|NCT00605475|449021615|FG002|Overall Study|Withdrawal by Subject|0|||
124833810|NCT00605475|449021616|FG003|Overall Study|Withdrawal by Subject|0|||
124833811|NCT00605475|449021617|FG004|Overall Study|Withdrawal by Subject|0|||
124833812|NCT00605475|449021618|FG005|Overall Study|Withdrawal by Subject|2|||
124833813|NCT00605475|449021619|FG006|Overall Study|Withdrawal by Subject|0|||
124833814|NCT00605475|449021620|FG007|Overall Study|Withdrawal by Subject|0|||
124833815|NCT00605475|449021621|FG008|Overall Study|Withdrawal by Subject|0|||
124833816|NCT00605475|449021622|FG009|Overall Study|Withdrawal by Subject|1|||
124833817|NCT00297037|449021625|FG000|Overall Study|Withdrawal by Subject|2|||
124833818|NCT00297037|449021626|FG001|Overall Study|Withdrawal by Subject|0|||
124833819|NCT00076011|449021627|FG000|Overall Study|Death|1|||
124833820|NCT00076011|449021627|FG000|Overall Study|Adverse Event|10|||
124833821|NCT00076011|449021627|FG000|Overall Study|Lack of Efficacy|25|||
124833822|NCT00076011|449021627|FG000|Overall Study|Withdrawal by Subject|1|||
124833823|NCT00076011|449021627|FG000|Overall Study|Study terminated by sponsor|3|||
124833824|NCT00076011|449021627|FG000|Overall Study|Other|11|||
124833825|NCT00076011|449021627|FG000|Overall Study|Ongoing|1|||
124833826|NCT00581776|449021628|FG000|Overall Study|Disease progression or no response|3|||
124833827|NCT03056755|449021633|FG000|Treatment- Core Phase|Progressive disease|89|||
124833828|NCT03056755|449021634|FG001|Treatment- Core Phase|Progressive disease|88|||
124833829|NCT03056755|449021635|FG002|Treatment- Core Phase|Progressive disease|90|||
124833830|NCT03056755|449021633|FG000|Treatment- Core Phase|Adverse Event|20|||
124833831|NCT03056755|449021634|FG001|Treatment- Core Phase|Adverse Event|14|||
124833832|NCT03056755|449021635|FG002|Treatment- Core Phase|Adverse Event|13|||
124833833|NCT03056755|449021633|FG000|Treatment- Core Phase|Physician Decision|7|||
124833834|NCT03056755|449021634|FG001|Treatment- Core Phase|Physician Decision|13|||
124833835|NCT03056755|449021635|FG002|Treatment- Core Phase|Physician Decision|5|||
124833836|NCT03056755|449021633|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
124833837|NCT03056755|449021634|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
124833838|NCT03056755|449021635|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
124833839|NCT03056755|449021633|FG000|Treatment- Core Phase|Death|3|||
124833840|NCT03056755|449021634|FG001|Treatment- Core Phase|Death|2|||
124833841|NCT03056755|449021635|FG002|Treatment- Core Phase|Death|4|||
124833842|NCT03056755|449021633|FG000|Treatment- Core Phase|Protocol deviation|1|||
124833843|NCT03056755|449021634|FG001|Treatment- Core Phase|Protocol deviation|1|||
124833844|NCT03056755|449021635|FG002|Treatment- Core Phase|Protocol deviation|0|||
124833845|NCT03056755|449021633|FG000|Treatment- Core Phase|Technical problems|1|||
124833846|NCT03056755|449021634|FG001|Treatment- Core Phase|Technical problems|0|||
124833847|NCT03056755|449021635|FG002|Treatment- Core Phase|Technical problems|0|||
124833848|NCT03056755|449021633|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
124833849|NCT03056755|449021634|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
124833850|NCT03056755|449021635|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
124833851|NCT03056755|449021633|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
124833852|NCT03056755|449021634|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
124833853|NCT03056755|449021635|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
124833854|NCT03056755|449021633|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
124833855|NCT03056755|449021634|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
124833856|NCT03056755|449021635|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
124833857|NCT03056755|449021633|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
124833858|NCT03056755|449021634|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
124833859|NCT03056755|449021635|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
124833860|NCT03615326|449021639|FG000|Overall Study|Death|266|||
124833861|NCT03615326|449021640|FG001|Overall Study|Death|286|||
124833862|NCT03615326|449021641|FG002|Overall Study|Death|14|||
124833863|NCT03615326|449021642|FG003|Overall Study|Death|17|||
124833864|NCT03615326|449021639|FG000|Overall Study|Lost to Follow-up|0|||
124833865|NCT03615326|449021640|FG001|Overall Study|Lost to Follow-up|1|||
124833866|NCT03615326|449021641|FG002|Overall Study|Lost to Follow-up|0|||
124833867|NCT03615326|449021642|FG003|Overall Study|Lost to Follow-up|0|||
124833868|NCT03615326|449021639|FG000|Overall Study|Withdrawal by Subject|1|||
124833869|NCT03615326|449021640|FG001|Overall Study|Withdrawal by Subject|3|||
124833870|NCT03615326|449021641|FG002|Overall Study|Withdrawal by Subject|0|||
124833871|NCT03615326|449021642|FG003|Overall Study|Withdrawal by Subject|0|||
124833872|NCT03615326|449021639|FG000|Overall Study|Participants Ongoing|83|||
124833873|NCT03615326|449021640|FG001|Overall Study|Participants Ongoing|58|||
124833874|NCT03615326|449021641|FG002|Overall Study|Participants Ongoing|6|||
124833875|NCT03615326|449021642|FG003|Overall Study|Participants Ongoing|3|||
124833876|NCT00405587|449021645|FG000|Overall Study|Death|0|||
124833877|NCT00405587|449021646|FG001|Overall Study|Death|0|||
124833878|NCT00405587|449021647|FG002|Overall Study|Death|0|||
124833879|NCT00405587|449021648|FG003|Overall Study|Death|1|||
124833880|NCT00405587|449021645|FG000|Overall Study|Disease Progression|22|||
124833881|NCT00405587|449021646|FG001|Overall Study|Disease Progression|23|||
124833882|NCT00405587|449021647|FG002|Overall Study|Disease Progression|21|||
124833883|NCT00405587|449021648|FG003|Overall Study|Disease Progression|17|||
124833884|NCT00405587|449021645|FG000|Overall Study|Physician Decision|3|||
124833885|NCT00405587|449021646|FG001|Overall Study|Physician Decision|2|||
124833886|NCT00405587|449021647|FG002|Overall Study|Physician Decision|0|||
124833887|NCT00405587|449021648|FG003|Overall Study|Physician Decision|0|||
124833888|NCT00405587|449021645|FG000|Overall Study|Adverse Event|1|||
124833889|NCT00405587|449021646|FG001|Overall Study|Adverse Event|0|||
124833890|NCT00405587|449021647|FG002|Overall Study|Adverse Event|0|||
124833891|NCT00405587|449021648|FG003|Overall Study|Adverse Event|0|||
124833892|NCT00405587|449021645|FG000|Overall Study|Lost to Follow-up|0|||
124833893|NCT00405587|449021646|FG001|Overall Study|Lost to Follow-up|1|||
124833894|NCT00405587|449021647|FG002|Overall Study|Lost to Follow-up|1|||
124833895|NCT00405587|449021648|FG003|Overall Study|Lost to Follow-up|0|||
124833896|NCT00405587|449021645|FG000|Overall Study|Radiation induced necrosis|0|||
124833897|NCT00405587|449021646|FG001|Overall Study|Radiation induced necrosis|1|||
124833898|NCT00405587|449021647|FG002|Overall Study|Radiation induced necrosis|0|||
124833899|NCT00405587|449021648|FG003|Overall Study|Radiation induced necrosis|0|||
124833900|NCT00405587|449021645|FG000|Overall Study|Withdrawal by Subject|0|||
124833901|NCT00405587|449021646|FG001|Overall Study|Withdrawal by Subject|0|||
124833902|NCT00405587|449021647|FG002|Overall Study|Withdrawal by Subject|0|||
124833903|NCT00405587|449021648|FG003|Overall Study|Withdrawal by Subject|2|||
124833904|NCT00405587|449021645|FG000|Overall Study|Participant not dosed|0|||
124833905|NCT00405587|449021646|FG001|Overall Study|Participant not dosed|1|||
124833906|NCT00405587|449021647|FG002|Overall Study|Participant not dosed|0|||
124833907|NCT00405587|449021648|FG003|Overall Study|Participant not dosed|0|||
124833908|NCT03506373|449021653|FG000|Overall Study|Adverse Event|6|||
124833909|NCT03506373|449021653|FG000|Overall Study|Withdrawal by Subject|2|||
124833910|NCT03506373|449021653|FG000|Overall Study|Disease progression|5|||
124833911|NCT03506373|449021653|FG000|Overall Study|Other|3|||
124833912|NCT02211131|449021654|FG000|Overall Study|Death|26|||
124833913|NCT02211131|449021655|FG001|Overall Study|Death|16|||
124833914|NCT02211131|449021654|FG000|Overall Study|Lost to Follow-up|4|||
124833915|NCT02211131|449021655|FG001|Overall Study|Lost to Follow-up|3|||
124833916|NCT02211131|449021654|FG000|Overall Study|Decision by Sponsor|1|||
124833917|NCT02211131|449021655|FG001|Overall Study|Decision by Sponsor|1|||
124833918|NCT02211131|449021654|FG000|Overall Study|Withdrawal by Subject|3|||
124833919|NCT02211131|449021655|FG001|Overall Study|Withdrawal by Subject|8|||
124833920|NCT02120950|449021656|FG000|Overall Study|Adverse Event|5|||
124833921|NCT02120950|449021657|FG001|Overall Study|Adverse Event|4|||
124833922|NCT02120950|449021658|FG002|Overall Study|Adverse Event|3|||
124833923|NCT02120950|449021656|FG000|Overall Study|Death|3|||
124833924|NCT02120950|449021657|FG001|Overall Study|Death|0|||
124833925|NCT02120950|449021658|FG002|Overall Study|Death|1|||
124833926|NCT02120950|449021656|FG000|Overall Study|Withdrawal by Subject|6|||
124833927|NCT02120950|449021657|FG001|Overall Study|Withdrawal by Subject|3|||
124833928|NCT02120950|449021658|FG002|Overall Study|Withdrawal by Subject|2|||
124833929|NCT02120950|449021656|FG000|Overall Study|Protocol Violation|1|||
124833930|NCT02120950|449021657|FG001|Overall Study|Protocol Violation|1|||
124833931|NCT02120950|449021658|FG002|Overall Study|Protocol Violation|7|||
124833932|NCT02120950|449021656|FG000|Overall Study|Other reasons|5|||
124833933|NCT02120950|449021657|FG001|Overall Study|Other reasons|4|||
124833934|NCT02120950|449021658|FG002|Overall Study|Other reasons|1|||
124833935|NCT02120950|449021656|FG000|Overall Study|Lost to Follow-up|0|||
124833936|NCT02120950|449021657|FG001|Overall Study|Lost to Follow-up|2|||
124833937|NCT02120950|449021658|FG002|Overall Study|Lost to Follow-up|1|||
124833938|NCT02424383|449021659|FG000|Overall Study|Withdrawal by Subject|32|||
124833939|NCT02424383|449021659|FG000|Overall Study|Death|170|||
124833940|NCT02424383|449021659|FG000|Overall Study|Sponsor's decision|3|||
124833941|NCT02424383|449021659|FG000|Overall Study|Investigator's decision|44|||
124833942|NCT02424383|449021659|FG000|Overall Study|Lost to Follow-up|81|||
124833943|NCT02424383|449021659|FG000|Overall Study|Other|7|||
124833944|NCT02424383|449021659|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
124833945|NCT01852812|449021660|FG000|Overall Study|Adverse Event|0|||
124833946|NCT01852812|449021661|FG001|Overall Study|Adverse Event|0|||
124833947|NCT01852812|449021662|FG002|Overall Study|Adverse Event|1|||
125304578|NCT00082407|450742689|FG000|Overall Study|Adverse Event|20|||
124833948|NCT01852812|449021660|FG000|Overall Study|Non-compliance With Study Drug|0|||
124833949|NCT01852812|449021661|FG001|Overall Study|Non-compliance With Study Drug|1|||
124833950|NCT01852812|449021662|FG002|Overall Study|Non-compliance With Study Drug|0|||
124833951|NCT02250443|449021663|FG000|Overall Study|Administrative problems|7|||
124833952|NCT02250443|449021663|FG000|Overall Study|Adverse Event|3|||
125304579|NCT00082407|450742690|FG001|Overall Study|Adverse Event|0|||
124833953|NCT01549964|449021664|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
124833954|NCT01549964|449021665|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
124833955|NCT01549964|449021666|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
124833956|NCT01549964|449021667|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
124833957|NCT01549964|449021664|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
124833958|NCT01549964|449021665|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
124833959|NCT01549964|449021666|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
124833960|NCT01549964|449021667|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
124833961|NCT01549964|449021664|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
124833962|NCT01549964|449021665|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
124833963|NCT01549964|449021666|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
124833964|NCT01549964|449021667|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
124833965|NCT01549964|449021664|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
124833966|NCT01549964|449021665|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
124833967|NCT01549964|449021666|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
124833968|NCT01549964|449021667|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
124833969|NCT01549964|449021664|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
124833970|NCT01549964|449021665|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
124833971|NCT01549964|449021666|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
124833972|NCT01549964|449021667|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
124833973|NCT01549964|449021664|FG000|24-Week Treatment Period|Other|1|||
124833974|NCT01549964|449021665|FG001|24-Week Treatment Period|Other|0|||
124833975|NCT01549964|449021666|FG002|24-Week Treatment Period|Other|1|||
124833976|NCT01549964|449021667|FG003|24-Week Treatment Period|Other|0|||
124833977|NCT01549964|449021664|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
124833978|NCT01549964|449021665|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
124833979|NCT01549964|449021666|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
124833980|NCT01549964|449021667|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
124833981|NCT01549964|449021664|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
124833982|NCT01549964|449021665|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
124833983|NCT01549964|449021666|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
124833984|NCT01549964|449021667|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
124833985|NCT01549964|449021664|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
124833986|NCT01549964|449021665|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
124833987|NCT01549964|449021666|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
124833988|NCT01549964|449021667|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
124833989|NCT01549964|449021664|FG000|80-Week Extension Period|Pregnancy|0|||
124833990|NCT01549964|449021665|FG001|80-Week Extension Period|Pregnancy|0|||
124833991|NCT01549964|449021666|FG002|80-Week Extension Period|Pregnancy|1|||
124833992|NCT01549964|449021667|FG003|80-Week Extension Period|Pregnancy|0|||
124833993|NCT01549964|449021664|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
124833994|NCT01549964|449021665|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
124833995|NCT01549964|449021666|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
124833996|NCT01549964|449021667|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
124833997|NCT01549964|449021664|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
124833998|NCT01549964|449021665|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
124833999|NCT01549964|449021666|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
124834000|NCT01549964|449021667|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
124834001|NCT01549964|449021664|FG000|80-Week Extension Period|Lost to Follow-up|1|||
124834002|NCT01549964|449021665|FG001|80-Week Extension Period|Lost to Follow-up|0|||
124834003|NCT01549964|449021666|FG002|80-Week Extension Period|Lost to Follow-up|2|||
124834004|NCT01549964|449021667|FG003|80-Week Extension Period|Lost to Follow-up|1|||
124834005|NCT01549964|449021664|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
124834006|NCT01549964|449021665|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
124834007|NCT01549964|449021666|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
124834008|NCT01549964|449021667|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
124834009|NCT02290821|449021668|FG000|Overall Study|Withdrawal by Subject|1|||
124834010|NCT02290821|449021669|FG001|Overall Study|Withdrawal by Subject|1|||
124834011|NCT02290821|449021668|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
124834012|NCT02290821|449021669|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
124834013|NCT02290821|449021668|FG000|Overall Study|Lost to Follow-up|3|||
124834014|NCT02290821|449021669|FG001|Overall Study|Lost to Follow-up|2|||
124834015|NCT00728130|449021670|FG000|Overall Study|Withdrawal by Subject|1|||
124834016|NCT00728130|449021670|FG000|Overall Study|Paperwork not completed in time|1|||
124834017|NCT00728130|449021670|FG000|Overall Study|Physician Decision|1|||
124834018|NCT01154218|449021671|FG000|Third Intervention Period|Adverse Event|0|||
124834019|NCT01154218|449021672|FG001|Third Intervention Period|Adverse Event|1|||
124834020|NCT01154218|449021673|FG002|Third Intervention Period|Adverse Event|0|||
124834021|NCT01154218|449021674|FG003|Third Intervention Period|Adverse Event|0|||
124834022|NCT01154218|449021671|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
124834023|NCT01154218|449021672|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
124834024|NCT01154218|449021673|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
124834025|NCT01154218|449021674|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
124834026|NCT01154218|449021671|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
124834027|NCT01154218|449021672|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
124834028|NCT01154218|449021673|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
124834029|NCT01154218|449021674|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
124834030|NCT00362115|449021677|FG000|Overall Study|Adverse Event|0|||
124834031|NCT00362115|449021678|FG001|Overall Study|Adverse Event|1|||
124834032|NCT00362115|449021679|FG002|Overall Study|Adverse Event|1|||
124834033|NCT00362115|449021680|FG003|Overall Study|Adverse Event|1|||
124834034|NCT00362115|449021681|FG004|Overall Study|Adverse Event|2|||
124834035|NCT00362115|449021682|FG005|Overall Study|Adverse Event|2|||
124834036|NCT00362115|449021683|FG006|Overall Study|Adverse Event|1|||
124834037|NCT00362115|449021677|FG000|Overall Study|Protocol Violation|0|||
124834038|NCT00362115|449021678|FG001|Overall Study|Protocol Violation|0|||
124834039|NCT00362115|449021679|FG002|Overall Study|Protocol Violation|0|||
124834040|NCT00362115|449021680|FG003|Overall Study|Protocol Violation|0|||
124834041|NCT00362115|449021681|FG004|Overall Study|Protocol Violation|0|||
124834042|NCT00362115|449021682|FG005|Overall Study|Protocol Violation|1|||
124834043|NCT00362115|449021683|FG006|Overall Study|Protocol Violation|0|||
124834044|NCT00362115|449021677|FG000|Overall Study|Lost to Follow-up|0|||
124834045|NCT00362115|449021678|FG001|Overall Study|Lost to Follow-up|1|||
124834046|NCT00362115|449021679|FG002|Overall Study|Lost to Follow-up|0|||
124834047|NCT00362115|449021680|FG003|Overall Study|Lost to Follow-up|0|||
124834048|NCT00362115|449021681|FG004|Overall Study|Lost to Follow-up|2|||
124834049|NCT00362115|449021682|FG005|Overall Study|Lost to Follow-up|0|||
124834050|NCT00362115|449021683|FG006|Overall Study|Lost to Follow-up|1|||
124834051|NCT00362115|449021677|FG000|Overall Study|Withdrawal by Subject|1|||
124834052|NCT00362115|449021678|FG001|Overall Study|Withdrawal by Subject|3|||
124834053|NCT00362115|449021679|FG002|Overall Study|Withdrawal by Subject|1|||
124834054|NCT00362115|449021680|FG003|Overall Study|Withdrawal by Subject|0|||
124834055|NCT00362115|449021681|FG004|Overall Study|Withdrawal by Subject|1|||
124834056|NCT00362115|449021682|FG005|Overall Study|Withdrawal by Subject|3|||
124834057|NCT00362115|449021683|FG006|Overall Study|Withdrawal by Subject|4|||
124834058|NCT00362115|449021677|FG000|Overall Study|Lack of Efficacy|1|||
124834059|NCT00362115|449021678|FG001|Overall Study|Lack of Efficacy|0|||
124834060|NCT00362115|449021679|FG002|Overall Study|Lack of Efficacy|5|||
124834061|NCT00362115|449021680|FG003|Overall Study|Lack of Efficacy|2|||
124834062|NCT00362115|449021681|FG004|Overall Study|Lack of Efficacy|2|||
124834063|NCT00362115|449021682|FG005|Overall Study|Lack of Efficacy|0|||
124834064|NCT00362115|449021683|FG006|Overall Study|Lack of Efficacy|3|||
124834065|NCT00362115|449021677|FG000|Overall Study|Physician Decision|0|||
124834066|NCT00362115|449021678|FG001|Overall Study|Physician Decision|0|||
124834067|NCT00362115|449021679|FG002|Overall Study|Physician Decision|0|||
124834068|NCT00362115|449021680|FG003|Overall Study|Physician Decision|0|||
124834069|NCT00362115|449021681|FG004|Overall Study|Physician Decision|0|||
124834070|NCT00362115|449021682|FG005|Overall Study|Physician Decision|0|||
124834071|NCT00362115|449021683|FG006|Overall Study|Physician Decision|3|||
124834072|NCT00362115|449021677|FG000|Overall Study|Other|0|||
124834073|NCT00362115|449021678|FG001|Overall Study|Other|1|||
124834074|NCT00362115|449021679|FG002|Overall Study|Other|0|||
124834075|NCT00362115|449021680|FG003|Overall Study|Other|1|||
124834076|NCT00362115|449021681|FG004|Overall Study|Other|0|||
124834077|NCT00362115|449021682|FG005|Overall Study|Other|1|||
124834078|NCT00362115|449021683|FG006|Overall Study|Other|0|||
124834079|NCT00335972|449021684|FG000|Overall Study|not given treatments|0|||
124834080|NCT00335972|449021685|FG001|Overall Study|not given treatments|3|||
124834081|NCT03803774|449021686|FG000|Dose Escalation|Withdrawal by Subject|0|||
124834082|NCT03803774|449021687|FG001|Dose Escalation|Withdrawal by Subject|0|||
125304580|NCT00082407|450742689|FG000|Overall Study|Protocol Violation|14|||
125304581|NCT00082407|450742690|FG001|Overall Study|Protocol Violation|12|||
124834083|NCT03803774|449021688|FG002|Dose Escalation|Withdrawal by Subject|0|||
124834084|NCT03803774|449021689|FG003|Dose Escalation|Withdrawal by Subject|1|||
124834085|NCT03803774|449021690|FG004|Dose Escalation|Withdrawal by Subject|0|||
124834086|NCT05497284|449021698|FG000|Overall Study|Adverse Event|1|||
124834087|NCT05497284|449021699|FG001|Overall Study|Adverse Event|0|||
124834088|NCT05497284|449021698|FG000|Overall Study|Physician Decision|0|||
124834089|NCT05497284|449021699|FG001|Overall Study|Physician Decision|1|||
124834090|NCT05497284|449021698|FG000|Overall Study|Study terminated by sponsor|7|||
125304582|NCT00082407|450742689|FG000|Overall Study|Patient Decision|13|||
124834091|NCT05497284|449021699|FG001|Overall Study|Study terminated by sponsor|4|||
124834092|NCT05497284|449021698|FG000|Overall Study|Subject Decision|0|||
124834093|NCT05497284|449021699|FG001|Overall Study|Subject Decision|1|||
124834094|NCT03878446|449021700|FG000|Overall Study|Withdrawn by parent or guardian|1|||
124834095|NCT03878446|449021701|FG001|Overall Study|Withdrawn by parent or guardian|0|||
124834096|NCT03878446|449021702|FG002|Overall Study|Withdrawn by parent or guardian|0|||
124834097|NCT03878446|449021703|FG003|Overall Study|Withdrawn by parent or guardian|0|||
124834098|NCT03878446|449021704|FG004|Overall Study|Withdrawn by parent or guardian|0|||
124834099|NCT04365556|449021705|FG000|Overall Study|No longer eligible due to treatment plan|1|||
124834100|NCT04365556|449021706|FG001|Overall Study|No longer eligible due to treatment plan|0|||
124834101|NCT04365556|449021705|FG000|Overall Study|Lost to Follow-up|3|||
124834102|NCT04365556|449021706|FG001|Overall Study|Lost to Follow-up|2|||
124834103|NCT03181399|449023563|FG000|6 Months on Treatment|Protocol non-compliance|7|||
124834104|NCT03181399|449023563|FG000|6 Months on Treatment|Adverse Event|4|||
124834105|NCT03181399|449023563|FG000|6 Months on Treatment|Tried alternative treatment|2|||
124834106|NCT03181399|449023563|FG000|6 Months on Treatment|Lost to Follow-up|2|||
124834107|NCT03181399|449023563|FG000|6 Months on Treatment|Personal reasons|1|||
124834108|NCT03181399|449023563|FG000|3 Months Off-treatment|Parent unable to travel|1|||
124834109|NCT05123222|449023564|FG000|Overall Study|Lost to Follow-up|2|||
124834110|NCT05123222|449023565|FG001|Overall Study|Lost to Follow-up|0|||
124834111|NCT05123222|449023566|FG002|Overall Study|Lost to Follow-up|0|||
124834112|NCT05123222|449023567|FG003|Overall Study|Lost to Follow-up|0|||
124834113|NCT05123222|449023564|FG000|Overall Study|Protocol Violation|0|||
124834114|NCT05123222|449023565|FG001|Overall Study|Protocol Violation|0|||
124834115|NCT05123222|449023566|FG002|Overall Study|Protocol Violation|1|||
124834116|NCT05123222|449023567|FG003|Overall Study|Protocol Violation|0|||
124834117|NCT00265343|449023568|FG000|Overall Study|Adverse Event|10|||
124834118|NCT00265343|449023569|FG001|Overall Study|Adverse Event|7|||
124834119|NCT00265343|449023568|FG000|Overall Study|Withdrawal by Subject|3|||
124834120|NCT00265343|449023569|FG001|Overall Study|Withdrawal by Subject|9|||
124834121|NCT00265343|449023568|FG000|Overall Study|Other|8|||
124834122|NCT00265343|449023569|FG001|Overall Study|Other|3|||
124834123|NCT04865354|449023570|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
124834124|NCT04865354|449023571|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
124834125|NCT04865354|449023570|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
124834126|NCT04865354|449023571|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
124834127|NCT04865354|449023570|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
124834128|NCT04865354|449023571|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
124834129|NCT00706641|449023572|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
124834130|NCT00706641|449023572|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
124834131|NCT00706641|449023572|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
124834132|NCT02515942|449023574|FG000|Overall Study|Adverse Event|5|||
124834133|NCT02515942|449023575|FG001|Overall Study|Adverse Event|0|||
124834134|NCT02515942|449023576|FG002|Overall Study|Adverse Event|0|||
124834135|NCT02515942|449023574|FG000|Overall Study|Death|0|||
124834136|NCT02515942|449023575|FG001|Overall Study|Death|0|||
124834137|NCT02515942|449023576|FG002|Overall Study|Death|1|||
124834138|NCT02515942|449023574|FG000|Overall Study|Lack of Efficacy|0|||
124834139|NCT02515942|449023575|FG001|Overall Study|Lack of Efficacy|0|||
124834140|NCT02515942|449023576|FG002|Overall Study|Lack of Efficacy|1|||
124834141|NCT02515942|449023574|FG000|Overall Study|Lost to Follow-up|2|||
124834142|NCT02515942|449023575|FG001|Overall Study|Lost to Follow-up|0|||
124834143|NCT02515942|449023576|FG002|Overall Study|Lost to Follow-up|0|||
124834144|NCT02515942|449023574|FG000|Overall Study|Withdrawal by Subject|0|||
124834145|NCT02515942|449023575|FG001|Overall Study|Withdrawal by Subject|3|||
124834146|NCT02515942|449023576|FG002|Overall Study|Withdrawal by Subject|2|||
124834147|NCT00902564|449023578|FG000|Overall Study|Withdrawal by Subject|2|||
124834148|NCT00922766|449023579|FG000|Overall Study|Death|3|||
124834149|NCT00922766|449023579|FG000|Overall Study|Withdrawal by Subject|2|||
124834150|NCT00922766|449023579|FG000|Overall Study|Other|1|||
124834151|NCT00922766|449023579|FG000|Overall Study|Adverse Event|1|||
124834152|NCT01649375|449023582|FG000|Up to Week 16|Adverse Event|2|||
124834153|NCT01649375|449023583|FG001|Up to Week 16|Adverse Event|5|||
124834154|NCT01649375|449023584|FG002|Up to Week 16|Adverse Event|4|||
124834155|NCT01649375|449023585|FG003|Up to Week 16|Adverse Event|0|||
124834156|NCT01649375|449023586|FG004|Up to Week 16|Adverse Event|0|||
124834157|NCT01649375|449023582|FG000|Up to Week 16|Lack of Efficacy|0|||
124834158|NCT01649375|449023583|FG001|Up to Week 16|Lack of Efficacy|0|||
124834159|NCT01649375|449023584|FG002|Up to Week 16|Lack of Efficacy|1|||
124834160|NCT01649375|449023585|FG003|Up to Week 16|Lack of Efficacy|0|||
124834161|NCT01649375|449023586|FG004|Up to Week 16|Lack of Efficacy|0|||
124834162|NCT01649375|449023582|FG000|Up to Week 16|Physician Decision|0|||
124834163|NCT01649375|449023583|FG001|Up to Week 16|Physician Decision|0|||
124834164|NCT01649375|449023584|FG002|Up to Week 16|Physician Decision|1|||
124834165|NCT01649375|449023585|FG003|Up to Week 16|Physician Decision|0|||
124834166|NCT01649375|449023586|FG004|Up to Week 16|Physician Decision|0|||
124834167|NCT01649375|449023582|FG000|Up to Week 16|Withdrawal by Subject|2|||
124834168|NCT01649375|449023583|FG001|Up to Week 16|Withdrawal by Subject|1|||
124834169|NCT01649375|449023584|FG002|Up to Week 16|Withdrawal by Subject|2|||
124834170|NCT01649375|449023585|FG003|Up to Week 16|Withdrawal by Subject|0|||
124834171|NCT01649375|449023586|FG004|Up to Week 16|Withdrawal by Subject|0|||
124834172|NCT01649375|449023582|FG000|Up to Week 16|Death|1|||
124834173|NCT01649375|449023583|FG001|Up to Week 16|Death|0|||
124834174|NCT01649375|449023584|FG002|Up to Week 16|Death|0|||
124834175|NCT01649375|449023585|FG003|Up to Week 16|Death|0|||
124834176|NCT01649375|449023586|FG004|Up to Week 16|Death|0|||
124834177|NCT01649375|449023582|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
124834178|NCT01649375|449023583|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
124834179|NCT01649375|449023584|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
124834180|NCT01649375|449023585|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
124834181|NCT01649375|449023586|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
124834182|NCT01649375|449023582|FG000|Week 16 up to Week 260|Non-compliance|0|||
124834183|NCT01649375|449023583|FG001|Week 16 up to Week 260|Non-compliance|1|||
124834184|NCT01649375|449023584|FG002|Week 16 up to Week 260|Non-compliance|0|||
124834185|NCT01649375|449023585|FG003|Week 16 up to Week 260|Non-compliance|1|||
124834186|NCT01649375|449023586|FG004|Week 16 up to Week 260|Non-compliance|0|||
124834187|NCT01649375|449023582|FG000|Week 16 up to Week 260|Physician Decision|0|||
124834188|NCT01649375|449023583|FG001|Week 16 up to Week 260|Physician Decision|2|||
124834189|NCT01649375|449023584|FG002|Week 16 up to Week 260|Physician Decision|0|||
124834190|NCT01649375|449023585|FG003|Week 16 up to Week 260|Physician Decision|0|||
124834191|NCT01649375|449023586|FG004|Week 16 up to Week 260|Physician Decision|0|||
124834192|NCT01649375|449023582|FG000|Week 16 up to Week 260|Technical issues|0|||
124834193|NCT01649375|449023583|FG001|Week 16 up to Week 260|Technical issues|1|||
124834194|NCT01649375|449023584|FG002|Week 16 up to Week 260|Technical issues|0|||
124834195|NCT01649375|449023585|FG003|Week 16 up to Week 260|Technical issues|1|||
124834196|NCT01649375|449023586|FG004|Week 16 up to Week 260|Technical issues|0|||
124834197|NCT01649375|449023582|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
124834198|NCT01649375|449023583|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
124834199|NCT01649375|449023584|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
124834200|NCT01649375|449023585|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
124834201|NCT01649375|449023586|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
124834202|NCT01649375|449023582|FG000|Week 16 up to Week 260|Death|1|||
124834203|NCT01649375|449023583|FG001|Week 16 up to Week 260|Death|1|||
124834204|NCT01649375|449023584|FG002|Week 16 up to Week 260|Death|0|||
124834205|NCT01649375|449023585|FG003|Week 16 up to Week 260|Death|0|||
124834206|NCT01649375|449023586|FG004|Week 16 up to Week 260|Death|0|||
124834207|NCT01649375|449023582|FG000|Week 16 up to Week 260|Adverse Event|5|||
124834208|NCT01649375|449023583|FG001|Week 16 up to Week 260|Adverse Event|2|||
124834209|NCT01649375|449023584|FG002|Week 16 up to Week 260|Adverse Event|0|||
124834210|NCT01649375|449023585|FG003|Week 16 up to Week 260|Adverse Event|3|||
124834211|NCT01649375|449023586|FG004|Week 16 up to Week 260|Adverse Event|2|||
124834212|NCT01762943|449023589|FG000|Overall Study|Physician Decision|1|||
124834213|NCT01762943|449023590|FG001|Overall Study|Physician Decision|1|||
124834214|NCT01762943|449023589|FG000|Overall Study|Protocol Violation|1|||
124834215|NCT01762943|449023590|FG001|Overall Study|Protocol Violation|0|||
124834216|NCT01762943|449023589|FG000|Overall Study|Withdrawal by Subject|2|||
124834217|NCT01762943|449023590|FG001|Overall Study|Withdrawal by Subject|1|||
124834218|NCT00539838|449023591|FG000|Overall Study|Fail to return|2|||
124834219|NCT00539838|449023592|FG001|Overall Study|Fail to return|0|||
124834220|NCT00539838|449023593|FG002|Overall Study|Fail to return|0|||
124834221|NCT00539838|449023591|FG000|Overall Study|Withdrawal by Subject|0|||
124834222|NCT00539838|449023592|FG001|Overall Study|Withdrawal by Subject|4|||
124834223|NCT00539838|449023593|FG002|Overall Study|Withdrawal by Subject|0|||
124834224|NCT00539838|449023591|FG000|Overall Study|Death|0|||
124834225|NCT00539838|449023592|FG001|Overall Study|Death|2|||
124834226|NCT00539838|449023593|FG002|Overall Study|Death|0|||
124834227|NCT00539838|449023591|FG000|Overall Study|Did not cooperate|1|||
124834228|NCT00539838|449023592|FG001|Overall Study|Did not cooperate|0|||
124834229|NCT00539838|449023593|FG002|Overall Study|Did not cooperate|1|||
124834230|NCT00539838|449023591|FG000|Overall Study|Administrative|4|||
124834231|NCT00539838|449023592|FG001|Overall Study|Administrative|0|||
124834232|NCT00539838|449023593|FG002|Overall Study|Administrative|8|||
124834233|NCT02658890|449023594|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834234|NCT02658890|449023595|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834235|NCT02658890|449023596|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834236|NCT02658890|449023597|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834237|NCT02658890|449023598|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834238|NCT02658890|449023599|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834239|NCT02658890|449023600|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834240|NCT02658890|449023601|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834241|NCT02658890|449023602|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
124834242|NCT02658890|449023603|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834243|NCT02658890|449023604|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834244|NCT02658890|449023605|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834245|NCT02658890|449023606|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834246|NCT02658890|449023607|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834247|NCT02658890|449023608|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834248|NCT02658890|449023609|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834249|NCT02658890|449023610|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834250|NCT02658890|449023611|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834251|NCT02658890|449023612|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834252|NCT02658890|449023613|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834253|NCT02658890|449023614|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834254|NCT02658890|449023615|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834255|NCT02658890|449023616|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834256|NCT02658890|449023617|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834257|NCT02658890|449023618|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834258|NCT02658890|449023619|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834259|NCT02658890|449023620|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834260|NCT02658890|449023594|FG000|Treatment Phase|Adverse Event|0|||
124834261|NCT02658890|449023595|FG001|Treatment Phase|Adverse Event|1|||
124834262|NCT02658890|449023596|FG002|Treatment Phase|Adverse Event|2|||
124834263|NCT02658890|449023597|FG003|Treatment Phase|Adverse Event|2|||
124834264|NCT02658890|449023598|FG004|Treatment Phase|Adverse Event|1|||
124834265|NCT02658890|449023599|FG005|Treatment Phase|Adverse Event|0|||
124834266|NCT02658890|449023600|FG006|Treatment Phase|Adverse Event|0|||
124834267|NCT02658890|449023601|FG007|Treatment Phase|Adverse Event|2|||
124834268|NCT02658890|449023602|FG008|Treatment Phase|Adverse Event|1|||
124834269|NCT02658890|449023603|FG009|Treatment Phase|Adverse Event|2|||
124834270|NCT02658890|449023604|FG010|Treatment Phase|Adverse Event|3|||
124834271|NCT02658890|449023605|FG011|Treatment Phase|Adverse Event|0|||
124834272|NCT02658890|449023606|FG012|Treatment Phase|Adverse Event|1|||
124834273|NCT02658890|449023607|FG013|Treatment Phase|Adverse Event|4|||
124834274|NCT02658890|449023608|FG014|Treatment Phase|Adverse Event|0|||
124834275|NCT02658890|449023609|FG015|Treatment Phase|Adverse Event|0|||
124834276|NCT02658890|449023610|FG016|Treatment Phase|Adverse Event|0|||
124834277|NCT02658890|449023611|FG017|Treatment Phase|Adverse Event|0|||
124834278|NCT02658890|449023612|FG018|Treatment Phase|Adverse Event|5|||
124834279|NCT02658890|449023613|FG019|Treatment Phase|Adverse Event|1|||
124834280|NCT02658890|449023614|FG020|Treatment Phase|Adverse Event|3|||
124834281|NCT02658890|449023615|FG021|Treatment Phase|Adverse Event|0|||
124834282|NCT02658890|449023616|FG022|Treatment Phase|Adverse Event|5|||
124834283|NCT02658890|449023617|FG023|Treatment Phase|Adverse Event|0|||
124834284|NCT02658890|449023618|FG024|Treatment Phase|Adverse Event|0|||
124834285|NCT02658890|449023619|FG025|Treatment Phase|Adverse Event|2|||
124834286|NCT02658890|449023620|FG026|Treatment Phase|Adverse Event|1|||
124834287|NCT02658890|449023594|FG000|Treatment Phase|Death|0|||
124834288|NCT02658890|449023595|FG001|Treatment Phase|Death|0|||
124834289|NCT02658890|449023596|FG002|Treatment Phase|Death|0|||
124834290|NCT02658890|449023597|FG003|Treatment Phase|Death|0|||
124834291|NCT02658890|449023598|FG004|Treatment Phase|Death|0|||
124834292|NCT02658890|449023599|FG005|Treatment Phase|Death|0|||
124834293|NCT02658890|449023600|FG006|Treatment Phase|Death|0|||
124834294|NCT02658890|449023601|FG007|Treatment Phase|Death|0|||
124834295|NCT02658890|449023602|FG008|Treatment Phase|Death|0|||
124834296|NCT02658890|449023603|FG009|Treatment Phase|Death|0|||
124834297|NCT02658890|449023604|FG010|Treatment Phase|Death|0|||
124834298|NCT02658890|449023605|FG011|Treatment Phase|Death|0|||
124834299|NCT02658890|449023606|FG012|Treatment Phase|Death|0|||
124834300|NCT02658890|449023607|FG013|Treatment Phase|Death|0|||
124834301|NCT02658890|449023608|FG014|Treatment Phase|Death|0|||
124834302|NCT02658890|449023609|FG015|Treatment Phase|Death|0|||
124834303|NCT02658890|449023610|FG016|Treatment Phase|Death|0|||
124834304|NCT02658890|449023611|FG017|Treatment Phase|Death|0|||
124834305|NCT02658890|449023612|FG018|Treatment Phase|Death|1|||
124834306|NCT02658890|449023613|FG019|Treatment Phase|Death|0|||
124834307|NCT02658890|449023614|FG020|Treatment Phase|Death|0|||
124834308|NCT02658890|449023615|FG021|Treatment Phase|Death|0|||
124834309|NCT02658890|449023616|FG022|Treatment Phase|Death|0|||
124834310|NCT02658890|449023617|FG023|Treatment Phase|Death|0|||
124834311|NCT02658890|449023618|FG024|Treatment Phase|Death|0|||
124834312|NCT02658890|449023619|FG025|Treatment Phase|Death|0|||
124834313|NCT02658890|449023620|FG026|Treatment Phase|Death|0|||
124834314|NCT02658890|449023594|FG000|Treatment Phase|Lost to Follow-up|0|||
124834315|NCT02658890|449023595|FG001|Treatment Phase|Lost to Follow-up|0|||
124834316|NCT02658890|449023596|FG002|Treatment Phase|Lost to Follow-up|0|||
124834317|NCT02658890|449023597|FG003|Treatment Phase|Lost to Follow-up|0|||
124834318|NCT02658890|449023598|FG004|Treatment Phase|Lost to Follow-up|0|||
124834319|NCT02658890|449023599|FG005|Treatment Phase|Lost to Follow-up|0|||
124834320|NCT02658890|449023600|FG006|Treatment Phase|Lost to Follow-up|1|||
124834321|NCT02658890|449023601|FG007|Treatment Phase|Lost to Follow-up|0|||
124834322|NCT02658890|449023602|FG008|Treatment Phase|Lost to Follow-up|0|||
124834323|NCT02658890|449023603|FG009|Treatment Phase|Lost to Follow-up|0|||
124834324|NCT02658890|449023604|FG010|Treatment Phase|Lost to Follow-up|0|||
124834325|NCT02658890|449023605|FG011|Treatment Phase|Lost to Follow-up|0|||
124834326|NCT02658890|449023606|FG012|Treatment Phase|Lost to Follow-up|0|||
125304583|NCT00082407|450742690|FG001|Overall Study|Patient Decision|6|||
124834327|NCT02658890|449023607|FG013|Treatment Phase|Lost to Follow-up|0|||
124834328|NCT02658890|449023608|FG014|Treatment Phase|Lost to Follow-up|0|||
124834329|NCT02658890|449023609|FG015|Treatment Phase|Lost to Follow-up|0|||
124834330|NCT02658890|449023610|FG016|Treatment Phase|Lost to Follow-up|0|||
124834331|NCT02658890|449023611|FG017|Treatment Phase|Lost to Follow-up|0|||
124834332|NCT02658890|449023612|FG018|Treatment Phase|Lost to Follow-up|0|||
124834333|NCT02658890|449023613|FG019|Treatment Phase|Lost to Follow-up|0|||
124834334|NCT02658890|449023614|FG020|Treatment Phase|Lost to Follow-up|0|||
124834335|NCT02658890|449023615|FG021|Treatment Phase|Lost to Follow-up|0|||
124834336|NCT02658890|449023616|FG022|Treatment Phase|Lost to Follow-up|0|||
124834337|NCT02658890|449023617|FG023|Treatment Phase|Lost to Follow-up|0|||
124834338|NCT02658890|449023618|FG024|Treatment Phase|Lost to Follow-up|0|||
124834339|NCT02658890|449023619|FG025|Treatment Phase|Lost to Follow-up|0|||
124834340|NCT02658890|449023620|FG026|Treatment Phase|Lost to Follow-up|0|||
124834341|NCT02658890|449023594|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
124834342|NCT02658890|449023595|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
124834343|NCT02658890|449023596|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
124834344|NCT02658890|449023597|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
124834345|NCT02658890|449023598|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
124834346|NCT02658890|449023599|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
124834347|NCT02658890|449023600|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
124834348|NCT02658890|449023601|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
124834349|NCT02658890|449023602|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
124834350|NCT02658890|449023603|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
124834351|NCT02658890|449023604|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
124834352|NCT02658890|449023605|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
124834353|NCT02658890|449023606|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
124834354|NCT02658890|449023607|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
124834355|NCT02658890|449023608|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
124834356|NCT02658890|449023609|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
124834357|NCT02658890|449023610|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
124834358|NCT02658890|449023611|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
124834359|NCT02658890|449023612|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
124834360|NCT02658890|449023613|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
124834361|NCT02658890|449023614|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
124834362|NCT02658890|449023615|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
124834363|NCT02658890|449023616|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
124834364|NCT02658890|449023617|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
124834365|NCT02658890|449023618|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
124834366|NCT02658890|449023619|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
124834367|NCT02658890|449023620|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
124834368|NCT02658890|449023594|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
124834369|NCT02658890|449023595|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
124834370|NCT02658890|449023596|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
124834371|NCT02658890|449023597|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
124834372|NCT02658890|449023598|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
124834373|NCT02658890|449023599|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
124834374|NCT02658890|449023600|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
124834375|NCT02658890|449023601|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
124834376|NCT02658890|449023602|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
124834377|NCT02658890|449023603|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
124834378|NCT02658890|449023604|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
124834379|NCT02658890|449023605|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
124834380|NCT02658890|449023606|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
124834381|NCT02658890|449023607|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
124834382|NCT02658890|449023608|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
124834383|NCT02658890|449023609|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
124834384|NCT02658890|449023610|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
124834385|NCT02658890|449023611|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
124834386|NCT02658890|449023612|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
124834387|NCT02658890|449023613|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
124834388|NCT02658890|449023614|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
124834389|NCT02658890|449023615|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
124834390|NCT02658890|449023616|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
124834391|NCT02658890|449023617|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
124834392|NCT02658890|449023618|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
124834393|NCT02658890|449023619|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
124834394|NCT02658890|449023620|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
125304584|NCT00082407|450742689|FG000|Overall Study|Physician Decision|5|||
124834395|NCT02658890|449023594|FG000|Treatment Phase|Other Reasons|0|||
124834396|NCT02658890|449023595|FG001|Treatment Phase|Other Reasons|0|||
124834397|NCT02658890|449023596|FG002|Treatment Phase|Other Reasons|0|||
125304585|NCT00082407|450742690|FG001|Overall Study|Physician Decision|3|||
125304586|NCT00082407|450742689|FG000|Overall Study|Loss of Glucose Control|2|||
125304587|NCT00082407|450742690|FG001|Overall Study|Loss of Glucose Control|2|||
124834398|NCT02658890|449023597|FG003|Treatment Phase|Other Reasons|0|||
125304588|NCT00082407|450742689|FG000|Overall Study|Death|2|||
125304589|NCT00082407|450742690|FG001|Overall Study|Death|1|||
125304590|NCT00082407|450742689|FG000|Overall Study|Lost to Follow-up|0|||
125304591|NCT00082407|450742690|FG001|Overall Study|Lost to Follow-up|3|||
125304592|NCT00891228|450742692|FG000|Overall Study|Adverse Event|0|||
125304593|NCT00891228|450742693|FG001|Overall Study|Adverse Event|2|||
125304594|NCT00891228|450742694|FG002|Overall Study|Adverse Event|3|||
125304595|NCT00891228|450742692|FG000|Overall Study|Withdrawal by Subject|2|||
125304596|NCT00891228|450742693|FG001|Overall Study|Withdrawal by Subject|4|||
125304597|NCT00891228|450742694|FG002|Overall Study|Withdrawal by Subject|5|||
125304598|NCT00891228|450742692|FG000|Overall Study|Protocol Violation|3|||
125304599|NCT00891228|450742693|FG001|Overall Study|Protocol Violation|1|||
125304600|NCT00891228|450742694|FG002|Overall Study|Protocol Violation|2|||
125304601|NCT00891228|450742692|FG000|Overall Study|Physician Decision|2|||
125304602|NCT00891228|450742693|FG001|Overall Study|Physician Decision|1|||
125304603|NCT00891228|450742694|FG002|Overall Study|Physician Decision|0|||
125304604|NCT00891228|450742692|FG000|Overall Study|Lost to Follow-up|4|||
125304605|NCT00891228|450742693|FG001|Overall Study|Lost to Follow-up|4|||
125304606|NCT00891228|450742694|FG002|Overall Study|Lost to Follow-up|5|||
125304607|NCT00891228|450742692|FG000|Overall Study|Pregnancy|0|||
125304608|NCT00891228|450742693|FG001|Overall Study|Pregnancy|1|||
125304609|NCT00891228|450742694|FG002|Overall Study|Pregnancy|0|||
125304610|NCT02688985|450742697|FG000|Overall Study|Adverse Event|1|||
125304611|NCT02688985|450742698|FG001|Overall Study|Adverse Event|2|||
125304612|NCT02688985|450742699|FG002|Overall Study|Adverse Event|2|||
125304613|NCT02688985|450742700|FG003|Overall Study|Adverse Event|0|||
125304614|NCT02688985|450742701|FG004|Overall Study|Adverse Event|0|||
125304615|NCT02688985|450742697|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
125304616|NCT02688985|450742698|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
125304617|NCT02688985|450742699|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
125304618|NCT02688985|450742700|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
125304619|NCT02688985|450742701|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
125304620|NCT02688985|450742697|FG000|Overall Study|Death|0|||
125304621|NCT02688985|450742698|FG001|Overall Study|Death|0|||
125304622|NCT02688985|450742699|FG002|Overall Study|Death|0|||
125304623|NCT02688985|450742700|FG003|Overall Study|Death|0|||
125304624|NCT02688985|450742701|FG004|Overall Study|Death|1|||
125304625|NCT02688985|450742697|FG000|Overall Study|Lack of Efficacy|0|||
125304626|NCT02688985|450742698|FG001|Overall Study|Lack of Efficacy|0|||
125304627|NCT02688985|450742699|FG002|Overall Study|Lack of Efficacy|0|||
125304628|NCT02688985|450742700|FG003|Overall Study|Lack of Efficacy|0|||
125304629|NCT02688985|450742701|FG004|Overall Study|Lack of Efficacy|1|||
125304630|NCT02688985|450742697|FG000|Overall Study|Lost to Follow-up|2|||
125304631|NCT02688985|450742698|FG001|Overall Study|Lost to Follow-up|0|||
125304632|NCT02688985|450742699|FG002|Overall Study|Lost to Follow-up|1|||
125304633|NCT02688985|450742700|FG003|Overall Study|Lost to Follow-up|1|||
125304634|NCT02688985|450742701|FG004|Overall Study|Lost to Follow-up|1|||
125304635|NCT02688985|450742697|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125304636|NCT02688985|450742698|FG001|Overall Study|Non-Compliance With Study Drug|3|||
125304637|NCT02688985|450742699|FG002|Overall Study|Non-Compliance With Study Drug|1|||
125304638|NCT02688985|450742700|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125304639|NCT02688985|450742701|FG004|Overall Study|Non-Compliance With Study Drug|1|||
125304640|NCT02688985|450742697|FG000|Overall Study|Other|3|||
125304641|NCT02688985|450742698|FG001|Overall Study|Other|4|||
125304642|NCT02688985|450742699|FG002|Overall Study|Other|1|||
125304643|NCT02688985|450742700|FG003|Overall Study|Other|0|||
125304644|NCT02688985|450742701|FG004|Overall Study|Other|0|||
125304645|NCT02688985|450742697|FG000|Overall Study|Physician Decision|2|||
125304646|NCT02688985|450742698|FG001|Overall Study|Physician Decision|2|||
125304647|NCT02688985|450742699|FG002|Overall Study|Physician Decision|0|||
125304648|NCT02688985|450742700|FG003|Overall Study|Physician Decision|0|||
125304649|NCT02688985|450742701|FG004|Overall Study|Physician Decision|1|||
125304650|NCT02688985|450742697|FG000|Overall Study|Pregnancy|0|||
125304651|NCT02688985|450742698|FG001|Overall Study|Pregnancy|0|||
125304652|NCT02688985|450742699|FG002|Overall Study|Pregnancy|2|||
125304653|NCT02688985|450742700|FG003|Overall Study|Pregnancy|1|||
125304654|NCT02688985|450742701|FG004|Overall Study|Pregnancy|0|||
125304655|NCT02688985|450742697|FG000|Overall Study|Study Terminated By Sponsor|0|||
125304656|NCT02688985|450742698|FG001|Overall Study|Study Terminated By Sponsor|0|||
125304657|NCT02688985|450742699|FG002|Overall Study|Study Terminated By Sponsor|0|||
125304658|NCT02688985|450742700|FG003|Overall Study|Study Terminated By Sponsor|1|||
125304659|NCT02688985|450742701|FG004|Overall Study|Study Terminated By Sponsor|0|||
125304660|NCT02688985|450742697|FG000|Overall Study|Withdrawal by Subject|2|||
125304661|NCT02688985|450742698|FG001|Overall Study|Withdrawal by Subject|8|||
125304662|NCT02688985|450742699|FG002|Overall Study|Withdrawal by Subject|7|||
125304663|NCT02688985|450742700|FG003|Overall Study|Withdrawal by Subject|1|||
124834399|NCT02658890|449023598|FG004|Treatment Phase|Other Reasons|0|||
125304664|NCT02688985|450742701|FG004|Overall Study|Withdrawal by Subject|4|||
125304665|NCT01726582|450742702|FG000|Overall Study|Physician Decision|99|||
125304666|NCT01726582|450742702|FG000|Overall Study|Death|85|||
125304667|NCT03704688|450742707|FG000|Overall Study|Adverse Event|0|||
125304668|NCT03704688|450742708|FG001|Overall Study|Adverse Event|0|||
125304669|NCT03704688|450742709|FG002|Overall Study|Adverse Event|0|||
125304670|NCT03704688|450742710|FG003|Overall Study|Adverse Event|4|||
125304671|NCT03704688|450742711|FG004|Overall Study|Adverse Event|1|||
125304672|NCT03704688|450742712|FG005|Overall Study|Adverse Event|0|||
125304673|NCT03704688|450742707|FG000|Overall Study|Disease Progression|0|||
125304674|NCT03704688|450742708|FG001|Overall Study|Disease Progression|0|||
125304675|NCT03704688|450742709|FG002|Overall Study|Disease Progression|0|||
125304676|NCT03704688|450742710|FG003|Overall Study|Disease Progression|3|||
125304677|NCT03704688|450742711|FG004|Overall Study|Disease Progression|1|||
125304678|NCT03704688|450742712|FG005|Overall Study|Disease Progression|0|||
125304679|NCT03704688|450742707|FG000|Overall Study|Death|0|||
125304680|NCT03704688|450742708|FG001|Overall Study|Death|0|||
125304681|NCT03704688|450742709|FG002|Overall Study|Death|0|||
125304682|NCT03704688|450742710|FG003|Overall Study|Death|0|||
125304683|NCT03704688|450742711|FG004|Overall Study|Death|3|||
125304684|NCT03704688|450742712|FG005|Overall Study|Death|0|||
125304685|NCT04878211|450742714|FG000|Overall Study|Lost to Follow-up|0|||
125304686|NCT04878211|450742715|FG001|Overall Study|Lost to Follow-up|0|||
125304687|NCT04878211|450742716|FG002|Overall Study|Lost to Follow-up|0|||
125304688|NCT04878211|450742717|FG003|Overall Study|Lost to Follow-up|1|||
125304689|NCT04878211|450742718|FG004|Overall Study|Lost to Follow-up|0|||
125304690|NCT04878211|450742719|FG005|Overall Study|Lost to Follow-up|1|||
125304691|NCT04878211|450742714|FG000|Overall Study|Protocol deviation|1|||
125304692|NCT04878211|450742715|FG001|Overall Study|Protocol deviation|0|||
125304693|NCT04878211|450742716|FG002|Overall Study|Protocol deviation|0|||
125304694|NCT04878211|450742717|FG003|Overall Study|Protocol deviation|0|||
125304695|NCT04878211|450742718|FG004|Overall Study|Protocol deviation|0|||
125304696|NCT04878211|450742719|FG005|Overall Study|Protocol deviation|0|||
125304697|NCT04878211|450742714|FG000|Overall Study|Study terminated by sponsor|0|||
125304698|NCT04878211|450742715|FG001|Overall Study|Study terminated by sponsor|0|||
125304699|NCT04878211|450742716|FG002|Overall Study|Study terminated by sponsor|0|||
125304700|NCT04878211|450742717|FG003|Overall Study|Study terminated by sponsor|0|||
124834400|NCT02658890|449023599|FG005|Treatment Phase|Other Reasons|0|||
124834401|NCT02658890|449023600|FG006|Treatment Phase|Other Reasons|1|||
124834402|NCT02658890|449023601|FG007|Treatment Phase|Other Reasons|0|||
124834403|NCT02658890|449023602|FG008|Treatment Phase|Other Reasons|1|||
124834404|NCT02658890|449023603|FG009|Treatment Phase|Other Reasons|0|||
124834405|NCT02658890|449023604|FG010|Treatment Phase|Other Reasons|0|||
124834406|NCT02658890|449023605|FG011|Treatment Phase|Other Reasons|0|||
124834407|NCT02658890|449023606|FG012|Treatment Phase|Other Reasons|0|||
124834408|NCT02658890|449023607|FG013|Treatment Phase|Other Reasons|2|||
124834409|NCT02658890|449023608|FG014|Treatment Phase|Other Reasons|0|||
124834410|NCT02658890|449023609|FG015|Treatment Phase|Other Reasons|0|||
124834411|NCT02658890|449023610|FG016|Treatment Phase|Other Reasons|0|||
124834412|NCT02658890|449023611|FG017|Treatment Phase|Other Reasons|0|||
124834413|NCT02658890|449023612|FG018|Treatment Phase|Other Reasons|1|||
124834414|NCT02658890|449023613|FG019|Treatment Phase|Other Reasons|0|||
124834415|NCT02658890|449023614|FG020|Treatment Phase|Other Reasons|0|||
124834416|NCT02658890|449023615|FG021|Treatment Phase|Other Reasons|0|||
124834417|NCT02658890|449023616|FG022|Treatment Phase|Other Reasons|0|||
124834418|NCT02658890|449023617|FG023|Treatment Phase|Other Reasons|0|||
124834419|NCT02658890|449023618|FG024|Treatment Phase|Other Reasons|1|||
124834420|NCT02658890|449023619|FG025|Treatment Phase|Other Reasons|0|||
124834421|NCT02658890|449023620|FG026|Treatment Phase|Other Reasons|1|||
124834422|NCT02658890|449023594|FG000|Treatment Phase|Progressive Disease|6|||
124834423|NCT02658890|449023595|FG001|Treatment Phase|Progressive Disease|7|||
124834424|NCT02658890|449023596|FG002|Treatment Phase|Progressive Disease|6|||
124834425|NCT02658890|449023597|FG003|Treatment Phase|Progressive Disease|12|||
124834426|NCT02658890|449023598|FG004|Treatment Phase|Progressive Disease|6|||
124834427|NCT02658890|449023599|FG005|Treatment Phase|Progressive Disease|18|||
124834428|NCT02658890|449023600|FG006|Treatment Phase|Progressive Disease|12|||
125304701|NCT04878211|450742718|FG004|Overall Study|Study terminated by sponsor|9|||
125304702|NCT04878211|450742719|FG005|Overall Study|Study terminated by sponsor|4|||
125304703|NCT04878211|450742714|FG000|Overall Study|Subject decision|0|||
125304704|NCT04878211|450742715|FG001|Overall Study|Subject decision|0|||
125304705|NCT04878211|450742716|FG002|Overall Study|Subject decision|0|||
125304706|NCT04878211|450742717|FG003|Overall Study|Subject decision|0|||
124834429|NCT02658890|449023601|FG007|Treatment Phase|Progressive Disease|19|||
124834430|NCT02658890|449023602|FG008|Treatment Phase|Progressive Disease|26|||
124834431|NCT02658890|449023603|FG009|Treatment Phase|Progressive Disease|8|||
124834432|NCT02658890|449023604|FG010|Treatment Phase|Progressive Disease|7|||
125304707|NCT04878211|450742718|FG004|Overall Study|Subject decision|1|||
125304708|NCT04878211|450742719|FG005|Overall Study|Subject decision|0|||
125304709|NCT02783599|450742720|FG000|Overall Study|Progressive disease|23|||
125304710|NCT02783599|450742720|FG000|Overall Study|Surgical Resection|10|||
125304711|NCT02783599|450742720|FG000|Overall Study|Adverse Event|4|||
125304712|NCT02783599|450742720|FG000|Overall Study|Physician Decision|2|||
124834433|NCT02658890|449023605|FG011|Treatment Phase|Progressive Disease|9|||
124834434|NCT02658890|449023606|FG012|Treatment Phase|Progressive Disease|8|||
124834435|NCT02658890|449023607|FG013|Treatment Phase|Progressive Disease|29|||
124834436|NCT02658890|449023608|FG014|Treatment Phase|Progressive Disease|6|||
124834437|NCT02658890|449023609|FG015|Treatment Phase|Progressive Disease|2|||
124834438|NCT02658890|449023610|FG016|Treatment Phase|Progressive Disease|32|||
124834439|NCT02658890|449023611|FG017|Treatment Phase|Progressive Disease|14|||
124834440|NCT02658890|449023612|FG018|Treatment Phase|Progressive Disease|40|||
124834441|NCT02658890|449023613|FG019|Treatment Phase|Progressive Disease|32|||
124834442|NCT02658890|449023614|FG020|Treatment Phase|Progressive Disease|19|||
124834443|NCT02658890|449023615|FG021|Treatment Phase|Progressive Disease|30|||
124834444|NCT02658890|449023616|FG022|Treatment Phase|Progressive Disease|15|||
124834445|NCT02658890|449023617|FG023|Treatment Phase|Progressive Disease|0|||
124834446|NCT02658890|449023618|FG024|Treatment Phase|Progressive Disease|0|||
124834447|NCT02658890|449023619|FG025|Treatment Phase|Progressive Disease|14|||
124834448|NCT02658890|449023620|FG026|Treatment Phase|Progressive Disease|11|||
124834449|NCT02658890|449023594|FG000|Treatment Phase|Study Drug Toxicity|0|||
124834450|NCT02658890|449023595|FG001|Treatment Phase|Study Drug Toxicity|0|||
124834451|NCT02658890|449023596|FG002|Treatment Phase|Study Drug Toxicity|2|||
124834452|NCT02658890|449023597|FG003|Treatment Phase|Study Drug Toxicity|0|||
124834453|NCT02658890|449023598|FG004|Treatment Phase|Study Drug Toxicity|0|||
124834454|NCT02658890|449023599|FG005|Treatment Phase|Study Drug Toxicity|0|||
124834455|NCT02658890|449023600|FG006|Treatment Phase|Study Drug Toxicity|0|||
124834456|NCT02658890|449023601|FG007|Treatment Phase|Study Drug Toxicity|0|||
124834457|NCT02658890|449023602|FG008|Treatment Phase|Study Drug Toxicity|3|||
124834458|NCT02658890|449023603|FG009|Treatment Phase|Study Drug Toxicity|0|||
124834459|NCT02658890|449023604|FG010|Treatment Phase|Study Drug Toxicity|1|||
124834460|NCT02658890|449023605|FG011|Treatment Phase|Study Drug Toxicity|1|||
124834461|NCT02658890|449023606|FG012|Treatment Phase|Study Drug Toxicity|2|||
124834462|NCT02658890|449023607|FG013|Treatment Phase|Study Drug Toxicity|9|||
124834463|NCT02658890|449023608|FG014|Treatment Phase|Study Drug Toxicity|0|||
124834464|NCT02658890|449023609|FG015|Treatment Phase|Study Drug Toxicity|1|||
124834465|NCT02658890|449023610|FG016|Treatment Phase|Study Drug Toxicity|1|||
124834466|NCT02658890|449023611|FG017|Treatment Phase|Study Drug Toxicity|0|||
124834467|NCT02658890|449023612|FG018|Treatment Phase|Study Drug Toxicity|8|||
124834468|NCT02658890|449023613|FG019|Treatment Phase|Study Drug Toxicity|3|||
124834469|NCT02658890|449023614|FG020|Treatment Phase|Study Drug Toxicity|2|||
124834470|NCT02658890|449023615|FG021|Treatment Phase|Study Drug Toxicity|0|||
124834471|NCT02658890|449023616|FG022|Treatment Phase|Study Drug Toxicity|8|||
124834472|NCT02658890|449023617|FG023|Treatment Phase|Study Drug Toxicity|0|||
124834473|NCT02658890|449023618|FG024|Treatment Phase|Study Drug Toxicity|0|||
124834474|NCT02658890|449023619|FG025|Treatment Phase|Study Drug Toxicity|2|||
124834475|NCT02658890|449023620|FG026|Treatment Phase|Study Drug Toxicity|0|||
124834476|NCT02658890|449023594|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834477|NCT02658890|449023595|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834478|NCT02658890|449023596|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834479|NCT02658890|449023597|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
124834480|NCT02658890|449023598|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834481|NCT02658890|449023599|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834482|NCT02658890|449023600|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834483|NCT02658890|449023601|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834484|NCT02658890|449023602|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834485|NCT02658890|449023603|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
124834486|NCT02658890|449023604|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834487|NCT02658890|449023605|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834488|NCT02658890|449023606|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834489|NCT02658890|449023607|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834490|NCT02658890|449023608|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834491|NCT02658890|449023609|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834492|NCT02658890|449023610|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834493|NCT02658890|449023611|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834494|NCT02658890|449023612|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
124834495|NCT02658890|449023613|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834496|NCT02658890|449023614|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834497|NCT02658890|449023615|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834498|NCT02658890|449023616|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
125304713|NCT02783599|450742720|FG000|Overall Study|Death|1|||
124834499|NCT02658890|449023617|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125304714|NCT00856544|450742721|FG000|Overall Study|Randomized but not treated|3|||
125304715|NCT00856544|450742722|FG001|Overall Study|Randomized but not treated|0|||
124834500|NCT02658890|449023618|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834501|NCT02658890|449023619|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834502|NCT02658890|449023620|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834503|NCT02658890|449023594|FG000|Treatment Phase|Withdrawal by Subject|0|||
124834504|NCT02658890|449023595|FG001|Treatment Phase|Withdrawal by Subject|1|||
124834505|NCT02658890|449023596|FG002|Treatment Phase|Withdrawal by Subject|0|||
124834506|NCT02658890|449023597|FG003|Treatment Phase|Withdrawal by Subject|0|||
124834507|NCT02658890|449023598|FG004|Treatment Phase|Withdrawal by Subject|0|||
124834508|NCT02658890|449023599|FG005|Treatment Phase|Withdrawal by Subject|0|||
124834509|NCT02658890|449023600|FG006|Treatment Phase|Withdrawal by Subject|1|||
124834510|NCT02658890|449023601|FG007|Treatment Phase|Withdrawal by Subject|0|||
124834511|NCT02658890|449023602|FG008|Treatment Phase|Withdrawal by Subject|0|||
124834512|NCT02658890|449023603|FG009|Treatment Phase|Withdrawal by Subject|1|||
124834513|NCT02658890|449023604|FG010|Treatment Phase|Withdrawal by Subject|0|||
124834514|NCT02658890|449023605|FG011|Treatment Phase|Withdrawal by Subject|0|||
124834515|NCT02658890|449023606|FG012|Treatment Phase|Withdrawal by Subject|1|||
124834516|NCT02658890|449023607|FG013|Treatment Phase|Withdrawal by Subject|3|||
124834517|NCT02658890|449023608|FG014|Treatment Phase|Withdrawal by Subject|0|||
124834518|NCT02658890|449023609|FG015|Treatment Phase|Withdrawal by Subject|0|||
124834519|NCT02658890|449023610|FG016|Treatment Phase|Withdrawal by Subject|1|||
124834520|NCT02658890|449023611|FG017|Treatment Phase|Withdrawal by Subject|0|||
124834521|NCT02658890|449023612|FG018|Treatment Phase|Withdrawal by Subject|4|||
124834522|NCT02658890|449023613|FG019|Treatment Phase|Withdrawal by Subject|3|||
124834523|NCT02658890|449023614|FG020|Treatment Phase|Withdrawal by Subject|0|||
124834524|NCT02658890|449023615|FG021|Treatment Phase|Withdrawal by Subject|4|||
124834525|NCT02658890|449023616|FG022|Treatment Phase|Withdrawal by Subject|1|||
124834526|NCT02658890|449023617|FG023|Treatment Phase|Withdrawal by Subject|1|||
124834527|NCT02658890|449023618|FG024|Treatment Phase|Withdrawal by Subject|0|||
124834528|NCT02658890|449023619|FG025|Treatment Phase|Withdrawal by Subject|0|||
124834529|NCT02658890|449023620|FG026|Treatment Phase|Withdrawal by Subject|0|||
124834530|NCT02474199|449023621|FG000|Overall Study|Lost to Follow-up|1|||
124834531|NCT02474199|449023622|FG001|Overall Study|Lost to Follow-up|0|||
124834532|NCT02474199|449023623|FG002|Overall Study|Lost to Follow-up|0|||
124834533|NCT02474199|449023624|FG003|Overall Study|Lost to Follow-up|0|||
124834534|NCT02474199|449023621|FG000|Overall Study|Withdrawal by Subject|1|||
124834535|NCT02474199|449023622|FG001|Overall Study|Withdrawal by Subject|2|||
124834536|NCT02474199|449023623|FG002|Overall Study|Withdrawal by Subject|0|||
124834537|NCT02474199|449023624|FG003|Overall Study|Withdrawal by Subject|1|||
124834538|NCT02474199|449023621|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
124834539|NCT02474199|449023622|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
124834540|NCT02474199|449023623|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
124834541|NCT02474199|449023624|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
124834542|NCT02474199|449023621|FG000|Overall Study|Did not meet eligibility criteria|0|||
124834543|NCT02474199|449023622|FG001|Overall Study|Did not meet eligibility criteria|0|||
124834544|NCT02474199|449023623|FG002|Overall Study|Did not meet eligibility criteria|2|||
124834545|NCT02474199|449023624|FG003|Overall Study|Did not meet eligibility criteria|2|||
124834546|NCT00952341|449023626|FG000|Cycle 1|Adverse Event|4|||
124834547|NCT00952341|449023627|FG001|Cycle 1|Adverse Event|1|||
124834548|NCT00952341|449023626|FG000|Cycle 1|Withdrawal by Subject|3|||
124834549|NCT00952341|449023627|FG001|Cycle 1|Withdrawal by Subject|8|||
124834550|NCT00952341|449023626|FG000|Cycle 1|Protocol Violation|2|||
124834551|NCT00952341|449023627|FG001|Cycle 1|Protocol Violation|1|||
124834552|NCT00952341|449023626|FG000|Cycle 1|Lost to Follow-up|11|||
124834553|NCT00952341|449023627|FG001|Cycle 1|Lost to Follow-up|2|||
124834554|NCT00952341|449023626|FG000|Cycle 1|Physician Decision|0|||
124834555|NCT00952341|449023627|FG001|Cycle 1|Physician Decision|1|||
124834556|NCT00952341|449023626|FG000|Cycle 2|Withdrawal by Subject|1|||
124834557|NCT00952341|449023627|FG001|Cycle 2|Withdrawal by Subject|1|||
124834558|NCT00952341|449023626|FG000|Cycle 2|Protocol Violation|1|||
124834559|NCT00952341|449023627|FG001|Cycle 2|Protocol Violation|0|||
124834560|NCT00952341|449023626|FG000|Cycle 2|Lost to Follow-up|6|||
125304716|NCT00856544|450742723|FG002|Overall Study|Randomized but not treated|0|||
125304717|NCT00856544|450742724|FG003|Overall Study|Randomized but not treated|0|||
124834561|NCT00952341|449023627|FG001|Cycle 2|Lost to Follow-up|9|||
124834562|NCT00952341|449023626|FG000|Cycle 2|Physician Decision|1|||
124834563|NCT00952341|449023627|FG001|Cycle 2|Physician Decision|1|||
124834564|NCT00952341|449023626|FG000|Cycle 2|Progressive Disease|0|||
124834565|NCT00952341|449023627|FG001|Cycle 2|Progressive Disease|1|||
124834566|NCT02419742|449023634|FG000|Overall Study|Adverse Event|2|||
124834567|NCT02419742|449023635|FG001|Overall Study|Adverse Event|0|||
124834568|NCT02419742|449023634|FG000|Overall Study|Disease Progression|0|||
124834569|NCT02419742|449023635|FG001|Overall Study|Disease Progression|1|||
124834570|NCT02419742|449023634|FG000|Overall Study|Withdrew Consent|2|||
124834571|NCT02419742|449023635|FG001|Overall Study|Withdrew Consent|1|||
124834572|NCT02419742|449023634|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
124834573|NCT02419742|449023635|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
124834574|NCT03340025|449023638|FG000|Overall Study|Lost to Follow-up|2|||
124834575|NCT03340025|449023639|FG001|Overall Study|Lost to Follow-up|2|||
124834576|NCT03897179|449023642|FG000|Overall Study|Withdrawal by Subject|1|||
124834577|NCT00704535|449023643|FG000|Overall Study|Adverse Event|2|||
124834578|NCT00704535|449023643|FG000|Overall Study|Death|2|||
124834579|NCT00704535|449023643|FG000|Overall Study|Lost to Follow-up|8|||
124834580|NCT00704535|449023643|FG000|Overall Study|Protocol Violation|10|||
124834581|NCT00704535|449023643|FG000|Overall Study|Completed status not on Case Report Form|124|||
124834582|NCT01480076|449023644|FG000|Overall Study|Run-in Failure|52|||
124834583|NCT01480076|449023644|FG000|Overall Study|Adverse Event|39|||
124834584|NCT01480076|449023644|FG000|Overall Study|Death|2|||
124834585|NCT01480076|449023644|FG000|Overall Study|Disease Progression|5|||
124834586|NCT01480076|449023644|FG000|Overall Study|Non-compliance With Study Protocol|15|||
124834587|NCT01480076|449023644|FG000|Overall Study|Withdrawal by Subject|105|||
124834588|NCT01480076|449023644|FG000|Overall Study|Lost to Follow-up|7|||
124834589|NCT01480076|449023644|FG000|Overall Study|Investigator Decision|13|||
124834590|NCT01480076|449023644|FG000|Overall Study|Other|52|||
124834591|NCT02503332|449023645|FG000|Overall Study|Adverse Event|17|||
124834592|NCT02503332|449023646|FG001|Overall Study|Adverse Event|5|||
124834593|NCT02503332|449023647|FG002|Overall Study|Adverse Event|3|||
124834594|NCT02503332|449023648|FG003|Overall Study|Adverse Event|1|||
124834595|NCT02503332|449023645|FG000|Overall Study|Investigator's Decision|5|||
124834596|NCT02503332|449023646|FG001|Overall Study|Investigator's Decision|1|||
124834597|NCT02503332|449023647|FG002|Overall Study|Investigator's Decision|0|||
124834598|NCT02503332|449023648|FG003|Overall Study|Investigator's Decision|0|||
124834599|NCT02503332|449023645|FG000|Overall Study|Sponsor's Decision|1|||
124834600|NCT02503332|449023646|FG001|Overall Study|Sponsor's Decision|0|||
124834601|NCT02503332|449023647|FG002|Overall Study|Sponsor's Decision|0|||
124834602|NCT02503332|449023648|FG003|Overall Study|Sponsor's Decision|1|||
124834603|NCT02503332|449023645|FG000|Overall Study|Subject Request|6|||
124834604|NCT02503332|449023646|FG001|Overall Study|Subject Request|5|||
124834605|NCT02503332|449023647|FG002|Overall Study|Subject Request|2|||
124834606|NCT02503332|449023648|FG003|Overall Study|Subject Request|1|||
124834607|NCT02503332|449023645|FG000|Overall Study|Death|0|||
124834608|NCT02503332|449023646|FG001|Overall Study|Death|2|||
124834609|NCT02503332|449023647|FG002|Overall Study|Death|2|||
124834610|NCT02503332|449023648|FG003|Overall Study|Death|0|||
124834611|NCT02503332|449023645|FG000|Overall Study|Other|5|||
124834612|NCT02503332|449023646|FG001|Overall Study|Other|6|||
124834613|NCT02503332|449023647|FG002|Overall Study|Other|1|||
124834614|NCT02503332|449023648|FG003|Overall Study|Other|1|||
124834615|NCT01413360|449023649|FG000|Overall Study|Lost to Follow-up|2|||
124834616|NCT01413360|449023649|FG000|Overall Study|Adverse Event|1|||
124834617|NCT00909779|449023660|FG000|Overall Study|Adverse Event|53|||
124834618|NCT00909779|449023661|FG001|Overall Study|Adverse Event|55|||
124834619|NCT00909779|449023660|FG000|Overall Study|Lack of Efficacy|7|||
124834620|NCT00909779|449023661|FG001|Overall Study|Lack of Efficacy|4|||
124834621|NCT00909779|449023660|FG000|Overall Study|Lost to Follow-up|19|||
124834622|NCT00909779|449023661|FG001|Overall Study|Lost to Follow-up|15|||
124834623|NCT00909779|449023660|FG000|Overall Study|Physician Decision|8|||
124834624|NCT00909779|449023661|FG001|Overall Study|Physician Decision|2|||
124834625|NCT00909779|449023660|FG000|Overall Study|Protocol Violation|2|||
124834626|NCT00909779|449023661|FG001|Overall Study|Protocol Violation|5|||
124834627|NCT00909779|449023660|FG000|Overall Study|Withdrawal by Subject|116|||
124834628|NCT00909779|449023661|FG001|Overall Study|Withdrawal by Subject|80|||
124834629|NCT00909779|449023660|FG000|Overall Study|Site Ceasing Operation|2|||
124834630|NCT00909779|449023661|FG001|Overall Study|Site Ceasing Operation|2|||
124834631|NCT00909779|449023660|FG000|Overall Study|Medical Monitor Decision|1|||
124834632|NCT00909779|449023661|FG001|Overall Study|Medical Monitor Decision|0|||
124834633|NCT00909779|449023660|FG000|Overall Study|Noncompliance|1|||
124834634|NCT00909779|449023661|FG001|Overall Study|Noncompliance|1|||
124834635|NCT00909779|449023660|FG000|Overall Study|Randomized in error|1|||
125304718|NCT00856544|450742721|FG000|Overall Study|Death|0|||
125304719|NCT00856544|450742722|FG001|Overall Study|Death|2|||
125304720|NCT00856544|450742723|FG002|Overall Study|Death|0|||
124834636|NCT00909779|449023661|FG001|Overall Study|Randomized in error|1|||
124834637|NCT02016482|449023664|FG000|Period A|Adverse Event|3|||
124834638|NCT02016482|449023665|FG001|Period A|Adverse Event|5|||
124834639|NCT02016482|449023664|FG000|Period A|Withdrawal by Subject|3|||
124834640|NCT02016482|449023665|FG001|Period A|Withdrawal by Subject|4|||
124834641|NCT02016482|449023664|FG000|Period A|Lost to Follow-up|3|||
124834642|NCT02016482|449023665|FG001|Period A|Lost to Follow-up|3|||
124834643|NCT02016482|449023664|FG000|Period A|Lack of Efficacy|2|||
124834644|NCT02016482|449023665|FG001|Period A|Lack of Efficacy|1|||
124834645|NCT02016482|449023664|FG000|Period A|Other|3|||
124834646|NCT02016482|449023665|FG001|Period A|Other|0|||
124834647|NCT02016482|449023664|FG000|Period A|Protocol Violation|0|||
124834648|NCT02016482|449023665|FG001|Period A|Protocol Violation|1|||
124834649|NCT02016482|449023664|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
125304721|NCT00856544|450742724|FG003|Overall Study|Death|0|||
124834650|NCT02016482|449023665|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
124834651|NCT02016482|449023664|FG000|Period B|Withdrawal by Subject|1|||
124834652|NCT02016482|449023665|FG001|Period B|Withdrawal by Subject|1|||
124834653|NCT02016482|449023664|FG000|Period B|Lost to Follow-up|2|||
124834654|NCT02016482|449023665|FG001|Period B|Lost to Follow-up|0|||
124834655|NCT02016482|449023664|FG000|Period B|Lack of Efficacy|6|||
124834656|NCT02016482|449023665|FG001|Period B|Lack of Efficacy|4|||
124834657|NCT02016482|449023664|FG000|Period B|Other|4|||
124834658|NCT02016482|449023665|FG001|Period B|Other|0|||
124834659|NCT02016482|449023664|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
124834660|NCT02016482|449023665|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
124834661|NCT02738333|449023667|FG000|Overall Study|Death|1|||
124834662|NCT02738333|449023668|FG001|Overall Study|Death|0|||
124834663|NCT02738333|449023669|FG002|Overall Study|Death|0|||
124834664|NCT02738333|449023667|FG000|Overall Study|Lost to Follow-up|1|||
124834665|NCT02738333|449023668|FG001|Overall Study|Lost to Follow-up|0|||
124834666|NCT02738333|449023669|FG002|Overall Study|Lost to Follow-up|0|||
124834667|NCT00949325|449023670|FG000|Overall Study|Adverse Event|0|||
124834668|NCT00949325|449023671|FG001|Overall Study|Adverse Event|2|||
124834669|NCT00949325|449023672|FG002|Overall Study|Adverse Event|0|||
124834670|NCT00791518|449023673|FG000|Overall Study|Protocol Violation|93|||
124834671|NCT01520363|449023674|FG000|Overall Study|Withdrawal by Subject|2|||
124834672|NCT01520363|449023675|FG001|Overall Study|Withdrawal by Subject|0|||
124834673|NCT01498952|449023679|FG000|Overall Study|Death|2|||
124834674|NCT01498952|449023680|FG001|Overall Study|Death|2|||
124834675|NCT01498952|449023681|FG002|Overall Study|Death|0|||
124834676|NCT01498952|449023682|FG003|Overall Study|Death|0|||
124834677|NCT01498952|449023683|FG004|Overall Study|Death|0|||
124834678|NCT00579826|449023684|FG000|Overall Study|Withdrawal by Subject|5|||
124834679|NCT00579826|449023685|FG001|Overall Study|Withdrawal by Subject|3|||
124834680|NCT00454987|449023686|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
124834681|NCT00454987|449023687|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
124834682|NCT00454987|449023688|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
124834683|NCT00454987|449023686|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
124834684|NCT00454987|449023687|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
124834685|NCT00454987|449023688|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
124834686|NCT00454987|449023686|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
124834687|NCT00454987|449023687|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
124834688|NCT00454987|449023688|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
124834689|NCT02073279|449023696|FG000|Double-blind Period|Adverse Event|1|||
124834690|NCT02073279|449023697|FG001|Double-blind Period|Adverse Event|1|||
124834691|NCT02073279|449023696|FG000|Double-blind Period|Switched to another treatment|1|||
124834692|NCT02073279|449023697|FG001|Double-blind Period|Switched to another treatment|2|||
124834693|NCT02073279|449023696|FG000|Double-blind Period|Protocol Violation|0|||
124834694|NCT02073279|449023697|FG001|Double-blind Period|Protocol Violation|1|||
124834695|NCT02073279|449023696|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
124834696|NCT02073279|449023697|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
124834697|NCT02073279|449023696|FG000|Double-blind Period|Withdrawal by Subject|2|||
124834698|NCT02073279|449023697|FG001|Double-blind Period|Withdrawal by Subject|2|||
124834699|NCT02073279|449023696|FG000|Open-label Extension Period|Adverse Event|1|||
124834700|NCT02073279|449023697|FG001|Open-label Extension Period|Adverse Event|0|||
124834701|NCT02073279|449023696|FG000|Open-label Extension Period|Lack of Efficacy|1|||
124834702|NCT02073279|449023697|FG001|Open-label Extension Period|Lack of Efficacy|0|||
124834703|NCT02073279|449023696|FG000|Open-label Extension Period|Lost to Follow-up|0|||
124834704|NCT02073279|449023697|FG001|Open-label Extension Period|Lost to Follow-up|4|||
124834705|NCT02073279|449023696|FG000|Open-label Extension Period|Switched to another treatment|1|||
124834706|NCT02073279|449023697|FG001|Open-label Extension Period|Switched to another treatment|4|||
124834707|NCT02073279|449023696|FG000|Open-label Extension Period|Protocol Violation|0|||
124834708|NCT02073279|449023697|FG001|Open-label Extension Period|Protocol Violation|1|||
124834709|NCT02073279|449023696|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
124834710|NCT02073279|449023697|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
124834711|NCT02073279|449023696|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
124834712|NCT02073279|449023697|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
124834713|NCT00304356|449023698|FG000|Nitazoxanide|Physician Decision|5|||
124834714|NCT00304356|449023698|FG000|Nitazoxanide|Physician Decision|1|||
124834715|NCT00304356|449023698|FG000|Nitazoxanide|number is 0|1|||
124834716|NCT00304356|449023698|FG000|Nitazoxanide|Physician Decision|1|||
124834717|NCT00304356|449023698|FG000|Nitazoxanide|Physician Decision|1|||
124834718|NCT00304356|449023698|FG000|Nitazoxanide|Physician Decision|1|||
124834719|NCT03082599|449023700|FG000|Overall Study|Lost to Follow-up|1|||
124834720|NCT03082599|449023701|FG001|Overall Study|Lost to Follow-up|0|||
124834721|NCT00729183|449023702|FG000|Overall Study|Adverse Event|11|||
124834722|NCT00729183|449023703|FG001|Overall Study|Adverse Event|5|||
124834723|NCT00729183|449023702|FG000|Overall Study|Lack of Efficacy|0|||
124834724|NCT00729183|449023703|FG001|Overall Study|Lack of Efficacy|1|||
124834725|NCT00729183|449023702|FG000|Overall Study|Lost to Follow-up|3|||
124834726|NCT00729183|449023703|FG001|Overall Study|Lost to Follow-up|1|||
124834727|NCT00729183|449023702|FG000|Overall Study|Physician Decision|1|||
124834728|NCT00729183|449023703|FG001|Overall Study|Physician Decision|1|||
124834729|NCT00729183|449023702|FG000|Overall Study|Protocol Violation|1|||
124834730|NCT00729183|449023703|FG001|Overall Study|Protocol Violation|0|||
124834731|NCT00729183|449023702|FG000|Overall Study|Withdrawal by Subject|9|||
124834732|NCT00729183|449023703|FG001|Overall Study|Withdrawal by Subject|7|||
124834733|NCT00323115|449023706|FG000|Vaccine Administration|Adverse Event|1|||
124834734|NCT00323115|449023706|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
124834735|NCT01502423|449023708|FG000|Overall Study|Withdrawal by Subject|0|||
124834736|NCT01502423|449023709|FG001|Overall Study|Withdrawal by Subject|1|||
124834737|NCT00567892|449023710|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
124834738|NCT00567892|449023711|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
124834739|NCT00567892|449023712|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
124834740|NCT00567892|449023713|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
124834741|NCT00567892|449023710|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
124834742|NCT00567892|449023711|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
124834743|NCT00567892|449023712|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
124834744|NCT00567892|449023713|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
124834745|NCT00004888|449025511|FG000|Overall Study|Adverse Event|5|||
124834746|NCT00004888|449025512|FG001|Overall Study|Adverse Event|10|||
124834747|NCT00004888|449025511|FG000|Overall Study|Withdrawal by Subject|0|||
124834748|NCT00004888|449025512|FG001|Overall Study|Withdrawal by Subject|3|||
124834749|NCT00004888|449025511|FG000|Overall Study|Physician Decision|1|||
124834750|NCT00004888|449025512|FG001|Overall Study|Physician Decision|1|||
124834751|NCT00004888|449025511|FG000|Overall Study|Progressive Disease|4|||
124834752|NCT00004888|449025512|FG001|Overall Study|Progressive Disease|9|||
124834753|NCT00004888|449025511|FG000|Overall Study|Death without progressive disease|0|||
124834754|NCT00004888|449025512|FG001|Overall Study|Death without progressive disease|1|||
124834755|NCT00004888|449025511|FG000|Overall Study|Toxic death|1|||
124834756|NCT00004888|449025512|FG001|Overall Study|Toxic death|0|||
124834757|NCT02579265|449025513|FG000|Overall Study|Weaned off earlier than 28 days|44|||
124834758|NCT02579265|449025514|FG001|Overall Study|Weaned off earlier than 28 days|43|||
124834759|NCT02579265|449025513|FG000|Overall Study|Adverse Event|2|||
124834760|NCT02579265|449025514|FG001|Overall Study|Adverse Event|0|||
124834761|NCT02579265|449025513|FG000|Overall Study|Any other reason not specified|0|||
124834762|NCT02579265|449025514|FG001|Overall Study|Any other reason not specified|2|||
124834763|NCT02579265|449025513|FG000|Overall Study|Withdrawal by Subject|2|||
124834764|NCT02579265|449025514|FG001|Overall Study|Withdrawal by Subject|0|||
124834765|NCT02579265|449025513|FG000|Overall Study|Physician Decision|1|||
124834766|NCT02579265|449025514|FG001|Overall Study|Physician Decision|0|||
124834767|NCT02579265|449025513|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
124834768|NCT02579265|449025514|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
124834769|NCT02174848|449025518|FG000|Overall Study|Adverse Event|2|||
124834770|NCT02174848|449025519|FG001|Overall Study|Adverse Event|1|||
124834771|NCT02174848|449025518|FG000|Overall Study|Withdrawal by Subject|3|||
124834772|NCT02174848|449025519|FG001|Overall Study|Withdrawal by Subject|3|||
124834773|NCT02174848|449025518|FG000|Overall Study|Lost to Follow-up|0|||
124834774|NCT02174848|449025519|FG001|Overall Study|Lost to Follow-up|1|||
124834775|NCT02174848|449025518|FG000|Overall Study|Worsening of disease|1|||
124834776|NCT02174848|449025519|FG001|Overall Study|Worsening of disease|1|||
124834777|NCT02174848|449025518|FG000|Overall Study|Unable to comply with study requirements|1|||
124834778|NCT02174848|449025519|FG001|Overall Study|Unable to comply with study requirements|0|||
124834779|NCT00644969|449025520|FG000|Treatment Phase|Randomized, not treated|1|||
124834780|NCT00644969|449025521|FG001|Treatment Phase|Randomized, not treated|0|||
124834781|NCT00644969|449025520|FG000|Treatment Phase|Adverse Event|3|||
124834782|NCT00644969|449025521|FG001|Treatment Phase|Adverse Event|0|||
124834783|NCT00644969|449025520|FG000|Treatment Phase|Withdrawal by Subject|4|||
124834784|NCT00644969|449025521|FG001|Treatment Phase|Withdrawal by Subject|0|||
124834785|NCT00644969|449025520|FG000|Treatment Phase|Lost to Follow-up|2|||
124834786|NCT00644969|449025521|FG001|Treatment Phase|Lost to Follow-up|2|||
124834787|NCT00644969|449025520|FG000|Treatment Phase|Other|4|||
124834788|NCT00644969|449025521|FG001|Treatment Phase|Other|1|||
124834789|NCT00644969|449025520|FG000|Post Treatment Phase|Death|1|||
124834790|NCT00644969|449025521|FG001|Post Treatment Phase|Death|0|||
124834791|NCT00644969|449025520|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
124834792|NCT00644969|449025521|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
124834793|NCT00644969|449025520|FG000|Post Treatment Phase|Lost to Follow-up|4|||
124834794|NCT00644969|449025521|FG001|Post Treatment Phase|Lost to Follow-up|1|||
124834795|NCT00644969|449025520|FG000|Post Treatment Phase|Other|1|||
124834796|NCT00644969|449025521|FG001|Post Treatment Phase|Other|0|||
124834797|NCT00277212|449025522|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
124834798|NCT00277212|449025523|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
124834799|NCT00277212|449025524|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
124834800|NCT00277212|449025522|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
124834801|NCT00277212|449025523|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
124834802|NCT00277212|449025524|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
124834803|NCT00277212|449025522|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
124834804|NCT00277212|449025523|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
124834805|NCT00277212|449025524|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
124834806|NCT00277212|449025522|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
124834807|NCT00277212|449025523|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
124834808|NCT00277212|449025524|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
124834809|NCT00277212|449025522|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
124834810|NCT00277212|449025523|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
124834811|NCT00277212|449025524|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
124834812|NCT00277212|449025522|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
124834813|NCT00277212|449025523|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
124834814|NCT00277212|449025524|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
124834815|NCT00277212|449025522|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
124834816|NCT00277212|449025523|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
124834817|NCT00277212|449025524|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
124834818|NCT00277212|449025522|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
124834819|NCT00277212|449025523|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
124834820|NCT00277212|449025524|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
124834821|NCT00277212|449025522|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
124834822|NCT00277212|449025523|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
124834823|NCT00277212|449025524|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
124834824|NCT00277212|449025522|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
124834825|NCT00277212|449025523|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
124834826|NCT00277212|449025524|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
124834827|NCT00277212|449025522|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
124834828|NCT00277212|449025523|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
124834829|NCT00277212|449025524|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
124834830|NCT00277212|449025522|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
124834831|NCT00277212|449025523|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
124834832|NCT00277212|449025524|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
124834833|NCT00277212|449025522|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
124834834|NCT00277212|449025523|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
124834835|NCT00277212|449025524|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
124834836|NCT00277212|449025522|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
124834837|NCT00277212|449025523|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
124834838|NCT00277212|449025524|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
124834839|NCT00277212|449025522|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
124834840|NCT00277212|449025523|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
124834841|NCT00277212|449025524|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
124834842|NCT00277212|449025522|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
124834843|NCT00277212|449025523|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
124834844|NCT00277212|449025524|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
124834845|NCT00277212|449025522|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
124834846|NCT00277212|449025523|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
124834847|NCT00277212|449025524|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
124834848|NCT00277212|449025522|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
124834849|NCT00277212|449025523|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
124834850|NCT00277212|449025524|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
124834851|NCT03336216|449025525|FG000|Randomization|Not reported|2|||
124834852|NCT03336216|449025526|FG001|Randomization|Not reported|0|||
124834853|NCT03336216|449025527|FG002|Randomization|Not reported|1|||
124834854|NCT03336216|449025528|FG003|Randomization|Not reported|0|||
124834855|NCT03336216|449025525|FG000|Randomization|Other reasons|1|||
124834856|NCT03336216|449025526|FG001|Randomization|Other reasons|1|||
124834857|NCT03336216|449025527|FG002|Randomization|Other reasons|1|||
124834858|NCT03336216|449025528|FG003|Randomization|Other reasons|0|||
124834859|NCT03336216|449025525|FG000|Randomization|Participant no longer meets study criteria|0|||
124834860|NCT03336216|449025526|FG001|Randomization|Participant no longer meets study criteria|2|||
125304722|NCT00856544|450742721|FG000|Overall Study|Adverse Event|20|||
124834861|NCT03336216|449025527|FG002|Randomization|Participant no longer meets study criteria|4|||
125304723|NCT00856544|450742722|FG001|Overall Study|Adverse Event|29|||
124834862|NCT03336216|449025528|FG003|Randomization|Participant no longer meets study criteria|1|||
124834863|NCT03336216|449025525|FG000|Randomization|Lost to Follow-up|1|||
124834864|NCT03336216|449025526|FG001|Randomization|Lost to Follow-up|0|||
124834865|NCT03336216|449025527|FG002|Randomization|Lost to Follow-up|0|||
124834866|NCT03336216|449025528|FG003|Randomization|Lost to Follow-up|0|||
124834867|NCT03336216|449025525|FG000|Randomization|Participant withdrew consent|9|||
124834868|NCT03336216|449025526|FG001|Randomization|Participant withdrew consent|1|||
124834869|NCT03336216|449025527|FG002|Randomization|Participant withdrew consent|0|||
124834870|NCT03336216|449025528|FG003|Randomization|Participant withdrew consent|0|||
124834871|NCT03336216|449025525|FG000|Randomization|Adverse Event|1|||
124834872|NCT03336216|449025526|FG001|Randomization|Adverse Event|1|||
124834873|NCT03336216|449025527|FG002|Randomization|Adverse Event|0|||
124834874|NCT03336216|449025528|FG003|Randomization|Adverse Event|0|||
124834875|NCT03336216|449025525|FG000|Treatment|Adverse Event|2|||
124834876|NCT03336216|449025526|FG001|Treatment|Adverse Event|3|||
124834877|NCT03336216|449025527|FG002|Treatment|Adverse Event|4|||
124834878|NCT03336216|449025528|FG003|Treatment|Adverse Event|4|||
124834879|NCT03336216|449025525|FG000|Treatment|Participant request to discontinue treatment|2|||
124834880|NCT03336216|449025526|FG001|Treatment|Participant request to discontinue treatment|1|||
124834881|NCT03336216|449025527|FG002|Treatment|Participant request to discontinue treatment|2|||
124834882|NCT03336216|449025528|FG003|Treatment|Participant request to discontinue treatment|2|||
124834883|NCT03336216|449025525|FG000|Treatment|Participant withdrew consent|7|||
124834884|NCT03336216|449025526|FG001|Treatment|Participant withdrew consent|2|||
124834885|NCT03336216|449025527|FG002|Treatment|Participant withdrew consent|3|||
124834886|NCT03336216|449025528|FG003|Treatment|Participant withdrew consent|2|||
124834887|NCT03336216|449025525|FG000|Treatment|Death|2|||
124834888|NCT03336216|449025526|FG001|Treatment|Death|3|||
124834889|NCT03336216|449025527|FG002|Treatment|Death|3|||
124834890|NCT03336216|449025528|FG003|Treatment|Death|4|||
124834891|NCT03336216|449025525|FG000|Treatment|Participant no longer meets study criteria|0|||
124834892|NCT03336216|449025526|FG001|Treatment|Participant no longer meets study criteria|1|||
124834893|NCT03336216|449025527|FG002|Treatment|Participant no longer meets study criteria|0|||
124834894|NCT03336216|449025528|FG003|Treatment|Participant no longer meets study criteria|0|||
124834895|NCT03336216|449025525|FG000|Treatment|Other reasons|2|||
124834896|NCT03336216|449025526|FG001|Treatment|Other reasons|0|||
124834897|NCT03336216|449025527|FG002|Treatment|Other reasons|0|||
124834898|NCT03336216|449025528|FG003|Treatment|Other reasons|3|||
124834899|NCT03336216|449025525|FG000|Treatment|Disease progression|23|||
124834900|NCT03336216|449025526|FG001|Treatment|Disease progression|34|||
124834901|NCT03336216|449025527|FG002|Treatment|Disease progression|33|||
124834902|NCT03336216|449025528|FG003|Treatment|Disease progression|26|||
124834903|NCT03336216|449025525|FG000|Treatment|Study drug toxicity|0|||
124834904|NCT03336216|449025526|FG001|Treatment|Study drug toxicity|3|||
124834905|NCT03336216|449025527|FG002|Treatment|Study drug toxicity|2|||
124834906|NCT03336216|449025528|FG003|Treatment|Study drug toxicity|0|||
124834907|NCT03336216|449025525|FG000|Treatment|Adverse Event unrelated to study drug|1|||
124834908|NCT03336216|449025526|FG001|Treatment|Adverse Event unrelated to study drug|1|||
124834909|NCT03336216|449025527|FG002|Treatment|Adverse Event unrelated to study drug|1|||
124834910|NCT03336216|449025528|FG003|Treatment|Adverse Event unrelated to study drug|0|||
124834911|NCT03336216|449025525|FG000|Treatment|Disease Recurrence|1|||
124834912|NCT03336216|449025526|FG001|Treatment|Disease Recurrence|0|||
124834913|NCT03336216|449025527|FG002|Treatment|Disease Recurrence|0|||
124834914|NCT03336216|449025528|FG003|Treatment|Disease Recurrence|0|||
124834915|NCT01023581|449025534|FG000|Overall Study|Adverse Event|4|||
124834916|NCT01023581|449025535|FG001|Overall Study|Adverse Event|4|||
124834917|NCT01023581|449025536|FG002|Overall Study|Adverse Event|7|||
124834918|NCT01023581|449025537|FG003|Overall Study|Adverse Event|3|||
124834919|NCT01023581|449025538|FG004|Overall Study|Adverse Event|2|||
124834920|NCT01023581|449025539|FG005|Overall Study|Adverse Event|5|||
124834921|NCT01023581|449025540|FG006|Overall Study|Adverse Event|11|||
124834922|NCT01023581|449025534|FG000|Overall Study|Major protocol deviation|2|||
124834923|NCT01023581|449025535|FG001|Overall Study|Major protocol deviation|0|||
124834924|NCT01023581|449025536|FG002|Overall Study|Major protocol deviation|3|||
124834925|NCT01023581|449025537|FG003|Overall Study|Major protocol deviation|0|||
124834926|NCT01023581|449025538|FG004|Overall Study|Major protocol deviation|0|||
124834927|NCT01023581|449025539|FG005|Overall Study|Major protocol deviation|0|||
124834928|NCT01023581|449025540|FG006|Overall Study|Major protocol deviation|0|||
124834929|NCT01023581|449025534|FG000|Overall Study|Lost to Follow-up|4|||
124834930|NCT01023581|449025535|FG001|Overall Study|Lost to Follow-up|8|||
124834931|NCT01023581|449025536|FG002|Overall Study|Lost to Follow-up|7|||
124834932|NCT01023581|449025537|FG003|Overall Study|Lost to Follow-up|2|||
124834933|NCT01023581|449025538|FG004|Overall Study|Lost to Follow-up|5|||
124834934|NCT01023581|449025539|FG005|Overall Study|Lost to Follow-up|2|||
124834935|NCT01023581|449025540|FG006|Overall Study|Lost to Follow-up|2|||
124834936|NCT01023581|449025534|FG000|Overall Study|Withdrawal by Subject|13|||
124834937|NCT01023581|449025535|FG001|Overall Study|Withdrawal by Subject|8|||
124834938|NCT01023581|449025536|FG002|Overall Study|Withdrawal by Subject|16|||
124834939|NCT01023581|449025537|FG003|Overall Study|Withdrawal by Subject|10|||
124834940|NCT01023581|449025538|FG004|Overall Study|Withdrawal by Subject|6|||
124834941|NCT01023581|449025539|FG005|Overall Study|Withdrawal by Subject|8|||
124834942|NCT01023581|449025540|FG006|Overall Study|Withdrawal by Subject|5|||
124834943|NCT01023581|449025534|FG000|Overall Study|Pregnancy|0|||
124834944|NCT01023581|449025535|FG001|Overall Study|Pregnancy|0|||
124834945|NCT01023581|449025536|FG002|Overall Study|Pregnancy|0|||
124834946|NCT01023581|449025537|FG003|Overall Study|Pregnancy|2|||
124834947|NCT01023581|449025538|FG004|Overall Study|Pregnancy|0|||
124834948|NCT01023581|449025539|FG005|Overall Study|Pregnancy|1|||
124834949|NCT01023581|449025540|FG006|Overall Study|Pregnancy|0|||
124834950|NCT01023581|449025534|FG000|Overall Study|Lack of Efficacy|9|||
124834951|NCT01023581|449025535|FG001|Overall Study|Lack of Efficacy|3|||
124834952|NCT01023581|449025536|FG002|Overall Study|Lack of Efficacy|6|||
124834953|NCT01023581|449025537|FG003|Overall Study|Lack of Efficacy|2|||
124834954|NCT01023581|449025538|FG004|Overall Study|Lack of Efficacy|1|||
124834955|NCT01023581|449025539|FG005|Overall Study|Lack of Efficacy|2|||
124834956|NCT01023581|449025540|FG006|Overall Study|Lack of Efficacy|1|||
124834957|NCT01023581|449025534|FG000|Overall Study|Physician Decision|2|||
124834958|NCT01023581|449025535|FG001|Overall Study|Physician Decision|0|||
124834959|NCT01023581|449025536|FG002|Overall Study|Physician Decision|2|||
124834960|NCT01023581|449025537|FG003|Overall Study|Physician Decision|1|||
124834961|NCT01023581|449025538|FG004|Overall Study|Physician Decision|1|||
124834962|NCT01023581|449025539|FG005|Overall Study|Physician Decision|1|||
124834963|NCT01023581|449025540|FG006|Overall Study|Physician Decision|1|||
124834964|NCT01023581|449025534|FG000|Overall Study|Other|1|||
124834965|NCT01023581|449025535|FG001|Overall Study|Other|0|||
124834966|NCT01023581|449025536|FG002|Overall Study|Other|1|||
124834967|NCT01023581|449025537|FG003|Overall Study|Other|0|||
124834968|NCT01023581|449025538|FG004|Overall Study|Other|1|||
124834969|NCT01023581|449025539|FG005|Overall Study|Other|0|||
124834970|NCT01023581|449025540|FG006|Overall Study|Other|0|||
124834971|NCT01231581|449025541|FG000|Overall Study|Lost to Follow-up|2|||
124834972|NCT01231581|449025542|FG001|Overall Study|Lost to Follow-up|2|||
124834973|NCT01231581|449025541|FG000|Overall Study|Withdrawal by Subject|6|||
124834974|NCT01231581|449025542|FG001|Overall Study|Withdrawal by Subject|9|||
124834975|NCT01231581|449025541|FG000|Overall Study|Study Closed/Terminated|6|||
124834976|NCT01231581|449025542|FG001|Overall Study|Study Closed/Terminated|5|||
124834977|NCT01231581|449025541|FG000|Overall Study|Death|65|||
124834978|NCT01231581|449025542|FG001|Overall Study|Death|64|||
124834979|NCT01231581|449025541|FG000|Overall Study|Ongoing|1|||
124834980|NCT01231581|449025542|FG001|Overall Study|Ongoing|0|||
124834981|NCT02510794|449025543|FG000|Overall Study|Adverse Event|0|||
124834982|NCT02510794|449025544|FG001|Overall Study|Adverse Event|1|||
124834983|NCT02510794|449025545|FG002|Overall Study|Adverse Event|0|||
124834984|NCT02510794|449025546|FG003|Overall Study|Adverse Event|0|||
124834985|NCT02510794|449025543|FG000|Overall Study|Death|1|||
124834986|NCT02510794|449025544|FG001|Overall Study|Death|2|||
124834987|NCT02510794|449025545|FG002|Overall Study|Death|1|||
124834988|NCT02510794|449025546|FG003|Overall Study|Death|1|||
124834989|NCT02510794|449025543|FG000|Overall Study|Lack of Efficacy|3|||
124834990|NCT02510794|449025544|FG001|Overall Study|Lack of Efficacy|1|||
124834991|NCT02510794|449025545|FG002|Overall Study|Lack of Efficacy|1|||
124834992|NCT02510794|449025546|FG003|Overall Study|Lack of Efficacy|0|||
124834993|NCT02510794|449025543|FG000|Overall Study|Participant moved out of the area|0|||
124834994|NCT02510794|449025544|FG001|Overall Study|Participant moved out of the area|0|||
124834995|NCT02510794|449025545|FG002|Overall Study|Participant moved out of the area|0|||
124834996|NCT02510794|449025546|FG003|Overall Study|Participant moved out of the area|1|||
124834997|NCT02510794|449025543|FG000|Overall Study|Physician Decision|3|||
124834998|NCT02510794|449025544|FG001|Overall Study|Physician Decision|0|||
124834999|NCT02510794|449025545|FG002|Overall Study|Physician Decision|0|||
124835000|NCT02510794|449025546|FG003|Overall Study|Physician Decision|0|||
124835001|NCT02510794|449025543|FG000|Overall Study|Protocol Violation|0|||
124835002|NCT02510794|449025544|FG001|Overall Study|Protocol Violation|0|||
124835003|NCT02510794|449025545|FG002|Overall Study|Protocol Violation|1|||
124835004|NCT02510794|449025546|FG003|Overall Study|Protocol Violation|0|||
124835005|NCT02510794|449025543|FG000|Overall Study|Withdrawal by Subject|1|||
124835006|NCT02510794|449025544|FG001|Overall Study|Withdrawal by Subject|2|||
124835007|NCT02510794|449025545|FG002|Overall Study|Withdrawal by Subject|4|||
125304724|NCT00856544|450742723|FG002|Overall Study|Adverse Event|2|||
125304725|NCT00856544|450742724|FG003|Overall Study|Adverse Event|3|||
125304726|NCT00856544|450742721|FG000|Overall Study|Lack of Efficacy|16|||
124835008|NCT02510794|449025546|FG003|Overall Study|Withdrawal by Subject|3|||
124835009|NCT03090100|449025547|FG000|Overall Study|Adverse Event|9|||
124835010|NCT03090100|449025548|FG001|Overall Study|Adverse Event|11|||
124835011|NCT03090100|449025547|FG000|Overall Study|Pregnancy|1|||
124835012|NCT03090100|449025548|FG001|Overall Study|Pregnancy|1|||
124835013|NCT03090100|449025547|FG000|Overall Study|Lack of Efficacy|2|||
124835014|NCT03090100|449025548|FG001|Overall Study|Lack of Efficacy|7|||
124835015|NCT03090100|449025547|FG000|Overall Study|Lost to Follow-up|2|||
124835016|NCT03090100|449025548|FG001|Overall Study|Lost to Follow-up|2|||
124835017|NCT03090100|449025547|FG000|Overall Study|Withdrawal by Subject|7|||
124835018|NCT03090100|449025548|FG001|Overall Study|Withdrawal by Subject|19|||
124835019|NCT03090100|449025547|FG000|Overall Study|Protocol Violation|2|||
124835020|NCT03090100|449025548|FG001|Overall Study|Protocol Violation|6|||
124835021|NCT03090100|449025547|FG000|Overall Study|Non-compliance|2|||
124835022|NCT03090100|449025548|FG001|Overall Study|Non-compliance|0|||
125304727|NCT00856544|450742722|FG001|Overall Study|Lack of Efficacy|12|||
124835023|NCT03090100|449025547|FG000|Overall Study|Other|2|||
124835024|NCT03090100|449025548|FG001|Overall Study|Other|2|||
124835025|NCT03253848|449025549|FG000|Overall Study|Adverse Event|7|||
124835026|NCT03253848|449025549|FG000|Overall Study|Death|5|||
124835027|NCT03253848|449025549|FG000|Overall Study|initiation of other treatments|3|||
124835028|NCT03253848|449025549|FG000|Overall Study|Other complicating disease|1|||
124835029|NCT03253848|449025549|FG000|Overall Study|Withdrawal by Subject|1|||
124835030|NCT03253848|449025549|FG000|Overall Study|Declining health|1|||
124835031|NCT05352815|449025550|FG000|Overall Study|Withdrawal by Subject|28|||
124835032|NCT05352815|449025551|FG001|Overall Study|Withdrawal by Subject|24|||
124835033|NCT05352815|449025550|FG000|Overall Study|Lost to Follow-up|4|||
124835034|NCT05352815|449025551|FG001|Overall Study|Lost to Follow-up|7|||
124835035|NCT05352815|449025550|FG000|Overall Study|Death|2|||
124835036|NCT05352815|449025551|FG001|Overall Study|Death|3|||
124835037|NCT05352815|449025550|FG000|Overall Study|Site closure|1|||
124835038|NCT05352815|449025551|FG001|Overall Study|Site closure|0|||
124835039|NCT02759120|449025552|FG000|Overall Study|Death|34|||
124835040|NCT02759120|449025553|FG001|Overall Study|Death|36|||
124835041|NCT02759120|449025552|FG000|Overall Study|Lost to Follow-up|4|||
124835042|NCT02759120|449025553|FG001|Overall Study|Lost to Follow-up|7|||
124835043|NCT02759120|449025552|FG000|Overall Study|Physician Decision|3|||
124835044|NCT02759120|449025553|FG001|Overall Study|Physician Decision|0|||
124835045|NCT02759120|449025552|FG000|Overall Study|Withdrawal by Subject|28|||
124835046|NCT02759120|449025553|FG001|Overall Study|Withdrawal by Subject|15|||
124835047|NCT02759120|449025552|FG000|Overall Study|Moved out of area|3|||
124835048|NCT02759120|449025553|FG001|Overall Study|Moved out of area|4|||
124835049|NCT02759120|449025552|FG000|Overall Study|Lung transplant|3|||
124835050|NCT02759120|449025553|FG001|Overall Study|Lung transplant|5|||
124835051|NCT02759120|449025552|FG000|Overall Study|Other reason not completed|10|||
124835052|NCT02759120|449025553|FG001|Overall Study|Other reason not completed|12|||
124835053|NCT04461015|449025555|FG000|Overall Study|IV access lost during the study|0|||
124835054|NCT04461015|449025556|FG001|Overall Study|IV access lost during the study|1|||
124835055|NCT04461015|449025555|FG000|Overall Study|Withdrawal by Subject|0|||
124835056|NCT04461015|449025556|FG001|Overall Study|Withdrawal by Subject|1|||
124835057|NCT05071183|449025563|FG000|Overall Study|Death|1|||
124835058|NCT05071183|449025564|FG001|Overall Study|Death|2|||
124835059|NCT05071183|449025565|FG002|Overall Study|Death|0|||
124835060|NCT05071183|449025563|FG000|Overall Study|Other Reasons|1|||
124835061|NCT05071183|449025564|FG001|Overall Study|Other Reasons|3|||
124835062|NCT05071183|449025565|FG002|Overall Study|Other Reasons|2|||
124835063|NCT02532647|449025580|FG000|Overall Study|Did not receive trial medication|1|||
124835064|NCT02532647|449025581|FG001|Overall Study|Did not receive trial medication|0|||
124835065|NCT02532647|449025582|FG002|Overall Study|Did not receive trial medication|1|||
124835066|NCT02420691|449025589|FG000|Overall Study|Adverse Event|3|||
124835067|NCT02420691|449025589|FG000|Overall Study|Withdrawal by Subject|3|||
124835068|NCT00325754|449025592|FG000|Overall Study|Adverse Event|4|||
124835069|NCT00325754|449025593|FG001|Overall Study|Adverse Event|1|||
124835070|NCT02625090|449025602|FG000|Overall Study|Participant wants to be pregnant|2|||
124835071|NCT02625090|449025602|FG000|Overall Study|For the Promoter|1|||
124835072|NCT02625090|449025602|FG000|Overall Study|Sponsor's Decision|9|||
124835073|NCT02625090|449025602|FG000|Overall Study|Somnolence|1|||
124835074|NCT02625090|449025602|FG000|Overall Study|Study terminated by Sponsor|7|||
124835075|NCT02625090|449025602|FG000|Overall Study|Negative Benefit/Risk|1|||
124835076|NCT02625090|449025602|FG000|Overall Study|Protocol Deviation|2|||
124835077|NCT02625090|449025602|FG000|Overall Study|Lack of Efficacy|16|||
124835078|NCT02625090|449025602|FG000|Overall Study|Adverse Event|3|||
124835079|NCT02439320|449025603|FG000|Overall Study|Adverse Event|0|||
124835080|NCT02439320|449025604|FG001|Overall Study|Adverse Event|2|||
124835081|NCT02439320|449025605|FG002|Overall Study|Adverse Event|0|||
124835082|NCT02439320|449025603|FG000|Overall Study|Lost to Follow-up|37|||
124835083|NCT02439320|449025604|FG001|Overall Study|Lost to Follow-up|34|||
125304728|NCT00856544|450742723|FG002|Overall Study|Lack of Efficacy|3|||
125304729|NCT00856544|450742724|FG003|Overall Study|Lack of Efficacy|3|||
125304730|NCT00856544|450742721|FG000|Overall Study|Other|9|||
125304731|NCT00856544|450742722|FG001|Overall Study|Other|16|||
125304732|NCT00856544|450742723|FG002|Overall Study|Other|1|||
124835084|NCT02439320|449025605|FG002|Overall Study|Lost to Follow-up|42|||
124835085|NCT02439320|449025603|FG000|Overall Study|Death|0|||
124835086|NCT02439320|449025604|FG001|Overall Study|Death|1|||
124835087|NCT02439320|449025605|FG002|Overall Study|Death|0|||
124835088|NCT02439320|449025603|FG000|Overall Study|Noncompliance with Protocol|10|||
124835089|NCT02439320|449025604|FG001|Overall Study|Noncompliance with Protocol|11|||
124835090|NCT02439320|449025605|FG002|Overall Study|Noncompliance with Protocol|7|||
124835091|NCT02439320|449025603|FG000|Overall Study|Pregnancy|0|||
124835092|NCT02439320|449025604|FG001|Overall Study|Pregnancy|1|||
124835093|NCT02439320|449025605|FG002|Overall Study|Pregnancy|1|||
124835094|NCT02439320|449025603|FG000|Overall Study|Withdrawal by Subject|12|||
124835095|NCT02439320|449025604|FG001|Overall Study|Withdrawal by Subject|16|||
124835096|NCT02439320|449025605|FG002|Overall Study|Withdrawal by Subject|14|||
124835097|NCT02439320|449025603|FG000|Overall Study|Physician Decision|2|||
124835098|NCT02439320|449025604|FG001|Overall Study|Physician Decision|1|||
124835099|NCT02439320|449025605|FG002|Overall Study|Physician Decision|0|||
124835100|NCT02439320|449025603|FG000|Overall Study|Sponsor Request|0|||
124835101|NCT02439320|449025604|FG001|Overall Study|Sponsor Request|2|||
124835102|NCT02439320|449025605|FG002|Overall Study|Sponsor Request|1|||
124835103|NCT02439320|449025603|FG000|Overall Study|Randomization Failure|35|||
124835104|NCT02439320|449025604|FG001|Overall Study|Randomization Failure|46|||
124835105|NCT02439320|449025605|FG002|Overall Study|Randomization Failure|34|||
124835106|NCT02972632|449025606|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
124835107|NCT02972632|449025606|FG000|Overall Study|Lost to Follow-up|4|||
124835108|NCT02972632|449025606|FG000|Overall Study|Voluntary Withdrawal|10|||
124835109|NCT01488097|449025614|FG000|Overall Study|Lost to Follow-up|1|||
124835110|NCT01251380|449025629|FG000|Overall Study|Other (Not otherwise specified)|12|||
124835111|NCT01251380|449025629|FG000|Overall Study|Withdrawal by Subject|6|||
124835112|NCT01251380|449025629|FG000|Overall Study|Lack of Efficacy|1|||
124835113|NCT01251380|449025629|FG000|Overall Study|Adverse Event|1|||
124835114|NCT01251380|449025629|FG000|Overall Study|Lost to Follow-up|2|||
124835115|NCT02205333|449025638|FG000|Overall Study|Death|5|||
124835116|NCT02205333|449025639|FG001|Overall Study|Death|6|||
124835117|NCT02205333|449025640|FG002|Overall Study|Death|2|||
124835118|NCT02205333|449025641|FG003|Overall Study|Death|6|||
124835119|NCT02205333|449025642|FG004|Overall Study|Death|5|||
124835120|NCT02205333|449025643|FG005|Overall Study|Death|3|||
124835121|NCT02205333|449025644|FG006|Overall Study|Death|3|||
124835122|NCT02205333|449025645|FG007|Overall Study|Death|2|||
124835123|NCT02205333|449025646|FG008|Overall Study|Death|0|||
124835124|NCT02205333|449025638|FG000|Overall Study|Withdrawal by Subject|1|||
124835125|NCT02205333|449025639|FG001|Overall Study|Withdrawal by Subject|0|||
124835126|NCT02205333|449025640|FG002|Overall Study|Withdrawal by Subject|0|||
124835127|NCT02205333|449025641|FG003|Overall Study|Withdrawal by Subject|1|||
124835128|NCT02205333|449025642|FG004|Overall Study|Withdrawal by Subject|0|||
124835129|NCT02205333|449025643|FG005|Overall Study|Withdrawal by Subject|0|||
124835130|NCT02205333|449025644|FG006|Overall Study|Withdrawal by Subject|2|||
124835131|NCT02205333|449025645|FG007|Overall Study|Withdrawal by Subject|0|||
124835132|NCT02205333|449025646|FG008|Overall Study|Withdrawal by Subject|0|||
124835133|NCT01476696|449025647|FG000|Overall Study|Sponsor decision|2|||
124835134|NCT01476696|449025648|FG001|Overall Study|Sponsor decision|1|||
124835135|NCT01476696|449025649|FG002|Overall Study|Sponsor decision|0|||
124835136|NCT01476696|449025647|FG000|Overall Study|Withdrawal by Subject|1|||
124835137|NCT01476696|449025648|FG001|Overall Study|Withdrawal by Subject|0|||
124835138|NCT01476696|449025649|FG002|Overall Study|Withdrawal by Subject|0|||
124835139|NCT03054870|449025653|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
124835140|NCT03054870|449025653|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
124835141|NCT02009046|449025654|FG000|Overall Study|Lost to Follow-up|256|||
124835142|NCT02009046|449025655|FG001|Overall Study|Lost to Follow-up|206|||
124835143|NCT01324388|449025656|FG000|Part 1 of Study|Adverse Event|2|||
124835144|NCT01324388|449025657|FG001|Part 1 of Study|Adverse Event|0|||
124835145|NCT01324388|449025658|FG002|Part 1 of Study|Adverse Event|0|||
124835146|NCT01324388|449025659|FG003|Part 1 of Study|Adverse Event|0|||
124835147|NCT01324388|449025656|FG000|Part 1 of Study|Protocol Violation|1|||
124835148|NCT01324388|449025657|FG001|Part 1 of Study|Protocol Violation|2|||
124835149|NCT01324388|449025658|FG002|Part 1 of Study|Protocol Violation|0|||
124835150|NCT01324388|449025659|FG003|Part 1 of Study|Protocol Violation|0|||
124835151|NCT01324388|449025656|FG000|Part 1 of Study|Physician Decision|1|||
124835152|NCT01324388|449025657|FG001|Part 1 of Study|Physician Decision|0|||
124835153|NCT01324388|449025658|FG002|Part 1 of Study|Physician Decision|0|||
124835154|NCT01324388|449025659|FG003|Part 1 of Study|Physician Decision|0|||
124835155|NCT01324388|449025656|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
124835156|NCT01324388|449025657|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
124835157|NCT01324388|449025658|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
124835158|NCT01324388|449025659|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
124835159|NCT01324388|449025656|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
124835160|NCT01324388|449025657|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
124835161|NCT01324388|449025658|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
124835162|NCT01324388|449025659|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
124835163|NCT00973479|449025662|FG000|Overall Study|Lost to Follow-up|0|||
124835164|NCT00973479|449025663|FG001|Overall Study|Lost to Follow-up|3|||
124835165|NCT00973479|449025662|FG000|Overall Study|Death|2|||
124835166|NCT00973479|449025663|FG001|Overall Study|Death|2|||
124835167|NCT00973479|449025662|FG000|Overall Study|Withdrawal by Subject|15|||
124835168|NCT00973479|449025663|FG001|Overall Study|Withdrawal by Subject|16|||
124835169|NCT00973479|449025662|FG000|Overall Study|Lack of Efficacy|5|||
124835170|NCT00973479|449025663|FG001|Overall Study|Lack of Efficacy|7|||
124835171|NCT00973479|449025662|FG000|Overall Study|Adverse Event|12|||
124835172|NCT00973479|449025663|FG001|Overall Study|Adverse Event|32|||
124835173|NCT00973479|449025662|FG000|Overall Study|Protocol Violation|2|||
124835174|NCT00973479|449025663|FG001|Overall Study|Protocol Violation|2|||
124835175|NCT00973479|449025662|FG000|Overall Study|Other|1|||
124835176|NCT00973479|449025663|FG001|Overall Study|Other|7|||
124835177|NCT03089606|449025664|FG000|Overall Study|Progression after Cycle 1|1|||
124835178|NCT02140567|449025668|FG000|Overall Study|Problems with recording equipment|6|||
124835179|NCT02802592|449025669|FG000|Overall Study|Study terminated due to loss of funding|4|||
124835180|NCT02136576|449025670|FG000|Overall Study|Lost to Follow-up|2|||
124835181|NCT02136576|449025671|FG001|Overall Study|Lost to Follow-up|0|||
124835182|NCT02136576|449025672|FG002|Overall Study|Lost to Follow-up|0|||
124835183|NCT00537381|449025673|FG000|Overall Study|Adverse Event|13|||
124835184|NCT00537381|449025674|FG001|Overall Study|Adverse Event|9|||
124835185|NCT00537381|449025673|FG000|Overall Study|Death|3|||
124835186|NCT00537381|449025674|FG001|Overall Study|Death|3|||
124835187|NCT00537381|449025673|FG000|Overall Study|Withdrawal by Subject|5|||
124835188|NCT00537381|449025674|FG001|Overall Study|Withdrawal by Subject|14|||
124835189|NCT00537381|449025673|FG000|Overall Study|Physician Decision|7|||
124835190|NCT00537381|449025674|FG001|Overall Study|Physician Decision|6|||
124835191|NCT00537381|449025673|FG000|Overall Study|Disease Progression|9|||
124835192|NCT00537381|449025674|FG001|Overall Study|Disease Progression|18|||
124835193|NCT00537381|449025673|FG000|Overall Study|Sponsor decision|14|||
124835194|NCT00537381|449025674|FG001|Overall Study|Sponsor decision|9|||
124835195|NCT00537381|449025673|FG000|Overall Study|Other|5|||
124835196|NCT00537381|449025674|FG001|Overall Study|Other|3|||
124835197|NCT00735878|449025678|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
124835198|NCT00735878|449025679|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
124835199|NCT00735878|449025680|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
124835200|NCT00352846|449025681|FG000|Overall Study|Disease progression|0|||
124835201|NCT00352846|449025682|FG001|Overall Study|Disease progression|2|||
124835202|NCT00352846|449025681|FG000|Overall Study|Withdrawal by Subject|3|||
124835203|NCT00352846|449025682|FG001|Overall Study|Withdrawal by Subject|8|||
124835204|NCT00352846|449025681|FG000|Overall Study|Ineligible|3|||
124835205|NCT00352846|449025682|FG001|Overall Study|Ineligible|2|||
124835206|NCT00352846|449025681|FG000|Overall Study|Non-compliance|2|||
124835207|NCT00352846|449025682|FG001|Overall Study|Non-compliance|0|||
124835208|NCT00352846|449025681|FG000|Overall Study|Death|0|||
124835209|NCT00352846|449025682|FG001|Overall Study|Death|1|||
124835210|NCT01527682|449025683|FG000|Overall Study|Protocol Violation|8|||
124835211|NCT00600938|449025684|FG000|Core Study|Abnormal test procedure result(s)|3|||
124835212|NCT00600938|449025685|FG001|Core Study|Abnormal test procedure result(s)|2|||
124835213|NCT00600938|449025686|FG002|Core Study|Abnormal test procedure result(s)|0|||
124835214|NCT00600938|449025687|FG003|Core Study|Abnormal test procedure result(s)|0|||
124835215|NCT00600938|449025684|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
124835216|NCT00600938|449025685|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
124835217|NCT00600938|449025686|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
124835218|NCT00600938|449025687|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
124835219|NCT00600938|449025684|FG000|Core Study|Patient withdrew consent|7|||
124835220|NCT00600938|449025685|FG001|Core Study|Patient withdrew consent|12|||
124835221|NCT00600938|449025686|FG002|Core Study|Patient withdrew consent|0|||
124835222|NCT00600938|449025687|FG003|Core Study|Patient withdrew consent|0|||
124835223|NCT00600938|449025684|FG000|Core Study|Lost to Follow-up|3|||
124835224|NCT00600938|449025685|FG001|Core Study|Lost to Follow-up|2|||
124835225|NCT00600938|449025686|FG002|Core Study|Lost to Follow-up|0|||
124835226|NCT00600938|449025687|FG003|Core Study|Lost to Follow-up|0|||
124835227|NCT00600938|449025684|FG000|Core Study|Death|1|||
124835228|NCT00600938|449025685|FG001|Core Study|Death|1|||
124835229|NCT00600938|449025686|FG002|Core Study|Death|0|||
124835230|NCT00600938|449025687|FG003|Core Study|Death|0|||
124835231|NCT00600938|449025684|FG000|Core Study|Protocol Violation|1|||
124835232|NCT00600938|449025685|FG001|Core Study|Protocol Violation|2|||
124835233|NCT00600938|449025686|FG002|Core Study|Protocol Violation|0|||
124835234|NCT00600938|449025687|FG003|Core Study|Protocol Violation|0|||
124835235|NCT00600938|449025684|FG000|Extension Study|Adverse Event|1|||
124835236|NCT00600938|449025685|FG001|Extension Study|Adverse Event|0|||
124835237|NCT00600938|449025686|FG002|Extension Study|Adverse Event|2|||
124835238|NCT00600938|449025687|FG003|Extension Study|Adverse Event|0|||
124835239|NCT00600938|449025684|FG000|Extension Study|Abnormal test procedure results|0|||
124835240|NCT00600938|449025685|FG001|Extension Study|Abnormal test procedure results|1|||
124835241|NCT00600938|449025686|FG002|Extension Study|Abnormal test procedure results|1|||
124835242|NCT00600938|449025687|FG003|Extension Study|Abnormal test procedure results|1|||
124835243|NCT00600938|449025684|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
124835244|NCT00600938|449025685|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
124835245|NCT00600938|449025686|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
124835246|NCT00600938|449025687|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
124835247|NCT00600938|449025684|FG000|Extension Study|Withdrawal by Subject|2|||
124835248|NCT00600938|449025685|FG001|Extension Study|Withdrawal by Subject|2|||
124835249|NCT00600938|449025686|FG002|Extension Study|Withdrawal by Subject|3|||
124835250|NCT00600938|449025687|FG003|Extension Study|Withdrawal by Subject|0|||
124835251|NCT00600938|449025684|FG000|Extension Study|Lost to Follow-up|1|||
124835252|NCT00600938|449025685|FG001|Extension Study|Lost to Follow-up|1|||
124835253|NCT00600938|449025686|FG002|Extension Study|Lost to Follow-up|2|||
124835254|NCT00600938|449025687|FG003|Extension Study|Lost to Follow-up|0|||
124835255|NCT00600938|449025684|FG000|Extension Study|Death|1|||
124835256|NCT00600938|449025685|FG001|Extension Study|Death|0|||
124835257|NCT00600938|449025686|FG002|Extension Study|Death|0|||
124835258|NCT00600938|449025687|FG003|Extension Study|Death|0|||
124835259|NCT00549562|449025688|FG000|Overall Study|Adverse Event|1|||
124835260|NCT00549562|449025688|FG000|Overall Study|Lack of Efficacy|1|||
124835261|NCT04709575|449026848|FG000|Overall Study|Withdrawal by Subject|6|||
124835262|NCT04709575|449026849|FG001|Overall Study|Withdrawal by Subject|2|||
124835263|NCT04709575|449026848|FG000|Overall Study|Lost to Follow-up|2|||
124835264|NCT04709575|449026849|FG001|Overall Study|Lost to Follow-up|2|||
124835265|NCT04709575|449026848|FG000|Overall Study|Adverse Event|1|||
124835266|NCT04709575|449026849|FG001|Overall Study|Adverse Event|0|||
124835267|NCT04709575|449026848|FG000|Overall Study|Protocol Violation|1|||
124835268|NCT04709575|449026849|FG001|Overall Study|Protocol Violation|1|||
124835269|NCT04254978|449026852|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
124835270|NCT04254978|449026852|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
124835271|NCT04254978|449026852|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
124835272|NCT04254978|449026852|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
124835273|NCT04254978|449026852|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
124835274|NCT04254978|449026852|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
124835275|NCT03239470|449026855|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
124835276|NCT03239470|449026856|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
124835277|NCT00666757|449026857|FG000|Overall Study|Lost to Follow-up|39|||
124835278|NCT00666757|449026858|FG001|Overall Study|Lost to Follow-up|35|||
124835279|NCT00666757|449026857|FG000|Overall Study|Protocol Violation|23|||
124835280|NCT00666757|449026858|FG001|Overall Study|Protocol Violation|24|||
124835281|NCT00666757|449026857|FG000|Overall Study|Adverse Event|22|||
124835282|NCT00666757|449026858|FG001|Overall Study|Adverse Event|12|||
124835283|NCT00666757|449026857|FG000|Overall Study|Withdrawal by Subject|13|||
124835284|NCT00666757|449026858|FG001|Overall Study|Withdrawal by Subject|17|||
124835285|NCT00666757|449026857|FG000|Overall Study|Lack of Efficacy|3|||
124835286|NCT00666757|449026858|FG001|Overall Study|Lack of Efficacy|6|||
124835287|NCT00666757|449026857|FG000|Overall Study|Physician Decision|0|||
124835288|NCT00666757|449026858|FG001|Overall Study|Physician Decision|2|||
124835289|NCT00666757|449026857|FG000|Overall Study|Sponsor decision|0|||
124835290|NCT00666757|449026858|FG001|Overall Study|Sponsor decision|1|||
124835291|NCT01660711|449026859|FG000|Overall Study|Adverse Event|7|||
124835292|NCT01660711|449026859|FG000|Overall Study|Withdrawal by Subject|1|||
124835293|NCT05664490|449026864|FG000|Overall Study|Withdrawal by Subject|0|||
124835294|NCT05664490|449026865|FG001|Overall Study|Withdrawal by Subject|1|||
124835295|NCT05664490|449026864|FG000|Overall Study|Lost to Follow-up|14|||
124835296|NCT05664490|449026865|FG001|Overall Study|Lost to Follow-up|22|||
124835297|NCT02939560|449026866|FG000|Overall Study|Withdrawal by Subject|2|||
124835298|NCT02939560|449026866|FG000|Overall Study|Protocol Violation|1|||
124835299|NCT05694546|449026874|FG000|Overall Study|Lost to Follow-up|11|||
124835300|NCT01589445|449026875|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
124835301|NCT01589445|449026875|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
124835302|NCT01589445|449026875|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
124835303|NCT01589445|449026875|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
124835304|NCT01589445|449026875|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
124835305|NCT01589445|449026875|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
124835306|NCT01589445|449026875|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
124835307|NCT01589445|449026875|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
124835308|NCT01589445|449026875|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
124835309|NCT01589445|449026875|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
124835310|NCT01505608|449026878|FG000|Phase I|Lack of Efficacy|0|||
124835311|NCT01505608|449026879|FG001|Phase I|Lack of Efficacy|4|||
124835312|NCT01505608|449026878|FG000|Phase I|Adverse Event|0|||
124835313|NCT01505608|449026879|FG001|Phase I|Adverse Event|1|||
124835314|NCT01505608|449026878|FG000|Phase I|Withdrawal by Subject|0|||
124835315|NCT01505608|449026879|FG001|Phase I|Withdrawal by Subject|1|||
124835316|NCT01505608|449026878|FG000|Phase II|Lack of Efficacy|2|||
124835317|NCT01505608|449026879|FG001|Phase II|Lack of Efficacy|1|||
124835318|NCT01505608|449026878|FG000|Phase II|Protocol Violation|0|||
124835319|NCT01505608|449026879|FG001|Phase II|Protocol Violation|1|||
124835320|NCT02319031|449026885|FG000|Treatment Period|Death|1|||
124835321|NCT02319031|449026886|FG001|Treatment Period|Death|0|||
124835322|NCT03519971|449026891|FG000|Overall Study|Death|142|||
124835323|NCT03519971|449026892|FG001|Overall Study|Death|69|||
124835324|NCT03519971|449026891|FG000|Overall Study|Lost to Follow-up|0|||
124835325|NCT03519971|449026892|FG001|Overall Study|Lost to Follow-up|1|||
124835326|NCT03519971|449026891|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
124835327|NCT03519971|449026892|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
124835328|NCT03519971|449026891|FG000|Overall Study|Withdrawal by Subject|3|||
124835329|NCT03519971|449026892|FG001|Overall Study|Withdrawal by Subject|2|||
124835330|NCT03519971|449026891|FG000|Overall Study|Other|1|||
124835331|NCT03519971|449026892|FG001|Overall Study|Other|0|||
124835332|NCT00129129|449026893|FG000|Primary Phase|Adverse Event|2|||
124835333|NCT00129129|449026894|FG001|Primary Phase|Adverse Event|1|||
124835334|NCT00129129|449026895|FG002|Primary Phase|Adverse Event|0|||
124835335|NCT00129129|449026896|FG003|Primary Phase|Adverse Event|0|||
124835336|NCT00129129|449026897|FG004|Primary Phase|Adverse Event|0|||
124835337|NCT00129129|449026893|FG000|Primary Phase|Withdrawal by Subject|12|||
124835338|NCT00129129|449026894|FG001|Primary Phase|Withdrawal by Subject|10|||
124835339|NCT00129129|449026895|FG002|Primary Phase|Withdrawal by Subject|0|||
124835340|NCT00129129|449026896|FG003|Primary Phase|Withdrawal by Subject|0|||
124835341|NCT00129129|449026897|FG004|Primary Phase|Withdrawal by Subject|0|||
124835342|NCT00129129|449026893|FG000|Primary Phase|Migration from study area|1|||
124835343|NCT00129129|449026894|FG001|Primary Phase|Migration from study area|3|||
124835344|NCT00129129|449026895|FG002|Primary Phase|Migration from study area|0|||
124835345|NCT00129129|449026896|FG003|Primary Phase|Migration from study area|0|||
124835346|NCT00129129|449026897|FG004|Primary Phase|Migration from study area|0|||
124835347|NCT00129129|449026893|FG000|Primary Phase|Lost to Follow-up|8|||
124835348|NCT00129129|449026894|FG001|Primary Phase|Lost to Follow-up|6|||
124835349|NCT00129129|449026895|FG002|Primary Phase|Lost to Follow-up|0|||
124835350|NCT00129129|449026896|FG003|Primary Phase|Lost to Follow-up|0|||
124835351|NCT00129129|449026897|FG004|Primary Phase|Lost to Follow-up|0|||
124835352|NCT00129129|449026893|FG000|Primary Phase|Other|2|||
124835353|NCT00129129|449026894|FG001|Primary Phase|Other|5|||
124835354|NCT00129129|449026895|FG002|Primary Phase|Other|0|||
124835355|NCT00129129|449026896|FG003|Primary Phase|Other|0|||
124835356|NCT00129129|449026897|FG004|Primary Phase|Other|0|||
124835357|NCT00129129|449026893|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
124835358|NCT00129129|449026894|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
124835359|NCT00129129|449026895|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
124835360|NCT00129129|449026896|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
124835361|NCT00129129|449026897|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
124835362|NCT00129129|449026893|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
124835363|NCT00129129|449026894|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
124835364|NCT00129129|449026895|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
124835365|NCT00129129|449026896|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
124835366|NCT00129129|449026897|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
124835367|NCT00129129|449026893|FG000|Fourth Dose Phase|Migration from study area|0|||
124835368|NCT00129129|449026894|FG001|Fourth Dose Phase|Migration from study area|0|||
124835369|NCT00129129|449026895|FG002|Fourth Dose Phase|Migration from study area|0|||
124835370|NCT00129129|449026896|FG003|Fourth Dose Phase|Migration from study area|0|||
124835371|NCT00129129|449026897|FG004|Fourth Dose Phase|Migration from study area|2|||
124835372|NCT00129129|449026893|FG000|Fourth Dose Phase|Other|0|||
124835373|NCT00129129|449026894|FG001|Fourth Dose Phase|Other|0|||
124835374|NCT00129129|449026895|FG002|Fourth Dose Phase|Other|0|||
124835375|NCT00129129|449026896|FG003|Fourth Dose Phase|Other|1|||
124835376|NCT00129129|449026897|FG004|Fourth Dose Phase|Other|1|||
124835377|NCT00129129|449026893|FG000|Fourth Dose Phase|Protocol Violation|0|||
124835378|NCT00129129|449026894|FG001|Fourth Dose Phase|Protocol Violation|0|||
124835379|NCT00129129|449026895|FG002|Fourth Dose Phase|Protocol Violation|0|||
124835380|NCT00129129|449026896|FG003|Fourth Dose Phase|Protocol Violation|1|||
124835381|NCT00129129|449026897|FG004|Fourth Dose Phase|Protocol Violation|0|||
124835382|NCT01524692|449026902|FG000|Overall Study|Withdrawal by Subject|3|||
124835383|NCT01709695|449026904|FG000|Overall Study|Withdrawal by Subject|1|||
124835384|NCT01709695|449026905|FG001|Overall Study|Withdrawal by Subject|1|||
124835385|NCT02882854|449026906|FG000|Overall Study|Lost to Follow-up|1|||
124835386|NCT02882854|449026907|FG001|Overall Study|Lost to Follow-up|2|||
124835387|NCT02882854|449026906|FG000|Overall Study|Physician Decision|0|||
124835388|NCT02882854|449026907|FG001|Overall Study|Physician Decision|1|||
124835389|NCT02039674|449026911|FG000|Overall Study|Adverse Event|0|||
124835390|NCT02039674|449026912|FG001|Overall Study|Adverse Event|0|||
124835391|NCT02039674|449026913|FG002|Overall Study|Adverse Event|0|||
124835392|NCT02039674|449026914|FG003|Overall Study|Adverse Event|1|||
124835393|NCT02039674|449026915|FG004|Overall Study|Adverse Event|0|||
124835394|NCT02039674|449026916|FG005|Overall Study|Adverse Event|0|||
124835395|NCT02039674|449026917|FG006|Overall Study|Adverse Event|0|||
124835396|NCT02039674|449026918|FG007|Overall Study|Adverse Event|0|||
124835397|NCT02039674|449026919|FG008|Overall Study|Adverse Event|2|||
124835398|NCT02039674|449026920|FG009|Overall Study|Adverse Event|1|||
124835399|NCT02039674|449026921|FG010|Overall Study|Adverse Event|0|||
124835400|NCT02039674|449026922|FG011|Overall Study|Adverse Event|2|||
124835401|NCT02039674|449026923|FG012|Overall Study|Adverse Event|3|||
124835402|NCT02039674|449026924|FG013|Overall Study|Adverse Event|1|||
124835403|NCT02039674|449026911|FG000|Overall Study|Death|2|||
124835404|NCT02039674|449026912|FG001|Overall Study|Death|0|||
124835405|NCT02039674|449026913|FG002|Overall Study|Death|2|||
124835406|NCT02039674|449026914|FG003|Overall Study|Death|3|||
124835407|NCT02039674|449026915|FG004|Overall Study|Death|0|||
124835408|NCT02039674|449026916|FG005|Overall Study|Death|0|||
124835409|NCT02039674|449026917|FG006|Overall Study|Death|1|||
124835410|NCT02039674|449026918|FG007|Overall Study|Death|0|||
124835411|NCT02039674|449026919|FG008|Overall Study|Death|2|||
124835412|NCT02039674|449026920|FG009|Overall Study|Death|0|||
124835413|NCT02039674|449026921|FG010|Overall Study|Death|1|||
124835414|NCT02039674|449026922|FG011|Overall Study|Death|3|||
124835415|NCT02039674|449026923|FG012|Overall Study|Death|2|||
124835416|NCT02039674|449026924|FG013|Overall Study|Death|8|||
124835417|NCT02039674|449026911|FG000|Overall Study|Excluded Medication|1|||
124835418|NCT02039674|449026912|FG001|Overall Study|Excluded Medication|1|||
124835419|NCT02039674|449026913|FG002|Overall Study|Excluded Medication|0|||
124835420|NCT02039674|449026914|FG003|Overall Study|Excluded Medication|1|||
124835421|NCT02039674|449026915|FG004|Overall Study|Excluded Medication|0|||
124835422|NCT02039674|449026916|FG005|Overall Study|Excluded Medication|1|||
124835423|NCT02039674|449026917|FG006|Overall Study|Excluded Medication|0|||
124835424|NCT02039674|449026918|FG007|Overall Study|Excluded Medication|0|||
124835425|NCT02039674|449026919|FG008|Overall Study|Excluded Medication|2|||
124835426|NCT02039674|449026920|FG009|Overall Study|Excluded Medication|3|||
124835427|NCT02039674|449026921|FG010|Overall Study|Excluded Medication|5|||
124835428|NCT02039674|449026922|FG011|Overall Study|Excluded Medication|6|||
124835429|NCT02039674|449026923|FG012|Overall Study|Excluded Medication|8|||
124835430|NCT02039674|449026924|FG013|Overall Study|Excluded Medication|3|||
124835431|NCT02039674|449026911|FG000|Overall Study|Lost to Follow-up|0|||
124835432|NCT02039674|449026912|FG001|Overall Study|Lost to Follow-up|0|||
124835433|NCT02039674|449026913|FG002|Overall Study|Lost to Follow-up|0|||
124835434|NCT02039674|449026914|FG003|Overall Study|Lost to Follow-up|0|||
124835435|NCT02039674|449026915|FG004|Overall Study|Lost to Follow-up|1|||
124835436|NCT02039674|449026916|FG005|Overall Study|Lost to Follow-up|1|||
124835437|NCT02039674|449026917|FG006|Overall Study|Lost to Follow-up|0|||
124835438|NCT02039674|449026918|FG007|Overall Study|Lost to Follow-up|0|||
124835439|NCT02039674|449026919|FG008|Overall Study|Lost to Follow-up|0|||
124835440|NCT02039674|449026920|FG009|Overall Study|Lost to Follow-up|0|||
124835441|NCT02039674|449026921|FG010|Overall Study|Lost to Follow-up|0|||
124835442|NCT02039674|449026922|FG011|Overall Study|Lost to Follow-up|2|||
124835443|NCT02039674|449026923|FG012|Overall Study|Lost to Follow-up|2|||
124835444|NCT02039674|449026924|FG013|Overall Study|Lost to Follow-up|1|||
124835445|NCT02039674|449026911|FG000|Overall Study|Physician Decision|0|||
124835446|NCT02039674|449026912|FG001|Overall Study|Physician Decision|0|||
124835447|NCT02039674|449026913|FG002|Overall Study|Physician Decision|0|||
124835448|NCT02039674|449026914|FG003|Overall Study|Physician Decision|0|||
124835449|NCT02039674|449026915|FG004|Overall Study|Physician Decision|0|||
124835450|NCT02039674|449026916|FG005|Overall Study|Physician Decision|0|||
124835451|NCT02039674|449026917|FG006|Overall Study|Physician Decision|0|||
124835452|NCT02039674|449026918|FG007|Overall Study|Physician Decision|0|||
124835453|NCT02039674|449026919|FG008|Overall Study|Physician Decision|0|||
124835454|NCT02039674|449026920|FG009|Overall Study|Physician Decision|0|||
124835455|NCT02039674|449026921|FG010|Overall Study|Physician Decision|0|||
124835456|NCT02039674|449026922|FG011|Overall Study|Physician Decision|1|||
124835457|NCT02039674|449026923|FG012|Overall Study|Physician Decision|1|||
124835458|NCT02039674|449026924|FG013|Overall Study|Physician Decision|0|||
124835459|NCT02039674|449026911|FG000|Overall Study|Progressive Disease|8|||
124835460|NCT02039674|449026912|FG001|Overall Study|Progressive Disease|8|||
124835461|NCT02039674|449026913|FG002|Overall Study|Progressive Disease|6|||
124835462|NCT02039674|449026914|FG003|Overall Study|Progressive Disease|7|||
124835463|NCT02039674|449026915|FG004|Overall Study|Progressive Disease|9|||
124835464|NCT02039674|449026916|FG005|Overall Study|Progressive Disease|10|||
124835465|NCT02039674|449026917|FG006|Overall Study|Progressive Disease|1|||
124835466|NCT02039674|449026918|FG007|Overall Study|Progressive Disease|3|||
124835467|NCT02039674|449026919|FG008|Overall Study|Progressive Disease|6|||
124835468|NCT02039674|449026920|FG009|Overall Study|Progressive Disease|4|||
124835469|NCT02039674|449026921|FG010|Overall Study|Progressive Disease|0|||
124835470|NCT02039674|449026922|FG011|Overall Study|Progressive Disease|34|||
124835471|NCT02039674|449026923|FG012|Overall Study|Progressive Disease|34|||
124835472|NCT02039674|449026924|FG013|Overall Study|Progressive Disease|18|||
124835473|NCT02039674|449026911|FG000|Overall Study|Withdrawal by Subject|1|||
124835474|NCT02039674|449026912|FG001|Overall Study|Withdrawal by Subject|2|||
124835475|NCT02039674|449026913|FG002|Overall Study|Withdrawal by Subject|3|||
124835476|NCT02039674|449026914|FG003|Overall Study|Withdrawal by Subject|0|||
124835477|NCT02039674|449026915|FG004|Overall Study|Withdrawal by Subject|1|||
124835478|NCT02039674|449026916|FG005|Overall Study|Withdrawal by Subject|0|||
124835479|NCT02039674|449026917|FG006|Overall Study|Withdrawal by Subject|0|||
124835480|NCT02039674|449026918|FG007|Overall Study|Withdrawal by Subject|0|||
124835481|NCT02039674|449026919|FG008|Overall Study|Withdrawal by Subject|0|||
124835482|NCT02039674|449026920|FG009|Overall Study|Withdrawal by Subject|1|||
124835483|NCT02039674|449026921|FG010|Overall Study|Withdrawal by Subject|1|||
124835484|NCT02039674|449026922|FG011|Overall Study|Withdrawal by Subject|4|||
124835485|NCT02039674|449026923|FG012|Overall Study|Withdrawal by Subject|6|||
124835486|NCT02039674|449026924|FG013|Overall Study|Withdrawal by Subject|2|||
124835487|NCT02039674|449026911|FG000|Overall Study|Clinical Progression|0|||
124835488|NCT02039674|449026912|FG001|Overall Study|Clinical Progression|0|||
125304733|NCT00856544|450742724|FG003|Overall Study|Other|6|||
124835489|NCT02039674|449026913|FG002|Overall Study|Clinical Progression|0|||
124835490|NCT02039674|449026914|FG003|Overall Study|Clinical Progression|0|||
124835491|NCT02039674|449026915|FG004|Overall Study|Clinical Progression|0|||
124835492|NCT02039674|449026916|FG005|Overall Study|Clinical Progression|0|||
124835493|NCT02039674|449026917|FG006|Overall Study|Clinical Progression|1|||
124835494|NCT02039674|449026918|FG007|Overall Study|Clinical Progression|0|||
124835495|NCT02039674|449026919|FG008|Overall Study|Clinical Progression|0|||
124835496|NCT02039674|449026920|FG009|Overall Study|Clinical Progression|0|||
124835497|NCT02039674|449026921|FG010|Overall Study|Clinical Progression|0|||
124835498|NCT02039674|449026922|FG011|Overall Study|Clinical Progression|0|||
124835499|NCT02039674|449026923|FG012|Overall Study|Clinical Progression|1|||
124835500|NCT02039674|449026924|FG013|Overall Study|Clinical Progression|0|||
124835501|NCT02039674|449026911|FG000|Overall Study|Sponsor Decision|1|||
124835502|NCT02039674|449026912|FG001|Overall Study|Sponsor Decision|1|||
124835503|NCT02039674|449026913|FG002|Overall Study|Sponsor Decision|1|||
124835504|NCT02039674|449026914|FG003|Overall Study|Sponsor Decision|1|||
124835505|NCT02039674|449026915|FG004|Overall Study|Sponsor Decision|1|||
124835506|NCT02039674|449026916|FG005|Overall Study|Sponsor Decision|0|||
124835507|NCT02039674|449026917|FG006|Overall Study|Sponsor Decision|0|||
124835508|NCT02039674|449026918|FG007|Overall Study|Sponsor Decision|0|||
124835509|NCT02039674|449026919|FG008|Overall Study|Sponsor Decision|0|||
124835510|NCT02039674|449026920|FG009|Overall Study|Sponsor Decision|3|||
124835511|NCT02039674|449026921|FG010|Overall Study|Sponsor Decision|0|||
124835512|NCT02039674|449026922|FG011|Overall Study|Sponsor Decision|8|||
124835513|NCT02039674|449026923|FG012|Overall Study|Sponsor Decision|5|||
124835514|NCT02039674|449026924|FG013|Overall Study|Sponsor Decision|0|||
124835515|NCT02039674|449026911|FG000|Overall Study|Other|0|||
124835516|NCT02039674|449026912|FG001|Overall Study|Other|0|||
124835517|NCT02039674|449026913|FG002|Overall Study|Other|0|||
124835518|NCT02039674|449026914|FG003|Overall Study|Other|0|||
124835519|NCT02039674|449026915|FG004|Overall Study|Other|0|||
124835520|NCT02039674|449026916|FG005|Overall Study|Other|0|||
124835521|NCT02039674|449026917|FG006|Overall Study|Other|0|||
124835522|NCT02039674|449026918|FG007|Overall Study|Other|0|||
124835523|NCT02039674|449026919|FG008|Overall Study|Other|0|||
124835524|NCT02039674|449026920|FG009|Overall Study|Other|0|||
124835525|NCT02039674|449026921|FG010|Overall Study|Other|0|||
124835526|NCT02039674|449026922|FG011|Overall Study|Other|0|||
124835527|NCT02039674|449026923|FG012|Overall Study|Other|1|||
124835528|NCT02039674|449026924|FG013|Overall Study|Other|0|||
124835529|NCT01358357|449026925|FG000|Open Label Phase|Adverse Event|0|||
124835530|NCT01358357|449026926|FG001|Open Label Phase|Adverse Event|0|||
124835531|NCT01358357|449026927|FG002|Open Label Phase|Adverse Event|59|||
124835532|NCT01358357|449026925|FG000|Open Label Phase|Lack of Efficacy|0|||
124835533|NCT01358357|449026926|FG001|Open Label Phase|Lack of Efficacy|0|||
124835534|NCT01358357|449026927|FG002|Open Label Phase|Lack of Efficacy|107|||
124835535|NCT01358357|449026925|FG000|Open Label Phase|Lost to Follow-up|0|||
124835536|NCT01358357|449026926|FG001|Open Label Phase|Lost to Follow-up|0|||
124835537|NCT01358357|449026927|FG002|Open Label Phase|Lost to Follow-up|76|||
124835538|NCT01358357|449026925|FG000|Open Label Phase|Protocol Violation|0|||
124835539|NCT01358357|449026926|FG001|Open Label Phase|Protocol Violation|0|||
124835540|NCT01358357|449026927|FG002|Open Label Phase|Protocol Violation|45|||
124835541|NCT01358357|449026925|FG000|Open Label Phase|Withdrawal by Subject|0|||
124835542|NCT01358357|449026926|FG001|Open Label Phase|Withdrawal by Subject|0|||
124835543|NCT01358357|449026927|FG002|Open Label Phase|Withdrawal by Subject|112|||
124835544|NCT01358357|449026925|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
124835545|NCT01358357|449026926|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
124835546|NCT01358357|449026927|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
124835547|NCT01358357|449026925|FG000|Open Label Phase|Terminated at study completion|0|||
124835548|NCT01358357|449026926|FG001|Open Label Phase|Terminated at study completion|0|||
124835549|NCT01358357|449026927|FG002|Open Label Phase|Terminated at study completion|5|||
124835550|NCT01358357|449026925|FG000|Open Label Phase|Mood episode|0|||
124835551|NCT01358357|449026926|FG001|Open Label Phase|Mood episode|0|||
124835552|NCT01358357|449026927|FG002|Open Label Phase|Mood episode|42|||
124835553|NCT01358357|449026925|FG000|Double-Blind Phase|Adverse Event|8|||
124835554|NCT01358357|449026926|FG001|Double-Blind Phase|Adverse Event|5|||
124835555|NCT01358357|449026927|FG002|Double-Blind Phase|Adverse Event|0|||
124835556|NCT01358357|449026925|FG000|Double-Blind Phase|Lost to Follow-up|5|||
124835557|NCT01358357|449026926|FG001|Double-Blind Phase|Lost to Follow-up|7|||
124835558|NCT01358357|449026927|FG002|Double-Blind Phase|Lost to Follow-up|0|||
124835559|NCT01358357|449026925|FG000|Double-Blind Phase|Protocol Violation|1|||
124835560|NCT01358357|449026926|FG001|Double-Blind Phase|Protocol Violation|11|||
124835561|NCT01358357|449026927|FG002|Double-Blind Phase|Protocol Violation|0|||
124835562|NCT01358357|449026925|FG000|Double-Blind Phase|Protocol Violation|16|||
124835563|NCT01358357|449026926|FG001|Double-Blind Phase|Protocol Violation|12|||
124835564|NCT01358357|449026927|FG002|Double-Blind Phase|Protocol Violation|0|||
124835565|NCT01358357|449026925|FG000|Double-Blind Phase|Terminated at study completion|2|||
124835566|NCT01358357|449026926|FG001|Double-Blind Phase|Terminated at study completion|0|||
124835567|NCT01358357|449026927|FG002|Double-Blind Phase|Terminated at study completion|0|||
124835568|NCT01358357|449026925|FG000|Double-Blind Phase|Recurrence of mood event|48|||
124835569|NCT01358357|449026926|FG001|Double-Blind Phase|Recurrence of mood event|64|||
124835570|NCT01358357|449026927|FG002|Double-Blind Phase|Recurrence of mood event|0|||
124835571|NCT01358357|449026925|FG000|Double-Blind Phase|Administrative|0|||
124835572|NCT01358357|449026926|FG001|Double-Blind Phase|Administrative|1|||
124835573|NCT01358357|449026927|FG002|Double-Blind Phase|Administrative|0|||
124835574|NCT02590939|449026928|FG000|Overall Study|Withdrawal by Subject|3|||
124835575|NCT02590939|449026929|FG001|Overall Study|Withdrawal by Subject|1|||
124835576|NCT02590939|449026928|FG000|Overall Study|Failed the nociceptive test|2|||
124835577|NCT02590939|449026929|FG001|Overall Study|Failed the nociceptive test|1|||
124835578|NCT02347189|449026934|FG000|Overall Study|No implant attempted of study device|9|||
124835579|NCT02347189|449026934|FG000|Overall Study|No primary outcome data available|2|||
124835580|NCT00994240|449026935|FG000|Overall Study|Lost to Follow-up|3|||
124835581|NCT00994240|449026936|FG001|Overall Study|Lost to Follow-up|2|||
124835582|NCT00994240|449026935|FG000|Overall Study|Withdrawal by Subject|1|||
124835583|NCT00994240|449026936|FG001|Overall Study|Withdrawal by Subject|0|||
124835584|NCT00994240|449026935|FG000|Overall Study|study termination|2|||
124835585|NCT00994240|449026936|FG001|Overall Study|study termination|3|||
124835586|NCT03979638|449026941|FG000|Period 1|Physician Decision|1|||
124835587|NCT03979638|449026942|FG001|Period 1|Physician Decision|1|||
124835588|NCT03979638|449026941|FG000|Period 1|Withdrawal by Subject|4|||
124835589|NCT03979638|449026942|FG001|Period 1|Withdrawal by Subject|3|||
124835590|NCT03979638|449026941|FG000|Period 1|Study terminated by Sponsor|1|||
124835591|NCT03979638|449026942|FG001|Period 1|Study terminated by Sponsor|3|||
124835592|NCT03979638|449026941|FG000|Period 1|Protocol Violation|1|||
124835593|NCT03979638|449026942|FG001|Period 1|Protocol Violation|0|||
124835594|NCT03979638|449026941|FG000|Period 2|Study terminated by Sponsor|1|||
124835595|NCT03979638|449026942|FG001|Period 2|Study terminated by Sponsor|1|||
124835596|NCT04248933|449026943|FG000|Overall Study|Lost to Follow-up|9|||
124835597|NCT04248933|449026943|FG000|Overall Study|Withdrawal by Subject|2|||
124835598|NCT00578942|449026944|FG000|Overall Study|Lost to Follow-up|1|||
124835599|NCT01063595|449026956|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
124835600|NCT01063595|449026957|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
124835601|NCT01063595|449026956|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
124835602|NCT01063595|449026957|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
124835603|NCT01063595|449026956|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
124835604|NCT01063595|449026957|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
124835605|NCT01063595|449026956|FG000|First Intervention|Adverse Event|1|||
124835606|NCT01063595|449026957|FG001|First Intervention|Adverse Event|4|||
124835607|NCT01063595|449026956|FG000|First Intervention|Withdrawal by Subject|1|||
124835608|NCT01063595|449026957|FG001|First Intervention|Withdrawal by Subject|0|||
124835609|NCT01063595|449026956|FG000|First Intervention|Reason not Specified|0|||
124835610|NCT01063595|449026957|FG001|First Intervention|Reason not Specified|1|||
124835611|NCT00747435|449026958|FG000|Overall Study|Lost to Follow-up|2|||
124835612|NCT00747435|449026958|FG000|Overall Study|Withdrawal by Subject|3|||
124835613|NCT00747435|449026958|FG000|Overall Study|Still undergoing follow up|1|||
124835614|NCT04439318|449026961|FG000|Overall Study|Ineligible|1|||
124835615|NCT04439318|449026961|FG000|Overall Study|Never Started Treatment|3|||
124835616|NCT04439318|449026961|FG000|Overall Study|Adverse Event|10|||
124835617|NCT04439318|449026961|FG000|Overall Study|Death|2|||
125304734|NCT00856544|450742721|FG000|Overall Study|Lost to Follow-up|1|||
125304735|NCT00856544|450742722|FG001|Overall Study|Lost to Follow-up|2|||
125304736|NCT00856544|450742723|FG002|Overall Study|Lost to Follow-up|2|||
125304737|NCT00856544|450742724|FG003|Overall Study|Lost to Follow-up|0|||
125304738|NCT00856544|450742721|FG000|Overall Study|Withdrawal by Subject|8|||
125304739|NCT00856544|450742722|FG001|Overall Study|Withdrawal by Subject|5|||
125304740|NCT00856544|450742723|FG002|Overall Study|Withdrawal by Subject|0|||
125304741|NCT00856544|450742724|FG003|Overall Study|Withdrawal by Subject|1|||
125304742|NCT00787189|450742725|FG000|Overall Study|Lost to Follow-up|2|||
125304743|NCT00787189|450742726|FG001|Overall Study|Lost to Follow-up|2|||
125304744|NCT00847886|450742727|FG000|Overall Study|Adverse Event|0|||
125304745|NCT00847886|450742728|FG001|Overall Study|Adverse Event|1|||
125304746|NCT03920254|450742733|FG000|Overall Study|Adverse Event|1|||
125304747|NCT03920254|450742734|FG001|Overall Study|Adverse Event|0|||
125304748|NCT03920254|450742735|FG002|Overall Study|Adverse Event|0|||
125304749|NCT03920254|450742733|FG000|Overall Study|Physician Decision|0|||
125304750|NCT03920254|450742734|FG001|Overall Study|Physician Decision|1|||
124835618|NCT04439318|449026961|FG000|Overall Study|Disease Progression|25|||
124835619|NCT04439318|449026961|FG000|Overall Study|Other Complicating Disease|2|||
124835620|NCT04439318|449026961|FG000|Overall Study|Withdrawal by Subject|4|||
125304751|NCT03920254|450742735|FG002|Overall Study|Physician Decision|2|||
125304752|NCT03920254|450742733|FG000|Overall Study|Study Terminated By Sponsor|12|||
125304753|NCT03920254|450742734|FG001|Overall Study|Study Terminated By Sponsor|17|||
125304754|NCT03920254|450742735|FG002|Overall Study|Study Terminated By Sponsor|12|||
125304755|NCT03920254|450742733|FG000|Overall Study|Withdrawal by Subject|0|||
125304756|NCT03920254|450742734|FG001|Overall Study|Withdrawal by Subject|0|||
125304757|NCT03920254|450742735|FG002|Overall Study|Withdrawal by Subject|1|||
125304758|NCT05274269|450742736|FG000|Overall Study|Adverse Event|0|||
125304759|NCT05274269|450742737|FG001|Overall Study|Adverse Event|3|||
125304760|NCT05274269|450742736|FG000|Overall Study|Death|0|||
125304761|NCT05274269|450742737|FG001|Overall Study|Death|1|||
125304762|NCT05274269|450742736|FG000|Overall Study|Other|0|||
125304763|NCT05274269|450742737|FG001|Overall Study|Other|2|||
125304764|NCT05274269|450742736|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
125304765|NCT05274269|450742737|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
125304766|NCT02206035|450742738|FG000|Overall Study|Physician Decision|10|||
125304767|NCT02206035|450742739|FG001|Overall Study|Physician Decision|0|||
125304768|NCT02206035|450742740|FG002|Overall Study|Physician Decision|175|||
125304769|NCT05173012|450742742|FG000|Overall Study|Adverse Event|2|||
125304770|NCT05173012|450742743|FG001|Overall Study|Adverse Event|3|||
125304771|NCT05173012|450742744|FG002|Overall Study|Adverse Event|4|||
125304772|NCT05173012|450742745|FG003|Overall Study|Adverse Event|13|||
125304773|NCT05173012|450742746|FG004|Overall Study|Adverse Event|0|||
125304774|NCT05173012|450742747|FG005|Overall Study|Adverse Event|0|||
125304775|NCT05173012|450742748|FG006|Overall Study|Adverse Event|2|||
125304776|NCT05173012|450742749|FG007|Overall Study|Adverse Event|4|||
125304777|NCT05173012|450742742|FG000|Overall Study|Lost to Follow-up|0|||
125304778|NCT05173012|450742743|FG001|Overall Study|Lost to Follow-up|0|||
125304779|NCT05173012|450742744|FG002|Overall Study|Lost to Follow-up|0|||
125304780|NCT05173012|450742745|FG003|Overall Study|Lost to Follow-up|1|||
125304781|NCT05173012|450742746|FG004|Overall Study|Lost to Follow-up|0|||
125304782|NCT05173012|450742747|FG005|Overall Study|Lost to Follow-up|0|||
125304783|NCT05173012|450742748|FG006|Overall Study|Lost to Follow-up|0|||
125304784|NCT05173012|450742749|FG007|Overall Study|Lost to Follow-up|0|||
125304785|NCT05173012|450742742|FG000|Overall Study|Withdrawal by Subject|1|||
125304786|NCT05173012|450742743|FG001|Overall Study|Withdrawal by Subject|0|||
125304787|NCT05173012|450742744|FG002|Overall Study|Withdrawal by Subject|1|||
125304788|NCT05173012|450742745|FG003|Overall Study|Withdrawal by Subject|3|||
125304789|NCT05173012|450742746|FG004|Overall Study|Withdrawal by Subject|1|||
125304790|NCT05173012|450742747|FG005|Overall Study|Withdrawal by Subject|0|||
125304791|NCT05173012|450742748|FG006|Overall Study|Withdrawal by Subject|1|||
125304792|NCT05173012|450742749|FG007|Overall Study|Withdrawal by Subject|0|||
125304793|NCT05173012|450742742|FG000|Overall Study|Protocol Deviation|0|||
125304794|NCT05173012|450742743|FG001|Overall Study|Protocol Deviation|0|||
125304795|NCT05173012|450742744|FG002|Overall Study|Protocol Deviation|0|||
125304796|NCT05173012|450742745|FG003|Overall Study|Protocol Deviation|1|||
125304797|NCT05173012|450742746|FG004|Overall Study|Protocol Deviation|0|||
125304798|NCT05173012|450742747|FG005|Overall Study|Protocol Deviation|0|||
125304799|NCT05173012|450742748|FG006|Overall Study|Protocol Deviation|0|||
125304800|NCT05173012|450742749|FG007|Overall Study|Protocol Deviation|0|||
125304801|NCT05173012|450742742|FG000|Overall Study|Other|0|||
125304802|NCT05173012|450742743|FG001|Overall Study|Other|0|||
125304803|NCT05173012|450742744|FG002|Overall Study|Other|0|||
125304804|NCT05173012|450742745|FG003|Overall Study|Other|2|||
125304805|NCT05173012|450742746|FG004|Overall Study|Other|0|||
125304806|NCT05173012|450742747|FG005|Overall Study|Other|0|||
125304807|NCT05173012|450742748|FG006|Overall Study|Other|0|||
125304808|NCT05173012|450742749|FG007|Overall Study|Other|0|||
125304809|NCT03668613|450742750|FG000|Overall Study|Adverse Event|1|||
125304810|NCT03668613|450742751|FG001|Overall Study|Adverse Event|2|||
125304811|NCT03668613|450742750|FG000|Overall Study|Lack of Efficacy|5|||
125304812|NCT03668613|450742751|FG001|Overall Study|Lack of Efficacy|1|||
125304813|NCT03668613|450742750|FG000|Overall Study|Pregnancy|0|||
125304814|NCT03668613|450742751|FG001|Overall Study|Pregnancy|2|||
125304815|NCT03668613|450742750|FG000|Overall Study|Protocol Violation|1|||
125304816|NCT03668613|450742751|FG001|Overall Study|Protocol Violation|0|||
125304817|NCT03668613|450742750|FG000|Overall Study|Physician Decision|1|||
125304818|NCT03668613|450742751|FG001|Overall Study|Physician Decision|0|||
125304819|NCT03668613|450742750|FG000|Overall Study|Withdrawal by Subject|2|||
125304820|NCT03668613|450742751|FG001|Overall Study|Withdrawal by Subject|1|||
125304821|NCT03668613|450742750|FG000|Overall Study|Guardian decision|1|||
125304822|NCT03668613|450742751|FG001|Overall Study|Guardian decision|0|||
125304823|NCT01068769|450742754|FG000|Overall Study|Ineligible|1|||
125304824|NCT00709618|450742755|FG000|Overall Study|Withdrawal by Subject|4|||
125304825|NCT00709618|450742755|FG000|Overall Study|Lost to Follow-up|1|||
125304826|NCT00709618|450742755|FG000|Overall Study|Study Closed/Terminated|25|||
125304827|NCT01948063|450742758|FG000|Overall Study|Boston MCI halted research protocol|0|||
125304828|NCT01948063|450742759|FG001|Overall Study|Boston MCI halted research protocol|1|||
125304829|NCT01948063|450742758|FG000|Overall Study|Discovered an enrollment in other study|0|||
125304830|NCT01948063|450742759|FG001|Overall Study|Discovered an enrollment in other study|1|||
125304831|NCT01948063|450742758|FG000|Overall Study|Blood samples were accidentally thawed|1|||
125304832|NCT01948063|450742759|FG001|Overall Study|Blood samples were accidentally thawed|0|||
125304833|NCT03781414|450742762|FG000|Overall Study|Study terminated by sponsor|39|||
125304834|NCT03781414|450742763|FG001|Overall Study|Study terminated by sponsor|34|||
125304835|NCT03781414|450742764|FG002|Overall Study|Study terminated by sponsor|25|||
125304836|NCT03781414|450742762|FG000|Overall Study|Adverse Event|3|||
125304837|NCT03781414|450742763|FG001|Overall Study|Adverse Event|6|||
125304838|NCT03781414|450742764|FG002|Overall Study|Adverse Event|3|||
125304839|NCT03781414|450742762|FG000|Overall Study|Physician Decision|2|||
125304840|NCT03781414|450742763|FG001|Overall Study|Physician Decision|0|||
125304841|NCT03781414|450742764|FG002|Overall Study|Physician Decision|1|||
125304842|NCT03781414|450742762|FG000|Overall Study|Withdrawal by Subject|2|||
125304843|NCT03781414|450742763|FG001|Overall Study|Withdrawal by Subject|3|||
125304844|NCT03781414|450742764|FG002|Overall Study|Withdrawal by Subject|3|||
125304845|NCT03781414|450742762|FG000|Overall Study|Death|1|||
125304846|NCT03781414|450742763|FG001|Overall Study|Death|4|||
125304847|NCT03781414|450742764|FG002|Overall Study|Death|0|||
125304848|NCT03781414|450742762|FG000|Overall Study|Lost to Follow-up|1|||
125304849|NCT03781414|450742763|FG001|Overall Study|Lost to Follow-up|1|||
125304850|NCT03781414|450742764|FG002|Overall Study|Lost to Follow-up|0|||
125304851|NCT04752358|450742765|FG000|Overall Study|Death|2|||
125304852|NCT04752358|450742766|FG001|Overall Study|Death|1|||
125304853|NCT00719355|450742767|FG000|Overall Study|Death|0|||
124835621|NCT04439318|449026961|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
124835622|NCT04439318|449026961|FG000|Overall Study|Non-Compliance|1|||
124835623|NCT04439318|449026961|FG000|Overall Study|Still on Treatment|1|||
124835624|NCT03509675|449028549|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
124835625|NCT03509675|449028550|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
124835626|NCT03509675|449028549|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
124835627|NCT03509675|449028550|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
124835628|NCT03509675|449028549|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
124835629|NCT03509675|449028550|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
124835630|NCT03509675|449028549|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
124835631|NCT03509675|449028550|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
124835632|NCT02622828|449028551|FG000|Overall Study|participant withdrew|3|||
124835633|NCT04920123|449028555|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
124835634|NCT04920123|449028556|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
124835635|NCT04920123|449028557|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
124835636|NCT00278954|449028560|FG000|Overall Study|Adverse Event|3|||
124835637|NCT00278954|449028560|FG000|Overall Study|Lost to Follow-up|1|||
124835638|NCT00278954|449028560|FG000|Overall Study|Withdrawal by Subject|1|||
124835639|NCT03406858|449028561|FG000|Overall Study|Failure to receive treatment drug.|1|||
124835640|NCT03406858|449028561|FG000|Overall Study|ineligible|1|||
124835641|NCT01817725|449028569|FG000|Overall Study|Withdrawal by Subject|1|||
124835642|NCT03412084|449028570|FG000|Overall Study|Withdrawal by Subject|2|||
124835643|NCT03412084|449028571|FG001|Overall Study|Withdrawal by Subject|0|||
124835644|NCT03412084|449028570|FG000|Overall Study|Participant moved|1|||
124835645|NCT03412084|449028571|FG001|Overall Study|Participant moved|0|||
124835646|NCT03412084|449028570|FG000|Overall Study|Lost to Follow-up|1|||
124835647|NCT03412084|449028571|FG001|Overall Study|Lost to Follow-up|1|||
124835648|NCT00481195|449028574|FG000|Overall Study|Adverse Event|16|||
124835649|NCT00481195|449028575|FG001|Overall Study|Adverse Event|11|||
124835650|NCT00481195|449028574|FG000|Overall Study|Lack of Efficacy|1|||
124835651|NCT00481195|449028575|FG001|Overall Study|Lack of Efficacy|3|||
124835652|NCT00481195|449028574|FG000|Overall Study|Lost to Follow-up|4|||
124835653|NCT00481195|449028575|FG001|Overall Study|Lost to Follow-up|6|||
124835654|NCT00481195|449028574|FG000|Overall Study|Physician Decision|3|||
124835655|NCT00481195|449028575|FG001|Overall Study|Physician Decision|1|||
124835656|NCT00481195|449028574|FG000|Overall Study|Protocol Violation|10|||
124835657|NCT00481195|449028575|FG001|Overall Study|Protocol Violation|7|||
124835658|NCT00481195|449028574|FG000|Overall Study|Withdrawal by Subject|3|||
124835659|NCT00481195|449028575|FG001|Overall Study|Withdrawal by Subject|9|||
124835660|NCT00481195|449028574|FG000|Overall Study|Miscellaneous|2|||
124835661|NCT00481195|449028575|FG001|Overall Study|Miscellaneous|2|||
125304854|NCT00719355|450742768|FG001|Overall Study|Death|1|||
125304855|NCT00719355|450742767|FG000|Overall Study|Medical|14|||
125304856|NCT00719355|450742768|FG001|Overall Study|Medical|5|||
124835662|NCT02932904|449028576|FG000|Overall Study|Reason not Specified|1|||
124835663|NCT02932904|449028577|FG001|Overall Study|Reason not Specified|0|||
124835664|NCT02932904|449028578|FG002|Overall Study|Reason not Specified|2|||
124835665|NCT02932904|449028579|FG003|Overall Study|Reason not Specified|2|||
124835666|NCT02932904|449028576|FG000|Overall Study|Noncompliance with Study Drug|2|||
124835667|NCT02932904|449028577|FG001|Overall Study|Noncompliance with Study Drug|3|||
125304857|NCT00719355|450742767|FG000|Overall Study|Compliance|4|||
125304858|NCT00719355|450742768|FG001|Overall Study|Compliance|6|||
125304859|NCT00719355|450742767|FG000|Overall Study|Moved|0|||
125304860|NCT00719355|450742768|FG001|Overall Study|Moved|1|||
125304861|NCT03364738|450742770|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
124835668|NCT02932904|449028578|FG002|Overall Study|Noncompliance with Study Drug|3|||
124835669|NCT02932904|449028579|FG003|Overall Study|Noncompliance with Study Drug|4|||
124835670|NCT02932904|449028576|FG000|Overall Study|Pregnancy|0|||
125304862|NCT03364738|450742770|FG000|Overall Study|Withdrawal by Subject|1|||
124835671|NCT02932904|449028577|FG001|Overall Study|Pregnancy|1|||
124835672|NCT02932904|449028578|FG002|Overall Study|Pregnancy|1|||
124835673|NCT02932904|449028579|FG003|Overall Study|Pregnancy|0|||
124835674|NCT02932904|449028576|FG000|Overall Study|Study Termination|0|||
124835675|NCT02932904|449028577|FG001|Overall Study|Study Termination|1|||
124835676|NCT02932904|449028578|FG002|Overall Study|Study Termination|0|||
124835677|NCT02932904|449028579|FG003|Overall Study|Study Termination|0|||
124835678|NCT02932904|449028576|FG000|Overall Study|Voluntary Withdrawal|2|||
124835679|NCT02932904|449028577|FG001|Overall Study|Voluntary Withdrawal|1|||
124835680|NCT02932904|449028578|FG002|Overall Study|Voluntary Withdrawal|4|||
124835681|NCT02932904|449028579|FG003|Overall Study|Voluntary Withdrawal|2|||
124835682|NCT02932904|449028576|FG000|Overall Study|Lost to Follow-up|5|||
124835683|NCT02932904|449028577|FG001|Overall Study|Lost to Follow-up|3|||
124835684|NCT02932904|449028578|FG002|Overall Study|Lost to Follow-up|6|||
124835685|NCT02932904|449028579|FG003|Overall Study|Lost to Follow-up|0|||
124835686|NCT02932904|449028576|FG000|Overall Study|Significant Protocol Deviation|2|||
124835687|NCT02932904|449028577|FG001|Overall Study|Significant Protocol Deviation|3|||
124835688|NCT02932904|449028578|FG002|Overall Study|Significant Protocol Deviation|6|||
124835689|NCT02932904|449028579|FG003|Overall Study|Significant Protocol Deviation|1|||
124835690|NCT02932904|449028576|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
124835691|NCT02932904|449028577|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
124835692|NCT02932904|449028578|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
124835693|NCT02932904|449028579|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
124835694|NCT02932904|449028576|FG000|Overall Study|Randomized But Not Treated|1|||
124835695|NCT02932904|449028577|FG001|Overall Study|Randomized But Not Treated|1|||
124835696|NCT02932904|449028578|FG002|Overall Study|Randomized But Not Treated|0|||
124835697|NCT02932904|449028579|FG003|Overall Study|Randomized But Not Treated|2|||
124835698|NCT03792672|449028584|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
124835699|NCT03792672|449028585|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
124835700|NCT03792672|449028586|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
124835701|NCT03792672|449028587|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
124835702|NCT03792672|449028588|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
124835703|NCT03792672|449028589|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
124835704|NCT03792672|449028584|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
124835705|NCT03792672|449028585|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
124835706|NCT03792672|449028586|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
124835707|NCT03792672|449028587|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
124835708|NCT03792672|449028588|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
124835709|NCT03792672|449028589|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
124835710|NCT03792672|449028584|FG000|Treatment Period 4 (2 Days)|Other|1|||
124835711|NCT03792672|449028585|FG001|Treatment Period 4 (2 Days)|Other|0|||
124835712|NCT03792672|449028586|FG002|Treatment Period 4 (2 Days)|Other|0|||
124835713|NCT03792672|449028587|FG003|Treatment Period 4 (2 Days)|Other|0|||
124835714|NCT03792672|449028588|FG004|Treatment Period 4 (2 Days)|Other|0|||
124835715|NCT03792672|449028589|FG005|Treatment Period 4 (2 Days)|Other|0|||
124835716|NCT01907828|449028592|FG000|Overall Study|Exclusion criteria not met|0|||
124835717|NCT01907828|449028593|FG001|Overall Study|Exclusion criteria not met|1|||
124835718|NCT01907828|449028592|FG000|Overall Study|Withdrawal by Subject|3|||
124835719|NCT01907828|449028593|FG001|Overall Study|Withdrawal by Subject|4|||
124835720|NCT01907828|449028592|FG000|Overall Study|Lost to Follow-up|3|||
124835721|NCT01907828|449028593|FG001|Overall Study|Lost to Follow-up|0|||
124835722|NCT01907828|449028592|FG000|Overall Study|Participant refused 24-month follow-up|1|||
124835723|NCT01907828|449028593|FG001|Overall Study|Participant refused 24-month follow-up|0|||
124835724|NCT01907828|449028592|FG000|Overall Study|Participant met exclusion criteria|0|||
124835725|NCT01907828|449028593|FG001|Overall Study|Participant met exclusion criteria|1|||
124835726|NCT04007523|449028596|FG000|Overall Study|Withdrawal by Subject|0|||
124835727|NCT04007523|449028597|FG001|Overall Study|Withdrawal by Subject|1|||
124835728|NCT04007523|449028598|FG002|Overall Study|Withdrawal by Subject|1|||
124835729|NCT04007523|449028599|FG003|Overall Study|Withdrawal by Subject|0|||
124835730|NCT04007523|449028596|FG000|Overall Study|ICU Transfer|0|||
125304863|NCT03364738|450742770|FG000|Overall Study|Adverse Event|1|||
124835731|NCT04007523|449028597|FG001|Overall Study|ICU Transfer|1|||
124835732|NCT04007523|449028598|FG002|Overall Study|ICU Transfer|0|||
124835733|NCT04007523|449028599|FG003|Overall Study|ICU Transfer|0|||
124835734|NCT04007523|449028596|FG000|Overall Study|COVID hospital closure|0|||
124835735|NCT04007523|449028597|FG001|Overall Study|COVID hospital closure|0|||
124835736|NCT04007523|449028598|FG002|Overall Study|COVID hospital closure|1|||
124835737|NCT04007523|449028599|FG003|Overall Study|COVID hospital closure|2|||
124835738|NCT04007523|449028596|FG000|Overall Study|Surgery cancelled|0|||
124835739|NCT04007523|449028597|FG001|Overall Study|Surgery cancelled|0|||
124835740|NCT04007523|449028598|FG002|Overall Study|Surgery cancelled|1|||
124835741|NCT04007523|449028599|FG003|Overall Study|Surgery cancelled|1|||
124835742|NCT02197806|449028601|FG000|Overall Study|Adverse Event|0|||
124835743|NCT02197806|449028602|FG001|Overall Study|Adverse Event|1|||
124835744|NCT02197806|449028603|FG002|Overall Study|Adverse Event|0|||
124835745|NCT02197806|449028604|FG003|Overall Study|Adverse Event|1|||
124835746|NCT03774433|449028606|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
124835747|NCT00108160|449028607|FG000|Overall Study|Lost to Follow-up|25|||
124835748|NCT00108160|449028608|FG001|Overall Study|Lost to Follow-up|12|||
124835749|NCT00108160|449028607|FG000|Overall Study|Death|1|||
124835750|NCT00108160|449028608|FG001|Overall Study|Death|2|||
124835751|NCT00108160|449028607|FG000|Overall Study|Withdrawal by Subject|4|||
124835752|NCT00108160|449028608|FG001|Overall Study|Withdrawal by Subject|2|||
124835753|NCT00108160|449028607|FG000|Overall Study|Protocol Violation|9|||
124835754|NCT00108160|449028608|FG001|Overall Study|Protocol Violation|5|||
124835755|NCT01150123|449028610|FG000|Overall Study|Withdrawal by Subject|1|||
124835756|NCT01150123|449028611|FG001|Overall Study|Withdrawal by Subject|1|||
124835757|NCT01150123|449028612|FG002|Overall Study|Withdrawal by Subject|2|||
124835758|NCT01150123|449028613|FG003|Overall Study|Withdrawal by Subject|1|||
124835759|NCT01150123|449028614|FG004|Overall Study|Withdrawal by Subject|1|||
124835760|NCT01150123|449028615|FG005|Overall Study|Withdrawal by Subject|1|||
124835761|NCT01150123|449028616|FG006|Overall Study|Withdrawal by Subject|0|||
124835762|NCT01150123|449028617|FG007|Overall Study|Withdrawal by Subject|3|||
124835763|NCT01150123|449028618|FG008|Overall Study|Withdrawal by Subject|2|||
124835764|NCT01150123|449028619|FG009|Overall Study|Withdrawal by Subject|0|||
124835765|NCT01150123|449028620|FG010|Overall Study|Withdrawal by Subject|1|||
124835766|NCT01150123|449028621|FG011|Overall Study|Withdrawal by Subject|0|||
124835767|NCT01150123|449028622|FG012|Overall Study|Withdrawal by Subject|1|||
124835768|NCT01150123|449028623|FG013|Overall Study|Withdrawal by Subject|0|||
124835769|NCT01150123|449028624|FG014|Overall Study|Withdrawal by Subject|0|||
124835770|NCT01150123|449028625|FG015|Overall Study|Withdrawal by Subject|1|||
124835771|NCT01150123|449028626|FG016|Overall Study|Withdrawal by Subject|0|||
124835772|NCT01150123|449028627|FG017|Overall Study|Withdrawal by Subject|1|||
124835773|NCT01150123|449028610|FG000|Overall Study|Lost to Follow-up|2|||
124835774|NCT01150123|449028611|FG001|Overall Study|Lost to Follow-up|1|||
124835775|NCT01150123|449028612|FG002|Overall Study|Lost to Follow-up|2|||
124835776|NCT01150123|449028613|FG003|Overall Study|Lost to Follow-up|2|||
124835777|NCT01150123|449028614|FG004|Overall Study|Lost to Follow-up|2|||
124835778|NCT01150123|449028615|FG005|Overall Study|Lost to Follow-up|5|||
124835779|NCT01150123|449028616|FG006|Overall Study|Lost to Follow-up|0|||
124835780|NCT01150123|449028617|FG007|Overall Study|Lost to Follow-up|0|||
124835781|NCT01150123|449028618|FG008|Overall Study|Lost to Follow-up|3|||
124835782|NCT01150123|449028619|FG009|Overall Study|Lost to Follow-up|1|||
124835783|NCT01150123|449028620|FG010|Overall Study|Lost to Follow-up|1|||
124835784|NCT01150123|449028621|FG011|Overall Study|Lost to Follow-up|1|||
124835785|NCT01150123|449028622|FG012|Overall Study|Lost to Follow-up|2|||
124835786|NCT01150123|449028623|FG013|Overall Study|Lost to Follow-up|0|||
124835787|NCT01150123|449028624|FG014|Overall Study|Lost to Follow-up|0|||
124835788|NCT01150123|449028625|FG015|Overall Study|Lost to Follow-up|0|||
124835789|NCT01150123|449028626|FG016|Overall Study|Lost to Follow-up|0|||
124835790|NCT01150123|449028627|FG017|Overall Study|Lost to Follow-up|0|||
124835791|NCT02486042|449028632|FG000|Overall Study|Physician Decision|1|||
124835792|NCT02486042|449028633|FG001|Overall Study|Physician Decision|7|||
124835793|NCT02486042|449028632|FG000|Overall Study|Hospital transfer|2|||
124835794|NCT02486042|449028633|FG001|Overall Study|Hospital transfer|2|||
124835795|NCT02486042|449028632|FG000|Overall Study|Withdrawal by Subject|0|||
124835796|NCT02486042|449028633|FG001|Overall Study|Withdrawal by Subject|2|||
124835797|NCT01466387|449028634|FG000|Overall Study|Adverse Event|0|||
124835798|NCT01466387|449028635|FG001|Overall Study|Adverse Event|0|||
124835799|NCT01466387|449028636|FG002|Overall Study|Adverse Event|1|||
124835800|NCT01466387|449028637|FG003|Overall Study|Adverse Event|1|||
124835801|NCT01466387|449028638|FG004|Overall Study|Adverse Event|0|||
124835802|NCT01466387|449028639|FG005|Overall Study|Adverse Event|0|||
124835803|NCT01466387|449028634|FG000|Overall Study|Lost to Follow-up|0|||
124835804|NCT01466387|449028635|FG001|Overall Study|Lost to Follow-up|0|||
124835805|NCT01466387|449028636|FG002|Overall Study|Lost to Follow-up|0|||
125304864|NCT00988091|450742777|FG000|Double-blind Period|Withdrawal by Subject|15|||
125304865|NCT00988091|450742778|FG001|Double-blind Period|Withdrawal by Subject|13|||
125304866|NCT00988091|450742777|FG000|Double-blind Period|Lost to Follow-up|12|||
124835806|NCT01466387|449028637|FG003|Overall Study|Lost to Follow-up|0|||
124835807|NCT01466387|449028638|FG004|Overall Study|Lost to Follow-up|0|||
124835808|NCT01466387|449028639|FG005|Overall Study|Lost to Follow-up|1|||
124835809|NCT01466387|449028634|FG000|Overall Study|Protocol Violation|1|||
124835810|NCT01466387|449028635|FG001|Overall Study|Protocol Violation|0|||
124835811|NCT01466387|449028636|FG002|Overall Study|Protocol Violation|0|||
124835812|NCT01466387|449028637|FG003|Overall Study|Protocol Violation|1|||
124835813|NCT01466387|449028638|FG004|Overall Study|Protocol Violation|0|||
124835814|NCT01466387|449028639|FG005|Overall Study|Protocol Violation|0|||
124835815|NCT02968979|449028642|FG000|Overall Study|Protocol Violation|7|||
124835816|NCT02968979|449028642|FG000|Overall Study|Withdrawal by Subject|1|||
124835817|NCT04404855|449028643|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
124835818|NCT04404855|449028644|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
124835819|NCT03320564|449028645|FG000|Overall Study|Protocol Violation|1|||
124835820|NCT00788827|449028646|FG000|Overall Study|Lack of Efficacy|2|||
124835821|NCT03745144|449028653|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
124835822|NCT03745144|449028654|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
124835823|NCT03745144|449028655|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
124835824|NCT03745144|449028653|FG000|Period 1|Other|0|||
124835825|NCT03745144|449028654|FG001|Period 1|Other|0|||
124835826|NCT03745144|449028655|FG002|Period 1|Other|1|||
124835827|NCT01586819|449028656|FG000|Overall Study|Withdrawal by Subject|1|||
124835828|NCT01586819|449028657|FG001|Overall Study|Withdrawal by Subject|0|||
124835829|NCT00896337|449028658|FG000|Overall Study|Death|7|||
124835830|NCT00896337|449028658|FG000|Overall Study|Withdrawal by Subject|7|||
124835831|NCT00896337|449028658|FG000|Overall Study|Lost to Follow-up|11|||
124835832|NCT01359254|449028659|FG000|Overall Study|Death|1|||
124835833|NCT01359254|449028660|FG001|Overall Study|Death|0|||
124835834|NCT04668950|449028661|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
124835835|NCT04668950|449028662|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
124835836|NCT04668950|449028661|FG000|Overall Study|Could not confirm started study medication|15|||
124835837|NCT04668950|449028662|FG001|Overall Study|Could not confirm started study medication|15|||
124835838|NCT04668950|449028661|FG000|Overall Study|Could not confirm baseline status|6|||
124835839|NCT04668950|449028662|FG001|Overall Study|Could not confirm baseline status|2|||
124835840|NCT04668950|449028661|FG000|Overall Study|Drop out and did not start medication|15|||
124835841|NCT04668950|449028662|FG001|Overall Study|Drop out and did not start medication|17|||
124835842|NCT04668950|449028661|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
124835843|NCT04668950|449028662|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
124835844|NCT04668950|449028661|FG000|Overall Study|Other|2|||
124835845|NCT04668950|449028662|FG001|Overall Study|Other|4|||
124835846|NCT01124643|449028665|FG000|Overall Study|Death|1|||
124835847|NCT02910167|449028666|FG000|Overall Study|Adverse Event|1|||
124835848|NCT02910167|449028666|FG000|Overall Study|Lost to Follow-up|18|||
124835849|NCT04220411|449028667|FG000|Overall Study|Adverse Event|0|||
124835850|NCT04220411|449028668|FG001|Overall Study|Adverse Event|0|||
124835851|NCT04220411|449028669|FG002|Overall Study|Adverse Event|0|||
124835852|NCT04220411|449028670|FG003|Overall Study|Adverse Event|1|||
124835853|NCT02028988|449028671|FG000|Overall Study|Withdrawal by Subject|2|||
124835854|NCT02680639|449028674|FG000|Screening Period|Screen Failure|7|||
124835855|NCT02680639|449028675|FG001|Screening Period|Screen Failure|0|||
124835856|NCT02680639|449028676|FG002|Screening Period|Screen Failure|0|||
124835857|NCT02678676|449028677|FG000|Overall Study|Death|619|||
124835858|NCT02678676|449028678|FG001|Overall Study|Death|649|||
124835859|NCT02678676|449028677|FG000|Overall Study|Withdrawal by Subject|13|||
124835860|NCT02678676|449028678|FG001|Overall Study|Withdrawal by Subject|5|||
124835861|NCT02678676|449028677|FG000|Overall Study|Lost to Follow-up|171|||
124835862|NCT02678676|449028678|FG001|Overall Study|Lost to Follow-up|151|||
124835863|NCT02678676|449028677|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
124835864|NCT02678676|449028678|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
124835865|NCT04059146|449028679|FG000|Overall Study|Withdrawal by Subject|0|||
124835866|NCT04059146|449028680|FG001|Overall Study|Withdrawal by Subject|1|||
124835867|NCT00851799|449028681|FG000|Overall Study|Death|1|||
124835868|NCT00851799|449028682|FG001|Overall Study|Death|0|||
124835869|NCT00851799|449028683|FG002|Overall Study|Death|1|||
124835870|NCT00851799|449028681|FG000|Overall Study|Lost to Follow-up|5|||
124835871|NCT00851799|449028682|FG001|Overall Study|Lost to Follow-up|3|||
124835872|NCT00851799|449028683|FG002|Overall Study|Lost to Follow-up|10|||
124835873|NCT00851799|449028681|FG000|Overall Study|Not able to get to clinic|8|||
124835874|NCT00851799|449028682|FG001|Overall Study|Not able to get to clinic|5|||
124835875|NCT00851799|449028683|FG002|Overall Study|Not able to get to clinic|9|||
124835876|NCT00851799|449028681|FG000|Overall Study|Not willing to adhere to requirements|1|||
124835877|NCT00851799|449028682|FG001|Overall Study|Not willing to adhere to requirements|2|||
124835878|NCT00851799|449028683|FG002|Overall Study|Not willing to adhere to requirements|2|||
124835879|NCT00851799|449028681|FG000|Overall Study|Withdrew consent prior study completion|1|||
124835880|NCT00851799|449028682|FG001|Overall Study|Withdrew consent prior study completion|2|||
124835881|NCT00851799|449028683|FG002|Overall Study|Withdrew consent prior study completion|1|||
124835882|NCT00851799|449028681|FG000|Overall Study|Severe Debilitation|0|||
125304867|NCT00988091|450742778|FG001|Double-blind Period|Lost to Follow-up|14|||
124835883|NCT00851799|449028682|FG001|Overall Study|Severe Debilitation|1|||
124835884|NCT00851799|449028683|FG002|Overall Study|Severe Debilitation|0|||
124835885|NCT00851799|449028681|FG000|Overall Study|Completed protocol due to pregnancy|0|||
124835886|NCT00851799|449028682|FG001|Overall Study|Completed protocol due to pregnancy|0|||
124835887|NCT00851799|449028683|FG002|Overall Study|Completed protocol due to pregnancy|1|||
124835888|NCT04056195|449028687|FG000|Overall Study|Adverse Event|1|||
124835889|NCT04056195|449028688|FG001|Overall Study|Adverse Event|0|||
124835890|NCT04056195|449028689|FG002|Overall Study|Adverse Event|0|||
124835891|NCT04056195|449028687|FG000|Overall Study|Withdrawal by Subject|0|||
124835892|NCT04056195|449028688|FG001|Overall Study|Withdrawal by Subject|1|||
124835893|NCT04056195|449028689|FG002|Overall Study|Withdrawal by Subject|1|||
125304868|NCT00988091|450742777|FG000|Double-blind Period|Other|8|||
124835894|NCT04056195|449028687|FG000|Overall Study|Physician Decision|1|||
124835895|NCT04056195|449028688|FG001|Overall Study|Physician Decision|1|||
124835896|NCT04056195|449028689|FG002|Overall Study|Physician Decision|1|||
124835897|NCT01342510|449028705|FG000|Overall Study|Protocol Violation|12|||
124835898|NCT01342510|449028706|FG001|Overall Study|Protocol Violation|6|||
124835899|NCT01342510|449028707|FG002|Overall Study|Protocol Violation|13|||
124835900|NCT01342510|449028708|FG003|Overall Study|Protocol Violation|11|||
124835901|NCT01400516|449028710|FG000|Primary Trial|Withdrawal by Subject|0|||
124835902|NCT01400516|449028711|FG001|Primary Trial|Withdrawal by Subject|2|||
124835903|NCT01796197|449028719|FG000|Overall Study|Lost to Follow-up|1|||
124835904|NCT01796197|449028719|FG000|Overall Study|Lack of Efficacy|1|||
124835905|NCT01380184|449028720|FG000|Part 1 (19 Days)|Adverse Event|1|||
124835906|NCT01380184|449028720|FG000|Part 2|Adverse Event|5|||
124835907|NCT01380184|449028720|FG000|Part 2|Disease Progression|8|||
124835908|NCT01380184|449028720|FG000|Part 2|Lost to Follow-up|1|||
124835909|NCT04243538|449028721|FG000|Overall Study|Withdrawal by Subject|0|||
124835910|NCT04243538|449028722|FG001|Overall Study|Withdrawal by Subject|2|||
124835911|NCT04243538|449028721|FG000|Overall Study|Lost to Follow-up|0|||
124835912|NCT04243538|449028722|FG001|Overall Study|Lost to Follow-up|3|||
124835913|NCT03532295|449028723|FG000|Overall Study|Did not start treatment|0|||
124835914|NCT03532295|449028724|FG001|Overall Study|Did not start treatment|2|||
124835915|NCT02776917|449028725|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
124835916|NCT02558790|449030476|FG000|Overall Study|Lost to Follow-up|2|||
124835917|NCT02558790|449030476|FG000|Overall Study|Physician Decision|1|||
124835918|NCT02558790|449030476|FG000|Overall Study|Withdrawal by Subject|1|||
124835919|NCT02558790|449030476|FG000|Overall Study|Screen Fail|3|||
124835920|NCT05620576|449030486|FG000|Overall Study|Adverse Event|1|||
124835921|NCT05620576|449030487|FG001|Overall Study|Adverse Event|1|||
124835922|NCT05620576|449030486|FG000|Overall Study|Lost to Follow-up|3|||
124835923|NCT05620576|449030487|FG001|Overall Study|Lost to Follow-up|1|||
124835924|NCT05620576|449030486|FG000|Overall Study|Physician Decision|0|||
124835925|NCT05620576|449030487|FG001|Overall Study|Physician Decision|1|||
124835926|NCT05620576|449030486|FG000|Overall Study|Protocol Deviation|1|||
124835927|NCT05620576|449030487|FG001|Overall Study|Protocol Deviation|1|||
124835928|NCT05620576|449030486|FG000|Overall Study|Withdrawal by Subject|2|||
124835929|NCT05620576|449030487|FG001|Overall Study|Withdrawal by Subject|3|||
124835930|NCT01203072|449030498|FG000|Overall Study|Adverse Event|5|||
124835931|NCT01203072|449030499|FG001|Overall Study|Adverse Event|3|||
124835932|NCT01203072|449030500|FG002|Overall Study|Adverse Event|2|||
124835933|NCT01203072|449030501|FG003|Overall Study|Adverse Event|4|||
124835934|NCT01203072|449030502|FG004|Overall Study|Adverse Event|2|||
124835935|NCT01203072|449030498|FG000|Overall Study|Lack of Efficacy|1|||
124835936|NCT01203072|449030499|FG001|Overall Study|Lack of Efficacy|0|||
124835937|NCT01203072|449030500|FG002|Overall Study|Lack of Efficacy|0|||
124835938|NCT01203072|449030501|FG003|Overall Study|Lack of Efficacy|0|||
124835939|NCT01203072|449030502|FG004|Overall Study|Lack of Efficacy|0|||
124835940|NCT01203072|449030498|FG000|Overall Study|Lost to Follow-up|0|||
124835941|NCT01203072|449030499|FG001|Overall Study|Lost to Follow-up|1|||
124835942|NCT01203072|449030500|FG002|Overall Study|Lost to Follow-up|0|||
124835943|NCT01203072|449030501|FG003|Overall Study|Lost to Follow-up|0|||
124835944|NCT01203072|449030502|FG004|Overall Study|Lost to Follow-up|0|||
124835945|NCT01203072|449030498|FG000|Overall Study|Protocol Violation|2|||
124835946|NCT01203072|449030499|FG001|Overall Study|Protocol Violation|0|||
124835947|NCT01203072|449030500|FG002|Overall Study|Protocol Violation|0|||
124835948|NCT01203072|449030501|FG003|Overall Study|Protocol Violation|0|||
124835949|NCT01203072|449030502|FG004|Overall Study|Protocol Violation|1|||
124835950|NCT01203072|449030498|FG000|Overall Study|Withdrawal by Subject|2|||
124835951|NCT01203072|449030499|FG001|Overall Study|Withdrawal by Subject|2|||
124835952|NCT01203072|449030500|FG002|Overall Study|Withdrawal by Subject|1|||
124835953|NCT01203072|449030501|FG003|Overall Study|Withdrawal by Subject|2|||
124835954|NCT01203072|449030502|FG004|Overall Study|Withdrawal by Subject|3|||
124835955|NCT02286193|449030508|FG000|Overall Study|Referred: CRS unable to make contact|62|||
124835956|NCT02286193|449030508|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
124835957|NCT02286193|449030508|FG000|Overall Study|Referred: Declined service|38|||
124835958|NCT02023151|449030509|FG000|Overall Study|Lost to Follow-up|4|||
124835959|NCT04064294|449030510|FG000|Overall Study|Adverse Event|1|||
124835960|NCT04064294|449030511|FG001|Overall Study|Adverse Event|0|||
124835961|NCT04064294|449030512|FG002|Overall Study|Adverse Event|0|||
125304869|NCT00988091|450742778|FG001|Double-blind Period|Other|8|||
125304870|NCT00988091|450742777|FG000|Double-blind Period|Adverse Event|6|||
124835962|NCT03450707|449030513|FG000|Overall Study|Outside enrollment window|4|||
124835963|NCT03450707|449030514|FG001|Overall Study|Outside enrollment window|1|||
124835964|NCT03450707|449030513|FG000|Overall Study|Death|1|||
124835965|NCT03450707|449030514|FG001|Overall Study|Death|0|||
124835966|NCT03450707|449030513|FG000|Overall Study|Indication for thiamine|1|||
124835967|NCT03450707|449030514|FG001|Overall Study|Indication for thiamine|1|||
124835968|NCT03450707|449030513|FG000|Overall Study|Evidence of traumatic brain injury|1|||
124835969|NCT03450707|449030514|FG001|Overall Study|Evidence of traumatic brain injury|0|||
125304871|NCT00988091|450742778|FG001|Double-blind Period|Adverse Event|9|||
124835970|NCT03450707|449030513|FG000|Overall Study|Following commands|0|||
124835971|NCT03450707|449030514|FG001|Overall Study|Following commands|3|||
124835972|NCT03450707|449030513|FG000|Overall Study|Lactate < 3.5|0|||
124835973|NCT03450707|449030514|FG001|Overall Study|Lactate < 3.5|2|||
124835974|NCT03450707|449030513|FG000|Overall Study|Rearrest with ECMO|0|||
124835975|NCT03450707|449030514|FG001|Overall Study|Rearrest with ECMO|1|||
124835976|NCT03450707|449030513|FG000|Overall Study|Indication for thiamine + head CT results|0|||
124835977|NCT03450707|449030514|FG001|Overall Study|Indication for thiamine + head CT results|1|||
124835978|NCT03450707|449030513|FG000|Overall Study|Family/patient goals of care|0|||
124835979|NCT03450707|449030514|FG001|Overall Study|Family/patient goals of care|1|||
124835980|NCT03343483|449030515|FG000|Overall Study|Death|0|||
124835981|NCT03343483|449030516|FG001|Overall Study|Death|3|||
124835982|NCT03343483|449030515|FG000|Overall Study|Lost to Follow-up|9|||
124835983|NCT03343483|449030516|FG001|Overall Study|Lost to Follow-up|13|||
124835984|NCT03343483|449030515|FG000|Overall Study|Withdrawal by Subject|8|||
124835985|NCT03343483|449030516|FG001|Overall Study|Withdrawal by Subject|17|||
124835986|NCT00337103|449030517|FG000|Overall Study|Progressive Disease|414|||
124835987|NCT00337103|449030518|FG001|Overall Study|Progressive Disease|410|||
124835988|NCT00337103|449030517|FG000|Overall Study|Adverse Event|45|||
124835989|NCT00337103|449030518|FG001|Overall Study|Adverse Event|59|||
124835990|NCT00337103|449030517|FG000|Overall Study|Subject Choice|34|||
124835991|NCT00337103|449030518|FG001|Overall Study|Subject Choice|27|||
124835992|NCT00337103|449030517|FG000|Overall Study|Clinical Progression|27|||
124835993|NCT00337103|449030518|FG001|Overall Study|Clinical Progression|24|||
124835994|NCT00337103|449030517|FG000|Overall Study|Physician Decision|15|||
124835995|NCT00337103|449030518|FG001|Overall Study|Physician Decision|14|||
124835996|NCT00337103|449030517|FG000|Overall Study|Withdrawal by Subject|8|||
124835997|NCT00337103|449030518|FG001|Overall Study|Withdrawal by Subject|5|||
124835998|NCT00337103|449030517|FG000|Overall Study|Other|5|||
124835999|NCT00337103|449030518|FG001|Overall Study|Other|6|||
124836000|NCT00337103|449030517|FG000|Overall Study|Entry Criteria Not Met|4|||
124836001|NCT00337103|449030518|FG001|Overall Study|Entry Criteria Not Met|1|||
124836002|NCT00337103|449030517|FG000|Overall Study|Lost to Follow-up|1|||
124836003|NCT00337103|449030518|FG001|Overall Study|Lost to Follow-up|2|||
125304872|NCT00988091|450742777|FG000|Double-blind Period|Use of exclusionary medication|2|||
125304873|NCT00988091|450742778|FG001|Double-blind Period|Use of exclusionary medication|3|||
125304874|NCT00988091|450742777|FG000|Open-label Period|Adverse Event|4|||
125304875|NCT00988091|450742778|FG001|Open-label Period|Adverse Event|7|||
125304876|NCT00988091|450742777|FG000|Open-label Period|Use of exclusionary medication|1|||
125304877|NCT00988091|450742778|FG001|Open-label Period|Use of exclusionary medication|1|||
125304878|NCT00988091|450742777|FG000|Open-label Period|Protocol Violation|1|||
125304879|NCT00988091|450742778|FG001|Open-label Period|Protocol Violation|1|||
125304880|NCT00988091|450742777|FG000|Open-label Period|Withdrawal by Subject|10|||
125304881|NCT00988091|450742778|FG001|Open-label Period|Withdrawal by Subject|16|||
125304882|NCT00988091|450742777|FG000|Open-label Period|Lost to Follow-up|3|||
125304883|NCT00988091|450742778|FG001|Open-label Period|Lost to Follow-up|5|||
125304884|NCT00988091|450742777|FG000|Open-label Period|Other|2|||
125304885|NCT00988091|450742778|FG001|Open-label Period|Other|3|||
124836004|NCT00337103|449030517|FG000|Overall Study|Death|1|||
124836005|NCT00337103|449030518|FG001|Overall Study|Death|0|||
124836006|NCT01577758|449030519|FG000|Dose Escalation Phase|Adverse Event|0|||
124836007|NCT01577758|449030520|FG001|Dose Escalation Phase|Adverse Event|0|||
124836008|NCT01577758|449030521|FG002|Dose Escalation Phase|Adverse Event|0|||
124836009|NCT01577758|449030522|FG003|Dose Escalation Phase|Adverse Event|0|||
125304886|NCT00994422|450742779|FG000|Overall Study|Lost to Follow-up|7|||
124836010|NCT01577758|449030523|FG004|Dose Escalation Phase|Adverse Event|0|||
124836011|NCT01577758|449030524|FG005|Dose Escalation Phase|Adverse Event|2|||
124836012|NCT01577758|449030525|FG006|Dose Escalation Phase|Adverse Event|1|||
124836013|NCT01577758|449030526|FG007|Dose Escalation Phase|Adverse Event|0|||
124836014|NCT01577758|449030519|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
124836015|NCT01577758|449030520|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
125304887|NCT00994422|450742780|FG001|Overall Study|Lost to Follow-up|1|||
125304888|NCT01846741|450742782|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
125304889|NCT03664765|450742783|FG000|Overall Study|Withdrawal by Subject|4|||
125304890|NCT03664765|450742784|FG001|Overall Study|Withdrawal by Subject|1|||
125304891|NCT03664765|450742783|FG000|Overall Study|Lost to Follow-up|0|||
125304892|NCT03664765|450742784|FG001|Overall Study|Lost to Follow-up|1|||
124836016|NCT01577758|449030521|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
124836017|NCT01577758|449030522|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
125304893|NCT01153698|450742785|FG000|Overall Study|Adverse Event|12|||
124836018|NCT01577758|449030523|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
124836019|NCT01577758|449030524|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
124836020|NCT01577758|449030525|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
124836021|NCT01577758|449030526|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
124836022|NCT01577758|449030519|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
125304894|NCT01153698|450742785|FG000|Overall Study|Lost to Follow-up|4|||
125304895|NCT01153698|450742785|FG000|Overall Study|Withdrawal by Subject|2|||
124836023|NCT01577758|449030520|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
124836024|NCT01577758|449030521|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
124836025|NCT01577758|449030522|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
124836026|NCT01577758|449030523|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
124836027|NCT01577758|449030524|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
124836028|NCT01577758|449030525|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
124836029|NCT01577758|449030526|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
124836030|NCT01577758|449030519|FG000|Dose Escalation Phase|Progression Disease|2|||
124836031|NCT01577758|449030520|FG001|Dose Escalation Phase|Progression Disease|2|||
124836032|NCT01577758|449030521|FG002|Dose Escalation Phase|Progression Disease|1|||
124836033|NCT01577758|449030522|FG003|Dose Escalation Phase|Progression Disease|2|||
124836034|NCT01577758|449030523|FG004|Dose Escalation Phase|Progression Disease|5|||
124836035|NCT01577758|449030524|FG005|Dose Escalation Phase|Progression Disease|0|||
124836036|NCT01577758|449030525|FG006|Dose Escalation Phase|Progression Disease|0|||
124836037|NCT01577758|449030526|FG007|Dose Escalation Phase|Progression Disease|0|||
124836038|NCT01577758|449030519|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
124836039|NCT01577758|449030520|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
124836040|NCT01577758|449030521|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
124836041|NCT01577758|449030522|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
124836042|NCT01577758|449030523|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
124836043|NCT01577758|449030524|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
124836044|NCT01577758|449030525|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
124836045|NCT01577758|449030526|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
124836046|NCT01577758|449030519|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
124836047|NCT01577758|449030520|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
124836048|NCT01577758|449030521|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
124836049|NCT01577758|449030522|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
124836050|NCT01577758|449030523|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
124836051|NCT01577758|449030524|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
124836052|NCT01577758|449030525|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
124836053|NCT01577758|449030526|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
124836054|NCT01577758|449030519|FG000|mCRC Expansion Phase|Progression Disease|0|||
124836055|NCT01577758|449030520|FG001|mCRC Expansion Phase|Progression Disease|0|||
124836056|NCT01577758|449030521|FG002|mCRC Expansion Phase|Progression Disease|0|||
124836057|NCT01577758|449030522|FG003|mCRC Expansion Phase|Progression Disease|0|||
124836058|NCT01577758|449030523|FG004|mCRC Expansion Phase|Progression Disease|0|||
124836059|NCT01577758|449030524|FG005|mCRC Expansion Phase|Progression Disease|0|||
124836060|NCT01577758|449030525|FG006|mCRC Expansion Phase|Progression Disease|0|||
124836061|NCT01577758|449030526|FG007|mCRC Expansion Phase|Progression Disease|19|||
124836062|NCT03387813|449030527|FG000|Overall Study|Death|40|||
124836063|NCT03387813|449030528|FG001|Overall Study|Death|37|||
124836064|NCT03387813|449030529|FG002|Overall Study|Death|190|||
124836065|NCT03387813|449030527|FG000|Overall Study|Withdrawal by Subject|9|||
124836066|NCT03387813|449030528|FG001|Overall Study|Withdrawal by Subject|19|||
124836067|NCT03387813|449030529|FG002|Overall Study|Withdrawal by Subject|32|||
124836068|NCT03387813|449030527|FG000|Overall Study|Lost to Follow-up|3|||
124836069|NCT03387813|449030528|FG001|Overall Study|Lost to Follow-up|9|||
124836070|NCT03387813|449030529|FG002|Overall Study|Lost to Follow-up|15|||
124836071|NCT03387813|449030527|FG000|Overall Study|Non-Compliance|6|||
124836072|NCT03387813|449030528|FG001|Overall Study|Non-Compliance|6|||
124836073|NCT03387813|449030529|FG002|Overall Study|Non-Compliance|31|||
124836074|NCT03387813|449030527|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
124836075|NCT03387813|449030528|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
124836076|NCT03387813|449030529|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
124836077|NCT01289847|449030530|FG000|Overall Study|Patient could not comply with visits|1|||
124836078|NCT04327999|449030535|FG000|Overall Study|Protocol Violation|1|||
124836079|NCT03975647|449030536|FG000|Overall Study|Death|71|||
124836080|NCT03975647|449030537|FG001|Overall Study|Death|63|||
124836081|NCT03975647|449030536|FG000|Overall Study|Lost to Follow-up|2|||
124836082|NCT03975647|449030537|FG001|Overall Study|Lost to Follow-up|2|||
124836083|NCT03975647|449030536|FG000|Overall Study|Subject withdrawal of consent|7|||
125304896|NCT01153698|450742785|FG000|Overall Study|Switch to other anticoagulants|4|||
125304897|NCT01153698|450742785|FG000|Overall Study|Other|2|||
124836084|NCT03975647|449030537|FG001|Overall Study|Subject withdrawal of consent|11|||
124836085|NCT02872116|449030538|FG000|Pre-Treatment|Disease Progression|0|||
124836086|NCT02872116|449030539|FG001|Pre-Treatment|Disease Progression|1|||
124836087|NCT02872116|449030540|FG002|Pre-Treatment|Disease Progression|0|||
124836088|NCT02872116|449030538|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
124836089|NCT02872116|449030539|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
124836090|NCT02872116|449030540|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
124836091|NCT02872116|449030538|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
124836092|NCT02872116|449030539|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
124836093|NCT02872116|449030540|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
124836094|NCT02872116|449030538|FG000|Pre-Treatment|Participant withdrew consent|2|||
124836095|NCT02872116|449030539|FG001|Pre-Treatment|Participant withdrew consent|20|||
124836096|NCT02872116|449030540|FG002|Pre-Treatment|Participant withdrew consent|3|||
124836097|NCT02872116|449030538|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
124836098|NCT02872116|449030539|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
124836099|NCT02872116|449030540|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
124836100|NCT02872116|449030538|FG000|Pre-Treatment|Other reasons|1|||
124836101|NCT02872116|449030539|FG001|Pre-Treatment|Other reasons|2|||
124836102|NCT02872116|449030540|FG002|Pre-Treatment|Other reasons|2|||
124836103|NCT02872116|449030538|FG000|Treatment|Death|121|||
124836104|NCT02872116|449030539|FG001|Treatment|Death|94|||
124836105|NCT02872116|449030540|FG002|Treatment|Death|68|||
124836106|NCT02872116|449030538|FG000|Treatment|Lost to Follow-up|5|||
124836107|NCT02872116|449030539|FG001|Treatment|Lost to Follow-up|7|||
124836108|NCT02872116|449030540|FG002|Treatment|Lost to Follow-up|3|||
124836109|NCT02872116|449030538|FG000|Treatment|Participant withdrew consent|20|||
124836110|NCT02872116|449030539|FG001|Treatment|Participant withdrew consent|40|||
124836111|NCT02872116|449030540|FG002|Treatment|Participant withdrew consent|8|||
124836112|NCT02872116|449030538|FG000|Treatment|Other reasons|13|||
124836113|NCT02872116|449030539|FG001|Treatment|Other reasons|12|||
124836114|NCT02872116|449030540|FG002|Treatment|Other reasons|5|||
124836115|NCT03735667|449030541|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
124836116|NCT03735667|449030542|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
124836117|NCT03735667|449030543|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
124836118|NCT03735667|449030541|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
124836119|NCT03735667|449030542|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
124836120|NCT03735667|449030543|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
124836121|NCT03735667|449030541|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
124836122|NCT03735667|449030542|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
124836123|NCT03735667|449030543|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
124836124|NCT03735667|449030541|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
124836125|NCT03735667|449030542|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
124836126|NCT03735667|449030543|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
124836127|NCT03735667|449030541|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
124836128|NCT03735667|449030542|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
124836129|NCT03735667|449030543|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
124836130|NCT03735667|449030541|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
124836131|NCT03735667|449030542|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
124836132|NCT03735667|449030543|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
124836133|NCT03735667|449030541|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
124836134|NCT03735667|449030542|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
124836135|NCT03735667|449030543|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
124836136|NCT03735667|449030541|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
124836137|NCT03735667|449030542|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
124836138|NCT03735667|449030543|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
124836139|NCT03735667|449030541|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
124836140|NCT03735667|449030542|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
124836141|NCT03735667|449030543|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
124836142|NCT03735667|449030541|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
124836143|NCT03735667|449030542|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
124836144|NCT03735667|449030543|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
124836145|NCT03735667|449030541|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
124836146|NCT03735667|449030542|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
124836147|NCT03735667|449030543|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
124836148|NCT03735667|449030541|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
124836149|NCT03735667|449030542|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
124836150|NCT03735667|449030543|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
124836151|NCT00006478|449030547|FG000|Overall Study|Vaccine could not be produced|1|||
124836152|NCT00006478|449030547|FG000|Overall Study|Physician Decision|6|||
124836153|NCT03161483|449030551|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
124836154|NCT03161483|449030552|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
124836155|NCT03161483|449030553|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
124836156|NCT03161483|449030554|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
124836157|NCT03161483|449030551|FG000|Treatment Period|Death|1|||
124836158|NCT03161483|449030552|FG001|Treatment Period|Death|0|||
125304898|NCT01153698|450742785|FG000|Overall Study|Not treated with Pradaxa|5|||
125304899|NCT01090063|450742786|FG000|Screen|Screen Failed|4|||
124836159|NCT03161483|449030553|FG002|Treatment Period|Death|0|||
124836160|NCT03161483|449030554|FG003|Treatment Period|Death|0|||
124836161|NCT03161483|449030551|FG000|Treatment Period|Adverse Event|5|||
124836162|NCT03161483|449030552|FG001|Treatment Period|Adverse Event|2|||
124836163|NCT03161483|449030553|FG002|Treatment Period|Adverse Event|1|||
124836164|NCT03161483|449030554|FG003|Treatment Period|Adverse Event|11|||
124836165|NCT03161483|449030551|FG000|Treatment Period|Pregnancy|1|||
124836166|NCT03161483|449030552|FG001|Treatment Period|Pregnancy|0|||
124836167|NCT03161483|449030553|FG002|Treatment Period|Pregnancy|0|||
124836168|NCT03161483|449030554|FG003|Treatment Period|Pregnancy|0|||
124836169|NCT03161483|449030551|FG000|Treatment Period|Lack of Efficacy|0|||
124836170|NCT03161483|449030552|FG001|Treatment Period|Lack of Efficacy|0|||
124836171|NCT03161483|449030553|FG002|Treatment Period|Lack of Efficacy|0|||
124836172|NCT03161483|449030554|FG003|Treatment Period|Lack of Efficacy|1|||
124836173|NCT03161483|449030551|FG000|Treatment Period|Withdrawal by Subject|2|||
124836174|NCT03161483|449030552|FG001|Treatment Period|Withdrawal by Subject|5|||
124836175|NCT03161483|449030553|FG002|Treatment Period|Withdrawal by Subject|2|||
124836176|NCT03161483|449030554|FG003|Treatment Period|Withdrawal by Subject|6|||
124836177|NCT03161483|449030551|FG000|Treatment Period|Lost to Follow-up|0|||
124836178|NCT03161483|449030552|FG001|Treatment Period|Lost to Follow-up|0|||
124836179|NCT03161483|449030553|FG002|Treatment Period|Lost to Follow-up|0|||
124836180|NCT03161483|449030554|FG003|Treatment Period|Lost to Follow-up|1|||
124836181|NCT03161483|449030551|FG000|Treatment Period|Protocol Violation|0|||
124836182|NCT03161483|449030552|FG001|Treatment Period|Protocol Violation|0|||
124836183|NCT03161483|449030553|FG002|Treatment Period|Protocol Violation|0|||
124836184|NCT03161483|449030554|FG003|Treatment Period|Protocol Violation|1|||
124836185|NCT03161483|449030551|FG000|Treatment Period|Other reasons|1|||
124836186|NCT03161483|449030552|FG001|Treatment Period|Other reasons|1|||
124836187|NCT03161483|449030553|FG002|Treatment Period|Other reasons|0|||
124836188|NCT03161483|449030554|FG003|Treatment Period|Other reasons|0|||
124836189|NCT02404350|449030565|FG000|Overall Study|Adverse Event|2|||
124836190|NCT02404350|449030566|FG001|Overall Study|Adverse Event|2|||
124836191|NCT02404350|449030567|FG002|Overall Study|Adverse Event|3|||
124836192|NCT02404350|449030568|FG003|Overall Study|Adverse Event|9|||
124836193|NCT02404350|449030565|FG000|Overall Study|Lack of Efficacy|3|||
124836194|NCT02404350|449030566|FG001|Overall Study|Lack of Efficacy|1|||
124836195|NCT02404350|449030567|FG002|Overall Study|Lack of Efficacy|0|||
124836196|NCT02404350|449030568|FG003|Overall Study|Lack of Efficacy|3|||
124836197|NCT02404350|449030565|FG000|Overall Study|Lost to Follow-up|2|||
124836198|NCT02404350|449030566|FG001|Overall Study|Lost to Follow-up|0|||
124836199|NCT02404350|449030567|FG002|Overall Study|Lost to Follow-up|0|||
124836200|NCT02404350|449030568|FG003|Overall Study|Lost to Follow-up|1|||
124836201|NCT02404350|449030565|FG000|Overall Study|Physician Decision|1|||
124836202|NCT02404350|449030566|FG001|Overall Study|Physician Decision|0|||
124836203|NCT02404350|449030567|FG002|Overall Study|Physician Decision|0|||
124836204|NCT02404350|449030568|FG003|Overall Study|Physician Decision|2|||
124836205|NCT02404350|449030565|FG000|Overall Study|Pregnancy|0|||
124836206|NCT02404350|449030566|FG001|Overall Study|Pregnancy|0|||
124836207|NCT02404350|449030567|FG002|Overall Study|Pregnancy|0|||
124836208|NCT02404350|449030568|FG003|Overall Study|Pregnancy|1|||
124836209|NCT02404350|449030565|FG000|Overall Study|Withdrawal by Subject|7|||
124836210|NCT02404350|449030566|FG001|Overall Study|Withdrawal by Subject|3|||
124836211|NCT02404350|449030567|FG002|Overall Study|Withdrawal by Subject|3|||
124836212|NCT02404350|449030568|FG003|Overall Study|Withdrawal by Subject|19|||
124836213|NCT02404350|449030565|FG000|Overall Study|Due to Non-compliance with treatment|0|||
124836214|NCT02404350|449030566|FG001|Overall Study|Due to Non-compliance with treatment|0|||
124836215|NCT02404350|449030567|FG002|Overall Study|Due to Non-compliance with treatment|0|||
124836216|NCT02404350|449030568|FG003|Overall Study|Due to Non-compliance with treatment|1|||
124836217|NCT02404350|449030565|FG000|Overall Study|Due to Technical problems|0|||
124836218|NCT02404350|449030566|FG001|Overall Study|Due to Technical problems|0|||
124836219|NCT02404350|449030567|FG002|Overall Study|Due to Technical problems|0|||
124836220|NCT02404350|449030568|FG003|Overall Study|Due to Technical problems|1|||
124836221|NCT04238728|449030569|FG000|Overall Study|Withdrawal by Subject|1|||
124836222|NCT04238728|449030569|FG000|Overall Study|Lost to Follow-up|2|||
124836223|NCT05389657|449030571|FG000|Overall Study|Lost to Follow-up|7|||
124836224|NCT05389657|449030572|FG001|Overall Study|Lost to Follow-up|8|||
124836225|NCT04414553|449030574|FG000|Overall Study|Lost to Follow-up|20|||
124836226|NCT01085097|449030575|FG000|Overall Study|Adverse Event|0|||
124836227|NCT01085097|449030576|FG001|Overall Study|Adverse Event|0|||
124836228|NCT01085097|449030577|FG002|Overall Study|Adverse Event|2|||
124836229|NCT01085097|449030575|FG000|Overall Study|Treatment failure|2|||
124836230|NCT01085097|449030576|FG001|Overall Study|Treatment failure|0|||
124836231|NCT01085097|449030577|FG002|Overall Study|Treatment failure|0|||
124836232|NCT00075582|449030584|FG000|Overall Study|Adverse Event|3|||
124836233|NCT00075582|449030585|FG001|Overall Study|Adverse Event|1|||
124836234|NCT00075582|449030584|FG000|Overall Study|Lack of Efficacy|4|||
124836235|NCT00075582|449030585|FG001|Overall Study|Lack of Efficacy|8|||
124836236|NCT00075582|449030584|FG000|Overall Study|Physician Decision|5|||
124836237|NCT00075582|449030585|FG001|Overall Study|Physician Decision|8|||
124836238|NCT00075582|449030584|FG000|Overall Study|Withdrawal by Subject|2|||
124836239|NCT00075582|449030585|FG001|Overall Study|Withdrawal by Subject|2|||
124836240|NCT00075582|449030584|FG000|Overall Study|Ineligible for study|36|||
124836241|NCT00075582|449030585|FG001|Overall Study|Ineligible for study|16|||
124836242|NCT02268812|449030586|FG000|Overall Study|Adverse Event|8|||
124836243|NCT02268812|449030587|FG001|Overall Study|Adverse Event|26|||
124836244|NCT02268812|449030588|FG002|Overall Study|Adverse Event|7|||
124836245|NCT02268812|449030589|FG003|Overall Study|Adverse Event|10|||
124836246|NCT02268812|449030586|FG000|Overall Study|Protocol deviation|0|||
124836247|NCT02268812|449030587|FG001|Overall Study|Protocol deviation|0|||
124836248|NCT02268812|449030588|FG002|Overall Study|Protocol deviation|1|||
124836249|NCT02268812|449030589|FG003|Overall Study|Protocol deviation|0|||
124836250|NCT02268812|449030586|FG000|Overall Study|Withdrawal by Subject|0|||
124836251|NCT02268812|449030587|FG001|Overall Study|Withdrawal by Subject|1|||
124836252|NCT02268812|449030588|FG002|Overall Study|Withdrawal by Subject|0|||
124836253|NCT02268812|449030589|FG003|Overall Study|Withdrawal by Subject|0|||
124836254|NCT02268812|449030586|FG000|Overall Study|Physician Decision|3|||
124836255|NCT02268812|449030587|FG001|Overall Study|Physician Decision|1|||
124836256|NCT02268812|449030588|FG002|Overall Study|Physician Decision|0|||
124836257|NCT02268812|449030589|FG003|Overall Study|Physician Decision|1|||
124836258|NCT02268812|449030586|FG000|Overall Study|Other|5|||
124836259|NCT02268812|449030587|FG001|Overall Study|Other|4|||
124836260|NCT02268812|449030588|FG002|Overall Study|Other|1|||
124836261|NCT02268812|449030589|FG003|Overall Study|Other|3|||
124836262|NCT05045144|449030590|FG000|Overall Study|Lost to Follow-up|3|||
124836263|NCT05045144|449030591|FG001|Overall Study|Lost to Follow-up|2|||
124836264|NCT05045144|449030592|FG002|Overall Study|Lost to Follow-up|3|||
124836265|NCT05045144|449030593|FG003|Overall Study|Lost to Follow-up|5|||
124836266|NCT05045144|449030594|FG004|Overall Study|Lost to Follow-up|13|||
124836267|NCT05045144|449030590|FG000|Overall Study|Withdrawal by Subject|0|||
124836268|NCT05045144|449030591|FG001|Overall Study|Withdrawal by Subject|1|||
124836269|NCT05045144|449030592|FG002|Overall Study|Withdrawal by Subject|0|||
124836270|NCT05045144|449030593|FG003|Overall Study|Withdrawal by Subject|0|||
124836271|NCT05045144|449030594|FG004|Overall Study|Withdrawal by Subject|0|||
124836272|NCT05045144|449030590|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124836273|NCT05045144|449030591|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124836274|NCT05045144|449030592|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
124836275|NCT05045144|449030593|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124836276|NCT05045144|449030594|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124836277|NCT02385084|449030595|FG000|Period 2|Protocol Violation|0|||
124836278|NCT02385084|449030596|FG001|Period 2|Protocol Violation|0|||
124836279|NCT02385084|449030597|FG002|Period 2|Protocol Violation|1|||
124836280|NCT02385084|449030598|FG003|Period 2|Protocol Violation|0|||
124836281|NCT02385084|449030599|FG004|Period 2|Protocol Violation|0|||
124836282|NCT02385084|449030600|FG005|Period 2|Protocol Violation|0|||
124836283|NCT00768144|449030601|FG000|Overall Study|Adverse Event|13|||
124836284|NCT00768144|449030601|FG000|Overall Study|Progressive Disease|21|||
124836285|NCT00768144|449030601|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
124836286|NCT00768144|449030601|FG000|Overall Study|Pt Withdrew Consent|1|||
124836287|NCT02268786|449030602|FG000|Overall Study|No Euploid Embryos available|42|||
124836288|NCT02268786|449030603|FG001|Overall Study|No Euploid Embryos available|0|||
124836289|NCT02268786|449030602|FG000|Overall Study|Withdrawal by Subject|7|||
124836290|NCT02268786|449030603|FG001|Overall Study|Withdrawal by Subject|14|||
124836291|NCT02268786|449030602|FG000|Overall Study|Thaw Failure|6|||
124836292|NCT02268786|449030603|FG001|Overall Study|Thaw Failure|4|||
124836293|NCT02268786|449030602|FG000|Overall Study|Protocol Violation|1|||
124836294|NCT02268786|449030603|FG001|Overall Study|Protocol Violation|0|||
124836295|NCT00744627|449030604|FG000|Overall Study|Adverse Event|6|||
124836296|NCT00744627|449030605|FG001|Overall Study|Adverse Event|9|||
124836297|NCT00744627|449030604|FG000|Overall Study|Lack of Efficacy|7|||
124836298|NCT00744627|449030605|FG001|Overall Study|Lack of Efficacy|3|||
124836299|NCT00744627|449030604|FG000|Overall Study|Noncompliance|0|||
124836300|NCT00744627|449030605|FG001|Overall Study|Noncompliance|1|||
124836301|NCT00744627|449030604|FG000|Overall Study|Protocol Deviations|0|||
124836302|NCT00744627|449030605|FG001|Overall Study|Protocol Deviations|2|||
124836303|NCT00744627|449030604|FG000|Overall Study|Voluntary Withdrawal|9|||
124836304|NCT00744627|449030605|FG001|Overall Study|Voluntary Withdrawal|6|||
124836305|NCT00744627|449030604|FG000|Overall Study|Lost to Follow-up|2|||
124836306|NCT00744627|449030605|FG001|Overall Study|Lost to Follow-up|1|||
124836307|NCT00744627|449030604|FG000|Overall Study|Other|1|||
124836308|NCT00744627|449030605|FG001|Overall Study|Other|0|||
124836309|NCT04251221|449030606|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
124836310|NCT04251221|449030607|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
124836311|NCT00323492|449030608|FG000|Study Phase 1|Adverse Event|2|||
124836312|NCT00323492|449030609|FG001|Study Phase 1|Adverse Event|0|||
124836313|NCT00323492|449030610|FG002|Study Phase 1|Adverse Event|0|||
124836314|NCT00323492|449030608|FG000|Study Phase 2|Adverse Event|1|||
124836315|NCT00323492|449030609|FG001|Study Phase 2|Adverse Event|0|||
124836316|NCT00323492|449030610|FG002|Study Phase 2|Adverse Event|0|||
124836317|NCT00323492|449030608|FG000|Study Phase 2|Physician Decision|1|||
124836318|NCT00323492|449030609|FG001|Study Phase 2|Physician Decision|0|||
124836319|NCT00323492|449030610|FG002|Study Phase 2|Physician Decision|0|||
124836320|NCT00323492|449030608|FG000|Study Phase 2|Lost to Follow-up|1|||
124836321|NCT00323492|449030609|FG001|Study Phase 2|Lost to Follow-up|0|||
124836322|NCT00323492|449030610|FG002|Study Phase 2|Lost to Follow-up|0|||
124836323|NCT00323492|449030608|FG000|Study Phase 2|Withdrawal by Subject|0|||
124836324|NCT00323492|449030609|FG001|Study Phase 2|Withdrawal by Subject|1|||
124836325|NCT00323492|449030610|FG002|Study Phase 2|Withdrawal by Subject|0|||
124836326|NCT00323492|449030608|FG000|Study Phase 2|Noncompliance with study schedule|0|||
124836327|NCT00323492|449030609|FG001|Study Phase 2|Noncompliance with study schedule|0|||
124836328|NCT00323492|449030610|FG002|Study Phase 2|Noncompliance with study schedule|1|||
124836329|NCT00323492|449030608|FG000|Study Phase 2|Protocol Violation|1|||
124836330|NCT00323492|449030609|FG001|Study Phase 2|Protocol Violation|0|||
124836331|NCT00323492|449030610|FG002|Study Phase 2|Protocol Violation|0|||
124836332|NCT01319877|449030613|FG000|Overall Study|Lost to Follow-up|100|||
124836333|NCT01319877|449030614|FG001|Overall Study|Lost to Follow-up|37|||
124836334|NCT01319877|449030613|FG000|Overall Study|Physician Decision|2|||
124836335|NCT01319877|449030614|FG001|Overall Study|Physician Decision|0|||
124836336|NCT01319877|449030613|FG000|Overall Study|Disease Progression|2|||
124836337|NCT01319877|449030614|FG001|Overall Study|Disease Progression|2|||
124836338|NCT01319877|449030613|FG000|Overall Study|Withdrawal by Subject|0|||
124836339|NCT01319877|449030614|FG001|Overall Study|Withdrawal by Subject|1|||
124836340|NCT01319877|449030613|FG000|Overall Study|Reason Not Specified|4|||
124836341|NCT01319877|449030614|FG001|Overall Study|Reason Not Specified|5|||
124836342|NCT03560531|449030615|FG000|Overall Study|Death|4|||
124836343|NCT03560531|449030616|FG001|Overall Study|Death|1|||
124836344|NCT03560531|449030617|FG002|Overall Study|Death|1|||
124836345|NCT03560531|449030618|FG003|Overall Study|Death|2|||
124836346|NCT03560531|449030619|FG004|Overall Study|Death|6|||
124836347|NCT03560531|449030620|FG005|Overall Study|Death|1|||
124836348|NCT03560531|449030621|FG006|Overall Study|Death|4|||
124836349|NCT03560531|449030622|FG007|Overall Study|Death|8|||
124836350|NCT03560531|449030623|FG008|Overall Study|Death|1|||
124836351|NCT03560531|449030624|FG009|Overall Study|Death|3|||
124836352|NCT03560531|449030625|FG010|Overall Study|Death|2|||
124836353|NCT03560531|449030626|FG011|Overall Study|Death|0|||
124836354|NCT03560531|449030627|FG012|Overall Study|Death|4|||
124836355|NCT03560531|449030628|FG013|Overall Study|Death|1|||
124836356|NCT03560531|449030615|FG000|Overall Study|Lost to Follow-up|1|||
124836357|NCT03560531|449030616|FG001|Overall Study|Lost to Follow-up|1|||
124836358|NCT03560531|449030617|FG002|Overall Study|Lost to Follow-up|0|||
124836359|NCT03560531|449030618|FG003|Overall Study|Lost to Follow-up|0|||
124836360|NCT03560531|449030619|FG004|Overall Study|Lost to Follow-up|0|||
124836361|NCT03560531|449030620|FG005|Overall Study|Lost to Follow-up|0|||
124836362|NCT03560531|449030621|FG006|Overall Study|Lost to Follow-up|1|||
124836363|NCT03560531|449030622|FG007|Overall Study|Lost to Follow-up|0|||
124836364|NCT03560531|449030623|FG008|Overall Study|Lost to Follow-up|0|||
124836365|NCT03560531|449030624|FG009|Overall Study|Lost to Follow-up|0|||
124836366|NCT03560531|449030625|FG010|Overall Study|Lost to Follow-up|0|||
124836367|NCT03560531|449030626|FG011|Overall Study|Lost to Follow-up|0|||
124836368|NCT03560531|449030627|FG012|Overall Study|Lost to Follow-up|0|||
124836369|NCT03560531|449030628|FG013|Overall Study|Lost to Follow-up|0|||
124836370|NCT03560531|449030615|FG000|Overall Study|Withdrawal by Subject|1|||
124836371|NCT03560531|449030616|FG001|Overall Study|Withdrawal by Subject|0|||
124836372|NCT03560531|449030617|FG002|Overall Study|Withdrawal by Subject|0|||
124836373|NCT03560531|449030618|FG003|Overall Study|Withdrawal by Subject|0|||
124836374|NCT03560531|449030619|FG004|Overall Study|Withdrawal by Subject|0|||
124836375|NCT03560531|449030620|FG005|Overall Study|Withdrawal by Subject|0|||
124836376|NCT03560531|449030621|FG006|Overall Study|Withdrawal by Subject|0|||
124836377|NCT03560531|449030622|FG007|Overall Study|Withdrawal by Subject|3|||
124836378|NCT03560531|449030623|FG008|Overall Study|Withdrawal by Subject|2|||
124836379|NCT03560531|449030624|FG009|Overall Study|Withdrawal by Subject|0|||
124836380|NCT03560531|449030625|FG010|Overall Study|Withdrawal by Subject|0|||
124836381|NCT03560531|449030626|FG011|Overall Study|Withdrawal by Subject|0|||
124836382|NCT03560531|449030627|FG012|Overall Study|Withdrawal by Subject|2|||
124836383|NCT03560531|449030628|FG013|Overall Study|Withdrawal by Subject|0|||
124836384|NCT03560531|449030615|FG000|Overall Study|Study end per-protocol|1|||
124836385|NCT03560531|449030616|FG001|Overall Study|Study end per-protocol|1|||
124836386|NCT03560531|449030617|FG002|Overall Study|Study end per-protocol|2|||
124836387|NCT03560531|449030618|FG003|Overall Study|Study end per-protocol|0|||
124836388|NCT03560531|449030619|FG004|Overall Study|Study end per-protocol|1|||
124836389|NCT03560531|449030620|FG005|Overall Study|Study end per-protocol|0|||
124836390|NCT03560531|449030621|FG006|Overall Study|Study end per-protocol|0|||
124836391|NCT03560531|449030622|FG007|Overall Study|Study end per-protocol|0|||
124836392|NCT03560531|449030623|FG008|Overall Study|Study end per-protocol|0|||
124836393|NCT03560531|449030624|FG009|Overall Study|Study end per-protocol|0|||
124836394|NCT03560531|449030625|FG010|Overall Study|Study end per-protocol|0|||
124836395|NCT03560531|449030626|FG011|Overall Study|Study end per-protocol|0|||
124836396|NCT03560531|449030627|FG012|Overall Study|Study end per-protocol|0|||
124836397|NCT03560531|449030628|FG013|Overall Study|Study end per-protocol|0|||
124836398|NCT03560531|449030615|FG000|Overall Study|Early study termination by sponsor|9|||
124836399|NCT03560531|449030616|FG001|Overall Study|Early study termination by sponsor|0|||
124836400|NCT03560531|449030617|FG002|Overall Study|Early study termination by sponsor|0|||
124836401|NCT03560531|449030618|FG003|Overall Study|Early study termination by sponsor|4|||
124836402|NCT03560531|449030619|FG004|Overall Study|Early study termination by sponsor|8|||
124836403|NCT03560531|449030620|FG005|Overall Study|Early study termination by sponsor|2|||
124836404|NCT03560531|449030621|FG006|Overall Study|Early study termination by sponsor|5|||
124836405|NCT03560531|449030622|FG007|Overall Study|Early study termination by sponsor|64|||
124836406|NCT03560531|449030623|FG008|Overall Study|Early study termination by sponsor|7|||
124836407|NCT03560531|449030624|FG009|Overall Study|Early study termination by sponsor|2|||
124836408|NCT03560531|449030625|FG010|Overall Study|Early study termination by sponsor|16|||
124836409|NCT03560531|449030626|FG011|Overall Study|Early study termination by sponsor|2|||
124836410|NCT03560531|449030627|FG012|Overall Study|Early study termination by sponsor|6|||
124836411|NCT03560531|449030628|FG013|Overall Study|Early study termination by sponsor|2|||
124836412|NCT01200797|449030631|FG000|Overall Study|symptomatic deterioration|2|||
124836413|NCT01200797|449030631|FG000|Overall Study|Adverse Event|4|||
124836414|NCT01200797|449030631|FG000|Overall Study|Disease Progression|13|||
124836415|NCT00642668|449030636|FG000|Overall Study|Lost to Follow-up|1|||
124836416|NCT00642668|449030636|FG000|Overall Study|Adverse Event|2|||
124836417|NCT00642668|449030636|FG000|Overall Study|Death|2|||
124836418|NCT00642668|449030636|FG000|Overall Study|Insufficient Therapeutic Response|1|||
124836419|NCT00642668|449030636|FG000|Overall Study|Failure to Return|1|||
124836420|NCT00642668|449030636|FG000|Overall Study|Dialysis Initiation|5|||
124836421|NCT00642668|449030636|FG000|Overall Study|Blood Transfusion|2|||
124836422|NCT03608774|449030637|FG000|Overall Study|Lost to Follow-up|5|||
124836423|NCT03608774|449030638|FG001|Overall Study|Lost to Follow-up|5|||
124836424|NCT03608774|449030637|FG000|Overall Study|Withdrawal by Subject|1|||
124836425|NCT03608774|449030638|FG001|Overall Study|Withdrawal by Subject|0|||
124836426|NCT03608774|449030637|FG000|Overall Study|Protocol Violation|1|||
124836427|NCT03608774|449030638|FG001|Overall Study|Protocol Violation|0|||
124836428|NCT03608774|449030637|FG000|Overall Study|Not eligible at enrollment|0|||
124836429|NCT03608774|449030638|FG001|Overall Study|Not eligible at enrollment|1|||
124836430|NCT03608774|449030637|FG000|Overall Study|Health related event|0|||
124836431|NCT03608774|449030638|FG001|Overall Study|Health related event|1|||
124836432|NCT01177540|449030639|FG000|Overall Study|Adverse Event|1|||
124836433|NCT01177540|449030640|FG001|Overall Study|Adverse Event|0|||
124836434|NCT01623596|449030646|FG000|Overall Study|Abnormal laboratory values|2|||
124836435|NCT01623596|449030647|FG001|Overall Study|Abnormal laboratory values|0|||
124836436|NCT01623596|449030646|FG000|Overall Study|Administrative problems|9|||
124836437|NCT01623596|449030647|FG001|Overall Study|Administrative problems|13|||
124836438|NCT01623596|449030646|FG000|Overall Study|Adverse Event|20|||
124836439|NCT01623596|449030647|FG001|Overall Study|Adverse Event|29|||
124836440|NCT01623596|449030646|FG000|Overall Study|Death|0|||
124836441|NCT01623596|449030647|FG001|Overall Study|Death|2|||
124836442|NCT01623596|449030646|FG000|Overall Study|Lost to Follow-up|12|||
124836443|NCT01623596|449030647|FG001|Overall Study|Lost to Follow-up|16|||
124836444|NCT01623596|449030646|FG000|Overall Study|Withdrawal by Subject|13|||
124836445|NCT01623596|449030647|FG001|Overall Study|Withdrawal by Subject|31|||
124836446|NCT01623596|449030646|FG000|Overall Study|Patient no longer requires study drug|1|||
124836447|NCT01623596|449030647|FG001|Overall Study|Patient no longer requires study drug|0|||
124836448|NCT01623596|449030646|FG000|Overall Study|Protocol Violation|0|||
124836449|NCT01623596|449030647|FG001|Overall Study|Protocol Violation|6|||
124836450|NCT01623596|449030646|FG000|Overall Study|Lack of Efficacy|5|||
124836451|NCT01623596|449030647|FG001|Overall Study|Lack of Efficacy|3|||
124836452|NCT00699972|449032143|FG000|Overall Study|Adverse Event|7|||
124836453|NCT00699972|449032144|FG001|Overall Study|Adverse Event|9|||
124836454|NCT00699972|449032145|FG002|Overall Study|Adverse Event|24|||
124836455|NCT00699972|449032143|FG000|Overall Study|Lost to Follow-up|0|||
124836456|NCT00699972|449032144|FG001|Overall Study|Lost to Follow-up|2|||
124836457|NCT00699972|449032145|FG002|Overall Study|Lost to Follow-up|0|||
124836458|NCT00699972|449032143|FG000|Overall Study|Withdrawal by Subject|3|||
124836459|NCT00699972|449032144|FG001|Overall Study|Withdrawal by Subject|7|||
124836460|NCT00699972|449032145|FG002|Overall Study|Withdrawal by Subject|4|||
124836461|NCT00699972|449032143|FG000|Overall Study|Lack of Efficacy|2|||
124836462|NCT00699972|449032144|FG001|Overall Study|Lack of Efficacy|0|||
124836463|NCT00699972|449032145|FG002|Overall Study|Lack of Efficacy|2|||
124836464|NCT00699972|449032143|FG000|Overall Study|Administrative/Other|3|||
124836465|NCT00699972|449032144|FG001|Overall Study|Administrative/Other|1|||
124836466|NCT00699972|449032145|FG002|Overall Study|Administrative/Other|4|||
124836467|NCT00699972|449032143|FG000|Overall Study|Randomized, Not Treated|1|||
124836468|NCT00699972|449032144|FG001|Overall Study|Randomized, Not Treated|0|||
124836469|NCT00699972|449032145|FG002|Overall Study|Randomized, Not Treated|1|||
124836470|NCT01545817|449032146|FG000|Pazopanib|Disease progression|51|||
124836471|NCT01545817|449032147|FG001|Pazopanib|Disease progression|0|||
124836472|NCT01545817|449032146|FG000|Pazopanib|Adverse Event|19|||
124836473|NCT01545817|449032147|FG001|Pazopanib|Adverse Event|0|||
124836474|NCT01545817|449032146|FG000|Pazopanib|Other reason|4|||
124836475|NCT01545817|449032147|FG001|Pazopanib|Other reason|0|||
124836476|NCT01545817|449032146|FG000|Everolimus|Other reason|0|||
124836477|NCT01545817|449032147|FG001|Everolimus|Other reason|7|||
124836478|NCT01545817|449032146|FG000|Everolimus|Disease progression|0|||
124836479|NCT01545817|449032147|FG001|Everolimus|Disease progression|25|||
124836480|NCT01545817|449032146|FG000|Everolimus|Adverse Event|0|||
124836481|NCT01545817|449032147|FG001|Everolimus|Adverse Event|6|||
124836482|NCT03314584|449032163|FG000|Overall Study|Withdrawal by Subject|3|||
124836483|NCT03314584|449032164|FG001|Overall Study|Withdrawal by Subject|3|||
124836484|NCT03314584|449032163|FG000|Overall Study|Lost to Follow-up|4|||
124836485|NCT03314584|449032164|FG001|Overall Study|Lost to Follow-up|0|||
124836486|NCT04214288|449032166|FG000|Overall Study|Ongoing in the study|41|||
124836487|NCT04214288|449032167|FG001|Overall Study|Ongoing in the study|51|||
124836488|NCT04214288|449032168|FG002|Overall Study|Ongoing in the study|12|||
124836489|NCT04214288|449032169|FG003|Overall Study|Ongoing in the study|39|||
124836490|NCT04214288|449032166|FG000|Overall Study|Adverse Event|1|||
124836491|NCT04214288|449032167|FG001|Overall Study|Adverse Event|0|||
124836492|NCT04214288|449032168|FG002|Overall Study|Adverse Event|0|||
124836493|NCT04214288|449032169|FG003|Overall Study|Adverse Event|0|||
124836494|NCT04214288|449032166|FG000|Overall Study|Death|22|||
124836495|NCT04214288|449032167|FG001|Overall Study|Death|13|||
124836496|NCT04214288|449032168|FG002|Overall Study|Death|7|||
124836497|NCT04214288|449032169|FG003|Overall Study|Death|19|||
124836498|NCT04214288|449032166|FG000|Overall Study|Lost to Follow-up|1|||
124836499|NCT04214288|449032167|FG001|Overall Study|Lost to Follow-up|2|||
124836500|NCT04214288|449032168|FG002|Overall Study|Lost to Follow-up|1|||
124836501|NCT04214288|449032169|FG003|Overall Study|Lost to Follow-up|0|||
124836502|NCT04214288|449032166|FG000|Overall Study|Other|1|||
124836503|NCT04214288|449032167|FG001|Overall Study|Other|2|||
124836504|NCT04214288|449032168|FG002|Overall Study|Other|0|||
124836505|NCT04214288|449032169|FG003|Overall Study|Other|6|||
124836506|NCT04214288|449032166|FG000|Overall Study|Protocol Violation|0|||
124836507|NCT04214288|449032167|FG001|Overall Study|Protocol Violation|1|||
124836508|NCT04214288|449032168|FG002|Overall Study|Protocol Violation|0|||
124836509|NCT04214288|449032169|FG003|Overall Study|Protocol Violation|0|||
124836510|NCT04214288|449032166|FG000|Overall Study|Withdrawal by Subject|8|||
124836511|NCT04214288|449032167|FG001|Overall Study|Withdrawal by Subject|4|||
124836512|NCT04214288|449032168|FG002|Overall Study|Withdrawal by Subject|0|||
124836513|NCT04214288|449032169|FG003|Overall Study|Withdrawal by Subject|9|||
124836514|NCT01990495|449032176|FG000|Overall Study|Physician Decision|5|||
124836515|NCT01990495|449032177|FG001|Overall Study|Physician Decision|4|||
124836516|NCT01928862|449032178|FG000|Overall Study|Lost to Follow-up|1|||
124836517|NCT01928862|449032179|FG001|Overall Study|Lost to Follow-up|0|||
124836518|NCT01928862|449032180|FG002|Overall Study|Lost to Follow-up|0|||
124836519|NCT01928862|449032181|FG003|Overall Study|Lost to Follow-up|0|||
124836520|NCT01928862|449032182|FG004|Overall Study|Lost to Follow-up|1|||
124836521|NCT01478321|449032183|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
124836522|NCT01478321|449032183|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
124836523|NCT01478321|449032183|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
124836524|NCT01478321|449032183|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
124836525|NCT01478321|449032183|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
124836526|NCT01478321|449032183|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
124836527|NCT01478321|449032183|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
124836528|NCT01478321|449032183|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
124836529|NCT03168464|449032184|FG000|Overall Study|Death|9|||
124836530|NCT03168464|449032184|FG000|Overall Study|Progression of disease|6|||
124836531|NCT04649164|449032185|FG000|Overall Study|Withdrawal by Subject|1|||
124836532|NCT04649164|449032186|FG001|Overall Study|Withdrawal by Subject|1|||
124836533|NCT04649164|449032187|FG002|Overall Study|Withdrawal by Subject|2|||
124836534|NCT04649164|449032185|FG000|Overall Study|Participant's care recipient expired|0|||
124836535|NCT04649164|449032186|FG001|Overall Study|Participant's care recipient expired|0|||
124836536|NCT04649164|449032187|FG002|Overall Study|Participant's care recipient expired|2|||
124836537|NCT02053753|449032188|FG000|Overall Study|Withdrawal by Subject|2|||
124836538|NCT02053753|449032189|FG001|Overall Study|Withdrawal by Subject|4|||
124836539|NCT02053753|449032188|FG000|Overall Study|Decision by Sponsor|1|||
124836540|NCT02053753|449032189|FG001|Overall Study|Decision by Sponsor|1|||
124836541|NCT02053753|449032188|FG000|Overall Study|Lost to Follow-up|4|||
124836542|NCT02053753|449032189|FG001|Overall Study|Lost to Follow-up|3|||
124836543|NCT00634088|449032194|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
124836544|NCT00634088|449032195|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
124836545|NCT00634088|449032196|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
124836546|NCT00634088|449032197|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
124836547|NCT00634088|449032194|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
124836548|NCT00634088|449032195|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
124836549|NCT00634088|449032196|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
124836550|NCT00634088|449032197|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
124836551|NCT00634088|449032194|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
124836552|NCT00634088|449032195|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
124836553|NCT00634088|449032196|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
124836554|NCT00634088|449032197|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
124836555|NCT00634088|449032194|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
124836556|NCT00634088|449032195|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
124836557|NCT00634088|449032196|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
124836558|NCT00634088|449032197|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
124836559|NCT00634088|449032194|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
124836560|NCT00634088|449032195|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
124836561|NCT00634088|449032196|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
124836562|NCT00634088|449032197|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
124836563|NCT00634088|449032194|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
124836564|NCT00634088|449032195|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
124836565|NCT00634088|449032196|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
124836566|NCT00634088|449032197|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
124836567|NCT01256593|449032202|FG000|Overall Study|Protocol Violation|26|||
124836568|NCT01256593|449032202|FG000|Overall Study|No Drug Administration Information|2|||
124836569|NCT01256593|449032202|FG000|Overall Study|No Visit After Treatment|186|||
124836570|NCT02689258|449032210|FG000|Overall Study|Subject Non-Compliance|0|||
124836571|NCT02689258|449032211|FG001|Overall Study|Subject Non-Compliance|1|||
124836572|NCT02689258|449032212|FG002|Overall Study|Subject Non-Compliance|0|||
124836573|NCT02689258|449032213|FG003|Overall Study|Subject Non-Compliance|0|||
124836574|NCT02689258|449032214|FG004|Overall Study|Subject Non-Compliance|0|||
124836575|NCT02689258|449032215|FG005|Overall Study|Subject Non-Compliance|0|||
124836576|NCT02689258|449032216|FG006|Overall Study|Subject Non-Compliance|0|||
124836577|NCT02689258|449032217|FG007|Overall Study|Subject Non-Compliance|0|||
124836578|NCT02689258|449032218|FG008|Overall Study|Subject Non-Compliance|0|||
124836579|NCT02689258|449032219|FG009|Overall Study|Subject Non-Compliance|0|||
124836580|NCT02689258|449032220|FG010|Overall Study|Subject Non-Compliance|0|||
124836581|NCT02689258|449032221|FG011|Overall Study|Subject Non-Compliance|0|||
124836582|NCT02689258|449032210|FG000|Overall Study|Subject Refusal to Continue|0|||
124836583|NCT02689258|449032211|FG001|Overall Study|Subject Refusal to Continue|1|||
124836584|NCT02689258|449032212|FG002|Overall Study|Subject Refusal to Continue|0|||
124836585|NCT02689258|449032213|FG003|Overall Study|Subject Refusal to Continue|0|||
124836586|NCT02689258|449032214|FG004|Overall Study|Subject Refusal to Continue|0|||
124836587|NCT02689258|449032215|FG005|Overall Study|Subject Refusal to Continue|0|||
124836588|NCT02689258|449032216|FG006|Overall Study|Subject Refusal to Continue|0|||
124836589|NCT02689258|449032217|FG007|Overall Study|Subject Refusal to Continue|0|||
124836590|NCT02689258|449032218|FG008|Overall Study|Subject Refusal to Continue|1|||
124836591|NCT02689258|449032219|FG009|Overall Study|Subject Refusal to Continue|0|||
124836592|NCT02689258|449032220|FG010|Overall Study|Subject Refusal to Continue|0|||
124836593|NCT02689258|449032221|FG011|Overall Study|Subject Refusal to Continue|1|||
124836594|NCT02689258|449032210|FG000|Overall Study|Other|0|||
124836595|NCT02689258|449032211|FG001|Overall Study|Other|2|||
124836596|NCT02689258|449032212|FG002|Overall Study|Other|0|||
124836597|NCT02689258|449032213|FG003|Overall Study|Other|0|||
124836598|NCT02689258|449032214|FG004|Overall Study|Other|1|||
124836599|NCT02689258|449032215|FG005|Overall Study|Other|0|||
124836600|NCT02689258|449032216|FG006|Overall Study|Other|0|||
124836601|NCT02689258|449032217|FG007|Overall Study|Other|0|||
124836602|NCT02689258|449032218|FG008|Overall Study|Other|1|||
124836603|NCT02689258|449032219|FG009|Overall Study|Other|0|||
124836604|NCT02689258|449032220|FG010|Overall Study|Other|0|||
124836605|NCT02689258|449032221|FG011|Overall Study|Other|0|||
124836606|NCT00439556|449032224|FG000|Overall Study|Patient was taken off study for non-comp|0|||
124836607|NCT00439556|449032225|FG001|Overall Study|Patient was taken off study for non-comp|1|||
124836608|NCT00439556|449032226|FG002|Overall Study|Patient was taken off study for non-comp|0|||
124836609|NCT01498640|449032229|FG000|Overall Study|Lost to Follow-up|1|||
124836610|NCT01498640|449032229|FG000|Overall Study|Death|1|||
124836611|NCT01498640|449032229|FG000|Overall Study|Other|3|||
124836612|NCT03065244|449032236|FG000|Overall Study|Lost to Follow-up|1|||
124836613|NCT03065244|449032237|FG001|Overall Study|Lost to Follow-up|1|||
124836614|NCT03065244|449032236|FG000|Overall Study|Diagnosed with a different disease|1|||
124836615|NCT03065244|449032237|FG001|Overall Study|Diagnosed with a different disease|1|||
124836616|NCT03065244|449032236|FG000|Overall Study|Protocol Violation|0|||
124836617|NCT03065244|449032237|FG001|Overall Study|Protocol Violation|1|||
124836618|NCT03065244|449032236|FG000|Overall Study|Withdrawal by Subject|1|||
124836619|NCT03065244|449032237|FG001|Overall Study|Withdrawal by Subject|1|||
124836620|NCT03717480|449032238|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
124836621|NCT01894152|449032239|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
124836622|NCT01708174|449032240|FG000|Treatment Period|Withdrawal by Subject|1|||
124836623|NCT01708174|449032241|FG001|Treatment Period|Withdrawal by Subject|0|||
124836624|NCT01708174|449032242|FG002|Treatment Period|Withdrawal by Subject|0|||
124836625|NCT01708174|449032240|FG000|Treatment Period|Progressive disease|0|||
124836626|NCT01708174|449032241|FG001|Treatment Period|Progressive disease|1|||
124836627|NCT01708174|449032242|FG002|Treatment Period|Progressive disease|0|||
124836628|NCT01708174|449032240|FG000|Treatment Period|Death|0|||
124836629|NCT01708174|449032241|FG001|Treatment Period|Death|0|||
124836630|NCT01708174|449032242|FG002|Treatment Period|Death|1|||
124836631|NCT01708174|449032240|FG000|Treatment Period|Adverse Event|0|||
124836632|NCT01708174|449032241|FG001|Treatment Period|Adverse Event|1|||
124836633|NCT01708174|449032242|FG002|Treatment Period|Adverse Event|0|||
124836634|NCT01774786|449032243|FG000|Overall Study|Death|300|||
124836635|NCT01774786|449032244|FG001|Overall Study|Death|319|||
124836636|NCT01774786|449032243|FG000|Overall Study|Lost to Follow-up|6|||
124836637|NCT01774786|449032244|FG001|Overall Study|Lost to Follow-up|7|||
124836638|NCT01774786|449032243|FG000|Overall Study|Withdrawal by Subject|18|||
124836639|NCT01774786|449032244|FG001|Overall Study|Withdrawal by Subject|14|||
124836640|NCT01774786|449032243|FG000|Overall Study|Physician Decision|2|||
124836641|NCT01774786|449032244|FG001|Overall Study|Physician Decision|0|||
124836642|NCT01774786|449032243|FG000|Overall Study|Non-compliance|0|||
124836643|NCT01774786|449032244|FG001|Overall Study|Non-compliance|1|||
124836644|NCT01774786|449032243|FG000|Overall Study|Reason Not Specified|2|||
124836645|NCT01774786|449032244|FG001|Overall Study|Reason Not Specified|5|||
124836646|NCT02965703|449032250|FG000|Overall Study|Withdrawal by Subject|6|||
124836647|NCT02965703|449032251|FG001|Overall Study|Withdrawal by Subject|3|||
124836648|NCT02965703|449032252|FG002|Overall Study|Withdrawal by Subject|1|||
124836649|NCT02965703|449032250|FG000|Overall Study|Protocol Violation|1|||
124836650|NCT02965703|449032251|FG001|Overall Study|Protocol Violation|0|||
124836651|NCT02965703|449032252|FG002|Overall Study|Protocol Violation|0|||
124836652|NCT02965703|449032250|FG000|Overall Study|Adverse Event|1|||
124836653|NCT02965703|449032251|FG001|Overall Study|Adverse Event|1|||
124836654|NCT02965703|449032252|FG002|Overall Study|Adverse Event|0|||
124836655|NCT02965703|449032250|FG000|Overall Study|Lost to Follow-up|2|||
124836656|NCT02965703|449032251|FG001|Overall Study|Lost to Follow-up|1|||
124836657|NCT02965703|449032252|FG002|Overall Study|Lost to Follow-up|1|||
124836658|NCT02171260|449032253|FG000|Overall Study|Death|0|||
124836659|NCT02171260|449032254|FG001|Overall Study|Death|0|||
124836660|NCT02171260|449032255|FG002|Overall Study|Death|0|||
124836661|NCT02171260|449032256|FG003|Overall Study|Death|1|||
124836662|NCT02171260|449032253|FG000|Overall Study|Physician Decision|1|||
124836663|NCT02171260|449032254|FG001|Overall Study|Physician Decision|0|||
124836664|NCT02171260|449032255|FG002|Overall Study|Physician Decision|1|||
124836665|NCT02171260|449032256|FG003|Overall Study|Physician Decision|0|||
124836666|NCT02171260|449032253|FG000|Overall Study|Withdrawal by Subject|1|||
124836667|NCT02171260|449032254|FG001|Overall Study|Withdrawal by Subject|0|||
124836668|NCT02171260|449032255|FG002|Overall Study|Withdrawal by Subject|0|||
124836669|NCT02171260|449032256|FG003|Overall Study|Withdrawal by Subject|0|||
124836670|NCT02171260|449032253|FG000|Overall Study|Evidence of progressive disease|4|||
124836671|NCT02171260|449032254|FG001|Overall Study|Evidence of progressive disease|6|||
124836672|NCT02171260|449032255|FG002|Overall Study|Evidence of progressive disease|4|||
124836673|NCT02171260|449032256|FG003|Overall Study|Evidence of progressive disease|4|||
124836674|NCT01062555|449032258|FG000|Phase 1|Death|10|||
124836675|NCT01062555|449032259|FG001|Phase 1|Death|17|||
124836676|NCT01062555|449032260|FG002|Phase 1|Death|0|||
124836677|NCT01062555|449032261|FG003|Phase 1|Death|0|||
124836678|NCT01062555|449032258|FG000|Phase 1|Graft Failure|12|||
124836679|NCT01062555|449032259|FG001|Phase 1|Graft Failure|8|||
124836680|NCT01062555|449032260|FG002|Phase 1|Graft Failure|0|||
124836681|NCT01062555|449032261|FG003|Phase 1|Graft Failure|0|||
124836682|NCT01062555|449032258|FG000|Phase 1|Withdrawal by Subject|1|||
124836683|NCT01062555|449032259|FG001|Phase 1|Withdrawal by Subject|1|||
124836684|NCT01062555|449032260|FG002|Phase 1|Withdrawal by Subject|0|||
124836685|NCT01062555|449032261|FG003|Phase 1|Withdrawal by Subject|0|||
124836686|NCT01062555|449032258|FG000|Phase 2|Death|0|||
124836687|NCT01062555|449032259|FG001|Phase 2|Death|0|||
124836688|NCT01062555|449032260|FG002|Phase 2|Death|8|||
124836689|NCT01062555|449032261|FG003|Phase 2|Death|3|||
124836690|NCT01062555|449032258|FG000|Phase 2|Graft failure|0|||
124836691|NCT01062555|449032259|FG001|Phase 2|Graft failure|0|||
125304900|NCT01090063|450742786|FG000|Treatment|Withdrawal by Subject|4|||
124836692|NCT01062555|449032260|FG002|Phase 2|Graft failure|7|||
124836693|NCT01062555|449032261|FG003|Phase 2|Graft failure|4|||
124836694|NCT01062555|449032258|FG000|Phase 2|Withdrawal by Subject|0|||
124836695|NCT01062555|449032259|FG001|Phase 2|Withdrawal by Subject|0|||
124836696|NCT01062555|449032260|FG002|Phase 2|Withdrawal by Subject|0|||
124836697|NCT01062555|449032261|FG003|Phase 2|Withdrawal by Subject|7|||
124836698|NCT01062555|449032258|FG000|Phase 2|Protocol Violation|0|||
124836699|NCT01062555|449032259|FG001|Phase 2|Protocol Violation|0|||
124836700|NCT01062555|449032260|FG002|Phase 2|Protocol Violation|0|||
124836701|NCT01062555|449032261|FG003|Phase 2|Protocol Violation|3|||
124836702|NCT01062555|449032258|FG000|Phase 2|Physician Decision|0|||
124836703|NCT01062555|449032259|FG001|Phase 2|Physician Decision|0|||
124836704|NCT01062555|449032260|FG002|Phase 2|Physician Decision|0|||
124836705|NCT01062555|449032261|FG003|Phase 2|Physician Decision|17|||
124836706|NCT04964128|449032262|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
124836707|NCT04964128|449032262|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
124836708|NCT01471379|449032263|FG000|Overall Study|Adverse Event|1|||
124836709|NCT01471379|449032264|FG001|Overall Study|Adverse Event|0|||
124836710|NCT01471379|449032265|FG002|Overall Study|Adverse Event|0|||
124836711|NCT01471379|449032263|FG000|Overall Study|Study terminated|0|||
124836712|NCT01471379|449032264|FG001|Overall Study|Study terminated|1|||
124836713|NCT01471379|449032265|FG002|Overall Study|Study terminated|0|||
124836714|NCT02120794|449032266|FG000|Overall Study|Withdrawal by Subject|43|||
124836715|NCT02120794|449032266|FG000|Overall Study|Adverse Event|10|||
124836716|NCT02120794|449032266|FG000|Overall Study|Physician Decision|4|||
124836717|NCT02120794|449032266|FG000|Overall Study|Due to insurance coverage|1|||
124836718|NCT00026793|449032273|FG000|Overall Study|Death on study due to underlying disease|4|||
124836719|NCT00026793|449032273|FG000|Overall Study|Physician Decision|2|||
124836720|NCT00026793|449032273|FG000|Overall Study|Off study|2|||
124836721|NCT04151290|449032274|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
124836722|NCT01449526|449032275|FG000|Overall Study|Lost to Follow-up|1|||
124836723|NCT01449526|449032276|FG001|Overall Study|Lost to Follow-up|2|||
124836724|NCT01449526|449032275|FG000|Overall Study|Withdrawal by Subject|1|||
124836725|NCT01449526|449032276|FG001|Overall Study|Withdrawal by Subject|1|||
124836726|NCT01449526|449032275|FG000|Overall Study|Symptoms/complaints|0|||
124836727|NCT01449526|449032276|FG001|Overall Study|Symptoms/complaints|1|||
124836728|NCT01449526|449032275|FG000|Overall Study|Lack of Motivation|0|||
124836729|NCT01449526|449032276|FG001|Overall Study|Lack of Motivation|1|||
124836730|NCT01449526|449032275|FG000|Overall Study|Cannot maintain visits|0|||
124836731|NCT01449526|449032276|FG001|Overall Study|Cannot maintain visits|1|||
124836732|NCT01132495|449032280|FG000|Overall Study|Various reasons|40|||
124836733|NCT01132495|449032281|FG001|Overall Study|Various reasons|38|||
124836734|NCT01132495|449032282|FG002|Overall Study|Various reasons|20|||
124836735|NCT01132495|449032283|FG003|Overall Study|Various reasons|12|||
124836736|NCT00082433|449032284|FG000|Overall Study|Adverse Event|12|||
124836737|NCT00082433|449032285|FG001|Overall Study|Adverse Event|17|||
124836738|NCT00082433|449032284|FG000|Overall Study|Death|8|||
124836739|NCT00082433|449032285|FG001|Overall Study|Death|18|||
124836740|NCT00082433|449032284|FG000|Overall Study|Disease Progression/Relapse|270|||
124836741|NCT00082433|449032285|FG001|Overall Study|Disease Progression/Relapse|388|||
124836742|NCT00082433|449032284|FG000|Overall Study|Physician Decision|50|||
124836743|NCT00082433|449032285|FG001|Overall Study|Physician Decision|61|||
124836744|NCT00082433|449032284|FG000|Overall Study|Lost to Follow-up|1|||
124836745|NCT00082433|449032285|FG001|Overall Study|Lost to Follow-up|2|||
124836746|NCT00082433|449032284|FG000|Overall Study|Study Drug Toxicity|179|||
124836747|NCT00082433|449032285|FG001|Overall Study|Study Drug Toxicity|66|||
124836748|NCT00082433|449032284|FG000|Overall Study|Withdrawal by Subject|55|||
124836749|NCT00082433|449032285|FG001|Overall Study|Withdrawal by Subject|30|||
124836750|NCT00082433|449032284|FG000|Overall Study|Still On Treatment|2|||
124836751|NCT00082433|449032285|FG001|Overall Study|Still On Treatment|1|||
124836752|NCT00082433|449032284|FG000|Overall Study|Not Treated|12|||
124836753|NCT00082433|449032285|FG001|Overall Study|Not Treated|11|||
124836754|NCT00082433|449032284|FG000|Overall Study|Ineligible|2|||
124836755|NCT00082433|449032285|FG001|Overall Study|Ineligible|1|||
124836756|NCT00082433|449032284|FG000|Overall Study|Noncompliance|2|||
124836757|NCT00082433|449032285|FG001|Overall Study|Noncompliance|1|||
124836758|NCT00082433|449032284|FG000|Overall Study|New primary cancer|1|||
124836759|NCT00082433|449032285|FG001|Overall Study|New primary cancer|0|||
124836760|NCT00082433|449032284|FG000|Overall Study|Impending surgery|0|||
124836761|NCT00082433|449032285|FG001|Overall Study|Impending surgery|1|||
124836762|NCT04097821|449032286|FG000|Overall Study|Subject Decision|0|||
124836763|NCT04097821|449032287|FG001|Overall Study|Subject Decision|0|||
124836764|NCT04097821|449032288|FG002|Overall Study|Subject Decision|0|||
124836765|NCT04097821|449032289|FG003|Overall Study|Subject Decision|1|||
124836766|NCT04097821|449032290|FG004|Overall Study|Subject Decision|2|||
124836767|NCT04097821|449032291|FG005|Overall Study|Subject Decision|2|||
124836768|NCT04097821|449032292|FG006|Overall Study|Subject Decision|0|||
124836769|NCT04097821|449032293|FG007|Overall Study|Subject Decision|1|||
124836770|NCT04097821|449032286|FG000|Overall Study|Death|0|||
124836771|NCT04097821|449032287|FG001|Overall Study|Death|0|||
124836772|NCT04097821|449032288|FG002|Overall Study|Death|3|||
124836773|NCT04097821|449032289|FG003|Overall Study|Death|1|||
124836774|NCT04097821|449032290|FG004|Overall Study|Death|0|||
124836775|NCT04097821|449032291|FG005|Overall Study|Death|0|||
124836776|NCT04097821|449032292|FG006|Overall Study|Death|0|||
124836777|NCT04097821|449032293|FG007|Overall Study|Death|0|||
124836778|NCT04097821|449032286|FG000|Overall Study|Physician Decision|1|||
124836779|NCT04097821|449032287|FG001|Overall Study|Physician Decision|2|||
124836780|NCT04097821|449032288|FG002|Overall Study|Physician Decision|0|||
124836781|NCT04097821|449032289|FG003|Overall Study|Physician Decision|0|||
124836782|NCT04097821|449032290|FG004|Overall Study|Physician Decision|0|||
124836783|NCT04097821|449032291|FG005|Overall Study|Physician Decision|0|||
124836784|NCT04097821|449032292|FG006|Overall Study|Physician Decision|0|||
124836785|NCT04097821|449032293|FG007|Overall Study|Physician Decision|0|||
124836786|NCT04097821|449032286|FG000|Overall Study|Adverse Event|0|||
124836787|NCT04097821|449032287|FG001|Overall Study|Adverse Event|0|||
124836788|NCT04097821|449032288|FG002|Overall Study|Adverse Event|1|||
124836789|NCT04097821|449032289|FG003|Overall Study|Adverse Event|1|||
124836790|NCT04097821|449032290|FG004|Overall Study|Adverse Event|0|||
124836791|NCT04097821|449032291|FG005|Overall Study|Adverse Event|0|||
124836792|NCT04097821|449032292|FG006|Overall Study|Adverse Event|0|||
124836793|NCT04097821|449032293|FG007|Overall Study|Adverse Event|0|||
124836794|NCT04097821|449032286|FG000|Overall Study|New Therapy For Study Indication|0|||
124836795|NCT04097821|449032287|FG001|Overall Study|New Therapy For Study Indication|0|||
124836796|NCT04097821|449032288|FG002|Overall Study|New Therapy For Study Indication|0|||
124836797|NCT04097821|449032289|FG003|Overall Study|New Therapy For Study Indication|0|||
124836798|NCT04097821|449032290|FG004|Overall Study|New Therapy For Study Indication|0|||
124836799|NCT04097821|449032291|FG005|Overall Study|New Therapy For Study Indication|0|||
125304901|NCT01817959|450742787|FG000|Overall Study|Graft loss|1|||
125304902|NCT01817959|450742788|FG001|Overall Study|Graft loss|1|||
125304903|NCT01817959|450742787|FG000|Overall Study|forbidden medication|1|||
125304904|NCT01817959|450742788|FG001|Overall Study|forbidden medication|1|||
125304905|NCT01817959|450742787|FG000|Overall Study|Adverse Event|1|||
125304906|NCT01817959|450742788|FG001|Overall Study|Adverse Event|0|||
125304907|NCT01817959|450742787|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
125304908|NCT01817959|450742788|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
125304909|NCT00330681|450742794|FG000|Overall Study|Adverse Event|3|||
125304910|NCT00330681|450742795|FG001|Overall Study|Adverse Event|6|||
125304911|NCT00330681|450742794|FG000|Overall Study|Protocol Violation|0|||
125304912|NCT00330681|450742795|FG001|Overall Study|Protocol Violation|1|||
125304913|NCT00330681|450742794|FG000|Overall Study|Withdrawal by Subject|5|||
125304914|NCT00330681|450742795|FG001|Overall Study|Withdrawal by Subject|5|||
125304915|NCT00330681|450742794|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
125304916|NCT00330681|450742795|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
125304917|NCT02578186|450742796|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
125304918|NCT02578186|450742797|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
125304919|NCT02578186|450742796|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
125304920|NCT02578186|450742797|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
125304921|NCT01140061|450742798|FG000|Part I|Adverse Event|1|||
125304922|NCT01140061|450742799|FG001|Part I|Adverse Event|0|||
125304923|NCT01140061|450742800|FG002|Part I|Adverse Event|0|||
125304924|NCT01140061|450742801|FG003|Part I|Adverse Event|0|||
125304925|NCT01140061|450742802|FG004|Part I|Adverse Event|0|||
125304926|NCT01140061|450742803|FG005|Part I|Adverse Event|0|||
125304927|NCT01140061|450742804|FG006|Part I|Adverse Event|0|||
125304928|NCT01140061|450742805|FG007|Part I|Adverse Event|0|||
125304929|NCT01140061|450742806|FG008|Part I|Adverse Event|0|||
125304930|NCT01140061|450742807|FG009|Part I|Adverse Event|0|||
125304931|NCT01140061|450742798|FG000|Extension|Laboratory Adverse Event|0|||
125304932|NCT01140061|450742799|FG001|Extension|Laboratory Adverse Event|0|||
125304933|NCT01140061|450742800|FG002|Extension|Laboratory Adverse Event|0|||
125304934|NCT01140061|450742801|FG003|Extension|Laboratory Adverse Event|0|||
125304935|NCT01140061|450742802|FG004|Extension|Laboratory Adverse Event|0|||
125304936|NCT01140061|450742803|FG005|Extension|Laboratory Adverse Event|0|||
125304937|NCT01140061|450742804|FG006|Extension|Laboratory Adverse Event|0|||
125304938|NCT01140061|450742805|FG007|Extension|Laboratory Adverse Event|0|||
125304939|NCT01140061|450742806|FG008|Extension|Laboratory Adverse Event|0|||
125304940|NCT01140061|450742807|FG009|Extension|Laboratory Adverse Event|1|||
125304941|NCT00428389|450742808|FG000|Core Phase|Adverse Event|6|||
125304942|NCT00428389|450742809|FG001|Core Phase|Adverse Event|4|||
125304943|NCT00428389|450742808|FG000|Core Phase|Lack of Efficacy|2|||
125304944|NCT00428389|450742809|FG001|Core Phase|Lack of Efficacy|0|||
125304945|NCT00428389|450742808|FG000|Core Phase|Abnormal test procedure result(s)|0|||
125304946|NCT00428389|450742809|FG001|Core Phase|Abnormal test procedure result(s)|1|||
125304947|NCT00428389|450742808|FG000|Core Phase|Withdrawal by Subject|3|||
125304948|NCT00428389|450742809|FG001|Core Phase|Withdrawal by Subject|4|||
125304949|NCT00428389|450742808|FG000|Core Phase|Protocol deviation|0|||
125304950|NCT00428389|450742809|FG001|Core Phase|Protocol deviation|2|||
125304951|NCT00428389|450742808|FG000|Extension Phase|Adverse Event|17|||
125304952|NCT00428389|450742809|FG001|Extension Phase|Adverse Event|11|||
125304953|NCT00428389|450742808|FG000|Extension Phase|Lack of Efficacy|4|||
125304954|NCT00428389|450742809|FG001|Extension Phase|Lack of Efficacy|3|||
125304955|NCT00428389|450742808|FG000|Extension Phase|Withdrawal by Subject|6|||
125304956|NCT00428389|450742809|FG001|Extension Phase|Withdrawal by Subject|6|||
125304957|NCT00428389|450742808|FG000|Extension Phase|Lost to Follow-up|0|||
125304958|NCT00428389|450742809|FG001|Extension Phase|Lost to Follow-up|3|||
125304959|NCT00428389|450742808|FG000|Extension Phase|Death|1|||
125304960|NCT00428389|450742809|FG001|Extension Phase|Death|0|||
125304961|NCT00428389|450742808|FG000|Extension Phase|Protocol Violation|3|||
125304962|NCT00428389|450742809|FG001|Extension Phase|Protocol Violation|2|||
125304963|NCT00428389|450742808|FG000|Extension Phase|Administrative problems|1|||
125304964|NCT00428389|450742809|FG001|Extension Phase|Administrative problems|1|||
124836800|NCT04097821|449032292|FG006|Overall Study|New Therapy For Study Indication|1|||
125304965|NCT03216746|450742810|FG000|Overall Study|Lost to Follow-up|6|||
125304966|NCT03216746|450742811|FG001|Overall Study|Lost to Follow-up|8|||
125304967|NCT03216746|450742812|FG002|Overall Study|Lost to Follow-up|5|||
125304968|NCT03216746|450742813|FG003|Overall Study|Lost to Follow-up|6|||
124836801|NCT04097821|449032293|FG007|Overall Study|New Therapy For Study Indication|0|||
124836802|NCT04477304|449032295|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
124836803|NCT04477304|449032296|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
124836804|NCT05756790|449032297|FG000|Overall Study|Withdrawal by Subject|1|||
124836805|NCT05756790|449032298|FG001|Overall Study|Withdrawal by Subject|1|||
124836806|NCT05756790|449032299|FG002|Overall Study|Withdrawal by Subject|1|||
124836807|NCT05756790|449032300|FG003|Overall Study|Withdrawal by Subject|1|||
124836808|NCT05756790|449032301|FG004|Overall Study|Withdrawal by Subject|0|||
124836809|NCT05756790|449032302|FG005|Overall Study|Withdrawal by Subject|0|||
124836810|NCT05756790|449032297|FG000|Overall Study|Protocol Violation|0|||
124836811|NCT05756790|449032298|FG001|Overall Study|Protocol Violation|0|||
124836812|NCT05756790|449032299|FG002|Overall Study|Protocol Violation|1|||
124836813|NCT05756790|449032300|FG003|Overall Study|Protocol Violation|1|||
124836814|NCT05756790|449032301|FG004|Overall Study|Protocol Violation|0|||
124836815|NCT05756790|449032302|FG005|Overall Study|Protocol Violation|0|||
124836816|NCT05756790|449032297|FG000|Overall Study|Ineligible|0|||
124836817|NCT05756790|449032298|FG001|Overall Study|Ineligible|0|||
124836818|NCT05756790|449032299|FG002|Overall Study|Ineligible|0|||
124836819|NCT05756790|449032300|FG003|Overall Study|Ineligible|0|||
124836820|NCT05756790|449032301|FG004|Overall Study|Ineligible|2|||
124836821|NCT05756790|449032302|FG005|Overall Study|Ineligible|2|||
124836822|NCT00502697|449033606|FG000|Overall Study|Withdrawal by Subject|3|||
124836823|NCT00502697|449033607|FG001|Overall Study|Withdrawal by Subject|1|||
124836824|NCT00502697|449033606|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
124836825|NCT00502697|449033607|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
124836826|NCT00502697|449033606|FG000|Overall Study|found not to meet eligibility criteria|3|||
124836827|NCT00502697|449033607|FG001|Overall Study|found not to meet eligibility criteria|4|||
124836828|NCT00502697|449033606|FG000|Overall Study|did not meet assignment criteria|4|||
124836829|NCT00502697|449033607|FG001|Overall Study|did not meet assignment criteria|2|||
124836830|NCT00589108|449033610|FG000|Overall Study|Lost to Follow-up|1|||
124836831|NCT00589108|449033611|FG001|Overall Study|Lost to Follow-up|1|||
124836832|NCT00589108|449033612|FG002|Overall Study|Lost to Follow-up|1|||
124836833|NCT00589108|449033610|FG000|Overall Study|Death|3|||
124836834|NCT00589108|449033611|FG001|Overall Study|Death|3|||
124836835|NCT00589108|449033612|FG002|Overall Study|Death|4|||
124836836|NCT03256552|449033613|FG000|Overall Study|Protocol Violation|1|||
124836837|NCT03256552|449033613|FG000|Overall Study|Physician Decision|1|||
124836838|NCT03256552|449033613|FG000|Overall Study|Adverse Event|1|||
124836839|NCT03256552|449033613|FG000|Overall Study|Withdrawal by Subject|2|||
124836840|NCT03026257|449033619|FG000|Overall Study|Adverse Event|3|||
124836841|NCT03026257|449033620|FG001|Overall Study|Adverse Event|0|||
124836842|NCT03026257|449033621|FG002|Overall Study|Adverse Event|0|||
124836843|NCT03026257|449033622|FG003|Overall Study|Adverse Event|0|||
124836844|NCT03026257|449033623|FG004|Overall Study|Adverse Event|0|||
124836845|NCT03026257|449033624|FG005|Overall Study|Adverse Event|0|||
124836846|NCT03026257|449033619|FG000|Overall Study|Lost to Follow-up|1|||
124836847|NCT03026257|449033620|FG001|Overall Study|Lost to Follow-up|0|||
124836848|NCT03026257|449033621|FG002|Overall Study|Lost to Follow-up|0|||
124836849|NCT03026257|449033622|FG003|Overall Study|Lost to Follow-up|0|||
124836850|NCT03026257|449033623|FG004|Overall Study|Lost to Follow-up|0|||
124836851|NCT03026257|449033624|FG005|Overall Study|Lost to Follow-up|0|||
124836852|NCT03026257|449033619|FG000|Overall Study|Protocol Violation|1|||
124836853|NCT03026257|449033620|FG001|Overall Study|Protocol Violation|0|||
124836854|NCT03026257|449033621|FG002|Overall Study|Protocol Violation|0|||
124836855|NCT03026257|449033622|FG003|Overall Study|Protocol Violation|1|||
124836856|NCT03026257|449033623|FG004|Overall Study|Protocol Violation|1|||
124836857|NCT03026257|449033624|FG005|Overall Study|Protocol Violation|0|||
124836858|NCT03026257|449033619|FG000|Overall Study|Withdrawal by Subject|1|||
124836859|NCT03026257|449033620|FG001|Overall Study|Withdrawal by Subject|1|||
124836860|NCT03026257|449033621|FG002|Overall Study|Withdrawal by Subject|0|||
124836861|NCT03026257|449033622|FG003|Overall Study|Withdrawal by Subject|0|||
124836862|NCT03026257|449033623|FG004|Overall Study|Withdrawal by Subject|0|||
124836863|NCT03026257|449033624|FG005|Overall Study|Withdrawal by Subject|0|||
124836864|NCT04380857|449033625|FG000|Overall Study|Lost to Follow-up|3|||
124836865|NCT04380857|449033626|FG001|Overall Study|Lost to Follow-up|3|||
124836866|NCT00838201|449033627|FG000|Overall Study|Investigator decision, or other reasons|2|||
124836867|NCT00838201|449033628|FG001|Overall Study|Investigator decision, or other reasons|3|||
124836868|NCT00838201|449033627|FG000|Overall Study|Noncompliance|0|||
124836869|NCT00838201|449033628|FG001|Overall Study|Noncompliance|1|||
124836870|NCT00838201|449033627|FG000|Overall Study|Administrative decision|1|||
124836871|NCT00838201|449033628|FG001|Overall Study|Administrative decision|2|||
124836872|NCT00838201|449033627|FG000|Overall Study|Disease progression|3|||
124836873|NCT00838201|449033628|FG001|Overall Study|Disease progression|3|||
124836874|NCT00838201|449033627|FG000|Overall Study|Consent withdrawn|16|||
124836875|NCT00838201|449033628|FG001|Overall Study|Consent withdrawn|19|||
124836876|NCT00838201|449033627|FG000|Overall Study|Lost to Follow-up|4|||
124836877|NCT00838201|449033628|FG001|Overall Study|Lost to Follow-up|3|||
124836878|NCT00838201|449033627|FG000|Overall Study|Adverse Event|5|||
124836879|NCT00838201|449033628|FG001|Overall Study|Adverse Event|9|||
124836880|NCT00838201|449033627|FG000|Overall Study|Death|11|||
124836881|NCT00838201|449033628|FG001|Overall Study|Death|13|||
124836882|NCT06134817|449033633|FG000|Overall Study|Physician Departure - termination of study|1|||
124836883|NCT01987427|449033639|FG000|Overall Study|Adverse Event|4|||
124836884|NCT01987427|449033640|FG001|Overall Study|Adverse Event|2|||
124836885|NCT01987427|449033641|FG002|Overall Study|Adverse Event|8|||
124836886|NCT01987427|449033639|FG000|Overall Study|Lost to Follow-up|6|||
124836887|NCT01987427|449033640|FG001|Overall Study|Lost to Follow-up|6|||
124836888|NCT01987427|449033641|FG002|Overall Study|Lost to Follow-up|9|||
124836889|NCT01987427|449033639|FG000|Overall Study|Withdrawal by Subject|2|||
124836890|NCT01987427|449033640|FG001|Overall Study|Withdrawal by Subject|1|||
124836891|NCT01987427|449033641|FG002|Overall Study|Withdrawal by Subject|3|||
124836892|NCT01987427|449033639|FG000|Overall Study|Lack of Efficacy|1|||
124836893|NCT01987427|449033640|FG001|Overall Study|Lack of Efficacy|0|||
124836894|NCT01987427|449033641|FG002|Overall Study|Lack of Efficacy|0|||
124836895|NCT01987427|449033639|FG000|Overall Study|Other|1|||
124836896|NCT01987427|449033640|FG001|Overall Study|Other|1|||
124836897|NCT01987427|449033641|FG002|Overall Study|Other|0|||
124836898|NCT01073865|449033642|FG000|Overall Study|Reasons other than below|19|||
124836899|NCT01073865|449033643|FG001|Overall Study|Reasons other than below|31|||
124836900|NCT01073865|449033642|FG000|Overall Study|Lost to Follow-up|1|||
124836901|NCT01073865|449033643|FG001|Overall Study|Lost to Follow-up|1|||
124836902|NCT01073865|449033642|FG000|Overall Study|Death|3|||
124836903|NCT01073865|449033643|FG001|Overall Study|Death|2|||
124836904|NCT01073865|449033642|FG000|Overall Study|Withdrawal by Subject|5|||
124836905|NCT01073865|449033643|FG001|Overall Study|Withdrawal by Subject|5|||
124836906|NCT00805766|449033644|FG000|Screening Period|Adverse Event|1|||
124836907|NCT00805766|449033644|FG000|Screening Period|Lack of Efficacy|2|||
124836908|NCT00805766|449033644|FG000|Screening Period|Pregnancy|1|||
124836909|NCT00805766|449033644|FG000|Screening Period|Responder|2|||
124836910|NCT00805766|449033644|FG000|Increased Dose Period|Adverse Event|4|||
124836911|NCT00805766|449033644|FG000|Increased Dose Period|Lack of Efficacy|7|||
124836912|NCT00805766|449033644|FG000|Increased Dose Period|Pregnancy|1|||
124836913|NCT00805766|449033644|FG000|Increased Dose Period|Withdrawal by Subject|1|||
124836914|NCT00600756|449033645|FG000|Analysis After 6 Months|Adverse Event|43|||
124836915|NCT00600756|449033646|FG001|Analysis After 6 Months|Adverse Event|33|||
124836916|NCT00600756|449033645|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
124836917|NCT00600756|449033646|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
124836918|NCT00600756|449033645|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
124836919|NCT00600756|449033646|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
124836920|NCT00600756|449033645|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
124836921|NCT00600756|449033646|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
124836922|NCT00600756|449033645|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
124836923|NCT00600756|449033646|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
124836924|NCT00600756|449033645|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
124836925|NCT00600756|449033646|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
124836926|NCT00600756|449033645|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
124836927|NCT00600756|449033646|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
124836928|NCT00600756|449033645|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
124836929|NCT00600756|449033646|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
124836930|NCT00600756|449033645|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
124836931|NCT00600756|449033646|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
124836932|NCT00600756|449033645|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
124836933|NCT00600756|449033646|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
124836934|NCT00600756|449033645|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
124836935|NCT00600756|449033646|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
124836936|NCT00600756|449033645|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
124836937|NCT00600756|449033646|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
124836938|NCT00600756|449033645|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
124836939|NCT00600756|449033646|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
124836940|NCT00600756|449033645|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
124836941|NCT00600756|449033646|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
124836942|NCT03261947|449033648|FG000|Overall Study|Death|10|||
124836943|NCT03261947|449033649|FG001|Overall Study|Death|13|||
124836944|NCT03261947|449033650|FG002|Overall Study|Death|17|||
124836945|NCT03261947|449033651|FG003|Overall Study|Death|12|||
124836946|NCT03261947|449033652|FG004|Overall Study|Death|8|||
124836947|NCT03261947|449033648|FG000|Overall Study|Lost to Follow-up|0|||
124836948|NCT03261947|449033649|FG001|Overall Study|Lost to Follow-up|0|||
124836949|NCT03261947|449033650|FG002|Overall Study|Lost to Follow-up|2|||
124836950|NCT03261947|449033651|FG003|Overall Study|Lost to Follow-up|1|||
124836951|NCT03261947|449033652|FG004|Overall Study|Lost to Follow-up|0|||
124836952|NCT03261947|449033648|FG000|Overall Study|Withdrawal by Subject|0|||
124836953|NCT03261947|449033649|FG001|Overall Study|Withdrawal by Subject|0|||
124836954|NCT03261947|449033650|FG002|Overall Study|Withdrawal by Subject|3|||
124836955|NCT03261947|449033651|FG003|Overall Study|Withdrawal by Subject|0|||
124836956|NCT03261947|449033652|FG004|Overall Study|Withdrawal by Subject|1|||
124836957|NCT03261947|449033648|FG000|Overall Study|Site Terminated by Sponsor|0|||
124836958|NCT03261947|449033649|FG001|Overall Study|Site Terminated by Sponsor|0|||
124836959|NCT03261947|449033650|FG002|Overall Study|Site Terminated by Sponsor|4|||
124836960|NCT03261947|449033651|FG003|Overall Study|Site Terminated by Sponsor|7|||
124836961|NCT03261947|449033652|FG004|Overall Study|Site Terminated by Sponsor|5|||
124836962|NCT03261947|449033648|FG000|Overall Study|Reason not Specified|2|||
124836963|NCT03261947|449033649|FG001|Overall Study|Reason not Specified|0|||
124836964|NCT03261947|449033650|FG002|Overall Study|Reason not Specified|4|||
124836965|NCT03261947|449033651|FG003|Overall Study|Reason not Specified|1|||
124836966|NCT03261947|449033652|FG004|Overall Study|Reason not Specified|3|||
124836967|NCT03969992|449033653|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
124836968|NCT03969992|449033654|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
124836969|NCT03969992|449033655|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
124836970|NCT03969992|449033653|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
124836971|NCT03969992|449033654|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
124836972|NCT03969992|449033655|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
124836973|NCT03969992|449033653|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
124836974|NCT03969992|449033654|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
124836975|NCT03969992|449033655|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
124836976|NCT03969992|449033653|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
124836977|NCT03969992|449033654|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
124836978|NCT03969992|449033655|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
124836979|NCT03969992|449033653|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
124836980|NCT03969992|449033654|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
124836981|NCT03969992|449033655|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
124836982|NCT02063737|449033656|FG000|Overall Study|Lost to Follow-up|11|||
124836983|NCT02063737|449033657|FG001|Overall Study|Lost to Follow-up|4|||
124836984|NCT03373383|449033660|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
124836985|NCT03373383|449033661|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
124836986|NCT03373383|449033662|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
124836987|NCT03373383|449033663|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
124836988|NCT03373383|449033664|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
124836989|NCT03373383|449033660|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
124836990|NCT03373383|449033661|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
124836991|NCT03373383|449033662|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
124836992|NCT03373383|449033663|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
124836993|NCT03373383|449033664|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
124836994|NCT03373383|449033660|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
124836995|NCT03373383|449033661|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
124836996|NCT03373383|449033662|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
124836997|NCT03373383|449033663|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
124836998|NCT03373383|449033664|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
124836999|NCT03373383|449033660|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
124837000|NCT03373383|449033661|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
124837001|NCT03373383|449033662|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
124837002|NCT03373383|449033663|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
124837003|NCT03373383|449033664|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
124837004|NCT03373383|449033660|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
124837005|NCT03373383|449033661|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
124837006|NCT03373383|449033662|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
124837007|NCT03373383|449033663|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
124837008|NCT03373383|449033664|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
124837009|NCT03373383|449033660|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
124837010|NCT03373383|449033661|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
124837011|NCT03373383|449033662|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
124837012|NCT03373383|449033663|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
124837013|NCT03373383|449033664|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
124837014|NCT03373383|449033660|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
124837015|NCT03373383|449033661|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
124837016|NCT03373383|449033662|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
124837017|NCT03373383|449033663|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
124837018|NCT03373383|449033664|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
124837019|NCT03373383|449033660|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
124837020|NCT03373383|449033661|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
124837021|NCT03373383|449033662|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
124837022|NCT03373383|449033663|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
124837023|NCT03373383|449033664|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
124837024|NCT03373383|449033660|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
124837025|NCT03373383|449033661|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
124837026|NCT03373383|449033662|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
124837027|NCT03373383|449033663|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
124837028|NCT03373383|449033664|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
124837029|NCT04753164|449033668|FG000|Overall Study|Adverse Event|0|||
124837030|NCT04753164|449033669|FG001|Overall Study|Adverse Event|2|||
124837031|NCT04753164|449033668|FG000|Overall Study|Withdrawal by Subject|9|||
124837032|NCT04753164|449033669|FG001|Overall Study|Withdrawal by Subject|7|||
124837033|NCT04753164|449033668|FG000|Overall Study|Lost to Follow-up|6|||
124837034|NCT04753164|449033669|FG001|Overall Study|Lost to Follow-up|6|||
124837035|NCT04753164|449033668|FG000|Overall Study|Other|12|||
124837036|NCT04753164|449033669|FG001|Overall Study|Other|5|||
124837037|NCT00694369|449033670|FG000|Overall Study|Adverse Event|0|||
124837038|NCT00694369|449033671|FG001|Overall Study|Adverse Event|1|||
124837039|NCT00694369|449033672|FG002|Overall Study|Adverse Event|0|||
124837040|NCT00694369|449033673|FG003|Overall Study|Adverse Event|1|||
124837041|NCT00694369|449033674|FG004|Overall Study|Adverse Event|3|||
124837042|NCT00694369|449033670|FG000|Overall Study|Lost to Follow-up|0|||
124837043|NCT00694369|449033671|FG001|Overall Study|Lost to Follow-up|0|||
124837044|NCT00694369|449033672|FG002|Overall Study|Lost to Follow-up|1|||
124837045|NCT00694369|449033673|FG003|Overall Study|Lost to Follow-up|1|||
124837046|NCT00694369|449033674|FG004|Overall Study|Lost to Follow-up|0|||
124837047|NCT00694369|449033670|FG000|Overall Study|Physician Decision|0|||
124837048|NCT00694369|449033671|FG001|Overall Study|Physician Decision|0|||
124837049|NCT00694369|449033672|FG002|Overall Study|Physician Decision|0|||
124837050|NCT00694369|449033673|FG003|Overall Study|Physician Decision|0|||
124837051|NCT00694369|449033674|FG004|Overall Study|Physician Decision|1|||
124837052|NCT00694369|449033670|FG000|Overall Study|Protocol Violation|0|||
124837053|NCT00694369|449033671|FG001|Overall Study|Protocol Violation|1|||
124837054|NCT00694369|449033672|FG002|Overall Study|Protocol Violation|0|||
124837055|NCT00694369|449033673|FG003|Overall Study|Protocol Violation|0|||
124837056|NCT00694369|449033674|FG004|Overall Study|Protocol Violation|0|||
124837057|NCT00694369|449033670|FG000|Overall Study|Withdrawal by Subject|1|||
124837058|NCT00694369|449033671|FG001|Overall Study|Withdrawal by Subject|1|||
124837059|NCT00694369|449033672|FG002|Overall Study|Withdrawal by Subject|1|||
124837060|NCT00694369|449033673|FG003|Overall Study|Withdrawal by Subject|1|||
124837061|NCT00694369|449033674|FG004|Overall Study|Withdrawal by Subject|2|||
124837062|NCT00907374|449033677|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
124837063|NCT00907374|449033678|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
124837064|NCT02871739|449033681|FG000|Overall Study|Lost to Follow-up|3|||
124837065|NCT02871739|449033682|FG001|Overall Study|Lost to Follow-up|2|||
124837066|NCT02871739|449033683|FG002|Overall Study|Lost to Follow-up|0|||
124837067|NCT02871739|449033684|FG003|Overall Study|Lost to Follow-up|2|||
124837068|NCT03818516|449033685|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
124837069|NCT04372602|449033688|FG000|Overall Study|Withdrawal by Subject|1|||
124837070|NCT04372602|449033689|FG001|Overall Study|Withdrawal by Subject|1|||
124837071|NCT04372602|449033688|FG000|Overall Study|Adverse Event|0|||
124837072|NCT04372602|449033689|FG001|Overall Study|Adverse Event|1|||
124837073|NCT04372602|449033688|FG000|Overall Study|Transitioned to comfort care|0|||
124837074|NCT04372602|449033689|FG001|Overall Study|Transitioned to comfort care|1|||
124837075|NCT00594464|449033690|FG000|Overall Study|Withdrawal by Subject|1|||
124837076|NCT00594464|449033690|FG000|Overall Study|Delay in operation|2|||
124837077|NCT00775437|449033694|FG000|Overall Study|Loss of efficacy|2|||
124837078|NCT00775437|449033694|FG000|Overall Study|Withdrawal by Subject|3|||
124837079|NCT00775437|449033694|FG000|Overall Study|Lost to Follow-up|1|||
124837080|NCT01183975|449033695|FG000|Overall Study|Lost to Follow-up|73|||
124837081|NCT02907359|449033696|FG000|Overall Study|Death|234|||
124837082|NCT02907359|449033697|FG001|Overall Study|Death|117|||
124837083|NCT02907359|449033696|FG000|Overall Study|Withdrawal by Subject|6|||
124837084|NCT02907359|449033697|FG001|Overall Study|Withdrawal by Subject|11|||
124837085|NCT02907359|449033696|FG000|Overall Study|Lost to Follow-up|1|||
124837086|NCT02907359|449033697|FG001|Overall Study|Lost to Follow-up|0|||
125304969|NCT04384523|450742814|FG000|Overall Study|Lost to Follow-up|0|||
125304970|NCT04384523|450742815|FG001|Overall Study|Lost to Follow-up|0|||
124837087|NCT01405963|449033698|FG000|Overall Study|Moved Away|2|||
124837088|NCT01405963|449033699|FG001|Overall Study|Moved Away|0|||
124837089|NCT01405963|449033698|FG000|Overall Study|Adverse Event|0|||
124837090|NCT01405963|449033699|FG001|Overall Study|Adverse Event|1|||
124837091|NCT01405963|449033698|FG000|Overall Study|Lost to Follow-up|0|||
124837092|NCT01405963|449033699|FG001|Overall Study|Lost to Follow-up|1|||
124837093|NCT04371380|449033708|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
124837094|NCT04371380|449033709|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
124837095|NCT04371380|449033710|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
124837096|NCT00680901|449033717|FG000|Overall Study|Ongoing: On Study Treatment|1|||
124837097|NCT00680901|449033718|FG001|Overall Study|Ongoing: On Study Treatment|0|||
124837098|NCT00680901|449033717|FG000|Overall Study|Ongoing: In Follow Up|1|||
124837099|NCT00680901|449033718|FG001|Overall Study|Ongoing: In Follow Up|0|||
124837100|NCT00680901|449033717|FG000|Overall Study|Adverse Event|1|||
124837101|NCT00680901|449033718|FG001|Overall Study|Adverse Event|1|||
124837102|NCT00680901|449033717|FG000|Overall Study|Lost to Follow-up|3|||
124837103|NCT00680901|449033718|FG001|Overall Study|Lost to Follow-up|5|||
124837104|NCT00680901|449033717|FG000|Overall Study|Subject decided to withdraw from the study|4|||
124837105|NCT00680901|449033718|FG001|Overall Study|Subject decided to withdraw from the study|15|||
124837106|NCT00680901|449033717|FG000|Overall Study|Sponsor decision|1|||
124837107|NCT00680901|449033718|FG001|Overall Study|Sponsor decision|0|||
124837108|NCT00680901|449033717|FG000|Overall Study|Physician Decision|0|||
124837109|NCT00680901|449033718|FG001|Overall Study|Physician Decision|2|||
124837110|NCT00680901|449033717|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
124837111|NCT00680901|449033718|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
124837112|NCT00680901|449033717|FG000|Overall Study|Other protocol defined stopping criteria|17|||
124837113|NCT00680901|449033718|FG001|Overall Study|Other protocol defined stopping criteria|17|||
124837114|NCT04544293|449033719|FG000|Double-blind|Adverse Event|2|||
124837115|NCT04544293|449033720|FG001|Double-blind|Adverse Event|1|||
124837116|NCT04544293|449033719|FG000|Double-blind|Pregnancy|0|||
124837117|NCT04544293|449033720|FG001|Double-blind|Pregnancy|1|||
124837118|NCT04544293|449033719|FG000|Double-blind|Lost to Follow-up|0|||
124837119|NCT04544293|449033720|FG001|Double-blind|Lost to Follow-up|1|||
124837120|NCT04544293|449033719|FG000|Open-Label Extension|Study ongoing|79|||
124837121|NCT04544293|449033720|FG001|Open-Label Extension|Study ongoing|81|||
124837122|NCT01951157|449033721|FG000|Overall Study|Progressive Disease|12|||
124837123|NCT01951157|449033722|FG001|Overall Study|Progressive Disease|13|||
124837124|NCT01951157|449033723|FG002|Overall Study|Progressive Disease|10|||
124837125|NCT01951157|449033721|FG000|Overall Study|Treatment-unrelated AE|1|||
124837126|NCT01951157|449033722|FG001|Overall Study|Treatment-unrelated AE|0|||
124837127|NCT01951157|449033723|FG002|Overall Study|Treatment-unrelated AE|3|||
124837128|NCT01951157|449033721|FG000|Overall Study|Study Termination|0|||
124837129|NCT01951157|449033722|FG001|Overall Study|Study Termination|0|||
124837130|NCT01951157|449033723|FG002|Overall Study|Study Termination|1|||
124837131|NCT01951157|449033721|FG000|Overall Study|Physician Decision|5|||
124837132|NCT01951157|449033722|FG001|Overall Study|Physician Decision|3|||
124837133|NCT01951157|449033723|FG002|Overall Study|Physician Decision|2|||
124837134|NCT01951157|449033721|FG000|Overall Study|Non-treatmentrelated death|2|||
124837135|NCT01951157|449033722|FG001|Overall Study|Non-treatmentrelated death|2|||
124837136|NCT01951157|449033723|FG002|Overall Study|Non-treatmentrelated death|2|||
124837137|NCT01951157|449033721|FG000|Overall Study|No treated|0|||
124837138|NCT01951157|449033722|FG001|Overall Study|No treated|1|||
124837139|NCT01951157|449033723|FG002|Overall Study|No treated|0|||
124837140|NCT01951157|449033721|FG000|Overall Study|Treatment-related AE|2|||
124837141|NCT01951157|449033722|FG001|Overall Study|Treatment-related AE|0|||
124837142|NCT01951157|449033723|FG002|Overall Study|Treatment-related AE|4|||
124837143|NCT01951157|449033721|FG000|Overall Study|Consent withdrawn by subject|0|||
124837144|NCT01951157|449033722|FG001|Overall Study|Consent withdrawn by subject|1|||
124837145|NCT01951157|449033723|FG002|Overall Study|Consent withdrawn by subject|3|||
124837146|NCT01951157|449033721|FG000|Overall Study|Treatment-related death|0|||
124837147|NCT01951157|449033722|FG001|Overall Study|Treatment-related death|2|||
124837148|NCT01951157|449033723|FG002|Overall Study|Treatment-related death|0|||
124837149|NCT04809220|449033724|FG000|Overall Study|Adverse Event|4|||
124837150|NCT04809220|449033725|FG001|Overall Study|Adverse Event|0|||
124837151|NCT04809220|449033724|FG000|Overall Study|Death|1|||
124837152|NCT04809220|449033725|FG001|Overall Study|Death|0|||
124837153|NCT04809220|449033724|FG000|Overall Study|Lost to Follow-up|3|||
124837154|NCT04809220|449033725|FG001|Overall Study|Lost to Follow-up|0|||
124837155|NCT04809220|449033724|FG000|Overall Study|Physician Decision|0|||
124837156|NCT04809220|449033725|FG001|Overall Study|Physician Decision|1|||
124837157|NCT04809220|449033724|FG000|Overall Study|Withdrawal by Subject|9|||
124837158|NCT04809220|449033725|FG001|Overall Study|Withdrawal by Subject|5|||
124837159|NCT04809220|449033724|FG000|Overall Study|Due to long-term overseas business trips|1|||
124837160|NCT04809220|449033725|FG001|Overall Study|Due to long-term overseas business trips|0|||
124837161|NCT00329407|449033732|FG000|Overall Study|Withdrawal by Subject|1|||
124837162|NCT00978068|449033733|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
124837163|NCT00978068|449033734|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
124837164|NCT00978068|449033733|FG000|Overall Study|Death|1|||
124837165|NCT00978068|449033734|FG001|Overall Study|Death|2|||
124837166|NCT00978068|449033733|FG000|Overall Study|Lost to Follow-up|1|||
124837167|NCT00978068|449033734|FG001|Overall Study|Lost to Follow-up|2|||
124837168|NCT00978068|449033733|FG000|Overall Study|Physician Decision|0|||
124837169|NCT00978068|449033734|FG001|Overall Study|Physician Decision|1|||
124837170|NCT00978068|449033733|FG000|Overall Study|Unable to Comply with Study|0|||
124837171|NCT00978068|449033734|FG001|Overall Study|Unable to Comply with Study|2|||
124837172|NCT04258605|449033736|FG000|Overall Study|Death|1|||
124837173|NCT04258605|449033737|FG001|Overall Study|Death|0|||
124837174|NCT04258605|449033736|FG000|Overall Study|Early study termination|21|||
124837175|NCT04258605|449033737|FG001|Overall Study|Early study termination|2|||
124837176|NCT01070316|449033752|FG000|Extension Phase|Lack of Efficacy|3|||
124837177|NCT01070316|449033752|FG000|Extension Phase|Withdrawal by Subject|1|||
124837178|NCT01712256|449033753|FG000|Overall Study|Lost to Follow-up|1|||
124837179|NCT00748215|449033756|FG000|Overall Study|Withdrawal by Subject|7|||
124837180|NCT00748215|449033757|FG001|Overall Study|Withdrawal by Subject|7|||
124837181|NCT00748215|449033756|FG000|Overall Study|Treatment change|2|||
124837182|NCT00748215|449033757|FG001|Overall Study|Treatment change|1|||
124837183|NCT00748215|449033756|FG000|Overall Study|Change in patient condition|0|||
124837184|NCT00748215|449033757|FG001|Overall Study|Change in patient condition|3|||
124837185|NCT00748215|449033756|FG000|Overall Study|Non-compliant|0|||
124837186|NCT00748215|449033757|FG001|Overall Study|Non-compliant|2|||
124837187|NCT00748215|449033756|FG000|Overall Study|Adverse Event|0|||
124837188|NCT00748215|449033757|FG001|Overall Study|Adverse Event|5|||
124837189|NCT03200899|449033762|FG000|Overall Study|Lost to Follow-up|10|||
124837190|NCT03200899|449033763|FG001|Overall Study|Lost to Follow-up|23|||
124837191|NCT05083442|449035797|FG000|Overall Study|Lost to Follow-up|1|||
124837192|NCT05083442|449035798|FG001|Overall Study|Lost to Follow-up|0|||
124837193|NCT05083442|449035797|FG000|Overall Study|Lack of Efficacy|0|||
124837194|NCT05083442|449035798|FG001|Overall Study|Lack of Efficacy|1|||
124837195|NCT05083442|449035797|FG000|Overall Study|Withdrawal by Subject|1|||
124837196|NCT05083442|449035798|FG001|Overall Study|Withdrawal by Subject|3|||
124837197|NCT05083442|449035797|FG000|Overall Study|scheduling difficulties|1|||
124837198|NCT05083442|449035798|FG001|Overall Study|scheduling difficulties|2|||
124837199|NCT03711162|449035801|FG000|Overall Study|Adverse Event|5|||
124837200|NCT03711162|449035802|FG001|Overall Study|Adverse Event|2|||
124837201|NCT03711162|449035803|FG002|Overall Study|Adverse Event|4|||
124837202|NCT03711162|449035801|FG000|Overall Study|Death|11|||
124837203|NCT03711162|449035802|FG001|Overall Study|Death|7|||
124837204|NCT03711162|449035803|FG002|Overall Study|Death|8|||
124837205|NCT03711162|449035801|FG000|Overall Study|Lost to Follow-up|1|||
124837206|NCT03711162|449035802|FG001|Overall Study|Lost to Follow-up|0|||
124837207|NCT03711162|449035803|FG002|Overall Study|Lost to Follow-up|1|||
124837208|NCT03711162|449035801|FG000|Overall Study|Study Terminated by Sponsor|139|||
124837209|NCT03711162|449035802|FG001|Overall Study|Study Terminated by Sponsor|152|||
124837210|NCT03711162|449035803|FG002|Overall Study|Study Terminated by Sponsor|146|||
124837211|NCT03711162|449035801|FG000|Overall Study|Withdrawal by Subject|17|||
124837212|NCT03711162|449035802|FG001|Overall Study|Withdrawal by Subject|10|||
124837213|NCT03711162|449035803|FG002|Overall Study|Withdrawal by Subject|10|||
124837214|NCT03711162|449035801|FG000|Overall Study|Miscellaneous|1|||
124837215|NCT03711162|449035802|FG001|Overall Study|Miscellaneous|2|||
124837216|NCT03711162|449035803|FG002|Overall Study|Miscellaneous|2|||
124837217|NCT03711162|449035801|FG000|Overall Study|Not Treated|1|||
124837218|NCT03711162|449035802|FG001|Overall Study|Not Treated|0|||
124837219|NCT03711162|449035803|FG002|Overall Study|Not Treated|1|||
124837220|NCT03711162|449035801|FG000|Overall Study|Physician Decision|0|||
124837221|NCT03711162|449035802|FG001|Overall Study|Physician Decision|2|||
124837222|NCT03711162|449035803|FG002|Overall Study|Physician Decision|0|||
124837223|NCT03711162|449035801|FG000|Overall Study|Lack of Efficacy|0|||
124837224|NCT03711162|449035802|FG001|Overall Study|Lack of Efficacy|0|||
124837225|NCT03711162|449035803|FG002|Overall Study|Lack of Efficacy|2|||
124837226|NCT03711162|449035801|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
124837227|NCT03711162|449035802|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
124837228|NCT03711162|449035803|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
124837229|NCT03034954|449035807|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
124837230|NCT03034954|449035808|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
124837231|NCT05228470|449035811|FG000|Overall Study|Death|6|||
124837232|NCT05228470|449035812|FG001|Overall Study|Death|11|||
124837233|NCT05228470|449035811|FG000|Overall Study|Withdrawal by Subject|1|||
124837234|NCT05228470|449035812|FG001|Overall Study|Withdrawal by Subject|8|||
124837235|NCT05228470|449035811|FG000|Overall Study|Ongoing|1|||
124837236|NCT05228470|449035812|FG001|Overall Study|Ongoing|11|||
124837237|NCT00136084|449035813|FG000|Overall Study|Death|12|||
124837238|NCT00136084|449035814|FG001|Overall Study|Death|5|||
125304971|NCT04384523|450742816|FG002|Overall Study|Lost to Follow-up|0|||
124837239|NCT00136084|449035813|FG000|Overall Study|Unacceptable toxicity|8|||
124837240|NCT00136084|449035814|FG001|Overall Study|Unacceptable toxicity|11|||
124837241|NCT00136084|449035813|FG000|Overall Study|Relapse|20|||
124837242|NCT00136084|449035814|FG001|Overall Study|Relapse|23|||
124837243|NCT00136084|449035813|FG000|Overall Study|Lost to Follow-up|2|||
124837244|NCT00136084|449035814|FG001|Overall Study|Lost to Follow-up|0|||
124837245|NCT00136084|449035813|FG000|Overall Study|No Response|1|||
124837246|NCT00136084|449035814|FG001|Overall Study|No Response|2|||
124837247|NCT00136084|449035813|FG000|Overall Study|Withdrawal by Subject|5|||
124837248|NCT00136084|449035814|FG001|Overall Study|Withdrawal by Subject|1|||
124837249|NCT02449239|449035815|FG000|Induction Phase|Lack of Efficacy|64|||
124837250|NCT02449239|449035815|FG000|Induction Phase|Adverse Event|1|||
124837251|NCT02449239|449035815|FG000|Induction Phase|Lost to Follow-up|1|||
124837252|NCT02449239|449035815|FG000|Induction Phase|Protocol Violation|1|||
124837253|NCT02449239|449035815|FG000|Induction Phase|Physician Decision|1|||
124837254|NCT02449239|449035815|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
124837255|NCT02449239|449035815|FG000|Induction Phase|Withdrawal by Subject|1|||
124837256|NCT02449239|449035815|FG000|Maintenance Month 3|Lack of Efficacy|14|||
124837257|NCT02449239|449035815|FG000|Maintenance Month 6|Lack of Efficacy|10|||
124837258|NCT02449239|449035815|FG000|Maintenance Month 6|Adverse Event|2|||
124837259|NCT02449239|449035815|FG000|Maintenance Month 6|Physician Decision|1|||
124837260|NCT02449239|449035815|FG000|Maintenance Month 9|Lack of Efficacy|2|||
124837261|NCT02449239|449035815|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
124837262|NCT02449239|449035815|FG000|Maintenance Month 12|Lack of Efficacy|5|||
124837263|NCT02449239|449035815|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
124837264|NCT02449239|449035815|FG000|Maintenance Month 12|Subject moved from area|1|||
124837265|NCT02449239|449035815|FG000|Maintenance Month 15|Lack of Efficacy|1|||
124837266|NCT02449239|449035815|FG000|Maintenance Month 21|Lack of Efficacy|1|||
124837267|NCT02449239|449035815|FG000|Maintenance Month 21|Sponsor decision|1|||
124837268|NCT00394212|449035817|FG000|Overall Study|Lost to Follow-up|3|||
124837269|NCT00394212|449035818|FG001|Overall Study|Lost to Follow-up|0|||
124837270|NCT00394212|449035817|FG000|Overall Study|Withdrawal by Subject|4|||
124837271|NCT00394212|449035818|FG001|Overall Study|Withdrawal by Subject|1|||
124837272|NCT00588445|449035819|FG000|Overall Study|Protocol Violation|1|||
124837273|NCT00588445|449035819|FG000|Overall Study|Withdrawal by Subject|3|||
124837274|NCT00588445|449035819|FG000|Overall Study|Disease Progression|1|||
124837275|NCT00588445|449035819|FG000|Overall Study|Not Treated|10|||
124837276|NCT03240133|449035820|FG000|Overall Study|Withdrawal by Subject|0|||
124837277|NCT03240133|449035821|FG001|Overall Study|Withdrawal by Subject|1|||
124837278|NCT03240133|449035822|FG002|Overall Study|Withdrawal by Subject|0|||
124837279|NCT03240133|449035820|FG000|Overall Study|Adverse Event|1|||
124837280|NCT03240133|449035821|FG001|Overall Study|Adverse Event|1|||
124837281|NCT03240133|449035822|FG002|Overall Study|Adverse Event|0|||
124837282|NCT03240133|449035820|FG000|Overall Study|Rash|1|||
124837283|NCT03240133|449035821|FG001|Overall Study|Rash|0|||
124837284|NCT03240133|449035822|FG002|Overall Study|Rash|0|||
124837285|NCT03240133|449035820|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
124837286|NCT03240133|449035821|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
124837287|NCT03240133|449035822|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
124837288|NCT03240133|449035820|FG000|Overall Study|Intercurrent illness.|0|||
124837289|NCT03240133|449035821|FG001|Overall Study|Intercurrent illness.|1|||
124837290|NCT03240133|449035822|FG002|Overall Study|Intercurrent illness.|0|||
124837291|NCT03240133|449035820|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
124837292|NCT03240133|449035821|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
124837293|NCT03240133|449035822|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
124837294|NCT01176292|449035823|FG000|Overall Study|Lost to Follow-up|2|||
124837295|NCT01176292|449035824|FG001|Overall Study|Lost to Follow-up|4|||
124837296|NCT01176292|449035823|FG000|Overall Study|Adverse Event|1|||
124837297|NCT01176292|449035824|FG001|Overall Study|Adverse Event|1|||
124837298|NCT01176292|449035823|FG000|Overall Study|Physician Decision|0|||
124837299|NCT01176292|449035824|FG001|Overall Study|Physician Decision|2|||
124837300|NCT01176292|449035823|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
124837301|NCT01176292|449035824|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
124837302|NCT00997503|449035825|FG000|Overall Study|Death|53|||
124837303|NCT00997503|449035825|FG000|Overall Study|Withdrawal by Subject|76|||
124837304|NCT00997503|449035825|FG000|Overall Study|Lost to Follow-up|33|||
124837305|NCT00997503|449035825|FG000|Overall Study|Adverse Event|3|||
124837306|NCT00997503|449035825|FG000|Overall Study|Physician Decision|10|||
124837307|NCT00997503|449035825|FG000|Overall Study|Missed 12-month follow-up|85|||
125304972|NCT04384523|450742817|FG003|Overall Study|Lost to Follow-up|0|||
125304973|NCT04384523|450742818|FG004|Overall Study|Lost to Follow-up|0|||
125304974|NCT04384523|450742819|FG005|Overall Study|Lost to Follow-up|1|||
125304975|NCT04384523|450742814|FG000|Overall Study|Protocol Violation|0|||
125304976|NCT04384523|450742815|FG001|Overall Study|Protocol Violation|1|||
125304977|NCT04384523|450742816|FG002|Overall Study|Protocol Violation|0|||
125304978|NCT04384523|450742817|FG003|Overall Study|Protocol Violation|0|||
125304979|NCT04384523|450742818|FG004|Overall Study|Protocol Violation|0|||
125304980|NCT04384523|450742819|FG005|Overall Study|Protocol Violation|0|||
125304981|NCT04384523|450742814|FG000|Overall Study|Withdrawal by Subject|1|||
125304982|NCT04384523|450742815|FG001|Overall Study|Withdrawal by Subject|0|||
125304983|NCT04384523|450742816|FG002|Overall Study|Withdrawal by Subject|0|||
125304984|NCT04384523|450742817|FG003|Overall Study|Withdrawal by Subject|0|||
124837308|NCT00997503|449035825|FG000|Overall Study|Other reason|13|||
124837309|NCT00116831|449035826|FG000|Overall Study|Adverse Event|14|||
124837310|NCT00116831|449035827|FG001|Overall Study|Adverse Event|16|||
124837311|NCT00116831|449035826|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
124837312|NCT00116831|449035827|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
124837313|NCT00116831|449035826|FG000|Overall Study|Lost to Follow-up|8|||
124837314|NCT00116831|449035827|FG001|Overall Study|Lost to Follow-up|6|||
124837315|NCT00116831|449035826|FG000|Overall Study|Protocol Violation|3|||
124837316|NCT00116831|449035827|FG001|Overall Study|Protocol Violation|6|||
124837317|NCT00116831|449035826|FG000|Overall Study|Hypoglycaemic events|1|||
124837318|NCT00116831|449035827|FG001|Overall Study|Hypoglycaemic events|0|||
124837319|NCT00116831|449035826|FG000|Overall Study|Low haemoglobin on screening|1|||
124837320|NCT00116831|449035827|FG001|Overall Study|Low haemoglobin on screening|0|||
124837321|NCT00116831|449035826|FG000|Overall Study|Withdrawn investigational product|1|||
124837322|NCT00116831|449035827|FG001|Overall Study|Withdrawn investigational product|0|||
124837323|NCT00116831|449035826|FG000|Overall Study|Withdrawal by Subject|32|||
124837324|NCT00116831|449035827|FG001|Overall Study|Withdrawal by Subject|32|||
124837325|NCT00116831|449035826|FG000|Overall Study|Insufficient therapeutic effect|0|||
124837326|NCT00116831|449035827|FG001|Overall Study|Insufficient therapeutic effect|1|||
124837327|NCT00116831|449035826|FG000|Overall Study|Missing data for participant|1|||
124837328|NCT00116831|449035827|FG001|Overall Study|Missing data for participant|0|||
124837329|NCT01933048|449035828|FG000|Overall Study|Lost to Follow-up|15|||
124837330|NCT01933048|449035829|FG001|Overall Study|Lost to Follow-up|18|||
124837331|NCT01933048|449035828|FG000|Overall Study|personal reasons|1|||
124837332|NCT01933048|449035829|FG001|Overall Study|personal reasons|1|||
124837333|NCT01933048|449035828|FG000|Overall Study|Protocol Violation|7|||
124837334|NCT01933048|449035829|FG001|Overall Study|Protocol Violation|8|||
124837335|NCT01933048|449035828|FG000|Overall Study|Physician Decision|1|||
124837336|NCT01933048|449035829|FG001|Overall Study|Physician Decision|0|||
124837337|NCT01933048|449035828|FG000|Overall Study|unknown reasons|1|||
124837338|NCT01933048|449035829|FG001|Overall Study|unknown reasons|1|||
124837339|NCT00110812|449035830|FG000|Main Study|Death|0|||
124837340|NCT00110812|449035831|FG001|Main Study|Death|0|||
124837341|NCT00110812|449035832|FG002|Main Study|Death|2|||
124837342|NCT00110812|449035830|FG000|Main Study|Withdrawal by Subject|0|||
124837343|NCT00110812|449035831|FG001|Main Study|Withdrawal by Subject|0|||
124837344|NCT00110812|449035832|FG002|Main Study|Withdrawal by Subject|1|||
124837345|NCT00110812|449035830|FG000|Main Study|Lost to Follow-up|8|||
124837346|NCT00110812|449035831|FG001|Main Study|Lost to Follow-up|11|||
124837347|NCT00110812|449035832|FG002|Main Study|Lost to Follow-up|10|||
124837348|NCT00110812|449035830|FG000|Extended Follow-up|Death|1|||
124837349|NCT00110812|449035831|FG001|Extended Follow-up|Death|0|||
124837350|NCT00110812|449035832|FG002|Extended Follow-up|Death|3|||
124837351|NCT00110812|449035830|FG000|Extended Follow-up|Withdrawal by Subject|0|||
124837352|NCT00110812|449035831|FG001|Extended Follow-up|Withdrawal by Subject|1|||
124837353|NCT00110812|449035832|FG002|Extended Follow-up|Withdrawal by Subject|0|||
124837354|NCT00110812|449035830|FG000|Extended Follow-up|Lost to Follow-up|1|||
124837355|NCT00110812|449035831|FG001|Extended Follow-up|Lost to Follow-up|3|||
124837356|NCT00110812|449035832|FG002|Extended Follow-up|Lost to Follow-up|1|||
124837357|NCT00380393|449035833|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
124837358|NCT00380393|449035834|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
124837359|NCT00380393|449035833|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
124837360|NCT00380393|449035834|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
124837361|NCT00380393|449035833|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
124837362|NCT00380393|449035834|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
124837363|NCT00380393|449035833|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
124837364|NCT00380393|449035834|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
124837365|NCT00380393|449035833|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
124837366|NCT00380393|449035834|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
124837367|NCT00380393|449035833|FG000|Month 14|Withdrawal by Subject|9|||
124837368|NCT00380393|449035834|FG001|Month 14|Withdrawal by Subject|7|||
124837369|NCT00380393|449035833|FG000|Month 14|Death|1|||
124837370|NCT00380393|449035834|FG001|Month 14|Death|0|||
124837371|NCT00380393|449035833|FG000|Month 14|Lost to Follow-up|0|||
124837372|NCT00380393|449035834|FG001|Month 14|Lost to Follow-up|1|||
124837373|NCT00380393|449035833|FG000|Month 14|Migrated/moved from study area|39|||
124837374|NCT00380393|449035834|FG001|Month 14|Migrated/moved from study area|42|||
124837375|NCT00380393|449035833|FG000|Month 14|Protocol Violation|2|||
124837376|NCT00380393|449035834|FG001|Month 14|Protocol Violation|0|||
124837377|NCT00380393|449035833|FG000|Month 14|Others|6|||
124837378|NCT00380393|449035834|FG001|Month 14|Others|6|||
124837379|NCT02780804|449035837|FG000|Overall Study|Death|1|||
124837380|NCT02780804|449035838|FG001|Overall Study|Death|0|||
124837381|NCT02780804|449035839|FG002|Overall Study|Death|0|||
124837382|NCT02780804|449035837|FG000|Overall Study|Lack of Efficacy|5|||
124837383|NCT02780804|449035838|FG001|Overall Study|Lack of Efficacy|8|||
124837384|NCT02780804|449035839|FG002|Overall Study|Lack of Efficacy|4|||
124837385|NCT02780804|449035837|FG000|Overall Study|Physician Decision|0|||
124837386|NCT02780804|449035838|FG001|Overall Study|Physician Decision|0|||
124837387|NCT02780804|449035839|FG002|Overall Study|Physician Decision|2|||
124837388|NCT02780804|449035837|FG000|Overall Study|Withdrawal by Subject|0|||
124837389|NCT02780804|449035838|FG001|Overall Study|Withdrawal by Subject|1|||
124837390|NCT02780804|449035839|FG002|Overall Study|Withdrawal by Subject|0|||
124837391|NCT02476968|449035840|FG000|Overall Study|Other|0|||
124837392|NCT02476968|449035841|FG001|Overall Study|Other|2|||
124837393|NCT02476968|449035842|FG002|Overall Study|Other|0|||
124837394|NCT02476968|449035840|FG000|Overall Study|Lost to Follow-up|10|||
124837395|NCT02476968|449035841|FG001|Overall Study|Lost to Follow-up|0|||
124837396|NCT02476968|449035842|FG002|Overall Study|Lost to Follow-up|1|||
124837397|NCT02476968|449035840|FG000|Overall Study|Death|48|||
124837398|NCT02476968|449035841|FG001|Overall Study|Death|8|||
124837399|NCT02476968|449035842|FG002|Overall Study|Death|1|||
124837400|NCT02476968|449035840|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124837401|NCT02476968|449035841|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
124837402|NCT02476968|449035842|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
124837403|NCT02476968|449035840|FG000|Overall Study|Patient decision|37|||
124837404|NCT02476968|449035841|FG001|Overall Study|Patient decision|8|||
124837405|NCT02476968|449035842|FG002|Overall Study|Patient decision|0|||
124837406|NCT01723163|449035843|FG000|Treatment Phase|Withdrawal by Subject|14|||
124837407|NCT01723163|449035844|FG001|Treatment Phase|Withdrawal by Subject|6|||
124837408|NCT01723163|449035843|FG000|Treatment Phase|Withdrawal by PI|5|||
124837409|NCT01723163|449035844|FG001|Treatment Phase|Withdrawal by PI|1|||
124837410|NCT01723163|449035843|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
124837411|NCT01723163|449035844|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
124837412|NCT01723163|449035843|FG000|3-Month Follow-up|Unable to Contact|12|||
124837413|NCT01723163|449035844|FG001|3-Month Follow-up|Unable to Contact|19|||
124837414|NCT01723163|449035843|FG000|6-Month Follow-up|Death|1|||
124837415|NCT01723163|449035844|FG001|6-Month Follow-up|Death|0|||
124837416|NCT01723163|449035843|FG000|6-Month Follow-up|Unable to Contact|17|||
124837417|NCT01723163|449035844|FG001|6-Month Follow-up|Unable to Contact|15|||
124837418|NCT01723163|449035843|FG000|12-Month Follow-up|Death|1|||
124837419|NCT01723163|449035844|FG001|12-Month Follow-up|Death|0|||
124837420|NCT01723163|449035843|FG000|12-Month Follow-up|Unable to Contact|23|||
124837421|NCT01723163|449035844|FG001|12-Month Follow-up|Unable to Contact|28|||
124837422|NCT01859507|449035847|FG000|Overall Study|left the country|4|||
124837423|NCT01921829|449035848|FG000|Overall Study|Withdrawal by Subject|0|||
124837424|NCT01921829|449035849|FG001|Overall Study|Withdrawal by Subject|1|||
124837425|NCT04476030|449035850|FG000|Overall Study|Withdrawal by Subject|20|||
124837426|NCT04476030|449035851|FG001|Overall Study|Withdrawal by Subject|16|||
124837427|NCT04476030|449035850|FG000|Overall Study|Adverse Event|10|||
124837428|NCT04476030|449035851|FG001|Overall Study|Adverse Event|11|||
124837429|NCT04476030|449035850|FG000|Overall Study|Lost to Follow-up|7|||
124837430|NCT04476030|449035851|FG001|Overall Study|Lost to Follow-up|4|||
124837431|NCT04476030|449035850|FG000|Overall Study|Physician Decision|1|||
124837432|NCT04476030|449035851|FG001|Overall Study|Physician Decision|1|||
124837433|NCT04476030|449035850|FG000|Overall Study|Protocol Deviation|2|||
124837434|NCT04476030|449035851|FG001|Overall Study|Protocol Deviation|0|||
124837435|NCT04476030|449035850|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
124837436|NCT04476030|449035851|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
124837437|NCT04476030|449035850|FG000|Overall Study|Randomized but not Dosed|2|||
124837438|NCT04476030|449035851|FG001|Overall Study|Randomized but not Dosed|8|||
124837439|NCT02404311|449035852|FG000|Part A: Month 0-18|Death|2|||
124837440|NCT02404311|449035853|FG001|Part A: Month 0-18|Death|0|||
124837441|NCT02404311|449035854|FG002|Part A: Month 0-18|Death|0|||
124837442|NCT02404311|449035855|FG003|Part A: Month 0-18|Death|0|||
124837443|NCT02404311|449035856|FG004|Part A: Month 0-18|Death|0|||
124837444|NCT02404311|449035852|FG000|Part A: Month 0-18|Physician Decision|1|||
124837445|NCT02404311|449035853|FG001|Part A: Month 0-18|Physician Decision|0|||
124837446|NCT02404311|449035854|FG002|Part A: Month 0-18|Physician Decision|0|||
124837447|NCT02404311|449035855|FG003|Part A: Month 0-18|Physician Decision|0|||
124837448|NCT02404311|449035856|FG004|Part A: Month 0-18|Physician Decision|0|||
124837449|NCT02404311|449035852|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
124837450|NCT02404311|449035853|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
124837451|NCT02404311|449035854|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
124837452|NCT02404311|449035855|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
124837453|NCT02404311|449035856|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
125304985|NCT04384523|450742818|FG004|Overall Study|Withdrawal by Subject|0|||
124837454|NCT02404311|449035852|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
124837455|NCT02404311|449035853|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
124837456|NCT02404311|449035854|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
124837457|NCT02404311|449035855|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
124837458|NCT02404311|449035856|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
124837459|NCT02404311|449035852|FG000|Part A: Month 0-18|HIV Infection|6|||
124837460|NCT02404311|449035853|FG001|Part A: Month 0-18|HIV Infection|2|||
124837461|NCT02404311|449035854|FG002|Part A: Month 0-18|HIV Infection|0|||
124837462|NCT02404311|449035855|FG003|Part A: Month 0-18|HIV Infection|0|||
124837463|NCT02404311|449035856|FG004|Part A: Month 0-18|HIV Infection|0|||
124837464|NCT02404311|449035852|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
124837465|NCT02404311|449035853|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
124837466|NCT02404311|449035854|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
124837467|NCT02404311|449035855|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
124837468|NCT02404311|449035856|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
124837469|NCT02256891|449035861|FG000|Overall Study|Death|0|||
124837470|NCT02256891|449035862|FG001|Overall Study|Death|2|||
124837471|NCT02256891|449035861|FG000|Overall Study|Lost to Follow-up|0|||
124837472|NCT02256891|449035862|FG001|Overall Study|Lost to Follow-up|3|||
124837473|NCT02256891|449035861|FG000|Overall Study|Physician Decision|7|||
124837474|NCT02256891|449035862|FG001|Overall Study|Physician Decision|3|||
124837475|NCT02256891|449035861|FG000|Overall Study|Screen Fail|5|||
124837476|NCT02256891|449035862|FG001|Overall Study|Screen Fail|4|||
124837477|NCT02256891|449035861|FG000|Overall Study|Equipment Malfunction|0|||
124837478|NCT02256891|449035862|FG001|Overall Study|Equipment Malfunction|1|||
124837479|NCT01344447|449035863|FG000|Overall Study|Adverse Event|1|||
124837480|NCT01344447|449035863|FG000|Overall Study|Protocol Violation|1|||
124837481|NCT01344447|449035863|FG000|Overall Study|Withdrawal by Subject|1|||
124837482|NCT01344447|449035863|FG000|Overall Study|The contrast was not seen|1|||
124837483|NCT01344447|449035863|FG000|Overall Study|Physician Decision|1|||
124837484|NCT01344447|449035863|FG000|Overall Study|MRA unsuccessful|1|||
124837485|NCT01344447|449035863|FG000|Overall Study|Bolus tracking failed|1|||
124837486|NCT01344447|449035863|FG000|Overall Study|Error of power injector|1|||
124837487|NCT00218296|449035864|FG000|Overall Study|Lost to Follow-up|9|||
124837488|NCT00218296|449035865|FG001|Overall Study|Lost to Follow-up|7|||
124837489|NCT00218296|449035864|FG000|Overall Study|Withdrawal by Subject|36|||
124837490|NCT00218296|449035865|FG001|Overall Study|Withdrawal by Subject|47|||
124837491|NCT00218296|449035864|FG000|Overall Study|Randomized but did not enter treatment|66|||
124837492|NCT00218296|449035865|FG001|Overall Study|Randomized but did not enter treatment|67|||
124837493|NCT01293240|449035871|FG000|Overall Study|Noncompliance|2|||
124837494|NCT01364428|449035879|FG000|Overall Study|Adverse Event|1|||
124837495|NCT01364428|449035880|FG001|Overall Study|Adverse Event|2|||
124837496|NCT01364428|449035879|FG000|Overall Study|Protocol Violation|2|||
124837497|NCT01364428|449035880|FG001|Overall Study|Protocol Violation|0|||
124837498|NCT01364428|449035879|FG000|Overall Study|Withdrawal Criteria|14|||
124837499|NCT01364428|449035880|FG001|Overall Study|Withdrawal Criteria|10|||
124837500|NCT01364428|449035879|FG000|Overall Study|Other|3|||
124837501|NCT01364428|449035880|FG001|Overall Study|Other|3|||
124837502|NCT00228917|449035881|FG000|Overall Study|Migrated/moved from study area|0|||
124837503|NCT00228917|449035882|FG001|Overall Study|Migrated/moved from study area|0|||
124837504|NCT00228917|449035883|FG002|Overall Study|Migrated/moved from study area|0|||
124837505|NCT00228917|449035884|FG003|Overall Study|Migrated/moved from study area|0|||
124837506|NCT00228917|449035885|FG004|Overall Study|Migrated/moved from study area|0|||
124837507|NCT00228917|449035886|FG005|Overall Study|Migrated/moved from study area|2|||
124837508|NCT00228917|449035887|FG006|Overall Study|Migrated/moved from study area|0|||
124837509|NCT00228917|449035888|FG007|Overall Study|Migrated/moved from study area|0|||
124837510|NCT03131440|449035890|FG000|Overall Study|Withdrawal by Subject|1|||
124837511|NCT03131440|449035891|FG001|Overall Study|Withdrawal by Subject|3|||
124837512|NCT03131440|449035892|FG002|Overall Study|Withdrawal by Subject|0|||
124837513|NCT03131440|449035893|FG003|Overall Study|Withdrawal by Subject|0|||
124837514|NCT03131440|449035894|FG004|Overall Study|Withdrawal by Subject|1|||
124837515|NCT03131440|449035895|FG005|Overall Study|Withdrawal by Subject|0|||
124837516|NCT03131440|449035896|FG006|Overall Study|Withdrawal by Subject|0|||
124837517|NCT03131440|449035897|FG007|Overall Study|Withdrawal by Subject|1|||
124837518|NCT03131440|449035898|FG008|Overall Study|Withdrawal by Subject|1|||
124837519|NCT03131440|449035899|FG009|Overall Study|Withdrawal by Subject|1|||
124837520|NCT03131440|449035900|FG010|Overall Study|Withdrawal by Subject|0|||
124837521|NCT03131440|449035901|FG011|Overall Study|Withdrawal by Subject|1|||
124837522|NCT03131440|449035902|FG012|Overall Study|Withdrawal by Subject|1|||
124837523|NCT03131440|449035903|FG013|Overall Study|Withdrawal by Subject|0|||
124837524|NCT03131440|449035904|FG014|Overall Study|Withdrawal by Subject|1|||
124837525|NCT03131440|449035905|FG015|Overall Study|Withdrawal by Subject|0|||
124837526|NCT03131440|449035906|FG016|Overall Study|Withdrawal by Subject|0|||
124837527|NCT03131440|449035907|FG017|Overall Study|Withdrawal by Subject|0|||
124837528|NCT03131440|449035908|FG018|Overall Study|Withdrawal by Subject|1|||
124837529|NCT03131440|449035909|FG019|Overall Study|Withdrawal by Subject|0|||
124837530|NCT03131440|449035910|FG020|Overall Study|Withdrawal by Subject|1|||
124837531|NCT03131440|449035911|FG021|Overall Study|Withdrawal by Subject|1|||
124837532|NCT03131440|449035912|FG022|Overall Study|Withdrawal by Subject|1|||
124837533|NCT03131440|449035913|FG023|Overall Study|Withdrawal by Subject|0|||
124837534|NCT03131440|449035914|FG024|Overall Study|Withdrawal by Subject|0|||
124837535|NCT03131440|449035915|FG025|Overall Study|Withdrawal by Subject|0|||
124837536|NCT03131440|449035916|FG026|Overall Study|Withdrawal by Subject|0|||
124837537|NCT03131440|449035917|FG027|Overall Study|Withdrawal by Subject|0|||
124837538|NCT03131440|449035918|FG028|Overall Study|Withdrawal by Subject|0|||
124837539|NCT03131440|449035919|FG029|Overall Study|Withdrawal by Subject|0|||
124837540|NCT03131440|449035920|FG030|Overall Study|Withdrawal by Subject|1|||
124837541|NCT03131440|449035921|FG031|Overall Study|Withdrawal by Subject|0|||
124837542|NCT03131440|449035890|FG000|Overall Study|Lost to Follow-up|0|||
124837543|NCT03131440|449035891|FG001|Overall Study|Lost to Follow-up|0|||
124837544|NCT03131440|449035892|FG002|Overall Study|Lost to Follow-up|0|||
124837545|NCT03131440|449035893|FG003|Overall Study|Lost to Follow-up|0|||
125304986|NCT04384523|450742819|FG005|Overall Study|Withdrawal by Subject|0|||
125304987|NCT04405076|450742820|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
125304988|NCT04405076|450742821|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
125304989|NCT04405076|450742822|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
125304990|NCT04405076|450742823|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
125304991|NCT04405076|450742824|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
125304992|NCT04405076|450742825|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
125304993|NCT04405076|450742826|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
124837546|NCT03131440|449035894|FG004|Overall Study|Lost to Follow-up|0|||
124837547|NCT03131440|449035895|FG005|Overall Study|Lost to Follow-up|1|||
124837548|NCT03131440|449035896|FG006|Overall Study|Lost to Follow-up|0|||
124837549|NCT03131440|449035897|FG007|Overall Study|Lost to Follow-up|0|||
124837550|NCT03131440|449035898|FG008|Overall Study|Lost to Follow-up|0|||
124837551|NCT03131440|449035899|FG009|Overall Study|Lost to Follow-up|0|||
124837552|NCT03131440|449035900|FG010|Overall Study|Lost to Follow-up|0|||
124837553|NCT03131440|449035901|FG011|Overall Study|Lost to Follow-up|0|||
124837554|NCT03131440|449035902|FG012|Overall Study|Lost to Follow-up|0|||
124837555|NCT03131440|449035903|FG013|Overall Study|Lost to Follow-up|0|||
124837556|NCT03131440|449035904|FG014|Overall Study|Lost to Follow-up|0|||
124837557|NCT03131440|449035905|FG015|Overall Study|Lost to Follow-up|0|||
124837558|NCT03131440|449035906|FG016|Overall Study|Lost to Follow-up|0|||
124837559|NCT03131440|449035907|FG017|Overall Study|Lost to Follow-up|0|||
124837560|NCT03131440|449035908|FG018|Overall Study|Lost to Follow-up|0|||
124837561|NCT03131440|449035909|FG019|Overall Study|Lost to Follow-up|2|||
124837562|NCT03131440|449035910|FG020|Overall Study|Lost to Follow-up|1|||
124837563|NCT03131440|449035911|FG021|Overall Study|Lost to Follow-up|0|||
124837564|NCT03131440|449035912|FG022|Overall Study|Lost to Follow-up|1|||
124837565|NCT03131440|449035913|FG023|Overall Study|Lost to Follow-up|0|||
124837566|NCT03131440|449035914|FG024|Overall Study|Lost to Follow-up|1|||
124837567|NCT03131440|449035915|FG025|Overall Study|Lost to Follow-up|0|||
124837568|NCT03131440|449035916|FG026|Overall Study|Lost to Follow-up|0|||
124837569|NCT03131440|449035917|FG027|Overall Study|Lost to Follow-up|2|||
124837570|NCT03131440|449035918|FG028|Overall Study|Lost to Follow-up|0|||
124837571|NCT03131440|449035919|FG029|Overall Study|Lost to Follow-up|2|||
124837572|NCT03131440|449035920|FG030|Overall Study|Lost to Follow-up|0|||
124837573|NCT03131440|449035921|FG031|Overall Study|Lost to Follow-up|0|||
124837574|NCT03131440|449035890|FG000|Overall Study|Death|0|||
124837575|NCT03131440|449035891|FG001|Overall Study|Death|0|||
124837576|NCT03131440|449035892|FG002|Overall Study|Death|0|||
124837577|NCT03131440|449035893|FG003|Overall Study|Death|0|||
124837578|NCT03131440|449035894|FG004|Overall Study|Death|0|||
124837579|NCT03131440|449035895|FG005|Overall Study|Death|0|||
124837580|NCT03131440|449035896|FG006|Overall Study|Death|0|||
124837581|NCT03131440|449035897|FG007|Overall Study|Death|0|||
124837582|NCT03131440|449035898|FG008|Overall Study|Death|0|||
124837583|NCT03131440|449035899|FG009|Overall Study|Death|0|||
124837584|NCT03131440|449035900|FG010|Overall Study|Death|0|||
124837585|NCT03131440|449035901|FG011|Overall Study|Death|0|||
124837586|NCT03131440|449035902|FG012|Overall Study|Death|0|||
124837587|NCT03131440|449035903|FG013|Overall Study|Death|0|||
124837588|NCT03131440|449035904|FG014|Overall Study|Death|0|||
124837589|NCT03131440|449035905|FG015|Overall Study|Death|0|||
124837590|NCT03131440|449035906|FG016|Overall Study|Death|0|||
124837591|NCT03131440|449035907|FG017|Overall Study|Death|0|||
124837592|NCT03131440|449035908|FG018|Overall Study|Death|0|||
124837593|NCT03131440|449035909|FG019|Overall Study|Death|0|||
124837594|NCT03131440|449035910|FG020|Overall Study|Death|0|||
124837595|NCT03131440|449035911|FG021|Overall Study|Death|0|||
124837596|NCT03131440|449035912|FG022|Overall Study|Death|0|||
124837597|NCT03131440|449035913|FG023|Overall Study|Death|0|||
124837598|NCT03131440|449035914|FG024|Overall Study|Death|0|||
124837599|NCT03131440|449035915|FG025|Overall Study|Death|1|||
124837600|NCT03131440|449035916|FG026|Overall Study|Death|0|||
124837601|NCT03131440|449035917|FG027|Overall Study|Death|0|||
124837602|NCT03131440|449035918|FG028|Overall Study|Death|0|||
124837603|NCT03131440|449035919|FG029|Overall Study|Death|0|||
124837604|NCT03131440|449035920|FG030|Overall Study|Death|0|||
124837605|NCT03131440|449035921|FG031|Overall Study|Death|0|||
124837606|NCT00746941|449035924|FG000|Overall Study|Death|2|||
124837607|NCT00746941|449035925|FG001|Overall Study|Death|0|||
124837608|NCT00746941|449035926|FG002|Overall Study|Death|0|||
124837609|NCT00746941|449035927|FG003|Overall Study|Death|6|||
124837610|NCT00746941|449035924|FG000|Overall Study|Physician Decision|0|||
124837611|NCT00746941|449035925|FG001|Overall Study|Physician Decision|0|||
124837612|NCT00746941|449035926|FG002|Overall Study|Physician Decision|2|||
124837613|NCT00746941|449035927|FG003|Overall Study|Physician Decision|0|||
124837614|NCT00746941|449035924|FG000|Overall Study|Withdrawal by Subject|3|||
124837615|NCT00746941|449035925|FG001|Overall Study|Withdrawal by Subject|0|||
124837616|NCT00746941|449035926|FG002|Overall Study|Withdrawal by Subject|0|||
124837617|NCT00746941|449035927|FG003|Overall Study|Withdrawal by Subject|2|||
124837618|NCT00746941|449035924|FG000|Overall Study|Other, reason not provided|2|||
124837619|NCT00746941|449035925|FG001|Overall Study|Other, reason not provided|4|||
124837620|NCT00746941|449035926|FG002|Overall Study|Other, reason not provided|0|||
124837621|NCT00746941|449035927|FG003|Overall Study|Other, reason not provided|4|||
124837622|NCT00746941|449035924|FG000|Overall Study|Adverse Event|0|||
124837623|NCT00746941|449035925|FG001|Overall Study|Adverse Event|0|||
124837624|NCT00746941|449035926|FG002|Overall Study|Adverse Event|0|||
124837625|NCT00746941|449035927|FG003|Overall Study|Adverse Event|1|||
124837626|NCT03190889|449035933|FG000|Overall Study|Lost to Follow-up|7|||
124837627|NCT03190889|449035934|FG001|Overall Study|Lost to Follow-up|7|||
124837628|NCT03190889|449035935|FG002|Overall Study|Lost to Follow-up|3|||
124837629|NCT03190889|449035933|FG000|Overall Study|Withdrawal by Subject|1|||
124837630|NCT03190889|449035934|FG001|Overall Study|Withdrawal by Subject|1|||
124837631|NCT03190889|449035935|FG002|Overall Study|Withdrawal by Subject|2|||
124837632|NCT03190889|449035933|FG000|Overall Study|Did not complete protocol|4|||
124837633|NCT03190889|449035934|FG001|Overall Study|Did not complete protocol|9|||
124837634|NCT03190889|449035935|FG002|Overall Study|Did not complete protocol|0|||
124837635|NCT03190889|449035933|FG000|Overall Study|COVID-19|1|||
124837636|NCT03190889|449035934|FG001|Overall Study|COVID-19|0|||
124837637|NCT03190889|449035935|FG002|Overall Study|COVID-19|2|||
124837638|NCT00405548|449035936|FG000|Overall Study|Cognitive Memory problems on study day|1|||
124837639|NCT00405548|449035937|FG001|Overall Study|Cognitive Memory problems on study day|0|||
124837640|NCT00405548|449035936|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
124837641|NCT00405548|449035937|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
124837642|NCT00405548|449035936|FG000|Overall Study|Unable to self-administer shots|1|||
124837643|NCT00405548|449035937|FG001|Overall Study|Unable to self-administer shots|0|||
124837644|NCT00405548|449035936|FG000|Overall Study|Venous access failed during study day|1|||
124837645|NCT00405548|449035937|FG001|Overall Study|Venous access failed during study day|0|||
124837646|NCT00405548|449035936|FG000|Overall Study|Withdrawal by Subject|1|||
124837647|NCT00405548|449035937|FG001|Overall Study|Withdrawal by Subject|0|||
124837648|NCT02741700|449035938|FG000|Overall Study|Lost to Follow-up|17|||
124837649|NCT02741700|449035939|FG001|Overall Study|Lost to Follow-up|8|||
124837650|NCT02741700|449035938|FG000|Overall Study|Withdrawal by Subject|2|||
124837651|NCT02741700|449035939|FG001|Overall Study|Withdrawal by Subject|5|||
124837652|NCT02741700|449035938|FG000|Overall Study|Physician Decision|3|||
124837653|NCT02741700|449035939|FG001|Overall Study|Physician Decision|0|||
124837654|NCT02741700|449035938|FG000|Overall Study|Moved out of State|0|||
124837655|NCT02741700|449035939|FG001|Overall Study|Moved out of State|1|||
124837656|NCT02741700|449035938|FG000|Overall Study|Death|4|||
124837657|NCT02741700|449035939|FG001|Overall Study|Death|5|||
124837658|NCT00923559|449035940|FG000|Overall Study|Lost to Follow-up|2|||
124837659|NCT00923559|449035941|FG001|Overall Study|Lost to Follow-up|3|||
124837660|NCT00811577|449035942|FG000|Overall Study|Lost to Follow-up|7|||
124837661|NCT00811577|449035943|FG001|Overall Study|Lost to Follow-up|1|||
124837662|NCT00811577|449035942|FG000|Overall Study|Withdrawal by Subject|3|||
124837663|NCT00811577|449035943|FG001|Overall Study|Withdrawal by Subject|0|||
124837664|NCT02641379|449035946|FG000|Overall Study|Exclusion criterion during screening|1|||
124837665|NCT02641379|449035947|FG001|Overall Study|Exclusion criterion during screening|0|||
124837666|NCT02641379|449035948|FG002|Overall Study|Exclusion criterion during screening|0|||
124837667|NCT02641379|449035949|FG003|Overall Study|Exclusion criterion during screening|1|||
124837668|NCT02641379|449035950|FG004|Overall Study|Exclusion criterion during screening|2|||
124837669|NCT02641379|449035951|FG005|Overall Study|Exclusion criterion during screening|0|||
124837670|NCT02641379|449035952|FG006|Overall Study|Exclusion criterion during screening|0|||
124837671|NCT02641379|449035953|FG007|Overall Study|Exclusion criterion during screening|0|||
124837672|NCT02641379|449035954|FG008|Overall Study|Exclusion criterion during screening|0|||
124837673|NCT02641379|449035955|FG009|Overall Study|Exclusion criterion during screening|0|||
124837674|NCT02641379|449035956|FG010|Overall Study|Exclusion criterion during screening|0|||
124837675|NCT02641379|449035946|FG000|Overall Study|Withdrawal of informed consent|0|||
124837676|NCT02641379|449035947|FG001|Overall Study|Withdrawal of informed consent|1|||
124837677|NCT02641379|449035948|FG002|Overall Study|Withdrawal of informed consent|0|||
124837678|NCT02641379|449035949|FG003|Overall Study|Withdrawal of informed consent|0|||
124837679|NCT02641379|449035950|FG004|Overall Study|Withdrawal of informed consent|0|||
124837680|NCT02641379|449035951|FG005|Overall Study|Withdrawal of informed consent|0|||
124837681|NCT02641379|449035952|FG006|Overall Study|Withdrawal of informed consent|0|||
124837682|NCT02641379|449035953|FG007|Overall Study|Withdrawal of informed consent|1|||
124837683|NCT02641379|449035954|FG008|Overall Study|Withdrawal of informed consent|0|||
124837684|NCT02641379|449035955|FG009|Overall Study|Withdrawal of informed consent|0|||
125304994|NCT04405076|450742827|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
125304995|NCT04405076|450742828|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
125304996|NCT04405076|450742820|FG000|Part A (Blinded Phase)|Physician Decision|1|||
125304997|NCT04405076|450742821|FG001|Part A (Blinded Phase)|Physician Decision|2|||
125304998|NCT04405076|450742822|FG002|Part A (Blinded Phase)|Physician Decision|0|||
125304999|NCT04405076|450742823|FG003|Part A (Blinded Phase)|Physician Decision|0|||
124837685|NCT02641379|449035956|FG010|Overall Study|Withdrawal of informed consent|0|||
124837686|NCT02641379|449035946|FG000|Overall Study|Adverse Event|7|||
124837687|NCT02641379|449035947|FG001|Overall Study|Adverse Event|8|||
124837688|NCT02641379|449035948|FG002|Overall Study|Adverse Event|2|||
124837689|NCT02641379|449035949|FG003|Overall Study|Adverse Event|2|||
124837690|NCT02641379|449035950|FG004|Overall Study|Adverse Event|5|||
124837691|NCT02641379|449035951|FG005|Overall Study|Adverse Event|1|||
124837692|NCT02641379|449035952|FG006|Overall Study|Adverse Event|5|||
124837693|NCT02641379|449035953|FG007|Overall Study|Adverse Event|0|||
124837694|NCT02641379|449035954|FG008|Overall Study|Adverse Event|1|||
125305000|NCT04405076|450742824|FG004|Part A (Blinded Phase)|Physician Decision|0|||
125305001|NCT04405076|450742825|FG005|Part A (Blinded Phase)|Physician Decision|0|||
124837695|NCT02641379|449035955|FG009|Overall Study|Adverse Event|1|||
124837696|NCT02641379|449035956|FG010|Overall Study|Adverse Event|5|||
124837697|NCT02641379|449035946|FG000|Overall Study|Lack of Efficacy|0|||
124837698|NCT02641379|449035947|FG001|Overall Study|Lack of Efficacy|0|||
124837699|NCT02641379|449035948|FG002|Overall Study|Lack of Efficacy|2|||
124837700|NCT02641379|449035949|FG003|Overall Study|Lack of Efficacy|0|||
124837701|NCT02641379|449035950|FG004|Overall Study|Lack of Efficacy|0|||
124837702|NCT02641379|449035951|FG005|Overall Study|Lack of Efficacy|2|||
124837703|NCT02641379|449035952|FG006|Overall Study|Lack of Efficacy|0|||
124837704|NCT02641379|449035953|FG007|Overall Study|Lack of Efficacy|5|||
124837705|NCT02641379|449035954|FG008|Overall Study|Lack of Efficacy|0|||
124837706|NCT02641379|449035955|FG009|Overall Study|Lack of Efficacy|0|||
124837707|NCT02641379|449035956|FG010|Overall Study|Lack of Efficacy|0|||
124837708|NCT02641379|449035946|FG000|Overall Study|Participant unable to attend study visit|4|||
124837709|NCT02641379|449035947|FG001|Overall Study|Participant unable to attend study visit|10|||
124837710|NCT02641379|449035948|FG002|Overall Study|Participant unable to attend study visit|1|||
124837711|NCT02641379|449035949|FG003|Overall Study|Participant unable to attend study visit|2|||
124837712|NCT02641379|449035950|FG004|Overall Study|Participant unable to attend study visit|5|||
124837713|NCT02641379|449035951|FG005|Overall Study|Participant unable to attend study visit|1|||
124837714|NCT02641379|449035952|FG006|Overall Study|Participant unable to attend study visit|1|||
124837715|NCT02641379|449035953|FG007|Overall Study|Participant unable to attend study visit|1|||
124837716|NCT02641379|449035954|FG008|Overall Study|Participant unable to attend study visit|0|||
124837717|NCT02641379|449035955|FG009|Overall Study|Participant unable to attend study visit|2|||
124837718|NCT02641379|449035956|FG010|Overall Study|Participant unable to attend study visit|0|||
124837719|NCT02641379|449035946|FG000|Overall Study|Participant's compliance|0|||
124837720|NCT02641379|449035947|FG001|Overall Study|Participant's compliance|1|||
124837721|NCT02641379|449035948|FG002|Overall Study|Participant's compliance|0|||
124837722|NCT02641379|449035949|FG003|Overall Study|Participant's compliance|1|||
124837723|NCT02641379|449035950|FG004|Overall Study|Participant's compliance|0|||
124837724|NCT02641379|449035951|FG005|Overall Study|Participant's compliance|2|||
124837725|NCT02641379|449035952|FG006|Overall Study|Participant's compliance|0|||
124837726|NCT02641379|449035953|FG007|Overall Study|Participant's compliance|0|||
124837727|NCT02641379|449035954|FG008|Overall Study|Participant's compliance|1|||
124837728|NCT02641379|449035955|FG009|Overall Study|Participant's compliance|1|||
124837729|NCT02641379|449035956|FG010|Overall Study|Participant's compliance|1|||
124837730|NCT02641379|449035946|FG000|Overall Study|Participant cannot be reached|4|||
124837731|NCT02641379|449035947|FG001|Overall Study|Participant cannot be reached|4|||
124837732|NCT02641379|449035948|FG002|Overall Study|Participant cannot be reached|0|||
124837733|NCT02641379|449035949|FG003|Overall Study|Participant cannot be reached|8|||
124837734|NCT02641379|449035950|FG004|Overall Study|Participant cannot be reached|2|||
124837735|NCT02641379|449035951|FG005|Overall Study|Participant cannot be reached|1|||
124837736|NCT02641379|449035952|FG006|Overall Study|Participant cannot be reached|0|||
124837737|NCT02641379|449035953|FG007|Overall Study|Participant cannot be reached|1|||
124837738|NCT02641379|449035954|FG008|Overall Study|Participant cannot be reached|0|||
124837739|NCT02641379|449035955|FG009|Overall Study|Participant cannot be reached|2|||
124837740|NCT02641379|449035956|FG010|Overall Study|Participant cannot be reached|1|||
124837741|NCT02641379|449035946|FG000|Overall Study|PCR positive at Week 24|15|||
124837742|NCT02641379|449035947|FG001|Overall Study|PCR positive at Week 24|21|||
124837743|NCT02641379|449035948|FG002|Overall Study|PCR positive at Week 24|62|||
124837744|NCT02641379|449035949|FG003|Overall Study|PCR positive at Week 24|0|||
124837745|NCT02641379|449035950|FG004|Overall Study|PCR positive at Week 24|0|||
124837746|NCT02641379|449035951|FG005|Overall Study|PCR positive at Week 24|6|||
124837747|NCT02641379|449035952|FG006|Overall Study|PCR positive at Week 24|3|||
124837748|NCT02641379|449035953|FG007|Overall Study|PCR positive at Week 24|8|||
124837749|NCT02641379|449035954|FG008|Overall Study|PCR positive at Week 24|0|||
124837750|NCT02641379|449035955|FG009|Overall Study|PCR positive at Week 24|1|||
124837751|NCT02641379|449035956|FG010|Overall Study|PCR positive at Week 24|0|||
124837752|NCT02641379|449035946|FG000|Overall Study|PCR positive at follow up 2|1|||
124837753|NCT02641379|449035947|FG001|Overall Study|PCR positive at follow up 2|0|||
124837754|NCT02641379|449035948|FG002|Overall Study|PCR positive at follow up 2|0|||
124837755|NCT02641379|449035949|FG003|Overall Study|PCR positive at follow up 2|0|||
124837756|NCT02641379|449035950|FG004|Overall Study|PCR positive at follow up 2|0|||
124837757|NCT02641379|449035951|FG005|Overall Study|PCR positive at follow up 2|0|||
124837758|NCT02641379|449035952|FG006|Overall Study|PCR positive at follow up 2|0|||
124837759|NCT02641379|449035953|FG007|Overall Study|PCR positive at follow up 2|0|||
124837760|NCT02641379|449035954|FG008|Overall Study|PCR positive at follow up 2|0|||
124837761|NCT02641379|449035955|FG009|Overall Study|PCR positive at follow up 2|0|||
124837762|NCT02641379|449035956|FG010|Overall Study|PCR positive at follow up 2|0|||
124837763|NCT02641379|449035946|FG000|Overall Study|Participant showed relapse|1|||
124837764|NCT02641379|449035947|FG001|Overall Study|Participant showed relapse|0|||
124837765|NCT02641379|449035948|FG002|Overall Study|Participant showed relapse|0|||
124837766|NCT02641379|449035949|FG003|Overall Study|Participant showed relapse|0|||
124837767|NCT02641379|449035950|FG004|Overall Study|Participant showed relapse|0|||
124837768|NCT02641379|449035951|FG005|Overall Study|Participant showed relapse|0|||
124837769|NCT02641379|449035952|FG006|Overall Study|Participant showed relapse|1|||
124837770|NCT02641379|449035953|FG007|Overall Study|Participant showed relapse|0|||
124837771|NCT02641379|449035954|FG008|Overall Study|Participant showed relapse|0|||
124837772|NCT02641379|449035955|FG009|Overall Study|Participant showed relapse|0|||
124837773|NCT02641379|449035956|FG010|Overall Study|Participant showed relapse|0|||
124837774|NCT02641379|449035946|FG000|Overall Study|Participant stopped study/treatment|1|||
124837775|NCT02641379|449035947|FG001|Overall Study|Participant stopped study/treatment|3|||
124837776|NCT02641379|449035948|FG002|Overall Study|Participant stopped study/treatment|1|||
124837777|NCT02641379|449035949|FG003|Overall Study|Participant stopped study/treatment|0|||
124837778|NCT02641379|449035950|FG004|Overall Study|Participant stopped study/treatment|0|||
124837779|NCT02641379|449035951|FG005|Overall Study|Participant stopped study/treatment|1|||
124837780|NCT02641379|449035952|FG006|Overall Study|Participant stopped study/treatment|2|||
124837781|NCT02641379|449035953|FG007|Overall Study|Participant stopped study/treatment|0|||
124837782|NCT02641379|449035954|FG008|Overall Study|Participant stopped study/treatment|1|||
124837783|NCT02641379|449035955|FG009|Overall Study|Participant stopped study/treatment|0|||
124837784|NCT02641379|449035956|FG010|Overall Study|Participant stopped study/treatment|0|||
124837785|NCT02641379|449035946|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
124837786|NCT02641379|449035947|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
124837787|NCT02641379|449035948|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
124837788|NCT02641379|449035949|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
124837789|NCT02641379|449035950|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
124837790|NCT02641379|449035951|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
124837791|NCT02641379|449035952|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
124837792|NCT02641379|449035953|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
124837793|NCT02641379|449035954|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
124837794|NCT02641379|449035955|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
124837795|NCT02641379|449035956|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
124837796|NCT02641379|449035946|FG000|Overall Study|Financial problems|0|||
124837797|NCT02641379|449035947|FG001|Overall Study|Financial problems|1|||
124837798|NCT02641379|449035948|FG002|Overall Study|Financial problems|0|||
124837799|NCT02641379|449035949|FG003|Overall Study|Financial problems|0|||
124837800|NCT02641379|449035950|FG004|Overall Study|Financial problems|0|||
124837801|NCT02641379|449035951|FG005|Overall Study|Financial problems|0|||
124837802|NCT02641379|449035952|FG006|Overall Study|Financial problems|0|||
124837803|NCT02641379|449035953|FG007|Overall Study|Financial problems|0|||
124837804|NCT02641379|449035954|FG008|Overall Study|Financial problems|0|||
124837805|NCT02641379|449035955|FG009|Overall Study|Financial problems|0|||
124837806|NCT02641379|449035956|FG010|Overall Study|Financial problems|0|||
124837807|NCT02641379|449035946|FG000|Overall Study|PCR positive at Week 68|0|||
124837808|NCT02641379|449035947|FG001|Overall Study|PCR positive at Week 68|1|||
124837809|NCT02641379|449035948|FG002|Overall Study|PCR positive at Week 68|0|||
124837810|NCT02641379|449035949|FG003|Overall Study|PCR positive at Week 68|0|||
124837811|NCT02641379|449035950|FG004|Overall Study|PCR positive at Week 68|0|||
124837812|NCT02641379|449035951|FG005|Overall Study|PCR positive at Week 68|0|||
124837813|NCT02641379|449035952|FG006|Overall Study|PCR positive at Week 68|0|||
124837814|NCT02641379|449035953|FG007|Overall Study|PCR positive at Week 68|0|||
124837815|NCT02641379|449035954|FG008|Overall Study|PCR positive at Week 68|0|||
124837816|NCT02641379|449035955|FG009|Overall Study|PCR positive at Week 68|0|||
124837817|NCT02641379|449035956|FG010|Overall Study|PCR positive at Week 68|0|||
124837818|NCT02641379|449035946|FG000|Overall Study|PCR positive at Week 48|0|||
124837819|NCT02641379|449035947|FG001|Overall Study|PCR positive at Week 48|1|||
124837820|NCT02641379|449035948|FG002|Overall Study|PCR positive at Week 48|0|||
124837821|NCT02641379|449035949|FG003|Overall Study|PCR positive at Week 48|0|||
124837822|NCT02641379|449035950|FG004|Overall Study|PCR positive at Week 48|0|||
124837823|NCT02641379|449035951|FG005|Overall Study|PCR positive at Week 48|0|||
124837824|NCT02641379|449035952|FG006|Overall Study|PCR positive at Week 48|0|||
124837825|NCT02641379|449035953|FG007|Overall Study|PCR positive at Week 48|0|||
124837826|NCT02641379|449035954|FG008|Overall Study|PCR positive at Week 48|0|||
124837827|NCT02641379|449035955|FG009|Overall Study|PCR positive at Week 48|0|||
124837828|NCT02641379|449035956|FG010|Overall Study|PCR positive at Week 48|0|||
124837829|NCT02641379|449035946|FG000|Overall Study|PCR not performed at Week 12|0|||
124837830|NCT02641379|449035947|FG001|Overall Study|PCR not performed at Week 12|0|||
124837831|NCT02641379|449035948|FG002|Overall Study|PCR not performed at Week 12|1|||
124837832|NCT02641379|449035949|FG003|Overall Study|PCR not performed at Week 12|0|||
124837833|NCT02641379|449035950|FG004|Overall Study|PCR not performed at Week 12|0|||
124837834|NCT02641379|449035951|FG005|Overall Study|PCR not performed at Week 12|0|||
124837835|NCT02641379|449035952|FG006|Overall Study|PCR not performed at Week 12|0|||
124837836|NCT02641379|449035953|FG007|Overall Study|PCR not performed at Week 12|0|||
124837837|NCT02641379|449035954|FG008|Overall Study|PCR not performed at Week 12|0|||
124837838|NCT02641379|449035955|FG009|Overall Study|PCR not performed at Week 12|0|||
124837839|NCT02641379|449035956|FG010|Overall Study|PCR not performed at Week 12|0|||
124837840|NCT02641379|449035946|FG000|Overall Study|No PCR at baseline|0|||
124837841|NCT02641379|449035947|FG001|Overall Study|No PCR at baseline|0|||
124837842|NCT02641379|449035948|FG002|Overall Study|No PCR at baseline|1|||
124837843|NCT02641379|449035949|FG003|Overall Study|No PCR at baseline|0|||
124837844|NCT02641379|449035950|FG004|Overall Study|No PCR at baseline|0|||
124837845|NCT02641379|449035951|FG005|Overall Study|No PCR at baseline|0|||
124837846|NCT02641379|449035952|FG006|Overall Study|No PCR at baseline|0|||
124837847|NCT02641379|449035953|FG007|Overall Study|No PCR at baseline|0|||
124837848|NCT02641379|449035954|FG008|Overall Study|No PCR at baseline|0|||
124837849|NCT02641379|449035955|FG009|Overall Study|No PCR at baseline|0|||
124837850|NCT02641379|449035956|FG010|Overall Study|No PCR at baseline|0|||
124837851|NCT02641379|449035946|FG000|Overall Study|PCR positive at Week 28|0|||
124837852|NCT02641379|449035947|FG001|Overall Study|PCR positive at Week 28|0|||
124837853|NCT02641379|449035948|FG002|Overall Study|PCR positive at Week 28|1|||
124837854|NCT02641379|449035949|FG003|Overall Study|PCR positive at Week 28|0|||
124837855|NCT02641379|449035950|FG004|Overall Study|PCR positive at Week 28|0|||
124837856|NCT02641379|449035951|FG005|Overall Study|PCR positive at Week 28|0|||
124837857|NCT02641379|449035952|FG006|Overall Study|PCR positive at Week 28|0|||
124837858|NCT02641379|449035953|FG007|Overall Study|PCR positive at Week 28|0|||
124837859|NCT02641379|449035954|FG008|Overall Study|PCR positive at Week 28|0|||
124837860|NCT02641379|449035955|FG009|Overall Study|PCR positive at Week 28|0|||
124837861|NCT02641379|449035956|FG010|Overall Study|PCR positive at Week 28|0|||
124837862|NCT02641379|449035946|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
124837863|NCT02641379|449035947|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
124837864|NCT02641379|449035948|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
124837865|NCT02641379|449035949|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
124837866|NCT02641379|449035950|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
124837867|NCT02641379|449035951|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
124837868|NCT02641379|449035952|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
124837869|NCT02641379|449035953|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
124837870|NCT02641379|449035954|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
124837871|NCT02641379|449035955|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
124837872|NCT02641379|449035956|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
124837873|NCT02641379|449035946|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
124837874|NCT02641379|449035947|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
124837875|NCT02641379|449035948|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
124837876|NCT02641379|449035949|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
124837877|NCT02641379|449035950|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
124837878|NCT02641379|449035951|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
124837879|NCT02641379|449035952|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
124837880|NCT02641379|449035953|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
124837881|NCT02641379|449035954|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
124837882|NCT02641379|449035955|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
124837883|NCT02641379|449035956|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
124837884|NCT02641379|449035946|FG000|Overall Study|Baseline viral load unavailable|0|||
124837885|NCT02641379|449035947|FG001|Overall Study|Baseline viral load unavailable|0|||
124837886|NCT02641379|449035948|FG002|Overall Study|Baseline viral load unavailable|0|||
124837887|NCT02641379|449035949|FG003|Overall Study|Baseline viral load unavailable|1|||
124837888|NCT02641379|449035950|FG004|Overall Study|Baseline viral load unavailable|0|||
124837889|NCT02641379|449035951|FG005|Overall Study|Baseline viral load unavailable|0|||
124837890|NCT02641379|449035952|FG006|Overall Study|Baseline viral load unavailable|0|||
124837891|NCT02641379|449035953|FG007|Overall Study|Baseline viral load unavailable|0|||
124837892|NCT02641379|449035954|FG008|Overall Study|Baseline viral load unavailable|0|||
124837893|NCT02641379|449035955|FG009|Overall Study|Baseline viral load unavailable|0|||
124837894|NCT02641379|449035956|FG010|Overall Study|Baseline viral load unavailable|0|||
124837895|NCT02641379|449035946|FG000|Overall Study|Blood could not be drawn|0|||
124837896|NCT02641379|449035947|FG001|Overall Study|Blood could not be drawn|0|||
124837897|NCT02641379|449035948|FG002|Overall Study|Blood could not be drawn|0|||
124837898|NCT02641379|449035949|FG003|Overall Study|Blood could not be drawn|0|||
124837899|NCT02641379|449035950|FG004|Overall Study|Blood could not be drawn|1|||
124837900|NCT02641379|449035951|FG005|Overall Study|Blood could not be drawn|0|||
124837901|NCT02641379|449035952|FG006|Overall Study|Blood could not be drawn|0|||
124837902|NCT02641379|449035953|FG007|Overall Study|Blood could not be drawn|0|||
124837903|NCT02641379|449035954|FG008|Overall Study|Blood could not be drawn|0|||
124837904|NCT02641379|449035955|FG009|Overall Study|Blood could not be drawn|0|||
124837905|NCT02641379|449035956|FG010|Overall Study|Blood could not be drawn|0|||
124837906|NCT02641379|449035946|FG000|Overall Study|Protocol Violation|0|||
124837907|NCT02641379|449035947|FG001|Overall Study|Protocol Violation|0|||
124837908|NCT02641379|449035948|FG002|Overall Study|Protocol Violation|0|||
124837909|NCT02641379|449035949|FG003|Overall Study|Protocol Violation|0|||
124837910|NCT02641379|449035950|FG004|Overall Study|Protocol Violation|2|||
124837911|NCT02641379|449035951|FG005|Overall Study|Protocol Violation|0|||
124837912|NCT02641379|449035952|FG006|Overall Study|Protocol Violation|0|||
124837913|NCT02641379|449035953|FG007|Overall Study|Protocol Violation|0|||
124837914|NCT02641379|449035954|FG008|Overall Study|Protocol Violation|1|||
124837915|NCT02641379|449035955|FG009|Overall Study|Protocol Violation|0|||
124837916|NCT02641379|449035956|FG010|Overall Study|Protocol Violation|0|||
124837917|NCT02641379|449035946|FG000|Overall Study|Participation in sili rescue study|0|||
124837918|NCT02641379|449035947|FG001|Overall Study|Participation in sili rescue study|0|||
124837919|NCT02641379|449035948|FG002|Overall Study|Participation in sili rescue study|0|||
124837920|NCT02641379|449035949|FG003|Overall Study|Participation in sili rescue study|0|||
124837921|NCT02641379|449035950|FG004|Overall Study|Participation in sili rescue study|0|||
124837922|NCT02641379|449035951|FG005|Overall Study|Participation in sili rescue study|1|||
124837923|NCT02641379|449035952|FG006|Overall Study|Participation in sili rescue study|0|||
124837924|NCT02641379|449035953|FG007|Overall Study|Participation in sili rescue study|0|||
124837925|NCT02641379|449035954|FG008|Overall Study|Participation in sili rescue study|0|||
124837926|NCT02641379|449035955|FG009|Overall Study|Participation in sili rescue study|0|||
124837927|NCT02641379|449035956|FG010|Overall Study|Participation in sili rescue study|0|||
124837928|NCT02641379|449035946|FG000|Overall Study|Lost to Follow-up|0|||
124837929|NCT02641379|449035947|FG001|Overall Study|Lost to Follow-up|0|||
124837930|NCT02641379|449035948|FG002|Overall Study|Lost to Follow-up|0|||
124837931|NCT02641379|449035949|FG003|Overall Study|Lost to Follow-up|0|||
124837932|NCT02641379|449035950|FG004|Overall Study|Lost to Follow-up|0|||
124837933|NCT02641379|449035951|FG005|Overall Study|Lost to Follow-up|0|||
124837934|NCT02641379|449035952|FG006|Overall Study|Lost to Follow-up|0|||
124837935|NCT02641379|449035953|FG007|Overall Study|Lost to Follow-up|0|||
124837936|NCT02641379|449035954|FG008|Overall Study|Lost to Follow-up|1|||
124837937|NCT02641379|449035955|FG009|Overall Study|Lost to Follow-up|0|||
124837938|NCT02641379|449035956|FG010|Overall Study|Lost to Follow-up|0|||
124837939|NCT02641379|449035946|FG000|Overall Study|Source data not found|0|||
124837940|NCT02641379|449035947|FG001|Overall Study|Source data not found|0|||
124837941|NCT02641379|449035948|FG002|Overall Study|Source data not found|0|||
124837942|NCT02641379|449035949|FG003|Overall Study|Source data not found|0|||
124837943|NCT02641379|449035950|FG004|Overall Study|Source data not found|0|||
124837944|NCT02641379|449035951|FG005|Overall Study|Source data not found|1|||
124837945|NCT02641379|449035952|FG006|Overall Study|Source data not found|0|||
124837946|NCT02641379|449035953|FG007|Overall Study|Source data not found|0|||
124837947|NCT02641379|449035954|FG008|Overall Study|Source data not found|0|||
124837948|NCT02641379|449035955|FG009|Overall Study|Source data not found|0|||
124837949|NCT02641379|449035956|FG010|Overall Study|Source data not found|0|||
124837950|NCT02641379|449035946|FG000|Overall Study|Participant showed weight reduction|0|||
124837951|NCT02641379|449035947|FG001|Overall Study|Participant showed weight reduction|0|||
124837952|NCT02641379|449035948|FG002|Overall Study|Participant showed weight reduction|0|||
124837953|NCT02641379|449035949|FG003|Overall Study|Participant showed weight reduction|0|||
124837954|NCT02641379|449035950|FG004|Overall Study|Participant showed weight reduction|0|||
124837955|NCT02641379|449035951|FG005|Overall Study|Participant showed weight reduction|0|||
124837956|NCT02641379|449035952|FG006|Overall Study|Participant showed weight reduction|0|||
124837957|NCT02641379|449035953|FG007|Overall Study|Participant showed weight reduction|1|||
124837958|NCT02641379|449035954|FG008|Overall Study|Participant showed weight reduction|0|||
124837959|NCT02641379|449035955|FG009|Overall Study|Participant showed weight reduction|0|||
124837960|NCT02641379|449035956|FG010|Overall Study|Participant showed weight reduction|0|||
124837961|NCT02641379|449035946|FG000|Overall Study|Non-response Week 12|0|||
124837962|NCT02641379|449035947|FG001|Overall Study|Non-response Week 12|0|||
124837963|NCT02641379|449035948|FG002|Overall Study|Non-response Week 12|0|||
124837964|NCT02641379|449035949|FG003|Overall Study|Non-response Week 12|0|||
124837965|NCT02641379|449035950|FG004|Overall Study|Non-response Week 12|0|||
124837966|NCT02641379|449035951|FG005|Overall Study|Non-response Week 12|0|||
124837967|NCT02641379|449035952|FG006|Overall Study|Non-response Week 12|0|||
124837968|NCT02641379|449035953|FG007|Overall Study|Non-response Week 12|1|||
124837969|NCT02641379|449035954|FG008|Overall Study|Non-response Week 12|0|||
124837970|NCT02641379|449035955|FG009|Overall Study|Non-response Week 12|0|||
124837971|NCT02641379|449035956|FG010|Overall Study|Non-response Week 12|0|||
124837972|NCT02641379|449035946|FG000|Overall Study|No 2 Log drop at Week 12|0|||
124837973|NCT02641379|449035947|FG001|Overall Study|No 2 Log drop at Week 12|0|||
124837974|NCT02641379|449035948|FG002|Overall Study|No 2 Log drop at Week 12|0|||
124837975|NCT02641379|449035949|FG003|Overall Study|No 2 Log drop at Week 12|0|||
124837976|NCT02641379|449035950|FG004|Overall Study|No 2 Log drop at Week 12|0|||
124837977|NCT02641379|449035951|FG005|Overall Study|No 2 Log drop at Week 12|0|||
124837978|NCT02641379|449035952|FG006|Overall Study|No 2 Log drop at Week 12|0|||
124837979|NCT02641379|449035953|FG007|Overall Study|No 2 Log drop at Week 12|0|||
124837980|NCT02641379|449035954|FG008|Overall Study|No 2 Log drop at Week 12|0|||
124837981|NCT02641379|449035955|FG009|Overall Study|No 2 Log drop at Week 12|0|||
124837982|NCT02641379|449035956|FG010|Overall Study|No 2 Log drop at Week 12|1|||
124837983|NCT02641379|449035946|FG000|Overall Study|Negative PCR result|0|||
124837984|NCT02641379|449035947|FG001|Overall Study|Negative PCR result|0|||
124837985|NCT02641379|449035948|FG002|Overall Study|Negative PCR result|0|||
124837986|NCT02641379|449035949|FG003|Overall Study|Negative PCR result|0|||
124837987|NCT02641379|449035950|FG004|Overall Study|Negative PCR result|0|||
124837988|NCT02641379|449035951|FG005|Overall Study|Negative PCR result|0|||
124837989|NCT02641379|449035952|FG006|Overall Study|Negative PCR result|0|||
125305002|NCT04405076|450742826|FG006|Part A (Blinded Phase)|Physician Decision|0|||
124837990|NCT02641379|449035953|FG007|Overall Study|Negative PCR result|0|||
124837991|NCT02641379|449035954|FG008|Overall Study|Negative PCR result|0|||
124837992|NCT02641379|449035955|FG009|Overall Study|Negative PCR result|1|||
124837993|NCT02641379|449035956|FG010|Overall Study|Negative PCR result|0|||
124837994|NCT02641379|449035946|FG000|Overall Study|Participant's PCR high|0|||
124837995|NCT02641379|449035947|FG001|Overall Study|Participant's PCR high|0|||
124837996|NCT02641379|449035948|FG002|Overall Study|Participant's PCR high|0|||
124837997|NCT02641379|449035949|FG003|Overall Study|Participant's PCR high|0|||
124837998|NCT02641379|449035950|FG004|Overall Study|Participant's PCR high|0|||
124837999|NCT02641379|449035951|FG005|Overall Study|Participant's PCR high|0|||
124838000|NCT02641379|449035952|FG006|Overall Study|Participant's PCR high|0|||
124838001|NCT02641379|449035953|FG007|Overall Study|Participant's PCR high|1|||
124838002|NCT02641379|449035954|FG008|Overall Study|Participant's PCR high|0|||
124838003|NCT02641379|449035955|FG009|Overall Study|Participant's PCR high|0|||
124838004|NCT02641379|449035956|FG010|Overall Study|Participant's PCR high|0|||
124838005|NCT02641379|449035946|FG000|Overall Study|Participant treated after Week 24|0|||
124838006|NCT02641379|449035947|FG001|Overall Study|Participant treated after Week 24|0|||
124838007|NCT02641379|449035948|FG002|Overall Study|Participant treated after Week 24|0|||
124838008|NCT02641379|449035949|FG003|Overall Study|Participant treated after Week 24|0|||
124838009|NCT02641379|449035950|FG004|Overall Study|Participant treated after Week 24|0|||
124838010|NCT02641379|449035951|FG005|Overall Study|Participant treated after Week 24|0|||
124838011|NCT02641379|449035952|FG006|Overall Study|Participant treated after Week 24|0|||
124838012|NCT02641379|449035953|FG007|Overall Study|Participant treated after Week 24|0|||
124838013|NCT02641379|449035954|FG008|Overall Study|Participant treated after Week 24|1|||
124838014|NCT02641379|449035955|FG009|Overall Study|Participant treated after Week 24|0|||
124838015|NCT02641379|449035956|FG010|Overall Study|Participant treated after Week 24|0|||
124838016|NCT02641379|449035946|FG000|Overall Study|Missing PCR result at Week 8|0|||
124838017|NCT02641379|449035947|FG001|Overall Study|Missing PCR result at Week 8|0|||
124838018|NCT02641379|449035948|FG002|Overall Study|Missing PCR result at Week 8|0|||
124838019|NCT02641379|449035949|FG003|Overall Study|Missing PCR result at Week 8|0|||
124838020|NCT02641379|449035950|FG004|Overall Study|Missing PCR result at Week 8|0|||
124838021|NCT02641379|449035951|FG005|Overall Study|Missing PCR result at Week 8|0|||
124838022|NCT02641379|449035952|FG006|Overall Study|Missing PCR result at Week 8|0|||
124838023|NCT02641379|449035953|FG007|Overall Study|Missing PCR result at Week 8|0|||
124838024|NCT02641379|449035954|FG008|Overall Study|Missing PCR result at Week 8|0|||
124838025|NCT02641379|449035955|FG009|Overall Study|Missing PCR result at Week 8|1|||
124838026|NCT02641379|449035956|FG010|Overall Study|Missing PCR result at Week 8|0|||
124838027|NCT02641379|449035946|FG000|Overall Study|PCR positive|0|||
124838028|NCT02641379|449035947|FG001|Overall Study|PCR positive|0|||
124838029|NCT02641379|449035948|FG002|Overall Study|PCR positive|0|||
124838030|NCT02641379|449035949|FG003|Overall Study|PCR positive|0|||
124838031|NCT02641379|449035950|FG004|Overall Study|PCR positive|0|||
125305003|NCT04405076|450742827|FG007|Part A (Blinded Phase)|Physician Decision|0|||
125305004|NCT04405076|450742828|FG008|Part A (Blinded Phase)|Physician Decision|0|||
125305005|NCT04405076|450742820|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
125305006|NCT04405076|450742821|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
125305007|NCT04405076|450742822|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
125305008|NCT04405076|450742823|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
125305009|NCT04405076|450742824|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
125305010|NCT04405076|450742825|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
125305011|NCT04405076|450742826|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
125305012|NCT04405076|450742827|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
125305013|NCT04405076|450742828|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
125305014|NCT04405076|450742820|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
125305015|NCT04405076|450742821|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
125305016|NCT04405076|450742822|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
125305017|NCT04405076|450742823|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
125305018|NCT04405076|450742824|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
125305019|NCT04405076|450742825|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
125305020|NCT04405076|450742826|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
125305021|NCT04405076|450742827|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
125305022|NCT04405076|450742828|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
125305023|NCT04405076|450742820|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
125305024|NCT04405076|450742821|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
125305025|NCT04405076|450742822|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
125305026|NCT04405076|450742823|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
125305027|NCT04405076|450742824|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
125305028|NCT04405076|450742825|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
125305029|NCT04405076|450742826|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
124838032|NCT02641379|449035951|FG005|Overall Study|PCR positive|0|||
124838033|NCT02641379|449035952|FG006|Overall Study|PCR positive|1|||
124838034|NCT02641379|449035953|FG007|Overall Study|PCR positive|0|||
124838035|NCT02641379|449035954|FG008|Overall Study|PCR positive|0|||
124838036|NCT02641379|449035955|FG009|Overall Study|PCR positive|0|||
124838037|NCT02641379|449035956|FG010|Overall Study|PCR positive|0|||
124838038|NCT01165138|449035957|FG000|Overall Study|Adverse Event|0|||
124838039|NCT01165138|449035958|FG001|Overall Study|Adverse Event|1|||
124838040|NCT01165138|449035959|FG002|Overall Study|Adverse Event|0|||
124838041|NCT01165138|449035960|FG003|Overall Study|Adverse Event|2|||
124838042|NCT01165138|449035957|FG000|Overall Study|Lack of Efficacy|0|||
124838043|NCT01165138|449035958|FG001|Overall Study|Lack of Efficacy|32|||
124838044|NCT01165138|449035959|FG002|Overall Study|Lack of Efficacy|6|||
124838045|NCT01165138|449035960|FG003|Overall Study|Lack of Efficacy|7|||
124838046|NCT01165138|449035957|FG000|Overall Study|Protocol Violation|0|||
124838047|NCT01165138|449035958|FG001|Overall Study|Protocol Violation|7|||
124838048|NCT01165138|449035959|FG002|Overall Study|Protocol Violation|0|||
124838049|NCT01165138|449035960|FG003|Overall Study|Protocol Violation|2|||
124838050|NCT01165138|449035957|FG000|Overall Study|Lost to Follow-up|0|||
124838051|NCT01165138|449035958|FG001|Overall Study|Lost to Follow-up|0|||
124838052|NCT01165138|449035959|FG002|Overall Study|Lost to Follow-up|1|||
124838053|NCT01165138|449035960|FG003|Overall Study|Lost to Follow-up|2|||
124838054|NCT01165138|449035957|FG000|Overall Study|Physician Decision|0|||
124838055|NCT01165138|449035958|FG001|Overall Study|Physician Decision|6|||
124838056|NCT01165138|449035959|FG002|Overall Study|Physician Decision|7|||
124838057|NCT01165138|449035960|FG003|Overall Study|Physician Decision|6|||
124838058|NCT01165138|449035957|FG000|Overall Study|Withdrawal by Subject|0|||
124838059|NCT01165138|449035958|FG001|Overall Study|Withdrawal by Subject|6|||
124838060|NCT01165138|449035959|FG002|Overall Study|Withdrawal by Subject|6|||
124838061|NCT01165138|449035960|FG003|Overall Study|Withdrawal by Subject|3|||
124838062|NCT04982250|449035961|FG000|Overall Study|Lost to Follow-up|0|||
124838063|NCT04982250|449035962|FG001|Overall Study|Lost to Follow-up|26|||
124838064|NCT04982250|449035963|FG002|Overall Study|Lost to Follow-up|0|||
124838065|NCT04982250|449035964|FG003|Overall Study|Lost to Follow-up|0|||
124838066|NCT04982250|449035965|FG004|Overall Study|Lost to Follow-up|72|||
124838067|NCT04982250|449035966|FG005|Overall Study|Lost to Follow-up|69|||
124838068|NCT04982250|449035961|FG000|Overall Study|Not Eligible to Enroll|0|||
124838069|NCT04982250|449035962|FG001|Overall Study|Not Eligible to Enroll|0|||
124838070|NCT04982250|449035963|FG002|Overall Study|Not Eligible to Enroll|0|||
124838071|NCT04982250|449035964|FG003|Overall Study|Not Eligible to Enroll|0|||
124838072|NCT04982250|449035965|FG004|Overall Study|Not Eligible to Enroll|10|||
124838073|NCT04982250|449035966|FG005|Overall Study|Not Eligible to Enroll|7|||
124838074|NCT01148511|449035967|FG000|Exposed to Study Drug|Protocol Violation|2|||
124838075|NCT01148511|449035968|FG001|Exposed to Study Drug|Protocol Violation|0|||
124838076|NCT01148511|449035969|FG002|Exposed to Study Drug|Protocol Violation|0|||
124838077|NCT01148511|449035967|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
124838078|NCT01148511|449035968|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
124838079|NCT01148511|449035969|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
124838080|NCT01148511|449035967|FG000|Randomized|Adverse Event|0|||
124838081|NCT01148511|449035968|FG001|Randomized|Adverse Event|1|||
124838082|NCT01148511|449035969|FG002|Randomized|Adverse Event|0|||
124838083|NCT01148511|449035967|FG000|Randomized|Protocol Violation|0|||
124838084|NCT01148511|449035968|FG001|Randomized|Protocol Violation|2|||
124838085|NCT01148511|449035969|FG002|Randomized|Protocol Violation|1|||
124838086|NCT01148511|449035967|FG000|Randomized|Lost to Follow-up|0|||
124838087|NCT01148511|449035968|FG001|Randomized|Lost to Follow-up|1|||
124838088|NCT01148511|449035969|FG002|Randomized|Lost to Follow-up|1|||
124838089|NCT01148511|449035967|FG000|Randomized|Consent withdrawal|0|||
124838090|NCT01148511|449035968|FG001|Randomized|Consent withdrawal|5|||
124838091|NCT01148511|449035969|FG002|Randomized|Consent withdrawal|3|||
124838092|NCT01148511|449035967|FG000|Randomized|Other|0|||
124838093|NCT01148511|449035968|FG001|Randomized|Other|1|||
124838094|NCT01148511|449035969|FG002|Randomized|Other|1|||
124838095|NCT01644175|449035972|FG000|Overall Study|Randomized But Not Treated|0|||
124838096|NCT01644175|449035973|FG001|Overall Study|Randomized But Not Treated|2|||
124838097|NCT01644175|449035972|FG000|Overall Study|Adverse Event|8|||
124838098|NCT01644175|449035973|FG001|Overall Study|Adverse Event|13|||
124838099|NCT01644175|449035972|FG000|Overall Study|Death|1|||
124838100|NCT01644175|449035973|FG001|Overall Study|Death|2|||
124838101|NCT01644175|449035972|FG000|Overall Study|Poor compliance to protocol|9|||
124838102|NCT01644175|449035973|FG001|Overall Study|Poor compliance to protocol|10|||
124838103|NCT01644175|449035972|FG000|Overall Study|Physician Decision|1|||
124838104|NCT01644175|449035973|FG001|Overall Study|Physician Decision|2|||
124838105|NCT01644175|449035972|FG000|Overall Study|Participant Moved|1|||
124838106|NCT01644175|449035973|FG001|Overall Study|Participant Moved|2|||
124838107|NCT01644175|449035972|FG000|Overall Study|Consent withdrawn by participant|3|||
124838108|NCT01644175|449035973|FG001|Overall Study|Consent withdrawn by participant|4|||
124838109|NCT01644175|449035972|FG000|Overall Study|Related to Autoinjector Administration|2|||
124838110|NCT01644175|449035973|FG001|Overall Study|Related to Autoinjector Administration|1|||
124838111|NCT01644175|449035972|FG000|Overall Study|Last visit outside protocol visit window|4|||
124838112|NCT01644175|449035973|FG001|Overall Study|Last visit outside protocol visit window|11|||
124838113|NCT01644175|449035972|FG000|Overall Study|Selection criteria finally not met|0|||
124838114|NCT01644175|449035973|FG001|Overall Study|Selection criteria finally not met|1|||
124838115|NCT01644175|449035972|FG000|Overall Study|Site closure|2|||
124838116|NCT01644175|449035973|FG001|Overall Study|Site closure|2|||
124838117|NCT01644175|449035972|FG000|Overall Study|Lost to Follow-up|1|||
124838118|NCT01644175|449035973|FG001|Overall Study|Lost to Follow-up|0|||
124838119|NCT01644175|449035972|FG000|Overall Study|Other than specified above|0|||
124838120|NCT01644175|449035973|FG001|Overall Study|Other than specified above|3|||
124838121|NCT02818777|449035979|FG000|Overall Study|Adverse Event|3|||
124838122|NCT01418937|449035980|FG000|Overall Study|Lost to Follow-up|5|||
124838123|NCT01418937|449035980|FG000|Overall Study|Protocol Violation|1|||
124838124|NCT01418937|449035980|FG000|Overall Study|Pregnancy|1|||
124838125|NCT01418937|449035980|FG000|Overall Study|Withdrawal by Subject|1|||
124838126|NCT01324349|449035990|FG000|Overall Study|Death|1|||
124838127|NCT01324349|449035991|FG001|Overall Study|Death|1|||
124838128|NCT01324349|449035990|FG000|Overall Study|Withdrawal by Subject|0|||
124838129|NCT01324349|449035991|FG001|Overall Study|Withdrawal by Subject|1|||
124838130|NCT02013167|449035994|FG000|Overall Study|Withdrawal by Subject|15|||
124838131|NCT02013167|449035995|FG001|Overall Study|Withdrawal by Subject|14|||
124838132|NCT02013167|449035994|FG000|Overall Study|Sponsor Decision|1|||
124838133|NCT02013167|449035995|FG001|Overall Study|Sponsor Decision|3|||
124838134|NCT02013167|449035994|FG000|Overall Study|Lost to Follow-up|0|||
124838135|NCT02013167|449035995|FG001|Overall Study|Lost to Follow-up|1|||
124838136|NCT02013167|449035994|FG000|Overall Study|Death|85|||
124838137|NCT02013167|449035995|FG001|Overall Study|Death|160|||
124838138|NCT01113879|449035996|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
124838139|NCT01113879|449035997|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
124838140|NCT04327986|449035998|FG000|Overall Study|Physician Decision|2|||
124838141|NCT04327986|449035999|FG001|Overall Study|Physician Decision|0|||
124838142|NCT04327986|449036000|FG002|Overall Study|Physician Decision|0|||
124838143|NCT04327986|449035998|FG000|Overall Study|Death|1|||
124838144|NCT04327986|449035999|FG001|Overall Study|Death|0|||
124838145|NCT04327986|449036000|FG002|Overall Study|Death|0|||
124838146|NCT01714310|449037558|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
124838147|NCT01714310|449037559|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
124838148|NCT01714310|449037560|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
124838149|NCT01714310|449037558|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
124838150|NCT01714310|449037559|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
124838151|NCT01714310|449037560|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
124838152|NCT01714310|449037558|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
124838153|NCT01714310|449037559|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
124838154|NCT01714310|449037560|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
124838155|NCT01714310|449037558|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
124838156|NCT01714310|449037559|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
124838157|NCT01714310|449037560|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
124838158|NCT00654381|449037565|FG000|1st Stage|Adverse Event|3|||
124838159|NCT00654381|449037566|FG001|1st Stage|Adverse Event|3|||
124838160|NCT00654381|449037567|FG002|1st Stage|Adverse Event|3|||
124838161|NCT00654381|449037568|FG003|1st Stage|Adverse Event|3|||
124838162|NCT00654381|449037569|FG004|1st Stage|Adverse Event|2|||
124838163|NCT00654381|449037570|FG005|1st Stage|Adverse Event|1|||
124838164|NCT00654381|449037565|FG000|1st Stage|Withdrawal by Subject|0|||
124838165|NCT00654381|449037566|FG001|1st Stage|Withdrawal by Subject|0|||
124838166|NCT00654381|449037567|FG002|1st Stage|Withdrawal by Subject|0|||
124838167|NCT00654381|449037568|FG003|1st Stage|Withdrawal by Subject|1|||
124838168|NCT00654381|449037569|FG004|1st Stage|Withdrawal by Subject|0|||
124838169|NCT00654381|449037570|FG005|1st Stage|Withdrawal by Subject|1|||
124838170|NCT00654381|449037565|FG000|1st Stage|Investigator's decision|0|||
124838171|NCT00654381|449037566|FG001|1st Stage|Investigator's decision|0|||
124838172|NCT00654381|449037567|FG002|1st Stage|Investigator's decision|0|||
124838173|NCT00654381|449037568|FG003|1st Stage|Investigator's decision|1|||
124838174|NCT00654381|449037569|FG004|1st Stage|Investigator's decision|0|||
124838175|NCT00654381|449037570|FG005|1st Stage|Investigator's decision|0|||
124838176|NCT00654381|449037565|FG000|2nd Stage|Adverse Event|2|||
124838177|NCT00654381|449037566|FG001|2nd Stage|Adverse Event|0|||
124838178|NCT00654381|449037567|FG002|2nd Stage|Adverse Event|2|||
124838179|NCT00654381|449037568|FG003|2nd Stage|Adverse Event|3|||
124838180|NCT00654381|449037569|FG004|2nd Stage|Adverse Event|7|||
124838181|NCT00654381|449037570|FG005|2nd Stage|Adverse Event|2|||
124838182|NCT00654381|449037565|FG000|2nd Stage|Withdrawal by Subject|0|||
124838183|NCT00654381|449037566|FG001|2nd Stage|Withdrawal by Subject|0|||
124838184|NCT00654381|449037567|FG002|2nd Stage|Withdrawal by Subject|0|||
124838185|NCT00654381|449037568|FG003|2nd Stage|Withdrawal by Subject|0|||
124838186|NCT00654381|449037569|FG004|2nd Stage|Withdrawal by Subject|1|||
124838187|NCT00654381|449037570|FG005|2nd Stage|Withdrawal by Subject|1|||
124838188|NCT00654381|449037565|FG000|2nd Stage|Investigator's decision|0|||
124838189|NCT00654381|449037566|FG001|2nd Stage|Investigator's decision|0|||
124838190|NCT00654381|449037567|FG002|2nd Stage|Investigator's decision|1|||
124838191|NCT00654381|449037568|FG003|2nd Stage|Investigator's decision|1|||
124838192|NCT00654381|449037569|FG004|2nd Stage|Investigator's decision|0|||
124838193|NCT00654381|449037570|FG005|2nd Stage|Investigator's decision|0|||
124838194|NCT00654381|449037565|FG000|Extension Stage|Adverse Event|1|||
124838195|NCT00654381|449037566|FG001|Extension Stage|Adverse Event|2|||
124838196|NCT00654381|449037567|FG002|Extension Stage|Adverse Event|9|||
124838197|NCT00654381|449037568|FG003|Extension Stage|Adverse Event|7|||
124838198|NCT00654381|449037569|FG004|Extension Stage|Adverse Event|1|||
124838199|NCT00654381|449037570|FG005|Extension Stage|Adverse Event|1|||
124838200|NCT00654381|449037565|FG000|Extension Stage|Protocol Violation|0|||
124838201|NCT00654381|449037566|FG001|Extension Stage|Protocol Violation|0|||
124838202|NCT00654381|449037567|FG002|Extension Stage|Protocol Violation|0|||
124838203|NCT00654381|449037568|FG003|Extension Stage|Protocol Violation|1|||
124838204|NCT00654381|449037569|FG004|Extension Stage|Protocol Violation|0|||
124838205|NCT00654381|449037570|FG005|Extension Stage|Protocol Violation|0|||
124838206|NCT00654381|449037565|FG000|Extension Stage|Lack of Efficacy|0|||
124838207|NCT00654381|449037566|FG001|Extension Stage|Lack of Efficacy|0|||
124838208|NCT00654381|449037567|FG002|Extension Stage|Lack of Efficacy|1|||
124838209|NCT00654381|449037568|FG003|Extension Stage|Lack of Efficacy|0|||
124838210|NCT00654381|449037569|FG004|Extension Stage|Lack of Efficacy|0|||
124838211|NCT00654381|449037570|FG005|Extension Stage|Lack of Efficacy|0|||
124838212|NCT00654381|449037565|FG000|Extension Stage|Withdrawal by Subject|0|||
124838213|NCT00654381|449037566|FG001|Extension Stage|Withdrawal by Subject|0|||
124838214|NCT00654381|449037567|FG002|Extension Stage|Withdrawal by Subject|1|||
124838215|NCT00654381|449037568|FG003|Extension Stage|Withdrawal by Subject|1|||
124838216|NCT00654381|449037569|FG004|Extension Stage|Withdrawal by Subject|1|||
124838217|NCT00654381|449037570|FG005|Extension Stage|Withdrawal by Subject|1|||
124838218|NCT00654381|449037565|FG000|Extension Stage|Closure of the trial site|0|||
124838219|NCT00654381|449037566|FG001|Extension Stage|Closure of the trial site|0|||
124838220|NCT00654381|449037567|FG002|Extension Stage|Closure of the trial site|0|||
124838221|NCT00654381|449037568|FG003|Extension Stage|Closure of the trial site|0|||
124838222|NCT00654381|449037569|FG004|Extension Stage|Closure of the trial site|1|||
124838223|NCT00654381|449037570|FG005|Extension Stage|Closure of the trial site|1|||
124838224|NCT04164901|449037575|FG000|Overall Study|Withdrawal by Subject|4|||
124838225|NCT04164901|449037576|FG001|Overall Study|Withdrawal by Subject|4|||
124838226|NCT00097721|449037584|FG000|Overall Study|Adverse Event|8|||
124838227|NCT00097721|449037585|FG001|Overall Study|Adverse Event|1|||
124838228|NCT00097721|449037584|FG000|Overall Study|Withdrawal by Subject|6|||
124838229|NCT00097721|449037585|FG001|Overall Study|Withdrawal by Subject|1|||
124838230|NCT00097721|449037584|FG000|Overall Study|Progressive Disease|55|||
124838231|NCT00097721|449037585|FG001|Overall Study|Progressive Disease|27|||
124838232|NCT00097721|449037584|FG000|Overall Study|Physician Decision|1|||
124838233|NCT00097721|449037585|FG001|Overall Study|Physician Decision|3|||
124838234|NCT00097721|449037584|FG000|Overall Study|Reason not given|1|||
124838235|NCT00097721|449037585|FG001|Overall Study|Reason not given|1|||
124838236|NCT01752855|449037589|FG000|Overall Study|Adverse Event|1|||
124838237|NCT01752855|449037590|FG001|Overall Study|Adverse Event|0|||
124838238|NCT01752855|449037589|FG000|Overall Study|Withdrew Consent|0|||
124838239|NCT01752855|449037590|FG001|Overall Study|Withdrew Consent|2|||
124838240|NCT01752855|449037589|FG000|Overall Study|Lack of Efficacy|0|||
124838241|NCT01752855|449037590|FG001|Overall Study|Lack of Efficacy|2|||
124838242|NCT02852265|449037595|FG000|3-month Follow-up|Lost to Follow-up|1|||
124838243|NCT02852265|449037596|FG001|3-month Follow-up|Lost to Follow-up|1|||
124838244|NCT03144180|449037598|FG000|Overall Study|STAT Delivery|1|||
124838245|NCT03144180|449037599|FG001|Overall Study|STAT Delivery|1|||
124838246|NCT03144180|449037598|FG000|Overall Study|Provider forgot to fill out forms|1|||
124838247|NCT03144180|449037599|FG001|Overall Study|Provider forgot to fill out forms|3|||
124838248|NCT03144180|449037598|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
124838249|NCT03144180|449037599|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
124838250|NCT03144180|449037598|FG000|Overall Study|Scrub tech removed tube cap|0|||
124838251|NCT03144180|449037599|FG001|Overall Study|Scrub tech removed tube cap|1|||
124838252|NCT00743652|449037600|FG000|Overall Study|Parent/Legal Guardian Request|3|||
124838253|NCT00743652|449037601|FG001|Overall Study|Parent/Legal Guardian Request|2|||
124838254|NCT00743652|449037602|FG002|Overall Study|Parent/Legal Guardian Request|2|||
124838255|NCT00743652|449037603|FG003|Overall Study|Parent/Legal Guardian Request|2|||
124838256|NCT00743652|449037604|FG004|Overall Study|Parent/Legal Guardian Request|0|||
124838257|NCT00743652|449037600|FG000|Overall Study|Adverse Event|3|||
124838258|NCT00743652|449037601|FG001|Overall Study|Adverse Event|0|||
124838259|NCT00743652|449037602|FG002|Overall Study|Adverse Event|0|||
124838260|NCT00743652|449037603|FG003|Overall Study|Adverse Event|0|||
124838261|NCT00743652|449037604|FG004|Overall Study|Adverse Event|0|||
124838262|NCT00743652|449037600|FG000|Overall Study|Death|2|||
124838263|NCT00743652|449037601|FG001|Overall Study|Death|0|||
124838264|NCT00743652|449037602|FG002|Overall Study|Death|0|||
124838265|NCT00743652|449037603|FG003|Overall Study|Death|0|||
124838266|NCT00743652|449037604|FG004|Overall Study|Death|0|||
124838267|NCT00743652|449037600|FG000|Overall Study|Investigator Request|0|||
124838268|NCT00743652|449037601|FG001|Overall Study|Investigator Request|0|||
124838269|NCT00743652|449037602|FG002|Overall Study|Investigator Request|0|||
124838270|NCT00743652|449037603|FG003|Overall Study|Investigator Request|2|||
124838271|NCT00743652|449037604|FG004|Overall Study|Investigator Request|0|||
124838272|NCT00743652|449037600|FG000|Overall Study|Other|1|||
124838273|NCT00743652|449037601|FG001|Overall Study|Other|1|||
124838274|NCT00743652|449037602|FG002|Overall Study|Other|0|||
124838275|NCT00743652|449037603|FG003|Overall Study|Other|0|||
124838276|NCT00743652|449037604|FG004|Overall Study|Other|0|||
124838277|NCT00743652|449037600|FG000|Overall Study|Lost to Follow-up|1|||
124838278|NCT00743652|449037601|FG001|Overall Study|Lost to Follow-up|0|||
124838279|NCT00743652|449037602|FG002|Overall Study|Lost to Follow-up|0|||
124838280|NCT00743652|449037603|FG003|Overall Study|Lost to Follow-up|0|||
124838281|NCT00743652|449037604|FG004|Overall Study|Lost to Follow-up|0|||
124838282|NCT02547129|449037605|FG000|Overall Study|Difficulty with ongoing infection|1|||
124838283|NCT02547129|449037606|FG001|Overall Study|Difficulty with ongoing infection|0|||
124838284|NCT03925324|449037607|FG000|Overall Study|Death|1|||
124838285|NCT03925324|449037608|FG001|Overall Study|Death|1|||
124838286|NCT00409617|449037611|FG000|Overall Study|Adverse Event|57|||
124838287|NCT00409617|449037611|FG000|Overall Study|Lack of Efficacy|54|||
124838288|NCT00409617|449037611|FG000|Overall Study|Lost to Follow-up|2|||
124838289|NCT00409617|449037611|FG000|Overall Study|Protocol Violation|24|||
124838290|NCT00409617|449037611|FG000|Overall Study|Withdrawal by Subject|8|||
124838291|NCT00409617|449037611|FG000|Overall Study|Administrative reasons|1|||
124838292|NCT00409617|449037611|FG000|Overall Study|Not described|14|||
124838293|NCT02159521|449037612|FG000|Overall Study|Enrolled but not treated|3|||
124838294|NCT02159521|449037612|FG000|Overall Study|Withdrawal by Subject|7|||
124838295|NCT02159521|449037612|FG000|Overall Study|Lost to Follow-up|6|||
124838296|NCT02159521|449037612|FG000|Overall Study|Death|1|||
124838297|NCT02159521|449037612|FG000|Overall Study|Other than specified|1|||
124838298|NCT03316885|449037617|FG000|Overall Study|Adverse Event|1|||
124838299|NCT03316885|449037617|FG000|Overall Study|Death|10|||
124838300|NCT03316885|449037617|FG000|Overall Study|Lost to Follow-up|4|||
124838301|NCT03316885|449037617|FG000|Overall Study|Withdrawal by Subject|9|||
124838302|NCT03316885|449037617|FG000|Overall Study|COVID related|8|||
124838303|NCT03216850|449037620|FG000|Overall Study|Pre-analytical error|6|||
124838304|NCT00500292|449037624|FG000|Overall Study|Adverse Event|3|||
124838305|NCT00500292|449037625|FG001|Overall Study|Adverse Event|6|||
124838306|NCT00500292|449037626|FG002|Overall Study|Adverse Event|4|||
124838307|NCT00500292|449037624|FG000|Overall Study|Condition under investigation worsened|21|||
124838308|NCT00500292|449037625|FG001|Overall Study|Condition under investigation worsened|23|||
124838309|NCT00500292|449037626|FG002|Overall Study|Condition under investigation worsened|19|||
124838310|NCT00500292|449037624|FG000|Overall Study|Withdrawal by Subject|0|||
124838311|NCT00500292|449037625|FG001|Overall Study|Withdrawal by Subject|1|||
124838312|NCT00500292|449037626|FG002|Overall Study|Withdrawal by Subject|0|||
124838313|NCT00500292|449037624|FG000|Overall Study|Other|1|||
124838314|NCT00500292|449037625|FG001|Overall Study|Other|1|||
124838315|NCT00500292|449037626|FG002|Overall Study|Other|4|||
124838316|NCT00856908|449037633|FG000|Overall Study|Lost to Follow-up|1|||
124838317|NCT00856908|449037634|FG001|Overall Study|Lost to Follow-up|0|||
124838318|NCT00962104|449037635|FG000|Overall Study|Adverse Event|10|||
124838319|NCT00962104|449037636|FG001|Overall Study|Adverse Event|3|||
124838320|NCT00962104|449037635|FG000|Overall Study|Entry Criteria Not Met|1|||
124838321|NCT00962104|449037636|FG001|Overall Study|Entry Criteria Not Met|2|||
124838322|NCT00962104|449037635|FG000|Overall Study|Lack of Efficacy|0|||
124838323|NCT00962104|449037636|FG001|Overall Study|Lack of Efficacy|1|||
124838324|NCT00962104|449037635|FG000|Overall Study|Lost to Follow-up|10|||
124838325|NCT00962104|449037636|FG001|Overall Study|Lost to Follow-up|4|||
124838326|NCT00962104|449037635|FG000|Overall Study|Physician Decision|1|||
124838327|NCT00962104|449037636|FG001|Overall Study|Physician Decision|0|||
124838328|NCT00962104|449037635|FG000|Overall Study|Protocol Violation|6|||
124838329|NCT00962104|449037636|FG001|Overall Study|Protocol Violation|8|||
124838330|NCT00962104|449037635|FG000|Overall Study|Sponsor Decision|0|||
124838331|NCT00962104|449037636|FG001|Overall Study|Sponsor Decision|1|||
124838332|NCT00962104|449037635|FG000|Overall Study|Withdrawal by Subject|10|||
124838333|NCT00962104|449037636|FG001|Overall Study|Withdrawal by Subject|6|||
124838334|NCT00962104|449037635|FG000|Overall Study|Other|2|||
124838335|NCT00962104|449037636|FG001|Overall Study|Other|0|||
124838336|NCT00842348|449037637|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
124838337|NCT00842348|449037638|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
124838338|NCT00842348|449037637|FG000|Study 729|Disease progression/death|19|||
124838339|NCT00842348|449037638|FG001|Study 729|Disease progression/death|30|||
124838340|NCT00842348|449037637|FG000|Study 729|Adverse Event|1|||
124838341|NCT00842348|449037638|FG001|Study 729|Adverse Event|1|||
124838342|NCT00842348|449037637|FG000|Study 729|Protocol Violation|1|||
124838343|NCT00842348|449037638|FG001|Study 729|Protocol Violation|1|||
124838344|NCT00842348|449037637|FG000|Study 729|Withdrawal by Subject|2|||
124838345|NCT00842348|449037638|FG001|Study 729|Withdrawal by Subject|4|||
124838346|NCT00842348|449037637|FG000|Study 729|Due to Sponsor stopping the study|1|||
124838347|NCT00842348|449037638|FG001|Study 729|Due to Sponsor stopping the study|1|||
124838348|NCT00842348|449037637|FG000|Study 729|Due to non-availability of IP|0|||
124838349|NCT00842348|449037638|FG001|Study 729|Due to non-availability of IP|1|||
124838350|NCT00842348|449037637|FG000|Study 729|Sponsor's decision|1|||
124838351|NCT00842348|449037638|FG001|Study 729|Sponsor's decision|0|||
124838352|NCT00842348|449037637|FG000|Study 729|Surgical resection|1|||
124838353|NCT00842348|449037638|FG001|Study 729|Surgical resection|0|||
124838354|NCT03274986|449037639|FG000|Overall Study|Withdrawal by Subject|0|||
124838355|NCT03274986|449037640|FG001|Overall Study|Withdrawal by Subject|1|||
124838356|NCT03274986|449037639|FG000|Overall Study|Lost to Follow-up|0|||
124838357|NCT03274986|449037640|FG001|Overall Study|Lost to Follow-up|1|||
124838358|NCT00603746|449037643|FG000|Overall Study|Adverse Event|2|||
124838359|NCT00603746|449037644|FG001|Overall Study|Adverse Event|3|||
124838360|NCT00603746|449037645|FG002|Overall Study|Adverse Event|0|||
124838361|NCT00603746|449037646|FG003|Overall Study|Adverse Event|1|||
124838362|NCT00603746|449037647|FG004|Overall Study|Adverse Event|0|||
124838363|NCT00603746|449037648|FG005|Overall Study|Adverse Event|4|||
124838364|NCT00603746|449037643|FG000|Overall Study|Lack of Efficacy|34|||
124838365|NCT00603746|449037644|FG001|Overall Study|Lack of Efficacy|11|||
124838366|NCT00603746|449037645|FG002|Overall Study|Lack of Efficacy|6|||
124838367|NCT00603746|449037646|FG003|Overall Study|Lack of Efficacy|11|||
124838368|NCT00603746|449037647|FG004|Overall Study|Lack of Efficacy|12|||
124838369|NCT00603746|449037648|FG005|Overall Study|Lack of Efficacy|8|||
124838370|NCT00603746|449037643|FG000|Overall Study|Protocol Violation|0|||
124838371|NCT00603746|449037644|FG001|Overall Study|Protocol Violation|3|||
124838372|NCT00603746|449037645|FG002|Overall Study|Protocol Violation|1|||
124838373|NCT00603746|449037646|FG003|Overall Study|Protocol Violation|0|||
124838374|NCT00603746|449037647|FG004|Overall Study|Protocol Violation|1|||
124838375|NCT00603746|449037648|FG005|Overall Study|Protocol Violation|0|||
124838376|NCT00603746|449037643|FG000|Overall Study|Lost to Follow-up|0|||
124838377|NCT00603746|449037644|FG001|Overall Study|Lost to Follow-up|1|||
124838378|NCT00603746|449037645|FG002|Overall Study|Lost to Follow-up|1|||
124838379|NCT00603746|449037646|FG003|Overall Study|Lost to Follow-up|0|||
124838380|NCT00603746|449037647|FG004|Overall Study|Lost to Follow-up|0|||
124838381|NCT00603746|449037648|FG005|Overall Study|Lost to Follow-up|0|||
124838382|NCT00603746|449037643|FG000|Overall Study|Physician Decision|1|||
124838383|NCT00603746|449037644|FG001|Overall Study|Physician Decision|0|||
124838384|NCT00603746|449037645|FG002|Overall Study|Physician Decision|0|||
124838385|NCT00603746|449037646|FG003|Overall Study|Physician Decision|0|||
124838386|NCT00603746|449037647|FG004|Overall Study|Physician Decision|1|||
124838387|NCT00603746|449037648|FG005|Overall Study|Physician Decision|0|||
124838388|NCT00603746|449037643|FG000|Overall Study|Withdrawal by Subject|1|||
124838389|NCT00603746|449037644|FG001|Overall Study|Withdrawal by Subject|0|||
124838390|NCT00603746|449037645|FG002|Overall Study|Withdrawal by Subject|0|||
124838391|NCT00603746|449037646|FG003|Overall Study|Withdrawal by Subject|1|||
124838392|NCT00603746|449037647|FG004|Overall Study|Withdrawal by Subject|3|||
124838393|NCT00603746|449037648|FG005|Overall Study|Withdrawal by Subject|1|||
124838394|NCT01524627|449037651|FG000|Overall Study|Physician Decision|0|||
124838395|NCT01524627|449037652|FG001|Overall Study|Physician Decision|1|||
124838396|NCT01524627|449037651|FG000|Overall Study|Lost to Follow-up|1|||
124838397|NCT01524627|449037652|FG001|Overall Study|Lost to Follow-up|1|||
124838398|NCT03323658|449037653|FG000|Overall Study|Adverse Event|0|||
124838399|NCT03323658|449037654|FG001|Overall Study|Adverse Event|1|||
124838400|NCT03323658|449037655|FG002|Overall Study|Adverse Event|0|||
124838401|NCT03913091|449037656|FG000|Overall Study|Lost to Follow-up|18|||
124838402|NCT03913091|449037657|FG001|Overall Study|Lost to Follow-up|11|||
124838403|NCT03913091|449037656|FG000|Overall Study|Required additional meds/surgery|1|||
124838404|NCT03913091|449037657|FG001|Overall Study|Required additional meds/surgery|2|||
124838405|NCT03913091|449037656|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
124838406|NCT03913091|449037657|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
124838407|NCT00969553|449037658|FG000|Overall Study|Progressive disease (PD)|2|||
124838408|NCT00969553|449037659|FG001|Overall Study|Progressive disease (PD)|2|||
124838409|NCT00969553|449037660|FG002|Overall Study|Progressive disease (PD)|6|||
124838410|NCT00969553|449037661|FG003|Overall Study|Progressive disease (PD)|9|||
124838411|NCT00969553|449037662|FG004|Overall Study|Progressive disease (PD)|2|||
124838412|NCT00969553|449037663|FG005|Overall Study|Progressive disease (PD)|4|||
124838413|NCT00969553|449037664|FG006|Overall Study|Progressive disease (PD)|2|||
124838414|NCT00969553|449037665|FG007|Overall Study|Progressive disease (PD)|12|||
124838415|NCT00969553|449037666|FG008|Overall Study|Progressive disease (PD)|3|||
124838416|NCT00969553|449037658|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
124838417|NCT00969553|449037659|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
124838418|NCT00969553|449037660|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
124838419|NCT00969553|449037661|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
124838420|NCT00969553|449037662|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
124838421|NCT00969553|449037663|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
124838422|NCT00969553|449037664|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
124838423|NCT00969553|449037665|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
124838424|NCT00969553|449037666|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
124838425|NCT00969553|449037658|FG000|Overall Study|Other Adverse Event|0|||
124838426|NCT00969553|449037659|FG001|Overall Study|Other Adverse Event|0|||
124838427|NCT00969553|449037660|FG002|Overall Study|Other Adverse Event|0|||
124838428|NCT00969553|449037661|FG003|Overall Study|Other Adverse Event|1|||
124838429|NCT00969553|449037662|FG004|Overall Study|Other Adverse Event|0|||
124838430|NCT00969553|449037663|FG005|Overall Study|Other Adverse Event|0|||
124838431|NCT00969553|449037664|FG006|Overall Study|Other Adverse Event|1|||
124838432|NCT00969553|449037665|FG007|Overall Study|Other Adverse Event|0|||
124838433|NCT00969553|449037666|FG008|Overall Study|Other Adverse Event|0|||
124838434|NCT00969553|449037658|FG000|Overall Study|Refused cont. medication|1|||
124838435|NCT00969553|449037659|FG001|Overall Study|Refused cont. medication|1|||
124838436|NCT00969553|449037660|FG002|Overall Study|Refused cont. medication|0|||
124838437|NCT00969553|449037661|FG003|Overall Study|Refused cont. medication|2|||
124838438|NCT00969553|449037662|FG004|Overall Study|Refused cont. medication|0|||
124838439|NCT00969553|449037663|FG005|Overall Study|Refused cont. medication|0|||
124838440|NCT00969553|449037664|FG006|Overall Study|Refused cont. medication|0|||
124838441|NCT00969553|449037665|FG007|Overall Study|Refused cont. medication|1|||
124838442|NCT00969553|449037666|FG008|Overall Study|Refused cont. medication|0|||
124838443|NCT00969553|449037658|FG000|Overall Study|Not specified above|0|||
124838444|NCT00969553|449037659|FG001|Overall Study|Not specified above|0|||
124838445|NCT00969553|449037660|FG002|Overall Study|Not specified above|0|||
124838446|NCT00969553|449037661|FG003|Overall Study|Not specified above|4|||
124838447|NCT00969553|449037662|FG004|Overall Study|Not specified above|0|||
124838448|NCT00969553|449037663|FG005|Overall Study|Not specified above|0|||
124838449|NCT00969553|449037664|FG006|Overall Study|Not specified above|1|||
124838450|NCT00969553|449037665|FG007|Overall Study|Not specified above|1|||
124838451|NCT00969553|449037666|FG008|Overall Study|Not specified above|0|||
124838452|NCT02276612|449037668|FG000|Overall Study|Death|1|||
124838453|NCT02276612|449037669|FG001|Overall Study|Death|0|||
124838454|NCT02276612|449037668|FG000|Overall Study|Pregnancy|1|||
124838455|NCT02276612|449037669|FG001|Overall Study|Pregnancy|0|||
124838456|NCT02276612|449037668|FG000|Overall Study|Withdrew Consent|1|||
124838457|NCT02276612|449037669|FG001|Overall Study|Withdrew Consent|0|||
124838458|NCT02276612|449037668|FG000|Overall Study|Lost to Follow-up|1|||
124838459|NCT02276612|449037669|FG001|Overall Study|Lost to Follow-up|0|||
124838460|NCT02196324|449037670|FG000|Overall Study|Withdrawal by Subject|8|||
124838461|NCT02196324|449037671|FG001|Overall Study|Withdrawal by Subject|4|||
124838462|NCT02196324|449037670|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
124838463|NCT02196324|449037671|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
124838464|NCT02196324|449037670|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
124838465|NCT02196324|449037671|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
124838466|NCT02196324|449037670|FG000|Overall Study|Other|1|||
124838467|NCT02196324|449037671|FG001|Overall Study|Other|0|||
124838468|NCT00692770|449037672|FG000|Overall Study|Protocol Violation|2|||
124838469|NCT00692770|449037673|FG001|Overall Study|Protocol Violation|7|||
124838470|NCT00692770|449037672|FG000|Overall Study|Withdrawal by Subject|97|||
124838471|NCT00692770|449037673|FG001|Overall Study|Withdrawal by Subject|36|||
124838472|NCT00692770|449037672|FG000|Overall Study|Adverse Event|136|||
124838473|NCT00692770|449037673|FG001|Overall Study|Adverse Event|41|||
124838474|NCT00692770|449037672|FG000|Overall Study|Death|10|||
124838475|NCT00692770|449037673|FG001|Overall Study|Death|5|||
124838476|NCT00692770|449037672|FG000|Overall Study|Lost to Follow-up|7|||
124838477|NCT00692770|449037673|FG001|Overall Study|Lost to Follow-up|3|||
124838478|NCT00692770|449037672|FG000|Overall Study|Non-compliant with study medication|11|||
124838479|NCT00692770|449037673|FG001|Overall Study|Non-compliant with study medication|5|||
124838480|NCT00692770|449037672|FG000|Overall Study|Progression by clinical judgment|2|||
124838481|NCT00692770|449037673|FG001|Overall Study|Progression by clinical judgment|3|||
124838482|NCT00692770|449037672|FG000|Overall Study|Physician decision not protocol driven|10|||
124838483|NCT00692770|449037673|FG001|Overall Study|Physician decision not protocol driven|14|||
124838484|NCT00692770|449037672|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
125305030|NCT04405076|450742827|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
125305031|NCT04405076|450742828|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
125305032|NCT04405076|450742820|FG000|Part A (Blinded Phase)|Other than Specified|0|||
125305033|NCT04405076|450742821|FG001|Part A (Blinded Phase)|Other than Specified|0|||
125305034|NCT04405076|450742822|FG002|Part A (Blinded Phase)|Other than Specified|3|||
125305035|NCT04405076|450742823|FG003|Part A (Blinded Phase)|Other than Specified|0|||
125305036|NCT04405076|450742824|FG004|Part A (Blinded Phase)|Other than Specified|0|||
124838485|NCT00692770|449037673|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
124838486|NCT00692770|449037672|FG000|Overall Study|Protocol driven decision point|3|||
124838487|NCT00692770|449037673|FG001|Overall Study|Protocol driven decision point|7|||
124838488|NCT00692770|449037672|FG000|Overall Study|Completed all planned assessments|79|||
124838489|NCT00692770|449037673|FG001|Overall Study|Completed all planned assessments|101|||
124838490|NCT00692770|449037672|FG000|Overall Study|Radiological and clinical progression|8|||
124838491|NCT00692770|449037673|FG001|Overall Study|Radiological and clinical progression|8|||
124838492|NCT00692770|449037672|FG000|Overall Study|Clinical endpoint reached|16|||
124838493|NCT00692770|449037673|FG001|Overall Study|Clinical endpoint reached|43|||
124838494|NCT00692770|449037672|FG000|Overall Study|Study terminated by sponsor|2|||
124838495|NCT00692770|449037673|FG001|Overall Study|Study terminated by sponsor|2|||
124838496|NCT00692770|449037672|FG000|Overall Study|Randomized but not treated|3|||
124838497|NCT00692770|449037673|FG001|Overall Study|Randomized but not treated|4|||
124838498|NCT04248816|449037674|FG000|Overall Study|Ineligible post-randomization|7|||
124838499|NCT04248816|449037675|FG001|Overall Study|Ineligible post-randomization|21|||
124838500|NCT04248816|449037676|FG002|Overall Study|Ineligible post-randomization|25|||
124838501|NCT00262067|449037677|FG000|Overall Study|Death|190|||
124838502|NCT00262067|449037678|FG001|Overall Study|Death|89|||
124838503|NCT00262067|449037679|FG002|Overall Study|Death|186|||
124838504|NCT00262067|449037680|FG003|Overall Study|Death|99|||
124838505|NCT00262067|449037677|FG000|Overall Study|Lost to Follow-up|5|||
124838506|NCT00262067|449037678|FG001|Overall Study|Lost to Follow-up|4|||
124838507|NCT00262067|449037679|FG002|Overall Study|Lost to Follow-up|7|||
124838508|NCT00262067|449037680|FG003|Overall Study|Lost to Follow-up|5|||
124838509|NCT00262067|449037677|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
124838510|NCT00262067|449037678|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
124838511|NCT00262067|449037679|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
124838512|NCT00262067|449037680|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
124838513|NCT00262067|449037677|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
124838514|NCT00262067|449037678|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
124838515|NCT00262067|449037679|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
124838516|NCT00262067|449037680|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
124838517|NCT00655564|449037681|FG000|Overall Study|Adverse Event|1|||
124838518|NCT00655564|449037681|FG000|Overall Study|Lost to Follow-up|1|||
124838519|NCT00655564|449037681|FG000|Overall Study|Desired Alternate Therapy|1|||
124838520|NCT04536727|449037682|FG000|Overall Study|Lost to Follow-up|1|||
124838521|NCT04536727|449037683|FG001|Overall Study|Lost to Follow-up|1|||
124838522|NCT04536727|449037682|FG000|Overall Study|Death|0|||
124838523|NCT04536727|449037683|FG001|Overall Study|Death|1|||
124838524|NCT01077804|449037684|FG000|Overall Study|Unreachable|102|||
124838525|NCT01077804|449037684|FG000|Overall Study|Refused to continue|79|||
124838526|NCT01077804|449037684|FG000|Overall Study|Other|18|||
124838527|NCT00256698|449037685|FG000|Overall Study|Withdrawal by Subject|7|||
124838528|NCT00256698|449037686|FG001|Overall Study|Withdrawal by Subject|7|||
124838529|NCT00256698|449037685|FG000|Overall Study|Adverse Event|13|||
124838530|NCT00256698|449037686|FG001|Overall Study|Adverse Event|6|||
124838531|NCT00256698|449037685|FG000|Overall Study|Protocol Violation|6|||
124838532|NCT00256698|449037686|FG001|Overall Study|Protocol Violation|5|||
124838533|NCT00256698|449037685|FG000|Overall Study|Lost to Follow-up|1|||
124838534|NCT00256698|449037686|FG001|Overall Study|Lost to Follow-up|3|||
124838535|NCT00256698|449037685|FG000|Overall Study|disease progression|97|||
124838536|NCT00256698|449037686|FG001|Overall Study|disease progression|105|||
124838537|NCT00256698|449037685|FG000|Overall Study|still ongoing at data cut-off|41|||
124838538|NCT00256698|449037686|FG001|Overall Study|still ongoing at data cut-off|46|||
124838539|NCT00256698|449037685|FG000|Overall Study|withdrawn due to osteoporosis|1|||
124838540|NCT00256698|449037686|FG001|Overall Study|withdrawn due to osteoporosis|0|||
124838541|NCT00256698|449037685|FG000|Overall Study|Prematurely Discontinued|1|||
124838542|NCT00256698|449037686|FG001|Overall Study|Prematurely Discontinued|0|||
124838543|NCT02620046|449037688|FG000|Overall Study|Adverse Event|22|||
124838544|NCT02620046|449037689|FG001|Overall Study|Adverse Event|42|||
124838545|NCT02620046|449037688|FG000|Overall Study|Lost to Follow-up|4|||
124838546|NCT02620046|449037689|FG001|Overall Study|Lost to Follow-up|10|||
124838547|NCT02620046|449037688|FG000|Overall Study|Withdrawal by Subject|36|||
124838548|NCT02620046|449037689|FG001|Overall Study|Withdrawal by Subject|66|||
124838549|NCT02620046|449037688|FG000|Overall Study|Site Termination|3|||
124838550|NCT02620046|449037689|FG001|Overall Study|Site Termination|3|||
124838551|NCT02620046|449037688|FG000|Overall Study|Pregnancy|3|||
124838552|NCT02620046|449037689|FG001|Overall Study|Pregnancy|7|||
124838553|NCT02620046|449037688|FG000|Overall Study|Lack of Efficacy|81|||
124838554|NCT02620046|449037689|FG001|Overall Study|Lack of Efficacy|146|||
124838555|NCT02620046|449037688|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
124838556|NCT02620046|449037689|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
124838557|NCT02620046|449037688|FG000|Overall Study|Reason Not Specified|13|||
124838558|NCT02620046|449037689|FG001|Overall Study|Reason Not Specified|21|||
124838559|NCT02620046|449037688|FG000|Overall Study|Significant Protocol Deviation|0|||
124838560|NCT02620046|449037689|FG001|Overall Study|Significant Protocol Deviation|1|||
124838561|NCT03962543|449037690|FG000|Treatment Phase|Death|0|||
124838562|NCT03962543|449037691|FG001|Treatment Phase|Death|1|||
124838563|NCT03962543|449037690|FG000|Treatment Phase|Withdrawal by Subject|3|||
124838564|NCT03962543|449037691|FG001|Treatment Phase|Withdrawal by Subject|0|||
124838565|NCT03962543|449037690|FG000|Treatment Phase|Adverse Event|3|||
124838566|NCT03962543|449037691|FG001|Treatment Phase|Adverse Event|12|||
124838567|NCT03962543|449037690|FG000|Treatment Phase|Lost to Follow-up|1|||
124838568|NCT03962543|449037691|FG001|Treatment Phase|Lost to Follow-up|2|||
124838569|NCT03962543|449037690|FG000|Treatment Phase|Radiographic PD|9|||
124838570|NCT03962543|449037691|FG001|Treatment Phase|Radiographic PD|3|||
124838571|NCT03962543|449037690|FG000|Treatment Phase|Participant Decision|3|||
124838572|NCT03962543|449037691|FG001|Treatment Phase|Participant Decision|8|||
124838573|NCT03962543|449037690|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
124838574|NCT03962543|449037691|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
124838575|NCT03962543|449037690|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
124838576|NCT03962543|449037691|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
125305037|NCT04405076|450742825|FG005|Part A (Blinded Phase)|Other than Specified|0|||
125305038|NCT04405076|450742826|FG006|Part A (Blinded Phase)|Other than Specified|0|||
125305039|NCT04405076|450742827|FG007|Part A (Blinded Phase)|Other than Specified|0|||
125305040|NCT04405076|450742828|FG008|Part A (Blinded Phase)|Other than Specified|0|||
125305041|NCT04405076|450742820|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
125305042|NCT04405076|450742821|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
125305043|NCT04405076|450742822|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
125305044|NCT04405076|450742823|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
125305045|NCT04405076|450742824|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
125305046|NCT04405076|450742825|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
125305047|NCT04405076|450742826|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
125305048|NCT04405076|450742827|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
125305049|NCT04405076|450742828|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
125305050|NCT04405076|450742820|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
125305051|NCT04405076|450742821|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
125305052|NCT04405076|450742822|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
125305053|NCT04405076|450742823|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
125305054|NCT04405076|450742824|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
124838577|NCT03962543|449037690|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
124838578|NCT03962543|449037691|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
124838579|NCT03962543|449037690|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
124838580|NCT03962543|449037691|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
124838581|NCT03962543|449037690|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
124838582|NCT03962543|449037691|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
124838583|NCT03962543|449037690|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
124838584|NCT03962543|449037691|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
124838585|NCT03962543|449037690|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
124838586|NCT03962543|449037691|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
124838587|NCT03962543|449037690|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
124838588|NCT03962543|449037691|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
124838589|NCT03962543|449037690|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
124838590|NCT03962543|449037691|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
124838591|NCT03962543|449037690|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
124838592|NCT03962543|449037691|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
124838593|NCT03252522|449038940|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
124838594|NCT03252522|449038941|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
124838595|NCT03252522|449038942|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
124838596|NCT03252522|449038940|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
124838597|NCT03252522|449038941|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
124838598|NCT03252522|449038942|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
124838599|NCT03252522|449038940|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
124838600|NCT03252522|449038941|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
124838601|NCT03252522|449038942|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
124838602|NCT03252522|449038940|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
124838603|NCT03252522|449038941|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
124838604|NCT03252522|449038942|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
124838605|NCT03252522|449038940|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
124838606|NCT03252522|449038941|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
124838607|NCT03252522|449038942|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
124838608|NCT03252522|449038940|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
124838609|NCT03252522|449038941|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
124838610|NCT03252522|449038942|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
124838611|NCT03252522|449038940|FG000|Phase 2: Open Label|Adverse Event|0|||
124838612|NCT03252522|449038941|FG001|Phase 2: Open Label|Adverse Event|0|||
124838613|NCT03252522|449038942|FG002|Phase 2: Open Label|Adverse Event|2|||
124838614|NCT03252522|449038940|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
124838615|NCT03252522|449038941|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
125305055|NCT04405076|450742825|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
125305056|NCT04405076|450742826|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
125305057|NCT04405076|450742827|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
125305058|NCT04405076|450742828|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
125305059|NCT04405076|450742820|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
125305060|NCT04405076|450742821|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
125305061|NCT04405076|450742822|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
125305062|NCT04405076|450742823|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
125305063|NCT04405076|450742824|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
125305064|NCT04405076|450742825|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
125305065|NCT04405076|450742826|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
125305066|NCT04405076|450742827|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
125305067|NCT04405076|450742828|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
125305068|NCT04405076|450742820|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
125305069|NCT04405076|450742821|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
125305070|NCT04405076|450742822|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
125305071|NCT04405076|450742823|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
125305072|NCT04405076|450742824|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
125305073|NCT04405076|450742825|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
125305074|NCT04405076|450742826|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
125305075|NCT04405076|450742827|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
125305076|NCT04405076|450742828|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
125305077|NCT04405076|450742820|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
125305078|NCT04405076|450742821|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
125305079|NCT04405076|450742822|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
125305080|NCT04405076|450742823|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
125305081|NCT04405076|450742824|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
125305082|NCT04405076|450742825|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
125305083|NCT04405076|450742826|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
125305084|NCT04405076|450742827|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
125305085|NCT04405076|450742828|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
125305086|NCT00392990|450742829|FG000|Treatment on Study|Adverse Event|3|||
125305087|NCT00392990|450742830|FG001|Treatment on Study|Adverse Event|1|||
124838616|NCT03252522|449038942|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
124838617|NCT02181556|449038943|FG000|Overall Study|Withdrawal by Subject|1|||
124838618|NCT01572038|449038944|FG000|Overall Study|Death|648|||
125305088|NCT00392990|450742829|FG000|Follow up for 2 Years|Death|4|||
125305089|NCT00392990|450742830|FG001|Follow up for 2 Years|Death|0|||
125305090|NCT02980133|450742831|FG000|Overall Study|Other than specified|1|||
125305091|NCT02980133|450742832|FG001|Overall Study|Other than specified|1|||
125305092|NCT02980133|450742833|FG002|Overall Study|Other than specified|2|||
125305093|NCT02980133|450742834|FG003|Overall Study|Other than specified|2|||
125305094|NCT02980133|450742831|FG000|Overall Study|Lost to Follow-up|0|||
125305095|NCT02980133|450742832|FG001|Overall Study|Lost to Follow-up|0|||
125305096|NCT02980133|450742833|FG002|Overall Study|Lost to Follow-up|1|||
125305097|NCT02980133|450742834|FG003|Overall Study|Lost to Follow-up|3|||
125305098|NCT02980133|450742831|FG000|Overall Study|Protocol Violation|0|||
125305099|NCT02980133|450742832|FG001|Overall Study|Protocol Violation|1|||
125305100|NCT02980133|450742833|FG002|Overall Study|Protocol Violation|0|||
125305101|NCT02980133|450742834|FG003|Overall Study|Protocol Violation|0|||
125305102|NCT02980133|450742831|FG000|Overall Study|Withdrawal by parent/guardian|6|||
125305103|NCT02980133|450742832|FG001|Overall Study|Withdrawal by parent/guardian|3|||
125305104|NCT02980133|450742833|FG002|Overall Study|Withdrawal by parent/guardian|3|||
125305105|NCT02980133|450742834|FG003|Overall Study|Withdrawal by parent/guardian|1|||
125305106|NCT02980133|450742831|FG000|Overall Study|Withdrawal by Subject|0|||
125305107|NCT02980133|450742832|FG001|Overall Study|Withdrawal by Subject|0|||
125305108|NCT02980133|450742833|FG002|Overall Study|Withdrawal by Subject|1|||
125305109|NCT02980133|450742834|FG003|Overall Study|Withdrawal by Subject|0|||
125305110|NCT00172042|450742835|FG000|Overall Study|Adverse Event|27|||
125305111|NCT00172042|450742836|FG001|Overall Study|Adverse Event|13|||
125305112|NCT00172042|450742835|FG000|Overall Study|Abnormal laboratory value(s)|5|||
125305113|NCT00172042|450742836|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125305114|NCT00172042|450742835|FG000|Overall Study|Abnormal test procedure(s)|0|||
125305115|NCT00172042|450742836|FG001|Overall Study|Abnormal test procedure(s)|3|||
125305116|NCT00172042|450742835|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
125305117|NCT00172042|450742836|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
125305118|NCT00172042|450742835|FG000|Overall Study|Patient no longer requires study drug|10|||
125305119|NCT00172042|450742836|FG001|Overall Study|Patient no longer requires study drug|8|||
125305120|NCT00172042|450742835|FG000|Overall Study|Protocol Violation|8|||
125305121|NCT00172042|450742836|FG001|Overall Study|Protocol Violation|7|||
125305122|NCT00172042|450742835|FG000|Overall Study|Withdrawal by Subject|37|||
125305123|NCT00172042|450742836|FG001|Overall Study|Withdrawal by Subject|25|||
125305124|NCT00172042|450742835|FG000|Overall Study|Lost to Follow-up|3|||
125305125|NCT00172042|450742836|FG001|Overall Study|Lost to Follow-up|5|||
125305126|NCT00172042|450742835|FG000|Overall Study|Administrative problems|13|||
125305127|NCT00172042|450742836|FG001|Overall Study|Administrative problems|10|||
125305128|NCT00172042|450742835|FG000|Overall Study|Death|42|||
125305129|NCT00172042|450742836|FG001|Overall Study|Death|42|||
125305130|NCT03052816|450742837|FG000|Overall Study|Withdrawal by Subject|1|||
125305131|NCT03052816|450742838|FG001|Overall Study|Withdrawal by Subject|0|||
125305132|NCT03052816|450742837|FG000|Overall Study|Desired opioids|2|||
125305133|NCT03052816|450742838|FG001|Overall Study|Desired opioids|0|||
125305134|NCT00408434|450742839|FG000|Overall Study|Adverse Event|0|||
125305135|NCT00408434|450742840|FG001|Overall Study|Adverse Event|0|||
125305136|NCT00408434|450742841|FG002|Overall Study|Adverse Event|1|||
125305137|NCT00408434|450742842|FG003|Overall Study|Adverse Event|0|||
125305138|NCT00408434|450742843|FG004|Overall Study|Adverse Event|0|||
125305139|NCT00408434|450742844|FG005|Overall Study|Adverse Event|0|||
125305140|NCT00408434|450742845|FG006|Overall Study|Adverse Event|0|||
125305141|NCT00408434|450742839|FG000|Overall Study|Progressive disease|6|||
125305142|NCT00408434|450742840|FG001|Overall Study|Progressive disease|3|||
125305143|NCT00408434|450742841|FG002|Overall Study|Progressive disease|4|||
125305144|NCT00408434|450742842|FG003|Overall Study|Progressive disease|3|||
125305145|NCT00408434|450742843|FG004|Overall Study|Progressive disease|3|||
125305146|NCT00408434|450742844|FG005|Overall Study|Progressive disease|1|||
125305147|NCT00408434|450742845|FG006|Overall Study|Progressive disease|4|||
125305148|NCT00408434|450742839|FG000|Overall Study|Other|0|||
125305149|NCT00408434|450742840|FG001|Overall Study|Other|0|||
125305150|NCT00408434|450742841|FG002|Overall Study|Other|1|||
125305151|NCT00408434|450742842|FG003|Overall Study|Other|0|||
125305152|NCT00408434|450742843|FG004|Overall Study|Other|2|||
125305153|NCT00408434|450742844|FG005|Overall Study|Other|1|||
125305154|NCT00408434|450742845|FG006|Overall Study|Other|0|||
125305155|NCT00408434|450742839|FG000|Overall Study|Terminated by Investigator|0|||
125305156|NCT00408434|450742840|FG001|Overall Study|Terminated by Investigator|0|||
125305157|NCT00408434|450742841|FG002|Overall Study|Terminated by Investigator|0|||
125305158|NCT00408434|450742842|FG003|Overall Study|Terminated by Investigator|0|||
125305159|NCT00408434|450742843|FG004|Overall Study|Terminated by Investigator|1|||
125305160|NCT00408434|450742844|FG005|Overall Study|Terminated by Investigator|1|||
125305161|NCT00408434|450742845|FG006|Overall Study|Terminated by Investigator|0|||
125305162|NCT01278797|450742846|FG000|Period 1|Adverse Event|0|||
125305163|NCT01278797|450742847|FG001|Period 1|Adverse Event|1|||
125305164|NCT01278797|450742846|FG000|Period 1|Protocol Violation|1|||
125305165|NCT01278797|450742847|FG001|Period 1|Protocol Violation|0|||
125305166|NCT00895453|450742848|FG000|Overall Study|Lost to Follow-up|25|||
125305167|NCT00895453|450742849|FG001|Overall Study|Lost to Follow-up|25|||
125305168|NCT00895453|450742850|FG002|Overall Study|Lost to Follow-up|23|||
125305169|NCT03188510|450742852|FG000|Overall Study|Inappropriate behavior with site staff|0|||
125305170|NCT03188510|450742853|FG001|Overall Study|Inappropriate behavior with site staff|1|||
125305171|NCT03188510|450742854|FG002|Overall Study|Inappropriate behavior with site staff|0|||
125305172|NCT03052049|450742856|FG000|Overall Study|Withdrawal by Subject|2|||
125305173|NCT03343626|450744993|FG000|Overall Study|Lost to Follow-up|4|||
125305174|NCT03343626|450744994|FG001|Overall Study|Lost to Follow-up|3|||
125305175|NCT03343626|450744995|FG002|Overall Study|Lost to Follow-up|2|||
125305176|NCT03343626|450744996|FG003|Overall Study|Lost to Follow-up|5|||
125305177|NCT03343626|450744997|FG004|Overall Study|Lost to Follow-up|4|||
125305178|NCT03343626|450744998|FG005|Overall Study|Lost to Follow-up|4|||
125305179|NCT03343626|450744999|FG006|Overall Study|Lost to Follow-up|4|||
125305180|NCT03343626|450745000|FG007|Overall Study|Lost to Follow-up|7|||
125305181|NCT03343626|450744993|FG000|Overall Study|Withdrawal of Consent|2|||
125305182|NCT03343626|450744994|FG001|Overall Study|Withdrawal of Consent|1|||
125305183|NCT03343626|450744995|FG002|Overall Study|Withdrawal of Consent|0|||
125305184|NCT03343626|450744996|FG003|Overall Study|Withdrawal of Consent|3|||
125305185|NCT03343626|450744997|FG004|Overall Study|Withdrawal of Consent|3|||
125305186|NCT03343626|450744998|FG005|Overall Study|Withdrawal of Consent|1|||
125305187|NCT03343626|450744999|FG006|Overall Study|Withdrawal of Consent|1|||
125305188|NCT03343626|450745000|FG007|Overall Study|Withdrawal of Consent|2|||
125305189|NCT03343626|450744993|FG000|Overall Study|Reason not Specified|0|||
125305190|NCT03343626|450744994|FG001|Overall Study|Reason not Specified|1|||
125305191|NCT03343626|450744995|FG002|Overall Study|Reason not Specified|0|||
125305192|NCT03343626|450744996|FG003|Overall Study|Reason not Specified|0|||
125305193|NCT03343626|450744997|FG004|Overall Study|Reason not Specified|0|||
125305194|NCT03343626|450744998|FG005|Overall Study|Reason not Specified|0|||
125305195|NCT03343626|450744999|FG006|Overall Study|Reason not Specified|0|||
125305196|NCT03343626|450745000|FG007|Overall Study|Reason not Specified|1|||
125305197|NCT03343626|450744993|FG000|Overall Study|Data Entry Error|0|||
125305198|NCT03343626|450744994|FG001|Overall Study|Data Entry Error|0|||
125305199|NCT03343626|450744995|FG002|Overall Study|Data Entry Error|0|||
125305200|NCT03343626|450744996|FG003|Overall Study|Data Entry Error|0|||
125305201|NCT03343626|450744997|FG004|Overall Study|Data Entry Error|0|||
125305202|NCT03343626|450744998|FG005|Overall Study|Data Entry Error|0|||
125305203|NCT03343626|450744999|FG006|Overall Study|Data Entry Error|0|||
125305204|NCT03343626|450745000|FG007|Overall Study|Data Entry Error|1|||
125305205|NCT02475278|450745008|FG000|Overall Study|Lost to Follow-up|1|||
125305206|NCT02475278|450745008|FG000|Overall Study|Reason Not Specified|1|||
125305207|NCT00826618|450745009|FG000|Overall Study|Withdrawal by Subject|1|||
125305208|NCT03712787|450745010|FG000|Overall Study|Adverse Event|2|||
125305209|NCT03712787|450745011|FG001|Overall Study|Adverse Event|3|||
125305210|NCT03712787|450745012|FG002|Overall Study|Adverse Event|0|||
125305211|NCT03712787|450745013|FG003|Overall Study|Adverse Event|4|||
125305212|NCT03712787|450745010|FG000|Overall Study|Withdrawal by Subject|4|||
125305213|NCT03712787|450745011|FG001|Overall Study|Withdrawal by Subject|14|||
125305214|NCT03712787|450745012|FG002|Overall Study|Withdrawal by Subject|12|||
124838619|NCT01572038|449038944|FG000|Overall Study|Withdrawal by Subject|204|||
124838620|NCT01572038|449038944|FG000|Overall Study|Lost to Follow-up|81|||
124838621|NCT01572038|449038944|FG000|Overall Study|Physician Decision|20|||
124838622|NCT01572038|449038944|FG000|Overall Study|Patient Decision|14|||
124838623|NCT01572038|449038944|FG000|Overall Study|Progressive Disease|8|||
124838624|NCT01572038|449038944|FG000|Overall Study|Site Closed Before Completing Form|6|||
124838625|NCT01572038|449038944|FG000|Overall Study|Enrolled into Another Trial|3|||
124838626|NCT01572038|449038944|FG000|Overall Study|Participated in Another Trial|3|||
125305215|NCT03712787|450745013|FG003|Overall Study|Withdrawal by Subject|8|||
125305216|NCT03712787|450745010|FG000|Overall Study|Lost to Follow-up|1|||
125305217|NCT03712787|450745011|FG001|Overall Study|Lost to Follow-up|1|||
125305218|NCT03712787|450745012|FG002|Overall Study|Lost to Follow-up|2|||
125305219|NCT03712787|450745013|FG003|Overall Study|Lost to Follow-up|1|||
125305220|NCT03712787|450745010|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
125305221|NCT03712787|450745011|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
124838627|NCT01572038|449038944|FG000|Overall Study|Termination by Sponsor|2|||
125305222|NCT03712787|450745012|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
125305223|NCT03712787|450745013|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
125305224|NCT03712787|450745010|FG000|Overall Study|COVID-19 Infection|0|||
125305225|NCT03712787|450745011|FG001|Overall Study|COVID-19 Infection|1|||
125305226|NCT03712787|450745012|FG002|Overall Study|COVID-19 Infection|0|||
125305227|NCT03712787|450745013|FG003|Overall Study|COVID-19 Infection|0|||
125305228|NCT03712787|450745010|FG000|Overall Study|Other, Not Specified|79|||
125305229|NCT03712787|450745011|FG001|Overall Study|Other, Not Specified|77|||
125305230|NCT03712787|450745012|FG002|Overall Study|Other, Not Specified|74|||
124838628|NCT01572038|449038944|FG000|Overall Study|Patient Deterioration|1|||
125305231|NCT03712787|450745013|FG003|Overall Study|Other, Not Specified|78|||
125305232|NCT00931606|450745015|FG000|Overall Study|Death|1|||
124838629|NCT01572038|449038944|FG000|Overall Study|Sponsor Decision|1|||
124838630|NCT01275066|449038951|FG000|Overall Study|Withdrawal by Subject|0|||
124838631|NCT01275066|449038952|FG001|Overall Study|Withdrawal by Subject|0|||
124838632|NCT01275066|449038953|FG002|Overall Study|Withdrawal by Subject|1|||
124838633|NCT01275066|449038951|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
124838634|NCT01275066|449038952|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
124838635|NCT01275066|449038953|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
124838636|NCT00850200|449038961|FG000|Overall Study|Physician Decision|2|||
124838637|NCT00850200|449038961|FG000|Overall Study|Did not recieve treatment|2|||
124838638|NCT00850200|449038961|FG000|Overall Study|Withdrawal by Subject|1|||
124838639|NCT02046148|449038965|FG000|Overall Study|Lost to Follow-up|1|||
124838640|NCT02046148|449038966|FG001|Overall Study|Lost to Follow-up|1|||
124838641|NCT02046148|449038965|FG000|Overall Study|Withdrawal by Subject|0|||
124838642|NCT02046148|449038966|FG001|Overall Study|Withdrawal by Subject|2|||
124838643|NCT00235872|449038971|FG000|Overall Study|Adverse Event|34|||
124838644|NCT00235872|449038971|FG000|Overall Study|Death|1|||
124838645|NCT00235872|449038971|FG000|Overall Study|Lost to Follow-up|1|||
124838646|NCT00235872|449038971|FG000|Overall Study|Withdrawal by Subject|50|||
124838647|NCT00235872|449038971|FG000|Overall Study|Administrative reason|61|||
124838648|NCT01446965|449038972|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
124838649|NCT01446965|449038973|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
124838650|NCT01446965|449038972|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
124838651|NCT01446965|449038973|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
124838652|NCT01232296|449038974|FG000|Overall Study|Adverse Event|24|||
124838653|NCT01232296|449038975|FG001|Overall Study|Adverse Event|12|||
124838654|NCT01232296|449038974|FG000|Overall Study|Physician Decision|1|||
124838655|NCT01232296|449038975|FG001|Overall Study|Physician Decision|1|||
124838656|NCT01232296|449038974|FG000|Overall Study|Progressive disease|43|||
124838657|NCT01232296|449038975|FG001|Overall Study|Progressive disease|61|||
124838658|NCT01232296|449038974|FG000|Overall Study|Study terminated by sponsor|0|||
124838659|NCT01232296|449038975|FG001|Overall Study|Study terminated by sponsor|1|||
124838660|NCT01232296|449038974|FG000|Overall Study|Technical problems|3|||
124838661|NCT01232296|449038975|FG001|Overall Study|Technical problems|0|||
124838662|NCT01232296|449038974|FG000|Overall Study|Subject/guardian decision|10|||
124838663|NCT01232296|449038975|FG001|Overall Study|Subject/guardian decision|2|||
124838664|NCT01232296|449038974|FG000|Overall Study|Death|1|||
124838665|NCT01232296|449038975|FG001|Overall Study|Death|6|||
124838666|NCT02871375|449038976|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
124838667|NCT02871375|449038977|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
124838668|NCT00606892|449038986|FG000|First Intervention|Protocol Violation|1|||
124838669|NCT00606892|449038987|FG001|First Intervention|Protocol Violation|4|||
124838670|NCT00794196|449038994|FG000|Overall Study|Lost to Follow-up|5|||
124838671|NCT00794196|449038995|FG001|Overall Study|Lost to Follow-up|23|||
124838672|NCT02129803|449038996|FG000|Overall Study|Protocol Violation|4|||
124838673|NCT02129803|449038997|FG001|Overall Study|Protocol Violation|0|||
124838674|NCT02129803|449038996|FG000|Overall Study|Physician Decision|0|||
124838675|NCT02129803|449038997|FG001|Overall Study|Physician Decision|1|||
124838676|NCT02129803|449038996|FG000|Overall Study|Difficulty sleeping|1|||
124838677|NCT02129803|449038997|FG001|Overall Study|Difficulty sleeping|0|||
124838678|NCT02129803|449038996|FG000|Overall Study|Morning headache|0|||
124838679|NCT02129803|449038997|FG001|Overall Study|Morning headache|1|||
124838680|NCT02129803|449038996|FG000|Overall Study|Withdrawal by Subject|1|||
124838681|NCT02129803|449038997|FG001|Overall Study|Withdrawal by Subject|1|||
124838682|NCT00149747|449038999|FG000|Overall Study|Death|1|||
124838683|NCT00149747|449039000|FG001|Overall Study|Death|0|||
124838684|NCT00149747|449038999|FG000|Overall Study|Withdrawal by Subject|3|||
124838685|NCT00149747|449039000|FG001|Overall Study|Withdrawal by Subject|3|||
124838686|NCT00850395|449039006|FG000|Overall Study|Death|1|||
124838687|NCT00850395|449039006|FG000|Overall Study|Adverse Event|1|||
124838688|NCT00850395|449039006|FG000|Overall Study|Insufficient clinical response|3|||
124838689|NCT00850395|449039006|FG000|Overall Study|Other|5|||
124838690|NCT06049043|449039007|FG000|Overall Study|Lost to Follow-up|11|||
124838691|NCT06049043|449039008|FG001|Overall Study|Lost to Follow-up|9|||
124838692|NCT02739269|449039012|FG000|Overall Study|Protocol Violation|5|||
124838693|NCT02739269|449039013|FG001|Overall Study|Protocol Violation|0|||
124838694|NCT02739269|449039012|FG000|Overall Study|Cycle cancellation|2|||
124838695|NCT02739269|449039013|FG001|Overall Study|Cycle cancellation|2|||
124838696|NCT02739269|449039012|FG000|Overall Study|Withdrawal by Subject|0|||
124838697|NCT02739269|449039013|FG001|Overall Study|Withdrawal by Subject|2|||
124838698|NCT01354496|449039014|FG000|Period 1|Adverse Event|0|||
124838699|NCT01354496|449039015|FG001|Period 1|Adverse Event|0|||
124838700|NCT01354496|449039016|FG002|Period 1|Adverse Event|1|||
124838701|NCT01354496|449039017|FG003|Period 1|Adverse Event|0|||
124838702|NCT01354496|449039018|FG004|Period 1|Adverse Event|0|||
124838703|NCT01354496|449039019|FG005|Period 1|Adverse Event|0|||
124838704|NCT01354496|449039014|FG000|Period 1|Physician Decision|0|||
124838705|NCT01354496|449039015|FG001|Period 1|Physician Decision|0|||
124838706|NCT01354496|449039016|FG002|Period 1|Physician Decision|1|||
124838707|NCT01354496|449039017|FG003|Period 1|Physician Decision|0|||
124838708|NCT01354496|449039018|FG004|Period 1|Physician Decision|0|||
124838709|NCT01354496|449039019|FG005|Period 1|Physician Decision|0|||
124838710|NCT01354496|449039014|FG000|Period 2|Adverse Event|0|||
124838711|NCT01354496|449039015|FG001|Period 2|Adverse Event|0|||
124838712|NCT01354496|449039016|FG002|Period 2|Adverse Event|0|||
124838713|NCT01354496|449039017|FG003|Period 2|Adverse Event|1|||
124838714|NCT01354496|449039018|FG004|Period 2|Adverse Event|0|||
124838715|NCT01354496|449039019|FG005|Period 2|Adverse Event|0|||
124838716|NCT01354496|449039014|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
124838717|NCT01354496|449039015|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
124838718|NCT01354496|449039016|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
124838719|NCT01354496|449039017|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
124838720|NCT01354496|449039018|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
124838721|NCT01354496|449039019|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
124838722|NCT03554291|449039020|FG000|Overall Study|Death|2|||
124838723|NCT03554291|449039021|FG001|Overall Study|Death|1|||
124838724|NCT03554291|449039020|FG000|Overall Study|Lost to Follow-up|1|||
124838725|NCT03554291|449039021|FG001|Overall Study|Lost to Follow-up|0|||
124838726|NCT03554291|449039020|FG000|Overall Study|Withdrawal by Subject|1|||
124838727|NCT03554291|449039021|FG001|Overall Study|Withdrawal by Subject|0|||
124838728|NCT03554291|449039020|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
124838729|NCT03554291|449039021|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
124838730|NCT01228747|449039022|FG000|Overall Study|Adverse Event|8|||
124838731|NCT01228747|449039023|FG001|Overall Study|Adverse Event|4|||
124838732|NCT01228747|449039022|FG000|Overall Study|Lack of Efficacy|40|||
124838733|NCT01228747|449039023|FG001|Overall Study|Lack of Efficacy|27|||
124838734|NCT01228747|449039022|FG000|Overall Study|Protocol Violation|6|||
124838735|NCT01228747|449039023|FG001|Overall Study|Protocol Violation|5|||
124838736|NCT01228747|449039022|FG000|Overall Study|Lost to Follow-up|4|||
124838737|NCT01228747|449039023|FG001|Overall Study|Lost to Follow-up|3|||
124838738|NCT01228747|449039022|FG000|Overall Study|Withdrawal by Subject|5|||
124838739|NCT01228747|449039023|FG001|Overall Study|Withdrawal by Subject|1|||
124838740|NCT01228747|449039022|FG000|Overall Study|Other Reason|2|||
124838741|NCT01228747|449039023|FG001|Overall Study|Other Reason|5|||
124838742|NCT02036502|449039024|FG000|Part 1:Dose Determination/Escalation|Death|3|||
124838743|NCT02036502|449039025|FG001|Part 1:Dose Determination/Escalation|Death|2|||
124838744|NCT02036502|449039026|FG002|Part 1:Dose Determination/Escalation|Death|0|||
124838745|NCT02036502|449039027|FG003|Part 1:Dose Determination/Escalation|Death|0|||
124838746|NCT02036502|449039028|FG004|Part 1:Dose Determination/Escalation|Death|0|||
124838747|NCT02036502|449039029|FG005|Part 1:Dose Determination/Escalation|Death|0|||
124838748|NCT02036502|449039030|FG006|Part 1:Dose Determination/Escalation|Death|0|||
124838749|NCT02036502|449039031|FG007|Part 1:Dose Determination/Escalation|Death|0|||
124838750|NCT02036502|449039024|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
124838751|NCT02036502|449039025|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
124838752|NCT02036502|449039026|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
124838753|NCT02036502|449039027|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
124838754|NCT02036502|449039028|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
124838755|NCT02036502|449039029|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
124838756|NCT02036502|449039030|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
124838757|NCT02036502|449039031|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
124838758|NCT02036502|449039024|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
124838759|NCT02036502|449039025|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
124838760|NCT02036502|449039026|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
125305233|NCT00931606|450745016|FG001|Overall Study|Death|3|||
125305234|NCT00931606|450745017|FG002|Overall Study|Death|2|||
125305235|NCT00931606|450745018|FG003|Overall Study|Death|0|||
125305236|NCT00931606|450745015|FG000|Overall Study|Lost to Follow-up|0|||
125305237|NCT00931606|450745016|FG001|Overall Study|Lost to Follow-up|1|||
125305238|NCT00931606|450745017|FG002|Overall Study|Lost to Follow-up|0|||
125305239|NCT00931606|450745018|FG003|Overall Study|Lost to Follow-up|0|||
125305240|NCT00931606|450745015|FG000|Overall Study|Physician Decision|0|||
125305241|NCT00931606|450745016|FG001|Overall Study|Physician Decision|0|||
125305242|NCT00931606|450745017|FG002|Overall Study|Physician Decision|3|||
125305243|NCT00931606|450745018|FG003|Overall Study|Physician Decision|0|||
125305244|NCT00931606|450745015|FG000|Overall Study|Sponsor Decision|1|||
125305245|NCT00931606|450745016|FG001|Overall Study|Sponsor Decision|4|||
125305246|NCT00931606|450745017|FG002|Overall Study|Sponsor Decision|0|||
125305247|NCT00931606|450745018|FG003|Overall Study|Sponsor Decision|2|||
124838761|NCT02036502|449039027|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
124838762|NCT02036502|449039028|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
124838763|NCT02036502|449039029|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
124838764|NCT02036502|449039030|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
124838765|NCT02036502|449039031|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
124838766|NCT02036502|449039024|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
124838767|NCT02036502|449039025|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
124838768|NCT02036502|449039026|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
124838769|NCT02036502|449039027|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
124838770|NCT02036502|449039028|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
124838771|NCT02036502|449039029|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
124838772|NCT02036502|449039030|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
124838773|NCT02036502|449039031|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
124838774|NCT02036502|449039024|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
124838775|NCT02036502|449039025|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
124838776|NCT02036502|449039026|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
124838777|NCT02036502|449039027|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
124838778|NCT02036502|449039028|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
124838779|NCT02036502|449039029|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
124838780|NCT02036502|449039030|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
124838781|NCT02036502|449039031|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
124838782|NCT02036502|449039024|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
124838783|NCT02036502|449039025|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
124838784|NCT02036502|449039026|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
125305248|NCT00931606|450745015|FG000|Overall Study|Withdrawal by Subject|3|||
125305249|NCT00931606|450745016|FG001|Overall Study|Withdrawal by Subject|1|||
125305250|NCT00931606|450745017|FG002|Overall Study|Withdrawal by Subject|1|||
125305251|NCT00931606|450745018|FG003|Overall Study|Withdrawal by Subject|1|||
125305252|NCT03412812|450745026|FG000|Level 1|Death|3|||
125305253|NCT03412812|450745027|FG001|Level 1|Death|0|||
125305254|NCT03412812|450745026|FG000|Level 1|Adverse Event|0|||
125305255|NCT03412812|450745027|FG001|Level 1|Adverse Event|1|||
125305256|NCT02391363|450745033|FG000|Overall Study|Lost to Follow-up|5|||
125305257|NCT02391363|450745034|FG001|Overall Study|Lost to Follow-up|5|||
125305258|NCT02391363|450745033|FG000|Overall Study|Withdrawal by Subject|6|||
125305259|NCT02391363|450745034|FG001|Overall Study|Withdrawal by Subject|3|||
125305260|NCT03828617|450745035|FG000|Overall Study|Lost to Follow-up|22|||
125305261|NCT03828617|450745036|FG001|Overall Study|Lost to Follow-up|12|||
125305262|NCT03828617|450745037|FG002|Overall Study|Lost to Follow-up|23|||
125305263|NCT03828617|450745038|FG003|Overall Study|Lost to Follow-up|7|||
125305264|NCT03828617|450745035|FG000|Overall Study|No longer met eligibility criteria|0|||
125305265|NCT03828617|450745036|FG001|Overall Study|No longer met eligibility criteria|1|||
125305266|NCT03828617|450745037|FG002|Overall Study|No longer met eligibility criteria|1|||
125305267|NCT03828617|450745038|FG003|Overall Study|No longer met eligibility criteria|3|||
125305268|NCT03828617|450745035|FG000|Overall Study|Protocol Violation|0|||
125305269|NCT03828617|450745036|FG001|Overall Study|Protocol Violation|2|||
125305270|NCT03828617|450745037|FG002|Overall Study|Protocol Violation|0|||
125305271|NCT03828617|450745038|FG003|Overall Study|Protocol Violation|0|||
125305272|NCT03828617|450745035|FG000|Overall Study|Withdrawal by Subject|2|||
125305273|NCT03828617|450745036|FG001|Overall Study|Withdrawal by Subject|0|||
125305274|NCT03828617|450745037|FG002|Overall Study|Withdrawal by Subject|2|||
125305275|NCT03828617|450745038|FG003|Overall Study|Withdrawal by Subject|0|||
125305276|NCT04794270|450745039|FG000|Period 1|Non Compliance|1|||
125305277|NCT04794270|450745040|FG001|Period 1|Non Compliance|0|||
125305278|NCT04794270|450745039|FG000|Period 1|Adverse Event|1|||
125305279|NCT04794270|450745040|FG001|Period 1|Adverse Event|0|||
125305280|NCT04794270|450745039|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
125305281|NCT04794270|450745040|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
125305282|NCT00732875|450745045|FG000|Overall Study|Adverse Event|16|||
125305283|NCT00732875|450745045|FG000|Overall Study|Withdrawal by Subject|6|||
125305284|NCT00732875|450745045|FG000|Overall Study|Lack of Efficacy|13|||
125305285|NCT03826186|450745046|FG000|Overall Study|Protocol Violation|2|||
125305286|NCT03826186|450745047|FG001|Overall Study|Protocol Violation|0|||
125305287|NCT03826186|450745046|FG000|Overall Study|Withdrawal by Subject|1|||
125305288|NCT03826186|450745047|FG001|Overall Study|Withdrawal by Subject|0|||
125305289|NCT03688074|450745049|FG000|Overall Study|Adverse Event|0|||
125305290|NCT03688074|450745050|FG001|Overall Study|Adverse Event|1|||
124838785|NCT02036502|449039027|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
124838786|NCT02036502|449039028|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
125305291|NCT03688074|450745049|FG000|Overall Study|Other|1|||
125305292|NCT03688074|450745050|FG001|Overall Study|Other|0|||
125305293|NCT03056339|450745064|FG000|Overall Study|Failed Requirements|0|||
125305294|NCT03056339|450745065|FG001|Overall Study|Failed Requirements|2|||
125305295|NCT03056339|450745066|FG002|Overall Study|Failed Requirements|7|||
125305296|NCT03056339|450745067|FG003|Overall Study|Failed Requirements|1|||
125305297|NCT01128244|450745073|FG000|Overall Study|Adverse Event|1|||
125305298|NCT01128244|450745073|FG000|Overall Study|Scheduling conflict|2|||
125305299|NCT02219334|450745076|FG000|Overall Study|Withdrawal by Subject|1|||
125305300|NCT02219334|450745077|FG001|Overall Study|Withdrawal by Subject|0|||
125305301|NCT02219334|450745076|FG000|Overall Study|Protocol Violation|7|||
125305302|NCT02219334|450745077|FG001|Overall Study|Protocol Violation|3|||
124838787|NCT02036502|449039029|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
124838788|NCT02036502|449039030|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
124838789|NCT02036502|449039031|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
124838790|NCT02036502|449039024|FG000|Part 2:Dose Confirmation|Death|0|||
124838791|NCT02036502|449039025|FG001|Part 2:Dose Confirmation|Death|0|||
124838792|NCT02036502|449039026|FG002|Part 2:Dose Confirmation|Death|1|||
124838793|NCT02036502|449039027|FG003|Part 2:Dose Confirmation|Death|0|||
124838794|NCT02036502|449039028|FG004|Part 2:Dose Confirmation|Death|0|||
124838795|NCT02036502|449039029|FG005|Part 2:Dose Confirmation|Death|0|||
124838796|NCT02036502|449039030|FG006|Part 2:Dose Confirmation|Death|0|||
124838797|NCT02036502|449039031|FG007|Part 2:Dose Confirmation|Death|0|||
124838798|NCT02036502|449039024|FG000|Part 2:Dose Confirmation|Not treated|0|||
124838799|NCT02036502|449039025|FG001|Part 2:Dose Confirmation|Not treated|0|||
124838800|NCT02036502|449039026|FG002|Part 2:Dose Confirmation|Not treated|0|||
124838801|NCT02036502|449039027|FG003|Part 2:Dose Confirmation|Not treated|1|||
124838802|NCT02036502|449039028|FG004|Part 2:Dose Confirmation|Not treated|0|||
124838803|NCT02036502|449039029|FG005|Part 2:Dose Confirmation|Not treated|0|||
124838804|NCT02036502|449039030|FG006|Part 2:Dose Confirmation|Not treated|0|||
124838805|NCT02036502|449039031|FG007|Part 2:Dose Confirmation|Not treated|0|||
124838806|NCT02036502|449039024|FG000|Part 3:Dose Expansion|Adverse Event|0|||
124838807|NCT02036502|449039025|FG001|Part 3:Dose Expansion|Adverse Event|0|||
124838808|NCT02036502|449039026|FG002|Part 3:Dose Expansion|Adverse Event|0|||
124838809|NCT02036502|449039027|FG003|Part 3:Dose Expansion|Adverse Event|0|||
124838810|NCT02036502|449039028|FG004|Part 3:Dose Expansion|Adverse Event|0|||
124838811|NCT02036502|449039029|FG005|Part 3:Dose Expansion|Adverse Event|4|||
124838812|NCT02036502|449039030|FG006|Part 3:Dose Expansion|Adverse Event|0|||
124838813|NCT02036502|449039031|FG007|Part 3:Dose Expansion|Adverse Event|2|||
124838814|NCT02036502|449039024|FG000|Part 3:Dose Expansion|Death|0|||
124838815|NCT02036502|449039025|FG001|Part 3:Dose Expansion|Death|0|||
124838816|NCT02036502|449039026|FG002|Part 3:Dose Expansion|Death|0|||
124838817|NCT02036502|449039027|FG003|Part 3:Dose Expansion|Death|0|||
124838818|NCT02036502|449039028|FG004|Part 3:Dose Expansion|Death|0|||
124838819|NCT02036502|449039029|FG005|Part 3:Dose Expansion|Death|24|||
124838820|NCT02036502|449039030|FG006|Part 3:Dose Expansion|Death|0|||
124838821|NCT02036502|449039031|FG007|Part 3:Dose Expansion|Death|3|||
124838822|NCT02036502|449039024|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
124838823|NCT02036502|449039025|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
124838824|NCT02036502|449039026|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
124838825|NCT02036502|449039027|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
124838826|NCT02036502|449039028|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
124838827|NCT02036502|449039029|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
124838828|NCT02036502|449039030|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
124838829|NCT02036502|449039031|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
124838830|NCT02036502|449039024|FG000|Part 3:Dose Expansion|Physician Decision|0|||
124838831|NCT02036502|449039025|FG001|Part 3:Dose Expansion|Physician Decision|0|||
124838832|NCT02036502|449039026|FG002|Part 3:Dose Expansion|Physician Decision|0|||
124838833|NCT02036502|449039027|FG003|Part 3:Dose Expansion|Physician Decision|0|||
124838834|NCT02036502|449039028|FG004|Part 3:Dose Expansion|Physician Decision|0|||
125305303|NCT04171219|450745078|FG000|Overall Study|Adverse Event|1|||
125305304|NCT04171219|450745079|FG001|Overall Study|Adverse Event|0|||
125305305|NCT04171219|450745078|FG000|Overall Study|Death|0|||
125305306|NCT04171219|450745079|FG001|Overall Study|Death|1|||
125305307|NCT04171219|450745078|FG000|Overall Study|Lack of Efficacy|9|||
125305308|NCT04171219|450745079|FG001|Overall Study|Lack of Efficacy|13|||
125305309|NCT04171219|450745078|FG000|Overall Study|Withdrawal by Subject|1|||
125305310|NCT04171219|450745079|FG001|Overall Study|Withdrawal by Subject|2|||
125305311|NCT04171219|450745078|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
125305312|NCT04171219|450745079|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
125305313|NCT04171219|450745078|FG000|Overall Study|Clinical PD/Patient choice|1|||
125305314|NCT04171219|450745079|FG001|Overall Study|Clinical PD/Patient choice|0|||
125305315|NCT04171219|450745078|FG000|Overall Study|Toxicity/ Patient choice|1|||
125305316|NCT04171219|450745079|FG001|Overall Study|Toxicity/ Patient choice|0|||
125305317|NCT04838626|450745080|FG000|Overall Study|Adverse Event|2|||
125305318|NCT04838626|450745080|FG000|Overall Study|Physician Decision|6|||
125305319|NCT04838626|450745080|FG000|Overall Study|Protocol Violation|3|||
125305320|NCT04838626|450745080|FG000|Overall Study|Withdrawal by Subject|9|||
124838835|NCT02036502|449039029|FG005|Part 3:Dose Expansion|Physician Decision|1|||
124838836|NCT02036502|449039030|FG006|Part 3:Dose Expansion|Physician Decision|0|||
124838837|NCT02036502|449039031|FG007|Part 3:Dose Expansion|Physician Decision|0|||
124838838|NCT02036502|449039024|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
124838839|NCT02036502|449039025|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
124838840|NCT02036502|449039026|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
124838841|NCT02036502|449039027|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
124838842|NCT02036502|449039028|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
125305321|NCT04838626|450745080|FG000|Overall Study|Technical Problems|2|||
124838843|NCT02036502|449039029|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
124838844|NCT02036502|449039030|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
124838845|NCT02036502|449039031|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
124838846|NCT02036502|449039024|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
124838847|NCT02036502|449039025|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
124838848|NCT02036502|449039026|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
124838849|NCT02036502|449039027|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
124838850|NCT02036502|449039028|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
124838851|NCT02036502|449039029|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
124838852|NCT02036502|449039030|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
124838853|NCT02036502|449039031|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
124838854|NCT02036502|449039024|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
124838855|NCT02036502|449039025|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
124838856|NCT02036502|449039026|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
124838857|NCT02036502|449039027|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
124838858|NCT02036502|449039028|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
124838859|NCT02036502|449039029|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
124838860|NCT02036502|449039030|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
124838861|NCT02036502|449039031|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
124838862|NCT02036502|449039024|FG000|Part 3:Dose Expansion|Not Treated|0|||
124838863|NCT02036502|449039025|FG001|Part 3:Dose Expansion|Not Treated|0|||
124838864|NCT02036502|449039026|FG002|Part 3:Dose Expansion|Not Treated|0|||
124838865|NCT02036502|449039027|FG003|Part 3:Dose Expansion|Not Treated|0|||
124838866|NCT02036502|449039028|FG004|Part 3:Dose Expansion|Not Treated|0|||
124838867|NCT02036502|449039029|FG005|Part 3:Dose Expansion|Not Treated|2|||
124838868|NCT02036502|449039030|FG006|Part 3:Dose Expansion|Not Treated|0|||
124838869|NCT02036502|449039031|FG007|Part 3:Dose Expansion|Not Treated|0|||
124838870|NCT01068509|449039032|FG000|Overall Study|Death|0|||
124838871|NCT01068509|449039033|FG001|Overall Study|Death|0|||
124838872|NCT01068509|449039034|FG002|Overall Study|Death|1|||
124838873|NCT01068509|449039032|FG000|Overall Study|Disease Progression|5|||
124838874|NCT01068509|449039033|FG001|Overall Study|Disease Progression|20|||
124838875|NCT01068509|449039034|FG002|Overall Study|Disease Progression|18|||
124838876|NCT01068509|449039032|FG000|Overall Study|Lost to Follow-up|1|||
124838877|NCT01068509|449039033|FG001|Overall Study|Lost to Follow-up|0|||
124838878|NCT01068509|449039034|FG002|Overall Study|Lost to Follow-up|0|||
124838879|NCT01068509|449039032|FG000|Overall Study|Withdrew Consent|0|||
124838880|NCT01068509|449039033|FG001|Overall Study|Withdrew Consent|1|||
124838881|NCT01068509|449039034|FG002|Overall Study|Withdrew Consent|2|||
124838882|NCT01068509|449039032|FG000|Overall Study|Reason Not Specified|0|||
124838883|NCT01068509|449039033|FG001|Overall Study|Reason Not Specified|1|||
124838884|NCT01068509|449039034|FG002|Overall Study|Reason Not Specified|0|||
124838885|NCT02442778|449039035|FG000|Overall Study|Adverse Event|2|||
124838886|NCT02442778|449039036|FG001|Overall Study|Adverse Event|6|||
124838887|NCT02442778|449039037|FG002|Overall Study|Adverse Event|6|||
124838888|NCT02442778|449039035|FG000|Overall Study|Death|0|||
124838889|NCT02442778|449039036|FG001|Overall Study|Death|2|||
124838890|NCT02442778|449039037|FG002|Overall Study|Death|0|||
124838891|NCT02442778|449039035|FG000|Overall Study|Lack of Efficacy|1|||
124838892|NCT02442778|449039036|FG001|Overall Study|Lack of Efficacy|0|||
124838893|NCT02442778|449039037|FG002|Overall Study|Lack of Efficacy|0|||
124838894|NCT02442778|449039035|FG000|Overall Study|Lost to Follow-up|1|||
124838895|NCT02442778|449039036|FG001|Overall Study|Lost to Follow-up|1|||
124838896|NCT02442778|449039037|FG002|Overall Study|Lost to Follow-up|1|||
124838897|NCT02442778|449039035|FG000|Overall Study|Non-compliance with study drug|2|||
124838898|NCT02442778|449039036|FG001|Overall Study|Non-compliance with study drug|0|||
124838899|NCT02442778|449039037|FG002|Overall Study|Non-compliance with study drug|1|||
124838900|NCT02442778|449039035|FG000|Overall Study|Physician Decision|1|||
124838901|NCT02442778|449039036|FG001|Overall Study|Physician Decision|1|||
124838902|NCT02442778|449039037|FG002|Overall Study|Physician Decision|1|||
124838903|NCT02442778|449039035|FG000|Overall Study|Protocol Deviation|3|||
124838904|NCT02442778|449039036|FG001|Overall Study|Protocol Deviation|0|||
124838905|NCT02442778|449039037|FG002|Overall Study|Protocol Deviation|1|||
124838906|NCT02442778|449039035|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
125305322|NCT01934010|450745085|FG000|Overall Study|Adverse Event|1|||
125305323|NCT01934010|450745086|FG001|Overall Study|Adverse Event|1|||
124838907|NCT02442778|449039036|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
124838908|NCT02442778|449039037|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
124838909|NCT02442778|449039035|FG000|Overall Study|Withdrawal by Subject|4|||
124838910|NCT02442778|449039036|FG001|Overall Study|Withdrawal by Subject|4|||
124838911|NCT02442778|449039037|FG002|Overall Study|Withdrawal by Subject|3|||
124838912|NCT02442778|449039035|FG000|Overall Study|Reason not specified|1|||
124838913|NCT02442778|449039036|FG001|Overall Study|Reason not specified|4|||
124838914|NCT02442778|449039037|FG002|Overall Study|Reason not specified|0|||
124838915|NCT00615056|449039043|FG000|Overall Study|Death|31|||
124838916|NCT00615056|449039044|FG001|Overall Study|Death|31|||
125305324|NCT01934010|450745087|FG002|Overall Study|Adverse Event|0|||
124838917|NCT00615056|449039045|FG002|Overall Study|Death|21|||
124838918|NCT00615056|449039046|FG003|Overall Study|Death|23|||
124838919|NCT00615056|449039043|FG000|Overall Study|Lost to Follow-up|1|||
124838920|NCT00615056|449039044|FG001|Overall Study|Lost to Follow-up|2|||
124838921|NCT00615056|449039045|FG002|Overall Study|Lost to Follow-up|4|||
124838922|NCT00615056|449039046|FG003|Overall Study|Lost to Follow-up|5|||
124838923|NCT00615056|449039043|FG000|Overall Study|Other|13|||
124838924|NCT00615056|449039044|FG001|Overall Study|Other|15|||
124838925|NCT00615056|449039045|FG002|Overall Study|Other|10|||
124838926|NCT00615056|449039046|FG003|Overall Study|Other|7|||
124838927|NCT00615056|449039043|FG000|Overall Study|Objective progression or relapse|0|||
124838928|NCT00615056|449039044|FG001|Overall Study|Objective progression or relapse|2|||
124838929|NCT00615056|449039045|FG002|Overall Study|Objective progression or relapse|0|||
124838930|NCT00615056|449039046|FG003|Overall Study|Objective progression or relapse|0|||
124838931|NCT00615056|449039043|FG000|Overall Study|Withdrawal by Subject|0|||
124838932|NCT00615056|449039044|FG001|Overall Study|Withdrawal by Subject|1|||
124838933|NCT00615056|449039045|FG002|Overall Study|Withdrawal by Subject|1|||
124838934|NCT00615056|449039046|FG003|Overall Study|Withdrawal by Subject|0|||
124838935|NCT00615056|449039043|FG000|Overall Study|Discontinued by Sponsor|1|||
124838936|NCT00615056|449039044|FG001|Overall Study|Discontinued by Sponsor|0|||
124838937|NCT00615056|449039045|FG002|Overall Study|Discontinued by Sponsor|0|||
124838938|NCT00615056|449039046|FG003|Overall Study|Discontinued by Sponsor|0|||
124838939|NCT00615056|449039043|FG000|Overall Study|Randomized but not treated|3|||
124838940|NCT00615056|449039044|FG001|Overall Study|Randomized but not treated|0|||
124838941|NCT00615056|449039045|FG002|Overall Study|Randomized but not treated|0|||
124838942|NCT00615056|449039046|FG003|Overall Study|Randomized but not treated|0|||
124838943|NCT02849548|449039052|FG000|Overall Study|Lost to Follow-up|1|||
124838944|NCT02849548|449039053|FG001|Overall Study|Lost to Follow-up|2|||
124838945|NCT02849548|449039052|FG000|Overall Study|Protocol Violation|1|||
124838946|NCT02849548|449039053|FG001|Overall Study|Protocol Violation|0|||
124838947|NCT02357147|449039055|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
124838948|NCT02357147|449039056|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
124838949|NCT02357147|449039055|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
124838950|NCT02357147|449039056|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
124838951|NCT02357147|449039055|FG000|Combination Treatment Phase|Investigator Discretion|1|||
124838952|NCT02357147|449039056|FG001|Combination Treatment Phase|Investigator Discretion|1|||
124838953|NCT02357147|449039055|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
124838954|NCT02357147|449039056|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
124838955|NCT02357147|449039055|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
124838956|NCT02357147|449039056|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
124838957|NCT02357147|449039055|FG000|Combination Treatment Phase|Adverse Event|12|||
124838958|NCT02357147|449039056|FG001|Combination Treatment Phase|Adverse Event|4|||
124838959|NCT02357147|449039055|FG000|Combination Treatment Phase|Death|1|||
124838960|NCT02357147|449039056|FG001|Combination Treatment Phase|Death|1|||
124838961|NCT02357147|449039055|FG000|Combination Treatment Phase|Sponsor Decision|0|||
124838962|NCT02357147|449039056|FG001|Combination Treatment Phase|Sponsor Decision|12|||
124838963|NCT02357147|449039055|FG000|Combination Treatment Phase|Other|1|||
124838964|NCT02357147|449039056|FG001|Combination Treatment Phase|Other|0|||
124838965|NCT02357147|449039055|FG000|Combination Treatment Phase|Not treated|0|||
124838966|NCT02357147|449039056|FG001|Combination Treatment Phase|Not treated|2|||
124838967|NCT02357147|449039055|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
124838968|NCT02357147|449039056|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
124838969|NCT02357147|449039055|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
124838970|NCT02357147|449039056|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
124838971|NCT02357147|449039055|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
124838972|NCT02357147|449039056|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
124838973|NCT02357147|449039055|FG000|Maintenance Treatment Phase|Adverse Event|0|||
124838974|NCT02357147|449039056|FG001|Maintenance Treatment Phase|Adverse Event|3|||
124838975|NCT02357147|449039055|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
124838976|NCT02357147|449039056|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
124838977|NCT02357147|449039055|FG000|Maintenance Treatment Phase|Not Treated|1|||
124838978|NCT02357147|449039056|FG001|Maintenance Treatment Phase|Not Treated|0|||
124838979|NCT00560950|449039058|FG000|Overall Study|Lost to Follow-up|1|||
124838980|NCT00560950|449039059|FG001|Overall Study|Lost to Follow-up|0|||
124838981|NCT03264404|449040760|FG000|Overall Study|Death|2|||
124838982|NCT03264404|449040760|FG000|Overall Study|Physician Decision|1|||
124838983|NCT03264404|449040760|FG000|Overall Study|Disease Progression|28|||
124838984|NCT03264404|449040760|FG000|Overall Study|Adverse Event|1|||
124838985|NCT03264404|449040760|FG000|Overall Study|Off study prior to treatment|2|||
124838986|NCT03036566|449040761|FG000|Overall Study|Lost to Follow-up|3|||
124838987|NCT01914666|449040765|FG000|Treatment Period|Lack of Efficacy|0|||
124838988|NCT01914666|449040766|FG001|Treatment Period|Lack of Efficacy|0|||
124838989|NCT01914666|449040767|FG002|Treatment Period|Lack of Efficacy|2|||
124838990|NCT01914666|449040765|FG000|Treatment Period|Adverse Event|10|||
124838991|NCT01914666|449040766|FG001|Treatment Period|Adverse Event|4|||
124838992|NCT01914666|449040767|FG002|Treatment Period|Adverse Event|2|||
124838993|NCT01914666|449040765|FG000|Treatment Period|Withdrawal by Subject|3|||
124838994|NCT01914666|449040766|FG001|Treatment Period|Withdrawal by Subject|2|||
124838995|NCT01914666|449040767|FG002|Treatment Period|Withdrawal by Subject|2|||
124838996|NCT01914666|449040765|FG000|Treatment Period|Physician Decision|0|||
124838997|NCT01914666|449040766|FG001|Treatment Period|Physician Decision|0|||
124838998|NCT01914666|449040767|FG002|Treatment Period|Physician Decision|2|||
124838999|NCT01940120|449040768|FG000|Overall Study|Death|40|||
124839000|NCT01940120|449040768|FG000|Overall Study|Withdrawal by Subject|8|||
124839001|NCT00427635|449040769|FG000|Treatment Phase|Withdrawal by Subject|1|||
124839002|NCT00427635|449040770|FG001|Treatment Phase|Withdrawal by Subject|0|||
124839003|NCT00427635|449040769|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
124839004|NCT00427635|449040770|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
124839005|NCT03277846|449040771|FG000|Overall Study|Inpatient stay too brief|12|||
124839006|NCT03277846|449040772|FG001|Overall Study|Inpatient stay too brief|11|||
124839007|NCT01888497|449040774|FG000|Washout Period 1|Withdrawal by Subject|0|||
124839008|NCT01888497|449040775|FG001|Washout Period 1|Withdrawal by Subject|0|||
124839009|NCT01888497|449040776|FG002|Washout Period 1|Withdrawal by Subject|1|||
124839010|NCT01888497|449040777|FG003|Washout Period 1|Withdrawal by Subject|1|||
124839011|NCT01888497|449040774|FG000|Washout Period 2|Adverse Event|0|||
124839012|NCT01888497|449040775|FG001|Washout Period 2|Adverse Event|0|||
124839013|NCT01888497|449040776|FG002|Washout Period 2|Adverse Event|0|||
124839014|NCT01888497|449040777|FG003|Washout Period 2|Adverse Event|1|||
124839015|NCT01888497|449040774|FG000|Washout Period 2|Withdrawal by Subject|0|||
124839016|NCT01888497|449040775|FG001|Washout Period 2|Withdrawal by Subject|0|||
124839017|NCT01888497|449040776|FG002|Washout Period 2|Withdrawal by Subject|0|||
124839018|NCT01888497|449040777|FG003|Washout Period 2|Withdrawal by Subject|1|||
124839019|NCT04152447|449040778|FG000|Overall Study|Lost to Follow-up|1|||
124839020|NCT04152447|449040779|FG001|Overall Study|Lost to Follow-up|0|||
124839021|NCT04152447|449040778|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
124839022|NCT04152447|449040779|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
124839023|NCT04152447|449040778|FG000|Overall Study|Withdrawal by Subject|0|||
124839024|NCT04152447|449040779|FG001|Overall Study|Withdrawal by Subject|1|||
124839025|NCT04152447|449040778|FG000|Overall Study|Found ineligible after enrolling|1|||
124839026|NCT04152447|449040779|FG001|Overall Study|Found ineligible after enrolling|1|||
124839027|NCT04152447|449040778|FG000|Overall Study|Did not receive VR headset in time.|0|||
124839028|NCT04152447|449040779|FG001|Overall Study|Did not receive VR headset in time.|2|||
124839029|NCT04013191|449040780|FG000|Overall Study|Adverse Event|1|||
124839030|NCT04013191|449040781|FG001|Overall Study|Adverse Event|0|||
124839031|NCT00913744|449040786|FG000|Overall Study|Adverse Event|2|||
124839032|NCT00913744|449040787|FG001|Overall Study|Adverse Event|0|||
124839033|NCT00913744|449040786|FG000|Overall Study|Withdrawal by Subject|2|||
124839034|NCT00913744|449040787|FG001|Overall Study|Withdrawal by Subject|1|||
124839035|NCT00913744|449040786|FG000|Overall Study|Death|1|||
124839036|NCT00913744|449040787|FG001|Overall Study|Death|0|||
124839037|NCT00805935|449040788|FG000|Overall Study|Stimulation Failure|1|||
124839038|NCT00805935|449040789|FG001|Overall Study|Stimulation Failure|5|||
124839039|NCT00805935|449040790|FG002|Overall Study|Stimulation Failure|2|||
124839040|NCT00805935|449040791|FG003|Overall Study|Stimulation Failure|2|||
124839041|NCT00805935|449040788|FG000|Overall Study|Cycle cancelled|0|||
124839042|NCT00805935|449040789|FG001|Overall Study|Cycle cancelled|0|||
124839043|NCT00805935|449040790|FG002|Overall Study|Cycle cancelled|2|||
124839044|NCT00805935|449040791|FG003|Overall Study|Cycle cancelled|0|||
124839045|NCT00805935|449040788|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
124839046|NCT00805935|449040789|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
124839047|NCT00805935|449040790|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
124839048|NCT00805935|449040791|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
124839049|NCT00805935|449040788|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
124839050|NCT00805935|449040789|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
124839051|NCT00805935|449040790|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
124839052|NCT00805935|449040791|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
124839053|NCT00805935|449040788|FG000|Overall Study|Lost to Follow-up|1|||
124839054|NCT00805935|449040789|FG001|Overall Study|Lost to Follow-up|0|||
124839055|NCT00805935|449040790|FG002|Overall Study|Lost to Follow-up|0|||
124839056|NCT00805935|449040791|FG003|Overall Study|Lost to Follow-up|0|||
124839057|NCT00805935|449040788|FG000|Overall Study|No positive serum pregnancy|8|||
124839058|NCT00805935|449040789|FG001|Overall Study|No positive serum pregnancy|7|||
124839059|NCT00805935|449040790|FG002|Overall Study|No positive serum pregnancy|6|||
124839060|NCT00805935|449040791|FG003|Overall Study|No positive serum pregnancy|5|||
124839061|NCT00805935|449040788|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
124839062|NCT00805935|449040789|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
124839063|NCT00805935|449040790|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
124839064|NCT00805935|449040791|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
124839065|NCT00805935|449040788|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
124839066|NCT00805935|449040789|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
124839067|NCT00805935|449040790|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
124839068|NCT00805935|449040791|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
124839069|NCT00805935|449040788|FG000|Overall Study|Biochemical pregnancy|0|||
124839070|NCT00805935|449040789|FG001|Overall Study|Biochemical pregnancy|1|||
124839071|NCT00805935|449040790|FG002|Overall Study|Biochemical pregnancy|0|||
124839072|NCT00805935|449040791|FG003|Overall Study|Biochemical pregnancy|0|||
124839073|NCT00805935|449040788|FG000|Overall Study|Chemical pregnancy|0|||
124839074|NCT00805935|449040789|FG001|Overall Study|Chemical pregnancy|5|||
124839075|NCT00805935|449040790|FG002|Overall Study|Chemical pregnancy|3|||
124839076|NCT00805935|449040791|FG003|Overall Study|Chemical pregnancy|2|||
124839077|NCT00805935|449040788|FG000|Overall Study|Ectopic pregnancy|0|||
124839078|NCT00805935|449040789|FG001|Overall Study|Ectopic pregnancy|0|||
124839079|NCT00805935|449040790|FG002|Overall Study|Ectopic pregnancy|1|||
124839080|NCT00805935|449040791|FG003|Overall Study|Ectopic pregnancy|0|||
124839081|NCT00805935|449040788|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
124839082|NCT00805935|449040789|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
124839083|NCT00805935|449040790|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
124839084|NCT00805935|449040791|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
124839085|NCT02945410|449040792|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
124839086|NCT02945410|449040793|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
124839087|NCT02945410|449040794|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
124839088|NCT02945410|449040795|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
124839089|NCT02945410|449040796|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
124839090|NCT02945410|449040797|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
124839091|NCT02945410|449040792|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
124839092|NCT02945410|449040793|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
124839093|NCT02945410|449040794|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
124839094|NCT02945410|449040795|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
124839095|NCT02945410|449040796|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
124839096|NCT02945410|449040797|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
124839097|NCT02945410|449040792|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
124839098|NCT02945410|449040793|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
124839099|NCT02945410|449040794|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
124839100|NCT02945410|449040795|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
124839101|NCT02945410|449040796|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
124839102|NCT02945410|449040797|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
124839103|NCT01344369|449040798|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
124839104|NCT01344369|449040799|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
124839105|NCT01344369|449040798|FG000|Washout of 28 Days|Physician Decision|0|||
124839106|NCT01344369|449040799|FG001|Washout of 28 Days|Physician Decision|1|||
124839107|NCT01344369|449040798|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
124839108|NCT01344369|449040799|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
124839109|NCT03848845|449040800|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
124839110|NCT03848845|449040801|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
124839111|NCT03848845|449040802|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
124839112|NCT03848845|449040803|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
124839113|NCT03848845|449040800|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
124839114|NCT03848845|449040801|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
124839115|NCT03848845|449040802|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
124839116|NCT03848845|449040803|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
124839117|NCT03848845|449040800|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
124839118|NCT03848845|449040801|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
124839119|NCT03848845|449040802|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
124839120|NCT03848845|449040803|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
124839121|NCT03848845|449040800|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
124839122|NCT03848845|449040801|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
124839123|NCT03848845|449040802|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
124839124|NCT03848845|449040803|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
124839125|NCT01454726|449040804|FG000|Overall Study|Withdrawal by Subject|0|||
124839126|NCT01454726|449040805|FG001|Overall Study|Withdrawal by Subject|1|||
124839127|NCT04200248|449040806|FG000|Overall Study|Personal reasons|0|||
124839128|NCT04200248|449040807|FG001|Overall Study|Personal reasons|0|||
124839129|NCT04200248|449040808|FG002|Overall Study|Personal reasons|1|||
124839130|NCT04200248|449040806|FG000|Overall Study|Discontinued prior to treatment|3|||
124839131|NCT04200248|449040807|FG001|Overall Study|Discontinued prior to treatment|3|||
124839132|NCT04200248|449040808|FG002|Overall Study|Discontinued prior to treatment|2|||
124839133|NCT00934544|449040811|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
124839134|NCT00934544|449040812|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
124839135|NCT00934544|449040813|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
124839136|NCT00934544|449040811|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
124839137|NCT00934544|449040812|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
124839138|NCT00934544|449040813|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
124839139|NCT00934544|449040811|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
124839140|NCT00934544|449040812|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
124839141|NCT00934544|449040813|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
124839142|NCT00934544|449040811|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
124839143|NCT00934544|449040812|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
124839144|NCT00934544|449040813|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
124839145|NCT00934544|449040811|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
124839146|NCT00934544|449040812|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
124839147|NCT00934544|449040813|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
124839148|NCT00934544|449040811|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
124839149|NCT00934544|449040812|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
124839150|NCT00934544|449040813|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
124839151|NCT00934544|449040811|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
124839152|NCT00934544|449040812|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
124839153|NCT00934544|449040813|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
124839154|NCT00934544|449040811|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
124839155|NCT00934544|449040812|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
124839156|NCT00934544|449040813|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
124839157|NCT00934544|449040811|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
124839158|NCT00934544|449040812|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
124839159|NCT00934544|449040813|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
124839160|NCT00934544|449040811|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
124839161|NCT00934544|449040812|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
124839162|NCT00934544|449040813|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
124839163|NCT00934544|449040811|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
124839164|NCT00934544|449040812|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
124839165|NCT00934544|449040813|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
124839166|NCT00934544|449040811|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
124839167|NCT00934544|449040812|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
124839168|NCT00934544|449040813|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
124839169|NCT00934544|449040811|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
124839170|NCT00934544|449040812|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
124839171|NCT00934544|449040813|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
124839172|NCT00934544|449040811|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
124839173|NCT00934544|449040812|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
124839174|NCT00934544|449040813|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
124839175|NCT00934544|449040811|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
124839176|NCT00934544|449040812|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
124839177|NCT00934544|449040813|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
124839178|NCT00934544|449040811|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
124839179|NCT00934544|449040812|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
124839180|NCT00934544|449040813|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
124839181|NCT00302003|449040814|FG000|Overall Study|Lack of Efficacy|62|||
124839182|NCT00302003|449040814|FG000|Overall Study|Lost to Follow-up|1|||
124839183|NCT00302003|449040814|FG000|Overall Study|Physician Decision|2|||
124839184|NCT00302003|449040814|FG000|Overall Study|Withdrawal by Subject|5|||
124839185|NCT00302003|449040814|FG000|Overall Study|Ineligible|9|||
124839186|NCT00302003|449040814|FG000|Overall Study|Protocol Violation|1|||
124839187|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
124839188|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
124839189|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
124839190|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
124839191|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
124839192|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
124839193|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
124839194|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
124839195|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
124839196|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
124839197|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
124839198|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
124839199|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
124839200|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
124839201|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
124839202|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
124839203|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
124839204|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
124839205|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
124839206|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
124839207|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
124839208|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
124839209|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
124839210|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
124839211|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
124839212|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
124839213|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
124839214|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
124839215|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
124839216|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
124839217|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
124839218|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
124839219|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
124839220|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
124839221|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
124839222|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
124839223|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
124839224|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
124839225|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
124839226|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
124839227|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
124839228|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
124839229|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
124839230|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
124839231|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
124839232|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
124839233|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
124839234|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
124839235|NCT02042924|449040819|FG000|Overall Study|Early Death|1|||
124839236|NCT00283439|449040820|FG000|Overall Study|Adverse Event|0|||
124839237|NCT00283439|449040821|FG001|Overall Study|Adverse Event|0|||
124839238|NCT00283439|449040822|FG002|Overall Study|Adverse Event|0|||
124839239|NCT00283439|449040823|FG003|Overall Study|Adverse Event|1|||
124839240|NCT00283439|449040820|FG000|Overall Study|Death|0|||
124839241|NCT00283439|449040821|FG001|Overall Study|Death|0|||
124839242|NCT00283439|449040822|FG002|Overall Study|Death|1|||
124839243|NCT00283439|449040823|FG003|Overall Study|Death|0|||
124839244|NCT00283439|449040820|FG000|Overall Study|Disease progression|0|||
124839245|NCT00283439|449040821|FG001|Overall Study|Disease progression|1|||
124839246|NCT00283439|449040822|FG002|Overall Study|Disease progression|0|||
124839247|NCT00283439|449040823|FG003|Overall Study|Disease progression|0|||
124839248|NCT00283439|449040820|FG000|Overall Study|Requirement for alternative therapy|1|||
124839249|NCT00283439|449040821|FG001|Overall Study|Requirement for alternative therapy|2|||
124839250|NCT00283439|449040822|FG002|Overall Study|Requirement for alternative therapy|5|||
124839251|NCT00283439|449040823|FG003|Overall Study|Requirement for alternative therapy|2|||
124839252|NCT00283439|449040820|FG000|Overall Study|Stem cell transplant|6|||
124839253|NCT00283439|449040821|FG001|Overall Study|Stem cell transplant|6|||
124839254|NCT00283439|449040822|FG002|Overall Study|Stem cell transplant|4|||
124839255|NCT00283439|449040823|FG003|Overall Study|Stem cell transplant|3|||
124839256|NCT00283439|449040820|FG000|Overall Study|Treatment discontinued|0|||
124839257|NCT00283439|449040821|FG001|Overall Study|Treatment discontinued|2|||
124839258|NCT00283439|449040822|FG002|Overall Study|Treatment discontinued|1|||
124839259|NCT00283439|449040823|FG003|Overall Study|Treatment discontinued|3|||
124839260|NCT00283439|449040820|FG000|Overall Study|Other|1|||
125305325|NCT01934010|450745085|FG000|Overall Study|Withdrawal by Subject|15|||
124839261|NCT00283439|449040821|FG001|Overall Study|Other|0|||
124839262|NCT00283439|449040822|FG002|Overall Study|Other|0|||
124839263|NCT00283439|449040823|FG003|Overall Study|Other|0|||
124839264|NCT04033003|449040825|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
124839265|NCT04033003|449040826|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
124839266|NCT04033003|449040825|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
125305326|NCT01934010|450745086|FG001|Overall Study|Withdrawal by Subject|6|||
124839267|NCT04033003|449040826|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
124839268|NCT04033003|449040825|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
124839269|NCT04033003|449040826|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
124839270|NCT04033003|449040825|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
124839271|NCT04033003|449040826|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
124839272|NCT04033003|449040825|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
124839273|NCT04033003|449040826|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
124839274|NCT04033003|449040825|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
124839275|NCT04033003|449040826|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
124839276|NCT04033003|449040825|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
124839277|NCT04033003|449040826|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
124839278|NCT04033003|449040825|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
124839279|NCT04033003|449040826|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
124839280|NCT04033003|449040825|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
124839281|NCT04033003|449040826|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
124839282|NCT04033003|449040825|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
124839283|NCT04033003|449040826|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
124839284|NCT04033003|449040825|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
124839285|NCT04033003|449040826|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
124839286|NCT04033003|449040825|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
124839287|NCT04033003|449040826|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
124839288|NCT04033003|449040825|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
124839289|NCT04033003|449040826|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
124839290|NCT00430092|449040827|FG000|Overall Study|Adverse Event|0|||
124839291|NCT00430092|449040828|FG001|Overall Study|Adverse Event|0|||
124839292|NCT00430092|449040829|FG002|Overall Study|Adverse Event|1|||
124839293|NCT00430092|449040827|FG000|Overall Study|Lack of Efficacy|5|||
124839294|NCT00430092|449040828|FG001|Overall Study|Lack of Efficacy|2|||
124839295|NCT00430092|449040829|FG002|Overall Study|Lack of Efficacy|54|||
124839296|NCT00430092|449040827|FG000|Overall Study|Lost to Follow-up|1|||
124839297|NCT00430092|449040828|FG001|Overall Study|Lost to Follow-up|0|||
124839298|NCT00430092|449040829|FG002|Overall Study|Lost to Follow-up|0|||
124839299|NCT00430092|449040827|FG000|Overall Study|Protocol Violation|0|||
124839300|NCT00430092|449040828|FG001|Overall Study|Protocol Violation|1|||
124839301|NCT00430092|449040829|FG002|Overall Study|Protocol Violation|1|||
124839302|NCT00430092|449040827|FG000|Overall Study|Withdrawal by Subject|0|||
124839303|NCT00430092|449040828|FG001|Overall Study|Withdrawal by Subject|1|||
124839304|NCT00430092|449040829|FG002|Overall Study|Withdrawal by Subject|1|||
124839305|NCT00706966|449040830|FG000|Overall Study|Adverse Event|1|||
124839306|NCT03100825|449040837|FG000|Overall Study|Participant/Guardian Decision|7|||
124839307|NCT03100825|449040837|FG000|Overall Study|Physician Decision|1|||
124839308|NCT01675882|449040846|FG000|Overall Study|Adverse Event|0|||
124839309|NCT01675882|449040847|FG001|Overall Study|Adverse Event|2|||
124839310|NCT01675882|449040848|FG002|Overall Study|Adverse Event|1|||
124839311|NCT01675882|449040849|FG003|Overall Study|Adverse Event|0|||
124839312|NCT01675882|449040846|FG000|Overall Study|Participant unwilling to continue|2|||
124839313|NCT01675882|449040847|FG001|Overall Study|Participant unwilling to continue|4|||
124839314|NCT01675882|449040848|FG002|Overall Study|Participant unwilling to continue|2|||
124839315|NCT01675882|449040849|FG003|Overall Study|Participant unwilling to continue|1|||
124839316|NCT01675882|449040846|FG000|Overall Study|Lost to Follow-up|0|||
124839317|NCT01675882|449040847|FG001|Overall Study|Lost to Follow-up|1|||
124839318|NCT01675882|449040848|FG002|Overall Study|Lost to Follow-up|0|||
124839319|NCT01675882|449040849|FG003|Overall Study|Lost to Follow-up|0|||
124839320|NCT01675882|449040846|FG000|Overall Study|Non-compliance|0|||
124839321|NCT01675882|449040847|FG001|Overall Study|Non-compliance|0|||
124839322|NCT01675882|449040848|FG002|Overall Study|Non-compliance|0|||
124839323|NCT01675882|449040849|FG003|Overall Study|Non-compliance|1|||
124839324|NCT00735371|449040853|FG000|Overall Study|Adverse Event|3|||
124839325|NCT00735371|449040854|FG001|Overall Study|Adverse Event|3|||
124839326|NCT00735371|449040855|FG002|Overall Study|Adverse Event|4|||
124839327|NCT00735371|449040856|FG003|Overall Study|Adverse Event|1|||
125305327|NCT01934010|450745087|FG002|Overall Study|Withdrawal by Subject|2|||
124839328|NCT00735371|449040853|FG000|Overall Study|Protocol Violation|2|||
124839329|NCT00735371|449040854|FG001|Overall Study|Protocol Violation|2|||
124839330|NCT00735371|449040855|FG002|Overall Study|Protocol Violation|0|||
124839331|NCT00735371|449040856|FG003|Overall Study|Protocol Violation|3|||
124839332|NCT00735371|449040853|FG000|Overall Study|Withdrawal by Subject|0|||
124839333|NCT00735371|449040854|FG001|Overall Study|Withdrawal by Subject|2|||
124839334|NCT00735371|449040855|FG002|Overall Study|Withdrawal by Subject|2|||
124839335|NCT00735371|449040856|FG003|Overall Study|Withdrawal by Subject|0|||
124839336|NCT00735371|449040853|FG000|Overall Study|Lost to Follow-up|1|||
124839337|NCT00735371|449040854|FG001|Overall Study|Lost to Follow-up|1|||
124839338|NCT00735371|449040855|FG002|Overall Study|Lost to Follow-up|3|||
125305328|NCT01934010|450745085|FG000|Overall Study|Lost to Follow-up|7|||
125305329|NCT01934010|450745086|FG001|Overall Study|Lost to Follow-up|4|||
124839339|NCT00735371|449040856|FG003|Overall Study|Lost to Follow-up|1|||
124839340|NCT00735371|449040853|FG000|Overall Study|Lack of Efficacy|4|||
124839341|NCT00735371|449040854|FG001|Overall Study|Lack of Efficacy|2|||
124839342|NCT00735371|449040855|FG002|Overall Study|Lack of Efficacy|0|||
124839343|NCT00735371|449040856|FG003|Overall Study|Lack of Efficacy|4|||
124839344|NCT00735371|449040853|FG000|Overall Study|Sponsor Decision|3|||
124839345|NCT00735371|449040854|FG001|Overall Study|Sponsor Decision|1|||
124839346|NCT00735371|449040855|FG002|Overall Study|Sponsor Decision|0|||
124839347|NCT00735371|449040856|FG003|Overall Study|Sponsor Decision|1|||
124839348|NCT00735371|449040853|FG000|Overall Study|Protocol Violation|0|||
124839349|NCT00735371|449040854|FG001|Overall Study|Protocol Violation|1|||
124839350|NCT00735371|449040855|FG002|Overall Study|Protocol Violation|2|||
124839351|NCT00735371|449040856|FG003|Overall Study|Protocol Violation|0|||
124839352|NCT00735371|449040853|FG000|Overall Study|Prior Vyvanse Exposure|1|||
124839353|NCT00735371|449040854|FG001|Overall Study|Prior Vyvanse Exposure|1|||
124839354|NCT00735371|449040855|FG002|Overall Study|Prior Vyvanse Exposure|0|||
124839355|NCT00735371|449040856|FG003|Overall Study|Prior Vyvanse Exposure|0|||
124839356|NCT00735371|449040853|FG000|Overall Study|Exclusion criteria|1|||
124839357|NCT00735371|449040854|FG001|Overall Study|Exclusion criteria|0|||
124839358|NCT00735371|449040855|FG002|Overall Study|Exclusion criteria|0|||
124839359|NCT00735371|449040856|FG003|Overall Study|Exclusion criteria|0|||
124839360|NCT00994448|449040857|FG000|Overall Study|Adverse Event|1|||
124839361|NCT00994448|449040858|FG001|Overall Study|Adverse Event|0|||
124839362|NCT00994448|449040857|FG000|Overall Study|Lost to Follow-up|5|||
124839363|NCT00994448|449040858|FG001|Overall Study|Lost to Follow-up|1|||
124839364|NCT00994448|449040857|FG000|Overall Study|Withdrawal by Subject|1|||
124839365|NCT00994448|449040858|FG001|Overall Study|Withdrawal by Subject|1|||
124839366|NCT00994448|449040857|FG000|Overall Study|Physician Decision|1|||
124839367|NCT00994448|449040858|FG001|Overall Study|Physician Decision|0|||
124839368|NCT01604343|449040859|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
124839369|NCT01604343|449040860|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
124839370|NCT01604343|449040861|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
124839371|NCT01604343|449040862|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
124839372|NCT01604343|449040863|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
124839373|NCT01604343|449040859|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
124839374|NCT01604343|449040860|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
124839375|NCT01604343|449040861|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
124839376|NCT01604343|449040862|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
124839377|NCT01604343|449040863|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
124839378|NCT01604343|449040859|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
124839379|NCT01604343|449040860|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
124839380|NCT01604343|449040861|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
124839381|NCT01604343|449040862|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
124839382|NCT01604343|449040863|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
124839383|NCT01604343|449040859|FG000|Prior to W52 Administration(Through W52)|Death|5|||
124839384|NCT01604343|449040860|FG001|Prior to W52 Administration(Through W52)|Death|0|||
124839385|NCT01604343|449040861|FG002|Prior to W52 Administration(Through W52)|Death|2|||
124839386|NCT01604343|449040862|FG003|Prior to W52 Administration(Through W52)|Death|0|||
124839387|NCT01604343|449040863|FG004|Prior to W52 Administration(Through W52)|Death|4|||
124839388|NCT01604343|449040859|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
124839389|NCT01604343|449040860|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
124839390|NCT01604343|449040861|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
124839391|NCT01604343|449040862|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
124839392|NCT01604343|449040863|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
124839393|NCT01604343|449040859|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
124839394|NCT01604343|449040860|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
124839395|NCT01604343|449040861|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
124839396|NCT01604343|449040862|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
124839397|NCT01604343|449040863|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
124839398|NCT01604343|449040859|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
124839399|NCT01604343|449040860|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
124839400|NCT01604343|449040861|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
124839401|NCT01604343|449040862|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
124839402|NCT01604343|449040863|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
124839403|NCT01604343|449040859|FG000|Prior to W52 Administration(Through W52)|Other|15|||
124839404|NCT01604343|449040860|FG001|Prior to W52 Administration(Through W52)|Other|0|||
124839405|NCT01604343|449040861|FG002|Prior to W52 Administration(Through W52)|Other|10|||
124839406|NCT01604343|449040862|FG003|Prior to W52 Administration(Through W52)|Other|0|||
124839407|NCT01604343|449040863|FG004|Prior to W52 Administration(Through W52)|Other|6|||
124839408|NCT01604343|449040859|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
124839409|NCT01604343|449040860|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
124839410|NCT01604343|449040861|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
124839411|NCT01604343|449040862|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
124839412|NCT01604343|449040863|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
124839413|NCT01604343|449040859|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
124839414|NCT01604343|449040860|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
124839415|NCT01604343|449040861|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
124839416|NCT01604343|449040862|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
124839417|NCT01604343|449040863|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
124839418|NCT01604343|449040859|FG000|Week 52 to Week 104|Adverse Event|0|||
124839419|NCT01604343|449040860|FG001|Week 52 to Week 104|Adverse Event|12|||
124839420|NCT01604343|449040861|FG002|Week 52 to Week 104|Adverse Event|26|||
125305330|NCT01934010|450745087|FG002|Overall Study|Lost to Follow-up|0|||
125305331|NCT01393821|450745088|FG000|Overall Study|Cancel|1|||
124839421|NCT01604343|449040862|FG003|Week 52 to Week 104|Adverse Event|21|||
124839422|NCT01604343|449040863|FG004|Week 52 to Week 104|Adverse Event|27|||
124839423|NCT01604343|449040859|FG000|Week 52 to Week 104|Death|0|||
124839424|NCT01604343|449040860|FG001|Week 52 to Week 104|Death|4|||
124839425|NCT01604343|449040861|FG002|Week 52 to Week 104|Death|2|||
124839426|NCT01604343|449040862|FG003|Week 52 to Week 104|Death|5|||
124839427|NCT01604343|449040863|FG004|Week 52 to Week 104|Death|0|||
124839428|NCT01604343|449040859|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
124839429|NCT01604343|449040860|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
124839430|NCT01604343|449040861|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
124839431|NCT01604343|449040862|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
124839432|NCT01604343|449040863|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
124839433|NCT01604343|449040859|FG000|Week 52 to Week 104|Physician Decision|0|||
124839434|NCT01604343|449040860|FG001|Week 52 to Week 104|Physician Decision|1|||
124839435|NCT01604343|449040861|FG002|Week 52 to Week 104|Physician Decision|0|||
124839436|NCT01604343|449040862|FG003|Week 52 to Week 104|Physician Decision|0|||
124839437|NCT01604343|449040863|FG004|Week 52 to Week 104|Physician Decision|2|||
124839438|NCT01604343|449040859|FG000|Week 52 to Week 104|Pregnancy|0|||
124839439|NCT01604343|449040860|FG001|Week 52 to Week 104|Pregnancy|0|||
124839440|NCT01604343|449040861|FG002|Week 52 to Week 104|Pregnancy|1|||
124839441|NCT01604343|449040862|FG003|Week 52 to Week 104|Pregnancy|2|||
124839442|NCT01604343|449040863|FG004|Week 52 to Week 104|Pregnancy|1|||
124839443|NCT01604343|449040859|FG000|Week 52 to Week 104|Other|0|||
124839444|NCT01604343|449040860|FG001|Week 52 to Week 104|Other|11|||
124839445|NCT01604343|449040861|FG002|Week 52 to Week 104|Other|11|||
124839446|NCT01604343|449040862|FG003|Week 52 to Week 104|Other|6|||
124839447|NCT01604343|449040863|FG004|Week 52 to Week 104|Other|3|||
124839448|NCT01604343|449040859|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
124839449|NCT01604343|449040860|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
124839450|NCT01604343|449040861|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
124839451|NCT01604343|449040862|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
124839452|NCT01604343|449040863|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
124839453|NCT01604343|449040859|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
124839454|NCT01604343|449040860|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
124839455|NCT01604343|449040861|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
124839456|NCT01604343|449040862|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
124839457|NCT01604343|449040863|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
124839458|NCT01604343|449040859|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
124839459|NCT01604343|449040860|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
124839460|NCT01604343|449040861|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
124839461|NCT01604343|449040862|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
124839462|NCT01604343|449040863|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
124839463|NCT00436748|449040868|FG000|Overall Study|Ineligibility Determined|1|||
124839464|NCT00436748|449040869|FG001|Overall Study|Ineligibility Determined|1|||
124839465|NCT00436748|449040868|FG000|Overall Study|Adverse Event|0|||
124839466|NCT00436748|449040869|FG001|Overall Study|Adverse Event|2|||
124839467|NCT00436748|449040868|FG000|Overall Study|Consent Withdrawn|1|||
124839468|NCT00436748|449040869|FG001|Overall Study|Consent Withdrawn|4|||
124839469|NCT00436748|449040868|FG000|Overall Study|Administrative Decision|1|||
124839470|NCT00436748|449040869|FG001|Overall Study|Administrative Decision|0|||
124839471|NCT00436748|449040868|FG000|Overall Study|Lost to Follow-up|0|||
124839472|NCT00436748|449040869|FG001|Overall Study|Lost to Follow-up|1|||
125305332|NCT01393821|450745089|FG001|Overall Study|Cancel|1|||
124839473|NCT00436748|449040868|FG000|Overall Study|Protocol-specified Criteria|5|||
124839474|NCT00436748|449040869|FG001|Overall Study|Protocol-specified Criteria|4|||
124839475|NCT00436748|449040868|FG000|Overall Study|Other|3|||
124839476|NCT00436748|449040869|FG001|Overall Study|Other|0|||
124839477|NCT01610791|449040870|FG000|Overall Study|Lost to Follow-up|7|||
124839478|NCT01610791|449040870|FG000|Overall Study|Adverse Event|6|||
124839479|NCT01610791|449040870|FG000|Overall Study|Physician Decision|1|||
124839480|NCT01610791|449040870|FG000|Overall Study|Adverse event and Investigator decision|1|||
124839481|NCT01610791|449040870|FG000|Overall Study|Death|1|||
124839482|NCT01610791|449040870|FG000|Overall Study|Not determined|5|||
124839483|NCT05040152|449040873|FG000|Overall Study|Withdrawal by Subject|5|||
124839484|NCT05040152|449040874|FG001|Overall Study|Withdrawal by Subject|0|||
124839485|NCT05040152|449040873|FG000|Overall Study|Lost to Follow-up|0|||
124839486|NCT05040152|449040874|FG001|Overall Study|Lost to Follow-up|2|||
124839487|NCT00314574|449040885|FG000|Overall Study|Death|3|||
124839488|NCT00314574|449040886|FG001|Overall Study|Death|0|||
124839489|NCT00314574|449040885|FG000|Overall Study|Adverse Event|11|||
124839490|NCT00314574|449040886|FG001|Overall Study|Adverse Event|16|||
124839491|NCT00314574|449040885|FG000|Overall Study|Lost to Follow-up|19|||
124839492|NCT00314574|449040886|FG001|Overall Study|Lost to Follow-up|25|||
124839493|NCT00314574|449040885|FG000|Overall Study|Withdrawal by Subject|33|||
124839494|NCT00314574|449040886|FG001|Overall Study|Withdrawal by Subject|22|||
124839495|NCT00314574|449040885|FG000|Overall Study|Physician Decision|22|||
124839496|NCT00314574|449040886|FG001|Overall Study|Physician Decision|15|||
124839497|NCT00314574|449040885|FG000|Overall Study|Pregnancy|6|||
124839498|NCT00314574|449040886|FG001|Overall Study|Pregnancy|4|||
124839499|NCT00314574|449040885|FG000|Overall Study|Data unknown at database lock|0|||
124839500|NCT00314574|449040886|FG001|Overall Study|Data unknown at database lock|1|||
124839501|NCT00449956|449040887|FG000|Overall Study|Adverse Event|7|||
124839502|NCT00449956|449040888|FG001|Overall Study|Adverse Event|1|||
124839503|NCT00449956|449040889|FG002|Overall Study|Adverse Event|6|||
124839504|NCT00449956|449040887|FG000|Overall Study|Lack of Efficacy|0|||
124839505|NCT00449956|449040888|FG001|Overall Study|Lack of Efficacy|0|||
124839506|NCT00449956|449040889|FG002|Overall Study|Lack of Efficacy|1|||
124839507|NCT00449956|449040887|FG000|Overall Study|Protocol Violation|1|||
124839508|NCT00449956|449040888|FG001|Overall Study|Protocol Violation|1|||
124839509|NCT00449956|449040889|FG002|Overall Study|Protocol Violation|1|||
124839510|NCT00449956|449040887|FG000|Overall Study|Withdrawal by Subject|0|||
124839511|NCT00449956|449040888|FG001|Overall Study|Withdrawal by Subject|1|||
124839512|NCT00449956|449040889|FG002|Overall Study|Withdrawal by Subject|0|||
124839513|NCT00449956|449040887|FG000|Overall Study|Physician Decision|2|||
124839514|NCT00449956|449040888|FG001|Overall Study|Physician Decision|1|||
124839515|NCT00449956|449040889|FG002|Overall Study|Physician Decision|1|||
124839516|NCT02086110|449040890|FG000|Overall Study|Withdrawal by Subject|1|||
124839517|NCT02086110|449040891|FG001|Overall Study|Withdrawal by Subject|1|||
124839518|NCT01828034|449040897|FG000|Overall Study|Withdrawal by Subject|0|||
124839519|NCT01828034|449040898|FG001|Overall Study|Withdrawal by Subject|0|||
124839520|NCT01828034|449040899|FG002|Overall Study|Withdrawal by Subject|0|||
124839521|NCT01828034|449040900|FG003|Overall Study|Withdrawal by Subject|1|||
124839522|NCT01988571|449040901|FG000|Overall Study|Death|3|||
124839523|NCT01988571|449040902|FG001|Overall Study|Death|1|||
124839524|NCT01988571|449040901|FG000|Overall Study|Physician Decision|2|||
124839525|NCT01988571|449040902|FG001|Overall Study|Physician Decision|1|||
124839526|NCT01988571|449040901|FG000|Overall Study|Lost to Follow-up|3|||
124839527|NCT01988571|449040902|FG001|Overall Study|Lost to Follow-up|0|||
124839528|NCT01988571|449040901|FG000|Overall Study|Withdrawal by Subject|31|||
124839529|NCT01988571|449040902|FG001|Overall Study|Withdrawal by Subject|33|||
124839530|NCT00004412|449040903|FG000|Randomized Period|Moved to Crossover Period|3|||
124839531|NCT00004412|449040904|FG001|Randomized Period|Moved to Crossover Period|0|||
124839532|NCT00004412|449040905|FG002|Randomized Period|Moved to Crossover Period|0|||
124839533|NCT02308735|449040906|FG000|Overall Study|Physician Decision|2|||
124839534|NCT02308735|449040907|FG001|Overall Study|Physician Decision|0|||
124839535|NCT02308735|449040908|FG002|Overall Study|Physician Decision|0|||
124839536|NCT02308735|449040909|FG003|Overall Study|Physician Decision|2|||
124839537|NCT00453999|449040910|FG000|Overall Study|Adverse Event|1|||
124839538|NCT00453999|449040911|FG001|Overall Study|Adverse Event|2|||
124839539|NCT00453999|449040912|FG002|Overall Study|Adverse Event|1|||
124839540|NCT00453999|449040910|FG000|Overall Study|Lost to Follow-up|0|||
124839541|NCT00453999|449040911|FG001|Overall Study|Lost to Follow-up|1|||
124839542|NCT00453999|449040912|FG002|Overall Study|Lost to Follow-up|1|||
124839543|NCT00453999|449040910|FG000|Overall Study|Withdrawal by Subject|2|||
124839544|NCT00453999|449040911|FG001|Overall Study|Withdrawal by Subject|1|||
124839545|NCT00453999|449040912|FG002|Overall Study|Withdrawal by Subject|1|||
124839546|NCT00453999|449040910|FG000|Overall Study|Subject Request|2|||
124839547|NCT00453999|449040911|FG001|Overall Study|Subject Request|1|||
124839548|NCT00453999|449040912|FG002|Overall Study|Subject Request|0|||
124839549|NCT00696137|449040921|FG000|Overall Study|Withdrawal by Subject|2|||
124839550|NCT03742141|449040928|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
124839551|NCT02376166|449040929|FG000|Overall Study|Adverse Event|1|||
124839552|NCT02376166|449040929|FG000|Overall Study|Discontinued metformin early|2|||
124839553|NCT04180020|449040930|FG000|Overall Study|missed visit|18|||
124839554|NCT04180020|449040931|FG001|Overall Study|missed visit|16|||
124839555|NCT04180020|449040930|FG000|Overall Study|Death|2|||
124839556|NCT04180020|449040931|FG001|Overall Study|Death|3|||
124839557|NCT04180020|449040930|FG000|Overall Study|Withdrawal by Subject|1|||
124839558|NCT04180020|449040931|FG001|Overall Study|Withdrawal by Subject|5|||
124839559|NCT04180020|449040930|FG000|Overall Study|incarcerated|1|||
124839560|NCT04180020|449040931|FG001|Overall Study|incarcerated|1|||
124839561|NCT04180020|449040930|FG000|Overall Study|Physician Decision|0|||
124839562|NCT04180020|449040931|FG001|Overall Study|Physician Decision|2|||
124839563|NCT02917031|449040938|FG000|Overall Study|Reason not specified|7|||
124839564|NCT02917031|449040939|FG001|Overall Study|Reason not specified|5|||
124839565|NCT02917031|449040940|FG002|Overall Study|Reason not specified|6|||
124839566|NCT02917031|449040938|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
124839567|NCT02917031|449040939|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
124839568|NCT02917031|449040940|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
124839569|NCT02917031|449040938|FG000|Overall Study|Withdrawal by Subject|3|||
124839570|NCT02917031|449040939|FG001|Overall Study|Withdrawal by Subject|3|||
124839571|NCT02917031|449040940|FG002|Overall Study|Withdrawal by Subject|0|||
124839572|NCT02917031|449040938|FG000|Overall Study|Physician Decision|1|||
124839573|NCT02917031|449040939|FG001|Overall Study|Physician Decision|0|||
124839574|NCT02917031|449040940|FG002|Overall Study|Physician Decision|0|||
124839575|NCT02917031|449040938|FG000|Overall Study|Adverse Event|4|||
124839576|NCT02917031|449040939|FG001|Overall Study|Adverse Event|1|||
124839577|NCT02917031|449040940|FG002|Overall Study|Adverse Event|5|||
124839578|NCT02917031|449040938|FG000|Overall Study|Death|2|||
124839579|NCT02917031|449040939|FG001|Overall Study|Death|3|||
124839580|NCT02917031|449040940|FG002|Overall Study|Death|4|||
124976565|NCT03832595|449540002|FG001|Overall Study|Medical management without dialysis|1|||
124976566|NCT03277352|449540003|FG000|Overall Study|Study Terminated By Sponsor|2|||
124976567|NCT03277352|449540003|FG000|Overall Study|Withdrawal by Subject|4|||
124976568|NCT03277352|449540003|FG000|Overall Study|Death|4|||
124976569|NCT02397447|449540004|FG000|Overall Study|Lost to Follow-up|2|||
124976570|NCT02397447|449540005|FG001|Overall Study|Lost to Follow-up|2|||
124976571|NCT01435772|449540006|FG000|Overall Study|Adverse Event|1|||
124976572|NCT01435772|449540007|FG001|Overall Study|Adverse Event|0|||
124976573|NCT01435772|449540008|FG002|Overall Study|Adverse Event|2|||
124976574|NCT01435772|449540006|FG000|Overall Study|Withdrawal by Subject|0|||
124976575|NCT01435772|449540007|FG001|Overall Study|Withdrawal by Subject|1|||
124976576|NCT01435772|449540008|FG002|Overall Study|Withdrawal by Subject|3|||
124976577|NCT01435772|449540006|FG000|Overall Study|Other - study termination|2|||
124976578|NCT01435772|449540007|FG001|Overall Study|Other - study termination|2|||
124976579|NCT01435772|449540008|FG002|Overall Study|Other - study termination|10|||
124976580|NCT03238963|449540009|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
124976581|NCT03238963|449540010|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
124976582|NCT03238963|449540009|FG000|Overall Study|Withdrawal by Subject|1|||
124976583|NCT03238963|449540010|FG001|Overall Study|Withdrawal by Subject|1|||
124976584|NCT03238963|449540009|FG000|Overall Study|Lost to Follow-up|1|||
124976585|NCT03238963|449540010|FG001|Overall Study|Lost to Follow-up|0|||
124976586|NCT03238963|449540009|FG000|Overall Study|Protocol Violation|1|||
124976587|NCT03238963|449540010|FG001|Overall Study|Protocol Violation|1|||
124976588|NCT03238963|449540009|FG000|Overall Study|Adverse Event|1|||
124976589|NCT03238963|449540010|FG001|Overall Study|Adverse Event|0|||
124976590|NCT01424813|449540013|FG000|Overall Study|Withdrawal by Subject|3|||
124976591|NCT01424813|449540014|FG001|Overall Study|Withdrawal by Subject|0|||
124976592|NCT01424813|449540013|FG000|Overall Study|Protocol Violation|1|||
124976593|NCT01424813|449540014|FG001|Overall Study|Protocol Violation|0|||
124976594|NCT01424813|449540013|FG000|Overall Study|Other|1|||
124976595|NCT01424813|449540014|FG001|Overall Study|Other|2|||
124976596|NCT02614183|449540015|FG000|Double Blind Treatment Phase|Adverse Event|10|||
124976597|NCT02614183|449540016|FG001|Double Blind Treatment Phase|Adverse Event|9|||
124976598|NCT02614183|449540017|FG002|Double Blind Treatment Phase|Adverse Event|7|||
124976599|NCT02614183|449540015|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
124976600|NCT02614183|449540016|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
124976601|NCT02614183|449540017|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
124976602|NCT02614183|449540015|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
124976603|NCT02614183|449540016|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
124976604|NCT02614183|449540017|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
124976605|NCT02614183|449540015|FG000|Double Blind Treatment Phase|Physician Decision|7|||
124976606|NCT02614183|449540016|FG001|Double Blind Treatment Phase|Physician Decision|3|||
124976607|NCT02614183|449540017|FG002|Double Blind Treatment Phase|Physician Decision|2|||
124976608|NCT02614183|449540015|FG000|Double Blind Treatment Phase|Pregnancy|2|||
124976609|NCT02614183|449540016|FG001|Double Blind Treatment Phase|Pregnancy|1|||
124976610|NCT02614183|449540017|FG002|Double Blind Treatment Phase|Pregnancy|3|||
124976611|NCT02614183|449540015|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
124976612|NCT02614183|449540016|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
124976613|NCT02614183|449540017|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
124976614|NCT02614183|449540015|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
124976615|NCT02614183|449540016|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
124976616|NCT02614183|449540017|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
124976617|NCT02614183|449540015|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
124976618|NCT02614183|449540016|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
124976619|NCT02614183|449540017|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
124839581|NCT00403273|449042769|FG000|Overall Study|Lost to Follow-up|3|||
124839582|NCT00403273|449042770|FG001|Overall Study|Lost to Follow-up|2|||
124839583|NCT00403273|449042769|FG000|Overall Study|Physician Decision|0|||
124839584|NCT00403273|449042770|FG001|Overall Study|Physician Decision|1|||
124839585|NCT00403273|449042769|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
124839586|NCT00403273|449042770|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
124839587|NCT01852292|449042774|FG000|Overall Study|Untreated - did not receive study drug|3|||
124839588|NCT01852292|449042775|FG001|Overall Study|Untreated - did not receive study drug|1|||
124839589|NCT01852292|449042774|FG000|Overall Study|Death|9|||
124839590|NCT01852292|449042775|FG001|Overall Study|Death|8|||
124839591|NCT01852292|449042774|FG000|Overall Study|Patient/guardian decision|8|||
124839592|NCT01852292|449042775|FG001|Overall Study|Patient/guardian decision|4|||
124839593|NCT01852292|449042774|FG000|Overall Study|Adverse Event|8|||
124839594|NCT01852292|449042775|FG001|Overall Study|Adverse Event|11|||
124839595|NCT01852292|449042774|FG000|Overall Study|Physician Decision|6|||
124839596|NCT01852292|449042775|FG001|Overall Study|Physician Decision|2|||
124839597|NCT01852292|449042774|FG000|Overall Study|Protocol Violation|2|||
124839598|NCT01852292|449042775|FG001|Overall Study|Protocol Violation|0|||
124839599|NCT01852292|449042774|FG000|Overall Study|Non-compliance with study treatment|1|||
124839600|NCT01852292|449042775|FG001|Overall Study|Non-compliance with study treatment|0|||
124839601|NCT01852292|449042774|FG000|Overall Study|Study terminated by Sponsor|0|||
124839602|NCT01852292|449042775|FG001|Overall Study|Study terminated by Sponsor|1|||
124839603|NCT01852292|449042774|FG000|Overall Study|Progressive disease|42|||
124839604|NCT01852292|449042775|FG001|Overall Study|Progressive disease|52|||
124839605|NCT02586012|449042776|FG000|Overall Study|Withdrawal by Subject|1|||
124839606|NCT02586012|449042777|FG001|Overall Study|Withdrawal by Subject|1|||
124839607|NCT02586012|449042778|FG002|Overall Study|Withdrawal by Subject|0|||
124839608|NCT02586012|449042779|FG003|Overall Study|Withdrawal by Subject|1|||
124839609|NCT02586012|449042780|FG004|Overall Study|Withdrawal by Subject|0|||
124839610|NCT02586012|449042781|FG005|Overall Study|Withdrawal by Subject|2|||
124839611|NCT02586012|449042776|FG000|Overall Study|Protocol Violation|0|||
124839612|NCT02586012|449042777|FG001|Overall Study|Protocol Violation|0|||
124839613|NCT02586012|449042778|FG002|Overall Study|Protocol Violation|0|||
124839614|NCT02586012|449042779|FG003|Overall Study|Protocol Violation|0|||
124839615|NCT02586012|449042780|FG004|Overall Study|Protocol Violation|0|||
124839616|NCT02586012|449042781|FG005|Overall Study|Protocol Violation|1|||
124839617|NCT02586012|449042776|FG000|Overall Study|study terminated|0|||
124839618|NCT02586012|449042777|FG001|Overall Study|study terminated|2|||
124839619|NCT02586012|449042778|FG002|Overall Study|study terminated|1|||
124839620|NCT02586012|449042779|FG003|Overall Study|study terminated|1|||
124839621|NCT02586012|449042780|FG004|Overall Study|study terminated|1|||
124839622|NCT02586012|449042781|FG005|Overall Study|study terminated|0|||
124839623|NCT02388737|449042783|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
124839624|NCT02388737|449042784|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
124839625|NCT02388737|449042785|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
124839626|NCT02388737|449042783|FG000|Overall Study|Major Protocol Deviation|18|||
124839627|NCT02388737|449042784|FG001|Overall Study|Major Protocol Deviation|25|||
124839628|NCT02388737|449042785|FG002|Overall Study|Major Protocol Deviation|22|||
124839629|NCT02388737|449042783|FG000|Overall Study|Lost to Follow-up|5|||
124839630|NCT02388737|449042784|FG001|Overall Study|Lost to Follow-up|1|||
124839631|NCT02388737|449042785|FG002|Overall Study|Lost to Follow-up|4|||
124839632|NCT02388737|449042783|FG000|Overall Study|Voluntary Withdrawal|10|||
124839633|NCT02388737|449042784|FG001|Overall Study|Voluntary Withdrawal|18|||
124839634|NCT02388737|449042785|FG002|Overall Study|Voluntary Withdrawal|17|||
124839635|NCT02388737|449042783|FG000|Overall Study|Lack of Efficacy|3|||
124839636|NCT02388737|449042784|FG001|Overall Study|Lack of Efficacy|0|||
124839637|NCT02388737|449042785|FG002|Overall Study|Lack of Efficacy|3|||
124839638|NCT02388737|449042783|FG000|Overall Study|Reason Not Specified|5|||
124839639|NCT02388737|449042784|FG001|Overall Study|Reason Not Specified|5|||
124839640|NCT02388737|449042785|FG002|Overall Study|Reason Not Specified|4|||
124839641|NCT03299842|449042787|FG000|Overall Study|Caregiver withdrew consent|2|||
124839642|NCT03299842|449042787|FG000|Overall Study|Child would not keep the watch on|3|||
124839643|NCT01816139|449042788|FG000|Overall Study|Adverse Event|6|||
124839644|NCT01816139|449042789|FG001|Overall Study|Adverse Event|8|||
124839645|NCT01816139|449042788|FG000|Overall Study|Lack of Efficacy|1|||
124839646|NCT01816139|449042789|FG001|Overall Study|Lack of Efficacy|2|||
124839647|NCT01816139|449042788|FG000|Overall Study|Lost to Follow-up|5|||
124839648|NCT01816139|449042789|FG001|Overall Study|Lost to Follow-up|3|||
124839649|NCT01816139|449042788|FG000|Overall Study|Withdrew Consent|6|||
124839650|NCT01816139|449042789|FG001|Overall Study|Withdrew Consent|4|||
124839651|NCT01816139|449042788|FG000|Overall Study|Protocol Violation|6|||
124839652|NCT01816139|449042789|FG001|Overall Study|Protocol Violation|3|||
124839653|NCT01816139|449042788|FG000|Overall Study|Reason not Specified|4|||
124839654|NCT01816139|449042789|FG001|Overall Study|Reason not Specified|2|||
124839655|NCT03240575|449042792|FG000|Overall Study|Adverse Event|0|||
124839656|NCT03240575|449042793|FG001|Overall Study|Adverse Event|2|||
124839657|NCT03240575|449042794|FG002|Overall Study|Adverse Event|0|||
124839658|NCT03240575|449042795|FG003|Overall Study|Adverse Event|1|||
124839659|NCT03240575|449042792|FG000|Overall Study|Withdrawal by Subject|2|||
124839660|NCT03240575|449042793|FG001|Overall Study|Withdrawal by Subject|11|||
124839661|NCT03240575|449042794|FG002|Overall Study|Withdrawal by Subject|0|||
124839662|NCT03240575|449042795|FG003|Overall Study|Withdrawal by Subject|1|||
124839663|NCT03240575|449042792|FG000|Overall Study|Other|0|||
125305333|NCT01393821|450745088|FG000|Overall Study|not evaluable for primary endpoint|4|||
125305334|NCT01393821|450745089|FG001|Overall Study|not evaluable for primary endpoint|2|||
125305335|NCT03422536|450745090|FG000|Randomized|Physician Decision|1|||
125305336|NCT03422536|450745091|FG001|Randomized|Physician Decision|1|||
125305337|NCT03422536|450745090|FG000|Allocation - Received Intervention|Disease progression|19|||
125305338|NCT03422536|450745091|FG001|Allocation - Received Intervention|Disease progression|25|||
125305339|NCT03422536|450745090|FG000|Allocation - Received Intervention|Death|1|||
125305340|NCT03422536|450745091|FG001|Allocation - Received Intervention|Death|3|||
125305341|NCT03422536|450745090|FG000|Allocation - Received Intervention|Adverse Event|1|||
125305342|NCT03422536|450745091|FG001|Allocation - Received Intervention|Adverse Event|0|||
125305343|NCT03422536|450745090|FG000|Allocation - Received Intervention|Physician Decision|1|||
125305344|NCT03422536|450745091|FG001|Allocation - Received Intervention|Physician Decision|1|||
125305345|NCT03422536|450745090|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
125305346|NCT03422536|450745091|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
125305347|NCT03422536|450745090|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
125305348|NCT03422536|450745091|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
125305349|NCT04929249|450745092|FG000|Overall Study|Adverse Event|2|||
125305350|NCT04929249|450745093|FG001|Overall Study|Adverse Event|1|||
125305351|NCT04929249|450745092|FG000|Overall Study|Death|2|||
125305352|NCT04929249|450745093|FG001|Overall Study|Death|1|||
125305353|NCT04929249|450745092|FG000|Overall Study|Lost to Follow-up|3|||
125305354|NCT04929249|450745093|FG001|Overall Study|Lost to Follow-up|11|||
125305355|NCT04929249|450745092|FG000|Overall Study|Technical problems|0|||
125305356|NCT04929249|450745093|FG001|Overall Study|Technical problems|1|||
125305357|NCT04929249|450745092|FG000|Overall Study|Subject decision|6|||
125305358|NCT04929249|450745093|FG001|Overall Study|Subject decision|8|||
125305359|NCT04929249|450745092|FG000|Overall Study|Withdrew consent|0|||
125305360|NCT04929249|450745093|FG001|Overall Study|Withdrew consent|8|||
125305361|NCT00395850|450745104|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
125305362|NCT00395850|450745105|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
125305363|NCT00395850|450745106|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
125305364|NCT00395850|450745107|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
125305365|NCT00395850|450745104|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
125305366|NCT00395850|450745105|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
125305367|NCT00395850|450745106|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
125305368|NCT00395850|450745107|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
125305369|NCT00395850|450745104|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
125305370|NCT00395850|450745105|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
125305371|NCT00395850|450745106|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
125305372|NCT00395850|450745107|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
125305373|NCT00395850|450745104|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
125305374|NCT00395850|450745105|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
125305375|NCT00395850|450745106|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
125305376|NCT00395850|450745107|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
125305377|NCT00395850|450745104|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
125305378|NCT00395850|450745105|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
125305379|NCT00395850|450745106|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
125305380|NCT00395850|450745107|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
125305381|NCT00395850|450745104|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
125305382|NCT00395850|450745105|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
125305383|NCT00395850|450745106|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
125305384|NCT00395850|450745107|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
125305385|NCT00395850|450745104|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
125305386|NCT00395850|450745105|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
125305387|NCT00395850|450745106|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
125305388|NCT00395850|450745107|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
125305389|NCT01620762|450745109|FG000|Overall Study|Protocol Violation|1|||
125305390|NCT01620762|450745110|FG001|Overall Study|Protocol Violation|1|||
125305391|NCT01620762|450745111|FG002|Overall Study|Protocol Violation|1|||
125305392|NCT01620762|450745109|FG000|Overall Study|Adverse Event|9|||
125305393|NCT01620762|450745110|FG001|Overall Study|Adverse Event|5|||
125305394|NCT01620762|450745111|FG002|Overall Study|Adverse Event|2|||
124839664|NCT03240575|449042793|FG001|Overall Study|Other|1|||
124839665|NCT03240575|449042794|FG002|Overall Study|Other|0|||
124839666|NCT03240575|449042795|FG003|Overall Study|Other|0|||
124839667|NCT02342704|449042805|FG000|Overall Study|Physician Decision|0|||
124839668|NCT02342704|449042806|FG001|Overall Study|Physician Decision|3|||
124839669|NCT02342704|449042805|FG000|Overall Study|Sponsor Termination|49|||
124839670|NCT02342704|449042806|FG001|Overall Study|Sponsor Termination|43|||
124839671|NCT02342704|449042805|FG000|Overall Study|Other|0|||
124839672|NCT02342704|449042806|FG001|Overall Study|Other|1|||
124839673|NCT02342704|449042805|FG000|Overall Study|Withdrawal by Subject|1|||
124839674|NCT02342704|449042806|FG001|Overall Study|Withdrawal by Subject|0|||
124839675|NCT02342704|449042805|FG000|Overall Study|Lost to Follow-up|2|||
124839676|NCT02342704|449042806|FG001|Overall Study|Lost to Follow-up|1|||
124839677|NCT02342704|449042805|FG000|Overall Study|Adverse Event|1|||
124839678|NCT02342704|449042806|FG001|Overall Study|Adverse Event|3|||
124839679|NCT02347527|449042808|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
124839680|NCT02347527|449042809|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
124839681|NCT02347527|449042810|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
124839682|NCT02347527|449042811|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
124839683|NCT02347527|449042808|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
124839684|NCT02347527|449042809|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
124839685|NCT02347527|449042810|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
124839686|NCT02347527|449042811|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
124839687|NCT02347527|449042808|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
124839688|NCT02347527|449042809|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
124839689|NCT02347527|449042810|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
124839690|NCT02347527|449042811|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
124839691|NCT02347527|449042808|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
124839692|NCT02347527|449042809|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
124839693|NCT02347527|449042810|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
124839694|NCT02347527|449042811|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
124839695|NCT02347527|449042808|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
124839696|NCT02347527|449042809|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
124839697|NCT02347527|449042810|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
124839698|NCT02347527|449042811|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
124839699|NCT01632891|449042812|FG000|Overall Study|Lost to Follow-up|0|||
124839700|NCT01632891|449042813|FG001|Overall Study|Lost to Follow-up|1|||
124839701|NCT01632891|449042812|FG000|Overall Study|Withdrawal by Subject|1|||
124839702|NCT01632891|449042813|FG001|Overall Study|Withdrawal by Subject|0|||
124839703|NCT02919670|449042814|FG000|Overall Study|Only 17 participants met compliance|43|||
124839704|NCT02919670|449042815|FG001|Overall Study|Only 17 participants met compliance|39|||
124839705|NCT01466270|449042816|FG000|Overall Study|Withdrawal by Subject|4|||
124839706|NCT01466270|449042817|FG001|Overall Study|Withdrawal by Subject|1|||
124839707|NCT01466270|449042816|FG000|Overall Study|Physician Decision|1|||
124839708|NCT01466270|449042817|FG001|Overall Study|Physician Decision|0|||
124839709|NCT01466270|449042816|FG000|Overall Study|Lost to Follow-up|1|||
124839710|NCT01466270|449042817|FG001|Overall Study|Lost to Follow-up|3|||
124839711|NCT01466270|449042816|FG000|Overall Study|Progression|1|||
124839712|NCT01466270|449042817|FG001|Overall Study|Progression|0|||
124839713|NCT01466270|449042816|FG000|Overall Study|Toxicity|4|||
124839714|NCT01466270|449042817|FG001|Overall Study|Toxicity|1|||
124839715|NCT01466270|449042816|FG000|Overall Study|Multiple|1|||
124839716|NCT01466270|449042817|FG001|Overall Study|Multiple|1|||
124839717|NCT02118428|449042822|FG000|Overall Study|Physician Decision|0|||
124839718|NCT02118428|449042823|FG001|Overall Study|Physician Decision|1|||
124839719|NCT02118428|449042824|FG002|Overall Study|Physician Decision|0|||
124839720|NCT02118428|449042822|FG000|Overall Study|Withdrawal by Subject|2|||
124839721|NCT02118428|449042823|FG001|Overall Study|Withdrawal by Subject|2|||
124839722|NCT02118428|449042824|FG002|Overall Study|Withdrawal by Subject|0|||
124839723|NCT02118428|449042822|FG000|Overall Study|Death|7|||
124839724|NCT02118428|449042823|FG001|Overall Study|Death|5|||
124839725|NCT02118428|449042824|FG002|Overall Study|Death|0|||
124839726|NCT02118428|449042822|FG000|Overall Study|Lost to Follow-up|3|||
124839727|NCT02118428|449042823|FG001|Overall Study|Lost to Follow-up|1|||
124839728|NCT02118428|449042824|FG002|Overall Study|Lost to Follow-up|0|||
124839729|NCT02118428|449042822|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
124839730|NCT02118428|449042823|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
124839731|NCT02118428|449042824|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
124839732|NCT04171414|449042825|FG000|Overall Study|Death|1|||
124839733|NCT04171414|449042825|FG000|Overall Study|Withdrawal by Subject|1|||
124839734|NCT02884089|449042832|FG000|Period 1|Dosing error|2|||
125305395|NCT01620762|450745109|FG000|Overall Study|Withdrawal by Subject|23|||
124839735|NCT02884089|449042833|FG001|Period 1|Dosing error|2|||
125305396|NCT01620762|450745110|FG001|Overall Study|Withdrawal by Subject|26|||
124839736|NCT02884089|449042834|FG002|Period 1|Dosing error|0|||
124839737|NCT02884089|449042835|FG003|Period 1|Dosing error|0|||
124839738|NCT02884089|449042832|FG000|Washout Period 1|Lost to Follow-up|0|||
124839739|NCT02884089|449042833|FG001|Washout Period 1|Lost to Follow-up|1|||
124839740|NCT02884089|449042834|FG002|Washout Period 1|Lost to Follow-up|0|||
124839741|NCT02884089|449042835|FG003|Washout Period 1|Lost to Follow-up|1|||
124839742|NCT02884089|449042832|FG000|Washout Period 1|Withdrawal by Subject|0|||
124839743|NCT02884089|449042833|FG001|Washout Period 1|Withdrawal by Subject|1|||
124839744|NCT02884089|449042834|FG002|Washout Period 1|Withdrawal by Subject|0|||
124839745|NCT02884089|449042835|FG003|Washout Period 1|Withdrawal by Subject|0|||
124839746|NCT02884089|449042832|FG000|Period 2|Adverse Event|1|||
124839747|NCT02884089|449042833|FG001|Period 2|Adverse Event|0|||
124839748|NCT02884089|449042834|FG002|Period 2|Adverse Event|0|||
124839749|NCT02884089|449042835|FG003|Period 2|Adverse Event|0|||
124839750|NCT02884089|449042832|FG000|Period 3|Withdrawal by Subject|0|||
124839751|NCT02884089|449042833|FG001|Period 3|Withdrawal by Subject|0|||
124839752|NCT02884089|449042834|FG002|Period 3|Withdrawal by Subject|1|||
124839753|NCT02884089|449042835|FG003|Period 3|Withdrawal by Subject|0|||
124839754|NCT02884089|449042832|FG000|Washout Period 3|Withdrawal by Subject|0|||
124839755|NCT02884089|449042833|FG001|Washout Period 3|Withdrawal by Subject|0|||
124839756|NCT02884089|449042834|FG002|Washout Period 3|Withdrawal by Subject|1|||
124839757|NCT02884089|449042835|FG003|Washout Period 3|Withdrawal by Subject|0|||
124839758|NCT02884089|449042832|FG000|Washout Period 3|Lost to Follow-up|0|||
124839759|NCT02884089|449042833|FG001|Washout Period 3|Lost to Follow-up|0|||
124839760|NCT02884089|449042834|FG002|Washout Period 3|Lost to Follow-up|0|||
124839761|NCT02884089|449042835|FG003|Washout Period 3|Lost to Follow-up|1|||
124839762|NCT02884089|449042832|FG000|Period 4|Withdrawal by Subject|0|||
124839763|NCT02884089|449042833|FG001|Period 4|Withdrawal by Subject|1|||
124839764|NCT02884089|449042834|FG002|Period 4|Withdrawal by Subject|0|||
124839765|NCT02884089|449042835|FG003|Period 4|Withdrawal by Subject|0|||
124839766|NCT02884089|449042832|FG000|Period 4|Lost to Follow-up|1|||
124839767|NCT02884089|449042833|FG001|Period 4|Lost to Follow-up|0|||
124839768|NCT02884089|449042834|FG002|Period 4|Lost to Follow-up|0|||
124839769|NCT02884089|449042835|FG003|Period 4|Lost to Follow-up|0|||
124839770|NCT02884089|449042832|FG000|Follow-up Visit|Withdrawal by Subject|1|||
124839771|NCT02884089|449042833|FG001|Follow-up Visit|Withdrawal by Subject|0|||
124839772|NCT02884089|449042834|FG002|Follow-up Visit|Withdrawal by Subject|0|||
124839773|NCT02884089|449042835|FG003|Follow-up Visit|Withdrawal by Subject|1|||
124839774|NCT01631474|449042836|FG000|Overall Study|Lost to Follow-up|8|||
124839775|NCT01631474|449042837|FG001|Overall Study|Lost to Follow-up|5|||
124839776|NCT01631474|449042838|FG002|Overall Study|Lost to Follow-up|7|||
124839777|NCT01631474|449042839|FG003|Overall Study|Lost to Follow-up|5|||
124839778|NCT01631474|449042840|FG004|Overall Study|Lost to Follow-up|5|||
124839779|NCT01631474|449042836|FG000|Overall Study|Withdrawal by Subject|4|||
124839780|NCT01631474|449042837|FG001|Overall Study|Withdrawal by Subject|4|||
124839781|NCT01631474|449042838|FG002|Overall Study|Withdrawal by Subject|2|||
124839782|NCT01631474|449042839|FG003|Overall Study|Withdrawal by Subject|6|||
124839783|NCT01631474|449042840|FG004|Overall Study|Withdrawal by Subject|5|||
124839784|NCT01631474|449042836|FG000|Overall Study|Lack of Efficacy|2|||
124839785|NCT01631474|449042837|FG001|Overall Study|Lack of Efficacy|2|||
124839786|NCT01631474|449042838|FG002|Overall Study|Lack of Efficacy|0|||
125305397|NCT01620762|450745111|FG002|Overall Study|Withdrawal by Subject|27|||
125305398|NCT01620762|450745109|FG000|Overall Study|Lost to Follow-up|11|||
125305399|NCT01620762|450745110|FG001|Overall Study|Lost to Follow-up|17|||
125305400|NCT01620762|450745111|FG002|Overall Study|Lost to Follow-up|10|||
125305401|NCT01620762|450745109|FG000|Overall Study|Protocol deviation|1|||
125305402|NCT01620762|450745110|FG001|Overall Study|Protocol deviation|1|||
125305403|NCT01620762|450745111|FG002|Overall Study|Protocol deviation|6|||
125305404|NCT01620762|450745109|FG000|Overall Study|Subject deterioration|0|||
125305405|NCT01620762|450745110|FG001|Overall Study|Subject deterioration|1|||
124839787|NCT01631474|449042839|FG003|Overall Study|Lack of Efficacy|0|||
124839788|NCT01631474|449042840|FG004|Overall Study|Lack of Efficacy|2|||
124839789|NCT01631474|449042836|FG000|Overall Study|Noncompliance with Study Drug|0|||
124839790|NCT01631474|449042837|FG001|Overall Study|Noncompliance with Study Drug|0|||
124839791|NCT01631474|449042838|FG002|Overall Study|Noncompliance with Study Drug|0|||
124839792|NCT01631474|449042839|FG003|Overall Study|Noncompliance with Study Drug|0|||
124839793|NCT01631474|449042840|FG004|Overall Study|Noncompliance with Study Drug|1|||
124839794|NCT01631474|449042836|FG000|Overall Study|Adverse Event|0|||
124839795|NCT01631474|449042837|FG001|Overall Study|Adverse Event|1|||
124839796|NCT01631474|449042838|FG002|Overall Study|Adverse Event|0|||
124839797|NCT01631474|449042839|FG003|Overall Study|Adverse Event|0|||
124839798|NCT01631474|449042840|FG004|Overall Study|Adverse Event|0|||
124839799|NCT02624284|449042841|FG000|Overall Study|Withdrawal by Subject|3|||
124839800|NCT02624284|449042842|FG001|Overall Study|Withdrawal by Subject|6|||
124839801|NCT02624284|449042843|FG002|Overall Study|Withdrawal by Subject|3|||
125305406|NCT01620762|450745111|FG002|Overall Study|Subject deterioration|1|||
124839802|NCT02624284|449042841|FG000|Overall Study|Protocol Violation|9|||
125305407|NCT01620762|450745109|FG000|Overall Study|Non-specified|3|||
124839803|NCT02624284|449042842|FG001|Overall Study|Protocol Violation|10|||
124839804|NCT02624284|449042843|FG002|Overall Study|Protocol Violation|7|||
124839805|NCT02624284|449042841|FG000|Overall Study|Revealed exclusionary condition|2|||
124839806|NCT02624284|449042842|FG001|Overall Study|Revealed exclusionary condition|2|||
124839807|NCT02624284|449042843|FG002|Overall Study|Revealed exclusionary condition|0|||
124839808|NCT02624284|449042841|FG000|Overall Study|Adverse Event|0|||
124839809|NCT02624284|449042842|FG001|Overall Study|Adverse Event|0|||
124839810|NCT02624284|449042843|FG002|Overall Study|Adverse Event|1|||
124839811|NCT02487394|449042844|FG000|Phase 1|Withdrawal by Subject|0|||
124839812|NCT02487394|449042845|FG001|Phase 1|Withdrawal by Subject|1|||
124839813|NCT01641367|449042849|FG000|Cohorts|Death|18|||
124839814|NCT01641367|449042850|FG001|Cohorts|Death|1|||
124839815|NCT01641367|449042851|FG002|Cohorts|Death|2|||
124839816|NCT01641367|449042852|FG003|Cohorts|Death|0|||
124839817|NCT01641367|449042853|FG004|Cohorts|Death|1|||
124839818|NCT01641367|449042854|FG005|Cohorts|Death|1|||
124839819|NCT01641367|449042855|FG006|Cohorts|Death|0|||
124839820|NCT01641367|449042856|FG007|Cohorts|Death|0|||
124839821|NCT01641367|449042849|FG000|Cohorts|Lost to Follow-up|16|||
124839822|NCT01641367|449042850|FG001|Cohorts|Lost to Follow-up|0|||
124839823|NCT01641367|449042851|FG002|Cohorts|Lost to Follow-up|2|||
124839824|NCT01641367|449042852|FG003|Cohorts|Lost to Follow-up|0|||
124839825|NCT01641367|449042853|FG004|Cohorts|Lost to Follow-up|2|||
124839826|NCT01641367|449042854|FG005|Cohorts|Lost to Follow-up|0|||
124839827|NCT01641367|449042855|FG006|Cohorts|Lost to Follow-up|0|||
124839828|NCT01641367|449042856|FG007|Cohorts|Lost to Follow-up|0|||
124839829|NCT01641367|449042849|FG000|Randomized Adherence Intervention|Death|0|||
124839830|NCT01641367|449042850|FG001|Randomized Adherence Intervention|Death|0|||
124839831|NCT01641367|449042851|FG002|Randomized Adherence Intervention|Death|0|||
124839832|NCT01641367|449042852|FG003|Randomized Adherence Intervention|Death|0|||
124839833|NCT01641367|449042853|FG004|Randomized Adherence Intervention|Death|0|||
124839834|NCT01641367|449042854|FG005|Randomized Adherence Intervention|Death|0|||
124839835|NCT01641367|449042855|FG006|Randomized Adherence Intervention|Death|11|||
124839836|NCT01641367|449042856|FG007|Randomized Adherence Intervention|Death|12|||
124839837|NCT01641367|449042849|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
124839838|NCT01641367|449042850|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
124839839|NCT01641367|449042851|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
124839840|NCT01641367|449042852|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
124839841|NCT01641367|449042853|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
124839842|NCT01641367|449042854|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
124839843|NCT01641367|449042855|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
124839844|NCT01641367|449042856|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
124839845|NCT02586493|449042857|FG000|Overall Study|Adverse Event|4|||
124839846|NCT02586493|449042857|FG000|Overall Study|Protocol Violation|6|||
124839847|NCT02586493|449042857|FG000|Overall Study|Lost to Follow-up|1|||
124839848|NCT02586493|449042857|FG000|Overall Study|Withdrawal by Subject|1|||
124839849|NCT02711800|449042859|FG000|Overall Study|Lost to Follow-up|1|||
124839850|NCT02711800|449042859|FG000|Overall Study|Withdrawal by Subject|1|||
124839851|NCT01869192|449042860|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
124839852|NCT01869192|449042861|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
124839853|NCT01869192|449042860|FG000|Postoperative Chemotherapy|Physician Decision|0|||
124839854|NCT01869192|449042861|FG001|Postoperative Chemotherapy|Physician Decision|2|||
124839855|NCT00423891|449042862|FG000|Enrolled|Withdrawal by Subject|0|||
124839856|NCT00423891|449042863|FG001|Enrolled|Withdrawal by Subject|0|||
124839857|NCT00423891|449042864|FG002|Enrolled|Withdrawal by Subject|1|||
124839858|NCT00423891|449042862|FG000|Enrolled|Lost to Follow-up|0|||
124839859|NCT00423891|449042863|FG001|Enrolled|Lost to Follow-up|0|||
124839860|NCT00423891|449042864|FG002|Enrolled|Lost to Follow-up|1|||
125305408|NCT01620762|450745110|FG001|Overall Study|Non-specified|6|||
125305409|NCT01620762|450745111|FG002|Overall Study|Non-specified|5|||
125305410|NCT01620762|450745109|FG000|Overall Study|Use of prohibted therapies|0|||
125305411|NCT01620762|450745110|FG001|Overall Study|Use of prohibted therapies|1|||
124839861|NCT00423891|449042862|FG000|Enrolled|No longer met criteria|11|||
124839862|NCT00423891|449042863|FG001|Enrolled|No longer met criteria|2|||
124839863|NCT00423891|449042864|FG002|Enrolled|No longer met criteria|1|||
124839864|NCT00423891|449042862|FG000|Treatment|Withdrawal by Subject|1|||
124839865|NCT00423891|449042863|FG001|Treatment|Withdrawal by Subject|0|||
124839866|NCT00423891|449042864|FG002|Treatment|Withdrawal by Subject|0|||
124839867|NCT00423891|449042862|FG000|Treatment|Lost to Follow-up|1|||
124839868|NCT00423891|449042863|FG001|Treatment|Lost to Follow-up|0|||
124839869|NCT00423891|449042864|FG002|Treatment|Lost to Follow-up|0|||
124839870|NCT00423891|449042862|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
124839871|NCT00423891|449042863|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
124839872|NCT00423891|449042864|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
124839873|NCT00423891|449042862|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
124839874|NCT00423891|449042863|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
124839875|NCT00423891|449042864|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
124839876|NCT00414661|449042865|FG000|Overall Study|Death|2|||
125305412|NCT01620762|450745111|FG002|Overall Study|Use of prohibted therapies|1|||
124839877|NCT00414661|449042866|FG001|Overall Study|Death|5|||
124839878|NCT00414661|449042867|FG002|Overall Study|Death|0|||
124839879|NCT00414661|449042868|FG003|Overall Study|Death|0|||
124839880|NCT00414661|449042865|FG000|Overall Study|Lost to Follow-up|1|||
124839881|NCT00414661|449042866|FG001|Overall Study|Lost to Follow-up|4|||
124839882|NCT00414661|449042867|FG002|Overall Study|Lost to Follow-up|0|||
124839883|NCT00414661|449042868|FG003|Overall Study|Lost to Follow-up|1|||
124839884|NCT00414661|449042865|FG000|Overall Study|Withdrawal by Subject|5|||
124839885|NCT00414661|449042866|FG001|Overall Study|Withdrawal by Subject|2|||
124839886|NCT00414661|449042867|FG002|Overall Study|Withdrawal by Subject|2|||
124839887|NCT00414661|449042868|FG003|Overall Study|Withdrawal by Subject|2|||
124839888|NCT00414661|449042865|FG000|Overall Study|Other|6|||
124839889|NCT00414661|449042866|FG001|Overall Study|Other|3|||
124839890|NCT00414661|449042867|FG002|Overall Study|Other|0|||
124839891|NCT00414661|449042868|FG003|Overall Study|Other|0|||
124839892|NCT00357370|449042869|FG000|Cohort 2|Lack of Efficacy|0|||
124839893|NCT00357370|449042870|FG001|Cohort 2|Lack of Efficacy|2|||
124839894|NCT00357370|449042871|FG002|Cohort 2|Lack of Efficacy|1|||
124839895|NCT00357370|449042869|FG000|Cohort 2|Adverse Event|1|||
124839896|NCT00357370|449042870|FG001|Cohort 2|Adverse Event|1|||
124839897|NCT00357370|449042871|FG002|Cohort 2|Adverse Event|1|||
124839898|NCT00357370|449042869|FG000|Cohort 2|Lost to Follow-up|0|||
124839899|NCT00357370|449042870|FG001|Cohort 2|Lost to Follow-up|1|||
124839900|NCT00357370|449042871|FG002|Cohort 2|Lost to Follow-up|0|||
124839901|NCT00357370|449042869|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
124839902|NCT00357370|449042870|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
124839903|NCT00357370|449042871|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
124839904|NCT00357370|449042869|FG000|Cohort 2|Withdrawal by Subject|0|||
124839905|NCT00357370|449042870|FG001|Cohort 2|Withdrawal by Subject|2|||
124839906|NCT00357370|449042871|FG002|Cohort 2|Withdrawal by Subject|0|||
124839907|NCT00937547|449042873|FG000|Overall Study|misdiagnosis|1|||
124839908|NCT00937547|449042874|FG001|Overall Study|misdiagnosis|6|||
124839909|NCT00937547|449042875|FG002|Overall Study|misdiagnosis|7|||
124839910|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
124839911|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
124839912|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
124839913|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
124839914|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
124839915|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
124839916|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
124839917|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
124839918|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
124839919|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
124839920|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
124839921|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
124839922|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
124839923|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
124839924|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
124839925|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
124839926|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
124839927|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
124839928|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Death|0|||
124839929|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Death|0|||
124839930|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Death|1|||
124839931|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Death|0|||
124839932|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Death|0|||
124839933|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Death|0|||
124839934|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Death|0|||
124839935|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Death|0|||
124839936|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Death|0|||
124839937|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
124839938|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
124839939|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
124839940|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
124839941|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
124839942|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
124839943|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
124839944|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
124839945|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
124839946|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
124839947|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
124839948|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
124839949|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
124839950|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
125305413|NCT00705146|450745116|FG000|Overall Study|Lost to Follow-up|1|||
124839951|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
124839952|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
124839953|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
124839954|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
124839955|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
124839956|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
124839957|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
124839958|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
124839959|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
124839960|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
124839961|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
124839962|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
124839963|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
124839964|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
124839965|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
124839966|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
124839967|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
124839968|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
124839969|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
124839970|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
124839971|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
124839972|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
124839973|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
124839974|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
124839975|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
124839976|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
124839977|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
124839978|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
124839979|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
124839980|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
124839981|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
124839982|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
124839983|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
124839984|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
124839985|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
124839986|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
124839987|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
124839988|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
124839989|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
124839990|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
124839991|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
124839992|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
124839993|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
124839994|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
124839995|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
124839996|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
124839997|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
124839998|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
124839999|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
124840000|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Other|0|||
124840001|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Other|1|||
124840002|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Other|0|||
124840003|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Other|0|||
124840004|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Other|0|||
124840005|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Other|0|||
124840006|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Other|0|||
124840007|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Other|0|||
124840008|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Other|0|||
124840009|NCT00404352|449042877|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
125305414|NCT00705146|450745117|FG001|Overall Study|Lost to Follow-up|1|||
124840010|NCT00404352|449042878|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
124840011|NCT00404352|449042879|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
124840012|NCT00404352|449042880|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
124840013|NCT00404352|449042881|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
124840014|NCT00404352|449042882|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
124840015|NCT00404352|449042883|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
125305415|NCT02669121|450745120|FG000|Overall Study|Adverse Event|4|||
125305416|NCT02669121|450745121|FG001|Overall Study|Adverse Event|5|||
125305417|NCT02669121|450745120|FG000|Overall Study|Lost to Follow-up|15|||
125305418|NCT02669121|450745121|FG001|Overall Study|Lost to Follow-up|27|||
124840016|NCT00404352|449042884|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
124840017|NCT00404352|449042885|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
124840018|NCT00404352|449042877|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
124840019|NCT00404352|449042878|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
124840020|NCT00404352|449042879|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
124840021|NCT00404352|449042880|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
124840022|NCT00404352|449042881|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
124840023|NCT00404352|449042882|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
124840024|NCT00404352|449042883|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
124840025|NCT00404352|449042884|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
124840026|NCT00404352|449042885|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
124840027|NCT00404352|449042877|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
124840028|NCT00404352|449042878|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
124840029|NCT00404352|449042879|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
124840030|NCT00404352|449042880|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
124840031|NCT00404352|449042881|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
124840032|NCT00404352|449042882|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
124840033|NCT00404352|449042883|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
124840034|NCT00404352|449042884|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
124840035|NCT00404352|449042885|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
124840036|NCT00404352|449042877|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
124840037|NCT00404352|449042878|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
124840038|NCT00404352|449042879|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
124840039|NCT00404352|449042880|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
124840040|NCT00404352|449042881|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
124840041|NCT00404352|449042882|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
124840042|NCT00404352|449042883|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
124840043|NCT00404352|449042884|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
124840044|NCT00404352|449042885|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
124840045|NCT00404352|449042877|FG000|Open Label (up to 24 Month)|Disease progression|0|||
124840046|NCT00404352|449042878|FG001|Open Label (up to 24 Month)|Disease progression|0|||
124840047|NCT00404352|449042879|FG002|Open Label (up to 24 Month)|Disease progression|0|||
124840048|NCT00404352|449042880|FG003|Open Label (up to 24 Month)|Disease progression|1|||
124840049|NCT00404352|449042881|FG004|Open Label (up to 24 Month)|Disease progression|0|||
124840050|NCT00404352|449042882|FG005|Open Label (up to 24 Month)|Disease progression|0|||
124840051|NCT00404352|449042883|FG006|Open Label (up to 24 Month)|Disease progression|0|||
124840052|NCT00404352|449042884|FG007|Open Label (up to 24 Month)|Disease progression|0|||
124840053|NCT00404352|449042885|FG008|Open Label (up to 24 Month)|Disease progression|0|||
124840054|NCT00404352|449042877|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
124840055|NCT00404352|449042878|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
124840056|NCT00404352|449042879|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
124840057|NCT00404352|449042880|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
124840058|NCT00404352|449042881|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
124840059|NCT00404352|449042882|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
124840060|NCT00404352|449042883|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
124840061|NCT00404352|449042884|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
124840062|NCT00404352|449042885|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
124840063|NCT00404352|449042877|FG000|Open Label Extension (up to 36 Months)|Other|0|||
124840064|NCT00404352|449042878|FG001|Open Label Extension (up to 36 Months)|Other|0|||
124840065|NCT00404352|449042879|FG002|Open Label Extension (up to 36 Months)|Other|0|||
124840066|NCT00404352|449042880|FG003|Open Label Extension (up to 36 Months)|Other|0|||
124840067|NCT00404352|449042881|FG004|Open Label Extension (up to 36 Months)|Other|0|||
124840068|NCT00404352|449042882|FG005|Open Label Extension (up to 36 Months)|Other|0|||
124840069|NCT00404352|449042883|FG006|Open Label Extension (up to 36 Months)|Other|0|||
124840070|NCT00404352|449042884|FG007|Open Label Extension (up to 36 Months)|Other|0|||
124840071|NCT00404352|449042885|FG008|Open Label Extension (up to 36 Months)|Other|2|||
124840072|NCT02346136|449042888|FG000|Overall Study|Withdrawal by Subject|7|||
124840073|NCT02346136|449042889|FG001|Overall Study|Withdrawal by Subject|5|||
125305419|NCT02669121|450745120|FG000|Overall Study|Withdrawal by Subject|132|||
125305420|NCT02669121|450745121|FG001|Overall Study|Withdrawal by Subject|140|||
125305421|NCT02669121|450745120|FG000|Overall Study|Pregnancy|0|||
125305422|NCT02669121|450745121|FG001|Overall Study|Pregnancy|1|||
125305423|NCT02669121|450745120|FG000|Overall Study|Discharged from US Military Active Service|117|||
125305424|NCT02669121|450745121|FG001|Overall Study|Discharged from US Military Active Service|91|||
125305425|NCT02669121|450745120|FG000|Overall Study|Reason not Specified|22|||
125305426|NCT02669121|450745121|FG001|Overall Study|Reason not Specified|18|||
125305427|NCT00825812|450745128|FG000|Overall Study|Never entered follow up|0|||
124840074|NCT02346136|449042888|FG000|Overall Study|Death|1|||
124840075|NCT02346136|449042889|FG001|Overall Study|Death|0|||
124840076|NCT02346136|449042888|FG000|Overall Study|Study termination|14|||
125305428|NCT00825812|450745129|FG001|Overall Study|Never entered follow up|0|||
125305429|NCT00825812|450745130|FG002|Overall Study|Never entered follow up|0|||
124840077|NCT02346136|449042889|FG001|Overall Study|Study termination|18|||
124840078|NCT00582933|449042892|FG000|Overall Study|Physician Decision|3|||
124840079|NCT03837899|449042895|FG000|Overall Study|Death|6|||
124840080|NCT03837899|449042896|FG001|Overall Study|Death|8|||
124840081|NCT03837899|449042897|FG002|Overall Study|Death|3|||
124840082|NCT03837899|449042898|FG003|Overall Study|Death|7|||
124840083|NCT03837899|449042899|FG004|Overall Study|Death|8|||
124840084|NCT03837899|449042900|FG005|Overall Study|Death|7|||
124840085|NCT03837899|449042895|FG000|Overall Study|Moved to post-trial access program|0|||
124840086|NCT03837899|449042896|FG001|Overall Study|Moved to post-trial access program|1|||
124840087|NCT03837899|449042897|FG002|Overall Study|Moved to post-trial access program|0|||
124840088|NCT03837899|449042898|FG003|Overall Study|Moved to post-trial access program|0|||
124840089|NCT03837899|449042899|FG004|Overall Study|Moved to post-trial access program|0|||
124840090|NCT03837899|449042900|FG005|Overall Study|Moved to post-trial access program|0|||
124840091|NCT03837899|449042895|FG000|Overall Study|Other|0|||
124840092|NCT03837899|449042896|FG001|Overall Study|Other|0|||
124840093|NCT03837899|449042897|FG002|Overall Study|Other|0|||
124840094|NCT03837899|449042898|FG003|Overall Study|Other|0|||
124840095|NCT03837899|449042899|FG004|Overall Study|Other|0|||
124840096|NCT03837899|449042900|FG005|Overall Study|Other|2|||
124840097|NCT03837899|449042895|FG000|Overall Study|Lost to Follow-up|0|||
124840098|NCT03837899|449042896|FG001|Overall Study|Lost to Follow-up|1|||
124840099|NCT03837899|449042897|FG002|Overall Study|Lost to Follow-up|0|||
124840100|NCT03837899|449042898|FG003|Overall Study|Lost to Follow-up|0|||
124840101|NCT03837899|449042899|FG004|Overall Study|Lost to Follow-up|0|||
124840102|NCT03837899|449042900|FG005|Overall Study|Lost to Follow-up|0|||
124840103|NCT03837899|449042895|FG000|Overall Study|Withdrawal by Subject|0|||
124840104|NCT03837899|449042896|FG001|Overall Study|Withdrawal by Subject|0|||
124840105|NCT03837899|449042897|FG002|Overall Study|Withdrawal by Subject|0|||
124840106|NCT03837899|449042898|FG003|Overall Study|Withdrawal by Subject|1|||
124840107|NCT03837899|449042899|FG004|Overall Study|Withdrawal by Subject|0|||
124840108|NCT03837899|449042900|FG005|Overall Study|Withdrawal by Subject|0|||
124840109|NCT03837899|449042895|FG000|Overall Study|Study specific discontinuation criteria|0|||
124840110|NCT03837899|449042896|FG001|Overall Study|Study specific discontinuation criteria|1|||
124840111|NCT03837899|449042897|FG002|Overall Study|Study specific discontinuation criteria|0|||
124840112|NCT03837899|449042898|FG003|Overall Study|Study specific discontinuation criteria|0|||
124840113|NCT03837899|449042899|FG004|Overall Study|Study specific discontinuation criteria|3|||
124840114|NCT03837899|449042900|FG005|Overall Study|Study specific discontinuation criteria|1|||
124840115|NCT01465464|449042901|FG000|Overall Study|Adverse Event|96|||
124840116|NCT01465464|449042902|FG001|Overall Study|Adverse Event|49|||
124840117|NCT01465464|449042901|FG000|Overall Study|Lack of Efficacy|139|||
124840118|NCT01465464|449042902|FG001|Overall Study|Lack of Efficacy|190|||
124840119|NCT01465464|449042901|FG000|Overall Study|Physician Decision|13|||
124840120|NCT01465464|449042902|FG001|Overall Study|Physician Decision|5|||
124840121|NCT01465464|449042901|FG000|Overall Study|Protocol Violation|1|||
124840122|NCT01465464|449042902|FG001|Overall Study|Protocol Violation|1|||
124840123|NCT01465464|449042901|FG000|Overall Study|Withdrawal by Subject|46|||
124840124|NCT01465464|449042902|FG001|Overall Study|Withdrawal by Subject|30|||
124840125|NCT01465464|449042901|FG000|Overall Study|Other|9|||
124840126|NCT01465464|449042902|FG001|Overall Study|Other|3|||
124840127|NCT01465464|449042901|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
124840128|NCT01465464|449042902|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
124840129|NCT00785486|449042903|FG000|Midazolam Alone|Withdrawal by Subject|1|||
124840130|NCT01554618|449042907|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
124840131|NCT01554618|449042908|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
124840132|NCT01554618|449042907|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
124840133|NCT01554618|449042908|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
124840134|NCT01554618|449042907|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
124840135|NCT01554618|449042908|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
124840136|NCT01554618|449042907|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
124840137|NCT01554618|449042908|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
124840138|NCT01554618|449042907|FG000|Open-Label Extension Period|Physician Decision|0|||
124840139|NCT01554618|449042908|FG001|Open-Label Extension Period|Physician Decision|1|||
124840140|NCT01554618|449042907|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
124840141|NCT01554618|449042908|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
124840142|NCT01116232|449042910|FG000|Overall Study|Progressive diease|4|||
124840143|NCT02357940|449042911|FG000|Overall Study|Adverse Event|0|||
124840144|NCT02357940|449042912|FG001|Overall Study|Adverse Event|1|||
124840145|NCT02357940|449042911|FG000|Overall Study|Investigator's judgement|0|||
124840146|NCT02357940|449042912|FG001|Overall Study|Investigator's judgement|1|||
124840147|NCT02275481|449042913|FG000|Overall Study|Death|2|||
124840148|NCT02275481|449042914|FG001|Overall Study|Death|1|||
124840149|NCT02275481|449042913|FG000|Overall Study|Lost to Follow-up|2|||
124840150|NCT02275481|449042914|FG001|Overall Study|Lost to Follow-up|0|||
124840151|NCT02275481|449042913|FG000|Overall Study|Withdrawal by Subject|3|||
124840152|NCT02275481|449042914|FG001|Overall Study|Withdrawal by Subject|0|||
124840153|NCT02275481|449042913|FG000|Overall Study|all other reasons combined|2|||
124840154|NCT02275481|449042914|FG001|Overall Study|all other reasons combined|1|||
124840155|NCT02275481|449042913|FG000|Overall Study|Physician Decision|0|||
124840156|NCT02275481|449042914|FG001|Overall Study|Physician Decision|1|||
124840157|NCT03350503|449042922|FG000|Overall Study|Adverse Event|5|||
124840158|NCT03350503|449042922|FG000|Overall Study|Withdrawal by Subject|5|||
124840159|NCT03350503|449042922|FG000|Overall Study|Continuation impossible due to move|4|||
124840160|NCT03350503|449042922|FG000|Overall Study|Physician Decision|3|||
124840161|NCT00344773|449042925|FG000|Overall Study|Adverse Event|2|||
124840162|NCT00344773|449042925|FG000|Overall Study|Objective Disease Progression|16|||
124840163|NCT00344773|449042925|FG000|Overall Study|Withdrawal by Subject|1|||
124840164|NCT00344773|449042925|FG000|Overall Study|Not Eligible for the study|2|||
124840165|NCT02141074|449042927|FG000|Pre-prophylaxis|Adverse Event|3|||
124840166|NCT02141074|449042928|FG001|Pre-prophylaxis|Adverse Event|0|||
124840167|NCT02141074|449042927|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
124840168|NCT02141074|449042928|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
124840169|NCT02141074|449042927|FG000|Prophylaxis|Adverse Event|0|||
124840170|NCT02141074|449042928|FG001|Prophylaxis|Adverse Event|4|||
124840171|NCT02141074|449042927|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
124840172|NCT02141074|449042928|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
124840173|NCT02141074|449042927|FG000|Prophylaxis|Withdrawal by Subject|0|||
124840174|NCT02141074|449042928|FG001|Prophylaxis|Withdrawal by Subject|1|||
124840175|NCT06023394|449042930|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
124840176|NCT06023394|449042931|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
124840177|NCT06023394|449042930|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
124840178|NCT06023394|449042931|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
124840179|NCT06023394|449042930|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
124840180|NCT06023394|449042931|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
124840181|NCT06023394|449042930|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
124840182|NCT06023394|449042931|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
124840183|NCT02283788|449042933|FG000|Overall Study|Adverse Event|1|||
124840184|NCT02283788|449042934|FG001|Overall Study|Adverse Event|3|||
124840185|NCT02283788|449042935|FG002|Overall Study|Adverse Event|5|||
124840186|NCT02283788|449042936|FG003|Overall Study|Adverse Event|1|||
124840187|NCT02283788|449042933|FG000|Overall Study|Withdrawal by Subject|0|||
124840188|NCT02283788|449042934|FG001|Overall Study|Withdrawal by Subject|1|||
124840189|NCT02283788|449042935|FG002|Overall Study|Withdrawal by Subject|0|||
124840190|NCT02283788|449042936|FG003|Overall Study|Withdrawal by Subject|1|||
124840191|NCT02565381|449044838|FG000|Overall Study|Lost to Follow-up|1|||
124840192|NCT02565381|449044839|FG001|Overall Study|Lost to Follow-up|0|||
124840193|NCT02565381|449044840|FG002|Overall Study|Lost to Follow-up|1|||
124840194|NCT02554656|449044847|FG000|Overall Study|Protocol Violation|3|||
124840195|NCT00749463|449044852|FG000|Overall Study|Adverse Event|0|||
124840196|NCT00749463|449044853|FG001|Overall Study|Adverse Event|4|||
124840197|NCT00749463|449044854|FG002|Overall Study|Adverse Event|1|||
124840198|NCT00749463|449044852|FG000|Overall Study|Withdrawal by Subject|1|||
124840199|NCT00749463|449044853|FG001|Overall Study|Withdrawal by Subject|0|||
124840200|NCT00749463|449044854|FG002|Overall Study|Withdrawal by Subject|0|||
124840201|NCT03643562|449044861|FG000|Overall Study|Adverse Event|1|||
124840202|NCT03643562|449044862|FG001|Overall Study|Adverse Event|0|||
124840203|NCT03643562|449044861|FG000|Overall Study|Lack of Efficacy|0|||
124840204|NCT03643562|449044862|FG001|Overall Study|Lack of Efficacy|1|||
124840205|NCT03643562|449044861|FG000|Overall Study|Physician Decision|0|||
124840206|NCT03643562|449044862|FG001|Overall Study|Physician Decision|1|||
124840207|NCT03643562|449044861|FG000|Overall Study|Study Terminated by Sponsor|2|||
124840208|NCT03643562|449044862|FG001|Overall Study|Study Terminated by Sponsor|10|||
124840209|NCT03643562|449044861|FG000|Overall Study|Withdrawal by Subject|2|||
124840210|NCT03643562|449044862|FG001|Overall Study|Withdrawal by Subject|2|||
124840211|NCT03643562|449044861|FG000|Overall Study|Other than specified|3|||
124840212|NCT03643562|449044862|FG001|Overall Study|Other than specified|2|||
124840213|NCT01982253|449044863|FG000|Overall Study|Withdrawal by Subject|1|||
124840214|NCT01982253|449044864|FG001|Overall Study|Withdrawal by Subject|0|||
124840215|NCT01982253|449044865|FG002|Overall Study|Withdrawal by Subject|0|||
124840216|NCT01982253|449044863|FG000|Overall Study|Study terminated by sponsor|1|||
124840217|NCT01982253|449044864|FG001|Overall Study|Study terminated by sponsor|4|||
124840218|NCT01982253|449044865|FG002|Overall Study|Study terminated by sponsor|4|||
124840219|NCT01886833|449044870|FG000|Overall Study|IgA not available from both periods|204|||
124840220|NCT02223767|449044878|FG000|Overall Study|Withdrawal by Subject|4|||
124840221|NCT02223767|449044879|FG001|Overall Study|Withdrawal by Subject|4|||
124840222|NCT00333229|449044882|FG000|Overall Study|Lack of Efficacy|0|||
124840223|NCT00333229|449044883|FG001|Overall Study|Lack of Efficacy|1|||
124840224|NCT00348556|449044884|FG000|Overall Study|Adverse Event|1|||
124840225|NCT00240071|449044885|FG000|Overall Study|Withdrawal by Subject|3|||
124840226|NCT01944059|449044886|FG000|Overall Study|Lost to Follow-up|1|||
124840227|NCT01944059|449044886|FG000|Overall Study|Physician Decision|3|||
124840228|NCT01944059|449044886|FG000|Overall Study|Withdrawal by Subject|1|||
124840229|NCT01944059|449044886|FG000|Overall Study|Adverse Event|2|||
124840230|NCT04206293|449044897|FG000|Overall Study|Consent withdrawal|1|||
124840231|NCT01454934|449044900|FG000|Overall Study|Clinical progression|28|||
124840232|NCT01454934|449044901|FG001|Overall Study|Clinical progression|25|||
124840233|NCT01454934|449044900|FG000|Overall Study|Other|6|||
124840234|NCT01454934|449044901|FG001|Overall Study|Other|17|||
124840235|NCT01454934|449044900|FG000|Overall Study|Adverse Event|28|||
124840236|NCT01454934|449044901|FG001|Overall Study|Adverse Event|24|||
124840237|NCT01454934|449044900|FG000|Overall Study|Withdrawn consent|2|||
124840238|NCT01454934|449044901|FG001|Overall Study|Withdrawn consent|5|||
124840239|NCT01454934|449044900|FG000|Overall Study|Withdrawal by Subject|11|||
124840240|NCT01454934|449044901|FG001|Overall Study|Withdrawal by Subject|15|||
124840241|NCT01454934|449044900|FG000|Overall Study|Disease progression|194|||
124840242|NCT01454934|449044901|FG001|Overall Study|Disease progression|181|||
124840243|NCT01454934|449044900|FG000|Overall Study|Lost to Follow-up|0|||
124840244|NCT01454934|449044901|FG001|Overall Study|Lost to Follow-up|1|||
124840245|NCT01454934|449044900|FG000|Overall Study|Not treated|1|||
124840246|NCT01454934|449044901|FG001|Overall Study|Not treated|2|||
124840247|NCT01802775|449044913|FG000|Overall Study|Death|0|||
124840248|NCT01802775|449044914|FG001|Overall Study|Death|3|||
124840249|NCT01802775|449044913|FG000|Overall Study|Reason not provided|0|||
124840250|NCT01802775|449044914|FG001|Overall Study|Reason not provided|1|||
124840251|NCT01802775|449044913|FG000|Overall Study|Physician Decision|1|||
124840252|NCT01802775|449044914|FG001|Overall Study|Physician Decision|0|||
124840253|NCT01802775|449044913|FG000|Overall Study|Adverse Event|1|||
124840254|NCT01802775|449044914|FG001|Overall Study|Adverse Event|1|||
124840255|NCT01802775|449044913|FG000|Overall Study|Withdrawal by Subject|3|||
124840256|NCT01802775|449044914|FG001|Overall Study|Withdrawal by Subject|5|||
124840257|NCT01802775|449044913|FG000|Overall Study|Lost to Follow-up|1|||
124840258|NCT01802775|449044914|FG001|Overall Study|Lost to Follow-up|2|||
124840259|NCT00782210|449044922|FG000|Overall Study|Adverse Event|21|||
124840260|NCT00782210|449044923|FG001|Overall Study|Adverse Event|17|||
124840261|NCT00782210|449044924|FG002|Overall Study|Adverse Event|16|||
124840262|NCT00782210|449044922|FG000|Overall Study|Lost to Follow-up|2|||
124840263|NCT00782210|449044923|FG001|Overall Study|Lost to Follow-up|1|||
124840264|NCT00782210|449044924|FG002|Overall Study|Lost to Follow-up|2|||
124840265|NCT00782210|449044922|FG000|Overall Study|Withdrawal by Subject|11|||
124840266|NCT00782210|449044923|FG001|Overall Study|Withdrawal by Subject|8|||
124840267|NCT00782210|449044924|FG002|Overall Study|Withdrawal by Subject|11|||
124840268|NCT00782210|449044922|FG000|Overall Study|Non compliance with protocol|0|||
124840269|NCT00782210|449044923|FG001|Overall Study|Non compliance with protocol|3|||
124840270|NCT00782210|449044924|FG002|Overall Study|Non compliance with protocol|2|||
124840271|NCT00782210|449044922|FG000|Overall Study|Lack of Efficacy|13|||
124840272|NCT00782210|449044923|FG001|Overall Study|Lack of Efficacy|4|||
124840273|NCT00782210|449044924|FG002|Overall Study|Lack of Efficacy|1|||
124840274|NCT00782210|449044922|FG000|Overall Study|Other reason not described above|3|||
124840275|NCT00782210|449044923|FG001|Overall Study|Other reason not described above|2|||
124840276|NCT00782210|449044924|FG002|Overall Study|Other reason not described above|3|||
124840277|NCT00826267|449044927|FG000|Overall Study|Other Adverse Event|1|||
124840278|NCT00826267|449044928|FG001|Overall Study|Other Adverse Event|0|||
124840279|NCT00826267|449044929|FG002|Overall Study|Other Adverse Event|0|||
124840280|NCT00048542|449044943|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
124840281|NCT00048542|449044944|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
124840282|NCT00048542|449044945|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
124840283|NCT00048542|449044946|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
124840284|NCT00048542|449044947|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
124840285|NCT00048542|449044948|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
124840286|NCT00048542|449044949|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
124840287|NCT00048542|449044950|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
124840288|NCT00048542|449044943|FG000|Double-Blind Phase|Protocol Violation|0|||
124840289|NCT00048542|449044944|FG001|Double-Blind Phase|Protocol Violation|0|||
124840290|NCT00048542|449044945|FG002|Double-Blind Phase|Protocol Violation|1|||
124840291|NCT00048542|449044946|FG003|Double-Blind Phase|Protocol Violation|0|||
124840292|NCT00048542|449044947|FG004|Double-Blind Phase|Protocol Violation|0|||
124840293|NCT00048542|449044948|FG005|Double-Blind Phase|Protocol Violation|0|||
124840294|NCT00048542|449044949|FG006|Double-Blind Phase|Protocol Violation|0|||
124840295|NCT00048542|449044950|FG007|Double-Blind Phase|Protocol Violation|0|||
124840296|NCT00048542|449044943|FG000|Double-Blind Phase|Sponsor request or decision|2|||
124840297|NCT00048542|449044944|FG001|Double-Blind Phase|Sponsor request or decision|0|||
124840298|NCT00048542|449044945|FG002|Double-Blind Phase|Sponsor request or decision|0|||
124840299|NCT00048542|449044946|FG003|Double-Blind Phase|Sponsor request or decision|0|||
124840300|NCT00048542|449044947|FG004|Double-Blind Phase|Sponsor request or decision|0|||
124840301|NCT00048542|449044948|FG005|Double-Blind Phase|Sponsor request or decision|0|||
124840302|NCT00048542|449044949|FG006|Double-Blind Phase|Sponsor request or decision|0|||
124840303|NCT00048542|449044950|FG007|Double-Blind Phase|Sponsor request or decision|0|||
124840304|NCT00048542|449044943|FG000|Double-Blind Phase|Randomized in error|1|||
124840305|NCT00048542|449044944|FG001|Double-Blind Phase|Randomized in error|0|||
124840306|NCT00048542|449044945|FG002|Double-Blind Phase|Randomized in error|0|||
124840307|NCT00048542|449044946|FG003|Double-Blind Phase|Randomized in error|0|||
124840308|NCT00048542|449044947|FG004|Double-Blind Phase|Randomized in error|0|||
124840309|NCT00048542|449044948|FG005|Double-Blind Phase|Randomized in error|0|||
124840310|NCT00048542|449044949|FG006|Double-Blind Phase|Randomized in error|0|||
124840311|NCT00048542|449044950|FG007|Double-Blind Phase|Randomized in error|0|||
124840312|NCT00048542|449044943|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
124840313|NCT00048542|449044944|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
124840314|NCT00048542|449044945|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
124840315|NCT00048542|449044946|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
124840316|NCT00048542|449044947|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
124840317|NCT00048542|449044948|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
124840318|NCT00048542|449044949|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
124840319|NCT00048542|449044950|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
124840320|NCT00048542|449044943|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
124840321|NCT00048542|449044944|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
124840322|NCT00048542|449044945|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
124840323|NCT00048542|449044946|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
124840324|NCT00048542|449044947|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
124840325|NCT00048542|449044948|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
124840326|NCT00048542|449044949|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
124840327|NCT00048542|449044950|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
124840328|NCT00048542|449044943|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
124840329|NCT00048542|449044944|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
124840330|NCT00048542|449044945|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
124840331|NCT00048542|449044946|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
124840332|NCT00048542|449044947|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
124840333|NCT00048542|449044948|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
124840334|NCT00048542|449044949|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
124840335|NCT00048542|449044950|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
124840336|NCT00048542|449044943|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
124840337|NCT00048542|449044944|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
124840338|NCT00048542|449044945|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
124840339|NCT00048542|449044946|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
124840340|NCT00048542|449044947|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
124840341|NCT00048542|449044948|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
124840342|NCT00048542|449044949|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
124840343|NCT00048542|449044950|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
124840344|NCT00048542|449044943|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
124840345|NCT00048542|449044944|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
124840346|NCT00048542|449044945|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
124840347|NCT00048542|449044946|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
124840348|NCT00048542|449044947|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
124840349|NCT00048542|449044948|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
124840350|NCT00048542|449044949|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
124840351|NCT00048542|449044950|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
124840352|NCT00048542|449044943|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
124840353|NCT00048542|449044944|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
124840354|NCT00048542|449044945|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
124840355|NCT00048542|449044946|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
124840356|NCT00048542|449044947|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
124840357|NCT00048542|449044948|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
124840358|NCT00048542|449044949|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
124840359|NCT00048542|449044950|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
124840360|NCT00048542|449044943|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
124840361|NCT00048542|449044944|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
124840362|NCT00048542|449044945|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
124840363|NCT00048542|449044946|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
124840364|NCT00048542|449044947|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
124840365|NCT00048542|449044948|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
124840366|NCT00048542|449044949|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
124840367|NCT00048542|449044950|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
124840368|NCT00048542|449044943|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
124840369|NCT00048542|449044944|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
124840370|NCT00048542|449044945|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
124840371|NCT00048542|449044946|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
124840372|NCT00048542|449044947|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
124840373|NCT00048542|449044948|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
124840374|NCT00048542|449044949|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
124840375|NCT00048542|449044950|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
124840376|NCT00048542|449044943|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
124840377|NCT00048542|449044944|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
124840378|NCT00048542|449044945|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
124840379|NCT00048542|449044946|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
124840380|NCT00048542|449044947|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
124840381|NCT00048542|449044948|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
124840382|NCT00048542|449044949|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
124840383|NCT00048542|449044950|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
124840384|NCT00048542|449044943|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
124840385|NCT00048542|449044944|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
124840386|NCT00048542|449044945|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
124840387|NCT00048542|449044946|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
124840388|NCT00048542|449044947|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
124840389|NCT00048542|449044948|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
124840390|NCT00048542|449044949|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
124840391|NCT00048542|449044950|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
124840392|NCT00048542|449044943|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
124840393|NCT00048542|449044944|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
124840394|NCT00048542|449044945|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
124840395|NCT00048542|449044946|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
124840396|NCT00048542|449044947|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
124840397|NCT00048542|449044948|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
124840398|NCT00048542|449044949|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
124840399|NCT00048542|449044950|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
124840400|NCT00578175|449044951|FG000|Overall Study|Adverse Event|0|||
124840401|NCT00578175|449044952|FG001|Overall Study|Adverse Event|1|||
124840402|NCT00578175|449044953|FG002|Overall Study|Adverse Event|1|||
124840403|NCT00578175|449044951|FG000|Overall Study|Other reasons|70|||
124840404|NCT00578175|449044952|FG001|Overall Study|Other reasons|42|||
124840405|NCT00578175|449044953|FG002|Overall Study|Other reasons|23|||
124840406|NCT02272413|449044955|FG000|Randomized Through Treatment Start|Not treated|3|||
124840407|NCT02272413|449044956|FG001|Randomized Through Treatment Start|Not treated|5|||
124840408|NCT02272413|449044955|FG000|Pre-switch Period|Adverse Event|38|||
124840409|NCT02272413|449044956|FG001|Pre-switch Period|Adverse Event|37|||
124840410|NCT02272413|449044955|FG000|Pre-switch Period|Death|26|||
124840411|NCT02272413|449044956|FG001|Pre-switch Period|Death|26|||
124840412|NCT02272413|449044955|FG000|Pre-switch Period|Withdrawal by Subject|27|||
124840413|NCT02272413|449044956|FG001|Pre-switch Period|Withdrawal by Subject|15|||
124840414|NCT02272413|449044955|FG000|Pre-switch Period|Physician Decision|6|||
124840415|NCT02272413|449044956|FG001|Pre-switch Period|Physician Decision|18|||
124840416|NCT02272413|449044955|FG000|Pre-switch Period|Progressive disease|185|||
124840417|NCT02272413|449044956|FG001|Pre-switch Period|Progressive disease|173|||
124840418|NCT02272413|449044955|FG000|Pre-switch Period|Lost to Follow-up|0|||
124840419|NCT02272413|449044956|FG001|Pre-switch Period|Lost to Follow-up|2|||
124840420|NCT02272413|449044955|FG000|Pre-switch Period|Protocol Violation|1|||
124840421|NCT02272413|449044956|FG001|Pre-switch Period|Protocol Violation|0|||
124840422|NCT02272413|449044955|FG000|Pre-switch Period|Other than listed|10|||
124840423|NCT02272413|449044956|FG001|Pre-switch Period|Other than listed|11|||
124840424|NCT02272413|449044955|FG000|Post-switch Period|Adverse Event|4|||
124840425|NCT02272413|449044956|FG001|Post-switch Period|Adverse Event|4|||
124840426|NCT02272413|449044955|FG000|Post-switch Period|Death|3|||
124840427|NCT02272413|449044956|FG001|Post-switch Period|Death|2|||
125305430|NCT00825812|450745131|FG003|Overall Study|Never entered follow up|1|||
125305431|NCT00825812|450745128|FG000|Overall Study|Adverse Event|0|||
125305432|NCT00825812|450745129|FG001|Overall Study|Adverse Event|0|||
125305433|NCT00825812|450745130|FG002|Overall Study|Adverse Event|0|||
125305434|NCT00825812|450745131|FG003|Overall Study|Adverse Event|1|||
125305435|NCT00825812|450745128|FG000|Overall Study|Subject withdrew consent|0|||
125305436|NCT00825812|450745129|FG001|Overall Study|Subject withdrew consent|0|||
125305437|NCT00825812|450745130|FG002|Overall Study|Subject withdrew consent|3|||
125305438|NCT00825812|450745131|FG003|Overall Study|Subject withdrew consent|2|||
124840428|NCT02272413|449044955|FG000|Post-switch Period|Withdrawal by Subject|1|||
124840429|NCT02272413|449044956|FG001|Post-switch Period|Withdrawal by Subject|2|||
124840430|NCT02272413|449044955|FG000|Post-switch Period|Physician Decision|1|||
124840431|NCT02272413|449044956|FG001|Post-switch Period|Physician Decision|1|||
125305439|NCT00825812|450745128|FG000|Overall Study|Non-compliance with protocol|0|||
125305440|NCT00825812|450745129|FG001|Overall Study|Non-compliance with protocol|0|||
125305441|NCT00825812|450745130|FG002|Overall Study|Non-compliance with protocol|0|||
125305442|NCT00825812|450745131|FG003|Overall Study|Non-compliance with protocol|1|||
125305443|NCT00825812|450745128|FG000|Overall Study|Administrative|0|||
125305444|NCT00825812|450745129|FG001|Overall Study|Administrative|1|||
125305445|NCT00825812|450745130|FG002|Overall Study|Administrative|3|||
125305446|NCT00825812|450745131|FG003|Overall Study|Administrative|5|||
125305447|NCT00483938|450745132|FG000|Overall Study|Protocol Violation|0|||
125305448|NCT00483938|450745133|FG001|Overall Study|Protocol Violation|0|||
125305449|NCT00483938|450745134|FG002|Overall Study|Protocol Violation|0|||
125305450|NCT00483938|450745135|FG003|Overall Study|Protocol Violation|0|||
125305451|NCT00483938|450745136|FG004|Overall Study|Protocol Violation|0|||
125305452|NCT00483938|450745137|FG005|Overall Study|Protocol Violation|0|||
125305453|NCT00483938|450745138|FG006|Overall Study|Protocol Violation|3|||
124840432|NCT02272413|449044955|FG000|Post-switch Period|Progressive disease|21|||
124840433|NCT02272413|449044956|FG001|Post-switch Period|Progressive disease|21|||
124840434|NCT02272413|449044955|FG000|Post-switch Period|Study terminated by sponsor|8|||
124840435|NCT02272413|449044956|FG001|Post-switch Period|Study terminated by sponsor|11|||
124840436|NCT02272413|449044955|FG000|Post-switch Period|Other than listed|4|||
124840437|NCT02272413|449044956|FG001|Post-switch Period|Other than listed|5|||
124840438|NCT02126969|449044957|FG000|Overall Study|Withdrawal by Subject|1|||
124840439|NCT02126969|449044958|FG001|Overall Study|Withdrawal by Subject|2|||
124840440|NCT01533246|449044959|FG000|Overall Study|Adverse Event|1|||
124840441|NCT01533246|449044959|FG000|Overall Study|Withdrawal by Subject|1|||
124840442|NCT01143090|449044960|FG000|Overall Study|Lack of Efficacy|2|||
124840443|NCT01143090|449044960|FG000|Overall Study|Adverse Event|17|||
124840444|NCT01143090|449044960|FG000|Overall Study|Lost to Follow-up|9|||
124840445|NCT01143090|449044960|FG000|Overall Study|Protocol Violation|2|||
124840446|NCT01143090|449044960|FG000|Overall Study|Withdrawal by Subject|18|||
124840447|NCT01143090|449044960|FG000|Overall Study|Non-compliance with study drug|1|||
124840448|NCT01143090|449044960|FG000|Overall Study|Failure to meet eligibility criteria|1|||
124840449|NCT01143090|449044960|FG000|Overall Study|Administrative|1|||
124840450|NCT01461096|449044966|FG000|Overall Study|Death|3|||
124840451|NCT01461096|449044967|FG001|Overall Study|Death|6|||
124840452|NCT01461096|449044966|FG000|Overall Study|Severe debilitation, unable to continue|1|||
124840453|NCT01461096|449044967|FG001|Overall Study|Severe debilitation, unable to continue|1|||
124840454|NCT01461096|449044966|FG000|Overall Study|Subj not able to get to clinic|15|||
124840455|NCT01461096|449044967|FG001|Overall Study|Subj not able to get to clinic|13|||
124840456|NCT01461096|449044966|FG000|Overall Study|Site is closing|27|||
124840457|NCT01461096|449044967|FG001|Overall Study|Site is closing|30|||
124840458|NCT01461096|449044966|FG000|Overall Study|Withdrawal by Subject|5|||
124840459|NCT01461096|449044967|FG001|Overall Study|Withdrawal by Subject|3|||
124840460|NCT01461096|449044966|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
124840461|NCT01461096|449044967|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
124840462|NCT01461096|449044966|FG000|Overall Study|Lost to Follow-up|8|||
124840463|NCT01461096|449044967|FG001|Overall Study|Lost to Follow-up|4|||
124840464|NCT04225923|449044976|FG000|Overall Study|Protocol Violation|1|||
124840465|NCT04225923|449044977|FG001|Overall Study|Protocol Violation|0|||
124840466|NCT04225923|449044978|FG002|Overall Study|Protocol Violation|1|||
124840467|NCT04225923|449044976|FG000|Overall Study|Withdrawal by Subject|4|||
124840468|NCT04225923|449044977|FG001|Overall Study|Withdrawal by Subject|1|||
124840469|NCT04225923|449044978|FG002|Overall Study|Withdrawal by Subject|3|||
124840470|NCT04225923|449044976|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
124840471|NCT04225923|449044977|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
124840472|NCT04225923|449044978|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
124840473|NCT01417481|449044979|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
124840474|NCT01417481|449044980|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
124840475|NCT00855309|449044981|FG000|Overall Study|patient never recieved drug|1|||
124840476|NCT00855309|449044982|FG001|Overall Study|patient never recieved drug|0|||
124840477|NCT00829296|449044983|FG000|Overall Study|Adverse Event|5|||
124840478|NCT00829296|449044984|FG001|Overall Study|Adverse Event|4|||
124840479|NCT04116710|449044988|FG000|Overall Study|Death|4|||
124840480|NCT04116710|449044989|FG001|Overall Study|Death|6|||
124840481|NCT04116710|449044990|FG002|Overall Study|Death|3|||
124840482|NCT04116710|449044991|FG003|Overall Study|Death|1|||
124840483|NCT04116710|449044988|FG000|Overall Study|Withdrawal by Subject|0|||
124840484|NCT04116710|449044989|FG001|Overall Study|Withdrawal by Subject|0|||
124840485|NCT04116710|449044990|FG002|Overall Study|Withdrawal by Subject|0|||
124840486|NCT04116710|449044991|FG003|Overall Study|Withdrawal by Subject|1|||
124840487|NCT01077960|449044994|FG000|Overall Study|Adverse Event|6|||
124840488|NCT01077960|449044994|FG000|Overall Study|Protocol Violation|3|||
124840489|NCT01077960|449044994|FG000|Overall Study|Lost to Follow-up|5|||
125305454|NCT00483938|450745132|FG000|Overall Study|Withdrawal by Subject|1|||
125305455|NCT00483938|450745133|FG001|Overall Study|Withdrawal by Subject|6|||
125305456|NCT00483938|450745134|FG002|Overall Study|Withdrawal by Subject|0|||
125305457|NCT00483938|450745135|FG003|Overall Study|Withdrawal by Subject|0|||
124840490|NCT01077960|449044994|FG000|Overall Study|Subject decision|1|||
124840491|NCT01077960|449044994|FG000|Overall Study|Reason unspecified|1|||
124840492|NCT01371656|449044995|FG000|Overall Study|Death|7|||
124840493|NCT01371656|449044996|FG001|Overall Study|Death|4|||
124840494|NCT01371656|449044995|FG000|Overall Study|Physician Decision|46|||
124840495|NCT01371656|449044996|FG001|Overall Study|Physician Decision|7|||
124840496|NCT01371656|449044995|FG000|Overall Study|Withdrawal by Subject|7|||
124840497|NCT01371656|449044996|FG001|Overall Study|Withdrawal by Subject|0|||
124840498|NCT01371656|449044995|FG000|Overall Study|Ineligible|4|||
124840499|NCT01371656|449044996|FG001|Overall Study|Ineligible|3|||
124840500|NCT01537783|449044997|FG000|Overall Study|Lost to Follow-up|11|||
124840501|NCT01537783|449044998|FG001|Overall Study|Lost to Follow-up|2|||
124840502|NCT00291668|449045003|FG000|Overall Study|Lack of Efficacy|1|||
124840503|NCT00291668|449045004|FG001|Overall Study|Lack of Efficacy|0|||
124840504|NCT00291668|449045005|FG002|Overall Study|Lack of Efficacy|0|||
124840505|NCT00291668|449045003|FG000|Overall Study|SAE, non-fatal|1|||
124840506|NCT00291668|449045004|FG001|Overall Study|SAE, non-fatal|1|||
124840507|NCT00291668|449045005|FG002|Overall Study|SAE, non-fatal|1|||
124840508|NCT00291668|449045003|FG000|Overall Study|AE, non-serious non-fatal|1|||
124840509|NCT00291668|449045004|FG001|Overall Study|AE, non-serious non-fatal|0|||
124840510|NCT00291668|449045005|FG002|Overall Study|AE, non-serious non-fatal|0|||
124840511|NCT00291668|449045003|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
124840512|NCT00291668|449045004|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
124840513|NCT00291668|449045005|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
124840514|NCT00313612|449045006|FG000|Overall Study|Patient never received treatment|0|||
124840515|NCT00313612|449045007|FG001|Overall Study|Patient never received treatment|1|||
124840516|NCT00451035|449045008|FG000|Overall Study|Disease progression|11|||
124840517|NCT00451035|449045008|FG000|Overall Study|Death|3|||
124840518|NCT00451035|449045008|FG000|Overall Study|New anti-neoplastic therapy|3|||
124840519|NCT01393405|449045011|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
124840520|NCT01393405|449045012|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
124840521|NCT01393405|449045013|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
124840522|NCT01393405|449045011|FG000|Induction Period (week1-16)|Adverse Event|16|||
124840523|NCT01393405|449045012|FG001|Induction Period (week1-16)|Adverse Event|0|||
124840524|NCT01393405|449045013|FG002|Induction Period (week1-16)|Adverse Event|0|||
124840525|NCT01393405|449045011|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
124840526|NCT01393405|449045012|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
124840527|NCT01393405|449045013|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
124840528|NCT01393405|449045011|FG000|Maintenance Period Week|Lack of Efficacy|0|||
124840529|NCT01393405|449045012|FG001|Maintenance Period Week|Lack of Efficacy|22|||
124840530|NCT01393405|449045013|FG002|Maintenance Period Week|Lack of Efficacy|22|||
124840531|NCT01393405|449045011|FG000|Maintenance Period Week|Adverse Event|0|||
124840532|NCT01393405|449045012|FG001|Maintenance Period Week|Adverse Event|5|||
124840533|NCT01393405|449045013|FG002|Maintenance Period Week|Adverse Event|2|||
124840534|NCT01393405|449045011|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
124840535|NCT01393405|449045012|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
124840536|NCT01393405|449045013|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
124840537|NCT01393405|449045011|FG000|Maintenance Period Week|Lost to Follow-up|0|||
124840538|NCT01393405|449045012|FG001|Maintenance Period Week|Lost to Follow-up|1|||
124840539|NCT01393405|449045013|FG002|Maintenance Period Week|Lost to Follow-up|0|||
124840540|NCT00717769|449045016|FG000|Overall Study|Adverse Event|9|||
124840541|NCT00717769|449045017|FG001|Overall Study|Adverse Event|6|||
124840542|NCT00717769|449045018|FG002|Overall Study|Adverse Event|1|||
124840543|NCT00717769|449045016|FG000|Overall Study|Lack of compliance|0|||
124840544|NCT00717769|449045017|FG001|Overall Study|Lack of compliance|2|||
124840545|NCT00717769|449045018|FG002|Overall Study|Lack of compliance|0|||
124840546|NCT00717769|449045016|FG000|Overall Study|Lost to Follow-up|3|||
124840547|NCT00717769|449045017|FG001|Overall Study|Lost to Follow-up|4|||
124840548|NCT00717769|449045018|FG002|Overall Study|Lost to Follow-up|0|||
124840549|NCT00717769|449045016|FG000|Overall Study|Lack of Efficacy|1|||
124840550|NCT00717769|449045017|FG001|Overall Study|Lack of Efficacy|2|||
124840551|NCT00717769|449045018|FG002|Overall Study|Lack of Efficacy|0|||
124840552|NCT00717769|449045016|FG000|Overall Study|Protocol Violation|0|||
124840553|NCT00717769|449045017|FG001|Overall Study|Protocol Violation|2|||
124840554|NCT00717769|449045018|FG002|Overall Study|Protocol Violation|0|||
124840555|NCT00717769|449045016|FG000|Overall Study|Sponsor decision|1|||
124840556|NCT00717769|449045017|FG001|Overall Study|Sponsor decision|0|||
124840557|NCT00717769|449045018|FG002|Overall Study|Sponsor decision|10|||
124840558|NCT00717769|449045016|FG000|Overall Study|Withdrew consent|2|||
124840559|NCT00717769|449045017|FG001|Overall Study|Withdrew consent|2|||
124840560|NCT00717769|449045018|FG002|Overall Study|Withdrew consent|0|||
124840561|NCT01399593|449045020|FG000|Overall Study|Physician Decision|1|||
124840562|NCT01399593|449045021|FG001|Overall Study|Physician Decision|0|||
124840563|NCT01399593|449045020|FG000|Overall Study|Adverse Event|1|||
124840564|NCT01399593|449045021|FG001|Overall Study|Adverse Event|0|||
124840565|NCT01399593|449045020|FG000|Overall Study|Death|1|||
124840566|NCT01399593|449045021|FG001|Overall Study|Death|1|||
124840567|NCT01399593|449045020|FG000|Overall Study|Transplantectomy|0|||
124840568|NCT01399593|449045021|FG001|Overall Study|Transplantectomy|1|||
124840569|NCT00244712|449045025|FG000|Overall Study|Adverse Event|20|||
124840570|NCT00244712|449045026|FG001|Overall Study|Adverse Event|21|||
124840571|NCT00244712|449045025|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
124840572|NCT00244712|449045026|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
124840573|NCT00244712|449045025|FG000|Overall Study|Lack of Compliance|10|||
124840574|NCT00244712|449045026|FG001|Overall Study|Lack of Compliance|11|||
124840575|NCT00244712|449045025|FG000|Overall Study|Lost to Follow-up|45|||
124840576|NCT00244712|449045026|FG001|Overall Study|Lost to Follow-up|52|||
124840577|NCT00244712|449045025|FG000|Overall Study|Withdrawal by Subject|13|||
124840578|NCT00244712|449045026|FG001|Overall Study|Withdrawal by Subject|23|||
124840579|NCT00244712|449045025|FG000|Overall Study|Protocol Violation, disease progression|13|||
124840580|NCT00244712|449045026|FG001|Overall Study|Protocol Violation, disease progression|11|||
124840581|NCT02777125|449045027|FG000|Overall Study|Consent form violation|14|||
124840582|NCT02777125|449045028|FG001|Overall Study|Consent form violation|12|||
124840583|NCT02777125|449045027|FG000|Overall Study|Assent form violation|21|||
124840584|NCT02777125|449045028|FG001|Overall Study|Assent form violation|23|||
124840585|NCT02777125|449045027|FG000|Overall Study|Protocol Violation|8|||
124840586|NCT02777125|449045028|FG001|Overall Study|Protocol Violation|12|||
124840587|NCT00574405|449046502|FG000|Overall Study|Withdrawal by Subject|3|||
124840588|NCT00574405|449046503|FG001|Overall Study|Withdrawal by Subject|2|||
124840589|NCT01336738|449046504|FG000|Overall Study|Adverse Event|0|||
124840590|NCT01336738|449046505|FG001|Overall Study|Adverse Event|3|||
124840591|NCT01336738|449046506|FG002|Overall Study|Adverse Event|2|||
124840592|NCT01336738|449046507|FG003|Overall Study|Adverse Event|1|||
124840593|NCT01336738|449046508|FG004|Overall Study|Adverse Event|3|||
124840594|NCT01336738|449046504|FG000|Overall Study|Lost to Follow-up|2|||
124840595|NCT01336738|449046505|FG001|Overall Study|Lost to Follow-up|1|||
124840596|NCT01336738|449046506|FG002|Overall Study|Lost to Follow-up|2|||
124840597|NCT01336738|449046507|FG003|Overall Study|Lost to Follow-up|2|||
124840598|NCT01336738|449046508|FG004|Overall Study|Lost to Follow-up|2|||
124840599|NCT01336738|449046504|FG000|Overall Study|Did not meet entrance criteria|0|||
124840600|NCT01336738|449046505|FG001|Overall Study|Did not meet entrance criteria|1|||
124840601|NCT01336738|449046506|FG002|Overall Study|Did not meet entrance criteria|0|||
124840602|NCT01336738|449046507|FG003|Overall Study|Did not meet entrance criteria|0|||
124840603|NCT01336738|449046508|FG004|Overall Study|Did not meet entrance criteria|0|||
124840604|NCT01336738|449046504|FG000|Overall Study|Protocol Violation|0|||
124840605|NCT01336738|449046505|FG001|Overall Study|Protocol Violation|1|||
124840606|NCT01336738|449046506|FG002|Overall Study|Protocol Violation|0|||
124840607|NCT01336738|449046507|FG003|Overall Study|Protocol Violation|0|||
124840608|NCT01336738|449046508|FG004|Overall Study|Protocol Violation|0|||
124840609|NCT01336738|449046504|FG000|Overall Study|Withdrawal by Subject|2|||
124840610|NCT01336738|449046505|FG001|Overall Study|Withdrawal by Subject|0|||
124840611|NCT01336738|449046506|FG002|Overall Study|Withdrawal by Subject|2|||
124840612|NCT01336738|449046507|FG003|Overall Study|Withdrawal by Subject|1|||
124840613|NCT01336738|449046508|FG004|Overall Study|Withdrawal by Subject|1|||
124840614|NCT01336738|449046504|FG000|Overall Study|Other|3|||
124840615|NCT01336738|449046505|FG001|Overall Study|Other|3|||
124840616|NCT01336738|449046506|FG002|Overall Study|Other|2|||
124840617|NCT01336738|449046507|FG003|Overall Study|Other|3|||
124840618|NCT01336738|449046508|FG004|Overall Study|Other|4|||
124840619|NCT02970968|449046510|FG000|Overall Study|Withdrawal by Subject|3|||
124840620|NCT02970968|449046511|FG001|Overall Study|Withdrawal by Subject|3|||
124840621|NCT02970968|449046510|FG000|Overall Study|Adverse Event|1|||
124840622|NCT02970968|449046511|FG001|Overall Study|Adverse Event|2|||
124840623|NCT02970968|449046510|FG000|Overall Study|Lost to Follow-up|1|||
124840624|NCT02970968|449046511|FG001|Overall Study|Lost to Follow-up|1|||
124840625|NCT02970968|449046510|FG000|Overall Study|Non-Compliance|0|||
124840626|NCT02970968|449046511|FG001|Overall Study|Non-Compliance|1|||
124840627|NCT03003520|449046512|FG000|Overall Study|Adverse Event|9|||
124840628|NCT03003520|449046513|FG001|Overall Study|Adverse Event|0|||
124840629|NCT03003520|449046512|FG000|Overall Study|Death|1|||
124840630|NCT03003520|449046513|FG001|Overall Study|Death|0|||
124840631|NCT03003520|449046512|FG000|Overall Study|Other reasons|4|||
124840632|NCT03003520|449046513|FG001|Overall Study|Other reasons|0|||
125305458|NCT00483938|450745136|FG004|Overall Study|Withdrawal by Subject|1|||
124840633|NCT03003520|449046512|FG000|Overall Study|Withdrawal by Subject|6|||
124840634|NCT03003520|449046513|FG001|Overall Study|Withdrawal by Subject|0|||
124840635|NCT03003520|449046512|FG000|Overall Study|Progressive disease|9|||
124840636|NCT03003520|449046513|FG001|Overall Study|Progressive disease|1|||
124840637|NCT01332149|449046514|FG000|Overall Study|Adverse Event|11|||
124840638|NCT01332149|449046515|FG001|Overall Study|Adverse Event|9|||
124840639|NCT01332149|449046514|FG000|Overall Study|Other unspecified|5|||
125305459|NCT00483938|450745137|FG005|Overall Study|Withdrawal by Subject|3|||
125305460|NCT00483938|450745138|FG006|Overall Study|Withdrawal by Subject|2|||
124840640|NCT01332149|449046515|FG001|Overall Study|Other unspecified|7|||
124840641|NCT01332149|449046514|FG000|Overall Study|Protocol Violation|1|||
124840642|NCT01332149|449046515|FG001|Overall Study|Protocol Violation|3|||
125305461|NCT00483938|450745132|FG000|Overall Study|Lost to Follow-up|1|||
124840643|NCT01332149|449046514|FG000|Overall Study|Withdrawal by Subject|4|||
124840644|NCT01332149|449046515|FG001|Overall Study|Withdrawal by Subject|5|||
124840645|NCT01332149|449046514|FG000|Overall Study|Lost to Follow-up|1|||
124840646|NCT01332149|449046515|FG001|Overall Study|Lost to Follow-up|1|||
124840647|NCT01332149|449046514|FG000|Overall Study|Insufficient clinical response|4|||
124840648|NCT01332149|449046515|FG001|Overall Study|Insufficient clinical response|7|||
124840649|NCT01332149|449046514|FG000|Overall Study|Did not meet entrance criteria|3|||
124840650|NCT01332149|449046515|FG001|Overall Study|Did not meet entrance criteria|4|||
124840651|NCT01332149|449046514|FG000|Overall Study|Randomized but not treated|1|||
124840652|NCT01332149|449046515|FG001|Overall Study|Randomized but not treated|2|||
124840653|NCT04615949|449046518|FG000|Overall Study|Withdrawal by Subject|2|||
124840654|NCT04615949|449046519|FG001|Overall Study|Withdrawal by Subject|4|||
124840655|NCT04615949|449046518|FG000|Overall Study|Lost to Follow-up|2|||
124840656|NCT04615949|449046519|FG001|Overall Study|Lost to Follow-up|2|||
124840657|NCT04615949|449046518|FG000|Overall Study|Death|0|||
124840658|NCT04615949|449046519|FG001|Overall Study|Death|2|||
124840659|NCT05458856|449046520|FG000|Overall Study|Withdrawal by Subject|5|||
124840660|NCT05458856|449046520|FG000|Overall Study|Death|4|||
124840661|NCT05458856|449046520|FG000|Overall Study|Protocol Deviation|3|||
124840662|NCT05458856|449046520|FG000|Overall Study|Physician Decision|1|||
124840663|NCT01920932|449046521|FG000|Overall Study|Death|1|||
124840664|NCT01920932|449046521|FG000|Overall Study|Withdrawal of consent|1|||
124840665|NCT01140477|449046522|FG000|Overall Study|Lost to Follow-up|4|||
124840666|NCT01140477|449046523|FG001|Overall Study|Lost to Follow-up|0|||
124840667|NCT01140477|449046522|FG000|Overall Study|Withdrawal by Subject|1|||
124840668|NCT01140477|449046523|FG001|Overall Study|Withdrawal by Subject|4|||
124840669|NCT01140477|449046522|FG000|Overall Study|Surgical complication preventing implant|2|||
124840670|NCT01140477|449046523|FG001|Overall Study|Surgical complication preventing implant|0|||
124840671|NCT01140477|449046522|FG000|Overall Study|Death|1|||
124840672|NCT01140477|449046523|FG001|Overall Study|Death|1|||
124840673|NCT01140477|449046522|FG000|Overall Study|Subject explanted|0|||
124840674|NCT01140477|449046523|FG001|Overall Study|Subject explanted|1|||
124840675|NCT01945489|449046528|FG000|Cycle 1|Adverse Event|2|||
124840676|NCT01945489|449046529|FG001|Cycle 1|Adverse Event|0|||
124840677|NCT01945489|449046528|FG000|Cycle 1|Lost to Follow-up|4|||
124840678|NCT01945489|449046529|FG001|Cycle 1|Lost to Follow-up|0|||
124840679|NCT01945489|449046528|FG000|Cycle 1|Personal Reasons|4|||
124840680|NCT01945489|449046529|FG001|Cycle 1|Personal Reasons|2|||
124840681|NCT01945489|449046528|FG000|Cycle 1|Protocol Violation|0|||
124840682|NCT01945489|449046529|FG001|Cycle 1|Protocol Violation|1|||
124840683|NCT01945489|449046528|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
124840684|NCT01945489|449046529|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
124840685|NCT01945489|449046528|FG000|Cycle 2|Adverse Event|1|||
124840686|NCT01945489|449046529|FG001|Cycle 2|Adverse Event|0|||
124840687|NCT01945489|449046528|FG000|Cycle 2|Lost to Follow-up|0|||
124840688|NCT01945489|449046529|FG001|Cycle 2|Lost to Follow-up|1|||
124840689|NCT00697346|449046530|FG000|Overall Study|Adverse Event|4|||
124840690|NCT00697346|449046531|FG001|Overall Study|Adverse Event|5|||
124840691|NCT00697346|449046532|FG002|Overall Study|Adverse Event|0|||
124840692|NCT00697346|449046530|FG000|Overall Study|Progressive Disease|19|||
124840693|NCT00697346|449046531|FG001|Overall Study|Progressive Disease|18|||
124840694|NCT00697346|449046532|FG002|Overall Study|Progressive Disease|0|||
124840695|NCT00697346|449046530|FG000|Overall Study|Symptomatic Deterioration|0|||
124840696|NCT00697346|449046531|FG001|Overall Study|Symptomatic Deterioration|1|||
124840697|NCT00697346|449046532|FG002|Overall Study|Symptomatic Deterioration|0|||
124840698|NCT00697346|449046530|FG000|Overall Study|Withdrawal by Subject|2|||
124840699|NCT00697346|449046531|FG001|Overall Study|Withdrawal by Subject|2|||
124840700|NCT00697346|449046532|FG002|Overall Study|Withdrawal by Subject|0|||
124840701|NCT00697346|449046530|FG000|Overall Study|Reason not Specified|3|||
124840702|NCT00697346|449046531|FG001|Overall Study|Reason not Specified|0|||
124840703|NCT00697346|449046532|FG002|Overall Study|Reason not Specified|1|||
124840704|NCT03569371|449046534|FG000|Overall Study|Lack of Efficacy|1|||
124840705|NCT03569371|449046534|FG000|Overall Study|Lost to Follow-up|1|||
124840706|NCT03569371|449046534|FG000|Overall Study|Adverse Event|1|||
125305462|NCT00483938|450745133|FG001|Overall Study|Lost to Follow-up|2|||
125305463|NCT00483938|450745134|FG002|Overall Study|Lost to Follow-up|0|||
124840707|NCT01236755|449046535|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
124840708|NCT01236755|449046535|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
124840709|NCT01236755|449046535|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
125305464|NCT00483938|450745135|FG003|Overall Study|Lost to Follow-up|2|||
125305465|NCT00483938|450745136|FG004|Overall Study|Lost to Follow-up|1|||
124840710|NCT01236755|449046535|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
124840711|NCT01539226|449046538|FG000|Overall Study|Withdrawal by Subject|24|||
124840712|NCT01539226|449046539|FG001|Overall Study|Withdrawal by Subject|54|||
124840713|NCT01539226|449046538|FG000|Overall Study|Lost to Follow-up|20|||
124840714|NCT01539226|449046539|FG001|Overall Study|Lost to Follow-up|54|||
125305466|NCT00483938|450745137|FG005|Overall Study|Lost to Follow-up|1|||
124840715|NCT01539226|449046538|FG000|Overall Study|Death|1|||
124840716|NCT01539226|449046539|FG001|Overall Study|Death|2|||
124840717|NCT01539226|449046538|FG000|Overall Study|Adverse Event|2|||
124840718|NCT01539226|449046539|FG001|Overall Study|Adverse Event|0|||
124840719|NCT01539226|449046538|FG000|Overall Study|Pregnancy|13|||
124840720|NCT01539226|449046539|FG001|Overall Study|Pregnancy|29|||
124840721|NCT01539226|449046538|FG000|Overall Study|inappropriate enrollment|0|||
124840722|NCT01539226|449046539|FG001|Overall Study|inappropriate enrollment|1|||
124840723|NCT01539226|449046538|FG000|Overall Study|Multiple Reasons|3|||
124840724|NCT01539226|449046539|FG001|Overall Study|Multiple Reasons|1|||
124840725|NCT01539226|449046538|FG000|Overall Study|not HIV seroconversion-related|93|||
124840726|NCT01539226|449046539|FG001|Overall Study|not HIV seroconversion-related|176|||
124840727|NCT01539226|449046538|FG000|Overall Study|HIV seroconversion-related|55|||
124840728|NCT01539226|449046539|FG001|Overall Study|HIV seroconversion-related|80|||
124840729|NCT01539226|449046538|FG000|Overall Study|Non-compliance|6|||
124840730|NCT01539226|449046539|FG001|Overall Study|Non-compliance|8|||
124840731|NCT02643251|449046540|FG000|Overall Study|Adverse Event|3|||
124840732|NCT02643251|449046541|FG001|Overall Study|Adverse Event|1|||
124840733|NCT02643251|449046540|FG000|Overall Study|Withdrawal by Subject|2|||
124840734|NCT02643251|449046541|FG001|Overall Study|Withdrawal by Subject|0|||
124840735|NCT02643251|449046540|FG000|Overall Study|Lost to Follow-up|4|||
124840736|NCT02643251|449046541|FG001|Overall Study|Lost to Follow-up|1|||
124840737|NCT02643251|449046540|FG000|Overall Study|Protocol Violation|1|||
124840738|NCT02643251|449046541|FG001|Overall Study|Protocol Violation|0|||
124840739|NCT02643251|449046540|FG000|Overall Study|PI Decision to terminate patient|1|||
124840740|NCT02643251|449046541|FG001|Overall Study|PI Decision to terminate patient|0|||
124840741|NCT02365636|449046543|FG000|Overall Study|Adverse Event|3|||
124840742|NCT02365636|449046544|FG001|Overall Study|Adverse Event|3|||
124840743|NCT02365636|449046545|FG002|Overall Study|Adverse Event|2|||
124840744|NCT02365636|449046543|FG000|Overall Study|Protocol Violation|1|||
124840745|NCT02365636|449046544|FG001|Overall Study|Protocol Violation|4|||
124840746|NCT02365636|449046545|FG002|Overall Study|Protocol Violation|0|||
124840747|NCT02365636|449046543|FG000|Overall Study|Lost to Follow-up|0|||
124840748|NCT02365636|449046544|FG001|Overall Study|Lost to Follow-up|0|||
124840749|NCT02365636|449046545|FG002|Overall Study|Lost to Follow-up|1|||
124840750|NCT02365636|449046543|FG000|Overall Study|Other|2|||
124840751|NCT02365636|449046544|FG001|Overall Study|Other|0|||
124840752|NCT02365636|449046545|FG002|Overall Study|Other|0|||
124840753|NCT00463060|449046551|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
124840754|NCT00463060|449046551|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
124840755|NCT01782313|449046552|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
124840756|NCT01782313|449046552|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
124840757|NCT01782313|449046552|FG000|Treated Cycle 3|Progressive Disease|21|||
124840758|NCT01782313|449046552|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
124840759|NCT01782313|449046552|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
124840760|NCT01782313|449046552|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
124840761|NCT01782313|449046552|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
124840762|NCT01782313|449046552|FG000|Survival Follow up|Lost to Follow-up|1|||
124840763|NCT02506816|449046553|FG000|Overall Study|Adverse Event|3|||
124840764|NCT04370691|449046560|FG000|Overall Study|Pending visit|48|||
124840765|NCT04370691|449046560|FG000|Overall Study|Have Not Reached Lower Window|15|||
124840766|NCT04370691|449046560|FG000|Overall Study|Termination|14|||
124840767|NCT04370691|449046560|FG000|Overall Study|Missed or Overdue|10|||
124840768|NCT03013543|449046564|FG000|Overall Study|Withdrawal by Subject|0|||
124840769|NCT03013543|449046565|FG001|Overall Study|Withdrawal by Subject|2|||
124840770|NCT03013543|449046566|FG002|Overall Study|Withdrawal by Subject|0|||
124840771|NCT03013543|449046567|FG003|Overall Study|Withdrawal by Subject|5|||
124840772|NCT03013543|449046568|FG004|Overall Study|Withdrawal by Subject|6|||
124840773|NCT03013543|449046569|FG005|Overall Study|Withdrawal by Subject|2|||
124840774|NCT03013543|449046570|FG006|Overall Study|Withdrawal by Subject|3|||
124840775|NCT03013543|449046571|FG007|Overall Study|Withdrawal by Subject|1|||
124840776|NCT03013543|449046572|FG008|Overall Study|Withdrawal by Subject|0|||
124840777|NCT03013543|449046573|FG009|Overall Study|Withdrawal by Subject|4|||
124840778|NCT03013543|449046564|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
124840779|NCT03013543|449046565|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
124840780|NCT03013543|449046566|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
124840781|NCT03013543|449046567|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
125305467|NCT00483938|450745138|FG006|Overall Study|Lost to Follow-up|3|||
125305468|NCT00483938|450745132|FG000|Overall Study|Death|0|||
124840782|NCT03013543|449046568|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
124840783|NCT03013543|449046569|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
125305469|NCT00483938|450745133|FG001|Overall Study|Death|2|||
125305470|NCT00483938|450745134|FG002|Overall Study|Death|0|||
125305471|NCT00483938|450745135|FG003|Overall Study|Death|0|||
124840784|NCT03013543|449046570|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
124840785|NCT03013543|449046571|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
124840786|NCT03013543|449046572|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
124840787|NCT03013543|449046573|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
124840788|NCT03013543|449046564|FG000|Overall Study|Other|0|||
124840789|NCT03013543|449046565|FG001|Overall Study|Other|0|||
124840790|NCT03013543|449046566|FG002|Overall Study|Other|2|||
124840791|NCT03013543|449046567|FG003|Overall Study|Other|0|||
124840792|NCT03013543|449046568|FG004|Overall Study|Other|2|||
124840793|NCT03013543|449046569|FG005|Overall Study|Other|0|||
124840794|NCT03013543|449046570|FG006|Overall Study|Other|0|||
124840795|NCT03013543|449046571|FG007|Overall Study|Other|0|||
124840796|NCT03013543|449046572|FG008|Overall Study|Other|1|||
124840797|NCT03013543|449046573|FG009|Overall Study|Other|0|||
124840798|NCT03013543|449046564|FG000|Overall Study|Adverse Event|0|||
124840799|NCT03013543|449046565|FG001|Overall Study|Adverse Event|0|||
124840800|NCT03013543|449046566|FG002|Overall Study|Adverse Event|0|||
124840801|NCT03013543|449046567|FG003|Overall Study|Adverse Event|3|||
124840802|NCT03013543|449046568|FG004|Overall Study|Adverse Event|2|||
124840803|NCT03013543|449046569|FG005|Overall Study|Adverse Event|1|||
124840804|NCT03013543|449046570|FG006|Overall Study|Adverse Event|3|||
124840805|NCT03013543|449046571|FG007|Overall Study|Adverse Event|8|||
124840806|NCT03013543|449046572|FG008|Overall Study|Adverse Event|0|||
124840807|NCT03013543|449046573|FG009|Overall Study|Adverse Event|2|||
124840808|NCT03013543|449046564|FG000|Overall Study|Death|0|||
124840809|NCT03013543|449046565|FG001|Overall Study|Death|0|||
124840810|NCT03013543|449046566|FG002|Overall Study|Death|0|||
124840811|NCT03013543|449046567|FG003|Overall Study|Death|1|||
124840812|NCT03013543|449046568|FG004|Overall Study|Death|0|||
124840813|NCT03013543|449046569|FG005|Overall Study|Death|0|||
124840814|NCT03013543|449046570|FG006|Overall Study|Death|0|||
124840815|NCT03013543|449046571|FG007|Overall Study|Death|0|||
124840816|NCT03013543|449046572|FG008|Overall Study|Death|0|||
124840817|NCT03013543|449046573|FG009|Overall Study|Death|0|||
124840818|NCT03013543|449046564|FG000|Overall Study|Lack of Efficacy|0|||
124840819|NCT03013543|449046565|FG001|Overall Study|Lack of Efficacy|0|||
124840820|NCT03013543|449046566|FG002|Overall Study|Lack of Efficacy|0|||
124840821|NCT03013543|449046567|FG003|Overall Study|Lack of Efficacy|1|||
124840822|NCT03013543|449046568|FG004|Overall Study|Lack of Efficacy|0|||
124840823|NCT03013543|449046569|FG005|Overall Study|Lack of Efficacy|0|||
124840824|NCT03013543|449046570|FG006|Overall Study|Lack of Efficacy|0|||
124840825|NCT03013543|449046571|FG007|Overall Study|Lack of Efficacy|0|||
124840826|NCT03013543|449046572|FG008|Overall Study|Lack of Efficacy|0|||
124840827|NCT03013543|449046573|FG009|Overall Study|Lack of Efficacy|0|||
124840828|NCT03013543|449046564|FG000|Overall Study|Lost to Follow-up|0|||
124840829|NCT03013543|449046565|FG001|Overall Study|Lost to Follow-up|0|||
124840830|NCT03013543|449046566|FG002|Overall Study|Lost to Follow-up|0|||
124840831|NCT03013543|449046567|FG003|Overall Study|Lost to Follow-up|1|||
124840832|NCT03013543|449046568|FG004|Overall Study|Lost to Follow-up|0|||
124840833|NCT03013543|449046569|FG005|Overall Study|Lost to Follow-up|0|||
124840834|NCT03013543|449046570|FG006|Overall Study|Lost to Follow-up|1|||
124840835|NCT03013543|449046571|FG007|Overall Study|Lost to Follow-up|0|||
124840836|NCT03013543|449046572|FG008|Overall Study|Lost to Follow-up|0|||
124840837|NCT03013543|449046573|FG009|Overall Study|Lost to Follow-up|2|||
124840838|NCT03013543|449046564|FG000|Overall Study|Non-Compliance With Study Drug|0|||
124840839|NCT03013543|449046565|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124840840|NCT03013543|449046566|FG002|Overall Study|Non-Compliance With Study Drug|0|||
124840841|NCT03013543|449046567|FG003|Overall Study|Non-Compliance With Study Drug|0|||
124840842|NCT03013543|449046568|FG004|Overall Study|Non-Compliance With Study Drug|0|||
124840843|NCT03013543|449046569|FG005|Overall Study|Non-Compliance With Study Drug|0|||
124840844|NCT03013543|449046570|FG006|Overall Study|Non-Compliance With Study Drug|0|||
124840845|NCT03013543|449046571|FG007|Overall Study|Non-Compliance With Study Drug|0|||
124840846|NCT03013543|449046572|FG008|Overall Study|Non-Compliance With Study Drug|1|||
124840847|NCT03013543|449046573|FG009|Overall Study|Non-Compliance With Study Drug|0|||
124840848|NCT03013543|449046564|FG000|Overall Study|Physician Decision|0|||
124840849|NCT03013543|449046565|FG001|Overall Study|Physician Decision|0|||
124840850|NCT03013543|449046566|FG002|Overall Study|Physician Decision|0|||
124840851|NCT03013543|449046567|FG003|Overall Study|Physician Decision|0|||
124840852|NCT03013543|449046568|FG004|Overall Study|Physician Decision|1|||
124840853|NCT03013543|449046569|FG005|Overall Study|Physician Decision|0|||
124840854|NCT03013543|449046570|FG006|Overall Study|Physician Decision|0|||
124840855|NCT03013543|449046571|FG007|Overall Study|Physician Decision|0|||
124840856|NCT03013543|449046572|FG008|Overall Study|Physician Decision|0|||
124840857|NCT03013543|449046573|FG009|Overall Study|Physician Decision|0|||
124840858|NCT03013543|449046564|FG000|Overall Study|Protocol Violation|0|||
124840859|NCT03013543|449046565|FG001|Overall Study|Protocol Violation|0|||
124840860|NCT03013543|449046566|FG002|Overall Study|Protocol Violation|0|||
124840861|NCT03013543|449046567|FG003|Overall Study|Protocol Violation|0|||
124840862|NCT03013543|449046568|FG004|Overall Study|Protocol Violation|0|||
124840863|NCT03013543|449046569|FG005|Overall Study|Protocol Violation|0|||
124840864|NCT03013543|449046570|FG006|Overall Study|Protocol Violation|0|||
124840865|NCT03013543|449046571|FG007|Overall Study|Protocol Violation|0|||
124840866|NCT03013543|449046572|FG008|Overall Study|Protocol Violation|0|||
124840867|NCT03013543|449046573|FG009|Overall Study|Protocol Violation|1|||
124840868|NCT04960228|449046574|FG000|Overall Study|Withdrawal by Subject|216|||
124840869|NCT04960228|449046575|FG001|Overall Study|Withdrawal by Subject|35|||
124840870|NCT04960228|449046574|FG000|Overall Study|Failed attention check|69|||
124840871|NCT04960228|449046575|FG001|Overall Study|Failed attention check|148|||
124840872|NCT04960228|449046574|FG000|Overall Study|Flagged for response quality by Dynata|3|||
124840873|NCT04960228|449046575|FG001|Overall Study|Flagged for response quality by Dynata|3|||
124840874|NCT02281552|449046578|FG000|Overall Study|Medication error|1|||
124840875|NCT02281552|449046579|FG001|Overall Study|Medication error|0|||
124840876|NCT02281552|449046578|FG000|Overall Study|Insufficient clinical response|0|||
124840877|NCT02281552|449046579|FG001|Overall Study|Insufficient clinical response|1|||
124840878|NCT02281552|449046578|FG000|Overall Study|Adverse Event|3|||
124840879|NCT02281552|449046579|FG001|Overall Study|Adverse Event|9|||
124840880|NCT04365699|449046582|FG000|Overall Study|Death|2|||
124840881|NCT04365699|449046583|FG001|Overall Study|Death|5|||
124840882|NCT04365699|449046584|FG002|Overall Study|Death|15|||
124840883|NCT02540954|449046585|FG000|Overall Study|Physician Decision|3|||
124840884|NCT02540954|449046586|FG001|Overall Study|Physician Decision|1|||
124840885|NCT02540954|449046585|FG000|Overall Study|Withdrawal by Subject|6|||
124840886|NCT02540954|449046586|FG001|Overall Study|Withdrawal by Subject|5|||
124840887|NCT02540954|449046585|FG000|Overall Study|Lost to Follow-up|1|||
124840888|NCT02540954|449046586|FG001|Overall Study|Lost to Follow-up|1|||
124840889|NCT02540954|449046585|FG000|Overall Study|Adverse Event|4|||
124840890|NCT02540954|449046586|FG001|Overall Study|Adverse Event|2|||
124840891|NCT02540954|449046585|FG000|Overall Study|Death|0|||
124840892|NCT02540954|449046586|FG001|Overall Study|Death|3|||
124840893|NCT02540954|449046585|FG000|Overall Study|Treatment failure|1|||
124840894|NCT02540954|449046586|FG001|Overall Study|Treatment failure|0|||
124840895|NCT02540954|449046585|FG000|Overall Study|Other reason|4|||
124840896|NCT02540954|449046586|FG001|Overall Study|Other reason|2|||
124840897|NCT01393743|449046587|FG000|Core Study|Adverse Event|5|||
124840898|NCT01393743|449046588|FG001|Core Study|Adverse Event|9|||
124840899|NCT01393743|449046589|FG002|Core Study|Adverse Event|0|||
124840900|NCT01393743|449046587|FG000|Core Study|Lost to Follow-up|1|||
124840901|NCT01393743|449046588|FG001|Core Study|Lost to Follow-up|1|||
124840902|NCT01393743|449046589|FG002|Core Study|Lost to Follow-up|0|||
124840903|NCT01393743|449046587|FG000|Core Study|Participant's Choice|2|||
124840904|NCT01393743|449046588|FG001|Core Study|Participant's Choice|3|||
124840905|NCT01393743|449046589|FG002|Core Study|Participant's Choice|0|||
124840906|NCT01393743|449046587|FG000|Core Study|Inadequate therapeutic effect|2|||
124840907|NCT01393743|449046588|FG001|Core Study|Inadequate therapeutic effect|0|||
124840908|NCT01393743|449046589|FG002|Core Study|Inadequate therapeutic effect|0|||
124840909|NCT01393743|449046587|FG000|Extension Phase|Adverse Event|0|||
124840910|NCT01393743|449046588|FG001|Extension Phase|Adverse Event|0|||
124840911|NCT01393743|449046589|FG002|Extension Phase|Adverse Event|12|||
124840912|NCT01393743|449046587|FG000|Extension Phase|Lost to Follow-up|0|||
124840913|NCT01393743|449046588|FG001|Extension Phase|Lost to Follow-up|0|||
124840914|NCT01393743|449046589|FG002|Extension Phase|Lost to Follow-up|2|||
124840915|NCT01393743|449046587|FG000|Extension Phase|Participant choice|0|||
124840916|NCT01393743|449046588|FG001|Extension Phase|Participant choice|0|||
124840917|NCT01393743|449046589|FG002|Extension Phase|Participant choice|16|||
124840918|NCT01393743|449046587|FG000|Extension Phase|Inadequate therapeutic effect|0|||
124840919|NCT01393743|449046588|FG001|Extension Phase|Inadequate therapeutic effect|0|||
124840920|NCT01393743|449046589|FG002|Extension Phase|Inadequate therapeutic effect|7|||
124840921|NCT01393743|449046587|FG000|Extension Phase|Withdrawal by Subject|0|||
124840922|NCT01393743|449046588|FG001|Extension Phase|Withdrawal by Subject|0|||
124840923|NCT01393743|449046589|FG002|Extension Phase|Withdrawal by Subject|8|||
124840924|NCT01393743|449046587|FG000|Extension Phase|Pregnancy|0|||
124840925|NCT01393743|449046588|FG001|Extension Phase|Pregnancy|0|||
124840926|NCT01393743|449046589|FG002|Extension Phase|Pregnancy|1|||
124840927|NCT01393743|449046587|FG000|Extension Phase|Other|0|||
124840928|NCT01393743|449046588|FG001|Extension Phase|Other|0|||
124840929|NCT01393743|449046589|FG002|Extension Phase|Other|14|||
124840930|NCT02321462|449046593|FG000|Overall Study|Withdrawal by Subject|5|||
124840931|NCT02321462|449046594|FG001|Overall Study|Withdrawal by Subject|2|||
124840932|NCT02321462|449046593|FG000|Overall Study|Subject withdrawn before any treatment|1|||
124840933|NCT02321462|449046594|FG001|Overall Study|Subject withdrawn before any treatment|1|||
124840934|NCT03044197|449046604|FG000|Overall Study|Withdrawal by Subject|3|||
124840935|NCT03044197|449046605|FG001|Overall Study|Withdrawal by Subject|1|||
124840936|NCT00834912|449046610|FG000|Treatment Period 1|Adverse Event|0|||
124840937|NCT00834912|449046611|FG001|Treatment Period 1|Adverse Event|1|||
124840938|NCT00834912|449046612|FG002|Treatment Period 1|Adverse Event|0|||
124840939|NCT00834912|449046613|FG003|Treatment Period 1|Adverse Event|1|||
124840940|NCT00834912|449046614|FG004|Treatment Period 1|Adverse Event|0|||
124840941|NCT00834912|449046615|FG005|Treatment Period 1|Adverse Event|0|||
124840942|NCT00834912|449046610|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124840943|NCT00834912|449046611|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124840944|NCT00834912|449046612|FG002|Treatment Period 2|Withdrawal by Subject|1|||
124840945|NCT00834912|449046613|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124840946|NCT00834912|449046614|FG004|Treatment Period 2|Withdrawal by Subject|1|||
124840947|NCT00834912|449046615|FG005|Treatment Period 2|Withdrawal by Subject|0|||
124840948|NCT03829046|449046619|FG000|Overall Study|Withdrawal by Subject|1|||
124840949|NCT03829046|449046620|FG001|Overall Study|Withdrawal by Subject|0|||
124840950|NCT00989833|449046621|FG000|Overall Study|Lost to Follow-up|0|||
124840951|NCT00989833|449046622|FG001|Overall Study|Lost to Follow-up|1|||
124840952|NCT00989833|449046623|FG002|Overall Study|Lost to Follow-up|0|||
124840953|NCT00989833|449046621|FG000|Overall Study|Protocol Violation|1|||
124840954|NCT00989833|449046622|FG001|Overall Study|Protocol Violation|2|||
124840955|NCT00989833|449046623|FG002|Overall Study|Protocol Violation|1|||
124840956|NCT00989833|449046621|FG000|Overall Study|Withdrawal by Subject|0|||
124840957|NCT00989833|449046622|FG001|Overall Study|Withdrawal by Subject|0|||
124840958|NCT00989833|449046623|FG002|Overall Study|Withdrawal by Subject|1|||
124840959|NCT00989833|449046621|FG000|Overall Study|Incorrectly randomized|1|||
124840960|NCT00989833|449046622|FG001|Overall Study|Incorrectly randomized|0|||
124840961|NCT00989833|449046623|FG002|Overall Study|Incorrectly randomized|0|||
124840962|NCT00500370|449046635|FG000|Overall Study|Adverse Event|9|||
124840963|NCT00500370|449046636|FG001|Overall Study|Adverse Event|3|||
124840964|NCT00500370|449046635|FG000|Overall Study|Lost to Follow-up|10|||
124840965|NCT00500370|449046636|FG001|Overall Study|Lost to Follow-up|10|||
124840966|NCT00500370|449046635|FG000|Overall Study|Protocol Violation|2|||
124840967|NCT00500370|449046636|FG001|Overall Study|Protocol Violation|4|||
124840968|NCT00500370|449046635|FG000|Overall Study|Sponsor Decision|2|||
124840969|NCT00500370|449046636|FG001|Overall Study|Sponsor Decision|0|||
124840970|NCT00500370|449046635|FG000|Overall Study|Subject Decision|10|||
124840971|NCT00500370|449046636|FG001|Overall Study|Subject Decision|17|||
124840972|NCT01282424|449046637|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
124840973|NCT01282424|449046637|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
124840974|NCT01282424|449046637|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
124840975|NCT01282424|449046637|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
124840976|NCT01282424|449046637|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
124840977|NCT01282424|449046637|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
124840978|NCT01282424|449046637|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
124840979|NCT01282424|449046637|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
124840980|NCT00714259|449046638|FG000|Overall Study|Death|2|||
124840981|NCT04804813|449046639|FG000|Overall Study|Protocol Violation|2|||
124840982|NCT04804813|449046640|FG001|Overall Study|Protocol Violation|0|||
124840983|NCT04804813|449046639|FG000|Overall Study|Withdrawal by Subject|1|||
124840984|NCT04804813|449046640|FG001|Overall Study|Withdrawal by Subject|0|||
124840985|NCT05627518|449046641|FG000|Treatment Period 1|Adverse Event|0|||
124840986|NCT05627518|449046642|FG001|Treatment Period 1|Adverse Event|0|||
124840987|NCT05627518|449046643|FG002|Treatment Period 1|Adverse Event|1|||
124840988|NCT05627518|449046644|FG003|Treatment Period 1|Adverse Event|0|||
124840989|NCT05627518|449046645|FG004|Treatment Period 1|Adverse Event|0|||
124840990|NCT05627518|449046646|FG005|Treatment Period 1|Adverse Event|0|||
124840991|NCT05627518|449046647|FG006|Treatment Period 1|Adverse Event|0|||
124840992|NCT05627518|449046648|FG007|Treatment Period 1|Adverse Event|1|||
124840993|NCT05627518|449046641|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124840994|NCT05627518|449046642|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124840995|NCT05627518|449046643|FG002|Treatment Period 1|Withdrawal by Subject|1|||
124840996|NCT05627518|449046644|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124840997|NCT05627518|449046645|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124840998|NCT05627518|449046646|FG005|Treatment Period 1|Withdrawal by Subject|1|||
124840999|NCT05627518|449046647|FG006|Treatment Period 1|Withdrawal by Subject|0|||
124841000|NCT05627518|449046648|FG007|Treatment Period 1|Withdrawal by Subject|0|||
124841001|NCT05627518|449046641|FG000|Treatment Period 1|Protocol Violation|0|||
124841002|NCT05627518|449046642|FG001|Treatment Period 1|Protocol Violation|0|||
124841003|NCT05627518|449046643|FG002|Treatment Period 1|Protocol Violation|0|||
124841004|NCT05627518|449046644|FG003|Treatment Period 1|Protocol Violation|0|||
124841005|NCT05627518|449046645|FG004|Treatment Period 1|Protocol Violation|0|||
124841006|NCT05627518|449046646|FG005|Treatment Period 1|Protocol Violation|0|||
124841007|NCT05627518|449046647|FG006|Treatment Period 1|Protocol Violation|6|||
124841008|NCT05627518|449046648|FG007|Treatment Period 1|Protocol Violation|6|||
124841009|NCT05627518|449046641|FG000|Treatment Period 2|Adverse Event|1|||
124841010|NCT05627518|449046642|FG001|Treatment Period 2|Adverse Event|0|||
124841011|NCT05627518|449046643|FG002|Treatment Period 2|Adverse Event|0|||
124841012|NCT05627518|449046644|FG003|Treatment Period 2|Adverse Event|0|||
124841013|NCT05627518|449046645|FG004|Treatment Period 2|Adverse Event|0|||
124841014|NCT05627518|449046646|FG005|Treatment Period 2|Adverse Event|0|||
124841015|NCT05627518|449046647|FG006|Treatment Period 2|Adverse Event|0|||
124841016|NCT05627518|449046648|FG007|Treatment Period 2|Adverse Event|0|||
124841017|NCT05627518|449046641|FG000|Treatment Period 2|Withdrawal by Subject|1|||
124841018|NCT05627518|449046642|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124841019|NCT05627518|449046643|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124841020|NCT05627518|449046644|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124841021|NCT05627518|449046645|FG004|Treatment Period 2|Withdrawal by Subject|0|||
124841022|NCT05627518|449046646|FG005|Treatment Period 2|Withdrawal by Subject|0|||
124841023|NCT05627518|449046647|FG006|Treatment Period 2|Withdrawal by Subject|0|||
124841024|NCT05627518|449046648|FG007|Treatment Period 2|Withdrawal by Subject|0|||
124841025|NCT05084053|449048254|FG000|Epoch 1: Up to 6 Months|Withdrawal by Subject|1|||
124841026|NCT05084053|449048255|FG001|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
124841027|NCT05084053|449048256|FG002|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
124841028|NCT05084053|449048257|FG003|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
124841029|NCT05084053|449048254|FG000|Epoch 1: Up to 6 Months|Physician Decision|1|||
124841030|NCT05084053|449048255|FG001|Epoch 1: Up to 6 Months|Physician Decision|0|||
124841031|NCT05084053|449048256|FG002|Epoch 1: Up to 6 Months|Physician Decision|0|||
124841032|NCT05084053|449048257|FG003|Epoch 1: Up to 6 Months|Physician Decision|0|||
124841033|NCT05084053|449048254|FG000|Epoch 2: Up to 6 Months|Physician Decision|0|||
124841034|NCT05084053|449048255|FG001|Epoch 2: Up to 6 Months|Physician Decision|0|||
124841035|NCT05084053|449048256|FG002|Epoch 2: Up to 6 Months|Physician Decision|1|||
124841036|NCT05084053|449048257|FG003|Epoch 2: Up to 6 Months|Physician Decision|0|||
124841037|NCT00071812|449048258|FG000|24-Week Double-Blind Period|Adverse Event|2|||
124841038|NCT00071812|449048259|FG001|24-Week Double-Blind Period|Adverse Event|3|||
124841039|NCT00071812|449048260|FG002|24-Week Double-Blind Period|Adverse Event|4|||
124841040|NCT00071812|449048261|FG003|24-Week Double-Blind Period|Adverse Event|4|||
124841041|NCT00071812|449048258|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
124841042|NCT00071812|449048259|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
124841043|NCT00071812|449048260|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
124841044|NCT00071812|449048261|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
124841045|NCT00071812|449048258|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
124841046|NCT00071812|449048259|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
124841047|NCT00071812|449048260|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
124841048|NCT00071812|449048261|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
124841049|NCT00071812|449048258|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
124841050|NCT00071812|449048259|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
124841051|NCT00071812|449048260|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
124841052|NCT00071812|449048261|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
124841053|NCT00071812|449048258|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
124841054|NCT00071812|449048259|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
124841055|NCT00071812|449048260|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
124841056|NCT00071812|449048261|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
124841057|NCT00071812|449048258|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
124841058|NCT00071812|449048259|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
124841059|NCT00071812|449048260|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
124841060|NCT00071812|449048261|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
124841061|NCT00071812|449048258|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
124841062|NCT00071812|449048259|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
124841063|NCT00071812|449048260|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
124841064|NCT00071812|449048261|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
124841065|NCT00071812|449048258|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
124841066|NCT00071812|449048259|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
124841067|NCT00071812|449048260|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
124841068|NCT00071812|449048261|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
124841069|NCT00071812|449048258|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
124841070|NCT00071812|449048259|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
124841071|NCT00071812|449048260|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
124841072|NCT00071812|449048261|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
124841073|NCT00071812|449048258|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
124841074|NCT00071812|449048259|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
124841075|NCT00071812|449048260|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
124841076|NCT00071812|449048261|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
124841077|NCT01589822|449048262|FG000|Overall Study|Withdrawal by Subject|1|||
124841078|NCT01589822|449048263|FG001|Overall Study|Withdrawal by Subject|2|||
124841079|NCT01589822|449048264|FG002|Overall Study|Withdrawal by Subject|0|||
124841080|NCT01589822|449048262|FG000|Overall Study|Death|1|||
124841081|NCT01589822|449048263|FG001|Overall Study|Death|0|||
124841082|NCT01589822|449048264|FG002|Overall Study|Death|0|||
124841083|NCT01589822|449048262|FG000|Overall Study|Missed 90 day visit|2|||
124841084|NCT01589822|449048263|FG001|Overall Study|Missed 90 day visit|1|||
124841085|NCT01589822|449048264|FG002|Overall Study|Missed 90 day visit|1|||
124841086|NCT05168475|449048265|FG000|Period 1|Protocol Violation|1|||
124841087|NCT05168475|449048265|FG000|Period 1|IMP shortage|2|||
124841088|NCT05168475|449048265|FG000|Period 1|Not randomised|2|||
124841089|NCT05168475|449048265|FG000|Period 2|IMP shortage|1|||
124841090|NCT03568942|449048268|FG000|Overall Study|Family emergency|1|||
124841091|NCT03568942|449048268|FG000|Overall Study|Lost to Follow-up|1|||
124841092|NCT00640510|449048271|FG000|Overall Study|Lack of Efficacy|0|||
124841093|NCT00640510|449048272|FG001|Overall Study|Lack of Efficacy|1|||
124841094|NCT00640510|449048271|FG000|Overall Study|Protocol Violation|1|||
125305472|NCT00483938|450745136|FG004|Overall Study|Death|0|||
125305473|NCT00483938|450745137|FG005|Overall Study|Death|0|||
124841095|NCT00640510|449048272|FG001|Overall Study|Protocol Violation|0|||
124841096|NCT00640510|449048271|FG000|Overall Study|Physician Decision|0|||
124841097|NCT00640510|449048272|FG001|Overall Study|Physician Decision|1|||
124841098|NCT01467076|449048276|FG000|Overall Study|Lost to Follow-up|1|||
124841099|NCT01467076|449048277|FG001|Overall Study|Lost to Follow-up|0|||
124841100|NCT01467076|449048278|FG002|Overall Study|Lost to Follow-up|0|||
124841101|NCT00418691|449048280|FG000|Overall Study|Lost to Follow-up|1|||
124841102|NCT00418691|449048281|FG001|Overall Study|Lost to Follow-up|2|||
124841103|NCT00418691|449048282|FG002|Overall Study|Lost to Follow-up|3|||
124841104|NCT00418691|449048280|FG000|Overall Study|Started new medication voiding entry|0|||
124841105|NCT00418691|449048281|FG001|Overall Study|Started new medication voiding entry|0|||
124841106|NCT00418691|449048282|FG002|Overall Study|Started new medication voiding entry|1|||
124841107|NCT00418691|449048280|FG000|Overall Study|Progressive Disease|1|||
124841108|NCT00418691|449048281|FG001|Overall Study|Progressive Disease|0|||
124841109|NCT00418691|449048282|FG002|Overall Study|Progressive Disease|1|||
124841110|NCT01067352|449048283|FG000|Overall Study|Withdrawal by Subject|1|||
124841111|NCT01067352|449048284|FG001|Overall Study|Withdrawal by Subject|2|||
124841112|NCT01067352|449048285|FG002|Overall Study|Withdrawal by Subject|1|||
124841113|NCT01067352|449048283|FG000|Overall Study|Physician Decision|0|||
124841114|NCT01067352|449048284|FG001|Overall Study|Physician Decision|1|||
124841115|NCT01067352|449048285|FG002|Overall Study|Physician Decision|0|||
124841116|NCT01096784|449048286|FG000|Overall Study|Withdrawal by Subject|2|||
124841117|NCT01096784|449048287|FG001|Overall Study|Withdrawal by Subject|1|||
124841118|NCT01096784|449048286|FG000|Overall Study|Adverse Event|11|||
124841119|NCT01096784|449048287|FG001|Overall Study|Adverse Event|9|||
124841120|NCT01096784|449048286|FG000|Overall Study|Protocol Deviation|2|||
124841121|NCT01096784|449048287|FG001|Overall Study|Protocol Deviation|2|||
124841122|NCT01096784|449048286|FG000|Overall Study|Administrative Decision|0|||
124841123|NCT01096784|449048287|FG001|Overall Study|Administrative Decision|1|||
124841124|NCT01096784|449048286|FG000|Overall Study|Other Unspecified|0|||
124841125|NCT01096784|449048287|FG001|Overall Study|Other Unspecified|1|||
124841126|NCT03761628|449048288|FG000|Overall Study|Withdrawal by Subject|3|||
124841127|NCT03761628|449048288|FG000|Overall Study|Physician Decision|1|||
124841128|NCT03761628|449048288|FG000|Overall Study|Pregnancy|1|||
124841129|NCT03761628|449048288|FG000|Overall Study|Lost to Follow-up|1|||
124841130|NCT03064126|449048289|FG000|Overall Study|Death|40|||
124841131|NCT03064126|449048290|FG001|Overall Study|Death|16|||
124841132|NCT03064126|449048291|FG002|Overall Study|Death|4|||
124841133|NCT03064126|449048292|FG003|Overall Study|Death|2|||
124841134|NCT03064126|449048289|FG000|Overall Study|Withdrawal by Subject|17|||
124841135|NCT03064126|449048290|FG001|Overall Study|Withdrawal by Subject|9|||
124841136|NCT03064126|449048291|FG002|Overall Study|Withdrawal by Subject|0|||
124841137|NCT03064126|449048292|FG003|Overall Study|Withdrawal by Subject|2|||
124841138|NCT03064126|449048289|FG000|Overall Study|Lost to Follow-up|7|||
124841139|NCT03064126|449048290|FG001|Overall Study|Lost to Follow-up|3|||
124841140|NCT03064126|449048291|FG002|Overall Study|Lost to Follow-up|0|||
124841141|NCT03064126|449048292|FG003|Overall Study|Lost to Follow-up|0|||
124841142|NCT03064126|449048289|FG000|Overall Study|Adverse Event|2|||
124841143|NCT03064126|449048290|FG001|Overall Study|Adverse Event|0|||
124841144|NCT03064126|449048291|FG002|Overall Study|Adverse Event|0|||
124841145|NCT03064126|449048292|FG003|Overall Study|Adverse Event|0|||
124841146|NCT03064126|449048289|FG000|Overall Study|Physician Decision|3|||
124841147|NCT03064126|449048290|FG001|Overall Study|Physician Decision|0|||
124841148|NCT03064126|449048291|FG002|Overall Study|Physician Decision|0|||
124841149|NCT03064126|449048292|FG003|Overall Study|Physician Decision|0|||
124841150|NCT03064126|449048289|FG000|Overall Study|Other reason for early termination|3|||
124841151|NCT03064126|449048290|FG001|Overall Study|Other reason for early termination|2|||
124841152|NCT03064126|449048291|FG002|Overall Study|Other reason for early termination|0|||
124841153|NCT03064126|449048292|FG003|Overall Study|Other reason for early termination|0|||
124841154|NCT03064126|449048289|FG000|Overall Study|Missed Visit|3|||
124841155|NCT03064126|449048290|FG001|Overall Study|Missed Visit|1|||
124841156|NCT03064126|449048291|FG002|Overall Study|Missed Visit|0|||
124841157|NCT03064126|449048292|FG003|Overall Study|Missed Visit|0|||
124841158|NCT02465528|449048296|FG000|Overall Study|Progressive disease|0|||
124841159|NCT02465528|449048297|FG001|Overall Study|Progressive disease|2|||
124841160|NCT02465528|449048298|FG002|Overall Study|Progressive disease|9|||
124841161|NCT02465528|449048299|FG003|Overall Study|Progressive disease|4|||
124841162|NCT02465528|449048296|FG000|Overall Study|Study terminated by sponsor|1|||
124841163|NCT02465528|449048297|FG001|Overall Study|Study terminated by sponsor|2|||
124841164|NCT02465528|449048298|FG002|Overall Study|Study terminated by sponsor|0|||
124841165|NCT02465528|449048299|FG003|Overall Study|Study terminated by sponsor|0|||
124841166|NCT02465528|449048296|FG000|Overall Study|Withdrawal by Subject|0|||
124841167|NCT02465528|449048297|FG001|Overall Study|Withdrawal by Subject|0|||
124841168|NCT02465528|449048298|FG002|Overall Study|Withdrawal by Subject|2|||
124841169|NCT02465528|449048299|FG003|Overall Study|Withdrawal by Subject|0|||
124841170|NCT02465528|449048296|FG000|Overall Study|Adverse Event|0|||
124841171|NCT02465528|449048297|FG001|Overall Study|Adverse Event|0|||
124841172|NCT02465528|449048298|FG002|Overall Study|Adverse Event|0|||
124841173|NCT02465528|449048299|FG003|Overall Study|Adverse Event|1|||
124841174|NCT02465528|449048296|FG000|Overall Study|Physician Decision|0|||
124841175|NCT02465528|449048297|FG001|Overall Study|Physician Decision|0|||
124841176|NCT02465528|449048298|FG002|Overall Study|Physician Decision|1|||
124841177|NCT02465528|449048299|FG003|Overall Study|Physician Decision|0|||
124841178|NCT03907683|449048301|FG000|Overall Study|Pregnancy|1|||
124841179|NCT03907683|449048301|FG000|Overall Study|Withdrawal by Subject|1|||
124841180|NCT02975934|449048302|FG000|Treatment Phase|Never initiated study drug|0|||
124841181|NCT02975934|449048303|FG001|Treatment Phase|Never initiated study drug|5|||
124841182|NCT02975934|449048304|FG002|Treatment Phase|Never initiated study drug|0|||
124841183|NCT02075840|449048305|FG000|Overall Study|Withdrawal by Subject|13|||
124841184|NCT02075840|449048306|FG001|Overall Study|Withdrawal by Subject|22|||
124841185|NCT02075840|449048305|FG000|Overall Study|Reason not specified|1|||
124841186|NCT02075840|449048306|FG001|Overall Study|Reason not specified|0|||
124841187|NCT02075840|449048305|FG000|Overall Study|Adverse Event|0|||
124841188|NCT02075840|449048306|FG001|Overall Study|Adverse Event|2|||
124841189|NCT02075840|449048305|FG000|Overall Study|Death|35|||
124841190|NCT02075840|449048306|FG001|Overall Study|Death|40|||
124841191|NCT02075840|449048305|FG000|Overall Study|Lost to Follow-up|3|||
124841192|NCT02075840|449048306|FG001|Overall Study|Lost to Follow-up|2|||
124841193|NCT02075840|449048305|FG000|Overall Study|Physician Decision|1|||
124841194|NCT02075840|449048306|FG001|Overall Study|Physician Decision|3|||
124841195|NCT02075840|449048305|FG000|Overall Study|Ongoing at CCOD|99|||
124841196|NCT02075840|449048306|FG001|Overall Study|Ongoing at CCOD|82|||
124841197|NCT00846742|449048307|FG000|Overall Study|Withdrawal by Subject|1|||
124841198|NCT02775344|449048308|FG000|Overall Study|No ovarian cyst identified|3|||
124841199|NCT02775344|449048309|FG001|Overall Study|No ovarian cyst identified|2|||
124841200|NCT03909165|449048318|FG000|Overall Study|Physician Decision|0|||
124841201|NCT03909165|449048319|FG001|Overall Study|Physician Decision|1|||
124841202|NCT03909165|449048320|FG002|Overall Study|Physician Decision|0|||
124841203|NCT03909165|449048321|FG003|Overall Study|Physician Decision|0|||
124841204|NCT03909165|449048322|FG004|Overall Study|Physician Decision|0|||
124841205|NCT03909165|449048318|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124841206|NCT03909165|449048319|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124841207|NCT03909165|449048320|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124841208|NCT03909165|449048321|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124841209|NCT03909165|449048322|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
124841210|NCT03909165|449048318|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
124841211|NCT03909165|449048319|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
124841212|NCT03909165|449048320|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
124841213|NCT03909165|449048321|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
124841214|NCT03909165|449048322|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
124841215|NCT03909165|449048318|FG000|Overall Study|Previous Drug Exposure|0|||
124841216|NCT03909165|449048319|FG001|Overall Study|Previous Drug Exposure|0|||
124841217|NCT03909165|449048320|FG002|Overall Study|Previous Drug Exposure|1|||
124841218|NCT03909165|449048321|FG003|Overall Study|Previous Drug Exposure|0|||
124841219|NCT03909165|449048322|FG004|Overall Study|Previous Drug Exposure|0|||
124841220|NCT03909165|449048318|FG000|Overall Study|Early Discharge|1|||
124841221|NCT03909165|449048319|FG001|Overall Study|Early Discharge|0|||
124841222|NCT03909165|449048320|FG002|Overall Study|Early Discharge|0|||
124841223|NCT03909165|449048321|FG003|Overall Study|Early Discharge|0|||
124841224|NCT03909165|449048322|FG004|Overall Study|Early Discharge|0|||
124841225|NCT02018458|449048324|FG000|Overall Study|Death|4|||
124841226|NCT00354172|449048325|FG000|Overall Study|Did not receive transplant|1|||
124841227|NCT01800916|449048326|FG000|Test Period 1 (1 Week)|Convex product user|0|||
124841228|NCT01800916|449048327|FG001|Test Period 1 (1 Week)|Convex product user|0|||
124841229|NCT01800916|449048328|FG002|Test Period 1 (1 Week)|Convex product user|0|||
124841230|NCT01800916|449048329|FG003|Test Period 1 (1 Week)|Convex product user|1|||
124841231|NCT01800916|449048330|FG004|Test Period 1 (1 Week)|Convex product user|0|||
124841232|NCT01800916|449048331|FG005|Test Period 1 (1 Week)|Convex product user|0|||
124841233|NCT01800916|449048332|FG006|Test Period 1 (1 Week)|Convex product user|0|||
124841234|NCT01800916|449048333|FG007|Test Period 1 (1 Week)|Convex product user|0|||
124841235|NCT01800916|449048334|FG008|Test Period 1 (1 Week)|Convex product user|0|||
124841236|NCT01800916|449048326|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
124841237|NCT01800916|449048327|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
124841238|NCT01800916|449048328|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
124841239|NCT01800916|449048329|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
124841240|NCT01800916|449048330|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
124841241|NCT01800916|449048331|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
124841242|NCT01800916|449048332|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
124841243|NCT01800916|449048333|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
124841244|NCT01800916|449048334|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
124841245|NCT00727714|449048335|FG000|Overall Study|Lost to Follow-up|2|||
124841246|NCT00325234|449048336|FG000|Overall Study|Adverse Event|10|||
124841247|NCT00325234|449048337|FG001|Overall Study|Adverse Event|7|||
124841248|NCT00325234|449048336|FG000|Overall Study|Death due to Study Disease|1|||
124841249|NCT00325234|449048337|FG001|Overall Study|Death due to Study Disease|0|||
124841250|NCT00325234|449048336|FG000|Overall Study|Entry Criteria Not Met|1|||
124841251|NCT00325234|449048337|FG001|Overall Study|Entry Criteria Not Met|2|||
124841252|NCT00325234|449048336|FG000|Overall Study|Subject Decision|6|||
124841253|NCT00325234|449048337|FG001|Overall Study|Subject Decision|8|||
124841254|NCT00325234|449048336|FG000|Overall Study|Physician Decision|17|||
124841255|NCT00325234|449048337|FG001|Overall Study|Physician Decision|12|||
124841256|NCT00325234|449048336|FG000|Overall Study|Progressive Disease|34|||
124841257|NCT00325234|449048337|FG001|Overall Study|Progressive Disease|37|||
124841258|NCT01234467|449048338|FG000|Overall Study|Adverse Event|3|||
124841259|NCT01234467|449048338|FG000|Overall Study|Death|2|||
124841260|NCT01234467|449048338|FG000|Overall Study|Withdrawal by Subject|2|||
124841261|NCT01234467|449048338|FG000|Overall Study|Disease Progression|2|||
124841262|NCT01234467|449048338|FG000|Overall Study|Clinical deterioration|1|||
124841263|NCT01234467|449048338|FG000|Overall Study|Physician Decision|1|||
124841264|NCT01234467|449048338|FG000|Overall Study|Other complicating disease (stroke)|1|||
124841265|NCT01639040|449048339|FG000|Overall Study|Adverse Event|1|||
124841266|NCT01639040|449048340|FG001|Overall Study|Adverse Event|0|||
124841267|NCT01479621|449048341|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
124841268|NCT01479621|449048342|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124841269|NCT01479621|449048343|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124841270|NCT01479621|449048344|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124841271|NCT01479621|449048345|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124841272|NCT01479621|449048346|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124841273|NCT01479621|449048347|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124841274|NCT01479621|449048341|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
124841275|NCT01479621|449048342|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124841276|NCT01479621|449048343|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124841277|NCT01479621|449048344|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124841278|NCT01479621|449048345|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124841279|NCT01479621|449048346|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124841280|NCT01479621|449048347|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124841281|NCT01479621|449048341|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
124841282|NCT01479621|449048342|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124841283|NCT01479621|449048343|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124841284|NCT01479621|449048344|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124841285|NCT01479621|449048345|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124841286|NCT01479621|449048346|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124841287|NCT01479621|449048347|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124841288|NCT01479621|449048341|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
124841289|NCT01479621|449048342|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124841290|NCT01479621|449048343|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124841291|NCT01479621|449048344|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124841292|NCT01479621|449048345|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124841293|NCT01479621|449048346|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124841294|NCT01479621|449048347|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124841295|NCT01479621|449048341|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
124841296|NCT01479621|449048342|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124841297|NCT01479621|449048343|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124841298|NCT01479621|449048344|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124841299|NCT01479621|449048345|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124841300|NCT01479621|449048346|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124841301|NCT01479621|449048347|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124841302|NCT01479621|449048341|FG000|Treatment Period|Adverse Event|0|||
124841303|NCT01479621|449048342|FG001|Treatment Period|Adverse Event|0|||
124841304|NCT01479621|449048343|FG002|Treatment Period|Adverse Event|0|||
124841305|NCT01479621|449048344|FG003|Treatment Period|Adverse Event|0|||
124841306|NCT01479621|449048345|FG004|Treatment Period|Adverse Event|1|||
124841307|NCT01479621|449048346|FG005|Treatment Period|Adverse Event|2|||
124841308|NCT01479621|449048347|FG006|Treatment Period|Adverse Event|2|||
124841309|NCT01479621|449048341|FG000|Treatment Period|Withdrawal by Subject|0|||
124841310|NCT01479621|449048342|FG001|Treatment Period|Withdrawal by Subject|4|||
124841311|NCT01479621|449048343|FG002|Treatment Period|Withdrawal by Subject|2|||
124841312|NCT01479621|449048344|FG003|Treatment Period|Withdrawal by Subject|2|||
124841313|NCT01479621|449048345|FG004|Treatment Period|Withdrawal by Subject|5|||
124841314|NCT01479621|449048346|FG005|Treatment Period|Withdrawal by Subject|5|||
124841315|NCT01479621|449048347|FG006|Treatment Period|Withdrawal by Subject|1|||
124841316|NCT01479621|449048341|FG000|Treatment Period|Physician Decision|0|||
125305474|NCT00483938|450745138|FG006|Overall Study|Death|0|||
125305475|NCT00483938|450745132|FG000|Overall Study|Other|3|||
124841317|NCT01479621|449048342|FG001|Treatment Period|Physician Decision|0|||
124841318|NCT01479621|449048343|FG002|Treatment Period|Physician Decision|0|||
124841319|NCT01479621|449048344|FG003|Treatment Period|Physician Decision|0|||
124841320|NCT01479621|449048345|FG004|Treatment Period|Physician Decision|1|||
124841321|NCT01479621|449048346|FG005|Treatment Period|Physician Decision|1|||
124841322|NCT01479621|449048347|FG006|Treatment Period|Physician Decision|0|||
124841323|NCT01479621|449048341|FG000|Treatment Period|Non-compliance to study drug|0|||
124841324|NCT01479621|449048342|FG001|Treatment Period|Non-compliance to study drug|1|||
124841325|NCT01479621|449048343|FG002|Treatment Period|Non-compliance to study drug|0|||
124841326|NCT01479621|449048344|FG003|Treatment Period|Non-compliance to study drug|0|||
124841327|NCT01479621|449048345|FG004|Treatment Period|Non-compliance to study drug|0|||
124841328|NCT01479621|449048346|FG005|Treatment Period|Non-compliance to study drug|0|||
124841329|NCT01479621|449048347|FG006|Treatment Period|Non-compliance to study drug|1|||
124841330|NCT01479621|449048341|FG000|Treatment Period|Protocol Violation|0|||
124841331|NCT01479621|449048342|FG001|Treatment Period|Protocol Violation|9|||
124841332|NCT01479621|449048343|FG002|Treatment Period|Protocol Violation|6|||
124841333|NCT01479621|449048344|FG003|Treatment Period|Protocol Violation|5|||
124841334|NCT01479621|449048345|FG004|Treatment Period|Protocol Violation|2|||
124841335|NCT01479621|449048346|FG005|Treatment Period|Protocol Violation|10|||
124841336|NCT01479621|449048347|FG006|Treatment Period|Protocol Violation|6|||
124841337|NCT01479621|449048341|FG000|Treatment Period|Pregnancy|0|||
124841338|NCT01479621|449048342|FG001|Treatment Period|Pregnancy|0|||
124841339|NCT01479621|449048343|FG002|Treatment Period|Pregnancy|2|||
124841340|NCT01479621|449048344|FG003|Treatment Period|Pregnancy|0|||
124841341|NCT01479621|449048345|FG004|Treatment Period|Pregnancy|0|||
124841342|NCT01479621|449048346|FG005|Treatment Period|Pregnancy|0|||
124841343|NCT01479621|449048347|FG006|Treatment Period|Pregnancy|0|||
124841344|NCT01479621|449048341|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
124841345|NCT01479621|449048342|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
124841346|NCT01479621|449048343|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
124841347|NCT01479621|449048344|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
124841348|NCT01479621|449048345|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
124841349|NCT01479621|449048346|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
124841350|NCT01479621|449048347|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
124841351|NCT01479621|449048341|FG000|Treatment Period|Lost to Follow-up|0|||
124841352|NCT01479621|449048342|FG001|Treatment Period|Lost to Follow-up|0|||
124841353|NCT01479621|449048343|FG002|Treatment Period|Lost to Follow-up|1|||
124841354|NCT01479621|449048344|FG003|Treatment Period|Lost to Follow-up|0|||
124841355|NCT01479621|449048345|FG004|Treatment Period|Lost to Follow-up|2|||
124841356|NCT01479621|449048346|FG005|Treatment Period|Lost to Follow-up|2|||
124841357|NCT01479621|449048347|FG006|Treatment Period|Lost to Follow-up|1|||
124841358|NCT01479621|449048341|FG000|Treatment Period|Met stopping criteria|0|||
124841359|NCT01479621|449048342|FG001|Treatment Period|Met stopping criteria|8|||
124841360|NCT01479621|449048343|FG002|Treatment Period|Met stopping criteria|7|||
124841361|NCT01479621|449048344|FG003|Treatment Period|Met stopping criteria|4|||
124841362|NCT01479621|449048345|FG004|Treatment Period|Met stopping criteria|9|||
124841363|NCT01479621|449048346|FG005|Treatment Period|Met stopping criteria|20|||
124841364|NCT01479621|449048347|FG006|Treatment Period|Met stopping criteria|6|||
124841365|NCT00486265|449048348|FG000|Overall Study|Adverse Event|1|||
124841366|NCT00486265|449048348|FG000|Overall Study|Lack of Efficacy|8|||
124841367|NCT01452412|449048349|FG000|Overall Study|Withdrawal by Subject|15|||
124841368|NCT01452412|449048350|FG001|Overall Study|Withdrawal by Subject|11|||
124841369|NCT01452412|449048349|FG000|Overall Study|Adverse Event|4|||
124841370|NCT01452412|449048350|FG001|Overall Study|Adverse Event|3|||
124841371|NCT01452412|449048349|FG000|Overall Study|Lost to Follow-up|5|||
124841372|NCT01452412|449048350|FG001|Overall Study|Lost to Follow-up|3|||
124841373|NCT01452412|449048349|FG000|Overall Study|Death|1|||
124841374|NCT01452412|449048350|FG001|Overall Study|Death|0|||
124841375|NCT01452412|449048349|FG000|Overall Study|Initiated dialysis|1|||
124841376|NCT01452412|449048350|FG001|Overall Study|Initiated dialysis|0|||
124841377|NCT01452412|449048349|FG000|Overall Study|Other|2|||
124841378|NCT01452412|449048350|FG001|Overall Study|Other|0|||
124841379|NCT03029624|449048351|FG000|Overall Study|Adverse Event|1|||
124841380|NCT03029624|449048351|FG000|Overall Study|Withdrawal by Subject|1|||
124841381|NCT03029624|449048351|FG000|Overall Study|Lack of Efficacy|1|||
124841382|NCT03029624|449048351|FG000|Overall Study|MRI need|2|||
124841383|NCT01640366|449048352|FG000|Overall Study|Withdrawal by Subject|1|||
124841384|NCT01640366|449048352|FG000|Overall Study|Protocol Violation|16|||
124841385|NCT01640366|449048352|FG000|Overall Study|Lost to Follow-up|5|||
124841386|NCT02722928|449048355|FG000|Overall Study|Standard CT was not as required per prot|5|||
124841387|NCT02722928|449048356|FG001|Overall Study|Standard CT was not as required per prot|13|||
124841388|NCT02722928|449048355|FG000|Overall Study|Required Intraoperative MRI|5|||
124841389|NCT02722928|449048356|FG001|Overall Study|Required Intraoperative MRI|7|||
124841390|NCT00838565|449048357|FG000|Overall Study|Withdrawal by Subject|0|||
124841391|NCT00838565|449048358|FG001|Overall Study|Withdrawal by Subject|0|||
125305476|NCT00483938|450745133|FG001|Overall Study|Other|9|||
124841392|NCT00838565|449048359|FG002|Overall Study|Withdrawal by Subject|1|||
124841393|NCT00838565|449048360|FG003|Overall Study|Withdrawal by Subject|0|||
124841394|NCT00838565|449048361|FG004|Overall Study|Withdrawal by Subject|0|||
124841395|NCT00838565|449048362|FG005|Overall Study|Withdrawal by Subject|2|||
124841396|NCT00838565|449048357|FG000|Overall Study|Other|0|||
124841397|NCT00838565|449048358|FG001|Overall Study|Other|2|||
124841398|NCT00838565|449048359|FG002|Overall Study|Other|0|||
124841399|NCT00838565|449048360|FG003|Overall Study|Other|0|||
124841400|NCT00838565|449048361|FG004|Overall Study|Other|0|||
124841401|NCT00838565|449048362|FG005|Overall Study|Other|0|||
124841402|NCT00838565|449048357|FG000|Overall Study|Randomized but not Treated|0|||
124841403|NCT00838565|449048358|FG001|Overall Study|Randomized but not Treated|1|||
124841404|NCT00838565|449048359|FG002|Overall Study|Randomized but not Treated|0|||
124841405|NCT00838565|449048360|FG003|Overall Study|Randomized but not Treated|0|||
124841406|NCT00838565|449048361|FG004|Overall Study|Randomized but not Treated|0|||
124841407|NCT00838565|449048362|FG005|Overall Study|Randomized but not Treated|0|||
124841408|NCT03571516|449048363|FG000|Overall Study|Severe diarrhea|1|||
124841409|NCT03571516|449048364|FG001|Overall Study|Severe diarrhea|0|||
124841410|NCT03571516|449048363|FG000|Overall Study|Withdrawal by Subject|0|||
124841411|NCT03571516|449048364|FG001|Overall Study|Withdrawal by Subject|1|||
124841412|NCT04011410|449048366|FG000|Overall Study|Withdrawal by Subject|1|||
124841413|NCT01838642|449048368|FG000|Overall Study|Died on study|1|||
124841414|NCT01557400|449048369|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
124841415|NCT01557400|449048369|FG000|Overall Study|Adverse Event|3|||
124841416|NCT01557400|449048369|FG000|Overall Study|Lost to Follow-up|5|||
124841417|NCT01557400|449048369|FG000|Overall Study|Withdrawal by Subject|9|||
124841418|NCT01434290|449048370|FG000|Overall Study|Protocol Violation|6|||
124841419|NCT01434290|449048371|FG001|Overall Study|Protocol Violation|3|||
124841420|NCT01434290|449048370|FG000|Overall Study|No protocol treatment|2|||
124841421|NCT01434290|449048371|FG001|Overall Study|No protocol treatment|4|||
124841422|NCT01224639|449048372|FG000|Overall Study|Withdrawal by Subject|0|||
124841423|NCT01224639|449048373|FG001|Overall Study|Withdrawal by Subject|0|||
124841424|NCT01224639|449048374|FG002|Overall Study|Withdrawal by Subject|0|||
124841425|NCT01224639|449048375|FG003|Overall Study|Withdrawal by Subject|0|||
124841426|NCT01224639|449048376|FG004|Overall Study|Withdrawal by Subject|2|||
124841427|NCT01224639|449048377|FG005|Overall Study|Withdrawal by Subject|0|||
124841428|NCT01224639|449048378|FG006|Overall Study|Withdrawal by Subject|1|||
124841429|NCT01224639|449048379|FG007|Overall Study|Withdrawal by Subject|1|||
124841430|NCT01224639|449048372|FG000|Overall Study|Adverse Event|0|||
124841431|NCT01224639|449048373|FG001|Overall Study|Adverse Event|0|||
124841432|NCT01224639|449048374|FG002|Overall Study|Adverse Event|0|||
124841433|NCT01224639|449048375|FG003|Overall Study|Adverse Event|0|||
124841434|NCT01224639|449048376|FG004|Overall Study|Adverse Event|0|||
124841435|NCT01224639|449048377|FG005|Overall Study|Adverse Event|0|||
124841436|NCT01224639|449048378|FG006|Overall Study|Adverse Event|0|||
124841437|NCT01224639|449048379|FG007|Overall Study|Adverse Event|1|||
124841438|NCT03465878|449048380|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
124841439|NCT03465878|449048381|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
124841440|NCT03465878|449048382|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
124841441|NCT03465878|449048383|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
124841442|NCT03465878|449048380|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
124841443|NCT03465878|449048381|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
124841444|NCT03465878|449048382|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
124841445|NCT03465878|449048383|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
124841446|NCT03465878|449048380|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
124841447|NCT03465878|449048381|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
124841448|NCT03465878|449048382|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
124841449|NCT03465878|449048383|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
124841450|NCT04656132|449048384|FG000|Overall Study|Lost to Follow-up|4|||
124841451|NCT04656132|449048384|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
124841452|NCT00677807|449048385|FG000|Overall Study|Adverse Event|4|||
124841453|NCT00677807|449048386|FG001|Overall Study|Adverse Event|1|||
124841454|NCT00677807|449048387|FG002|Overall Study|Adverse Event|6|||
124841455|NCT00677807|449048385|FG000|Overall Study|Lack of Efficacy|0|||
124841456|NCT00677807|449048386|FG001|Overall Study|Lack of Efficacy|0|||
124841457|NCT00677807|449048387|FG002|Overall Study|Lack of Efficacy|2|||
124841458|NCT00677807|449048385|FG000|Overall Study|Participant no longer needs study drug|0|||
125305477|NCT00483938|450745134|FG002|Overall Study|Other|0|||
125305478|NCT00483938|450745135|FG003|Overall Study|Other|4|||
125305479|NCT00483938|450745136|FG004|Overall Study|Other|0|||
124841459|NCT00677807|449048386|FG001|Overall Study|Participant no longer needs study drug|0|||
124841460|NCT00677807|449048387|FG002|Overall Study|Participant no longer needs study drug|1|||
124841461|NCT00677807|449048385|FG000|Overall Study|Withdrawal by Subject|10|||
124841462|NCT00677807|449048386|FG001|Overall Study|Withdrawal by Subject|3|||
125305480|NCT00483938|450745137|FG005|Overall Study|Other|4|||
124841463|NCT00677807|449048387|FG002|Overall Study|Withdrawal by Subject|6|||
124841464|NCT00677807|449048385|FG000|Overall Study|Lost to Follow-up|2|||
124841465|NCT00677807|449048386|FG001|Overall Study|Lost to Follow-up|2|||
124841466|NCT00677807|449048387|FG002|Overall Study|Lost to Follow-up|2|||
124841467|NCT00677807|449048385|FG000|Overall Study|Administrative problems|1|||
124841468|NCT00677807|449048386|FG001|Overall Study|Administrative problems|1|||
124841469|NCT00677807|449048387|FG002|Overall Study|Administrative problems|2|||
124841470|NCT00677807|449048385|FG000|Overall Study|Death|0|||
124841471|NCT00677807|449048386|FG001|Overall Study|Death|1|||
124841472|NCT00677807|449048387|FG002|Overall Study|Death|1|||
124841473|NCT00677807|449048385|FG000|Overall Study|Protocol Deviation|1|||
124841474|NCT00677807|449048386|FG001|Overall Study|Protocol Deviation|3|||
124841475|NCT00677807|449048387|FG002|Overall Study|Protocol Deviation|0|||
124841476|NCT04019041|449048388|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
124841477|NCT04019041|449048389|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
124841478|NCT04019041|449048390|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
124841479|NCT04019041|449048391|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
124841480|NCT04019041|449048392|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
124841481|NCT04019041|449048393|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
124841482|NCT04019041|449048388|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
124841483|NCT04019041|449048389|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
124841484|NCT04019041|449048390|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
124841485|NCT04019041|449048391|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
124841486|NCT04019041|449048392|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
124841487|NCT04019041|449048393|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
124841488|NCT04019041|449048388|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
124841489|NCT04019041|449048389|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
124841490|NCT04019041|449048390|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
124841491|NCT04019041|449048391|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
124841492|NCT04019041|449048392|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
124841493|NCT04019041|449048393|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
124841494|NCT04019041|449048388|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
124841495|NCT04019041|449048389|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
124841496|NCT04019041|449048390|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
124841497|NCT04019041|449048391|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
124841498|NCT04019041|449048392|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
124841499|NCT04019041|449048393|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
124841500|NCT04019041|449048388|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
124841501|NCT04019041|449048389|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
124841502|NCT04019041|449048390|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
124841503|NCT04019041|449048391|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
124841504|NCT04019041|449048392|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
124841505|NCT04019041|449048393|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
124841506|NCT04019041|449048388|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
124841507|NCT04019041|449048389|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
124841508|NCT04019041|449048390|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
124841509|NCT04019041|449048391|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
124841510|NCT04019041|449048392|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
124841511|NCT04019041|449048393|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
124841512|NCT04019041|449048388|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
124841513|NCT04019041|449048389|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
124841514|NCT04019041|449048390|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
124841515|NCT04019041|449048391|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
124841516|NCT04019041|449048392|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
124841517|NCT04019041|449048393|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
124841518|NCT04019041|449048388|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
124841519|NCT04019041|449048389|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
124841520|NCT04019041|449048390|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
124841521|NCT04019041|449048391|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
124841522|NCT04019041|449048392|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
124841523|NCT04019041|449048393|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
124841524|NCT04019041|449048388|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
124841525|NCT04019041|449048389|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
124841526|NCT04019041|449048390|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
124841527|NCT04019041|449048391|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
124841528|NCT04019041|449048392|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
124841529|NCT04019041|449048393|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
124841530|NCT00314366|449048394|FG000|Overall Study|not treated due to patient medical condi|1|||
124841531|NCT00314366|449048395|FG001|Overall Study|not treated due to patient medical condi|0|||
124841532|NCT01806896|449048397|FG000|Overall Study|Adverse Event|2|||
124841533|NCT01806896|449048398|FG001|Overall Study|Adverse Event|0|||
124841534|NCT01806896|449048397|FG000|Overall Study|Other|1|||
124841535|NCT01806896|449048398|FG001|Overall Study|Other|0|||
124841536|NCT01083433|449050029|FG000|Overall Study|Lost to Follow-up|2|||
124841537|NCT01083433|449050030|FG001|Overall Study|Lost to Follow-up|1|||
124841538|NCT01083433|449050031|FG002|Overall Study|Lost to Follow-up|1|||
124841539|NCT01083433|449050029|FG000|Overall Study|Withdrawal by Subject|0|||
124841540|NCT01083433|449050030|FG001|Overall Study|Withdrawal by Subject|5|||
124841541|NCT01083433|449050031|FG002|Overall Study|Withdrawal by Subject|3|||
124841542|NCT01083433|449050029|FG000|Overall Study|Pregnancy|0|||
124841543|NCT01083433|449050030|FG001|Overall Study|Pregnancy|0|||
124841544|NCT01083433|449050031|FG002|Overall Study|Pregnancy|1|||
124841545|NCT01581593|449050032|FG000|Overall Study|Withdrawal by Subject|1|||
124841546|NCT04982029|449050033|FG000|Overall Study|Lost to Follow-up|2|||
124841547|NCT04982029|449050034|FG001|Overall Study|Lost to Follow-up|3|||
124841548|NCT05308901|449050035|FG000|Overall Study|Death|6|||
124841549|NCT01896895|449050036|FG000|Double-blind MP|Physician Decision|0|||
124841550|NCT01896895|449050037|FG001|Double-blind MP|Physician Decision|0|||
124841551|NCT01896895|449050038|FG002|Double-blind MP|Physician Decision|1|||
124841552|NCT01896895|449050039|FG003|Double-blind MP|Physician Decision|0|||
124841553|NCT01896895|449050036|FG000|Double-blind MP|Withdrawal by Subject|0|||
124841554|NCT01896895|449050037|FG001|Double-blind MP|Withdrawal by Subject|2|||
124841555|NCT01896895|449050038|FG002|Double-blind MP|Withdrawal by Subject|1|||
124841556|NCT01896895|449050039|FG003|Double-blind MP|Withdrawal by Subject|0|||
124841557|NCT01896895|449050036|FG000|Double-blind MP|Lost to Follow-up|1|||
124841558|NCT01896895|449050037|FG001|Double-blind MP|Lost to Follow-up|0|||
124841559|NCT01896895|449050038|FG002|Double-blind MP|Lost to Follow-up|1|||
124841560|NCT01896895|449050039|FG003|Double-blind MP|Lost to Follow-up|0|||
124841561|NCT04127786|449050040|FG000|Primary Series|Adverse Event|1|||
124841562|NCT04127786|449050041|FG001|Primary Series|Adverse Event|0|||
124841563|NCT04127786|449050042|FG002|Primary Series|Adverse Event|0|||
124841564|NCT04127786|449050043|FG003|Primary Series|Adverse Event|1|||
124841565|NCT04127786|449050044|FG004|Primary Series|Adverse Event|0|||
124841566|NCT04127786|449050045|FG005|Primary Series|Adverse Event|1|||
124841567|NCT04127786|449050040|FG000|Primary Series|Protocol Violation|5|||
124841568|NCT04127786|449050041|FG001|Primary Series|Protocol Violation|3|||
124841569|NCT04127786|449050042|FG002|Primary Series|Protocol Violation|4|||
124841570|NCT04127786|449050043|FG003|Primary Series|Protocol Violation|3|||
124841571|NCT04127786|449050044|FG004|Primary Series|Protocol Violation|2|||
124841572|NCT04127786|449050045|FG005|Primary Series|Protocol Violation|0|||
124841573|NCT04127786|449050040|FG000|Primary Series|Withdrawal by Subject|0|||
124841574|NCT04127786|449050041|FG001|Primary Series|Withdrawal by Subject|0|||
124841575|NCT04127786|449050042|FG002|Primary Series|Withdrawal by Subject|0|||
124841576|NCT04127786|449050043|FG003|Primary Series|Withdrawal by Subject|1|||
124841577|NCT04127786|449050044|FG004|Primary Series|Withdrawal by Subject|0|||
124841578|NCT04127786|449050045|FG005|Primary Series|Withdrawal by Subject|0|||
124841579|NCT04127786|449050040|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
124841580|NCT04127786|449050041|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
124841581|NCT04127786|449050042|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
124841582|NCT04127786|449050043|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
124841583|NCT04127786|449050044|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
124841584|NCT04127786|449050045|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
124841585|NCT04127786|449050040|FG000|Booster Phase|Withdrawal by Subject|2|||
124841586|NCT04127786|449050041|FG001|Booster Phase|Withdrawal by Subject|0|||
124841587|NCT04127786|449050042|FG002|Booster Phase|Withdrawal by Subject|0|||
124841588|NCT04127786|449050043|FG003|Booster Phase|Withdrawal by Subject|0|||
124841589|NCT04127786|449050044|FG004|Booster Phase|Withdrawal by Subject|0|||
124841590|NCT04127786|449050045|FG005|Booster Phase|Withdrawal by Subject|0|||
124841591|NCT01904604|449050046|FG000|Overall Study|Withdrew before receiving dosing|0|||
124841592|NCT01904604|449050047|FG001|Overall Study|Withdrew before receiving dosing|1|||
124841593|NCT01904604|449050048|FG002|Overall Study|Withdrew before receiving dosing|0|||
124841594|NCT01904604|449050046|FG000|Overall Study|Non-compliance|1|||
124841595|NCT01904604|449050047|FG001|Overall Study|Non-compliance|0|||
124841596|NCT01904604|449050048|FG002|Overall Study|Non-compliance|0|||
124841597|NCT01904604|449050046|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
124841598|NCT01904604|449050047|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
124841599|NCT01904604|449050048|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
124841600|NCT01904604|449050046|FG000|Overall Study|Patch site reactions|1|||
124841601|NCT01904604|449050047|FG001|Overall Study|Patch site reactions|1|||
124841602|NCT01904604|449050048|FG002|Overall Study|Patch site reactions|0|||
124841603|NCT01904604|449050046|FG000|Overall Study|Increased syncope|0|||
124841604|NCT01904604|449050047|FG001|Overall Study|Increased syncope|1|||
124841605|NCT01904604|449050048|FG002|Overall Study|Increased syncope|0|||
124841606|NCT01904604|449050046|FG000|Overall Study|Unrelated illness|0|||
124841607|NCT01904604|449050047|FG001|Overall Study|Unrelated illness|1|||
124841608|NCT01904604|449050048|FG002|Overall Study|Unrelated illness|0|||
124841609|NCT01904604|449050046|FG000|Overall Study|Passed Week 52 OFC|1|||
124841610|NCT01904604|449050047|FG001|Overall Study|Passed Week 52 OFC|0|||
124841611|NCT01904604|449050048|FG002|Overall Study|Passed Week 52 OFC|0|||
124841612|NCT01904604|449050046|FG000|Overall Study|Withdrawal by Subject|1|||
124841613|NCT01904604|449050047|FG001|Overall Study|Withdrawal by Subject|2|||
124841614|NCT01904604|449050048|FG002|Overall Study|Withdrawal by Subject|0|||
124841615|NCT01904604|449050046|FG000|Overall Study|Participant Relocated|1|||
124841616|NCT01904604|449050047|FG001|Overall Study|Participant Relocated|1|||
124841617|NCT01904604|449050048|FG002|Overall Study|Participant Relocated|1|||
124841618|NCT01904604|449050046|FG000|Overall Study|Lost to Follow-up|0|||
124841619|NCT01904604|449050047|FG001|Overall Study|Lost to Follow-up|0|||
124841620|NCT01904604|449050048|FG002|Overall Study|Lost to Follow-up|1|||
124841621|NCT00358527|449050055|FG000|Overall Study|Adverse Event|4|||
124841622|NCT00358527|449050056|FG001|Overall Study|Adverse Event|0|||
124841623|NCT00358527|449050055|FG000|Overall Study|Withdrawal by Subject|1|||
124841624|NCT00358527|449050056|FG001|Overall Study|Withdrawal by Subject|1|||
124841625|NCT00358527|449050055|FG000|Overall Study|Non-compliance with protocol|6|||
124841626|NCT00358527|449050056|FG001|Overall Study|Non-compliance with protocol|1|||
124841627|NCT00358527|449050055|FG000|Overall Study|Administrative|2|||
124841628|NCT00358527|449050056|FG001|Overall Study|Administrative|1|||
124841629|NCT04144166|449050057|FG000|Overall Study|Discharged before study start|1|||
124841630|NCT04144166|449050057|FG000|Overall Study|Pregnancy|1|||
124841631|NCT04144166|449050057|FG000|Overall Study|Nail polish could not be removed from finger|1|||
124841632|NCT00145509|449050058|FG000|Overall Study|Adverse Event|10|||
124841633|NCT00145509|449050059|FG001|Overall Study|Adverse Event|3|||
124841634|NCT00145509|449050058|FG000|Overall Study|Lack of Efficacy|3|||
124841635|NCT00145509|449050059|FG001|Overall Study|Lack of Efficacy|1|||
124841636|NCT00145509|449050058|FG000|Overall Study|Lost to Follow-up|5|||
124841637|NCT00145509|449050059|FG001|Overall Study|Lost to Follow-up|9|||
124841638|NCT00145509|449050058|FG000|Overall Study|Withdrew Consent|2|||
124841639|NCT00145509|449050059|FG001|Overall Study|Withdrew Consent|7|||
124841640|NCT00145509|449050058|FG000|Overall Study|Reason not provided|2|||
124841641|NCT00145509|449050059|FG001|Overall Study|Reason not provided|1|||
124841642|NCT04145895|449050062|FG000|Overall Study|Physician Decision|2|||
124841643|NCT04145895|449050063|FG001|Overall Study|Physician Decision|0|||
124841644|NCT04145895|449050062|FG000|Overall Study|Withdrawal by Subject|0|||
124841645|NCT04145895|449050063|FG001|Overall Study|Withdrawal by Subject|2|||
124841646|NCT01481116|449050064|FG000|Overall Study|Adverse Event|26|||
124841647|NCT01481116|449050065|FG001|Overall Study|Adverse Event|26|||
124841648|NCT01481116|449050066|FG002|Overall Study|Adverse Event|42|||
124841649|NCT01481116|449050064|FG000|Overall Study|Major Protocol Deviation|3|||
124841650|NCT01481116|449050065|FG001|Overall Study|Major Protocol Deviation|7|||
124841651|NCT01481116|449050066|FG002|Overall Study|Major Protocol Deviation|1|||
124841652|NCT01481116|449050064|FG000|Overall Study|Lost to Follow-up|8|||
124841653|NCT01481116|449050065|FG001|Overall Study|Lost to Follow-up|12|||
124841654|NCT01481116|449050066|FG002|Overall Study|Lost to Follow-up|11|||
124841655|NCT01481116|449050064|FG000|Overall Study|Withdrawal by Subject|37|||
124841656|NCT01481116|449050065|FG001|Overall Study|Withdrawal by Subject|33|||
124841657|NCT01481116|449050066|FG002|Overall Study|Withdrawal by Subject|37|||
124841658|NCT01481116|449050064|FG000|Overall Study|Study Termination|730|||
124841659|NCT01481116|449050065|FG001|Overall Study|Study Termination|729|||
124841660|NCT01481116|449050066|FG002|Overall Study|Study Termination|713|||
124841661|NCT01481116|449050064|FG000|Overall Study|Pregnancy|0|||
124841662|NCT01481116|449050065|FG001|Overall Study|Pregnancy|0|||
124841663|NCT01481116|449050066|FG002|Overall Study|Pregnancy|1|||
124841664|NCT01481116|449050064|FG000|Overall Study|Lack of Efficacy|3|||
124841665|NCT01481116|449050065|FG001|Overall Study|Lack of Efficacy|3|||
124841666|NCT01481116|449050066|FG002|Overall Study|Lack of Efficacy|1|||
124841667|NCT01481116|449050064|FG000|Overall Study|Contraindications|1|||
124841668|NCT01481116|449050065|FG001|Overall Study|Contraindications|1|||
125305481|NCT00483938|450745138|FG006|Overall Study|Other|32|||
125305482|NCT02218008|450745139|FG000|Stage 1 (S1)|Adverse Event|6|||
125305483|NCT02218008|450745140|FG001|Stage 1 (S1)|Adverse Event|5|||
124841669|NCT01481116|449050066|FG002|Overall Study|Contraindications|0|||
124841670|NCT01481116|449050064|FG000|Overall Study|Other|1|||
124841671|NCT01481116|449050065|FG001|Overall Study|Other|1|||
124841672|NCT01481116|449050066|FG002|Overall Study|Other|0|||
124841673|NCT01481116|449050064|FG000|Overall Study|Participant Started Taking Glipizide|1|||
124841674|NCT01481116|449050065|FG001|Overall Study|Participant Started Taking Glipizide|0|||
124841675|NCT01481116|449050066|FG002|Overall Study|Participant Started Taking Glipizide|0|||
124841676|NCT01481116|449050064|FG000|Overall Study|Participant Moved Out of Area|2|||
124841677|NCT01481116|449050065|FG001|Overall Study|Participant Moved Out of Area|0|||
125305484|NCT02218008|450745141|FG002|Stage 1 (S1)|Adverse Event|11|||
125305485|NCT02218008|450745142|FG003|Stage 1 (S1)|Adverse Event|0|||
124841678|NCT01481116|449050066|FG002|Overall Study|Participant Moved Out of Area|1|||
125305486|NCT02218008|450745143|FG004|Stage 1 (S1)|Adverse Event|0|||
125305487|NCT02218008|450745144|FG005|Stage 1 (S1)|Adverse Event|0|||
124841679|NCT01481116|449050064|FG000|Overall Study|Participant Moved Out of Country|1|||
124841680|NCT01481116|449050065|FG001|Overall Study|Participant Moved Out of Country|0|||
124841681|NCT01481116|449050066|FG002|Overall Study|Participant Moved Out of Country|1|||
124841682|NCT01481116|449050064|FG000|Overall Study|Investigator Decision|3|||
124841683|NCT01481116|449050065|FG001|Overall Study|Investigator Decision|2|||
124841684|NCT01481116|449050066|FG002|Overall Study|Investigator Decision|1|||
124841685|NCT01481116|449050064|FG000|Overall Study|Sponsor Decision|0|||
124841686|NCT01481116|449050065|FG001|Overall Study|Sponsor Decision|1|||
124841687|NCT01481116|449050066|FG002|Overall Study|Sponsor Decision|3|||
124841688|NCT01481116|449050064|FG000|Overall Study|Non-Compliant With Study Drug|0|||
124841689|NCT01481116|449050065|FG001|Overall Study|Non-Compliant With Study Drug|1|||
124841690|NCT01481116|449050066|FG002|Overall Study|Non-Compliant With Study Drug|1|||
124841691|NCT01481116|449050064|FG000|Overall Study|Investigator's Discretion|2|||
124841692|NCT01481116|449050065|FG001|Overall Study|Investigator's Discretion|0|||
124841693|NCT01481116|449050066|FG002|Overall Study|Investigator's Discretion|0|||
124841694|NCT01481116|449050064|FG000|Overall Study|Death|2|||
124841695|NCT01481116|449050065|FG001|Overall Study|Death|1|||
124841696|NCT01481116|449050066|FG002|Overall Study|Death|0|||
124841697|NCT01481116|449050064|FG000|Overall Study|Hypoglycemic Event|4|||
124841698|NCT01481116|449050065|FG001|Overall Study|Hypoglycemic Event|0|||
124841699|NCT01481116|449050066|FG002|Overall Study|Hypoglycemic Event|0|||
124841700|NCT04904185|449050067|FG000|Overall Study|Expansion failure|1|||
124841701|NCT04904185|449050068|FG001|Overall Study|Expansion failure|0|||
124841702|NCT04904185|449050067|FG000|Overall Study|Late response on prior treatment|1|||
124841703|NCT04904185|449050068|FG001|Overall Study|Late response on prior treatment|0|||
124841704|NCT02789176|449050069|FG000|Overall Study|Death|0|||
124841705|NCT02789176|449050070|FG001|Overall Study|Death|0|||
124841706|NCT02789176|449050071|FG002|Overall Study|Death|3|||
124841707|NCT02789176|449050072|FG003|Overall Study|Death|0|||
124841708|NCT02789176|449050069|FG000|Overall Study|Withdrawal by Subject|0|||
124841709|NCT02789176|449050070|FG001|Overall Study|Withdrawal by Subject|0|||
124841710|NCT02789176|449050071|FG002|Overall Study|Withdrawal by Subject|1|||
124841711|NCT02789176|449050072|FG003|Overall Study|Withdrawal by Subject|0|||
124841712|NCT02789176|449050069|FG000|Overall Study|Lost to Follow-up|8|||
124841713|NCT02789176|449050070|FG001|Overall Study|Lost to Follow-up|2|||
124841714|NCT02789176|449050071|FG002|Overall Study|Lost to Follow-up|6|||
124841715|NCT02789176|449050072|FG003|Overall Study|Lost to Follow-up|1|||
124841716|NCT02433834|449050073|FG000|Overall Study|Protocol-specified criteria|7|||
124841717|NCT02433834|449050073|FG000|Overall Study|Protocol Violation|3|||
124841718|NCT02433834|449050073|FG000|Overall Study|Lost to Follow-up|6|||
124841719|NCT02433834|449050073|FG000|Overall Study|Withdrawal by Subject|14|||
124841720|NCT02433834|449050073|FG000|Overall Study|Adverse Event|6|||
124841721|NCT02433834|449050073|FG000|Overall Study|Physician Decision|1|||
124841722|NCT00596011|449050074|FG000|Overall Study|Withdrawal by Subject|2|||
124841723|NCT00596011|449050075|FG001|Overall Study|Withdrawal by Subject|3|||
124841724|NCT00596011|449050074|FG000|Overall Study|Adverse Event|11|||
124841725|NCT00596011|449050075|FG001|Overall Study|Adverse Event|7|||
124841726|NCT02821962|449050076|FG000|Overall Study|Lost to Follow-up|2|||
124841727|NCT02821962|449050077|FG001|Overall Study|Lost to Follow-up|0|||
124841728|NCT01956110|449050080|FG000|Overall Study|Protocol Violation|25|||
124841729|NCT01956110|449050081|FG001|Overall Study|Protocol Violation|11|||
124841730|NCT01956110|449050080|FG000|Overall Study|Adverse Event|9|||
124841731|NCT01956110|449050081|FG001|Overall Study|Adverse Event|10|||
124841732|NCT01956110|449050080|FG000|Overall Study|Personal reasons|1|||
124841733|NCT01956110|449050081|FG001|Overall Study|Personal reasons|1|||
124841734|NCT00910715|449050090|FG000|Overall Study|Lost to Follow-up|22|||
124841735|NCT00910715|449050091|FG001|Overall Study|Lost to Follow-up|26|||
124841736|NCT00910715|449050092|FG002|Overall Study|Lost to Follow-up|0|||
124841737|NCT05923229|449050093|FG000|Overall Study|Withdrawal by Subject|3|||
124841738|NCT05923229|449050094|FG001|Overall Study|Withdrawal by Subject|0|||
124841739|NCT05923229|449050093|FG000|Overall Study|Health related|2|||
124841740|NCT05923229|449050094|FG001|Overall Study|Health related|1|||
124841741|NCT05288556|449050095|FG000|Overall Study|Protocol Violation|1|||
124841742|NCT05288556|449050095|FG000|Overall Study|Withdrawal by Subject|1|||
124841743|NCT03400332|449050098|FG000|Pre-Treatment|Other reasons|0|||
124841744|NCT03400332|449050099|FG001|Pre-Treatment|Other reasons|0|||
124841745|NCT03400332|449050100|FG002|Pre-Treatment|Other reasons|0|||
124841746|NCT03400332|449050101|FG003|Pre-Treatment|Other reasons|0|||
125305488|NCT02218008|450745139|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
124841747|NCT03400332|449050102|FG004|Pre-Treatment|Other reasons|0|||
124841748|NCT03400332|449050103|FG005|Pre-Treatment|Other reasons|0|||
124841749|NCT03400332|449050104|FG006|Pre-Treatment|Other reasons|0|||
124841750|NCT03400332|449050105|FG007|Pre-Treatment|Other reasons|0|||
124841751|NCT03400332|449050106|FG008|Pre-Treatment|Other reasons|1|||
124841752|NCT03400332|449050098|FG000|Pre-Treatment|No longer met study criteria|0|||
124841753|NCT03400332|449050099|FG001|Pre-Treatment|No longer met study criteria|0|||
124841754|NCT03400332|449050100|FG002|Pre-Treatment|No longer met study criteria|0|||
124841755|NCT03400332|449050101|FG003|Pre-Treatment|No longer met study criteria|0|||
124841756|NCT03400332|449050102|FG004|Pre-Treatment|No longer met study criteria|0|||
124841757|NCT03400332|449050103|FG005|Pre-Treatment|No longer met study criteria|0|||
124841758|NCT03400332|449050104|FG006|Pre-Treatment|No longer met study criteria|0|||
124841759|NCT03400332|449050105|FG007|Pre-Treatment|No longer met study criteria|0|||
124841760|NCT03400332|449050106|FG008|Pre-Treatment|No longer met study criteria|1|||
124841761|NCT03400332|449050098|FG000|Pre-Treatment|Withdrawal by Subject|0|||
124841762|NCT03400332|449050099|FG001|Pre-Treatment|Withdrawal by Subject|0|||
124841763|NCT03400332|449050100|FG002|Pre-Treatment|Withdrawal by Subject|0|||
124841764|NCT03400332|449050101|FG003|Pre-Treatment|Withdrawal by Subject|0|||
124841765|NCT03400332|449050102|FG004|Pre-Treatment|Withdrawal by Subject|0|||
124841766|NCT03400332|449050103|FG005|Pre-Treatment|Withdrawal by Subject|0|||
124841767|NCT03400332|449050104|FG006|Pre-Treatment|Withdrawal by Subject|0|||
124841768|NCT03400332|449050105|FG007|Pre-Treatment|Withdrawal by Subject|0|||
124841769|NCT03400332|449050106|FG008|Pre-Treatment|Withdrawal by Subject|1|||
124841770|NCT03400332|449050098|FG000|Treatment|Participant withdrew consent|2|||
124841771|NCT03400332|449050099|FG001|Treatment|Participant withdrew consent|2|||
124841772|NCT03400332|449050100|FG002|Treatment|Participant withdrew consent|0|||
124841773|NCT03400332|449050101|FG003|Treatment|Participant withdrew consent|0|||
124841774|NCT03400332|449050102|FG004|Treatment|Participant withdrew consent|3|||
124841775|NCT03400332|449050103|FG005|Treatment|Participant withdrew consent|3|||
124841776|NCT03400332|449050104|FG006|Treatment|Participant withdrew consent|1|||
124841777|NCT03400332|449050105|FG007|Treatment|Participant withdrew consent|1|||
124841778|NCT03400332|449050106|FG008|Treatment|Participant withdrew consent|1|||
124841779|NCT03400332|449050098|FG000|Treatment|Other reasons|0|||
124841780|NCT03400332|449050099|FG001|Treatment|Other reasons|1|||
124841781|NCT03400332|449050100|FG002|Treatment|Other reasons|1|||
124841782|NCT03400332|449050101|FG003|Treatment|Other reasons|0|||
124841783|NCT03400332|449050102|FG004|Treatment|Other reasons|3|||
124841784|NCT03400332|449050103|FG005|Treatment|Other reasons|1|||
124841785|NCT03400332|449050104|FG006|Treatment|Other reasons|2|||
124841786|NCT03400332|449050105|FG007|Treatment|Other reasons|0|||
124841787|NCT03400332|449050106|FG008|Treatment|Other reasons|1|||
124841788|NCT03400332|449050098|FG000|Treatment|Lost to Follow-up|0|||
124841789|NCT03400332|449050099|FG001|Treatment|Lost to Follow-up|1|||
124841790|NCT03400332|449050100|FG002|Treatment|Lost to Follow-up|0|||
124841791|NCT03400332|449050101|FG003|Treatment|Lost to Follow-up|0|||
124841792|NCT03400332|449050102|FG004|Treatment|Lost to Follow-up|0|||
124841793|NCT03400332|449050103|FG005|Treatment|Lost to Follow-up|0|||
124841794|NCT03400332|449050104|FG006|Treatment|Lost to Follow-up|0|||
124841795|NCT03400332|449050105|FG007|Treatment|Lost to Follow-up|0|||
124841796|NCT03400332|449050106|FG008|Treatment|Lost to Follow-up|0|||
124841797|NCT03400332|449050098|FG000|Treatment|Death|3|||
124841798|NCT03400332|449050099|FG001|Treatment|Death|1|||
124841799|NCT03400332|449050100|FG002|Treatment|Death|2|||
124841800|NCT03400332|449050101|FG003|Treatment|Death|3|||
124841801|NCT03400332|449050102|FG004|Treatment|Death|6|||
124841802|NCT03400332|449050103|FG005|Treatment|Death|2|||
124841803|NCT03400332|449050104|FG006|Treatment|Death|1|||
124841804|NCT03400332|449050105|FG007|Treatment|Death|3|||
124841805|NCT03400332|449050106|FG008|Treatment|Death|6|||
124841806|NCT04476017|449050109|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
124841807|NCT04476017|449050110|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
124841808|NCT02704364|449050111|FG000|Overall Study|Adverse Event|1|||
124841809|NCT02704364|449050112|FG001|Overall Study|Adverse Event|1|||
124841810|NCT02704364|449050113|FG002|Overall Study|Adverse Event|0|||
124841811|NCT02704364|449050111|FG000|Overall Study|Noncompliance with study drug|1|||
124841812|NCT02704364|449050112|FG001|Overall Study|Noncompliance with study drug|1|||
124841813|NCT02704364|449050113|FG002|Overall Study|Noncompliance with study drug|0|||
124841814|NCT02704364|449050111|FG000|Overall Study|Other|0|||
124841815|NCT02704364|449050112|FG001|Overall Study|Other|1|||
124841816|NCT02704364|449050113|FG002|Overall Study|Other|1|||
124841817|NCT04627064|449050117|FG000|Overall Study|Progressive disease|8|||
124841818|NCT04627064|449050118|FG001|Overall Study|Progressive disease|0|||
124841819|NCT04627064|449050117|FG000|Overall Study|Withdrawal by Subject|2|||
124841820|NCT04627064|449050118|FG001|Overall Study|Withdrawal by Subject|0|||
124841821|NCT04627064|449050117|FG000|Overall Study|Physician Decision|1|||
124841822|NCT04627064|449050118|FG001|Overall Study|Physician Decision|0|||
124841823|NCT04033159|449050121|FG000|Washout Period|Physician Decision|0|||
124841824|NCT04033159|449050122|FG001|Washout Period|Physician Decision|1|||
124841825|NCT04033159|449050123|FG002|Washout Period|Physician Decision|0|||
124841826|NCT04033159|449050121|FG000|Washout Period|Study terminated by Sponsor|0|||
124841827|NCT04033159|449050122|FG001|Washout Period|Study terminated by Sponsor|7|||
124841828|NCT04033159|449050123|FG002|Washout Period|Study terminated by Sponsor|0|||
124841829|NCT04033159|449050121|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
124841830|NCT04033159|449050122|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
124841831|NCT04033159|449050123|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
124841832|NCT00006489|449050126|FG000|Overall Study|Adverse Event|3|||
124841833|NCT00006489|449050127|FG001|Overall Study|Adverse Event|2|||
124841834|NCT00006489|449050128|FG002|Overall Study|Adverse Event|4|||
124841835|NCT00006489|449050129|FG003|Overall Study|Adverse Event|3|||
124841836|NCT00006489|449050126|FG000|Overall Study|Withdrawal by Subject|10|||
124841837|NCT00006489|449050127|FG001|Overall Study|Withdrawal by Subject|9|||
124841838|NCT00006489|449050128|FG002|Overall Study|Withdrawal by Subject|9|||
124841839|NCT00006489|449050129|FG003|Overall Study|Withdrawal by Subject|6|||
124841840|NCT00006489|449050126|FG000|Overall Study|Scheduling Conflict|0|||
124841841|NCT00006489|449050127|FG001|Overall Study|Scheduling Conflict|3|||
124841842|NCT00006489|449050128|FG002|Overall Study|Scheduling Conflict|2|||
124841843|NCT00006489|449050129|FG003|Overall Study|Scheduling Conflict|1|||
124841844|NCT00006489|449050126|FG000|Overall Study|Death|0|||
124841845|NCT00006489|449050127|FG001|Overall Study|Death|0|||
124841846|NCT00006489|449050128|FG002|Overall Study|Death|0|||
124841847|NCT00006489|449050129|FG003|Overall Study|Death|1|||
124841848|NCT03491150|449050135|FG000|Overall Study|Adverse Event|1|||
124841849|NCT03491150|449050136|FG001|Overall Study|Adverse Event|0|||
124841850|NCT03491150|449050135|FG000|Overall Study|Study Terminated by Sponsor|74|||
124841851|NCT03491150|449050136|FG001|Overall Study|Study Terminated by Sponsor|70|||
124841852|NCT03491150|449050135|FG000|Overall Study|Other|0|||
124841853|NCT03491150|449050136|FG001|Overall Study|Other|1|||
124841854|NCT03491150|449050135|FG000|Overall Study|Withdrawal by Subject|1|||
124841855|NCT03491150|449050136|FG001|Overall Study|Withdrawal by Subject|2|||
124841856|NCT02287896|449050148|FG000|Second Injection Visit|Withdrawal by Subject|0|||
124841857|NCT02287896|449050149|FG001|Second Injection Visit|Withdrawal by Subject|1|||
124841858|NCT00559962|449050150|FG000|Overall Study|Adverse Event|1|||
124841859|NCT00559962|449050151|FG001|Overall Study|Adverse Event|7|||
124841860|NCT00559962|449050152|FG002|Overall Study|Adverse Event|8|||
124841861|NCT00559962|449050153|FG003|Overall Study|Adverse Event|5|||
124841862|NCT00559962|449050154|FG004|Overall Study|Adverse Event|11|||
124841863|NCT00559962|449050155|FG005|Overall Study|Adverse Event|4|||
124841864|NCT00559962|449050156|FG006|Overall Study|Adverse Event|4|||
124841865|NCT00559962|449050157|FG007|Overall Study|Adverse Event|2|||
124841866|NCT00559962|449050150|FG000|Overall Study|Lost to Follow-up|0|||
124841867|NCT00559962|449050151|FG001|Overall Study|Lost to Follow-up|1|||
124841868|NCT00559962|449050152|FG002|Overall Study|Lost to Follow-up|0|||
124841869|NCT00559962|449050153|FG003|Overall Study|Lost to Follow-up|0|||
124841870|NCT00559962|449050154|FG004|Overall Study|Lost to Follow-up|0|||
124841871|NCT00559962|449050155|FG005|Overall Study|Lost to Follow-up|0|||
124841872|NCT00559962|449050156|FG006|Overall Study|Lost to Follow-up|0|||
124841873|NCT00559962|449050157|FG007|Overall Study|Lost to Follow-up|0|||
124841874|NCT00559962|449050150|FG000|Overall Study|Withdrawal by Subject|1|||
124841875|NCT00559962|449050151|FG001|Overall Study|Withdrawal by Subject|1|||
124841876|NCT00559962|449050152|FG002|Overall Study|Withdrawal by Subject|2|||
124841877|NCT00559962|449050153|FG003|Overall Study|Withdrawal by Subject|0|||
124841878|NCT00559962|449050154|FG004|Overall Study|Withdrawal by Subject|3|||
124841879|NCT00559962|449050155|FG005|Overall Study|Withdrawal by Subject|1|||
124841880|NCT00559962|449050156|FG006|Overall Study|Withdrawal by Subject|0|||
124841881|NCT00559962|449050157|FG007|Overall Study|Withdrawal by Subject|2|||
124841882|NCT00559962|449050150|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
124841883|NCT00559962|449050151|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
124841884|NCT00559962|449050152|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
124841885|NCT00559962|449050153|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
124841886|NCT00559962|449050154|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
124841887|NCT00559962|449050155|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
124841888|NCT00559962|449050156|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
124841889|NCT00559962|449050157|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
124841890|NCT00323414|449050168|FG000|Overall Study|Withdrawal by Subject|0|||
124841891|NCT00323414|449050169|FG001|Overall Study|Withdrawal by Subject|1|||
124841892|NCT02552316|449050170|FG000|Overall Study|Withdrawal by Subject|1|||
124841893|NCT02552316|449050170|FG000|Overall Study|Withdrawal due to non-compliance|1|||
124841894|NCT04382911|449050171|FG000|Overall Study|unable to be imaged prior to surgery|2|||
124841895|NCT02385799|449050172|FG000|Overall Study|Lost to Follow-up|1|||
124841896|NCT02385799|449050173|FG001|Overall Study|Lost to Follow-up|2|||
124841897|NCT02385799|449050172|FG000|Overall Study|Adverse Event|4|||
124841898|NCT02385799|449050173|FG001|Overall Study|Adverse Event|2|||
124841899|NCT02385799|449050172|FG000|Overall Study|Withdrawal by Subject|0|||
124841900|NCT02385799|449050173|FG001|Overall Study|Withdrawal by Subject|4|||
124841901|NCT00376168|449050177|FG000|Overall Study|Adverse Event|1|||
124841902|NCT00376168|449050178|FG001|Overall Study|Adverse Event|1|||
124841903|NCT00376168|449050177|FG000|Overall Study|Pregnancy|1|||
124841904|NCT00376168|449050178|FG001|Overall Study|Pregnancy|0|||
124841905|NCT02350309|449050179|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
124841906|NCT02350309|449050180|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
124841907|NCT02350309|449050181|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
124841908|NCT02350309|449050182|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
124841909|NCT02350309|449050183|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
124841910|NCT02350309|449050184|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
124841911|NCT02350309|449050179|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
124841912|NCT02350309|449050180|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
124841913|NCT02350309|449050181|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
124841914|NCT02350309|449050182|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
124841915|NCT02350309|449050183|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
124841916|NCT02350309|449050184|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
124841917|NCT00058825|449050185|FG000|Overall Study|Relapse|9|||
124841918|NCT00058825|449050185|FG000|Overall Study|Progressive Disease|5|||
124841919|NCT00058825|449050185|FG000|Overall Study|Graft Failure|5|||
124841920|NCT00058825|449050185|FG000|Overall Study|Death|3|||
124841921|NCT04399161|449050186|FG000|Overall Study|Withdrawal by Subject|1|||
124841922|NCT04399161|449050187|FG001|Overall Study|Withdrawal by Subject|0|||
124841923|NCT04399161|449050188|FG002|Overall Study|Withdrawal by Subject|2|||
124841924|NCT04399161|449050186|FG000|Overall Study|Protocol Violation|1|||
124841925|NCT04399161|449050187|FG001|Overall Study|Protocol Violation|2|||
124841926|NCT04399161|449050188|FG002|Overall Study|Protocol Violation|0|||
125305489|NCT02218008|450745140|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
125305490|NCT02218008|450745141|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
125305491|NCT02218008|450745142|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
125305492|NCT02218008|450745143|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
125305493|NCT02218008|450745144|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
125305494|NCT02218008|450745139|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
125305495|NCT02218008|450745140|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
125305496|NCT02218008|450745141|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
124841935|NCT00477672|449050193|FG000|Overall Study|Adverse Event|3|||
124841936|NCT00477672|449050194|FG001|Overall Study|Adverse Event|5|||
124841937|NCT00477672|449050195|FG002|Overall Study|Adverse Event|6|||
124841938|NCT00477672|449050193|FG000|Overall Study|Death|0|||
124841939|NCT00477672|449050194|FG001|Overall Study|Death|1|||
124841940|NCT00477672|449050195|FG002|Overall Study|Death|0|||
124841941|NCT00477672|449050193|FG000|Overall Study|Disease progression|0|||
124841942|NCT00477672|449050194|FG001|Overall Study|Disease progression|1|||
124841943|NCT00477672|449050195|FG002|Overall Study|Disease progression|0|||
124841944|NCT00477672|449050193|FG000|Overall Study|Physician Decision|1|||
124841945|NCT00477672|449050194|FG001|Overall Study|Physician Decision|0|||
124841946|NCT00477672|449050195|FG002|Overall Study|Physician Decision|0|||
124841947|NCT00477672|449050193|FG000|Overall Study|Protocol noncompliance|0|||
124841948|NCT00477672|449050194|FG001|Overall Study|Protocol noncompliance|2|||
124841949|NCT00477672|449050195|FG002|Overall Study|Protocol noncompliance|0|||
124841950|NCT00477672|449050193|FG000|Overall Study|Consent withdrawn|2|||
124841951|NCT00477672|449050194|FG001|Overall Study|Consent withdrawn|5|||
124841952|NCT00477672|449050195|FG002|Overall Study|Consent withdrawn|10|||
124841953|NCT00477672|449050193|FG000|Overall Study|Discretion of Sponsor|1|||
124841954|NCT00477672|449050194|FG001|Overall Study|Discretion of Sponsor|2|||
124841955|NCT00477672|449050195|FG002|Overall Study|Discretion of Sponsor|0|||
124841956|NCT01398956|449050202|FG000|Overall Study|Withdrawal by Subject|4|||
124841957|NCT01398956|449050202|FG000|Overall Study|AE, non-serious non-fatal|4|||
124841958|NCT01398956|449050202|FG000|Overall Study|Withdrawal Criteria No.3|1|||
124841959|NCT01398956|449050202|FG000|Overall Study|Subject moved a long distance|1|||
124841960|NCT03925727|449050212|FG000|Overall Study|Adverse Event|4|||
124841961|NCT03925727|449050213|FG001|Overall Study|Adverse Event|0|||
124841962|NCT03925727|449050214|FG002|Overall Study|Adverse Event|3|||
124841963|NCT03925727|449050212|FG000|Overall Study|Protocol Violation|1|||
124841964|NCT03925727|449050213|FG001|Overall Study|Protocol Violation|2|||
124841965|NCT03925727|449050214|FG002|Overall Study|Protocol Violation|2|||
124841966|NCT03925727|449050212|FG000|Overall Study|Withdrawal by Subject|3|||
124841967|NCT03925727|449050213|FG001|Overall Study|Withdrawal by Subject|2|||
124841968|NCT03925727|449050214|FG002|Overall Study|Withdrawal by Subject|4|||
124841969|NCT03925727|449050212|FG000|Overall Study|Administrative Reasons|3|||
124841970|NCT03925727|449050213|FG001|Overall Study|Administrative Reasons|1|||
124841971|NCT03925727|449050214|FG002|Overall Study|Administrative Reasons|2|||
124841972|NCT03925727|449050212|FG000|Overall Study|Randomized in error or Disqualified|8|||
124841973|NCT03925727|449050213|FG001|Overall Study|Randomized in error or Disqualified|1|||
124841974|NCT03925727|449050214|FG002|Overall Study|Randomized in error or Disqualified|7|||
124841975|NCT00558103|449050215|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
124841976|NCT00558103|449050216|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
124841977|NCT00558103|449050217|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
124841978|NCT00558103|449050218|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
124841979|NCT00558103|449050219|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
124841980|NCT00558103|449050220|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
124841981|NCT00558103|449050215|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
124841982|NCT00558103|449050216|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
124841983|NCT00558103|449050217|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
124841984|NCT00558103|449050218|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
125305497|NCT02218008|450745142|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
125305498|NCT02218008|450745143|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
125305499|NCT02218008|450745144|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
124841985|NCT00558103|449050219|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
124841986|NCT00558103|449050220|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
124841987|NCT00558103|449050215|FG000|Randomized Treatment Phase|Disease Progression|1|||
124841988|NCT00558103|449050216|FG001|Randomized Treatment Phase|Disease Progression|0|||
124841989|NCT00558103|449050217|FG002|Randomized Treatment Phase|Disease Progression|1|||
124841990|NCT00558103|449050218|FG003|Randomized Treatment Phase|Disease Progression|0|||
124841991|NCT00558103|449050219|FG004|Randomized Treatment Phase|Disease Progression|0|||
124841992|NCT00558103|449050220|FG005|Randomized Treatment Phase|Disease Progression|0|||
124841993|NCT00558103|449050215|FG000|Randomized Treatment Phase|Adverse Event|0|||
124841994|NCT00558103|449050216|FG001|Randomized Treatment Phase|Adverse Event|0|||
124841995|NCT00558103|449050217|FG002|Randomized Treatment Phase|Adverse Event|0|||
124841996|NCT00558103|449050218|FG003|Randomized Treatment Phase|Adverse Event|1|||
124841997|NCT00558103|449050219|FG004|Randomized Treatment Phase|Adverse Event|1|||
124841998|NCT00558103|449050220|FG005|Randomized Treatment Phase|Adverse Event|0|||
124841999|NCT00558103|449050215|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
124842000|NCT00558103|449050216|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
124842001|NCT00558103|449050217|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
124842002|NCT00558103|449050218|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
124842003|NCT00558103|449050219|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
124842004|NCT00558103|449050220|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
124842005|NCT00558103|449050215|FG000|Monotherapy Extension Phase|Disease Progression|0|||
124842006|NCT00558103|449050216|FG001|Monotherapy Extension Phase|Disease Progression|0|||
124842007|NCT00558103|449050217|FG002|Monotherapy Extension Phase|Disease Progression|0|||
124842008|NCT00558103|449050218|FG003|Monotherapy Extension Phase|Disease Progression|0|||
124842009|NCT00558103|449050219|FG004|Monotherapy Extension Phase|Disease Progression|0|||
124842010|NCT00558103|449050220|FG005|Monotherapy Extension Phase|Disease Progression|8|||
124842011|NCT00978731|449052309|FG000|Overall Study|Death|4|||
124842012|NCT00978731|449052310|FG001|Overall Study|Death|1|||
124842013|NCT00978731|449052311|FG002|Overall Study|Death|1|||
124842014|NCT00978731|449052312|FG003|Overall Study|Death|0|||
124842015|NCT00978731|449052309|FG000|Overall Study|Lost to Follow-up|0|||
124842016|NCT00978731|449052310|FG001|Overall Study|Lost to Follow-up|0|||
124842017|NCT00978731|449052311|FG002|Overall Study|Lost to Follow-up|0|||
124842018|NCT00978731|449052312|FG003|Overall Study|Lost to Follow-up|1|||
124842019|NCT00978731|449052309|FG000|Overall Study|Adverse Event|5|||
124842020|NCT00978731|449052310|FG001|Overall Study|Adverse Event|2|||
124842021|NCT00978731|449052311|FG002|Overall Study|Adverse Event|0|||
124842022|NCT00978731|449052312|FG003|Overall Study|Adverse Event|0|||
124842023|NCT00978731|449052309|FG000|Overall Study|Participant's request|1|||
124842024|NCT00978731|449052310|FG001|Overall Study|Participant's request|0|||
124842025|NCT00978731|449052311|FG002|Overall Study|Participant's request|0|||
124842026|NCT00978731|449052312|FG003|Overall Study|Participant's request|0|||
124842027|NCT00978731|449052309|FG000|Overall Study|Administrative reason|3|||
124842028|NCT00978731|449052310|FG001|Overall Study|Administrative reason|3|||
124842029|NCT00978731|449052311|FG002|Overall Study|Administrative reason|1|||
124842030|NCT00978731|449052312|FG003|Overall Study|Administrative reason|0|||
124842031|NCT00978731|449052309|FG000|Overall Study|Deterioration without progression|0|||
124842032|NCT00978731|449052310|FG001|Overall Study|Deterioration without progression|1|||
124842033|NCT00978731|449052311|FG002|Overall Study|Deterioration without progression|0|||
124842034|NCT00978731|449052312|FG003|Overall Study|Deterioration without progression|0|||
124842035|NCT00978731|449052309|FG000|Overall Study|Disease progression/relapse|5|||
124842036|NCT00978731|449052310|FG001|Overall Study|Disease progression/relapse|4|||
124842037|NCT00978731|449052311|FG002|Overall Study|Disease progression/relapse|2|||
124842038|NCT00978731|449052312|FG003|Overall Study|Disease progression/relapse|2|||
124842039|NCT00978731|449052309|FG000|Overall Study|Study closure|3|||
124842040|NCT00978731|449052310|FG001|Overall Study|Study closure|4|||
124842041|NCT00978731|449052311|FG002|Overall Study|Study closure|1|||
124842042|NCT00978731|449052312|FG003|Overall Study|Study closure|1|||
124842043|NCT00978731|449052309|FG000|Overall Study|No response|1|||
124842044|NCT00978731|449052310|FG001|Overall Study|No response|0|||
124842045|NCT00978731|449052311|FG002|Overall Study|No response|0|||
124842046|NCT00978731|449052312|FG003|Overall Study|No response|0|||
124842047|NCT00293384|449052315|FG000|Overall Study|Non-compliance|2|||
124842048|NCT00293384|449052315|FG000|Overall Study|Missed dosage/study drug|1|||
124842049|NCT00293384|449052315|FG000|Overall Study|Ineligible|2|||
124842050|NCT00773175|449052316|FG000|Overall Study|Adverse Event|2|||
124842051|NCT00773175|449052317|FG001|Overall Study|Adverse Event|0|||
124842052|NCT00773175|449052316|FG000|Overall Study|Consent Withdrawn|0|||
124842053|NCT00773175|449052317|FG001|Overall Study|Consent Withdrawn|2|||
124842054|NCT01302964|449052318|FG000|Overall Study|Adverse Event|1|||
124842055|NCT01302964|449052319|FG001|Overall Study|Adverse Event|0|||
124842056|NCT00192075|449052322|FG000|Overall Study|Disease Progression|23|||
124842057|NCT00192075|449052323|FG001|Overall Study|Disease Progression|6|||
124842058|NCT00192075|449052322|FG000|Overall Study|Adverse Event|1|||
124842059|NCT00192075|449052323|FG001|Overall Study|Adverse Event|3|||
124842060|NCT00192075|449052322|FG000|Overall Study|Death|0|||
124842061|NCT00192075|449052323|FG001|Overall Study|Death|1|||
124842062|NCT00192075|449052322|FG000|Overall Study|Lack of Efficacy|0|||
124842063|NCT00192075|449052323|FG001|Overall Study|Lack of Efficacy|0|||
124842064|NCT00192075|449052322|FG000|Overall Study|Physician Decision|3|||
124842065|NCT00192075|449052323|FG001|Overall Study|Physician Decision|0|||
124842066|NCT00192075|449052322|FG000|Overall Study|Withdrawal by Subject|5|||
124842067|NCT00192075|449052323|FG001|Overall Study|Withdrawal by Subject|5|||
124842068|NCT00192075|449052322|FG000|Overall Study|Patient Non-Compliance|0|||
124842069|NCT00192075|449052323|FG001|Overall Study|Patient Non-Compliance|1|||
124842070|NCT00192075|449052322|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
124842071|NCT00192075|449052323|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
124842072|NCT00192075|449052322|FG000|Overall Study|Other|5|||
124842073|NCT00192075|449052323|FG001|Overall Study|Other|2|||
124842074|NCT00779675|449052324|FG000|Treatment Period|Adverse Event|87|||
124842075|NCT00779675|449052324|FG000|Treatment Period|Treatment Failure|80|||
124842076|NCT00779675|449052324|FG000|Treatment Period|Transferred to Another Study|38|||
124842077|NCT00779675|449052324|FG000|Treatment Period|Lost to Follow-up|23|||
124842078|NCT00779675|449052324|FG000|Treatment Period|Withdrawal by Subject|46|||
124842079|NCT00779675|449052324|FG000|Treatment Period|Protocol Violation|54|||
124842080|NCT00779675|449052324|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
124842081|NCT00779675|449052324|FG000|Treatment Period|Administrative|3|||
124842082|NCT00779675|449052324|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
124842083|NCT00779675|449052324|FG000|Extended Treatment Period|Protocol Violation|13|||
124842084|NCT00779675|449052324|FG000|Extended Treatment Period|Adverse Event|6|||
124842085|NCT00779675|449052324|FG000|Extended Treatment Period|Treatment Failure|11|||
124842086|NCT00779675|449052324|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
124842087|NCT00779675|449052324|FG000|Extended Treatment Period|Lost to Follow-up|6|||
124842088|NCT00355238|449052332|FG000|Overall Study|Adverse event unrelated to study drug|2|||
124842089|NCT00355238|449052333|FG001|Overall Study|Adverse event unrelated to study drug|2|||
124842090|NCT00355238|449052334|FG002|Overall Study|Adverse event unrelated to study drug|0|||
124842091|NCT00355238|449052335|FG003|Overall Study|Adverse event unrelated to study drug|1|||
124842092|NCT00355238|449052332|FG000|Overall Study|Death|1|||
124842093|NCT00355238|449052333|FG001|Overall Study|Death|0|||
124842094|NCT00355238|449052334|FG002|Overall Study|Death|0|||
124842095|NCT00355238|449052335|FG003|Overall Study|Death|0|||
124842096|NCT00355238|449052332|FG000|Overall Study|Disease progression|37|||
124842097|NCT00355238|449052333|FG001|Overall Study|Disease progression|36|||
124842098|NCT00355238|449052334|FG002|Overall Study|Disease progression|16|||
124842099|NCT00355238|449052335|FG003|Overall Study|Disease progression|11|||
124842100|NCT00355238|449052332|FG000|Overall Study|Study drug toxicity|11|||
124842101|NCT00355238|449052333|FG001|Overall Study|Study drug toxicity|7|||
124842102|NCT00355238|449052334|FG002|Overall Study|Study drug toxicity|5|||
124842103|NCT00355238|449052335|FG003|Overall Study|Study drug toxicity|2|||
124842104|NCT00355238|449052332|FG000|Overall Study|Participant withdrew consent|3|||
124842105|NCT00355238|449052333|FG001|Overall Study|Participant withdrew consent|1|||
124842106|NCT00355238|449052334|FG002|Overall Study|Participant withdrew consent|0|||
124842107|NCT00355238|449052335|FG003|Overall Study|Participant withdrew consent|0|||
124842108|NCT00355238|449052332|FG000|Overall Study|Participant request to discontinue study treatment|1|||
124842109|NCT00355238|449052333|FG001|Overall Study|Participant request to discontinue study treatment|0|||
124842110|NCT00355238|449052334|FG002|Overall Study|Participant request to discontinue study treatment|1|||
124842111|NCT00355238|449052335|FG003|Overall Study|Participant request to discontinue study treatment|0|||
124842112|NCT04300296|449052336|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
124842113|NCT04300296|449052337|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
124842114|NCT04300296|449052338|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
124842115|NCT04300296|449052339|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
124842116|NCT04300296|449052340|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
124842117|NCT04300296|449052341|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
124842118|NCT04300296|449052336|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
124842119|NCT04300296|449052337|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
124842120|NCT04300296|449052338|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
124842121|NCT04300296|449052339|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
124842122|NCT04300296|449052340|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
124842123|NCT04300296|449052341|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
124842124|NCT04300296|449052336|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
124842125|NCT04300296|449052337|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
124842126|NCT04300296|449052338|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
124842127|NCT04300296|449052339|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
124842128|NCT04300296|449052340|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
124842129|NCT04300296|449052341|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
124842130|NCT04300296|449052336|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
124842131|NCT04300296|449052337|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
124842132|NCT04300296|449052338|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
124842133|NCT04300296|449052339|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
124842134|NCT04300296|449052340|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
124842135|NCT04300296|449052341|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
124842136|NCT04300296|449052336|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
124842137|NCT04300296|449052337|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
124842138|NCT04300296|449052338|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
124842139|NCT04300296|449052339|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
124842140|NCT04300296|449052340|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
124842141|NCT04300296|449052341|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
124842142|NCT04300296|449052336|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
124842143|NCT04300296|449052337|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
124842144|NCT04300296|449052338|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
124842145|NCT04300296|449052339|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
124842146|NCT04300296|449052340|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
124842147|NCT04300296|449052341|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
124842148|NCT04300296|449052336|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
124842149|NCT04300296|449052337|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
124842150|NCT04300296|449052338|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
124842151|NCT04300296|449052339|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
124842152|NCT04300296|449052340|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
124842153|NCT04300296|449052341|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
124842154|NCT03325166|449052342|FG000|Overall Study|Adverse Event|1|||
124842155|NCT01633944|449052343|FG000|Open-label Titration Phase|Adverse Event|109|||
124842156|NCT01633944|449052344|FG001|Open-label Titration Phase|Adverse Event|0|||
124842157|NCT01633944|449052345|FG002|Open-label Titration Phase|Adverse Event|0|||
124842158|NCT01633944|449052343|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
124842159|NCT01633944|449052344|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
124842160|NCT01633944|449052345|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
124842161|NCT01633944|449052343|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
124842162|NCT01633944|449052344|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
124842163|NCT01633944|449052345|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
124842164|NCT01633944|449052343|FG000|Open-label Titration Phase|Protocol Violation|24|||
124842165|NCT01633944|449052344|FG001|Open-label Titration Phase|Protocol Violation|0|||
124842166|NCT01633944|449052345|FG002|Open-label Titration Phase|Protocol Violation|0|||
124842167|NCT01633944|449052343|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
124842168|NCT01633944|449052344|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
124842169|NCT01633944|449052345|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
124842170|NCT01633944|449052343|FG000|Open-label Titration Phase|Other|68|||
124842171|NCT01633944|449052344|FG001|Open-label Titration Phase|Other|0|||
124842172|NCT01633944|449052345|FG002|Open-label Titration Phase|Other|0|||
124842173|NCT01633944|449052343|FG000|Double-blind Treatment Phase|Adverse Event|0|||
124842174|NCT01633944|449052344|FG001|Double-blind Treatment Phase|Adverse Event|13|||
124842175|NCT01633944|449052345|FG002|Double-blind Treatment Phase|Adverse Event|7|||
124842176|NCT01633944|449052343|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
124842177|NCT01633944|449052344|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
124842178|NCT01633944|449052345|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
124842179|NCT01633944|449052343|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
124842180|NCT01633944|449052344|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
124842181|NCT01633944|449052345|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
124842182|NCT01633944|449052343|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
124842183|NCT01633944|449052344|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
124842184|NCT01633944|449052345|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
124842185|NCT01633944|449052343|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
124842186|NCT01633944|449052344|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
124842187|NCT01633944|449052345|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
124842188|NCT01633944|449052343|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
124842189|NCT01633944|449052344|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
124842190|NCT01633944|449052345|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
124842191|NCT01633944|449052343|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
124842192|NCT01633944|449052344|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
124842193|NCT01633944|449052345|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
124842194|NCT01633944|449052343|FG000|Double-blind Treatment Phase|Other|0|||
124842195|NCT01633944|449052344|FG001|Double-blind Treatment Phase|Other|7|||
124842196|NCT01633944|449052345|FG002|Double-blind Treatment Phase|Other|0|||
124842197|NCT02412631|449052349|FG000|Overall Study|Adverse Event|1|||
124842198|NCT02412631|449052350|FG001|Overall Study|Adverse Event|2|||
124842199|NCT02412631|449052349|FG000|Overall Study|Lost to Follow-up|5|||
124842200|NCT02412631|449052350|FG001|Overall Study|Lost to Follow-up|9|||
124842201|NCT02412631|449052349|FG000|Overall Study|Withdrawal by Subject|9|||
124842202|NCT02412631|449052350|FG001|Overall Study|Withdrawal by Subject|3|||
124842203|NCT02412631|449052349|FG000|Overall Study|Early stop by FDA|5|||
124842204|NCT02412631|449052350|FG001|Overall Study|Early stop by FDA|2|||
124842205|NCT02412631|449052349|FG000|Overall Study|Unspecified reason|6|||
124842206|NCT02412631|449052350|FG001|Overall Study|Unspecified reason|8|||
124842207|NCT00958776|449052351|FG000|Overall Study|Adverse Event|0|||
124842208|NCT00958776|449052352|FG001|Overall Study|Adverse Event|1|||
124842209|NCT00958776|449052351|FG000|Overall Study|Physician Decision|1|||
124842210|NCT00958776|449052352|FG001|Overall Study|Physician Decision|0|||
124842211|NCT00958776|449052351|FG000|Overall Study|Lost to Follow-up|2|||
124842212|NCT00958776|449052352|FG001|Overall Study|Lost to Follow-up|6|||
124842213|NCT00958776|449052351|FG000|Overall Study|Withdrawal by Subject|7|||
124842214|NCT00958776|449052352|FG001|Overall Study|Withdrawal by Subject|16|||
124842215|NCT00958776|449052351|FG000|Overall Study|Protocol Violation|1|||
124842216|NCT00958776|449052352|FG001|Overall Study|Protocol Violation|1|||
124842217|NCT00958776|449052351|FG000|Overall Study|Death|2|||
124842218|NCT00958776|449052352|FG001|Overall Study|Death|1|||
124842219|NCT00958776|449052351|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
124842220|NCT00958776|449052352|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
124842221|NCT00958776|449052351|FG000|Overall Study|Missing|1|||
124842222|NCT00958776|449052352|FG001|Overall Study|Missing|1|||
124842223|NCT03795610|449052354|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
124842224|NCT03795610|449052354|FG000|Overall Study|Withdrawal by Subject|1|||
124842225|NCT03795610|449052354|FG000|Overall Study|Screen Failure (Unknown)|1|||
124842226|NCT04098458|449052378|FG000|Overall Study|Death|1|||
124842227|NCT04098458|449052378|FG000|Overall Study|did not meet study inclusion criteria|3|||
124842228|NCT03762083|449052379|FG000|Overall Study|Withdrawal by Subject|2|||
124842229|NCT03762083|449052379|FG000|Overall Study|Physician Decision|1|||
124842230|NCT00116558|449052380|FG000|Overall Study|Death|11|||
124842231|NCT00116558|449052381|FG001|Overall Study|Death|5|||
124842232|NCT00116558|449052382|FG002|Overall Study|Death|3|||
124842233|NCT00116558|449052380|FG000|Overall Study|Withdrawal by Subject|17|||
124842234|NCT00116558|449052381|FG001|Overall Study|Withdrawal by Subject|3|||
124842235|NCT00116558|449052382|FG002|Overall Study|Withdrawal by Subject|12|||
124842236|NCT00116558|449052380|FG000|Overall Study|disease progression|3|||
124842237|NCT00116558|449052381|FG001|Overall Study|disease progression|7|||
124842238|NCT00116558|449052382|FG002|Overall Study|disease progression|18|||
124842239|NCT02027844|449052383|FG000|Overall Study|Withdrawal by Subject|3|||
124842240|NCT02027844|449052384|FG001|Overall Study|Withdrawal by Subject|2|||
124842241|NCT02027844|449052385|FG002|Overall Study|Withdrawal by Subject|1|||
124842242|NCT02027844|449052383|FG000|Overall Study|Lost to Follow-up|0|||
124842243|NCT02027844|449052384|FG001|Overall Study|Lost to Follow-up|2|||
124842244|NCT02027844|449052385|FG002|Overall Study|Lost to Follow-up|1|||
124842245|NCT02027844|449052383|FG000|Overall Study|Protocol Violation|0|||
124842246|NCT02027844|449052384|FG001|Overall Study|Protocol Violation|2|||
124842247|NCT02027844|449052385|FG002|Overall Study|Protocol Violation|0|||
124842248|NCT02027844|449052383|FG000|Overall Study|Incomlete data|2|||
124842249|NCT02027844|449052384|FG001|Overall Study|Incomlete data|0|||
124842250|NCT02027844|449052385|FG002|Overall Study|Incomlete data|0|||
124842251|NCT00378014|449052386|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
124842252|NCT00378014|449052387|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
124842253|NCT00378014|449052386|FG000|Core (Randomization to Month 11)|Graft loss|1|||
124842254|NCT00378014|449052387|FG001|Core (Randomization to Month 11)|Graft loss|2|||
124842255|NCT00378014|449052386|FG000|Core (Randomization to Month 11)|Death|5|||
124842256|NCT00378014|449052387|FG001|Core (Randomization to Month 11)|Death|3|||
124842257|NCT00378014|449052386|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
124842258|NCT00378014|449052387|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
124842259|NCT00378014|449052386|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
124842260|NCT00378014|449052387|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
124842261|NCT00378014|449052386|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
124842262|NCT00378014|449052387|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
124842263|NCT00378014|449052386|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
124842264|NCT00378014|449052387|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
124842265|NCT00378014|449052386|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
124842266|NCT00378014|449052387|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
124842267|NCT00378014|449052386|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
124842268|NCT00378014|449052387|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
124842269|NCT00378014|449052386|FG000|Extension (Month 12 to Month 59)|Death|1|||
124842270|NCT00378014|449052387|FG001|Extension (Month 12 to Month 59)|Death|2|||
124842271|NCT00378014|449052386|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
124842272|NCT00378014|449052387|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
124842273|NCT00378014|449052386|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
124842274|NCT00378014|449052387|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
124842275|NCT00378014|449052386|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
124842276|NCT00378014|449052387|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
124842277|NCT00378014|449052386|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
124842278|NCT00378014|449052387|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
124842279|NCT04889625|449052390|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
124842280|NCT04889625|449052391|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
124842281|NCT04889625|449052390|FG000|Period 1|Subject out of window|0|||
124842282|NCT04889625|449052391|FG001|Period 1|Subject out of window|1|||
124842283|NCT04889625|449052390|FG000|Period 1|Wrong add power dispensed|0|||
124842284|NCT04889625|449052391|FG001|Period 1|Wrong add power dispensed|1|||
124842285|NCT04889625|449052390|FG000|Period 1|Discontinued due to fitting guide error|1|||
124842286|NCT04889625|449052391|FG001|Period 1|Discontinued due to fitting guide error|1|||
124842287|NCT04889625|449052390|FG000|Period 2|Test article no longer available|1|||
124842288|NCT04889625|449052391|FG001|Period 2|Test article no longer available|0|||
124842289|NCT04889625|449052390|FG000|Period 2|Incorrect lens dispensed|1|||
124842290|NCT04889625|449052391|FG001|Period 2|Incorrect lens dispensed|0|||
124842291|NCT04889625|449052390|FG000|Period 2|Wrong add power dispensed|0|||
124842292|NCT04889625|449052391|FG001|Period 2|Wrong add power dispensed|1|||
124842293|NCT03746522|449052392|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
124842294|NCT03746522|449052393|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
124842295|NCT03746522|449052394|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
124842296|NCT03746522|449052392|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
124842297|NCT03746522|449052393|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
124842298|NCT03746522|449052394|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
124842299|NCT03746522|449052392|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
124842300|NCT03746522|449052393|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
124842301|NCT03746522|449052394|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
124842302|NCT03746522|449052392|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
124842303|NCT03746522|449052393|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
124842304|NCT03746522|449052394|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
124842305|NCT03746522|449052392|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
124842306|NCT03746522|449052393|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
124842307|NCT03746522|449052394|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
124842308|NCT03047135|449052397|FG000|Overall Study|Still being treated|3|||
124842309|NCT02659020|449052399|FG000|Overall Study|Adverse Event|0|||
124842310|NCT02659020|449052400|FG001|Overall Study|Adverse Event|0|||
124842311|NCT02659020|449052401|FG002|Overall Study|Adverse Event|0|||
124842312|NCT02659020|449052402|FG003|Overall Study|Adverse Event|2|||
124842313|NCT02659020|449052403|FG004|Overall Study|Adverse Event|0|||
124842314|NCT02659020|449052404|FG005|Overall Study|Adverse Event|0|||
124842315|NCT02659020|449052405|FG006|Overall Study|Adverse Event|2|||
124842316|NCT02659020|449052399|FG000|Overall Study|Lost to Follow-up|1|||
124842317|NCT02659020|449052400|FG001|Overall Study|Lost to Follow-up|2|||
124842318|NCT02659020|449052401|FG002|Overall Study|Lost to Follow-up|1|||
124842319|NCT02659020|449052402|FG003|Overall Study|Lost to Follow-up|6|||
124842320|NCT02659020|449052403|FG004|Overall Study|Lost to Follow-up|1|||
124842321|NCT02659020|449052404|FG005|Overall Study|Lost to Follow-up|5|||
124842322|NCT02659020|449052405|FG006|Overall Study|Lost to Follow-up|0|||
124842323|NCT02659020|449052399|FG000|Overall Study|Physician Decision|0|||
124842324|NCT02659020|449052400|FG001|Overall Study|Physician Decision|0|||
124842325|NCT02659020|449052401|FG002|Overall Study|Physician Decision|0|||
124842326|NCT02659020|449052402|FG003|Overall Study|Physician Decision|1|||
124842327|NCT02659020|449052403|FG004|Overall Study|Physician Decision|1|||
124842328|NCT02659020|449052404|FG005|Overall Study|Physician Decision|0|||
124842329|NCT02659020|449052405|FG006|Overall Study|Physician Decision|1|||
124842330|NCT02659020|449052399|FG000|Overall Study|Withdrawal by Subject|2|||
124842331|NCT02659020|449052400|FG001|Overall Study|Withdrawal by Subject|1|||
124842332|NCT02659020|449052401|FG002|Overall Study|Withdrawal by Subject|0|||
124842333|NCT02659020|449052402|FG003|Overall Study|Withdrawal by Subject|3|||
124842334|NCT02659020|449052403|FG004|Overall Study|Withdrawal by Subject|3|||
124842335|NCT02659020|449052404|FG005|Overall Study|Withdrawal by Subject|6|||
124842336|NCT02659020|449052405|FG006|Overall Study|Withdrawal by Subject|3|||
124842337|NCT02659020|449052399|FG000|Overall Study|Progressive Disease|0|||
124842338|NCT02659020|449052400|FG001|Overall Study|Progressive Disease|0|||
124842339|NCT02659020|449052401|FG002|Overall Study|Progressive Disease|0|||
124842340|NCT02659020|449052402|FG003|Overall Study|Progressive Disease|4|||
124842341|NCT02659020|449052403|FG004|Overall Study|Progressive Disease|1|||
124842342|NCT02659020|449052404|FG005|Overall Study|Progressive Disease|0|||
124842343|NCT02659020|449052405|FG006|Overall Study|Progressive Disease|2|||
124842344|NCT01585766|449052406|FG000|Overall Study|Withdrawal by Subject|0|||
124842345|NCT01585766|449052407|FG001|Overall Study|Withdrawal by Subject|1|||
124842346|NCT01585766|449052408|FG002|Overall Study|Withdrawal by Subject|1|||
124842347|NCT01585766|449052409|FG003|Overall Study|Withdrawal by Subject|0|||
124842348|NCT01585766|449052410|FG004|Overall Study|Withdrawal by Subject|0|||
124842349|NCT01585766|449052411|FG005|Overall Study|Withdrawal by Subject|0|||
124842350|NCT01585766|449052406|FG000|Overall Study|Death|0|||
124842351|NCT01585766|449052407|FG001|Overall Study|Death|1|||
124842352|NCT01585766|449052408|FG002|Overall Study|Death|0|||
124842353|NCT01585766|449052409|FG003|Overall Study|Death|0|||
124842354|NCT01585766|449052410|FG004|Overall Study|Death|0|||
124842355|NCT01585766|449052411|FG005|Overall Study|Death|0|||
124842356|NCT01585766|449052406|FG000|Overall Study|Physician Decision|0|||
124842357|NCT01585766|449052407|FG001|Overall Study|Physician Decision|0|||
124842358|NCT01585766|449052408|FG002|Overall Study|Physician Decision|1|||
124842359|NCT01585766|449052409|FG003|Overall Study|Physician Decision|0|||
124842360|NCT01585766|449052410|FG004|Overall Study|Physician Decision|0|||
124842361|NCT01585766|449052411|FG005|Overall Study|Physician Decision|0|||
124842362|NCT01120210|449052412|FG000|MAIN INFUSION|Adverse Event|1|||
124842363|NCT01120210|449052413|FG001|MAIN INFUSION|Adverse Event|0|||
124842364|NCT01120210|449052412|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
124842365|NCT01120210|449052413|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
124842366|NCT02043015|449052414|FG000|Overall Study|Lost to Follow-up|4|||
124842367|NCT02043015|449052414|FG000|Overall Study|Withdrawal by Subject|4|||
124842368|NCT02043015|449052414|FG000|Overall Study|Removed once target enrollment reached|15|||
124842369|NCT02043015|449052414|FG000|Overall Study|Participant moved away from study city|4|||
124842370|NCT02043015|449052414|FG000|Overall Study|Incarceration|1|||
124842371|NCT00974571|449052415|FG000|Overall Study|Adverse Event|31|||
124842372|NCT00974571|449052416|FG001|Overall Study|Adverse Event|4|||
124842373|NCT00974571|449052417|FG002|Overall Study|Adverse Event|27|||
124842374|NCT00974571|449052415|FG000|Overall Study|Lack of Efficacy|3|||
124842375|NCT00974571|449052416|FG001|Overall Study|Lack of Efficacy|2|||
124842376|NCT00974571|449052417|FG002|Overall Study|Lack of Efficacy|9|||
124842377|NCT00974571|449052415|FG000|Overall Study|Lost to Follow-up|2|||
124842378|NCT00974571|449052416|FG001|Overall Study|Lost to Follow-up|1|||
124842379|NCT00974571|449052417|FG002|Overall Study|Lost to Follow-up|2|||
124842380|NCT00974571|449052415|FG000|Overall Study|Protocol Violation|13|||
124842381|NCT00974571|449052416|FG001|Overall Study|Protocol Violation|4|||
124842382|NCT00974571|449052417|FG002|Overall Study|Protocol Violation|18|||
124842383|NCT00974571|449052415|FG000|Overall Study|Withdrawal by Subject|14|||
124842384|NCT00974571|449052416|FG001|Overall Study|Withdrawal by Subject|5|||
124842385|NCT00974571|449052417|FG002|Overall Study|Withdrawal by Subject|16|||
124842386|NCT00974571|449052415|FG000|Overall Study|Patient Moved|1|||
124842387|NCT00974571|449052416|FG001|Overall Study|Patient Moved|0|||
124842388|NCT00974571|449052417|FG002|Overall Study|Patient Moved|1|||
124842389|NCT00974571|449052415|FG000|Overall Study|Other|4|||
124842390|NCT00974571|449052416|FG001|Overall Study|Other|0|||
124842391|NCT00974571|449052417|FG002|Overall Study|Other|10|||
124842392|NCT01494610|449052431|FG000|Period 1|Withdrawal by Subject|1|||
124842393|NCT01494610|449052432|FG001|Period 1|Withdrawal by Subject|1|||
124842394|NCT01494610|449052431|FG000|Period 3|Adverse Event|1|||
124842395|NCT01494610|449052432|FG001|Period 3|Adverse Event|0|||
124842396|NCT01494610|449052431|FG000|Period 3|Withdrawal by Subject|1|||
124842397|NCT01494610|449052432|FG001|Period 3|Withdrawal by Subject|0|||
124842398|NCT01494610|449052431|FG000|Period 4|Protocol Violation|1|||
124842399|NCT01494610|449052432|FG001|Period 4|Protocol Violation|0|||
124842400|NCT02130765|449052439|FG000|Overall Study|Did not receive treatment|4|||
124842401|NCT02130765|449052440|FG001|Overall Study|Did not receive treatment|0|||
124842402|NCT02130765|449052441|FG002|Overall Study|Did not receive treatment|0|||
124842403|NCT02130765|449052442|FG003|Overall Study|Did not receive treatment|0|||
124842404|NCT02244580|449052446|FG000|Overall Study|No cancer tissues available|241|||
124842405|NCT01736696|449052447|FG000|Overall Study|Withdrawal by Subject|0|||
124842406|NCT01736696|449052448|FG001|Overall Study|Withdrawal by Subject|0|||
124842407|NCT01736696|449052449|FG002|Overall Study|Withdrawal by Subject|1|||
124842408|NCT01736696|449052450|FG003|Overall Study|Withdrawal by Subject|0|||
124842409|NCT01736696|449052451|FG004|Overall Study|Withdrawal by Subject|0|||
124842410|NCT01736696|449052452|FG005|Overall Study|Withdrawal by Subject|0|||
124842411|NCT01736696|449052453|FG006|Overall Study|Withdrawal by Subject|0|||
124842412|NCT02114879|449052454|FG000|Overall Study|Withdrawal by Subject|9|||
124842413|NCT02114879|449052455|FG001|Overall Study|Withdrawal by Subject|5|||
124842414|NCT02114879|449052454|FG000|Overall Study|Death|6|||
124842415|NCT02114879|449052455|FG001|Overall Study|Death|11|||
124842416|NCT02114879|449052454|FG000|Overall Study|Lost to Follow-up|4|||
124842417|NCT02114879|449052455|FG001|Overall Study|Lost to Follow-up|6|||
124842418|NCT02114879|449052454|FG000|Overall Study|Physician Decision|0|||
124842419|NCT02114879|449052455|FG001|Overall Study|Physician Decision|2|||
124842420|NCT01455012|449052456|FG000|Overall Study|Adverse Event|0|||
124842421|NCT01455012|449052457|FG001|Overall Study|Adverse Event|2|||
124842422|NCT01455012|449052456|FG000|Overall Study|Lack of Efficacy|6|||
124842423|NCT01455012|449052457|FG001|Overall Study|Lack of Efficacy|1|||
124842424|NCT01455012|449052456|FG000|Overall Study|Withdrawal by Subject|3|||
124842425|NCT01455012|449052457|FG001|Overall Study|Withdrawal by Subject|1|||
124842426|NCT01455012|449052456|FG000|Overall Study|Unknown reason|2|||
124842427|NCT01455012|449052457|FG001|Overall Study|Unknown reason|0|||
124842428|NCT00613509|449052458|FG000|Cycle 1|Adverse Event|2|||
124842429|NCT00613509|449052459|FG001|Cycle 1|Adverse Event|1|||
124842430|NCT00613509|449052458|FG000|Cycle 1|Disease Progression|2|||
124842431|NCT00613509|449052459|FG001|Cycle 1|Disease Progression|6|||
124842432|NCT00613509|449052458|FG000|Cycle 1|Unacceptable Toxicity|1|||
124842433|NCT00613509|449052459|FG001|Cycle 1|Unacceptable Toxicity|0|||
124842434|NCT00613509|449052458|FG000|Cycle 1|Other administrative reason|0|||
124842435|NCT00613509|449052459|FG001|Cycle 1|Other administrative reason|1|||
124842436|NCT01215227|449052460|FG000|Overall Study|Adverse Event|11|||
124842437|NCT01215227|449052461|FG001|Overall Study|Adverse Event|11|||
124842438|NCT01215227|449052462|FG002|Overall Study|Adverse Event|4|||
124842439|NCT01215227|449052463|FG003|Overall Study|Adverse Event|8|||
124842440|NCT01215227|449052464|FG004|Overall Study|Adverse Event|7|||
124842441|NCT01215227|449052465|FG005|Overall Study|Adverse Event|6|||
124842442|NCT01215227|449052460|FG000|Overall Study|Treatment Failure|8|||
124842443|NCT01215227|449052461|FG001|Overall Study|Treatment Failure|4|||
124842444|NCT01215227|449052462|FG002|Overall Study|Treatment Failure|1|||
124842445|NCT01215227|449052463|FG003|Overall Study|Treatment Failure|5|||
124842446|NCT01215227|449052464|FG004|Overall Study|Treatment Failure|1|||
124842447|NCT01215227|449052465|FG005|Overall Study|Treatment Failure|1|||
124842448|NCT01215227|449052460|FG000|Overall Study|Lost to Follow-up|1|||
124842449|NCT01215227|449052461|FG001|Overall Study|Lost to Follow-up|4|||
124842450|NCT01215227|449052462|FG002|Overall Study|Lost to Follow-up|1|||
124842451|NCT01215227|449052463|FG003|Overall Study|Lost to Follow-up|1|||
124842452|NCT01215227|449052464|FG004|Overall Study|Lost to Follow-up|1|||
124842453|NCT01215227|449052465|FG005|Overall Study|Lost to Follow-up|2|||
124842454|NCT01215227|449052460|FG000|Overall Study|Subject Withdrew Consent|16|||
124842455|NCT01215227|449052461|FG001|Overall Study|Subject Withdrew Consent|20|||
124842456|NCT01215227|449052462|FG002|Overall Study|Subject Withdrew Consent|7|||
124842457|NCT01215227|449052463|FG003|Overall Study|Subject Withdrew Consent|10|||
124842458|NCT01215227|449052464|FG004|Overall Study|Subject Withdrew Consent|11|||
124842459|NCT01215227|449052465|FG005|Overall Study|Subject Withdrew Consent|8|||
124842460|NCT01215227|449052460|FG000|Overall Study|Non-Compliance With Protocol|2|||
124842461|NCT01215227|449052461|FG001|Overall Study|Non-Compliance With Protocol|6|||
124842462|NCT01215227|449052462|FG002|Overall Study|Non-Compliance With Protocol|1|||
124842463|NCT01215227|449052463|FG003|Overall Study|Non-Compliance With Protocol|0|||
124842464|NCT01215227|449052464|FG004|Overall Study|Non-Compliance With Protocol|0|||
124842465|NCT01215227|449052465|FG005|Overall Study|Non-Compliance With Protocol|0|||
124842466|NCT01215227|449052460|FG000|Overall Study|Administrative|83|||
124842467|NCT01215227|449052461|FG001|Overall Study|Administrative|73|||
124842468|NCT01215227|449052462|FG002|Overall Study|Administrative|42|||
124842469|NCT01215227|449052463|FG003|Overall Study|Administrative|24|||
124842470|NCT01215227|449052464|FG004|Overall Study|Administrative|28|||
124842471|NCT01215227|449052465|FG005|Overall Study|Administrative|40|||
124842472|NCT01215227|449052460|FG000|Overall Study|Missing Status|0|||
124842473|NCT01215227|449052461|FG001|Overall Study|Missing Status|1|||
124842474|NCT01215227|449052462|FG002|Overall Study|Missing Status|0|||
124842475|NCT01215227|449052463|FG003|Overall Study|Missing Status|0|||
124842476|NCT01215227|449052464|FG004|Overall Study|Missing Status|0|||
124842477|NCT01215227|449052465|FG005|Overall Study|Missing Status|0|||
124842478|NCT01215227|449052460|FG000|Overall Study|Randomized but not treated|0|||
124842479|NCT01215227|449052461|FG001|Overall Study|Randomized but not treated|0|||
124842480|NCT01215227|449052462|FG002|Overall Study|Randomized but not treated|1|||
124842481|NCT01215227|449052463|FG003|Overall Study|Randomized but not treated|1|||
124842482|NCT01215227|449052464|FG004|Overall Study|Randomized but not treated|0|||
124842483|NCT01215227|449052465|FG005|Overall Study|Randomized but not treated|1|||
124842484|NCT02253810|449052466|FG000|Overall Study|Withdrawal by Subject|2|||
124842485|NCT02253810|449052467|FG001|Overall Study|Withdrawal by Subject|1|||
124842486|NCT02253810|449052466|FG000|Overall Study|Unknown concomitant procedure|3|||
124842487|NCT02253810|449052467|FG001|Overall Study|Unknown concomitant procedure|2|||
124842488|NCT00213148|449052474|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
124842489|NCT00213148|449052475|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
124842490|NCT00213148|449052476|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
124842491|NCT00213148|449052477|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
124842492|NCT00213148|449052478|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
124842493|NCT00213148|449052474|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
124842494|NCT00213148|449052475|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
124842495|NCT00213148|449052476|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
124842496|NCT00213148|449052477|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
124842497|NCT00213148|449052478|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
124842498|NCT00213148|449052474|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
124842499|NCT00213148|449052475|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
124842500|NCT00213148|449052476|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
124842501|NCT00213148|449052477|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
124842502|NCT00213148|449052478|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
124842503|NCT00213148|449052474|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
124842504|NCT00213148|449052475|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
124842505|NCT00213148|449052476|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
124842506|NCT00213148|449052477|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
124842507|NCT00213148|449052478|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
124842508|NCT00213148|449052474|FG000|Cycle 1 (1 Month)|Other|3|||
124842509|NCT00213148|449052475|FG001|Cycle 1 (1 Month)|Other|0|||
124842510|NCT00213148|449052476|FG002|Cycle 1 (1 Month)|Other|2|||
124842511|NCT00213148|449052477|FG003|Cycle 1 (1 Month)|Other|2|||
124842512|NCT00213148|449052478|FG004|Cycle 1 (1 Month)|Other|7|||
124842513|NCT00213148|449052474|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
124842514|NCT00213148|449052475|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
124842515|NCT00213148|449052476|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
124842516|NCT00213148|449052477|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
124842517|NCT00213148|449052478|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
124842518|NCT00213148|449052474|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
124842519|NCT00213148|449052475|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
124842520|NCT00213148|449052476|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
124842521|NCT00213148|449052477|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
124842522|NCT00213148|449052478|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
124842523|NCT00213148|449052474|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
124842524|NCT00213148|449052475|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
124842525|NCT00213148|449052476|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
124842526|NCT00213148|449052477|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
124842527|NCT00213148|449052478|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
124842528|NCT00213148|449052474|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
124842529|NCT00213148|449052475|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
124842530|NCT00213148|449052476|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
124842531|NCT00213148|449052477|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
124842532|NCT00213148|449052478|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
124842533|NCT00213148|449052474|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
124842534|NCT00213148|449052475|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
124842535|NCT00213148|449052476|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
124842536|NCT00213148|449052477|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
124842537|NCT00213148|449052478|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
124842538|NCT00213148|449052474|FG000|Cycle 2 (1 Month)|Other|2|||
124842539|NCT00213148|449052475|FG001|Cycle 2 (1 Month)|Other|1|||
124842540|NCT00213148|449052476|FG002|Cycle 2 (1 Month)|Other|2|||
124842541|NCT00213148|449052477|FG003|Cycle 2 (1 Month)|Other|8|||
124842542|NCT00213148|449052478|FG004|Cycle 2 (1 Month)|Other|7|||
124842543|NCT00213148|449052474|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
124842544|NCT00213148|449052475|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
124842545|NCT00213148|449052476|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
124842546|NCT00213148|449052477|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
124842547|NCT00213148|449052478|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
124842548|NCT00213148|449052474|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
124842549|NCT00213148|449052475|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
124842550|NCT00213148|449052476|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
124842551|NCT00213148|449052477|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
124842552|NCT00213148|449052478|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
124842553|NCT00213148|449052474|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
124842554|NCT00213148|449052475|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
124842555|NCT00213148|449052476|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
124842556|NCT00213148|449052477|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
124842557|NCT00213148|449052478|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
124842558|NCT00213148|449052474|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
124842559|NCT00213148|449052475|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
124842560|NCT00213148|449052476|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
124842561|NCT00213148|449052477|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
124842562|NCT00213148|449052478|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
124842563|NCT00213148|449052474|FG000|Cycle 3 (1 Month)|Other|0|||
124842564|NCT00213148|449052475|FG001|Cycle 3 (1 Month)|Other|0|||
124842565|NCT00213148|449052476|FG002|Cycle 3 (1 Month)|Other|1|||
124842566|NCT00213148|449052477|FG003|Cycle 3 (1 Month)|Other|1|||
124842567|NCT00213148|449052478|FG004|Cycle 3 (1 Month)|Other|0|||
124842568|NCT03400033|449052481|FG000|Overall Study|Withdrawal by Subject|1|||
124842569|NCT03400033|449052482|FG001|Overall Study|Withdrawal by Subject|2|||
124842570|NCT02469610|449052485|FG000|Overall Study|Death|1|||
124842571|NCT02469610|449052486|FG001|Overall Study|Death|0|||
124842572|NCT02469610|449052485|FG000|Overall Study|Lost to Follow-up|1|||
124842573|NCT02469610|449052486|FG001|Overall Study|Lost to Follow-up|0|||
124842574|NCT02469610|449052485|FG000|Overall Study|exclusion criteria|2|||
124842575|NCT02469610|449052486|FG001|Overall Study|exclusion criteria|1|||
124842576|NCT02434770|449052487|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
124842577|NCT02434770|449052488|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
124842578|NCT02434770|449052489|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
124842579|NCT02434770|449052487|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
124842580|NCT02434770|449052488|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
124842581|NCT02434770|449052489|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
124842582|NCT02434770|449052487|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
124842583|NCT02434770|449052488|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
124842584|NCT02434770|449052489|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
124842585|NCT02434770|449052487|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
124842586|NCT02434770|449052488|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
124842587|NCT02434770|449052489|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
124842588|NCT02434770|449052487|FG000|Week 1 to Week 18|Death|1|||
124842589|NCT02434770|449052488|FG001|Week 1 to Week 18|Death|0|||
124842590|NCT02434770|449052489|FG002|Week 1 to Week 18|Death|0|||
124842591|NCT02434770|449052487|FG000|Week 18 to Week|Lost to Follow-up|2|||
124842592|NCT02434770|449052488|FG001|Week 18 to Week|Lost to Follow-up|2|||
124842593|NCT02434770|449052489|FG002|Week 18 to Week|Lost to Follow-up|1|||
124842594|NCT02434770|449052487|FG000|Week 18 to Week|Withdrawal by Subject|0|||
124842595|NCT02434770|449052488|FG001|Week 18 to Week|Withdrawal by Subject|0|||
124842596|NCT02434770|449052489|FG002|Week 18 to Week|Withdrawal by Subject|2|||
124842597|NCT02434770|449052487|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
124842598|NCT02434770|449052488|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
124842599|NCT02434770|449052489|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
124842600|NCT01574352|449052490|FG000|Overall Study|Withdrawal by Subject|6|||
124842601|NCT01574352|449052491|FG001|Overall Study|Withdrawal by Subject|13|||
124842602|NCT01574352|449052490|FG000|Overall Study|Injury in non-camp related sport|1|||
124842603|NCT01574352|449052491|FG001|Overall Study|Injury in non-camp related sport|0|||
124842604|NCT00245765|449052492|FG000|Overall Study|Adverse Event|1|||
124842605|NCT00245765|449052493|FG001|Overall Study|Adverse Event|1|||
124842606|NCT00245765|449052494|FG002|Overall Study|Adverse Event|0|||
125305500|NCT02218008|450745139|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
125305501|NCT02218008|450745140|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
125305502|NCT02218008|450745141|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
125305503|NCT02218008|450745142|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
125305504|NCT02218008|450745143|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
125305505|NCT02218008|450745144|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
124842607|NCT00245765|449052492|FG000|Overall Study|Lack of Efficacy|14|||
124842608|NCT00245765|449052493|FG001|Overall Study|Lack of Efficacy|7|||
124842609|NCT00245765|449052494|FG002|Overall Study|Lack of Efficacy|0|||
124842610|NCT00245765|449052492|FG000|Overall Study|Lost to Follow-up|1|||
124842611|NCT00245765|449052493|FG001|Overall Study|Lost to Follow-up|2|||
124842612|NCT00245765|449052494|FG002|Overall Study|Lost to Follow-up|0|||
124842613|NCT00245765|449052492|FG000|Overall Study|Withdrawal by Subject|1|||
124842614|NCT00245765|449052493|FG001|Overall Study|Withdrawal by Subject|0|||
124842615|NCT00245765|449052494|FG002|Overall Study|Withdrawal by Subject|3|||
124842616|NCT00245765|449052492|FG000|Overall Study|Other reason|2|||
124842617|NCT00245765|449052493|FG001|Overall Study|Other reason|0|||
124842618|NCT00245765|449052494|FG002|Overall Study|Other reason|1|||
124842619|NCT00245765|449052492|FG000|Overall Study|Other|13|||
124842620|NCT00245765|449052493|FG001|Overall Study|Other|4|||
124842621|NCT00245765|449052494|FG002|Overall Study|Other|4|||
124842622|NCT00660348|449052495|FG000|Overall Study|Withdrawal by Subject|1|||
124842623|NCT00660348|449052496|FG001|Overall Study|Withdrawal by Subject|0|||
124842624|NCT03316872|449052500|FG000|Overall Study|Death|1|||
124842625|NCT04074317|449052503|FG000|Third Period|Withdrawal by Subject|0|||
124842626|NCT04074317|449052504|FG001|Third Period|Withdrawal by Subject|0|||
124842627|NCT04074317|449052505|FG002|Third Period|Withdrawal by Subject|0|||
124842628|NCT04074317|449052506|FG003|Third Period|Withdrawal by Subject|1|||
124842629|NCT04074317|449052507|FG004|Third Period|Withdrawal by Subject|0|||
124842630|NCT04074317|449052508|FG005|Third Period|Withdrawal by Subject|0|||
124842631|NCT00653224|449054438|FG000|Overall Study|Adverse Event|2|||
124842632|NCT00653224|449054439|FG001|Overall Study|Adverse Event|1|||
124842633|NCT00653224|449054438|FG000|Overall Study|Lack of Efficacy|1|||
124842634|NCT00653224|449054439|FG001|Overall Study|Lack of Efficacy|2|||
124842635|NCT00653224|449054438|FG000|Overall Study|Loss of efficacy|1|||
124842636|NCT00653224|449054439|FG001|Overall Study|Loss of efficacy|0|||
124842637|NCT00653224|449054438|FG000|Overall Study|Lost to Follow-up|1|||
124842638|NCT00653224|449054439|FG001|Overall Study|Lost to Follow-up|0|||
125305506|NCT02218008|450745139|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
124842639|NCT00653224|449054438|FG000|Overall Study|Other|2|||
124842640|NCT00653224|449054439|FG001|Overall Study|Other|4|||
124842641|NCT04482179|449054440|FG000|Overall Study|Death|1|||
124842642|NCT04482179|449054441|FG001|Overall Study|Death|0|||
124842643|NCT04482179|449054440|FG000|Overall Study|Withdrawal by Subject|1|||
124842644|NCT04482179|449054441|FG001|Overall Study|Withdrawal by Subject|0|||
124842645|NCT04709237|449054442|FG000|Overall Study|Lost to Follow-up|1|||
124842646|NCT04709237|449054443|FG001|Overall Study|Lost to Follow-up|0|||
124842647|NCT04709237|449054444|FG002|Overall Study|Lost to Follow-up|0|||
124842648|NCT02489318|449054446|FG000|Randomized|Withdrawal by Subject|0|||
124842649|NCT02489318|449054447|FG001|Randomized|Withdrawal by Subject|1|||
124842650|NCT02489318|449054446|FG000|Treated|Adverse Event|19|||
124842651|NCT02489318|449054447|FG001|Treated|Adverse Event|62|||
124842652|NCT02489318|449054446|FG000|Treated|Death|13|||
124842653|NCT02489318|449054447|FG001|Treated|Death|11|||
124842654|NCT02489318|449054446|FG000|Treated|Physician Decision|4|||
124842655|NCT02489318|449054447|FG001|Treated|Physician Decision|6|||
124842656|NCT02489318|449054446|FG000|Treated|Protocol Violation|1|||
124842657|NCT02489318|449054447|FG001|Treated|Protocol Violation|2|||
124842658|NCT02489318|449054446|FG000|Treated|Withdrawal by Subject|37|||
124842659|NCT02489318|449054447|FG001|Treated|Withdrawal by Subject|36|||
124842660|NCT02489318|449054446|FG000|Treated|Other: Progressive Disease|245|||
124842661|NCT02489318|449054447|FG001|Treated|Other: Progressive Disease|138|||
124842662|NCT02489318|449054446|FG000|Treated|Other|0|||
124842663|NCT02489318|449054447|FG001|Treated|Other|2|||
124842664|NCT02489318|449054446|FG000|Treated|Ongoing|0|||
124842665|NCT02489318|449054447|FG001|Treated|Ongoing|267|||
124842666|NCT05723770|449054448|FG000|Overall Study|Lost to Follow-up|4|||
124842667|NCT05723770|449054448|FG000|Overall Study|Withdrawal by Subject|2|||
124842668|NCT01171898|449054449|FG000|Overall Study|Death|0|||
124842669|NCT01171898|449054450|FG001|Overall Study|Death|0|||
124842670|NCT01171898|449054451|FG002|Overall Study|Death|2|||
124842671|NCT01171898|449054452|FG003|Overall Study|Death|0|||
124842672|NCT01171898|449054449|FG000|Overall Study|Lost to Follow-up|0|||
124842673|NCT01171898|449054450|FG001|Overall Study|Lost to Follow-up|1|||
124842674|NCT01171898|449054451|FG002|Overall Study|Lost to Follow-up|1|||
124842675|NCT01171898|449054452|FG003|Overall Study|Lost to Follow-up|1|||
124842676|NCT01171898|449054449|FG000|Overall Study|Withdrawal by Subject|1|||
124842677|NCT01171898|449054450|FG001|Overall Study|Withdrawal by Subject|4|||
124842678|NCT01171898|449054451|FG002|Overall Study|Withdrawal by Subject|6|||
124842679|NCT01171898|449054452|FG003|Overall Study|Withdrawal by Subject|3|||
124842680|NCT01171898|449054449|FG000|Overall Study|Terminated by Sponsor|1|||
124842681|NCT01171898|449054450|FG001|Overall Study|Terminated by Sponsor|0|||
124842682|NCT01171898|449054451|FG002|Overall Study|Terminated by Sponsor|0|||
124842683|NCT01171898|449054452|FG003|Overall Study|Terminated by Sponsor|0|||
124842684|NCT01171898|449054449|FG000|Overall Study|Ongoing|1|||
124842685|NCT01171898|449054450|FG001|Overall Study|Ongoing|9|||
124842686|NCT01171898|449054451|FG002|Overall Study|Ongoing|3|||
124842687|NCT01171898|449054452|FG003|Overall Study|Ongoing|0|||
124842688|NCT01171898|449054449|FG000|Overall Study|Other|1|||
124842689|NCT01171898|449054450|FG001|Overall Study|Other|5|||
124842690|NCT01171898|449054451|FG002|Overall Study|Other|0|||
124842691|NCT01171898|449054452|FG003|Overall Study|Other|2|||
124842692|NCT00419562|449054453|FG000|Overall Study|Lost to Follow-up|12|||
124842693|NCT00419562|449054454|FG001|Overall Study|Lost to Follow-up|13|||
124842694|NCT00419562|449054453|FG000|Overall Study|Withdrawal by Subject|20|||
124842695|NCT00419562|449054454|FG001|Overall Study|Withdrawal by Subject|18|||
124842696|NCT00419562|449054453|FG000|Overall Study|Participant Institutionalized|1|||
124842697|NCT00419562|449054454|FG001|Overall Study|Participant Institutionalized|0|||
124842698|NCT00701129|449054463|FG000|Overall Study|Death|2|||
124842699|NCT00976898|449054473|FG000|Overall Study|Protocol Violation|1|||
124842700|NCT00976898|449054473|FG000|Overall Study|Adverse Event|1|||
124842701|NCT00976898|449054473|FG000|Overall Study|Physician Decision|1|||
124842702|NCT00976898|449054473|FG000|Overall Study|Liver Transplant|1|||
124842703|NCT00976898|449054473|FG000|Overall Study|Progressive Disease|1|||
124842704|NCT05107128|449054474|FG000|Overall Study|Adverse Event|2|||
124842705|NCT05107128|449054475|FG001|Overall Study|Adverse Event|0|||
124842706|NCT05107128|449054474|FG000|Overall Study|Withdrawal by Subject|3|||
124842707|NCT05107128|449054475|FG001|Overall Study|Withdrawal by Subject|3|||
124842708|NCT05107128|449054474|FG000|Overall Study|Withdrawal of Consent|0|||
124842709|NCT05107128|449054475|FG001|Overall Study|Withdrawal of Consent|1|||
124842710|NCT05107128|449054474|FG000|Overall Study|Reason Not Specified|2|||
124842711|NCT05107128|449054475|FG001|Overall Study|Reason Not Specified|0|||
124842712|NCT01470469|449054476|FG000|Overall Study|Withdrawal by Subject|4|||
124842713|NCT01470469|449054477|FG001|Overall Study|Withdrawal by Subject|6|||
124842714|NCT01470469|449054476|FG000|Overall Study|Lack of Efficacy|1|||
124842715|NCT01470469|449054477|FG001|Overall Study|Lack of Efficacy|7|||
124842716|NCT01470469|449054476|FG000|Overall Study|Adverse Event|0|||
124842717|NCT01470469|449054477|FG001|Overall Study|Adverse Event|7|||
124842718|NCT01470469|449054476|FG000|Overall Study|Lost to Follow-up|2|||
124842719|NCT01470469|449054477|FG001|Overall Study|Lost to Follow-up|2|||
124842720|NCT01470469|449054476|FG000|Overall Study|Protocol Violation|1|||
124842721|NCT01470469|449054477|FG001|Overall Study|Protocol Violation|1|||
124842722|NCT01470469|449054476|FG000|Overall Study|Other|2|||
124842723|NCT01470469|449054477|FG001|Overall Study|Other|1|||
124842724|NCT04988295|449054478|FG000|Overall Study|Withdrawal by Subject|9|||
124842725|NCT04988295|449054479|FG001|Overall Study|Withdrawal by Subject|29|||
124842726|NCT04988295|449054480|FG002|Overall Study|Withdrawal by Subject|6|||
124842727|NCT04988295|449054481|FG003|Overall Study|Withdrawal by Subject|0|||
124842728|NCT04988295|449054478|FG000|Overall Study|Lost to Follow-up|1|||
124842729|NCT04988295|449054479|FG001|Overall Study|Lost to Follow-up|0|||
124842730|NCT04988295|449054480|FG002|Overall Study|Lost to Follow-up|0|||
124842731|NCT04988295|449054481|FG003|Overall Study|Lost to Follow-up|0|||
124842732|NCT04988295|449054478|FG000|Overall Study|Study participation ongoing|186|||
124842733|NCT04988295|449054479|FG001|Overall Study|Study participation ongoing|169|||
124842734|NCT04988295|449054480|FG002|Overall Study|Study participation ongoing|99|||
124842735|NCT04988295|449054481|FG003|Overall Study|Study participation ongoing|119|||
124842736|NCT04649151|449054482|FG000|Overall Study|Pregnancy|0|||
124842737|NCT04649151|449054483|FG001|Overall Study|Pregnancy|0|||
124842738|NCT04649151|449054484|FG002|Overall Study|Pregnancy|0|||
124842739|NCT04649151|449054485|FG003|Overall Study|Pregnancy|0|||
124842740|NCT04649151|449054486|FG004|Overall Study|Pregnancy|3|||
124842741|NCT04649151|449054482|FG000|Overall Study|Physician Decision|10|||
124842742|NCT04649151|449054483|FG001|Overall Study|Physician Decision|0|||
124842743|NCT04649151|449054484|FG002|Overall Study|Physician Decision|0|||
124842744|NCT04649151|449054485|FG003|Overall Study|Physician Decision|1|||
124842745|NCT04649151|449054486|FG004|Overall Study|Physician Decision|1|||
124842746|NCT04649151|449054482|FG000|Overall Study|Protocol Deviation|25|||
124842747|NCT04649151|449054483|FG001|Overall Study|Protocol Deviation|3|||
124842748|NCT04649151|449054484|FG002|Overall Study|Protocol Deviation|0|||
124842749|NCT04649151|449054485|FG003|Overall Study|Protocol Deviation|0|||
124842750|NCT04649151|449054486|FG004|Overall Study|Protocol Deviation|0|||
124842751|NCT04649151|449054482|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
124842752|NCT04649151|449054483|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
124842753|NCT04649151|449054484|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
124842754|NCT04649151|449054485|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
124842755|NCT04649151|449054486|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
124842756|NCT04649151|449054482|FG000|Overall Study|Withdrawal by Subject|370|||
124842757|NCT04649151|449054483|FG001|Overall Study|Withdrawal by Subject|113|||
124842758|NCT04649151|449054484|FG002|Overall Study|Withdrawal by Subject|2|||
124842759|NCT04649151|449054485|FG003|Overall Study|Withdrawal by Subject|7|||
124842760|NCT04649151|449054486|FG004|Overall Study|Withdrawal by Subject|15|||
124842761|NCT04649151|449054482|FG000|Overall Study|Adverse Event|1|||
124842762|NCT04649151|449054483|FG001|Overall Study|Adverse Event|0|||
124842763|NCT04649151|449054484|FG002|Overall Study|Adverse Event|0|||
124842764|NCT04649151|449054485|FG003|Overall Study|Adverse Event|0|||
124842765|NCT04649151|449054486|FG004|Overall Study|Adverse Event|0|||
124842766|NCT04649151|449054482|FG000|Overall Study|Lost to Follow-up|256|||
124842767|NCT04649151|449054483|FG001|Overall Study|Lost to Follow-up|29|||
124842768|NCT04649151|449054484|FG002|Overall Study|Lost to Follow-up|10|||
124842769|NCT04649151|449054485|FG003|Overall Study|Lost to Follow-up|3|||
124842770|NCT04649151|449054486|FG004|Overall Study|Lost to Follow-up|6|||
124842771|NCT04649151|449054482|FG000|Overall Study|Other than specified|59|||
124842772|NCT04649151|449054483|FG001|Overall Study|Other than specified|294|||
124842773|NCT04649151|449054484|FG002|Overall Study|Other than specified|0|||
124842774|NCT04649151|449054485|FG003|Overall Study|Other than specified|0|||
124842775|NCT04649151|449054486|FG004|Overall Study|Other than specified|4|||
124842776|NCT04649151|449054482|FG000|Overall Study|Death|0|||
124842777|NCT04649151|449054483|FG001|Overall Study|Death|0|||
124842778|NCT04649151|449054484|FG002|Overall Study|Death|0|||
124842779|NCT04649151|449054485|FG003|Overall Study|Death|0|||
124842780|NCT04649151|449054486|FG004|Overall Study|Death|1|||
124842781|NCT03752619|449054487|FG000|Overall Study|Lost to Follow-up|2|||
124842782|NCT03752619|449054488|FG001|Overall Study|Lost to Follow-up|1|||
124842783|NCT03752619|449054487|FG000|Overall Study|Withdrawal by Subject|1|||
124842784|NCT03752619|449054488|FG001|Overall Study|Withdrawal by Subject|1|||
124842785|NCT03752619|449054487|FG000|Overall Study|Adverse Event|0|||
124842786|NCT03752619|449054488|FG001|Overall Study|Adverse Event|1|||
124842787|NCT03362502|449054490|FG000|Overall Study|Death|0|||
124842788|NCT03362502|449054491|FG001|Overall Study|Death|0|||
124842789|NCT03362502|449054492|FG002|Overall Study|Death|1|||
124842790|NCT00433654|449054493|FG000|Overall Study|Death|4|||
124842791|NCT00433654|449054494|FG001|Overall Study|Death|0|||
124842792|NCT00433654|449054493|FG000|Overall Study|Missed visit|6|||
124842793|NCT00433654|449054494|FG001|Overall Study|Missed visit|3|||
124842794|NCT00433654|449054493|FG000|Overall Study|Subject not yet due for visit|4|||
124842795|NCT00433654|449054494|FG001|Overall Study|Subject not yet due for visit|0|||
124842796|NCT00433654|449054493|FG000|Overall Study|Withdrawal by Subject|1|||
124842797|NCT00433654|449054494|FG001|Overall Study|Withdrawal by Subject|2|||
124842798|NCT01428193|449054495|FG000|Overall Study|Physician Decision|1|||
124842799|NCT01428193|449054495|FG000|Overall Study|Elevated screening liver enzymes|1|||
124842800|NCT04049760|449054510|FG000|Overall Study|Withdrawal by Subject|1|||
124842801|NCT02457598|449054511|FG000|Overall Study|Progressive Disease|2|||
124842802|NCT02457598|449054512|FG001|Overall Study|Progressive Disease|2|||
124842803|NCT02457598|449054513|FG002|Overall Study|Progressive Disease|1|||
124842804|NCT02457598|449054514|FG003|Overall Study|Progressive Disease|11|||
124842805|NCT02457598|449054515|FG004|Overall Study|Progressive Disease|7|||
124842806|NCT02457598|449054516|FG005|Overall Study|Progressive Disease|3|||
124842807|NCT02457598|449054517|FG006|Overall Study|Progressive Disease|2|||
124842808|NCT02457598|449054518|FG007|Overall Study|Progressive Disease|1|||
124842809|NCT02457598|449054519|FG008|Overall Study|Progressive Disease|1|||
124842810|NCT02457598|449054520|FG009|Overall Study|Progressive Disease|2|||
124842811|NCT02457598|449054521|FG010|Overall Study|Progressive Disease|45|||
124842812|NCT02457598|449054522|FG011|Overall Study|Progressive Disease|6|||
124842813|NCT02457598|449054523|FG012|Overall Study|Progressive Disease|2|||
124842814|NCT02457598|449054524|FG013|Overall Study|Progressive Disease|2|||
124842815|NCT02457598|449054525|FG014|Overall Study|Progressive Disease|10|||
124842816|NCT02457598|449054526|FG015|Overall Study|Progressive Disease|1|||
124842817|NCT02457598|449054527|FG016|Overall Study|Progressive Disease|1|||
124842818|NCT02457598|449054511|FG000|Overall Study|Investigator's Discretion|0|||
124842819|NCT02457598|449054512|FG001|Overall Study|Investigator's Discretion|2|||
124842820|NCT02457598|449054513|FG002|Overall Study|Investigator's Discretion|2|||
124842821|NCT02457598|449054514|FG003|Overall Study|Investigator's Discretion|2|||
124842822|NCT02457598|449054515|FG004|Overall Study|Investigator's Discretion|0|||
124842823|NCT02457598|449054516|FG005|Overall Study|Investigator's Discretion|0|||
124842824|NCT02457598|449054517|FG006|Overall Study|Investigator's Discretion|0|||
124842825|NCT02457598|449054518|FG007|Overall Study|Investigator's Discretion|1|||
124842826|NCT02457598|449054519|FG008|Overall Study|Investigator's Discretion|2|||
124842827|NCT02457598|449054520|FG009|Overall Study|Investigator's Discretion|0|||
124842828|NCT02457598|449054521|FG010|Overall Study|Investigator's Discretion|10|||
124842829|NCT02457598|449054522|FG011|Overall Study|Investigator's Discretion|2|||
124842830|NCT02457598|449054523|FG012|Overall Study|Investigator's Discretion|2|||
124842831|NCT02457598|449054524|FG013|Overall Study|Investigator's Discretion|1|||
124842832|NCT02457598|449054525|FG014|Overall Study|Investigator's Discretion|5|||
124842833|NCT02457598|449054526|FG015|Overall Study|Investigator's Discretion|0|||
124842834|NCT02457598|449054527|FG016|Overall Study|Investigator's Discretion|0|||
124842835|NCT02457598|449054511|FG000|Overall Study|Study Terminated by Sponsor|0|||
124842836|NCT02457598|449054512|FG001|Overall Study|Study Terminated by Sponsor|1|||
124842837|NCT02457598|449054513|FG002|Overall Study|Study Terminated by Sponsor|0|||
124842838|NCT02457598|449054514|FG003|Overall Study|Study Terminated by Sponsor|4|||
124842839|NCT02457598|449054515|FG004|Overall Study|Study Terminated by Sponsor|1|||
124842840|NCT02457598|449054516|FG005|Overall Study|Study Terminated by Sponsor|0|||
124842841|NCT02457598|449054517|FG006|Overall Study|Study Terminated by Sponsor|1|||
124842842|NCT02457598|449054518|FG007|Overall Study|Study Terminated by Sponsor|0|||
124842843|NCT02457598|449054519|FG008|Overall Study|Study Terminated by Sponsor|0|||
124842844|NCT02457598|449054520|FG009|Overall Study|Study Terminated by Sponsor|0|||
124842845|NCT02457598|449054521|FG010|Overall Study|Study Terminated by Sponsor|4|||
124842846|NCT02457598|449054522|FG011|Overall Study|Study Terminated by Sponsor|0|||
124842847|NCT02457598|449054523|FG012|Overall Study|Study Terminated by Sponsor|1|||
124842848|NCT02457598|449054524|FG013|Overall Study|Study Terminated by Sponsor|0|||
124842849|NCT02457598|449054525|FG014|Overall Study|Study Terminated by Sponsor|8|||
124842850|NCT02457598|449054526|FG015|Overall Study|Study Terminated by Sponsor|1|||
124842851|NCT02457598|449054527|FG016|Overall Study|Study Terminated by Sponsor|0|||
124842852|NCT02457598|449054511|FG000|Overall Study|Adverse Event|0|||
124842853|NCT02457598|449054512|FG001|Overall Study|Adverse Event|1|||
124842854|NCT02457598|449054513|FG002|Overall Study|Adverse Event|1|||
124842855|NCT02457598|449054514|FG003|Overall Study|Adverse Event|4|||
124842856|NCT02457598|449054515|FG004|Overall Study|Adverse Event|1|||
124842857|NCT02457598|449054516|FG005|Overall Study|Adverse Event|0|||
124842858|NCT02457598|449054517|FG006|Overall Study|Adverse Event|0|||
124842859|NCT02457598|449054518|FG007|Overall Study|Adverse Event|1|||
124842860|NCT02457598|449054519|FG008|Overall Study|Adverse Event|0|||
124842861|NCT02457598|449054520|FG009|Overall Study|Adverse Event|1|||
124842862|NCT02457598|449054521|FG010|Overall Study|Adverse Event|6|||
124842863|NCT02457598|449054522|FG011|Overall Study|Adverse Event|0|||
124842864|NCT02457598|449054523|FG012|Overall Study|Adverse Event|0|||
124842865|NCT02457598|449054524|FG013|Overall Study|Adverse Event|1|||
124842866|NCT02457598|449054525|FG014|Overall Study|Adverse Event|2|||
124842867|NCT02457598|449054526|FG015|Overall Study|Adverse Event|0|||
124842868|NCT02457598|449054527|FG016|Overall Study|Adverse Event|0|||
124842869|NCT02457598|449054511|FG000|Overall Study|Death|0|||
124842870|NCT02457598|449054512|FG001|Overall Study|Death|0|||
124842871|NCT02457598|449054513|FG002|Overall Study|Death|0|||
124842872|NCT02457598|449054514|FG003|Overall Study|Death|3|||
124842873|NCT02457598|449054515|FG004|Overall Study|Death|0|||
124842874|NCT02457598|449054516|FG005|Overall Study|Death|1|||
124842875|NCT02457598|449054517|FG006|Overall Study|Death|0|||
124842876|NCT02457598|449054518|FG007|Overall Study|Death|0|||
124842877|NCT02457598|449054519|FG008|Overall Study|Death|0|||
124842878|NCT02457598|449054520|FG009|Overall Study|Death|0|||
124842879|NCT02457598|449054521|FG010|Overall Study|Death|3|||
124842880|NCT02457598|449054522|FG011|Overall Study|Death|0|||
124842881|NCT02457598|449054523|FG012|Overall Study|Death|0|||
124842882|NCT02457598|449054524|FG013|Overall Study|Death|1|||
124842883|NCT02457598|449054525|FG014|Overall Study|Death|2|||
124842884|NCT02457598|449054526|FG015|Overall Study|Death|0|||
124842885|NCT02457598|449054527|FG016|Overall Study|Death|1|||
124842886|NCT02457598|449054511|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
124842887|NCT02457598|449054512|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
124842888|NCT02457598|449054513|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
124842889|NCT02457598|449054514|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
124842890|NCT02457598|449054515|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
124842891|NCT02457598|449054516|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
124842892|NCT02457598|449054517|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
124842893|NCT02457598|449054518|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
124842894|NCT02457598|449054519|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
124842895|NCT02457598|449054520|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
124842896|NCT02457598|449054521|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
124842897|NCT02457598|449054522|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
124842898|NCT02457598|449054523|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
124842899|NCT02457598|449054524|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
124842900|NCT02457598|449054525|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
124842901|NCT02457598|449054526|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
124842902|NCT02457598|449054527|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
124842903|NCT02457598|449054511|FG000|Overall Study|Withdrew Consent|0|||
124842904|NCT02457598|449054512|FG001|Overall Study|Withdrew Consent|0|||
124842905|NCT02457598|449054513|FG002|Overall Study|Withdrew Consent|0|||
124842906|NCT02457598|449054514|FG003|Overall Study|Withdrew Consent|0|||
124842907|NCT02457598|449054515|FG004|Overall Study|Withdrew Consent|0|||
124842908|NCT02457598|449054516|FG005|Overall Study|Withdrew Consent|0|||
124842909|NCT02457598|449054517|FG006|Overall Study|Withdrew Consent|0|||
124842910|NCT02457598|449054518|FG007|Overall Study|Withdrew Consent|2|||
124842911|NCT02457598|449054519|FG008|Overall Study|Withdrew Consent|0|||
124842912|NCT02457598|449054520|FG009|Overall Study|Withdrew Consent|0|||
124842913|NCT02457598|449054521|FG010|Overall Study|Withdrew Consent|3|||
124842914|NCT02457598|449054522|FG011|Overall Study|Withdrew Consent|0|||
124842915|NCT02457598|449054523|FG012|Overall Study|Withdrew Consent|0|||
124842916|NCT02457598|449054524|FG013|Overall Study|Withdrew Consent|1|||
124842917|NCT02457598|449054525|FG014|Overall Study|Withdrew Consent|0|||
124842918|NCT02457598|449054526|FG015|Overall Study|Withdrew Consent|0|||
124842919|NCT02457598|449054527|FG016|Overall Study|Withdrew Consent|0|||
124842920|NCT02457598|449054511|FG000|Overall Study|Unacceptable Toxicity|0|||
124842921|NCT02457598|449054512|FG001|Overall Study|Unacceptable Toxicity|0|||
124842922|NCT02457598|449054513|FG002|Overall Study|Unacceptable Toxicity|0|||
124842923|NCT02457598|449054514|FG003|Overall Study|Unacceptable Toxicity|0|||
124842924|NCT02457598|449054515|FG004|Overall Study|Unacceptable Toxicity|0|||
124842925|NCT02457598|449054516|FG005|Overall Study|Unacceptable Toxicity|0|||
124842926|NCT02457598|449054517|FG006|Overall Study|Unacceptable Toxicity|0|||
124842927|NCT02457598|449054518|FG007|Overall Study|Unacceptable Toxicity|0|||
124842928|NCT02457598|449054519|FG008|Overall Study|Unacceptable Toxicity|0|||
124842929|NCT02457598|449054520|FG009|Overall Study|Unacceptable Toxicity|0|||
124842930|NCT02457598|449054521|FG010|Overall Study|Unacceptable Toxicity|1|||
124842931|NCT02457598|449054522|FG011|Overall Study|Unacceptable Toxicity|0|||
124842932|NCT02457598|449054523|FG012|Overall Study|Unacceptable Toxicity|1|||
124842933|NCT02457598|449054524|FG013|Overall Study|Unacceptable Toxicity|1|||
124842934|NCT02457598|449054525|FG014|Overall Study|Unacceptable Toxicity|1|||
124842935|NCT02457598|449054526|FG015|Overall Study|Unacceptable Toxicity|0|||
124842936|NCT02457598|449054527|FG016|Overall Study|Unacceptable Toxicity|0|||
124842937|NCT02457598|449054511|FG000|Overall Study|Intercurrent Illness|0|||
124842938|NCT02457598|449054512|FG001|Overall Study|Intercurrent Illness|0|||
124842939|NCT02457598|449054513|FG002|Overall Study|Intercurrent Illness|0|||
124842940|NCT02457598|449054514|FG003|Overall Study|Intercurrent Illness|0|||
124842941|NCT02457598|449054515|FG004|Overall Study|Intercurrent Illness|0|||
124842942|NCT02457598|449054516|FG005|Overall Study|Intercurrent Illness|0|||
124842943|NCT02457598|449054517|FG006|Overall Study|Intercurrent Illness|0|||
124842944|NCT02457598|449054518|FG007|Overall Study|Intercurrent Illness|0|||
124842945|NCT02457598|449054519|FG008|Overall Study|Intercurrent Illness|0|||
124842946|NCT02457598|449054520|FG009|Overall Study|Intercurrent Illness|0|||
124842947|NCT02457598|449054521|FG010|Overall Study|Intercurrent Illness|1|||
124842948|NCT02457598|449054522|FG011|Overall Study|Intercurrent Illness|0|||
124842949|NCT02457598|449054523|FG012|Overall Study|Intercurrent Illness|0|||
124842950|NCT02457598|449054524|FG013|Overall Study|Intercurrent Illness|0|||
124842951|NCT02457598|449054525|FG014|Overall Study|Intercurrent Illness|0|||
124842952|NCT02457598|449054526|FG015|Overall Study|Intercurrent Illness|0|||
124842953|NCT02457598|449054527|FG016|Overall Study|Intercurrent Illness|0|||
124842954|NCT02457598|449054511|FG000|Overall Study|Protocol Violation|0|||
124842955|NCT02457598|449054512|FG001|Overall Study|Protocol Violation|0|||
124842956|NCT02457598|449054513|FG002|Overall Study|Protocol Violation|0|||
125305507|NCT02218008|450745140|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
125305508|NCT02218008|450745141|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
125305509|NCT02218008|450745142|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
125305510|NCT02218008|450745143|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
124842957|NCT02457598|449054514|FG003|Overall Study|Protocol Violation|0|||
124842958|NCT02457598|449054515|FG004|Overall Study|Protocol Violation|0|||
124842959|NCT02457598|449054516|FG005|Overall Study|Protocol Violation|0|||
124842960|NCT02457598|449054517|FG006|Overall Study|Protocol Violation|0|||
124842961|NCT02457598|449054518|FG007|Overall Study|Protocol Violation|0|||
124842962|NCT02457598|449054519|FG008|Overall Study|Protocol Violation|0|||
124842963|NCT02457598|449054520|FG009|Overall Study|Protocol Violation|0|||
124842964|NCT02457598|449054521|FG010|Overall Study|Protocol Violation|1|||
124842965|NCT02457598|449054522|FG011|Overall Study|Protocol Violation|0|||
124842966|NCT02457598|449054523|FG012|Overall Study|Protocol Violation|0|||
124842967|NCT02457598|449054524|FG013|Overall Study|Protocol Violation|0|||
124842968|NCT02457598|449054525|FG014|Overall Study|Protocol Violation|0|||
124842969|NCT02457598|449054526|FG015|Overall Study|Protocol Violation|0|||
124842970|NCT02457598|449054527|FG016|Overall Study|Protocol Violation|0|||
124842971|NCT01403974|449054528|FG000|Overall Study|Progressive disease according to RECIST|3|||
124842972|NCT01403974|449054529|FG001|Overall Study|Progressive disease according to RECIST|3|||
124842973|NCT01403974|449054530|FG002|Overall Study|Progressive disease according to RECIST|2|||
124842974|NCT01403974|449054531|FG003|Overall Study|Progressive disease according to RECIST|3|||
124842975|NCT01403974|449054532|FG004|Overall Study|Progressive disease according to RECIST|3|||
124842976|NCT01403974|449054533|FG005|Overall Study|Progressive disease according to RECIST|2|||
124842977|NCT01403974|449054534|FG006|Overall Study|Progressive disease according to RECIST|3|||
124842978|NCT01403974|449054535|FG007|Overall Study|Progressive disease according to RECIST|2|||
124842979|NCT01403974|449054536|FG008|Overall Study|Progressive disease according to RECIST|6|||
124842980|NCT01403974|449054537|FG009|Overall Study|Progressive disease according to RECIST|2|||
124842981|NCT01403974|449054538|FG010|Overall Study|Progressive disease according to RECIST|3|||
124842982|NCT01403974|449054539|FG011|Overall Study|Progressive disease according to RECIST|2|||
124842983|NCT01403974|449054540|FG012|Overall Study|Progressive disease according to RECIST|2|||
124842984|NCT01403974|449054541|FG013|Overall Study|Progressive disease according to RECIST|3|||
124842985|NCT01403974|449054542|FG014|Overall Study|Progressive disease according to RECIST|1|||
124842986|NCT01403974|449054543|FG015|Overall Study|Progressive disease according to RECIST|8|||
124842987|NCT01403974|449054528|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
124842988|NCT01403974|449054529|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
124842989|NCT01403974|449054530|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
124842990|NCT01403974|449054531|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
124842991|NCT01403974|449054532|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
124842992|NCT01403974|449054533|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
124842993|NCT01403974|449054534|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
124842994|NCT01403974|449054535|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
124842995|NCT01403974|449054536|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
124842996|NCT01403974|449054537|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
124842997|NCT01403974|449054538|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
124842998|NCT01403974|449054539|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
124842999|NCT01403974|449054540|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
124843000|NCT01403974|449054541|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
124843001|NCT01403974|449054542|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
124843002|NCT01403974|449054543|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
124843003|NCT01403974|449054528|FG000|Overall Study|Refused to continue study medication|0|||
124843004|NCT01403974|449054529|FG001|Overall Study|Refused to continue study medication|0|||
124843005|NCT01403974|449054530|FG002|Overall Study|Refused to continue study medication|0|||
124843006|NCT01403974|449054531|FG003|Overall Study|Refused to continue study medication|0|||
124843007|NCT01403974|449054532|FG004|Overall Study|Refused to continue study medication|0|||
124843008|NCT01403974|449054533|FG005|Overall Study|Refused to continue study medication|1|||
124843009|NCT01403974|449054534|FG006|Overall Study|Refused to continue study medication|0|||
124843010|NCT01403974|449054535|FG007|Overall Study|Refused to continue study medication|0|||
124843011|NCT01403974|449054536|FG008|Overall Study|Refused to continue study medication|1|||
124843012|NCT01403974|449054537|FG009|Overall Study|Refused to continue study medication|0|||
124843013|NCT01403974|449054538|FG010|Overall Study|Refused to continue study medication|1|||
124843014|NCT01403974|449054539|FG011|Overall Study|Refused to continue study medication|0|||
124843015|NCT01403974|449054540|FG012|Overall Study|Refused to continue study medication|0|||
124843016|NCT01403974|449054541|FG013|Overall Study|Refused to continue study medication|0|||
124843017|NCT01403974|449054542|FG014|Overall Study|Refused to continue study medication|0|||
124843018|NCT01403974|449054543|FG015|Overall Study|Refused to continue study medication|4|||
124843019|NCT01403974|449054528|FG000|Overall Study|Adverse Event|0|||
124843020|NCT01403974|449054529|FG001|Overall Study|Adverse Event|0|||
124843021|NCT01403974|449054530|FG002|Overall Study|Adverse Event|1|||
124843022|NCT01403974|449054531|FG003|Overall Study|Adverse Event|0|||
124843023|NCT01403974|449054532|FG004|Overall Study|Adverse Event|0|||
124843024|NCT01403974|449054533|FG005|Overall Study|Adverse Event|0|||
124843025|NCT01403974|449054534|FG006|Overall Study|Adverse Event|0|||
124843026|NCT01403974|449054535|FG007|Overall Study|Adverse Event|1|||
124843027|NCT01403974|449054536|FG008|Overall Study|Adverse Event|0|||
124843028|NCT01403974|449054537|FG009|Overall Study|Adverse Event|0|||
124843029|NCT01403974|449054538|FG010|Overall Study|Adverse Event|0|||
124843030|NCT01403974|449054539|FG011|Overall Study|Adverse Event|0|||
124843031|NCT01403974|449054540|FG012|Overall Study|Adverse Event|1|||
124843032|NCT01403974|449054541|FG013|Overall Study|Adverse Event|0|||
124843033|NCT01403974|449054542|FG014|Overall Study|Adverse Event|0|||
124843034|NCT01403974|449054543|FG015|Overall Study|Adverse Event|0|||
124843035|NCT01403974|449054528|FG000|Overall Study|Other than specified|0|||
124843036|NCT01403974|449054529|FG001|Overall Study|Other than specified|0|||
124843037|NCT01403974|449054530|FG002|Overall Study|Other than specified|0|||
124843038|NCT01403974|449054531|FG003|Overall Study|Other than specified|0|||
124843039|NCT01403974|449054532|FG004|Overall Study|Other than specified|0|||
124843040|NCT01403974|449054533|FG005|Overall Study|Other than specified|0|||
124843041|NCT01403974|449054534|FG006|Overall Study|Other than specified|0|||
124843042|NCT01403974|449054535|FG007|Overall Study|Other than specified|0|||
124843043|NCT01403974|449054536|FG008|Overall Study|Other than specified|0|||
124843044|NCT01403974|449054537|FG009|Overall Study|Other than specified|1|||
124843045|NCT01403974|449054538|FG010|Overall Study|Other than specified|0|||
124843046|NCT01403974|449054539|FG011|Overall Study|Other than specified|1|||
124843047|NCT01403974|449054540|FG012|Overall Study|Other than specified|0|||
124843048|NCT01403974|449054541|FG013|Overall Study|Other than specified|0|||
124843049|NCT01403974|449054542|FG014|Overall Study|Other than specified|0|||
124843050|NCT01403974|449054543|FG015|Overall Study|Other than specified|0|||
124843051|NCT01526889|449054544|FG000|Treatment Period|Adverse Event|2|||
124843052|NCT01526889|449054545|FG001|Treatment Period|Adverse Event|0|||
124843053|NCT01526889|449054544|FG000|Treatment Extension Period|Administrative problems|1|||
124843054|NCT01526889|449054545|FG001|Treatment Extension Period|Administrative problems|0|||
124843055|NCT02703636|449054547|FG000|Overall Study|Adverse Event|14|||
124843056|NCT02703636|449054547|FG000|Overall Study|Study stopped by sponsor|1|||
124843057|NCT02703636|449054547|FG000|Overall Study|Withdrawal by Subject|1|||
124843058|NCT00393939|449054548|FG000|Overall Study|Protocol Violation|1|||
124843059|NCT00393939|449054549|FG001|Overall Study|Protocol Violation|1|||
124843060|NCT00393939|449054548|FG000|Overall Study|Lost to Follow-up|2|||
124843061|NCT00393939|449054549|FG001|Overall Study|Lost to Follow-up|4|||
124843062|NCT00393939|449054548|FG000|Overall Study|Death|10|||
124843063|NCT00393939|449054549|FG001|Overall Study|Death|4|||
124843064|NCT00393939|449054548|FG000|Overall Study|Sponsor|5|||
124843065|NCT00393939|449054549|FG001|Overall Study|Sponsor|13|||
124843066|NCT00393939|449054548|FG000|Overall Study|Objective progression or relapse|239|||
124843067|NCT00393939|449054549|FG001|Overall Study|Objective progression or relapse|223|||
124843068|NCT00393939|449054548|FG000|Overall Study|Withdrawal by Subject|2|||
124843069|NCT00393939|449054549|FG001|Overall Study|Withdrawal by Subject|7|||
124843070|NCT00393939|449054548|FG000|Overall Study|Other|37|||
124843071|NCT00393939|449054549|FG001|Overall Study|Other|45|||
124843072|NCT04334460|449054555|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
124843073|NCT04334460|449054556|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
124843074|NCT04334460|449054555|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
124843075|NCT04334460|449054556|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
124843076|NCT00547703|449054557|FG000|Overall Study|Lost to Follow-up|1|||
124843077|NCT00547703|449054558|FG001|Overall Study|Lost to Follow-up|0|||
124843078|NCT03995953|449054561|FG000|Overall Study|Death|3|||
124843079|NCT03995953|449054562|FG001|Overall Study|Death|0|||
124843080|NCT03995953|449054563|FG002|Overall Study|Death|3|||
124843081|NCT03995953|449054564|FG003|Overall Study|Death|0|||
124843082|NCT03995953|449054565|FG004|Overall Study|Death|3|||
124843083|NCT03995953|449054566|FG005|Overall Study|Death|0|||
124843084|NCT03995953|449054567|FG006|Overall Study|Death|0|||
124843085|NCT03995953|449054568|FG007|Overall Study|Death|0|||
124843086|NCT03995953|449054569|FG008|Overall Study|Death|1|||
124843087|NCT03995953|449054570|FG009|Overall Study|Death|0|||
124843088|NCT03995953|449054571|FG010|Overall Study|Death|0|||
124843089|NCT03995953|449054572|FG011|Overall Study|Death|0|||
124843090|NCT03995953|449054561|FG000|Overall Study|Lost to Follow-up|6|||
124843091|NCT03995953|449054562|FG001|Overall Study|Lost to Follow-up|54|||
124843092|NCT03995953|449054563|FG002|Overall Study|Lost to Follow-up|3|||
124843093|NCT03995953|449054564|FG003|Overall Study|Lost to Follow-up|32|||
124843094|NCT03995953|449054565|FG004|Overall Study|Lost to Follow-up|5|||
124843095|NCT03995953|449054566|FG005|Overall Study|Lost to Follow-up|44|||
124843096|NCT03995953|449054567|FG006|Overall Study|Lost to Follow-up|0|||
124843097|NCT03995953|449054568|FG007|Overall Study|Lost to Follow-up|31|||
124843098|NCT03995953|449054569|FG008|Overall Study|Lost to Follow-up|8|||
124843099|NCT03995953|449054570|FG009|Overall Study|Lost to Follow-up|36|||
124843100|NCT03995953|449054571|FG010|Overall Study|Lost to Follow-up|5|||
124843101|NCT03995953|449054572|FG011|Overall Study|Lost to Follow-up|41|||
124843102|NCT03995953|449054561|FG000|Overall Study|Withdrawal by Subject|4|||
124843103|NCT03995953|449054562|FG001|Overall Study|Withdrawal by Subject|0|||
124843104|NCT03995953|449054563|FG002|Overall Study|Withdrawal by Subject|1|||
124843105|NCT03995953|449054564|FG003|Overall Study|Withdrawal by Subject|0|||
124843106|NCT03995953|449054565|FG004|Overall Study|Withdrawal by Subject|1|||
124843107|NCT03995953|449054566|FG005|Overall Study|Withdrawal by Subject|0|||
125305511|NCT02218008|450745144|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
124843108|NCT03995953|449054567|FG006|Overall Study|Withdrawal by Subject|1|||
124843109|NCT03995953|449054568|FG007|Overall Study|Withdrawal by Subject|0|||
124843110|NCT03995953|449054569|FG008|Overall Study|Withdrawal by Subject|3|||
124843111|NCT03995953|449054570|FG009|Overall Study|Withdrawal by Subject|0|||
124843112|NCT03995953|449054571|FG010|Overall Study|Withdrawal by Subject|3|||
124843113|NCT03995953|449054572|FG011|Overall Study|Withdrawal by Subject|0|||
124843114|NCT03995953|449054561|FG000|Overall Study|Health Issues|0|||
124843115|NCT03995953|449054562|FG001|Overall Study|Health Issues|0|||
124843116|NCT03995953|449054563|FG002|Overall Study|Health Issues|0|||
124843117|NCT03995953|449054564|FG003|Overall Study|Health Issues|0|||
124843118|NCT03995953|449054565|FG004|Overall Study|Health Issues|1|||
124843119|NCT03995953|449054566|FG005|Overall Study|Health Issues|0|||
124843120|NCT03995953|449054567|FG006|Overall Study|Health Issues|0|||
124843121|NCT03995953|449054568|FG007|Overall Study|Health Issues|0|||
124843122|NCT03995953|449054569|FG008|Overall Study|Health Issues|4|||
124843123|NCT03995953|449054570|FG009|Overall Study|Health Issues|0|||
124843124|NCT03995953|449054571|FG010|Overall Study|Health Issues|0|||
124843125|NCT03995953|449054572|FG011|Overall Study|Health Issues|0|||
124843126|NCT03995953|449054561|FG000|Overall Study|Relocated|11|||
124843127|NCT03995953|449054562|FG001|Overall Study|Relocated|0|||
124843128|NCT03995953|449054563|FG002|Overall Study|Relocated|16|||
124843129|NCT03995953|449054564|FG003|Overall Study|Relocated|0|||
124843130|NCT03995953|449054565|FG004|Overall Study|Relocated|14|||
124843131|NCT03995953|449054566|FG005|Overall Study|Relocated|0|||
124843132|NCT03995953|449054567|FG006|Overall Study|Relocated|16|||
124843133|NCT03995953|449054568|FG007|Overall Study|Relocated|0|||
124843134|NCT03995953|449054569|FG008|Overall Study|Relocated|14|||
124843135|NCT03995953|449054570|FG009|Overall Study|Relocated|0|||
124843136|NCT03995953|449054571|FG010|Overall Study|Relocated|15|||
124843137|NCT03995953|449054572|FG011|Overall Study|Relocated|0|||
124843138|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
124843139|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
124843140|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
124843141|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
124843142|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
124843143|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
124843144|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
124843145|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
124843146|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
124843147|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
124843148|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
124843149|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
124843150|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
124843151|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
124843152|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
124843153|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
124843154|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
124843155|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
124843156|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
124843157|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
124843158|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
124843159|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
124843160|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
124843161|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
124843162|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
124843163|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
124843164|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
124843165|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
124843166|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
124843167|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
124843168|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
124843169|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
124843170|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
124843171|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
124843172|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
124843173|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
124843174|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
124843175|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
124843176|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
124843177|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
124843178|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
124843179|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
124843180|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
124843181|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
124843182|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
124843183|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
124843184|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
124843185|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
124843186|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
124843187|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
124843188|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
124843189|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
124843190|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
124843191|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
124843192|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
124843193|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
124843194|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
124843195|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
124843196|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
124843197|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
124843198|NCT04951622|449054580|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
124843199|NCT04951622|449054581|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
124843200|NCT04951622|449054582|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
124843201|NCT04951622|449054583|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
124843202|NCT04951622|449054584|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
124843203|NCT04951622|449054580|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
124843204|NCT04951622|449054581|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
124843205|NCT04951622|449054582|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
124843206|NCT04951622|449054583|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
124843207|NCT04951622|449054584|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
124843208|NCT04951622|449054580|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
124843209|NCT04951622|449054581|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
124843210|NCT04951622|449054582|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
124843211|NCT04951622|449054583|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
124843212|NCT04951622|449054584|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
124843213|NCT04951622|449054580|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
124843214|NCT04951622|449054581|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
124843215|NCT04951622|449054582|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
124843216|NCT04951622|449054583|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
124843217|NCT04951622|449054584|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
124843218|NCT04951622|449054580|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
124843219|NCT04951622|449054581|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
124843220|NCT04951622|449054582|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
124843221|NCT04951622|449054583|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
124843222|NCT04951622|449054584|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
124843223|NCT04951622|449054580|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
124843224|NCT04951622|449054581|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
124843225|NCT04951622|449054582|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
124843226|NCT04951622|449054583|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
124843227|NCT04951622|449054584|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
124843228|NCT04951622|449054580|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
124843229|NCT04951622|449054581|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
124843230|NCT04951622|449054582|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
124843231|NCT04951622|449054583|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
124843232|NCT04951622|449054584|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
124843233|NCT04951622|449054580|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
124843234|NCT04951622|449054581|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
124843235|NCT04951622|449054582|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
124843236|NCT04951622|449054583|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
124843237|NCT04951622|449054584|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
124843238|NCT04108208|449054585|FG000|Overall Study|Withdrawal by Subject|2|||
125305512|NCT02218008|450745139|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
125305513|NCT02218008|450745140|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
125305514|NCT02218008|450745141|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
125305515|NCT02218008|450745142|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
125305516|NCT02218008|450745143|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
125305517|NCT02218008|450745144|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
125305518|NCT02218008|450745139|FG000|Stage 1 (S1)|Pregnancy|0|||
124843239|NCT04108208|449054586|FG001|Overall Study|Withdrawal by Subject|6|||
124843240|NCT04108208|449054585|FG000|Overall Study|other-ongoing|20|||
124843241|NCT04108208|449054586|FG001|Overall Study|other-ongoing|40|||
124843242|NCT04108208|449054585|FG000|Overall Study|Death|1|||
124843243|NCT04108208|449054586|FG001|Overall Study|Death|4|||
124843244|NCT04108208|449054585|FG000|Overall Study|Lost to Follow-up|2|||
124843245|NCT04108208|449054586|FG001|Overall Study|Lost to Follow-up|0|||
124843246|NCT02948842|449054588|FG000|Overall Study|Withdrawal by Subject|4|||
124843247|NCT04181827|449054592|FG000|Overall Study|Ongoing|124|||
124843248|NCT04181827|449054593|FG001|Overall Study|Ongoing|157|||
124843249|NCT04181827|449054592|FG000|Overall Study|Death|82|||
124843250|NCT04181827|449054593|FG001|Overall Study|Death|50|||
124843251|NCT04181827|449054592|FG000|Overall Study|Lost to Follow-up|0|||
124843252|NCT04181827|449054593|FG001|Overall Study|Lost to Follow-up|1|||
124843253|NCT04181827|449054592|FG000|Overall Study|Withdrawal by Subject|5|||
124843254|NCT04181827|449054593|FG001|Overall Study|Withdrawal by Subject|0|||
124843255|NCT01256710|449054594|FG000|Overall Study|Death|449|||
124843256|NCT01256710|449054594|FG000|Overall Study|System Explant|67|||
124843257|NCT01256710|449054594|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
124843258|NCT01256710|449054594|FG000|Overall Study|Lost to Follow-up|67|||
124843259|NCT01256710|449054594|FG000|Overall Study|Withdrawal by Subject|29|||
124843260|NCT01256710|449054594|FG000|Overall Study|Physician Decision|9|||
124843261|NCT01256710|449054594|FG000|Overall Study|Subject Noncompliance|2|||
124843262|NCT01256710|449054594|FG000|Overall Study|Study Terminated by Sponsor|273|||
124843263|NCT02681302|449054595|FG000|Overall Study|Withdrawal by Subject|1|||
124843264|NCT02681302|449054596|FG001|Overall Study|Withdrawal by Subject|1|||
124843265|NCT02681302|449054597|FG002|Overall Study|Withdrawal by Subject|0|||
124843266|NCT02681302|449054598|FG003|Overall Study|Withdrawal by Subject|0|||
124843267|NCT02681302|449054599|FG004|Overall Study|Withdrawal by Subject|1|||
124843268|NCT02681302|449054600|FG005|Overall Study|Withdrawal by Subject|0|||
124843269|NCT02681302|449054595|FG000|Overall Study|Screen Failure|2|||
124843270|NCT02681302|449054596|FG001|Overall Study|Screen Failure|4|||
124843271|NCT02681302|449054597|FG002|Overall Study|Screen Failure|2|||
124843272|NCT02681302|449054598|FG003|Overall Study|Screen Failure|0|||
124843273|NCT02681302|449054599|FG004|Overall Study|Screen Failure|1|||
124843274|NCT02681302|449054600|FG005|Overall Study|Screen Failure|1|||
124843275|NCT02681302|449054595|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
124843276|NCT02681302|449054596|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
124843277|NCT02681302|449054597|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
124843278|NCT02681302|449054598|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
124843279|NCT02681302|449054599|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
124843280|NCT02681302|449054600|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
124843281|NCT02942017|449054601|FG000|Overall Study|Adverse Event|0|||
124843282|NCT02942017|449054602|FG001|Overall Study|Adverse Event|1|||
124843283|NCT02942017|449054601|FG000|Overall Study|Withdrawal by Subject|0|||
124843284|NCT02942017|449054602|FG001|Overall Study|Withdrawal by Subject|1|||
124843285|NCT02942017|449054601|FG000|Overall Study|Lost to Follow-up|1|||
124843286|NCT02942017|449054602|FG001|Overall Study|Lost to Follow-up|1|||
124843287|NCT02942017|449054601|FG000|Overall Study|Randomized but not dosed|1|||
124843288|NCT02942017|449054602|FG001|Overall Study|Randomized but not dosed|3|||
124843289|NCT05059600|449054605|FG000|Overall Study|Enrolled but not Treated|10|||
124843290|NCT02152995|449054606|FG000|Overall Study|Withdrawal by Subject|1|||
124843291|NCT02152995|449054607|FG001|Overall Study|Withdrawal by Subject|0|||
124843292|NCT04552587|449054609|FG000|Overall Study|Lost to Follow-up|4|||
124843293|NCT00480779|449054610|FG000|Overall Study|Other|2|||
124843294|NCT00480779|449054611|FG001|Overall Study|Other|0|||
124843295|NCT00480779|449054610|FG000|Overall Study|Job and Health-related|0|||
124843296|NCT00480779|449054611|FG001|Overall Study|Job and Health-related|3|||
124843297|NCT04907032|449054613|FG000|Overall Study|Withdrawal by Subject|7|||
124843298|NCT04907032|449054614|FG001|Overall Study|Withdrawal by Subject|1|||
124843299|NCT02741115|449054622|FG000|Overall Study|Adverse Event|1|||
124843300|NCT02741115|449054623|FG001|Overall Study|Adverse Event|0|||
124843301|NCT02741115|449054622|FG000|Overall Study|Lost to Follow-up|7|||
124843302|NCT02741115|449054623|FG001|Overall Study|Lost to Follow-up|4|||
124843303|NCT02741115|449054622|FG000|Overall Study|Withdrawal by Subject|4|||
124843304|NCT02741115|449054623|FG001|Overall Study|Withdrawal by Subject|2|||
124843305|NCT03548584|449056066|FG000|Overall Study|Lost to Follow-up|0|||
124843306|NCT03548584|449056067|FG001|Overall Study|Lost to Follow-up|0|||
125305519|NCT02218008|450745140|FG001|Stage 1 (S1)|Pregnancy|0|||
124843307|NCT03548584|449056068|FG002|Overall Study|Lost to Follow-up|1|||
124843308|NCT03548584|449056066|FG000|Overall Study|Adverse Event|1|||
124843309|NCT03548584|449056067|FG001|Overall Study|Adverse Event|11|||
124843310|NCT03548584|449056068|FG002|Overall Study|Adverse Event|5|||
124843311|NCT03548584|449056066|FG000|Overall Study|Site Terminated by Sponsor|1|||
124843312|NCT03548584|449056067|FG001|Overall Study|Site Terminated by Sponsor|3|||
124843313|NCT03548584|449056068|FG002|Overall Study|Site Terminated by Sponsor|2|||
124843314|NCT03548584|449056066|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
125305520|NCT02218008|450745141|FG002|Stage 1 (S1)|Pregnancy|1|||
124843315|NCT03548584|449056067|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
124843316|NCT03548584|449056068|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
124843317|NCT03548584|449056066|FG000|Overall Study|Lack of Efficacy|0|||
124843318|NCT03548584|449056067|FG001|Overall Study|Lack of Efficacy|1|||
124843319|NCT03548584|449056068|FG002|Overall Study|Lack of Efficacy|0|||
124843320|NCT03548584|449056066|FG000|Overall Study|Non-compliance with Study Drug|0|||
124843321|NCT03548584|449056067|FG001|Overall Study|Non-compliance with Study Drug|1|||
124843322|NCT03548584|449056068|FG002|Overall Study|Non-compliance with Study Drug|0|||
124843323|NCT03548584|449056066|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
124843324|NCT03548584|449056067|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
124843325|NCT03548584|449056068|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
124843326|NCT01101841|449056069|FG000|Overall Study|Adverse Event|15|||
124843327|NCT01101841|449056070|FG001|Overall Study|Adverse Event|15|||
124843328|NCT01101841|449056069|FG000|Overall Study|Lost to Follow-up|9|||
124843329|NCT01101841|449056070|FG001|Overall Study|Lost to Follow-up|3|||
124843330|NCT01101841|449056069|FG000|Overall Study|Withdrawal by Subject|21|||
124843331|NCT01101841|449056070|FG001|Overall Study|Withdrawal by Subject|40|||
124843332|NCT01101841|449056069|FG000|Overall Study|Protocol Violation|1|||
124843333|NCT01101841|449056070|FG001|Overall Study|Protocol Violation|1|||
124843334|NCT01101841|449056069|FG000|Overall Study|Physician Decision|0|||
124843335|NCT01101841|449056070|FG001|Overall Study|Physician Decision|2|||
124843336|NCT01101841|449056069|FG000|Overall Study|Lack of Efficacy|0|||
124843337|NCT01101841|449056070|FG001|Overall Study|Lack of Efficacy|2|||
124843338|NCT01101841|449056069|FG000|Overall Study|Other|0|||
124843339|NCT01101841|449056070|FG001|Overall Study|Other|1|||
124843340|NCT01101841|449056069|FG000|Overall Study|Suicidality Tracking Scale|3|||
124843341|NCT01101841|449056070|FG001|Overall Study|Suicidality Tracking Scale|1|||
124843342|NCT01101841|449056069|FG000|Overall Study|Eligibility Criteria|1|||
124843343|NCT01101841|449056070|FG001|Overall Study|Eligibility Criteria|2|||
124843344|NCT03633396|449056075|FG000|Overall Study|Withdrawal by Subject|4|||
124843345|NCT03633396|449056076|FG001|Overall Study|Withdrawal by Subject|4|||
124843346|NCT03633396|449056075|FG000|Overall Study|Adverse Event|1|||
124843347|NCT03633396|449056076|FG001|Overall Study|Adverse Event|1|||
124843348|NCT03633396|449056075|FG000|Overall Study|Lack of Efficacy|1|||
124843349|NCT03633396|449056076|FG001|Overall Study|Lack of Efficacy|0|||
124843350|NCT03633396|449056075|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
124843351|NCT03633396|449056076|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
124843352|NCT01012817|449056077|FG000|Overall Study|Withdrawal by Subject|0|||
124843353|NCT01012817|449056078|FG001|Overall Study|Withdrawal by Subject|0|||
124843354|NCT01012817|449056079|FG002|Overall Study|Withdrawal by Subject|0|||
124843355|NCT01012817|449056080|FG003|Overall Study|Withdrawal by Subject|1|||
124843356|NCT01012817|449056081|FG004|Overall Study|Withdrawal by Subject|0|||
124843357|NCT01012817|449056082|FG005|Overall Study|Withdrawal by Subject|0|||
124843358|NCT01012817|449056083|FG006|Overall Study|Withdrawal by Subject|0|||
124843359|NCT01012817|449056084|FG007|Overall Study|Withdrawal by Subject|1|||
124843360|NCT01012817|449056085|FG008|Overall Study|Withdrawal by Subject|0|||
124843361|NCT01012817|449056086|FG009|Overall Study|Withdrawal by Subject|0|||
124843362|NCT01012817|449056087|FG010|Overall Study|Withdrawal by Subject|1|||
124843363|NCT01012817|449056088|FG011|Overall Study|Withdrawal by Subject|1|||
124843364|NCT01012817|449056089|FG012|Overall Study|Withdrawal by Subject|0|||
124843365|NCT01012817|449056090|FG013|Overall Study|Withdrawal by Subject|1|||
124843366|NCT01012817|449056077|FG000|Overall Study|Adverse Event|0|||
124843367|NCT01012817|449056078|FG001|Overall Study|Adverse Event|0|||
124843368|NCT01012817|449056079|FG002|Overall Study|Adverse Event|0|||
124843369|NCT01012817|449056080|FG003|Overall Study|Adverse Event|0|||
124843370|NCT01012817|449056081|FG004|Overall Study|Adverse Event|0|||
124843371|NCT01012817|449056082|FG005|Overall Study|Adverse Event|1|||
124843372|NCT01012817|449056083|FG006|Overall Study|Adverse Event|0|||
124843373|NCT01012817|449056084|FG007|Overall Study|Adverse Event|0|||
124843374|NCT01012817|449056085|FG008|Overall Study|Adverse Event|0|||
124843375|NCT01012817|449056086|FG009|Overall Study|Adverse Event|0|||
124843376|NCT01012817|449056087|FG010|Overall Study|Adverse Event|1|||
124843377|NCT01012817|449056088|FG011|Overall Study|Adverse Event|0|||
124843378|NCT01012817|449056089|FG012|Overall Study|Adverse Event|0|||
124843379|NCT01012817|449056090|FG013|Overall Study|Adverse Event|1|||
124843380|NCT02143414|449056091|FG000|Induction|Adverse Event|1|||
125305521|NCT02218008|450745142|FG003|Stage 1 (S1)|Pregnancy|0|||
124843381|NCT02143414|449056092|FG001|Induction|Adverse Event|2|||
124843382|NCT02143414|449056091|FG000|Induction|Death|1|||
124843383|NCT02143414|449056092|FG001|Induction|Death|2|||
124843384|NCT02143414|449056091|FG000|Induction|Patient refusal|1|||
124843385|NCT02143414|449056092|FG001|Induction|Patient refusal|1|||
124843386|NCT02143414|449056091|FG000|Induction|Refractory|1|||
124843387|NCT02143414|449056092|FG001|Induction|Refractory|0|||
124843388|NCT02143414|449056091|FG000|Induction|Began alternative treatment|1|||
124843389|NCT02143414|449056092|FG001|Induction|Began alternative treatment|0|||
124843390|NCT02143414|449056091|FG000|Induction|Ineligible for postremission|5|||
124843391|NCT02143414|449056092|FG001|Induction|Ineligible for postremission|1|||
124843392|NCT02143414|449056091|FG000|Post-remission|Adverse Event|0|||
124843393|NCT02143414|449056092|FG001|Post-remission|Adverse Event|2|||
124843394|NCT02143414|449056091|FG000|Post-remission|Disease progression/relapse|5|||
124843395|NCT02143414|449056092|FG001|Post-remission|Disease progression/relapse|0|||
124843396|NCT02143414|449056091|FG000|Maintenance|Adverse Event|4|||
124843397|NCT02143414|449056092|FG001|Maintenance|Adverse Event|6|||
124843398|NCT02143414|449056091|FG000|Maintenance|Disease progression/relapse|3|||
124843399|NCT02143414|449056092|FG001|Maintenance|Disease progression/relapse|2|||
124843400|NCT02143414|449056091|FG000|Maintenance|Patient refusal|2|||
124843401|NCT02143414|449056092|FG001|Maintenance|Patient refusal|1|||
124843402|NCT02143414|449056091|FG000|Maintenance|Physician Decision|1|||
124843403|NCT02143414|449056092|FG001|Maintenance|Physician Decision|0|||
124843404|NCT02143414|449056091|FG000|Maintenance|Death|0|||
124843405|NCT02143414|449056092|FG001|Maintenance|Death|1|||
124843406|NCT02143414|449056091|FG000|Maintenance|On protocol treatment|0|||
124843407|NCT02143414|449056092|FG001|Maintenance|On protocol treatment|6|||
124843408|NCT00679341|449056097|FG000|Overall Study|Disease progression|42|||
124843409|NCT00679341|449056098|FG001|Overall Study|Disease progression|36|||
124843410|NCT00679341|449056097|FG000|Overall Study|Adverse Event|5|||
124843411|NCT00679341|449056098|FG001|Overall Study|Adverse Event|6|||
124843412|NCT00679341|449056097|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
124843413|NCT00679341|449056098|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
124843414|NCT00679341|449056097|FG000|Overall Study|Death|1|||
124843415|NCT00679341|449056098|FG001|Overall Study|Death|1|||
124843416|NCT00679341|449056097|FG000|Overall Study|Other|1|||
124843417|NCT00679341|449056098|FG001|Overall Study|Other|0|||
124843418|NCT00679341|449056097|FG000|Overall Study|Physician Decision|1|||
124843419|NCT00679341|449056098|FG001|Overall Study|Physician Decision|0|||
124843420|NCT00679341|449056097|FG000|Overall Study|Not treated|0|||
124843421|NCT00679341|449056098|FG001|Overall Study|Not treated|2|||
124843422|NCT00679341|449056097|FG000|Overall Study|Physician/patient decision to withdraw|0|||
124843423|NCT00679341|449056098|FG001|Overall Study|Physician/patient decision to withdraw|6|||
124843424|NCT01433263|449056101|FG000|Overall Study|Adverse Event|3|||
124843425|NCT01433263|449056102|FG001|Overall Study|Adverse Event|1|||
124843426|NCT01433263|449056101|FG000|Overall Study|Death|5|||
124843427|NCT01433263|449056102|FG001|Overall Study|Death|3|||
124843428|NCT01433263|449056101|FG000|Overall Study|Lost to Follow-up|0|||
124843429|NCT01433263|449056102|FG001|Overall Study|Lost to Follow-up|1|||
124843430|NCT01433263|449056101|FG000|Overall Study|Protocol Deviation|1|||
124843431|NCT01433263|449056102|FG001|Overall Study|Protocol Deviation|0|||
124843432|NCT01433263|449056101|FG000|Overall Study|Withdrawal by Subject|10|||
124843433|NCT01433263|449056102|FG001|Overall Study|Withdrawal by Subject|7|||
124843434|NCT03107988|449056103|FG000|Overall Study|Adverse Event|0|||
124843435|NCT03107988|449056104|FG001|Overall Study|Adverse Event|0|||
124843436|NCT03107988|449056105|FG002|Overall Study|Adverse Event|0|||
124843437|NCT03107988|449056106|FG003|Overall Study|Adverse Event|1|||
124843438|NCT03107988|449056107|FG004|Overall Study|Adverse Event|0|||
124843439|NCT03107988|449056108|FG005|Overall Study|Adverse Event|1|||
124843440|NCT03107988|449056109|FG006|Overall Study|Adverse Event|0|||
124843441|NCT03107988|449056110|FG007|Overall Study|Adverse Event|1|||
124843442|NCT03107988|449056111|FG008|Overall Study|Adverse Event|0|||
124843443|NCT03107988|449056112|FG009|Overall Study|Adverse Event|0|||
124843444|NCT03107988|449056113|FG010|Overall Study|Adverse Event|0|||
124843445|NCT03107988|449056114|FG011|Overall Study|Adverse Event|0|||
124843446|NCT03107988|449056115|FG012|Overall Study|Adverse Event|0|||
124843447|NCT03107988|449056103|FG000|Overall Study|Disease Progression or Relapse|1|||
124843448|NCT03107988|449056104|FG001|Overall Study|Disease Progression or Relapse|2|||
124843449|NCT03107988|449056105|FG002|Overall Study|Disease Progression or Relapse|2|||
124843450|NCT03107988|449056106|FG003|Overall Study|Disease Progression or Relapse|5|||
124843451|NCT03107988|449056107|FG004|Overall Study|Disease Progression or Relapse|1|||
125305522|NCT02218008|450745143|FG004|Stage 1 (S1)|Pregnancy|0|||
125305523|NCT02218008|450745144|FG005|Stage 1 (S1)|Pregnancy|0|||
125305524|NCT02218008|450745139|FG000|Stage 1 (S1)|Protocol Violation|0|||
124843452|NCT03107988|449056108|FG005|Overall Study|Disease Progression or Relapse|1|||
124843453|NCT03107988|449056109|FG006|Overall Study|Disease Progression or Relapse|0|||
124843454|NCT03107988|449056110|FG007|Overall Study|Disease Progression or Relapse|0|||
124843455|NCT03107988|449056111|FG008|Overall Study|Disease Progression or Relapse|0|||
124843456|NCT03107988|449056112|FG009|Overall Study|Disease Progression or Relapse|1|||
124843457|NCT03107988|449056113|FG010|Overall Study|Disease Progression or Relapse|4|||
124843458|NCT03107988|449056114|FG011|Overall Study|Disease Progression or Relapse|0|||
124843459|NCT03107988|449056115|FG012|Overall Study|Disease Progression or Relapse|0|||
124843460|NCT03107988|449056103|FG000|Overall Study|Ineligible|0|||
124843461|NCT03107988|449056104|FG001|Overall Study|Ineligible|0|||
124843462|NCT03107988|449056105|FG002|Overall Study|Ineligible|0|||
124843463|NCT03107988|449056106|FG003|Overall Study|Ineligible|0|||
124843464|NCT03107988|449056107|FG004|Overall Study|Ineligible|0|||
124843465|NCT03107988|449056108|FG005|Overall Study|Ineligible|0|||
124843466|NCT03107988|449056109|FG006|Overall Study|Ineligible|0|||
124843467|NCT03107988|449056110|FG007|Overall Study|Ineligible|0|||
124843468|NCT03107988|449056111|FG008|Overall Study|Ineligible|1|||
124843469|NCT03107988|449056112|FG009|Overall Study|Ineligible|0|||
124843470|NCT03107988|449056113|FG010|Overall Study|Ineligible|0|||
124843471|NCT03107988|449056114|FG011|Overall Study|Ineligible|0|||
124843472|NCT03107988|449056115|FG012|Overall Study|Ineligible|0|||
124843473|NCT01359592|449056116|FG000|Initial Registration|Adverse Event|1|||
124843474|NCT01359592|449056117|FG001|Initial Registration|Adverse Event|0|||
124843475|NCT01359592|449056118|FG002|Initial Registration|Adverse Event|0|||
124843476|NCT01359592|449056119|FG003|Initial Registration|Adverse Event|0|||
124843477|NCT01359592|449056116|FG000|Initial Registration|Death|1|||
124843478|NCT01359592|449056117|FG001|Initial Registration|Death|0|||
124843479|NCT01359592|449056118|FG002|Initial Registration|Death|0|||
124843480|NCT01359592|449056119|FG003|Initial Registration|Death|0|||
124843481|NCT01359592|449056116|FG000|Initial Registration|Other reason not protocol specified|1|||
124843482|NCT01359592|449056117|FG001|Initial Registration|Other reason not protocol specified|0|||
124843483|NCT01359592|449056118|FG002|Initial Registration|Other reason not protocol specified|0|||
124843484|NCT01359592|449056119|FG003|Initial Registration|Other reason not protocol specified|0|||
124843485|NCT01359592|449056116|FG000|Initial Registration|Ineligible|26|||
124843486|NCT01359592|449056117|FG001|Initial Registration|Ineligible|0|||
124843487|NCT01359592|449056118|FG002|Initial Registration|Ineligible|0|||
124843488|NCT01359592|449056119|FG003|Initial Registration|Ineligible|0|||
124843489|NCT01359592|449056116|FG000|PET-Directed Therapy|Adverse Event|0|||
124843490|NCT01359592|449056117|FG001|PET-Directed Therapy|Adverse Event|0|||
124843491|NCT01359592|449056118|FG002|PET-Directed Therapy|Adverse Event|1|||
124843492|NCT01359592|449056119|FG003|PET-Directed Therapy|Adverse Event|0|||
124843493|NCT01359592|449056116|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
124843494|NCT01359592|449056117|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
124843495|NCT01359592|449056118|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
124843496|NCT01359592|449056119|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
124843497|NCT01359592|449056116|FG000|PET-Directed Therapy|Ineligible|0|||
124843498|NCT01359592|449056117|FG001|PET-Directed Therapy|Ineligible|0|||
124843499|NCT01359592|449056118|FG002|PET-Directed Therapy|Ineligible|24|||
124843500|NCT01359592|449056119|FG003|PET-Directed Therapy|Ineligible|0|||
124843501|NCT00326612|449056120|FG000|Overall Study|They did not have a seizure requiring tx|129|||
124843502|NCT00326612|449056121|FG001|Overall Study|They did not have a seizure requiring tx|137|||
124843503|NCT00548808|449056122|FG000|Overall Study|Lost to Follow-up|9|||
124843504|NCT00548808|449056123|FG001|Overall Study|Lost to Follow-up|3|||
124843505|NCT00548808|449056122|FG000|Overall Study|Protocol Violation|8|||
124843506|NCT00548808|449056123|FG001|Overall Study|Protocol Violation|8|||
124843507|NCT00548808|449056122|FG000|Overall Study|Withdrawal by Subject|8|||
124843508|NCT00548808|449056123|FG001|Overall Study|Withdrawal by Subject|4|||
124843509|NCT00548808|449056122|FG000|Overall Study|Physician Decision|6|||
124843510|NCT00548808|449056123|FG001|Overall Study|Physician Decision|3|||
124843511|NCT00548808|449056122|FG000|Overall Study|Adverse Event|4|||
124843512|NCT00548808|449056123|FG001|Overall Study|Adverse Event|5|||
124843513|NCT00548808|449056122|FG000|Overall Study|Death|2|||
124843514|NCT00548808|449056123|FG001|Overall Study|Death|0|||
124843515|NCT00548808|449056122|FG000|Overall Study|Entry Criteria Not Met|2|||
124843516|NCT00548808|449056123|FG001|Overall Study|Entry Criteria Not Met|2|||
124843517|NCT00548808|449056122|FG000|Overall Study|Lack of Efficacy|2|||
124843518|NCT00548808|449056123|FG001|Overall Study|Lack of Efficacy|0|||
124843519|NCT00548808|449056122|FG000|Overall Study|Sponsor Decision|1|||
124843520|NCT00548808|449056123|FG001|Overall Study|Sponsor Decision|1|||
124843521|NCT00749775|449056124|FG000|Overall Study|Protocol Violation|24|||
124843522|NCT00749775|449056124|FG000|Overall Study|Lost to Follow-up|36|||
124843523|NCT00749775|449056124|FG000|Overall Study|No visit after first day of treatment|44|||
124843524|NCT00749775|449056124|FG000|Overall Study|No drug administration|3|||
124843525|NCT01400841|449056125|FG000|Initial Study Phase (6 Months)|Death|1|||
124843526|NCT01400841|449056125|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
124843527|NCT00770120|449056126|FG000|Overall Study|Progression|31|||
124843528|NCT00770120|449056126|FG000|Overall Study|Adverse Event|11|||
124843529|NCT00770120|449056126|FG000|Overall Study|Not Protocol Specified|11|||
124843530|NCT00770120|449056126|FG000|Overall Study|Death|3|||
124843531|NCT00770120|449056126|FG000|Overall Study|Withdrawal by Subject|2|||
124843532|NCT00770120|449056126|FG000|Overall Study|Ineligible|1|||
124843533|NCT00770120|449056126|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
124843534|NCT00770120|449056126|FG000|Overall Study|Reason under Review|1|||
124843535|NCT00480636|449056127|FG000|Overall Study|Death|12|||
124843536|NCT00480636|449056127|FG000|Overall Study|Lost to Follow-up|4|||
124843537|NCT00480636|449056127|FG000|Overall Study|Other|2|||
124843538|NCT00480636|449056127|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
124843539|NCT02583256|449056130|FG000|Overall Study|Withdrawal by Subject|0|||
124843540|NCT02583256|449056131|FG001|Overall Study|Withdrawal by Subject|1|||
124843541|NCT02583256|449056132|FG002|Overall Study|Withdrawal by Subject|1|||
124843542|NCT02583256|449056133|FG003|Overall Study|Withdrawal by Subject|0|||
124843543|NCT02583256|449056130|FG000|Overall Study|Lost to Follow-up|1|||
124843544|NCT02583256|449056131|FG001|Overall Study|Lost to Follow-up|1|||
124843545|NCT02583256|449056132|FG002|Overall Study|Lost to Follow-up|0|||
124843546|NCT02583256|449056133|FG003|Overall Study|Lost to Follow-up|1|||
124843547|NCT02583256|449056130|FG000|Overall Study|Administrative/Other|2|||
124843548|NCT02583256|449056131|FG001|Overall Study|Administrative/Other|0|||
124843549|NCT02583256|449056132|FG002|Overall Study|Administrative/Other|1|||
124843550|NCT02583256|449056133|FG003|Overall Study|Administrative/Other|2|||
124843551|NCT04537806|449056134|FG000|Overall Study|Randomized but not treated|1|||
124843552|NCT04537806|449056135|FG001|Overall Study|Randomized but not treated|0|||
124843553|NCT04537806|449056134|FG000|Overall Study|Adverse Event|1|||
124843554|NCT04537806|449056135|FG001|Overall Study|Adverse Event|1|||
124843555|NCT05459129|449056136|FG000|Overall Study|Death|1|||
124843556|NCT05459129|449056137|FG001|Overall Study|Death|0|||
124843557|NCT05459129|449056136|FG000|Overall Study|Study Terminated By Sponsor|5|||
124843558|NCT05459129|449056137|FG001|Overall Study|Study Terminated By Sponsor|6|||
124843559|NCT04182100|449056138|FG000|Overall Study|Adverse Event|1|||
124843560|NCT04182100|449056138|FG000|Overall Study|Withdrawal by Subject|1|||
124843561|NCT04083976|449056140|FG000|Overall Study|Lost to Follow-up|3|||
124843562|NCT04083976|449056141|FG001|Overall Study|Lost to Follow-up|0|||
124843563|NCT04083976|449056142|FG002|Overall Study|Lost to Follow-up|0|||
124843564|NCT04083976|449056143|FG003|Overall Study|Lost to Follow-up|1|||
124843565|NCT04083976|449056140|FG000|Overall Study|Withdrawal by Subject|16|||
124843566|NCT04083976|449056141|FG001|Overall Study|Withdrawal by Subject|1|||
124843567|NCT04083976|449056142|FG002|Overall Study|Withdrawal by Subject|9|||
124843568|NCT04083976|449056143|FG003|Overall Study|Withdrawal by Subject|0|||
124843569|NCT04083976|449056140|FG000|Overall Study|Sponsor Decision|14|||
124843570|NCT04083976|449056141|FG001|Overall Study|Sponsor Decision|0|||
124843571|NCT04083976|449056142|FG002|Overall Study|Sponsor Decision|0|||
124843572|NCT04083976|449056143|FG003|Overall Study|Sponsor Decision|7|||
124843573|NCT04083976|449056140|FG000|Overall Study|Other|1|||
124843574|NCT04083976|449056141|FG001|Overall Study|Other|0|||
124843575|NCT04083976|449056142|FG002|Overall Study|Other|1|||
124843576|NCT04083976|449056143|FG003|Overall Study|Other|0|||
124843577|NCT05358821|449056144|FG000|Overall Study|Withdrawal by Subject|0|||
124843578|NCT05358821|449056145|FG001|Overall Study|Withdrawal by Subject|1|||
124843579|NCT05358821|449056146|FG002|Overall Study|Withdrawal by Subject|0|||
124843580|NCT05358821|449056144|FG000|Overall Study|Withdrawal of Consent|0|||
124843581|NCT05358821|449056145|FG001|Overall Study|Withdrawal of Consent|0|||
124843582|NCT05358821|449056146|FG002|Overall Study|Withdrawal of Consent|1|||
124843583|NCT02504372|449056147|FG000|Overall Study|Death|136|||
124843584|NCT02504372|449056148|FG001|Overall Study|Death|154|||
124843585|NCT02504372|449056147|FG000|Overall Study|Lost to Follow-up|0|||
124843586|NCT02504372|449056148|FG001|Overall Study|Lost to Follow-up|2|||
124843587|NCT02504372|449056147|FG000|Overall Study|Withdrawal of consent|25|||
124843588|NCT02504372|449056148|FG001|Overall Study|Withdrawal of consent|16|||
124843589|NCT02504372|449056147|FG000|Overall Study|Participants ongoing|429|||
124843590|NCT02504372|449056148|FG001|Overall Study|Participants ongoing|415|||
124843591|NCT03901963|449056149|FG000|Overall Study|Lost to Follow-up|1|||
124843592|NCT03901963|449056150|FG001|Overall Study|Lost to Follow-up|1|||
124843593|NCT03901963|449056149|FG000|Overall Study|Physician Decision|1|||
124843594|NCT03901963|449056150|FG001|Overall Study|Physician Decision|2|||
124843595|NCT03901963|449056149|FG000|Overall Study|Protocol Violation|1|||
124843596|NCT03901963|449056150|FG001|Overall Study|Protocol Violation|1|||
124843597|NCT03901963|449056149|FG000|Overall Study|Withdrawal by Subject|4|||
124843598|NCT03901963|449056150|FG001|Overall Study|Withdrawal by Subject|11|||
124843599|NCT03901963|449056149|FG000|Overall Study|Ongoing|84|||
124843600|NCT03901963|449056150|FG001|Overall Study|Ongoing|73|||
124843601|NCT03901963|449056149|FG000|Overall Study|Randomized but not treated|3|||
124843602|NCT03901963|449056150|FG001|Overall Study|Randomized but not treated|3|||
124843603|NCT02365597|449056162|FG000|Overall Study|Lost to Follow-up|0|||
124843604|NCT02365597|449056163|FG001|Overall Study|Lost to Follow-up|1|||
124843605|NCT02365597|449056164|FG002|Overall Study|Lost to Follow-up|0|||
124843606|NCT02365597|449056165|FG003|Overall Study|Lost to Follow-up|1|||
124843607|NCT02365597|449056162|FG000|Overall Study|Withdrawal by Subject|1|||
124843608|NCT02365597|449056163|FG001|Overall Study|Withdrawal by Subject|8|||
124843609|NCT02365597|449056164|FG002|Overall Study|Withdrawal by Subject|5|||
124843610|NCT02365597|449056165|FG003|Overall Study|Withdrawal by Subject|1|||
124843611|NCT02365597|449056162|FG000|Overall Study|Sponsor's decision|1|||
124843612|NCT02365597|449056163|FG001|Overall Study|Sponsor's decision|3|||
124843613|NCT02365597|449056164|FG002|Overall Study|Sponsor's decision|13|||
124843614|NCT02365597|449056165|FG003|Overall Study|Sponsor's decision|0|||
124843615|NCT02365597|449056162|FG000|Overall Study|Other|0|||
124843616|NCT02365597|449056163|FG001|Overall Study|Other|4|||
124843617|NCT02365597|449056164|FG002|Overall Study|Other|0|||
124843618|NCT02365597|449056165|FG003|Overall Study|Other|0|||
124843619|NCT02365597|449056162|FG000|Overall Study|Enrolled but not treated|0|||
124843620|NCT02365597|449056163|FG001|Overall Study|Enrolled but not treated|1|||
124843621|NCT02365597|449056164|FG002|Overall Study|Enrolled but not treated|1|||
124843622|NCT02365597|449056165|FG003|Overall Study|Enrolled but not treated|0|||
124843623|NCT02365597|449056162|FG000|Overall Study|Ongoing|0|||
124843624|NCT02365597|449056163|FG001|Overall Study|Ongoing|0|||
124843625|NCT02365597|449056164|FG002|Overall Study|Ongoing|0|||
124843626|NCT02365597|449056165|FG003|Overall Study|Ongoing|17|||
124843627|NCT05132127|449056166|FG000|Overall Study|Adverse Event|1|||
124843628|NCT05619692|449056167|FG000|Overall Study|Adverse Event|2|||
124843629|NCT05619692|449056168|FG001|Overall Study|Adverse Event|2|||
124843630|NCT05619692|449056167|FG000|Overall Study|Withdrawal by Participant|3|||
124843631|NCT05619692|449056168|FG001|Overall Study|Withdrawal by Participant|4|||
124843632|NCT05619692|449056167|FG000|Overall Study|Lost to Follow-up|2|||
124843633|NCT05619692|449056168|FG001|Overall Study|Lost to Follow-up|1|||
124843634|NCT05619692|449056167|FG000|Overall Study|Randomized but not treated|1|||
124843635|NCT05619692|449056168|FG001|Overall Study|Randomized but not treated|3|||
124843636|NCT01946204|449056169|FG000|Overall Study|Death|38|||
124843637|NCT01946204|449056170|FG001|Overall Study|Death|59|||
124843638|NCT01946204|449056169|FG000|Overall Study|Withdrawal by Subject|37|||
124843639|NCT01946204|449056170|FG001|Overall Study|Withdrawal by Subject|50|||
124843640|NCT01946204|449056169|FG000|Overall Study|Lost to Follow-up|3|||
124843641|NCT01946204|449056170|FG001|Overall Study|Lost to Follow-up|7|||
124843642|NCT01946204|449056169|FG000|Overall Study|Ongoing|316|||
124843643|NCT01946204|449056170|FG001|Overall Study|Ongoing|687|||
124843644|NCT01946204|449056169|FG000|Overall Study|Other|7|||
124843645|NCT01946204|449056170|FG001|Overall Study|Other|3|||
124843646|NCT03466411|449056171|FG000|Overall Study|Lost to Follow-up|0|||
124843647|NCT03466411|449056172|FG001|Overall Study|Lost to Follow-up|1|||
124843648|NCT03466411|449056173|FG002|Overall Study|Lost to Follow-up|1|||
124843649|NCT03466411|449056174|FG003|Overall Study|Lost to Follow-up|0|||
124843650|NCT03466411|449056175|FG004|Overall Study|Lost to Follow-up|0|||
124843651|NCT03466411|449056176|FG005|Overall Study|Lost to Follow-up|0|||
124843652|NCT03466411|449056177|FG006|Overall Study|Lost to Follow-up|1|||
124843653|NCT03466411|449056178|FG007|Overall Study|Lost to Follow-up|1|||
124843654|NCT03466411|449056179|FG008|Overall Study|Lost to Follow-up|0|||
124843655|NCT03466411|449056180|FG009|Overall Study|Lost to Follow-up|1|||
124843656|NCT03466411|449056181|FG010|Overall Study|Lost to Follow-up|1|||
124843657|NCT03466411|449056182|FG011|Overall Study|Lost to Follow-up|1|||
124843658|NCT03466411|449056183|FG012|Overall Study|Lost to Follow-up|0|||
124843659|NCT03466411|449056171|FG000|Overall Study|Withdrawal by Subject|14|||
124843660|NCT03466411|449056172|FG001|Overall Study|Withdrawal by Subject|7|||
124843661|NCT03466411|449056173|FG002|Overall Study|Withdrawal by Subject|8|||
124843662|NCT03466411|449056174|FG003|Overall Study|Withdrawal by Subject|4|||
124843663|NCT03466411|449056175|FG004|Overall Study|Withdrawal by Subject|6|||
124843664|NCT03466411|449056176|FG005|Overall Study|Withdrawal by Subject|3|||
124843665|NCT03466411|449056177|FG006|Overall Study|Withdrawal by Subject|6|||
124843666|NCT03466411|449056178|FG007|Overall Study|Withdrawal by Subject|9|||
124843667|NCT03466411|449056179|FG008|Overall Study|Withdrawal by Subject|6|||
124843668|NCT03466411|449056180|FG009|Overall Study|Withdrawal by Subject|11|||
124843669|NCT03466411|449056181|FG010|Overall Study|Withdrawal by Subject|14|||
124843670|NCT03466411|449056182|FG011|Overall Study|Withdrawal by Subject|12|||
124843671|NCT03466411|449056183|FG012|Overall Study|Withdrawal by Subject|7|||
124843672|NCT03466411|449056171|FG000|Overall Study|Other|1|||
124843673|NCT03466411|449056172|FG001|Overall Study|Other|1|||
124843674|NCT03466411|449056173|FG002|Overall Study|Other|0|||
124843675|NCT03466411|449056174|FG003|Overall Study|Other|1|||
124843676|NCT03466411|449056175|FG004|Overall Study|Other|2|||
124843677|NCT03466411|449056176|FG005|Overall Study|Other|0|||
124843678|NCT03466411|449056177|FG006|Overall Study|Other|0|||
124843679|NCT03466411|449056178|FG007|Overall Study|Other|0|||
124843680|NCT03466411|449056179|FG008|Overall Study|Other|0|||
124843681|NCT03466411|449056180|FG009|Overall Study|Other|1|||
124843682|NCT03466411|449056181|FG010|Overall Study|Other|2|||
124843683|NCT03466411|449056182|FG011|Overall Study|Other|0|||
124843684|NCT03466411|449056183|FG012|Overall Study|Other|0|||
124843685|NCT03466411|449056171|FG000|Overall Study|Randomized but not Treated|0|||
124843686|NCT03466411|449056172|FG001|Overall Study|Randomized but not Treated|0|||
124843687|NCT03466411|449056173|FG002|Overall Study|Randomized but not Treated|0|||
124843688|NCT03466411|449056174|FG003|Overall Study|Randomized but not Treated|0|||
124843689|NCT03466411|449056175|FG004|Overall Study|Randomized but not Treated|0|||
124843690|NCT03466411|449056176|FG005|Overall Study|Randomized but not Treated|0|||
124843691|NCT03466411|449056177|FG006|Overall Study|Randomized but not Treated|1|||
124843692|NCT03466411|449056178|FG007|Overall Study|Randomized but not Treated|0|||
124843693|NCT03466411|449056179|FG008|Overall Study|Randomized but not Treated|0|||
124843694|NCT03466411|449056180|FG009|Overall Study|Randomized but not Treated|0|||
124843695|NCT03466411|449056181|FG010|Overall Study|Randomized but not Treated|0|||
124843696|NCT03466411|449056182|FG011|Overall Study|Randomized but not Treated|0|||
124843697|NCT03466411|449056183|FG012|Overall Study|Randomized but not Treated|0|||
124843698|NCT03778931|449056184|FG000|Overall Study|Withdrawal by Subject|12|||
124843699|NCT03778931|449056185|FG001|Overall Study|Withdrawal by Subject|25|||
124843700|NCT03778931|449056184|FG000|Overall Study|Physician Decision|1|||
124843701|NCT03778931|449056185|FG001|Overall Study|Physician Decision|3|||
124843702|NCT03778931|449056184|FG000|Overall Study|Participant Noncompliance|1|||
124843703|NCT03778931|449056185|FG001|Overall Study|Participant Noncompliance|1|||
124843704|NCT03778931|449056184|FG000|Overall Study|Lost to Follow-up|4|||
124843705|NCT03778931|449056185|FG001|Overall Study|Lost to Follow-up|1|||
124843706|NCT03778931|449056184|FG000|Overall Study|Death|69|||
124843707|NCT03778931|449056185|FG001|Overall Study|Death|79|||
124843708|NCT02115282|449056186|FG000|Overall Study|Disease progression during treatment|216|||
124843709|NCT02115282|449056187|FG001|Overall Study|Disease progression during treatment|229|||
124843710|NCT02115282|449056186|FG000|Overall Study|Adverse Event|49|||
124843711|NCT02115282|449056187|FG001|Overall Study|Adverse Event|23|||
124843712|NCT02115282|449056186|FG000|Overall Study|Death|1|||
124843713|NCT02115282|449056187|FG001|Overall Study|Death|3|||
124843714|NCT02115282|449056186|FG000|Overall Study|Alternative therapy|1|||
124843715|NCT02115282|449056187|FG001|Overall Study|Alternative therapy|1|||
124843716|NCT02115282|449056186|FG000|Overall Study|Complicating disease|0|||
124843717|NCT02115282|449056187|FG001|Overall Study|Complicating disease|3|||
124843718|NCT02115282|449056186|FG000|Overall Study|Withdrawal by Subject|12|||
124843719|NCT02115282|449056187|FG001|Overall Study|Withdrawal by Subject|10|||
124843720|NCT02115282|449056186|FG000|Overall Study|Symptomatic progression/deterioration|7|||
124843721|NCT02115282|449056187|FG001|Overall Study|Symptomatic progression/deterioration|18|||
124843722|NCT02115282|449056186|FG000|Overall Study|Non-compliance|5|||
124843723|NCT02115282|449056187|FG001|Overall Study|Non-compliance|1|||
124843724|NCT02115282|449056186|FG000|Overall Study|Protocol Violation|2|||
124843725|NCT02115282|449056187|FG001|Overall Study|Protocol Violation|2|||
124843726|NCT02115282|449056186|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
124843727|NCT02115282|449056187|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
124843728|NCT02115282|449056186|FG000|Overall Study|Not start protocol therapy|9|||
124843729|NCT02115282|449056187|FG001|Overall Study|Not start protocol therapy|10|||
124843730|NCT03431350|449056188|FG000|Overall Study|ONGOING|0|||
124843731|NCT03431350|449056189|FG001|Overall Study|ONGOING|0|||
124843732|NCT03431350|449056190|FG002|Overall Study|ONGOING|2|||
124843733|NCT03431350|449056191|FG003|Overall Study|ONGOING|0|||
124843734|NCT03431350|449056192|FG004|Overall Study|ONGOING|1|||
124843735|NCT03431350|449056193|FG005|Overall Study|ONGOING|3|||
124843736|NCT03431350|449056194|FG006|Overall Study|ONGOING|0|||
124843737|NCT03431350|449056195|FG007|Overall Study|ONGOING|1|||
124843738|NCT03431350|449056196|FG008|Overall Study|ONGOING|3|||
124843739|NCT03431350|449056197|FG009|Overall Study|ONGOING|4|||
124843740|NCT03431350|449056198|FG010|Overall Study|ONGOING|2|||
124843741|NCT03431350|449056199|FG011|Overall Study|ONGOING|1|||
124843742|NCT03431350|449056188|FG000|Overall Study|Death|6|||
124843743|NCT03431350|449056189|FG001|Overall Study|Death|5|||
124843744|NCT03431350|449056190|FG002|Overall Study|Death|18|||
124843745|NCT03431350|449056191|FG003|Overall Study|Death|7|||
124843746|NCT03431350|449056192|FG004|Overall Study|Death|4|||
124843747|NCT03431350|449056193|FG005|Overall Study|Death|3|||
124843748|NCT03431350|449056194|FG006|Overall Study|Death|2|||
124843749|NCT03431350|449056195|FG007|Overall Study|Death|0|||
124843750|NCT03431350|449056196|FG008|Overall Study|Death|0|||
124843751|NCT03431350|449056197|FG009|Overall Study|Death|0|||
124843752|NCT03431350|449056198|FG010|Overall Study|Death|4|||
124843753|NCT03431350|449056199|FG011|Overall Study|Death|0|||
124843754|NCT03431350|449056188|FG000|Overall Study|Lost to Follow-up|0|||
124843755|NCT03431350|449056189|FG001|Overall Study|Lost to Follow-up|1|||
124843756|NCT03431350|449056190|FG002|Overall Study|Lost to Follow-up|0|||
124843757|NCT03431350|449056191|FG003|Overall Study|Lost to Follow-up|0|||
124843758|NCT03431350|449056192|FG004|Overall Study|Lost to Follow-up|0|||
124843759|NCT03431350|449056193|FG005|Overall Study|Lost to Follow-up|0|||
124843760|NCT03431350|449056194|FG006|Overall Study|Lost to Follow-up|0|||
125305525|NCT02218008|450745140|FG001|Stage 1 (S1)|Protocol Violation|0|||
125305526|NCT02218008|450745141|FG002|Stage 1 (S1)|Protocol Violation|1|||
124843761|NCT03431350|449056195|FG007|Overall Study|Lost to Follow-up|0|||
124843762|NCT03431350|449056196|FG008|Overall Study|Lost to Follow-up|0|||
124843763|NCT03431350|449056197|FG009|Overall Study|Lost to Follow-up|0|||
124843764|NCT03431350|449056198|FG010|Overall Study|Lost to Follow-up|0|||
124843765|NCT03431350|449056199|FG011|Overall Study|Lost to Follow-up|0|||
124843766|NCT03431350|449056188|FG000|Overall Study|Withdrawal by Subject|0|||
124843767|NCT03431350|449056189|FG001|Overall Study|Withdrawal by Subject|0|||
124843768|NCT03431350|449056190|FG002|Overall Study|Withdrawal by Subject|0|||
124843769|NCT03431350|449056191|FG003|Overall Study|Withdrawal by Subject|1|||
124843770|NCT03431350|449056192|FG004|Overall Study|Withdrawal by Subject|1|||
124843771|NCT03431350|449056193|FG005|Overall Study|Withdrawal by Subject|1|||
124843772|NCT03431350|449056194|FG006|Overall Study|Withdrawal by Subject|0|||
124843773|NCT03431350|449056195|FG007|Overall Study|Withdrawal by Subject|0|||
124843774|NCT03431350|449056196|FG008|Overall Study|Withdrawal by Subject|0|||
124843775|NCT03431350|449056197|FG009|Overall Study|Withdrawal by Subject|2|||
124843776|NCT03431350|449056198|FG010|Overall Study|Withdrawal by Subject|0|||
124843777|NCT03431350|449056199|FG011|Overall Study|Withdrawal by Subject|1|||
124843778|NCT03431350|449056188|FG000|Overall Study|Other|0|||
124843779|NCT03431350|449056189|FG001|Overall Study|Other|0|||
124843780|NCT03431350|449056190|FG002|Overall Study|Other|1|||
124843781|NCT03431350|449056191|FG003|Overall Study|Other|3|||
124843782|NCT03431350|449056192|FG004|Overall Study|Other|2|||
124843783|NCT03431350|449056193|FG005|Overall Study|Other|2|||
124843784|NCT03431350|449056194|FG006|Overall Study|Other|4|||
124843785|NCT03431350|449056195|FG007|Overall Study|Other|0|||
124843786|NCT03431350|449056196|FG008|Overall Study|Other|14|||
124843787|NCT03431350|449056197|FG009|Overall Study|Other|11|||
124843788|NCT03431350|449056198|FG010|Overall Study|Other|11|||
124843789|NCT03431350|449056199|FG011|Overall Study|Other|15|||
124843790|NCT04325828|449056200|FG000|Overall Study|Ongoing|26|||
124843791|NCT04602624|449056205|FG000|Overall Study|Protocol Deviation|1|||
124843792|NCT04602624|449056205|FG000|Overall Study|Withdrawal by Participant|1|||
124843793|NCT04084769|449056206|FG000|Overall Study|Protocol Violation|1|||
124843794|NCT04084769|449056207|FG001|Overall Study|Protocol Violation|3|||
124843795|NCT04084769|449056208|FG002|Overall Study|Protocol Violation|0|||
124843796|NCT04084769|449056209|FG003|Overall Study|Protocol Violation|1|||
124843797|NCT04084769|449056206|FG000|Overall Study|Withdrawal by Subject|0|||
124843798|NCT04084769|449056207|FG001|Overall Study|Withdrawal by Subject|1|||
124843799|NCT04084769|449056208|FG002|Overall Study|Withdrawal by Subject|0|||
124843800|NCT04084769|449056209|FG003|Overall Study|Withdrawal by Subject|0|||
124843801|NCT04084769|449056206|FG000|Overall Study|Withdrawal by parent/guardian|1|||
124843802|NCT04084769|449056207|FG001|Overall Study|Withdrawal by parent/guardian|0|||
124843803|NCT04084769|449056208|FG002|Overall Study|Withdrawal by parent/guardian|0|||
124843804|NCT04084769|449056209|FG003|Overall Study|Withdrawal by parent/guardian|1|||
124843805|NCT04084769|449056206|FG000|Overall Study|Lost to Follow-up|2|||
124843806|NCT04084769|449056207|FG001|Overall Study|Lost to Follow-up|0|||
124843807|NCT04084769|449056208|FG002|Overall Study|Lost to Follow-up|0|||
124843808|NCT04084769|449056209|FG003|Overall Study|Lost to Follow-up|0|||
124843809|NCT03492177|449056210|FG000|Overall Study|Adverse Event|1|||
124843810|NCT03492177|449056211|FG001|Overall Study|Adverse Event|0|||
124843811|NCT03492177|449056212|FG002|Overall Study|Adverse Event|0|||
124843812|NCT03492177|449056210|FG000|Overall Study|Death|3|||
124843813|NCT03492177|449056211|FG001|Overall Study|Death|0|||
124843814|NCT03492177|449056212|FG002|Overall Study|Death|3|||
124843815|NCT03492177|449056210|FG000|Overall Study|Lack of Efficacy|1|||
124843816|NCT03492177|449056211|FG001|Overall Study|Lack of Efficacy|2|||
124843817|NCT03492177|449056212|FG002|Overall Study|Lack of Efficacy|0|||
124843818|NCT03492177|449056210|FG000|Overall Study|Other|1|||
124843819|NCT03492177|449056211|FG001|Overall Study|Other|0|||
124843820|NCT03492177|449056212|FG002|Overall Study|Other|0|||
124843821|NCT03492177|449056210|FG000|Overall Study|Ongoing|16|||
124843822|NCT03492177|449056211|FG001|Overall Study|Ongoing|19|||
124843823|NCT03492177|449056212|FG002|Overall Study|Ongoing|17|||
124843824|NCT06425458|449056213|FG000|Overall Study|Removed by study team|2|||
124843825|NCT06425458|449056213|FG000|Overall Study|Lost to Follow-up|5|||
124843826|NCT03945981|449056214|FG000|Overall Study|Lost to Follow-up|12|||
124843827|NCT03945981|449056214|FG000|Overall Study|Physician Decision|4|||
124843828|NCT03945981|449056214|FG000|Overall Study|Withdrawal by Subject|6|||
124843829|NCT03945981|449056214|FG000|Overall Study|Protocol Violation|1|||
124843830|NCT03665038|449056215|FG000|Overall Study|Lost to Follow-up|0|||
124843831|NCT03665038|449056216|FG001|Overall Study|Lost to Follow-up|0|||
124843832|NCT03665038|449056217|FG002|Overall Study|Lost to Follow-up|1|||
124843833|NCT04466891|449056218|FG000|Overall Study|Death|60|||
124843834|NCT04466891|449056219|FG001|Overall Study|Death|6|||
124843835|NCT04466891|449056218|FG000|Overall Study|Withdrawal by Subject|8|||
124843836|NCT04466891|449056219|FG001|Overall Study|Withdrawal by Subject|1|||
124843837|NCT04466891|449056218|FG000|Overall Study|Study terminated by sponsor|5|||
124843838|NCT04466891|449056219|FG001|Overall Study|Study terminated by sponsor|0|||
124843839|NCT04466891|449056218|FG000|Overall Study|Lost to Follow-up|2|||
124843840|NCT04466891|449056219|FG001|Overall Study|Lost to Follow-up|0|||
124843841|NCT04466891|449056218|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
124843842|NCT04466891|449056219|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
124843843|NCT00445328|449056220|FG000|Overall Study|Death|0|||
124843844|NCT00445328|449056221|FG001|Overall Study|Death|1|||
124843845|NCT00445328|449056220|FG000|Overall Study|Adverse Event|0|||
124843846|NCT00445328|449056221|FG001|Overall Study|Adverse Event|3|||
124843847|NCT00445328|449056220|FG000|Overall Study|Other|0|||
124843848|NCT00445328|449056221|FG001|Overall Study|Other|2|||
124843849|NCT00445328|449056220|FG000|Overall Study|Withdrawal by Subject|2|||
124843850|NCT00445328|449056221|FG001|Overall Study|Withdrawal by Subject|0|||
124843851|NCT00445328|449056220|FG000|Overall Study|Protocol Violation|1|||
124843852|NCT00445328|449056221|FG001|Overall Study|Protocol Violation|0|||
124843853|NCT00316199|449056224|FG000|Overall Study|Adverse Event|2|||
124843854|NCT00316199|449056224|FG000|Overall Study|Death|8|||
124843855|NCT00316199|449056224|FG000|Overall Study|Lost to Follow-up|2|||
124843856|NCT00590954|449056225|FG000|Overall Study|Inevaluable|2|||
124843857|NCT03890367|449056227|FG000|Overall Study|Withdrawal by parent/guardian|1|||
124843858|NCT03890367|449056228|FG001|Overall Study|Withdrawal by parent/guardian|3|||
124843859|NCT03890367|449056229|FG002|Overall Study|Withdrawal by parent/guardian|0|||
124843860|NCT03890367|449056227|FG000|Overall Study|Protocol deviation|2|||
124843861|NCT03890367|449056228|FG001|Overall Study|Protocol deviation|2|||
124843862|NCT03890367|449056229|FG002|Overall Study|Protocol deviation|1|||
124843863|NCT03890367|449056227|FG000|Overall Study|Lost to Follow-up|1|||
124843864|NCT03890367|449056228|FG001|Overall Study|Lost to Follow-up|1|||
124843865|NCT03890367|449056229|FG002|Overall Study|Lost to Follow-up|0|||
124843866|NCT01707004|449057782|FG000|Overall Study|Physician Decision|3|||
124843867|NCT04368429|449057783|FG000|Overall Study|Adverse Event|1|||
124843868|NCT04368429|449057784|FG001|Overall Study|Adverse Event|0|||
124843869|NCT03756558|449057787|FG000|Overall Study|Death|1|||
124843870|NCT03756558|449057787|FG000|Overall Study|Lost to Follow-up|2|||
124843871|NCT03756558|449057787|FG000|Overall Study|Withdrawal by Subject|2|||
124843872|NCT00326911|449057788|FG000|Overall Study|Hospitalization prior to treatment|0|||
124843873|NCT00326911|449057789|FG001|Overall Study|Hospitalization prior to treatment|1|||
124843874|NCT00326911|449057788|FG000|Overall Study|Physician decision prior to treatment|1|||
124843875|NCT00326911|449057789|FG001|Overall Study|Physician decision prior to treatment|0|||
124843876|NCT00326911|449057788|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
124843877|NCT00326911|449057789|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
124843878|NCT03019627|449057794|FG000|Overall Study|Adverse Event|8|||
124843879|NCT03019627|449057795|FG001|Overall Study|Adverse Event|0|||
124843880|NCT03019627|449057794|FG000|Overall Study|Unrelated to adverse event|1|||
124843881|NCT03019627|449057795|FG001|Overall Study|Unrelated to adverse event|3|||
124843882|NCT03019627|449057794|FG000|Overall Study|Lost to Follow-up|2|||
124843883|NCT03019627|449057795|FG001|Overall Study|Lost to Follow-up|1|||
124843884|NCT03019627|449057794|FG000|Overall Study|not compliance|2|||
124843885|NCT03019627|449057795|FG001|Overall Study|not compliance|2|||
124843886|NCT03019627|449057794|FG000|Overall Study|Other|2|||
124843887|NCT03019627|449057795|FG001|Overall Study|Other|2|||
124843888|NCT03364049|449057796|FG000|Overall Study|Death|6|||
124843889|NCT03364049|449057797|FG001|Overall Study|Death|4|||
124843890|NCT03364049|449057798|FG002|Overall Study|Death|5|||
124843891|NCT03364049|449057799|FG003|Overall Study|Death|14|||
124843892|NCT03364049|449057796|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
124843893|NCT03364049|449057797|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
124843894|NCT03364049|449057798|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
124843895|NCT03364049|449057799|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
124843896|NCT03364049|449057796|FG000|Overall Study|Withdrawal by Subject|0|||
124843897|NCT03364049|449057797|FG001|Overall Study|Withdrawal by Subject|1|||
124843898|NCT03364049|449057798|FG002|Overall Study|Withdrawal by Subject|1|||
124843899|NCT03364049|449057799|FG003|Overall Study|Withdrawal by Subject|1|||
124843900|NCT02953821|449057800|FG000|Overall Study|Adverse Event|0|||
124843901|NCT02953821|449057801|FG001|Overall Study|Adverse Event|4|||
124843902|NCT02953821|449057800|FG000|Overall Study|Death|1|||
124843903|NCT02953821|449057801|FG001|Overall Study|Death|0|||
124843904|NCT02953821|449057800|FG000|Overall Study|Progressive Disease|5|||
124843905|NCT02953821|449057801|FG001|Overall Study|Progressive Disease|1|||
124843906|NCT02953821|449057800|FG000|Overall Study|Lost to Follow-up|2|||
124843907|NCT02953821|449057801|FG001|Overall Study|Lost to Follow-up|0|||
124843908|NCT02953821|449057800|FG000|Overall Study|Physician Decision|1|||
124843909|NCT02953821|449057801|FG001|Overall Study|Physician Decision|1|||
124843910|NCT02953821|449057800|FG000|Overall Study|Withdrawal by Subject|3|||
124843911|NCT02953821|449057801|FG001|Overall Study|Withdrawal by Subject|3|||
124843912|NCT02953821|449057800|FG000|Overall Study|Change of address|0|||
124843913|NCT02953821|449057801|FG001|Overall Study|Change of address|1|||
124843914|NCT02953821|449057800|FG000|Overall Study|Lack of Efficacy|1|||
124843915|NCT02953821|449057801|FG001|Overall Study|Lack of Efficacy|0|||
124843916|NCT02953821|449057800|FG000|Overall Study|Out of state for indeterminate time|0|||
124843917|NCT02953821|449057801|FG001|Overall Study|Out of state for indeterminate time|1|||
124843918|NCT02953821|449057800|FG000|Overall Study|No improvement|0|||
124843919|NCT02953821|449057801|FG001|Overall Study|No improvement|1|||
124843920|NCT02953821|449057800|FG000|Overall Study|Refused follow-up visit|2|||
124843921|NCT02953821|449057801|FG001|Overall Study|Refused follow-up visit|1|||
124843922|NCT02103478|449057802|FG000|Overall Study|Adverse Event|0|||
124843923|NCT02103478|449057803|FG001|Overall Study|Adverse Event|0|||
124843924|NCT02103478|449057804|FG002|Overall Study|Adverse Event|1|||
124843925|NCT02103478|449057805|FG003|Overall Study|Adverse Event|1|||
124843926|NCT02103478|449057806|FG004|Overall Study|Adverse Event|2|||
124843927|NCT02103478|449057807|FG005|Overall Study|Adverse Event|1|||
124843928|NCT02103478|449057808|FG006|Overall Study|Adverse Event|0|||
124843929|NCT02103478|449057809|FG007|Overall Study|Adverse Event|0|||
124843930|NCT02103478|449057810|FG008|Overall Study|Adverse Event|0|||
124843931|NCT02103478|449057802|FG000|Overall Study|Death|2|||
124843932|NCT02103478|449057803|FG001|Overall Study|Death|2|||
124843933|NCT02103478|449057804|FG002|Overall Study|Death|1|||
124843934|NCT02103478|449057805|FG003|Overall Study|Death|1|||
124843935|NCT02103478|449057806|FG004|Overall Study|Death|5|||
124843936|NCT02103478|449057807|FG005|Overall Study|Death|15|||
124843937|NCT02103478|449057808|FG006|Overall Study|Death|14|||
124843938|NCT02103478|449057809|FG007|Overall Study|Death|10|||
124843939|NCT02103478|449057810|FG008|Overall Study|Death|11|||
124843940|NCT02103478|449057802|FG000|Overall Study|Progressive Disease|2|||
124843941|NCT02103478|449057803|FG001|Overall Study|Progressive Disease|1|||
124843942|NCT02103478|449057804|FG002|Overall Study|Progressive Disease|2|||
124843943|NCT02103478|449057805|FG003|Overall Study|Progressive Disease|0|||
124843944|NCT02103478|449057806|FG004|Overall Study|Progressive Disease|9|||
124843945|NCT02103478|449057807|FG005|Overall Study|Progressive Disease|1|||
124843946|NCT02103478|449057808|FG006|Overall Study|Progressive Disease|2|||
124843947|NCT02103478|449057809|FG007|Overall Study|Progressive Disease|0|||
124843948|NCT02103478|449057810|FG008|Overall Study|Progressive Disease|1|||
124843949|NCT02103478|449057802|FG000|Overall Study|Withdrawal by Subject|2|||
124843950|NCT02103478|449057803|FG001|Overall Study|Withdrawal by Subject|0|||
124843951|NCT02103478|449057804|FG002|Overall Study|Withdrawal by Subject|0|||
124843952|NCT02103478|449057805|FG003|Overall Study|Withdrawal by Subject|4|||
124843953|NCT02103478|449057806|FG004|Overall Study|Withdrawal by Subject|0|||
124843954|NCT02103478|449057807|FG005|Overall Study|Withdrawal by Subject|0|||
124843955|NCT02103478|449057808|FG006|Overall Study|Withdrawal by Subject|1|||
124843956|NCT02103478|449057809|FG007|Overall Study|Withdrawal by Subject|1|||
124843957|NCT02103478|449057810|FG008|Overall Study|Withdrawal by Subject|0|||
124843958|NCT02103478|449057802|FG000|Overall Study|Lost to Follow-up|0|||
124843959|NCT02103478|449057803|FG001|Overall Study|Lost to Follow-up|0|||
124843960|NCT02103478|449057804|FG002|Overall Study|Lost to Follow-up|0|||
124843961|NCT02103478|449057805|FG003|Overall Study|Lost to Follow-up|0|||
124843962|NCT02103478|449057806|FG004|Overall Study|Lost to Follow-up|0|||
124843963|NCT02103478|449057807|FG005|Overall Study|Lost to Follow-up|0|||
124843964|NCT02103478|449057808|FG006|Overall Study|Lost to Follow-up|0|||
124843965|NCT02103478|449057809|FG007|Overall Study|Lost to Follow-up|1|||
124843966|NCT02103478|449057810|FG008|Overall Study|Lost to Follow-up|0|||
124843967|NCT02103478|449057802|FG000|Overall Study|Other|1|||
124843968|NCT02103478|449057803|FG001|Overall Study|Other|3|||
124843969|NCT02103478|449057804|FG002|Overall Study|Other|2|||
124843970|NCT02103478|449057805|FG003|Overall Study|Other|0|||
124843971|NCT02103478|449057806|FG004|Overall Study|Other|3|||
124843972|NCT02103478|449057807|FG005|Overall Study|Other|8|||
124843973|NCT02103478|449057808|FG006|Overall Study|Other|8|||
124843974|NCT02103478|449057809|FG007|Overall Study|Other|4|||
124843975|NCT02103478|449057810|FG008|Overall Study|Other|2|||
124843976|NCT03219333|449057811|FG000|Overall Study|Withdrawal by Subject|9|||
124843977|NCT03219333|449057812|FG001|Overall Study|Withdrawal by Subject|4|||
124843978|NCT03219333|449057811|FG000|Overall Study|Lost to Follow-up|1|||
124843979|NCT03219333|449057812|FG001|Overall Study|Lost to Follow-up|1|||
124843980|NCT03219333|449057811|FG000|Overall Study|Death|104|||
124843981|NCT03219333|449057812|FG001|Overall Study|Death|72|||
124843982|NCT03219333|449057811|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
124843983|NCT03219333|449057812|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
124843984|NCT03219333|449057811|FG000|Overall Study|Other|2|||
124843985|NCT03219333|449057812|FG001|Overall Study|Other|2|||
124843986|NCT04530552|449057815|FG000|Overall Study|Physician Decision|0|||
124843987|NCT04530552|449057816|FG001|Overall Study|Physician Decision|1|||
124843988|NCT04530552|449057815|FG000|Overall Study|Withdrawal by Subject|0|||
124843989|NCT04530552|449057816|FG001|Overall Study|Withdrawal by Subject|1|||
124843990|NCT04530552|449057815|FG000|Overall Study|Adverse Event|0|||
124843991|NCT04530552|449057816|FG001|Overall Study|Adverse Event|1|||
124843992|NCT04530552|449057815|FG000|Overall Study|No surgery|0|||
124843993|NCT04530552|449057816|FG001|Overall Study|No surgery|1|||
124843994|NCT03748641|449057817|FG000|Overall Study|Ongoing|155|||
124843995|NCT03748641|449057818|FG001|Overall Study|Ongoing|148|||
124843996|NCT03748641|449057819|FG002|Overall Study|Ongoing|66|||
124843997|NCT03748641|449057820|FG003|Overall Study|Ongoing|79|||
124843998|NCT03748641|449057821|FG004|Overall Study|Ongoing|84|||
124843999|NCT03748641|449057817|FG000|Overall Study|Death|54|||
124844000|NCT03748641|449057818|FG001|Overall Study|Death|59|||
124844001|NCT03748641|449057819|FG002|Overall Study|Death|51|||
124844002|NCT03748641|449057820|FG003|Overall Study|Death|42|||
124844003|NCT03748641|449057821|FG004|Overall Study|Death|9|||
124844004|NCT03748641|449057817|FG000|Overall Study|Lost to Follow-up|0|||
124844005|NCT03748641|449057818|FG001|Overall Study|Lost to Follow-up|2|||
124844006|NCT03748641|449057819|FG002|Overall Study|Lost to Follow-up|1|||
124844007|NCT03748641|449057820|FG003|Overall Study|Lost to Follow-up|0|||
124844008|NCT03748641|449057821|FG004|Overall Study|Lost to Follow-up|0|||
124844009|NCT03748641|449057817|FG000|Overall Study|Withdrawal by Subject|3|||
124844010|NCT03748641|449057818|FG001|Overall Study|Withdrawal by Subject|2|||
124844011|NCT03748641|449057819|FG002|Overall Study|Withdrawal by Subject|5|||
124844012|NCT03748641|449057820|FG003|Overall Study|Withdrawal by Subject|3|||
124844013|NCT03748641|449057821|FG004|Overall Study|Withdrawal by Subject|2|||
124844014|NCT06034496|449057822|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
124844015|NCT06034496|449057823|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
124844016|NCT06034496|449057822|FG000|Overall Study|Withdrawal by Subject|5|||
124844017|NCT06034496|449057823|FG001|Overall Study|Withdrawal by Subject|4|||
124844018|NCT04397263|449057824|FG000|Overall Study|Withdrawal by Subject|2|||
124844019|NCT03277261|449057827|FG000|Overall Study|Adverse Event|17|||
124844020|NCT03277261|449057828|FG001|Overall Study|Adverse Event|1|||
124844021|NCT03277261|449057827|FG000|Overall Study|Participant Withdrawal of Consent|6|||
124844022|NCT03277261|449057828|FG001|Overall Study|Participant Withdrawal of Consent|15|||
124844023|NCT03277261|449057827|FG000|Overall Study|Investigator / Sponsor Decision|4|||
124844024|NCT03277261|449057828|FG001|Overall Study|Investigator / Sponsor Decision|2|||
124844025|NCT03277261|449057827|FG000|Overall Study|Pregnancy|2|||
124844026|NCT03277261|449057828|FG001|Overall Study|Pregnancy|0|||
124844027|NCT03277261|449057827|FG000|Overall Study|Lost to Follow-up|2|||
124844028|NCT03277261|449057828|FG001|Overall Study|Lost to Follow-up|2|||
124844029|NCT03277261|449057827|FG000|Overall Study|Lack of Efficacy|2|||
124844030|NCT03277261|449057828|FG001|Overall Study|Lack of Efficacy|2|||
124844031|NCT03277261|449057827|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
124844032|NCT03277261|449057828|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
124844033|NCT00499603|449057829|FG000|Overall Study|Adverse Event|0|||
124844034|NCT00499603|449057830|FG001|Overall Study|Adverse Event|1|||
124844035|NCT05179421|449057831|FG000|First Infusion Day|Adverse Event|1|||
124844036|NCT05179421|449057832|FG001|First Infusion Day|Adverse Event|0|||
124844037|NCT03473743|449057834|FG000|Overall Study|Withdrawal by Subject|0|||
124844038|NCT03473743|449057835|FG001|Overall Study|Withdrawal by Subject|0|||
124844039|NCT03473743|449057836|FG002|Overall Study|Withdrawal by Subject|0|||
124844040|NCT03473743|449057837|FG003|Overall Study|Withdrawal by Subject|0|||
124844041|NCT03473743|449057838|FG004|Overall Study|Withdrawal by Subject|0|||
124844042|NCT03473743|449057839|FG005|Overall Study|Withdrawal by Subject|0|||
124844043|NCT03473743|449057840|FG006|Overall Study|Withdrawal by Subject|0|||
124844044|NCT03473743|449057841|FG007|Overall Study|Withdrawal by Subject|3|||
124844045|NCT03473743|449057834|FG000|Overall Study|Other|0|||
124844046|NCT03473743|449057835|FG001|Overall Study|Other|0|||
124844047|NCT03473743|449057836|FG002|Overall Study|Other|0|||
124844048|NCT03473743|449057837|FG003|Overall Study|Other|1|||
124844049|NCT03473743|449057838|FG004|Overall Study|Other|0|||
124844050|NCT03473743|449057839|FG005|Overall Study|Other|0|||
124844051|NCT03473743|449057840|FG006|Overall Study|Other|0|||
124844052|NCT03473743|449057841|FG007|Overall Study|Other|0|||
124844053|NCT03473743|449057834|FG000|Overall Study|Ongoing|0|||
124844054|NCT03473743|449057835|FG001|Overall Study|Ongoing|0|||
124844055|NCT03473743|449057836|FG002|Overall Study|Ongoing|6|||
124844056|NCT03473743|449057837|FG003|Overall Study|Ongoing|8|||
124844057|NCT03473743|449057838|FG004|Overall Study|Ongoing|1|||
124844058|NCT03473743|449057839|FG005|Overall Study|Ongoing|1|||
124844059|NCT03473743|449057840|FG006|Overall Study|Ongoing|22|||
124844060|NCT03473743|449057841|FG007|Overall Study|Ongoing|24|||
124844061|NCT03473743|449057834|FG000|Overall Study|Randomized but not treated|0|||
124844062|NCT03473743|449057835|FG001|Overall Study|Randomized but not treated|0|||
124844063|NCT03473743|449057836|FG002|Overall Study|Randomized but not treated|0|||
124844064|NCT03473743|449057837|FG003|Overall Study|Randomized but not treated|0|||
124844065|NCT03473743|449057838|FG004|Overall Study|Randomized but not treated|0|||
124844066|NCT03473743|449057839|FG005|Overall Study|Randomized but not treated|0|||
124844067|NCT03473743|449057840|FG006|Overall Study|Randomized but not treated|1|||
124844068|NCT03473743|449057841|FG007|Overall Study|Randomized but not treated|1|||
124844069|NCT02052739|449057847|FG000|Overall Study|Withdrew due to Adverse Event|3|||
124844070|NCT02052739|449057848|FG001|Overall Study|Withdrew due to Adverse Event|0|||
124844071|NCT02052739|449057847|FG000|Overall Study|Participant Died|2|||
124844072|NCT02052739|449057848|FG001|Overall Study|Participant Died|1|||
124844073|NCT05267054|449057849|FG000|Overall Study|Death|13|||
124844074|NCT05267054|449057850|FG001|Overall Study|Death|14|||
124844075|NCT05267054|449057849|FG000|Overall Study|Study Ended by Sponsor|9|||
124844076|NCT05267054|449057850|FG001|Overall Study|Study Ended by Sponsor|13|||
124844077|NCT05267054|449057849|FG000|Overall Study|Lost to Follow-up|1|||
124844078|NCT05267054|449057850|FG001|Overall Study|Lost to Follow-up|1|||
124844079|NCT05267054|449057849|FG000|Overall Study|Withdrawal by Subject|1|||
124844080|NCT05267054|449057850|FG001|Overall Study|Withdrawal by Subject|1|||
124844081|NCT01552226|449057851|FG000|Overall Study|Withdrawal by Subject|4|||
124844082|NCT01552226|449057852|FG001|Overall Study|Withdrawal by Subject|4|||
124844083|NCT04697628|449057853|FG000|Overall Study|Withdrawal by Subject|17|||
124844084|NCT04697628|449057854|FG001|Overall Study|Withdrawal by Subject|23|||
124844085|NCT04697628|449057853|FG000|Overall Study|Lost to Follow-up|0|||
124844086|NCT04697628|449057854|FG001|Overall Study|Lost to Follow-up|4|||
125305527|NCT02218008|450745142|FG003|Stage 1 (S1)|Protocol Violation|0|||
124844087|NCT04697628|449057853|FG000|Overall Study|On-going in study|122|||
124844088|NCT04697628|449057854|FG001|Overall Study|On-going in study|91|||
124844089|NCT03604692|449057855|FG000|Overall Study|Investigator's Decision|0|||
124844090|NCT03604692|449057856|FG001|Overall Study|Investigator's Decision|0|||
124844091|NCT03604692|449057857|FG002|Overall Study|Investigator's Decision|0|||
124844092|NCT03604692|449057858|FG003|Overall Study|Investigator's Decision|1|||
124844093|NCT03604692|449057859|FG004|Overall Study|Investigator's Decision|0|||
124844094|NCT03604692|449057860|FG005|Overall Study|Investigator's Decision|7|||
125305528|NCT02218008|450745143|FG004|Stage 1 (S1)|Protocol Violation|0|||
124844095|NCT03604692|449057855|FG000|Overall Study|Withdrawal by Subject|0|||
124844096|NCT03604692|449057856|FG001|Overall Study|Withdrawal by Subject|0|||
124844097|NCT03604692|449057857|FG002|Overall Study|Withdrawal by Subject|0|||
124844098|NCT03604692|449057858|FG003|Overall Study|Withdrawal by Subject|0|||
124844099|NCT03604692|449057859|FG004|Overall Study|Withdrawal by Subject|0|||
124844100|NCT03604692|449057860|FG005|Overall Study|Withdrawal by Subject|2|||
124844101|NCT03604692|449057855|FG000|Overall Study|Progressive Disease|1|||
124844102|NCT03604692|449057856|FG001|Overall Study|Progressive Disease|0|||
124844103|NCT03604692|449057857|FG002|Overall Study|Progressive Disease|1|||
124844104|NCT03604692|449057858|FG003|Overall Study|Progressive Disease|0|||
124844105|NCT03604692|449057859|FG004|Overall Study|Progressive Disease|3|||
124844106|NCT03604692|449057860|FG005|Overall Study|Progressive Disease|4|||
124844107|NCT03604692|449057855|FG000|Overall Study|Difficulty Coming into Site|0|||
124844108|NCT03604692|449057856|FG001|Overall Study|Difficulty Coming into Site|0|||
124844109|NCT03604692|449057857|FG002|Overall Study|Difficulty Coming into Site|0|||
124844110|NCT03604692|449057858|FG003|Overall Study|Difficulty Coming into Site|0|||
124844111|NCT03604692|449057859|FG004|Overall Study|Difficulty Coming into Site|0|||
124844112|NCT03604692|449057860|FG005|Overall Study|Difficulty Coming into Site|1|||
124844113|NCT03604692|449057855|FG000|Overall Study|Death|0|||
124844114|NCT03604692|449057856|FG001|Overall Study|Death|0|||
124844115|NCT03604692|449057857|FG002|Overall Study|Death|1|||
124844116|NCT03604692|449057858|FG003|Overall Study|Death|0|||
124844117|NCT03604692|449057859|FG004|Overall Study|Death|0|||
124844118|NCT03604692|449057860|FG005|Overall Study|Death|0|||
124844119|NCT03604692|449057855|FG000|Overall Study|Drug Intolerance|0|||
124844120|NCT03604692|449057856|FG001|Overall Study|Drug Intolerance|0|||
124844121|NCT03604692|449057857|FG002|Overall Study|Drug Intolerance|0|||
124844122|NCT03604692|449057858|FG003|Overall Study|Drug Intolerance|1|||
124844123|NCT03604692|449057859|FG004|Overall Study|Drug Intolerance|0|||
124844124|NCT03604692|449057860|FG005|Overall Study|Drug Intolerance|0|||
124844125|NCT03604692|449057855|FG000|Overall Study|Noncompliance with follow-up visit|0|||
124844126|NCT03604692|449057856|FG001|Overall Study|Noncompliance with follow-up visit|0|||
124844127|NCT03604692|449057857|FG002|Overall Study|Noncompliance with follow-up visit|0|||
124844128|NCT03604692|449057858|FG003|Overall Study|Noncompliance with follow-up visit|1|||
124844129|NCT03604692|449057859|FG004|Overall Study|Noncompliance with follow-up visit|0|||
124844130|NCT03604692|449057860|FG005|Overall Study|Noncompliance with follow-up visit|0|||
124844131|NCT03604692|449057855|FG000|Overall Study|Not Treated|0|||
124844132|NCT03604692|449057856|FG001|Overall Study|Not Treated|0|||
124844133|NCT03604692|449057857|FG002|Overall Study|Not Treated|0|||
124844134|NCT03604692|449057858|FG003|Overall Study|Not Treated|0|||
124844135|NCT03604692|449057859|FG004|Overall Study|Not Treated|1|||
124844136|NCT03604692|449057860|FG005|Overall Study|Not Treated|0|||
125305529|NCT02218008|450745144|FG005|Stage 1 (S1)|Protocol Violation|0|||
125305530|NCT02218008|450745139|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
125305531|NCT02218008|450745140|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
125305532|NCT02218008|450745141|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
125305533|NCT02218008|450745142|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
125305534|NCT02218008|450745143|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
125305535|NCT02218008|450745144|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
125305536|NCT02218008|450745139|FG000|Stage 2 (S2)|Adverse Event|0|||
125305537|NCT02218008|450745140|FG001|Stage 2 (S2)|Adverse Event|0|||
125305538|NCT02218008|450745141|FG002|Stage 2 (S2)|Adverse Event|0|||
125305539|NCT02218008|450745142|FG003|Stage 2 (S2)|Adverse Event|2|||
125305540|NCT02218008|450745143|FG004|Stage 2 (S2)|Adverse Event|3|||
125305541|NCT02218008|450745144|FG005|Stage 2 (S2)|Adverse Event|3|||
125305542|NCT02218008|450745139|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
125305543|NCT02218008|450745140|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
125305544|NCT02218008|450745141|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
125305545|NCT02218008|450745142|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
125305546|NCT02218008|450745143|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
125305547|NCT02218008|450745144|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
125305548|NCT02218008|450745139|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
125305549|NCT02218008|450745140|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
125305550|NCT02218008|450745141|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
125305551|NCT02218008|450745142|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
125305552|NCT02218008|450745143|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
125305553|NCT02218008|450745144|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
125305554|NCT02218008|450745139|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
125305555|NCT02218008|450745140|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
125305556|NCT02218008|450745141|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
125305557|NCT02218008|450745142|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
125305558|NCT02218008|450745143|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
125305559|NCT02218008|450745144|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
125305560|NCT02218008|450745139|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
124844137|NCT00006184|449057861|FG000|Overall Study|Death|1|||
124844138|NCT00006184|449057862|FG001|Overall Study|Death|0|||
124844139|NCT01110915|449057865|FG000|Overall Study|Death|2|||
124844140|NCT01110915|449057866|FG001|Overall Study|Death|1|||
124844141|NCT01110915|449057865|FG000|Overall Study|Lost to Follow-up|1|||
124844142|NCT01110915|449057866|FG001|Overall Study|Lost to Follow-up|0|||
124844143|NCT01110915|449057865|FG000|Overall Study|Withdrawal by Subject|7|||
124844144|NCT01110915|449057866|FG001|Overall Study|Withdrawal by Subject|1|||
124844145|NCT02161718|449057869|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
124844146|NCT02161718|449057870|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
124844147|NCT02161718|449057871|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
124844148|NCT02161718|449057869|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
124844149|NCT02161718|449057870|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
124844150|NCT02161718|449057871|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
124844151|NCT02161718|449057869|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
124844152|NCT02161718|449057870|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
124844153|NCT02161718|449057871|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
124844154|NCT02161718|449057869|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
124844155|NCT02161718|449057870|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
124844156|NCT02161718|449057871|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
124844157|NCT02161718|449057869|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
124844158|NCT02161718|449057870|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
124844159|NCT02161718|449057871|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
124844160|NCT02161718|449057869|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
124844161|NCT02161718|449057870|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
124844162|NCT02161718|449057871|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
124844163|NCT02161718|449057869|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
124844164|NCT02161718|449057870|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
124844165|NCT02161718|449057871|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
124844166|NCT02161718|449057869|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
124844167|NCT02161718|449057870|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
124844168|NCT02161718|449057871|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
124844169|NCT02161718|449057869|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
124844170|NCT02161718|449057870|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
124844171|NCT02161718|449057871|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
124844172|NCT02161718|449057869|FG000|Post- Randomization Period|Lost to Follow-up|0|||
124844173|NCT02161718|449057870|FG001|Post- Randomization Period|Lost to Follow-up|9|||
124844174|NCT02161718|449057871|FG002|Post- Randomization Period|Lost to Follow-up|15|||
124844175|NCT02161718|449057869|FG000|Post- Randomization Period|Adverse Event|0|||
124844176|NCT02161718|449057870|FG001|Post- Randomization Period|Adverse Event|9|||
124844177|NCT02161718|449057871|FG002|Post- Randomization Period|Adverse Event|10|||
124844178|NCT02161718|449057869|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
124844179|NCT02161718|449057870|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
124844180|NCT02161718|449057871|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
124844181|NCT02161718|449057869|FG000|Post- Randomization Period|Physician Decision|0|||
124844182|NCT02161718|449057870|FG001|Post- Randomization Period|Physician Decision|2|||
124844183|NCT02161718|449057871|FG002|Post- Randomization Period|Physician Decision|4|||
124844184|NCT02161718|449057869|FG000|Post- Randomization Period|Protocol Violation|0|||
124844185|NCT02161718|449057870|FG001|Post- Randomization Period|Protocol Violation|2|||
124844186|NCT02161718|449057871|FG002|Post- Randomization Period|Protocol Violation|3|||
124844187|NCT02161718|449057869|FG000|Post- Randomization Period|Lack of Efficacy|0|||
124844188|NCT02161718|449057870|FG001|Post- Randomization Period|Lack of Efficacy|0|||
124844189|NCT02161718|449057871|FG002|Post- Randomization Period|Lack of Efficacy|1|||
124844190|NCT02161718|449057869|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
124844191|NCT02161718|449057870|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
124844192|NCT02161718|449057871|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
124844193|NCT02161718|449057869|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
124844194|NCT02161718|449057870|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
124844195|NCT02161718|449057871|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
124844196|NCT02161718|449057869|FG000|Post- Randomization Period|Relocation|0|||
124844197|NCT02161718|449057870|FG001|Post- Randomization Period|Relocation|3|||
124844198|NCT02161718|449057871|FG002|Post- Randomization Period|Relocation|0|||
124844199|NCT00207142|449057874|FG000|Induction Phase|Adverse Event|9|||
124844200|NCT00207142|449057875|FG001|Induction Phase|Adverse Event|0|||
124844201|NCT00207142|449057876|FG002|Induction Phase|Adverse Event|0|||
124844202|NCT00207142|449057877|FG003|Induction Phase|Adverse Event|0|||
124844203|NCT00207142|449057874|FG000|Induction Phase|Death|1|||
124844204|NCT00207142|449057875|FG001|Induction Phase|Death|0|||
124844205|NCT00207142|449057876|FG002|Induction Phase|Death|0|||
124844206|NCT00207142|449057877|FG003|Induction Phase|Death|0|||
124844207|NCT00207142|449057874|FG000|Induction Phase|Lack of Efficacy|1|||
125305561|NCT02218008|450745140|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
125305562|NCT02218008|450745141|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
124844208|NCT00207142|449057875|FG001|Induction Phase|Lack of Efficacy|0|||
125305563|NCT02218008|450745142|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
124844209|NCT00207142|449057876|FG002|Induction Phase|Lack of Efficacy|0|||
124844210|NCT00207142|449057877|FG003|Induction Phase|Lack of Efficacy|0|||
124844211|NCT00207142|449057874|FG000|Induction Phase|Lost to Follow-up|5|||
124844212|NCT00207142|449057875|FG001|Induction Phase|Lost to Follow-up|0|||
124844213|NCT00207142|449057876|FG002|Induction Phase|Lost to Follow-up|0|||
124844214|NCT00207142|449057877|FG003|Induction Phase|Lost to Follow-up|0|||
124844215|NCT00207142|449057874|FG000|Induction Phase|Physician Decision|2|||
124844216|NCT00207142|449057875|FG001|Induction Phase|Physician Decision|0|||
124844217|NCT00207142|449057876|FG002|Induction Phase|Physician Decision|0|||
124844218|NCT00207142|449057877|FG003|Induction Phase|Physician Decision|0|||
124844219|NCT00207142|449057874|FG000|Induction Phase|Poor/noncompliance|2|||
124844220|NCT00207142|449057875|FG001|Induction Phase|Poor/noncompliance|0|||
124844221|NCT00207142|449057876|FG002|Induction Phase|Poor/noncompliance|0|||
124844222|NCT00207142|449057877|FG003|Induction Phase|Poor/noncompliance|0|||
124844223|NCT00207142|449057874|FG000|Induction Phase|Pregnancy|1|||
124844224|NCT00207142|449057875|FG001|Induction Phase|Pregnancy|0|||
124844225|NCT00207142|449057876|FG002|Induction Phase|Pregnancy|0|||
124844226|NCT00207142|449057877|FG003|Induction Phase|Pregnancy|0|||
124844227|NCT00207142|449057874|FG000|Induction Phase|Subject no longer meets study criteria|3|||
124844228|NCT00207142|449057875|FG001|Induction Phase|Subject no longer meets study criteria|0|||
124844229|NCT00207142|449057876|FG002|Induction Phase|Subject no longer meets study criteria|0|||
124844230|NCT00207142|449057877|FG003|Induction Phase|Subject no longer meets study criteria|0|||
124844231|NCT00207142|449057874|FG000|Induction Phase|Withdrawal by Subject|4|||
124844232|NCT00207142|449057875|FG001|Induction Phase|Withdrawal by Subject|0|||
124844233|NCT00207142|449057876|FG002|Induction Phase|Withdrawal by Subject|0|||
124844234|NCT00207142|449057877|FG003|Induction Phase|Withdrawal by Subject|0|||
124844235|NCT00207142|449057874|FG000|Induction Phase|Incarceration|1|||
124844236|NCT00207142|449057875|FG001|Induction Phase|Incarceration|0|||
124844237|NCT00207142|449057876|FG002|Induction Phase|Incarceration|0|||
124844238|NCT00207142|449057877|FG003|Induction Phase|Incarceration|0|||
124844239|NCT00207142|449057874|FG000|Induction Phase|Missing lab data|1|||
124844240|NCT00207142|449057875|FG001|Induction Phase|Missing lab data|0|||
124844241|NCT00207142|449057876|FG002|Induction Phase|Missing lab data|0|||
124844242|NCT00207142|449057877|FG003|Induction Phase|Missing lab data|0|||
124844243|NCT00207142|449057874|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
124844244|NCT00207142|449057875|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
124844245|NCT00207142|449057876|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
124844246|NCT00207142|449057877|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
124844247|NCT00207142|449057874|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
124844248|NCT00207142|449057875|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
124844249|NCT00207142|449057876|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
124844250|NCT00207142|449057877|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
124844251|NCT00207142|449057874|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
124844252|NCT00207142|449057875|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
124844253|NCT00207142|449057876|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
124844254|NCT00207142|449057877|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
124844255|NCT00207142|449057874|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
124844256|NCT00207142|449057875|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
124844257|NCT00207142|449057876|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
124844258|NCT00207142|449057877|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
124844259|NCT00207142|449057874|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
124844260|NCT00207142|449057875|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
124844261|NCT00207142|449057876|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
124844262|NCT00207142|449057877|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
124844263|NCT00207142|449057874|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
124844264|NCT00207142|449057875|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
124844265|NCT00207142|449057876|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
124844266|NCT00207142|449057877|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
124844267|NCT00207142|449057874|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
124844268|NCT00207142|449057875|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
124844269|NCT00207142|449057876|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
124844270|NCT00207142|449057877|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
124844271|NCT00207142|449057874|FG000|Maintenance Phase/Rescue Phase|Death|0|||
124844272|NCT00207142|449057875|FG001|Maintenance Phase/Rescue Phase|Death|0|||
124844273|NCT00207142|449057876|FG002|Maintenance Phase/Rescue Phase|Death|0|||
124844274|NCT00207142|449057877|FG003|Maintenance Phase/Rescue Phase|Death|1|||
124844275|NCT00207142|449057874|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
124844276|NCT00207142|449057875|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
124844277|NCT00207142|449057876|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
124844278|NCT00207142|449057877|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
124844279|NCT01857063|449057878|FG000|Period 1 (7 Days)|Adverse Event|0|||
124844280|NCT01857063|449057879|FG001|Period 1 (7 Days)|Adverse Event|1|||
124844281|NCT01857063|449057878|FG000|Period 1 (7 Days)|Physician Decision|1|||
124844282|NCT01857063|449057879|FG001|Period 1 (7 Days)|Physician Decision|0|||
124844283|NCT01857063|449057878|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
124844284|NCT01857063|449057879|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
124844285|NCT01857063|449057878|FG000|Period 2 (7 Days)|Adverse Event|2|||
124844286|NCT01857063|449057879|FG001|Period 2 (7 Days)|Adverse Event|1|||
124844287|NCT01857063|449057878|FG000|Period 2 (7 Days)|Physician Decision|1|||
124844288|NCT01857063|449057879|FG001|Period 2 (7 Days)|Physician Decision|1|||
124844289|NCT01857063|449057878|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
124844290|NCT01857063|449057879|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
124844291|NCT04115358|449057882|FG000|Overall Study|exfoliation|0|||
124844292|NCT04115358|449057883|FG001|Overall Study|exfoliation|0|||
124844293|NCT04115358|449057884|FG002|Overall Study|exfoliation|1|||
124844294|NCT01205165|449057885|FG000|Overall Study|Lost to Follow-up|2|||
124844295|NCT03306264|449057888|FG000|Overall Study|Death|33|||
124844296|NCT03306264|449057889|FG001|Overall Study|Death|25|||
124844297|NCT03306264|449057890|FG002|Overall Study|Death|34|||
124844298|NCT03306264|449057891|FG003|Overall Study|Death|34|||
124844299|NCT03306264|449057888|FG000|Overall Study|Complete Consent Withdrawal|4|||
124844300|NCT03306264|449057889|FG001|Overall Study|Complete Consent Withdrawal|4|||
124844301|NCT03306264|449057890|FG002|Overall Study|Complete Consent Withdrawal|1|||
124844302|NCT03306264|449057891|FG003|Overall Study|Complete Consent Withdrawal|8|||
124844303|NCT03306264|449057888|FG000|Overall Study|Lost to Follow-up|1|||
124844304|NCT03306264|449057889|FG001|Overall Study|Lost to Follow-up|0|||
124844305|NCT03306264|449057890|FG002|Overall Study|Lost to Follow-up|1|||
124844306|NCT03306264|449057891|FG003|Overall Study|Lost to Follow-up|0|||
124844307|NCT03306264|449057888|FG000|Overall Study|Rollover to ASTX727-06|10|||
124844308|NCT03306264|449057889|FG001|Overall Study|Rollover to ASTX727-06|18|||
124844309|NCT03306264|449057890|FG002|Overall Study|Rollover to ASTX727-06|4|||
124844310|NCT03306264|449057891|FG003|Overall Study|Rollover to ASTX727-06|2|||
124844311|NCT03306264|449057888|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
124844312|NCT03306264|449057889|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
124844313|NCT03306264|449057890|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
124844314|NCT03306264|449057891|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
124844315|NCT00458484|449057892|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
124844316|NCT00458484|449057893|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
124844317|NCT00458484|449057894|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
124844318|NCT00458484|449057895|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
124844319|NCT00458484|449057896|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
124844320|NCT00458484|449057897|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
124844321|NCT00458484|449057898|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
124844322|NCT04538664|449057899|FG000|Overall Study|Withdrawal by Subject|5|||
124844323|NCT04538664|449057900|FG001|Overall Study|Withdrawal by Subject|9|||
124844324|NCT04538664|449057899|FG000|Overall Study|Lost to Follow-up|2|||
124844325|NCT04538664|449057900|FG001|Overall Study|Lost to Follow-up|1|||
124844326|NCT04538664|449057899|FG000|Overall Study|Ongoing|106|||
124844327|NCT04538664|449057900|FG001|Overall Study|Ongoing|115|||
124844328|NCT04136912|449057901|FG000|Overall Study|Operational reasons|0|||
124844329|NCT04136912|449057902|FG001|Overall Study|Operational reasons|0|||
124844330|NCT04136912|449057903|FG002|Overall Study|Operational reasons|2|||
124844331|NCT02448875|449057904|FG000|Overall Study|Adverse Event|2|||
124844332|NCT02448875|449057905|FG001|Overall Study|Adverse Event|1|||
124844333|NCT02448875|449057906|FG002|Overall Study|Adverse Event|0|||
124844334|NCT02448875|449057904|FG000|Overall Study|Lost to Follow-up|1|||
124844335|NCT02448875|449057905|FG001|Overall Study|Lost to Follow-up|0|||
124844336|NCT02448875|449057906|FG002|Overall Study|Lost to Follow-up|0|||
124844337|NCT02448875|449057904|FG000|Overall Study|Investigator Decision|3|||
124844338|NCT02448875|449057905|FG001|Overall Study|Investigator Decision|0|||
124844339|NCT02448875|449057906|FG002|Overall Study|Investigator Decision|1|||
124844340|NCT02448875|449057904|FG000|Overall Study|Withdrawal by Subject|1|||
124844341|NCT02448875|449057905|FG001|Overall Study|Withdrawal by Subject|0|||
124844342|NCT02448875|449057906|FG002|Overall Study|Withdrawal by Subject|0|||
124844343|NCT03390504|449057908|FG000|Overall Study|Lost to Follow-up|2|||
124844344|NCT03390504|449057909|FG001|Overall Study|Lost to Follow-up|4|||
124844345|NCT03390504|449057910|FG002|Overall Study|Lost to Follow-up|0|||
124844346|NCT03390504|449057911|FG003|Overall Study|Lost to Follow-up|1|||
124844347|NCT03390504|449057908|FG000|Overall Study|Withdrawal by Subject|3|||
124844348|NCT03390504|449057909|FG001|Overall Study|Withdrawal by Subject|15|||
124844349|NCT03390504|449057910|FG002|Overall Study|Withdrawal by Subject|5|||
124844350|NCT03390504|449057911|FG003|Overall Study|Withdrawal by Subject|2|||
124844351|NCT03390504|449057908|FG000|Overall Study|Other|1|||
124844352|NCT03390504|449057909|FG001|Overall Study|Other|2|||
124844353|NCT03390504|449057910|FG002|Overall Study|Other|2|||
124844354|NCT03390504|449057911|FG003|Overall Study|Other|6|||
124844355|NCT03508219|449057912|FG000|Overall Study|Death|2|||
124844356|NCT03508219|449057912|FG000|Overall Study|Withdrawal by Subject|1|||
124844357|NCT03508219|449057912|FG000|Overall Study|Lost to Follow-up|4|||
124844358|NCT03508219|449057912|FG000|Overall Study|Missed visit|2|||
124844359|NCT02782949|449057915|FG000|Overall Study|Protocol Violation|1|||
124844360|NCT02782949|449057916|FG001|Overall Study|Protocol Violation|0|||
124844361|NCT02782949|449057915|FG000|Overall Study|Withdrawal by Subject|0|||
124844362|NCT02782949|449057916|FG001|Overall Study|Withdrawal by Subject|1|||
124844363|NCT05645432|449057917|FG000|Overall Study|Withdrawal by Subject|1|||
124844364|NCT03370341|449058800|FG000|Overall Study|Lost to Follow-up|0|||
124844365|NCT03370341|449058801|FG001|Overall Study|Lost to Follow-up|1|||
124844366|NCT00634647|449058803|FG000|Overall Study|death on study|3|||
124844367|NCT00634647|449058803|FG000|Overall Study|refused further treatment|3|||
124844368|NCT00634647|449058803|FG000|Overall Study|declined to participate before treatment|1|||
124844369|NCT02984020|449058804|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
124844370|NCT02984020|449058804|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
124844371|NCT02984020|449058804|FG000|Overall Study|Other significant protocol violation|2|||
124844372|NCT01700179|449058806|FG000|Overall Study|Physician Decision|2|||
124844373|NCT00667342|449058807|FG000|Overall Study|Protocol Violation|1|||
124844374|NCT00667342|449058808|FG001|Overall Study|Protocol Violation|0|||
124844375|NCT00667342|449058809|FG002|Overall Study|Protocol Violation|0|||
124844376|NCT00667342|449058807|FG000|Overall Study|Withdrawal by Subject|1|||
124844377|NCT00667342|449058808|FG001|Overall Study|Withdrawal by Subject|0|||
124844378|NCT00667342|449058809|FG002|Overall Study|Withdrawal by Subject|0|||
124844379|NCT00667342|449058807|FG000|Overall Study|Physician Decision|3|||
124844380|NCT00667342|449058808|FG001|Overall Study|Physician Decision|0|||
124844381|NCT00667342|449058809|FG002|Overall Study|Physician Decision|0|||
124844382|NCT00667342|449058807|FG000|Overall Study|Relapse or tumor progression|9|||
124844383|NCT00667342|449058808|FG001|Overall Study|Relapse or tumor progression|0|||
124844384|NCT00667342|449058809|FG002|Overall Study|Relapse or tumor progression|7|||
124844385|NCT00667342|449058807|FG000|Overall Study|Adverse Event|0|||
124844386|NCT00667342|449058808|FG001|Overall Study|Adverse Event|0|||
124844387|NCT00667342|449058809|FG002|Overall Study|Adverse Event|1|||
124844388|NCT00667342|449058807|FG000|Overall Study|Ineligible|0|||
124844389|NCT00667342|449058808|FG001|Overall Study|Ineligible|0|||
124844390|NCT00667342|449058809|FG002|Overall Study|Ineligible|1|||
124844391|NCT05220397|449058810|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
124844392|NCT05220397|449058811|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
124844393|NCT05220397|449058812|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
124844394|NCT05220397|449058813|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
124844395|NCT05220397|449058814|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
124844396|NCT05091528|449058815|FG000|Overall Study|Study Termination by Sponsor|0|||
124844397|NCT05091528|449058816|FG001|Overall Study|Study Termination by Sponsor|1|||
124844398|NCT05091528|449058817|FG002|Overall Study|Study Termination by Sponsor|0|||
124844399|NCT05091528|449058818|FG003|Overall Study|Study Termination by Sponsor|1|||
124844400|NCT04958109|449058819|FG000|Overall Study|Withdrawal by Subject|0|||
124844401|NCT04958109|449058820|FG001|Overall Study|Withdrawal by Subject|1|||
124844402|NCT04958109|449058819|FG000|Overall Study|Lost to Follow-up|0|||
124844403|NCT04958109|449058820|FG001|Overall Study|Lost to Follow-up|1|||
124844404|NCT01573624|449058823|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
124844405|NCT01573624|449058824|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
124844406|NCT01573624|449058825|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
124844407|NCT01573624|449058826|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
124844408|NCT01573624|449058827|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
124844409|NCT01573624|449058828|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
124844410|NCT01573624|449058829|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
124844411|NCT01573624|449058823|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
124844412|NCT01573624|449058824|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
124844413|NCT01573624|449058825|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
124844414|NCT01573624|449058826|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
124844415|NCT01573624|449058827|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
124844416|NCT01573624|449058828|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
124844417|NCT01573624|449058829|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
124844418|NCT01573624|449058823|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
124844419|NCT01573624|449058824|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
124844420|NCT01573624|449058825|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
124844421|NCT01573624|449058826|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
124844422|NCT01573624|449058827|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
124844423|NCT01573624|449058828|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
124844424|NCT01573624|449058829|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
124844425|NCT01573624|449058823|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
124844426|NCT01573624|449058824|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124844427|NCT01573624|449058825|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
124844428|NCT01573624|449058826|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124844429|NCT01573624|449058827|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124844430|NCT01573624|449058828|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
124844431|NCT01573624|449058829|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124844432|NCT01573624|449058823|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
124844433|NCT01573624|449058824|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
124844434|NCT01573624|449058825|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
124844435|NCT01573624|449058826|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
124844436|NCT01573624|449058827|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
124844437|NCT01573624|449058828|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
124844438|NCT01573624|449058829|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
124844439|NCT01573624|449058823|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
124844440|NCT01573624|449058824|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
124844441|NCT01573624|449058825|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
124844442|NCT01573624|449058826|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
124844443|NCT01573624|449058827|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
124844444|NCT01573624|449058828|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
124844445|NCT01573624|449058829|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
124844446|NCT01573624|449058823|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
124844447|NCT01573624|449058824|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
124844448|NCT01573624|449058825|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
124844449|NCT01573624|449058826|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
124844450|NCT01573624|449058827|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
124844451|NCT01573624|449058828|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
124844452|NCT01573624|449058829|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
124844453|NCT01573624|449058823|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
124844454|NCT01573624|449058824|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124844455|NCT01573624|449058825|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
124844456|NCT01573624|449058826|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
124844457|NCT01573624|449058827|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124844458|NCT01573624|449058828|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124844459|NCT01573624|449058829|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124844460|NCT01573624|449058823|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
124844461|NCT01573624|449058824|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
124844462|NCT01573624|449058825|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
124844463|NCT01573624|449058826|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
124844464|NCT01573624|449058827|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
124844465|NCT01573624|449058828|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
124844466|NCT01573624|449058829|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
124844467|NCT01573624|449058823|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
124844468|NCT01573624|449058824|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
124844469|NCT01573624|449058825|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
124844470|NCT01573624|449058826|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
124844471|NCT01573624|449058827|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
124844472|NCT01573624|449058828|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
124844473|NCT01573624|449058829|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
124844474|NCT01573624|449058823|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
124844475|NCT01573624|449058824|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
124844476|NCT01573624|449058825|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
124844477|NCT01573624|449058826|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
124844478|NCT01573624|449058827|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
124844479|NCT01573624|449058828|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
124844480|NCT01573624|449058829|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
124844481|NCT01573624|449058823|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
124844482|NCT01573624|449058824|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
124844483|NCT01573624|449058825|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
124844484|NCT01573624|449058826|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
124844485|NCT01573624|449058827|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
124844486|NCT01573624|449058828|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
124844487|NCT01573624|449058829|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
124844488|NCT01573624|449058823|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
124844489|NCT01573624|449058824|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
124844490|NCT01573624|449058825|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
124844491|NCT01573624|449058826|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
124844492|NCT01573624|449058827|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
124844493|NCT01573624|449058828|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
124844494|NCT01573624|449058829|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
124844495|NCT01573624|449058823|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
124844496|NCT01573624|449058824|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
124844497|NCT01573624|449058825|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
124844498|NCT01573624|449058826|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
124844499|NCT01573624|449058827|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
124844500|NCT01573624|449058828|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
124844501|NCT01573624|449058829|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
124844502|NCT01573624|449058823|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
124844503|NCT01573624|449058824|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
124844504|NCT01573624|449058825|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
124844505|NCT01573624|449058826|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
124844506|NCT01573624|449058827|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
124844507|NCT01573624|449058828|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
124844508|NCT01573624|449058829|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
124844509|NCT01573624|449058823|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
124844510|NCT01573624|449058824|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
124844511|NCT01573624|449058825|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
124844512|NCT01573624|449058826|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
124844513|NCT01573624|449058827|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
124844514|NCT01573624|449058828|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
124844515|NCT01573624|449058829|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
124844516|NCT01573624|449058823|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
124844517|NCT01573624|449058824|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
124844518|NCT01573624|449058825|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
124844519|NCT01573624|449058826|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
124844520|NCT01573624|449058827|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
124844521|NCT01573624|449058828|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
124844522|NCT01573624|449058829|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
124844523|NCT01573624|449058823|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
124844524|NCT01573624|449058824|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
124844525|NCT01573624|449058825|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
124844526|NCT01573624|449058826|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
124844527|NCT01573624|449058827|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
124844528|NCT01573624|449058828|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
124844529|NCT01573624|449058829|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
124844530|NCT01573624|449058823|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
124844531|NCT01573624|449058824|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
124844532|NCT01573624|449058825|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
124844533|NCT01573624|449058826|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
124844534|NCT01573624|449058827|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
124844535|NCT01573624|449058828|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
124844536|NCT01573624|449058829|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
124844537|NCT01573624|449058823|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
124844538|NCT01573624|449058824|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
124844539|NCT01573624|449058825|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
124844540|NCT01573624|449058826|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
124844541|NCT01573624|449058827|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
124844542|NCT01573624|449058828|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
124844543|NCT01573624|449058829|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
124844544|NCT01573624|449058823|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
124844545|NCT01573624|449058824|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
124844546|NCT01573624|449058825|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
125305564|NCT02218008|450745143|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
125305565|NCT02218008|450745144|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
125305566|NCT00106353|450745145|FG000|Part 1|Disease progression|3|||
125305567|NCT00106353|450745146|FG001|Part 1|Disease progression|4|||
125305568|NCT00106353|450745147|FG002|Part 1|Disease progression|1|||
125305569|NCT00106353|450745148|FG003|Part 1|Disease progression|3|||
125305570|NCT00106353|450745149|FG004|Part 1|Disease progression|0|||
124844547|NCT01573624|449058826|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
124844548|NCT01573624|449058827|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
124844549|NCT01573624|449058828|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
124844550|NCT01573624|449058829|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
124844551|NCT01573624|449058823|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
124844552|NCT01573624|449058824|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
124844553|NCT01573624|449058825|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
124844554|NCT01573624|449058826|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
124844555|NCT01573624|449058827|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
124844556|NCT01573624|449058828|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
124844557|NCT01573624|449058829|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
124844558|NCT01573624|449058823|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
124844559|NCT01573624|449058824|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
124844560|NCT01573624|449058825|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
124844561|NCT01573624|449058826|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
124844562|NCT01573624|449058827|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
124844563|NCT01573624|449058828|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
124844564|NCT01573624|449058829|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
124844565|NCT01573624|449058823|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
124844566|NCT01573624|449058824|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
124844567|NCT01573624|449058825|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
124844568|NCT01573624|449058826|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
124844569|NCT01573624|449058827|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
124844570|NCT01573624|449058828|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
124844571|NCT01573624|449058829|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
124844572|NCT01573624|449058823|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
124844573|NCT01573624|449058824|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
124844574|NCT01573624|449058825|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
124844575|NCT01573624|449058826|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
124844576|NCT01573624|449058827|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
124844577|NCT01573624|449058828|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
124844578|NCT01573624|449058829|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
124844579|NCT01573624|449058823|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
124844580|NCT01573624|449058824|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
124844581|NCT01573624|449058825|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
124844582|NCT01573624|449058826|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
124844583|NCT01573624|449058827|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
124844584|NCT01573624|449058828|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
124844585|NCT01573624|449058829|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
124844586|NCT01573624|449058823|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
124844587|NCT01573624|449058824|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
124844588|NCT01573624|449058825|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
124844589|NCT01573624|449058826|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
124844590|NCT01573624|449058827|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
124844591|NCT01573624|449058828|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
124844592|NCT01573624|449058829|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
124844593|NCT02257736|449058845|FG000|Overall Study|Progressive disease|365|||
124844594|NCT02257736|449058846|FG001|Overall Study|Progressive disease|327|||
124844595|NCT02257736|449058845|FG000|Overall Study|Adverse Event|45|||
124844596|NCT02257736|449058846|FG001|Overall Study|Adverse Event|56|||
124844597|NCT02257736|449058845|FG000|Overall Study|Withdrawal by Subject|21|||
124844598|NCT02257736|449058846|FG001|Overall Study|Withdrawal by Subject|38|||
124844599|NCT02257736|449058845|FG000|Overall Study|Death|11|||
124844600|NCT02257736|449058846|FG001|Overall Study|Death|6|||
124844601|NCT02257736|449058845|FG000|Overall Study|Physician Decision|5|||
124844602|NCT02257736|449058846|FG001|Overall Study|Physician Decision|9|||
124844603|NCT02257736|449058845|FG000|Overall Study|Non-Compliance with study drug|1|||
124844604|NCT02257736|449058846|FG001|Overall Study|Non-Compliance with study drug|2|||
124844605|NCT02257736|449058845|FG000|Overall Study|Protocol Violation|1|||
124844606|NCT02257736|449058846|FG001|Overall Study|Protocol Violation|0|||
124844607|NCT02257736|449058845|FG000|Overall Study|Other|1|||
124844608|NCT02257736|449058846|FG001|Overall Study|Other|7|||
124844609|NCT02257736|449058845|FG000|Overall Study|Randomized, not treated|1|||
124844610|NCT02257736|449058846|FG001|Overall Study|Randomized, not treated|2|||
124844611|NCT00308711|449058847|FG000|Overall Study|Withdrawal by Subject|1|||
124844612|NCT00308711|449058848|FG001|Overall Study|Withdrawal by Subject|0|||
124844613|NCT00308711|449058849|FG002|Overall Study|Withdrawal by Subject|1|||
124844614|NCT00308711|449058847|FG000|Overall Study|Protocol Violation|0|||
124844615|NCT00308711|449058848|FG001|Overall Study|Protocol Violation|1|||
124844616|NCT00308711|449058849|FG002|Overall Study|Protocol Violation|1|||
124844617|NCT00308711|449058847|FG000|Overall Study|Lost to Follow-up|0|||
124844618|NCT00308711|449058848|FG001|Overall Study|Lost to Follow-up|1|||
124844619|NCT00308711|449058849|FG002|Overall Study|Lost to Follow-up|0|||
124844620|NCT00308711|449058847|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
124844621|NCT00308711|449058848|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
124844622|NCT00308711|449058849|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
124844623|NCT00308711|449058847|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
124844624|NCT00308711|449058848|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
124844625|NCT00308711|449058849|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
124844626|NCT02167256|449058850|FG000|Overall Study|Adverse Event|13|||
124844627|NCT02167256|449058851|FG001|Overall Study|Adverse Event|6|||
124844628|NCT02167256|449058850|FG000|Overall Study|Withdrawal by Subject|4|||
124844629|NCT02167256|449058851|FG001|Overall Study|Withdrawal by Subject|4|||
124844630|NCT02167256|449058850|FG000|Overall Study|non-compliance|3|||
124844631|NCT02167256|449058851|FG001|Overall Study|non-compliance|0|||
124844632|NCT02167256|449058850|FG000|Overall Study|Study partner unable to participate|1|||
124844633|NCT02167256|449058851|FG001|Overall Study|Study partner unable to participate|0|||
124844634|NCT00414388|449058854|FG000|Overall Study|Adverse Event|1|||
124844635|NCT03591575|449058855|FG000|Overall Study|Adverse Event|2|||
124844636|NCT03591575|449058856|FG001|Overall Study|Adverse Event|0|||
124844637|NCT03591575|449058855|FG000|Overall Study|Withdrawal by Subject|4|||
124844638|NCT03591575|449058856|FG001|Overall Study|Withdrawal by Subject|1|||
124844639|NCT01723228|449058857|FG000|Overall Study|Adverse Event|2|||
124844640|NCT01723228|449058858|FG001|Overall Study|Adverse Event|6|||
124844641|NCT01723228|449058857|FG000|Overall Study|Withdrawal by Subject|2|||
124844642|NCT01723228|449058858|FG001|Overall Study|Withdrawal by Subject|1|||
124844643|NCT01723228|449058857|FG000|Overall Study|Protocol Violation|0|||
124844644|NCT01723228|449058858|FG001|Overall Study|Protocol Violation|2|||
124844645|NCT01723228|449058857|FG000|Overall Study|Lost to Follow-up|2|||
124844646|NCT01723228|449058858|FG001|Overall Study|Lost to Follow-up|1|||
124844647|NCT01723228|449058857|FG000|Overall Study|Other|2|||
124844648|NCT01723228|449058858|FG001|Overall Study|Other|1|||
124844649|NCT00218543|449058859|FG000|Overall Study|Lost to Follow-up|8|||
124844650|NCT00218543|449058859|FG000|Overall Study|relocated|1|||
124844651|NCT00218543|449058859|FG000|Overall Study|Withdrawal by Subject|1|||
124844652|NCT00218543|449058859|FG000|Overall Study|Physician Decision|3|||
124844653|NCT00218543|449058859|FG000|Overall Study|Adverse Event|2|||
124844654|NCT01864291|449058860|FG000|Overall Study|need for revision surgery|2|||
124844655|NCT01451424|449058861|FG000|Overall Study|Withdrawal by Subject|1|||
124844656|NCT01451424|449058862|FG001|Overall Study|Withdrawal by Subject|1|||
124844657|NCT01451424|449058863|FG002|Overall Study|Withdrawal by Subject|0|||
124844658|NCT01451424|449058864|FG003|Overall Study|Withdrawal by Subject|2|||
124844659|NCT01451424|449058861|FG000|Overall Study|Lost to Follow-up|0|||
124844660|NCT01451424|449058862|FG001|Overall Study|Lost to Follow-up|1|||
124844661|NCT01451424|449058863|FG002|Overall Study|Lost to Follow-up|0|||
124844662|NCT01451424|449058864|FG003|Overall Study|Lost to Follow-up|1|||
124844663|NCT01451424|449058861|FG000|Overall Study|Physician Decision|0|||
124844664|NCT01451424|449058862|FG001|Overall Study|Physician Decision|0|||
124844665|NCT01451424|449058863|FG002|Overall Study|Physician Decision|1|||
124844666|NCT01451424|449058864|FG003|Overall Study|Physician Decision|1|||
124844667|NCT01451424|449058861|FG000|Overall Study|Adverse Event|0|||
124844668|NCT01451424|449058862|FG001|Overall Study|Adverse Event|0|||
124844669|NCT01451424|449058863|FG002|Overall Study|Adverse Event|0|||
124844670|NCT01451424|449058864|FG003|Overall Study|Adverse Event|1|||
124844671|NCT00689481|449058865|FG000|Overall Study|Adverse Event|7|||
124844672|NCT00689481|449058866|FG001|Overall Study|Adverse Event|1|||
124844673|NCT00689481|449058865|FG000|Overall Study|Lost to Follow-up|4|||
124844674|NCT00689481|449058866|FG001|Overall Study|Lost to Follow-up|3|||
124844675|NCT00689481|449058865|FG000|Overall Study|Lack of Efficacy|4|||
124844676|NCT00689481|449058866|FG001|Overall Study|Lack of Efficacy|3|||
124844677|NCT00689481|449058865|FG000|Overall Study|Non-compliance with study treatment|1|||
124844678|NCT00689481|449058866|FG001|Overall Study|Non-compliance with study treatment|1|||
124844679|NCT00689481|449058865|FG000|Overall Study|Withdrawal by Subject|8|||
124844680|NCT00689481|449058866|FG001|Overall Study|Withdrawal by Subject|4|||
124844681|NCT00689481|449058865|FG000|Overall Study|Excluded medication started during study|0|||
124844682|NCT00689481|449058866|FG001|Overall Study|Excluded medication started during study|1|||
124844683|NCT00689481|449058865|FG000|Overall Study|Subject early term, left on vacation|0|||
124844684|NCT00689481|449058866|FG001|Overall Study|Subject early term, left on vacation|1|||
124844685|NCT02254278|449058867|FG000|Overall Study|Protocol Violation|1|||
124844686|NCT02254278|449058868|FG001|Overall Study|Protocol Violation|1|||
124844687|NCT04745689|449058870|FG000|Overall Study|Death|9|||
124844688|NCT04745689|449058871|FG001|Overall Study|Death|6|||
124844689|NCT04745689|449058870|FG000|Overall Study|Lost to Follow-up|1|||
124844690|NCT04745689|449058871|FG001|Overall Study|Lost to Follow-up|0|||
124844691|NCT04745689|449058870|FG000|Overall Study|Withdrawal by Subject|2|||
124844692|NCT04745689|449058871|FG001|Overall Study|Withdrawal by Subject|0|||
124844693|NCT04745689|449058870|FG000|Overall Study|Study terminated by sponsor|10|||
124844694|NCT04745689|449058871|FG001|Overall Study|Study terminated by sponsor|3|||
124844695|NCT03091192|449058872|FG000|Overall Study|Study terminated by sponsor|21|||
124844696|NCT03091192|449058873|FG001|Overall Study|Study terminated by sponsor|14|||
124844697|NCT03091192|449058872|FG000|Overall Study|Death|9|||
124844698|NCT03091192|449058873|FG001|Overall Study|Death|13|||
124844699|NCT03091192|449058872|FG000|Overall Study|Withdrawal by Subject|2|||
124844700|NCT03091192|449058873|FG001|Overall Study|Withdrawal by Subject|0|||
124844701|NCT03091192|449058872|FG000|Overall Study|Lost to Follow-up|1|||
124844702|NCT03091192|449058873|FG001|Overall Study|Lost to Follow-up|0|||
124844703|NCT01038778|449058876|FG000|Overall Study|Withdrawal by Subject|0|||
124844704|NCT01038778|449058877|FG001|Overall Study|Withdrawal by Subject|2|||
124844705|NCT01038778|449058878|FG002|Overall Study|Withdrawal by Subject|3|||
124844706|NCT04487080|449058879|FG000|Overall Study|Withdrawal by Subject|19|||
124844707|NCT04487080|449058880|FG001|Overall Study|Withdrawal by Subject|18|||
124844708|NCT04487080|449058881|FG002|Overall Study|Withdrawal by Subject|13|||
124844709|NCT04487080|449058879|FG000|Overall Study|Lost to Follow-up|3|||
124844710|NCT04487080|449058880|FG001|Overall Study|Lost to Follow-up|1|||
124844711|NCT04487080|449058881|FG002|Overall Study|Lost to Follow-up|0|||
124844712|NCT04487080|449058879|FG000|Overall Study|Ongoing|313|||
124844713|NCT04487080|449058880|FG001|Overall Study|Ongoing|297|||
124844714|NCT04487080|449058881|FG002|Overall Study|Ongoing|149|||
124844715|NCT03195478|449058882|FG000|Overall Study|Disease Progression|5|||
124844716|NCT03195478|449058883|FG001|Overall Study|Disease Progression|4|||
124844717|NCT03195478|449058884|FG002|Overall Study|Disease Progression|6|||
124844718|NCT03195478|449058885|FG003|Overall Study|Disease Progression|1|||
124844719|NCT03195478|449058882|FG000|Overall Study|Study Drug Toxicity|2|||
124844720|NCT03195478|449058883|FG001|Overall Study|Study Drug Toxicity|0|||
124844721|NCT03195478|449058884|FG002|Overall Study|Study Drug Toxicity|0|||
124844722|NCT03195478|449058885|FG003|Overall Study|Study Drug Toxicity|1|||
124844723|NCT03195478|449058882|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
124844724|NCT03195478|449058883|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
124844725|NCT03195478|449058884|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
124844726|NCT03195478|449058885|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
124844727|NCT03195478|449058882|FG000|Overall Study|Participant Withdrew Consent|1|||
124844728|NCT03195478|449058883|FG001|Overall Study|Participant Withdrew Consent|0|||
124844729|NCT03195478|449058884|FG002|Overall Study|Participant Withdrew Consent|0|||
124844730|NCT03195478|449058885|FG003|Overall Study|Participant Withdrew Consent|0|||
124844731|NCT03195478|449058882|FG000|Overall Study|Maximum Clinical benefit|0|||
124844732|NCT03195478|449058883|FG001|Overall Study|Maximum Clinical benefit|0|||
124844733|NCT03195478|449058884|FG002|Overall Study|Maximum Clinical benefit|1|||
124844734|NCT03195478|449058885|FG003|Overall Study|Maximum Clinical benefit|0|||
124844735|NCT03195478|449058882|FG000|Overall Study|Other Reasons|0|||
124844736|NCT03195478|449058883|FG001|Overall Study|Other Reasons|0|||
124844737|NCT03195478|449058884|FG002|Overall Study|Other Reasons|1|||
124844738|NCT03195478|449058885|FG003|Overall Study|Other Reasons|0|||
124844739|NCT01677195|449060092|FG000|Overall Study|Lost to Follow-up|14|||
124844740|NCT01677195|449060093|FG001|Overall Study|Lost to Follow-up|22|||
124844741|NCT01677195|449060094|FG002|Overall Study|Lost to Follow-up|22|||
124844742|NCT01677195|449060092|FG000|Overall Study|Withdrawal by Subject|1|||
124844743|NCT01677195|449060093|FG001|Overall Study|Withdrawal by Subject|0|||
124844744|NCT01677195|449060094|FG002|Overall Study|Withdrawal by Subject|1|||
124844745|NCT01677195|449060092|FG000|Overall Study|Adverse Event|6|||
124844746|NCT01677195|449060093|FG001|Overall Study|Adverse Event|4|||
124844747|NCT01677195|449060094|FG002|Overall Study|Adverse Event|1|||
124844748|NCT01677195|449060092|FG000|Overall Study|Physician Decision|1|||
124844749|NCT01677195|449060093|FG001|Overall Study|Physician Decision|2|||
124844750|NCT01677195|449060094|FG002|Overall Study|Physician Decision|2|||
124844751|NCT01677195|449060092|FG000|Overall Study|Pregnancy|0|||
125305571|NCT00106353|450745150|FG005|Part 1|Disease progression|0|||
125305572|NCT00106353|450745151|FG006|Part 1|Disease progression|0|||
125305573|NCT00106353|450745145|FG000|Part 1|Withdrawal by Subject|0|||
125305574|NCT00106353|450745146|FG001|Part 1|Withdrawal by Subject|0|||
125305575|NCT00106353|450745147|FG002|Part 1|Withdrawal by Subject|1|||
125305576|NCT00106353|450745148|FG003|Part 1|Withdrawal by Subject|2|||
125305577|NCT00106353|450745149|FG004|Part 1|Withdrawal by Subject|0|||
125305578|NCT00106353|450745150|FG005|Part 1|Withdrawal by Subject|0|||
125305579|NCT00106353|450745151|FG006|Part 1|Withdrawal by Subject|0|||
125305580|NCT00106353|450745145|FG000|Part 1|Symptomatic deterioration|0|||
125305581|NCT00106353|450745146|FG001|Part 1|Symptomatic deterioration|0|||
125305582|NCT00106353|450745147|FG002|Part 1|Symptomatic deterioration|1|||
125305583|NCT00106353|450745148|FG003|Part 1|Symptomatic deterioration|0|||
125305584|NCT00106353|450745149|FG004|Part 1|Symptomatic deterioration|0|||
125305585|NCT00106353|450745150|FG005|Part 1|Symptomatic deterioration|0|||
125305586|NCT00106353|450745151|FG006|Part 1|Symptomatic deterioration|0|||
125305587|NCT00106353|450745145|FG000|Part 1|Entered follow-up phase|1|||
125305588|NCT00106353|450745146|FG001|Part 1|Entered follow-up phase|1|||
125305589|NCT00106353|450745147|FG002|Part 1|Entered follow-up phase|0|||
125305590|NCT00106353|450745148|FG003|Part 1|Entered follow-up phase|1|||
125305591|NCT00106353|450745149|FG004|Part 1|Entered follow-up phase|0|||
125305592|NCT00106353|450745150|FG005|Part 1|Entered follow-up phase|0|||
125305593|NCT00106353|450745151|FG006|Part 1|Entered follow-up phase|0|||
125305594|NCT00106353|450745145|FG000|Part 1|Adverse Event|0|||
125305595|NCT00106353|450745146|FG001|Part 1|Adverse Event|0|||
125305596|NCT00106353|450745147|FG002|Part 1|Adverse Event|0|||
125305597|NCT00106353|450745148|FG003|Part 1|Adverse Event|1|||
125305598|NCT00106353|450745149|FG004|Part 1|Adverse Event|0|||
125305599|NCT00106353|450745150|FG005|Part 1|Adverse Event|0|||
125305600|NCT00106353|450745151|FG006|Part 1|Adverse Event|0|||
125305601|NCT00106353|450745145|FG000|Part 2|Disease progression|0|||
125305602|NCT00106353|450745146|FG001|Part 2|Disease progression|0|||
125305603|NCT00106353|450745147|FG002|Part 2|Disease progression|0|||
125305604|NCT00106353|450745148|FG003|Part 2|Disease progression|0|||
125305605|NCT00106353|450745149|FG004|Part 2|Disease progression|8|||
125305606|NCT00106353|450745150|FG005|Part 2|Disease progression|14|||
125305607|NCT00106353|450745151|FG006|Part 2|Disease progression|13|||
125305608|NCT00106353|450745145|FG000|Part 2|Death|0|||
125305609|NCT00106353|450745146|FG001|Part 2|Death|0|||
125305610|NCT00106353|450745147|FG002|Part 2|Death|0|||
125305611|NCT00106353|450745148|FG003|Part 2|Death|0|||
125305612|NCT00106353|450745149|FG004|Part 2|Death|3|||
125305613|NCT00106353|450745150|FG005|Part 2|Death|0|||
125305614|NCT00106353|450745151|FG006|Part 2|Death|1|||
125305615|NCT00106353|450745145|FG000|Part 2|Symptomatic deterioration|0|||
125305616|NCT00106353|450745146|FG001|Part 2|Symptomatic deterioration|0|||
125305617|NCT00106353|450745147|FG002|Part 2|Symptomatic deterioration|0|||
125305618|NCT00106353|450745148|FG003|Part 2|Symptomatic deterioration|0|||
125305619|NCT00106353|450745149|FG004|Part 2|Symptomatic deterioration|3|||
125305620|NCT00106353|450745150|FG005|Part 2|Symptomatic deterioration|0|||
125305621|NCT00106353|450745151|FG006|Part 2|Symptomatic deterioration|0|||
125305622|NCT00106353|450745145|FG000|Part 2|Adverse Event|0|||
125305623|NCT00106353|450745146|FG001|Part 2|Adverse Event|0|||
125305624|NCT00106353|450745147|FG002|Part 2|Adverse Event|0|||
125305625|NCT00106353|450745148|FG003|Part 2|Adverse Event|0|||
125305626|NCT00106353|450745149|FG004|Part 2|Adverse Event|0|||
125305627|NCT00106353|450745150|FG005|Part 2|Adverse Event|2|||
125305628|NCT00106353|450745151|FG006|Part 2|Adverse Event|1|||
125305629|NCT00106353|450745145|FG000|Part 2|Other|0|||
125305630|NCT00106353|450745146|FG001|Part 2|Other|0|||
125305631|NCT00106353|450745147|FG002|Part 2|Other|0|||
125305632|NCT00106353|450745148|FG003|Part 2|Other|0|||
125305633|NCT00106353|450745149|FG004|Part 2|Other|1|||
125305634|NCT00106353|450745150|FG005|Part 2|Other|1|||
125305635|NCT00106353|450745151|FG006|Part 2|Other|1|||
125305636|NCT00106353|450745145|FG000|Part 2|Withdrawal by Subject|0|||
125305637|NCT00106353|450745146|FG001|Part 2|Withdrawal by Subject|0|||
125305638|NCT00106353|450745147|FG002|Part 2|Withdrawal by Subject|0|||
125305639|NCT00106353|450745148|FG003|Part 2|Withdrawal by Subject|0|||
124844752|NCT01677195|449060093|FG001|Overall Study|Pregnancy|1|||
124844753|NCT01677195|449060094|FG002|Overall Study|Pregnancy|0|||
124844754|NCT01677195|449060092|FG000|Overall Study|Protocol Violation|7|||
125305640|NCT00106353|450745149|FG004|Part 2|Withdrawal by Subject|1|||
125305641|NCT00106353|450745150|FG005|Part 2|Withdrawal by Subject|0|||
125305642|NCT00106353|450745151|FG006|Part 2|Withdrawal by Subject|0|||
125305643|NCT00106353|450745145|FG000|Part 2|Physician Decision|0|||
125305644|NCT00106353|450745146|FG001|Part 2|Physician Decision|0|||
125305645|NCT00106353|450745147|FG002|Part 2|Physician Decision|0|||
125305646|NCT00106353|450745148|FG003|Part 2|Physician Decision|0|||
124844755|NCT01677195|449060093|FG001|Overall Study|Protocol Violation|3|||
124844756|NCT01677195|449060094|FG002|Overall Study|Protocol Violation|4|||
124844757|NCT02472756|449060096|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
124844758|NCT02472756|449060096|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
124844759|NCT02472756|449060096|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
124844760|NCT02472756|449060096|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
124844761|NCT02472756|449060096|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
124844762|NCT00110266|449060100|FG000|Overall Study|Adverse Event|27|||
124844763|NCT00110266|449060100|FG000|Overall Study|Abnormal laboratory value|15|||
124844764|NCT00110266|449060100|FG000|Overall Study|Withdrawal by Subject|16|||
124844765|NCT00110266|449060100|FG000|Overall Study|Death|17|||
124844766|NCT00110266|449060100|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124844767|NCT00110266|449060100|FG000|Overall Study|Participant condition no longer requires study drug|1|||
124844768|NCT02896400|449060101|FG000|1 Month Follow-up|Lost to Follow-up|7|||
124844769|NCT02896400|449060102|FG001|1 Month Follow-up|Lost to Follow-up|7|||
124844770|NCT02896400|449060103|FG002|1 Month Follow-up|Lost to Follow-up|5|||
124844771|NCT02896400|449060104|FG003|1 Month Follow-up|Lost to Follow-up|8|||
124844772|NCT02896400|449060105|FG004|1 Month Follow-up|Lost to Follow-up|9|||
124844773|NCT02896400|449060106|FG005|1 Month Follow-up|Lost to Follow-up|6|||
124844774|NCT02896400|449060107|FG006|1 Month Follow-up|Lost to Follow-up|5|||
124844775|NCT02896400|449060108|FG007|1 Month Follow-up|Lost to Follow-up|6|||
124844776|NCT02896400|449060109|FG008|1 Month Follow-up|Lost to Follow-up|4|||
124844777|NCT02896400|449060110|FG009|1 Month Follow-up|Lost to Follow-up|7|||
124844778|NCT02896400|449060111|FG010|1 Month Follow-up|Lost to Follow-up|5|||
124844779|NCT02896400|449060112|FG011|1 Month Follow-up|Lost to Follow-up|5|||
124844780|NCT02896400|449060113|FG012|1 Month Follow-up|Lost to Follow-up|3|||
125305647|NCT00106353|450745149|FG004|Part 2|Physician Decision|0|||
125305648|NCT00106353|450745150|FG005|Part 2|Physician Decision|1|||
125305649|NCT00106353|450745151|FG006|Part 2|Physician Decision|0|||
125305650|NCT02038075|450745152|FG000|Overall Study|Withdrawal by Subject|3|||
125305651|NCT02038075|450745153|FG001|Overall Study|Withdrawal by Subject|0|||
125305652|NCT04000581|450745154|FG000|Overall Study|Withdrawal by Subject|0|||
125305653|NCT04000581|450745155|FG001|Overall Study|Withdrawal by Subject|1|||
125305654|NCT00588354|450745156|FG000|Baseline to 2 Weeks|Adverse Event|1|||
125305655|NCT00588354|450745157|FG001|Baseline to 2 Weeks|Adverse Event|0|||
125305656|NCT00588354|450745156|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
125305657|NCT00588354|450745157|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
125305658|NCT00588354|450745156|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
125305659|NCT00588354|450745157|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
125305660|NCT03477838|450745158|FG000|Overall Study|Lost to Follow-up|14|||
125305661|NCT02519595|450745159|FG000|Overall Study|Protocol Violation|8|||
125305662|NCT02519595|450745160|FG001|Overall Study|Protocol Violation|22|||
125305663|NCT02519595|450745161|FG002|Overall Study|Protocol Violation|16|||
125305664|NCT00850538|450745164|FG000|Overall Study|unable/unwilling to complete MRI|13|||
125305665|NCT00850538|450745164|FG000|Overall Study|specimen missed due to scheduling error|14|||
125305666|NCT00850538|450745164|FG000|Overall Study|specimen unusable|7|||
125305667|NCT00850538|450745164|FG000|Overall Study|Withdrawal by Subject|3|||
125305668|NCT00850538|450745164|FG000|Overall Study|radiology error|2|||
125305669|NCT00850538|450745164|FG000|Overall Study|Protocol Violation|2|||
125305670|NCT02328027|450745170|FG000|Overall Study|Withdrawal by Subject|0|||
125305671|NCT02328027|450745171|FG001|Overall Study|Withdrawal by Subject|1|||
125305672|NCT00999518|450745175|FG000|Overall Study|Adverse Event|1|||
125305673|NCT00999518|450745176|FG001|Overall Study|Adverse Event|6|||
125305674|NCT00999518|450745177|FG002|Overall Study|Adverse Event|3|||
125305675|NCT00999518|450745178|FG003|Overall Study|Adverse Event|1|||
125305676|NCT00999518|450745179|FG004|Overall Study|Adverse Event|2|||
125305677|NCT00999518|450745175|FG000|Overall Study|Lack of Efficacy|2|||
125305678|NCT00999518|450745176|FG001|Overall Study|Lack of Efficacy|0|||
125305679|NCT00999518|450745177|FG002|Overall Study|Lack of Efficacy|0|||
125305680|NCT00999518|450745178|FG003|Overall Study|Lack of Efficacy|2|||
125305681|NCT00999518|450745179|FG004|Overall Study|Lack of Efficacy|2|||
125305682|NCT00999518|450745175|FG000|Overall Study|Lost to Follow-up|0|||
125305683|NCT00999518|450745176|FG001|Overall Study|Lost to Follow-up|0|||
125305684|NCT00999518|450745177|FG002|Overall Study|Lost to Follow-up|0|||
125305685|NCT00999518|450745178|FG003|Overall Study|Lost to Follow-up|4|||
125305686|NCT00999518|450745179|FG004|Overall Study|Lost to Follow-up|1|||
125305687|NCT00999518|450745175|FG000|Overall Study|Did not meet entrance criteria|0|||
125305688|NCT00999518|450745176|FG001|Overall Study|Did not meet entrance criteria|0|||
125305689|NCT00999518|450745177|FG002|Overall Study|Did not meet entrance criteria|0|||
125305690|NCT00999518|450745178|FG003|Overall Study|Did not meet entrance criteria|0|||
125305691|NCT00999518|450745179|FG004|Overall Study|Did not meet entrance criteria|1|||
125305692|NCT00999518|450745175|FG000|Overall Study|Study terminated by sponsor|10|||
125305693|NCT00999518|450745176|FG001|Overall Study|Study terminated by sponsor|6|||
124844781|NCT02896400|449060114|FG013|1 Month Follow-up|Lost to Follow-up|4|||
125305694|NCT00999518|450745177|FG002|Overall Study|Study terminated by sponsor|5|||
125305695|NCT00999518|450745178|FG003|Overall Study|Study terminated by sponsor|5|||
124844782|NCT02896400|449060115|FG014|1 Month Follow-up|Lost to Follow-up|1|||
124844783|NCT02896400|449060116|FG015|1 Month Follow-up|Lost to Follow-up|2|||
124844784|NCT02896400|449060101|FG000|1 Month Follow-up|Death|0|||
124844785|NCT02896400|449060102|FG001|1 Month Follow-up|Death|0|||
124844786|NCT02896400|449060103|FG002|1 Month Follow-up|Death|0|||
124844787|NCT02896400|449060104|FG003|1 Month Follow-up|Death|0|||
124844788|NCT02896400|449060105|FG004|1 Month Follow-up|Death|0|||
125305696|NCT00999518|450745179|FG004|Overall Study|Study terminated by sponsor|9|||
125305697|NCT00999518|450745175|FG000|Overall Study|Pregnancy|0|||
125305698|NCT00999518|450745176|FG001|Overall Study|Pregnancy|0|||
125305699|NCT00999518|450745177|FG002|Overall Study|Pregnancy|1|||
125305700|NCT00999518|450745178|FG003|Overall Study|Pregnancy|0|||
125305701|NCT00999518|450745179|FG004|Overall Study|Pregnancy|0|||
125305702|NCT00999518|450745175|FG000|Overall Study|Protocol Violation|0|||
125305703|NCT00999518|450745176|FG001|Overall Study|Protocol Violation|1|||
125305704|NCT00999518|450745177|FG002|Overall Study|Protocol Violation|0|||
125305705|NCT00999518|450745178|FG003|Overall Study|Protocol Violation|0|||
125305706|NCT00999518|450745179|FG004|Overall Study|Protocol Violation|2|||
125305707|NCT00999518|450745175|FG000|Overall Study|Withdrawal by Subject|5|||
125305708|NCT00999518|450745176|FG001|Overall Study|Withdrawal by Subject|4|||
125305709|NCT00999518|450745177|FG002|Overall Study|Withdrawal by Subject|10|||
125305710|NCT00999518|450745178|FG003|Overall Study|Withdrawal by Subject|6|||
125305711|NCT00999518|450745179|FG004|Overall Study|Withdrawal by Subject|1|||
125305712|NCT00999518|450745175|FG000|Overall Study|Other|5|||
125305713|NCT00999518|450745176|FG001|Overall Study|Other|7|||
125305714|NCT00999518|450745177|FG002|Overall Study|Other|1|||
125305715|NCT00999518|450745178|FG003|Overall Study|Other|4|||
125305716|NCT00999518|450745179|FG004|Overall Study|Other|5|||
125305717|NCT00999518|450745175|FG000|Overall Study|Randomized but not Treated|1|||
125305718|NCT00999518|450745176|FG001|Overall Study|Randomized but not Treated|1|||
125305719|NCT00999518|450745177|FG002|Overall Study|Randomized but not Treated|2|||
125305720|NCT00999518|450745178|FG003|Overall Study|Randomized but not Treated|0|||
125305721|NCT00999518|450745179|FG004|Overall Study|Randomized but not Treated|1|||
125305722|NCT03319212|450745180|FG000|Overall Study|Discontinued as moving out of local area|0|||
125305723|NCT03319212|450745181|FG001|Overall Study|Discontinued as moving out of local area|1|||
125305724|NCT03319212|450745180|FG000|Overall Study|Adverse Event|2|||
125305725|NCT03319212|450745181|FG001|Overall Study|Adverse Event|2|||
125305726|NCT03319212|450745180|FG000|Overall Study|Withdrawal by Subject|0|||
125305727|NCT03319212|450745181|FG001|Overall Study|Withdrawal by Subject|1|||
125305728|NCT03319212|450745180|FG000|Overall Study|Lost to Follow-up|0|||
125305729|NCT03319212|450745181|FG001|Overall Study|Lost to Follow-up|1|||
125305730|NCT03319212|450745180|FG000|Overall Study|Physician Decision|1|||
125305731|NCT03319212|450745181|FG001|Overall Study|Physician Decision|0|||
125305732|NCT00250276|450745182|FG000|Overall Study|Serious Adverse Event|0|||
125305733|NCT00250276|450745183|FG001|Overall Study|Serious Adverse Event|0|||
125305734|NCT00250276|450745184|FG002|Overall Study|Serious Adverse Event|1|||
125305735|NCT00250276|450745185|FG003|Overall Study|Serious Adverse Event|0|||
125305736|NCT00250276|450745182|FG000|Overall Study|Non-serious Adverse Event|2|||
125305737|NCT00250276|450745183|FG001|Overall Study|Non-serious Adverse Event|0|||
125305738|NCT00250276|450745184|FG002|Overall Study|Non-serious Adverse Event|0|||
125305739|NCT00250276|450745185|FG003|Overall Study|Non-serious Adverse Event|2|||
125305740|NCT00250276|450745182|FG000|Overall Study|Protocol Violation|0|||
125305741|NCT00250276|450745183|FG001|Overall Study|Protocol Violation|1|||
125305742|NCT00250276|450745184|FG002|Overall Study|Protocol Violation|0|||
125305743|NCT00250276|450745185|FG003|Overall Study|Protocol Violation|0|||
125305744|NCT00250276|450745182|FG000|Overall Study|Withdrawal by Subject|1|||
125305745|NCT00250276|450745183|FG001|Overall Study|Withdrawal by Subject|2|||
125305746|NCT00250276|450745184|FG002|Overall Study|Withdrawal by Subject|3|||
125305747|NCT00250276|450745185|FG003|Overall Study|Withdrawal by Subject|2|||
125305748|NCT00250276|450745182|FG000|Overall Study|Migrated/moved from study area|3|||
125305749|NCT00250276|450745183|FG001|Overall Study|Migrated/moved from study area|0|||
125305750|NCT00250276|450745184|FG002|Overall Study|Migrated/moved from study area|2|||
125305751|NCT00250276|450745185|FG003|Overall Study|Migrated/moved from study area|7|||
125305752|NCT00250276|450745182|FG000|Overall Study|Lost to Follow-up|11|||
125305753|NCT00250276|450745183|FG001|Overall Study|Lost to Follow-up|18|||
125305754|NCT00250276|450745184|FG002|Overall Study|Lost to Follow-up|13|||
125305755|NCT00250276|450745185|FG003|Overall Study|Lost to Follow-up|8|||
125305756|NCT01088399|450745186|FG000|Overall Study|Adverse Event|211|||
125305757|NCT01088399|450745187|FG001|Overall Study|Adverse Event|16|||
125305758|NCT01088399|450745188|FG002|Overall Study|Adverse Event|0|||
125305759|NCT01088399|450745186|FG000|Overall Study|Death|204|||
125305760|NCT01088399|450745187|FG001|Overall Study|Death|45|||
125305761|NCT01088399|450745188|FG002|Overall Study|Death|0|||
125305762|NCT01088399|450745186|FG000|Overall Study|Lack of Efficacy|298|||
125305763|NCT01088399|450745187|FG001|Overall Study|Lack of Efficacy|7|||
125305764|NCT01088399|450745188|FG002|Overall Study|Lack of Efficacy|5|||
124844789|NCT02896400|449060106|FG005|1 Month Follow-up|Death|0|||
125305765|NCT01088399|450745186|FG000|Overall Study|Lost to Follow-up|1070|||
125305766|NCT01088399|450745187|FG001|Overall Study|Lost to Follow-up|278|||
124844790|NCT02896400|449060107|FG006|1 Month Follow-up|Death|0|||
124844791|NCT02896400|449060108|FG007|1 Month Follow-up|Death|0|||
124844792|NCT02896400|449060109|FG008|1 Month Follow-up|Death|0|||
124844793|NCT02896400|449060110|FG009|1 Month Follow-up|Death|0|||
124844794|NCT02896400|449060111|FG010|1 Month Follow-up|Death|0|||
124844795|NCT02896400|449060112|FG011|1 Month Follow-up|Death|0|||
124844796|NCT02896400|449060113|FG012|1 Month Follow-up|Death|0|||
124844797|NCT02896400|449060114|FG013|1 Month Follow-up|Death|0|||
124844798|NCT02896400|449060115|FG014|1 Month Follow-up|Death|0|||
124844799|NCT02896400|449060116|FG015|1 Month Follow-up|Death|1|||
124844800|NCT02896400|449060101|FG000|3 Month Follow-up|Lost to Follow-up|6|||
124844801|NCT02896400|449060102|FG001|3 Month Follow-up|Lost to Follow-up|3|||
124844802|NCT02896400|449060103|FG002|3 Month Follow-up|Lost to Follow-up|6|||
124844803|NCT02896400|449060104|FG003|3 Month Follow-up|Lost to Follow-up|11|||
124844804|NCT02896400|449060105|FG004|3 Month Follow-up|Lost to Follow-up|12|||
124844805|NCT02896400|449060106|FG005|3 Month Follow-up|Lost to Follow-up|6|||
124844806|NCT02896400|449060107|FG006|3 Month Follow-up|Lost to Follow-up|4|||
124844807|NCT02896400|449060108|FG007|3 Month Follow-up|Lost to Follow-up|3|||
124844808|NCT02896400|449060109|FG008|3 Month Follow-up|Lost to Follow-up|6|||
124844809|NCT02896400|449060110|FG009|3 Month Follow-up|Lost to Follow-up|5|||
124844810|NCT02896400|449060111|FG010|3 Month Follow-up|Lost to Follow-up|6|||
124844811|NCT02896400|449060112|FG011|3 Month Follow-up|Lost to Follow-up|6|||
124844812|NCT02896400|449060113|FG012|3 Month Follow-up|Lost to Follow-up|3|||
124844813|NCT02896400|449060114|FG013|3 Month Follow-up|Lost to Follow-up|5|||
124844814|NCT02896400|449060115|FG014|3 Month Follow-up|Lost to Follow-up|3|||
124844815|NCT02896400|449060116|FG015|3 Month Follow-up|Lost to Follow-up|2|||
124844816|NCT02896400|449060101|FG000|3 Month Follow-up|Death|0|||
124844817|NCT02896400|449060102|FG001|3 Month Follow-up|Death|0|||
124844818|NCT02896400|449060103|FG002|3 Month Follow-up|Death|0|||
124844819|NCT02896400|449060104|FG003|3 Month Follow-up|Death|0|||
124844820|NCT02896400|449060105|FG004|3 Month Follow-up|Death|0|||
124844821|NCT02896400|449060106|FG005|3 Month Follow-up|Death|0|||
124844822|NCT02896400|449060107|FG006|3 Month Follow-up|Death|0|||
124844823|NCT02896400|449060108|FG007|3 Month Follow-up|Death|0|||
124844824|NCT02896400|449060109|FG008|3 Month Follow-up|Death|0|||
124844825|NCT02896400|449060110|FG009|3 Month Follow-up|Death|0|||
124844826|NCT02896400|449060111|FG010|3 Month Follow-up|Death|0|||
124844827|NCT02896400|449060112|FG011|3 Month Follow-up|Death|0|||
124844828|NCT02896400|449060113|FG012|3 Month Follow-up|Death|0|||
124844829|NCT02896400|449060114|FG013|3 Month Follow-up|Death|1|||
124844830|NCT02896400|449060115|FG014|3 Month Follow-up|Death|1|||
124844831|NCT02896400|449060116|FG015|3 Month Follow-up|Death|0|||
124844832|NCT02896400|449060101|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
124844833|NCT02896400|449060102|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
124844834|NCT02896400|449060103|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
124844835|NCT02896400|449060104|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
124844836|NCT02896400|449060105|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
124844837|NCT02896400|449060106|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
124844838|NCT02896400|449060107|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
124844839|NCT02896400|449060108|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
124844840|NCT02896400|449060109|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
124844841|NCT02896400|449060110|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
124844842|NCT02896400|449060111|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
124844843|NCT02896400|449060112|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
124844844|NCT02896400|449060113|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
124844845|NCT02896400|449060114|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
124844846|NCT02896400|449060115|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
125305767|NCT01088399|450745188|FG002|Overall Study|Lost to Follow-up|58|||
125305768|NCT01088399|450745186|FG000|Overall Study|Physician Decision|531|||
124844847|NCT02896400|449060116|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
124844848|NCT02896400|449060101|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
124844849|NCT02896400|449060102|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
124844850|NCT02896400|449060103|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
124844851|NCT02896400|449060104|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
124844852|NCT02896400|449060105|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
124844853|NCT02896400|449060106|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
124844854|NCT02896400|449060107|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
124844855|NCT02896400|449060108|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
124844856|NCT02896400|449060109|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
124844857|NCT02896400|449060110|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
124844858|NCT02896400|449060111|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
124844859|NCT02896400|449060112|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
125305769|NCT01088399|450745187|FG001|Overall Study|Physician Decision|88|||
124976620|NCT02614183|449540015|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
125305770|NCT01088399|450745188|FG002|Overall Study|Physician Decision|16|||
125305771|NCT01088399|450745186|FG000|Overall Study|Withdrawal by Subject|544|||
125305772|NCT01088399|450745187|FG001|Overall Study|Withdrawal by Subject|195|||
125305773|NCT01088399|450745188|FG002|Overall Study|Withdrawal by Subject|33|||
125305774|NCT01088399|450745186|FG000|Overall Study|Change to or start of somatropin therapy|234|||
125305775|NCT01088399|450745187|FG001|Overall Study|Change to or start of somatropin therapy|17|||
125305776|NCT01088399|450745188|FG002|Overall Study|Change to or start of somatropin therapy|12|||
125305777|NCT01088399|450745186|FG000|Overall Study|Sponsor decision|1573|||
125305778|NCT01088399|450745187|FG001|Overall Study|Sponsor decision|298|||
125305779|NCT01088399|450745188|FG002|Overall Study|Sponsor decision|7|||
125305780|NCT01088399|450745186|FG000|Overall Study|Protocol Violation|10|||
125305781|NCT01088399|450745187|FG001|Overall Study|Protocol Violation|1|||
125305782|NCT01088399|450745188|FG002|Overall Study|Protocol Violation|0|||
125305783|NCT01088399|450745186|FG000|Overall Study|Enrollment criteria not met|48|||
125305784|NCT01088399|450745187|FG001|Overall Study|Enrollment criteria not met|119|||
125305785|NCT01088399|450745188|FG002|Overall Study|Enrollment criteria not met|70|||
125305786|NCT01088399|450745186|FG000|Overall Study|Study summary visit not completed|2398|||
125305787|NCT01088399|450745187|FG001|Overall Study|Study summary visit not completed|283|||
125305788|NCT01088399|450745188|FG002|Overall Study|Study summary visit not completed|80|||
125305789|NCT00782483|450745189|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
125305790|NCT01811186|450745191|FG000|Overall Study|Adverse Event|54|||
125305791|NCT01811186|450745192|FG001|Overall Study|Adverse Event|38|||
125305792|NCT01811186|450745191|FG000|Overall Study|Protocol Violation|5|||
125305793|NCT01811186|450745192|FG001|Overall Study|Protocol Violation|6|||
125305794|NCT01811186|450745191|FG000|Overall Study|Withdrawal by Subject|5|||
125305795|NCT01811186|450745192|FG001|Overall Study|Withdrawal by Subject|10|||
125305796|NCT01811186|450745191|FG000|Overall Study|Lack of Efficacy|3|||
125305797|NCT01811186|450745192|FG001|Overall Study|Lack of Efficacy|6|||
125305798|NCT01811186|450745191|FG000|Overall Study|Lost to Follow-up|4|||
125305799|NCT01811186|450745192|FG001|Overall Study|Lost to Follow-up|2|||
125305800|NCT03369236|450745195|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
125305801|NCT03369236|450745196|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
125305802|NCT03369236|450745195|FG000|Open-label Extension Period|Lack of Efficacy|2|||
125305803|NCT03369236|450745196|FG001|Open-label Extension Period|Lack of Efficacy|1|||
125305804|NCT03369236|450745195|FG000|Open-label Extension Period|Adverse Event|0|||
125305805|NCT03369236|450745196|FG001|Open-label Extension Period|Adverse Event|1|||
125305806|NCT03369236|450745195|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
125305807|NCT03369236|450745196|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
125305808|NCT01865448|450746673|FG000|Overall Study|Adverse Event|1|||
125305809|NCT01865448|450746674|FG001|Overall Study|Adverse Event|1|||
125305810|NCT01865448|450746673|FG000|Overall Study|Pregnancy|0|||
125305811|NCT01865448|450746674|FG001|Overall Study|Pregnancy|1|||
125305812|NCT01865448|450746673|FG000|Overall Study|dropout unrelated to study|1|||
125305813|NCT01865448|450746674|FG001|Overall Study|dropout unrelated to study|1|||
125305814|NCT00872599|450746676|FG000|Second Washout Period|Adverse Event|1|||
125305815|NCT00872599|450746677|FG001|Second Washout Period|Adverse Event|1|||
125305816|NCT00801229|450746678|FG000|Signed Consent|Withdrawal by Subject|2|||
125305817|NCT00801229|450746679|FG001|Signed Consent|Withdrawal by Subject|2|||
125305818|NCT00801229|450746678|FG000|Signed Consent|Found Ineligible|1|||
125305819|NCT00801229|450746679|FG001|Signed Consent|Found Ineligible|1|||
125305820|NCT00801229|450746678|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
125305821|NCT00801229|450746679|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
125305822|NCT00801229|450746678|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
125305823|NCT00801229|450746679|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
125305824|NCT00801229|450746678|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
125305825|NCT00801229|450746679|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
125305826|NCT00801229|450746678|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
125305827|NCT00801229|450746679|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
125305828|NCT00801229|450746678|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
125305829|NCT00801229|450746679|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
125305830|NCT00801229|450746678|FG000|Received Study Drug/Placebo|Adverse Event|1|||
125305831|NCT00801229|450746679|FG001|Received Study Drug/Placebo|Adverse Event|1|||
125305832|NCT02255461|450746680|FG000|Overall Study|Adverse Event|0|||
125305833|NCT02255461|450746681|FG001|Overall Study|Adverse Event|1|||
125305834|NCT02255461|450746682|FG002|Overall Study|Adverse Event|0|||
125305835|NCT02255461|450746683|FG003|Overall Study|Adverse Event|0|||
125305836|NCT02255461|450746684|FG004|Overall Study|Adverse Event|1|||
125305837|NCT02255461|450746680|FG000|Overall Study|Withdrawal by Subject|0|||
125305838|NCT02255461|450746681|FG001|Overall Study|Withdrawal by Subject|0|||
125305839|NCT02255461|450746682|FG002|Overall Study|Withdrawal by Subject|1|||
125305840|NCT02255461|450746683|FG003|Overall Study|Withdrawal by Subject|0|||
125305841|NCT02255461|450746684|FG004|Overall Study|Withdrawal by Subject|1|||
125305842|NCT02255461|450746680|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
124844860|NCT02896400|449060113|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
124844861|NCT02896400|449060114|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
124844862|NCT02896400|449060115|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
124844863|NCT02896400|449060116|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
124844864|NCT01207778|449060117|FG000|Overall Study|Lost to Follow-up|0|||
124844865|NCT01207778|449060118|FG001|Overall Study|Lost to Follow-up|3|||
124844866|NCT01207778|449060119|FG002|Overall Study|Lost to Follow-up|3|||
124844867|NCT00646204|449060120|FG000|Overall Study|Adverse Event|3|||
124844868|NCT00646204|449060121|FG001|Overall Study|Adverse Event|0|||
124844869|NCT00646204|449060120|FG000|Overall Study|Withdrawal by Subject|1|||
124844870|NCT00646204|449060121|FG001|Overall Study|Withdrawal by Subject|0|||
124844871|NCT00298896|449060128|FG000|Overall Study|Death|3|||
124844872|NCT00298896|449060128|FG000|Overall Study|Physician Decision|2|||
124844873|NCT00298896|449060128|FG000|Overall Study|Intercurrent Illness|1|||
124844874|NCT00298896|449060128|FG000|Overall Study|Disease Progression|41|||
124844875|NCT00298896|449060128|FG000|Overall Study|Withdrawal by Subject|2|||
124844876|NCT00298896|449060128|FG000|Overall Study|Assigned to treatment in error|1|||
124844877|NCT02649972|449060131|FG000|Overall Study|Not treated|1|||
124844878|NCT03285646|449060138|FG000|Overall Study|Adverse Event|1|||
124844879|NCT03285646|449060139|FG001|Overall Study|Adverse Event|0|||
124844880|NCT03285646|449060138|FG000|Overall Study|Withdrawal by Subject|10|||
124844881|NCT03285646|449060139|FG001|Overall Study|Withdrawal by Subject|2|||
124844882|NCT03285646|449060138|FG000|Overall Study|Lost to Follow-up|2|||
124844883|NCT03285646|449060139|FG001|Overall Study|Lost to Follow-up|1|||
124844884|NCT03285646|449060138|FG000|Overall Study|Investigator/Sponsor Decision|0|||
124844885|NCT03285646|449060139|FG001|Overall Study|Investigator/Sponsor Decision|1|||
124844886|NCT00503841|449060141|FG000|Overall Study|All screen failures|44|||
124844887|NCT01344057|449060142|FG000|Overall Study|Premature Withdrawal|1|||
124844888|NCT00306592|449060143|FG000|Overall Study|Adverse Event|8|||
124844889|NCT00306592|449060144|FG001|Overall Study|Adverse Event|15|||
124844890|NCT00306592|449060143|FG000|Overall Study|Lost to Follow-up|1|||
124844891|NCT00306592|449060144|FG001|Overall Study|Lost to Follow-up|0|||
124844892|NCT00306592|449060143|FG000|Overall Study|Noncompliance|0|||
124844893|NCT00306592|449060144|FG001|Overall Study|Noncompliance|2|||
124844894|NCT00306592|449060143|FG000|Overall Study|Persistent Antibodies|6|||
124844895|NCT00306592|449060144|FG001|Overall Study|Persistent Antibodies|3|||
124844896|NCT00306592|449060143|FG000|Overall Study|Voluntary|10|||
124844897|NCT00306592|449060144|FG001|Overall Study|Voluntary|6|||
124844898|NCT00306592|449060143|FG000|Overall Study|Other|5|||
124844899|NCT00306592|449060144|FG001|Overall Study|Other|10|||
124844900|NCT00306592|449060143|FG000|Overall Study|Other|1|||
124844901|NCT00306592|449060144|FG001|Overall Study|Other|2|||
124844902|NCT00306592|449060143|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
124844903|NCT00306592|449060144|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
124844904|NCT02488629|449060145|FG000|Overall Study|Lack of Efficacy|3|||
124844905|NCT02488629|449060146|FG001|Overall Study|Lack of Efficacy|1|||
124844906|NCT02488629|449060147|FG002|Overall Study|Lack of Efficacy|0|||
124844907|NCT02488629|449060148|FG003|Overall Study|Lack of Efficacy|0|||
124844908|NCT02488629|449060145|FG000|Overall Study|Withdrawal by Subject|0|||
124844909|NCT02488629|449060146|FG001|Overall Study|Withdrawal by Subject|1|||
124844910|NCT02488629|449060147|FG002|Overall Study|Withdrawal by Subject|0|||
124844911|NCT02488629|449060148|FG003|Overall Study|Withdrawal by Subject|0|||
124844912|NCT02940691|449060149|FG000|Overall Study|Lost to Follow-up|5|||
124844913|NCT02940691|449060149|FG000|Overall Study|Incarceration|1|||
124844914|NCT03912233|449060150|FG000|Overall Study|Adverse Event|1|||
124844915|NCT03912233|449060151|FG001|Overall Study|Adverse Event|0|||
124844916|NCT03912233|449060152|FG002|Overall Study|Adverse Event|0|||
124844917|NCT03912233|449060153|FG003|Overall Study|Adverse Event|0|||
124844918|NCT03912233|449060154|FG004|Overall Study|Adverse Event|0|||
124844919|NCT03912233|449060155|FG005|Overall Study|Adverse Event|0|||
124844920|NCT03912233|449060150|FG000|Overall Study|Physician Decision|1|||
124844921|NCT03912233|449060151|FG001|Overall Study|Physician Decision|0|||
124844922|NCT03912233|449060152|FG002|Overall Study|Physician Decision|0|||
124844923|NCT03912233|449060153|FG003|Overall Study|Physician Decision|0|||
124844924|NCT03912233|449060154|FG004|Overall Study|Physician Decision|0|||
124844925|NCT03912233|449060155|FG005|Overall Study|Physician Decision|0|||
124844926|NCT03912233|449060150|FG000|Overall Study|Other|0|||
124844927|NCT03912233|449060151|FG001|Overall Study|Other|0|||
124844928|NCT03912233|449060152|FG002|Overall Study|Other|0|||
124844929|NCT03912233|449060153|FG003|Overall Study|Other|0|||
124844930|NCT03912233|449060154|FG004|Overall Study|Other|7|||
124844931|NCT03912233|449060155|FG005|Overall Study|Other|12|||
124844932|NCT00654628|449060156|FG000|6-week Active Treatment Period|Adverse Event|9|||
124844933|NCT00654628|449060156|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
124844934|NCT00654628|449060156|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
124844935|NCT00654628|449060156|FG000|6-week Active Treatment Period|Out of window period|1|||
124844936|NCT00654628|449060156|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
124844937|NCT00654628|449060156|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
124844938|NCT02177266|449060157|FG000|Overall Study|Adverse Event|0|||
124844939|NCT02177266|449060158|FG001|Overall Study|Adverse Event|1|||
124844940|NCT02177266|449060157|FG000|Overall Study|Withdrawal by Subject|1|||
124844941|NCT02177266|449060158|FG001|Overall Study|Withdrawal by Subject|0|||
124844942|NCT00546715|449060162|FG000|Overall Study|Withdrawal by Subject|0|||
124844943|NCT00546715|449060163|FG001|Overall Study|Withdrawal by Subject|1|||
124844944|NCT00546715|449060164|FG002|Overall Study|Withdrawal by Subject|0|||
124844945|NCT00546715|449060165|FG003|Overall Study|Withdrawal by Subject|0|||
124844946|NCT00723606|449060166|FG000|Overall Study|Adverse Event|2|||
124844947|NCT00723606|449060167|FG001|Overall Study|Adverse Event|5|||
124844948|NCT00723606|449060166|FG000|Overall Study|Other|2|||
124844949|NCT00723606|449060167|FG001|Overall Study|Other|0|||
124844950|NCT00723606|449060166|FG000|Overall Study|Withdrawal by Subject|0|||
124844951|NCT00723606|449060167|FG001|Overall Study|Withdrawal by Subject|2|||
124844952|NCT01502644|449060170|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
124844953|NCT01502644|449060171|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
124844954|NCT01502644|449060172|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
124844955|NCT01502644|449060173|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
124844956|NCT01502644|449060170|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
124844957|NCT01502644|449060171|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
124844958|NCT01502644|449060172|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
124844959|NCT01502644|449060173|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
124844960|NCT01502644|449060170|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
124844961|NCT01502644|449060171|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
124844962|NCT01502644|449060172|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
124844963|NCT01502644|449060173|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
124844964|NCT01502644|449060170|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
124844965|NCT01502644|449060171|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
124844966|NCT01502644|449060172|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
124844967|NCT01502644|449060173|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
124844968|NCT01502644|449060170|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
124844969|NCT01502644|449060171|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
124844970|NCT01502644|449060172|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
125305843|NCT02255461|450746681|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
125305844|NCT02255461|450746682|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
125305845|NCT02255461|450746683|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
125305846|NCT02255461|450746684|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
125305847|NCT04809285|450746687|FG000|Phase 1|Lost to Follow-up|6|||
125305848|NCT04809285|450746687|FG000|Phase 1|Protocol Violation|2|||
125305849|NCT04809285|450746687|FG000|Phase 1|Physician Decision|3|||
125305850|NCT04809285|450746687|FG000|Phase 1|Withdrawal by Subject|29|||
125305851|NCT04809285|450746687|FG000|Phase 2|Protocol Violation|3|||
125305852|NCT04809285|450746687|FG000|Phase 2|Withdrawal by Subject|4|||
125305853|NCT03350815|450746689|FG000|Period 1|Adverse Event|10|||
125305854|NCT03350815|450746690|FG001|Period 1|Adverse Event|0|||
125305855|NCT03350815|450746691|FG002|Period 1|Adverse Event|0|||
125305856|NCT03350815|450746692|FG003|Period 1|Adverse Event|0|||
125305857|NCT03350815|450746689|FG000|Period 1|Technical problems|1|||
125305858|NCT03350815|450746690|FG001|Period 1|Technical problems|0|||
125305859|NCT03350815|450746691|FG002|Period 1|Technical problems|0|||
125305860|NCT03350815|450746692|FG003|Period 1|Technical problems|0|||
125305861|NCT03350815|450746689|FG000|Period 1|Lost to Follow-up|3|||
125305862|NCT03350815|450746690|FG001|Period 1|Lost to Follow-up|0|||
125305863|NCT03350815|450746691|FG002|Period 1|Lost to Follow-up|0|||
125305864|NCT03350815|450746692|FG003|Period 1|Lost to Follow-up|0|||
125305865|NCT03350815|450746689|FG000|Period 1|Physician Decision|1|||
125305866|NCT03350815|450746690|FG001|Period 1|Physician Decision|0|||
125305867|NCT03350815|450746691|FG002|Period 1|Physician Decision|0|||
125305868|NCT03350815|450746692|FG003|Period 1|Physician Decision|0|||
125305869|NCT03350815|450746689|FG000|Period 1|Withdrawal by Subject|8|||
125305870|NCT03350815|450746690|FG001|Period 1|Withdrawal by Subject|0|||
125305871|NCT03350815|450746691|FG002|Period 1|Withdrawal by Subject|0|||
125305872|NCT03350815|450746692|FG003|Period 1|Withdrawal by Subject|0|||
125305873|NCT03350815|450746689|FG000|Period 1|Lack of Efficacy|15|||
125305874|NCT03350815|450746690|FG001|Period 1|Lack of Efficacy|0|||
125305875|NCT03350815|450746691|FG002|Period 1|Lack of Efficacy|0|||
125305876|NCT03350815|450746692|FG003|Period 1|Lack of Efficacy|0|||
125305877|NCT03350815|450746689|FG000|Period 1|Non-compliance with study treatment|2|||
125305878|NCT03350815|450746690|FG001|Period 1|Non-compliance with study treatment|0|||
125305879|NCT03350815|450746691|FG002|Period 1|Non-compliance with study treatment|0|||
125305880|NCT03350815|450746692|FG003|Period 1|Non-compliance with study treatment|0|||
125305881|NCT03350815|450746689|FG000|Period 1|Protocol Violation|3|||
125305882|NCT03350815|450746690|FG001|Period 1|Protocol Violation|0|||
125305883|NCT03350815|450746691|FG002|Period 1|Protocol Violation|0|||
125305884|NCT03350815|450746692|FG003|Period 1|Protocol Violation|0|||
125305885|NCT03350815|450746689|FG000|Period 2|Adverse Event|0|||
125305886|NCT03350815|450746690|FG001|Period 2|Adverse Event|3|||
125305887|NCT03350815|450746691|FG002|Period 2|Adverse Event|5|||
125305888|NCT03350815|450746692|FG003|Period 2|Adverse Event|0|||
125305889|NCT03350815|450746689|FG000|Period 2|Technical problem|0|||
125305890|NCT03350815|450746690|FG001|Period 2|Technical problem|1|||
125305891|NCT03350815|450746691|FG002|Period 2|Technical problem|0|||
125305892|NCT03350815|450746692|FG003|Period 2|Technical problem|0|||
125305893|NCT03350815|450746689|FG000|Period 2|Lost to Follow-up|0|||
125305894|NCT03350815|450746690|FG001|Period 2|Lost to Follow-up|3|||
125305895|NCT03350815|450746691|FG002|Period 2|Lost to Follow-up|3|||
125305896|NCT03350815|450746692|FG003|Period 2|Lost to Follow-up|0|||
125305897|NCT03350815|450746689|FG000|Period 2|Physician Decision|0|||
125305898|NCT03350815|450746690|FG001|Period 2|Physician Decision|0|||
125305899|NCT03350815|450746691|FG002|Period 2|Physician Decision|1|||
125305900|NCT03350815|450746692|FG003|Period 2|Physician Decision|0|||
125305901|NCT03350815|450746689|FG000|Period 2|Withdrawal by Subject|0|||
125305902|NCT03350815|450746690|FG001|Period 2|Withdrawal by Subject|3|||
125305903|NCT03350815|450746691|FG002|Period 2|Withdrawal by Subject|4|||
125305904|NCT03350815|450746692|FG003|Period 2|Withdrawal by Subject|0|||
125305905|NCT03350815|450746689|FG000|Period 2|Lack of Efficacy|0|||
125305906|NCT03350815|450746690|FG001|Period 2|Lack of Efficacy|6|||
125305907|NCT03350815|450746691|FG002|Period 2|Lack of Efficacy|2|||
125305908|NCT03350815|450746692|FG003|Period 2|Lack of Efficacy|0|||
125305909|NCT03350815|450746689|FG000|Period 2|Protocol Violation|0|||
125305910|NCT03350815|450746690|FG001|Period 2|Protocol Violation|0|||
125305911|NCT03350815|450746691|FG002|Period 2|Protocol Violation|1|||
125305912|NCT03350815|450746692|FG003|Period 2|Protocol Violation|0|||
125305913|NCT03350815|450746689|FG000|Period 2|New therapy for study indication|0|||
125305914|NCT03350815|450746690|FG001|Period 2|New therapy for study indication|0|||
125305915|NCT03350815|450746691|FG002|Period 2|New therapy for study indication|1|||
125305916|NCT03350815|450746692|FG003|Period 2|New therapy for study indication|0|||
125305917|NCT02630472|450746693|FG000|Overall Study|Physician Decision|10|||
125305918|NCT02630472|450746694|FG001|Overall Study|Physician Decision|0|||
125305919|NCT03040674|450746697|FG000|Overall Study|Lost to Follow-up|225|||
125305920|NCT03040674|450746697|FG000|Overall Study|Death|23|||
125305921|NCT02936843|450746698|FG000|Overall Study|Lost to Follow-up|3|||
125305922|NCT02936843|450746699|FG001|Overall Study|Lost to Follow-up|1|||
125305923|NCT02936843|450746698|FG000|Overall Study|Withdrawal by Subject|1|||
125305924|NCT02936843|450746699|FG001|Overall Study|Withdrawal by Subject|1|||
125305925|NCT03386487|450746700|FG000|Overall Study|Lost to Follow-up|5|||
125305926|NCT03386487|450746701|FG001|Overall Study|Lost to Follow-up|6|||
125305927|NCT03386487|450746700|FG000|Overall Study|Withdrawal by Subject|11|||
125305928|NCT03386487|450746701|FG001|Overall Study|Withdrawal by Subject|7|||
125305929|NCT03386487|450746700|FG000|Overall Study|Physician Decision|11|||
125305930|NCT03386487|450746701|FG001|Overall Study|Physician Decision|8|||
125305931|NCT02703324|450746702|FG000|Period Two|Withdrawal by Subject|0|||
125305932|NCT02703324|450746703|FG001|Period Two|Withdrawal by Subject|0|||
125305933|NCT02703324|450746704|FG002|Period Two|Withdrawal by Subject|1|||
125305934|NCT02703324|450746705|FG003|Period Two|Withdrawal by Subject|0|||
125305935|NCT02703324|450746706|FG004|Period Two|Withdrawal by Subject|0|||
125305936|NCT02703324|450746707|FG005|Period Two|Withdrawal by Subject|0|||
125305937|NCT04303572|450746708|FG000|Overall Study|Study closed due to poor enrollment|1|||
125305938|NCT06312592|450746709|FG000|Overall Study|Lost to Follow-up|29|||
125305939|NCT06312592|450746710|FG001|Overall Study|Lost to Follow-up|13|||
125305940|NCT01858766|450746711|FG000|Overall Study|Randomized but Never Treated|0|||
125305941|NCT01858766|450746712|FG001|Overall Study|Randomized but Never Treated|0|||
125305942|NCT01858766|450746713|FG002|Overall Study|Randomized but Never Treated|0|||
125305943|NCT01858766|450746714|FG003|Overall Study|Randomized but Never Treated|0|||
125305944|NCT01858766|450746715|FG004|Overall Study|Randomized but Never Treated|0|||
125305945|NCT01858766|450746716|FG005|Overall Study|Randomized but Never Treated|1|||
125305946|NCT01858766|450746717|FG006|Overall Study|Randomized but Never Treated|0|||
125305947|NCT01858766|450746718|FG007|Overall Study|Randomized but Never Treated|0|||
125305948|NCT01858766|450746719|FG008|Overall Study|Randomized but Never Treated|0|||
125305949|NCT01858766|450746720|FG009|Overall Study|Randomized but Never Treated|0|||
125305950|NCT01858766|450746721|FG010|Overall Study|Randomized but Never Treated|0|||
125305951|NCT01858766|450746722|FG011|Overall Study|Randomized but Never Treated|0|||
125305952|NCT01858766|450746723|FG012|Overall Study|Randomized but Never Treated|0|||
125305953|NCT01858766|450746724|FG013|Overall Study|Randomized but Never Treated|0|||
125305954|NCT01858766|450746725|FG014|Overall Study|Randomized but Never Treated|0|||
125305955|NCT01858766|450746726|FG015|Overall Study|Randomized but Never Treated|0|||
125305956|NCT01858766|450746727|FG016|Overall Study|Randomized but Never Treated|0|||
125305957|NCT01858766|450746728|FG017|Overall Study|Randomized but Never Treated|1|||
125305958|NCT01858766|450746729|FG018|Overall Study|Randomized but Never Treated|0|||
125305959|NCT01858766|450746711|FG000|Overall Study|Death|0|||
125305960|NCT01858766|450746712|FG001|Overall Study|Death|0|||
125305961|NCT01858766|450746713|FG002|Overall Study|Death|1|||
125305962|NCT01858766|450746714|FG003|Overall Study|Death|0|||
125305963|NCT01858766|450746715|FG004|Overall Study|Death|0|||
125305964|NCT01858766|450746716|FG005|Overall Study|Death|0|||
125305965|NCT01858766|450746717|FG006|Overall Study|Death|0|||
125305966|NCT01858766|450746718|FG007|Overall Study|Death|0|||
125305967|NCT01858766|450746719|FG008|Overall Study|Death|0|||
125305968|NCT01858766|450746720|FG009|Overall Study|Death|0|||
125305969|NCT01858766|450746721|FG010|Overall Study|Death|0|||
125305970|NCT01858766|450746722|FG011|Overall Study|Death|0|||
125305971|NCT01858766|450746723|FG012|Overall Study|Death|0|||
125305972|NCT01858766|450746724|FG013|Overall Study|Death|0|||
125305973|NCT01858766|450746725|FG014|Overall Study|Death|0|||
125305974|NCT01858766|450746726|FG015|Overall Study|Death|0|||
125305975|NCT01858766|450746727|FG016|Overall Study|Death|0|||
125305976|NCT01858766|450746728|FG017|Overall Study|Death|0|||
125305977|NCT01858766|450746729|FG018|Overall Study|Death|0|||
125305978|NCT01858766|450746711|FG000|Overall Study|Lack of Efficacy|1|||
125305979|NCT01858766|450746712|FG001|Overall Study|Lack of Efficacy|0|||
125305980|NCT01858766|450746713|FG002|Overall Study|Lack of Efficacy|0|||
125305981|NCT01858766|450746714|FG003|Overall Study|Lack of Efficacy|0|||
125305982|NCT01858766|450746715|FG004|Overall Study|Lack of Efficacy|1|||
125305983|NCT01858766|450746716|FG005|Overall Study|Lack of Efficacy|2|||
125305984|NCT01858766|450746717|FG006|Overall Study|Lack of Efficacy|0|||
125305985|NCT01858766|450746718|FG007|Overall Study|Lack of Efficacy|0|||
125305986|NCT01858766|450746719|FG008|Overall Study|Lack of Efficacy|0|||
125305987|NCT01858766|450746720|FG009|Overall Study|Lack of Efficacy|0|||
125305988|NCT01858766|450746721|FG010|Overall Study|Lack of Efficacy|0|||
125305989|NCT01858766|450746722|FG011|Overall Study|Lack of Efficacy|3|||
125305990|NCT01858766|450746723|FG012|Overall Study|Lack of Efficacy|5|||
125305991|NCT01858766|450746724|FG013|Overall Study|Lack of Efficacy|3|||
125305992|NCT01858766|450746725|FG014|Overall Study|Lack of Efficacy|5|||
125305993|NCT01858766|450746726|FG015|Overall Study|Lack of Efficacy|5|||
125305994|NCT01858766|450746727|FG016|Overall Study|Lack of Efficacy|2|||
125305995|NCT01858766|450746728|FG017|Overall Study|Lack of Efficacy|3|||
125305996|NCT01858766|450746729|FG018|Overall Study|Lack of Efficacy|3|||
125305997|NCT01858766|450746711|FG000|Overall Study|Lost to Follow-up|0|||
125305998|NCT01858766|450746712|FG001|Overall Study|Lost to Follow-up|0|||
125305999|NCT01858766|450746713|FG002|Overall Study|Lost to Follow-up|0|||
125306000|NCT01858766|450746714|FG003|Overall Study|Lost to Follow-up|0|||
125306001|NCT01858766|450746715|FG004|Overall Study|Lost to Follow-up|0|||
125306002|NCT01858766|450746716|FG005|Overall Study|Lost to Follow-up|1|||
124844971|NCT01502644|449060173|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
124844972|NCT00637195|449060174|FG000|Overall Study|Lost to Follow-up|1|||
124844973|NCT00637195|449060175|FG001|Overall Study|Lost to Follow-up|0|||
124844974|NCT00637195|449060174|FG000|Overall Study|Other|2|||
124844975|NCT00637195|449060175|FG001|Overall Study|Other|0|||
124844976|NCT00637195|449060174|FG000|Overall Study|Withdrawal by Subject|0|||
124844977|NCT00637195|449060175|FG001|Overall Study|Withdrawal by Subject|1|||
124844978|NCT02388997|449060176|FG000|Overall Study|Adverse Event|1|||
124844979|NCT02388997|449060177|FG001|Overall Study|Adverse Event|2|||
124844980|NCT02388997|449060176|FG000|Overall Study|Withdrawal by Subject|2|||
124844981|NCT02388997|449060177|FG001|Overall Study|Withdrawal by Subject|1|||
124844982|NCT02388997|449060176|FG000|Overall Study|Lung function exclusion criteria|0|||
124844983|NCT02388997|449060177|FG001|Overall Study|Lung function exclusion criteria|2|||
124844984|NCT02388997|449060176|FG000|Overall Study|Tested positive for virus during run-in|0|||
124844985|NCT02388997|449060177|FG001|Overall Study|Tested positive for virus during run-in|1|||
124844986|NCT03025828|449060178|FG000|Overall Study|Lost to Follow-up|1|||
124844987|NCT01020019|449060179|FG000|Overall Study|Lost to Follow-up|21|||
124844988|NCT01020019|449060180|FG001|Overall Study|Lost to Follow-up|18|||
124844989|NCT01020019|449060179|FG000|Overall Study|Adverse Event|1|||
124844990|NCT01020019|449060180|FG001|Overall Study|Adverse Event|5|||
124844991|NCT01020019|449060179|FG000|Overall Study|not interested in treatment|4|||
124844992|NCT01020019|449060180|FG001|Overall Study|not interested in treatment|4|||
124844993|NCT01020019|449060179|FG000|Overall Study|moving|0|||
124844994|NCT01020019|449060180|FG001|Overall Study|moving|2|||
124844995|NCT02375672|449060181|FG000|Overall Study|remain on follow up|20|||
124844996|NCT01559311|449060182|FG000|Overall Study|Protocol Violation|0|||
124844997|NCT01559311|449060183|FG001|Overall Study|Protocol Violation|0|||
124844998|NCT01559311|449060184|FG002|Overall Study|Protocol Violation|2|||
124844999|NCT01559311|449060182|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
124845000|NCT01559311|449060183|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
124845001|NCT01559311|449060184|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
125306003|NCT01858766|450746717|FG006|Overall Study|Lost to Follow-up|0|||
124845002|NCT01559311|449060182|FG000|Overall Study|Withdrawal by Subject|2|||
124845003|NCT01559311|449060183|FG001|Overall Study|Withdrawal by Subject|1|||
124845004|NCT01559311|449060184|FG002|Overall Study|Withdrawal by Subject|0|||
124845005|NCT01559311|449060182|FG000|Overall Study|Death|0|||
124845006|NCT01559311|449060183|FG001|Overall Study|Death|2|||
124845007|NCT01559311|449060184|FG002|Overall Study|Death|3|||
124845008|NCT01559311|449060182|FG000|Overall Study|Lost to Follow-up|0|||
124845009|NCT01559311|449060183|FG001|Overall Study|Lost to Follow-up|3|||
124845010|NCT01559311|449060184|FG002|Overall Study|Lost to Follow-up|2|||
124845011|NCT01559311|449060182|FG000|Overall Study|Adverse Event|0|||
124845012|NCT01559311|449060183|FG001|Overall Study|Adverse Event|0|||
124845013|NCT01559311|449060184|FG002|Overall Study|Adverse Event|1|||
124845014|NCT02346240|449060186|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845015|NCT02346240|449060187|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
124845016|NCT02346240|449060188|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
124845017|NCT02346240|449060189|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
124845018|NCT02346240|449060190|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845019|NCT02346240|449060191|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845020|NCT02346240|449060192|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845021|NCT02346240|449060193|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845022|NCT02346240|449060194|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845023|NCT02346240|449060195|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845024|NCT02346240|449060196|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845025|NCT02346240|449060197|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845026|NCT02346240|449060198|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845027|NCT02346240|449060199|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845028|NCT02346240|449060200|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845029|NCT02346240|449060201|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845030|NCT02346240|449060202|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845031|NCT02346240|449060203|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845032|NCT02346240|449060204|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845033|NCT02346240|449060205|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845034|NCT02346240|449060206|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845035|NCT02346240|449060207|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845036|NCT02346240|449060208|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845037|NCT02346240|449060209|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845038|NCT02346240|449060186|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845039|NCT02346240|449060187|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
124845040|NCT02346240|449060188|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845041|NCT02346240|449060189|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845042|NCT02346240|449060190|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845043|NCT02346240|449060191|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845044|NCT02346240|449060192|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845045|NCT02346240|449060193|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845046|NCT02346240|449060194|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845047|NCT02346240|449060195|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845048|NCT02346240|449060196|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845049|NCT02346240|449060197|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845050|NCT02346240|449060198|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845051|NCT02346240|449060199|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845052|NCT02346240|449060200|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845053|NCT02346240|449060201|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845054|NCT02346240|449060202|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845055|NCT02346240|449060203|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845056|NCT02346240|449060204|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845057|NCT02346240|449060205|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845058|NCT02346240|449060206|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845059|NCT02346240|449060207|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845060|NCT02346240|449060208|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845061|NCT02346240|449060209|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845062|NCT02346240|449060186|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845063|NCT02346240|449060187|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
124845064|NCT02346240|449060188|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845065|NCT02346240|449060189|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845066|NCT02346240|449060190|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845067|NCT02346240|449060191|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845068|NCT02346240|449060192|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845069|NCT02346240|449060193|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845070|NCT02346240|449060194|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845071|NCT02346240|449060195|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845072|NCT02346240|449060196|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845073|NCT02346240|449060197|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845074|NCT02346240|449060198|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845075|NCT02346240|449060199|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845076|NCT02346240|449060200|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845077|NCT02346240|449060201|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845078|NCT02346240|449060202|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845079|NCT02346240|449060203|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845080|NCT02346240|449060204|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845081|NCT02346240|449060205|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845082|NCT02346240|449060206|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845083|NCT02346240|449060207|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845084|NCT02346240|449060208|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845085|NCT02346240|449060209|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845086|NCT02346240|449060186|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
124845087|NCT02346240|449060187|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
124845088|NCT02346240|449060188|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
124845089|NCT02346240|449060189|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
124845090|NCT02346240|449060190|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845091|NCT02346240|449060191|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845092|NCT02346240|449060192|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845093|NCT02346240|449060193|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845094|NCT02346240|449060194|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845095|NCT02346240|449060195|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845096|NCT02346240|449060196|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845097|NCT02346240|449060197|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845098|NCT02346240|449060198|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845099|NCT02346240|449060199|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845100|NCT02346240|449060200|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845101|NCT02346240|449060201|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845102|NCT02346240|449060202|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845103|NCT02346240|449060203|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845104|NCT02346240|449060204|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845105|NCT02346240|449060205|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845106|NCT02346240|449060206|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845107|NCT02346240|449060207|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845108|NCT02346240|449060208|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845109|NCT02346240|449060209|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845110|NCT02346240|449060186|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
124845111|NCT02346240|449060187|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
124845112|NCT02346240|449060188|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
124845113|NCT02346240|449060189|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
124845114|NCT02346240|449060190|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845115|NCT02346240|449060191|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845116|NCT02346240|449060192|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845117|NCT02346240|449060193|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845118|NCT02346240|449060194|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845119|NCT02346240|449060195|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845120|NCT02346240|449060196|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845121|NCT02346240|449060197|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845122|NCT02346240|449060198|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845123|NCT02346240|449060199|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845124|NCT02346240|449060200|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845125|NCT02346240|449060201|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845126|NCT02346240|449060202|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845127|NCT02346240|449060203|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845128|NCT02346240|449060204|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845129|NCT02346240|449060205|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845130|NCT02346240|449060206|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845131|NCT02346240|449060207|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845132|NCT02346240|449060208|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845133|NCT02346240|449060209|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845134|NCT02346240|449060186|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845135|NCT02346240|449060187|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
124845136|NCT02346240|449060188|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845137|NCT02346240|449060189|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
124845138|NCT02346240|449060190|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845139|NCT02346240|449060191|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845140|NCT02346240|449060192|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845141|NCT02346240|449060193|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845142|NCT02346240|449060194|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845143|NCT02346240|449060195|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845144|NCT02346240|449060196|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845145|NCT02346240|449060197|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845146|NCT02346240|449060198|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845147|NCT02346240|449060199|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845148|NCT02346240|449060200|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845149|NCT02346240|449060201|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845150|NCT02346240|449060202|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845151|NCT02346240|449060203|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845152|NCT02346240|449060204|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845153|NCT02346240|449060205|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845154|NCT02346240|449060206|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845155|NCT02346240|449060207|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845156|NCT02346240|449060208|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845157|NCT02346240|449060209|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845158|NCT02346240|449060186|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845159|NCT02346240|449060187|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845160|NCT02346240|449060188|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
124845161|NCT02346240|449060189|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845162|NCT02346240|449060190|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845163|NCT02346240|449060191|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845164|NCT02346240|449060192|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845165|NCT02346240|449060193|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125306004|NCT01858766|450746718|FG007|Overall Study|Lost to Follow-up|2|||
125306005|NCT01858766|450746719|FG008|Overall Study|Lost to Follow-up|0|||
125306006|NCT01858766|450746720|FG009|Overall Study|Lost to Follow-up|0|||
125306007|NCT01858766|450746721|FG010|Overall Study|Lost to Follow-up|0|||
125306008|NCT01858766|450746722|FG011|Overall Study|Lost to Follow-up|1|||
125306009|NCT01858766|450746723|FG012|Overall Study|Lost to Follow-up|0|||
125306010|NCT01858766|450746724|FG013|Overall Study|Lost to Follow-up|0|||
125306011|NCT01858766|450746725|FG014|Overall Study|Lost to Follow-up|3|||
125306012|NCT01858766|450746726|FG015|Overall Study|Lost to Follow-up|1|||
125306013|NCT01858766|450746727|FG016|Overall Study|Lost to Follow-up|1|||
125306014|NCT01858766|450746728|FG017|Overall Study|Lost to Follow-up|0|||
125306015|NCT01858766|450746729|FG018|Overall Study|Lost to Follow-up|1|||
125306016|NCT01858766|450746711|FG000|Overall Study|Withdrew Consent|0|||
125306017|NCT01858766|450746712|FG001|Overall Study|Withdrew Consent|0|||
124845166|NCT02346240|449060194|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845167|NCT02346240|449060195|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845168|NCT02346240|449060196|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845169|NCT02346240|449060197|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845170|NCT02346240|449060198|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845171|NCT02346240|449060199|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845172|NCT02346240|449060200|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845173|NCT02346240|449060201|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125306018|NCT01858766|450746713|FG002|Overall Study|Withdrew Consent|0|||
125306019|NCT01858766|450746714|FG003|Overall Study|Withdrew Consent|0|||
125306020|NCT01858766|450746715|FG004|Overall Study|Withdrew Consent|0|||
124845174|NCT02346240|449060202|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845175|NCT02346240|449060203|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845176|NCT02346240|449060204|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845177|NCT02346240|449060205|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845178|NCT02346240|449060206|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845179|NCT02346240|449060207|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845180|NCT02346240|449060208|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845181|NCT02346240|449060209|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845182|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845183|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845184|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845185|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845186|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845187|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845188|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845189|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
124845190|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
124845191|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845192|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845193|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845194|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845195|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
124845196|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
124845197|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
124845198|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
124845199|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845200|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845201|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845202|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845203|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845204|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845205|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845206|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845207|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845208|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845209|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845210|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125306021|NCT01858766|450746716|FG005|Overall Study|Withdrew Consent|0|||
125306022|NCT01858766|450746717|FG006|Overall Study|Withdrew Consent|0|||
125306023|NCT01858766|450746718|FG007|Overall Study|Withdrew Consent|0|||
125306024|NCT01858766|450746719|FG008|Overall Study|Withdrew Consent|0|||
125306025|NCT01858766|450746720|FG009|Overall Study|Withdrew Consent|0|||
125306026|NCT01858766|450746721|FG010|Overall Study|Withdrew Consent|0|||
125306027|NCT01858766|450746722|FG011|Overall Study|Withdrew Consent|1|||
125306028|NCT01858766|450746723|FG012|Overall Study|Withdrew Consent|0|||
125306029|NCT01858766|450746724|FG013|Overall Study|Withdrew Consent|0|||
125306030|NCT01858766|450746725|FG014|Overall Study|Withdrew Consent|0|||
125306031|NCT01858766|450746726|FG015|Overall Study|Withdrew Consent|0|||
125306032|NCT01858766|450746727|FG016|Overall Study|Withdrew Consent|0|||
125306033|NCT01858766|450746728|FG017|Overall Study|Withdrew Consent|0|||
125306034|NCT01858766|450746729|FG018|Overall Study|Withdrew Consent|0|||
125306035|NCT03517228|450746730|FG000|Overall Study|Withdrawal by Subject|2|||
125306036|NCT03517228|450746730|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
125306037|NCT03517228|450746730|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
125306038|NCT03517228|450746730|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
125306039|NCT03517228|450746730|FG000|Overall Study|Canceled due to device being updated|1|||
125306040|NCT03517228|450746730|FG000|Overall Study|No V Cares in stock|1|||
125306041|NCT03517228|450746730|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
125306042|NCT00475709|450746738|FG000|Overall Study|Did not meet eligibility criteria|8|||
125306043|NCT00475709|450746738|FG000|Overall Study|Death|41|||
125306044|NCT00475709|450746738|FG000|Overall Study|Device Explant|6|||
124845211|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845212|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845213|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845214|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845215|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845216|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845217|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845218|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845219|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
124845220|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845221|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
124845222|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845223|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845224|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845225|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845226|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845227|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845228|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845229|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845230|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845231|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845232|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845233|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845234|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845235|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845236|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845237|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125306045|NCT00475709|450746738|FG000|Overall Study|Lost to Follow-up|21|||
125306046|NCT01835158|450746741|FG000|Overall Study|Withdrawal by Subject|1|||
125306047|NCT01835158|450746742|FG001|Overall Study|Withdrawal by Subject|6|||
125306048|NCT01415401|450746743|FG000|Overall Study|Adverse Event|5|||
125306049|NCT01415401|450746743|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
124845238|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845239|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845240|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845241|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125306050|NCT01415401|450746743|FG000|Overall Study|Terminated by Sponsor|1|||
125306051|NCT00532298|450746754|FG000|Overall Study|Adverse Event|1|||
124845242|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845243|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125306052|NCT00532298|450746755|FG001|Overall Study|Adverse Event|0|||
124845244|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
124845245|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845246|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845247|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845248|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845249|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845250|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845251|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845252|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845253|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845254|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845255|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845256|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845257|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845258|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845259|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
124845260|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
124845261|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
124845262|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
124845263|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845264|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
124845265|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
124845266|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845267|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
124845268|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
124845269|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
124845270|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
124845271|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845272|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845273|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845274|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845275|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845276|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845277|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845278|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845279|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845280|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845281|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845282|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845283|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845284|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845285|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845286|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845287|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845288|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845289|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845290|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845291|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
124845292|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
124845293|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
124845294|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
124845295|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845296|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845297|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845298|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845299|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845300|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845301|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845302|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845303|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845304|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845305|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845306|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845307|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845308|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
124845309|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845310|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845311|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845312|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845313|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845314|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125306053|NCT00532298|450746756|FG002|Overall Study|Adverse Event|0|||
125306054|NCT00532298|450746757|FG003|Overall Study|Adverse Event|0|||
125306055|NCT00532298|450746758|FG004|Overall Study|Adverse Event|1|||
125306056|NCT00532298|450746759|FG005|Overall Study|Adverse Event|1|||
125306057|NCT00532298|450746754|FG000|Overall Study|Lost to Follow-up|1|||
125306058|NCT00532298|450746755|FG001|Overall Study|Lost to Follow-up|1|||
125306059|NCT00532298|450746756|FG002|Overall Study|Lost to Follow-up|1|||
125306060|NCT00532298|450746757|FG003|Overall Study|Lost to Follow-up|0|||
125306061|NCT00532298|450746758|FG004|Overall Study|Lost to Follow-up|0|||
125306062|NCT00532298|450746759|FG005|Overall Study|Lost to Follow-up|1|||
125306063|NCT02023996|450746760|FG000|Overall Study|Protocol Violation|6|||
125306064|NCT00095173|450746764|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
125306065|NCT00095173|450746765|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
125306066|NCT00095173|450746766|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
125306067|NCT00095173|450746767|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
125306068|NCT00095173|450746768|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
125306069|NCT00095173|450746769|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
125306070|NCT00095173|450746764|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
125306071|NCT00095173|450746765|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
125306072|NCT00095173|450746766|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
125306073|NCT00095173|450746767|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
125306074|NCT00095173|450746768|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
125306075|NCT00095173|450746769|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
125306076|NCT00095173|450746764|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
125306077|NCT00095173|450746765|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
125306078|NCT00095173|450746766|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
125306079|NCT00095173|450746767|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
125306080|NCT00095173|450746768|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
125306081|NCT00095173|450746769|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
125306082|NCT00095173|450746764|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
125306083|NCT00095173|450746765|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
125306084|NCT00095173|450746766|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
125306085|NCT00095173|450746767|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
125306086|NCT00095173|450746768|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
125306087|NCT00095173|450746769|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
125306088|NCT00095173|450746764|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
125306089|NCT00095173|450746765|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
125306090|NCT00095173|450746766|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
125306091|NCT00095173|450746767|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
125306092|NCT00095173|450746768|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
125306093|NCT00095173|450746769|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
125306094|NCT00095173|450746764|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
125306095|NCT00095173|450746765|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
125306096|NCT00095173|450746766|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
125306097|NCT00095173|450746767|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
125306098|NCT00095173|450746768|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
125306099|NCT00095173|450746769|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
125306100|NCT00095173|450746764|FG000|Open-Label Extension Phase (Period C)|Death|0|||
125306101|NCT00095173|450746765|FG001|Open-Label Extension Phase (Period C)|Death|0|||
125306102|NCT00095173|450746766|FG002|Open-Label Extension Phase (Period C)|Death|0|||
125306103|NCT00095173|450746767|FG003|Open-Label Extension Phase (Period C)|Death|0|||
125306104|NCT00095173|450746768|FG004|Open-Label Extension Phase (Period C)|Death|0|||
125306105|NCT00095173|450746769|FG005|Open-Label Extension Phase (Period C)|Death|1|||
125306106|NCT00095173|450746764|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
125306107|NCT00095173|450746765|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
125306108|NCT00095173|450746766|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
125306109|NCT00095173|450746767|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
125306110|NCT00095173|450746768|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
125306111|NCT00095173|450746769|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
125306112|NCT00095173|450746764|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
125306113|NCT00095173|450746765|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
125306114|NCT00095173|450746766|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
125306115|NCT00095173|450746767|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
125306116|NCT00095173|450746768|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
125306117|NCT00095173|450746769|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
125306118|NCT00095173|450746764|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
125306119|NCT00095173|450746765|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
125306120|NCT00095173|450746766|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
125306121|NCT00095173|450746767|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
125306122|NCT00095173|450746768|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
125306123|NCT00095173|450746769|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
125306124|NCT00095173|450746764|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
125306125|NCT00095173|450746765|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
125306126|NCT00095173|450746766|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
125306127|NCT00095173|450746767|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
125306128|NCT00095173|450746768|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
125306129|NCT00095173|450746769|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
125306130|NCT00095173|450746764|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
125306131|NCT00095173|450746765|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
125306132|NCT00095173|450746766|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
125306133|NCT00095173|450746767|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
125306134|NCT00095173|450746768|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
125306135|NCT00095173|450746769|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
125306136|NCT00095173|450746764|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
125306137|NCT00095173|450746765|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
125306138|NCT00095173|450746766|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
125306139|NCT00095173|450746767|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
125306140|NCT00095173|450746768|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
125306141|NCT00095173|450746769|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
125306142|NCT00095173|450746764|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
125306143|NCT00095173|450746765|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
125306144|NCT00095173|450746766|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
125306145|NCT00095173|450746767|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
125306146|NCT00095173|450746768|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
125306147|NCT00095173|450746769|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
125306148|NCT00095173|450746764|FG000|Open-Label Extension Phase (Period C)|Other|0|||
125306149|NCT00095173|450746765|FG001|Open-Label Extension Phase (Period C)|Other|0|||
125306150|NCT00095173|450746766|FG002|Open-Label Extension Phase (Period C)|Other|0|||
125306151|NCT00095173|450746767|FG003|Open-Label Extension Phase (Period C)|Other|4|||
125306152|NCT00095173|450746768|FG004|Open-Label Extension Phase (Period C)|Other|6|||
125306153|NCT00095173|450746769|FG005|Open-Label Extension Phase (Period C)|Other|8|||
125306154|NCT02708355|450746772|FG000|Overall Study|Adverse Event|1|||
125306155|NCT02708355|450746773|FG001|Overall Study|Adverse Event|0|||
125306156|NCT02708355|450746774|FG002|Overall Study|Adverse Event|0|||
124845315|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845316|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845317|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845318|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845319|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845320|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845321|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845322|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845323|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845324|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845325|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845326|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845327|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845328|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845329|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845330|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845331|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845332|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845333|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845334|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
124845335|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845336|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845337|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
124845338|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845339|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
124845340|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
124845341|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845342|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845343|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845344|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845345|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845346|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845347|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845348|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845349|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845350|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845351|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845352|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845353|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845354|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845355|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845356|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845357|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845358|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845359|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
124845360|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845361|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845362|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845363|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845364|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845365|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125306157|NCT01019369|450746776|FG000|Overall Study|Lost to Follow-up|10|||
125306158|NCT01019369|450746777|FG001|Overall Study|Lost to Follow-up|6|||
125306159|NCT01019369|450746776|FG000|Overall Study|Withdrawal by Subject|0|||
125306160|NCT01019369|450746777|FG001|Overall Study|Withdrawal by Subject|1|||
125306161|NCT01380834|450746778|FG000|Overall Study|Physician Decision|1|||
125306162|NCT01380834|450746779|FG001|Overall Study|Physician Decision|0|||
125306163|NCT04310566|450746780|FG000|Period 1|Study Termination due to COVID-19|15|||
125306164|NCT04310566|450746781|FG001|Period 1|Study Termination due to COVID-19|17|||
125306165|NCT04310566|450746780|FG000|Period 1|Protocol Violation|0|||
125306166|NCT04310566|450746781|FG001|Period 1|Protocol Violation|1|||
125306167|NCT04310566|450746780|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
125306168|NCT04310566|450746781|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
125306169|NCT04310566|450746780|FG000|Period 1|Lost to Follow-up|1|||
125306170|NCT04310566|450746781|FG001|Period 1|Lost to Follow-up|0|||
125306171|NCT04310566|450746780|FG000|Period 1|Withdrawal by Subject|0|||
125306172|NCT04310566|450746781|FG001|Period 1|Withdrawal by Subject|1|||
125306173|NCT04310566|450746780|FG000|Period 2|Study Termination|7|||
125306174|NCT04310566|450746781|FG001|Period 2|Study Termination|5|||
125306175|NCT01711645|450746782|FG000|Overall Study|Withdrawal by Subject|8|||
125306176|NCT01711645|450746782|FG000|Overall Study|Lost to Follow-up|6|||
125306177|NCT01711645|450746782|FG000|Overall Study|Physician Decision|5|||
125306178|NCT01746173|450746788|FG000|Overall Study|Disease Progression|2|||
125306179|NCT01771250|450746790|FG000|Period 1|Met exclusion criteria|1|||
125306180|NCT01771250|450746791|FG001|Period 1|Met exclusion criteria|0|||
125306181|NCT01153724|450746797|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125306182|NCT01153724|450746797|FG000|Treatment Period 2|Adverse Event|1|||
125306183|NCT01153724|450746797|FG000|Treatment Period 2|Other reason not defined above|1|||
125306184|NCT04230213|450746803|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
125306185|NCT04230213|450746804|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
125306186|NCT04230213|450746805|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
125306187|NCT04230213|450746803|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
125306188|NCT04230213|450746804|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
125306189|NCT04230213|450746805|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
125306190|NCT04230213|450746803|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
125306191|NCT04230213|450746804|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
125306192|NCT04230213|450746805|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
125306193|NCT04230213|450746803|FG000|TP2: Week 10 to Week 16|Other|0|||
125306194|NCT04230213|450746804|FG001|TP2: Week 10 to Week 16|Other|2|||
125306195|NCT04230213|450746805|FG002|TP2: Week 10 to Week 16|Other|1|||
125306196|NCT04230213|450746803|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
125306197|NCT04230213|450746804|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
125306198|NCT04230213|450746805|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
125306199|NCT04230213|450746803|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
125306200|NCT04230213|450746804|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
125306201|NCT04230213|450746805|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
125306202|NCT04230213|450746803|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
125306203|NCT04230213|450746804|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
125306204|NCT04230213|450746805|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
125306205|NCT04230213|450746803|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
125306206|NCT04230213|450746804|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
124845366|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845367|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845368|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845369|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845370|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845371|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845372|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845373|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845374|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845375|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845376|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845377|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845378|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845379|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845380|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845381|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845382|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845383|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125306207|NCT04230213|450746805|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
125306208|NCT04230213|450746803|FG000|TP3: Week 16 to Week 22|Other|0|||
125306209|NCT04230213|450746804|FG001|TP3: Week 16 to Week 22|Other|1|||
125306210|NCT04230213|450746805|FG002|TP3: Week 16 to Week 22|Other|3|||
125306211|NCT04230213|450746803|FG000|TP4: Week 22 to Week 32|Other|0|||
125306212|NCT04230213|450746804|FG001|TP4: Week 22 to Week 32|Other|5|||
125306213|NCT04230213|450746805|FG002|TP4: Week 22 to Week 32|Other|5|||
125306214|NCT04230213|450746803|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
125306215|NCT04230213|450746804|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
125306216|NCT04230213|450746805|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
125306217|NCT04230213|450746803|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
125306218|NCT04230213|450746804|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
125306219|NCT04230213|450746805|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
125306220|NCT04230213|450746803|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
125306221|NCT04230213|450746804|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
125306222|NCT04230213|450746805|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
125306223|NCT04230213|450746803|FG000|Follow up: Week 32 to Week 36|Other|0|||
125306224|NCT04230213|450746804|FG001|Follow up: Week 32 to Week 36|Other|1|||
125306225|NCT04230213|450746805|FG002|Follow up: Week 32 to Week 36|Other|1|||
125306226|NCT02508428|450746808|FG000|Overall Study|Death|32|||
125306227|NCT02508428|450746809|FG001|Overall Study|Death|33|||
125306228|NCT02508428|450746808|FG000|Overall Study|Liner revised|3|||
125306229|NCT02508428|450746809|FG001|Overall Study|Liner revised|19|||
125306230|NCT02508428|450746808|FG000|Overall Study|Incomplete follow-up|17|||
125306231|NCT02508428|450746809|FG001|Overall Study|Incomplete follow-up|15|||
125306232|NCT00534976|450746817|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
125306233|NCT00534976|450746818|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
125306234|NCT00534976|450746817|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
125306235|NCT00534976|450746818|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
125306236|NCT00534976|450746817|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
125306237|NCT00534976|450746818|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
125306238|NCT00861471|450746819|FG000|Overall Study|Withdrawal by Subject|1|||
125306239|NCT00861471|450746819|FG000|Overall Study|Adverse Event|2|||
125306240|NCT00861471|450746819|FG000|Overall Study|Lack of Efficacy|3|||
125306241|NCT00861471|450746819|FG000|Overall Study|treatment for lumbar laminectomy|1|||
125306242|NCT00861471|450746819|FG000|Overall Study|Physician Decision|2|||
125306243|NCT02834247|450746820|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
125306244|NCT02834247|450746821|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
125306245|NCT02834247|450746822|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
125306246|NCT02834247|450746823|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
125306247|NCT02834247|450746820|FG000|Dose Escalation Phase|Death|5|||
125306248|NCT02834247|450746821|FG001|Dose Escalation Phase|Death|6|||
125306249|NCT02834247|450746822|FG002|Dose Escalation Phase|Death|5|||
125306250|NCT02834247|450746823|FG003|Dose Escalation Phase|Death|0|||
125306251|NCT02834247|450746820|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
125306252|NCT02834247|450746821|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
125306253|NCT02834247|450746822|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
125306254|NCT02834247|450746823|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
125306255|NCT02834247|450746820|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
125306256|NCT02834247|450746821|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
124845384|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
124845385|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845386|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845387|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845388|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845389|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845390|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845391|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845392|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845393|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845394|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845395|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845396|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845397|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845398|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845399|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125306257|NCT02834247|450746822|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
125306258|NCT02834247|450746823|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
125306259|NCT02834247|450746820|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
125306260|NCT02834247|450746821|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
125306261|NCT02834247|450746822|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
125306262|NCT02834247|450746823|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
125306263|NCT02834247|450746820|FG000|Dose Expansion Phase|Death|0|||
125306264|NCT02834247|450746821|FG001|Dose Expansion Phase|Death|0|||
125306265|NCT02834247|450746822|FG002|Dose Expansion Phase|Death|0|||
125306266|NCT02834247|450746823|FG003|Dose Expansion Phase|Death|8|||
125306267|NCT02834247|450746820|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
125306268|NCT02834247|450746821|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
125306269|NCT02834247|450746822|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
125306270|NCT02834247|450746823|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
125306271|NCT02834247|450746820|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
125306272|NCT02834247|450746821|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
125306273|NCT02834247|450746822|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
125306274|NCT02834247|450746823|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
125306275|NCT05111249|450748982|FG000|Overall Study|Lost to Follow-up|0|||
125306276|NCT05111249|450748983|FG001|Overall Study|Lost to Follow-up|2|||
125306277|NCT05111249|450748982|FG000|Overall Study|Physician Decision|0|||
125306278|NCT05111249|450748983|FG001|Overall Study|Physician Decision|1|||
125306279|NCT05111249|450748982|FG000|Overall Study|Participant decision|1|||
125306280|NCT05111249|450748983|FG001|Overall Study|Participant decision|5|||
125306281|NCT05128578|450748984|FG000|Overall Study|Withdrawal by Subject|9|||
125306282|NCT05128578|450748984|FG000|Overall Study|Lost to Follow-up|5|||
125306283|NCT01016600|450748987|FG000|Overall Study|Did not start treatment|1|||
125306284|NCT01016600|450748988|FG001|Overall Study|Did not start treatment|0|||
125306285|NCT01016600|450748989|FG002|Overall Study|Did not start treatment|0|||
125306286|NCT01016600|450748990|FG003|Overall Study|Did not start treatment|0|||
125306287|NCT02679755|450748991|FG000|Overall Study|Death|0|||
125306288|NCT02679755|450748992|FG001|Overall Study|Death|3|||
125306289|NCT02679755|450748991|FG000|Overall Study|Global deterioration of health status|1|||
125306290|NCT02679755|450748992|FG001|Overall Study|Global deterioration of health status|8|||
125306291|NCT02679755|450748991|FG000|Overall Study|Lost to Follow-up|1|||
125306292|NCT02679755|450748992|FG001|Overall Study|Lost to Follow-up|0|||
125306293|NCT02679755|450748991|FG000|Overall Study|Objective progression or relapse|24|||
125306294|NCT02679755|450748992|FG001|Overall Study|Objective progression or relapse|83|||
125306295|NCT02679755|450748991|FG000|Overall Study|Not defined|0|||
125306296|NCT02679755|450748992|FG001|Overall Study|Not defined|2|||
125306297|NCT02679755|450748991|FG000|Overall Study|Withdrawal by participant|6|||
125306298|NCT02679755|450748992|FG001|Overall Study|Withdrawal by participant|3|||
125306299|NCT02679755|450748991|FG000|Overall Study|Adverse Event|1|||
125306300|NCT02679755|450748992|FG001|Overall Study|Adverse Event|4|||
125306301|NCT02679755|450748991|FG000|Overall Study|Adverse events not related to study drug|1|||
125306302|NCT02679755|450748992|FG001|Overall Study|Adverse events not related to study drug|2|||
125306303|NCT02451917|450748995|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
125306304|NCT02451917|450748996|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
125306305|NCT02451917|450748995|FG000|First Intervention (24 Weeks)|Death|0|||
125306306|NCT02451917|450748996|FG001|First Intervention (24 Weeks)|Death|1|||
125306307|NCT02451917|450748995|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
125306308|NCT02451917|450748996|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
125306309|NCT02300259|450748999|FG000|Period 1|Adverse Event|0|||
125306310|NCT02300259|450749000|FG001|Period 1|Adverse Event|0|||
125306311|NCT02300259|450749001|FG002|Period 1|Adverse Event|1|||
125306312|NCT02300259|450748999|FG000|Period 1|Withdrawal by Subject|0|||
124845400|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845401|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845402|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125306313|NCT02300259|450749000|FG001|Period 1|Withdrawal by Subject|0|||
125306314|NCT02300259|450749001|FG002|Period 1|Withdrawal by Subject|1|||
125306315|NCT02300259|450748999|FG000|Period 2|Adverse Event|1|||
125306316|NCT02300259|450749000|FG001|Period 2|Adverse Event|0|||
125306317|NCT02300259|450749001|FG002|Period 2|Adverse Event|0|||
125306318|NCT02300259|450748999|FG000|Period 2|Withdrawal by Subject|0|||
125306319|NCT02300259|450749000|FG001|Period 2|Withdrawal by Subject|0|||
125306320|NCT02300259|450749001|FG002|Period 2|Withdrawal by Subject|1|||
125306321|NCT04737278|450749002|FG000|Overall Study|Lost to Follow-up|1|||
125306322|NCT04737278|450749003|FG001|Overall Study|Lost to Follow-up|1|||
125306323|NCT04737278|450749002|FG000|Overall Study|Withdrawal by Subject|1|||
125306324|NCT04737278|450749003|FG001|Overall Study|Withdrawal by Subject|0|||
125306325|NCT04737278|450749002|FG000|Overall Study|Protocol Violation|1|||
125306326|NCT04737278|450749003|FG001|Overall Study|Protocol Violation|1|||
125306327|NCT04737278|450749002|FG000|Overall Study|failure to complete questionnaire|1|||
125306328|NCT04737278|450749003|FG001|Overall Study|failure to complete questionnaire|1|||
125306329|NCT02737475|450749004|FG000|Overall Study|Other reasons|0|||
125306330|NCT02737475|450749005|FG001|Overall Study|Other reasons|0|||
125306331|NCT02737475|450749006|FG002|Overall Study|Other reasons|0|||
125306332|NCT02737475|450749007|FG003|Overall Study|Other reasons|0|||
125306333|NCT02737475|450749008|FG004|Overall Study|Other reasons|1|||
125306334|NCT02737475|450749009|FG005|Overall Study|Other reasons|1|||
125306335|NCT02737475|450749010|FG006|Overall Study|Other reasons|0|||
125306336|NCT02737475|450749011|FG007|Overall Study|Other reasons|0|||
125306337|NCT02737475|450749012|FG008|Overall Study|Other reasons|1|||
125306338|NCT02737475|450749013|FG009|Overall Study|Other reasons|0|||
125306339|NCT02737475|450749014|FG010|Overall Study|Other reasons|1|||
125306340|NCT02737475|450749015|FG011|Overall Study|Other reasons|0|||
125306341|NCT02737475|450749016|FG012|Overall Study|Other reasons|0|||
125306342|NCT02737475|450749017|FG013|Overall Study|Other reasons|0|||
125306343|NCT02737475|450749018|FG014|Overall Study|Other reasons|0|||
125306344|NCT02737475|450749019|FG015|Overall Study|Other reasons|0|||
125306345|NCT02737475|450749020|FG016|Overall Study|Other reasons|0|||
125306346|NCT02737475|450749021|FG017|Overall Study|Other reasons|0|||
125306347|NCT02737475|450749022|FG018|Overall Study|Other reasons|0|||
125306348|NCT02737475|450749023|FG019|Overall Study|Other reasons|0|||
125306349|NCT02737475|450749024|FG020|Overall Study|Other reasons|0|||
125306350|NCT02737475|450749025|FG021|Overall Study|Other reasons|1|||
125306351|NCT02737475|450749026|FG022|Overall Study|Other reasons|0|||
125306352|NCT02737475|450749027|FG023|Overall Study|Other reasons|1|||
125306353|NCT02737475|450749028|FG024|Overall Study|Other reasons|1|||
125306354|NCT02737475|450749029|FG025|Overall Study|Other reasons|1|||
125306355|NCT02737475|450749030|FG026|Overall Study|Other reasons|0|||
125306356|NCT02737475|450749004|FG000|Overall Study|Death|1|||
125306357|NCT02737475|450749005|FG001|Overall Study|Death|0|||
125306358|NCT02737475|450749006|FG002|Overall Study|Death|0|||
125306359|NCT02737475|450749007|FG003|Overall Study|Death|1|||
125306360|NCT02737475|450749008|FG004|Overall Study|Death|0|||
125306361|NCT02737475|450749009|FG005|Overall Study|Death|0|||
125306362|NCT02737475|450749010|FG006|Overall Study|Death|0|||
125306363|NCT02737475|450749011|FG007|Overall Study|Death|2|||
125306364|NCT02737475|450749012|FG008|Overall Study|Death|0|||
125306365|NCT02737475|450749013|FG009|Overall Study|Death|0|||
125306366|NCT02737475|450749014|FG010|Overall Study|Death|0|||
125306367|NCT02737475|450749015|FG011|Overall Study|Death|4|||
125306368|NCT02737475|450749016|FG012|Overall Study|Death|2|||
125306369|NCT02737475|450749017|FG013|Overall Study|Death|2|||
125306370|NCT02737475|450749018|FG014|Overall Study|Death|0|||
125306371|NCT02737475|450749019|FG015|Overall Study|Death|2|||
125306372|NCT02737475|450749020|FG016|Overall Study|Death|2|||
125306373|NCT02737475|450749021|FG017|Overall Study|Death|2|||
125306374|NCT02737475|450749022|FG018|Overall Study|Death|1|||
125306375|NCT02737475|450749023|FG019|Overall Study|Death|0|||
125306376|NCT02737475|450749024|FG020|Overall Study|Death|0|||
125306377|NCT02737475|450749025|FG021|Overall Study|Death|0|||
124845403|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845404|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845405|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845406|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845407|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845408|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845409|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845410|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845411|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845412|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
124845413|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845414|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845415|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845416|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845417|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845418|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845419|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845420|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845421|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845422|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845423|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845424|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845425|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845426|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845427|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845428|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845429|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845430|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845431|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845432|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845433|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845434|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845435|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845436|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
124845437|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845438|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845439|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845440|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845441|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845442|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845443|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845444|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845445|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845446|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845447|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845448|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845449|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845450|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845451|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845452|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845453|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845454|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845455|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845456|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845457|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845458|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845459|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125306378|NCT02737475|450749026|FG022|Overall Study|Death|0|||
124845460|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
124845461|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845462|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845463|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845464|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845465|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845466|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845467|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845468|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845469|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845470|NCT02346240|449060186|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845471|NCT02346240|449060187|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845472|NCT02346240|449060188|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845473|NCT02346240|449060189|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845474|NCT02346240|449060190|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845475|NCT02346240|449060191|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845476|NCT02346240|449060192|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845477|NCT02346240|449060193|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845478|NCT02346240|449060194|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845479|NCT02346240|449060195|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845480|NCT02346240|449060196|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845481|NCT02346240|449060197|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845482|NCT02346240|449060198|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845483|NCT02346240|449060199|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845484|NCT02346240|449060200|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845485|NCT02346240|449060201|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845486|NCT02346240|449060202|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845487|NCT02346240|449060203|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
124845488|NCT02346240|449060204|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
124845489|NCT02346240|449060205|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
124845490|NCT02346240|449060206|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
124845491|NCT02346240|449060207|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
124845492|NCT02346240|449060208|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
124845493|NCT02346240|449060209|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
124845494|NCT02346240|449060186|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845495|NCT02346240|449060187|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845496|NCT02346240|449060188|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845497|NCT02346240|449060189|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845498|NCT02346240|449060190|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845499|NCT02346240|449060191|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845500|NCT02346240|449060192|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845501|NCT02346240|449060193|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845502|NCT02346240|449060194|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845503|NCT02346240|449060195|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845504|NCT02346240|449060196|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845505|NCT02346240|449060197|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845506|NCT02346240|449060198|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845507|NCT02346240|449060199|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845508|NCT02346240|449060200|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845509|NCT02346240|449060201|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845510|NCT02346240|449060202|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845511|NCT02346240|449060203|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845512|NCT02346240|449060204|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
124845513|NCT02346240|449060205|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
124845514|NCT02346240|449060206|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845515|NCT02346240|449060207|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
124845516|NCT02346240|449060208|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845517|NCT02346240|449060209|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845518|NCT02346240|449060186|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845519|NCT02346240|449060187|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845520|NCT02346240|449060188|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845521|NCT02346240|449060189|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845522|NCT02346240|449060190|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845523|NCT02346240|449060191|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845524|NCT02346240|449060192|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845525|NCT02346240|449060193|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845526|NCT02346240|449060194|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845527|NCT02346240|449060195|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845528|NCT02346240|449060196|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845529|NCT02346240|449060197|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845530|NCT02346240|449060198|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845531|NCT02346240|449060199|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845532|NCT02346240|449060200|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845533|NCT02346240|449060201|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845534|NCT02346240|449060202|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845535|NCT02346240|449060203|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845536|NCT02346240|449060204|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
124845537|NCT02346240|449060205|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845538|NCT02346240|449060206|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845539|NCT02346240|449060207|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
124845540|NCT02346240|449060208|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845541|NCT02346240|449060209|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845542|NCT02346240|449060186|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845543|NCT02346240|449060187|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845544|NCT02346240|449060188|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845545|NCT02346240|449060189|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845546|NCT02346240|449060190|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845547|NCT02346240|449060191|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845548|NCT02346240|449060192|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845549|NCT02346240|449060193|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845550|NCT02346240|449060194|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845551|NCT02346240|449060195|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845552|NCT02346240|449060196|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845553|NCT02346240|449060197|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845554|NCT02346240|449060198|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845555|NCT02346240|449060199|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845556|NCT02346240|449060200|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845557|NCT02346240|449060201|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845558|NCT02346240|449060202|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845559|NCT02346240|449060203|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845560|NCT02346240|449060204|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845561|NCT02346240|449060205|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845562|NCT02346240|449060206|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845563|NCT02346240|449060207|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
124845564|NCT02346240|449060208|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845565|NCT02346240|449060209|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845566|NCT02346240|449060186|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845567|NCT02346240|449060187|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845568|NCT02346240|449060188|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845569|NCT02346240|449060189|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845570|NCT02346240|449060190|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845571|NCT02346240|449060191|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845572|NCT02346240|449060192|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845573|NCT02346240|449060193|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845574|NCT02346240|449060194|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125306379|NCT02737475|450749027|FG023|Overall Study|Death|0|||
124845575|NCT02346240|449060195|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845576|NCT02346240|449060196|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845577|NCT02346240|449060197|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125306380|NCT02737475|450749028|FG024|Overall Study|Death|0|||
125306381|NCT02737475|450749029|FG025|Overall Study|Death|0|||
125306382|NCT02737475|450749030|FG026|Overall Study|Death|0|||
125306383|NCT02737475|450749004|FG000|Overall Study|Participant withdrew consent|0|||
124845578|NCT02346240|449060198|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845579|NCT02346240|449060199|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845580|NCT02346240|449060200|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845581|NCT02346240|449060201|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845582|NCT02346240|449060202|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845583|NCT02346240|449060203|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
124845584|NCT02346240|449060204|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
124845585|NCT02346240|449060205|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
124845586|NCT02346240|449060206|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845587|NCT02346240|449060207|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
124845588|NCT02346240|449060208|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
124845589|NCT02346240|449060209|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
124845590|NCT02346240|449060186|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845591|NCT02346240|449060187|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845592|NCT02346240|449060188|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845593|NCT02346240|449060189|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845594|NCT02346240|449060190|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845595|NCT02346240|449060191|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845596|NCT02346240|449060192|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845597|NCT02346240|449060193|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845598|NCT02346240|449060194|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845599|NCT02346240|449060195|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845600|NCT02346240|449060196|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845601|NCT02346240|449060197|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845602|NCT02346240|449060198|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845603|NCT02346240|449060199|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845604|NCT02346240|449060200|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845605|NCT02346240|449060201|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845606|NCT02346240|449060202|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845607|NCT02346240|449060203|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845608|NCT02346240|449060204|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
124845609|NCT02346240|449060205|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
124845610|NCT02346240|449060206|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845611|NCT02346240|449060207|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
124845612|NCT02346240|449060208|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
124845613|NCT02346240|449060209|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
124845614|NCT02346240|449060186|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845615|NCT02346240|449060187|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845616|NCT02346240|449060188|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845617|NCT02346240|449060189|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845618|NCT02346240|449060190|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845619|NCT02346240|449060191|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845620|NCT02346240|449060192|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845621|NCT02346240|449060193|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845622|NCT02346240|449060194|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845623|NCT02346240|449060195|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845624|NCT02346240|449060196|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845625|NCT02346240|449060197|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845626|NCT02346240|449060198|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845627|NCT02346240|449060199|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845628|NCT02346240|449060200|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845629|NCT02346240|449060201|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845630|NCT02346240|449060202|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845631|NCT02346240|449060203|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845632|NCT02346240|449060204|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
124845633|NCT02346240|449060205|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125306384|NCT02737475|450749005|FG001|Overall Study|Participant withdrew consent|0|||
124845634|NCT02346240|449060206|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845635|NCT02346240|449060207|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
124845636|NCT02346240|449060208|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
124845637|NCT02346240|449060209|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
125306385|NCT02737475|450749006|FG002|Overall Study|Participant withdrew consent|0|||
124845638|NCT02346240|449060186|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845639|NCT02346240|449060187|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845640|NCT02346240|449060188|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845641|NCT02346240|449060189|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845642|NCT02346240|449060190|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845643|NCT02346240|449060191|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845644|NCT02346240|449060192|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845645|NCT02346240|449060193|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845646|NCT02346240|449060194|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845647|NCT02346240|449060195|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845648|NCT02346240|449060196|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845649|NCT02346240|449060197|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845650|NCT02346240|449060198|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845651|NCT02346240|449060199|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845652|NCT02346240|449060200|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845653|NCT02346240|449060201|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845654|NCT02346240|449060202|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845655|NCT02346240|449060203|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845656|NCT02346240|449060204|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
124845657|NCT02346240|449060205|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845658|NCT02346240|449060206|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845659|NCT02346240|449060207|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845660|NCT02346240|449060208|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845661|NCT02346240|449060209|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845662|NCT03417141|449060211|FG000|Overall Study|Withdrawal by Subject|1|||
124845663|NCT03417141|449060211|FG000|Overall Study|Protocol Violation|3|||
124845664|NCT03706690|449060214|FG000|Overall Study|Withdrawal by Subject|8|||
124845665|NCT03706690|449060215|FG001|Overall Study|Withdrawal by Subject|8|||
124845666|NCT03706690|449060214|FG000|Overall Study|Death|143|||
124845667|NCT03706690|449060215|FG001|Overall Study|Death|75|||
124845668|NCT03706690|449060214|FG000|Overall Study|Ongoing at DCO|121|||
124845669|NCT03706690|449060215|FG001|Overall Study|Ongoing at DCO|52|||
124845670|NCT02098109|449060216|FG000|Overall Study|Protocol Violation|3|||
124845671|NCT02098109|449060217|FG001|Overall Study|Protocol Violation|0|||
124845672|NCT02143843|449060218|FG000|Overall Study|Adverse Event|8|||
124845673|NCT02143843|449060218|FG000|Overall Study|Lack of Efficacy|2|||
124845674|NCT02143843|449060218|FG000|Overall Study|Withdrawal by Subject|2|||
124845675|NCT01822132|449060219|FG000|Overall Study|Lost to Follow-up|4|||
124845676|NCT01822132|449060220|FG001|Overall Study|Lost to Follow-up|2|||
124845677|NCT02519712|449060223|FG000|Overall Study|Disease Relapse|1|||
124845678|NCT02519712|449060223|FG000|Overall Study|Disease Progression|1|||
124845679|NCT02519712|449060223|FG000|Overall Study|Accruals are donors|2|||
124845680|NCT00006916|449060226|FG000|Overall Study|Device not inserted|4|||
124845681|NCT00006916|449060226|FG000|Overall Study|Complication of device insertion|1|||
124845682|NCT01524770|449060230|FG000|First Intervention|Withdrawal by Subject|1|||
124845683|NCT01524770|449060231|FG001|First Intervention|Withdrawal by Subject|0|||
124845684|NCT01524770|449060230|FG000|First Intervention|Adverse Event|1|||
124845685|NCT01524770|449060231|FG001|First Intervention|Adverse Event|1|||
124845686|NCT01524770|449060230|FG000|First Intervention|Protocol Violation|1|||
124845687|NCT01524770|449060231|FG001|First Intervention|Protocol Violation|0|||
124845688|NCT02751983|449060232|FG000|Treatment|Stopped ACT, but Remained in study|2|||
124845689|NCT02751983|449060233|FG001|Treatment|Stopped ACT, but Remained in study|0|||
124845690|NCT02751983|449060232|FG000|Treatment|Discharged prior to beginning ACT|2|||
124845691|NCT02751983|449060233|FG001|Treatment|Discharged prior to beginning ACT|0|||
124845692|NCT02751983|449060232|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
125306386|NCT02737475|450749007|FG003|Overall Study|Participant withdrew consent|0|||
125306387|NCT02737475|450749008|FG004|Overall Study|Participant withdrew consent|0|||
124845693|NCT02751983|449060233|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
124845694|NCT02751983|449060232|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
124845695|NCT02751983|449060233|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
124845696|NCT02751983|449060232|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
124845697|NCT02751983|449060233|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
124845698|NCT01420081|449060234|FG000|Overall Study|Death|1|||
124845699|NCT01420081|449060235|FG001|Overall Study|Death|0|||
124845700|NCT01420081|449060236|FG002|Overall Study|Death|8|||
124845701|NCT01420081|449060237|FG003|Overall Study|Death|0|||
124845702|NCT01420081|449060238|FG004|Overall Study|Death|7|||
124845703|NCT01420081|449060239|FG005|Overall Study|Death|12|||
125306388|NCT02737475|450749009|FG005|Overall Study|Participant withdrew consent|2|||
124845704|NCT01420081|449060240|FG006|Overall Study|Death|0|||
124845705|NCT01420081|449060241|FG007|Overall Study|Death|1|||
124845706|NCT01420081|449060242|FG008|Overall Study|Death|1|||
124845707|NCT01420081|449060234|FG000|Overall Study|Lost to Follow-up|0|||
124845708|NCT01420081|449060235|FG001|Overall Study|Lost to Follow-up|0|||
124845709|NCT01420081|449060236|FG002|Overall Study|Lost to Follow-up|0|||
124845710|NCT01420081|449060237|FG003|Overall Study|Lost to Follow-up|0|||
124845711|NCT01420081|449060238|FG004|Overall Study|Lost to Follow-up|1|||
124845712|NCT01420081|449060239|FG005|Overall Study|Lost to Follow-up|1|||
124845713|NCT01420081|449060240|FG006|Overall Study|Lost to Follow-up|0|||
124845714|NCT01420081|449060241|FG007|Overall Study|Lost to Follow-up|0|||
124845715|NCT01420081|449060242|FG008|Overall Study|Lost to Follow-up|0|||
124845716|NCT01420081|449060234|FG000|Overall Study|Study Terminated by Sponsor|2|||
124845717|NCT01420081|449060235|FG001|Overall Study|Study Terminated by Sponsor|1|||
124845718|NCT01420081|449060236|FG002|Overall Study|Study Terminated by Sponsor|1|||
124845719|NCT01420081|449060237|FG003|Overall Study|Study Terminated by Sponsor|3|||
124845720|NCT01420081|449060238|FG004|Overall Study|Study Terminated by Sponsor|11|||
124845721|NCT01420081|449060239|FG005|Overall Study|Study Terminated by Sponsor|7|||
124845722|NCT01420081|449060240|FG006|Overall Study|Study Terminated by Sponsor|3|||
124845723|NCT01420081|449060241|FG007|Overall Study|Study Terminated by Sponsor|2|||
124845724|NCT01420081|449060242|FG008|Overall Study|Study Terminated by Sponsor|2|||
124845725|NCT01420081|449060234|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
124845726|NCT01420081|449060235|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
124845727|NCT01420081|449060236|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
124845728|NCT01420081|449060237|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
124845729|NCT01420081|449060238|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
124845730|NCT01420081|449060239|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
124845731|NCT01420081|449060240|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
124845732|NCT01420081|449060241|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
124845733|NCT01420081|449060242|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
124845734|NCT01420081|449060234|FG000|Overall Study|Other Reasons|0|||
124845735|NCT01420081|449060235|FG001|Overall Study|Other Reasons|0|||
124845736|NCT01420081|449060236|FG002|Overall Study|Other Reasons|1|||
124845737|NCT01420081|449060237|FG003|Overall Study|Other Reasons|0|||
124845738|NCT01420081|449060238|FG004|Overall Study|Other Reasons|0|||
124845739|NCT01420081|449060239|FG005|Overall Study|Other Reasons|0|||
124845740|NCT01420081|449060240|FG006|Overall Study|Other Reasons|0|||
124845741|NCT01420081|449060241|FG007|Overall Study|Other Reasons|0|||
124845742|NCT01420081|449060242|FG008|Overall Study|Other Reasons|0|||
124845743|NCT03467425|449060243|FG000|Overall Study|Adverse Event|9|||
124845744|NCT03467425|449060244|FG001|Overall Study|Adverse Event|9|||
124845745|NCT03467425|449060243|FG000|Overall Study|Lack of Efficacy|3|||
124845746|NCT03467425|449060244|FG001|Overall Study|Lack of Efficacy|1|||
124845747|NCT03467425|449060243|FG000|Overall Study|Protocol Violation|0|||
124845748|NCT03467425|449060244|FG001|Overall Study|Protocol Violation|1|||
124845749|NCT03467425|449060243|FG000|Overall Study|Lost to Follow-up|18|||
124845750|NCT03467425|449060244|FG001|Overall Study|Lost to Follow-up|25|||
124845751|NCT03467425|449060243|FG000|Overall Study|Physician Decision|2|||
124845752|NCT03467425|449060244|FG001|Overall Study|Physician Decision|1|||
124845753|NCT03467425|449060243|FG000|Overall Study|Withdrawal by Subject|15|||
124845754|NCT03467425|449060244|FG001|Overall Study|Withdrawal by Subject|17|||
124845755|NCT02318693|449060246|FG000|Overall Study|Protocol Violation|0|||
124845756|NCT02318693|449060247|FG001|Overall Study|Protocol Violation|1|||
124845757|NCT00025883|449060248|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
124845758|NCT00025883|449060248|FG000|Overall Study|no baseline data|1|||
124845759|NCT00025883|449060248|FG000|Overall Study|Death|1|||
124845760|NCT00025883|449060248|FG000|Overall Study|Adverse Event|1|||
124845761|NCT00025883|449060248|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
124845762|NCT00528528|449060254|FG000|Overall Study|Lost to Follow-up|0|||
124845763|NCT00528528|449060255|FG001|Overall Study|Lost to Follow-up|0|||
124845764|NCT00528528|449060256|FG002|Overall Study|Lost to Follow-up|1|||
124845765|NCT00528528|449060257|FG003|Overall Study|Lost to Follow-up|1|||
124845766|NCT00528528|449060254|FG000|Overall Study|Ineligible to continue the trial|0|||
125306389|NCT02737475|450749010|FG006|Overall Study|Participant withdrew consent|0|||
125306390|NCT02737475|450749011|FG007|Overall Study|Participant withdrew consent|0|||
124845767|NCT00528528|449060255|FG001|Overall Study|Ineligible to continue the trial|0|||
124845768|NCT00528528|449060256|FG002|Overall Study|Ineligible to continue the trial|0|||
124845769|NCT00528528|449060257|FG003|Overall Study|Ineligible to continue the trial|1|||
124845770|NCT00528528|449060254|FG000|Overall Study|Other|0|||
124845771|NCT00528528|449060255|FG001|Overall Study|Other|1|||
124845772|NCT00528528|449060256|FG002|Overall Study|Other|0|||
124845773|NCT00528528|449060257|FG003|Overall Study|Other|0|||
124845774|NCT00528528|449060254|FG000|Overall Study|Withdrawal by Subject|3|||
124845775|NCT00528528|449060255|FG001|Overall Study|Withdrawal by Subject|2|||
124845776|NCT00528528|449060256|FG002|Overall Study|Withdrawal by Subject|1|||
124845777|NCT00528528|449060257|FG003|Overall Study|Withdrawal by Subject|1|||
124845778|NCT00528528|449060254|FG000|Overall Study|Ongoing participant|0|||
124845779|NCT00528528|449060255|FG001|Overall Study|Ongoing participant|0|||
124845780|NCT00528528|449060256|FG002|Overall Study|Ongoing participant|1|||
124845781|NCT00528528|449060257|FG003|Overall Study|Ongoing participant|0|||
124845782|NCT04197713|449060260|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
124845783|NCT04197713|449060261|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
124845784|NCT05569954|449060262|FG000|Overall Study|Lost to Follow-up|3|||
124845785|NCT05569954|449060263|FG001|Overall Study|Lost to Follow-up|4|||
124845786|NCT05569954|449060262|FG000|Overall Study|Protocol Violation|1|||
124845787|NCT05569954|449060263|FG001|Overall Study|Protocol Violation|2|||
124845788|NCT05569954|449060262|FG000|Overall Study|Withdrawal by Subject|4|||
124845789|NCT05569954|449060263|FG001|Overall Study|Withdrawal by Subject|2|||
124845790|NCT01660412|449060264|FG000|Overall Study|Protocol Violation|0|||
124845791|NCT01660412|449060265|FG001|Overall Study|Protocol Violation|3|||
124845792|NCT04579679|449060266|FG000|Overall Study|New Antitumor Therapy|6|||
124845793|NCT04579679|449060267|FG001|Overall Study|New Antitumor Therapy|4|||
124845794|NCT04579679|449060268|FG002|Overall Study|New Antitumor Therapy|7|||
124845795|NCT04579679|449060269|FG003|Overall Study|New Antitumor Therapy|0|||
124845796|NCT04579679|449060266|FG000|Overall Study|Withdrawal of Consent|1|||
124845797|NCT04579679|449060267|FG001|Overall Study|Withdrawal of Consent|1|||
124845798|NCT04579679|449060268|FG002|Overall Study|Withdrawal of Consent|2|||
124845799|NCT04579679|449060269|FG003|Overall Study|Withdrawal of Consent|4|||
124845800|NCT04579679|449060266|FG000|Overall Study|Death|2|||
124845801|NCT04579679|449060267|FG001|Overall Study|Death|2|||
124845802|NCT04579679|449060268|FG002|Overall Study|Death|2|||
124845803|NCT04579679|449060269|FG003|Overall Study|Death|0|||
124845804|NCT04579679|449060266|FG000|Overall Study|Adverse Event|0|||
124845805|NCT04579679|449060267|FG001|Overall Study|Adverse Event|4|||
124845806|NCT04579679|449060268|FG002|Overall Study|Adverse Event|0|||
124845807|NCT04579679|449060269|FG003|Overall Study|Adverse Event|0|||
124845808|NCT04579679|449060266|FG000|Overall Study|Disease Progression|9|||
124845809|NCT04579679|449060267|FG001|Overall Study|Disease Progression|13|||
124845810|NCT04579679|449060268|FG002|Overall Study|Disease Progression|7|||
124845811|NCT04579679|449060269|FG003|Overall Study|Disease Progression|0|||
124845812|NCT04579679|449060266|FG000|Overall Study|Physician Decision|0|||
124845813|NCT04579679|449060267|FG001|Overall Study|Physician Decision|0|||
124845814|NCT04579679|449060268|FG002|Overall Study|Physician Decision|1|||
124845815|NCT04579679|449060269|FG003|Overall Study|Physician Decision|0|||
124845816|NCT04579679|449060266|FG000|Overall Study|Study Terminated by Sponsor|2|||
124845817|NCT04579679|449060267|FG001|Overall Study|Study Terminated by Sponsor|7|||
124845818|NCT04579679|449060268|FG002|Overall Study|Study Terminated by Sponsor|1|||
125306391|NCT02737475|450749012|FG008|Overall Study|Participant withdrew consent|0|||
125306392|NCT02737475|450749013|FG009|Overall Study|Participant withdrew consent|0|||
125306393|NCT02737475|450749014|FG010|Overall Study|Participant withdrew consent|0|||
125306394|NCT02737475|450749015|FG011|Overall Study|Participant withdrew consent|0|||
125306395|NCT02737475|450749016|FG012|Overall Study|Participant withdrew consent|0|||
125306396|NCT02737475|450749017|FG013|Overall Study|Participant withdrew consent|0|||
124845819|NCT04579679|449060269|FG003|Overall Study|Study Terminated by Sponsor|0|||
124845820|NCT04740034|449060270|FG000|Overall Study|Death|0|||
124845821|NCT04740034|449060271|FG001|Overall Study|Death|1|||
124845822|NCT04740034|449060272|FG002|Overall Study|Death|2|||
124845823|NCT04740034|449060273|FG003|Overall Study|Death|3|||
124845824|NCT04740034|449060274|FG004|Overall Study|Death|4|||
124845825|NCT04740034|449060275|FG005|Overall Study|Death|4|||
124845826|NCT04740034|449060276|FG006|Overall Study|Death|2|||
124845827|NCT04740034|449060277|FG007|Overall Study|Death|2|||
124845828|NCT04740034|449060278|FG008|Overall Study|Death|2|||
124845829|NCT04740034|449060279|FG009|Overall Study|Death|4|||
124845830|NCT04740034|449060280|FG010|Overall Study|Death|0|||
124845831|NCT04740034|449060270|FG000|Overall Study|Lost to Follow-up|0|||
124845832|NCT04740034|449060271|FG001|Overall Study|Lost to Follow-up|0|||
124845833|NCT04740034|449060272|FG002|Overall Study|Lost to Follow-up|0|||
124845834|NCT04740034|449060273|FG003|Overall Study|Lost to Follow-up|1|||
124845835|NCT04740034|449060274|FG004|Overall Study|Lost to Follow-up|2|||
124845836|NCT04740034|449060275|FG005|Overall Study|Lost to Follow-up|2|||
124845837|NCT04740034|449060276|FG006|Overall Study|Lost to Follow-up|0|||
124845838|NCT04740034|449060277|FG007|Overall Study|Lost to Follow-up|0|||
124845839|NCT04740034|449060278|FG008|Overall Study|Lost to Follow-up|0|||
124845840|NCT04740034|449060279|FG009|Overall Study|Lost to Follow-up|1|||
124845841|NCT04740034|449060280|FG010|Overall Study|Lost to Follow-up|0|||
124845842|NCT04740034|449060270|FG000|Overall Study|Withdrawal by Subject|1|||
124845843|NCT04740034|449060271|FG001|Overall Study|Withdrawal by Subject|0|||
124845844|NCT04740034|449060272|FG002|Overall Study|Withdrawal by Subject|0|||
124845845|NCT04740034|449060273|FG003|Overall Study|Withdrawal by Subject|0|||
124845846|NCT04740034|449060274|FG004|Overall Study|Withdrawal by Subject|0|||
124845847|NCT04740034|449060275|FG005|Overall Study|Withdrawal by Subject|0|||
124845848|NCT04740034|449060276|FG006|Overall Study|Withdrawal by Subject|0|||
124845849|NCT04740034|449060277|FG007|Overall Study|Withdrawal by Subject|1|||
124845850|NCT04740034|449060278|FG008|Overall Study|Withdrawal by Subject|0|||
124845851|NCT04740034|449060279|FG009|Overall Study|Withdrawal by Subject|1|||
124845852|NCT04740034|449060280|FG010|Overall Study|Withdrawal by Subject|0|||
124845853|NCT04740034|449060270|FG000|Overall Study|Decision by sponsor|0|||
124845854|NCT04740034|449060271|FG001|Overall Study|Decision by sponsor|0|||
124845855|NCT04740034|449060272|FG002|Overall Study|Decision by sponsor|1|||
124845856|NCT04740034|449060273|FG003|Overall Study|Decision by sponsor|0|||
124845857|NCT04740034|449060274|FG004|Overall Study|Decision by sponsor|0|||
124845858|NCT04740034|449060275|FG005|Overall Study|Decision by sponsor|0|||
124845859|NCT04740034|449060276|FG006|Overall Study|Decision by sponsor|1|||
124845860|NCT04740034|449060277|FG007|Overall Study|Decision by sponsor|2|||
124845861|NCT04740034|449060278|FG008|Overall Study|Decision by sponsor|1|||
124845862|NCT04740034|449060279|FG009|Overall Study|Decision by sponsor|1|||
124845863|NCT04740034|449060280|FG010|Overall Study|Decision by sponsor|2|||
124845864|NCT04346615|449062105|FG000|Overall Study|Lost to Follow-up|0|||
124845865|NCT04346615|449062106|FG001|Overall Study|Lost to Follow-up|2|||
124845866|NCT04346615|449062105|FG000|Overall Study|Withdrawal by Subject|1|||
124845867|NCT04346615|449062106|FG001|Overall Study|Withdrawal by Subject|0|||
124845868|NCT04346615|449062105|FG000|Overall Study|Death|5|||
124845869|NCT04346615|449062106|FG001|Overall Study|Death|1|||
124845870|NCT04346615|449062105|FG000|Overall Study|Other|0|||
124845871|NCT04346615|449062106|FG001|Overall Study|Other|2|||
124845872|NCT04346615|449062105|FG000|Overall Study|Randomized not treated|1|||
124845873|NCT04346615|449062106|FG001|Overall Study|Randomized not treated|0|||
124845874|NCT04524403|449062109|FG000|Overall Study|Withdrawal by Subject|10|||
124845875|NCT04524403|449062110|FG001|Overall Study|Withdrawal by Subject|3|||
124845876|NCT04524403|449062111|FG002|Overall Study|Withdrawal by Subject|8|||
124845877|NCT04524403|449062109|FG000|Overall Study|Lost to Follow-up|3|||
124845878|NCT04524403|449062110|FG001|Overall Study|Lost to Follow-up|4|||
124845879|NCT04524403|449062111|FG002|Overall Study|Lost to Follow-up|3|||
124845880|NCT04524403|449062109|FG000|Overall Study|Adverse Event|3|||
124845881|NCT04524403|449062110|FG001|Overall Study|Adverse Event|1|||
124845882|NCT04524403|449062111|FG002|Overall Study|Adverse Event|4|||
124845883|NCT04524403|449062109|FG000|Overall Study|Non-compliant with study drug|1|||
124845884|NCT04524403|449062110|FG001|Overall Study|Non-compliant with study drug|2|||
124845885|NCT04524403|449062111|FG002|Overall Study|Non-compliant with study drug|3|||
124845886|NCT04524403|449062109|FG000|Overall Study|Moved|0|||
124845887|NCT04524403|449062110|FG001|Overall Study|Moved|1|||
124845888|NCT04524403|449062111|FG002|Overall Study|Moved|0|||
124845889|NCT00533949|449062114|FG000|Overall Study|Protocol Violation|12|||
124845890|NCT00533949|449062115|FG001|Overall Study|Protocol Violation|12|||
124845891|NCT00533949|449062116|FG002|Overall Study|Protocol Violation|9|||
124845892|NCT00533949|449062117|FG003|Overall Study|Protocol Violation|9|||
124845893|NCT00533949|449062114|FG000|Overall Study|Withdrawal by Subject|3|||
124845894|NCT00533949|449062115|FG001|Overall Study|Withdrawal by Subject|2|||
124845895|NCT00533949|449062116|FG002|Overall Study|Withdrawal by Subject|1|||
124845896|NCT00533949|449062117|FG003|Overall Study|Withdrawal by Subject|1|||
124845897|NCT00727194|449062118|FG000|Screening Period|Low QMG scores|0|||
124845898|NCT00727194|449062119|FG001|Screening Period|Low QMG scores|0|||
124845899|NCT00727194|449062120|FG002|Screening Period|Low QMG scores|6|||
124845900|NCT00727194|449062118|FG000|Screening Period|Lacked AChR antibodies|0|||
124845901|NCT00727194|449062119|FG001|Screening Period|Lacked AChR antibodies|0|||
124845902|NCT00727194|449062120|FG002|Screening Period|Lacked AChR antibodies|5|||
124845903|NCT00727194|449062118|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
124845904|NCT00727194|449062119|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
124845905|NCT00727194|449062120|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
124845906|NCT00727194|449062118|FG000|Screening Period|Severe infections|0|||
124845907|NCT00727194|449062119|FG001|Screening Period|Severe infections|0|||
124845908|NCT00727194|449062120|FG002|Screening Period|Severe infections|2|||
124845909|NCT00727194|449062118|FG000|Screening Period|History of thymoma|0|||
124845910|NCT00727194|449062119|FG001|Screening Period|History of thymoma|0|||
124845911|NCT00727194|449062120|FG002|Screening Period|History of thymoma|1|||
124845912|NCT00727194|449062118|FG000|Treatment Period 2|Lack of Efficacy|0|||
124845913|NCT00727194|449062119|FG001|Treatment Period 2|Lack of Efficacy|1|||
124845914|NCT00727194|449062120|FG002|Treatment Period 2|Lack of Efficacy|0|||
124845915|NCT04269161|449062126|FG000|Overall Study|Change of modality and no longer eligible|3|||
124845916|NCT04269161|449062127|FG001|Overall Study|Change of modality and no longer eligible|3|||
124845917|NCT04269161|449062126|FG000|Overall Study|Required procedure outside of NICU|1|||
124845918|NCT04269161|449062127|FG001|Overall Study|Required procedure outside of NICU|0|||
124845919|NCT04269161|449062126|FG000|Overall Study|Equipment issue|1|||
124845920|NCT04269161|449062127|FG001|Overall Study|Equipment issue|1|||
124845921|NCT01513317|449062128|FG000|Overall Study|Withdrawal by Subject|15|||
124845922|NCT01513317|449062129|FG001|Overall Study|Withdrawal by Subject|4|||
124845923|NCT01513317|449062128|FG000|Overall Study|Death|1|||
124845924|NCT01513317|449062129|FG001|Overall Study|Death|1|||
124845925|NCT01513317|449062128|FG000|Overall Study|Study terminated by sponsor|18|||
124845926|NCT01513317|449062129|FG001|Overall Study|Study terminated by sponsor|18|||
124845927|NCT01513317|449062128|FG000|Overall Study|Other|0|||
124845928|NCT01513317|449062129|FG001|Overall Study|Other|1|||
124845929|NCT04108130|449062130|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
124845930|NCT04108130|449062131|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
124845931|NCT04108130|449062130|FG000|Overall Study|Consent Withdrawn|9|||
124845932|NCT04108130|449062131|FG001|Overall Study|Consent Withdrawn|6|||
124845933|NCT04108130|449062130|FG000|Overall Study|Surgery Cancelled|4|||
124845934|NCT04108130|449062131|FG001|Overall Study|Surgery Cancelled|4|||
124845935|NCT04108130|449062130|FG000|Overall Study|Found Ineligible for Study|4|||
124845936|NCT04108130|449062131|FG001|Overall Study|Found Ineligible for Study|3|||
124845937|NCT04108130|449062130|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
124845938|NCT04108130|449062131|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
124845939|NCT04108130|449062130|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
124845940|NCT04108130|449062131|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
124845941|NCT02610192|449062137|FG000|Overall Study|Received other treatment|8|||
124845942|NCT02610192|449062137|FG000|Overall Study|Physician Decision|1|||
124845943|NCT00279708|449062138|FG000|Overall Study|Withdrawal by Subject|2|||
124845944|NCT00279708|449062139|FG001|Overall Study|Withdrawal by Subject|3|||
124845945|NCT00279708|449062138|FG000|Overall Study|Adverse Event|1|||
124845946|NCT00279708|449062139|FG001|Overall Study|Adverse Event|1|||
124845947|NCT03354429|449062140|FG000|Overall Study|Withdrawal by Subject|8|||
124845948|NCT03354429|449062141|FG001|Overall Study|Withdrawal by Subject|7|||
124845949|NCT03354429|449062140|FG000|Overall Study|Lost to Follow-up|1|||
124845950|NCT03354429|449062141|FG001|Overall Study|Lost to Follow-up|0|||
124845951|NCT00953329|449062144|FG000|Overall Study|Lack of Efficacy|1|||
124845952|NCT01465802|449062145|FG000|Overall Study|Study terminated by sponsor|1|||
124845953|NCT01465802|449062146|FG001|Overall Study|Study terminated by sponsor|0|||
124845954|NCT01465802|449062147|FG002|Overall Study|Study terminated by sponsor|0|||
124845955|NCT01465802|449062148|FG003|Overall Study|Study terminated by sponsor|1|||
124845956|NCT01465802|449062149|FG004|Overall Study|Study terminated by sponsor|7|||
124845957|NCT01465802|449062145|FG000|Overall Study|Withdrawal by Subject|7|||
124845958|NCT01465802|449062146|FG001|Overall Study|Withdrawal by Subject|7|||
124845959|NCT01465802|449062147|FG002|Overall Study|Withdrawal by Subject|0|||
124845960|NCT01465802|449062148|FG003|Overall Study|Withdrawal by Subject|8|||
124845961|NCT01465802|449062149|FG004|Overall Study|Withdrawal by Subject|1|||
124845962|NCT01465802|449062145|FG000|Overall Study|Lost to Follow-up|1|||
124845963|NCT01465802|449062146|FG001|Overall Study|Lost to Follow-up|1|||
124845964|NCT01465802|449062147|FG002|Overall Study|Lost to Follow-up|0|||
124845965|NCT01465802|449062148|FG003|Overall Study|Lost to Follow-up|0|||
124845966|NCT01465802|449062149|FG004|Overall Study|Lost to Follow-up|0|||
124845967|NCT01465802|449062145|FG000|Overall Study|Reason not specified|9|||
124845968|NCT01465802|449062146|FG001|Overall Study|Reason not specified|4|||
124845969|NCT01465802|449062147|FG002|Overall Study|Reason not specified|0|||
124845970|NCT01465802|449062148|FG003|Overall Study|Reason not specified|10|||
124845971|NCT01465802|449062149|FG004|Overall Study|Reason not specified|2|||
124845972|NCT01465802|449062145|FG000|Overall Study|Death|15|||
124845973|NCT01465802|449062146|FG001|Overall Study|Death|12|||
124845974|NCT01465802|449062147|FG002|Overall Study|Death|0|||
124845975|NCT01465802|449062148|FG003|Overall Study|Death|10|||
124845976|NCT01465802|449062149|FG004|Overall Study|Death|2|||
124845977|NCT01340976|449062150|FG000|Overall Study|Physician Decision|2|||
124845978|NCT01340976|449062151|FG001|Overall Study|Physician Decision|0|||
124845979|NCT01340976|449062152|FG002|Overall Study|Physician Decision|1|||
124845980|NCT01340976|449062153|FG003|Overall Study|Physician Decision|1|||
124845981|NCT01340976|449062154|FG004|Overall Study|Physician Decision|1|||
124845982|NCT01340976|449062155|FG005|Overall Study|Physician Decision|0|||
124845983|NCT01340976|449062150|FG000|Overall Study|Death|0|||
124845984|NCT01340976|449062151|FG001|Overall Study|Death|1|||
124845985|NCT01340976|449062152|FG002|Overall Study|Death|0|||
124845986|NCT01340976|449062153|FG003|Overall Study|Death|0|||
124845987|NCT01340976|449062154|FG004|Overall Study|Death|0|||
124845988|NCT01340976|449062155|FG005|Overall Study|Death|0|||
124845989|NCT01340976|449062150|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
124845990|NCT01340976|449062151|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
124845991|NCT01340976|449062152|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
124845992|NCT01340976|449062153|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
124845993|NCT01340976|449062154|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
124845994|NCT01340976|449062155|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
124845995|NCT01340976|449062150|FG000|Overall Study|Withdrawal by Subject|0|||
124845996|NCT01340976|449062151|FG001|Overall Study|Withdrawal by Subject|0|||
124845997|NCT01340976|449062152|FG002|Overall Study|Withdrawal by Subject|0|||
124845998|NCT01340976|449062153|FG003|Overall Study|Withdrawal by Subject|1|||
124845999|NCT01340976|449062154|FG004|Overall Study|Withdrawal by Subject|1|||
124846000|NCT01340976|449062155|FG005|Overall Study|Withdrawal by Subject|0|||
124846001|NCT01340976|449062150|FG000|Overall Study|Other anemia treatment|1|||
124846002|NCT01340976|449062151|FG001|Overall Study|Other anemia treatment|0|||
124846003|NCT01340976|449062152|FG002|Overall Study|Other anemia treatment|2|||
124846004|NCT01340976|449062153|FG003|Overall Study|Other anemia treatment|1|||
124846005|NCT01340976|449062154|FG004|Overall Study|Other anemia treatment|0|||
124846006|NCT01340976|449062155|FG005|Overall Study|Other anemia treatment|1|||
124846007|NCT01340976|449062150|FG000|Overall Study|Adverse Event|0|||
124846008|NCT01340976|449062151|FG001|Overall Study|Adverse Event|1|||
124846009|NCT01340976|449062152|FG002|Overall Study|Adverse Event|0|||
124846010|NCT01340976|449062153|FG003|Overall Study|Adverse Event|0|||
124846011|NCT01340976|449062154|FG004|Overall Study|Adverse Event|0|||
124846012|NCT01340976|449062155|FG005|Overall Study|Adverse Event|0|||
124846013|NCT02331446|449062156|FG000|Overall Study|Lost to Follow-up|2|||
124846014|NCT02331446|449062157|FG001|Overall Study|Lost to Follow-up|1|||
124846015|NCT02331446|449062158|FG002|Overall Study|Lost to Follow-up|0|||
124846016|NCT02331446|449062159|FG003|Overall Study|Lost to Follow-up|1|||
124846017|NCT02331446|449062156|FG000|Overall Study|Personal Problem|2|||
124846018|NCT02331446|449062157|FG001|Overall Study|Personal Problem|0|||
124846019|NCT02331446|449062158|FG002|Overall Study|Personal Problem|0|||
124846020|NCT02331446|449062159|FG003|Overall Study|Personal Problem|0|||
124846021|NCT02331446|449062156|FG000|Overall Study|Disease|0|||
124846022|NCT02331446|449062157|FG001|Overall Study|Disease|2|||
124846023|NCT02331446|449062158|FG002|Overall Study|Disease|2|||
124846024|NCT02331446|449062159|FG003|Overall Study|Disease|1|||
124846025|NCT02331446|449062156|FG000|Overall Study|Physician Decision|0|||
124846026|NCT02331446|449062157|FG001|Overall Study|Physician Decision|1|||
124846027|NCT02331446|449062158|FG002|Overall Study|Physician Decision|0|||
124846028|NCT02331446|449062159|FG003|Overall Study|Physician Decision|1|||
124846029|NCT02331446|449062156|FG000|Overall Study|Lost before baseline analysis|0|||
124846030|NCT02331446|449062157|FG001|Overall Study|Lost before baseline analysis|1|||
124846031|NCT02331446|449062158|FG002|Overall Study|Lost before baseline analysis|1|||
124846032|NCT02331446|449062159|FG003|Overall Study|Lost before baseline analysis|0|||
124846033|NCT02566759|449062160|FG000|All Parts|Withdrawal by Subject|0|||
124846034|NCT02566759|449062161|FG001|All Parts|Withdrawal by Subject|1|||
124846035|NCT02566759|449062162|FG002|All Parts|Withdrawal by Subject|0|||
124846036|NCT02566759|449062163|FG003|All Parts|Withdrawal by Subject|0|||
124846037|NCT02566759|449062164|FG004|All Parts|Withdrawal by Subject|0|||
124846038|NCT02566759|449062165|FG005|All Parts|Withdrawal by Subject|0|||
124846039|NCT02566759|449062166|FG006|All Parts|Withdrawal by Subject|0|||
124846040|NCT02566759|449062167|FG007|All Parts|Withdrawal by Subject|0|||
124846041|NCT02566759|449062168|FG008|All Parts|Withdrawal by Subject|0|||
124846042|NCT02566759|449062169|FG009|All Parts|Withdrawal by Subject|0|||
124846043|NCT02566759|449062170|FG010|All Parts|Withdrawal by Subject|0|||
124846044|NCT02566759|449062171|FG011|All Parts|Withdrawal by Subject|0|||
124846045|NCT02566759|449062172|FG012|All Parts|Withdrawal by Subject|0|||
124846046|NCT02566759|449062173|FG013|All Parts|Withdrawal by Subject|0|||
124846047|NCT02566759|449062174|FG014|All Parts|Withdrawal by Subject|0|||
124846048|NCT02566759|449062175|FG015|All Parts|Withdrawal by Subject|0|||
124846049|NCT02566759|449062176|FG016|All Parts|Withdrawal by Subject|0|||
124846050|NCT02566759|449062160|FG000|All Parts|Adverse Event|0|||
124846051|NCT02566759|449062161|FG001|All Parts|Adverse Event|0|||
124846052|NCT02566759|449062162|FG002|All Parts|Adverse Event|0|||
124846053|NCT02566759|449062163|FG003|All Parts|Adverse Event|0|||
124846054|NCT02566759|449062164|FG004|All Parts|Adverse Event|0|||
124846055|NCT02566759|449062165|FG005|All Parts|Adverse Event|0|||
124846056|NCT02566759|449062166|FG006|All Parts|Adverse Event|0|||
124846057|NCT02566759|449062167|FG007|All Parts|Adverse Event|0|||
124846058|NCT02566759|449062168|FG008|All Parts|Adverse Event|0|||
124846059|NCT02566759|449062169|FG009|All Parts|Adverse Event|0|||
124846060|NCT02566759|449062170|FG010|All Parts|Adverse Event|0|||
124846061|NCT02566759|449062171|FG011|All Parts|Adverse Event|0|||
124846062|NCT02566759|449062172|FG012|All Parts|Adverse Event|1|||
124846063|NCT02566759|449062173|FG013|All Parts|Adverse Event|3|||
124846064|NCT02566759|449062174|FG014|All Parts|Adverse Event|0|||
124846065|NCT02566759|449062175|FG015|All Parts|Adverse Event|0|||
124846066|NCT02566759|449062176|FG016|All Parts|Adverse Event|0|||
124846067|NCT02566759|449062160|FG000|All Parts|Other|0|||
124846068|NCT02566759|449062161|FG001|All Parts|Other|0|||
124846069|NCT02566759|449062162|FG002|All Parts|Other|0|||
124846070|NCT02566759|449062163|FG003|All Parts|Other|0|||
124846071|NCT02566759|449062164|FG004|All Parts|Other|0|||
124846072|NCT02566759|449062165|FG005|All Parts|Other|0|||
124846073|NCT02566759|449062166|FG006|All Parts|Other|0|||
124846074|NCT02566759|449062167|FG007|All Parts|Other|0|||
124846075|NCT02566759|449062168|FG008|All Parts|Other|0|||
124846076|NCT02566759|449062169|FG009|All Parts|Other|0|||
124846077|NCT02566759|449062170|FG010|All Parts|Other|0|||
124846078|NCT02566759|449062171|FG011|All Parts|Other|0|||
124846079|NCT02566759|449062172|FG012|All Parts|Other|0|||
124846080|NCT02566759|449062173|FG013|All Parts|Other|2|||
124846081|NCT02566759|449062174|FG014|All Parts|Other|0|||
124846082|NCT02566759|449062175|FG015|All Parts|Other|0|||
124846083|NCT02566759|449062176|FG016|All Parts|Other|0|||
124846084|NCT02566759|449062160|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846085|NCT02566759|449062161|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846086|NCT02566759|449062162|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846087|NCT02566759|449062163|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846088|NCT02566759|449062164|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846089|NCT02566759|449062165|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846090|NCT02566759|449062166|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846091|NCT02566759|449062167|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846092|NCT02566759|449062168|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846093|NCT02566759|449062169|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846094|NCT02566759|449062170|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846095|NCT02566759|449062171|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846096|NCT02566759|449062172|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846097|NCT02566759|449062173|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846098|NCT02566759|449062174|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846099|NCT02566759|449062175|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846100|NCT02566759|449062176|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
124846101|NCT00226941|449062177|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
124846102|NCT00226941|449062178|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
124846103|NCT00226941|449062179|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
124846104|NCT00226941|449062180|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
124846105|NCT00226941|449062177|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
124846106|NCT00226941|449062178|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
124846107|NCT00226941|449062179|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
124846108|NCT00226941|449062180|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
124846109|NCT01513291|449062181|FG000|Treatment Period|Adverse Event|8|||
124846110|NCT01513291|449062182|FG001|Treatment Period|Adverse Event|4|||
124846111|NCT01513291|449062183|FG002|Treatment Period|Adverse Event|0|||
124846112|NCT01513291|449062184|FG003|Treatment Period|Adverse Event|0|||
124846113|NCT01513291|449062185|FG004|Treatment Period|Adverse Event|0|||
124846114|NCT01513291|449062181|FG000|Treatment Period|Lack of Efficacy|3|||
124846115|NCT01513291|449062182|FG001|Treatment Period|Lack of Efficacy|0|||
124846116|NCT01513291|449062183|FG002|Treatment Period|Lack of Efficacy|0|||
124846117|NCT01513291|449062184|FG003|Treatment Period|Lack of Efficacy|0|||
124846118|NCT01513291|449062185|FG004|Treatment Period|Lack of Efficacy|0|||
124846119|NCT01513291|449062181|FG000|Treatment Period|Lost to Follow-up|2|||
124846120|NCT01513291|449062182|FG001|Treatment Period|Lost to Follow-up|3|||
124846121|NCT01513291|449062183|FG002|Treatment Period|Lost to Follow-up|0|||
124846122|NCT01513291|449062184|FG003|Treatment Period|Lost to Follow-up|0|||
124846123|NCT01513291|449062185|FG004|Treatment Period|Lost to Follow-up|0|||
124846124|NCT01513291|449062181|FG000|Treatment Period|Physician Decision|1|||
124846125|NCT01513291|449062182|FG001|Treatment Period|Physician Decision|0|||
124846126|NCT01513291|449062183|FG002|Treatment Period|Physician Decision|0|||
124846127|NCT01513291|449062184|FG003|Treatment Period|Physician Decision|0|||
124846128|NCT01513291|449062185|FG004|Treatment Period|Physician Decision|0|||
124846129|NCT01513291|449062181|FG000|Treatment Period|Protocol Violation|1|||
124846130|NCT01513291|449062182|FG001|Treatment Period|Protocol Violation|2|||
124846131|NCT01513291|449062183|FG002|Treatment Period|Protocol Violation|0|||
124846132|NCT01513291|449062184|FG003|Treatment Period|Protocol Violation|0|||
124846133|NCT01513291|449062185|FG004|Treatment Period|Protocol Violation|0|||
124846134|NCT01513291|449062181|FG000|Treatment Period|Withdrawal by Subject|8|||
124846135|NCT01513291|449062182|FG001|Treatment Period|Withdrawal by Subject|5|||
124846136|NCT01513291|449062183|FG002|Treatment Period|Withdrawal by Subject|0|||
124846137|NCT01513291|449062184|FG003|Treatment Period|Withdrawal by Subject|0|||
124846138|NCT01513291|449062185|FG004|Treatment Period|Withdrawal by Subject|0|||
124846139|NCT01513291|449062181|FG000|Treatment Period|Randomized not treated|0|||
124846140|NCT01513291|449062182|FG001|Treatment Period|Randomized not treated|2|||
124846141|NCT01513291|449062183|FG002|Treatment Period|Randomized not treated|0|||
124846142|NCT01513291|449062184|FG003|Treatment Period|Randomized not treated|0|||
124846143|NCT01513291|449062185|FG004|Treatment Period|Randomized not treated|0|||
124846144|NCT01513291|449062181|FG000|Run-out Period|Lost to Follow-up|0|||
124846145|NCT01513291|449062182|FG001|Run-out Period|Lost to Follow-up|0|||
124846146|NCT01513291|449062183|FG002|Run-out Period|Lost to Follow-up|0|||
124846147|NCT01513291|449062184|FG003|Run-out Period|Lost to Follow-up|1|||
124846148|NCT01513291|449062185|FG004|Run-out Period|Lost to Follow-up|0|||
124846149|NCT01513291|449062181|FG000|Run-out Period|Withdrawal by Subject|0|||
124846150|NCT01513291|449062182|FG001|Run-out Period|Withdrawal by Subject|0|||
124846151|NCT01513291|449062183|FG002|Run-out Period|Withdrawal by Subject|0|||
124846152|NCT01513291|449062184|FG003|Run-out Period|Withdrawal by Subject|1|||
124846153|NCT01513291|449062185|FG004|Run-out Period|Withdrawal by Subject|0|||
124846154|NCT03732638|449062186|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
124846155|NCT03732638|449062187|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
124846156|NCT03732638|449062186|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
124846157|NCT03732638|449062187|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
124846158|NCT03732638|449062186|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
124846159|NCT03732638|449062187|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
124846160|NCT03732638|449062186|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
124846161|NCT03732638|449062187|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
124846162|NCT03732638|449062186|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
124846163|NCT03732638|449062187|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
124846164|NCT03732638|449062186|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
124846165|NCT03732638|449062187|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
124846166|NCT03732638|449062186|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
124846167|NCT03732638|449062187|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
124846168|NCT03732638|449062186|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
124846169|NCT03732638|449062187|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
124846170|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
124846171|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
124846172|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
124846173|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
124846174|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
124846175|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
124846176|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
124846177|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
124846178|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
124846179|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
124846180|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
124846181|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
124846182|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
124846183|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
124846184|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
124846185|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
124846186|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
124846187|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
124846188|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
124846189|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
124846190|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
124846191|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
124846192|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
124846193|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
124846194|NCT03732638|449062186|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
124846195|NCT03732638|449062187|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
124846196|NCT03732638|449062186|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
124846197|NCT03732638|449062187|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
124846198|NCT03732638|449062186|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
124846199|NCT03732638|449062187|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
124846200|NCT03732638|449062186|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
124846201|NCT03732638|449062187|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
124846202|NCT01358981|449062188|FG000|Period 1|Withdrawal by Subject|0|||
124846203|NCT01358981|449062189|FG001|Period 1|Withdrawal by Subject|0|||
124846204|NCT01358981|449062190|FG002|Period 1|Withdrawal by Subject|0|||
124846205|NCT01358981|449062191|FG003|Period 1|Withdrawal by Subject|1|||
124846206|NCT01358981|449062192|FG004|Period 1|Withdrawal by Subject|0|||
124846207|NCT01358981|449062193|FG005|Period 1|Withdrawal by Subject|0|||
124846208|NCT01358981|449062194|FG006|Period 1|Withdrawal by Subject|0|||
124846209|NCT03728582|449062195|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
124846210|NCT03728582|449062196|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
124846211|NCT03728582|449062195|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
124846212|NCT03728582|449062196|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
124846213|NCT01034397|449062197|FG000|Overall Study|Lack of compliance|0|||
124846214|NCT01034397|449062198|FG001|Overall Study|Lack of compliance|1|||
124846215|NCT01034397|449062197|FG000|Overall Study|Lack of Efficacy|3|||
124846216|NCT01034397|449062198|FG001|Overall Study|Lack of Efficacy|0|||
124846217|NCT01034397|449062197|FG000|Overall Study|Adverse Event|4|||
124846218|NCT01034397|449062198|FG001|Overall Study|Adverse Event|0|||
124846219|NCT01034397|449062197|FG000|Overall Study|Other|0|||
124846220|NCT01034397|449062198|FG001|Overall Study|Other|1|||
124846221|NCT01018264|449062199|FG000|Overall Study|Withdrawal by Subject|1|||
124846222|NCT01018264|449062200|FG001|Overall Study|Withdrawal by Subject|0|||
124846223|NCT01018264|449062199|FG000|Overall Study|Lost to Follow-up|0|||
124846224|NCT01018264|449062200|FG001|Overall Study|Lost to Follow-up|1|||
124846225|NCT01785524|449062201|FG000|Overall Study|Withdrawal by Subject|2|||
124846226|NCT01785524|449062202|FG001|Overall Study|Withdrawal by Subject|2|||
124846227|NCT03217136|449062207|FG000|Overall Study|Lost to Follow-up|2|||
124846228|NCT03217136|449062208|FG001|Overall Study|Lost to Follow-up|1|||
124846229|NCT03217136|449062207|FG000|Overall Study|Site Randomized Participant in Error|0|||
124846230|NCT03217136|449062208|FG001|Overall Study|Site Randomized Participant in Error|1|||
124846231|NCT03217136|449062207|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
124846232|NCT03217136|449062208|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
124846233|NCT03217136|449062207|FG000|Overall Study|Dispensing Error|1|||
124846234|NCT03217136|449062208|FG001|Overall Study|Dispensing Error|0|||
124846235|NCT03217136|449062207|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
124846236|NCT03217136|449062208|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124846237|NCT03670810|449062211|FG000|Main Study|Adverse Event|37|||
124846238|NCT03670810|449062212|FG001|Main Study|Adverse Event|38|||
124846239|NCT03670810|449062213|FG002|Main Study|Adverse Event|3|||
124846240|NCT03670810|449062214|FG003|Main Study|Adverse Event|4|||
124846241|NCT03670810|449062215|FG004|Main Study|Adverse Event|4|||
124846242|NCT03670810|449062216|FG005|Main Study|Adverse Event|5|||
124846243|NCT03670810|449062217|FG006|Main Study|Adverse Event|0|||
124846244|NCT03670810|449062218|FG007|Main Study|Adverse Event|0|||
124846245|NCT03670810|449062219|FG008|Main Study|Adverse Event|0|||
124846246|NCT03670810|449062211|FG000|Main Study|Lack of Efficacy|8|||
124846247|NCT03670810|449062212|FG001|Main Study|Lack of Efficacy|9|||
124846248|NCT03670810|449062213|FG002|Main Study|Lack of Efficacy|3|||
124846249|NCT03670810|449062214|FG003|Main Study|Lack of Efficacy|4|||
124846250|NCT03670810|449062215|FG004|Main Study|Lack of Efficacy|0|||
124846251|NCT03670810|449062216|FG005|Main Study|Lack of Efficacy|0|||
124846252|NCT03670810|449062217|FG006|Main Study|Lack of Efficacy|0|||
124846253|NCT03670810|449062218|FG007|Main Study|Lack of Efficacy|0|||
124846254|NCT03670810|449062219|FG008|Main Study|Lack of Efficacy|0|||
124846255|NCT03670810|449062211|FG000|Main Study|Lost to Follow-up|9|||
124846256|NCT03670810|449062212|FG001|Main Study|Lost to Follow-up|7|||
124846257|NCT03670810|449062213|FG002|Main Study|Lost to Follow-up|4|||
124846258|NCT03670810|449062214|FG003|Main Study|Lost to Follow-up|6|||
124846259|NCT03670810|449062215|FG004|Main Study|Lost to Follow-up|1|||
124846260|NCT03670810|449062216|FG005|Main Study|Lost to Follow-up|0|||
124846261|NCT03670810|449062217|FG006|Main Study|Lost to Follow-up|0|||
124846262|NCT03670810|449062218|FG007|Main Study|Lost to Follow-up|0|||
124846263|NCT03670810|449062219|FG008|Main Study|Lost to Follow-up|0|||
124846264|NCT03670810|449062211|FG000|Main Study|Non-compliance with Study Drug|0|||
124846265|NCT03670810|449062212|FG001|Main Study|Non-compliance with Study Drug|2|||
124846266|NCT03670810|449062213|FG002|Main Study|Non-compliance with Study Drug|3|||
124846267|NCT03670810|449062214|FG003|Main Study|Non-compliance with Study Drug|0|||
124846268|NCT03670810|449062215|FG004|Main Study|Non-compliance with Study Drug|0|||
124846269|NCT03670810|449062216|FG005|Main Study|Non-compliance with Study Drug|0|||
124846270|NCT03670810|449062217|FG006|Main Study|Non-compliance with Study Drug|0|||
124846271|NCT03670810|449062218|FG007|Main Study|Non-compliance with Study Drug|1|||
124846272|NCT03670810|449062219|FG008|Main Study|Non-compliance with Study Drug|0|||
124846273|NCT03670810|449062211|FG000|Main Study|Physician Decision|3|||
124846274|NCT03670810|449062212|FG001|Main Study|Physician Decision|0|||
124846275|NCT03670810|449062213|FG002|Main Study|Physician Decision|1|||
124846276|NCT03670810|449062214|FG003|Main Study|Physician Decision|0|||
124846277|NCT03670810|449062215|FG004|Main Study|Physician Decision|0|||
124846278|NCT03670810|449062216|FG005|Main Study|Physician Decision|0|||
124846279|NCT03670810|449062217|FG006|Main Study|Physician Decision|1|||
124846280|NCT03670810|449062218|FG007|Main Study|Physician Decision|1|||
124846281|NCT03670810|449062219|FG008|Main Study|Physician Decision|0|||
124846282|NCT03670810|449062211|FG000|Main Study|Pregnancy|1|||
124846283|NCT03670810|449062212|FG001|Main Study|Pregnancy|2|||
124846284|NCT03670810|449062213|FG002|Main Study|Pregnancy|0|||
124846285|NCT03670810|449062214|FG003|Main Study|Pregnancy|0|||
124846286|NCT03670810|449062215|FG004|Main Study|Pregnancy|0|||
124846287|NCT03670810|449062216|FG005|Main Study|Pregnancy|0|||
124846288|NCT03670810|449062217|FG006|Main Study|Pregnancy|0|||
124846289|NCT03670810|449062218|FG007|Main Study|Pregnancy|0|||
124846290|NCT03670810|449062219|FG008|Main Study|Pregnancy|0|||
124846291|NCT03670810|449062211|FG000|Main Study|Protocol Deviation|2|||
124846292|NCT03670810|449062212|FG001|Main Study|Protocol Deviation|12|||
124846293|NCT03670810|449062213|FG002|Main Study|Protocol Deviation|8|||
124846294|NCT03670810|449062214|FG003|Main Study|Protocol Deviation|4|||
124846295|NCT03670810|449062215|FG004|Main Study|Protocol Deviation|0|||
124846296|NCT03670810|449062216|FG005|Main Study|Protocol Deviation|0|||
124846297|NCT03670810|449062217|FG006|Main Study|Protocol Deviation|0|||
124846298|NCT03670810|449062218|FG007|Main Study|Protocol Deviation|0|||
124846299|NCT03670810|449062219|FG008|Main Study|Protocol Deviation|0|||
124846300|NCT03670810|449062211|FG000|Main Study|Withdrawal by Subject|21|||
124846301|NCT03670810|449062212|FG001|Main Study|Withdrawal by Subject|21|||
124846302|NCT03670810|449062213|FG002|Main Study|Withdrawal by Subject|8|||
124846303|NCT03670810|449062214|FG003|Main Study|Withdrawal by Subject|9|||
124846304|NCT03670810|449062215|FG004|Main Study|Withdrawal by Subject|5|||
124846305|NCT03670810|449062216|FG005|Main Study|Withdrawal by Subject|2|||
124846306|NCT03670810|449062217|FG006|Main Study|Withdrawal by Subject|1|||
124846307|NCT03670810|449062218|FG007|Main Study|Withdrawal by Subject|1|||
124846308|NCT03670810|449062219|FG008|Main Study|Withdrawal by Subject|0|||
124846309|NCT03670810|449062211|FG000|Main Study|Participant did not want to take the three other treatments|1|||
124846310|NCT03670810|449062212|FG001|Main Study|Participant did not want to take the three other treatments|0|||
124846311|NCT03670810|449062213|FG002|Main Study|Participant did not want to take the three other treatments|0|||
124846312|NCT03670810|449062214|FG003|Main Study|Participant did not want to take the three other treatments|0|||
124846313|NCT03670810|449062215|FG004|Main Study|Participant did not want to take the three other treatments|0|||
124846314|NCT03670810|449062216|FG005|Main Study|Participant did not want to take the three other treatments|0|||
124846315|NCT03670810|449062217|FG006|Main Study|Participant did not want to take the three other treatments|0|||
124846316|NCT03670810|449062218|FG007|Main Study|Participant did not want to take the three other treatments|0|||
124846317|NCT03670810|449062219|FG008|Main Study|Participant did not want to take the three other treatments|0|||
124846318|NCT03670810|449062211|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
124846319|NCT03670810|449062212|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
124846320|NCT03670810|449062213|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
124846321|NCT03670810|449062214|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
124846322|NCT03670810|449062215|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
124846323|NCT03670810|449062216|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
124846324|NCT03670810|449062217|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
124846325|NCT03670810|449062218|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
124846326|NCT03670810|449062219|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
124846327|NCT03670810|449062211|FG000|Main Study|Travel and Coronavirus issues|0|||
124846328|NCT03670810|449062212|FG001|Main Study|Travel and Coronavirus issues|0|||
124846329|NCT03670810|449062213|FG002|Main Study|Travel and Coronavirus issues|0|||
124846330|NCT03670810|449062214|FG003|Main Study|Travel and Coronavirus issues|1|||
124846331|NCT03670810|449062215|FG004|Main Study|Travel and Coronavirus issues|0|||
124846332|NCT03670810|449062216|FG005|Main Study|Travel and Coronavirus issues|0|||
124846333|NCT03670810|449062217|FG006|Main Study|Travel and Coronavirus issues|0|||
124846334|NCT03670810|449062218|FG007|Main Study|Travel and Coronavirus issues|0|||
124846335|NCT03670810|449062219|FG008|Main Study|Travel and Coronavirus issues|0|||
124846336|NCT03670810|449062211|FG000|Open Label Extension|Protocol Deviation|0|||
124846337|NCT03670810|449062212|FG001|Open Label Extension|Protocol Deviation|0|||
124846338|NCT03670810|449062213|FG002|Open Label Extension|Protocol Deviation|0|||
124846339|NCT03670810|449062214|FG003|Open Label Extension|Protocol Deviation|0|||
124846340|NCT03670810|449062215|FG004|Open Label Extension|Protocol Deviation|0|||
124846341|NCT03670810|449062216|FG005|Open Label Extension|Protocol Deviation|0|||
124846342|NCT03670810|449062217|FG006|Open Label Extension|Protocol Deviation|0|||
124846343|NCT03670810|449062218|FG007|Open Label Extension|Protocol Deviation|0|||
124846344|NCT03670810|449062219|FG008|Open Label Extension|Protocol Deviation|5|||
124846345|NCT03670810|449062211|FG000|Open Label Extension|Death|0|||
124846346|NCT03670810|449062212|FG001|Open Label Extension|Death|0|||
124846347|NCT03670810|449062213|FG002|Open Label Extension|Death|0|||
124846348|NCT03670810|449062214|FG003|Open Label Extension|Death|0|||
124846349|NCT03670810|449062215|FG004|Open Label Extension|Death|0|||
124846350|NCT03670810|449062216|FG005|Open Label Extension|Death|0|||
124846351|NCT03670810|449062217|FG006|Open Label Extension|Death|0|||
124846352|NCT03670810|449062218|FG007|Open Label Extension|Death|0|||
124846353|NCT03670810|449062219|FG008|Open Label Extension|Death|1|||
124846354|NCT03670810|449062211|FG000|Open Label Extension|COVID-19|0|||
124846355|NCT03670810|449062212|FG001|Open Label Extension|COVID-19|0|||
124846356|NCT03670810|449062213|FG002|Open Label Extension|COVID-19|0|||
124846357|NCT03670810|449062214|FG003|Open Label Extension|COVID-19|0|||
124846358|NCT03670810|449062215|FG004|Open Label Extension|COVID-19|0|||
124846359|NCT03670810|449062216|FG005|Open Label Extension|COVID-19|0|||
124846360|NCT03670810|449062217|FG006|Open Label Extension|COVID-19|0|||
124846361|NCT03670810|449062218|FG007|Open Label Extension|COVID-19|0|||
124846362|NCT03670810|449062219|FG008|Open Label Extension|COVID-19|1|||
124846363|NCT03670810|449062211|FG000|Open Label Extension|Lack of Efficacy|0|||
124846364|NCT03670810|449062212|FG001|Open Label Extension|Lack of Efficacy|0|||
124846365|NCT03670810|449062213|FG002|Open Label Extension|Lack of Efficacy|0|||
124846366|NCT03670810|449062214|FG003|Open Label Extension|Lack of Efficacy|0|||
124846367|NCT03670810|449062215|FG004|Open Label Extension|Lack of Efficacy|0|||
124846368|NCT03670810|449062216|FG005|Open Label Extension|Lack of Efficacy|0|||
124846369|NCT03670810|449062217|FG006|Open Label Extension|Lack of Efficacy|0|||
124846370|NCT03670810|449062218|FG007|Open Label Extension|Lack of Efficacy|0|||
124846371|NCT03670810|449062219|FG008|Open Label Extension|Lack of Efficacy|39|||
124846372|NCT03670810|449062211|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
124846373|NCT03670810|449062212|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
124846374|NCT03670810|449062213|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
124846375|NCT03670810|449062214|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
124846376|NCT03670810|449062215|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
124846377|NCT03670810|449062216|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
124846378|NCT03670810|449062217|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
124846379|NCT03670810|449062218|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
124846380|NCT03670810|449062219|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
124846381|NCT03670810|449062211|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
124846382|NCT03670810|449062212|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
124846383|NCT03670810|449062213|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
124846384|NCT03670810|449062214|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
125306397|NCT02737475|450749018|FG014|Overall Study|Participant withdrew consent|1|||
125306398|NCT02737475|450749019|FG015|Overall Study|Participant withdrew consent|0|||
124846385|NCT03670810|449062215|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
124846386|NCT03670810|449062216|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
124846387|NCT03670810|449062217|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
124846388|NCT03670810|449062218|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
124846389|NCT03670810|449062219|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
124846390|NCT03670810|449062211|FG000|Open Label Extension|Withdrawal by Subject|0|||
124846391|NCT03670810|449062212|FG001|Open Label Extension|Withdrawal by Subject|0|||
124846392|NCT03670810|449062213|FG002|Open Label Extension|Withdrawal by Subject|0|||
124846393|NCT03670810|449062214|FG003|Open Label Extension|Withdrawal by Subject|0|||
124846394|NCT03670810|449062215|FG004|Open Label Extension|Withdrawal by Subject|0|||
124846395|NCT03670810|449062216|FG005|Open Label Extension|Withdrawal by Subject|0|||
124846396|NCT03670810|449062217|FG006|Open Label Extension|Withdrawal by Subject|0|||
124846397|NCT03670810|449062218|FG007|Open Label Extension|Withdrawal by Subject|0|||
124846398|NCT03670810|449062219|FG008|Open Label Extension|Withdrawal by Subject|46|||
124846399|NCT03670810|449062211|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
125306399|NCT02737475|450749020|FG016|Overall Study|Participant withdrew consent|0|||
124846400|NCT03670810|449062212|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
124846401|NCT03670810|449062213|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
124846402|NCT03670810|449062214|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
124846403|NCT03670810|449062215|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
124846404|NCT03670810|449062216|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
124846405|NCT03670810|449062217|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
124846406|NCT03670810|449062218|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
124846407|NCT03670810|449062219|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
124846408|NCT03670810|449062211|FG000|Open Label Extension|Physician Decision|0|||
124846409|NCT03670810|449062212|FG001|Open Label Extension|Physician Decision|0|||
124846410|NCT03670810|449062213|FG002|Open Label Extension|Physician Decision|0|||
124846411|NCT03670810|449062214|FG003|Open Label Extension|Physician Decision|0|||
124846412|NCT03670810|449062215|FG004|Open Label Extension|Physician Decision|0|||
124846413|NCT03670810|449062216|FG005|Open Label Extension|Physician Decision|0|||
124846414|NCT03670810|449062217|FG006|Open Label Extension|Physician Decision|0|||
124846415|NCT03670810|449062218|FG007|Open Label Extension|Physician Decision|0|||
124846416|NCT03670810|449062219|FG008|Open Label Extension|Physician Decision|2|||
124846417|NCT03670810|449062211|FG000|Open Label Extension|Non-compliance with study drug|0|||
124846418|NCT03670810|449062212|FG001|Open Label Extension|Non-compliance with study drug|0|||
124846419|NCT03670810|449062213|FG002|Open Label Extension|Non-compliance with study drug|0|||
124846420|NCT03670810|449062214|FG003|Open Label Extension|Non-compliance with study drug|0|||
124846421|NCT03670810|449062215|FG004|Open Label Extension|Non-compliance with study drug|0|||
124846422|NCT03670810|449062216|FG005|Open Label Extension|Non-compliance with study drug|0|||
124846423|NCT03670810|449062217|FG006|Open Label Extension|Non-compliance with study drug|0|||
124846424|NCT03670810|449062218|FG007|Open Label Extension|Non-compliance with study drug|0|||
124846425|NCT03670810|449062219|FG008|Open Label Extension|Non-compliance with study drug|5|||
124846426|NCT03670810|449062211|FG000|Open Label Extension|Pregnancy|0|||
124846427|NCT03670810|449062212|FG001|Open Label Extension|Pregnancy|0|||
124846428|NCT03670810|449062213|FG002|Open Label Extension|Pregnancy|0|||
124846429|NCT03670810|449062214|FG003|Open Label Extension|Pregnancy|0|||
124846430|NCT03670810|449062215|FG004|Open Label Extension|Pregnancy|0|||
124846431|NCT03670810|449062216|FG005|Open Label Extension|Pregnancy|0|||
124846432|NCT03670810|449062217|FG006|Open Label Extension|Pregnancy|0|||
124846433|NCT03670810|449062218|FG007|Open Label Extension|Pregnancy|0|||
124846434|NCT03670810|449062219|FG008|Open Label Extension|Pregnancy|3|||
124846435|NCT03670810|449062211|FG000|Open Label Extension|Adverse Event|0|||
124846436|NCT03670810|449062212|FG001|Open Label Extension|Adverse Event|0|||
124846437|NCT03670810|449062213|FG002|Open Label Extension|Adverse Event|0|||
124846438|NCT03670810|449062214|FG003|Open Label Extension|Adverse Event|0|||
124846439|NCT03670810|449062215|FG004|Open Label Extension|Adverse Event|0|||
124846440|NCT03670810|449062216|FG005|Open Label Extension|Adverse Event|0|||
124846441|NCT03670810|449062217|FG006|Open Label Extension|Adverse Event|0|||
124846442|NCT03670810|449062218|FG007|Open Label Extension|Adverse Event|0|||
124846443|NCT03670810|449062219|FG008|Open Label Extension|Adverse Event|24|||
124846444|NCT03670810|449062211|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
124846445|NCT03670810|449062212|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
124846446|NCT03670810|449062213|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
124846447|NCT03670810|449062214|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
124846448|NCT03670810|449062215|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
124846449|NCT03670810|449062216|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
124846450|NCT03670810|449062217|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
124846451|NCT03670810|449062218|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
124846452|NCT03670810|449062219|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
124846453|NCT03670810|449062211|FG000|Open Label Extension|Lost to Follow-up|0|||
124846454|NCT03670810|449062212|FG001|Open Label Extension|Lost to Follow-up|0|||
124846455|NCT03670810|449062213|FG002|Open Label Extension|Lost to Follow-up|0|||
124846456|NCT03670810|449062214|FG003|Open Label Extension|Lost to Follow-up|0|||
124846457|NCT03670810|449062215|FG004|Open Label Extension|Lost to Follow-up|0|||
124846458|NCT03670810|449062216|FG005|Open Label Extension|Lost to Follow-up|0|||
124846459|NCT03670810|449062217|FG006|Open Label Extension|Lost to Follow-up|0|||
124846460|NCT03670810|449062218|FG007|Open Label Extension|Lost to Follow-up|0|||
124846461|NCT03670810|449062219|FG008|Open Label Extension|Lost to Follow-up|23|||
124846462|NCT03192150|449062220|FG000|Overall Study|Adverse Event|14|||
124846463|NCT03192150|449062221|FG001|Overall Study|Adverse Event|12|||
124846464|NCT03192150|449062220|FG000|Overall Study|Lack of Efficacy|23|||
124846465|NCT03192150|449062221|FG001|Overall Study|Lack of Efficacy|30|||
124846466|NCT03192150|449062220|FG000|Overall Study|Lost to Follow-up|1|||
124846467|NCT03192150|449062221|FG001|Overall Study|Lost to Follow-up|1|||
124846468|NCT03192150|449062220|FG000|Overall Study|Withdrawal by Subject|4|||
124846469|NCT03192150|449062221|FG001|Overall Study|Withdrawal by Subject|2|||
124846470|NCT03192150|449062220|FG000|Overall Study|Protocol Violation|5|||
124846471|NCT03192150|449062221|FG001|Overall Study|Protocol Violation|2|||
124846472|NCT03192150|449062220|FG000|Overall Study|Surgery Canceled|6|||
124846473|NCT03192150|449062221|FG001|Overall Study|Surgery Canceled|2|||
124846474|NCT03192150|449062220|FG000|Overall Study|Other-Various Administrative Reasons|2|||
124846475|NCT03192150|449062221|FG001|Overall Study|Other-Various Administrative Reasons|5|||
124846476|NCT02579616|449062222|FG000|Overall Study|Participants did not receive treatment|3|||
124846477|NCT00482391|449062223|FG000|Overall Study|Withdrawal by Subject|1|||
124846478|NCT00482391|449062223|FG000|Overall Study|Adverse Event|1|||
124846479|NCT00482391|449062223|FG000|Overall Study|Death|1|||
124846480|NCT01350128|449062238|FG000|Overall Study|Withdrawal by Subject|3|||
124846481|NCT01350128|449062238|FG000|Overall Study|Protocol discontinuation criteria|8|||
124846482|NCT01350128|449062238|FG000|Overall Study|Physician Decision|1|||
124846483|NCT01350128|449062238|FG000|Overall Study|Lost to Follow-up|2|||
124846484|NCT02644967|449062244|FG000|Overall Study|Death|26|||
124846485|NCT02644967|449062244|FG000|Overall Study|Physician Decision|1|||
124846486|NCT02644967|449062244|FG000|Overall Study|Withdrawal by Subject|2|||
124846487|NCT02644967|449062244|FG000|Overall Study|Protocol Violation|1|||
124846488|NCT02644967|449062244|FG000|Overall Study|Progressive Disease|1|||
124846489|NCT02644967|449062244|FG000|Overall Study|Study Terminated by Sponsor|4|||
124846490|NCT03323099|449062246|FG000|Overall Study|Withdrawal by Subject|6|||
124846491|NCT03323099|449062247|FG001|Overall Study|Withdrawal by Subject|12|||
124846492|NCT03323099|449062246|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
124846493|NCT03323099|449062247|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
124846494|NCT03254134|449062252|FG000|Overall Study|Not eligible patients|599|||
124846495|NCT03254134|449062253|FG001|Overall Study|Not eligible patients|3630|||
124846496|NCT00806546|449062254|FG000|Overall Study|Enrolled, not treated|35|||
124846497|NCT00806546|449062254|FG000|Overall Study|Lost to Follow-up|32|||
124846498|NCT00806546|449062254|FG000|Overall Study|Adverse Event|74|||
124846499|NCT00806546|449062254|FG000|Overall Study|Withdrawal by Subject|75|||
124846500|NCT00806546|449062254|FG000|Overall Study|Protocol Violation|49|||
124846501|NCT00806546|449062254|FG000|Overall Study|Various|42|||
124846502|NCT01247090|449062255|FG000|Overall Study|Physician Decision|1|||
124846503|NCT01247090|449062256|FG001|Overall Study|Physician Decision|0|||
124846504|NCT01247090|449062257|FG002|Overall Study|Physician Decision|0|||
124846505|NCT01247090|449062255|FG000|Overall Study|Withdrawal by Subject|0|||
124846506|NCT01247090|449062256|FG001|Overall Study|Withdrawal by Subject|1|||
124846507|NCT01247090|449062257|FG002|Overall Study|Withdrawal by Subject|0|||
124846508|NCT03385239|449062261|FG000|Overall Study|Voluntary Withdrawal|2|||
124846509|NCT03385239|449062262|FG001|Overall Study|Voluntary Withdrawal|3|||
124846510|NCT03385239|449062263|FG002|Overall Study|Voluntary Withdrawal|2|||
124846511|NCT03385239|449062264|FG003|Overall Study|Voluntary Withdrawal|3|||
124846512|NCT03385239|449062265|FG004|Overall Study|Voluntary Withdrawal|0|||
124846513|NCT03385239|449062261|FG000|Overall Study|Adverse Event|0|||
124846514|NCT03385239|449062262|FG001|Overall Study|Adverse Event|0|||
124846515|NCT03385239|449062263|FG002|Overall Study|Adverse Event|1|||
124846516|NCT03385239|449062264|FG003|Overall Study|Adverse Event|0|||
124846517|NCT03385239|449062265|FG004|Overall Study|Adverse Event|0|||
124846518|NCT03385239|449062261|FG000|Overall Study|Other|0|||
124846519|NCT03385239|449062262|FG001|Overall Study|Other|0|||
124846520|NCT03385239|449062263|FG002|Overall Study|Other|0|||
124846521|NCT03385239|449062264|FG003|Overall Study|Other|1|||
124846522|NCT03385239|449062265|FG004|Overall Study|Other|0|||
124846523|NCT01574703|449062266|FG000|Overall Study|Adverse Event|0|||
124846524|NCT01574703|449062267|FG001|Overall Study|Adverse Event|2|||
124846525|NCT01574703|449062268|FG002|Overall Study|Adverse Event|1|||
124846526|NCT01574703|449062269|FG003|Overall Study|Adverse Event|1|||
124846527|NCT01574703|449062266|FG000|Overall Study|Protocol Violation|0|||
124846528|NCT01574703|449062267|FG001|Overall Study|Protocol Violation|0|||
125306400|NCT02737475|450749021|FG017|Overall Study|Participant withdrew consent|2|||
124846529|NCT01574703|449062268|FG002|Overall Study|Protocol Violation|0|||
124846530|NCT01574703|449062269|FG003|Overall Study|Protocol Violation|1|||
124846531|NCT01574703|449062266|FG000|Overall Study|Unspecified Reason|27|||
124846532|NCT01574703|449062267|FG001|Overall Study|Unspecified Reason|15|||
124846533|NCT01574703|449062268|FG002|Overall Study|Unspecified Reason|20|||
124846534|NCT01574703|449062269|FG003|Overall Study|Unspecified Reason|16|||
124846535|NCT01574703|449062266|FG000|Overall Study|Withdrawal by Subject|53|||
124846536|NCT01574703|449062267|FG001|Overall Study|Withdrawal by Subject|52|||
124846537|NCT01574703|449062268|FG002|Overall Study|Withdrawal by Subject|36|||
124846538|NCT01574703|449062269|FG003|Overall Study|Withdrawal by Subject|61|||
125306401|NCT02737475|450749022|FG018|Overall Study|Participant withdrew consent|1|||
124846539|NCT01574703|449062266|FG000|Overall Study|Met Withdrawal Criteria|0|||
124846540|NCT01574703|449062267|FG001|Overall Study|Met Withdrawal Criteria|1|||
124846541|NCT01574703|449062268|FG002|Overall Study|Met Withdrawal Criteria|1|||
124846542|NCT01574703|449062269|FG003|Overall Study|Met Withdrawal Criteria|0|||
124846543|NCT01574703|449062266|FG000|Overall Study|Lost to Follow-up|43|||
124846544|NCT01574703|449062267|FG001|Overall Study|Lost to Follow-up|41|||
124846545|NCT01574703|449062268|FG002|Overall Study|Lost to Follow-up|46|||
125306402|NCT02737475|450749023|FG019|Overall Study|Participant withdrew consent|0|||
124846546|NCT01574703|449062269|FG003|Overall Study|Lost to Follow-up|35|||
124846547|NCT01574703|449062266|FG000|Overall Study|Death|2|||
124846548|NCT01574703|449062267|FG001|Overall Study|Death|1|||
124846549|NCT01574703|449062268|FG002|Overall Study|Death|1|||
124846550|NCT01574703|449062269|FG003|Overall Study|Death|0|||
124846551|NCT00813358|449062272|FG000|Overall Study|Death|32|||
124846552|NCT00813358|449062272|FG000|Overall Study|Lost to Follow-up|12|||
124846553|NCT00813358|449062272|FG000|Overall Study|other endpoints|5|||
124846554|NCT00813358|449062272|FG000|Overall Study|Withdrawal by Subject|20|||
124846555|NCT01282216|449062273|FG000|Overall Study|Graft failure|0|||
124846556|NCT01282216|449062274|FG001|Overall Study|Graft failure|0|||
124846557|NCT01282216|449062275|FG002|Overall Study|Graft failure|3|||
124846558|NCT01282216|449062276|FG003|Overall Study|Graft failure|2|||
124846559|NCT01282216|449062273|FG000|Overall Study|Physician Decision|0|||
124846560|NCT01282216|449062274|FG001|Overall Study|Physician Decision|0|||
124846561|NCT01282216|449062275|FG002|Overall Study|Physician Decision|11|||
124846562|NCT01282216|449062276|FG003|Overall Study|Physician Decision|0|||
124846563|NCT01282216|449062273|FG000|Overall Study|Relapse|0|||
124846564|NCT01282216|449062274|FG001|Overall Study|Relapse|0|||
124846565|NCT01282216|449062275|FG002|Overall Study|Relapse|17|||
124846566|NCT01282216|449062276|FG003|Overall Study|Relapse|6|||
124846567|NCT01282216|449062273|FG000|Overall Study|Death|0|||
124846568|NCT01282216|449062274|FG001|Overall Study|Death|0|||
124846569|NCT01282216|449062275|FG002|Overall Study|Death|2|||
124846570|NCT01282216|449062276|FG003|Overall Study|Death|0|||
124846571|NCT03851016|449062277|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
124846572|NCT03851016|449062278|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
124846573|NCT03080961|449062279|FG000|Overall Study|Withdrawal by Subject|3|||
124846574|NCT03878134|449062280|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
124846575|NCT00586469|449062281|FG000|Overall Study|Adverse Event|0|||
124846576|NCT00586469|449062282|FG001|Overall Study|Adverse Event|1|||
124846577|NCT02908529|449062284|FG000|Overall Study|Lost to Follow-up|0|||
124846578|NCT02908529|449062285|FG001|Overall Study|Lost to Follow-up|2|||
124846579|NCT03337724|449062288|FG000|Overall Study|Reason not Specified|12|||
124846580|NCT03337724|449062289|FG001|Overall Study|Reason not Specified|21|||
124846581|NCT03337724|449062290|FG002|Overall Study|Reason not Specified|9|||
124846582|NCT03337724|449062291|FG003|Overall Study|Reason not Specified|9|||
124846583|NCT03337724|449062292|FG004|Overall Study|Reason not Specified|29|||
124846584|NCT03337724|449062288|FG000|Overall Study|Withdrawal by Subject|13|||
124846585|NCT03337724|449062289|FG001|Overall Study|Withdrawal by Subject|15|||
124846586|NCT03337724|449062290|FG002|Overall Study|Withdrawal by Subject|4|||
124846587|NCT03337724|449062291|FG003|Overall Study|Withdrawal by Subject|15|||
124846588|NCT03337724|449062292|FG004|Overall Study|Withdrawal by Subject|6|||
124846589|NCT03337724|449062288|FG000|Overall Study|Protocol Deviation|0|||
124846590|NCT03337724|449062289|FG001|Overall Study|Protocol Deviation|1|||
124846591|NCT03337724|449062290|FG002|Overall Study|Protocol Deviation|1|||
124846592|NCT03337724|449062291|FG003|Overall Study|Protocol Deviation|1|||
124846593|NCT03337724|449062292|FG004|Overall Study|Protocol Deviation|0|||
124846594|NCT03337724|449062288|FG000|Overall Study|Adverse Event|1|||
124846595|NCT03337724|449062289|FG001|Overall Study|Adverse Event|1|||
124846596|NCT03337724|449062290|FG002|Overall Study|Adverse Event|0|||
124846597|NCT03337724|449062291|FG003|Overall Study|Adverse Event|1|||
124846598|NCT03337724|449062292|FG004|Overall Study|Adverse Event|0|||
124846599|NCT03337724|449062288|FG000|Overall Study|Death|40|||
124846600|NCT03337724|449062289|FG001|Overall Study|Death|89|||
124846601|NCT03337724|449062290|FG002|Overall Study|Death|43|||
124846602|NCT03337724|449062291|FG003|Overall Study|Death|76|||
124846603|NCT03337724|449062292|FG004|Overall Study|Death|50|||
124846604|NCT03337724|449062288|FG000|Overall Study|Lost to Follow-up|5|||
124846605|NCT03337724|449062289|FG001|Overall Study|Lost to Follow-up|5|||
124846606|NCT03337724|449062290|FG002|Overall Study|Lost to Follow-up|4|||
124846607|NCT03337724|449062291|FG003|Overall Study|Lost to Follow-up|7|||
124846608|NCT03337724|449062292|FG004|Overall Study|Lost to Follow-up|4|||
124846609|NCT03337724|449062288|FG000|Overall Study|Physician Decision|16|||
124846610|NCT03337724|449062289|FG001|Overall Study|Physician Decision|34|||
124846611|NCT03337724|449062290|FG002|Overall Study|Physician Decision|14|||
124846612|NCT03337724|449062291|FG003|Overall Study|Physician Decision|34|||
124846613|NCT03337724|449062292|FG004|Overall Study|Physician Decision|13|||
124846614|NCT03337724|449062288|FG000|Overall Study|Progressive Disease|0|||
124846615|NCT03337724|449062289|FG001|Overall Study|Progressive Disease|2|||
124846616|NCT03337724|449062290|FG002|Overall Study|Progressive Disease|1|||
124846617|NCT03337724|449062291|FG003|Overall Study|Progressive Disease|2|||
124846618|NCT03337724|449062292|FG004|Overall Study|Progressive Disease|0|||
124846619|NCT03337724|449062288|FG000|Overall Study|Symptomatic Deterioration|0|||
124846620|NCT03337724|449062289|FG001|Overall Study|Symptomatic Deterioration|0|||
124846621|NCT03337724|449062290|FG002|Overall Study|Symptomatic Deterioration|0|||
124846622|NCT03337724|449062291|FG003|Overall Study|Symptomatic Deterioration|1|||
124846623|NCT03337724|449062292|FG004|Overall Study|Symptomatic Deterioration|0|||
124846624|NCT03551210|449062293|FG000|Overall Study|Adverse Event|5|||
124846625|NCT03551210|449062294|FG001|Overall Study|Adverse Event|6|||
124846626|NCT03551210|449062293|FG000|Overall Study|Withdrawal by Subject|1|||
124846627|NCT03551210|449062294|FG001|Overall Study|Withdrawal by Subject|7|||
124846628|NCT03551210|449062293|FG000|Overall Study|Needed in other antibiotic treatment|2|||
124846629|NCT03551210|449062294|FG001|Overall Study|Needed in other antibiotic treatment|5|||
124846630|NCT03551210|449062293|FG000|Overall Study|Lost to Follow-up|1|||
124846631|NCT03551210|449062294|FG001|Overall Study|Lost to Follow-up|1|||
124846632|NCT03551210|449062293|FG000|Overall Study|Absence of visit 4 and 5|1|||
124846633|NCT03551210|449062294|FG001|Overall Study|Absence of visit 4 and 5|0|||
124846634|NCT03551210|449062293|FG000|Overall Study|No drug for dispensing|0|||
124846635|NCT03551210|449062294|FG001|Overall Study|No drug for dispensing|1|||
124846636|NCT02239536|449062297|FG000|Overall Study|Non-neoplastic polyp|23|||
124846637|NCT02239536|449062298|FG001|Overall Study|Non-neoplastic polyp|17|||
124846638|NCT02564198|449064091|FG000|Overall Study|Withdrawal by Subject|2|||
124846639|NCT02564198|449064092|FG001|Overall Study|Withdrawal by Subject|4|||
124846640|NCT02564198|449064093|FG002|Overall Study|Withdrawal by Subject|0|||
124846641|NCT02564198|449064091|FG000|Overall Study|Adverse Event|0|||
124846642|NCT02564198|449064092|FG001|Overall Study|Adverse Event|1|||
124846643|NCT02564198|449064093|FG002|Overall Study|Adverse Event|0|||
124846644|NCT01440322|449064094|FG000|Overall Study|Discomfort|2|||
124846645|NCT01440322|449064095|FG001|Overall Study|Discomfort|0|||
124846646|NCT01440322|449064094|FG000|Overall Study|Biomicroscopy|1|||
124846647|NCT01440322|449064095|FG001|Overall Study|Biomicroscopy|0|||
124846648|NCT01440322|449064094|FG000|Overall Study|Symptoms and Problems|1|||
124846649|NCT01440322|449064095|FG001|Overall Study|Symptoms and Problems|0|||
124846650|NCT01440322|449064094|FG000|Overall Study|Unacceptable Subjective Vision|1|||
124846651|NCT01440322|449064095|FG001|Overall Study|Unacceptable Subjective Vision|0|||
124846652|NCT01440322|449064094|FG000|Overall Study|Other Product Related|1|||
124846653|NCT01440322|449064095|FG001|Overall Study|Other Product Related|0|||
124846654|NCT01440322|449064094|FG000|Overall Study|Unrelated Medical Problem|0|||
124846655|NCT01440322|449064095|FG001|Overall Study|Unrelated Medical Problem|1|||
124846656|NCT01440322|449064094|FG000|Overall Study|Other Non-Product Related|1|||
124846657|NCT01440322|449064095|FG001|Overall Study|Other Non-Product Related|0|||
124846658|NCT03394391|449064097|FG000|Overall Study|Lost to Follow-up|1|||
124846659|NCT03394391|449064098|FG001|Overall Study|Lost to Follow-up|2|||
124846660|NCT05044234|449064099|FG000|Overall Study|Lost to Follow-up|2|||
124846661|NCT05044234|449064100|FG001|Overall Study|Lost to Follow-up|1|||
124846662|NCT05044234|449064101|FG002|Overall Study|Lost to Follow-up|1|||
124846663|NCT05044234|449064102|FG003|Overall Study|Lost to Follow-up|2|||
124846664|NCT05044234|449064099|FG000|Overall Study|Withdrawal by Subject|6|||
124846665|NCT05044234|449064100|FG001|Overall Study|Withdrawal by Subject|4|||
124846666|NCT05044234|449064101|FG002|Overall Study|Withdrawal by Subject|5|||
124846667|NCT05044234|449064102|FG003|Overall Study|Withdrawal by Subject|8|||
124846668|NCT05044234|449064099|FG000|Overall Study|Study terminated by Sponsor|21|||
124846669|NCT05044234|449064100|FG001|Overall Study|Study terminated by Sponsor|21|||
124846670|NCT05044234|449064101|FG002|Overall Study|Study terminated by Sponsor|20|||
124846671|NCT05044234|449064102|FG003|Overall Study|Study terminated by Sponsor|14|||
124846672|NCT05044234|449064099|FG000|Overall Study|Other, not specified|0|||
124846673|NCT05044234|449064100|FG001|Overall Study|Other, not specified|0|||
124846674|NCT05044234|449064101|FG002|Overall Study|Other, not specified|1|||
124846675|NCT05044234|449064102|FG003|Overall Study|Other, not specified|2|||
124846676|NCT05044234|449064099|FG000|Overall Study|Delayed data entry|0|||
124846677|NCT05044234|449064100|FG001|Overall Study|Delayed data entry|0|||
124846678|NCT05044234|449064101|FG002|Overall Study|Delayed data entry|0|||
124846679|NCT05044234|449064102|FG003|Overall Study|Delayed data entry|1|||
124846680|NCT02896127|449064103|FG000|COMPLETED WEEK 52|Adverse Event|9|||
124846681|NCT02896127|449064104|FG001|COMPLETED WEEK 52|Adverse Event|2|||
124846682|NCT02896127|449064103|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
124846683|NCT02896127|449064104|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
124846684|NCT02896127|449064103|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
124846685|NCT02896127|449064104|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
124846686|NCT02896127|449064103|FG000|COMPLETED WEEK 52|Physician Decision|1|||
124846687|NCT02896127|449064104|FG001|COMPLETED WEEK 52|Physician Decision|1|||
124846688|NCT02896127|449064103|FG000|COMPLETED WEEK 52|Pregnancy|2|||
124846689|NCT02896127|449064104|FG001|COMPLETED WEEK 52|Pregnancy|0|||
124846690|NCT02896127|449064103|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
124846691|NCT02896127|449064104|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
124846692|NCT02896127|449064103|FG000|COMPLETED WEEK 52|Technical problems|1|||
124846693|NCT02896127|449064104|FG001|COMPLETED WEEK 52|Technical problems|0|||
124846694|NCT02896127|449064103|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
124846695|NCT02896127|449064104|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
124846696|NCT02896127|449064103|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
124846697|NCT02896127|449064104|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
124846698|NCT02896127|449064103|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
124846699|NCT02896127|449064104|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
124846700|NCT02896127|449064103|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
124846701|NCT02896127|449064104|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
124846702|NCT02896127|449064103|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
124846703|NCT02896127|449064104|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
124846704|NCT01434823|449064107|FG000|Overall Study|Incomplete data in medical record|4|||
124846705|NCT01434823|449064108|FG001|Overall Study|Incomplete data in medical record|7|||
124846706|NCT02477020|449064111|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
124846707|NCT02477020|449064112|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
124846708|NCT02477020|449064111|FG000|Overall Study|Voluntary Withdrawal|7|||
124846709|NCT02477020|449064112|FG001|Overall Study|Voluntary Withdrawal|16|||
124846710|NCT02477020|449064111|FG000|Overall Study|Reason not Specified|3|||
124846711|NCT02477020|449064112|FG001|Overall Study|Reason not Specified|1|||
124846712|NCT02477020|449064111|FG000|Overall Study|Lack of Efficacy|14|||
124846713|NCT02477020|449064112|FG001|Overall Study|Lack of Efficacy|5|||
124846714|NCT00519649|449064114|FG000|Overall Study|Withdrawal by Subject|1|||
124846715|NCT04879745|449064115|FG000|Overall Study|Lost to Follow-up|4|||
124846716|NCT04879745|449064116|FG001|Overall Study|Lost to Follow-up|1|||
124846717|NCT00120042|449064117|FG000|Overall Study|all completed protocl|0|||
124846718|NCT00120042|449064118|FG001|Overall Study|all completed protocl|0|||
124846719|NCT00120042|449064119|FG002|Overall Study|all completed protocl|0|||
124846720|NCT01126541|449064126|FG000|Overall Study|Adverse Event|0|||
124846721|NCT01126541|449064127|FG001|Overall Study|Adverse Event|2|||
124846722|NCT01126541|449064128|FG002|Overall Study|Adverse Event|4|||
124846723|NCT01126541|449064126|FG000|Overall Study|Death|0|||
124846724|NCT01126541|449064127|FG001|Overall Study|Death|1|||
124846725|NCT01126541|449064128|FG002|Overall Study|Death|0|||
124846726|NCT01126541|449064126|FG000|Overall Study|Lack of Efficacy|6|||
124846727|NCT01126541|449064127|FG001|Overall Study|Lack of Efficacy|1|||
124846728|NCT01126541|449064128|FG002|Overall Study|Lack of Efficacy|11|||
124846729|NCT01126541|449064126|FG000|Overall Study|Lost to Follow-up|1|||
124846730|NCT01126541|449064127|FG001|Overall Study|Lost to Follow-up|2|||
124846731|NCT01126541|449064128|FG002|Overall Study|Lost to Follow-up|2|||
124846732|NCT01126541|449064126|FG000|Overall Study|Withdrawal by Subject|2|||
124846733|NCT01126541|449064127|FG001|Overall Study|Withdrawal by Subject|5|||
124846734|NCT01126541|449064128|FG002|Overall Study|Withdrawal by Subject|6|||
124846735|NCT01126541|449064126|FG000|Overall Study|Protocol Violation|0|||
124846736|NCT01126541|449064127|FG001|Overall Study|Protocol Violation|0|||
124846737|NCT01126541|449064128|FG002|Overall Study|Protocol Violation|1|||
124846738|NCT01126541|449064126|FG000|Overall Study|Administrative reason or other|1|||
124846739|NCT01126541|449064127|FG001|Overall Study|Administrative reason or other|1|||
124846740|NCT01126541|449064128|FG002|Overall Study|Administrative reason or other|2|||
124846741|NCT01263873|449064131|FG000|Overall Study|One provider unable to complete numbers|1|||
124846742|NCT01263873|449064132|FG001|Overall Study|One provider unable to complete numbers|1|||
124846743|NCT06640829|449064140|FG000|Overall Study|Withdrawal by Subject|1|||
124846744|NCT06640829|449064140|FG000|Overall Study|Lost to Follow-up|1|||
124846745|NCT01859715|449064141|FG000|Overall Study|No 2nd VAS|16|||
124846746|NCT01859715|449064142|FG001|Overall Study|No 2nd VAS|8|||
124846747|NCT01859715|449064143|FG002|Overall Study|No 2nd VAS|23|||
124846748|NCT01252290|449064144|FG000|Overall Study|Withdrawal by Subject|1|||
124846749|NCT00086580|449064145|FG000|Treatment Period|Disease progression|9|||
124846750|NCT00086580|449064146|FG001|Treatment Period|Disease progression|8|||
124846751|NCT00086580|449064145|FG000|Treatment Period|Unable to comply with protocol|3|||
124846752|NCT00086580|449064146|FG001|Treatment Period|Unable to comply with protocol|1|||
124846753|NCT00086580|449064145|FG000|Treatment Period|Withdrawal by Subject|7|||
124846754|NCT00086580|449064146|FG001|Treatment Period|Withdrawal by Subject|8|||
124846755|NCT00086580|449064145|FG000|Treatment Period|Physician Decision|13|||
124846756|NCT00086580|449064146|FG001|Treatment Period|Physician Decision|7|||
124846757|NCT00086580|449064145|FG000|Treatment Period|AE - not treatment related|7|||
124846758|NCT00086580|449064146|FG001|Treatment Period|AE - not treatment related|7|||
124846759|NCT00086580|449064145|FG000|Treatment Period|Toxicity - treatment related|15|||
124846760|NCT00086580|449064146|FG001|Treatment Period|Toxicity - treatment related|15|||
124846761|NCT00086580|449064145|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
124846762|NCT00086580|449064146|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
124846763|NCT00086580|449064145|FG000|Treatment Period|Death|5|||
124846764|NCT00086580|449064146|FG001|Treatment Period|Death|7|||
124846765|NCT00086580|449064145|FG000|Treatment Period|Other|5|||
124846766|NCT00086580|449064146|FG001|Treatment Period|Other|3|||
124846767|NCT00086580|449064145|FG000|Follow-up Period|Disease progression|72|||
124846768|NCT00086580|449064146|FG001|Follow-up Period|Disease progression|99|||
124846769|NCT00086580|449064145|FG000|Follow-up Period|Unable to comply with protocol|5|||
124846770|NCT00086580|449064146|FG001|Follow-up Period|Unable to comply with protocol|0|||
124846771|NCT00086580|449064145|FG000|Follow-up Period|Withdrawal by Subject|6|||
124846772|NCT00086580|449064146|FG001|Follow-up Period|Withdrawal by Subject|6|||
124846773|NCT00086580|449064145|FG000|Follow-up Period|Physician Decision|0|||
124846774|NCT00086580|449064146|FG001|Follow-up Period|Physician Decision|1|||
124846775|NCT00086580|449064145|FG000|Follow-up Period|AE - not related|1|||
124846776|NCT00086580|449064146|FG001|Follow-up Period|AE - not related|0|||
124846777|NCT00086580|449064145|FG000|Follow-up Period|Death|13|||
124846778|NCT00086580|449064146|FG001|Follow-up Period|Death|7|||
124846779|NCT00086580|449064145|FG000|Follow-up Period|Other|7|||
124846780|NCT00086580|449064146|FG001|Follow-up Period|Other|6|||
124846781|NCT00086580|449064145|FG000|Observation Period|Unable to comply with protocol|1|||
124846782|NCT00086580|449064146|FG001|Observation Period|Unable to comply with protocol|1|||
124846783|NCT00086580|449064145|FG000|Observation Period|Withdrawal by Subject|4|||
124846784|NCT00086580|449064146|FG001|Observation Period|Withdrawal by Subject|2|||
124846785|NCT00086580|449064145|FG000|Observation Period|Death|33|||
124846786|NCT00086580|449064146|FG001|Observation Period|Death|55|||
124846787|NCT00086580|449064145|FG000|Observation Period|Other|8|||
124846788|NCT00086580|449064146|FG001|Observation Period|Other|7|||
124846789|NCT00261716|449064147|FG000|Overall Study|Withdrawal by Subject|6|||
124846790|NCT00261716|449064148|FG001|Overall Study|Withdrawal by Subject|8|||
124846791|NCT00261716|449064147|FG000|Overall Study|Lost to Follow-up|0|||
124846792|NCT00261716|449064148|FG001|Overall Study|Lost to Follow-up|2|||
124846793|NCT02075437|449064149|FG000|Overall Study|Withdrawal by Subject|5|||
124846794|NCT02075437|449064149|FG000|Overall Study|Lost to Follow-up|1|||
124846795|NCT04439240|449064150|FG000|Overall Study|Ineligible|2|||
124846796|NCT04439240|449064150|FG000|Overall Study|Never started treatment|2|||
124846797|NCT04439240|449064150|FG000|Overall Study|Adverse Event|12|||
124846798|NCT04439240|449064150|FG000|Overall Study|Death|2|||
124846799|NCT04439240|449064150|FG000|Overall Study|Disease progression|25|||
124846800|NCT04439240|449064150|FG000|Overall Study|Other diseases|2|||
124846801|NCT04439240|449064150|FG000|Overall Study|Withdrawal by Subject|3|||
124846802|NCT04439240|449064150|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
124846803|NCT04439240|449064150|FG000|Overall Study|Symptomatic decline|1|||
124846804|NCT04439240|449064150|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
124846805|NCT04439240|449064150|FG000|Overall Study|Clinical progression|1|||
124846806|NCT00673452|449064151|FG000|Acute Double-Blind Phase|Adverse Event|41|||
124846807|NCT00673452|449064152|FG001|Acute Double-Blind Phase|Adverse Event|24|||
124846808|NCT00673452|449064151|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
124846809|NCT00673452|449064152|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
124846810|NCT00673452|449064151|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
124846811|NCT00673452|449064152|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
124846812|NCT00673452|449064151|FG000|Acute Double-Blind Phase|Physician Decision|0|||
124846813|NCT00673452|449064152|FG001|Acute Double-Blind Phase|Physician Decision|6|||
124846814|NCT00673452|449064151|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
124846815|NCT00673452|449064152|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
124846816|NCT00673452|449064151|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
124846817|NCT00673452|449064152|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
124846818|NCT00673452|449064151|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
124846819|NCT00673452|449064152|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
124846820|NCT00673452|449064151|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
124846821|NCT00673452|449064152|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
124846822|NCT00673452|449064151|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
124846823|NCT00673452|449064152|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
124846824|NCT00673452|449064151|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
124846825|NCT00673452|449064152|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
124846826|NCT00673452|449064151|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
124846827|NCT00673452|449064152|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
124846828|NCT00673452|449064151|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
124846829|NCT00673452|449064152|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
124846830|NCT00673452|449064151|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
124846831|NCT00673452|449064152|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
124846832|NCT00673452|449064151|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
124846833|NCT00673452|449064152|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
124846834|NCT00673452|449064151|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
124846835|NCT00673452|449064152|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
124846836|NCT00813124|449064153|FG000|Overall Study|Death|2|||
124846837|NCT00813124|449064153|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
124846838|NCT00813124|449064153|FG000|Overall Study|Withdrawal by Subject|1|||
124846839|NCT00767676|449064154|FG000|Overall Study|Investigator error|54|||
124846840|NCT00079274|449064155|FG000|Overall Study|Withdrawal by Subject|111|||
124846841|NCT00079274|449064156|FG001|Overall Study|Withdrawal by Subject|10|||
124846842|NCT00079274|449064157|FG002|Overall Study|Withdrawal by Subject|12|||
124846843|NCT00079274|449064158|FG003|Overall Study|Withdrawal by Subject|163|||
124846844|NCT00079274|449064159|FG004|Overall Study|Withdrawal by Subject|7|||
124846845|NCT00079274|449064160|FG005|Overall Study|Withdrawal by Subject|8|||
124846846|NCT00079274|449064161|FG006|Overall Study|Withdrawal by Subject|0|||
124846847|NCT00079274|449064155|FG000|Overall Study|Adverse Event|130|||
124846848|NCT00079274|449064156|FG001|Overall Study|Adverse Event|8|||
124846849|NCT00079274|449064157|FG002|Overall Study|Adverse Event|8|||
124846850|NCT00079274|449064158|FG003|Overall Study|Adverse Event|184|||
124846851|NCT00079274|449064159|FG004|Overall Study|Adverse Event|7|||
124846852|NCT00079274|449064160|FG005|Overall Study|Adverse Event|8|||
124846853|NCT00079274|449064161|FG006|Overall Study|Adverse Event|0|||
124846854|NCT00079274|449064155|FG000|Overall Study|Recurrence|21|||
124846855|NCT00079274|449064156|FG001|Overall Study|Recurrence|0|||
124846856|NCT00079274|449064157|FG002|Overall Study|Recurrence|1|||
124846857|NCT00079274|449064158|FG003|Overall Study|Recurrence|15|||
124846858|NCT00079274|449064159|FG004|Overall Study|Recurrence|0|||
124846859|NCT00079274|449064160|FG005|Overall Study|Recurrence|2|||
124846860|NCT00079274|449064161|FG006|Overall Study|Recurrence|0|||
124846861|NCT00079274|449064155|FG000|Overall Study|Alternate Treatment|6|||
124846862|NCT00079274|449064156|FG001|Overall Study|Alternate Treatment|1|||
124846863|NCT00079274|449064157|FG002|Overall Study|Alternate Treatment|0|||
124846864|NCT00079274|449064158|FG003|Overall Study|Alternate Treatment|3|||
124846865|NCT00079274|449064159|FG004|Overall Study|Alternate Treatment|0|||
124846866|NCT00079274|449064160|FG005|Overall Study|Alternate Treatment|0|||
124846867|NCT00079274|449064161|FG006|Overall Study|Alternate Treatment|0|||
124846868|NCT00079274|449064155|FG000|Overall Study|Other Medical Problems|6|||
124846869|NCT00079274|449064156|FG001|Overall Study|Other Medical Problems|1|||
124846870|NCT00079274|449064157|FG002|Overall Study|Other Medical Problems|0|||
124846871|NCT00079274|449064158|FG003|Overall Study|Other Medical Problems|7|||
124846872|NCT00079274|449064159|FG004|Overall Study|Other Medical Problems|0|||
124846873|NCT00079274|449064160|FG005|Overall Study|Other Medical Problems|0|||
124846874|NCT00079274|449064161|FG006|Overall Study|Other Medical Problems|0|||
124846875|NCT00079274|449064155|FG000|Overall Study|Death|4|||
124846876|NCT00079274|449064156|FG001|Overall Study|Death|0|||
124846877|NCT00079274|449064157|FG002|Overall Study|Death|1|||
124846878|NCT00079274|449064158|FG003|Overall Study|Death|15|||
124846879|NCT00079274|449064159|FG004|Overall Study|Death|0|||
124846880|NCT00079274|449064160|FG005|Overall Study|Death|0|||
124846881|NCT00079274|449064161|FG006|Overall Study|Death|0|||
124846882|NCT00079274|449064155|FG000|Overall Study|Cytogenetic resistance|0|||
124846883|NCT00079274|449064156|FG001|Overall Study|Cytogenetic resistance|0|||
124846884|NCT00079274|449064157|FG002|Overall Study|Cytogenetic resistance|0|||
124846885|NCT00079274|449064158|FG003|Overall Study|Cytogenetic resistance|2|||
124846886|NCT00079274|449064159|FG004|Overall Study|Cytogenetic resistance|0|||
124846887|NCT00079274|449064160|FG005|Overall Study|Cytogenetic resistance|0|||
124846888|NCT00079274|449064161|FG006|Overall Study|Cytogenetic resistance|0|||
124846889|NCT00079274|449064155|FG000|Overall Study|Other|43|||
124846890|NCT00079274|449064156|FG001|Overall Study|Other|7|||
124846891|NCT00079274|449064157|FG002|Overall Study|Other|5|||
124846892|NCT00079274|449064158|FG003|Overall Study|Other|55|||
124846893|NCT00079274|449064159|FG004|Overall Study|Other|1|||
124846894|NCT00079274|449064160|FG005|Overall Study|Other|2|||
124846895|NCT00079274|449064161|FG006|Overall Study|Other|0|||
124846896|NCT00617240|449064162|FG000|Overall Study|Lack of Efficacy|1|||
124846897|NCT00617240|449064163|FG001|Overall Study|Lack of Efficacy|0|||
124846898|NCT01611259|449064164|FG000|Overall Study|Physician Decision|1|||
124846899|NCT01611259|449064164|FG000|Overall Study|Lack of Efficacy|2|||
124846900|NCT01611259|449064164|FG000|Overall Study|Adverse Event|4|||
124846901|NCT01611259|449064164|FG000|Overall Study|Withdrawal by Subject|7|||
124846902|NCT04936685|449064165|FG000|Overall Study|Protocol Violation|1|||
124846903|NCT04936685|449064166|FG001|Overall Study|Protocol Violation|0|||
124846904|NCT03969212|449064169|FG000|Overall Study|Adverse Event|1|||
124846905|NCT03969212|449064170|FG001|Overall Study|Adverse Event|0|||
124846906|NCT03969212|449064171|FG002|Overall Study|Adverse Event|0|||
124846907|NCT03969212|449064172|FG003|Overall Study|Adverse Event|0|||
124846908|NCT03969212|449064169|FG000|Overall Study|Lost to Follow-up|2|||
124846909|NCT03969212|449064170|FG001|Overall Study|Lost to Follow-up|2|||
124846910|NCT03969212|449064171|FG002|Overall Study|Lost to Follow-up|2|||
124846911|NCT03969212|449064172|FG003|Overall Study|Lost to Follow-up|2|||
124846912|NCT03969212|449064169|FG000|Overall Study|Protocol Violation|0|||
124846913|NCT03969212|449064170|FG001|Overall Study|Protocol Violation|0|||
124846914|NCT03969212|449064171|FG002|Overall Study|Protocol Violation|0|||
124846915|NCT03969212|449064172|FG003|Overall Study|Protocol Violation|1|||
124846916|NCT03969212|449064169|FG000|Overall Study|Withdrawal by Subject|7|||
124846917|NCT03969212|449064170|FG001|Overall Study|Withdrawal by Subject|13|||
124846918|NCT03969212|449064171|FG002|Overall Study|Withdrawal by Subject|5|||
124846919|NCT03969212|449064172|FG003|Overall Study|Withdrawal by Subject|11|||
124846920|NCT03969212|449064169|FG000|Overall Study|Physician Decision|0|||
124846921|NCT03969212|449064170|FG001|Overall Study|Physician Decision|0|||
124846922|NCT03969212|449064171|FG002|Overall Study|Physician Decision|1|||
124846923|NCT03969212|449064172|FG003|Overall Study|Physician Decision|0|||
124846924|NCT03969212|449064169|FG000|Overall Study|Reason not Specified|22|||
124846925|NCT03969212|449064170|FG001|Overall Study|Reason not Specified|23|||
124846926|NCT03969212|449064171|FG002|Overall Study|Reason not Specified|28|||
124846927|NCT03969212|449064172|FG003|Overall Study|Reason not Specified|26|||
124846928|NCT02075320|449064173|FG000|Overall Study|Withdrawal by Subject|2|||
124846929|NCT01147653|449064175|FG000|Year 2|Withdrawal by Subject|2|||
124846930|NCT01147653|449064176|FG001|Year 2|Withdrawal by Subject|3|||
124846931|NCT00353366|449064177|FG000|Overall Study|Adverse Event|8|||
124846932|NCT00353366|449064177|FG000|Overall Study|Protocol Violation|12|||
124846933|NCT00353366|449064177|FG000|Overall Study|Withdrawal by Subject|12|||
124846934|NCT00353366|449064177|FG000|Overall Study|Lost to Follow-up|92|||
124846935|NCT00353366|449064177|FG000|Overall Study|Other|19|||
124846936|NCT00259857|449064178|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
124846937|NCT00259857|449064179|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
124846938|NCT00259857|449064178|FG000|24 Months Treatment|Lost to Follow-up|0|||
124846939|NCT00259857|449064179|FG001|24 Months Treatment|Lost to Follow-up|3|||
124846940|NCT01813019|449064186|FG000|Overall Study|Adverse Event|0|||
124846941|NCT01813019|449064187|FG001|Overall Study|Adverse Event|3|||
124846942|NCT01813019|449064186|FG000|Overall Study|Withdrawal by Subject|3|||
124846943|NCT01813019|449064187|FG001|Overall Study|Withdrawal by Subject|2|||
124846944|NCT01813019|449064186|FG000|Overall Study|administrative problems|2|||
124846945|NCT01813019|449064187|FG001|Overall Study|administrative problems|0|||
124846946|NCT01813019|449064186|FG000|Overall Study|Protocol Deviation|2|||
124846947|NCT01813019|449064187|FG001|Overall Study|Protocol Deviation|1|||
124846948|NCT03075644|449064188|FG000|Overall Study|Withdrawal by Subject|1|||
124846949|NCT03075644|449064189|FG001|Overall Study|Withdrawal by Subject|1|||
124846950|NCT01458171|449064193|FG000|Overall Study|Adverse Event|1|||
124846951|NCT02214121|449064197|FG000|Part A|Patient decision|2|||
124846952|NCT02214121|449064198|FG001|Part A|Patient decision|0|||
124846953|NCT02214121|449064199|FG002|Part A|Patient decision|0|||
124846954|NCT02214121|449064197|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
124846955|NCT02214121|449064198|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
124846956|NCT02214121|449064199|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
124846957|NCT02214121|449064197|FG000|Part A|Other|1|||
124846958|NCT02214121|449064198|FG001|Part A|Other|0|||
124846959|NCT02214121|449064199|FG002|Part A|Other|0|||
124846960|NCT02214121|449064197|FG000|Part B|Patient decision|0|||
124846961|NCT02214121|449064198|FG001|Part B|Patient decision|1|||
124846962|NCT02214121|449064199|FG002|Part B|Patient decision|0|||
124846963|NCT02214121|449064197|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
124846964|NCT02214121|449064198|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
124846965|NCT02214121|449064199|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
124846966|NCT02214121|449064197|FG000|Part B|Lost to Follow-up|0|||
124846967|NCT02214121|449064198|FG001|Part B|Lost to Follow-up|0|||
124846968|NCT02214121|449064199|FG002|Part B|Lost to Follow-up|1|||
124846969|NCT00715793|449064200|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
124846970|NCT00715793|449064201|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
124846971|NCT00715793|449064200|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
124846972|NCT00715793|449064201|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
124846973|NCT01849588|449064203|FG000|Overall Study|Lack of Efficacy|3|||
124846974|NCT00094653|449064204|FG000|Overall Study|Death|306|||
124846975|NCT00094653|449064205|FG001|Overall Study|Death|100|||
124846976|NCT00094653|449064206|FG002|Overall Study|Death|119|||
124846977|NCT00094653|449064204|FG000|Overall Study|Subject Withdrew Consent|10|||
124846978|NCT00094653|449064205|FG001|Overall Study|Subject Withdrew Consent|2|||
124846979|NCT00094653|449064206|FG002|Overall Study|Subject Withdrew Consent|3|||
124846980|NCT00094653|449064204|FG000|Overall Study|Other|2|||
124846981|NCT00094653|449064205|FG001|Overall Study|Other|2|||
124846982|NCT00094653|449064206|FG002|Overall Study|Other|2|||
124846983|NCT00094653|449064204|FG000|Overall Study|Lost to Follow-up|3|||
124846984|NCT00094653|449064205|FG001|Overall Study|Lost to Follow-up|2|||
124846985|NCT00094653|449064206|FG002|Overall Study|Lost to Follow-up|1|||
124846986|NCT00094653|449064204|FG000|Overall Study|Protocol Violation|0|||
124846987|NCT00094653|449064205|FG001|Overall Study|Protocol Violation|0|||
124846988|NCT00094653|449064206|FG002|Overall Study|Protocol Violation|1|||
124846989|NCT03921411|449064207|FG000|Overall Study|Withdrawal by Subject|1|||
124846990|NCT03921411|449064207|FG000|Overall Study|Protocol Deviation|2|||
124846991|NCT03921411|449064207|FG000|Overall Study|Enrolled, but never treated|2|||
124846992|NCT03120013|449064210|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
124846993|NCT03120013|449064211|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
124846994|NCT01541826|449064213|FG000|Overall Study|Lost to Follow-up|2|||
124846995|NCT01541826|449064214|FG001|Overall Study|Lost to Follow-up|3|||
124846996|NCT01541826|449064215|FG002|Overall Study|Lost to Follow-up|0|||
125306403|NCT02737475|450749024|FG020|Overall Study|Participant withdrew consent|2|||
124846997|NCT01541826|449064213|FG000|Overall Study|Withdrawal by Subject|2|||
124846998|NCT01541826|449064214|FG001|Overall Study|Withdrawal by Subject|0|||
124846999|NCT01541826|449064215|FG002|Overall Study|Withdrawal by Subject|0|||
124847000|NCT01365273|449064218|FG000|Overall Study|Lost to Follow-up|1|||
124847001|NCT01365273|449064219|FG001|Overall Study|Lost to Follow-up|0|||
124847002|NCT01365273|449064218|FG000|Overall Study|Protocol Violation|0|||
124847003|NCT01365273|449064219|FG001|Overall Study|Protocol Violation|1|||
124847004|NCT01365273|449064218|FG000|Overall Study|Physician Decision|1|||
124847005|NCT01365273|449064219|FG001|Overall Study|Physician Decision|0|||
124847006|NCT01339390|449064222|FG000|Overall Study|Death|32|||
124847007|NCT01339390|449064223|FG001|Overall Study|Death|29|||
124847008|NCT01339390|449064222|FG000|Overall Study|Lost to Follow-up|125|||
124847009|NCT01339390|449064223|FG001|Overall Study|Lost to Follow-up|127|||
124847010|NCT04847674|449064224|FG000|Overall Study|Withdrawal by Subject|0|||
125306404|NCT02737475|450749025|FG021|Overall Study|Participant withdrew consent|0|||
125306405|NCT02737475|450749026|FG022|Overall Study|Participant withdrew consent|0|||
125306406|NCT02737475|450749027|FG023|Overall Study|Participant withdrew consent|0|||
125306407|NCT02737475|450749028|FG024|Overall Study|Participant withdrew consent|0|||
125306408|NCT02737475|450749029|FG025|Overall Study|Participant withdrew consent|0|||
125306409|NCT02737475|450749030|FG026|Overall Study|Participant withdrew consent|0|||
125306410|NCT02737475|450749004|FG000|Overall Study|Lost to Follow-up|0|||
125306411|NCT02737475|450749005|FG001|Overall Study|Lost to Follow-up|0|||
125306412|NCT02737475|450749006|FG002|Overall Study|Lost to Follow-up|0|||
125306413|NCT02737475|450749007|FG003|Overall Study|Lost to Follow-up|0|||
125306414|NCT02737475|450749008|FG004|Overall Study|Lost to Follow-up|0|||
125306415|NCT02737475|450749009|FG005|Overall Study|Lost to Follow-up|0|||
125306416|NCT02737475|450749010|FG006|Overall Study|Lost to Follow-up|0|||
125306417|NCT02737475|450749011|FG007|Overall Study|Lost to Follow-up|0|||
125306418|NCT02737475|450749012|FG008|Overall Study|Lost to Follow-up|0|||
125306419|NCT02737475|450749013|FG009|Overall Study|Lost to Follow-up|0|||
125306420|NCT02737475|450749014|FG010|Overall Study|Lost to Follow-up|0|||
125306421|NCT02737475|450749015|FG011|Overall Study|Lost to Follow-up|0|||
125306422|NCT02737475|450749016|FG012|Overall Study|Lost to Follow-up|0|||
125306423|NCT02737475|450749017|FG013|Overall Study|Lost to Follow-up|0|||
125306424|NCT02737475|450749018|FG014|Overall Study|Lost to Follow-up|0|||
125306425|NCT02737475|450749019|FG015|Overall Study|Lost to Follow-up|1|||
125306426|NCT02737475|450749020|FG016|Overall Study|Lost to Follow-up|0|||
125306427|NCT02737475|450749021|FG017|Overall Study|Lost to Follow-up|0|||
125306428|NCT02737475|450749022|FG018|Overall Study|Lost to Follow-up|0|||
125306429|NCT02737475|450749023|FG019|Overall Study|Lost to Follow-up|0|||
125306430|NCT02737475|450749024|FG020|Overall Study|Lost to Follow-up|0|||
125306431|NCT02737475|450749025|FG021|Overall Study|Lost to Follow-up|0|||
125306432|NCT02737475|450749026|FG022|Overall Study|Lost to Follow-up|0|||
125306433|NCT02737475|450749027|FG023|Overall Study|Lost to Follow-up|0|||
125306434|NCT02737475|450749028|FG024|Overall Study|Lost to Follow-up|0|||
125306435|NCT02737475|450749029|FG025|Overall Study|Lost to Follow-up|0|||
125306436|NCT02737475|450749030|FG026|Overall Study|Lost to Follow-up|0|||
125306437|NCT02737475|450749004|FG000|Overall Study|Disease Progression|0|||
125306438|NCT02737475|450749005|FG001|Overall Study|Disease Progression|0|||
125306439|NCT02737475|450749006|FG002|Overall Study|Disease Progression|0|||
124847011|NCT04847674|449064225|FG001|Overall Study|Withdrawal by Subject|1|||
124847012|NCT04847674|449064226|FG002|Overall Study|Withdrawal by Subject|0|||
124847013|NCT04847674|449064224|FG000|Overall Study|Lost to Follow-up|0|||
124847014|NCT04847674|449064225|FG001|Overall Study|Lost to Follow-up|0|||
124847015|NCT04847674|449064226|FG002|Overall Study|Lost to Follow-up|2|||
124847016|NCT04847674|449064224|FG000|Overall Study|Other than specified|21|||
124847017|NCT04847674|449064225|FG001|Overall Study|Other than specified|20|||
124847018|NCT04847674|449064226|FG002|Overall Study|Other than specified|20|||
124847019|NCT02563028|449064228|FG000|Overall Study|Lack of equipment|1|||
124847020|NCT02563028|449064228|FG000|Overall Study|Unable to elicit VEP post induction|1|||
124847021|NCT01462357|449064230|FG000|Overall Study|Death|0|||
124847022|NCT01462357|449064231|FG001|Overall Study|Death|0|||
124847023|NCT01462357|449064232|FG002|Overall Study|Death|1|||
124847024|NCT01462357|449064230|FG000|Overall Study|Withdrawal by Subject|3|||
124847025|NCT01462357|449064231|FG001|Overall Study|Withdrawal by Subject|11|||
124847026|NCT01462357|449064232|FG002|Overall Study|Withdrawal by Subject|3|||
124847027|NCT01462357|449064230|FG000|Overall Study|Migrated/moved from study area|2|||
124847028|NCT01462357|449064231|FG001|Overall Study|Migrated/moved from study area|3|||
124847029|NCT01462357|449064232|FG002|Overall Study|Migrated/moved from study area|1|||
125306440|NCT02737475|450749007|FG003|Overall Study|Disease Progression|0|||
125306441|NCT02737475|450749008|FG004|Overall Study|Disease Progression|0|||
125306442|NCT02737475|450749009|FG005|Overall Study|Disease Progression|0|||
125306443|NCT02737475|450749010|FG006|Overall Study|Disease Progression|0|||
125306444|NCT02737475|450749011|FG007|Overall Study|Disease Progression|0|||
125306445|NCT02737475|450749012|FG008|Overall Study|Disease Progression|0|||
125306446|NCT02737475|450749013|FG009|Overall Study|Disease Progression|0|||
125306447|NCT02737475|450749014|FG010|Overall Study|Disease Progression|0|||
125306448|NCT02737475|450749015|FG011|Overall Study|Disease Progression|0|||
125306449|NCT02737475|450749016|FG012|Overall Study|Disease Progression|0|||
125306450|NCT02737475|450749017|FG013|Overall Study|Disease Progression|0|||
125306451|NCT02737475|450749018|FG014|Overall Study|Disease Progression|0|||
125306452|NCT02737475|450749019|FG015|Overall Study|Disease Progression|0|||
125306453|NCT02737475|450749020|FG016|Overall Study|Disease Progression|0|||
124847030|NCT01462357|449064230|FG000|Overall Study|Lost to Follow-up|3|||
124847031|NCT01462357|449064231|FG001|Overall Study|Lost to Follow-up|5|||
124847032|NCT01462357|449064232|FG002|Overall Study|Lost to Follow-up|7|||
125306454|NCT02737475|450749021|FG017|Overall Study|Disease Progression|0|||
124847033|NCT00096044|449064233|FG000|Overall Study|Withdrawal by Subject|9|||
124847034|NCT00096044|449064233|FG000|Overall Study|Adverse Event|21|||
124847035|NCT00096044|449064233|FG000|Overall Study|Disease Progression|4|||
124847036|NCT00004031|449064234|FG000|Overall Study|Adverse Event|5|||
125306455|NCT02737475|450749022|FG018|Overall Study|Disease Progression|0|||
125306456|NCT02737475|450749023|FG019|Overall Study|Disease Progression|0|||
125306457|NCT02737475|450749024|FG020|Overall Study|Disease Progression|0|||
125306458|NCT02737475|450749025|FG021|Overall Study|Disease Progression|0|||
125306459|NCT02737475|450749026|FG022|Overall Study|Disease Progression|0|||
125306460|NCT02737475|450749027|FG023|Overall Study|Disease Progression|0|||
125306461|NCT02737475|450749028|FG024|Overall Study|Disease Progression|0|||
125306462|NCT02737475|450749029|FG025|Overall Study|Disease Progression|0|||
125306463|NCT02737475|450749030|FG026|Overall Study|Disease Progression|1|||
124847037|NCT00004031|449064235|FG001|Overall Study|Adverse Event|0|||
124847038|NCT00004031|449064234|FG000|Overall Study|Refusal unrelated to adverse events|2|||
124847039|NCT00004031|449064235|FG001|Overall Study|Refusal unrelated to adverse events|11|||
124847040|NCT00004031|449064234|FG000|Overall Study|Progression/relapse|9|||
124847041|NCT00004031|449064235|FG001|Overall Study|Progression/relapse|4|||
124847042|NCT00004031|449064234|FG000|Overall Study|Death|3|||
124847043|NCT00004031|449064235|FG001|Overall Study|Death|1|||
124847044|NCT00004031|449064234|FG000|Overall Study|Other- not protocol specified|3|||
124847045|NCT00004031|449064235|FG001|Overall Study|Other- not protocol specified|3|||
124847046|NCT00004031|449064234|FG000|Overall Study|Reason under review|3|||
124847047|NCT00004031|449064235|FG001|Overall Study|Reason under review|2|||
124847048|NCT01387607|449064236|FG000|Overall Study|Adverse Event|23|||
125306464|NCT00546000|450749031|FG000|Overall Study|Adverse Event|1|||
125306465|NCT00546000|450749031|FG000|Overall Study|Lost to Follow-up|1|||
124847049|NCT01387607|449064237|FG001|Overall Study|Adverse Event|11|||
124847050|NCT01387607|449064236|FG000|Overall Study|Lack of Efficacy|8|||
124847051|NCT01387607|449064237|FG001|Overall Study|Lack of Efficacy|6|||
124847052|NCT01387607|449064236|FG000|Overall Study|Lost to Follow-up|2|||
124847053|NCT01387607|449064237|FG001|Overall Study|Lost to Follow-up|1|||
124847054|NCT01387607|449064236|FG000|Overall Study|No longer meets eligibility criteria|0|||
124847055|NCT01387607|449064237|FG001|Overall Study|No longer meets eligibility criteria|1|||
124847056|NCT01387607|449064236|FG000|Overall Study|Protocol Violation|1|||
124847057|NCT01387607|449064237|FG001|Overall Study|Protocol Violation|5|||
124847058|NCT01387607|449064236|FG000|Overall Study|Withdrawal by Subject|13|||
124847059|NCT01387607|449064237|FG001|Overall Study|Withdrawal by Subject|14|||
124847060|NCT01387607|449064236|FG000|Overall Study|Other|1|||
124847061|NCT01387607|449064237|FG001|Overall Study|Other|1|||
124847062|NCT01387607|449064236|FG000|Overall Study|Randomized, not treated|3|||
125306466|NCT00546000|450749031|FG000|Overall Study|Baseline HPA Axis Supression|2|||
125306467|NCT00660179|450749033|FG000|Overall Study|Death|44|||
125306468|NCT00660179|450749034|FG001|Overall Study|Death|47|||
125306469|NCT00660179|450749035|FG002|Overall Study|Death|34|||
125306470|NCT00660179|450749033|FG000|Overall Study|Withdrawal of consent|4|||
125306471|NCT00660179|450749034|FG001|Overall Study|Withdrawal of consent|6|||
125306472|NCT00660179|450749035|FG002|Overall Study|Withdrawal of consent|4|||
125306473|NCT00660179|450749033|FG000|Overall Study|Lost to Follow-up|7|||
125306474|NCT00660179|450749034|FG001|Overall Study|Lost to Follow-up|5|||
125306475|NCT00660179|450749035|FG002|Overall Study|Lost to Follow-up|2|||
125306476|NCT00660179|450749033|FG000|Overall Study|Administrative reason|0|||
125306477|NCT00660179|450749034|FG001|Overall Study|Administrative reason|0|||
125306478|NCT00660179|450749035|FG002|Overall Study|Administrative reason|1|||
125306479|NCT00660179|450749033|FG000|Overall Study|Incorrect randomization|1|||
125306480|NCT00660179|450749034|FG001|Overall Study|Incorrect randomization|0|||
125306481|NCT00660179|450749035|FG002|Overall Study|Incorrect randomization|0|||
125306482|NCT01504412|450749036|FG000|Overall Study|Adverse Event|1|||
125306483|NCT01504412|450749037|FG001|Overall Study|Adverse Event|8|||
125306484|NCT01504412|450749038|FG002|Overall Study|Adverse Event|1|||
125306485|NCT01504412|450749039|FG003|Overall Study|Adverse Event|7|||
125306486|NCT01504412|450749040|FG004|Overall Study|Adverse Event|10|||
125306487|NCT01504412|450749036|FG000|Overall Study|Withdrawal by Subject|2|||
125306488|NCT01504412|450749037|FG001|Overall Study|Withdrawal by Subject|1|||
125306489|NCT01504412|450749038|FG002|Overall Study|Withdrawal by Subject|1|||
125306490|NCT01504412|450749039|FG003|Overall Study|Withdrawal by Subject|5|||
125306491|NCT01504412|450749040|FG004|Overall Study|Withdrawal by Subject|1|||
124847063|NCT01387607|449064237|FG001|Overall Study|Randomized, not treated|6|||
125306492|NCT01504412|450749036|FG000|Overall Study|Other|2|||
125306493|NCT01504412|450749037|FG001|Overall Study|Other|1|||
125306494|NCT01504412|450749038|FG002|Overall Study|Other|1|||
124847064|NCT03013491|449064239|FG000|Main Study|Death|2|||
124847065|NCT03013491|449064240|FG001|Main Study|Death|2|||
124847066|NCT03013491|449064241|FG002|Main Study|Death|5|||
124847067|NCT03013491|449064242|FG003|Main Study|Death|3|||
124847068|NCT03013491|449064243|FG004|Main Study|Death|9|||
124847069|NCT03013491|449064244|FG005|Main Study|Death|12|||
125306495|NCT01504412|450749039|FG003|Overall Study|Other|6|||
125306496|NCT01504412|450749040|FG004|Overall Study|Other|1|||
125306497|NCT01504412|450749036|FG000|Overall Study|Lost to Follow-up|0|||
125306498|NCT01504412|450749037|FG001|Overall Study|Lost to Follow-up|2|||
124847070|NCT03013491|449064245|FG006|Main Study|Death|3|||
125306499|NCT01504412|450749038|FG002|Overall Study|Lost to Follow-up|0|||
125306500|NCT01504412|450749039|FG003|Overall Study|Lost to Follow-up|0|||
125306501|NCT01504412|450749040|FG004|Overall Study|Lost to Follow-up|0|||
125306502|NCT01504412|450749036|FG000|Overall Study|Lack of Efficacy|0|||
125306503|NCT01504412|450749037|FG001|Overall Study|Lack of Efficacy|0|||
125306504|NCT01504412|450749038|FG002|Overall Study|Lack of Efficacy|1|||
125306505|NCT01504412|450749039|FG003|Overall Study|Lack of Efficacy|0|||
125306506|NCT01504412|450749040|FG004|Overall Study|Lack of Efficacy|1|||
125306507|NCT01504412|450749036|FG000|Overall Study|Death|0|||
125306508|NCT01504412|450749037|FG001|Overall Study|Death|0|||
125306509|NCT01504412|450749038|FG002|Overall Study|Death|0|||
125306510|NCT01504412|450749039|FG003|Overall Study|Death|1|||
125306511|NCT01504412|450749040|FG004|Overall Study|Death|0|||
125306512|NCT01449006|450749041|FG000|Overall Study|Lost to Follow-up|1|||
125306513|NCT01449006|450749042|FG001|Overall Study|Lost to Follow-up|0|||
125306514|NCT01449006|450749041|FG000|Overall Study|Withdrawal by Subject|1|||
125306515|NCT01449006|450749042|FG001|Overall Study|Withdrawal by Subject|0|||
125306516|NCT01449006|450749041|FG000|Overall Study|Protocol Violation|1|||
125306517|NCT01449006|450749042|FG001|Overall Study|Protocol Violation|0|||
125306518|NCT02221674|450749046|FG000|Overall Study|Lost to Follow-up|1|||
125306519|NCT02221674|450749047|FG001|Overall Study|Lost to Follow-up|0|||
125306520|NCT02221674|450749048|FG002|Overall Study|Lost to Follow-up|0|||
125306521|NCT05292131|450749049|FG000|Overall Study|Lost to Follow-up|1|||
125306522|NCT05292131|450749050|FG001|Overall Study|Lost to Follow-up|1|||
125306523|NCT05292131|450749049|FG000|Overall Study|Withdrawal by Subject|0|||
125306524|NCT05292131|450749050|FG001|Overall Study|Withdrawal by Subject|1|||
125306525|NCT04390880|450749052|FG000|Overall Study|Withdrawal by Subject|1|||
125306526|NCT02557542|450749053|FG000|Overall Study|Poor recruitment|3|||
125306527|NCT02557542|450749054|FG001|Overall Study|Poor recruitment|0|||
125306528|NCT06136897|450749055|FG000|Overall Study|Ineligible|3|||
125306529|NCT06136897|450749055|FG000|Overall Study|Mutation status not confirmed|7|||
125306530|NCT06136897|450749055|FG000|Overall Study|Adverse Event|2|||
125306531|NCT06136897|450749055|FG000|Overall Study|Death|1|||
125306532|NCT06136897|450749055|FG000|Overall Study|Disease progression|18|||
125306533|NCT06136897|450749055|FG000|Overall Study|Other complicating disease|1|||
125306534|NCT06136897|450749055|FG000|Overall Study|Withdrawal by Subject|1|||
125306535|NCT06136897|450749055|FG000|Overall Study|Still on treatment|1|||
125306536|NCT06136897|450749055|FG000|Overall Study|Lost to Follow-up|1|||
125306537|NCT03705559|450749056|FG000|Overall Study|COVID Shut down|1|||
125306538|NCT01979952|450749059|FG000|Overall Study|Adverse Event|4|||
125306539|NCT01979952|450749060|FG001|Overall Study|Adverse Event|5|||
125306540|NCT01979952|450749059|FG000|Overall Study|Protocol Violation|1|||
125306541|NCT01979952|450749060|FG001|Overall Study|Protocol Violation|0|||
125306542|NCT01979952|450749059|FG000|Overall Study|Withdrawal by Subject|2|||
125306543|NCT01979952|450749060|FG001|Overall Study|Withdrawal by Subject|1|||
125306544|NCT01979952|450749059|FG000|Overall Study|Other than specified above|1|||
125306545|NCT01979952|450749060|FG001|Overall Study|Other than specified above|0|||
125306546|NCT05438576|450749061|FG000|Overall Study|Death|1|||
125306547|NCT05438576|450749062|FG001|Overall Study|Death|1|||
125306548|NCT05438576|450749061|FG000|Overall Study|Withdrawal by Subject|4|||
125306549|NCT05438576|450749062|FG001|Overall Study|Withdrawal by Subject|2|||
125306550|NCT05438576|450749061|FG000|Overall Study|Not Eligible|2|||
125306551|NCT05438576|450749062|FG001|Overall Study|Not Eligible|1|||
125306552|NCT05438576|450749061|FG000|Overall Study|Did not complete baseline testing|22|||
125306553|NCT05438576|450749062|FG001|Overall Study|Did not complete baseline testing|4|||
125306554|NCT01067144|450749068|FG000|Treatment|Did not receive allocated intervention|4|||
125306555|NCT01067144|450749069|FG001|Treatment|Did not receive allocated intervention|7|||
124847071|NCT03013491|449064246|FG007|Main Study|Death|5|||
124847072|NCT03013491|449064247|FG008|Main Study|Death|1|||
124847073|NCT03013491|449064248|FG009|Main Study|Death|2|||
124847074|NCT03013491|449064249|FG010|Main Study|Death|4|||
125306556|NCT01067144|450749068|FG000|Follow-up|Lost to Follow-up|22|||
125306557|NCT01067144|450749069|FG001|Follow-up|Lost to Follow-up|12|||
125306558|NCT01067144|450749068|FG000|Follow-up|Censored owing to second surgery|19|||
125306559|NCT01067144|450749069|FG001|Follow-up|Censored owing to second surgery|28|||
125306560|NCT01067144|450749068|FG000|Follow-up|Withdrawal by Subject|18|||
125306561|NCT01067144|450749069|FG001|Follow-up|Withdrawal by Subject|14|||
125306562|NCT01067144|450749068|FG000|Follow-up|Surgery cancelled|0|||
125306563|NCT01067144|450749069|FG001|Follow-up|Surgery cancelled|1|||
125306564|NCT01067144|450749068|FG000|Follow-up|Death|0|||
125306565|NCT01067144|450749069|FG001|Follow-up|Death|1|||
125306566|NCT00203424|450749071|FG000|Treatment Period|Withdrawal by Subject|4|||
125306567|NCT00203424|450749071|FG000|Treatment Period|Adverse Event|5|||
125306568|NCT00203424|450749071|FG000|Treatment Period|progressive disease|2|||
125306569|NCT00203424|450749071|FG000|Follow-up Period|Withdrawal by Subject|1|||
125306570|NCT00203424|450749071|FG000|Follow-up Period|progressive disease|4|||
125306571|NCT00203424|450749071|FG000|Follow-up Period|Lost to Follow-up|1|||
125306572|NCT00555672|450749072|FG000|Overall Study|Death|0|||
125306573|NCT00555672|450749073|FG001|Overall Study|Death|2|||
124847075|NCT03013491|449064250|FG011|Main Study|Death|1|||
124847076|NCT03013491|449064251|FG012|Main Study|Death|1|||
124847077|NCT03013491|449064252|FG013|Main Study|Death|4|||
125306574|NCT00555672|450749072|FG000|Overall Study|Adverse Event|8|||
125306575|NCT00555672|450749073|FG001|Overall Study|Adverse Event|2|||
125306576|NCT00555672|450749072|FG000|Overall Study|Objective progression or relapse|11|||
125306577|NCT00555672|450749073|FG001|Overall Study|Objective progression or relapse|5|||
125306578|NCT00555672|450749072|FG000|Overall Study|Other|3|||
125306579|NCT00555672|450749073|FG001|Overall Study|Other|1|||
125306580|NCT00555672|450749072|FG000|Overall Study|Participant refused|2|||
125306581|NCT00555672|450749073|FG001|Overall Study|Participant refused|0|||
125306582|NCT01053988|450749074|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
125306583|NCT01053988|450749075|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125306584|NCT01053988|450749076|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125306585|NCT01053988|450749077|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125306586|NCT01053988|450749078|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125306587|NCT01053988|450749079|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125306588|NCT01053988|450749074|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
125306589|NCT01053988|450749075|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125306590|NCT01053988|450749076|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125306591|NCT01053988|450749077|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125306592|NCT01053988|450749078|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125306593|NCT01053988|450749079|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125306594|NCT01053988|450749074|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
125306595|NCT01053988|450749075|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125306596|NCT01053988|450749076|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125306597|NCT01053988|450749077|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125306598|NCT01053988|450749078|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125306599|NCT01053988|450749079|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125306600|NCT01053988|450749074|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
125306601|NCT01053988|450749075|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
125306602|NCT01053988|450749076|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
125306603|NCT01053988|450749077|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
125306604|NCT01053988|450749078|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
125306605|NCT01053988|450749079|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
125306606|NCT01053988|450749074|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
125306607|NCT01053988|450749075|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
125306608|NCT01053988|450749076|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
125306609|NCT01053988|450749077|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
125306610|NCT01053988|450749078|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
125306611|NCT01053988|450749079|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
125306612|NCT01053988|450749074|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
125306613|NCT01053988|450749075|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125306614|NCT01053988|450749076|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125306615|NCT01053988|450749077|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125306616|NCT01053988|450749078|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125306617|NCT01053988|450749079|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125306618|NCT01053988|450749074|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
125306619|NCT01053988|450749075|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
125306620|NCT01053988|450749076|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
124847078|NCT03013491|449064253|FG014|Main Study|Death|0|||
124847079|NCT03013491|449064254|FG015|Main Study|Death|3|||
124847080|NCT03013491|449064255|FG016|Main Study|Death|5|||
124847081|NCT03013491|449064256|FG017|Main Study|Death|1|||
124847082|NCT03013491|449064257|FG018|Main Study|Death|47|||
124847083|NCT03013491|449064239|FG000|Main Study|Lost to Follow-up|0|||
124847084|NCT03013491|449064240|FG001|Main Study|Lost to Follow-up|0|||
124847085|NCT03013491|449064241|FG002|Main Study|Lost to Follow-up|1|||
124847086|NCT03013491|449064242|FG003|Main Study|Lost to Follow-up|0|||
124847087|NCT03013491|449064243|FG004|Main Study|Lost to Follow-up|1|||
124847088|NCT03013491|449064244|FG005|Main Study|Lost to Follow-up|0|||
124847089|NCT03013491|449064245|FG006|Main Study|Lost to Follow-up|0|||
124847090|NCT03013491|449064246|FG007|Main Study|Lost to Follow-up|0|||
124847091|NCT03013491|449064247|FG008|Main Study|Lost to Follow-up|0|||
124847092|NCT03013491|449064248|FG009|Main Study|Lost to Follow-up|0|||
124847093|NCT03013491|449064249|FG010|Main Study|Lost to Follow-up|0|||
125306621|NCT01053988|450749077|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
125306622|NCT01053988|450749078|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
125306623|NCT01053988|450749079|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
125306624|NCT01053988|450749074|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125306625|NCT01053988|450749075|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
124847094|NCT03013491|449064250|FG011|Main Study|Lost to Follow-up|0|||
124847095|NCT03013491|449064251|FG012|Main Study|Lost to Follow-up|0|||
124847096|NCT03013491|449064252|FG013|Main Study|Lost to Follow-up|0|||
124847097|NCT03013491|449064253|FG014|Main Study|Lost to Follow-up|0|||
124847098|NCT03013491|449064254|FG015|Main Study|Lost to Follow-up|0|||
124847099|NCT03013491|449064255|FG016|Main Study|Lost to Follow-up|0|||
124847100|NCT03013491|449064256|FG017|Main Study|Lost to Follow-up|0|||
124847101|NCT03013491|449064257|FG018|Main Study|Lost to Follow-up|3|||
124847102|NCT03013491|449064239|FG000|Main Study|Termination of the study by Sponsor|0|||
124847103|NCT03013491|449064240|FG001|Main Study|Termination of the study by Sponsor|0|||
124847104|NCT03013491|449064241|FG002|Main Study|Termination of the study by Sponsor|2|||
124847105|NCT03013491|449064242|FG003|Main Study|Termination of the study by Sponsor|0|||
124847106|NCT03013491|449064243|FG004|Main Study|Termination of the study by Sponsor|1|||
124847107|NCT03013491|449064244|FG005|Main Study|Termination of the study by Sponsor|2|||
124847108|NCT03013491|449064245|FG006|Main Study|Termination of the study by Sponsor|0|||
124847109|NCT03013491|449064246|FG007|Main Study|Termination of the study by Sponsor|0|||
124847110|NCT03013491|449064247|FG008|Main Study|Termination of the study by Sponsor|1|||
124847111|NCT03013491|449064248|FG009|Main Study|Termination of the study by Sponsor|1|||
124847112|NCT03013491|449064249|FG010|Main Study|Termination of the study by Sponsor|1|||
124847113|NCT03013491|449064250|FG011|Main Study|Termination of the study by Sponsor|2|||
124847114|NCT03013491|449064251|FG012|Main Study|Termination of the study by Sponsor|0|||
124847115|NCT03013491|449064252|FG013|Main Study|Termination of the study by Sponsor|0|||
124847116|NCT03013491|449064253|FG014|Main Study|Termination of the study by Sponsor|0|||
124847117|NCT03013491|449064254|FG015|Main Study|Termination of the study by Sponsor|0|||
124847118|NCT03013491|449064255|FG016|Main Study|Termination of the study by Sponsor|0|||
124847119|NCT03013491|449064256|FG017|Main Study|Termination of the study by Sponsor|1|||
124847120|NCT03013491|449064257|FG018|Main Study|Termination of the study by Sponsor|13|||
124847121|NCT03013491|449064239|FG000|Main Study|Withdrawal by Subject|0|||
124847122|NCT03013491|449064240|FG001|Main Study|Withdrawal by Subject|0|||
124847123|NCT03013491|449064241|FG002|Main Study|Withdrawal by Subject|0|||
124847124|NCT03013491|449064242|FG003|Main Study|Withdrawal by Subject|4|||
124847125|NCT03013491|449064243|FG004|Main Study|Withdrawal by Subject|2|||
124847126|NCT03013491|449064244|FG005|Main Study|Withdrawal by Subject|1|||
124847127|NCT03013491|449064245|FG006|Main Study|Withdrawal by Subject|0|||
124847128|NCT03013491|449064246|FG007|Main Study|Withdrawal by Subject|0|||
124847129|NCT03013491|449064247|FG008|Main Study|Withdrawal by Subject|0|||
124847130|NCT03013491|449064248|FG009|Main Study|Withdrawal by Subject|0|||
124847131|NCT03013491|449064249|FG010|Main Study|Withdrawal by Subject|1|||
124847132|NCT03013491|449064250|FG011|Main Study|Withdrawal by Subject|2|||
124847133|NCT03013491|449064251|FG012|Main Study|Withdrawal by Subject|0|||
124847134|NCT03013491|449064252|FG013|Main Study|Withdrawal by Subject|2|||
124847135|NCT03013491|449064253|FG014|Main Study|Withdrawal by Subject|0|||
124847136|NCT03013491|449064254|FG015|Main Study|Withdrawal by Subject|0|||
124847137|NCT03013491|449064255|FG016|Main Study|Withdrawal by Subject|0|||
124847138|NCT03013491|449064256|FG017|Main Study|Withdrawal by Subject|0|||
124847139|NCT03013491|449064257|FG018|Main Study|Withdrawal by Subject|18|||
124847140|NCT03013491|449064239|FG000|Main Study|Disease progression|0|||
124847141|NCT03013491|449064240|FG001|Main Study|Disease progression|0|||
124847142|NCT03013491|449064241|FG002|Main Study|Disease progression|0|||
124847143|NCT03013491|449064242|FG003|Main Study|Disease progression|1|||
124847144|NCT03013491|449064243|FG004|Main Study|Disease progression|0|||
124847145|NCT03013491|449064244|FG005|Main Study|Disease progression|0|||
124847146|NCT03013491|449064245|FG006|Main Study|Disease progression|0|||
124847147|NCT03013491|449064246|FG007|Main Study|Disease progression|0|||
124847148|NCT03013491|449064247|FG008|Main Study|Disease progression|1|||
124847149|NCT03013491|449064248|FG009|Main Study|Disease progression|0|||
124847150|NCT03013491|449064249|FG010|Main Study|Disease progression|1|||
124847151|NCT03013491|449064250|FG011|Main Study|Disease progression|0|||
124847152|NCT03013491|449064251|FG012|Main Study|Disease progression|0|||
124847153|NCT03013491|449064252|FG013|Main Study|Disease progression|0|||
124847154|NCT03013491|449064253|FG014|Main Study|Disease progression|0|||
124847155|NCT03013491|449064254|FG015|Main Study|Disease progression|0|||
124847156|NCT03013491|449064255|FG016|Main Study|Disease progression|0|||
124847157|NCT03013491|449064256|FG017|Main Study|Disease progression|0|||
124847158|NCT03013491|449064257|FG018|Main Study|Disease progression|4|||
124847159|NCT03013491|449064239|FG000|Main Study|Symptomatic deterioration|0|||
124847160|NCT03013491|449064240|FG001|Main Study|Symptomatic deterioration|0|||
124847161|NCT03013491|449064241|FG002|Main Study|Symptomatic deterioration|0|||
124847162|NCT03013491|449064242|FG003|Main Study|Symptomatic deterioration|0|||
124847163|NCT03013491|449064243|FG004|Main Study|Symptomatic deterioration|0|||
124847164|NCT03013491|449064244|FG005|Main Study|Symptomatic deterioration|1|||
124847165|NCT03013491|449064245|FG006|Main Study|Symptomatic deterioration|0|||
124847166|NCT03013491|449064246|FG007|Main Study|Symptomatic deterioration|0|||
124847167|NCT03013491|449064247|FG008|Main Study|Symptomatic deterioration|0|||
124847168|NCT03013491|449064248|FG009|Main Study|Symptomatic deterioration|0|||
124847169|NCT03013491|449064249|FG010|Main Study|Symptomatic deterioration|0|||
124847170|NCT03013491|449064250|FG011|Main Study|Symptomatic deterioration|0|||
124847171|NCT03013491|449064251|FG012|Main Study|Symptomatic deterioration|0|||
124847172|NCT03013491|449064252|FG013|Main Study|Symptomatic deterioration|0|||
124847173|NCT03013491|449064253|FG014|Main Study|Symptomatic deterioration|0|||
124847174|NCT03013491|449064254|FG015|Main Study|Symptomatic deterioration|0|||
125306626|NCT01053988|450749076|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
125306627|NCT01053988|450749077|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
125306628|NCT01053988|450749078|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
125306629|NCT01053988|450749079|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125306630|NCT01053988|450749074|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
125306631|NCT01053988|450749075|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
125306632|NCT01053988|450749076|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
125306633|NCT01053988|450749077|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
125306634|NCT01053988|450749078|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
125306635|NCT01053988|450749079|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
125306636|NCT01053988|450749074|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
125306637|NCT01053988|450749075|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
125306638|NCT01053988|450749076|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
125306639|NCT01053988|450749077|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
125306640|NCT01053988|450749078|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
125306641|NCT01053988|450749079|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
125306642|NCT01053988|450749074|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
125306643|NCT01053988|450749075|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
125306644|NCT01053988|450749076|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
125306645|NCT01053988|450749077|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
125306646|NCT01053988|450749078|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
125306647|NCT01053988|450749079|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
125306648|NCT01053988|450749074|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125306649|NCT01053988|450749075|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
125306650|NCT01053988|450749076|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125306651|NCT01053988|450749077|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
125306652|NCT01053988|450749078|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
125306653|NCT01053988|450749079|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
125306654|NCT01053988|450749074|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
125306655|NCT01053988|450749075|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
125306656|NCT01053988|450749076|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
125306657|NCT01053988|450749077|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
125306658|NCT01053988|450749078|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
125306659|NCT01053988|450749079|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
125306660|NCT01053988|450749074|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
125306661|NCT01053988|450749075|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
125306662|NCT01053988|450749076|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
125306663|NCT01053988|450749077|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
125306664|NCT01053988|450749078|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
125306665|NCT01053988|450749079|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
125306666|NCT01824355|450749084|FG000|Overall Study|Adverse Event|2|||
125306667|NCT01824355|450749084|FG000|Overall Study|unevaluable reference method results per|1|||
125306668|NCT04427072|450749086|FG000|Randomized Treatment Phase|Progressive disease|9|||
125306669|NCT04427072|450749087|FG001|Randomized Treatment Phase|Progressive disease|4|||
125306670|NCT04427072|450749086|FG000|Randomized Treatment Phase|Adverse Event|3|||
125306671|NCT04427072|450749087|FG001|Randomized Treatment Phase|Adverse Event|1|||
125306672|NCT04427072|450749086|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
125306673|NCT04427072|450749087|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
125306674|NCT04427072|450749086|FG000|Randomized Treatment Phase|Death|0|||
125306675|NCT04427072|450749087|FG001|Randomized Treatment Phase|Death|1|||
125306676|NCT04427072|450749086|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
125306677|NCT04427072|450749087|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
125306678|NCT04427072|450749086|FG000|Extension Treatment Phase|Progressive disease|0|||
125306679|NCT04427072|450749087|FG001|Extension Treatment Phase|Progressive disease|5|||
125306680|NCT02104947|450749093|FG000|Overall Study|Withdrawal by Subject|10|||
125306681|NCT02104947|450749094|FG001|Overall Study|Withdrawal by Subject|3|||
125306682|NCT02104947|450749093|FG000|Overall Study|Lost to Follow-up|4|||
125306683|NCT02104947|450749094|FG001|Overall Study|Lost to Follow-up|4|||
125306684|NCT02104947|450749093|FG000|Overall Study|Protocol Violation|6|||
125306685|NCT02104947|450749094|FG001|Overall Study|Protocol Violation|8|||
125306686|NCT02104947|450749093|FG000|Overall Study|Adverse Event|57|||
125306687|NCT02104947|450749094|FG001|Overall Study|Adverse Event|38|||
125306688|NCT02104947|450749093|FG000|Overall Study|Other than stated above|2|||
125306689|NCT02104947|450749094|FG001|Overall Study|Other than stated above|3|||
125306690|NCT04698993|450749099|FG000|Overall Study|PCR results not accessible|2|||
125306691|NCT04698993|450749100|FG001|Overall Study|PCR results not accessible|7|||
125306692|NCT04698993|450749099|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
125306693|NCT04698993|450749100|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
125306694|NCT00145574|450749101|FG000|Double Blind|Adverse Event|0|||
125306695|NCT00145574|450749102|FG001|Double Blind|Adverse Event|3|||
125306696|NCT00145574|450749103|FG002|Double Blind|Adverse Event|1|||
125306697|NCT00145574|450749101|FG000|Double Blind|Withdrawal by Subject|1|||
125306698|NCT00145574|450749102|FG001|Double Blind|Withdrawal by Subject|1|||
125306699|NCT00145574|450749103|FG002|Double Blind|Withdrawal by Subject|1|||
125306700|NCT00145574|450749101|FG000|Double Blind|required restricted medicine|0|||
125306701|NCT00145574|450749102|FG001|Double Blind|required restricted medicine|1|||
125306702|NCT00145574|450749103|FG002|Double Blind|required restricted medicine|0|||
125306703|NCT00145574|450749101|FG000|Open Label Long-term Extension|Adverse Event|0|||
125306704|NCT00145574|450749102|FG001|Open Label Long-term Extension|Adverse Event|0|||
125306705|NCT00145574|450749103|FG002|Open Label Long-term Extension|Adverse Event|5|||
125306706|NCT00145574|450749101|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
125306707|NCT00145574|450749102|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
125306708|NCT00145574|450749103|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
125306709|NCT00145574|450749101|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
125306710|NCT00145574|450749102|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
125306711|NCT00145574|450749103|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
125306712|NCT00145574|450749101|FG000|Open Label Long-term Extension|required restricted medicine|0|||
125306713|NCT00145574|450749102|FG001|Open Label Long-term Extension|required restricted medicine|0|||
125306714|NCT00145574|450749103|FG002|Open Label Long-term Extension|required restricted medicine|1|||
125306715|NCT00527904|450749104|FG000|Overall Study|Adverse Event|45|||
125306716|NCT00527904|450749104|FG000|Overall Study|Withdrawal by Subject|21|||
125306717|NCT00527904|450749104|FG000|Overall Study|Lost to Follow-up|8|||
125306718|NCT00527904|450749104|FG000|Overall Study|misc|22|||
125306719|NCT01320202|450749108|FG000|Overall Study|Adverse Event|5|||
125306720|NCT01320202|450749109|FG001|Overall Study|Adverse Event|5|||
125306721|NCT01320202|450749108|FG000|Overall Study|Death|5|||
125306722|NCT01320202|450749109|FG001|Overall Study|Death|3|||
125306723|NCT01320202|450749108|FG000|Overall Study|Lost to Follow-up|1|||
125306724|NCT01320202|450749109|FG001|Overall Study|Lost to Follow-up|0|||
125306725|NCT01320202|450749108|FG000|Overall Study|Physician Decision|3|||
125306726|NCT01320202|450749109|FG001|Overall Study|Physician Decision|1|||
125306727|NCT01320202|450749108|FG000|Overall Study|Protocol Violation|2|||
125306728|NCT01320202|450749109|FG001|Overall Study|Protocol Violation|1|||
125306729|NCT01320202|450749108|FG000|Overall Study|Withdrawal by Subject|10|||
125306730|NCT01320202|450749109|FG001|Overall Study|Withdrawal by Subject|3|||
125306731|NCT01320202|450749108|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
125306732|NCT01320202|450749109|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
125306733|NCT01320202|450749108|FG000|Overall Study|kidney transplant|1|||
124847175|NCT03013491|449064255|FG016|Main Study|Symptomatic deterioration|0|||
124847176|NCT03013491|449064256|FG017|Main Study|Symptomatic deterioration|0|||
124847177|NCT03013491|449064257|FG018|Main Study|Symptomatic deterioration|0|||
124847178|NCT03013491|449064239|FG000|Main Study|Protocol version 8.0 approval|0|||
124847179|NCT03013491|449064240|FG001|Main Study|Protocol version 8.0 approval|0|||
124847180|NCT03013491|449064241|FG002|Main Study|Protocol version 8.0 approval|0|||
124847181|NCT03013491|449064242|FG003|Main Study|Protocol version 8.0 approval|0|||
124847182|NCT03013491|449064243|FG004|Main Study|Protocol version 8.0 approval|0|||
124847183|NCT03013491|449064244|FG005|Main Study|Protocol version 8.0 approval|0|||
124847184|NCT03013491|449064245|FG006|Main Study|Protocol version 8.0 approval|0|||
125306734|NCT01320202|450749109|FG001|Overall Study|kidney transplant|2|||
125306735|NCT01320202|450749108|FG000|Overall Study|blood transfusion|1|||
125306736|NCT01320202|450749109|FG001|Overall Study|blood transfusion|7|||
125306737|NCT01320202|450749108|FG000|Overall Study|moved/changed dialysis|5|||
125306738|NCT01320202|450749109|FG001|Overall Study|moved/changed dialysis|2|||
125306739|NCT01320202|450749108|FG000|Overall Study|sponsor request|2|||
125306740|NCT01320202|450749109|FG001|Overall Study|sponsor request|0|||
125306741|NCT01320202|450749108|FG000|Overall Study|ineligible|3|||
125306742|NCT01320202|450749109|FG001|Overall Study|ineligible|0|||
125306743|NCT01320202|450749108|FG000|Overall Study|regained renal function|1|||
125306744|NCT01320202|450749109|FG001|Overall Study|regained renal function|0|||
124847185|NCT03013491|449064246|FG007|Main Study|Protocol version 8.0 approval|0|||
125306745|NCT00635882|450749110|FG000|Overall Study|Protocol Violation|1|||
125306746|NCT00635882|450749111|FG001|Overall Study|Protocol Violation|0|||
125306747|NCT00635882|450749112|FG002|Overall Study|Protocol Violation|0|||
125306748|NCT00635882|450749113|FG003|Overall Study|Protocol Violation|0|||
124847186|NCT03013491|449064247|FG008|Main Study|Protocol version 8.0 approval|0|||
125306749|NCT00635882|450749114|FG004|Overall Study|Protocol Violation|0|||
125306750|NCT00635882|450749115|FG005|Overall Study|Protocol Violation|0|||
125306751|NCT00858637|450749116|FG000|Active Comparison Phase|Adverse Event|14|||
125306752|NCT00858637|450749117|FG001|Active Comparison Phase|Adverse Event|0|||
125306753|NCT00858637|450749118|FG002|Active Comparison Phase|Adverse Event|0|||
125306754|NCT00858637|450749119|FG003|Active Comparison Phase|Adverse Event|9|||
125306755|NCT00858637|450749120|FG004|Active Comparison Phase|Adverse Event|0|||
125306756|NCT00858637|450749121|FG005|Active Comparison Phase|Adverse Event|0|||
125306757|NCT00858637|450749116|FG000|Active Comparison Phase|Death|1|||
125306758|NCT00858637|450749117|FG001|Active Comparison Phase|Death|0|||
125306759|NCT00858637|450749118|FG002|Active Comparison Phase|Death|0|||
125306760|NCT00858637|450749119|FG003|Active Comparison Phase|Death|1|||
125306761|NCT00858637|450749120|FG004|Active Comparison Phase|Death|0|||
125306762|NCT00858637|450749121|FG005|Active Comparison Phase|Death|0|||
125306763|NCT00858637|450749116|FG000|Active Comparison Phase|Physician Decision|1|||
125306764|NCT00858637|450749117|FG001|Active Comparison Phase|Physician Decision|0|||
125306765|NCT00858637|450749118|FG002|Active Comparison Phase|Physician Decision|0|||
125306766|NCT00858637|450749119|FG003|Active Comparison Phase|Physician Decision|1|||
125306767|NCT00858637|450749120|FG004|Active Comparison Phase|Physician Decision|0|||
125306768|NCT00858637|450749121|FG005|Active Comparison Phase|Physician Decision|0|||
125306769|NCT00858637|450749116|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
125306770|NCT00858637|450749117|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
125306771|NCT00858637|450749118|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
125306772|NCT00858637|450749119|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
125306773|NCT00858637|450749120|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
125306774|NCT00858637|450749121|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
125306775|NCT00858637|450749116|FG000|Active Comparison Phase|Other Reasons|1|||
125306776|NCT00858637|450749117|FG001|Active Comparison Phase|Other Reasons|0|||
125306777|NCT00858637|450749118|FG002|Active Comparison Phase|Other Reasons|0|||
125306778|NCT00858637|450749119|FG003|Active Comparison Phase|Other Reasons|1|||
125306779|NCT00858637|450749120|FG004|Active Comparison Phase|Other Reasons|0|||
125306780|NCT00858637|450749121|FG005|Active Comparison Phase|Other Reasons|0|||
125306781|NCT00858637|450749116|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
125306782|NCT00858637|450749117|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
125306783|NCT00858637|450749118|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
125306784|NCT00858637|450749119|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
125306785|NCT00858637|450749120|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
125306786|NCT00858637|450749121|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
125306787|NCT00858637|450749116|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
125306788|NCT00858637|450749117|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
125306789|NCT00858637|450749118|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
125306790|NCT00858637|450749119|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
125306791|NCT00858637|450749120|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
125306792|NCT00858637|450749121|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
125306793|NCT00835341|450749122|FG000|Overall Study|Lost to Follow-up|3|||
125306794|NCT00835341|450749123|FG001|Overall Study|Lost to Follow-up|12|||
125306795|NCT02305238|450749124|FG000|Overall Study|Death|2|||
125306796|NCT02305238|450749125|FG001|Overall Study|Death|1|||
125306797|NCT02305238|450749126|FG002|Overall Study|Death|0|||
125306798|NCT02305238|450749124|FG000|Overall Study|Progressive disease|4|||
125306799|NCT02305238|450749125|FG001|Overall Study|Progressive disease|4|||
125306800|NCT02305238|450749126|FG002|Overall Study|Progressive disease|0|||
125306801|NCT02305238|450749124|FG000|Overall Study|Logistical difficulties|1|||
125306802|NCT02305238|450749125|FG001|Overall Study|Logistical difficulties|3|||
125306803|NCT02305238|450749126|FG002|Overall Study|Logistical difficulties|0|||
125306804|NCT02305238|450749124|FG000|Overall Study|Protocol Violation|0|||
125306805|NCT02305238|450749125|FG001|Overall Study|Protocol Violation|3|||
125306806|NCT02305238|450749126|FG002|Overall Study|Protocol Violation|0|||
125306807|NCT02305238|450749124|FG000|Overall Study|Physician Decision|2|||
125306808|NCT02305238|450749125|FG001|Overall Study|Physician Decision|1|||
125306809|NCT02305238|450749126|FG002|Overall Study|Physician Decision|0|||
125306810|NCT02305238|450749124|FG000|Overall Study|Adverse Event|4|||
125306811|NCT02305238|450749125|FG001|Overall Study|Adverse Event|2|||
125306812|NCT02305238|450749126|FG002|Overall Study|Adverse Event|0|||
125306813|NCT02305238|450749124|FG000|Overall Study|Withdrawal by Subject|3|||
125306814|NCT02305238|450749125|FG001|Overall Study|Withdrawal by Subject|4|||
125306815|NCT02305238|450749126|FG002|Overall Study|Withdrawal by Subject|0|||
125306816|NCT02305238|450749124|FG000|Overall Study|Randomized failure|0|||
124847187|NCT03013491|449064248|FG009|Main Study|Protocol version 8.0 approval|0|||
124847188|NCT03013491|449064249|FG010|Main Study|Protocol version 8.0 approval|1|||
125306817|NCT02305238|450749125|FG001|Overall Study|Randomized failure|0|||
124847189|NCT03013491|449064250|FG011|Main Study|Protocol version 8.0 approval|0|||
125306818|NCT02305238|450749126|FG002|Overall Study|Randomized failure|8|||
125306819|NCT02305238|450749124|FG000|Overall Study|Required procedure failed|0|||
125306820|NCT02305238|450749125|FG001|Overall Study|Required procedure failed|1|||
125306821|NCT02305238|450749126|FG002|Overall Study|Required procedure failed|0|||
125306822|NCT02513472|450749127|FG000|Overall Study|Radiological Disease Progression|45|||
125306823|NCT02513472|450749128|FG001|Overall Study|Radiological Disease Progression|57|||
125306824|NCT02513472|450749127|FG000|Overall Study|Clinical Disease Progression|5|||
125306825|NCT02513472|450749128|FG001|Overall Study|Clinical Disease Progression|13|||
125306826|NCT02513472|450749127|FG000|Overall Study|Adverse Event|8|||
125306827|NCT02513472|450749128|FG001|Overall Study|Adverse Event|11|||
125306828|NCT02513472|450749127|FG000|Overall Study|Withdrawal by Subject|0|||
125306829|NCT02513472|450749128|FG001|Overall Study|Withdrawal by Subject|4|||
125306830|NCT02513472|450749127|FG000|Overall Study|Subject Choice|2|||
125306831|NCT02513472|450749128|FG001|Overall Study|Subject Choice|7|||
125306832|NCT02513472|450749127|FG000|Overall Study|Treatment Completed as per Protocol|3|||
125306833|NCT02513472|450749128|FG001|Overall Study|Treatment Completed as per Protocol|3|||
125306834|NCT02513472|450749127|FG000|Overall Study|Other|3|||
125306835|NCT02513472|450749128|FG001|Overall Study|Other|6|||
125306836|NCT04565951|450749134|FG000|Overall Study|Lost to Follow-up|66|||
125306837|NCT04565951|450749135|FG001|Overall Study|Lost to Follow-up|38|||
125306838|NCT04565951|450749134|FG000|Overall Study|Withdrawal by Subject|14|||
125306839|NCT04565951|450749135|FG001|Overall Study|Withdrawal by Subject|7|||
125306840|NCT04565951|450749134|FG000|Overall Study|Death|0|||
125306841|NCT04565951|450749135|FG001|Overall Study|Death|1|||
125306842|NCT04677504|450749136|FG000|Overall Study|Death|51|||
125306843|NCT04677504|450749137|FG001|Overall Study|Death|49|||
125306844|NCT04677504|450749136|FG000|Overall Study|Progressive Disease|1|||
125306845|NCT04677504|450749137|FG001|Overall Study|Progressive Disease|0|||
125306846|NCT04677504|450749136|FG000|Overall Study|Symptomatic Deterioration|1|||
125306847|NCT04677504|450749137|FG001|Overall Study|Symptomatic Deterioration|0|||
125306848|NCT04677504|450749136|FG000|Overall Study|Withdrawal by Subject|2|||
125306849|NCT04677504|450749137|FG001|Overall Study|Withdrawal by Subject|5|||
125306850|NCT04677504|450749136|FG000|Overall Study|Study Terminated By Sponsor|28|||
125306851|NCT04677504|450749137|FG001|Overall Study|Study Terminated By Sponsor|24|||
125306852|NCT04677504|450749136|FG000|Overall Study|Adverse Event|0|||
125306853|NCT04677504|450749137|FG001|Overall Study|Adverse Event|1|||
125306854|NCT00167310|450749148|FG000|Overall Study|Protocol Violation|5|||
125306855|NCT00167310|450749149|FG001|Overall Study|Protocol Violation|3|||
125306856|NCT00167310|450749148|FG000|Overall Study|Withdrawal by Subject|3|||
125306857|NCT00167310|450749149|FG001|Overall Study|Withdrawal by Subject|7|||
125306858|NCT03543137|450749150|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
125306859|NCT03543137|450749151|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
125306860|NCT03543137|450749150|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
125306861|NCT03543137|450749151|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
125306862|NCT03543137|450749150|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
125306863|NCT03543137|450749151|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
125306864|NCT00445770|450749152|FG000|Overall Study|Adverse Event|9|||
125306865|NCT00445770|450749153|FG001|Overall Study|Adverse Event|15|||
125306866|NCT00445770|450749154|FG002|Overall Study|Adverse Event|19|||
125306867|NCT00445770|450749152|FG000|Overall Study|Lack of Efficacy|38|||
125306868|NCT00445770|450749153|FG001|Overall Study|Lack of Efficacy|13|||
125306869|NCT00445770|450749154|FG002|Overall Study|Lack of Efficacy|6|||
125306870|NCT00445770|450749152|FG000|Overall Study|Lost to Follow-up|0|||
125306871|NCT00445770|450749153|FG001|Overall Study|Lost to Follow-up|2|||
125306872|NCT00445770|450749154|FG002|Overall Study|Lost to Follow-up|0|||
125306873|NCT00445770|450749152|FG000|Overall Study|Other|6|||
125306874|NCT00445770|450749153|FG001|Overall Study|Other|5|||
125306875|NCT00445770|450749154|FG002|Overall Study|Other|6|||
125306876|NCT03857542|450749155|FG000|Overall Study|Adverse Event|1|||
125306877|NCT03857542|450749156|FG001|Overall Study|Adverse Event|3|||
125306878|NCT03857542|450749155|FG000|Overall Study|Withdrawal by Subject|2|||
125306879|NCT03857542|450749156|FG001|Overall Study|Withdrawal by Subject|1|||
125306880|NCT03857542|450749155|FG000|Overall Study|Lost to Follow-up|2|||
125306881|NCT03857542|450749156|FG001|Overall Study|Lost to Follow-up|1|||
125306882|NCT03857542|450749155|FG000|Overall Study|Reason not Specified|1|||
125306883|NCT03857542|450749156|FG001|Overall Study|Reason not Specified|0|||
125306884|NCT00934128|450749157|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
125306885|NCT00934128|450749158|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
125306886|NCT00934128|450749157|FG000|First Intervention (2 Hours)|Adverse Event|4|||
125306887|NCT00934128|450749158|FG001|First Intervention (2 Hours)|Adverse Event|1|||
125306888|NCT00934128|450749157|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
125306889|NCT00934128|450749158|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
125306890|NCT00934128|450749157|FG000|Washout Period (1 Hour)|Patient preference|1|||
125306891|NCT00934128|450749158|FG001|Washout Period (1 Hour)|Patient preference|3|||
125306892|NCT00934128|450749157|FG000|Washout Period (1 Hour)|Pain|1|||
125306893|NCT00934128|450749158|FG001|Washout Period (1 Hour)|Pain|0|||
125306894|NCT00934128|450749157|FG000|Washout Period (1 Hour)|Too tired|1|||
125306895|NCT00934128|450749158|FG001|Washout Period (1 Hour)|Too tired|0|||
125306896|NCT00934128|450749157|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
125306897|NCT00934128|450749158|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
125306898|NCT00934128|450749157|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
125306899|NCT00934128|450749158|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
125306900|NCT01946152|450751236|FG000|Overall Study|Adverse Event|1|||
125306901|NCT01946152|450751237|FG001|Overall Study|Adverse Event|0|||
125306902|NCT01946152|450751238|FG002|Overall Study|Adverse Event|0|||
125306903|NCT01946152|450751239|FG003|Overall Study|Adverse Event|0|||
125306904|NCT01946152|450751236|FG000|Overall Study|Withdrawal by Subject|0|||
125306905|NCT01946152|450751237|FG001|Overall Study|Withdrawal by Subject|2|||
125306906|NCT01946152|450751238|FG002|Overall Study|Withdrawal by Subject|0|||
125306907|NCT01946152|450751239|FG003|Overall Study|Withdrawal by Subject|0|||
125306908|NCT01946152|450751236|FG000|Overall Study|Progression|0|||
125306909|NCT01946152|450751237|FG001|Overall Study|Progression|1|||
125306910|NCT01946152|450751238|FG002|Overall Study|Progression|4|||
125306911|NCT01946152|450751239|FG003|Overall Study|Progression|7|||
125306912|NCT01946152|450751236|FG000|Overall Study|Physician Decision|0|||
125306913|NCT01946152|450751237|FG001|Overall Study|Physician Decision|0|||
125306914|NCT01946152|450751238|FG002|Overall Study|Physician Decision|1|||
125306915|NCT01946152|450751239|FG003|Overall Study|Physician Decision|0|||
125306916|NCT01946152|450751236|FG000|Overall Study|Second malignancy|0|||
125306917|NCT01946152|450751237|FG001|Overall Study|Second malignancy|0|||
125306918|NCT01946152|450751238|FG002|Overall Study|Second malignancy|1|||
125306919|NCT01946152|450751239|FG003|Overall Study|Second malignancy|0|||
125306920|NCT01946152|450751236|FG000|Overall Study|Adverse Event|0|||
125306921|NCT01946152|450751237|FG001|Overall Study|Adverse Event|0|||
125306922|NCT01946152|450751238|FG002|Overall Study|Adverse Event|0|||
125306923|NCT01946152|450751239|FG003|Overall Study|Adverse Event|1|||
125306924|NCT01698814|450751240|FG000|Overall Study|Adverse Event|0|||
125306925|NCT01698814|450751241|FG001|Overall Study|Adverse Event|2|||
125306926|NCT01698814|450751240|FG000|Overall Study|Lost to Follow-up|0|||
125306927|NCT01698814|450751241|FG001|Overall Study|Lost to Follow-up|1|||
125306928|NCT01698814|450751240|FG000|Overall Study|Pregnancy|1|||
125306929|NCT01698814|450751241|FG001|Overall Study|Pregnancy|0|||
125306930|NCT01698814|450751240|FG000|Overall Study|Randomized in error|1|||
125306931|NCT01698814|450751241|FG001|Overall Study|Randomized in error|0|||
125306932|NCT01061359|450751246|FG000|Overall Study|Death|32|||
125306933|NCT01061359|450751246|FG000|Overall Study|Lost to Follow-up|1072|||
125306934|NCT01061359|450751246|FG000|Overall Study|Relapse|187|||
125306935|NCT01061359|450751246|FG000|Overall Study|Secondary neoplasm|11|||
125306936|NCT04014062|450751247|FG000|Period I: Dosing|Medical Grounds|4|||
125306937|NCT04014062|450751248|FG001|Period I: Dosing|Medical Grounds|5|||
125306938|NCT04014062|450751247|FG000|Period I: Dosing|Withdrawal by Subject|3|||
125306939|NCT04014062|450751248|FG001|Period I: Dosing|Withdrawal by Subject|1|||
125306940|NCT03038126|450751249|FG000|Overall Study|Death|1|||
125306941|NCT03038126|450751250|FG001|Overall Study|Death|1|||
125306942|NCT03038126|450751249|FG000|Overall Study|Withdrawal by Subject|5|||
125306943|NCT03038126|450751250|FG001|Overall Study|Withdrawal by Subject|0|||
125306944|NCT03038126|450751249|FG000|Overall Study|Lost to Follow-up|0|||
125306945|NCT03038126|450751250|FG001|Overall Study|Lost to Follow-up|1|||
125306946|NCT03038126|450751249|FG000|Overall Study|Long Term Hospitalization|2|||
125306947|NCT03038126|450751250|FG001|Overall Study|Long Term Hospitalization|0|||
125306948|NCT03038126|450751249|FG000|Overall Study|Too Ill to Participate|1|||
125306949|NCT03038126|450751250|FG001|Overall Study|Too Ill to Participate|2|||
125306950|NCT02610777|450751251|FG000|Overall Study|Lost to Follow-up|1|||
125306951|NCT02610777|450751252|FG001|Overall Study|Lost to Follow-up|0|||
125306952|NCT02610777|450751251|FG000|Overall Study|Site Terminated by Sponsor|9|||
125306953|NCT02610777|450751252|FG001|Overall Study|Site Terminated by Sponsor|8|||
125306954|NCT02610777|450751251|FG000|Overall Study|Withdrawal by Subject|2|||
125306955|NCT02610777|450751252|FG001|Overall Study|Withdrawal by Subject|2|||
125306956|NCT02610777|450751251|FG000|Overall Study|Reason not Specified|0|||
125306957|NCT02610777|450751252|FG001|Overall Study|Reason not Specified|1|||
125306958|NCT02610777|450751251|FG000|Overall Study|Death|50|||
125306959|NCT02610777|450751252|FG001|Overall Study|Death|47|||
125306960|NCT01724866|450751253|FG000|Overall Study|Adverse Event|0|||
125306961|NCT01724866|450751254|FG001|Overall Study|Adverse Event|0|||
125306962|NCT01724866|450751255|FG002|Overall Study|Adverse Event|1|||
125306963|NCT01724866|450751256|FG003|Overall Study|Adverse Event|1|||
125306964|NCT01724866|450751253|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
125306965|NCT01724866|450751254|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
125306966|NCT01724866|450751255|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
125306967|NCT01724866|450751256|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
125306968|NCT01724866|450751253|FG000|Overall Study|Investigator's Discretion|0|||
125306969|NCT01724866|450751254|FG001|Overall Study|Investigator's Discretion|1|||
125306970|NCT01724866|450751255|FG002|Overall Study|Investigator's Discretion|1|||
125306971|NCT01724866|450751256|FG003|Overall Study|Investigator's Discretion|0|||
125306972|NCT01724866|450751253|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
125306973|NCT01724866|450751254|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
125306974|NCT01724866|450751255|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
125306975|NCT01724866|450751256|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
125306976|NCT01724866|450751253|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
125306977|NCT01724866|450751254|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
125306978|NCT01724866|450751255|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
125306979|NCT01724866|450751256|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
125306980|NCT01424501|450751259|FG000|Overall Study|Withdrawal by Subject|1|||
125306981|NCT01424501|450751260|FG001|Overall Study|Withdrawal by Subject|0|||
125306982|NCT01424501|450751261|FG002|Overall Study|Withdrawal by Subject|1|||
125306983|NCT01424501|450751262|FG003|Overall Study|Withdrawal by Subject|0|||
125306984|NCT01424501|450751263|FG004|Overall Study|Withdrawal by Subject|0|||
125306985|NCT01424501|450751264|FG005|Overall Study|Withdrawal by Subject|0|||
125306986|NCT01424501|450751259|FG000|Overall Study|Lost to Follow-up|0|||
125306987|NCT01424501|450751260|FG001|Overall Study|Lost to Follow-up|1|||
125306988|NCT01424501|450751261|FG002|Overall Study|Lost to Follow-up|1|||
125306989|NCT01424501|450751262|FG003|Overall Study|Lost to Follow-up|0|||
125306990|NCT01424501|450751263|FG004|Overall Study|Lost to Follow-up|0|||
125306991|NCT01424501|450751264|FG005|Overall Study|Lost to Follow-up|0|||
125306992|NCT01980095|450751265|FG000|Overall Study|Lost to Follow-up|6|||
125306993|NCT01980095|450751266|FG001|Overall Study|Lost to Follow-up|7|||
125306994|NCT01980095|450751265|FG000|Overall Study|Withdrawal by Subject|2|||
125306995|NCT01980095|450751266|FG001|Overall Study|Withdrawal by Subject|3|||
125306996|NCT01980095|450751265|FG000|Overall Study|Poor compliance|5|||
125306997|NCT01980095|450751266|FG001|Overall Study|Poor compliance|0|||
125306998|NCT01980095|450751265|FG000|Overall Study|Safety issue|0|||
125306999|NCT01980095|450751266|FG001|Overall Study|Safety issue|1|||
125307000|NCT01980095|450751265|FG000|Overall Study|Study drug discontinued|1|||
125307001|NCT01980095|450751266|FG001|Overall Study|Study drug discontinued|0|||
125307002|NCT01980095|450751265|FG000|Overall Study|Randomized by mistake|1|||
125307003|NCT01980095|450751266|FG001|Overall Study|Randomized by mistake|0|||
125307004|NCT00398567|450751270|FG000|Overall Study|Disease Progression|3|||
125307005|NCT00398567|450751271|FG001|Overall Study|Disease Progression|4|||
125307006|NCT00398567|450751272|FG002|Overall Study|Disease Progression|27|||
125307007|NCT00398567|450751270|FG000|Overall Study|Withdrawal by Subject|1|||
125307008|NCT00398567|450751271|FG001|Overall Study|Withdrawal by Subject|0|||
125307009|NCT00398567|450751272|FG002|Overall Study|Withdrawal by Subject|4|||
125307010|NCT00398567|450751270|FG000|Overall Study|Adverse Event|0|||
125307011|NCT00398567|450751271|FG001|Overall Study|Adverse Event|0|||
125307012|NCT00398567|450751272|FG002|Overall Study|Adverse Event|2|||
125307013|NCT00398567|450751270|FG000|Overall Study|Protocol Violation|0|||
125307014|NCT00398567|450751271|FG001|Overall Study|Protocol Violation|0|||
125307015|NCT00398567|450751272|FG002|Overall Study|Protocol Violation|1|||
125307016|NCT02837029|450751273|FG000|Screening|Failed to meet screening requirements.|7|||
125307017|NCT02837029|450751274|FG001|Screening|Failed to meet screening requirements.|3|||
125307018|NCT02837029|450751275|FG002|Screening|Failed to meet screening requirements.|0|||
125307019|NCT02837029|450751273|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
125307020|NCT02837029|450751274|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
125307021|NCT02837029|450751275|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
125307022|NCT02837029|450751273|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
125307023|NCT02837029|450751274|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
125307024|NCT02837029|450751275|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
125307025|NCT02837029|450751273|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
125307026|NCT02837029|450751274|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
125307027|NCT02837029|450751275|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
125307028|NCT02837029|450751273|FG000|Cycle 2 and Beyond|Adverse Event|1|||
125307029|NCT02837029|450751274|FG001|Cycle 2 and Beyond|Adverse Event|0|||
125307030|NCT02837029|450751275|FG002|Cycle 2 and Beyond|Adverse Event|0|||
125307031|NCT02837029|450751273|FG000|2 Year Follow-up|Death|6|||
125307032|NCT02837029|450751274|FG001|2 Year Follow-up|Death|7|||
125307033|NCT02837029|450751275|FG002|2 Year Follow-up|Death|0|||
125307034|NCT02034877|450751276|FG000|Overall Study|Lost to Follow-up|0|||
125307035|NCT02034877|450751277|FG001|Overall Study|Lost to Follow-up|3|||
125307036|NCT02034877|450751276|FG000|Overall Study|No Longer Willing to Participate|0|||
125307037|NCT02034877|450751277|FG001|Overall Study|No Longer Willing to Participate|3|||
125307038|NCT04426318|450751280|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
125307039|NCT04426318|450751281|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
125307040|NCT01564732|450751292|FG000|Overall Study|Early termination by the study sponsor|6|||
124847190|NCT03013491|449064251|FG012|Main Study|Protocol version 8.0 approval|0|||
125307041|NCT01564732|450751293|FG001|Overall Study|Early termination by the study sponsor|5|||
125307042|NCT01036321|450751296|FG000|Overall Study|Ineligible after randomization|0|||
125307043|NCT01036321|450751297|FG001|Overall Study|Ineligible after randomization|1|||
125307044|NCT01036321|450751296|FG000|Overall Study|Withdrawal by Subject|3|||
124847191|NCT03013491|449064252|FG013|Main Study|Protocol version 8.0 approval|0|||
125307045|NCT01036321|450751297|FG001|Overall Study|Withdrawal by Subject|2|||
125307046|NCT01036321|450751296|FG000|Overall Study|Adverse Event|2|||
125307047|NCT01036321|450751297|FG001|Overall Study|Adverse Event|1|||
125307048|NCT01957202|450751298|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307049|NCT01957202|450751299|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
125307050|NCT01957202|450751300|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307051|NCT01957202|450751301|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307052|NCT01957202|450751302|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307053|NCT01957202|450751303|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307054|NCT01957202|450751304|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307055|NCT01957202|450751305|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307056|NCT01957202|450751306|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307057|NCT01957202|450751307|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307058|NCT01957202|450751308|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307059|NCT01957202|450751309|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307060|NCT01957202|450751310|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307061|NCT01957202|450751311|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307062|NCT01957202|450751312|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307063|NCT01957202|450751313|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307064|NCT01957202|450751314|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
125307065|NCT01957202|450751315|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307066|NCT01957202|450751298|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307067|NCT01957202|450751299|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307068|NCT01957202|450751300|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307069|NCT01957202|450751301|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307070|NCT01957202|450751302|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307071|NCT01957202|450751303|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307072|NCT01957202|450751304|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307073|NCT01957202|450751305|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307074|NCT01957202|450751306|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307075|NCT01957202|450751307|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307076|NCT01957202|450751308|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307077|NCT01957202|450751309|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307078|NCT01957202|450751310|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307079|NCT01957202|450751311|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307080|NCT01957202|450751312|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307081|NCT01957202|450751313|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307082|NCT01957202|450751314|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
125307083|NCT01957202|450751315|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307084|NCT00381693|450751318|FG000|Overall Study|Death|1|||
125307085|NCT00381693|450751318|FG000|Overall Study|Adverse Event|4|||
125307086|NCT00381693|450751318|FG000|Overall Study|Patient Choice|1|||
125307087|NCT00381693|450751318|FG000|Overall Study|Progression|2|||
125307088|NCT02506192|450751330|FG000|Overall Study|Withdrawal by Subject|1|||
125307089|NCT02506192|450751331|FG001|Overall Study|Withdrawal by Subject|1|||
125307090|NCT01922271|450751333|FG000|WASHOUT Period|Withdrawal by Subject|1|||
125307091|NCT01922271|450751334|FG001|WASHOUT Period|Withdrawal by Subject|0|||
125307092|NCT00836186|450751337|FG000|Overall Study|Blood could not be drawn|1|||
125307093|NCT04531241|450751339|FG000|Period 1|Withdrawal by Subject|2|||
125307094|NCT04531241|450751340|FG001|Period 1|Withdrawal by Subject|0|||
125307095|NCT04531241|450751339|FG000|Period 1|Dispesed incorrect lens power|1|||
125307096|NCT04531241|450751340|FG001|Period 1|Dispesed incorrect lens power|0|||
125307097|NCT04531241|450751339|FG000|Period 1|Protocol Violation|1|||
125307098|NCT04531241|450751340|FG001|Period 1|Protocol Violation|0|||
125307099|NCT04531241|450751339|FG000|Period 1|No longer eligible|0|||
125307100|NCT04531241|450751340|FG001|Period 1|No longer eligible|1|||
125307101|NCT04531241|450751339|FG000|Period 1|Lens Discomfort|0|||
125307102|NCT04531241|450751340|FG001|Period 1|Lens Discomfort|1|||
125307103|NCT04531241|450751339|FG000|Period 2|Covid-19 Related|1|||
125307104|NCT04531241|450751340|FG001|Period 2|Covid-19 Related|1|||
125307105|NCT02576795|450751341|FG000|Overall Study|Lost to Follow-up|0|||
125307106|NCT02576795|450751342|FG001|Overall Study|Lost to Follow-up|0|||
125307107|NCT02576795|450751343|FG002|Overall Study|Lost to Follow-up|1|||
125307108|NCT02576795|450751344|FG003|Overall Study|Lost to Follow-up|0|||
125307109|NCT05232864|450751346|FG000|Overall Study|Adverse Event|0|||
125307110|NCT05232864|450751347|FG001|Overall Study|Adverse Event|1|||
125307111|NCT05232864|450751346|FG000|Overall Study|Study terminated by sponsor|16|||
124847192|NCT03013491|449064253|FG014|Main Study|Protocol version 8.0 approval|0|||
124847193|NCT03013491|449064254|FG015|Main Study|Protocol version 8.0 approval|0|||
125307112|NCT05232864|450751347|FG001|Overall Study|Study terminated by sponsor|14|||
125307113|NCT04765202|450751362|FG000|Overall Study|Lost to Follow-up|1|||
125307114|NCT04765202|450751363|FG001|Overall Study|Lost to Follow-up|1|||
125307115|NCT04765202|450751364|FG002|Overall Study|Lost to Follow-up|2|||
125307116|NCT04765202|450751365|FG003|Overall Study|Lost to Follow-up|2|||
125307117|NCT04765202|450751362|FG000|Overall Study|Physician Decision|0|||
125307118|NCT04765202|450751363|FG001|Overall Study|Physician Decision|0|||
125307119|NCT04765202|450751364|FG002|Overall Study|Physician Decision|1|||
125307120|NCT04765202|450751365|FG003|Overall Study|Physician Decision|1|||
125307121|NCT00465452|450751366|FG000|Overall Study|Adverse Event|1|||
125307122|NCT01635855|450751368|FG000|Overall Study|Withdrawal by Subject|4|||
125307123|NCT03828019|450751369|FG000|Overall Study|Withdrawal by Subject|3|||
125307124|NCT03828019|450751370|FG001|Overall Study|Withdrawal by Subject|8|||
125307125|NCT03828019|450751369|FG000|Overall Study|Lost to Follow-up|1|||
125307126|NCT03828019|450751370|FG001|Overall Study|Lost to Follow-up|6|||
125307127|NCT03828019|450751369|FG000|Overall Study|Incarcerated|1|||
125307128|NCT03828019|450751370|FG001|Overall Study|Incarcerated|0|||
125307129|NCT03828019|450751369|FG000|Overall Study|Adverse Event|0|||
125307130|NCT03828019|450751370|FG001|Overall Study|Adverse Event|1|||
125307131|NCT03400176|450751371|FG000|Dose Escalation|Progressive disease|1|||
125307132|NCT03400176|450751372|FG001|Dose Escalation|Progressive disease|1|||
125307133|NCT03400176|450751373|FG002|Dose Escalation|Progressive disease|0|||
125307134|NCT03400176|450751374|FG003|Dose Escalation|Progressive disease|0|||
125307135|NCT03400176|450751375|FG004|Dose Escalation|Progressive disease|1|||
125307136|NCT03400176|450751371|FG000|Dose Escalation|Patient decision|0|||
125307137|NCT03400176|450751372|FG001|Dose Escalation|Patient decision|0|||
125307138|NCT03400176|450751373|FG002|Dose Escalation|Patient decision|0|||
125307139|NCT03400176|450751374|FG003|Dose Escalation|Patient decision|0|||
125307140|NCT03400176|450751375|FG004|Dose Escalation|Patient decision|1|||
125307141|NCT03400176|450751371|FG000|Dose Expansion|Patient decision|0|||
125307142|NCT03400176|450751372|FG001|Dose Expansion|Patient decision|0|||
125307143|NCT03400176|450751373|FG002|Dose Expansion|Patient decision|0|||
125307144|NCT03400176|450751374|FG003|Dose Expansion|Patient decision|1|||
125307145|NCT03400176|450751375|FG004|Dose Expansion|Patient decision|0|||
125307146|NCT03400176|450751371|FG000|Dose Expansion|Adverse Event|0|||
125307147|NCT03400176|450751372|FG001|Dose Expansion|Adverse Event|0|||
125307148|NCT03400176|450751373|FG002|Dose Expansion|Adverse Event|0|||
125307149|NCT03400176|450751374|FG003|Dose Expansion|Adverse Event|1|||
125307150|NCT03400176|450751375|FG004|Dose Expansion|Adverse Event|0|||
125307151|NCT03400176|450751371|FG000|Dose Expansion|Physician Decision|0|||
125307152|NCT03400176|450751372|FG001|Dose Expansion|Physician Decision|0|||
125307153|NCT03400176|450751373|FG002|Dose Expansion|Physician Decision|0|||
125307154|NCT03400176|450751374|FG003|Dose Expansion|Physician Decision|1|||
125307155|NCT03400176|450751375|FG004|Dose Expansion|Physician Decision|0|||
125307156|NCT03400176|450751371|FG000|Dose Expansion|Progressive disease|0|||
125307157|NCT03400176|450751372|FG001|Dose Expansion|Progressive disease|0|||
125307158|NCT03400176|450751373|FG002|Dose Expansion|Progressive disease|1|||
125307159|NCT03400176|450751374|FG003|Dose Expansion|Progressive disease|1|||
125307160|NCT03400176|450751375|FG004|Dose Expansion|Progressive disease|0|||
125307161|NCT00206440|450751376|FG000|Overall Study|Protocol Violation|1|||
125307162|NCT00206440|450751377|FG001|Overall Study|Protocol Violation|2|||
125307163|NCT00206440|450751376|FG000|Overall Study|Adverse Event|4|||
125307164|NCT00206440|450751377|FG001|Overall Study|Adverse Event|2|||
125307165|NCT01298765|450751378|FG000|Titration Period|Adverse Event|26|||
125307166|NCT01298765|450751378|FG000|Titration Period|Death|1|||
125307167|NCT01298765|450751378|FG000|Titration Period|Lack of Efficacy|21|||
125307168|NCT01298765|450751378|FG000|Titration Period|Lost to Follow-up|9|||
125307169|NCT01298765|450751378|FG000|Titration Period|Physician Decision|1|||
125307170|NCT01298765|450751378|FG000|Titration Period|Withdrawal by Subject|10|||
125307171|NCT01298765|450751378|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
125307172|NCT01298765|450751378|FG000|Long-Term Treatment Period|Adverse Event|19|||
125307173|NCT01298765|450751378|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
125307174|NCT01298765|450751378|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
125307175|NCT01298765|450751378|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
125307176|NCT01298765|450751378|FG000|Long-Term Treatment Period|Physician Decision|1|||
125307177|NCT01298765|450751378|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
125307178|NCT03302247|450751381|FG000|Overall Study|the study has closed prematurely|2|||
125307179|NCT03302247|450751381|FG000|Overall Study|Death|1|||
125307180|NCT04090242|450751382|FG000|Overall Study|Withdrawal by Subject|1|||
125307181|NCT04090242|450751383|FG001|Overall Study|Withdrawal by Subject|0|||
125307182|NCT03214406|450751384|FG000|Overall Study|did not meet enrollment criteria|9|||
125307183|NCT03214406|450751385|FG001|Overall Study|did not meet enrollment criteria|13|||
125307184|NCT03214406|450751384|FG000|Overall Study|Withdrawal by Subject|1|||
125307185|NCT03214406|450751385|FG001|Overall Study|Withdrawal by Subject|0|||
125307186|NCT03214406|450751384|FG000|Overall Study|Lost to Follow-up|0|||
125307187|NCT03214406|450751385|FG001|Overall Study|Lost to Follow-up|2|||
125307188|NCT01098305|450751389|FG000|Overall Study|Lost to Follow-up|31|||
125307189|NCT01098305|450751390|FG001|Overall Study|Lost to Follow-up|33|||
125307190|NCT03182907|450751391|FG000|Overall Study|Death|3|||
125307191|NCT03182907|450751392|FG001|Overall Study|Death|0|||
125307192|NCT03182907|450751391|FG000|Overall Study|Protocol Violation|4|||
125307193|NCT03182907|450751392|FG001|Overall Study|Protocol Violation|0|||
125307194|NCT03182907|450751391|FG000|Overall Study|Lost to Follow-up|1|||
125307195|NCT03182907|450751392|FG001|Overall Study|Lost to Follow-up|0|||
125307196|NCT03182907|450751391|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125307197|NCT03182907|450751392|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
125307198|NCT00429169|450751393|FG000|Overall Study|Lost to Follow-up|0|||
125307199|NCT00429169|450751394|FG001|Overall Study|Lost to Follow-up|1|||
125307200|NCT00429169|450751393|FG000|Overall Study|Ineligibility discovered after entry|2|||
125307201|NCT00429169|450751394|FG001|Overall Study|Ineligibility discovered after entry|1|||
125307202|NCT01180296|450751399|FG000|Overall Study|Protocol Violation|1|||
125307203|NCT01180296|450751400|FG001|Overall Study|Protocol Violation|2|||
125307204|NCT01371552|450751405|FG000|Part 1, First 3 Days|Inconvenience|0|||
125307205|NCT01371552|450751406|FG001|Part 1, First 3 Days|Inconvenience|0|||
125307206|NCT01371552|450751407|FG002|Part 1, First 3 Days|Inconvenience|1|||
125307207|NCT01371552|450751408|FG003|Part 1, First 3 Days|Inconvenience|0|||
125307208|NCT01371552|450751409|FG004|Part 1, First 3 Days|Inconvenience|0|||
125307209|NCT01371552|450751410|FG005|Part 1, First 3 Days|Inconvenience|0|||
125307210|NCT03364309|450751411|FG000|Induction Period|Adverse Event|4|||
125307211|NCT03364309|450751412|FG001|Induction Period|Adverse Event|0|||
125307212|NCT03364309|450751413|FG002|Induction Period|Adverse Event|1|||
125307213|NCT03364309|450751414|FG003|Induction Period|Adverse Event|0|||
125307214|NCT03364309|450751415|FG004|Induction Period|Adverse Event|0|||
125307215|NCT03364309|450751416|FG005|Induction Period|Adverse Event|0|||
125307216|NCT03364309|450751417|FG006|Induction Period|Adverse Event|0|||
125307217|NCT03364309|450751418|FG007|Induction Period|Adverse Event|0|||
125307218|NCT03364309|450751419|FG008|Induction Period|Adverse Event|0|||
125307219|NCT03364309|450751420|FG009|Induction Period|Adverse Event|0|||
125307220|NCT03364309|450751421|FG010|Induction Period|Adverse Event|0|||
125307221|NCT03364309|450751422|FG011|Induction Period|Adverse Event|0|||
125307222|NCT03364309|450751423|FG012|Induction Period|Adverse Event|0|||
125307223|NCT03364309|450751424|FG013|Induction Period|Adverse Event|0|||
125307224|NCT03364309|450751425|FG014|Induction Period|Adverse Event|0|||
125307225|NCT03364309|450751426|FG015|Induction Period|Adverse Event|0|||
125307226|NCT03364309|450751427|FG016|Induction Period|Adverse Event|0|||
125307227|NCT03364309|450751428|FG017|Induction Period|Adverse Event|0|||
125307228|NCT03364309|450751429|FG018|Induction Period|Adverse Event|0|||
125307229|NCT03364309|450751411|FG000|Induction Period|Withdrawal by Subject|1|||
125307230|NCT03364309|450751412|FG001|Induction Period|Withdrawal by Subject|3|||
125307231|NCT03364309|450751413|FG002|Induction Period|Withdrawal by Subject|0|||
125307232|NCT03364309|450751414|FG003|Induction Period|Withdrawal by Subject|0|||
125307233|NCT03364309|450751415|FG004|Induction Period|Withdrawal by Subject|0|||
125307234|NCT03364309|450751416|FG005|Induction Period|Withdrawal by Subject|0|||
125307235|NCT03364309|450751417|FG006|Induction Period|Withdrawal by Subject|0|||
125307236|NCT03364309|450751418|FG007|Induction Period|Withdrawal by Subject|0|||
125307237|NCT03364309|450751419|FG008|Induction Period|Withdrawal by Subject|0|||
125307238|NCT03364309|450751420|FG009|Induction Period|Withdrawal by Subject|0|||
125307239|NCT03364309|450751421|FG010|Induction Period|Withdrawal by Subject|0|||
125307240|NCT03364309|450751422|FG011|Induction Period|Withdrawal by Subject|0|||
125307241|NCT03364309|450751423|FG012|Induction Period|Withdrawal by Subject|0|||
125307242|NCT03364309|450751424|FG013|Induction Period|Withdrawal by Subject|0|||
125307243|NCT03364309|450751425|FG014|Induction Period|Withdrawal by Subject|0|||
125307244|NCT03364309|450751426|FG015|Induction Period|Withdrawal by Subject|0|||
125307245|NCT03364309|450751427|FG016|Induction Period|Withdrawal by Subject|0|||
125307246|NCT03364309|450751428|FG017|Induction Period|Withdrawal by Subject|0|||
125307247|NCT03364309|450751429|FG018|Induction Period|Withdrawal by Subject|0|||
125307248|NCT03364309|450751411|FG000|Induction Period|Lost to Follow-up|1|||
125307249|NCT03364309|450751412|FG001|Induction Period|Lost to Follow-up|0|||
125307250|NCT03364309|450751413|FG002|Induction Period|Lost to Follow-up|0|||
125307251|NCT03364309|450751414|FG003|Induction Period|Lost to Follow-up|0|||
125307252|NCT03364309|450751415|FG004|Induction Period|Lost to Follow-up|0|||
125307253|NCT03364309|450751416|FG005|Induction Period|Lost to Follow-up|0|||
125307254|NCT03364309|450751417|FG006|Induction Period|Lost to Follow-up|0|||
125307255|NCT03364309|450751418|FG007|Induction Period|Lost to Follow-up|0|||
125307256|NCT03364309|450751419|FG008|Induction Period|Lost to Follow-up|0|||
125307257|NCT03364309|450751420|FG009|Induction Period|Lost to Follow-up|0|||
125307258|NCT03364309|450751421|FG010|Induction Period|Lost to Follow-up|0|||
125307259|NCT03364309|450751422|FG011|Induction Period|Lost to Follow-up|0|||
125307260|NCT03364309|450751423|FG012|Induction Period|Lost to Follow-up|0|||
125307261|NCT03364309|450751424|FG013|Induction Period|Lost to Follow-up|0|||
125307262|NCT03364309|450751425|FG014|Induction Period|Lost to Follow-up|0|||
125307263|NCT03364309|450751426|FG015|Induction Period|Lost to Follow-up|0|||
125307264|NCT03364309|450751427|FG016|Induction Period|Lost to Follow-up|0|||
125307265|NCT03364309|450751428|FG017|Induction Period|Lost to Follow-up|0|||
125307266|NCT03364309|450751429|FG018|Induction Period|Lost to Follow-up|0|||
125307267|NCT03364309|450751411|FG000|Induction Period|Physician Decision|0|||
125307268|NCT03364309|450751412|FG001|Induction Period|Physician Decision|1|||
125307269|NCT03364309|450751413|FG002|Induction Period|Physician Decision|0|||
125307270|NCT03364309|450751414|FG003|Induction Period|Physician Decision|0|||
125307271|NCT03364309|450751415|FG004|Induction Period|Physician Decision|0|||
125307272|NCT03364309|450751416|FG005|Induction Period|Physician Decision|0|||
125307273|NCT03364309|450751417|FG006|Induction Period|Physician Decision|0|||
125307274|NCT03364309|450751418|FG007|Induction Period|Physician Decision|0|||
125307275|NCT03364309|450751419|FG008|Induction Period|Physician Decision|0|||
125307276|NCT03364309|450751420|FG009|Induction Period|Physician Decision|0|||
125307277|NCT03364309|450751421|FG010|Induction Period|Physician Decision|0|||
125307278|NCT03364309|450751422|FG011|Induction Period|Physician Decision|0|||
125307279|NCT03364309|450751423|FG012|Induction Period|Physician Decision|0|||
125307280|NCT03364309|450751424|FG013|Induction Period|Physician Decision|0|||
125307281|NCT03364309|450751425|FG014|Induction Period|Physician Decision|0|||
125307282|NCT03364309|450751426|FG015|Induction Period|Physician Decision|0|||
125307283|NCT03364309|450751427|FG016|Induction Period|Physician Decision|0|||
125307284|NCT03364309|450751428|FG017|Induction Period|Physician Decision|0|||
125307285|NCT03364309|450751429|FG018|Induction Period|Physician Decision|0|||
125307286|NCT03364309|450751411|FG000|Maintenance Period|Withdrawal by Subject|0|||
125307287|NCT03364309|450751412|FG001|Maintenance Period|Withdrawal by Subject|0|||
125307288|NCT03364309|450751413|FG002|Maintenance Period|Withdrawal by Subject|0|||
125307289|NCT03364309|450751414|FG003|Maintenance Period|Withdrawal by Subject|1|||
125307290|NCT03364309|450751415|FG004|Maintenance Period|Withdrawal by Subject|3|||
125307291|NCT03364309|450751416|FG005|Maintenance Period|Withdrawal by Subject|1|||
125307292|NCT03364309|450751417|FG006|Maintenance Period|Withdrawal by Subject|3|||
125307293|NCT03364309|450751418|FG007|Maintenance Period|Withdrawal by Subject|0|||
125307294|NCT03364309|450751419|FG008|Maintenance Period|Withdrawal by Subject|1|||
125307295|NCT03364309|450751420|FG009|Maintenance Period|Withdrawal by Subject|1|||
125307296|NCT03364309|450751421|FG010|Maintenance Period|Withdrawal by Subject|2|||
125307297|NCT03364309|450751422|FG011|Maintenance Period|Withdrawal by Subject|0|||
125307298|NCT03364309|450751423|FG012|Maintenance Period|Withdrawal by Subject|0|||
125307299|NCT03364309|450751424|FG013|Maintenance Period|Withdrawal by Subject|0|||
125307300|NCT03364309|450751425|FG014|Maintenance Period|Withdrawal by Subject|0|||
125307301|NCT03364309|450751426|FG015|Maintenance Period|Withdrawal by Subject|0|||
125307302|NCT03364309|450751427|FG016|Maintenance Period|Withdrawal by Subject|0|||
125307303|NCT03364309|450751428|FG017|Maintenance Period|Withdrawal by Subject|0|||
125307304|NCT03364309|450751429|FG018|Maintenance Period|Withdrawal by Subject|0|||
125307305|NCT03364309|450751411|FG000|Maintenance Period|Adverse Event|0|||
125307306|NCT03364309|450751412|FG001|Maintenance Period|Adverse Event|0|||
125307307|NCT03364309|450751413|FG002|Maintenance Period|Adverse Event|0|||
125307308|NCT03364309|450751414|FG003|Maintenance Period|Adverse Event|0|||
125307309|NCT03364309|450751415|FG004|Maintenance Period|Adverse Event|2|||
125307310|NCT03364309|450751416|FG005|Maintenance Period|Adverse Event|0|||
125307311|NCT03364309|450751417|FG006|Maintenance Period|Adverse Event|3|||
125307312|NCT03364309|450751418|FG007|Maintenance Period|Adverse Event|0|||
125307313|NCT03364309|450751419|FG008|Maintenance Period|Adverse Event|1|||
125307314|NCT03364309|450751420|FG009|Maintenance Period|Adverse Event|0|||
125307315|NCT03364309|450751421|FG010|Maintenance Period|Adverse Event|2|||
125307316|NCT03364309|450751422|FG011|Maintenance Period|Adverse Event|0|||
125307317|NCT03364309|450751423|FG012|Maintenance Period|Adverse Event|0|||
125307318|NCT03364309|450751424|FG013|Maintenance Period|Adverse Event|0|||
125307319|NCT03364309|450751425|FG014|Maintenance Period|Adverse Event|0|||
125307320|NCT03364309|450751426|FG015|Maintenance Period|Adverse Event|0|||
125307321|NCT03364309|450751427|FG016|Maintenance Period|Adverse Event|0|||
125307322|NCT03364309|450751428|FG017|Maintenance Period|Adverse Event|0|||
125307323|NCT03364309|450751429|FG018|Maintenance Period|Adverse Event|0|||
125307324|NCT03364309|450751411|FG000|Maintenance Period|Relapsed|0|||
125307325|NCT03364309|450751412|FG001|Maintenance Period|Relapsed|0|||
125307326|NCT03364309|450751413|FG002|Maintenance Period|Relapsed|0|||
125307327|NCT03364309|450751414|FG003|Maintenance Period|Relapsed|43|||
125307328|NCT03364309|450751415|FG004|Maintenance Period|Relapsed|7|||
125307329|NCT03364309|450751416|FG005|Maintenance Period|Relapsed|45|||
125307330|NCT03364309|450751417|FG006|Maintenance Period|Relapsed|10|||
125307331|NCT03364309|450751418|FG007|Maintenance Period|Relapsed|2|||
125307332|NCT03364309|450751419|FG008|Maintenance Period|Relapsed|0|||
125307333|NCT03364309|450751420|FG009|Maintenance Period|Relapsed|0|||
125307334|NCT03364309|450751421|FG010|Maintenance Period|Relapsed|0|||
125307335|NCT03364309|450751422|FG011|Maintenance Period|Relapsed|0|||
125307336|NCT03364309|450751423|FG012|Maintenance Period|Relapsed|0|||
125307337|NCT03364309|450751424|FG013|Maintenance Period|Relapsed|0|||
124847194|NCT03013491|449064255|FG016|Main Study|Protocol version 8.0 approval|0|||
124847195|NCT03013491|449064256|FG017|Main Study|Protocol version 8.0 approval|0|||
124847196|NCT03013491|449064257|FG018|Main Study|Protocol version 8.0 approval|0|||
125307338|NCT03364309|450751425|FG014|Maintenance Period|Relapsed|0|||
125307339|NCT03364309|450751426|FG015|Maintenance Period|Relapsed|0|||
125307340|NCT03364309|450751427|FG016|Maintenance Period|Relapsed|0|||
125307341|NCT03364309|450751428|FG017|Maintenance Period|Relapsed|0|||
125307342|NCT03364309|450751429|FG018|Maintenance Period|Relapsed|0|||
125307343|NCT03364309|450751411|FG000|Maintenance Period|Lack of Efficacy|0|||
125307344|NCT03364309|450751412|FG001|Maintenance Period|Lack of Efficacy|0|||
125307345|NCT03364309|450751413|FG002|Maintenance Period|Lack of Efficacy|0|||
125307346|NCT03364309|450751414|FG003|Maintenance Period|Lack of Efficacy|0|||
125307347|NCT03364309|450751415|FG004|Maintenance Period|Lack of Efficacy|0|||
125307348|NCT03364309|450751416|FG005|Maintenance Period|Lack of Efficacy|0|||
125307349|NCT03364309|450751417|FG006|Maintenance Period|Lack of Efficacy|0|||
125307350|NCT03364309|450751418|FG007|Maintenance Period|Lack of Efficacy|0|||
125307351|NCT03364309|450751419|FG008|Maintenance Period|Lack of Efficacy|1|||
125307352|NCT03364309|450751420|FG009|Maintenance Period|Lack of Efficacy|3|||
125307353|NCT03364309|450751421|FG010|Maintenance Period|Lack of Efficacy|2|||
125307354|NCT03364309|450751422|FG011|Maintenance Period|Lack of Efficacy|0|||
125307355|NCT03364309|450751423|FG012|Maintenance Period|Lack of Efficacy|0|||
125307356|NCT03364309|450751424|FG013|Maintenance Period|Lack of Efficacy|0|||
125307357|NCT03364309|450751425|FG014|Maintenance Period|Lack of Efficacy|0|||
125307358|NCT03364309|450751426|FG015|Maintenance Period|Lack of Efficacy|0|||
125307359|NCT03364309|450751427|FG016|Maintenance Period|Lack of Efficacy|0|||
125307360|NCT03364309|450751428|FG017|Maintenance Period|Lack of Efficacy|0|||
125307361|NCT03364309|450751429|FG018|Maintenance Period|Lack of Efficacy|0|||
125307362|NCT03364309|450751411|FG000|Maintenance Period|Death|0|||
125307363|NCT03364309|450751412|FG001|Maintenance Period|Death|0|||
125307364|NCT03364309|450751413|FG002|Maintenance Period|Death|0|||
125307365|NCT03364309|450751414|FG003|Maintenance Period|Death|0|||
125307366|NCT03364309|450751415|FG004|Maintenance Period|Death|0|||
125307367|NCT03364309|450751416|FG005|Maintenance Period|Death|0|||
125307368|NCT03364309|450751417|FG006|Maintenance Period|Death|0|||
125307369|NCT03364309|450751418|FG007|Maintenance Period|Death|0|||
125307370|NCT03364309|450751419|FG008|Maintenance Period|Death|1|||
125307371|NCT03364309|450751420|FG009|Maintenance Period|Death|0|||
125307372|NCT03364309|450751421|FG010|Maintenance Period|Death|0|||
125307373|NCT03364309|450751422|FG011|Maintenance Period|Death|0|||
125307374|NCT03364309|450751423|FG012|Maintenance Period|Death|0|||
125307375|NCT03364309|450751424|FG013|Maintenance Period|Death|0|||
125307376|NCT03364309|450751425|FG014|Maintenance Period|Death|0|||
125307377|NCT03364309|450751426|FG015|Maintenance Period|Death|0|||
125307378|NCT03364309|450751427|FG016|Maintenance Period|Death|0|||
125307379|NCT03364309|450751428|FG017|Maintenance Period|Death|0|||
125307380|NCT03364309|450751429|FG018|Maintenance Period|Death|0|||
125307381|NCT03364309|450751411|FG000|Maintenance Period|Lost to Follow-up|0|||
125307382|NCT03364309|450751412|FG001|Maintenance Period|Lost to Follow-up|0|||
125307383|NCT03364309|450751413|FG002|Maintenance Period|Lost to Follow-up|0|||
125307384|NCT03364309|450751414|FG003|Maintenance Period|Lost to Follow-up|0|||
125307385|NCT03364309|450751415|FG004|Maintenance Period|Lost to Follow-up|0|||
125307386|NCT03364309|450751416|FG005|Maintenance Period|Lost to Follow-up|0|||
125307387|NCT03364309|450751417|FG006|Maintenance Period|Lost to Follow-up|0|||
125307388|NCT03364309|450751418|FG007|Maintenance Period|Lost to Follow-up|0|||
125307389|NCT03364309|450751419|FG008|Maintenance Period|Lost to Follow-up|1|||
125307390|NCT03364309|450751420|FG009|Maintenance Period|Lost to Follow-up|0|||
125307391|NCT03364309|450751421|FG010|Maintenance Period|Lost to Follow-up|0|||
125307392|NCT03364309|450751422|FG011|Maintenance Period|Lost to Follow-up|0|||
125307393|NCT03364309|450751423|FG012|Maintenance Period|Lost to Follow-up|0|||
125307394|NCT03364309|450751424|FG013|Maintenance Period|Lost to Follow-up|0|||
125307395|NCT03364309|450751425|FG014|Maintenance Period|Lost to Follow-up|0|||
125307396|NCT03364309|450751426|FG015|Maintenance Period|Lost to Follow-up|0|||
125307397|NCT03364309|450751427|FG016|Maintenance Period|Lost to Follow-up|0|||
125307398|NCT03364309|450751428|FG017|Maintenance Period|Lost to Follow-up|0|||
125307399|NCT03364309|450751429|FG018|Maintenance Period|Lost to Follow-up|0|||
125307400|NCT03364309|450751411|FG000|Maintenance Period|Miscellaneous|0|||
125307401|NCT03364309|450751412|FG001|Maintenance Period|Miscellaneous|0|||
125307402|NCT03364309|450751413|FG002|Maintenance Period|Miscellaneous|0|||
125307403|NCT03364309|450751414|FG003|Maintenance Period|Miscellaneous|0|||
125307404|NCT03364309|450751415|FG004|Maintenance Period|Miscellaneous|0|||
125307405|NCT03364309|450751416|FG005|Maintenance Period|Miscellaneous|0|||
125307406|NCT03364309|450751417|FG006|Maintenance Period|Miscellaneous|0|||
125307407|NCT03364309|450751418|FG007|Maintenance Period|Miscellaneous|0|||
125307408|NCT03364309|450751419|FG008|Maintenance Period|Miscellaneous|1|||
125307409|NCT03364309|450751420|FG009|Maintenance Period|Miscellaneous|0|||
125307410|NCT03364309|450751421|FG010|Maintenance Period|Miscellaneous|0|||
125307411|NCT03364309|450751422|FG011|Maintenance Period|Miscellaneous|0|||
125307412|NCT03364309|450751423|FG012|Maintenance Period|Miscellaneous|0|||
124847197|NCT03013491|449064239|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
124847198|NCT03013491|449064240|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
125307413|NCT03364309|450751424|FG013|Maintenance Period|Miscellaneous|0|||
125307414|NCT03364309|450751425|FG014|Maintenance Period|Miscellaneous|0|||
125307415|NCT03364309|450751426|FG015|Maintenance Period|Miscellaneous|0|||
125307416|NCT03364309|450751427|FG016|Maintenance Period|Miscellaneous|0|||
125307417|NCT03364309|450751428|FG017|Maintenance Period|Miscellaneous|0|||
125307418|NCT03364309|450751429|FG018|Maintenance Period|Miscellaneous|0|||
125307419|NCT03364309|450751411|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307420|NCT03364309|450751412|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307421|NCT03364309|450751413|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307422|NCT03364309|450751414|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307423|NCT03364309|450751415|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307424|NCT03364309|450751416|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307425|NCT03364309|450751417|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307426|NCT03364309|450751418|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307427|NCT03364309|450751419|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307428|NCT03364309|450751420|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307429|NCT03364309|450751421|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307430|NCT03364309|450751422|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307431|NCT03364309|450751423|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307432|NCT03364309|450751424|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
125307433|NCT03364309|450751425|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
125307434|NCT03364309|450751426|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
125307435|NCT03364309|450751427|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307436|NCT03364309|450751428|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307437|NCT03364309|450751429|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307438|NCT03364309|450751411|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307439|NCT03364309|450751412|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307440|NCT03364309|450751413|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307441|NCT03364309|450751414|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307442|NCT03364309|450751415|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307443|NCT03364309|450751416|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307444|NCT03364309|450751417|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307445|NCT03364309|450751418|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307446|NCT03364309|450751419|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307447|NCT03364309|450751420|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307448|NCT03364309|450751421|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307449|NCT03364309|450751422|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307450|NCT03364309|450751423|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307451|NCT03364309|450751424|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307452|NCT03364309|450751425|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
125307453|NCT03364309|450751426|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307454|NCT03364309|450751427|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307455|NCT03364309|450751428|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307456|NCT03364309|450751429|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307457|NCT03364309|450751411|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
125307458|NCT03364309|450751412|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
125307459|NCT03364309|450751413|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
125307460|NCT03364309|450751414|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
125307461|NCT03364309|450751415|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
125307462|NCT03364309|450751416|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
125307463|NCT03364309|450751417|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
125307464|NCT03364309|450751418|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
125307465|NCT03364309|450751419|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
125307466|NCT03364309|450751420|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
125307467|NCT03364309|450751421|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
125307468|NCT03364309|450751422|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
125307469|NCT03364309|450751423|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
125307470|NCT03364309|450751424|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
125307471|NCT03364309|450751425|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
125307472|NCT03364309|450751426|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
125307473|NCT03364309|450751427|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
125307474|NCT03364309|450751428|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
125307475|NCT03364309|450751429|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
125307476|NCT03364309|450751411|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307477|NCT03364309|450751412|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307478|NCT03364309|450751413|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307479|NCT03364309|450751414|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307480|NCT03364309|450751415|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307481|NCT03364309|450751416|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307482|NCT03364309|450751417|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307483|NCT03364309|450751418|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307484|NCT03364309|450751419|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307485|NCT03364309|450751420|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307486|NCT03364309|450751421|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307487|NCT03364309|450751422|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307488|NCT03364309|450751423|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307489|NCT03364309|450751424|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307490|NCT03364309|450751425|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307491|NCT03364309|450751426|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307492|NCT03364309|450751427|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
125307493|NCT03364309|450751428|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
125307494|NCT03364309|450751429|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
125307495|NCT03364309|450751411|FG000|Post-Treatment Followup Period|Adverse Event|0|||
125307496|NCT03364309|450751412|FG001|Post-Treatment Followup Period|Adverse Event|0|||
125307497|NCT03364309|450751413|FG002|Post-Treatment Followup Period|Adverse Event|0|||
125307498|NCT03364309|450751414|FG003|Post-Treatment Followup Period|Adverse Event|0|||
125307499|NCT03364309|450751415|FG004|Post-Treatment Followup Period|Adverse Event|0|||
125307500|NCT03364309|450751416|FG005|Post-Treatment Followup Period|Adverse Event|0|||
125307501|NCT03364309|450751417|FG006|Post-Treatment Followup Period|Adverse Event|0|||
125307502|NCT03364309|450751418|FG007|Post-Treatment Followup Period|Adverse Event|0|||
125307503|NCT03364309|450751419|FG008|Post-Treatment Followup Period|Adverse Event|0|||
125307504|NCT03364309|450751420|FG009|Post-Treatment Followup Period|Adverse Event|0|||
125307505|NCT03364309|450751421|FG010|Post-Treatment Followup Period|Adverse Event|0|||
125307506|NCT03364309|450751422|FG011|Post-Treatment Followup Period|Adverse Event|0|||
125307507|NCT03364309|450751423|FG012|Post-Treatment Followup Period|Adverse Event|0|||
125307508|NCT03364309|450751424|FG013|Post-Treatment Followup Period|Adverse Event|0|||
125307509|NCT03364309|450751425|FG014|Post-Treatment Followup Period|Adverse Event|0|||
125307510|NCT03364309|450751426|FG015|Post-Treatment Followup Period|Adverse Event|0|||
125307511|NCT03364309|450751427|FG016|Post-Treatment Followup Period|Adverse Event|2|||
125307512|NCT03364309|450751428|FG017|Post-Treatment Followup Period|Adverse Event|6|||
125307513|NCT03364309|450751429|FG018|Post-Treatment Followup Period|Adverse Event|1|||
125307514|NCT03364309|450751411|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307515|NCT03364309|450751412|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307516|NCT03364309|450751413|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307517|NCT03364309|450751414|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307518|NCT03364309|450751415|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307519|NCT03364309|450751416|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307520|NCT03364309|450751417|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307521|NCT03364309|450751418|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307522|NCT03364309|450751419|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307523|NCT03364309|450751420|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307524|NCT03364309|450751421|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307525|NCT03364309|450751422|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307526|NCT03364309|450751423|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307527|NCT03364309|450751424|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307528|NCT03364309|450751425|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307529|NCT03364309|450751426|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307530|NCT03364309|450751427|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307531|NCT03364309|450751428|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
125307532|NCT03364309|450751429|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307533|NCT03364309|450751411|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
125307534|NCT03364309|450751412|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
125307535|NCT03364309|450751413|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
125307536|NCT03364309|450751414|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
125307537|NCT03364309|450751415|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
125307538|NCT03364309|450751416|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
125307539|NCT03364309|450751417|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
125307540|NCT03364309|450751418|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
125307541|NCT03364309|450751419|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
125307542|NCT03364309|450751420|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
125307543|NCT03364309|450751421|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
125307544|NCT03364309|450751422|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
125307545|NCT03364309|450751423|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
125307546|NCT03364309|450751424|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
125307547|NCT03364309|450751425|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
125307548|NCT03364309|450751426|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
125307549|NCT03364309|450751427|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
125307550|NCT03364309|450751428|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
125307551|NCT03364309|450751429|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
124847199|NCT03013491|449064241|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
125307552|NCT03304873|450751430|FG000|Overall Study|Lost to Follow-up|1|||
125307553|NCT03304873|450751431|FG001|Overall Study|Lost to Follow-up|8|||
125307554|NCT01546688|450751432|FG000|Overall Study|Adverse Event|0|||
125307555|NCT01546688|450751433|FG001|Overall Study|Adverse Event|4|||
125307556|NCT01546688|450751432|FG000|Overall Study|Withdrawal by Subject|2|||
125307557|NCT01546688|450751433|FG001|Overall Study|Withdrawal by Subject|1|||
125307558|NCT01546688|450751432|FG000|Overall Study|Lack of Efficacy|1|||
125307559|NCT01546688|450751433|FG001|Overall Study|Lack of Efficacy|0|||
124847200|NCT03013491|449064242|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
124847201|NCT03013491|449064243|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
124847202|NCT03013491|449064244|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
125307560|NCT01052077|450751437|FG000|Phase A|Lost to Follow-up|22|||
125307561|NCT01052077|450751438|FG001|Phase A|Lost to Follow-up|0|||
125307562|NCT01052077|450751439|FG002|Phase A|Lost to Follow-up|0|||
125307563|NCT01052077|450751440|FG003|Phase A|Lost to Follow-up|0|||
125307564|NCT01052077|450751437|FG000|Phase A|Adverse Event|32|||
125307565|NCT01052077|450751438|FG001|Phase A|Adverse Event|0|||
125307566|NCT01052077|450751439|FG002|Phase A|Adverse Event|0|||
125307567|NCT01052077|450751440|FG003|Phase A|Adverse Event|0|||
125307568|NCT01052077|450751437|FG000|Phase A|Met Withdrawal Criteria|26|||
125307569|NCT01052077|450751438|FG001|Phase A|Met Withdrawal Criteria|0|||
125307570|NCT01052077|450751439|FG002|Phase A|Met Withdrawal Criteria|0|||
125307571|NCT01052077|450751440|FG003|Phase A|Met Withdrawal Criteria|0|||
125307572|NCT01052077|450751437|FG000|Phase A|Physician Decision|10|||
125307573|NCT01052077|450751438|FG001|Phase A|Physician Decision|0|||
125307574|NCT01052077|450751439|FG002|Phase A|Physician Decision|0|||
125307575|NCT01052077|450751440|FG003|Phase A|Physician Decision|0|||
125307576|NCT01052077|450751437|FG000|Phase A|Withdrawal by Subject|29|||
125307577|NCT01052077|450751438|FG001|Phase A|Withdrawal by Subject|0|||
125307578|NCT01052077|450751439|FG002|Phase A|Withdrawal by Subject|0|||
125307579|NCT01052077|450751440|FG003|Phase A|Withdrawal by Subject|0|||
125307580|NCT01052077|450751437|FG000|Phase A|Protocol Deviation|27|||
125307581|NCT01052077|450751438|FG001|Phase A|Protocol Deviation|0|||
125307582|NCT01052077|450751439|FG002|Phase A|Protocol Deviation|0|||
125307583|NCT01052077|450751440|FG003|Phase A|Protocol Deviation|0|||
125307584|NCT01052077|450751437|FG000|Phase B|Lost to Follow-up|0|||
125307585|NCT01052077|450751438|FG001|Phase B|Lost to Follow-up|2|||
125307586|NCT01052077|450751439|FG002|Phase B|Lost to Follow-up|3|||
125307587|NCT01052077|450751440|FG003|Phase B|Lost to Follow-up|0|||
125307588|NCT01052077|450751437|FG000|Phase B|Adverse Event|0|||
125307589|NCT01052077|450751438|FG001|Phase B|Adverse Event|9|||
125307590|NCT01052077|450751439|FG002|Phase B|Adverse Event|2|||
125307591|NCT01052077|450751440|FG003|Phase B|Adverse Event|0|||
125307592|NCT01052077|450751437|FG000|Phase B|Met Withdrawal Criteria|0|||
125307593|NCT01052077|450751438|FG001|Phase B|Met Withdrawal Criteria|2|||
125307594|NCT01052077|450751439|FG002|Phase B|Met Withdrawal Criteria|1|||
125307595|NCT01052077|450751440|FG003|Phase B|Met Withdrawal Criteria|0|||
125307596|NCT01052077|450751437|FG000|Phase B|Physician Decision|0|||
125307597|NCT01052077|450751438|FG001|Phase B|Physician Decision|1|||
125307598|NCT01052077|450751439|FG002|Phase B|Physician Decision|1|||
125307599|NCT01052077|450751440|FG003|Phase B|Physician Decision|0|||
125307600|NCT01052077|450751437|FG000|Phase B|Withdrawal by Subject|0|||
125307601|NCT01052077|450751438|FG001|Phase B|Withdrawal by Subject|0|||
125307602|NCT01052077|450751439|FG002|Phase B|Withdrawal by Subject|5|||
125307603|NCT01052077|450751440|FG003|Phase B|Withdrawal by Subject|0|||
125307604|NCT01052077|450751437|FG000|Phase B|Protocol Deviation|0|||
125307605|NCT01052077|450751438|FG001|Phase B|Protocol Deviation|3|||
125307606|NCT01052077|450751439|FG002|Phase B|Protocol Deviation|4|||
125307607|NCT01052077|450751440|FG003|Phase B|Protocol Deviation|0|||
125307608|NCT01052077|450751437|FG000|Phase B|Lack of Efficacy|0|||
125307609|NCT01052077|450751438|FG001|Phase B|Lack of Efficacy|1|||
125307610|NCT01052077|450751439|FG002|Phase B|Lack of Efficacy|0|||
125307611|NCT01052077|450751440|FG003|Phase B|Lack of Efficacy|0|||
125307612|NCT01052077|450751437|FG000|Phase A+|Lost to Follow-up|0|||
125307613|NCT01052077|450751438|FG001|Phase A+|Lost to Follow-up|0|||
125307614|NCT01052077|450751439|FG002|Phase A+|Lost to Follow-up|0|||
125307615|NCT01052077|450751440|FG003|Phase A+|Lost to Follow-up|8|||
125307616|NCT01052077|450751437|FG000|Phase A+|Adverse Event|0|||
125307617|NCT01052077|450751438|FG001|Phase A+|Adverse Event|0|||
125307618|NCT01052077|450751439|FG002|Phase A+|Adverse Event|0|||
125307619|NCT01052077|450751440|FG003|Phase A+|Adverse Event|4|||
125307620|NCT01052077|450751437|FG000|Phase A+|Met Withdrawal Criteria|0|||
125307621|NCT01052077|450751438|FG001|Phase A+|Met Withdrawal Criteria|0|||
125307622|NCT01052077|450751439|FG002|Phase A+|Met Withdrawal Criteria|0|||
125307623|NCT01052077|450751440|FG003|Phase A+|Met Withdrawal Criteria|2|||
125307624|NCT01052077|450751437|FG000|Phase A+|Withdrawal by Subject|0|||
125307625|NCT01052077|450751438|FG001|Phase A+|Withdrawal by Subject|0|||
125307626|NCT01052077|450751439|FG002|Phase A+|Withdrawal by Subject|0|||
125307627|NCT01052077|450751440|FG003|Phase A+|Withdrawal by Subject|7|||
125307628|NCT02465203|450751441|FG000|Overall Study|Protocol Violation|1|||
125307629|NCT02465203|450751442|FG001|Overall Study|Protocol Violation|1|||
125307630|NCT02465203|450751443|FG002|Overall Study|Protocol Violation|1|||
125307631|NCT02465203|450751441|FG000|Overall Study|Study terminated by sponsor|50|||
125307632|NCT02465203|450751442|FG001|Overall Study|Study terminated by sponsor|34|||
125307633|NCT02465203|450751443|FG002|Overall Study|Study terminated by sponsor|11|||
125307634|NCT02465203|450751441|FG000|Overall Study|New therapy for study indication|4|||
125307635|NCT02465203|450751442|FG001|Overall Study|New therapy for study indication|0|||
125307636|NCT02465203|450751443|FG002|Overall Study|New therapy for study indication|0|||
125307637|NCT02465203|450751441|FG000|Overall Study|Patient/guardian decision|1|||
125307638|NCT02465203|450751442|FG001|Overall Study|Patient/guardian decision|1|||
125307639|NCT02465203|450751443|FG002|Overall Study|Patient/guardian decision|1|||
125307640|NCT00042991|450751444|FG000|Overall Study|Adverse Event|1|||
125307641|NCT00042991|450751445|FG001|Overall Study|Adverse Event|4|||
125307642|NCT00042991|450751446|FG002|Overall Study|Adverse Event|2|||
125307643|NCT00042991|450751447|FG003|Overall Study|Adverse Event|0|||
125307644|NCT00042991|450751448|FG004|Overall Study|Adverse Event|0|||
125307645|NCT00042991|450751449|FG005|Overall Study|Adverse Event|1|||
125307646|NCT00042991|450751450|FG006|Overall Study|Adverse Event|0|||
125307647|NCT00042991|450751444|FG000|Overall Study|Withdrawal by Subject|0|||
125307648|NCT00042991|450751445|FG001|Overall Study|Withdrawal by Subject|7|||
125307649|NCT00042991|450751446|FG002|Overall Study|Withdrawal by Subject|2|||
125307650|NCT00042991|450751447|FG003|Overall Study|Withdrawal by Subject|0|||
125307651|NCT00042991|450751448|FG004|Overall Study|Withdrawal by Subject|1|||
125307652|NCT00042991|450751449|FG005|Overall Study|Withdrawal by Subject|0|||
125307653|NCT00042991|450751450|FG006|Overall Study|Withdrawal by Subject|0|||
125307654|NCT00042991|450751444|FG000|Overall Study|Disease Progression|5|||
125307655|NCT00042991|450751445|FG001|Overall Study|Disease Progression|29|||
125307656|NCT00042991|450751446|FG002|Overall Study|Disease Progression|2|||
125307657|NCT00042991|450751447|FG003|Overall Study|Disease Progression|2|||
125307658|NCT00042991|450751448|FG004|Overall Study|Disease Progression|1|||
125307659|NCT00042991|450751449|FG005|Overall Study|Disease Progression|4|||
125307660|NCT00042991|450751450|FG006|Overall Study|Disease Progression|2|||
125307661|NCT00042991|450751444|FG000|Overall Study|Alternative Therapy|0|||
125307662|NCT00042991|450751445|FG001|Overall Study|Alternative Therapy|0|||
125307663|NCT00042991|450751446|FG002|Overall Study|Alternative Therapy|0|||
125307664|NCT00042991|450751447|FG003|Overall Study|Alternative Therapy|0|||
125307665|NCT00042991|450751448|FG004|Overall Study|Alternative Therapy|1|||
125307666|NCT00042991|450751449|FG005|Overall Study|Alternative Therapy|0|||
125307667|NCT00042991|450751450|FG006|Overall Study|Alternative Therapy|0|||
125307668|NCT04072887|450751451|FG000|Overall Study|Withdrawal by Subject|3|||
125307669|NCT04072887|450751452|FG001|Overall Study|Withdrawal by Subject|8|||
125307670|NCT04072887|450751453|FG002|Overall Study|Withdrawal by Subject|1|||
125307671|NCT04072887|450751454|FG003|Overall Study|Withdrawal by Subject|3|||
125307672|NCT04072887|450751455|FG004|Overall Study|Withdrawal by Subject|3|||
125307673|NCT04072887|450751456|FG005|Overall Study|Withdrawal by Subject|13|||
125307674|NCT04072887|450751451|FG000|Overall Study|Adverse Event|2|||
125307675|NCT04072887|450751452|FG001|Overall Study|Adverse Event|4|||
125307676|NCT04072887|450751453|FG002|Overall Study|Adverse Event|1|||
125307677|NCT04072887|450751454|FG003|Overall Study|Adverse Event|4|||
125307678|NCT04072887|450751455|FG004|Overall Study|Adverse Event|0|||
125307679|NCT04072887|450751456|FG005|Overall Study|Adverse Event|1|||
125307680|NCT04072887|450751451|FG000|Overall Study|Physician Decision|2|||
125307681|NCT04072887|450751452|FG001|Overall Study|Physician Decision|0|||
125307682|NCT04072887|450751453|FG002|Overall Study|Physician Decision|0|||
125307683|NCT04072887|450751454|FG003|Overall Study|Physician Decision|0|||
125307684|NCT04072887|450751455|FG004|Overall Study|Physician Decision|0|||
125307685|NCT04072887|450751456|FG005|Overall Study|Physician Decision|1|||
125307686|NCT04072887|450751451|FG000|Overall Study|Lost to Follow-up|1|||
125307687|NCT04072887|450751452|FG001|Overall Study|Lost to Follow-up|3|||
125307688|NCT04072887|450751453|FG002|Overall Study|Lost to Follow-up|0|||
125307689|NCT04072887|450751454|FG003|Overall Study|Lost to Follow-up|0|||
125307690|NCT04072887|450751455|FG004|Overall Study|Lost to Follow-up|0|||
125307691|NCT04072887|450751456|FG005|Overall Study|Lost to Follow-up|0|||
125307692|NCT04072887|450751451|FG000|Overall Study|Death|0|||
125307693|NCT04072887|450751452|FG001|Overall Study|Death|2|||
125307694|NCT04072887|450751453|FG002|Overall Study|Death|0|||
125307695|NCT04072887|450751454|FG003|Overall Study|Death|2|||
125307696|NCT04072887|450751455|FG004|Overall Study|Death|3|||
125307697|NCT04072887|450751456|FG005|Overall Study|Death|0|||
125307698|NCT03193736|450751457|FG000|Overall Study|Death|2|||
125307699|NCT03193736|450751457|FG000|Overall Study|Withdrawal by Subject|1|||
125307700|NCT03193736|450751457|FG000|Overall Study|Lost to Follow-up|1|||
125307701|NCT03193736|450751457|FG000|Overall Study|implant not received|1|||
125307702|NCT00423449|450751458|FG000|Overall Study|Clinical Adverse Event|1|||
125307703|NCT00423449|450751459|FG001|Overall Study|Clinical Adverse Event|0|||
125307704|NCT00423449|450751460|FG002|Overall Study|Clinical Adverse Event|1|||
125307705|NCT00423449|450751461|FG003|Overall Study|Clinical Adverse Event|8|||
125307706|NCT00423449|450751462|FG004|Overall Study|Clinical Adverse Event|2|||
125307707|NCT00423449|450751458|FG000|Overall Study|Death|1|||
125307708|NCT00423449|450751459|FG001|Overall Study|Death|0|||
125307709|NCT00423449|450751460|FG002|Overall Study|Death|2|||
125307710|NCT00423449|450751461|FG003|Overall Study|Death|1|||
125307711|NCT00423449|450751462|FG004|Overall Study|Death|1|||
125307712|NCT00423449|450751458|FG000|Overall Study|Progressive Disease|1|||
125307713|NCT00423449|450751459|FG001|Overall Study|Progressive Disease|3|||
125307714|NCT00423449|450751460|FG002|Overall Study|Progressive Disease|8|||
125307715|NCT00423449|450751461|FG003|Overall Study|Progressive Disease|11|||
125307716|NCT00423449|450751462|FG004|Overall Study|Progressive Disease|4|||
125307717|NCT00423449|450751458|FG000|Overall Study|Laboratory Adverse Event|0|||
125307718|NCT00423449|450751459|FG001|Overall Study|Laboratory Adverse Event|1|||
125307719|NCT00423449|450751460|FG002|Overall Study|Laboratory Adverse Event|2|||
125307720|NCT00423449|450751461|FG003|Overall Study|Laboratory Adverse Event|0|||
125307721|NCT00423449|450751462|FG004|Overall Study|Laboratory Adverse Event|0|||
125307722|NCT00423449|450751458|FG000|Overall Study|Other|0|||
125307723|NCT00423449|450751459|FG001|Overall Study|Other|0|||
125307724|NCT00423449|450751460|FG002|Overall Study|Other|0|||
125307725|NCT00423449|450751461|FG003|Overall Study|Other|1|||
125307726|NCT00423449|450751462|FG004|Overall Study|Other|0|||
125307727|NCT00423449|450751458|FG000|Overall Study|Protocol Violation|0|||
125307728|NCT00423449|450751459|FG001|Overall Study|Protocol Violation|0|||
125307729|NCT00423449|450751460|FG002|Overall Study|Protocol Violation|2|||
125307730|NCT00423449|450751461|FG003|Overall Study|Protocol Violation|1|||
125307731|NCT00423449|450751462|FG004|Overall Study|Protocol Violation|0|||
125307732|NCT02697435|450751463|FG000|Overall Study|Withdrawal by Subject|1|||
125307733|NCT02697435|450751464|FG001|Overall Study|Withdrawal by Subject|0|||
125307734|NCT02697435|450751463|FG000|Overall Study|Physician Decision|0|||
125307735|NCT02697435|450751464|FG001|Overall Study|Physician Decision|4|||
125307736|NCT04371666|450751465|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
125307737|NCT04371666|450751466|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
125307738|NCT04371666|450751465|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
125307739|NCT04371666|450751466|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
125307740|NCT04371666|450751465|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
125307741|NCT04371666|450751466|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
125307742|NCT04371666|450751465|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
125307743|NCT04371666|450751466|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
125307744|NCT04371666|450751465|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
125307745|NCT04371666|450751466|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
125307746|NCT04371666|450751465|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
125307747|NCT04371666|450751466|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
125307748|NCT01445080|450751473|FG000|Overall Study|Adverse Event|5|||
125307749|NCT01445080|450751474|FG001|Overall Study|Adverse Event|3|||
125307750|NCT01445080|450751475|FG002|Overall Study|Adverse Event|11|||
125307751|NCT01445080|450751476|FG003|Overall Study|Adverse Event|6|||
125307752|NCT01445080|450751477|FG004|Overall Study|Adverse Event|2|||
125307753|NCT01445080|450751478|FG005|Overall Study|Adverse Event|3|||
125307754|NCT01445080|450751479|FG006|Overall Study|Adverse Event|0|||
125307755|NCT01445080|450751480|FG007|Overall Study|Adverse Event|3|||
125307756|NCT01445080|450751481|FG008|Overall Study|Adverse Event|10|||
125307757|NCT01445080|450751473|FG000|Overall Study|Physician Decision|0|||
125307758|NCT01445080|450751474|FG001|Overall Study|Physician Decision|0|||
125307759|NCT01445080|450751475|FG002|Overall Study|Physician Decision|1|||
125307760|NCT01445080|450751476|FG003|Overall Study|Physician Decision|0|||
125307761|NCT01445080|450751477|FG004|Overall Study|Physician Decision|0|||
125307762|NCT01445080|450751478|FG005|Overall Study|Physician Decision|3|||
125307763|NCT01445080|450751479|FG006|Overall Study|Physician Decision|2|||
125307764|NCT01445080|450751480|FG007|Overall Study|Physician Decision|2|||
125307765|NCT01445080|450751481|FG008|Overall Study|Physician Decision|0|||
125307766|NCT01445080|450751473|FG000|Overall Study|Withdrawal by Subject|1|||
125307767|NCT01445080|450751474|FG001|Overall Study|Withdrawal by Subject|0|||
125307768|NCT01445080|450751475|FG002|Overall Study|Withdrawal by Subject|0|||
125307769|NCT01445080|450751476|FG003|Overall Study|Withdrawal by Subject|1|||
125307770|NCT01445080|450751477|FG004|Overall Study|Withdrawal by Subject|0|||
125307771|NCT01445080|450751478|FG005|Overall Study|Withdrawal by Subject|0|||
125307772|NCT01445080|450751479|FG006|Overall Study|Withdrawal by Subject|0|||
125307773|NCT01445080|450751480|FG007|Overall Study|Withdrawal by Subject|0|||
125307774|NCT01445080|450751481|FG008|Overall Study|Withdrawal by Subject|2|||
125307775|NCT01445080|450751473|FG000|Overall Study|Ineligible/Inevaluable|1|||
125307776|NCT01445080|450751474|FG001|Overall Study|Ineligible/Inevaluable|2|||
125307777|NCT01445080|450751475|FG002|Overall Study|Ineligible/Inevaluable|0|||
125307778|NCT01445080|450751476|FG003|Overall Study|Ineligible/Inevaluable|1|||
125307779|NCT01445080|450751477|FG004|Overall Study|Ineligible/Inevaluable|2|||
125307780|NCT01445080|450751478|FG005|Overall Study|Ineligible/Inevaluable|3|||
125307781|NCT01445080|450751479|FG006|Overall Study|Ineligible/Inevaluable|0|||
125307782|NCT01445080|450751480|FG007|Overall Study|Ineligible/Inevaluable|0|||
125307783|NCT01445080|450751481|FG008|Overall Study|Ineligible/Inevaluable|6|||
125307784|NCT02123576|450751482|FG000|Overall Study|Adverse Event|1|||
124847203|NCT03013491|449064245|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
124847204|NCT03013491|449064246|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
125307785|NCT02123576|450751483|FG001|Overall Study|Adverse Event|0|||
125307786|NCT02974257|450753308|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
125307787|NCT02974257|450753309|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
125307788|NCT02974257|450753308|FG000|Overall Study|Clinical indication for thiamine|1|||
125307789|NCT02974257|450753309|FG001|Overall Study|Clinical indication for thiamine|0|||
125307790|NCT02974257|450753308|FG000|Overall Study|Already on thiamine|1|||
125307791|NCT02974257|450753309|FG001|Overall Study|Already on thiamine|0|||
125307792|NCT02974257|450753308|FG000|Overall Study|Extubated prior to study drug|0|||
125307793|NCT02974257|450753309|FG001|Overall Study|Extubated prior to study drug|1|||
125307794|NCT02974257|450753308|FG000|Overall Study|Death|0|||
125307795|NCT02974257|450753309|FG001|Overall Study|Death|1|||
125307796|NCT02828436|450753312|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
125307797|NCT02828436|450753313|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
125307798|NCT02828436|450753312|FG000|Period 1|Lost to Follow-up|0|||
125307799|NCT02828436|450753313|FG001|Period 1|Lost to Follow-up|1|||
125307800|NCT02828436|450753312|FG000|Period 2|Withdrawal by Subject|4|||
125307801|NCT02828436|450753313|FG001|Period 2|Withdrawal by Subject|0|||
125307802|NCT02828436|450753312|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
125307803|NCT02828436|450753313|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
125307804|NCT02828436|450753312|FG000|Period 2|Lost to Follow-up|1|||
125307805|NCT02828436|450753313|FG001|Period 2|Lost to Follow-up|0|||
125307806|NCT01136408|450753314|FG000|Overall Study|Adverse Event|4|||
125307807|NCT01136408|450753315|FG001|Overall Study|Adverse Event|8|||
125307808|NCT01136408|450753316|FG002|Overall Study|Adverse Event|4|||
125307809|NCT01136408|450753314|FG000|Overall Study|Protocol Violation|1|||
125307810|NCT01136408|450753315|FG001|Overall Study|Protocol Violation|1|||
125307811|NCT01136408|450753316|FG002|Overall Study|Protocol Violation|1|||
125307812|NCT04421482|450753320|FG000|Overall Study|Physician Decision|1|||
125307813|NCT02128724|450753323|FG000|Overall Study|Death|1|||
125307814|NCT02128724|450753324|FG001|Overall Study|Death|0|||
125307815|NCT02128724|450753325|FG002|Overall Study|Death|0|||
125307816|NCT02128724|450753326|FG003|Overall Study|Death|0|||
125307817|NCT02128724|450753323|FG000|Overall Study|Adverse Event|0|||
125307818|NCT02128724|450753324|FG001|Overall Study|Adverse Event|1|||
125307819|NCT02128724|450753325|FG002|Overall Study|Adverse Event|0|||
125307820|NCT02128724|450753326|FG003|Overall Study|Adverse Event|0|||
125307821|NCT02128724|450753323|FG000|Overall Study|Physician Decision|0|||
125307822|NCT02128724|450753324|FG001|Overall Study|Physician Decision|0|||
125307823|NCT02128724|450753325|FG002|Overall Study|Physician Decision|0|||
125307824|NCT02128724|450753326|FG003|Overall Study|Physician Decision|2|||
125307825|NCT02128724|450753323|FG000|Overall Study|Withdrawal by Subject|0|||
125307826|NCT02128724|450753324|FG001|Overall Study|Withdrawal by Subject|0|||
125307827|NCT02128724|450753325|FG002|Overall Study|Withdrawal by Subject|0|||
125307828|NCT02128724|450753326|FG003|Overall Study|Withdrawal by Subject|1|||
125307829|NCT03329092|450753327|FG000|Overall Study|Other|2|||
125307830|NCT03329092|450753328|FG001|Overall Study|Other|2|||
125307831|NCT03329092|450753327|FG000|Overall Study|Withdrawal by Subject|16|||
125307832|NCT03329092|450753328|FG001|Overall Study|Withdrawal by Subject|3|||
125307833|NCT03329092|450753327|FG000|Overall Study|Physician Decision|1|||
125307834|NCT03329092|450753328|FG001|Overall Study|Physician Decision|0|||
125307835|NCT03329092|450753327|FG000|Overall Study|Death|17|||
125307836|NCT03329092|450753328|FG001|Overall Study|Death|11|||
125307837|NCT03329092|450753327|FG000|Overall Study|Adverse Event|3|||
125307838|NCT03329092|450753328|FG001|Overall Study|Adverse Event|1|||
125307839|NCT03329092|450753327|FG000|Overall Study|Lost to Follow-up|1|||
125307840|NCT03329092|450753328|FG001|Overall Study|Lost to Follow-up|1|||
125307841|NCT05786508|450753329|FG000|Overall Study|Withdrawal by Subject|2|||
125307842|NCT05786508|450753330|FG001|Overall Study|Withdrawal by Subject|0|||
125307843|NCT04273893|450753331|FG000|Overall Study|Withdrawal by Subject|0|||
125307844|NCT04273893|450753332|FG001|Overall Study|Withdrawal by Subject|2|||
125307845|NCT04273893|450753331|FG000|Overall Study|Treatment of Disease Progression|0|||
125307846|NCT04273893|450753332|FG001|Overall Study|Treatment of Disease Progression|2|||
125307847|NCT04273893|450753331|FG000|Overall Study|Death|1|||
125307848|NCT04273893|450753332|FG001|Overall Study|Death|2|||
125307849|NCT04273893|450753331|FG000|Overall Study|Lost to Follow-up|0|||
125307850|NCT04273893|450753332|FG001|Overall Study|Lost to Follow-up|2|||
125307851|NCT04273893|450753331|FG000|Overall Study|Physician Decision|1|||
124847205|NCT03013491|449064247|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
124847206|NCT03013491|449064248|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
124847207|NCT03013491|449064249|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
125307852|NCT04273893|450753332|FG001|Overall Study|Physician Decision|0|||
125307853|NCT03906071|450753333|FG000|Overall Study|Death|180|||
125307854|NCT03906071|450753334|FG001|Overall Study|Death|185|||
125307855|NCT03906071|450753333|FG000|Overall Study|Lost to Follow-up|3|||
125307856|NCT03906071|450753334|FG001|Overall Study|Lost to Follow-up|3|||
125307857|NCT03906071|450753333|FG000|Overall Study|Withdrawal by Subject|15|||
125307858|NCT03906071|450753334|FG001|Overall Study|Withdrawal by Subject|27|||
125307859|NCT03906071|450753333|FG000|Overall Study|Other|2|||
125307860|NCT03906071|450753334|FG001|Overall Study|Other|1|||
125307861|NCT01456169|450753338|FG000|Overall Study|Adverse Event|1|||
125307862|NCT01456169|450753339|FG001|Overall Study|Adverse Event|2|||
125307863|NCT01456169|450753340|FG002|Overall Study|Adverse Event|7|||
125307864|NCT01456169|450753338|FG000|Overall Study|Major Protocol Deviation|3|||
125307865|NCT01456169|450753339|FG001|Overall Study|Major Protocol Deviation|2|||
125307866|NCT01456169|450753340|FG002|Overall Study|Major Protocol Deviation|3|||
125307867|NCT01456169|450753338|FG000|Overall Study|Voluntary Withdrawal|3|||
125307868|NCT01456169|450753339|FG001|Overall Study|Voluntary Withdrawal|0|||
125307869|NCT01456169|450753340|FG002|Overall Study|Voluntary Withdrawal|2|||
125307870|NCT01456169|450753338|FG000|Overall Study|Lack of Efficacy|2|||
125307871|NCT01456169|450753339|FG001|Overall Study|Lack of Efficacy|0|||
125307872|NCT01456169|450753340|FG002|Overall Study|Lack of Efficacy|0|||
125307873|NCT01456169|450753338|FG000|Overall Study|Other|1|||
125307874|NCT01456169|450753339|FG001|Overall Study|Other|1|||
125307875|NCT01456169|450753340|FG002|Overall Study|Other|0|||
125307876|NCT02598297|450753341|FG000|Overall Study|Study terminated by Sponsor|21|||
125307877|NCT02598297|450753342|FG001|Overall Study|Study terminated by Sponsor|23|||
125307878|NCT02598297|450753341|FG000|Overall Study|Adverse Event|1|||
125307879|NCT02598297|450753342|FG001|Overall Study|Adverse Event|1|||
125307880|NCT02598297|450753341|FG000|Overall Study|Physician Decision|1|||
125307881|NCT02598297|450753342|FG001|Overall Study|Physician Decision|0|||
125307882|NCT02598297|450753341|FG000|Overall Study|Subject/guardian decision|1|||
125307883|NCT02598297|450753342|FG001|Overall Study|Subject/guardian decision|0|||
125307884|NCT02598297|450753341|FG000|Overall Study|Followed for survival|1|||
125307885|NCT02598297|450753342|FG001|Overall Study|Followed for survival|0|||
125307886|NCT00394706|450753348|FG000|Overall Study|Withdrawal by Subject|2|||
125307887|NCT00394706|450753349|FG001|Overall Study|Withdrawal by Subject|0|||
125307888|NCT00394706|450753350|FG002|Overall Study|Withdrawal by Subject|1|||
125307889|NCT00394706|450753351|FG003|Overall Study|Withdrawal by Subject|0|||
125307890|NCT00394706|450753352|FG004|Overall Study|Withdrawal by Subject|0|||
125307891|NCT00394706|450753353|FG005|Overall Study|Withdrawal by Subject|2|||
125307892|NCT00394706|450753354|FG006|Overall Study|Withdrawal by Subject|1|||
125307893|NCT00394706|450753355|FG007|Overall Study|Withdrawal by Subject|0|||
125307894|NCT00394706|450753348|FG000|Overall Study|Lost to Follow-up|2|||
125307895|NCT00394706|450753349|FG001|Overall Study|Lost to Follow-up|2|||
125307896|NCT00394706|450753350|FG002|Overall Study|Lost to Follow-up|8|||
125307897|NCT00394706|450753351|FG003|Overall Study|Lost to Follow-up|1|||
125307898|NCT00394706|450753352|FG004|Overall Study|Lost to Follow-up|2|||
125307899|NCT00394706|450753353|FG005|Overall Study|Lost to Follow-up|5|||
125307900|NCT00394706|450753354|FG006|Overall Study|Lost to Follow-up|2|||
125307901|NCT00394706|450753355|FG007|Overall Study|Lost to Follow-up|0|||
125307902|NCT02003534|450753359|FG000|Overall Study|Lost to Follow-up|47|||
125307903|NCT02652156|450753360|FG000|Overall Study|Physician Decision|1|||
125307904|NCT02652156|450753361|FG001|Overall Study|Physician Decision|0|||
125307905|NCT02652156|450753362|FG002|Overall Study|Physician Decision|0|||
125307906|NCT02342223|450753364|FG000|Overall Study|Lost to Follow-up|1|||
125307907|NCT00496080|450753367|FG000|Overall Study|Lost to Follow-up|9|||
125307908|NCT00496080|450753367|FG000|Overall Study|Surgical re-intervention|7|||
125307909|NCT00496080|450753367|FG000|Overall Study|Withdrawal by Subject|5|||
125307910|NCT00496080|450753367|FG000|Overall Study|Physician Decision|6|||
125307911|NCT01200368|450753372|FG000|Infant Series|Adverse Event|2|||
125307912|NCT01200368|450753373|FG001|Infant Series|Adverse Event|2|||
125307913|NCT01200368|450753374|FG002|Infant Series|Adverse Event|3|||
125307914|NCT01200368|450753372|FG000|Infant Series|Withdrawal by Subject|0|||
125307915|NCT01200368|450753373|FG001|Infant Series|Withdrawal by Subject|2|||
125307916|NCT01200368|450753374|FG002|Infant Series|Withdrawal by Subject|2|||
125307917|NCT01200368|450753372|FG000|Infant Series|Did not meet entrance criteria|0|||
125307918|NCT01200368|450753373|FG001|Infant Series|Did not meet entrance criteria|1|||
125307919|NCT01200368|450753374|FG002|Infant Series|Did not meet entrance criteria|0|||
125307920|NCT01200368|450753372|FG000|Infant Series|Randomized, not vaccinated|0|||
125307921|NCT01200368|450753373|FG001|Infant Series|Randomized, not vaccinated|1|||
125307922|NCT01200368|450753374|FG002|Infant Series|Randomized, not vaccinated|1|||
125307923|NCT01200368|450753372|FG000|Infant Series|Other|1|||
125307924|NCT01200368|450753373|FG001|Infant Series|Other|0|||
125307925|NCT01200368|450753374|FG002|Infant Series|Other|0|||
125307926|NCT01200368|450753372|FG000|After Infant Series|Adverse Event|6|||
125307927|NCT01200368|450753373|FG001|After Infant Series|Adverse Event|6|||
125307928|NCT01200368|450753374|FG002|After Infant Series|Adverse Event|3|||
125307929|NCT01200368|450753372|FG000|After Infant Series|Withdrawal by Subject|10|||
125307930|NCT01200368|450753373|FG001|After Infant Series|Withdrawal by Subject|8|||
125307931|NCT01200368|450753374|FG002|After Infant Series|Withdrawal by Subject|4|||
125307932|NCT01200368|450753372|FG000|After Infant Series|Lost to Follow-up|1|||
125307933|NCT01200368|450753373|FG001|After Infant Series|Lost to Follow-up|0|||
125307934|NCT01200368|450753374|FG002|After Infant Series|Lost to Follow-up|0|||
125307935|NCT01200368|450753372|FG000|After Infant Series|Other|1|||
125307936|NCT01200368|450753373|FG001|After Infant Series|Other|2|||
125307937|NCT01200368|450753374|FG002|After Infant Series|Other|2|||
125307938|NCT01200368|450753372|FG000|Toddler Dose|Adverse Event|0|||
125307939|NCT01200368|450753373|FG001|Toddler Dose|Adverse Event|3|||
125307940|NCT01200368|450753374|FG002|Toddler Dose|Adverse Event|1|||
125307941|NCT00570310|450753375|FG000|Overall Study|Adverse Event|1|||
125307942|NCT00570310|450753376|FG001|Overall Study|Adverse Event|2|||
125307943|NCT00570310|450753375|FG000|Overall Study|Lack of Efficacy|1|||
125307944|NCT00570310|450753376|FG001|Overall Study|Lack of Efficacy|4|||
125307945|NCT00108862|450753377|FG000|Overall Study|Death|31|||
125307946|NCT00108862|450753378|FG001|Overall Study|Death|37|||
125307947|NCT00108862|450753377|FG000|Overall Study|Withdrawal by Subject|10|||
125307948|NCT00108862|450753378|FG001|Overall Study|Withdrawal by Subject|6|||
125307949|NCT00108862|450753377|FG000|Overall Study|Lost to Follow-up|27|||
125307950|NCT00108862|450753378|FG001|Overall Study|Lost to Follow-up|19|||
124847208|NCT03013491|449064250|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
124847209|NCT03013491|449064251|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
124847210|NCT03013491|449064252|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
124847211|NCT03013491|449064253|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
124847212|NCT03013491|449064254|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
124847213|NCT03013491|449064255|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
124847214|NCT03013491|449064256|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
124847215|NCT03013491|449064257|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
124847216|NCT03013491|449064239|FG000|Main Study|Start of new anticancer therapy|0|||
124847217|NCT03013491|449064240|FG001|Main Study|Start of new anticancer therapy|0|||
124847218|NCT03013491|449064241|FG002|Main Study|Start of new anticancer therapy|0|||
124847219|NCT03013491|449064242|FG003|Main Study|Start of new anticancer therapy|0|||
124847220|NCT03013491|449064243|FG004|Main Study|Start of new anticancer therapy|0|||
124847221|NCT03013491|449064244|FG005|Main Study|Start of new anticancer therapy|0|||
124847222|NCT03013491|449064245|FG006|Main Study|Start of new anticancer therapy|0|||
124847223|NCT03013491|449064246|FG007|Main Study|Start of new anticancer therapy|0|||
124847224|NCT03013491|449064247|FG008|Main Study|Start of new anticancer therapy|0|||
124847225|NCT03013491|449064248|FG009|Main Study|Start of new anticancer therapy|0|||
124847226|NCT03013491|449064249|FG010|Main Study|Start of new anticancer therapy|0|||
124847227|NCT03013491|449064250|FG011|Main Study|Start of new anticancer therapy|0|||
124847228|NCT03013491|449064251|FG012|Main Study|Start of new anticancer therapy|0|||
124847229|NCT03013491|449064252|FG013|Main Study|Start of new anticancer therapy|0|||
124847230|NCT03013491|449064253|FG014|Main Study|Start of new anticancer therapy|0|||
124847231|NCT03013491|449064254|FG015|Main Study|Start of new anticancer therapy|0|||
124847232|NCT03013491|449064255|FG016|Main Study|Start of new anticancer therapy|0|||
124847233|NCT03013491|449064256|FG017|Main Study|Start of new anticancer therapy|0|||
124847234|NCT03013491|449064257|FG018|Main Study|Start of new anticancer therapy|2|||
124847235|NCT03013491|449064239|FG000|Long-term Extension|Disease progression|0|||
125307951|NCT03534141|450753379|FG000|Overall Study|Enrolled in other clinical trial|1|||
125307952|NCT03534141|450753380|FG001|Overall Study|Enrolled in other clinical trial|0|||
125307953|NCT03534141|450753379|FG000|Overall Study|Liver transplant aborted after randomization|0|||
125307954|NCT03534141|450753380|FG001|Overall Study|Liver transplant aborted after randomization|2|||
125307955|NCT03534141|450753379|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
125307956|NCT03534141|450753380|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
125307957|NCT03785405|450753383|FG000|Overall Study|Adverse Event|16|||
125307958|NCT03785405|450753384|FG001|Overall Study|Adverse Event|1|||
125307959|NCT03785405|450753383|FG000|Overall Study|Death|6|||
125307960|NCT03785405|450753384|FG001|Overall Study|Death|4|||
125307961|NCT03785405|450753383|FG000|Overall Study|Guardian decision|4|||
125307962|NCT03785405|450753384|FG001|Overall Study|Guardian decision|1|||
125307963|NCT03785405|450753383|FG000|Overall Study|Lost to Follow-up|1|||
125307964|NCT03785405|450753384|FG001|Overall Study|Lost to Follow-up|0|||
125307965|NCT03785405|450753383|FG000|Overall Study|Physician Decision|8|||
125307966|NCT03785405|450753384|FG001|Overall Study|Physician Decision|5|||
125307967|NCT03785405|450753383|FG000|Overall Study|Participant decision|2|||
125307968|NCT03785405|450753384|FG001|Overall Study|Participant decision|0|||
125307969|NCT03785405|450753383|FG000|Overall Study|Other|1|||
125307970|NCT03785405|450753384|FG001|Overall Study|Other|0|||
125307971|NCT03785405|450753383|FG000|Overall Study|No treatment was received|0|||
125307972|NCT03785405|450753384|FG001|Overall Study|No treatment was received|1|||
125307973|NCT02881762|450753387|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
125307974|NCT02881762|450753388|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
125307975|NCT04137731|450753391|FG000|Overall Study|Surgery Cancellation|1|||
125307976|NCT04137731|450753392|FG001|Overall Study|Surgery Cancellation|2|||
125307977|NCT04137731|450753391|FG000|Overall Study|Withdrawal by Subject|2|||
125307978|NCT04137731|450753392|FG001|Overall Study|Withdrawal by Subject|0|||
125307979|NCT04137731|450753391|FG000|Overall Study|Protocol Violation|0|||
125307980|NCT04137731|450753392|FG001|Overall Study|Protocol Violation|1|||
125307981|NCT03983304|450753396|FG000|Overall Study|Withdrawal by Subject|5|||
125307982|NCT03983304|450753396|FG000|Overall Study|Lost to Follow-up|2|||
125307983|NCT00310817|450753397|FG000|Overall Study|AE or Death|3|||
125307984|NCT00310817|450753398|FG001|Overall Study|AE or Death|1|||
125307985|NCT00310817|450753399|FG002|Overall Study|AE or Death|0|||
125307986|NCT00310817|450753400|FG003|Overall Study|AE or Death|0|||
125307987|NCT00310817|450753397|FG000|Overall Study|Withdrawal by Subject|1|||
125307988|NCT00310817|450753398|FG001|Overall Study|Withdrawal by Subject|4|||
125307989|NCT00310817|450753399|FG002|Overall Study|Withdrawal by Subject|6|||
125307990|NCT00310817|450753400|FG003|Overall Study|Withdrawal by Subject|7|||
125307991|NCT00310817|450753397|FG000|Overall Study|Lost to Follow-up|2|||
125307992|NCT00310817|450753398|FG001|Overall Study|Lost to Follow-up|1|||
125307993|NCT00310817|450753399|FG002|Overall Study|Lost to Follow-up|0|||
125307994|NCT00310817|450753400|FG003|Overall Study|Lost to Follow-up|0|||
125307995|NCT00310817|450753397|FG000|Overall Study|Inappropriate Enrollment|1|||
125307996|NCT00310817|450753398|FG001|Overall Study|Inappropriate Enrollment|0|||
125307997|NCT00310817|450753399|FG002|Overall Study|Inappropriate Enrollment|1|||
125307998|NCT00310817|450753400|FG003|Overall Study|Inappropriate Enrollment|0|||
125307999|NCT00310817|450753397|FG000|Overall Study|Protocol Violation|1|||
125308000|NCT00310817|450753398|FG001|Overall Study|Protocol Violation|1|||
125308001|NCT00310817|450753399|FG002|Overall Study|Protocol Violation|1|||
125308002|NCT00310817|450753400|FG003|Overall Study|Protocol Violation|1|||
125308003|NCT00310817|450753397|FG000|Overall Study|Unable to classify|3|||
125308004|NCT00310817|450753398|FG001|Overall Study|Unable to classify|1|||
125308005|NCT00310817|450753399|FG002|Overall Study|Unable to classify|0|||
125308006|NCT00310817|450753400|FG003|Overall Study|Unable to classify|0|||
125308007|NCT01702246|450753401|FG000|Overall Study|Lost to Follow-up|2|||
125308008|NCT01702246|450753401|FG000|Overall Study|Withdrawal by Subject|2|||
125308009|NCT01702246|450753401|FG000|Overall Study|Physician Decision|1|||
125308010|NCT01587040|450753402|FG000|Overall Study|Protocol Violation|0|||
125308011|NCT01587040|450753403|FG001|Overall Study|Protocol Violation|0|||
125308012|NCT01587040|450753404|FG002|Overall Study|Protocol Violation|1|||
125308013|NCT01587040|450753405|FG003|Overall Study|Protocol Violation|0|||
125308014|NCT01587040|450753402|FG000|Overall Study|Adverse Event|0|||
125308015|NCT01587040|450753403|FG001|Overall Study|Adverse Event|1|||
125308016|NCT01587040|450753404|FG002|Overall Study|Adverse Event|10|||
125308017|NCT01587040|450753405|FG003|Overall Study|Adverse Event|0|||
125308018|NCT01587040|450753402|FG000|Overall Study|Disease progression|12|||
125308019|NCT01587040|450753403|FG001|Overall Study|Disease progression|1|||
125308020|NCT01587040|450753404|FG002|Overall Study|Disease progression|15|||
125308021|NCT01587040|450753405|FG003|Overall Study|Disease progression|3|||
125308022|NCT01587040|450753402|FG000|Overall Study|Other than specified|5|||
125308023|NCT01587040|450753403|FG001|Overall Study|Other than specified|1|||
125308024|NCT01587040|450753404|FG002|Overall Study|Other than specified|11|||
125308025|NCT01587040|450753405|FG003|Overall Study|Other than specified|1|||
125308026|NCT01518374|450753408|FG000|Overall Study|Withdrawal by Subject|2|||
125308027|NCT01518374|450753408|FG000|Overall Study|Protocol Violation|3|||
125308028|NCT01518374|450753408|FG000|Overall Study|Lost to Follow-up|2|||
125308029|NCT04300309|450753409|FG000|Overall Study|Lost to Follow-up|1|||
125308030|NCT04300309|450753410|FG001|Overall Study|Lost to Follow-up|0|||
125308031|NCT03724890|450753413|FG000|Overall Study|Death|2|||
125308032|NCT03724890|450753414|FG001|Overall Study|Death|6|||
125308033|NCT03724890|450753415|FG002|Overall Study|Death|3|||
125308034|NCT03724890|450753416|FG003|Overall Study|Death|5|||
125308035|NCT03724890|450753417|FG004|Overall Study|Death|2|||
125308036|NCT03724890|450753418|FG005|Overall Study|Death|0|||
125308037|NCT03724890|450753419|FG006|Overall Study|Death|2|||
125308038|NCT03724890|450753420|FG007|Overall Study|Death|3|||
125308039|NCT03724890|450753421|FG008|Overall Study|Death|4|||
125308040|NCT03724890|450753422|FG009|Overall Study|Death|2|||
125308041|NCT03724890|450753423|FG010|Overall Study|Death|2|||
125308042|NCT03724890|450753413|FG000|Overall Study|Lost to Follow-up|0|||
125308043|NCT03724890|450753414|FG001|Overall Study|Lost to Follow-up|3|||
125308044|NCT03724890|450753415|FG002|Overall Study|Lost to Follow-up|0|||
125308045|NCT03724890|450753416|FG003|Overall Study|Lost to Follow-up|1|||
125308046|NCT03724890|450753417|FG004|Overall Study|Lost to Follow-up|2|||
125308047|NCT03724890|450753418|FG005|Overall Study|Lost to Follow-up|2|||
125308048|NCT03724890|450753419|FG006|Overall Study|Lost to Follow-up|1|||
125308049|NCT03724890|450753420|FG007|Overall Study|Lost to Follow-up|0|||
125308050|NCT03724890|450753421|FG008|Overall Study|Lost to Follow-up|2|||
125308051|NCT03724890|450753422|FG009|Overall Study|Lost to Follow-up|0|||
125308052|NCT03724890|450753423|FG010|Overall Study|Lost to Follow-up|0|||
125308053|NCT03724890|450753413|FG000|Overall Study|Withdrawal by Subject|1|||
124847236|NCT03013491|449064240|FG001|Long-term Extension|Disease progression|0|||
125308054|NCT03724890|450753414|FG001|Overall Study|Withdrawal by Subject|2|||
125308055|NCT03724890|450753415|FG002|Overall Study|Withdrawal by Subject|1|||
125308056|NCT03724890|450753416|FG003|Overall Study|Withdrawal by Subject|0|||
125308057|NCT03724890|450753417|FG004|Overall Study|Withdrawal by Subject|0|||
125308058|NCT03724890|450753418|FG005|Overall Study|Withdrawal by Subject|1|||
125308059|NCT03724890|450753419|FG006|Overall Study|Withdrawal by Subject|0|||
125308060|NCT03724890|450753420|FG007|Overall Study|Withdrawal by Subject|0|||
125308061|NCT03724890|450753421|FG008|Overall Study|Withdrawal by Subject|2|||
125308062|NCT03724890|450753422|FG009|Overall Study|Withdrawal by Subject|2|||
125308063|NCT03724890|450753423|FG010|Overall Study|Withdrawal by Subject|1|||
125308064|NCT03724890|450753413|FG000|Overall Study|Other|1|||
125308065|NCT03724890|450753414|FG001|Overall Study|Other|0|||
125308066|NCT03724890|450753415|FG002|Overall Study|Other|0|||
124847237|NCT03013491|449064241|FG002|Long-term Extension|Disease progression|0|||
124847238|NCT03013491|449064242|FG003|Long-term Extension|Disease progression|1|||
125308067|NCT03724890|450753416|FG003|Overall Study|Other|0|||
125308068|NCT03724890|450753417|FG004|Overall Study|Other|0|||
125308069|NCT03724890|450753418|FG005|Overall Study|Other|0|||
125308070|NCT03724890|450753419|FG006|Overall Study|Other|0|||
125308071|NCT03724890|450753420|FG007|Overall Study|Other|1|||
125308072|NCT03724890|450753421|FG008|Overall Study|Other|1|||
125308073|NCT03724890|450753422|FG009|Overall Study|Other|0|||
125308074|NCT03724890|450753423|FG010|Overall Study|Other|2|||
125308075|NCT04607837|450753426|FG000|Overall Study|Adverse Event|8|||
125308076|NCT04607837|450753427|FG001|Overall Study|Adverse Event|2|||
125308077|NCT04607837|450753426|FG000|Overall Study|Withdrawal by Subject|8|||
125308078|NCT04607837|450753427|FG001|Overall Study|Withdrawal by Subject|7|||
125308079|NCT04607837|450753426|FG000|Overall Study|Physician Decision|2|||
125308080|NCT04607837|450753427|FG001|Overall Study|Physician Decision|0|||
125308081|NCT04607837|450753426|FG000|Overall Study|Lack of Efficacy|2|||
125308082|NCT04607837|450753427|FG001|Overall Study|Lack of Efficacy|0|||
125308083|NCT04607837|450753426|FG000|Overall Study|Participant terminated by sponsor|1|||
125308084|NCT04607837|450753427|FG001|Overall Study|Participant terminated by sponsor|0|||
125308085|NCT04607837|450753426|FG000|Overall Study|Disease worsening|36|||
125308086|NCT04607837|450753427|FG001|Overall Study|Disease worsening|36|||
125308087|NCT04607837|450753426|FG000|Overall Study|Other|1|||
125308088|NCT04607837|450753427|FG001|Overall Study|Other|0|||
125308089|NCT02362464|450753428|FG000|Overall Study|Switched to alternative therapy|1|||
125308090|NCT02362464|450753428|FG000|Overall Study|Refused further treatment|1|||
125308091|NCT02362464|450753428|FG000|Overall Study|Physician Decision|4|||
125308092|NCT04346654|450753429|FG000|Overall Study|Adverse Event|2|||
125308093|NCT04346654|450753430|FG001|Overall Study|Adverse Event|0|||
125308094|NCT04346654|450753429|FG000|Overall Study|Non-response|1|||
125308095|NCT04346654|450753430|FG001|Overall Study|Non-response|1|||
125308096|NCT04346654|450753429|FG000|Overall Study|Withdrawal by Subject|2|||
125308097|NCT04346654|450753430|FG001|Overall Study|Withdrawal by Subject|0|||
125308098|NCT04346654|450753429|FG000|Overall Study|Lost to Follow-up|0|||
125308099|NCT04346654|450753430|FG001|Overall Study|Lost to Follow-up|1|||
125308100|NCT04346654|450753429|FG000|Overall Study|Pregnancy|0|||
125308101|NCT04346654|450753430|FG001|Overall Study|Pregnancy|1|||
125308102|NCT05715242|450753431|FG000|Overall Study|Lost to Follow-up|0|||
125308103|NCT05715242|450753432|FG001|Overall Study|Lost to Follow-up|0|||
125308104|NCT05715242|450753433|FG002|Overall Study|Lost to Follow-up|1|||
125308105|NCT05715242|450753434|FG003|Overall Study|Lost to Follow-up|0|||
125308106|NCT05715242|450753435|FG004|Overall Study|Lost to Follow-up|0|||
125308107|NCT05715242|450753436|FG005|Overall Study|Lost to Follow-up|1|||
125308108|NCT05715242|450753437|FG006|Overall Study|Lost to Follow-up|0|||
125308109|NCT05715242|450753438|FG007|Overall Study|Lost to Follow-up|0|||
125308110|NCT05715242|450753439|FG008|Overall Study|Lost to Follow-up|0|||
125308111|NCT05715242|450753440|FG009|Overall Study|Lost to Follow-up|0|||
125308112|NCT05715242|450753441|FG010|Overall Study|Lost to Follow-up|0|||
125308113|NCT05715242|450753442|FG011|Overall Study|Lost to Follow-up|0|||
125308114|NCT05715242|450753443|FG012|Overall Study|Lost to Follow-up|0|||
125308115|NCT05715242|450753444|FG013|Overall Study|Lost to Follow-up|0|||
125308116|NCT05715242|450753445|FG014|Overall Study|Lost to Follow-up|0|||
125308117|NCT05715242|450753446|FG015|Overall Study|Lost to Follow-up|0|||
125308118|NCT02915978|450753447|FG000|Overall Study|Adverse Event|2|||
125308119|NCT02915978|450753448|FG001|Overall Study|Adverse Event|1|||
125308120|NCT02915978|450753449|FG002|Overall Study|Adverse Event|0|||
125308121|NCT02343406|450753455|FG000|Overall Study|Progressive disease|72|||
125308122|NCT02343406|450753456|FG001|Overall Study|Progressive disease|70|||
125308123|NCT02343406|450753457|FG002|Overall Study|Progressive disease|43|||
125308124|NCT02343406|450753458|FG003|Overall Study|Progressive disease|15|||
125308125|NCT02343406|450753459|FG004|Overall Study|Progressive disease|5|||
125308126|NCT02343406|450753455|FG000|Overall Study|Adverse Event|6|||
125308127|NCT02343406|450753456|FG001|Overall Study|Adverse Event|8|||
125308128|NCT02343406|450753457|FG002|Overall Study|Adverse Event|6|||
125308129|NCT02343406|450753458|FG003|Overall Study|Adverse Event|3|||
125308130|NCT02343406|450753459|FG004|Overall Study|Adverse Event|0|||
125308131|NCT02343406|450753455|FG000|Overall Study|Withdrawal by Subject|6|||
125308132|NCT02343406|450753456|FG001|Overall Study|Withdrawal by Subject|4|||
125308133|NCT02343406|450753457|FG002|Overall Study|Withdrawal by Subject|8|||
125308134|NCT02343406|450753458|FG003|Overall Study|Withdrawal by Subject|3|||
125308135|NCT02343406|450753459|FG004|Overall Study|Withdrawal by Subject|0|||
125308136|NCT02343406|450753455|FG000|Overall Study|Death|2|||
125308137|NCT02343406|450753456|FG001|Overall Study|Death|1|||
125308138|NCT02343406|450753457|FG002|Overall Study|Death|0|||
125308139|NCT02343406|450753458|FG003|Overall Study|Death|0|||
125308140|NCT02343406|450753459|FG004|Overall Study|Death|0|||
125308141|NCT02343406|450753455|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
125308142|NCT02343406|450753456|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
125308143|NCT02343406|450753457|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
125308144|NCT02343406|450753458|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
125308145|NCT02343406|450753459|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
125308146|NCT02343406|450753455|FG000|Overall Study|Other primary malignancy|0|||
125308147|NCT02343406|450753456|FG001|Overall Study|Other primary malignancy|1|||
125308148|NCT02343406|450753457|FG002|Overall Study|Other primary malignancy|0|||
125308149|NCT02343406|450753458|FG003|Overall Study|Other primary malignancy|0|||
125308150|NCT02343406|450753459|FG004|Overall Study|Other primary malignancy|0|||
125308151|NCT02343406|450753455|FG000|Overall Study|Other, not specified|2|||
125308152|NCT02343406|450753456|FG001|Overall Study|Other, not specified|1|||
125308153|NCT02343406|450753457|FG002|Overall Study|Other, not specified|1|||
125308154|NCT02343406|450753458|FG003|Overall Study|Other, not specified|4|||
125308155|NCT02343406|450753459|FG004|Overall Study|Other, not specified|0|||
125308156|NCT02451124|450753460|FG000|Overall Study|Withdrawal by Subject|1|||
125308157|NCT00766051|450753461|FG000|Overall Study|Withdrawal by Subject|2|||
125308158|NCT00766051|450753462|FG001|Overall Study|Withdrawal by Subject|0|||
125308159|NCT03058692|450755063|FG000|Overall Study|Lost to Follow-up|2|||
125308160|NCT03058692|450755064|FG001|Overall Study|Lost to Follow-up|1|||
125308161|NCT03058692|450755063|FG000|Overall Study|Withdrawal by Subject|1|||
125308162|NCT03058692|450755064|FG001|Overall Study|Withdrawal by Subject|1|||
125308163|NCT01392547|450755065|FG000|Overall Study|Adverse Event|2|||
125308164|NCT01392547|450755065|FG000|Overall Study|Non-compliance|2|||
125308165|NCT01392547|450755065|FG000|Overall Study|Withdrawal criteria|3|||
125308166|NCT01392547|450755065|FG000|Overall Study|Unclassified|1|||
125308167|NCT00799266|450755070|FG000|Overall Study|Adverse Event|0|||
125308168|NCT00799266|450755071|FG001|Overall Study|Adverse Event|1|||
125308169|NCT00799266|450755070|FG000|Overall Study|Subject withdrew consent|3|||
125308170|NCT00799266|450755071|FG001|Overall Study|Subject withdrew consent|0|||
125308171|NCT01362608|450755083|FG000|Overall Study|Protocol Violation|0|||
125308172|NCT01362608|450755084|FG001|Overall Study|Protocol Violation|1|||
125308173|NCT01362608|450755083|FG000|Overall Study|Lost to Follow-up|3|||
125308174|NCT01362608|450755084|FG001|Overall Study|Lost to Follow-up|1|||
125308175|NCT01362608|450755083|FG000|Overall Study|Withdrawal by Subject|1|||
125308176|NCT01362608|450755084|FG001|Overall Study|Withdrawal by Subject|2|||
125308177|NCT01362608|450755083|FG000|Overall Study|Lack of Efficacy|0|||
125308178|NCT01362608|450755084|FG001|Overall Study|Lack of Efficacy|2|||
125308179|NCT01362608|450755083|FG000|Overall Study|Adverse Event|0|||
125308180|NCT01362608|450755084|FG001|Overall Study|Adverse Event|2|||
125308181|NCT04506502|450755089|FG000|Overall Study|Withdrawal by Subject|1|||
125308182|NCT04506502|450755089|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
125308183|NCT00699608|450755090|FG000|First Intervention|Withdrawal by Subject|0|||
125308184|NCT00699608|450755091|FG001|First Intervention|Withdrawal by Subject|0|||
125308185|NCT00699608|450755092|FG002|First Intervention|Withdrawal by Subject|1|||
125308186|NCT00699608|450755093|FG003|First Intervention|Withdrawal by Subject|0|||
125308187|NCT00699608|450755094|FG004|First Intervention|Withdrawal by Subject|0|||
125308188|NCT00699608|450755095|FG005|First Intervention|Withdrawal by Subject|0|||
125308189|NCT00699608|450755090|FG000|First Intervention|Protocol Violation|0|||
125308190|NCT00699608|450755091|FG001|First Intervention|Protocol Violation|0|||
125308191|NCT00699608|450755092|FG002|First Intervention|Protocol Violation|0|||
125308192|NCT00699608|450755093|FG003|First Intervention|Protocol Violation|0|||
125308193|NCT00699608|450755094|FG004|First Intervention|Protocol Violation|1|||
125308194|NCT00699608|450755095|FG005|First Intervention|Protocol Violation|0|||
125308195|NCT00699608|450755090|FG000|Second Intervention|Adverse Event|0|||
125308196|NCT00699608|450755091|FG001|Second Intervention|Adverse Event|0|||
125308197|NCT00699608|450755092|FG002|Second Intervention|Adverse Event|1|||
125308198|NCT00699608|450755093|FG003|Second Intervention|Adverse Event|0|||
125308199|NCT00699608|450755094|FG004|Second Intervention|Adverse Event|0|||
125308200|NCT00699608|450755095|FG005|Second Intervention|Adverse Event|0|||
125308201|NCT00699608|450755090|FG000|Second Intervention|Withdrawal by Subject|0|||
125308202|NCT00699608|450755091|FG001|Second Intervention|Withdrawal by Subject|0|||
125308203|NCT00699608|450755092|FG002|Second Intervention|Withdrawal by Subject|0|||
125308204|NCT00699608|450755093|FG003|Second Intervention|Withdrawal by Subject|1|||
125308205|NCT00699608|450755094|FG004|Second Intervention|Withdrawal by Subject|0|||
125308206|NCT00699608|450755095|FG005|Second Intervention|Withdrawal by Subject|0|||
125308207|NCT03010319|450755098|FG000|Overall Study|Adverse Event|15|||
125308208|NCT03010319|450755099|FG001|Overall Study|Adverse Event|9|||
125308209|NCT03010319|450755098|FG000|Overall Study|Withdrawal by Subject|1|||
125308210|NCT03010319|450755099|FG001|Overall Study|Withdrawal by Subject|6|||
125308211|NCT03010319|450755098|FG000|Overall Study|Physician Decision|2|||
125308212|NCT03010319|450755099|FG001|Overall Study|Physician Decision|4|||
125308213|NCT03010319|450755098|FG000|Overall Study|Sponsor requested withdrawal|2|||
125308214|NCT03010319|450755099|FG001|Overall Study|Sponsor requested withdrawal|2|||
125308215|NCT03010319|450755098|FG000|Overall Study|Death|1|||
125308216|NCT03010319|450755099|FG001|Overall Study|Death|0|||
125308217|NCT03010319|450755098|FG000|Overall Study|Lost to Follow-up|0|||
125308218|NCT03010319|450755099|FG001|Overall Study|Lost to Follow-up|1|||
125308219|NCT03010319|450755098|FG000|Overall Study|Other Reason|5|||
124847239|NCT03013491|449064243|FG004|Long-term Extension|Disease progression|0|||
125308220|NCT03010319|450755099|FG001|Overall Study|Other Reason|7|||
125308221|NCT04720417|450755100|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
125308222|NCT02588261|450755103|FG000|Overall Study|Study Terminated by Sponsor|157|||
125308223|NCT02588261|450755104|FG001|Overall Study|Study Terminated by Sponsor|142|||
125308224|NCT02588261|450755103|FG000|Overall Study|Protocol Deviation|1|||
125308225|NCT02588261|450755104|FG001|Overall Study|Protocol Deviation|0|||
125308226|NCT02588261|450755103|FG000|Overall Study|Death|1|||
125308227|NCT02588261|450755104|FG001|Overall Study|Death|2|||
125308228|NCT02588261|450755103|FG000|Overall Study|Withdrawal by Subject|12|||
125308229|NCT02588261|450755104|FG001|Overall Study|Withdrawal by Subject|8|||
125308230|NCT02588261|450755103|FG000|Overall Study|Noncompliance with Study Drug|0|||
125308231|NCT02588261|450755104|FG001|Overall Study|Noncompliance with Study Drug|1|||
125308232|NCT02588261|450755103|FG000|Overall Study|Miscellaneous|5|||
125308233|NCT02588261|450755104|FG001|Overall Study|Miscellaneous|4|||
125308234|NCT02588261|450755103|FG000|Overall Study|Progressive Disease|61|||
125308235|NCT02588261|450755104|FG001|Overall Study|Progressive Disease|82|||
125308236|NCT02588261|450755103|FG000|Overall Study|Adverse Event|29|||
125308237|NCT02588261|450755104|FG001|Overall Study|Adverse Event|24|||
125308238|NCT02588261|450755103|FG000|Overall Study|Lost to Follow-up|1|||
125308239|NCT02588261|450755104|FG001|Overall Study|Lost to Follow-up|0|||
125308240|NCT03781778|450755105|FG000|Overall Study|Withdrawal by Subject|2|||
125308241|NCT03781778|450755106|FG001|Overall Study|Withdrawal by Subject|2|||
125308242|NCT02287467|450755107|FG000|Overall Study|Protocol Violation|12|||
125308243|NCT02287467|450755108|FG001|Overall Study|Protocol Violation|9|||
125308244|NCT03472950|450755111|FG000|Overall Study|Lost to Follow-up|0|||
125308245|NCT03472950|450755112|FG001|Overall Study|Lost to Follow-up|1|||
125308246|NCT03472950|450755111|FG000|Overall Study|Adverse Event|0|||
125308247|NCT03472950|450755112|FG001|Overall Study|Adverse Event|3|||
125308248|NCT00517361|450755117|FG000|Overall Study|Death|6|||
125308249|NCT00517361|450755117|FG000|Overall Study|The study was terminated|5|||
125308250|NCT00195091|450755118|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
125308251|NCT00245037|450755124|FG000|Overall Study|Death|17|||
125308252|NCT06964165|450755129|FG000|Overall Study|Withdrawal by Subject|0|||
125308253|NCT06964165|450755130|FG001|Overall Study|Withdrawal by Subject|1|||
125308254|NCT06964165|450755129|FG000|Overall Study|Ongoing at the time of analysis|15|||
125308255|NCT06964165|450755130|FG001|Overall Study|Ongoing at the time of analysis|14|||
125308256|NCT06964165|450755129|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
125308257|NCT06964165|450755130|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
125308258|NCT06964165|450755129|FG000|Overall Study|Participant removed due to non-compliance|0|||
125308259|NCT06964165|450755130|FG001|Overall Study|Participant removed due to non-compliance|1|||
125308260|NCT01514201|450755144|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
125308261|NCT01514201|450755145|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
125308262|NCT01514201|450755146|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
125308263|NCT01514201|450755147|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
125308264|NCT01514201|450755144|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
125308265|NCT01514201|450755145|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
125308266|NCT01514201|450755146|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
125308267|NCT01514201|450755147|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
125308268|NCT01514201|450755144|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
125308269|NCT01514201|450755145|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
125308270|NCT01514201|450755146|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
125308271|NCT01514201|450755147|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
125308272|NCT01514201|450755144|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
125308273|NCT01514201|450755145|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
125308274|NCT01514201|450755146|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
125308275|NCT01514201|450755147|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
125308276|NCT01514201|450755144|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
125308277|NCT01514201|450755145|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
125308278|NCT01514201|450755146|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
125308279|NCT01514201|450755147|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
125308280|NCT01514201|450755144|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
125308281|NCT01514201|450755145|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
125308282|NCT01514201|450755146|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
125308283|NCT01514201|450755147|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
125308284|NCT01514201|450755144|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
125308285|NCT01514201|450755145|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
125308286|NCT01514201|450755146|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
125308287|NCT01514201|450755147|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
125308288|NCT01514201|450755144|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
125308289|NCT01514201|450755145|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
125308290|NCT01514201|450755146|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
125308291|NCT01514201|450755147|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
125308292|NCT01514201|450755144|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
125308293|NCT01514201|450755145|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
125308294|NCT01514201|450755146|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
125308295|NCT01514201|450755147|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
125308296|NCT01514201|450755144|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
125308297|NCT01514201|450755145|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
125308298|NCT01514201|450755146|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
125308299|NCT01514201|450755147|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
125308300|NCT01514201|450755144|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
125308301|NCT01514201|450755145|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
125308302|NCT01514201|450755146|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
125308303|NCT01514201|450755147|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
125308304|NCT01514201|450755144|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
125308305|NCT01514201|450755145|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
125308306|NCT01514201|450755146|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
125308307|NCT01514201|450755147|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
125308308|NCT05888181|450755148|FG000|Overall Study|Lost to Follow-up|1|||
125308309|NCT05888181|450755149|FG001|Overall Study|Lost to Follow-up|1|||
125308310|NCT05888181|450755150|FG002|Overall Study|Lost to Follow-up|0|||
125308311|NCT02735343|450755154|FG000|Overall Study|screen fail|0|||
125308312|NCT02735343|450755155|FG001|Overall Study|screen fail|2|||
125308313|NCT00637416|450755156|FG000|Overall Study|Lost to Follow-up|1|||
125308314|NCT00637416|450755157|FG001|Overall Study|Lost to Follow-up|1|||
125308315|NCT00637416|450755156|FG000|Overall Study|Unable to take study drug|0|||
125308316|NCT00637416|450755157|FG001|Overall Study|Unable to take study drug|1|||
125308317|NCT02534909|450755161|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
125308318|NCT01625000|450755164|FG000|Overall Study|Physician Decision|15|||
125308319|NCT01625000|450755165|FG001|Overall Study|Physician Decision|7|||
125308320|NCT01625000|450755166|FG002|Overall Study|Physician Decision|7|||
125308321|NCT01625000|450755167|FG003|Overall Study|Physician Decision|2|||
125308322|NCT01625000|450755168|FG004|Overall Study|Physician Decision|15|||
125308323|NCT01625000|450755164|FG000|Overall Study|Protocol Violation|3|||
125308324|NCT01625000|450755165|FG001|Overall Study|Protocol Violation|10|||
125308325|NCT01625000|450755166|FG002|Overall Study|Protocol Violation|4|||
125308326|NCT01625000|450755167|FG003|Overall Study|Protocol Violation|1|||
125308327|NCT01625000|450755168|FG004|Overall Study|Protocol Violation|2|||
125308328|NCT01625000|450755164|FG000|Overall Study|Withdrawal by Subject|19|||
125308329|NCT01625000|450755165|FG001|Overall Study|Withdrawal by Subject|16|||
125308330|NCT01625000|450755166|FG002|Overall Study|Withdrawal by Subject|11|||
125308331|NCT01625000|450755167|FG003|Overall Study|Withdrawal by Subject|9|||
125308332|NCT01625000|450755168|FG004|Overall Study|Withdrawal by Subject|17|||
125308333|NCT01625000|450755164|FG000|Overall Study|Adverse Event (including Death)|15|||
125308334|NCT01625000|450755165|FG001|Overall Study|Adverse Event (including Death)|19|||
125308335|NCT01625000|450755166|FG002|Overall Study|Adverse Event (including Death)|11|||
125308336|NCT01625000|450755167|FG003|Overall Study|Adverse Event (including Death)|7|||
125308337|NCT01625000|450755168|FG004|Overall Study|Adverse Event (including Death)|21|||
125308338|NCT00566852|450755169|FG000|Overall Study|Protocol Violation|22|||
125308339|NCT00566852|450755170|FG001|Overall Study|Protocol Violation|24|||
125308340|NCT00566852|450755169|FG000|Overall Study|Death|95|||
125308341|NCT00566852|450755170|FG001|Overall Study|Death|78|||
125308342|NCT00566852|450755169|FG000|Overall Study|Withdrawal by Subject|30|||
125308343|NCT00566852|450755170|FG001|Overall Study|Withdrawal by Subject|25|||
125308344|NCT00566852|450755169|FG000|Overall Study|Patient refusal|37|||
125308345|NCT00566852|450755170|FG001|Overall Study|Patient refusal|37|||
125308346|NCT00566852|450755169|FG000|Overall Study|Not tested due to disability|6|||
125308347|NCT00566852|450755170|FG001|Overall Study|Not tested due to disability|12|||
125308348|NCT00566852|450755169|FG000|Overall Study|Missing reason not specified|1|||
125308349|NCT00566852|450755170|FG001|Overall Study|Missing reason not specified|2|||
125308350|NCT00566852|450755169|FG000|Overall Study|Missing reason not reported|16|||
125308351|NCT00566852|450755170|FG001|Overall Study|Missing reason not reported|20|||
125308352|NCT00577824|450755173|FG000|Overall Study|Adverse Event|6|||
125308353|NCT00577824|450755174|FG001|Overall Study|Adverse Event|18|||
125308354|NCT00577824|450755175|FG002|Overall Study|Adverse Event|1|||
125308355|NCT00577824|450755173|FG000|Overall Study|Patient decision|0|||
125308356|NCT00577824|450755174|FG001|Overall Study|Patient decision|1|||
125308357|NCT00577824|450755175|FG002|Overall Study|Patient decision|1|||
125308358|NCT00577824|450755173|FG000|Overall Study|Protocol Violation|1|||
125308359|NCT00577824|450755174|FG001|Overall Study|Protocol Violation|1|||
125308360|NCT00577824|450755175|FG002|Overall Study|Protocol Violation|0|||
125308361|NCT04079816|450755176|FG000|Overall Study|Request of Subject|2|||
125308362|NCT04079816|450755176|FG000|Overall Study|Unable to draw samples|1|||
125308363|NCT00362648|450755177|FG000|Overall Study|Adverse Event|12|||
125308364|NCT00362648|450755178|FG001|Overall Study|Adverse Event|21|||
125308365|NCT00362648|450755179|FG002|Overall Study|Adverse Event|1|||
125308366|NCT00362648|450755180|FG003|Overall Study|Adverse Event|0|||
125308367|NCT00362648|450755177|FG000|Overall Study|Lost to Follow-up|62|||
125308368|NCT00362648|450755178|FG001|Overall Study|Lost to Follow-up|69|||
125308369|NCT00362648|450755179|FG002|Overall Study|Lost to Follow-up|4|||
125308370|NCT00362648|450755180|FG003|Overall Study|Lost to Follow-up|3|||
125308371|NCT00362648|450755177|FG000|Overall Study|Protocol Violation|4|||
125308372|NCT00362648|450755178|FG001|Overall Study|Protocol Violation|2|||
125308373|NCT00362648|450755179|FG002|Overall Study|Protocol Violation|2|||
125308374|NCT00362648|450755180|FG003|Overall Study|Protocol Violation|2|||
125308375|NCT00362648|450755177|FG000|Overall Study|Withdrawal by Subject|48|||
125308376|NCT00362648|450755178|FG001|Overall Study|Withdrawal by Subject|42|||
125308377|NCT00362648|450755179|FG002|Overall Study|Withdrawal by Subject|2|||
125308378|NCT00362648|450755180|FG003|Overall Study|Withdrawal by Subject|6|||
125308379|NCT02123823|450755182|FG000|Overall Study|Lack of Efficacy|0|||
125308380|NCT02123823|450755183|FG001|Overall Study|Lack of Efficacy|2|||
125308381|NCT02123823|450755184|FG002|Overall Study|Lack of Efficacy|8|||
125308382|NCT02123823|450755185|FG003|Overall Study|Lack of Efficacy|10|||
125308383|NCT02123823|450755182|FG000|Overall Study|Progressive disease|3|||
125308384|NCT02123823|450755183|FG001|Overall Study|Progressive disease|19|||
125308385|NCT02123823|450755184|FG002|Overall Study|Progressive disease|52|||
125308386|NCT02123823|450755185|FG003|Overall Study|Progressive disease|53|||
125308387|NCT02123823|450755182|FG000|Overall Study|Withdrawal by Subject|0|||
125308388|NCT02123823|450755183|FG001|Overall Study|Withdrawal by Subject|0|||
125308389|NCT02123823|450755184|FG002|Overall Study|Withdrawal by Subject|7|||
125308390|NCT02123823|450755185|FG003|Overall Study|Withdrawal by Subject|2|||
125308391|NCT02123823|450755182|FG000|Overall Study|Adverse Event|0|||
125308392|NCT02123823|450755183|FG001|Overall Study|Adverse Event|0|||
125308393|NCT02123823|450755184|FG002|Overall Study|Adverse Event|3|||
125308394|NCT02123823|450755185|FG003|Overall Study|Adverse Event|5|||
125308395|NCT05870865|450755191|FG000|Randomized|Did not receive study treatment|2|||
125308396|NCT05870865|450755192|FG001|Randomized|Did not receive study treatment|4|||
125308397|NCT05870865|450755193|FG002|Randomized|Did not receive study treatment|4|||
125308398|NCT05870865|450755194|FG003|Randomized|Did not receive study treatment|3|||
125308399|NCT05870865|450755191|FG000|Treatment Period|Adverse Event|1|||
125308400|NCT05870865|450755192|FG001|Treatment Period|Adverse Event|1|||
125308401|NCT05870865|450755193|FG002|Treatment Period|Adverse Event|1|||
125308402|NCT05870865|450755194|FG003|Treatment Period|Adverse Event|1|||
125308403|NCT05870865|450755191|FG000|Treatment Period|Lost to Follow-up|0|||
125308404|NCT05870865|450755192|FG001|Treatment Period|Lost to Follow-up|1|||
125308405|NCT05870865|450755193|FG002|Treatment Period|Lost to Follow-up|2|||
125308406|NCT05870865|450755194|FG003|Treatment Period|Lost to Follow-up|0|||
125308407|NCT05870865|450755191|FG000|Treatment Period|Protocol Violation|0|||
125308408|NCT05870865|450755192|FG001|Treatment Period|Protocol Violation|0|||
125308409|NCT05870865|450755193|FG002|Treatment Period|Protocol Violation|0|||
125308410|NCT05870865|450755194|FG003|Treatment Period|Protocol Violation|1|||
125308411|NCT05870865|450755191|FG000|Treatment Period|Withdrawal by Subject|0|||
125308412|NCT05870865|450755192|FG001|Treatment Period|Withdrawal by Subject|1|||
125308413|NCT05870865|450755193|FG002|Treatment Period|Withdrawal by Subject|1|||
125308414|NCT05870865|450755194|FG003|Treatment Period|Withdrawal by Subject|1|||
125308415|NCT04752332|450755195|FG000|Overall Study|Adverse Event|3|||
125308416|NCT04752332|450755196|FG001|Overall Study|Adverse Event|1|||
125308417|NCT04752332|450755195|FG000|Overall Study|Disease Relapse|1|||
125308418|NCT04752332|450755196|FG001|Overall Study|Disease Relapse|0|||
125308419|NCT04752332|450755195|FG000|Overall Study|Non-compliance With Study Drug|2|||
125308420|NCT04752332|450755196|FG001|Overall Study|Non-compliance With Study Drug|0|||
125308421|NCT04752332|450755195|FG000|Overall Study|Physician Decision|2|||
125308422|NCT04752332|450755196|FG001|Overall Study|Physician Decision|1|||
125308423|NCT04752332|450755195|FG000|Overall Study|Protocol Violation|1|||
125308424|NCT04752332|450755196|FG001|Overall Study|Protocol Violation|1|||
125308425|NCT04752332|450755195|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
125308426|NCT04752332|450755196|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
125308427|NCT04752332|450755195|FG000|Overall Study|Study Terminated by Sponsor|10|||
125308428|NCT04752332|450755196|FG001|Overall Study|Study Terminated by Sponsor|48|||
125308429|NCT04752332|450755195|FG000|Overall Study|Withdrawal by Subject|11|||
125308430|NCT04752332|450755196|FG001|Overall Study|Withdrawal by Subject|3|||
125308431|NCT01868477|450755198|FG000|Overall Study|Adverse Event|2|||
125308432|NCT01868477|450755199|FG001|Overall Study|Adverse Event|4|||
125308433|NCT01868477|450755198|FG000|Overall Study|Disease progression|1|||
125308434|NCT01868477|450755199|FG001|Overall Study|Disease progression|1|||
124847240|NCT03013491|449064244|FG005|Long-term Extension|Disease progression|0|||
124847241|NCT03013491|449064245|FG006|Long-term Extension|Disease progression|0|||
124847242|NCT03013491|449064246|FG007|Long-term Extension|Disease progression|0|||
125308435|NCT01868477|450755198|FG000|Overall Study|Withdrawal by Subject|1|||
125308436|NCT01868477|450755199|FG001|Overall Study|Withdrawal by Subject|0|||
125308437|NCT00856297|450755205|FG000|Overall Study|Unable to classify|2|||
125308438|NCT00856297|450755206|FG001|Overall Study|Unable to classify|0|||
125308439|NCT00856297|450755207|FG002|Overall Study|Unable to classify|0|||
125308440|NCT00856297|450755208|FG003|Overall Study|Unable to classify|0|||
125308441|NCT00856297|450755209|FG004|Overall Study|Unable to classify|0|||
125308442|NCT03526146|450756463|FG000|Overall Study|Lost to Follow-up|5|||
125308443|NCT03526146|450756463|FG000|Overall Study|Withdrawal by Subject|6|||
125308444|NCT03526146|450756463|FG000|Overall Study|class canceled due to COVID-19|4|||
125308445|NCT02517541|450756468|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
125308446|NCT02517541|450756468|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
125308447|NCT02517541|450756468|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
125308448|NCT02517541|450756468|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
125308449|NCT02517541|450756468|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
125308450|NCT02517541|450756468|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
125308451|NCT01510158|450756469|FG000|Overall Study|Adverse Event|7|||
125308452|NCT01510158|450756470|FG001|Overall Study|Adverse Event|8|||
125308453|NCT01510158|450756471|FG002|Overall Study|Adverse Event|5|||
125308454|NCT01510158|450756469|FG000|Overall Study|Gout flare|1|||
125308455|NCT01510158|450756470|FG001|Overall Study|Gout flare|0|||
125308456|NCT01510158|450756471|FG002|Overall Study|Gout flare|0|||
125308457|NCT01510158|450756469|FG000|Overall Study|Protocol Violation|17|||
125308458|NCT01510158|450756470|FG001|Overall Study|Protocol Violation|16|||
125308459|NCT01510158|450756471|FG002|Overall Study|Protocol Violation|24|||
125308460|NCT01510158|450756469|FG000|Overall Study|Sponsor terminated study.|2|||
125308461|NCT01510158|450756470|FG001|Overall Study|Sponsor terminated study.|0|||
125308462|NCT01510158|450756471|FG002|Overall Study|Sponsor terminated study.|2|||
125308463|NCT01510158|450756469|FG000|Overall Study|Lost to Follow-up|13|||
125308464|NCT01510158|450756470|FG001|Overall Study|Lost to Follow-up|16|||
125308465|NCT01510158|450756471|FG002|Overall Study|Lost to Follow-up|9|||
125308466|NCT01510158|450756469|FG000|Overall Study|Withdrawal by Subject|10|||
125308467|NCT01510158|450756470|FG001|Overall Study|Withdrawal by Subject|13|||
125308468|NCT01510158|450756471|FG002|Overall Study|Withdrawal by Subject|10|||
125308469|NCT01510158|450756469|FG000|Overall Study|Death|1|||
125308470|NCT01510158|450756470|FG001|Overall Study|Death|0|||
125308471|NCT01510158|450756471|FG002|Overall Study|Death|0|||
125308472|NCT03078556|450756472|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
125308473|NCT03078556|450756473|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
125308474|NCT03078556|450756474|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
125308475|NCT03078556|450756475|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
125308476|NCT03078556|450756472|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
125308477|NCT03078556|450756473|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
125308478|NCT03078556|450756474|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
125308479|NCT03078556|450756475|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
125308480|NCT03078556|450756472|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
125308481|NCT03078556|450756473|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
125308482|NCT03078556|450756474|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
125308483|NCT03078556|450756475|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
125308484|NCT03078556|450756472|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
125308485|NCT03078556|450756473|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
125308486|NCT03078556|450756474|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
125308487|NCT03078556|450756475|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
125308488|NCT03314987|450756476|FG000|Overall Study|Lost to Follow-up|13|||
125308489|NCT03314987|450756477|FG001|Overall Study|Lost to Follow-up|13|||
125308490|NCT03574779|450756478|FG000|Overall Study|Screening failure|13|||
125308491|NCT03574779|450756479|FG001|Overall Study|Screening failure|83|||
125308492|NCT02751580|450756480|FG000|Overall Study|Lost to Follow-up|4|||
125308493|NCT02751580|450756480|FG000|Overall Study|Death|2|||
125308494|NCT02152761|450756487|FG000|Epoch: Treatment Epoch|Technical problems|0|||
125308495|NCT02152761|450756488|FG001|Epoch: Treatment Epoch|Technical problems|0|||
125308496|NCT02152761|450756489|FG002|Epoch: Treatment Epoch|Technical problems|0|||
125308497|NCT02152761|450756490|FG003|Epoch: Treatment Epoch|Technical problems|1|||
125308498|NCT02152761|450756487|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
125308499|NCT02152761|450756488|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
125308500|NCT02152761|450756489|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
125308501|NCT02152761|450756490|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
125308502|NCT02152761|450756487|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
125308503|NCT02152761|450756488|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
125308504|NCT02152761|450756489|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
125308505|NCT02152761|450756490|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
125308506|NCT02152761|450756487|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
125308507|NCT02152761|450756488|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
125308508|NCT02152761|450756489|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
125308509|NCT02152761|450756490|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
125308510|NCT02152761|450756487|FG000|Epoch: Treatment Epoch|Death|0|||
125308511|NCT02152761|450756488|FG001|Epoch: Treatment Epoch|Death|3|||
125308512|NCT02152761|450756489|FG002|Epoch: Treatment Epoch|Death|1|||
125308513|NCT02152761|450756490|FG003|Epoch: Treatment Epoch|Death|0|||
125308514|NCT02152761|450756487|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
125308515|NCT02152761|450756488|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
125308516|NCT02152761|450756489|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
124847243|NCT03013491|449064247|FG008|Long-term Extension|Disease progression|0|||
125308517|NCT02152761|450756490|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
125308518|NCT02152761|450756487|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
125308519|NCT02152761|450756488|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
125308520|NCT02152761|450756489|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
125308521|NCT02152761|450756490|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
125308522|NCT02152761|450756487|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
125308523|NCT02152761|450756488|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
125308524|NCT02152761|450756489|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
125308525|NCT02152761|450756490|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
125308526|NCT02152761|450756487|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
125308527|NCT02152761|450756488|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
125308528|NCT02152761|450756489|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
125308529|NCT02152761|450756490|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
125308530|NCT02152761|450756487|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
125308531|NCT02152761|450756488|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
125308532|NCT02152761|450756489|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
125308533|NCT02152761|450756490|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
125308534|NCT03755882|450756491|FG000|Period 1|Protocol Violation|1|||
125308535|NCT03755882|450756492|FG001|Period 1|Protocol Violation|0|||
125308536|NCT03755882|450756491|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
125308537|NCT03755882|450756492|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
125308538|NCT02292446|450756493|FG000|Overall Study|Adverse Event|12|||
125308539|NCT02292446|450756493|FG000|Overall Study|Death|1|||
125308540|NCT02292446|450756493|FG000|Overall Study|Disease progression|2|||
125308541|NCT02292446|450756493|FG000|Overall Study|Subject/guardian decision|2|||
125308542|NCT02292446|450756493|FG000|Overall Study|Withdrawal by Subject|3|||
125308543|NCT03329846|450756497|FG000|Overall Study|Disease progression|4|||
125308544|NCT03329846|450756498|FG001|Overall Study|Disease progression|6|||
125308545|NCT03329846|450756497|FG000|Overall Study|Study drug toxicity|1|||
125308546|NCT03329846|450756498|FG001|Overall Study|Study drug toxicity|0|||
125308547|NCT03329846|450756497|FG000|Overall Study|Participant request to discontinue treatment|0|||
125308548|NCT03329846|450756498|FG001|Overall Study|Participant request to discontinue treatment|1|||
125308549|NCT03329846|450756497|FG000|Overall Study|Participant withdrew consent|1|||
125308550|NCT03329846|450756498|FG001|Overall Study|Participant withdrew consent|0|||
125308551|NCT03329846|450756497|FG000|Overall Study|Other reasons|2|||
125308552|NCT03329846|450756498|FG001|Overall Study|Other reasons|2|||
125308553|NCT03066193|450756499|FG000|Overall Study|Withdrawal by Subject|1|||
125308554|NCT02631551|450756500|FG000|Overall Study|Adverse Event|1|||
125308555|NCT02631551|450756501|FG001|Overall Study|Adverse Event|2|||
125308556|NCT02631551|450756502|FG002|Overall Study|Adverse Event|4|||
125308557|NCT02631551|450756503|FG003|Overall Study|Adverse Event|0|||
125308558|NCT02631551|450756500|FG000|Overall Study|Lack of Efficacy|0|||
125308559|NCT02631551|450756501|FG001|Overall Study|Lack of Efficacy|0|||
125308560|NCT02631551|450756502|FG002|Overall Study|Lack of Efficacy|1|||
125308561|NCT02631551|450756503|FG003|Overall Study|Lack of Efficacy|0|||
125308562|NCT02631551|450756500|FG000|Overall Study|Lost to Follow-up|1|||
125308563|NCT02631551|450756501|FG001|Overall Study|Lost to Follow-up|2|||
125308564|NCT02631551|450756502|FG002|Overall Study|Lost to Follow-up|0|||
125308565|NCT02631551|450756503|FG003|Overall Study|Lost to Follow-up|3|||
125308566|NCT02631551|450756500|FG000|Overall Study|Withdrawal by Subject|2|||
125308567|NCT02631551|450756501|FG001|Overall Study|Withdrawal by Subject|2|||
125308568|NCT02631551|450756502|FG002|Overall Study|Withdrawal by Subject|0|||
125308569|NCT02631551|450756503|FG003|Overall Study|Withdrawal by Subject|5|||
125308570|NCT02631551|450756500|FG000|Overall Study|Protocol deviation|3|||
125308571|NCT02631551|450756501|FG001|Overall Study|Protocol deviation|6|||
125308572|NCT02631551|450756502|FG002|Overall Study|Protocol deviation|3|||
125308573|NCT02631551|450756503|FG003|Overall Study|Protocol deviation|0|||
125308574|NCT02631551|450756500|FG000|Overall Study|Non-compliance with study procedures|0|||
125308575|NCT02631551|450756501|FG001|Overall Study|Non-compliance with study procedures|0|||
125308576|NCT02631551|450756502|FG002|Overall Study|Non-compliance with study procedures|1|||
125308577|NCT02631551|450756503|FG003|Overall Study|Non-compliance with study procedures|1|||
125308578|NCT02631551|450756500|FG000|Overall Study|Non-compliance with study drug|1|||
125308579|NCT02631551|450756501|FG001|Overall Study|Non-compliance with study drug|0|||
125308580|NCT02631551|450756502|FG002|Overall Study|Non-compliance with study drug|0|||
125308581|NCT02631551|450756503|FG003|Overall Study|Non-compliance with study drug|0|||
125308582|NCT02631551|450756500|FG000|Overall Study|Other, specific reasons not collected|5|||
125308583|NCT02631551|450756501|FG001|Overall Study|Other, specific reasons not collected|7|||
125308584|NCT02631551|450756502|FG002|Overall Study|Other, specific reasons not collected|2|||
125308585|NCT02631551|450756503|FG003|Overall Study|Other, specific reasons not collected|2|||
125308586|NCT05636852|450756512|FG000|Overall Study|Withdrawal by Subject|1|||
125308587|NCT05636852|450756512|FG000|Overall Study|Other than specified|1|||
125308588|NCT00377858|450756513|FG000|Overall Study|Withdrawal by Subject|12|||
125308589|NCT00377858|450756514|FG001|Overall Study|Withdrawal by Subject|11|||
125308590|NCT00377858|450756513|FG000|Overall Study|Lost to Follow-up|6|||
125308591|NCT00377858|450756514|FG001|Overall Study|Lost to Follow-up|1|||
125308592|NCT00377858|450756513|FG000|Overall Study|Physician Decision|5|||
125308593|NCT00377858|450756514|FG001|Overall Study|Physician Decision|5|||
125308594|NCT00377858|450756513|FG000|Overall Study|Protocol Violation|3|||
125308595|NCT00377858|450756514|FG001|Overall Study|Protocol Violation|4|||
125308596|NCT00377858|450756513|FG000|Overall Study|Adverse Event|2|||
125308597|NCT00377858|450756514|FG001|Overall Study|Adverse Event|1|||
125308598|NCT00377858|450756513|FG000|Overall Study|Entry Criteria Not Met|2|||
125308599|NCT00377858|450756514|FG001|Overall Study|Entry Criteria Not Met|0|||
125308600|NCT00377858|450756513|FG000|Overall Study|Sponsor Decision|1|||
125308601|NCT00377858|450756514|FG001|Overall Study|Sponsor Decision|2|||
125308602|NCT00377858|450756513|FG000|Overall Study|Death|0|||
125308603|NCT00377858|450756514|FG001|Overall Study|Death|3|||
125308604|NCT01685697|450756515|FG000|Overall Study|Protocol Violation|3|||
125308605|NCT01685697|450756516|FG001|Overall Study|Protocol Violation|3|||
125308606|NCT01076036|450756517|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
125308607|NCT04034004|450756522|FG000|Overall Study|Withdrawal by Subject|1|||
125308608|NCT04034004|450756523|FG001|Overall Study|Withdrawal by Subject|2|||
125308609|NCT04034004|450756524|FG002|Overall Study|Withdrawal by Subject|2|||
125308610|NCT04034004|450756525|FG003|Overall Study|Withdrawal by Subject|3|||
125308611|NCT04034004|450756522|FG000|Overall Study|could not find vein to administer IV|2|||
125308612|NCT04034004|450756523|FG001|Overall Study|could not find vein to administer IV|1|||
125308613|NCT04034004|450756524|FG002|Overall Study|could not find vein to administer IV|0|||
125308614|NCT04034004|450756525|FG003|Overall Study|could not find vein to administer IV|0|||
125308615|NCT04034004|450756522|FG000|Overall Study|nurse accidentally unblinded subject|0|||
125308616|NCT04034004|450756523|FG001|Overall Study|nurse accidentally unblinded subject|0|||
125308617|NCT04034004|450756524|FG002|Overall Study|nurse accidentally unblinded subject|0|||
125308618|NCT04034004|450756525|FG003|Overall Study|nurse accidentally unblinded subject|1|||
125308619|NCT01345188|450756526|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
125308620|NCT01345188|450756526|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
125308621|NCT01397461|450756527|FG000|Overall Study|Withdrawal by Subject|2|||
125308622|NCT01397461|450756528|FG001|Overall Study|Withdrawal by Subject|1|||
125308623|NCT01397461|450756529|FG002|Overall Study|Withdrawal by Subject|0|||
125308624|NCT01397461|450756527|FG000|Overall Study|Lost to Follow-up|0|||
125308625|NCT01397461|450756528|FG001|Overall Study|Lost to Follow-up|2|||
125308626|NCT01397461|450756529|FG002|Overall Study|Lost to Follow-up|1|||
125308627|NCT01397461|450756527|FG000|Overall Study|Lack of Efficacy|0|||
125308628|NCT01397461|450756528|FG001|Overall Study|Lack of Efficacy|3|||
125308629|NCT01397461|450756529|FG002|Overall Study|Lack of Efficacy|0|||
125308630|NCT01397461|450756527|FG000|Overall Study|Not treated|0|||
125308631|NCT01397461|450756528|FG001|Overall Study|Not treated|0|||
125308632|NCT01397461|450756529|FG002|Overall Study|Not treated|1|||
125308633|NCT05729568|450756546|FG000|Overall Study|Still on Study|52|||
125308634|NCT05729568|450756547|FG001|Overall Study|Still on Study|26|||
125308635|NCT05729568|450756546|FG000|Overall Study|Randomized but Never Treated|3|||
125308636|NCT05729568|450756547|FG001|Overall Study|Randomized but Never Treated|0|||
125308637|NCT05729568|450756546|FG000|Overall Study|Adverse Event|0|||
125308638|NCT05729568|450756547|FG001|Overall Study|Adverse Event|1|||
125308639|NCT05729568|450756546|FG000|Overall Study|Investigator's Discretion|1|||
125308640|NCT05729568|450756547|FG001|Overall Study|Investigator's Discretion|0|||
125308641|NCT04181762|450756548|FG000|Overall Study|Adverse Event|1|||
125308642|NCT04181762|450756549|FG001|Overall Study|Adverse Event|3|||
125308643|NCT04181762|450756548|FG000|Overall Study|Lost to Follow-up|1|||
125308644|NCT04181762|450756549|FG001|Overall Study|Lost to Follow-up|1|||
125308645|NCT04181762|450756548|FG000|Overall Study|Physician Decision|1|||
125308646|NCT04181762|450756549|FG001|Overall Study|Physician Decision|3|||
125308647|NCT04181762|450756548|FG000|Overall Study|Pregnancy|0|||
125308648|NCT04181762|450756549|FG001|Overall Study|Pregnancy|1|||
125308649|NCT04181762|450756548|FG000|Overall Study|Lack of Efficacy|2|||
125308650|NCT04181762|450756549|FG001|Overall Study|Lack of Efficacy|2|||
125308651|NCT04181762|450756548|FG000|Overall Study|Study terminated by sponsor|95|||
125308652|NCT04181762|450756549|FG001|Overall Study|Study terminated by sponsor|97|||
125308653|NCT04181762|450756548|FG000|Overall Study|Subject decision|11|||
125308654|NCT04181762|450756549|FG001|Overall Study|Subject decision|4|||
125308655|NCT04181762|450756548|FG000|Overall Study|Death|1|||
125308656|NCT04181762|450756549|FG001|Overall Study|Death|1|||
125308657|NCT04181762|450756548|FG000|Overall Study|Protocol deviation|1|||
125308658|NCT04181762|450756549|FG001|Overall Study|Protocol deviation|0|||
125308659|NCT04181762|450756548|FG000|Overall Study|Withdrawal of informed consent|1|||
125308660|NCT04181762|450756549|FG001|Overall Study|Withdrawal of informed consent|3|||
125308661|NCT04526145|450756550|FG000|Overall Study|Withdrawal by Subject|5|||
125308662|NCT00048347|450756559|FG000|Overall Study|Screen failure|2|||
125308663|NCT00958165|450756560|FG000|Overall Study|Lost to Follow-up|5|||
125308664|NCT00958165|450756560|FG000|Overall Study|Not eligible|9|||
125308665|NCT00195663|450756561|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
125308666|NCT00195663|450756562|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
125308667|NCT00195663|450756563|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
125308668|NCT00195663|450756561|FG000|2-year Double-blind Treatment Period|Death|0|||
125308669|NCT00195663|450756562|FG001|2-year Double-blind Treatment Period|Death|2|||
125308670|NCT00195663|450756563|FG002|2-year Double-blind Treatment Period|Death|0|||
125308671|NCT00195663|450756561|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
125308672|NCT00195663|450756562|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
125308673|NCT00195663|450756563|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
125308674|NCT00195663|450756561|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
125308675|NCT00195663|450756562|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
125308676|NCT00195663|450756563|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
125308677|NCT00195663|450756561|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
125308678|NCT00195663|450756562|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
125308679|NCT00195663|450756563|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
125308680|NCT00195663|450756561|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
125308681|NCT00195663|450756562|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
125308682|NCT00195663|450756563|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
125308683|NCT00195663|450756561|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
125308684|NCT00195663|450756562|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
125308685|NCT00195663|450756563|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
125308686|NCT00195663|450756561|FG000|2-year Double-blind Treatment Period|Recovery|1|||
125308687|NCT00195663|450756562|FG001|2-year Double-blind Treatment Period|Recovery|0|||
125308688|NCT00195663|450756563|FG002|2-year Double-blind Treatment Period|Recovery|1|||
125308689|NCT00195663|450756561|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
125308690|NCT00195663|450756562|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
125308691|NCT00195663|450756563|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
125308692|NCT00195663|450756561|FG000|Open-Label Extension Period|Adverse Event|21|||
125308693|NCT00195663|450756562|FG001|Open-Label Extension Period|Adverse Event|32|||
125308694|NCT00195663|450756563|FG002|Open-Label Extension Period|Adverse Event|36|||
125308695|NCT00195663|450756561|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
125308696|NCT00195663|450756562|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
125308697|NCT00195663|450756563|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
125308698|NCT00195663|450756561|FG000|Open-Label Extension Period|Recovery|0|||
125308699|NCT00195663|450756562|FG001|Open-Label Extension Period|Recovery|2|||
125308700|NCT00195663|450756563|FG002|Open-Label Extension Period|Recovery|2|||
125308701|NCT00195663|450756561|FG000|Open-Label Extension Period|Protocol Violation|3|||
125308702|NCT00195663|450756562|FG001|Open-Label Extension Period|Protocol Violation|4|||
125308703|NCT00195663|450756563|FG002|Open-Label Extension Period|Protocol Violation|4|||
125308704|NCT00195663|450756561|FG000|Open-Label Extension Period|Death|2|||
125308705|NCT00195663|450756562|FG001|Open-Label Extension Period|Death|2|||
125308706|NCT00195663|450756563|FG002|Open-Label Extension Period|Death|2|||
125308707|NCT00195663|450756561|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
125308708|NCT00195663|450756562|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
125308709|NCT00195663|450756563|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
125308710|NCT00195663|450756561|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
125308711|NCT00195663|450756562|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
125308712|NCT00195663|450756563|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
125308713|NCT00195663|450756561|FG000|Open-Label Extension Period|Administrative reasons|11|||
125308714|NCT00195663|450756562|FG001|Open-Label Extension Period|Administrative reasons|11|||
125308715|NCT00195663|450756563|FG002|Open-Label Extension Period|Administrative reasons|13|||
125308716|NCT00604695|450756564|FG000|Overall Study|Did not receive first bolus.|0|||
125308717|NCT00604695|450756565|FG001|Overall Study|Did not receive first bolus.|4|||
125308718|NCT02058563|450756569|FG000|Overall Study|Lost to Follow-up|26|||
125308719|NCT02058563|450756570|FG001|Overall Study|Lost to Follow-up|22|||
125308720|NCT02058563|450756569|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
125308721|NCT02058563|450756570|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
125308722|NCT02058563|450756569|FG000|Overall Study|Consent Withdrawal|1|||
125308723|NCT02058563|450756570|FG001|Overall Study|Consent Withdrawal|1|||
125308724|NCT02058563|450756569|FG000|Overall Study|Other (patient incarcerated)|0|||
125308725|NCT02058563|450756570|FG001|Overall Study|Other (patient incarcerated)|1|||
125308726|NCT00166439|450756571|FG000|Overall Study|Ineligible|5|||
125308727|NCT04039217|450756572|FG000|Overall Study|Lost to Follow-up|1|||
125308728|NCT00615992|450756573|FG000|Overall Study|Protocol Violation|67|||
125308729|NCT04522141|450756574|FG000|Overall Study|Withdrawal by Subject|1|||
125308730|NCT04522141|450756575|FG001|Overall Study|Withdrawal by Subject|0|||
125308731|NCT03508609|450756576|FG000|Overall Study|Withdrawal by Subject|1|||
125308732|NCT00555217|450756577|FG000|Overall Study|Withdrawal by Subject|35|||
125308733|NCT00555217|450756578|FG001|Overall Study|Withdrawal by Subject|31|||
125308734|NCT00555217|450756577|FG000|Overall Study|Lost to Follow-up|19|||
125308735|NCT00555217|450756578|FG001|Overall Study|Lost to Follow-up|20|||
125308736|NCT00555217|450756577|FG000|Overall Study|close out sites|21|||
125308737|NCT00555217|450756578|FG001|Overall Study|close out sites|17|||
125308738|NCT00367835|450756580|FG000|Overall Study|Adverse Event|14|||
125308739|NCT00367835|450756581|FG001|Overall Study|Adverse Event|1|||
125308740|NCT00367835|450756580|FG000|Overall Study|Protocol Violation|1|||
125308741|NCT00367835|450756581|FG001|Overall Study|Protocol Violation|7|||
125308742|NCT00367835|450756580|FG000|Overall Study|Withdrawal by Subject|7|||
125308743|NCT00367835|450756581|FG001|Overall Study|Withdrawal by Subject|6|||
125308744|NCT00367835|450756580|FG000|Overall Study|Lost to Follow-up|1|||
125308745|NCT00367835|450756581|FG001|Overall Study|Lost to Follow-up|4|||
125308746|NCT00367835|450756580|FG000|Overall Study|Lack of Efficacy|3|||
125308747|NCT00367835|450756581|FG001|Overall Study|Lack of Efficacy|12|||
125308748|NCT00367835|450756580|FG000|Overall Study|Subject in juvenile detention center|1|||
125308749|NCT00367835|450756581|FG001|Overall Study|Subject in juvenile detention center|0|||
125308750|NCT00367835|450756580|FG000|Overall Study|refused blood collection|1|||
125308751|NCT00367835|450756581|FG001|Overall Study|refused blood collection|0|||
125308752|NCT00367835|450756580|FG000|Overall Study|Did not respond to calls|1|||
125308753|NCT00367835|450756581|FG001|Overall Study|Did not respond to calls|0|||
125308754|NCT00367835|450756580|FG000|Overall Study|History of lead poisoning|0|||
125308755|NCT00367835|450756581|FG001|Overall Study|History of lead poisoning|1|||
125308756|NCT03761810|450756585|FG000|Overall Study|Adverse Event|12|||
125308757|NCT03761810|450756586|FG001|Overall Study|Adverse Event|0|||
125308758|NCT03761810|450756585|FG000|Overall Study|Lost to Follow-up|15|||
125308759|NCT03761810|450756586|FG001|Overall Study|Lost to Follow-up|7|||
125308760|NCT03761810|450756585|FG000|Overall Study|Pregnancy|1|||
125308761|NCT03761810|450756586|FG001|Overall Study|Pregnancy|0|||
125308762|NCT03761810|450756585|FG000|Overall Study|Withdrawal by Subject|14|||
125308763|NCT03761810|450756586|FG001|Overall Study|Withdrawal by Subject|5|||
125308764|NCT03761810|450756585|FG000|Overall Study|Physician Decision|1|||
125308765|NCT03761810|450756586|FG001|Overall Study|Physician Decision|0|||
125308766|NCT03761810|450756585|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
125308767|NCT03761810|450756586|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125308768|NCT03761810|450756585|FG000|Overall Study|Other Than Specified|1|||
125308769|NCT03761810|450756586|FG001|Overall Study|Other Than Specified|0|||
125308770|NCT01574651|450756587|FG000|Overall Study|Lost to Follow-up|2|||
125308771|NCT01574651|450756588|FG001|Overall Study|Lost to Follow-up|4|||
125308772|NCT01574651|450756587|FG000|Overall Study|Administrative problems|0|||
125308773|NCT01574651|450756588|FG001|Overall Study|Administrative problems|1|||
125308774|NCT01574651|450756587|FG000|Overall Study|Death|3|||
125308775|NCT01574651|450756588|FG001|Overall Study|Death|3|||
125308776|NCT01574651|450756587|FG000|Overall Study|Patient's inability to use the device|0|||
125308777|NCT01574651|450756588|FG001|Overall Study|Patient's inability to use the device|1|||
125308778|NCT01574651|450756587|FG000|Overall Study|Adverse Event|36|||
125308779|NCT01574651|450756588|FG001|Overall Study|Adverse Event|27|||
125308780|NCT01574651|450756587|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125308781|NCT01574651|450756588|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125308782|NCT01574651|450756587|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125308783|NCT01574651|450756588|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125308784|NCT01574651|450756587|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
125308785|NCT01574651|450756588|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125308786|NCT01574651|450756587|FG000|Overall Study|Protocol Violation|3|||
125308787|NCT01574651|450756588|FG001|Overall Study|Protocol Violation|5|||
125308788|NCT01574651|450756587|FG000|Overall Study|Withdrawal by Subject|9|||
125308789|NCT01574651|450756588|FG001|Overall Study|Withdrawal by Subject|10|||
125308790|NCT03887221|450756589|FG000|Overall Study|Protocol Violation|1|||
125308791|NCT03887221|450756590|FG001|Overall Study|Protocol Violation|0|||
125308792|NCT02487030|450756591|FG000|Overall Study|Lack of Efficacy|2|||
125308793|NCT02487030|450756592|FG001|Overall Study|Lack of Efficacy|4|||
125308794|NCT02487030|450756593|FG002|Overall Study|Lack of Efficacy|1|||
125308795|NCT02487030|450756594|FG003|Overall Study|Lack of Efficacy|0|||
125308796|NCT02487030|450756595|FG004|Overall Study|Lack of Efficacy|1|||
125308797|NCT02487030|450756596|FG005|Overall Study|Lack of Efficacy|0|||
125308798|NCT02487030|450756597|FG006|Overall Study|Lack of Efficacy|0|||
125308799|NCT02487030|450756591|FG000|Overall Study|Lost to Follow-up|0|||
125308800|NCT02487030|450756592|FG001|Overall Study|Lost to Follow-up|0|||
125308801|NCT02487030|450756593|FG002|Overall Study|Lost to Follow-up|1|||
125308802|NCT02487030|450756594|FG003|Overall Study|Lost to Follow-up|1|||
125308803|NCT02487030|450756595|FG004|Overall Study|Lost to Follow-up|0|||
125308804|NCT02487030|450756596|FG005|Overall Study|Lost to Follow-up|1|||
125308805|NCT02487030|450756597|FG006|Overall Study|Lost to Follow-up|0|||
125308806|NCT02487030|450756591|FG000|Overall Study|Adverse Event|0|||
125308807|NCT02487030|450756592|FG001|Overall Study|Adverse Event|0|||
125308808|NCT02487030|450756593|FG002|Overall Study|Adverse Event|0|||
125308809|NCT02487030|450756594|FG003|Overall Study|Adverse Event|1|||
125308810|NCT02487030|450756595|FG004|Overall Study|Adverse Event|0|||
125308811|NCT02487030|450756596|FG005|Overall Study|Adverse Event|0|||
125308812|NCT02487030|450756597|FG006|Overall Study|Adverse Event|0|||
125308813|NCT02487030|450756591|FG000|Overall Study|Death|0|||
125308814|NCT02487030|450756592|FG001|Overall Study|Death|0|||
125308815|NCT02487030|450756593|FG002|Overall Study|Death|0|||
125308816|NCT02487030|450756594|FG003|Overall Study|Death|0|||
125308817|NCT02487030|450756595|FG004|Overall Study|Death|1|||
125308818|NCT02487030|450756596|FG005|Overall Study|Death|0|||
125308819|NCT02487030|450756597|FG006|Overall Study|Death|0|||
125308820|NCT02092025|450756598|FG000|Overall Study|Case Report Forms Uncollected|44|||
125308821|NCT02092025|450756598|FG000|Overall Study|Protocol Deviation|24|||
125308822|NCT00264537|450756599|FG000|Overall Study|Death|0|||
125308823|NCT00264537|450756600|FG001|Overall Study|Death|3|||
125308824|NCT00264537|450756601|FG002|Overall Study|Death|3|||
125308825|NCT00264537|450756602|FG003|Overall Study|Death|2|||
125308826|NCT00264537|450756599|FG000|Overall Study|Lost to Follow-up|3|||
125308827|NCT00264537|450756600|FG001|Overall Study|Lost to Follow-up|4|||
125308828|NCT00264537|450756601|FG002|Overall Study|Lost to Follow-up|7|||
125308829|NCT00264537|450756602|FG003|Overall Study|Lost to Follow-up|6|||
125308830|NCT00264537|450756599|FG000|Overall Study|Adverse Event|21|||
125308831|NCT00264537|450756600|FG001|Overall Study|Adverse Event|32|||
125308832|NCT00264537|450756601|FG002|Overall Study|Adverse Event|24|||
125308833|NCT00264537|450756602|FG003|Overall Study|Adverse Event|34|||
125308834|NCT00264537|450756599|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
125308835|NCT00264537|450756600|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
125308836|NCT00264537|450756601|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
125308837|NCT00264537|450756602|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
125308838|NCT00264537|450756599|FG000|Overall Study|Other|21|||
125308839|NCT00264537|450756600|FG001|Overall Study|Other|11|||
125308840|NCT00264537|450756601|FG002|Overall Study|Other|10|||
125308841|NCT00264537|450756602|FG003|Overall Study|Other|11|||
125308842|NCT00264537|450756599|FG000|Overall Study|Not treated|0|||
125308843|NCT00264537|450756600|FG001|Overall Study|Not treated|2|||
125308844|NCT00264537|450756601|FG002|Overall Study|Not treated|1|||
125308845|NCT00264537|450756602|FG003|Overall Study|Not treated|0|||
125308846|NCT03228212|450756604|FG000|Period 1|Adverse Event|1|||
125308847|NCT03228212|450756605|FG001|Period 1|Adverse Event|0|||
125308848|NCT03228212|450756604|FG000|Period 1|no longer meets eligibility criteria|0|||
125308849|NCT03228212|450756605|FG001|Period 1|no longer meets eligibility criteria|1|||
125308850|NCT03228212|450756604|FG000|Period 2|Lost to Follow-up|1|||
125308851|NCT03228212|450756605|FG001|Period 2|Lost to Follow-up|0|||
125308852|NCT01807299|450756606|FG000|Overall Study|Protocol Violation|3|||
125308853|NCT01807299|450756607|FG001|Overall Study|Protocol Violation|1|||
125308854|NCT01807299|450756608|FG002|Overall Study|Protocol Violation|0|||
125308855|NCT01807299|450756609|FG003|Overall Study|Protocol Violation|2|||
125308856|NCT00811174|450756610|FG000|Overall Study|Protocol Violation|2|||
125308857|NCT00811174|450756610|FG000|Overall Study|Sponsors Decision|1|||
125308858|NCT00999544|450758036|FG000|Overall Study|Withdrawal by Subject|1|||
125308859|NCT02407223|450758038|FG000|Overall Study|Adverse Event|1|||
125308860|NCT02407223|450758039|FG001|Overall Study|Adverse Event|0|||
125308861|NCT02407223|450758040|FG002|Overall Study|Adverse Event|1|||
125308862|NCT02407223|450758038|FG000|Overall Study|Lack of Efficacy|6|||
125308863|NCT02407223|450758039|FG001|Overall Study|Lack of Efficacy|6|||
125308864|NCT02407223|450758040|FG002|Overall Study|Lack of Efficacy|4|||
125308865|NCT02407223|450758038|FG000|Overall Study|Lost to Follow-up|1|||
125308866|NCT02407223|450758039|FG001|Overall Study|Lost to Follow-up|0|||
125308867|NCT02407223|450758040|FG002|Overall Study|Lost to Follow-up|2|||
125308868|NCT02407223|450758038|FG000|Overall Study|Withdrawal by Subject|2|||
125308869|NCT02407223|450758039|FG001|Overall Study|Withdrawal by Subject|4|||
125308870|NCT02407223|450758040|FG002|Overall Study|Withdrawal by Subject|4|||
125308871|NCT02407223|450758038|FG000|Overall Study|Study Terminated by Sponsor|77|||
125308872|NCT02407223|450758039|FG001|Overall Study|Study Terminated by Sponsor|80|||
125308873|NCT02407223|450758040|FG002|Overall Study|Study Terminated by Sponsor|86|||
125308874|NCT02407223|450758038|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
125308875|NCT02407223|450758039|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
125308876|NCT02407223|450758040|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
125308877|NCT02407223|450758038|FG000|Overall Study|Other|29|||
125308878|NCT02407223|450758039|FG001|Overall Study|Other|27|||
125308879|NCT02407223|450758040|FG002|Overall Study|Other|25|||
125308880|NCT04864639|450758041|FG000|Overall Study|Death|1|||
125308881|NCT04864639|450758041|FG000|Overall Study|Lost to Follow-up|1|||
125308882|NCT00615017|450758042|FG000|Overall Study|Adverse Event|0|||
125308883|NCT00615017|450758043|FG001|Overall Study|Adverse Event|1|||
125308884|NCT00615017|450758044|FG002|Overall Study|Adverse Event|2|||
125308885|NCT00615017|450758045|FG003|Overall Study|Adverse Event|0|||
125308886|NCT00615017|450758046|FG004|Overall Study|Adverse Event|0|||
125308887|NCT00615017|450758047|FG005|Overall Study|Adverse Event|1|||
125308888|NCT00615017|450758042|FG000|Overall Study|Death|0|||
125308889|NCT00615017|450758043|FG001|Overall Study|Death|0|||
125308890|NCT00615017|450758044|FG002|Overall Study|Death|2|||
125308891|NCT00615017|450758045|FG003|Overall Study|Death|0|||
125308892|NCT00615017|450758046|FG004|Overall Study|Death|1|||
125308893|NCT00615017|450758047|FG005|Overall Study|Death|1|||
125308894|NCT00615017|450758042|FG000|Overall Study|Sepsis resolved|0|||
125308895|NCT00615017|450758043|FG001|Overall Study|Sepsis resolved|0|||
125308896|NCT00615017|450758044|FG002|Overall Study|Sepsis resolved|1|||
125308897|NCT00615017|450758045|FG003|Overall Study|Sepsis resolved|0|||
125308898|NCT00615017|450758046|FG004|Overall Study|Sepsis resolved|0|||
125308899|NCT00615017|450758047|FG005|Overall Study|Sepsis resolved|0|||
125308900|NCT00615017|450758042|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
125308901|NCT00615017|450758043|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
125308902|NCT00615017|450758044|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
125308903|NCT00615017|450758045|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
125308904|NCT00615017|450758046|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
125308905|NCT00615017|450758047|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
125308906|NCT00615017|450758042|FG000|Overall Study|Physician discontinued drug|0|||
125308907|NCT00615017|450758043|FG001|Overall Study|Physician discontinued drug|0|||
125308908|NCT00615017|450758044|FG002|Overall Study|Physician discontinued drug|0|||
125308909|NCT00615017|450758045|FG003|Overall Study|Physician discontinued drug|0|||
125308910|NCT00615017|450758046|FG004|Overall Study|Physician discontinued drug|0|||
125308911|NCT00615017|450758047|FG005|Overall Study|Physician discontinued drug|1|||
125308912|NCT00806988|450758048|FG000|Overall Study|Death|15|||
125308913|NCT00806988|450758049|FG001|Overall Study|Death|16|||
125308914|NCT00806988|450758048|FG000|Overall Study|Withdrawal by Subject|8|||
125308915|NCT00806988|450758049|FG001|Overall Study|Withdrawal by Subject|8|||
125308916|NCT00806988|450758048|FG000|Overall Study|Lost to Follow-up|4|||
125308917|NCT00806988|450758049|FG001|Overall Study|Lost to Follow-up|19|||
125308918|NCT01478971|450758050|FG000|Standard of Care Period|Adverse Event|1|||
125308919|NCT01478971|450758050|FG000|Standard of Care Period|Withdrawal by Subject|3|||
125308920|NCT01478971|450758050|FG000|Standard of Care Period|Death|8|||
125308921|NCT01478971|450758050|FG000|Standard of Care Period|Lost to Follow-up|9|||
125308922|NCT01478971|450758050|FG000|Standard of Care Period|Other|4|||
125308923|NCT01478971|450758050|FG000|Peginesatide Treatment Period|Adverse Event|1|||
125308924|NCT01478971|450758050|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
125308925|NCT01478971|450758050|FG000|Peginesatide Treatment Period|Death|4|||
125308926|NCT01478971|450758050|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
125308927|NCT01478971|450758050|FG000|Peginesatide Treatment Period|Other|4|||
125308928|NCT00584012|450758051|FG000|Overall Study|Withdrawal by Subject|1|||
125308929|NCT01525615|450758052|FG000|Overall Study|Adverse Event|11|||
125308930|NCT01525615|450758053|FG001|Overall Study|Adverse Event|7|||
125308931|NCT01525615|450758054|FG002|Overall Study|Adverse Event|5|||
125308932|NCT01525615|450758052|FG000|Overall Study|Lost to Follow-up|1|||
125308933|NCT01525615|450758053|FG001|Overall Study|Lost to Follow-up|0|||
125308934|NCT01525615|450758054|FG002|Overall Study|Lost to Follow-up|0|||
125308935|NCT01525615|450758052|FG000|Overall Study|Withdrawal by Subject|1|||
125308936|NCT01525615|450758053|FG001|Overall Study|Withdrawal by Subject|0|||
125308937|NCT01525615|450758054|FG002|Overall Study|Withdrawal by Subject|0|||
125308938|NCT01525615|450758052|FG000|Overall Study|Other reason not described above|1|||
125308939|NCT01525615|450758053|FG001|Overall Study|Other reason not described above|0|||
125308940|NCT01525615|450758054|FG002|Overall Study|Other reason not described above|1|||
125308941|NCT04050618|450758055|FG000|First Intervention|Withdrawal by Subject|2|||
125308942|NCT04050618|450758056|FG001|First Intervention|Withdrawal by Subject|0|||
125308943|NCT04050618|450758055|FG000|Second Intervention|Withdrawal by Subject|1|||
125308944|NCT04050618|450758056|FG001|Second Intervention|Withdrawal by Subject|0|||
125308945|NCT04404556|450758057|FG000|Intervention|Withdrawal by Subject|15|||
125308946|NCT04404556|450758058|FG001|Intervention|Withdrawal by Subject|3|||
125308947|NCT04404556|450758057|FG000|Intervention|Did not complete all intervention sessions|2|||
125308948|NCT04404556|450758058|FG001|Intervention|Did not complete all intervention sessions|1|||
125308949|NCT04404556|450758057|FG000|Post-Intervention|Missing Data|1|||
125308950|NCT04404556|450758058|FG001|Post-Intervention|Missing Data|2|||
125308951|NCT04404556|450758057|FG000|Follow-up 1|Withdrawal by Subject|5|||
125308952|NCT04404556|450758058|FG001|Follow-up 1|Withdrawal by Subject|1|||
125308953|NCT04404556|450758057|FG000|Follow-up 1|Missing Data|4|||
125308954|NCT04404556|450758058|FG001|Follow-up 1|Missing Data|7|||
125308955|NCT04404556|450758057|FG000|Follow-up 2|Withdrawal by Subject|1|||
125308956|NCT04404556|450758058|FG001|Follow-up 2|Withdrawal by Subject|1|||
125308957|NCT04404556|450758057|FG000|Follow-up 2|Missing Data|6|||
125308958|NCT04404556|450758058|FG001|Follow-up 2|Missing Data|5|||
125308959|NCT04775953|450758059|FG000|Overall Study|Lost to Follow-up|6|||
125308960|NCT04775953|450758060|FG001|Overall Study|Lost to Follow-up|11|||
125308961|NCT04775953|450758059|FG000|Overall Study|Death|5|||
125308962|NCT04775953|450758060|FG001|Overall Study|Death|4|||
125308963|NCT04775953|450758059|FG000|Overall Study|Withdrawal by Subject|3|||
125308964|NCT04775953|450758060|FG001|Overall Study|Withdrawal by Subject|3|||
125308965|NCT04775953|450758059|FG000|Overall Study|Protocol Violation|2|||
125308966|NCT04775953|450758060|FG001|Overall Study|Protocol Violation|0|||
124847244|NCT03013491|449064248|FG009|Long-term Extension|Disease progression|0|||
125308967|NCT04775953|450758059|FG000|Overall Study|Participant non-compliance|0|||
125308968|NCT04775953|450758060|FG001|Overall Study|Participant non-compliance|1|||
125308969|NCT00855959|450758061|FG000|Overall Study|Adverse Event|2|||
125308970|NCT00855959|450758061|FG000|Overall Study|Lost to Follow-up|2|||
125308971|NCT00855959|450758061|FG000|Overall Study|Withdrawal by Subject|3|||
125308972|NCT00855959|450758061|FG000|Overall Study|Pregnancy|1|||
125308973|NCT00855959|450758061|FG000|Overall Study|Incorrect enrolment|1|||
125308974|NCT02451943|450758062|FG000|Overall Study|Withdrawal by Subject|13|||
125308975|NCT02451943|450758063|FG001|Overall Study|Withdrawal by Subject|16|||
125308976|NCT02451943|450758062|FG000|Overall Study|Lost to Follow-up|3|||
125308977|NCT02451943|450758063|FG001|Overall Study|Lost to Follow-up|4|||
125308978|NCT02451943|450758062|FG000|Overall Study|Sponsor Decision|0|||
125308979|NCT02451943|450758063|FG001|Overall Study|Sponsor Decision|4|||
125308980|NCT00368641|450758064|FG000|Overall Study|Adverse Event|2|||
125308981|NCT00368641|450758065|FG001|Overall Study|Adverse Event|1|||
125308982|NCT00368641|450758064|FG000|Overall Study|Death|1|||
125308983|NCT00368641|450758065|FG001|Overall Study|Death|0|||
125308984|NCT00368641|450758064|FG000|Overall Study|Withdrawal by Subject|1|||
125308985|NCT00368641|450758065|FG001|Overall Study|Withdrawal by Subject|0|||
125308986|NCT00368641|450758064|FG000|Overall Study|Sponsor decision to terminate study|2|||
125308987|NCT00368641|450758065|FG001|Overall Study|Sponsor decision to terminate study|5|||
125308988|NCT00763386|450758067|FG000|Overall Study|Adverse Event|43|||
125308989|NCT00763386|450758068|FG001|Overall Study|Adverse Event|33|||
125308990|NCT00763386|450758067|FG000|Overall Study|Death|1|||
125308991|NCT00763386|450758068|FG001|Overall Study|Death|2|||
125308992|NCT00763386|450758067|FG000|Overall Study|Lost to Follow-up|3|||
125308993|NCT00763386|450758068|FG001|Overall Study|Lost to Follow-up|3|||
125308994|NCT00763386|450758067|FG000|Overall Study|Withdrawal by Subject|0|||
125308995|NCT00763386|450758068|FG001|Overall Study|Withdrawal by Subject|1|||
125308996|NCT00763386|450758067|FG000|Overall Study|CRF missing|0|||
125308997|NCT00763386|450758068|FG001|Overall Study|CRF missing|1|||
125308998|NCT00763386|450758067|FG000|Overall Study|Study Prosthesis Removed|1|||
125308999|NCT00763386|450758068|FG001|Overall Study|Study Prosthesis Removed|0|||
125309000|NCT01290757|450758071|FG000|Overall Study|Adverse Event|1|||
125309001|NCT01290757|450758072|FG001|Overall Study|Adverse Event|0|||
125309002|NCT01290757|450758071|FG000|Overall Study|Protocol Violation|1|||
125309003|NCT01290757|450758072|FG001|Overall Study|Protocol Violation|1|||
125309004|NCT01290757|450758071|FG000|Overall Study|Other|0|||
125309005|NCT01290757|450758072|FG001|Overall Study|Other|1|||
125309006|NCT00887549|450758073|FG000|Induction Therapy|Adverse Event|8|||
125309007|NCT00887549|450758073|FG000|Induction Therapy|Physician Decision|1|||
125309008|NCT00887549|450758073|FG000|Induction Therapy|Progressive Disease|13|||
125309009|NCT00887549|450758073|FG000|Induction Therapy|Death due to Study Disease|4|||
125309010|NCT00887549|450758073|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
125309011|NCT00887549|450758073|FG000|Maintenance Therapy|Adverse Event|16|||
125309012|NCT00887549|450758073|FG000|Maintenance Therapy|Physician Decision|1|||
125309013|NCT00887549|450758073|FG000|Maintenance Therapy|Progressive Disease|25|||
125309014|NCT00887549|450758073|FG000|Maintenance Therapy|Death due to adverse event|1|||
125309015|NCT00479336|450758075|FG000|Overall Study|Adverse Event|1|||
125309016|NCT00479336|450758076|FG001|Overall Study|Adverse Event|1|||
125309017|NCT00479336|450758077|FG002|Overall Study|Adverse Event|1|||
125309018|NCT00479336|450758078|FG003|Overall Study|Adverse Event|3|||
125309019|NCT00479336|450758075|FG000|Overall Study|Lack of Efficacy|1|||
125309020|NCT00479336|450758076|FG001|Overall Study|Lack of Efficacy|0|||
125309021|NCT00479336|450758077|FG002|Overall Study|Lack of Efficacy|0|||
125309022|NCT00479336|450758078|FG003|Overall Study|Lack of Efficacy|0|||
125309023|NCT00479336|450758075|FG000|Overall Study|Protocol Violation|0|||
125309024|NCT00479336|450758076|FG001|Overall Study|Protocol Violation|1|||
125309025|NCT00479336|450758077|FG002|Overall Study|Protocol Violation|0|||
125309026|NCT00479336|450758078|FG003|Overall Study|Protocol Violation|0|||
125309027|NCT00479336|450758075|FG000|Overall Study|Withdrawal by Subject|1|||
125309028|NCT00479336|450758076|FG001|Overall Study|Withdrawal by Subject|2|||
125309029|NCT00479336|450758077|FG002|Overall Study|Withdrawal by Subject|0|||
125309030|NCT00479336|450758078|FG003|Overall Study|Withdrawal by Subject|0|||
125309031|NCT00479336|450758075|FG000|Overall Study|Physician Decision|0|||
125309032|NCT00479336|450758076|FG001|Overall Study|Physician Decision|1|||
125309033|NCT00479336|450758077|FG002|Overall Study|Physician Decision|0|||
125309034|NCT00479336|450758078|FG003|Overall Study|Physician Decision|2|||
124847245|NCT03013491|449064249|FG010|Long-term Extension|Disease progression|0|||
124847246|NCT03013491|449064250|FG011|Long-term Extension|Disease progression|0|||
125309035|NCT00479336|450758075|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
125309036|NCT00479336|450758076|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
125309037|NCT00479336|450758077|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
125309038|NCT00479336|450758078|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
124847247|NCT03013491|449064251|FG012|Long-term Extension|Disease progression|0|||
125309039|NCT02021643|450758079|FG000|Overall Study|Enrolled but Never Treated|1|||
125309040|NCT02021643|450758080|FG001|Overall Study|Enrolled but Never Treated|0|||
125309041|NCT02021643|450758081|FG002|Overall Study|Enrolled but Never Treated|0|||
125309042|NCT02021643|450758082|FG003|Overall Study|Enrolled but Never Treated|0|||
125309043|NCT02021643|450758079|FG000|Overall Study|Adverse Event|0|||
124847248|NCT03013491|449064252|FG013|Long-term Extension|Disease progression|0|||
125309044|NCT02021643|450758080|FG001|Overall Study|Adverse Event|1|||
125309045|NCT02021643|450758081|FG002|Overall Study|Adverse Event|0|||
125309046|NCT02021643|450758082|FG003|Overall Study|Adverse Event|0|||
125309047|NCT02021643|450758079|FG000|Overall Study|Death|0|||
125309048|NCT02021643|450758080|FG001|Overall Study|Death|1|||
125309049|NCT02021643|450758081|FG002|Overall Study|Death|0|||
125309050|NCT02021643|450758082|FG003|Overall Study|Death|0|||
125309051|NCT02021643|450758079|FG000|Overall Study|Investigator's Discretion|1|||
125309052|NCT02021643|450758080|FG001|Overall Study|Investigator's Discretion|0|||
125309053|NCT02021643|450758081|FG002|Overall Study|Investigator's Discretion|0|||
125309054|NCT02021643|450758082|FG003|Overall Study|Investigator's Discretion|0|||
125309055|NCT02021643|450758079|FG000|Overall Study|Lack of Efficacy|7|||
125309056|NCT02021643|450758080|FG001|Overall Study|Lack of Efficacy|6|||
125309057|NCT02021643|450758081|FG002|Overall Study|Lack of Efficacy|0|||
125309058|NCT02021643|450758082|FG003|Overall Study|Lack of Efficacy|12|||
125309059|NCT02021643|450758079|FG000|Overall Study|Lost to Follow-up|0|||
125309060|NCT02021643|450758080|FG001|Overall Study|Lost to Follow-up|1|||
125309061|NCT02021643|450758081|FG002|Overall Study|Lost to Follow-up|0|||
125309062|NCT02021643|450758082|FG003|Overall Study|Lost to Follow-up|0|||
125309063|NCT02021643|450758079|FG000|Overall Study|Withdrew Consent|0|||
125309064|NCT02021643|450758080|FG001|Overall Study|Withdrew Consent|1|||
125309065|NCT02021643|450758081|FG002|Overall Study|Withdrew Consent|0|||
125309066|NCT02021643|450758082|FG003|Overall Study|Withdrew Consent|0|||
125309067|NCT04854551|450758085|FG000|Overall Study|Withdrawal by Subject|1|||
125309068|NCT04854551|450758086|FG001|Overall Study|Withdrawal by Subject|1|||
125309069|NCT04112303|450758087|FG000|Overall Study|Death|1|||
125309070|NCT00726232|450758088|FG000|Initial Phase (Dose-finding)|Death|0|||
125309071|NCT00726232|450758089|FG001|Initial Phase (Dose-finding)|Death|0|||
125309072|NCT00726232|450758090|FG002|Initial Phase (Dose-finding)|Death|0|||
125309073|NCT00726232|450758091|FG003|Initial Phase (Dose-finding)|Death|0|||
125309074|NCT00726232|450758092|FG004|Initial Phase (Dose-finding)|Death|1|||
125309075|NCT00726232|450758093|FG005|Initial Phase (Dose-finding)|Death|0|||
125309076|NCT00726232|450758094|FG006|Initial Phase (Dose-finding)|Death|0|||
125309077|NCT00726232|450758095|FG007|Initial Phase (Dose-finding)|Death|0|||
125309078|NCT00726232|450758088|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
125309079|NCT00726232|450758089|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
125309080|NCT00726232|450758090|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
125309081|NCT00726232|450758091|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
125309082|NCT00726232|450758092|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
125309083|NCT00726232|450758093|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
125309084|NCT00726232|450758094|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
125309085|NCT00726232|450758095|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
125309086|NCT00726232|450758088|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
125309087|NCT00726232|450758089|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
125309088|NCT00726232|450758090|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
125309089|NCT00726232|450758091|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
125309090|NCT00726232|450758092|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
125309091|NCT00726232|450758093|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
125309092|NCT00726232|450758094|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
125309093|NCT00726232|450758095|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
125309094|NCT00726232|450758088|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
125309095|NCT00726232|450758089|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
125309096|NCT00726232|450758090|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
125309097|NCT00726232|450758091|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
125309098|NCT00726232|450758092|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
125309099|NCT00726232|450758093|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
125309100|NCT00726232|450758094|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
125309101|NCT00726232|450758095|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
125309102|NCT00726232|450758088|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
125309103|NCT00726232|450758089|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
125309104|NCT00726232|450758090|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
125309105|NCT00726232|450758091|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
125309106|NCT00726232|450758092|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
125309107|NCT00726232|450758093|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
125309108|NCT00726232|450758094|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
125309109|NCT00726232|450758095|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
125309110|NCT00726232|450758088|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
125309111|NCT00726232|450758089|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
124847249|NCT03013491|449064253|FG014|Long-term Extension|Disease progression|0|||
125309112|NCT00726232|450758090|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
125309113|NCT00726232|450758091|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
125309114|NCT00726232|450758092|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
125309115|NCT00726232|450758093|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
125309116|NCT00726232|450758094|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
125309117|NCT00726232|450758095|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
125309118|NCT00726232|450758088|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
125309119|NCT00726232|450758089|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
125309120|NCT00726232|450758090|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
125309121|NCT00726232|450758091|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
125309122|NCT00726232|450758092|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
125309123|NCT00726232|450758093|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
125309124|NCT00726232|450758094|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
125309125|NCT00726232|450758095|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
125309126|NCT00726232|450758088|FG000|Expansion Phase|Death|0|||
125309127|NCT00726232|450758089|FG001|Expansion Phase|Death|0|||
125309128|NCT00726232|450758090|FG002|Expansion Phase|Death|0|||
125309129|NCT00726232|450758091|FG003|Expansion Phase|Death|0|||
125309130|NCT00726232|450758092|FG004|Expansion Phase|Death|0|||
125309131|NCT00726232|450758093|FG005|Expansion Phase|Death|0|||
125309132|NCT00726232|450758094|FG006|Expansion Phase|Death|0|||
125309133|NCT00726232|450758095|FG007|Expansion Phase|Death|1|||
125309134|NCT00726232|450758088|FG000|Expansion Phase|Adverse Event|0|||
125309135|NCT00726232|450758089|FG001|Expansion Phase|Adverse Event|0|||
125309136|NCT00726232|450758090|FG002|Expansion Phase|Adverse Event|0|||
125309137|NCT00726232|450758091|FG003|Expansion Phase|Adverse Event|0|||
125309138|NCT00726232|450758092|FG004|Expansion Phase|Adverse Event|0|||
125309139|NCT00726232|450758093|FG005|Expansion Phase|Adverse Event|0|||
125309140|NCT00726232|450758094|FG006|Expansion Phase|Adverse Event|6|||
125309141|NCT00726232|450758095|FG007|Expansion Phase|Adverse Event|11|||
125309142|NCT00726232|450758088|FG000|Expansion Phase|Withdrawal by Subject|0|||
125309143|NCT00726232|450758089|FG001|Expansion Phase|Withdrawal by Subject|0|||
125309144|NCT00726232|450758090|FG002|Expansion Phase|Withdrawal by Subject|0|||
125309145|NCT00726232|450758091|FG003|Expansion Phase|Withdrawal by Subject|0|||
125309146|NCT00726232|450758092|FG004|Expansion Phase|Withdrawal by Subject|0|||
125309147|NCT00726232|450758093|FG005|Expansion Phase|Withdrawal by Subject|0|||
125309148|NCT00726232|450758094|FG006|Expansion Phase|Withdrawal by Subject|2|||
125309149|NCT00726232|450758095|FG007|Expansion Phase|Withdrawal by Subject|3|||
125309150|NCT00726232|450758088|FG000|Expansion Phase|Disease progression|0|||
125309151|NCT00726232|450758089|FG001|Expansion Phase|Disease progression|0|||
125309152|NCT00726232|450758090|FG002|Expansion Phase|Disease progression|0|||
125309153|NCT00726232|450758091|FG003|Expansion Phase|Disease progression|0|||
125309154|NCT00726232|450758092|FG004|Expansion Phase|Disease progression|0|||
125309155|NCT00726232|450758093|FG005|Expansion Phase|Disease progression|0|||
125309156|NCT00726232|450758094|FG006|Expansion Phase|Disease progression|4|||
125309157|NCT00726232|450758095|FG007|Expansion Phase|Disease progression|0|||
125309158|NCT00726232|450758088|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
125309159|NCT00726232|450758089|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
125309160|NCT00726232|450758090|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
125309161|NCT00726232|450758091|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
125309162|NCT00726232|450758092|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
125309163|NCT00726232|450758093|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
125309164|NCT00726232|450758094|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
125309165|NCT00726232|450758095|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
125309166|NCT00726232|450758088|FG000|Expansion Phase|Per Investigator: lack of response|0|||
125309167|NCT00726232|450758089|FG001|Expansion Phase|Per Investigator: lack of response|0|||
125309168|NCT00726232|450758090|FG002|Expansion Phase|Per Investigator: lack of response|0|||
125309169|NCT00726232|450758091|FG003|Expansion Phase|Per Investigator: lack of response|0|||
125309170|NCT00726232|450758092|FG004|Expansion Phase|Per Investigator: lack of response|0|||
125309171|NCT00726232|450758093|FG005|Expansion Phase|Per Investigator: lack of response|0|||
125309172|NCT00726232|450758094|FG006|Expansion Phase|Per Investigator: lack of response|1|||
125309173|NCT00726232|450758095|FG007|Expansion Phase|Per Investigator: lack of response|7|||
125309174|NCT00726232|450758088|FG000|Expansion Phase|Unspecified reason|0|||
125309175|NCT00726232|450758089|FG001|Expansion Phase|Unspecified reason|0|||
125309176|NCT00726232|450758090|FG002|Expansion Phase|Unspecified reason|0|||
125309177|NCT00726232|450758091|FG003|Expansion Phase|Unspecified reason|0|||
125309178|NCT00726232|450758092|FG004|Expansion Phase|Unspecified reason|0|||
125309179|NCT00726232|450758093|FG005|Expansion Phase|Unspecified reason|0|||
125309180|NCT00726232|450758094|FG006|Expansion Phase|Unspecified reason|1|||
124847250|NCT03013491|449064254|FG015|Long-term Extension|Disease progression|0|||
124847251|NCT03013491|449064255|FG016|Long-term Extension|Disease progression|0|||
124847252|NCT03013491|449064256|FG017|Long-term Extension|Disease progression|0|||
125309181|NCT00726232|450758095|FG007|Expansion Phase|Unspecified reason|0|||
125309182|NCT03088917|450758096|FG000|Overall Study|In care/cured elsewhere|15|||
125309183|NCT03088917|450758096|FG000|Overall Study|Refuse re-evaluation|13|||
125309184|NCT03088917|450758096|FG000|Overall Study|Contact not established|13|||
125309185|NCT03088917|450758096|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
125309186|NCT03088917|450758096|FG000|Overall Study|Moved outside study region|50|||
125309187|NCT05447663|450758098|FG000|Overall Study|Study terminated by Sponsor|5|||
125309188|NCT05447663|450758098|FG000|Overall Study|Death|2|||
125309189|NCT05447663|450758098|FG000|Overall Study|Withdrawal by Subject|1|||
125309190|NCT06041919|450758099|FG000|Overall Study|Lost to Follow-up|1|||
125309191|NCT06041919|450758100|FG001|Overall Study|Lost to Follow-up|0|||
125309192|NCT06041919|450758101|FG002|Overall Study|Lost to Follow-up|0|||
125309193|NCT06041919|450758102|FG003|Overall Study|Lost to Follow-up|0|||
125309194|NCT06041919|450758103|FG004|Overall Study|Lost to Follow-up|0|||
125309195|NCT06041919|450758099|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
125309196|NCT06041919|450758100|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
125309197|NCT06041919|450758101|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
125309198|NCT06041919|450758102|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
125309199|NCT06041919|450758103|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
125309200|NCT01502228|450758104|FG000|Overall Study|Death|1|||
125309201|NCT01221350|450758111|FG000|Overall Study|Discontinued intervention (GERD)|1|||
125309202|NCT01221350|450758112|FG001|Overall Study|Discontinued intervention (GERD)|0|||
125309203|NCT01221350|450758111|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
125309204|NCT01221350|450758112|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
125309205|NCT01221350|450758111|FG000|Overall Study|Withdrawal by Subject|4|||
125309206|NCT01221350|450758112|FG001|Overall Study|Withdrawal by Subject|2|||
125309207|NCT04209205|450758118|FG000|Overall Study|Adverse Event|2|||
125309208|NCT04209205|450758119|FG001|Overall Study|Adverse Event|3|||
125309209|NCT04209205|450758118|FG000|Overall Study|Lost to Follow-up|3|||
125309210|NCT04209205|450758119|FG001|Overall Study|Lost to Follow-up|1|||
125309211|NCT04209205|450758118|FG000|Overall Study|Physician Decision|1|||
125309212|NCT04209205|450758119|FG001|Overall Study|Physician Decision|1|||
125309213|NCT04209205|450758118|FG000|Overall Study|Subject decision|10|||
125309214|NCT04209205|450758119|FG001|Overall Study|Subject decision|10|||
125309215|NCT04209205|450758118|FG000|Overall Study|Progressive disease|1|||
125309216|NCT04209205|450758119|FG001|Overall Study|Progressive disease|0|||
125309217|NCT04209205|450758118|FG000|Overall Study|Protocol deviation|0|||
125309218|NCT04209205|450758119|FG001|Overall Study|Protocol deviation|1|||
125309219|NCT04209205|450758118|FG000|Overall Study|New therapy for study indication|1|||
125309220|NCT04209205|450758119|FG001|Overall Study|New therapy for study indication|0|||
125309221|NCT04209205|450758118|FG000|Overall Study|Adverse event - placebo not switched|0|||
125309222|NCT04209205|450758119|FG001|Overall Study|Adverse event - placebo not switched|1|||
125309223|NCT04209205|450758118|FG000|Overall Study|Subject decision - placebo not switched|0|||
125309224|NCT04209205|450758119|FG001|Overall Study|Subject decision - placebo not switched|5|||
125309225|NCT04209205|450758118|FG000|Overall Study|Death - placebo not switched|0|||
125309226|NCT04209205|450758119|FG001|Overall Study|Death - placebo not switched|1|||
125309227|NCT05236257|450758152|FG000|Overall Study|Ongoing with study treatment|29|||
125309228|NCT05236257|450758153|FG001|Overall Study|Ongoing with study treatment|1|||
125309229|NCT05236257|450758152|FG000|Overall Study|Discontinued study treatment|22|||
125309230|NCT05236257|450758153|FG001|Overall Study|Discontinued study treatment|41|||
125309231|NCT00924443|450758157|FG000|Overall Study|Physician Decision|2|||
125309232|NCT00924443|450758157|FG000|Overall Study|Protocol Violation|1|||
125309233|NCT01746225|450758159|FG000|Overall Study|Death|1|||
125309234|NCT01746225|450758160|FG001|Overall Study|Death|0|||
125309235|NCT01746225|450758161|FG002|Overall Study|Death|1|||
125309236|NCT01746225|450758159|FG000|Overall Study|Withdrawal by Subject|5|||
125309237|NCT01746225|450758160|FG001|Overall Study|Withdrawal by Subject|15|||
125309238|NCT01746225|450758161|FG002|Overall Study|Withdrawal by Subject|19|||
125309239|NCT01746225|450758159|FG000|Overall Study|Physician Decision|14|||
125309240|NCT01746225|450758160|FG001|Overall Study|Physician Decision|11|||
125309241|NCT01746225|450758161|FG002|Overall Study|Physician Decision|3|||
125309242|NCT01746225|450758159|FG000|Overall Study|Adverse Event|15|||
125309243|NCT01746225|450758160|FG001|Overall Study|Adverse Event|12|||
125309244|NCT01746225|450758161|FG002|Overall Study|Adverse Event|17|||
125309245|NCT01746225|450758159|FG000|Overall Study|Continuing Treatment|5|||
125309246|NCT01746225|450758160|FG001|Overall Study|Continuing Treatment|8|||
125309247|NCT01746225|450758161|FG002|Overall Study|Continuing Treatment|3|||
125309248|NCT03405818|450758162|FG000|Overall Study|Withdrawal by Subject|4|||
125309249|NCT03405818|450758162|FG000|Overall Study|Lost to Follow-up|4|||
125309250|NCT03197376|450758166|FG000|Primary and Booster Phase|Adverse Event|0|||
124847253|NCT03013491|449064257|FG018|Long-term Extension|Disease progression|1|||
124847254|NCT03013491|449064239|FG000|Long-term Extension|Withdrawal by Subject|0|||
124847255|NCT03013491|449064240|FG001|Long-term Extension|Withdrawal by Subject|0|||
124847256|NCT03013491|449064241|FG002|Long-term Extension|Withdrawal by Subject|0|||
124847257|NCT03013491|449064242|FG003|Long-term Extension|Withdrawal by Subject|0|||
124847258|NCT03013491|449064243|FG004|Long-term Extension|Withdrawal by Subject|0|||
124847259|NCT03013491|449064244|FG005|Long-term Extension|Withdrawal by Subject|0|||
124847260|NCT03013491|449064245|FG006|Long-term Extension|Withdrawal by Subject|0|||
124847261|NCT03013491|449064246|FG007|Long-term Extension|Withdrawal by Subject|1|||
124847262|NCT03013491|449064247|FG008|Long-term Extension|Withdrawal by Subject|0|||
124847263|NCT03013491|449064248|FG009|Long-term Extension|Withdrawal by Subject|0|||
124847264|NCT03013491|449064249|FG010|Long-term Extension|Withdrawal by Subject|0|||
124847265|NCT03013491|449064250|FG011|Long-term Extension|Withdrawal by Subject|0|||
124847266|NCT03013491|449064251|FG012|Long-term Extension|Withdrawal by Subject|0|||
124847267|NCT03013491|449064252|FG013|Long-term Extension|Withdrawal by Subject|0|||
124847268|NCT03013491|449064253|FG014|Long-term Extension|Withdrawal by Subject|0|||
124847269|NCT03013491|449064254|FG015|Long-term Extension|Withdrawal by Subject|0|||
124847270|NCT03013491|449064255|FG016|Long-term Extension|Withdrawal by Subject|0|||
124847271|NCT03013491|449064256|FG017|Long-term Extension|Withdrawal by Subject|0|||
124847272|NCT03013491|449064257|FG018|Long-term Extension|Withdrawal by Subject|0|||
124847273|NCT03013491|449064239|FG000|Long-term Extension|Adverse Event|0|||
124847274|NCT03013491|449064240|FG001|Long-term Extension|Adverse Event|0|||
124847275|NCT03013491|449064241|FG002|Long-term Extension|Adverse Event|0|||
124847276|NCT03013491|449064242|FG003|Long-term Extension|Adverse Event|0|||
124847277|NCT03013491|449064243|FG004|Long-term Extension|Adverse Event|0|||
124847278|NCT03013491|449064244|FG005|Long-term Extension|Adverse Event|0|||
124847279|NCT03013491|449064245|FG006|Long-term Extension|Adverse Event|0|||
124847280|NCT03013491|449064246|FG007|Long-term Extension|Adverse Event|0|||
124847281|NCT03013491|449064247|FG008|Long-term Extension|Adverse Event|0|||
124847282|NCT03013491|449064248|FG009|Long-term Extension|Adverse Event|0|||
124847283|NCT03013491|449064249|FG010|Long-term Extension|Adverse Event|0|||
124847284|NCT03013491|449064250|FG011|Long-term Extension|Adverse Event|0|||
124847285|NCT03013491|449064251|FG012|Long-term Extension|Adverse Event|0|||
124847286|NCT03013491|449064252|FG013|Long-term Extension|Adverse Event|0|||
124847287|NCT03013491|449064253|FG014|Long-term Extension|Adverse Event|0|||
124847288|NCT03013491|449064254|FG015|Long-term Extension|Adverse Event|0|||
124847289|NCT03013491|449064255|FG016|Long-term Extension|Adverse Event|0|||
124847290|NCT03013491|449064256|FG017|Long-term Extension|Adverse Event|0|||
124847291|NCT03013491|449064257|FG018|Long-term Extension|Adverse Event|1|||
124847292|NCT03013491|449064239|FG000|Long-term Extension|Death|0|||
124847293|NCT03013491|449064240|FG001|Long-term Extension|Death|0|||
124847294|NCT03013491|449064241|FG002|Long-term Extension|Death|0|||
124847295|NCT03013491|449064242|FG003|Long-term Extension|Death|0|||
124847296|NCT03013491|449064243|FG004|Long-term Extension|Death|0|||
124847297|NCT03013491|449064244|FG005|Long-term Extension|Death|0|||
124847298|NCT03013491|449064245|FG006|Long-term Extension|Death|0|||
124847299|NCT03013491|449064246|FG007|Long-term Extension|Death|0|||
124847300|NCT03013491|449064247|FG008|Long-term Extension|Death|0|||
124847301|NCT03013491|449064248|FG009|Long-term Extension|Death|0|||
124847302|NCT03013491|449064249|FG010|Long-term Extension|Death|0|||
124847303|NCT03013491|449064250|FG011|Long-term Extension|Death|0|||
124847304|NCT03013491|449064251|FG012|Long-term Extension|Death|0|||
124847305|NCT03013491|449064252|FG013|Long-term Extension|Death|0|||
124847306|NCT03013491|449064253|FG014|Long-term Extension|Death|0|||
124847307|NCT03013491|449064254|FG015|Long-term Extension|Death|0|||
124847308|NCT03013491|449064255|FG016|Long-term Extension|Death|0|||
124847309|NCT03013491|449064256|FG017|Long-term Extension|Death|0|||
124847310|NCT03013491|449064257|FG018|Long-term Extension|Death|1|||
124847311|NCT03265119|449064258|FG000|Overall Study|Adverse Event|2|||
124847312|NCT03265119|449064259|FG001|Overall Study|Adverse Event|1|||
124847313|NCT03265119|449064258|FG000|Overall Study|Lack of Efficacy|3|||
124847314|NCT03265119|449064259|FG001|Overall Study|Lack of Efficacy|0|||
124847315|NCT03265119|449064258|FG000|Overall Study|Protocol Violation|1|||
124847316|NCT03265119|449064259|FG001|Overall Study|Protocol Violation|2|||
124847317|NCT03265119|449064258|FG000|Overall Study|Withdrawal by Subject|2|||
124847318|NCT03265119|449064259|FG001|Overall Study|Withdrawal by Subject|4|||
124847319|NCT03265119|449064258|FG000|Overall Study|Lost to Follow-up|1|||
124847320|NCT03265119|449064259|FG001|Overall Study|Lost to Follow-up|0|||
124847321|NCT03265119|449064258|FG000|Overall Study|Lack of Compliance|1|||
124847322|NCT03265119|449064259|FG001|Overall Study|Lack of Compliance|0|||
124847323|NCT03238911|449064260|FG000|Overall Study|Withdrawal by Subject|1|||
124847324|NCT03238911|449064261|FG001|Overall Study|Withdrawal by Subject|2|||
124847325|NCT03238911|449064260|FG000|Overall Study|Lost to Follow-up|2|||
124847326|NCT03238911|449064261|FG001|Overall Study|Lost to Follow-up|1|||
124847327|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
124847328|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
124847329|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
124847330|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Death|1|||
124847331|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Death|0|||
124847332|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Death|0|||
124847333|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
124847334|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
124847335|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
124847336|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
124847337|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
124847338|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
124847339|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
124847340|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
124847341|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
124847342|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
124847343|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
124847344|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
124847345|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
124847346|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
124847347|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
124847348|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
124847349|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
124847350|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
124847351|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
124847352|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
124847353|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
124847354|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
124847355|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
124847356|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
124847357|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
124847358|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
124847359|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
124847360|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Other|0|||
124847361|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Other|2|||
124847362|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Other|2|||
124847363|NCT03655236|449064262|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
124847364|NCT03655236|449064263|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
124847365|NCT03655236|449064264|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
124847366|NCT03655236|449064262|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
124847367|NCT03655236|449064263|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
124847368|NCT03655236|449064264|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
124847369|NCT03655236|449064262|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
124847370|NCT03655236|449064263|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
124847371|NCT03655236|449064264|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
124847372|NCT03655236|449064262|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
124847373|NCT03655236|449064263|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
124847374|NCT03655236|449064264|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
124847375|NCT03655236|449064262|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
124847376|NCT03655236|449064263|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
124847377|NCT03655236|449064264|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
124847378|NCT03655236|449064262|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
124847379|NCT03655236|449064263|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
124847380|NCT03655236|449064264|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
124847381|NCT03655236|449064262|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
124847382|NCT03655236|449064263|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
124847383|NCT03655236|449064264|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
124847384|NCT03655236|449064262|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
124847385|NCT03655236|449064263|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
124847386|NCT03655236|449064264|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
124847387|NCT03655236|449064262|FG000|Subject Disposition in Part 2 Period|Other|1|||
124847388|NCT03655236|449064263|FG001|Subject Disposition in Part 2 Period|Other|0|||
124847389|NCT03655236|449064264|FG002|Subject Disposition in Part 2 Period|Other|0|||
124847390|NCT00991302|449065942|FG000|Overall Study|Death|0|||
124847391|NCT00991302|449065943|FG001|Overall Study|Death|1|||
124847392|NCT00991302|449065942|FG000|Overall Study|Lost to Follow-up|14|||
124847393|NCT00991302|449065943|FG001|Overall Study|Lost to Follow-up|12|||
124847394|NCT01709318|449065944|FG000|Overall Study|Adverse Event|3|||
124847395|NCT01709318|449065945|FG001|Overall Study|Adverse Event|4|||
124847396|NCT01709318|449065946|FG002|Overall Study|Adverse Event|2|||
124847397|NCT01709318|449065947|FG003|Overall Study|Adverse Event|2|||
124847398|NCT01709318|449065948|FG004|Overall Study|Adverse Event|0|||
124847399|NCT01709318|449065949|FG005|Overall Study|Adverse Event|1|||
124847400|NCT01709318|449065950|FG006|Overall Study|Adverse Event|2|||
124847401|NCT01709318|449065944|FG000|Overall Study|Lost to Follow-up|2|||
124847402|NCT01709318|449065945|FG001|Overall Study|Lost to Follow-up|0|||
124847403|NCT01709318|449065946|FG002|Overall Study|Lost to Follow-up|0|||
124847404|NCT01709318|449065947|FG003|Overall Study|Lost to Follow-up|0|||
124847405|NCT01709318|449065948|FG004|Overall Study|Lost to Follow-up|1|||
124847406|NCT01709318|449065949|FG005|Overall Study|Lost to Follow-up|1|||
124847407|NCT01709318|449065950|FG006|Overall Study|Lost to Follow-up|1|||
124847408|NCT01709318|449065944|FG000|Overall Study|Non-compliance with Study Drug|0|||
124847409|NCT01709318|449065945|FG001|Overall Study|Non-compliance with Study Drug|2|||
124847410|NCT01709318|449065946|FG002|Overall Study|Non-compliance with Study Drug|1|||
124847411|NCT01709318|449065947|FG003|Overall Study|Non-compliance with Study Drug|1|||
124847412|NCT01709318|449065948|FG004|Overall Study|Non-compliance with Study Drug|0|||
124847413|NCT01709318|449065949|FG005|Overall Study|Non-compliance with Study Drug|0|||
124847414|NCT01709318|449065950|FG006|Overall Study|Non-compliance with Study Drug|2|||
124847415|NCT01709318|449065944|FG000|Overall Study|Physician Decision|0|||
124847416|NCT01709318|449065945|FG001|Overall Study|Physician Decision|0|||
124847417|NCT01709318|449065946|FG002|Overall Study|Physician Decision|0|||
124847418|NCT01709318|449065947|FG003|Overall Study|Physician Decision|0|||
124847419|NCT01709318|449065948|FG004|Overall Study|Physician Decision|0|||
124847420|NCT01709318|449065949|FG005|Overall Study|Physician Decision|0|||
124847421|NCT01709318|449065950|FG006|Overall Study|Physician Decision|1|||
124847422|NCT01709318|449065944|FG000|Overall Study|Pregnancy|0|||
124847423|NCT01709318|449065945|FG001|Overall Study|Pregnancy|0|||
124847424|NCT01709318|449065946|FG002|Overall Study|Pregnancy|0|||
124847425|NCT01709318|449065947|FG003|Overall Study|Pregnancy|0|||
124847426|NCT01709318|449065948|FG004|Overall Study|Pregnancy|1|||
124847427|NCT01709318|449065949|FG005|Overall Study|Pregnancy|0|||
124847428|NCT01709318|449065950|FG006|Overall Study|Pregnancy|0|||
124847429|NCT01709318|449065944|FG000|Overall Study|Protocol Violation|0|||
124847430|NCT01709318|449065945|FG001|Overall Study|Protocol Violation|0|||
124847431|NCT01709318|449065946|FG002|Overall Study|Protocol Violation|0|||
124847432|NCT01709318|449065947|FG003|Overall Study|Protocol Violation|0|||
124847433|NCT01709318|449065948|FG004|Overall Study|Protocol Violation|2|||
124847434|NCT01709318|449065949|FG005|Overall Study|Protocol Violation|0|||
124847435|NCT01709318|449065950|FG006|Overall Study|Protocol Violation|1|||
124847436|NCT01709318|449065944|FG000|Overall Study|Technical Problems|1|||
124847437|NCT01709318|449065945|FG001|Overall Study|Technical Problems|0|||
124847438|NCT01709318|449065946|FG002|Overall Study|Technical Problems|0|||
124847439|NCT01709318|449065947|FG003|Overall Study|Technical Problems|0|||
124847440|NCT01709318|449065948|FG004|Overall Study|Technical Problems|0|||
124847441|NCT01709318|449065949|FG005|Overall Study|Technical Problems|0|||
124847442|NCT01709318|449065950|FG006|Overall Study|Technical Problems|0|||
124847443|NCT01709318|449065944|FG000|Overall Study|Withdrawal by Subject|3|||
124847444|NCT01709318|449065945|FG001|Overall Study|Withdrawal by Subject|0|||
124847445|NCT01709318|449065946|FG002|Overall Study|Withdrawal by Subject|3|||
124847446|NCT01709318|449065947|FG003|Overall Study|Withdrawal by Subject|3|||
124847447|NCT01709318|449065948|FG004|Overall Study|Withdrawal by Subject|0|||
124847448|NCT01709318|449065949|FG005|Overall Study|Withdrawal by Subject|2|||
124847449|NCT01709318|449065950|FG006|Overall Study|Withdrawal by Subject|4|||
124847450|NCT01709318|449065944|FG000|Overall Study|Other Protocol Specified Criteria|0|||
124847451|NCT01709318|449065945|FG001|Overall Study|Other Protocol Specified Criteria|1|||
124847452|NCT01709318|449065946|FG002|Overall Study|Other Protocol Specified Criteria|0|||
124847453|NCT01709318|449065947|FG003|Overall Study|Other Protocol Specified Criteria|0|||
124847454|NCT01709318|449065948|FG004|Overall Study|Other Protocol Specified Criteria|0|||
124847455|NCT01709318|449065949|FG005|Overall Study|Other Protocol Specified Criteria|0|||
124847456|NCT01709318|449065950|FG006|Overall Study|Other Protocol Specified Criteria|0|||
124847457|NCT03042312|449065951|FG000|Overall Study|Administrative Reason|1|||
124847458|NCT03042312|449065952|FG001|Overall Study|Administrative Reason|1|||
124847459|NCT03042312|449065951|FG000|Overall Study|Adverse Event|0|||
124847460|NCT03042312|449065952|FG001|Overall Study|Adverse Event|1|||
124847461|NCT03042312|449065951|FG000|Overall Study|Lost to Follow-up|1|||
124847462|NCT03042312|449065952|FG001|Overall Study|Lost to Follow-up|3|||
124847463|NCT03042312|449065951|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
124847464|NCT03042312|449065952|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
124847465|NCT03042312|449065951|FG000|Overall Study|Withdrawal by Subject|4|||
124847466|NCT03042312|449065952|FG001|Overall Study|Withdrawal by Subject|5|||
124847467|NCT02383758|449065953|FG000|Overall Study|Withdrawal by Subject|0|||
124847468|NCT02383758|449065954|FG001|Overall Study|Withdrawal by Subject|2|||
124847469|NCT00646958|449065959|FG000|Overall Study|Lack of Efficacy|1|||
124847470|NCT00646958|449065960|FG001|Overall Study|Lack of Efficacy|0|||
124847471|NCT00646958|449065961|FG002|Overall Study|Lack of Efficacy|0|||
124847472|NCT00646958|449065959|FG000|Overall Study|Adverse Event|4|||
124847473|NCT00646958|449065960|FG001|Overall Study|Adverse Event|0|||
124847474|NCT00646958|449065961|FG002|Overall Study|Adverse Event|0|||
124847475|NCT00646958|449065959|FG000|Overall Study|Lost to Follow-up|1|||
124847476|NCT00646958|449065960|FG001|Overall Study|Lost to Follow-up|5|||
124847477|NCT00646958|449065961|FG002|Overall Study|Lost to Follow-up|7|||
124847478|NCT00646958|449065959|FG000|Overall Study|Protocol Violation|1|||
124847479|NCT00646958|449065960|FG001|Overall Study|Protocol Violation|1|||
124847480|NCT00646958|449065961|FG002|Overall Study|Protocol Violation|0|||
124847481|NCT00646958|449065959|FG000|Overall Study|Abnormal screening lab tests|1|||
124847482|NCT00646958|449065960|FG001|Overall Study|Abnormal screening lab tests|1|||
124847483|NCT00646958|449065961|FG002|Overall Study|Abnormal screening lab tests|0|||
124847484|NCT00646958|449065959|FG000|Overall Study|Withdrawal by Subject|1|||
124847485|NCT00646958|449065960|FG001|Overall Study|Withdrawal by Subject|2|||
124847486|NCT00646958|449065961|FG002|Overall Study|Withdrawal by Subject|0|||
124847487|NCT00646958|449065959|FG000|Overall Study|Did not receive study drug|2|||
124847488|NCT00646958|449065960|FG001|Overall Study|Did not receive study drug|0|||
124847489|NCT00646958|449065961|FG002|Overall Study|Did not receive study drug|2|||
124847490|NCT03085927|449065963|FG000|Overall Study|Withdrawal by Subject|1|||
124847491|NCT03085927|449065964|FG001|Overall Study|Withdrawal by Subject|4|||
124847492|NCT03085927|449065963|FG000|Overall Study|Lost to Follow-up|3|||
124847493|NCT03085927|449065964|FG001|Overall Study|Lost to Follow-up|1|||
124847494|NCT03085927|449065963|FG000|Overall Study|Death|1|||
124847495|NCT03085927|449065964|FG001|Overall Study|Death|0|||
124847496|NCT03085927|449065963|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
124847497|NCT03085927|449065964|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
124847498|NCT03085927|449065963|FG000|Overall Study|Dyad Became Ineligible|0|||
124847499|NCT03085927|449065964|FG001|Overall Study|Dyad Became Ineligible|1|||
124847500|NCT02349711|449065965|FG000|Overall Study|Withdrawal by Subject|2|||
124847501|NCT02349711|449065966|FG001|Overall Study|Withdrawal by Subject|1|||
124847502|NCT02349711|449065965|FG000|Overall Study|Lost to Follow-up|1|||
124847503|NCT02349711|449065966|FG001|Overall Study|Lost to Follow-up|1|||
124847504|NCT00194012|449065967|FG000|Randomized Phase|Lack of Efficacy|8|||
124847505|NCT00194012|449065968|FG001|Randomized Phase|Lack of Efficacy|18|||
124847506|NCT00194012|449065967|FG000|Randomized Phase|Study nonadherence|2|||
124847507|NCT00194012|449065968|FG001|Randomized Phase|Study nonadherence|1|||
124847508|NCT00194012|449065967|FG000|Randomized Phase|Withdrawal by Subject|3|||
124847509|NCT00194012|449065968|FG001|Randomized Phase|Withdrawal by Subject|3|||
124847510|NCT00194012|449065967|FG000|Randomized Phase|Adverse Event|2|||
124847511|NCT00194012|449065968|FG001|Randomized Phase|Adverse Event|1|||
124847512|NCT00194012|449065967|FG000|Randomized Phase|Participant reported having a rash|1|||
124847513|NCT00194012|449065968|FG001|Randomized Phase|Participant reported having a rash|0|||
124847514|NCT00194012|449065967|FG000|Randomized Phase|Emesis and enuresis|0|||
124847515|NCT00194012|449065968|FG001|Randomized Phase|Emesis and enuresis|1|||
124847516|NCT00194012|449065967|FG000|Randomized Phase|Oral/nasal twitching|0|||
124847517|NCT00194012|449065968|FG001|Randomized Phase|Oral/nasal twitching|1|||
124847518|NCT00194012|449065967|FG000|Open Label Extension (OLE)|Weight Gain|1|||
124847519|NCT00194012|449065968|FG001|Open Label Extension (OLE)|Weight Gain|0|||
124847520|NCT00194012|449065967|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
124847521|NCT00194012|449065968|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
124847522|NCT00194012|449065967|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
124847523|NCT00194012|449065968|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
124847524|NCT00194012|449065967|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
124847525|NCT00194012|449065968|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
124847526|NCT02200042|449065974|FG000|Overall Study|Withdrawal by Subject|0|||
124847527|NCT02200042|449065975|FG001|Overall Study|Withdrawal by Subject|1|||
124847528|NCT02097134|449065976|FG000|Overall Study|Physician Decision|4|||
124847529|NCT02097134|449065976|FG000|Overall Study|Non-Protocol Therapy|1|||
124847530|NCT02097134|449065976|FG000|Overall Study|Progressive Disease|3|||
124847531|NCT02097134|449065976|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
124847532|NCT02939404|449065981|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
124847533|NCT02939404|449065982|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
124847534|NCT02939404|449065981|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
124847535|NCT02939404|449065982|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
124847536|NCT02047110|449065986|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
124847537|NCT02047110|449065987|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
124847538|NCT02047110|449065988|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
124847539|NCT02047110|449065989|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
124847540|NCT02047110|449065986|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
124847541|NCT02047110|449065987|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
124847542|NCT02047110|449065988|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
124847543|NCT02047110|449065989|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
124847544|NCT02047110|449065986|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
124847545|NCT02047110|449065987|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
124847546|NCT02047110|449065988|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
124847547|NCT02047110|449065989|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
124847548|NCT02047110|449065986|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
124847549|NCT02047110|449065987|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
124847550|NCT02047110|449065988|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
124847551|NCT02047110|449065989|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
124847552|NCT02047110|449065986|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
124847553|NCT02047110|449065987|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
124847554|NCT02047110|449065988|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
124847555|NCT02047110|449065989|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
124847556|NCT02047110|449065986|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
124847557|NCT02047110|449065987|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
124847558|NCT02047110|449065988|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
124847559|NCT02047110|449065989|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
124847560|NCT02047110|449065986|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
124847561|NCT02047110|449065987|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
124847562|NCT02047110|449065988|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
124847563|NCT02047110|449065989|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
124847564|NCT02047110|449065986|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
124847565|NCT02047110|449065987|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
124847566|NCT02047110|449065988|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
124847567|NCT02047110|449065989|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
124847568|NCT02047110|449065986|FG000|Escape Treatment Period|Adverse Event|1|||
124847569|NCT02047110|449065987|FG001|Escape Treatment Period|Adverse Event|2|||
124847570|NCT02047110|449065988|FG002|Escape Treatment Period|Adverse Event|2|||
124847571|NCT02047110|449065989|FG003|Escape Treatment Period|Adverse Event|0|||
124847572|NCT02047110|449065986|FG000|Escape Treatment Period|Other than specified|1|||
124847573|NCT02047110|449065987|FG001|Escape Treatment Period|Other than specified|2|||
124847574|NCT02047110|449065988|FG002|Escape Treatment Period|Other than specified|0|||
124847575|NCT02047110|449065989|FG003|Escape Treatment Period|Other than specified|1|||
124847576|NCT02047110|449065986|FG000|OLE Treatment Period|Other than specified|0|||
124847577|NCT02047110|449065987|FG001|OLE Treatment Period|Other than specified|0|||
124847578|NCT02047110|449065988|FG002|OLE Treatment Period|Other than specified|1|||
124847579|NCT02047110|449065989|FG003|OLE Treatment Period|Other than specified|0|||
124847580|NCT02247349|449065990|FG000|Overall Study|Disease Progression|7|||
124847581|NCT02247349|449065991|FG001|Overall Study|Disease Progression|4|||
124847582|NCT02247349|449065992|FG002|Overall Study|Disease Progression|26|||
124847583|NCT02247349|449065993|FG003|Overall Study|Disease Progression|31|||
124847584|NCT02247349|449065994|FG004|Overall Study|Disease Progression|16|||
124847585|NCT02247349|449065995|FG005|Overall Study|Disease Progression|6|||
124847586|NCT02247349|449065990|FG000|Overall Study|Study drug toxicity|0|||
124847587|NCT02247349|449065991|FG001|Overall Study|Study drug toxicity|1|||
124847588|NCT02247349|449065992|FG002|Overall Study|Study drug toxicity|1|||
124847589|NCT02247349|449065993|FG003|Overall Study|Study drug toxicity|1|||
124847590|NCT02247349|449065994|FG004|Overall Study|Study drug toxicity|2|||
124847591|NCT02247349|449065995|FG005|Overall Study|Study drug toxicity|2|||
124847592|NCT02247349|449065990|FG000|Overall Study|Death|0|||
124847593|NCT02247349|449065991|FG001|Overall Study|Death|0|||
124847594|NCT02247349|449065992|FG002|Overall Study|Death|0|||
124847595|NCT02247349|449065993|FG003|Overall Study|Death|1|||
124847596|NCT02247349|449065994|FG004|Overall Study|Death|0|||
124847597|NCT02247349|449065995|FG005|Overall Study|Death|0|||
124847598|NCT02247349|449065990|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
124847599|NCT02247349|449065991|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
124847600|NCT02247349|449065992|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
124847601|NCT02247349|449065993|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
124847602|NCT02247349|449065994|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
124847603|NCT02247349|449065995|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
124847604|NCT02247349|449065990|FG000|Overall Study|Participant request to discontinue study treatment|0|||
124847605|NCT02247349|449065991|FG001|Overall Study|Participant request to discontinue study treatment|0|||
124847606|NCT02247349|449065992|FG002|Overall Study|Participant request to discontinue study treatment|1|||
124847607|NCT02247349|449065993|FG003|Overall Study|Participant request to discontinue study treatment|2|||
124847608|NCT02247349|449065994|FG004|Overall Study|Participant request to discontinue study treatment|1|||
124847609|NCT02247349|449065995|FG005|Overall Study|Participant request to discontinue study treatment|0|||
124847610|NCT02247349|449065990|FG000|Overall Study|Withdrawal by Subject|0|||
124847611|NCT02247349|449065991|FG001|Overall Study|Withdrawal by Subject|1|||
124847612|NCT02247349|449065992|FG002|Overall Study|Withdrawal by Subject|0|||
124847613|NCT02247349|449065993|FG003|Overall Study|Withdrawal by Subject|0|||
124847614|NCT02247349|449065994|FG004|Overall Study|Withdrawal by Subject|0|||
124847615|NCT02247349|449065995|FG005|Overall Study|Withdrawal by Subject|0|||
124847616|NCT02247349|449065990|FG000|Overall Study|Administrative reason by sponsor|0|||
124847617|NCT02247349|449065991|FG001|Overall Study|Administrative reason by sponsor|0|||
124847618|NCT02247349|449065992|FG002|Overall Study|Administrative reason by sponsor|0|||
124847619|NCT02247349|449065993|FG003|Overall Study|Administrative reason by sponsor|0|||
124847620|NCT02247349|449065994|FG004|Overall Study|Administrative reason by sponsor|1|||
124847621|NCT02247349|449065995|FG005|Overall Study|Administrative reason by sponsor|0|||
124847622|NCT02247349|449065990|FG000|Overall Study|Other reasons|0|||
124847623|NCT02247349|449065991|FG001|Overall Study|Other reasons|0|||
124847624|NCT02247349|449065992|FG002|Overall Study|Other reasons|1|||
124847625|NCT02247349|449065993|FG003|Overall Study|Other reasons|0|||
124847626|NCT02247349|449065994|FG004|Overall Study|Other reasons|0|||
124847627|NCT02247349|449065995|FG005|Overall Study|Other reasons|0|||
124847628|NCT01959581|449066000|FG000|Overall Study|Lost to Follow-up|5|||
124847629|NCT03773757|449066003|FG000|Overall Study|Withdrawal by Subject|2|||
124847630|NCT03773757|449066004|FG001|Overall Study|Withdrawal by Subject|4|||
124847631|NCT01109316|449066005|FG000|Study Period 1|Adverse Event|0|||
124847632|NCT01109316|449066006|FG001|Study Period 1|Adverse Event|0|||
124847633|NCT01109316|449066007|FG002|Study Period 1|Adverse Event|1|||
124847634|NCT01109316|449066008|FG003|Study Period 1|Adverse Event|0|||
124847635|NCT01109316|449066009|FG004|Study Period 1|Adverse Event|0|||
124847636|NCT01109316|449066010|FG005|Study Period 1|Adverse Event|0|||
124847637|NCT01109316|449066005|FG000|Study Period 1|Lost to Follow-up|0|||
124847638|NCT01109316|449066006|FG001|Study Period 1|Lost to Follow-up|0|||
124847639|NCT01109316|449066007|FG002|Study Period 1|Lost to Follow-up|1|||
124847640|NCT01109316|449066008|FG003|Study Period 1|Lost to Follow-up|1|||
124847641|NCT01109316|449066009|FG004|Study Period 1|Lost to Follow-up|0|||
124847642|NCT01109316|449066010|FG005|Study Period 1|Lost to Follow-up|0|||
124847643|NCT01109316|449066005|FG000|Study Period 1|Withdrawal by Subject|0|||
124847644|NCT01109316|449066006|FG001|Study Period 1|Withdrawal by Subject|0|||
124847645|NCT01109316|449066007|FG002|Study Period 1|Withdrawal by Subject|1|||
124847646|NCT01109316|449066008|FG003|Study Period 1|Withdrawal by Subject|0|||
124847647|NCT01109316|449066009|FG004|Study Period 1|Withdrawal by Subject|2|||
124847648|NCT01109316|449066010|FG005|Study Period 1|Withdrawal by Subject|0|||
124847649|NCT01109316|449066005|FG000|Study Period 1|Sponsor Decision|0|||
124847650|NCT01109316|449066006|FG001|Study Period 1|Sponsor Decision|0|||
124847651|NCT01109316|449066007|FG002|Study Period 1|Sponsor Decision|0|||
124847652|NCT01109316|449066008|FG003|Study Period 1|Sponsor Decision|0|||
124847653|NCT01109316|449066009|FG004|Study Period 1|Sponsor Decision|0|||
124847654|NCT01109316|449066010|FG005|Study Period 1|Sponsor Decision|2|||
124847655|NCT01109316|449066005|FG000|Study Period 2|Entry Criteria Not Met|0|||
124847656|NCT01109316|449066006|FG001|Study Period 2|Entry Criteria Not Met|1|||
124847657|NCT01109316|449066007|FG002|Study Period 2|Entry Criteria Not Met|0|||
124847658|NCT01109316|449066008|FG003|Study Period 2|Entry Criteria Not Met|0|||
124847659|NCT01109316|449066009|FG004|Study Period 2|Entry Criteria Not Met|0|||
124847660|NCT01109316|449066010|FG005|Study Period 2|Entry Criteria Not Met|0|||
124847661|NCT01109316|449066005|FG000|Study Period 2|Physician Decision|0|||
124847662|NCT01109316|449066006|FG001|Study Period 2|Physician Decision|0|||
124847663|NCT01109316|449066007|FG002|Study Period 2|Physician Decision|0|||
124847664|NCT01109316|449066008|FG003|Study Period 2|Physician Decision|1|||
124847665|NCT01109316|449066009|FG004|Study Period 2|Physician Decision|0|||
124847666|NCT01109316|449066010|FG005|Study Period 2|Physician Decision|0|||
124847667|NCT01109316|449066005|FG000|Study Period 2|Protocol Violation|1|||
124847668|NCT01109316|449066006|FG001|Study Period 2|Protocol Violation|0|||
124847669|NCT01109316|449066007|FG002|Study Period 2|Protocol Violation|0|||
124847670|NCT01109316|449066008|FG003|Study Period 2|Protocol Violation|0|||
124847671|NCT01109316|449066009|FG004|Study Period 2|Protocol Violation|0|||
124847672|NCT01109316|449066010|FG005|Study Period 2|Protocol Violation|0|||
124847673|NCT01109316|449066005|FG000|Study Period 2|Withdrawal by Subject|0|||
124847674|NCT01109316|449066006|FG001|Study Period 2|Withdrawal by Subject|0|||
124847675|NCT01109316|449066007|FG002|Study Period 2|Withdrawal by Subject|1|||
124847676|NCT01109316|449066008|FG003|Study Period 2|Withdrawal by Subject|0|||
124847677|NCT01109316|449066009|FG004|Study Period 2|Withdrawal by Subject|0|||
124847678|NCT01109316|449066010|FG005|Study Period 2|Withdrawal by Subject|1|||
124847679|NCT01109316|449066005|FG000|Study Period 3|Lost to Follow-up|0|||
124847680|NCT01109316|449066006|FG001|Study Period 3|Lost to Follow-up|0|||
124847681|NCT01109316|449066007|FG002|Study Period 3|Lost to Follow-up|0|||
124847682|NCT01109316|449066008|FG003|Study Period 3|Lost to Follow-up|0|||
124847683|NCT01109316|449066009|FG004|Study Period 3|Lost to Follow-up|1|||
124847684|NCT01109316|449066010|FG005|Study Period 3|Lost to Follow-up|0|||
124847685|NCT01109316|449066005|FG000|Study Period 3|Withdrawal by Subject|1|||
124847686|NCT01109316|449066006|FG001|Study Period 3|Withdrawal by Subject|0|||
124847687|NCT01109316|449066007|FG002|Study Period 3|Withdrawal by Subject|0|||
124847688|NCT01109316|449066008|FG003|Study Period 3|Withdrawal by Subject|0|||
124847689|NCT01109316|449066009|FG004|Study Period 3|Withdrawal by Subject|1|||
124847690|NCT01109316|449066010|FG005|Study Period 3|Withdrawal by Subject|0|||
124847691|NCT01302392|449066013|FG000|Overall Study|Lost to Follow-up|1|||
124847692|NCT01302392|449066014|FG001|Overall Study|Lost to Follow-up|0|||
124847693|NCT01302392|449066013|FG000|Overall Study|Withdrawal by Subject|6|||
124847694|NCT01302392|449066014|FG001|Overall Study|Withdrawal by Subject|1|||
124847695|NCT00670228|449066015|FG000|Overall Study|Adverse Event|1|||
124847696|NCT00670228|449066016|FG001|Overall Study|Adverse Event|0|||
124847697|NCT00670228|449066015|FG000|Overall Study|Death or MACE|0|||
124847698|NCT00670228|449066016|FG001|Overall Study|Death or MACE|1|||
124847699|NCT00670228|449066015|FG000|Overall Study|Not treated|2|||
124847700|NCT00670228|449066016|FG001|Overall Study|Not treated|2|||
124847701|NCT00670228|449066015|FG000|Overall Study|Not meeting the selection criteria|2|||
124847702|NCT00670228|449066016|FG001|Overall Study|Not meeting the selection criteria|0|||
124847703|NCT03049813|449066023|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
124847704|NCT03049813|449066024|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
124847705|NCT03049813|449066025|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
124847706|NCT03049813|449066026|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
124847707|NCT03049813|449066023|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
124847708|NCT03049813|449066024|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
124847709|NCT03049813|449066025|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
124847710|NCT03049813|449066026|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
124847711|NCT03049813|449066023|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
124847712|NCT03049813|449066024|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
124847713|NCT03049813|449066025|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
124847714|NCT03049813|449066026|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
124847715|NCT03049813|449066023|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
124847716|NCT03049813|449066024|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
124847717|NCT03049813|449066025|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
124847718|NCT03049813|449066026|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
124847719|NCT00550836|449066027|FG000|Overall Study|Withdrawal by Subject|3|||
124847720|NCT00550836|449066028|FG001|Overall Study|Withdrawal by Subject|9|||
124847721|NCT00179413|449066029|FG000|Overall Study|Adverse Event|38|||
124847722|NCT00179413|449066030|FG001|Overall Study|Adverse Event|20|||
124847723|NCT00179413|449066029|FG000|Overall Study|Withdrawal by Subject|87|||
124847724|NCT00179413|449066030|FG001|Overall Study|Withdrawal by Subject|95|||
124847725|NCT01696032|449066036|FG000|Overall Study|Withdrawal by Subject|0|||
124847726|NCT01696032|449066037|FG001|Overall Study|Withdrawal by Subject|0|||
124847727|NCT01696032|449066038|FG002|Overall Study|Withdrawal by Subject|1|||
124847728|NCT01696032|449066039|FG003|Overall Study|Withdrawal by Subject|2|||
124847729|NCT01696032|449066036|FG000|Overall Study|Death|14|||
124847730|NCT01696032|449066037|FG001|Overall Study|Death|4|||
124847731|NCT01696032|449066038|FG002|Overall Study|Death|43|||
124847732|NCT01696032|449066039|FG003|Overall Study|Death|18|||
124847733|NCT01696032|449066036|FG000|Overall Study|Lost to Follow-up|0|||
124847734|NCT01696032|449066037|FG001|Overall Study|Lost to Follow-up|1|||
124847735|NCT01696032|449066038|FG002|Overall Study|Lost to Follow-up|0|||
124847736|NCT01696032|449066039|FG003|Overall Study|Lost to Follow-up|0|||
124847737|NCT01696032|449066036|FG000|Overall Study|Database lock|0|||
124847738|NCT01696032|449066037|FG001|Overall Study|Database lock|1|||
124847739|NCT01696032|449066038|FG002|Overall Study|Database lock|7|||
124847740|NCT01696032|449066039|FG003|Overall Study|Database lock|2|||
124847741|NCT01192152|449066042|FG000|Period 1|left prematurely (while on treatment B)|0|||
124847742|NCT01192152|449066043|FG001|Period 1|left prematurely (while on treatment B)|1|||
124847743|NCT01192152|449066042|FG000|Period 3|family emergency|1|||
124847744|NCT01192152|449066043|FG001|Period 3|family emergency|0|||
124847745|NCT05013905|449066044|FG000|Overall Study|Adverse Event|1|||
124847746|NCT05013905|449066044|FG000|Overall Study|Lack of Efficacy|1|||
124847747|NCT04666259|449066046|FG000|Treatment Phase|Physician Decision|9|||
124847748|NCT04666259|449066047|FG001|Treatment Phase|Physician Decision|3|||
124847749|NCT04666259|449066048|FG002|Treatment Phase|Physician Decision|3|||
124847750|NCT04666259|449066046|FG000|Treatment Phase|Adverse Event|3|||
124847751|NCT04666259|449066047|FG001|Treatment Phase|Adverse Event|1|||
124847752|NCT04666259|449066048|FG002|Treatment Phase|Adverse Event|0|||
124847753|NCT04666259|449066046|FG000|Treatment Phase|Subject decision|1|||
124847754|NCT04666259|449066047|FG001|Treatment Phase|Subject decision|2|||
124847755|NCT04666259|449066048|FG002|Treatment Phase|Subject decision|0|||
124847756|NCT04666259|449066046|FG000|Treatment Phase|Progressive disease|0|||
124847757|NCT04666259|449066047|FG001|Treatment Phase|Progressive disease|1|||
124847758|NCT04666259|449066048|FG002|Treatment Phase|Progressive disease|0|||
124847759|NCT04666259|449066046|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
124847760|NCT04666259|449066047|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
124847761|NCT04666259|449066048|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
124847762|NCT04666259|449066046|FG000|Safety Follow-up Phase|Physician Decision|2|||
124847763|NCT04666259|449066047|FG001|Safety Follow-up Phase|Physician Decision|0|||
124847764|NCT04666259|449066048|FG002|Safety Follow-up Phase|Physician Decision|0|||
124847765|NCT04666259|449066046|FG000|Safety Follow-up Phase|Subject decision|1|||
124847766|NCT04666259|449066047|FG001|Safety Follow-up Phase|Subject decision|0|||
124847767|NCT04666259|449066048|FG002|Safety Follow-up Phase|Subject decision|0|||
124847768|NCT04666259|449066046|FG000|Safety Follow-up Phase|Death|0|||
124847769|NCT04666259|449066047|FG001|Safety Follow-up Phase|Death|1|||
124847770|NCT04666259|449066048|FG002|Safety Follow-up Phase|Death|0|||
124847771|NCT00854581|449066049|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
124847772|NCT00854581|449066049|FG000|Induction (Up to Day 21)|Death|1|||
124847773|NCT00854581|449066049|FG000|Induction (Up to Day 21)|Physician Decision|1|||
124847774|NCT00854581|449066049|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
124847775|NCT00378703|449066052|FG000|Overall Study|Disease progression|59|||
124847776|NCT00378703|449066053|FG001|Overall Study|Disease progression|43|||
124847777|NCT00378703|449066054|FG002|Overall Study|Disease progression|48|||
124847778|NCT00378703|449066055|FG003|Overall Study|Disease progression|49|||
124847779|NCT00378703|449066052|FG000|Overall Study|Adverse Event|11|||
124847780|NCT00378703|449066053|FG001|Overall Study|Adverse Event|17|||
124847781|NCT00378703|449066054|FG002|Overall Study|Adverse Event|20|||
124847782|NCT00378703|449066055|FG003|Overall Study|Adverse Event|18|||
124847783|NCT00378703|449066052|FG000|Overall Study|Death|2|||
124847784|NCT00378703|449066053|FG001|Overall Study|Death|2|||
124847785|NCT00378703|449066054|FG002|Overall Study|Death|4|||
124847786|NCT00378703|449066055|FG003|Overall Study|Death|3|||
124847787|NCT00378703|449066052|FG000|Overall Study|Withdrawal by Subject|4|||
124847788|NCT00378703|449066053|FG001|Overall Study|Withdrawal by Subject|8|||
124847789|NCT00378703|449066054|FG002|Overall Study|Withdrawal by Subject|5|||
124847790|NCT00378703|449066055|FG003|Overall Study|Withdrawal by Subject|7|||
124847791|NCT00378703|449066052|FG000|Overall Study|Physician Decision|1|||
124847792|NCT00378703|449066053|FG001|Overall Study|Physician Decision|4|||
124847793|NCT00378703|449066054|FG002|Overall Study|Physician Decision|1|||
124847794|NCT00378703|449066055|FG003|Overall Study|Physician Decision|0|||
124847795|NCT00378703|449066052|FG000|Overall Study|Alternative therapy|4|||
124847796|NCT00378703|449066053|FG001|Overall Study|Alternative therapy|2|||
124847797|NCT00378703|449066054|FG002|Overall Study|Alternative therapy|0|||
124847798|NCT00378703|449066055|FG003|Overall Study|Alternative therapy|0|||
124847799|NCT00378703|449066052|FG000|Overall Study|Other complicated disease|0|||
124847800|NCT00378703|449066053|FG001|Overall Study|Other complicated disease|2|||
124847801|NCT00378703|449066054|FG002|Overall Study|Other complicated disease|2|||
124847802|NCT00378703|449066055|FG003|Overall Study|Other complicated disease|0|||
124847803|NCT00378703|449066052|FG000|Overall Study|Symptomatic deterioration|0|||
124847804|NCT00378703|449066053|FG001|Overall Study|Symptomatic deterioration|1|||
124847805|NCT00378703|449066054|FG002|Overall Study|Symptomatic deterioration|0|||
124847806|NCT00378703|449066055|FG003|Overall Study|Symptomatic deterioration|2|||
124847807|NCT00378703|449066052|FG000|Overall Study|Surgery|1|||
124847808|NCT00378703|449066053|FG001|Overall Study|Surgery|0|||
124847809|NCT00378703|449066054|FG002|Overall Study|Surgery|0|||
124847810|NCT00378703|449066055|FG003|Overall Study|Surgery|1|||
124847811|NCT00378703|449066052|FG000|Overall Study|Joint decision of physician and patient|1|||
124847812|NCT00378703|449066053|FG001|Overall Study|Joint decision of physician and patient|0|||
124847813|NCT00378703|449066054|FG002|Overall Study|Joint decision of physician and patient|0|||
124847814|NCT00378703|449066055|FG003|Overall Study|Joint decision of physician and patient|0|||
124847815|NCT00378703|449066052|FG000|Overall Study|Adverse events and progressive disease|0|||
124847816|NCT00378703|449066053|FG001|Overall Study|Adverse events and progressive disease|0|||
124847817|NCT00378703|449066054|FG002|Overall Study|Adverse events and progressive disease|0|||
124847818|NCT00378703|449066055|FG003|Overall Study|Adverse events and progressive disease|1|||
124847819|NCT00378703|449066052|FG000|Overall Study|Relocation|0|||
124847820|NCT00378703|449066053|FG001|Overall Study|Relocation|0|||
124847821|NCT00378703|449066054|FG002|Overall Study|Relocation|1|||
124847822|NCT00378703|449066055|FG003|Overall Study|Relocation|0|||
124847823|NCT00378703|449066052|FG000|Overall Study|Ineligible|4|||
124847824|NCT00378703|449066053|FG001|Overall Study|Ineligible|7|||
124847825|NCT00378703|449066054|FG002|Overall Study|Ineligible|7|||
124847826|NCT00378703|449066055|FG003|Overall Study|Ineligible|7|||
124847827|NCT00378703|449066052|FG000|Overall Study|Never started treatment|1|||
124847828|NCT00378703|449066053|FG001|Overall Study|Never started treatment|4|||
124847829|NCT00378703|449066054|FG002|Overall Study|Never started treatment|0|||
124847830|NCT00378703|449066055|FG003|Overall Study|Never started treatment|0|||
124847831|NCT00378703|449066052|FG000|Overall Study|Other|1|||
124847832|NCT00378703|449066053|FG001|Overall Study|Other|1|||
124847833|NCT00378703|449066054|FG002|Overall Study|Other|2|||
124847834|NCT00378703|449066055|FG003|Overall Study|Other|3|||
124847835|NCT02705820|449066056|FG000|Overall Study|Death|2|||
124847836|NCT02705820|449066056|FG000|Overall Study|Disease Progression|34|||
124847837|NCT02705820|449066056|FG000|Overall Study|Clinical Deterioration|3|||
124847838|NCT05402995|449066057|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
124847839|NCT05402995|449066058|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
124847840|NCT05402995|449066059|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
124847841|NCT05402995|449066060|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
124847842|NCT01009099|449066061|FG000|Overall Study|Lost to Follow-up|1|||
124847843|NCT01009099|449066062|FG001|Overall Study|Lost to Follow-up|0|||
124847844|NCT01009099|449066061|FG000|Overall Study|Physician Decision|3|||
124847845|NCT01009099|449066062|FG001|Overall Study|Physician Decision|2|||
124847846|NCT01009099|449066061|FG000|Overall Study|Withdrawal by Subject|1|||
124847847|NCT01009099|449066062|FG001|Overall Study|Withdrawal by Subject|1|||
124847848|NCT01009099|449066061|FG000|Overall Study|Death|0|||
124847849|NCT01009099|449066062|FG001|Overall Study|Death|1|||
124847850|NCT02702401|449066063|FG000|Overall Study|Death|242|||
124847851|NCT02702401|449066064|FG001|Overall Study|Death|125|||
124847852|NCT02702401|449066063|FG000|Overall Study|Withdrawal by Subject|15|||
124847853|NCT02702401|449066064|FG001|Overall Study|Withdrawal by Subject|5|||
124847854|NCT02702401|449066063|FG000|Overall Study|Sponsor Decision|19|||
124847855|NCT02702401|449066064|FG001|Overall Study|Sponsor Decision|3|||
124847856|NCT02702401|449066063|FG000|Overall Study|Physician Decision|1|||
124847857|NCT02702401|449066064|FG001|Overall Study|Physician Decision|2|||
124847858|NCT02702401|449066063|FG000|Overall Study|Lost to Follow-up|1|||
124847859|NCT02702401|449066064|FG001|Overall Study|Lost to Follow-up|0|||
124847860|NCT04292730|449066074|FG000|Overall Study|Lost to Follow-up|8|||
124847861|NCT04292730|449066075|FG001|Overall Study|Lost to Follow-up|12|||
124847862|NCT04292730|449066076|FG002|Overall Study|Lost to Follow-up|12|||
124847863|NCT04292730|449066077|FG003|Overall Study|Lost to Follow-up|48|||
124847864|NCT04292730|449066074|FG000|Overall Study|Death|2|||
124847865|NCT04292730|449066075|FG001|Overall Study|Death|2|||
124847866|NCT04292730|449066076|FG002|Overall Study|Death|4|||
124847867|NCT04292730|449066077|FG003|Overall Study|Death|12|||
124847868|NCT04292730|449066074|FG000|Overall Study|Withdrew Consent|2|||
124847869|NCT04292730|449066075|FG001|Overall Study|Withdrew Consent|2|||
124847870|NCT04292730|449066076|FG002|Overall Study|Withdrew Consent|5|||
124847871|NCT04292730|449066077|FG003|Overall Study|Withdrew Consent|6|||
124847872|NCT04292730|449066074|FG000|Overall Study|Non-Compliance with Study Drug|0|||
124847873|NCT04292730|449066075|FG001|Overall Study|Non-Compliance with Study Drug|1|||
124847874|NCT04292730|449066076|FG002|Overall Study|Non-Compliance with Study Drug|0|||
124847875|NCT04292730|449066077|FG003|Overall Study|Non-Compliance with Study Drug|0|||
124847876|NCT04292730|449066074|FG000|Overall Study|Protocol Violation|0|||
124847877|NCT04292730|449066075|FG001|Overall Study|Protocol Violation|0|||
124847878|NCT04292730|449066076|FG002|Overall Study|Protocol Violation|1|||
124847879|NCT04292730|449066077|FG003|Overall Study|Protocol Violation|0|||
124847880|NCT04292730|449066074|FG000|Overall Study|Randomized but not Treated|8|||
124847881|NCT04292730|449066075|FG001|Overall Study|Randomized but not Treated|4|||
124847882|NCT04292730|449066076|FG002|Overall Study|Randomized but not Treated|0|||
124847883|NCT04292730|449066077|FG003|Overall Study|Randomized but not Treated|14|||
124847884|NCT01527292|449066079|FG000|Overall Study|Physician Decision|0|||
124847885|NCT01527292|449066080|FG001|Overall Study|Physician Decision|3|||
124847886|NCT01482767|449066081|FG000|Overall Study|Death|1|||
124847887|NCT01482767|449066082|FG001|Overall Study|Death|1|||
124847888|NCT01482767|449066081|FG000|Overall Study|Withdrawal by Subject|7|||
124847889|NCT01482767|449066082|FG001|Overall Study|Withdrawal by Subject|5|||
124847890|NCT01482767|449066081|FG000|Overall Study|Lost to Follow-up|12|||
124847891|NCT01482767|449066082|FG001|Overall Study|Lost to Follow-up|6|||
124847892|NCT01482767|449066081|FG000|Overall Study|Adverse Event|0|||
124847893|NCT01482767|449066082|FG001|Overall Study|Adverse Event|3|||
124847894|NCT01482767|449066081|FG000|Overall Study|Site closure|22|||
124847895|NCT01482767|449066082|FG001|Overall Study|Site closure|14|||
124847896|NCT01482767|449066081|FG000|Overall Study|Non-adherence to study requirements|4|||
124847897|NCT01482767|449066082|FG001|Overall Study|Non-adherence to study requirements|7|||
124847898|NCT01482767|449066081|FG000|Overall Study|Alternate HCV treatment|7|||
124847899|NCT01482767|449066082|FG001|Overall Study|Alternate HCV treatment|8|||
124847900|NCT01482767|449066081|FG000|Overall Study|Ineligible|0|||
124847901|NCT01482767|449066082|FG001|Overall Study|Ineligible|5|||
124847902|NCT01482767|449066081|FG000|Overall Study|Nurse error|1|||
124847903|NCT01482767|449066082|FG001|Overall Study|Nurse error|0|||
124847904|NCT01856543|449066083|FG000|Overall Study|Treatment discontinued|6|||
124847905|NCT01856543|449066084|FG001|Overall Study|Treatment discontinued|3|||
124847906|NCT01856543|449066083|FG000|Overall Study|Withdrawn before start|7|||
124847907|NCT01856543|449066084|FG001|Overall Study|Withdrawn before start|3|||
124847908|NCT01541930|449066087|FG000|Overall Study|Withdrawal by Subject|1|||
124847909|NCT02501096|449066088|FG000|Overall Study|Lost to Follow-up|0|||
124847910|NCT02501096|449066089|FG001|Overall Study|Lost to Follow-up|0|||
124847911|NCT02501096|449066090|FG002|Overall Study|Lost to Follow-up|0|||
124847912|NCT02501096|449066091|FG003|Overall Study|Lost to Follow-up|0|||
124847913|NCT02501096|449066092|FG004|Overall Study|Lost to Follow-up|1|||
124847914|NCT02501096|449066093|FG005|Overall Study|Lost to Follow-up|1|||
124847915|NCT02501096|449066094|FG006|Overall Study|Lost to Follow-up|3|||
124847916|NCT02501096|449066095|FG007|Overall Study|Lost to Follow-up|0|||
124847917|NCT02501096|449066096|FG008|Overall Study|Lost to Follow-up|0|||
124847918|NCT02501096|449066088|FG000|Overall Study|Withdrawal by Subject|1|||
124847919|NCT02501096|449066089|FG001|Overall Study|Withdrawal by Subject|0|||
124847920|NCT02501096|449066090|FG002|Overall Study|Withdrawal by Subject|7|||
124847921|NCT02501096|449066091|FG003|Overall Study|Withdrawal by Subject|13|||
124847922|NCT02501096|449066092|FG004|Overall Study|Withdrawal by Subject|2|||
124847923|NCT02501096|449066093|FG005|Overall Study|Withdrawal by Subject|2|||
124847924|NCT02501096|449066094|FG006|Overall Study|Withdrawal by Subject|2|||
124847925|NCT02501096|449066095|FG007|Overall Study|Withdrawal by Subject|3|||
124847926|NCT02501096|449066096|FG008|Overall Study|Withdrawal by Subject|0|||
124847927|NCT02501096|449066088|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
124847928|NCT02501096|449066089|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
124847929|NCT02501096|449066090|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
124847930|NCT02501096|449066091|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
124847931|NCT02501096|449066092|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
124847932|NCT02501096|449066093|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
124847933|NCT02501096|449066094|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
124847934|NCT02501096|449066095|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
124847935|NCT02501096|449066096|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
124847936|NCT02501096|449066088|FG000|Overall Study|Death|1|||
124847937|NCT02501096|449066089|FG001|Overall Study|Death|1|||
124847938|NCT02501096|449066090|FG002|Overall Study|Death|88|||
124847939|NCT02501096|449066091|FG003|Overall Study|Death|74|||
124847940|NCT02501096|449066092|FG004|Overall Study|Death|15|||
124847941|NCT02501096|449066093|FG005|Overall Study|Death|16|||
124847942|NCT02501096|449066094|FG006|Overall Study|Death|15|||
124847943|NCT02501096|449066095|FG007|Overall Study|Death|16|||
124847944|NCT02501096|449066096|FG008|Overall Study|Death|1|||
124847945|NCT04187196|449066097|FG000|Overall Study|Screen Failure|2|||
124847946|NCT04187196|449066098|FG001|Overall Study|Screen Failure|0|||
124847947|NCT03139916|449066101|FG000|Overall Study|Withdrawal by Subject|2|||
124847948|NCT03139916|449066101|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
124847949|NCT01957475|449066102|FG000|Test Period 1|Withdrawal by Subject|1|||
124847950|NCT01957475|449066103|FG001|Test Period 1|Withdrawal by Subject|0|||
124847951|NCT01957475|449066102|FG000|Test Period 1|Other|1|||
124847952|NCT01957475|449066103|FG001|Test Period 1|Other|0|||
124847953|NCT01957475|449066102|FG000|Test Period 1|Lack of Efficacy|0|||
124847954|NCT01957475|449066103|FG001|Test Period 1|Lack of Efficacy|1|||
124847955|NCT01957475|449066102|FG000|Test Period 2|Adverse Event|1|||
124847956|NCT01957475|449066103|FG001|Test Period 2|Adverse Event|0|||
124847957|NCT04587193|449066104|FG000|Overall Study|Screen failure after consent|3|||
124847958|NCT04587193|449066105|FG001|Overall Study|Screen failure after consent|0|||
124847959|NCT04587193|449066104|FG000|Overall Study|Device broke during study|3|||
124847960|NCT04587193|449066105|FG001|Overall Study|Device broke during study|2|||
124847961|NCT01552772|449066106|FG000|Overall Study|Lost to Follow-up|2|||
124847962|NCT01552772|449066106|FG000|Overall Study|Adverse Event|1|||
124847963|NCT01552772|449066106|FG000|Overall Study|Protocol Deviation|1|||
124847964|NCT02920983|449066107|FG000|Dispense 1|Unacceptable Lens Fit|0|||
124847965|NCT02920983|449066108|FG001|Dispense 1|Unacceptable Lens Fit|0|||
124847966|NCT02920983|449066109|FG002|Dispense 1|Unacceptable Lens Fit|0|||
124847967|NCT02920983|449066110|FG003|Dispense 1|Unacceptable Lens Fit|0|||
124847968|NCT02920983|449066111|FG004|Dispense 1|Unacceptable Lens Fit|1|||
124847969|NCT02920983|449066112|FG005|Dispense 1|Unacceptable Lens Fit|0|||
124847970|NCT02920983|449066107|FG000|Dispense 2|Unscceptable lens fit|1|||
124847971|NCT02920983|449066108|FG001|Dispense 2|Unscceptable lens fit|0|||
124847972|NCT02920983|449066109|FG002|Dispense 2|Unscceptable lens fit|0|||
124847973|NCT02920983|449066110|FG003|Dispense 2|Unscceptable lens fit|0|||
124847974|NCT02920983|449066111|FG004|Dispense 2|Unscceptable lens fit|1|||
124847975|NCT02920983|449066112|FG005|Dispense 2|Unscceptable lens fit|0|||
124847976|NCT02920983|449066107|FG000|Dispense 3|Unacceptable Lens Fit|1|||
124847977|NCT02920983|449066108|FG001|Dispense 3|Unacceptable Lens Fit|1|||
124847978|NCT02920983|449066109|FG002|Dispense 3|Unacceptable Lens Fit|0|||
124847979|NCT02920983|449066110|FG003|Dispense 3|Unacceptable Lens Fit|0|||
124847980|NCT02920983|449066111|FG004|Dispense 3|Unacceptable Lens Fit|1|||
124847981|NCT02920983|449066112|FG005|Dispense 3|Unacceptable Lens Fit|0|||
124847982|NCT02553421|449066117|FG000|Overall Study|Lost to Follow-up|21|||
124847983|NCT02553421|449066118|FG001|Overall Study|Lost to Follow-up|1|||
124847984|NCT02553421|449066117|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
124847985|NCT02553421|449066118|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
124847986|NCT02553421|449066117|FG000|Overall Study|Improper Device Placement|3|||
124847987|NCT02553421|449066118|FG001|Overall Study|Improper Device Placement|0|||
124847988|NCT02453594|449067221|FG000|Overall Study|Protocol Violation|0|||
124847989|NCT02453594|449067222|FG001|Overall Study|Protocol Violation|0|||
124847990|NCT02453594|449067223|FG002|Overall Study|Protocol Violation|1|||
124847991|NCT02453594|449067221|FG000|Overall Study|Cohort Was Closed|17|||
124847992|NCT02453594|449067222|FG001|Overall Study|Cohort Was Closed|21|||
124847993|NCT02453594|449067223|FG002|Overall Study|Cohort Was Closed|14|||
124847994|NCT02453594|449067221|FG000|Overall Study|Death|20|||
124847995|NCT02453594|449067222|FG001|Overall Study|Death|24|||
124847996|NCT02453594|449067223|FG002|Overall Study|Death|16|||
124847997|NCT02453594|449067221|FG000|Overall Study|Lost to Follow-up|6|||
124847998|NCT02453594|449067222|FG001|Overall Study|Lost to Follow-up|14|||
124847999|NCT02453594|449067223|FG002|Overall Study|Lost to Follow-up|2|||
124848000|NCT02453594|449067221|FG000|Overall Study|Physician Decision|2|||
124848001|NCT02453594|449067222|FG001|Overall Study|Physician Decision|4|||
124848002|NCT02453594|449067223|FG002|Overall Study|Physician Decision|0|||
124848003|NCT02453594|449067221|FG000|Overall Study|Site Terminated by Sponsor|1|||
124848004|NCT02453594|449067222|FG001|Overall Study|Site Terminated by Sponsor|0|||
124848005|NCT02453594|449067223|FG002|Overall Study|Site Terminated by Sponsor|1|||
124848006|NCT02453594|449067221|FG000|Overall Study|Transitioned to Extension Study|16|||
124848007|NCT02453594|449067222|FG001|Overall Study|Transitioned to Extension Study|9|||
124848008|NCT02453594|449067223|FG002|Overall Study|Transitioned to Extension Study|16|||
124848009|NCT02453594|449067221|FG000|Overall Study|Withdrawal by Subject|7|||
124848010|NCT02453594|449067222|FG001|Overall Study|Withdrawal by Subject|9|||
124848011|NCT02453594|449067223|FG002|Overall Study|Withdrawal by Subject|11|||
124848012|NCT04101526|449067227|FG000|Overall Study|Did not complete all sleep diary entries|0|||
124848013|NCT04101526|449067228|FG001|Overall Study|Did not complete all sleep diary entries|1|||
124848014|NCT02932891|449067229|FG000|Overall Study|Lost to Follow-up|2|||
124848015|NCT02932891|449067229|FG000|Overall Study|HPA Suppress|2|||
124848016|NCT02652624|449067230|FG000|Randomized Phase|Pregnancy|3|||
124848017|NCT02652624|449067231|FG001|Randomized Phase|Pregnancy|1|||
124848018|NCT02652624|449067230|FG000|Randomized Phase|Investigator's Discretion|0|||
124848019|NCT02652624|449067231|FG001|Randomized Phase|Investigator's Discretion|2|||
124848020|NCT02652624|449067230|FG000|Randomized Phase|Death|0|||
124848021|NCT02652624|449067231|FG001|Randomized Phase|Death|1|||
124848022|NCT02652624|449067230|FG000|Randomized Phase|Lost to Follow-up|0|||
124848023|NCT02652624|449067231|FG001|Randomized Phase|Lost to Follow-up|1|||
124848024|NCT02652624|449067230|FG000|Extension Phase|Lost to Follow-up|3|||
124848025|NCT02652624|449067231|FG001|Extension Phase|Lost to Follow-up|1|||
124848026|NCT02652624|449067230|FG000|Extension Phase|Pregnancy|1|||
124848027|NCT02652624|449067231|FG001|Extension Phase|Pregnancy|1|||
124848028|NCT02652624|449067230|FG000|Extension Phase|Adverse Event|0|||
124848029|NCT02652624|449067231|FG001|Extension Phase|Adverse Event|1|||
124848030|NCT02652624|449067230|FG000|Extension Phase|Withdrew Consent|0|||
124848031|NCT02652624|449067231|FG001|Extension Phase|Withdrew Consent|1|||
124848032|NCT01023659|449067232|FG000|Overall Study|Lost to Follow-up|73|||
124848033|NCT01023659|449067233|FG001|Overall Study|Lost to Follow-up|228|||
124848034|NCT01023659|449067234|FG002|Overall Study|Lost to Follow-up|99|||
124848035|NCT00501540|449067237|FG000|Overall Study|Death|5|||
124848036|NCT01797536|449067238|FG000|Overall Study|Adverse Event|0|||
124848037|NCT01797536|449067239|FG001|Overall Study|Adverse Event|1|||
124848038|NCT01797536|449067240|FG002|Overall Study|Adverse Event|0|||
124848039|NCT01797536|449067241|FG003|Overall Study|Adverse Event|0|||
124848040|NCT00098839|449067242|FG000|Overall Study|Adverse Event|5|||
124848041|NCT00098839|449067243|FG001|Overall Study|Adverse Event|2|||
124848042|NCT00098839|449067242|FG000|Overall Study|Death|1|||
124848043|NCT00098839|449067243|FG001|Overall Study|Death|2|||
124848044|NCT00098839|449067242|FG000|Overall Study|Physician Decision|4|||
124848045|NCT00098839|449067243|FG001|Overall Study|Physician Decision|14|||
124848046|NCT00098839|449067242|FG000|Overall Study|Withdrawal by Subject|1|||
124848047|NCT00098839|449067243|FG001|Overall Study|Withdrawal by Subject|0|||
124848048|NCT00098839|449067242|FG000|Overall Study|Refusal of further protocol therapy|3|||
124848049|NCT00098839|449067243|FG001|Overall Study|Refusal of further protocol therapy|1|||
124848050|NCT00098839|449067242|FG000|Overall Study|Relapse|6|||
124848051|NCT00098839|449067243|FG001|Overall Study|Relapse|3|||
124848052|NCT00098839|449067242|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
124848053|NCT00098839|449067243|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
124848054|NCT00098839|449067242|FG000|Overall Study|Ineligible|2|||
124848055|NCT00098839|449067243|FG001|Overall Study|Ineligible|0|||
124848056|NCT03228680|449067246|FG000|Overall Study|Adverse Event|13|||
124848057|NCT03228680|449067247|FG001|Overall Study|Adverse Event|18|||
124848058|NCT03228680|449067246|FG000|Overall Study|Randomization failure|0|||
124848059|NCT03228680|449067247|FG001|Overall Study|Randomization failure|1|||
124848060|NCT03228680|449067246|FG000|Overall Study|Withdrawal by Subject|1|||
124848061|NCT03228680|449067247|FG001|Overall Study|Withdrawal by Subject|0|||
124848062|NCT03228680|449067246|FG000|Overall Study|Other|9|||
124848063|NCT03228680|449067247|FG001|Overall Study|Other|16|||
124848064|NCT02167035|449067255|FG000|Overall Study|Adverse Event|2|||
124848065|NCT02167035|449067256|FG001|Overall Study|Adverse Event|2|||
124848066|NCT02167035|449067255|FG000|Overall Study|Lost to Follow-up|3|||
124848067|NCT02167035|449067256|FG001|Overall Study|Lost to Follow-up|3|||
124848068|NCT02167035|449067255|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
124848069|NCT02167035|449067256|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
124848070|NCT02148003|449067257|FG000|Overall Study|Failed inclusion criteria|1|||
124848071|NCT02148003|449067258|FG001|Overall Study|Failed inclusion criteria|0|||
124848072|NCT02148003|449067257|FG000|Overall Study|Met exclusion criteria|0|||
124848073|NCT02148003|449067258|FG001|Overall Study|Met exclusion criteria|1|||
124848074|NCT02148003|449067257|FG000|Overall Study|Withdrawal by Subject|0|||
124848075|NCT02148003|449067258|FG001|Overall Study|Withdrawal by Subject|1|||
124848076|NCT02489981|449067259|FG000|Overall Study|Adverse Event|21|||
124848077|NCT02489981|449067259|FG000|Overall Study|Insufficient effectiveness|16|||
124848078|NCT02489981|449067259|FG000|Overall Study|Improved|31|||
124848079|NCT02489981|449067259|FG000|Overall Study|Lost to Follow-up|31|||
124848080|NCT02489981|449067259|FG000|Overall Study|Other than listed|28|||
124848081|NCT03852316|449067264|FG000|Overall Study|Protocol Violation|1|||
124848082|NCT03852316|449067264|FG000|Overall Study|Withdrawal by Subject|2|||
124848083|NCT03852316|449067264|FG000|Overall Study|Enrolled but Device not Utilized|1|||
124848084|NCT03592641|449067265|FG000|Overall Study|Withdrawal by Subject|1|||
124848085|NCT00436280|449067266|FG000|Period 1: Induction|Adverse Event|8|||
124848086|NCT00436280|449067266|FG000|Period 1: Induction|Progressive Disease|12|||
124848087|NCT00436280|449067266|FG000|Period 1: Induction|Stable Disease|6|||
124848088|NCT00436280|449067266|FG000|Period 1: Induction|Withdrawal by Subject|1|||
124848089|NCT00436280|449067266|FG000|Period 1: Induction|Death|1|||
124848090|NCT00436280|449067266|FG000|Period 2: Consolidation|Adverse Event|1|||
124848091|NCT00436280|449067266|FG000|Period 2: Consolidation|Progressive Disease|10|||
124848092|NCT00436280|449067266|FG000|Period 2: Consolidation|Stable Disease|1|||
124848093|NCT00436280|449067266|FG000|Period 2: Consolidation|Physician Decision|2|||
124848094|NCT00436280|449067266|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
124848095|NCT00436280|449067266|FG000|Period 2: Consolidation|Death|1|||
124848096|NCT00436280|449067266|FG000|Period 3: Maintenance|Adverse Event|6|||
124848097|NCT00436280|449067266|FG000|Period 3: Maintenance|Progressive Disease|12|||
124848098|NCT01049919|449067269|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
124848099|NCT01049919|449067270|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
124848100|NCT01049919|449067269|FG000|Overall Study|Withdrawal by Subject|5|||
124848101|NCT01049919|449067270|FG001|Overall Study|Withdrawal by Subject|0|||
124848102|NCT01049919|449067269|FG000|Overall Study|Lost to Follow-up|6|||
124848103|NCT01049919|449067270|FG001|Overall Study|Lost to Follow-up|1|||
124848104|NCT01049919|449067269|FG000|Overall Study|Physician Decision|2|||
124848105|NCT01049919|449067270|FG001|Overall Study|Physician Decision|0|||
124848106|NCT01049919|449067269|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
124848107|NCT01049919|449067270|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
124848108|NCT01049919|449067269|FG000|Overall Study|Early study termination by sponsor.|2|||
124848109|NCT01049919|449067270|FG001|Overall Study|Early study termination by sponsor.|0|||
124848110|NCT01532687|449067276|FG000|Overall Study|Death|2|||
124848111|NCT01532687|449067277|FG001|Overall Study|Death|0|||
124848112|NCT01532687|449067276|FG000|Overall Study|Adverse Event|6|||
124848113|NCT01532687|449067277|FG001|Overall Study|Adverse Event|1|||
124848114|NCT01532687|449067276|FG000|Overall Study|Withdrawal by Subject|1|||
124848115|NCT01532687|449067277|FG001|Overall Study|Withdrawal by Subject|0|||
124848116|NCT01532687|449067276|FG000|Overall Study|Physician Decision|2|||
124848117|NCT01532687|449067277|FG001|Overall Study|Physician Decision|1|||
124848118|NCT01532687|449067276|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
124848119|NCT01532687|449067277|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
124848120|NCT03160703|449067278|FG000|Overall Study|Withdrawal by Subject|0|||
124848121|NCT03160703|449067279|FG001|Overall Study|Withdrawal by Subject|0|||
124848122|NCT03160703|449067280|FG002|Overall Study|Withdrawal by Subject|0|||
124848123|NCT03160703|449067281|FG003|Overall Study|Withdrawal by Subject|1|||
124848124|NCT02984995|449067282|FG000|Overall Study|Required stem cell transplant|13|||
124848125|NCT02984995|449067283|FG001|Overall Study|Required stem cell transplant|2|||
124848126|NCT02984995|449067282|FG000|Overall Study|Progressive disease|11|||
124848127|NCT02984995|449067283|FG001|Overall Study|Progressive disease|1|||
124848128|NCT02984995|449067282|FG000|Overall Study|Adverse Event|1|||
124848129|NCT02984995|449067283|FG001|Overall Study|Adverse Event|0|||
124848130|NCT00047463|449067284|FG000|Overall Study|Withdrawal by Subject|0|||
124848131|NCT00047463|449067285|FG001|Overall Study|Withdrawal by Subject|3|||
124848132|NCT01401530|449067287|FG000|Overall Study|Disease Progression|1|||
124848133|NCT01401530|449067288|FG001|Overall Study|Disease Progression|2|||
124848134|NCT01401530|449067289|FG002|Overall Study|Disease Progression|1|||
124848135|NCT01401530|449067287|FG000|Overall Study|Adverse Event|1|||
124848136|NCT01401530|449067288|FG001|Overall Study|Adverse Event|1|||
124848137|NCT01401530|449067289|FG002|Overall Study|Adverse Event|1|||
124848138|NCT01401530|449067287|FG000|Overall Study|Participant Choice|1|||
124848139|NCT01401530|449067288|FG001|Overall Study|Participant Choice|2|||
124848140|NCT01401530|449067289|FG002|Overall Study|Participant Choice|1|||
124848141|NCT01401530|449067287|FG000|Overall Study|Physician Decision|0|||
124848142|NCT01401530|449067288|FG001|Overall Study|Physician Decision|1|||
124848143|NCT01401530|449067289|FG002|Overall Study|Physician Decision|0|||
124848144|NCT02104557|449067290|FG000|Overall Study|Adverse Event|24|||
124848145|NCT02104557|449067290|FG000|Overall Study|Lost to Follow-up|34|||
124848146|NCT02104557|449067290|FG000|Overall Study|Violated the usage and dosage|14|||
124848147|NCT02104557|449067290|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
124848148|NCT02104557|449067290|FG000|Overall Study|Administered Sayana prior to the contract|1|||
124848149|NCT02104557|449067290|FG000|Overall Study|Other|17|||
124848150|NCT02104557|449067290|FG000|Overall Study|Change to other contraception methods|5|||
124848151|NCT02104557|449067290|FG000|Overall Study|Discontinuation due to no pain|1|||
124848152|NCT02104557|449067290|FG000|Overall Study|Withdrawal consent|2|||
124848153|NCT02104557|449067290|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
124848154|NCT02104557|449067290|FG000|Overall Study|Discontinuation of contraception|9|||
124848155|NCT01448850|449067292|FG000|Overall Study|Death|3|||
124848156|NCT01448850|449067293|FG001|Overall Study|Death|6|||
124848157|NCT01448850|449067292|FG000|Overall Study|Withdrawal by Subject|13|||
124848158|NCT01448850|449067293|FG001|Overall Study|Withdrawal by Subject|21|||
124848159|NCT01448850|449067292|FG000|Overall Study|Lost to Follow-up|3|||
124848160|NCT01448850|449067293|FG001|Overall Study|Lost to Follow-up|1|||
124848161|NCT01448850|449067292|FG000|Overall Study|Other|15|||
124848162|NCT01448850|449067293|FG001|Overall Study|Other|12|||
124848163|NCT00280566|449067297|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
124848164|NCT00280566|449067298|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
124848165|NCT00280566|449067299|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
124848166|NCT00280566|449067297|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
124848167|NCT00280566|449067298|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
124848168|NCT00280566|449067299|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
124848169|NCT00280566|449067297|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
124848170|NCT00280566|449067298|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
124848171|NCT00280566|449067299|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
124848172|NCT00280566|449067297|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
124848173|NCT00280566|449067298|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
124848174|NCT00280566|449067299|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
124848175|NCT00280566|449067297|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
124848176|NCT00280566|449067298|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
124848177|NCT00280566|449067299|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
124848178|NCT00280566|449067297|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
124848179|NCT00280566|449067298|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
124848180|NCT00280566|449067299|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
124848181|NCT00280566|449067297|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
124848182|NCT00280566|449067298|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
124848183|NCT00280566|449067299|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
124848184|NCT00280566|449067297|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
124848185|NCT00280566|449067298|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
124848186|NCT00280566|449067299|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
124848187|NCT00280566|449067297|FG000|Period 2 Double Blind|Adverse Event|0|||
124848188|NCT00280566|449067298|FG001|Period 2 Double Blind|Adverse Event|11|||
124848189|NCT00280566|449067299|FG002|Period 2 Double Blind|Adverse Event|15|||
124848190|NCT00280566|449067297|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
124848191|NCT00280566|449067298|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
124848192|NCT00280566|449067299|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
124848193|NCT00280566|449067297|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
124848194|NCT00280566|449067298|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
124848195|NCT00280566|449067299|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
124848196|NCT00280566|449067297|FG000|Period 2 Double Blind|miscellaneous|0|||
124848197|NCT00280566|449067298|FG001|Period 2 Double Blind|miscellaneous|10|||
124848198|NCT00280566|449067299|FG002|Period 2 Double Blind|miscellaneous|5|||
124848199|NCT04542070|449067301|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
124848200|NCT04542070|449067302|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
124848201|NCT04542070|449067303|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
124848202|NCT04542070|449067304|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
124848203|NCT04542070|449067301|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
124848204|NCT04542070|449067302|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
124848205|NCT04542070|449067303|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
124848206|NCT04542070|449067304|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
124848207|NCT04542070|449067301|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
124848208|NCT04542070|449067302|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
124848209|NCT04542070|449067303|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
124848210|NCT04542070|449067304|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
124848211|NCT04542070|449067301|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
124848212|NCT04542070|449067302|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
124848213|NCT04542070|449067303|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
124848214|NCT04542070|449067304|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
124848215|NCT04542070|449067301|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
124848216|NCT04542070|449067302|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
124848217|NCT04542070|449067303|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
124848218|NCT04542070|449067304|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
124848219|NCT04542070|449067301|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
124848220|NCT04542070|449067302|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
124848221|NCT04542070|449067303|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
124848222|NCT04542070|449067304|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
124848223|NCT04542070|449067301|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
124848224|NCT04542070|449067302|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
124848225|NCT04542070|449067303|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
124848226|NCT04542070|449067304|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
124848227|NCT04542070|449067301|FG000|Maintenance + Extension Period|Adverse Event|10|||
124848228|NCT04542070|449067302|FG001|Maintenance + Extension Period|Adverse Event|2|||
124848229|NCT04542070|449067303|FG002|Maintenance + Extension Period|Adverse Event|0|||
124848230|NCT04542070|449067304|FG003|Maintenance + Extension Period|Adverse Event|0|||
124848231|NCT04542070|449067301|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
124848232|NCT04542070|449067302|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
124848233|NCT04542070|449067303|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
124848234|NCT04542070|449067304|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
124848235|NCT04542070|449067301|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
124848236|NCT04542070|449067302|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
124848237|NCT04542070|449067303|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
124848238|NCT04542070|449067304|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
124848239|NCT04542070|449067301|FG000|Maintenance + Extension Period|Physician Decision|1|||
124848240|NCT04542070|449067302|FG001|Maintenance + Extension Period|Physician Decision|1|||
124848241|NCT04542070|449067303|FG002|Maintenance + Extension Period|Physician Decision|0|||
124848242|NCT04542070|449067304|FG003|Maintenance + Extension Period|Physician Decision|0|||
124848243|NCT04542070|449067301|FG000|Maintenance + Extension Period|Protocol Violation|2|||
124848244|NCT04542070|449067302|FG001|Maintenance + Extension Period|Protocol Violation|5|||
124848245|NCT04542070|449067303|FG002|Maintenance + Extension Period|Protocol Violation|0|||
124848246|NCT04542070|449067304|FG003|Maintenance + Extension Period|Protocol Violation|0|||
124848247|NCT04542070|449067301|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
124848248|NCT04542070|449067302|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
124848249|NCT04542070|449067303|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
124848250|NCT04542070|449067304|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
124848251|NCT04542070|449067301|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
124848252|NCT04542070|449067302|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
124848253|NCT04542070|449067303|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
124848254|NCT04542070|449067304|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
124848255|NCT04542070|449067301|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
124848256|NCT04542070|449067302|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
124848257|NCT04542070|449067303|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
124848258|NCT04542070|449067304|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
124848259|NCT04542070|449067301|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
124848260|NCT04542070|449067302|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
124848261|NCT04542070|449067303|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
124848262|NCT04542070|449067304|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
124848263|NCT04542070|449067301|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
124848264|NCT04542070|449067302|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
124848265|NCT04542070|449067303|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
124848266|NCT04542070|449067304|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
124848267|NCT04542070|449067301|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
124848268|NCT04542070|449067302|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
124848269|NCT04542070|449067303|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
124848270|NCT04542070|449067304|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
124848271|NCT04542070|449067301|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
124848272|NCT04542070|449067302|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
124848273|NCT04542070|449067303|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
124848274|NCT04542070|449067304|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
124848275|NCT02188485|449067306|FG000|Overall Study|Withdrawal by Subject|2|||
124848276|NCT02188485|449067307|FG001|Overall Study|Withdrawal by Subject|1|||
124848277|NCT02188485|449067306|FG000|Overall Study|PI withdrew, lack of capacity|0|||
124848278|NCT02188485|449067307|FG001|Overall Study|PI withdrew, lack of capacity|2|||
124848279|NCT02457325|449067311|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
124848280|NCT02457325|449067312|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
124848281|NCT00773097|449067318|FG000|Overall Study|Withdrawal by Subject|1|||
124848282|NCT00773097|449067318|FG000|Overall Study|Physician Decision|6|||
124848283|NCT02707640|449067319|FG000|Overall Study|Adverse Event|4|||
124848284|NCT02707640|449067320|FG001|Overall Study|Adverse Event|2|||
124848285|NCT02707640|449067319|FG000|Overall Study|Death|1|||
124848286|NCT02707640|449067320|FG001|Overall Study|Death|2|||
124848287|NCT02707640|449067319|FG000|Overall Study|Physician Decision|2|||
124848288|NCT02707640|449067320|FG001|Overall Study|Physician Decision|0|||
124848289|NCT02707640|449067319|FG000|Overall Study|Withdrawal by Subject|0|||
124848290|NCT02707640|449067320|FG001|Overall Study|Withdrawal by Subject|1|||
124848291|NCT02707640|449067319|FG000|Overall Study|Participant's Personal Decision|1|||
124848292|NCT02707640|449067320|FG001|Overall Study|Participant's Personal Decision|2|||
124848293|NCT02707640|449067319|FG000|Overall Study|Sponsor Discretion|1|||
124848294|NCT02707640|449067320|FG001|Overall Study|Sponsor Discretion|0|||
124848295|NCT02517905|449067321|FG000|Overall Study|Lost to Follow-up|4|||
124848296|NCT02517905|449067322|FG001|Overall Study|Lost to Follow-up|0|||
124848297|NCT02517905|449067321|FG000|Overall Study|Withdrawal by Subject|4|||
124848298|NCT02517905|449067322|FG001|Overall Study|Withdrawal by Subject|0|||
124848299|NCT02517905|449067321|FG000|Overall Study|Screen failure|2|||
124848300|NCT02517905|449067322|FG001|Overall Study|Screen failure|2|||
124848301|NCT02742103|449068734|FG000|Overall Study|Protocol Violation|1|||
124848302|NCT02742103|449068735|FG001|Overall Study|Protocol Violation|0|||
124848303|NCT02742103|449068734|FG000|Overall Study|Death|2|||
124848304|NCT02742103|449068735|FG001|Overall Study|Death|2|||
124848305|NCT02742103|449068734|FG000|Overall Study|Adverse Event|1|||
124848306|NCT02742103|449068735|FG001|Overall Study|Adverse Event|0|||
124848307|NCT02742103|449068734|FG000|Overall Study|Moved to another town|0|||
124848308|NCT02742103|449068735|FG001|Overall Study|Moved to another town|1|||
124848309|NCT02742103|449068734|FG000|Overall Study|Withdrawal by Subject|5|||
124848310|NCT02742103|449068735|FG001|Overall Study|Withdrawal by Subject|2|||
124848311|NCT00600821|449068736|FG000|Overall Study|Death|45|||
124848312|NCT00600821|449068737|FG001|Overall Study|Death|46|||
124848313|NCT00600821|449068736|FG000|Overall Study|Lost to Follow-up|2|||
124848314|NCT00600821|449068737|FG001|Overall Study|Lost to Follow-up|2|||
124848315|NCT00600821|449068736|FG000|Overall Study|Withdrawal by Subject|1|||
124848316|NCT00600821|449068737|FG001|Overall Study|Withdrawal by Subject|1|||
124848317|NCT00600821|449068736|FG000|Overall Study|Terminated by sponsor|8|||
124848318|NCT00600821|449068737|FG001|Overall Study|Terminated by sponsor|6|||
124848319|NCT00600821|449068736|FG000|Overall Study|Objective progression or relapse|0|||
124848320|NCT00600821|449068737|FG001|Overall Study|Objective progression or relapse|1|||
124848321|NCT00600821|449068736|FG000|Overall Study|Randomized but not treated|0|||
124848322|NCT00600821|449068737|FG001|Overall Study|Randomized but not treated|1|||
124848323|NCT00600821|449068736|FG000|Overall Study|Other|2|||
124848324|NCT00600821|449068737|FG001|Overall Study|Other|3|||
124848325|NCT00659646|449068743|FG000|Overall Study|Protocol Violation|12|||
124848326|NCT00659646|449068744|FG001|Overall Study|Protocol Violation|8|||
124848327|NCT00659646|449068743|FG000|Overall Study|Adverse Event|1|||
124848328|NCT00659646|449068744|FG001|Overall Study|Adverse Event|0|||
124848329|NCT00659646|449068743|FG000|Overall Study|Lost to Follow-up|1|||
124848330|NCT00659646|449068744|FG001|Overall Study|Lost to Follow-up|0|||
124848331|NCT00659646|449068743|FG000|Overall Study|protocol noncompliance after randomized|1|||
124848332|NCT00659646|449068744|FG001|Overall Study|protocol noncompliance after randomized|0|||
124848333|NCT00023673|449068745|FG000|Overall Study|Ineligible / no protocol treatment|0|||
124848334|NCT00023673|449068746|FG001|Overall Study|Ineligible / no protocol treatment|0|||
124848335|NCT00023673|449068747|FG002|Overall Study|Ineligible / no protocol treatment|0|||
124848336|NCT00023673|449068748|FG003|Overall Study|Ineligible / no protocol treatment|1|||
124848337|NCT00023673|449068745|FG000|Overall Study|Patient withdrew consent|0|||
124848338|NCT00023673|449068746|FG001|Overall Study|Patient withdrew consent|0|||
124848339|NCT00023673|449068747|FG002|Overall Study|Patient withdrew consent|0|||
124848340|NCT00023673|449068748|FG003|Overall Study|Patient withdrew consent|1|||
124848341|NCT00424372|449068758|FG000|Overall Study|Death|1|||
124848342|NCT00424372|449068758|FG000|Overall Study|Adverse Event|18|||
124848343|NCT00424372|449068758|FG000|Overall Study|Lack of Efficacy|6|||
124848344|NCT00424372|449068758|FG000|Overall Study|Withdrawal by Subject|4|||
124848345|NCT00424372|449068758|FG000|Overall Study|Protocol Violation|1|||
124848346|NCT00424372|449068758|FG000|Overall Study|Health deterioration|1|||
124848347|NCT04622254|449068759|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
124848348|NCT04622254|449068760|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
124848349|NCT04622254|449068761|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
124848350|NCT04622254|449068762|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
124848351|NCT04622254|449068763|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
124848352|NCT04622254|449068764|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
124848353|NCT04622254|449068759|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
124848354|NCT04622254|449068760|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
124848355|NCT04622254|449068761|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
124848356|NCT04622254|449068762|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
124848357|NCT04622254|449068763|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
124848358|NCT04622254|449068764|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
124848359|NCT04622254|449068759|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
124848360|NCT04622254|449068760|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
124848361|NCT04622254|449068761|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
124848362|NCT04622254|449068762|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
124848363|NCT04622254|449068763|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
124848364|NCT04622254|449068764|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
124848365|NCT04622254|449068759|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
124848366|NCT04622254|449068760|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
124848367|NCT04622254|449068761|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
124848368|NCT04622254|449068762|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
124848369|NCT04622254|449068763|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
124848370|NCT04622254|449068764|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
124848371|NCT04622254|449068759|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
124848372|NCT04622254|449068760|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
124848373|NCT04622254|449068761|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
124848374|NCT04622254|449068762|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
124848375|NCT04622254|449068763|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
124848376|NCT04622254|449068764|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
124848377|NCT04622254|449068759|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
124848378|NCT04622254|449068760|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
124848379|NCT04622254|449068761|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
124848380|NCT04622254|449068762|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
124848381|NCT04622254|449068763|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
124848382|NCT04622254|449068764|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
124848383|NCT04622254|449068759|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
124848384|NCT04622254|449068760|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
124848385|NCT04622254|449068761|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
124848386|NCT04622254|449068762|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
124848387|NCT04622254|449068763|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
124848388|NCT04622254|449068764|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
124848389|NCT04622254|449068759|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
124848390|NCT04622254|449068760|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
124848391|NCT04622254|449068761|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
124848392|NCT04622254|449068762|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
124848393|NCT04622254|449068763|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
124848394|NCT04622254|449068764|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
124848395|NCT04622254|449068759|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
124848396|NCT04622254|449068760|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
124848397|NCT04622254|449068761|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
124848398|NCT04622254|449068762|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
124848399|NCT04622254|449068763|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
124848400|NCT04622254|449068764|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
124848401|NCT04622254|449068759|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
124848402|NCT04622254|449068760|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
124848403|NCT04622254|449068761|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
124848404|NCT04622254|449068762|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
124848405|NCT04622254|449068763|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
124848406|NCT04622254|449068764|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
124848407|NCT04622254|449068759|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
124848408|NCT04622254|449068760|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
124848409|NCT04622254|449068761|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
124848410|NCT04622254|449068762|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
124848411|NCT04622254|449068763|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
124848412|NCT04622254|449068764|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
124848413|NCT00912405|449068765|FG000|Overall Study|Lost to Follow-up|5|||
124848414|NCT00796861|449068766|FG000|Overall Study|Withdrawal by Subject|2|||
124848415|NCT00796861|449068766|FG000|Overall Study|Death|2|||
124848416|NCT02370888|449068767|FG000|Overall Study|disease progression|2|||
124848417|NCT02370888|449068767|FG000|Overall Study|did not meet chimerism criteria|6|||
124848418|NCT02178475|449068768|FG000|Overall Study|Withdrawal by Subject|7|||
124848419|NCT02178475|449068768|FG000|Overall Study|Lost to Follow-up|10|||
124848420|NCT02178475|449068768|FG000|Overall Study|Death|13|||
124848421|NCT02178475|449068768|FG000|Overall Study|Protocol-specified Criteria|99|||
124848422|NCT01430585|449068769|FG000|Overall Study|Death|1|||
124848423|NCT01430585|449068769|FG000|Overall Study|Objective Progression or Relapse|3|||
124848424|NCT01430585|449068769|FG000|Overall Study|Study Terminated by Sponsor|3|||
124848425|NCT01430585|449068769|FG000|Overall Study|Other|7|||
124848426|NCT01412424|449068770|FG000|Core Treatment Period|Treatment Failure|24|||
124848427|NCT01412424|449068770|FG000|Core Treatment Period|Adverse Event|21|||
124848428|NCT01412424|449068770|FG000|Core Treatment Period|Patient Request|5|||
124848429|NCT01412424|449068770|FG000|Core Treatment Period|Lost to Follow-up|2|||
124848430|NCT01412424|449068770|FG000|Core Treatment Period|Sponsor Request|1|||
124848431|NCT01412424|449068770|FG000|Extension Treatment Period|Adverse Event|2|||
124848432|NCT01412424|449068770|FG000|Extension Treatment Period|Treatment Failure|2|||
124848433|NCT01412424|449068770|FG000|Extension Treatment Period|Patient Request|2|||
124848434|NCT04304001|449068773|FG000|Overall Study|Lost to Follow-up|13|||
124848435|NCT04304001|449068774|FG001|Overall Study|Lost to Follow-up|9|||
124848436|NCT02664038|449068780|FG000|13 Week|Lost to Follow-up|7|||
124848437|NCT02664038|449068781|FG001|13 Week|Lost to Follow-up|14|||
124848438|NCT02664038|449068780|FG000|13 Week|Withdrawal by Subject|1|||
124848439|NCT02664038|449068781|FG001|13 Week|Withdrawal by Subject|0|||
124848440|NCT02664038|449068780|FG000|26 Week|Lost to Follow-up|5|||
124848441|NCT02664038|449068781|FG001|26 Week|Lost to Follow-up|4|||
124848442|NCT02606136|449068786|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
124848443|NCT02606136|449068786|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
124848444|NCT02606136|449068786|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
124848445|NCT02606136|449068786|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
124848446|NCT03296696|449068787|FG000|Overall Study|Started Other Antitumor Therapy|1|||
124848447|NCT03296696|449068788|FG001|Overall Study|Started Other Antitumor Therapy|2|||
124848448|NCT03296696|449068789|FG002|Overall Study|Started Other Antitumor Therapy|1|||
124848449|NCT03296696|449068790|FG003|Overall Study|Started Other Antitumor Therapy|2|||
124848450|NCT03296696|449068791|FG004|Overall Study|Started Other Antitumor Therapy|1|||
124848451|NCT03296696|449068792|FG005|Overall Study|Started Other Antitumor Therapy|1|||
124848452|NCT03296696|449068793|FG006|Overall Study|Started Other Antitumor Therapy|2|||
124848453|NCT03296696|449068794|FG007|Overall Study|Started Other Antitumor Therapy|3|||
124848454|NCT03296696|449068795|FG008|Overall Study|Started Other Antitumor Therapy|1|||
124848455|NCT03296696|449068796|FG009|Overall Study|Started Other Antitumor Therapy|0|||
124848456|NCT03296696|449068787|FG000|Overall Study|Death|0|||
124848457|NCT03296696|449068788|FG001|Overall Study|Death|1|||
124848458|NCT03296696|449068789|FG002|Overall Study|Death|1|||
124848459|NCT03296696|449068790|FG003|Overall Study|Death|2|||
124848460|NCT03296696|449068791|FG004|Overall Study|Death|2|||
124848461|NCT03296696|449068792|FG005|Overall Study|Death|3|||
124848462|NCT03296696|449068793|FG006|Overall Study|Death|1|||
124848463|NCT03296696|449068794|FG007|Overall Study|Death|2|||
124848464|NCT03296696|449068795|FG008|Overall Study|Death|0|||
124848465|NCT03296696|449068796|FG009|Overall Study|Death|0|||
124848466|NCT03296696|449068787|FG000|Overall Study|Withdrawal by Subject|0|||
124848467|NCT03296696|449068788|FG001|Overall Study|Withdrawal by Subject|0|||
124848468|NCT03296696|449068789|FG002|Overall Study|Withdrawal by Subject|1|||
124848469|NCT03296696|449068790|FG003|Overall Study|Withdrawal by Subject|0|||
124848470|NCT03296696|449068791|FG004|Overall Study|Withdrawal by Subject|1|||
124848471|NCT03296696|449068792|FG005|Overall Study|Withdrawal by Subject|0|||
124848472|NCT03296696|449068793|FG006|Overall Study|Withdrawal by Subject|0|||
124848473|NCT03296696|449068794|FG007|Overall Study|Withdrawal by Subject|0|||
124848474|NCT03296696|449068795|FG008|Overall Study|Withdrawal by Subject|0|||
124848475|NCT03296696|449068796|FG009|Overall Study|Withdrawal by Subject|1|||
124848476|NCT04694131|449068800|FG000|Overall Study|Withdrawal by Subject|7|||
124848477|NCT04694131|449068800|FG000|Overall Study|Screen Failure|1|||
124848478|NCT04694131|449068800|FG000|Overall Study|High stimulation threshold|3|||
124848479|NCT04456699|449068801|FG000|Overall Study|Death|48|||
124848480|NCT04456699|449068802|FG001|Overall Study|Death|50|||
124848481|NCT04456699|449068803|FG002|Overall Study|Death|52|||
124848482|NCT04456699|449068801|FG000|Overall Study|Physician Decision|0|||
124848483|NCT04456699|449068802|FG001|Overall Study|Physician Decision|0|||
124848484|NCT04456699|449068803|FG002|Overall Study|Physician Decision|2|||
124848485|NCT04456699|449068801|FG000|Overall Study|Sponsor Decision|55|||
124848486|NCT04456699|449068802|FG001|Overall Study|Sponsor Decision|61|||
124848487|NCT04456699|449068803|FG002|Overall Study|Sponsor Decision|50|||
124848488|NCT04456699|449068801|FG000|Overall Study|Withdrawal by Subject|8|||
124848489|NCT04456699|449068802|FG001|Overall Study|Withdrawal by Subject|4|||
124848490|NCT04456699|449068803|FG002|Overall Study|Withdrawal by Subject|5|||
124848491|NCT04112810|449068804|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
124848492|NCT02357576|449068814|FG000|Treatment Period|Withdrawal by Subject|0|||
124848493|NCT02357576|449068815|FG001|Treatment Period|Withdrawal by Subject|1|||
124848494|NCT02357576|449068814|FG000|Treatment Period|Physician Decision|0|||
124848495|NCT02357576|449068815|FG001|Treatment Period|Physician Decision|1|||
124848496|NCT02357576|449068814|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
124848497|NCT02357576|449068815|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
124848498|NCT02357576|449068814|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
124848499|NCT02357576|449068815|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
124848500|NCT02357576|449068814|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
124848501|NCT02357576|449068815|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
124848502|NCT02357576|449068814|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
124848503|NCT02357576|449068815|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
124848504|NCT00699699|449068818|FG000|Overall Study|Adverse Event|36|||
124848505|NCT00699699|449068818|FG000|Overall Study|Individual different reasons|21|||
124848506|NCT01000051|449068821|FG000|Overall Study|Withdrawal by Subject|1|||
124848507|NCT01000051|449068822|FG001|Overall Study|Withdrawal by Subject|1|||
124848508|NCT01000051|449068821|FG000|Overall Study|Disease Progression|1|||
124848509|NCT01000051|449068822|FG001|Overall Study|Disease Progression|0|||
124848510|NCT01000051|449068821|FG000|Overall Study|Serious noncompliance|1|||
124848511|NCT01000051|449068822|FG001|Overall Study|Serious noncompliance|0|||
124848512|NCT00414050|449068823|FG000|Overall Study|Adverse Event|1|||
124848513|NCT00414050|449068824|FG001|Overall Study|Adverse Event|1|||
124848514|NCT00414050|449068825|FG002|Overall Study|Adverse Event|1|||
124848515|NCT00414050|449068826|FG003|Overall Study|Adverse Event|1|||
124848516|NCT00414050|449068823|FG000|Overall Study|Lost to Follow-up|2|||
124848517|NCT00414050|449068824|FG001|Overall Study|Lost to Follow-up|2|||
124848518|NCT00414050|449068825|FG002|Overall Study|Lost to Follow-up|1|||
124848519|NCT00414050|449068826|FG003|Overall Study|Lost to Follow-up|1|||
124848520|NCT00414050|449068823|FG000|Overall Study|Withdrawal by Subject|5|||
124848521|NCT00414050|449068824|FG001|Overall Study|Withdrawal by Subject|3|||
124848522|NCT00414050|449068825|FG002|Overall Study|Withdrawal by Subject|2|||
124848523|NCT00414050|449068826|FG003|Overall Study|Withdrawal by Subject|4|||
124848524|NCT00414050|449068823|FG000|Overall Study|Subject discontinued for other reason|1|||
124848525|NCT00414050|449068824|FG001|Overall Study|Subject discontinued for other reason|2|||
124848526|NCT00414050|449068825|FG002|Overall Study|Subject discontinued for other reason|2|||
124848527|NCT00414050|449068826|FG003|Overall Study|Subject discontinued for other reason|1|||
124848528|NCT00414050|449068823|FG000|Overall Study|Subject Moved|0|||
124848529|NCT00414050|449068824|FG001|Overall Study|Subject Moved|0|||
124848530|NCT00414050|449068825|FG002|Overall Study|Subject Moved|0|||
124848531|NCT00414050|449068826|FG003|Overall Study|Subject Moved|1|||
124848532|NCT03495908|449068827|FG000|Overall Study|Withdrawal by Subject|3|||
124848533|NCT03495908|449068828|FG001|Overall Study|Withdrawal by Subject|1|||
124848534|NCT03495908|449068827|FG000|Overall Study|Lost to Follow-up|1|||
124848535|NCT03495908|449068828|FG001|Overall Study|Lost to Follow-up|4|||
124848536|NCT03495908|449068827|FG000|Overall Study|Adverse Event|0|||
124848537|NCT03495908|449068828|FG001|Overall Study|Adverse Event|2|||
124848538|NCT03495908|449068827|FG000|Overall Study|Death|1|||
124848539|NCT03495908|449068828|FG001|Overall Study|Death|0|||
124848540|NCT03495908|449068827|FG000|Overall Study|Physician Decision|5|||
124848541|NCT03495908|449068828|FG001|Overall Study|Physician Decision|4|||
124848542|NCT03495908|449068827|FG000|Overall Study|No documented reason|0|||
124848543|NCT03495908|449068828|FG001|Overall Study|No documented reason|2|||
124848544|NCT01469065|449068840|FG000|Overall Study|Lack of Efficacy|0|||
124848545|NCT01469065|449068841|FG001|Overall Study|Lack of Efficacy|0|||
124848546|NCT01469065|449068842|FG002|Overall Study|Lack of Efficacy|0|||
124848547|NCT01469065|449068843|FG003|Overall Study|Lack of Efficacy|0|||
124848548|NCT01469065|449068844|FG004|Overall Study|Lack of Efficacy|1|||
124848549|NCT01469065|449068840|FG000|Overall Study|Other|0|||
124848550|NCT01469065|449068841|FG001|Overall Study|Other|1|||
124848551|NCT01469065|449068842|FG002|Overall Study|Other|0|||
124848552|NCT01469065|449068843|FG003|Overall Study|Other|0|||
124848553|NCT01469065|449068844|FG004|Overall Study|Other|0|||
124848554|NCT00578565|449068845|FG000|Overall Study|Adverse Event|3|||
124848555|NCT01752933|449068846|FG000|Treatment|Disease Progression|3|||
124848556|NCT01752933|449068847|FG001|Treatment|Disease Progression|29|||
124848557|NCT01752933|449068846|FG000|Treatment|Withdrawal by Subject|0|||
124848558|NCT01752933|449068847|FG001|Treatment|Withdrawal by Subject|5|||
124848559|NCT01752933|449068846|FG000|Treatment|Adverse Event|1|||
124848560|NCT01752933|449068847|FG001|Treatment|Adverse Event|4|||
124848561|NCT01752933|449068846|FG000|Treatment|Physician Decision|0|||
124848562|NCT01752933|449068847|FG001|Treatment|Physician Decision|3|||
124848563|NCT01752933|449068846|FG000|Treatment|Death|0|||
124848564|NCT01752933|449068847|FG001|Treatment|Death|2|||
124848565|NCT01752933|449068846|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
124848566|NCT01752933|449068847|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
124848567|NCT01752933|449068846|FG000|Treatment|Patient noncompliant|0|||
124848568|NCT01752933|449068847|FG001|Treatment|Patient noncompliant|1|||
124848569|NCT01752933|449068846|FG000|Treatment|Patient unable to travel to appointments|0|||
124848570|NCT01752933|449068847|FG001|Treatment|Patient unable to travel to appointments|1|||
124848571|NCT01752933|449068846|FG000|Overall Study and Follow-up|Death|4|||
124848572|NCT01752933|449068847|FG001|Overall Study and Follow-up|Death|34|||
124848573|NCT01752933|449068846|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
124848574|NCT01752933|449068847|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
124848575|NCT01752933|449068846|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
124848576|NCT01752933|449068847|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
124848577|NCT01752933|449068846|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
124848578|NCT01752933|449068847|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
124848579|NCT02203591|449068848|FG000|Overall Study|Did not meet treatment day baseline|147|||
124848580|NCT02203591|449068849|FG001|Overall Study|Did not meet treatment day baseline|141|||
124848581|NCT02203591|449068850|FG002|Overall Study|Did not meet treatment day baseline|150|||
124848582|NCT02203591|449068851|FG003|Overall Study|Did not meet treatment day baseline|45|||
124848583|NCT02203591|449068852|FG004|Overall Study|Did not meet treatment day baseline|33|||
124848584|NCT02203591|449068853|FG005|Overall Study|Did not meet treatment day baseline|35|||
124848585|NCT02203591|449068854|FG006|Overall Study|Did not meet treatment day baseline|29|||
124848586|NCT02203591|449068855|FG007|Overall Study|Did not meet treatment day baseline|12|||
124848587|NCT02203591|449068848|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
124848588|NCT02203591|449068849|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
124848589|NCT02203591|449068850|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
124848590|NCT02203591|449068851|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
124848591|NCT02203591|449068852|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
124848592|NCT02203591|449068853|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
124848593|NCT02203591|449068854|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
124848594|NCT02203591|449068855|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
124848595|NCT01706250|449068857|FG000|Overall Study|Lost to Follow-up|2|||
124848596|NCT01565291|449068861|FG000|Overall Study|Withdrawal by Subject|1|||
124848597|NCT01565291|449068862|FG001|Overall Study|Withdrawal by Subject|0|||
124848598|NCT03149237|449068865|FG000|Overall Study|Withdrawal by Subject|4|||
124848599|NCT03149237|449068866|FG001|Overall Study|Withdrawal by Subject|5|||
124848600|NCT04568122|449068867|FG000|Overall Study|Lost to Follow-up|48|||
124848601|NCT04568122|449068868|FG001|Overall Study|Lost to Follow-up|44|||
124848602|NCT04568122|449068869|FG002|Overall Study|Lost to Follow-up|4|||
124848603|NCT04568122|449068870|FG003|Overall Study|Lost to Follow-up|0|||
124848604|NCT04568122|449068871|FG004|Overall Study|Lost to Follow-up|0|||
124848605|NCT01227512|449068872|FG000|Overall Study|Physician Decision|6|||
124848606|NCT01227512|449068873|FG001|Overall Study|Physician Decision|6|||
124848607|NCT01227512|449068872|FG000|Overall Study|Adverse Event|4|||
124848608|NCT01227512|449068873|FG001|Overall Study|Adverse Event|3|||
124848609|NCT01227512|449068872|FG000|Overall Study|Withdrawal by Subject|3|||
124848610|NCT01227512|449068873|FG001|Overall Study|Withdrawal by Subject|0|||
124848611|NCT01227512|449068872|FG000|Overall Study|Participant met withdrawal criteria|0|||
124848612|NCT01227512|449068873|FG001|Overall Study|Participant met withdrawal criteria|1|||
124848613|NCT04497987|449068874|FG000|Overall Study|Adverse Event|1|||
124848614|NCT04497987|449068875|FG001|Overall Study|Adverse Event|0|||
124848615|NCT04497987|449068874|FG000|Overall Study|Death|21|||
124848616|NCT04497987|449068875|FG001|Overall Study|Death|13|||
124848617|NCT04497987|449068874|FG000|Overall Study|Lost to Follow-up|19|||
124848618|NCT04497987|449068875|FG001|Overall Study|Lost to Follow-up|17|||
124848619|NCT04497987|449068874|FG000|Overall Study|Other - as reported by the investigator|22|||
124848620|NCT04497987|449068875|FG001|Overall Study|Other - as reported by the investigator|16|||
124848621|NCT04497987|449068874|FG000|Overall Study|Physician Decision|1|||
124848622|NCT04497987|449068875|FG001|Overall Study|Physician Decision|0|||
124848623|NCT04497987|449068874|FG000|Overall Study|Withdrawal by Subject|35|||
124848624|NCT04497987|449068875|FG001|Overall Study|Withdrawal by Subject|21|||
124848625|NCT00512096|449068876|FG000|Overall Study|Adverse Event|2|||
124848626|NCT00512096|449068876|FG000|Overall Study|Withdrawal by Subject|2|||
124848627|NCT00512096|449068876|FG000|Overall Study|Lack of Efficacy|3|||
124848628|NCT00298038|449068877|FG000|Overall Study|Lost to Follow-up|0|||
124848629|NCT00298038|449068878|FG001|Overall Study|Lost to Follow-up|1|||
124848630|NCT00298038|449068877|FG000|Overall Study|Liver Transplant|0|||
124848631|NCT00298038|449068878|FG001|Overall Study|Liver Transplant|1|||
124848632|NCT00298038|449068877|FG000|Overall Study|Protocol Violation|1|||
124848633|NCT00298038|449068878|FG001|Overall Study|Protocol Violation|3|||
124848634|NCT00298038|449068877|FG000|Overall Study|Death|6|||
124848635|NCT00298038|449068878|FG001|Overall Study|Death|3|||
124848636|NCT00298038|449068877|FG000|Overall Study|Withdrawal by Subject|6|||
124848637|NCT00298038|449068878|FG001|Overall Study|Withdrawal by Subject|9|||
124848638|NCT00298038|449068877|FG000|Overall Study|Adverse Event|8|||
124848639|NCT00298038|449068878|FG001|Overall Study|Adverse Event|7|||
124848640|NCT00298038|449068877|FG000|Overall Study|Breakthrough overt HE episode|28|||
124848641|NCT00298038|449068878|FG001|Overall Study|Breakthrough overt HE episode|69|||
124848642|NCT00298038|449068877|FG000|Overall Study|Noncompliance|1|||
124848643|NCT00298038|449068878|FG001|Overall Study|Noncompliance|0|||
124848644|NCT00298038|449068877|FG000|Overall Study|Cocaine Abuse|1|||
124848645|NCT00298038|449068878|FG001|Overall Study|Cocaine Abuse|0|||
124848646|NCT00298038|449068877|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
124848647|NCT00298038|449068878|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
124848648|NCT02696096|449068879|FG000|Overall Study|ruled out at screening|1|||
124848649|NCT02696096|449068879|FG000|Overall Study|did not attend second fMRI|1|||
124848650|NCT01755416|449068882|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
124848651|NCT01755416|449068883|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
124848652|NCT02573324|449070898|FG000|Overall Study|Withdrawal by Subject|26|||
124848653|NCT02573324|449070899|FG001|Overall Study|Withdrawal by Subject|23|||
124848654|NCT02573324|449070900|FG002|Overall Study|Withdrawal by Subject|3|||
124848655|NCT02573324|449070898|FG000|Overall Study|Lost to Follow-up|4|||
124848656|NCT02573324|449070899|FG001|Overall Study|Lost to Follow-up|5|||
124848657|NCT02573324|449070900|FG002|Overall Study|Lost to Follow-up|0|||
124848658|NCT02573324|449070898|FG000|Overall Study|Study Terminated by Sponsor|107|||
124848659|NCT02573324|449070899|FG001|Overall Study|Study Terminated by Sponsor|89|||
124848660|NCT02573324|449070900|FG002|Overall Study|Study Terminated by Sponsor|2|||
124848661|NCT02573324|449070898|FG000|Overall Study|Death|182|||
124848662|NCT02573324|449070899|FG001|Overall Study|Death|200|||
124848663|NCT02573324|449070900|FG002|Overall Study|Death|1|||
124848664|NCT02573324|449070898|FG000|Overall Study|Other, Not Specified|20|||
124848665|NCT02573324|449070899|FG001|Overall Study|Other, Not Specified|27|||
124848666|NCT02573324|449070900|FG002|Overall Study|Other, Not Specified|0|||
124848667|NCT02573324|449070898|FG000|Overall Study|Unknown Reason|2|||
124848668|NCT02573324|449070899|FG001|Overall Study|Unknown Reason|0|||
124848669|NCT02573324|449070900|FG002|Overall Study|Unknown Reason|0|||
124848670|NCT01105533|449070901|FG000|Overall Study|Death|0|||
124848671|NCT01105533|449070902|FG001|Overall Study|Death|0|||
124848672|NCT01105533|449070903|FG002|Overall Study|Death|0|||
124848673|NCT01105533|449070904|FG003|Overall Study|Death|0|||
124848674|NCT01105533|449070905|FG004|Overall Study|Death|1|||
124848675|NCT01105533|449070906|FG005|Overall Study|Death|0|||
124848676|NCT01105533|449070907|FG006|Overall Study|Death|0|||
124848677|NCT01105533|449070908|FG007|Overall Study|Death|0|||
124848678|NCT01105533|449070909|FG008|Overall Study|Death|0|||
124848679|NCT01105533|449070901|FG000|Overall Study|Lack of Efficacy|1|||
124848680|NCT01105533|449070902|FG001|Overall Study|Lack of Efficacy|1|||
124848681|NCT01105533|449070903|FG002|Overall Study|Lack of Efficacy|3|||
124848682|NCT01105533|449070904|FG003|Overall Study|Lack of Efficacy|3|||
124848683|NCT01105533|449070905|FG004|Overall Study|Lack of Efficacy|4|||
124848684|NCT01105533|449070906|FG005|Overall Study|Lack of Efficacy|5|||
124848685|NCT01105533|449070907|FG006|Overall Study|Lack of Efficacy|3|||
124848686|NCT01105533|449070908|FG007|Overall Study|Lack of Efficacy|2|||
124848687|NCT01105533|449070909|FG008|Overall Study|Lack of Efficacy|9|||
124848688|NCT01105533|449070901|FG000|Overall Study|Adverse Event|0|||
124848689|NCT01105533|449070902|FG001|Overall Study|Adverse Event|0|||
124848690|NCT01105533|449070903|FG002|Overall Study|Adverse Event|0|||
124848691|NCT01105533|449070904|FG003|Overall Study|Adverse Event|0|||
124848692|NCT01105533|449070905|FG004|Overall Study|Adverse Event|1|||
124848693|NCT01105533|449070906|FG005|Overall Study|Adverse Event|2|||
124848694|NCT01105533|449070907|FG006|Overall Study|Adverse Event|2|||
124848695|NCT01105533|449070908|FG007|Overall Study|Adverse Event|0|||
124848696|NCT01105533|449070909|FG008|Overall Study|Adverse Event|1|||
124848697|NCT01105533|449070901|FG000|Overall Study|Other|0|||
124848698|NCT01105533|449070902|FG001|Overall Study|Other|0|||
124848699|NCT01105533|449070903|FG002|Overall Study|Other|0|||
124848700|NCT01105533|449070904|FG003|Overall Study|Other|0|||
124848701|NCT01105533|449070905|FG004|Overall Study|Other|1|||
124848702|NCT01105533|449070906|FG005|Overall Study|Other|0|||
124848703|NCT01105533|449070907|FG006|Overall Study|Other|3|||
124848704|NCT01105533|449070908|FG007|Overall Study|Other|1|||
124848705|NCT01105533|449070909|FG008|Overall Study|Other|2|||
124848706|NCT01105533|449070901|FG000|Overall Study|Physician Decision|0|||
124848707|NCT01105533|449070902|FG001|Overall Study|Physician Decision|0|||
124848708|NCT01105533|449070903|FG002|Overall Study|Physician Decision|0|||
124848709|NCT01105533|449070904|FG003|Overall Study|Physician Decision|0|||
124848710|NCT01105533|449070905|FG004|Overall Study|Physician Decision|0|||
124848711|NCT01105533|449070906|FG005|Overall Study|Physician Decision|0|||
124848712|NCT01105533|449070907|FG006|Overall Study|Physician Decision|0|||
124848713|NCT01105533|449070908|FG007|Overall Study|Physician Decision|1|||
124848714|NCT01105533|449070909|FG008|Overall Study|Physician Decision|0|||
124848715|NCT02096835|449070910|FG000|Overall Study|Withdrawal by Subject|1|||
124848716|NCT02096835|449070911|FG001|Overall Study|Withdrawal by Subject|0|||
124848717|NCT02096835|449070912|FG002|Overall Study|Withdrawal by Subject|0|||
124848718|NCT02096835|449070910|FG000|Overall Study|converted to open procedures|1|||
124848719|NCT02096835|449070911|FG001|Overall Study|converted to open procedures|0|||
124848720|NCT02096835|449070912|FG002|Overall Study|converted to open procedures|0|||
124848721|NCT02096835|449070910|FG000|Overall Study|Lost to Follow-up|1|||
124848722|NCT02096835|449070911|FG001|Overall Study|Lost to Follow-up|0|||
124848723|NCT02096835|449070912|FG002|Overall Study|Lost to Follow-up|1|||
124848724|NCT03892889|449070913|FG000|Overall Study|Adverse Event|17|||
124848725|NCT03892889|449070913|FG000|Overall Study|Lack of Efficacy|1|||
124848726|NCT03892889|449070913|FG000|Overall Study|Lost to Follow-up|46|||
124848727|NCT03892889|449070913|FG000|Overall Study|Non-compliance with study drug|22|||
124848728|NCT03892889|449070913|FG000|Overall Study|Pregnancy|1|||
124848729|NCT03892889|449070913|FG000|Overall Study|Protocol Deviation|3|||
124848730|NCT03892889|449070913|FG000|Overall Study|Withdrawal by Subject|50|||
124848731|NCT03892889|449070913|FG000|Overall Study|Withdrawal by Caregiver|1|||
124848732|NCT03892889|449070913|FG000|Overall Study|Study Terminated by Sponsor|50|||
124848733|NCT03892889|449070913|FG000|Overall Study|Physician Decision|8|||
124848734|NCT03892889|449070913|FG000|Overall Study|Reason not Specified|5|||
124848735|NCT04260191|449070914|FG000|Overall Study|Decision by Sponsor|0|||
124848736|NCT04260191|449070915|FG001|Overall Study|Decision by Sponsor|1|||
124848737|NCT04260191|449070916|FG002|Overall Study|Decision by Sponsor|0|||
124848738|NCT04260191|449070914|FG000|Overall Study|Withdrawal by Subject|1|||
124848739|NCT04260191|449070915|FG001|Overall Study|Withdrawal by Subject|0|||
124848740|NCT04260191|449070916|FG002|Overall Study|Withdrawal by Subject|3|||
124848741|NCT04260191|449070914|FG000|Overall Study|Death|4|||
124848742|NCT04260191|449070915|FG001|Overall Study|Death|3|||
124848743|NCT04260191|449070916|FG002|Overall Study|Death|2|||
124848744|NCT01643473|449070917|FG000|Overall Study|Lost to Follow-up|1|||
124848745|NCT01643473|449070918|FG001|Overall Study|Lost to Follow-up|0|||
124848746|NCT01519518|449070919|FG000|Overall Study|Consent not available|7|||
124848747|NCT01519518|449070920|FG001|Overall Study|Consent not available|10|||
124848748|NCT01312909|449070922|FG000|Overall Study|Randomized but not treated|1|||
124848749|NCT01312909|449070923|FG001|Overall Study|Randomized but not treated|3|||
124848750|NCT01312909|449070924|FG002|Overall Study|Randomized but not treated|1|||
124848751|NCT01312909|449070922|FG000|Overall Study|Adverse Event|1|||
124848752|NCT01312909|449070923|FG001|Overall Study|Adverse Event|0|||
124848753|NCT01312909|449070924|FG002|Overall Study|Adverse Event|3|||
124848754|NCT01312909|449070922|FG000|Overall Study|Protocol Violation|2|||
124848755|NCT01312909|449070923|FG001|Overall Study|Protocol Violation|0|||
124848756|NCT01312909|449070924|FG002|Overall Study|Protocol Violation|2|||
124848757|NCT01312909|449070922|FG000|Overall Study|Other|9|||
124848758|NCT01312909|449070923|FG001|Overall Study|Other|6|||
124848759|NCT01312909|449070924|FG002|Overall Study|Other|11|||
124848760|NCT01312909|449070922|FG000|Overall Study|Withdrawal by Subject|8|||
124848761|NCT01312909|449070923|FG001|Overall Study|Withdrawal by Subject|10|||
124848762|NCT01312909|449070924|FG002|Overall Study|Withdrawal by Subject|7|||
124848763|NCT01312909|449070922|FG000|Overall Study|Lost to Follow-up|21|||
124848764|NCT01312909|449070923|FG001|Overall Study|Lost to Follow-up|17|||
124848765|NCT01312909|449070924|FG002|Overall Study|Lost to Follow-up|20|||
124848766|NCT01312909|449070922|FG000|Overall Study|Insufficient clinical response|0|||
124848767|NCT01312909|449070923|FG001|Overall Study|Insufficient clinical response|0|||
124848768|NCT01312909|449070924|FG002|Overall Study|Insufficient clinical response|1|||
124848769|NCT01312909|449070922|FG000|Overall Study|Entrance criteria not met|0|||
124848770|NCT01312909|449070923|FG001|Overall Study|Entrance criteria not met|0|||
124848771|NCT01312909|449070924|FG002|Overall Study|Entrance criteria not met|2|||
124848772|NCT00938431|449070929|FG000|Overall Study|Adverse Event|5|||
124848773|NCT00938431|449070930|FG001|Overall Study|Adverse Event|8|||
124848774|NCT00938431|449070931|FG002|Overall Study|Adverse Event|6|||
124848775|NCT00938431|449070929|FG000|Overall Study|Lack of Efficacy|0|||
124848776|NCT00938431|449070930|FG001|Overall Study|Lack of Efficacy|1|||
124848777|NCT00938431|449070931|FG002|Overall Study|Lack of Efficacy|0|||
124848778|NCT00938431|449070929|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
124848779|NCT00938431|449070930|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
124848780|NCT00938431|449070931|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
124848781|NCT00938431|449070929|FG000|Overall Study|Dosing compliance issue|0|||
124848782|NCT00938431|449070930|FG001|Overall Study|Dosing compliance issue|0|||
124848783|NCT00938431|449070931|FG002|Overall Study|Dosing compliance issue|1|||
124848784|NCT00938431|449070929|FG000|Overall Study|Reached maximum dose early|0|||
124848785|NCT00938431|449070930|FG001|Overall Study|Reached maximum dose early|0|||
124848786|NCT00938431|449070931|FG002|Overall Study|Reached maximum dose early|1|||
124848787|NCT02086591|449070932|FG000|Overall Study|Adverse Event|1|||
124848788|NCT02086591|449070932|FG000|Overall Study|Withdrawal by Subject|1|||
124848789|NCT02086591|449070932|FG000|Overall Study|protocol terminated|3|||
124848790|NCT01774903|449070933|FG000|Overall Study|Adverse Event|7|||
124848791|NCT01774903|449070933|FG000|Overall Study|Withdrawal by Subject|2|||
124848792|NCT01774903|449070933|FG000|Overall Study|Lack of Efficacy|1|||
124848793|NCT01774903|449070933|FG000|Overall Study|Ineligible to continue the trial|1|||
124848794|NCT02212730|449070936|FG000|Overall Study|Tumor not of the required cell histology|1|||
124848795|NCT02212730|449070937|FG001|Overall Study|Tumor not of the required cell histology|0|||
124848796|NCT02212730|449070936|FG000|Overall Study|Withdrawal by Subject|1|||
124848797|NCT02212730|449070937|FG001|Overall Study|Withdrawal by Subject|0|||
124848798|NCT02212730|449070936|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
124848799|NCT02212730|449070937|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
124848800|NCT02880371|449070938|FG000|Phase 1b|Lost to Follow-up|1|||
124848801|NCT02880371|449070939|FG001|Phase 1b|Lost to Follow-up|0|||
124848802|NCT02880371|449070940|FG002|Phase 1b|Lost to Follow-up|0|||
124848803|NCT02880371|449070941|FG003|Phase 1b|Lost to Follow-up|0|||
124848804|NCT02880371|449070942|FG004|Phase 1b|Lost to Follow-up|0|||
124848805|NCT02880371|449070943|FG005|Phase 1b|Lost to Follow-up|0|||
124848806|NCT02880371|449070944|FG006|Phase 1b|Lost to Follow-up|0|||
124848807|NCT02880371|449070945|FG007|Phase 1b|Lost to Follow-up|0|||
124848808|NCT02880371|449070938|FG000|Phase 1b|Participants terminated by Sponsor|1|||
124848809|NCT02880371|449070939|FG001|Phase 1b|Participants terminated by Sponsor|0|||
124848810|NCT02880371|449070940|FG002|Phase 1b|Participants terminated by Sponsor|0|||
124848811|NCT02880371|449070941|FG003|Phase 1b|Participants terminated by Sponsor|0|||
124848812|NCT02880371|449070942|FG004|Phase 1b|Participants terminated by Sponsor|0|||
124848813|NCT02880371|449070943|FG005|Phase 1b|Participants terminated by Sponsor|0|||
124848814|NCT02880371|449070944|FG006|Phase 1b|Participants terminated by Sponsor|0|||
124848815|NCT02880371|449070945|FG007|Phase 1b|Participants terminated by Sponsor|0|||
124848816|NCT02880371|449070938|FG000|Phase 1b|Withdrawal by Subject|0|||
124848817|NCT02880371|449070939|FG001|Phase 1b|Withdrawal by Subject|0|||
124848818|NCT02880371|449070940|FG002|Phase 1b|Withdrawal by Subject|1|||
124848819|NCT02880371|449070941|FG003|Phase 1b|Withdrawal by Subject|0|||
124848820|NCT02880371|449070942|FG004|Phase 1b|Withdrawal by Subject|0|||
124848821|NCT02880371|449070943|FG005|Phase 1b|Withdrawal by Subject|0|||
124848822|NCT02880371|449070944|FG006|Phase 1b|Withdrawal by Subject|0|||
124848823|NCT02880371|449070945|FG007|Phase 1b|Withdrawal by Subject|0|||
124848824|NCT02880371|449070938|FG000|Phase 1b|Death|4|||
124848825|NCT02880371|449070939|FG001|Phase 1b|Death|6|||
124848826|NCT02880371|449070940|FG002|Phase 1b|Death|5|||
124848827|NCT02880371|449070941|FG003|Phase 1b|Death|1|||
124848828|NCT02880371|449070942|FG004|Phase 1b|Death|0|||
124848829|NCT02880371|449070943|FG005|Phase 1b|Death|0|||
124848830|NCT02880371|449070944|FG006|Phase 1b|Death|0|||
124848831|NCT02880371|449070945|FG007|Phase 1b|Death|0|||
124848832|NCT02880371|449070938|FG000|Phase 1b|Enrolled but not Treated|0|||
124848833|NCT02880371|449070939|FG001|Phase 1b|Enrolled but not Treated|1|||
124848834|NCT02880371|449070940|FG002|Phase 1b|Enrolled but not Treated|0|||
124848835|NCT02880371|449070941|FG003|Phase 1b|Enrolled but not Treated|0|||
124848836|NCT02880371|449070942|FG004|Phase 1b|Enrolled but not Treated|0|||
124848837|NCT02880371|449070943|FG005|Phase 1b|Enrolled but not Treated|0|||
124848838|NCT02880371|449070944|FG006|Phase 1b|Enrolled but not Treated|0|||
124848839|NCT02880371|449070945|FG007|Phase 1b|Enrolled but not Treated|0|||
124848840|NCT02880371|449070938|FG000|Phase 2|Enrolled but not Treated|0|||
124848841|NCT02880371|449070939|FG001|Phase 2|Enrolled but not Treated|0|||
124848842|NCT02880371|449070940|FG002|Phase 2|Enrolled but not Treated|0|||
124848843|NCT02880371|449070941|FG003|Phase 2|Enrolled but not Treated|0|||
124848844|NCT02880371|449070942|FG004|Phase 2|Enrolled but not Treated|0|||
124848845|NCT02880371|449070943|FG005|Phase 2|Enrolled but not Treated|1|||
124848846|NCT02880371|449070944|FG006|Phase 2|Enrolled but not Treated|1|||
124848847|NCT02880371|449070945|FG007|Phase 2|Enrolled but not Treated|0|||
124848848|NCT02880371|449070938|FG000|Phase 2|Other|0|||
124848849|NCT02880371|449070939|FG001|Phase 2|Other|0|||
124848850|NCT02880371|449070940|FG002|Phase 2|Other|0|||
124848851|NCT02880371|449070941|FG003|Phase 2|Other|0|||
124848852|NCT02880371|449070942|FG004|Phase 2|Other|0|||
124848853|NCT02880371|449070943|FG005|Phase 2|Other|1|||
124848854|NCT02880371|449070944|FG006|Phase 2|Other|2|||
124848855|NCT02880371|449070945|FG007|Phase 2|Other|1|||
124848856|NCT02880371|449070938|FG000|Phase 2|Participants terminated by Sponsor|0|||
124848857|NCT02880371|449070939|FG001|Phase 2|Participants terminated by Sponsor|0|||
124848858|NCT02880371|449070940|FG002|Phase 2|Participants terminated by Sponsor|0|||
124848859|NCT02880371|449070941|FG003|Phase 2|Participants terminated by Sponsor|0|||
124848860|NCT02880371|449070942|FG004|Phase 2|Participants terminated by Sponsor|1|||
124848861|NCT02880371|449070943|FG005|Phase 2|Participants terminated by Sponsor|6|||
124848862|NCT02880371|449070944|FG006|Phase 2|Participants terminated by Sponsor|1|||
124848863|NCT02880371|449070945|FG007|Phase 2|Participants terminated by Sponsor|5|||
124848864|NCT02880371|449070938|FG000|Phase 2|Death|0|||
124848865|NCT02880371|449070939|FG001|Phase 2|Death|0|||
124848866|NCT02880371|449070940|FG002|Phase 2|Death|0|||
124848867|NCT02880371|449070941|FG003|Phase 2|Death|0|||
124848868|NCT02880371|449070942|FG004|Phase 2|Death|1|||
124848869|NCT02880371|449070943|FG005|Phase 2|Death|10|||
124848870|NCT02880371|449070944|FG006|Phase 2|Death|20|||
124848871|NCT02880371|449070945|FG007|Phase 2|Death|5|||
124848872|NCT02880371|449070938|FG000|Phase 2|Lost to Follow-up|0|||
124848873|NCT02880371|449070939|FG001|Phase 2|Lost to Follow-up|0|||
124848874|NCT02880371|449070940|FG002|Phase 2|Lost to Follow-up|0|||
124848875|NCT02880371|449070941|FG003|Phase 2|Lost to Follow-up|0|||
124848876|NCT02880371|449070942|FG004|Phase 2|Lost to Follow-up|0|||
124848877|NCT02880371|449070943|FG005|Phase 2|Lost to Follow-up|0|||
124848878|NCT02880371|449070944|FG006|Phase 2|Lost to Follow-up|3|||
124848879|NCT02880371|449070945|FG007|Phase 2|Lost to Follow-up|0|||
124848880|NCT02880371|449070938|FG000|Phase 2|Withdrawal by Subject|0|||
124848881|NCT02880371|449070939|FG001|Phase 2|Withdrawal by Subject|0|||
124848882|NCT02880371|449070940|FG002|Phase 2|Withdrawal by Subject|0|||
124848883|NCT02880371|449070941|FG003|Phase 2|Withdrawal by Subject|0|||
124848884|NCT02880371|449070942|FG004|Phase 2|Withdrawal by Subject|0|||
124848885|NCT02880371|449070943|FG005|Phase 2|Withdrawal by Subject|1|||
124848886|NCT02880371|449070944|FG006|Phase 2|Withdrawal by Subject|1|||
124848887|NCT02880371|449070945|FG007|Phase 2|Withdrawal by Subject|0|||
124848888|NCT02880371|449070938|FG000|Phase 2|End of Study page not completed by error|0|||
124848889|NCT02880371|449070939|FG001|Phase 2|End of Study page not completed by error|0|||
124848890|NCT02880371|449070940|FG002|Phase 2|End of Study page not completed by error|0|||
124848891|NCT02880371|449070941|FG003|Phase 2|End of Study page not completed by error|0|||
124848892|NCT02880371|449070942|FG004|Phase 2|End of Study page not completed by error|0|||
124848893|NCT02880371|449070943|FG005|Phase 2|End of Study page not completed by error|1|||
124848894|NCT02880371|449070944|FG006|Phase 2|End of Study page not completed by error|0|||
124848895|NCT02880371|449070945|FG007|Phase 2|End of Study page not completed by error|0|||
124848896|NCT01777997|449070948|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
124848897|NCT01777997|449070948|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
124848898|NCT01777997|449070948|FG000|Weeks 48 to 72/96 on ART|Death|1|||
124848899|NCT01777997|449070948|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
124848900|NCT02660359|449070949|FG000|Overall Study|Protocol Deviation|0|||
124848901|NCT02660359|449070950|FG001|Overall Study|Protocol Deviation|0|||
124848902|NCT02660359|449070951|FG002|Overall Study|Protocol Deviation|1|||
124848903|NCT02660359|449070949|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
124848904|NCT02660359|449070950|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
124848905|NCT02660359|449070951|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
124848906|NCT02660359|449070949|FG000|Overall Study|Lack of Efficacy|1|||
124848907|NCT02660359|449070950|FG001|Overall Study|Lack of Efficacy|1|||
124848908|NCT02660359|449070951|FG002|Overall Study|Lack of Efficacy|1|||
124848909|NCT02660359|449070949|FG000|Overall Study|Adverse Event|0|||
124848910|NCT02660359|449070950|FG001|Overall Study|Adverse Event|1|||
124848911|NCT02660359|449070951|FG002|Overall Study|Adverse Event|0|||
124848912|NCT02660359|449070949|FG000|Overall Study|Other|2|||
124848913|NCT02660359|449070950|FG001|Overall Study|Other|1|||
124848914|NCT02660359|449070951|FG002|Overall Study|Other|3|||
124848915|NCT02660359|449070949|FG000|Overall Study|Withdrawal by Subject|7|||
124848916|NCT02660359|449070950|FG001|Overall Study|Withdrawal by Subject|5|||
124848917|NCT02660359|449070951|FG002|Overall Study|Withdrawal by Subject|8|||
124848918|NCT02660359|449070949|FG000|Overall Study|Lost to Follow-up|3|||
124848919|NCT02660359|449070950|FG001|Overall Study|Lost to Follow-up|3|||
124848920|NCT02660359|449070951|FG002|Overall Study|Lost to Follow-up|0|||
124848921|NCT02944578|449070957|FG000|Overall Study|Physician Decision|1|||
124848922|NCT02944578|449070958|FG001|Overall Study|Physician Decision|0|||
124848923|NCT02691455|449070959|FG000|Overall Study|Withdrawal by Subject|1|||
124848924|NCT02691455|449070960|FG001|Overall Study|Withdrawal by Subject|2|||
124848925|NCT02691455|449070959|FG000|Overall Study|Lost to Follow-up|15|||
124848926|NCT02691455|449070960|FG001|Overall Study|Lost to Follow-up|15|||
124848927|NCT01257204|449070961|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
124848928|NCT01257204|449070962|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
124848929|NCT01257204|449070963|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
124848930|NCT01257204|449070961|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
124848931|NCT01257204|449070962|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
124848932|NCT01257204|449070963|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
124848933|NCT01257204|449070961|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
124848934|NCT01257204|449070962|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
124848935|NCT01257204|449070963|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
124848936|NCT01257204|449070961|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
124848937|NCT01257204|449070962|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
124848938|NCT01257204|449070963|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
124848939|NCT01257204|449070961|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
124848940|NCT01257204|449070962|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
124848941|NCT01257204|449070963|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
124848942|NCT01257204|449070961|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
124848943|NCT01257204|449070962|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
124848944|NCT01257204|449070963|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
124848945|NCT01257204|449070961|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
124848946|NCT01257204|449070962|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
124848947|NCT01257204|449070963|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
124848948|NCT01257204|449070961|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
124848949|NCT01257204|449070962|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
124848950|NCT01257204|449070963|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
124848951|NCT01257204|449070961|FG000|Follow-up Period (up to Week 48)|Other|0|||
124848952|NCT01257204|449070962|FG001|Follow-up Period (up to Week 48)|Other|0|||
124848953|NCT01257204|449070963|FG002|Follow-up Period (up to Week 48)|Other|5|||
124848954|NCT00451282|449070967|FG000|Overall Study|Lost to Follow-up|6|||
124848955|NCT00451282|449070968|FG001|Overall Study|Lost to Follow-up|5|||
124848956|NCT00577122|449070969|FG000|Overall Study|Adverse Event|0|||
124848957|NCT00577122|449070970|FG001|Overall Study|Adverse Event|2|||
124848958|NCT00577122|449070969|FG000|Overall Study|Progression, relapse during active trt|6|||
124848959|NCT00577122|449070970|FG001|Overall Study|Progression, relapse during active trt|8|||
124848960|NCT00577122|449070969|FG000|Overall Study|Prog, refract disease during active trt|8|||
124848961|NCT00577122|449070970|FG001|Overall Study|Prog, refract disease during active trt|5|||
124848962|NCT00577122|449070969|FG000|Overall Study|Alternative Therapy|0|||
124848963|NCT00577122|449070970|FG001|Overall Study|Alternative Therapy|1|||
124848964|NCT00529386|449070976|FG000|Overall Study|Lost to Follow-up|1|||
124848965|NCT04532112|449070977|FG000|Overall Study|Adverse Event|3|||
124848966|NCT04532112|449070978|FG001|Overall Study|Adverse Event|0|||
124848967|NCT03348904|449070979|FG000|Overall Study|Administrative reason by the sponsor|0|||
124848968|NCT03348904|449070980|FG001|Overall Study|Administrative reason by the sponsor|1|||
124848969|NCT03348904|449070981|FG002|Overall Study|Administrative reason by the sponsor|0|||
124848970|NCT02039427|449070987|FG000|Overall Study|Duration of surgery > 3h|1|||
124848971|NCT02039427|449070988|FG001|Overall Study|Duration of surgery > 3h|1|||
124848972|NCT02039427|449070989|FG002|Overall Study|Duration of surgery > 3h|0|||
124848973|NCT02039427|449070990|FG003|Overall Study|Duration of surgery > 3h|0|||
124848974|NCT02039427|449070987|FG000|Overall Study|Withdrawal on concent|0|||
124848975|NCT02039427|449070988|FG001|Overall Study|Withdrawal on concent|0|||
124848976|NCT02039427|449070989|FG002|Overall Study|Withdrawal on concent|0|||
124848977|NCT02039427|449070990|FG003|Overall Study|Withdrawal on concent|1|||
124848978|NCT02039427|449070987|FG000|Overall Study|Cancellation of surgery|0|||
124848979|NCT02039427|449070988|FG001|Overall Study|Cancellation of surgery|0|||
124848980|NCT02039427|449070989|FG002|Overall Study|Cancellation of surgery|1|||
124848981|NCT02039427|449070990|FG003|Overall Study|Cancellation of surgery|0|||
124848982|NCT02039427|449070987|FG000|Overall Study|Loss of follow - up|1|||
124848983|NCT02039427|449070988|FG001|Overall Study|Loss of follow - up|0|||
124848984|NCT02039427|449070989|FG002|Overall Study|Loss of follow - up|2|||
124848985|NCT02039427|449070990|FG003|Overall Study|Loss of follow - up|4|||
124848986|NCT02039427|449070987|FG000|Overall Study|Steroid Use|1|||
124848987|NCT02039427|449070988|FG001|Overall Study|Steroid Use|0|||
124848988|NCT02039427|449070989|FG002|Overall Study|Steroid Use|0|||
124848989|NCT02039427|449070990|FG003|Overall Study|Steroid Use|0|||
124848990|NCT04354831|449070991|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
124848991|NCT04354831|449070992|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
124848992|NCT02732847|449070993|FG000|Overall Study|some filled early|42|||
124848993|NCT02732847|449070994|FG001|Overall Study|some filled early|42|||
124848994|NCT04027686|449070995|FG000|Overall Study|Lost to Follow-up|2|||
124848995|NCT04027686|449070996|FG001|Overall Study|Lost to Follow-up|0|||
124848996|NCT04027686|449070995|FG000|Overall Study|Withdrawal by Subject|0|||
124848997|NCT04027686|449070996|FG001|Overall Study|Withdrawal by Subject|1|||
124848998|NCT00111228|449070997|FG000|Overall Study|Withdrawal by Subject|5|||
124848999|NCT00111228|449070998|FG001|Overall Study|Withdrawal by Subject|1|||
124849000|NCT00111228|449070999|FG002|Overall Study|Withdrawal by Subject|0|||
124849001|NCT00779766|449071000|FG000|Month 24|Serious Adverse Event|2|||
124849002|NCT00779766|449071001|FG001|Month 24|Serious Adverse Event|3|||
124849003|NCT00779766|449071000|FG000|Month 24|Adverse Event|3|||
124849004|NCT00779766|449071001|FG001|Month 24|Adverse Event|3|||
124849005|NCT00779766|449071000|FG000|Month 24|Protocol Violation|3|||
124849006|NCT00779766|449071001|FG001|Month 24|Protocol Violation|1|||
124849007|NCT00779766|449071000|FG000|Month 24|Withdrawal by Subject|159|||
124849008|NCT00779766|449071001|FG001|Month 24|Withdrawal by Subject|127|||
124849009|NCT00779766|449071000|FG000|Month 24|Migrated/moved from study area|138|||
124849010|NCT00779766|449071001|FG001|Month 24|Migrated/moved from study area|162|||
124849011|NCT00779766|449071000|FG000|Month 24|Lost to Follow-up|9|||
124849012|NCT00779766|449071001|FG001|Month 24|Lost to Follow-up|9|||
124849013|NCT00779766|449071000|FG000|Month 24|Other|18|||
124849014|NCT00779766|449071001|FG001|Month 24|Other|27|||
124849015|NCT00779766|449071000|FG000|Month 48|Withdrawal by Subject|68|||
124849016|NCT00779766|449071001|FG001|Month 48|Withdrawal by Subject|63|||
124849017|NCT00779766|449071000|FG000|Month 48|Migrated/moved from study area|76|||
124849018|NCT00779766|449071001|FG001|Month 48|Migrated/moved from study area|75|||
124849019|NCT00779766|449071000|FG000|Month 48|Lost to Follow-up|29|||
124849020|NCT00779766|449071001|FG001|Month 48|Lost to Follow-up|30|||
124849021|NCT00779766|449071000|FG000|Month 48|Other|1|||
124849022|NCT00779766|449071001|FG001|Month 48|Other|0|||
124849023|NCT00779766|449071000|FG000|Month 72|Withdrawal by Subject|55|||
124849024|NCT00779766|449071001|FG001|Month 72|Withdrawal by Subject|71|||
124849025|NCT00779766|449071000|FG000|Month 72|Migrated/moved from study area|124|||
124849026|NCT00779766|449071001|FG001|Month 72|Migrated/moved from study area|109|||
124849027|NCT00779766|449071000|FG000|Month 72|Lost to Follow-up|6|||
124849028|NCT00779766|449071001|FG001|Month 72|Lost to Follow-up|8|||
124849029|NCT00779766|449071000|FG000|Month 72|Other|0|||
124849030|NCT00779766|449071001|FG001|Month 72|Other|1|||
124849031|NCT01274637|449071004|FG000|Overall Study|Withdrawal by Subject|0|||
124849032|NCT01274637|449071005|FG001|Overall Study|Withdrawal by Subject|1|||
124849033|NCT01274637|449071004|FG000|Overall Study|Lost to Follow-up|0|||
124849034|NCT01274637|449071005|FG001|Overall Study|Lost to Follow-up|1|||
124849035|NCT02170727|449071009|FG000|Overall Study|Lost to Follow-up|1|||
124849036|NCT02170727|449071010|FG001|Overall Study|Lost to Follow-up|0|||
124849037|NCT02170727|449071009|FG000|Overall Study|Withdrawal by Subject|2|||
124849038|NCT02170727|449071010|FG001|Overall Study|Withdrawal by Subject|0|||
124849039|NCT00720876|449071011|FG000|Overall Study|found to be ineligible after starting tx|2|||
124849040|NCT03304379|449071013|FG000|Overall Study|Protocol Violation|8|||
124849041|NCT03304379|449071014|FG001|Overall Study|Protocol Violation|10|||
124849042|NCT03304379|449071015|FG002|Overall Study|Protocol Violation|5|||
124849043|NCT03304379|449071016|FG003|Overall Study|Protocol Violation|0|||
124849044|NCT03304379|449071017|FG004|Overall Study|Protocol Violation|2|||
124849045|NCT03304379|449071013|FG000|Overall Study|Adverse Event|4|||
124849046|NCT03304379|449071014|FG001|Overall Study|Adverse Event|20|||
124849047|NCT03304379|449071015|FG002|Overall Study|Adverse Event|17|||
124849048|NCT03304379|449071016|FG003|Overall Study|Adverse Event|1|||
124849049|NCT03304379|449071017|FG004|Overall Study|Adverse Event|0|||
124849050|NCT03304379|449071013|FG000|Overall Study|Lack of Efficacy|17|||
124849051|NCT03304379|449071014|FG001|Overall Study|Lack of Efficacy|16|||
124849052|NCT03304379|449071015|FG002|Overall Study|Lack of Efficacy|20|||
124849053|NCT03304379|449071016|FG003|Overall Study|Lack of Efficacy|0|||
124849054|NCT03304379|449071017|FG004|Overall Study|Lack of Efficacy|0|||
124849055|NCT03304379|449071013|FG000|Overall Study|Physician Decision|6|||
124849056|NCT03304379|449071014|FG001|Overall Study|Physician Decision|10|||
124849057|NCT03304379|449071015|FG002|Overall Study|Physician Decision|6|||
124849058|NCT03304379|449071016|FG003|Overall Study|Physician Decision|9|||
124849059|NCT03304379|449071017|FG004|Overall Study|Physician Decision|10|||
124849060|NCT03304379|449071013|FG000|Overall Study|Withdrawal by Subject|26|||
124849061|NCT03304379|449071014|FG001|Overall Study|Withdrawal by Subject|58|||
124849062|NCT03304379|449071015|FG002|Overall Study|Withdrawal by Subject|66|||
124849063|NCT03304379|449071016|FG003|Overall Study|Withdrawal by Subject|3|||
124849064|NCT03304379|449071017|FG004|Overall Study|Withdrawal by Subject|5|||
124849065|NCT03304379|449071013|FG000|Overall Study|Lost to Follow-up|8|||
124849066|NCT03304379|449071014|FG001|Overall Study|Lost to Follow-up|24|||
124849067|NCT03304379|449071015|FG002|Overall Study|Lost to Follow-up|35|||
124849068|NCT03304379|449071016|FG003|Overall Study|Lost to Follow-up|4|||
124849069|NCT03304379|449071017|FG004|Overall Study|Lost to Follow-up|0|||
124849070|NCT03304379|449071013|FG000|Overall Study|Death|1|||
124849071|NCT03304379|449071014|FG001|Overall Study|Death|2|||
124849072|NCT03304379|449071015|FG002|Overall Study|Death|0|||
124849073|NCT03304379|449071016|FG003|Overall Study|Death|0|||
124849074|NCT03304379|449071017|FG004|Overall Study|Death|0|||
124849075|NCT03304379|449071013|FG000|Overall Study|Other|0|||
124849076|NCT03304379|449071014|FG001|Overall Study|Other|1|||
124849077|NCT03304379|449071015|FG002|Overall Study|Other|0|||
124849078|NCT03304379|449071016|FG003|Overall Study|Other|0|||
124849079|NCT03304379|449071017|FG004|Overall Study|Other|0|||
124849080|NCT03511560|449071028|FG000|Overall Study|Death|0|||
124849081|NCT03511560|449071029|FG001|Overall Study|Death|1|||
124849082|NCT03511560|449071028|FG000|Overall Study|Adverse Event|0|||
124849083|NCT03511560|449071029|FG001|Overall Study|Adverse Event|2|||
124849084|NCT03511560|449071028|FG000|Overall Study|Transplant cancelled|0|||
124849085|NCT03511560|449071029|FG001|Overall Study|Transplant cancelled|1|||
124849086|NCT03511560|449071028|FG000|Overall Study|Patient switched to another drug|1|||
124849087|NCT03511560|449071029|FG001|Overall Study|Patient switched to another drug|0|||
124849088|NCT02985736|449071034|FG000|Overall Study|Lost to Follow-up|3|||
124849089|NCT00382733|449071035|FG000|Overall Study|Withdrawal by Subject|0|||
124849090|NCT00382733|449071036|FG001|Overall Study|Withdrawal by Subject|1|||
124849091|NCT00382733|449071037|FG002|Overall Study|Withdrawal by Subject|0|||
124849092|NCT00382733|449071038|FG003|Overall Study|Withdrawal by Subject|0|||
124849093|NCT00382733|449071039|FG004|Overall Study|Withdrawal by Subject|0|||
124849094|NCT02185768|449071044|FG000|Overall Study|Patients were not treated|2|||
124849095|NCT02550652|449071046|FG000|Overall Study|Death|1|||
124849096|NCT02550652|449071047|FG001|Overall Study|Death|4|||
124849097|NCT02550652|449071046|FG000|Overall Study|Lack of Efficacy|1|||
124849098|NCT02550652|449071047|FG001|Overall Study|Lack of Efficacy|0|||
124849099|NCT02550652|449071046|FG000|Overall Study|Withdrawal by Subject|4|||
124849100|NCT02550652|449071047|FG001|Overall Study|Withdrawal by Subject|7|||
124849101|NCT02550652|449071046|FG000|Overall Study|Post Trial Access|1|||
124849102|NCT02550652|449071047|FG001|Overall Study|Post Trial Access|0|||
124849103|NCT02550652|449071046|FG000|Overall Study|Lost to Follow-up|1|||
124849104|NCT02550652|449071047|FG001|Overall Study|Lost to Follow-up|3|||
124849105|NCT02550652|449071046|FG000|Overall Study|Physician Decision|0|||
124849106|NCT02550652|449071047|FG001|Overall Study|Physician Decision|2|||
124849107|NCT02550652|449071046|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
124849108|NCT02550652|449071047|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
124849109|NCT03286140|449071048|FG000|Overall Study|Withdrawal by Subject|10|||
124849110|NCT03286140|449071049|FG001|Overall Study|Withdrawal by Subject|5|||
124849111|NCT03286140|449071048|FG000|Overall Study|Lost to Follow-up|5|||
124849112|NCT03286140|449071049|FG001|Overall Study|Lost to Follow-up|10|||
124849113|NCT03286140|449071048|FG000|Overall Study|Failure to comply|0|||
124849114|NCT03286140|449071049|FG001|Overall Study|Failure to comply|1|||
124849115|NCT00515827|449071050|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
124849116|NCT00515827|449071051|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
124849117|NCT00515827|449071050|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
124849118|NCT00515827|449071051|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
124849119|NCT03181542|449071052|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
124849120|NCT03181542|449071053|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
124849121|NCT04055116|449071059|FG000|First Intervention|Physician Decision|2|||
124849122|NCT04055116|449071060|FG001|First Intervention|Physician Decision|7|||
124849123|NCT02774681|449071067|FG000|Treatment on Study|Progressive Disease|7|||
124849124|NCT02774681|449071067|FG000|Follow-Up for 3 Years|Death|11|||
124849125|NCT02774681|449071067|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
124849126|NCT01069289|449071068|FG000|Overall Study|Withdrawal by Subject|15|||
124849127|NCT01069289|449071069|FG001|Overall Study|Withdrawal by Subject|26|||
124849128|NCT01069289|449071068|FG000|Overall Study|Adverse Event|21|||
124849129|NCT01069289|449071069|FG001|Overall Study|Adverse Event|28|||
124849130|NCT01069289|449071068|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
124849131|NCT01069289|449071069|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
124849132|NCT01069289|449071068|FG000|Overall Study|Severe non-compliance to protocol|3|||
124849133|NCT01069289|449071069|FG001|Overall Study|Severe non-compliance to protocol|2|||
124849134|NCT01069289|449071068|FG000|Overall Study|Due to deteriorating health condition|1|||
124849135|NCT01069289|449071069|FG001|Overall Study|Due to deteriorating health condition|0|||
124849136|NCT02047604|449071070|FG000|Overall Study|Withdrawal by Subject|0|||
124849137|NCT02047604|449071071|FG001|Overall Study|Withdrawal by Subject|0|||
124849138|NCT02047604|449071072|FG002|Overall Study|Withdrawal by Subject|0|||
124849139|NCT02047604|449071073|FG003|Overall Study|Withdrawal by Subject|0|||
124849140|NCT02047604|449071074|FG004|Overall Study|Withdrawal by Subject|1|||
124849141|NCT02047604|449071075|FG005|Overall Study|Withdrawal by Subject|1|||
124849142|NCT04035486|449071076|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
124849143|NCT04035486|449071077|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
124849144|NCT04035486|449071078|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
124849145|NCT04035486|449071079|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
124849146|NCT04035486|449071076|FG000|Overall Study|Death|6|||
124849147|NCT04035486|449071077|FG001|Overall Study|Death|3|||
124849148|NCT04035486|449071078|FG002|Overall Study|Death|70|||
124849149|NCT04035486|449071079|FG003|Overall Study|Death|77|||
124849150|NCT04035486|449071076|FG000|Overall Study|Screen Failure|0|||
124849151|NCT04035486|449071077|FG001|Overall Study|Screen Failure|0|||
124849152|NCT04035486|449071078|FG002|Overall Study|Screen Failure|1|||
124849153|NCT04035486|449071079|FG003|Overall Study|Screen Failure|1|||
124849154|NCT04035486|449071076|FG000|Overall Study|Withdrawal by Subject|1|||
124849155|NCT04035486|449071077|FG001|Overall Study|Withdrawal by Subject|1|||
124849156|NCT04035486|449071078|FG002|Overall Study|Withdrawal by Subject|11|||
124849157|NCT04035486|449071079|FG003|Overall Study|Withdrawal by Subject|9|||
124849158|NCT02556710|449073144|FG000|Overall Study|Surgical treatment|3|||
124849159|NCT02556710|449073145|FG001|Overall Study|Surgical treatment|0|||
124849160|NCT02556710|449073144|FG000|Overall Study|Required proscribed pain medication|2|||
124849161|NCT02556710|449073145|FG001|Overall Study|Required proscribed pain medication|1|||
124849162|NCT02556710|449073144|FG000|Overall Study|Lack of Efficacy|1|||
124849163|NCT02556710|449073145|FG001|Overall Study|Lack of Efficacy|0|||
124849164|NCT02556710|449073144|FG000|Overall Study|Worsening osteoarthritis|1|||
124849165|NCT02556710|449073145|FG001|Overall Study|Worsening osteoarthritis|0|||
124849166|NCT02556710|449073144|FG000|Overall Study|Moved out of state|1|||
124849167|NCT02556710|449073145|FG001|Overall Study|Moved out of state|0|||
124849168|NCT02556710|449073144|FG000|Overall Study|Missing reason|3|||
124849169|NCT02556710|449073145|FG001|Overall Study|Missing reason|1|||
124849170|NCT02556710|449073144|FG000|Overall Study|Pain as lack of efficacy|0|||
124849171|NCT02556710|449073145|FG001|Overall Study|Pain as lack of efficacy|4|||
124849172|NCT04258839|449073148|FG000|Overall Study|Adverse Event|2|||
124849173|NCT04258839|449073149|FG001|Overall Study|Adverse Event|4|||
124849174|NCT04258839|449073148|FG000|Overall Study|Lack of Efficacy|0|||
124849175|NCT04258839|449073149|FG001|Overall Study|Lack of Efficacy|2|||
124849176|NCT04258839|449073148|FG000|Overall Study|Lost to Follow-up|2|||
124849177|NCT04258839|449073149|FG001|Overall Study|Lost to Follow-up|0|||
124849178|NCT04258839|449073148|FG000|Overall Study|Withdrawal by Subject|1|||
124849179|NCT04258839|449073149|FG001|Overall Study|Withdrawal by Subject|2|||
124849180|NCT04258839|449073148|FG000|Overall Study|Withdrawal by Caregiver|5|||
124849181|NCT04258839|449073149|FG001|Overall Study|Withdrawal by Caregiver|6|||
124849182|NCT04258839|449073148|FG000|Overall Study|Reason not Specified|0|||
124849183|NCT04258839|449073149|FG001|Overall Study|Reason not Specified|1|||
124849184|NCT01607905|449073150|FG000|Overall Study|Withdrawal by participant|7|||
124849185|NCT01607905|449073151|FG001|Overall Study|Withdrawal by participant|2|||
124849186|NCT01607905|449073152|FG002|Overall Study|Withdrawal by participant|4|||
124849187|NCT01607905|449073153|FG003|Overall Study|Withdrawal by participant|6|||
124849188|NCT01607905|449073154|FG004|Overall Study|Withdrawal by participant|0|||
124849189|NCT01607905|449073155|FG005|Overall Study|Withdrawal by participant|4|||
124849190|NCT01607905|449073156|FG006|Overall Study|Withdrawal by participant|12|||
124849191|NCT01607905|449073150|FG000|Overall Study|Incidence or severity of AEs|5|||
124849192|NCT01607905|449073151|FG001|Overall Study|Incidence or severity of AEs|1|||
124849193|NCT01607905|449073152|FG002|Overall Study|Incidence or severity of AEs|1|||
124849194|NCT01607905|449073153|FG003|Overall Study|Incidence or severity of AEs|3|||
124849195|NCT01607905|449073154|FG004|Overall Study|Incidence or severity of AEs|0|||
124849196|NCT01607905|449073155|FG005|Overall Study|Incidence or severity of AEs|2|||
124849197|NCT01607905|449073156|FG006|Overall Study|Incidence or severity of AEs|8|||
124849198|NCT01607905|449073150|FG000|Overall Study|Disease progression|44|||
124849199|NCT01607905|449073151|FG001|Overall Study|Disease progression|16|||
124849200|NCT01607905|449073152|FG002|Overall Study|Disease progression|15|||
124849201|NCT01607905|449073153|FG003|Overall Study|Disease progression|11|||
124849202|NCT01607905|449073154|FG004|Overall Study|Disease progression|6|||
124849203|NCT01607905|449073155|FG005|Overall Study|Disease progression|7|||
124849204|NCT01607905|449073156|FG006|Overall Study|Disease progression|21|||
124849205|NCT01607905|449073150|FG000|Overall Study|Non-compliance with study procedures|0|||
124849206|NCT01607905|449073151|FG001|Overall Study|Non-compliance with study procedures|0|||
124849207|NCT01607905|449073152|FG002|Overall Study|Non-compliance with study procedures|0|||
124849208|NCT01607905|449073153|FG003|Overall Study|Non-compliance with study procedures|0|||
124849209|NCT01607905|449073154|FG004|Overall Study|Non-compliance with study procedures|0|||
124849210|NCT01607905|449073155|FG005|Overall Study|Non-compliance with study procedures|0|||
124849211|NCT01607905|449073156|FG006|Overall Study|Non-compliance with study procedures|1|||
124849212|NCT01607905|449073150|FG000|Overall Study|Death|1|||
124849213|NCT01607905|449073151|FG001|Overall Study|Death|1|||
124849214|NCT01607905|449073152|FG002|Overall Study|Death|1|||
124849215|NCT01607905|449073153|FG003|Overall Study|Death|1|||
124849216|NCT01607905|449073154|FG004|Overall Study|Death|0|||
124849217|NCT01607905|449073155|FG005|Overall Study|Death|0|||
124849218|NCT01607905|449073156|FG006|Overall Study|Death|3|||
124849219|NCT01607905|449073150|FG000|Overall Study|Other treatments become available|1|||
124849220|NCT01607905|449073151|FG001|Overall Study|Other treatments become available|0|||
124849221|NCT01607905|449073152|FG002|Overall Study|Other treatments become available|0|||
124849222|NCT01607905|449073153|FG003|Overall Study|Other treatments become available|0|||
124849223|NCT01607905|449073154|FG004|Overall Study|Other treatments become available|0|||
124849224|NCT01607905|449073155|FG005|Overall Study|Other treatments become available|0|||
124849225|NCT01607905|449073156|FG006|Overall Study|Other treatments become available|1|||
124849226|NCT01607905|449073150|FG000|Overall Study|Investigator discretion|0|||
124849227|NCT01607905|449073151|FG001|Overall Study|Investigator discretion|0|||
124849228|NCT01607905|449073152|FG002|Overall Study|Investigator discretion|0|||
124849229|NCT01607905|449073153|FG003|Overall Study|Investigator discretion|0|||
124849230|NCT01607905|449073154|FG004|Overall Study|Investigator discretion|0|||
124849231|NCT01607905|449073155|FG005|Overall Study|Investigator discretion|1|||
124849232|NCT01607905|449073156|FG006|Overall Study|Investigator discretion|0|||
124849233|NCT01607905|449073150|FG000|Overall Study|Other|1|||
124849234|NCT01607905|449073151|FG001|Overall Study|Other|0|||
124849235|NCT01607905|449073152|FG002|Overall Study|Other|0|||
124849236|NCT01607905|449073153|FG003|Overall Study|Other|0|||
124849237|NCT01607905|449073154|FG004|Overall Study|Other|0|||
124849238|NCT01607905|449073155|FG005|Overall Study|Other|0|||
124849239|NCT01607905|449073156|FG006|Overall Study|Other|1|||
124849240|NCT01607905|449073150|FG000|Overall Study|Randomized but not treated|1|||
124849241|NCT01607905|449073151|FG001|Overall Study|Randomized but not treated|0|||
124849242|NCT01607905|449073152|FG002|Overall Study|Randomized but not treated|0|||
124849243|NCT01607905|449073153|FG003|Overall Study|Randomized but not treated|0|||
124849244|NCT01607905|449073154|FG004|Overall Study|Randomized but not treated|1|||
124849245|NCT01607905|449073155|FG005|Overall Study|Randomized but not treated|1|||
124849246|NCT01607905|449073156|FG006|Overall Study|Randomized but not treated|0|||
124849247|NCT01602315|449073157|FG000|Overall Study|Protocol Violation|0|||
124849248|NCT01602315|449073158|FG001|Overall Study|Protocol Violation|0|||
124849249|NCT01602315|449073159|FG002|Overall Study|Protocol Violation|0|||
124849250|NCT01602315|449073160|FG003|Overall Study|Protocol Violation|0|||
124849251|NCT01602315|449073161|FG004|Overall Study|Protocol Violation|0|||
124849252|NCT01602315|449073162|FG005|Overall Study|Protocol Violation|1|||
124849253|NCT01602315|449073163|FG006|Overall Study|Protocol Violation|0|||
124849254|NCT01602315|449073157|FG000|Overall Study|Physician Decision|2|||
124849255|NCT01602315|449073158|FG001|Overall Study|Physician Decision|0|||
124849256|NCT01602315|449073159|FG002|Overall Study|Physician Decision|0|||
124849257|NCT01602315|449073160|FG003|Overall Study|Physician Decision|0|||
124849258|NCT01602315|449073161|FG004|Overall Study|Physician Decision|2|||
124849259|NCT01602315|449073162|FG005|Overall Study|Physician Decision|1|||
124849260|NCT01602315|449073163|FG006|Overall Study|Physician Decision|1|||
124849261|NCT01602315|449073157|FG000|Overall Study|Disease progression|6|||
124849262|NCT01602315|449073158|FG001|Overall Study|Disease progression|3|||
124849263|NCT01602315|449073159|FG002|Overall Study|Disease progression|10|||
124849264|NCT01602315|449073160|FG003|Overall Study|Disease progression|1|||
124849265|NCT01602315|449073161|FG004|Overall Study|Disease progression|41|||
124849266|NCT01602315|449073162|FG005|Overall Study|Disease progression|12|||
124849267|NCT01602315|449073163|FG006|Overall Study|Disease progression|15|||
124849268|NCT01602315|449073157|FG000|Overall Study|Death|1|||
124849269|NCT01602315|449073158|FG001|Overall Study|Death|1|||
124849270|NCT01602315|449073159|FG002|Overall Study|Death|1|||
124849271|NCT01602315|449073160|FG003|Overall Study|Death|1|||
124849272|NCT01602315|449073161|FG004|Overall Study|Death|7|||
124849273|NCT01602315|449073162|FG005|Overall Study|Death|2|||
124849274|NCT01602315|449073163|FG006|Overall Study|Death|2|||
124849275|NCT01602315|449073157|FG000|Overall Study|Withdrawal by Subject|2|||
124849276|NCT01602315|449073158|FG001|Overall Study|Withdrawal by Subject|0|||
124849277|NCT01602315|449073159|FG002|Overall Study|Withdrawal by Subject|2|||
124849278|NCT01602315|449073160|FG003|Overall Study|Withdrawal by Subject|0|||
124849279|NCT01602315|449073161|FG004|Overall Study|Withdrawal by Subject|6|||
124849280|NCT01602315|449073162|FG005|Overall Study|Withdrawal by Subject|0|||
124849281|NCT01602315|449073163|FG006|Overall Study|Withdrawal by Subject|1|||
124849282|NCT01602315|449073157|FG000|Overall Study|Adverse Event|5|||
124849283|NCT01602315|449073158|FG001|Overall Study|Adverse Event|1|||
124849284|NCT01602315|449073159|FG002|Overall Study|Adverse Event|5|||
124849285|NCT01602315|449073160|FG003|Overall Study|Adverse Event|4|||
124849286|NCT01602315|449073161|FG004|Overall Study|Adverse Event|15|||
124849287|NCT01602315|449073162|FG005|Overall Study|Adverse Event|3|||
124849288|NCT01602315|449073163|FG006|Overall Study|Adverse Event|9|||
124849289|NCT01602315|449073157|FG000|Overall Study|Subject/guardian decision|0|||
124849290|NCT01602315|449073158|FG001|Overall Study|Subject/guardian decision|0|||
124849291|NCT01602315|449073159|FG002|Overall Study|Subject/guardian decision|0|||
124849292|NCT01602315|449073160|FG003|Overall Study|Subject/guardian decision|0|||
124849293|NCT01602315|449073161|FG004|Overall Study|Subject/guardian decision|0|||
124849294|NCT01602315|449073162|FG005|Overall Study|Subject/guardian decision|0|||
124849295|NCT01602315|449073163|FG006|Overall Study|Subject/guardian decision|1|||
124849296|NCT01602315|449073157|FG000|Overall Study|Cross-over patients to combo treatment|0|||
124849297|NCT01602315|449073158|FG001|Overall Study|Cross-over patients to combo treatment|0|||
124849298|NCT01602315|449073159|FG002|Overall Study|Cross-over patients to combo treatment|0|||
124849299|NCT01602315|449073160|FG003|Overall Study|Cross-over patients to combo treatment|0|||
124849300|NCT01602315|449073161|FG004|Overall Study|Cross-over patients to combo treatment|0|||
124849301|NCT01602315|449073162|FG005|Overall Study|Cross-over patients to combo treatment|16|||
124849302|NCT01602315|449073163|FG006|Overall Study|Cross-over patients to combo treatment|0|||
124849303|NCT00440271|449073165|FG000|Overall Study|Protocol Violation|1|||
124849304|NCT00440271|449073166|FG001|Overall Study|Protocol Violation|1|||
124849305|NCT00440271|449073165|FG000|Overall Study|Adverse Event|0|||
124849306|NCT00440271|449073166|FG001|Overall Study|Adverse Event|1|||
124849307|NCT00440271|449073165|FG000|Overall Study|Lost to Follow-up|1|||
124849308|NCT00440271|449073166|FG001|Overall Study|Lost to Follow-up|0|||
124849309|NCT00440271|449073165|FG000|Overall Study|Withdrawal by Subject|0|||
124849310|NCT00440271|449073166|FG001|Overall Study|Withdrawal by Subject|2|||
124849311|NCT00440271|449073165|FG000|Overall Study|Lack of Efficacy|0|||
124849312|NCT00440271|449073166|FG001|Overall Study|Lack of Efficacy|1|||
124849313|NCT00440271|449073165|FG000|Overall Study|Due to closure of trial|8|||
124849314|NCT00440271|449073166|FG001|Overall Study|Due to closure of trial|10|||
124849315|NCT00440271|449073165|FG000|Overall Study|Other|2|||
124849316|NCT00440271|449073166|FG001|Overall Study|Other|0|||
124849317|NCT00723801|449073167|FG000|Overall Study|Lost to Follow-up|1|||
124849318|NCT00723801|449073168|FG001|Overall Study|Lost to Follow-up|2|||
124849319|NCT00723801|449073167|FG000|Overall Study|Protocol Violation|2|||
124849320|NCT00723801|449073168|FG001|Overall Study|Protocol Violation|1|||
124849321|NCT01565993|449073171|FG000|Overall Study|Physician Decision|0|||
124849322|NCT01565993|449073172|FG001|Overall Study|Physician Decision|3|||
124849323|NCT01824303|449073173|FG000|Randomized Study|Withdrawal by Subject|1|||
124849324|NCT01824303|449073174|FG001|Randomized Study|Withdrawal by Subject|1|||
124849325|NCT01824303|449073173|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
124849326|NCT01824303|449073174|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
124849327|NCT04086472|449073175|FG000|Overall Study|Lost to Follow-up|1|||
124849328|NCT04086472|449073176|FG001|Overall Study|Lost to Follow-up|0|||
124849329|NCT04086472|449073177|FG002|Overall Study|Lost to Follow-up|0|||
124849330|NCT04086472|449073178|FG003|Overall Study|Lost to Follow-up|0|||
124849331|NCT04086472|449073179|FG004|Overall Study|Lost to Follow-up|1|||
124849332|NCT04086472|449073175|FG000|Overall Study|Physician Decision|0|||
124849333|NCT04086472|449073176|FG001|Overall Study|Physician Decision|1|||
124849334|NCT04086472|449073177|FG002|Overall Study|Physician Decision|1|||
124849335|NCT04086472|449073178|FG003|Overall Study|Physician Decision|0|||
124849336|NCT04086472|449073179|FG004|Overall Study|Physician Decision|0|||
124849337|NCT04086472|449073175|FG000|Overall Study|Withdrawal by Subject|1|||
124849338|NCT04086472|449073176|FG001|Overall Study|Withdrawal by Subject|1|||
124849339|NCT04086472|449073177|FG002|Overall Study|Withdrawal by Subject|1|||
124849340|NCT04086472|449073178|FG003|Overall Study|Withdrawal by Subject|0|||
124849341|NCT04086472|449073179|FG004|Overall Study|Withdrawal by Subject|0|||
124849342|NCT04086472|449073175|FG000|Overall Study|Various reasons|2|||
124849343|NCT04086472|449073176|FG001|Overall Study|Various reasons|0|||
124849344|NCT04086472|449073177|FG002|Overall Study|Various reasons|0|||
124849345|NCT04086472|449073178|FG003|Overall Study|Various reasons|3|||
124849346|NCT04086472|449073179|FG004|Overall Study|Various reasons|1|||
124849347|NCT00844545|449073180|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
124849348|NCT00844545|449073180|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
124849349|NCT00844545|449073180|FG000|Extension Treatment Period|Adverse Event|2|||
124849350|NCT00844545|449073180|FG000|Post Treatment Period|Withdrawal by Subject|1|||
124849351|NCT01743092|449073181|FG000|Overall Study|Lost to Follow-up|14|||
124849352|NCT01743092|449073182|FG001|Overall Study|Lost to Follow-up|15|||
124849353|NCT03586869|449073188|FG000|Overall Study|Progressive Disease|3|||
124849354|NCT00403455|449073189|FG000|Overall Study|Withdrawal by Subject|1|||
124849355|NCT02809976|449073196|FG000|Overall Study|Lost to Follow-up|1|||
124849356|NCT02809976|449073196|FG000|Overall Study|Withdrawal by Subject|1|||
124849357|NCT00087568|449073197|FG000|Overall Study|Adverse Event|4|||
124849358|NCT00087568|449073198|FG001|Overall Study|Adverse Event|0|||
124849359|NCT00087568|449073197|FG000|Overall Study|Withdrawal by Subject|1|||
124849360|NCT00087568|449073198|FG001|Overall Study|Withdrawal by Subject|1|||
124849361|NCT00087568|449073197|FG000|Overall Study|Lost to Follow-up|1|||
124849362|NCT00087568|449073198|FG001|Overall Study|Lost to Follow-up|0|||
124849363|NCT00087568|449073197|FG000|Overall Study|Lack of Efficacy|24|||
124849364|NCT00087568|449073198|FG001|Overall Study|Lack of Efficacy|1|||
124849365|NCT04394351|449073199|FG000|Part A (16 Weeks)|Adverse Event|1|||
124849366|NCT04394351|449073200|FG001|Part A (16 Weeks)|Adverse Event|0|||
124849367|NCT04394351|449073201|FG002|Part A (16 Weeks)|Adverse Event|0|||
124849368|NCT04394351|449073202|FG003|Part A (16 Weeks)|Adverse Event|0|||
124849369|NCT04394351|449073203|FG004|Part A (16 Weeks)|Adverse Event|0|||
124849370|NCT04394351|449073204|FG005|Part A (16 Weeks)|Adverse Event|0|||
124849371|NCT04394351|449073205|FG006|Part A (16 Weeks)|Adverse Event|0|||
124849372|NCT04394351|449073206|FG007|Part A (16 Weeks)|Adverse Event|0|||
124849373|NCT04394351|449073199|FG000|Part A (16 Weeks)|Physician Decision|0|||
124849374|NCT04394351|449073200|FG001|Part A (16 Weeks)|Physician Decision|1|||
124849375|NCT04394351|449073201|FG002|Part A (16 Weeks)|Physician Decision|0|||
124849376|NCT04394351|449073202|FG003|Part A (16 Weeks)|Physician Decision|0|||
124849377|NCT04394351|449073203|FG004|Part A (16 Weeks)|Physician Decision|0|||
124849378|NCT04394351|449073204|FG005|Part A (16 Weeks)|Physician Decision|0|||
124849379|NCT04394351|449073205|FG006|Part A (16 Weeks)|Physician Decision|0|||
124849380|NCT04394351|449073206|FG007|Part A (16 Weeks)|Physician Decision|0|||
124849381|NCT04394351|449073199|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
124849382|NCT04394351|449073200|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
124849383|NCT04394351|449073201|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
124849384|NCT04394351|449073202|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
124849385|NCT04394351|449073203|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
124849386|NCT04394351|449073204|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
124849387|NCT04394351|449073205|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
124849388|NCT04394351|449073206|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
124849389|NCT04394351|449073199|FG000|Part B (36 Weeks)|Adverse Event|0|||
124849390|NCT04394351|449073200|FG001|Part B (36 Weeks)|Adverse Event|0|||
124849391|NCT04394351|449073201|FG002|Part B (36 Weeks)|Adverse Event|0|||
124849392|NCT04394351|449073202|FG003|Part B (36 Weeks)|Adverse Event|0|||
124849393|NCT04394351|449073203|FG004|Part B (36 Weeks)|Adverse Event|0|||
124849394|NCT04394351|449073204|FG005|Part B (36 Weeks)|Adverse Event|0|||
124849395|NCT04394351|449073205|FG006|Part B (36 Weeks)|Adverse Event|1|||
124849396|NCT04394351|449073206|FG007|Part B (36 Weeks)|Adverse Event|0|||
124849397|NCT02738775|449073211|FG000|Overall Study|Withdrawal by Subject|0|||
124849398|NCT02738775|449073212|FG001|Overall Study|Withdrawal by Subject|1|||
124849399|NCT02738775|449073213|FG002|Overall Study|Withdrawal by Subject|0|||
124849400|NCT02738775|449073214|FG003|Overall Study|Withdrawal by Subject|0|||
124849401|NCT02738775|449073215|FG004|Overall Study|Withdrawal by Subject|0|||
124849402|NCT02738775|449073216|FG005|Overall Study|Withdrawal by Subject|0|||
124849403|NCT02738775|449073211|FG000|Overall Study|Adverse Event|0|||
124849404|NCT02738775|449073212|FG001|Overall Study|Adverse Event|0|||
124849405|NCT02738775|449073213|FG002|Overall Study|Adverse Event|0|||
124849406|NCT02738775|449073214|FG003|Overall Study|Adverse Event|1|||
124849407|NCT02738775|449073215|FG004|Overall Study|Adverse Event|0|||
124849408|NCT02738775|449073216|FG005|Overall Study|Adverse Event|0|||
124849409|NCT02738775|449073211|FG000|Overall Study|Pregnancy|0|||
124849410|NCT02738775|449073212|FG001|Overall Study|Pregnancy|1|||
124849411|NCT02738775|449073213|FG002|Overall Study|Pregnancy|0|||
124849412|NCT02738775|449073214|FG003|Overall Study|Pregnancy|0|||
124849413|NCT02738775|449073215|FG004|Overall Study|Pregnancy|0|||
124849414|NCT02738775|449073216|FG005|Overall Study|Pregnancy|0|||
124849415|NCT02738775|449073211|FG000|Overall Study|Missing|0|||
124849416|NCT02738775|449073212|FG001|Overall Study|Missing|0|||
124849417|NCT02738775|449073213|FG002|Overall Study|Missing|0|||
124849418|NCT02738775|449073214|FG003|Overall Study|Missing|0|||
124849419|NCT02738775|449073215|FG004|Overall Study|Missing|0|||
124849420|NCT02738775|449073216|FG005|Overall Study|Missing|1|||
124849421|NCT02992899|449073217|FG000|Overall Study|Withdrawal by Subject|1|||
124849422|NCT02992899|449073218|FG001|Overall Study|Withdrawal by Subject|0|||
124849423|NCT02992899|449073217|FG000|Overall Study|Lost to Follow-up|1|||
124849424|NCT02992899|449073218|FG001|Overall Study|Lost to Follow-up|3|||
124849425|NCT04574362|449073219|FG000|Overall Study|Other|0|||
124849426|NCT04574362|449073220|FG001|Overall Study|Other|5|||
124849427|NCT04574362|449073219|FG000|Overall Study|COVID-19|0|||
124849428|NCT04574362|449073220|FG001|Overall Study|COVID-19|1|||
124849429|NCT04574362|449073219|FG000|Overall Study|Adverse Event|1|||
124849430|NCT04574362|449073220|FG001|Overall Study|Adverse Event|1|||
124849431|NCT04574362|449073219|FG000|Overall Study|Withdrawal by Subject|2|||
124849432|NCT04574362|449073220|FG001|Overall Study|Withdrawal by Subject|4|||
124849433|NCT04574362|449073219|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
124849434|NCT04574362|449073220|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
124849435|NCT04574362|449073219|FG000|Overall Study|Participant refused to come to the hospital|1|||
124849436|NCT04574362|449073220|FG001|Overall Study|Participant refused to come to the hospital|0|||
124849437|NCT04574362|449073219|FG000|Overall Study|Participant refused the visit|1|||
124849438|NCT04574362|449073220|FG001|Overall Study|Participant refused the visit|0|||
124849439|NCT04574362|449073219|FG000|Overall Study|Participant quit early because of business trip|1|||
124849440|NCT04574362|449073220|FG001|Overall Study|Participant quit early because of business trip|0|||
124849441|NCT01060384|449073221|FG000|Overall Study|Withdrawal by Subject|0|||
124849442|NCT01060384|449073222|FG001|Overall Study|Withdrawal by Subject|1|||
124849443|NCT01060384|449073223|FG002|Overall Study|Withdrawal by Subject|0|||
124849444|NCT01060384|449073224|FG003|Overall Study|Withdrawal by Subject|0|||
124849445|NCT01060384|449073225|FG004|Overall Study|Withdrawal by Subject|0|||
124849446|NCT01060384|449073221|FG000|Overall Study|Death|0|||
124849447|NCT01060384|449073222|FG001|Overall Study|Death|0|||
124849448|NCT01060384|449073223|FG002|Overall Study|Death|0|||
124849449|NCT01060384|449073224|FG003|Overall Study|Death|0|||
124849450|NCT01060384|449073225|FG004|Overall Study|Death|1|||
124849451|NCT01060384|449073221|FG000|Overall Study|Intercurrent illness|0|||
124849452|NCT01060384|449073222|FG001|Overall Study|Intercurrent illness|0|||
124849453|NCT01060384|449073223|FG002|Overall Study|Intercurrent illness|0|||
124849454|NCT01060384|449073224|FG003|Overall Study|Intercurrent illness|0|||
124849455|NCT01060384|449073225|FG004|Overall Study|Intercurrent illness|1|||
124849456|NCT00812929|449073228|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
124849457|NCT00812929|449073229|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
124849458|NCT00812929|449073230|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
124849459|NCT00812929|449073231|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
124849460|NCT00812929|449073232|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
124849461|NCT00812929|449073233|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
124849462|NCT00812929|449073234|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
124849463|NCT00812929|449073235|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
124849464|NCT00812929|449073236|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
124849465|NCT00812929|449073237|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
124849466|NCT00812929|449073228|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
124849467|NCT00812929|449073229|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
124849468|NCT00812929|449073230|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
124849469|NCT00812929|449073231|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
124849470|NCT00812929|449073232|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
124849471|NCT00812929|449073233|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
124849472|NCT00812929|449073234|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
124849473|NCT00812929|449073235|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
124849474|NCT00812929|449073236|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
124849475|NCT00812929|449073237|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
124849476|NCT00812929|449073228|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
124849477|NCT00812929|449073229|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
124849478|NCT00812929|449073230|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
124849479|NCT00812929|449073231|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
124849480|NCT00812929|449073232|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
124849481|NCT00812929|449073233|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
124849482|NCT00812929|449073234|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
124849483|NCT00812929|449073235|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
124849484|NCT00812929|449073236|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
124849485|NCT00812929|449073237|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
124849486|NCT00211081|449073239|FG000|Overall Study|Withdrawal by Subject|2|||
124849487|NCT01332305|449073240|FG000|Overall Study|Adverse Event|1|||
124849488|NCT01332305|449073241|FG001|Overall Study|Adverse Event|4|||
124849489|NCT01332305|449073242|FG002|Overall Study|Adverse Event|6|||
124849490|NCT01332305|449073243|FG003|Overall Study|Adverse Event|3|||
124849491|NCT01332305|449073244|FG004|Overall Study|Adverse Event|5|||
124849492|NCT01332305|449073240|FG000|Overall Study|Withdrawal by Subject|6|||
124849493|NCT01332305|449073241|FG001|Overall Study|Withdrawal by Subject|5|||
124849494|NCT01332305|449073242|FG002|Overall Study|Withdrawal by Subject|4|||
124849495|NCT01332305|449073243|FG003|Overall Study|Withdrawal by Subject|1|||
124849496|NCT01332305|449073244|FG004|Overall Study|Withdrawal by Subject|0|||
124849497|NCT01332305|449073240|FG000|Overall Study|Lost to Follow-up|0|||
124849498|NCT01332305|449073241|FG001|Overall Study|Lost to Follow-up|2|||
124849499|NCT01332305|449073242|FG002|Overall Study|Lost to Follow-up|3|||
124849500|NCT01332305|449073243|FG003|Overall Study|Lost to Follow-up|2|||
124849501|NCT01332305|449073244|FG004|Overall Study|Lost to Follow-up|3|||
124849502|NCT01332305|449073240|FG000|Overall Study|Protocol Violation|1|||
124849503|NCT01332305|449073241|FG001|Overall Study|Protocol Violation|2|||
124849504|NCT01332305|449073242|FG002|Overall Study|Protocol Violation|1|||
124849505|NCT01332305|449073243|FG003|Overall Study|Protocol Violation|0|||
124849506|NCT01332305|449073244|FG004|Overall Study|Protocol Violation|3|||
124849507|NCT01332305|449073240|FG000|Overall Study|Withdrawal by Sponsor|1|||
124849508|NCT01332305|449073241|FG001|Overall Study|Withdrawal by Sponsor|0|||
124849509|NCT01332305|449073242|FG002|Overall Study|Withdrawal by Sponsor|0|||
124849510|NCT01332305|449073243|FG003|Overall Study|Withdrawal by Sponsor|1|||
124849511|NCT01332305|449073244|FG004|Overall Study|Withdrawal by Sponsor|1|||
124849512|NCT01332305|449073240|FG000|Overall Study|Treatment Failure|1|||
124849513|NCT01332305|449073241|FG001|Overall Study|Treatment Failure|1|||
124849514|NCT01332305|449073242|FG002|Overall Study|Treatment Failure|0|||
124849515|NCT01332305|449073243|FG003|Overall Study|Treatment Failure|0|||
124849516|NCT01332305|449073244|FG004|Overall Study|Treatment Failure|0|||
124849517|NCT01332305|449073240|FG000|Overall Study|Physician Decision|0|||
124849518|NCT01332305|449073241|FG001|Overall Study|Physician Decision|0|||
124849519|NCT01332305|449073242|FG002|Overall Study|Physician Decision|0|||
124849520|NCT01332305|449073243|FG003|Overall Study|Physician Decision|1|||
124849521|NCT01332305|449073244|FG004|Overall Study|Physician Decision|0|||
124849522|NCT01600040|449073245|FG000|Overall Study|Withdrawal by Subject|1|||
124849523|NCT04713748|449073246|FG000|Overall Study|Not enough kits allocated|35|||
124849524|NCT00113516|449073247|FG000|Part 1|Adverse Event|6|||
124849525|NCT00113516|449073248|FG001|Part 1|Adverse Event|0|||
124849526|NCT00113516|449073247|FG000|Part 1|Death|3|||
124849527|NCT00113516|449073248|FG001|Part 1|Death|0|||
124849528|NCT00113516|449073247|FG000|Part 1|Other|3|||
124849529|NCT00113516|449073248|FG001|Part 1|Other|0|||
124849530|NCT00113516|449073247|FG000|Part 1|Withdrawal by Subject|2|||
124849531|NCT00113516|449073248|FG001|Part 1|Withdrawal by Subject|0|||
124849532|NCT00113516|449073247|FG000|Part 1|Lack of Efficacy|2|||
124849533|NCT00113516|449073248|FG001|Part 1|Lack of Efficacy|0|||
124849534|NCT00113516|449073247|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
124849535|NCT00113516|449073248|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
124849536|NCT00113516|449073247|FG000|Part 1|Laboratory Abnormality|1|||
124849537|NCT00113516|449073248|FG001|Part 1|Laboratory Abnormality|0|||
124849538|NCT00113516|449073247|FG000|Part 1|Ongoing|1|||
124849539|NCT00113516|449073248|FG001|Part 1|Ongoing|0|||
124849540|NCT00113516|449073247|FG000|Part 1|Missing|65|||
124849541|NCT00113516|449073248|FG001|Part 1|Missing|0|||
124849542|NCT00113516|449073247|FG000|Part 2|Adverse Event|0|||
124849543|NCT00113516|449073248|FG001|Part 2|Adverse Event|16|||
124849544|NCT00113516|449073247|FG000|Part 2|Death|0|||
124849545|NCT00113516|449073248|FG001|Part 2|Death|5|||
124849546|NCT00113516|449073247|FG000|Part 2|Lack of Efficacy|0|||
124849547|NCT00113516|449073248|FG001|Part 2|Lack of Efficacy|37|||
124849548|NCT00113516|449073247|FG000|Part 2|Withdrawal by Subject|0|||
124849549|NCT00113516|449073248|FG001|Part 2|Withdrawal by Subject|3|||
124849550|NCT00113516|449073247|FG000|Part 2|Other|0|||
124849551|NCT00113516|449073248|FG001|Part 2|Other|3|||
124849552|NCT00113516|449073247|FG000|Part 2|Laboratory Abnormality|0|||
124849553|NCT00113516|449073248|FG001|Part 2|Laboratory Abnormality|1|||
124849554|NCT00113516|449073247|FG000|Part 2|Ongoing|0|||
124849555|NCT00113516|449073248|FG001|Part 2|Ongoing|1|||
124849556|NCT00642304|449073249|FG000|Overall Study|Adverse Event|1|||
124849557|NCT00642304|449073249|FG000|Overall Study|Death|1|||
124849558|NCT00642304|449073249|FG000|Overall Study|Blood transfusion|2|||
124849559|NCT00642304|449073249|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
124849560|NCT00642304|449073249|FG000|Overall Study|Transplantation|1|||
124849561|NCT00812812|449073259|FG000|Overall Study|Adverse Event|2|||
124849562|NCT00812812|449073260|FG001|Overall Study|Adverse Event|1|||
124849563|NCT00812812|449073259|FG000|Overall Study|Lack of Efficacy|1|||
124849564|NCT00812812|449073260|FG001|Overall Study|Lack of Efficacy|0|||
124849565|NCT00812812|449073259|FG000|Overall Study|Lost to Follow-up|0|||
124849566|NCT00812812|449073260|FG001|Overall Study|Lost to Follow-up|1|||
124849567|NCT00812812|449073259|FG000|Overall Study|Withdrawal by Subject|0|||
124849568|NCT00812812|449073260|FG001|Overall Study|Withdrawal by Subject|2|||
124849569|NCT03755765|449073261|FG000|Overall Study|Withdrawal by Subject|2|||
124849570|NCT03755765|449073262|FG001|Overall Study|Withdrawal by Subject|4|||
124849571|NCT03755765|449073263|FG002|Overall Study|Withdrawal by Subject|4|||
124849572|NCT00678691|449073269|FG000|Overall Study|Adverse Event|6|||
124849573|NCT00678691|449073270|FG001|Overall Study|Adverse Event|4|||
124849574|NCT01599650|449073278|FG000|Overall Study|Administrative issue|1|||
124849575|NCT01599650|449073279|FG001|Overall Study|Administrative issue|0|||
124849576|NCT01599650|449073280|FG002|Overall Study|Administrative issue|1|||
124849577|NCT01599650|449073278|FG000|Overall Study|Physician Decision|2|||
124849578|NCT01599650|449073279|FG001|Overall Study|Physician Decision|0|||
124849579|NCT01599650|449073280|FG002|Overall Study|Physician Decision|7|||
124849580|NCT01599650|449073278|FG000|Overall Study|Protocol Violation|0|||
124849581|NCT01599650|449073279|FG001|Overall Study|Protocol Violation|3|||
124849582|NCT01599650|449073280|FG002|Overall Study|Protocol Violation|0|||
124849583|NCT01599650|449073278|FG000|Overall Study|Death|2|||
124849584|NCT01599650|449073279|FG001|Overall Study|Death|1|||
124849585|NCT01599650|449073280|FG002|Overall Study|Death|2|||
124849586|NCT01599650|449073278|FG000|Overall Study|Lost to Follow-up|3|||
124849587|NCT01599650|449073279|FG001|Overall Study|Lost to Follow-up|3|||
124849588|NCT01599650|449073280|FG002|Overall Study|Lost to Follow-up|3|||
124849589|NCT01599650|449073278|FG000|Overall Study|Withdrawal by Subject|11|||
124849590|NCT01599650|449073279|FG001|Overall Study|Withdrawal by Subject|11|||
124849591|NCT01599650|449073280|FG002|Overall Study|Withdrawal by Subject|10|||
124849592|NCT01599650|449073278|FG000|Overall Study|Adverse Event|3|||
124849593|NCT01599650|449073279|FG001|Overall Study|Adverse Event|8|||
124849594|NCT01599650|449073280|FG002|Overall Study|Adverse Event|4|||
124849595|NCT00684424|449073284|FG000|Overall Study|Adverse Event|1|||
124849596|NCT00684424|449073284|FG000|Overall Study|Lost to Follow-up|2|||
124849597|NCT00684424|449073284|FG000|Overall Study|Other|2|||
124849598|NCT02410811|449073285|FG000|Overall Study|Withdrawal by Subject|0|||
124849599|NCT02410811|449073286|FG001|Overall Study|Withdrawal by Subject|0|||
124849600|NCT02410811|449073287|FG002|Overall Study|Withdrawal by Subject|1|||
124849601|NCT02410811|449073288|FG003|Overall Study|Withdrawal by Subject|0|||
124849602|NCT00057746|449073289|FG000|Overall Study|Withdrawal by Subject|0|||
124849603|NCT00057746|449073290|FG001|Overall Study|Withdrawal by Subject|0|||
124849604|NCT00057746|449073291|FG002|Overall Study|Withdrawal by Subject|1|||
124849605|NCT00439140|449073294|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
124849606|NCT00439140|449073295|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
124849607|NCT00439140|449073296|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
124849608|NCT00439140|449073294|FG000|Treatment Cycle 1|Personal reasons|0|||
124849609|NCT00439140|449073295|FG001|Treatment Cycle 1|Personal reasons|2|||
124849610|NCT00439140|449073296|FG002|Treatment Cycle 1|Personal reasons|0|||
124849611|NCT00439140|449073294|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
124849612|NCT00439140|449073295|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
124849613|NCT00439140|449073296|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
124849614|NCT00439140|449073294|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
124849615|NCT00439140|449073295|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
124849616|NCT00439140|449073296|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
124849617|NCT00439140|449073294|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
124849618|NCT00439140|449073295|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
124849619|NCT00439140|449073296|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
124849620|NCT04154631|449073297|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
124849621|NCT04154631|449073298|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
124849622|NCT01466192|449073308|FG000|Overall Study|Physician Decision|1|||
124849623|NCT01466192|449073308|FG000|Overall Study|Withdrawal by Subject|3|||
124849624|NCT00700011|449073311|FG000|Overall Study|Death|0|||
124849625|NCT00700011|449073312|FG001|Overall Study|Death|1|||
124849626|NCT00678561|449073313|FG000|Overall Study|Adverse Event|0|||
124849627|NCT00678561|449073314|FG001|Overall Study|Adverse Event|1|||
124849628|NCT00678561|449073315|FG002|Overall Study|Adverse Event|1|||
124849629|NCT00678561|449073316|FG003|Overall Study|Adverse Event|0|||
124849630|NCT00678561|449073317|FG004|Overall Study|Adverse Event|1|||
124849631|NCT00678561|449073318|FG005|Overall Study|Adverse Event|0|||
124849632|NCT00678561|449073319|FG006|Overall Study|Adverse Event|0|||
124849633|NCT00678561|449073320|FG007|Overall Study|Adverse Event|0|||
124849634|NCT00678561|449073313|FG000|Overall Study|Protocol Violation|0|||
124849635|NCT00678561|449073314|FG001|Overall Study|Protocol Violation|0|||
124849636|NCT00678561|449073315|FG002|Overall Study|Protocol Violation|0|||
124849637|NCT00678561|449073316|FG003|Overall Study|Protocol Violation|0|||
124849638|NCT00678561|449073317|FG004|Overall Study|Protocol Violation|1|||
124849639|NCT00678561|449073318|FG005|Overall Study|Protocol Violation|1|||
124849640|NCT00678561|449073319|FG006|Overall Study|Protocol Violation|0|||
124849641|NCT00678561|449073320|FG007|Overall Study|Protocol Violation|0|||
124849642|NCT00678561|449073313|FG000|Overall Study|Withdrawal by Subject|0|||
124849643|NCT00678561|449073314|FG001|Overall Study|Withdrawal by Subject|0|||
124849644|NCT00678561|449073315|FG002|Overall Study|Withdrawal by Subject|0|||
124849645|NCT00678561|449073316|FG003|Overall Study|Withdrawal by Subject|0|||
124849646|NCT00678561|449073317|FG004|Overall Study|Withdrawal by Subject|0|||
124849647|NCT00678561|449073318|FG005|Overall Study|Withdrawal by Subject|0|||
124849648|NCT00678561|449073319|FG006|Overall Study|Withdrawal by Subject|0|||
124849649|NCT00678561|449073320|FG007|Overall Study|Withdrawal by Subject|1|||
124849650|NCT00437034|449073321|FG000|Overall Study|Adverse Event|1|||
124849651|NCT00437034|449073321|FG000|Overall Study|Disease progression during treatment|5|||
124849652|NCT00853658|449073323|FG000|Overall Study|Death|713|||
124849653|NCT00853658|449073324|FG001|Overall Study|Death|768|||
124849654|NCT00853658|449073325|FG002|Overall Study|Death|753|||
124849655|NCT00853658|449073323|FG000|Overall Study|Lost to Follow-up|11|||
124849656|NCT00853658|449073324|FG001|Overall Study|Lost to Follow-up|6|||
124849657|NCT00853658|449073325|FG002|Overall Study|Lost to Follow-up|11|||
124849658|NCT00853658|449073323|FG000|Overall Study|H.A. Request|26|||
124849659|NCT00853658|449073324|FG001|Overall Study|H.A. Request|23|||
124849660|NCT00853658|449073325|FG002|Overall Study|H.A. Request|19|||
124849661|NCT00853658|449073323|FG000|Overall Study|IRB request|0|||
124849662|NCT00853658|449073324|FG001|Overall Study|IRB request|0|||
124849663|NCT00853658|449073325|FG002|Overall Study|IRB request|2|||
124849664|NCT00853658|449073323|FG000|Overall Study|Vital Status known (alive) at study end|2|||
124849665|NCT00853658|449073324|FG001|Overall Study|Vital Status known (alive) at study end|3|||
124849666|NCT00853658|449073325|FG002|Overall Study|Vital Status known (alive) at study end|3|||
124849667|NCT00853658|449073323|FG000|Overall Study|Vital Status unknown at study end|1|||
124849668|NCT00853658|449073324|FG001|Overall Study|Vital Status unknown at study end|1|||
124849669|NCT00853658|449073325|FG002|Overall Study|Vital Status unknown at study end|0|||
124849670|NCT00853658|449073323|FG000|Overall Study|Vital Status at study end N/A|8|||
124849671|NCT00853658|449073324|FG001|Overall Study|Vital Status at study end N/A|10|||
124849672|NCT00853658|449073325|FG002|Overall Study|Vital Status at study end N/A|10|||
124849673|NCT00853658|449073323|FG000|Overall Study|Patient's request|21|||
124849674|NCT00853658|449073324|FG001|Overall Study|Patient's request|17|||
124849675|NCT00853658|449073325|FG002|Overall Study|Patient's request|11|||
124849676|NCT00853658|449073323|FG000|Overall Study|Missing study completion information|5|||
124849677|NCT00853658|449073324|FG001|Overall Study|Missing study completion information|4|||
124849678|NCT00853658|449073325|FG002|Overall Study|Missing study completion information|6|||
124849679|NCT01976845|449073326|FG000|Overall Study|Physician Decision|8|||
124849680|NCT01976845|449073327|FG001|Overall Study|Physician Decision|8|||
124849681|NCT01976845|449073328|FG002|Overall Study|Physician Decision|3|||
124849682|NCT03246529|449073330|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
124849683|NCT03246529|449073331|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
124849684|NCT03246529|449073332|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
124849685|NCT03246529|449073330|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
124849686|NCT03246529|449073331|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
124849687|NCT03246529|449073332|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
124849688|NCT03246529|449073330|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
124849689|NCT03246529|449073331|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
124849690|NCT03246529|449073332|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
124849691|NCT03246529|449073330|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
124849692|NCT03246529|449073331|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
124849693|NCT03246529|449073332|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
124849694|NCT03246529|449073330|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
124849695|NCT03246529|449073331|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
124849696|NCT03246529|449073332|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
124849697|NCT03246529|449073330|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
124849698|NCT03246529|449073331|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
124849699|NCT03246529|449073332|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
124849700|NCT03246529|449073330|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
124849701|NCT03246529|449073331|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
124849702|NCT03246529|449073332|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
124849703|NCT03246529|449073330|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
124849704|NCT03246529|449073331|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
124849705|NCT03246529|449073332|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
124849706|NCT03246529|449073330|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
124849707|NCT03246529|449073331|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
124849708|NCT03246529|449073332|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
124849709|NCT01209624|449073333|FG000|Overall Study|Death|2|||
124849710|NCT01209624|449073333|FG000|Overall Study|Adverse Event|13|||
124849711|NCT01209624|449073333|FG000|Overall Study|Lack of Efficacy|17|||
124849712|NCT01209624|449073333|FG000|Overall Study|Lost to Follow-up|290|||
124849713|NCT01209624|449073333|FG000|Overall Study|Other|4|||
124849714|NCT00441337|449073338|FG000|Overall Study|Disease Progression|6|||
124849715|NCT00441337|449073339|FG001|Overall Study|Disease Progression|6|||
124849716|NCT00441337|449073340|FG002|Overall Study|Disease Progression|4|||
124849717|NCT00441337|449073341|FG003|Overall Study|Disease Progression|18|||
124849718|NCT00441337|449073338|FG000|Overall Study|Lost to Follow-up|0|||
124849719|NCT00441337|449073339|FG001|Overall Study|Lost to Follow-up|0|||
124849720|NCT00441337|449073340|FG002|Overall Study|Lost to Follow-up|0|||
124849721|NCT00441337|449073341|FG003|Overall Study|Lost to Follow-up|1|||
124849722|NCT00441337|449073338|FG000|Overall Study|Sponsor Decision|0|||
124849723|NCT00441337|449073339|FG001|Overall Study|Sponsor Decision|0|||
124849724|NCT00441337|449073340|FG002|Overall Study|Sponsor Decision|1|||
124849725|NCT00441337|449073341|FG003|Overall Study|Sponsor Decision|2|||
124849726|NCT00441337|449073338|FG000|Overall Study|Did not meet inclusion criteria|0|||
124849727|NCT00441337|449073339|FG001|Overall Study|Did not meet inclusion criteria|0|||
124849728|NCT00441337|449073340|FG002|Overall Study|Did not meet inclusion criteria|1|||
124849729|NCT00441337|449073341|FG003|Overall Study|Did not meet inclusion criteria|0|||
124849730|NCT06748040|449073342|FG000|Overall Study|Death|3|||
124849731|NCT06748040|449073343|FG001|Overall Study|Death|4|||
124849732|NCT06748040|449073342|FG000|Overall Study|Lost to Follow-up|134|||
124849733|NCT06748040|449073343|FG001|Overall Study|Lost to Follow-up|132|||
124849734|NCT06748040|449073342|FG000|Overall Study|Withdrawal by Subject|3|||
124849735|NCT06748040|449073343|FG001|Overall Study|Withdrawal by Subject|5|||
124849736|NCT00827372|449075874|FG000|Overall Study|Adverse Event|5|||
124849737|NCT00827372|449075874|FG000|Overall Study|Lack of Efficacy|3|||
124849738|NCT02293005|449075875|FG000|Overall Study|Adverse Event|2|||
124849739|NCT02293005|449075875|FG000|Overall Study|Death|4|||
124849740|NCT02293005|449075875|FG000|Overall Study|Lost to Follow-up|1|||
124849741|NCT02293005|449075875|FG000|Overall Study|Withdrawal by Subject|2|||
124849742|NCT02293005|449075875|FG000|Overall Study|Progression|17|||
124849743|NCT00941733|449075880|FG000|Overall Study|Death|24|||
124849744|NCT00941733|449075881|FG001|Overall Study|Death|10|||
124849745|NCT00941733|449075880|FG000|Overall Study|Withdrawal by Subject|14|||
124849746|NCT00941733|449075881|FG001|Overall Study|Withdrawal by Subject|6|||
124849747|NCT00941733|449075880|FG000|Overall Study|Adverse Event|20|||
124849748|NCT00941733|449075881|FG001|Overall Study|Adverse Event|4|||
124849749|NCT00941733|449075880|FG000|Overall Study|Lost to Follow-up|1|||
124849750|NCT00941733|449075881|FG001|Overall Study|Lost to Follow-up|2|||
124849751|NCT00941733|449075880|FG000|Overall Study|Protocol Violation|15|||
124849752|NCT00941733|449075881|FG001|Overall Study|Protocol Violation|6|||
124849753|NCT00612066|449075884|FG000|Overall Study|Adverse Event|1|||
124849754|NCT00630877|449075885|FG000|Overall Study|Adverse Event|11|||
124849755|NCT00630877|449075886|FG001|Overall Study|Adverse Event|8|||
124849756|NCT00630877|449075887|FG002|Overall Study|Adverse Event|7|||
124849757|NCT00630877|449075885|FG000|Overall Study|Withdrawal by Subject|3|||
124849758|NCT00630877|449075886|FG001|Overall Study|Withdrawal by Subject|4|||
124849759|NCT00630877|449075887|FG002|Overall Study|Withdrawal by Subject|0|||
124849760|NCT00630877|449075885|FG000|Overall Study|Lost to Follow-up|2|||
124849761|NCT00630877|449075886|FG001|Overall Study|Lost to Follow-up|0|||
124849762|NCT00630877|449075887|FG002|Overall Study|Lost to Follow-up|0|||
124849763|NCT00630877|449075885|FG000|Overall Study|Noncompliance|2|||
124849764|NCT00630877|449075886|FG001|Overall Study|Noncompliance|3|||
124849765|NCT00630877|449075887|FG002|Overall Study|Noncompliance|1|||
124849766|NCT00630877|449075885|FG000|Overall Study|Protocol violation|1|||
124849767|NCT00630877|449075886|FG001|Overall Study|Protocol violation|0|||
124849768|NCT00630877|449075887|FG002|Overall Study|Protocol violation|1|||
124849769|NCT00630877|449075885|FG000|Overall Study|Personal reasons|0|||
124849770|NCT00630877|449075886|FG001|Overall Study|Personal reasons|0|||
124849771|NCT00630877|449075887|FG002|Overall Study|Personal reasons|1|||
124849772|NCT01529645|449075888|FG000|Overall Study|Lost to Follow-up|0|||
124849773|NCT01529645|449075889|FG001|Overall Study|Lost to Follow-up|1|||
124849774|NCT01529645|449075890|FG002|Overall Study|Lost to Follow-up|1|||
124849775|NCT01529645|449075891|FG003|Overall Study|Lost to Follow-up|1|||
124849776|NCT01529645|449075892|FG004|Overall Study|Lost to Follow-up|1|||
124849777|NCT01529645|449075893|FG005|Overall Study|Lost to Follow-up|0|||
124849778|NCT01529645|449075894|FG006|Overall Study|Lost to Follow-up|2|||
124849779|NCT01529645|449075895|FG007|Overall Study|Lost to Follow-up|0|||
124849780|NCT01529645|449075896|FG008|Overall Study|Lost to Follow-up|1|||
124849781|NCT01529645|449075897|FG009|Overall Study|Lost to Follow-up|0|||
124849782|NCT01529645|449075888|FG000|Overall Study|SAE - Premature contractions|0|||
124849783|NCT01529645|449075889|FG001|Overall Study|SAE - Premature contractions|0|||
124849784|NCT01529645|449075890|FG002|Overall Study|SAE - Premature contractions|1|||
124849785|NCT01529645|449075891|FG003|Overall Study|SAE - Premature contractions|0|||
124849786|NCT01529645|449075892|FG004|Overall Study|SAE - Premature contractions|0|||
124849787|NCT01529645|449075893|FG005|Overall Study|SAE - Premature contractions|0|||
124849788|NCT01529645|449075894|FG006|Overall Study|SAE - Premature contractions|0|||
124849789|NCT01529645|449075895|FG007|Overall Study|SAE - Premature contractions|0|||
124849790|NCT01529645|449075896|FG008|Overall Study|SAE - Premature contractions|0|||
124849791|NCT01529645|449075897|FG009|Overall Study|SAE - Premature contractions|0|||
124849792|NCT01529645|449075888|FG000|Overall Study|Withdrawal by Subject|2|||
124849793|NCT01529645|449075889|FG001|Overall Study|Withdrawal by Subject|0|||
124849794|NCT01529645|449075890|FG002|Overall Study|Withdrawal by Subject|0|||
124849795|NCT01529645|449075891|FG003|Overall Study|Withdrawal by Subject|1|||
124849796|NCT01529645|449075892|FG004|Overall Study|Withdrawal by Subject|1|||
124849797|NCT01529645|449075893|FG005|Overall Study|Withdrawal by Subject|1|||
124849798|NCT01529645|449075894|FG006|Overall Study|Withdrawal by Subject|0|||
124849799|NCT01529645|449075895|FG007|Overall Study|Withdrawal by Subject|0|||
124849800|NCT01529645|449075896|FG008|Overall Study|Withdrawal by Subject|0|||
124849801|NCT01529645|449075897|FG009|Overall Study|Withdrawal by Subject|0|||
124849802|NCT00048724|449075898|FG000|Overall Study|Adverse Event|53|||
124849803|NCT00048724|449075899|FG001|Overall Study|Adverse Event|12|||
124849804|NCT00048724|449075898|FG000|Overall Study|Withdrawal by Subject|34|||
124849805|NCT00048724|449075899|FG001|Overall Study|Withdrawal by Subject|54|||
124849806|NCT00048724|449075898|FG000|Overall Study|Lost to Follow-up|5|||
124849807|NCT00048724|449075899|FG001|Overall Study|Lost to Follow-up|5|||
124849808|NCT00048724|449075898|FG000|Overall Study|Protocol-defined Clinical Event|17|||
124849809|NCT00048724|449075899|FG001|Overall Study|Protocol-defined Clinical Event|32|||
124849810|NCT00048724|449075898|FG000|Overall Study|Noncompliance With Protocol|4|||
124849811|NCT00048724|449075899|FG001|Overall Study|Noncompliance With Protocol|12|||
124849812|NCT00048724|449075898|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
124849813|NCT00048724|449075899|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
124849814|NCT00048724|449075898|FG000|Overall Study|Administrative|1|||
124849815|NCT00048724|449075899|FG001|Overall Study|Administrative|1|||
124849816|NCT02863354|449075902|FG000|Year 1|Lost to Follow-up|1|||
124849817|NCT02863354|449075903|FG001|Year 1|Lost to Follow-up|1|||
124849818|NCT02863354|449075902|FG000|Year 1|Withdrawal by Subject|3|||
124849819|NCT02863354|449075903|FG001|Year 1|Withdrawal by Subject|0|||
124849820|NCT02863354|449075902|FG000|Year 1|Death|0|||
124849821|NCT02863354|449075903|FG001|Year 1|Death|1|||
124849822|NCT02863354|449075902|FG000|Year 2|Lost to Follow-up|2|||
124849823|NCT02863354|449075903|FG001|Year 2|Lost to Follow-up|2|||
124849824|NCT03235024|449075904|FG000|Overall Study|Adverse Event|2|||
124849825|NCT03235024|449075905|FG001|Overall Study|Adverse Event|2|||
124849826|NCT03235024|449075904|FG000|Overall Study|Death|1|||
124849827|NCT03235024|449075905|FG001|Overall Study|Death|0|||
124849828|NCT03235024|449075904|FG000|Overall Study|Lost to Follow-up|2|||
124849829|NCT03235024|449075905|FG001|Overall Study|Lost to Follow-up|5|||
124849830|NCT03235024|449075904|FG000|Overall Study|Protocol Violation|1|||
124849831|NCT03235024|449075905|FG001|Overall Study|Protocol Violation|0|||
124849832|NCT03235024|449075904|FG000|Overall Study|Withdrawal by Subject|0|||
124849833|NCT03235024|449075905|FG001|Overall Study|Withdrawal by Subject|3|||
124849834|NCT01632800|449075906|FG000|Overall Study|Subject did not fit in apparatus|1|||
124849835|NCT01243944|449075907|FG000|Overall Study|Adverse Event|15|||
124849836|NCT01243944|449075908|FG001|Overall Study|Adverse Event|13|||
124849837|NCT01243944|449075907|FG000|Overall Study|Lost to Follow-up|2|||
124849838|NCT01243944|449075908|FG001|Overall Study|Lost to Follow-up|1|||
124849839|NCT01243944|449075907|FG000|Overall Study|Physician Decision|2|||
124849840|NCT01243944|449075908|FG001|Overall Study|Physician Decision|7|||
124849841|NCT01243944|449075907|FG000|Overall Study|Disease progression|12|||
124849842|NCT01243944|449075908|FG001|Overall Study|Disease progression|11|||
124849843|NCT01243944|449075907|FG000|Overall Study|Protocol deviation|1|||
124849844|NCT01243944|449075908|FG001|Overall Study|Protocol deviation|1|||
124849845|NCT01243944|449075907|FG000|Overall Study|Participant decision|10|||
124849846|NCT01243944|449075908|FG001|Overall Study|Participant decision|15|||
124849847|NCT01243944|449075907|FG000|Overall Study|Death|2|||
124849848|NCT01243944|449075908|FG001|Overall Study|Death|3|||
124849849|NCT01243944|449075907|FG000|Overall Study|Non-compliance with study treatment|1|||
124849850|NCT01243944|449075908|FG001|Overall Study|Non-compliance with study treatment|0|||
124849851|NCT01416805|449075914|FG000|Overall Study|Lost to Follow-up|4|||
124849852|NCT01416805|449075915|FG001|Overall Study|Lost to Follow-up|4|||
124849853|NCT02802345|449075916|FG000|Overall Study|Not Treated|0|||
124849854|NCT02802345|449075917|FG001|Overall Study|Not Treated|1|||
124849855|NCT02802345|449075916|FG000|Overall Study|Adverse Event|28|||
124849856|NCT02802345|449075917|FG001|Overall Study|Adverse Event|20|||
124849857|NCT02802345|449075916|FG000|Overall Study|Withdrawal by Subject|3|||
124849858|NCT02802345|449075917|FG001|Overall Study|Withdrawal by Subject|3|||
124849859|NCT02802345|449075916|FG000|Overall Study|Protocol Violation|0|||
124849860|NCT02802345|449075917|FG001|Overall Study|Protocol Violation|1|||
124849861|NCT02802345|449075916|FG000|Overall Study|Other than listed|1|||
124849862|NCT02802345|449075917|FG001|Overall Study|Other than listed|5|||
124849863|NCT04632940|449075918|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
124849864|NCT04632940|449075919|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
124849865|NCT04632940|449075918|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
124849866|NCT04632940|449075919|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
124849867|NCT04632940|449075918|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
124849868|NCT04632940|449075919|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
124849869|NCT04632940|449075918|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
124849870|NCT04632940|449075919|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
124849871|NCT04632940|449075918|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
124849872|NCT04632940|449075919|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
124849873|NCT04632940|449075918|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
124849874|NCT04632940|449075919|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
124849875|NCT04632940|449075918|FG000|OLE Period (52 Weeks)|Other than specified|0|||
124849876|NCT04632940|449075919|FG001|OLE Period (52 Weeks)|Other than specified|1|||
124849877|NCT04632940|449075918|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
124849878|NCT04632940|449075919|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
124849879|NCT05857527|449075922|FG000|Overall Study|Withdrawal by Subject|0|||
124849880|NCT05857527|449075923|FG001|Overall Study|Withdrawal by Subject|1|||
124849881|NCT02799082|449075926|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
124849882|NCT02799082|449075927|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
124849883|NCT02799082|449075926|FG000|Overall Study|Protocol Violation|0|||
124849884|NCT02799082|449075927|FG001|Overall Study|Protocol Violation|1|||
124849885|NCT01748994|449075932|FG000|Overall Study|Lost to Follow-up|8|||
124849886|NCT01748994|449075933|FG001|Overall Study|Lost to Follow-up|6|||
124849887|NCT02520531|449075941|FG000|Overall Study|Revision of study device components|2|||
124849888|NCT02520531|449075942|FG001|Overall Study|Revision of study device components|2|||
124849889|NCT02520531|449075941|FG000|Overall Study|Death|1|||
124849890|NCT02520531|449075942|FG001|Overall Study|Death|2|||
124849891|NCT02520531|449075941|FG000|Overall Study|Lost to Follow-up|1|||
124849892|NCT02520531|449075942|FG001|Overall Study|Lost to Follow-up|1|||
124849893|NCT02520531|449075941|FG000|Overall Study|Meet exclusion criterion|0|||
124849894|NCT02520531|449075942|FG001|Overall Study|Meet exclusion criterion|1|||
124849895|NCT02520531|449075941|FG000|Overall Study|Withdrawal by Subject|1|||
124849896|NCT02520531|449075942|FG001|Overall Study|Withdrawal by Subject|0|||
124849897|NCT02520531|449075941|FG000|Overall Study|Not study device|1|||
124849898|NCT02520531|449075942|FG001|Overall Study|Not study device|0|||
124849899|NCT01723904|449075945|FG000|Overall Study|Noncompliant|3|||
124849900|NCT01723904|449075945|FG000|Overall Study|Adverse Event|5|||
124849901|NCT01723904|449075945|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
124849902|NCT03251924|449075946|FG000|Overall Study|Disease Progression|6|||
124849903|NCT03251924|449075947|FG001|Overall Study|Disease Progression|6|||
124849904|NCT03251924|449075948|FG002|Overall Study|Disease Progression|7|||
124849905|NCT03251924|449075949|FG003|Overall Study|Disease Progression|8|||
124849906|NCT03251924|449075950|FG004|Overall Study|Disease Progression|8|||
124849907|NCT03251924|449075951|FG005|Overall Study|Disease Progression|7|||
124849908|NCT03251924|449075952|FG006|Overall Study|Disease Progression|6|||
124849909|NCT03251924|449075953|FG007|Overall Study|Disease Progression|10|||
124849910|NCT03251924|449075954|FG008|Overall Study|Disease Progression|6|||
124849911|NCT03251924|449075946|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
124849912|NCT03251924|449075947|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
124849913|NCT03251924|449075948|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
124849914|NCT03251924|449075949|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
124849915|NCT03251924|449075950|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
124849916|NCT03251924|449075951|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
124849917|NCT03251924|449075952|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
124849918|NCT03251924|449075953|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
124849919|NCT03251924|449075954|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
124849920|NCT03251924|449075946|FG000|Overall Study|Death|0|||
124849921|NCT03251924|449075947|FG001|Overall Study|Death|1|||
124849922|NCT03251924|449075948|FG002|Overall Study|Death|0|||
124849923|NCT03251924|449075949|FG003|Overall Study|Death|1|||
124849924|NCT03251924|449075950|FG004|Overall Study|Death|1|||
124849925|NCT03251924|449075951|FG005|Overall Study|Death|1|||
124849926|NCT03251924|449075952|FG006|Overall Study|Death|0|||
124849927|NCT03251924|449075953|FG007|Overall Study|Death|0|||
124849928|NCT03251924|449075954|FG008|Overall Study|Death|0|||
124849929|NCT03251924|449075946|FG000|Overall Study|Study Drug Toxicity|0|||
124849930|NCT03251924|449075947|FG001|Overall Study|Study Drug Toxicity|0|||
124849931|NCT03251924|449075948|FG002|Overall Study|Study Drug Toxicity|0|||
124849932|NCT03251924|449075949|FG003|Overall Study|Study Drug Toxicity|1|||
124849933|NCT03251924|449075950|FG004|Overall Study|Study Drug Toxicity|0|||
124849934|NCT03251924|449075951|FG005|Overall Study|Study Drug Toxicity|0|||
124849935|NCT03251924|449075952|FG006|Overall Study|Study Drug Toxicity|0|||
124849936|NCT03251924|449075953|FG007|Overall Study|Study Drug Toxicity|0|||
124849937|NCT03251924|449075954|FG008|Overall Study|Study Drug Toxicity|1|||
124849938|NCT03251924|449075946|FG000|Overall Study|Other Reasons|0|||
124849939|NCT03251924|449075947|FG001|Overall Study|Other Reasons|0|||
124849940|NCT03251924|449075948|FG002|Overall Study|Other Reasons|0|||
124849941|NCT03251924|449075949|FG003|Overall Study|Other Reasons|0|||
124849942|NCT03251924|449075950|FG004|Overall Study|Other Reasons|0|||
124849943|NCT03251924|449075951|FG005|Overall Study|Other Reasons|0|||
124849944|NCT03251924|449075952|FG006|Overall Study|Other Reasons|0|||
124849945|NCT03251924|449075953|FG007|Overall Study|Other Reasons|0|||
124849946|NCT03251924|449075954|FG008|Overall Study|Other Reasons|1|||
124849947|NCT03251924|449075946|FG000|Overall Study|Participant request to discontinue study treatment|0|||
124849948|NCT03251924|449075947|FG001|Overall Study|Participant request to discontinue study treatment|0|||
124849949|NCT03251924|449075948|FG002|Overall Study|Participant request to discontinue study treatment|0|||
124849950|NCT03251924|449075949|FG003|Overall Study|Participant request to discontinue study treatment|0|||
124849951|NCT03251924|449075950|FG004|Overall Study|Participant request to discontinue study treatment|0|||
124849952|NCT03251924|449075951|FG005|Overall Study|Participant request to discontinue study treatment|0|||
124849953|NCT03251924|449075952|FG006|Overall Study|Participant request to discontinue study treatment|0|||
124849954|NCT03251924|449075953|FG007|Overall Study|Participant request to discontinue study treatment|1|||
124849955|NCT03251924|449075954|FG008|Overall Study|Participant request to discontinue study treatment|0|||
124849956|NCT01193556|449075955|FG000|Overall Study|Study termination|26|||
124849957|NCT01193556|449075956|FG001|Overall Study|Study termination|25|||
124849958|NCT02617589|449075957|FG000|Randomization|Request to Discontinue Study Treatment|1|||
124849959|NCT02617589|449075958|FG001|Randomization|Request to Discontinue Study Treatment|3|||
124849960|NCT02617589|449075957|FG000|Randomization|Participant Withdrew Consent|1|||
124849961|NCT02617589|449075958|FG001|Randomization|Participant Withdrew Consent|2|||
124849962|NCT02617589|449075957|FG000|Treatment|Other Reasons|3|||
124849963|NCT02617589|449075958|FG001|Treatment|Other Reasons|3|||
124849964|NCT02617589|449075957|FG000|Treatment|Poor/Non Compliance|1|||
124849965|NCT02617589|449075958|FG001|Treatment|Poor/Non Compliance|1|||
124849966|NCT02617589|449075957|FG000|Treatment|Maximum Clinical Benefit|0|||
124849967|NCT02617589|449075958|FG001|Treatment|Maximum Clinical Benefit|2|||
124849968|NCT02617589|449075957|FG000|Treatment|Participant Withdrew Consent|2|||
124849969|NCT02617589|449075958|FG001|Treatment|Participant Withdrew Consent|6|||
124849970|NCT02617589|449075957|FG000|Treatment|Participant Request to Discontinue|12|||
124849971|NCT02617589|449075958|FG001|Treatment|Participant Request to Discontinue|21|||
124849972|NCT02617589|449075957|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
124849973|NCT02617589|449075958|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
124849974|NCT02617589|449075957|FG000|Treatment|Death|1|||
124849975|NCT02617589|449075958|FG001|Treatment|Death|1|||
124849976|NCT02617589|449075957|FG000|Treatment|Study Drug Toxicity|27|||
124849977|NCT02617589|449075958|FG001|Treatment|Study Drug Toxicity|20|||
124849978|NCT02617589|449075957|FG000|Treatment|Disease Progression|216|||
124849979|NCT02617589|449075958|FG001|Treatment|Disease Progression|136|||
124849980|NCT00835406|449075963|FG000|Period: First Intervention|Adverse Event|0|||
124849981|NCT00835406|449075964|FG001|Period: First Intervention|Adverse Event|1|||
124849982|NCT00835406|449075963|FG000|Period: First Intervention|Withdrawal by Subject|2|||
124849983|NCT00835406|449075964|FG001|Period: First Intervention|Withdrawal by Subject|0|||
124849984|NCT00835406|449075963|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
124849985|NCT00835406|449075964|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
124849986|NCT02138214|449075967|FG000|Overall Study|Withdrawal by Subject|0|||
124849987|NCT02138214|449075968|FG001|Overall Study|Withdrawal by Subject|1|||
124849988|NCT02138214|449075969|FG002|Overall Study|Withdrawal by Subject|0|||
124849989|NCT02138214|449075967|FG000|Overall Study|Lost to Follow-up|0|||
124849990|NCT02138214|449075968|FG001|Overall Study|Lost to Follow-up|2|||
124849991|NCT02138214|449075969|FG002|Overall Study|Lost to Follow-up|4|||
124849992|NCT02138214|449075967|FG000|Overall Study|Screen Failure|0|||
124849993|NCT02138214|449075968|FG001|Overall Study|Screen Failure|1|||
124849994|NCT02138214|449075969|FG002|Overall Study|Screen Failure|0|||
124849995|NCT02158039|449075972|FG000|Overall Study|Withdrawal by Subject|1|||
124849996|NCT02158039|449075972|FG000|Overall Study|Screen Failure|9|||
124849997|NCT03509948|449075984|FG000|Overall Study|Protocol Violation|0|||
124849998|NCT03509948|449075985|FG001|Overall Study|Protocol Violation|1|||
124849999|NCT01334866|449075986|FG000|Overall Study|Withdrawal by Subject|10|||
124850000|NCT01334866|449075986|FG000|Overall Study|Lost to Follow-up|3|||
124850001|NCT01334866|449075986|FG000|Overall Study|Physician Decision|3|||
124850002|NCT01334866|449075986|FG000|Overall Study|medically necessary prior to procedure|2|||
124850003|NCT01334866|449075986|FG000|Overall Study|medically necessary post-procedure|1|||
124850004|NCT01071512|449075993|FG000|Overall Study|Adverse Event|1|||
124850005|NCT01071512|449075993|FG000|Overall Study|Development of antibodies to drug|2|||
124850006|NCT01071512|449075993|FG000|Overall Study|positive anti-JC virus antibody test|2|||
124850007|NCT00799617|449076002|FG000|Main Testosterone Trial|Randomized in error|1|||
124850008|NCT00799617|449076003|FG001|Main Testosterone Trial|Randomized in error|1|||
124850009|NCT00799617|449076002|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
124850010|NCT00799617|449076003|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
124850011|NCT00799617|449076002|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
124850012|NCT00799617|449076003|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
124850013|NCT00799617|449076002|FG000|Sexual Funtion Trial|No Baseline Data|4|||
124850014|NCT00799617|449076003|FG001|Sexual Funtion Trial|No Baseline Data|7|||
124850015|NCT00799617|449076002|FG000|Physical Function Trial|Lost to Follow-up|6|||
124850016|NCT00799617|449076003|FG001|Physical Function Trial|Lost to Follow-up|11|||
124850017|NCT00799617|449076002|FG000|Vitality Trial|Lost to Follow-up|7|||
124850018|NCT00799617|449076003|FG001|Vitality Trial|Lost to Follow-up|22|||
124850019|NCT00799617|449076002|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
124850020|NCT00799617|449076003|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
124850021|NCT00799617|449076002|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
124850022|NCT00799617|449076003|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
124850023|NCT00799617|449076002|FG000|Bone Trial|Month 12 scan not available|6|||
124850024|NCT00799617|449076003|FG001|Bone Trial|Month 12 scan not available|16|||
124850025|NCT00799617|449076002|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
124850026|NCT00799617|449076003|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
124850027|NCT00799617|449076002|FG000|Anemia Trial|Withdrawal by Subject|3|||
124850028|NCT00799617|449076003|FG001|Anemia Trial|Withdrawal by Subject|3|||
124850029|NCT04545515|449076004|FG000|Overall Study|Adverse Event|1|||
124850030|NCT04545515|449076004|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
124850031|NCT04545515|449076004|FG000|Overall Study|Commercial drug is available for participant|7|||
124850032|NCT00958880|449076005|FG000|Overall Study|Lost to Follow-up|2|||
124850033|NCT00958880|449076006|FG001|Overall Study|Lost to Follow-up|2|||
124850034|NCT01848990|449076007|FG000|Overall Study|Adverse Event|6|||
124850035|NCT01848990|449076008|FG001|Overall Study|Adverse Event|2|||
124850036|NCT01848990|449076009|FG002|Overall Study|Adverse Event|0|||
124850037|NCT01848990|449076007|FG000|Overall Study|Lost to Follow-up|6|||
124850038|NCT01848990|449076008|FG001|Overall Study|Lost to Follow-up|2|||
124850039|NCT01848990|449076009|FG002|Overall Study|Lost to Follow-up|2|||
124850040|NCT01848990|449076007|FG000|Overall Study|Protocol Violation|1|||
124850041|NCT01848990|449076008|FG001|Overall Study|Protocol Violation|1|||
124850042|NCT01848990|449076009|FG002|Overall Study|Protocol Violation|0|||
124850043|NCT01848990|449076007|FG000|Overall Study|Withdrawal by Subject|29|||
124850044|NCT01848990|449076008|FG001|Overall Study|Withdrawal by Subject|10|||
124850045|NCT01848990|449076009|FG002|Overall Study|Withdrawal by Subject|11|||
124850046|NCT01848990|449076007|FG000|Overall Study|Physician Decision|1|||
124850047|NCT01848990|449076008|FG001|Overall Study|Physician Decision|1|||
124850048|NCT01848990|449076009|FG002|Overall Study|Physician Decision|0|||
124850049|NCT01848990|449076007|FG000|Overall Study|Non Compliance|1|||
124850050|NCT01848990|449076008|FG001|Overall Study|Non Compliance|0|||
124850051|NCT01848990|449076009|FG002|Overall Study|Non Compliance|0|||
124850052|NCT01848990|449076007|FG000|Overall Study|Death|1|||
124850053|NCT01848990|449076008|FG001|Overall Study|Death|0|||
124850054|NCT01848990|449076009|FG002|Overall Study|Death|1|||
124850055|NCT01848990|449076007|FG000|Overall Study|Other|1|||
124850056|NCT01848990|449076008|FG001|Overall Study|Other|4|||
124850057|NCT01848990|449076009|FG002|Overall Study|Other|2|||
124850058|NCT01712984|449076010|FG000|Overall Study|Adverse Event|0|||
124850059|NCT01712984|449076011|FG001|Overall Study|Adverse Event|0|||
124850060|NCT01712984|449076012|FG002|Overall Study|Adverse Event|1|||
124850061|NCT01712984|449076010|FG000|Overall Study|Protocol Violation|2|||
124850062|NCT01712984|449076011|FG001|Overall Study|Protocol Violation|0|||
124850063|NCT01712984|449076012|FG002|Overall Study|Protocol Violation|1|||
124850064|NCT01712984|449076010|FG000|Overall Study|Lost to Follow-up|8|||
124850065|NCT01712984|449076011|FG001|Overall Study|Lost to Follow-up|10|||
124850066|NCT01712984|449076012|FG002|Overall Study|Lost to Follow-up|1|||
124850067|NCT01712984|449076010|FG000|Overall Study|Withdrawal by Subject|6|||
124850068|NCT01712984|449076011|FG001|Overall Study|Withdrawal by Subject|6|||
124850069|NCT01712984|449076012|FG002|Overall Study|Withdrawal by Subject|7|||
124850070|NCT02755831|449076015|FG000|Overall Study|Lost to Follow-up|3|||
124850071|NCT02755831|449076016|FG001|Overall Study|Lost to Follow-up|3|||
124850072|NCT01720069|449076017|FG000|Overall Study|Could not use e-diary correctly|0|||
124850073|NCT01720069|449076018|FG001|Overall Study|Could not use e-diary correctly|1|||
124850074|NCT01720069|449076019|FG002|Overall Study|Could not use e-diary correctly|1|||
124850075|NCT01720069|449076017|FG000|Overall Study|Randomised without baseline values|0|||
124850076|NCT01720069|449076018|FG001|Overall Study|Randomised without baseline values|0|||
124850077|NCT01720069|449076019|FG002|Overall Study|Randomised without baseline values|1|||
124850078|NCT01720069|449076017|FG000|Overall Study|Adverse Event|0|||
124850079|NCT01720069|449076018|FG001|Overall Study|Adverse Event|0|||
124850080|NCT01720069|449076019|FG002|Overall Study|Adverse Event|1|||
124850081|NCT01720069|449076017|FG000|Overall Study|Lack of Efficacy|0|||
124850082|NCT01720069|449076018|FG001|Overall Study|Lack of Efficacy|4|||
124850083|NCT01720069|449076019|FG002|Overall Study|Lack of Efficacy|0|||
124850084|NCT01720069|449076017|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
124850085|NCT01720069|449076018|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
124850086|NCT01720069|449076019|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
124850087|NCT01720069|449076017|FG000|Overall Study|Withdrawal by Subject|0|||
124850088|NCT01720069|449076018|FG001|Overall Study|Withdrawal by Subject|2|||
124850089|NCT01720069|449076019|FG002|Overall Study|Withdrawal by Subject|1|||
124850090|NCT01720069|449076017|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
124850091|NCT01720069|449076018|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
124850092|NCT01720069|449076019|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
124850093|NCT01720069|449076017|FG000|Overall Study|Non-compliance on using e-diary|0|||
124850094|NCT01720069|449076018|FG001|Overall Study|Non-compliance on using e-diary|0|||
124850095|NCT01720069|449076019|FG002|Overall Study|Non-compliance on using e-diary|1|||
124850096|NCT01720069|449076017|FG000|Overall Study|Lost to Follow-up|0|||
124850097|NCT01720069|449076018|FG001|Overall Study|Lost to Follow-up|0|||
124850098|NCT01720069|449076019|FG002|Overall Study|Lost to Follow-up|1|||
124850099|NCT00508742|449076020|FG000|Period 1: Infant Series|Adverse Event|5|||
124850100|NCT00508742|449076021|FG001|Period 1: Infant Series|Adverse Event|4|||
124850101|NCT00508742|449076020|FG000|Period 1: Infant Series|Protocol Violation|1|||
124850102|NCT00508742|449076021|FG001|Period 1: Infant Series|Protocol Violation|0|||
124850103|NCT00508742|449076020|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
124850104|NCT00508742|449076021|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
124850105|NCT00508742|449076020|FG000|Period 1: Infant Series|Physician Decision|1|||
124850106|NCT00508742|449076021|FG001|Period 1: Infant Series|Physician Decision|0|||
124850107|NCT00508742|449076020|FG000|Period 1: Infant Series|Other|4|||
124850108|NCT00508742|449076021|FG001|Period 1: Infant Series|Other|1|||
124850109|NCT00508742|449076020|FG000|Period 2: After Infant Series|Adverse Event|2|||
124850110|NCT00508742|449076021|FG001|Period 2: After Infant Series|Adverse Event|6|||
124850111|NCT00508742|449076020|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
124850112|NCT00508742|449076021|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
124850113|NCT00508742|449076020|FG000|Period 2: After Infant Series|Protocol Violation|1|||
124850114|NCT00508742|449076021|FG001|Period 2: After Infant Series|Protocol Violation|0|||
124850115|NCT00508742|449076020|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
124850116|NCT00508742|449076021|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
124850117|NCT00508742|449076020|FG000|Period 2: After Infant Series|Failed to Return|1|||
124850118|NCT00508742|449076021|FG001|Period 2: After Infant Series|Failed to Return|0|||
124850119|NCT00508742|449076020|FG000|Period 2: After Infant Series|Other|2|||
124850120|NCT00508742|449076021|FG001|Period 2: After Infant Series|Other|1|||
124850121|NCT00508742|449076020|FG000|Period 3: Toddler Dose|Adverse Event|1|||
124850122|NCT00508742|449076021|FG001|Period 3: Toddler Dose|Adverse Event|0|||
124850123|NCT00508742|449076020|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
124850124|NCT00508742|449076021|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
124850125|NCT00508742|449076020|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
124850126|NCT00508742|449076021|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
124850127|NCT00508742|449076020|FG000|Period 3: Toddler Dose|Other|5|||
124850128|NCT00508742|449076021|FG001|Period 3: Toddler Dose|Other|4|||
124850129|NCT02460224|449076026|FG000|Overall Study|Adverse Event|0|||
124850130|NCT02460224|449076027|FG001|Overall Study|Adverse Event|0|||
124850131|NCT02460224|449076028|FG002|Overall Study|Adverse Event|0|||
124850132|NCT02460224|449076029|FG003|Overall Study|Adverse Event|0|||
124850133|NCT02460224|449076030|FG004|Overall Study|Adverse Event|0|||
124850134|NCT02460224|449076031|FG005|Overall Study|Adverse Event|0|||
124850135|NCT02460224|449076032|FG006|Overall Study|Adverse Event|1|||
124850136|NCT02460224|449076033|FG007|Overall Study|Adverse Event|0|||
124850137|NCT02460224|449076034|FG008|Overall Study|Adverse Event|0|||
124850138|NCT02460224|449076035|FG009|Overall Study|Adverse Event|0|||
124850139|NCT02460224|449076036|FG010|Overall Study|Adverse Event|0|||
124850140|NCT02460224|449076037|FG011|Overall Study|Adverse Event|0|||
124850141|NCT02460224|449076038|FG012|Overall Study|Adverse Event|1|||
124850142|NCT02460224|449076039|FG013|Overall Study|Adverse Event|0|||
124850143|NCT02460224|449076040|FG014|Overall Study|Adverse Event|0|||
124850144|NCT02460224|449076041|FG015|Overall Study|Adverse Event|0|||
124850145|NCT02460224|449076042|FG016|Overall Study|Adverse Event|1|||
124850146|NCT02460224|449076043|FG017|Overall Study|Adverse Event|0|||
124850147|NCT02460224|449076044|FG018|Overall Study|Adverse Event|1|||
124850148|NCT02460224|449076045|FG019|Overall Study|Adverse Event|0|||
124850149|NCT02460224|449076046|FG020|Overall Study|Adverse Event|1|||
124850150|NCT02460224|449076047|FG021|Overall Study|Adverse Event|1|||
124850151|NCT02460224|449076048|FG022|Overall Study|Adverse Event|1|||
124850152|NCT02460224|449076049|FG023|Overall Study|Adverse Event|0|||
124850153|NCT02460224|449076050|FG024|Overall Study|Adverse Event|0|||
124850154|NCT02460224|449076051|FG025|Overall Study|Adverse Event|0|||
124850155|NCT02460224|449076052|FG026|Overall Study|Adverse Event|11|||
124850156|NCT02460224|449076053|FG027|Overall Study|Adverse Event|1|||
124850157|NCT02460224|449076054|FG028|Overall Study|Adverse Event|6|||
124850158|NCT02460224|449076026|FG000|Overall Study|Death|0|||
124850159|NCT02460224|449076027|FG001|Overall Study|Death|0|||
124850160|NCT02460224|449076028|FG002|Overall Study|Death|0|||
124850161|NCT02460224|449076029|FG003|Overall Study|Death|0|||
124850162|NCT02460224|449076030|FG004|Overall Study|Death|0|||
124850163|NCT02460224|449076031|FG005|Overall Study|Death|2|||
124850164|NCT02460224|449076032|FG006|Overall Study|Death|1|||
124850165|NCT02460224|449076033|FG007|Overall Study|Death|0|||
124850166|NCT02460224|449076034|FG008|Overall Study|Death|0|||
124850167|NCT02460224|449076035|FG009|Overall Study|Death|1|||
124850168|NCT02460224|449076036|FG010|Overall Study|Death|0|||
124850169|NCT02460224|449076037|FG011|Overall Study|Death|0|||
124850170|NCT02460224|449076038|FG012|Overall Study|Death|0|||
124850171|NCT02460224|449076039|FG013|Overall Study|Death|1|||
124850172|NCT02460224|449076040|FG014|Overall Study|Death|0|||
124850173|NCT02460224|449076041|FG015|Overall Study|Death|0|||
124850174|NCT02460224|449076042|FG016|Overall Study|Death|2|||
124850175|NCT02460224|449076043|FG017|Overall Study|Death|1|||
124850176|NCT02460224|449076044|FG018|Overall Study|Death|0|||
124850177|NCT02460224|449076045|FG019|Overall Study|Death|2|||
124850178|NCT02460224|449076046|FG020|Overall Study|Death|0|||
124850179|NCT02460224|449076047|FG021|Overall Study|Death|0|||
124850180|NCT02460224|449076048|FG022|Overall Study|Death|0|||
124850181|NCT02460224|449076049|FG023|Overall Study|Death|0|||
124850182|NCT02460224|449076050|FG024|Overall Study|Death|1|||
124850183|NCT02460224|449076051|FG025|Overall Study|Death|1|||
124850184|NCT02460224|449076052|FG026|Overall Study|Death|5|||
124850185|NCT02460224|449076053|FG027|Overall Study|Death|0|||
124850186|NCT02460224|449076054|FG028|Overall Study|Death|1|||
124850187|NCT02460224|449076026|FG000|Overall Study|Lost to Follow-up|0|||
124850188|NCT02460224|449076027|FG001|Overall Study|Lost to Follow-up|0|||
124850189|NCT02460224|449076028|FG002|Overall Study|Lost to Follow-up|0|||
124850190|NCT02460224|449076029|FG003|Overall Study|Lost to Follow-up|0|||
124850191|NCT02460224|449076030|FG004|Overall Study|Lost to Follow-up|0|||
124850192|NCT02460224|449076031|FG005|Overall Study|Lost to Follow-up|0|||
124850193|NCT02460224|449076032|FG006|Overall Study|Lost to Follow-up|0|||
124850194|NCT02460224|449076033|FG007|Overall Study|Lost to Follow-up|0|||
124850195|NCT02460224|449076034|FG008|Overall Study|Lost to Follow-up|0|||
124850196|NCT02460224|449076035|FG009|Overall Study|Lost to Follow-up|0|||
124850197|NCT02460224|449076036|FG010|Overall Study|Lost to Follow-up|0|||
124850198|NCT02460224|449076037|FG011|Overall Study|Lost to Follow-up|0|||
124850199|NCT02460224|449076038|FG012|Overall Study|Lost to Follow-up|0|||
124850200|NCT02460224|449076039|FG013|Overall Study|Lost to Follow-up|0|||
124850201|NCT02460224|449076040|FG014|Overall Study|Lost to Follow-up|0|||
124850202|NCT02460224|449076041|FG015|Overall Study|Lost to Follow-up|0|||
124850203|NCT02460224|449076042|FG016|Overall Study|Lost to Follow-up|0|||
124850204|NCT02460224|449076043|FG017|Overall Study|Lost to Follow-up|0|||
124850205|NCT02460224|449076044|FG018|Overall Study|Lost to Follow-up|0|||
124850206|NCT02460224|449076045|FG019|Overall Study|Lost to Follow-up|0|||
124850207|NCT02460224|449076046|FG020|Overall Study|Lost to Follow-up|0|||
124850208|NCT02460224|449076047|FG021|Overall Study|Lost to Follow-up|0|||
124850209|NCT02460224|449076048|FG022|Overall Study|Lost to Follow-up|1|||
124850210|NCT02460224|449076049|FG023|Overall Study|Lost to Follow-up|0|||
124850211|NCT02460224|449076050|FG024|Overall Study|Lost to Follow-up|0|||
124850212|NCT02460224|449076051|FG025|Overall Study|Lost to Follow-up|0|||
124850213|NCT02460224|449076052|FG026|Overall Study|Lost to Follow-up|0|||
124850214|NCT02460224|449076053|FG027|Overall Study|Lost to Follow-up|0|||
124850215|NCT02460224|449076054|FG028|Overall Study|Lost to Follow-up|0|||
124850216|NCT02460224|449076026|FG000|Overall Study|Physician Decision|0|||
124850217|NCT02460224|449076027|FG001|Overall Study|Physician Decision|1|||
124850218|NCT02460224|449076028|FG002|Overall Study|Physician Decision|0|||
124850219|NCT02460224|449076029|FG003|Overall Study|Physician Decision|0|||
124850220|NCT02460224|449076030|FG004|Overall Study|Physician Decision|1|||
124850221|NCT02460224|449076031|FG005|Overall Study|Physician Decision|0|||
124850222|NCT02460224|449076032|FG006|Overall Study|Physician Decision|0|||
124850223|NCT02460224|449076033|FG007|Overall Study|Physician Decision|1|||
124850224|NCT02460224|449076034|FG008|Overall Study|Physician Decision|0|||
124850225|NCT02460224|449076035|FG009|Overall Study|Physician Decision|0|||
124850226|NCT02460224|449076036|FG010|Overall Study|Physician Decision|0|||
124850227|NCT02460224|449076037|FG011|Overall Study|Physician Decision|1|||
124850228|NCT02460224|449076038|FG012|Overall Study|Physician Decision|0|||
124850229|NCT02460224|449076039|FG013|Overall Study|Physician Decision|1|||
124850230|NCT02460224|449076040|FG014|Overall Study|Physician Decision|0|||
124850231|NCT02460224|449076041|FG015|Overall Study|Physician Decision|0|||
124850232|NCT02460224|449076042|FG016|Overall Study|Physician Decision|2|||
124850233|NCT02460224|449076043|FG017|Overall Study|Physician Decision|1|||
124850234|NCT02460224|449076044|FG018|Overall Study|Physician Decision|1|||
124850235|NCT02460224|449076045|FG019|Overall Study|Physician Decision|2|||
124850236|NCT02460224|449076046|FG020|Overall Study|Physician Decision|1|||
124850237|NCT02460224|449076047|FG021|Overall Study|Physician Decision|1|||
124850238|NCT02460224|449076048|FG022|Overall Study|Physician Decision|0|||
124850239|NCT02460224|449076049|FG023|Overall Study|Physician Decision|0|||
124850240|NCT02460224|449076050|FG024|Overall Study|Physician Decision|1|||
124850241|NCT02460224|449076051|FG025|Overall Study|Physician Decision|0|||
124850242|NCT02460224|449076052|FG026|Overall Study|Physician Decision|14|||
124850243|NCT02460224|449076053|FG027|Overall Study|Physician Decision|1|||
124850244|NCT02460224|449076054|FG028|Overall Study|Physician Decision|6|||
124850245|NCT02460224|449076026|FG000|Overall Study|Progressive disease|15|||
124850246|NCT02460224|449076027|FG001|Overall Study|Progressive disease|11|||
124850247|NCT02460224|449076028|FG002|Overall Study|Progressive disease|5|||
124850248|NCT02460224|449076029|FG003|Overall Study|Progressive disease|6|||
124850249|NCT02460224|449076030|FG004|Overall Study|Progressive disease|3|||
124850250|NCT02460224|449076031|FG005|Overall Study|Progressive disease|26|||
124850251|NCT02460224|449076032|FG006|Overall Study|Progressive disease|28|||
124850252|NCT02460224|449076033|FG007|Overall Study|Progressive disease|4|||
124850253|NCT02460224|449076034|FG008|Overall Study|Progressive disease|5|||
124850254|NCT02460224|449076035|FG009|Overall Study|Progressive disease|9|||
124850255|NCT02460224|449076036|FG010|Overall Study|Progressive disease|5|||
124850256|NCT02460224|449076037|FG011|Overall Study|Progressive disease|4|||
124850257|NCT02460224|449076038|FG012|Overall Study|Progressive disease|5|||
124850258|NCT02460224|449076039|FG013|Overall Study|Progressive disease|4|||
124850259|NCT02460224|449076040|FG014|Overall Study|Progressive disease|5|||
124850260|NCT02460224|449076041|FG015|Overall Study|Progressive disease|5|||
124850261|NCT02460224|449076042|FG016|Overall Study|Progressive disease|15|||
124850262|NCT02460224|449076043|FG017|Overall Study|Progressive disease|3|||
124850263|NCT02460224|449076044|FG018|Overall Study|Progressive disease|8|||
124850264|NCT02460224|449076045|FG019|Overall Study|Progressive disease|3|||
124850265|NCT02460224|449076046|FG020|Overall Study|Progressive disease|4|||
124850266|NCT02460224|449076047|FG021|Overall Study|Progressive disease|9|||
124850267|NCT02460224|449076048|FG022|Overall Study|Progressive disease|4|||
124850268|NCT02460224|449076049|FG023|Overall Study|Progressive disease|11|||
124850269|NCT02460224|449076050|FG024|Overall Study|Progressive disease|4|||
124850270|NCT02460224|449076051|FG025|Overall Study|Progressive disease|5|||
124850271|NCT02460224|449076052|FG026|Overall Study|Progressive disease|85|||
124850272|NCT02460224|449076053|FG027|Overall Study|Progressive disease|17|||
124850273|NCT02460224|449076054|FG028|Overall Study|Progressive disease|77|||
124850274|NCT02460224|449076026|FG000|Overall Study|Subject/guardian decision|2|||
124850275|NCT02460224|449076027|FG001|Overall Study|Subject/guardian decision|0|||
124850276|NCT02460224|449076028|FG002|Overall Study|Subject/guardian decision|1|||
124850277|NCT02460224|449076029|FG003|Overall Study|Subject/guardian decision|0|||
124850278|NCT02460224|449076030|FG004|Overall Study|Subject/guardian decision|2|||
124850279|NCT02460224|449076031|FG005|Overall Study|Subject/guardian decision|2|||
124850280|NCT02460224|449076032|FG006|Overall Study|Subject/guardian decision|0|||
124850281|NCT02460224|449076033|FG007|Overall Study|Subject/guardian decision|0|||
124850282|NCT02460224|449076034|FG008|Overall Study|Subject/guardian decision|1|||
124850283|NCT02460224|449076035|FG009|Overall Study|Subject/guardian decision|1|||
124850284|NCT02460224|449076036|FG010|Overall Study|Subject/guardian decision|0|||
124850285|NCT02460224|449076037|FG011|Overall Study|Subject/guardian decision|1|||
124850286|NCT02460224|449076038|FG012|Overall Study|Subject/guardian decision|0|||
124850287|NCT02460224|449076039|FG013|Overall Study|Subject/guardian decision|0|||
124850288|NCT02460224|449076040|FG014|Overall Study|Subject/guardian decision|0|||
124850289|NCT02460224|449076041|FG015|Overall Study|Subject/guardian decision|1|||
124850290|NCT02460224|449076042|FG016|Overall Study|Subject/guardian decision|0|||
124850291|NCT02460224|449076043|FG017|Overall Study|Subject/guardian decision|1|||
124850292|NCT02460224|449076044|FG018|Overall Study|Subject/guardian decision|2|||
124850293|NCT02460224|449076045|FG019|Overall Study|Subject/guardian decision|0|||
124850294|NCT02460224|449076046|FG020|Overall Study|Subject/guardian decision|0|||
124850295|NCT02460224|449076047|FG021|Overall Study|Subject/guardian decision|1|||
124850296|NCT02460224|449076048|FG022|Overall Study|Subject/guardian decision|0|||
124850297|NCT02460224|449076049|FG023|Overall Study|Subject/guardian decision|0|||
124850298|NCT02460224|449076050|FG024|Overall Study|Subject/guardian decision|0|||
124850299|NCT02460224|449076051|FG025|Overall Study|Subject/guardian decision|0|||
124850300|NCT02460224|449076052|FG026|Overall Study|Subject/guardian decision|6|||
124850301|NCT02460224|449076053|FG027|Overall Study|Subject/guardian decision|2|||
124850302|NCT02460224|449076054|FG028|Overall Study|Subject/guardian decision|3|||
124850303|NCT03146650|449076056|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
124850304|NCT03146650|449076056|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
124850305|NCT03146650|449076056|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
124850306|NCT03146650|449076056|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
124850307|NCT03146650|449076056|FG000|2 Year Follow-up|Death|11|||
124850308|NCT03146650|449076056|FG000|2 Year Follow-up|Still in follow-up|7|||
124850309|NCT03146650|449076056|FG000|2 Year Follow-up|Lost to Follow-up|1|||
124850310|NCT03333486|449076059|FG000|Overall Study|Withdrawal by Subject|1|||
124850311|NCT03333486|449076059|FG000|Overall Study|Lost to Follow-up|1|||
124850312|NCT00774995|449076060|FG000|Overall Study|Protocol Violation|0|||
124850313|NCT00774995|449076061|FG001|Overall Study|Protocol Violation|0|||
124850314|NCT00774995|449076062|FG002|Overall Study|Protocol Violation|1|||
124850315|NCT00774995|449076063|FG003|Overall Study|Protocol Violation|0|||
124850316|NCT01818336|449077924|FG000|Overall Study|Declined retest visit|0|||
124850317|NCT01818336|449077925|FG001|Overall Study|Declined retest visit|11|||
124850318|NCT01818336|449077924|FG000|Overall Study|Lost to Follow-up|0|||
124850319|NCT01818336|449077925|FG001|Overall Study|Lost to Follow-up|1|||
124850320|NCT02139644|449077926|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
124850321|NCT02139644|449077927|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124850322|NCT02139644|449077928|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124850323|NCT02139644|449077929|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124850324|NCT02139644|449077930|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124850325|NCT02139644|449077931|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124850326|NCT02139644|449077926|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
124850327|NCT02139644|449077927|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124850328|NCT02139644|449077928|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124850329|NCT02139644|449077929|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124850330|NCT02139644|449077930|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124850331|NCT02139644|449077931|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124850332|NCT02139644|449077926|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
124850333|NCT02139644|449077927|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124850334|NCT02139644|449077928|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124850335|NCT02139644|449077929|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124850336|NCT02139644|449077930|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124850337|NCT02139644|449077931|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124850338|NCT02139644|449077926|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
124850339|NCT02139644|449077927|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124850340|NCT02139644|449077928|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124850341|NCT02139644|449077929|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124850342|NCT02139644|449077930|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124850343|NCT02139644|449077931|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124850344|NCT02139644|449077926|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
124850345|NCT02139644|449077927|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124850346|NCT02139644|449077928|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124850347|NCT02139644|449077929|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124850348|NCT02139644|449077930|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124850349|NCT02139644|449077931|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124850350|NCT02139644|449077926|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
124850351|NCT02139644|449077927|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
124850352|NCT02139644|449077928|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
124850353|NCT02139644|449077929|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
124850354|NCT02139644|449077930|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
124850355|NCT02139644|449077931|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
124850356|NCT02139644|449077926|FG000|Run-In Period (Pre-assignment)|Other|6|||
124850357|NCT02139644|449077927|FG001|Run-In Period (Pre-assignment)|Other|0|||
124850358|NCT02139644|449077928|FG002|Run-In Period (Pre-assignment)|Other|0|||
124850359|NCT02139644|449077929|FG003|Run-In Period (Pre-assignment)|Other|0|||
124850360|NCT02139644|449077930|FG004|Run-In Period (Pre-assignment)|Other|0|||
124850361|NCT02139644|449077931|FG005|Run-In Period (Pre-assignment)|Other|0|||
124850362|NCT02139644|449077926|FG000|Treatment Period|Adverse Event|0|||
124850363|NCT02139644|449077927|FG001|Treatment Period|Adverse Event|0|||
124850364|NCT02139644|449077928|FG002|Treatment Period|Adverse Event|3|||
124850365|NCT02139644|449077929|FG003|Treatment Period|Adverse Event|2|||
124850366|NCT02139644|449077930|FG004|Treatment Period|Adverse Event|1|||
124850367|NCT02139644|449077931|FG005|Treatment Period|Adverse Event|6|||
124850368|NCT02139644|449077926|FG000|Treatment Period|Withdrawal by Subject|0|||
124850369|NCT02139644|449077927|FG001|Treatment Period|Withdrawal by Subject|0|||
124850370|NCT02139644|449077928|FG002|Treatment Period|Withdrawal by Subject|2|||
124850371|NCT02139644|449077929|FG003|Treatment Period|Withdrawal by Subject|2|||
124850372|NCT02139644|449077930|FG004|Treatment Period|Withdrawal by Subject|3|||
124850373|NCT02139644|449077931|FG005|Treatment Period|Withdrawal by Subject|2|||
124850374|NCT02139644|449077926|FG000|Treatment Period|Non-compliance|0|||
124850375|NCT02139644|449077927|FG001|Treatment Period|Non-compliance|0|||
124850376|NCT02139644|449077928|FG002|Treatment Period|Non-compliance|0|||
124850377|NCT02139644|449077929|FG003|Treatment Period|Non-compliance|1|||
124850378|NCT02139644|449077930|FG004|Treatment Period|Non-compliance|0|||
124850379|NCT02139644|449077931|FG005|Treatment Period|Non-compliance|0|||
124850380|NCT02139644|449077926|FG000|Treatment Period|Protocol Violation|0|||
124850381|NCT02139644|449077927|FG001|Treatment Period|Protocol Violation|0|||
124850382|NCT02139644|449077928|FG002|Treatment Period|Protocol Violation|0|||
124850383|NCT02139644|449077929|FG003|Treatment Period|Protocol Violation|1|||
124850384|NCT02139644|449077930|FG004|Treatment Period|Protocol Violation|1|||
124850385|NCT02139644|449077931|FG005|Treatment Period|Protocol Violation|1|||
124850386|NCT02139644|449077926|FG000|Treatment Period|Disease progression|0|||
124850387|NCT02139644|449077927|FG001|Treatment Period|Disease progression|0|||
124850388|NCT02139644|449077928|FG002|Treatment Period|Disease progression|0|||
124850389|NCT02139644|449077929|FG003|Treatment Period|Disease progression|1|||
124850390|NCT02139644|449077930|FG004|Treatment Period|Disease progression|1|||
124850391|NCT02139644|449077931|FG005|Treatment Period|Disease progression|2|||
124850392|NCT02139644|449077926|FG000|Treatment Period|Lost to Follow-up|0|||
124850393|NCT02139644|449077927|FG001|Treatment Period|Lost to Follow-up|0|||
124850394|NCT02139644|449077928|FG002|Treatment Period|Lost to Follow-up|1|||
124850395|NCT02139644|449077929|FG003|Treatment Period|Lost to Follow-up|1|||
124850396|NCT02139644|449077930|FG004|Treatment Period|Lost to Follow-up|1|||
124850397|NCT02139644|449077931|FG005|Treatment Period|Lost to Follow-up|1|||
124850398|NCT02139644|449077926|FG000|Treatment Period|Lack of Efficacy|0|||
124850399|NCT02139644|449077927|FG001|Treatment Period|Lack of Efficacy|0|||
124850400|NCT02139644|449077928|FG002|Treatment Period|Lack of Efficacy|1|||
124850401|NCT02139644|449077929|FG003|Treatment Period|Lack of Efficacy|0|||
124850402|NCT02139644|449077930|FG004|Treatment Period|Lack of Efficacy|1|||
124850403|NCT02139644|449077931|FG005|Treatment Period|Lack of Efficacy|4|||
124850404|NCT02139644|449077926|FG000|Treatment Period|Other|0|||
124850405|NCT02139644|449077927|FG001|Treatment Period|Other|3|||
124850406|NCT02139644|449077928|FG002|Treatment Period|Other|1|||
124850407|NCT02139644|449077929|FG003|Treatment Period|Other|1|||
124850408|NCT02139644|449077930|FG004|Treatment Period|Other|0|||
124850409|NCT02139644|449077931|FG005|Treatment Period|Other|1|||
124850410|NCT00608829|449077935|FG000|Overall Study|Death|6|||
124850411|NCT00608829|449077935|FG000|Overall Study|Withdrawal by Subject|4|||
124850412|NCT00608829|449077935|FG000|Overall Study|Subject refuses to follow up or return.|5|||
124850413|NCT02602288|449077936|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
124850414|NCT02602288|449077937|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
124850415|NCT02602288|449077936|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
124850416|NCT02602288|449077937|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
124850417|NCT02602288|449077936|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
124850418|NCT02602288|449077937|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
124850419|NCT02602288|449077936|FG000|12 Month Follow-up|Lost to Follow-up|0|||
124850420|NCT02602288|449077937|FG001|12 Month Follow-up|Lost to Follow-up|4|||
124850421|NCT02602288|449077936|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
124850422|NCT02602288|449077937|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
124850423|NCT01310413|449077938|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
124850424|NCT01310413|449077939|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
124850425|NCT01310413|449077940|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
124850426|NCT01310413|449077941|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
124850427|NCT01310413|449077942|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
124850428|NCT01310413|449077943|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
124850429|NCT01310413|449077944|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
124850430|NCT01310413|449077938|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
124850431|NCT01310413|449077939|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
124850432|NCT01310413|449077940|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
124850433|NCT01310413|449077941|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
124850434|NCT01310413|449077942|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
124850435|NCT01310413|449077943|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
124850436|NCT01310413|449077944|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
124850437|NCT01310413|449077938|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
124850438|NCT01310413|449077939|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
124850439|NCT01310413|449077940|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
124850440|NCT01310413|449077941|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
124850441|NCT01310413|449077942|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
124850442|NCT01310413|449077943|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
124850443|NCT01310413|449077944|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
124850444|NCT01310413|449077938|FG000|Day 0 to Day 385|Other|1|||
124850445|NCT01310413|449077939|FG001|Day 0 to Day 385|Other|0|||
124850446|NCT01310413|449077940|FG002|Day 0 to Day 385|Other|3|||
124850447|NCT01310413|449077941|FG003|Day 0 to Day 385|Other|0|||
124850448|NCT01310413|449077942|FG004|Day 0 to Day 385|Other|0|||
124850449|NCT01310413|449077943|FG005|Day 0 to Day 385|Other|0|||
124850450|NCT01310413|449077944|FG006|Day 0 to Day 385|Other|0|||
124850451|NCT01310413|449077938|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
124850452|NCT01310413|449077939|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
124850453|NCT01310413|449077940|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
124850454|NCT01310413|449077941|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
124850455|NCT01310413|449077942|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
124850456|NCT01310413|449077943|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
124850457|NCT01310413|449077944|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
124850458|NCT01310413|449077938|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
124850459|NCT01310413|449077939|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
124850460|NCT01310413|449077940|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
124850461|NCT01310413|449077941|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
124850462|NCT01310413|449077942|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
124850463|NCT01310413|449077943|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
124850464|NCT01310413|449077944|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
124850465|NCT02564471|449077945|FG000|Overall Study|Adverse Event|1|||
124850466|NCT02564471|449077946|FG001|Overall Study|Adverse Event|0|||
124850467|NCT02564471|449077947|FG002|Overall Study|Adverse Event|0|||
124850468|NCT02564471|449077948|FG003|Overall Study|Adverse Event|0|||
124850469|NCT02564471|449077945|FG000|Overall Study|Withdrawal by Subject|2|||
124850470|NCT02564471|449077946|FG001|Overall Study|Withdrawal by Subject|1|||
124850471|NCT02564471|449077947|FG002|Overall Study|Withdrawal by Subject|3|||
124850472|NCT02564471|449077948|FG003|Overall Study|Withdrawal by Subject|0|||
124850473|NCT02564471|449077945|FG000|Overall Study|Lost to Follow-up|0|||
124850474|NCT02564471|449077946|FG001|Overall Study|Lost to Follow-up|2|||
124850475|NCT02564471|449077947|FG002|Overall Study|Lost to Follow-up|0|||
124850476|NCT02564471|449077948|FG003|Overall Study|Lost to Follow-up|0|||
124850477|NCT02805257|449077949|FG000|Overall Study|Lost to Follow-up|7|||
124850478|NCT02805257|449077950|FG001|Overall Study|Lost to Follow-up|6|||
124850479|NCT02805257|449077949|FG000|Overall Study|Death|0|||
124850480|NCT02805257|449077950|FG001|Overall Study|Death|1|||
124850481|NCT02033889|449077954|FG000|Overall Study|Adverse Event|3|||
124850482|NCT02033889|449077955|FG001|Overall Study|Adverse Event|1|||
124850483|NCT02033889|449077956|FG002|Overall Study|Adverse Event|3|||
124850484|NCT02033889|449077954|FG000|Overall Study|Death|3|||
124850485|NCT02033889|449077955|FG001|Overall Study|Death|1|||
124850486|NCT02033889|449077956|FG002|Overall Study|Death|2|||
124850487|NCT02033889|449077954|FG000|Overall Study|Excluded Medication|1|||
124850488|NCT02033889|449077955|FG001|Overall Study|Excluded Medication|1|||
124850489|NCT02033889|449077956|FG002|Overall Study|Excluded Medication|0|||
124850490|NCT02033889|449077954|FG000|Overall Study|Lost to Follow-up|8|||
124850491|NCT02033889|449077955|FG001|Overall Study|Lost to Follow-up|5|||
124850492|NCT02033889|449077956|FG002|Overall Study|Lost to Follow-up|6|||
124850493|NCT02033889|449077954|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124850494|NCT02033889|449077955|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124850495|NCT02033889|449077956|FG002|Overall Study|Non-Compliance With Study Drug|0|||
124850496|NCT02033889|449077954|FG000|Overall Study|Physician Decision|0|||
124850497|NCT02033889|449077955|FG001|Overall Study|Physician Decision|1|||
124850498|NCT02033889|449077956|FG002|Overall Study|Physician Decision|1|||
124850499|NCT02033889|449077954|FG000|Overall Study|Participant moved|0|||
124850500|NCT02033889|449077955|FG001|Overall Study|Participant moved|1|||
124850501|NCT02033889|449077956|FG002|Overall Study|Participant moved|0|||
124850502|NCT02033889|449077954|FG000|Overall Study|Withdrawal by Subject|18|||
124850503|NCT02033889|449077955|FG001|Overall Study|Withdrawal by Subject|10|||
124850504|NCT02033889|449077956|FG002|Overall Study|Withdrawal by Subject|13|||
124850505|NCT02080091|449077957|FG000|Overall Study|Study Terminated|22|||
124850506|NCT02080091|449077957|FG000|Overall Study|Death|1|||
124850507|NCT02080091|449077957|FG000|Overall Study|Withdrawal by Subject|1|||
124850508|NCT02080091|449077957|FG000|Overall Study|Other|1|||
124850509|NCT03143829|449077958|FG000|Overall Study|Withdrawal by Subject|2|||
124850510|NCT03143829|449077959|FG001|Overall Study|Withdrawal by Subject|5|||
124850511|NCT03143829|449077958|FG000|Overall Study|Lost to Follow-up|0|||
124850512|NCT03143829|449077959|FG001|Overall Study|Lost to Follow-up|2|||
124850513|NCT03143829|449077958|FG000|Overall Study|Death|1|||
124850514|NCT03143829|449077959|FG001|Overall Study|Death|1|||
124850515|NCT03143829|449077958|FG000|Overall Study|changed treatment, no longer eligible|2|||
124850516|NCT03143829|449077959|FG001|Overall Study|changed treatment, no longer eligible|2|||
124850517|NCT02391948|449077962|FG000|6-month Assessment|Death|0|||
124850518|NCT02391948|449077963|FG001|6-month Assessment|Death|0|||
124850519|NCT02391948|449077964|FG002|6-month Assessment|Death|0|||
124850520|NCT02391948|449077965|FG003|6-month Assessment|Death|0|||
124850521|NCT02391948|449077966|FG004|6-month Assessment|Death|1|||
124850522|NCT02391948|449077962|FG000|6-month Assessment|Withdrawal by Subject|0|||
124850523|NCT02391948|449077963|FG001|6-month Assessment|Withdrawal by Subject|0|||
124850524|NCT02391948|449077964|FG002|6-month Assessment|Withdrawal by Subject|1|||
124850525|NCT02391948|449077965|FG003|6-month Assessment|Withdrawal by Subject|2|||
124850526|NCT02391948|449077966|FG004|6-month Assessment|Withdrawal by Subject|0|||
124850527|NCT02391948|449077962|FG000|6-month Assessment|Lost to Follow-up|4|||
124850528|NCT02391948|449077963|FG001|6-month Assessment|Lost to Follow-up|5|||
124850529|NCT02391948|449077964|FG002|6-month Assessment|Lost to Follow-up|2|||
124850530|NCT02391948|449077965|FG003|6-month Assessment|Lost to Follow-up|3|||
124850531|NCT02391948|449077966|FG004|6-month Assessment|Lost to Follow-up|1|||
124850532|NCT02391948|449077962|FG000|6-month Assessment|Medical issue/illness|1|||
124850533|NCT02391948|449077963|FG001|6-month Assessment|Medical issue/illness|1|||
124850534|NCT02391948|449077964|FG002|6-month Assessment|Medical issue/illness|0|||
124850535|NCT02391948|449077965|FG003|6-month Assessment|Medical issue/illness|0|||
124850536|NCT02391948|449077966|FG004|6-month Assessment|Medical issue/illness|0|||
124850537|NCT02391948|449077962|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
124850538|NCT02391948|449077963|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
124850539|NCT02391948|449077964|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
124850540|NCT02391948|449077965|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
124850541|NCT02391948|449077966|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
124850542|NCT02391948|449077962|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
124850543|NCT02391948|449077963|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
124850544|NCT02391948|449077964|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
124850545|NCT02391948|449077965|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
124850546|NCT02391948|449077966|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
124850547|NCT02391948|449077962|FG000|12-month Assessment|Death|0|||
124850548|NCT02391948|449077963|FG001|12-month Assessment|Death|0|||
124850549|NCT02391948|449077964|FG002|12-month Assessment|Death|0|||
124850550|NCT02391948|449077965|FG003|12-month Assessment|Death|1|||
124850551|NCT02391948|449077966|FG004|12-month Assessment|Death|0|||
124850552|NCT02391948|449077962|FG000|12-month Assessment|Withdrawal by Subject|1|||
124850553|NCT02391948|449077963|FG001|12-month Assessment|Withdrawal by Subject|0|||
124850554|NCT02391948|449077964|FG002|12-month Assessment|Withdrawal by Subject|0|||
124850555|NCT02391948|449077965|FG003|12-month Assessment|Withdrawal by Subject|1|||
124850556|NCT02391948|449077966|FG004|12-month Assessment|Withdrawal by Subject|0|||
124850557|NCT02391948|449077962|FG000|12-month Assessment|Lost to Follow-up|5|||
124850558|NCT02391948|449077963|FG001|12-month Assessment|Lost to Follow-up|4|||
124850559|NCT02391948|449077964|FG002|12-month Assessment|Lost to Follow-up|4|||
124850560|NCT02391948|449077965|FG003|12-month Assessment|Lost to Follow-up|4|||
124850561|NCT02391948|449077966|FG004|12-month Assessment|Lost to Follow-up|5|||
124850562|NCT02391948|449077962|FG000|12-month Assessment|Medical issue/illness|0|||
124850563|NCT02391948|449077963|FG001|12-month Assessment|Medical issue/illness|1|||
124850564|NCT02391948|449077964|FG002|12-month Assessment|Medical issue/illness|0|||
124850565|NCT02391948|449077965|FG003|12-month Assessment|Medical issue/illness|1|||
124850566|NCT02391948|449077966|FG004|12-month Assessment|Medical issue/illness|0|||
124850567|NCT02391948|449077962|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
124850568|NCT02391948|449077963|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
124850569|NCT02391948|449077964|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
124850570|NCT02391948|449077965|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
124850571|NCT02391948|449077966|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
124850572|NCT02391948|449077962|FG000|18-month Assessment|Death|0|||
124850573|NCT02391948|449077963|FG001|18-month Assessment|Death|0|||
124850574|NCT02391948|449077964|FG002|18-month Assessment|Death|0|||
124850575|NCT02391948|449077965|FG003|18-month Assessment|Death|1|||
124850576|NCT02391948|449077966|FG004|18-month Assessment|Death|1|||
124850577|NCT02391948|449077962|FG000|18-month Assessment|Withdrawal by Subject|1|||
124850578|NCT02391948|449077963|FG001|18-month Assessment|Withdrawal by Subject|0|||
124850579|NCT02391948|449077964|FG002|18-month Assessment|Withdrawal by Subject|0|||
124850580|NCT02391948|449077965|FG003|18-month Assessment|Withdrawal by Subject|1|||
124850581|NCT02391948|449077966|FG004|18-month Assessment|Withdrawal by Subject|0|||
124850582|NCT02391948|449077962|FG000|18-month Assessment|Lost to Follow-up|2|||
124850583|NCT02391948|449077963|FG001|18-month Assessment|Lost to Follow-up|6|||
124850584|NCT02391948|449077964|FG002|18-month Assessment|Lost to Follow-up|2|||
124850585|NCT02391948|449077965|FG003|18-month Assessment|Lost to Follow-up|2|||
124850586|NCT02391948|449077966|FG004|18-month Assessment|Lost to Follow-up|3|||
124850587|NCT02391948|449077962|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
124850588|NCT02391948|449077963|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
124850589|NCT02391948|449077964|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
124850590|NCT02391948|449077965|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
124850591|NCT02391948|449077966|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
124850592|NCT02391948|449077962|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
124850593|NCT02391948|449077963|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
124850594|NCT02391948|449077964|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
124850595|NCT02391948|449077965|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
124850596|NCT02391948|449077966|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
124850597|NCT02391948|449077962|FG000|24-month Assessment|Death|0|||
124850598|NCT02391948|449077963|FG001|24-month Assessment|Death|0|||
124850599|NCT02391948|449077964|FG002|24-month Assessment|Death|0|||
124850600|NCT02391948|449077965|FG003|24-month Assessment|Death|0|||
124850601|NCT02391948|449077966|FG004|24-month Assessment|Death|1|||
124850602|NCT02391948|449077962|FG000|24-month Assessment|Withdrawal by Subject|1|||
124850603|NCT02391948|449077963|FG001|24-month Assessment|Withdrawal by Subject|1|||
124850604|NCT02391948|449077964|FG002|24-month Assessment|Withdrawal by Subject|0|||
124850605|NCT02391948|449077965|FG003|24-month Assessment|Withdrawal by Subject|0|||
124850606|NCT02391948|449077966|FG004|24-month Assessment|Withdrawal by Subject|1|||
124850607|NCT02391948|449077962|FG000|24-month Assessment|Lost to Follow-up|5|||
124850608|NCT02391948|449077963|FG001|24-month Assessment|Lost to Follow-up|4|||
124850609|NCT02391948|449077964|FG002|24-month Assessment|Lost to Follow-up|0|||
124850610|NCT02391948|449077965|FG003|24-month Assessment|Lost to Follow-up|0|||
124850611|NCT02391948|449077966|FG004|24-month Assessment|Lost to Follow-up|0|||
124850612|NCT02391948|449077962|FG000|24-month Assessment|Medical issue/illness|0|||
124850613|NCT02391948|449077963|FG001|24-month Assessment|Medical issue/illness|0|||
124850614|NCT02391948|449077964|FG002|24-month Assessment|Medical issue/illness|1|||
124850615|NCT02391948|449077965|FG003|24-month Assessment|Medical issue/illness|0|||
124850616|NCT02391948|449077966|FG004|24-month Assessment|Medical issue/illness|0|||
124850617|NCT02391948|449077962|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
124850618|NCT02391948|449077963|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
124850619|NCT02391948|449077964|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
124850620|NCT02391948|449077965|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
124850621|NCT02391948|449077966|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
124850622|NCT02886572|449077969|FG000|Overall Study|Death|8|||
124850623|NCT00982319|449077972|FG000|Overall Study|Surgery date change|1|||
124850624|NCT00982319|449077973|FG001|Overall Study|Surgery date change|0|||
124850625|NCT00982319|449077972|FG000|Overall Study|Preop values out of acceptable range|1|||
124850626|NCT00982319|449077973|FG001|Overall Study|Preop values out of acceptable range|1|||
124850627|NCT00982319|449077972|FG000|Overall Study|Pregnancy|0|||
124850628|NCT00982319|449077973|FG001|Overall Study|Pregnancy|1|||
124850629|NCT01923181|449077974|FG000|Overall Study|Protocol Violation|2|||
124850630|NCT01923181|449077975|FG001|Overall Study|Protocol Violation|2|||
124850631|NCT01923181|449077976|FG002|Overall Study|Protocol Violation|0|||
124850632|NCT01923181|449077977|FG003|Overall Study|Protocol Violation|2|||
124850633|NCT01923181|449077978|FG004|Overall Study|Protocol Violation|2|||
124850634|NCT01923181|449077979|FG005|Overall Study|Protocol Violation|1|||
124850635|NCT01923181|449077980|FG006|Overall Study|Protocol Violation|1|||
124850636|NCT01923181|449077981|FG007|Overall Study|Protocol Violation|2|||
124850637|NCT01923181|449077982|FG008|Overall Study|Protocol Violation|1|||
124850638|NCT01923181|449077974|FG000|Overall Study|Withdrawal by Subject|0|||
124850639|NCT01923181|449077975|FG001|Overall Study|Withdrawal by Subject|1|||
124850640|NCT01923181|449077976|FG002|Overall Study|Withdrawal by Subject|0|||
124850641|NCT01923181|449077977|FG003|Overall Study|Withdrawal by Subject|1|||
124850642|NCT01923181|449077978|FG004|Overall Study|Withdrawal by Subject|4|||
124850643|NCT01923181|449077979|FG005|Overall Study|Withdrawal by Subject|2|||
124850644|NCT01923181|449077980|FG006|Overall Study|Withdrawal by Subject|4|||
124850645|NCT01923181|449077981|FG007|Overall Study|Withdrawal by Subject|3|||
124850646|NCT01923181|449077982|FG008|Overall Study|Withdrawal by Subject|1|||
124850647|NCT01923181|449077974|FG000|Overall Study|Other|1|||
124850648|NCT01923181|449077975|FG001|Overall Study|Other|0|||
124850649|NCT01923181|449077976|FG002|Overall Study|Other|0|||
124850650|NCT01923181|449077977|FG003|Overall Study|Other|1|||
124850651|NCT01923181|449077978|FG004|Overall Study|Other|0|||
124850652|NCT01923181|449077979|FG005|Overall Study|Other|0|||
124850653|NCT01923181|449077980|FG006|Overall Study|Other|0|||
124850654|NCT01923181|449077981|FG007|Overall Study|Other|0|||
124850655|NCT01923181|449077982|FG008|Overall Study|Other|0|||
124850656|NCT01923181|449077974|FG000|Overall Study|Lost to Follow-up|0|||
124850657|NCT01923181|449077975|FG001|Overall Study|Lost to Follow-up|3|||
124850658|NCT01923181|449077976|FG002|Overall Study|Lost to Follow-up|2|||
124850659|NCT01923181|449077977|FG003|Overall Study|Lost to Follow-up|1|||
124850660|NCT01923181|449077978|FG004|Overall Study|Lost to Follow-up|2|||
124850661|NCT01923181|449077979|FG005|Overall Study|Lost to Follow-up|1|||
124850662|NCT01923181|449077980|FG006|Overall Study|Lost to Follow-up|3|||
124850663|NCT01923181|449077981|FG007|Overall Study|Lost to Follow-up|3|||
124850664|NCT01923181|449077982|FG008|Overall Study|Lost to Follow-up|1|||
124850665|NCT01863446|449077983|FG000|Overall Study|Withdrawal by Subject|1|||
124850666|NCT01863446|449077984|FG001|Overall Study|Withdrawal by Subject|0|||
124850667|NCT01863446|449077985|FG002|Overall Study|Withdrawal by Subject|1|||
124850668|NCT01863446|449077986|FG003|Overall Study|Withdrawal by Subject|2|||
124850669|NCT01863446|449077983|FG000|Overall Study|Physician Decision|0|||
124850670|NCT01863446|449077984|FG001|Overall Study|Physician Decision|0|||
124850671|NCT01863446|449077985|FG002|Overall Study|Physician Decision|1|||
124850672|NCT01863446|449077986|FG003|Overall Study|Physician Decision|0|||
124850673|NCT03603964|449077991|FG000|Overall Study|Death|9|||
124850674|NCT03603964|449077991|FG000|Overall Study|Withdrawal by participant|7|||
124850675|NCT03603964|449077991|FG000|Overall Study|Study terminated by Sponsor|19|||
124850676|NCT00563797|449077992|FG000|Overall Study|Lost to Follow-up|7|||
124850677|NCT00563797|449077993|FG001|Overall Study|Lost to Follow-up|2|||
124850678|NCT04317586|449077994|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
124850679|NCT04317586|449077994|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
124850680|NCT00807092|449077995|FG000|Overall Study|Adverse Event|0|||
124850681|NCT00807092|449077996|FG001|Overall Study|Adverse Event|1|||
124850682|NCT00807092|449077995|FG000|Overall Study|Protocol Violation|0|||
124850683|NCT00807092|449077996|FG001|Overall Study|Protocol Violation|2|||
124850684|NCT00807092|449077995|FG000|Overall Study|Withdrawal by Subject|1|||
124850685|NCT00807092|449077996|FG001|Overall Study|Withdrawal by Subject|0|||
124850686|NCT00807092|449077995|FG000|Overall Study|CGMS data collection failed|0|||
124850687|NCT00807092|449077996|FG001|Overall Study|CGMS data collection failed|1|||
124850688|NCT04116229|449077997|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
124850689|NCT04116229|449077998|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
124850690|NCT04116229|449077997|FG000|Overall Study|Scheduling not possible.|0|||
124850691|NCT04116229|449077998|FG001|Overall Study|Scheduling not possible.|1|||
124850692|NCT01794949|449077999|FG000|Overall Study|Lost to Follow-up|1|||
124850693|NCT01794949|449078000|FG001|Overall Study|Lost to Follow-up|0|||
124850694|NCT03003676|449078001|FG000|Overall Study|Lack of Efficacy|5|||
124850695|NCT03003676|449078002|FG001|Overall Study|Lack of Efficacy|7|||
124850696|NCT03003676|449078001|FG000|Overall Study|Withdrawal by Subject|0|||
124850697|NCT03003676|449078002|FG001|Overall Study|Withdrawal by Subject|1|||
124850698|NCT03003676|449078001|FG000|Overall Study|Hepatitis B infection|1|||
124850699|NCT03003676|449078002|FG001|Overall Study|Hepatitis B infection|0|||
124850700|NCT02443298|449078009|FG000|Overall Study|Adverse Event|3|||
124850701|NCT02443298|449078010|FG001|Overall Study|Adverse Event|3|||
124850702|NCT02443298|449078009|FG000|Overall Study|Withdrawal by Subject|1|||
124850703|NCT02443298|449078010|FG001|Overall Study|Withdrawal by Subject|2|||
124850704|NCT03698773|449078015|FG000|Overall Study|Lost to Follow-up|2|||
124850705|NCT03698773|449078016|FG001|Overall Study|Lost to Follow-up|1|||
124850706|NCT00908960|449078017|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
124850707|NCT00908960|449078018|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
124850708|NCT00908960|449078019|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
124850709|NCT05074433|449078020|FG000|Overall Study|Adverse Event|0|||
124850710|NCT05074433|449078021|FG001|Overall Study|Adverse Event|2|||
124850711|NCT05074433|449078022|FG002|Overall Study|Adverse Event|0|||
124850712|NCT05074433|449078023|FG003|Overall Study|Adverse Event|1|||
124850713|NCT05074433|449078020|FG000|Overall Study|Sponsor Request|0|||
124850714|NCT05074433|449078021|FG001|Overall Study|Sponsor Request|1|||
124850715|NCT05074433|449078022|FG002|Overall Study|Sponsor Request|1|||
124850716|NCT05074433|449078023|FG003|Overall Study|Sponsor Request|0|||
124850717|NCT05074433|449078020|FG000|Overall Study|Death|1|||
124850718|NCT05074433|449078021|FG001|Overall Study|Death|0|||
124850719|NCT05074433|449078022|FG002|Overall Study|Death|0|||
124850720|NCT05074433|449078023|FG003|Overall Study|Death|0|||
124850721|NCT05074433|449078020|FG000|Overall Study|Lost to Follow-up|0|||
124850722|NCT05074433|449078021|FG001|Overall Study|Lost to Follow-up|0|||
124850723|NCT05074433|449078022|FG002|Overall Study|Lost to Follow-up|2|||
124850724|NCT05074433|449078023|FG003|Overall Study|Lost to Follow-up|0|||
124850725|NCT05074433|449078020|FG000|Overall Study|Subject Decision|8|||
124850726|NCT05074433|449078021|FG001|Overall Study|Subject Decision|6|||
124850727|NCT05074433|449078022|FG002|Overall Study|Subject Decision|4|||
124850728|NCT05074433|449078023|FG003|Overall Study|Subject Decision|5|||
124850729|NCT01158924|449078025|FG000|Overall Study|Withdrawal by Subject|1|||
124850730|NCT01158924|449078026|FG001|Overall Study|Withdrawal by Subject|2|||
124850731|NCT01158924|449078025|FG000|Overall Study|Lost to Follow-up|0|||
124850732|NCT01158924|449078026|FG001|Overall Study|Lost to Follow-up|1|||
124850733|NCT03795922|449078027|FG000|Overall Study|Adverse Event|2|||
124850734|NCT03795922|449078028|FG001|Overall Study|Adverse Event|1|||
124850735|NCT03795922|449078027|FG000|Overall Study|Withdrawal by Subject|5|||
124850736|NCT03795922|449078028|FG001|Overall Study|Withdrawal by Subject|13|||
124850737|NCT03795922|449078027|FG000|Overall Study|Lost to Follow-up|2|||
124850738|NCT03795922|449078028|FG001|Overall Study|Lost to Follow-up|3|||
124850739|NCT03795922|449078027|FG000|Overall Study|Pregnancy|0|||
124850740|NCT03795922|449078028|FG001|Overall Study|Pregnancy|1|||
124850741|NCT03795922|449078027|FG000|Overall Study|Physician Decision|1|||
124850742|NCT03795922|449078028|FG001|Overall Study|Physician Decision|2|||
124850743|NCT03795922|449078027|FG000|Overall Study|Protocol Violation|0|||
124850744|NCT03795922|449078028|FG001|Overall Study|Protocol Violation|1|||
124850745|NCT03795922|449078027|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
124850746|NCT03795922|449078028|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
124850747|NCT00705575|449078029|FG000|Overall Study|Abnormal laboratory value(s)|0|||
124850748|NCT00705575|449078030|FG001|Overall Study|Abnormal laboratory value(s)|3|||
124850749|NCT00705575|449078029|FG000|Overall Study|Abnormal test procedure result(s)|2|||
124850750|NCT00705575|449078030|FG001|Overall Study|Abnormal test procedure result(s)|12|||
124850751|NCT00705575|449078029|FG000|Overall Study|Adverse Event|11|||
124850752|NCT00705575|449078030|FG001|Overall Study|Adverse Event|15|||
124850753|NCT00705575|449078029|FG000|Overall Study|Lost to Follow-up|3|||
124850754|NCT00705575|449078030|FG001|Overall Study|Lost to Follow-up|4|||
124850755|NCT00705575|449078029|FG000|Overall Study|Protocol Violation|2|||
124850756|NCT00705575|449078030|FG001|Overall Study|Protocol Violation|2|||
124850757|NCT00705575|449078029|FG000|Overall Study|Withdrawal by Subject|5|||
124850758|NCT00705575|449078030|FG001|Overall Study|Withdrawal by Subject|10|||
124850759|NCT02822794|449078033|FG000|Overall Study|Withdrew Consent|1|||
124850760|NCT02822794|449078034|FG001|Overall Study|Withdrew Consent|0|||
124850761|NCT03056690|449078035|FG000|Overall Study|Adverse Event|3|||
124850762|NCT03056690|449078036|FG001|Overall Study|Adverse Event|2|||
124850763|NCT03056690|449078035|FG000|Overall Study|Lack of Efficacy|1|||
124850764|NCT03056690|449078036|FG001|Overall Study|Lack of Efficacy|2|||
124850765|NCT03056690|449078035|FG000|Overall Study|Lost to Follow-up|3|||
124850766|NCT03056690|449078036|FG001|Overall Study|Lost to Follow-up|2|||
124850767|NCT03056690|449078035|FG000|Overall Study|Protocol Violation|2|||
124850768|NCT03056690|449078036|FG001|Overall Study|Protocol Violation|2|||
124850769|NCT03056690|449078035|FG000|Overall Study|Withdrawal by Subject|3|||
124850770|NCT03056690|449078036|FG001|Overall Study|Withdrawal by Subject|6|||
124850771|NCT03056690|449078035|FG000|Overall Study|Non-compliance with Study Drug|1|||
124850772|NCT03056690|449078036|FG001|Overall Study|Non-compliance with Study Drug|0|||
124850773|NCT03056690|449078035|FG000|Overall Study|Miscellaneous|1|||
124850774|NCT03056690|449078036|FG001|Overall Study|Miscellaneous|2|||
124850775|NCT01591681|449078049|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
124850776|NCT01591681|449078049|FG000|Overall Study|Failed to use system during run-in|1|||
124850777|NCT00179647|449078050|FG000|Overall Study|Adverse Event|294|||
124850778|NCT00179647|449078050|FG000|Overall Study|Lack of Efficacy|478|||
124850779|NCT00179647|449078050|FG000|Overall Study|Withdrawal by Subject|83|||
124850780|NCT00179647|449078050|FG000|Overall Study|Lost to Follow-up|4|||
124850781|NCT00179647|449078050|FG000|Overall Study|Death|94|||
124850782|NCT00179647|449078050|FG000|Overall Study|Other|960|||
124850783|NCT03027466|449078051|FG000|Overall Study|Opting out of the app|1869|||
124850784|NCT03027466|449078052|FG001|Overall Study|Opting out of the app|1819|||
124850785|NCT03027466|449078053|FG002|Overall Study|Opting out of the app|1743|||
124850786|NCT03027466|449078054|FG003|Overall Study|Opting out of the app|1821|||
124850787|NCT01440946|449078055|FG000|Overall Study|Lost to Follow-up|1|||
124850788|NCT01440946|449078056|FG001|Overall Study|Lost to Follow-up|1|||
124850789|NCT01440946|449078055|FG000|Overall Study|Physician Decision|1|||
124850790|NCT01440946|449078056|FG001|Overall Study|Physician Decision|0|||
124850791|NCT02486406|449078057|FG000|Overall Study|Withdrew consent|1|||
124850792|NCT02486406|449078058|FG001|Overall Study|Withdrew consent|0|||
124850793|NCT02486406|449078059|FG002|Overall Study|Withdrew consent|0|||
124850794|NCT02486406|449078060|FG003|Overall Study|Withdrew consent|1|||
124850795|NCT02486406|449078057|FG000|Overall Study|Lost to Follow-up|1|||
124850796|NCT02486406|449078058|FG001|Overall Study|Lost to Follow-up|3|||
124850797|NCT02486406|449078059|FG002|Overall Study|Lost to Follow-up|1|||
124850798|NCT02486406|449078060|FG003|Overall Study|Lost to Follow-up|3|||
124850799|NCT02486406|449078057|FG000|Overall Study|Other, not specified|0|||
124850800|NCT02486406|449078058|FG001|Overall Study|Other, not specified|0|||
124850801|NCT02486406|449078059|FG002|Overall Study|Other, not specified|1|||
124850802|NCT02486406|449078060|FG003|Overall Study|Other, not specified|0|||
124850803|NCT01826825|449078065|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
124850804|NCT01826825|449078066|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
124850805|NCT01858194|449078067|FG000|Overall Study|Total Artificial Heart Implant|0|||
124850806|NCT01858194|449078068|FG001|Overall Study|Total Artificial Heart Implant|1|||
124850807|NCT01858194|449078067|FG000|Overall Study|Lost to Follow-up|0|||
124850808|NCT01858194|449078068|FG001|Overall Study|Lost to Follow-up|1|||
124850809|NCT03062891|449078069|FG000|Overall Study|Withdrawal by Subject|2|||
124850810|NCT03062891|449078070|FG001|Overall Study|Withdrawal by Subject|0|||
124850811|NCT03062891|449078069|FG000|Overall Study|Lost to Follow-up|50|||
124850812|NCT03062891|449078070|FG001|Overall Study|Lost to Follow-up|38|||
124850813|NCT02127307|449078071|FG000|Overall Study|Protocol Violation|36|||
124850814|NCT02127307|449078071|FG000|Overall Study|Lost to Follow-up|2|||
124850815|NCT02127307|449078071|FG000|Overall Study|Death|101|||
124850816|NCT02127307|449078071|FG000|Overall Study|Other than specified above|169|||
124850817|NCT03221257|449078072|FG000|Overall Study|Lost to Follow-up|0|||
124850818|NCT03221257|449078073|FG001|Overall Study|Lost to Follow-up|1|||
124850819|NCT03221257|449078072|FG000|Overall Study|Withdrawal by Subject|1|||
124850820|NCT03221257|449078073|FG001|Overall Study|Withdrawal by Subject|1|||
124850821|NCT01687166|449078085|FG000|Overall Study|Attempt subject|2|||
124850822|NCT01687166|449078086|FG001|Overall Study|Attempt subject|3|||
124850823|NCT01687166|449078087|FG002|Overall Study|Attempt subject|2|||
124850824|NCT01687166|449078088|FG003|Overall Study|Attempt subject|0|||
124850825|NCT01687166|449078085|FG000|Overall Study|Did not meet eligibility criteria|4|||
124850826|NCT01687166|449078086|FG001|Overall Study|Did not meet eligibility criteria|6|||
124850827|NCT01687166|449078087|FG002|Overall Study|Did not meet eligibility criteria|1|||
124850828|NCT01687166|449078088|FG003|Overall Study|Did not meet eligibility criteria|1|||
124850829|NCT01687166|449078085|FG000|Overall Study|Adverse Event|2|||
124850830|NCT01687166|449078086|FG001|Overall Study|Adverse Event|1|||
124850831|NCT01687166|449078087|FG002|Overall Study|Adverse Event|0|||
124850832|NCT01687166|449078088|FG003|Overall Study|Adverse Event|0|||
124850833|NCT01687166|449078085|FG000|Overall Study|Physician Decision|3|||
124850834|NCT01687166|449078086|FG001|Overall Study|Physician Decision|2|||
124850835|NCT01687166|449078087|FG002|Overall Study|Physician Decision|1|||
124850836|NCT01687166|449078088|FG003|Overall Study|Physician Decision|0|||
124850837|NCT01687166|449078085|FG000|Overall Study|Withdrawal by Subject|11|||
124850838|NCT01687166|449078086|FG001|Overall Study|Withdrawal by Subject|4|||
124850839|NCT01687166|449078087|FG002|Overall Study|Withdrawal by Subject|3|||
124850840|NCT01687166|449078088|FG003|Overall Study|Withdrawal by Subject|0|||
124850841|NCT01687166|449078085|FG000|Overall Study|Lost to Follow-up|2|||
124850842|NCT01687166|449078086|FG001|Overall Study|Lost to Follow-up|5|||
124850843|NCT01687166|449078087|FG002|Overall Study|Lost to Follow-up|1|||
124850844|NCT01687166|449078088|FG003|Overall Study|Lost to Follow-up|0|||
124850845|NCT01687166|449078085|FG000|Overall Study|Equipment/Device Availability|0|||
124850846|NCT01687166|449078086|FG001|Overall Study|Equipment/Device Availability|1|||
124850847|NCT01687166|449078087|FG002|Overall Study|Equipment/Device Availability|0|||
124850848|NCT01687166|449078088|FG003|Overall Study|Equipment/Device Availability|0|||
124850849|NCT01687166|449078085|FG000|Overall Study|Death|1|||
124850850|NCT01687166|449078086|FG001|Overall Study|Death|1|||
124850851|NCT01687166|449078087|FG002|Overall Study|Death|0|||
124850852|NCT01687166|449078088|FG003|Overall Study|Death|0|||
124850853|NCT01687166|449078085|FG000|Overall Study|Protocol Violation|1|||
124850854|NCT01687166|449078086|FG001|Overall Study|Protocol Violation|1|||
124850855|NCT01687166|449078087|FG002|Overall Study|Protocol Violation|1|||
124850856|NCT01687166|449078088|FG003|Overall Study|Protocol Violation|0|||
124850857|NCT01687166|449078085|FG000|Overall Study|Subject moved out of state|0|||
124850858|NCT01687166|449078086|FG001|Overall Study|Subject moved out of state|1|||
124850859|NCT01687166|449078087|FG002|Overall Study|Subject moved out of state|0|||
124850860|NCT01687166|449078088|FG003|Overall Study|Subject moved out of state|0|||
124850861|NCT01687166|449078085|FG000|Overall Study|Patient unable to be compliant|1|||
124850862|NCT01687166|449078086|FG001|Overall Study|Patient unable to be compliant|0|||
124850863|NCT01687166|449078087|FG002|Overall Study|Patient unable to be compliant|0|||
124850864|NCT01687166|449078088|FG003|Overall Study|Patient unable to be compliant|0|||
124850865|NCT01687166|449078085|FG000|Overall Study|Physician choice to use different device|1|||
124850866|NCT01687166|449078086|FG001|Overall Study|Physician choice to use different device|2|||
124850867|NCT01687166|449078087|FG002|Overall Study|Physician choice to use different device|4|||
124850868|NCT01687166|449078088|FG003|Overall Study|Physician choice to use different device|0|||
124850869|NCT01687166|449078085|FG000|Overall Study|Insurance|0|||
124850870|NCT01687166|449078086|FG001|Overall Study|Insurance|0|||
124850871|NCT01687166|449078087|FG002|Overall Study|Insurance|1|||
124850872|NCT01687166|449078088|FG003|Overall Study|Insurance|1|||
124850873|NCT02296112|449078089|FG000|Overall Study|Disease progression|7|||
124850874|NCT02296112|449078089|FG000|Overall Study|Toxicity|1|||
124850875|NCT02296112|449078089|FG000|Overall Study|Began an alternate therapy|1|||
124850876|NCT02442830|449078090|FG000|Overall Study|Technical Failure|0|||
124850877|NCT02442830|449078091|FG001|Overall Study|Technical Failure|1|||
124850878|NCT01516879|449078092|FG000|Overall Study|Withdrawal by Subject|9|||
124850879|NCT01516879|449078093|FG001|Overall Study|Withdrawal by Subject|11|||
124850880|NCT01516879|449078092|FG000|Overall Study|Death|0|||
124850881|NCT01516879|449078093|FG001|Overall Study|Death|2|||
124850882|NCT01516879|449078092|FG000|Overall Study|Lost to Follow-up|2|||
124850883|NCT01516879|449078093|FG001|Overall Study|Lost to Follow-up|11|||
124850884|NCT01516879|449078092|FG000|Overall Study|Other|5|||
124850885|NCT01516879|449078093|FG001|Overall Study|Other|10|||
124850886|NCT00183872|449078094|FG000|Overall Study|Death|3|||
124850887|NCT00183872|449078094|FG000|Overall Study|Adverse Event|9|||
124850888|NCT00183872|449078094|FG000|Overall Study|Withdrawal by Subject|2|||
124850889|NCT00183872|449078094|FG000|Overall Study|Drug delayed more than 28 days|2|||
124850890|NCT02797262|449078095|FG000|Overall Study|Withdrawal by Subject|5|||
124850891|NCT02797262|449078096|FG001|Overall Study|Withdrawal by Subject|1|||
124850892|NCT02797262|449078095|FG000|Overall Study|Lost to Follow-up|10|||
124850893|NCT02797262|449078096|FG001|Overall Study|Lost to Follow-up|7|||
124850894|NCT02797262|449078095|FG000|Overall Study|Death|1|||
124850895|NCT02797262|449078096|FG001|Overall Study|Death|2|||
124850896|NCT02797262|449078095|FG000|Overall Study|Adverse Event|1|||
124850897|NCT02797262|449078096|FG001|Overall Study|Adverse Event|0|||
124850898|NCT02797262|449078095|FG000|Overall Study|COVID-19|2|||
124850899|NCT02797262|449078096|FG001|Overall Study|COVID-19|1|||
124850900|NCT02797262|449078095|FG000|Overall Study|Out-of-country|1|||
124850901|NCT02797262|449078096|FG001|Overall Study|Out-of-country|0|||
124850902|NCT01600586|449078097|FG000|Overall Study|Physician Decision|3|||
124850903|NCT01600586|449078098|FG001|Overall Study|Physician Decision|3|||
124850904|NCT01898793|449078099|FG000|Overall Study|Death|2|||
124850905|NCT01898793|449078100|FG001|Overall Study|Death|1|||
124850906|NCT01898793|449078101|FG002|Overall Study|Death|4|||
124850907|NCT01898793|449078102|FG003|Overall Study|Death|0|||
124850908|NCT01898793|449078103|FG004|Overall Study|Death|0|||
124850909|NCT01898793|449078104|FG005|Overall Study|Death|0|||
124850910|NCT01898793|449078105|FG006|Overall Study|Death|0|||
124850911|NCT00931307|449078106|FG000|Overall Study|Lack of Efficacy|12|||
124850912|NCT00931307|449078106|FG000|Overall Study|Biomicroscopy|1|||
124850913|NCT00983814|449078107|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
124850914|NCT00983814|449078108|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
124850915|NCT00983814|449078109|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
124850916|NCT00983814|449078107|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
124850917|NCT00983814|449078108|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
124850918|NCT00983814|449078109|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
124850919|NCT00983814|449078107|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
124850920|NCT00983814|449078108|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
124850921|NCT00983814|449078109|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
124850922|NCT00983814|449078107|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
124850923|NCT00983814|449078108|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
124850924|NCT00983814|449078109|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
124850925|NCT00983814|449078107|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
124850926|NCT00983814|449078108|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
124850927|NCT00983814|449078109|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
124850928|NCT00829621|449078110|FG000|Overall Study|Death|1|||
124850929|NCT00829621|449078111|FG001|Overall Study|Death|0|||
124850930|NCT00829621|449078110|FG000|Overall Study|Lost to Follow-up|3|||
124850931|NCT00829621|449078111|FG001|Overall Study|Lost to Follow-up|4|||
124850932|NCT02766608|449079651|FG000|Overall Study|Adverse Event|27|||
124850933|NCT02766608|449079652|FG001|Overall Study|Adverse Event|22|||
124850934|NCT02766608|449079653|FG002|Overall Study|Adverse Event|17|||
124850935|NCT02766608|449079654|FG003|Overall Study|Adverse Event|13|||
124850936|NCT02766608|449079655|FG004|Overall Study|Adverse Event|12|||
124850937|NCT02766608|449079651|FG000|Overall Study|Withdrawal by Subject|21|||
124850938|NCT02766608|449079652|FG001|Overall Study|Withdrawal by Subject|20|||
124850939|NCT02766608|449079653|FG002|Overall Study|Withdrawal by Subject|24|||
124850940|NCT02766608|449079654|FG003|Overall Study|Withdrawal by Subject|13|||
124850941|NCT02766608|449079655|FG004|Overall Study|Withdrawal by Subject|10|||
124850942|NCT02766608|449079651|FG000|Overall Study|Lack of Efficacy|16|||
124850943|NCT02766608|449079652|FG001|Overall Study|Lack of Efficacy|15|||
124850944|NCT02766608|449079653|FG002|Overall Study|Lack of Efficacy|32|||
124850945|NCT02766608|449079654|FG003|Overall Study|Lack of Efficacy|8|||
124850946|NCT02766608|449079655|FG004|Overall Study|Lack of Efficacy|2|||
124850947|NCT02766608|449079651|FG000|Overall Study|Lost to Follow-up|6|||
124850948|NCT02766608|449079652|FG001|Overall Study|Lost to Follow-up|3|||
124850949|NCT02766608|449079653|FG002|Overall Study|Lost to Follow-up|5|||
124850950|NCT02766608|449079654|FG003|Overall Study|Lost to Follow-up|2|||
124850951|NCT02766608|449079655|FG004|Overall Study|Lost to Follow-up|2|||
124850952|NCT02766608|449079651|FG000|Overall Study|Physician Decision|3|||
124850953|NCT02766608|449079652|FG001|Overall Study|Physician Decision|2|||
124850954|NCT02766608|449079653|FG002|Overall Study|Physician Decision|3|||
124850955|NCT02766608|449079654|FG003|Overall Study|Physician Decision|1|||
124850956|NCT02766608|449079655|FG004|Overall Study|Physician Decision|2|||
124850957|NCT02766608|449079651|FG000|Overall Study|Protocol disc criteria|3|||
124850958|NCT02766608|449079652|FG001|Overall Study|Protocol disc criteria|3|||
124850959|NCT02766608|449079653|FG002|Overall Study|Protocol disc criteria|4|||
124850960|NCT02766608|449079654|FG003|Overall Study|Protocol disc criteria|0|||
124850961|NCT02766608|449079655|FG004|Overall Study|Protocol disc criteria|0|||
124850962|NCT02766608|449079651|FG000|Overall Study|Protocol Violation|0|||
124850963|NCT02766608|449079652|FG001|Overall Study|Protocol Violation|4|||
124850964|NCT02766608|449079653|FG002|Overall Study|Protocol Violation|4|||
124850965|NCT02766608|449079654|FG003|Overall Study|Protocol Violation|0|||
124850966|NCT02766608|449079655|FG004|Overall Study|Protocol Violation|1|||
124850967|NCT02766608|449079651|FG000|Overall Study|Administrative Reasons|3|||
124850968|NCT02766608|449079652|FG001|Overall Study|Administrative Reasons|1|||
124850969|NCT02766608|449079653|FG002|Overall Study|Administrative Reasons|1|||
124850970|NCT02766608|449079654|FG003|Overall Study|Administrative Reasons|0|||
124850971|NCT02766608|449079655|FG004|Overall Study|Administrative Reasons|0|||
124850972|NCT02066298|449079656|FG000|Overall Study|Lost to Follow-up|3|||
124850973|NCT02066298|449079657|FG001|Overall Study|Lost to Follow-up|2|||
124850974|NCT02066298|449079658|FG002|Overall Study|Lost to Follow-up|3|||
124850975|NCT02066298|449079659|FG003|Overall Study|Lost to Follow-up|2|||
124850976|NCT02066298|449079660|FG004|Overall Study|Lost to Follow-up|3|||
124850977|NCT02066298|449079661|FG005|Overall Study|Lost to Follow-up|4|||
124850978|NCT02066298|449079656|FG000|Overall Study|Withdrawal by Subject|6|||
124850979|NCT02066298|449079657|FG001|Overall Study|Withdrawal by Subject|6|||
124850980|NCT02066298|449079658|FG002|Overall Study|Withdrawal by Subject|6|||
124850981|NCT02066298|449079659|FG003|Overall Study|Withdrawal by Subject|4|||
124850982|NCT02066298|449079660|FG004|Overall Study|Withdrawal by Subject|5|||
124850983|NCT02066298|449079661|FG005|Overall Study|Withdrawal by Subject|8|||
124850984|NCT02066298|449079656|FG000|Overall Study|Physician Decision|0|||
124850985|NCT02066298|449079657|FG001|Overall Study|Physician Decision|0|||
124850986|NCT02066298|449079658|FG002|Overall Study|Physician Decision|1|||
124850987|NCT02066298|449079659|FG003|Overall Study|Physician Decision|0|||
124850988|NCT02066298|449079660|FG004|Overall Study|Physician Decision|1|||
124850989|NCT02066298|449079661|FG005|Overall Study|Physician Decision|0|||
124850990|NCT02343458|449079666|FG000|Overall Study|Adverse Event|15|||
124850991|NCT02343458|449079667|FG001|Overall Study|Adverse Event|14|||
124850992|NCT02343458|449079668|FG002|Overall Study|Adverse Event|15|||
124850993|NCT02343458|449079669|FG003|Overall Study|Adverse Event|3|||
124850994|NCT02343458|449079666|FG000|Overall Study|Lack of Efficacy|3|||
124850995|NCT02343458|449079667|FG001|Overall Study|Lack of Efficacy|8|||
124850996|NCT02343458|449079668|FG002|Overall Study|Lack of Efficacy|4|||
124850997|NCT02343458|449079669|FG003|Overall Study|Lack of Efficacy|8|||
124850998|NCT02343458|449079666|FG000|Overall Study|Withdrawal by Subject|18|||
124850999|NCT02343458|449079667|FG001|Overall Study|Withdrawal by Subject|17|||
124851000|NCT02343458|449079668|FG002|Overall Study|Withdrawal by Subject|23|||
124851001|NCT02343458|449079669|FG003|Overall Study|Withdrawal by Subject|14|||
124851002|NCT02343458|449079666|FG000|Overall Study|Physician Decision|1|||
124851003|NCT02343458|449079667|FG001|Overall Study|Physician Decision|4|||
124851004|NCT02343458|449079668|FG002|Overall Study|Physician Decision|2|||
124851005|NCT02343458|449079669|FG003|Overall Study|Physician Decision|2|||
124851006|NCT02343458|449079666|FG000|Overall Study|Lost to Follow-up|5|||
124851007|NCT02343458|449079667|FG001|Overall Study|Lost to Follow-up|5|||
124851008|NCT02343458|449079668|FG002|Overall Study|Lost to Follow-up|3|||
124851009|NCT02343458|449079669|FG003|Overall Study|Lost to Follow-up|1|||
124851010|NCT02343458|449079666|FG000|Overall Study|Protocol Violation|2|||
124851011|NCT02343458|449079667|FG001|Overall Study|Protocol Violation|5|||
124851012|NCT02343458|449079668|FG002|Overall Study|Protocol Violation|2|||
124851013|NCT02343458|449079669|FG003|Overall Study|Protocol Violation|2|||
124851014|NCT02343458|449079666|FG000|Overall Study|Protocol Specified Criteria|17|||
124851015|NCT02343458|449079667|FG001|Overall Study|Protocol Specified Criteria|13|||
124851016|NCT02343458|449079668|FG002|Overall Study|Protocol Specified Criteria|14|||
124851017|NCT02343458|449079669|FG003|Overall Study|Protocol Specified Criteria|8|||
124851018|NCT01913041|449079670|FG000|Overall Study|Protocol Violation|35|||
124851019|NCT01913041|449079670|FG000|Overall Study|Withdrawal by Subject|3|||
124851020|NCT01913041|449079670|FG000|Overall Study|Physician Decision|1|||
124851021|NCT01265953|449079672|FG000|Overall Study|Non compliance|5|||
124851022|NCT01265953|449079673|FG001|Overall Study|Non compliance|3|||
124851023|NCT01610700|449079674|FG000|Overall Study|Adverse Event|3|||
124851024|NCT01610700|449079675|FG001|Overall Study|Adverse Event|1|||
124851025|NCT01610700|449079674|FG000|Overall Study|Withdrawal by Subject|0|||
124851026|NCT01610700|449079675|FG001|Overall Study|Withdrawal by Subject|1|||
124851027|NCT01610700|449079674|FG000|Overall Study|subject took one dose of street cannabis|0|||
124851028|NCT01610700|449079675|FG001|Overall Study|subject took one dose of street cannabis|1|||
124851029|NCT02648698|449079676|FG000|Overall Study|Protocol Violation|1|||
124851030|NCT02648698|449079677|FG001|Overall Study|Protocol Violation|5|||
124851031|NCT01640301|449079678|FG000|Overall Study|Death|0|||
124851032|NCT01640301|449079679|FG001|Overall Study|Death|8|||
124851033|NCT00672477|449079682|FG000|Overall Study|Adverse Event|10|||
124851034|NCT00672477|449079683|FG001|Overall Study|Adverse Event|7|||
124851035|NCT00672477|449079682|FG000|Overall Study|Death|7|||
124851036|NCT00672477|449079683|FG001|Overall Study|Death|11|||
124851037|NCT00672477|449079682|FG000|Overall Study|Physician Decision|2|||
124851038|NCT00672477|449079683|FG001|Overall Study|Physician Decision|0|||
124851039|NCT00672477|449079682|FG000|Overall Study|Protocol Violation|1|||
124851040|NCT00672477|449079683|FG001|Overall Study|Protocol Violation|1|||
124851041|NCT00672477|449079682|FG000|Overall Study|Withdrawal by Subject|5|||
124851042|NCT00672477|449079683|FG001|Overall Study|Withdrawal by Subject|3|||
124851043|NCT00672477|449079682|FG000|Overall Study|Lack of Efficacy|1|||
124851044|NCT00672477|449079683|FG001|Overall Study|Lack of Efficacy|1|||
124851045|NCT00672477|449079682|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
124851046|NCT00672477|449079683|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
124851047|NCT02348489|449079684|FG000|Overall Study|Death|336|||
124851048|NCT02348489|449079685|FG001|Overall Study|Death|335|||
124851049|NCT02348489|449079684|FG000|Overall Study|Withdrawal by Subject|14|||
124851050|NCT02348489|449079685|FG001|Overall Study|Withdrawal by Subject|27|||
124851051|NCT02348489|449079684|FG000|Overall Study|Lost to Follow-up|3|||
124851052|NCT02348489|449079685|FG001|Overall Study|Lost to Follow-up|5|||
124851053|NCT01639001|449079686|FG000|Overall Study|Refused further follow-up|9|||
124851054|NCT01639001|449079687|FG001|Overall Study|Refused further follow-up|12|||
124851055|NCT01639001|449079686|FG000|Overall Study|Lost to Follow-up|3|||
124851056|NCT01639001|449079687|FG001|Overall Study|Lost to Follow-up|0|||
124851057|NCT01639001|449079686|FG000|Overall Study|Death|62|||
124851058|NCT01639001|449079687|FG001|Overall Study|Death|61|||
124851059|NCT01639001|449079686|FG000|Overall Study|Randomized but not treated|0|||
124851060|NCT01639001|449079687|FG001|Overall Study|Randomized but not treated|2|||
124851061|NCT01639001|449079686|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
124851062|NCT01639001|449079687|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
124851063|NCT02866682|449079688|FG000|Overall Study|Death|0|||
124851064|NCT02866682|449079689|FG001|Overall Study|Death|1|||
124851065|NCT02866682|449079688|FG000|Overall Study|Lost to Follow-up|0|||
124851066|NCT02866682|449079689|FG001|Overall Study|Lost to Follow-up|4|||
124851067|NCT02866682|449079688|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
124851068|NCT02866682|449079689|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
124851069|NCT02866682|449079688|FG000|Overall Study|Other|0|||
124851070|NCT02866682|449079689|FG001|Overall Study|Other|1|||
124851071|NCT00201006|449079690|FG000|Overall Study|Withdrawal by Subject|7|||
124851072|NCT00201006|449079691|FG001|Overall Study|Withdrawal by Subject|2|||
124851073|NCT00201006|449079692|FG002|Overall Study|Withdrawal by Subject|3|||
124851074|NCT00201006|449079690|FG000|Overall Study|Adverse Event|1|||
124851075|NCT00201006|449079691|FG001|Overall Study|Adverse Event|0|||
124851076|NCT00201006|449079692|FG002|Overall Study|Adverse Event|1|||
124851077|NCT00274716|449079696|FG000|Phase A|Other non-reported reason|4|||
124851078|NCT00274716|449079697|FG001|Phase A|Other non-reported reason|2|||
124851079|NCT00274716|449079698|FG002|Phase A|Other non-reported reason|1|||
124851080|NCT00274716|449079699|FG003|Phase A|Other non-reported reason|2|||
124851081|NCT00274716|449079700|FG004|Phase A|Other non-reported reason|0|||
124851082|NCT00274716|449079701|FG005|Phase A|Other non-reported reason|1|||
124851083|NCT00274716|449079696|FG000|Phase A|Participant moved|0|||
124851084|NCT00274716|449079697|FG001|Phase A|Participant moved|0|||
124851085|NCT00274716|449079698|FG002|Phase A|Participant moved|1|||
124851086|NCT00274716|449079699|FG003|Phase A|Participant moved|0|||
124851087|NCT00274716|449079700|FG004|Phase A|Participant moved|0|||
124851088|NCT00274716|449079701|FG005|Phase A|Participant moved|1|||
124851089|NCT00274716|449079696|FG000|Phase A|Site Terminated|0|||
124851090|NCT00274716|449079697|FG001|Phase A|Site Terminated|0|||
124851091|NCT00274716|449079698|FG002|Phase A|Site Terminated|0|||
124851092|NCT00274716|449079699|FG003|Phase A|Site Terminated|1|||
124851093|NCT00274716|449079700|FG004|Phase A|Site Terminated|0|||
124851094|NCT00274716|449079701|FG005|Phase A|Site Terminated|0|||
124851095|NCT00274716|449079696|FG000|Phase A|Protocol Violation|1|||
124851096|NCT00274716|449079697|FG001|Phase A|Protocol Violation|0|||
124851097|NCT00274716|449079698|FG002|Phase A|Protocol Violation|0|||
124851098|NCT00274716|449079699|FG003|Phase A|Protocol Violation|1|||
124851099|NCT00274716|449079700|FG004|Phase A|Protocol Violation|0|||
124851100|NCT00274716|449079701|FG005|Phase A|Protocol Violation|0|||
124851101|NCT00274716|449079696|FG000|Phase A|Met criteria for discontinuation|1|||
124851102|NCT00274716|449079697|FG001|Phase A|Met criteria for discontinuation|1|||
124851103|NCT00274716|449079698|FG002|Phase A|Met criteria for discontinuation|0|||
124851104|NCT00274716|449079699|FG003|Phase A|Met criteria for discontinuation|0|||
124851105|NCT00274716|449079700|FG004|Phase A|Met criteria for discontinuation|0|||
124851106|NCT00274716|449079701|FG005|Phase A|Met criteria for discontinuation|0|||
124851107|NCT00274716|449079696|FG000|Phase A|Withdrawal by Subject|2|||
124851108|NCT00274716|449079697|FG001|Phase A|Withdrawal by Subject|2|||
124851109|NCT00274716|449079698|FG002|Phase A|Withdrawal by Subject|1|||
124851110|NCT00274716|449079699|FG003|Phase A|Withdrawal by Subject|3|||
124851111|NCT00274716|449079700|FG004|Phase A|Withdrawal by Subject|0|||
124851112|NCT00274716|449079701|FG005|Phase A|Withdrawal by Subject|1|||
124851113|NCT00274716|449079696|FG000|Phase A|Adverse Event|2|||
124851114|NCT00274716|449079697|FG001|Phase A|Adverse Event|3|||
124851115|NCT00274716|449079698|FG002|Phase A|Adverse Event|3|||
124851116|NCT00274716|449079699|FG003|Phase A|Adverse Event|0|||
124851117|NCT00274716|449079700|FG004|Phase A|Adverse Event|2|||
124851118|NCT00274716|449079701|FG005|Phase A|Adverse Event|0|||
124851119|NCT00274716|449079696|FG000|Phase A|Completed but did not enter Phase B|1|||
124851120|NCT00274716|449079697|FG001|Phase A|Completed but did not enter Phase B|2|||
124851121|NCT00274716|449079698|FG002|Phase A|Completed but did not enter Phase B|2|||
124851122|NCT00274716|449079699|FG003|Phase A|Completed but did not enter Phase B|2|||
124851123|NCT00274716|449079700|FG004|Phase A|Completed but did not enter Phase B|1|||
124851124|NCT00274716|449079701|FG005|Phase A|Completed but did not enter Phase B|1|||
124851125|NCT00274716|449079696|FG000|Phase B|Adverse Event|0|||
124851126|NCT00274716|449079697|FG001|Phase B|Adverse Event|0|||
124851127|NCT00274716|449079698|FG002|Phase B|Adverse Event|2|||
124851128|NCT00274716|449079699|FG003|Phase B|Adverse Event|0|||
124851129|NCT00274716|449079700|FG004|Phase B|Adverse Event|0|||
124851130|NCT00274716|449079701|FG005|Phase B|Adverse Event|1|||
124851131|NCT00274716|449079696|FG000|Phase B|Protocol Violation|0|||
124851132|NCT00274716|449079697|FG001|Phase B|Protocol Violation|2|||
124851133|NCT00274716|449079698|FG002|Phase B|Protocol Violation|0|||
124851134|NCT00274716|449079699|FG003|Phase B|Protocol Violation|0|||
124851135|NCT00274716|449079700|FG004|Phase B|Protocol Violation|0|||
124851136|NCT00274716|449079701|FG005|Phase B|Protocol Violation|0|||
124851137|NCT00274716|449079696|FG000|Phase B|Withdrawal by Subject|0|||
124851138|NCT00274716|449079697|FG001|Phase B|Withdrawal by Subject|1|||
124851139|NCT00274716|449079698|FG002|Phase B|Withdrawal by Subject|0|||
124851140|NCT00274716|449079699|FG003|Phase B|Withdrawal by Subject|0|||
124851141|NCT00274716|449079700|FG004|Phase B|Withdrawal by Subject|0|||
124851142|NCT00274716|449079701|FG005|Phase B|Withdrawal by Subject|0|||
124851143|NCT00274716|449079696|FG000|Phase B|Participant moved|1|||
124851144|NCT00274716|449079697|FG001|Phase B|Participant moved|0|||
124851145|NCT00274716|449079698|FG002|Phase B|Participant moved|0|||
124851146|NCT00274716|449079699|FG003|Phase B|Participant moved|0|||
124851147|NCT00274716|449079700|FG004|Phase B|Participant moved|0|||
124851148|NCT00274716|449079701|FG005|Phase B|Participant moved|0|||
124851149|NCT00274716|449079696|FG000|Phase B|Other non-reported reason|0|||
124851150|NCT00274716|449079697|FG001|Phase B|Other non-reported reason|0|||
124851151|NCT00274716|449079698|FG002|Phase B|Other non-reported reason|1|||
124851152|NCT00274716|449079699|FG003|Phase B|Other non-reported reason|1|||
124851153|NCT00274716|449079700|FG004|Phase B|Other non-reported reason|0|||
124851154|NCT00274716|449079701|FG005|Phase B|Other non-reported reason|0|||
124851155|NCT00274716|449079696|FG000|Phase B|Lost to Follow-up|0|||
124851156|NCT00274716|449079697|FG001|Phase B|Lost to Follow-up|1|||
124851157|NCT00274716|449079698|FG002|Phase B|Lost to Follow-up|0|||
124851158|NCT00274716|449079699|FG003|Phase B|Lost to Follow-up|0|||
124851159|NCT00274716|449079700|FG004|Phase B|Lost to Follow-up|0|||
124851160|NCT00274716|449079701|FG005|Phase B|Lost to Follow-up|0|||
124851161|NCT00975975|449079704|FG000|Overall Study|Death|6|||
124851162|NCT00961259|449079705|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
124851163|NCT00961259|449079706|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
124851164|NCT00961259|449079707|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
124851165|NCT01252251|449079710|FG000|Overall Study|Withdrawal by Subject|1|||
124851166|NCT01324024|449079711|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
124851167|NCT01324024|449079712|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
124851168|NCT02057757|449079718|FG000|Overall Study|Withdrawal by Subject|3|||
124851169|NCT02057757|449079719|FG001|Overall Study|Withdrawal by Subject|5|||
124851170|NCT02057757|449079718|FG000|Overall Study|Death|2|||
124851171|NCT02057757|449079719|FG001|Overall Study|Death|0|||
124851172|NCT02057757|449079718|FG000|Overall Study|Lost to Follow-up|8|||
124851173|NCT02057757|449079719|FG001|Overall Study|Lost to Follow-up|3|||
124851174|NCT02057757|449079718|FG000|Overall Study|Non-compliance|1|||
124851175|NCT02057757|449079719|FG001|Overall Study|Non-compliance|0|||
124851176|NCT03614793|449079720|FG000|Overall Study|Lost to Follow-up|1|||
124851177|NCT03614793|449079721|FG001|Overall Study|Lost to Follow-up|2|||
124851178|NCT03614793|449079720|FG000|Overall Study|Lack of Efficacy|0|||
124851179|NCT03614793|449079721|FG001|Overall Study|Lack of Efficacy|5|||
124851180|NCT03614793|449079720|FG000|Overall Study|Withdrawal by Subject|0|||
124851181|NCT03614793|449079721|FG001|Overall Study|Withdrawal by Subject|1|||
124851182|NCT03614793|449079720|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
124851183|NCT03614793|449079721|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
124851184|NCT02082522|449079722|FG000|Overall Study|Sponsor termination|5|||
124851185|NCT02082522|449079723|FG001|Overall Study|Sponsor termination|3|||
124851186|NCT02082522|449079722|FG000|Overall Study|Withdrawal by Subject|2|||
124851187|NCT02082522|449079723|FG001|Overall Study|Withdrawal by Subject|4|||
124851188|NCT02082522|449079722|FG000|Overall Study|Death|1|||
124851189|NCT02082522|449079723|FG001|Overall Study|Death|0|||
124851190|NCT02082522|449079722|FG000|Overall Study|Lost to Follow-up|1|||
124851191|NCT02082522|449079723|FG001|Overall Study|Lost to Follow-up|0|||
124851192|NCT02082522|449079722|FG000|Overall Study|Physician Decision|3|||
124851193|NCT02082522|449079723|FG001|Overall Study|Physician Decision|1|||
124851194|NCT02082522|449079722|FG000|Overall Study|Disease progression|2|||
124851195|NCT02082522|449079723|FG001|Overall Study|Disease progression|2|||
124851196|NCT02082522|449079722|FG000|Overall Study|Chemotherapy change|1|||
124851197|NCT02082522|449079723|FG001|Overall Study|Chemotherapy change|3|||
124851198|NCT00456092|449079724|FG000|Extension Phase|Grade 2 or Greater AE|2|||
124851199|NCT00456092|449079725|FG001|Extension Phase|Grade 2 or Greater AE|2|||
124851200|NCT00456092|449079726|FG002|Extension Phase|Grade 2 or Greater AE|0|||
124851201|NCT00456092|449079727|FG003|Extension Phase|Grade 2 or Greater AE|0|||
124851202|NCT00456092|449079728|FG004|Extension Phase|Grade 2 or Greater AE|2|||
124851203|NCT00456092|449079724|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
124851204|NCT00456092|449079725|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
124851205|NCT00456092|449079726|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
124851206|NCT00456092|449079727|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
124851207|NCT00456092|449079728|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
124851208|NCT00456092|449079724|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
124851209|NCT00456092|449079725|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
124851210|NCT00456092|449079726|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
124851211|NCT00456092|449079727|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
124851212|NCT00456092|449079728|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
124851213|NCT00456092|449079724|FG000|Extension Phase|Withdrew Consent|2|||
124851214|NCT00456092|449079725|FG001|Extension Phase|Withdrew Consent|0|||
124851215|NCT00456092|449079726|FG002|Extension Phase|Withdrew Consent|0|||
124851216|NCT00456092|449079727|FG003|Extension Phase|Withdrew Consent|0|||
124851217|NCT00456092|449079728|FG004|Extension Phase|Withdrew Consent|0|||
124851218|NCT00456092|449079724|FG000|Extension Phase|Lost to Follow-up|1|||
124851219|NCT00456092|449079725|FG001|Extension Phase|Lost to Follow-up|1|||
124851220|NCT00456092|449079726|FG002|Extension Phase|Lost to Follow-up|0|||
124851221|NCT00456092|449079727|FG003|Extension Phase|Lost to Follow-up|0|||
124851222|NCT00456092|449079728|FG004|Extension Phase|Lost to Follow-up|1|||
124851223|NCT00456092|449079724|FG000|Extension Phase|Other|2|||
124851224|NCT00456092|449079725|FG001|Extension Phase|Other|0|||
124851225|NCT00456092|449079726|FG002|Extension Phase|Other|0|||
124851226|NCT00456092|449079727|FG003|Extension Phase|Other|1|||
124851227|NCT00456092|449079728|FG004|Extension Phase|Other|1|||
124851228|NCT00456092|449079724|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
124851229|NCT00456092|449079725|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
124851230|NCT00456092|449079726|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
124851231|NCT00456092|449079727|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
124851232|NCT00456092|449079728|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
124851233|NCT00456092|449079724|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
124851234|NCT00456092|449079725|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
124851235|NCT00456092|449079726|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
124851236|NCT00456092|449079727|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
124851237|NCT00456092|449079728|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
124851238|NCT00456092|449079724|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
124851239|NCT00456092|449079725|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
124851240|NCT00456092|449079726|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
124851241|NCT00456092|449079727|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
124851242|NCT00456092|449079728|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
124851243|NCT00456092|449079724|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
124851244|NCT00456092|449079725|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
124851245|NCT00456092|449079726|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
124851246|NCT00456092|449079727|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
124851247|NCT00456092|449079728|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
124851248|NCT00456092|449079724|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
124851249|NCT00456092|449079725|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
124851250|NCT00456092|449079726|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
124851251|NCT00456092|449079727|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
124851252|NCT00456092|449079728|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
124851253|NCT00456092|449079724|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
124851254|NCT00456092|449079725|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
124851255|NCT00456092|449079726|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
124851256|NCT00456092|449079727|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
124851257|NCT00456092|449079728|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
124851258|NCT00456092|449079724|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
124851259|NCT00456092|449079725|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
124851260|NCT00456092|449079726|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
124851261|NCT00456092|449079727|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
124851262|NCT00456092|449079728|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
124851263|NCT00456092|449079724|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
124851264|NCT00456092|449079725|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
124851265|NCT00456092|449079726|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
124851266|NCT00456092|449079727|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
124851267|NCT00456092|449079728|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
124851268|NCT00456092|449079724|FG000|Treatment Phase (12 Weeks)|Other|1|||
124851269|NCT00456092|449079725|FG001|Treatment Phase (12 Weeks)|Other|0|||
124851270|NCT00456092|449079726|FG002|Treatment Phase (12 Weeks)|Other|1|||
124851271|NCT00456092|449079727|FG003|Treatment Phase (12 Weeks)|Other|0|||
124851272|NCT00456092|449079728|FG004|Treatment Phase (12 Weeks)|Other|0|||
124851273|NCT02840877|449079729|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
124851274|NCT02840877|449079729|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
124851275|NCT02840877|449079729|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
124851276|NCT02840877|449079729|FG000|Baseline to 12 Weeks|Death|1|||
124851277|NCT02840877|449079729|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
124851278|NCT02840877|449079729|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
124851279|NCT02840877|449079729|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
124851280|NCT02840877|449079729|FG000|12 Weeks to 6 Months|Treatment failure|1|||
124851281|NCT02840877|449079729|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
124851282|NCT02840877|449079729|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
124851283|NCT02840877|449079729|FG000|12 Weeks to 6 Months|Death|1|||
124851284|NCT02840877|449079729|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
124851285|NCT02840877|449079729|FG000|6 Months to 18 Months|Treatment failure|7|||
124851286|NCT02840877|449079729|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
124851287|NCT02840877|449079729|FG000|6 Months to 18 Months|Moved/transferred out|6|||
124851288|NCT02840877|449079729|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
124851289|NCT02840877|449079729|FG000|6 Months to 18 Months|Death|4|||
124851290|NCT02840877|449079729|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
124851291|NCT02840877|449079729|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
124851292|NCT02840877|449079729|FG000|6 Months to 18 Months|Still in study.|14|||
124851293|NCT01168999|449079730|FG000|Overall Study|Lost to Follow-up|2|||
124851294|NCT01168999|449079731|FG001|Overall Study|Lost to Follow-up|1|||
124851295|NCT01168999|449079732|FG002|Overall Study|Lost to Follow-up|0|||
124851296|NCT01168999|449079733|FG003|Overall Study|Lost to Follow-up|0|||
124851297|NCT01276327|449079734|FG000|Overall Study|Adverse Event|1|||
124851298|NCT01276327|449079735|FG001|Overall Study|Adverse Event|3|||
124851299|NCT01276327|449079734|FG000|Overall Study|Withdrawal by Subject|1|||
124851300|NCT01276327|449079735|FG001|Overall Study|Withdrawal by Subject|0|||
124851301|NCT01047683|449079736|FG000|Overall Study|Adverse Event|3|||
124851302|NCT01047683|449079737|FG001|Overall Study|Adverse Event|1|||
124851303|NCT01047683|449079738|FG002|Overall Study|Adverse Event|0|||
124851304|NCT01047683|449079736|FG000|Overall Study|Withdrew Consent|1|||
124851305|NCT01047683|449079737|FG001|Overall Study|Withdrew Consent|4|||
124851306|NCT01047683|449079738|FG002|Overall Study|Withdrew Consent|2|||
124851307|NCT01047683|449079736|FG000|Overall Study|Lost to Follow-up|0|||
124851308|NCT01047683|449079737|FG001|Overall Study|Lost to Follow-up|1|||
124851309|NCT01047683|449079738|FG002|Overall Study|Lost to Follow-up|0|||
124851310|NCT01047683|449079736|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
124851311|NCT01047683|449079737|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
124851312|NCT01047683|449079738|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
124851313|NCT03732248|449079739|FG000|Overall Study|Withdrawal by Subject|1|||
124851314|NCT03732248|449079740|FG001|Overall Study|Withdrawal by Subject|0|||
124851315|NCT00733824|449079741|FG000|Phase I|Withdrawal by Subject|1|||
124851316|NCT00733824|449079742|FG001|Phase I|Withdrawal by Subject|0|||
124851317|NCT00733824|449079743|FG002|Phase I|Withdrawal by Subject|0|||
124851318|NCT00733824|449079744|FG003|Phase I|Withdrawal by Subject|0|||
124851319|NCT00733824|449079745|FG004|Phase I|Withdrawal by Subject|0|||
124851320|NCT02480621|449079750|FG000|Randomization|Withdrawal by Subject|1|||
124851321|NCT02480621|449079751|FG001|Randomization|Withdrawal by Subject|0|||
124851322|NCT02480621|449079750|FG000|Randomization|Surgeon did not give intervention|0|||
124851323|NCT02480621|449079751|FG001|Randomization|Surgeon did not give intervention|1|||
124851324|NCT02480621|449079750|FG000|Follow Up|Lost to Follow-up|4|||
124851325|NCT02480621|449079751|FG001|Follow Up|Lost to Follow-up|2|||
124851326|NCT00235989|449079756|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
124851327|NCT00235989|449079757|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
124851328|NCT00235989|449079758|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
124851329|NCT00235989|449079759|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
124851330|NCT00235989|449079760|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
124851331|NCT00235989|449079761|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
124851332|NCT00235989|449079756|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
124851333|NCT00235989|449079757|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
124851334|NCT00235989|449079758|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
124851335|NCT00235989|449079759|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
124851336|NCT00235989|449079760|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
124851337|NCT00235989|449079761|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
124851338|NCT00235989|449079756|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
124851339|NCT00235989|449079757|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
124851340|NCT00235989|449079758|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
124851341|NCT00235989|449079759|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
124851342|NCT00235989|449079760|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
124851343|NCT00235989|449079761|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
124851344|NCT00235989|449079756|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
124851345|NCT00235989|449079757|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
124851346|NCT00235989|449079758|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
124851347|NCT00235989|449079759|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
124851348|NCT00235989|449079760|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
124851349|NCT00235989|449079761|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
124851350|NCT00235989|449079756|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
124851351|NCT00235989|449079757|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
124851352|NCT00235989|449079758|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
124851353|NCT00235989|449079759|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
124851354|NCT00235989|449079760|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
124851355|NCT00235989|449079761|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
124851356|NCT00983580|449079765|FG000|Overall Study|Cancel Prior to treatment|1|||
124851357|NCT00983580|449079766|FG001|Overall Study|Cancel Prior to treatment|3|||
124851358|NCT00983580|449079765|FG000|Overall Study|Protocol Violation|1|||
124851359|NCT00983580|449079766|FG001|Overall Study|Protocol Violation|1|||
124851360|NCT00983580|449079765|FG000|Overall Study|Ineligible|3|||
124851361|NCT00983580|449079766|FG001|Overall Study|Ineligible|0|||
124851362|NCT01971346|449079769|FG000|Overall Study|Protocol Violation|3|||
124851363|NCT01971346|449079769|FG000|Overall Study|Lost to Follow-up|2|||
124851364|NCT01971346|449079769|FG000|Overall Study|Withdrawal by Subject|2|||
124851365|NCT01971346|449079769|FG000|Overall Study|Physician Decision|1|||
124851366|NCT01652716|449079770|FG000|Overall Study|Loss of glucose control|1|||
124851367|NCT01652716|449079771|FG001|Overall Study|Loss of glucose control|0|||
124851368|NCT01652716|449079770|FG000|Overall Study|Administrative|0|||
124851369|NCT01652716|449079771|FG001|Overall Study|Administrative|2|||
124851370|NCT01652716|449079770|FG000|Overall Study|Investigator decision|1|||
124851371|NCT01652716|449079771|FG001|Overall Study|Investigator decision|4|||
124851372|NCT01652716|449079770|FG000|Overall Study|Lost to Follow-up|12|||
124851373|NCT01652716|449079771|FG001|Overall Study|Lost to Follow-up|11|||
124851374|NCT01652716|449079770|FG000|Overall Study|Protocol Violation|2|||
124851375|NCT01652716|449079771|FG001|Overall Study|Protocol Violation|1|||
124851376|NCT01652716|449079770|FG000|Overall Study|Adverse Event|7|||
124851377|NCT01652716|449079771|FG001|Overall Study|Adverse Event|10|||
124851378|NCT01652716|449079770|FG000|Overall Study|Withdrawal by Subject|33|||
124851379|NCT01652716|449079771|FG001|Overall Study|Withdrawal by Subject|18|||
124851380|NCT00360334|449079774|FG000|Overall Study|Adverse Event|7|||
124851381|NCT00360334|449079775|FG001|Overall Study|Adverse Event|4|||
124851382|NCT00360334|449079774|FG000|Overall Study|Protocol Violation|1|||
124851383|NCT00360334|449079775|FG001|Overall Study|Protocol Violation|1|||
124851384|NCT00360334|449079774|FG000|Overall Study|Physician Decision|2|||
124851385|NCT00360334|449079775|FG001|Overall Study|Physician Decision|3|||
124851386|NCT00360334|449079774|FG000|Overall Study|Lack of Efficacy|0|||
124851387|NCT00360334|449079775|FG001|Overall Study|Lack of Efficacy|1|||
124851388|NCT00360334|449079774|FG000|Overall Study|Entry criterion not met|1|||
124851389|NCT00360334|449079775|FG001|Overall Study|Entry criterion not met|2|||
124851390|NCT00360334|449079774|FG000|Overall Study|Subject decision|8|||
124851391|NCT00360334|449079775|FG001|Overall Study|Subject decision|2|||
124851392|NCT01978184|449079778|FG000|Overall Study|Progressive disease|5|||
124851393|NCT01978184|449079779|FG001|Overall Study|Progressive disease|5|||
124851394|NCT01978184|449079778|FG000|Overall Study|Other than PDA|2|||
124851395|NCT01978184|449079779|FG001|Overall Study|Other than PDA|2|||
124851396|NCT01978184|449079778|FG000|Overall Study|Physician Decision|0|||
124851397|NCT01978184|449079779|FG001|Overall Study|Physician Decision|3|||
124851398|NCT01978184|449079778|FG000|Overall Study|Noncompliance|1|||
124851399|NCT01978184|449079779|FG001|Overall Study|Noncompliance|2|||
124851400|NCT01978184|449079778|FG000|Overall Study|Death|1|||
124851401|NCT01978184|449079779|FG001|Overall Study|Death|0|||
124851402|NCT01978184|449079778|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
124851403|NCT01978184|449079779|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
124851404|NCT02447991|449079797|FG000|Overall Study|Withdrawn by subject - no data|0|||
124851405|NCT02447991|449079798|FG001|Overall Study|Withdrawn by subject - no data|2|||
124851406|NCT02447991|449079797|FG000|Overall Study|Withdrawn by Subject - with data|4|||
124851407|NCT02447991|449079798|FG001|Overall Study|Withdrawn by Subject - with data|4|||
124851408|NCT02447991|449079797|FG000|Overall Study|Lost to Follow-up - no data|3|||
124851409|NCT02447991|449079798|FG001|Overall Study|Lost to Follow-up - no data|6|||
124851410|NCT02447991|449079797|FG000|Overall Study|Lost to follow-up - with data|0|||
124851411|NCT02447991|449079798|FG001|Overall Study|Lost to follow-up - with data|3|||
124851412|NCT02447991|449079797|FG000|Overall Study|End of study - no treatment results|3|||
124851413|NCT02447991|449079798|FG001|Overall Study|End of study - no treatment results|6|||
124851414|NCT02447991|449079797|FG000|Overall Study|End of study - partial treatment results|0|||
124851415|NCT02447991|449079798|FG001|Overall Study|End of study - partial treatment results|9|||
124851416|NCT00459134|449079799|FG000|Overall Study|Physician Decision|1|||
124851417|NCT00459134|449079800|FG001|Overall Study|Physician Decision|1|||
124851418|NCT00459134|449079799|FG000|Overall Study|Withdrawal by Subject|8|||
124851419|NCT00459134|449079800|FG001|Overall Study|Withdrawal by Subject|7|||
124851420|NCT00459134|449079799|FG000|Overall Study|Lost to Follow-up|6|||
124851421|NCT00459134|449079800|FG001|Overall Study|Lost to Follow-up|7|||
124851422|NCT00459134|449079799|FG000|Overall Study|Surgery|1|||
124851423|NCT00459134|449079800|FG001|Overall Study|Surgery|2|||
124851424|NCT00459134|449079799|FG000|Overall Study|Toxicity|4|||
124851425|NCT00459134|449079800|FG001|Overall Study|Toxicity|5|||
124851426|NCT00459134|449079799|FG000|Overall Study|Progression|1|||
124851427|NCT00459134|449079800|FG001|Overall Study|Progression|0|||
124851428|NCT00459134|449079799|FG000|Overall Study|Multiple Reasons|2|||
124851429|NCT00459134|449079800|FG001|Overall Study|Multiple Reasons|3|||
124851430|NCT03568461|449079808|FG000|Overall Study|Death|7|||
124851431|NCT03568461|449079808|FG000|Overall Study|Physician Decision|5|||
124851432|NCT03568461|449079808|FG000|Overall Study|Subject decision|5|||
124851433|NCT03568461|449079808|FG000|Overall Study|Lost to Follow-up|1|||
124851434|NCT03964454|449079809|FG000|Overall Study|Lost to Follow-up|13|||
124851435|NCT03964454|449079810|FG001|Overall Study|Lost to Follow-up|7|||
124851436|NCT03964454|449079809|FG000|Overall Study|Withdrawal by Subject|4|||
124851437|NCT03964454|449079810|FG001|Overall Study|Withdrawal by Subject|11|||
124851438|NCT03328897|449081244|FG000|Randomized-treatment Epoch|Adverse Event|4|||
124851439|NCT03328897|449081245|FG001|Randomized-treatment Epoch|Adverse Event|1|||
124851440|NCT03328897|449081246|FG002|Randomized-treatment Epoch|Adverse Event|1|||
124851441|NCT03328897|449081244|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
124851442|NCT03328897|449081245|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
124851443|NCT03328897|449081246|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
124851444|NCT03328897|449081244|FG000|Randomized-treatment Epoch|Pregnancy|3|||
124851445|NCT03328897|449081245|FG001|Randomized-treatment Epoch|Pregnancy|0|||
124851446|NCT03328897|449081246|FG002|Randomized-treatment Epoch|Pregnancy|0|||
124851447|NCT03328897|449081244|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
124851448|NCT03328897|449081245|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
124851449|NCT03328897|449081246|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
124851450|NCT03328897|449081244|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
124851451|NCT03328897|449081245|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
124851452|NCT03328897|449081246|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
124851453|NCT03328897|449081244|FG000|Follow-up Epoch|Adverse Event|4|||
124851454|NCT03328897|449081245|FG001|Follow-up Epoch|Adverse Event|0|||
124851455|NCT03328897|449081246|FG002|Follow-up Epoch|Adverse Event|1|||
124851456|NCT03328897|449081244|FG000|Follow-up Epoch|Lack of Efficacy|1|||
124851457|NCT03328897|449081245|FG001|Follow-up Epoch|Lack of Efficacy|1|||
124851458|NCT03328897|449081246|FG002|Follow-up Epoch|Lack of Efficacy|1|||
124851459|NCT03328897|449081244|FG000|Follow-up Epoch|Lost to Follow-up|0|||
124851460|NCT03328897|449081245|FG001|Follow-up Epoch|Lost to Follow-up|1|||
124851461|NCT03328897|449081246|FG002|Follow-up Epoch|Lost to Follow-up|0|||
124851462|NCT03328897|449081244|FG000|Follow-up Epoch|Pregnancy|1|||
124851463|NCT03328897|449081245|FG001|Follow-up Epoch|Pregnancy|0|||
124851464|NCT03328897|449081246|FG002|Follow-up Epoch|Pregnancy|0|||
124851465|NCT03328897|449081244|FG000|Follow-up Epoch|Patient/guardian decision|2|||
124851466|NCT03328897|449081245|FG001|Follow-up Epoch|Patient/guardian decision|1|||
124851467|NCT03328897|449081246|FG002|Follow-up Epoch|Patient/guardian decision|0|||
124851468|NCT01750268|449081248|FG000|Overall Study|Lost to Follow-up|0|||
124851469|NCT01750268|449081249|FG001|Overall Study|Lost to Follow-up|2|||
124851470|NCT01750268|449081248|FG000|Overall Study|Physician Decision|0|||
124851471|NCT01750268|449081249|FG001|Overall Study|Physician Decision|3|||
124851472|NCT01750268|449081248|FG000|Overall Study|Withdrawal by Subject|2|||
124851473|NCT01750268|449081249|FG001|Overall Study|Withdrawal by Subject|0|||
124851474|NCT01969838|449081253|FG000|Double-blind Phase|Adverse Event|10|||
124851475|NCT01969838|449081254|FG001|Double-blind Phase|Adverse Event|4|||
124851476|NCT01969838|449081255|FG002|Double-blind Phase|Adverse Event|0|||
124851477|NCT01969838|449081256|FG003|Double-blind Phase|Adverse Event|0|||
124851478|NCT01969838|449081253|FG000|Double-blind Phase|Death|5|||
124851479|NCT01969838|449081254|FG001|Double-blind Phase|Death|2|||
124851480|NCT01969838|449081255|FG002|Double-blind Phase|Death|0|||
124851481|NCT01969838|449081256|FG003|Double-blind Phase|Death|0|||
124851482|NCT01969838|449081253|FG000|Double-blind Phase|Physician Decision|5|||
124851483|NCT01969838|449081254|FG001|Double-blind Phase|Physician Decision|1|||
124851484|NCT01969838|449081255|FG002|Double-blind Phase|Physician Decision|0|||
124851485|NCT01969838|449081256|FG003|Double-blind Phase|Physician Decision|0|||
124851486|NCT01969838|449081253|FG000|Double-blind Phase|Subject Decision|4|||
124851487|NCT01969838|449081254|FG001|Double-blind Phase|Subject Decision|2|||
124851488|NCT01969838|449081255|FG002|Double-blind Phase|Subject Decision|0|||
124851489|NCT01969838|449081256|FG003|Double-blind Phase|Subject Decision|0|||
124851490|NCT01969838|449081253|FG000|Double-blind Phase|Disease Progression|2|||
124851491|NCT01969838|449081254|FG001|Double-blind Phase|Disease Progression|0|||
124851492|NCT01969838|449081255|FG002|Double-blind Phase|Disease Progression|0|||
124851493|NCT01969838|449081256|FG003|Double-blind Phase|Disease Progression|0|||
124851494|NCT01969838|449081253|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
124851495|NCT01969838|449081254|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
124851496|NCT01969838|449081255|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
124851497|NCT01969838|449081256|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
124851498|NCT01969838|449081253|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
124851499|NCT01969838|449081254|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
124851500|NCT01969838|449081255|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
124851501|NCT01969838|449081256|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
124851502|NCT01969838|449081253|FG000|Open-label Phase|Adverse Event|0|||
124851503|NCT01969838|449081254|FG001|Open-label Phase|Adverse Event|0|||
124851504|NCT01969838|449081255|FG002|Open-label Phase|Adverse Event|37|||
124851505|NCT01969838|449081256|FG003|Open-label Phase|Adverse Event|49|||
124851506|NCT01969838|449081253|FG000|Open-label Phase|Disease Progression|0|||
124851507|NCT01969838|449081254|FG001|Open-label Phase|Disease Progression|0|||
124851508|NCT01969838|449081255|FG002|Open-label Phase|Disease Progression|26|||
124851509|NCT01969838|449081256|FG003|Open-label Phase|Disease Progression|27|||
124851510|NCT01969838|449081253|FG000|Open-label Phase|Lack of Efficacy|0|||
124851511|NCT01969838|449081254|FG001|Open-label Phase|Lack of Efficacy|0|||
124851512|NCT01969838|449081255|FG002|Open-label Phase|Lack of Efficacy|17|||
124851513|NCT01969838|449081256|FG003|Open-label Phase|Lack of Efficacy|19|||
124851514|NCT01969838|449081253|FG000|Open-label Phase|Subject Decision|0|||
124851515|NCT01969838|449081254|FG001|Open-label Phase|Subject Decision|0|||
124851516|NCT01969838|449081255|FG002|Open-label Phase|Subject Decision|14|||
124851517|NCT01969838|449081256|FG003|Open-label Phase|Subject Decision|15|||
124851518|NCT01969838|449081253|FG000|Open-label Phase|Death|0|||
124851519|NCT01969838|449081254|FG001|Open-label Phase|Death|0|||
124851520|NCT01969838|449081255|FG002|Open-label Phase|Death|13|||
124851521|NCT01969838|449081256|FG003|Open-label Phase|Death|11|||
124851522|NCT01969838|449081253|FG000|Open-label Phase|Physician Decision|0|||
124851523|NCT01969838|449081254|FG001|Open-label Phase|Physician Decision|0|||
124851524|NCT01969838|449081255|FG002|Open-label Phase|Physician Decision|9|||
124851525|NCT01969838|449081256|FG003|Open-label Phase|Physician Decision|14|||
124851526|NCT01969838|449081253|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
124851527|NCT01969838|449081254|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
124851528|NCT01969838|449081255|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
124851529|NCT01969838|449081256|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
124851530|NCT03087591|449081257|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
124851531|NCT03087591|449081257|FG000|Overall Study|Withdrawal by Subject|1|||
124851532|NCT00408993|449081258|FG000|Overall Study|Adverse Event|15|||
124851533|NCT00408993|449081259|FG001|Overall Study|Adverse Event|4|||
124851534|NCT00408993|449081258|FG000|Overall Study|Protocol Violation|1|||
124851535|NCT00408993|449081259|FG001|Overall Study|Protocol Violation|6|||
124851536|NCT00408993|449081258|FG000|Overall Study|Lack of Efficacy|1|||
124851537|NCT00408993|449081259|FG001|Overall Study|Lack of Efficacy|4|||
124851538|NCT00408993|449081258|FG000|Overall Study|Withdrawal by Subject|2|||
124851539|NCT00408993|449081259|FG001|Overall Study|Withdrawal by Subject|3|||
124851540|NCT03738865|449081260|FG000|Overall Study|Withdrawal by Subject|3|||
124851541|NCT03738865|449081261|FG001|Overall Study|Withdrawal by Subject|3|||
124851542|NCT03738865|449081260|FG000|Overall Study|Adverse Event|2|||
124851543|NCT03738865|449081261|FG001|Overall Study|Adverse Event|0|||
124851544|NCT03738865|449081260|FG000|Overall Study|Physician Decision|0|||
124851545|NCT03738865|449081261|FG001|Overall Study|Physician Decision|1|||
124851546|NCT02621606|449081262|FG000|Overall Study|Withdrawal by Subject|0|||
124851547|NCT02621606|449081263|FG001|Overall Study|Withdrawal by Subject|1|||
124851548|NCT02621606|449081264|FG002|Overall Study|Withdrawal by Subject|0|||
124851549|NCT01694706|449081265|FG000|Overall Study|Adverse Event|0|||
124851550|NCT01694706|449081266|FG001|Overall Study|Adverse Event|1|||
124851551|NCT01694706|449081267|FG002|Overall Study|Adverse Event|0|||
124851552|NCT01694706|449081265|FG000|Overall Study|other reason not defined above|1|||
124851553|NCT01694706|449081266|FG001|Overall Study|other reason not defined above|0|||
124851554|NCT01694706|449081267|FG002|Overall Study|other reason not defined above|0|||
124851555|NCT02252081|449081270|FG000|Overall Study|Withdrawal by Subject|2|||
124851556|NCT02252081|449081271|FG001|Overall Study|Withdrawal by Subject|1|||
124851557|NCT02252081|449081270|FG000|Overall Study|Adverse Event|4|||
124851558|NCT02252081|449081271|FG001|Overall Study|Adverse Event|1|||
124851559|NCT02252081|449081270|FG000|Overall Study|non compliance & others|0|||
124851560|NCT02252081|449081271|FG001|Overall Study|non compliance & others|2|||
124851561|NCT03766646|449081274|FG000|Overall Study|Withdrawal by Subject|1|||
124851562|NCT03766646|449081275|FG001|Overall Study|Withdrawal by Subject|0|||
124851563|NCT03766646|449081274|FG000|Overall Study|Protocol Violation|0|||
124851564|NCT03766646|449081275|FG001|Overall Study|Protocol Violation|3|||
124851565|NCT00659269|449081295|FG000|Overall Study|Physician Decision|1|||
124851566|NCT00659269|449081296|FG001|Overall Study|Physician Decision|1|||
124851567|NCT01158222|449081297|FG000|Overall Study|Not eligible for intermediate phase|17|||
124851568|NCT01490060|449081302|FG000|Cycle 1|Change of Treatment|0|||
124851569|NCT01490060|449081303|FG001|Cycle 1|Change of Treatment|1|||
124851570|NCT01490060|449081304|FG002|Cycle 1|Change of Treatment|1|||
124851571|NCT01490060|449081305|FG003|Cycle 1|Change of Treatment|1|||
124851572|NCT01490060|449081302|FG000|Cycle 1|Insurance Denied|0|||
124851573|NCT01490060|449081303|FG001|Cycle 1|Insurance Denied|0|||
124851574|NCT01490060|449081304|FG002|Cycle 1|Insurance Denied|2|||
124851575|NCT01490060|449081305|FG003|Cycle 1|Insurance Denied|0|||
124851576|NCT01490060|449081302|FG000|Cycle 1|Withdrawal by Subject|0|||
124851577|NCT01490060|449081303|FG001|Cycle 1|Withdrawal by Subject|0|||
124851578|NCT01490060|449081304|FG002|Cycle 1|Withdrawal by Subject|0|||
124851579|NCT01490060|449081305|FG003|Cycle 1|Withdrawal by Subject|1|||
124851580|NCT01490060|449081302|FG000|Cycle 1|Treatment at Another Facility|0|||
124851581|NCT01490060|449081303|FG001|Cycle 1|Treatment at Another Facility|0|||
124851582|NCT01490060|449081304|FG002|Cycle 1|Treatment at Another Facility|0|||
124851583|NCT01490060|449081305|FG003|Cycle 1|Treatment at Another Facility|1|||
124851584|NCT01490060|449081302|FG000|Cycle 2|Change of Treatment|1|||
124851585|NCT01490060|449081303|FG001|Cycle 2|Change of Treatment|1|||
124851586|NCT01490060|449081304|FG002|Cycle 2|Change of Treatment|0|||
124851587|NCT01490060|449081305|FG003|Cycle 2|Change of Treatment|0|||
124851588|NCT01490060|449081302|FG000|Cycle 2|Non-Compliance|0|||
124851589|NCT01490060|449081303|FG001|Cycle 2|Non-Compliance|0|||
124851590|NCT01490060|449081304|FG002|Cycle 2|Non-Compliance|1|||
124851591|NCT01490060|449081305|FG003|Cycle 2|Non-Compliance|0|||
124851592|NCT01490060|449081302|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
124851593|NCT01490060|449081303|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
124851594|NCT01490060|449081304|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
124851595|NCT01490060|449081305|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
124851596|NCT01877421|449081306|FG000|Phase 2|Lost to Follow-up|0|||
124851597|NCT01877421|449081307|FG001|Phase 2|Lost to Follow-up|0|||
124851598|NCT01877421|449081308|FG002|Phase 2|Lost to Follow-up|0|||
124851599|NCT01877421|449081309|FG003|Phase 2|Lost to Follow-up|0|||
124851600|NCT01877421|449081310|FG004|Phase 2|Lost to Follow-up|0|||
124851601|NCT01877421|449081311|FG005|Phase 2|Lost to Follow-up|0|||
124851602|NCT01877421|449081312|FG006|Phase 2|Lost to Follow-up|1|||
124851603|NCT01877421|449081313|FG007|Phase 2|Lost to Follow-up|0|||
124851604|NCT01877421|449081314|FG008|Phase 2|Lost to Follow-up|0|||
124851605|NCT01877421|449081315|FG009|Phase 2|Lost to Follow-up|0|||
124851606|NCT01877421|449081316|FG010|Phase 2|Lost to Follow-up|0|||
124851607|NCT01877421|449081317|FG011|Phase 2|Lost to Follow-up|0|||
124851608|NCT01877421|449081318|FG012|Phase 2|Lost to Follow-up|0|||
124851609|NCT01877421|449081319|FG013|Phase 2|Lost to Follow-up|0|||
124851610|NCT01877421|449081320|FG014|Phase 2|Lost to Follow-up|0|||
124851611|NCT01877421|449081321|FG015|Phase 2|Lost to Follow-up|0|||
124851612|NCT01877421|449081322|FG016|Phase 2|Lost to Follow-up|0|||
124851613|NCT01877421|449081323|FG017|Phase 2|Lost to Follow-up|0|||
124851614|NCT01877421|449081306|FG000|Phase 2|Withdrawal by Subject|0|||
124851615|NCT01877421|449081307|FG001|Phase 2|Withdrawal by Subject|0|||
124851616|NCT01877421|449081308|FG002|Phase 2|Withdrawal by Subject|0|||
124851617|NCT01877421|449081309|FG003|Phase 2|Withdrawal by Subject|0|||
124851618|NCT01877421|449081310|FG004|Phase 2|Withdrawal by Subject|0|||
124851619|NCT01877421|449081311|FG005|Phase 2|Withdrawal by Subject|0|||
124851620|NCT01877421|449081312|FG006|Phase 2|Withdrawal by Subject|0|||
124851621|NCT01877421|449081313|FG007|Phase 2|Withdrawal by Subject|0|||
124851622|NCT01877421|449081314|FG008|Phase 2|Withdrawal by Subject|1|||
124851623|NCT01877421|449081315|FG009|Phase 2|Withdrawal by Subject|0|||
124851624|NCT01877421|449081316|FG010|Phase 2|Withdrawal by Subject|1|||
124851625|NCT01877421|449081317|FG011|Phase 2|Withdrawal by Subject|0|||
124851626|NCT01877421|449081318|FG012|Phase 2|Withdrawal by Subject|1|||
124851627|NCT01877421|449081319|FG013|Phase 2|Withdrawal by Subject|0|||
124851628|NCT01877421|449081320|FG014|Phase 2|Withdrawal by Subject|0|||
124851629|NCT01877421|449081321|FG015|Phase 2|Withdrawal by Subject|1|||
124851630|NCT01877421|449081322|FG016|Phase 2|Withdrawal by Subject|0|||
124851631|NCT01877421|449081323|FG017|Phase 2|Withdrawal by Subject|0|||
124851632|NCT01877421|449081306|FG000|Phase 2|Protocol Violation|0|||
124851633|NCT01877421|449081307|FG001|Phase 2|Protocol Violation|0|||
124851634|NCT01877421|449081308|FG002|Phase 2|Protocol Violation|0|||
124851635|NCT01877421|449081309|FG003|Phase 2|Protocol Violation|0|||
124851636|NCT01877421|449081310|FG004|Phase 2|Protocol Violation|0|||
124851637|NCT01877421|449081311|FG005|Phase 2|Protocol Violation|0|||
124851638|NCT01877421|449081312|FG006|Phase 2|Protocol Violation|0|||
124851639|NCT01877421|449081313|FG007|Phase 2|Protocol Violation|0|||
124851640|NCT01877421|449081314|FG008|Phase 2|Protocol Violation|0|||
124851641|NCT01877421|449081315|FG009|Phase 2|Protocol Violation|0|||
124851642|NCT01877421|449081316|FG010|Phase 2|Protocol Violation|1|||
124851643|NCT01877421|449081317|FG011|Phase 2|Protocol Violation|0|||
124851644|NCT01877421|449081318|FG012|Phase 2|Protocol Violation|0|||
124851645|NCT01877421|449081319|FG013|Phase 2|Protocol Violation|0|||
124851646|NCT01877421|449081320|FG014|Phase 2|Protocol Violation|0|||
124851647|NCT01877421|449081321|FG015|Phase 2|Protocol Violation|0|||
124851648|NCT01877421|449081322|FG016|Phase 2|Protocol Violation|0|||
124851649|NCT01877421|449081323|FG017|Phase 2|Protocol Violation|0|||
124851650|NCT00724451|449081327|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
124851651|NCT00724451|449081327|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
124851652|NCT00724451|449081327|FG000|Overall Study|Not Eligible for Treatment|431|||
124851653|NCT00724451|449081327|FG000|Overall Study|Participant Refused Treatment|89|||
124851654|NCT00724451|449081327|FG000|Overall Study|Never Started Treatment|89|||
124851655|NCT00724451|449081327|FG000|Overall Study|Unknown; No Data Sources Available|9|||
124851656|NCT00724451|449081327|FG000|Overall Study|Physician Decision|116|||
124851657|NCT00724451|449081327|FG000|Overall Study|Withdrawal by Subject|45|||
124851658|NCT00724451|449081327|FG000|Overall Study|Investigator + Participant Decision|13|||
124851659|NCT01260922|449081329|FG000|First Intervention|Withdrawal by Subject|0|||
124851660|NCT01260922|449081330|FG001|First Intervention|Withdrawal by Subject|1|||
124851661|NCT01260922|449081329|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
124851662|NCT01260922|449081330|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
124851663|NCT01260922|449081329|FG000|Second Intervention|Emesis|0|||
124851664|NCT01260922|449081330|FG001|Second Intervention|Emesis|2|||
124851665|NCT03653429|449081334|FG000|Overall Study|Physician Decision|4|||
124851666|NCT03653429|449081335|FG001|Overall Study|Physician Decision|10|||
124851667|NCT01525082|449081336|FG000|Overall Study|Death|1|||
124851668|NCT01767116|449081339|FG000|Overall Study|Lost to Follow-up|2|||
124851669|NCT01767116|449081340|FG001|Overall Study|Lost to Follow-up|2|||
124851670|NCT02141516|449081341|FG000|Overall Study|Adverse Event|0|||
124851671|NCT02141516|449081342|FG001|Overall Study|Adverse Event|1|||
124851672|NCT02141516|449081343|FG002|Overall Study|Adverse Event|0|||
124851673|NCT02141516|449081341|FG000|Overall Study|Lost to Follow-up|0|||
124851674|NCT02141516|449081342|FG001|Overall Study|Lost to Follow-up|1|||
124851675|NCT02141516|449081343|FG002|Overall Study|Lost to Follow-up|0|||
124851676|NCT02141516|449081341|FG000|Overall Study|Other|0|||
124851677|NCT02141516|449081342|FG001|Overall Study|Other|3|||
124851678|NCT02141516|449081343|FG002|Overall Study|Other|0|||
124851679|NCT00153101|449081346|FG000|Overall Study|Lost to Follow-up|14|||
124851680|NCT00153101|449081347|FG001|Overall Study|Lost to Follow-up|14|||
124851681|NCT00153101|449081348|FG002|Overall Study|Lost to Follow-up|12|||
124851682|NCT00153101|449081349|FG003|Overall Study|Lost to Follow-up|5|||
124851683|NCT00153101|449081350|FG004|Overall Study|Lost to Follow-up|5|||
124851684|NCT00153101|449081346|FG000|Overall Study|Withdrawal by Subject|3|||
124851685|NCT00153101|449081347|FG001|Overall Study|Withdrawal by Subject|4|||
124851686|NCT00153101|449081348|FG002|Overall Study|Withdrawal by Subject|3|||
124851687|NCT00153101|449081349|FG003|Overall Study|Withdrawal by Subject|3|||
124851688|NCT00153101|449081350|FG004|Overall Study|Withdrawal by Subject|5|||
124851689|NCT02610140|449081351|FG000|Randomization and Treatment Period|Radiological progression|23|||
124851690|NCT02610140|449081352|FG001|Randomization and Treatment Period|Radiological progression|15|||
124851691|NCT02610140|449081351|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
124851692|NCT02610140|449081352|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
124851693|NCT02610140|449081351|FG000|Randomization and Treatment Period|Protocol Violation|1|||
124851694|NCT02610140|449081352|FG001|Randomization and Treatment Period|Protocol Violation|0|||
124851695|NCT02610140|449081351|FG000|Randomization and Treatment Period|Physician Decision|0|||
124851696|NCT02610140|449081352|FG001|Randomization and Treatment Period|Physician Decision|1|||
124851697|NCT02610140|449081351|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
124851698|NCT02610140|449081352|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
124851699|NCT02610140|449081351|FG000|Randomization and Treatment Period|Death|7|||
124851700|NCT02610140|449081352|FG001|Randomization and Treatment Period|Death|1|||
124851701|NCT02610140|449081351|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
124851702|NCT02610140|449081352|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
124851703|NCT02610140|449081351|FG000|Randomization and Treatment Period|Adverse Event|44|||
124851704|NCT02610140|449081352|FG001|Randomization and Treatment Period|Adverse Event|13|||
124851705|NCT02610140|449081351|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
124851706|NCT02610140|449081352|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
124851707|NCT02610140|449081351|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
124851708|NCT02610140|449081352|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
124851709|NCT02610140|449081351|FG000|Randomization and Treatment Period|Not treated|3|||
124851710|NCT02610140|449081352|FG001|Randomization and Treatment Period|Not treated|10|||
124851711|NCT02610140|449081351|FG000|Safety Follow-up|Other|0|||
124851712|NCT02610140|449081352|FG001|Safety Follow-up|Other|2|||
124851713|NCT02610140|449081351|FG000|Safety Follow-up|Lost to Follow-up|1|||
124851714|NCT02610140|449081352|FG001|Safety Follow-up|Lost to Follow-up|0|||
124851715|NCT02610140|449081351|FG000|Safety Follow-up|No follow-up|5|||
124851716|NCT02610140|449081352|FG001|Safety Follow-up|No follow-up|3|||
124851717|NCT02610140|449081351|FG000|Safety Follow-up|Death|12|||
124851718|NCT02610140|449081352|FG001|Safety Follow-up|Death|2|||
124851719|NCT02610140|449081351|FG000|Safety Follow-up|Deterioration of general conditions|15|||
124851720|NCT02610140|449081352|FG001|Safety Follow-up|Deterioration of general conditions|5|||
124851721|NCT02610140|449081351|FG000|Safety Follow-up|Withdrawal by Subject|12|||
124851722|NCT02610140|449081352|FG001|Safety Follow-up|Withdrawal by Subject|12|||
124851723|NCT02610140|449081351|FG000|Active Follow-up|Progressive disease - radiological|30|||
124851724|NCT02610140|449081352|FG001|Active Follow-up|Progressive disease - radiological|22|||
124851725|NCT02610140|449081351|FG000|Active Follow-up|Death|8|||
124851726|NCT02610140|449081352|FG001|Active Follow-up|Death|1|||
124851727|NCT02610140|449081351|FG000|Active Follow-up|Withdrawal by Subject|4|||
124851728|NCT02610140|449081352|FG001|Active Follow-up|Withdrawal by Subject|0|||
124851729|NCT02610140|449081351|FG000|Active Follow-up|Progressive disease - clinical|1|||
124851730|NCT02610140|449081352|FG001|Active Follow-up|Progressive disease - clinical|2|||
124851731|NCT02610140|449081351|FG000|Active Follow-up|Deterioration of general conditions|1|||
124851732|NCT02610140|449081352|FG001|Active Follow-up|Deterioration of general conditions|0|||
124851733|NCT02610140|449081351|FG000|Active Follow-up|Ongoing but not completed|4|||
124851734|NCT02610140|449081352|FG001|Active Follow-up|Ongoing but not completed|1|||
124851735|NCT02610140|449081351|FG000|Long-term Follow-up|Death|86|||
124851736|NCT02610140|449081352|FG001|Long-term Follow-up|Death|44|||
124851737|NCT02610140|449081351|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
124851738|NCT02610140|449081352|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
124851739|NCT02610140|449081351|FG000|Long-term Follow-up|Lost to Follow-up|1|||
124851740|NCT02610140|449081352|FG001|Long-term Follow-up|Lost to Follow-up|2|||
124851741|NCT02610140|449081351|FG000|Long-term Follow-up|Ongoing but not completed|30|||
124851742|NCT02610140|449081352|FG001|Long-term Follow-up|Ongoing but not completed|17|||
124851743|NCT03169153|449081353|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
124851744|NCT03169153|449081354|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
124851745|NCT03169153|449081353|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
124851746|NCT03169153|449081354|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
124851747|NCT03169153|449081353|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
124851748|NCT03169153|449081354|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
124851749|NCT03169153|449081353|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
124851750|NCT03169153|449081354|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
124851751|NCT01975389|449081359|FG000|Overall Study|Adverse Event|10|||
124851752|NCT01975389|449081360|FG001|Overall Study|Adverse Event|6|||
124851753|NCT01975389|449081359|FG000|Overall Study|Death|61|||
124851754|NCT01975389|449081360|FG001|Overall Study|Death|54|||
124851755|NCT01975389|449081359|FG000|Overall Study|Lost to Follow-up|81|||
124851756|NCT01975389|449081360|FG001|Overall Study|Lost to Follow-up|86|||
124851757|NCT01975389|449081359|FG000|Overall Study|Withdrawal by Subject|90|||
124851758|NCT01975389|449081360|FG001|Overall Study|Withdrawal by Subject|76|||
124851759|NCT01975389|449081359|FG000|Overall Study|Other|6|||
124851760|NCT01975389|449081360|FG001|Overall Study|Other|9|||
124851761|NCT01975389|449081359|FG000|Overall Study|Randomized, not treated|4|||
124851762|NCT01975389|449081360|FG001|Overall Study|Randomized, not treated|5|||
124851763|NCT04278417|449081368|FG000|Overall Study|Withdrawal by Subject|20|||
124851764|NCT04278417|449081369|FG001|Overall Study|Withdrawal by Subject|20|||
124851765|NCT04278417|449081368|FG000|Overall Study|Progressive disease|0|||
124851766|NCT04278417|449081369|FG001|Overall Study|Progressive disease|2|||
124851767|NCT04278417|449081368|FG000|Overall Study|Physician Decision|4|||
124851768|NCT04278417|449081369|FG001|Overall Study|Physician Decision|6|||
124851769|NCT04278417|449081368|FG000|Overall Study|Lost to Follow-up|11|||
124851770|NCT04278417|449081369|FG001|Overall Study|Lost to Follow-up|13|||
124851771|NCT04278417|449081368|FG000|Overall Study|Death|8|||
124851772|NCT04278417|449081369|FG001|Overall Study|Death|9|||
124851773|NCT04278417|449081368|FG000|Overall Study|Adverse Event|3|||
124851774|NCT04278417|449081369|FG001|Overall Study|Adverse Event|5|||
124851775|NCT01603875|449081371|FG000|Overall Study|Preexisting rabies antibody|3|||
124851776|NCT01603875|449081372|FG001|Overall Study|Preexisting rabies antibody|4|||
124851777|NCT01603875|449081373|FG002|Overall Study|Preexisting rabies antibody|3|||
124851778|NCT01603875|449081371|FG000|Overall Study|Lost to Follow-up|4|||
124851779|NCT01603875|449081372|FG001|Overall Study|Lost to Follow-up|3|||
124851780|NCT01603875|449081373|FG002|Overall Study|Lost to Follow-up|6|||
124851781|NCT01603875|449081371|FG000|Overall Study|Protocol Violation|0|||
124851782|NCT01603875|449081372|FG001|Overall Study|Protocol Violation|1|||
124851783|NCT01603875|449081373|FG002|Overall Study|Protocol Violation|0|||
124851784|NCT00298831|449081374|FG000|Overall Study|Adverse Event|1|||
124851785|NCT00298831|449081374|FG000|Overall Study|Lost to Follow-up|3|||
124851786|NCT00298831|449081374|FG000|Overall Study|Withdrawal by Subject|1|||
124851787|NCT00298831|449081374|FG000|Overall Study|Participants did not receive treatment|27|||
124851788|NCT01306617|449081375|FG000|Overall Study|Adverse Event|1|||
124851789|NCT01306617|449081376|FG001|Overall Study|Adverse Event|0|||
124851790|NCT01306617|449081377|FG002|Overall Study|Adverse Event|0|||
124851791|NCT01306617|449081375|FG000|Overall Study|Virologic Failure|0|||
124851792|NCT01306617|449081376|FG001|Overall Study|Virologic Failure|0|||
124851793|NCT01306617|449081377|FG002|Overall Study|Virologic Failure|5|||
124851794|NCT01306617|449081375|FG000|Overall Study|Non-compliance|0|||
124851795|NCT01306617|449081376|FG001|Overall Study|Non-compliance|1|||
124851796|NCT01306617|449081377|FG002|Overall Study|Non-compliance|0|||
124851797|NCT04028388|449081378|FG000|Overall Study|Evaluations missing|3|||
124851798|NCT04028388|449081379|FG001|Overall Study|Evaluations missing|6|||
124851799|NCT04028388|449081378|FG000|Overall Study|Not started|2|||
124851800|NCT04028388|449081379|FG001|Overall Study|Not started|0|||
124851801|NCT01114516|449081380|FG000|Overall Study|Lost to Follow-up|2|||
124851802|NCT01114516|449081381|FG001|Overall Study|Lost to Follow-up|1|||
124851803|NCT00129259|449081382|FG000|Overall Study|Lost to Follow-up|1|||
124851804|NCT00129259|449081383|FG001|Overall Study|Lost to Follow-up|1|||
124851805|NCT00129259|449081382|FG000|Overall Study|Withdrawal by Subject|2|||
124851806|NCT00129259|449081383|FG001|Overall Study|Withdrawal by Subject|1|||
124851807|NCT00129259|449081382|FG000|Overall Study|Only available minimal phone assessments|0|||
124851808|NCT00129259|449081383|FG001|Overall Study|Only available minimal phone assessments|1|||
124851809|NCT02758236|449081384|FG000|Overall Study|Investigator discretion|43|||
124851810|NCT05789875|449081385|FG000|Overall Study|Lost to Follow-up|6|||
124851811|NCT01994395|449081386|FG000|Overall Study|Withdrawal by Subject|1|||
124851812|NCT01994395|449081387|FG001|Overall Study|Withdrawal by Subject|2|||
124851813|NCT01940705|449081388|FG000|Overall Study|Lost to Follow-up|1|||
124851814|NCT01940705|449081389|FG001|Overall Study|Lost to Follow-up|3|||
124851815|NCT01940705|449081390|FG002|Overall Study|Lost to Follow-up|2|||
124851816|NCT01940705|449081391|FG003|Overall Study|Lost to Follow-up|2|||
124851817|NCT01940705|449081388|FG000|Overall Study|Withdrawal by Subject|2|||
124851818|NCT01940705|449081389|FG001|Overall Study|Withdrawal by Subject|2|||
124851819|NCT01940705|449081390|FG002|Overall Study|Withdrawal by Subject|3|||
124851820|NCT01940705|449081391|FG003|Overall Study|Withdrawal by Subject|2|||
124851821|NCT01940705|449081388|FG000|Overall Study|Intervention not given|0|||
124851822|NCT01940705|449081389|FG001|Overall Study|Intervention not given|3|||
124851823|NCT01940705|449081390|FG002|Overall Study|Intervention not given|3|||
124851824|NCT01940705|449081391|FG003|Overall Study|Intervention not given|0|||
124851825|NCT01940705|449081388|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
124851826|NCT01940705|449081389|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
124851827|NCT01940705|449081390|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
124851828|NCT01940705|449081391|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
124851829|NCT01632579|449081394|FG000|Washout Period|Adverse Event|1|||
124851830|NCT01632579|449081395|FG001|Washout Period|Adverse Event|0|||
124851831|NCT01632579|449081396|FG002|Washout Period|Adverse Event|0|||
124851832|NCT01632579|449081397|FG003|Washout Period|Adverse Event|0|||
124851833|NCT01632579|449081398|FG004|Washout Period|Adverse Event|0|||
124851834|NCT01632579|449081399|FG005|Washout Period|Adverse Event|0|||
124851835|NCT01632579|449081400|FG006|Washout Period|Adverse Event|0|||
124851836|NCT01632579|449081401|FG007|Washout Period|Adverse Event|0|||
124851837|NCT01632579|449081402|FG008|Washout Period|Adverse Event|0|||
124851838|NCT01632579|449081394|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
124851839|NCT01632579|449081395|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
124851840|NCT01632579|449081396|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
124851841|NCT01632579|449081397|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
124851842|NCT01632579|449081398|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
124851843|NCT01632579|449081399|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
124851844|NCT01632579|449081400|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
124851845|NCT01632579|449081401|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
124851846|NCT01632579|449081402|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
124851847|NCT00818441|449081403|FG000|Overall Study|Death|69|||
124851848|NCT00818441|449081404|FG001|Overall Study|Death|26|||
124851849|NCT00818441|449081403|FG000|Overall Study|Other|5|||
124851850|NCT00818441|449081404|FG001|Overall Study|Other|0|||
124851851|NCT00818441|449081403|FG000|Overall Study|Lost to Follow-up|2|||
124851852|NCT00818441|449081404|FG001|Overall Study|Lost to Follow-up|1|||
124851853|NCT00818441|449081403|FG000|Overall Study|Withdrawal by Subject|2|||
124851854|NCT00818441|449081404|FG001|Overall Study|Withdrawal by Subject|0|||
124851855|NCT00818441|449081403|FG000|Overall Study|Adverse Event|0|||
124851856|NCT00818441|449081404|FG001|Overall Study|Adverse Event|1|||
124851857|NCT00818441|449081403|FG000|Overall Study|Study terminated by sponsor|11|||
124851858|NCT00818441|449081404|FG001|Overall Study|Study terminated by sponsor|2|||
124851859|NCT00612313|449081405|FG000|Overall Study|Withdrawal by Subject|6|||
124851860|NCT00612313|449081406|FG001|Overall Study|Withdrawal by Subject|9|||
124851861|NCT00612313|449081405|FG000|Overall Study|Lost to Follow-up|11|||
124851862|NCT00612313|449081406|FG001|Overall Study|Lost to Follow-up|4|||
124851863|NCT01337089|449083123|FG000|Overall Study|Adverse Event|237|||
124851864|NCT01337089|449083123|FG000|Overall Study|Withdrawal by Subject|129|||
124851865|NCT01337089|449083123|FG000|Overall Study|Withdrawal by Investigator|33|||
124851866|NCT01337089|449083123|FG000|Overall Study|Met Withdrawal Criteria|3|||
124851867|NCT01337089|449083123|FG000|Overall Study|Lost to Follow-up|2|||
124851868|NCT02461589|449083131|FG000|Overall Study|Withdrawal by Subject|5|||
124851869|NCT02461589|449083132|FG001|Overall Study|Withdrawal by Subject|1|||
124851870|NCT02461589|449083133|FG002|Overall Study|Withdrawal by Subject|3|||
124851871|NCT02461589|449083134|FG003|Overall Study|Withdrawal by Subject|2|||
124851872|NCT02461589|449083135|FG004|Overall Study|Withdrawal by Subject|1|||
124851873|NCT02461589|449083136|FG005|Overall Study|Withdrawal by Subject|2|||
124851874|NCT02461589|449083137|FG006|Overall Study|Withdrawal by Subject|1|||
124851875|NCT02461589|449083138|FG007|Overall Study|Withdrawal by Subject|3|||
124851876|NCT02461589|449083139|FG008|Overall Study|Withdrawal by Subject|3|||
124851877|NCT02461589|449083140|FG009|Overall Study|Withdrawal by Subject|1|||
124851878|NCT02461589|449083131|FG000|Overall Study|Lost to Follow-up|0|||
124851879|NCT02461589|449083132|FG001|Overall Study|Lost to Follow-up|0|||
124851880|NCT02461589|449083133|FG002|Overall Study|Lost to Follow-up|2|||
124851881|NCT02461589|449083134|FG003|Overall Study|Lost to Follow-up|3|||
124851882|NCT02461589|449083135|FG004|Overall Study|Lost to Follow-up|1|||
124851883|NCT02461589|449083136|FG005|Overall Study|Lost to Follow-up|1|||
124851884|NCT02461589|449083137|FG006|Overall Study|Lost to Follow-up|3|||
124851885|NCT02461589|449083138|FG007|Overall Study|Lost to Follow-up|1|||
124851886|NCT02461589|449083139|FG008|Overall Study|Lost to Follow-up|3|||
124851887|NCT02461589|449083140|FG009|Overall Study|Lost to Follow-up|1|||
124851888|NCT02461589|449083131|FG000|Overall Study|Death|0|||
124851889|NCT02461589|449083132|FG001|Overall Study|Death|0|||
124851890|NCT02461589|449083133|FG002|Overall Study|Death|0|||
124851891|NCT02461589|449083134|FG003|Overall Study|Death|0|||
124851892|NCT02461589|449083135|FG004|Overall Study|Death|0|||
124851893|NCT02461589|449083136|FG005|Overall Study|Death|0|||
124851894|NCT02461589|449083137|FG006|Overall Study|Death|0|||
124851895|NCT02461589|449083138|FG007|Overall Study|Death|1|||
124851896|NCT02461589|449083139|FG008|Overall Study|Death|0|||
124851897|NCT02461589|449083140|FG009|Overall Study|Death|0|||
124851898|NCT02461589|449083131|FG000|Overall Study|Unclassified|0|||
124851899|NCT02461589|449083132|FG001|Overall Study|Unclassified|0|||
124851900|NCT02461589|449083133|FG002|Overall Study|Unclassified|0|||
124851901|NCT02461589|449083134|FG003|Overall Study|Unclassified|0|||
124851902|NCT02461589|449083135|FG004|Overall Study|Unclassified|0|||
124851903|NCT02461589|449083136|FG005|Overall Study|Unclassified|0|||
124851904|NCT02461589|449083137|FG006|Overall Study|Unclassified|1|||
124851905|NCT02461589|449083138|FG007|Overall Study|Unclassified|0|||
124851906|NCT02461589|449083139|FG008|Overall Study|Unclassified|0|||
124851907|NCT02461589|449083140|FG009|Overall Study|Unclassified|2|||
124851908|NCT02461589|449083131|FG000|Overall Study|Missing follow-up information|1|||
124851909|NCT02461589|449083132|FG001|Overall Study|Missing follow-up information|1|||
124851910|NCT02461589|449083133|FG002|Overall Study|Missing follow-up information|0|||
124851911|NCT02461589|449083134|FG003|Overall Study|Missing follow-up information|0|||
124851912|NCT02461589|449083135|FG004|Overall Study|Missing follow-up information|0|||
124851913|NCT02461589|449083136|FG005|Overall Study|Missing follow-up information|0|||
124851914|NCT02461589|449083137|FG006|Overall Study|Missing follow-up information|1|||
124851915|NCT02461589|449083138|FG007|Overall Study|Missing follow-up information|0|||
124851916|NCT02461589|449083139|FG008|Overall Study|Missing follow-up information|0|||
124851917|NCT02461589|449083140|FG009|Overall Study|Missing follow-up information|0|||
124851918|NCT02461589|449083131|FG000|Overall Study|Withdrawal from trial before exposure|0|||
124851919|NCT02461589|449083132|FG001|Overall Study|Withdrawal from trial before exposure|0|||
124851920|NCT02461589|449083133|FG002|Overall Study|Withdrawal from trial before exposure|0|||
124851921|NCT02461589|449083134|FG003|Overall Study|Withdrawal from trial before exposure|0|||
124851922|NCT02461589|449083135|FG004|Overall Study|Withdrawal from trial before exposure|0|||
124851923|NCT02461589|449083136|FG005|Overall Study|Withdrawal from trial before exposure|0|||
124851924|NCT02461589|449083137|FG006|Overall Study|Withdrawal from trial before exposure|0|||
124851925|NCT02461589|449083138|FG007|Overall Study|Withdrawal from trial before exposure|0|||
124851926|NCT02461589|449083139|FG008|Overall Study|Withdrawal from trial before exposure|0|||
124851927|NCT02461589|449083140|FG009|Overall Study|Withdrawal from trial before exposure|1|||
124851928|NCT01978119|449083141|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
124851929|NCT01978119|449083142|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
124851930|NCT01978119|449083141|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
124851931|NCT01978119|449083142|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
124851932|NCT01978119|449083141|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124851933|NCT01978119|449083142|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
124851934|NCT03295201|449083143|FG000|Overall Study|Lost to Follow-up|1|||
124851935|NCT03295201|449083144|FG001|Overall Study|Lost to Follow-up|1|||
124851936|NCT03295201|449083143|FG000|Overall Study|Hospital admission|0|||
124851937|NCT03295201|449083144|FG001|Overall Study|Hospital admission|1|||
124851938|NCT01465334|449083145|FG000|Overall Study|Disease Progression|1|||
124851939|NCT01465334|449083146|FG001|Overall Study|Disease Progression|0|||
124851940|NCT01465334|449083145|FG000|Overall Study|Adverse Event|1|||
124851941|NCT01465334|449083146|FG001|Overall Study|Adverse Event|0|||
124851942|NCT01465334|449083145|FG000|Overall Study|Richter's transformation|0|||
124851943|NCT01465334|449083146|FG001|Overall Study|Richter's transformation|3|||
124851944|NCT01465334|449083145|FG000|Overall Study|Refractory Disease|0|||
124851945|NCT01465334|449083146|FG001|Overall Study|Refractory Disease|3|||
124851946|NCT00572572|449083147|FG000|Overall Study|Withdrawal by Subject|3|||
124851947|NCT00572572|449083148|FG001|Overall Study|Withdrawal by Subject|6|||
124851948|NCT01831089|449083149|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
124851949|NCT01831089|449083150|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
124851950|NCT01831089|449083151|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
124851951|NCT01831089|449083152|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
124851952|NCT01831089|449083153|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
124851953|NCT01831089|449083154|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
124851954|NCT01831089|449083149|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
124851955|NCT01831089|449083150|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
124851956|NCT01831089|449083151|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
124851957|NCT01831089|449083152|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
124851958|NCT01831089|449083153|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
124851959|NCT01831089|449083154|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
124851960|NCT01831089|449083149|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
124851961|NCT01831089|449083150|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
124851962|NCT01831089|449083151|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
124851963|NCT01831089|449083152|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
124851964|NCT01831089|449083153|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
124851965|NCT01831089|449083154|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
124851966|NCT01831089|449083149|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
124851967|NCT01831089|449083150|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
124851968|NCT01831089|449083151|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
124851969|NCT01831089|449083152|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
124851970|NCT01831089|449083153|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
124851971|NCT01831089|449083154|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
124851972|NCT01831089|449083149|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
124851973|NCT01831089|449083150|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
124851974|NCT01831089|449083151|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
124851975|NCT01831089|449083152|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
124851976|NCT01831089|449083153|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
124851977|NCT01831089|449083154|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
124851978|NCT01831089|449083149|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
124851979|NCT01831089|449083150|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
124851980|NCT01831089|449083151|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
124851981|NCT01831089|449083152|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
124851982|NCT01831089|449083153|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
124851983|NCT01831089|449083154|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
124851984|NCT01831089|449083149|FG000|Cohort III: Dose Level 3|Global end of study|0|||
124851985|NCT01831089|449083150|FG001|Cohort III: Dose Level 3|Global end of study|0|||
124851986|NCT01831089|449083151|FG002|Cohort III: Dose Level 3|Global end of study|1|||
124851987|NCT01831089|449083152|FG003|Cohort III: Dose Level 3|Global end of study|0|||
124851988|NCT01831089|449083153|FG004|Cohort III: Dose Level 3|Global end of study|0|||
124851989|NCT01831089|449083154|FG005|Cohort III: Dose Level 3|Global end of study|0|||
124851990|NCT01831089|449083149|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
124851991|NCT01831089|449083150|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
124851992|NCT01831089|449083151|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
124851993|NCT01831089|449083152|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
124851994|NCT01831089|449083153|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
124851995|NCT01831089|449083154|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
124851996|NCT01831089|449083149|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
124851997|NCT01831089|449083150|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
124851998|NCT01831089|449083151|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
124851999|NCT01831089|449083152|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
124852000|NCT01831089|449083153|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
124852001|NCT01831089|449083154|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
124852002|NCT01831089|449083149|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
124852003|NCT01831089|449083150|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
124852004|NCT01831089|449083151|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
124852005|NCT01831089|449083152|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
124852006|NCT01831089|449083153|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
124852007|NCT01831089|449083154|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
124852008|NCT01831089|449083149|FG000|Cohort V: Dose Level 5|Death|0|||
124852009|NCT01831089|449083150|FG001|Cohort V: Dose Level 5|Death|0|||
124852010|NCT01831089|449083151|FG002|Cohort V: Dose Level 5|Death|0|||
124852011|NCT01831089|449083152|FG003|Cohort V: Dose Level 5|Death|0|||
124852012|NCT01831089|449083153|FG004|Cohort V: Dose Level 5|Death|1|||
124852013|NCT01831089|449083154|FG005|Cohort V: Dose Level 5|Death|0|||
124852014|NCT01831089|449083149|FG000|Cohort V: Dose Level 5|Global end of study|0|||
124852015|NCT01831089|449083150|FG001|Cohort V: Dose Level 5|Global end of study|0|||
124852016|NCT01831089|449083151|FG002|Cohort V: Dose Level 5|Global end of study|0|||
124852017|NCT01831089|449083152|FG003|Cohort V: Dose Level 5|Global end of study|0|||
124852018|NCT01831089|449083153|FG004|Cohort V: Dose Level 5|Global end of study|2|||
124852019|NCT01831089|449083154|FG005|Cohort V: Dose Level 5|Global end of study|0|||
124852020|NCT01831089|449083149|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
124852021|NCT01831089|449083150|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
124852022|NCT01831089|449083151|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
124852023|NCT01831089|449083152|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
124852024|NCT01831089|449083153|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
124852025|NCT01831089|449083154|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
124852026|NCT01831089|449083149|FG000|Cohort B: Arm B|Progressive disease|0|||
124852027|NCT01831089|449083150|FG001|Cohort B: Arm B|Progressive disease|0|||
124852028|NCT01831089|449083151|FG002|Cohort B: Arm B|Progressive disease|0|||
124852029|NCT01831089|449083152|FG003|Cohort B: Arm B|Progressive disease|0|||
124852030|NCT01831089|449083153|FG004|Cohort B: Arm B|Progressive disease|0|||
124852031|NCT01831089|449083154|FG005|Cohort B: Arm B|Progressive disease|8|||
124852032|NCT01831089|449083149|FG000|Cohort B: Arm B|Physician Decision|0|||
124852033|NCT01831089|449083150|FG001|Cohort B: Arm B|Physician Decision|0|||
124852034|NCT01831089|449083151|FG002|Cohort B: Arm B|Physician Decision|0|||
124852035|NCT01831089|449083152|FG003|Cohort B: Arm B|Physician Decision|0|||
124852036|NCT01831089|449083153|FG004|Cohort B: Arm B|Physician Decision|0|||
124852037|NCT01831089|449083154|FG005|Cohort B: Arm B|Physician Decision|2|||
124852038|NCT01831089|449083149|FG000|Cohort B: Arm B|Never treated|0|||
124852039|NCT01831089|449083150|FG001|Cohort B: Arm B|Never treated|0|||
124852040|NCT01831089|449083151|FG002|Cohort B: Arm B|Never treated|0|||
124852041|NCT01831089|449083152|FG003|Cohort B: Arm B|Never treated|0|||
124852042|NCT01831089|449083153|FG004|Cohort B: Arm B|Never treated|0|||
124852043|NCT01831089|449083154|FG005|Cohort B: Arm B|Never treated|2|||
124852044|NCT01831089|449083149|FG000|Cohort B: Arm B|Adverse Event|0|||
124852045|NCT01831089|449083150|FG001|Cohort B: Arm B|Adverse Event|0|||
124852046|NCT01831089|449083151|FG002|Cohort B: Arm B|Adverse Event|0|||
124852047|NCT01831089|449083152|FG003|Cohort B: Arm B|Adverse Event|0|||
124852048|NCT01831089|449083153|FG004|Cohort B: Arm B|Adverse Event|0|||
124852049|NCT01831089|449083154|FG005|Cohort B: Arm B|Adverse Event|1|||
124852050|NCT01831089|449083149|FG000|Cohort B: Arm B|Global end of study|0|||
124852051|NCT01831089|449083150|FG001|Cohort B: Arm B|Global end of study|0|||
124852052|NCT01831089|449083151|FG002|Cohort B: Arm B|Global end of study|0|||
124852053|NCT01831089|449083152|FG003|Cohort B: Arm B|Global end of study|0|||
124852054|NCT01831089|449083153|FG004|Cohort B: Arm B|Global end of study|0|||
124852055|NCT01831089|449083154|FG005|Cohort B: Arm B|Global end of study|1|||
124852056|NCT01958918|449083155|FG000|Overall Study|Death|1|||
124852057|NCT01958918|449083156|FG001|Overall Study|Death|3|||
124852058|NCT01958918|449083155|FG000|Overall Study|Lost to Follow-up|4|||
124852059|NCT01958918|449083156|FG001|Overall Study|Lost to Follow-up|7|||
124852060|NCT01958918|449083155|FG000|Overall Study|Withdrawal by Subject|13|||
124852061|NCT01958918|449083156|FG001|Overall Study|Withdrawal by Subject|8|||
124852062|NCT01958918|449083155|FG000|Overall Study|Lack of Efficacy|13|||
124852063|NCT01958918|449083156|FG001|Overall Study|Lack of Efficacy|10|||
124852064|NCT01958918|449083155|FG000|Overall Study|Adverse Event|12|||
124852065|NCT01958918|449083156|FG001|Overall Study|Adverse Event|12|||
124852066|NCT01958918|449083155|FG000|Overall Study|administrative problems|0|||
124852067|NCT01958918|449083156|FG001|Overall Study|administrative problems|2|||
124852068|NCT01925183|449083157|FG000|Overall Study|Adverse Event|1|||
124852069|NCT01925183|449083158|FG001|Overall Study|Adverse Event|0|||
124852070|NCT02114892|449083159|FG000|Overall Study|Lost to Follow-up|1|||
124852071|NCT02114892|449083160|FG001|Overall Study|Lost to Follow-up|2|||
124852072|NCT04327934|449083163|FG000|Overall Study|Did not qualify|7|||
124852073|NCT04327934|449083164|FG001|Overall Study|Did not qualify|4|||
124852074|NCT04327934|449083163|FG000|Overall Study|Physician Decision|0|||
124852075|NCT04327934|449083164|FG001|Overall Study|Physician Decision|1|||
124852076|NCT03525834|449083165|FG000|Overall Study|Progressive disease|1|||
124852077|NCT03095417|449083166|FG000|Overall Study|missed|1|||
124852078|NCT03095417|449083167|FG001|Overall Study|missed|2|||
124852079|NCT03095417|449083168|FG002|Overall Study|missed|0|||
124852080|NCT03095417|449083169|FG003|Overall Study|missed|1|||
124852081|NCT03095417|449083166|FG000|Overall Study|Lost to Follow-up|2|||
124852082|NCT03095417|449083167|FG001|Overall Study|Lost to Follow-up|2|||
124852083|NCT03095417|449083168|FG002|Overall Study|Lost to Follow-up|1|||
124852084|NCT03095417|449083169|FG003|Overall Study|Lost to Follow-up|0|||
124852085|NCT03095417|449083166|FG000|Overall Study|refusal|0|||
124852086|NCT03095417|449083167|FG001|Overall Study|refusal|1|||
124852087|NCT03095417|449083168|FG002|Overall Study|refusal|0|||
124852088|NCT03095417|449083169|FG003|Overall Study|refusal|1|||
124852089|NCT03095417|449083166|FG000|Overall Study|Withdrawal by Subject|8|||
124852090|NCT03095417|449083167|FG001|Overall Study|Withdrawal by Subject|2|||
124852091|NCT03095417|449083168|FG002|Overall Study|Withdrawal by Subject|5|||
124852092|NCT03095417|449083169|FG003|Overall Study|Withdrawal by Subject|4|||
124852093|NCT03095417|449083166|FG000|Overall Study|Physician Decision|1|||
124852094|NCT03095417|449083167|FG001|Overall Study|Physician Decision|2|||
124852095|NCT03095417|449083168|FG002|Overall Study|Physician Decision|2|||
124852096|NCT03095417|449083169|FG003|Overall Study|Physician Decision|2|||
124852097|NCT03095417|449083166|FG000|Overall Study|Death|1|||
124852098|NCT03095417|449083167|FG001|Overall Study|Death|2|||
124852099|NCT03095417|449083168|FG002|Overall Study|Death|1|||
124852100|NCT03095417|449083169|FG003|Overall Study|Death|3|||
124852101|NCT01410110|449083170|FG000|Overall Study|Withdrawal by Subject|4|||
124852102|NCT01410110|449083171|FG001|Overall Study|Withdrawal by Subject|2|||
124852103|NCT03783923|449083178|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
124852104|NCT03783923|449083179|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
124852105|NCT03783923|449083178|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
124852106|NCT03783923|449083179|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
124852107|NCT03783923|449083178|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
124852108|NCT03783923|449083179|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
124852109|NCT03783923|449083178|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
124852110|NCT03783923|449083179|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
124852111|NCT03783923|449083178|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
124852112|NCT03783923|449083179|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
124852113|NCT02543346|449083180|FG000|Second Priming Visit|Withdrawal by Subject|0|||
124852114|NCT02543346|449083181|FG001|Second Priming Visit|Withdrawal by Subject|2|||
124852115|NCT02543346|449083182|FG002|Second Priming Visit|Withdrawal by Subject|2|||
124852116|NCT02543346|449083183|FG003|Second Priming Visit|Withdrawal by Subject|2|||
124852117|NCT02543346|449083180|FG000|Second Priming Visit|Adverse Event|1|||
124852118|NCT02543346|449083181|FG001|Second Priming Visit|Adverse Event|0|||
124852119|NCT02543346|449083182|FG002|Second Priming Visit|Adverse Event|0|||
124852120|NCT02543346|449083183|FG003|Second Priming Visit|Adverse Event|0|||
124852121|NCT00887341|449083188|FG000|Overall Study|Refused treatment|1|||
124852122|NCT00887341|449083189|FG001|Overall Study|Refused treatment|0|||
124852123|NCT00887341|449083188|FG000|Overall Study|Withdrawal by Subject|1|||
124852124|NCT00887341|449083189|FG001|Overall Study|Withdrawal by Subject|1|||
124852125|NCT00887341|449083188|FG000|Overall Study|Adverse Event|0|||
124852126|NCT00887341|449083189|FG001|Overall Study|Adverse Event|1|||
124852127|NCT00887341|449083188|FG000|Overall Study|Lost to Follow-up|0|||
124852128|NCT00887341|449083189|FG001|Overall Study|Lost to Follow-up|1|||
124852129|NCT01649856|449083190|FG000|Overall Study|Withdrawal by Subject|14|||
124852130|NCT01649856|449083191|FG001|Overall Study|Withdrawal by Subject|14|||
124852131|NCT01649856|449083190|FG000|Overall Study|Protocol Violation|4|||
124852132|NCT01649856|449083191|FG001|Overall Study|Protocol Violation|4|||
124852133|NCT01649856|449083190|FG000|Overall Study|Treatment Failure|1|||
124852134|NCT01649856|449083191|FG001|Overall Study|Treatment Failure|1|||
124852135|NCT01649856|449083190|FG000|Overall Study|Death|69|||
124852136|NCT01649856|449083191|FG001|Overall Study|Death|34|||
124852137|NCT01649856|449083190|FG000|Overall Study|Stable or Progressed Disease|5|||
124852138|NCT01649856|449083191|FG001|Overall Study|Stable or Progressed Disease|3|||
124852139|NCT01649856|449083190|FG000|Overall Study|Lost to Follow-up|20|||
124852140|NCT01649856|449083191|FG001|Overall Study|Lost to Follow-up|16|||
124852141|NCT01649856|449083190|FG000|Overall Study|Lack of Compliance|6|||
124852142|NCT01649856|449083191|FG001|Overall Study|Lack of Compliance|1|||
124852143|NCT01649856|449083190|FG000|Overall Study|Other|20|||
124852144|NCT01649856|449083191|FG001|Overall Study|Other|5|||
124852145|NCT00622635|449083192|FG000|Treatment Period 1|Adverse Event|0|||
124852146|NCT00622635|449083193|FG001|Treatment Period 1|Adverse Event|0|||
124852147|NCT00622635|449083194|FG002|Treatment Period 1|Adverse Event|1|||
124852148|NCT00622635|449083195|FG003|Treatment Period 1|Adverse Event|0|||
124852149|NCT00622635|449083196|FG004|Treatment Period 1|Adverse Event|0|||
124852150|NCT00622635|449083197|FG005|Treatment Period 1|Adverse Event|0|||
124852151|NCT00622635|449083192|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124852152|NCT00622635|449083193|FG001|Treatment Period 1|Withdrawal by Subject|1|||
124852153|NCT00622635|449083194|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124852154|NCT00622635|449083195|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124852155|NCT00622635|449083196|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124852156|NCT00622635|449083197|FG005|Treatment Period 1|Withdrawal by Subject|0|||
124852157|NCT00622635|449083192|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
124852158|NCT00622635|449083193|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
124852159|NCT00622635|449083194|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
124852160|NCT00622635|449083195|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
124852161|NCT00622635|449083196|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
124852162|NCT00622635|449083197|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
124852163|NCT00622635|449083192|FG000|Treatment Period 2|Adverse Event|1|||
124852164|NCT00622635|449083193|FG001|Treatment Period 2|Adverse Event|0|||
124852165|NCT00622635|449083194|FG002|Treatment Period 2|Adverse Event|0|||
124852166|NCT00622635|449083195|FG003|Treatment Period 2|Adverse Event|0|||
124852167|NCT00622635|449083196|FG004|Treatment Period 2|Adverse Event|0|||
124852168|NCT00622635|449083197|FG005|Treatment Period 2|Adverse Event|0|||
124852169|NCT00622635|449083192|FG000|Treatment Period 3|Adverse Event|0|||
124852170|NCT00622635|449083193|FG001|Treatment Period 3|Adverse Event|0|||
124852171|NCT00622635|449083194|FG002|Treatment Period 3|Adverse Event|0|||
124852172|NCT00622635|449083195|FG003|Treatment Period 3|Adverse Event|2|||
124852173|NCT00622635|449083196|FG004|Treatment Period 3|Adverse Event|0|||
124852174|NCT00622635|449083197|FG005|Treatment Period 3|Adverse Event|0|||
124852175|NCT00622635|449083192|FG000|Treatment Period 3|Withdrawal by Subject|0|||
124852176|NCT00622635|449083193|FG001|Treatment Period 3|Withdrawal by Subject|0|||
124852177|NCT00622635|449083194|FG002|Treatment Period 3|Withdrawal by Subject|0|||
124852178|NCT00622635|449083195|FG003|Treatment Period 3|Withdrawal by Subject|1|||
124852179|NCT00622635|449083196|FG004|Treatment Period 3|Withdrawal by Subject|0|||
124852180|NCT00622635|449083197|FG005|Treatment Period 3|Withdrawal by Subject|0|||
124852181|NCT00281840|449083198|FG000|Overall Study|Adverse Event|12|||
124852182|NCT00281840|449083198|FG000|Overall Study|Physician Decision|6|||
124852183|NCT00281840|449083198|FG000|Overall Study|Withdrawal by Subject|3|||
124852184|NCT00281840|449083198|FG000|Overall Study|Disease Progression|2|||
124852185|NCT00281840|449083198|FG000|Overall Study|exceed maximum delay in treatment|1|||
124852186|NCT00281840|449083198|FG000|Overall Study|Complicating Disease|1|||
124852187|NCT01079234|449083204|FG000|Main: Week 0 to 26|Adverse Event|5|||
124852188|NCT01079234|449083205|FG001|Main: Week 0 to 26|Adverse Event|4|||
124852189|NCT01079234|449083206|FG002|Main: Week 0 to 26|Adverse Event|1|||
124852190|NCT01079234|449083207|FG003|Main: Week 0 to 26|Adverse Event|0|||
124852191|NCT01079234|449083204|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
124852192|NCT01079234|449083205|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
124852193|NCT01079234|449083206|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
124852194|NCT01079234|449083207|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
124852195|NCT01079234|449083204|FG000|Main: Week 0 to 26|Protocol Violation|6|||
124852196|NCT01079234|449083205|FG001|Main: Week 0 to 26|Protocol Violation|2|||
124852197|NCT01079234|449083206|FG002|Main: Week 0 to 26|Protocol Violation|4|||
124852198|NCT01079234|449083207|FG003|Main: Week 0 to 26|Protocol Violation|0|||
124852199|NCT01079234|449083204|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
124852200|NCT01079234|449083205|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
124852201|NCT01079234|449083206|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
124852202|NCT01079234|449083207|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
124852203|NCT01079234|449083204|FG000|Main: Week 0 to 26|Unclassified|7|||
124852204|NCT01079234|449083205|FG001|Main: Week 0 to 26|Unclassified|13|||
124852205|NCT01079234|449083206|FG002|Main: Week 0 to 26|Unclassified|4|||
124852206|NCT01079234|449083207|FG003|Main: Week 0 to 26|Unclassified|0|||
124852207|NCT01079234|449083204|FG000|Extension: Week 27 to 52|Adverse Event|0|||
124852208|NCT01079234|449083205|FG001|Extension: Week 27 to 52|Adverse Event|0|||
124852209|NCT01079234|449083206|FG002|Extension: Week 27 to 52|Adverse Event|1|||
124852210|NCT01079234|449083207|FG003|Extension: Week 27 to 52|Adverse Event|0|||
124852211|NCT01079234|449083204|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
124852212|NCT01079234|449083205|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
124852213|NCT01079234|449083206|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
124852214|NCT01079234|449083207|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
124852215|NCT01079234|449083204|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
124852216|NCT01079234|449083205|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
124852217|NCT01079234|449083206|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
124852218|NCT01079234|449083207|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
124852219|NCT01079234|449083204|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
124852220|NCT01079234|449083205|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
124852221|NCT01079234|449083206|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
124852222|NCT01079234|449083207|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
124852223|NCT01079234|449083204|FG000|Extension: Week 27 to 52|Unclassified|0|||
124852224|NCT01079234|449083205|FG001|Extension: Week 27 to 52|Unclassified|0|||
124852225|NCT01079234|449083206|FG002|Extension: Week 27 to 52|Unclassified|4|||
124852226|NCT01079234|449083207|FG003|Extension: Week 27 to 52|Unclassified|7|||
124852227|NCT01312961|449083213|FG000|Overall Study|Adverse Event|3|||
124852228|NCT01312961|449083214|FG001|Overall Study|Adverse Event|3|||
124852229|NCT01312961|449083213|FG000|Overall Study|Lack of Efficacy|11|||
124852230|NCT01312961|449083214|FG001|Overall Study|Lack of Efficacy|1|||
124852231|NCT01312961|449083213|FG000|Overall Study|Poor compliance to protocol|1|||
124852232|NCT01312961|449083214|FG001|Overall Study|Poor compliance to protocol|0|||
124852233|NCT01312961|449083213|FG000|Overall Study|Other than specified above|2|||
124852234|NCT01312961|449083214|FG001|Overall Study|Other than specified above|3|||
124852235|NCT00205712|449083216|FG000|Overall Study|Lost to Follow-up|0|||
124852236|NCT00205712|449083217|FG001|Overall Study|Lost to Follow-up|1|||
124852237|NCT01337297|449083225|FG000|Overall Study|They entered to single anodal tDCS|4|||
124852238|NCT01337297|449083226|FG001|Overall Study|They entered to single anodal tDCS|3|||
124852239|NCT01337297|449083225|FG000|Overall Study|Lost to Follow-up|1|||
124852240|NCT01337297|449083226|FG001|Overall Study|Lost to Follow-up|3|||
124852241|NCT02316717|449083227|FG000|Overall Study|Adverse Event|2|||
124852242|NCT02316717|449083228|FG001|Overall Study|Adverse Event|2|||
124852243|NCT02316717|449083229|FG002|Overall Study|Adverse Event|0|||
124852244|NCT02316717|449083227|FG000|Overall Study|Lost to Follow-up|1|||
124852245|NCT02316717|449083228|FG001|Overall Study|Lost to Follow-up|2|||
124852246|NCT02316717|449083229|FG002|Overall Study|Lost to Follow-up|1|||
124852247|NCT02316717|449083227|FG000|Overall Study|Non compliance|3|||
124852248|NCT02316717|449083228|FG001|Overall Study|Non compliance|1|||
124852249|NCT02316717|449083229|FG002|Overall Study|Non compliance|0|||
124852250|NCT02316717|449083227|FG000|Overall Study|Protocol Violation|2|||
124852251|NCT02316717|449083228|FG001|Overall Study|Protocol Violation|0|||
124852252|NCT02316717|449083229|FG002|Overall Study|Protocol Violation|0|||
124852253|NCT02316717|449083227|FG000|Overall Study|Withdrawal by Subject|2|||
124852254|NCT02316717|449083228|FG001|Overall Study|Withdrawal by Subject|1|||
124852255|NCT02316717|449083229|FG002|Overall Study|Withdrawal by Subject|1|||
124852256|NCT02316717|449083227|FG000|Overall Study|Death|0|||
124852257|NCT02316717|449083228|FG001|Overall Study|Death|0|||
124852258|NCT02316717|449083229|FG002|Overall Study|Death|1|||
124852259|NCT02316717|449083227|FG000|Overall Study|Physician Decision|0|||
124852260|NCT02316717|449083228|FG001|Overall Study|Physician Decision|1|||
124852261|NCT02316717|449083229|FG002|Overall Study|Physician Decision|0|||
124852262|NCT02316717|449083227|FG000|Overall Study|TBC|1|||
124852263|NCT02316717|449083228|FG001|Overall Study|TBC|0|||
124852264|NCT02316717|449083229|FG002|Overall Study|TBC|0|||
124852265|NCT02778204|449083230|FG000|Overall Study|Adverse Event|1|||
124852266|NCT02778204|449083231|FG001|Overall Study|Adverse Event|0|||
124852267|NCT02778204|449083232|FG002|Overall Study|Adverse Event|0|||
124852268|NCT02778204|449083233|FG003|Overall Study|Adverse Event|0|||
124852269|NCT02778204|449083230|FG000|Overall Study|Withdrawal by Subject|0|||
124852270|NCT02778204|449083231|FG001|Overall Study|Withdrawal by Subject|0|||
124852271|NCT02778204|449083232|FG002|Overall Study|Withdrawal by Subject|1|||
124852272|NCT02778204|449083233|FG003|Overall Study|Withdrawal by Subject|2|||
124852273|NCT02778204|449083230|FG000|Overall Study|Lost to Follow-up|1|||
124852274|NCT02778204|449083231|FG001|Overall Study|Lost to Follow-up|0|||
124852275|NCT02778204|449083232|FG002|Overall Study|Lost to Follow-up|2|||
124852276|NCT02778204|449083233|FG003|Overall Study|Lost to Follow-up|1|||
124852277|NCT02778204|449083230|FG000|Overall Study|Protocol Violation|0|||
124852278|NCT02778204|449083231|FG001|Overall Study|Protocol Violation|0|||
124852279|NCT02778204|449083232|FG002|Overall Study|Protocol Violation|1|||
124852280|NCT02778204|449083233|FG003|Overall Study|Protocol Violation|0|||
124852281|NCT02778204|449083230|FG000|Overall Study|Eligibility Violation|0|||
124852282|NCT02778204|449083231|FG001|Overall Study|Eligibility Violation|0|||
124852283|NCT02778204|449083232|FG002|Overall Study|Eligibility Violation|0|||
124852284|NCT02778204|449083233|FG003|Overall Study|Eligibility Violation|1|||
124852285|NCT04122443|449083234|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
124852286|NCT04122443|449083235|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
124852287|NCT04122443|449083236|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
124852288|NCT04122443|449083234|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
124852289|NCT04122443|449083235|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
124852290|NCT04122443|449083236|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
124852291|NCT01072201|449083237|FG000|Overall Study|Lost to Follow-up|0|||
124852292|NCT01072201|449083238|FG001|Overall Study|Lost to Follow-up|1|||
124852293|NCT02052466|449083239|FG000|Overall Study|Withdrawal by Subject|1|||
124852294|NCT02052466|449083239|FG000|Overall Study|Acromial fracture|1|||
124852295|NCT00595582|449083240|FG000|Overall Study|Pilot study that PI terminated|2|||
124852296|NCT00595582|449083240|FG000|Overall Study|Lost to Follow-up|1|||
124852297|NCT00595582|449083240|FG000|Overall Study|Adverse Event|2|||
124852298|NCT00595582|449083240|FG000|Overall Study|Physician Decision|5|||
124852299|NCT00965848|449083242|FG000|Overall Study|Protocol Violation|3|||
124852300|NCT00965848|449083243|FG001|Overall Study|Protocol Violation|0|||
124852301|NCT00965848|449083244|FG002|Overall Study|Protocol Violation|1|||
124852302|NCT00965848|449083242|FG000|Overall Study|Death|11|||
124852303|NCT00965848|449083243|FG001|Overall Study|Death|1|||
124852304|NCT00965848|449083244|FG002|Overall Study|Death|5|||
124852305|NCT00965848|449083242|FG000|Overall Study|Lost to Follow-up|0|||
124852306|NCT00965848|449083243|FG001|Overall Study|Lost to Follow-up|0|||
124852307|NCT00965848|449083244|FG002|Overall Study|Lost to Follow-up|1|||
124852308|NCT00965848|449083242|FG000|Overall Study|Withdrawal by Subject|1|||
124852309|NCT00965848|449083243|FG001|Overall Study|Withdrawal by Subject|0|||
124852310|NCT00965848|449083244|FG002|Overall Study|Withdrawal by Subject|0|||
124852311|NCT00965848|449083242|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
124852312|NCT00965848|449083243|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
124852313|NCT00965848|449083244|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
124852314|NCT00965848|449083242|FG000|Overall Study|Not Clinically Evaluable|7|||
124852315|NCT00965848|449083243|FG001|Overall Study|Not Clinically Evaluable|1|||
124852316|NCT00965848|449083244|FG002|Overall Study|Not Clinically Evaluable|1|||
124852317|NCT00965848|449083242|FG000|Overall Study|Other|5|||
124852318|NCT00965848|449083243|FG001|Overall Study|Other|0|||
124852319|NCT00965848|449083244|FG002|Overall Study|Other|1|||
124852320|NCT00555438|449083253|FG000|10 Days Post-operative|Death|4|||
124852321|NCT00555438|449083253|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
124852322|NCT00061048|449083254|FG000|Overall Study|Adverse Event|2|||
124852323|NCT00061048|449083254|FG000|Overall Study|disease progression|20|||
124852324|NCT01431508|449083255|FG000|Overall Study|Lack of Efficacy|1|||
124852325|NCT01431508|449083255|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
124852326|NCT01609556|449083260|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852327|NCT01609556|449083261|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852328|NCT01609556|449083262|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852329|NCT01609556|449083263|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852330|NCT01609556|449083264|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
124852331|NCT01609556|449083265|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852332|NCT01609556|449083266|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852333|NCT01609556|449083267|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
124852334|NCT01609556|449083268|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
124852335|NCT01609556|449083269|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852336|NCT01609556|449083270|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
124852337|NCT01609556|449083271|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
124852338|NCT01609556|449083272|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852339|NCT01609556|449083273|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852340|NCT01609556|449083274|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852341|NCT01609556|449083275|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852342|NCT01609556|449083260|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
124852343|NCT01609556|449083261|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
124852344|NCT01609556|449083262|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
124852345|NCT01609556|449083263|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
124852346|NCT01609556|449083264|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
124852347|NCT01609556|449083265|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
124852348|NCT01609556|449083266|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
124852349|NCT01609556|449083267|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
124852350|NCT01609556|449083268|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
124852351|NCT01609556|449083269|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
124852352|NCT01609556|449083270|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
124852353|NCT01609556|449083271|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
124852354|NCT01609556|449083272|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
124852355|NCT01609556|449083273|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
124852356|NCT01609556|449083274|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
124852357|NCT01609556|449083275|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
124852358|NCT01609556|449083260|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852359|NCT01609556|449083261|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852360|NCT01609556|449083262|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852361|NCT01609556|449083263|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852362|NCT01609556|449083264|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852363|NCT01609556|449083265|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
124852364|NCT01609556|449083266|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
124852365|NCT01609556|449083267|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852366|NCT01609556|449083268|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852367|NCT01609556|449083269|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
124852368|NCT01609556|449083270|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
124852369|NCT01609556|449083271|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
124852370|NCT01609556|449083272|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852371|NCT01609556|449083273|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852372|NCT01609556|449083274|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852373|NCT01609556|449083275|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852374|NCT01609556|449083260|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852375|NCT01609556|449083261|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852376|NCT01609556|449083262|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852377|NCT01609556|449083263|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852378|NCT01609556|449083264|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852379|NCT01609556|449083265|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
124852380|NCT01609556|449083266|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852381|NCT01609556|449083267|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852382|NCT01609556|449083268|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852383|NCT01609556|449083269|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852384|NCT01609556|449083270|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852385|NCT01609556|449083271|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
124852386|NCT01609556|449083272|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852387|NCT01609556|449083273|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852388|NCT01609556|449083274|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852389|NCT01609556|449083275|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852390|NCT01609556|449083260|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852391|NCT01609556|449083261|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852392|NCT01609556|449083262|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852393|NCT01609556|449083263|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852394|NCT01609556|449083264|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852395|NCT01609556|449083265|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
124852396|NCT01609556|449083266|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852397|NCT01609556|449083267|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852398|NCT01609556|449083268|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852399|NCT01609556|449083269|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852400|NCT01609556|449083270|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852401|NCT01609556|449083271|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852402|NCT01609556|449083272|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852403|NCT01609556|449083273|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852404|NCT01609556|449083274|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852405|NCT01609556|449083275|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852406|NCT01609556|449083260|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852407|NCT01609556|449083261|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852408|NCT01609556|449083262|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852409|NCT01609556|449083263|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852410|NCT01609556|449083264|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852411|NCT01609556|449083265|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852412|NCT01609556|449083266|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852413|NCT01609556|449083267|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852414|NCT01609556|449083268|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
124852415|NCT01609556|449083269|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852416|NCT01609556|449083270|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852417|NCT01609556|449083271|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852418|NCT01609556|449083272|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852419|NCT01609556|449083273|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852420|NCT01609556|449083274|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852421|NCT01609556|449083275|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852422|NCT01609556|449083260|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
124852423|NCT01609556|449083261|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852424|NCT01609556|449083262|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852425|NCT01609556|449083263|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852426|NCT01609556|449083264|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852427|NCT01609556|449083265|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
124852428|NCT01609556|449083266|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852429|NCT01609556|449083267|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852430|NCT01609556|449083268|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852431|NCT01609556|449083269|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852432|NCT01609556|449083270|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
124852433|NCT01609556|449083271|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852434|NCT01609556|449083272|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852435|NCT01609556|449083273|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852436|NCT01609556|449083274|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852437|NCT01609556|449083275|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852438|NCT01609556|449083260|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852439|NCT01609556|449083261|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852440|NCT01609556|449083262|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852441|NCT01609556|449083263|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852442|NCT01609556|449083264|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852443|NCT01609556|449083265|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852444|NCT01609556|449083266|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852445|NCT01609556|449083267|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852446|NCT01609556|449083268|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852447|NCT01609556|449083269|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852448|NCT01609556|449083270|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852449|NCT01609556|449083271|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852450|NCT01609556|449083272|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
124852451|NCT01609556|449083273|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
124852452|NCT01609556|449083274|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
124852453|NCT01609556|449083275|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
124852454|NCT01609556|449083260|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852455|NCT01609556|449083261|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852456|NCT01609556|449083262|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852457|NCT01609556|449083263|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852458|NCT01609556|449083264|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852459|NCT01609556|449083265|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852460|NCT01609556|449083266|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852461|NCT01609556|449083267|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852462|NCT01609556|449083268|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852463|NCT01609556|449083269|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852464|NCT01609556|449083270|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852465|NCT01609556|449083271|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852466|NCT01609556|449083272|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
124852467|NCT01609556|449083273|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
124852468|NCT01609556|449083274|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
124852469|NCT01609556|449083275|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
124852470|NCT01609556|449083260|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852471|NCT01609556|449083261|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852472|NCT01609556|449083262|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852473|NCT01609556|449083263|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852474|NCT01609556|449083264|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852475|NCT01609556|449083265|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852476|NCT01609556|449083266|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852477|NCT01609556|449083267|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852478|NCT01609556|449083268|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852479|NCT01609556|449083269|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852480|NCT01609556|449083270|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852481|NCT01609556|449083271|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852482|NCT01609556|449083272|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
124852483|NCT01609556|449083273|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
124852484|NCT01609556|449083274|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
124852485|NCT01609556|449083275|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
124852486|NCT01609556|449083260|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852487|NCT01609556|449083261|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852488|NCT01609556|449083262|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852489|NCT01609556|449083263|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852490|NCT01609556|449083264|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852491|NCT01609556|449083265|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852492|NCT01609556|449083266|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852493|NCT01609556|449083267|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852494|NCT01609556|449083268|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852495|NCT01609556|449083269|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852496|NCT01609556|449083270|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852497|NCT01609556|449083271|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852498|NCT01609556|449083272|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
124852499|NCT01609556|449083273|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852500|NCT01609556|449083274|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852501|NCT01609556|449083275|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852502|NCT01609556|449083260|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852503|NCT01609556|449083261|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852504|NCT01609556|449083262|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852505|NCT01609556|449083263|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852506|NCT01609556|449083264|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852507|NCT01609556|449083265|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852508|NCT01609556|449083266|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852509|NCT01609556|449083267|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852510|NCT01609556|449083268|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852511|NCT01609556|449083269|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852512|NCT01609556|449083270|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852513|NCT01609556|449083271|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852514|NCT01609556|449083272|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
124852515|NCT01609556|449083273|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
124852516|NCT01609556|449083274|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
124852517|NCT01609556|449083275|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
124852518|NCT01609556|449083260|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852519|NCT01609556|449083261|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852520|NCT01609556|449083262|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852521|NCT01609556|449083263|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852522|NCT01609556|449083264|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852523|NCT01609556|449083265|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852524|NCT01609556|449083266|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852525|NCT01609556|449083267|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852526|NCT01609556|449083268|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852527|NCT01609556|449083269|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852528|NCT01609556|449083270|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852529|NCT01609556|449083271|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852530|NCT01609556|449083272|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852531|NCT01609556|449083273|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852532|NCT01609556|449083274|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852533|NCT01609556|449083275|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
124852534|NCT01609556|449083260|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852535|NCT01609556|449083261|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852536|NCT01609556|449083262|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852537|NCT01609556|449083263|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852538|NCT01609556|449083264|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852539|NCT01609556|449083265|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852540|NCT01609556|449083266|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852541|NCT01609556|449083267|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852542|NCT01609556|449083268|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852543|NCT01609556|449083269|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852544|NCT01609556|449083270|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852545|NCT01609556|449083271|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852546|NCT01609556|449083272|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
124852547|NCT01609556|449083273|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
124852548|NCT01609556|449083274|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852549|NCT01609556|449083275|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
124852550|NCT01609556|449083260|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852551|NCT01609556|449083261|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852552|NCT01609556|449083262|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852553|NCT01609556|449083263|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852554|NCT01609556|449083264|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852555|NCT01609556|449083265|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852556|NCT01609556|449083266|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852557|NCT01609556|449083267|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852558|NCT01609556|449083268|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852559|NCT01609556|449083269|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852560|NCT01609556|449083270|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852561|NCT01609556|449083271|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852562|NCT01609556|449083272|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
124852563|NCT01609556|449083273|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852564|NCT01609556|449083274|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852565|NCT01609556|449083275|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852566|NCT04452344|449083276|FG000|Overall Study|Withdrawal by Subject|3|||
124852567|NCT04452344|449083277|FG001|Overall Study|Withdrawal by Subject|6|||
124852568|NCT04452344|449083276|FG000|Overall Study|Adverse Event|1|||
124852569|NCT04452344|449083277|FG001|Overall Study|Adverse Event|2|||
124852570|NCT04452344|449083276|FG000|Overall Study|Lost to Follow-up|2|||
124852571|NCT04452344|449083277|FG001|Overall Study|Lost to Follow-up|2|||
124852572|NCT04452344|449083276|FG000|Overall Study|No Post-Op Visit|6|||
124852573|NCT04452344|449083277|FG001|Overall Study|No Post-Op Visit|7|||
124852574|NCT00023452|449083278|FG000|Overall Study|Ineligible for Study|163|||
124852575|NCT00023452|449083279|FG001|Overall Study|Ineligible for Study|159|||
124852576|NCT00023452|449083278|FG000|Overall Study|Out of Window|129|||
124852577|NCT00023452|449083279|FG001|Overall Study|Out of Window|69|||
124852578|NCT00023452|449083278|FG000|Overall Study|Death|2|||
124852579|NCT00023452|449083279|FG001|Overall Study|Death|0|||
124852580|NCT00023452|449083278|FG000|Overall Study|Withdrawal by Subject|66|||
124852581|NCT00023452|449083279|FG001|Overall Study|Withdrawal by Subject|54|||
124852582|NCT00023452|449083278|FG000|Overall Study|Adverse Event|139|||
124852583|NCT00023452|449083279|FG001|Overall Study|Adverse Event|196|||
124852584|NCT00023452|449083278|FG000|Overall Study|Lost to Follow-up|293|||
124852585|NCT00023452|449083279|FG001|Overall Study|Lost to Follow-up|60|||
124852586|NCT00023452|449083278|FG000|Overall Study|Physician Decision|49|||
124852587|NCT00023452|449083279|FG001|Overall Study|Physician Decision|21|||
124852588|NCT00023452|449083278|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
124852589|NCT00023452|449083279|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
124852590|NCT00023452|449083278|FG000|Overall Study|Pregnant|53|||
124852591|NCT00023452|449083279|FG001|Overall Study|Pregnant|20|||
124852592|NCT00023452|449083278|FG000|Overall Study|Other|204|||
124852593|NCT00023452|449083279|FG001|Overall Study|Other|69|||
124852594|NCT03779841|449083281|FG000|Randomized Population|Did Not Receive Treatment|3|||
124852595|NCT03779841|449083282|FG001|Randomized Population|Did Not Receive Treatment|1|||
124852596|NCT03779841|449083283|FG002|Randomized Population|Did Not Receive Treatment|0|||
124852597|NCT03779841|449083281|FG000|Treated (Safety) Population|Adverse Event|1|||
124852598|NCT03779841|449083282|FG001|Treated (Safety) Population|Adverse Event|1|||
124852599|NCT03779841|449083283|FG002|Treated (Safety) Population|Adverse Event|0|||
124852600|NCT03779841|449083281|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
124852601|NCT03779841|449083282|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
124852602|NCT03779841|449083283|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
124852603|NCT03779841|449083281|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
124852604|NCT03779841|449083282|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
124852605|NCT03779841|449083283|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
124852606|NCT03779841|449083281|FG000|Treated (Safety) Population|Death|1|||
124852607|NCT03779841|449083282|FG001|Treated (Safety) Population|Death|0|||
124852608|NCT03779841|449083283|FG002|Treated (Safety) Population|Death|2|||
124852609|NCT00162136|449083284|FG000|Overall Study|Adverse Event|1|||
124852610|NCT00162136|449083284|FG000|Overall Study|Death|1|||
124852611|NCT00162136|449083284|FG000|Overall Study|Disease Progression/Relapse|23|||
124852612|NCT00162136|449083284|FG000|Overall Study|Investigator Request|5|||
124852613|NCT00162136|449083284|FG000|Overall Study|Study Drug Toxicity|4|||
124852614|NCT00162136|449083284|FG000|Overall Study|Withdrawal by Subject|1|||
124852615|NCT02788175|449083285|FG000|Overall Study|Protocol Violation|3|||
124852616|NCT02788175|449083285|FG000|Overall Study|Withdrawal by Subject|4|||
124852617|NCT02788175|449083285|FG000|Overall Study|Ineligible prior to study agent|6|||
124852618|NCT03930745|449083286|FG000|Overall Study|Lost to Follow-up|10|||
124852619|NCT03930745|449083287|FG001|Overall Study|Lost to Follow-up|5|||
124852620|NCT03930745|449083286|FG000|Overall Study|Withdrawal by Subject|1|||
124852621|NCT03930745|449083287|FG001|Overall Study|Withdrawal by Subject|2|||
124852622|NCT03930745|449083286|FG000|Overall Study|Protocol Violation|2|||
124852623|NCT03930745|449083287|FG001|Overall Study|Protocol Violation|2|||
124852624|NCT03930745|449083286|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
124852625|NCT03930745|449083287|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
124852626|NCT03930745|449083286|FG000|Overall Study|Adverse Event|0|||
124852627|NCT03930745|449083287|FG001|Overall Study|Adverse Event|1|||
124852628|NCT03930745|449083286|FG000|Overall Study|Pregnancy|0|||
124852629|NCT03930745|449083287|FG001|Overall Study|Pregnancy|1|||
124852630|NCT04095858|449083292|FG000|Overall Study|Death|1|||
124852631|NCT04095858|449083293|FG001|Overall Study|Death|0|||
124852632|NCT04095858|449083292|FG000|Overall Study|Study terminated by Sponsor|2|||
124852633|NCT04095858|449083293|FG001|Overall Study|Study terminated by Sponsor|4|||
124852634|NCT03483623|449083295|FG000|Overall Study|43 complete sets achieved|1|||
124852635|NCT02770391|449083296|FG000|Overall Study|Lost to Follow-up|2|||
124852636|NCT02770391|449083296|FG000|Overall Study|Withdrawal by Subject|1|||
124852637|NCT02770391|449083296|FG000|Overall Study|Surgery delayed unevaluable|2|||
124852638|NCT02770391|449083296|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
124852639|NCT02199691|449083297|FG000|Overall Study|Protocol Violation|3|||
124852640|NCT02199691|449083298|FG001|Overall Study|Protocol Violation|3|||
124852641|NCT02199691|449083299|FG002|Overall Study|Protocol Violation|6|||
124852642|NCT02199691|449083300|FG003|Overall Study|Protocol Violation|7|||
124852643|NCT02199691|449083297|FG000|Overall Study|Withdrawal by Subject|5|||
124852644|NCT02199691|449083298|FG001|Overall Study|Withdrawal by Subject|3|||
124852645|NCT02199691|449083299|FG002|Overall Study|Withdrawal by Subject|12|||
124852646|NCT02199691|449083300|FG003|Overall Study|Withdrawal by Subject|13|||
124852647|NCT02199691|449083297|FG000|Overall Study|Lost to Follow-up|2|||
124852648|NCT02199691|449083298|FG001|Overall Study|Lost to Follow-up|1|||
124852649|NCT02199691|449083299|FG002|Overall Study|Lost to Follow-up|9|||
124852650|NCT02199691|449083300|FG003|Overall Study|Lost to Follow-up|10|||
124852651|NCT00836875|449083306|FG000|Overall Study|Death|3|||
124852652|NCT00836875|449083307|FG001|Overall Study|Death|2|||
124852653|NCT00836875|449083306|FG000|Overall Study|Withdrawal by Subject|0|||
124852654|NCT00836875|449083307|FG001|Overall Study|Withdrawal by Subject|1|||
124852655|NCT03403634|449083310|FG000|Overall Study|Disease progression|3|||
124852656|NCT03403634|449083310|FG000|Overall Study|Did not meet eligibility criteria|4|||
124852657|NCT00428610|449083311|FG000|Overall Study|Death Due to Adverse Event|3|||
124852658|NCT00428610|449083312|FG001|Overall Study|Death Due to Adverse Event|0|||
124852659|NCT00428610|449083313|FG002|Overall Study|Death Due to Adverse Event|5|||
124852660|NCT00428610|449083311|FG000|Overall Study|Death Due to Progressive Disease|0|||
124852661|NCT00428610|449083312|FG001|Overall Study|Death Due to Progressive Disease|0|||
124852662|NCT00428610|449083313|FG002|Overall Study|Death Due to Progressive Disease|2|||
124852663|NCT00428610|449083311|FG000|Overall Study|Adverse Event|2|||
124852664|NCT00428610|449083312|FG001|Overall Study|Adverse Event|3|||
124852665|NCT00428610|449083313|FG002|Overall Study|Adverse Event|2|||
124852666|NCT00428610|449083311|FG000|Overall Study|Investigator Decision|2|||
124852667|NCT00428610|449083312|FG001|Overall Study|Investigator Decision|1|||
124852668|NCT00428610|449083313|FG002|Overall Study|Investigator Decision|1|||
124852669|NCT00428610|449083311|FG000|Overall Study|Progressive Disease|42|||
124852670|NCT00428610|449083312|FG001|Overall Study|Progressive Disease|14|||
124852671|NCT00428610|449083313|FG002|Overall Study|Progressive Disease|22|||
124852672|NCT00428610|449083311|FG000|Overall Study|Withdrawal by Subject|4|||
124852673|NCT00428610|449083312|FG001|Overall Study|Withdrawal by Subject|0|||
124852674|NCT00428610|449083313|FG002|Overall Study|Withdrawal by Subject|0|||
124852675|NCT01043874|449085724|FG000|Overall Study|Adverse Event|3|||
124852676|NCT01043874|449085724|FG000|Overall Study|Withdrawal by Subject|1|||
124852677|NCT01043874|449085724|FG000|Overall Study|Lack of Efficacy|1|||
124852678|NCT01043874|449085724|FG000|Overall Study|Administrative Problems|1|||
124852679|NCT00182689|449085730|FG000|Overall Study|Adverse Event|8|||
124852680|NCT00182689|449085731|FG001|Overall Study|Adverse Event|11|||
124852681|NCT00182689|449085730|FG000|Overall Study|Withdrawal by Subject|2|||
124852682|NCT00182689|449085731|FG001|Overall Study|Withdrawal by Subject|2|||
124852683|NCT00182689|449085730|FG000|Overall Study|Progression|27|||
124852684|NCT00182689|449085731|FG001|Overall Study|Progression|29|||
124852685|NCT00182689|449085730|FG000|Overall Study|Death|1|||
124852686|NCT00182689|449085731|FG001|Overall Study|Death|0|||
124852687|NCT00182689|449085730|FG000|Overall Study|not protocol specified|0|||
124852688|NCT00182689|449085731|FG001|Overall Study|not protocol specified|3|||
124852689|NCT00182689|449085730|FG000|Overall Study|Ineligible|1|||
124852690|NCT00182689|449085731|FG001|Overall Study|Ineligible|4|||
124852691|NCT00182689|449085730|FG000|Overall Study|Never received treatment|1|||
124852692|NCT00182689|449085731|FG001|Overall Study|Never received treatment|0|||
124852693|NCT03422003|449085732|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
124852694|NCT03422003|449085733|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
124852695|NCT03422003|449085732|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
124852696|NCT03422003|449085733|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
124852697|NCT01040871|449085736|FG000|Overall Study|Adverse Event|6|||
124852698|NCT01040871|449085737|FG001|Overall Study|Adverse Event|2|||
124852699|NCT01040871|449085736|FG000|Overall Study|Withdrawal by Subject|2|||
124852700|NCT01040871|449085737|FG001|Overall Study|Withdrawal by Subject|0|||
124852701|NCT01040871|449085736|FG000|Overall Study|Death|1|||
124852702|NCT01040871|449085737|FG001|Overall Study|Death|3|||
124852703|NCT01040871|449085736|FG000|Overall Study|Lack of Efficacy|1|||
124852704|NCT01040871|449085737|FG001|Overall Study|Lack of Efficacy|1|||
124852705|NCT01040871|449085736|FG000|Overall Study|drug supply issue|1|||
124852706|NCT01040871|449085737|FG001|Overall Study|drug supply issue|0|||
124852707|NCT01040871|449085736|FG000|Overall Study|Randomized and Not Treated|2|||
124852708|NCT01040871|449085737|FG001|Overall Study|Randomized and Not Treated|1|||
124852709|NCT00673049|449085742|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
124852710|NCT00673049|449085743|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
124852711|NCT00673049|449085744|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
124852712|NCT00673049|449085745|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
124852713|NCT00673049|449085742|FG000|Before Progression on Erlotinib|Death|235|||
124852714|NCT00673049|449085743|FG001|Before Progression on Erlotinib|Death|167|||
124852715|NCT00673049|449085744|FG002|Before Progression on Erlotinib|Death|1|||
124852716|NCT00673049|449085745|FG003|Before Progression on Erlotinib|Death|0|||
124852717|NCT00673049|449085742|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
124852718|NCT00673049|449085743|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
124852719|NCT00673049|449085744|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
124852720|NCT00673049|449085745|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
124852721|NCT00673049|449085742|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
124852722|NCT00673049|449085743|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
124852723|NCT00673049|449085744|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
124852724|NCT00673049|449085745|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
124852725|NCT00673049|449085742|FG000|Before Progression on Erlotinib|Other|1|||
124852726|NCT00673049|449085743|FG001|Before Progression on Erlotinib|Other|2|||
124852727|NCT00673049|449085744|FG002|Before Progression on Erlotinib|Other|0|||
124852728|NCT00673049|449085745|FG003|Before Progression on Erlotinib|Other|0|||
124852729|NCT00673049|449085742|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
124852730|NCT00673049|449085743|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
124852731|NCT00673049|449085744|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
124852732|NCT00673049|449085745|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
124852733|NCT00673049|449085742|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
124852734|NCT00673049|449085743|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
124852735|NCT00673049|449085744|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
124852736|NCT00673049|449085745|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
124852737|NCT00673049|449085742|FG000|After Progression on Erlotinib|Death|0|||
124852738|NCT00673049|449085743|FG001|After Progression on Erlotinib|Death|0|||
124852739|NCT00673049|449085744|FG002|After Progression on Erlotinib|Death|0|||
124852740|NCT00673049|449085745|FG003|After Progression on Erlotinib|Death|71|||
124852741|NCT00673049|449085742|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
124852742|NCT00673049|449085743|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
124852743|NCT00673049|449085744|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
124852744|NCT00673049|449085745|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
124852745|NCT00673049|449085742|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
124852746|NCT00673049|449085743|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
124852747|NCT00673049|449085744|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
124852748|NCT00673049|449085745|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
124852749|NCT00673049|449085742|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
124852750|NCT00673049|449085743|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
124852751|NCT00673049|449085744|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
124852752|NCT00673049|449085745|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
124852753|NCT01175824|449085746|FG000|Overall Study|Adverse Event|2|||
124852754|NCT01175824|449085747|FG001|Overall Study|Adverse Event|1|||
124852755|NCT01175824|449085746|FG000|Overall Study|Lack of Efficacy|2|||
124852756|NCT01175824|449085747|FG001|Overall Study|Lack of Efficacy|0|||
124852757|NCT01175824|449085746|FG000|Overall Study|Lost to Follow-up|0|||
124852758|NCT01175824|449085747|FG001|Overall Study|Lost to Follow-up|1|||
124852759|NCT01175824|449085746|FG000|Overall Study|Physician Decision|0|||
124852760|NCT01175824|449085747|FG001|Overall Study|Physician Decision|4|||
124852761|NCT01175824|449085746|FG000|Overall Study|Protocol Violation|2|||
124852762|NCT01175824|449085747|FG001|Overall Study|Protocol Violation|5|||
124852763|NCT01175824|449085746|FG000|Overall Study|Withdrawal by Subject|3|||
124852764|NCT01175824|449085747|FG001|Overall Study|Withdrawal by Subject|7|||
124852765|NCT01175824|449085746|FG000|Overall Study|Sponsor Decision|1|||
124852766|NCT01175824|449085747|FG001|Overall Study|Sponsor Decision|0|||
124852767|NCT01175824|449085746|FG000|Overall Study|Entry Criteria Not Met|6|||
124852768|NCT01175824|449085747|FG001|Overall Study|Entry Criteria Not Met|4|||
124852769|NCT00924950|449085748|FG000|Overall Study|Lost to Follow-up|2|||
124852770|NCT02979535|449085749|FG000|Overall Study|Non compliance with the protocol|78|||
124852771|NCT02979535|449085750|FG001|Overall Study|Non compliance with the protocol|82|||
124852772|NCT02979535|449085749|FG000|Overall Study|Consent withdrawn by participant|11|||
124852773|NCT02979535|449085750|FG001|Overall Study|Consent withdrawn by participant|18|||
124852774|NCT02979535|449085749|FG000|Overall Study|Lost to Follow-up|6|||
124852775|NCT02979535|449085750|FG001|Overall Study|Lost to Follow-up|1|||
124852776|NCT02530619|449085754|FG000|Registered for Study|Withdrawal by Subject|2|||
124852777|NCT02530619|449085754|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
124852778|NCT02530619|449085754|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
124852779|NCT02530619|449085754|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
124852780|NCT02530619|449085754|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
124852781|NCT02530619|449085754|FG000|Follow-up Period (6 Months)|Death|4|||
124852782|NCT02530619|449085754|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
124852783|NCT02530619|449085754|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
124852784|NCT00009737|449085756|FG000|Overall Study|Adverse Event|112|||
124852785|NCT00009737|449085757|FG001|Overall Study|Adverse Event|75|||
124852786|NCT00009737|449085756|FG000|Overall Study|Death|4|||
124852787|NCT00009737|449085757|FG001|Overall Study|Death|6|||
124852788|NCT00009737|449085756|FG000|Overall Study|Lack of Efficacy|17|||
124852789|NCT00009737|449085757|FG001|Overall Study|Lack of Efficacy|15|||
124852790|NCT00009737|449085756|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
124852791|NCT00009737|449085757|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
124852792|NCT00009737|449085756|FG000|Overall Study|Other Protocol Violation|1|||
124852793|NCT00009737|449085757|FG001|Overall Study|Other Protocol Violation|0|||
124852794|NCT00009737|449085756|FG000|Overall Study|Refused Treatment|15|||
124852795|NCT00009737|449085757|FG001|Overall Study|Refused Treatment|16|||
124852796|NCT00009737|449085756|FG000|Overall Study|Lost to Follow-up|1|||
124852797|NCT00009737|449085757|FG001|Overall Study|Lost to Follow-up|1|||
124852798|NCT00009737|449085756|FG000|Overall Study|Administrative/Other Reasons|7|||
124852799|NCT00009737|449085757|FG001|Overall Study|Administrative/Other Reasons|1|||
124852800|NCT01163682|449085761|FG000|Overall Study|Lost to Follow-up|6|||
124852801|NCT01163682|449085762|FG001|Overall Study|Lost to Follow-up|9|||
124852802|NCT00530023|449085768|FG000|Overall Study|Withdrawal by Subject|0|||
124852803|NCT00530023|449085769|FG001|Overall Study|Withdrawal by Subject|1|||
124852804|NCT00359762|449085770|FG000|Period II|Adverse Event|17|||
124852805|NCT00359762|449085771|FG001|Period II|Adverse Event|0|||
124852806|NCT00359762|449085772|FG002|Period II|Adverse Event|0|||
124852807|NCT00359762|449085773|FG003|Period II|Adverse Event|0|||
124852808|NCT00359762|449085774|FG004|Period II|Adverse Event|49|||
124852809|NCT00359762|449085770|FG000|Period II|Protocol Violation|18|||
124852810|NCT00359762|449085771|FG001|Period II|Protocol Violation|0|||
124852811|NCT00359762|449085772|FG002|Period II|Protocol Violation|0|||
124852812|NCT00359762|449085773|FG003|Period II|Protocol Violation|0|||
124852813|NCT00359762|449085774|FG004|Period II|Protocol Violation|11|||
124852814|NCT00359762|449085770|FG000|Period II|Physician Decision|17|||
124852815|NCT00359762|449085771|FG001|Period II|Physician Decision|0|||
124852816|NCT00359762|449085772|FG002|Period II|Physician Decision|0|||
124852817|NCT00359762|449085773|FG003|Period II|Physician Decision|0|||
124852818|NCT00359762|449085774|FG004|Period II|Physician Decision|23|||
124852819|NCT00359762|449085770|FG000|Period II|Death|2|||
124852820|NCT00359762|449085771|FG001|Period II|Death|0|||
124852821|NCT00359762|449085772|FG002|Period II|Death|0|||
124852822|NCT00359762|449085773|FG003|Period II|Death|0|||
124852823|NCT00359762|449085774|FG004|Period II|Death|4|||
124852824|NCT00359762|449085770|FG000|Period II|Lack of Efficacy|11|||
124852825|NCT00359762|449085771|FG001|Period II|Lack of Efficacy|0|||
124852826|NCT00359762|449085772|FG002|Period II|Lack of Efficacy|0|||
124852827|NCT00359762|449085773|FG003|Period II|Lack of Efficacy|0|||
124852828|NCT00359762|449085774|FG004|Period II|Lack of Efficacy|8|||
124852829|NCT00359762|449085770|FG000|Period II|Lost to follow up|5|||
124852830|NCT00359762|449085771|FG001|Period II|Lost to follow up|0|||
124852831|NCT00359762|449085772|FG002|Period II|Lost to follow up|0|||
124852832|NCT00359762|449085773|FG003|Period II|Lost to follow up|0|||
124852833|NCT00359762|449085774|FG004|Period II|Lost to follow up|5|||
124852834|NCT00359762|449085770|FG000|Period II|Entry Criteria Not Met|8|||
124852835|NCT00359762|449085771|FG001|Period II|Entry Criteria Not Met|0|||
124852836|NCT00359762|449085772|FG002|Period II|Entry Criteria Not Met|0|||
124852837|NCT00359762|449085773|FG003|Period II|Entry Criteria Not Met|0|||
124852838|NCT00359762|449085774|FG004|Period II|Entry Criteria Not Met|4|||
124852839|NCT00359762|449085770|FG000|Period II|Subject Decision|50|||
124852840|NCT00359762|449085771|FG001|Period II|Subject Decision|0|||
124852841|NCT00359762|449085772|FG002|Period II|Subject Decision|0|||
124852842|NCT00359762|449085773|FG003|Period II|Subject Decision|0|||
124852843|NCT00359762|449085774|FG004|Period II|Subject Decision|70|||
124852844|NCT00359762|449085770|FG000|Period III|Protocol Violation|0|||
124852845|NCT00359762|449085771|FG001|Period III|Protocol Violation|5|||
124852846|NCT00359762|449085772|FG002|Period III|Protocol Violation|3|||
124852847|NCT00359762|449085773|FG003|Period III|Protocol Violation|8|||
124852848|NCT00359762|449085774|FG004|Period III|Protocol Violation|0|||
124852849|NCT00359762|449085770|FG000|Period III|Adverse Event|0|||
124852850|NCT00359762|449085771|FG001|Period III|Adverse Event|3|||
124852851|NCT00359762|449085772|FG002|Period III|Adverse Event|4|||
124852852|NCT00359762|449085773|FG003|Period III|Adverse Event|10|||
124852853|NCT00359762|449085774|FG004|Period III|Adverse Event|0|||
124852854|NCT00359762|449085770|FG000|Period III|Physician Decision|0|||
124852855|NCT00359762|449085771|FG001|Period III|Physician Decision|5|||
124852856|NCT00359762|449085772|FG002|Period III|Physician Decision|9|||
124852857|NCT00359762|449085773|FG003|Period III|Physician Decision|15|||
124852858|NCT00359762|449085774|FG004|Period III|Physician Decision|0|||
124852859|NCT00359762|449085770|FG000|Period III|Lack of Efficacy|0|||
124852860|NCT00359762|449085771|FG001|Period III|Lack of Efficacy|7|||
124852861|NCT00359762|449085772|FG002|Period III|Lack of Efficacy|5|||
124852862|NCT00359762|449085773|FG003|Period III|Lack of Efficacy|9|||
124852863|NCT00359762|449085774|FG004|Period III|Lack of Efficacy|0|||
124852864|NCT00359762|449085770|FG000|Period III|Lost to follow up|0|||
124852865|NCT00359762|449085771|FG001|Period III|Lost to follow up|1|||
124852866|NCT00359762|449085772|FG002|Period III|Lost to follow up|1|||
124852867|NCT00359762|449085773|FG003|Period III|Lost to follow up|2|||
124852868|NCT00359762|449085774|FG004|Period III|Lost to follow up|0|||
124852869|NCT00359762|449085770|FG000|Period III|Entry Criteria Not Met|0|||
124852870|NCT00359762|449085771|FG001|Period III|Entry Criteria Not Met|1|||
124852871|NCT00359762|449085772|FG002|Period III|Entry Criteria Not Met|0|||
124852872|NCT00359762|449085773|FG003|Period III|Entry Criteria Not Met|1|||
124852873|NCT00359762|449085774|FG004|Period III|Entry Criteria Not Met|0|||
124852874|NCT00359762|449085770|FG000|Period III|Subject Decision|0|||
124852875|NCT00359762|449085771|FG001|Period III|Subject Decision|7|||
124852876|NCT00359762|449085772|FG002|Period III|Subject Decision|8|||
124852877|NCT00359762|449085773|FG003|Period III|Subject Decision|20|||
124852878|NCT00359762|449085774|FG004|Period III|Subject Decision|0|||
124852879|NCT01172938|449085778|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
124852880|NCT01172938|449085779|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
124852881|NCT01172938|449085780|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
124852882|NCT01172938|449085781|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
124852883|NCT01172938|449085782|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
124852884|NCT01172938|449085783|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
124852885|NCT01172938|449085784|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
124852886|NCT01172938|449085785|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
124852887|NCT01172938|449085786|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
124852888|NCT01172938|449085778|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
124852889|NCT01172938|449085779|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
124852890|NCT01172938|449085780|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
124852891|NCT01172938|449085781|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
124852892|NCT01172938|449085782|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
124852893|NCT01172938|449085783|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
124852894|NCT01172938|449085784|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
124852895|NCT01172938|449085785|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
124852896|NCT01172938|449085786|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
124852897|NCT01172938|449085778|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
124852898|NCT01172938|449085779|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
124852899|NCT01172938|449085780|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
124852900|NCT01172938|449085781|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
124852901|NCT01172938|449085782|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
124852902|NCT01172938|449085783|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
124852903|NCT01172938|449085784|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
124852904|NCT01172938|449085785|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
124852905|NCT01172938|449085786|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
124852906|NCT01172938|449085778|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
124852907|NCT01172938|449085779|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
124852908|NCT01172938|449085780|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
124852909|NCT01172938|449085781|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
124852910|NCT01172938|449085782|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
124852911|NCT01172938|449085783|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
124852912|NCT01172938|449085784|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
124852913|NCT01172938|449085785|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
124852914|NCT01172938|449085786|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
124852915|NCT01172938|449085778|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
124852916|NCT01172938|449085779|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
124852917|NCT01172938|449085780|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
124852918|NCT01172938|449085781|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
124852919|NCT01172938|449085782|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
124852920|NCT01172938|449085783|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
124852921|NCT01172938|449085784|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
124852922|NCT01172938|449085785|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
124852923|NCT01172938|449085786|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
124852924|NCT01172938|449085778|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
124852925|NCT01172938|449085779|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124852926|NCT01172938|449085780|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124852927|NCT01172938|449085781|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124852928|NCT01172938|449085782|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124852929|NCT01172938|449085783|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124852930|NCT01172938|449085784|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124852931|NCT01172938|449085785|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124852932|NCT01172938|449085786|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124852933|NCT01172938|449085778|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
124852934|NCT01172938|449085779|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
124852935|NCT01172938|449085780|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
124852936|NCT01172938|449085781|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
124852937|NCT01172938|449085782|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
124852938|NCT01172938|449085783|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
124852939|NCT01172938|449085784|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
124852940|NCT01172938|449085785|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
124852941|NCT01172938|449085786|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
124852942|NCT01172938|449085778|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
124852943|NCT01172938|449085779|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
124852944|NCT01172938|449085780|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
124852945|NCT01172938|449085781|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
124852946|NCT01172938|449085782|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
124852947|NCT01172938|449085783|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
124852948|NCT01172938|449085784|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
124852949|NCT01172938|449085785|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
124852950|NCT01172938|449085786|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
124852951|NCT01172938|449085778|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
124852952|NCT01172938|449085779|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
124852953|NCT01172938|449085780|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
124852954|NCT01172938|449085781|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
124852955|NCT01172938|449085782|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
124852956|NCT01172938|449085783|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
124852957|NCT01172938|449085784|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
124852958|NCT01172938|449085785|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
124852959|NCT01172938|449085786|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
124852960|NCT01172938|449085778|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
124852961|NCT01172938|449085779|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
124852962|NCT01172938|449085780|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
124852963|NCT01172938|449085781|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
124852964|NCT01172938|449085782|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
124852965|NCT01172938|449085783|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
124852966|NCT01172938|449085784|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
124852967|NCT01172938|449085785|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
124852968|NCT01172938|449085786|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
124852969|NCT01172938|449085778|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
124852970|NCT01172938|449085779|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
124852971|NCT01172938|449085780|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
124852972|NCT01172938|449085781|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
124852973|NCT01172938|449085782|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
124852974|NCT01172938|449085783|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
124852975|NCT01172938|449085784|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
124852976|NCT01172938|449085785|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
124852977|NCT01172938|449085786|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
124852978|NCT01172938|449085778|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
124852979|NCT01172938|449085779|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
124852980|NCT01172938|449085780|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
124852981|NCT01172938|449085781|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
124852982|NCT01172938|449085782|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
124852983|NCT01172938|449085783|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
124852984|NCT01172938|449085784|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
124852985|NCT01172938|449085785|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
124852986|NCT01172938|449085786|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
124852987|NCT01172938|449085778|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
124852988|NCT01172938|449085779|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
124852989|NCT01172938|449085780|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
124852990|NCT01172938|449085781|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
124852991|NCT01172938|449085782|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
124852992|NCT01172938|449085783|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
124852993|NCT01172938|449085784|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
124852994|NCT01172938|449085785|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
124852995|NCT01172938|449085786|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
124852996|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
124852997|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
124852998|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
124852999|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
124853000|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
124853001|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
124853002|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
124853003|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
124853004|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
124853005|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
124853006|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
124853007|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
124853008|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
124853009|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
124853010|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
124853011|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
124853012|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
124853013|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
124853014|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
124853015|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
124853016|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
124853017|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
124853018|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
124976621|NCT02614183|449540016|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
124853019|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
124853020|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
124853021|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
124853022|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
124853023|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
124853024|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
124853025|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
124853026|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
124853027|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
124853028|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
124853029|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
124853030|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
124853031|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
124853032|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
124853033|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
124853034|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
124853035|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
124853036|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
124853037|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
124853038|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
124853039|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
124853040|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
124853041|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
124853042|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
124853043|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
124853044|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
124853045|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
124853046|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
124853047|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
124853048|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
124853049|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
124853050|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
124853051|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
124853052|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
124853053|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
124853054|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
124853055|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
124853056|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
124853057|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
124853058|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
124853059|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
124853060|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
124853061|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
124853062|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
124853063|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
124853064|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
124853065|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
124853066|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
124853067|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
124853068|NCT01172938|449085778|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
124853069|NCT01172938|449085779|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
124853070|NCT01172938|449085780|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
124853071|NCT01172938|449085781|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
124853072|NCT01172938|449085782|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
124853073|NCT01172938|449085783|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
124853074|NCT01172938|449085784|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
124853075|NCT01172938|449085785|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
124853076|NCT01172938|449085786|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
124853077|NCT01172938|449085778|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
124853078|NCT01172938|449085779|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
124853079|NCT01172938|449085780|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
124853080|NCT01172938|449085781|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
124853081|NCT01172938|449085782|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
124853082|NCT01172938|449085783|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
124853083|NCT01172938|449085784|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
124853084|NCT01172938|449085785|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
124853085|NCT01172938|449085786|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
124853086|NCT01172938|449085778|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
124853087|NCT01172938|449085779|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
124853088|NCT01172938|449085780|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
124853089|NCT01172938|449085781|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
124853090|NCT01172938|449085782|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
124853091|NCT01172938|449085783|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
124853092|NCT01172938|449085784|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
124853093|NCT01172938|449085785|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
124853094|NCT01172938|449085786|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
124853095|NCT01172938|449085778|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
124853096|NCT01172938|449085779|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
124853097|NCT01172938|449085780|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
124853098|NCT01172938|449085781|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
124853099|NCT01172938|449085782|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
124853100|NCT01172938|449085783|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
124853101|NCT01172938|449085784|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
124853102|NCT01172938|449085785|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
124853103|NCT01172938|449085786|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
124853104|NCT01172938|449085778|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
124853105|NCT01172938|449085779|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
124853106|NCT01172938|449085780|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
124853107|NCT01172938|449085781|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
124853108|NCT01172938|449085782|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
124853109|NCT01172938|449085783|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
124853110|NCT01172938|449085784|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
124853111|NCT01172938|449085785|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
124853112|NCT01172938|449085786|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
124853113|NCT01172938|449085778|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
124853114|NCT01172938|449085779|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
124853115|NCT01172938|449085780|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
124853116|NCT01172938|449085781|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
124853117|NCT01172938|449085782|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
124853118|NCT01172938|449085783|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
124853119|NCT01172938|449085784|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
124853120|NCT01172938|449085785|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
124853121|NCT01172938|449085786|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
124853122|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
124853123|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
124853124|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
124853125|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
124853126|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
124853127|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
124853128|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
124853129|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
124853130|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
124853131|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
124853132|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
124853133|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
124853134|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
124853135|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
124853136|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
124853137|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
124853138|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
124853139|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
124853140|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
124853141|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
124853142|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
124853143|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
124853144|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
124853145|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
124853146|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
124853147|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
124853148|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
124853149|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
124853150|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
124853151|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
124853152|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
124853153|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
124853154|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
124853155|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
124853156|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
124853157|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
124853158|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
124853159|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
124853160|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
124853161|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
124853162|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
124853163|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
124853164|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
124853165|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
124853166|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
124853167|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
124853168|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
124853169|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
124853170|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
124853171|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
124853172|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
124853173|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
124853174|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
124853175|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
124853176|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
124853177|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
124853178|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
124853179|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
124853180|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
124853181|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
124853182|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
124853183|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
124853184|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
124853185|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
124853186|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
124853187|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
124853188|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
124853189|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
124853190|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
124853191|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
124853192|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
124853193|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
124853194|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
124853195|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
124853196|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
124853197|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
124853198|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
124853199|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
124853200|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
124853201|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
124853202|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
124853203|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
124853204|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
124853205|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
124853206|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
124853207|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
124853208|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
124853209|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
124853210|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
124853211|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
124853212|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
124853213|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
124853214|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
124853215|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
124853216|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
124853217|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
124853218|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
124853219|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
124853220|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
124853221|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
124853222|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
124853223|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
124853224|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
124853225|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
124853226|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
124853227|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
124853228|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
124853229|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
124853230|NCT00003498|449085787|FG000|Overall Study|Not evaluable.|4|||
124853231|NCT05282004|449085791|FG000|Overall Study|Adverse Event|2|||
124853232|NCT04808609|449085792|FG000|Overall Study|Lost to Follow-up|0|||
124853233|NCT04808609|449085793|FG001|Overall Study|Lost to Follow-up|2|||
124853234|NCT04808609|449085792|FG000|Overall Study|Administrative Withdrawal|0|||
124853235|NCT04808609|449085793|FG001|Overall Study|Administrative Withdrawal|1|||
124853236|NCT01993719|449085797|FG000|First Drug Administration|Not treated|1|||
124853237|NCT01993719|449085798|FG001|First Drug Administration|Not treated|0|||
124853238|NCT01993719|449085799|FG002|First Drug Administration|Not treated|0|||
124853239|NCT01993719|449085800|FG003|First Drug Administration|Not treated|0|||
124853240|NCT01993719|449085801|FG004|First Drug Administration|Not treated|0|||
124853241|NCT04382326|449085805|FG000|Overall Study|Adverse Event, not serious|1|||
124853242|NCT04382326|449085806|FG001|Overall Study|Adverse Event, not serious|2|||
124853243|NCT04382326|449085805|FG000|Overall Study|Other|1|||
124853244|NCT04382326|449085806|FG001|Overall Study|Other|0|||
124853245|NCT04382326|449085805|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
124853246|NCT04382326|449085806|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
124853247|NCT04382326|449085805|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
124853248|NCT04382326|449085806|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
124853249|NCT04382326|449085805|FG000|Overall Study|Protocol Violation|29|||
124853250|NCT04382326|449085806|FG001|Overall Study|Protocol Violation|23|||
124853251|NCT04382326|449085805|FG000|Overall Study|Physician Decision|0|||
124853252|NCT04382326|449085806|FG001|Overall Study|Physician Decision|1|||
124853253|NCT04382326|449085805|FG000|Overall Study|Lost to Follow-up|48|||
124853254|NCT04382326|449085806|FG001|Overall Study|Lost to Follow-up|63|||
124853255|NCT04382326|449085805|FG000|Overall Study|Adverse Event, non-fatal|1|||
124853256|NCT04382326|449085806|FG001|Overall Study|Adverse Event, non-fatal|1|||
124853257|NCT03224468|449085811|FG000|Overall Study|Did not obtain MM card|53|||
124853258|NCT03224468|449085812|FG001|Overall Study|Did not obtain MM card|0|||
124853259|NCT03224468|449085811|FG000|Overall Study|Lost to Follow-up|4|||
124853260|NCT03224468|449085812|FG001|Overall Study|Lost to Follow-up|11|||
124853261|NCT03224468|449085811|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
124853262|NCT03224468|449085812|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
124853263|NCT04067141|449085813|FG000|First Intervention|Withdrawal by Subject|0|||
124853264|NCT04067141|449085814|FG001|First Intervention|Withdrawal by Subject|1|||
124853265|NCT04067141|449085813|FG000|Second Intervention|Adverse Event|0|||
124853266|NCT04067141|449085814|FG001|Second Intervention|Adverse Event|2|||
124853267|NCT01038921|449085815|FG000|Overall Study|Withdrawal by Subject|1|||
124853268|NCT01038921|449085816|FG001|Overall Study|Withdrawal by Subject|0|||
124853269|NCT01038921|449085815|FG000|Overall Study|Physician Decision|1|||
124853270|NCT01038921|449085816|FG001|Overall Study|Physician Decision|0|||
124853271|NCT02352493|449085817|FG000|Overall Study|Pregnancy|0|||
124853272|NCT02352493|449085818|FG001|Overall Study|Pregnancy|0|||
124853273|NCT02352493|449085819|FG002|Overall Study|Pregnancy|0|||
124853274|NCT02352493|449085820|FG003|Overall Study|Pregnancy|0|||
124853275|NCT02352493|449085821|FG004|Overall Study|Pregnancy|0|||
124853276|NCT02352493|449085822|FG005|Overall Study|Pregnancy|0|||
124853277|NCT02352493|449085823|FG006|Overall Study|Pregnancy|1|||
124853278|NCT02352493|449085824|FG007|Overall Study|Pregnancy|0|||
124853279|NCT02352493|449085825|FG008|Overall Study|Pregnancy|1|||
124853280|NCT02352493|449085826|FG009|Overall Study|Pregnancy|0|||
124853281|NCT02352493|449085827|FG010|Overall Study|Pregnancy|0|||
124853282|NCT02352493|449085828|FG011|Overall Study|Pregnancy|0|||
124853283|NCT02352493|449085829|FG012|Overall Study|Pregnancy|0|||
124853284|NCT02352493|449085830|FG013|Overall Study|Pregnancy|0|||
124853285|NCT02352493|449085831|FG014|Overall Study|Pregnancy|0|||
124853286|NCT02352493|449085832|FG015|Overall Study|Pregnancy|0|||
124853287|NCT02352493|449085833|FG016|Overall Study|Pregnancy|0|||
124853288|NCT02352493|449085834|FG017|Overall Study|Pregnancy|0|||
124853289|NCT02352493|449085817|FG000|Overall Study|Withdrawal by Subject|0|||
124853290|NCT02352493|449085818|FG001|Overall Study|Withdrawal by Subject|0|||
124853291|NCT02352493|449085819|FG002|Overall Study|Withdrawal by Subject|0|||
124853292|NCT02352493|449085820|FG003|Overall Study|Withdrawal by Subject|0|||
124853293|NCT02352493|449085821|FG004|Overall Study|Withdrawal by Subject|0|||
124853294|NCT02352493|449085822|FG005|Overall Study|Withdrawal by Subject|0|||
124853295|NCT02352493|449085823|FG006|Overall Study|Withdrawal by Subject|0|||
124853296|NCT02352493|449085824|FG007|Overall Study|Withdrawal by Subject|0|||
124853297|NCT02352493|449085825|FG008|Overall Study|Withdrawal by Subject|1|||
124853298|NCT02352493|449085826|FG009|Overall Study|Withdrawal by Subject|0|||
124853299|NCT02352493|449085827|FG010|Overall Study|Withdrawal by Subject|0|||
124853300|NCT02352493|449085828|FG011|Overall Study|Withdrawal by Subject|0|||
124853301|NCT02352493|449085829|FG012|Overall Study|Withdrawal by Subject|0|||
124853302|NCT02352493|449085830|FG013|Overall Study|Withdrawal by Subject|0|||
124853303|NCT02352493|449085831|FG014|Overall Study|Withdrawal by Subject|1|||
124853304|NCT02352493|449085832|FG015|Overall Study|Withdrawal by Subject|0|||
124853305|NCT02352493|449085833|FG016|Overall Study|Withdrawal by Subject|0|||
124853306|NCT02352493|449085834|FG017|Overall Study|Withdrawal by Subject|0|||
124853307|NCT02352493|449085817|FG000|Overall Study|Lost to Follow-up|0|||
124853308|NCT02352493|449085818|FG001|Overall Study|Lost to Follow-up|0|||
124853309|NCT02352493|449085819|FG002|Overall Study|Lost to Follow-up|0|||
124853310|NCT02352493|449085820|FG003|Overall Study|Lost to Follow-up|0|||
124853311|NCT02352493|449085821|FG004|Overall Study|Lost to Follow-up|0|||
124853312|NCT02352493|449085822|FG005|Overall Study|Lost to Follow-up|0|||
124853313|NCT02352493|449085823|FG006|Overall Study|Lost to Follow-up|0|||
124853314|NCT02352493|449085824|FG007|Overall Study|Lost to Follow-up|0|||
124853315|NCT02352493|449085825|FG008|Overall Study|Lost to Follow-up|0|||
124853316|NCT02352493|449085826|FG009|Overall Study|Lost to Follow-up|1|||
124853317|NCT02352493|449085827|FG010|Overall Study|Lost to Follow-up|0|||
124853318|NCT02352493|449085828|FG011|Overall Study|Lost to Follow-up|0|||
124853319|NCT02352493|449085829|FG012|Overall Study|Lost to Follow-up|1|||
124853320|NCT02352493|449085830|FG013|Overall Study|Lost to Follow-up|2|||
124853321|NCT02352493|449085831|FG014|Overall Study|Lost to Follow-up|0|||
124853322|NCT02352493|449085832|FG015|Overall Study|Lost to Follow-up|0|||
124853323|NCT02352493|449085833|FG016|Overall Study|Lost to Follow-up|0|||
124853324|NCT02352493|449085834|FG017|Overall Study|Lost to Follow-up|0|||
124853325|NCT00889421|449085835|FG000|Overall Study|Lack of Efficacy|3|||
124853326|NCT03586999|449085838|FG000|Overall Study|Lack of Efficacy|2|||
124853327|NCT04096560|449085839|FG000|Overall Study|Reason not Specified|1|||
124853328|NCT04096560|449085840|FG001|Overall Study|Reason not Specified|0|||
124853329|NCT04096560|449085841|FG002|Overall Study|Reason not Specified|0|||
124853330|NCT04096560|449085842|FG003|Overall Study|Reason not Specified|0|||
124853331|NCT04096560|449085843|FG004|Overall Study|Reason not Specified|1|||
124853332|NCT04096560|449085844|FG005|Overall Study|Reason not Specified|1|||
124853333|NCT04096560|449085845|FG006|Overall Study|Reason not Specified|1|||
124853334|NCT04096560|449085846|FG007|Overall Study|Reason not Specified|0|||
124853335|NCT04096560|449085839|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
124853336|NCT04096560|449085840|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
124853337|NCT04096560|449085841|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
124853338|NCT04096560|449085842|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
124853339|NCT04096560|449085843|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
124853340|NCT04096560|449085844|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
124853341|NCT04096560|449085845|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
124853342|NCT04096560|449085846|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
124853343|NCT04096560|449085839|FG000|Overall Study|Study Terminated by Sponsor|0|||
124853344|NCT04096560|449085840|FG001|Overall Study|Study Terminated by Sponsor|0|||
124853345|NCT04096560|449085841|FG002|Overall Study|Study Terminated by Sponsor|0|||
124853346|NCT04096560|449085842|FG003|Overall Study|Study Terminated by Sponsor|5|||
124853347|NCT04096560|449085843|FG004|Overall Study|Study Terminated by Sponsor|6|||
124853348|NCT04096560|449085844|FG005|Overall Study|Study Terminated by Sponsor|4|||
124853349|NCT04096560|449085845|FG006|Overall Study|Study Terminated by Sponsor|6|||
124853350|NCT04096560|449085846|FG007|Overall Study|Study Terminated by Sponsor|1|||
124853351|NCT04096560|449085839|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
124853352|NCT04096560|449085840|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
124853353|NCT04096560|449085841|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
124853354|NCT04096560|449085842|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
124853355|NCT04096560|449085843|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
124853356|NCT04096560|449085844|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
124853357|NCT04096560|449085845|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
124853358|NCT04096560|449085846|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
124853359|NCT02464969|449085847|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
124853360|NCT02464969|449085848|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
124853361|NCT02464969|449085847|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
124853362|NCT02464969|449085848|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
124853363|NCT02464969|449085847|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
124853364|NCT02464969|449085848|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
124853365|NCT02464969|449085847|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
124853366|NCT02464969|449085848|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
124853367|NCT02464969|449085847|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
124853368|NCT02464969|449085848|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
124853369|NCT02464969|449085847|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
124853370|NCT02464969|449085848|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
124853371|NCT02464969|449085847|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
124853372|NCT02464969|449085848|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
124853373|NCT02464969|449085847|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
124853374|NCT02464969|449085848|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
124853375|NCT02464969|449085847|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
124853376|NCT02464969|449085848|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
124853377|NCT02464969|449085847|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
124853378|NCT02464969|449085848|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
124853379|NCT02464969|449085847|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
124853380|NCT02464969|449085848|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
124853381|NCT00534352|449085849|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
124853382|NCT00534352|449085849|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
124853383|NCT00534352|449085849|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
124853384|NCT00534352|449085849|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
124853385|NCT00534352|449085849|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
124853386|NCT00534352|449085849|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
124853387|NCT02399085|449085854|FG000|Overall Study|Adverse Event|16|||
124853388|NCT02399085|449085854|FG000|Overall Study|Death|2|||
124853389|NCT02399085|449085854|FG000|Overall Study|Withdrawal by Subject|8|||
124853390|NCT02399085|449085854|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
124853391|NCT02399085|449085854|FG000|Overall Study|Physician Decision|5|||
124853392|NCT02673697|449085857|FG000|Overall Study|Adverse Event|2|||
124853393|NCT02673697|449085858|FG001|Overall Study|Adverse Event|0|||
124853394|NCT02673697|449085857|FG000|Overall Study|Death|32|||
124853395|NCT02673697|449085858|FG001|Overall Study|Death|24|||
124853396|NCT02673697|449085857|FG000|Overall Study|Lost to Follow-up|5|||
124853397|NCT02673697|449085858|FG001|Overall Study|Lost to Follow-up|2|||
124853398|NCT02673697|449085857|FG000|Overall Study|Physician Decision|2|||
124853399|NCT02673697|449085858|FG001|Overall Study|Physician Decision|1|||
124853400|NCT02673697|449085857|FG000|Overall Study|Withdrawal by Subject|10|||
124853401|NCT02673697|449085858|FG001|Overall Study|Withdrawal by Subject|7|||
124853402|NCT02673697|449085857|FG000|Overall Study|Change subj medical status|1|||
124853403|NCT02673697|449085858|FG001|Overall Study|Change subj medical status|2|||
124853404|NCT02673697|449085857|FG000|Overall Study|Explant|10|||
124853405|NCT02673697|449085858|FG001|Overall Study|Explant|5|||
124853406|NCT02673697|449085857|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
124853407|NCT02673697|449085858|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
124853408|NCT02041429|449085868|FG000|Overall Study|Progressive Disease|2|||
124853409|NCT02041429|449085869|FG001|Overall Study|Progressive Disease|2|||
124853410|NCT02041429|449085870|FG002|Overall Study|Progressive Disease|3|||
124853411|NCT02041429|449085871|FG003|Overall Study|Progressive Disease|2|||
124853412|NCT02041429|449085868|FG000|Overall Study|Toxicity|0|||
124853413|NCT02041429|449085869|FG001|Overall Study|Toxicity|1|||
124853414|NCT02041429|449085870|FG002|Overall Study|Toxicity|4|||
124853415|NCT02041429|449085871|FG003|Overall Study|Toxicity|2|||
124853416|NCT02041429|449085868|FG000|Overall Study|Withdrawal by Subject|0|||
124853417|NCT02041429|449085869|FG001|Overall Study|Withdrawal by Subject|1|||
124853418|NCT02041429|449085870|FG002|Overall Study|Withdrawal by Subject|0|||
124853419|NCT02041429|449085871|FG003|Overall Study|Withdrawal by Subject|0|||
124853420|NCT02041429|449085868|FG000|Overall Study|On Maintenance Therapy|1|||
124853421|NCT02041429|449085869|FG001|Overall Study|On Maintenance Therapy|0|||
124853422|NCT02041429|449085870|FG002|Overall Study|On Maintenance Therapy|0|||
124853423|NCT02041429|449085871|FG003|Overall Study|On Maintenance Therapy|2|||
124853424|NCT00861341|449085872|FG000|Overall Study|Withdrawal by Subject|2|||
124853425|NCT03299192|449085873|FG000|Overall Study|Fell before classes started|1|||
124853426|NCT03299192|449085874|FG001|Overall Study|Fell before classes started|0|||
124853427|NCT03299192|449085875|FG002|Overall Study|Fell before classes started|0|||
124853428|NCT03299192|449085873|FG000|Overall Study|Other|0|||
124853429|NCT03299192|449085874|FG001|Overall Study|Other|2|||
124853430|NCT03299192|449085875|FG002|Overall Study|Other|1|||
124853431|NCT01418209|449085876|FG000|Overall Study|Withdrawal by Subject|1|||
124853432|NCT01418209|449085877|FG001|Overall Study|Withdrawal by Subject|0|||
124853433|NCT01418209|449085878|FG002|Overall Study|Withdrawal by Subject|1|||
124853434|NCT01418209|449085876|FG000|Overall Study|Did not provide hot flash diary data|1|||
124853435|NCT01418209|449085877|FG001|Overall Study|Did not provide hot flash diary data|3|||
124853436|NCT01418209|449085878|FG002|Overall Study|Did not provide hot flash diary data|3|||
124853437|NCT01916304|449085883|FG000|Overall Study|Screening failure|17|||
124853438|NCT02460198|449085885|FG000|Overall Study|Adverse Event|1|||
124853439|NCT02460198|449085886|FG001|Overall Study|Adverse Event|3|||
124853440|NCT02460198|449085885|FG000|Overall Study|Death|36|||
124853441|NCT02460198|449085886|FG001|Overall Study|Death|28|||
124853442|NCT02460198|449085885|FG000|Overall Study|Lost to Follow-up|1|||
124853443|NCT02460198|449085886|FG001|Overall Study|Lost to Follow-up|1|||
124853444|NCT02460198|449085885|FG000|Overall Study|Transferred to Extension Study|15|||
124853445|NCT02460198|449085886|FG001|Overall Study|Transferred to Extension Study|15|||
124853446|NCT02460198|449085885|FG000|Overall Study|Withdrawal by Subject|2|||
124853447|NCT02460198|449085886|FG001|Overall Study|Withdrawal by Subject|4|||
124853448|NCT02460198|449085885|FG000|Overall Study|Site Terminated By Sponsor|0|||
124853449|NCT02460198|449085886|FG001|Overall Study|Site Terminated By Sponsor|1|||
124853450|NCT02460198|449085885|FG000|Overall Study|Did Not Continue on Extension Study|6|||
124853451|NCT02460198|449085886|FG001|Overall Study|Did Not Continue on Extension Study|11|||
124853452|NCT04382612|449085887|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
124853453|NCT04666441|449085888|FG000|Overall Study|Lost to Follow-up|1|||
124853454|NCT04666441|449085889|FG001|Overall Study|Lost to Follow-up|4|||
124853455|NCT04666441|449085890|FG002|Overall Study|Lost to Follow-up|1|||
124853456|NCT04666441|449085891|FG003|Overall Study|Lost to Follow-up|3|||
124853457|NCT04666441|449085892|FG004|Overall Study|Lost to Follow-up|0|||
124853458|NCT04666441|449085893|FG005|Overall Study|Lost to Follow-up|2|||
124853459|NCT04666441|449085894|FG006|Overall Study|Lost to Follow-up|2|||
124853460|NCT04666441|449085895|FG007|Overall Study|Lost to Follow-up|2|||
124853461|NCT04666441|449085888|FG000|Overall Study|Subject Decision|1|||
124853462|NCT04666441|449085889|FG001|Overall Study|Subject Decision|1|||
124853463|NCT04666441|449085890|FG002|Overall Study|Subject Decision|3|||
124853464|NCT04666441|449085891|FG003|Overall Study|Subject Decision|1|||
124853465|NCT04666441|449085892|FG004|Overall Study|Subject Decision|0|||
124853466|NCT04666441|449085893|FG005|Overall Study|Subject Decision|1|||
124853467|NCT04666441|449085894|FG006|Overall Study|Subject Decision|3|||
124853468|NCT04666441|449085895|FG007|Overall Study|Subject Decision|2|||
124853469|NCT03149328|449085896|FG000|Overall Study|Withdrawal by Subject|30|||
124853470|NCT03149328|449085897|FG001|Overall Study|Withdrawal by Subject|26|||
124853471|NCT03149328|449085896|FG000|Overall Study|Changed Dialysis Modality|18|||
124853472|NCT03149328|449085897|FG001|Overall Study|Changed Dialysis Modality|1|||
124853473|NCT03149328|449085896|FG000|Overall Study|Transplant|9|||
124853474|NCT03149328|449085897|FG001|Overall Study|Transplant|1|||
124853475|NCT03149328|449085896|FG000|Overall Study|Lost to Follow-up|25|||
124853476|NCT03149328|449085897|FG001|Overall Study|Lost to Follow-up|16|||
124853477|NCT03149328|449085896|FG000|Overall Study|Left Study Site|1|||
124853478|NCT03149328|449085897|FG001|Overall Study|Left Study Site|2|||
124853479|NCT03149328|449085896|FG000|Overall Study|Language Barrier|1|||
124853480|NCT03149328|449085897|FG001|Overall Study|Language Barrier|0|||
124853481|NCT01328002|449085898|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
124853482|NCT01328002|449085899|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
124853483|NCT01328002|449085898|FG000|Open-Label Period|Adverse Event|8|||
124853484|NCT01328002|449085899|FG001|Open-Label Period|Adverse Event|0|||
124853485|NCT01328002|449085898|FG000|Open-Label Period|Lack of Efficacy|3|||
124853486|NCT01328002|449085899|FG001|Open-Label Period|Lack of Efficacy|0|||
124853487|NCT01328002|449085898|FG000|Open-Label Period|Protocol Violation|2|||
124853488|NCT01328002|449085899|FG001|Open-Label Period|Protocol Violation|0|||
124853489|NCT01328002|449085898|FG000|Open-Label Period|Withdrawal by Subject|9|||
124853490|NCT01328002|449085899|FG001|Open-Label Period|Withdrawal by Subject|0|||
124853491|NCT01328002|449085898|FG000|Open-Label Period|Lost to Follow-up|6|||
124853492|NCT01328002|449085899|FG001|Open-Label Period|Lost to Follow-up|0|||
124853493|NCT01328002|449085898|FG000|Open-Label Period|Other Reason|2|||
124853494|NCT01328002|449085899|FG001|Open-Label Period|Other Reason|0|||
124853495|NCT01328002|449085898|FG000|Double-Blind Period|Adverse Event|1|||
124853496|NCT01328002|449085899|FG001|Double-Blind Period|Adverse Event|0|||
124853497|NCT01328002|449085898|FG000|Double-Blind Period|Lack of Efficacy|1|||
124853498|NCT01328002|449085899|FG001|Double-Blind Period|Lack of Efficacy|0|||
124853499|NCT00813761|449085900|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
124853500|NCT00813761|449085901|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
124853501|NCT00813761|449085902|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
124853502|NCT00813761|449085903|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
124853503|NCT00813761|449085900|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
124853504|NCT00813761|449085901|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
124853505|NCT00813761|449085902|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
124853506|NCT00813761|449085903|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
124853507|NCT00813761|449085900|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
124853508|NCT00813761|449085901|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
124853509|NCT00813761|449085902|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
124853510|NCT00813761|449085903|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
124853511|NCT00813761|449085900|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
124853512|NCT00813761|449085901|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
124853513|NCT00813761|449085902|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
124853514|NCT00813761|449085903|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
124853515|NCT00813761|449085900|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
124853516|NCT00813761|449085901|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
124853517|NCT00813761|449085902|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
124853518|NCT00813761|449085903|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
124853519|NCT00813761|449085900|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
124853520|NCT00813761|449085901|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
124853521|NCT00813761|449085902|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
124853522|NCT00813761|449085903|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
124853523|NCT00813761|449085900|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
124853524|NCT00813761|449085901|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
124853525|NCT00813761|449085902|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
124853526|NCT00813761|449085903|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
124853527|NCT00813761|449085900|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
124853528|NCT00813761|449085901|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
124853529|NCT00813761|449085902|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
124853530|NCT00813761|449085903|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
124853531|NCT00813761|449085900|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
124853532|NCT00813761|449085901|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
124853533|NCT00813761|449085902|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
124853534|NCT00813761|449085903|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
124853535|NCT00813761|449085900|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
124853536|NCT00813761|449085901|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
124853537|NCT00813761|449085902|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
124853538|NCT00813761|449085903|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
124853539|NCT00813761|449085900|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
124853540|NCT00813761|449085901|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
124853541|NCT00813761|449085902|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
124853542|NCT00813761|449085903|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
124853543|NCT00813761|449085900|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
124853544|NCT00813761|449085901|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
124853545|NCT00813761|449085902|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
124853546|NCT00813761|449085903|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
124853547|NCT00691210|449085904|FG000|Overall Study|Progression of Disease|0|||
124853548|NCT00691210|449085905|FG001|Overall Study|Progression of Disease|0|||
124853549|NCT00691210|449085906|FG002|Overall Study|Progression of Disease|0|||
124853550|NCT00691210|449085907|FG003|Overall Study|Progression of Disease|2|||
124853551|NCT00691210|449085908|FG004|Overall Study|Progression of Disease|0|||
124853552|NCT00691210|449085909|FG005|Overall Study|Progression of Disease|0|||
124853553|NCT00691210|449085910|FG006|Overall Study|Progression of Disease|0|||
124853554|NCT00691210|449085911|FG007|Overall Study|Progression of Disease|0|||
124853555|NCT00691210|449085904|FG000|Overall Study|Lack of Efficacy|0|||
124853556|NCT00691210|449085905|FG001|Overall Study|Lack of Efficacy|0|||
124853557|NCT00691210|449085906|FG002|Overall Study|Lack of Efficacy|0|||
124853558|NCT00691210|449085907|FG003|Overall Study|Lack of Efficacy|1|||
124853559|NCT00691210|449085908|FG004|Overall Study|Lack of Efficacy|0|||
124853560|NCT00691210|449085909|FG005|Overall Study|Lack of Efficacy|1|||
124853561|NCT00691210|449085910|FG006|Overall Study|Lack of Efficacy|0|||
124853562|NCT00691210|449085911|FG007|Overall Study|Lack of Efficacy|0|||
124853563|NCT01208233|449085912|FG000|Overall Study|Adverse Event|0|||
124853564|NCT01208233|449085913|FG001|Overall Study|Adverse Event|1|||
124853565|NCT01208233|449085914|FG002|Overall Study|Adverse Event|2|||
124853566|NCT01208233|449085915|FG003|Overall Study|Adverse Event|0|||
124853567|NCT01208233|449085916|FG004|Overall Study|Adverse Event|3|||
124853568|NCT01208233|449085917|FG005|Overall Study|Adverse Event|5|||
124853569|NCT01208233|449085912|FG000|Overall Study|Death|0|||
124853570|NCT01208233|449085913|FG001|Overall Study|Death|0|||
124853571|NCT01208233|449085914|FG002|Overall Study|Death|0|||
124853572|NCT01208233|449085915|FG003|Overall Study|Death|0|||
124853573|NCT01208233|449085916|FG004|Overall Study|Death|3|||
124853574|NCT01208233|449085917|FG005|Overall Study|Death|5|||
124853575|NCT01208233|449085912|FG000|Overall Study|Did not meet entrance criteria|2|||
124853576|NCT01208233|449085913|FG001|Overall Study|Did not meet entrance criteria|1|||
124853577|NCT01208233|449085914|FG002|Overall Study|Did not meet entrance criteria|1|||
124853578|NCT01208233|449085915|FG003|Overall Study|Did not meet entrance criteria|0|||
124853579|NCT01208233|449085916|FG004|Overall Study|Did not meet entrance criteria|1|||
124853580|NCT01208233|449085917|FG005|Overall Study|Did not meet entrance criteria|0|||
124853581|NCT01208233|449085912|FG000|Overall Study|Medication error without adverse event|0|||
124853582|NCT01208233|449085913|FG001|Overall Study|Medication error without adverse event|0|||
124853583|NCT01208233|449085914|FG002|Overall Study|Medication error without adverse event|0|||
124853584|NCT01208233|449085915|FG003|Overall Study|Medication error without adverse event|0|||
124853585|NCT01208233|449085916|FG004|Overall Study|Medication error without adverse event|0|||
124853586|NCT01208233|449085917|FG005|Overall Study|Medication error without adverse event|1|||
124853587|NCT01208233|449085912|FG000|Overall Study|Study terminated by sponsor|0|||
124853588|NCT01208233|449085913|FG001|Overall Study|Study terminated by sponsor|0|||
124853589|NCT01208233|449085914|FG002|Overall Study|Study terminated by sponsor|0|||
124853590|NCT01208233|449085915|FG003|Overall Study|Study terminated by sponsor|0|||
124853591|NCT01208233|449085916|FG004|Overall Study|Study terminated by sponsor|10|||
124853592|NCT01208233|449085917|FG005|Overall Study|Study terminated by sponsor|7|||
124853593|NCT01208233|449085912|FG000|Overall Study|Protocol Violation|0|||
124853594|NCT01208233|449085913|FG001|Overall Study|Protocol Violation|0|||
124853595|NCT01208233|449085914|FG002|Overall Study|Protocol Violation|0|||
124853596|NCT01208233|449085915|FG003|Overall Study|Protocol Violation|0|||
124853597|NCT01208233|449085916|FG004|Overall Study|Protocol Violation|3|||
124853598|NCT01208233|449085917|FG005|Overall Study|Protocol Violation|0|||
124853599|NCT01208233|449085912|FG000|Overall Study|Other|2|||
124853600|NCT01208233|449085913|FG001|Overall Study|Other|1|||
124853601|NCT01208233|449085914|FG002|Overall Study|Other|0|||
124853602|NCT01208233|449085915|FG003|Overall Study|Other|0|||
124853603|NCT01208233|449085916|FG004|Overall Study|Other|0|||
124853604|NCT01208233|449085917|FG005|Overall Study|Other|1|||
124853605|NCT01208233|449085912|FG000|Overall Study|Withdrawal by Subject|1|||
124853606|NCT01208233|449085913|FG001|Overall Study|Withdrawal by Subject|0|||
124853607|NCT01208233|449085914|FG002|Overall Study|Withdrawal by Subject|1|||
124853608|NCT01208233|449085915|FG003|Overall Study|Withdrawal by Subject|1|||
124853609|NCT01208233|449085916|FG004|Overall Study|Withdrawal by Subject|4|||
124853610|NCT01208233|449085917|FG005|Overall Study|Withdrawal by Subject|2|||
124853611|NCT00132769|449085918|FG000|Overall Study|Withdrawal by Subject|1|||
124853612|NCT00132769|449085919|FG001|Overall Study|Withdrawal by Subject|3|||
124853613|NCT00132769|449085918|FG000|Overall Study|Lack of Efficacy|7|||
124853614|NCT00132769|449085919|FG001|Overall Study|Lack of Efficacy|6|||
124853615|NCT00132769|449085918|FG000|Overall Study|Adverse Event|2|||
124853616|NCT00132769|449085919|FG001|Overall Study|Adverse Event|1|||
124853617|NCT00132769|449085918|FG000|Overall Study|Protocol Violation|1|||
124853618|NCT00132769|449085919|FG001|Overall Study|Protocol Violation|1|||
124853619|NCT00560833|449085935|FG000|Overall Study|Adverse Event|16|||
124853620|NCT00560833|449085936|FG001|Overall Study|Adverse Event|10|||
124853621|NCT00560833|449085937|FG002|Overall Study|Adverse Event|25|||
124853622|NCT00560833|449085938|FG003|Overall Study|Adverse Event|23|||
124853623|NCT00560833|449085939|FG004|Overall Study|Adverse Event|35|||
124853624|NCT00560833|449085935|FG000|Overall Study|Lost to Follow-up|0|||
124853625|NCT00560833|449085936|FG001|Overall Study|Lost to Follow-up|0|||
124853626|NCT00560833|449085937|FG002|Overall Study|Lost to Follow-up|1|||
124853627|NCT00560833|449085938|FG003|Overall Study|Lost to Follow-up|0|||
124853628|NCT00560833|449085939|FG004|Overall Study|Lost to Follow-up|0|||
124853629|NCT00560833|449085935|FG000|Overall Study|Lack of Efficacy|22|||
124853630|NCT00560833|449085936|FG001|Overall Study|Lack of Efficacy|9|||
124853631|NCT00560833|449085937|FG002|Overall Study|Lack of Efficacy|6|||
124853632|NCT00560833|449085938|FG003|Overall Study|Lack of Efficacy|4|||
124853633|NCT00560833|449085939|FG004|Overall Study|Lack of Efficacy|4|||
124853634|NCT00560833|449085935|FG000|Overall Study|Participant uncooperative|5|||
124853635|NCT00560833|449085936|FG001|Overall Study|Participant uncooperative|5|||
124853636|NCT00560833|449085937|FG002|Overall Study|Participant uncooperative|4|||
124853637|NCT00560833|449085938|FG003|Overall Study|Participant uncooperative|4|||
124853638|NCT00560833|449085939|FG004|Overall Study|Participant uncooperative|2|||
124853639|NCT00560833|449085935|FG000|Overall Study|Other|1|||
124853640|NCT00560833|449085936|FG001|Overall Study|Other|1|||
124853641|NCT00560833|449085937|FG002|Overall Study|Other|3|||
124853642|NCT00560833|449085938|FG003|Overall Study|Other|0|||
124853643|NCT00560833|449085939|FG004|Overall Study|Other|0|||
124853644|NCT00560833|449085935|FG000|Overall Study|Never received drug|0|||
124853645|NCT00560833|449085936|FG001|Overall Study|Never received drug|1|||
124853646|NCT00560833|449085937|FG002|Overall Study|Never received drug|0|||
124853647|NCT00560833|449085938|FG003|Overall Study|Never received drug|0|||
124853648|NCT00560833|449085939|FG004|Overall Study|Never received drug|1|||
124853649|NCT05350449|449085940|FG000|Overall Study|Withdrawal by Subject|4|||
124853650|NCT05350449|449085941|FG001|Overall Study|Withdrawal by Subject|8|||
124853651|NCT01076400|449087568|FG000|Overall Study|Adverse Event|2|||
124853652|NCT01076400|449087569|FG001|Overall Study|Adverse Event|0|||
124853653|NCT01076400|449087570|FG002|Overall Study|Adverse Event|0|||
124853654|NCT01076400|449087568|FG000|Overall Study|Progressive Disease|5|||
124853655|NCT01076400|449087569|FG001|Overall Study|Progressive Disease|0|||
124853656|NCT01076400|449087570|FG002|Overall Study|Progressive Disease|0|||
124853657|NCT02696850|449087573|FG000|Overall Study|Withdrawal by Subject|3|||
124853658|NCT02696850|449087574|FG001|Overall Study|Withdrawal by Subject|3|||
124853659|NCT02696850|449087573|FG000|Overall Study|Lost to Follow-up|8|||
124853660|NCT02696850|449087574|FG001|Overall Study|Lost to Follow-up|5|||
124853661|NCT03455855|449087575|FG000|Overall Study|Lost to Follow-up|4|||
124853662|NCT03455855|449087576|FG001|Overall Study|Lost to Follow-up|2|||
124853663|NCT04193202|449087577|FG000|Overall Study|Adverse Event|2|||
124853664|NCT04193202|449087578|FG001|Overall Study|Adverse Event|1|||
124853665|NCT04193202|449087577|FG000|Overall Study|Death|0|||
124853666|NCT04193202|449087578|FG001|Overall Study|Death|1|||
124853667|NCT04193202|449087577|FG000|Overall Study|Physician Decision|1|||
124853668|NCT04193202|449087578|FG001|Overall Study|Physician Decision|1|||
124853669|NCT04193202|449087577|FG000|Overall Study|Protocol Violation|2|||
124853670|NCT04193202|449087578|FG001|Overall Study|Protocol Violation|2|||
124853671|NCT04193202|449087577|FG000|Overall Study|Withdrawal by Subject|11|||
124853672|NCT04193202|449087578|FG001|Overall Study|Withdrawal by Subject|5|||
124853673|NCT00581945|449087581|FG000|Overall Study|Adverse Event|4|||
124853674|NCT00581945|449087582|FG001|Overall Study|Adverse Event|4|||
124853675|NCT00581945|449087581|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124853676|NCT00581945|449087582|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124853677|NCT00581945|449087581|FG000|Overall Study|Withdrawal by Subject|2|||
124853678|NCT00581945|449087582|FG001|Overall Study|Withdrawal by Subject|6|||
124853679|NCT00581945|449087581|FG000|Overall Study|Death|1|||
124853680|NCT00581945|449087582|FG001|Overall Study|Death|0|||
124853681|NCT04820673|449087583|FG000|Overall Study|Adverse Event|6|||
124853682|NCT04820673|449087583|FG000|Overall Study|Due to Lack of Effectiveness|1|||
124853683|NCT04820673|449087583|FG000|Overall Study|Pregnancy|1|||
124853684|NCT04820673|449087583|FG000|Overall Study|Voluntary Withdrawal|20|||
124853685|NCT04820673|449087583|FG000|Overall Study|Lost to Follow-up|10|||
124853686|NCT00587587|449087586|FG000|Overall Study|Lost to Follow-up|6|||
124853687|NCT00587587|449087587|FG001|Overall Study|Lost to Follow-up|1|||
124853688|NCT01075321|449087595|FG000|Overall Study|Withdrawal by Subject|0|||
124853689|NCT01075321|449087596|FG001|Overall Study|Withdrawal by Subject|0|||
124853690|NCT01075321|449087597|FG002|Overall Study|Withdrawal by Subject|1|||
124853691|NCT01075321|449087598|FG003|Overall Study|Withdrawal by Subject|1|||
124853692|NCT01075321|449087595|FG000|Overall Study|Protocol Violation|0|||
124853693|NCT01075321|449087596|FG001|Overall Study|Protocol Violation|0|||
124853694|NCT01075321|449087597|FG002|Overall Study|Protocol Violation|1|||
124853695|NCT01075321|449087598|FG003|Overall Study|Protocol Violation|0|||
124853696|NCT01075321|449087595|FG000|Overall Study|Treatment Incomplete due to progression|1|||
124853697|NCT01075321|449087596|FG001|Overall Study|Treatment Incomplete due to progression|0|||
124853698|NCT01075321|449087597|FG002|Overall Study|Treatment Incomplete due to progression|0|||
124853699|NCT01075321|449087598|FG003|Overall Study|Treatment Incomplete due to progression|0|||
124853700|NCT01075321|449087595|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
124853701|NCT01075321|449087596|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
124853702|NCT01075321|449087597|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
124853703|NCT01075321|449087598|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
124853704|NCT01933334|449087602|FG000|Overall Study|Adverse Event|5|||
124853705|NCT01933334|449087603|FG001|Overall Study|Adverse Event|1|||
124853706|NCT01933334|449087602|FG000|Overall Study|Withdrawal by Subject|0|||
124853707|NCT01933334|449087603|FG001|Overall Study|Withdrawal by Subject|1|||
124853708|NCT00767000|449087604|FG000|54-week Study|Adverse Event|4|||
124853709|NCT00767000|449087605|FG001|54-week Study|Adverse Event|6|||
124853710|NCT00767000|449087606|FG002|54-week Study|Adverse Event|6|||
124853711|NCT00767000|449087607|FG003|54-week Study|Adverse Event|8|||
124853712|NCT00767000|449087608|FG004|54-week Study|Adverse Event|4|||
124853713|NCT00767000|449087604|FG000|54-week Study|Creaninine/creatinine clearance|2|||
124853714|NCT00767000|449087605|FG001|54-week Study|Creaninine/creatinine clearance|1|||
124853715|NCT00767000|449087606|FG002|54-week Study|Creaninine/creatinine clearance|2|||
124853716|NCT00767000|449087607|FG003|54-week Study|Creaninine/creatinine clearance|2|||
124853717|NCT00767000|449087608|FG004|54-week Study|Creaninine/creatinine clearance|4|||
124853718|NCT00767000|449087604|FG000|54-week Study|Hyperglycemia|0|||
124853719|NCT00767000|449087605|FG001|54-week Study|Hyperglycemia|0|||
124853720|NCT00767000|449087606|FG002|54-week Study|Hyperglycemia|1|||
124853721|NCT00767000|449087607|FG003|54-week Study|Hyperglycemia|0|||
124853722|NCT00767000|449087608|FG004|54-week Study|Hyperglycemia|1|||
124853723|NCT00767000|449087604|FG000|54-week Study|Hypoglycemia|0|||
124853724|NCT00767000|449087605|FG001|54-week Study|Hypoglycemia|1|||
124853725|NCT00767000|449087606|FG002|54-week Study|Hypoglycemia|0|||
124853726|NCT00767000|449087607|FG003|54-week Study|Hypoglycemia|0|||
124853727|NCT00767000|449087608|FG004|54-week Study|Hypoglycemia|0|||
124853728|NCT00767000|449087604|FG000|54-week Study|Interruption of study medication|0|||
124853729|NCT00767000|449087605|FG001|54-week Study|Interruption of study medication|0|||
124853730|NCT00767000|449087606|FG002|54-week Study|Interruption of study medication|1|||
124853731|NCT00767000|449087607|FG003|54-week Study|Interruption of study medication|0|||
124853732|NCT00767000|449087608|FG004|54-week Study|Interruption of study medication|0|||
124853733|NCT00767000|449087604|FG000|54-week Study|Lack of Efficacy|2|||
124853734|NCT00767000|449087605|FG001|54-week Study|Lack of Efficacy|0|||
124853735|NCT00767000|449087606|FG002|54-week Study|Lack of Efficacy|1|||
124853736|NCT00767000|449087607|FG003|54-week Study|Lack of Efficacy|0|||
124853737|NCT00767000|449087608|FG004|54-week Study|Lack of Efficacy|5|||
124853738|NCT00767000|449087604|FG000|54-week Study|Lost to Follow-up|4|||
124853739|NCT00767000|449087605|FG001|54-week Study|Lost to Follow-up|0|||
124853740|NCT00767000|449087606|FG002|54-week Study|Lost to Follow-up|1|||
124853741|NCT00767000|449087607|FG003|54-week Study|Lost to Follow-up|4|||
124853742|NCT00767000|449087608|FG004|54-week Study|Lost to Follow-up|2|||
124853743|NCT00767000|449087604|FG000|54-week Study|Physician Decision|4|||
124853744|NCT00767000|449087605|FG001|54-week Study|Physician Decision|0|||
124853745|NCT00767000|449087606|FG002|54-week Study|Physician Decision|1|||
124853746|NCT00767000|449087607|FG003|54-week Study|Physician Decision|1|||
124853747|NCT00767000|449087608|FG004|54-week Study|Physician Decision|1|||
124853748|NCT00767000|449087604|FG000|54-week Study|Progressive disease|0|||
124853749|NCT00767000|449087605|FG001|54-week Study|Progressive disease|0|||
124853750|NCT00767000|449087606|FG002|54-week Study|Progressive disease|1|||
124853751|NCT00767000|449087607|FG003|54-week Study|Progressive disease|0|||
124853752|NCT00767000|449087608|FG004|54-week Study|Progressive disease|0|||
124853753|NCT00767000|449087604|FG000|54-week Study|Protocol Violation|0|||
124853754|NCT00767000|449087605|FG001|54-week Study|Protocol Violation|0|||
124853755|NCT00767000|449087606|FG002|54-week Study|Protocol Violation|1|||
124853756|NCT00767000|449087607|FG003|54-week Study|Protocol Violation|2|||
124853757|NCT00767000|449087608|FG004|54-week Study|Protocol Violation|0|||
124853758|NCT00767000|449087604|FG000|54-week Study|Withdrawal by Subject|2|||
124853759|NCT00767000|449087605|FG001|54-week Study|Withdrawal by Subject|3|||
124853760|NCT00767000|449087606|FG002|54-week Study|Withdrawal by Subject|5|||
124853761|NCT00767000|449087607|FG003|54-week Study|Withdrawal by Subject|11|||
124853762|NCT00767000|449087608|FG004|54-week Study|Withdrawal by Subject|13|||
124853763|NCT00767000|449087604|FG000|54-week Study|Study terminated by sponsor|90|||
124853764|NCT00767000|449087605|FG001|54-week Study|Study terminated by sponsor|102|||
124853765|NCT00767000|449087606|FG002|54-week Study|Study terminated by sponsor|89|||
124853766|NCT00767000|449087607|FG003|54-week Study|Study terminated by sponsor|196|||
124853767|NCT00767000|449087608|FG004|54-week Study|Study terminated by sponsor|194|||
124853768|NCT00767000|449087604|FG000|54-week Study|Reason not reported|0|||
124853769|NCT00767000|449087605|FG001|54-week Study|Reason not reported|0|||
124853770|NCT00767000|449087606|FG002|54-week Study|Reason not reported|0|||
124853771|NCT00767000|449087607|FG003|54-week Study|Reason not reported|1|||
124853772|NCT00767000|449087608|FG004|54-week Study|Reason not reported|0|||
124853773|NCT00767000|449087604|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
124853774|NCT00767000|449087605|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
124853775|NCT00767000|449087606|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
124853776|NCT00767000|449087607|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
124853777|NCT00767000|449087608|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
124853778|NCT02039505|449087610|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
124853779|NCT02039505|449087611|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
124853780|NCT02039505|449087612|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
124853781|NCT02039505|449087613|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
124853782|NCT02039505|449087614|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
124853783|NCT02039505|449087615|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
124853784|NCT02039505|449087616|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
124853785|NCT02039505|449087610|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
124853786|NCT02039505|449087611|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
124853787|NCT02039505|449087612|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
124853788|NCT02039505|449087613|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
124853789|NCT02039505|449087614|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
124853790|NCT02039505|449087615|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
124853791|NCT02039505|449087616|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
124853792|NCT02039505|449087610|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
124853793|NCT02039505|449087611|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
124853794|NCT02039505|449087612|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
124853795|NCT02039505|449087613|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
124853796|NCT02039505|449087614|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
124853797|NCT02039505|449087615|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
124853798|NCT02039505|449087616|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
124853799|NCT02039505|449087610|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
124853800|NCT02039505|449087611|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
124853801|NCT02039505|449087612|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
124853802|NCT02039505|449087613|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
124853803|NCT02039505|449087614|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
124853804|NCT02039505|449087615|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
124853805|NCT02039505|449087616|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
124853806|NCT02039505|449087610|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
124853807|NCT02039505|449087611|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
124853808|NCT02039505|449087612|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
124853809|NCT02039505|449087613|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
124853810|NCT02039505|449087614|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
124853811|NCT02039505|449087615|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
124853812|NCT02039505|449087616|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
124853813|NCT02039505|449087610|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
124853814|NCT02039505|449087611|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
124853815|NCT02039505|449087612|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
124853816|NCT02039505|449087613|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
124853817|NCT02039505|449087614|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
124853818|NCT02039505|449087615|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
124853819|NCT02039505|449087616|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
124853820|NCT02039505|449087610|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
124853821|NCT02039505|449087611|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
124853822|NCT02039505|449087612|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
124853823|NCT02039505|449087613|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
124853824|NCT02039505|449087614|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
124853825|NCT02039505|449087615|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
124853826|NCT02039505|449087616|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
124853827|NCT02039505|449087610|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
124853828|NCT02039505|449087611|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
124853829|NCT02039505|449087612|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
124853830|NCT02039505|449087613|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
124853831|NCT02039505|449087614|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
124853832|NCT02039505|449087615|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
124853833|NCT02039505|449087616|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
124853834|NCT02039505|449087610|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
124853835|NCT02039505|449087611|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
124853836|NCT02039505|449087612|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
124853837|NCT02039505|449087613|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
124853838|NCT02039505|449087614|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
124853839|NCT02039505|449087615|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
124853840|NCT02039505|449087616|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
124853841|NCT02039505|449087610|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
124853842|NCT02039505|449087611|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
124853843|NCT02039505|449087612|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
124853844|NCT02039505|449087613|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
124853845|NCT02039505|449087614|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
124853846|NCT02039505|449087615|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
124853847|NCT02039505|449087616|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
124853848|NCT02039505|449087610|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
124853849|NCT02039505|449087611|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
124853850|NCT02039505|449087612|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
124853851|NCT02039505|449087613|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
124853852|NCT02039505|449087614|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
124853853|NCT02039505|449087615|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
124853854|NCT02039505|449087616|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
124853855|NCT00633984|449087619|FG000|Overall Study|Lost to Follow-up|0|||
124853856|NCT00633984|449087620|FG001|Overall Study|Lost to Follow-up|6|||
124853857|NCT00633984|449087619|FG000|Overall Study|Withdrawal by Subject|8|||
124853858|NCT00633984|449087620|FG001|Overall Study|Withdrawal by Subject|7|||
124853859|NCT00633984|449087619|FG000|Overall Study|Hospitalized|1|||
124853860|NCT00633984|449087620|FG001|Overall Study|Hospitalized|0|||
124853861|NCT00097591|449087621|FG000|Overall Study|Withdrawal of consent|342|||
124853862|NCT00097591|449087622|FG001|Overall Study|Withdrawal of consent|323|||
124853863|NCT00097591|449087621|FG000|Overall Study|Less than 6 months on study drug|9|||
124853864|NCT00097591|449087622|FG001|Overall Study|Less than 6 months on study drug|7|||
124853865|NCT00097591|449087621|FG000|Overall Study|Unable to attend termination visit|53|||
124853866|NCT00097591|449087622|FG001|Overall Study|Unable to attend termination visit|51|||
124853867|NCT00097591|449087621|FG000|Overall Study|Lost to follow up|6|||
124853868|NCT00097591|449087622|FG001|Overall Study|Lost to follow up|10|||
124853869|NCT00097591|449087621|FG000|Overall Study|Other|0|||
124853870|NCT00097591|449087622|FG001|Overall Study|Other|3|||
124853871|NCT01557946|449087625|FG000|Overall Study|Adverse Event|3|||
124853872|NCT01557946|449087626|FG001|Overall Study|Adverse Event|0|||
124853873|NCT01114646|449087631|FG000|Overall Study|Withdrawal by Subject|3|||
124853874|NCT01114646|449087632|FG001|Overall Study|Withdrawal by Subject|2|||
124853875|NCT00718042|449087638|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
124853876|NCT00718042|449087639|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
124853877|NCT00718042|449087640|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
124853878|NCT00718042|449087641|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
124853879|NCT00718042|449087642|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
124853880|NCT00718042|449087643|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
124853881|NCT00718042|449087638|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
124853882|NCT00718042|449087639|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
124853883|NCT00718042|449087640|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
124853884|NCT00718042|449087641|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
124853885|NCT00718042|449087642|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
124853886|NCT00718042|449087643|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
124853887|NCT00718042|449087638|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
124853888|NCT00718042|449087639|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
124853889|NCT00718042|449087640|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
124853890|NCT00718042|449087641|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
124853891|NCT00718042|449087642|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
124853892|NCT00718042|449087643|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
124853893|NCT00718042|449087638|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
124853894|NCT00718042|449087639|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
124853895|NCT00718042|449087640|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
124853896|NCT00718042|449087641|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
124853897|NCT00718042|449087642|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
124853898|NCT00718042|449087643|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
124853899|NCT00718042|449087638|FG000|Donor Follow-up|Lost to Follow-up|13|||
124853900|NCT00718042|449087639|FG001|Donor Follow-up|Lost to Follow-up|0|||
124853901|NCT00718042|449087640|FG002|Donor Follow-up|Lost to Follow-up|0|||
124853902|NCT00718042|449087641|FG003|Donor Follow-up|Lost to Follow-up|0|||
124853903|NCT00718042|449087642|FG004|Donor Follow-up|Lost to Follow-up|19|||
124853904|NCT00718042|449087643|FG005|Donor Follow-up|Lost to Follow-up|0|||
124853905|NCT00575588|449087644|FG000|Overall Study|Adverse Event|11|||
124853906|NCT00575588|449087645|FG001|Overall Study|Adverse Event|13|||
124853907|NCT00575588|449087644|FG000|Overall Study|Withdrawal by Subject|27|||
124853908|NCT00575588|449087645|FG001|Overall Study|Withdrawal by Subject|31|||
124853909|NCT00575588|449087644|FG000|Overall Study|Lost to Follow-up|1|||
124853910|NCT00575588|449087645|FG001|Overall Study|Lost to Follow-up|3|||
124853911|NCT00575588|449087644|FG000|Overall Study|Death|4|||
124853912|NCT00575588|449087645|FG001|Overall Study|Death|2|||
124853913|NCT00575588|449087644|FG000|Overall Study|Incorrect enrollment|8|||
124853914|NCT00575588|449087645|FG001|Overall Study|Incorrect enrollment|4|||
124853915|NCT00575588|449087644|FG000|Overall Study|Study specific discontinuation criteria|203|||
124853916|NCT00575588|449087645|FG001|Overall Study|Study specific discontinuation criteria|218|||
124853917|NCT00575588|449087644|FG000|Overall Study|Severe non-compliance to protocol|5|||
124853918|NCT00575588|449087645|FG001|Overall Study|Severe non-compliance to protocol|7|||
124853919|NCT00575588|449087644|FG000|Overall Study|Safety reasons|2|||
124853920|NCT00575588|449087645|FG001|Overall Study|Safety reasons|1|||
124853921|NCT00575588|449087644|FG000|Overall Study|Elevated triglyceride|1|||
124853922|NCT00575588|449087645|FG001|Overall Study|Elevated triglyceride|0|||
124853923|NCT00575588|449087644|FG000|Overall Study|Patient moved|1|||
124853924|NCT00575588|449087645|FG001|Overall Study|Patient moved|3|||
124853925|NCT00575588|449087644|FG000|Overall Study|Impossible to determine HbA1c|0|||
124853926|NCT00575588|449087645|FG001|Overall Study|Impossible to determine HbA1c|1|||
124853927|NCT00614939|449087646|FG000|Overall Study|Withdrawal by Subject|10|||
124853928|NCT00614939|449087647|FG001|Overall Study|Withdrawal by Subject|17|||
124853929|NCT00614939|449087646|FG000|Overall Study|Study specific discontinuation criteris|13|||
124853930|NCT00614939|449087647|FG001|Overall Study|Study specific discontinuation criteris|16|||
124853931|NCT00614939|449087646|FG000|Overall Study|Adverse Event|2|||
124853932|NCT00614939|449087647|FG001|Overall Study|Adverse Event|5|||
124853933|NCT00614939|449087646|FG000|Overall Study|Incorrect enrollment|1|||
124853934|NCT00614939|449087647|FG001|Overall Study|Incorrect enrollment|2|||
124853935|NCT00614939|449087646|FG000|Overall Study|Death|4|||
124853936|NCT00614939|449087647|FG001|Overall Study|Death|3|||
124853937|NCT00614939|449087646|FG000|Overall Study|Poor/non-compliance|4|||
124853938|NCT00614939|449087647|FG001|Overall Study|Poor/non-compliance|0|||
124853939|NCT00614939|449087646|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
124853940|NCT00614939|449087647|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
124853941|NCT00840970|449087648|FG000|Overall Study|Adverse Event|0|||
124853942|NCT00840970|449087649|FG001|Overall Study|Adverse Event|0|||
124853943|NCT00840970|449087650|FG002|Overall Study|Adverse Event|1|||
124853944|NCT00504829|449087651|FG000|Overall Study|Protocol Violation|6|||
124853945|NCT00504829|449087652|FG001|Overall Study|Protocol Violation|4|||
124853946|NCT00504829|449087653|FG002|Overall Study|Protocol Violation|10|||
124853947|NCT01854827|449087654|FG000|Overall Study|Death|1|||
124853948|NCT02571452|449087655|FG000|Overall Study Treatment|Protocol Violation|0|||
124853949|NCT02571452|449087656|FG001|Overall Study Treatment|Protocol Violation|1|||
124853950|NCT02571452|449087655|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
124853951|NCT02571452|449087656|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
124853952|NCT02571452|449087655|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
124853953|NCT02571452|449087656|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
124853954|NCT02660944|449087669|FG000|Overall Study|Adverse Event|3|||
124853955|NCT02660944|449087670|FG001|Overall Study|Adverse Event|4|||
124853956|NCT02660944|449087669|FG000|Overall Study|Physician Decision|3|||
124853957|NCT02660944|449087670|FG001|Overall Study|Physician Decision|1|||
124853958|NCT02660944|449087669|FG000|Overall Study|Withdrawal by Subject|5|||
124853959|NCT02660944|449087670|FG001|Overall Study|Withdrawal by Subject|3|||
124853960|NCT02660944|449087669|FG000|Overall Study|Lost to Follow-up|4|||
124853961|NCT02660944|449087670|FG001|Overall Study|Lost to Follow-up|1|||
124853962|NCT02660944|449087669|FG000|Overall Study|Subject schedule|0|||
124853963|NCT02660944|449087670|FG001|Overall Study|Subject schedule|1|||
124853964|NCT02660944|449087669|FG000|Overall Study|Exclusion criteria met|2|||
124853965|NCT02660944|449087670|FG001|Overall Study|Exclusion criteria met|0|||
124853966|NCT00833924|449087674|FG000|Overall Study|Death|21|||
124853967|NCT00833924|449087674|FG000|Overall Study|Conversion|2|||
124853968|NCT00833924|449087674|FG000|Overall Study|Lost to Follow-up|2|||
124853969|NCT00833924|449087674|FG000|Overall Study|Withdrawal by Subject|13|||
124853970|NCT00833924|449087674|FG000|Overall Study|In study follow-up|71|||
124853971|NCT01485861|449087675|FG000|Phase Ib|Death|1|||
124853972|NCT01485861|449087676|FG001|Phase Ib|Death|0|||
124853973|NCT01485861|449087677|FG002|Phase Ib|Death|0|||
124853974|NCT01485861|449087678|FG003|Phase Ib|Death|0|||
124853975|NCT01485861|449087679|FG004|Phase Ib|Death|0|||
124853976|NCT01485861|449087680|FG005|Phase Ib|Death|0|||
124853977|NCT01485861|449087675|FG000|Phase Ib|Physician Decision|1|||
124853978|NCT01485861|449087676|FG001|Phase Ib|Physician Decision|1|||
124853979|NCT01485861|449087677|FG002|Phase Ib|Physician Decision|0|||
124853980|NCT01485861|449087678|FG003|Phase Ib|Physician Decision|0|||
124853981|NCT01485861|449087679|FG004|Phase Ib|Physician Decision|0|||
124853982|NCT01485861|449087680|FG005|Phase Ib|Physician Decision|0|||
124853983|NCT01485861|449087675|FG000|Phase Ib|Adverse Event|0|||
124853984|NCT01485861|449087676|FG001|Phase Ib|Adverse Event|4|||
124853985|NCT01485861|449087677|FG002|Phase Ib|Adverse Event|0|||
124853986|NCT01485861|449087678|FG003|Phase Ib|Adverse Event|0|||
124853987|NCT01485861|449087679|FG004|Phase Ib|Adverse Event|0|||
124853988|NCT01485861|449087680|FG005|Phase Ib|Adverse Event|0|||
124853989|NCT01485861|449087675|FG000|Phase Ib|Progression of disease|5|||
124853990|NCT01485861|449087676|FG001|Phase Ib|Progression of disease|0|||
124853991|NCT01485861|449087677|FG002|Phase Ib|Progression of disease|0|||
124853992|NCT01485861|449087678|FG003|Phase Ib|Progression of disease|0|||
124853993|NCT01485861|449087679|FG004|Phase Ib|Progression of disease|0|||
124853994|NCT01485861|449087680|FG005|Phase Ib|Progression of disease|0|||
124853995|NCT01485861|449087675|FG000|Phase Ib|Other|3|||
124853996|NCT01485861|449087676|FG001|Phase Ib|Other|0|||
124853997|NCT01485861|449087677|FG002|Phase Ib|Other|0|||
124853998|NCT01485861|449087678|FG003|Phase Ib|Other|0|||
124853999|NCT01485861|449087679|FG004|Phase Ib|Other|0|||
124854000|NCT01485861|449087680|FG005|Phase Ib|Other|0|||
124854001|NCT01485861|449087675|FG000|Phase Ib|Withdrawal by Subject|4|||
124854002|NCT01485861|449087676|FG001|Phase Ib|Withdrawal by Subject|1|||
124854003|NCT01485861|449087677|FG002|Phase Ib|Withdrawal by Subject|0|||
124854004|NCT01485861|449087678|FG003|Phase Ib|Withdrawal by Subject|0|||
124854005|NCT01485861|449087679|FG004|Phase Ib|Withdrawal by Subject|0|||
124854006|NCT01485861|449087680|FG005|Phase Ib|Withdrawal by Subject|0|||
124854007|NCT01485861|449087675|FG000|Phase II|Death|0|||
124854008|NCT01485861|449087676|FG001|Phase II|Death|0|||
124854009|NCT01485861|449087677|FG002|Phase II|Death|67|||
124854010|NCT01485861|449087678|FG003|Phase II|Death|71|||
124854011|NCT01485861|449087679|FG004|Phase II|Death|68|||
124854012|NCT01485861|449087680|FG005|Phase II|Death|0|||
124854013|NCT01485861|449087675|FG000|Phase II|Progression of Disease|0|||
124854014|NCT01485861|449087676|FG001|Phase II|Progression of Disease|0|||
124854015|NCT01485861|449087677|FG002|Phase II|Progression of Disease|1|||
124854016|NCT01485861|449087678|FG003|Phase II|Progression of Disease|0|||
124854017|NCT01485861|449087679|FG004|Phase II|Progression of Disease|0|||
124854018|NCT01485861|449087680|FG005|Phase II|Progression of Disease|0|||
124854019|NCT01485861|449087675|FG000|Phase II|Other|0|||
124854020|NCT01485861|449087676|FG001|Phase II|Other|0|||
124854021|NCT01485861|449087677|FG002|Phase II|Other|0|||
124854022|NCT01485861|449087678|FG003|Phase II|Other|1|||
124854023|NCT01485861|449087679|FG004|Phase II|Other|0|||
124854024|NCT01485861|449087680|FG005|Phase II|Other|0|||
124854025|NCT01485861|449087675|FG000|Phase II|Withdrawal by Subject|0|||
124854026|NCT01485861|449087676|FG001|Phase II|Withdrawal by Subject|0|||
124854027|NCT01485861|449087677|FG002|Phase II|Withdrawal by Subject|6|||
124854028|NCT01485861|449087678|FG003|Phase II|Withdrawal by Subject|3|||
124854029|NCT01485861|449087679|FG004|Phase II|Withdrawal by Subject|4|||
124854030|NCT01485861|449087680|FG005|Phase II|Withdrawal by Subject|0|||
124854031|NCT01485861|449087675|FG000|Phase II|Lost to Follow-up|0|||
124854032|NCT01485861|449087676|FG001|Phase II|Lost to Follow-up|0|||
124854033|NCT01485861|449087677|FG002|Phase II|Lost to Follow-up|2|||
124854034|NCT01485861|449087678|FG003|Phase II|Lost to Follow-up|3|||
124854035|NCT01485861|449087679|FG004|Phase II|Lost to Follow-up|5|||
124854036|NCT01485861|449087680|FG005|Phase II|Lost to Follow-up|0|||
124854037|NCT01485861|449087675|FG000|Phase II|Study Ended|0|||
124854038|NCT01485861|449087676|FG001|Phase II|Study Ended|0|||
124854039|NCT01485861|449087677|FG002|Phase II|Study Ended|7|||
124854040|NCT01485861|449087678|FG003|Phase II|Study Ended|8|||
124854041|NCT01485861|449087679|FG004|Phase II|Study Ended|6|||
124854042|NCT01485861|449087680|FG005|Phase II|Study Ended|0|||
124854043|NCT01485861|449087675|FG000|Safety Phase|Death|0|||
124854044|NCT01485861|449087676|FG001|Safety Phase|Death|0|||
124854045|NCT01485861|449087677|FG002|Safety Phase|Death|0|||
124854046|NCT01485861|449087678|FG003|Safety Phase|Death|0|||
124854047|NCT01485861|449087679|FG004|Safety Phase|Death|0|||
124854048|NCT01485861|449087680|FG005|Safety Phase|Death|2|||
124854049|NCT01485861|449087675|FG000|Safety Phase|Adverse Event|0|||
124854050|NCT01485861|449087676|FG001|Safety Phase|Adverse Event|0|||
124854051|NCT01485861|449087677|FG002|Safety Phase|Adverse Event|0|||
124854052|NCT01485861|449087678|FG003|Safety Phase|Adverse Event|0|||
124854053|NCT01485861|449087679|FG004|Safety Phase|Adverse Event|0|||
124854054|NCT01485861|449087680|FG005|Safety Phase|Adverse Event|1|||
124854055|NCT01485861|449087675|FG000|Safety Phase|Other|0|||
124854056|NCT01485861|449087676|FG001|Safety Phase|Other|0|||
124854057|NCT01485861|449087677|FG002|Safety Phase|Other|0|||
124854058|NCT01485861|449087678|FG003|Safety Phase|Other|0|||
124854059|NCT01485861|449087679|FG004|Safety Phase|Other|0|||
124854060|NCT01485861|449087680|FG005|Safety Phase|Other|5|||
124854061|NCT01485861|449087675|FG000|Safety Phase|Progression of Disease|0|||
124854062|NCT01485861|449087676|FG001|Safety Phase|Progression of Disease|0|||
124854063|NCT01485861|449087677|FG002|Safety Phase|Progression of Disease|0|||
124854064|NCT01485861|449087678|FG003|Safety Phase|Progression of Disease|0|||
124854065|NCT01485861|449087679|FG004|Safety Phase|Progression of Disease|0|||
124854066|NCT01485861|449087680|FG005|Safety Phase|Progression of Disease|9|||
124854067|NCT01485861|449087675|FG000|Safety Phase|Withdrawal by Subject|0|||
124854068|NCT01485861|449087676|FG001|Safety Phase|Withdrawal by Subject|0|||
124854069|NCT01485861|449087677|FG002|Safety Phase|Withdrawal by Subject|0|||
124854070|NCT01485861|449087678|FG003|Safety Phase|Withdrawal by Subject|0|||
124854071|NCT01485861|449087679|FG004|Safety Phase|Withdrawal by Subject|0|||
124854072|NCT01485861|449087680|FG005|Safety Phase|Withdrawal by Subject|6|||
124854073|NCT01485861|449087675|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
124854074|NCT01485861|449087676|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
124854075|NCT01485861|449087677|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
124854076|NCT01485861|449087678|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
124854077|NCT01485861|449087679|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
124854078|NCT01485861|449087680|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
124854079|NCT04796610|449087685|FG000|Overall Study|Withdrawal by Subject|1|||
124854080|NCT04796610|449087686|FG001|Overall Study|Withdrawal by Subject|0|||
124854081|NCT04796610|449087687|FG002|Overall Study|Withdrawal by Subject|0|||
124854082|NCT04796610|449087688|FG003|Overall Study|Withdrawal by Subject|0|||
124854083|NCT04796610|449087685|FG000|Overall Study|Lost to Follow-up|2|||
124854084|NCT04796610|449087686|FG001|Overall Study|Lost to Follow-up|0|||
124854085|NCT04796610|449087687|FG002|Overall Study|Lost to Follow-up|1|||
124854086|NCT04796610|449087688|FG003|Overall Study|Lost to Follow-up|1|||
124854087|NCT02059148|449087689|FG000|Treatment 1|Protocol Violation|0|||
124854088|NCT02059148|449087690|FG001|Treatment 1|Protocol Violation|0|||
124854089|NCT02059148|449087691|FG002|Treatment 1|Protocol Violation|0|||
124854090|NCT02059148|449087692|FG003|Treatment 1|Protocol Violation|0|||
124854091|NCT02059148|449087693|FG004|Treatment 1|Protocol Violation|0|||
124854092|NCT02059148|449087694|FG005|Treatment 1|Protocol Violation|1|||
124854093|NCT00403546|449087698|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
124854094|NCT00403546|449087699|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
124854095|NCT00403546|449087700|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
124854096|NCT00403546|449087698|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
124854097|NCT00403546|449087699|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
124854098|NCT00403546|449087700|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
124854099|NCT00403546|449087698|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
124854100|NCT00403546|449087699|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
124854101|NCT00403546|449087700|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
124854102|NCT00403546|449087698|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
124854103|NCT00403546|449087699|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
124854104|NCT00403546|449087700|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
124854105|NCT00403546|449087698|FG000|Screening Phase|Screening Failure|22|||
124854106|NCT00403546|449087699|FG001|Screening Phase|Screening Failure|0|||
124854107|NCT00403546|449087700|FG002|Screening Phase|Screening Failure|0|||
124854108|NCT00403546|449087698|FG000|Screening Phase|Adverse Event|1|||
124854109|NCT00403546|449087699|FG001|Screening Phase|Adverse Event|0|||
124854110|NCT00403546|449087700|FG002|Screening Phase|Adverse Event|0|||
124854111|NCT00403546|449087698|FG000|Screening Phase|Terminated Prior to Randomization|5|||
124854112|NCT00403546|449087699|FG001|Screening Phase|Terminated Prior to Randomization|0|||
124854113|NCT00403546|449087700|FG002|Screening Phase|Terminated Prior to Randomization|0|||
124854114|NCT00403546|449087698|FG000|Randomized Trial|Early Terminations|0|||
124854115|NCT00403546|449087699|FG001|Randomized Trial|Early Terminations|17|||
124854116|NCT00403546|449087700|FG002|Randomized Trial|Early Terminations|16|||
124854117|NCT00437489|449087701|FG000|Overall Study|Study terminated by sponsor|23|||
124854118|NCT00437489|449087702|FG001|Overall Study|Study terminated by sponsor|21|||
124854119|NCT00437489|449087701|FG000|Overall Study|Lost to Follow-up|0|||
124854120|NCT00437489|449087702|FG001|Overall Study|Lost to Follow-up|1|||
124854121|NCT03893448|449087705|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
124854122|NCT03893448|449087706|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
124854123|NCT03893448|449087705|FG000|Overall Study|Physician Decision|8|||
124854124|NCT03893448|449087706|FG001|Overall Study|Physician Decision|14|||
124854125|NCT03893448|449087705|FG000|Overall Study|Lost to Follow-up|34|||
124854126|NCT03893448|449087706|FG001|Overall Study|Lost to Follow-up|27|||
124854127|NCT03893448|449087705|FG000|Overall Study|Death|1|||
124854128|NCT03893448|449087706|FG001|Overall Study|Death|0|||
124854129|NCT03321981|449087712|FG000|Overall Study|Progressive Disease (PD)|15|||
124854130|NCT03321981|449087713|FG001|Overall Study|Progressive Disease (PD)|30|||
124854131|NCT03321981|449087714|FG002|Overall Study|Progressive Disease (PD)|47|||
124854132|NCT03321981|449087712|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
124854133|NCT03321981|449087713|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
124854134|NCT03321981|449087714|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
124854135|NCT03321981|449087712|FG000|Overall Study|Adverse Event|0|||
124854136|NCT03321981|449087713|FG001|Overall Study|Adverse Event|0|||
124854137|NCT03321981|449087714|FG002|Overall Study|Adverse Event|2|||
124854138|NCT03321981|449087712|FG000|Overall Study|symptomatic deterioration|0|||
124854139|NCT03321981|449087713|FG001|Overall Study|symptomatic deterioration|1|||
124854140|NCT03321981|449087714|FG002|Overall Study|symptomatic deterioration|1|||
124854141|NCT03321981|449087712|FG000|Overall Study|Lack of compliance|0|||
124854142|NCT03321981|449087713|FG001|Overall Study|Lack of compliance|1|||
124854143|NCT03321981|449087714|FG002|Overall Study|Lack of compliance|0|||
124854144|NCT03321981|449087712|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
124854145|NCT03321981|449087713|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
124854146|NCT03321981|449087714|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
124854147|NCT03321981|449087712|FG000|Overall Study|Death|0|||
124854148|NCT03321981|449087713|FG001|Overall Study|Death|1|||
124854149|NCT03321981|449087714|FG002|Overall Study|Death|0|||
124854150|NCT03321981|449087712|FG000|Overall Study|Subject withdrawal of investigational product|0|||
124854151|NCT03321981|449087713|FG001|Overall Study|Subject withdrawal of investigational product|1|||
124854152|NCT03321981|449087714|FG002|Overall Study|Subject withdrawal of investigational product|0|||
124854153|NCT03321981|449087712|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
124854154|NCT03321981|449087713|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
124854155|NCT03321981|449087714|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
124854156|NCT03321981|449087712|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
124854157|NCT03321981|449087713|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
124854158|NCT03321981|449087714|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
124854159|NCT05061446|449087715|FG000|Overall Study|Adverse Event|2|||
124854160|NCT05061446|449087716|FG001|Overall Study|Adverse Event|0|||
124854161|NCT05061446|449087717|FG002|Overall Study|Adverse Event|0|||
124854162|NCT05061446|449087715|FG000|Overall Study|Participant no longer available due to personal reason|0|||
124854163|NCT05061446|449087716|FG001|Overall Study|Participant no longer available due to personal reason|1|||
124854164|NCT05061446|449087717|FG002|Overall Study|Participant no longer available due to personal reason|0|||
124854165|NCT03880578|449087718|FG000|Overall Study|Withdrawal by Subject|0|||
124854166|NCT03880578|449087719|FG001|Overall Study|Withdrawal by Subject|3|||
124854167|NCT03880578|449087720|FG002|Overall Study|Withdrawal by Subject|1|||
124854168|NCT03880578|449087718|FG000|Overall Study|Death|0|||
124854169|NCT03880578|449087719|FG001|Overall Study|Death|1|||
124854170|NCT03880578|449087720|FG002|Overall Study|Death|0|||
124854171|NCT04934670|449087721|FG000|Overall Study|Death|4|||
124854172|NCT04934670|449087722|FG001|Overall Study|Death|0|||
124854173|NCT04934670|449087721|FG000|Overall Study|Lost to Follow-up|1|||
124854174|NCT04934670|449087722|FG001|Overall Study|Lost to Follow-up|4|||
124854175|NCT00817089|449087724|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
124854176|NCT00817089|449087725|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
124854177|NCT00817089|449087726|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
124854178|NCT00817089|449087727|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
124854179|NCT00817089|449087724|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
124854180|NCT00817089|449087725|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
124854181|NCT00817089|449087726|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
124854182|NCT00817089|449087727|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
124854183|NCT03067441|449087728|FG000|Overall Study|Withdrawal by Subject|16|||
124854184|NCT03067441|449087729|FG001|Overall Study|Withdrawal by Subject|34|||
124854185|NCT03067441|449087728|FG000|Overall Study|Lost to Follow-up|7|||
124854186|NCT03067441|449087729|FG001|Overall Study|Lost to Follow-up|5|||
124854187|NCT03067441|449087728|FG000|Overall Study|Adverse Event|7|||
124854188|NCT03067441|449087729|FG001|Overall Study|Adverse Event|14|||
124854189|NCT03067441|449087728|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
124854190|NCT03067441|449087729|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
124854191|NCT03067441|449087728|FG000|Overall Study|Physician Decision|1|||
124854192|NCT03067441|449087729|FG001|Overall Study|Physician Decision|3|||
124854193|NCT03067441|449087728|FG000|Overall Study|Other|1|||
124854194|NCT03067441|449087729|FG001|Overall Study|Other|1|||
124854195|NCT01785602|449087730|FG000|Overall Study|Withdrawal by Subject|2|||
124854196|NCT01785602|449087731|FG001|Overall Study|Withdrawal by Subject|0|||
124854197|NCT01785602|449087730|FG000|Overall Study|Lost to Follow-up|1|||
124854198|NCT01785602|449087731|FG001|Overall Study|Lost to Follow-up|1|||
124854199|NCT01785602|449087730|FG000|Overall Study|Adverse Event|3|||
124854200|NCT01785602|449087731|FG001|Overall Study|Adverse Event|5|||
124854201|NCT01785602|449087730|FG000|Overall Study|Administrative problems|7|||
124854202|NCT01785602|449087731|FG001|Overall Study|Administrative problems|3|||
124854203|NCT04177108|449087732|FG000|Overall Study|Withdrawal by Subject|4|||
124854204|NCT04177108|449087733|FG001|Overall Study|Withdrawal by Subject|8|||
124854205|NCT04177108|449087734|FG002|Overall Study|Withdrawal by Subject|9|||
124854206|NCT04177108|449087735|FG003|Overall Study|Withdrawal by Subject|11|||
124854207|NCT04177108|449087736|FG004|Overall Study|Withdrawal by Subject|13|||
124854208|NCT04177108|449087732|FG000|Overall Study|Physician Decision|23|||
124854209|NCT04177108|449087733|FG001|Overall Study|Physician Decision|15|||
124854210|NCT04177108|449087734|FG002|Overall Study|Physician Decision|18|||
124854211|NCT04177108|449087735|FG003|Overall Study|Physician Decision|29|||
124854212|NCT04177108|449087736|FG004|Overall Study|Physician Decision|23|||
124854213|NCT04177108|449087732|FG000|Overall Study|Reason Not Specified|0|||
124854214|NCT04177108|449087733|FG001|Overall Study|Reason Not Specified|1|||
124854215|NCT04177108|449087734|FG002|Overall Study|Reason Not Specified|0|||
124854216|NCT04177108|449087735|FG003|Overall Study|Reason Not Specified|0|||
124854217|NCT04177108|449087736|FG004|Overall Study|Reason Not Specified|2|||
124854218|NCT04177108|449087732|FG000|Overall Study|Lost to Follow-up|0|||
124854219|NCT04177108|449087733|FG001|Overall Study|Lost to Follow-up|0|||
124854220|NCT04177108|449087734|FG002|Overall Study|Lost to Follow-up|1|||
124854221|NCT04177108|449087735|FG003|Overall Study|Lost to Follow-up|1|||
124854222|NCT04177108|449087736|FG004|Overall Study|Lost to Follow-up|1|||
124854223|NCT04177108|449087732|FG000|Overall Study|Death|16|||
124854224|NCT04177108|449087733|FG001|Overall Study|Death|19|||
124854225|NCT04177108|449087734|FG002|Overall Study|Death|13|||
124854226|NCT04177108|449087735|FG003|Overall Study|Death|17|||
124854227|NCT04177108|449087736|FG004|Overall Study|Death|18|||
124854228|NCT01827904|449087740|FG000|Main Study|Withdrawal by Subject|1|||
124854229|NCT01827904|449087741|FG001|Main Study|Withdrawal by Subject|0|||
124854230|NCT01827904|449087742|FG002|Main Study|Withdrawal by Subject|0|||
124854231|NCT01827904|449087740|FG000|Main Study|Adverse Event|1|||
124854232|NCT01827904|449087741|FG001|Main Study|Adverse Event|0|||
124854233|NCT01827904|449087742|FG002|Main Study|Adverse Event|0|||
124854234|NCT01827904|449087740|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
124854235|NCT01827904|449087741|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
124854236|NCT01827904|449087742|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
124854237|NCT01827904|449087740|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
124854238|NCT01827904|449087741|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
124854239|NCT01827904|449087742|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
124854240|NCT01827904|449087740|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
124854241|NCT01827904|449087741|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
124854242|NCT01827904|449087742|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
124854243|NCT01827904|449087740|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
124854244|NCT01827904|449087741|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
124854245|NCT01827904|449087742|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
124854246|NCT01827904|449087740|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
124854247|NCT01827904|449087741|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
124854248|NCT01827904|449087742|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
124854249|NCT01827904|449087740|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
124854250|NCT01827904|449087741|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
124854251|NCT01827904|449087742|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
124854252|NCT01827904|449087740|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
124854253|NCT01827904|449087741|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
124854254|NCT01827904|449087742|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
124854255|NCT01827904|449087740|FG000|Long-term Annual Follow-up|Physician Decision|1|||
124854256|NCT01827904|449087741|FG001|Long-term Annual Follow-up|Physician Decision|0|||
124854257|NCT01827904|449087742|FG002|Long-term Annual Follow-up|Physician Decision|0|||
124854258|NCT01827904|449087740|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
124854259|NCT01827904|449087741|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
124854260|NCT01827904|449087742|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
124854261|NCT01827904|449087740|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
124854262|NCT01827904|449087741|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
124854263|NCT01827904|449087742|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
124854264|NCT00101101|449087743|FG000|Overall Study|never received vaccine|20|||
124854265|NCT01800903|449087744|FG000|Second Test Period|unable to catheterise|1|||
124854266|NCT01800903|449087745|FG001|Second Test Period|unable to catheterise|0|||
124854267|NCT01800903|449087746|FG002|Second Test Period|unable to catheterise|0|||
124854268|NCT01800903|449087747|FG003|Second Test Period|unable to catheterise|0|||
124854269|NCT01800903|449087748|FG004|Second Test Period|unable to catheterise|0|||
124854270|NCT01800903|449087749|FG005|Second Test Period|unable to catheterise|0|||
124854271|NCT01181895|449087753|FG000|Overall Study|Adverse Event|3|||
124854272|NCT01181895|449087754|FG001|Overall Study|Adverse Event|1|||
124854273|NCT01181895|449087755|FG002|Overall Study|Adverse Event|1|||
124854274|NCT01181895|449087753|FG000|Overall Study|Lack of Efficacy|8|||
124854275|NCT01181895|449087754|FG001|Overall Study|Lack of Efficacy|9|||
124854276|NCT01181895|449087755|FG002|Overall Study|Lack of Efficacy|9|||
124854277|NCT01181895|449087753|FG000|Overall Study|Protocol Violation|2|||
124854278|NCT01181895|449087754|FG001|Overall Study|Protocol Violation|1|||
124854279|NCT01181895|449087755|FG002|Overall Study|Protocol Violation|0|||
124854280|NCT01181895|449087753|FG000|Overall Study|Lost to Follow-up|0|||
124854281|NCT01181895|449087754|FG001|Overall Study|Lost to Follow-up|1|||
124854282|NCT01181895|449087755|FG002|Overall Study|Lost to Follow-up|2|||
124854283|NCT01181895|449087753|FG000|Overall Study|Investigator Discretion|1|||
124854284|NCT01181895|449087754|FG001|Overall Study|Investigator Discretion|2|||
124854285|NCT01181895|449087755|FG002|Overall Study|Investigator Discretion|1|||
124854286|NCT01181895|449087753|FG000|Overall Study|Withdrawal by Subject|3|||
124854287|NCT01181895|449087754|FG001|Overall Study|Withdrawal by Subject|0|||
124854288|NCT01181895|449087755|FG002|Overall Study|Withdrawal by Subject|5|||
124854289|NCT00766415|449087758|FG000|Overall Study|Withdrawal by Subject|0|||
124854290|NCT00766415|449087759|FG001|Overall Study|Withdrawal by Subject|1|||
124854291|NCT01312467|449087760|FG000|Overall Study|Adverse Event|4|||
124854292|NCT01312467|449087760|FG000|Overall Study|Lost to Follow-up|1|||
124854293|NCT01312467|449087760|FG000|Overall Study|Withdrawal by Subject|2|||
124854294|NCT01312467|449087760|FG000|Overall Study|Deported to country of origin|1|||
124854295|NCT01312467|449087760|FG000|Overall Study|Another medical condition|1|||
124854296|NCT01312467|449087760|FG000|Overall Study|Ineligible|4|||
124854297|NCT02752048|449087763|FG000|Overall Study|Withdrawal by Subject|0|||
124854298|NCT02752048|449087764|FG001|Overall Study|Withdrawal by Subject|0|||
124854299|NCT02752048|449087765|FG002|Overall Study|Withdrawal by Subject|3|||
124854300|NCT00898677|449087768|FG000|Overall Study|Adverse Event|0|||
124854301|NCT00898677|449087769|FG001|Overall Study|Adverse Event|0|||
124854302|NCT00898677|449087770|FG002|Overall Study|Adverse Event|1|||
124854303|NCT00898677|449087771|FG003|Overall Study|Adverse Event|0|||
124854304|NCT00898677|449087768|FG000|Overall Study|Lost to Follow-up|0|||
124854305|NCT00898677|449087769|FG001|Overall Study|Lost to Follow-up|0|||
124854306|NCT00898677|449087770|FG002|Overall Study|Lost to Follow-up|2|||
124854307|NCT00898677|449087771|FG003|Overall Study|Lost to Follow-up|0|||
124854308|NCT00898677|449087768|FG000|Overall Study|Protocol Violation|1|||
124854309|NCT00898677|449087769|FG001|Overall Study|Protocol Violation|1|||
124854310|NCT00898677|449087770|FG002|Overall Study|Protocol Violation|2|||
124854311|NCT00898677|449087771|FG003|Overall Study|Protocol Violation|0|||
124854312|NCT00898677|449087768|FG000|Overall Study|Withdrawal by Subject|0|||
124854313|NCT00898677|449087769|FG001|Overall Study|Withdrawal by Subject|0|||
124854314|NCT00898677|449087770|FG002|Overall Study|Withdrawal by Subject|0|||
124854315|NCT00898677|449087771|FG003|Overall Study|Withdrawal by Subject|1|||
124854316|NCT00898677|449087768|FG000|Overall Study|Not Treated: Adverse Event|0|||
124854317|NCT00898677|449087769|FG001|Overall Study|Not Treated: Adverse Event|2|||
124854318|NCT00898677|449087770|FG002|Overall Study|Not Treated: Adverse Event|1|||
124854319|NCT00898677|449087771|FG003|Overall Study|Not Treated: Adverse Event|0|||
124854320|NCT00898677|449087768|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
124854321|NCT00898677|449087769|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
124854322|NCT00898677|449087770|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
124854323|NCT00898677|449087771|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
124854324|NCT00898677|449087768|FG000|Overall Study|Not Treated: Pregnancy|0|||
124854325|NCT00898677|449087769|FG001|Overall Study|Not Treated: Pregnancy|0|||
124854326|NCT00898677|449087770|FG002|Overall Study|Not Treated: Pregnancy|1|||
124854327|NCT00898677|449087771|FG003|Overall Study|Not Treated: Pregnancy|0|||
124854328|NCT00898677|449087768|FG000|Overall Study|Not Treated: Protocol Violation|2|||
124854329|NCT00898677|449087769|FG001|Overall Study|Not Treated: Protocol Violation|0|||
124854330|NCT00898677|449087770|FG002|Overall Study|Not Treated: Protocol Violation|2|||
124854331|NCT00898677|449087771|FG003|Overall Study|Not Treated: Protocol Violation|0|||
124854332|NCT00898677|449087768|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
124854333|NCT00898677|449087769|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
124854334|NCT00898677|449087770|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
124854335|NCT00898677|449087771|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
124854336|NCT00898677|449087768|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
124854337|NCT00898677|449087769|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
124854338|NCT00898677|449087770|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
124854339|NCT00898677|449087771|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
124854340|NCT00898677|449087768|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
124854341|NCT00898677|449087769|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
124854342|NCT00898677|449087770|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
124854343|NCT00898677|449087771|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
124854344|NCT00898677|449087768|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
124854345|NCT00898677|449087769|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
124854346|NCT00898677|449087770|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
124854347|NCT00898677|449087771|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
124854348|NCT00898677|449087768|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
124854349|NCT00898677|449087769|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
124854350|NCT00898677|449087770|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
124854351|NCT00898677|449087771|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
124854352|NCT00898677|449087768|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
124854353|NCT00898677|449087769|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
124854354|NCT00898677|449087770|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
124854355|NCT00898677|449087771|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
124854356|NCT00898677|449087768|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
124854357|NCT00898677|449087769|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
124854358|NCT00898677|449087770|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
124854359|NCT00898677|449087771|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
124854360|NCT01850004|449087778|FG000|Overall Study|Poor/Non-compliance|1|||
124854361|NCT01850004|449087778|FG000|Overall Study|Participant Withdrew Consent|9|||
124854362|NCT01850004|449087778|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
124854363|NCT01850004|449087778|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
124854364|NCT01850004|449087778|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
124854365|NCT01850004|449087778|FG000|Overall Study|Other Reasons|2|||
124854366|NCT01850004|449087778|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
124854367|NCT01850004|449087778|FG000|Overall Study|Maximum Clinical Benefit|4|||
124854368|NCT03019536|449089563|FG000|Overall Study|Withdrawal by Subject|1|||
124854369|NCT03019536|449089564|FG001|Overall Study|Withdrawal by Subject|1|||
124854370|NCT03019536|449089565|FG002|Overall Study|Withdrawal by Subject|0|||
124854371|NCT03019536|449089563|FG000|Overall Study|Adverse Event|0|||
124854372|NCT03019536|449089564|FG001|Overall Study|Adverse Event|0|||
124854373|NCT03019536|449089565|FG002|Overall Study|Adverse Event|2|||
124854374|NCT01782131|449089568|FG000|Overall Study|Death|93|||
124854375|NCT01782131|449089569|FG001|Overall Study|Death|96|||
124854376|NCT01782131|449089568|FG000|Overall Study|Lost to Follow-up|1|||
124854377|NCT01782131|449089569|FG001|Overall Study|Lost to Follow-up|3|||
124854378|NCT01782131|449089568|FG000|Overall Study|Withdrawal by Subject|10|||
124854379|NCT01782131|449089569|FG001|Overall Study|Withdrawal by Subject|10|||
124854380|NCT01782131|449089568|FG000|Overall Study|Randomized but not treated|5|||
124854381|NCT01782131|449089569|FG001|Overall Study|Randomized but not treated|5|||
124854382|NCT01782131|449089568|FG000|Overall Study|Reason not provided|0|||
124854383|NCT01782131|449089569|FG001|Overall Study|Reason not provided|1|||
124854384|NCT01627249|449089570|FG000|Overall Study|Death|3|||
124854385|NCT01627249|449089571|FG001|Overall Study|Death|5|||
124854386|NCT01627249|449089572|FG002|Overall Study|Death|3|||
124854387|NCT01627249|449089570|FG000|Overall Study|Withdrawal by Subject|12|||
124854388|NCT01627249|449089571|FG001|Overall Study|Withdrawal by Subject|6|||
124854389|NCT01627249|449089572|FG002|Overall Study|Withdrawal by Subject|9|||
124854390|NCT01627249|449089570|FG000|Overall Study|Missed Visit|1|||
124854391|NCT01627249|449089571|FG001|Overall Study|Missed Visit|1|||
124854392|NCT01627249|449089572|FG002|Overall Study|Missed Visit|0|||
124854393|NCT00796718|449089573|FG000|Overall Study|Adverse Event|2|||
124854394|NCT00796718|449089573|FG000|Overall Study|Exclusion Criteria|1|||
124854395|NCT00796718|449089573|FG000|Overall Study|Lost to Follow-up|5|||
124854396|NCT00796718|449089573|FG000|Overall Study|Withdrawal by Informed Consent|1|||
124854397|NCT03266588|449089574|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
124854398|NCT03266588|449089575|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
124854399|NCT03266588|449089576|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
124854400|NCT03266588|449089574|FG000|Observational Period|Withdrawal by Subject|44|||
124854401|NCT03266588|449089575|FG001|Observational Period|Withdrawal by Subject|22|||
124854402|NCT03266588|449089576|FG002|Observational Period|Withdrawal by Subject|13|||
124854403|NCT03266588|449089574|FG000|Observational Period|Non-compliance|18|||
124854404|NCT03266588|449089575|FG001|Observational Period|Non-compliance|12|||
124854405|NCT03266588|449089576|FG002|Observational Period|Non-compliance|10|||
124854406|NCT03266588|449089574|FG000|Observational Period|Lost to Follow-up|8|||
124854407|NCT03266588|449089575|FG001|Observational Period|Lost to Follow-up|12|||
124854408|NCT03266588|449089576|FG002|Observational Period|Lost to Follow-up|4|||
124854409|NCT03266588|449089574|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
124854410|NCT03266588|449089575|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
124854411|NCT03266588|449089576|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
124854412|NCT03266588|449089574|FG000|Observational Period|Protocol Deviation|1|||
124854413|NCT03266588|449089575|FG001|Observational Period|Protocol Deviation|0|||
124854414|NCT03266588|449089576|FG002|Observational Period|Protocol Deviation|0|||
124854415|NCT03266588|449089574|FG000|Observational Period|Other Reasons|3|||
124854416|NCT03266588|449089575|FG001|Observational Period|Other Reasons|0|||
124854417|NCT03266588|449089576|FG002|Observational Period|Other Reasons|1|||
124854418|NCT03266588|449089574|FG000|Long-term Treatment Period|Adverse Event|33|||
124854419|NCT03266588|449089575|FG001|Long-term Treatment Period|Adverse Event|17|||
124854420|NCT03266588|449089576|FG002|Long-term Treatment Period|Adverse Event|8|||
124854421|NCT03266588|449089574|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
124854422|NCT03266588|449089575|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
124854423|NCT03266588|449089576|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
124854424|NCT03266588|449089574|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
124854425|NCT03266588|449089575|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
124854426|NCT03266588|449089576|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
124854427|NCT03266588|449089574|FG000|Long-term Treatment Period|Non-Compliance|126|||
124854428|NCT03266588|449089575|FG001|Long-term Treatment Period|Non-Compliance|57|||
124854429|NCT03266588|449089576|FG002|Long-term Treatment Period|Non-Compliance|7|||
124854430|NCT03266588|449089574|FG000|Long-term Treatment Period|Pregnancy|11|||
124854431|NCT03266588|449089575|FG001|Long-term Treatment Period|Pregnancy|5|||
124854432|NCT03266588|449089576|FG002|Long-term Treatment Period|Pregnancy|0|||
124854433|NCT03266588|449089574|FG000|Long-term Treatment Period|Protocol Deviation|17|||
124854434|NCT03266588|449089575|FG001|Long-term Treatment Period|Protocol Deviation|10|||
124854435|NCT03266588|449089576|FG002|Long-term Treatment Period|Protocol Deviation|4|||
124854436|NCT03266588|449089574|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
124854437|NCT03266588|449089575|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
124854438|NCT03266588|449089576|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
124854439|NCT03266588|449089574|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
124854440|NCT03266588|449089575|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
124854441|NCT03266588|449089576|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
124854442|NCT03266588|449089574|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
124854443|NCT03266588|449089575|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
124854444|NCT03266588|449089576|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
124854445|NCT03266588|449089574|FG000|Long-term Treatment Period|Other Reasons|5|||
124854446|NCT03266588|449089575|FG001|Long-term Treatment Period|Other Reasons|0|||
124854447|NCT03266588|449089576|FG002|Long-term Treatment Period|Other Reasons|0|||
124854448|NCT03266588|449089574|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
124854449|NCT03266588|449089575|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
124854450|NCT03266588|449089576|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
124854451|NCT02627677|449089578|FG000|Overall Study|Adverse event (not progressive disease)|1|||
124854452|NCT02627677|449089579|FG001|Overall Study|Adverse event (not progressive disease)|4|||
124854453|NCT02627677|449089580|FG002|Overall Study|Adverse event (not progressive disease)|1|||
124854454|NCT02627677|449089578|FG000|Overall Study|Progressive disease|1|||
124854455|NCT02627677|449089579|FG001|Overall Study|Progressive disease|3|||
124854456|NCT02627677|449089580|FG002|Overall Study|Progressive disease|0|||
124854457|NCT02627677|449089578|FG000|Overall Study|Lack of Efficacy|1|||
124854458|NCT02627677|449089579|FG001|Overall Study|Lack of Efficacy|2|||
124854459|NCT02627677|449089580|FG002|Overall Study|Lack of Efficacy|0|||
124854460|NCT02627677|449089578|FG000|Overall Study|Lost to Follow-up|0|||
124854461|NCT02627677|449089579|FG001|Overall Study|Lost to Follow-up|0|||
124854462|NCT02627677|449089580|FG002|Overall Study|Lost to Follow-up|1|||
124854463|NCT02627677|449089578|FG000|Overall Study|Pregnancy|0|||
124854464|NCT02627677|449089579|FG001|Overall Study|Pregnancy|1|||
124854465|NCT02627677|449089580|FG002|Overall Study|Pregnancy|0|||
124854466|NCT02627677|449089578|FG000|Overall Study|Study Terminated by Sponsor|5|||
124854467|NCT02627677|449089579|FG001|Overall Study|Study Terminated by Sponsor|10|||
124854468|NCT02627677|449089580|FG002|Overall Study|Study Terminated by Sponsor|6|||
124854469|NCT02627677|449089578|FG000|Overall Study|Physician Decision|0|||
124854470|NCT02627677|449089579|FG001|Overall Study|Physician Decision|0|||
124854471|NCT02627677|449089580|FG002|Overall Study|Physician Decision|2|||
124854472|NCT02627677|449089578|FG000|Overall Study|Withdrawal by Subject|2|||
124854473|NCT02627677|449089579|FG001|Overall Study|Withdrawal by Subject|1|||
124854474|NCT02627677|449089580|FG002|Overall Study|Withdrawal by Subject|1|||
124854475|NCT02627677|449089578|FG000|Overall Study|Reason not Specified|0|||
124854476|NCT02627677|449089579|FG001|Overall Study|Reason not Specified|0|||
124854477|NCT02627677|449089580|FG002|Overall Study|Reason not Specified|1|||
124854478|NCT02627677|449089578|FG000|Overall Study|Randomized but not Treated|1|||
124854479|NCT02627677|449089579|FG001|Overall Study|Randomized but not Treated|0|||
124854480|NCT02627677|449089580|FG002|Overall Study|Randomized but not Treated|0|||
124854481|NCT00966940|449089581|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
124854482|NCT00966940|449089582|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
124854483|NCT00966940|449089581|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
124854484|NCT00966940|449089582|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
124854485|NCT01073618|449089583|FG000|Overall Study|Death|208|||
124854486|NCT01073618|449089583|FG000|Overall Study|Adverse Event|19|||
124854487|NCT01073618|449089583|FG000|Overall Study|Other|80|||
124854488|NCT02044510|449089586|FG000|Overall Study|Adverse Event|1|||
124854489|NCT02044510|449089587|FG001|Overall Study|Adverse Event|2|||
124854490|NCT02032901|449089588|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
124854491|NCT02032901|449089589|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
124854492|NCT02032901|449089588|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
124854493|NCT02032901|449089589|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
124854494|NCT00982020|449089590|FG000|Overall Study|Adverse Event|19|||
124854495|NCT00982020|449089591|FG001|Overall Study|Adverse Event|15|||
124854496|NCT00982020|449089590|FG000|Overall Study|Withdrawal by Subject|11|||
124854497|NCT00982020|449089591|FG001|Overall Study|Withdrawal by Subject|14|||
124854498|NCT00982020|449089590|FG000|Overall Study|Lost to Follow-up|5|||
124854499|NCT00982020|449089591|FG001|Overall Study|Lost to Follow-up|11|||
124854500|NCT00982020|449089590|FG000|Overall Study|Lack of Efficacy|10|||
124854501|NCT00982020|449089591|FG001|Overall Study|Lack of Efficacy|4|||
124854502|NCT00982020|449089590|FG000|Overall Study|Parent/Caregiver Decision|5|||
124854503|NCT00982020|449089591|FG001|Overall Study|Parent/Caregiver Decision|5|||
124854504|NCT00982020|449089590|FG000|Overall Study|Treatment Non-compliance|3|||
124854505|NCT00982020|449089591|FG001|Overall Study|Treatment Non-compliance|6|||
124854506|NCT00982020|449089590|FG000|Overall Study|Physician Decision|2|||
124854507|NCT00982020|449089591|FG001|Overall Study|Physician Decision|5|||
124854508|NCT00982020|449089590|FG000|Overall Study|Entry Criteria Not Met|2|||
124854509|NCT00982020|449089591|FG001|Overall Study|Entry Criteria Not Met|1|||
124854510|NCT00982020|449089590|FG000|Overall Study|Protocol Violation|0|||
124854511|NCT00982020|449089591|FG001|Overall Study|Protocol Violation|2|||
124854512|NCT00982020|449089590|FG000|Overall Study|Clinical Relapse|0|||
124854513|NCT00982020|449089591|FG001|Overall Study|Clinical Relapse|1|||
124854514|NCT01722331|449089592|FG000|Part 1|Adverse Event|5|||
124854515|NCT01722331|449089593|FG001|Part 1|Adverse Event|0|||
124854516|NCT01722331|449089594|FG002|Part 1|Adverse Event|0|||
124854517|NCT01722331|449089595|FG003|Part 1|Adverse Event|0|||
124854518|NCT01722331|449089596|FG004|Part 1|Adverse Event|0|||
124854519|NCT01722331|449089597|FG005|Part 1|Adverse Event|0|||
124854520|NCT01722331|449089598|FG006|Part 1|Adverse Event|0|||
124854521|NCT01722331|449089592|FG000|Part 1|Lack of Efficacy|0|||
124854522|NCT01722331|449089593|FG001|Part 1|Lack of Efficacy|0|||
124854523|NCT01722331|449089594|FG002|Part 1|Lack of Efficacy|1|||
124854524|NCT01722331|449089595|FG003|Part 1|Lack of Efficacy|0|||
124854525|NCT01722331|449089596|FG004|Part 1|Lack of Efficacy|2|||
124854526|NCT01722331|449089597|FG005|Part 1|Lack of Efficacy|0|||
124854527|NCT01722331|449089598|FG006|Part 1|Lack of Efficacy|0|||
124854528|NCT01722331|449089592|FG000|Part 1|Lost to Follow-up|1|||
124854529|NCT01722331|449089593|FG001|Part 1|Lost to Follow-up|0|||
124854530|NCT01722331|449089594|FG002|Part 1|Lost to Follow-up|2|||
124854531|NCT01722331|449089595|FG003|Part 1|Lost to Follow-up|0|||
124854532|NCT01722331|449089596|FG004|Part 1|Lost to Follow-up|1|||
124854533|NCT01722331|449089597|FG005|Part 1|Lost to Follow-up|0|||
124854534|NCT01722331|449089598|FG006|Part 1|Lost to Follow-up|0|||
124854535|NCT01722331|449089592|FG000|Part 1|Physician Decision|0|||
124854536|NCT01722331|449089593|FG001|Part 1|Physician Decision|0|||
124854537|NCT01722331|449089594|FG002|Part 1|Physician Decision|3|||
124854538|NCT01722331|449089595|FG003|Part 1|Physician Decision|0|||
124854539|NCT01722331|449089596|FG004|Part 1|Physician Decision|1|||
124854540|NCT01722331|449089597|FG005|Part 1|Physician Decision|0|||
124854541|NCT01722331|449089598|FG006|Part 1|Physician Decision|0|||
124854542|NCT01722331|449089592|FG000|Part 1|Pregnancy|1|||
124854543|NCT01722331|449089593|FG001|Part 1|Pregnancy|0|||
124854544|NCT01722331|449089594|FG002|Part 1|Pregnancy|0|||
124854545|NCT01722331|449089595|FG003|Part 1|Pregnancy|0|||
124854546|NCT01722331|449089596|FG004|Part 1|Pregnancy|0|||
124854547|NCT01722331|449089597|FG005|Part 1|Pregnancy|0|||
124854548|NCT01722331|449089598|FG006|Part 1|Pregnancy|0|||
124854549|NCT01722331|449089592|FG000|Part 1|Progressive Disease|0|||
124854550|NCT01722331|449089593|FG001|Part 1|Progressive Disease|0|||
124854551|NCT01722331|449089594|FG002|Part 1|Progressive Disease|0|||
124854552|NCT01722331|449089595|FG003|Part 1|Progressive Disease|0|||
124854553|NCT01722331|449089596|FG004|Part 1|Progressive Disease|1|||
124854554|NCT01722331|449089597|FG005|Part 1|Progressive Disease|0|||
124854555|NCT01722331|449089598|FG006|Part 1|Progressive Disease|0|||
124854556|NCT01722331|449089592|FG000|Part 1|Protocol Violation|1|||
124854557|NCT01722331|449089593|FG001|Part 1|Protocol Violation|0|||
124854558|NCT01722331|449089594|FG002|Part 1|Protocol Violation|0|||
124854559|NCT01722331|449089595|FG003|Part 1|Protocol Violation|0|||
124854560|NCT01722331|449089596|FG004|Part 1|Protocol Violation|1|||
124854561|NCT01722331|449089597|FG005|Part 1|Protocol Violation|0|||
124854562|NCT01722331|449089598|FG006|Part 1|Protocol Violation|0|||
124854563|NCT01722331|449089592|FG000|Part 1|Withdrawal by Subject|2|||
124854564|NCT01722331|449089593|FG001|Part 1|Withdrawal by Subject|0|||
124854565|NCT01722331|449089594|FG002|Part 1|Withdrawal by Subject|3|||
124854566|NCT01722331|449089595|FG003|Part 1|Withdrawal by Subject|0|||
124854567|NCT01722331|449089596|FG004|Part 1|Withdrawal by Subject|3|||
124854568|NCT01722331|449089597|FG005|Part 1|Withdrawal by Subject|0|||
124854569|NCT01722331|449089598|FG006|Part 1|Withdrawal by Subject|0|||
124854570|NCT01722331|449089592|FG000|Part 2|Adverse Event|3|||
124854571|NCT01722331|449089593|FG001|Part 2|Adverse Event|0|||
124854572|NCT01722331|449089594|FG002|Part 2|Adverse Event|0|||
124854573|NCT01722331|449089595|FG003|Part 2|Adverse Event|0|||
124854574|NCT01722331|449089596|FG004|Part 2|Adverse Event|0|||
124854575|NCT01722331|449089597|FG005|Part 2|Adverse Event|1|||
124854576|NCT01722331|449089598|FG006|Part 2|Adverse Event|0|||
124854577|NCT01722331|449089592|FG000|Part 2|Lack of Efficacy|3|||
124854578|NCT01722331|449089593|FG001|Part 2|Lack of Efficacy|0|||
124854579|NCT01722331|449089594|FG002|Part 2|Lack of Efficacy|11|||
124854580|NCT01722331|449089595|FG003|Part 2|Lack of Efficacy|0|||
124854581|NCT01722331|449089596|FG004|Part 2|Lack of Efficacy|0|||
124854582|NCT01722331|449089597|FG005|Part 2|Lack of Efficacy|3|||
124854583|NCT01722331|449089598|FG006|Part 2|Lack of Efficacy|3|||
124854584|NCT01722331|449089592|FG000|Part 2|Lost to Follow-up|0|||
124854585|NCT01722331|449089593|FG001|Part 2|Lost to Follow-up|0|||
124854586|NCT01722331|449089594|FG002|Part 2|Lost to Follow-up|3|||
124854587|NCT01722331|449089595|FG003|Part 2|Lost to Follow-up|0|||
124854588|NCT01722331|449089596|FG004|Part 2|Lost to Follow-up|0|||
124854589|NCT01722331|449089597|FG005|Part 2|Lost to Follow-up|1|||
124854590|NCT01722331|449089598|FG006|Part 2|Lost to Follow-up|1|||
124854591|NCT01722331|449089592|FG000|Part 2|Non-Compliance with Study Drug|1|||
124854592|NCT01722331|449089593|FG001|Part 2|Non-Compliance with Study Drug|0|||
124854593|NCT01722331|449089594|FG002|Part 2|Non-Compliance with Study Drug|1|||
124854594|NCT01722331|449089595|FG003|Part 2|Non-Compliance with Study Drug|0|||
124854595|NCT01722331|449089596|FG004|Part 2|Non-Compliance with Study Drug|0|||
124854596|NCT01722331|449089597|FG005|Part 2|Non-Compliance with Study Drug|0|||
124854597|NCT01722331|449089598|FG006|Part 2|Non-Compliance with Study Drug|0|||
124854598|NCT01722331|449089592|FG000|Part 2|Physician Decision|0|||
124854599|NCT01722331|449089593|FG001|Part 2|Physician Decision|0|||
124854600|NCT01722331|449089594|FG002|Part 2|Physician Decision|2|||
124854601|NCT01722331|449089595|FG003|Part 2|Physician Decision|0|||
124854602|NCT01722331|449089596|FG004|Part 2|Physician Decision|0|||
124854603|NCT01722331|449089597|FG005|Part 2|Physician Decision|0|||
124854604|NCT01722331|449089598|FG006|Part 2|Physician Decision|0|||
124854605|NCT01722331|449089592|FG000|Part 2|Pregnancy|0|||
124854606|NCT01722331|449089593|FG001|Part 2|Pregnancy|0|||
124854607|NCT01722331|449089594|FG002|Part 2|Pregnancy|0|||
124854608|NCT01722331|449089595|FG003|Part 2|Pregnancy|0|||
124854609|NCT01722331|449089596|FG004|Part 2|Pregnancy|0|||
124854610|NCT01722331|449089597|FG005|Part 2|Pregnancy|1|||
124854611|NCT01722331|449089598|FG006|Part 2|Pregnancy|0|||
124854612|NCT01722331|449089592|FG000|Part 2|Progressive Disease|0|||
124854613|NCT01722331|449089593|FG001|Part 2|Progressive Disease|0|||
124854614|NCT01722331|449089594|FG002|Part 2|Progressive Disease|1|||
124854615|NCT01722331|449089595|FG003|Part 2|Progressive Disease|0|||
124854616|NCT01722331|449089596|FG004|Part 2|Progressive Disease|0|||
124854617|NCT01722331|449089597|FG005|Part 2|Progressive Disease|0|||
124854618|NCT01722331|449089598|FG006|Part 2|Progressive Disease|0|||
124854619|NCT01722331|449089592|FG000|Part 2|Protocol Violation|1|||
124854620|NCT01722331|449089593|FG001|Part 2|Protocol Violation|0|||
124854621|NCT01722331|449089594|FG002|Part 2|Protocol Violation|0|||
124854622|NCT01722331|449089595|FG003|Part 2|Protocol Violation|0|||
124854623|NCT01722331|449089596|FG004|Part 2|Protocol Violation|0|||
124854624|NCT01722331|449089597|FG005|Part 2|Protocol Violation|0|||
124854625|NCT01722331|449089598|FG006|Part 2|Protocol Violation|0|||
124854626|NCT01722331|449089592|FG000|Part 2|Withdrawal by Subject|5|||
124854627|NCT01722331|449089593|FG001|Part 2|Withdrawal by Subject|0|||
124854628|NCT01722331|449089594|FG002|Part 2|Withdrawal by Subject|3|||
124854629|NCT01722331|449089595|FG003|Part 2|Withdrawal by Subject|0|||
124854630|NCT01722331|449089596|FG004|Part 2|Withdrawal by Subject|0|||
124854631|NCT01722331|449089597|FG005|Part 2|Withdrawal by Subject|2|||
124854632|NCT01722331|449089598|FG006|Part 2|Withdrawal by Subject|2|||
124854633|NCT01722331|449089592|FG000|Part 2|Other Protocol Specified Criteria|6|||
124854634|NCT01722331|449089593|FG001|Part 2|Other Protocol Specified Criteria|0|||
124854635|NCT01722331|449089594|FG002|Part 2|Other Protocol Specified Criteria|10|||
124854636|NCT01722331|449089595|FG003|Part 2|Other Protocol Specified Criteria|0|||
124854637|NCT01722331|449089596|FG004|Part 2|Other Protocol Specified Criteria|0|||
124854638|NCT01722331|449089597|FG005|Part 2|Other Protocol Specified Criteria|2|||
124854639|NCT01722331|449089598|FG006|Part 2|Other Protocol Specified Criteria|1|||
124854640|NCT01722331|449089592|FG000|Part 3|Adverse Event|2|||
124854641|NCT01722331|449089593|FG001|Part 3|Adverse Event|2|||
124854642|NCT01722331|449089594|FG002|Part 3|Adverse Event|0|||
124854643|NCT01722331|449089595|FG003|Part 3|Adverse Event|1|||
124854644|NCT01722331|449089596|FG004|Part 3|Adverse Event|0|||
124854645|NCT01722331|449089597|FG005|Part 3|Adverse Event|0|||
124854646|NCT01722331|449089598|FG006|Part 3|Adverse Event|0|||
124854647|NCT01722331|449089592|FG000|Part 3|Death|1|||
124854648|NCT01722331|449089593|FG001|Part 3|Death|0|||
124854649|NCT01722331|449089594|FG002|Part 3|Death|0|||
124854650|NCT01722331|449089595|FG003|Part 3|Death|0|||
124854651|NCT01722331|449089596|FG004|Part 3|Death|0|||
124854652|NCT01722331|449089597|FG005|Part 3|Death|0|||
124854653|NCT01722331|449089598|FG006|Part 3|Death|0|||
124854654|NCT01722331|449089592|FG000|Part 3|Lack of Efficacy|1|||
124854655|NCT01722331|449089593|FG001|Part 3|Lack of Efficacy|0|||
124854656|NCT01722331|449089594|FG002|Part 3|Lack of Efficacy|0|||
124854657|NCT01722331|449089595|FG003|Part 3|Lack of Efficacy|0|||
124854658|NCT01722331|449089596|FG004|Part 3|Lack of Efficacy|0|||
124854659|NCT01722331|449089597|FG005|Part 3|Lack of Efficacy|0|||
124854660|NCT01722331|449089598|FG006|Part 3|Lack of Efficacy|0|||
124854661|NCT01722331|449089592|FG000|Part 3|Lost to Follow-up|3|||
124854662|NCT01722331|449089593|FG001|Part 3|Lost to Follow-up|4|||
124854663|NCT01722331|449089594|FG002|Part 3|Lost to Follow-up|0|||
124854664|NCT01722331|449089595|FG003|Part 3|Lost to Follow-up|0|||
124854665|NCT01722331|449089596|FG004|Part 3|Lost to Follow-up|0|||
124854666|NCT01722331|449089597|FG005|Part 3|Lost to Follow-up|1|||
124854667|NCT01722331|449089598|FG006|Part 3|Lost to Follow-up|0|||
124854668|NCT01722331|449089592|FG000|Part 3|Non-Compliance with Study Drug|0|||
124854669|NCT01722331|449089593|FG001|Part 3|Non-Compliance with Study Drug|1|||
124854670|NCT01722331|449089594|FG002|Part 3|Non-Compliance with Study Drug|0|||
124854671|NCT01722331|449089595|FG003|Part 3|Non-Compliance with Study Drug|0|||
124854672|NCT01722331|449089596|FG004|Part 3|Non-Compliance with Study Drug|0|||
124854673|NCT01722331|449089597|FG005|Part 3|Non-Compliance with Study Drug|0|||
124854674|NCT01722331|449089598|FG006|Part 3|Non-Compliance with Study Drug|0|||
124854675|NCT01722331|449089592|FG000|Part 3|Physician Decision|1|||
124854676|NCT01722331|449089593|FG001|Part 3|Physician Decision|1|||
124854677|NCT01722331|449089594|FG002|Part 3|Physician Decision|0|||
124854678|NCT01722331|449089595|FG003|Part 3|Physician Decision|0|||
124854679|NCT01722331|449089596|FG004|Part 3|Physician Decision|0|||
124854680|NCT01722331|449089597|FG005|Part 3|Physician Decision|0|||
124854681|NCT01722331|449089598|FG006|Part 3|Physician Decision|1|||
124854682|NCT01722331|449089592|FG000|Part 3|Protocol Violation|2|||
124854683|NCT01722331|449089593|FG001|Part 3|Protocol Violation|1|||
124854684|NCT01722331|449089594|FG002|Part 3|Protocol Violation|0|||
124854685|NCT01722331|449089595|FG003|Part 3|Protocol Violation|0|||
124854686|NCT01722331|449089596|FG004|Part 3|Protocol Violation|0|||
124854687|NCT01722331|449089597|FG005|Part 3|Protocol Violation|0|||
124854688|NCT01722331|449089598|FG006|Part 3|Protocol Violation|0|||
124854689|NCT01722331|449089592|FG000|Part 3|Withdrawal by Subject|4|||
124854690|NCT01722331|449089593|FG001|Part 3|Withdrawal by Subject|7|||
124854691|NCT01722331|449089594|FG002|Part 3|Withdrawal by Subject|0|||
124854692|NCT01722331|449089595|FG003|Part 3|Withdrawal by Subject|0|||
124854693|NCT01722331|449089596|FG004|Part 3|Withdrawal by Subject|0|||
124854694|NCT01722331|449089597|FG005|Part 3|Withdrawal by Subject|2|||
124854695|NCT01722331|449089598|FG006|Part 3|Withdrawal by Subject|1|||
124854696|NCT01722331|449089592|FG000|Part 3|Other Protocol Specified Criteria|1|||
124854697|NCT01722331|449089593|FG001|Part 3|Other Protocol Specified Criteria|1|||
124854698|NCT01722331|449089594|FG002|Part 3|Other Protocol Specified Criteria|0|||
124854699|NCT01722331|449089595|FG003|Part 3|Other Protocol Specified Criteria|0|||
124854700|NCT01722331|449089596|FG004|Part 3|Other Protocol Specified Criteria|0|||
124854701|NCT01722331|449089597|FG005|Part 3|Other Protocol Specified Criteria|0|||
124854702|NCT01722331|449089598|FG006|Part 3|Other Protocol Specified Criteria|0|||
124854703|NCT00262834|449089599|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
124854704|NCT00262834|449089600|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
124854705|NCT00003457|449089601|FG000|Overall Study|Not evaluable|9|||
124854706|NCT02246998|449089605|FG000|Overall Study|Adverse Event|0|||
124854707|NCT02246998|449089606|FG001|Overall Study|Adverse Event|1|||
124854708|NCT02246998|449089607|FG002|Overall Study|Adverse Event|1|||
124854709|NCT02246998|449089608|FG003|Overall Study|Adverse Event|0|||
124854710|NCT02246998|449089605|FG000|Overall Study|Lost to Follow-up|1|||
124854711|NCT02246998|449089606|FG001|Overall Study|Lost to Follow-up|0|||
124854712|NCT02246998|449089607|FG002|Overall Study|Lost to Follow-up|0|||
124854713|NCT02246998|449089608|FG003|Overall Study|Lost to Follow-up|1|||
124854714|NCT02246998|449089605|FG000|Overall Study|Randomized but Never Dosed|1|||
124854715|NCT02246998|449089606|FG001|Overall Study|Randomized but Never Dosed|2|||
124854716|NCT02246998|449089607|FG002|Overall Study|Randomized but Never Dosed|2|||
124854717|NCT02246998|449089608|FG003|Overall Study|Randomized but Never Dosed|1|||
124854718|NCT02525133|449089611|FG000|Overall Study|Adverse Event|0|||
124854719|NCT02525133|449089612|FG001|Overall Study|Adverse Event|1|||
124854720|NCT02525133|449089611|FG000|Overall Study|Death|0|||
124854721|NCT02525133|449089612|FG001|Overall Study|Death|1|||
124854722|NCT02525133|449089611|FG000|Overall Study|did not meet randomization criteria|1|||
124854723|NCT02525133|449089612|FG001|Overall Study|did not meet randomization criteria|0|||
124854724|NCT02525133|449089611|FG000|Overall Study|Lost to Follow-up|5|||
124854725|NCT02525133|449089612|FG001|Overall Study|Lost to Follow-up|1|||
124854726|NCT02525133|449089611|FG000|Overall Study|randomized not enrolled|3|||
124854727|NCT02525133|449089612|FG001|Overall Study|randomized not enrolled|0|||
124854728|NCT02525133|449089611|FG000|Overall Study|Withdrawal by Subject|1|||
124854729|NCT02525133|449089612|FG001|Overall Study|Withdrawal by Subject|0|||
124854730|NCT01343082|449089613|FG000|The run-in Period|Not meeting criteria|3|||
124854731|NCT01343082|449089614|FG001|The run-in Period|Not meeting criteria|4|||
124854732|NCT01343082|449089615|FG002|The run-in Period|Not meeting criteria|5|||
124854733|NCT01343082|449089613|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
124854734|NCT01343082|449089614|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
124854735|NCT01343082|449089615|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
124854736|NCT01343082|449089613|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
124854737|NCT01343082|449089614|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
124854738|NCT01343082|449089615|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
124854739|NCT01343082|449089613|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
124854740|NCT01343082|449089614|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
124854741|NCT01343082|449089615|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
124854742|NCT01343082|449089613|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
124854743|NCT01343082|449089614|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
124854744|NCT01343082|449089615|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
124854745|NCT01075074|449089616|FG000|Overall Study|Surgeon changed to open incisional case|1|||
124854746|NCT01075074|449089617|FG001|Overall Study|Surgeon changed to open incisional case|2|||
124854747|NCT01075074|449089618|FG002|Overall Study|Surgeon changed to open incisional case|2|||
124854748|NCT04265755|449089619|FG000|Overall Study|Withdrawal by Subject|39|||
124854749|NCT04265755|449089619|FG000|Overall Study|Decision by sponsor|2|||
124854750|NCT04265755|449089619|FG000|Overall Study|Lost to Follow-up|11|||
124854751|NCT04265755|449089619|FG000|Overall Study|Death|1|||
124854752|NCT01575561|449089620|FG000|Overall Study|Adverse Event|9|||
124854753|NCT01575561|449089620|FG000|Overall Study|Lack of Efficacy|8|||
124854754|NCT01575561|449089620|FG000|Overall Study|Lost to Follow-up|6|||
124854755|NCT01575561|449089620|FG000|Overall Study|Protocol Violation|4|||
124854756|NCT01575561|449089620|FG000|Overall Study|Withdrawal by Subject|11|||
124854757|NCT01575561|449089620|FG000|Overall Study|administration|1|||
124854758|NCT02496884|449089621|FG000|Overall Study|Counted twice as enrolled|2|||
124854759|NCT02496884|449089622|FG001|Overall Study|Counted twice as enrolled|0|||
124854760|NCT02496884|449089623|FG002|Overall Study|Counted twice as enrolled|0|||
124854761|NCT02496884|449089624|FG003|Overall Study|Counted twice as enrolled|0|||
124854762|NCT02496884|449089621|FG000|Overall Study|Withdrawal by Subject|0|||
124854763|NCT02496884|449089622|FG001|Overall Study|Withdrawal by Subject|3|||
124854764|NCT02496884|449089623|FG002|Overall Study|Withdrawal by Subject|0|||
124854765|NCT02496884|449089624|FG003|Overall Study|Withdrawal by Subject|0|||
124854766|NCT02956629|449089625|FG000|Overall Study|Adverse Event|0|||
124854767|NCT02956629|449089626|FG001|Overall Study|Adverse Event|0|||
124854768|NCT02956629|449089627|FG002|Overall Study|Adverse Event|1|||
124854769|NCT02956629|449089628|FG003|Overall Study|Adverse Event|0|||
124854770|NCT02956629|449089629|FG004|Overall Study|Adverse Event|0|||
124854771|NCT02956629|449089630|FG005|Overall Study|Adverse Event|0|||
124854772|NCT02956629|449089625|FG000|Overall Study|Lost to Follow-up|2|||
124854773|NCT02956629|449089626|FG001|Overall Study|Lost to Follow-up|5|||
124854774|NCT02956629|449089627|FG002|Overall Study|Lost to Follow-up|3|||
124854775|NCT02956629|449089628|FG003|Overall Study|Lost to Follow-up|1|||
124854776|NCT02956629|449089629|FG004|Overall Study|Lost to Follow-up|0|||
124854777|NCT02956629|449089630|FG005|Overall Study|Lost to Follow-up|1|||
124854778|NCT02956629|449089625|FG000|Overall Study|Withdrawal by Subject|3|||
124854779|NCT02956629|449089626|FG001|Overall Study|Withdrawal by Subject|1|||
124854780|NCT02956629|449089627|FG002|Overall Study|Withdrawal by Subject|0|||
124854781|NCT02956629|449089628|FG003|Overall Study|Withdrawal by Subject|0|||
124854782|NCT02956629|449089629|FG004|Overall Study|Withdrawal by Subject|0|||
124854783|NCT02956629|449089630|FG005|Overall Study|Withdrawal by Subject|0|||
124854784|NCT01762761|449089633|FG000|Overall Study|Adverse Event|15|||
124854785|NCT01762761|449089634|FG001|Overall Study|Adverse Event|17|||
124854786|NCT01762761|449089633|FG000|Overall Study|Lack of Efficacy|9|||
124854787|NCT01762761|449089634|FG001|Overall Study|Lack of Efficacy|25|||
124854788|NCT01762761|449089633|FG000|Overall Study|Protocol Violation|1|||
124854789|NCT01762761|449089634|FG001|Overall Study|Protocol Violation|1|||
124854790|NCT01762761|449089633|FG000|Overall Study|Study closed/terminated|0|||
124854791|NCT01762761|449089634|FG001|Overall Study|Study closed/terminated|2|||
124854792|NCT01762761|449089633|FG000|Overall Study|Lost to Follow-up|3|||
124854793|NCT01762761|449089634|FG001|Overall Study|Lost to Follow-up|6|||
124854794|NCT01762761|449089633|FG000|Overall Study|Physician Decision|4|||
124854795|NCT01762761|449089634|FG001|Overall Study|Physician Decision|6|||
124854796|NCT01762761|449089633|FG000|Overall Study|Withdrawal by Subject|7|||
124854797|NCT01762761|449089634|FG001|Overall Study|Withdrawal by Subject|8|||
124854798|NCT00795600|449089641|FG000|Overall Study|Adverse Event|1|||
124854799|NCT00795600|449089642|FG001|Overall Study|Adverse Event|1|||
124854800|NCT00795600|449089641|FG000|Overall Study|Protocol Violation|1|||
124854801|NCT00795600|449089642|FG001|Overall Study|Protocol Violation|2|||
124854802|NCT00795600|449089641|FG000|Overall Study|Withdrawal by Subject|1|||
124854803|NCT00795600|449089642|FG001|Overall Study|Withdrawal by Subject|0|||
124854804|NCT00795600|449089641|FG000|Overall Study|Unclassified|1|||
124854805|NCT00795600|449089642|FG001|Overall Study|Unclassified|1|||
124854806|NCT03936244|449089643|FG000|Overall Study|Lost to Follow-up|5|||
124854807|NCT03936244|449089644|FG001|Overall Study|Lost to Follow-up|1|||
124854808|NCT03936244|449089643|FG000|Overall Study|Physician Decision|7|||
124854809|NCT03936244|449089644|FG001|Overall Study|Physician Decision|3|||
124854810|NCT01046110|449089645|FG000|Overall Study|Adverse Event|9|||
124854811|NCT01046110|449089646|FG001|Overall Study|Adverse Event|2|||
124854812|NCT01046110|449089645|FG000|Overall Study|Lack of Efficacy|0|||
124854813|NCT01046110|449089646|FG001|Overall Study|Lack of Efficacy|1|||
124854814|NCT01046110|449089645|FG000|Overall Study|Protocol Violation|7|||
124854815|NCT01046110|449089646|FG001|Overall Study|Protocol Violation|12|||
124854816|NCT01046110|449089645|FG000|Overall Study|Withdrawal Criteria|3|||
124854817|NCT01046110|449089646|FG001|Overall Study|Withdrawal Criteria|5|||
124854818|NCT01046110|449089645|FG000|Overall Study|Unclassified|36|||
124854819|NCT01046110|449089646|FG001|Overall Study|Unclassified|35|||
124854820|NCT02013765|449089651|FG000|Overall Study|Trial was terminated by sponsor|1|||
124854821|NCT01430130|449089662|FG000|Overall Study|Lost to Follow-up|1|||
124854822|NCT01430130|449089662|FG000|Overall Study|Infection on Control Side of Incision|1|||
124854823|NCT01751568|449089664|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
124854824|NCT01751568|449089665|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
124854825|NCT01751568|449089666|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
124854826|NCT04079933|449089667|FG000|Overall Study|Withdrawal by Subject|3|||
124854827|NCT04079933|449089668|FG001|Overall Study|Withdrawal by Subject|4|||
124854828|NCT04079933|449089667|FG000|Overall Study|Lost to Follow-up|0|||
124854829|NCT04079933|449089668|FG001|Overall Study|Lost to Follow-up|1|||
124854830|NCT01229436|449089669|FG000|Overall Study|Withdrawal by Subject|2|||
124854831|NCT01229436|449089669|FG000|Overall Study|Lost to Follow-up|3|||
124854832|NCT05101252|449089670|FG000|Overall Study|Unsatisfactory Test Article|1|||
124854833|NCT05101252|449089671|FG001|Overall Study|Unsatisfactory Test Article|0|||
124854834|NCT05101252|449089670|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
124854835|NCT05101252|449089671|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
124854836|NCT05101252|449089670|FG000|Overall Study|Withdrew Consent during study|0|||
124854837|NCT05101252|449089671|FG001|Overall Study|Withdrew Consent during study|1|||
124854838|NCT05101252|449089670|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
124854839|NCT05101252|449089671|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
124854840|NCT01459796|449089672|FG000|Overall Study|Non compliance with protocol|2|||
124854841|NCT01459796|449089673|FG001|Overall Study|Non compliance with protocol|4|||
124854842|NCT01459796|449089672|FG000|Overall Study|Adverse Event|5|||
124854843|NCT01459796|449089673|FG001|Overall Study|Adverse Event|5|||
124854844|NCT01459796|449089672|FG000|Overall Study|Withdrawal by Subject|6|||
124854845|NCT01459796|449089673|FG001|Overall Study|Withdrawal by Subject|3|||
124854846|NCT01459796|449089672|FG000|Overall Study|Lost to Follow-up|5|||
124854847|NCT01459796|449089673|FG001|Overall Study|Lost to Follow-up|4|||
124854848|NCT01459796|449089672|FG000|Overall Study|Reason unspecified|1|||
124854849|NCT01459796|449089673|FG001|Overall Study|Reason unspecified|2|||
124854850|NCT01459796|449089672|FG000|Overall Study|Decision by the sponsor|75|||
124854851|NCT01459796|449089673|FG001|Overall Study|Decision by the sponsor|108|||
124854852|NCT00345579|449089677|FG000|Overall Study|Adverse Event|9|||
124854853|NCT00345579|449089678|FG001|Overall Study|Adverse Event|6|||
124854854|NCT00345579|449089677|FG000|Overall Study|Protocol Violation|14|||
124854855|NCT00345579|449089678|FG001|Overall Study|Protocol Violation|5|||
124854856|NCT00345579|449089677|FG000|Overall Study|Withdrawal by Subject|50|||
124854857|NCT00345579|449089678|FG001|Overall Study|Withdrawal by Subject|17|||
124854858|NCT00345579|449089677|FG000|Overall Study|Lost to Follow-up|82|||
124854859|NCT00345579|449089678|FG001|Overall Study|Lost to Follow-up|36|||
124854860|NCT00345579|449089677|FG000|Overall Study|Other|9|||
124854861|NCT00345579|449089678|FG001|Overall Study|Other|1|||
124854862|NCT01731171|449089679|FG000|Overall Study|Withdrawal by Subject|4|||
124854863|NCT01731171|449089680|FG001|Overall Study|Withdrawal by Subject|1|||
124854864|NCT01731171|449089679|FG000|Overall Study|Lost to Follow-up|3|||
124854865|NCT01731171|449089680|FG001|Overall Study|Lost to Follow-up|2|||
124854866|NCT01731171|449089679|FG000|Overall Study|Moved out of Area|0|||
124854867|NCT01731171|449089680|FG001|Overall Study|Moved out of Area|2|||
124854868|NCT01731171|449089679|FG000|Overall Study|Terminated for Lack of Adherence|0|||
124854869|NCT01731171|449089680|FG001|Overall Study|Terminated for Lack of Adherence|1|||
124854870|NCT01731171|449089679|FG000|Overall Study|Terminated for Safety Reasons|0|||
124854871|NCT01731171|449089680|FG001|Overall Study|Terminated for Safety Reasons|1|||
124854872|NCT00413413|449089681|FG000|Single-Blind|Adverse Event|0|||
124854873|NCT00413413|449089682|FG001|Single-Blind|Adverse Event|9|||
124854874|NCT00413413|449089683|FG002|Single-Blind|Adverse Event|0|||
124854875|NCT00413413|449089681|FG000|Single-Blind|Lack of Efficacy|0|||
124854876|NCT00413413|449089682|FG001|Single-Blind|Lack of Efficacy|5|||
124854877|NCT00413413|449089683|FG002|Single-Blind|Lack of Efficacy|0|||
124854878|NCT00413413|449089681|FG000|Single-Blind|Subject no longer requires study drug|0|||
124854879|NCT00413413|449089682|FG001|Single-Blind|Subject no longer requires study drug|151|||
124854880|NCT00413413|449089683|FG002|Single-Blind|Subject no longer requires study drug|0|||
124854881|NCT00413413|449089681|FG000|Single-Blind|Protocol Violation|0|||
124854882|NCT00413413|449089682|FG001|Single-Blind|Protocol Violation|16|||
124854883|NCT00413413|449089683|FG002|Single-Blind|Protocol Violation|0|||
124854884|NCT00413413|449089681|FG000|Single-Blind|Withdrawal by Subject|0|||
124854885|NCT00413413|449089682|FG001|Single-Blind|Withdrawal by Subject|27|||
124854886|NCT00413413|449089683|FG002|Single-Blind|Withdrawal by Subject|0|||
124854887|NCT00413413|449089681|FG000|Single-Blind|Lost to Follow-up|0|||
124854888|NCT00413413|449089682|FG001|Single-Blind|Lost to Follow-up|8|||
124854889|NCT00413413|449089683|FG002|Single-Blind|Lost to Follow-up|0|||
124854890|NCT00413413|449089681|FG000|Double-Blind|Adverse Event|6|||
124854891|NCT00413413|449089682|FG001|Double-Blind|Adverse Event|0|||
124854892|NCT00413413|449089683|FG002|Double-Blind|Adverse Event|5|||
124854893|NCT00413413|449089681|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
124854894|NCT00413413|449089682|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
124854895|NCT00413413|449089683|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
124854896|NCT00413413|449089681|FG000|Double-Blind|Protocol deviation|1|||
124854897|NCT00413413|449089682|FG001|Double-Blind|Protocol deviation|2|||
124854898|NCT00413413|449089683|FG002|Double-Blind|Protocol deviation|1|||
124854899|NCT00413413|449089681|FG000|Double-Blind|Subject withdrew consent|4|||
124854900|NCT00413413|449089682|FG001|Double-Blind|Subject withdrew consent|6|||
124854901|NCT00413413|449089683|FG002|Double-Blind|Subject withdrew consent|9|||
124854902|NCT00413413|449089681|FG000|Double-Blind|Lost to Follow-up|3|||
124854903|NCT00413413|449089682|FG001|Double-Blind|Lost to Follow-up|4|||
124854904|NCT00413413|449089683|FG002|Double-Blind|Lost to Follow-up|2|||
124854905|NCT02604589|449089690|FG000|Overall Study|catheter dislodgement|0|||
124854906|NCT02604589|449089691|FG001|Overall Study|catheter dislodgement|0|||
124854907|NCT02604589|449089692|FG002|Overall Study|catheter dislodgement|1|||
124854908|NCT01592708|449089708|FG000|Overall Study|Protocol Violation|3|||
124854909|NCT01592708|449089709|FG001|Overall Study|Protocol Violation|0|||
124854910|NCT03136068|449091789|FG000|Overall Study|Lost to Follow-up|1|||
124854911|NCT03136068|449091790|FG001|Overall Study|Lost to Follow-up|1|||
124854912|NCT03136068|449091789|FG000|Overall Study|Protocol Violation|1|||
124854913|NCT03136068|449091790|FG001|Overall Study|Protocol Violation|0|||
124854914|NCT00432380|449091796|FG000|Overall Study|Migrated/moved from study area|3|||
124854915|NCT00432380|449091797|FG001|Overall Study|Migrated/moved from study area|4|||
124854916|NCT00432380|449091798|FG002|Overall Study|Migrated/moved from study area|1|||
124854917|NCT00432380|449091796|FG000|Overall Study|Adverse Event|1|||
124854918|NCT00432380|449091797|FG001|Overall Study|Adverse Event|0|||
124854919|NCT00432380|449091798|FG002|Overall Study|Adverse Event|0|||
124854920|NCT01071395|449091806|FG000|Overall Study|Withdrawal by Subject|2|||
124854921|NCT01071395|449091807|FG001|Overall Study|Withdrawal by Subject|1|||
124854922|NCT01071395|449091806|FG000|Overall Study|Adverse Event|3|||
124854923|NCT01071395|449091807|FG001|Overall Study|Adverse Event|1|||
124854924|NCT01539291|449091808|FG000|Study GS-US-312-0116|Adverse Event|9|||
124854925|NCT01539291|449091809|FG001|Study GS-US-312-0116|Adverse Event|0|||
124854926|NCT01539291|449091810|FG002|Study GS-US-312-0116|Adverse Event|0|||
124854927|NCT01539291|449091811|FG003|Study GS-US-312-0116|Adverse Event|0|||
124854928|NCT01539291|449091808|FG000|Study GS-US-312-0116|Physician Decision|1|||
124854929|NCT01539291|449091809|FG001|Study GS-US-312-0116|Physician Decision|0|||
124854930|NCT01539291|449091810|FG002|Study GS-US-312-0116|Physician Decision|0|||
124854931|NCT01539291|449091811|FG003|Study GS-US-312-0116|Physician Decision|0|||
124854932|NCT01539291|449091808|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
124854933|NCT01539291|449091809|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
124854934|NCT01539291|449091810|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
124854935|NCT01539291|449091811|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
124854936|NCT01539291|449091808|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
124854937|NCT01539291|449091809|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
124854938|NCT01539291|449091810|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
124854939|NCT01539291|449091811|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
124854940|NCT01539291|449091808|FG000|Study GS-US-312-0116|Other|1|||
124854941|NCT01539291|449091809|FG001|Study GS-US-312-0116|Other|0|||
124854942|NCT01539291|449091810|FG002|Study GS-US-312-0116|Other|0|||
124854943|NCT01539291|449091811|FG003|Study GS-US-312-0116|Other|0|||
124854944|NCT01539291|449091808|FG000|Study GS-US-312-0117|Adverse Event|22|||
124854945|NCT01539291|449091809|FG001|Study GS-US-312-0117|Adverse Event|1|||
124854946|NCT01539291|449091810|FG002|Study GS-US-312-0117|Adverse Event|9|||
124854947|NCT01539291|449091811|FG003|Study GS-US-312-0117|Adverse Event|12|||
124854948|NCT01539291|449091808|FG000|Study GS-US-312-0117|Physician Decision|9|||
124854949|NCT01539291|449091809|FG001|Study GS-US-312-0117|Physician Decision|0|||
124854950|NCT01539291|449091810|FG002|Study GS-US-312-0117|Physician Decision|6|||
124854951|NCT01539291|449091811|FG003|Study GS-US-312-0117|Physician Decision|4|||
124854952|NCT01539291|449091808|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
124854953|NCT01539291|449091809|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
124854954|NCT01539291|449091810|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
124854955|NCT01539291|449091811|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
124854956|NCT01539291|449091808|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
124854957|NCT01539291|449091809|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
124854958|NCT01539291|449091810|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
124854959|NCT01539291|449091811|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
124854960|NCT01539291|449091808|FG000|Study GS-US-312-0117|Other|2|||
124854961|NCT01539291|449091809|FG001|Study GS-US-312-0117|Other|1|||
124854962|NCT01539291|449091810|FG002|Study GS-US-312-0117|Other|1|||
124854963|NCT01539291|449091811|FG003|Study GS-US-312-0117|Other|1|||
124854964|NCT02239510|449091812|FG000|Overall Study|Lost to Follow-up|2|||
124854965|NCT02239510|449091813|FG001|Overall Study|Lost to Follow-up|1|||
124854966|NCT00466193|449091814|FG000|Overall Study|Adverse Event|0|||
124854967|NCT00466193|449091815|FG001|Overall Study|Adverse Event|1|||
124854968|NCT00466193|449091814|FG000|Overall Study|Lost to Follow-up|2|||
124854969|NCT00466193|449091815|FG001|Overall Study|Lost to Follow-up|4|||
124854970|NCT00466193|449091814|FG000|Overall Study|Physician Decision|1|||
124854971|NCT00466193|449091815|FG001|Overall Study|Physician Decision|0|||
124854972|NCT00466193|449091814|FG000|Overall Study|Protocol Violation|1|||
124854973|NCT00466193|449091815|FG001|Overall Study|Protocol Violation|1|||
124854974|NCT00466193|449091814|FG000|Overall Study|Withdrawal by Subject|7|||
124854975|NCT00466193|449091815|FG001|Overall Study|Withdrawal by Subject|2|||
124854976|NCT00466193|449091814|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
124854977|NCT00466193|449091815|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
124854978|NCT01054729|449091816|FG000|Overall Study|Randomized but Not Treated|0|||
124854979|NCT01054729|449091817|FG001|Overall Study|Randomized but Not Treated|1|||
124854980|NCT01054729|449091818|FG002|Overall Study|Randomized but Not Treated|0|||
124854981|NCT01054729|449091819|FG003|Overall Study|Randomized but Not Treated|0|||
124854982|NCT01054729|449091816|FG000|Overall Study|Adverse Event|1|||
124854983|NCT01054729|449091817|FG001|Overall Study|Adverse Event|1|||
124854984|NCT01054729|449091818|FG002|Overall Study|Adverse Event|2|||
124854985|NCT01054729|449091819|FG003|Overall Study|Adverse Event|1|||
124854986|NCT01054729|449091816|FG000|Overall Study|Withdrawal by Subject|1|||
124854987|NCT01054729|449091817|FG001|Overall Study|Withdrawal by Subject|0|||
124854988|NCT01054729|449091818|FG002|Overall Study|Withdrawal by Subject|1|||
124854989|NCT01054729|449091819|FG003|Overall Study|Withdrawal by Subject|0|||
124854990|NCT01054729|449091816|FG000|Overall Study|Lost to Follow-up|0|||
124854991|NCT01054729|449091817|FG001|Overall Study|Lost to Follow-up|1|||
124854992|NCT01054729|449091818|FG002|Overall Study|Lost to Follow-up|0|||
124854993|NCT01054729|449091819|FG003|Overall Study|Lost to Follow-up|0|||
124854994|NCT01054729|449091816|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
124854995|NCT01054729|449091817|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
124854996|NCT01054729|449091818|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
124854997|NCT01054729|449091819|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
124854998|NCT01054729|449091816|FG000|Overall Study|Non-responder|1|||
124854999|NCT01054729|449091817|FG001|Overall Study|Non-responder|0|||
124855000|NCT01054729|449091818|FG002|Overall Study|Non-responder|1|||
124855001|NCT01054729|449091819|FG003|Overall Study|Non-responder|1|||
124855002|NCT01054729|449091816|FG000|Overall Study|PEG/RBV Non-responder|1|||
124855003|NCT01054729|449091817|FG001|Overall Study|PEG/RBV Non-responder|0|||
124855004|NCT01054729|449091818|FG002|Overall Study|PEG/RBV Non-responder|1|||
124855005|NCT01054729|449091819|FG003|Overall Study|PEG/RBV Non-responder|0|||
124855006|NCT01054729|449091816|FG000|Overall Study|Personal/Obligations|0|||
124855007|NCT01054729|449091817|FG001|Overall Study|Personal/Obligations|1|||
124855008|NCT01054729|449091818|FG002|Overall Study|Personal/Obligations|0|||
124855009|NCT01054729|449091819|FG003|Overall Study|Personal/Obligations|0|||
124855010|NCT01054729|449091816|FG000|Overall Study|Subject moved|0|||
124855011|NCT01054729|449091817|FG001|Overall Study|Subject moved|0|||
124855012|NCT01054729|449091818|FG002|Overall Study|Subject moved|1|||
124855013|NCT01054729|449091819|FG003|Overall Study|Subject moved|0|||
124855014|NCT01054729|449091816|FG000|Overall Study|Lack of Efficacy|0|||
124855015|NCT01054729|449091817|FG001|Overall Study|Lack of Efficacy|0|||
124855016|NCT01054729|449091818|FG002|Overall Study|Lack of Efficacy|0|||
124855017|NCT01054729|449091819|FG003|Overall Study|Lack of Efficacy|1|||
124855018|NCT01375049|449091820|FG000|Overall Study|Adverse Event|2|||
124855019|NCT01375049|449091820|FG000|Overall Study|Lost to Follow-up|1|||
124855020|NCT01375049|449091820|FG000|Overall Study|Withdrawal by Subject|2|||
124855021|NCT01375049|449091820|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
124855022|NCT01175382|449091823|FG000|Overall Study|Lost to Follow-up|4|||
124855023|NCT01175382|449091824|FG001|Overall Study|Lost to Follow-up|3|||
124855024|NCT01175382|449091825|FG002|Overall Study|Lost to Follow-up|1|||
124855025|NCT01175382|449091823|FG000|Overall Study|Physician Decision|0|||
124855026|NCT01175382|449091824|FG001|Overall Study|Physician Decision|1|||
124855027|NCT01175382|449091825|FG002|Overall Study|Physician Decision|0|||
124855028|NCT01175382|449091823|FG000|Overall Study|Withdrawal by Subject|0|||
124855029|NCT01175382|449091824|FG001|Overall Study|Withdrawal by Subject|0|||
124855030|NCT01175382|449091825|FG002|Overall Study|Withdrawal by Subject|1|||
124855031|NCT01175382|449091823|FG000|Overall Study|No longer having problem|1|||
124855032|NCT01175382|449091824|FG001|Overall Study|No longer having problem|0|||
124855033|NCT01175382|449091825|FG002|Overall Study|No longer having problem|1|||
124855034|NCT01175382|449091823|FG000|Overall Study|Unable/unwilling to attend visits|3|||
124855035|NCT01175382|449091824|FG001|Overall Study|Unable/unwilling to attend visits|1|||
124855036|NCT01175382|449091825|FG002|Overall Study|Unable/unwilling to attend visits|2|||
124855037|NCT01175382|449091823|FG000|Overall Study|Unwilling to follow protocol|0|||
124855038|NCT01175382|449091824|FG001|Overall Study|Unwilling to follow protocol|1|||
124855039|NCT01175382|449091825|FG002|Overall Study|Unwilling to follow protocol|0|||
124855040|NCT01175382|449091823|FG000|Overall Study|Unable to tolerate study meds|0|||
124855041|NCT01175382|449091824|FG001|Overall Study|Unable to tolerate study meds|1|||
124855042|NCT01175382|449091825|FG002|Overall Study|Unable to tolerate study meds|1|||
124855043|NCT00774787|449091826|FG000|Overall Study|Lost to Follow-up|1|||
124855044|NCT02554773|449091827|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
124855045|NCT02554773|449091828|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
124855046|NCT02554773|449091827|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
124855047|NCT02554773|449091828|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
124855048|NCT02554773|449091827|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
124855049|NCT02554773|449091828|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
124855050|NCT02554773|449091827|FG000|Original Dose Regimen (SAS 1)|Death|1|||
124855051|NCT02554773|449091828|FG001|Original Dose Regimen (SAS 1)|Death|0|||
124855052|NCT02554773|449091827|FG000|Original Dose Regimen (SAS 1)|Other|4|||
124855053|NCT02554773|449091828|FG001|Original Dose Regimen (SAS 1)|Other|0|||
124855054|NCT02554773|449091827|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
124855055|NCT02554773|449091828|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
124855056|NCT02554773|449091827|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
124855057|NCT02554773|449091828|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
124855058|NCT02554773|449091827|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
124855059|NCT02554773|449091828|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
124855060|NCT02554773|449091827|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
124855061|NCT02554773|449091828|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
124855062|NCT02031276|449091831|FG000|Period 1 Double-blind IV|Adverse Event|6|||
124855063|NCT02031276|449091832|FG001|Period 1 Double-blind IV|Adverse Event|5|||
124855064|NCT02031276|449091833|FG002|Period 1 Double-blind IV|Adverse Event|1|||
124855065|NCT02031276|449091831|FG000|Period 1 Double-blind IV|Other|0|||
124855066|NCT02031276|449091832|FG001|Period 1 Double-blind IV|Other|1|||
124855067|NCT02031276|449091833|FG002|Period 1 Double-blind IV|Other|0|||
124855068|NCT02031276|449091831|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
124855069|NCT02031276|449091832|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
124855070|NCT02031276|449091833|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
124855071|NCT02031276|449091831|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
124855072|NCT02031276|449091832|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
124855073|NCT02031276|449091833|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
124855074|NCT02031276|449091831|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
124855075|NCT02031276|449091832|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
124855076|NCT02031276|449091833|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
124855077|NCT02031276|449091831|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
124855078|NCT02031276|449091832|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
124855079|NCT02031276|449091833|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
124855080|NCT02031276|449091831|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
124855081|NCT02031276|449091832|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
124855082|NCT02031276|449091833|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
124855083|NCT02031276|449091831|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
124855084|NCT02031276|449091832|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
124855085|NCT02031276|449091833|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
124855086|NCT02031276|449091831|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
124855087|NCT02031276|449091832|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
124855088|NCT02031276|449091833|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
124855089|NCT01148810|449091834|FG000|Overall Study|Adverse Event|0|||
124855090|NCT01148810|449091835|FG001|Overall Study|Adverse Event|2|||
124855091|NCT01148810|449091834|FG000|Overall Study|Lack of Efficacy|0|||
124855092|NCT01148810|449091835|FG001|Overall Study|Lack of Efficacy|1|||
124855093|NCT01148810|449091834|FG000|Overall Study|Withdrawal by Subject|0|||
124855094|NCT01148810|449091835|FG001|Overall Study|Withdrawal by Subject|2|||
124855095|NCT01148810|449091834|FG000|Overall Study|Protocol Violation|1|||
124855096|NCT01148810|449091835|FG001|Overall Study|Protocol Violation|0|||
124855097|NCT01854554|449091836|FG000|Overall Study|Denial of Insurance Coverage|12|||
124855098|NCT01854554|449091837|FG001|Overall Study|Denial of Insurance Coverage|0|||
124855099|NCT01854554|449091836|FG000|Overall Study|Decided to get treatment locally|1|||
124855100|NCT01854554|449091837|FG001|Overall Study|Decided to get treatment locally|5|||
124855101|NCT01854554|449091836|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
124855102|NCT01854554|449091837|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
124855103|NCT01854554|449091836|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
124855104|NCT01854554|449091837|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
124855105|NCT01854554|449091836|FG000|Overall Study|Progression|0|||
124855106|NCT01854554|449091837|FG001|Overall Study|Progression|1|||
124855107|NCT01854554|449091836|FG000|Overall Study|Lost to Follow-up|0|||
124855108|NCT01854554|449091837|FG001|Overall Study|Lost to Follow-up|1|||
124855109|NCT02613481|449091842|FG000|Overall Study|Lost to Follow-up|7|||
124855110|NCT02613481|449091842|FG000|Overall Study|Withdrawal by Subject|2|||
124855111|NCT01033747|449091843|FG000|Overall Study|Adverse Event|9|||
124855112|NCT01033747|449091844|FG001|Overall Study|Adverse Event|4|||
124855113|NCT01033747|449091843|FG000|Overall Study|Abnormal Laboratory Value|1|||
124855114|NCT01033747|449091844|FG001|Overall Study|Abnormal Laboratory Value|0|||
124855115|NCT01033747|449091843|FG000|Overall Study|Abnormal test procedure|0|||
124855116|NCT01033747|449091844|FG001|Overall Study|Abnormal test procedure|1|||
124855117|NCT01033747|449091843|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
124855118|NCT01033747|449091844|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
124855119|NCT01033747|449091843|FG000|Overall Study|Protocol Violation|1|||
124855120|NCT01033747|449091844|FG001|Overall Study|Protocol Violation|0|||
124855121|NCT01033747|449091843|FG000|Overall Study|Withdrawal by Subject|9|||
124855122|NCT01033747|449091844|FG001|Overall Study|Withdrawal by Subject|6|||
124855123|NCT01033747|449091843|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
124855124|NCT01033747|449091844|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
124855125|NCT01033747|449091843|FG000|Overall Study|Stopped at end of Extension 1|2|||
124855126|NCT01033747|449091844|FG001|Overall Study|Stopped at end of Extension 1|0|||
124855127|NCT00844194|449091845|FG000|Overall Study|Adverse Event|17|||
124855128|NCT00844194|449091846|FG001|Overall Study|Adverse Event|5|||
124855129|NCT00844194|449091845|FG000|Overall Study|Protocol Violation|1|||
124855130|NCT00844194|449091846|FG001|Overall Study|Protocol Violation|1|||
124855131|NCT00844194|449091845|FG000|Overall Study|Lost to Follow-up|1|||
124855132|NCT00844194|449091846|FG001|Overall Study|Lost to Follow-up|1|||
124855133|NCT00844194|449091845|FG000|Overall Study|Withdrawal by Subject|2|||
124855134|NCT00844194|449091846|FG001|Overall Study|Withdrawal by Subject|1|||
124855135|NCT00844194|449091845|FG000|Overall Study|Lack of Efficacy|3|||
124855136|NCT00844194|449091846|FG001|Overall Study|Lack of Efficacy|0|||
124855137|NCT00844194|449091845|FG000|Overall Study|Other reason (not specified)|1|||
124855138|NCT00844194|449091846|FG001|Overall Study|Other reason (not specified)|0|||
124855139|NCT02647658|449091847|FG000|Overall Study|Consent refusal|15|||
124855140|NCT02647658|449091848|FG001|Overall Study|Consent refusal|24|||
124855141|NCT00803023|449091849|FG000|Overall Study|Adverse Event|5|||
124855142|NCT00803023|449091850|FG001|Overall Study|Adverse Event|4|||
124855143|NCT00803023|449091851|FG002|Overall Study|Adverse Event|8|||
124855144|NCT00803023|449091852|FG003|Overall Study|Adverse Event|6|||
124855145|NCT00803023|449091849|FG000|Overall Study|Withdrawal by Subject|0|||
124855146|NCT00803023|449091850|FG001|Overall Study|Withdrawal by Subject|2|||
124855147|NCT00803023|449091851|FG002|Overall Study|Withdrawal by Subject|0|||
124855148|NCT00803023|449091852|FG003|Overall Study|Withdrawal by Subject|0|||
124855149|NCT00803023|449091849|FG000|Overall Study|Lost to Follow-up|0|||
124855150|NCT00803023|449091850|FG001|Overall Study|Lost to Follow-up|1|||
124855151|NCT00803023|449091851|FG002|Overall Study|Lost to Follow-up|2|||
124855152|NCT00803023|449091852|FG003|Overall Study|Lost to Follow-up|1|||
124855153|NCT00803023|449091849|FG000|Overall Study|Lack of Efficacy|0|||
124855154|NCT00803023|449091850|FG001|Overall Study|Lack of Efficacy|1|||
124855155|NCT00803023|449091851|FG002|Overall Study|Lack of Efficacy|1|||
124855156|NCT00803023|449091852|FG003|Overall Study|Lack of Efficacy|1|||
124855157|NCT01542528|449091857|FG000|Overall Study|Lost to Follow-up|2|||
124855158|NCT01542528|449091858|FG001|Overall Study|Lost to Follow-up|1|||
124855159|NCT01542528|449091857|FG000|Overall Study|Physician Decision|1|||
124855160|NCT01542528|449091858|FG001|Overall Study|Physician Decision|0|||
124855161|NCT01542528|449091857|FG000|Overall Study|Withdrawal by Subject|9|||
124855162|NCT01542528|449091858|FG001|Overall Study|Withdrawal by Subject|6|||
124855163|NCT01931839|449091861|FG000|Overall Study|Death|0|||
124855164|NCT01931839|449091862|FG001|Overall Study|Death|1|||
124855165|NCT01931839|449091863|FG002|Overall Study|Death|2|||
124855166|NCT01931839|449091864|FG003|Overall Study|Death|0|||
124855167|NCT01931839|449091865|FG004|Overall Study|Death|0|||
124855168|NCT01931839|449091866|FG005|Overall Study|Death|0|||
124855169|NCT01931839|449091867|FG006|Overall Study|Death|0|||
124855170|NCT01931839|449091861|FG000|Overall Study|Physician Decision|1|||
124855171|NCT01931839|449091862|FG001|Overall Study|Physician Decision|0|||
124855172|NCT01931839|449091863|FG002|Overall Study|Physician Decision|1|||
124855173|NCT01931839|449091864|FG003|Overall Study|Physician Decision|0|||
124855174|NCT01931839|449091865|FG004|Overall Study|Physician Decision|0|||
124855175|NCT01931839|449091866|FG005|Overall Study|Physician Decision|0|||
124855176|NCT01931839|449091867|FG006|Overall Study|Physician Decision|1|||
124855177|NCT01931839|449091861|FG000|Overall Study|Withdrawal of consent|0|||
124855178|NCT01931839|449091862|FG001|Overall Study|Withdrawal of consent|0|||
124855179|NCT01931839|449091863|FG002|Overall Study|Withdrawal of consent|0|||
124855180|NCT01931839|449091864|FG003|Overall Study|Withdrawal of consent|0|||
124855181|NCT01931839|449091865|FG004|Overall Study|Withdrawal of consent|1|||
124855182|NCT01931839|449091866|FG005|Overall Study|Withdrawal of consent|0|||
124855183|NCT01931839|449091867|FG006|Overall Study|Withdrawal of consent|0|||
124855184|NCT01931839|449091861|FG000|Overall Study|Adverse Event|9|||
124855185|NCT01931839|449091862|FG001|Overall Study|Adverse Event|4|||
124855186|NCT01931839|449091863|FG002|Overall Study|Adverse Event|1|||
124855187|NCT01931839|449091864|FG003|Overall Study|Adverse Event|3|||
124855188|NCT01931839|449091865|FG004|Overall Study|Adverse Event|0|||
124855189|NCT01931839|449091866|FG005|Overall Study|Adverse Event|0|||
124855190|NCT01931839|449091867|FG006|Overall Study|Adverse Event|1|||
124855191|NCT01931839|449091861|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
124855192|NCT01931839|449091862|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
124855193|NCT01931839|449091863|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
124855194|NCT01931839|449091864|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
124855195|NCT01931839|449091865|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
124855196|NCT01931839|449091866|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
124855197|NCT01931839|449091867|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
124855198|NCT01931839|449091861|FG000|Overall Study|Other non-compliance|15|||
124855199|NCT01931839|449091862|FG001|Overall Study|Other non-compliance|9|||
124855200|NCT01931839|449091863|FG002|Overall Study|Other non-compliance|12|||
124855201|NCT01931839|449091864|FG003|Overall Study|Other non-compliance|3|||
124855202|NCT01931839|449091865|FG004|Overall Study|Other non-compliance|0|||
124855203|NCT01931839|449091866|FG005|Overall Study|Other non-compliance|3|||
124855204|NCT01931839|449091867|FG006|Overall Study|Other non-compliance|0|||
124855205|NCT01931839|449091861|FG000|Overall Study|Lost to Follow-up|1|||
124855206|NCT01931839|449091862|FG001|Overall Study|Lost to Follow-up|2|||
124855207|NCT01931839|449091863|FG002|Overall Study|Lost to Follow-up|4|||
124855208|NCT01931839|449091864|FG003|Overall Study|Lost to Follow-up|5|||
124855209|NCT01931839|449091865|FG004|Overall Study|Lost to Follow-up|0|||
124855210|NCT01931839|449091866|FG005|Overall Study|Lost to Follow-up|0|||
124855211|NCT01931839|449091867|FG006|Overall Study|Lost to Follow-up|0|||
124855212|NCT01931839|449091861|FG000|Overall Study|Other|4|||
124855213|NCT01931839|449091862|FG001|Overall Study|Other|2|||
124855214|NCT01931839|449091863|FG002|Overall Study|Other|6|||
124855215|NCT01931839|449091864|FG003|Overall Study|Other|0|||
124855216|NCT01931839|449091865|FG004|Overall Study|Other|0|||
124855217|NCT01931839|449091866|FG005|Overall Study|Other|0|||
124855218|NCT01931839|449091867|FG006|Overall Study|Other|0|||
124855219|NCT01992536|449091869|FG000|Overall Study|Administrative Reason|0|||
124855220|NCT01992536|449091870|FG001|Overall Study|Administrative Reason|0|||
124855221|NCT01992536|449091871|FG002|Overall Study|Administrative Reason|0|||
124855222|NCT01992536|449091872|FG003|Overall Study|Administrative Reason|0|||
124855223|NCT01992536|449091873|FG004|Overall Study|Administrative Reason|0|||
124855224|NCT01992536|449091874|FG005|Overall Study|Administrative Reason|0|||
124855225|NCT01992536|449091875|FG006|Overall Study|Administrative Reason|7|||
124855226|NCT01992536|449091876|FG007|Overall Study|Administrative Reason|0|||
124855227|NCT01992536|449091877|FG008|Overall Study|Administrative Reason|0|||
124855228|NCT01992536|449091878|FG009|Overall Study|Administrative Reason|0|||
124855229|NCT01992536|449091869|FG000|Overall Study|Lost to Follow-up|4|||
124855230|NCT01992536|449091870|FG001|Overall Study|Lost to Follow-up|2|||
124855231|NCT01992536|449091871|FG002|Overall Study|Lost to Follow-up|1|||
124855232|NCT01992536|449091872|FG003|Overall Study|Lost to Follow-up|0|||
124855233|NCT01992536|449091873|FG004|Overall Study|Lost to Follow-up|0|||
124855234|NCT01992536|449091874|FG005|Overall Study|Lost to Follow-up|1|||
124855235|NCT01992536|449091875|FG006|Overall Study|Lost to Follow-up|0|||
124855236|NCT01992536|449091876|FG007|Overall Study|Lost to Follow-up|0|||
124855237|NCT01992536|449091877|FG008|Overall Study|Lost to Follow-up|1|||
124855238|NCT01992536|449091878|FG009|Overall Study|Lost to Follow-up|1|||
124855239|NCT01992536|449091869|FG000|Overall Study|Withdrawal by Subject|0|||
124855240|NCT01992536|449091870|FG001|Overall Study|Withdrawal by Subject|1|||
124855241|NCT01992536|449091871|FG002|Overall Study|Withdrawal by Subject|0|||
124855242|NCT01992536|449091872|FG003|Overall Study|Withdrawal by Subject|2|||
124855243|NCT01992536|449091873|FG004|Overall Study|Withdrawal by Subject|0|||
124855244|NCT01992536|449091874|FG005|Overall Study|Withdrawal by Subject|0|||
124855245|NCT01992536|449091875|FG006|Overall Study|Withdrawal by Subject|0|||
124855246|NCT01992536|449091876|FG007|Overall Study|Withdrawal by Subject|0|||
124855247|NCT01992536|449091877|FG008|Overall Study|Withdrawal by Subject|0|||
124855248|NCT01992536|449091878|FG009|Overall Study|Withdrawal by Subject|0|||
124855249|NCT01709227|449091882|FG000|Overall Study|Physician Decision|1|||
124855250|NCT01709227|449091883|FG001|Overall Study|Physician Decision|0|||
124855251|NCT01709227|449091882|FG000|Overall Study|Pleural Peritoneal communication|0|||
124855252|NCT01709227|449091883|FG001|Overall Study|Pleural Peritoneal communication|9|||
124855253|NCT03669081|449091884|FG000|Overall Study|Data could not be validated|1|||
124855254|NCT03669081|449091885|FG001|Overall Study|Data could not be validated|1|||
124855255|NCT00389324|449091887|FG000|Run-In Phase|Adverse Event|1|||
124855256|NCT00389324|449091887|FG000|Run-In Phase|Lost to Follow-up|1|||
124855257|NCT00389324|449091887|FG000|Run-In Phase|Withdrawal by Subject|1|||
124855258|NCT00389324|449091887|FG000|Subcutaneous Phase|Adverse Event|2|||
124855259|NCT00389324|449091887|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
124855260|NCT00389324|449091887|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
124855261|NCT00389324|449091887|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
124855262|NCT02317575|449091888|FG000|Period 1|Difficulty with venous cannulation|0|||
124855263|NCT02317575|449091889|FG001|Period 1|Difficulty with venous cannulation|1|||
124855264|NCT02317575|449091890|FG002|Period 1|Difficulty with venous cannulation|0|||
124855265|NCT02317575|449091891|FG003|Period 1|Difficulty with venous cannulation|0|||
124855266|NCT02317575|449091892|FG004|Period 1|Difficulty with venous cannulation|0|||
124855267|NCT02317575|449091888|FG000|Period 1|Withdrawal by Subject|1|||
124855268|NCT02317575|449091889|FG001|Period 1|Withdrawal by Subject|0|||
124855269|NCT02317575|449091890|FG002|Period 1|Withdrawal by Subject|0|||
124855270|NCT02317575|449091891|FG003|Period 1|Withdrawal by Subject|0|||
124855271|NCT02317575|449091892|FG004|Period 1|Withdrawal by Subject|0|||
124855272|NCT01921348|449091893|FG000|Overall Study|Withdrawal by Subject|1|||
124855273|NCT01921348|449091894|FG001|Overall Study|Withdrawal by Subject|0|||
124855274|NCT01921348|449091893|FG000|Overall Study|Lost to Follow-up|0|||
124855275|NCT01921348|449091894|FG001|Overall Study|Lost to Follow-up|2|||
124855276|NCT04788147|449091901|FG000|Overall Study|Screen Failure|3|||
124855277|NCT04788147|449091902|FG001|Overall Study|Screen Failure|10|||
124855278|NCT04788147|449091901|FG000|Overall Study|Incomplete RMRS image session|2|||
124855279|NCT04788147|449091902|FG001|Overall Study|Incomplete RMRS image session|0|||
124855280|NCT00781326|449091903|FG000|Phase I|Adverse Event|1|||
124855281|NCT00781326|449091903|FG000|Phase I|Withdrawal by Subject|1|||
124855282|NCT00781326|449091903|FG000|Phase I|Physician Decision|2|||
124855283|NCT02266381|449091904|FG000|Overall Study|Physician Decision|3|||
124855284|NCT02266381|449091905|FG001|Overall Study|Physician Decision|5|||
124855285|NCT02266381|449091906|FG002|Overall Study|Physician Decision|4|||
124855286|NCT02401672|449091907|FG000|Overall Study|Withdrawal by Subject|1|||
124855287|NCT02401672|449091908|FG001|Overall Study|Withdrawal by Subject|3|||
124855288|NCT00701051|449091909|FG000|Screening|Failed Screening|40|||
124855289|NCT00701051|449091910|FG001|Screening|Failed Screening|0|||
124855290|NCT00701051|449091911|FG002|Screening|Failed Screening|0|||
124855291|NCT00701051|449091909|FG000|Screening|Time conflicts|19|||
124855292|NCT00701051|449091910|FG001|Screening|Time conflicts|0|||
124855293|NCT00701051|449091911|FG002|Screening|Time conflicts|0|||
124855294|NCT00701051|449091909|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
124855295|NCT00701051|449091910|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
124855296|NCT00701051|449091911|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
124855297|NCT03207750|449091922|FG000|Overall Study|Adverse Event|3|||
124855298|NCT03207750|449091923|FG001|Overall Study|Adverse Event|2|||
124855299|NCT03207750|449091922|FG000|Overall Study|Lost to Follow-up|21|||
124855300|NCT03207750|449091923|FG001|Overall Study|Lost to Follow-up|29|||
124855301|NCT03207750|449091922|FG000|Overall Study|Protocol Violation|0|||
124855302|NCT03207750|449091923|FG001|Overall Study|Protocol Violation|1|||
124855303|NCT03207750|449091922|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
124855304|NCT03207750|449091923|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
124855305|NCT03207750|449091922|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
124855306|NCT03207750|449091923|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
124855307|NCT03207750|449091922|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
124855308|NCT03207750|449091923|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
124855309|NCT03207750|449091922|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
124855310|NCT03207750|449091923|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
124855311|NCT03207750|449091922|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
124855312|NCT03207750|449091923|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
124855313|NCT00793910|449091924|FG000|Overall Study|discarded study pills|0|||
124855314|NCT00793910|449091925|FG001|Overall Study|discarded study pills|1|||
124855315|NCT00793910|449091924|FG000|Overall Study|did not pick up medications|1|||
124855316|NCT00793910|449091925|FG001|Overall Study|did not pick up medications|1|||
124855317|NCT00793910|449091924|FG000|Overall Study|ineligible based on entry criteria|2|||
124855318|NCT00793910|449091925|FG001|Overall Study|ineligible based on entry criteria|3|||
124855319|NCT00793910|449091924|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
124855320|NCT00793910|449091925|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
124855321|NCT00793910|449091924|FG000|Overall Study|Withdrawal by Subject|0|||
124855322|NCT00793910|449091925|FG001|Overall Study|Withdrawal by Subject|1|||
124855323|NCT01700946|449091926|FG000|Overall Study|Lost to Follow-up|1|||
124855324|NCT01700946|449091927|FG001|Overall Study|Lost to Follow-up|0|||
124855325|NCT01700946|449091926|FG000|Overall Study|Physician Decision|7|||
124855326|NCT01700946|449091927|FG001|Overall Study|Physician Decision|12|||
124855327|NCT01700946|449091926|FG000|Overall Study|Withdrawal by Subject|0|||
124855328|NCT01700946|449091927|FG001|Overall Study|Withdrawal by Subject|2|||
124855329|NCT01700946|449091926|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
124855330|NCT01700946|449091927|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
124855331|NCT01700946|449091926|FG000|Overall Study|Relapse|2|||
124855332|NCT01700946|449091927|FG001|Overall Study|Relapse|1|||
124855333|NCT01700946|449091926|FG000|Overall Study|Unacceptable toxicity|1|||
124855334|NCT01700946|449091927|FG001|Overall Study|Unacceptable toxicity|0|||
124855335|NCT03634579|449091930|FG000|Overall Study|study termination|9|||
124855336|NCT04111497|449091931|FG000|Overall Study|relapse of primary disease|1|||
124855337|NCT04111497|449091931|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
124855338|NCT03321019|449091932|FG000|Overall Study|Withdrawal by Subject|0|||
124855339|NCT03321019|449091933|FG001|Overall Study|Withdrawal by Subject|6|||
124855340|NCT03321019|449091932|FG000|Overall Study|Lost to Follow-up|0|||
124855341|NCT03321019|449091933|FG001|Overall Study|Lost to Follow-up|22|||
124855342|NCT03433456|449091937|FG000|Overall Study|Death|1|||
124855343|NCT03433456|449091938|FG001|Overall Study|Death|1|||
124855344|NCT03433456|449091937|FG000|Overall Study|Lost to Follow-up|14|||
124855345|NCT03433456|449091938|FG001|Overall Study|Lost to Follow-up|11|||
124855346|NCT03433456|449091937|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
124855347|NCT03433456|449091938|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
124855348|NCT03694548|449091939|FG000|Part A Survey|Protocol Violation|3|||
124855349|NCT03694548|449091940|FG001|Part A Survey|Protocol Violation|3|||
124855350|NCT03694548|449091941|FG002|Part A Survey|Protocol Violation|0|||
124855351|NCT03694548|449091939|FG000|Part B Yoga Program|Protocol Violation|0|||
124855352|NCT03694548|449091940|FG001|Part B Yoga Program|Protocol Violation|0|||
124855353|NCT03694548|449091941|FG002|Part B Yoga Program|Protocol Violation|3|||
124855354|NCT03694548|449091939|FG000|Part B Yoga Program|Did not attend intervention|0|||
124855355|NCT03694548|449091940|FG001|Part B Yoga Program|Did not attend intervention|0|||
124855356|NCT03694548|449091941|FG002|Part B Yoga Program|Did not attend intervention|8|||
124855357|NCT04496258|449091942|FG000|Overall Study|Withdrawal by Subject|2|||
124855358|NCT04496258|449091943|FG001|Overall Study|Withdrawal by Subject|1|||
124855359|NCT04102501|449091944|FG000|Overall Study|Withdrawal by Subject|7|||
124855360|NCT04102501|449091945|FG001|Overall Study|Withdrawal by Subject|9|||
124855361|NCT04102501|449091944|FG000|Overall Study|Adverse Event|1|||
124855362|NCT04102501|449091945|FG001|Overall Study|Adverse Event|3|||
124855363|NCT01427712|449091946|FG000|Overall Study|Transfer to a different hospital|2|||
124855364|NCT01427712|449091946|FG000|Overall Study|Lost to Follow-up|1|||
124855365|NCT01427712|449091946|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
124855366|NCT01427712|449091946|FG000|Overall Study|Failure to visit|1|||
124855367|NCT00968617|449091948|FG000|Overall Study|Study terminated by sponsor|6|||
124855368|NCT01024387|449091954|FG000|Overall Study|Radiographic Progression|29|||
124855369|NCT01024387|449091954|FG000|Overall Study|Symptomatic Progression|10|||
124855370|NCT01024387|449091954|FG000|Overall Study|Physician Decision|5|||
124855371|NCT01024387|449091954|FG000|Overall Study|Withdrawal by Subject|5|||
124855372|NCT01024387|449091954|FG000|Overall Study|Death|2|||
124855373|NCT01024387|449091954|FG000|Overall Study|Prolonged Treatment Delay|1|||
124855374|NCT01024387|449091954|FG000|Overall Study|Adverse Event|3|||
124855375|NCT01024387|449091954|FG000|Overall Study|Other|5|||
124855376|NCT03864900|449091955|FG000|Overall Study|Withdrawal by Subject|1|||
124855377|NCT03864900|449091956|FG001|Overall Study|Withdrawal by Subject|1|||
124855378|NCT03864900|449091955|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
124855379|NCT03864900|449091956|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
124855380|NCT03191903|449091957|FG000|Overall Study|Withdrawal by Subject|6|||
124855381|NCT03191903|449091958|FG001|Overall Study|Withdrawal by Subject|5|||
124855382|NCT03191903|449091959|FG002|Overall Study|Withdrawal by Subject|4|||
124855383|NCT03191903|449091957|FG000|Overall Study|Adverse Event|1|||
124855384|NCT03191903|449091958|FG001|Overall Study|Adverse Event|0|||
124855385|NCT03191903|449091959|FG002|Overall Study|Adverse Event|0|||
124855386|NCT01578551|449091962|FG000|Overall Study|Adverse Event|1|||
124855387|NCT01578551|449091963|FG001|Overall Study|Adverse Event|0|||
124855388|NCT04369469|449091970|FG000|Overall Study|Lost to Follow-up|2|||
124855389|NCT04369469|449091971|FG001|Overall Study|Lost to Follow-up|4|||
124855390|NCT04369469|449091970|FG000|Overall Study|Physician Decision|2|||
124855391|NCT04369469|449091971|FG001|Overall Study|Physician Decision|1|||
124855392|NCT04369469|449091970|FG000|Overall Study|Withdrawal by Subject|2|||
124855393|NCT04369469|449091971|FG001|Overall Study|Withdrawal by Subject|3|||
124855394|NCT04369469|449091970|FG000|Overall Study|Adverse Event|1|||
124855395|NCT04369469|449091971|FG001|Overall Study|Adverse Event|0|||
124855396|NCT04369469|449091970|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
124855397|NCT04369469|449091971|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
124855398|NCT04369469|449091970|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
124855399|NCT04369469|449091971|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
124855400|NCT04369469|449091970|FG000|Overall Study|Unable to Provide Consent|0|||
124855401|NCT04369469|449091971|FG001|Overall Study|Unable to Provide Consent|1|||
124855402|NCT01344460|449091974|FG000|Overall Study|Withdrawal by Subject|1|||
124855403|NCT01344460|449091974|FG000|Overall Study|Lost to Follow-up|2|||
124855404|NCT03283670|449091975|FG000|Placebo Gas|Withdrawal by Subject|2|||
124855405|NCT03283670|449091975|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
124855406|NCT03283670|449091975|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
124855407|NCT03823651|449091982|FG000|Overall Study|Death|5|||
124855408|NCT03823651|449091983|FG001|Overall Study|Death|0|||
124855409|NCT03823651|449091982|FG000|Overall Study|Physician Decision|1|||
124855410|NCT03823651|449091983|FG001|Overall Study|Physician Decision|0|||
124855411|NCT03823651|449091982|FG000|Overall Study|Caregiver to patient who died|0|||
124855412|NCT03823651|449091983|FG001|Overall Study|Caregiver to patient who died|5|||
124855413|NCT03823651|449091982|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
124855414|NCT03823651|449091983|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
124855415|NCT03864614|449091984|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
124855416|NCT03864614|449091985|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
124855417|NCT03864614|449091986|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
124855418|NCT03864614|449091987|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
124855419|NCT03864614|449091984|FG000|Overall Study|Withdrawal by Subject|72|||
124855420|NCT03864614|449091985|FG001|Overall Study|Withdrawal by Subject|100|||
124855421|NCT03864614|449091986|FG002|Overall Study|Withdrawal by Subject|1|||
124855422|NCT03864614|449091987|FG003|Overall Study|Withdrawal by Subject|21|||
124855423|NCT03864614|449091984|FG000|Overall Study|Lost to Follow-up|45|||
124855424|NCT03864614|449091985|FG001|Overall Study|Lost to Follow-up|54|||
124855425|NCT03864614|449091986|FG002|Overall Study|Lost to Follow-up|0|||
124855426|NCT03864614|449091987|FG003|Overall Study|Lost to Follow-up|9|||
124855427|NCT03864614|449091984|FG000|Overall Study|Adverse Event|42|||
124855428|NCT03864614|449091985|FG001|Overall Study|Adverse Event|30|||
124855429|NCT03864614|449091986|FG002|Overall Study|Adverse Event|1|||
124855430|NCT03864614|449091987|FG003|Overall Study|Adverse Event|9|||
124855431|NCT03864614|449091984|FG000|Overall Study|Protocol Deviation|6|||
124855432|NCT03864614|449091985|FG001|Overall Study|Protocol Deviation|26|||
124855433|NCT03864614|449091986|FG002|Overall Study|Protocol Deviation|0|||
124855434|NCT03864614|449091987|FG003|Overall Study|Protocol Deviation|1|||
124855435|NCT03864614|449091984|FG000|Overall Study|Physician Decision|7|||
124855436|NCT03864614|449091985|FG001|Overall Study|Physician Decision|10|||
124855437|NCT03864614|449091986|FG002|Overall Study|Physician Decision|1|||
124855438|NCT03864614|449091987|FG003|Overall Study|Physician Decision|5|||
124855439|NCT03864614|449091984|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
124855440|NCT03864614|449091985|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
124855441|NCT03864614|449091986|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
124855442|NCT03864614|449091987|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
124855443|NCT03864614|449091984|FG000|Overall Study|Sponsor Decision|1|||
124855444|NCT03864614|449091985|FG001|Overall Study|Sponsor Decision|2|||
124855445|NCT03864614|449091986|FG002|Overall Study|Sponsor Decision|0|||
124855446|NCT03864614|449091987|FG003|Overall Study|Sponsor Decision|0|||
124855447|NCT03864614|449091984|FG000|Overall Study|Pregnancy|0|||
124855448|NCT03864614|449091985|FG001|Overall Study|Pregnancy|1|||
124855449|NCT03864614|449091986|FG002|Overall Study|Pregnancy|0|||
124855450|NCT03864614|449091987|FG003|Overall Study|Pregnancy|0|||
124855451|NCT03864614|449091984|FG000|Overall Study|Other|7|||
124855452|NCT03864614|449091985|FG001|Overall Study|Other|9|||
124855453|NCT03864614|449091986|FG002|Overall Study|Other|1|||
124855454|NCT03864614|449091987|FG003|Overall Study|Other|4|||
124855455|NCT03864614|449091984|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
124855456|NCT03864614|449091985|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
124855457|NCT03864614|449091986|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
124855458|NCT03864614|449091987|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
124855459|NCT03859323|449093843|FG000|Overall Study|Lost to Follow-up|0|||
124855460|NCT03859323|449093844|FG001|Overall Study|Lost to Follow-up|0|||
124855461|NCT03859323|449093845|FG002|Overall Study|Lost to Follow-up|0|||
124855462|NCT03859323|449093846|FG003|Overall Study|Lost to Follow-up|0|||
124855463|NCT03859323|449093847|FG004|Overall Study|Lost to Follow-up|0|||
124855464|NCT03859323|449093848|FG005|Overall Study|Lost to Follow-up|0|||
124855465|NCT03859323|449093849|FG006|Overall Study|Lost to Follow-up|1|||
124855466|NCT03859323|449093850|FG007|Overall Study|Lost to Follow-up|0|||
124855467|NCT03859323|449093851|FG008|Overall Study|Lost to Follow-up|0|||
124855468|NCT03859323|449093852|FG009|Overall Study|Lost to Follow-up|0|||
124855469|NCT03859323|449093853|FG010|Overall Study|Lost to Follow-up|0|||
124855470|NCT03859323|449093854|FG011|Overall Study|Lost to Follow-up|0|||
124855471|NCT03859323|449093855|FG012|Overall Study|Lost to Follow-up|0|||
124855472|NCT03859323|449093843|FG000|Overall Study|Withdrawal by Subject|0|||
124855473|NCT03859323|449093844|FG001|Overall Study|Withdrawal by Subject|0|||
124855474|NCT03859323|449093845|FG002|Overall Study|Withdrawal by Subject|1|||
124855475|NCT03859323|449093846|FG003|Overall Study|Withdrawal by Subject|0|||
124855476|NCT03859323|449093847|FG004|Overall Study|Withdrawal by Subject|0|||
124855477|NCT03859323|449093848|FG005|Overall Study|Withdrawal by Subject|1|||
124855478|NCT03859323|449093849|FG006|Overall Study|Withdrawal by Subject|0|||
124855479|NCT03859323|449093850|FG007|Overall Study|Withdrawal by Subject|0|||
124855480|NCT03859323|449093851|FG008|Overall Study|Withdrawal by Subject|0|||
124855481|NCT03859323|449093852|FG009|Overall Study|Withdrawal by Subject|1|||
124855482|NCT03859323|449093853|FG010|Overall Study|Withdrawal by Subject|1|||
124855483|NCT03859323|449093854|FG011|Overall Study|Withdrawal by Subject|2|||
124855484|NCT03859323|449093855|FG012|Overall Study|Withdrawal by Subject|1|||
124855485|NCT03859323|449093843|FG000|Overall Study|Pregnancy|0|||
124855486|NCT03859323|449093844|FG001|Overall Study|Pregnancy|0|||
124855487|NCT03859323|449093845|FG002|Overall Study|Pregnancy|0|||
124855488|NCT03859323|449093846|FG003|Overall Study|Pregnancy|0|||
124855489|NCT03859323|449093847|FG004|Overall Study|Pregnancy|0|||
124855490|NCT03859323|449093848|FG005|Overall Study|Pregnancy|0|||
124855491|NCT03859323|449093849|FG006|Overall Study|Pregnancy|0|||
124855492|NCT03859323|449093850|FG007|Overall Study|Pregnancy|0|||
124855493|NCT03859323|449093851|FG008|Overall Study|Pregnancy|0|||
124855494|NCT03859323|449093852|FG009|Overall Study|Pregnancy|1|||
124855495|NCT03859323|449093853|FG010|Overall Study|Pregnancy|0|||
124855496|NCT03859323|449093854|FG011|Overall Study|Pregnancy|0|||
124855497|NCT03859323|449093855|FG012|Overall Study|Pregnancy|0|||
124855498|NCT01404312|449093858|FG000|Overall Study|Death|21|||
124855499|NCT01404312|449093859|FG001|Overall Study|Death|27|||
124855500|NCT01404312|449093858|FG000|Overall Study|Withdrawal by Subject|15|||
124855501|NCT01404312|449093859|FG001|Overall Study|Withdrawal by Subject|18|||
124855502|NCT01404312|449093858|FG000|Overall Study|Participant Unable to get to clinic|93|||
124855503|NCT01404312|449093859|FG001|Overall Study|Participant Unable to get to clinic|103|||
124855504|NCT01404312|449093858|FG000|Overall Study|Lost to Follow-up|115|||
124855505|NCT01404312|449093859|FG001|Overall Study|Lost to Follow-up|111|||
124855506|NCT01404312|449093858|FG000|Overall Study|Site closed|22|||
124855507|NCT01404312|449093859|FG001|Overall Study|Site closed|21|||
124855508|NCT01404312|449093858|FG000|Overall Study|Participant not willing to adhere to req|31|||
124855509|NCT01404312|449093859|FG001|Overall Study|Participant not willing to adhere to req|29|||
124855510|NCT01404312|449093858|FG000|Overall Study|Severe debilitation, unable to continue|1|||
124855511|NCT01404312|449093859|FG001|Overall Study|Severe debilitation, unable to continue|2|||
124855512|NCT04419493|449093860|FG000|Wash-out After Period 1|Adverse Event|1|||
124855513|NCT04419493|449093861|FG001|Wash-out After Period 1|Adverse Event|2|||
124855514|NCT04419493|449093862|FG002|Wash-out After Period 1|Adverse Event|1|||
124855515|NCT04419493|449093863|FG003|Wash-out After Period 1|Adverse Event|0|||
124855516|NCT00524134|449093864|FG000|Overall Study|Withdrawal by Subject|1|||
124855517|NCT00524134|449093864|FG000|Overall Study|Physician Decision|1|||
124855518|NCT00129987|449093865|FG000|1st Educational Session|Withdrawal by Subject|141|||
124855519|NCT00129987|449093866|FG001|1st Educational Session|Withdrawal by Subject|109|||
124855520|NCT00129987|449093865|FG000|1 Year|Withdrawal by Subject|32|||
124855521|NCT00129987|449093866|FG001|1 Year|Withdrawal by Subject|21|||
124855522|NCT01760954|449093870|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
124855523|NCT01760954|449093871|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
124855524|NCT01760954|449093872|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
124855525|NCT01760954|449093873|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
124855526|NCT01760954|449093870|FG000|Treatment Period (6 Months)|Adverse Event|5|||
124855527|NCT01760954|449093871|FG001|Treatment Period (6 Months)|Adverse Event|3|||
124855528|NCT01760954|449093872|FG002|Treatment Period (6 Months)|Adverse Event|4|||
124855529|NCT01760954|449093873|FG003|Treatment Period (6 Months)|Adverse Event|10|||
124855530|NCT01760954|449093870|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
124855531|NCT01760954|449093871|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
124855532|NCT01760954|449093872|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
124855533|NCT01760954|449093873|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
124855534|NCT01760954|449093870|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
124855535|NCT01760954|449093871|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
124855536|NCT01760954|449093872|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
124855537|NCT01760954|449093873|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
124855538|NCT01760954|449093870|FG000|Treatment Period (6 Months)|Pregnancy|5|||
124855539|NCT01760954|449093871|FG001|Treatment Period (6 Months)|Pregnancy|0|||
124855540|NCT01760954|449093872|FG002|Treatment Period (6 Months)|Pregnancy|3|||
124855541|NCT01760954|449093873|FG003|Treatment Period (6 Months)|Pregnancy|2|||
124855542|NCT01760954|449093870|FG000|Treatment Period (6 Months)|Non-compliance|1|||
124855543|NCT01760954|449093871|FG001|Treatment Period (6 Months)|Non-compliance|4|||
124855544|NCT01760954|449093872|FG002|Treatment Period (6 Months)|Non-compliance|0|||
124855545|NCT01760954|449093873|FG003|Treatment Period (6 Months)|Non-compliance|3|||
124855546|NCT01760954|449093870|FG000|Treatment Period (6 Months)|Other|0|||
124855547|NCT01760954|449093871|FG001|Treatment Period (6 Months)|Other|3|||
124855548|NCT01760954|449093872|FG002|Treatment Period (6 Months)|Other|3|||
124855549|NCT01760954|449093873|FG003|Treatment Period (6 Months)|Other|1|||
124855550|NCT01760954|449093870|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
124855551|NCT01760954|449093871|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
124855552|NCT01760954|449093872|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
124855553|NCT01760954|449093873|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
124855554|NCT01760954|449093870|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
124855555|NCT01760954|449093871|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
124855556|NCT01760954|449093872|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
124855557|NCT01760954|449093873|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
124855558|NCT01760954|449093870|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
124855559|NCT01760954|449093871|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
124855560|NCT01760954|449093872|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
124855561|NCT01760954|449093873|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
124855562|NCT01760954|449093870|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
124855563|NCT01760954|449093871|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
124855564|NCT01760954|449093872|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
124855565|NCT01760954|449093873|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
124855566|NCT01760954|449093870|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
124855567|NCT01760954|449093871|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
124855568|NCT01760954|449093872|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
124855569|NCT01760954|449093873|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
124855570|NCT01760954|449093870|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
124855571|NCT01760954|449093871|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
124855572|NCT01760954|449093872|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
124855573|NCT01760954|449093873|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
124855574|NCT01760954|449093870|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
124855575|NCT01760954|449093871|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
124855576|NCT01760954|449093872|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
124855577|NCT01760954|449093873|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
124855578|NCT01760954|449093870|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
124855579|NCT01760954|449093871|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
124855580|NCT01760954|449093872|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
124855581|NCT01760954|449093873|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
124855582|NCT03320070|449093874|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
124855583|NCT03320070|449093875|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
124855584|NCT03320070|449093874|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
124855585|NCT03320070|449093875|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
124855586|NCT03320070|449093874|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
124855587|NCT03320070|449093875|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
124855588|NCT03320070|449093874|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
124855589|NCT03320070|449093875|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
124855590|NCT03320070|449093874|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
124855591|NCT03320070|449093875|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
124855592|NCT03320070|449093874|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
124855593|NCT03320070|449093875|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
124855594|NCT00996996|449093876|FG000|Overall Study|Progressive Disease|10|||
124855595|NCT00996996|449093876|FG000|Overall Study|Non-compliance|8|||
124855596|NCT00996996|449093876|FG000|Overall Study|Lost to Follow-up|9|||
124855597|NCT00996996|449093876|FG000|Overall Study|Death|5|||
124855598|NCT00996996|449093876|FG000|Overall Study|Did Not Receive Study Medications|1|||
124855599|NCT02819726|449093877|FG000|Part A (All Participants)|Lost to Follow-up|0|||
124855600|NCT02819726|449093878|FG001|Part A (All Participants)|Lost to Follow-up|1|||
124855601|NCT02819726|449093879|FG002|Part A (All Participants)|Lost to Follow-up|0|||
124855602|NCT02819726|449093880|FG003|Part A (All Participants)|Lost to Follow-up|0|||
124855603|NCT02819726|449093877|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
124855604|NCT02819726|449093878|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
124855605|NCT02819726|449093879|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
124855606|NCT02819726|449093880|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
124855607|NCT02819726|449093877|FG000|Part A (All Participants)|Protocol non-compliance|3|||
124855608|NCT02819726|449093878|FG001|Part A (All Participants)|Protocol non-compliance|4|||
124855609|NCT02819726|449093879|FG002|Part A (All Participants)|Protocol non-compliance|5|||
124855610|NCT02819726|449093880|FG003|Part A (All Participants)|Protocol non-compliance|0|||
124855611|NCT02819726|449093877|FG000|Part B (All Participants)|Lost to Follow-up|1|||
124855612|NCT02819726|449093878|FG001|Part B (All Participants)|Lost to Follow-up|1|||
124855613|NCT02819726|449093879|FG002|Part B (All Participants)|Lost to Follow-up|2|||
124855614|NCT02819726|449093880|FG003|Part B (All Participants)|Lost to Follow-up|2|||
124855615|NCT02819726|449093877|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
124855616|NCT02819726|449093878|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
124855617|NCT02819726|449093879|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
124855618|NCT02819726|449093880|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
124855619|NCT02819726|449093877|FG000|Part B (All Participants)|Protocol non-compliance|0|||
124855620|NCT02819726|449093878|FG001|Part B (All Participants)|Protocol non-compliance|0|||
124855621|NCT02819726|449093879|FG002|Part B (All Participants)|Protocol non-compliance|1|||
124855622|NCT02819726|449093880|FG003|Part B (All Participants)|Protocol non-compliance|0|||
124855623|NCT00406029|449093881|FG000|Overall Study|Adverse Event|12|||
124855624|NCT00406029|449093882|FG001|Overall Study|Adverse Event|2|||
124855625|NCT00406029|449093883|FG002|Overall Study|Adverse Event|5|||
124855626|NCT00406029|449093884|FG003|Overall Study|Adverse Event|10|||
124855627|NCT00406029|449093885|FG004|Overall Study|Adverse Event|7|||
124855628|NCT00406029|449093881|FG000|Overall Study|Withdrawal by Subject|3|||
124855629|NCT00406029|449093882|FG001|Overall Study|Withdrawal by Subject|4|||
124855630|NCT00406029|449093883|FG002|Overall Study|Withdrawal by Subject|2|||
124855631|NCT00406029|449093884|FG003|Overall Study|Withdrawal by Subject|2|||
124855632|NCT00406029|449093885|FG004|Overall Study|Withdrawal by Subject|0|||
124855633|NCT00406029|449093881|FG000|Overall Study|Protocol Violation|1|||
124855634|NCT00406029|449093882|FG001|Overall Study|Protocol Violation|2|||
124855635|NCT00406029|449093883|FG002|Overall Study|Protocol Violation|0|||
124855636|NCT00406029|449093884|FG003|Overall Study|Protocol Violation|2|||
124855637|NCT00406029|449093885|FG004|Overall Study|Protocol Violation|0|||
124855638|NCT00406029|449093881|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
124855639|NCT00406029|449093882|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
124855640|NCT00406029|449093883|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
124855641|NCT00406029|449093884|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
124855642|NCT00406029|449093885|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
124855643|NCT00406029|449093881|FG000|Overall Study|Randomized in Error|0|||
124855644|NCT00406029|449093882|FG001|Overall Study|Randomized in Error|0|||
124855645|NCT00406029|449093883|FG002|Overall Study|Randomized in Error|2|||
124855646|NCT00406029|449093884|FG003|Overall Study|Randomized in Error|3|||
124855647|NCT00406029|449093885|FG004|Overall Study|Randomized in Error|1|||
124855648|NCT02162810|449093886|FG000|Overall Study|Protocol Violation|1|||
124855649|NCT02162810|449093887|FG001|Overall Study|Protocol Violation|0|||
124855650|NCT02162810|449093886|FG000|Overall Study|patients did not report compliance|4|||
124855651|NCT02162810|449093887|FG001|Overall Study|patients did not report compliance|1|||
124855652|NCT02223390|449093888|FG000|Overall Study|Lost to Follow-up|9|||
124855653|NCT02223390|449093889|FG001|Overall Study|Lost to Follow-up|4|||
124855654|NCT02843568|449093894|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
124855655|NCT02843568|449093895|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
124855656|NCT02843568|449093894|FG000|Overall Study|Death|3|||
124855657|NCT02843568|449093895|FG001|Overall Study|Death|3|||
124855658|NCT02843568|449093894|FG000|Overall Study|Withdrawal by Subject|1|||
124855659|NCT02843568|449093895|FG001|Overall Study|Withdrawal by Subject|1|||
124855660|NCT02843568|449093894|FG000|Overall Study|Lost to Follow-up|2|||
124855661|NCT02843568|449093895|FG001|Overall Study|Lost to Follow-up|0|||
124855662|NCT01255358|449093896|FG000|Overall Study|Adverse Event|2|||
124855663|NCT01255358|449093896|FG000|Overall Study|Protocol Violation|2|||
124855664|NCT00096941|449093908|FG000|Overall Study|disease progression|3|||
124855665|NCT00022516|449093909|FG000|Overall Study|Adverse Event|0|||
124855666|NCT00022516|449093910|FG001|Overall Study|Adverse Event|59|||
124855667|NCT00022516|449093909|FG000|Overall Study|Lack of Efficacy|0|||
124855668|NCT00022516|449093910|FG001|Overall Study|Lack of Efficacy|27|||
124855669|NCT00022516|449093909|FG000|Overall Study|Physician Decision|0|||
124855670|NCT00022516|449093910|FG001|Overall Study|Physician Decision|1|||
124855671|NCT00022516|449093909|FG000|Overall Study|Protocol Violation|1|||
124855672|NCT00022516|449093910|FG001|Overall Study|Protocol Violation|3|||
124855673|NCT00022516|449093909|FG000|Overall Study|Withdrawal by Subject|2|||
124855674|NCT00022516|449093910|FG001|Overall Study|Withdrawal by Subject|113|||
124855675|NCT00022516|449093909|FG000|Overall Study|Incomplete documentation|0|||
124855676|NCT00022516|449093910|FG001|Overall Study|Incomplete documentation|27|||
124855677|NCT02056301|449093913|FG000|Overall Study|Protocol Violation|1|||
124855678|NCT02056301|449093914|FG001|Overall Study|Protocol Violation|2|||
124855679|NCT02056301|449093913|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
124855680|NCT02056301|449093914|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
124855681|NCT02056301|449093913|FG000|Overall Study|Withdrawal by Subject|0|||
124855682|NCT02056301|449093914|FG001|Overall Study|Withdrawal by Subject|1|||
124855683|NCT02056301|449093913|FG000|Overall Study|Issues with epidural|0|||
124855684|NCT02056301|449093914|FG001|Overall Study|Issues with epidural|3|||
124855685|NCT02209324|449093915|FG000|Overall Study|Adverse Event|2|||
124855686|NCT02209324|449093915|FG000|Overall Study|Lack of Efficacy|1|||
124855687|NCT02209324|449093915|FG000|Overall Study|Lost to Follow-up|1|||
124855688|NCT02209324|449093915|FG000|Overall Study|Physician Decision|3|||
124855689|NCT02209324|449093915|FG000|Overall Study|Protocol Violation|14|||
124855690|NCT02209324|449093915|FG000|Overall Study|Withdrawal by Subject|8|||
124855691|NCT02209324|449093915|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
124855692|NCT02209324|449093915|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
124855693|NCT02209324|449093915|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
124855694|NCT01198600|449093916|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
124855695|NCT01198600|449093917|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
124855696|NCT01198600|449093918|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
124855697|NCT01198600|449093919|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
124855698|NCT01198600|449093916|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
124855699|NCT01198600|449093917|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
124855700|NCT01198600|449093918|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
124855701|NCT01198600|449093919|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
124855702|NCT01198600|449093916|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
124855703|NCT01198600|449093917|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
124855704|NCT01198600|449093918|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
124855705|NCT01198600|449093919|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
124855706|NCT01198600|449093916|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
124855707|NCT01198600|449093917|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
124855708|NCT01198600|449093918|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
124855709|NCT01198600|449093919|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
124855710|NCT01198600|449093916|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
124855711|NCT01198600|449093917|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
124855712|NCT01198600|449093918|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
124855713|NCT01198600|449093919|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
124855714|NCT01198600|449093916|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
124855715|NCT01198600|449093917|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
124855716|NCT01198600|449093918|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
124855717|NCT01198600|449093919|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
124855718|NCT01198600|449093916|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
124855719|NCT01198600|449093917|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
124855720|NCT01198600|449093918|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
124855721|NCT01198600|449093919|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
124855722|NCT04798586|449093920|FG000|Overall Study|Death|2|||
124855723|NCT01669343|449093921|FG000|Part A: All Patients|Withdrawal by Subject|7|||
124855724|NCT01669343|449093921|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
124855725|NCT01669343|449093921|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
124855726|NCT01669343|449093921|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
124855727|NCT01669343|449093921|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
124855728|NCT04433767|449093922|FG000|Overall Study|Adverse Event|1|||
124855729|NCT00439777|449093927|FG000|Treatment Period|Death|29|||
124855730|NCT00439777|449093928|FG001|Treatment Period|Death|21|||
124855731|NCT00439777|449093927|FG000|Treatment Period|Study terminated by sponsor|125|||
124855732|NCT00439777|449093928|FG001|Treatment Period|Study terminated by sponsor|132|||
124855733|NCT00439777|449093927|FG000|Treatment Period|Site closed by investigator|0|||
124855734|NCT00439777|449093928|FG001|Treatment Period|Site closed by investigator|1|||
124855735|NCT00439777|449093927|FG000|Treatment Period|Did not take study treatment|7|||
124855736|NCT00439777|449093928|FG001|Treatment Period|Did not take study treatment|8|||
124855737|NCT00439777|449093927|FG000|Treatment Period|Adverse Event|111|||
124855738|NCT00439777|449093928|FG001|Treatment Period|Adverse Event|92|||
124855739|NCT00439777|449093927|FG000|Treatment Period|Protocol Violation|23|||
124855740|NCT00439777|449093928|FG001|Treatment Period|Protocol Violation|30|||
124855741|NCT00439777|449093927|FG000|Treatment Period|Withdrawal by Subject|66|||
124855742|NCT00439777|449093928|FG001|Treatment Period|Withdrawal by Subject|118|||
124855743|NCT00439777|449093927|FG000|Treatment Period|Lack of Efficacy|1|||
124855744|NCT00439777|449093928|FG001|Treatment Period|Lack of Efficacy|4|||
124855745|NCT00439777|449093927|FG000|Treatment Period|Lost to Follow-up|8|||
124855746|NCT00439777|449093928|FG001|Treatment Period|Lost to Follow-up|10|||
124855747|NCT00439777|449093927|FG000|Treatment Period|Protocol driven decision point|1|||
124855748|NCT00439777|449093928|FG001|Treatment Period|Protocol driven decision point|3|||
124855749|NCT00439777|449093927|FG000|Treatment Period|Physician Decision|7|||
124855750|NCT00439777|449093928|FG001|Treatment Period|Physician Decision|18|||
124855751|NCT00439777|449093927|FG000|Treatment Period|Clinical endpoint reached|26|||
124855752|NCT00439777|449093928|FG001|Treatment Period|Clinical endpoint reached|13|||
124855753|NCT00439777|449093927|FG000|Treatment Period|Technical problems|3|||
124855754|NCT00439777|449093928|FG001|Treatment Period|Technical problems|1|||
124855755|NCT00439777|449093927|FG000|Treatment Period|Participant convenience|12|||
124855756|NCT00439777|449093928|FG001|Treatment Period|Participant convenience|8|||
124855757|NCT00439777|449093927|FG000|Observational Period|Protocol Violation|0|||
124855758|NCT00439777|449093928|FG001|Observational Period|Protocol Violation|2|||
124855759|NCT00439777|449093927|FG000|Observational Period|Withdrawal by Subject|9|||
124855760|NCT00439777|449093928|FG001|Observational Period|Withdrawal by Subject|5|||
124855761|NCT00439777|449093927|FG000|Observational Period|Lost to Follow-up|1|||
124855762|NCT00439777|449093928|FG001|Observational Period|Lost to Follow-up|11|||
124855763|NCT00439777|449093927|FG000|Observational Period|Death|27|||
124855764|NCT00439777|449093928|FG001|Observational Period|Death|20|||
124855765|NCT00439777|449093927|FG000|Observational Period|Study terminated by sponsor|3|||
124855766|NCT00439777|449093928|FG001|Observational Period|Study terminated by sponsor|1|||
124855767|NCT00439777|449093927|FG000|Observational Period|Protocol driven decision point|0|||
124855768|NCT00439777|449093928|FG001|Observational Period|Protocol driven decision point|1|||
124855769|NCT00439777|449093927|FG000|Observational Period|Lack of Efficacy|1|||
124855770|NCT00439777|449093928|FG001|Observational Period|Lack of Efficacy|0|||
124855771|NCT00439777|449093927|FG000|Observational Period|Technical problems|0|||
124855772|NCT00439777|449093928|FG001|Observational Period|Technical problems|1|||
124855773|NCT00661492|449093929|FG000|Overall Study|Adverse Event|16|||
124855774|NCT00661492|449093930|FG001|Overall Study|Adverse Event|13|||
124855775|NCT00661492|449093929|FG000|Overall Study|Disease Progression|44|||
124855776|NCT00661492|449093930|FG001|Overall Study|Disease Progression|14|||
124855777|NCT00661492|449093929|FG000|Overall Study|Patient Request|6|||
124855778|NCT00661492|449093930|FG001|Overall Study|Patient Request|1|||
124855779|NCT00661492|449093929|FG000|Overall Study|Investigator Request|1|||
124855780|NCT00661492|449093930|FG001|Overall Study|Investigator Request|0|||
124855781|NCT00661492|449093929|FG000|Overall Study|Lost to Follow-up|0|||
124855782|NCT00661492|449093930|FG001|Overall Study|Lost to Follow-up|1|||
124855783|NCT00661492|449093929|FG000|Overall Study|Other|1|||
124855784|NCT00661492|449093930|FG001|Overall Study|Other|0|||
124855785|NCT03855189|449093931|FG000|Overall Study|Adverse Event|5|||
124855786|NCT03855189|449093932|FG001|Overall Study|Adverse Event|2|||
124855787|NCT03855189|449093933|FG002|Overall Study|Adverse Event|4|||
124855788|NCT03855189|449093931|FG000|Overall Study|Treatment Failure|1|||
124855789|NCT03855189|449093932|FG001|Overall Study|Treatment Failure|1|||
124855790|NCT03855189|449093933|FG002|Overall Study|Treatment Failure|2|||
124855791|NCT03855189|449093931|FG000|Overall Study|Noncompliance with Protocol|0|||
124855792|NCT03855189|449093932|FG001|Overall Study|Noncompliance with Protocol|1|||
124855793|NCT03855189|449093933|FG002|Overall Study|Noncompliance with Protocol|0|||
124855794|NCT03855189|449093931|FG000|Overall Study|Did Not Return|4|||
124855795|NCT03855189|449093932|FG001|Overall Study|Did Not Return|3|||
124855796|NCT03855189|449093933|FG002|Overall Study|Did Not Return|0|||
124855797|NCT01143259|449093934|FG000|Overall Study|Withdrawal by Subject|3|||
124855798|NCT01143259|449093935|FG001|Overall Study|Withdrawal by Subject|2|||
124855799|NCT01143259|449093934|FG000|Overall Study|Protocol Violation|13|||
124855800|NCT01143259|449093935|FG001|Overall Study|Protocol Violation|9|||
124855801|NCT01143259|449093934|FG000|Overall Study|Screen Failure|7|||
124855802|NCT01143259|449093935|FG001|Overall Study|Screen Failure|9|||
124855803|NCT00099983|449093936|FG000|Overall Study|Lost to Follow-up|2|||
124855804|NCT00099983|449093937|FG001|Overall Study|Lost to Follow-up|3|||
124855805|NCT00099983|449093936|FG000|Overall Study|Missing Source Documents|14|||
124855806|NCT00099983|449093937|FG001|Overall Study|Missing Source Documents|15|||
124855807|NCT00099983|449093936|FG000|Overall Study|Withdrawal by Subject|3|||
124855808|NCT00099983|449093937|FG001|Overall Study|Withdrawal by Subject|2|||
124855809|NCT00099983|449093936|FG000|Overall Study|Adverse Event|1|||
124855810|NCT00099983|449093937|FG001|Overall Study|Adverse Event|1|||
124855811|NCT00099983|449093936|FG000|Overall Study|Lack of Efficacy|0|||
124855812|NCT00099983|449093937|FG001|Overall Study|Lack of Efficacy|1|||
124855813|NCT00099983|449093936|FG000|Overall Study|Unable to return for appointments|1|||
124855814|NCT00099983|449093937|FG001|Overall Study|Unable to return for appointments|1|||
124855815|NCT00099983|449093936|FG000|Overall Study|Moved|1|||
124855816|NCT00099983|449093937|FG001|Overall Study|Moved|0|||
124855817|NCT00099983|449093936|FG000|Overall Study|Other psychiatric problem|1|||
124855818|NCT00099983|449093937|FG001|Overall Study|Other psychiatric problem|0|||
124855819|NCT00099983|449093936|FG000|Overall Study|Incarcerated|0|||
124855820|NCT00099983|449093937|FG001|Overall Study|Incarcerated|1|||
124855821|NCT00099983|449093936|FG000|Overall Study|Intolerant of burden of visits|0|||
124855822|NCT00099983|449093937|FG001|Overall Study|Intolerant of burden of visits|1|||
124855823|NCT00099983|449093936|FG000|Overall Study|Other issue|1|||
124855824|NCT00099983|449093937|FG001|Overall Study|Other issue|0|||
124855825|NCT02641080|449093938|FG000|Overall Study|Physician Decision|2|||
124855826|NCT02641080|449093939|FG001|Overall Study|Physician Decision|0|||
124855827|NCT02641080|449093938|FG000|Overall Study|Withdrawal by Subject|0|||
124855828|NCT02641080|449093939|FG001|Overall Study|Withdrawal by Subject|1|||
124855829|NCT02641080|449093938|FG000|Overall Study|Rehab Center denied use of pumps|0|||
124855830|NCT02641080|449093939|FG001|Overall Study|Rehab Center denied use of pumps|3|||
124855831|NCT02641080|449093938|FG000|Overall Study|Lost to Follow-up|0|||
124855832|NCT02641080|449093939|FG001|Overall Study|Lost to Follow-up|3|||
124855833|NCT00803634|449093940|FG000|Overall Study|Withdrew Consent|1|||
124855834|NCT00803634|449093941|FG001|Overall Study|Withdrew Consent|0|||
124855835|NCT00803634|449093940|FG000|Overall Study|Lost to Follow-up|2|||
124855836|NCT00803634|449093941|FG001|Overall Study|Lost to Follow-up|3|||
124855837|NCT00803634|449093940|FG000|Overall Study|Death|3|||
124855838|NCT00803634|449093941|FG001|Overall Study|Death|2|||
124855839|NCT04307186|449093944|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
124855840|NCT04307186|449093944|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
124855841|NCT04307186|449093944|FG000|Washout 3-14 Days|Progressive disease|1|||
124855842|NCT04307186|449093944|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
124855843|NCT04307186|449093944|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
124855844|NCT03238001|449093948|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
124855845|NCT03238001|449093948|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
124855846|NCT03238001|449093948|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
124855847|NCT03238001|449093948|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
124855848|NCT03238001|449093948|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
124855849|NCT03238001|449093948|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
124855850|NCT03238001|449093948|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
124855851|NCT03238001|449093948|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
124855852|NCT03165045|449093949|FG000|Visit 1|No registration after visit 1|9|||
124855853|NCT03165045|449093949|FG000|Visit 1|No treatment documented|10|||
124855854|NCT03165045|449093949|FG000|Visit 1|No visit 1|10|||
124855855|NCT03165045|449093949|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
124855856|NCT03165045|449093949|FG000|Visit 2|No available total CCQ score at all|29|||
124855857|NCT03165045|449093949|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
124855858|NCT00759109|449093950|FG000|Overall Study|Adverse Event|17|||
124855859|NCT00759109|449093951|FG001|Overall Study|Adverse Event|12|||
124855860|NCT00759109|449093950|FG000|Overall Study|Inability to comply|1|||
124855861|NCT00759109|449093951|FG001|Overall Study|Inability to comply|1|||
124855862|NCT00759109|449093950|FG000|Overall Study|Withdrawal by Subject|9|||
124855863|NCT00759109|449093951|FG001|Overall Study|Withdrawal by Subject|5|||
124855864|NCT00759109|449093950|FG000|Overall Study|Death|4|||
124855865|NCT00759109|449093951|FG001|Overall Study|Death|3|||
124855866|NCT00759109|449093950|FG000|Overall Study|Lost to Follow-up|4|||
124855867|NCT00759109|449093951|FG001|Overall Study|Lost to Follow-up|6|||
124855868|NCT00759109|449093950|FG000|Overall Study|Started new therapy|2|||
124855869|NCT00759109|449093951|FG001|Overall Study|Started new therapy|6|||
124855870|NCT00759109|449093950|FG000|Overall Study|HCV RNA negative|1|||
124855871|NCT00759109|449093951|FG001|Overall Study|HCV RNA negative|0|||
124855872|NCT00759109|449093950|FG000|Overall Study|Participant moved to a different city|0|||
124855873|NCT00759109|449093951|FG001|Overall Study|Participant moved to a different city|1|||
124855874|NCT00759109|449093950|FG000|Overall Study|Participant had a liver transplant|0|||
124855875|NCT00759109|449093951|FG001|Overall Study|Participant had a liver transplant|1|||
124855876|NCT00759109|449093950|FG000|Overall Study|Lost during study|1|||
124855877|NCT00759109|449093951|FG001|Overall Study|Lost during study|0|||
124855878|NCT01866709|449093955|FG000|Overall Study|Adverse Event|1|||
124855879|NCT01866709|449093956|FG001|Overall Study|Adverse Event|0|||
124855880|NCT03791398|449093957|FG000|Overall Study|Progression of Disease Under Study|2|||
124855881|NCT03791398|449093958|FG001|Overall Study|Progression of Disease Under Study|0|||
124855882|NCT03791398|449093959|FG002|Overall Study|Progression of Disease Under Study|0|||
124855883|NCT02207829|449093960|FG000|Overall Study|Adverse Event|10|||
124855884|NCT02207829|449093961|FG001|Overall Study|Adverse Event|9|||
124855885|NCT02207829|449093960|FG000|Overall Study|Lack of Efficacy|7|||
124855886|NCT02207829|449093961|FG001|Overall Study|Lack of Efficacy|5|||
124855887|NCT02207829|449093960|FG000|Overall Study|Lost to Follow-up|2|||
124855888|NCT02207829|449093961|FG001|Overall Study|Lost to Follow-up|2|||
124855889|NCT02207829|449093960|FG000|Overall Study|Protocol deviation|5|||
124855890|NCT02207829|449093961|FG001|Overall Study|Protocol deviation|4|||
124855891|NCT02207829|449093960|FG000|Overall Study|Withdrew consent|18|||
124855892|NCT02207829|449093961|FG001|Overall Study|Withdrew consent|14|||
124855893|NCT00766376|449093962|FG000|Overall Study|Withdrawal by Subject|27|||
124855894|NCT00927927|449093968|FG000|Overall Study|Withdrawal by Subject|0|||
124855895|NCT00927927|449093969|FG001|Overall Study|Withdrawal by Subject|0|||
124855896|NCT00927927|449093970|FG002|Overall Study|Withdrawal by Subject|0|||
124855897|NCT00927927|449093971|FG003|Overall Study|Withdrawal by Subject|0|||
124855898|NCT00927927|449093972|FG004|Overall Study|Withdrawal by Subject|0|||
124855899|NCT00927927|449093973|FG005|Overall Study|Withdrawal by Subject|0|||
124855900|NCT00927927|449093974|FG006|Overall Study|Withdrawal by Subject|0|||
124855901|NCT00927927|449093975|FG007|Overall Study|Withdrawal by Subject|2|||
124855902|NCT00927927|449093976|FG008|Overall Study|Withdrawal by Subject|0|||
124855903|NCT00927927|449093977|FG009|Overall Study|Withdrawal by Subject|0|||
124855904|NCT00927927|449093978|FG010|Overall Study|Withdrawal by Subject|0|||
124855905|NCT00927927|449093979|FG011|Overall Study|Withdrawal by Subject|2|||
124855906|NCT00927927|449093980|FG012|Overall Study|Withdrawal by Subject|0|||
124855907|NCT00927927|449093981|FG013|Overall Study|Withdrawal by Subject|0|||
124855908|NCT00927927|449093982|FG014|Overall Study|Withdrawal by Subject|0|||
124855909|NCT01110239|449093987|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
124855910|NCT01110239|449093988|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
124855911|NCT01110239|449093989|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
124855912|NCT01110239|449093990|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
124855913|NCT01110239|449093987|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
124855914|NCT01110239|449093988|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
124855915|NCT01110239|449093989|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
124855916|NCT01110239|449093990|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
124855917|NCT00080223|449093993|FG000|Overall Study|Adverse Event|23|||
124855918|NCT00080223|449093993|FG000|Overall Study|Death|21|||
124855919|NCT00080223|449093993|FG000|Overall Study|Withdrawal by Subject|13|||
124855920|NCT00080223|449093993|FG000|Overall Study|Lung Transplantation|9|||
124855921|NCT00080223|449093993|FG000|Overall Study|Non-compliance With Study Treatment|7|||
124855922|NCT00080223|449093993|FG000|Overall Study|Participant unwilling to continue|2|||
124855923|NCT00080223|449093993|FG000|Overall Study|Physician Decision|1|||
124855924|NCT05204134|449093996|FG000|Overall Study|Withdrawal by Subject|3|||
124855925|NCT05204134|449093996|FG000|Overall Study|Physician Decision|1|||
124855926|NCT03135522|449093997|FG000|Overall Study|Adverse Event|1|||
124855927|NCT03135522|449093998|FG001|Overall Study|Adverse Event|0|||
124855928|NCT03099382|449093999|FG000|Overall Study|Protocol Violation|2|||
124855929|NCT03099382|449094000|FG001|Overall Study|Protocol Violation|3|||
124855930|NCT00499369|449094001|FG000|Overall Study|Adverse Event|2|||
124855931|NCT00499369|449094002|FG001|Overall Study|Adverse Event|2|||
124855932|NCT00499369|449094003|FG002|Overall Study|Adverse Event|3|||
124855933|NCT00499369|449094004|FG003|Overall Study|Adverse Event|1|||
124855934|NCT00499369|449094005|FG004|Overall Study|Adverse Event|2|||
124855935|NCT00499369|449094001|FG000|Overall Study|Withdrawal by Subject|0|||
124855936|NCT00499369|449094002|FG001|Overall Study|Withdrawal by Subject|1|||
124855937|NCT00499369|449094003|FG002|Overall Study|Withdrawal by Subject|1|||
124855938|NCT00499369|449094004|FG003|Overall Study|Withdrawal by Subject|0|||
124855939|NCT00499369|449094005|FG004|Overall Study|Withdrawal by Subject|0|||
124855940|NCT00499369|449094001|FG000|Overall Study|Progression|10|||
124855941|NCT00499369|449094002|FG001|Overall Study|Progression|12|||
124855942|NCT00499369|449094003|FG002|Overall Study|Progression|9|||
124855943|NCT00499369|449094004|FG003|Overall Study|Progression|6|||
124855944|NCT00499369|449094005|FG004|Overall Study|Progression|10|||
124855945|NCT00499369|449094001|FG000|Overall Study|Death|0|||
124855946|NCT00499369|449094002|FG001|Overall Study|Death|1|||
124855947|NCT00499369|449094003|FG002|Overall Study|Death|0|||
124855948|NCT00499369|449094004|FG003|Overall Study|Death|0|||
124855949|NCT00499369|449094005|FG004|Overall Study|Death|0|||
124855950|NCT00499369|449094001|FG000|Overall Study|Not protocol specified|2|||
124855951|NCT00499369|449094002|FG001|Overall Study|Not protocol specified|0|||
124855952|NCT00499369|449094003|FG002|Overall Study|Not protocol specified|3|||
124855953|NCT00499369|449094004|FG003|Overall Study|Not protocol specified|1|||
124855954|NCT00499369|449094005|FG004|Overall Study|Not protocol specified|0|||
124855955|NCT00499369|449094001|FG000|Overall Study|Ineligible|2|||
124855956|NCT00499369|449094002|FG001|Overall Study|Ineligible|2|||
124855957|NCT00499369|449094003|FG002|Overall Study|Ineligible|1|||
124855958|NCT00499369|449094004|FG003|Overall Study|Ineligible|1|||
124855959|NCT00499369|449094005|FG004|Overall Study|Ineligible|0|||
124855960|NCT01802411|449094006|FG000|Overall Study|Death|2|||
124855961|NCT01802411|449094007|FG001|Overall Study|Death|1|||
124855962|NCT01802411|449094006|FG000|Overall Study|Adverse Event|2|||
124855963|NCT01802411|449094007|FG001|Overall Study|Adverse Event|7|||
124855964|NCT01802411|449094006|FG000|Overall Study|Lack of Efficacy|8|||
124855965|NCT01802411|449094007|FG001|Overall Study|Lack of Efficacy|10|||
124855966|NCT01802411|449094006|FG000|Overall Study|Withdrawal by Subject|0|||
124855967|NCT01802411|449094007|FG001|Overall Study|Withdrawal by Subject|2|||
124855968|NCT01802411|449094006|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
124855969|NCT01802411|449094007|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
124855970|NCT01802411|449094006|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
124855971|NCT01802411|449094007|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
124855972|NCT01802411|449094006|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
124855973|NCT01802411|449094007|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
124855974|NCT03285477|449094010|FG000|Treatment and Response Assessment Period|Death|1|||
124855975|NCT03285477|449094011|FG001|Treatment and Response Assessment Period|Death|0|||
124855976|NCT03285477|449094010|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
124855977|NCT03285477|449094011|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
124855978|NCT03285477|449094010|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
124855979|NCT03285477|449094011|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
124855980|NCT03285477|449094010|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
124855981|NCT03285477|449094011|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
124855982|NCT03285477|449094010|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
124855983|NCT03285477|449094011|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
124855984|NCT00852397|449094014|FG000|Overall Study|Adverse Event|4|||
124855985|NCT00852397|449094015|FG001|Overall Study|Adverse Event|6|||
124855986|NCT00852397|449094016|FG002|Overall Study|Adverse Event|4|||
124855987|NCT00852397|449094014|FG000|Overall Study|Death|0|||
124855988|NCT00852397|449094015|FG001|Overall Study|Death|0|||
124855989|NCT00852397|449094016|FG002|Overall Study|Death|1|||
124855990|NCT00852397|449094014|FG000|Overall Study|Withdrawal by Subject|4|||
124855991|NCT00852397|449094015|FG001|Overall Study|Withdrawal by Subject|1|||
124855992|NCT00852397|449094016|FG002|Overall Study|Withdrawal by Subject|2|||
124855993|NCT00852397|449094014|FG000|Overall Study|Study terminated by sponsor|2|||
124855994|NCT00852397|449094015|FG001|Overall Study|Study terminated by sponsor|1|||
124855995|NCT00852397|449094016|FG002|Overall Study|Study terminated by sponsor|6|||
124855996|NCT00852397|449094014|FG000|Overall Study|Difficulty in study site visit|1|||
124855997|NCT00852397|449094015|FG001|Overall Study|Difficulty in study site visit|0|||
124855998|NCT00852397|449094016|FG002|Overall Study|Difficulty in study site visit|0|||
124855999|NCT00852397|449094014|FG000|Overall Study|Protocol Violation|0|||
124856000|NCT00852397|449094015|FG001|Overall Study|Protocol Violation|0|||
124856001|NCT00852397|449094016|FG002|Overall Study|Protocol Violation|1|||
124856002|NCT02345512|449094017|FG000|Overall Study|Adverse Event|1|||
124856003|NCT02345512|449094017|FG000|Overall Study|Withdrawal by Subject|1|||
124856004|NCT02663817|449094018|FG000|Overall Study|Screen failure|2|||
124856005|NCT01438541|449094019|FG000|Overall Study|Physician Decision|1|||
124856006|NCT01438541|449094019|FG000|Overall Study|Withdrawal by Subject|1|||
124856007|NCT01438541|449094019|FG000|Overall Study|discharge from the hospital|5|||
124856008|NCT01968434|449094022|FG000|Overall Study|Lost to Follow-up|3|||
124856009|NCT01968434|449094023|FG001|Overall Study|Lost to Follow-up|6|||
124856010|NCT02091167|449094025|FG000|Overall Study|Lost to Follow-up|0|||
124856011|NCT02091167|449094026|FG001|Overall Study|Lost to Follow-up|2|||
124856012|NCT00489970|449096042|FG000|Persistence Year 9|Lost to Follow-up|2|||
124856013|NCT00489970|449096043|FG001|Persistence Year 9|Lost to Follow-up|2|||
124856014|NCT00489970|449096044|FG002|Persistence Year 9|Lost to Follow-up|3|||
124856015|NCT00489970|449096042|FG000|Persistence Year 9|Other|1|||
124856016|NCT00489970|449096043|FG001|Persistence Year 9|Other|0|||
124856017|NCT00489970|449096044|FG002|Persistence Year 9|Other|2|||
124856018|NCT00116805|449096045|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
124856019|NCT00116805|449096046|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
124856020|NCT00116805|449096045|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
124856021|NCT00116805|449096046|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
124856022|NCT00116805|449096045|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
124856023|NCT00116805|449096046|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
124856024|NCT00116805|449096045|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
124856025|NCT00116805|449096046|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
124856026|NCT00116805|449096045|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
124856027|NCT00116805|449096046|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
124856028|NCT00116805|449096045|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
124856029|NCT00116805|449096046|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
124856030|NCT00116805|449096045|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
124856031|NCT00116805|449096046|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
124856032|NCT00116805|449096045|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
124856033|NCT00116805|449096046|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
124856034|NCT00116805|449096045|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
124856035|NCT00116805|449096046|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
124856036|NCT00116805|449096045|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
124856037|NCT00116805|449096046|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
124856038|NCT00116805|449096045|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
124856039|NCT00116805|449096046|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
124856040|NCT00116805|449096045|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
124856041|NCT00116805|449096046|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
124856042|NCT00116805|449096045|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
124856043|NCT00116805|449096046|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
124856044|NCT00116805|449096045|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
124856045|NCT00116805|449096046|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
124856046|NCT00116805|449096045|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
124856047|NCT00116805|449096046|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
124856048|NCT00116805|449096045|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
124856049|NCT00116805|449096046|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
124856050|NCT00116805|449096045|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
124856051|NCT00116805|449096046|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
124856052|NCT00116805|449096045|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
124856053|NCT00116805|449096046|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
124856054|NCT00116805|449096045|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
124856055|NCT00116805|449096046|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
124856056|NCT00116805|449096045|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
124856057|NCT00116805|449096046|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
124856058|NCT00116805|449096045|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
124856059|NCT00116805|449096046|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
124856060|NCT00116805|449096045|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
124856061|NCT00116805|449096046|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
124856062|NCT00116805|449096045|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
124856063|NCT00116805|449096046|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
124856064|NCT00116805|449096045|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
124856065|NCT00116805|449096046|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
124856066|NCT00116805|449096045|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
124856067|NCT00116805|449096046|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
124856068|NCT00116805|449096045|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
124856069|NCT00116805|449096046|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
124856070|NCT00116805|449096045|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
124856071|NCT00116805|449096046|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
124856072|NCT00116805|449096045|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
124856073|NCT00116805|449096046|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
124856074|NCT00116805|449096045|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
124856075|NCT00116805|449096046|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
124856076|NCT00116805|449096045|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
124856077|NCT00116805|449096046|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
124856078|NCT00116805|449096045|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
124856079|NCT00116805|449096046|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
124856080|NCT00116805|449096045|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
124856081|NCT00116805|449096046|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
124856082|NCT00116805|449096045|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
124856083|NCT00116805|449096046|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
124856084|NCT00116805|449096045|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
124856085|NCT00116805|449096046|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
124856086|NCT00116805|449096045|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
124856087|NCT00116805|449096046|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
124856088|NCT00116805|449096045|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
124856089|NCT00116805|449096046|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
124856090|NCT00116805|449096045|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
124856091|NCT00116805|449096046|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
124856092|NCT00116805|449096045|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
124856093|NCT00116805|449096046|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
124856094|NCT00116805|449096045|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
124856095|NCT00116805|449096046|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
124856096|NCT00116805|449096045|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
124856097|NCT00116805|449096046|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
124856098|NCT00116805|449096045|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
124856099|NCT00116805|449096046|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
124856100|NCT00116805|449096045|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
124856101|NCT00116805|449096046|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
124856102|NCT00116805|449096045|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
124856103|NCT00116805|449096046|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
124856104|NCT00116805|449096045|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
124856105|NCT00116805|449096046|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
124856106|NCT00116805|449096045|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
124856107|NCT00116805|449096046|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
124856108|NCT02707055|449096053|FG000|Phase 1|Withdrawal by Subject|1|||
124856109|NCT02707055|449096054|FG001|Phase 1|Withdrawal by Subject|2|||
124856110|NCT02707055|449096053|FG000|Phase 1|Physician Decision|0|||
124856111|NCT02707055|449096054|FG001|Phase 1|Physician Decision|1|||
124856112|NCT02707055|449096053|FG000|Phase 2|Adverse Event|1|||
124856113|NCT02707055|449096054|FG001|Phase 2|Adverse Event|2|||
124856114|NCT03564496|449096055|FG000|Overall Study|Withdrawal by Subject|1|||
124856115|NCT03564496|449096056|FG001|Overall Study|Withdrawal by Subject|1|||
124856116|NCT03564496|449096057|FG002|Overall Study|Withdrawal by Subject|0|||
124856117|NCT03564496|449096055|FG000|Overall Study|Screen failure|0|||
124856118|NCT03564496|449096056|FG001|Overall Study|Screen failure|3|||
124856119|NCT03564496|449096057|FG002|Overall Study|Screen failure|0|||
124856120|NCT01159938|449096058|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
124856121|NCT01159938|449096059|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
124856122|NCT01159938|449096060|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
124856123|NCT01159938|449096061|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
124856124|NCT01159938|449096062|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
124856125|NCT00317772|449096066|FG000|Overall Study|Adverse Event|0|||
124856126|NCT00317772|449096067|FG001|Overall Study|Adverse Event|0|||
124856127|NCT00317772|449096068|FG002|Overall Study|Adverse Event|0|||
124856128|NCT00317772|449096069|FG003|Overall Study|Adverse Event|2|||
124856129|NCT00317772|449096066|FG000|Overall Study|Disease Progression|2|||
124856130|NCT00317772|449096067|FG001|Overall Study|Disease Progression|2|||
124856131|NCT00317772|449096068|FG002|Overall Study|Disease Progression|1|||
124856132|NCT00317772|449096069|FG003|Overall Study|Disease Progression|7|||
124856133|NCT00353704|449096082|FG000|Overall Study|Protocol Violation|3|||
124856134|NCT00353704|449096083|FG001|Overall Study|Protocol Violation|1|||
124856135|NCT04495374|449096084|FG000|Overall Study|Protocol Violation|2|||
124856136|NCT04495374|449096085|FG001|Overall Study|Protocol Violation|1|||
124856137|NCT02473614|449096086|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
124856138|NCT02473614|449096087|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
124856139|NCT01303627|449096088|FG000|Overall Study|the failure while performing URS|0|||
124856140|NCT01303627|449096089|FG001|Overall Study|the failure while performing URS|1|||
124856141|NCT02416791|449096091|FG000|6 Months|Lost to Follow-up|0|||
124856142|NCT02416791|449096092|FG001|6 Months|Lost to Follow-up|0|||
124856143|NCT02416791|449096093|FG002|6 Months|Lost to Follow-up|1|||
124856144|NCT01054820|449096094|FG000|Overall Study|Withdrawal by Subject|2|||
124856145|NCT01154166|449096096|FG000|Overall Study|Adverse Event|14|||
124856146|NCT01154166|449096097|FG001|Overall Study|Adverse Event|9|||
124856147|NCT01154166|449096096|FG000|Overall Study|Lost to Follow-up|1|||
124856148|NCT01154166|449096097|FG001|Overall Study|Lost to Follow-up|1|||
124856149|NCT01154166|449096096|FG000|Overall Study|Protocol Violation|4|||
124856150|NCT01154166|449096097|FG001|Overall Study|Protocol Violation|1|||
124856151|NCT01154166|449096096|FG000|Overall Study|Withdrawal by Subject|10|||
124856152|NCT01154166|449096097|FG001|Overall Study|Withdrawal by Subject|1|||
124856153|NCT01154166|449096096|FG000|Overall Study|Lack of Efficacy|3|||
124856154|NCT01154166|449096097|FG001|Overall Study|Lack of Efficacy|0|||
124856155|NCT01154166|449096096|FG000|Overall Study|Disease Progression|1|||
124856156|NCT01154166|449096097|FG001|Overall Study|Disease Progression|0|||
124856157|NCT01154166|449096096|FG000|Overall Study|Poor Compliance|1|||
124856158|NCT01154166|449096097|FG001|Overall Study|Poor Compliance|0|||
124856159|NCT04121962|449096100|FG000|Overall Study|Lost to Follow-up|42|||
124856160|NCT04121962|449096101|FG001|Overall Study|Lost to Follow-up|39|||
124856161|NCT02019719|449096102|FG000|Overall Study|Adverse Event|1|||
124856162|NCT02019719|449096103|FG001|Overall Study|Adverse Event|0|||
124856163|NCT02019719|449096104|FG002|Overall Study|Adverse Event|0|||
124856164|NCT02019719|449096105|FG003|Overall Study|Adverse Event|1|||
124856165|NCT02019719|449096106|FG004|Overall Study|Adverse Event|1|||
124856166|NCT02019719|449096102|FG000|Overall Study|Protocol Violation|1|||
124856167|NCT02019719|449096103|FG001|Overall Study|Protocol Violation|1|||
124856168|NCT02019719|449096104|FG002|Overall Study|Protocol Violation|0|||
124856169|NCT02019719|449096105|FG003|Overall Study|Protocol Violation|0|||
124856170|NCT02019719|449096106|FG004|Overall Study|Protocol Violation|0|||
124856171|NCT02019719|449096102|FG000|Overall Study|Protocol defined stopping criteria|2|||
124856172|NCT02019719|449096103|FG001|Overall Study|Protocol defined stopping criteria|0|||
124856173|NCT02019719|449096104|FG002|Overall Study|Protocol defined stopping criteria|0|||
124856174|NCT02019719|449096105|FG003|Overall Study|Protocol defined stopping criteria|1|||
124856175|NCT02019719|449096106|FG004|Overall Study|Protocol defined stopping criteria|1|||
124856176|NCT02019719|449096102|FG000|Overall Study|Physician Decision|2|||
124856177|NCT02019719|449096103|FG001|Overall Study|Physician Decision|0|||
124856178|NCT02019719|449096104|FG002|Overall Study|Physician Decision|0|||
124856179|NCT02019719|449096105|FG003|Overall Study|Physician Decision|0|||
124856180|NCT02019719|449096106|FG004|Overall Study|Physician Decision|0|||
124856181|NCT04535037|449096107|FG000|Overall Study|Protocol Violation|1|||
124856182|NCT04535037|449096108|FG001|Overall Study|Protocol Violation|0|||
124856183|NCT04535037|449096107|FG000|Overall Study|Withdrawal by Subject|8|||
124856184|NCT04535037|449096108|FG001|Overall Study|Withdrawal by Subject|9|||
124856185|NCT04535037|449096107|FG000|Overall Study|Migrated / moved from the study area|1|||
124856186|NCT04535037|449096108|FG001|Overall Study|Migrated / moved from the study area|4|||
124856187|NCT04535037|449096107|FG000|Overall Study|Other|2|||
124856188|NCT04535037|449096108|FG001|Overall Study|Other|5|||
124856189|NCT02731131|449096116|FG000|Overall Study|Psychiatric Disorder|0|||
124856190|NCT02731131|449096117|FG001|Overall Study|Psychiatric Disorder|1|||
124856191|NCT02731131|449096116|FG000|Overall Study|Refused Therapy|0|||
124856192|NCT02731131|449096117|FG001|Overall Study|Refused Therapy|1|||
124856193|NCT02348216|449096118|FG000|Overall Study|Death|5|||
124856194|NCT02348216|449096119|FG001|Overall Study|Death|53|||
124856195|NCT02348216|449096120|FG002|Overall Study|Death|11|||
124856196|NCT02348216|449096121|FG003|Overall Study|Death|20|||
124856197|NCT02348216|449096122|FG004|Overall Study|Death|16|||
124856198|NCT02348216|449096123|FG005|Overall Study|Death|32|||
124856199|NCT02348216|449096124|FG006|Overall Study|Death|17|||
124856200|NCT02348216|449096118|FG000|Overall Study|Full consent withdrawal|0|||
124856201|NCT02348216|449096119|FG001|Overall Study|Full consent withdrawal|0|||
124856202|NCT02348216|449096120|FG002|Overall Study|Full consent withdrawal|0|||
124856203|NCT02348216|449096121|FG003|Overall Study|Full consent withdrawal|1|||
124856204|NCT02348216|449096122|FG004|Overall Study|Full consent withdrawal|3|||
124856205|NCT02348216|449096123|FG005|Overall Study|Full consent withdrawal|0|||
124856206|NCT02348216|449096124|FG006|Overall Study|Full consent withdrawal|3|||
124856207|NCT02348216|449096118|FG000|Overall Study|Lost to Follow-up|0|||
124856208|NCT02348216|449096119|FG001|Overall Study|Lost to Follow-up|5|||
124856209|NCT02348216|449096120|FG002|Overall Study|Lost to Follow-up|2|||
124856210|NCT02348216|449096121|FG003|Overall Study|Lost to Follow-up|0|||
124856211|NCT02348216|449096122|FG004|Overall Study|Lost to Follow-up|1|||
124856212|NCT02348216|449096123|FG005|Overall Study|Lost to Follow-up|1|||
124856213|NCT02348216|449096124|FG006|Overall Study|Lost to Follow-up|1|||
124856214|NCT02348216|449096118|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
124856215|NCT02348216|449096119|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
124856216|NCT02348216|449096120|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
124856217|NCT02348216|449096121|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
124856218|NCT02348216|449096122|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
124856219|NCT02348216|449096123|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
124856220|NCT02348216|449096124|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
124856221|NCT02348216|449096118|FG000|Overall Study|Reason not specified|2|||
124856222|NCT02348216|449096119|FG001|Overall Study|Reason not specified|19|||
124856223|NCT02348216|449096120|FG002|Overall Study|Reason not specified|11|||
124856224|NCT02348216|449096121|FG003|Overall Study|Reason not specified|17|||
124856225|NCT02348216|449096122|FG004|Overall Study|Reason not specified|21|||
124856226|NCT02348216|449096123|FG005|Overall Study|Reason not specified|17|||
124856227|NCT02348216|449096124|FG006|Overall Study|Reason not specified|19|||
124856228|NCT00765245|449096125|FG000|Overall Study|disease progression|3|||
124856229|NCT00765245|449096126|FG001|Overall Study|disease progression|2|||
124856230|NCT00765245|449096125|FG000|Overall Study|Withdrawal by Subject|3|||
124856231|NCT00765245|449096126|FG001|Overall Study|Withdrawal by Subject|0|||
124856232|NCT00765245|449096125|FG000|Overall Study|Adverse Event|5|||
124856233|NCT00765245|449096126|FG001|Overall Study|Adverse Event|0|||
124856234|NCT00765245|449096125|FG000|Overall Study|Physician Decision|1|||
124856235|NCT00765245|449096126|FG001|Overall Study|Physician Decision|0|||
124856236|NCT00765245|449096125|FG000|Overall Study|Death|1|||
124856237|NCT00765245|449096126|FG001|Overall Study|Death|0|||
124856238|NCT01181921|449096130|FG000|Overall Study|Lost to Follow-up|1|||
124856239|NCT04408469|449096131|FG000|Overall Study|Lost to Follow-up|6|||
124856240|NCT04408469|449096132|FG001|Overall Study|Lost to Follow-up|9|||
124856241|NCT04408469|449096131|FG000|Overall Study|Withdrawal by Subject|6|||
124856242|NCT04408469|449096132|FG001|Overall Study|Withdrawal by Subject|1|||
124856243|NCT04408469|449096131|FG000|Overall Study|Dismissal due to ineligibility|0|||
124856244|NCT04408469|449096132|FG001|Overall Study|Dismissal due to ineligibility|1|||
124856245|NCT04321460|449096135|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
124856246|NCT04321460|449096136|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
124856247|NCT01308749|449096143|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
124856248|NCT01308749|449096144|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
124856249|NCT01308749|449096143|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
124856250|NCT01308749|449096144|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
124856251|NCT01308749|449096143|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
124856252|NCT01308749|449096144|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
124856253|NCT02519504|449096145|FG000|Overall Study|Protocol Violation|6|||
124856254|NCT02519504|449096146|FG001|Overall Study|Protocol Violation|5|||
124856255|NCT02519504|449096145|FG000|Overall Study|Ineligible for direct testing|12|||
124856256|NCT02519504|449096146|FG001|Overall Study|Ineligible for direct testing|12|||
124856257|NCT02519504|449096145|FG000|Overall Study|Did not participate in direct testing|95|||
124856258|NCT02519504|449096146|FG001|Overall Study|Did not participate in direct testing|86|||
124856259|NCT04726709|449096147|FG000|Overall Study|Withdrawal by Subject|2|||
124856260|NCT04726709|449096148|FG001|Overall Study|Withdrawal by Subject|2|||
124856261|NCT02546544|449096149|FG000|Overall Study|Disease Progression|14|||
124856262|NCT02546544|449096149|FG000|Overall Study|Adverse Event|1|||
124856263|NCT02546544|449096149|FG000|Overall Study|Withdrawal by Subject|1|||
124856264|NCT02548962|449096150|FG000|Overall Study|Withdrawal by Subject|1|||
124856265|NCT02548962|449096151|FG001|Overall Study|Withdrawal by Subject|0|||
124856266|NCT01197950|449096152|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
124856267|NCT01197950|449096153|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
124856268|NCT01197950|449096154|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
124856269|NCT04831736|449096155|FG000|Overall Study|Withdrawal by Subject|0|||
124856270|NCT04831736|449096156|FG001|Overall Study|Withdrawal by Subject|1|||
124856271|NCT01666002|449096159|FG000|Overall Study|Lost to Follow-up|5|||
124856272|NCT01666002|449096160|FG001|Overall Study|Lost to Follow-up|0|||
124856273|NCT02159482|449096161|FG000|Overall Study|Withdrawal by Subject|2|||
124856274|NCT02159482|449096161|FG000|Overall Study|Physician Decision|3|||
124856275|NCT02828111|449096164|FG000|Overall Study|Withdrawal by Subject|0|||
124856276|NCT02828111|449096165|FG001|Overall Study|Withdrawal by Subject|0|||
124856277|NCT02828111|449096166|FG002|Overall Study|Withdrawal by Subject|2|||
124856278|NCT02828111|449096167|FG003|Overall Study|Withdrawal by Subject|0|||
124856279|NCT02828111|449096168|FG004|Overall Study|Withdrawal by Subject|0|||
124856280|NCT02828111|449096164|FG000|Overall Study|Lost to Follow-up|0|||
124856281|NCT02828111|449096165|FG001|Overall Study|Lost to Follow-up|0|||
124856282|NCT02828111|449096166|FG002|Overall Study|Lost to Follow-up|0|||
124856283|NCT02828111|449096167|FG003|Overall Study|Lost to Follow-up|1|||
124856284|NCT02828111|449096168|FG004|Overall Study|Lost to Follow-up|1|||
124856285|NCT03465540|449096171|FG000|Overall Study|Withdrawal by Subject|0|||
124856286|NCT03465540|449096172|FG001|Overall Study|Withdrawal by Subject|0|||
124856287|NCT03465540|449096173|FG002|Overall Study|Withdrawal by Subject|1|||
124856288|NCT03465540|449096174|FG003|Overall Study|Withdrawal by Subject|1|||
124856289|NCT03465540|449096175|FG004|Overall Study|Withdrawal by Subject|1|||
124856290|NCT03465540|449096176|FG005|Overall Study|Withdrawal by Subject|0|||
124856291|NCT03465540|449096171|FG000|Overall Study|Lost to Follow-up|0|||
124856292|NCT03465540|449096172|FG001|Overall Study|Lost to Follow-up|1|||
124856293|NCT03465540|449096173|FG002|Overall Study|Lost to Follow-up|0|||
124856294|NCT03465540|449096174|FG003|Overall Study|Lost to Follow-up|0|||
124856295|NCT03465540|449096175|FG004|Overall Study|Lost to Follow-up|1|||
124856296|NCT03465540|449096176|FG005|Overall Study|Lost to Follow-up|0|||
124856297|NCT03465540|449096171|FG000|Overall Study|Death|1|||
124856298|NCT03465540|449096172|FG001|Overall Study|Death|1|||
124856299|NCT03465540|449096173|FG002|Overall Study|Death|0|||
124856300|NCT03465540|449096174|FG003|Overall Study|Death|2|||
124856301|NCT03465540|449096175|FG004|Overall Study|Death|0|||
124856302|NCT03465540|449096176|FG005|Overall Study|Death|2|||
124856303|NCT03465540|449096171|FG000|Overall Study|Protocol specified criteria|0|||
124856304|NCT03465540|449096172|FG001|Overall Study|Protocol specified criteria|2|||
124856305|NCT03465540|449096173|FG002|Overall Study|Protocol specified criteria|2|||
124856306|NCT03465540|449096174|FG003|Overall Study|Protocol specified criteria|0|||
124856307|NCT03465540|449096175|FG004|Overall Study|Protocol specified criteria|2|||
124856308|NCT03465540|449096176|FG005|Overall Study|Protocol specified criteria|0|||
124856309|NCT02844946|449096177|FG000|Overall Study|Lost to Follow-up|7|||
124856310|NCT02844946|449096178|FG001|Overall Study|Lost to Follow-up|0|||
124856311|NCT00736996|449096179|FG000|Overall Study|Lost to Follow-up|1|||
124856312|NCT00736996|449096180|FG001|Overall Study|Lost to Follow-up|9|||
124856313|NCT00736996|449096181|FG002|Overall Study|Lost to Follow-up|2|||
124856314|NCT02806986|449096182|FG000|Treatment Stage 1|Adverse Event|1|||
124856315|NCT02806986|449096182|FG000|Treatment Stage 2|Adverse Event|3|||
124856316|NCT02806986|449096182|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
124856317|NCT00462384|449096183|FG000|Overall Study|Adverse Event|2|||
124856318|NCT00462384|449096183|FG000|Overall Study|Death|2|||
124856319|NCT00462384|449096183|FG000|Overall Study|Withdrawal by Subject|1|||
124856320|NCT00462384|449096183|FG000|Overall Study|Other|4|||
124856321|NCT02667912|449096184|FG000|Overall Study|Death|3|||
124856322|NCT02667912|449096185|FG001|Overall Study|Death|1|||
124856323|NCT02667912|449096184|FG000|Overall Study|Withdrawal by Subject|1|||
124856324|NCT02667912|449096185|FG001|Overall Study|Withdrawal by Subject|2|||
124856325|NCT02667912|449096184|FG000|Overall Study|Withdrawal by Subject|1|||
124856326|NCT02667912|449096185|FG001|Overall Study|Withdrawal by Subject|0|||
124856327|NCT04443218|449096186|FG000|Overall Study|Exited study for other reasons|9|||
124856328|NCT04443218|449096186|FG000|Overall Study|Withdrawal by Subject|1|||
124856329|NCT04443218|449096186|FG000|Overall Study|Lost to Follow-up|4|||
124856330|NCT04443218|449096186|FG000|Overall Study|Death|19|||
124856331|NCT00346034|449096187|FG000|Overall Study|Adverse Event|34|||
124856332|NCT00346034|449096187|FG000|Overall Study|Lack of Efficacy|8|||
124856333|NCT00346034|449096187|FG000|Overall Study|Withdrawal by Subject|13|||
124856334|NCT00346034|449096187|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
124856335|NCT00346034|449096187|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
124856336|NCT04000165|449096188|FG000|Overall Study|Physician Decision|1|||
124856337|NCT04000165|449096188|FG000|Overall Study|Withdrawal by Subject|1|||
124856338|NCT05799495|449096189|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
124856339|NCT05799495|449096190|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
124856340|NCT05799495|449096191|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
124856341|NCT05799495|449096192|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
124856342|NCT05799495|449096189|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
124856343|NCT05799495|449096190|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
124856344|NCT05799495|449096191|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
124856345|NCT05799495|449096192|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
124856346|NCT05799495|449096189|FG000|Treatment (Up to 5 Days)|Other|0|||
124856347|NCT05799495|449096190|FG001|Treatment (Up to 5 Days)|Other|1|||
124856348|NCT05799495|449096191|FG002|Treatment (Up to 5 Days)|Other|0|||
124856349|NCT05799495|449096192|FG003|Treatment (Up to 5 Days)|Other|0|||
124856350|NCT05799495|449096189|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
124856351|NCT05799495|449096190|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
124856352|NCT05799495|449096191|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
124856353|NCT05799495|449096192|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
124856354|NCT05799495|449096189|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
124856355|NCT05799495|449096190|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
124856356|NCT05799495|449096191|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
124856357|NCT05799495|449096192|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
124856358|NCT05799495|449096189|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
124856359|NCT05799495|449096190|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
124856360|NCT05799495|449096191|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
124856361|NCT05799495|449096192|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
124856362|NCT03105362|449096193|FG000|Overall Study|Withdrawal by Subject|1|||
124856363|NCT03105362|449096193|FG000|Overall Study|Lost to Follow-up|1|||
124856364|NCT02371369|449096195|FG000|Part 1|Physician Decision|0|||
124856365|NCT02371369|449096196|FG001|Part 1|Physician Decision|3|||
124856366|NCT02371369|449096195|FG000|Part 1|Adverse Event|8|||
124856367|NCT02371369|449096196|FG001|Part 1|Adverse Event|0|||
124856368|NCT02371369|449096195|FG000|Part 1|Withdrawal by Subject|1|||
124856369|NCT02371369|449096196|FG001|Part 1|Withdrawal by Subject|6|||
124856370|NCT02371369|449096195|FG000|Part 1|Disease progression|0|||
124856371|NCT02371369|449096196|FG001|Part 1|Disease progression|1|||
124856372|NCT02371369|449096195|FG000|Part 1|Protocol Violation|0|||
124856373|NCT02371369|449096196|FG001|Part 1|Protocol Violation|1|||
124856374|NCT02371369|449096195|FG000|Part 2|Adverse Event|6|||
124856375|NCT02371369|449096196|FG001|Part 2|Adverse Event|5|||
124856376|NCT02371369|449096195|FG000|Part 2|Withdrawal by Subject|16|||
124856377|NCT02371369|449096196|FG001|Part 2|Withdrawal by Subject|6|||
124856378|NCT02371369|449096195|FG000|Part 2|Investigator decision|1|||
124856379|NCT02371369|449096196|FG001|Part 2|Investigator decision|2|||
124856380|NCT02371369|449096195|FG000|Part 2|Death|0|||
124856381|NCT02371369|449096196|FG001|Part 2|Death|1|||
124856382|NCT02371369|449096195|FG000|Part 2|Disease progression|1|||
124856383|NCT02371369|449096196|FG001|Part 2|Disease progression|0|||
124856384|NCT02371369|449096195|FG000|Part 2|Subject Noncompliance|1|||
124856385|NCT02371369|449096196|FG001|Part 2|Subject Noncompliance|0|||
124856386|NCT02371369|449096195|FG000|Part 2|Lost to Follow-up|1|||
124856387|NCT02371369|449096196|FG001|Part 2|Lost to Follow-up|1|||
124856388|NCT02371369|449096195|FG000|Part 2|Subject transitioned to commercial supply|6|||
124856389|NCT02371369|449096196|FG001|Part 2|Subject transitioned to commercial supply|4|||
124856390|NCT02371369|449096195|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
124856391|NCT02371369|449096196|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
124856392|NCT02371369|449096195|FG000|Part 2|Surgical resection of tumor|1|||
124856393|NCT02371369|449096196|FG001|Part 2|Surgical resection of tumor|1|||
124856394|NCT02371369|449096195|FG000|Part 2|Other|0|||
124856395|NCT02371369|449096196|FG001|Part 2|Other|1|||
124856396|NCT00503685|449096201|FG000|Overall Study|Adverse Event|0|||
124856397|NCT00503685|449096202|FG001|Overall Study|Adverse Event|0|||
124856398|NCT00503685|449096203|FG002|Overall Study|Adverse Event|2|||
124856399|NCT00503685|449096201|FG000|Overall Study|Withdrawal by Subject|0|||
124856400|NCT00503685|449096202|FG001|Overall Study|Withdrawal by Subject|1|||
124856401|NCT00503685|449096203|FG002|Overall Study|Withdrawal by Subject|0|||
124856402|NCT00503685|449096201|FG000|Overall Study|Protocol Violation|0|||
124856403|NCT00503685|449096202|FG001|Overall Study|Protocol Violation|1|||
124856404|NCT00503685|449096203|FG002|Overall Study|Protocol Violation|0|||
124856405|NCT00503685|449096201|FG000|Overall Study|Eligibility Criteria Not Met|0|||
124856406|NCT00503685|449096202|FG001|Overall Study|Eligibility Criteria Not Met|1|||
124856407|NCT00503685|449096203|FG002|Overall Study|Eligibility Criteria Not Met|0|||
124856408|NCT02838017|449096205|FG000|Overall Study|Lost to Follow-up|14|||
124856409|NCT02838017|449096206|FG001|Overall Study|Lost to Follow-up|11|||
124856410|NCT02120924|449096207|FG000|Overall Study|Lack of Efficacy|1|||
124856411|NCT02120924|449096208|FG001|Overall Study|Lack of Efficacy|2|||
124856412|NCT02120924|449096209|FG002|Overall Study|Lack of Efficacy|3|||
124856413|NCT02120924|449096207|FG000|Overall Study|Adverse Event|0|||
124856414|NCT02120924|449096208|FG001|Overall Study|Adverse Event|1|||
124856415|NCT02120924|449096209|FG002|Overall Study|Adverse Event|3|||
124856416|NCT02120924|449096207|FG000|Overall Study|Withdrawal by Subject|16|||
124856417|NCT02120924|449096208|FG001|Overall Study|Withdrawal by Subject|20|||
124856418|NCT02120924|449096209|FG002|Overall Study|Withdrawal by Subject|8|||
124856419|NCT02120924|449096207|FG000|Overall Study|Lost to Follow-up|14|||
124856420|NCT02120924|449096208|FG001|Overall Study|Lost to Follow-up|14|||
124856421|NCT02120924|449096209|FG002|Overall Study|Lost to Follow-up|11|||
124856422|NCT02120924|449096207|FG000|Overall Study|Pregnancy|2|||
124856423|NCT02120924|449096208|FG001|Overall Study|Pregnancy|0|||
124856424|NCT02120924|449096209|FG002|Overall Study|Pregnancy|0|||
124856425|NCT02120924|449096207|FG000|Overall Study|Protocol Violation|3|||
124856426|NCT02120924|449096208|FG001|Overall Study|Protocol Violation|7|||
124856427|NCT02120924|449096209|FG002|Overall Study|Protocol Violation|2|||
124856428|NCT02120924|449096207|FG000|Overall Study|Physician Decision|0|||
124856429|NCT02120924|449096208|FG001|Overall Study|Physician Decision|1|||
124856430|NCT02120924|449096209|FG002|Overall Study|Physician Decision|1|||
124856431|NCT02120924|449096207|FG000|Overall Study|Death|1|||
124856432|NCT02120924|449096208|FG001|Overall Study|Death|0|||
124856433|NCT02120924|449096209|FG002|Overall Study|Death|0|||
124856434|NCT02120924|449096207|FG000|Overall Study|Compliance with IP|5|||
124856435|NCT02120924|449096208|FG001|Overall Study|Compliance with IP|1|||
124856436|NCT02120924|449096209|FG002|Overall Study|Compliance with IP|1|||
124856437|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
124856438|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
124856439|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
124856440|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
124856441|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
124856442|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
124856443|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
124856444|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
124856445|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
124856446|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
124856447|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
124856448|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
124856449|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
124856450|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
124856451|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
124856452|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
124856453|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
124856454|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
124856455|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
124856456|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
124856457|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
124856458|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
124856459|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
124856460|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
124856461|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
124856462|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
124856463|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
124856464|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
124856465|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
124856466|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
124856467|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
124856468|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
124856469|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
124856470|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
124856471|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
124856472|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
124856473|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
124856474|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
124856475|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
124856476|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
124856477|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
124856478|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
124856479|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
124856480|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
124856481|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
124856482|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
124856483|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
124856484|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
124856485|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
124856486|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
124856487|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
124856488|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
124856489|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
124856490|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
124856491|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
124856492|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
124856493|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
124856494|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
124856495|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
124856496|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
124856497|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
124856498|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
124856499|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
124856500|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
124856501|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
124856502|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
124856503|NCT01059617|449096213|FG000|Overall Study|Other|7|||
124856504|NCT01059617|449096214|FG001|Overall Study|Other|1|||
124856505|NCT01059617|449096215|FG002|Overall Study|Other|8|||
124856506|NCT01059617|449096216|FG003|Overall Study|Other|6|||
124856507|NCT00074282|449097979|FG000|Step 1|Adverse Event|32|||
124856508|NCT00074282|449097980|FG001|Step 1|Adverse Event|0|||
124856509|NCT00074282|449097981|FG002|Step 1|Adverse Event|0|||
124856510|NCT00074282|449097979|FG000|Step 1|Death|6|||
124856511|NCT00074282|449097980|FG001|Step 1|Death|0|||
124856512|NCT00074282|449097981|FG002|Step 1|Death|0|||
124856513|NCT00074282|449097979|FG000|Step 1|Withdrawal by Subject|7|||
124856514|NCT00074282|449097980|FG001|Step 1|Withdrawal by Subject|0|||
124856515|NCT00074282|449097981|FG002|Step 1|Withdrawal by Subject|0|||
124856516|NCT00074282|449097979|FG000|Step 1|Disease progression|2|||
124856517|NCT00074282|449097980|FG001|Step 1|Disease progression|0|||
124856518|NCT00074282|449097981|FG002|Step 1|Disease progression|0|||
124856519|NCT00074282|449097979|FG000|Step 1|Alternative therapy|2|||
124856520|NCT00074282|449097980|FG001|Step 1|Alternative therapy|0|||
124856521|NCT00074282|449097981|FG002|Step 1|Alternative therapy|0|||
124856522|NCT00074282|449097979|FG000|Step 1|Other complicating disease|2|||
124856523|NCT00074282|449097980|FG001|Step 1|Other complicating disease|0|||
124856524|NCT00074282|449097981|FG002|Step 1|Other complicating disease|0|||
124856525|NCT00074282|449097979|FG000|Step 1|Physician Decision|1|||
124856526|NCT00074282|449097980|FG001|Step 1|Physician Decision|0|||
124856527|NCT00074282|449097981|FG002|Step 1|Physician Decision|0|||
124856528|NCT00074282|449097979|FG000|Step 1|Ineligible|4|||
124856529|NCT00074282|449097980|FG001|Step 1|Ineligible|0|||
124856530|NCT00074282|449097981|FG002|Step 1|Ineligible|0|||
124856531|NCT00074282|449097979|FG000|Step 1|Never started treatment|2|||
124856532|NCT00074282|449097980|FG001|Step 1|Never started treatment|0|||
124856533|NCT00074282|449097981|FG002|Step 1|Never started treatment|0|||
124856534|NCT00074282|449097979|FG000|Step 2|Adverse Event|0|||
124856535|NCT00074282|449097980|FG001|Step 2|Adverse Event|2|||
124856536|NCT00074282|449097981|FG002|Step 2|Adverse Event|12|||
124856537|NCT00074282|449097979|FG000|Step 2|Disease progression|0|||
124856538|NCT00074282|449097980|FG001|Step 2|Disease progression|0|||
124856539|NCT00074282|449097981|FG002|Step 2|Disease progression|5|||
124856540|NCT00074282|449097979|FG000|Step 2|Death|0|||
124856541|NCT00074282|449097980|FG001|Step 2|Death|0|||
124856542|NCT00074282|449097981|FG002|Step 2|Death|3|||
124856543|NCT00074282|449097979|FG000|Step 2|Withdrawal by Subject|0|||
124856544|NCT00074282|449097980|FG001|Step 2|Withdrawal by Subject|0|||
124856545|NCT00074282|449097981|FG002|Step 2|Withdrawal by Subject|2|||
124856546|NCT00074282|449097979|FG000|Step 2|Physician Decision|0|||
124856547|NCT00074282|449097980|FG001|Step 2|Physician Decision|0|||
124856548|NCT00074282|449097981|FG002|Step 2|Physician Decision|1|||
124856549|NCT00074282|449097979|FG000|Step 2|Ineligible|0|||
124856550|NCT00074282|449097980|FG001|Step 2|Ineligible|0|||
124856551|NCT00074282|449097981|FG002|Step 2|Ineligible|1|||
124856552|NCT00464542|449097982|FG000|Pre-treatment|Withdrawal by Subject|2|||
124856553|NCT01773226|449097984|FG000|Overall Study|Withdrawal by Subject|1|||
124856554|NCT02055352|449097989|FG000|Overall Study|Adverse Event|0|||
124856555|NCT02055352|449097990|FG001|Overall Study|Adverse Event|1|||
124856556|NCT02055352|449097989|FG000|Overall Study|Non-eligible|0|||
124856557|NCT02055352|449097990|FG001|Overall Study|Non-eligible|1|||
124856558|NCT02055352|449097989|FG000|Overall Study|Poor compliance|1|||
124856559|NCT02055352|449097990|FG001|Overall Study|Poor compliance|1|||
124856560|NCT02055352|449097989|FG000|Overall Study|Death|1|||
124856561|NCT02055352|449097990|FG001|Overall Study|Death|2|||
124856562|NCT02055352|449097989|FG000|Overall Study|Patient decision|1|||
124856563|NCT02055352|449097990|FG001|Overall Study|Patient decision|1|||
124856564|NCT02055352|449097989|FG000|Overall Study|Use of prohibited treatment|0|||
124856565|NCT02055352|449097990|FG001|Overall Study|Use of prohibited treatment|3|||
124856566|NCT02055352|449097989|FG000|Overall Study|AE, study drug would be detrimental|1|||
124856567|NCT02055352|449097990|FG001|Overall Study|AE, study drug would be detrimental|3|||
124856568|NCT02055352|449097989|FG000|Overall Study|Withdrawal of informed consent|1|||
124856569|NCT02055352|449097990|FG001|Overall Study|Withdrawal of informed consent|0|||
124856570|NCT02055352|449097989|FG000|Overall Study|Reason unknown|1|||
124856571|NCT02055352|449097990|FG001|Overall Study|Reason unknown|5|||
124856572|NCT03794089|449097997|FG000|Overall Study|Lost to Follow-up|4|||
124856573|NCT03794089|449097998|FG001|Overall Study|Lost to Follow-up|1|||
124856574|NCT03794089|449097997|FG000|Overall Study|Withdrawal by Subject|2|||
124856575|NCT03794089|449097998|FG001|Overall Study|Withdrawal by Subject|0|||
124856576|NCT03985423|449097999|FG000|Overall Study|Adverse Event|1|||
124856577|NCT03985423|449097999|FG000|Overall Study|Death|2|||
124856578|NCT03985423|449097999|FG000|Overall Study|Physician Decision|1|||
124856579|NCT03985423|449097999|FG000|Overall Study|Withdrawal by Subject|2|||
124856580|NCT03985423|449097999|FG000|Overall Study|Lack of insurance and citizenship|1|||
124856581|NCT01045447|449098010|FG000|Overall Study|Adverse Event|0|||
124856582|NCT01045447|449098011|FG001|Overall Study|Adverse Event|1|||
124856583|NCT01045447|449098010|FG000|Overall Study|Lack of Efficacy|3|||
124856584|NCT01045447|449098011|FG001|Overall Study|Lack of Efficacy|1|||
124856585|NCT01045447|449098010|FG000|Overall Study|Protocol Violation|6|||
124856586|NCT01045447|449098011|FG001|Overall Study|Protocol Violation|3|||
124856587|NCT01045447|449098010|FG000|Overall Study|Withdrawal Criteria|10|||
124856588|NCT01045447|449098011|FG001|Overall Study|Withdrawal Criteria|10|||
124856589|NCT01045447|449098010|FG000|Overall Study|Unclassified|17|||
124856590|NCT01045447|449098011|FG001|Overall Study|Unclassified|13|||
124856591|NCT02318329|449098016|FG000|Overall Study|Progressive Disease|2|||
124856592|NCT02318329|449098017|FG001|Overall Study|Progressive Disease|3|||
124856593|NCT02318329|449098018|FG002|Overall Study|Progressive Disease|2|||
124856594|NCT02318329|449098019|FG003|Overall Study|Progressive Disease|3|||
124856595|NCT02318329|449098020|FG004|Overall Study|Progressive Disease|3|||
124856596|NCT02318329|449098021|FG005|Overall Study|Progressive Disease|3|||
124856597|NCT02318329|449098022|FG006|Overall Study|Progressive Disease|1|||
124856598|NCT02318329|449098023|FG007|Overall Study|Progressive Disease|1|||
124856599|NCT02318329|449098024|FG008|Overall Study|Progressive Disease|5|||
124856600|NCT02318329|449098025|FG009|Overall Study|Progressive Disease|39|||
124856601|NCT02318329|449098016|FG000|Overall Study|Death|0|||
124856602|NCT02318329|449098017|FG001|Overall Study|Death|0|||
124856603|NCT02318329|449098018|FG002|Overall Study|Death|0|||
124856604|NCT02318329|449098019|FG003|Overall Study|Death|0|||
124856605|NCT02318329|449098020|FG004|Overall Study|Death|0|||
124856606|NCT02318329|449098021|FG005|Overall Study|Death|0|||
124856607|NCT02318329|449098022|FG006|Overall Study|Death|0|||
124856608|NCT02318329|449098023|FG007|Overall Study|Death|0|||
124856609|NCT02318329|449098024|FG008|Overall Study|Death|0|||
124856610|NCT02318329|449098025|FG009|Overall Study|Death|5|||
124856611|NCT02318329|449098016|FG000|Overall Study|Lost to Follow-up|0|||
124856612|NCT02318329|449098017|FG001|Overall Study|Lost to Follow-up|0|||
124856613|NCT02318329|449098018|FG002|Overall Study|Lost to Follow-up|0|||
124856614|NCT02318329|449098019|FG003|Overall Study|Lost to Follow-up|0|||
124856615|NCT02318329|449098020|FG004|Overall Study|Lost to Follow-up|0|||
124856616|NCT02318329|449098021|FG005|Overall Study|Lost to Follow-up|0|||
124856617|NCT02318329|449098022|FG006|Overall Study|Lost to Follow-up|0|||
124856618|NCT02318329|449098023|FG007|Overall Study|Lost to Follow-up|0|||
124856619|NCT02318329|449098024|FG008|Overall Study|Lost to Follow-up|0|||
124856620|NCT02318329|449098025|FG009|Overall Study|Lost to Follow-up|1|||
124856621|NCT02318329|449098016|FG000|Overall Study|Withdrawal by Subject|0|||
124856622|NCT02318329|449098017|FG001|Overall Study|Withdrawal by Subject|0|||
124856623|NCT02318329|449098018|FG002|Overall Study|Withdrawal by Subject|0|||
124856624|NCT02318329|449098019|FG003|Overall Study|Withdrawal by Subject|0|||
124856625|NCT02318329|449098020|FG004|Overall Study|Withdrawal by Subject|0|||
124856626|NCT02318329|449098021|FG005|Overall Study|Withdrawal by Subject|0|||
124856627|NCT02318329|449098022|FG006|Overall Study|Withdrawal by Subject|0|||
124856628|NCT02318329|449098023|FG007|Overall Study|Withdrawal by Subject|0|||
124856629|NCT02318329|449098024|FG008|Overall Study|Withdrawal by Subject|0|||
124856630|NCT02318329|449098025|FG009|Overall Study|Withdrawal by Subject|6|||
124856631|NCT02318329|449098016|FG000|Overall Study|Other|1|||
124856632|NCT02318329|449098017|FG001|Overall Study|Other|1|||
124856633|NCT02318329|449098018|FG002|Overall Study|Other|1|||
124856634|NCT02318329|449098019|FG003|Overall Study|Other|0|||
124856635|NCT02318329|449098020|FG004|Overall Study|Other|0|||
124856636|NCT02318329|449098021|FG005|Overall Study|Other|0|||
124856637|NCT02318329|449098022|FG006|Overall Study|Other|0|||
124856638|NCT02318329|449098023|FG007|Overall Study|Other|0|||
124856639|NCT02318329|449098024|FG008|Overall Study|Other|1|||
124856640|NCT02318329|449098025|FG009|Overall Study|Other|1|||
124856641|NCT00086346|449098026|FG000|Randomization|Did not receive test article|4|||
124856642|NCT00086346|449098027|FG001|Randomization|Did not receive test article|4|||
124856643|NCT00086346|449098026|FG000|Patients Dosed With Test Article|Adverse Event|94|||
124856644|NCT00086346|449098027|FG001|Patients Dosed With Test Article|Adverse Event|11|||
124856645|NCT00086346|449098026|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
124856646|NCT00086346|449098027|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
124856647|NCT00086346|449098026|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
124856648|NCT00086346|449098027|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
124856649|NCT00086346|449098026|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
124856650|NCT00086346|449098027|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
124856651|NCT00086346|449098026|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
124856652|NCT00086346|449098027|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
124856653|NCT00086346|449098026|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
124856654|NCT00086346|449098027|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
124856655|NCT03268811|449098028|FG000|Overall Study|Adverse Event|0|||
124856656|NCT03268811|449098029|FG001|Overall Study|Adverse Event|1|||
124856657|NCT01055639|449098030|FG000|Overall Study|Adverse Event|0|||
124856658|NCT01055639|449098031|FG001|Overall Study|Adverse Event|1|||
124856659|NCT01055639|449098030|FG000|Overall Study|Lack of Efficacy|0|||
124856660|NCT01055639|449098031|FG001|Overall Study|Lack of Efficacy|1|||
124856661|NCT01055639|449098030|FG000|Overall Study|Lost to Follow-up|8|||
124856662|NCT01055639|449098031|FG001|Overall Study|Lost to Follow-up|11|||
124856663|NCT01055639|449098030|FG000|Overall Study|Protocol Violation|5|||
124856664|NCT01055639|449098031|FG001|Overall Study|Protocol Violation|5|||
124856665|NCT01055639|449098030|FG000|Overall Study|Withdrawal by Subject|8|||
124856666|NCT01055639|449098031|FG001|Overall Study|Withdrawal by Subject|11|||
124856667|NCT00562159|449098032|FG000|Overall Study|Adverse Event|11|||
124856668|NCT00562159|449098033|FG001|Overall Study|Adverse Event|8|||
124856669|NCT00562159|449098032|FG000|Overall Study|Lost to Follow-up|5|||
124856670|NCT00562159|449098033|FG001|Overall Study|Lost to Follow-up|4|||
124856671|NCT00562159|449098032|FG000|Overall Study|Withdrawal by Subject|9|||
124856672|NCT00562159|449098033|FG001|Overall Study|Withdrawal by Subject|8|||
124856673|NCT00562159|449098032|FG000|Overall Study|Protocol Violation|12|||
124856674|NCT00562159|449098033|FG001|Overall Study|Protocol Violation|12|||
124856675|NCT00562159|449098032|FG000|Overall Study|Did not meet protocol eligibility|1|||
124856676|NCT00562159|449098033|FG001|Overall Study|Did not meet protocol eligibility|1|||
124856677|NCT02417246|449098034|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
124856678|NCT02417246|449098035|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
124856679|NCT02417246|449098034|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
124856680|NCT02417246|449098035|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
124856681|NCT02417246|449098034|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
124856682|NCT02417246|449098035|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
124856683|NCT02417246|449098034|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
124856684|NCT02417246|449098035|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
124856685|NCT01233817|449098039|FG000|Overall Study|Lost to Follow-up|1|||
124856686|NCT01233817|449098039|FG000|Overall Study|Withdrawal by Subject|2|||
124856687|NCT01248884|449098040|FG000|Overall Study|Withdrawal by Subject|1|||
124856688|NCT01248884|449098041|FG001|Overall Study|Withdrawal by Subject|3|||
124856689|NCT01248884|449098042|FG002|Overall Study|Withdrawal by Subject|1|||
124856690|NCT01248884|449098040|FG000|Overall Study|Adverse Event|1|||
124856691|NCT01248884|449098041|FG001|Overall Study|Adverse Event|0|||
124856692|NCT01248884|449098042|FG002|Overall Study|Adverse Event|0|||
124856693|NCT02511431|449098043|FG000|Treatment|Lost to Follow-up|0|||
124856694|NCT02511431|449098044|FG001|Treatment|Lost to Follow-up|0|||
124856695|NCT02511431|449098045|FG002|Treatment|Lost to Follow-up|1|||
124856696|NCT02511431|449098046|FG003|Treatment|Lost to Follow-up|0|||
124856697|NCT02511431|449098047|FG004|Treatment|Lost to Follow-up|0|||
124856698|NCT02511431|449098048|FG005|Treatment|Lost to Follow-up|1|||
124856699|NCT04479618|449098049|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
124856700|NCT04479618|449098050|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
124856701|NCT04479618|449098051|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
124856702|NCT04479618|449098049|FG000|Overall Study|Lack of Efficacy|1|||
124856703|NCT04479618|449098050|FG001|Overall Study|Lack of Efficacy|0|||
124856704|NCT04479618|449098051|FG002|Overall Study|Lack of Efficacy|0|||
124856705|NCT04479618|449098049|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
124856706|NCT04479618|449098050|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
124856707|NCT04479618|449098051|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
124856708|NCT04479618|449098049|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
124856709|NCT04479618|449098050|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
124856710|NCT04479618|449098051|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
124856711|NCT04479618|449098049|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
124856712|NCT04479618|449098050|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
124856713|NCT04479618|449098051|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
124856714|NCT04479618|449098049|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
124856715|NCT04479618|449098050|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
124856716|NCT04479618|449098051|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
124856717|NCT01202773|449098052|FG000|Overall Study|Adverse Event|4|||
124856718|NCT01202773|449098053|FG001|Overall Study|Adverse Event|5|||
124856719|NCT01202773|449098054|FG002|Overall Study|Adverse Event|5|||
124856720|NCT01202773|449098052|FG000|Overall Study|Lack of Efficacy|5|||
124856721|NCT01202773|449098053|FG001|Overall Study|Lack of Efficacy|4|||
124856722|NCT01202773|449098054|FG002|Overall Study|Lack of Efficacy|9|||
124856723|NCT01202773|449098052|FG000|Overall Study|Entry Criteria Not Met|2|||
124856724|NCT01202773|449098053|FG001|Overall Study|Entry Criteria Not Met|0|||
124856725|NCT01202773|449098054|FG002|Overall Study|Entry Criteria Not Met|1|||
124856726|NCT01202773|449098052|FG000|Overall Study|Lost to Follow-up|1|||
124856727|NCT01202773|449098053|FG001|Overall Study|Lost to Follow-up|2|||
124856728|NCT01202773|449098054|FG002|Overall Study|Lost to Follow-up|2|||
124856729|NCT01202773|449098052|FG000|Overall Study|Withdrawal by Subject|13|||
124856730|NCT01202773|449098053|FG001|Overall Study|Withdrawal by Subject|6|||
124856731|NCT01202773|449098054|FG002|Overall Study|Withdrawal by Subject|5|||
124856732|NCT01202773|449098052|FG000|Overall Study|Physician Decision|2|||
124856733|NCT01202773|449098053|FG001|Overall Study|Physician Decision|0|||
124856734|NCT01202773|449098054|FG002|Overall Study|Physician Decision|0|||
124856735|NCT01202773|449098052|FG000|Overall Study|Protocol Violation|11|||
124856736|NCT01202773|449098053|FG001|Overall Study|Protocol Violation|6|||
124856737|NCT01202773|449098054|FG002|Overall Study|Protocol Violation|10|||
124856738|NCT01202773|449098052|FG000|Overall Study|Sponsor Decision|19|||
124856739|NCT01202773|449098053|FG001|Overall Study|Sponsor Decision|20|||
124856740|NCT01202773|449098054|FG002|Overall Study|Sponsor Decision|23|||
124856741|NCT04827212|449098061|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
124856742|NCT04827212|449098062|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
124856743|NCT04827212|449098061|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
124856744|NCT04827212|449098062|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
124856745|NCT04360824|449098065|FG000|Overall Study|Withdrawal by Subject|2|||
124856746|NCT04360824|449098066|FG001|Overall Study|Withdrawal by Subject|1|||
124856747|NCT04360824|449098065|FG000|Overall Study|Did not receive assigned treatment|1|||
124856748|NCT04360824|449098066|FG001|Overall Study|Did not receive assigned treatment|3|||
124856749|NCT00320216|449098067|FG000|Overall Study|Adverse Event|0|||
124856750|NCT00320216|449098068|FG001|Overall Study|Adverse Event|6|||
124856751|NCT00320216|449098069|FG002|Overall Study|Adverse Event|0|||
124856752|NCT00320216|449098070|FG003|Overall Study|Adverse Event|2|||
124856753|NCT00320216|449098071|FG004|Overall Study|Adverse Event|2|||
124856754|NCT00320216|449098067|FG000|Overall Study|Lack of Efficacy|6|||
124856755|NCT00320216|449098068|FG001|Overall Study|Lack of Efficacy|2|||
124856756|NCT00320216|449098069|FG002|Overall Study|Lack of Efficacy|1|||
124856757|NCT00320216|449098070|FG003|Overall Study|Lack of Efficacy|0|||
124856758|NCT00320216|449098071|FG004|Overall Study|Lack of Efficacy|1|||
124856759|NCT00320216|449098067|FG000|Overall Study|Lost to Follow-up|3|||
124856760|NCT00320216|449098068|FG001|Overall Study|Lost to Follow-up|0|||
124856761|NCT00320216|449098069|FG002|Overall Study|Lost to Follow-up|0|||
124856762|NCT00320216|449098070|FG003|Overall Study|Lost to Follow-up|0|||
124856763|NCT00320216|449098071|FG004|Overall Study|Lost to Follow-up|0|||
124856764|NCT00320216|449098067|FG000|Overall Study|Other|7|||
124856765|NCT00320216|449098068|FG001|Overall Study|Other|2|||
124856766|NCT00320216|449098069|FG002|Overall Study|Other|5|||
124856767|NCT00320216|449098070|FG003|Overall Study|Other|1|||
124856768|NCT00320216|449098071|FG004|Overall Study|Other|3|||
124856769|NCT02265705|449098072|FG000|Treatment Period Week 0-24|Adverse Event|3|||
124856770|NCT02265705|449098073|FG001|Treatment Period Week 0-24|Adverse Event|2|||
124856771|NCT02265705|449098074|FG002|Treatment Period Week 0-24|Adverse Event|0|||
124856772|NCT02265705|449098075|FG003|Treatment Period Week 0-24|Adverse Event|0|||
124856773|NCT02265705|449098076|FG004|Treatment Period Week 0-24|Adverse Event|0|||
124856774|NCT02265705|449098077|FG005|Treatment Period Week 0-24|Adverse Event|0|||
124856775|NCT02265705|449098078|FG006|Treatment Period Week 0-24|Adverse Event|0|||
124856776|NCT02265705|449098072|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
124856777|NCT02265705|449098073|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
124856778|NCT02265705|449098074|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
124856779|NCT02265705|449098075|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
124856780|NCT02265705|449098076|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
124856781|NCT02265705|449098077|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
124856782|NCT02265705|449098078|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
124856783|NCT02265705|449098072|FG000|Treatment Period Week 0-24|Physician Decision|1|||
124856784|NCT02265705|449098073|FG001|Treatment Period Week 0-24|Physician Decision|0|||
124856785|NCT02265705|449098074|FG002|Treatment Period Week 0-24|Physician Decision|0|||
124856786|NCT02265705|449098075|FG003|Treatment Period Week 0-24|Physician Decision|0|||
124856787|NCT02265705|449098076|FG004|Treatment Period Week 0-24|Physician Decision|0|||
124856788|NCT02265705|449098077|FG005|Treatment Period Week 0-24|Physician Decision|0|||
124856789|NCT02265705|449098078|FG006|Treatment Period Week 0-24|Physician Decision|0|||
124856790|NCT02265705|449098072|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
124856791|NCT02265705|449098073|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
124856792|NCT02265705|449098074|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
124856793|NCT02265705|449098075|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
124856794|NCT02265705|449098076|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
124856795|NCT02265705|449098077|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
124856796|NCT02265705|449098078|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
124856797|NCT02265705|449098072|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
124856798|NCT02265705|449098073|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
124856799|NCT02265705|449098074|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
124856800|NCT02265705|449098075|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
124856801|NCT02265705|449098076|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
124856802|NCT02265705|449098077|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
124856803|NCT02265705|449098078|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
124856804|NCT02265705|449098072|FG000|Rescue Period|Withdrawal by Subject|0|||
124856805|NCT02265705|449098073|FG001|Rescue Period|Withdrawal by Subject|0|||
124856806|NCT02265705|449098074|FG002|Rescue Period|Withdrawal by Subject|1|||
124856807|NCT02265705|449098075|FG003|Rescue Period|Withdrawal by Subject|0|||
124856808|NCT02265705|449098076|FG004|Rescue Period|Withdrawal by Subject|0|||
124856809|NCT02265705|449098077|FG005|Rescue Period|Withdrawal by Subject|0|||
124856810|NCT02265705|449098078|FG006|Rescue Period|Withdrawal by Subject|0|||
124856811|NCT02265705|449098072|FG000|Rescue Period|Death|0|||
124856812|NCT02265705|449098073|FG001|Rescue Period|Death|0|||
124856813|NCT02265705|449098074|FG002|Rescue Period|Death|1|||
124856814|NCT02265705|449098075|FG003|Rescue Period|Death|0|||
124856815|NCT02265705|449098076|FG004|Rescue Period|Death|0|||
124856816|NCT02265705|449098077|FG005|Rescue Period|Death|0|||
124856817|NCT02265705|449098078|FG006|Rescue Period|Death|0|||
124856818|NCT02265705|449098072|FG000|Rescue Period|Lack of Efficacy|0|||
124856819|NCT02265705|449098073|FG001|Rescue Period|Lack of Efficacy|0|||
124856820|NCT02265705|449098074|FG002|Rescue Period|Lack of Efficacy|1|||
124856821|NCT02265705|449098075|FG003|Rescue Period|Lack of Efficacy|0|||
124856822|NCT02265705|449098076|FG004|Rescue Period|Lack of Efficacy|0|||
124856823|NCT02265705|449098077|FG005|Rescue Period|Lack of Efficacy|0|||
124856824|NCT02265705|449098078|FG006|Rescue Period|Lack of Efficacy|0|||
124856825|NCT02265705|449098072|FG000|Open Label Period|Adverse Event|0|||
124856826|NCT02265705|449098073|FG001|Open Label Period|Adverse Event|0|||
124856827|NCT02265705|449098074|FG002|Open Label Period|Adverse Event|0|||
124856828|NCT02265705|449098075|FG003|Open Label Period|Adverse Event|2|||
124856829|NCT02265705|449098076|FG004|Open Label Period|Adverse Event|2|||
124856830|NCT02265705|449098077|FG005|Open Label Period|Adverse Event|0|||
124856831|NCT02265705|449098078|FG006|Open Label Period|Adverse Event|0|||
124856832|NCT02265705|449098072|FG000|Open Label Period|Physician Decision|0|||
124856833|NCT02265705|449098073|FG001|Open Label Period|Physician Decision|0|||
124856834|NCT02265705|449098074|FG002|Open Label Period|Physician Decision|0|||
124856835|NCT02265705|449098075|FG003|Open Label Period|Physician Decision|0|||
124856836|NCT02265705|449098076|FG004|Open Label Period|Physician Decision|1|||
124856837|NCT02265705|449098077|FG005|Open Label Period|Physician Decision|0|||
124856838|NCT02265705|449098078|FG006|Open Label Period|Physician Decision|0|||
124856839|NCT02265705|449098072|FG000|Open Label Period|Withdrawal by Subject|0|||
124856840|NCT02265705|449098073|FG001|Open Label Period|Withdrawal by Subject|0|||
124856841|NCT02265705|449098074|FG002|Open Label Period|Withdrawal by Subject|0|||
124856842|NCT02265705|449098075|FG003|Open Label Period|Withdrawal by Subject|0|||
124856843|NCT02265705|449098076|FG004|Open Label Period|Withdrawal by Subject|2|||
124856844|NCT02265705|449098077|FG005|Open Label Period|Withdrawal by Subject|0|||
124856845|NCT02265705|449098078|FG006|Open Label Period|Withdrawal by Subject|0|||
124856846|NCT02265705|449098072|FG000|Follow-up Period|Sponsor Decision|0|||
124856847|NCT02265705|449098073|FG001|Follow-up Period|Sponsor Decision|0|||
124856848|NCT02265705|449098074|FG002|Follow-up Period|Sponsor Decision|0|||
124856849|NCT02265705|449098075|FG003|Follow-up Period|Sponsor Decision|0|||
124856850|NCT02265705|449098076|FG004|Follow-up Period|Sponsor Decision|0|||
124856851|NCT02265705|449098077|FG005|Follow-up Period|Sponsor Decision|1|||
124856852|NCT02265705|449098078|FG006|Follow-up Period|Sponsor Decision|6|||
124856853|NCT02265705|449098072|FG000|Follow-up Period|Adverse Event|0|||
124856854|NCT02265705|449098073|FG001|Follow-up Period|Adverse Event|0|||
124856855|NCT02265705|449098074|FG002|Follow-up Period|Adverse Event|0|||
124856856|NCT02265705|449098075|FG003|Follow-up Period|Adverse Event|0|||
124856857|NCT02265705|449098076|FG004|Follow-up Period|Adverse Event|0|||
124856858|NCT02265705|449098077|FG005|Follow-up Period|Adverse Event|0|||
124856859|NCT02265705|449098078|FG006|Follow-up Period|Adverse Event|3|||
124856860|NCT02265705|449098072|FG000|Follow-up Period|Physician Decision|0|||
124856861|NCT02265705|449098073|FG001|Follow-up Period|Physician Decision|0|||
124856862|NCT02265705|449098074|FG002|Follow-up Period|Physician Decision|0|||
124856863|NCT02265705|449098075|FG003|Follow-up Period|Physician Decision|0|||
124856864|NCT02265705|449098076|FG004|Follow-up Period|Physician Decision|0|||
124856865|NCT02265705|449098077|FG005|Follow-up Period|Physician Decision|0|||
124856866|NCT02265705|449098078|FG006|Follow-up Period|Physician Decision|1|||
124856867|NCT02265705|449098072|FG000|Follow-up Period|Withdrawal by Subject|0|||
124856868|NCT02265705|449098073|FG001|Follow-up Period|Withdrawal by Subject|0|||
124856869|NCT02265705|449098074|FG002|Follow-up Period|Withdrawal by Subject|0|||
124856870|NCT02265705|449098075|FG003|Follow-up Period|Withdrawal by Subject|0|||
124856871|NCT02265705|449098076|FG004|Follow-up Period|Withdrawal by Subject|0|||
124856872|NCT02265705|449098077|FG005|Follow-up Period|Withdrawal by Subject|0|||
124856873|NCT02265705|449098078|FG006|Follow-up Period|Withdrawal by Subject|1|||
124856874|NCT00377676|449098080|FG000|Overall Study|Adverse Event|498|||
124856875|NCT00377676|449098081|FG001|Overall Study|Adverse Event|107|||
124856876|NCT00377676|449098080|FG000|Overall Study|Protocol Violation|33|||
124856877|NCT00377676|449098081|FG001|Overall Study|Protocol Violation|27|||
124856878|NCT00377676|449098080|FG000|Overall Study|Death|5|||
124856879|NCT00377676|449098081|FG001|Overall Study|Death|2|||
124856880|NCT00377676|449098080|FG000|Overall Study|Withdrawal by Subject|187|||
124856881|NCT00377676|449098081|FG001|Overall Study|Withdrawal by Subject|72|||
124856882|NCT00377676|449098080|FG000|Overall Study|Lost to Follow-up|120|||
124856883|NCT00377676|449098081|FG001|Overall Study|Lost to Follow-up|56|||
124856884|NCT00377676|449098080|FG000|Overall Study|Other|118|||
124856885|NCT00377676|449098081|FG001|Overall Study|Other|58|||
124856886|NCT00779246|449098086|FG000|Overall Study|Missing sufficient data for analysis|33|||
124856887|NCT00779246|449098087|FG001|Overall Study|Missing sufficient data for analysis|53|||
124856888|NCT00941603|449098095|FG000|Overall Study|Adverse Event|10|||
124856889|NCT00941603|449098096|FG001|Overall Study|Adverse Event|15|||
124856890|NCT00941603|449098097|FG002|Overall Study|Adverse Event|5|||
124856891|NCT00941603|449098098|FG003|Overall Study|Adverse Event|1|||
124856892|NCT00941603|449098099|FG004|Overall Study|Adverse Event|4|||
124856893|NCT00941603|449098100|FG005|Overall Study|Adverse Event|0|||
124856894|NCT00941603|449098095|FG000|Overall Study|Lost to Follow-up|0|||
124856895|NCT00941603|449098096|FG001|Overall Study|Lost to Follow-up|0|||
124856896|NCT00941603|449098097|FG002|Overall Study|Lost to Follow-up|0|||
124856897|NCT00941603|449098098|FG003|Overall Study|Lost to Follow-up|1|||
124856898|NCT00941603|449098099|FG004|Overall Study|Lost to Follow-up|0|||
124856899|NCT00941603|449098100|FG005|Overall Study|Lost to Follow-up|2|||
124856900|NCT00941603|449098095|FG000|Overall Study|Withdrawal by Subject|0|||
124856901|NCT00941603|449098096|FG001|Overall Study|Withdrawal by Subject|0|||
124856902|NCT00941603|449098097|FG002|Overall Study|Withdrawal by Subject|0|||
124856903|NCT00941603|449098098|FG003|Overall Study|Withdrawal by Subject|2|||
124856904|NCT00941603|449098099|FG004|Overall Study|Withdrawal by Subject|0|||
124856905|NCT00941603|449098100|FG005|Overall Study|Withdrawal by Subject|1|||
124856906|NCT00941603|449098095|FG000|Overall Study|Protocol Violation|0|||
124856907|NCT00941603|449098096|FG001|Overall Study|Protocol Violation|1|||
124856908|NCT00941603|449098097|FG002|Overall Study|Protocol Violation|0|||
124856909|NCT00941603|449098098|FG003|Overall Study|Protocol Violation|0|||
124856910|NCT00941603|449098099|FG004|Overall Study|Protocol Violation|0|||
124856911|NCT00941603|449098100|FG005|Overall Study|Protocol Violation|0|||
124856912|NCT00941603|449098095|FG000|Overall Study|Did not meet protocol eligibility|1|||
124856913|NCT00941603|449098096|FG001|Overall Study|Did not meet protocol eligibility|0|||
124856914|NCT00941603|449098097|FG002|Overall Study|Did not meet protocol eligibility|0|||
124856915|NCT00941603|449098098|FG003|Overall Study|Did not meet protocol eligibility|0|||
124856916|NCT00941603|449098099|FG004|Overall Study|Did not meet protocol eligibility|0|||
124856917|NCT00941603|449098100|FG005|Overall Study|Did not meet protocol eligibility|0|||
124856918|NCT02014116|449098101|FG000|Overall Study|Progressive Disease|3|||
124856919|NCT02014116|449098102|FG001|Overall Study|Progressive Disease|4|||
124856920|NCT02014116|449098103|FG002|Overall Study|Progressive Disease|2|||
124856921|NCT02014116|449098104|FG003|Overall Study|Progressive Disease|6|||
124856922|NCT02014116|449098105|FG004|Overall Study|Progressive Disease|1|||
124856923|NCT02014116|449098106|FG005|Overall Study|Progressive Disease|13|||
124856924|NCT02014116|449098107|FG006|Overall Study|Progressive Disease|1|||
124856925|NCT02014116|449098108|FG007|Overall Study|Progressive Disease|3|||
124856926|NCT02014116|449098109|FG008|Overall Study|Progressive Disease|7|||
124856927|NCT02014116|449098101|FG000|Overall Study|Adverse Event|0|||
124856928|NCT02014116|449098102|FG001|Overall Study|Adverse Event|0|||
124856929|NCT02014116|449098103|FG002|Overall Study|Adverse Event|0|||
124856930|NCT02014116|449098104|FG003|Overall Study|Adverse Event|0|||
124856931|NCT02014116|449098105|FG004|Overall Study|Adverse Event|1|||
124856932|NCT02014116|449098106|FG005|Overall Study|Adverse Event|0|||
124856933|NCT02014116|449098107|FG006|Overall Study|Adverse Event|0|||
124856934|NCT02014116|449098108|FG007|Overall Study|Adverse Event|1|||
124856935|NCT02014116|449098109|FG008|Overall Study|Adverse Event|0|||
124856936|NCT02014116|449098101|FG000|Overall Study|Lost to Follow-up|0|||
124856937|NCT02014116|449098102|FG001|Overall Study|Lost to Follow-up|0|||
124856938|NCT02014116|449098103|FG002|Overall Study|Lost to Follow-up|0|||
124856939|NCT02014116|449098104|FG003|Overall Study|Lost to Follow-up|0|||
124856940|NCT02014116|449098105|FG004|Overall Study|Lost to Follow-up|0|||
124856941|NCT02014116|449098106|FG005|Overall Study|Lost to Follow-up|1|||
124856942|NCT02014116|449098107|FG006|Overall Study|Lost to Follow-up|0|||
124856943|NCT02014116|449098108|FG007|Overall Study|Lost to Follow-up|0|||
124856944|NCT02014116|449098109|FG008|Overall Study|Lost to Follow-up|1|||
124856945|NCT02014116|449098101|FG000|Overall Study|Death|0|||
124856946|NCT02014116|449098102|FG001|Overall Study|Death|0|||
124856947|NCT02014116|449098103|FG002|Overall Study|Death|0|||
124856948|NCT02014116|449098104|FG003|Overall Study|Death|0|||
124856949|NCT02014116|449098105|FG004|Overall Study|Death|0|||
124856950|NCT02014116|449098106|FG005|Overall Study|Death|0|||
124856951|NCT02014116|449098107|FG006|Overall Study|Death|0|||
124856952|NCT02014116|449098108|FG007|Overall Study|Death|1|||
124856953|NCT02014116|449098109|FG008|Overall Study|Death|1|||
124856954|NCT02014116|449098101|FG000|Overall Study|Withdrawal by Subject|0|||
124856955|NCT02014116|449098102|FG001|Overall Study|Withdrawal by Subject|0|||
124856956|NCT02014116|449098103|FG002|Overall Study|Withdrawal by Subject|1|||
124856957|NCT02014116|449098104|FG003|Overall Study|Withdrawal by Subject|1|||
124856958|NCT02014116|449098105|FG004|Overall Study|Withdrawal by Subject|0|||
124856959|NCT02014116|449098106|FG005|Overall Study|Withdrawal by Subject|1|||
124856960|NCT02014116|449098107|FG006|Overall Study|Withdrawal by Subject|0|||
124856961|NCT02014116|449098108|FG007|Overall Study|Withdrawal by Subject|0|||
124856962|NCT02014116|449098109|FG008|Overall Study|Withdrawal by Subject|0|||
124856963|NCT02014116|449098101|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
124856964|NCT02014116|449098102|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
124856965|NCT02014116|449098103|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
124856966|NCT02014116|449098104|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
124856967|NCT02014116|449098105|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
124856968|NCT02014116|449098106|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
124856969|NCT02014116|449098107|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
124856970|NCT02014116|449098108|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
124856971|NCT02014116|449098109|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
124856972|NCT02014116|449098101|FG000|Overall Study|Physician Decision|0|||
124856973|NCT02014116|449098102|FG001|Overall Study|Physician Decision|0|||
124856974|NCT02014116|449098103|FG002|Overall Study|Physician Decision|0|||
124856975|NCT02014116|449098104|FG003|Overall Study|Physician Decision|0|||
124856976|NCT02014116|449098105|FG004|Overall Study|Physician Decision|0|||
124856977|NCT02014116|449098106|FG005|Overall Study|Physician Decision|0|||
124856978|NCT02014116|449098107|FG006|Overall Study|Physician Decision|0|||
124856979|NCT02014116|449098108|FG007|Overall Study|Physician Decision|0|||
124856980|NCT02014116|449098109|FG008|Overall Study|Physician Decision|1|||
124856981|NCT01753193|449098110|FG000|Overall Study|Withdrawal by Subject|23|||
124856982|NCT01753193|449098110|FG000|Overall Study|Lost to Follow-up|6|||
124856983|NCT01753193|449098110|FG000|Overall Study|Death|1|||
124856984|NCT01753193|449098110|FG000|Overall Study|Other|16|||
124856985|NCT00383435|449098111|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
124856986|NCT00383435|449098112|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
124856987|NCT00383435|449098113|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
124856988|NCT00383435|449098114|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
124856989|NCT00383435|449098115|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
124856990|NCT00383435|449098111|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
124856991|NCT00383435|449098112|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
124856992|NCT00383435|449098113|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
124856993|NCT00383435|449098114|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
124856994|NCT00383435|449098115|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
124856995|NCT00383435|449098111|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
124856996|NCT00383435|449098112|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
124856997|NCT00383435|449098113|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
124856998|NCT00383435|449098114|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
124856999|NCT00383435|449098115|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
124857000|NCT00383435|449098111|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
124857001|NCT00383435|449098112|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
124857002|NCT00383435|449098113|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
124857003|NCT00383435|449098114|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
124857004|NCT00383435|449098115|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
124857005|NCT00383435|449098111|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
124857006|NCT00383435|449098112|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
124857007|NCT00383435|449098113|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
124857008|NCT00383435|449098114|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
124857009|NCT00383435|449098115|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
124857010|NCT00383435|449098111|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
124857011|NCT00383435|449098112|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
124857012|NCT00383435|449098113|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
124857013|NCT00383435|449098114|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
124857014|NCT00383435|449098115|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
124857015|NCT00383435|449098111|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
124857016|NCT00383435|449098112|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
124857017|NCT00383435|449098113|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
124857018|NCT00383435|449098114|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
124857019|NCT00383435|449098115|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
124857020|NCT00383435|449098111|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
124857021|NCT00383435|449098112|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
124857022|NCT00383435|449098113|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
124857023|NCT00383435|449098114|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
124857024|NCT00383435|449098115|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
124857025|NCT00383435|449098111|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
124857026|NCT00383435|449098112|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
124857027|NCT00383435|449098113|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
124857028|NCT00383435|449098114|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
124857029|NCT00383435|449098115|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
124857030|NCT00383435|449098111|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
124857031|NCT00383435|449098112|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
124857032|NCT00383435|449098113|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
124857033|NCT00383435|449098114|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
124857034|NCT00383435|449098115|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
124857035|NCT00383435|449098111|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
124857036|NCT00383435|449098112|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
124857037|NCT00383435|449098113|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
124857038|NCT00383435|449098114|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
124857039|NCT00383435|449098115|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
124857040|NCT00383435|449098111|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
124857041|NCT00383435|449098112|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
124857042|NCT00383435|449098113|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
124857043|NCT00383435|449098114|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
124857044|NCT00383435|449098115|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
124857045|NCT00383435|449098111|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
124857046|NCT00383435|449098112|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
124857047|NCT00383435|449098113|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
124857048|NCT00383435|449098114|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
124857049|NCT00383435|449098115|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
124857050|NCT00383435|449098111|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
124857051|NCT00383435|449098112|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
124857052|NCT00383435|449098113|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
124857053|NCT00383435|449098114|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
124857054|NCT00383435|449098115|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
124857055|NCT00383435|449098111|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
124857056|NCT00383435|449098112|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
124857057|NCT00383435|449098113|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
124857058|NCT00383435|449098114|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
124857059|NCT00383435|449098115|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
124857060|NCT00383435|449098111|FG000|26-Week Treatment Safety Extension|Administrative|1|||
124857061|NCT00383435|449098112|FG001|26-Week Treatment Safety Extension|Administrative|1|||
124857062|NCT00383435|449098113|FG002|26-Week Treatment Safety Extension|Administrative|0|||
124857063|NCT00383435|449098114|FG003|26-Week Treatment Safety Extension|Administrative|1|||
124857064|NCT00383435|449098115|FG004|26-Week Treatment Safety Extension|Administrative|0|||
124857065|NCT00583557|449098116|FG000|Overall Study|Withdrawal by Subject|18|||
124857066|NCT00583557|449098116|FG000|Overall Study|Adverse Event|9|||
124857067|NCT00583557|449098116|FG000|Overall Study|Lack of Efficacy|31|||
124857068|NCT00583557|449098116|FG000|Overall Study|Lack of Compliance|5|||
124857069|NCT00583557|449098116|FG000|Overall Study|Other|5|||
124857070|NCT00583557|449098116|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
124857071|NCT01131312|449098117|FG000|Overall Study|Lost to Follow-up|425|||
124857072|NCT01131312|449098118|FG001|Overall Study|Lost to Follow-up|229|||
124857073|NCT01131312|449098119|FG002|Overall Study|Lost to Follow-up|351|||
124857074|NCT02682264|449098120|FG000|Overall Study|Withdrawal by Subject|56|||
124857075|NCT02682264|449098121|FG001|Overall Study|Withdrawal by Subject|45|||
124857076|NCT02682264|449098120|FG000|Overall Study|Lost to Follow-up|49|||
124857077|NCT02682264|449098121|FG001|Overall Study|Lost to Follow-up|41|||
124857078|NCT02682264|449098120|FG000|Overall Study|Lack of Efficacy|14|||
124857079|NCT02682264|449098121|FG001|Overall Study|Lack of Efficacy|16|||
124857080|NCT02682264|449098120|FG000|Overall Study|Withdrawal by Parent|6|||
124857081|NCT02682264|449098121|FG001|Overall Study|Withdrawal by Parent|7|||
124857082|NCT02682264|449098120|FG000|Overall Study|Adverse Event|9|||
124857083|NCT02682264|449098121|FG001|Overall Study|Adverse Event|0|||
124857084|NCT02682264|449098120|FG000|Overall Study|Noncompliance with study drug|1|||
124857085|NCT02682264|449098121|FG001|Overall Study|Noncompliance with study drug|4|||
124857086|NCT02682264|449098120|FG000|Overall Study|Pregnancy|1|||
124857087|NCT02682264|449098121|FG001|Overall Study|Pregnancy|2|||
124857088|NCT02682264|449098120|FG000|Overall Study|Recovery|1|||
124857089|NCT02682264|449098121|FG001|Overall Study|Recovery|2|||
124857090|NCT02682264|449098120|FG000|Overall Study|Progressive Disease|1|||
124857091|NCT02682264|449098121|FG001|Overall Study|Progressive Disease|0|||
124857092|NCT02682264|449098120|FG000|Overall Study|Technical Problems|0|||
124857093|NCT02682264|449098121|FG001|Overall Study|Technical Problems|1|||
124857094|NCT02682264|449098120|FG000|Overall Study|Moved abroad and unable to continue|0|||
124857095|NCT02682264|449098121|FG001|Overall Study|Moved abroad and unable to continue|3|||
124857096|NCT02682264|449098120|FG000|Overall Study|Stopped test article application|0|||
124857097|NCT02682264|449098121|FG001|Overall Study|Stopped test article application|1|||
124857098|NCT03264989|449098126|FG000|Overall Study|Lost to Follow-up|1|||
124857099|NCT03264989|449098127|FG001|Overall Study|Lost to Follow-up|0|||
124857100|NCT03264989|449098126|FG000|Overall Study|New Therapy for study Indication|1|||
124857101|NCT03264989|449098127|FG001|Overall Study|New Therapy for study Indication|0|||
124857102|NCT03264989|449098126|FG000|Overall Study|Protocol Violation|0|||
124857103|NCT03264989|449098127|FG001|Overall Study|Protocol Violation|1|||
124857104|NCT03264989|449098126|FG000|Overall Study|Patient decision|13|||
124857105|NCT03264989|449098127|FG001|Overall Study|Patient decision|0|||
124857106|NCT03264989|449098126|FG000|Overall Study|Physician Decision|6|||
124857107|NCT03264989|449098127|FG001|Overall Study|Physician Decision|4|||
124857108|NCT03264989|449098126|FG000|Overall Study|Adverse Event|2|||
124857109|NCT03264989|449098127|FG001|Overall Study|Adverse Event|1|||
124857110|NCT03264989|449098126|FG000|Overall Study|Death|1|||
124857111|NCT03264989|449098127|FG001|Overall Study|Death|1|||
124857112|NCT03264989|449098126|FG000|Overall Study|Pregnancy|2|||
124857113|NCT03264989|449098127|FG001|Overall Study|Pregnancy|0|||
124857114|NCT03264989|449098126|FG000|Overall Study|End of Study|19|||
124857115|NCT03264989|449098127|FG001|Overall Study|End of Study|5|||
124857116|NCT00797667|449098128|FG000|Overall Study|Lack of Efficacy|0|||
124857117|NCT00797667|449098129|FG001|Overall Study|Lack of Efficacy|1|||
124857118|NCT00797667|449098130|FG002|Overall Study|Lack of Efficacy|0|||
124857119|NCT00797667|449098128|FG000|Overall Study|Lost to Follow-up|8|||
124857120|NCT00797667|449098129|FG001|Overall Study|Lost to Follow-up|12|||
124857121|NCT00797667|449098130|FG002|Overall Study|Lost to Follow-up|2|||
124857122|NCT00797667|449098128|FG000|Overall Study|Physician Decision|3|||
124857123|NCT00797667|449098129|FG001|Overall Study|Physician Decision|1|||
124857124|NCT00797667|449098130|FG002|Overall Study|Physician Decision|0|||
124857125|NCT00797667|449098128|FG000|Overall Study|Pregnancy|2|||
124857126|NCT00797667|449098129|FG001|Overall Study|Pregnancy|0|||
124857127|NCT00797667|449098130|FG002|Overall Study|Pregnancy|0|||
124857128|NCT00797667|449098128|FG000|Overall Study|Protocol Violation|2|||
124857129|NCT00797667|449098129|FG001|Overall Study|Protocol Violation|7|||
124857130|NCT00797667|449098130|FG002|Overall Study|Protocol Violation|0|||
124857131|NCT00797667|449098128|FG000|Overall Study|Study Terminated by Sponsor|217|||
124857132|NCT00797667|449098129|FG001|Overall Study|Study Terminated by Sponsor|216|||
124857133|NCT00797667|449098130|FG002|Overall Study|Study Terminated by Sponsor|115|||
124857134|NCT00797667|449098128|FG000|Overall Study|Withdrawal by Subject|9|||
124857135|NCT00797667|449098129|FG001|Overall Study|Withdrawal by Subject|14|||
124857136|NCT00797667|449098130|FG002|Overall Study|Withdrawal by Subject|2|||
124857137|NCT00797667|449098128|FG000|Overall Study|Adverse Event|19|||
124857138|NCT00797667|449098129|FG001|Overall Study|Adverse Event|8|||
124857139|NCT00797667|449098130|FG002|Overall Study|Adverse Event|8|||
124857140|NCT01986829|449098131|FG000|Overall Study|Death|1|||
124857141|NCT01775137|449098132|FG000|Overall Study|Death|1|||
124857142|NCT01775137|449098132|FG000|Overall Study|Protocol deviation|2|||
124857143|NCT01775137|449098132|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124857144|NCT01775137|449098132|FG000|Overall Study|Adverse Event|1|||
124857145|NCT01775137|449098132|FG000|Overall Study|Withdrawal by participants|5|||
124857146|NCT03029208|449098133|FG000|Overall Study|Withdrawal by Subject|2|||
124857147|NCT03029208|449098134|FG001|Overall Study|Withdrawal by Subject|3|||
124857148|NCT03029208|449098133|FG000|Overall Study|Lost to Follow-up|0|||
124857149|NCT03029208|449098134|FG001|Overall Study|Lost to Follow-up|1|||
124857150|NCT01732835|449098135|FG000|6-month Primary Endpoint|Did not receive device|19|||
124857151|NCT01732835|449098135|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
124857152|NCT01732835|449098135|FG000|6-month Primary Endpoint|Adverse Event|3|||
124857153|NCT01732835|449098135|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
124857154|NCT01732835|449098135|FG000|2-year Extended Follow-up|Adverse Event|3|||
124857155|NCT01732835|449098135|FG000|2-year Extended Follow-up|Death|1|||
124857156|NCT02334748|449098136|FG000|Overall Study|Adverse Event|1|||
124857157|NCT02334748|449098136|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
124857158|NCT02334748|449098136|FG000|Overall Study|Patient no longer required study drug|2|||
124857159|NCT02334748|449098136|FG000|Overall Study|Lack of Efficacy|4|||
124857160|NCT00305058|449098137|FG000|Overall Study|Participant too young|1|||
124857161|NCT00305058|449098138|FG001|Overall Study|Participant too young|0|||
124857162|NCT00305058|449098137|FG000|Overall Study|Missing data collection instrument|3|||
124857163|NCT00305058|449098138|FG001|Overall Study|Missing data collection instrument|2|||
124857164|NCT00305058|449098137|FG000|Overall Study|Missing outcome data|3|||
124857165|NCT00305058|449098138|FG001|Overall Study|Missing outcome data|2|||
124857166|NCT03965052|449098142|FG000|Overall Study|Protocol Violation|1|||
124857167|NCT03965052|449098143|FG001|Overall Study|Protocol Violation|0|||
124857168|NCT01910519|449098147|FG000|Overall Study|Withdrawal by Subject|2|||
124857169|NCT01910519|449098148|FG001|Overall Study|Withdrawal by Subject|0|||
124857170|NCT01910519|449098147|FG000|Overall Study|Adverse Event|2|||
124857171|NCT01910519|449098148|FG001|Overall Study|Adverse Event|0|||
124857172|NCT04266028|449098149|FG000|Overall Study|Adverse Event|0|||
124857173|NCT04266028|449098150|FG001|Overall Study|Adverse Event|0|||
124857174|NCT04266028|449098151|FG002|Overall Study|Adverse Event|1|||
124857175|NCT04266028|449098152|FG003|Overall Study|Adverse Event|0|||
124857176|NCT04266028|449098153|FG004|Overall Study|Adverse Event|1|||
124857177|NCT04266028|449098154|FG005|Overall Study|Adverse Event|0|||
124857178|NCT04266028|449098155|FG006|Overall Study|Adverse Event|2|||
124857179|NCT04266028|449098156|FG007|Overall Study|Adverse Event|0|||
124857180|NCT04266028|449098149|FG000|Overall Study|temporary halt of the study|0|||
124857181|NCT04266028|449098150|FG001|Overall Study|temporary halt of the study|0|||
124857182|NCT04266028|449098151|FG002|Overall Study|temporary halt of the study|0|||
124857183|NCT04266028|449098152|FG003|Overall Study|temporary halt of the study|0|||
124857184|NCT04266028|449098153|FG004|Overall Study|temporary halt of the study|0|||
124857185|NCT04266028|449098154|FG005|Overall Study|temporary halt of the study|0|||
124857186|NCT04266028|449098155|FG006|Overall Study|temporary halt of the study|2|||
124857187|NCT04266028|449098156|FG007|Overall Study|temporary halt of the study|1|||
124857188|NCT04266028|449098149|FG000|Overall Study|Onset of birch pollen season|0|||
124857189|NCT04266028|449098150|FG001|Overall Study|Onset of birch pollen season|0|||
124857190|NCT04266028|449098151|FG002|Overall Study|Onset of birch pollen season|0|||
124857191|NCT04266028|449098152|FG003|Overall Study|Onset of birch pollen season|0|||
124857192|NCT04266028|449098153|FG004|Overall Study|Onset of birch pollen season|1|||
124857193|NCT04266028|449098154|FG005|Overall Study|Onset of birch pollen season|0|||
124857194|NCT04266028|449098155|FG006|Overall Study|Onset of birch pollen season|0|||
124857195|NCT04266028|449098156|FG007|Overall Study|Onset of birch pollen season|0|||
124857196|NCT02863991|449098157|FG000|Overall Study|Death|0|||
124857197|NCT02863991|449098158|FG001|Overall Study|Death|3|||
124857198|NCT02863991|449098157|FG000|Overall Study|Lack of Efficacy|0|||
124857199|NCT02863991|449098158|FG001|Overall Study|Lack of Efficacy|1|||
124857200|NCT02863991|449098157|FG000|Overall Study|Study Terminated|2|||
124857201|NCT02863991|449098158|FG001|Overall Study|Study Terminated|8|||
124857202|NCT03096782|449098162|FG000|Overall Study|Death|1|||
124857203|NCT03096782|449098162|FG000|Overall Study|Participant Relapsed|1|||
124857204|NCT00993447|449099994|FG000|Overall Study|Withdrawal by Subject|23|||
124857205|NCT00993447|449099995|FG001|Overall Study|Withdrawal by Subject|8|||
124857206|NCT00993447|449099994|FG000|Overall Study|Protocol Violation|12|||
124857207|NCT00993447|449099995|FG001|Overall Study|Protocol Violation|8|||
124857208|NCT00993447|449099994|FG000|Overall Study|Lost to Follow-up|1|||
124857209|NCT00993447|449099995|FG001|Overall Study|Lost to Follow-up|3|||
124857210|NCT00993447|449099994|FG000|Overall Study|Adverse Event|1|||
124857211|NCT00993447|449099995|FG001|Overall Study|Adverse Event|0|||
124857212|NCT00970502|449099996|FG000|Overall Study|Withdrawal by Subject|1|||
124857213|NCT03811912|449099997|FG000|Overall Study|Withdrew Consent|4|||
124857214|NCT03811912|449099998|FG001|Overall Study|Withdrew Consent|2|||
124857215|NCT00566228|449099999|FG000|Overall Study|Withdrawal by Subject|1|||
124857216|NCT00566228|449100000|FG001|Overall Study|Withdrawal by Subject|0|||
124857217|NCT00566228|449099999|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
124857218|NCT00566228|449100000|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
124857219|NCT00566228|449099999|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
124857220|NCT00566228|449100000|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
124857221|NCT00566228|449099999|FG000|Overall Study|progressed before infusion could occur|0|||
124857222|NCT00566228|449100000|FG001|Overall Study|progressed before infusion could occur|1|||
124857223|NCT03521635|449100001|FG000|Overall Study|Adverse Event|1|||
124857224|NCT03521635|449100002|FG001|Overall Study|Adverse Event|1|||
124857225|NCT03521635|449100001|FG000|Overall Study|Refused to complete study visit|1|||
124857226|NCT03521635|449100002|FG001|Overall Study|Refused to complete study visit|0|||
124857227|NCT03521635|449100001|FG000|Overall Study|Refused to continue trial medication|2|||
124857228|NCT03521635|449100002|FG001|Overall Study|Refused to continue trial medication|2|||
124857229|NCT03521635|449100001|FG000|Overall Study|Lost to Follow-up|0|||
124857230|NCT03521635|449100002|FG001|Overall Study|Lost to Follow-up|1|||
124857231|NCT03521635|449100001|FG000|Overall Study|Meet exclusion criteria|0|||
124857232|NCT03521635|449100002|FG001|Overall Study|Meet exclusion criteria|1|||
124857233|NCT03521635|449100001|FG000|Overall Study|Patient not taken study medicine|0|||
124857234|NCT03521635|449100002|FG001|Overall Study|Patient not taken study medicine|1|||
124857235|NCT02244944|449100003|FG000|Overall Study|Withdrawal by Subject|1|||
124857236|NCT02244944|449100003|FG000|Overall Study|Study Terminated|1|||
124857237|NCT00512135|449100006|FG000|Overall Study|Not Treated|5|||
124857238|NCT00512135|449100006|FG000|Overall Study|Lack of Efficacy|2|||
124857239|NCT00512135|449100006|FG000|Overall Study|Adverse Event|6|||
124857240|NCT00512135|449100006|FG000|Overall Study|Withdrawal by Subject|22|||
124857241|NCT00512135|449100006|FG000|Overall Study|Lost to Follow-up|27|||
124857242|NCT00512135|449100006|FG000|Overall Study|Other|22|||
124857243|NCT01659021|449100007|FG000|Main Study|Adverse Event|2|||
124857244|NCT01659021|449100008|FG001|Main Study|Adverse Event|3|||
124857245|NCT01659021|449100007|FG000|Main Study|Lost to Follow-up|1|||
124857246|NCT01659021|449100008|FG001|Main Study|Lost to Follow-up|0|||
124857247|NCT01659021|449100007|FG000|Main Study|Unknown Reasons|2|||
124857248|NCT01659021|449100008|FG001|Main Study|Unknown Reasons|1|||
124857249|NCT01659021|449100007|FG000|Main Study|Physician Decision|34|||
124857250|NCT01659021|449100008|FG001|Main Study|Physician Decision|16|||
124857251|NCT01659021|449100007|FG000|Main Study|Withdrawal by Subject|19|||
124857252|NCT01659021|449100008|FG001|Main Study|Withdrawal by Subject|16|||
124857253|NCT01659021|449100007|FG000|Main Study|Study Terminated by Sponsor|16|||
124857254|NCT01659021|449100008|FG001|Main Study|Study Terminated by Sponsor|1|||
124857255|NCT01659021|449100007|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
124857256|NCT01659021|449100008|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
124857257|NCT01659021|449100007|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
124857258|NCT01659021|449100008|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
124857259|NCT01205685|449100009|FG000|Overall Study|Disease Progression|10|||
124857260|NCT01205685|449100009|FG000|Overall Study|Withdrawal by Subject|1|||
124857261|NCT03058679|449100013|FG000|Baseline to Week 6|Lost to Follow-up|3|||
124857262|NCT03058679|449100014|FG001|Baseline to Week 6|Lost to Follow-up|2|||
124857263|NCT03058679|449100013|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
124857264|NCT03058679|449100014|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
124857265|NCT03058679|449100013|FG000|Baseline to Week 6|Adverse Event|6|||
124857266|NCT03058679|449100014|FG001|Baseline to Week 6|Adverse Event|6|||
124857267|NCT03058679|449100013|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
124857268|NCT03058679|449100014|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
124857269|NCT03058679|449100013|FG000|Baseline to Week 6|Difficulty following the diet|0|||
124857270|NCT03058679|449100014|FG001|Baseline to Week 6|Difficulty following the diet|2|||
124857271|NCT03058679|449100013|FG000|Baseline to Week 6|Physician Decision|1|||
124857272|NCT03058679|449100014|FG001|Baseline to Week 6|Physician Decision|0|||
124857273|NCT03058679|449100013|FG000|Week 6 to Week 12|Change in medication|5|||
124857274|NCT03058679|449100014|FG001|Week 6 to Week 12|Change in medication|7|||
124857275|NCT03058679|449100013|FG000|Week 6 to Week 12|Adverse Event|4|||
124857276|NCT03058679|449100014|FG001|Week 6 to Week 12|Adverse Event|3|||
124857277|NCT03058679|449100013|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
124857278|NCT03058679|449100014|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
124857279|NCT03058679|449100013|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
124857280|NCT03058679|449100014|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
124857281|NCT00599326|449100023|FG000|Overall Study|Lost to Follow-up|1|||
124857282|NCT00599326|449100023|FG000|Overall Study|Noncompliant|1|||
124857283|NCT00784810|449100026|FG000|Overall Study|Adverse Event|32|||
124857284|NCT00784810|449100027|FG001|Overall Study|Adverse Event|20|||
124857285|NCT00784810|449100026|FG000|Overall Study|Lack of Efficacy|14|||
124857286|NCT00784810|449100027|FG001|Overall Study|Lack of Efficacy|11|||
124857287|NCT00784810|449100026|FG000|Overall Study|Withdrawal by Subject|11|||
124857288|NCT00784810|449100027|FG001|Overall Study|Withdrawal by Subject|9|||
124857289|NCT00784810|449100026|FG000|Overall Study|Administrative|5|||
124857290|NCT00784810|449100027|FG001|Overall Study|Administrative|8|||
124857291|NCT00784810|449100026|FG000|Overall Study|Lost to Follow-up|1|||
124857292|NCT00784810|449100027|FG001|Overall Study|Lost to Follow-up|1|||
124857293|NCT02862106|449100028|FG000|Overall Study|Adverse Event|4|||
124857294|NCT02862106|449100029|FG001|Overall Study|Adverse Event|0|||
124857295|NCT02862106|449100028|FG000|Overall Study|Protocol Violation|16|||
124857296|NCT02862106|449100029|FG001|Overall Study|Protocol Violation|1|||
124857297|NCT02862106|449100028|FG000|Overall Study|Lost to Follow-up|15|||
124857298|NCT02862106|449100029|FG001|Overall Study|Lost to Follow-up|5|||
124857299|NCT02862106|449100028|FG000|Overall Study|Withdrawal by Subject|2|||
124857300|NCT02862106|449100029|FG001|Overall Study|Withdrawal by Subject|0|||
124857301|NCT02862106|449100028|FG000|Overall Study|Subjects moved to other city|1|||
124857302|NCT02862106|449100029|FG001|Overall Study|Subjects moved to other city|0|||
124857303|NCT04137380|449100034|FG000|Overall Study|Physician Decision|0|||
124857304|NCT04137380|449100035|FG001|Overall Study|Physician Decision|0|||
124857305|NCT04137380|449100036|FG002|Overall Study|Physician Decision|0|||
124857306|NCT04137380|449100037|FG003|Overall Study|Physician Decision|1|||
124857307|NCT04137380|449100038|FG004|Overall Study|Physician Decision|0|||
124857308|NCT04137380|449100039|FG005|Overall Study|Physician Decision|0|||
124857309|NCT04137380|449100040|FG006|Overall Study|Physician Decision|0|||
124857310|NCT00563784|449100041|FG000|Overall Study|Withdrawal by Subject|2|||
124857311|NCT00563784|449100041|FG000|Overall Study|Screen Failures|20|||
124857312|NCT03434119|449100045|FG000|Overall Study|Randomized but not treated|1|||
124857313|NCT03434119|449100046|FG001|Overall Study|Randomized but not treated|0|||
124857314|NCT03434119|449100045|FG000|Overall Study|Adverse Event|1|||
124857315|NCT03434119|449100046|FG001|Overall Study|Adverse Event|0|||
124857316|NCT03434119|449100045|FG000|Overall Study|Poor Compliance to Protocol|0|||
124857317|NCT03434119|449100046|FG001|Overall Study|Poor Compliance to Protocol|1|||
124857318|NCT03434119|449100045|FG000|Overall Study|Study Terminated by Sponsor|91|||
124857319|NCT03434119|449100046|FG001|Overall Study|Study Terminated by Sponsor|102|||
124857320|NCT03434119|449100045|FG000|Overall Study|Withdrawal by Subject|7|||
124857321|NCT03434119|449100046|FG001|Overall Study|Withdrawal by Subject|5|||
124857322|NCT03434119|449100045|FG000|Overall Study|Other than specified|7|||
124857323|NCT03434119|449100046|FG001|Overall Study|Other than specified|5|||
124857324|NCT00304070|449100047|FG000|Overall Study|Death|0|||
124857325|NCT00304070|449100048|FG001|Overall Study|Death|0|||
124857326|NCT00304070|449100049|FG002|Overall Study|Death|3|||
124857327|NCT00304070|449100047|FG000|Overall Study|Lost to Follow-up|0|||
124857328|NCT00304070|449100048|FG001|Overall Study|Lost to Follow-up|0|||
124857329|NCT00304070|449100049|FG002|Overall Study|Lost to Follow-up|1|||
124857330|NCT00304070|449100047|FG000|Overall Study|Physician Decision|0|||
124857331|NCT00304070|449100048|FG001|Overall Study|Physician Decision|0|||
124857332|NCT00304070|449100049|FG002|Overall Study|Physician Decision|3|||
124857333|NCT00304070|449100047|FG000|Overall Study|Withdrawal by Subject|0|||
124857334|NCT00304070|449100048|FG001|Overall Study|Withdrawal by Subject|0|||
124857335|NCT00304070|449100049|FG002|Overall Study|Withdrawal by Subject|1|||
124857336|NCT00304070|449100047|FG000|Overall Study|Progressive Disease|3|||
124857337|NCT00304070|449100048|FG001|Overall Study|Progressive Disease|7|||
124857338|NCT00304070|449100049|FG002|Overall Study|Progressive Disease|4|||
124857339|NCT03579459|449100050|FG000|Overall Study|Adverse Event|7|||
124857340|NCT03579459|449100051|FG001|Overall Study|Adverse Event|6|||
124857341|NCT03579459|449100052|FG002|Overall Study|Adverse Event|2|||
124857342|NCT03579459|449100053|FG003|Overall Study|Adverse Event|6|||
124857343|NCT03579459|449100050|FG000|Overall Study|Death|1|||
124857344|NCT03579459|449100051|FG001|Overall Study|Death|0|||
124857345|NCT03579459|449100052|FG002|Overall Study|Death|1|||
124857346|NCT03579459|449100053|FG003|Overall Study|Death|2|||
124857347|NCT03579459|449100050|FG000|Overall Study|Lost to Follow-up|6|||
124857348|NCT03579459|449100051|FG001|Overall Study|Lost to Follow-up|2|||
124857349|NCT03579459|449100052|FG002|Overall Study|Lost to Follow-up|4|||
124857350|NCT03579459|449100053|FG003|Overall Study|Lost to Follow-up|1|||
124857351|NCT03579459|449100050|FG000|Overall Study|Physician Decision|0|||
124857352|NCT03579459|449100051|FG001|Overall Study|Physician Decision|1|||
124857353|NCT03579459|449100052|FG002|Overall Study|Physician Decision|0|||
124857354|NCT03579459|449100053|FG003|Overall Study|Physician Decision|1|||
124857355|NCT03579459|449100050|FG000|Overall Study|Protocol Violation|1|||
124857356|NCT03579459|449100051|FG001|Overall Study|Protocol Violation|2|||
124857357|NCT03579459|449100052|FG002|Overall Study|Protocol Violation|3|||
124857358|NCT03579459|449100053|FG003|Overall Study|Protocol Violation|5|||
124857359|NCT03579459|449100050|FG000|Overall Study|Withdrawal by Subject|12|||
124857360|NCT03579459|449100051|FG001|Overall Study|Withdrawal by Subject|8|||
124857361|NCT03579459|449100052|FG002|Overall Study|Withdrawal by Subject|11|||
124857362|NCT03579459|449100053|FG003|Overall Study|Withdrawal by Subject|8|||
124857363|NCT03579459|449100050|FG000|Overall Study|Medication error without associated adverse event|2|||
124857364|NCT03579459|449100051|FG001|Overall Study|Medication error without associated adverse event|1|||
124857365|NCT03579459|449100052|FG002|Overall Study|Medication error without associated adverse event|1|||
124857366|NCT03579459|449100053|FG003|Overall Study|Medication error without associated adverse event|0|||
124857367|NCT03579459|449100050|FG000|Overall Study|Other|0|||
124857368|NCT03579459|449100051|FG001|Overall Study|Other|1|||
124857369|NCT03579459|449100052|FG002|Overall Study|Other|1|||
124857370|NCT03579459|449100053|FG003|Overall Study|Other|0|||
124857371|NCT03579459|449100050|FG000|Overall Study|Randomized not vaccinated|0|||
124857372|NCT03579459|449100051|FG001|Overall Study|Randomized not vaccinated|2|||
124857373|NCT03579459|449100052|FG002|Overall Study|Randomized not vaccinated|0|||
124857374|NCT03579459|449100053|FG003|Overall Study|Randomized not vaccinated|1|||
124857375|NCT00148343|449100054|FG000|Overall Study|Withdrawal by Subject|12|||
124857376|NCT00148343|449100055|FG001|Overall Study|Withdrawal by Subject|7|||
124857377|NCT00148343|449100054|FG000|Overall Study|Physician Decision|3|||
124857378|NCT00148343|449100055|FG001|Overall Study|Physician Decision|4|||
124857379|NCT02528214|449100060|FG000|Overall Study|Protocol Violation|0|||
124857380|NCT02528214|449100061|FG001|Overall Study|Protocol Violation|1|||
124857381|NCT02528214|449100060|FG000|Overall Study|Adverse Event|0|||
124857382|NCT02528214|449100061|FG001|Overall Study|Adverse Event|1|||
124857383|NCT02528214|449100060|FG000|Overall Study|Other than specified above|0|||
124857384|NCT02528214|449100061|FG001|Overall Study|Other than specified above|1|||
124857385|NCT03447769|449100063|FG000|Overall Study|Progressive disease|138|||
124857386|NCT03447769|449100064|FG001|Overall Study|Progressive disease|148|||
124857387|NCT03447769|449100063|FG000|Overall Study|Study terminated by Sponsor|60|||
124857388|NCT03447769|449100064|FG001|Overall Study|Study terminated by Sponsor|44|||
124857389|NCT03447769|449100063|FG000|Overall Study|Adverse Event|34|||
124857390|NCT03447769|449100064|FG001|Overall Study|Adverse Event|31|||
124857391|NCT03447769|449100063|FG000|Overall Study|Patient decision|27|||
124857392|NCT03447769|449100064|FG001|Overall Study|Patient decision|27|||
124857393|NCT03447769|449100063|FG000|Overall Study|Protocol deviation|4|||
124857394|NCT03447769|449100064|FG001|Overall Study|Protocol deviation|6|||
124857395|NCT03447769|449100063|FG000|Overall Study|Death|2|||
124857396|NCT03447769|449100064|FG001|Overall Study|Death|7|||
124857397|NCT03447769|449100063|FG000|Overall Study|Technical problems|1|||
124857398|NCT03447769|449100064|FG001|Overall Study|Technical problems|0|||
124857399|NCT03447769|449100063|FG000|Overall Study|Lost to Follow-up|0|||
124857400|NCT03447769|449100064|FG001|Overall Study|Lost to Follow-up|1|||
124857401|NCT03447769|449100063|FG000|Overall Study|Physician Decision|13|||
124857402|NCT03447769|449100064|FG001|Overall Study|Physician Decision|5|||
124857403|NCT01343407|449100065|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
124857404|NCT01343407|449100066|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
124857405|NCT01343407|449100067|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
124857406|NCT01343407|449100068|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
124857407|NCT01343407|449100069|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
124857408|NCT01343407|449100070|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
124857409|NCT01343407|449100065|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
124857410|NCT01343407|449100066|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
124857411|NCT01343407|449100067|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
124857412|NCT01343407|449100068|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
124857413|NCT01343407|449100069|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
124857414|NCT01343407|449100070|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
124857415|NCT03950739|449100071|FG000|Treatment Phase|Adverse Event|2|||
124857416|NCT03950739|449100071|FG000|Optional Extension Phase|Death|1|||
124857417|NCT03950739|449100071|FG000|Optional Extension Phase|Progressive Disease|5|||
124857418|NCT03950739|449100071|FG000|Optional Extension Phase|Adverse Event|7|||
124857419|NCT03950739|449100071|FG000|Optional Extension Phase|Lost to Follow-up|2|||
124857420|NCT03950739|449100071|FG000|Optional Extension Phase|Site Closure|2|||
124857421|NCT03950739|449100071|FG000|Optional Extension Phase|Pregnancy|1|||
124857422|NCT02504866|449100073|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
124857423|NCT02504866|449100074|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
124857424|NCT02504866|449100075|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
124857425|NCT01343056|449100078|FG000|Overall Study|Lost to Follow-up|7|||
124857426|NCT01343056|449100079|FG001|Overall Study|Lost to Follow-up|5|||
124857427|NCT01343056|449100080|FG002|Overall Study|Lost to Follow-up|3|||
124857428|NCT01343056|449100081|FG003|Overall Study|Lost to Follow-up|9|||
124857429|NCT03231371|449100082|FG000|Overall Study|Withdrawal by Subject|1|||
124857430|NCT03231371|449100082|FG000|Overall Study|chose or were ineligible to have MRI|12|||
124857431|NCT02493361|449100088|FG000|Overall Study|Withdrawal by Subject|3|||
124857432|NCT01046643|449100089|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
124857433|NCT01046643|449100090|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
124857434|NCT01046643|449100091|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
124857435|NCT01046643|449100092|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
124857436|NCT00553267|449100103|FG000|Overall Study|Adverse Event|8|||
124857437|NCT00553267|449100104|FG001|Overall Study|Adverse Event|10|||
124857438|NCT00553267|449100105|FG002|Overall Study|Adverse Event|5|||
124857439|NCT00553267|449100103|FG000|Overall Study|Non compliant with protocol|3|||
124857440|NCT00553267|449100104|FG001|Overall Study|Non compliant with protocol|3|||
124857441|NCT00553267|449100105|FG002|Overall Study|Non compliant with protocol|2|||
124857442|NCT00553267|449100103|FG000|Overall Study|Lost to Follow-up|0|||
124857443|NCT00553267|449100104|FG001|Overall Study|Lost to Follow-up|0|||
124857444|NCT00553267|449100105|FG002|Overall Study|Lost to Follow-up|1|||
124857445|NCT00553267|449100103|FG000|Overall Study|Consent withdrawn|2|||
124857446|NCT00553267|449100104|FG001|Overall Study|Consent withdrawn|3|||
124857447|NCT00553267|449100105|FG002|Overall Study|Consent withdrawn|1|||
124857448|NCT00553267|449100103|FG000|Overall Study|Specified category|1|||
124857449|NCT00553267|449100104|FG001|Overall Study|Specified category|2|||
124857450|NCT00553267|449100105|FG002|Overall Study|Specified category|1|||
124857451|NCT01310036|449100106|FG000|Overall Study|Administrative/other|10|||
124857452|NCT01310036|449100106|FG000|Overall Study|Withdrew Consent|11|||
124857453|NCT01310036|449100106|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
124857454|NCT01310036|449100106|FG000|Overall Study|Progression of Disease|164|||
124857455|NCT01310036|449100106|FG000|Overall Study|Death|1|||
124857456|NCT01310036|449100106|FG000|Overall Study|Adverse event or intercurrent illness|12|||
124857457|NCT01175668|449100107|FG000|Overall Study|Withdrawal by Subject|2|||
124857458|NCT01175668|449100108|FG001|Overall Study|Withdrawal by Subject|0|||
124857459|NCT00096135|449100114|FG000|Overall Study|Physician Decision|20|||
124857460|NCT00096135|449100115|FG001|Overall Study|Physician Decision|4|||
124857461|NCT00096135|449100114|FG000|Overall Study|Refusal of further protocol therapy|4|||
124857462|NCT00096135|449100115|FG001|Overall Study|Refusal of further protocol therapy|1|||
124857463|NCT00096135|449100114|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
124857464|NCT00096135|449100115|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
124857465|NCT00096135|449100114|FG000|Overall Study|Other, specify|15|||
124857466|NCT00096135|449100115|FG001|Overall Study|Other, specify|3|||
124857467|NCT00096135|449100114|FG000|Overall Study|Ineligible|2|||
124857468|NCT00096135|449100115|FG001|Overall Study|Ineligible|0|||
124857469|NCT01568047|449100117|FG000|Overall Study|Ineligibility|1|||
124857470|NCT01568047|449100118|FG001|Overall Study|Ineligibility|0|||
124857471|NCT01568047|449100119|FG002|Overall Study|Ineligibility|0|||
124857472|NCT01568047|449100120|FG003|Overall Study|Ineligibility|0|||
124857473|NCT01568047|449100117|FG000|Overall Study|Withdrawal by Subject|0|||
124857474|NCT01568047|449100118|FG001|Overall Study|Withdrawal by Subject|1|||
124857475|NCT01568047|449100119|FG002|Overall Study|Withdrawal by Subject|0|||
124857476|NCT01568047|449100120|FG003|Overall Study|Withdrawal by Subject|0|||
124857477|NCT01568047|449100117|FG000|Overall Study|Adverse Event|0|||
124857478|NCT01568047|449100118|FG001|Overall Study|Adverse Event|0|||
124857479|NCT01568047|449100119|FG002|Overall Study|Adverse Event|1|||
124857480|NCT01568047|449100120|FG003|Overall Study|Adverse Event|1|||
124857481|NCT00874029|449100121|FG000|Overall Study|Withdrawal by Subject|10|||
124857482|NCT00874029|449100121|FG000|Overall Study|Pregnancy|4|||
124857483|NCT00874029|449100121|FG000|Overall Study|Physician Decision|1|||
124857484|NCT00874029|449100121|FG000|Overall Study|Adverse Event|1|||
124857485|NCT00874029|449100121|FG000|Overall Study|Lost to Follow-up|5|||
124857486|NCT03359096|449100122|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
124857487|NCT03359096|449100123|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
124857488|NCT03359096|449100122|FG000|First Intervention (4 Weeks)|Death|1|||
124857489|NCT03359096|449100123|FG001|First Intervention (4 Weeks)|Death|0|||
124857490|NCT03359096|449100122|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
124857491|NCT03359096|449100123|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
124857492|NCT00856583|449100124|FG000|Overall Study|Lack of Efficacy|389|||
124857493|NCT00856583|449100125|FG001|Overall Study|Lack of Efficacy|377|||
124857494|NCT00856583|449100124|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
124857495|NCT00856583|449100125|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
124857496|NCT00856583|449100124|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
124857497|NCT00856583|449100125|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
124857498|NCT00856583|449100124|FG000|Overall Study|Non-compliance|305|||
124857499|NCT00856583|449100125|FG001|Overall Study|Non-compliance|262|||
124857500|NCT00856583|449100124|FG000|Overall Study|Withdrawal by Subject|1092|||
124857501|NCT00856583|449100125|FG001|Overall Study|Withdrawal by Subject|919|||
124857502|NCT00856583|449100124|FG000|Overall Study|Physician Decision|59|||
124857503|NCT00856583|449100125|FG001|Overall Study|Physician Decision|82|||
124857504|NCT00856583|449100124|FG000|Overall Study|Pregnancy|14|||
124857505|NCT00856583|449100125|FG001|Overall Study|Pregnancy|5|||
124857506|NCT00856583|449100124|FG000|Overall Study|Other|92|||
124857507|NCT00856583|449100125|FG001|Overall Study|Other|104|||
124857508|NCT00856583|449100124|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
124857509|NCT00856583|449100125|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
124857510|NCT01944046|449100129|FG000|Randomized to DB|Adverse Event|5|||
124857511|NCT01944046|449100130|FG001|Randomized to DB|Adverse Event|2|||
124857512|NCT01944046|449100129|FG000|Randomized to DB|Clinical Worsening|3|||
124857513|NCT01944046|449100130|FG001|Randomized to DB|Clinical Worsening|2|||
124857514|NCT01944046|449100129|FG000|Randomized to DB|Lost to Follow-up|3|||
124857515|NCT01944046|449100130|FG001|Randomized to DB|Lost to Follow-up|3|||
124857516|NCT01944046|449100129|FG000|Randomized to DB|Withdrawal by Subject|2|||
124857517|NCT01944046|449100130|FG001|Randomized to DB|Withdrawal by Subject|4|||
124857518|NCT01944046|449100129|FG000|Randomized to DB|Physician Decision|1|||
124857519|NCT01944046|449100130|FG001|Randomized to DB|Physician Decision|2|||
124857520|NCT01944046|449100129|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
124857521|NCT01944046|449100130|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
124857522|NCT01944046|449100129|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
124857523|NCT01944046|449100130|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
124857524|NCT01944046|449100129|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
124857525|NCT01944046|449100130|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
124857526|NCT01944046|449100129|FG000|Open Label Eligible and Consented|Adverse Event|6|||
124857527|NCT01944046|449100130|FG001|Open Label Eligible and Consented|Adverse Event|1|||
124857528|NCT01944046|449100129|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
124857529|NCT01944046|449100130|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
124857530|NCT01944046|449100129|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
124857531|NCT01944046|449100130|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
124857532|NCT02328326|449100134|FG000|Overall Study|Withdrawal by Subject|10|||
124857533|NCT02328326|449100135|FG001|Overall Study|Withdrawal by Subject|3|||
124857534|NCT02328326|449100134|FG000|Overall Study|Death|2|||
124857535|NCT02328326|449100135|FG001|Overall Study|Death|1|||
124857536|NCT02328326|449100134|FG000|Overall Study|Lost to Follow-up|10|||
124857537|NCT02328326|449100135|FG001|Overall Study|Lost to Follow-up|4|||
124857538|NCT06281548|449100147|FG000|Overall Study|Lost to Follow-up|3|||
124857539|NCT01618838|449100148|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
124857540|NCT00288587|449100149|FG000|Overall Study|Death|4|||
124857541|NCT00288587|449100150|FG001|Overall Study|Death|4|||
124857542|NCT00288587|449100149|FG000|Overall Study|Transplant|0|||
124857543|NCT00288587|449100150|FG001|Overall Study|Transplant|3|||
124857544|NCT00288587|449100149|FG000|Overall Study|Adverse Event|0|||
124857545|NCT00288587|449100150|FG001|Overall Study|Adverse Event|1|||
124857546|NCT00288587|449100149|FG000|Overall Study|Physician Decision|0|||
124857547|NCT00288587|449100150|FG001|Overall Study|Physician Decision|2|||
124857548|NCT00288587|449100149|FG000|Overall Study|Severe Aortic Stenosis|1|||
124857549|NCT00288587|449100150|FG001|Overall Study|Severe Aortic Stenosis|0|||
124857550|NCT04401579|449102031|FG000|Overall Study|Death|23|||
124857551|NCT04401579|449102032|FG001|Overall Study|Death|36|||
124857552|NCT04401579|449102031|FG000|Overall Study|Lost to Follow-up|40|||
124857553|NCT04401579|449102032|FG001|Overall Study|Lost to Follow-up|41|||
124857554|NCT04401579|449102031|FG000|Overall Study|Withdrawal by Subject|8|||
124857555|NCT04401579|449102032|FG001|Overall Study|Withdrawal by Subject|16|||
124857556|NCT04401579|449102031|FG000|Overall Study|Physician Decision|1|||
124857557|NCT04401579|449102032|FG001|Overall Study|Physician Decision|2|||
124857558|NCT04401579|449102031|FG000|Overall Study|Became ineligible after enrollment|1|||
124857559|NCT04401579|449102032|FG001|Overall Study|Became ineligible after enrollment|1|||
124857560|NCT04401579|449102031|FG000|Overall Study|Enrolled but treatment not administered|7|||
124857561|NCT04401579|449102032|FG001|Overall Study|Enrolled but treatment not administered|9|||
124857562|NCT04401579|449102031|FG000|Overall Study|Adverse Event|2|||
124857563|NCT04401579|449102032|FG001|Overall Study|Adverse Event|1|||
124857564|NCT04401579|449102031|FG000|Overall Study|Scheduling error|1|||
124857565|NCT04401579|449102032|FG001|Overall Study|Scheduling error|2|||
124857566|NCT04401579|449102031|FG000|Overall Study|Transferred to another hospital|1|||
124857567|NCT04401579|449102032|FG001|Overall Study|Transferred to another hospital|2|||
124857568|NCT01438411|449102033|FG000|Overall Study|Adverse Event|8|||
124857569|NCT01438411|449102033|FG000|Overall Study|Lost to Follow-up|1|||
124857570|NCT01438411|449102033|FG000|Overall Study|Lack of Efficacy|1|||
124857571|NCT01438411|449102033|FG000|Overall Study|Withdrawal by Subject|3|||
124857572|NCT01863680|449102034|FG000|Overall Study|Adverse Event|17|||
124857573|NCT01863680|449102034|FG000|Overall Study|Risk of OHSS|17|||
124857574|NCT01863680|449102034|FG000|Overall Study|Spontaneous pregnancy|2|||
124857575|NCT01863680|449102034|FG000|Overall Study|Withdrawal by Subject|1|||
124857576|NCT01863680|449102034|FG000|Overall Study|Did not undergo IVF/ET|14|||
124857577|NCT01863680|449102034|FG000|Overall Study|Other|6|||
124857578|NCT00618514|449102035|FG000|Overall Study|Lost to Follow-up|11|||
124857579|NCT00618514|449102036|FG001|Overall Study|Lost to Follow-up|12|||
124857580|NCT00618514|449102037|FG002|Overall Study|Lost to Follow-up|4|||
124857581|NCT02053350|449102038|FG000|Overall Study|Withdrawal by Subject|1|||
124857582|NCT02053350|449102038|FG000|Overall Study|Adverse Event|4|||
124857583|NCT02367911|449102043|FG000|Overall Study|Withdrawal by Subject|3|||
124857584|NCT02367911|449102044|FG001|Overall Study|Withdrawal by Subject|2|||
124857585|NCT02367911|449102043|FG000|Overall Study|Lost to Follow-up|2|||
124857586|NCT02367911|449102044|FG001|Overall Study|Lost to Follow-up|2|||
124857587|NCT00902304|449102045|FG000|Overall Study|Adverse Event|4|||
124857588|NCT00902304|449102046|FG001|Overall Study|Adverse Event|10|||
124857589|NCT00902304|449102047|FG002|Overall Study|Adverse Event|25|||
124857590|NCT00902304|449102045|FG000|Overall Study|Investigator discretion|3|||
124857591|NCT00902304|449102046|FG001|Overall Study|Investigator discretion|5|||
124857592|NCT00902304|449102047|FG002|Overall Study|Investigator discretion|13|||
124857593|NCT00902304|449102045|FG000|Overall Study|Lost to Follow-up|7|||
124857594|NCT00902304|449102046|FG001|Overall Study|Lost to Follow-up|7|||
124857595|NCT00902304|449102047|FG002|Overall Study|Lost to Follow-up|7|||
124857596|NCT00902304|449102045|FG000|Overall Study|Protocol Violation|9|||
124857597|NCT00902304|449102046|FG001|Overall Study|Protocol Violation|18|||
124857598|NCT00902304|449102047|FG002|Overall Study|Protocol Violation|20|||
124857599|NCT00902304|449102045|FG000|Overall Study|Withdrawal by Subject|32|||
124857600|NCT00902304|449102046|FG001|Overall Study|Withdrawal by Subject|22|||
124857601|NCT00902304|449102047|FG002|Overall Study|Withdrawal by Subject|43|||
124857602|NCT00902304|449102045|FG000|Overall Study|includes pregnancy|3|||
124857603|NCT00902304|449102046|FG001|Overall Study|includes pregnancy|9|||
124857604|NCT00902304|449102047|FG002|Overall Study|includes pregnancy|2|||
124857605|NCT01153633|449102048|FG000|Overall Study|Protocol Violation|1|||
124857606|NCT01153633|449102049|FG001|Overall Study|Protocol Violation|1|||
124857607|NCT01153633|449102048|FG000|Overall Study|Therapeutic failure|3|||
124857608|NCT01153633|449102049|FG001|Overall Study|Therapeutic failure|3|||
124857609|NCT00384085|449102050|FG000|Overall Study|Adverse Event|5|||
124857610|NCT00384085|449102051|FG001|Overall Study|Adverse Event|5|||
124857611|NCT00384085|449102052|FG002|Overall Study|Adverse Event|4|||
124857612|NCT00384085|449102050|FG000|Overall Study|Lack of Efficacy|0|||
124857613|NCT00384085|449102051|FG001|Overall Study|Lack of Efficacy|3|||
124857614|NCT00384085|449102052|FG002|Overall Study|Lack of Efficacy|2|||
124857615|NCT00384085|449102050|FG000|Overall Study|No longer Requires Study Treatment|1|||
124857616|NCT00384085|449102051|FG001|Overall Study|No longer Requires Study Treatment|0|||
124857617|NCT00384085|449102052|FG002|Overall Study|No longer Requires Study Treatment|1|||
124857618|NCT00384085|449102050|FG000|Overall Study|Protocol Violation|2|||
124857619|NCT00384085|449102051|FG001|Overall Study|Protocol Violation|2|||
124857620|NCT00384085|449102052|FG002|Overall Study|Protocol Violation|2|||
124857621|NCT00384085|449102050|FG000|Overall Study|Lost to Follow-up|9|||
124857622|NCT00384085|449102051|FG001|Overall Study|Lost to Follow-up|9|||
124857623|NCT00384085|449102052|FG002|Overall Study|Lost to Follow-up|10|||
124857624|NCT00384085|449102050|FG000|Overall Study|Progressive Disease|0|||
124857625|NCT00384085|449102051|FG001|Overall Study|Progressive Disease|1|||
124857626|NCT00384085|449102052|FG002|Overall Study|Progressive Disease|0|||
124857627|NCT00384085|449102050|FG000|Overall Study|Withdrawal by Subject|14|||
124857628|NCT00384085|449102051|FG001|Overall Study|Withdrawal by Subject|19|||
124857629|NCT00384085|449102052|FG002|Overall Study|Withdrawal by Subject|29|||
124857630|NCT00384085|449102050|FG000|Overall Study|Patient non-compliant|4|||
124857631|NCT00384085|449102051|FG001|Overall Study|Patient non-compliant|4|||
124857632|NCT00384085|449102052|FG002|Overall Study|Patient non-compliant|5|||
124857633|NCT00384085|449102050|FG000|Overall Study|Physician Decision|1|||
124857634|NCT00384085|449102051|FG001|Overall Study|Physician Decision|0|||
124857635|NCT00384085|449102052|FG002|Overall Study|Physician Decision|0|||
124857636|NCT00384085|449102050|FG000|Overall Study|Loss of site personnel|1|||
124857637|NCT00384085|449102051|FG001|Overall Study|Loss of site personnel|0|||
124857638|NCT00384085|449102052|FG002|Overall Study|Loss of site personnel|1|||
124857639|NCT00384085|449102050|FG000|Overall Study|Sponsor decision|1|||
124857640|NCT00384085|449102051|FG001|Overall Study|Sponsor decision|2|||
124857641|NCT00384085|449102052|FG002|Overall Study|Sponsor decision|1|||
124857642|NCT00384085|449102050|FG000|Overall Study|Patient moved|1|||
124857643|NCT00384085|449102051|FG001|Overall Study|Patient moved|0|||
124857644|NCT00384085|449102052|FG002|Overall Study|Patient moved|1|||
124857645|NCT00384085|449102050|FG000|Overall Study|Patient required surgery|0|||
124857646|NCT00384085|449102051|FG001|Overall Study|Patient required surgery|1|||
124857647|NCT00384085|449102052|FG002|Overall Study|Patient required surgery|0|||
124857648|NCT00352365|449102055|FG000|Induction Therapy|Adverse Event|7|||
124857649|NCT00352365|449102055|FG000|Induction Therapy|Progression/Relapse|8|||
124857650|NCT00352365|449102055|FG000|Induction Therapy|Death|7|||
124857651|NCT00352365|449102055|FG000|Induction Therapy|Not protocol specified|1|||
124857652|NCT00352365|449102055|FG000|Induction Therapy|Not eligible|3|||
124857653|NCT00352365|449102055|FG000|Induction Therapy|Death before starting protocol therapy|1|||
124857654|NCT00352365|449102055|FG000|Maintenance Therapy|Progression/Relapse|3|||
124857655|NCT00352365|449102055|FG000|Maintenance Therapy|Death|2|||
124857656|NCT00352365|449102055|FG000|Maintenance Therapy|Not protocol specified|3|||
124857657|NCT00352365|449102055|FG000|Maintenance Therapy|Not eligible|4|||
124857658|NCT00987467|449102059|FG000|Overall Study|Lost to Follow-up|2|||
124857659|NCT02646423|449102060|FG000|Overall Study|Adverse Event|5|||
124857660|NCT02646423|449102061|FG001|Overall Study|Adverse Event|7|||
124857661|NCT02646423|449102060|FG000|Overall Study|Ineligible|2|||
124857662|NCT02646423|449102061|FG001|Overall Study|Ineligible|1|||
124857663|NCT02807948|449102062|FG000|Overall Study|Physician Decision|1|||
124857664|NCT02807948|449102063|FG001|Overall Study|Physician Decision|0|||
124857665|NCT02624804|449102064|FG000|Overall Study|Screen Failure|5|||
124857666|NCT01227889|449102068|FG000|Randomized Phase (RP)|Adverse Event|13|||
124857667|NCT01227889|449102069|FG001|Randomized Phase (RP)|Adverse Event|0|||
124857668|NCT01227889|449102068|FG000|Randomized Phase (RP)|Physician Decision|13|||
124857669|NCT01227889|449102069|FG001|Randomized Phase (RP)|Physician Decision|5|||
124857670|NCT01227889|449102068|FG000|Randomized Phase (RP)|Progressive Disease|135|||
124857671|NCT01227889|449102069|FG001|Randomized Phase (RP)|Progressive Disease|52|||
124857672|NCT01227889|449102068|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
124857673|NCT01227889|449102069|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
124857674|NCT01227889|449102068|FG000|Randomized Phase (RP)|Missing|1|||
124857675|NCT01227889|449102069|FG001|Randomized Phase (RP)|Missing|3|||
124857676|NCT01227889|449102068|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
124857677|NCT01227889|449102069|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
124857678|NCT01227889|449102068|FG000|Crossover Phase|Adverse Event|0|||
124857679|NCT01227889|449102069|FG001|Crossover Phase|Adverse Event|1|||
124857680|NCT01227889|449102068|FG000|Crossover Phase|Physician Decision|0|||
124857681|NCT01227889|449102069|FG001|Crossover Phase|Physician Decision|3|||
124857682|NCT01227889|449102068|FG000|Crossover Phase|Progressive Disease|0|||
124857683|NCT01227889|449102069|FG001|Crossover Phase|Progressive Disease|31|||
124857684|NCT01227889|449102068|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
124857685|NCT01227889|449102069|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
124857686|NCT01227889|449102068|FG000|Crossover Phase|Withdrawal by Subject|0|||
124857687|NCT01227889|449102069|FG001|Crossover Phase|Withdrawal by Subject|1|||
124857688|NCT03073603|449102072|FG000|Overall Study|Noncompliance|3|||
124857689|NCT03073603|449102073|FG001|Overall Study|Noncompliance|1|||
124857690|NCT03073603|449102072|FG000|Overall Study|Adverse Event|5|||
124857691|NCT03073603|449102073|FG001|Overall Study|Adverse Event|3|||
124857692|NCT03073603|449102072|FG000|Overall Study|Physician Decision|1|||
124857693|NCT03073603|449102073|FG001|Overall Study|Physician Decision|2|||
124857694|NCT03073603|449102072|FG000|Overall Study|Required treatment not allowed by protocol|1|||
124857695|NCT03073603|449102073|FG001|Overall Study|Required treatment not allowed by protocol|0|||
124857696|NCT03073603|449102072|FG000|Overall Study|Financial or insurance-related|8|||
124857697|NCT03073603|449102073|FG001|Overall Study|Financial or insurance-related|0|||
124857698|NCT03073603|449102072|FG000|Overall Study|Withdrawal by Subject|0|||
124857699|NCT03073603|449102073|FG001|Overall Study|Withdrawal by Subject|1|||
124857700|NCT03073603|449102072|FG000|Overall Study|Discontinued DMT|4|||
124857701|NCT03073603|449102073|FG001|Overall Study|Discontinued DMT|0|||
124857702|NCT03073603|449102072|FG000|Overall Study|Restarted DMT|0|||
124857703|NCT03073603|449102073|FG001|Overall Study|Restarted DMT|1|||
124857704|NCT02553330|449102076|FG000|Overall Study|Study Terminated by Sponsor|2|||
124857705|NCT02553330|449102077|FG001|Overall Study|Study Terminated by Sponsor|13|||
124857706|NCT02553330|449102078|FG002|Overall Study|Study Terminated by Sponsor|12|||
124857707|NCT02553330|449102076|FG000|Overall Study|Withdrawal by Subject|3|||
124857708|NCT02553330|449102077|FG001|Overall Study|Withdrawal by Subject|19|||
124857709|NCT02553330|449102078|FG002|Overall Study|Withdrawal by Subject|21|||
124857710|NCT02553330|449102076|FG000|Overall Study|Other|0|||
124857711|NCT02553330|449102077|FG001|Overall Study|Other|1|||
124857712|NCT02553330|449102078|FG002|Overall Study|Other|0|||
124857713|NCT02553330|449102076|FG000|Overall Study|Non compliance to study treatment|0|||
124857714|NCT02553330|449102077|FG001|Overall Study|Non compliance to study treatment|1|||
124857715|NCT02553330|449102078|FG002|Overall Study|Non compliance to study treatment|0|||
124857716|NCT02553330|449102076|FG000|Overall Study|Adverse Event|0|||
124857717|NCT02553330|449102077|FG001|Overall Study|Adverse Event|1|||
124857718|NCT02553330|449102078|FG002|Overall Study|Adverse Event|0|||
124857719|NCT02553330|449102076|FG000|Overall Study|Lost to Follow-up|0|||
124857720|NCT02553330|449102077|FG001|Overall Study|Lost to Follow-up|4|||
124857721|NCT02553330|449102078|FG002|Overall Study|Lost to Follow-up|4|||
124857722|NCT03551938|449102081|FG000|3-Month Follow Up|Lost to Follow-up|39|||
124857723|NCT03551938|449102082|FG001|3-Month Follow Up|Lost to Follow-up|38|||
124857724|NCT03551938|449102081|FG000|6-Month Follow Up|Lost to Follow-up|46|||
124857725|NCT03551938|449102082|FG001|6-Month Follow Up|Lost to Follow-up|42|||
124857726|NCT03551938|449102081|FG000|9-Month Follow Up|Lost to Follow-up|44|||
124857727|NCT03551938|449102082|FG001|9-Month Follow Up|Lost to Follow-up|43|||
124857728|NCT02079805|449102085|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
124857729|NCT02079805|449102086|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
124857730|NCT02079805|449102085|FG000|Overall Study|Voluntary Withdrawal|0|||
124857731|NCT02079805|449102086|FG001|Overall Study|Voluntary Withdrawal|1|||
124857732|NCT02347761|449102087|FG000|All Collected|Death|1|||
124857733|NCT02347761|449102088|FG001|All Collected|Death|0|||
124857734|NCT02347761|449102089|FG002|All Collected|Death|0|||
124857735|NCT02347761|449102087|FG000|All Collected|Lost to Follow-up|3|||
124857736|NCT02347761|449102088|FG001|All Collected|Lost to Follow-up|2|||
124857737|NCT02347761|449102089|FG002|All Collected|Lost to Follow-up|3|||
124857738|NCT02347761|449102087|FG000|All Collected|Withdrawal by Subject|11|||
124857739|NCT02347761|449102088|FG001|All Collected|Withdrawal by Subject|11|||
124857740|NCT02347761|449102089|FG002|All Collected|Withdrawal by Subject|22|||
124857741|NCT02347761|449102087|FG000|All Collected|invetigator disretion|2|||
124857742|NCT02347761|449102088|FG001|All Collected|invetigator disretion|0|||
124857743|NCT02347761|449102089|FG002|All Collected|invetigator disretion|0|||
124857744|NCT02347761|449102087|FG000|All Collected|instillation site pain|0|||
124857745|NCT02347761|449102088|FG001|All Collected|instillation site pain|0|||
124857746|NCT02347761|449102089|FG002|All Collected|instillation site pain|1|||
124857747|NCT02347761|449102087|FG000|All Collected|exacerbation of COPD|0|||
124857748|NCT02347761|449102088|FG001|All Collected|exacerbation of COPD|0|||
124857749|NCT02347761|449102089|FG002|All Collected|exacerbation of COPD|1|||
124857750|NCT02347761|449102087|FG000|All Collected|moved/travel|0|||
124857751|NCT02347761|449102088|FG001|All Collected|moved/travel|1|||
124857752|NCT02347761|449102089|FG002|All Collected|moved/travel|0|||
124857753|NCT02347761|449102087|FG000|On Study Treatment|Lack of Efficacy|2|||
124857754|NCT02347761|449102088|FG001|On Study Treatment|Lack of Efficacy|3|||
124857755|NCT02347761|449102089|FG002|On Study Treatment|Lack of Efficacy|4|||
124857756|NCT02347761|449102087|FG000|On Study Treatment|non-compliance with study medication|0|||
124857757|NCT02347761|449102088|FG001|On Study Treatment|non-compliance with study medication|0|||
124857758|NCT02347761|449102089|FG002|On Study Treatment|non-compliance with study medication|2|||
124857759|NCT02347761|449102087|FG000|On Study Treatment|Withdrawal by Subject|7|||
124857760|NCT02347761|449102088|FG001|On Study Treatment|Withdrawal by Subject|3|||
124857761|NCT02347761|449102089|FG002|On Study Treatment|Withdrawal by Subject|5|||
124857762|NCT02347761|449102087|FG000|On Study Treatment|move/travel|2|||
124857763|NCT02347761|449102088|FG001|On Study Treatment|move/travel|6|||
124857764|NCT02347761|449102089|FG002|On Study Treatment|move/travel|5|||
124857765|NCT02347761|449102087|FG000|On Study Treatment|dissastisfaction with device|2|||
124857766|NCT02347761|449102088|FG001|On Study Treatment|dissastisfaction with device|1|||
124857767|NCT02347761|449102089|FG002|On Study Treatment|dissastisfaction with device|4|||
124857768|NCT02347761|449102087|FG000|On Study Treatment|Lost to Follow-up|2|||
124857769|NCT02347761|449102088|FG001|On Study Treatment|Lost to Follow-up|1|||
124857770|NCT02347761|449102089|FG002|On Study Treatment|Lost to Follow-up|1|||
124857771|NCT02347761|449102087|FG000|On Study Treatment|investigator discretion|2|||
124857772|NCT02347761|449102088|FG001|On Study Treatment|investigator discretion|0|||
124857773|NCT02347761|449102089|FG002|On Study Treatment|investigator discretion|0|||
124857774|NCT02347761|449102087|FG000|On Study Treatment|durg not working|0|||
124857775|NCT02347761|449102088|FG001|On Study Treatment|durg not working|1|||
124857776|NCT02347761|449102089|FG002|On Study Treatment|durg not working|1|||
124857777|NCT02347761|449102087|FG000|On Study Treatment|Adverse Event|10|||
124857778|NCT02347761|449102088|FG001|On Study Treatment|Adverse Event|8|||
124857779|NCT02347761|449102089|FG002|On Study Treatment|Adverse Event|20|||
124857780|NCT03879798|449102090|FG000|Overall Study|Adverse Event|0|||
124857781|NCT03879798|449102091|FG001|Overall Study|Adverse Event|0|||
124857782|NCT03879798|449102092|FG002|Overall Study|Adverse Event|0|||
124857783|NCT03879798|449102093|FG003|Overall Study|Adverse Event|0|||
124857784|NCT03879798|449102094|FG004|Overall Study|Adverse Event|0|||
124857785|NCT03879798|449102095|FG005|Overall Study|Adverse Event|1|||
124857786|NCT03879798|449102090|FG000|Overall Study|Lack of Efficacy|0|||
124857787|NCT03879798|449102091|FG001|Overall Study|Lack of Efficacy|0|||
124857788|NCT03879798|449102092|FG002|Overall Study|Lack of Efficacy|0|||
124857789|NCT03879798|449102093|FG003|Overall Study|Lack of Efficacy|0|||
124857790|NCT03879798|449102094|FG004|Overall Study|Lack of Efficacy|0|||
124857791|NCT03879798|449102095|FG005|Overall Study|Lack of Efficacy|1|||
124857792|NCT03879798|449102090|FG000|Overall Study|Withdrawal by Subject|0|||
124857793|NCT03879798|449102091|FG001|Overall Study|Withdrawal by Subject|0|||
124857794|NCT03879798|449102092|FG002|Overall Study|Withdrawal by Subject|0|||
124857795|NCT03879798|449102093|FG003|Overall Study|Withdrawal by Subject|0|||
124857796|NCT03879798|449102094|FG004|Overall Study|Withdrawal by Subject|0|||
124857797|NCT03879798|449102095|FG005|Overall Study|Withdrawal by Subject|1|||
124857798|NCT03625570|449102096|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
124857799|NCT03625570|449102097|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
124857800|NCT03625570|449102096|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
124857801|NCT03625570|449102097|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
124857802|NCT03625570|449102096|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
124857803|NCT03625570|449102097|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
124857804|NCT01040130|449102105|FG000|Overall Study|Adverse Event|1|||
124857805|NCT01040130|449102106|FG001|Overall Study|Adverse Event|1|||
124857806|NCT01040130|449102107|FG002|Overall Study|Adverse Event|0|||
124857807|NCT01040130|449102108|FG003|Overall Study|Adverse Event|5|||
124857808|NCT01040130|449102109|FG004|Overall Study|Adverse Event|0|||
124857809|NCT01040130|449102110|FG005|Overall Study|Adverse Event|3|||
124857810|NCT01040130|449102105|FG000|Overall Study|Protocol Violation|0|||
124857811|NCT01040130|449102106|FG001|Overall Study|Protocol Violation|0|||
124857812|NCT01040130|449102107|FG002|Overall Study|Protocol Violation|2|||
124857813|NCT01040130|449102108|FG003|Overall Study|Protocol Violation|0|||
124857814|NCT01040130|449102109|FG004|Overall Study|Protocol Violation|0|||
124857815|NCT01040130|449102110|FG005|Overall Study|Protocol Violation|0|||
124857816|NCT01040130|449102105|FG000|Overall Study|Withdrawal by Subject|0|||
124857817|NCT01040130|449102106|FG001|Overall Study|Withdrawal by Subject|2|||
124857818|NCT01040130|449102107|FG002|Overall Study|Withdrawal by Subject|0|||
124857819|NCT01040130|449102108|FG003|Overall Study|Withdrawal by Subject|0|||
124857820|NCT01040130|449102109|FG004|Overall Study|Withdrawal by Subject|0|||
124857821|NCT01040130|449102110|FG005|Overall Study|Withdrawal by Subject|1|||
124857822|NCT01040130|449102105|FG000|Overall Study|Other reasons not listed above|2|||
124857823|NCT01040130|449102106|FG001|Overall Study|Other reasons not listed above|0|||
124857824|NCT01040130|449102107|FG002|Overall Study|Other reasons not listed above|0|||
124857825|NCT01040130|449102108|FG003|Overall Study|Other reasons not listed above|0|||
124857826|NCT01040130|449102109|FG004|Overall Study|Other reasons not listed above|0|||
124857827|NCT01040130|449102110|FG005|Overall Study|Other reasons not listed above|0|||
124857828|NCT02937545|449102114|FG000|Overall Study|Withdrawal by Subject|1|||
124857829|NCT02937545|449102115|FG001|Overall Study|Withdrawal by Subject|2|||
124857830|NCT02937545|449102116|FG002|Overall Study|Withdrawal by Subject|6|||
124857831|NCT02937545|449102117|FG003|Overall Study|Withdrawal by Subject|7|||
124857832|NCT02937545|449102114|FG000|Overall Study|Lost to Follow-up|1|||
124857833|NCT02937545|449102115|FG001|Overall Study|Lost to Follow-up|0|||
124857834|NCT02937545|449102116|FG002|Overall Study|Lost to Follow-up|0|||
124857835|NCT02937545|449102117|FG003|Overall Study|Lost to Follow-up|0|||
124857836|NCT02007577|449102118|FG000|Overall Study|Adverse Event|1|||
124857837|NCT02007577|449102119|FG001|Overall Study|Adverse Event|0|||
124857838|NCT02007577|449102118|FG000|Overall Study|Withdrawal by Subject|0|||
124857839|NCT02007577|449102119|FG001|Overall Study|Withdrawal by Subject|1|||
124857840|NCT02504294|449102120|FG000|Overall Study|Adverse Event|15|||
124857841|NCT02504294|449102121|FG001|Overall Study|Adverse Event|12|||
124857842|NCT02504294|449102120|FG000|Overall Study|Withdrawal by Subject|7|||
124857843|NCT02504294|449102121|FG001|Overall Study|Withdrawal by Subject|1|||
124857844|NCT02504294|449102120|FG000|Overall Study|Protocol Violation|27|||
124857845|NCT02504294|449102121|FG001|Overall Study|Protocol Violation|26|||
124857846|NCT02504294|449102120|FG000|Overall Study|Physician Decision|1|||
124857847|NCT02504294|449102121|FG001|Overall Study|Physician Decision|2|||
124857848|NCT02504294|449102120|FG000|Overall Study|Lost to Follow-up|6|||
124857849|NCT02504294|449102121|FG001|Overall Study|Lost to Follow-up|7|||
124857850|NCT02252211|449102122|FG000|Overall Study|Adverse Event|0|||
124857851|NCT02252211|449102123|FG001|Overall Study|Adverse Event|1|||
124857852|NCT02252211|449102124|FG002|Overall Study|Adverse Event|0|||
124857853|NCT02252211|449102122|FG000|Overall Study|Progressive disease|3|||
124857854|NCT02252211|449102123|FG001|Overall Study|Progressive disease|2|||
124857855|NCT02252211|449102124|FG002|Overall Study|Progressive disease|0|||
124857856|NCT02252211|449102122|FG000|Overall Study|Withdrawal by Subject|1|||
124857857|NCT02252211|449102123|FG001|Overall Study|Withdrawal by Subject|0|||
124857858|NCT02252211|449102124|FG002|Overall Study|Withdrawal by Subject|0|||
124857859|NCT02252211|449102122|FG000|Overall Study|Serious Adverse Event During Screening|1|||
124857860|NCT02252211|449102123|FG001|Overall Study|Serious Adverse Event During Screening|0|||
124857861|NCT02252211|449102124|FG002|Overall Study|Serious Adverse Event During Screening|1|||
124857862|NCT01985126|449102125|FG000|Overall Study|Death|15|||
124857863|NCT01985126|449102126|FG001|Overall Study|Death|69|||
124857864|NCT01985126|449102125|FG000|Overall Study|Lost to Follow-up|0|||
124857865|NCT01985126|449102126|FG001|Overall Study|Lost to Follow-up|8|||
124857866|NCT01985126|449102125|FG000|Overall Study|Study Terminated By Sponsor|1|||
124857867|NCT01985126|449102126|FG001|Overall Study|Study Terminated By Sponsor|22|||
124857868|NCT01985126|449102125|FG000|Overall Study|Withdrawal by Subject|2|||
124857869|NCT01985126|449102126|FG001|Overall Study|Withdrawal by Subject|7|||
124857870|NCT00968669|449102127|FG000|Overall Study|Lost to Follow-up|5|||
124857871|NCT00968669|449102128|FG001|Overall Study|Lost to Follow-up|2|||
124857872|NCT00968669|449102129|FG002|Overall Study|Lost to Follow-up|1|||
124857873|NCT00968669|449102130|FG003|Overall Study|Lost to Follow-up|4|||
124857874|NCT00968669|449102127|FG000|Overall Study|Withdrawal by Subject|9|||
124857875|NCT00968669|449102128|FG001|Overall Study|Withdrawal by Subject|7|||
124857876|NCT00968669|449102129|FG002|Overall Study|Withdrawal by Subject|5|||
124857877|NCT00968669|449102130|FG003|Overall Study|Withdrawal by Subject|3|||
124857878|NCT00968669|449102127|FG000|Overall Study|Pregnancy|0|||
124857879|NCT00968669|449102128|FG001|Overall Study|Pregnancy|0|||
124857880|NCT00968669|449102129|FG002|Overall Study|Pregnancy|2|||
124857881|NCT00968669|449102130|FG003|Overall Study|Pregnancy|0|||
124857882|NCT00968669|449102127|FG000|Overall Study|AE|1|||
124857883|NCT00968669|449102128|FG001|Overall Study|AE|0|||
124857884|NCT00968669|449102129|FG002|Overall Study|AE|0|||
124857885|NCT00968669|449102130|FG003|Overall Study|AE|0|||
124857886|NCT00968669|449102127|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
124857887|NCT00968669|449102128|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
124857888|NCT00968669|449102129|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
124857889|NCT00968669|449102130|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
124857890|NCT00968669|449102127|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
124857891|NCT00968669|449102128|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
124857892|NCT00968669|449102129|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
124857893|NCT00968669|449102130|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
124857894|NCT00968669|449102127|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
124857895|NCT00968669|449102128|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
124857896|NCT00968669|449102129|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
124857897|NCT00968669|449102130|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
124857898|NCT00968669|449102127|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
124857899|NCT00968669|449102128|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
124857900|NCT00968669|449102129|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
124857901|NCT00968669|449102130|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
124857902|NCT00968669|449102127|FG000|Overall Study|EARLY WITHDRAWAL|0|||
124857903|NCT00968669|449102128|FG001|Overall Study|EARLY WITHDRAWAL|1|||
124857904|NCT00968669|449102129|FG002|Overall Study|EARLY WITHDRAWAL|0|||
124857905|NCT00968669|449102130|FG003|Overall Study|EARLY WITHDRAWAL|0|||
124857906|NCT00968669|449102127|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
124857907|NCT00968669|449102128|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
124857908|NCT00968669|449102129|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
124857909|NCT00968669|449102130|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
124857910|NCT00968669|449102127|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
124857911|NCT00968669|449102128|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
124857912|NCT00968669|449102129|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
124857913|NCT00968669|449102130|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
124857914|NCT00968669|449102127|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
124857915|NCT00968669|449102128|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
124857916|NCT00968669|449102129|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
124857917|NCT00968669|449102130|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
124857918|NCT00968669|449102127|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
124857919|NCT00968669|449102128|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
124857920|NCT00968669|449102129|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
124857921|NCT00968669|449102130|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
124857922|NCT00968669|449102127|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
124857923|NCT00968669|449102128|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
124857924|NCT00968669|449102129|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
124857925|NCT00968669|449102130|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
124857926|NCT00968669|449102127|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
124857927|NCT00968669|449102128|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
124857928|NCT00968669|449102129|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
124857929|NCT00968669|449102130|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
124857930|NCT00968669|449102127|FG000|Overall Study|SPONSOR DECISION|0|||
124857931|NCT00968669|449102128|FG001|Overall Study|SPONSOR DECISION|1|||
124857932|NCT00968669|449102129|FG002|Overall Study|SPONSOR DECISION|0|||
124857933|NCT00968669|449102130|FG003|Overall Study|SPONSOR DECISION|0|||
124857934|NCT00968669|449102127|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
124857935|NCT00968669|449102128|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
124857936|NCT00968669|449102129|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
124857937|NCT00968669|449102130|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
124857938|NCT00968669|449102127|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
124857939|NCT00968669|449102128|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
124857940|NCT00968669|449102129|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
124857941|NCT00968669|449102130|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
124857942|NCT00968669|449102127|FG000|Overall Study|SUBJECT INCARCERATED|0|||
124857943|NCT00968669|449102128|FG001|Overall Study|SUBJECT INCARCERATED|1|||
124857944|NCT00968669|449102129|FG002|Overall Study|SUBJECT INCARCERATED|0|||
124857945|NCT00968669|449102130|FG003|Overall Study|SUBJECT INCARCERATED|0|||
124857946|NCT00968669|449102127|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
124857947|NCT00968669|449102128|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
124857948|NCT00968669|449102129|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
124857949|NCT00968669|449102130|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
124857950|NCT00968669|449102127|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
124857951|NCT00968669|449102128|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
124857952|NCT00968669|449102129|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
124857953|NCT00968669|449102130|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
124857954|NCT00144339|449102133|FG000|Overall Study|Adverse Event|746|||
124857955|NCT00144339|449102134|FG001|Overall Study|Adverse Event|627|||
124857956|NCT00144339|449102133|FG000|Overall Study|Protocol Violation|75|||
124857957|NCT00144339|449102134|FG001|Overall Study|Protocol Violation|48|||
124857958|NCT00144339|449102133|FG000|Overall Study|Withdrawal by Subject|403|||
124857959|NCT00144339|449102134|FG001|Overall Study|Withdrawal by Subject|300|||
124857960|NCT00144339|449102133|FG000|Overall Study|Lost to Follow-up|76|||
124857961|NCT00144339|449102134|FG001|Overall Study|Lost to Follow-up|64|||
124857962|NCT00144339|449102133|FG000|Overall Study|Other|58|||
124857963|NCT00144339|449102134|FG001|Overall Study|Other|60|||
124857964|NCT01109992|449102135|FG000|Overall Study|Withdrawal by Subject|0|||
124857965|NCT01109992|449102136|FG001|Overall Study|Withdrawal by Subject|1|||
124857966|NCT01109992|449102135|FG000|Overall Study|Movement during rest scan.|0|||
124857967|NCT01109992|449102136|FG001|Overall Study|Movement during rest scan.|1|||
124857968|NCT02338362|449102137|FG000|Overall Study|Withdrawal by Subject|1|||
124857969|NCT02338362|449102138|FG001|Overall Study|Withdrawal by Subject|1|||
124857970|NCT00690755|449102139|FG000|Overall Study|Physician Decision|2|||
124857971|NCT00690755|449102140|FG001|Overall Study|Physician Decision|0|||
124857972|NCT00690755|449102141|FG002|Overall Study|Physician Decision|46|||
124857973|NCT00690755|449102142|FG003|Overall Study|Physician Decision|5|||
124857974|NCT00690755|449102143|FG004|Overall Study|Physician Decision|0|||
124857975|NCT00690755|449102144|FG005|Overall Study|Physician Decision|4|||
124857976|NCT00690755|449102145|FG006|Overall Study|Physician Decision|0|||
124857977|NCT00784043|449102146|FG000|Overall Study|Withdrawal by Subject|8|||
124857978|NCT00784043|449102147|FG001|Overall Study|Withdrawal by Subject|5|||
124857979|NCT00784043|449102146|FG000|Overall Study|Protocol Terminated|23|||
124857980|NCT00784043|449102147|FG001|Overall Study|Protocol Terminated|1|||
124857981|NCT03538626|449102148|FG000|Overall Study|Withdrawal by Subject|0|||
124857982|NCT03538626|449102149|FG001|Overall Study|Withdrawal by Subject|1|||
124857983|NCT03538626|449102150|FG002|Overall Study|Withdrawal by Subject|0|||
124857984|NCT03538626|449102151|FG003|Overall Study|Withdrawal by Subject|0|||
124857985|NCT03538626|449102152|FG004|Overall Study|Withdrawal by Subject|0|||
124857986|NCT03538626|449102153|FG005|Overall Study|Withdrawal by Subject|0|||
124857987|NCT03538626|449102154|FG006|Overall Study|Withdrawal by Subject|0|||
124857988|NCT03538626|449102155|FG007|Overall Study|Withdrawal by Subject|0|||
124857989|NCT03538626|449102148|FG000|Overall Study|Lost to Follow-up|0|||
124857990|NCT03538626|449102149|FG001|Overall Study|Lost to Follow-up|0|||
124857991|NCT03538626|449102150|FG002|Overall Study|Lost to Follow-up|0|||
124857992|NCT03538626|449102151|FG003|Overall Study|Lost to Follow-up|0|||
124857993|NCT03538626|449102152|FG004|Overall Study|Lost to Follow-up|0|||
124857994|NCT03538626|449102153|FG005|Overall Study|Lost to Follow-up|0|||
124857995|NCT03538626|449102154|FG006|Overall Study|Lost to Follow-up|1|||
124857996|NCT03538626|449102155|FG007|Overall Study|Lost to Follow-up|0|||
124857997|NCT01434602|449102160|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
124857998|NCT01434602|449102161|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
124857999|NCT01434602|449102162|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
124858000|NCT01434602|449102163|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
124858001|NCT01434602|449102164|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
124858002|NCT01434602|449102160|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
124858003|NCT01434602|449102161|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
124858004|NCT01434602|449102162|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
124858005|NCT01434602|449102163|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
124858006|NCT01434602|449102164|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
124858007|NCT01434602|449102160|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
124858008|NCT01434602|449102161|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
124858009|NCT01434602|449102162|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
124858010|NCT01434602|449102163|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
124858011|NCT01434602|449102164|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
124858012|NCT01434602|449102160|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
124858013|NCT01434602|449102161|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
124858014|NCT01434602|449102162|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
124858015|NCT01434602|449102163|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
124858016|NCT01434602|449102164|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
124858017|NCT01434602|449102160|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
124858018|NCT01434602|449102161|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
124858019|NCT01434602|449102162|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
124858020|NCT01434602|449102163|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
124858021|NCT01434602|449102164|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
124858022|NCT01434602|449102160|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
124858023|NCT01434602|449102161|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
124858024|NCT01434602|449102162|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
124858025|NCT01434602|449102163|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
124858026|NCT01434602|449102164|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
124858027|NCT01434602|449102160|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
124858028|NCT01434602|449102161|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
124858029|NCT01434602|449102162|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
124858030|NCT01434602|449102163|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
124858031|NCT01434602|449102164|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
124858032|NCT01434602|449102160|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
124858033|NCT01434602|449102161|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
124858034|NCT01434602|449102162|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
124858035|NCT01434602|449102163|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
124858036|NCT01434602|449102164|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
124858037|NCT01434602|449102160|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
124858038|NCT01434602|449102161|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
124858039|NCT01434602|449102162|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
124858040|NCT01434602|449102163|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
124858041|NCT01434602|449102164|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
124858042|NCT01434602|449102160|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
124858043|NCT01434602|449102161|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
124858044|NCT01434602|449102162|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
124858045|NCT01434602|449102163|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
124858046|NCT01434602|449102164|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
124858047|NCT00499889|449102178|FG000|Overall Study|Infection prior to treatment|1|||
124858048|NCT00345397|449102182|FG000|Overall Study|Death|1|||
124858049|NCT03351049|449102185|FG000|Overall Study|Withdrawal|26|||
124858050|NCT03351049|449102186|FG001|Overall Study|Withdrawal|22|||
124858051|NCT03832192|449102191|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
124858052|NCT03832192|449102192|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
124858053|NCT03738150|449102193|FG000|Base Study|Withdrawal by Subject|1|||
124858054|NCT03738150|449102193|FG000|Extension Study|Withdrawal by Subject|1|||
124858055|NCT01898195|449102198|FG000|Smoking Abstinence|Did not have good measurements|35|||
124858056|NCT01898195|449102199|FG001|Smoking Abstinence|Did not have good measurements|38|||
124858057|NCT01898195|449102200|FG002|Smoking Abstinence|Did not have good measurements|36|||
124858058|NCT02720484|449102202|FG000|Treatment on Study|Adverse Event|1|||
124858059|NCT02720484|449102202|FG000|Treatment on Study|Withdrawal by Subject|1|||
124858060|NCT02720484|449102202|FG000|Treatment on Study|Progressive Disease|4|||
124858061|NCT02720484|449102202|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
124858062|NCT02720484|449102202|FG000|Follow Up for 2 Years|Death|3|||
124858063|NCT02720484|449102202|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
124858064|NCT05070897|449102206|FG000|Overall Study|Protocol Violation|123|||
124858065|NCT05070897|449102207|FG001|Overall Study|Protocol Violation|68|||
124858066|NCT01617629|449102210|FG000|Overall Study|Death|2|||
124858067|NCT01617629|449102210|FG000|Overall Study|Investigator's Clinical Judgement|1|||
124858068|NCT01617629|449102210|FG000|Overall Study|Reason Not Specified|1|||
124858069|NCT01617629|449102210|FG000|Overall Study|Participant Withdrew Consent|2|||
124858070|NCT01337245|449102211|FG000|Overall Study|Lost to Follow-up|1|||
124858071|NCT01663636|449102212|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
124858072|NCT01663636|449102213|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
124858073|NCT03832946|449102214|FG000|Overall Study|Adverse Event|3|||
124858074|NCT03832946|449102215|FG001|Overall Study|Adverse Event|1|||
124858075|NCT03832946|449102214|FG000|Overall Study|Lost to Follow-up|1|||
124858076|NCT03832946|449102215|FG001|Overall Study|Lost to Follow-up|0|||
124858077|NCT03832946|449102214|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
124858078|NCT03832946|449102215|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
124858079|NCT03832946|449102214|FG000|Overall Study|Lack of Efficacy|1|||
124858080|NCT03832946|449102215|FG001|Overall Study|Lack of Efficacy|0|||
124858081|NCT03832946|449102214|FG000|Overall Study|Withdrawal by Subject|12|||
124858082|NCT03832946|449102215|FG001|Overall Study|Withdrawal by Subject|9|||
124858083|NCT00136955|449103979|FG000|Overall Study|Adverse Event|8|||
124858084|NCT00136955|449103979|FG000|Overall Study|Lost to Follow-up|1|||
124858085|NCT00136955|449103979|FG000|Overall Study|Withdrawal by Subject|2|||
124858086|NCT00136955|449103979|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
124858087|NCT00773968|449103981|FG000|Overall Study|Adverse Event|2|||
124858088|NCT00773968|449103981|FG000|Overall Study|Death|1|||
124858089|NCT00773968|449103981|FG000|Overall Study|Failure to Return|2|||
124858090|NCT00773968|449103981|FG000|Overall Study|Lack of Efficacy|3|||
124858091|NCT00773968|449103981|FG000|Overall Study|Protocol Violation|1|||
124858092|NCT00773968|449103981|FG000|Overall Study|Withdrawal by Subject|11|||
124858093|NCT00773968|449103981|FG000|Overall Study|Screen Failure|17|||
124858094|NCT00773968|449103981|FG000|Overall Study|Other|8|||
124858095|NCT04579757|449103982|FG000|Overall Study|Adverse Event|0|||
124858096|NCT04579757|449103983|FG001|Overall Study|Adverse Event|0|||
124858097|NCT04579757|449103984|FG002|Overall Study|Adverse Event|0|||
124858098|NCT04579757|449103985|FG003|Overall Study|Adverse Event|2|||
124858099|NCT04579757|449103986|FG004|Overall Study|Adverse Event|1|||
124858100|NCT04579757|449103987|FG005|Overall Study|Adverse Event|1|||
124858101|NCT04579757|449103988|FG006|Overall Study|Adverse Event|0|||
124858102|NCT04579757|449103989|FG007|Overall Study|Adverse Event|0|||
124858103|NCT04579757|449103990|FG008|Overall Study|Adverse Event|0|||
124858104|NCT04579757|449103982|FG000|Overall Study|Death|4|||
124858105|NCT04579757|449103983|FG001|Overall Study|Death|1|||
124858106|NCT04579757|449103984|FG002|Overall Study|Death|14|||
124858107|NCT04579757|449103985|FG003|Overall Study|Death|3|||
124858108|NCT04579757|449103986|FG004|Overall Study|Death|2|||
124858109|NCT04579757|449103987|FG005|Overall Study|Death|7|||
124858110|NCT04579757|449103988|FG006|Overall Study|Death|0|||
124858111|NCT04579757|449103989|FG007|Overall Study|Death|1|||
124858112|NCT04579757|449103990|FG008|Overall Study|Death|3|||
124858113|NCT04579757|449103982|FG000|Overall Study|Physician Decision|0|||
124858114|NCT04579757|449103983|FG001|Overall Study|Physician Decision|0|||
124858115|NCT04579757|449103984|FG002|Overall Study|Physician Decision|0|||
124858116|NCT04579757|449103985|FG003|Overall Study|Physician Decision|2|||
124858117|NCT04579757|449103986|FG004|Overall Study|Physician Decision|1|||
124858118|NCT04579757|449103987|FG005|Overall Study|Physician Decision|1|||
124858119|NCT04579757|449103988|FG006|Overall Study|Physician Decision|1|||
124858120|NCT04579757|449103989|FG007|Overall Study|Physician Decision|0|||
124858121|NCT04579757|449103990|FG008|Overall Study|Physician Decision|0|||
124858122|NCT04579757|449103982|FG000|Overall Study|Study Terminated By Sponsor|0|||
124858123|NCT04579757|449103983|FG001|Overall Study|Study Terminated By Sponsor|0|||
124858124|NCT04579757|449103984|FG002|Overall Study|Study Terminated By Sponsor|0|||
124858125|NCT04579757|449103985|FG003|Overall Study|Study Terminated By Sponsor|0|||
124858126|NCT04579757|449103986|FG004|Overall Study|Study Terminated By Sponsor|2|||
124858127|NCT04579757|449103987|FG005|Overall Study|Study Terminated By Sponsor|0|||
124858128|NCT04579757|449103988|FG006|Overall Study|Study Terminated By Sponsor|0|||
124858129|NCT04579757|449103989|FG007|Overall Study|Study Terminated By Sponsor|2|||
124858130|NCT04579757|449103990|FG008|Overall Study|Study Terminated By Sponsor|0|||
124858131|NCT04579757|449103982|FG000|Overall Study|Withdrawal by Subject|1|||
124858132|NCT04579757|449103983|FG001|Overall Study|Withdrawal by Subject|1|||
124858133|NCT04579757|449103984|FG002|Overall Study|Withdrawal by Subject|0|||
124858134|NCT04579757|449103985|FG003|Overall Study|Withdrawal by Subject|0|||
124858135|NCT04579757|449103986|FG004|Overall Study|Withdrawal by Subject|2|||
124858136|NCT04579757|449103987|FG005|Overall Study|Withdrawal by Subject|1|||
124858137|NCT04579757|449103988|FG006|Overall Study|Withdrawal by Subject|0|||
124858138|NCT04579757|449103989|FG007|Overall Study|Withdrawal by Subject|3|||
124858139|NCT04579757|449103990|FG008|Overall Study|Withdrawal by Subject|0|||
124858140|NCT04579757|449103982|FG000|Overall Study|Radiological or Clinical PD|1|||
124858141|NCT04579757|449103983|FG001|Overall Study|Radiological or Clinical PD|4|||
124858142|NCT04579757|449103984|FG002|Overall Study|Radiological or Clinical PD|1|||
124858143|NCT04579757|449103985|FG003|Overall Study|Radiological or Clinical PD|3|||
124858144|NCT04579757|449103986|FG004|Overall Study|Radiological or Clinical PD|9|||
124858145|NCT04579757|449103987|FG005|Overall Study|Radiological or Clinical PD|4|||
124858146|NCT04579757|449103988|FG006|Overall Study|Radiological or Clinical PD|2|||
124858147|NCT04579757|449103989|FG007|Overall Study|Radiological or Clinical PD|2|||
124858148|NCT04579757|449103990|FG008|Overall Study|Radiological or Clinical PD|0|||
124858149|NCT04579757|449103982|FG000|Overall Study|Start of New Therapy|0|||
124858150|NCT04579757|449103983|FG001|Overall Study|Start of New Therapy|0|||
124858151|NCT04579757|449103984|FG002|Overall Study|Start of New Therapy|0|||
124858152|NCT04579757|449103985|FG003|Overall Study|Start of New Therapy|0|||
124858153|NCT04579757|449103986|FG004|Overall Study|Start of New Therapy|2|||
124858154|NCT04579757|449103987|FG005|Overall Study|Start of New Therapy|1|||
124858155|NCT04579757|449103988|FG006|Overall Study|Start of New Therapy|0|||
124858156|NCT04579757|449103989|FG007|Overall Study|Start of New Therapy|0|||
124858157|NCT04579757|449103990|FG008|Overall Study|Start of New Therapy|0|||
124858158|NCT00071487|449103991|FG000|52-Week Double-Blind Period|Adverse Event|5|||
124858159|NCT00071487|449103992|FG001|52-Week Double-Blind Period|Adverse Event|8|||
124858160|NCT00071487|449103993|FG002|52-Week Double-Blind Period|Adverse Event|4|||
124858161|NCT00071487|449103994|FG003|52-Week Double-Blind Period|Adverse Event|8|||
124858162|NCT00071487|449103991|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
124858163|NCT00071487|449103992|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
124858164|NCT00071487|449103993|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
124858165|NCT00071487|449103994|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
124858166|NCT00071487|449103991|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
124858167|NCT00071487|449103992|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
124858168|NCT00071487|449103993|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
124858169|NCT00071487|449103994|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
124858170|NCT00071487|449103991|FG000|52-Week Double-Blind Period|Physician Decision|1|||
124858171|NCT00071487|449103992|FG001|52-Week Double-Blind Period|Physician Decision|0|||
124858172|NCT00071487|449103993|FG002|52-Week Double-Blind Period|Physician Decision|0|||
124858173|NCT00071487|449103994|FG003|52-Week Double-Blind Period|Physician Decision|0|||
124858174|NCT00071487|449103991|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
124858175|NCT00071487|449103992|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
124858176|NCT00071487|449103993|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
124858177|NCT00071487|449103994|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
124858178|NCT00071487|449103991|FG000|52-Week Double-Blind Period|Pregnancy|0|||
124858179|NCT00071487|449103992|FG001|52-Week Double-Blind Period|Pregnancy|1|||
124858180|NCT00071487|449103993|FG002|52-Week Double-Blind Period|Pregnancy|0|||
124858181|NCT00071487|449103994|FG003|52-Week Double-Blind Period|Pregnancy|0|||
124858182|NCT00071487|449103991|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
124858183|NCT00071487|449103992|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
124858184|NCT00071487|449103993|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
124858185|NCT00071487|449103994|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
124858186|NCT00071487|449103991|FG000|52-Week Double-Blind Period|Death|0|||
124858187|NCT00071487|449103992|FG001|52-Week Double-Blind Period|Death|1|||
124858188|NCT00071487|449103993|FG002|52-Week Double-Blind Period|Death|0|||
124858189|NCT00071487|449103994|FG003|52-Week Double-Blind Period|Death|0|||
124858190|NCT00071487|449103991|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
124858191|NCT00071487|449103992|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
124858192|NCT00071487|449103993|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
124858193|NCT00071487|449103994|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
124858194|NCT00071487|449103991|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
124858195|NCT00071487|449103992|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
124858196|NCT00071487|449103993|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
124858197|NCT00071487|449103994|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
124858198|NCT00071487|449103991|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
124858199|NCT00071487|449103992|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
124858200|NCT00071487|449103993|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
124858201|NCT00071487|449103994|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
124858202|NCT00071487|449103991|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
124858203|NCT00071487|449103992|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
124858204|NCT00071487|449103993|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
124858205|NCT00071487|449103994|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
124858206|NCT00071487|449103991|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
124858207|NCT00071487|449103992|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
124858208|NCT00071487|449103993|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
124858209|NCT00071487|449103994|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
124858210|NCT00071487|449103991|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
124858211|NCT00071487|449103992|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
124858212|NCT00071487|449103993|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
124858213|NCT00071487|449103994|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
124858214|NCT00071487|449103991|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
124858215|NCT00071487|449103992|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
124858216|NCT00071487|449103993|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
124858217|NCT00071487|449103994|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
124858218|NCT03725982|449103995|FG000|First Intervention|Withdrawal by Subject|0|||
124858219|NCT03725982|449103996|FG001|First Intervention|Withdrawal by Subject|1|||
124858220|NCT03725982|449103995|FG000|First Intervention|Physician Decision|1|||
124858221|NCT03725982|449103996|FG001|First Intervention|Physician Decision|1|||
124858222|NCT01262651|449103997|FG000|Overall Study|Adverse Event|40|||
124858223|NCT01262651|449103998|FG001|Overall Study|Adverse Event|35|||
124858224|NCT01262651|449103997|FG000|Overall Study|Withdrawal by Subject|15|||
124858225|NCT01262651|449103998|FG001|Overall Study|Withdrawal by Subject|11|||
124858226|NCT01262651|449103997|FG000|Overall Study|Withdrawal by Investigator|2|||
124858227|NCT01262651|449103998|FG001|Overall Study|Withdrawal by Investigator|2|||
124858228|NCT01262651|449103997|FG000|Overall Study|Met Withdrawal Criteria|1|||
124858229|NCT01262651|449103998|FG001|Overall Study|Met Withdrawal Criteria|0|||
124858230|NCT04743908|449104001|FG000|Overall Study|Death|1|||
124858231|NCT04743908|449104002|FG001|Overall Study|Death|0|||
124858232|NCT04743908|449104001|FG000|Overall Study|Lost to Follow-up|181|||
124858233|NCT04743908|449104002|FG001|Overall Study|Lost to Follow-up|180|||
124858234|NCT04743908|449104001|FG000|Overall Study|Withdrawal by Subject|1|||
124858235|NCT04743908|449104002|FG001|Overall Study|Withdrawal by Subject|2|||
124858236|NCT04969783|449104003|FG000|Overall Study|Lost to Follow-up|2|||
124858237|NCT04969783|449104004|FG001|Overall Study|Lost to Follow-up|0|||
124858238|NCT04969783|449104003|FG000|Overall Study|Withdrawal by Subject|4|||
124858239|NCT04969783|449104004|FG001|Overall Study|Withdrawal by Subject|0|||
124858240|NCT04969783|449104003|FG000|Overall Study|Physician Decision|6|||
124858241|NCT04969783|449104004|FG001|Overall Study|Physician Decision|0|||
124858242|NCT04837482|449104005|FG000|Period 2|Withdrawal by Subject|0|||
124858243|NCT04837482|449104006|FG001|Period 2|Withdrawal by Subject|1|||
124858244|NCT00328510|449104007|FG000|Overall Study|Gag disorder, could not use frame|4|||
124858245|NCT00328510|449104008|FG001|Overall Study|Gag disorder, could not use frame|0|||
124858246|NCT00328510|449104007|FG000|Overall Study|Dentition problems, could not use frame|1|||
124858247|NCT00328510|449104008|FG001|Overall Study|Dentition problems, could not use frame|0|||
124858248|NCT00328510|449104007|FG000|Overall Study|Withdrawal by Subject|4|||
124858249|NCT00328510|449104008|FG001|Overall Study|Withdrawal by Subject|2|||
124858250|NCT00328510|449104007|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
124858251|NCT00328510|449104008|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
124858252|NCT00328510|449104007|FG000|Overall Study|Treatment changed to a single fraction|1|||
124858253|NCT00328510|449104008|FG001|Overall Study|Treatment changed to a single fraction|1|||
124858254|NCT03701555|449104016|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
124858255|NCT03701555|449104017|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
124858256|NCT03701555|449104018|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
124858257|NCT03701555|449104019|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
124858258|NCT03701555|449104020|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
124858259|NCT03701555|449104021|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
124858260|NCT03701555|449104022|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
124858261|NCT03701555|449104023|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
124858262|NCT03701555|449104024|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
124858263|NCT03701555|449104025|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
124858264|NCT03701555|449104026|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
124858265|NCT03701555|449104027|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
124858266|NCT03701555|449104028|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
124858267|NCT03701555|449104029|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
124858268|NCT03701555|449104030|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
124858269|NCT03701555|449104031|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
124858270|NCT03701555|449104032|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
124858271|NCT03701555|449104033|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
124858272|NCT03701555|449104034|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
124858273|NCT03701555|449104035|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
124858274|NCT03701555|449104036|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
124858275|NCT03701555|449104037|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
124858276|NCT03701555|449104038|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
124858277|NCT03701555|449104039|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
124858278|NCT03701555|449104040|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
124858279|NCT03701555|449104041|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
124858280|NCT03701555|449104042|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
124858281|NCT03701555|449104043|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
124858282|NCT03701555|449104044|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
124858283|NCT03701555|449104045|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
124858284|NCT03701555|449104046|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
124858285|NCT03701555|449104047|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
124858286|NCT03701555|449104048|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
124858287|NCT03701555|449104049|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
124858288|NCT03701555|449104050|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
124858289|NCT03701555|449104051|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
124858290|NCT03701555|449104016|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
124858291|NCT03701555|449104017|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
124858292|NCT03701555|449104018|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
124858293|NCT03701555|449104019|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
124858294|NCT03701555|449104020|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
124858295|NCT03701555|449104021|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
124858296|NCT03701555|449104022|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
124858297|NCT03701555|449104023|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
124858298|NCT03701555|449104024|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
124858299|NCT03701555|449104025|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
124858300|NCT03701555|449104026|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
124858301|NCT03701555|449104027|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
124858302|NCT03701555|449104028|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
124858303|NCT03701555|449104029|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
124858304|NCT03701555|449104030|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
124858305|NCT03701555|449104031|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
124858306|NCT03701555|449104032|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
124858307|NCT03701555|449104033|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
124858308|NCT03701555|449104034|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
124858309|NCT03701555|449104035|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
124858310|NCT03701555|449104036|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
124858311|NCT03701555|449104037|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
124858312|NCT03701555|449104038|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
124858313|NCT03701555|449104039|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
124858314|NCT03701555|449104040|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
124858315|NCT03701555|449104041|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
124858316|NCT03701555|449104042|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
124858317|NCT03701555|449104043|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
124858318|NCT03701555|449104044|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
124858319|NCT03701555|449104045|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
124858320|NCT03701555|449104046|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
124858321|NCT03701555|449104047|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
124858322|NCT03701555|449104048|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
124858323|NCT03701555|449104049|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
124858324|NCT03701555|449104050|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
124858325|NCT03701555|449104051|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
124858326|NCT03701555|449104016|FG000|Part 2 (Day 1)|Other|0|||
124858327|NCT03701555|449104017|FG001|Part 2 (Day 1)|Other|0|||
124858328|NCT03701555|449104018|FG002|Part 2 (Day 1)|Other|0|||
124858329|NCT03701555|449104019|FG003|Part 2 (Day 1)|Other|0|||
124858330|NCT03701555|449104020|FG004|Part 2 (Day 1)|Other|0|||
124858331|NCT03701555|449104021|FG005|Part 2 (Day 1)|Other|0|||
124858332|NCT03701555|449104022|FG006|Part 2 (Day 1)|Other|0|||
124858333|NCT03701555|449104023|FG007|Part 2 (Day 1)|Other|0|||
124858334|NCT03701555|449104024|FG008|Part 2 (Day 1)|Other|0|||
124858335|NCT03701555|449104025|FG009|Part 2 (Day 1)|Other|0|||
124858336|NCT03701555|449104026|FG010|Part 2 (Day 1)|Other|3|||
124858337|NCT03701555|449104027|FG011|Part 2 (Day 1)|Other|1|||
124858338|NCT03701555|449104028|FG012|Part 2 (Day 1)|Other|0|||
124858339|NCT03701555|449104029|FG013|Part 2 (Day 1)|Other|1|||
124858340|NCT03701555|449104030|FG014|Part 2 (Day 1)|Other|0|||
124858341|NCT03701555|449104031|FG015|Part 2 (Day 1)|Other|2|||
124858342|NCT03701555|449104032|FG016|Part 2 (Day 1)|Other|2|||
124858343|NCT03701555|449104033|FG017|Part 2 (Day 1)|Other|0|||
124858344|NCT03701555|449104034|FG018|Part 2 (Day 1)|Other|0|||
124858345|NCT03701555|449104035|FG019|Part 2 (Day 1)|Other|0|||
124858346|NCT03701555|449104036|FG020|Part 2 (Day 1)|Other|0|||
124858347|NCT03701555|449104037|FG021|Part 2 (Day 1)|Other|0|||
124858348|NCT03701555|449104038|FG022|Part 2 (Day 1)|Other|0|||
124858349|NCT03701555|449104039|FG023|Part 2 (Day 1)|Other|0|||
124858350|NCT03701555|449104040|FG024|Part 2 (Day 1)|Other|0|||
124858351|NCT03701555|449104041|FG025|Part 2 (Day 1)|Other|0|||
124858352|NCT03701555|449104042|FG026|Part 2 (Day 1)|Other|0|||
124858353|NCT03701555|449104043|FG027|Part 2 (Day 1)|Other|0|||
124858354|NCT03701555|449104044|FG028|Part 2 (Day 1)|Other|0|||
124858355|NCT03701555|449104045|FG029|Part 2 (Day 1)|Other|0|||
124858356|NCT03701555|449104046|FG030|Part 2 (Day 1)|Other|0|||
124858357|NCT03701555|449104047|FG031|Part 2 (Day 1)|Other|0|||
124858358|NCT03701555|449104048|FG032|Part 2 (Day 1)|Other|0|||
124858359|NCT03701555|449104049|FG033|Part 2 (Day 1)|Other|0|||
124858360|NCT03701555|449104050|FG034|Part 2 (Day 1)|Other|0|||
124858361|NCT03701555|449104051|FG035|Part 2 (Day 1)|Other|0|||
124858362|NCT03701555|449104016|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
124858363|NCT03701555|449104017|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
124858364|NCT03701555|449104018|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
124858365|NCT03701555|449104019|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
124858366|NCT03701555|449104020|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
124858367|NCT03701555|449104021|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
124858368|NCT03701555|449104022|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
124858369|NCT03701555|449104023|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
124858370|NCT03701555|449104024|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
124858371|NCT03701555|449104025|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
124858372|NCT03701555|449104026|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
124858373|NCT03701555|449104027|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
124858374|NCT03701555|449104028|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
124858375|NCT03701555|449104029|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
124858376|NCT03701555|449104030|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
124858377|NCT03701555|449104031|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
124858378|NCT03701555|449104032|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
124858379|NCT03701555|449104033|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
124858380|NCT03701555|449104034|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
124858381|NCT03701555|449104035|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
124858382|NCT03701555|449104036|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
124858383|NCT03701555|449104037|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
124858384|NCT03701555|449104038|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
124858385|NCT03701555|449104039|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
124858386|NCT03701555|449104040|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
124858387|NCT03701555|449104041|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
124858388|NCT03701555|449104042|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
124858389|NCT03701555|449104043|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
124858390|NCT03701555|449104044|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
124858391|NCT03701555|449104045|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
124858392|NCT03701555|449104046|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
124858393|NCT03701555|449104047|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
124858394|NCT03701555|449104048|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
124858395|NCT03701555|449104049|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
124858396|NCT03701555|449104050|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
124858397|NCT03701555|449104051|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
124858398|NCT03701555|449104016|FG000|Part 3 (Day 1)|Subject Decision|0|||
124858399|NCT03701555|449104017|FG001|Part 3 (Day 1)|Subject Decision|0|||
124858400|NCT03701555|449104018|FG002|Part 3 (Day 1)|Subject Decision|0|||
124858401|NCT03701555|449104019|FG003|Part 3 (Day 1)|Subject Decision|0|||
124858402|NCT03701555|449104020|FG004|Part 3 (Day 1)|Subject Decision|0|||
124858403|NCT03701555|449104021|FG005|Part 3 (Day 1)|Subject Decision|0|||
124858404|NCT03701555|449104022|FG006|Part 3 (Day 1)|Subject Decision|0|||
124858405|NCT03701555|449104023|FG007|Part 3 (Day 1)|Subject Decision|0|||
124858406|NCT03701555|449104024|FG008|Part 3 (Day 1)|Subject Decision|0|||
124858407|NCT03701555|449104025|FG009|Part 3 (Day 1)|Subject Decision|0|||
124858408|NCT03701555|449104026|FG010|Part 3 (Day 1)|Subject Decision|0|||
124858409|NCT03701555|449104027|FG011|Part 3 (Day 1)|Subject Decision|0|||
124858410|NCT03701555|449104028|FG012|Part 3 (Day 1)|Subject Decision|0|||
124858411|NCT03701555|449104029|FG013|Part 3 (Day 1)|Subject Decision|0|||
124858412|NCT03701555|449104030|FG014|Part 3 (Day 1)|Subject Decision|0|||
124858413|NCT03701555|449104031|FG015|Part 3 (Day 1)|Subject Decision|0|||
124858414|NCT03701555|449104032|FG016|Part 3 (Day 1)|Subject Decision|0|||
124858415|NCT03701555|449104033|FG017|Part 3 (Day 1)|Subject Decision|0|||
124858416|NCT03701555|449104034|FG018|Part 3 (Day 1)|Subject Decision|0|||
124858417|NCT03701555|449104035|FG019|Part 3 (Day 1)|Subject Decision|0|||
124858418|NCT03701555|449104036|FG020|Part 3 (Day 1)|Subject Decision|0|||
124858419|NCT03701555|449104037|FG021|Part 3 (Day 1)|Subject Decision|0|||
124858420|NCT03701555|449104038|FG022|Part 3 (Day 1)|Subject Decision|0|||
124858421|NCT03701555|449104039|FG023|Part 3 (Day 1)|Subject Decision|0|||
124858422|NCT03701555|449104040|FG024|Part 3 (Day 1)|Subject Decision|0|||
124858423|NCT03701555|449104041|FG025|Part 3 (Day 1)|Subject Decision|0|||
124858424|NCT03701555|449104042|FG026|Part 3 (Day 1)|Subject Decision|1|||
124858425|NCT03701555|449104043|FG027|Part 3 (Day 1)|Subject Decision|0|||
124858426|NCT03701555|449104044|FG028|Part 3 (Day 1)|Subject Decision|0|||
124858427|NCT03701555|449104045|FG029|Part 3 (Day 1)|Subject Decision|0|||
124858428|NCT03701555|449104046|FG030|Part 3 (Day 1)|Subject Decision|0|||
124858429|NCT03701555|449104047|FG031|Part 3 (Day 1)|Subject Decision|2|||
124858430|NCT03701555|449104048|FG032|Part 3 (Day 1)|Subject Decision|1|||
124858431|NCT03701555|449104049|FG033|Part 3 (Day 1)|Subject Decision|1|||
124858432|NCT03701555|449104050|FG034|Part 3 (Day 1)|Subject Decision|0|||
124858433|NCT03701555|449104051|FG035|Part 3 (Day 1)|Subject Decision|0|||
124858434|NCT03701555|449104016|FG000|Part 3 (Day 1)|Other|0|||
124858435|NCT03701555|449104017|FG001|Part 3 (Day 1)|Other|0|||
124858436|NCT03701555|449104018|FG002|Part 3 (Day 1)|Other|0|||
124858437|NCT03701555|449104019|FG003|Part 3 (Day 1)|Other|0|||
124858438|NCT03701555|449104020|FG004|Part 3 (Day 1)|Other|0|||
124858439|NCT03701555|449104021|FG005|Part 3 (Day 1)|Other|0|||
124858440|NCT03701555|449104022|FG006|Part 3 (Day 1)|Other|0|||
124858441|NCT03701555|449104023|FG007|Part 3 (Day 1)|Other|0|||
124858442|NCT03701555|449104024|FG008|Part 3 (Day 1)|Other|0|||
124858443|NCT03701555|449104025|FG009|Part 3 (Day 1)|Other|0|||
124858444|NCT03701555|449104026|FG010|Part 3 (Day 1)|Other|0|||
124858445|NCT03701555|449104027|FG011|Part 3 (Day 1)|Other|0|||
124858446|NCT03701555|449104028|FG012|Part 3 (Day 1)|Other|0|||
124858447|NCT03701555|449104029|FG013|Part 3 (Day 1)|Other|0|||
124858448|NCT03701555|449104030|FG014|Part 3 (Day 1)|Other|0|||
124858449|NCT03701555|449104031|FG015|Part 3 (Day 1)|Other|0|||
124858450|NCT03701555|449104032|FG016|Part 3 (Day 1)|Other|0|||
124858451|NCT03701555|449104033|FG017|Part 3 (Day 1)|Other|0|||
124858452|NCT03701555|449104034|FG018|Part 3 (Day 1)|Other|0|||
124858453|NCT03701555|449104035|FG019|Part 3 (Day 1)|Other|0|||
124858454|NCT03701555|449104036|FG020|Part 3 (Day 1)|Other|0|||
124858455|NCT03701555|449104037|FG021|Part 3 (Day 1)|Other|0|||
124858456|NCT03701555|449104038|FG022|Part 3 (Day 1)|Other|0|||
124858457|NCT03701555|449104039|FG023|Part 3 (Day 1)|Other|0|||
124858458|NCT03701555|449104040|FG024|Part 3 (Day 1)|Other|1|||
124858459|NCT03701555|449104041|FG025|Part 3 (Day 1)|Other|1|||
124858460|NCT03701555|449104042|FG026|Part 3 (Day 1)|Other|0|||
124858461|NCT03701555|449104043|FG027|Part 3 (Day 1)|Other|0|||
124858462|NCT03701555|449104044|FG028|Part 3 (Day 1)|Other|0|||
124858463|NCT03701555|449104045|FG029|Part 3 (Day 1)|Other|1|||
124858464|NCT03701555|449104046|FG030|Part 3 (Day 1)|Other|1|||
124858465|NCT03701555|449104047|FG031|Part 3 (Day 1)|Other|0|||
124858466|NCT03701555|449104048|FG032|Part 3 (Day 1)|Other|1|||
124858467|NCT03701555|449104049|FG033|Part 3 (Day 1)|Other|1|||
124858468|NCT03701555|449104050|FG034|Part 3 (Day 1)|Other|0|||
124858469|NCT03701555|449104051|FG035|Part 3 (Day 1)|Other|0|||
124858470|NCT04757649|449104052|FG000|Overall Study|Withdrawal by Subject|1|||
124858471|NCT04757649|449104052|FG000|Overall Study|Adverse Event|1|||
124858472|NCT01286779|449104053|FG000|Overall Study|Withdrawal by Subject|9|||
124858473|NCT01286779|449104053|FG000|Overall Study|Protocol Violation|5|||
124858474|NCT01286779|449104053|FG000|Overall Study|Physician Decision|2|||
124858475|NCT01286779|449104053|FG000|Overall Study|Participant had scheduled surgery|1|||
124858476|NCT01286779|449104053|FG000|Overall Study|Participant moved to another country|1|||
124858477|NCT01286779|449104053|FG000|Overall Study|Discontinued by sponsor|1|||
124858478|NCT02896855|449104054|FG000|Overall Study|Death|50|||
124858479|NCT02896855|449104055|FG001|Overall Study|Death|40|||
124858480|NCT02896855|449104054|FG000|Overall Study|Lost to Follow-up|15|||
124858481|NCT02896855|449104055|FG001|Overall Study|Lost to Follow-up|9|||
124858482|NCT02896855|449104054|FG000|Overall Study|Withdrawal by Subject|7|||
124858483|NCT02896855|449104055|FG001|Overall Study|Withdrawal by Subject|4|||
124858484|NCT02370602|449104056|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
124858485|NCT02370602|449104057|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
124858486|NCT02370602|449104058|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
124858487|NCT02370602|449104059|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
124858488|NCT02370602|449104060|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
124858489|NCT02370602|449104061|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
124858490|NCT01296568|449104062|FG000|Continued Access Phase|Lost to Follow-up|1|||
124858491|NCT01296568|449104062|FG000|Continued Access Phase|Withdrawal by Subject|1|||
124858492|NCT01296568|449104062|FG000|Continued Access Phase|Disease Progression|1|||
124858493|NCT00237744|449104063|FG000|Overall Study|Withdrawal by Subject|3|||
124858494|NCT00237744|449104064|FG001|Overall Study|Withdrawal by Subject|1|||
124858495|NCT00237744|449104065|FG002|Overall Study|Withdrawal by Subject|0|||
124858496|NCT00574080|449104066|FG000|Overall Study|Death|10|||
124858497|NCT00574080|449104067|FG001|Overall Study|Death|10|||
124858498|NCT00407537|449104068|FG000|Overall Study|Death|5|||
124858499|NCT00407537|449104069|FG001|Overall Study|Death|2|||
124858500|NCT00407537|449104068|FG000|Overall Study|Adverse Event|36|||
124858501|NCT00407537|449104069|FG001|Overall Study|Adverse Event|0|||
124858502|NCT00407537|449104068|FG000|Overall Study|Lost to Follow-up|12|||
124858503|NCT00407537|449104069|FG001|Overall Study|Lost to Follow-up|19|||
124858504|NCT00407537|449104068|FG000|Overall Study|Other|6|||
124858505|NCT00407537|449104069|FG001|Overall Study|Other|7|||
124858506|NCT00407537|449104068|FG000|Overall Study|Withdrawal by Subject|34|||
124858507|NCT00407537|449104069|FG001|Overall Study|Withdrawal by Subject|16|||
124858508|NCT01519206|449104070|FG000|Overall Study|Lost to Follow-up|3|||
124858509|NCT01519206|449104070|FG000|Overall Study|Missed Visit|2|||
124858510|NCT04139317|449104071|FG000|Overall Study|Adverse Event|10|||
124858511|NCT04139317|449104072|FG001|Overall Study|Adverse Event|2|||
124858512|NCT04139317|449104071|FG000|Overall Study|Death|6|||
124858513|NCT04139317|449104072|FG001|Overall Study|Death|4|||
124858514|NCT04139317|449104071|FG000|Overall Study|Lost to Follow-up|1|||
124858515|NCT04139317|449104072|FG001|Overall Study|Lost to Follow-up|0|||
124858516|NCT04139317|449104071|FG000|Overall Study|Physician Decision|3|||
124858517|NCT04139317|449104072|FG001|Overall Study|Physician Decision|1|||
124858518|NCT04139317|449104071|FG000|Overall Study|Progressive Disease|19|||
124858519|NCT04139317|449104072|FG001|Overall Study|Progressive Disease|9|||
124858520|NCT04139317|449104071|FG000|Overall Study|Subject Decision|2|||
124858521|NCT04139317|449104072|FG001|Overall Study|Subject Decision|2|||
124858522|NCT06027216|449104075|FG000|Overall Study|Did not qualify|8|||
124858523|NCT05348681|449104076|FG000|Overall Study|Study terminated by Sponsor|8|||
124858524|NCT05348681|449104077|FG001|Overall Study|Study terminated by Sponsor|3|||
124858525|NCT05348681|449104076|FG000|Overall Study|Withdrawal by Subject|1|||
124858526|NCT05348681|449104077|FG001|Overall Study|Withdrawal by Subject|1|||
124858527|NCT05348681|449104076|FG000|Overall Study|Lost to Follow-up|1|||
124858528|NCT05348681|449104077|FG001|Overall Study|Lost to Follow-up|1|||
124858529|NCT05348681|449104076|FG000|Overall Study|Adverse Event|1|||
124858530|NCT05348681|449104077|FG001|Overall Study|Adverse Event|0|||
124858531|NCT05348681|449104076|FG000|Overall Study|Other|2|||
124858532|NCT05348681|449104077|FG001|Overall Study|Other|1|||
124858533|NCT03646513|449104081|FG000|Overall Study|Premature study termination|4|||
124858534|NCT00782340|449104082|FG000|Open Label Titration|Adverse Event|12|||
124858535|NCT00782340|449104083|FG001|Open Label Titration|Adverse Event|0|||
124858536|NCT00782340|449104084|FG002|Open Label Titration|Adverse Event|0|||
124858537|NCT00782340|449104082|FG000|Open Label Titration|Treatment failure|50|||
124858538|NCT00782340|449104083|FG001|Open Label Titration|Treatment failure|0|||
124858539|NCT00782340|449104084|FG002|Open Label Titration|Treatment failure|0|||
124858540|NCT00782340|449104082|FG000|Open Label Titration|Protocol Violation|5|||
124858541|NCT00782340|449104083|FG001|Open Label Titration|Protocol Violation|0|||
124858542|NCT00782340|449104084|FG002|Open Label Titration|Protocol Violation|0|||
124858543|NCT00782340|449104082|FG000|Open Label Titration|Withdrawal by Subject|5|||
124858544|NCT00782340|449104083|FG001|Open Label Titration|Withdrawal by Subject|0|||
124858545|NCT00782340|449104084|FG002|Open Label Titration|Withdrawal by Subject|0|||
124858546|NCT00782340|449104082|FG000|Open Label Titration|Enrollment capped|16|||
124858547|NCT00782340|449104083|FG001|Open Label Titration|Enrollment capped|0|||
124858548|NCT00782340|449104084|FG002|Open Label Titration|Enrollment capped|0|||
124858549|NCT00782340|449104082|FG000|Open Label Titration|Did not meet responder criteria|2|||
124858550|NCT00782340|449104083|FG001|Open Label Titration|Did not meet responder criteria|0|||
124858551|NCT00782340|449104084|FG002|Open Label Titration|Did not meet responder criteria|0|||
124858552|NCT00782340|449104082|FG000|Open Label Titration|Lost to Follow-up|5|||
124858553|NCT00782340|449104083|FG001|Open Label Titration|Lost to Follow-up|0|||
124858554|NCT00782340|449104084|FG002|Open Label Titration|Lost to Follow-up|0|||
124858555|NCT00782340|449104082|FG000|Open Label Titration|Randomized in error|6|||
124858556|NCT00782340|449104083|FG001|Open Label Titration|Randomized in error|0|||
124858557|NCT00782340|449104084|FG002|Open Label Titration|Randomized in error|0|||
124858558|NCT02219932|449104089|FG000|Overall Study|Other|5|||
124858559|NCT02219932|449104090|FG001|Overall Study|Other|11|||
124858560|NCT02219932|449104089|FG000|Overall Study|Death|1|||
124858561|NCT02219932|449104090|FG001|Overall Study|Death|1|||
124858562|NCT02219932|449104089|FG000|Overall Study|Investigator Decision|0|||
124858563|NCT02219932|449104090|FG001|Overall Study|Investigator Decision|1|||
124858564|NCT02219932|449104089|FG000|Overall Study|Consent Withdrawn|11|||
124858565|NCT02219932|449104090|FG001|Overall Study|Consent Withdrawn|7|||
124858566|NCT02219932|449104089|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
124858567|NCT02219932|449104090|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
124858568|NCT02219932|449104089|FG000|Overall Study|Protocol Violation|10|||
124858569|NCT02219932|449104090|FG001|Overall Study|Protocol Violation|6|||
124858570|NCT02219932|449104089|FG000|Overall Study|Pregnancy|1|||
124858571|NCT02219932|449104090|FG001|Overall Study|Pregnancy|0|||
124858572|NCT02219932|449104089|FG000|Overall Study|Lost to Follow-up|4|||
124858573|NCT02219932|449104090|FG001|Overall Study|Lost to Follow-up|2|||
124858574|NCT02219932|449104089|FG000|Overall Study|Adverse Event|23|||
124858575|NCT02219932|449104090|FG001|Overall Study|Adverse Event|21|||
124858576|NCT00093145|449104092|FG000|Overall Study|Unacceptable Toxicity Only|2|||
124858577|NCT00093145|449104092|FG000|Overall Study|Physician Decision|5|||
124858578|NCT00093145|449104092|FG000|Overall Study|Withdrawal by Subject|9|||
124858579|NCT00093145|449104092|FG000|Overall Study|Other|1|||
124858580|NCT04389840|449104093|FG000|Overall Study|Adverse Event|0|||
124858581|NCT04389840|449104094|FG001|Overall Study|Adverse Event|0|||
124858582|NCT04389840|449104095|FG002|Overall Study|Adverse Event|0|||
124858583|NCT04389840|449104096|FG003|Overall Study|Adverse Event|1|||
124858584|NCT04389840|449104097|FG004|Overall Study|Adverse Event|0|||
124858585|NCT04389840|449104098|FG005|Overall Study|Adverse Event|0|||
124858586|NCT04389840|449104093|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
124858587|NCT04389840|449104094|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
124858588|NCT04389840|449104095|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
124858589|NCT04389840|449104096|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
124858590|NCT04389840|449104097|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
124858591|NCT04389840|449104098|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
124858592|NCT04389840|449104093|FG000|Overall Study|Death|0|||
124858593|NCT04389840|449104094|FG001|Overall Study|Death|1|||
124858594|NCT04389840|449104095|FG002|Overall Study|Death|0|||
124858595|NCT04389840|449104096|FG003|Overall Study|Death|0|||
124858596|NCT04389840|449104097|FG004|Overall Study|Death|0|||
124858597|NCT04389840|449104098|FG005|Overall Study|Death|0|||
124858598|NCT01953926|449104101|FG000|Overall Study|Withdrawal by Subject|23|||
124858599|NCT01953926|449104102|FG001|Overall Study|Withdrawal by Subject|3|||
124858600|NCT01953926|449104103|FG002|Overall Study|Withdrawal by Subject|3|||
124858601|NCT01953926|449104104|FG003|Overall Study|Withdrawal by Subject|5|||
124858602|NCT01953926|449104105|FG004|Overall Study|Withdrawal by Subject|6|||
124858603|NCT01953926|449104106|FG005|Overall Study|Withdrawal by Subject|0|||
124858604|NCT01953926|449104107|FG006|Overall Study|Withdrawal by Subject|1|||
124858605|NCT01953926|449104101|FG000|Overall Study|Physician Decision|1|||
124858606|NCT01953926|449104102|FG001|Overall Study|Physician Decision|0|||
124858607|NCT01953926|449104103|FG002|Overall Study|Physician Decision|0|||
124858608|NCT01953926|449104104|FG003|Overall Study|Physician Decision|0|||
124858609|NCT01953926|449104105|FG004|Overall Study|Physician Decision|2|||
124858610|NCT01953926|449104106|FG005|Overall Study|Physician Decision|0|||
124858611|NCT01953926|449104107|FG006|Overall Study|Physician Decision|0|||
124858612|NCT01953926|449104101|FG000|Overall Study|Lost to Follow-up|18|||
124858613|NCT01953926|449104102|FG001|Overall Study|Lost to Follow-up|3|||
124858614|NCT01953926|449104103|FG002|Overall Study|Lost to Follow-up|0|||
124858615|NCT01953926|449104104|FG003|Overall Study|Lost to Follow-up|5|||
124858616|NCT01953926|449104105|FG004|Overall Study|Lost to Follow-up|3|||
124858617|NCT01953926|449104106|FG005|Overall Study|Lost to Follow-up|0|||
124858618|NCT01953926|449104107|FG006|Overall Study|Lost to Follow-up|0|||
124858619|NCT01953926|449104101|FG000|Overall Study|Protocol Violation|1|||
124858620|NCT01953926|449104102|FG001|Overall Study|Protocol Violation|0|||
124858621|NCT01953926|449104103|FG002|Overall Study|Protocol Violation|0|||
124858622|NCT01953926|449104104|FG003|Overall Study|Protocol Violation|0|||
124858623|NCT01953926|449104105|FG004|Overall Study|Protocol Violation|0|||
124858624|NCT01953926|449104106|FG005|Overall Study|Protocol Violation|0|||
124858625|NCT01953926|449104107|FG006|Overall Study|Protocol Violation|0|||
124858626|NCT01953926|449104101|FG000|Overall Study|Other, Disease progression|2|||
124858627|NCT01953926|449104102|FG001|Overall Study|Other, Disease progression|1|||
124858628|NCT01953926|449104103|FG002|Overall Study|Other, Disease progression|0|||
124858629|NCT01953926|449104104|FG003|Overall Study|Other, Disease progression|0|||
124858630|NCT01953926|449104105|FG004|Overall Study|Other, Disease progression|1|||
124858631|NCT01953926|449104106|FG005|Overall Study|Other, Disease progression|0|||
124858632|NCT01953926|449104107|FG006|Overall Study|Other, Disease progression|0|||
124858633|NCT01953926|449104101|FG000|Overall Study|Discontinuation of study by sponsor|41|||
124858634|NCT01953926|449104102|FG001|Overall Study|Discontinuation of study by sponsor|7|||
124858635|NCT01953926|449104103|FG002|Overall Study|Discontinuation of study by sponsor|5|||
124858636|NCT01953926|449104104|FG003|Overall Study|Discontinuation of study by sponsor|12|||
124858637|NCT01953926|449104105|FG004|Overall Study|Discontinuation of study by sponsor|46|||
124858638|NCT01953926|449104106|FG005|Overall Study|Discontinuation of study by sponsor|5|||
124858639|NCT01953926|449104107|FG006|Overall Study|Discontinuation of study by sponsor|6|||
124858640|NCT01953926|449104101|FG000|Overall Study|Not Treated|1|||
124858641|NCT01953926|449104102|FG001|Overall Study|Not Treated|0|||
124858642|NCT01953926|449104103|FG002|Overall Study|Not Treated|1|||
124858643|NCT01953926|449104104|FG003|Overall Study|Not Treated|0|||
124858644|NCT01953926|449104105|FG004|Overall Study|Not Treated|0|||
124858645|NCT01953926|449104106|FG005|Overall Study|Not Treated|0|||
124858646|NCT01953926|449104107|FG006|Overall Study|Not Treated|0|||
124858647|NCT01272934|449104111|FG000|Overall Study|Adverse Event|0|||
124858648|NCT01272934|449104112|FG001|Overall Study|Adverse Event|1|||
124858649|NCT01272934|449104111|FG000|Overall Study|Abnormal Laboratory Value|0|||
124858650|NCT01272934|449104112|FG001|Overall Study|Abnormal Laboratory Value|1|||
124858651|NCT00214136|449104113|FG000|Overall Study|Death|5|||
124858652|NCT04287920|449104114|FG000|Overall Study|Lost to Follow-up|1|||
124858653|NCT04287920|449104115|FG001|Overall Study|Lost to Follow-up|1|||
124858654|NCT04287920|449104114|FG000|Overall Study|Withdrawal by Subject|0|||
124858655|NCT04287920|449104115|FG001|Overall Study|Withdrawal by Subject|3|||
124858656|NCT04313634|449104116|FG000|Overall Study|Adverse Event|2|||
124858657|NCT04313634|449104117|FG001|Overall Study|Adverse Event|2|||
124858658|NCT04313634|449104118|FG002|Overall Study|Adverse Event|0|||
124858659|NCT04313634|449104116|FG000|Overall Study|Withdrawal by Subject|1|||
124858660|NCT04313634|449104117|FG001|Overall Study|Withdrawal by Subject|0|||
124858661|NCT04313634|449104118|FG002|Overall Study|Withdrawal by Subject|1|||
124858662|NCT04313634|449104116|FG000|Overall Study|Protocol Violation|0|||
124858663|NCT04313634|449104117|FG001|Overall Study|Protocol Violation|0|||
124858664|NCT04313634|449104118|FG002|Overall Study|Protocol Violation|1|||
124858665|NCT03585244|449104125|FG000|Overall Study|Withdrawal by Subject|15|||
124858666|NCT01764945|449104128|FG000|Overall Study|Adverse Event|0|||
124858667|NCT01764945|449104129|FG001|Overall Study|Adverse Event|1|||
124858668|NCT01764945|449104130|FG002|Overall Study|Adverse Event|0|||
124858669|NCT01764945|449104131|FG003|Overall Study|Adverse Event|0|||
124858670|NCT01764945|449104132|FG004|Overall Study|Adverse Event|0|||
124858671|NCT01764945|449104133|FG005|Overall Study|Adverse Event|0|||
124858672|NCT01764945|449104134|FG006|Overall Study|Adverse Event|1|||
124858673|NCT01764945|449104135|FG007|Overall Study|Adverse Event|0|||
124858674|NCT05077267|449104136|FG000|Treatment Period|Lost to Follow-up|0|||
124858675|NCT05077267|449104137|FG001|Treatment Period|Lost to Follow-up|1|||
124858676|NCT05077267|449104138|FG002|Treatment Period|Lost to Follow-up|0|||
124858677|NCT05077267|449104136|FG000|Treatment Period|Withdrawal by Subject|0|||
124858678|NCT05077267|449104137|FG001|Treatment Period|Withdrawal by Subject|1|||
124858679|NCT05077267|449104138|FG002|Treatment Period|Withdrawal by Subject|0|||
124858680|NCT05077267|449104136|FG000|Follow-up Period|Lost to Follow-up|0|||
124858681|NCT05077267|449104137|FG001|Follow-up Period|Lost to Follow-up|5|||
124858682|NCT05077267|449104138|FG002|Follow-up Period|Lost to Follow-up|7|||
124858683|NCT05077267|449104136|FG000|Follow-up Period|Withdrawal by Subject|0|||
124858684|NCT05077267|449104137|FG001|Follow-up Period|Withdrawal by Subject|2|||
124858685|NCT05077267|449104138|FG002|Follow-up Period|Withdrawal by Subject|5|||
124858686|NCT05077267|449104136|FG000|Follow-up Period|Study terminated by sponsor|0|||
124858687|NCT05077267|449104137|FG001|Follow-up Period|Study terminated by sponsor|27|||
124858688|NCT05077267|449104138|FG002|Follow-up Period|Study terminated by sponsor|23|||
124858689|NCT05077267|449104136|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
124858690|NCT05077267|449104137|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
124858691|NCT05077267|449104138|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
124858692|NCT05077267|449104136|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
124858693|NCT05077267|449104137|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
124858694|NCT05077267|449104138|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
124858695|NCT02911948|449104139|FG000|Overall Study|Protocol Violation|0|||
124858696|NCT02911948|449104140|FG001|Overall Study|Protocol Violation|1|||
124858697|NCT02911948|449104139|FG000|Overall Study|Withdrawal by Subject|0|||
124858698|NCT02911948|449104140|FG001|Overall Study|Withdrawal by Subject|2|||
124858699|NCT02911948|449104139|FG000|Overall Study|Lack of Efficacy|0|||
124858700|NCT02911948|449104140|FG001|Overall Study|Lack of Efficacy|1|||
124858701|NCT02911948|449104139|FG000|Overall Study|Unclassified|0|||
124858702|NCT02911948|449104140|FG001|Overall Study|Unclassified|3|||
124858703|NCT00142909|449104145|FG000|Randomization|Various Reasons|7|||
124858704|NCT00142909|449104146|FG001|Randomization|Various Reasons|10|||
124858705|NCT00142909|449104145|FG000|Medications Begin|Protocol Violation|2|||
124858706|NCT00142909|449104146|FG001|Medications Begin|Protocol Violation|0|||
124858707|NCT00142909|449104145|FG000|Medications Begin|Withdrawal by Subject|5|||
124858708|NCT00142909|449104146|FG001|Medications Begin|Withdrawal by Subject|3|||
124858709|NCT00142909|449104145|FG000|Medications Begin|Withdrawal by Subject|2|||
124858710|NCT00142909|449104146|FG001|Medications Begin|Withdrawal by Subject|0|||
124858711|NCT01307501|449104147|FG000|Overall Study|Treatment Failure|1|||
124858712|NCT01307501|449104147|FG000|Overall Study|Death|20|||
124858713|NCT01307501|449104147|FG000|Overall Study|Lost to Follow-up|1|||
124858714|NCT01307501|449104147|FG000|Overall Study|Starting Hospice|1|||
124858715|NCT02005471|449104148|FG000|Main Study|Adverse Event|0|||
124858716|NCT02005471|449104149|FG001|Main Study|Adverse Event|1|||
124858717|NCT02005471|449104150|FG002|Main Study|Adverse Event|0|||
124858718|NCT02005471|449104151|FG003|Main Study|Adverse Event|0|||
124858719|NCT02005471|449104148|FG000|Main Study|Death|83|||
124858720|NCT02005471|449104149|FG001|Main Study|Death|52|||
124858721|NCT02005471|449104150|FG002|Main Study|Death|0|||
124858722|NCT02005471|449104151|FG003|Main Study|Death|0|||
124858723|NCT02005471|449104148|FG000|Main Study|Lost to Follow-up|4|||
124858724|NCT02005471|449104149|FG001|Main Study|Lost to Follow-up|5|||
124858725|NCT02005471|449104150|FG002|Main Study|Lost to Follow-up|0|||
124858726|NCT02005471|449104151|FG003|Main Study|Lost to Follow-up|0|||
124858727|NCT02005471|449104148|FG000|Main Study|Physician Decision|3|||
124858728|NCT02005471|449104149|FG001|Main Study|Physician Decision|1|||
124858729|NCT02005471|449104150|FG002|Main Study|Physician Decision|0|||
124858730|NCT02005471|449104151|FG003|Main Study|Physician Decision|0|||
124858731|NCT02005471|449104148|FG000|Main Study|Withdrawal by Subject|26|||
124858732|NCT02005471|449104149|FG001|Main Study|Withdrawal by Subject|11|||
124858733|NCT02005471|449104150|FG002|Main Study|Withdrawal by Subject|0|||
124858734|NCT02005471|449104151|FG003|Main Study|Withdrawal by Subject|0|||
124858735|NCT02005471|449104148|FG000|Main Study|Reason not Specified|0|||
124858736|NCT02005471|449104149|FG001|Main Study|Reason not Specified|6|||
124858737|NCT02005471|449104150|FG002|Main Study|Reason not Specified|0|||
124858738|NCT02005471|449104151|FG003|Main Study|Reason not Specified|0|||
124858739|NCT02005471|449104148|FG000|Main Study|Randomized but not Dosed|8|||
124858740|NCT02005471|449104149|FG001|Main Study|Randomized but not Dosed|0|||
124858741|NCT02005471|449104150|FG002|Main Study|Randomized but not Dosed|0|||
124858742|NCT02005471|449104151|FG003|Main Study|Randomized but not Dosed|0|||
124858743|NCT02005471|449104148|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
124858744|NCT02005471|449104149|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
124858745|NCT02005471|449104150|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
124858746|NCT02005471|449104151|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
124858747|NCT02005471|449104148|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
124858748|NCT02005471|449104149|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
124858749|NCT02005471|449104150|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
124858750|NCT02005471|449104151|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
124858751|NCT02005471|449104148|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
124858752|NCT02005471|449104149|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
124858753|NCT02005471|449104150|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
124858754|NCT02005471|449104151|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
124858755|NCT03478891|449104152|FG000|Overall Study|Enrolled, but product never administered|0|||
124858756|NCT03478891|449104153|FG001|Overall Study|Enrolled, but product never administered|0|||
124858757|NCT03478891|449104154|FG002|Overall Study|Enrolled, but product never administered|1|||
124858758|NCT03478891|449104152|FG000|Overall Study|Moved from area|0|||
124858759|NCT03478891|449104153|FG001|Overall Study|Moved from area|0|||
124858760|NCT03478891|449104154|FG002|Overall Study|Moved from area|1|||
124858761|NCT03478891|449104152|FG000|Overall Study|Lost to Follow-up|1|||
124858762|NCT03478891|449104153|FG001|Overall Study|Lost to Follow-up|0|||
124858763|NCT03478891|449104154|FG002|Overall Study|Lost to Follow-up|1|||
124858764|NCT03662750|449104155|FG000|Overall Study|Withdrawal by Subject|1|||
124858765|NCT00932893|449104156|FG000|Overall Study|Death|115|||
124858766|NCT00932893|449104157|FG001|Overall Study|Death|24|||
124858767|NCT00932893|449104156|FG000|Overall Study|Lost to Follow-up|8|||
124858768|NCT00932893|449104157|FG001|Overall Study|Lost to Follow-up|0|||
124858769|NCT00932893|449104156|FG000|Overall Study|Withdrawal by Subject|5|||
124858770|NCT00932893|449104157|FG001|Overall Study|Withdrawal by Subject|2|||
124858771|NCT00932893|449104156|FG000|Overall Study|Other|5|||
124858772|NCT00932893|449104157|FG001|Overall Study|Other|144|||
124858773|NCT04450264|449106040|FG000|Overall Study|Incomplete survey|13|||
124858774|NCT04450264|449106041|FG001|Overall Study|Incomplete survey|19|||
124858775|NCT04295564|449106042|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
124858776|NCT04295564|449106043|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
124858777|NCT01682460|449106044|FG000|Overall Study|Withdrawal by Subject|2|||
124858778|NCT01682460|449106044|FG000|Overall Study|Did not meet inclusion criteria|2|||
124858779|NCT05349617|449106046|FG000|Overall Study|Death|1|||
124858780|NCT05349617|449106047|FG001|Overall Study|Death|1|||
124858781|NCT05349617|449106046|FG000|Overall Study|Lost to Follow-up|3|||
124858782|NCT05349617|449106047|FG001|Overall Study|Lost to Follow-up|8|||
124858783|NCT05349617|449106046|FG000|Overall Study|Withdrawal by Subject|2|||
124858784|NCT05349617|449106047|FG001|Overall Study|Withdrawal by Subject|10|||
124858785|NCT00724282|449106048|FG000|Overall Study|Withdrawal by Subject|3|||
124858786|NCT00724282|449106048|FG000|Overall Study|Physician Decision|1|||
124858787|NCT01159691|449106049|FG000|Overall Study|Lost to Follow-up|2|||
124858788|NCT01159691|449106049|FG000|Overall Study|Unknown reasons|1|||
124858789|NCT01159691|449106049|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
124858790|NCT01159691|449106049|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
124858791|NCT01159691|449106049|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
124858792|NCT01159691|449106049|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
124858793|NCT01159691|449106049|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
124858794|NCT01159691|449106049|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
124858795|NCT01928719|449106050|FG000|Overall Study|Lost to Follow-up|26|||
124858796|NCT01928719|449106051|FG001|Overall Study|Lost to Follow-up|11|||
124858797|NCT01928719|449106050|FG000|Overall Study|Withdrawal by Subject|22|||
124858798|NCT01928719|449106051|FG001|Overall Study|Withdrawal by Subject|7|||
124858799|NCT01928719|449106050|FG000|Overall Study|Protocol Violation|3|||
124858800|NCT01928719|449106051|FG001|Overall Study|Protocol Violation|1|||
124858801|NCT01928719|449106050|FG000|Overall Study|Adverse Event|1|||
124858802|NCT01928719|449106051|FG001|Overall Study|Adverse Event|0|||
124858803|NCT05732454|449106057|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
124858804|NCT05732454|449106058|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
124858805|NCT05732454|449106057|FG000|Part 1: DB Period|Adverse Event|1|||
124858806|NCT05732454|449106058|FG001|Part 1: DB Period|Adverse Event|0|||
124858807|NCT05732454|449106057|FG000|Part 1: DB Period|Lost to Follow-up|1|||
124858808|NCT05732454|449106058|FG001|Part 1: DB Period|Lost to Follow-up|0|||
124858809|NCT05732454|449106057|FG000|Part 1: DB Period|Protocol Violation|0|||
124858810|NCT05732454|449106058|FG001|Part 1: DB Period|Protocol Violation|1|||
124858811|NCT05732454|449106057|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
124858812|NCT05732454|449106058|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
124858813|NCT05732454|449106057|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
124858814|NCT05732454|449106058|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
124858815|NCT05732454|449106057|FG000|Part 1: OLE Period|Adverse Event|0|||
124858816|NCT05732454|449106058|FG001|Part 1: OLE Period|Adverse Event|1|||
124858817|NCT05732454|449106057|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
124858818|NCT05732454|449106058|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
124858819|NCT00377819|449106062|FG000|Overall Study|Adverse Event|2|||
124858820|NCT00377819|449106063|FG001|Overall Study|Adverse Event|3|||
124858821|NCT00377819|449106062|FG000|Overall Study|Withdrawal by Subject|10|||
124858822|NCT00377819|449106063|FG001|Overall Study|Withdrawal by Subject|4|||
124858823|NCT00377819|449106062|FG000|Overall Study|Death|0|||
124858824|NCT00377819|449106063|FG001|Overall Study|Death|1|||
124858825|NCT00377819|449106062|FG000|Overall Study|Lost to Follow-up|0|||
124858826|NCT00377819|449106063|FG001|Overall Study|Lost to Follow-up|1|||
124858827|NCT00377819|449106062|FG000|Overall Study|Protocol Violation|1|||
124858828|NCT00377819|449106063|FG001|Overall Study|Protocol Violation|1|||
124858829|NCT02091726|449106064|FG000|Overall Study|Lost to Follow-up|6|||
124858830|NCT03727750|449106065|FG000|Overall Study|Death|45|||
124858831|NCT03727750|449106065|FG000|Overall Study|Withdrawal by Subject|2|||
124858832|NCT03727750|449106065|FG000|Overall Study|Lost to Follow-up|1|||
124858833|NCT03727750|449106065|FG000|Overall Study|Other|1|||
124858834|NCT00823719|449106073|FG000|Overall Study|Adverse Event|1|||
124858835|NCT00823719|449106074|FG001|Overall Study|Adverse Event|2|||
124858836|NCT00823719|449106073|FG000|Overall Study|Physician Decision|1|||
124858837|NCT00823719|449106074|FG001|Overall Study|Physician Decision|4|||
124858838|NCT00823719|449106073|FG000|Overall Study|Withdrawal by Subject|0|||
124858839|NCT00823719|449106074|FG001|Overall Study|Withdrawal by Subject|1|||
124858840|NCT00823719|449106073|FG000|Overall Study|Disease Progression|4|||
124858841|NCT00823719|449106074|FG001|Overall Study|Disease Progression|4|||
124858842|NCT01380327|449106078|FG000|Overall Study|Lost to Follow-up|0|||
124858843|NCT01380327|449106079|FG001|Overall Study|Lost to Follow-up|1|||
124858844|NCT01380327|449106080|FG002|Overall Study|Lost to Follow-up|1|||
124858845|NCT01380327|449106078|FG000|Overall Study|Protocol Violation|3|||
124858846|NCT01380327|449106079|FG001|Overall Study|Protocol Violation|2|||
124858847|NCT01380327|449106080|FG002|Overall Study|Protocol Violation|3|||
124858848|NCT01380327|449106078|FG000|Overall Study|Withdrawal by Subject|0|||
124858849|NCT01380327|449106079|FG001|Overall Study|Withdrawal by Subject|0|||
124858850|NCT01380327|449106080|FG002|Overall Study|Withdrawal by Subject|1|||
124858851|NCT01380327|449106078|FG000|Overall Study|Housing situation precluded ability to k|0|||
124858852|NCT01380327|449106079|FG001|Overall Study|Housing situation precluded ability to k|0|||
124858853|NCT01380327|449106080|FG002|Overall Study|Housing situation precluded ability to k|1|||
124858854|NCT01380327|449106078|FG000|Overall Study|Questionable onset of epilepsy|0|||
124858855|NCT01380327|449106079|FG001|Overall Study|Questionable onset of epilepsy|0|||
124858856|NCT01380327|449106080|FG002|Overall Study|Questionable onset of epilepsy|1|||
124858857|NCT00586105|449106081|FG000|Overall Study|Adverse Event|4|||
124858858|NCT00586105|449106081|FG000|Overall Study|Death|2|||
124858859|NCT00586105|449106081|FG000|Overall Study|Protocol Violation|1|||
124858860|NCT00586105|449106081|FG000|Overall Study|Withdrawal by Subject|3|||
124858861|NCT00586105|449106081|FG000|Overall Study|Disease progression|19|||
124858862|NCT00586105|449106081|FG000|Overall Study|Switched to commercial drug|9|||
124858863|NCT00586105|449106081|FG000|Overall Study|Reason not reported|1|||
124858864|NCT03835533|449106082|FG000|Overall Study|Death|5|||
124858865|NCT03835533|449106083|FG001|Overall Study|Death|10|||
124858866|NCT03835533|449106084|FG002|Overall Study|Death|9|||
124858867|NCT03835533|449106082|FG000|Overall Study|Withdrawal by Subject|2|||
124858868|NCT03835533|449106083|FG001|Overall Study|Withdrawal by Subject|2|||
124858869|NCT03835533|449106084|FG002|Overall Study|Withdrawal by Subject|2|||
124858870|NCT03835533|449106082|FG000|Overall Study|Lost to Follow-up|1|||
124858871|NCT03835533|449106083|FG001|Overall Study|Lost to Follow-up|0|||
124858872|NCT03835533|449106084|FG002|Overall Study|Lost to Follow-up|0|||
124858873|NCT03867734|449106085|FG000|Overall Study|Lost to Follow-up|2|||
124858874|NCT01136291|449106086|FG000|Overall Study|Lost to Follow-up|1|||
124858875|NCT01136291|449106087|FG001|Overall Study|Lost to Follow-up|1|||
124858876|NCT02308033|449106090|FG000|Overall Study|Normal Gram stain at Baseline|13|||
124858877|NCT02308033|449106091|FG001|Overall Study|Normal Gram stain at Baseline|10|||
124858878|NCT02308033|449106090|FG000|Overall Study|Positive for STD at Baseline|7|||
124858879|NCT02308033|449106091|FG001|Overall Study|Positive for STD at Baseline|4|||
124858880|NCT02308033|449106090|FG000|Overall Study|Lost to Follow-up|6|||
124858881|NCT02308033|449106091|FG001|Overall Study|Lost to Follow-up|5|||
124858882|NCT01870843|449106094|FG000|Overall Study|Adverse Event|10|||
124858883|NCT01870843|449106094|FG000|Overall Study|Lost to Follow-up|24|||
124858884|NCT01870843|449106094|FG000|Overall Study|Death|1|||
124858885|NCT01870843|449106094|FG000|Overall Study|Withdrawal by Subject|18|||
124858886|NCT03021187|449106095|FG000|Overall Study|Death|0|||
124858887|NCT03021187|449106096|FG001|Overall Study|Death|0|||
124858888|NCT03021187|449106097|FG002|Overall Study|Death|3|||
124858889|NCT03021187|449106098|FG003|Overall Study|Death|0|||
124858890|NCT03021187|449106095|FG000|Overall Study|Withdrawal by Subject|0|||
124858891|NCT03021187|449106096|FG001|Overall Study|Withdrawal by Subject|6|||
124858892|NCT03021187|449106097|FG002|Overall Study|Withdrawal by Subject|2|||
124858893|NCT03021187|449106098|FG003|Overall Study|Withdrawal by Subject|5|||
124858894|NCT03021187|449106095|FG000|Overall Study|Lost to Follow-up|10|||
124858895|NCT03021187|449106096|FG001|Overall Study|Lost to Follow-up|3|||
124858896|NCT03021187|449106097|FG002|Overall Study|Lost to Follow-up|1|||
124858897|NCT03021187|449106098|FG003|Overall Study|Lost to Follow-up|4|||
124858898|NCT01664078|449106099|FG000|Overall Study|Death|9|||
124858899|NCT01664078|449106099|FG000|Overall Study|Withdrawal by Subject|4|||
124858900|NCT01664078|449106099|FG000|Overall Study|Lost to Follow-up|2|||
124858901|NCT01664078|449106099|FG000|Overall Study|missed 5 year visit|1|||
124858902|NCT01664078|449106099|FG000|Overall Study|Other|53|||
124858903|NCT00718718|449106100|FG000|Prior to Week 12|Adverse Event|0|||
124858904|NCT00718718|449106101|FG001|Prior to Week 12|Adverse Event|0|||
124858905|NCT00718718|449106102|FG002|Prior to Week 12|Adverse Event|0|||
124858906|NCT00718718|449106103|FG003|Prior to Week 12|Adverse Event|0|||
124858907|NCT00718718|449106104|FG004|Prior to Week 12|Adverse Event|0|||
124858908|NCT00718718|449106105|FG005|Prior to Week 12|Adverse Event|0|||
124858909|NCT00718718|449106106|FG006|Prior to Week 12|Adverse Event|0|||
124858910|NCT00718718|449106107|FG007|Prior to Week 12|Adverse Event|1|||
124858911|NCT00718718|449106108|FG008|Prior to Week 12|Adverse Event|1|||
124858912|NCT00718718|449106109|FG009|Prior to Week 12|Adverse Event|0|||
124858913|NCT00718718|449106100|FG000|Prior to Week 12|Withdrawal by Subject|0|||
124858914|NCT00718718|449106101|FG001|Prior to Week 12|Withdrawal by Subject|0|||
124858915|NCT00718718|449106102|FG002|Prior to Week 12|Withdrawal by Subject|0|||
124858916|NCT00718718|449106103|FG003|Prior to Week 12|Withdrawal by Subject|0|||
124858917|NCT00718718|449106104|FG004|Prior to Week 12|Withdrawal by Subject|3|||
124858918|NCT00718718|449106105|FG005|Prior to Week 12|Withdrawal by Subject|0|||
124858919|NCT00718718|449106106|FG006|Prior to Week 12|Withdrawal by Subject|1|||
124858920|NCT00718718|449106107|FG007|Prior to Week 12|Withdrawal by Subject|1|||
124858921|NCT00718718|449106108|FG008|Prior to Week 12|Withdrawal by Subject|1|||
124858922|NCT00718718|449106109|FG009|Prior to Week 12|Withdrawal by Subject|0|||
124858923|NCT00718718|449106100|FG000|Prior to Week 12|Other|1|||
124858924|NCT00718718|449106101|FG001|Prior to Week 12|Other|0|||
124858925|NCT00718718|449106102|FG002|Prior to Week 12|Other|1|||
124858926|NCT00718718|449106103|FG003|Prior to Week 12|Other|0|||
124858927|NCT00718718|449106104|FG004|Prior to Week 12|Other|0|||
124858928|NCT00718718|449106105|FG005|Prior to Week 12|Other|0|||
124858929|NCT00718718|449106106|FG006|Prior to Week 12|Other|0|||
124858930|NCT00718718|449106107|FG007|Prior to Week 12|Other|0|||
124858931|NCT00718718|449106108|FG008|Prior to Week 12|Other|0|||
124858932|NCT00718718|449106109|FG009|Prior to Week 12|Other|0|||
124858933|NCT00718718|449106100|FG000|Week 12 to End of Study|Adverse Event|0|||
124858934|NCT00718718|449106101|FG001|Week 12 to End of Study|Adverse Event|0|||
124858935|NCT00718718|449106102|FG002|Week 12 to End of Study|Adverse Event|0|||
124858936|NCT00718718|449106103|FG003|Week 12 to End of Study|Adverse Event|0|||
124858937|NCT00718718|449106104|FG004|Week 12 to End of Study|Adverse Event|0|||
124858938|NCT00718718|449106105|FG005|Week 12 to End of Study|Adverse Event|0|||
124858939|NCT00718718|449106106|FG006|Week 12 to End of Study|Adverse Event|0|||
124858940|NCT00718718|449106107|FG007|Week 12 to End of Study|Adverse Event|1|||
124858941|NCT00718718|449106108|FG008|Week 12 to End of Study|Adverse Event|0|||
124858942|NCT00718718|449106109|FG009|Week 12 to End of Study|Adverse Event|0|||
124858943|NCT00718718|449106100|FG000|Week 12 to End of Study|Death|0|||
124858944|NCT00718718|449106101|FG001|Week 12 to End of Study|Death|0|||
124858945|NCT00718718|449106102|FG002|Week 12 to End of Study|Death|0|||
124858946|NCT00718718|449106103|FG003|Week 12 to End of Study|Death|0|||
124858947|NCT00718718|449106104|FG004|Week 12 to End of Study|Death|0|||
124858948|NCT00718718|449106105|FG005|Week 12 to End of Study|Death|1|||
124858949|NCT00718718|449106106|FG006|Week 12 to End of Study|Death|0|||
124858950|NCT00718718|449106107|FG007|Week 12 to End of Study|Death|0|||
124858951|NCT00718718|449106108|FG008|Week 12 to End of Study|Death|0|||
124858952|NCT00718718|449106109|FG009|Week 12 to End of Study|Death|0|||
124858953|NCT00718718|449106100|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
124858954|NCT00718718|449106101|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
124858955|NCT00718718|449106102|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
124858956|NCT00718718|449106103|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
124858957|NCT00718718|449106104|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
124858958|NCT00718718|449106105|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
124858959|NCT00718718|449106106|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
124858960|NCT00718718|449106107|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
124858961|NCT00718718|449106108|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
124858962|NCT00718718|449106109|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
124858963|NCT00718718|449106100|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
124858964|NCT00718718|449106101|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
124858965|NCT00718718|449106102|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
124858966|NCT00718718|449106103|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
124858967|NCT00718718|449106104|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
124858968|NCT00718718|449106105|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
124858969|NCT00718718|449106106|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
124858970|NCT00718718|449106107|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
124858971|NCT00718718|449106108|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
124858972|NCT00718718|449106109|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
124858973|NCT00718718|449106100|FG000|Week 12 to End of Study|Other|0|||
124858974|NCT00718718|449106101|FG001|Week 12 to End of Study|Other|1|||
124858975|NCT00718718|449106102|FG002|Week 12 to End of Study|Other|0|||
124858976|NCT00718718|449106103|FG003|Week 12 to End of Study|Other|1|||
124858977|NCT00718718|449106104|FG004|Week 12 to End of Study|Other|0|||
124858978|NCT00718718|449106105|FG005|Week 12 to End of Study|Other|0|||
124858979|NCT00718718|449106106|FG006|Week 12 to End of Study|Other|1|||
124858980|NCT00718718|449106107|FG007|Week 12 to End of Study|Other|0|||
124858981|NCT00718718|449106108|FG008|Week 12 to End of Study|Other|0|||
124858982|NCT00718718|449106109|FG009|Week 12 to End of Study|Other|0|||
124858983|NCT04558346|449106118|FG000|Overall Study|Withdrawal by Subject|2|||
124858984|NCT04558346|449106119|FG001|Overall Study|Withdrawal by Subject|0|||
124858985|NCT04558346|449106118|FG000|Overall Study|Lost to Follow-up|0|||
124858986|NCT04558346|449106119|FG001|Overall Study|Lost to Follow-up|1|||
124858987|NCT04558346|449106118|FG000|Overall Study|Adverse Event|0|||
124858988|NCT04558346|449106119|FG001|Overall Study|Adverse Event|1|||
124858989|NCT01462344|449106120|FG000|Overall Study|Withdrawal by Subject|245|||
124858990|NCT01462344|449106121|FG001|Overall Study|Withdrawal by Subject|226|||
124858991|NCT01462344|449106120|FG000|Overall Study|Adverse Event|24|||
124858992|NCT01462344|449106121|FG001|Overall Study|Adverse Event|23|||
124858993|NCT01462344|449106120|FG000|Overall Study|Asthma Exacerbation|34|||
124858994|NCT01462344|449106121|FG001|Overall Study|Asthma Exacerbation|35|||
124858995|NCT01462344|449106120|FG000|Overall Study|Lack of Efficacy|5|||
124858996|NCT01462344|449106121|FG001|Overall Study|Lack of Efficacy|6|||
124858997|NCT01462344|449106120|FG000|Overall Study|Protocol Violation|68|||
124858998|NCT01462344|449106121|FG001|Overall Study|Protocol Violation|53|||
124858999|NCT01462344|449106120|FG000|Overall Study|Lost to Follow-up|7|||
124859000|NCT01462344|449106121|FG001|Overall Study|Lost to Follow-up|7|||
124859001|NCT00724971|449106122|FG000|Overall Study|Adverse Event|5|||
124859002|NCT00724971|449106122|FG000|Overall Study|Withdrawal by Subject|1|||
124859003|NCT01003249|449106123|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
124859004|NCT01003249|449106124|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
124859005|NCT01003249|449106123|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
124859006|NCT01003249|449106124|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
124859007|NCT01003249|449106123|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
124859008|NCT01003249|449106124|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
124859009|NCT01003249|449106123|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
124859010|NCT01003249|449106124|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
124859011|NCT01962974|449106127|FG000|Overall Study|Study termination|7|||
124859012|NCT01692197|449106128|FG000|Overall Study|Failed Screening|3|||
124859013|NCT02276482|449106136|FG000|Overall Study|Adverse Event|1|||
124859014|NCT02276482|449106137|FG001|Overall Study|Adverse Event|0|||
124859015|NCT02276482|449106136|FG000|Overall Study|Withdrawal by Subject|1|||
124859016|NCT02276482|449106137|FG001|Overall Study|Withdrawal by Subject|0|||
124859017|NCT02276482|449106136|FG000|Overall Study|Gram-negative infection|1|||
124859018|NCT02276482|449106137|FG001|Overall Study|Gram-negative infection|0|||
124859019|NCT02276482|449106136|FG000|Overall Study|Reason not specified|0|||
124859020|NCT02276482|449106137|FG001|Overall Study|Reason not specified|1|||
124859021|NCT01165281|449106143|FG000|Overall Study|Adverse Event|12|||
124859022|NCT01165281|449106144|FG001|Overall Study|Adverse Event|14|||
124859023|NCT01165281|449106143|FG000|Overall Study|Death|3|||
124859024|NCT01165281|449106144|FG001|Overall Study|Death|4|||
124859025|NCT01165281|449106143|FG000|Overall Study|Lack of Efficacy|4|||
124859026|NCT01165281|449106144|FG001|Overall Study|Lack of Efficacy|1|||
124859027|NCT01165281|449106143|FG000|Overall Study|Lost to Follow-up|0|||
124859028|NCT01165281|449106144|FG001|Overall Study|Lost to Follow-up|1|||
124859029|NCT01165281|449106143|FG000|Overall Study|Physician Decision|8|||
124859030|NCT01165281|449106144|FG001|Overall Study|Physician Decision|1|||
124859031|NCT01165281|449106143|FG000|Overall Study|Protocol Violation|6|||
124859032|NCT01165281|449106144|FG001|Overall Study|Protocol Violation|5|||
124859033|NCT01165281|449106143|FG000|Overall Study|Withdrawal by Subject|8|||
124859034|NCT01165281|449106144|FG001|Overall Study|Withdrawal by Subject|7|||
124859035|NCT01165281|449106143|FG000|Overall Study|Noncompliance with Study Drug|1|||
124859036|NCT01165281|449106144|FG001|Overall Study|Noncompliance with Study Drug|4|||
124859037|NCT01165281|449106143|FG000|Overall Study|Progressive Disease|10|||
124859038|NCT01165281|449106144|FG001|Overall Study|Progressive Disease|14|||
124859039|NCT01165281|449106143|FG000|Overall Study|Other|6|||
124859040|NCT01165281|449106144|FG001|Overall Study|Other|0|||
124859041|NCT00363766|449106149|FG000|Overall Study|Progressive Disease|15|||
124859042|NCT00363766|449106150|FG001|Overall Study|Progressive Disease|9|||
124859043|NCT00363766|449106149|FG000|Overall Study|Adverse Event|10|||
124859044|NCT00363766|449106150|FG001|Overall Study|Adverse Event|2|||
124859045|NCT00363766|449106149|FG000|Overall Study|Disease Related Death|1|||
124859046|NCT00363766|449106150|FG001|Overall Study|Disease Related Death|3|||
124859047|NCT00363766|449106149|FG000|Overall Study|Not Disease Related Death|3|||
124859048|NCT00363766|449106150|FG001|Overall Study|Not Disease Related Death|4|||
124859049|NCT00363766|449106149|FG000|Overall Study|Withdrawal by Subject|2|||
124859050|NCT00363766|449106150|FG001|Overall Study|Withdrawal by Subject|0|||
124859051|NCT00363766|449106149|FG000|Overall Study|Physician Decision|1|||
124859052|NCT00363766|449106150|FG001|Overall Study|Physician Decision|2|||
124859053|NCT00558285|449106151|FG000|Overall Study|Adverse Event|1|||
124859054|NCT00558285|449106152|FG001|Overall Study|Adverse Event|1|||
124859055|NCT00558285|449106153|FG002|Overall Study|Adverse Event|4|||
124859056|NCT00558285|449106154|FG003|Overall Study|Adverse Event|1|||
124859057|NCT00558285|449106155|FG004|Overall Study|Adverse Event|2|||
124859058|NCT00558285|449106151|FG000|Overall Study|Abnormal test procedure result(s)|1|||
124859059|NCT00558285|449106152|FG001|Overall Study|Abnormal test procedure result(s)|0|||
124859060|NCT00558285|449106153|FG002|Overall Study|Abnormal test procedure result(s)|0|||
124859061|NCT00558285|449106154|FG003|Overall Study|Abnormal test procedure result(s)|0|||
124859062|NCT00558285|449106155|FG004|Overall Study|Abnormal test procedure result(s)|0|||
124859063|NCT00558285|449106151|FG000|Overall Study|Subject withdrew consent|2|||
124859064|NCT00558285|449106152|FG001|Overall Study|Subject withdrew consent|0|||
124859065|NCT00558285|449106153|FG002|Overall Study|Subject withdrew consent|1|||
124859066|NCT00558285|449106154|FG003|Overall Study|Subject withdrew consent|1|||
124859067|NCT00558285|449106155|FG004|Overall Study|Subject withdrew consent|1|||
124859068|NCT00558285|449106151|FG000|Overall Study|Lost to Follow-up|1|||
124859069|NCT00558285|449106152|FG001|Overall Study|Lost to Follow-up|1|||
124859070|NCT00558285|449106153|FG002|Overall Study|Lost to Follow-up|0|||
124859071|NCT00558285|449106154|FG003|Overall Study|Lost to Follow-up|0|||
124859072|NCT00558285|449106155|FG004|Overall Study|Lost to Follow-up|0|||
124859073|NCT00558285|449106151|FG000|Overall Study|Administrative problems|0|||
124859074|NCT00558285|449106152|FG001|Overall Study|Administrative problems|0|||
124859075|NCT00558285|449106153|FG002|Overall Study|Administrative problems|0|||
124859076|NCT00558285|449106154|FG003|Overall Study|Administrative problems|1|||
124859077|NCT00558285|449106155|FG004|Overall Study|Administrative problems|1|||
124859078|NCT00558285|449106151|FG000|Overall Study|Protocol deviation|1|||
124859079|NCT00558285|449106152|FG001|Overall Study|Protocol deviation|1|||
124859080|NCT00558285|449106153|FG002|Overall Study|Protocol deviation|0|||
124859081|NCT00558285|449106154|FG003|Overall Study|Protocol deviation|1|||
124859082|NCT00558285|449106155|FG004|Overall Study|Protocol deviation|0|||
124859083|NCT02730819|449106156|FG000|Overall Study|Lost to Follow-up|9|||
124859084|NCT02121847|449106158|FG000|Overall Study|Administrative Reasons|1|||
124859085|NCT02121847|449106158|FG000|Overall Study|Adverse Event|2|||
124859086|NCT01660906|449106159|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
124859087|NCT00809757|449106165|FG000|Overall Study|Adverse Event|2|||
124859088|NCT00809757|449106166|FG001|Overall Study|Adverse Event|3|||
124859089|NCT00809757|449106167|FG002|Overall Study|Adverse Event|3|||
124859090|NCT00809757|449106165|FG000|Overall Study|Lost to Follow-up|0|||
124859091|NCT00809757|449106166|FG001|Overall Study|Lost to Follow-up|0|||
124859092|NCT00809757|449106167|FG002|Overall Study|Lost to Follow-up|1|||
124859093|NCT00809757|449106165|FG000|Overall Study|Protocol Violation|1|||
124859094|NCT00809757|449106166|FG001|Overall Study|Protocol Violation|1|||
124859095|NCT00809757|449106167|FG002|Overall Study|Protocol Violation|1|||
124859096|NCT00809757|449106165|FG000|Overall Study|Withdrawal by Subject|2|||
124859097|NCT00809757|449106166|FG001|Overall Study|Withdrawal by Subject|1|||
124859098|NCT00809757|449106167|FG002|Overall Study|Withdrawal by Subject|3|||
124859099|NCT00809757|449106165|FG000|Overall Study|Subject Uncooperative|1|||
124859100|NCT00809757|449106166|FG001|Overall Study|Subject Uncooperative|0|||
124859101|NCT00809757|449106167|FG002|Overall Study|Subject Uncooperative|2|||
124859102|NCT00809757|449106165|FG000|Overall Study|Noncompliance with Medication|0|||
124859103|NCT00809757|449106166|FG001|Overall Study|Noncompliance with Medication|0|||
124859104|NCT00809757|449106167|FG002|Overall Study|Noncompliance with Medication|1|||
124859105|NCT00253864|449106168|FG000|Overall Study|Lost to Follow-up|5|||
124859106|NCT00253864|449106169|FG001|Overall Study|Lost to Follow-up|8|||
124859107|NCT00659334|449106170|FG000|Overall Study|Screen Failure|8|||
124859108|NCT00659334|449106171|FG001|Overall Study|Screen Failure|5|||
124859109|NCT00659334|449106172|FG002|Overall Study|Screen Failure|0|||
124859110|NCT00659334|449106173|FG003|Overall Study|Screen Failure|0|||
124859111|NCT00659334|449106174|FG004|Overall Study|Screen Failure|0|||
124859112|NCT00659334|449106175|FG005|Overall Study|Screen Failure|0|||
124859113|NCT00659334|449106176|FG006|Overall Study|Screen Failure|1|||
124859114|NCT01174342|449106180|FG000|Overall Study|Conversion to cesarean section|4|||
124859115|NCT01410448|449106181|FG000|Overall Study|No conversion to everolimus|0|||
124859116|NCT01410448|449106182|FG001|Overall Study|No conversion to everolimus|24|||
124859117|NCT01410448|449106181|FG000|Overall Study|Graft loss|4|||
124859118|NCT01410448|449106182|FG001|Overall Study|Graft loss|1|||
124859119|NCT01410448|449106181|FG000|Overall Study|Administrative issues|2|||
124859120|NCT01410448|449106182|FG001|Overall Study|Administrative issues|1|||
124859121|NCT01410448|449106181|FG000|Overall Study|Lost to Follow-up|1|||
124859122|NCT01410448|449106182|FG001|Overall Study|Lost to Follow-up|0|||
124859123|NCT01410448|449106181|FG000|Overall Study|Withdrawal by Subject|3|||
124859124|NCT01410448|449106182|FG001|Overall Study|Withdrawal by Subject|2|||
124859125|NCT01410448|449106181|FG000|Overall Study|Protocol Violation|0|||
124859126|NCT01410448|449106182|FG001|Overall Study|Protocol Violation|4|||
124859127|NCT01410448|449106181|FG000|Overall Study|Death|2|||
124859128|NCT01410448|449106182|FG001|Overall Study|Death|3|||
124859129|NCT01308580|449106183|FG000|Overall Study|Lost to Follow-up|12|||
124859130|NCT01308580|449106184|FG001|Overall Study|Lost to Follow-up|7|||
124859131|NCT00360529|449106185|FG000|Overall Study|Adverse Event|10|||
124859132|NCT00360529|449106186|FG001|Overall Study|Adverse Event|23|||
124859133|NCT00360529|449106187|FG002|Overall Study|Adverse Event|33|||
124859134|NCT00360529|449106185|FG000|Overall Study|Protocol Violation|3|||
124859135|NCT00360529|449106186|FG001|Overall Study|Protocol Violation|3|||
124859136|NCT00360529|449106187|FG002|Overall Study|Protocol Violation|11|||
124859137|NCT00360529|449106185|FG000|Overall Study|Lost to Follow-up|14|||
124859138|NCT00360529|449106186|FG001|Overall Study|Lost to Follow-up|10|||
124859139|NCT00360529|449106187|FG002|Overall Study|Lost to Follow-up|13|||
124859140|NCT00360529|449106185|FG000|Overall Study|Withdrawal by Subject|22|||
124859141|NCT00360529|449106186|FG001|Overall Study|Withdrawal by Subject|14|||
124859142|NCT00360529|449106187|FG002|Overall Study|Withdrawal by Subject|18|||
124859143|NCT00360529|449106185|FG000|Overall Study|Lack of Efficacy|8|||
124859144|NCT00360529|449106186|FG001|Overall Study|Lack of Efficacy|6|||
124859145|NCT00360529|449106187|FG002|Overall Study|Lack of Efficacy|5|||
124859146|NCT00360529|449106185|FG000|Overall Study|Reason discontinued not explained above|4|||
124859147|NCT00360529|449106186|FG001|Overall Study|Reason discontinued not explained above|9|||
124859148|NCT00360529|449106187|FG002|Overall Study|Reason discontinued not explained above|11|||
124859149|NCT03712917|449106188|FG000|Overall Study|Pregnancy|0|||
124859150|NCT03712917|449106189|FG001|Overall Study|Pregnancy|0|||
124859151|NCT03712917|449106190|FG002|Overall Study|Pregnancy|1|||
124859152|NCT03712917|449106188|FG000|Overall Study|Adverse Event|0|||
124859153|NCT03712917|449106189|FG001|Overall Study|Adverse Event|4|||
124859154|NCT03712917|449106190|FG002|Overall Study|Adverse Event|3|||
124859155|NCT03712917|449106188|FG000|Overall Study|Lost to Follow-up|9|||
124859156|NCT03712917|449106189|FG001|Overall Study|Lost to Follow-up|4|||
124859157|NCT03712917|449106190|FG002|Overall Study|Lost to Follow-up|5|||
124859158|NCT01218438|449106191|FG000|Epoch 1|Physician Decision|2|||
124859159|NCT01218438|449106191|FG000|Epoch 1|Adverse Event|1|||
124859160|NCT01218438|449106191|FG000|Epoch 3|Withdrawal by Subject|3|||
124859161|NCT01218438|449106191|FG000|Epoch 3|Adverse Event|1|||
124859162|NCT01218438|449106191|FG000|Epoch 4|Physician Decision|1|||
124859163|NCT01218438|449106191|FG000|Epoch 4|Withdrawal by Subject|2|||
124859164|NCT01218646|449106193|FG000|Overall Study|Adverse Event|0|||
124859165|NCT01218646|449106194|FG001|Overall Study|Adverse Event|0|||
124859166|NCT01218646|449106195|FG002|Overall Study|Adverse Event|1|||
124859167|NCT01218646|449106196|FG003|Overall Study|Adverse Event|0|||
124859168|NCT01218646|449106193|FG000|Overall Study|Lost to Follow-up|1|||
124859169|NCT01218646|449106194|FG001|Overall Study|Lost to Follow-up|0|||
124859170|NCT01218646|449106195|FG002|Overall Study|Lost to Follow-up|0|||
124859171|NCT01218646|449106196|FG003|Overall Study|Lost to Follow-up|0|||
124859172|NCT01218646|449106193|FG000|Overall Study|Protocol Violation|0|||
124859173|NCT01218646|449106194|FG001|Overall Study|Protocol Violation|0|||
124859174|NCT01218646|449106195|FG002|Overall Study|Protocol Violation|1|||
124859175|NCT01218646|449106196|FG003|Overall Study|Protocol Violation|1|||
124859176|NCT05437510|449106199|FG000|Overall Study|Adverse Event|1|||
124859177|NCT05437510|449106200|FG001|Overall Study|Adverse Event|1|||
124859178|NCT05437510|449106199|FG000|Overall Study|Protocol Deviation|1|||
124859179|NCT05437510|449106200|FG001|Overall Study|Protocol Deviation|6|||
124859180|NCT05437510|449106199|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
124859181|NCT05437510|449106200|FG001|Overall Study|Withdrawal by Parent/Guardian|22|||
124859182|NCT05437510|449106199|FG000|Overall Study|Lost to Follow-up|219|||
124859183|NCT05437510|449106200|FG001|Overall Study|Lost to Follow-up|289|||
124859184|NCT05437510|449106199|FG000|Overall Study|Ongoing in the Study Extension|1387|||
124859185|NCT05437510|449106200|FG001|Overall Study|Ongoing in the Study Extension|1352|||
124859186|NCT05706506|449108225|FG000|Overall Study|Adverse Event|1|||
124859187|NCT05706506|449108225|FG000|Overall Study|Withdrawal by Subject|4|||
124859188|NCT05706506|449108225|FG000|Overall Study|Lost to Follow-up|2|||
124859189|NCT05706506|449108225|FG000|Overall Study|Inadvertent Enrolment|12|||
124859190|NCT05706506|449108225|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
124859191|NCT05706506|449108225|FG000|Overall Study|Participant Moved Out of State|1|||
124859192|NCT00838110|449108226|FG000|Overall Study|Death|0|||
124859193|NCT00838110|449108227|FG001|Overall Study|Death|0|||
124859194|NCT00838110|449108228|FG002|Overall Study|Death|1|||
124859195|NCT00838110|449108229|FG003|Overall Study|Death|2|||
124859196|NCT00838110|449108226|FG000|Overall Study|Adverse Event|11|||
124859197|NCT00838110|449108227|FG001|Overall Study|Adverse Event|10|||
124859198|NCT00838110|449108228|FG002|Overall Study|Adverse Event|8|||
124859199|NCT00838110|449108229|FG003|Overall Study|Adverse Event|7|||
124859200|NCT00838110|449108226|FG000|Overall Study|Withdrawal by Subject|5|||
124859201|NCT00838110|449108227|FG001|Overall Study|Withdrawal by Subject|6|||
124859202|NCT00838110|449108228|FG002|Overall Study|Withdrawal by Subject|3|||
124859203|NCT00838110|449108229|FG003|Overall Study|Withdrawal by Subject|4|||
124859204|NCT00838110|449108226|FG000|Overall Study|Other|3|||
124859205|NCT00838110|449108227|FG001|Overall Study|Other|3|||
124859206|NCT00838110|449108228|FG002|Overall Study|Other|3|||
124859207|NCT00838110|449108229|FG003|Overall Study|Other|2|||
124859208|NCT00838110|449108226|FG000|Overall Study|Protocol Violation|0|||
124859209|NCT00838110|449108227|FG001|Overall Study|Protocol Violation|2|||
124859210|NCT00838110|449108228|FG002|Overall Study|Protocol Violation|1|||
124859211|NCT00838110|449108229|FG003|Overall Study|Protocol Violation|1|||
124859212|NCT00838110|449108226|FG000|Overall Study|Lost to Follow-up|3|||
124859213|NCT00838110|449108227|FG001|Overall Study|Lost to Follow-up|0|||
124859214|NCT00838110|449108228|FG002|Overall Study|Lost to Follow-up|0|||
124859215|NCT00838110|449108229|FG003|Overall Study|Lost to Follow-up|0|||
124859216|NCT00838110|449108226|FG000|Overall Study|Did not meet eligibility criteria|0|||
124859217|NCT00838110|449108227|FG001|Overall Study|Did not meet eligibility criteria|0|||
124859218|NCT00838110|449108228|FG002|Overall Study|Did not meet eligibility criteria|1|||
124859219|NCT00838110|449108229|FG003|Overall Study|Did not meet eligibility criteria|2|||
124859220|NCT00838110|449108226|FG000|Overall Study|Randomized but not treated|0|||
124859221|NCT00838110|449108227|FG001|Overall Study|Randomized but not treated|1|||
124859222|NCT00838110|449108228|FG002|Overall Study|Randomized but not treated|0|||
124859223|NCT00838110|449108229|FG003|Overall Study|Randomized but not treated|0|||
124859224|NCT03240588|449108231|FG000|Overall Study|Death|3|||
124859225|NCT03240588|449108232|FG001|Overall Study|Death|0|||
124859226|NCT03240588|449108233|FG002|Overall Study|Death|0|||
124859227|NCT03240588|449108231|FG000|Overall Study|Adverse Event|5|||
124859228|NCT03240588|449108232|FG001|Overall Study|Adverse Event|4|||
124859229|NCT03240588|449108233|FG002|Overall Study|Adverse Event|0|||
124859230|NCT03240588|449108231|FG000|Overall Study|Lost to Follow-up|9|||
124859231|NCT03240588|449108232|FG001|Overall Study|Lost to Follow-up|4|||
124859232|NCT03240588|449108233|FG002|Overall Study|Lost to Follow-up|0|||
124859233|NCT03240588|449108231|FG000|Overall Study|Physician Decision|3|||
124859234|NCT03240588|449108232|FG001|Overall Study|Physician Decision|2|||
124859235|NCT03240588|449108233|FG002|Overall Study|Physician Decision|0|||
124859236|NCT03240588|449108231|FG000|Overall Study|Did not meet eligibility criteria|0|||
124859237|NCT03240588|449108232|FG001|Overall Study|Did not meet eligibility criteria|6|||
124859238|NCT03240588|449108233|FG002|Overall Study|Did not meet eligibility criteria|0|||
124859239|NCT03240588|449108231|FG000|Overall Study|No longer meets protocol criteria|12|||
124859240|NCT03240588|449108232|FG001|Overall Study|No longer meets protocol criteria|7|||
124859241|NCT03240588|449108233|FG002|Overall Study|No longer meets protocol criteria|0|||
124859242|NCT03240588|449108231|FG000|Overall Study|Withdrawal by Subject|60|||
124859243|NCT03240588|449108232|FG001|Overall Study|Withdrawal by Subject|52|||
124859244|NCT03240588|449108233|FG002|Overall Study|Withdrawal by Subject|7|||
124859245|NCT03240588|449108231|FG000|Overall Study|Other, additional details not available.|0|||
124859246|NCT03240588|449108232|FG001|Overall Study|Other, additional details not available.|12|||
124859247|NCT03240588|449108233|FG002|Overall Study|Other, additional details not available.|1|||
124859248|NCT03240588|449108231|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
124859249|NCT03240588|449108232|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
124859250|NCT03240588|449108233|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
124859251|NCT03240588|449108231|FG000|Overall Study|Closure of study|55|||
124859252|NCT03240588|449108232|FG001|Overall Study|Closure of study|3|||
124859253|NCT03240588|449108233|FG002|Overall Study|Closure of study|0|||
124859254|NCT03240588|449108231|FG000|Overall Study|Subject non-compliance|23|||
124859255|NCT03240588|449108232|FG001|Overall Study|Subject non-compliance|2|||
124859256|NCT03240588|449108233|FG002|Overall Study|Subject non-compliance|1|||
124859257|NCT03240588|449108231|FG000|Overall Study|Device Deficiency|1|||
124859258|NCT03240588|449108232|FG001|Overall Study|Device Deficiency|0|||
124859259|NCT03240588|449108233|FG002|Overall Study|Device Deficiency|0|||
124859260|NCT03240588|449108231|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
124859261|NCT03240588|449108232|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
124859262|NCT03240588|449108233|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
124859263|NCT01914926|449108234|FG000|Overall Study|Adverse Event|1|||
124859264|NCT01914926|449108235|FG001|Overall Study|Adverse Event|0|||
124859265|NCT01914926|449108234|FG000|Overall Study|uncooperative, agitated and removed|0|||
124859266|NCT01914926|449108235|FG001|Overall Study|uncooperative, agitated and removed|1|||
124859267|NCT00467870|449108236|FG000|Overall Study|Adverse Event|13|||
124859268|NCT00467870|449108237|FG001|Overall Study|Adverse Event|9|||
124859269|NCT00467870|449108238|FG002|Overall Study|Adverse Event|1|||
124859270|NCT00467870|449108239|FG003|Overall Study|Adverse Event|15|||
124859271|NCT00467870|449108240|FG004|Overall Study|Adverse Event|15|||
124859272|NCT00467870|449108241|FG005|Overall Study|Adverse Event|1|||
124859273|NCT00467870|449108236|FG000|Overall Study|Protocol Violation|2|||
124859274|NCT00467870|449108237|FG001|Overall Study|Protocol Violation|1|||
124859275|NCT00467870|449108238|FG002|Overall Study|Protocol Violation|1|||
124859276|NCT00467870|449108239|FG003|Overall Study|Protocol Violation|2|||
124859277|NCT00467870|449108240|FG004|Overall Study|Protocol Violation|0|||
124859278|NCT00467870|449108241|FG005|Overall Study|Protocol Violation|0|||
124859279|NCT00467870|449108236|FG000|Overall Study|Withdrawal by Subject|14|||
124859280|NCT00467870|449108237|FG001|Overall Study|Withdrawal by Subject|21|||
124859281|NCT00467870|449108238|FG002|Overall Study|Withdrawal by Subject|0|||
124859282|NCT00467870|449108239|FG003|Overall Study|Withdrawal by Subject|9|||
124859283|NCT00467870|449108240|FG004|Overall Study|Withdrawal by Subject|10|||
124859284|NCT00467870|449108241|FG005|Overall Study|Withdrawal by Subject|1|||
124859285|NCT00467870|449108236|FG000|Overall Study|Lost to Follow-up|5|||
124859286|NCT00467870|449108237|FG001|Overall Study|Lost to Follow-up|3|||
124859287|NCT00467870|449108238|FG002|Overall Study|Lost to Follow-up|1|||
124859288|NCT00467870|449108239|FG003|Overall Study|Lost to Follow-up|1|||
124859289|NCT00467870|449108240|FG004|Overall Study|Lost to Follow-up|3|||
124859290|NCT00467870|449108241|FG005|Overall Study|Lost to Follow-up|0|||
124859291|NCT00467870|449108236|FG000|Overall Study|Subject Non-compliance|3|||
124859292|NCT00467870|449108237|FG001|Overall Study|Subject Non-compliance|4|||
124859293|NCT00467870|449108238|FG002|Overall Study|Subject Non-compliance|0|||
124859294|NCT00467870|449108239|FG003|Overall Study|Subject Non-compliance|1|||
124859295|NCT00467870|449108240|FG004|Overall Study|Subject Non-compliance|5|||
124859296|NCT00467870|449108241|FG005|Overall Study|Subject Non-compliance|0|||
124859297|NCT00467870|449108236|FG000|Overall Study|Other/Unknown|8|||
124859298|NCT00467870|449108237|FG001|Overall Study|Other/Unknown|5|||
124859299|NCT00467870|449108238|FG002|Overall Study|Other/Unknown|1|||
124859300|NCT00467870|449108239|FG003|Overall Study|Other/Unknown|5|||
124859301|NCT00467870|449108240|FG004|Overall Study|Other/Unknown|4|||
124859302|NCT00467870|449108241|FG005|Overall Study|Other/Unknown|0|||
124859303|NCT00321919|449108242|FG000|Overall Study|Adverse Event|17|||
124859304|NCT00321919|449108243|FG001|Overall Study|Adverse Event|10|||
124859305|NCT00321919|449108242|FG000|Overall Study|Death|21|||
124859306|NCT00321919|449108243|FG001|Overall Study|Death|17|||
124859307|NCT00321919|449108242|FG000|Overall Study|Insufficient Therapeutic Response|1|||
124859308|NCT00321919|449108243|FG001|Overall Study|Insufficient Therapeutic Response|0|||
124859309|NCT00321919|449108242|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
124859310|NCT00321919|449108243|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
124859311|NCT00321919|449108242|FG000|Overall Study|Refused Treatment|23|||
124859312|NCT00321919|449108243|FG001|Overall Study|Refused Treatment|14|||
124859313|NCT00321919|449108242|FG000|Overall Study|Other Protocol Violation|2|||
124859314|NCT00321919|449108243|FG001|Overall Study|Other Protocol Violation|3|||
124859315|NCT00321919|449108242|FG000|Overall Study|Failure to Return|3|||
124859316|NCT00321919|449108243|FG001|Overall Study|Failure to Return|1|||
124859317|NCT00321919|449108242|FG000|Overall Study|Other withdrawal reason|7|||
124859318|NCT00321919|449108243|FG001|Overall Study|Other withdrawal reason|6|||
124859319|NCT02261363|449108244|FG000|Overall Study|Lost to Follow-up|21|||
124859320|NCT01517802|449108245|FG000|Overall Study|Death|1|||
124859321|NCT02590354|449108246|FG000|Phase 1|Active hepatitis B or C infection|1|||
124859322|NCT02590354|449108246|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
124859323|NCT02590354|449108246|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
124859324|NCT02590354|449108246|FG000|Phase 1|Subject does not want to participate|20|||
124859325|NCT02590354|449108246|FG000|Phase 1|Lost to Follow-up|1|||
124859326|NCT02590354|449108246|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
124859327|NCT00760929|449108247|FG000|Overall Study|Adverse Event|2|||
124859328|NCT00760929|449108248|FG001|Overall Study|Adverse Event|0|||
124859329|NCT00760929|449108249|FG002|Overall Study|Adverse Event|6|||
124859330|NCT00760929|449108250|FG003|Overall Study|Adverse Event|10|||
124859331|NCT00760929|449108247|FG000|Overall Study|Lack of Efficacy|0|||
124859332|NCT00760929|449108248|FG001|Overall Study|Lack of Efficacy|2|||
124859333|NCT00760929|449108249|FG002|Overall Study|Lack of Efficacy|1|||
124859334|NCT00760929|449108250|FG003|Overall Study|Lack of Efficacy|0|||
124859335|NCT00760929|449108247|FG000|Overall Study|Withdrawal by Subject|1|||
124859336|NCT00760929|449108248|FG001|Overall Study|Withdrawal by Subject|0|||
124859337|NCT00760929|449108249|FG002|Overall Study|Withdrawal by Subject|9|||
124859338|NCT00760929|449108250|FG003|Overall Study|Withdrawal by Subject|1|||
124859339|NCT00760929|449108247|FG000|Overall Study|Lost to Follow-up|0|||
124859340|NCT00760929|449108248|FG001|Overall Study|Lost to Follow-up|0|||
124859341|NCT00760929|449108249|FG002|Overall Study|Lost to Follow-up|1|||
124859342|NCT00760929|449108250|FG003|Overall Study|Lost to Follow-up|0|||
124859343|NCT00760929|449108247|FG000|Overall Study|Progression of Disease|21|||
124859344|NCT00760929|449108248|FG001|Overall Study|Progression of Disease|26|||
124859345|NCT00760929|449108249|FG002|Overall Study|Progression of Disease|38|||
124859346|NCT00760929|449108250|FG003|Overall Study|Progression of Disease|42|||
124859347|NCT00760929|449108247|FG000|Overall Study|Other|2|||
124859348|NCT00760929|449108248|FG001|Overall Study|Other|0|||
124859349|NCT00760929|449108249|FG002|Overall Study|Other|2|||
124859350|NCT00760929|449108250|FG003|Overall Study|Other|1|||
124859351|NCT00760929|449108247|FG000|Overall Study|Death|0|||
124859352|NCT00760929|449108248|FG001|Overall Study|Death|0|||
124859353|NCT00760929|449108249|FG002|Overall Study|Death|1|||
124859354|NCT00760929|449108250|FG003|Overall Study|Death|0|||
124859355|NCT00760929|449108247|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
124859356|NCT00760929|449108248|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
124859357|NCT00760929|449108249|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
124859358|NCT00760929|449108250|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
124859359|NCT02099838|449108251|FG000|Overall Study|Death|1|||
124859360|NCT02099838|449108252|FG001|Overall Study|Death|0|||
124859361|NCT02099838|449108251|FG000|Overall Study|Lost to Follow-up|3|||
124859362|NCT02099838|449108252|FG001|Overall Study|Lost to Follow-up|1|||
124859363|NCT02099838|449108251|FG000|Overall Study|Withdrawal by Subject|0|||
124859364|NCT02099838|449108252|FG001|Overall Study|Withdrawal by Subject|1|||
124859365|NCT02301143|449108253|FG000|Induction Period|Enrolled But Not Treated|1|||
124859366|NCT02301143|449108254|FG001|Induction Period|Enrolled But Not Treated|0|||
124859367|NCT02301143|449108253|FG000|Induction Period|Death|1|||
124859368|NCT02301143|449108254|FG001|Induction Period|Death|0|||
124859369|NCT02301143|449108253|FG000|Induction Period|Adverse Event|22|||
124859370|NCT02301143|449108254|FG001|Induction Period|Adverse Event|0|||
124859371|NCT02301143|449108253|FG000|Induction Period|Progressive Disease|8|||
124859372|NCT02301143|449108254|FG001|Induction Period|Progressive Disease|0|||
124859373|NCT02301143|449108253|FG000|Induction Period|Withdrawal by Subject|3|||
124859374|NCT02301143|449108254|FG001|Induction Period|Withdrawal by Subject|0|||
124859375|NCT02301143|449108253|FG000|Induction Period|Noncompliance with Study Drug|1|||
124859376|NCT02301143|449108254|FG001|Induction Period|Noncompliance with Study Drug|0|||
124859377|NCT02301143|449108253|FG000|Induction Period|Physician Decision|4|||
124859378|NCT02301143|449108254|FG001|Induction Period|Physician Decision|0|||
124859379|NCT02301143|449108253|FG000|Induction Period|Symptomatic Deterioration|2|||
124859380|NCT02301143|449108254|FG001|Induction Period|Symptomatic Deterioration|0|||
124859381|NCT02301143|449108253|FG000|Induction Period|Protocol Violation|2|||
124859382|NCT02301143|449108254|FG001|Induction Period|Protocol Violation|0|||
124859383|NCT02301143|449108253|FG000|Induction Period|Other|1|||
124859384|NCT02301143|449108254|FG001|Induction Period|Other|0|||
124859385|NCT02301143|449108253|FG000|Investigator's Choice|Adverse Event|0|||
124859386|NCT02301143|449108254|FG001|Investigator's Choice|Adverse Event|3|||
124859387|NCT02301143|449108253|FG000|Investigator's Choice|Progressive Disease|0|||
124859388|NCT02301143|449108254|FG001|Investigator's Choice|Progressive Disease|3|||
124859389|NCT02301143|449108253|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
124859390|NCT02301143|449108254|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
124859391|NCT02301143|449108253|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
124859392|NCT02301143|449108254|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
124859393|NCT02301143|449108253|FG000|Investigator's Choice|Other|0|||
124859394|NCT02301143|449108254|FG001|Investigator's Choice|Other|1|||
124859395|NCT02301143|449108253|FG000|Investigator's Choice|Unresectable Surgery|0|||
124859396|NCT02301143|449108254|FG001|Investigator's Choice|Unresectable Surgery|1|||
124859397|NCT02536508|449108257|FG000|Overall Study|Withdrawal by Subject|18|||
124859398|NCT02536508|449108258|FG001|Overall Study|Withdrawal by Subject|13|||
124859399|NCT02536508|449108259|FG002|Overall Study|Withdrawal by Subject|7|||
124859400|NCT02536508|449108257|FG000|Overall Study|Adverse Event|14|||
124859401|NCT02536508|449108258|FG001|Overall Study|Adverse Event|13|||
124859402|NCT02536508|449108259|FG002|Overall Study|Adverse Event|6|||
124859403|NCT02536508|449108257|FG000|Overall Study|Lost to Follow-up|12|||
124859404|NCT02536508|449108258|FG001|Overall Study|Lost to Follow-up|4|||
124859405|NCT02536508|449108259|FG002|Overall Study|Lost to Follow-up|0|||
124859406|NCT02536508|449108257|FG000|Overall Study|Lack of Efficacy|3|||
124859407|NCT02536508|449108258|FG001|Overall Study|Lack of Efficacy|5|||
124859408|NCT02536508|449108259|FG002|Overall Study|Lack of Efficacy|4|||
124859409|NCT02536508|449108257|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
124859410|NCT02536508|449108258|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
124859411|NCT02536508|449108259|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
124859412|NCT02536508|449108257|FG000|Overall Study|Physician Decision|0|||
124859413|NCT02536508|449108258|FG001|Overall Study|Physician Decision|4|||
124859414|NCT02536508|449108259|FG002|Overall Study|Physician Decision|2|||
124859415|NCT02536508|449108257|FG000|Overall Study|Major Protocol Deviation|2|||
124859416|NCT02536508|449108258|FG001|Overall Study|Major Protocol Deviation|2|||
124859417|NCT02536508|449108259|FG002|Overall Study|Major Protocol Deviation|2|||
124859418|NCT02536508|449108257|FG000|Overall Study|Administrative Reasons|0|||
124859419|NCT02536508|449108258|FG001|Overall Study|Administrative Reasons|1|||
124859420|NCT02536508|449108259|FG002|Overall Study|Administrative Reasons|0|||
124859421|NCT02460991|449108263|FG000|Overall Study|Withdrawal by Subject|0|||
124859422|NCT02460991|449108264|FG001|Overall Study|Withdrawal by Subject|2|||
124859423|NCT00434057|449108265|FG000|Overall Study|Withdrawal by Subject|1|||
124859424|NCT02473952|449108266|FG000|Overall Study|Adverse Event|2|||
124859425|NCT02473952|449108267|FG001|Overall Study|Adverse Event|2|||
124859426|NCT02473952|449108266|FG000|Overall Study|Withdrawal by Subject|0|||
124859427|NCT02473952|449108267|FG001|Overall Study|Withdrawal by Subject|6|||
124859428|NCT00455195|449108268|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
124859429|NCT00455195|449108269|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
124859430|NCT00455195|449108268|FG000|Double-blind Study AGLU02704|Death|1|||
124859431|NCT00455195|449108269|FG001|Double-blind Study AGLU02704|Death|0|||
124859432|NCT00455195|449108268|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
124859433|NCT00455195|449108269|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
124859434|NCT00455195|449108268|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
124859435|NCT00455195|449108269|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
124859436|NCT02117570|449108270|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
124859437|NCT02117570|449108271|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
124859438|NCT02117570|449108272|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
124859439|NCT02117570|449108270|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
124859440|NCT02117570|449108271|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
124859441|NCT02117570|449108272|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
124859442|NCT02117570|449108270|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
124859443|NCT02117570|449108271|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
124859444|NCT02117570|449108272|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
124859445|NCT02117570|449108270|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
124859446|NCT02117570|449108271|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
124859447|NCT02117570|449108272|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
124859448|NCT02117570|449108270|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
124859449|NCT02117570|449108271|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
124859450|NCT02117570|449108272|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
124859451|NCT02117570|449108270|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
124859452|NCT02117570|449108271|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
124859453|NCT02117570|449108272|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
124859454|NCT02117570|449108270|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
124859455|NCT02117570|449108271|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
124859456|NCT02117570|449108272|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
124859457|NCT02508311|449108275|FG000|Overall Study|Withdrawal by Subject|1|||
124859458|NCT02508311|449108276|FG001|Overall Study|Withdrawal by Subject|0|||
124859459|NCT02169674|449108277|FG000|Overall Study|Withdrawal by Subject|2|||
124859460|NCT02169674|449108278|FG001|Overall Study|Withdrawal by Subject|1|||
124859461|NCT02169674|449108277|FG000|Overall Study|Seroprotected|30|||
124859462|NCT02169674|449108278|FG001|Overall Study|Seroprotected|76|||
124859463|NCT02169674|449108277|FG000|Overall Study|Lost to Follow-up|0|||
124859464|NCT02169674|449108278|FG001|Overall Study|Lost to Follow-up|1|||
124859465|NCT03349710|449108279|FG000|Treatment Period|Death|0|||
124859466|NCT03349710|449108280|FG001|Treatment Period|Death|0|||
124859467|NCT03349710|449108281|FG002|Treatment Period|Death|1|||
124859468|NCT03349710|449108282|FG003|Treatment Period|Death|0|||
124859469|NCT03349710|449108279|FG000|Treatment Period|Disease Progression|0|||
124859470|NCT03349710|449108280|FG001|Treatment Period|Disease Progression|2|||
124859471|NCT03349710|449108281|FG002|Treatment Period|Disease Progression|0|||
124859472|NCT03349710|449108282|FG003|Treatment Period|Disease Progression|1|||
124859473|NCT03349710|449108279|FG000|Treatment Period|Study Drug Toxicity|1|||
124859474|NCT03349710|449108280|FG001|Treatment Period|Study Drug Toxicity|0|||
124859475|NCT03349710|449108281|FG002|Treatment Period|Study Drug Toxicity|1|||
124859476|NCT03349710|449108282|FG003|Treatment Period|Study Drug Toxicity|1|||
124859477|NCT03349710|449108279|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
124859478|NCT03349710|449108280|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
124859479|NCT03349710|449108281|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
124859480|NCT03349710|449108282|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
124859481|NCT03349710|449108279|FG000|Treatment Period|admin reason by sponsor|0|||
124859482|NCT03349710|449108280|FG001|Treatment Period|admin reason by sponsor|7|||
124859483|NCT03349710|449108281|FG002|Treatment Period|admin reason by sponsor|0|||
124859484|NCT03349710|449108282|FG003|Treatment Period|admin reason by sponsor|19|||
124859485|NCT03349710|449108279|FG000|Treatment Period|Other Reason|2|||
124859486|NCT03349710|449108280|FG001|Treatment Period|Other Reason|0|||
124859487|NCT03349710|449108281|FG002|Treatment Period|Other Reason|2|||
124859488|NCT03349710|449108282|FG003|Treatment Period|Other Reason|1|||
124859489|NCT03349710|449108279|FG000|Treatment Period|completed|6|||
124859490|NCT03349710|449108280|FG001|Treatment Period|completed|0|||
124859491|NCT03349710|449108281|FG002|Treatment Period|completed|18|||
124859492|NCT03349710|449108282|FG003|Treatment Period|completed|1|||
124859493|NCT03349710|449108279|FG000|Treatment Period|participant request to discontinue|0|||
124859494|NCT03349710|449108280|FG001|Treatment Period|participant request to discontinue|0|||
124859495|NCT03349710|449108281|FG002|Treatment Period|participant request to discontinue|4|||
124859496|NCT03349710|449108282|FG003|Treatment Period|participant request to discontinue|0|||
124859497|NCT03349710|449108279|FG000|Treatment Period|participant withdrew consent|1|||
124859498|NCT03349710|449108280|FG001|Treatment Period|participant withdrew consent|0|||
124859499|NCT03349710|449108281|FG002|Treatment Period|participant withdrew consent|0|||
124859500|NCT03349710|449108282|FG003|Treatment Period|participant withdrew consent|0|||
124859501|NCT04258020|449108287|FG000|Overall Study|Withdrawal by Subject|1|||
124859502|NCT04258020|449108288|FG001|Overall Study|Withdrawal by Subject|0|||
124859503|NCT00833989|449108293|FG000|Overall Study|Physician Decision|0|||
124859504|NCT00833989|449108294|FG001|Overall Study|Physician Decision|0|||
124859505|NCT00833989|449108295|FG002|Overall Study|Physician Decision|0|||
124859506|NCT00833989|449108296|FG003|Overall Study|Physician Decision|1|||
124859507|NCT00833989|449108293|FG000|Overall Study|Withdrawal by Subject|3|||
124859508|NCT00833989|449108294|FG001|Overall Study|Withdrawal by Subject|0|||
124859509|NCT00833989|449108295|FG002|Overall Study|Withdrawal by Subject|1|||
124859510|NCT00833989|449108296|FG003|Overall Study|Withdrawal by Subject|1|||
124859511|NCT02105948|449108304|FG000|Overall Study|Adverse Event|10|||
124859512|NCT02105948|449108305|FG001|Overall Study|Adverse Event|7|||
124859513|NCT02105948|449108306|FG002|Overall Study|Adverse Event|11|||
124859514|NCT02105948|449108307|FG003|Overall Study|Adverse Event|11|||
124859515|NCT02105948|449108304|FG000|Overall Study|Lack of Efficacy|0|||
124859516|NCT02105948|449108305|FG001|Overall Study|Lack of Efficacy|1|||
124859517|NCT02105948|449108306|FG002|Overall Study|Lack of Efficacy|3|||
124859518|NCT02105948|449108307|FG003|Overall Study|Lack of Efficacy|2|||
124859519|NCT02105948|449108304|FG000|Overall Study|Lost to Follow-up|0|||
124859520|NCT02105948|449108305|FG001|Overall Study|Lost to Follow-up|0|||
124859521|NCT02105948|449108306|FG002|Overall Study|Lost to Follow-up|2|||
124859522|NCT02105948|449108307|FG003|Overall Study|Lost to Follow-up|1|||
124859523|NCT02105948|449108304|FG000|Overall Study|Physician Decision|2|||
124859524|NCT02105948|449108305|FG001|Overall Study|Physician Decision|2|||
124859525|NCT02105948|449108306|FG002|Overall Study|Physician Decision|2|||
124859526|NCT02105948|449108307|FG003|Overall Study|Physician Decision|2|||
124859527|NCT02105948|449108304|FG000|Overall Study|Withdrawal by Subject|15|||
124859528|NCT02105948|449108305|FG001|Overall Study|Withdrawal by Subject|10|||
124859529|NCT02105948|449108306|FG002|Overall Study|Withdrawal by Subject|10|||
124859530|NCT02105948|449108307|FG003|Overall Study|Withdrawal by Subject|11|||
124859531|NCT01587651|449108312|FG000|Overall Study|Adverse Event|0|||
124859532|NCT01587651|449108313|FG001|Overall Study|Adverse Event|1|||
124859533|NCT01587651|449108314|FG002|Overall Study|Adverse Event|0|||
124859534|NCT01587651|449108312|FG000|Overall Study|Protocol Violation|0|||
124859535|NCT01587651|449108313|FG001|Overall Study|Protocol Violation|1|||
124859536|NCT01587651|449108314|FG002|Overall Study|Protocol Violation|1|||
124859537|NCT01587651|449108312|FG000|Overall Study|Withdrawal by Subject|0|||
124859538|NCT01587651|449108313|FG001|Overall Study|Withdrawal by Subject|1|||
124859539|NCT01587651|449108314|FG002|Overall Study|Withdrawal by Subject|0|||
124859540|NCT00355082|449108315|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
124859541|NCT00355082|449108316|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
124859542|NCT00355082|449108317|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
124859543|NCT00355082|449108315|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
124859544|NCT00355082|449108316|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
124859545|NCT00355082|449108317|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
124859546|NCT00355082|449108315|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
124859547|NCT00355082|449108316|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
124859548|NCT00355082|449108317|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
124859549|NCT00355082|449108315|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
124859550|NCT00355082|449108316|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
124859551|NCT00355082|449108317|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
124859552|NCT00355082|449108315|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
124859553|NCT00355082|449108316|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
124859554|NCT00355082|449108317|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
124859555|NCT00355082|449108315|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
124859556|NCT00355082|449108316|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
124859557|NCT00355082|449108317|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
124859558|NCT00355082|449108315|FG000|Continuation Phase|Adverse Event|2|||
124859559|NCT00355082|449108316|FG001|Continuation Phase|Adverse Event|0|||
124859560|NCT00355082|449108317|FG002|Continuation Phase|Adverse Event|1|||
124859561|NCT00355082|449108315|FG000|Continuation Phase|Lost to Follow-up|2|||
124859562|NCT00355082|449108316|FG001|Continuation Phase|Lost to Follow-up|0|||
124859563|NCT00355082|449108317|FG002|Continuation Phase|Lost to Follow-up|1|||
124859564|NCT00355082|449108315|FG000|Continuation Phase|Protocol Violation|1|||
124859565|NCT00355082|449108316|FG001|Continuation Phase|Protocol Violation|0|||
124859566|NCT00355082|449108317|FG002|Continuation Phase|Protocol Violation|1|||
124859567|NCT00355082|449108315|FG000|Continuation Phase|Withdrawal by Subject|4|||
124859568|NCT00355082|449108316|FG001|Continuation Phase|Withdrawal by Subject|0|||
124859569|NCT00355082|449108317|FG002|Continuation Phase|Withdrawal by Subject|0|||
124859570|NCT00355082|449108315|FG000|Continuation Phase|Lack of Efficacy|5|||
124859571|NCT00355082|449108316|FG001|Continuation Phase|Lack of Efficacy|0|||
124859572|NCT00355082|449108317|FG002|Continuation Phase|Lack of Efficacy|0|||
124859573|NCT00355082|449108315|FG000|Continuation Phase|Site Closed by Sponsor|8|||
124859574|NCT00355082|449108316|FG001|Continuation Phase|Site Closed by Sponsor|0|||
124859575|NCT00355082|449108317|FG002|Continuation Phase|Site Closed by Sponsor|0|||
124859576|NCT00355082|449108315|FG000|Continuation Phase|Scheduling Error|1|||
124859577|NCT00355082|449108316|FG001|Continuation Phase|Scheduling Error|0|||
124859578|NCT00355082|449108317|FG002|Continuation Phase|Scheduling Error|0|||
124859579|NCT00355082|449108315|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
124859580|NCT00355082|449108316|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
124859581|NCT00355082|449108317|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
124859582|NCT04323436|449108318|FG000|Overall Study|Adverse Event|7|||
124859583|NCT04323436|449108319|FG001|Overall Study|Adverse Event|0|||
124859584|NCT04323436|449108320|FG002|Overall Study|Adverse Event|0|||
124859585|NCT04323436|449108318|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
124859586|NCT04323436|449108319|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
124859587|NCT04323436|449108320|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
124859588|NCT04323436|449108318|FG000|Overall Study|Death|1|||
124859589|NCT04323436|449108319|FG001|Overall Study|Death|0|||
124859590|NCT04323436|449108320|FG002|Overall Study|Death|0|||
124859591|NCT04323436|449108318|FG000|Overall Study|Physician Decision|2|||
124859592|NCT04323436|449108319|FG001|Overall Study|Physician Decision|0|||
124859593|NCT04323436|449108320|FG002|Overall Study|Physician Decision|0|||
124859594|NCT04323436|449108318|FG000|Overall Study|Progressive disease|10|||
124859595|NCT04323436|449108319|FG001|Overall Study|Progressive disease|0|||
124859596|NCT04323436|449108320|FG002|Overall Study|Progressive disease|0|||
124859597|NCT04323436|449108318|FG000|Overall Study|Subject decision|3|||
124859598|NCT04323436|449108319|FG001|Overall Study|Subject decision|0|||
124859599|NCT04323436|449108320|FG002|Overall Study|Subject decision|0|||
124859600|NCT01660763|449108324|FG000|Overall Study|Lack of Efficacy|45|||
124859601|NCT01660763|449108325|FG001|Overall Study|Lack of Efficacy|50|||
124859602|NCT01660763|449108324|FG000|Overall Study|Adverse Event|22|||
124859603|NCT01660763|449108325|FG001|Overall Study|Adverse Event|7|||
124859604|NCT01660763|449108324|FG000|Overall Study|Protocol Violation|1|||
124859605|NCT01660763|449108325|FG001|Overall Study|Protocol Violation|0|||
124859606|NCT01660763|449108324|FG000|Overall Study|Withdrawal by Subject|4|||
124859607|NCT01660763|449108325|FG001|Overall Study|Withdrawal by Subject|0|||
124859608|NCT01660763|449108324|FG000|Overall Study|Patient ready for early discharge|28|||
124859609|NCT01660763|449108325|FG001|Overall Study|Patient ready for early discharge|4|||
124859610|NCT03325712|449108326|FG000|Overall Study|Protocol Violation|0|||
124859611|NCT03325712|449108327|FG001|Overall Study|Protocol Violation|0|||
124859612|NCT03325712|449108328|FG002|Overall Study|Protocol Violation|0|||
124859613|NCT03325712|449108329|FG003|Overall Study|Protocol Violation|0|||
124859614|NCT03325712|449108330|FG004|Overall Study|Protocol Violation|1|||
124859615|NCT03325712|449108331|FG005|Overall Study|Protocol Violation|0|||
124859616|NCT03325712|449108332|FG006|Overall Study|Protocol Violation|0|||
124859617|NCT03325712|449108333|FG007|Overall Study|Protocol Violation|0|||
124859618|NCT03325712|449108326|FG000|Overall Study|Adverse Event|0|||
124859619|NCT03325712|449108327|FG001|Overall Study|Adverse Event|0|||
124859620|NCT03325712|449108328|FG002|Overall Study|Adverse Event|0|||
124859621|NCT03325712|449108329|FG003|Overall Study|Adverse Event|0|||
124859622|NCT03325712|449108330|FG004|Overall Study|Adverse Event|1|||
124859623|NCT03325712|449108331|FG005|Overall Study|Adverse Event|0|||
124859624|NCT03325712|449108332|FG006|Overall Study|Adverse Event|0|||
124859625|NCT03325712|449108333|FG007|Overall Study|Adverse Event|0|||
124859626|NCT02265237|449108335|FG000|As Treated (Overall Study)|Adverse Event|1|||
124859627|NCT02265237|449108336|FG001|As Treated (Overall Study)|Adverse Event|1|||
124859628|NCT02265237|449108337|FG002|As Treated (Overall Study)|Adverse Event|0|||
124859629|NCT02265237|449108338|FG003|As Treated (Overall Study)|Adverse Event|0|||
124859630|NCT02265237|449108335|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
124859631|NCT02265237|449108336|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
124859632|NCT02265237|449108337|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
124859633|NCT02265237|449108338|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
124859634|NCT02265237|449108335|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
124859635|NCT02265237|449108336|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
124859636|NCT02265237|449108337|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
124859637|NCT02265237|449108338|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
124859638|NCT02265237|449108335|FG000|As Treated (Overall Study)|Other|2|||
124859639|NCT02265237|449108336|FG001|As Treated (Overall Study)|Other|0|||
124859640|NCT02265237|449108337|FG002|As Treated (Overall Study)|Other|3|||
124859641|NCT02265237|449108338|FG003|As Treated (Overall Study)|Other|1|||
124859642|NCT01178853|449108340|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
124859643|NCT01178853|449108341|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
124859644|NCT01178853|449108340|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
124859645|NCT01178853|449108341|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
124859646|NCT01178853|449108340|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
124859647|NCT01178853|449108341|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
124859648|NCT01178853|449108340|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
124859649|NCT01178853|449108341|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
124859650|NCT01178853|449108340|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
124859651|NCT01178853|449108341|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
124859652|NCT03550313|449108342|FG000|Overall Study|Adverse Event|0|||
124859653|NCT03550313|449108343|FG001|Overall Study|Adverse Event|1|||
124859654|NCT03550313|449108344|FG002|Overall Study|Adverse Event|0|||
124859655|NCT03550313|449108342|FG000|Overall Study|Lost to Follow-up|5|||
124859656|NCT03550313|449108343|FG001|Overall Study|Lost to Follow-up|7|||
124859657|NCT03550313|449108344|FG002|Overall Study|Lost to Follow-up|12|||
124859658|NCT03550313|449108342|FG000|Overall Study|Study terminated by sponsor|44|||
124859659|NCT03550313|449108343|FG001|Overall Study|Study terminated by sponsor|37|||
124859660|NCT03550313|449108344|FG002|Overall Study|Study terminated by sponsor|48|||
124859661|NCT03550313|449108342|FG000|Overall Study|No longer met eligibility criteria|3|||
124859662|NCT03550313|449108343|FG001|Overall Study|No longer met eligibility criteria|5|||
124859663|NCT03550313|449108344|FG002|Overall Study|No longer met eligibility criteria|6|||
124859664|NCT03550313|449108342|FG000|Overall Study|Withdrawal by parent/guardian|20|||
124859665|NCT03550313|449108343|FG001|Overall Study|Withdrawal by parent/guardian|18|||
124859666|NCT03550313|449108344|FG002|Overall Study|Withdrawal by parent/guardian|26|||
124859667|NCT03550313|449108342|FG000|Overall Study|Other|4|||
124859668|NCT03550313|449108343|FG001|Overall Study|Other|2|||
124859669|NCT03550313|449108344|FG002|Overall Study|Other|2|||
124859670|NCT03550313|449108342|FG000|Overall Study|Randomized but not vaccinated|3|||
124859671|NCT03550313|449108343|FG001|Overall Study|Randomized but not vaccinated|23|||
124859672|NCT03550313|449108344|FG002|Overall Study|Randomized but not vaccinated|2|||
124859673|NCT03550313|449108342|FG000|Overall Study|Sites terminated due to quality issues|18|||
124859674|NCT03550313|449108343|FG001|Overall Study|Sites terminated due to quality issues|17|||
124859675|NCT03550313|449108344|FG002|Overall Study|Sites terminated due to quality issues|18|||
124859676|NCT00839072|449108345|FG000|First Intervention Period|Withdrawal by Subject|1|||
124859677|NCT00839072|449108346|FG001|First Intervention Period|Withdrawal by Subject|0|||
124859678|NCT00839072|449108345|FG000|First Intervention Period|Adverse Event|1|||
124859679|NCT00839072|449108346|FG001|First Intervention Period|Adverse Event|1|||
124859680|NCT00839072|449108345|FG000|Second Intervention Period|Withdrawal by Subject|1|||
124859681|NCT00839072|449108346|FG001|Second Intervention Period|Withdrawal by Subject|0|||
124859682|NCT00380068|449108348|FG000|Overall Study|Adverse Event|40|||
124859683|NCT00380068|449108348|FG000|Overall Study|Withdrawal by Subject|10|||
124859684|NCT00380068|449108348|FG000|Overall Study|Not compliant|6|||
124859685|NCT00380068|449108348|FG000|Overall Study|Lost to Follow-up|1|||
124859686|NCT00380068|449108348|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
124859687|NCT00380068|449108348|FG000|Overall Study|Lung transplant|3|||
124859688|NCT00380068|449108348|FG000|Overall Study|Physician Decision|2|||
124859689|NCT00380068|449108348|FG000|Overall Study|Partipant moved away|1|||
124859690|NCT00380068|449108348|FG000|Overall Study|Lack of Efficacy|5|||
124859691|NCT01297062|449108349|FG000|Overall Study|Adverse Event|2|||
124859692|NCT01297062|449108350|FG001|Overall Study|Adverse Event|0|||
124859693|NCT01297062|449108351|FG002|Overall Study|Adverse Event|1|||
124859694|NCT01297062|449108352|FG003|Overall Study|Adverse Event|0|||
124859695|NCT01297062|449108353|FG004|Overall Study|Adverse Event|0|||
124859696|NCT01297062|449108354|FG005|Overall Study|Adverse Event|0|||
124859697|NCT01297062|449108355|FG006|Overall Study|Adverse Event|0|||
124859698|NCT01297062|449108349|FG000|Overall Study|Physician Decision|1|||
124859699|NCT01297062|449108350|FG001|Overall Study|Physician Decision|0|||
124859700|NCT01297062|449108351|FG002|Overall Study|Physician Decision|1|||
124859701|NCT01297062|449108352|FG003|Overall Study|Physician Decision|0|||
124859702|NCT01297062|449108353|FG004|Overall Study|Physician Decision|0|||
124859703|NCT01297062|449108354|FG005|Overall Study|Physician Decision|0|||
124859704|NCT01297062|449108355|FG006|Overall Study|Physician Decision|6|||
124859705|NCT01297062|449108349|FG000|Overall Study|Protocol Violation|0|||
124859706|NCT01297062|449108350|FG001|Overall Study|Protocol Violation|0|||
124859707|NCT01297062|449108351|FG002|Overall Study|Protocol Violation|0|||
124859708|NCT01297062|449108352|FG003|Overall Study|Protocol Violation|0|||
124859709|NCT01297062|449108353|FG004|Overall Study|Protocol Violation|1|||
124859710|NCT01297062|449108354|FG005|Overall Study|Protocol Violation|0|||
124859711|NCT01297062|449108355|FG006|Overall Study|Protocol Violation|0|||
124859712|NCT01297062|449108349|FG000|Overall Study|Subject Decision|1|||
124859713|NCT01297062|449108350|FG001|Overall Study|Subject Decision|1|||
124859714|NCT01297062|449108351|FG002|Overall Study|Subject Decision|0|||
124859715|NCT01297062|449108352|FG003|Overall Study|Subject Decision|1|||
124859716|NCT01297062|449108353|FG004|Overall Study|Subject Decision|1|||
124859717|NCT01297062|449108354|FG005|Overall Study|Subject Decision|1|||
124859718|NCT01297062|449108355|FG006|Overall Study|Subject Decision|2|||
124859719|NCT01458574|449108356|FG000|Overall Study|Adverse Event|5|||
124859720|NCT01458574|449108357|FG001|Overall Study|Adverse Event|9|||
124859721|NCT01458574|449108358|FG002|Overall Study|Adverse Event|7|||
124859722|NCT01458574|449108356|FG000|Overall Study|Lack of Efficacy|70|||
124859723|NCT01458574|449108357|FG001|Overall Study|Lack of Efficacy|53|||
124859724|NCT01458574|449108358|FG002|Overall Study|Lack of Efficacy|132|||
124859725|NCT01458574|449108356|FG000|Overall Study|Lost to Follow-up|3|||
124859726|NCT01458574|449108357|FG001|Overall Study|Lost to Follow-up|2|||
124859727|NCT01458574|449108358|FG002|Overall Study|Lost to Follow-up|1|||
124859728|NCT01458574|449108356|FG000|Overall Study|Pregnancy|1|||
124859729|NCT01458574|449108357|FG001|Overall Study|Pregnancy|1|||
124859730|NCT01458574|449108358|FG002|Overall Study|Pregnancy|0|||
124859731|NCT01458574|449108356|FG000|Overall Study|Protocol Violation|0|||
124859732|NCT01458574|449108357|FG001|Overall Study|Protocol Violation|1|||
124859733|NCT01458574|449108358|FG002|Overall Study|Protocol Violation|0|||
124859734|NCT01458574|449108356|FG000|Overall Study|Withdrawal by Subject|6|||
124859735|NCT01458574|449108357|FG001|Overall Study|Withdrawal by Subject|3|||
124859736|NCT01458574|449108358|FG002|Overall Study|Withdrawal by Subject|5|||
124859737|NCT01458574|449108356|FG000|Overall Study|Other|2|||
124859738|NCT01458574|449108357|FG001|Overall Study|Other|1|||
124859739|NCT01458574|449108358|FG002|Overall Study|Other|0|||
124859740|NCT01458574|449108356|FG000|Overall Study|Randomized but not treated|0|||
124859741|NCT01458574|449108357|FG001|Overall Study|Randomized but not treated|1|||
124859742|NCT01458574|449108358|FG002|Overall Study|Randomized but not treated|0|||
124859743|NCT02125786|449108359|FG000|Overall Study|Still in Follow-up|3|||
124859744|NCT02125786|449108359|FG000|Overall Study|Screen Failure|2|||
124859745|NCT02125786|449108359|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
124859746|NCT02125786|449108359|FG000|Overall Study|Progressive Disease|44|||
124859747|NCT02125786|449108359|FG000|Overall Study|Death|8|||
124859748|NCT04964089|449108360|FG000|Overall Study|Adverse Event|8|||
124859749|NCT04964089|449108361|FG001|Overall Study|Adverse Event|6|||
124859750|NCT04964089|449108360|FG000|Overall Study|Non-compliance with study schedule|1|||
124859751|NCT04964089|449108361|FG001|Overall Study|Non-compliance with study schedule|0|||
124859752|NCT04964089|449108360|FG000|Overall Study|Withdrawal by Subject|6|||
124859753|NCT04964089|449108361|FG001|Overall Study|Withdrawal by Subject|5|||
124859754|NCT04964089|449108360|FG000|Overall Study|Lost to Follow-up|1|||
124859755|NCT04964089|449108361|FG001|Overall Study|Lost to Follow-up|1|||
124859756|NCT04964089|449108360|FG000|Overall Study|Progressive disease|4|||
124859757|NCT04964089|449108361|FG001|Overall Study|Progressive disease|0|||
124859758|NCT04964089|449108360|FG000|Overall Study|Physician Decision|1|||
124859759|NCT04964089|449108361|FG001|Overall Study|Physician Decision|0|||
124859760|NCT04964089|449108360|FG000|Overall Study|Participant did not want to continue study treatment|1|||
124859761|NCT04964089|449108361|FG001|Overall Study|Participant did not want to continue study treatment|0|||
124859762|NCT04964089|449108360|FG000|Overall Study|Participant moved to different state|1|||
124859763|NCT04964089|449108361|FG001|Overall Study|Participant moved to different state|0|||
124859764|NCT04964089|449108360|FG000|Overall Study|Participant decided to discontinue|0|||
124859765|NCT04964089|449108361|FG001|Overall Study|Participant decided to discontinue|1|||
124859766|NCT01682837|449108362|FG000|Baseline|Withdrawal by Subject|5|||
124859767|NCT01196975|449108363|FG000|Overall Study|Adverse Event|2|||
124859768|NCT01196975|449108364|FG001|Overall Study|Adverse Event|2|||
124859769|NCT01196975|449108365|FG002|Overall Study|Adverse Event|0|||
124859770|NCT01196975|449108366|FG003|Overall Study|Adverse Event|0|||
124859771|NCT01196975|449108367|FG004|Overall Study|Adverse Event|2|||
124859772|NCT01196975|449108363|FG000|Overall Study|Withdrawal by Subject|2|||
124859773|NCT01196975|449108364|FG001|Overall Study|Withdrawal by Subject|1|||
124859774|NCT01196975|449108365|FG002|Overall Study|Withdrawal by Subject|0|||
124859775|NCT01196975|449108366|FG003|Overall Study|Withdrawal by Subject|1|||
124859776|NCT01196975|449108367|FG004|Overall Study|Withdrawal by Subject|0|||
124859777|NCT01196975|449108363|FG000|Overall Study|Lost to Follow-up|11|||
124859778|NCT01196975|449108364|FG001|Overall Study|Lost to Follow-up|6|||
124859779|NCT01196975|449108365|FG002|Overall Study|Lost to Follow-up|5|||
124859780|NCT01196975|449108366|FG003|Overall Study|Lost to Follow-up|5|||
124859781|NCT01196975|449108367|FG004|Overall Study|Lost to Follow-up|11|||
124859782|NCT01365494|449108368|FG000|Overall Study|Adverse Event|1|||
124859783|NCT01365494|449108369|FG001|Overall Study|Adverse Event|0|||
124859784|NCT01365494|449108368|FG000|Overall Study|Withdrawal by Subject|0|||
124859785|NCT01365494|449108369|FG001|Overall Study|Withdrawal by Subject|1|||
124859786|NCT01365494|449108368|FG000|Overall Study|Lost to Follow-up|1|||
124859787|NCT01365494|449108369|FG001|Overall Study|Lost to Follow-up|2|||
124859788|NCT03086447|449108374|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
124859789|NCT03086447|449108375|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
124859790|NCT03086447|449108374|FG000|Overall Study|Lost Lens|2|||
124859791|NCT03086447|449108375|FG001|Overall Study|Lost Lens|5|||
124859792|NCT03086447|449108374|FG000|Overall Study|Product quality complaint|0|||
124859793|NCT03086447|449108375|FG001|Overall Study|Product quality complaint|1|||
124859794|NCT03086447|449108374|FG000|Overall Study|Lens Damage|1|||
124859795|NCT03086447|449108375|FG001|Overall Study|Lens Damage|6|||
124859796|NCT03086447|449108374|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
124859797|NCT03086447|449108375|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
124859798|NCT03086447|449108374|FG000|Overall Study|Test Article No Longer Available|1|||
124859799|NCT03086447|449108375|FG001|Overall Study|Test Article No Longer Available|0|||
124859800|NCT03086447|449108374|FG000|Overall Study|Protocol Violation|2|||
124859801|NCT03086447|449108375|FG001|Overall Study|Protocol Violation|4|||
124859802|NCT03086447|449108374|FG000|Overall Study|Lost to Follow-up|0|||
124859803|NCT03086447|449108375|FG001|Overall Study|Lost to Follow-up|1|||
124859804|NCT03086447|449108374|FG000|Overall Study|Adverse Event|3|||
124859805|NCT03086447|449108375|FG001|Overall Study|Adverse Event|0|||
124859806|NCT03086447|449108374|FG000|Overall Study|Lens Discomfort|2|||
124859807|NCT03086447|449108375|FG001|Overall Study|Lens Discomfort|1|||
124859808|NCT03394924|449108379|FG000|Overall Study|Adverse Event|0|||
124859809|NCT03394924|449108380|FG001|Overall Study|Adverse Event|5|||
124859810|NCT03394924|449108381|FG002|Overall Study|Adverse Event|0|||
124859811|NCT03394924|449108379|FG000|Overall Study|Withdrawal by Subject|2|||
124859812|NCT03394924|449108380|FG001|Overall Study|Withdrawal by Subject|0|||
124859813|NCT03394924|449108381|FG002|Overall Study|Withdrawal by Subject|0|||
124859814|NCT03394924|449108379|FG000|Overall Study|Lost to Follow-up|0|||
124859815|NCT03394924|449108380|FG001|Overall Study|Lost to Follow-up|1|||
124859816|NCT03394924|449108381|FG002|Overall Study|Lost to Follow-up|0|||
124859817|NCT03394924|449108379|FG000|Overall Study|Did not meet all inclusion criteria|1|||
124859818|NCT03394924|449108380|FG001|Overall Study|Did not meet all inclusion criteria|0|||
124859819|NCT03394924|449108381|FG002|Overall Study|Did not meet all inclusion criteria|0|||
124859820|NCT03588572|449108384|FG000|Visitation 1|Lack of Efficacy|1|||
124859821|NCT03588572|449108385|FG001|Visitation 1|Lack of Efficacy|1|||
124859822|NCT03588572|449108384|FG000|Visitation 2|Lost to Follow-up|1|||
124859823|NCT03588572|449108385|FG001|Visitation 2|Lost to Follow-up|1|||
124859824|NCT03588572|449108384|FG000|Visitation 2|Lack of Efficacy|0|||
124859825|NCT03588572|449108385|FG001|Visitation 2|Lack of Efficacy|1|||
124859826|NCT03588572|449108384|FG000|Visitation 2|Withdrawal by Subject|1|||
124859827|NCT03588572|449108385|FG001|Visitation 2|Withdrawal by Subject|0|||
124859828|NCT03588572|449108384|FG000|Visitation 3|Lost to Follow-up|1|||
124859829|NCT03588572|449108385|FG001|Visitation 3|Lost to Follow-up|1|||
124859830|NCT03588572|449108384|FG000|Visitation 3|Physician Decision|1|||
124859831|NCT03588572|449108385|FG001|Visitation 3|Physician Decision|1|||
124859832|NCT03588572|449108384|FG000|Visitation 3|Withdrawal by Subject|1|||
124859833|NCT03588572|449108385|FG001|Visitation 3|Withdrawal by Subject|0|||
124859834|NCT00364858|449108388|FG000|Overall Study|Adverse Event|1|||
124859835|NCT00364858|449108389|FG001|Overall Study|Adverse Event|5|||
124859836|NCT00364858|449108388|FG000|Overall Study|Withdrawal by Subject|1|||
124859837|NCT00364858|449108389|FG001|Overall Study|Withdrawal by Subject|1|||
124859838|NCT00364858|449108388|FG000|Overall Study|Pregnancy|1|||
124859839|NCT00364858|449108389|FG001|Overall Study|Pregnancy|1|||
124859840|NCT00364858|449108388|FG000|Overall Study|Clinical failure|2|||
124859841|NCT00364858|449108389|FG001|Overall Study|Clinical failure|13|||
124859842|NCT00364858|449108388|FG000|Overall Study|Discontinuation at baseline|1|||
124859843|NCT00364858|449108389|FG001|Overall Study|Discontinuation at baseline|0|||
124859844|NCT00364858|449108388|FG000|Overall Study|Non-compliant|1|||
124859845|NCT00364858|449108389|FG001|Overall Study|Non-compliant|0|||
124859846|NCT00364858|449108388|FG000|Overall Study|Return to Q2 regimen|0|||
124859847|NCT00364858|449108389|FG001|Overall Study|Return to Q2 regimen|1|||
124859848|NCT00364858|449108388|FG000|Overall Study|Clinical baseline issue|0|||
124859849|NCT00364858|449108389|FG001|Overall Study|Clinical baseline issue|1|||
124859850|NCT00627705|449108390|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
124859851|NCT00627705|449108391|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
124859852|NCT00627705|449108390|FG000|Overall Study|Adverse Event|1|||
124859853|NCT00627705|449108391|FG001|Overall Study|Adverse Event|0|||
124859854|NCT00627705|449108390|FG000|Overall Study|Withdrawal by Subject|0|||
124859855|NCT00627705|449108391|FG001|Overall Study|Withdrawal by Subject|2|||
124859856|NCT00627705|449108390|FG000|Overall Study|Lost to Follow-up|0|||
124859857|NCT00627705|449108391|FG001|Overall Study|Lost to Follow-up|1|||
124859858|NCT02535065|449108400|FG000|Overall Study|Death|13|||
124859859|NCT02535065|449108400|FG000|Overall Study|Lost to Follow-up|1|||
124859860|NCT02535065|449108400|FG000|Overall Study|Withdrawal by Subject|6|||
124859861|NCT00110617|449108401|FG000|Overall Study|Adverse Event|2|||
124859862|NCT00110617|449108402|FG001|Overall Study|Adverse Event|4|||
124859863|NCT00110617|449108401|FG000|Overall Study|Abnormal Laboratory Value|4|||
124859864|NCT00110617|449108402|FG001|Overall Study|Abnormal Laboratory Value|2|||
124859865|NCT00110617|449108401|FG000|Overall Study|Lack of Efficacy|1|||
124859866|NCT00110617|449108402|FG001|Overall Study|Lack of Efficacy|0|||
124859867|NCT00110617|449108401|FG000|Overall Study|Patient no longer requires study drug|1|||
124859868|NCT00110617|449108402|FG001|Overall Study|Patient no longer requires study drug|0|||
124859869|NCT00110617|449108401|FG000|Overall Study|Protocol Violation|5|||
124859870|NCT00110617|449108402|FG001|Overall Study|Protocol Violation|0|||
124859871|NCT00110617|449108401|FG000|Overall Study|Withdrawal by Subject|10|||
124859872|NCT00110617|449108402|FG001|Overall Study|Withdrawal by Subject|4|||
124859873|NCT00110617|449108401|FG000|Overall Study|Lost to Follow-up|9|||
124859874|NCT00110617|449108402|FG001|Overall Study|Lost to Follow-up|1|||
124859875|NCT00110617|449108401|FG000|Overall Study|Administrative problems|6|||
124859876|NCT00110617|449108402|FG001|Overall Study|Administrative problems|5|||
124859877|NCT00110617|449108401|FG000|Overall Study|Death|1|||
124859878|NCT00110617|449108402|FG001|Overall Study|Death|1|||
124859879|NCT00110617|449108401|FG000|Overall Study|Did not receive study drug|0|||
124859880|NCT00110617|449108402|FG001|Overall Study|Did not receive study drug|12|||
124859881|NCT01781572|449108403|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
124859882|NCT01781572|449108404|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
124859883|NCT01781572|449108405|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
124859884|NCT01781572|449108403|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
124859885|NCT01781572|449108404|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
124859886|NCT01781572|449108405|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
124859887|NCT01781572|449108403|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
124859888|NCT01781572|449108404|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
124859889|NCT01781572|449108405|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
124859890|NCT01781572|449108403|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
124859891|NCT01781572|449108404|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
124859892|NCT01781572|449108405|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
124859893|NCT01781572|449108403|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
124859894|NCT01781572|449108404|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
124859895|NCT01781572|449108405|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
124859896|NCT01781572|449108403|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
124859897|NCT01781572|449108404|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
124859898|NCT01781572|449108405|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
124859899|NCT01781572|449108403|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
124859900|NCT01781572|449108404|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
124859901|NCT01781572|449108405|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
124859902|NCT01781572|449108403|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
124859903|NCT01781572|449108404|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
124859904|NCT01781572|449108405|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
124859905|NCT01781572|449108403|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
124859906|NCT01781572|449108404|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
124859907|NCT01781572|449108405|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
124859908|NCT01781572|449108403|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
124859909|NCT01781572|449108404|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
124859910|NCT01781572|449108405|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
124859911|NCT01781572|449108403|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
124859912|NCT01781572|449108404|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
124859913|NCT01781572|449108405|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
124859914|NCT01781572|449108403|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
124859915|NCT01781572|449108404|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
124859916|NCT01781572|449108405|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
124859917|NCT01781572|449108403|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
124859918|NCT01781572|449108404|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
124859919|NCT01781572|449108405|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
124859920|NCT01781572|449108403|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
124859921|NCT01781572|449108404|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
124859922|NCT01781572|449108405|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
124859923|NCT01781572|449108403|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
124859924|NCT01781572|449108404|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
124859925|NCT01781572|449108405|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
124859926|NCT01781572|449108403|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
124859927|NCT01781572|449108404|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
124859928|NCT01781572|449108405|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
124859929|NCT01781572|449108403|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
124859930|NCT01781572|449108404|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
124859931|NCT01781572|449108405|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
124859932|NCT01781572|449108403|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
124859933|NCT01781572|449108404|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
124859934|NCT01781572|449108405|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
124859935|NCT00045110|449108406|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
124859936|NCT00045110|449108407|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
124859937|NCT00045110|449108408|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
124859938|NCT00045110|449108406|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
124859939|NCT00045110|449108407|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
124859940|NCT00045110|449108408|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
124859941|NCT00045110|449108406|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
124859942|NCT00045110|449108407|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
124859943|NCT00045110|449108408|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
124859944|NCT00660010|449108409|FG000|Overall Study|Withdrawal by Subject|2|||
124859945|NCT00660010|449108409|FG000|Overall Study|Lost to Follow-up|3|||
124859946|NCT00660010|449108409|FG000|Overall Study|Adverse Event|1|||
124859947|NCT00660010|449108409|FG000|Overall Study|Noncompliance with visit schedule|3|||
124859948|NCT04827576|449110066|FG000|Overall Study|Death|5|||
124859949|NCT04827576|449110067|FG001|Overall Study|Death|17|||
124859950|NCT04827576|449110068|FG002|Overall Study|Death|17|||
124859951|NCT04827576|449110069|FG003|Overall Study|Death|32|||
124859952|NCT04827576|449110066|FG000|Overall Study|Study Terminated by Sponsor|2|||
124859953|NCT04827576|449110067|FG001|Overall Study|Study Terminated by Sponsor|9|||
124859954|NCT04827576|449110068|FG002|Overall Study|Study Terminated by Sponsor|7|||
124859955|NCT04827576|449110069|FG003|Overall Study|Study Terminated by Sponsor|5|||
124859956|NCT04827576|449110066|FG000|Overall Study|Investigator's Discretion|1|||
124859957|NCT04827576|449110067|FG001|Overall Study|Investigator's Discretion|0|||
124859958|NCT04827576|449110068|FG002|Overall Study|Investigator's Discretion|2|||
124859959|NCT04827576|449110069|FG003|Overall Study|Investigator's Discretion|5|||
124859960|NCT04827576|449110066|FG000|Overall Study|Withdrew Consent|0|||
124859961|NCT04827576|449110067|FG001|Overall Study|Withdrew Consent|3|||
124859962|NCT04827576|449110068|FG002|Overall Study|Withdrew Consent|0|||
124859963|NCT04827576|449110069|FG003|Overall Study|Withdrew Consent|0|||
124859964|NCT04827576|449110066|FG000|Overall Study|Lost to Follow-up|1|||
124859965|NCT04827576|449110067|FG001|Overall Study|Lost to Follow-up|0|||
124859966|NCT04827576|449110068|FG002|Overall Study|Lost to Follow-up|0|||
124859967|NCT04827576|449110069|FG003|Overall Study|Lost to Follow-up|0|||
124859968|NCT03069482|449110070|FG000|Overall Study|Lost to Follow-up|0|||
124859969|NCT03069482|449110071|FG001|Overall Study|Lost to Follow-up|1|||
124859970|NCT03069482|449110070|FG000|Overall Study|Physician Decision|1|||
124859971|NCT03069482|449110071|FG001|Overall Study|Physician Decision|0|||
124859972|NCT04537923|449110072|FG000|Overall Study|Adverse Event|2|||
124859973|NCT04537923|449110073|FG001|Overall Study|Adverse Event|1|||
124859974|NCT04537923|449110074|FG002|Overall Study|Adverse Event|2|||
124859975|NCT04537923|449110075|FG003|Overall Study|Adverse Event|4|||
124859976|NCT04537923|449110072|FG000|Overall Study|Death|3|||
124859977|NCT04537923|449110073|FG001|Overall Study|Death|3|||
124859978|NCT04537923|449110074|FG002|Overall Study|Death|1|||
124859979|NCT04537923|449110075|FG003|Overall Study|Death|11|||
124859980|NCT04537923|449110072|FG000|Overall Study|Lost to Follow-up|1|||
124859981|NCT04537923|449110073|FG001|Overall Study|Lost to Follow-up|2|||
124859982|NCT04537923|449110074|FG002|Overall Study|Lost to Follow-up|1|||
124859983|NCT04537923|449110075|FG003|Overall Study|Lost to Follow-up|6|||
124859984|NCT04537923|449110072|FG000|Overall Study|Physician Decision|1|||
124859985|NCT04537923|449110073|FG001|Overall Study|Physician Decision|0|||
124859986|NCT04537923|449110074|FG002|Overall Study|Physician Decision|2|||
124859987|NCT04537923|449110075|FG003|Overall Study|Physician Decision|5|||
124859988|NCT04537923|449110072|FG000|Overall Study|Pregnancy|1|||
124859989|NCT04537923|449110073|FG001|Overall Study|Pregnancy|0|||
124859990|NCT04537923|449110074|FG002|Overall Study|Pregnancy|0|||
124859991|NCT04537923|449110075|FG003|Overall Study|Pregnancy|0|||
124859992|NCT04537923|449110072|FG000|Overall Study|Withdrawal by Subject|4|||
124859993|NCT04537923|449110073|FG001|Overall Study|Withdrawal by Subject|4|||
124859994|NCT04537923|449110074|FG002|Overall Study|Withdrawal by Subject|4|||
124859995|NCT04537923|449110075|FG003|Overall Study|Withdrawal by Subject|58|||
124859996|NCT04537923|449110072|FG000|Overall Study|Missed study visits|2|||
124859997|NCT04537923|449110073|FG001|Overall Study|Missed study visits|0|||
124859998|NCT04537923|449110074|FG002|Overall Study|Missed study visits|0|||
124859999|NCT04537923|449110075|FG003|Overall Study|Missed study visits|3|||
124860000|NCT04537923|449110072|FG000|Overall Study|Sponsor's decision|0|||
124860001|NCT04537923|449110073|FG001|Overall Study|Sponsor's decision|0|||
124860002|NCT04537923|449110074|FG002|Overall Study|Sponsor's decision|1|||
124860003|NCT04537923|449110075|FG003|Overall Study|Sponsor's decision|1|||
124860004|NCT04537923|449110072|FG000|Overall Study|Safety reasons|1|||
124860005|NCT04537923|449110073|FG001|Overall Study|Safety reasons|0|||
124860006|NCT04537923|449110074|FG002|Overall Study|Safety reasons|0|||
124860007|NCT04537923|449110075|FG003|Overall Study|Safety reasons|0|||
124860008|NCT01261611|449110076|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
124860009|NCT01261611|449110077|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
124860010|NCT01261611|449110078|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
124860011|NCT01261611|449110076|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
124860012|NCT01261611|449110077|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
124860013|NCT01261611|449110078|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
124860014|NCT01261611|449110076|FG000|Treatment Cycle 1|Adverse Event|0|||
124860015|NCT01261611|449110077|FG001|Treatment Cycle 1|Adverse Event|1|||
124860016|NCT01261611|449110078|FG002|Treatment Cycle 1|Adverse Event|0|||
124860017|NCT01261611|449110076|FG000|Treatment Cycle 1|Protocol Violation|0|||
124860018|NCT01261611|449110077|FG001|Treatment Cycle 1|Protocol Violation|0|||
124860019|NCT01261611|449110078|FG002|Treatment Cycle 1|Protocol Violation|2|||
124860020|NCT01261611|449110076|FG000|Treatment Cycle 2|Completed study|4|||
124860021|NCT01261611|449110077|FG001|Treatment Cycle 2|Completed study|0|||
124860022|NCT01261611|449110078|FG002|Treatment Cycle 2|Completed study|0|||
124860023|NCT01261611|449110076|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
124860024|NCT01261611|449110077|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
124860025|NCT01261611|449110078|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
124860026|NCT01261611|449110076|FG000|Treatment Cycle 2|Adverse Event|1|||
124860027|NCT01261611|449110077|FG001|Treatment Cycle 2|Adverse Event|0|||
124860028|NCT01261611|449110078|FG002|Treatment Cycle 2|Adverse Event|0|||
124860029|NCT01261611|449110076|FG000|Treatment Cycle 2|Protocol Violation|2|||
124860030|NCT01261611|449110077|FG001|Treatment Cycle 2|Protocol Violation|0|||
124860031|NCT01261611|449110078|FG002|Treatment Cycle 2|Protocol Violation|0|||
124860032|NCT01261611|449110076|FG000|Treatment Cycle 2|Not otherwise specified|2|||
124860033|NCT01261611|449110077|FG001|Treatment Cycle 2|Not otherwise specified|0|||
124860034|NCT01261611|449110078|FG002|Treatment Cycle 2|Not otherwise specified|0|||
124860035|NCT01261611|449110076|FG000|Treatment Cycle 3|Completed study|24|||
124860036|NCT01261611|449110077|FG001|Treatment Cycle 3|Completed study|0|||
124860037|NCT01261611|449110078|FG002|Treatment Cycle 3|Completed study|0|||
124860038|NCT01261611|449110076|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
124860039|NCT01261611|449110077|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
124860040|NCT01261611|449110078|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
124860041|NCT01261611|449110076|FG000|Treatment Cycle 3|Adverse Event|1|||
124860042|NCT01261611|449110077|FG001|Treatment Cycle 3|Adverse Event|0|||
124860043|NCT01261611|449110078|FG002|Treatment Cycle 3|Adverse Event|0|||
124860044|NCT01261611|449110076|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
124860045|NCT01261611|449110077|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
124860046|NCT01261611|449110078|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
124860047|NCT01261611|449110076|FG000|Treatment Cycle 4|Completed study|87|||
124860048|NCT01261611|449110077|FG001|Treatment Cycle 4|Completed study|0|||
124860049|NCT01261611|449110078|FG002|Treatment Cycle 4|Completed study|0|||
124860050|NCT01261611|449110076|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
124860051|NCT01261611|449110077|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
124860052|NCT01261611|449110078|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
124860053|NCT01261611|449110076|FG000|Treatment Cycle 4|Adverse Event|1|||
124860054|NCT01261611|449110077|FG001|Treatment Cycle 4|Adverse Event|0|||
124860055|NCT01261611|449110078|FG002|Treatment Cycle 4|Adverse Event|0|||
124860056|NCT01261611|449110076|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
124860057|NCT01261611|449110077|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
124860058|NCT01261611|449110078|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
124860059|NCT01261611|449110076|FG000|Treatment Cycle 4|Not otherwise specified|3|||
124860060|NCT01261611|449110077|FG001|Treatment Cycle 4|Not otherwise specified|0|||
124860061|NCT01261611|449110078|FG002|Treatment Cycle 4|Not otherwise specified|0|||
124860062|NCT01261611|449110076|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
124860063|NCT01261611|449110077|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
124860064|NCT01261611|449110078|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
124860065|NCT01261611|449110076|FG000|Treatment Cycle 5|Adverse Event|1|||
124860066|NCT01261611|449110077|FG001|Treatment Cycle 5|Adverse Event|0|||
124860067|NCT01261611|449110078|FG002|Treatment Cycle 5|Adverse Event|0|||
124860068|NCT01261611|449110076|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
124860069|NCT01261611|449110077|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
124860070|NCT01261611|449110078|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
124860071|NCT02527798|449110079|FG000|Overall Study|Physician Decision|1|||
124860072|NCT02527798|449110080|FG001|Overall Study|Physician Decision|0|||
124860073|NCT02527798|449110081|FG002|Overall Study|Physician Decision|1|||
124860074|NCT02527798|449110082|FG003|Overall Study|Physician Decision|1|||
124860075|NCT02527798|449110083|FG004|Overall Study|Physician Decision|0|||
124860076|NCT02527798|449110084|FG005|Overall Study|Physician Decision|0|||
124860077|NCT02527798|449110079|FG000|Overall Study|Death|0|||
124860078|NCT02527798|449110080|FG001|Overall Study|Death|0|||
124860079|NCT02527798|449110081|FG002|Overall Study|Death|1|||
124860080|NCT02527798|449110082|FG003|Overall Study|Death|0|||
124860081|NCT02527798|449110083|FG004|Overall Study|Death|0|||
124860082|NCT02527798|449110084|FG005|Overall Study|Death|0|||
124860083|NCT02527798|449110079|FG000|Overall Study|Withdrawal by Subject|0|||
124860084|NCT02527798|449110080|FG001|Overall Study|Withdrawal by Subject|1|||
124860085|NCT02527798|449110081|FG002|Overall Study|Withdrawal by Subject|2|||
124860086|NCT02527798|449110082|FG003|Overall Study|Withdrawal by Subject|0|||
124860087|NCT02527798|449110083|FG004|Overall Study|Withdrawal by Subject|0|||
124860088|NCT02527798|449110084|FG005|Overall Study|Withdrawal by Subject|0|||
124860089|NCT02527798|449110079|FG000|Overall Study|Reason undisclosed|1|||
124860090|NCT02527798|449110080|FG001|Overall Study|Reason undisclosed|0|||
124860091|NCT02527798|449110081|FG002|Overall Study|Reason undisclosed|1|||
124860092|NCT02527798|449110082|FG003|Overall Study|Reason undisclosed|0|||
124860093|NCT02527798|449110083|FG004|Overall Study|Reason undisclosed|0|||
124860094|NCT02527798|449110084|FG005|Overall Study|Reason undisclosed|0|||
124860095|NCT02527798|449110079|FG000|Overall Study|Did not receive intervention|1|||
124860096|NCT02527798|449110080|FG001|Overall Study|Did not receive intervention|1|||
124860097|NCT02527798|449110081|FG002|Overall Study|Did not receive intervention|0|||
124860098|NCT02527798|449110082|FG003|Overall Study|Did not receive intervention|0|||
124860099|NCT02527798|449110083|FG004|Overall Study|Did not receive intervention|0|||
124860100|NCT02527798|449110084|FG005|Overall Study|Did not receive intervention|0|||
124860101|NCT00920426|449110087|FG000|ITZ111451|Adverse Event|1|||
124860102|NCT00920426|449110088|FG001|ITZ111451|Adverse Event|0|||
124860103|NCT00920426|449110089|FG002|ITZ111451|Adverse Event|0|||
124860104|NCT00920426|449110090|FG003|ITZ111451|Adverse Event|0|||
124860105|NCT01432366|449110093|FG000|Overall Study|Non-Responder|7|||
124860106|NCT01432366|449110093|FG000|Overall Study|Adverse Event|8|||
124860107|NCT01432366|449110093|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
124860108|NCT01432366|449110093|FG000|Overall Study|Pregnancy|1|||
124860109|NCT01432366|449110093|FG000|Overall Study|Lost to Follow-up|13|||
124860110|NCT01432366|449110093|FG000|Overall Study|Lack of Efficacy|1|||
124860111|NCT01432366|449110093|FG000|Overall Study|Site Closed|20|||
124860112|NCT01432366|449110093|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
124860113|NCT01432366|449110093|FG000|Overall Study|Other|14|||
124860114|NCT01275625|449110099|FG000|Overall Study|Death|1|||
124860115|NCT01275625|449110099|FG000|Overall Study|Lack of Efficacy|2|||
124860116|NCT01275625|449110099|FG000|Overall Study|Lost to Follow-up|1|||
124860117|NCT01275625|449110099|FG000|Overall Study|Withdrawal by Subject|3|||
124860118|NCT01275625|449110099|FG000|Overall Study|Protocol Violation|1|||
124860119|NCT01275625|449110099|FG000|Overall Study|Adverse Event|4|||
124860120|NCT01275625|449110099|FG000|Overall Study|Other|1|||
124860121|NCT01349569|449110100|FG000|Overall Study|Lack of Efficacy|4|||
124860122|NCT02105116|449110101|FG000|Overall Study|not eligible for step 2 of trial|5|||
124860123|NCT02105116|449110101|FG000|Overall Study|Death|1|||
124860124|NCT00263666|449110102|FG000|Overall Study|Adverse Event|6|||
124860125|NCT00263666|449110103|FG001|Overall Study|Adverse Event|8|||
124860126|NCT00263666|449110102|FG000|Overall Study|Lost to Follow-up|1|||
124860127|NCT00263666|449110103|FG001|Overall Study|Lost to Follow-up|2|||
124860128|NCT00263666|449110102|FG000|Overall Study|Withdrawal by Subject|0|||
124860129|NCT00263666|449110103|FG001|Overall Study|Withdrawal by Subject|1|||
124860130|NCT00896168|449110104|FG000|Overall Study|Adverse Event|4|||
124860131|NCT00896168|449110105|FG001|Overall Study|Adverse Event|7|||
124860132|NCT00896168|449110104|FG000|Overall Study|Treatment failure|8|||
124860133|NCT00896168|449110105|FG001|Overall Study|Treatment failure|10|||
124860134|NCT00896168|449110104|FG000|Overall Study|Lost to Follow-up|1|||
124860135|NCT00896168|449110105|FG001|Overall Study|Lost to Follow-up|1|||
124860136|NCT00896168|449110104|FG000|Overall Study|Other|1|||
124860137|NCT00896168|449110105|FG001|Overall Study|Other|1|||
124860138|NCT02492100|449110106|FG000|Overall Study|Death|1|||
124860139|NCT01003899|449110110|FG000|Overall Study|Other Adverse Event|8|||
124860140|NCT01003899|449110110|FG000|Overall Study|Not entered|4|||
124860141|NCT01003899|449110110|FG000|Overall Study|Not treated|1|||
124860142|NCT01003899|449110110|FG000|Overall Study|Progressive disease|34|||
124860143|NCT02489500|449110114|FG000|Overall Study|Death|1|||
124860144|NCT02489500|449110115|FG001|Overall Study|Death|1|||
124860145|NCT02863926|449110116|FG000|Overall Study|Physician Decision|1|||
124860146|NCT02863926|449110117|FG001|Overall Study|Physician Decision|0|||
124860147|NCT02863926|449110116|FG000|Overall Study|Lost to Follow-up|1|||
124860148|NCT02863926|449110117|FG001|Overall Study|Lost to Follow-up|1|||
124860149|NCT01259713|449110118|FG000|Overall Study|Adverse Event|54|||
124860150|NCT01259713|449110119|FG001|Overall Study|Adverse Event|23|||
124860151|NCT01259713|449110118|FG000|Overall Study|Death Not Related to IFI|8|||
124860152|NCT01259713|449110119|FG001|Overall Study|Death Not Related to IFI|1|||
124860153|NCT01259713|449110118|FG000|Overall Study|Investigators Discretion|14|||
124860154|NCT01259713|449110119|FG001|Overall Study|Investigators Discretion|6|||
124860155|NCT01259713|449110118|FG000|Overall Study|Lack of Efficacy|2|||
124860156|NCT01259713|449110119|FG001|Overall Study|Lack of Efficacy|0|||
124860157|NCT01259713|449110118|FG000|Overall Study|Protocol Violation|5|||
124860158|NCT01259713|449110119|FG001|Overall Study|Protocol Violation|4|||
124860159|NCT01259713|449110118|FG000|Overall Study|Subject Withdrew Consent|12|||
124860160|NCT01259713|449110119|FG001|Overall Study|Subject Withdrew Consent|7|||
124860161|NCT03422250|449110120|FG000|Intervention|Adverse Event|0|||
124860162|NCT03422250|449110121|FG001|Intervention|Adverse Event|1|||
124860163|NCT03422250|449110122|FG002|Intervention|Adverse Event|0|||
124860164|NCT03422250|449110123|FG003|Intervention|Adverse Event|1|||
124860165|NCT03422250|449110120|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
124860166|NCT03422250|449110121|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
124860167|NCT03422250|449110122|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
124860168|NCT03422250|449110123|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
124860169|NCT03422250|449110120|FG000|Follow-up|Withdrawal by Subject|0|||
124860170|NCT03422250|449110121|FG001|Follow-up|Withdrawal by Subject|0|||
124860171|NCT03422250|449110122|FG002|Follow-up|Withdrawal by Subject|0|||
124860172|NCT03422250|449110123|FG003|Follow-up|Withdrawal by Subject|1|||
124860173|NCT03422250|449110120|FG000|Follow-up|Adverse Event|0|||
124860174|NCT03422250|449110121|FG001|Follow-up|Adverse Event|0|||
124860175|NCT03422250|449110122|FG002|Follow-up|Adverse Event|0|||
124860176|NCT03422250|449110123|FG003|Follow-up|Adverse Event|1|||
124860177|NCT06111742|449110132|FG000|Overall Study|Did not receive intervention|1|||
124860178|NCT06111742|449110133|FG001|Overall Study|Did not receive intervention|0|||
124860179|NCT06111742|449110134|FG002|Overall Study|Did not receive intervention|0|||
124860180|NCT06111742|449110132|FG000|Overall Study|Withdrawal by Subject|2|||
124860181|NCT06111742|449110133|FG001|Overall Study|Withdrawal by Subject|0|||
124860182|NCT06111742|449110134|FG002|Overall Study|Withdrawal by Subject|0|||
124860183|NCT01917526|449110135|FG000|Overall Study|Protocol Violation|1|||
124860184|NCT01917526|449110136|FG001|Overall Study|Protocol Violation|1|||
124860185|NCT04717596|449110137|FG000|Overall Study|Withdrawal by Subject|4|||
124860186|NCT02864082|449110139|FG000|Overall Study|Adverse Event|1|||
124860187|NCT02864082|449110140|FG001|Overall Study|Adverse Event|1|||
124860188|NCT02864082|449110139|FG000|Overall Study|Lost to Follow-up|0|||
124860189|NCT02864082|449110140|FG001|Overall Study|Lost to Follow-up|1|||
124860190|NCT02864082|449110139|FG000|Overall Study|Withdrawal by Subject|2|||
124860191|NCT02864082|449110140|FG001|Overall Study|Withdrawal by Subject|2|||
124860192|NCT01127178|449110141|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
124860193|NCT01127178|449110142|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
124860194|NCT01127178|449110141|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
124860195|NCT01127178|449110142|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
124860196|NCT01127178|449110141|FG000|Dose Escalation: Treatment Phase|Other|2|||
124860197|NCT01127178|449110142|FG001|Dose Escalation: Treatment Phase|Other|0|||
124860198|NCT01127178|449110141|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
124860199|NCT01127178|449110142|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
124860200|NCT01127178|449110141|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
124860201|NCT01127178|449110142|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
124860202|NCT01127178|449110141|FG000|Dose Escalation: Extension Phase|Other|1|||
124860203|NCT01127178|449110142|FG001|Dose Escalation: Extension Phase|Other|0|||
124860204|NCT03621696|449110143|FG000|Overall Study|Not eligible|0|||
124860205|NCT03621696|449110144|FG001|Overall Study|Not eligible|0|||
124860206|NCT03621696|449110145|FG002|Overall Study|Not eligible|0|||
124860207|NCT03621696|449110146|FG003|Overall Study|Not eligible|5|||
124860208|NCT03621696|449110143|FG000|Overall Study|Withdrawal by Subject|1|||
124860209|NCT03621696|449110144|FG001|Overall Study|Withdrawal by Subject|1|||
124860210|NCT03621696|449110145|FG002|Overall Study|Withdrawal by Subject|1|||
124860211|NCT03621696|449110146|FG003|Overall Study|Withdrawal by Subject|0|||
124860212|NCT03621696|449110143|FG000|Overall Study|Physician Decision|0|||
124860213|NCT03621696|449110144|FG001|Overall Study|Physician Decision|0|||
124860214|NCT03621696|449110145|FG002|Overall Study|Physician Decision|1|||
124860215|NCT03621696|449110146|FG003|Overall Study|Physician Decision|0|||
124860216|NCT04349553|449110147|FG000|Overall Study|Withdrawal by Subject|1|||
124860217|NCT04349553|449110148|FG001|Overall Study|Withdrawal by Subject|0|||
124860218|NCT04349553|449110149|FG002|Overall Study|Withdrawal by Subject|1|||
124860219|NCT04349553|449110150|FG003|Overall Study|Withdrawal by Subject|0|||
124860220|NCT02063724|449110151|FG000|Overall Study|Disease progression|1|||
124860221|NCT01715805|449110152|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
124860222|NCT01715805|449110153|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
124860223|NCT01715805|449110154|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
124860224|NCT01715805|449110155|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
124860225|NCT01715805|449110152|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
124860226|NCT01715805|449110153|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
124860227|NCT01715805|449110154|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
124860228|NCT01715805|449110155|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
124860229|NCT01715805|449110152|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
124860230|NCT01715805|449110153|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
124860231|NCT01715805|449110154|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
124860232|NCT01715805|449110155|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
124860233|NCT01715805|449110152|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
124860234|NCT01715805|449110153|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
124860235|NCT01715805|449110154|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
124860236|NCT01715805|449110155|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
124860237|NCT01715805|449110152|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
124860238|NCT01715805|449110153|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
124860239|NCT01715805|449110154|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
124860240|NCT01715805|449110155|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
124860241|NCT01715805|449110152|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
124860242|NCT01715805|449110153|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
124860243|NCT01715805|449110154|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
124860244|NCT01715805|449110155|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
124860245|NCT01715805|449110152|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
124860246|NCT01715805|449110153|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
124860247|NCT01715805|449110154|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
124860248|NCT01715805|449110155|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
124860249|NCT01715805|449110152|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
124860250|NCT01715805|449110153|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
124860251|NCT01715805|449110154|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
124860252|NCT01715805|449110155|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
124860253|NCT01715805|449110152|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
124860254|NCT01715805|449110153|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
124860255|NCT01715805|449110154|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
124860256|NCT01715805|449110155|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
124860257|NCT01715805|449110152|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
124860258|NCT01715805|449110153|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
124860259|NCT01715805|449110154|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
124860260|NCT01715805|449110155|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
124860261|NCT01715805|449110152|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
124860262|NCT01715805|449110153|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
124860263|NCT01715805|449110154|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
124860264|NCT01715805|449110155|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
124860265|NCT01715805|449110152|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
124860266|NCT01715805|449110153|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
124860267|NCT01715805|449110154|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
124860268|NCT01715805|449110155|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
124860269|NCT01715805|449110152|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
124860270|NCT01715805|449110153|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
124860271|NCT01715805|449110154|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
124860272|NCT01715805|449110155|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
124860273|NCT01715805|449110152|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
124860274|NCT01715805|449110153|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
124860275|NCT01715805|449110154|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
124860276|NCT01715805|449110155|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
124860277|NCT05177770|449110158|FG000|Overall Study|Death|4|||
124860278|NCT05177770|449110158|FG000|Overall Study|Withdrawal by Subject|1|||
124860279|NCT05177770|449110158|FG000|Overall Study|Adverse Event prior to dosing|1|||
124860280|NCT02365467|449110159|FG000|Overall Study|Death|3|||
124860281|NCT02043782|449110160|FG000|Period 1|Adverse Event|0|||
124860282|NCT02043782|449110161|FG001|Period 1|Adverse Event|0|||
124860283|NCT02043782|449110162|FG002|Period 1|Adverse Event|1|||
124860284|NCT02043782|449110163|FG003|Period 1|Adverse Event|0|||
124860285|NCT02043782|449110164|FG004|Period 1|Adverse Event|0|||
124860286|NCT02043782|449110165|FG005|Period 1|Adverse Event|0|||
124860287|NCT00709722|449110166|FG000|Overall Study|Adverse Event|1|||
124860288|NCT04667117|449110167|FG000|Investigational Period|Lost to Follow-up|0|||
124860289|NCT04667117|449110168|FG001|Investigational Period|Lost to Follow-up|0|||
124860290|NCT04667117|449110169|FG002|Investigational Period|Lost to Follow-up|1|||
124860291|NCT04667117|449110167|FG000|Investigational Period|Protocol Deviation|0|||
124860292|NCT04667117|449110168|FG001|Investigational Period|Protocol Deviation|1|||
124860293|NCT04667117|449110169|FG002|Investigational Period|Protocol Deviation|0|||
124860294|NCT04667117|449110167|FG000|Extension Period|Lost to Follow-up|1|||
124860295|NCT04667117|449110168|FG001|Extension Period|Lost to Follow-up|0|||
124860296|NCT04667117|449110169|FG002|Extension Period|Lost to Follow-up|0|||
124860297|NCT01306162|449110170|FG000|Period 1|Adverse Event|0|||
124860298|NCT01306162|449110171|FG001|Period 1|Adverse Event|0|||
124860299|NCT01306162|449110172|FG002|Period 1|Adverse Event|0|||
124860300|NCT01306162|449110173|FG003|Period 1|Adverse Event|1|||
124860301|NCT01306162|449110170|FG000|Washout 1|Non-compliance to protocol|0|||
124860302|NCT01306162|449110171|FG001|Washout 1|Non-compliance to protocol|1|||
124860303|NCT01306162|449110172|FG002|Washout 1|Non-compliance to protocol|0|||
124860304|NCT01306162|449110173|FG003|Washout 1|Non-compliance to protocol|0|||
124860305|NCT02959437|449110179|FG000|Overall Study|Death|33|||
124860306|NCT02959437|449110180|FG001|Overall Study|Death|3|||
124860307|NCT02959437|449110181|FG002|Overall Study|Death|0|||
124860308|NCT02959437|449110182|FG003|Overall Study|Death|0|||
124860309|NCT02959437|449110179|FG000|Overall Study|Lost to Follow-up|3|||
124860310|NCT02959437|449110180|FG001|Overall Study|Lost to Follow-up|1|||
124860311|NCT02959437|449110181|FG002|Overall Study|Lost to Follow-up|0|||
124860312|NCT02959437|449110182|FG003|Overall Study|Lost to Follow-up|0|||
124860313|NCT02959437|449110179|FG000|Overall Study|Withdrawal by Subject|11|||
124860314|NCT02959437|449110180|FG001|Overall Study|Withdrawal by Subject|3|||
124860315|NCT02959437|449110181|FG002|Overall Study|Withdrawal by Subject|0|||
124860316|NCT02959437|449110182|FG003|Overall Study|Withdrawal by Subject|0|||
124860317|NCT02959437|449110179|FG000|Overall Study|Progressive Disease|9|||
124860318|NCT02959437|449110180|FG001|Overall Study|Progressive Disease|1|||
124860319|NCT02959437|449110181|FG002|Overall Study|Progressive Disease|0|||
124860320|NCT02959437|449110182|FG003|Overall Study|Progressive Disease|0|||
124860321|NCT02959437|449110179|FG000|Overall Study|Study Terminated by Sponsor|4|||
124860322|NCT02959437|449110180|FG001|Overall Study|Study Terminated by Sponsor|0|||
124860323|NCT02959437|449110181|FG002|Overall Study|Study Terminated by Sponsor|0|||
124860324|NCT02959437|449110182|FG003|Overall Study|Study Terminated by Sponsor|0|||
124860325|NCT02959437|449110179|FG000|Overall Study|Other Unspecified|2|||
124860326|NCT02959437|449110180|FG001|Overall Study|Other Unspecified|0|||
124860327|NCT02959437|449110181|FG002|Overall Study|Other Unspecified|0|||
124860328|NCT02959437|449110182|FG003|Overall Study|Other Unspecified|0|||
124860329|NCT01949480|449110188|FG000|Overall Study|Physician Decision|5|||
124860330|NCT01949480|449110189|FG001|Overall Study|Physician Decision|8|||
124860331|NCT02372396|449110190|FG000|Overall Study|Lost to Follow-up|7|||
124860332|NCT02372396|449110191|FG001|Overall Study|Lost to Follow-up|9|||
124860333|NCT02952924|449110196|FG000|Overall Study|Protocol Violation|0|||
124860334|NCT02952924|449110197|FG001|Overall Study|Protocol Violation|0|||
124860335|NCT02952924|449110198|FG002|Overall Study|Protocol Violation|0|||
124860336|NCT02952924|449110199|FG003|Overall Study|Protocol Violation|0|||
124860337|NCT02952924|449110200|FG004|Overall Study|Protocol Violation|0|||
124860338|NCT02952924|449110201|FG005|Overall Study|Protocol Violation|0|||
124860339|NCT02952924|449110202|FG006|Overall Study|Protocol Violation|0|||
124860340|NCT02952924|449110203|FG007|Overall Study|Protocol Violation|0|||
124860341|NCT02952924|449110204|FG008|Overall Study|Protocol Violation|0|||
124860342|NCT02952924|449110205|FG009|Overall Study|Protocol Violation|0|||
124860343|NCT02952924|449110206|FG010|Overall Study|Protocol Violation|0|||
124860344|NCT02952924|449110207|FG011|Overall Study|Protocol Violation|0|||
124860345|NCT02952924|449110208|FG012|Overall Study|Protocol Violation|0|||
124860346|NCT02952924|449110209|FG013|Overall Study|Protocol Violation|0|||
124860347|NCT02952924|449110210|FG014|Overall Study|Protocol Violation|0|||
124860348|NCT02952924|449110211|FG015|Overall Study|Protocol Violation|0|||
124860349|NCT02952924|449110212|FG016|Overall Study|Protocol Violation|0|||
124860350|NCT02952924|449110213|FG017|Overall Study|Protocol Violation|0|||
124860351|NCT02952924|449110214|FG018|Overall Study|Protocol Violation|0|||
124860352|NCT02952924|449110215|FG019|Overall Study|Protocol Violation|1|||
124860353|NCT02952924|449110216|FG020|Overall Study|Protocol Violation|0|||
124860354|NCT02952924|449110217|FG021|Overall Study|Protocol Violation|0|||
124860355|NCT02952924|449110196|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
124860356|NCT02952924|449110197|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
124860357|NCT02952924|449110198|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
124860358|NCT02952924|449110199|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
124860359|NCT02952924|449110200|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
124860360|NCT02952924|449110201|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
124860361|NCT02952924|449110202|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
124860362|NCT02952924|449110203|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
124860363|NCT02952924|449110204|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
124860364|NCT02952924|449110205|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
124860365|NCT02952924|449110206|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
124860366|NCT02952924|449110207|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
124860367|NCT02952924|449110208|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
124860368|NCT02952924|449110209|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
124860369|NCT02952924|449110210|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
124860370|NCT02952924|449110211|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
124860371|NCT02952924|449110212|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
124860372|NCT02952924|449110213|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
124860373|NCT02952924|449110214|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
124860374|NCT02952924|449110215|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
124860375|NCT02952924|449110216|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
124860376|NCT02952924|449110217|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
124860377|NCT02952924|449110196|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860378|NCT02952924|449110197|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860379|NCT02952924|449110198|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860380|NCT02952924|449110199|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860381|NCT02952924|449110200|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860382|NCT02952924|449110201|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860383|NCT02952924|449110202|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860384|NCT02952924|449110203|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860385|NCT02952924|449110204|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860386|NCT02952924|449110205|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860387|NCT02952924|449110206|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860388|NCT02952924|449110207|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860389|NCT02952924|449110208|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860390|NCT02952924|449110209|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860391|NCT02952924|449110210|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860392|NCT02952924|449110211|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860393|NCT02952924|449110212|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860394|NCT02952924|449110213|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860395|NCT02952924|449110214|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860396|NCT02952924|449110215|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860397|NCT02952924|449110216|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860398|NCT02952924|449110217|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
124860399|NCT02952924|449110196|FG000|Overall Study|Noncompliance with study drug|0|||
124860400|NCT02952924|449110197|FG001|Overall Study|Noncompliance with study drug|0|||
124860401|NCT02952924|449110198|FG002|Overall Study|Noncompliance with study drug|0|||
124860402|NCT02952924|449110199|FG003|Overall Study|Noncompliance with study drug|0|||
124860403|NCT02952924|449110200|FG004|Overall Study|Noncompliance with study drug|0|||
124860404|NCT02952924|449110201|FG005|Overall Study|Noncompliance with study drug|0|||
124860405|NCT02952924|449110202|FG006|Overall Study|Noncompliance with study drug|0|||
124860406|NCT02952924|449110203|FG007|Overall Study|Noncompliance with study drug|0|||
124860407|NCT02952924|449110204|FG008|Overall Study|Noncompliance with study drug|0|||
124860408|NCT02952924|449110205|FG009|Overall Study|Noncompliance with study drug|0|||
124860409|NCT02952924|449110206|FG010|Overall Study|Noncompliance with study drug|0|||
124860410|NCT02952924|449110207|FG011|Overall Study|Noncompliance with study drug|0|||
124860411|NCT02952924|449110208|FG012|Overall Study|Noncompliance with study drug|0|||
124860412|NCT02952924|449110209|FG013|Overall Study|Noncompliance with study drug|0|||
124860413|NCT02952924|449110210|FG014|Overall Study|Noncompliance with study drug|0|||
124860414|NCT02952924|449110211|FG015|Overall Study|Noncompliance with study drug|0|||
124860415|NCT02952924|449110212|FG016|Overall Study|Noncompliance with study drug|0|||
124860416|NCT02952924|449110213|FG017|Overall Study|Noncompliance with study drug|0|||
124860417|NCT02952924|449110214|FG018|Overall Study|Noncompliance with study drug|0|||
124860418|NCT02952924|449110215|FG019|Overall Study|Noncompliance with study drug|0|||
124860419|NCT02952924|449110216|FG020|Overall Study|Noncompliance with study drug|0|||
124860420|NCT02952924|449110217|FG021|Overall Study|Noncompliance with study drug|1|||
124860421|NCT02232893|449110222|FG000|Overall Study|Withdrawal by Subject|4|||
124860422|NCT02232893|449110223|FG001|Overall Study|Withdrawal by Subject|1|||
124860423|NCT02232893|449110222|FG000|Overall Study|Adverse Event|0|||
124860424|NCT02232893|449110223|FG001|Overall Study|Adverse Event|1|||
124860425|NCT02232893|449110222|FG000|Overall Study|Sponsor request early termination|0|||
124860426|NCT02232893|449110223|FG001|Overall Study|Sponsor request early termination|1|||
124860427|NCT02232893|449110222|FG000|Overall Study|Developed exclusion criteria|0|||
124860428|NCT02232893|449110223|FG001|Overall Study|Developed exclusion criteria|1|||
124860429|NCT02232893|449110222|FG000|Overall Study|Other|0|||
124860430|NCT02232893|449110223|FG001|Overall Study|Other|3|||
124860431|NCT01358526|449110224|FG000|Open-label Titration Period|Adverse Event|95|||
124860432|NCT01358526|449110225|FG001|Open-label Titration Period|Adverse Event|0|||
124860433|NCT01358526|449110226|FG002|Open-label Titration Period|Adverse Event|0|||
124860434|NCT01358526|449110224|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
124860435|NCT01358526|449110225|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
124860436|NCT01358526|449110226|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
124860437|NCT01358526|449110224|FG000|Open-label Titration Period|Lost to Follow-up|25|||
124860438|NCT01358526|449110225|FG001|Open-label Titration Period|Lost to Follow-up|0|||
124860439|NCT01358526|449110226|FG002|Open-label Titration Period|Lost to Follow-up|0|||
124860440|NCT01358526|449110224|FG000|Open-label Titration Period|Lack of Efficacy|107|||
124860441|NCT01358526|449110225|FG001|Open-label Titration Period|Lack of Efficacy|0|||
124860442|NCT01358526|449110226|FG002|Open-label Titration Period|Lack of Efficacy|0|||
124860443|NCT01358526|449110224|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
124860444|NCT01358526|449110225|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
124860445|NCT01358526|449110226|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
124860446|NCT01358526|449110224|FG000|Open-label Titration Period|Administrative|8|||
124860447|NCT01358526|449110225|FG001|Open-label Titration Period|Administrative|0|||
124860448|NCT01358526|449110226|FG002|Open-label Titration Period|Administrative|0|||
124860449|NCT01358526|449110224|FG000|Open-label Titration Period|Did not qualify|178|||
124860450|NCT01358526|449110225|FG001|Open-label Titration Period|Did not qualify|0|||
124860451|NCT01358526|449110226|FG002|Open-label Titration Period|Did not qualify|0|||
124860452|NCT01358526|449110224|FG000|Double-blind Phase|Adverse Event|0|||
124860453|NCT01358526|449110225|FG001|Double-blind Phase|Adverse Event|24|||
124860454|NCT01358526|449110226|FG002|Double-blind Phase|Adverse Event|23|||
124860455|NCT01358526|449110224|FG000|Double-blind Phase|Withdrawal by Subject|0|||
124860456|NCT01358526|449110225|FG001|Double-blind Phase|Withdrawal by Subject|10|||
124860457|NCT01358526|449110226|FG002|Double-blind Phase|Withdrawal by Subject|8|||
124860458|NCT01358526|449110224|FG000|Double-blind Phase|Lost to Follow-up|0|||
124860459|NCT01358526|449110225|FG001|Double-blind Phase|Lost to Follow-up|4|||
124860460|NCT01358526|449110226|FG002|Double-blind Phase|Lost to Follow-up|1|||
124860461|NCT01358526|449110224|FG000|Double-blind Phase|Lack of Efficacy|0|||
124860462|NCT01358526|449110225|FG001|Double-blind Phase|Lack of Efficacy|31|||
124860463|NCT01358526|449110226|FG002|Double-blind Phase|Lack of Efficacy|73|||
124860464|NCT01358526|449110224|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
124860465|NCT01358526|449110225|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
124860466|NCT01358526|449110226|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
124860467|NCT01358526|449110224|FG000|Double-blind Phase|Administrative|0|||
124860468|NCT01358526|449110225|FG001|Double-blind Phase|Administrative|6|||
124860469|NCT01358526|449110226|FG002|Double-blind Phase|Administrative|10|||
124860470|NCT00156065|449112754|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
124860471|NCT00156065|449112755|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
124860472|NCT00156065|449112756|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
124860473|NCT00156065|449112754|FG000|Overall Study|Adverse Event|8|||
124860474|NCT00156065|449112755|FG001|Overall Study|Adverse Event|11|||
124860475|NCT00156065|449112756|FG002|Overall Study|Adverse Event|4|||
124860476|NCT00156065|449112754|FG000|Overall Study|Lack of Efficacy|2|||
124860477|NCT00156065|449112755|FG001|Overall Study|Lack of Efficacy|9|||
124860478|NCT00156065|449112756|FG002|Overall Study|Lack of Efficacy|3|||
124860479|NCT00156065|449112754|FG000|Overall Study|Withdrawal by Subject|13|||
124860480|NCT00156065|449112755|FG001|Overall Study|Withdrawal by Subject|26|||
124860481|NCT00156065|449112756|FG002|Overall Study|Withdrawal by Subject|16|||
124860482|NCT00156065|449112754|FG000|Overall Study|Lost to Follow-up|5|||
124860483|NCT00156065|449112755|FG001|Overall Study|Lost to Follow-up|7|||
124860484|NCT00156065|449112756|FG002|Overall Study|Lost to Follow-up|1|||
124860485|NCT00156065|449112754|FG000|Overall Study|Other|2|||
124860486|NCT00156065|449112755|FG001|Overall Study|Other|9|||
124860487|NCT00156065|449112756|FG002|Overall Study|Other|3|||
124860488|NCT04745169|449112757|FG000|Overall Study|Kidney transplantation|1|||
124860489|NCT04745169|449112757|FG000|Overall Study|Participant health problems|3|||
124860490|NCT04745169|449112757|FG000|Overall Study|Physician Decision|2|||
124860491|NCT01292603|449112758|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
124860492|NCT01292603|449112759|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
124860493|NCT01292603|449112760|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
124860494|NCT01292603|449112761|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
124860495|NCT01292603|449112762|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
124860496|NCT01292603|449112763|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
124860497|NCT01292603|449112758|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
124860498|NCT01292603|449112759|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
124860499|NCT01292603|449112760|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
124860500|NCT01292603|449112761|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
124860501|NCT01292603|449112762|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
124860502|NCT01292603|449112763|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
124860503|NCT01292603|449112758|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
124860504|NCT01292603|449112759|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
124860505|NCT01292603|449112760|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
124860506|NCT01292603|449112761|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
124860507|NCT01292603|449112762|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
124860508|NCT01292603|449112763|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
124860509|NCT01292603|449112758|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
124860510|NCT01292603|449112759|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
124860511|NCT01292603|449112760|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
124860512|NCT01292603|449112761|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
124860513|NCT01292603|449112762|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
124860514|NCT01292603|449112763|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
124860515|NCT01292603|449112758|FG000|Part 1: Regular Follow-Up Period|Death|3|||
124860516|NCT01292603|449112759|FG001|Part 1: Regular Follow-Up Period|Death|1|||
124860517|NCT01292603|449112760|FG002|Part 1: Regular Follow-Up Period|Death|3|||
124860518|NCT01292603|449112761|FG003|Part 1: Regular Follow-Up Period|Death|1|||
124860519|NCT01292603|449112762|FG004|Part 1: Regular Follow-Up Period|Death|0|||
124860520|NCT01292603|449112763|FG005|Part 1: Regular Follow-Up Period|Death|0|||
124860521|NCT01292603|449112758|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
124860522|NCT01292603|449112759|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
124860523|NCT01292603|449112760|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
124860524|NCT01292603|449112761|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
124860525|NCT01292603|449112762|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
124860526|NCT01292603|449112763|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
124860527|NCT01292603|449112758|FG000|Part 2: Dose Confirmation Period|Death|0|||
124860528|NCT01292603|449112759|FG001|Part 2: Dose Confirmation Period|Death|0|||
124860529|NCT01292603|449112760|FG002|Part 2: Dose Confirmation Period|Death|0|||
124860530|NCT01292603|449112761|FG003|Part 2: Dose Confirmation Period|Death|0|||
124860531|NCT01292603|449112762|FG004|Part 2: Dose Confirmation Period|Death|1|||
124860532|NCT01292603|449112763|FG005|Part 2: Dose Confirmation Period|Death|0|||
124860533|NCT01292603|449112758|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
124860534|NCT01292603|449112759|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
124860535|NCT01292603|449112760|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
124860536|NCT01292603|449112761|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
124860537|NCT01292603|449112762|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
124860538|NCT01292603|449112763|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
124860539|NCT01292603|449112758|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
124860540|NCT01292603|449112759|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
124860541|NCT01292603|449112760|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
124860542|NCT01292603|449112761|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
124860543|NCT01292603|449112762|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
124860544|NCT01292603|449112763|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
124860545|NCT01292603|449112758|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
124860546|NCT01292603|449112759|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
124860547|NCT01292603|449112760|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
124860548|NCT01292603|449112761|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
124860549|NCT01292603|449112762|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
124860550|NCT01292603|449112763|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
124860551|NCT01292603|449112758|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
124860552|NCT01292603|449112759|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
124860553|NCT01292603|449112760|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
124860554|NCT01292603|449112761|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
124860555|NCT01292603|449112762|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
124860556|NCT01292603|449112763|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
124860557|NCT01292603|449112758|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
124860558|NCT01292603|449112759|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
124860559|NCT01292603|449112760|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
124860560|NCT01292603|449112761|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
124860561|NCT01292603|449112762|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
124860562|NCT01292603|449112763|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
124860563|NCT01292603|449112758|FG000|Part 2: Regular Follow-Up|Death|0|||
124860564|NCT01292603|449112759|FG001|Part 2: Regular Follow-Up|Death|0|||
124860565|NCT01292603|449112760|FG002|Part 2: Regular Follow-Up|Death|0|||
124860566|NCT01292603|449112761|FG003|Part 2: Regular Follow-Up|Death|0|||
124860567|NCT01292603|449112762|FG004|Part 2: Regular Follow-Up|Death|6|||
124860568|NCT01292603|449112763|FG005|Part 2: Regular Follow-Up|Death|3|||
124860569|NCT01292603|449112758|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
124860570|NCT01292603|449112759|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
124860571|NCT01292603|449112760|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
124860572|NCT01292603|449112761|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
124860573|NCT01292603|449112762|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
124860574|NCT01292603|449112763|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
124860575|NCT01292603|449112758|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
124860576|NCT01292603|449112759|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
124860577|NCT01292603|449112760|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
124860578|NCT01292603|449112761|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
124860579|NCT01292603|449112762|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
124860580|NCT01292603|449112763|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
124860581|NCT01292603|449112758|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
124860582|NCT01292603|449112759|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
124860583|NCT01292603|449112760|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
124860584|NCT01292603|449112761|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
124860585|NCT01292603|449112762|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
124860586|NCT01292603|449112763|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
124860587|NCT01292603|449112758|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
124860588|NCT01292603|449112759|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
124860589|NCT01292603|449112760|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
124860590|NCT01292603|449112761|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
124860591|NCT01292603|449112762|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
124860592|NCT01292603|449112763|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
124860593|NCT01292603|449112758|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
124860594|NCT01292603|449112759|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
124860595|NCT01292603|449112760|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
124860596|NCT01292603|449112761|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
124860597|NCT01292603|449112762|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
124860598|NCT01292603|449112763|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
124860599|NCT01292603|449112758|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
124860600|NCT01292603|449112759|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
124860601|NCT01292603|449112760|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
124860602|NCT01292603|449112761|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
124860603|NCT01292603|449112762|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
124860604|NCT01292603|449112763|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
124860605|NCT01292603|449112758|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
124860606|NCT01292603|449112759|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
124860607|NCT01292603|449112760|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
124860608|NCT01292603|449112761|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
124860609|NCT01292603|449112762|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
124860610|NCT01292603|449112763|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
124860611|NCT01292603|449112758|FG000|Overall Survival Status|Death|3|||
124860612|NCT01292603|449112759|FG001|Overall Survival Status|Death|1|||
124860613|NCT01292603|449112760|FG002|Overall Survival Status|Death|3|||
124860614|NCT01292603|449112761|FG003|Overall Survival Status|Death|1|||
124860615|NCT01292603|449112762|FG004|Overall Survival Status|Death|16|||
124860616|NCT01292603|449112763|FG005|Overall Survival Status|Death|10|||
124860617|NCT01808690|449112764|FG000|Overall Study|Withdrawal by Subject|1|||
124860618|NCT01808690|449112765|FG001|Overall Study|Withdrawal by Subject|2|||
124860619|NCT03870763|449112766|FG000|Overall Study|Study terminated by sponsor|0|||
124860620|NCT03870763|449112767|FG001|Overall Study|Study terminated by sponsor|2|||
124860621|NCT03870763|449112768|FG002|Overall Study|Study terminated by sponsor|0|||
124860622|NCT03870763|449112766|FG000|Overall Study|Withdrawal by Subject|0|||
124860623|NCT03870763|449112767|FG001|Overall Study|Withdrawal by Subject|1|||
124860624|NCT03870763|449112768|FG002|Overall Study|Withdrawal by Subject|0|||
124860625|NCT03870763|449112766|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
124860626|NCT03870763|449112767|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
124860627|NCT03870763|449112768|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
124860628|NCT02891187|449112769|FG000|Overall Study|Lost to Follow-up|1|||
124860629|NCT02891187|449112770|FG001|Overall Study|Lost to Follow-up|2|||
124860630|NCT03586648|449112773|FG000|Period 1|Withdrawal by Subject|0|||
124860631|NCT03586648|449112774|FG001|Period 1|Withdrawal by Subject|1|||
124860632|NCT03586648|449112773|FG000|Period 1|Lost to Follow-up|1|||
124860633|NCT03586648|449112774|FG001|Period 1|Lost to Follow-up|1|||
124860634|NCT03586648|449112773|FG000|Period 1|Adverse Event|1|||
124860635|NCT03586648|449112774|FG001|Period 1|Adverse Event|0|||
124860636|NCT03586648|449112773|FG000|Period 1|Study related symptoms or complaints|2|||
124860637|NCT03586648|449112774|FG001|Period 1|Study related symptoms or complaints|1|||
124860638|NCT03586648|449112773|FG000|Period 1|Physician Decision|0|||
124860639|NCT03586648|449112774|FG001|Period 1|Physician Decision|1|||
124860640|NCT03586648|449112773|FG000|Period 2|Adverse Event|1|||
124860641|NCT03586648|449112774|FG001|Period 2|Adverse Event|0|||
124860642|NCT02041195|449112775|FG000|Overall Study|Adverse Event|1|||
124860643|NCT02041195|449112776|FG001|Overall Study|Adverse Event|2|||
124860644|NCT02041195|449112777|FG002|Overall Study|Adverse Event|0|||
124860645|NCT02041195|449112778|FG003|Overall Study|Adverse Event|0|||
124860646|NCT02041195|449112779|FG004|Overall Study|Adverse Event|0|||
124860647|NCT02041195|449112780|FG005|Overall Study|Adverse Event|0|||
124860648|NCT02041195|449112781|FG006|Overall Study|Adverse Event|3|||
124860649|NCT02041195|449112782|FG007|Overall Study|Adverse Event|0|||
124860650|NCT02041195|449112775|FG000|Overall Study|Withdrawal by Subject|1|||
124860651|NCT02041195|449112776|FG001|Overall Study|Withdrawal by Subject|0|||
124860652|NCT02041195|449112777|FG002|Overall Study|Withdrawal by Subject|0|||
124860653|NCT02041195|449112778|FG003|Overall Study|Withdrawal by Subject|0|||
124860654|NCT02041195|449112779|FG004|Overall Study|Withdrawal by Subject|0|||
124860655|NCT02041195|449112780|FG005|Overall Study|Withdrawal by Subject|0|||
124860656|NCT02041195|449112781|FG006|Overall Study|Withdrawal by Subject|4|||
124860657|NCT02041195|449112782|FG007|Overall Study|Withdrawal by Subject|3|||
124860658|NCT02041195|449112775|FG000|Overall Study|Unable to comply with study visits|0|||
124860659|NCT02041195|449112776|FG001|Overall Study|Unable to comply with study visits|1|||
124860660|NCT02041195|449112777|FG002|Overall Study|Unable to comply with study visits|0|||
124860661|NCT02041195|449112778|FG003|Overall Study|Unable to comply with study visits|0|||
124860662|NCT02041195|449112779|FG004|Overall Study|Unable to comply with study visits|1|||
124860663|NCT02041195|449112780|FG005|Overall Study|Unable to comply with study visits|0|||
124860664|NCT02041195|449112781|FG006|Overall Study|Unable to comply with study visits|0|||
124860665|NCT02041195|449112782|FG007|Overall Study|Unable to comply with study visits|0|||
124860666|NCT02395120|449112783|FG000|Overall Study|Missed follow-up dental exam|57|||
124860667|NCT02395120|449112784|FG001|Overall Study|Missed follow-up dental exam|62|||
124860668|NCT02395120|449112785|FG002|Overall Study|Missed follow-up dental exam|6|||
124860669|NCT02395120|449112786|FG003|Overall Study|Missed follow-up dental exam|6|||
124860670|NCT02395120|449112787|FG004|Overall Study|Missed follow-up dental exam|51|||
124860671|NCT00674986|449112789|FG000|Overall Study|Adverse Event|2|||
124860672|NCT00674986|449112790|FG001|Overall Study|Adverse Event|1|||
124860673|NCT00674986|449112789|FG000|Overall Study|Subject withdrew consent|12|||
124860674|NCT00674986|449112790|FG001|Overall Study|Subject withdrew consent|19|||
124860675|NCT00674986|449112789|FG000|Overall Study|Lost to Follow-up|25|||
124860676|NCT00674986|449112790|FG001|Overall Study|Lost to Follow-up|53|||
124860677|NCT00674986|449112789|FG000|Overall Study|Other reasons|4|||
124860678|NCT00674986|449112790|FG001|Overall Study|Other reasons|8|||
124860679|NCT02526693|449112791|FG000|Overall Study|Physician Decision|3|||
124860680|NCT02526693|449112792|FG001|Overall Study|Physician Decision|1|||
124860681|NCT01585103|449112794|FG000|Overall Study|Unable to swallow Cytosponge|6|||
124860682|NCT03581305|449112796|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
124860683|NCT03581305|449112797|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
124860684|NCT03581305|449112796|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
124860685|NCT03581305|449112797|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
124860686|NCT03581305|449112796|FG000|Serotonergic Study|Withdrawal by Subject|5|||
124860687|NCT03581305|449112797|FG001|Serotonergic Study|Withdrawal by Subject|1|||
124860688|NCT01798927|449112800|FG000|Overall Study|Withdrawal by Subject|1|||
124860689|NCT03750552|449112801|FG000|Overall Study|Adverse Event|5|||
124860690|NCT03750552|449112802|FG001|Overall Study|Adverse Event|1|||
124860691|NCT03750552|449112801|FG000|Overall Study|Withdrawal by Subject|1|||
124860692|NCT03750552|449112802|FG001|Overall Study|Withdrawal by Subject|1|||
124860693|NCT03750552|449112801|FG000|Overall Study|Other|2|||
124860694|NCT03750552|449112802|FG001|Overall Study|Other|0|||
124860695|NCT00626522|449112803|FG000|Overall Study|Protocol Violation|0|||
124860696|NCT00626522|449112804|FG001|Overall Study|Protocol Violation|0|||
124860697|NCT00626522|449112805|FG002|Overall Study|Protocol Violation|0|||
124860698|NCT00626522|449112806|FG003|Overall Study|Protocol Violation|0|||
124860699|NCT00626522|449112807|FG004|Overall Study|Protocol Violation|1|||
124860700|NCT00626522|449112808|FG005|Overall Study|Protocol Violation|0|||
124860701|NCT00626522|449112803|FG000|Overall Study|Adverse Event|2|||
124860702|NCT00626522|449112804|FG001|Overall Study|Adverse Event|1|||
124860703|NCT00626522|449112805|FG002|Overall Study|Adverse Event|2|||
124860704|NCT00626522|449112806|FG003|Overall Study|Adverse Event|0|||
124860705|NCT00626522|449112807|FG004|Overall Study|Adverse Event|1|||
124860706|NCT00626522|449112808|FG005|Overall Study|Adverse Event|1|||
124860707|NCT00626522|449112803|FG000|Overall Study|Withdrawal by Subject|2|||
124860708|NCT00626522|449112804|FG001|Overall Study|Withdrawal by Subject|5|||
124860709|NCT00626522|449112805|FG002|Overall Study|Withdrawal by Subject|5|||
124860710|NCT00626522|449112806|FG003|Overall Study|Withdrawal by Subject|0|||
124860711|NCT00626522|449112807|FG004|Overall Study|Withdrawal by Subject|4|||
124860712|NCT00626522|449112808|FG005|Overall Study|Withdrawal by Subject|1|||
124860713|NCT00626522|449112803|FG000|Overall Study|COPD exacerbation|0|||
124860714|NCT00626522|449112804|FG001|Overall Study|COPD exacerbation|0|||
124860715|NCT00626522|449112805|FG002|Overall Study|COPD exacerbation|0|||
124860716|NCT00626522|449112806|FG003|Overall Study|COPD exacerbation|1|||
124860717|NCT00626522|449112807|FG004|Overall Study|COPD exacerbation|1|||
124860718|NCT00626522|449112808|FG005|Overall Study|COPD exacerbation|0|||
124860719|NCT00626522|449112803|FG000|Overall Study|Lost to Follow-up|0|||
124860720|NCT00626522|449112804|FG001|Overall Study|Lost to Follow-up|1|||
124860721|NCT00626522|449112805|FG002|Overall Study|Lost to Follow-up|0|||
124860722|NCT00626522|449112806|FG003|Overall Study|Lost to Follow-up|0|||
124860723|NCT00626522|449112807|FG004|Overall Study|Lost to Follow-up|0|||
124860724|NCT00626522|449112808|FG005|Overall Study|Lost to Follow-up|0|||
124860725|NCT00626522|449112803|FG000|Overall Study|Inconsistent reason reported|1|||
124860726|NCT00626522|449112804|FG001|Overall Study|Inconsistent reason reported|0|||
124860727|NCT00626522|449112805|FG002|Overall Study|Inconsistent reason reported|0|||
124860728|NCT00626522|449112806|FG003|Overall Study|Inconsistent reason reported|0|||
124860729|NCT00626522|449112807|FG004|Overall Study|Inconsistent reason reported|0|||
124860730|NCT00626522|449112808|FG005|Overall Study|Inconsistent reason reported|0|||
124860731|NCT00626522|449112803|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
124860732|NCT00626522|449112804|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
124860733|NCT00626522|449112805|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
124860734|NCT00626522|449112806|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
124860735|NCT00626522|449112807|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
124860736|NCT00626522|449112808|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
124860737|NCT01490632|449112811|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
124860738|NCT01490632|449112812|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
124860739|NCT01490632|449112813|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
124860740|NCT01490632|449112814|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
124860741|NCT01490632|449112815|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
124860742|NCT01490632|449112816|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
124860743|NCT01490632|449112817|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
124860744|NCT01490632|449112818|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
124860745|NCT01490632|449112819|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
124860746|NCT01490632|449112820|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
124860747|NCT01490632|449112821|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
124860748|NCT01490632|449112822|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
124860749|NCT01490632|449112823|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
124860750|NCT01490632|449112824|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
124860751|NCT01490632|449112825|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
124860752|NCT01490632|449112826|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
124860753|NCT01490632|449112827|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
124860754|NCT01490632|449112828|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
124860755|NCT01490632|449112829|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
124860756|NCT01490632|449112830|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
124860757|NCT01490632|449112811|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
124860758|NCT01490632|449112812|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
124860759|NCT01490632|449112813|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
124860760|NCT01490632|449112814|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
124860761|NCT01490632|449112815|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860762|NCT01490632|449112816|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860763|NCT01490632|449112817|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860764|NCT01490632|449112818|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860765|NCT01490632|449112819|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860766|NCT01490632|449112820|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860767|NCT01490632|449112821|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860768|NCT01490632|449112822|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860769|NCT01490632|449112823|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860770|NCT01490632|449112824|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860771|NCT01490632|449112825|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860772|NCT01490632|449112826|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860773|NCT01490632|449112827|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860774|NCT01490632|449112828|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860775|NCT01490632|449112829|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860776|NCT01490632|449112830|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860777|NCT01490632|449112811|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860778|NCT01490632|449112812|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860779|NCT01490632|449112813|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
124860780|NCT01490632|449112814|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
124860781|NCT01490632|449112815|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
124860782|NCT01490632|449112816|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860783|NCT01490632|449112817|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860784|NCT01490632|449112818|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860785|NCT01490632|449112819|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860786|NCT01490632|449112820|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860787|NCT01490632|449112821|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860788|NCT01490632|449112822|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860789|NCT01490632|449112823|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860790|NCT01490632|449112824|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860791|NCT01490632|449112825|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860792|NCT01490632|449112826|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860793|NCT01490632|449112827|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860794|NCT01490632|449112828|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860795|NCT01490632|449112829|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860796|NCT01490632|449112830|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860797|NCT01490632|449112811|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
124860798|NCT01490632|449112812|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
124860799|NCT01490632|449112813|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
124860800|NCT01490632|449112814|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
124860801|NCT01490632|449112815|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
124860802|NCT01490632|449112816|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
124860803|NCT01490632|449112817|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
124860804|NCT01490632|449112818|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
124860805|NCT01490632|449112819|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
124860806|NCT01490632|449112820|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
124860807|NCT01490632|449112821|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
124860808|NCT01490632|449112822|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
124860809|NCT01490632|449112823|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
124860810|NCT01490632|449112824|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
124860811|NCT01490632|449112825|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
124860812|NCT01490632|449112826|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
124860813|NCT01490632|449112827|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
124860814|NCT01490632|449112828|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
124860815|NCT01490632|449112829|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
124860816|NCT01490632|449112830|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
124860817|NCT01490632|449112811|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
124860818|NCT01490632|449112812|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860819|NCT01490632|449112813|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860820|NCT01490632|449112814|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860821|NCT01490632|449112815|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860822|NCT01490632|449112816|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860823|NCT01490632|449112817|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860824|NCT01490632|449112818|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860825|NCT01490632|449112819|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860826|NCT01490632|449112820|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860827|NCT01490632|449112821|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860828|NCT01490632|449112822|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860829|NCT01490632|449112823|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860830|NCT01490632|449112824|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860831|NCT01490632|449112825|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860832|NCT01490632|449112826|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860833|NCT01490632|449112827|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860834|NCT01490632|449112828|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860835|NCT01490632|449112829|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860836|NCT01490632|449112830|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860837|NCT01490632|449112811|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
124860838|NCT01490632|449112812|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
124860839|NCT01490632|449112813|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860840|NCT01490632|449112814|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
124860841|NCT01490632|449112815|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
124860842|NCT01490632|449112816|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860843|NCT01490632|449112817|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860844|NCT01490632|449112818|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860845|NCT01490632|449112819|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860846|NCT01490632|449112820|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860847|NCT01490632|449112821|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860848|NCT01490632|449112822|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860849|NCT01490632|449112823|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860850|NCT01490632|449112824|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860851|NCT01490632|449112825|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860852|NCT01490632|449112826|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860853|NCT01490632|449112827|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860854|NCT01490632|449112828|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860855|NCT01490632|449112829|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860856|NCT01490632|449112830|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860857|NCT01490632|449112811|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860858|NCT01490632|449112812|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860859|NCT01490632|449112813|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860860|NCT01490632|449112814|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860861|NCT01490632|449112815|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
124860862|NCT01490632|449112816|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860863|NCT01490632|449112817|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860864|NCT01490632|449112818|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860865|NCT01490632|449112819|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860866|NCT01490632|449112820|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860867|NCT01490632|449112821|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860868|NCT01490632|449112822|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860869|NCT01490632|449112823|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860870|NCT01490632|449112824|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860871|NCT01490632|449112825|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860872|NCT01490632|449112826|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860873|NCT01490632|449112827|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860874|NCT01490632|449112828|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860875|NCT01490632|449112829|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860876|NCT01490632|449112830|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860877|NCT01490632|449112811|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860878|NCT01490632|449112812|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860879|NCT01490632|449112813|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860880|NCT01490632|449112814|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860881|NCT01490632|449112815|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860882|NCT01490632|449112816|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
124860883|NCT01490632|449112817|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
124860884|NCT01490632|449112818|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860885|NCT01490632|449112819|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860886|NCT01490632|449112820|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
124860887|NCT01490632|449112821|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
124860888|NCT01490632|449112822|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
124860889|NCT01490632|449112823|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860890|NCT01490632|449112824|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860891|NCT01490632|449112825|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860892|NCT01490632|449112826|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860893|NCT01490632|449112827|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860894|NCT01490632|449112828|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860895|NCT01490632|449112829|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860896|NCT01490632|449112830|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860897|NCT01490632|449112811|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860898|NCT01490632|449112812|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860899|NCT01490632|449112813|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860900|NCT01490632|449112814|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860901|NCT01490632|449112815|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860902|NCT01490632|449112816|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860903|NCT01490632|449112817|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
124860904|NCT01490632|449112818|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860905|NCT01490632|449112819|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
124860906|NCT01490632|449112820|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
124860907|NCT01490632|449112821|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
124860908|NCT01490632|449112822|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860909|NCT01490632|449112823|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860910|NCT01490632|449112824|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860911|NCT01490632|449112825|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860912|NCT01490632|449112826|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860913|NCT01490632|449112827|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860914|NCT01490632|449112828|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860915|NCT01490632|449112829|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860916|NCT01490632|449112830|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860917|NCT01490632|449112811|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860918|NCT01490632|449112812|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860919|NCT01490632|449112813|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860920|NCT01490632|449112814|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860921|NCT01490632|449112815|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860922|NCT01490632|449112816|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860923|NCT01490632|449112817|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
124860924|NCT01490632|449112818|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860925|NCT01490632|449112819|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860926|NCT01490632|449112820|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
124860927|NCT01490632|449112821|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860928|NCT01490632|449112822|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860929|NCT01490632|449112823|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860930|NCT01490632|449112824|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860931|NCT01490632|449112825|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860932|NCT01490632|449112826|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860933|NCT01490632|449112827|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860934|NCT01490632|449112828|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860935|NCT01490632|449112829|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860936|NCT01490632|449112830|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860937|NCT01490632|449112811|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860938|NCT01490632|449112812|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860939|NCT01490632|449112813|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860940|NCT01490632|449112814|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860941|NCT01490632|449112815|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860942|NCT01490632|449112816|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860943|NCT01490632|449112817|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
124860944|NCT01490632|449112818|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860945|NCT01490632|449112819|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860946|NCT01490632|449112820|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860947|NCT01490632|449112821|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860948|NCT01490632|449112822|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860949|NCT01490632|449112823|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860950|NCT01490632|449112824|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860951|NCT01490632|449112825|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860952|NCT01490632|449112826|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860953|NCT01490632|449112827|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860954|NCT01490632|449112828|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860955|NCT01490632|449112829|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860956|NCT01490632|449112830|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860957|NCT01490632|449112811|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860958|NCT01490632|449112812|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860959|NCT01490632|449112813|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860960|NCT01490632|449112814|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860961|NCT01490632|449112815|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860962|NCT01490632|449112816|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
124860963|NCT01490632|449112817|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860964|NCT01490632|449112818|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860965|NCT01490632|449112819|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860966|NCT01490632|449112820|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860967|NCT01490632|449112821|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860968|NCT01490632|449112822|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860969|NCT01490632|449112823|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860970|NCT01490632|449112824|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860971|NCT01490632|449112825|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860972|NCT01490632|449112826|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860973|NCT01490632|449112827|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860974|NCT01490632|449112828|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860975|NCT01490632|449112829|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860976|NCT01490632|449112830|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860977|NCT01490632|449112811|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860978|NCT01490632|449112812|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860979|NCT01490632|449112813|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860980|NCT01490632|449112814|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860981|NCT01490632|449112815|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860982|NCT01490632|449112816|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860983|NCT01490632|449112817|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
124860984|NCT01490632|449112818|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860985|NCT01490632|449112819|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
124860986|NCT01490632|449112820|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860987|NCT01490632|449112821|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
124860988|NCT01490632|449112822|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
124860989|NCT01490632|449112823|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860990|NCT01490632|449112824|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860991|NCT01490632|449112825|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860992|NCT01490632|449112826|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860993|NCT01490632|449112827|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860994|NCT01490632|449112828|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860995|NCT01490632|449112829|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860996|NCT01490632|449112830|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860997|NCT01490632|449112811|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124860998|NCT01490632|449112812|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124860999|NCT01490632|449112813|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861000|NCT01490632|449112814|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861001|NCT01490632|449112815|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861002|NCT01490632|449112816|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
124861003|NCT01490632|449112817|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
124861004|NCT01490632|449112818|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
124861005|NCT01490632|449112819|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
124861006|NCT01490632|449112820|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
124861007|NCT01490632|449112821|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
124861008|NCT01490632|449112822|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
124861009|NCT01490632|449112823|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861010|NCT01490632|449112824|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861011|NCT01490632|449112825|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861012|NCT01490632|449112826|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861013|NCT01490632|449112827|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861014|NCT01490632|449112828|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861015|NCT01490632|449112829|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861016|NCT01490632|449112830|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861017|NCT01490632|449112811|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861018|NCT01490632|449112812|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861019|NCT01490632|449112813|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861020|NCT01490632|449112814|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861021|NCT01490632|449112815|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861022|NCT01490632|449112816|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861023|NCT01490632|449112817|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861024|NCT01490632|449112818|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861025|NCT01490632|449112819|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861026|NCT01490632|449112820|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861027|NCT01490632|449112821|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861028|NCT01490632|449112822|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861029|NCT01490632|449112823|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861030|NCT01490632|449112824|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861031|NCT01490632|449112825|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
124861032|NCT01490632|449112826|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
124861033|NCT01490632|449112827|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861034|NCT01490632|449112828|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861035|NCT01490632|449112829|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861036|NCT01490632|449112830|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861037|NCT01490632|449112811|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861038|NCT01490632|449112812|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861039|NCT01490632|449112813|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861040|NCT01490632|449112814|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861041|NCT01490632|449112815|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861042|NCT01490632|449112816|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861043|NCT01490632|449112817|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861044|NCT01490632|449112818|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861045|NCT01490632|449112819|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861046|NCT01490632|449112820|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861047|NCT01490632|449112821|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861048|NCT01490632|449112822|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861049|NCT01490632|449112823|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861050|NCT01490632|449112824|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
124861051|NCT01490632|449112825|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861052|NCT01490632|449112826|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861053|NCT01490632|449112827|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861054|NCT01490632|449112828|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861055|NCT01490632|449112829|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861056|NCT01490632|449112830|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861057|NCT01490632|449112811|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861058|NCT01490632|449112812|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861059|NCT01490632|449112813|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861060|NCT01490632|449112814|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861061|NCT01490632|449112815|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861062|NCT01490632|449112816|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861063|NCT01490632|449112817|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861064|NCT01490632|449112818|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861065|NCT01490632|449112819|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861066|NCT01490632|449112820|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861067|NCT01490632|449112821|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861068|NCT01490632|449112822|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861069|NCT01490632|449112823|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861070|NCT01490632|449112824|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861071|NCT01490632|449112825|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
124861072|NCT01490632|449112826|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
124861073|NCT01490632|449112827|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861074|NCT01490632|449112828|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861075|NCT01490632|449112829|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861076|NCT01490632|449112830|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861077|NCT01490632|449112811|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861078|NCT01490632|449112812|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861079|NCT01490632|449112813|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861080|NCT01490632|449112814|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861081|NCT01490632|449112815|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861082|NCT01490632|449112816|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861083|NCT01490632|449112817|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861084|NCT01490632|449112818|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861085|NCT01490632|449112819|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861086|NCT01490632|449112820|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861087|NCT01490632|449112821|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861088|NCT01490632|449112822|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861089|NCT01490632|449112823|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
124861090|NCT01490632|449112824|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
124861091|NCT01490632|449112825|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
124861092|NCT01490632|449112826|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
124861093|NCT01490632|449112827|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861094|NCT01490632|449112828|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861095|NCT01490632|449112829|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861096|NCT01490632|449112830|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861097|NCT01490632|449112811|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
124861098|NCT01490632|449112812|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
124861099|NCT01490632|449112813|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
124861100|NCT01490632|449112814|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
124861101|NCT01490632|449112815|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
124861102|NCT01490632|449112816|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
124861103|NCT01490632|449112817|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
124861104|NCT01490632|449112818|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
124861105|NCT01490632|449112819|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
124861106|NCT01490632|449112820|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
124861107|NCT01490632|449112821|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
124861108|NCT01490632|449112822|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
124861109|NCT01490632|449112823|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
124861110|NCT01490632|449112824|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
124861111|NCT01490632|449112825|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
124861112|NCT01490632|449112826|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
124861113|NCT01490632|449112827|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
124861114|NCT01490632|449112828|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
124861115|NCT01490632|449112829|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
124861116|NCT01490632|449112830|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
124861117|NCT01490632|449112811|FG000|Part D: Re-Treatment Period|Death|0|||
124861118|NCT01490632|449112812|FG001|Part D: Re-Treatment Period|Death|0|||
124861119|NCT01490632|449112813|FG002|Part D: Re-Treatment Period|Death|0|||
124861120|NCT01490632|449112814|FG003|Part D: Re-Treatment Period|Death|0|||
124861121|NCT01490632|449112815|FG004|Part D: Re-Treatment Period|Death|0|||
124861122|NCT01490632|449112816|FG005|Part D: Re-Treatment Period|Death|0|||
124861123|NCT01490632|449112817|FG006|Part D: Re-Treatment Period|Death|0|||
124861124|NCT01490632|449112818|FG007|Part D: Re-Treatment Period|Death|0|||
124861125|NCT01490632|449112819|FG008|Part D: Re-Treatment Period|Death|0|||
124861126|NCT01490632|449112820|FG009|Part D: Re-Treatment Period|Death|0|||
124861127|NCT01490632|449112821|FG010|Part D: Re-Treatment Period|Death|0|||
124861128|NCT01490632|449112822|FG011|Part D: Re-Treatment Period|Death|0|||
124861129|NCT01490632|449112823|FG012|Part D: Re-Treatment Period|Death|0|||
124861130|NCT01490632|449112824|FG013|Part D: Re-Treatment Period|Death|0|||
124861131|NCT01490632|449112825|FG014|Part D: Re-Treatment Period|Death|0|||
124861132|NCT01490632|449112826|FG015|Part D: Re-Treatment Period|Death|0|||
124861133|NCT01490632|449112827|FG016|Part D: Re-Treatment Period|Death|0|||
124861134|NCT01490632|449112828|FG017|Part D: Re-Treatment Period|Death|0|||
124861135|NCT01490632|449112829|FG018|Part D: Re-Treatment Period|Death|1|||
124861136|NCT01490632|449112830|FG019|Part D: Re-Treatment Period|Death|0|||
124861137|NCT01490632|449112811|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861138|NCT01490632|449112812|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861139|NCT01490632|449112813|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861140|NCT01490632|449112814|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861141|NCT01490632|449112815|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861142|NCT01490632|449112816|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861143|NCT01490632|449112817|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861144|NCT01490632|449112818|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861145|NCT01490632|449112819|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861146|NCT01490632|449112820|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861147|NCT01490632|449112821|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861148|NCT01490632|449112822|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861149|NCT01490632|449112823|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861150|NCT01490632|449112824|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861151|NCT01490632|449112825|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861152|NCT01490632|449112826|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861153|NCT01490632|449112827|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861154|NCT01490632|449112828|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
124861155|NCT01490632|449112829|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
124861156|NCT01490632|449112830|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
124861157|NCT01490632|449112811|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861158|NCT01490632|449112812|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861159|NCT01490632|449112813|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861160|NCT01490632|449112814|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861161|NCT01490632|449112815|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861162|NCT01490632|449112816|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861163|NCT01490632|449112817|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861164|NCT01490632|449112818|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861165|NCT01490632|449112819|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861166|NCT01490632|449112820|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861167|NCT01490632|449112821|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861168|NCT01490632|449112822|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861169|NCT01490632|449112823|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861170|NCT01490632|449112824|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861171|NCT01490632|449112825|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861172|NCT01490632|449112826|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861173|NCT01490632|449112827|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861174|NCT01490632|449112828|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861175|NCT01490632|449112829|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
124861176|NCT01490632|449112830|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861177|NCT01490632|449112811|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
124861178|NCT01490632|449112812|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
124861179|NCT01490632|449112813|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
124861180|NCT01490632|449112814|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
124861181|NCT01490632|449112815|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
124861182|NCT01490632|449112816|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
124861183|NCT01490632|449112817|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
124861184|NCT01490632|449112818|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
124861185|NCT01490632|449112819|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
124861186|NCT01490632|449112820|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
124861187|NCT01490632|449112821|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
124861188|NCT01490632|449112822|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
124861189|NCT01490632|449112823|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
124861190|NCT01490632|449112824|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
124861191|NCT01490632|449112825|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
124861192|NCT01490632|449112826|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
124861193|NCT01490632|449112827|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
124861194|NCT01490632|449112828|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
124861195|NCT01490632|449112829|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
124861196|NCT01490632|449112830|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
124861197|NCT01490632|449112811|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
124861198|NCT01490632|449112812|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
124861199|NCT01490632|449112813|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
124861200|NCT01490632|449112814|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
124861201|NCT01490632|449112815|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
124861202|NCT01490632|449112816|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
124861203|NCT01490632|449112817|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
124861204|NCT01490632|449112818|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
124861205|NCT01490632|449112819|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
124861206|NCT01490632|449112820|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
124861207|NCT01490632|449112821|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
124861208|NCT01490632|449112822|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
124861209|NCT01490632|449112823|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
124861210|NCT01490632|449112824|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
124861211|NCT01490632|449112825|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
124861212|NCT01490632|449112826|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
124861213|NCT01490632|449112827|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
124861214|NCT01490632|449112828|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
124861215|NCT01490632|449112829|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
124861216|NCT01490632|449112830|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
124861217|NCT01490632|449112811|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861218|NCT01490632|449112812|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861219|NCT01490632|449112813|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861220|NCT01490632|449112814|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861221|NCT01490632|449112815|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861222|NCT01490632|449112816|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861223|NCT01490632|449112817|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861224|NCT01490632|449112818|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861225|NCT01490632|449112819|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861226|NCT01490632|449112820|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861227|NCT01490632|449112821|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861228|NCT01490632|449112822|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861229|NCT01490632|449112823|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861230|NCT01490632|449112824|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861231|NCT01490632|449112825|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861232|NCT01490632|449112826|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861233|NCT01490632|449112827|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861234|NCT01490632|449112828|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
124861235|NCT01490632|449112829|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
124861236|NCT01490632|449112830|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
124861237|NCT03822533|449112831|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
124861238|NCT03822533|449112832|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
124861239|NCT03822533|449112831|FG000|3 Month Follow-up|Lost to Follow-up|2|||
124861240|NCT03822533|449112832|FG001|3 Month Follow-up|Lost to Follow-up|2|||
124861241|NCT03822533|449112831|FG000|6 Month Follow-up|Lost to Follow-up|3|||
124861242|NCT03822533|449112832|FG001|6 Month Follow-up|Lost to Follow-up|0|||
124861243|NCT03822533|449112831|FG000|12 Month Follow-up|Lost to Follow-up|2|||
124861244|NCT03822533|449112832|FG001|12 Month Follow-up|Lost to Follow-up|3|||
124861245|NCT03822533|449112831|FG000|12 Month Follow-up|Pregnancy|0|||
124861246|NCT03822533|449112832|FG001|12 Month Follow-up|Pregnancy|1|||
124861247|NCT03822533|449112831|FG000|12 Month Follow-up|Surgery|2|||
124861248|NCT03822533|449112832|FG001|12 Month Follow-up|Surgery|0|||
124861249|NCT03822533|449112831|FG000|12 Month Follow-up|Wrong address|1|||
124861250|NCT03822533|449112832|FG001|12 Month Follow-up|Wrong address|0|||
124861251|NCT03822533|449112831|FG000|12 Month Follow-up|No symptoms|1|||
124861252|NCT03822533|449112832|FG001|12 Month Follow-up|No symptoms|0|||
124861253|NCT03822533|449112831|FG000|12 Month Follow-up|Changed primary care center|0|||
124861254|NCT03822533|449112832|FG001|12 Month Follow-up|Changed primary care center|1|||
124861255|NCT02349295|449112834|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
124861256|NCT02349295|449112835|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
124861257|NCT02349295|449112836|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
124861258|NCT02349295|449112837|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861259|NCT02349295|449112838|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861260|NCT02349295|449112839|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861261|NCT02349295|449112840|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861262|NCT02349295|449112841|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861263|NCT02349295|449112842|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861264|NCT02349295|449112843|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861265|NCT02349295|449112844|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861266|NCT02349295|449112845|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861267|NCT02349295|449112846|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861268|NCT02349295|449112847|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861269|NCT02349295|449112834|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
124861270|NCT02349295|449112835|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
124861271|NCT02349295|449112836|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
124861272|NCT02349295|449112837|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861273|NCT02349295|449112838|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861274|NCT02349295|449112839|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861275|NCT02349295|449112840|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861276|NCT02349295|449112841|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861277|NCT02349295|449112842|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861278|NCT02349295|449112843|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861279|NCT02349295|449112844|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861280|NCT02349295|449112845|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861281|NCT02349295|449112846|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861282|NCT02349295|449112847|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861283|NCT02349295|449112834|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
124861284|NCT02349295|449112835|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
124861285|NCT02349295|449112836|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
124861286|NCT02349295|449112837|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861287|NCT02349295|449112838|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861288|NCT02349295|449112839|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861289|NCT02349295|449112840|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861290|NCT02349295|449112841|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861291|NCT02349295|449112842|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861292|NCT02349295|449112843|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861293|NCT02349295|449112844|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861294|NCT02349295|449112845|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861295|NCT02349295|449112846|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861296|NCT02349295|449112847|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861297|NCT02349295|449112834|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
124861298|NCT02349295|449112835|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
124861299|NCT02349295|449112836|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
124861300|NCT02349295|449112837|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861301|NCT02349295|449112838|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861302|NCT02349295|449112839|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861303|NCT02349295|449112840|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861304|NCT02349295|449112841|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861305|NCT02349295|449112842|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861306|NCT02349295|449112843|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861307|NCT02349295|449112844|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861308|NCT02349295|449112845|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861309|NCT02349295|449112846|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861310|NCT02349295|449112847|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861311|NCT02349295|449112834|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861312|NCT02349295|449112835|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
124861313|NCT02349295|449112836|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
124861314|NCT02349295|449112837|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861315|NCT02349295|449112838|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861316|NCT02349295|449112839|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861317|NCT02349295|449112840|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861318|NCT02349295|449112841|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861319|NCT02349295|449112842|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861320|NCT02349295|449112843|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861321|NCT02349295|449112844|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861322|NCT02349295|449112845|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861323|NCT02349295|449112846|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861324|NCT02349295|449112847|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861325|NCT02349295|449112834|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
124861326|NCT02349295|449112835|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
124861327|NCT02349295|449112836|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
124861328|NCT02349295|449112837|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
124861329|NCT02349295|449112838|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
124861330|NCT02349295|449112839|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
124861331|NCT02349295|449112840|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
124861332|NCT02349295|449112841|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
124861333|NCT02349295|449112842|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
124861334|NCT02349295|449112843|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
124861335|NCT02349295|449112844|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
124861336|NCT02349295|449112845|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
124861337|NCT02349295|449112846|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
124861338|NCT02349295|449112847|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
124861339|NCT02349295|449112834|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
124861340|NCT02349295|449112835|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
124861341|NCT02349295|449112836|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
124861342|NCT02349295|449112837|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
124861343|NCT02349295|449112838|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
124861344|NCT02349295|449112839|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
124861345|NCT02349295|449112840|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
124861346|NCT02349295|449112841|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
124861347|NCT02349295|449112842|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
124861348|NCT02349295|449112843|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
124861349|NCT02349295|449112844|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
124861350|NCT02349295|449112845|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
124861351|NCT02349295|449112846|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
124861352|NCT02349295|449112847|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
124861353|NCT02349295|449112834|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
124861354|NCT02349295|449112835|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
124861355|NCT02349295|449112836|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
124861356|NCT02349295|449112837|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
124861357|NCT02349295|449112838|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
124861358|NCT02349295|449112839|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
124861359|NCT02349295|449112840|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
124861360|NCT02349295|449112841|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
124861361|NCT02349295|449112842|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
124861362|NCT02349295|449112843|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
124861363|NCT02349295|449112844|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
124861364|NCT02349295|449112845|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
124861365|NCT02349295|449112846|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
124861366|NCT02349295|449112847|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
124861367|NCT02349295|449112834|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861368|NCT02349295|449112835|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861369|NCT02349295|449112836|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861370|NCT02349295|449112837|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861371|NCT02349295|449112838|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861372|NCT02349295|449112839|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861373|NCT02349295|449112840|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861374|NCT02349295|449112841|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
124861375|NCT02349295|449112842|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861376|NCT02349295|449112843|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
124861377|NCT02349295|449112844|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861378|NCT02349295|449112845|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861379|NCT02349295|449112846|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861380|NCT02349295|449112847|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861381|NCT02349295|449112834|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
124861382|NCT02349295|449112835|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
124861383|NCT02349295|449112836|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
124861384|NCT02349295|449112837|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
124861385|NCT02349295|449112838|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
124861386|NCT02349295|449112839|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
124861387|NCT02349295|449112840|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
124861388|NCT02349295|449112841|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
124861389|NCT02349295|449112842|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
124861390|NCT02349295|449112843|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
124861391|NCT02349295|449112844|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
124861392|NCT02349295|449112845|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
124861393|NCT02349295|449112846|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
124861394|NCT02349295|449112847|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
124861395|NCT02349295|449112834|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
124861396|NCT02349295|449112835|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
124861397|NCT02349295|449112836|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
124861398|NCT02349295|449112837|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
124861399|NCT02349295|449112838|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
124861400|NCT02349295|449112839|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
124861401|NCT02349295|449112840|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
124861402|NCT02349295|449112841|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
124861403|NCT02349295|449112842|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
124861404|NCT02349295|449112843|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
124861405|NCT02349295|449112844|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
124861406|NCT02349295|449112845|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
124861407|NCT02349295|449112846|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
124861408|NCT02349295|449112847|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
124861409|NCT02349295|449112834|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861410|NCT02349295|449112835|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861411|NCT02349295|449112836|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861412|NCT02349295|449112837|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861413|NCT02349295|449112838|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861414|NCT02349295|449112839|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861415|NCT02349295|449112840|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861416|NCT02349295|449112841|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
124861417|NCT02349295|449112842|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
124861418|NCT02349295|449112843|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861419|NCT02349295|449112844|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861420|NCT02349295|449112845|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861421|NCT02349295|449112846|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861422|NCT02349295|449112847|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861423|NCT02349295|449112834|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861424|NCT02349295|449112835|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861425|NCT02349295|449112836|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861426|NCT02349295|449112837|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861427|NCT02349295|449112838|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861428|NCT02349295|449112839|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861429|NCT02349295|449112840|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861430|NCT02349295|449112841|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
124861431|NCT02349295|449112842|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
124861432|NCT02349295|449112843|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861433|NCT02349295|449112844|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861434|NCT02349295|449112845|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861435|NCT02349295|449112846|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861436|NCT02349295|449112847|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861437|NCT02349295|449112834|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861438|NCT02349295|449112835|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861439|NCT02349295|449112836|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861440|NCT02349295|449112837|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861441|NCT02349295|449112838|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861442|NCT02349295|449112839|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861443|NCT02349295|449112840|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861444|NCT02349295|449112841|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861445|NCT02349295|449112842|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861446|NCT02349295|449112843|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861447|NCT02349295|449112844|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861448|NCT02349295|449112845|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
124861449|NCT02349295|449112846|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
124861450|NCT02349295|449112847|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
124861451|NCT02349295|449112834|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861452|NCT02349295|449112835|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861453|NCT02349295|449112836|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861454|NCT02349295|449112837|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861455|NCT02349295|449112838|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861456|NCT02349295|449112839|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861457|NCT02349295|449112840|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861458|NCT02349295|449112841|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861459|NCT02349295|449112842|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861460|NCT02349295|449112843|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861461|NCT02349295|449112844|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861462|NCT02349295|449112845|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
124861463|NCT02349295|449112846|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
124861464|NCT02349295|449112847|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861465|NCT02349295|449112834|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861466|NCT02349295|449112835|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861467|NCT02349295|449112836|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861468|NCT02349295|449112837|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861469|NCT02349295|449112838|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861470|NCT02349295|449112839|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861471|NCT02349295|449112840|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861472|NCT02349295|449112841|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861473|NCT02349295|449112842|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861474|NCT02349295|449112843|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861475|NCT02349295|449112844|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861476|NCT02349295|449112845|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
124861477|NCT02349295|449112846|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
124861478|NCT02349295|449112847|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861479|NCT02349295|449112834|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861480|NCT02349295|449112835|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861481|NCT02349295|449112836|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861482|NCT02349295|449112837|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861483|NCT02349295|449112838|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861484|NCT02349295|449112839|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861485|NCT02349295|449112840|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861486|NCT02349295|449112841|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861487|NCT02349295|449112842|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861488|NCT02349295|449112843|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861489|NCT02349295|449112844|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861490|NCT02349295|449112845|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
124861491|NCT02349295|449112846|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861492|NCT02349295|449112847|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861493|NCT02349295|449112834|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861494|NCT02349295|449112835|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861495|NCT02349295|449112836|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861496|NCT02349295|449112837|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861497|NCT02349295|449112838|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861498|NCT02349295|449112839|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861499|NCT02349295|449112840|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861500|NCT02349295|449112841|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861501|NCT02349295|449112842|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861502|NCT02349295|449112843|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861503|NCT02349295|449112844|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861504|NCT02349295|449112845|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
124861505|NCT02349295|449112846|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861506|NCT02349295|449112847|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861507|NCT02148250|449112850|FG000|Screening|Withdrawal by Subject|5|||
124861508|NCT02148250|449112851|FG001|Screening|Withdrawal by Subject|0|||
124861509|NCT00695903|449112856|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
124861510|NCT00695903|449112857|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
124861511|NCT00695903|449112856|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
124861512|NCT00695903|449112857|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
124861513|NCT00695903|449112856|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
124861514|NCT00695903|449112857|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
124861515|NCT00695903|449112856|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
124861516|NCT00695903|449112857|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
124861517|NCT00695903|449112856|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
124861518|NCT00695903|449112857|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
124861519|NCT00695903|449112856|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
124861520|NCT00695903|449112857|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
124861521|NCT00695903|449112856|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
124861522|NCT00695903|449112857|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
124861523|NCT00695903|449112856|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
124861524|NCT00695903|449112857|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
124861525|NCT00695903|449112856|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
124861526|NCT00695903|449112857|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
124861527|NCT04723576|449112858|FG000|Overall Study|Withdrawal by Subject|2133|||
124861528|NCT04723576|449112859|FG001|Overall Study|Withdrawal by Subject|3234|||
124861529|NCT02097472|449112860|FG000|Received Vaccination 2|Adverse Event|0|||
124861530|NCT02097472|449112861|FG001|Received Vaccination 2|Adverse Event|0|||
124861531|NCT02097472|449112862|FG002|Received Vaccination 2|Adverse Event|0|||
124861532|NCT02097472|449112863|FG003|Received Vaccination 2|Adverse Event|0|||
124861533|NCT02097472|449112864|FG004|Received Vaccination 2|Adverse Event|0|||
124861534|NCT02097472|449112865|FG005|Received Vaccination 2|Adverse Event|0|||
124861535|NCT02097472|449112866|FG006|Received Vaccination 2|Adverse Event|1|||
124861536|NCT02097472|449112867|FG007|Received Vaccination 2|Adverse Event|0|||
124861537|NCT03966157|449112868|FG000|Overall Study|Physician Decision|1|||
124861538|NCT03966157|449112869|FG001|Overall Study|Physician Decision|0|||
124861539|NCT03305016|449112870|FG000|Overall Study|Withdrawal by Subject|2|||
124861540|NCT01362140|449112871|FG000|Overall Study|Noncompliance|1|||
124861541|NCT01362140|449112872|FG001|Overall Study|Noncompliance|0|||
124861542|NCT01362140|449112871|FG000|Overall Study|Adverse Event|2|||
124861543|NCT01362140|449112872|FG001|Overall Study|Adverse Event|2|||
124861544|NCT01362140|449112871|FG000|Overall Study|Withdrawal by Subject|3|||
124861545|NCT01362140|449112872|FG001|Overall Study|Withdrawal by Subject|3|||
124861546|NCT01362140|449112871|FG000|Overall Study|Administrative Decision|0|||
124861547|NCT01362140|449112872|FG001|Overall Study|Administrative Decision|1|||
124861548|NCT01362140|449112871|FG000|Overall Study|Death|2|||
124861549|NCT01362140|449112872|FG001|Overall Study|Death|1|||
124861550|NCT01362140|449112871|FG000|Overall Study|Other|1|||
124861551|NCT01362140|449112872|FG001|Overall Study|Other|1|||
124861552|NCT01362140|449112871|FG000|Overall Study|Protocol-specified Criteria|1|||
124861553|NCT01362140|449112872|FG001|Overall Study|Protocol-specified Criteria|2|||
124861554|NCT01362140|449112871|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
124861555|NCT01362140|449112872|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
124861556|NCT06476366|449112874|FG000|Overall Study|Lost to Follow-up|1|||
124861557|NCT06476366|449112875|FG001|Overall Study|Lost to Follow-up|3|||
124861558|NCT06476366|449112874|FG000|Overall Study|Adverse Event|1|||
124861559|NCT06476366|449112875|FG001|Overall Study|Adverse Event|0|||
124861560|NCT02310750|449112880|FG000|HP Period 1|Lost to Follow-up|0|||
124861561|NCT02310750|449112881|FG001|HP Period 1|Lost to Follow-up|0|||
124861562|NCT02310750|449112882|FG002|HP Period 1|Lost to Follow-up|0|||
124861563|NCT02310750|449112883|FG003|HP Period 1|Lost to Follow-up|0|||
124861564|NCT02310750|449112884|FG004|HP Period 1|Lost to Follow-up|0|||
124861565|NCT02310750|449112885|FG005|HP Period 1|Lost to Follow-up|0|||
124861566|NCT02310750|449112886|FG006|HP Period 1|Lost to Follow-up|1|||
124861567|NCT02310750|449112887|FG007|HP Period 1|Lost to Follow-up|0|||
124861568|NCT02310750|449112888|FG008|HP Period 1|Lost to Follow-up|0|||
124861569|NCT02310750|449112889|FG009|HP Period 1|Lost to Follow-up|0|||
124861570|NCT02310750|449112890|FG010|HP Period 1|Lost to Follow-up|0|||
124861571|NCT02310750|449112891|FG011|HP Period 1|Lost to Follow-up|0|||
124861572|NCT02310750|449112892|FG012|HP Period 1|Lost to Follow-up|0|||
124861573|NCT02310750|449112893|FG013|HP Period 1|Lost to Follow-up|0|||
124861574|NCT02310750|449112894|FG014|HP Period 1|Lost to Follow-up|0|||
124861575|NCT02310750|449112895|FG015|HP Period 1|Lost to Follow-up|0|||
124861576|NCT02310750|449112880|FG000|HP Period 1|Withdrawal by Subject|1|||
124861577|NCT02310750|449112881|FG001|HP Period 1|Withdrawal by Subject|0|||
124861578|NCT02310750|449112882|FG002|HP Period 1|Withdrawal by Subject|0|||
124861579|NCT02310750|449112883|FG003|HP Period 1|Withdrawal by Subject|1|||
124861580|NCT02310750|449112884|FG004|HP Period 1|Withdrawal by Subject|0|||
124861581|NCT02310750|449112885|FG005|HP Period 1|Withdrawal by Subject|0|||
124861582|NCT02310750|449112886|FG006|HP Period 1|Withdrawal by Subject|0|||
124861583|NCT02310750|449112887|FG007|HP Period 1|Withdrawal by Subject|0|||
124861584|NCT02310750|449112888|FG008|HP Period 1|Withdrawal by Subject|0|||
124861585|NCT02310750|449112889|FG009|HP Period 1|Withdrawal by Subject|0|||
124861586|NCT02310750|449112890|FG010|HP Period 1|Withdrawal by Subject|0|||
124861587|NCT02310750|449112891|FG011|HP Period 1|Withdrawal by Subject|0|||
124861588|NCT02310750|449112892|FG012|HP Period 1|Withdrawal by Subject|0|||
124861589|NCT02310750|449112893|FG013|HP Period 1|Withdrawal by Subject|0|||
124861590|NCT02310750|449112894|FG014|HP Period 1|Withdrawal by Subject|0|||
124861591|NCT02310750|449112895|FG015|HP Period 1|Withdrawal by Subject|0|||
124861592|NCT02310750|449112880|FG000|HP Washout 1|Lost to Follow-up|0|||
124861593|NCT02310750|449112881|FG001|HP Washout 1|Lost to Follow-up|0|||
124861594|NCT02310750|449112882|FG002|HP Washout 1|Lost to Follow-up|1|||
124861595|NCT02310750|449112883|FG003|HP Washout 1|Lost to Follow-up|1|||
124861596|NCT02310750|449112884|FG004|HP Washout 1|Lost to Follow-up|2|||
124861597|NCT02310750|449112885|FG005|HP Washout 1|Lost to Follow-up|2|||
124861598|NCT02310750|449112886|FG006|HP Washout 1|Lost to Follow-up|3|||
124861599|NCT02310750|449112887|FG007|HP Washout 1|Lost to Follow-up|0|||
124861600|NCT02310750|449112888|FG008|HP Washout 1|Lost to Follow-up|0|||
124861601|NCT02310750|449112889|FG009|HP Washout 1|Lost to Follow-up|0|||
124861602|NCT02310750|449112890|FG010|HP Washout 1|Lost to Follow-up|0|||
124861603|NCT02310750|449112891|FG011|HP Washout 1|Lost to Follow-up|0|||
124861604|NCT02310750|449112892|FG012|HP Washout 1|Lost to Follow-up|0|||
124861605|NCT02310750|449112893|FG013|HP Washout 1|Lost to Follow-up|0|||
124861606|NCT02310750|449112894|FG014|HP Washout 1|Lost to Follow-up|0|||
124861607|NCT02310750|449112895|FG015|HP Washout 1|Lost to Follow-up|0|||
124861608|NCT02310750|449112880|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861609|NCT02310750|449112881|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861610|NCT02310750|449112882|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861611|NCT02310750|449112883|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
124861612|NCT02310750|449112884|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861613|NCT02310750|449112885|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
124861614|NCT02310750|449112886|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861615|NCT02310750|449112887|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861616|NCT02310750|449112888|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
124861617|NCT02310750|449112889|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
124861618|NCT02310750|449112890|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861619|NCT02310750|449112891|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861620|NCT02310750|449112892|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861621|NCT02310750|449112893|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861622|NCT02310750|449112894|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861623|NCT02310750|449112895|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861624|NCT02310750|449112880|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861625|NCT02310750|449112881|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861626|NCT02310750|449112882|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861627|NCT02310750|449112883|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861628|NCT02310750|449112884|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861629|NCT02310750|449112885|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861630|NCT02310750|449112886|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861631|NCT02310750|449112887|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861632|NCT02310750|449112888|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861633|NCT02310750|449112889|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
124861634|NCT02310750|449112890|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861635|NCT02310750|449112891|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861636|NCT02310750|449112892|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861637|NCT02310750|449112893|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861638|NCT02310750|449112894|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861639|NCT02310750|449112895|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861640|NCT02310750|449112880|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861641|NCT02310750|449112881|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861642|NCT02310750|449112882|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861643|NCT02310750|449112883|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861644|NCT02310750|449112884|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861645|NCT02310750|449112885|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861646|NCT02310750|449112886|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861647|NCT02310750|449112887|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
124861648|NCT02310750|449112888|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
124861649|NCT02310750|449112889|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
124861650|NCT02310750|449112890|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861651|NCT02310750|449112891|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861652|NCT02310750|449112892|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861653|NCT02310750|449112893|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861654|NCT02310750|449112894|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861655|NCT02310750|449112895|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861656|NCT02310750|449112880|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861657|NCT02310750|449112881|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861658|NCT02310750|449112882|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861659|NCT02310750|449112883|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861660|NCT02310750|449112884|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861661|NCT02310750|449112885|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861662|NCT02310750|449112886|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861663|NCT02310750|449112887|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
124861664|NCT02310750|449112888|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
124861665|NCT02310750|449112889|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861666|NCT02310750|449112890|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861667|NCT02310750|449112891|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861668|NCT02310750|449112892|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861669|NCT02310750|449112893|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861670|NCT02310750|449112894|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861671|NCT02310750|449112895|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861672|NCT02310750|449112880|FG000|HP Washout 2|Lost to Follow-up|0|||
124861673|NCT02310750|449112881|FG001|HP Washout 2|Lost to Follow-up|0|||
124861674|NCT02310750|449112882|FG002|HP Washout 2|Lost to Follow-up|0|||
124861675|NCT02310750|449112883|FG003|HP Washout 2|Lost to Follow-up|0|||
124861676|NCT02310750|449112884|FG004|HP Washout 2|Lost to Follow-up|1|||
124861677|NCT02310750|449112885|FG005|HP Washout 2|Lost to Follow-up|0|||
124861678|NCT02310750|449112886|FG006|HP Washout 2|Lost to Follow-up|7|||
124861679|NCT02310750|449112887|FG007|HP Washout 2|Lost to Follow-up|0|||
124861680|NCT02310750|449112888|FG008|HP Washout 2|Lost to Follow-up|0|||
124861681|NCT02310750|449112889|FG009|HP Washout 2|Lost to Follow-up|0|||
124861682|NCT02310750|449112890|FG010|HP Washout 2|Lost to Follow-up|0|||
124861683|NCT02310750|449112891|FG011|HP Washout 2|Lost to Follow-up|0|||
124861684|NCT02310750|449112892|FG012|HP Washout 2|Lost to Follow-up|0|||
124861685|NCT02310750|449112893|FG013|HP Washout 2|Lost to Follow-up|0|||
124861686|NCT02310750|449112894|FG014|HP Washout 2|Lost to Follow-up|0|||
124861687|NCT02310750|449112895|FG015|HP Washout 2|Lost to Follow-up|0|||
124861688|NCT01226745|449112896|FG000|Overall Study|Did not complete schedule of assessments|8|||
124861689|NCT01226745|449112897|FG001|Overall Study|Did not complete schedule of assessments|3|||
124861690|NCT01226745|449112898|FG002|Overall Study|Did not complete schedule of assessments|6|||
124861691|NCT01226745|449112899|FG003|Overall Study|Did not complete schedule of assessments|0|||
124861692|NCT01226745|449112900|FG004|Overall Study|Did not complete schedule of assessments|0|||
124861693|NCT01226745|449112901|FG005|Overall Study|Did not complete schedule of assessments|1|||
124861694|NCT01226745|449112896|FG000|Overall Study|Lost to Follow-up|2|||
124861695|NCT01226745|449112897|FG001|Overall Study|Lost to Follow-up|6|||
124861696|NCT01226745|449112898|FG002|Overall Study|Lost to Follow-up|6|||
124861697|NCT01226745|449112899|FG003|Overall Study|Lost to Follow-up|1|||
124861698|NCT01226745|449112900|FG004|Overall Study|Lost to Follow-up|1|||
124861699|NCT01226745|449112901|FG005|Overall Study|Lost to Follow-up|2|||
124861700|NCT01226745|449112896|FG000|Overall Study|Death|1|||
124861701|NCT01226745|449112897|FG001|Overall Study|Death|0|||
124861702|NCT01226745|449112898|FG002|Overall Study|Death|0|||
124861703|NCT01226745|449112899|FG003|Overall Study|Death|0|||
124861704|NCT01226745|449112900|FG004|Overall Study|Death|0|||
124861705|NCT01226745|449112901|FG005|Overall Study|Death|1|||
124861706|NCT01226745|449112896|FG000|Overall Study|Other|6|||
124861707|NCT01226745|449112897|FG001|Overall Study|Other|7|||
124861708|NCT01226745|449112898|FG002|Overall Study|Other|8|||
124861709|NCT01226745|449112899|FG003|Overall Study|Other|4|||
124861710|NCT01226745|449112900|FG004|Overall Study|Other|3|||
124861711|NCT01226745|449112901|FG005|Overall Study|Other|1|||
124861712|NCT01435577|449112904|FG000|Overall Study|Adverse Event|10|||
124861713|NCT01435577|449112905|FG001|Overall Study|Adverse Event|0|||
124861714|NCT01435577|449112904|FG000|Overall Study|Lack of Efficacy|7|||
124861715|NCT01435577|449112905|FG001|Overall Study|Lack of Efficacy|51|||
124861716|NCT01435577|449112904|FG000|Overall Study|Alternative treatment started|0|||
124861717|NCT01435577|449112905|FG001|Overall Study|Alternative treatment started|1|||
124861718|NCT01934218|449112906|FG000|Double-blind Phase|Adverse Event|8|||
124861719|NCT01934218|449112907|FG001|Double-blind Phase|Adverse Event|8|||
124861720|NCT01934218|449112906|FG000|Double-blind Phase|Lack of Efficacy|6|||
124861721|NCT01934218|449112907|FG001|Double-blind Phase|Lack of Efficacy|7|||
124861722|NCT01934218|449112906|FG000|Double-blind Phase|Lost to Follow-up|7|||
124861723|NCT01934218|449112907|FG001|Double-blind Phase|Lost to Follow-up|14|||
124861724|NCT01934218|449112906|FG000|Double-blind Phase|Physician Decision|1|||
124861725|NCT01934218|449112907|FG001|Double-blind Phase|Physician Decision|2|||
124861726|NCT01934218|449112906|FG000|Double-blind Phase|Protocol Violation|4|||
124861727|NCT01934218|449112907|FG001|Double-blind Phase|Protocol Violation|0|||
124861728|NCT01934218|449112906|FG000|Double-blind Phase|Withdrawal by Subject|16|||
124861729|NCT01934218|449112907|FG001|Double-blind Phase|Withdrawal by Subject|13|||
124861730|NCT01934218|449112906|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
124861731|NCT01934218|449112907|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
124861732|NCT01934218|449112906|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
124861733|NCT01934218|449112907|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
124861734|NCT01934218|449112906|FG000|Open-Label Phase|Adverse Event|2|||
124861735|NCT01934218|449112907|FG001|Open-Label Phase|Adverse Event|4|||
124861736|NCT01934218|449112906|FG000|Open-Label Phase|Lack of Efficacy|1|||
124861737|NCT01934218|449112907|FG001|Open-Label Phase|Lack of Efficacy|4|||
124861738|NCT01934218|449112906|FG000|Open-Label Phase|Lost to Follow-up|4|||
124861739|NCT01934218|449112907|FG001|Open-Label Phase|Lost to Follow-up|2|||
124861740|NCT01934218|449112906|FG000|Open-Label Phase|Physician Decision|1|||
124861741|NCT01934218|449112907|FG001|Open-Label Phase|Physician Decision|0|||
124861742|NCT01934218|449112906|FG000|Open-Label Phase|Protocol Violation|1|||
124861743|NCT01934218|449112907|FG001|Open-Label Phase|Protocol Violation|0|||
124861744|NCT01934218|449112906|FG000|Open-Label Phase|Withdrawal by Subject|13|||
124861745|NCT01934218|449112907|FG001|Open-Label Phase|Withdrawal by Subject|11|||
124861746|NCT01934218|449112906|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
124861747|NCT01934218|449112907|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
124861748|NCT01934218|449112906|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
124861749|NCT01934218|449112907|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
124861750|NCT01939028|449112910|FG000|Overall Study|Withdrawal by Subject|5|||
124861751|NCT01939028|449112910|FG000|Overall Study|Physician Decision|7|||
124861752|NCT00700401|449112915|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
124861753|NCT00700401|449112915|FG000|Overall Study|Adverse Event|5|||
124861754|NCT00700401|449112915|FG000|Overall Study|Refused Treatment|2|||
124861755|NCT00700401|449112915|FG000|Overall Study|Lost to Follow-up|1|||
124861756|NCT00700401|449112915|FG000|Overall Study|Treatment never started|1|||
124861757|NCT00700401|449112915|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
124861758|NCT00700401|449112915|FG000|Overall Study|Withdrawal by Subject|2|||
124861759|NCT01220557|449112916|FG000|Overall Study|Lost to Follow-up|5|||
124861760|NCT01220557|449112917|FG001|Overall Study|Lost to Follow-up|3|||
124861761|NCT01220557|449112916|FG000|Overall Study|attended less than 6 lessons|1|||
124861762|NCT01220557|449112917|FG001|Overall Study|attended less than 6 lessons|2|||
124861763|NCT01650259|449112918|FG000|Overall Study|Improvement|105|||
124861764|NCT01650259|449112919|FG001|Overall Study|Improvement|0|||
124861765|NCT01650259|449112918|FG000|Overall Study|Adverse Event|127|||
124861766|NCT01650259|449112919|FG001|Overall Study|Adverse Event|0|||
124861767|NCT01650259|449112918|FG000|Overall Study|Lack of Efficacy|143|||
124861768|NCT01650259|449112919|FG001|Overall Study|Lack of Efficacy|0|||
124861769|NCT01650259|449112918|FG000|Overall Study|Lost to Follow-up|435|||
124861770|NCT01650259|449112919|FG001|Overall Study|Lost to Follow-up|0|||
124861771|NCT01650259|449112918|FG000|Overall Study|Patients had no visit after entry|70|||
124861772|NCT01650259|449112919|FG001|Overall Study|Patients had no visit after entry|0|||
124861773|NCT01650259|449112918|FG000|Overall Study|CRF not collected|98|||
124861774|NCT01650259|449112919|FG001|Overall Study|CRF not collected|82|||
124861775|NCT01650259|449112918|FG000|Overall Study|Not treated|1|||
124861776|NCT01650259|449112919|FG001|Overall Study|Not treated|7|||
124861777|NCT01650259|449112918|FG000|Overall Study|Other than listed|64|||
124861778|NCT01650259|449112919|FG001|Overall Study|Other than listed|146|||
124861779|NCT04782323|449112920|FG000|Overall Study|Death|1|||
124861780|NCT04782323|449112921|FG001|Overall Study|Death|0|||
124861781|NCT04782323|449112922|FG002|Overall Study|Death|0|||
124861782|NCT04782323|449112923|FG003|Overall Study|Death|0|||
124861783|NCT04782323|449112924|FG004|Overall Study|Death|1|||
124861784|NCT04782323|449112925|FG005|Overall Study|Death|1|||
124861785|NCT04782323|449112926|FG006|Overall Study|Death|1|||
124861786|NCT04782323|449112927|FG007|Overall Study|Death|0|||
124861787|NCT04782323|449112920|FG000|Overall Study|Withdrawal by Subject|0|||
124861788|NCT04782323|449112921|FG001|Overall Study|Withdrawal by Subject|0|||
124861789|NCT04782323|449112922|FG002|Overall Study|Withdrawal by Subject|1|||
124861790|NCT04782323|449112923|FG003|Overall Study|Withdrawal by Subject|0|||
124861791|NCT04782323|449112924|FG004|Overall Study|Withdrawal by Subject|0|||
124861792|NCT04782323|449112925|FG005|Overall Study|Withdrawal by Subject|1|||
124861793|NCT04782323|449112926|FG006|Overall Study|Withdrawal by Subject|0|||
124861794|NCT04782323|449112927|FG007|Overall Study|Withdrawal by Subject|1|||
124861795|NCT04782323|449112920|FG000|Overall Study|Lost to Follow-up|0|||
124861796|NCT04782323|449112921|FG001|Overall Study|Lost to Follow-up|1|||
124861797|NCT04782323|449112922|FG002|Overall Study|Lost to Follow-up|1|||
124861798|NCT04782323|449112923|FG003|Overall Study|Lost to Follow-up|0|||
124861799|NCT04782323|449112924|FG004|Overall Study|Lost to Follow-up|0|||
124861800|NCT04782323|449112925|FG005|Overall Study|Lost to Follow-up|1|||
124861801|NCT04782323|449112926|FG006|Overall Study|Lost to Follow-up|1|||
124861802|NCT04782323|449112927|FG007|Overall Study|Lost to Follow-up|2|||
124861803|NCT04782323|449112920|FG000|Overall Study|randomization in error|1|||
124861804|NCT04782323|449112921|FG001|Overall Study|randomization in error|0|||
124861805|NCT04782323|449112922|FG002|Overall Study|randomization in error|0|||
124861806|NCT04782323|449112923|FG003|Overall Study|randomization in error|0|||
124861807|NCT04782323|449112924|FG004|Overall Study|randomization in error|0|||
124861808|NCT04782323|449112925|FG005|Overall Study|randomization in error|0|||
124861809|NCT04782323|449112926|FG006|Overall Study|randomization in error|0|||
124861810|NCT04782323|449112927|FG007|Overall Study|randomization in error|0|||
124861811|NCT02663128|449112932|FG000|Period 2|Physician Decision|0|||
124861812|NCT02663128|449112933|FG001|Period 2|Physician Decision|0|||
124861813|NCT02663128|449112934|FG002|Period 2|Physician Decision|0|||
124861814|NCT02663128|449112935|FG003|Period 2|Physician Decision|0|||
124861815|NCT02663128|449112936|FG004|Period 2|Physician Decision|1|||
124861816|NCT02663128|449112937|FG005|Period 2|Physician Decision|0|||
124861817|NCT02715765|449112946|FG000|Overall Study|Study Termination|3|||
124861818|NCT02715765|449112947|FG001|Overall Study|Study Termination|0|||
124861819|NCT02715765|449112948|FG002|Overall Study|Study Termination|0|||
124861820|NCT03387852|449112952|FG000|Overall Study|Adverse event (AE)|3|||
124861821|NCT03387852|449112953|FG001|Overall Study|Adverse event (AE)|0|||
124861822|NCT03387852|449112954|FG002|Overall Study|Adverse event (AE)|2|||
124861823|NCT03387852|449112955|FG003|Overall Study|Adverse event (AE)|0|||
124861824|NCT03387852|449112952|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
124861825|NCT03387852|449112953|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
124861826|NCT03387852|449112954|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
124861827|NCT03387852|449112955|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
124861828|NCT03387852|449112952|FG000|Overall Study|Withdrawal by participant|1|||
124861829|NCT03387852|449112953|FG001|Overall Study|Withdrawal by participant|1|||
124861830|NCT03387852|449112954|FG002|Overall Study|Withdrawal by participant|3|||
124861831|NCT03387852|449112955|FG003|Overall Study|Withdrawal by participant|2|||
124861832|NCT03387852|449112952|FG000|Overall Study|Other- Unspecified|1|||
124861833|NCT03387852|449112953|FG001|Overall Study|Other- Unspecified|1|||
124861834|NCT03387852|449112954|FG002|Overall Study|Other- Unspecified|2|||
124861835|NCT03387852|449112955|FG003|Overall Study|Other- Unspecified|1|||
124861836|NCT03387852|449112952|FG000|Overall Study|Poor compliance to protocol|0|||
124861837|NCT03387852|449112953|FG001|Overall Study|Poor compliance to protocol|0|||
124861838|NCT03387852|449112954|FG002|Overall Study|Poor compliance to protocol|0|||
124861839|NCT03387852|449112955|FG003|Overall Study|Poor compliance to protocol|1|||
124861840|NCT03387852|449112952|FG000|Overall Study|Randomized and not treated|0|||
124861841|NCT03387852|449112953|FG001|Overall Study|Randomized and not treated|0|||
124861842|NCT03387852|449112954|FG002|Overall Study|Randomized and not treated|0|||
124861843|NCT03387852|449112955|FG003|Overall Study|Randomized and not treated|1|||
124861844|NCT02194621|449112966|FG000|Overall Study|6 withdrew prior to randomization|2|||
124861845|NCT02194621|449112967|FG001|Overall Study|6 withdrew prior to randomization|2|||
124861846|NCT02194621|449112968|FG002|Overall Study|6 withdrew prior to randomization|2|||
124861847|NCT02194621|449112966|FG000|Overall Study|Withdrawal by Subject|4|||
124861848|NCT02194621|449112967|FG001|Overall Study|Withdrawal by Subject|4|||
124861849|NCT02194621|449112968|FG002|Overall Study|Withdrawal by Subject|7|||
124861850|NCT02763384|449112969|FG000|Overall Study|Physician Decision|1|||
124861851|NCT02763384|449112969|FG000|Overall Study|Rapid decline - went on hospice|1|||
124861852|NCT02493127|449112970|FG000|Overall Study|Lost to Follow-up|1|||
124861853|NCT02493127|449112971|FG001|Overall Study|Lost to Follow-up|1|||
124861854|NCT03034577|449112973|FG000|Overall Study|Withdrawal by Subject|6|||
124861855|NCT03034577|449112974|FG001|Overall Study|Withdrawal by Subject|9|||
124861856|NCT03034577|449112973|FG000|Overall Study|Lost to Follow-up|25|||
124861857|NCT03034577|449112974|FG001|Overall Study|Lost to Follow-up|26|||
124861858|NCT04177758|449112975|FG000|Overall Study|Lost to Follow-up|19|||
124861859|NCT04177758|449112976|FG001|Overall Study|Lost to Follow-up|11|||
124861860|NCT03156023|449112980|FG000|Overall Study|Withdrawal by Subject|1|||
124861861|NCT03156023|449112981|FG001|Overall Study|Withdrawal by Subject|0|||
124861862|NCT03156023|449112982|FG002|Overall Study|Withdrawal by Subject|2|||
124861863|NCT03156023|449112983|FG003|Overall Study|Withdrawal by Subject|1|||
124861864|NCT03156023|449112984|FG004|Overall Study|Withdrawal by Subject|1|||
124861865|NCT03156023|449112980|FG000|Overall Study|Lost to Follow-up|0|||
124861866|NCT03156023|449112981|FG001|Overall Study|Lost to Follow-up|0|||
124861867|NCT03156023|449112982|FG002|Overall Study|Lost to Follow-up|0|||
124861868|NCT03156023|449112983|FG003|Overall Study|Lost to Follow-up|0|||
124861869|NCT03156023|449112984|FG004|Overall Study|Lost to Follow-up|1|||
124861870|NCT02010060|449112985|FG000|Overall Study|Lost to Follow-up|1|||
124861871|NCT02010060|449112986|FG001|Overall Study|Lost to Follow-up|2|||
124861872|NCT02010060|449112987|FG002|Overall Study|Lost to Follow-up|2|||
124861873|NCT02010060|449112985|FG000|Overall Study|Injury|0|||
124861874|NCT02010060|449112986|FG001|Overall Study|Injury|1|||
124861875|NCT02010060|449112987|FG002|Overall Study|Injury|0|||
124861876|NCT00726752|449112988|FG000|Overall Study|Lack of Efficacy|6|||
124861877|NCT00791765|449115259|FG000|Weeks 1 to 12|Adverse Event|0|||
124861878|NCT00791765|449115260|FG001|Weeks 1 to 12|Adverse Event|1|||
124861879|NCT00791765|449115259|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
124861880|NCT00791765|449115260|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
124861881|NCT00791765|449115259|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
124861882|NCT00791765|449115260|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
124861883|NCT00791765|449115259|FG000|Weeks 1 to 12|Physician Decision|1|||
124861884|NCT00791765|449115260|FG001|Weeks 1 to 12|Physician Decision|0|||
124861885|NCT00791765|449115259|FG000|Weeks 1 to 12|Disease progression|3|||
124861886|NCT00791765|449115260|FG001|Weeks 1 to 12|Disease progression|0|||
124861887|NCT00791765|449115259|FG000|Weeks 1 to 12|Ineligibility determined|0|||
124861888|NCT00791765|449115260|FG001|Weeks 1 to 12|Ineligibility determined|3|||
124861889|NCT00791765|449115259|FG000|Weeks 13 to 24|Protocol deviation|2|||
124861890|NCT00791765|449115260|FG001|Weeks 13 to 24|Protocol deviation|0|||
124861891|NCT00791765|449115259|FG000|Weeks 13 to 24|Adverse Event|0|||
124861892|NCT00791765|449115260|FG001|Weeks 13 to 24|Adverse Event|3|||
124861893|NCT00791765|449115259|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
124861894|NCT00791765|449115260|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
124861895|NCT00791765|449115259|FG000|Weeks 13 to 24|Disease progression|0|||
124861896|NCT00791765|449115260|FG001|Weeks 13 to 24|Disease progression|1|||
124861897|NCT00791765|449115259|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
124861898|NCT00791765|449115260|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
124861899|NCT00791765|449115259|FG000|Weeks 13 to 24|Other|0|||
124861900|NCT00791765|449115260|FG001|Weeks 13 to 24|Other|1|||
124861901|NCT00907153|449115276|FG000|Overall Study|Lost to Follow-up|1|||
124861902|NCT00907153|449115277|FG001|Overall Study|Lost to Follow-up|1|||
124861903|NCT00907153|449115276|FG000|Overall Study|Withdrawal by Subject|1|||
124861904|NCT00907153|449115277|FG001|Overall Study|Withdrawal by Subject|3|||
124861905|NCT04546581|449115278|FG000|Overall Study|Adverse Event|9|||
124861906|NCT04546581|449115279|FG001|Overall Study|Adverse Event|3|||
124861907|NCT04546581|449115278|FG000|Overall Study|Physician Decision|0|||
124861908|NCT04546581|449115279|FG001|Overall Study|Physician Decision|1|||
124861909|NCT04546581|449115278|FG000|Overall Study|Protocol Violation|1|||
124861910|NCT04546581|449115279|FG001|Overall Study|Protocol Violation|2|||
124861911|NCT04546581|449115278|FG000|Overall Study|Withdrawal by Subject|3|||
124861912|NCT04546581|449115279|FG001|Overall Study|Withdrawal by Subject|7|||
124861913|NCT03147248|449115280|FG000|Overall Study|Adverse Event|0|||
124861914|NCT03147248|449115281|FG001|Overall Study|Adverse Event|2|||
124861915|NCT03147248|449115282|FG002|Overall Study|Adverse Event|2|||
124861916|NCT03147248|449115283|FG003|Overall Study|Adverse Event|2|||
124861917|NCT03147248|449115284|FG004|Overall Study|Adverse Event|6|||
124861918|NCT03147248|449115285|FG005|Overall Study|Adverse Event|11|||
124861919|NCT03147248|449115280|FG000|Overall Study|Disease progression|1|||
124861920|NCT03147248|449115281|FG001|Overall Study|Disease progression|0|||
124861921|NCT03147248|449115282|FG002|Overall Study|Disease progression|0|||
124861922|NCT03147248|449115283|FG003|Overall Study|Disease progression|0|||
124861923|NCT03147248|449115284|FG004|Overall Study|Disease progression|0|||
124861924|NCT03147248|449115285|FG005|Overall Study|Disease progression|2|||
124861925|NCT03147248|449115280|FG000|Overall Study|Withdrawal by Subject|0|||
124861926|NCT03147248|449115281|FG001|Overall Study|Withdrawal by Subject|0|||
124861927|NCT03147248|449115282|FG002|Overall Study|Withdrawal by Subject|0|||
124861928|NCT03147248|449115283|FG003|Overall Study|Withdrawal by Subject|0|||
124861929|NCT03147248|449115284|FG004|Overall Study|Withdrawal by Subject|12|||
124861930|NCT03147248|449115285|FG005|Overall Study|Withdrawal by Subject|9|||
124861931|NCT03147248|449115280|FG000|Overall Study|Protocol Violation|0|||
124861932|NCT03147248|449115281|FG001|Overall Study|Protocol Violation|0|||
124861933|NCT03147248|449115282|FG002|Overall Study|Protocol Violation|0|||
124861934|NCT03147248|449115283|FG003|Overall Study|Protocol Violation|0|||
124861935|NCT03147248|449115284|FG004|Overall Study|Protocol Violation|2|||
124861936|NCT03147248|449115285|FG005|Overall Study|Protocol Violation|0|||
124861937|NCT03147248|449115280|FG000|Overall Study|Lost to Follow-up|0|||
124861938|NCT03147248|449115281|FG001|Overall Study|Lost to Follow-up|0|||
124861939|NCT03147248|449115282|FG002|Overall Study|Lost to Follow-up|0|||
124861940|NCT03147248|449115283|FG003|Overall Study|Lost to Follow-up|0|||
124861941|NCT03147248|449115284|FG004|Overall Study|Lost to Follow-up|2|||
124861942|NCT03147248|449115285|FG005|Overall Study|Lost to Follow-up|0|||
124861943|NCT03147248|449115280|FG000|Overall Study|Pregnancy|0|||
124861944|NCT03147248|449115281|FG001|Overall Study|Pregnancy|0|||
124861945|NCT03147248|449115282|FG002|Overall Study|Pregnancy|0|||
124861946|NCT03147248|449115283|FG003|Overall Study|Pregnancy|0|||
124861947|NCT03147248|449115284|FG004|Overall Study|Pregnancy|1|||
124861948|NCT03147248|449115285|FG005|Overall Study|Pregnancy|0|||
124861949|NCT03147248|449115280|FG000|Overall Study|Death|0|||
124861950|NCT03147248|449115281|FG001|Overall Study|Death|0|||
124861951|NCT03147248|449115282|FG002|Overall Study|Death|0|||
124861952|NCT03147248|449115283|FG003|Overall Study|Death|0|||
124861953|NCT03147248|449115284|FG004|Overall Study|Death|0|||
124861954|NCT03147248|449115285|FG005|Overall Study|Death|4|||
124861955|NCT03147248|449115280|FG000|Overall Study|Physician Decision|0|||
124861956|NCT03147248|449115281|FG001|Overall Study|Physician Decision|0|||
124861957|NCT03147248|449115282|FG002|Overall Study|Physician Decision|0|||
124861958|NCT03147248|449115283|FG003|Overall Study|Physician Decision|0|||
124861959|NCT03147248|449115284|FG004|Overall Study|Physician Decision|2|||
124861960|NCT03147248|449115285|FG005|Overall Study|Physician Decision|4|||
124861961|NCT03147248|449115280|FG000|Overall Study|Prolonged Dosing Interval|0|||
124861962|NCT03147248|449115281|FG001|Overall Study|Prolonged Dosing Interval|0|||
124861963|NCT03147248|449115282|FG002|Overall Study|Prolonged Dosing Interval|0|||
124861964|NCT03147248|449115283|FG003|Overall Study|Prolonged Dosing Interval|0|||
124861965|NCT03147248|449115284|FG004|Overall Study|Prolonged Dosing Interval|1|||
124861966|NCT03147248|449115285|FG005|Overall Study|Prolonged Dosing Interval|1|||
124861967|NCT02062632|449115286|FG000|Overall Study|No treatment data|1|||
124861968|NCT02280044|449115289|FG000|Overall Study|Planned alternate|0|||
124861969|NCT02280044|449115290|FG001|Overall Study|Planned alternate|2|||
124861970|NCT02332720|449115298|FG000|Part A and Part B|Lost to Follow-up|1|||
124861971|NCT02332720|449115299|FG001|Part A and Part B|Lost to Follow-up|0|||
124861972|NCT02332720|449115300|FG002|Part A and Part B|Lost to Follow-up|0|||
124861973|NCT02332720|449115301|FG003|Part A and Part B|Lost to Follow-up|0|||
124861974|NCT02332720|449115302|FG004|Part A and Part B|Lost to Follow-up|0|||
124861975|NCT02332720|449115303|FG005|Part A and Part B|Lost to Follow-up|2|||
124861976|NCT02332720|449115304|FG006|Part A and Part B|Lost to Follow-up|1|||
124861977|NCT02332720|449115305|FG007|Part A and Part B|Lost to Follow-up|1|||
124861978|NCT02332720|449115306|FG008|Part A and Part B|Lost to Follow-up|0|||
124861979|NCT02332720|449115307|FG009|Part A and Part B|Lost to Follow-up|0|||
124861980|NCT02332720|449115308|FG010|Part A and Part B|Lost to Follow-up|0|||
124861981|NCT02332720|449115309|FG011|Part A and Part B|Lost to Follow-up|0|||
124861982|NCT02332720|449115310|FG012|Part A and Part B|Lost to Follow-up|0|||
124861983|NCT02332720|449115311|FG013|Part A and Part B|Lost to Follow-up|0|||
124861984|NCT02332720|449115312|FG014|Part A and Part B|Lost to Follow-up|0|||
124861985|NCT02332720|449115313|FG015|Part A and Part B|Lost to Follow-up|1|||
124861986|NCT02332720|449115314|FG016|Part A and Part B|Lost to Follow-up|0|||
124861987|NCT02332720|449115315|FG017|Part A and Part B|Lost to Follow-up|0|||
124861988|NCT02332720|449115316|FG018|Part A and Part B|Lost to Follow-up|0|||
124861989|NCT02332720|449115317|FG019|Part A and Part B|Lost to Follow-up|0|||
124861990|NCT02332720|449115318|FG020|Part A and Part B|Lost to Follow-up|0|||
124861991|NCT02332720|449115319|FG021|Part A and Part B|Lost to Follow-up|0|||
124861992|NCT02332720|449115320|FG022|Part A and Part B|Lost to Follow-up|0|||
124861993|NCT02332720|449115298|FG000|Part A and Part B|Adverse Event|0|||
124861994|NCT02332720|449115299|FG001|Part A and Part B|Adverse Event|0|||
124861995|NCT02332720|449115300|FG002|Part A and Part B|Adverse Event|0|||
124861996|NCT02332720|449115301|FG003|Part A and Part B|Adverse Event|0|||
124861997|NCT02332720|449115302|FG004|Part A and Part B|Adverse Event|0|||
124861998|NCT02332720|449115303|FG005|Part A and Part B|Adverse Event|0|||
124861999|NCT02332720|449115304|FG006|Part A and Part B|Adverse Event|0|||
124862000|NCT02332720|449115305|FG007|Part A and Part B|Adverse Event|0|||
124862001|NCT02332720|449115306|FG008|Part A and Part B|Adverse Event|0|||
124862002|NCT02332720|449115307|FG009|Part A and Part B|Adverse Event|0|||
124862003|NCT02332720|449115308|FG010|Part A and Part B|Adverse Event|0|||
124862004|NCT02332720|449115309|FG011|Part A and Part B|Adverse Event|0|||
124862005|NCT02332720|449115310|FG012|Part A and Part B|Adverse Event|0|||
124862006|NCT02332720|449115311|FG013|Part A and Part B|Adverse Event|0|||
124862007|NCT02332720|449115312|FG014|Part A and Part B|Adverse Event|0|||
124862008|NCT02332720|449115313|FG015|Part A and Part B|Adverse Event|0|||
124862009|NCT02332720|449115314|FG016|Part A and Part B|Adverse Event|0|||
124862010|NCT02332720|449115315|FG017|Part A and Part B|Adverse Event|1|||
124862011|NCT02332720|449115316|FG018|Part A and Part B|Adverse Event|0|||
124862012|NCT02332720|449115317|FG019|Part A and Part B|Adverse Event|0|||
124862013|NCT02332720|449115318|FG020|Part A and Part B|Adverse Event|0|||
124862014|NCT02332720|449115319|FG021|Part A and Part B|Adverse Event|0|||
124862015|NCT02332720|449115320|FG022|Part A and Part B|Adverse Event|0|||
124862016|NCT02332720|449115298|FG000|Part A and Part B|Physician Decision|0|||
124862017|NCT02332720|449115299|FG001|Part A and Part B|Physician Decision|0|||
124862018|NCT02332720|449115300|FG002|Part A and Part B|Physician Decision|0|||
124862019|NCT02332720|449115301|FG003|Part A and Part B|Physician Decision|0|||
124862020|NCT02332720|449115302|FG004|Part A and Part B|Physician Decision|0|||
124862021|NCT02332720|449115303|FG005|Part A and Part B|Physician Decision|0|||
124862022|NCT02332720|449115304|FG006|Part A and Part B|Physician Decision|0|||
124862023|NCT02332720|449115305|FG007|Part A and Part B|Physician Decision|0|||
124862024|NCT02332720|449115306|FG008|Part A and Part B|Physician Decision|0|||
124862025|NCT02332720|449115307|FG009|Part A and Part B|Physician Decision|0|||
124862026|NCT02332720|449115308|FG010|Part A and Part B|Physician Decision|0|||
124862027|NCT02332720|449115309|FG011|Part A and Part B|Physician Decision|0|||
124862028|NCT02332720|449115310|FG012|Part A and Part B|Physician Decision|0|||
124862029|NCT02332720|449115311|FG013|Part A and Part B|Physician Decision|0|||
124862030|NCT02332720|449115312|FG014|Part A and Part B|Physician Decision|0|||
124862031|NCT02332720|449115313|FG015|Part A and Part B|Physician Decision|0|||
124862032|NCT02332720|449115314|FG016|Part A and Part B|Physician Decision|0|||
124862033|NCT02332720|449115315|FG017|Part A and Part B|Physician Decision|0|||
124862034|NCT02332720|449115316|FG018|Part A and Part B|Physician Decision|1|||
124862035|NCT02332720|449115317|FG019|Part A and Part B|Physician Decision|0|||
124862036|NCT02332720|449115318|FG020|Part A and Part B|Physician Decision|0|||
124862037|NCT02332720|449115319|FG021|Part A and Part B|Physician Decision|0|||
124862038|NCT02332720|449115320|FG022|Part A and Part B|Physician Decision|0|||
124862039|NCT02332720|449115298|FG000|Part A and Part B|Withdrawal by Subject|0|||
124862040|NCT02332720|449115299|FG001|Part A and Part B|Withdrawal by Subject|0|||
124862041|NCT02332720|449115300|FG002|Part A and Part B|Withdrawal by Subject|0|||
124862042|NCT02332720|449115301|FG003|Part A and Part B|Withdrawal by Subject|0|||
124862043|NCT02332720|449115302|FG004|Part A and Part B|Withdrawal by Subject|0|||
124862044|NCT02332720|449115303|FG005|Part A and Part B|Withdrawal by Subject|1|||
124862045|NCT02332720|449115304|FG006|Part A and Part B|Withdrawal by Subject|0|||
124862046|NCT02332720|449115305|FG007|Part A and Part B|Withdrawal by Subject|0|||
124862047|NCT02332720|449115306|FG008|Part A and Part B|Withdrawal by Subject|0|||
124862048|NCT02332720|449115307|FG009|Part A and Part B|Withdrawal by Subject|0|||
124862049|NCT02332720|449115308|FG010|Part A and Part B|Withdrawal by Subject|0|||
124862050|NCT02332720|449115309|FG011|Part A and Part B|Withdrawal by Subject|0|||
124862051|NCT02332720|449115310|FG012|Part A and Part B|Withdrawal by Subject|0|||
124862052|NCT02332720|449115311|FG013|Part A and Part B|Withdrawal by Subject|0|||
124862053|NCT02332720|449115312|FG014|Part A and Part B|Withdrawal by Subject|0|||
124862054|NCT02332720|449115313|FG015|Part A and Part B|Withdrawal by Subject|0|||
124862055|NCT02332720|449115314|FG016|Part A and Part B|Withdrawal by Subject|0|||
124862056|NCT02332720|449115315|FG017|Part A and Part B|Withdrawal by Subject|0|||
124862057|NCT02332720|449115316|FG018|Part A and Part B|Withdrawal by Subject|0|||
124862058|NCT02332720|449115317|FG019|Part A and Part B|Withdrawal by Subject|1|||
124862059|NCT02332720|449115318|FG020|Part A and Part B|Withdrawal by Subject|0|||
124862060|NCT02332720|449115319|FG021|Part A and Part B|Withdrawal by Subject|0|||
124862061|NCT02332720|449115320|FG022|Part A and Part B|Withdrawal by Subject|0|||
124862062|NCT03832010|449115321|FG000|Overall Study|Withdrawal by Subject|2|||
124862063|NCT03832010|449115322|FG001|Overall Study|Withdrawal by Subject|1|||
124862064|NCT03832010|449115323|FG002|Overall Study|Withdrawal by Subject|0|||
124862065|NCT03832010|449115321|FG000|Overall Study|Lost to Follow-up|2|||
124862066|NCT03832010|449115322|FG001|Overall Study|Lost to Follow-up|1|||
124862067|NCT03832010|449115323|FG002|Overall Study|Lost to Follow-up|1|||
124862068|NCT01412944|449115324|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
124862069|NCT01412944|449115325|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
124862070|NCT01412944|449115326|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
124862071|NCT01412944|449115327|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
124862072|NCT01412944|449115328|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
124862073|NCT01412944|449115329|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
124862074|NCT01412944|449115324|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
124862075|NCT01412944|449115325|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
124862076|NCT01412944|449115326|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
124862077|NCT01412944|449115327|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
124862078|NCT01412944|449115328|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
124862079|NCT01412944|449115329|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
124862080|NCT01412944|449115324|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
124862081|NCT01412944|449115325|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
124862082|NCT01412944|449115326|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
124862083|NCT01412944|449115327|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
124862084|NCT01412944|449115328|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
124862085|NCT01412944|449115329|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
124862086|NCT01412944|449115324|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
124862087|NCT01412944|449115325|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
124862088|NCT01412944|449115326|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
124862089|NCT01412944|449115327|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
124862090|NCT01412944|449115328|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
124862091|NCT01412944|449115329|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
124862092|NCT01412944|449115324|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
124862093|NCT01412944|449115325|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
124862094|NCT01412944|449115326|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
124862095|NCT01412944|449115327|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
124862096|NCT01412944|449115328|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
124862097|NCT01412944|449115329|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
124862098|NCT01412944|449115324|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
124862099|NCT01412944|449115325|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
124862100|NCT01412944|449115326|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
124862101|NCT01412944|449115327|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
124862102|NCT01412944|449115328|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
124862103|NCT01412944|449115329|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
124862104|NCT01412944|449115324|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
124862105|NCT01412944|449115325|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
124862106|NCT01412944|449115326|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
124862107|NCT01412944|449115327|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
124862108|NCT01412944|449115328|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
124862109|NCT01412944|449115329|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
124862110|NCT01412944|449115324|FG000|Entire: IV + Maintenance|Adverse Event|0|||
124862111|NCT01412944|449115325|FG001|Entire: IV + Maintenance|Adverse Event|0|||
124862112|NCT01412944|449115326|FG002|Entire: IV + Maintenance|Adverse Event|0|||
124862113|NCT01412944|449115327|FG003|Entire: IV + Maintenance|Adverse Event|0|||
124862114|NCT01412944|449115328|FG004|Entire: IV + Maintenance|Adverse Event|1|||
124862115|NCT01412944|449115329|FG005|Entire: IV + Maintenance|Adverse Event|0|||
124862116|NCT01412944|449115324|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
124862117|NCT01412944|449115325|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
124862118|NCT01412944|449115326|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
124862119|NCT01412944|449115327|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
124862120|NCT01412944|449115328|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
124862121|NCT01412944|449115329|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
124862122|NCT01412944|449115324|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
124862123|NCT01412944|449115325|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
124862124|NCT01412944|449115326|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
124862125|NCT01412944|449115327|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
124862126|NCT01412944|449115328|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
124862127|NCT01412944|449115329|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
124862128|NCT01412944|449115324|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
124862129|NCT01412944|449115325|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
124862130|NCT01412944|449115326|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
124862131|NCT01412944|449115327|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
124862132|NCT01412944|449115328|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
124862133|NCT01412944|449115329|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
124862134|NCT01412944|449115324|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
124862135|NCT01412944|449115325|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
124862136|NCT01412944|449115326|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
124862137|NCT01412944|449115327|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
124862138|NCT01412944|449115328|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
124862139|NCT01412944|449115329|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
124862140|NCT01412944|449115324|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
124862141|NCT01412944|449115325|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
124862142|NCT01412944|449115326|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
124862143|NCT01412944|449115327|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
124862144|NCT01412944|449115328|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
124862145|NCT01412944|449115329|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
124862146|NCT01412944|449115324|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
124862147|NCT01412944|449115325|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
124862148|NCT01412944|449115326|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
124862149|NCT01412944|449115327|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
124862150|NCT01412944|449115328|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
124862151|NCT01412944|449115329|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
124862152|NCT01412944|449115324|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
124862153|NCT01412944|449115325|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
124862154|NCT01412944|449115326|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
124862155|NCT01412944|449115327|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
124862156|NCT01412944|449115328|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
124862157|NCT01412944|449115329|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
124862158|NCT01412944|449115324|FG000|Entire: IV + Maintenance|Adverse Event|0|||
124862159|NCT01412944|449115325|FG001|Entire: IV + Maintenance|Adverse Event|1|||
124862160|NCT01412944|449115326|FG002|Entire: IV + Maintenance|Adverse Event|0|||
124862161|NCT01412944|449115327|FG003|Entire: IV + Maintenance|Adverse Event|0|||
124862162|NCT01412944|449115328|FG004|Entire: IV + Maintenance|Adverse Event|0|||
124862163|NCT01412944|449115329|FG005|Entire: IV + Maintenance|Adverse Event|0|||
124862164|NCT01990950|449115330|FG000|Overall Study|Death|3|||
124862165|NCT01990950|449115330|FG000|Overall Study|Lost to Follow-up|2|||
124862166|NCT01990950|449115330|FG000|Overall Study|Withdrawal by Subject|6|||
124862167|NCT00922428|449115331|FG000|Overall Study|retrospective/extremely implausible data|2|||
124862168|NCT00922428|449115331|FG000|Overall Study|no medication use or questionable use|13|||
124862169|NCT01343368|449115332|FG000|Overall Study|Death|1|||
124862170|NCT01343368|449115333|FG001|Overall Study|Death|0|||
124862171|NCT01343368|449115332|FG000|Overall Study|Lost to Follow-up|1|||
124862172|NCT01343368|449115333|FG001|Overall Study|Lost to Follow-up|0|||
124862173|NCT00321854|449115334|FG000|Overall Study|Adverse Event|41|||
124862174|NCT00321854|449115335|FG001|Overall Study|Adverse Event|43|||
124862175|NCT00321854|449115334|FG000|Overall Study|Lack of Efficacy|9|||
124862176|NCT00321854|449115335|FG001|Overall Study|Lack of Efficacy|14|||
124862177|NCT00321854|449115334|FG000|Overall Study|Protocol Violation|6|||
124862178|NCT00321854|449115335|FG001|Overall Study|Protocol Violation|5|||
124862179|NCT00321854|449115334|FG000|Overall Study|Lost to Follow-up|0|||
124862180|NCT00321854|449115335|FG001|Overall Study|Lost to Follow-up|2|||
124862181|NCT00321854|449115334|FG000|Overall Study|Withdrawal by Subject|6|||
124862182|NCT00321854|449115335|FG001|Overall Study|Withdrawal by Subject|17|||
124862183|NCT00321854|449115334|FG000|Overall Study|Other|1|||
124862184|NCT00321854|449115335|FG001|Overall Study|Other|1|||
124862185|NCT03204279|449115336|FG000|Overall Study|Withdrawal by Subject|0|||
124862186|NCT03204279|449115337|FG001|Overall Study|Withdrawal by Subject|1|||
124862187|NCT02119416|449115338|FG000|Overall Study|Protocol Violation|1|||
124862188|NCT02119416|449115339|FG001|Overall Study|Protocol Violation|1|||
124862189|NCT02119416|449115340|FG002|Overall Study|Protocol Violation|1|||
124862190|NCT02119416|449115338|FG000|Overall Study|wrong pubertal stage|1|||
124862191|NCT02119416|449115339|FG001|Overall Study|wrong pubertal stage|0|||
124862192|NCT02119416|449115340|FG002|Overall Study|wrong pubertal stage|1|||
124862193|NCT02384759|449115344|FG000|Overall Study|Patients not treated|3|||
124862194|NCT02384759|449115345|FG001|Overall Study|Patients not treated|2|||
124862195|NCT03043664|449115346|FG000|Overall Study|Lost to Follow-up|1|||
124862196|NCT03593655|449115348|FG000|First Product Use Period|Withdrawal by Subject|1|||
124862197|NCT03593655|449115349|FG001|First Product Use Period|Withdrawal by Subject|1|||
124862198|NCT03593655|449115348|FG000|First Product Use Period|Lost to Follow-up|1|||
124862199|NCT03593655|449115349|FG001|First Product Use Period|Lost to Follow-up|3|||
124862200|NCT03593655|449115348|FG000|Second Product Use Period|Withdrawal by Subject|1|||
124862201|NCT03593655|449115349|FG001|Second Product Use Period|Withdrawal by Subject|1|||
124862202|NCT03593655|449115348|FG000|Second Product Use Period|Lost to Follow-up|1|||
124862203|NCT03593655|449115349|FG001|Second Product Use Period|Lost to Follow-up|0|||
124862204|NCT03593655|449115348|FG000|Third Product Use Period|Lost to Follow-up|1|||
124862205|NCT03593655|449115349|FG001|Third Product Use Period|Lost to Follow-up|2|||
124862206|NCT03593655|449115348|FG000|Third Product Use Period|Physician Decision|0|||
124862207|NCT03593655|449115349|FG001|Third Product Use Period|Physician Decision|1|||
124862208|NCT03593655|449115348|FG000|Third Product Use Period|Withdrawal by Subject|0|||
124862209|NCT03593655|449115349|FG001|Third Product Use Period|Withdrawal by Subject|1|||
124862210|NCT03732209|449115354|FG000|Overall Study|Lost to Follow-up|4|||
124862211|NCT03732209|449115355|FG001|Overall Study|Lost to Follow-up|4|||
124862212|NCT03732209|449115354|FG000|Overall Study|Withdrawal by Subject|8|||
124862213|NCT03732209|449115355|FG001|Overall Study|Withdrawal by Subject|9|||
124862214|NCT05046795|449115356|FG000|Overall Study|Adverse Event|13|||
124862215|NCT05046795|449115357|FG001|Overall Study|Adverse Event|15|||
124862216|NCT05046795|449115356|FG000|Overall Study|Withdrawal by Subject|4|||
124862217|NCT05046795|449115357|FG001|Overall Study|Withdrawal by Subject|7|||
124862218|NCT05046795|449115356|FG000|Overall Study|Physician Decision|1|||
124862219|NCT05046795|449115357|FG001|Overall Study|Physician Decision|2|||
124862220|NCT05046795|449115356|FG000|Overall Study|Protocol Violation|1|||
124862221|NCT05046795|449115357|FG001|Overall Study|Protocol Violation|2|||
124862222|NCT05046795|449115356|FG000|Overall Study|Death|1|||
124862223|NCT05046795|449115357|FG001|Overall Study|Death|0|||
124862224|NCT05046795|449115356|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
124862225|NCT05046795|449115357|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
124862226|NCT03759873|449115360|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
124862227|NCT03759873|449115361|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
124862228|NCT03759873|449115362|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
124862229|NCT03759873|449115363|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
124862230|NCT03759873|449115360|FG000|Overall Study|Moved outside eligible area|0|||
124862231|NCT03759873|449115361|FG001|Overall Study|Moved outside eligible area|2|||
124862232|NCT03759873|449115362|FG002|Overall Study|Moved outside eligible area|0|||
124862233|NCT03759873|449115363|FG003|Overall Study|Moved outside eligible area|0|||
124862234|NCT03759873|449115360|FG000|Overall Study|Withdrawal by Subject|0|||
124862235|NCT03759873|449115361|FG001|Overall Study|Withdrawal by Subject|0|||
124862236|NCT03759873|449115362|FG002|Overall Study|Withdrawal by Subject|1|||
124862237|NCT03759873|449115363|FG003|Overall Study|Withdrawal by Subject|0|||
124862238|NCT03579563|449115364|FG000|Overall Study|Lost to Follow-up|0|||
124862239|NCT03579563|449115365|FG001|Overall Study|Lost to Follow-up|0|||
124862240|NCT03579563|449115366|FG002|Overall Study|Lost to Follow-up|0|||
124862241|NCT03579563|449115367|FG003|Overall Study|Lost to Follow-up|0|||
124862242|NCT03579563|449115368|FG004|Overall Study|Lost to Follow-up|1|||
124862243|NCT03579563|449115369|FG005|Overall Study|Lost to Follow-up|0|||
124862244|NCT03579563|449115364|FG000|Overall Study|Lack of Efficacy|1|||
124862245|NCT03579563|449115365|FG001|Overall Study|Lack of Efficacy|1|||
124862246|NCT03579563|449115366|FG002|Overall Study|Lack of Efficacy|4|||
124862247|NCT03579563|449115367|FG003|Overall Study|Lack of Efficacy|1|||
124862248|NCT03579563|449115368|FG004|Overall Study|Lack of Efficacy|2|||
124862249|NCT03579563|449115369|FG005|Overall Study|Lack of Efficacy|3|||
124862250|NCT03579563|449115364|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
124862251|NCT03579563|449115365|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
124862252|NCT03579563|449115366|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
124862253|NCT03579563|449115367|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
124862254|NCT03579563|449115368|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
124862255|NCT03579563|449115369|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
124862256|NCT03579563|449115364|FG000|Overall Study|Time/distance concern|0|||
124862257|NCT03579563|449115365|FG001|Overall Study|Time/distance concern|0|||
124862258|NCT03579563|449115366|FG002|Overall Study|Time/distance concern|1|||
124862259|NCT03579563|449115367|FG003|Overall Study|Time/distance concern|0|||
124862260|NCT03579563|449115368|FG004|Overall Study|Time/distance concern|0|||
124862261|NCT03579563|449115369|FG005|Overall Study|Time/distance concern|1|||
124862262|NCT03579563|449115364|FG000|Overall Study|COVID shutdown|2|||
124862263|NCT03579563|449115365|FG001|Overall Study|COVID shutdown|3|||
124862264|NCT03579563|449115366|FG002|Overall Study|COVID shutdown|4|||
124862265|NCT03579563|449115367|FG003|Overall Study|COVID shutdown|3|||
124862266|NCT03579563|449115368|FG004|Overall Study|COVID shutdown|1|||
124862267|NCT03579563|449115369|FG005|Overall Study|COVID shutdown|2|||
124862268|NCT03579563|449115364|FG000|Overall Study|Protocol administration error|1|||
124862269|NCT03579563|449115365|FG001|Overall Study|Protocol administration error|0|||
124862270|NCT03579563|449115366|FG002|Overall Study|Protocol administration error|1|||
124862271|NCT03579563|449115367|FG003|Overall Study|Protocol administration error|0|||
124862272|NCT03579563|449115368|FG004|Overall Study|Protocol administration error|1|||
124862273|NCT03579563|449115369|FG005|Overall Study|Protocol administration error|5|||
124862274|NCT02647359|449115370|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
124862275|NCT02647359|449115371|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
124862276|NCT02647359|449115370|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
124862277|NCT02647359|449115371|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
124862278|NCT02647359|449115370|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
124862279|NCT02647359|449115371|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
124862280|NCT02647359|449115370|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
124862281|NCT02647359|449115371|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
124862282|NCT02647359|449115370|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
124862283|NCT02647359|449115371|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
124862284|NCT02647359|449115370|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
124862285|NCT02647359|449115371|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
124862286|NCT02513563|449115372|FG000|Overall Study|Death|4|||
124862287|NCT02513563|449115372|FG000|Overall Study|Withdrawal by Subject|4|||
124862288|NCT02513563|449115372|FG000|Overall Study|Physician Decision|1|||
124862289|NCT04818346|449115376|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
124862290|NCT04818346|449115377|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
124862291|NCT04818346|449115378|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
124862292|NCT04818346|449115379|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
124862293|NCT04818346|449115376|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
124862294|NCT04818346|449115377|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
124862295|NCT04818346|449115378|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
124862296|NCT04818346|449115379|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
124862297|NCT04818346|449115376|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
124862298|NCT04818346|449115377|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
124862299|NCT04818346|449115378|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
124862300|NCT04818346|449115379|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
124862301|NCT04818346|449115376|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
124862302|NCT04818346|449115377|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
124862303|NCT04818346|449115378|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
124862304|NCT04818346|449115379|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
124862305|NCT04818346|449115376|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
124862306|NCT04818346|449115377|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
124862307|NCT04818346|449115378|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
124862308|NCT04818346|449115379|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
124862309|NCT04818346|449115376|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
124862310|NCT04818346|449115377|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
124862311|NCT04818346|449115378|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
124862312|NCT04818346|449115379|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
124862313|NCT04818346|449115376|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
124862314|NCT04818346|449115377|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
124862315|NCT04818346|449115378|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
124862316|NCT04818346|449115379|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
124862317|NCT04818346|449115376|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
124862318|NCT04818346|449115377|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
124862319|NCT04818346|449115378|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
124862320|NCT04818346|449115379|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
124862321|NCT04818346|449115376|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
124862322|NCT04818346|449115377|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
124862323|NCT04818346|449115378|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
124862324|NCT04818346|449115379|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
124862325|NCT04818346|449115376|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
124862326|NCT04818346|449115377|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
124862327|NCT04818346|449115378|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
124862328|NCT04818346|449115379|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
124862329|NCT04818346|449115376|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
124862330|NCT04818346|449115377|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
124862331|NCT04818346|449115378|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
124862332|NCT04818346|449115379|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
124862333|NCT04818346|449115376|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
124862334|NCT04818346|449115377|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
124862335|NCT04818346|449115378|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
124862336|NCT04818346|449115379|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
124862337|NCT04818346|449115376|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
124862338|NCT04818346|449115377|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
124862339|NCT04818346|449115378|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
124862340|NCT04818346|449115379|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
124862341|NCT04818346|449115376|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
124862342|NCT04818346|449115377|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
124862343|NCT04818346|449115378|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
124862344|NCT04818346|449115379|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
124862345|NCT04818346|449115376|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
124862346|NCT04818346|449115377|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
124862347|NCT04818346|449115378|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
124862348|NCT04818346|449115379|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
124862349|NCT03150056|449115380|FG000|Overall Study|Withdrawal by Subject|0|||
124862350|NCT03150056|449115381|FG001|Overall Study|Withdrawal by Subject|0|||
124862351|NCT03150056|449115382|FG002|Overall Study|Withdrawal by Subject|0|||
124862352|NCT03150056|449115383|FG003|Overall Study|Withdrawal by Subject|0|||
124862353|NCT03150056|449115384|FG004|Overall Study|Withdrawal by Subject|0|||
124862354|NCT03150056|449115385|FG005|Overall Study|Withdrawal by Subject|2|||
124862355|NCT03150056|449115380|FG000|Overall Study|Study terminated by Sponsor|1|||
124862356|NCT03150056|449115381|FG001|Overall Study|Study terminated by Sponsor|3|||
124862357|NCT03150056|449115382|FG002|Overall Study|Study terminated by Sponsor|1|||
124862358|NCT03150056|449115383|FG003|Overall Study|Study terminated by Sponsor|1|||
124862359|NCT03150056|449115384|FG004|Overall Study|Study terminated by Sponsor|5|||
124862360|NCT03150056|449115385|FG005|Overall Study|Study terminated by Sponsor|6|||
124862361|NCT03150056|449115380|FG000|Overall Study|Death|9|||
124862362|NCT03150056|449115381|FG001|Overall Study|Death|2|||
124862363|NCT03150056|449115382|FG002|Overall Study|Death|2|||
124862364|NCT03150056|449115383|FG003|Overall Study|Death|7|||
124862365|NCT03150056|449115384|FG004|Overall Study|Death|8|||
124862366|NCT03150056|449115385|FG005|Overall Study|Death|10|||
124862367|NCT00965523|449115386|FG000|Study 221|Progressive Disease|4|||
124862368|NCT00965523|449115386|FG000|Study 221|Physician Decision|3|||
124862369|NCT00965523|449115386|FG000|Study 224|Progressive Disease|5|||
124862370|NCT00965523|449115386|FG000|Study 224|Physician Decision|1|||
124862371|NCT01581281|449115388|FG000|Overall Study|Early Study Closure|15|||
124862372|NCT01581281|449115389|FG001|Overall Study|Early Study Closure|6|||
124862373|NCT01581281|449115390|FG002|Overall Study|Early Study Closure|12|||
124862374|NCT02187991|449115391|FG000|Overall Study|Adverse Event|13|||
124862375|NCT02187991|449115392|FG001|Overall Study|Adverse Event|14|||
124862376|NCT02187991|449115393|FG002|Overall Study|Adverse Event|3|||
124862377|NCT02187991|449115394|FG003|Overall Study|Adverse Event|2|||
124862378|NCT02187991|449115391|FG000|Overall Study|Withdrawal by Subject|9|||
124862379|NCT02187991|449115392|FG001|Overall Study|Withdrawal by Subject|6|||
124862380|NCT02187991|449115393|FG002|Overall Study|Withdrawal by Subject|3|||
124862381|NCT02187991|449115394|FG003|Overall Study|Withdrawal by Subject|2|||
124862382|NCT02187991|449115391|FG000|Overall Study|Physician Decision|4|||
124862383|NCT02187991|449115392|FG001|Overall Study|Physician Decision|4|||
124862384|NCT02187991|449115393|FG002|Overall Study|Physician Decision|0|||
124862385|NCT02187991|449115394|FG003|Overall Study|Physician Decision|2|||
124862386|NCT02187991|449115391|FG000|Overall Study|Other, unrelated complication|7|||
124862387|NCT02187991|449115392|FG001|Overall Study|Other, unrelated complication|1|||
124862388|NCT02187991|449115393|FG002|Overall Study|Other, unrelated complication|1|||
124862389|NCT02187991|449115394|FG003|Overall Study|Other, unrelated complication|2|||
124862390|NCT02187991|449115391|FG000|Overall Study|Death|1|||
124862391|NCT02187991|449115392|FG001|Overall Study|Death|3|||
124862392|NCT02187991|449115393|FG002|Overall Study|Death|0|||
124862393|NCT02187991|449115394|FG003|Overall Study|Death|0|||
124862394|NCT03273946|449115400|FG000|Overall Study|Withdrawal by Subject|5|||
124862395|NCT03273946|449115400|FG000|Overall Study|Unwillingness of the guardian|1|||
124862396|NCT03273946|449115400|FG000|Overall Study|Participant refused to use the drug|2|||
124862397|NCT03273946|449115400|FG000|Overall Study|Participant relative refused to use drug|1|||
124862398|NCT00092131|449115402|FG000|Treatment Period I|Adverse Event|1|||
124862399|NCT00092131|449115403|FG001|Treatment Period I|Adverse Event|0|||
124862400|NCT00092131|449115402|FG000|Treatment Period II|Adverse Event|0|||
124862401|NCT00092131|449115403|FG001|Treatment Period II|Adverse Event|1|||
124862402|NCT01808313|449115406|FG000|Overall Study|Adverse Event|5|||
124862403|NCT01808313|449115406|FG000|Overall Study|Protocol Violation|2|||
124862404|NCT01808313|449115406|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
124862405|NCT01808313|449115406|FG000|Overall Study|Lost to Follow-up|1|||
124862406|NCT01808313|449115406|FG000|Overall Study|Physician Decision|1|||
124862407|NCT01954017|449115414|FG000|Overall Study|Adverse Event|0|||
124862408|NCT01954017|449115415|FG001|Overall Study|Adverse Event|0|||
124862409|NCT01954017|449115416|FG002|Overall Study|Adverse Event|1|||
124862410|NCT01954017|449115414|FG000|Overall Study|Death|2|||
124862411|NCT01954017|449115415|FG001|Overall Study|Death|1|||
124862412|NCT01954017|449115416|FG002|Overall Study|Death|1|||
124862413|NCT01954017|449115414|FG000|Overall Study|Withdrawal by Subject|0|||
124862414|NCT01954017|449115415|FG001|Overall Study|Withdrawal by Subject|1|||
124862415|NCT01954017|449115416|FG002|Overall Study|Withdrawal by Subject|0|||
124862416|NCT01954017|449115414|FG000|Overall Study|Protocol Violation|0|||
124862417|NCT01954017|449115415|FG001|Overall Study|Protocol Violation|3|||
124862418|NCT01954017|449115416|FG002|Overall Study|Protocol Violation|2|||
124862419|NCT01954017|449115414|FG000|Overall Study|Necrotizing enterocolitis|1|||
124862420|NCT01954017|449115415|FG001|Overall Study|Necrotizing enterocolitis|0|||
124862421|NCT01954017|449115416|FG002|Overall Study|Necrotizing enterocolitis|1|||
124862422|NCT01954017|449115414|FG000|Overall Study|Enteral intake stopped >7 days|0|||
124862423|NCT01954017|449115415|FG001|Overall Study|Enteral intake stopped >7 days|1|||
124862424|NCT01954017|449115416|FG002|Overall Study|Enteral intake stopped >7 days|1|||
124862425|NCT01954017|449115414|FG000|Overall Study|All other reasons|2|||
124862426|NCT01954017|449115415|FG001|Overall Study|All other reasons|2|||
124862427|NCT01954017|449115416|FG002|Overall Study|All other reasons|7|||
124862428|NCT04598152|449115417|FG000|Overall Study|Lost to Follow-up|0|||
124862429|NCT04598152|449115418|FG001|Overall Study|Lost to Follow-up|1|||
124862430|NCT03346759|449115429|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
124862431|NCT03346759|449115430|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
124862432|NCT03346759|449115429|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
124862433|NCT03346759|449115430|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
124862434|NCT03346759|449115429|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
124862435|NCT03346759|449115430|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
124862436|NCT03277313|449115431|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
124862437|NCT03277313|449115432|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
124862438|NCT03277313|449115431|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
124862439|NCT03277313|449115432|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
124862440|NCT03277313|449115431|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
124862441|NCT03277313|449115432|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
124862442|NCT03277313|449115431|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
124862443|NCT03277313|449115432|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
124862444|NCT03277313|449115431|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
124862445|NCT03277313|449115432|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
124862446|NCT02132611|449115436|FG000|Overall Study|Death|2|||
124862447|NCT02096900|449115437|FG000|Overall Study|Did not receive medication|3|||
124862448|NCT02096900|449115438|FG001|Overall Study|Did not receive medication|1|||
124862449|NCT02096900|449115437|FG000|Overall Study|Surgery cancelled- medication received|1|||
124862450|NCT02096900|449115438|FG001|Overall Study|Surgery cancelled- medication received|1|||
124862451|NCT05819749|449115448|FG000|Overall Study|Lost to Follow-up|1|||
124862452|NCT01877408|449117028|FG000|Overall Study|Lost to Follow-up|0|||
124862453|NCT01877408|449117029|FG001|Overall Study|Lost to Follow-up|2|||
124862454|NCT00377234|449117030|FG000|Overall Study|Adverse Event|14|||
124862455|NCT00377234|449117031|FG001|Overall Study|Adverse Event|17|||
124862456|NCT00377234|449117030|FG000|Overall Study|Withdrawal by Subject|11|||
124862457|NCT00377234|449117031|FG001|Overall Study|Withdrawal by Subject|9|||
124862458|NCT00377234|449117030|FG000|Overall Study|Lost to Follow-up|4|||
124862459|NCT00377234|449117031|FG001|Overall Study|Lost to Follow-up|2|||
124862460|NCT00377234|449117030|FG000|Overall Study|Administrative|2|||
124862461|NCT00377234|449117031|FG001|Overall Study|Administrative|1|||
124862462|NCT00377234|449117030|FG000|Overall Study|Not assigned|3|||
124862463|NCT00377234|449117031|FG001|Overall Study|Not assigned|2|||
124862464|NCT01880424|449117032|FG000|Overall Study|Adverse Event|7|||
124862465|NCT01880424|449117033|FG001|Overall Study|Adverse Event|6|||
124862466|NCT01880424|449117032|FG000|Overall Study|Lack of Efficacy|1|||
124862467|NCT01880424|449117033|FG001|Overall Study|Lack of Efficacy|4|||
124862468|NCT01880424|449117032|FG000|Overall Study|Lost to Follow-up|3|||
124862469|NCT01880424|449117033|FG001|Overall Study|Lost to Follow-up|2|||
124862470|NCT01880424|449117032|FG000|Overall Study|Protocol Violation|11|||
124862471|NCT01880424|449117033|FG001|Overall Study|Protocol Violation|13|||
124862472|NCT01880424|449117032|FG000|Overall Study|Withdrawal by Subject|10|||
124862473|NCT01880424|449117033|FG001|Overall Study|Withdrawal by Subject|30|||
124862474|NCT01880424|449117032|FG000|Overall Study|Other|1|||
124862475|NCT01880424|449117033|FG001|Overall Study|Other|0|||
124862476|NCT01983293|449117036|FG000|Overall Study|Withdrawal by Subject|29|||
124862477|NCT01983293|449117037|FG001|Overall Study|Withdrawal by Subject|15|||
124862478|NCT01983293|449117036|FG000|Overall Study|Missing 12-month visit|3|||
124862479|NCT01983293|449117037|FG001|Overall Study|Missing 12-month visit|3|||
124862480|NCT01983293|449117036|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
124862481|NCT01983293|449117037|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
124862482|NCT01747772|449117038|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
124862483|NCT01944631|449117042|FG000|Overall Study|Adverse Event|1|||
124862484|NCT01944631|449117043|FG001|Overall Study|Adverse Event|0|||
124862485|NCT01944631|449117042|FG000|Overall Study|Lost to Follow-up|3|||
124862486|NCT01944631|449117043|FG001|Overall Study|Lost to Follow-up|1|||
124862487|NCT01944631|449117042|FG000|Overall Study|Withdrawal by Subject|0|||
124862488|NCT01944631|449117043|FG001|Overall Study|Withdrawal by Subject|1|||
124862489|NCT02388724|449117045|FG000|Overall Study|Reason not Specified|0|||
124862490|NCT02388724|449117046|FG001|Overall Study|Reason not Specified|1|||
124862491|NCT02388724|449117045|FG000|Overall Study|Major Protocol Deviation|3|||
124862492|NCT02388724|449117046|FG001|Overall Study|Major Protocol Deviation|3|||
124862493|NCT02388724|449117045|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
124862494|NCT02388724|449117046|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
124862495|NCT02388724|449117045|FG000|Overall Study|Voluntary Withdrawal|6|||
124862496|NCT02388724|449117046|FG001|Overall Study|Voluntary Withdrawal|5|||
124862497|NCT02388724|449117045|FG000|Overall Study|Randomized but not Treated|0|||
124862498|NCT02388724|449117046|FG001|Overall Study|Randomized but not Treated|2|||
124862499|NCT02605954|449117048|FG000|Overall Study|Adverse Event|5|||
124862500|NCT02605954|449117049|FG001|Overall Study|Adverse Event|1|||
124862501|NCT02605954|449117048|FG000|Overall Study|Investigator's Discretion|1|||
124862502|NCT02605954|449117049|FG001|Overall Study|Investigator's Discretion|0|||
124862503|NCT02605954|449117048|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124862504|NCT02605954|449117049|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124862505|NCT02605954|449117048|FG000|Overall Study|Withdrew Consent|2|||
124862506|NCT02605954|449117049|FG001|Overall Study|Withdrew Consent|2|||
124862507|NCT02605954|449117048|FG000|Overall Study|Lost to Follow-up|3|||
124862508|NCT02605954|449117049|FG001|Overall Study|Lost to Follow-up|0|||
124862509|NCT02605954|449117048|FG000|Overall Study|Randomized but not treated|0|||
124862510|NCT02605954|449117049|FG001|Overall Study|Randomized but not treated|1|||
124862511|NCT00856856|449117053|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
124862512|NCT00856856|449117053|FG000|4-year Clinical Follow-up|Missed visit|1|||
124862513|NCT02696317|449117056|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
124862514|NCT02696317|449117057|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
124862515|NCT02696317|449117056|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
124862516|NCT02696317|449117057|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
124862517|NCT00413153|449117058|FG000|Overall Study|Withdrawal by Subject|1|||
124862518|NCT00413153|449117059|FG001|Overall Study|Withdrawal by Subject|1|||
124862519|NCT00413153|449117058|FG000|Overall Study|Adverse Event|1|||
124862520|NCT00413153|449117059|FG001|Overall Study|Adverse Event|0|||
124862521|NCT02277106|449117060|FG000|Stage 2|Adverse Event|0|||
124862522|NCT02277106|449117061|FG001|Stage 2|Adverse Event|0|||
124862523|NCT02277106|449117062|FG002|Stage 2|Adverse Event|1|||
124862524|NCT01669629|449117064|FG000|Period 1|protocol deviation|1|||
124862525|NCT01669629|449117065|FG001|Period 1|protocol deviation|2|||
124862526|NCT01221597|449117066|FG000|Overall Study|Adverse Event|4|||
124862527|NCT01221597|449117067|FG001|Overall Study|Adverse Event|1|||
124862528|NCT01221597|449117066|FG000|Overall Study|Withdrawal by Subject|20|||
124862529|NCT01221597|449117067|FG001|Overall Study|Withdrawal by Subject|6|||
124862530|NCT01221597|449117066|FG000|Overall Study|Lost to Follow-up|6|||
124862531|NCT01221597|449117067|FG001|Overall Study|Lost to Follow-up|5|||
124862532|NCT01221597|449117066|FG000|Overall Study|Protocol Violation|1|||
124862533|NCT01221597|449117067|FG001|Overall Study|Protocol Violation|0|||
124862534|NCT01221597|449117066|FG000|Overall Study|Other|3|||
124862535|NCT01221597|449117067|FG001|Overall Study|Other|4|||
124862536|NCT01221597|449117066|FG000|Overall Study|Death|2|||
124862537|NCT01221597|449117067|FG001|Overall Study|Death|0|||
124862538|NCT00487162|449117070|FG000|Overall Study|Adverse Event|0|||
124862539|NCT00487162|449117071|FG001|Overall Study|Adverse Event|1|||
124862540|NCT00487162|449117070|FG000|Overall Study|Physician Decision|0|||
124862541|NCT00487162|449117071|FG001|Overall Study|Physician Decision|1|||
124862542|NCT00487162|449117070|FG000|Overall Study|Withdrawal by Subject|2|||
124862543|NCT00487162|449117071|FG001|Overall Study|Withdrawal by Subject|3|||
124862544|NCT02278328|449117072|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
124862545|NCT02278328|449117073|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
124862546|NCT02278328|449117074|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
124862547|NCT02278328|449117072|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
124862548|NCT02278328|449117073|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
124862549|NCT02278328|449117074|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
124862550|NCT02278328|449117072|FG000|Neuropsych Screening|incomplete consent|0|||
124862551|NCT02278328|449117073|FG001|Neuropsych Screening|incomplete consent|0|||
124862552|NCT02278328|449117074|FG002|Neuropsych Screening|incomplete consent|2|||
124862553|NCT03834779|449117080|FG000|Overall Study|Death|1|||
124862554|NCT03834779|449117081|FG001|Overall Study|Death|2|||
124862555|NCT03834779|449117080|FG000|Overall Study|Lost to Follow-up|6|||
124862556|NCT03834779|449117081|FG001|Overall Study|Lost to Follow-up|4|||
124862557|NCT01059565|449117082|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
124862558|NCT01059565|449117083|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
124862559|NCT01059565|449117082|FG000|24-Week Randomized Phase|Adverse Event|5|||
124862560|NCT01059565|449117083|FG001|24-Week Randomized Phase|Adverse Event|0|||
124862561|NCT01059565|449117082|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
124862562|NCT01059565|449117083|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
124862563|NCT01059565|449117082|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
124862564|NCT01059565|449117083|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
124862565|NCT01059565|449117082|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
124862566|NCT01059565|449117083|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
124862567|NCT01059565|449117082|FG000|24-Week Open-Label Phase|Adverse Event|2|||
124862568|NCT01059565|449117083|FG001|24-Week Open-Label Phase|Adverse Event|0|||
124862569|NCT01059565|449117082|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
124862570|NCT01059565|449117083|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
124862571|NCT01059565|449117082|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
124862572|NCT01059565|449117083|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
124862573|NCT01059565|449117082|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
124862574|NCT01059565|449117083|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
124862575|NCT01059565|449117082|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
124862576|NCT01059565|449117083|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
124862577|NCT01059565|449117082|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
124862578|NCT01059565|449117083|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
124862579|NCT03638141|449117089|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
124862580|NCT03526250|449117092|FG000|Overall Study|Adverse Event|4|||
124862581|NCT03526250|449117092|FG000|Overall Study|Progressive Disease|16|||
124862582|NCT03526250|449117092|FG000|Overall Study|No Treatment|3|||
124862583|NCT00522275|449117095|FG000|Overall Study|Adverse Event|35|||
124862584|NCT00522275|449117095|FG000|Overall Study|Lack of Efficacy|80|||
124862585|NCT00522275|449117095|FG000|Overall Study|Subject withdrew consent|16|||
124862586|NCT00522275|449117095|FG000|Overall Study|Protocol deviation|1|||
124862587|NCT00522275|449117095|FG000|Overall Study|Unsatisfactory compliance|11|||
124862588|NCT00522275|449117095|FG000|Overall Study|Lost to Follow-up|8|||
124862589|NCT00522275|449117095|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
124862590|NCT00522275|449117095|FG000|Overall Study|Other: Subject is pregnant|2|||
124862591|NCT00522275|449117095|FG000|Overall Study|Other: Subject relocated|2|||
124862592|NCT00522275|449117095|FG000|Overall Study|Other: Subject arrested|1|||
124862593|NCT00522275|449117095|FG000|Overall Study|Other: Site / clinic closed|4|||
124862594|NCT00522275|449117095|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
124862595|NCT00522275|449117095|FG000|Overall Study|Other: Sponsor request|2|||
124862596|NCT00522275|449117095|FG000|Overall Study|Other: Subject ran out of medication|1|||
124862597|NCT00522275|449117095|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
124862598|NCT02576067|449117096|FG000|Overall Study|Death|0|||
124862599|NCT02576067|449117097|FG001|Overall Study|Death|1|||
124862600|NCT02576067|449117096|FG000|Overall Study|Lack of Efficacy|1|||
124862601|NCT02576067|449117097|FG001|Overall Study|Lack of Efficacy|0|||
124862602|NCT02576067|449117096|FG000|Overall Study|Lost to Follow-up|11|||
124862603|NCT02576067|449117097|FG001|Overall Study|Lost to Follow-up|0|||
124862604|NCT02576067|449117096|FG000|Overall Study|Withdrawal by Subject|11|||
124862605|NCT02576067|449117097|FG001|Overall Study|Withdrawal by Subject|2|||
124862606|NCT02576067|449117096|FG000|Overall Study|study closure of main CIRT trial)|0|||
124862607|NCT02576067|449117097|FG001|Overall Study|study closure of main CIRT trial)|8|||
124862608|NCT02576067|449117096|FG000|Overall Study|not randomized, failed run-in|7|||
124862609|NCT02576067|449117097|FG001|Overall Study|not randomized, failed run-in|0|||
124862610|NCT02576067|449117096|FG000|Overall Study|screen failure/ re-enrolled|0|||
124862611|NCT02576067|449117097|FG001|Overall Study|screen failure/ re-enrolled|25|||
124862612|NCT02576067|449117096|FG000|Overall Study|Physician Decision|4|||
124862613|NCT02576067|449117097|FG001|Overall Study|Physician Decision|0|||
124862614|NCT04773587|449117098|FG000|Overall Study|Lost to Follow-up|11|||
124862615|NCT04773587|449117099|FG001|Overall Study|Lost to Follow-up|3|||
124862616|NCT04773587|449117098|FG000|Overall Study|Adverse Event|6|||
124862617|NCT04773587|449117099|FG001|Overall Study|Adverse Event|3|||
124862618|NCT04773587|449117098|FG000|Overall Study|Lack of Efficacy|5|||
124862619|NCT04773587|449117099|FG001|Overall Study|Lack of Efficacy|2|||
124862620|NCT04773587|449117098|FG000|Overall Study|Withdrawal by Subject|4|||
124862621|NCT04773587|449117099|FG001|Overall Study|Withdrawal by Subject|5|||
124862622|NCT04773587|449117098|FG000|Overall Study|Noncompliance|1|||
124862623|NCT04773587|449117099|FG001|Overall Study|Noncompliance|0|||
124862624|NCT04773587|449117098|FG000|Overall Study|Protocol Violation|1|||
124862625|NCT04773587|449117099|FG001|Overall Study|Protocol Violation|0|||
124862626|NCT04773587|449117098|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
124862627|NCT04773587|449117099|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
124862628|NCT02372409|449117100|FG000|Overall Study|Lost to Follow-up|1|||
124862629|NCT02372409|449117101|FG001|Overall Study|Lost to Follow-up|0|||
124862630|NCT02372409|449117100|FG000|Overall Study|Disease progression|1|||
124862631|NCT02372409|449117101|FG001|Overall Study|Disease progression|1|||
124862632|NCT00622167|449117103|FG000|Overall Study|Did not meet angiographic criteria|20|||
124862633|NCT03674177|449117107|FG000|Overall Study|Lost to Follow-up|2|||
124862634|NCT03674177|449117108|FG001|Overall Study|Lost to Follow-up|1|||
124862635|NCT03674177|449117109|FG002|Overall Study|Lost to Follow-up|0|||
124862636|NCT03674177|449117110|FG003|Overall Study|Lost to Follow-up|2|||
124862637|NCT00714168|449117111|FG000|Overall Study|Pregnancy|5|||
124862638|NCT00714168|449117112|FG001|Overall Study|Pregnancy|4|||
124862639|NCT00714168|449117111|FG000|Overall Study|Lost to Follow-up|32|||
124862640|NCT00714168|449117112|FG001|Overall Study|Lost to Follow-up|50|||
124862641|NCT00714168|449117111|FG000|Overall Study|Relocation|4|||
124862642|NCT00714168|449117112|FG001|Overall Study|Relocation|3|||
124862643|NCT00714168|449117111|FG000|Overall Study|Non-study medical condition|3|||
124862644|NCT00714168|449117112|FG001|Overall Study|Non-study medical condition|2|||
124862645|NCT03230916|449117116|FG000|Overall Study|Withdrawal by Subject|0|||
124862646|NCT03230916|449117117|FG001|Overall Study|Withdrawal by Subject|0|||
124862647|NCT03230916|449117118|FG002|Overall Study|Withdrawal by Subject|0|||
124862648|NCT03230916|449117119|FG003|Overall Study|Withdrawal by Subject|0|||
124862649|NCT03230916|449117120|FG004|Overall Study|Withdrawal by Subject|0|||
124862650|NCT03230916|449117121|FG005|Overall Study|Withdrawal by Subject|1|||
124862651|NCT03230916|449117122|FG006|Overall Study|Withdrawal by Subject|0|||
124862652|NCT03230916|449117123|FG007|Overall Study|Withdrawal by Subject|0|||
124862653|NCT03230916|449117124|FG008|Overall Study|Withdrawal by Subject|0|||
124862654|NCT03230916|449117125|FG009|Overall Study|Withdrawal by Subject|0|||
124862655|NCT03230916|449117126|FG010|Overall Study|Withdrawal by Subject|0|||
124862656|NCT01128413|449117128|FG000|Overall Study|Withdrawal by Subject|1|||
124862657|NCT01128413|449117129|FG001|Overall Study|Withdrawal by Subject|0|||
124862658|NCT01128413|449117128|FG000|Overall Study|NICOM Monitor Problems|2|||
124862659|NCT01128413|449117129|FG001|Overall Study|NICOM Monitor Problems|1|||
124862660|NCT01128413|449117128|FG000|Overall Study|Pt made DNR|1|||
124862661|NCT01128413|449117129|FG001|Overall Study|Pt made DNR|0|||
124862662|NCT03077724|449117131|FG000|Overall Study|Lost to Follow-up|5|||
124862663|NCT03077724|449117132|FG001|Overall Study|Lost to Follow-up|1|||
124862664|NCT03077724|449117131|FG000|Overall Study|Withdrawal by Subject|3|||
124862665|NCT03077724|449117132|FG001|Overall Study|Withdrawal by Subject|1|||
124862666|NCT04370054|449117135|FG000|Treatment Phase|Lost to Follow-up|1|||
124862667|NCT04370054|449117135|FG000|Treatment Phase|Withdrawal by Subject|1|||
124862668|NCT04370054|449117135|FG000|Follow-Up Phase|Ongoing|75|||
124862669|NCT00722761|449117136|FG000|Overall Study|Lost to Follow-up|1|||
124862670|NCT00722761|449117137|FG001|Overall Study|Lost to Follow-up|4|||
124862671|NCT00722761|449117136|FG000|Overall Study|Withdrawal by Subject|5|||
124862672|NCT00722761|449117137|FG001|Overall Study|Withdrawal by Subject|2|||
124862673|NCT02075593|449117139|FG000|Overall Study|Withdrawal by Subject|1|||
124862674|NCT02522494|449118972|FG000|Overall Study|Lost to Follow-up|6|||
124862675|NCT02522494|449118973|FG001|Overall Study|Lost to Follow-up|2|||
124862676|NCT02522494|449118972|FG000|Overall Study|Withdrawal by Subject|1|||
124862677|NCT02522494|449118973|FG001|Overall Study|Withdrawal by Subject|0|||
124862678|NCT02522494|449118972|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
124862679|NCT02522494|449118973|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
124862680|NCT02522494|449118972|FG000|Overall Study|Participant did not watch the video|1|||
124862681|NCT02522494|449118973|FG001|Overall Study|Participant did not watch the video|0|||
124862682|NCT02522494|449118972|FG000|Overall Study|Death|0|||
124862683|NCT02522494|449118973|FG001|Overall Study|Death|1|||
124862684|NCT02239679|449118974|FG000|Overall Study|Lost to Follow-up|1|||
124862685|NCT02239679|449118975|FG001|Overall Study|Lost to Follow-up|0|||
124862686|NCT02239679|449118976|FG002|Overall Study|Lost to Follow-up|0|||
124862687|NCT02239679|449118974|FG000|Overall Study|Withdrawal by Subject|2|||
124862688|NCT02239679|449118975|FG001|Overall Study|Withdrawal by Subject|3|||
124862689|NCT02239679|449118976|FG002|Overall Study|Withdrawal by Subject|1|||
124862690|NCT02047045|449118980|FG000|Baseline|Withdrawal by Subject|3|||
124862691|NCT02047045|449118981|FG001|Baseline|Withdrawal by Subject|2|||
124862692|NCT02047045|449118980|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
124862693|NCT02047045|449118981|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
124862694|NCT02047045|449118980|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
124862695|NCT02047045|449118981|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
124862696|NCT02047045|449118980|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
124862697|NCT02047045|449118981|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
124862698|NCT02047045|449118980|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
124862699|NCT02047045|449118981|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
124862700|NCT02047045|449118980|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
124862701|NCT02047045|449118981|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
124862702|NCT02047045|449118980|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
124862703|NCT02047045|449118981|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
124862704|NCT02047045|449118980|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
124862705|NCT02047045|449118981|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
124862706|NCT02047045|449118980|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
124862707|NCT02047045|449118981|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
124862708|NCT03214367|449118982|FG000|Lead-in Period|Withdrawal by Subject|50|||
124862709|NCT03214367|449118983|FG001|Lead-in Period|Withdrawal by Subject|0|||
124862710|NCT03214367|449118984|FG002|Lead-in Period|Withdrawal by Subject|0|||
124862711|NCT03214367|449118985|FG003|Lead-in Period|Withdrawal by Subject|0|||
124862712|NCT03214367|449118986|FG004|Lead-in Period|Withdrawal by Subject|2|||
124862713|NCT03214367|449118987|FG005|Lead-in Period|Withdrawal by Subject|0|||
124862714|NCT03214367|449118988|FG006|Lead-in Period|Withdrawal by Subject|0|||
124862715|NCT03214367|449118989|FG007|Lead-in Period|Withdrawal by Subject|0|||
124862716|NCT03214367|449118982|FG000|Lead-in Period|Adverse Event|3|||
124862717|NCT03214367|449118983|FG001|Lead-in Period|Adverse Event|0|||
124862718|NCT03214367|449118984|FG002|Lead-in Period|Adverse Event|0|||
124862719|NCT03214367|449118985|FG003|Lead-in Period|Adverse Event|0|||
124862720|NCT03214367|449118986|FG004|Lead-in Period|Adverse Event|0|||
124862721|NCT03214367|449118987|FG005|Lead-in Period|Adverse Event|0|||
124862722|NCT03214367|449118988|FG006|Lead-in Period|Adverse Event|0|||
124862723|NCT03214367|449118989|FG007|Lead-in Period|Adverse Event|0|||
124862724|NCT03214367|449118982|FG000|Lead-in Period|Lost to Follow-up|12|||
124862725|NCT03214367|449118983|FG001|Lead-in Period|Lost to Follow-up|0|||
124862726|NCT03214367|449118984|FG002|Lead-in Period|Lost to Follow-up|0|||
124862727|NCT03214367|449118985|FG003|Lead-in Period|Lost to Follow-up|0|||
124862728|NCT03214367|449118986|FG004|Lead-in Period|Lost to Follow-up|0|||
124862729|NCT03214367|449118987|FG005|Lead-in Period|Lost to Follow-up|0|||
124862730|NCT03214367|449118988|FG006|Lead-in Period|Lost to Follow-up|0|||
124862731|NCT03214367|449118989|FG007|Lead-in Period|Lost to Follow-up|0|||
124862732|NCT03214367|449118982|FG000|Lead-in Period|Sponsor Decision|11|||
124862733|NCT03214367|449118983|FG001|Lead-in Period|Sponsor Decision|0|||
124862734|NCT03214367|449118984|FG002|Lead-in Period|Sponsor Decision|0|||
124862735|NCT03214367|449118985|FG003|Lead-in Period|Sponsor Decision|0|||
124862736|NCT03214367|449118986|FG004|Lead-in Period|Sponsor Decision|0|||
124862737|NCT03214367|449118987|FG005|Lead-in Period|Sponsor Decision|0|||
124862738|NCT03214367|449118988|FG006|Lead-in Period|Sponsor Decision|0|||
124862739|NCT03214367|449118989|FG007|Lead-in Period|Sponsor Decision|0|||
124862740|NCT03214367|449118982|FG000|Lead-in Period|Physician Decision|12|||
124862741|NCT03214367|449118983|FG001|Lead-in Period|Physician Decision|0|||
124862742|NCT03214367|449118984|FG002|Lead-in Period|Physician Decision|0|||
124862743|NCT03214367|449118985|FG003|Lead-in Period|Physician Decision|0|||
124862744|NCT03214367|449118986|FG004|Lead-in Period|Physician Decision|0|||
124862745|NCT03214367|449118987|FG005|Lead-in Period|Physician Decision|0|||
124862746|NCT03214367|449118988|FG006|Lead-in Period|Physician Decision|0|||
124862747|NCT03214367|449118989|FG007|Lead-in Period|Physician Decision|0|||
124862748|NCT03214367|449118982|FG000|Lead-in Period|Protocol Violation|5|||
124862749|NCT03214367|449118983|FG001|Lead-in Period|Protocol Violation|0|||
124862750|NCT03214367|449118984|FG002|Lead-in Period|Protocol Violation|0|||
124862751|NCT03214367|449118985|FG003|Lead-in Period|Protocol Violation|0|||
124862752|NCT03214367|449118986|FG004|Lead-in Period|Protocol Violation|0|||
124862753|NCT03214367|449118987|FG005|Lead-in Period|Protocol Violation|0|||
124862754|NCT03214367|449118988|FG006|Lead-in Period|Protocol Violation|0|||
124862755|NCT03214367|449118989|FG007|Lead-in Period|Protocol Violation|0|||
124862756|NCT03214367|449118982|FG000|Lead-in Period|Treatment Interruption|1|||
124862757|NCT03214367|449118983|FG001|Lead-in Period|Treatment Interruption|0|||
124862758|NCT03214367|449118984|FG002|Lead-in Period|Treatment Interruption|0|||
124862759|NCT03214367|449118985|FG003|Lead-in Period|Treatment Interruption|0|||
124862760|NCT03214367|449118986|FG004|Lead-in Period|Treatment Interruption|0|||
124862761|NCT03214367|449118987|FG005|Lead-in Period|Treatment Interruption|0|||
124862762|NCT03214367|449118988|FG006|Lead-in Period|Treatment Interruption|0|||
124862763|NCT03214367|449118989|FG007|Lead-in Period|Treatment Interruption|0|||
124862764|NCT03214367|449118982|FG000|Treatment Period|Adverse Event|0|||
124862765|NCT03214367|449118983|FG001|Treatment Period|Adverse Event|1|||
124862766|NCT03214367|449118984|FG002|Treatment Period|Adverse Event|4|||
124862767|NCT03214367|449118985|FG003|Treatment Period|Adverse Event|2|||
124862768|NCT03214367|449118986|FG004|Treatment Period|Adverse Event|0|||
124862769|NCT03214367|449118987|FG005|Treatment Period|Adverse Event|0|||
124862770|NCT03214367|449118988|FG006|Treatment Period|Adverse Event|0|||
124862771|NCT03214367|449118989|FG007|Treatment Period|Adverse Event|0|||
124862772|NCT03214367|449118982|FG000|Treatment Period|Death|0|||
124862773|NCT03214367|449118983|FG001|Treatment Period|Death|1|||
124862774|NCT03214367|449118984|FG002|Treatment Period|Death|1|||
124862775|NCT03214367|449118985|FG003|Treatment Period|Death|1|||
124862776|NCT03214367|449118986|FG004|Treatment Period|Death|0|||
124862777|NCT03214367|449118987|FG005|Treatment Period|Death|0|||
124862778|NCT03214367|449118988|FG006|Treatment Period|Death|0|||
124862779|NCT03214367|449118989|FG007|Treatment Period|Death|0|||
124862780|NCT03214367|449118982|FG000|Treatment Period|Lost to Follow-up|0|||
124862781|NCT03214367|449118983|FG001|Treatment Period|Lost to Follow-up|5|||
124862782|NCT03214367|449118984|FG002|Treatment Period|Lost to Follow-up|3|||
124862783|NCT03214367|449118985|FG003|Treatment Period|Lost to Follow-up|2|||
124862784|NCT03214367|449118986|FG004|Treatment Period|Lost to Follow-up|0|||
124862785|NCT03214367|449118987|FG005|Treatment Period|Lost to Follow-up|2|||
124862786|NCT03214367|449118988|FG006|Treatment Period|Lost to Follow-up|1|||
124862787|NCT03214367|449118989|FG007|Treatment Period|Lost to Follow-up|0|||
124862788|NCT03214367|449118982|FG000|Treatment Period|Sponsor Decision|0|||
124862789|NCT03214367|449118983|FG001|Treatment Period|Sponsor Decision|3|||
124862790|NCT03214367|449118984|FG002|Treatment Period|Sponsor Decision|0|||
124862791|NCT03214367|449118985|FG003|Treatment Period|Sponsor Decision|0|||
124862792|NCT03214367|449118986|FG004|Treatment Period|Sponsor Decision|0|||
124862793|NCT03214367|449118987|FG005|Treatment Period|Sponsor Decision|0|||
124862794|NCT03214367|449118988|FG006|Treatment Period|Sponsor Decision|0|||
124862795|NCT03214367|449118989|FG007|Treatment Period|Sponsor Decision|0|||
124862796|NCT03214367|449118982|FG000|Treatment Period|Physician Decision|0|||
124862797|NCT03214367|449118983|FG001|Treatment Period|Physician Decision|1|||
124862798|NCT03214367|449118984|FG002|Treatment Period|Physician Decision|2|||
124862799|NCT03214367|449118985|FG003|Treatment Period|Physician Decision|0|||
124862800|NCT03214367|449118986|FG004|Treatment Period|Physician Decision|0|||
124862801|NCT03214367|449118987|FG005|Treatment Period|Physician Decision|0|||
124862802|NCT03214367|449118988|FG006|Treatment Period|Physician Decision|0|||
124862803|NCT03214367|449118989|FG007|Treatment Period|Physician Decision|0|||
124862804|NCT03214367|449118982|FG000|Treatment Period|Protocol Violation|0|||
124862805|NCT03214367|449118983|FG001|Treatment Period|Protocol Violation|3|||
124862806|NCT03214367|449118984|FG002|Treatment Period|Protocol Violation|0|||
124862807|NCT03214367|449118985|FG003|Treatment Period|Protocol Violation|0|||
124862808|NCT03214367|449118986|FG004|Treatment Period|Protocol Violation|0|||
124862809|NCT03214367|449118987|FG005|Treatment Period|Protocol Violation|0|||
124862810|NCT03214367|449118988|FG006|Treatment Period|Protocol Violation|0|||
124862811|NCT03214367|449118989|FG007|Treatment Period|Protocol Violation|0|||
124862812|NCT03214367|449118982|FG000|Treatment Period|Withdrawal by Subject|0|||
124862813|NCT03214367|449118983|FG001|Treatment Period|Withdrawal by Subject|20|||
124862814|NCT03214367|449118984|FG002|Treatment Period|Withdrawal by Subject|23|||
124862815|NCT03214367|449118985|FG003|Treatment Period|Withdrawal by Subject|14|||
124862816|NCT03214367|449118986|FG004|Treatment Period|Withdrawal by Subject|0|||
124862817|NCT03214367|449118987|FG005|Treatment Period|Withdrawal by Subject|1|||
124862818|NCT03214367|449118988|FG006|Treatment Period|Withdrawal by Subject|1|||
124862819|NCT03214367|449118989|FG007|Treatment Period|Withdrawal by Subject|1|||
124862820|NCT03508843|449118990|FG000|Overall Study|Withdrawal by Subject|1|||
124862821|NCT03508843|449118990|FG000|Overall Study|technical difficulties|2|||
124862822|NCT00765843|449118991|FG000|Overall Study|Lost to Follow-up|1|||
124862823|NCT00765843|449118992|FG001|Overall Study|Lost to Follow-up|3|||
124862824|NCT00765843|449118993|FG002|Overall Study|Lost to Follow-up|2|||
124862825|NCT00765843|449118991|FG000|Overall Study|did not return to receive intervention|0|||
124862826|NCT00765843|449118992|FG001|Overall Study|did not return to receive intervention|1|||
124862827|NCT00765843|449118993|FG002|Overall Study|did not return to receive intervention|0|||
124862828|NCT00765843|449118991|FG000|Overall Study|Adverse Event|0|||
124862829|NCT00765843|449118992|FG001|Overall Study|Adverse Event|0|||
124862830|NCT00765843|449118993|FG002|Overall Study|Adverse Event|1|||
124862831|NCT03555396|449118994|FG000|Overall Study|Death|3|||
124862832|NCT03555396|449118995|FG001|Overall Study|Death|1|||
124862833|NCT03555396|449118994|FG000|Overall Study|Lost to Follow-up|0|||
124862834|NCT03555396|449118995|FG001|Overall Study|Lost to Follow-up|2|||
124862835|NCT00448539|449118998|FG000|Overall Study|Medication non-compliance|4|||
124862836|NCT00448539|449118999|FG001|Overall Study|Medication non-compliance|1|||
124862837|NCT00448539|449118998|FG000|Overall Study|Protocol Violation|1|||
124862838|NCT00448539|449118999|FG001|Overall Study|Protocol Violation|0|||
124862839|NCT00448539|449118998|FG000|Overall Study|Request of the investigator or sponsor|67|||
124862840|NCT00448539|449118999|FG001|Overall Study|Request of the investigator or sponsor|54|||
124862841|NCT00448539|449118998|FG000|Overall Study|Withdrawal by Subject|20|||
124862842|NCT00448539|449118999|FG001|Overall Study|Withdrawal by Subject|24|||
124862843|NCT00448539|449118998|FG000|Overall Study|Diary non-compliance|1|||
124862844|NCT00448539|449118999|FG001|Overall Study|Diary non-compliance|0|||
124862845|NCT00448539|449118998|FG000|Overall Study|Adverse Event|9|||
124862846|NCT00448539|449118999|FG001|Overall Study|Adverse Event|26|||
124862847|NCT00448539|449118998|FG000|Overall Study|Lack of Efficacy|27|||
124862848|NCT00448539|449118999|FG001|Overall Study|Lack of Efficacy|40|||
124862849|NCT00448539|449118998|FG000|Overall Study|Miscellaneous|2|||
124862850|NCT00448539|449118999|FG001|Overall Study|Miscellaneous|1|||
124862851|NCT00448539|449118998|FG000|Overall Study|Change of meds|2|||
124862852|NCT00448539|449118999|FG001|Overall Study|Change of meds|3|||
124862853|NCT00448539|449118998|FG000|Overall Study|Lost to Follow-up|1|||
124862854|NCT00448539|449118999|FG001|Overall Study|Lost to Follow-up|3|||
124862855|NCT02103439|449119000|FG000|Overall Study|Adverse Event|0|||
124862856|NCT02103439|449119001|FG001|Overall Study|Adverse Event|2|||
124862857|NCT02103439|449119000|FG000|Overall Study|Withdrawal by Subject|3|||
124862858|NCT02103439|449119001|FG001|Overall Study|Withdrawal by Subject|1|||
124862859|NCT04955639|449119003|FG000|Overall Study|Withdrawal by Subject|2|||
124862860|NCT04955639|449119004|FG001|Overall Study|Withdrawal by Subject|2|||
124862861|NCT04955639|449119003|FG000|Overall Study|Week 26 survey not completed|2|||
124862862|NCT04955639|449119004|FG001|Overall Study|Week 26 survey not completed|2|||
124862863|NCT04447404|449119005|FG000|Overall Study|Death|2|||
124862864|NCT04447404|449119006|FG001|Overall Study|Death|0|||
124862865|NCT01369342|449119007|FG000|Overall Study|Withdrawal by Subject|7|||
124862866|NCT01369342|449119008|FG001|Overall Study|Withdrawal by Subject|7|||
124862867|NCT01369342|449119009|FG002|Overall Study|Withdrawal by Subject|2|||
124862868|NCT01369342|449119007|FG000|Overall Study|Lost to Follow-up|5|||
124862869|NCT01369342|449119008|FG001|Overall Study|Lost to Follow-up|2|||
124862870|NCT01369342|449119009|FG002|Overall Study|Lost to Follow-up|1|||
124862871|NCT01369342|449119007|FG000|Overall Study|Not Treated|1|||
124862872|NCT01369342|449119008|FG001|Overall Study|Not Treated|0|||
124862873|NCT01369342|449119009|FG002|Overall Study|Not Treated|0|||
124862874|NCT01816594|449119010|FG000|Overall Study|Local Progress|0|||
124862875|NCT01816594|449119011|FG001|Overall Study|Local Progress|2|||
124862876|NCT01816594|449119010|FG000|Overall Study|Adverse Event|9|||
124862877|NCT01816594|449119011|FG001|Overall Study|Adverse Event|0|||
124862878|NCT01816594|449119010|FG000|Overall Study|Withdrawal by Subject|1|||
124862879|NCT01816594|449119011|FG001|Overall Study|Withdrawal by Subject|0|||
124862880|NCT01816594|449119010|FG000|Overall Study|Physician Decision|1|||
124862881|NCT01816594|449119011|FG001|Overall Study|Physician Decision|0|||
124862882|NCT03905655|449119012|FG000|Overall Study|Adverse Event|1|||
124862883|NCT03905655|449119013|FG001|Overall Study|Adverse Event|0|||
124862884|NCT03905655|449119014|FG002|Overall Study|Adverse Event|1|||
124862885|NCT03905655|449119015|FG003|Overall Study|Adverse Event|1|||
124862886|NCT01064739|449119016|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
124862887|NCT03667053|449119019|FG000|Overall Study|Withdrawal by Subject|1|||
124862888|NCT03667053|449119020|FG001|Overall Study|Withdrawal by Subject|0|||
124862889|NCT03667053|449119021|FG002|Overall Study|Withdrawal by Subject|0|||
124862890|NCT01292928|449119022|FG000|Overall Study|Death|8|||
124862891|NCT01292928|449119022|FG000|Overall Study|Withdrawal by Subject|8|||
124862892|NCT01292928|449119022|FG000|Overall Study|Lost to Follow-up|6|||
124862893|NCT01292928|449119022|FG000|Overall Study|Physician Decision|2|||
124862894|NCT00130533|449119023|FG000|Overall Study|Withdrawal by Subject|33|||
124862895|NCT00130533|449119024|FG001|Overall Study|Withdrawal by Subject|6|||
124862896|NCT00130533|449119023|FG000|Overall Study|Adverse Event|34|||
124862897|NCT00130533|449119024|FG001|Overall Study|Adverse Event|1|||
124862898|NCT00130533|449119023|FG000|Overall Study|Disease relapse|9|||
124862899|NCT00130533|449119024|FG001|Overall Study|Disease relapse|13|||
124862900|NCT00130533|449119023|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
124862901|NCT00130533|449119024|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
124862902|NCT00130533|449119023|FG000|Overall Study|Death|4|||
124862903|NCT00130533|449119024|FG001|Overall Study|Death|2|||
124862904|NCT00130533|449119023|FG000|Overall Study|Protocol Violation|5|||
124862905|NCT00130533|449119024|FG001|Overall Study|Protocol Violation|1|||
124862906|NCT00130533|449119023|FG000|Overall Study|Lost to Follow-up|1|||
124862907|NCT00130533|449119024|FG001|Overall Study|Lost to Follow-up|1|||
124862908|NCT00130533|449119023|FG000|Overall Study|Sponsor´s decision|2|||
124862909|NCT00130533|449119024|FG001|Overall Study|Sponsor´s decision|0|||
124862910|NCT00130533|449119023|FG000|Overall Study|Second Primary Malignancy|0|||
124862911|NCT00130533|449119024|FG001|Overall Study|Second Primary Malignancy|1|||
124862912|NCT00130533|449119023|FG000|Overall Study|Other|12|||
124862913|NCT00130533|449119024|FG001|Overall Study|Other|5|||
124862914|NCT03263429|449119025|FG000|Overall Study|Withdrawal by Subject|0|||
124862915|NCT03263429|449119026|FG001|Overall Study|Withdrawal by Subject|1|||
124862916|NCT03263429|449119027|FG002|Overall Study|Withdrawal by Subject|0|||
124862917|NCT03263429|449119025|FG000|Overall Study|Follow-Up Period Completed|0|||
124862918|NCT03263429|449119026|FG001|Overall Study|Follow-Up Period Completed|2|||
124862919|NCT03263429|449119027|FG002|Overall Study|Follow-Up Period Completed|0|||
124862920|NCT03263429|449119025|FG000|Overall Study|Death|3|||
124862921|NCT03263429|449119026|FG001|Overall Study|Death|5|||
124862922|NCT03263429|449119027|FG002|Overall Study|Death|16|||
124862923|NCT03263429|449119025|FG000|Overall Study|Participant unable to return|0|||
124862924|NCT03263429|449119026|FG001|Overall Study|Participant unable to return|0|||
124862925|NCT03263429|449119027|FG002|Overall Study|Participant unable to return|1|||
124862926|NCT03263429|449119025|FG000|Overall Study|Study Closed|0|||
124862927|NCT03263429|449119026|FG001|Overall Study|Study Closed|0|||
124862928|NCT03263429|449119027|FG002|Overall Study|Study Closed|1|||
124862929|NCT01605617|449119028|FG000|First Intervention|Adverse Event|0|||
124862930|NCT01605617|449119029|FG001|First Intervention|Adverse Event|1|||
124862931|NCT01605617|449119028|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
124862932|NCT01605617|449119029|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
124862933|NCT01314118|449119035|FG000|Overall Study|Adverse Event|9|||
124862934|NCT01314118|449119035|FG000|Overall Study|Progressive disease|27|||
124862935|NCT01314118|449119035|FG000|Overall Study|Physician Decision|11|||
124862936|NCT01314118|449119035|FG000|Overall Study|Death|4|||
124862937|NCT01314118|449119035|FG000|Overall Study|Protocol Violation|5|||
124862938|NCT01314118|449119035|FG000|Overall Study|Withdrawal by Subject|11|||
124862939|NCT01314118|449119035|FG000|Overall Study|Other|2|||
124862940|NCT01314118|449119035|FG000|Overall Study|Ongoing|62|||
124862941|NCT05545072|449119036|FG000|Overall Study|Lost to Follow-up|1|||
124862942|NCT05545072|449119037|FG001|Overall Study|Lost to Follow-up|0|||
124862943|NCT05545072|449119036|FG000|Overall Study|Study ended prematurely due to funding|2|||
124862944|NCT05545072|449119037|FG001|Overall Study|Study ended prematurely due to funding|2|||
124862945|NCT05585307|449119038|FG000|Overall Study|Lost to Follow-up|0|||
124862946|NCT05585307|449119039|FG001|Overall Study|Lost to Follow-up|0|||
124862947|NCT05585307|449119040|FG002|Overall Study|Lost to Follow-up|0|||
124862948|NCT05585307|449119041|FG003|Overall Study|Lost to Follow-up|0|||
124862949|NCT05585307|449119042|FG004|Overall Study|Lost to Follow-up|0|||
124862950|NCT05585307|449119043|FG005|Overall Study|Lost to Follow-up|0|||
124862951|NCT05585307|449119044|FG006|Overall Study|Lost to Follow-up|1|||
124862952|NCT05585307|449119045|FG007|Overall Study|Lost to Follow-up|0|||
124862953|NCT04420221|449119051|FG000|Overall Study|Withdrawal by Subject|0|||
124862954|NCT04420221|449119052|FG001|Overall Study|Withdrawal by Subject|0|||
124862955|NCT04420221|449119053|FG002|Overall Study|Withdrawal by Subject|0|||
124862956|NCT04420221|449119054|FG003|Overall Study|Withdrawal by Subject|0|||
124862957|NCT04420221|449119055|FG004|Overall Study|Withdrawal by Subject|0|||
124862958|NCT04420221|449119056|FG005|Overall Study|Withdrawal by Subject|20|||
124862959|NCT04420221|449119057|FG006|Overall Study|Withdrawal by Subject|5|||
124862960|NCT04420221|449119051|FG000|Overall Study|Other|0|||
124862961|NCT04420221|449119052|FG001|Overall Study|Other|0|||
124862962|NCT04420221|449119053|FG002|Overall Study|Other|0|||
124862963|NCT04420221|449119054|FG003|Overall Study|Other|0|||
124862964|NCT04420221|449119055|FG004|Overall Study|Other|0|||
124862965|NCT04420221|449119056|FG005|Overall Study|Other|1|||
124862966|NCT04420221|449119057|FG006|Overall Study|Other|1|||
124862967|NCT04420221|449119051|FG000|Overall Study|Lost to Follow-up|0|||
124862968|NCT04420221|449119052|FG001|Overall Study|Lost to Follow-up|0|||
124862969|NCT04420221|449119053|FG002|Overall Study|Lost to Follow-up|0|||
124862970|NCT04420221|449119054|FG003|Overall Study|Lost to Follow-up|0|||
124862971|NCT04420221|449119055|FG004|Overall Study|Lost to Follow-up|0|||
124862972|NCT04420221|449119056|FG005|Overall Study|Lost to Follow-up|3|||
124862973|NCT04420221|449119057|FG006|Overall Study|Lost to Follow-up|2|||
124862974|NCT04420221|449119051|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
124862975|NCT04420221|449119052|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
124862976|NCT04420221|449119053|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
124862977|NCT04420221|449119054|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
124862978|NCT04420221|449119055|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
124862979|NCT04420221|449119056|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
124862980|NCT04420221|449119057|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
124862981|NCT01618864|449119058|FG000|Overall Study|Withdrawal by Subject|2|||
124862982|NCT01618864|449119058|FG000|Overall Study|Lost to Follow-up|2|||
124862983|NCT02085408|449119062|FG000|Step 1: Induction|Disease Progression|19|||
124862984|NCT02085408|449119063|FG001|Step 1: Induction|Disease Progression|19|||
124862985|NCT02085408|449119062|FG000|Step 1: Induction|Adverse Event|18|||
124862986|NCT02085408|449119063|FG001|Step 1: Induction|Adverse Event|17|||
124862987|NCT02085408|449119062|FG000|Step 1: Induction|Death|33|||
124862988|NCT02085408|449119063|FG001|Step 1: Induction|Death|30|||
124862989|NCT02085408|449119062|FG000|Step 1: Induction|Withdrawal by Subject|16|||
124862990|NCT02085408|449119063|FG001|Step 1: Induction|Withdrawal by Subject|8|||
124862991|NCT02085408|449119062|FG000|Step 1: Induction|Alternative Therapy|15|||
124862992|NCT02085408|449119063|FG001|Step 1: Induction|Alternative Therapy|19|||
124862993|NCT02085408|449119062|FG000|Step 1: Induction|Complicating Disease|2|||
124862994|NCT02085408|449119063|FG001|Step 1: Induction|Complicating Disease|3|||
124862995|NCT02085408|449119062|FG000|Step 1: Induction|Other|27|||
124862996|NCT02085408|449119063|FG001|Step 1: Induction|Other|39|||
124862997|NCT02085408|449119062|FG000|Step 1: Induction|Never started treatment|6|||
124862998|NCT02085408|449119063|FG001|Step 1: Induction|Never started treatment|4|||
124862999|NCT02085408|449119062|FG000|Step 2: Consolidation|Disease Progression|5|||
124863000|NCT02085408|449119063|FG001|Step 2: Consolidation|Disease Progression|20|||
124863001|NCT02085408|449119062|FG000|Step 2: Consolidation|Adverse Event|9|||
124863002|NCT02085408|449119063|FG001|Step 2: Consolidation|Adverse Event|8|||
124863003|NCT02085408|449119062|FG000|Step 2: Consolidation|Death|4|||
124863004|NCT02085408|449119063|FG001|Step 2: Consolidation|Death|3|||
124863005|NCT02085408|449119062|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
124863006|NCT02085408|449119063|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
124863007|NCT02085408|449119062|FG000|Step 2: Consolidation|Alternative Therapy|9|||
124863008|NCT02085408|449119063|FG001|Step 2: Consolidation|Alternative Therapy|3|||
124863009|NCT02085408|449119062|FG000|Step 2: Consolidation|Complicating Disease|0|||
124863010|NCT02085408|449119063|FG001|Step 2: Consolidation|Complicating Disease|2|||
124863011|NCT02085408|449119062|FG000|Step 2: Consolidation|Other|6|||
124863012|NCT02085408|449119063|FG001|Step 2: Consolidation|Other|6|||
124863013|NCT02085408|449119062|FG000|Step 2: Consolidation|Never started treatment|4|||
124863014|NCT02085408|449119063|FG001|Step 2: Consolidation|Never started treatment|3|||
124863015|NCT02085408|449119062|FG000|Step 3: Maintenance|Disease Progression|13|||
124863016|NCT02085408|449119063|FG001|Step 3: Maintenance|Disease Progression|11|||
124863017|NCT02085408|449119062|FG000|Step 3: Maintenance|Adverse Event|2|||
124863018|NCT02085408|449119063|FG001|Step 3: Maintenance|Adverse Event|4|||
124863019|NCT02085408|449119062|FG000|Step 3: Maintenance|Death|1|||
124863020|NCT02085408|449119063|FG001|Step 3: Maintenance|Death|2|||
124863021|NCT02085408|449119062|FG000|Step 3: Maintenance|Alternative Therapy|1|||
124863022|NCT02085408|449119063|FG001|Step 3: Maintenance|Alternative Therapy|1|||
124863023|NCT02085408|449119062|FG000|Step 3: Maintenance|Complicating Disease|0|||
124863024|NCT02085408|449119063|FG001|Step 3: Maintenance|Complicating Disease|1|||
124863025|NCT02085408|449119062|FG000|Step 3: Maintenance|Other|3|||
124863026|NCT02085408|449119063|FG001|Step 3: Maintenance|Other|2|||
124863027|NCT02085408|449119062|FG000|Step 3: Maintenance|Never started treatment|5|||
124863028|NCT02085408|449119063|FG001|Step 3: Maintenance|Never started treatment|1|||
124863029|NCT01672801|449119069|FG000|Overall Study|Screen Failure|0|||
124863030|NCT01672801|449119070|FG001|Overall Study|Screen Failure|1|||
124863031|NCT02273141|449119073|FG000|Overall Study|Adverse Event|0|||
124863032|NCT02273141|449119074|FG001|Overall Study|Adverse Event|1|||
124863033|NCT02273141|449119073|FG000|Overall Study|Lost to Follow-up|1|||
124863034|NCT02273141|449119074|FG001|Overall Study|Lost to Follow-up|3|||
124863035|NCT02273141|449119073|FG000|Overall Study|Withdrawal by Subject|10|||
124863036|NCT02273141|449119074|FG001|Overall Study|Withdrawal by Subject|15|||
124863037|NCT02273141|449119073|FG000|Overall Study|Various|6|||
124863038|NCT02273141|449119074|FG001|Overall Study|Various|6|||
124863039|NCT00492284|449119075|FG000|Overall Study|Adverse Event|0|||
124863040|NCT00492284|449119076|FG001|Overall Study|Adverse Event|1|||
124863041|NCT00492284|449119077|FG002|Overall Study|Adverse Event|1|||
124863042|NCT00492284|449119078|FG003|Overall Study|Adverse Event|2|||
124863043|NCT00492284|449119075|FG000|Overall Study|Lost to Follow-up|0|||
124863044|NCT00492284|449119076|FG001|Overall Study|Lost to Follow-up|0|||
124863045|NCT00492284|449119077|FG002|Overall Study|Lost to Follow-up|3|||
124863046|NCT00492284|449119078|FG003|Overall Study|Lost to Follow-up|1|||
124863047|NCT00492284|449119075|FG000|Overall Study|Death|0|||
124863048|NCT00492284|449119076|FG001|Overall Study|Death|3|||
124863049|NCT00492284|449119077|FG002|Overall Study|Death|2|||
124863050|NCT00492284|449119078|FG003|Overall Study|Death|5|||
124863051|NCT00492284|449119075|FG000|Overall Study|Withdrawal by Subject|1|||
124863052|NCT00492284|449119076|FG001|Overall Study|Withdrawal by Subject|0|||
124863053|NCT00492284|449119077|FG002|Overall Study|Withdrawal by Subject|0|||
124863054|NCT00492284|449119078|FG003|Overall Study|Withdrawal by Subject|2|||
124863055|NCT01556438|449119079|FG000|Overall Study|Adverse Event|4|||
124863056|NCT01556438|449119080|FG001|Overall Study|Adverse Event|2|||
124863057|NCT01556438|449119079|FG000|Overall Study|Sponsor Decision|0|||
124863058|NCT01556438|449119080|FG001|Overall Study|Sponsor Decision|2|||
124863059|NCT01556438|449119079|FG000|Overall Study|Progressive Disease|0|||
124863060|NCT01556438|449119080|FG001|Overall Study|Progressive Disease|6|||
124863061|NCT01556438|449119079|FG000|Overall Study|Death|0|||
124863062|NCT01556438|449119080|FG001|Overall Study|Death|1|||
124863063|NCT00529399|449119081|FG000|Overall Study|Lost to Follow-up|1|||
124863064|NCT00529399|449119082|FG001|Overall Study|Lost to Follow-up|0|||
124863065|NCT00529399|449119083|FG002|Overall Study|Lost to Follow-up|1|||
124863066|NCT00529399|449119081|FG000|Overall Study|Withdrawal by Subject|1|||
124863067|NCT00529399|449119082|FG001|Overall Study|Withdrawal by Subject|0|||
124863068|NCT00529399|449119083|FG002|Overall Study|Withdrawal by Subject|1|||
124863069|NCT00529399|449119081|FG000|Overall Study|Non-compliant|0|||
124863070|NCT00529399|449119082|FG001|Overall Study|Non-compliant|1|||
124863071|NCT00529399|449119083|FG002|Overall Study|Non-compliant|0|||
124863072|NCT02734212|449119085|FG000|Overall Study|Lost to Follow-up|5|||
124863073|NCT02734212|449119086|FG001|Overall Study|Lost to Follow-up|10|||
124863074|NCT04313881|449119087|FG000|Overall Study|Death|138|||
124863075|NCT04313881|449119088|FG001|Overall Study|Death|126|||
124863076|NCT04313881|449119087|FG000|Overall Study|Study terminated by sponsor|108|||
124863077|NCT04313881|449119088|FG001|Overall Study|Study terminated by sponsor|129|||
124863078|NCT04313881|449119087|FG000|Overall Study|Consent withdrawn|19|||
124863079|NCT04313881|449119088|FG001|Overall Study|Consent withdrawn|15|||
124863080|NCT04313881|449119087|FG000|Overall Study|Reason not Specified|3|||
124863081|NCT04313881|449119088|FG001|Overall Study|Reason not Specified|1|||
124863082|NCT04732286|449119092|FG000|Overall Study|Progressive Disease|2|||
124863083|NCT04732286|449119092|FG000|Overall Study|Physician Decision|1|||
124863084|NCT04732286|449119092|FG000|Overall Study|Study Terminated by Sponsor|31|||
124863085|NCT04732286|449119092|FG000|Overall Study|Withdrawal by Subject|10|||
124863086|NCT04732286|449119092|FG000|Overall Study|Non-compliance With Study Drug|1|||
124863087|NCT04732286|449119092|FG000|Overall Study|Lost to Follow-up|4|||
124863088|NCT04732286|449119092|FG000|Overall Study|Death|51|||
124863089|NCT01910129|449119096|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
124863090|NCT01910129|449119097|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
124863091|NCT01910129|449119098|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
124863092|NCT01910129|449119096|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
124863093|NCT01910129|449119097|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
124863094|NCT01910129|449119098|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
124863095|NCT03595904|449119100|FG000|Overall Study|Protocol Violation|3|||
124863096|NCT03595904|449119101|FG001|Overall Study|Protocol Violation|1|||
124863097|NCT03595904|449119100|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
124863098|NCT03595904|449119101|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
124863099|NCT03595904|449119100|FG000|Overall Study|Insurance complications|1|||
124863100|NCT03595904|449119101|FG001|Overall Study|Insurance complications|0|||
124863101|NCT03595904|449119100|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
124863102|NCT03595904|449119101|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
124863103|NCT01392560|449119102|FG000|Overall Study|Adverse Event|2|||
124863104|NCT01392560|449119102|FG000|Overall Study|not entered|8|||
124863105|NCT01392560|449119102|FG000|Overall Study|discontinued during placebo run-in|2|||
124863106|NCT04764396|449119115|FG000|Overall Study|Physician Decision|1|||
124863107|NCT04764396|449119116|FG001|Overall Study|Physician Decision|0|||
124863108|NCT02653482|449119117|FG000|Overall Study|Death|1|||
124863109|NCT02653482|449119118|FG001|Overall Study|Death|1|||
124863110|NCT04657211|449119119|FG000|Overall Study|Withdrawal by Subject|21|||
124863111|NCT04657211|449119119|FG000|Overall Study|Lost to Follow-up|113|||
124863112|NCT04657211|449119119|FG000|Overall Study|Death|47|||
124863113|NCT04657211|449119119|FG000|Overall Study|Transfer to another institution|21|||
124863114|NCT04657211|449119119|FG000|Overall Study|Other|29|||
124863115|NCT03776136|449119120|FG000|Overall Study|Death|85|||
124863116|NCT03776136|449119120|FG000|Overall Study|Withdrawal by Subject|3|||
124863117|NCT03776136|449119120|FG000|Overall Study|Sponsor Decision|15|||
124863118|NCT00613951|449119121|FG000|Overall Study|Adverse Event|1|||
124863119|NCT00613951|449119122|FG001|Overall Study|Adverse Event|0|||
124863120|NCT00613951|449119123|FG002|Overall Study|Adverse Event|1|||
124863121|NCT00613951|449119121|FG000|Overall Study|Lack of Efficacy|0|||
124863122|NCT00613951|449119122|FG001|Overall Study|Lack of Efficacy|1|||
124863123|NCT00613951|449119123|FG002|Overall Study|Lack of Efficacy|1|||
124863124|NCT00613951|449119121|FG000|Overall Study|Protocol Violation|1|||
124863125|NCT00613951|449119122|FG001|Overall Study|Protocol Violation|1|||
124863126|NCT00613951|449119123|FG002|Overall Study|Protocol Violation|1|||
124863127|NCT00613951|449119121|FG000|Overall Study|Unclassified|5|||
124863128|NCT00613951|449119122|FG001|Overall Study|Unclassified|3|||
124863129|NCT00613951|449119123|FG002|Overall Study|Unclassified|2|||
124863130|NCT01329029|449119128|FG000|Overall Study|Withdrawal by Subject|117|||
124863131|NCT01329029|449119129|FG001|Overall Study|Withdrawal by Subject|87|||
124863132|NCT01329029|449119128|FG000|Overall Study|Adverse Event|82|||
124863133|NCT01329029|449119129|FG001|Overall Study|Adverse Event|29|||
124863134|NCT01329029|449119128|FG000|Overall Study|Death|16|||
124863135|NCT01329029|449119129|FG001|Overall Study|Death|19|||
124863136|NCT01329029|449119128|FG000|Overall Study|Other|14|||
124863137|NCT01329029|449119129|FG001|Overall Study|Other|20|||
124863138|NCT01329029|449119128|FG000|Overall Study|COPD Exacerbation|11|||
124863139|NCT01329029|449119129|FG001|Overall Study|COPD Exacerbation|18|||
124863140|NCT01329029|449119128|FG000|Overall Study|Physician Decision|16|||
124863141|NCT01329029|449119129|FG001|Overall Study|Physician Decision|13|||
124863142|NCT01329029|449119128|FG000|Overall Study|Lost to Follow-up|8|||
124863143|NCT01329029|449119129|FG001|Overall Study|Lost to Follow-up|5|||
124863144|NCT01329029|449119128|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
124863145|NCT01329029|449119129|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
124863146|NCT00680407|449119133|FG000|Overall Study|Lost to Follow-up|3|||
124863147|NCT00680407|449119134|FG001|Overall Study|Lost to Follow-up|3|||
124863148|NCT00680407|449119135|FG002|Overall Study|Lost to Follow-up|1|||
124863149|NCT00680407|449119133|FG000|Overall Study|Withdrawal by Subject|5|||
124863150|NCT00680407|449119134|FG001|Overall Study|Withdrawal by Subject|2|||
124863151|NCT00680407|449119135|FG002|Overall Study|Withdrawal by Subject|2|||
124863152|NCT06167031|449119136|FG000|Overall Study|Lost to Follow-up|5|||
124863153|NCT06167031|449119137|FG001|Overall Study|Lost to Follow-up|1|||
124863154|NCT01266642|449119138|FG000|Overall Study|Protocol Violation|0|||
124863155|NCT01266642|449119139|FG001|Overall Study|Protocol Violation|1|||
124863156|NCT00924287|449120966|FG000|Overall Study|Death|1|||
124863157|NCT02621931|449120967|FG000|Overall Study|Death|0|||
124863158|NCT02621931|449120968|FG001|Overall Study|Death|1|||
124863159|NCT02621931|449120969|FG002|Overall Study|Death|0|||
124863160|NCT02621931|449120967|FG000|Overall Study|Adverse Event|8|||
124863161|NCT02621931|449120968|FG001|Overall Study|Adverse Event|5|||
124863162|NCT02621931|449120969|FG002|Overall Study|Adverse Event|7|||
124863163|NCT02621931|449120967|FG000|Overall Study|Withdrawal by Subject|12|||
124863164|NCT02621931|449120968|FG001|Overall Study|Withdrawal by Subject|10|||
124863165|NCT02621931|449120969|FG002|Overall Study|Withdrawal by Subject|11|||
124863166|NCT02621931|449120967|FG000|Overall Study|Protocol Violation|2|||
124863167|NCT02621931|449120968|FG001|Overall Study|Protocol Violation|2|||
124863168|NCT02621931|449120969|FG002|Overall Study|Protocol Violation|2|||
124863169|NCT02621931|449120967|FG000|Overall Study|Pregnancy|2|||
124863170|NCT02621931|449120968|FG001|Overall Study|Pregnancy|0|||
124863171|NCT02621931|449120969|FG002|Overall Study|Pregnancy|0|||
124863172|NCT02621931|449120967|FG000|Overall Study|Noncompliance to study procedures|0|||
124863173|NCT02621931|449120968|FG001|Overall Study|Noncompliance to study procedures|1|||
124863174|NCT02621931|449120969|FG002|Overall Study|Noncompliance to study procedures|2|||
124863175|NCT02621931|449120967|FG000|Overall Study|Lost to Follow-up|8|||
124863176|NCT02621931|449120968|FG001|Overall Study|Lost to Follow-up|7|||
124863177|NCT02621931|449120969|FG002|Overall Study|Lost to Follow-up|10|||
124863178|NCT02621931|449120967|FG000|Overall Study|Lack of Efficacy|0|||
124863179|NCT02621931|449120968|FG001|Overall Study|Lack of Efficacy|0|||
124863180|NCT02621931|449120969|FG002|Overall Study|Lack of Efficacy|1|||
124863181|NCT02621931|449120967|FG000|Overall Study|Other|1|||
124863182|NCT02621931|449120968|FG001|Overall Study|Other|1|||
124863183|NCT02621931|449120969|FG002|Overall Study|Other|3|||
124863184|NCT01912612|449120970|FG000|Overall Study|Adverse Event|4|||
124863185|NCT01912612|449120971|FG001|Overall Study|Adverse Event|0|||
124863186|NCT01912612|449120972|FG002|Overall Study|Adverse Event|0|||
124863187|NCT01912612|449120970|FG000|Overall Study|Withdrew consent|1|||
124863188|NCT01912612|449120971|FG001|Overall Study|Withdrew consent|0|||
124863189|NCT01912612|449120972|FG002|Overall Study|Withdrew consent|0|||
124863190|NCT01912612|449120970|FG000|Overall Study|Study design change|0|||
124863191|NCT01912612|449120971|FG001|Overall Study|Study design change|0|||
124863192|NCT01912612|449120972|FG002|Overall Study|Study design change|3|||
124863193|NCT01588184|449120973|FG000|Overall Study|Death|1|||
124863194|NCT01588184|449120974|FG001|Overall Study|Death|0|||
124863195|NCT01588184|449120975|FG002|Overall Study|Death|0|||
124863196|NCT01588184|449120976|FG003|Overall Study|Death|1|||
124863197|NCT01588184|449120977|FG004|Overall Study|Death|1|||
124863198|NCT01588184|449120978|FG005|Overall Study|Death|1|||
124863199|NCT01588184|449120973|FG000|Overall Study|Withdrawal by Subject|2|||
124863200|NCT01588184|449120974|FG001|Overall Study|Withdrawal by Subject|4|||
124863201|NCT01588184|449120975|FG002|Overall Study|Withdrawal by Subject|0|||
124863202|NCT01588184|449120976|FG003|Overall Study|Withdrawal by Subject|1|||
124863203|NCT01588184|449120977|FG004|Overall Study|Withdrawal by Subject|0|||
124863204|NCT01588184|449120978|FG005|Overall Study|Withdrawal by Subject|0|||
124863205|NCT01588184|449120973|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
124863206|NCT01588184|449120974|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
124863207|NCT01588184|449120975|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
124863208|NCT01588184|449120976|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
124863209|NCT01588184|449120977|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
124863210|NCT01588184|449120978|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
124863211|NCT01588184|449120973|FG000|Overall Study|multiple reasons|0|||
124863212|NCT01588184|449120974|FG001|Overall Study|multiple reasons|3|||
124863213|NCT01588184|449120975|FG002|Overall Study|multiple reasons|0|||
124863214|NCT01588184|449120976|FG003|Overall Study|multiple reasons|1|||
124863215|NCT01588184|449120977|FG004|Overall Study|multiple reasons|0|||
124863216|NCT01588184|449120978|FG005|Overall Study|multiple reasons|0|||
124863217|NCT05912400|449120980|FG000|Overall Study|Lost to Follow-up|1|||
124863218|NCT05912400|449120981|FG001|Overall Study|Lost to Follow-up|0|||
124863219|NCT05912400|449120980|FG000|Overall Study|Physician Decision|6|||
124863220|NCT05912400|449120981|FG001|Overall Study|Physician Decision|0|||
124863221|NCT05912400|449120980|FG000|Overall Study|Withdrawal by Subject|1|||
124863222|NCT05912400|449120981|FG001|Overall Study|Withdrawal by Subject|0|||
124863223|NCT03461003|449120986|FG000|Overall Study|Lost to Follow-up|2|||
124863224|NCT03461003|449120987|FG001|Overall Study|Lost to Follow-up|2|||
124863225|NCT03461003|449120986|FG000|Overall Study|Withdrawal by Subject|3|||
124863226|NCT03461003|449120987|FG001|Overall Study|Withdrawal by Subject|1|||
124863227|NCT03489304|449120988|FG000|Overall Study|Lost to Follow-up|4|||
124863228|NCT02566031|449120996|FG000|Overall Study|Patient/guardian decision|14|||
124863229|NCT02566031|449120997|FG001|Overall Study|Patient/guardian decision|7|||
124863230|NCT02566031|449120996|FG000|Overall Study|Protocol deviation|2|||
124863231|NCT02566031|449120997|FG001|Overall Study|Protocol deviation|3|||
124863232|NCT02566031|449120996|FG000|Overall Study|Adverse Event|3|||
124863233|NCT02566031|449120997|FG001|Overall Study|Adverse Event|1|||
124863234|NCT02566031|449120996|FG000|Overall Study|Lost to Follow-up|1|||
124863235|NCT02566031|449120997|FG001|Overall Study|Lost to Follow-up|1|||
124863236|NCT02479412|449121000|FG000|Overall Study|Adverse Event|0|||
124863237|NCT02479412|449121001|FG001|Overall Study|Adverse Event|0|||
124863238|NCT02479412|449121002|FG002|Overall Study|Adverse Event|1|||
124863239|NCT02479412|449121003|FG003|Overall Study|Adverse Event|0|||
124863240|NCT02479412|449121004|FG004|Overall Study|Adverse Event|0|||
124863241|NCT02479412|449121005|FG005|Overall Study|Adverse Event|0|||
124863242|NCT02479412|449121006|FG006|Overall Study|Adverse Event|0|||
124863243|NCT02479412|449121007|FG007|Overall Study|Adverse Event|0|||
124863244|NCT02479412|449121008|FG008|Overall Study|Adverse Event|0|||
124863245|NCT02479412|449121000|FG000|Overall Study|Study-specific withdrawal criteria|0|||
124863246|NCT02479412|449121001|FG001|Overall Study|Study-specific withdrawal criteria|0|||
124863247|NCT02479412|449121002|FG002|Overall Study|Study-specific withdrawal criteria|1|||
124863248|NCT02479412|449121003|FG003|Overall Study|Study-specific withdrawal criteria|1|||
124863249|NCT02479412|449121004|FG004|Overall Study|Study-specific withdrawal criteria|0|||
124863250|NCT02479412|449121005|FG005|Overall Study|Study-specific withdrawal criteria|0|||
124863251|NCT02479412|449121006|FG006|Overall Study|Study-specific withdrawal criteria|0|||
124863252|NCT02479412|449121007|FG007|Overall Study|Study-specific withdrawal criteria|1|||
124863253|NCT02479412|449121008|FG008|Overall Study|Study-specific withdrawal criteria|1|||
124863254|NCT02479412|449121000|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
124863255|NCT02479412|449121001|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
124863256|NCT02479412|449121002|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
124863257|NCT02479412|449121003|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
124863258|NCT02479412|449121004|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
124863259|NCT02479412|449121005|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
124863260|NCT02479412|449121006|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
124863261|NCT02479412|449121007|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
124863262|NCT02479412|449121008|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
124863263|NCT04969250|449121009|FG000|Overall Study|Protocol Violation|0|||
124863264|NCT04969250|449121010|FG001|Overall Study|Protocol Violation|2|||
124863265|NCT04969250|449121011|FG002|Overall Study|Protocol Violation|3|||
124863266|NCT04969250|449121012|FG003|Overall Study|Protocol Violation|8|||
124863267|NCT04969250|449121009|FG000|Overall Study|Withdrawal by Subject|0|||
124863268|NCT04969250|449121010|FG001|Overall Study|Withdrawal by Subject|1|||
124863269|NCT04969250|449121011|FG002|Overall Study|Withdrawal by Subject|0|||
124863270|NCT04969250|449121012|FG003|Overall Study|Withdrawal by Subject|0|||
124863271|NCT04642638|449121018|FG000|Overall Study|Withdrawal by Subject|23|||
124863272|NCT04642638|449121019|FG001|Overall Study|Withdrawal by Subject|29|||
124863273|NCT04642638|449121020|FG002|Overall Study|Withdrawal by Subject|9|||
124863274|NCT04642638|449121021|FG003|Overall Study|Withdrawal by Subject|7|||
124863275|NCT04642638|449121022|FG004|Overall Study|Withdrawal by Subject|61|||
124863276|NCT04642638|449121023|FG005|Overall Study|Withdrawal by Subject|27|||
124863277|NCT04642638|449121018|FG000|Overall Study|Lost to Follow-up|17|||
124863278|NCT04642638|449121019|FG001|Overall Study|Lost to Follow-up|18|||
124863279|NCT04642638|449121020|FG002|Overall Study|Lost to Follow-up|5|||
124863280|NCT04642638|449121021|FG003|Overall Study|Lost to Follow-up|5|||
124863281|NCT04642638|449121022|FG004|Overall Study|Lost to Follow-up|6|||
124863282|NCT04642638|449121023|FG005|Overall Study|Lost to Follow-up|3|||
124863283|NCT04642638|449121018|FG000|Overall Study|Adverse Event|0|||
124863284|NCT04642638|449121019|FG001|Overall Study|Adverse Event|0|||
124863285|NCT04642638|449121020|FG002|Overall Study|Adverse Event|1|||
124863286|NCT04642638|449121021|FG003|Overall Study|Adverse Event|0|||
124863287|NCT04642638|449121022|FG004|Overall Study|Adverse Event|10|||
124863288|NCT04642638|449121023|FG005|Overall Study|Adverse Event|3|||
124863289|NCT04642638|449121018|FG000|Overall Study|Reason Not Specified|1|||
124863290|NCT04642638|449121019|FG001|Overall Study|Reason Not Specified|4|||
124863291|NCT04642638|449121020|FG002|Overall Study|Reason Not Specified|0|||
124863292|NCT04642638|449121021|FG003|Overall Study|Reason Not Specified|0|||
124863293|NCT04642638|449121022|FG004|Overall Study|Reason Not Specified|38|||
124863294|NCT04642638|449121023|FG005|Overall Study|Reason Not Specified|16|||
124863295|NCT04642638|449121018|FG000|Overall Study|Physician Decision|0|||
124863296|NCT04642638|449121019|FG001|Overall Study|Physician Decision|0|||
124863297|NCT04642638|449121020|FG002|Overall Study|Physician Decision|0|||
124863298|NCT04642638|449121021|FG003|Overall Study|Physician Decision|0|||
124863299|NCT04642638|449121022|FG004|Overall Study|Physician Decision|2|||
124863300|NCT04642638|449121023|FG005|Overall Study|Physician Decision|1|||
124863301|NCT04642638|449121018|FG000|Overall Study|Protocol Deviation|0|||
124863302|NCT04642638|449121019|FG001|Overall Study|Protocol Deviation|0|||
124863303|NCT04642638|449121020|FG002|Overall Study|Protocol Deviation|0|||
124863304|NCT04642638|449121021|FG003|Overall Study|Protocol Deviation|0|||
124863305|NCT04642638|449121022|FG004|Overall Study|Protocol Deviation|1|||
124863306|NCT04642638|449121023|FG005|Overall Study|Protocol Deviation|3|||
124863307|NCT04642638|449121018|FG000|Overall Study|Study Terminated|0|||
124863308|NCT04642638|449121019|FG001|Overall Study|Study Terminated|0|||
124863309|NCT04642638|449121020|FG002|Overall Study|Study Terminated|0|||
124863310|NCT04642638|449121021|FG003|Overall Study|Study Terminated|0|||
124863311|NCT04642638|449121022|FG004|Overall Study|Study Terminated|484|||
124863312|NCT04642638|449121023|FG005|Overall Study|Study Terminated|250|||
124863313|NCT04642638|449121018|FG000|Overall Study|Pregnancy|0|||
124863314|NCT04642638|449121019|FG001|Overall Study|Pregnancy|0|||
124863315|NCT04642638|449121020|FG002|Overall Study|Pregnancy|0|||
124863316|NCT04642638|449121021|FG003|Overall Study|Pregnancy|0|||
124863317|NCT04642638|449121022|FG004|Overall Study|Pregnancy|1|||
124863318|NCT04642638|449121023|FG005|Overall Study|Pregnancy|0|||
124863319|NCT00511004|449121024|FG000|Overall Study|Lost to Follow-up|0|||
124863320|NCT00511004|449121025|FG001|Overall Study|Lost to Follow-up|0|||
124863321|NCT00511004|449121026|FG002|Overall Study|Lost to Follow-up|4|||
124863322|NCT00990652|449121027|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
124863323|NCT00990652|449121027|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
124863324|NCT03695172|449121028|FG000|Overall Study|Withdrawal by Subject|1|||
124863325|NCT03695172|449121029|FG001|Overall Study|Withdrawal by Subject|1|||
124863326|NCT03695172|449121030|FG002|Overall Study|Withdrawal by Subject|0|||
124863327|NCT00727272|449121046|FG000|Washout Period A|Adverse Event|0|||
124863328|NCT00727272|449121047|FG001|Washout Period A|Adverse Event|0|||
124863329|NCT00727272|449121048|FG002|Washout Period A|Adverse Event|1|||
124863330|NCT00727272|449121046|FG000|Washout Period B|Withdrawal by Subject|0|||
124863331|NCT00727272|449121047|FG001|Washout Period B|Withdrawal by Subject|0|||
124863332|NCT00727272|449121048|FG002|Washout Period B|Withdrawal by Subject|1|||
124863333|NCT00651664|449121049|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
124863334|NCT00651664|449121050|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
124863335|NCT00651664|449121051|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
124863336|NCT00651664|449121052|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
124863337|NCT00651664|449121053|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
124863338|NCT00651664|449121054|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
124863339|NCT00651664|449121055|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
124863340|NCT00651664|449121056|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
124863341|NCT00651664|449121057|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
124863342|NCT00651664|449121058|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
124863343|NCT00651664|449121049|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
124863344|NCT00651664|449121050|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
124863345|NCT00651664|449121051|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
124863346|NCT00651664|449121052|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
124863347|NCT00651664|449121053|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
124863348|NCT00651664|449121054|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
124863349|NCT00651664|449121055|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
124863350|NCT00651664|449121056|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
124863351|NCT00651664|449121057|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
124863352|NCT00651664|449121058|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
124863353|NCT00651664|449121049|FG000|Overall Study|Progressive Disease|3|||
124863354|NCT00651664|449121050|FG001|Overall Study|Progressive Disease|3|||
124863355|NCT00651664|449121051|FG002|Overall Study|Progressive Disease|3|||
124863356|NCT00651664|449121052|FG003|Overall Study|Progressive Disease|12|||
124863357|NCT00651664|449121053|FG004|Overall Study|Progressive Disease|4|||
124863358|NCT00651664|449121054|FG005|Overall Study|Progressive Disease|1|||
124863359|NCT00651664|449121055|FG006|Overall Study|Progressive Disease|3|||
124863360|NCT00651664|449121056|FG007|Overall Study|Progressive Disease|6|||
124863361|NCT00651664|449121057|FG008|Overall Study|Progressive Disease|5|||
124863362|NCT00651664|449121058|FG009|Overall Study|Progressive Disease|5|||
124863363|NCT00651664|449121049|FG000|Overall Study|Patient Declined Further Treatment|0|||
124863364|NCT00651664|449121050|FG001|Overall Study|Patient Declined Further Treatment|0|||
124863365|NCT00651664|449121051|FG002|Overall Study|Patient Declined Further Treatment|0|||
124863366|NCT00651664|449121052|FG003|Overall Study|Patient Declined Further Treatment|1|||
124863367|NCT00651664|449121053|FG004|Overall Study|Patient Declined Further Treatment|1|||
124863368|NCT00651664|449121054|FG005|Overall Study|Patient Declined Further Treatment|1|||
124863369|NCT00651664|449121055|FG006|Overall Study|Patient Declined Further Treatment|0|||
124863370|NCT00651664|449121056|FG007|Overall Study|Patient Declined Further Treatment|0|||
124863371|NCT00651664|449121057|FG008|Overall Study|Patient Declined Further Treatment|0|||
124863372|NCT00651664|449121058|FG009|Overall Study|Patient Declined Further Treatment|1|||
124863373|NCT00651664|449121049|FG000|Overall Study|Symptomatic Deterioration|0|||
124863374|NCT00651664|449121050|FG001|Overall Study|Symptomatic Deterioration|0|||
124863375|NCT00651664|449121051|FG002|Overall Study|Symptomatic Deterioration|0|||
124863376|NCT00651664|449121052|FG003|Overall Study|Symptomatic Deterioration|1|||
124863377|NCT00651664|449121053|FG004|Overall Study|Symptomatic Deterioration|0|||
124863378|NCT00651664|449121054|FG005|Overall Study|Symptomatic Deterioration|0|||
124863379|NCT00651664|449121055|FG006|Overall Study|Symptomatic Deterioration|1|||
124863380|NCT00651664|449121056|FG007|Overall Study|Symptomatic Deterioration|0|||
124863381|NCT00651664|449121057|FG008|Overall Study|Symptomatic Deterioration|1|||
124863382|NCT00651664|449121058|FG009|Overall Study|Symptomatic Deterioration|0|||
124863383|NCT00651664|449121049|FG000|Overall Study|Reason not Specified|0|||
124863384|NCT00651664|449121050|FG001|Overall Study|Reason not Specified|0|||
124863385|NCT00651664|449121051|FG002|Overall Study|Reason not Specified|0|||
124863386|NCT00651664|449121052|FG003|Overall Study|Reason not Specified|0|||
124863387|NCT00651664|449121053|FG004|Overall Study|Reason not Specified|0|||
124863388|NCT00651664|449121054|FG005|Overall Study|Reason not Specified|0|||
124863389|NCT00651664|449121055|FG006|Overall Study|Reason not Specified|1|||
124863390|NCT00651664|449121056|FG007|Overall Study|Reason not Specified|0|||
124863391|NCT00651664|449121057|FG008|Overall Study|Reason not Specified|0|||
124863392|NCT00651664|449121058|FG009|Overall Study|Reason not Specified|0|||
124863393|NCT00688636|449121061|FG000|Overall Study|Adverse Event|2|||
124863394|NCT00688636|449121062|FG001|Overall Study|Adverse Event|1|||
124863395|NCT01572727|449121063|FG000|Overall Study|Adverse Event|43|||
124863396|NCT01572727|449121064|FG001|Overall Study|Adverse Event|15|||
124863397|NCT01572727|449121063|FG000|Overall Study|Lost to Follow-up|1|||
124863398|NCT01572727|449121064|FG001|Overall Study|Lost to Follow-up|1|||
124863399|NCT01572727|449121063|FG000|Overall Study|Physician Decision|23|||
124863400|NCT01572727|449121064|FG001|Overall Study|Physician Decision|9|||
124863401|NCT01572727|449121063|FG000|Overall Study|Progressive disease|59|||
124863402|NCT01572727|449121064|FG001|Overall Study|Progressive disease|82|||
124863403|NCT01572727|449121063|FG000|Overall Study|Protocol Violation|0|||
124863404|NCT01572727|449121064|FG001|Overall Study|Protocol Violation|1|||
124863405|NCT01572727|449121063|FG000|Overall Study|Study terminated by sponsor|61|||
124863406|NCT01572727|449121064|FG001|Overall Study|Study terminated by sponsor|83|||
124863407|NCT01572727|449121063|FG000|Overall Study|Parent/guardian decision|14|||
124863408|NCT01572727|449121064|FG001|Overall Study|Parent/guardian decision|9|||
124863409|NCT01572727|449121063|FG000|Overall Study|Death|2|||
124863410|NCT01572727|449121064|FG001|Overall Study|Death|2|||
124863411|NCT01572727|449121063|FG000|Overall Study|Untreated|4|||
124863412|NCT01572727|449121064|FG001|Overall Study|Untreated|7|||
124863413|NCT04053764|449121065|FG000|Overall Study|Withdrawal by Subject|6|||
124863414|NCT04053764|449121066|FG001|Overall Study|Withdrawal by Subject|2|||
124863415|NCT04053764|449121065|FG000|Overall Study|Physician Decision|2|||
124863416|NCT04053764|449121066|FG001|Overall Study|Physician Decision|1|||
124863417|NCT04053764|449121065|FG000|Overall Study|Adverse Event|1|||
124863418|NCT04053764|449121066|FG001|Overall Study|Adverse Event|0|||
124863419|NCT04053764|449121065|FG000|Overall Study|Pregnancy|1|||
124863420|NCT04053764|449121066|FG001|Overall Study|Pregnancy|0|||
124863421|NCT02384954|449121067|FG000|Phase 1|Progressive Disease|2|||
124863422|NCT02384954|449121068|FG001|Phase 1|Progressive Disease|0|||
124863423|NCT02384954|449121069|FG002|Phase 1|Progressive Disease|1|||
124863424|NCT02384954|449121070|FG003|Phase 1|Progressive Disease|1|||
124863425|NCT02384954|449121071|FG004|Phase 1|Progressive Disease|0|||
124863426|NCT02384954|449121072|FG005|Phase 1|Progressive Disease|0|||
124863427|NCT02384954|449121073|FG006|Phase 1|Progressive Disease|0|||
124863428|NCT02384954|449121074|FG007|Phase 1|Progressive Disease|0|||
124863429|NCT02384954|449121075|FG008|Phase 1|Progressive Disease|0|||
124863430|NCT02384954|449121067|FG000|Phase 1|Adverse Event|0|||
124863431|NCT02384954|449121068|FG001|Phase 1|Adverse Event|0|||
124863432|NCT02384954|449121069|FG002|Phase 1|Adverse Event|1|||
124863433|NCT02384954|449121070|FG003|Phase 1|Adverse Event|0|||
124863434|NCT02384954|449121071|FG004|Phase 1|Adverse Event|0|||
124863435|NCT02384954|449121072|FG005|Phase 1|Adverse Event|0|||
124863436|NCT02384954|449121073|FG006|Phase 1|Adverse Event|0|||
124863437|NCT02384954|449121074|FG007|Phase 1|Adverse Event|0|||
124863438|NCT02384954|449121075|FG008|Phase 1|Adverse Event|0|||
124863439|NCT02384954|449121067|FG000|Phase 2|Progressive Disease|0|||
124863440|NCT02384954|449121068|FG001|Phase 2|Progressive Disease|0|||
124863441|NCT02384954|449121069|FG002|Phase 2|Progressive Disease|0|||
124863442|NCT02384954|449121070|FG003|Phase 2|Progressive Disease|0|||
124863443|NCT02384954|449121071|FG004|Phase 2|Progressive Disease|0|||
124863444|NCT02384954|449121072|FG005|Phase 2|Progressive Disease|0|||
124863445|NCT02384954|449121073|FG006|Phase 2|Progressive Disease|0|||
124863446|NCT02384954|449121074|FG007|Phase 2|Progressive Disease|1|||
124863447|NCT02384954|449121075|FG008|Phase 2|Progressive Disease|2|||
124863448|NCT02384954|449121067|FG000|Phase 2|Adverse Event|0|||
124863449|NCT02384954|449121068|FG001|Phase 2|Adverse Event|0|||
124863450|NCT02384954|449121069|FG002|Phase 2|Adverse Event|0|||
124863451|NCT02384954|449121070|FG003|Phase 2|Adverse Event|0|||
124863452|NCT02384954|449121071|FG004|Phase 2|Adverse Event|0|||
124863453|NCT02384954|449121072|FG005|Phase 2|Adverse Event|0|||
124863454|NCT02384954|449121073|FG006|Phase 2|Adverse Event|0|||
124863455|NCT02384954|449121074|FG007|Phase 2|Adverse Event|1|||
124863456|NCT02384954|449121075|FG008|Phase 2|Adverse Event|1|||
124863457|NCT02384954|449121067|FG000|Phase 2|Failure to meet continuation criteria|0|||
124863458|NCT02384954|449121068|FG001|Phase 2|Failure to meet continuation criteria|0|||
124863459|NCT02384954|449121069|FG002|Phase 2|Failure to meet continuation criteria|0|||
124863460|NCT02384954|449121070|FG003|Phase 2|Failure to meet continuation criteria|0|||
124863461|NCT02384954|449121071|FG004|Phase 2|Failure to meet continuation criteria|0|||
124863462|NCT02384954|449121072|FG005|Phase 2|Failure to meet continuation criteria|0|||
124863463|NCT02384954|449121073|FG006|Phase 2|Failure to meet continuation criteria|0|||
124863464|NCT02384954|449121074|FG007|Phase 2|Failure to meet continuation criteria|1|||
124863465|NCT02384954|449121075|FG008|Phase 2|Failure to meet continuation criteria|0|||
124863466|NCT01474681|449121079|FG000|Overall Study|Death|0|||
124863467|NCT01474681|449121080|FG001|Overall Study|Death|3|||
124863468|NCT01474681|449121081|FG002|Overall Study|Death|2|||
124863469|NCT01474681|449121082|FG003|Overall Study|Death|6|||
124863470|NCT03998618|449121083|FG000|Overall Study|Death|7|||
124863471|NCT03998618|449121084|FG001|Overall Study|Death|11|||
124863472|NCT03998618|449121083|FG000|Overall Study|hospice enrollment|3|||
124863473|NCT03998618|449121084|FG001|Overall Study|hospice enrollment|3|||
124863474|NCT03998618|449121083|FG000|Overall Study|Not feeling well/health problems|3|||
124863475|NCT03998618|449121084|FG001|Overall Study|Not feeling well/health problems|5|||
124863476|NCT03998618|449121083|FG000|Overall Study|Lost to Follow-up|6|||
124863477|NCT03998618|449121084|FG001|Overall Study|Lost to Follow-up|6|||
124863478|NCT03998618|449121083|FG000|Overall Study|Withdrawal by Subject|0|||
124863479|NCT03998618|449121084|FG001|Overall Study|Withdrawal by Subject|4|||
124863480|NCT00319098|449121085|FG000|Overall Study|Serious adverse event|3|||
124863481|NCT00319098|449121086|FG001|Overall Study|Serious adverse event|0|||
124863482|NCT00319098|449121085|FG000|Overall Study|Adverse Event|20|||
124863483|NCT00319098|449121086|FG001|Overall Study|Adverse Event|1|||
124863484|NCT00319098|449121085|FG000|Overall Study|Withdrawal by Subject|37|||
124863485|NCT00319098|449121086|FG001|Overall Study|Withdrawal by Subject|8|||
124863486|NCT00319098|449121085|FG000|Overall Study|Migrated/moved from study area|2|||
124863487|NCT00319098|449121086|FG001|Overall Study|Migrated/moved from study area|1|||
124863488|NCT00319098|449121085|FG000|Overall Study|Lost to Follow-up|37|||
124863489|NCT00319098|449121086|FG001|Overall Study|Lost to Follow-up|13|||
124863490|NCT00319098|449121085|FG000|Overall Study|Others|33|||
124863491|NCT00319098|449121086|FG001|Overall Study|Others|8|||
124863492|NCT00319098|449121085|FG000|Overall Study|Protocol Violation|3|||
124863493|NCT00319098|449121086|FG001|Overall Study|Protocol Violation|1|||
124863494|NCT00295750|449121091|FG000|Overall Study|Adverse Event|19|||
124863495|NCT00295750|449121092|FG001|Overall Study|Adverse Event|15|||
124863496|NCT00295750|449121093|FG002|Overall Study|Adverse Event|12|||
124863497|NCT00295750|449121091|FG000|Overall Study|Lack of Efficacy|1|||
124863498|NCT00295750|449121092|FG001|Overall Study|Lack of Efficacy|1|||
124863499|NCT00295750|449121093|FG002|Overall Study|Lack of Efficacy|0|||
124863500|NCT00295750|449121091|FG000|Overall Study|Lost to Follow-up|1|||
124863501|NCT00295750|449121092|FG001|Overall Study|Lost to Follow-up|4|||
124863502|NCT00295750|449121093|FG002|Overall Study|Lost to Follow-up|1|||
124863503|NCT00295750|449121091|FG000|Overall Study|Taking prohibited therapy|2|||
124863504|NCT00295750|449121092|FG001|Overall Study|Taking prohibited therapy|3|||
124863505|NCT00295750|449121093|FG002|Overall Study|Taking prohibited therapy|2|||
124863506|NCT00295750|449121091|FG000|Overall Study|Administrative errors|2|||
124863507|NCT00295750|449121092|FG001|Overall Study|Administrative errors|4|||
124863508|NCT00295750|449121093|FG002|Overall Study|Administrative errors|5|||
124863509|NCT00295750|449121091|FG000|Overall Study|Trial drug errors|1|||
124863510|NCT00295750|449121092|FG001|Overall Study|Trial drug errors|1|||
124863511|NCT00295750|449121093|FG002|Overall Study|Trial drug errors|0|||
124863512|NCT00295750|449121091|FG000|Overall Study|Disease progression|2|||
124863513|NCT00295750|449121092|FG001|Overall Study|Disease progression|1|||
124863514|NCT00295750|449121093|FG002|Overall Study|Disease progression|0|||
124863515|NCT00295750|449121091|FG000|Overall Study|Personal reasons|0|||
124863516|NCT00295750|449121092|FG001|Overall Study|Personal reasons|1|||
124863517|NCT00295750|449121093|FG002|Overall Study|Personal reasons|0|||
124863518|NCT00295750|449121091|FG000|Overall Study|Randomized but never received trial drug|4|||
124863519|NCT00295750|449121092|FG001|Overall Study|Randomized but never received trial drug|3|||
124863520|NCT00295750|449121093|FG002|Overall Study|Randomized but never received trial drug|3|||
124863521|NCT00295750|449121091|FG000|Overall Study|Withdrawal by Subject|9|||
124863522|NCT00295750|449121092|FG001|Overall Study|Withdrawal by Subject|4|||
124863523|NCT00295750|449121093|FG002|Overall Study|Withdrawal by Subject|7|||
124863524|NCT00295750|449121091|FG000|Overall Study|Protocol Violation|2|||
124863525|NCT00295750|449121092|FG001|Overall Study|Protocol Violation|4|||
124863526|NCT00295750|449121093|FG002|Overall Study|Protocol Violation|2|||
124863527|NCT00936858|449121095|FG000|Overall Study|Death|3|||
124863528|NCT00936858|449121095|FG000|Overall Study|Progression|29|||
124863529|NCT00936858|449121095|FG000|Overall Study|Withdrawal by Subject|5|||
124863530|NCT00936858|449121095|FG000|Overall Study|Adverse Event|1|||
124863531|NCT00936858|449121095|FG000|Overall Study|Physician Decision|7|||
124863532|NCT00936858|449121095|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
124863533|NCT00936858|449121095|FG000|Overall Study|Lost to Follow-up|1|||
124863534|NCT02199028|449121106|FG000|Week 1|Adverse Event|1|||
124863535|NCT02199028|449121107|FG001|Week 1|Adverse Event|0|||
124863536|NCT02199028|449121106|FG000|Week 3|Adverse Event|1|||
124863537|NCT02199028|449121107|FG001|Week 3|Adverse Event|0|||
124863538|NCT01881126|449121108|FG000|Overall Study|Non-compliance|1|||
124863539|NCT01881126|449121109|FG001|Overall Study|Non-compliance|1|||
124863540|NCT01881126|449121108|FG000|Overall Study|Adverse Event|0|||
124863541|NCT01881126|449121109|FG001|Overall Study|Adverse Event|1|||
124863542|NCT02341417|449121114|FG000|Overall Study|Withdrawal by Subject|0|||
124863543|NCT02341417|449121115|FG001|Overall Study|Withdrawal by Subject|2|||
124863544|NCT02341417|449121116|FG002|Overall Study|Withdrawal by Subject|0|||
124863545|NCT02341417|449121114|FG000|Overall Study|Decision by sponsor|2|||
124863546|NCT02341417|449121115|FG001|Overall Study|Decision by sponsor|0|||
124863547|NCT02341417|449121116|FG002|Overall Study|Decision by sponsor|0|||
124863548|NCT02341417|449121114|FG000|Overall Study|Death|0|||
124863549|NCT02341417|449121115|FG001|Overall Study|Death|0|||
124863550|NCT02341417|449121116|FG002|Overall Study|Death|1|||
124863551|NCT04403698|449121118|FG000|Overall Study|Adverse Event|1|||
124863552|NCT04403698|449121119|FG001|Overall Study|Adverse Event|1|||
124863553|NCT04403698|449121118|FG000|Overall Study|Lost to Follow-up|1|||
124863554|NCT04403698|449121119|FG001|Overall Study|Lost to Follow-up|0|||
124863555|NCT04403698|449121118|FG000|Overall Study|Protocol Violation|0|||
124863556|NCT04403698|449121119|FG001|Overall Study|Protocol Violation|1|||
124863557|NCT03152552|449121120|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
124863558|NCT03152552|449121121|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
124863559|NCT03152552|449121122|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
124863560|NCT03152552|449121123|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
124863561|NCT03152552|449121124|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
124863562|NCT03152552|449121120|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
124863563|NCT03152552|449121121|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
124863564|NCT03152552|449121122|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
124863565|NCT03152552|449121123|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
124863566|NCT03152552|449121124|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
124863567|NCT03152552|449121120|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
124863568|NCT03152552|449121121|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
124863569|NCT03152552|449121122|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
124863570|NCT03152552|449121123|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
124863571|NCT03152552|449121124|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
124863572|NCT03152552|449121120|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124863573|NCT03152552|449121121|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124863574|NCT03152552|449121122|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
124863575|NCT03152552|449121123|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124863576|NCT03152552|449121124|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124863577|NCT03152552|449121120|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
124863578|NCT03152552|449121121|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
124863579|NCT03152552|449121122|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
124863580|NCT03152552|449121123|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
124863581|NCT03152552|449121124|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
124863582|NCT03152552|449121120|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
124863583|NCT03152552|449121121|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
124863584|NCT03152552|449121122|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
124863585|NCT03152552|449121123|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
124863586|NCT03152552|449121124|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
124863587|NCT03152552|449121120|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
124863588|NCT03152552|449121121|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
124863589|NCT03152552|449121122|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
124863590|NCT03152552|449121123|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
124863591|NCT03152552|449121124|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
124863592|NCT04899349|449121130|FG000|Overall Study|Study terminated by Sponsor|2|||
124863593|NCT04899349|449121131|FG001|Overall Study|Study terminated by Sponsor|0|||
124863594|NCT01857531|449121132|FG000|Overall Study|Withdrawal by Subject|4|||
124863595|NCT04656847|449121136|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
124863596|NCT03301051|449121137|FG000|Overall Study|Adverse Event|0|||
124863597|NCT03301051|449121138|FG001|Overall Study|Adverse Event|4|||
124863598|NCT03301051|449121137|FG000|Overall Study|Withdrawal by Subject|59|||
124863599|NCT03301051|449121138|FG001|Overall Study|Withdrawal by Subject|65|||
124863600|NCT03301051|449121137|FG000|Overall Study|Lost to Follow-up|263|||
124863601|NCT03301051|449121138|FG001|Overall Study|Lost to Follow-up|282|||
124863602|NCT03301051|449121137|FG000|Overall Study|Protocol Violation|1|||
124863603|NCT03301051|449121138|FG001|Overall Study|Protocol Violation|3|||
124863604|NCT03301051|449121137|FG000|Overall Study|Physician Decision|1|||
124863605|NCT03301051|449121138|FG001|Overall Study|Physician Decision|3|||
124863606|NCT03301051|449121137|FG000|Overall Study|Death|1|||
124863607|NCT03301051|449121138|FG001|Overall Study|Death|1|||
124863608|NCT03301051|449121137|FG000|Overall Study|Miscellaneous|8|||
124863609|NCT03301051|449121138|FG001|Overall Study|Miscellaneous|4|||
124863610|NCT03301051|449121137|FG000|Overall Study|Randomized, not vaccinated|13|||
124863611|NCT03301051|449121138|FG001|Overall Study|Randomized, not vaccinated|10|||
124863612|NCT00047879|449121139|FG000|Overall Study|Progressive disease|4|||
124863613|NCT00047879|449121140|FG001|Overall Study|Progressive disease|3|||
124863614|NCT00435370|449121141|FG000|Overall Study|Adverse Event|8|||
124863615|NCT00435370|449121142|FG001|Overall Study|Adverse Event|8|||
124863616|NCT00435370|449121141|FG000|Overall Study|Withdrawal by Subject|10|||
124863617|NCT00435370|449121142|FG001|Overall Study|Withdrawal by Subject|10|||
124863618|NCT00435370|449121141|FG000|Overall Study|Antipsychotic medication changed|4|||
124863619|NCT00435370|449121142|FG001|Overall Study|Antipsychotic medication changed|2|||
124863620|NCT01965834|449121143|FG000|Overall Study|Lack of Efficacy|4|||
124863621|NCT03943095|449121144|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
124863622|NCT03943095|449121145|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
124863623|NCT03943095|449121144|FG000|Overall Study|Withdrawal by Subject|1|||
124863624|NCT03943095|449121145|FG001|Overall Study|Withdrawal by Subject|0|||
124863625|NCT00710424|449121151|FG000|Overall Study|Adverse Event|30|||
124863626|NCT00710424|449121152|FG001|Overall Study|Adverse Event|12|||
124863627|NCT00710424|449121151|FG000|Overall Study|Lack of Efficacy|4|||
124863628|NCT00710424|449121152|FG001|Overall Study|Lack of Efficacy|5|||
124863629|NCT00710424|449121151|FG000|Overall Study|Withdrawal by Subject|5|||
124863630|NCT00710424|449121152|FG001|Overall Study|Withdrawal by Subject|3|||
124863631|NCT00710424|449121151|FG000|Overall Study|Lost to Follow-up|0|||
124863632|NCT00710424|449121152|FG001|Overall Study|Lost to Follow-up|1|||
124863633|NCT00710424|449121151|FG000|Overall Study|Refused medication, no side effects|1|||
124863634|NCT00710424|449121152|FG001|Overall Study|Refused medication, no side effects|0|||
124863635|NCT00710424|449121151|FG000|Overall Study|Non-compliance with stable analgesia|1|||
124863636|NCT00710424|449121152|FG001|Overall Study|Non-compliance with stable analgesia|0|||
124863637|NCT00710424|449121151|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
124863638|NCT00710424|449121152|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
124863639|NCT00710424|449121151|FG000|Overall Study|Subject thought medication changed|1|||
124863640|NCT00710424|449121152|FG001|Overall Study|Subject thought medication changed|0|||
124863641|NCT00710424|449121151|FG000|Overall Study|Ceased treatment due to travel|1|||
124863642|NCT00710424|449121152|FG001|Overall Study|Ceased treatment due to travel|0|||
124863643|NCT00710424|449121151|FG000|Overall Study|Subject preferred paracetamol|0|||
124863644|NCT00710424|449121152|FG001|Overall Study|Subject preferred paracetamol|1|||
124863645|NCT00710424|449121151|FG000|Overall Study|Felt good so stopped treatment|0|||
124863646|NCT00710424|449121152|FG001|Overall Study|Felt good so stopped treatment|1|||
124863647|NCT01962493|449121153|FG000|Overall Study|Adverse Event|1|||
124863648|NCT01962493|449121154|FG001|Overall Study|Adverse Event|2|||
124863649|NCT01962493|449121153|FG000|Overall Study|Protocol Violation|0|||
124863650|NCT01962493|449121154|FG001|Overall Study|Protocol Violation|1|||
124863651|NCT01962493|449121153|FG000|Overall Study|Withdrawal by Subject|4|||
124863652|NCT01962493|449121154|FG001|Overall Study|Withdrawal by Subject|2|||
124863653|NCT06273774|449121155|FG000|Overall Study|Participant was out of state.|0|||
124863654|NCT06273774|449121156|FG001|Overall Study|Participant was out of state.|0|||
124863655|NCT06273774|449121157|FG002|Overall Study|Participant was out of state.|0|||
124863656|NCT06273774|449121158|FG003|Overall Study|Participant was out of state.|0|||
124863657|NCT06273774|449121159|FG004|Overall Study|Participant was out of state.|0|||
124863658|NCT06273774|449121160|FG005|Overall Study|Participant was out of state.|1|||
124863659|NCT06273774|449121155|FG000|Overall Study|Lost to Follow-up|0|||
124863660|NCT06273774|449121156|FG001|Overall Study|Lost to Follow-up|0|||
124863661|NCT06273774|449121157|FG002|Overall Study|Lost to Follow-up|0|||
124863662|NCT06273774|449121158|FG003|Overall Study|Lost to Follow-up|0|||
124863663|NCT06273774|449121159|FG004|Overall Study|Lost to Follow-up|1|||
124863664|NCT06273774|449121160|FG005|Overall Study|Lost to Follow-up|0|||
124863665|NCT04414696|449121165|FG000|3-month Follow up|Withdrawal by Subject|1|||
124863666|NCT04414696|449121166|FG001|3-month Follow up|Withdrawal by Subject|0|||
124863667|NCT04414696|449121165|FG000|3-month Follow up|Lost to Follow-up|22|||
124863668|NCT04414696|449121166|FG001|3-month Follow up|Lost to Follow-up|23|||
124863669|NCT04414696|449121165|FG000|6-month Follow up|Withdrawal by Subject|1|||
124863670|NCT04414696|449121166|FG001|6-month Follow up|Withdrawal by Subject|2|||
124863671|NCT04414696|449121165|FG000|6-month Follow up|Lost to Follow-up|5|||
124863672|NCT04414696|449121166|FG001|6-month Follow up|Lost to Follow-up|2|||
124863673|NCT01625897|449123465|FG000|Overall Study|Adverse Event|27|||
124863674|NCT01625897|449123466|FG001|Overall Study|Adverse Event|10|||
124863675|NCT01625897|449123465|FG000|Overall Study|Physician Decision|0|||
124863676|NCT01625897|449123466|FG001|Overall Study|Physician Decision|1|||
124863677|NCT01625897|449123465|FG000|Overall Study|Withdrawal by Subject|25|||
124863678|NCT01625897|449123466|FG001|Overall Study|Withdrawal by Subject|3|||
124863679|NCT02985866|449123469|FG000|Overall Study|Poor CGM data|1|||
124863680|NCT02985866|449123470|FG001|Overall Study|Poor CGM data|1|||
124863681|NCT02008890|449123471|FG000|Period 1|Withdrawal by Subject|7|||
124863682|NCT02008890|449123472|FG001|Period 1|Withdrawal by Subject|7|||
124863683|NCT02008890|449123473|FG002|Period 1|Withdrawal by Subject|5|||
124863684|NCT02008890|449123474|FG003|Period 1|Withdrawal by Subject|0|||
124863685|NCT02008890|449123475|FG004|Period 1|Withdrawal by Subject|0|||
124863686|NCT02008890|449123471|FG000|Period 1|Pregnancy|1|||
124863687|NCT02008890|449123472|FG001|Period 1|Pregnancy|0|||
124863688|NCT02008890|449123473|FG002|Period 1|Pregnancy|0|||
124863689|NCT02008890|449123474|FG003|Period 1|Pregnancy|0|||
124863690|NCT02008890|449123475|FG004|Period 1|Pregnancy|0|||
124863691|NCT02008890|449123471|FG000|Period 1|Physician Decision|1|||
124863692|NCT02008890|449123472|FG001|Period 1|Physician Decision|0|||
124863693|NCT02008890|449123473|FG002|Period 1|Physician Decision|1|||
124863694|NCT02008890|449123474|FG003|Period 1|Physician Decision|0|||
124863695|NCT02008890|449123475|FG004|Period 1|Physician Decision|0|||
124863696|NCT02008890|449123471|FG000|Period 1|Adverse Event|6|||
124863697|NCT02008890|449123472|FG001|Period 1|Adverse Event|8|||
124863698|NCT02008890|449123473|FG002|Period 1|Adverse Event|6|||
124863699|NCT02008890|449123474|FG003|Period 1|Adverse Event|0|||
124863700|NCT02008890|449123475|FG004|Period 1|Adverse Event|0|||
124863701|NCT02008890|449123471|FG000|Period 2|Adverse Event|12|||
124863702|NCT02008890|449123472|FG001|Period 2|Adverse Event|7|||
124863703|NCT02008890|449123473|FG002|Period 2|Adverse Event|0|||
124863704|NCT02008890|449123474|FG003|Period 2|Adverse Event|5|||
124863705|NCT02008890|449123475|FG004|Period 2|Adverse Event|5|||
124863706|NCT02008890|449123471|FG000|Period 2|Withdrawal by Subject|11|||
124863707|NCT02008890|449123472|FG001|Period 2|Withdrawal by Subject|8|||
124863708|NCT02008890|449123473|FG002|Period 2|Withdrawal by Subject|0|||
124863709|NCT02008890|449123474|FG003|Period 2|Withdrawal by Subject|7|||
124863710|NCT02008890|449123475|FG004|Period 2|Withdrawal by Subject|2|||
124863711|NCT02008890|449123471|FG000|Period 2|Physician Decision|4|||
124863712|NCT02008890|449123472|FG001|Period 2|Physician Decision|0|||
124863713|NCT02008890|449123473|FG002|Period 2|Physician Decision|0|||
124863714|NCT02008890|449123474|FG003|Period 2|Physician Decision|2|||
124863715|NCT02008890|449123475|FG004|Period 2|Physician Decision|1|||
124863716|NCT02008890|449123471|FG000|Period 2|Lost to Follow-up|0|||
124863717|NCT02008890|449123472|FG001|Period 2|Lost to Follow-up|0|||
124863718|NCT02008890|449123473|FG002|Period 2|Lost to Follow-up|1|||
124863719|NCT02008890|449123474|FG003|Period 2|Lost to Follow-up|0|||
124863720|NCT02008890|449123475|FG004|Period 2|Lost to Follow-up|0|||
124863721|NCT02008890|449123471|FG000|Extension Period|Withdrawal by Subject|3|||
124863722|NCT02008890|449123472|FG001|Extension Period|Withdrawal by Subject|2|||
124863723|NCT02008890|449123473|FG002|Extension Period|Withdrawal by Subject|0|||
124863724|NCT02008890|449123474|FG003|Extension Period|Withdrawal by Subject|4|||
124863725|NCT02008890|449123475|FG004|Extension Period|Withdrawal by Subject|2|||
124863726|NCT02008890|449123471|FG000|Extension Period|Lost to Follow-up|1|||
124863727|NCT02008890|449123472|FG001|Extension Period|Lost to Follow-up|0|||
124863728|NCT02008890|449123473|FG002|Extension Period|Lost to Follow-up|0|||
124863729|NCT02008890|449123474|FG003|Extension Period|Lost to Follow-up|0|||
124863730|NCT02008890|449123475|FG004|Extension Period|Lost to Follow-up|0|||
124863731|NCT02008890|449123471|FG000|Extension Period|Adverse Event|1|||
124863732|NCT02008890|449123472|FG001|Extension Period|Adverse Event|3|||
124863733|NCT02008890|449123473|FG002|Extension Period|Adverse Event|0|||
124863734|NCT02008890|449123474|FG003|Extension Period|Adverse Event|0|||
124863735|NCT02008890|449123475|FG004|Extension Period|Adverse Event|2|||
124863736|NCT02207816|449123476|FG000|Overall Study|Serious Adverse Event|0|||
124863737|NCT02207816|449123477|FG001|Overall Study|Serious Adverse Event|5|||
124863738|NCT02207816|449123478|FG002|Overall Study|Serious Adverse Event|2|||
124863739|NCT02207816|449123476|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
124863740|NCT02207816|449123477|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
124863741|NCT02207816|449123478|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
124863742|NCT02207816|449123476|FG000|Overall Study|Withdrawal by Subject|4|||
124863743|NCT02207816|449123477|FG001|Overall Study|Withdrawal by Subject|9|||
124863744|NCT02207816|449123478|FG002|Overall Study|Withdrawal by Subject|7|||
124863745|NCT02207816|449123476|FG000|Overall Study|Migrated/Moved From Study Area|41|||
124863746|NCT02207816|449123477|FG001|Overall Study|Migrated/Moved From Study Area|60|||
124863747|NCT02207816|449123478|FG002|Overall Study|Migrated/Moved From Study Area|51|||
124863748|NCT02207816|449123476|FG000|Overall Study|Lost to Follow-up|3|||
124863749|NCT02207816|449123477|FG001|Overall Study|Lost to Follow-up|9|||
124863750|NCT02207816|449123478|FG002|Overall Study|Lost to Follow-up|1|||
124863751|NCT02207816|449123476|FG000|Overall Study|Other|1|||
124863752|NCT02207816|449123477|FG001|Overall Study|Other|2|||
124863753|NCT02207816|449123478|FG002|Overall Study|Other|4|||
124863754|NCT00686166|449123479|FG000|Overall Study|Adverse Event|7|||
124863755|NCT00686166|449123479|FG000|Overall Study|Withdrawal by Subject|1|||
124863756|NCT00686166|449123479|FG000|Overall Study|Progression/Relapse|1|||
124863757|NCT00686166|449123479|FG000|Overall Study|Death|1|||
124863758|NCT00686166|449123479|FG000|Overall Study|Not Protocol Specified|1|||
124863759|NCT00686166|449123479|FG000|Overall Study|Ineligible|5|||
124863760|NCT00686166|449123479|FG000|Overall Study|Did not begin protocol therapy|4|||
124863761|NCT00360308|449123480|FG000|Overall Study|Adverse Event|15|||
124863762|NCT00360308|449123481|FG001|Overall Study|Adverse Event|14|||
124863763|NCT00360308|449123482|FG002|Overall Study|Adverse Event|25|||
124863764|NCT00360308|449123480|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
124863765|NCT00360308|449123481|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
124863766|NCT00360308|449123482|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
124863767|NCT00360308|449123480|FG000|Overall Study|Protocol Violation|2|||
124863768|NCT00360308|449123481|FG001|Overall Study|Protocol Violation|1|||
124863769|NCT00360308|449123482|FG002|Overall Study|Protocol Violation|2|||
124863770|NCT00360308|449123480|FG000|Overall Study|Withdrawal by Subject|11|||
124863771|NCT00360308|449123481|FG001|Overall Study|Withdrawal by Subject|7|||
124863772|NCT00360308|449123482|FG002|Overall Study|Withdrawal by Subject|14|||
124863773|NCT00360308|449123480|FG000|Overall Study|Lack of Efficacy|3|||
124863774|NCT00360308|449123481|FG001|Overall Study|Lack of Efficacy|0|||
124863775|NCT00360308|449123482|FG002|Overall Study|Lack of Efficacy|2|||
124863776|NCT00360308|449123480|FG000|Overall Study|Other|2|||
124863777|NCT00360308|449123481|FG001|Overall Study|Other|1|||
124863778|NCT00360308|449123482|FG002|Overall Study|Other|1|||
124863779|NCT00360308|449123480|FG000|Overall Study|Study termination by sponsor|43|||
124863780|NCT00360308|449123481|FG001|Overall Study|Study termination by sponsor|55|||
124863781|NCT00360308|449123482|FG002|Overall Study|Study termination by sponsor|44|||
124863782|NCT01217073|449123483|FG000|Base Period|Adverse Event|1|||
124863783|NCT01217073|449123484|FG001|Base Period|Adverse Event|0|||
124863784|NCT01217073|449123485|FG002|Base Period|Adverse Event|1|||
124863785|NCT01217073|449123486|FG003|Base Period|Adverse Event|0|||
124863786|NCT01217073|449123487|FG004|Base Period|Adverse Event|4|||
124863787|NCT01217073|449123488|FG005|Base Period|Adverse Event|1|||
124863788|NCT01217073|449123489|FG006|Base Period|Adverse Event|0|||
124863789|NCT01217073|449123490|FG007|Base Period|Adverse Event|0|||
124863790|NCT01217073|449123483|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
124863791|NCT01217073|449123484|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
124863792|NCT01217073|449123485|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
124863793|NCT01217073|449123486|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
124863794|NCT01217073|449123487|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
124863795|NCT01217073|449123488|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
124863796|NCT01217073|449123489|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
124863797|NCT01217073|449123490|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
124863798|NCT01217073|449123483|FG000|Base Period|Excluded medication|0|||
124863799|NCT01217073|449123484|FG001|Base Period|Excluded medication|0|||
124863800|NCT01217073|449123485|FG002|Base Period|Excluded medication|0|||
124863801|NCT01217073|449123486|FG003|Base Period|Excluded medication|0|||
124863802|NCT01217073|449123487|FG004|Base Period|Excluded medication|1|||
124863803|NCT01217073|449123488|FG005|Base Period|Excluded medication|0|||
124863804|NCT01217073|449123489|FG006|Base Period|Excluded medication|0|||
124863805|NCT01217073|449123490|FG007|Base Period|Excluded medication|0|||
124863806|NCT01217073|449123483|FG000|Base Period|Lack of Efficacy|0|||
124863807|NCT01217073|449123484|FG001|Base Period|Lack of Efficacy|0|||
124863808|NCT01217073|449123485|FG002|Base Period|Lack of Efficacy|0|||
124863809|NCT01217073|449123486|FG003|Base Period|Lack of Efficacy|0|||
124863810|NCT01217073|449123487|FG004|Base Period|Lack of Efficacy|0|||
124863811|NCT01217073|449123488|FG005|Base Period|Lack of Efficacy|1|||
124863812|NCT01217073|449123489|FG006|Base Period|Lack of Efficacy|0|||
124863813|NCT01217073|449123490|FG007|Base Period|Lack of Efficacy|0|||
124863814|NCT01217073|449123483|FG000|Base Period|Lost to Follow-up|0|||
124863815|NCT01217073|449123484|FG001|Base Period|Lost to Follow-up|0|||
124863816|NCT01217073|449123485|FG002|Base Period|Lost to Follow-up|1|||
124863817|NCT01217073|449123486|FG003|Base Period|Lost to Follow-up|1|||
124863818|NCT01217073|449123487|FG004|Base Period|Lost to Follow-up|3|||
124863819|NCT01217073|449123488|FG005|Base Period|Lost to Follow-up|0|||
124863820|NCT01217073|449123489|FG006|Base Period|Lost to Follow-up|0|||
124863821|NCT01217073|449123490|FG007|Base Period|Lost to Follow-up|0|||
124863822|NCT01217073|449123483|FG000|Base Period|Physician Decision|0|||
124863823|NCT01217073|449123484|FG001|Base Period|Physician Decision|0|||
124863824|NCT01217073|449123485|FG002|Base Period|Physician Decision|0|||
124863825|NCT01217073|449123486|FG003|Base Period|Physician Decision|0|||
124863826|NCT01217073|449123487|FG004|Base Period|Physician Decision|1|||
124863827|NCT01217073|449123488|FG005|Base Period|Physician Decision|0|||
124863828|NCT01217073|449123489|FG006|Base Period|Physician Decision|0|||
124863829|NCT01217073|449123490|FG007|Base Period|Physician Decision|0|||
124863830|NCT01217073|449123483|FG000|Base Period|Protocol Violation|1|||
124863831|NCT01217073|449123484|FG001|Base Period|Protocol Violation|0|||
124863832|NCT01217073|449123485|FG002|Base Period|Protocol Violation|0|||
124863833|NCT01217073|449123486|FG003|Base Period|Protocol Violation|0|||
124863834|NCT01217073|449123487|FG004|Base Period|Protocol Violation|1|||
124863835|NCT01217073|449123488|FG005|Base Period|Protocol Violation|2|||
124863836|NCT01217073|449123489|FG006|Base Period|Protocol Violation|0|||
124863837|NCT01217073|449123490|FG007|Base Period|Protocol Violation|0|||
124863838|NCT01217073|449123483|FG000|Base Period|Withdrawal by Subject|4|||
124863839|NCT01217073|449123484|FG001|Base Period|Withdrawal by Subject|5|||
124863840|NCT01217073|449123485|FG002|Base Period|Withdrawal by Subject|5|||
124863841|NCT01217073|449123486|FG003|Base Period|Withdrawal by Subject|1|||
124863842|NCT01217073|449123487|FG004|Base Period|Withdrawal by Subject|5|||
124863843|NCT01217073|449123488|FG005|Base Period|Withdrawal by Subject|5|||
124863844|NCT01217073|449123489|FG006|Base Period|Withdrawal by Subject|0|||
124863845|NCT01217073|449123490|FG007|Base Period|Withdrawal by Subject|0|||
124863846|NCT01217073|449123483|FG000|Extension Period|Adverse Event|0|||
124863847|NCT01217073|449123484|FG001|Extension Period|Adverse Event|0|||
124863848|NCT01217073|449123485|FG002|Extension Period|Adverse Event|0|||
124863849|NCT01217073|449123486|FG003|Extension Period|Adverse Event|0|||
124863850|NCT01217073|449123487|FG004|Extension Period|Adverse Event|0|||
124863851|NCT01217073|449123488|FG005|Extension Period|Adverse Event|0|||
124863852|NCT01217073|449123489|FG006|Extension Period|Adverse Event|19|||
124863853|NCT01217073|449123490|FG007|Extension Period|Adverse Event|5|||
124863854|NCT01217073|449123483|FG000|Extension Period|ALT/AST|0|||
124863855|NCT01217073|449123484|FG001|Extension Period|ALT/AST|0|||
124863856|NCT01217073|449123485|FG002|Extension Period|ALT/AST|0|||
124863857|NCT01217073|449123486|FG003|Extension Period|ALT/AST|0|||
124863858|NCT01217073|449123487|FG004|Extension Period|ALT/AST|0|||
124863859|NCT01217073|449123488|FG005|Extension Period|ALT/AST|0|||
124863860|NCT01217073|449123489|FG006|Extension Period|ALT/AST|2|||
124863861|NCT01217073|449123490|FG007|Extension Period|ALT/AST|0|||
124863862|NCT01217073|449123483|FG000|Extension Period|Contraindication to study medication|0|||
124863863|NCT01217073|449123484|FG001|Extension Period|Contraindication to study medication|0|||
124863864|NCT01217073|449123485|FG002|Extension Period|Contraindication to study medication|0|||
124863865|NCT01217073|449123486|FG003|Extension Period|Contraindication to study medication|0|||
124863866|NCT01217073|449123487|FG004|Extension Period|Contraindication to study medication|0|||
124863867|NCT01217073|449123488|FG005|Extension Period|Contraindication to study medication|0|||
124863868|NCT01217073|449123489|FG006|Extension Period|Contraindication to study medication|1|||
124863869|NCT01217073|449123490|FG007|Extension Period|Contraindication to study medication|0|||
124863870|NCT01217073|449123483|FG000|Extension Period|Creatinine/eGFR|0|||
124863871|NCT01217073|449123484|FG001|Extension Period|Creatinine/eGFR|0|||
124863872|NCT01217073|449123485|FG002|Extension Period|Creatinine/eGFR|0|||
124863873|NCT01217073|449123486|FG003|Extension Period|Creatinine/eGFR|0|||
124863874|NCT01217073|449123487|FG004|Extension Period|Creatinine/eGFR|0|||
124863875|NCT01217073|449123488|FG005|Extension Period|Creatinine/eGFR|0|||
124863876|NCT01217073|449123489|FG006|Extension Period|Creatinine/eGFR|11|||
124863877|NCT01217073|449123490|FG007|Extension Period|Creatinine/eGFR|1|||
124863878|NCT01217073|449123483|FG000|Extension Period|Death|0|||
124863879|NCT01217073|449123484|FG001|Extension Period|Death|0|||
124863880|NCT01217073|449123485|FG002|Extension Period|Death|0|||
124863881|NCT01217073|449123486|FG003|Extension Period|Death|0|||
124863882|NCT01217073|449123487|FG004|Extension Period|Death|0|||
124863883|NCT01217073|449123488|FG005|Extension Period|Death|0|||
124863884|NCT01217073|449123489|FG006|Extension Period|Death|1|||
124863885|NCT01217073|449123490|FG007|Extension Period|Death|0|||
124863886|NCT01217073|449123483|FG000|Extension Period|Excluded medication|0|||
124863887|NCT01217073|449123484|FG001|Extension Period|Excluded medication|0|||
124863888|NCT01217073|449123485|FG002|Extension Period|Excluded medication|0|||
124863889|NCT01217073|449123486|FG003|Extension Period|Excluded medication|0|||
124863890|NCT01217073|449123487|FG004|Extension Period|Excluded medication|0|||
124863891|NCT01217073|449123488|FG005|Extension Period|Excluded medication|0|||
124863892|NCT01217073|449123489|FG006|Extension Period|Excluded medication|2|||
124863893|NCT01217073|449123490|FG007|Extension Period|Excluded medication|0|||
124863894|NCT01217073|449123483|FG000|Extension Period|Lack of Efficacy|0|||
124863895|NCT01217073|449123484|FG001|Extension Period|Lack of Efficacy|0|||
124863896|NCT01217073|449123485|FG002|Extension Period|Lack of Efficacy|0|||
124863897|NCT01217073|449123486|FG003|Extension Period|Lack of Efficacy|0|||
124863898|NCT01217073|449123487|FG004|Extension Period|Lack of Efficacy|0|||
124863899|NCT01217073|449123488|FG005|Extension Period|Lack of Efficacy|0|||
124863900|NCT01217073|449123489|FG006|Extension Period|Lack of Efficacy|3|||
124863901|NCT01217073|449123490|FG007|Extension Period|Lack of Efficacy|0|||
124863902|NCT01217073|449123483|FG000|Extension Period|Lost to Follow-up|0|||
124863903|NCT01217073|449123484|FG001|Extension Period|Lost to Follow-up|0|||
124863904|NCT01217073|449123485|FG002|Extension Period|Lost to Follow-up|0|||
124863905|NCT01217073|449123486|FG003|Extension Period|Lost to Follow-up|0|||
124863906|NCT01217073|449123487|FG004|Extension Period|Lost to Follow-up|0|||
124863907|NCT01217073|449123488|FG005|Extension Period|Lost to Follow-up|0|||
124863908|NCT01217073|449123489|FG006|Extension Period|Lost to Follow-up|9|||
124863909|NCT01217073|449123490|FG007|Extension Period|Lost to Follow-up|1|||
124863910|NCT01217073|449123483|FG000|Extension Period|Non-compliance with study drug|0|||
124863911|NCT01217073|449123484|FG001|Extension Period|Non-compliance with study drug|0|||
124863912|NCT01217073|449123485|FG002|Extension Period|Non-compliance with study drug|0|||
124863913|NCT01217073|449123486|FG003|Extension Period|Non-compliance with study drug|0|||
124863914|NCT01217073|449123487|FG004|Extension Period|Non-compliance with study drug|0|||
124863915|NCT01217073|449123488|FG005|Extension Period|Non-compliance with study drug|0|||
124863916|NCT01217073|449123489|FG006|Extension Period|Non-compliance with study drug|0|||
124863917|NCT01217073|449123490|FG007|Extension Period|Non-compliance with study drug|1|||
124863918|NCT01217073|449123483|FG000|Extension Period|Physician Decision|0|||
124863919|NCT01217073|449123484|FG001|Extension Period|Physician Decision|0|||
124863920|NCT01217073|449123485|FG002|Extension Period|Physician Decision|0|||
124863921|NCT01217073|449123486|FG003|Extension Period|Physician Decision|0|||
124863922|NCT01217073|449123487|FG004|Extension Period|Physician Decision|0|||
124863923|NCT01217073|449123488|FG005|Extension Period|Physician Decision|0|||
124863924|NCT01217073|449123489|FG006|Extension Period|Physician Decision|4|||
124863925|NCT01217073|449123490|FG007|Extension Period|Physician Decision|1|||
124863926|NCT01217073|449123483|FG000|Extension Period|Protocol Violation|0|||
124863927|NCT01217073|449123484|FG001|Extension Period|Protocol Violation|0|||
124863928|NCT01217073|449123485|FG002|Extension Period|Protocol Violation|0|||
124863929|NCT01217073|449123486|FG003|Extension Period|Protocol Violation|0|||
124863930|NCT01217073|449123487|FG004|Extension Period|Protocol Violation|0|||
124863931|NCT01217073|449123488|FG005|Extension Period|Protocol Violation|0|||
124863932|NCT01217073|449123489|FG006|Extension Period|Protocol Violation|2|||
124863933|NCT01217073|449123490|FG007|Extension Period|Protocol Violation|1|||
124863934|NCT01217073|449123483|FG000|Extension Period|Site discontinued study participation|0|||
124863935|NCT01217073|449123484|FG001|Extension Period|Site discontinued study participation|0|||
124863936|NCT01217073|449123485|FG002|Extension Period|Site discontinued study participation|0|||
124863937|NCT01217073|449123486|FG003|Extension Period|Site discontinued study participation|0|||
124863938|NCT01217073|449123487|FG004|Extension Period|Site discontinued study participation|0|||
124863939|NCT01217073|449123488|FG005|Extension Period|Site discontinued study participation|0|||
124863940|NCT01217073|449123489|FG006|Extension Period|Site discontinued study participation|7|||
124863941|NCT01217073|449123490|FG007|Extension Period|Site discontinued study participation|2|||
124863942|NCT01217073|449123483|FG000|Extension Period|Withdrawal by Subject|0|||
124863943|NCT01217073|449123484|FG001|Extension Period|Withdrawal by Subject|0|||
124863944|NCT01217073|449123485|FG002|Extension Period|Withdrawal by Subject|0|||
124863945|NCT01217073|449123486|FG003|Extension Period|Withdrawal by Subject|0|||
124863946|NCT01217073|449123487|FG004|Extension Period|Withdrawal by Subject|0|||
124863947|NCT01217073|449123488|FG005|Extension Period|Withdrawal by Subject|0|||
124863948|NCT01217073|449123489|FG006|Extension Period|Withdrawal by Subject|30|||
124863949|NCT01217073|449123490|FG007|Extension Period|Withdrawal by Subject|8|||
124863950|NCT02564523|449123491|FG000|Overall Study|Withdrawal by Subject|3|||
124863951|NCT02564523|449123492|FG001|Overall Study|Withdrawal by Subject|0|||
124863952|NCT02564523|449123493|FG002|Overall Study|Withdrawal by Subject|1|||
124863953|NCT02564523|449123494|FG003|Overall Study|Withdrawal by Subject|0|||
124863954|NCT02564523|449123495|FG004|Overall Study|Withdrawal by Subject|1|||
124863955|NCT02564523|449123496|FG005|Overall Study|Withdrawal by Subject|0|||
124863956|NCT02564523|449123497|FG006|Overall Study|Withdrawal by Subject|1|||
124863957|NCT02564523|449123498|FG007|Overall Study|Withdrawal by Subject|0|||
124863958|NCT02564523|449123499|FG008|Overall Study|Withdrawal by Subject|0|||
124863959|NCT02564523|449123500|FG009|Overall Study|Withdrawal by Subject|0|||
124863960|NCT02564523|449123501|FG010|Overall Study|Withdrawal by Subject|1|||
124863961|NCT02564523|449123502|FG011|Overall Study|Withdrawal by Subject|0|||
124863962|NCT02564523|449123503|FG012|Overall Study|Withdrawal by Subject|1|||
124863963|NCT02564523|449123504|FG013|Overall Study|Withdrawal by Subject|0|||
124863964|NCT02564523|449123505|FG014|Overall Study|Withdrawal by Subject|0|||
124863965|NCT02564523|449123506|FG015|Overall Study|Withdrawal by Subject|0|||
124863966|NCT02564523|449123507|FG016|Overall Study|Withdrawal by Subject|0|||
124863967|NCT02564523|449123508|FG017|Overall Study|Withdrawal by Subject|0|||
124863968|NCT02564523|449123491|FG000|Overall Study|Adverse Event|0|||
124863969|NCT02564523|449123492|FG001|Overall Study|Adverse Event|0|||
124863970|NCT02564523|449123493|FG002|Overall Study|Adverse Event|0|||
124863971|NCT02564523|449123494|FG003|Overall Study|Adverse Event|0|||
124863972|NCT02564523|449123495|FG004|Overall Study|Adverse Event|0|||
124863973|NCT02564523|449123496|FG005|Overall Study|Adverse Event|0|||
124863974|NCT02564523|449123497|FG006|Overall Study|Adverse Event|0|||
124863975|NCT02564523|449123498|FG007|Overall Study|Adverse Event|0|||
124863976|NCT02564523|449123499|FG008|Overall Study|Adverse Event|0|||
124863977|NCT02564523|449123500|FG009|Overall Study|Adverse Event|0|||
124863978|NCT02564523|449123501|FG010|Overall Study|Adverse Event|0|||
124863979|NCT02564523|449123502|FG011|Overall Study|Adverse Event|0|||
124863980|NCT02564523|449123503|FG012|Overall Study|Adverse Event|0|||
124863981|NCT02564523|449123504|FG013|Overall Study|Adverse Event|0|||
124863982|NCT02564523|449123505|FG014|Overall Study|Adverse Event|0|||
124863983|NCT02564523|449123506|FG015|Overall Study|Adverse Event|0|||
124863984|NCT02564523|449123507|FG016|Overall Study|Adverse Event|0|||
124863985|NCT02564523|449123508|FG017|Overall Study|Adverse Event|1|||
124863986|NCT02564523|449123491|FG000|Overall Study|Death|0|||
124863987|NCT02564523|449123492|FG001|Overall Study|Death|0|||
124863988|NCT02564523|449123493|FG002|Overall Study|Death|0|||
124863989|NCT02564523|449123494|FG003|Overall Study|Death|0|||
124863990|NCT02564523|449123495|FG004|Overall Study|Death|0|||
124863991|NCT02564523|449123496|FG005|Overall Study|Death|0|||
124863992|NCT02564523|449123497|FG006|Overall Study|Death|1|||
124863993|NCT02564523|449123498|FG007|Overall Study|Death|0|||
124863994|NCT02564523|449123499|FG008|Overall Study|Death|0|||
124863995|NCT02564523|449123500|FG009|Overall Study|Death|0|||
124863996|NCT02564523|449123501|FG010|Overall Study|Death|1|||
124863997|NCT02564523|449123502|FG011|Overall Study|Death|0|||
124863998|NCT02564523|449123503|FG012|Overall Study|Death|0|||
124863999|NCT02564523|449123504|FG013|Overall Study|Death|0|||
124864000|NCT02564523|449123505|FG014|Overall Study|Death|0|||
124864001|NCT02564523|449123506|FG015|Overall Study|Death|0|||
124864002|NCT02564523|449123507|FG016|Overall Study|Death|0|||
124864003|NCT02564523|449123508|FG017|Overall Study|Death|0|||
124864004|NCT02564523|449123491|FG000|Overall Study|Lost to Follow-up|2|||
124864005|NCT02564523|449123492|FG001|Overall Study|Lost to Follow-up|1|||
124864006|NCT02564523|449123493|FG002|Overall Study|Lost to Follow-up|4|||
124864007|NCT02564523|449123494|FG003|Overall Study|Lost to Follow-up|0|||
124864008|NCT02564523|449123495|FG004|Overall Study|Lost to Follow-up|1|||
124864009|NCT02564523|449123496|FG005|Overall Study|Lost to Follow-up|0|||
124864010|NCT02564523|449123497|FG006|Overall Study|Lost to Follow-up|1|||
124864011|NCT02564523|449123498|FG007|Overall Study|Lost to Follow-up|0|||
124864012|NCT02564523|449123499|FG008|Overall Study|Lost to Follow-up|0|||
124864013|NCT02564523|449123500|FG009|Overall Study|Lost to Follow-up|0|||
124864014|NCT02564523|449123501|FG010|Overall Study|Lost to Follow-up|0|||
124864015|NCT02564523|449123502|FG011|Overall Study|Lost to Follow-up|1|||
124864016|NCT02564523|449123503|FG012|Overall Study|Lost to Follow-up|1|||
124864017|NCT02564523|449123504|FG013|Overall Study|Lost to Follow-up|0|||
124864018|NCT02564523|449123505|FG014|Overall Study|Lost to Follow-up|0|||
124864019|NCT02564523|449123506|FG015|Overall Study|Lost to Follow-up|0|||
124864020|NCT02564523|449123507|FG016|Overall Study|Lost to Follow-up|0|||
124864021|NCT02564523|449123508|FG017|Overall Study|Lost to Follow-up|0|||
124864022|NCT02564523|449123491|FG000|Overall Study|Physician Decision|0|||
124864023|NCT02564523|449123492|FG001|Overall Study|Physician Decision|0|||
124864024|NCT02564523|449123493|FG002|Overall Study|Physician Decision|0|||
124864025|NCT02564523|449123494|FG003|Overall Study|Physician Decision|0|||
124864026|NCT02564523|449123495|FG004|Overall Study|Physician Decision|1|||
124864027|NCT02564523|449123496|FG005|Overall Study|Physician Decision|0|||
124864028|NCT02564523|449123497|FG006|Overall Study|Physician Decision|0|||
124864029|NCT02564523|449123498|FG007|Overall Study|Physician Decision|0|||
124864030|NCT02564523|449123499|FG008|Overall Study|Physician Decision|0|||
124864031|NCT02564523|449123500|FG009|Overall Study|Physician Decision|0|||
124864032|NCT02564523|449123501|FG010|Overall Study|Physician Decision|1|||
124864033|NCT02564523|449123502|FG011|Overall Study|Physician Decision|0|||
124864034|NCT02564523|449123503|FG012|Overall Study|Physician Decision|0|||
124864035|NCT02564523|449123504|FG013|Overall Study|Physician Decision|0|||
124864036|NCT02564523|449123505|FG014|Overall Study|Physician Decision|0|||
124864037|NCT02564523|449123506|FG015|Overall Study|Physician Decision|0|||
124864038|NCT02564523|449123507|FG016|Overall Study|Physician Decision|0|||
124864039|NCT02564523|449123508|FG017|Overall Study|Physician Decision|0|||
124864040|NCT02564523|449123491|FG000|Overall Study|Protocol Violation|2|||
124864041|NCT02564523|449123492|FG001|Overall Study|Protocol Violation|2|||
124864042|NCT02564523|449123493|FG002|Overall Study|Protocol Violation|5|||
124864043|NCT02564523|449123494|FG003|Overall Study|Protocol Violation|0|||
124864044|NCT02564523|449123495|FG004|Overall Study|Protocol Violation|1|||
124864045|NCT02564523|449123496|FG005|Overall Study|Protocol Violation|0|||
124864046|NCT02564523|449123497|FG006|Overall Study|Protocol Violation|0|||
124864047|NCT02564523|449123498|FG007|Overall Study|Protocol Violation|0|||
124864048|NCT02564523|449123499|FG008|Overall Study|Protocol Violation|0|||
124864049|NCT02564523|449123500|FG009|Overall Study|Protocol Violation|0|||
124864050|NCT02564523|449123501|FG010|Overall Study|Protocol Violation|0|||
124864051|NCT02564523|449123502|FG011|Overall Study|Protocol Violation|0|||
124864052|NCT02564523|449123503|FG012|Overall Study|Protocol Violation|0|||
124864053|NCT02564523|449123504|FG013|Overall Study|Protocol Violation|0|||
124864054|NCT02564523|449123505|FG014|Overall Study|Protocol Violation|0|||
124864055|NCT02564523|449123506|FG015|Overall Study|Protocol Violation|0|||
124864056|NCT02564523|449123507|FG016|Overall Study|Protocol Violation|0|||
124864057|NCT02564523|449123508|FG017|Overall Study|Protocol Violation|0|||
124864058|NCT02564523|449123491|FG000|Overall Study|Other|3|||
124864059|NCT02564523|449123492|FG001|Overall Study|Other|0|||
124864060|NCT02564523|449123493|FG002|Overall Study|Other|0|||
124864061|NCT02564523|449123494|FG003|Overall Study|Other|1|||
124864062|NCT02564523|449123495|FG004|Overall Study|Other|0|||
124864063|NCT02564523|449123496|FG005|Overall Study|Other|0|||
124864064|NCT02564523|449123497|FG006|Overall Study|Other|0|||
124864065|NCT02564523|449123498|FG007|Overall Study|Other|0|||
124864066|NCT02564523|449123499|FG008|Overall Study|Other|0|||
124864067|NCT02564523|449123500|FG009|Overall Study|Other|0|||
124864068|NCT02564523|449123501|FG010|Overall Study|Other|0|||
124864069|NCT02564523|449123502|FG011|Overall Study|Other|0|||
124864070|NCT02564523|449123503|FG012|Overall Study|Other|0|||
124864071|NCT02564523|449123504|FG013|Overall Study|Other|0|||
124864072|NCT02564523|449123505|FG014|Overall Study|Other|0|||
124864073|NCT02564523|449123506|FG015|Overall Study|Other|0|||
124864074|NCT02564523|449123507|FG016|Overall Study|Other|0|||
124864075|NCT02564523|449123508|FG017|Overall Study|Other|0|||
124864076|NCT04862143|449123523|FG000|Overall Study|Adverse Event|1|||
124864077|NCT04862143|449123523|FG000|Overall Study|Study terminated by sponsor|1|||
124864078|NCT03031938|449123524|FG000|Overall Study|Death|1|||
124864079|NCT03031938|449123525|FG001|Overall Study|Death|0|||
124864080|NCT00454051|449123526|FG000|Overall Study|Adverse Event|1|||
124864081|NCT00454051|449123527|FG001|Overall Study|Adverse Event|2|||
124864082|NCT00454051|449123526|FG000|Overall Study|Withdrawal by Subject|1|||
124864083|NCT00454051|449123527|FG001|Overall Study|Withdrawal by Subject|0|||
124864084|NCT00454051|449123526|FG000|Overall Study|Protocol Violation|1|||
124864085|NCT00454051|449123527|FG001|Overall Study|Protocol Violation|1|||
124864086|NCT01571362|449123528|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
124864087|NCT01571362|449123529|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
124864088|NCT01571362|449123530|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
124864089|NCT01571362|449123528|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
124864090|NCT01571362|449123529|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
124864091|NCT01571362|449123530|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
124864092|NCT01571362|449123528|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
124864093|NCT01571362|449123529|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
124864094|NCT01571362|449123530|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
124864095|NCT01571362|449123528|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
124864096|NCT01571362|449123529|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
124864097|NCT01571362|449123530|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
124864098|NCT01571362|449123528|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
124864099|NCT01571362|449123529|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
124864100|NCT01571362|449123530|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
124864101|NCT01571362|449123528|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
124864102|NCT01571362|449123529|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
124864103|NCT01571362|449123530|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
124864104|NCT01571362|449123528|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124864105|NCT01571362|449123529|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
124864106|NCT01571362|449123530|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
124864107|NCT01571362|449123528|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
124864108|NCT01571362|449123529|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
124864109|NCT01571362|449123530|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
124864110|NCT01571362|449123528|FG000|Double-Blind Treatment Period|Adverse Event|0|||
124864111|NCT01571362|449123529|FG001|Double-Blind Treatment Period|Adverse Event|9|||
124864112|NCT01571362|449123530|FG002|Double-Blind Treatment Period|Adverse Event|14|||
124864113|NCT01571362|449123528|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
124864114|NCT01571362|449123529|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
124864115|NCT01571362|449123530|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
124864116|NCT01571362|449123528|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
124864117|NCT01571362|449123529|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
124864118|NCT01571362|449123530|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
124864119|NCT01571362|449123528|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
124864120|NCT01571362|449123529|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
124864121|NCT01571362|449123530|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
124864122|NCT01491854|449123541|FG000|Overall Study|mainly due to premature termination|93|||
124864123|NCT01491854|449123541|FG000|Overall Study|Death|1|||
124864124|NCT01491854|449123541|FG000|Overall Study|Withdrawal by Subject|3|||
124864125|NCT01491854|449123541|FG000|Overall Study|Lost to Follow-up|33|||
124864126|NCT00121238|449123543|FG000|Overall Study|disease progression before intervention|1|||
124864127|NCT00121238|449123543|FG000|Overall Study|Protocol Violation|2|||
124864128|NCT01026974|449123555|FG000|Overall Study|Withdrawal by Subject|0|||
124864129|NCT01026974|449123556|FG001|Overall Study|Withdrawal by Subject|1|||
124864130|NCT01026974|449123557|FG002|Overall Study|Withdrawal by Subject|7|||
124864131|NCT01026974|449123558|FG003|Overall Study|Withdrawal by Subject|2|||
124864132|NCT01026974|449123555|FG000|Overall Study|Lost to Follow-up|1|||
124864133|NCT01026974|449123556|FG001|Overall Study|Lost to Follow-up|1|||
124864134|NCT01026974|449123557|FG002|Overall Study|Lost to Follow-up|4|||
124864135|NCT01026974|449123558|FG003|Overall Study|Lost to Follow-up|0|||
124864136|NCT01026974|449123555|FG000|Overall Study|Adverse Event|0|||
124864137|NCT01026974|449123556|FG001|Overall Study|Adverse Event|0|||
124864138|NCT01026974|449123557|FG002|Overall Study|Adverse Event|0|||
124864139|NCT01026974|449123558|FG003|Overall Study|Adverse Event|1|||
124864140|NCT01026974|449123555|FG000|Overall Study|Inappropriate enrollment|0|||
124864141|NCT01026974|449123556|FG001|Overall Study|Inappropriate enrollment|0|||
124864142|NCT01026974|449123557|FG002|Overall Study|Inappropriate enrollment|1|||
124864143|NCT01026974|449123558|FG003|Overall Study|Inappropriate enrollment|0|||
124864144|NCT00325468|449123560|FG000|Overall Study|Adverse Event|1|||
124864145|NCT00325468|449123561|FG001|Overall Study|Adverse Event|1|||
124864146|NCT00325468|449123562|FG002|Overall Study|Adverse Event|0|||
124864147|NCT00325468|449123563|FG003|Overall Study|Adverse Event|5|||
124864148|NCT00325468|449123564|FG004|Overall Study|Adverse Event|1|||
124864149|NCT00325468|449123560|FG000|Overall Study|Death|2|||
124864150|NCT00325468|449123561|FG001|Overall Study|Death|0|||
124864151|NCT00325468|449123562|FG002|Overall Study|Death|2|||
124864152|NCT00325468|449123563|FG003|Overall Study|Death|4|||
124864153|NCT00325468|449123564|FG004|Overall Study|Death|0|||
124864154|NCT00325468|449123560|FG000|Overall Study|Lost to Follow-up|0|||
124864155|NCT00325468|449123561|FG001|Overall Study|Lost to Follow-up|0|||
124864156|NCT00325468|449123562|FG002|Overall Study|Lost to Follow-up|1|||
124864157|NCT00325468|449123563|FG003|Overall Study|Lost to Follow-up|2|||
124864158|NCT00325468|449123564|FG004|Overall Study|Lost to Follow-up|2|||
124864159|NCT00325468|449123560|FG000|Overall Study|Physician Decision|1|||
124864160|NCT00325468|449123561|FG001|Overall Study|Physician Decision|1|||
124864161|NCT00325468|449123562|FG002|Overall Study|Physician Decision|0|||
124864162|NCT00325468|449123563|FG003|Overall Study|Physician Decision|1|||
124864163|NCT00325468|449123564|FG004|Overall Study|Physician Decision|0|||
124864164|NCT00325468|449123560|FG000|Overall Study|Withdrawal by Subject|3|||
124864165|NCT00325468|449123561|FG001|Overall Study|Withdrawal by Subject|1|||
124864166|NCT00325468|449123562|FG002|Overall Study|Withdrawal by Subject|0|||
124864167|NCT00325468|449123563|FG003|Overall Study|Withdrawal by Subject|14|||
124864168|NCT00325468|449123564|FG004|Overall Study|Withdrawal by Subject|4|||
124864169|NCT00325468|449123560|FG000|Overall Study|site closure etc|4|||
124864170|NCT00325468|449123561|FG001|Overall Study|site closure etc|2|||
124864171|NCT00325468|449123562|FG002|Overall Study|site closure etc|1|||
124864172|NCT00325468|449123563|FG003|Overall Study|site closure etc|8|||
124864173|NCT00325468|449123564|FG004|Overall Study|site closure etc|1|||
124864174|NCT03280121|449123565|FG000|Overall Study|Physician Decision|1|||
124864175|NCT03280121|449123565|FG000|Overall Study|Lost to Follow-up|1|||
124864176|NCT03280121|449123565|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
124864177|NCT02701985|449123566|FG000|Overall Study|Withdrawal by Subject|1|||
124864178|NCT02701985|449123567|FG001|Overall Study|Withdrawal by Subject|1|||
124864179|NCT02701985|449123566|FG000|Overall Study|Lost to Follow-up|1|||
124864180|NCT02701985|449123567|FG001|Overall Study|Lost to Follow-up|0|||
124864181|NCT02701985|449123566|FG000|Overall Study|Death|1|||
124864182|NCT02701985|449123567|FG001|Overall Study|Death|0|||
124864183|NCT02701985|449123566|FG000|Overall Study|Adverse Event|0|||
124864184|NCT02701985|449123567|FG001|Overall Study|Adverse Event|5|||
124864185|NCT01640808|449123568|FG000|Overall Study|Unable to continue dynamic CT|14|||
124864186|NCT01640808|449123569|FG001|Overall Study|Unable to continue dynamic CT|4|||
124864187|NCT01640808|449123568|FG000|Overall Study|Withdrawal by Subject|12|||
124864188|NCT01640808|449123569|FG001|Overall Study|Withdrawal by Subject|4|||
124864189|NCT01640808|449123568|FG000|Overall Study|Lost to Follow-up|4|||
124864190|NCT01640808|449123569|FG001|Overall Study|Lost to Follow-up|0|||
124864191|NCT01640808|449123568|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
124864192|NCT01640808|449123569|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
124864193|NCT01640808|449123568|FG000|Overall Study|Administration of anticancer drugs|2|||
124864194|NCT01640808|449123569|FG001|Overall Study|Administration of anticancer drugs|1|||
124864195|NCT01640808|449123568|FG000|Overall Study|Physician Decision|19|||
124864196|NCT01640808|449123569|FG001|Overall Study|Physician Decision|5|||
124864197|NCT01640808|449123568|FG000|Overall Study|Randomized but not treated|4|||
124864198|NCT01640808|449123569|FG001|Overall Study|Randomized but not treated|2|||
124864199|NCT04391023|449123570|FG000|Overall Study|Withdrawal by Subject|2|||
124864200|NCT04391023|449123571|FG001|Overall Study|Withdrawal by Subject|2|||
124864201|NCT04009291|449123572|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
124864202|NCT04009291|449123573|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
124864203|NCT04009291|449123574|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
124864204|NCT04009291|449123575|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
124864205|NCT04009291|449123576|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
124864206|NCT04009291|449123572|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
124864207|NCT04009291|449123573|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
124864208|NCT04009291|449123574|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
124864209|NCT04009291|449123575|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
124864210|NCT04009291|449123576|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
124864211|NCT02189798|449123577|FG000|Extended Use Phase|Withdrawal by Subject|0|||
124864212|NCT02189798|449123578|FG001|Extended Use Phase|Withdrawal by Subject|4|||
124864213|NCT02189798|449123577|FG000|Extended Use Phase|Physician Decision|1|||
124864214|NCT02189798|449123578|FG001|Extended Use Phase|Physician Decision|0|||
124864215|NCT02189798|449123577|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
124864216|NCT02189798|449123578|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
124864217|NCT02189798|449123577|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
124864218|NCT02189798|449123578|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
124864219|NCT02189798|449123577|FG000|Extended Use Phase|Travel Issues|2|||
124864220|NCT02189798|449123578|FG001|Extended Use Phase|Travel Issues|1|||
124864221|NCT02189798|449123577|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
124864222|NCT02189798|449123578|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
124864223|NCT02834780|449123579|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
124864224|NCT02834780|449123580|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
124864225|NCT02834780|449123581|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
124864226|NCT02834780|449123582|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
124864227|NCT02834780|449123583|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
124864228|NCT02834780|449123584|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
124864229|NCT02834780|449123585|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
124864230|NCT02834780|449123586|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
124864231|NCT02834780|449123587|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
124864232|NCT02834780|449123588|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
124864233|NCT02834780|449123589|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
124864234|NCT02834780|449123590|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
124864235|NCT02834780|449123591|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
124864236|NCT02834780|449123579|FG000|Overall Study|Withdrawal by Subject|0|||
124864237|NCT02834780|449123580|FG001|Overall Study|Withdrawal by Subject|0|||
124864238|NCT02834780|449123581|FG002|Overall Study|Withdrawal by Subject|1|||
124864239|NCT02834780|449123582|FG003|Overall Study|Withdrawal by Subject|0|||
124864240|NCT02834780|449123583|FG004|Overall Study|Withdrawal by Subject|0|||
124864241|NCT02834780|449123584|FG005|Overall Study|Withdrawal by Subject|0|||
124864242|NCT02834780|449123585|FG006|Overall Study|Withdrawal by Subject|0|||
124864243|NCT02834780|449123586|FG007|Overall Study|Withdrawal by Subject|0|||
124864244|NCT02834780|449123587|FG008|Overall Study|Withdrawal by Subject|0|||
124864245|NCT02834780|449123588|FG009|Overall Study|Withdrawal by Subject|0|||
124864246|NCT02834780|449123589|FG010|Overall Study|Withdrawal by Subject|1|||
124864247|NCT02834780|449123590|FG011|Overall Study|Withdrawal by Subject|0|||
124864248|NCT02834780|449123591|FG012|Overall Study|Withdrawal by Subject|0|||
124864249|NCT02834780|449123579|FG000|Overall Study|Adverse Event|0|||
124864250|NCT02834780|449123580|FG001|Overall Study|Adverse Event|0|||
124864251|NCT02834780|449123581|FG002|Overall Study|Adverse Event|0|||
124864252|NCT02834780|449123582|FG003|Overall Study|Adverse Event|0|||
124864253|NCT02834780|449123583|FG004|Overall Study|Adverse Event|1|||
124864254|NCT02834780|449123584|FG005|Overall Study|Adverse Event|0|||
124864255|NCT02834780|449123585|FG006|Overall Study|Adverse Event|1|||
124864256|NCT02834780|449123586|FG007|Overall Study|Adverse Event|1|||
124864257|NCT02834780|449123587|FG008|Overall Study|Adverse Event|0|||
124864258|NCT02834780|449123588|FG009|Overall Study|Adverse Event|2|||
124864259|NCT02834780|449123589|FG010|Overall Study|Adverse Event|0|||
124864260|NCT02834780|449123590|FG011|Overall Study|Adverse Event|3|||
124864261|NCT02834780|449123591|FG012|Overall Study|Adverse Event|2|||
124864262|NCT02834780|449123579|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
124864263|NCT02834780|449123580|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
124864264|NCT02834780|449123581|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
124864265|NCT02834780|449123582|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
124864266|NCT02834780|449123583|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
124864267|NCT02834780|449123584|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
124864268|NCT02834780|449123585|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
124864269|NCT02834780|449123586|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
124864270|NCT02834780|449123587|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
124864271|NCT02834780|449123588|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
124864272|NCT02834780|449123589|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
124864273|NCT02834780|449123590|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
124864274|NCT02834780|449123591|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
124864275|NCT02834780|449123579|FG000|Overall Study|Other|1|||
124864276|NCT02834780|449123580|FG001|Overall Study|Other|0|||
124864277|NCT02834780|449123581|FG002|Overall Study|Other|1|||
124864278|NCT02834780|449123582|FG003|Overall Study|Other|2|||
124864279|NCT02834780|449123583|FG004|Overall Study|Other|0|||
124864280|NCT02834780|449123584|FG005|Overall Study|Other|0|||
124864281|NCT02834780|449123585|FG006|Overall Study|Other|0|||
124864282|NCT02834780|449123586|FG007|Overall Study|Other|0|||
124864283|NCT02834780|449123587|FG008|Overall Study|Other|0|||
124864284|NCT02834780|449123588|FG009|Overall Study|Other|0|||
124864285|NCT02834780|449123589|FG010|Overall Study|Other|0|||
124864286|NCT02834780|449123590|FG011|Overall Study|Other|0|||
124864287|NCT02834780|449123591|FG012|Overall Study|Other|1|||
124864288|NCT03449030|449123592|FG000|Overall Study|Withdrawal by Subject|0|||
124864289|NCT03449030|449123593|FG001|Overall Study|Withdrawal by Subject|0|||
124864290|NCT03449030|449123594|FG002|Overall Study|Withdrawal by Subject|0|||
124864291|NCT03449030|449123595|FG003|Overall Study|Withdrawal by Subject|1|||
124864292|NCT03449030|449123596|FG004|Overall Study|Withdrawal by Subject|1|||
124864293|NCT03449030|449123597|FG005|Overall Study|Withdrawal by Subject|1|||
124864294|NCT03449030|449123598|FG006|Overall Study|Withdrawal by Subject|1|||
124864295|NCT03449030|449123599|FG007|Overall Study|Withdrawal by Subject|2|||
124864296|NCT03449030|449123600|FG008|Overall Study|Withdrawal by Subject|0|||
124864297|NCT03449030|449123601|FG009|Overall Study|Withdrawal by Subject|0|||
124864298|NCT03449030|449123592|FG000|Overall Study|Symptomatic Deterioration|0|||
124864299|NCT03449030|449123593|FG001|Overall Study|Symptomatic Deterioration|1|||
124864300|NCT03449030|449123594|FG002|Overall Study|Symptomatic Deterioration|0|||
124864301|NCT03449030|449123595|FG003|Overall Study|Symptomatic Deterioration|0|||
124864302|NCT03449030|449123596|FG004|Overall Study|Symptomatic Deterioration|0|||
124864303|NCT03449030|449123597|FG005|Overall Study|Symptomatic Deterioration|1|||
124864304|NCT03449030|449123598|FG006|Overall Study|Symptomatic Deterioration|1|||
124864305|NCT03449030|449123599|FG007|Overall Study|Symptomatic Deterioration|0|||
124864306|NCT03449030|449123600|FG008|Overall Study|Symptomatic Deterioration|2|||
124864307|NCT03449030|449123601|FG009|Overall Study|Symptomatic Deterioration|0|||
124864308|NCT03449030|449123592|FG000|Overall Study|Progressive Disease|1|||
124864309|NCT03449030|449123593|FG001|Overall Study|Progressive Disease|0|||
124864310|NCT03449030|449123594|FG002|Overall Study|Progressive Disease|1|||
124864311|NCT03449030|449123595|FG003|Overall Study|Progressive Disease|4|||
124864312|NCT03449030|449123596|FG004|Overall Study|Progressive Disease|5|||
124864313|NCT03449030|449123597|FG005|Overall Study|Progressive Disease|3|||
124864314|NCT03449030|449123598|FG006|Overall Study|Progressive Disease|0|||
124864315|NCT03449030|449123599|FG007|Overall Study|Progressive Disease|1|||
124864316|NCT03449030|449123600|FG008|Overall Study|Progressive Disease|1|||
124864317|NCT03449030|449123601|FG009|Overall Study|Progressive Disease|1|||
124864318|NCT03449030|449123592|FG000|Overall Study|Adverse Event|0|||
124864319|NCT03449030|449123593|FG001|Overall Study|Adverse Event|0|||
124864320|NCT03449030|449123594|FG002|Overall Study|Adverse Event|0|||
124864321|NCT03449030|449123595|FG003|Overall Study|Adverse Event|0|||
124864322|NCT03449030|449123596|FG004|Overall Study|Adverse Event|0|||
124864323|NCT03449030|449123597|FG005|Overall Study|Adverse Event|2|||
124864324|NCT03449030|449123598|FG006|Overall Study|Adverse Event|0|||
124864325|NCT03449030|449123599|FG007|Overall Study|Adverse Event|0|||
124864326|NCT03449030|449123600|FG008|Overall Study|Adverse Event|0|||
124864327|NCT03449030|449123601|FG009|Overall Study|Adverse Event|0|||
124864328|NCT03449030|449123592|FG000|Overall Study|Death|0|||
124864329|NCT03449030|449123593|FG001|Overall Study|Death|0|||
124864330|NCT03449030|449123594|FG002|Overall Study|Death|0|||
124864331|NCT03449030|449123595|FG003|Overall Study|Death|0|||
124864332|NCT03449030|449123596|FG004|Overall Study|Death|1|||
124864333|NCT03449030|449123597|FG005|Overall Study|Death|0|||
124864334|NCT03449030|449123598|FG006|Overall Study|Death|0|||
124864335|NCT03449030|449123599|FG007|Overall Study|Death|0|||
124864336|NCT03449030|449123600|FG008|Overall Study|Death|0|||
124864337|NCT03449030|449123601|FG009|Overall Study|Death|0|||
124864338|NCT02415400|449123602|FG000|Overall Study|Adverse Event|0|||
124864339|NCT02415400|449123603|FG001|Overall Study|Adverse Event|1|||
124864340|NCT02415400|449123604|FG002|Overall Study|Adverse Event|1|||
124864341|NCT02415400|449123605|FG003|Overall Study|Adverse Event|2|||
124864342|NCT02415400|449123602|FG000|Overall Study|Participant request to stop therapy|4|||
124864343|NCT02415400|449123603|FG001|Overall Study|Participant request to stop therapy|3|||
124864344|NCT02415400|449123604|FG002|Overall Study|Participant request to stop therapy|8|||
124864345|NCT02415400|449123605|FG003|Overall Study|Participant request to stop therapy|6|||
124864346|NCT02415400|449123602|FG000|Overall Study|Participant withdrew consent|14|||
124864347|NCT02415400|449123603|FG001|Overall Study|Participant withdrew consent|12|||
124864348|NCT02415400|449123604|FG002|Overall Study|Participant withdrew consent|30|||
124864349|NCT02415400|449123605|FG003|Overall Study|Participant withdrew consent|21|||
124864350|NCT02415400|449123602|FG000|Overall Study|Death|39|||
124864351|NCT02415400|449123603|FG001|Overall Study|Death|41|||
124864352|NCT02415400|449123604|FG002|Overall Study|Death|35|||
124864353|NCT02415400|449123605|FG003|Overall Study|Death|42|||
124864354|NCT02415400|449123602|FG000|Overall Study|Lost to Follow-up|3|||
124864355|NCT02415400|449123603|FG001|Overall Study|Lost to Follow-up|3|||
124864356|NCT02415400|449123604|FG002|Overall Study|Lost to Follow-up|2|||
124864357|NCT02415400|449123605|FG003|Overall Study|Lost to Follow-up|5|||
124864358|NCT02415400|449123602|FG000|Overall Study|Poor/Non-Compliance|0|||
124864359|NCT02415400|449123603|FG001|Overall Study|Poor/Non-Compliance|1|||
124864360|NCT02415400|449123604|FG002|Overall Study|Poor/Non-Compliance|3|||
124864361|NCT02415400|449123605|FG003|Overall Study|Poor/Non-Compliance|4|||
124864362|NCT02415400|449123602|FG000|Overall Study|Participant no longer meets criteria|2|||
124864363|NCT02415400|449123603|FG001|Overall Study|Participant no longer meets criteria|0|||
124864364|NCT02415400|449123604|FG002|Overall Study|Participant no longer meets criteria|0|||
124864365|NCT02415400|449123605|FG003|Overall Study|Participant no longer meets criteria|1|||
124864366|NCT02415400|449123602|FG000|Overall Study|Participant doesn't answer phone|1|||
124864367|NCT02415400|449123603|FG001|Overall Study|Participant doesn't answer phone|0|||
124864368|NCT02415400|449123604|FG002|Overall Study|Participant doesn't answer phone|0|||
124864369|NCT02415400|449123605|FG003|Overall Study|Participant doesn't answer phone|0|||
124864370|NCT02415400|449123602|FG000|Overall Study|Participant wanted home visits|1|||
124864371|NCT02415400|449123603|FG001|Overall Study|Participant wanted home visits|0|||
124864372|NCT02415400|449123604|FG002|Overall Study|Participant wanted home visits|0|||
124864373|NCT02415400|449123605|FG003|Overall Study|Participant wanted home visits|0|||
124864374|NCT02415400|449123602|FG000|Overall Study|Randomized in error|2|||
124864375|NCT02415400|449123603|FG001|Overall Study|Randomized in error|0|||
124864376|NCT02415400|449123604|FG002|Overall Study|Randomized in error|0|||
124864377|NCT02415400|449123605|FG003|Overall Study|Randomized in error|0|||
124864378|NCT02415400|449123602|FG000|Overall Study|No study drug on site|0|||
124864379|NCT02415400|449123603|FG001|Overall Study|No study drug on site|1|||
124864380|NCT02415400|449123604|FG002|Overall Study|No study drug on site|0|||
124864381|NCT02415400|449123605|FG003|Overall Study|No study drug on site|0|||
124864382|NCT02415400|449123602|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
124864383|NCT02415400|449123603|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
124864384|NCT02415400|449123604|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
124864385|NCT02415400|449123605|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
124864386|NCT02415400|449123602|FG000|Overall Study|Coagulation values cannot be set|0|||
124864387|NCT02415400|449123603|FG001|Overall Study|Coagulation values cannot be set|0|||
124864388|NCT02415400|449123604|FG002|Overall Study|Coagulation values cannot be set|1|||
124864389|NCT02415400|449123605|FG003|Overall Study|Coagulation values cannot be set|0|||
124864390|NCT02415400|449123602|FG000|Overall Study|State regulations prevent participation|0|||
124864391|NCT02415400|449123603|FG001|Overall Study|State regulations prevent participation|0|||
124864392|NCT02415400|449123604|FG002|Overall Study|State regulations prevent participation|1|||
124864393|NCT02415400|449123605|FG003|Overall Study|State regulations prevent participation|0|||
124864394|NCT02415400|449123602|FG000|Overall Study|Poor treatment monitoring|0|||
124864395|NCT02415400|449123603|FG001|Overall Study|Poor treatment monitoring|0|||
124864396|NCT02415400|449123604|FG002|Overall Study|Poor treatment monitoring|1|||
124864397|NCT02415400|449123605|FG003|Overall Study|Poor treatment monitoring|0|||
124864398|NCT02415400|449123602|FG000|Overall Study|Participant in jail|0|||
124864399|NCT02415400|449123603|FG001|Overall Study|Participant in jail|0|||
124864400|NCT02415400|449123604|FG002|Overall Study|Participant in jail|1|||
124864401|NCT02415400|449123605|FG003|Overall Study|Participant in jail|0|||
124864402|NCT02415400|449123602|FG000|Overall Study|Investigator decision|0|||
124864403|NCT02415400|449123603|FG001|Overall Study|Investigator decision|0|||
124864404|NCT02415400|449123604|FG002|Overall Study|Investigator decision|1|||
124864405|NCT02415400|449123605|FG003|Overall Study|Investigator decision|1|||
124864406|NCT02415400|449123602|FG000|Overall Study|Site closure; participant won't transfer|0|||
124864407|NCT02415400|449123603|FG001|Overall Study|Site closure; participant won't transfer|0|||
124864408|NCT02415400|449123604|FG002|Overall Study|Site closure; participant won't transfer|0|||
124864409|NCT02415400|449123605|FG003|Overall Study|Site closure; participant won't transfer|1|||
124864410|NCT02270450|449123606|FG000|Overall Study|Refusal unrelated to adverse event|3|||
124864411|NCT02270450|449123607|FG001|Overall Study|Refusal unrelated to adverse event|1|||
124864412|NCT02270450|449123608|FG002|Overall Study|Refusal unrelated to adverse event|5|||
124864413|NCT02270450|449123609|FG003|Overall Study|Refusal unrelated to adverse event|14|||
124864414|NCT02270450|449123606|FG000|Overall Study|Progression/relapse|1|||
124864415|NCT02270450|449123607|FG001|Overall Study|Progression/relapse|2|||
124864416|NCT02270450|449123608|FG002|Overall Study|Progression/relapse|4|||
124864417|NCT02270450|449123609|FG003|Overall Study|Progression/relapse|9|||
124864418|NCT02270450|449123606|FG000|Overall Study|Death|19|||
124864419|NCT02270450|449123607|FG001|Overall Study|Death|19|||
124864420|NCT02270450|449123608|FG002|Overall Study|Death|31|||
124864421|NCT02270450|449123609|FG003|Overall Study|Death|59|||
124864422|NCT02363738|449123610|FG000|Overall Study|Adverse Event|5|||
124864423|NCT02363738|449123611|FG001|Overall Study|Adverse Event|2|||
124864424|NCT02363738|449123610|FG000|Overall Study|Lack of Efficacy|1|||
124864425|NCT02363738|449123611|FG001|Overall Study|Lack of Efficacy|2|||
124864426|NCT02363738|449123610|FG000|Overall Study|Lost to Follow-up|2|||
124864427|NCT02363738|449123611|FG001|Overall Study|Lost to Follow-up|1|||
124864428|NCT03282227|449123614|FG000|Overall Study|Exposure Goals Achieved|60|||
124864429|NCT03282227|449123614|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
124864430|NCT03282227|449123614|FG000|Overall Study|Adverse Event|15|||
124864431|NCT03282227|449123614|FG000|Overall Study|Lost to Follow-up|21|||
124864432|NCT03282227|449123614|FG000|Overall Study|Withdrawal by Subject|20|||
124864433|NCT03282227|449123614|FG000|Overall Study|Lack of Efficacy|12|||
124864434|NCT03282227|449123614|FG000|Overall Study|Sponsor decision|3|||
124864435|NCT03282227|449123614|FG000|Overall Study|Physician Decision|2|||
124864436|NCT03282227|449123614|FG000|Overall Study|Pregnancy|2|||
124864437|NCT03282227|449123614|FG000|Overall Study|Other|1|||
124864438|NCT04330638|449123615|FG000|Overall Study|Adverse Event|9|||
124864439|NCT04330638|449123616|FG001|Overall Study|Adverse Event|10|||
124864440|NCT04330638|449123617|FG002|Overall Study|Adverse Event|15|||
124864441|NCT04330638|449123618|FG003|Overall Study|Adverse Event|6|||
124864442|NCT04330638|449123619|FG004|Overall Study|Adverse Event|10|||
124864443|NCT04330638|449123620|FG005|Overall Study|Adverse Event|5|||
124864444|NCT04330638|449123615|FG000|Overall Study|Other|2|||
124864445|NCT04330638|449123616|FG001|Overall Study|Other|2|||
124864446|NCT04330638|449123617|FG002|Overall Study|Other|5|||
124864447|NCT04330638|449123618|FG003|Overall Study|Other|1|||
124864448|NCT04330638|449123619|FG004|Overall Study|Other|3|||
124864449|NCT04330638|449123620|FG005|Overall Study|Other|2|||
124864450|NCT04330638|449123615|FG000|Overall Study|Withdrawal by Subject|4|||
124864451|NCT04330638|449123616|FG001|Overall Study|Withdrawal by Subject|0|||
124864452|NCT04330638|449123617|FG002|Overall Study|Withdrawal by Subject|0|||
124864453|NCT04330638|449123618|FG003|Overall Study|Withdrawal by Subject|0|||
124864454|NCT04330638|449123619|FG004|Overall Study|Withdrawal by Subject|0|||
124864455|NCT04330638|449123620|FG005|Overall Study|Withdrawal by Subject|0|||
124864456|NCT04330638|449123615|FG000|Overall Study|Lost to Follow-up|3|||
124864457|NCT04330638|449123616|FG001|Overall Study|Lost to Follow-up|2|||
124864458|NCT04330638|449123617|FG002|Overall Study|Lost to Follow-up|3|||
124864459|NCT04330638|449123618|FG003|Overall Study|Lost to Follow-up|2|||
124864460|NCT04330638|449123619|FG004|Overall Study|Lost to Follow-up|3|||
124864461|NCT04330638|449123620|FG005|Overall Study|Lost to Follow-up|0|||
124864462|NCT00989287|449123623|FG000|Overall Study|Adverse Event|1|||
124864463|NCT00989287|449123624|FG001|Overall Study|Adverse Event|0|||
124864464|NCT00989287|449123623|FG000|Overall Study|Lost to Follow-up|0|||
124864465|NCT00989287|449123624|FG001|Overall Study|Lost to Follow-up|1|||
124864466|NCT03743038|449123625|FG000|Overall Study|Physician Decision|1|||
124864467|NCT01300546|449123626|FG000|Overall Study|Withdrawal by Subject|1|||
124864468|NCT01300546|449123627|FG001|Overall Study|Withdrawal by Subject|0|||
124864469|NCT01300546|449123626|FG000|Overall Study|Lost to Follow-up|0|||
124864470|NCT01300546|449123627|FG001|Overall Study|Lost to Follow-up|2|||
124864471|NCT01300546|449123626|FG000|Overall Study|Lack of Efficacy|0|||
124864472|NCT01300546|449123627|FG001|Overall Study|Lack of Efficacy|3|||
124864473|NCT01300546|449123626|FG000|Overall Study|Adverse Event|0|||
124864474|NCT01300546|449123627|FG001|Overall Study|Adverse Event|1|||
124864475|NCT02820623|449123628|FG000|Overall Study|Withdrawal by Subject|1|||
124864476|NCT02820623|449123629|FG001|Overall Study|Withdrawal by Subject|3|||
124864477|NCT02820623|449123630|FG002|Overall Study|Withdrawal by Subject|3|||
124864478|NCT02820623|449123628|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
124864479|NCT02820623|449123629|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
124864480|NCT02820623|449123630|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
124864481|NCT02820623|449123628|FG000|Overall Study|Therapist unable to enroll clients|1|||
124864482|NCT02820623|449123629|FG001|Overall Study|Therapist unable to enroll clients|1|||
124864483|NCT02820623|449123630|FG002|Overall Study|Therapist unable to enroll clients|3|||
124864484|NCT02820623|449123628|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
124864485|NCT02820623|449123629|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
124864486|NCT02820623|449123630|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
124864487|NCT00617344|449123632|FG000|Overall Study|Serious adverse event|1|||
124864488|NCT00617344|449123633|FG001|Overall Study|Serious adverse event|0|||
124864489|NCT00617344|449123634|FG002|Overall Study|Serious adverse event|0|||
124864490|NCT00617344|449123632|FG000|Overall Study|Other Adverse Event|1|||
124864491|NCT00617344|449123633|FG001|Overall Study|Other Adverse Event|1|||
124864492|NCT00617344|449123634|FG002|Overall Study|Other Adverse Event|0|||
124864493|NCT00617344|449123632|FG000|Overall Study|Protocol Violation|10|||
124864494|NCT00617344|449123633|FG001|Overall Study|Protocol Violation|8|||
124864495|NCT00617344|449123634|FG002|Overall Study|Protocol Violation|5|||
124864496|NCT00617344|449123632|FG000|Overall Study|Lost to Follow-up|5|||
124864497|NCT00617344|449123633|FG001|Overall Study|Lost to Follow-up|4|||
124864498|NCT00617344|449123634|FG002|Overall Study|Lost to Follow-up|1|||
124864499|NCT00617344|449123632|FG000|Overall Study|Withdrawal by Subject|8|||
124864500|NCT00617344|449123633|FG001|Overall Study|Withdrawal by Subject|9|||
124864501|NCT00617344|449123634|FG002|Overall Study|Withdrawal by Subject|2|||
124864502|NCT01864564|449123639|FG000|Overall Study|Lost to Follow-up|17|||
124864503|NCT01864564|449123640|FG001|Overall Study|Lost to Follow-up|23|||
124864504|NCT01864564|449123639|FG000|Overall Study|Withdrawal by Subject|20|||
124864505|NCT01864564|449123640|FG001|Overall Study|Withdrawal by Subject|11|||
124864506|NCT01864564|449123639|FG000|Overall Study|Protocol Violation|0|||
124864507|NCT01864564|449123640|FG001|Overall Study|Protocol Violation|27|||
124864508|NCT01864564|449123639|FG000|Overall Study|not reported|0|||
124864509|NCT01864564|449123640|FG001|Overall Study|not reported|34|||
124864510|NCT02269670|449123641|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
124864511|NCT00941330|449123642|FG000|Overall Study|Other|1|||
124864512|NCT00941330|449123643|FG001|Overall Study|Other|0|||
124864513|NCT00941330|449123642|FG000|Overall Study|Physician Decision|0|||
124864514|NCT00941330|449123643|FG001|Overall Study|Physician Decision|2|||
124864515|NCT02693665|449123644|FG000|Overall Study|Death|3|||
124864516|NCT02693665|449123645|FG001|Overall Study|Death|2|||
124864517|NCT02693665|449123644|FG000|Overall Study|Lost to Follow-up|7|||
124864518|NCT02693665|449123645|FG001|Overall Study|Lost to Follow-up|3|||
124864519|NCT02693665|449123644|FG000|Overall Study|Protocol Violation|1|||
124864520|NCT02693665|449123645|FG001|Overall Study|Protocol Violation|0|||
124864521|NCT02693665|449123644|FG000|Overall Study|Withdrawal by Subject|2|||
124864522|NCT02693665|449123645|FG001|Overall Study|Withdrawal by Subject|0|||
124864523|NCT02693665|449123644|FG000|Overall Study|patient wanted to leave it behind|1|||
124864524|NCT02693665|449123645|FG001|Overall Study|patient wanted to leave it behind|0|||
124864525|NCT02693665|449123644|FG000|Overall Study|anxiety|1|||
124864526|NCT02693665|449123645|FG001|Overall Study|anxiety|0|||
124864527|NCT02693665|449123644|FG000|Overall Study|family issues|1|||
124864528|NCT02693665|449123645|FG001|Overall Study|family issues|0|||
124864529|NCT02693665|449123644|FG000|Overall Study|no reason given|1|||
124864530|NCT02693665|449123645|FG001|Overall Study|no reason given|0|||
124864531|NCT00655980|449123647|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
124864532|NCT00655980|449123648|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
124864533|NCT00655980|449123649|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
124864534|NCT04439110|449123650|FG000|Overall Study|Ineligible|2|||
124864535|NCT04439110|449123650|FG000|Overall Study|Adverse Event|4|||
124864536|NCT04439110|449123650|FG000|Overall Study|Death|2|||
124864537|NCT04439110|449123650|FG000|Overall Study|Disease proression|25|||
124864538|NCT04439110|449123650|FG000|Overall Study|Withdrawal by Subject|1|||
124864539|NCT04439110|449123650|FG000|Overall Study|Alternative therapy|1|||
124864540|NCT04439110|449123650|FG000|Overall Study|Other complicating disease|1|||
124864541|NCT04439110|449123650|FG000|Overall Study|Personal reasons|1|||
124864542|NCT04439110|449123650|FG000|Overall Study|Still on treatment|1|||
124864543|NCT00127608|449123653|FG000|Overall Study|VZV DNA negative|1|||
124864544|NCT05245864|449123654|FG000|Overall Study|Withdrawal by Subject|1|||
124864545|NCT05245864|449123655|FG001|Overall Study|Withdrawal by Subject|1|||
124864546|NCT02811861|449125619|FG000|Overall Study|Radiological Disease Progression|123|||
124864547|NCT02811861|449125620|FG001|Overall Study|Radiological Disease Progression|97|||
124864548|NCT02811861|449125621|FG002|Overall Study|Radiological Disease Progression|174|||
124864549|NCT02811861|449125619|FG000|Overall Study|Clinical Disease Progression|20|||
124864550|NCT02811861|449125620|FG001|Overall Study|Clinical Disease Progression|19|||
124864551|NCT02811861|449125621|FG002|Overall Study|Clinical Disease Progression|22|||
124864552|NCT02811861|449125619|FG000|Overall Study|Adverse Event|63|||
124864553|NCT02811861|449125620|FG001|Overall Study|Adverse Event|60|||
124864554|NCT02811861|449125621|FG002|Overall Study|Adverse Event|41|||
124864555|NCT02811861|449125619|FG000|Overall Study|Lost to Follow-up|0|||
124864556|NCT02811861|449125620|FG001|Overall Study|Lost to Follow-up|0|||
124864557|NCT02811861|449125621|FG002|Overall Study|Lost to Follow-up|1|||
124864558|NCT02811861|449125619|FG000|Overall Study|Subject Choice|29|||
124864559|NCT02811861|449125620|FG001|Overall Study|Subject Choice|17|||
124864560|NCT02811861|449125621|FG002|Overall Study|Subject Choice|23|||
124864561|NCT02811861|449125619|FG000|Overall Study|Withdrawal by Subject|4|||
124864562|NCT02811861|449125620|FG001|Overall Study|Withdrawal by Subject|4|||
124864563|NCT02811861|449125621|FG002|Overall Study|Withdrawal by Subject|9|||
124864564|NCT02811861|449125619|FG000|Overall Study|Other|4|||
124864565|NCT02811861|449125620|FG001|Overall Study|Other|13|||
124864566|NCT02811861|449125621|FG002|Overall Study|Other|3|||
124864567|NCT02811861|449125619|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
124864568|NCT02811861|449125620|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
124864569|NCT02811861|449125621|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
124864570|NCT02811861|449125619|FG000|Overall Study|Randomized but not treated|2|||
124864571|NCT02811861|449125620|FG001|Overall Study|Randomized but not treated|3|||
124864572|NCT02811861|449125621|FG002|Overall Study|Randomized but not treated|17|||
124864573|NCT02925455|449125622|FG000|Overall Study|Withdrawal by Subject|2|||
124864574|NCT02925455|449125623|FG001|Overall Study|Withdrawal by Subject|0|||
124864575|NCT03912259|449125626|FG000|Overall Study|Adverse Event (AE)|2|||
124864576|NCT03912259|449125627|FG001|Overall Study|Adverse Event (AE)|4|||
124864577|NCT03912259|449125626|FG000|Overall Study|Lack of Efficacy|4|||
124864578|NCT03912259|449125627|FG001|Overall Study|Lack of Efficacy|1|||
124864579|NCT03912259|449125626|FG000|Overall Study|Withdrawal by Subject|11|||
124864580|NCT03912259|449125627|FG001|Overall Study|Withdrawal by Subject|1|||
124864581|NCT01549613|449125628|FG000|Overall Study|Lost to Follow-up|11|||
124864582|NCT01549613|449125629|FG001|Overall Study|Lost to Follow-up|11|||
124864583|NCT02216123|449125630|FG000|Overall Study|Lost to Follow-up|4|||
124864584|NCT02216123|449125631|FG001|Overall Study|Lost to Follow-up|2|||
124864585|NCT02216123|449125630|FG000|Overall Study|Withdrawal by Subject|2|||
124864586|NCT02216123|449125631|FG001|Overall Study|Withdrawal by Subject|0|||
124864587|NCT03162224|449125634|FG000|Overall Study|Death|4|||
124864588|NCT03162224|449125635|FG001|Overall Study|Death|5|||
124864589|NCT03162224|449125636|FG002|Overall Study|Death|8|||
124864590|NCT03162224|449125634|FG000|Overall Study|Withdrawal by Subject|1|||
124864591|NCT03162224|449125635|FG001|Overall Study|Withdrawal by Subject|0|||
124864592|NCT03162224|449125636|FG002|Overall Study|Withdrawal by Subject|1|||
124864593|NCT03162224|449125634|FG000|Overall Study|Lost to Follow-up|0|||
124864594|NCT03162224|449125635|FG001|Overall Study|Lost to Follow-up|1|||
124864595|NCT03162224|449125636|FG002|Overall Study|Lost to Follow-up|0|||
124864596|NCT03162224|449125634|FG000|Overall Study|Other|6|||
124864597|NCT03162224|449125635|FG001|Overall Study|Other|2|||
124864598|NCT03162224|449125636|FG002|Overall Study|Other|1|||
124864599|NCT04066114|449125637|FG000|Overall Study|Adverse Event|1|||
124864600|NCT04066114|449125638|FG001|Overall Study|Adverse Event|0|||
124864601|NCT04066114|449125639|FG002|Overall Study|Adverse Event|0|||
124864602|NCT04066114|449125637|FG000|Overall Study|Withdrawal by Subject|1|||
124864603|NCT04066114|449125638|FG001|Overall Study|Withdrawal by Subject|0|||
124864604|NCT04066114|449125639|FG002|Overall Study|Withdrawal by Subject|0|||
124864605|NCT04066114|449125637|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
124864606|NCT04066114|449125638|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
124864607|NCT04066114|449125639|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
124864608|NCT00254982|449125640|FG000|Overall Study|Other|2|||
124864609|NCT00254982|449125641|FG001|Overall Study|Other|1|||
124864610|NCT00254982|449125640|FG000|Overall Study|Lack of Efficacy|5|||
124864611|NCT00254982|449125641|FG001|Overall Study|Lack of Efficacy|3|||
124864612|NCT00254982|449125640|FG000|Overall Study|Lost to Follow-up|5|||
124864613|NCT00254982|449125641|FG001|Overall Study|Lost to Follow-up|3|||
124864614|NCT00254982|449125640|FG000|Overall Study|Adverse Event|18|||
124864615|NCT00254982|449125641|FG001|Overall Study|Adverse Event|16|||
124864616|NCT00254982|449125640|FG000|Overall Study|Withdrawal by Subject|1|||
124864617|NCT00254982|449125641|FG001|Overall Study|Withdrawal by Subject|1|||
124864618|NCT00254982|449125640|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
124864619|NCT00254982|449125641|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
124864620|NCT00254982|449125640|FG000|Overall Study|Protocol deviation|1|||
124864621|NCT00254982|449125641|FG001|Overall Study|Protocol deviation|1|||
124864622|NCT00254982|449125640|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
124864623|NCT00254982|449125641|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
124864624|NCT00254982|449125640|FG000|Overall Study|Malignancy|0|||
124864625|NCT00254982|449125641|FG001|Overall Study|Malignancy|2|||
124864626|NCT00254982|449125640|FG000|Overall Study|Opportunistic infection|1|||
124864627|NCT00254982|449125641|FG001|Overall Study|Opportunistic infection|0|||
124864628|NCT00254982|449125640|FG000|Overall Study|Abnormal liver function tests|2|||
124864629|NCT00254982|449125641|FG001|Overall Study|Abnormal liver function tests|1|||
124864630|NCT03117738|449125644|FG000|Overall Study|Withdrawal by Subject|3|||
124864631|NCT03117738|449125645|FG001|Overall Study|Withdrawal by Subject|1|||
124864632|NCT03117738|449125644|FG000|Overall Study|Lost to Follow-up|1|||
124864633|NCT03117738|449125645|FG001|Overall Study|Lost to Follow-up|4|||
124864634|NCT04004611|449125646|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
124864635|NCT04004611|449125647|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
124864636|NCT04004611|449125648|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
124864637|NCT04004611|449125649|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
124864638|NCT04004611|449125650|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
124864639|NCT04004611|449125651|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
124864640|NCT04004611|449125652|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
124864641|NCT04004611|449125653|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
124864642|NCT04004611|449125654|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
124864643|NCT04004611|449125646|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
124864644|NCT04004611|449125647|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
124864645|NCT04004611|449125648|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
124864646|NCT04004611|449125649|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
124864647|NCT04004611|449125650|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
124864648|NCT04004611|449125651|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
124864649|NCT04004611|449125652|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
124864650|NCT04004611|449125653|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
124864651|NCT04004611|449125654|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
124864652|NCT04004611|449125646|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
124864653|NCT04004611|449125647|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
124864654|NCT04004611|449125648|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
124864655|NCT04004611|449125649|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
124864656|NCT04004611|449125650|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
124864657|NCT04004611|449125651|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
124864658|NCT04004611|449125652|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
124864659|NCT04004611|449125653|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
124864660|NCT04004611|449125654|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
124864661|NCT04004611|449125646|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
124864662|NCT04004611|449125647|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
124864663|NCT04004611|449125648|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
124864664|NCT04004611|449125649|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
124864665|NCT04004611|449125650|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
124864666|NCT04004611|449125651|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
124864667|NCT04004611|449125652|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
124864668|NCT04004611|449125653|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
124864669|NCT04004611|449125654|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
124864670|NCT04004611|449125646|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
124864671|NCT04004611|449125647|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
124864672|NCT04004611|449125648|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
124864673|NCT04004611|449125649|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
124864674|NCT04004611|449125650|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
124864675|NCT04004611|449125651|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
124864676|NCT04004611|449125652|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
124864677|NCT04004611|449125653|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
124864678|NCT04004611|449125654|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
124864679|NCT04004611|449125646|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
124864680|NCT04004611|449125647|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
124864681|NCT04004611|449125648|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
124864682|NCT04004611|449125649|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
124864683|NCT04004611|449125650|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
124864684|NCT04004611|449125651|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
124864685|NCT04004611|449125652|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
124864686|NCT04004611|449125653|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
124864687|NCT04004611|449125654|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
124864688|NCT04420689|449125655|FG000|Overall Study|COVID-19 related hospitalization|0|||
124864689|NCT04420689|449125656|FG001|Overall Study|COVID-19 related hospitalization|0|||
124864690|NCT04420689|449125657|FG002|Overall Study|COVID-19 related hospitalization|0|||
124864691|NCT04420689|449125658|FG003|Overall Study|COVID-19 related hospitalization|0|||
124864692|NCT04420689|449125659|FG004|Overall Study|COVID-19 related hospitalization|1|||
124864693|NCT04420689|449125660|FG005|Overall Study|COVID-19 related hospitalization|0|||
124864694|NCT04420689|449125661|FG006|Overall Study|COVID-19 related hospitalization|0|||
124864695|NCT04420689|449125655|FG000|Overall Study|Physician Decision|0|||
124864696|NCT04420689|449125656|FG001|Overall Study|Physician Decision|0|||
124864697|NCT04420689|449125657|FG002|Overall Study|Physician Decision|0|||
124864698|NCT04420689|449125658|FG003|Overall Study|Physician Decision|0|||
124864699|NCT04420689|449125659|FG004|Overall Study|Physician Decision|0|||
124864700|NCT04420689|449125660|FG005|Overall Study|Physician Decision|1|||
124864701|NCT04420689|449125661|FG006|Overall Study|Physician Decision|0|||
124864702|NCT00515502|449125662|FG000|Treatment Period 1|Adverse Event|0|||
124864703|NCT00515502|449125663|FG001|Treatment Period 1|Adverse Event|0|||
124864704|NCT00515502|449125664|FG002|Treatment Period 1|Adverse Event|0|||
124864705|NCT00515502|449125665|FG003|Treatment Period 1|Adverse Event|0|||
124864706|NCT00515502|449125666|FG004|Treatment Period 1|Adverse Event|0|||
124864707|NCT00515502|449125667|FG005|Treatment Period 1|Adverse Event|0|||
124864708|NCT00515502|449125668|FG006|Treatment Period 1|Adverse Event|1|||
124864709|NCT00515502|449125669|FG007|Treatment Period 1|Adverse Event|0|||
124864710|NCT00515502|449125670|FG008|Treatment Period 1|Adverse Event|1|||
124864711|NCT00515502|449125671|FG009|Treatment Period 1|Adverse Event|0|||
124864712|NCT00515502|449125672|FG010|Treatment Period 1|Adverse Event|0|||
124864713|NCT00515502|449125673|FG011|Treatment Period 1|Adverse Event|1|||
124864714|NCT00515502|449125662|FG000|Treatment Period 2|Adverse Event|0|||
124864715|NCT00515502|449125663|FG001|Treatment Period 2|Adverse Event|1|||
124864716|NCT00515502|449125664|FG002|Treatment Period 2|Adverse Event|0|||
124864717|NCT00515502|449125665|FG003|Treatment Period 2|Adverse Event|0|||
124864718|NCT00515502|449125666|FG004|Treatment Period 2|Adverse Event|0|||
124864719|NCT00515502|449125667|FG005|Treatment Period 2|Adverse Event|0|||
124864720|NCT00515502|449125668|FG006|Treatment Period 2|Adverse Event|0|||
124864721|NCT00515502|449125669|FG007|Treatment Period 2|Adverse Event|0|||
124864722|NCT00515502|449125670|FG008|Treatment Period 2|Adverse Event|0|||
124864723|NCT00515502|449125671|FG009|Treatment Period 2|Adverse Event|0|||
124864724|NCT00515502|449125672|FG010|Treatment Period 2|Adverse Event|0|||
124864725|NCT00515502|449125673|FG011|Treatment Period 2|Adverse Event|0|||
124864726|NCT02732938|449125677|FG000|Overall Study|Death|0|||
124864727|NCT02732938|449125678|FG001|Overall Study|Death|11|||
124864728|NCT02732938|449125679|FG002|Overall Study|Death|0|||
124864729|NCT02732938|449125677|FG000|Overall Study|Randomized but did not receive treatment|0|||
124864730|NCT02732938|449125678|FG001|Overall Study|Randomized but did not receive treatment|1|||
124864731|NCT02732938|449125679|FG002|Overall Study|Randomized but did not receive treatment|0|||
124864732|NCT02732938|449125677|FG000|Overall Study|Refused further follow-up|1|||
124864733|NCT02732938|449125678|FG001|Overall Study|Refused further follow-up|0|||
124864734|NCT02732938|449125679|FG002|Overall Study|Refused further follow-up|0|||
124864735|NCT02732938|449125677|FG000|Overall Study|Study terminated by sponsor|3|||
124864736|NCT02732938|449125678|FG001|Overall Study|Study terminated by sponsor|6|||
124864737|NCT02732938|449125679|FG002|Overall Study|Study terminated by sponsor|0|||
124864738|NCT03927950|449125680|FG000|Overall Study|Adverse Event|9|||
124864739|NCT03647501|449125681|FG000|Overall Study|Lost to Follow-up|1|||
124864740|NCT03647501|449125682|FG001|Overall Study|Lost to Follow-up|1|||
124864741|NCT03647501|449125681|FG000|Overall Study|Withdrawal by Subject|0|||
124864742|NCT03647501|449125682|FG001|Overall Study|Withdrawal by Subject|1|||
124864743|NCT04530448|449125683|FG000|Overall Study|Physician Decision|3|||
124864744|NCT04530448|449125684|FG001|Overall Study|Physician Decision|0|||
124864745|NCT01613248|449125685|FG000|Overall Study|Adverse Event|0|||
124864746|NCT01613248|449125686|FG001|Overall Study|Adverse Event|0|||
124864747|NCT01613248|449125687|FG002|Overall Study|Adverse Event|0|||
124864748|NCT01613248|449125688|FG003|Overall Study|Adverse Event|1|||
124864749|NCT01613248|449125689|FG004|Overall Study|Adverse Event|0|||
124864750|NCT01613248|449125690|FG005|Overall Study|Adverse Event|0|||
124864751|NCT01613248|449125685|FG000|Overall Study|Withdrawal by Subject|3|||
124864752|NCT01613248|449125686|FG001|Overall Study|Withdrawal by Subject|2|||
124864753|NCT01613248|449125687|FG002|Overall Study|Withdrawal by Subject|2|||
124864754|NCT01613248|449125688|FG003|Overall Study|Withdrawal by Subject|5|||
124864755|NCT01613248|449125689|FG004|Overall Study|Withdrawal by Subject|0|||
124864756|NCT01613248|449125690|FG005|Overall Study|Withdrawal by Subject|1|||
124864757|NCT01613248|449125685|FG000|Overall Study|Lost to Follow-up|5|||
124864758|NCT01613248|449125686|FG001|Overall Study|Lost to Follow-up|7|||
124864759|NCT01613248|449125687|FG002|Overall Study|Lost to Follow-up|4|||
124864760|NCT01613248|449125688|FG003|Overall Study|Lost to Follow-up|8|||
124864761|NCT01613248|449125689|FG004|Overall Study|Lost to Follow-up|4|||
124864762|NCT01613248|449125690|FG005|Overall Study|Lost to Follow-up|2|||
124864763|NCT01613248|449125685|FG000|Overall Study|Study Terminated by Sponsor|4|||
124864764|NCT01613248|449125686|FG001|Overall Study|Study Terminated by Sponsor|6|||
124864765|NCT01613248|449125687|FG002|Overall Study|Study Terminated by Sponsor|8|||
124864766|NCT01613248|449125688|FG003|Overall Study|Study Terminated by Sponsor|8|||
124864767|NCT01613248|449125689|FG004|Overall Study|Study Terminated by Sponsor|9|||
124864768|NCT01613248|449125690|FG005|Overall Study|Study Terminated by Sponsor|11|||
124864769|NCT01613248|449125685|FG000|Overall Study|Physician Decision|8|||
124864770|NCT01613248|449125686|FG001|Overall Study|Physician Decision|8|||
124864771|NCT01613248|449125687|FG002|Overall Study|Physician Decision|9|||
124864772|NCT01613248|449125688|FG003|Overall Study|Physician Decision|4|||
124864773|NCT01613248|449125689|FG004|Overall Study|Physician Decision|7|||
124864774|NCT01613248|449125690|FG005|Overall Study|Physician Decision|6|||
124864775|NCT01613248|449125685|FG000|Overall Study|Lack of Qualifying Event|9|||
124864776|NCT01613248|449125686|FG001|Overall Study|Lack of Qualifying Event|11|||
124864777|NCT01613248|449125687|FG002|Overall Study|Lack of Qualifying Event|10|||
124864778|NCT01613248|449125688|FG003|Overall Study|Lack of Qualifying Event|11|||
124864779|NCT01613248|449125689|FG004|Overall Study|Lack of Qualifying Event|15|||
124864780|NCT01613248|449125690|FG005|Overall Study|Lack of Qualifying Event|18|||
124864781|NCT01613248|449125685|FG000|Overall Study|Pregnancy|0|||
124864782|NCT01613248|449125686|FG001|Overall Study|Pregnancy|0|||
124864783|NCT01613248|449125687|FG002|Overall Study|Pregnancy|0|||
124864784|NCT01613248|449125688|FG003|Overall Study|Pregnancy|1|||
124864785|NCT01613248|449125689|FG004|Overall Study|Pregnancy|0|||
124864786|NCT01613248|449125690|FG005|Overall Study|Pregnancy|0|||
124864787|NCT01433354|449125692|FG000|Overall Study|Adverse Event|6|||
124864788|NCT01433354|449125692|FG000|Overall Study|Lost to Follow-up|1|||
124864789|NCT01433354|449125692|FG000|Overall Study|Administrative problems|90|||
124864790|NCT01433354|449125692|FG000|Overall Study|Protocol Violation|2|||
124864791|NCT01433354|449125692|FG000|Overall Study|Lack of Efficacy|17|||
124864792|NCT01433354|449125692|FG000|Overall Study|Subject Withdrew Consent|3|||
124864793|NCT02015676|449125699|FG000|Overall Study|Adverse Event|2|||
124864794|NCT02015676|449125700|FG001|Overall Study|Adverse Event|18|||
124864795|NCT02015676|449125701|FG002|Overall Study|Adverse Event|0|||
124864796|NCT02015676|449125699|FG000|Overall Study|Lack of Efficacy|2|||
124864797|NCT02015676|449125700|FG001|Overall Study|Lack of Efficacy|4|||
124864798|NCT02015676|449125701|FG002|Overall Study|Lack of Efficacy|0|||
124864799|NCT02015676|449125699|FG000|Overall Study|Protocol Violation|1|||
124864800|NCT02015676|449125700|FG001|Overall Study|Protocol Violation|0|||
124864801|NCT02015676|449125701|FG002|Overall Study|Protocol Violation|0|||
124864802|NCT02015676|449125699|FG000|Overall Study|Withdrawal by Subject|1|||
124864803|NCT02015676|449125700|FG001|Overall Study|Withdrawal by Subject|7|||
124864804|NCT02015676|449125701|FG002|Overall Study|Withdrawal by Subject|1|||
124864805|NCT02015676|449125699|FG000|Overall Study|Administrative reasons|0|||
124864806|NCT02015676|449125700|FG001|Overall Study|Administrative reasons|3|||
124864807|NCT02015676|449125701|FG002|Overall Study|Administrative reasons|1|||
124864808|NCT02015676|449125699|FG000|Overall Study|Death|0|||
124864809|NCT02015676|449125700|FG001|Overall Study|Death|1|||
124864810|NCT02015676|449125701|FG002|Overall Study|Death|0|||
124864811|NCT02015676|449125699|FG000|Overall Study|Disease progression|3|||
124864812|NCT02015676|449125700|FG001|Overall Study|Disease progression|1|||
124864813|NCT02015676|449125701|FG002|Overall Study|Disease progression|1|||
124864814|NCT02013622|449125707|FG000|Overall Study|Lost to Follow-up|10|||
124864815|NCT02013622|449125707|FG000|Overall Study|Adverse Event|3|||
124864816|NCT02013622|449125707|FG000|Overall Study|Met Withdrawal Criteria|3|||
124864817|NCT02013622|449125707|FG000|Overall Study|Withdrawal by Subject|6|||
124864818|NCT02013622|449125707|FG000|Overall Study|Protocol Deviation|1|||
124864819|NCT02013622|449125707|FG000|Overall Study|Lack of Efficacy|1|||
124864820|NCT04307004|449125715|FG000|Randomization 1|Withdrawal by Subject|25|||
124864821|NCT04307004|449125716|FG001|Randomization 1|Withdrawal by Subject|26|||
124864822|NCT04307004|449125717|FG002|Randomization 1|Withdrawal by Subject|0|||
124864823|NCT04307004|449125718|FG003|Randomization 1|Withdrawal by Subject|0|||
124864824|NCT04307004|449125715|FG000|Randomization 2|Withdrawal by Subject|0|||
124864825|NCT04307004|449125716|FG001|Randomization 2|Withdrawal by Subject|0|||
124864826|NCT04307004|449125717|FG002|Randomization 2|Withdrawal by Subject|28|||
124864827|NCT04307004|449125718|FG003|Randomization 2|Withdrawal by Subject|23|||
124864828|NCT02081846|449125719|FG000|Overall Study|Withdrawal by Subject|1|||
124864829|NCT02081846|449125720|FG001|Overall Study|Withdrawal by Subject|0|||
124864830|NCT02081846|449125719|FG000|Overall Study|invalid consent|1|||
124864831|NCT02081846|449125720|FG001|Overall Study|invalid consent|0|||
124864832|NCT02576678|449125721|FG000|Overall Study|Adverse Event|0|||
124864833|NCT02576678|449125722|FG001|Overall Study|Adverse Event|0|||
124864834|NCT02576678|449125723|FG002|Overall Study|Adverse Event|2|||
124864835|NCT02576678|449125721|FG000|Overall Study|Withdrawal by Subject|3|||
124864836|NCT02576678|449125722|FG001|Overall Study|Withdrawal by Subject|1|||
124864837|NCT02576678|449125723|FG002|Overall Study|Withdrawal by Subject|2|||
124864838|NCT02576678|449125721|FG000|Overall Study|Lost to Follow-up|0|||
124864839|NCT02576678|449125722|FG001|Overall Study|Lost to Follow-up|0|||
124864840|NCT02576678|449125723|FG002|Overall Study|Lost to Follow-up|1|||
124864841|NCT02576678|449125721|FG000|Overall Study|Miscellaneous|2|||
124864842|NCT02576678|449125722|FG001|Overall Study|Miscellaneous|0|||
124864843|NCT02576678|449125723|FG002|Overall Study|Miscellaneous|0|||
124864844|NCT02251990|449125727|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
124864845|NCT02251990|449125728|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
124864846|NCT02251990|449125727|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
124864847|NCT02251990|449125728|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
124864848|NCT02251990|449125727|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
124864849|NCT02251990|449125728|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
124864850|NCT02251990|449125727|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
124864851|NCT02251990|449125728|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
124864852|NCT02251990|449125727|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
124864853|NCT02251990|449125728|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
124864854|NCT02251990|449125727|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
124864855|NCT02251990|449125728|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
124864856|NCT03265600|449125729|FG000|Overall Study|Lost to Follow-up|17|||
124864857|NCT03265600|449125730|FG001|Overall Study|Lost to Follow-up|5|||
124864858|NCT03265600|449125729|FG000|Overall Study|Withdrawal by Subject|4|||
124864859|NCT03265600|449125730|FG001|Overall Study|Withdrawal by Subject|2|||
124864860|NCT03265600|449125729|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
124864861|NCT03265600|449125730|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
124864862|NCT02293538|449125731|FG000|Overall Study|Adverse Event|0|||
124864863|NCT02293538|449125732|FG001|Overall Study|Adverse Event|1|||
124864864|NCT02293538|449125731|FG000|Overall Study|Lost to Follow-up|1|||
124864865|NCT02293538|449125732|FG001|Overall Study|Lost to Follow-up|0|||
124864866|NCT02293538|449125731|FG000|Overall Study|Withdrawal by Subject|0|||
124864867|NCT02293538|449125732|FG001|Overall Study|Withdrawal by Subject|1|||
124864868|NCT00322348|449125736|FG000|Overall Study|Adverse Event|0|||
124864869|NCT00322348|449125737|FG001|Overall Study|Adverse Event|1|||
124864870|NCT00322348|449125736|FG000|Overall Study|Withdrawal by Subject|1|||
124864871|NCT00322348|449125737|FG001|Overall Study|Withdrawal by Subject|4|||
124864872|NCT00322348|449125736|FG000|Overall Study|Lost to Follow-up|1|||
124864873|NCT00322348|449125737|FG001|Overall Study|Lost to Follow-up|0|||
124864874|NCT00322348|449125736|FG000|Overall Study|Death|0|||
124864875|NCT00322348|449125737|FG001|Overall Study|Death|2|||
124864876|NCT00322348|449125736|FG000|Overall Study|Disease Progression|30|||
124864877|NCT00322348|449125737|FG001|Overall Study|Disease Progression|25|||
124864878|NCT00322348|449125736|FG000|Overall Study|Reasons not specified|5|||
124864879|NCT00322348|449125737|FG001|Overall Study|Reasons not specified|1|||
124864880|NCT01090453|449125740|FG000|Overall Study|Withdrawal by Subject|1|||
124864881|NCT01090453|449125741|FG001|Overall Study|Withdrawal by Subject|2|||
124864882|NCT01090453|449125740|FG000|Overall Study|Lost to Follow-up|7|||
124864883|NCT01090453|449125741|FG001|Overall Study|Lost to Follow-up|7|||
124864884|NCT01090453|449125740|FG000|Overall Study|Non serious AEs|1|||
124864885|NCT01090453|449125741|FG001|Overall Study|Non serious AEs|0|||
124864886|NCT01090453|449125740|FG000|Overall Study|Protocol Violation|2|||
124864887|NCT01090453|449125741|FG001|Overall Study|Protocol Violation|0|||
124864888|NCT01090453|449125740|FG000|Overall Study|Other|2|||
124864889|NCT01090453|449125741|FG001|Overall Study|Other|4|||
124864890|NCT01090453|449125740|FG000|Overall Study|Eligibility Criteria|0|||
124864891|NCT01090453|449125741|FG001|Overall Study|Eligibility Criteria|1|||
124864892|NCT00729833|449125742|FG000|Overall Study|Death|5|||
124864893|NCT00729833|449125743|FG001|Overall Study|Death|1|||
124864894|NCT00729833|449125744|FG002|Overall Study|Death|3|||
124864895|NCT00729833|449125745|FG003|Overall Study|Death|5|||
124864896|NCT00729833|449125742|FG000|Overall Study|Study Terminated by Sponsor|0|||
124864897|NCT00729833|449125743|FG001|Overall Study|Study Terminated by Sponsor|0|||
124864898|NCT00729833|449125744|FG002|Overall Study|Study Terminated by Sponsor|1|||
124864899|NCT00729833|449125745|FG003|Overall Study|Study Terminated by Sponsor|0|||
124864900|NCT00729833|449125742|FG000|Overall Study|Lost to Follow-up|1|||
124864901|NCT00729833|449125743|FG001|Overall Study|Lost to Follow-up|0|||
124864902|NCT00729833|449125744|FG002|Overall Study|Lost to Follow-up|0|||
124864903|NCT00729833|449125745|FG003|Overall Study|Lost to Follow-up|0|||
124864904|NCT00729833|449125742|FG000|Overall Study|Withdrawal by Subject|3|||
124864905|NCT00729833|449125743|FG001|Overall Study|Withdrawal by Subject|1|||
124864906|NCT00729833|449125744|FG002|Overall Study|Withdrawal by Subject|3|||
124864907|NCT00729833|449125745|FG003|Overall Study|Withdrawal by Subject|0|||
124864908|NCT00729833|449125742|FG000|Overall Study|Unspecified Reasons|11|||
124864909|NCT00729833|449125743|FG001|Overall Study|Unspecified Reasons|5|||
124864910|NCT00729833|449125744|FG002|Overall Study|Unspecified Reasons|5|||
124864911|NCT00729833|449125745|FG003|Overall Study|Unspecified Reasons|1|||
124864912|NCT00695669|449125746|FG000|Overall Study|Adverse Event|0|||
124864913|NCT00695669|449125747|FG001|Overall Study|Adverse Event|0|||
124864914|NCT00695669|449125748|FG002|Overall Study|Adverse Event|2|||
124864915|NCT00695669|449125749|FG003|Overall Study|Adverse Event|0|||
124864916|NCT00695669|449125746|FG000|Overall Study|Lost to Follow-up|4|||
124864917|NCT00695669|449125747|FG001|Overall Study|Lost to Follow-up|4|||
124864918|NCT00695669|449125748|FG002|Overall Study|Lost to Follow-up|1|||
124864919|NCT00695669|449125749|FG003|Overall Study|Lost to Follow-up|4|||
124864920|NCT05045625|449125750|FG000|Overall Study|Lost to Follow-up|3|||
124864921|NCT00417079|449125751|FG000|Overall Study|Disease progression|267|||
124864922|NCT00417079|449125752|FG001|Overall Study|Disease progression|180|||
124864923|NCT00417079|449125751|FG000|Overall Study|Adverse Event|32|||
124864924|NCT00417079|449125752|FG001|Overall Study|Adverse Event|67|||
124864925|NCT00417079|449125751|FG000|Overall Study|Non-compliance to protocol|0|||
124864926|NCT00417079|449125752|FG001|Overall Study|Non-compliance to protocol|1|||
124864927|NCT00417079|449125751|FG000|Overall Study|Lost to Follow-up|2|||
124864928|NCT00417079|449125752|FG001|Overall Study|Lost to Follow-up|0|||
124864929|NCT00417079|449125751|FG000|Overall Study|Withdrawal by Subject|17|||
124864930|NCT00417079|449125752|FG001|Overall Study|Withdrawal by Subject|8|||
124864931|NCT00417079|449125751|FG000|Overall Study|Not treated|6|||
124864932|NCT00417079|449125752|FG001|Overall Study|Not treated|7|||
124864933|NCT00417079|449125751|FG000|Overall Study|Screened failure|2|||
124864934|NCT00417079|449125752|FG001|Overall Study|Screened failure|1|||
124864935|NCT00417079|449125751|FG000|Overall Study|Investigator's decision|1|||
124864936|NCT00417079|449125752|FG001|Overall Study|Investigator's decision|4|||
124864937|NCT00417079|449125751|FG000|Overall Study|Non-confirmed Disease progression|1|||
124864938|NCT00417079|449125752|FG001|Overall Study|Non-confirmed Disease progression|1|||
124864939|NCT00417079|449125751|FG000|Overall Study|Clinical deterioration|1|||
124864940|NCT00417079|449125752|FG001|Overall Study|Clinical deterioration|0|||
124864941|NCT00417079|449125751|FG000|Overall Study|Screening error|2|||
124864942|NCT00417079|449125752|FG001|Overall Study|Screening error|1|||
124864943|NCT00417079|449125751|FG000|Overall Study|Withdrawal by subject's family|0|||
124864944|NCT00417079|449125752|FG001|Overall Study|Withdrawal by subject's family|1|||
124864945|NCT00417079|449125751|FG000|Overall Study|Patient unable to come to the clinic|0|||
124864946|NCT00417079|449125752|FG001|Overall Study|Patient unable to come to the clinic|1|||
124864947|NCT00417079|449125751|FG000|Overall Study|abnormal liver function tests|0|||
124864948|NCT00417079|449125752|FG001|Overall Study|abnormal liver function tests|1|||
124864949|NCT03570619|449125763|FG000|Overall Study|Adverse Event|2|||
124864950|NCT03570619|449125764|FG001|Overall Study|Adverse Event|0|||
124864951|NCT03570619|449125765|FG002|Overall Study|Adverse Event|1|||
124864952|NCT03570619|449125763|FG000|Overall Study|new diagnosis of new malignancy|1|||
124864953|NCT03570619|449125764|FG001|Overall Study|new diagnosis of new malignancy|0|||
124864954|NCT03570619|449125765|FG002|Overall Study|new diagnosis of new malignancy|0|||
124864955|NCT03570619|449125763|FG000|Overall Study|Physician Decision|1|||
124864956|NCT03570619|449125764|FG001|Overall Study|Physician Decision|1|||
124864957|NCT03570619|449125765|FG002|Overall Study|Physician Decision|0|||
124864958|NCT03570619|449125763|FG000|Overall Study|Withdrawal by Subject|0|||
124864959|NCT03570619|449125764|FG001|Overall Study|Withdrawal by Subject|2|||
124864960|NCT03570619|449125765|FG002|Overall Study|Withdrawal by Subject|0|||
124864961|NCT01022762|449125767|FG000|Overall Study|Adverse Event|3|||
124864962|NCT01022762|449125768|FG001|Overall Study|Adverse Event|1|||
124864963|NCT01022762|449125767|FG000|Overall Study|Lack of Efficacy|0|||
124864964|NCT01022762|449125768|FG001|Overall Study|Lack of Efficacy|1|||
124864965|NCT01022762|449125767|FG000|Overall Study|Protocol Violation|7|||
124864966|NCT01022762|449125768|FG001|Overall Study|Protocol Violation|6|||
124864967|NCT01022762|449125767|FG000|Overall Study|Unclassified|12|||
124864968|NCT01022762|449125768|FG001|Overall Study|Unclassified|20|||
124864969|NCT01302119|449125769|FG000|Overall Study|Withdrawal by Subject|30|||
124864970|NCT01302119|449125770|FG001|Overall Study|Withdrawal by Subject|20|||
124864971|NCT01302119|449125769|FG000|Overall Study|Lost to Follow-up|10|||
124864972|NCT01302119|449125770|FG001|Overall Study|Lost to Follow-up|4|||
124864973|NCT01302119|449125769|FG000|Overall Study|Adverse Event|2|||
124864974|NCT01302119|449125770|FG001|Overall Study|Adverse Event|1|||
124864975|NCT01302119|449125769|FG000|Overall Study|Non-compliance|4|||
124864976|NCT01302119|449125770|FG001|Overall Study|Non-compliance|2|||
124864977|NCT01302119|449125769|FG000|Overall Study|Non-specific|4|||
124864978|NCT01302119|449125770|FG001|Overall Study|Non-specific|1|||
124864979|NCT03336619|449125772|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
124864980|NCT03336619|449125773|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
124864981|NCT03336619|449125772|FG000|Overall Study|Withdrawal by Subject|17|||
124864982|NCT03336619|449125773|FG001|Overall Study|Withdrawal by Subject|16|||
124864983|NCT03336619|449125772|FG000|Overall Study|Adverse Event|2|||
124864984|NCT03336619|449125773|FG001|Overall Study|Adverse Event|5|||
124864985|NCT03336619|449125772|FG000|Overall Study|Physician Decision|3|||
124864986|NCT03336619|449125773|FG001|Overall Study|Physician Decision|0|||
124864987|NCT00744653|449125778|FG000|Overall Study|antineoplastic treatment|11|||
124864988|NCT00744653|449125778|FG000|Overall Study|Death|1|||
124864989|NCT00744653|449125778|FG000|Overall Study|Lost to Follow-up|1|||
124864990|NCT00744653|449125778|FG000|Overall Study|Physician Decision|3|||
124864991|NCT03826667|449125781|FG000|Overall Study|Protocol deviation|21|||
124864992|NCT00679939|449125783|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
124864993|NCT00679939|449125784|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
124864994|NCT00679939|449125783|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
124864995|NCT00679939|449125784|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
124864996|NCT00679939|449125783|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
124864997|NCT00679939|449125784|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
124864998|NCT00679939|449125783|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
124864999|NCT00679939|449125784|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
124865000|NCT00679939|449125783|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
124865001|NCT00679939|449125784|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
124865002|NCT00679939|449125783|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
124865003|NCT00679939|449125784|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
124865004|NCT00679939|449125783|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
124865005|NCT00679939|449125784|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
124865006|NCT00679939|449125783|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
124865007|NCT00679939|449125784|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
124865008|NCT00679939|449125783|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
124865009|NCT00679939|449125784|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
124865010|NCT00679939|449125783|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
124865011|NCT00679939|449125784|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
124865012|NCT05608629|449125786|FG000|Overall Study|Lost to Follow-up|2|||
124865013|NCT00983073|449125787|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
124865014|NCT00983073|449125787|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
124865015|NCT00983073|449125787|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
124865016|NCT00983073|449125787|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
124865017|NCT00983073|449125787|FG000|Titration and Optimal Dose Period|Other reason|4|||
124865018|NCT00983073|449125787|FG000|Maintenance Period|Adverse Event|5|||
124865019|NCT00983073|449125787|FG000|Maintenance Period|Withdrawal by Subject|2|||
124865020|NCT00983073|449125787|FG000|Maintenance Period|Lack of Efficacy|2|||
124865021|NCT00983073|449125787|FG000|Maintenance Period|Other Reason|7|||
124865022|NCT01453595|449125788|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
124865023|NCT01453595|449125789|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
124865024|NCT01453595|449125790|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
124865025|NCT02962908|449125793|FG000|Overall Study|Lost to Follow-up|0|||
124865026|NCT02962908|449125794|FG001|Overall Study|Lost to Follow-up|3|||
124865027|NCT02962908|449125795|FG002|Overall Study|Lost to Follow-up|0|||
124865028|NCT02962908|449125796|FG003|Overall Study|Lost to Follow-up|1|||
124865029|NCT02962908|449125793|FG000|Overall Study|Withdrawal by Subject|0|||
124865030|NCT02962908|449125794|FG001|Overall Study|Withdrawal by Subject|3|||
124865031|NCT02962908|449125795|FG002|Overall Study|Withdrawal by Subject|0|||
124865032|NCT02962908|449125796|FG003|Overall Study|Withdrawal by Subject|2|||
124865033|NCT02962908|449125793|FG000|Overall Study|Protocol Violation|0|||
124865034|NCT02962908|449125794|FG001|Overall Study|Protocol Violation|1|||
124865035|NCT02962908|449125795|FG002|Overall Study|Protocol Violation|0|||
124865036|NCT02962908|449125796|FG003|Overall Study|Protocol Violation|0|||
124865037|NCT02962908|449125793|FG000|Overall Study|Physician Decision|0|||
124865038|NCT02962908|449125794|FG001|Overall Study|Physician Decision|1|||
124865039|NCT02962908|449125795|FG002|Overall Study|Physician Decision|0|||
124865040|NCT02962908|449125796|FG003|Overall Study|Physician Decision|0|||
124865041|NCT00936390|449125797|FG000|Overall Study|Protocol Violation|21|||
124865042|NCT00936390|449125798|FG001|Overall Study|Protocol Violation|25|||
124865043|NCT04348604|449125799|FG000|Week 8|Withdrawal by Subject|1|||
124865044|NCT04348604|449125800|FG001|Week 8|Withdrawal by Subject|1|||
124865045|NCT04348604|449125799|FG000|Week 8|Lost to Follow-up|1|||
124865046|NCT04348604|449125800|FG001|Week 8|Lost to Follow-up|2|||
124865047|NCT04348604|449125799|FG000|Week 8|Suspended|0|||
124865048|NCT04348604|449125800|FG001|Week 8|Suspended|1|||
124865049|NCT04348604|449125799|FG000|Week 12|Lost to Follow-up|1|||
124865050|NCT04348604|449125800|FG001|Week 12|Lost to Follow-up|2|||
124865051|NCT04348604|449125799|FG000|Week 12|Withdrawal by Subject|1|||
124865052|NCT04348604|449125800|FG001|Week 12|Withdrawal by Subject|0|||
124865053|NCT04348604|449125799|FG000|Week 24|Lost to Follow-up|2|||
124865054|NCT04348604|449125800|FG001|Week 24|Lost to Follow-up|1|||
124865055|NCT02097108|449125801|FG000|Overall Study|Adverse Event|1|||
124865056|NCT02097108|449125801|FG000|Overall Study|patient was abroad for 6 months|1|||
124865057|NCT00506493|449125804|FG000|Overall Study|Death|6|||
124865058|NCT00506493|449125804|FG000|Overall Study|Withdrawal by Subject|5|||
124865059|NCT00955357|449126922|FG000|Titration Phase|Adverse Event|9|||
124865060|NCT00955357|449126923|FG001|Titration Phase|Adverse Event|46|||
124865061|NCT00955357|449126922|FG000|Titration Phase|Lack of Efficacy|0|||
124865062|NCT00955357|449126923|FG001|Titration Phase|Lack of Efficacy|2|||
124865063|NCT00955357|449126922|FG000|Titration Phase|Protocol Violation|3|||
124865064|NCT00955357|449126923|FG001|Titration Phase|Protocol Violation|7|||
124865065|NCT00955357|449126922|FG000|Titration Phase|Lost to Follow-up|1|||
124865066|NCT00955357|449126923|FG001|Titration Phase|Lost to Follow-up|3|||
124865067|NCT00955357|449126922|FG000|Titration Phase|Withdrawal by Subject|3|||
124865068|NCT00955357|449126923|FG001|Titration Phase|Withdrawal by Subject|5|||
124865069|NCT00955357|449126922|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
124865070|NCT00955357|449126923|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
124865071|NCT00955357|449126922|FG000|Titration Phase|Study medication not tolerated|0|||
124865072|NCT00955357|449126923|FG001|Titration Phase|Study medication not tolerated|1|||
124865073|NCT00955357|449126922|FG000|Titration Phase|Non compliance to study procedures|0|||
124865074|NCT00955357|449126923|FG001|Titration Phase|Non compliance to study procedures|1|||
124865075|NCT00955357|449126922|FG000|Maintenance Phase|Adverse Event|3|||
124865076|NCT00955357|449126923|FG001|Maintenance Phase|Adverse Event|23|||
124865077|NCT00955357|449126922|FG000|Maintenance Phase|Lack of Efficacy|0|||
124865078|NCT00955357|449126923|FG001|Maintenance Phase|Lack of Efficacy|4|||
124865079|NCT00955357|449126922|FG000|Maintenance Phase|Protocol Violation|2|||
124865080|NCT00955357|449126923|FG001|Maintenance Phase|Protocol Violation|6|||
124865081|NCT00955357|449126922|FG000|Maintenance Phase|Lost to Follow-up|2|||
124865082|NCT00955357|449126923|FG001|Maintenance Phase|Lost to Follow-up|7|||
124865083|NCT00955357|449126922|FG000|Maintenance Phase|Withdrawal by Subject|4|||
124865084|NCT00955357|449126923|FG001|Maintenance Phase|Withdrawal by Subject|4|||
124865085|NCT00955357|449126922|FG000|Maintenance Phase|Patient moving out of area|0|||
124865086|NCT00955357|449126923|FG001|Maintenance Phase|Patient moving out of area|1|||
124865087|NCT00955357|449126922|FG000|Maintenance Phase|Non compliance to study procedures|1|||
124865088|NCT00955357|449126923|FG001|Maintenance Phase|Non compliance to study procedures|0|||
124865089|NCT00868439|449126938|FG000|Overall Study|Adverse Event|4|||
124865090|NCT00868439|449126939|FG001|Overall Study|Adverse Event|3|||
124865091|NCT00868439|449126938|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
124865092|NCT00868439|449126939|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
124865093|NCT00868439|449126938|FG000|Overall Study|Death|0|||
124865094|NCT00868439|449126939|FG001|Overall Study|Death|1|||
124865095|NCT00868439|449126938|FG000|Overall Study|Protocol Violation|1|||
124865096|NCT00868439|449126939|FG001|Overall Study|Protocol Violation|1|||
124865097|NCT00868439|449126938|FG000|Overall Study|Physician Decision|1|||
124865098|NCT00868439|449126939|FG001|Overall Study|Physician Decision|0|||
124865099|NCT00868439|449126938|FG000|Overall Study|Withdrawal by Subject|0|||
124865100|NCT00868439|449126939|FG001|Overall Study|Withdrawal by Subject|1|||
124865101|NCT00971048|449126943|FG000|Overall Study|Protocol Violation|1|||
124865102|NCT00971048|449126944|FG001|Overall Study|Protocol Violation|2|||
124865103|NCT00971048|449126945|FG002|Overall Study|Protocol Violation|0|||
124865104|NCT00971048|449126946|FG003|Overall Study|Protocol Violation|1|||
124865105|NCT00971048|449126943|FG000|Overall Study|Adverse Event|0|||
124865106|NCT00971048|449126944|FG001|Overall Study|Adverse Event|0|||
124865107|NCT00971048|449126945|FG002|Overall Study|Adverse Event|1|||
124865108|NCT00971048|449126946|FG003|Overall Study|Adverse Event|0|||
124865109|NCT00971048|449126943|FG000|Overall Study|Physician Decision|0|||
124865110|NCT00971048|449126944|FG001|Overall Study|Physician Decision|0|||
124865111|NCT00971048|449126945|FG002|Overall Study|Physician Decision|0|||
124865112|NCT00971048|449126946|FG003|Overall Study|Physician Decision|1|||
124865113|NCT03321396|449126951|FG000|Overall Study|Physician Decision|1|||
124865114|NCT01540851|449126955|FG000|Overall Study|Lost to Follow-up|14|||
124865115|NCT01540851|449126956|FG001|Overall Study|Lost to Follow-up|15|||
124865116|NCT01540851|449126955|FG000|Overall Study|Withdrawal by Subject|7|||
124865117|NCT01540851|449126956|FG001|Overall Study|Withdrawal by Subject|3|||
124865118|NCT00937924|449126959|FG000|Overall Study|Lost to Follow-up|44|||
124865119|NCT00937924|449126960|FG001|Overall Study|Lost to Follow-up|44|||
124865120|NCT00937924|449126961|FG002|Overall Study|Lost to Follow-up|41|||
124865121|NCT00224874|449126962|FG000|Overall Study|Withdrawal by Subject|0|||
124865122|NCT00224874|449126963|FG001|Overall Study|Withdrawal by Subject|0|||
124865123|NCT00224874|449126964|FG002|Overall Study|Withdrawal by Subject|1|||
124865124|NCT00224874|449126965|FG003|Overall Study|Withdrawal by Subject|0|||
124865125|NCT03644186|449126970|FG000|Overall Study|Withdrawal by Subject|1|||
124865126|NCT03644186|449126971|FG001|Overall Study|Withdrawal by Subject|1|||
124865127|NCT02192502|449126973|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
124865128|NCT02192502|449126974|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
124865129|NCT02192502|449126973|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
124865130|NCT02192502|449126974|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
124865131|NCT02192502|449126973|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
124865132|NCT02192502|449126974|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
124865133|NCT01381692|449126975|FG000|Overall Study|Adverse Event|1|||
124865134|NCT01381692|449126976|FG001|Overall Study|Adverse Event|0|||
124865135|NCT01381692|449126977|FG002|Overall Study|Adverse Event|0|||
124865136|NCT01381692|449126978|FG003|Overall Study|Adverse Event|0|||
124865137|NCT01381692|449126979|FG004|Overall Study|Adverse Event|0|||
124865138|NCT01381692|449126980|FG005|Overall Study|Adverse Event|0|||
124865139|NCT01869491|449126981|FG000|Overall Study|Adverse Event|3|||
124865140|NCT01869491|449126982|FG001|Overall Study|Adverse Event|5|||
124865141|NCT01869491|449126981|FG000|Overall Study|Lack of Efficacy|0|||
124865142|NCT01869491|449126982|FG001|Overall Study|Lack of Efficacy|3|||
124865143|NCT01869491|449126981|FG000|Overall Study|Withdrawal by Subject|6|||
124865144|NCT01869491|449126982|FG001|Overall Study|Withdrawal by Subject|7|||
124865145|NCT01869491|449126981|FG000|Overall Study|Lost to Follow-up|11|||
124865146|NCT01869491|449126982|FG001|Overall Study|Lost to Follow-up|9|||
124865147|NCT01869491|449126981|FG000|Overall Study|No further need of investigational product|1|||
124865148|NCT01869491|449126982|FG001|Overall Study|No further need of investigational product|0|||
124865149|NCT01270347|449126983|FG000|Core Phase|Adverse Event|1|||
124865150|NCT01270347|449126984|FG001|Core Phase|Adverse Event|6|||
124865151|NCT01270347|449126983|FG000|Core Phase|Withdrawal by Subject|1|||
124865152|NCT01270347|449126984|FG001|Core Phase|Withdrawal by Subject|2|||
124865153|NCT01270347|449126983|FG000|Core Phase|Lost to Follow-up|0|||
124865154|NCT01270347|449126984|FG001|Core Phase|Lost to Follow-up|1|||
124865155|NCT01270347|449126983|FG000|Core Phase|Miscellaneous|8|||
124865156|NCT01270347|449126984|FG001|Core Phase|Miscellaneous|14|||
124865157|NCT01270347|449126983|FG000|Extension Phase|Adverse Event|1|||
124865158|NCT01270347|449126984|FG001|Extension Phase|Adverse Event|3|||
124865159|NCT01270347|449126983|FG000|Extension Phase|Withdrawal by Subject|3|||
124865160|NCT01270347|449126984|FG001|Extension Phase|Withdrawal by Subject|4|||
124865161|NCT01270347|449126983|FG000|Extension Phase|Miscellaneous|2|||
124865162|NCT01270347|449126984|FG001|Extension Phase|Miscellaneous|2|||
124865163|NCT02195986|449126989|FG000|Overall Study|Adverse Event|3|||
124865164|NCT02195986|449126990|FG001|Overall Study|Adverse Event|0|||
124865165|NCT02195986|449126991|FG002|Overall Study|Adverse Event|0|||
124865166|NCT02195986|449126989|FG000|Overall Study|Withdrawal by Subject|0|||
124865167|NCT02195986|449126990|FG001|Overall Study|Withdrawal by Subject|3|||
124865168|NCT02195986|449126991|FG002|Overall Study|Withdrawal by Subject|0|||
124865169|NCT02195986|449126989|FG000|Overall Study|Family Emergency|0|||
124865170|NCT02195986|449126990|FG001|Overall Study|Family Emergency|0|||
124865171|NCT02195986|449126991|FG002|Overall Study|Family Emergency|1|||
124865172|NCT02195986|449126989|FG000|Overall Study|Protocol Violation|0|||
124865173|NCT02195986|449126990|FG001|Overall Study|Protocol Violation|1|||
124865174|NCT02195986|449126991|FG002|Overall Study|Protocol Violation|1|||
124865175|NCT02195986|449126989|FG000|Overall Study|Non-compliance|0|||
124865176|NCT02195986|449126990|FG001|Overall Study|Non-compliance|1|||
124865177|NCT02195986|449126991|FG002|Overall Study|Non-compliance|0|||
124865178|NCT02491671|449127004|FG000|Overall Study|Adverse Event|6|||
124865179|NCT02491671|449127005|FG001|Overall Study|Adverse Event|8|||
124865180|NCT02491671|449127004|FG000|Overall Study|Death|0|||
124865181|NCT02491671|449127005|FG001|Overall Study|Death|2|||
124865182|NCT02491671|449127004|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
124865183|NCT02491671|449127005|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
124865184|NCT00535730|449127006|FG000|Overall Study|Adverse Event|1|||
124865185|NCT00535730|449127007|FG001|Overall Study|Adverse Event|1|||
124865186|NCT00535730|449127006|FG000|Overall Study|Lost to Follow-up|0|||
124865187|NCT00535730|449127007|FG001|Overall Study|Lost to Follow-up|1|||
124865188|NCT00535730|449127006|FG000|Overall Study|Physician Decision|0|||
124865189|NCT00535730|449127007|FG001|Overall Study|Physician Decision|1|||
124865190|NCT00535730|449127006|FG000|Overall Study|Protocol Violation|1|||
124865191|NCT00535730|449127007|FG001|Overall Study|Protocol Violation|0|||
124865192|NCT00535730|449127006|FG000|Overall Study|Withdrawal by Subject|0|||
124865193|NCT00535730|449127007|FG001|Overall Study|Withdrawal by Subject|4|||
124865194|NCT04072159|449127016|FG000|Overall Study|Lost to Follow-up|6|||
124865195|NCT04072159|449127017|FG001|Overall Study|Lost to Follow-up|6|||
124865196|NCT04072159|449127016|FG000|Overall Study|Withdrawal by Subject|2|||
124865197|NCT04072159|449127017|FG001|Overall Study|Withdrawal by Subject|0|||
124865198|NCT04084314|449127020|FG000|Overall Study|Subject/guardian decision|91|||
124865199|NCT04084314|449127020|FG000|Overall Study|Adverse Event|24|||
124865200|NCT04084314|449127020|FG000|Overall Study|Lost to Follow-up|19|||
124865201|NCT04084314|449127020|FG000|Overall Study|New therapy for study indication|9|||
124865202|NCT04084314|449127020|FG000|Overall Study|Pregnancy|9|||
124865203|NCT04084314|449127020|FG000|Overall Study|Withdrawal of informed consent|8|||
124865204|NCT04084314|449127020|FG000|Overall Study|Physician Decision|4|||
124865205|NCT04084314|449127020|FG000|Overall Study|Protocol Deviation|3|||
124865206|NCT00802074|449127023|FG000|Overall Study|Adverse Event|1|||
124865207|NCT00802074|449127024|FG001|Overall Study|Adverse Event|1|||
124865208|NCT00802074|449127025|FG002|Overall Study|Adverse Event|1|||
124865209|NCT00802074|449127026|FG003|Overall Study|Adverse Event|0|||
124865210|NCT00802074|449127027|FG004|Overall Study|Adverse Event|0|||
124865211|NCT00802074|449127028|FG005|Overall Study|Adverse Event|0|||
124865212|NCT00802074|449127023|FG000|Overall Study|Withdrawal by Subject|1|||
124865213|NCT00802074|449127024|FG001|Overall Study|Withdrawal by Subject|0|||
124865214|NCT00802074|449127025|FG002|Overall Study|Withdrawal by Subject|0|||
124865215|NCT00802074|449127026|FG003|Overall Study|Withdrawal by Subject|0|||
124865216|NCT00802074|449127027|FG004|Overall Study|Withdrawal by Subject|0|||
124865217|NCT00802074|449127028|FG005|Overall Study|Withdrawal by Subject|0|||
124865218|NCT02298192|449127031|FG000|Overall Study|Unclassified|3|||
124865219|NCT02298192|449127032|FG001|Overall Study|Unclassified|2|||
124865220|NCT02298192|449127031|FG000|Overall Study|Withdrawal criteria|2|||
124865221|NCT02298192|449127032|FG001|Overall Study|Withdrawal criteria|0|||
124865222|NCT02298192|449127031|FG000|Overall Study|Withdrawal by Subject|6|||
124865223|NCT02298192|449127032|FG001|Overall Study|Withdrawal by Subject|1|||
124865224|NCT02298192|449127031|FG000|Overall Study|Lost to Follow-up|2|||
124865225|NCT02298192|449127032|FG001|Overall Study|Lost to Follow-up|1|||
124865226|NCT02298192|449127031|FG000|Overall Study|Adverse Event|6|||
124865227|NCT02298192|449127032|FG001|Overall Study|Adverse Event|2|||
124865228|NCT01371851|449127033|FG000|Overall Study|Lost to Follow-up|5|||
124865229|NCT01371851|449127034|FG001|Overall Study|Lost to Follow-up|8|||
124865230|NCT01371851|449127033|FG000|Overall Study|was arrested and put in jail|0|||
124865231|NCT01371851|449127034|FG001|Overall Study|was arrested and put in jail|1|||
124865232|NCT01371851|449127033|FG000|Overall Study|non study related adverse event|1|||
124865233|NCT01371851|449127034|FG001|Overall Study|non study related adverse event|0|||
124865234|NCT01371851|449127033|FG000|Overall Study|Blood Pressure outside study parameters|2|||
124865235|NCT01371851|449127034|FG001|Overall Study|Blood Pressure outside study parameters|0|||
124865236|NCT00833638|449127035|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
124865237|NCT00833638|449127036|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
124865238|NCT00833638|449127037|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
124865239|NCT00833638|449127035|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
124865240|NCT00833638|449127036|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
124865241|NCT00833638|449127037|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
124865242|NCT00833638|449127035|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
124865243|NCT00833638|449127036|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
124865244|NCT00833638|449127037|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
124865245|NCT00833638|449127035|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
124865246|NCT00833638|449127036|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
124865247|NCT00833638|449127037|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
124865248|NCT00833638|449127035|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
124865249|NCT00833638|449127036|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
124865250|NCT00833638|449127037|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
124865251|NCT00833638|449127035|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
124865252|NCT00833638|449127036|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
124865253|NCT00833638|449127037|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
124865254|NCT00833638|449127035|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
124865255|NCT00833638|449127036|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
124865256|NCT00833638|449127037|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
124865257|NCT00833638|449127035|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
124865258|NCT00833638|449127036|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
124865259|NCT00833638|449127037|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
124865260|NCT00833638|449127035|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
124865261|NCT00833638|449127036|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
124865262|NCT00833638|449127037|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
124865263|NCT01669122|449127038|FG000|Period I|Lost to Follow-up|1|||
124865264|NCT01669122|449127038|FG000|Washout Period II|Protocol Violation|2|||
124865265|NCT03543254|449127039|FG000|Overall Study|Lost to Follow-up|1|||
124865266|NCT01261338|449127040|FG000|Overall Study|Withdrawal by Subject|3|||
124865267|NCT01261338|449127041|FG001|Overall Study|Withdrawal by Subject|2|||
124865268|NCT00234065|449127042|FG000|Overall Study|Adverse Event|268|||
124865269|NCT00234065|449127043|FG001|Overall Study|Adverse Event|166|||
124865270|NCT00234065|449127042|FG000|Overall Study|Withdrawal by Subject|73|||
124865271|NCT00234065|449127043|FG001|Overall Study|Withdrawal by Subject|56|||
124865272|NCT00234065|449127042|FG000|Overall Study|Physician Decision|23|||
124865273|NCT00234065|449127043|FG001|Overall Study|Physician Decision|22|||
124865274|NCT00234065|449127042|FG000|Overall Study|Not Classified|111|||
124865275|NCT00234065|449127043|FG001|Overall Study|Not Classified|112|||
124865276|NCT05374421|449127044|FG000|Overall Study|Withdrawal by Subject|3|||
124865277|NCT05374421|449127045|FG001|Overall Study|Withdrawal by Subject|4|||
124865278|NCT05132699|449127046|FG000|Overall Study|Withdrawal by Subject|3|||
124865279|NCT05132699|449127047|FG001|Overall Study|Withdrawal by Subject|0|||
124865280|NCT02899728|449127048|FG000|Overall Study|Withdrawal by Subject|1|||
124865281|NCT02899728|449127049|FG001|Overall Study|Withdrawal by Subject|1|||
124865282|NCT05557942|449127050|FG000|Overall Study|Death|0|||
124865283|NCT05557942|449127051|FG001|Overall Study|Death|0|||
124865284|NCT05557942|449127052|FG002|Overall Study|Death|0|||
124865285|NCT05557942|449127053|FG003|Overall Study|Death|2|||
124865286|NCT05557942|449127054|FG004|Overall Study|Death|1|||
124865287|NCT05557942|449127055|FG005|Overall Study|Death|1|||
124865288|NCT05557942|449127050|FG000|Overall Study|Physician Decision|1|||
124865289|NCT05557942|449127051|FG001|Overall Study|Physician Decision|1|||
124865290|NCT05557942|449127052|FG002|Overall Study|Physician Decision|2|||
124865291|NCT05557942|449127053|FG003|Overall Study|Physician Decision|3|||
124865292|NCT05557942|449127054|FG004|Overall Study|Physician Decision|0|||
124865293|NCT05557942|449127055|FG005|Overall Study|Physician Decision|2|||
124865294|NCT05557942|449127050|FG000|Overall Study|Study terminated by sponsor|17|||
124865295|NCT05557942|449127051|FG001|Overall Study|Study terminated by sponsor|17|||
124865296|NCT05557942|449127052|FG002|Overall Study|Study terminated by sponsor|14|||
124865297|NCT05557942|449127053|FG003|Overall Study|Study terminated by sponsor|40|||
124865298|NCT05557942|449127054|FG004|Overall Study|Study terminated by sponsor|45|||
124865299|NCT05557942|449127055|FG005|Overall Study|Study terminated by sponsor|37|||
124865300|NCT05557942|449127050|FG000|Overall Study|Protocol Violation|0|||
124865301|NCT05557942|449127051|FG001|Overall Study|Protocol Violation|0|||
124865302|NCT05557942|449127052|FG002|Overall Study|Protocol Violation|0|||
124865303|NCT05557942|449127053|FG003|Overall Study|Protocol Violation|0|||
124865304|NCT05557942|449127054|FG004|Overall Study|Protocol Violation|0|||
124865305|NCT05557942|449127055|FG005|Overall Study|Protocol Violation|1|||
124865306|NCT05557942|449127050|FG000|Overall Study|Withdrawal by Subject|0|||
124865307|NCT05557942|449127051|FG001|Overall Study|Withdrawal by Subject|0|||
124865308|NCT05557942|449127052|FG002|Overall Study|Withdrawal by Subject|0|||
124865309|NCT05557942|449127053|FG003|Overall Study|Withdrawal by Subject|0|||
124865310|NCT05557942|449127054|FG004|Overall Study|Withdrawal by Subject|2|||
124865311|NCT05557942|449127055|FG005|Overall Study|Withdrawal by Subject|0|||
124865312|NCT02477618|449127056|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
124865313|NCT02477618|449127057|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
124865314|NCT02477618|449127056|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
124865315|NCT02477618|449127057|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
124865316|NCT02477618|449127056|FG000|Overall Study|Adverse Event|1|||
124865317|NCT02477618|449127057|FG001|Overall Study|Adverse Event|1|||
124865318|NCT02477618|449127056|FG000|Overall Study|Transferred Away from Study Site|1|||
124865319|NCT02477618|449127057|FG001|Overall Study|Transferred Away from Study Site|0|||
124865320|NCT02477618|449127056|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
124865321|NCT02477618|449127057|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
124865322|NCT05540522|449127061|FG000|Overall Study|Adverse Event|1|||
124865323|NCT05540522|449127062|FG001|Overall Study|Adverse Event|0|||
124865324|NCT05540522|449127063|FG002|Overall Study|Adverse Event|2|||
124865325|NCT05540522|449127064|FG003|Overall Study|Adverse Event|5|||
124865326|NCT05540522|449127061|FG000|Overall Study|Lost to Follow-up|487|||
124865327|NCT05540522|449127062|FG001|Overall Study|Lost to Follow-up|427|||
124865328|NCT05540522|449127063|FG002|Overall Study|Lost to Follow-up|146|||
124865329|NCT05540522|449127064|FG003|Overall Study|Lost to Follow-up|166|||
124865330|NCT05540522|449127061|FG000|Overall Study|Physician Decision|11|||
124865331|NCT05540522|449127062|FG001|Overall Study|Physician Decision|19|||
124865332|NCT05540522|449127063|FG002|Overall Study|Physician Decision|8|||
124865333|NCT05540522|449127064|FG003|Overall Study|Physician Decision|13|||
124865334|NCT05540522|449127061|FG000|Overall Study|Pregnancy|1|||
124865335|NCT05540522|449127062|FG001|Overall Study|Pregnancy|0|||
124865336|NCT05540522|449127063|FG002|Overall Study|Pregnancy|0|||
124865337|NCT05540522|449127064|FG003|Overall Study|Pregnancy|0|||
124865338|NCT05540522|449127061|FG000|Overall Study|Protocol Violation|3|||
124865339|NCT05540522|449127062|FG001|Overall Study|Protocol Violation|1|||
124865340|NCT05540522|449127063|FG002|Overall Study|Protocol Violation|9|||
124865341|NCT05540522|449127064|FG003|Overall Study|Protocol Violation|7|||
124865342|NCT05540522|449127061|FG000|Overall Study|Withdrawal by Subject|168|||
124865343|NCT05540522|449127062|FG001|Overall Study|Withdrawal by Subject|134|||
124865344|NCT05540522|449127063|FG002|Overall Study|Withdrawal by Subject|331|||
124865345|NCT05540522|449127064|FG003|Overall Study|Withdrawal by Subject|322|||
124865346|NCT05540522|449127061|FG000|Overall Study|Death|7|||
124865347|NCT05540522|449127062|FG001|Overall Study|Death|9|||
124865348|NCT05540522|449127063|FG002|Overall Study|Death|49|||
124865349|NCT05540522|449127064|FG003|Overall Study|Death|46|||
124865350|NCT05540522|449127061|FG000|Overall Study|Not vaccinated|34|||
124865351|NCT05540522|449127062|FG001|Overall Study|Not vaccinated|53|||
124865352|NCT05540522|449127063|FG002|Overall Study|Not vaccinated|57|||
124865353|NCT05540522|449127064|FG003|Overall Study|Not vaccinated|50|||
124865354|NCT05540522|449127061|FG000|Overall Study|No longer meets eligibility criteria|0|||
124865355|NCT05540522|449127062|FG001|Overall Study|No longer meets eligibility criteria|0|||
124865356|NCT05540522|449127063|FG002|Overall Study|No longer meets eligibility criteria|3|||
124865357|NCT05540522|449127064|FG003|Overall Study|No longer meets eligibility criteria|2|||
124865358|NCT05540522|449127061|FG000|Overall Study|Other (Unspecified)|8|||
124865359|NCT05540522|449127062|FG001|Overall Study|Other (Unspecified)|10|||
124865360|NCT05540522|449127063|FG002|Overall Study|Other (Unspecified)|4|||
124865361|NCT05540522|449127064|FG003|Overall Study|Other (Unspecified)|2|||
124865362|NCT03754803|449127065|FG000|Overall Study|Withdrawal by Subject|2|||
124865363|NCT05239039|449127066|FG000|Overall Study|Withdrawal by Subject|0|||
124865364|NCT05239039|449127067|FG001|Overall Study|Withdrawal by Subject|1|||
124976622|NCT02614183|449540017|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
124976623|NCT02614183|449540015|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
124976624|NCT02614183|449540016|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
124976625|NCT02614183|449540017|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
124976626|NCT02614183|449540015|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
124976627|NCT02614183|449540016|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
124976628|NCT02614183|449540017|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
124976629|NCT02614183|449540015|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
124976630|NCT02614183|449540016|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
124976631|NCT02614183|449540017|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
125309251|NCT03197376|450758167|FG001|Primary and Booster Phase|Adverse Event|0|||
125309252|NCT03197376|450758168|FG002|Primary and Booster Phase|Adverse Event|0|||
125309253|NCT03197376|450758169|FG003|Primary and Booster Phase|Adverse Event|1|||
125309254|NCT03197376|450758166|FG000|Primary and Booster Phase|Death|1|||
125309255|NCT03197376|450758167|FG001|Primary and Booster Phase|Death|0|||
125309256|NCT03197376|450758168|FG002|Primary and Booster Phase|Death|0|||
125309257|NCT03197376|450758169|FG003|Primary and Booster Phase|Death|2|||
125309258|NCT03197376|450758166|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
125309259|NCT03197376|450758167|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
125309260|NCT03197376|450758168|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
125309261|NCT03197376|450758169|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
125309262|NCT03197376|450758166|FG000|Primary and Booster Phase|Physician Decision|1|||
125309263|NCT03197376|450758167|FG001|Primary and Booster Phase|Physician Decision|0|||
125309264|NCT03197376|450758168|FG002|Primary and Booster Phase|Physician Decision|1|||
125309265|NCT03197376|450758169|FG003|Primary and Booster Phase|Physician Decision|3|||
125309266|NCT03197376|450758166|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
125309267|NCT03197376|450758167|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
125309268|NCT03197376|450758168|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
125309269|NCT03197376|450758169|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
125309270|NCT03197376|450758166|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
125309271|NCT03197376|450758167|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
125309272|NCT03197376|450758168|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
125309273|NCT03197376|450758169|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
125309274|NCT03197376|450758166|FG000|Primary and Booster Phase|Not vaccine related|1|||
125309275|NCT03197376|450758167|FG001|Primary and Booster Phase|Not vaccine related|2|||
125309276|NCT03197376|450758168|FG002|Primary and Booster Phase|Not vaccine related|0|||
125309277|NCT03197376|450758169|FG003|Primary and Booster Phase|Not vaccine related|6|||
125309278|NCT03197376|450758166|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
125309279|NCT03197376|450758167|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
125309280|NCT03197376|450758168|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
125309281|NCT03197376|450758169|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
125309282|NCT03197376|450758166|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
125309283|NCT03197376|450758167|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
125309284|NCT03197376|450758168|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
125309285|NCT03197376|450758169|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
125309286|NCT03197376|450758166|FG000|Immune Persistence Phase|Not vaccine related|1|||
125309287|NCT03197376|450758167|FG001|Immune Persistence Phase|Not vaccine related|0|||
125309288|NCT03197376|450758168|FG002|Immune Persistence Phase|Not vaccine related|1|||
125309289|NCT03197376|450758169|FG003|Immune Persistence Phase|Not vaccine related|1|||
125309290|NCT00003199|450758170|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
125309291|NCT00003199|450758170|FG000|Overall Study|Lack of insurance clearance|2|||
125309292|NCT00003199|450758170|FG000|Overall Study|Screen fail|15|||
125309293|NCT01223183|450758172|FG000|Imaging Day 1|Physician Decision|0|||
125309294|NCT01223183|450758173|FG001|Imaging Day 1|Physician Decision|1|||
125309295|NCT01223183|450758172|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
125309296|NCT01223183|450758173|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
125309297|NCT01223183|450758172|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
125309298|NCT01223183|450758173|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
125309299|NCT03777059|450760015|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
125309300|NCT03777059|450760016|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
125309301|NCT03777059|450760017|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
125309302|NCT03777059|450760018|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
125309303|NCT03777059|450760015|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
125309304|NCT03777059|450760016|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
125309305|NCT03777059|450760017|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
125309306|NCT03777059|450760018|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
125309307|NCT03777059|450760015|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
125309308|NCT03777059|450760016|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
125309309|NCT03777059|450760017|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
125309310|NCT03777059|450760018|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
125309311|NCT03777059|450760015|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
125309312|NCT03777059|450760016|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
125309313|NCT03777059|450760017|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
125309314|NCT03777059|450760018|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
125309315|NCT03777059|450760015|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
125309316|NCT03777059|450760016|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
125309317|NCT03777059|450760017|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
125309318|NCT03777059|450760018|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
125309319|NCT03777059|450760015|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
125309320|NCT03777059|450760016|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
125309321|NCT03777059|450760017|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
125309322|NCT03777059|450760018|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
125309323|NCT03777059|450760015|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
125309324|NCT03777059|450760016|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
125309325|NCT03777059|450760017|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
125309326|NCT03777059|450760018|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
125309327|NCT03777059|450760015|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
125309328|NCT03777059|450760016|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
125309329|NCT03777059|450760017|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
125309330|NCT03777059|450760018|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
125309331|NCT03777059|450760015|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
125309332|NCT03777059|450760016|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
125309333|NCT03777059|450760017|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
125309334|NCT03777059|450760018|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
125309335|NCT03777059|450760015|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
125309336|NCT03777059|450760016|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
125309337|NCT03777059|450760017|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
125309338|NCT03777059|450760018|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
125309339|NCT03777059|450760015|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
125309340|NCT03777059|450760016|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
125309341|NCT03777059|450760017|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
125309342|NCT03777059|450760018|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
125309343|NCT02813889|450760019|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
125309344|NCT02813889|450760020|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
125309345|NCT01101035|450760027|FG000|Overall Study|Adverse Event|191|||
125309346|NCT01101035|450760028|FG001|Overall Study|Adverse Event|172|||
125309347|NCT01101035|450760027|FG000|Overall Study|Major Protocol Deviation|52|||
125309348|NCT01101035|450760028|FG001|Overall Study|Major Protocol Deviation|46|||
125309349|NCT01101035|450760027|FG000|Overall Study|Lost to Follow-up|226|||
125309350|NCT01101035|450760028|FG001|Overall Study|Lost to Follow-up|223|||
125309351|NCT01101035|450760027|FG000|Overall Study|Voluntary Withdrawal|595|||
125309352|NCT01101035|450760028|FG001|Overall Study|Voluntary Withdrawal|587|||
125309353|NCT01101035|450760027|FG000|Overall Study|Reason not Specified|333|||
125309354|NCT01101035|450760028|FG001|Overall Study|Reason not Specified|363|||
125309355|NCT00681629|450760029|FG000|Overall Study|Study termination|4|||
125309356|NCT00681629|450760030|FG001|Overall Study|Study termination|2|||
125309357|NCT00681629|450760029|FG000|Overall Study|Adverse Event|1|||
125309358|NCT00681629|450760030|FG001|Overall Study|Adverse Event|0|||
125309359|NCT00411671|450760031|FG000|Overall Study|Adverse Event|15|||
125309360|NCT00411671|450760031|FG000|Overall Study|Death|2|||
125309361|NCT00411671|450760031|FG000|Overall Study|Lost to Follow-up|3|||
125309362|NCT01173601|450760035|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
125309363|NCT01173601|450760036|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
125309364|NCT01173601|450760037|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
125309365|NCT01173601|450760038|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
125309366|NCT01173601|450760039|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
125309367|NCT01173601|450760035|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
125309368|NCT01173601|450760036|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
125309369|NCT01173601|450760037|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
125309370|NCT01173601|450760038|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
125309371|NCT01173601|450760039|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
125309372|NCT01173601|450760035|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
125309373|NCT01173601|450760036|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
125309374|NCT01173601|450760037|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
125309375|NCT01173601|450760038|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
125309376|NCT01173601|450760039|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
125309377|NCT01173601|450760035|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
125309378|NCT01173601|450760036|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
125309379|NCT01173601|450760037|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
125309380|NCT01173601|450760038|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
125309381|NCT01173601|450760039|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
125309382|NCT01173601|450760035|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
125309383|NCT01173601|450760036|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
125309384|NCT01173601|450760037|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
125309385|NCT01173601|450760038|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
125309386|NCT01173601|450760039|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
125309387|NCT01173601|450760035|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
125309388|NCT01173601|450760036|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
125309389|NCT01173601|450760037|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
125309390|NCT01173601|450760038|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
125309391|NCT01173601|450760039|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
125309392|NCT01173601|450760035|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
125309393|NCT01173601|450760036|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
125309394|NCT01173601|450760037|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
125309395|NCT01173601|450760038|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
125309396|NCT01173601|450760039|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
125309397|NCT01173601|450760035|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
125309398|NCT01173601|450760036|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
125309399|NCT01173601|450760037|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
125309400|NCT01173601|450760038|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
125309401|NCT01173601|450760039|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
125309402|NCT01173601|450760035|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
125309403|NCT01173601|450760036|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
125309404|NCT01173601|450760037|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
125309405|NCT01173601|450760038|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
125309406|NCT01173601|450760039|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
125309407|NCT01173601|450760035|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
125309408|NCT01173601|450760036|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
125309409|NCT01173601|450760037|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
125309410|NCT01173601|450760038|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
125309411|NCT01173601|450760039|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
125309412|NCT01173601|450760035|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
125309413|NCT01173601|450760036|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
125309414|NCT01173601|450760037|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
125309415|NCT01173601|450760038|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
125309416|NCT01173601|450760039|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
125309417|NCT01173601|450760035|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
125309418|NCT01173601|450760036|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
125309419|NCT01173601|450760037|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
125309420|NCT01173601|450760038|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
125309421|NCT01173601|450760039|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
125309422|NCT01173601|450760035|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
125309423|NCT01173601|450760036|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
125309424|NCT01173601|450760037|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
125309425|NCT01173601|450760038|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
125309426|NCT01173601|450760039|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
125309427|NCT01173601|450760035|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
125309428|NCT01173601|450760036|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
125309429|NCT01173601|450760037|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
125309430|NCT01173601|450760038|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
125309431|NCT01173601|450760039|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
125309432|NCT03951077|450760040|FG000|Overall Study|Adverse Event|1|||
125309433|NCT03951077|450760041|FG001|Overall Study|Adverse Event|0|||
125309434|NCT03951077|450760042|FG002|Overall Study|Adverse Event|0|||
125309435|NCT03951077|450760043|FG003|Overall Study|Adverse Event|0|||
125309436|NCT03951077|450760044|FG004|Overall Study|Adverse Event|0|||
125309437|NCT03951077|450760045|FG005|Overall Study|Adverse Event|0|||
125309438|NCT03951077|450760040|FG000|Overall Study|Withdrawal by Subject|3|||
125309439|NCT03951077|450760041|FG001|Overall Study|Withdrawal by Subject|3|||
125309440|NCT03951077|450760042|FG002|Overall Study|Withdrawal by Subject|0|||
125309441|NCT03951077|450760043|FG003|Overall Study|Withdrawal by Subject|3|||
125309442|NCT03951077|450760044|FG004|Overall Study|Withdrawal by Subject|3|||
125309443|NCT03951077|450760045|FG005|Overall Study|Withdrawal by Subject|2|||
125309444|NCT03951077|450760040|FG000|Overall Study|Lost to Follow-up|1|||
125309445|NCT03951077|450760041|FG001|Overall Study|Lost to Follow-up|1|||
125309446|NCT03951077|450760042|FG002|Overall Study|Lost to Follow-up|2|||
125309447|NCT03951077|450760043|FG003|Overall Study|Lost to Follow-up|3|||
125309448|NCT03951077|450760044|FG004|Overall Study|Lost to Follow-up|2|||
125309449|NCT03951077|450760045|FG005|Overall Study|Lost to Follow-up|3|||
125309450|NCT03951077|450760040|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
125309451|NCT03951077|450760041|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
125309452|NCT03951077|450760042|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
125309453|NCT03951077|450760043|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
125309454|NCT03951077|450760044|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
125309455|NCT03951077|450760045|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
125309456|NCT03951077|450760040|FG000|Overall Study|Other, Not Specified|12|||
125309457|NCT03951077|450760041|FG001|Overall Study|Other, Not Specified|10|||
125309458|NCT03951077|450760042|FG002|Overall Study|Other, Not Specified|10|||
125309459|NCT03951077|450760043|FG003|Overall Study|Other, Not Specified|5|||
125309460|NCT03951077|450760044|FG004|Overall Study|Other, Not Specified|9|||
125309461|NCT03951077|450760045|FG005|Overall Study|Other, Not Specified|6|||
125309462|NCT03951077|450760040|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
125309463|NCT03951077|450760041|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
125309464|NCT03951077|450760042|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
125309465|NCT03951077|450760043|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
125309466|NCT03951077|450760044|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
125309467|NCT03951077|450760045|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
125309468|NCT01395901|450760048|FG000|Overall Study|Lost to Follow-up|4|||
125309469|NCT01395901|450760049|FG001|Overall Study|Lost to Follow-up|0|||
125309470|NCT01395901|450760048|FG000|Overall Study|Randomized but not received study drug|5|||
125309471|NCT01395901|450760049|FG001|Overall Study|Randomized but not received study drug|4|||
125309472|NCT01395901|450760048|FG000|Overall Study|Adverse Event|0|||
125309473|NCT01395901|450760049|FG001|Overall Study|Adverse Event|1|||
125309474|NCT01395901|450760048|FG000|Overall Study|Withdrawal of consent|1|||
125309475|NCT01395901|450760049|FG001|Overall Study|Withdrawal of consent|0|||
125309476|NCT00713544|450760055|FG000|Overall Study|Adverse Event|5|||
125309477|NCT00713544|450760056|FG001|Overall Study|Adverse Event|3|||
125309478|NCT00713544|450760057|FG002|Overall Study|Adverse Event|7|||
125309479|NCT00713544|450760058|FG003|Overall Study|Adverse Event|7|||
125309480|NCT00713544|450760059|FG004|Overall Study|Adverse Event|3|||
125309481|NCT00713544|450760060|FG005|Overall Study|Adverse Event|5|||
125309482|NCT00713544|450760055|FG000|Overall Study|Withdrawal by Subject|2|||
125309483|NCT00713544|450760056|FG001|Overall Study|Withdrawal by Subject|0|||
125309484|NCT00713544|450760057|FG002|Overall Study|Withdrawal by Subject|3|||
125309485|NCT00713544|450760058|FG003|Overall Study|Withdrawal by Subject|2|||
125309486|NCT00713544|450760059|FG004|Overall Study|Withdrawal by Subject|3|||
125309487|NCT00713544|450760060|FG005|Overall Study|Withdrawal by Subject|1|||
125309488|NCT00713544|450760055|FG000|Overall Study|Protocol Violation|0|||
125309489|NCT00713544|450760056|FG001|Overall Study|Protocol Violation|0|||
125309490|NCT00713544|450760057|FG002|Overall Study|Protocol Violation|0|||
125309491|NCT00713544|450760058|FG003|Overall Study|Protocol Violation|0|||
125309492|NCT00713544|450760059|FG004|Overall Study|Protocol Violation|0|||
125309493|NCT00713544|450760060|FG005|Overall Study|Protocol Violation|1|||
125309494|NCT00713544|450760055|FG000|Overall Study|Physician Decision|0|||
125309495|NCT00713544|450760056|FG001|Overall Study|Physician Decision|0|||
125309496|NCT00713544|450760057|FG002|Overall Study|Physician Decision|0|||
125309497|NCT00713544|450760058|FG003|Overall Study|Physician Decision|0|||
125309498|NCT00713544|450760059|FG004|Overall Study|Physician Decision|0|||
125309499|NCT00713544|450760060|FG005|Overall Study|Physician Decision|2|||
125309500|NCT00713544|450760055|FG000|Overall Study|Lack of Efficacy|0|||
125309501|NCT00713544|450760056|FG001|Overall Study|Lack of Efficacy|1|||
125309502|NCT00713544|450760057|FG002|Overall Study|Lack of Efficacy|0|||
125309503|NCT00713544|450760058|FG003|Overall Study|Lack of Efficacy|1|||
125309504|NCT00713544|450760059|FG004|Overall Study|Lack of Efficacy|1|||
125309505|NCT00713544|450760060|FG005|Overall Study|Lack of Efficacy|0|||
125309506|NCT00713544|450760055|FG000|Overall Study|Lost to Follow-up|0|||
125309507|NCT00713544|450760056|FG001|Overall Study|Lost to Follow-up|0|||
125309508|NCT00713544|450760057|FG002|Overall Study|Lost to Follow-up|1|||
125309509|NCT00713544|450760058|FG003|Overall Study|Lost to Follow-up|0|||
125309510|NCT00713544|450760059|FG004|Overall Study|Lost to Follow-up|0|||
125309511|NCT00713544|450760060|FG005|Overall Study|Lost to Follow-up|0|||
125309512|NCT00713544|450760055|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
125309513|NCT00713544|450760056|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
125309514|NCT00713544|450760057|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
125309515|NCT00713544|450760058|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
125309516|NCT00713544|450760059|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
125309517|NCT00713544|450760060|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
125309518|NCT00713544|450760055|FG000|Overall Study|Incorrect enrollment|0|||
125309519|NCT00713544|450760056|FG001|Overall Study|Incorrect enrollment|1|||
125309520|NCT00713544|450760057|FG002|Overall Study|Incorrect enrollment|0|||
125309521|NCT00713544|450760058|FG003|Overall Study|Incorrect enrollment|0|||
125309522|NCT00713544|450760059|FG004|Overall Study|Incorrect enrollment|0|||
125309523|NCT00713544|450760060|FG005|Overall Study|Incorrect enrollment|0|||
125309524|NCT00713544|450760055|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
125309525|NCT00713544|450760056|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
125309526|NCT00713544|450760057|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
125309527|NCT00713544|450760058|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
125309528|NCT00713544|450760059|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
125309529|NCT00713544|450760060|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
125309530|NCT02380287|450760061|FG000|Overall Study|Adverse Event|0|||
125309531|NCT02380287|450760062|FG001|Overall Study|Adverse Event|0|||
125309532|NCT02380287|450760063|FG002|Overall Study|Adverse Event|1|||
125309533|NCT02380287|450760064|FG003|Overall Study|Adverse Event|0|||
125309534|NCT02380287|450760065|FG004|Overall Study|Adverse Event|0|||
125309535|NCT02380287|450760066|FG005|Overall Study|Adverse Event|0|||
125309536|NCT02380287|450760067|FG006|Overall Study|Adverse Event|0|||
125309537|NCT02380287|450760068|FG007|Overall Study|Adverse Event|0|||
125309538|NCT01641601|450760069|FG000|Overall Study|Study discontinued.|3|||
125309539|NCT01641601|450760070|FG001|Overall Study|Study discontinued.|5|||
125309540|NCT00950846|450760074|FG000|Overall Study|Death|6|||
125309541|NCT00950846|450760074|FG000|Overall Study|Lost to Follow-up|3|||
125309542|NCT00950846|450760074|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
125309543|NCT02178995|450760075|FG000|Double Blind|Adverse Event|0|||
125309544|NCT02178995|450760076|FG001|Double Blind|Adverse Event|0|||
125309545|NCT02178995|450760077|FG002|Double Blind|Adverse Event|0|||
125309546|NCT02178995|450760078|FG003|Double Blind|Adverse Event|0|||
125309547|NCT02178995|450760079|FG004|Double Blind|Adverse Event|0|||
125309548|NCT02178995|450760080|FG005|Double Blind|Adverse Event|1|||
125309549|NCT02178995|450760081|FG006|Double Blind|Adverse Event|0|||
125309550|NCT02178995|450760082|FG007|Double Blind|Adverse Event|1|||
125309551|NCT02178995|450760083|FG008|Double Blind|Adverse Event|1|||
125309552|NCT02178995|450760075|FG000|Double Blind|Lost to Follow-up|0|||
125309553|NCT02178995|450760076|FG001|Double Blind|Lost to Follow-up|1|||
125309554|NCT02178995|450760077|FG002|Double Blind|Lost to Follow-up|0|||
125309555|NCT02178995|450760078|FG003|Double Blind|Lost to Follow-up|0|||
125309556|NCT02178995|450760079|FG004|Double Blind|Lost to Follow-up|0|||
125309557|NCT02178995|450760080|FG005|Double Blind|Lost to Follow-up|0|||
125309558|NCT02178995|450760081|FG006|Double Blind|Lost to Follow-up|0|||
125309559|NCT02178995|450760082|FG007|Double Blind|Lost to Follow-up|1|||
125309560|NCT02178995|450760083|FG008|Double Blind|Lost to Follow-up|0|||
125309561|NCT02178995|450760075|FG000|Open Label|Adverse Event|2|||
125309562|NCT02178995|450760076|FG001|Open Label|Adverse Event|0|||
125309563|NCT02178995|450760077|FG002|Open Label|Adverse Event|0|||
125309564|NCT02178995|450760078|FG003|Open Label|Adverse Event|0|||
125309565|NCT02178995|450760079|FG004|Open Label|Adverse Event|0|||
125309566|NCT02178995|450760080|FG005|Open Label|Adverse Event|0|||
125309567|NCT02178995|450760081|FG006|Open Label|Adverse Event|0|||
125309568|NCT02178995|450760082|FG007|Open Label|Adverse Event|0|||
125309569|NCT02178995|450760083|FG008|Open Label|Adverse Event|0|||
125309570|NCT00587158|450760084|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
125309571|NCT00587158|450760085|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
125309572|NCT00587158|450760084|FG000|Overall Study|Physician Decision|0|||
125309573|NCT00587158|450760085|FG001|Overall Study|Physician Decision|1|||
125309574|NCT00587158|450760084|FG000|Overall Study|Lost to Follow-up|1|||
125309575|NCT00587158|450760085|FG001|Overall Study|Lost to Follow-up|2|||
125309576|NCT00587158|450760084|FG000|Overall Study|Death|0|||
125309577|NCT00587158|450760085|FG001|Overall Study|Death|1|||
125309578|NCT00587158|450760084|FG000|Overall Study|Subject did not want to take study med|0|||
125309579|NCT00587158|450760085|FG001|Overall Study|Subject did not want to take study med|1|||
125309580|NCT05258149|450760086|FG000|Period 1|Protocol Deviation|1|||
125309581|NCT05258149|450760087|FG001|Period 1|Protocol Deviation|0|||
125309582|NCT05258149|450760086|FG000|Period 1|Adverse Event|0|||
125309583|NCT05258149|450760087|FG001|Period 1|Adverse Event|1|||
125309584|NCT05258149|450760086|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
125309585|NCT05258149|450760087|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
125309586|NCT05258149|450760086|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
125309587|NCT05258149|450760087|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
125309588|NCT05258149|450760086|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
125309589|NCT05258149|450760087|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
125309590|NCT00832416|450760088|FG000|Overall Study|Lack of Efficacy|17|||
125309591|NCT00832416|450760089|FG001|Overall Study|Lack of Efficacy|15|||
125309592|NCT00832416|450760090|FG002|Overall Study|Lack of Efficacy|13|||
125309593|NCT00832416|450760091|FG003|Overall Study|Lack of Efficacy|52|||
125309594|NCT00832416|450760088|FG000|Overall Study|Withdrawal by Subject|5|||
125309595|NCT00832416|450760089|FG001|Overall Study|Withdrawal by Subject|7|||
125309596|NCT00832416|450760090|FG002|Overall Study|Withdrawal by Subject|2|||
125309597|NCT00832416|450760091|FG003|Overall Study|Withdrawal by Subject|10|||
125309598|NCT00832416|450760088|FG000|Overall Study|Physician Decision|2|||
125309599|NCT00832416|450760089|FG001|Overall Study|Physician Decision|12|||
125309600|NCT00832416|450760090|FG002|Overall Study|Physician Decision|5|||
125309601|NCT00832416|450760091|FG003|Overall Study|Physician Decision|10|||
125309602|NCT00832416|450760088|FG000|Overall Study|Administrative|0|||
125309603|NCT00832416|450760089|FG001|Overall Study|Administrative|0|||
125309604|NCT00832416|450760090|FG002|Overall Study|Administrative|0|||
125309605|NCT00832416|450760091|FG003|Overall Study|Administrative|1|||
125309606|NCT00832416|450760088|FG000|Overall Study|Adverse Event|21|||
125309607|NCT00832416|450760089|FG001|Overall Study|Adverse Event|19|||
125309608|NCT00832416|450760090|FG002|Overall Study|Adverse Event|41|||
125309609|NCT00832416|450760091|FG003|Overall Study|Adverse Event|10|||
125309610|NCT00832416|450760088|FG000|Overall Study|Death|1|||
125309611|NCT00832416|450760089|FG001|Overall Study|Death|0|||
125309612|NCT00832416|450760090|FG002|Overall Study|Death|0|||
125309613|NCT00832416|450760091|FG003|Overall Study|Death|0|||
125309614|NCT02114606|450760092|FG000|Overall Study|Unable to swallow Cytosponge|6|||
125309615|NCT00981461|450760093|FG000|Overall Study|Lost to Follow-up|5|||
125309616|NCT00981461|450760094|FG001|Overall Study|Lost to Follow-up|2|||
125309617|NCT01910402|450760105|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
125309618|NCT01910402|450760106|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
125309619|NCT01910402|450760107|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
125309620|NCT01910402|450760105|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
125309621|NCT01910402|450760106|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
125309622|NCT01910402|450760107|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
125309623|NCT01910402|450760105|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
125309624|NCT01910402|450760106|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
125309625|NCT01910402|450760107|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
125309626|NCT01910402|450760105|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
125309627|NCT01910402|450760106|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
125309628|NCT01910402|450760107|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
125309629|NCT01910402|450760105|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
125309630|NCT01910402|450760106|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
125309631|NCT01910402|450760107|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
125309632|NCT01910402|450760105|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
125309633|NCT01910402|450760106|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
125309634|NCT01910402|450760107|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
125309635|NCT01910402|450760105|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
125309636|NCT01910402|450760106|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
125309637|NCT01910402|450760107|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
125309638|NCT01910402|450760105|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
125309639|NCT01910402|450760106|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
125309640|NCT01910402|450760107|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
125309641|NCT01910402|450760105|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
125309642|NCT01910402|450760106|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
125309643|NCT01910402|450760107|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
125309644|NCT01910402|450760105|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
125309645|NCT01910402|450760106|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
125309646|NCT01910402|450760107|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
125309647|NCT01910402|450760105|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
125309648|NCT01910402|450760106|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
125309649|NCT01910402|450760107|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
125309650|NCT01910402|450760105|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
125309651|NCT01910402|450760106|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
125309652|NCT01910402|450760107|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
125309653|NCT01910402|450760105|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
125309654|NCT01910402|450760106|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
125309655|NCT01910402|450760107|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
125309656|NCT00483405|450760108|FG000|Overall Study|Adverse Event|8|||
125309657|NCT00483405|450760108|FG000|Overall Study|Lack of Efficacy|14|||
125309658|NCT00483405|450760108|FG000|Overall Study|Death|3|||
125309659|NCT00483405|450760108|FG000|Overall Study|Withdrawal by Subject|2|||
125309660|NCT00483405|450760108|FG000|Overall Study|Other complicating disease|1|||
125309661|NCT00571038|450760109|FG000|Overall Study|Lost to Follow-up|1|||
125309662|NCT00571038|450760110|FG001|Overall Study|Lost to Follow-up|4|||
125309663|NCT00571038|450760109|FG000|Overall Study|Death|7|||
125309664|NCT00571038|450760110|FG001|Overall Study|Death|5|||
125309665|NCT00571038|450760109|FG000|Overall Study|Withdrawal by Subject|1|||
125309666|NCT00571038|450760110|FG001|Overall Study|Withdrawal by Subject|3|||
125309667|NCT00571038|450760109|FG000|Overall Study|Moved out of state|2|||
125309668|NCT00571038|450760110|FG001|Overall Study|Moved out of state|2|||
125309669|NCT01442714|450760111|FG000|Overall Study|Death|11|||
125309670|NCT01442714|450760111|FG000|Overall Study|Withdrawal by Subject|1|||
125309671|NCT04306510|450760112|FG000|Overall Study|Voluntarily withdrawal|1|||
125309672|NCT04306510|450760112|FG000|Overall Study|Enrolled but Not Treated|1|||
125309673|NCT04829916|450760119|FG000|Overall Study|Withdrawal by Subject|1|||
125309674|NCT04829916|450760120|FG001|Overall Study|Withdrawal by Subject|0|||
125309675|NCT04343755|450760121|FG000|Overall Study|Death|11|||
125309676|NCT04343755|450760121|FG000|Overall Study|Screen Failure|1|||
125309677|NCT00193206|450760122|FG000|Preoperative Therapy|Lack of Efficacy|2|||
125309678|NCT00193206|450760122|FG000|Preoperative Therapy|Adverse Event|2|||
125309679|NCT00193206|450760122|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
125309680|NCT00193206|450760122|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
125309681|NCT00193206|450760122|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
125309682|NCT00193206|450760122|FG000|Postoperative Therapy|Physician Decision|3|||
125309683|NCT00193206|450760122|FG000|Postoperative Therapy|Intercurrent Illness|2|||
125309684|NCT00193206|450760122|FG000|Postoperative Therapy|Lack of Efficacy|1|||
125309685|NCT00193206|450760122|FG000|Postoperative Therapy|Protocol Violation|1|||
125309686|NCT02940496|450760123|FG000|Overall Study|Adverse Event|1|||
125309687|NCT02940496|450760124|FG001|Overall Study|Adverse Event|0|||
125309688|NCT02940496|450760123|FG000|Overall Study|Death|2|||
125309689|NCT02940496|450760124|FG001|Overall Study|Death|0|||
125309690|NCT02940496|450760123|FG000|Overall Study|Hospice Care|1|||
125309691|NCT02940496|450760124|FG001|Overall Study|Hospice Care|0|||
125309692|NCT02940496|450760123|FG000|Overall Study|No MRE Done|1|||
125309693|NCT02940496|450760124|FG001|Overall Study|No MRE Done|0|||
125309694|NCT02940496|450760123|FG000|Overall Study|MRE Failure|1|||
125309695|NCT02940496|450760124|FG001|Overall Study|MRE Failure|0|||
125309696|NCT01147055|450760132|FG000|First Intervention Period|Lost to Follow-up|1|||
125309697|NCT01147055|450760133|FG001|First Intervention Period|Lost to Follow-up|0|||
125309698|NCT00132808|450760134|FG000|Stratum I|Adverse Event|2|||
125309699|NCT00132808|450760135|FG001|Stratum I|Adverse Event|1|||
125309700|NCT00132808|450760136|FG002|Stratum I|Adverse Event|0|||
125309701|NCT00132808|450760134|FG000|Stratum I|Lost to Follow-up|3|||
125309702|NCT00132808|450760135|FG001|Stratum I|Lost to Follow-up|4|||
125309703|NCT00132808|450760136|FG002|Stratum I|Lost to Follow-up|1|||
125309704|NCT00132808|450760134|FG000|Stratum I|Withdrawal by Subject|4|||
125309705|NCT00132808|450760135|FG001|Stratum I|Withdrawal by Subject|7|||
125309706|NCT00132808|450760136|FG002|Stratum I|Withdrawal by Subject|3|||
125309707|NCT00132808|450760134|FG000|Stratum I|Abnormal test procedure result (s)|0|||
125309708|NCT00132808|450760135|FG001|Stratum I|Abnormal test procedure result (s)|0|||
125309709|NCT00132808|450760136|FG002|Stratum I|Abnormal test procedure result (s)|1|||
125309710|NCT00132808|450760134|FG000|Stratum II|Adverse Event|1|||
125309711|NCT00132808|450760135|FG001|Stratum II|Adverse Event|2|||
125309712|NCT00132808|450760136|FG002|Stratum II|Adverse Event|1|||
125309713|NCT00132808|450760134|FG000|Stratum II|Death|1|||
125309714|NCT00132808|450760135|FG001|Stratum II|Death|0|||
125309715|NCT00132808|450760136|FG002|Stratum II|Death|0|||
125309716|NCT00132808|450760134|FG000|Stratum II|Lost to Follow-up|2|||
125309717|NCT00132808|450760135|FG001|Stratum II|Lost to Follow-up|2|||
125309718|NCT00132808|450760136|FG002|Stratum II|Lost to Follow-up|1|||
125309719|NCT00132808|450760134|FG000|Stratum II|Protocol Violation|0|||
125309720|NCT00132808|450760135|FG001|Stratum II|Protocol Violation|2|||
125309721|NCT00132808|450760136|FG002|Stratum II|Protocol Violation|1|||
125309722|NCT00132808|450760134|FG000|Stratum II|Withdrawal by Subject|4|||
125309723|NCT00132808|450760135|FG001|Stratum II|Withdrawal by Subject|9|||
125309724|NCT00132808|450760136|FG002|Stratum II|Withdrawal by Subject|6|||
125309725|NCT02204072|450760143|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
125309726|NCT02204072|450760144|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
125309727|NCT02204072|450760145|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
125309728|NCT02204072|450760146|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
125309729|NCT02204072|450760147|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
125309730|NCT02204072|450760143|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
125309731|NCT02204072|450760144|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
125309732|NCT02204072|450760145|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
125309733|NCT02204072|450760146|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
125309734|NCT02204072|450760147|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
125309735|NCT02204072|450760143|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
125309736|NCT02204072|450760144|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
125309737|NCT02204072|450760145|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
125309738|NCT02204072|450760146|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
125309739|NCT02204072|450760147|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
125309740|NCT02204072|450760143|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
125309741|NCT02204072|450760144|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
125309742|NCT02204072|450760145|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
125309743|NCT02204072|450760146|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
125309744|NCT02204072|450760147|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
125309745|NCT00874848|450760154|FG000|Overall Study|Adverse Event|13|||
125309746|NCT00874848|450760155|FG001|Overall Study|Adverse Event|2|||
125309747|NCT00874848|450760154|FG000|Overall Study|Progressive neoplastic disease|38|||
125309748|NCT00874848|450760155|FG001|Overall Study|Progressive neoplastic disease|18|||
125309749|NCT00874848|450760154|FG000|Overall Study|Withdrawal by Subject|7|||
125309750|NCT00874848|450760155|FG001|Overall Study|Withdrawal by Subject|4|||
125309751|NCT00874848|450760154|FG000|Overall Study|Noncompliance|1|||
125309752|NCT00874848|450760155|FG001|Overall Study|Noncompliance|1|||
125309753|NCT00874848|450760154|FG000|Overall Study|Failure to comply with protocol|0|||
125309754|NCT00874848|450760155|FG001|Overall Study|Failure to comply with protocol|1|||
125309755|NCT00874848|450760154|FG000|Overall Study|Physician Decision|0|||
125309756|NCT00874848|450760155|FG001|Overall Study|Physician Decision|2|||
125309757|NCT01870726|450760160|FG000|Overall Study|Withdrawal of informed consent|0|||
125309758|NCT01870726|450760161|FG001|Overall Study|Withdrawal of informed consent|0|||
125309759|NCT01870726|450760162|FG002|Overall Study|Withdrawal of informed consent|0|||
125309760|NCT01870726|450760163|FG003|Overall Study|Withdrawal of informed consent|1|||
125309761|NCT01870726|450760164|FG004|Overall Study|Withdrawal of informed consent|0|||
125309762|NCT01870726|450760165|FG005|Overall Study|Withdrawal of informed consent|0|||
125309763|NCT01870726|450760166|FG006|Overall Study|Withdrawal of informed consent|0|||
125309764|NCT01870726|450760160|FG000|Overall Study|Withdrawal by Subject|0|||
125309765|NCT01870726|450760161|FG001|Overall Study|Withdrawal by Subject|1|||
125309766|NCT01870726|450760162|FG002|Overall Study|Withdrawal by Subject|0|||
125309767|NCT01870726|450760163|FG003|Overall Study|Withdrawal by Subject|0|||
125309768|NCT01870726|450760164|FG004|Overall Study|Withdrawal by Subject|0|||
125309769|NCT01870726|450760165|FG005|Overall Study|Withdrawal by Subject|0|||
125309770|NCT01870726|450760166|FG006|Overall Study|Withdrawal by Subject|0|||
125309771|NCT01870726|450760160|FG000|Overall Study|Adverse Event|0|||
125309772|NCT01870726|450760161|FG001|Overall Study|Adverse Event|0|||
125309773|NCT01870726|450760162|FG002|Overall Study|Adverse Event|0|||
125309774|NCT01870726|450760163|FG003|Overall Study|Adverse Event|0|||
125309775|NCT01870726|450760164|FG004|Overall Study|Adverse Event|1|||
125309776|NCT01870726|450760165|FG005|Overall Study|Adverse Event|1|||
125309777|NCT01870726|450760166|FG006|Overall Study|Adverse Event|0|||
125309778|NCT01870726|450760160|FG000|Overall Study|Progressive disease|5|||
125309779|NCT01870726|450760161|FG001|Overall Study|Progressive disease|5|||
125309780|NCT01870726|450760162|FG002|Overall Study|Progressive disease|4|||
125309781|NCT01870726|450760163|FG003|Overall Study|Progressive disease|5|||
125309782|NCT01870726|450760164|FG004|Overall Study|Progressive disease|6|||
125309783|NCT01870726|450760165|FG005|Overall Study|Progressive disease|4|||
125309784|NCT01870726|450760166|FG006|Overall Study|Progressive disease|10|||
125309785|NCT00286429|450760167|FG000|Overall Study|Adverse Event|4|||
125309786|NCT00286429|450760168|FG001|Overall Study|Adverse Event|1|||
125309787|NCT00286429|450760169|FG002|Overall Study|Adverse Event|6|||
125309788|NCT00286429|450760167|FG000|Overall Study|Lack of Efficacy|52|||
125309789|NCT00286429|450760168|FG001|Overall Study|Lack of Efficacy|27|||
125309790|NCT00286429|450760169|FG002|Overall Study|Lack of Efficacy|25|||
125309791|NCT00286429|450760167|FG000|Overall Study|Lost to Follow-up|2|||
125309792|NCT00286429|450760168|FG001|Overall Study|Lost to Follow-up|4|||
125309793|NCT00286429|450760169|FG002|Overall Study|Lost to Follow-up|3|||
125309794|NCT00286429|450760167|FG000|Overall Study|Physician Decision|10|||
125309795|NCT00286429|450760168|FG001|Overall Study|Physician Decision|7|||
125309796|NCT00286429|450760169|FG002|Overall Study|Physician Decision|7|||
125309797|NCT00286429|450760167|FG000|Overall Study|Protocol Violation|3|||
125309798|NCT00286429|450760168|FG001|Overall Study|Protocol Violation|5|||
125309799|NCT00286429|450760169|FG002|Overall Study|Protocol Violation|4|||
125309800|NCT00286429|450760167|FG000|Overall Study|Withdrawal by Subject|3|||
125309801|NCT00286429|450760168|FG001|Overall Study|Withdrawal by Subject|2|||
125309802|NCT00286429|450760169|FG002|Overall Study|Withdrawal by Subject|6|||
125309803|NCT00286429|450760167|FG000|Overall Study|Administrative Error|1|||
125309804|NCT00286429|450760168|FG001|Overall Study|Administrative Error|1|||
125309805|NCT00286429|450760169|FG002|Overall Study|Administrative Error|1|||
125309806|NCT00286429|450760167|FG000|Overall Study|Administrative Decision|0|||
125309807|NCT00286429|450760168|FG001|Overall Study|Administrative Decision|1|||
125309808|NCT00286429|450760169|FG002|Overall Study|Administrative Decision|0|||
125309809|NCT00595478|450760172|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
125309810|NCT00595478|450760173|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
125309811|NCT00595478|450760172|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
125309812|NCT00595478|450760173|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
125309813|NCT01123395|450760175|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
125309814|NCT01123395|450760176|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
125309815|NCT03691571|450760177|FG000|Overall Study|Withdrawal by Subject|9|||
125309816|NCT03691571|450760178|FG001|Overall Study|Withdrawal by Subject|2|||
125309817|NCT00186901|450760180|FG000|Overall Study|Pregnancy|6|||
125309818|NCT00186901|450760181|FG001|Overall Study|Pregnancy|3|||
125309819|NCT00186901|450760182|FG002|Overall Study|Pregnancy|0|||
125309820|NCT00186901|450760180|FG000|Overall Study|Lost to Follow-up|6|||
125309821|NCT00186901|450760181|FG001|Overall Study|Lost to Follow-up|3|||
125309822|NCT00186901|450760182|FG002|Overall Study|Lost to Follow-up|0|||
125309823|NCT00186901|450760180|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
125309824|NCT00186901|450760181|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
125309825|NCT00186901|450760182|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
125309826|NCT00186901|450760180|FG000|Overall Study|ALL relapse or second malignancy|1|||
125309827|NCT00186901|450760181|FG001|Overall Study|ALL relapse or second malignancy|2|||
125309828|NCT00186901|450760182|FG002|Overall Study|ALL relapse or second malignancy|0|||
125309829|NCT00186901|450760180|FG000|Overall Study|Withdrawal by Subject|4|||
125309830|NCT00186901|450760181|FG001|Overall Study|Withdrawal by Subject|5|||
125309831|NCT00186901|450760182|FG002|Overall Study|Withdrawal by Subject|0|||
125309832|NCT00186901|450760180|FG000|Overall Study|Open label|3|||
125309833|NCT00186901|450760181|FG001|Overall Study|Open label|2|||
125309834|NCT00186901|450760182|FG002|Overall Study|Open label|0|||
125309835|NCT00186901|450760180|FG000|Overall Study|Limited adherence to study requirements|20|||
125309836|NCT00186901|450760181|FG001|Overall Study|Limited adherence to study requirements|23|||
125309837|NCT00186901|450760182|FG002|Overall Study|Limited adherence to study requirements|0|||
125309838|NCT00186901|450760180|FG000|Overall Study|Bone Mineral Density > 0|0|||
125309839|NCT00186901|450760181|FG001|Overall Study|Bone Mineral Density > 0|0|||
125309840|NCT00186901|450760182|FG002|Overall Study|Bone Mineral Density > 0|149|||
125309841|NCT02363959|450760187|FG000|Overall Study|Medical instability|1|||
125309842|NCT02363959|450760188|FG001|Overall Study|Medical instability|0|||
125309843|NCT00950248|450760191|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
125309844|NCT00950248|450760192|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
125309845|NCT00950248|450760193|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
125309846|NCT00950248|450760191|FG000|Year 1: Baseline|worsening of symptoms|2|||
125309847|NCT00950248|450760192|FG001|Year 1: Baseline|worsening of symptoms|0|||
125309848|NCT00950248|450760193|FG002|Year 1: Baseline|worsening of symptoms|0|||
125309849|NCT00950248|450760191|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
125309850|NCT00950248|450760192|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
125309851|NCT00950248|450760193|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
125309852|NCT00950248|450760191|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
125309853|NCT00950248|450760192|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
125309854|NCT00950248|450760193|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
125309855|NCT00950248|450760191|FG000|Year 2&3 Treatment Randomization|Death|0|||
125309856|NCT00950248|450760192|FG001|Year 2&3 Treatment Randomization|Death|0|||
125309857|NCT00950248|450760193|FG002|Year 2&3 Treatment Randomization|Death|1|||
125309858|NCT00950248|450760191|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
125309859|NCT00950248|450760192|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
125309860|NCT00950248|450760193|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
125309861|NCT00869518|450760197|FG000|Overall Study|Lost to Follow-up|1|||
125309862|NCT00869518|450760198|FG001|Overall Study|Lost to Follow-up|1|||
125309863|NCT00947115|450760199|FG000|Overall Study|Missed reporting interval|3|||
125309864|NCT00947115|450760200|FG001|Overall Study|Missed reporting interval|4|||
125309865|NCT00947115|450760201|FG002|Overall Study|Missed reporting interval|2|||
125309866|NCT00947115|450760199|FG000|Overall Study|Physician Decision|0|||
125309867|NCT00947115|450760200|FG001|Overall Study|Physician Decision|2|||
125309868|NCT00947115|450760201|FG002|Overall Study|Physician Decision|0|||
125309869|NCT00947115|450760199|FG000|Overall Study|Death|0|||
125309870|NCT00947115|450760200|FG001|Overall Study|Death|1|||
125309871|NCT00947115|450760201|FG002|Overall Study|Death|1|||
125309872|NCT00947115|450760199|FG000|Overall Study|Migrated from study area|2|||
125309873|NCT00947115|450760200|FG001|Overall Study|Migrated from study area|0|||
125309874|NCT00947115|450760201|FG002|Overall Study|Migrated from study area|0|||
125309875|NCT00947115|450760199|FG000|Overall Study|Withdrawal by Subject|1|||
125309876|NCT00947115|450760200|FG001|Overall Study|Withdrawal by Subject|3|||
125309877|NCT00947115|450760201|FG002|Overall Study|Withdrawal by Subject|4|||
125309883|NCT00511238|450760204|FG000|Overall Study|Withdrawal by Subject|2|||
125309884|NCT00511238|450760205|FG001|Overall Study|Withdrawal by Subject|22|||
125309885|NCT00511238|450760204|FG000|Overall Study|Progressive Disease|23|||
125309886|NCT00511238|450760205|FG001|Overall Study|Progressive Disease|157|||
125309887|NCT00511238|450760204|FG000|Overall Study|various reasons|4|||
125309888|NCT00511238|450760205|FG001|Overall Study|various reasons|14|||
125309889|NCT02587819|450760206|FG000|Overall Study|Adverse Event|1|||
125309890|NCT02587819|450760206|FG000|Overall Study|Lost to Follow-up|1|||
125309891|NCT03772665|450760207|FG000|Overall Study|Protocol Violation|1|||
125309892|NCT03772665|450760208|FG001|Overall Study|Protocol Violation|0|||
